Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - olfactory bulb [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - olfactory bulb [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
RHO	"CSNBAD1, OPN2, RP4"	ENSG00000163914	Rhodopsin	P08100	3	129528639-129535344	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Vision"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"	"Congenital stationary night blindness, Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6147	"retina: 4097.5"	"Cell type enriched"	"Detected in some"	7	"Rod photoreceptor cells: 4509.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	4	"hippocampal formation: 9.7"	"Region enhanced"	"Detected in single"		"hippocampal formation: 1.1"	"HPA013440, CAB022486, CAB034887, CAB034888"	Enhanced					NA	NA					"CAB022486: , CAB034887: AB_785511, CAB034888: AB_785512, HPA013440: AB_2668844"	"unprognostic (4.32e-2)"			"unprognostic (1.21e-1)"	"unprognostic (1.68e-1)"		"unprognostic (1.83e-1)"	"unprognostic (2.87e-1)"		"unprognostic (1.94e-1)"			"unprognostic (9.19e-11)"	"unprognostic (4.24e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.91e-1)"		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4097.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.6	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	369.9	0.0	0.0	0.6	0.0	0.0	0.0	454.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	26.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	218.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	590.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4509.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
CTRC	"CLCR, ELA4"	ENSG00000162438	"Chymotrypsin C"	Q99895	1	15438442-15449242	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4560	"pancreas: 25923.7"	"Cell type enriched"	"Detected in some"	9	"Exocrine glandular cells: 6566.4"	"Cancer enriched"	"Detected in some"	168	"pancreatic cancer: 236.0"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA046920	Enhanced				"Secreted to digestive system"	NA	NA					"HPA046920: AB_2679865"	"unprognostic (2.62e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.81e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.94e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.34e-1)"	"unprognostic (2.00e-1)"	"unprognostic (9.55e-11)"	"unprognostic (4.98e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.99e-3)"	5.6	1.2	0.3	0.2	0.3	0.7	2.9	0.7	0.5	1.6	0.2	1.1	1.2	1.4	0.1	1.9	0.9	0.0	2.2	0.4	0.1	1.2	3.5	1.0	0.3	0.2	0.2	0.2	5.6	25923.7	0.0	1.5	0.7	0.3	1.8	0.0	0.1	2.1	0.0	1.0	1.7	1.7	0.0	0.2	2.0	2.3	1.0	0.2	0.0	1.1	0.0	0.0	0.6	1.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.1	0.1	0.0	0.0	0.3	0.3	0.7	0.5	0.4	0.1	0.2	0.2	0.2	0.3	0.2	0.2	0.5	0.2	0.0	0.5	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.7	0.0	0.0	17.3	0.0	0.6	1.0	0.7	0.0	0.0	0.2	6566.4	0.1	0.2	0.0	2.1	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.9	0.0	0.0	1.1	1.8	0.0	24.3	0.0	1.0	0.0	0.0	673.8	0.0	0.0	0.1	0.3	0.4	0.1	0.0	0.0	0.0	1.3	3.5	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.1	0.3
SPP2	SPP24	ENSG00000072080	"Secreted phosphoprotein 2"	Q13103	2	234050679-234077134	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	4368	"liver: 523.3"	"Cell type enriched"	"Detected in some"	20	"Hepatocytes: 258.7"	"Cancer enriched"	"Detected in some"	112	"liver cancer: 65.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA		480000000										"prognostic favorable (2.33e-6)"	"unprognostic (7.02e-3)"		"unprognostic (9.62e-3)"								0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	523.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	3.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	5.3	0.3	0.6	0.0	0.7	0.0	0.1	5.1	0.0	5.0	258.7	0.1	0.0	0.1	0.0	0.0	3.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0
AHSG	"A2HS, FETUA, HSGA"	ENSG00000145192	"Alpha 2-HS glycoprotein"	P02765	3	186613060-186621318	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Mineral balance"		"Cancer-related genes, Disease variant, Hypotrichosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4297	"liver: 5864.7"	"Cell type enriched"	"Detected in some"	38	"Hepatocytes: 1242.5"	"Cancer enriched"	"Detected in some"	284	"liver cancer: 1231.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	78	"Hep G2: 2287.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001524, HPA001525, CAB026209"	Enhanced		Enhanced	"Golgi apparatus"	"Secreted to blood"	NA	NA	864000000000	110000000000	"Golgi apparatus"		"CAB026209: , HPA001524: AB_1078851, HPA001525: AB_1078849"		"unprognostic (6.40e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.47e-3)"	"unprognostic (3.05e-1)"	"unprognostic (5.27e-2)"	"unprognostic (8.64e-2)"		"unprognostic (3.99e-7)"	"unprognostic (5.21e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.04e-1)"		0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	1.3	5864.7	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.2	0.0	0.7	0.7	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.9	1.0	2287.3	0.0	4.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.1	3.5	0.0	0.0	1.1	0.2	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.4	0.0	1.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.2	0.0	0.0	0.0	0.2	0.0	0.1	3.9	0.2	4.3	0.2	0.1	0.9	0.0	32.0	0.6	0.6	2.4	0.1	0.0	0.1	0.0	0.0	28.2	1242.5	1.3	0.0	0.1	0.0	0.0	32.4	0.0	23.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.9	2.0	0.0	0.0	0.1
PGA5		ENSG00000256713	"Pepsinogen A5"	P0DJD9	11	61241175-61251444	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Aspartyl protease, Hydrolase, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	3701	"stomach 1: 40192.3"	"Cell type enriched"	"Detected in some"	77	"Exocrine glandular cells: 4383.1"	"Cancer enriched"	"Detected in some"	12	"stomach cancer: 15.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	29	"classical monocyte: 1.8;intermediate monocyte: 4.3;non-classical monocyte: 2.4"	"Lineage enriched"	"Detected in single"	44	"monocytes: 4.3"	"Cell line enriched"	"Detected in some"	19	"BJ hTERT+: 28.8"									HPA046875	Supported				"Secreted to digestive system"	NA	NA					"HPA046875: AB_2679851"				"unprognostic (1.36e-3)"	"unprognostic (2.98e-2)"		"unprognostic (5.83e-3)"			"unprognostic (2.11e-1)"	"unprognostic (4.22e-1)"		"unprognostic (4.36e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.10e-2)"		10.8	4.4	0.4	1.1	0.3	0.0	4.5	0.1	0.4	2.9	0.0	4.0	0.6	1.9	0.0	7.0	5.1	0.1	2.9	0.8	0.2	2.4	7.1	5.5	0.0	0.1	0.1	0.6	2.6	8.3	0.0	3.8	0.5	0.1	1.8	0.1	1.5	2.5	0.5	1.9	2.2	2.1	0.9	0.0	4.0	40192.3	2.3	0.0	0.2	3.1	0.2	0.1	2.4	2.5	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	28.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.3	0.4	0.3	0.1	0.4	0.8	0.2	0.1	0.1	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.5	0.0	0.0	0.0	0.0	0.0	0.1	4383.1	0.0	0.1	56.6	0.0	0.0	0.2	0.0	0.0	6.7	0.0	0.0	0.0	0.0	5.1	0.0	1.6	0.9	1.3	0.0	0.0	1.0	25.1	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0
MBL2	"COLEC1, MBL"	ENSG00000165471	"Mannose binding lectin 2"	P11226	10	52765380-52772784	"Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement activation lectin pathway, Complement pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	2833	"liver: 283.2"	"Cell type enriched"	"Detected in some"	66	"Hepatocytes: 238.5"	"Cancer enriched"	"Detected in single"	275	"liver cancer: 22.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	10	"Hep G2: 2.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	11	"basal ganglia: 1.1"	"HPA002027, CAB016782"	Enhanced				"Secreted to blood"	NA	NA	1220000000	1900000000			"CAB016782: , HPA002027: AB_1079324"							"unprognostic (1.72e-2)"		"unprognostic (3.03e-1)"									0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	283.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	238.5	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0
CFHR2	"CFHL2, FHR2, HFL3"	ENSG00000080910	"Complement factor H related 2"	P36980	1	196943738-196959622	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	2749	"liver: 1322.7"	"Cell type enriched"	"Detected in some"	14	"Hepatocytes: 38.5"	"Cancer enriched"	"Detected in single"	175	"liver cancer: 8.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA038915, HPA040726, HPA049813"	Supported				"Secreted to blood"	NA	NA		4800000000			"HPA038915: AB_2676269, HPA040726: AB_2677101, HPA049813: AB_2680895"							"unprognostic (1.25e-2)"											0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.4	1322.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	38.5	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
OPN1LW	"CBBM, CBP, COD5, RCP"	ENSG00000102076	"Opsin 1, long wave sensitive"	P04000	X	154144243-154159032	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Vision"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	2590	"retina: 259.0"	"Cell type enriched"	"Detected in some"	20	"Cone photoreceptor cells: 725.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA															"unprognostic (6.05e-2)"								0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	259.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	725.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.9	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
F9	FIX	ENSG00000101981	"Coagulation factor IX"	P00740	X	139530739-139563459	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets, Hemophilia, Thrombophilia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	2470	"liver: 710.7"	"Cell type enriched"	"Detected in some"	32	"Hepatocytes: 609.1"	"Cancer enriched"	"Detected in single"	1354	"liver cancer: 67.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA		8200000000										"prognostic favorable (6.69e-4)"											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	710.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	609.1	0.0	0.0	0.1	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0
CTRB2		ENSG00000168928	"Chymotrypsinogen B2"	Q6GPI1	16	75204103-75207161	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	2442	"pancreas: 99499.3"	"Cell type enriched"	"Detected in some"	9	"Exocrine glandular cells: 53114.3"	"Cancer enriched"	"Detected in single"	1696	"pancreatic cancer: 540.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.4;U-2 OS: 5.8;U-251 MG: 1.6;U-266/84: 1.8;U-698: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to digestive system"	NA	NA							"unprognostic (9.41e-4)"			"unprognostic (2.20e-1)"	"unprognostic (1.28e-2)"		"unprognostic (2.10e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.77e-1)"	"unprognostic (5.95e-2)"	"unprognostic (9.56e-2)"	"unprognostic (3.54e-3)"	"unprognostic (7.06e-2)"	"unprognostic (2.17e-1)"	"unprognostic (7.57e-2)"		20.5	4.9	0.3	1.5	0.2	1.9	9.2	0.5	0.4	5.2	0.1	4.4	9.2	4.8	0.1	6.7	3.8	0.2	13.9	0.2	0.2	4.4	12.9	3.1	2.9	0.2	0.2	0.2	40.7	99499.3	0.0	5.7	5.7	0.2	11.9	0.0	0.0	16.8	0.1	3.7	4.3	6.6	0.0	0.2	7.3	8.1	3.7	0.2	0.0	3.1	0.0	0.0	2.8	4.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.8	0.0	1.6	0.0	1.8	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.5	0.4	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	108.8	2.0	0.3	0.0	1.5	0.0	0.0	0.0	53114.3	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.3	6.0	0.0	0.0	215.5	0.0	0.0	0.0	0.0	5324.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	30.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1
CTRB1	CTRB	ENSG00000168925	"Chymotrypsinogen B1"	P17538	16	75218988-75226338	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	2383	"pancreas: 134989.3"	"Cell type enriched"	"Detected in some"	21	"Exocrine glandular cells: 31269.6"	"Cancer enriched"	"Detected in some"	1905	"pancreatic cancer: 962.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.2;HDLM-2: 1.6"														"Secreted to digestive system"	NA	NA										"unprognostic (1.76e-1)"				"unprognostic (2.62e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.22e-2)"	"unprognostic (4.43e-3)"	"unprognostic (2.96e-1)"		"unprognostic (1.17e-2)"		21.1	5.1	0.3	2.1	0.2	1.1	9.6	0.5	0.3	6.1	0.0	3.9	16.8	4.2	0.5	6.9	3.0	0.0	22.5	0.3	0.1	4.3	13.3	2.9	2.7	0.1	0.1	0.0	56.6	134989.3	0.0	7.2	6.6	0.1	5.6	0.0	0.0	22.5	0.2	3.9	4.7	8.9	0.0	0.1	11.8	7.6	3.5	0.2	0.0	2.8	0.1	0.0	2.4	3.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.1	0.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.5	0.3	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.7	0.0	0.1	0.1	2.0	0.0	0.0	0.1	31269.6	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	151.9	0.0	0.0	0.0	0.1	1430.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	7.9	0.0	0.2	0.0	0.0	0.0	0.0	1.2	0.0	0.0
PNLIPRP1	PLRP1	ENSG00000187021	"Pancreatic lipase related protein 1"	P54315	10	116590385-116609175	"Metabolic proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	2341	"pancreas: 10916.9"	"Cell type enriched"	"Detected in some"	10	"Exocrine glandular cells: 688.3"	"Cancer enriched"	"Detected in single"	476	"pancreatic cancer: 32.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-266/84: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to digestive system"	NA	NA		340000						"unprognostic (1.21e-1)"	"unprognostic (4.08e-3)"						"unprognostic (1.40e-1)"	"unprognostic (1.80e-1)"		"unprognostic (2.76e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.49e-1)"		1.5	0.2	0.0	0.2	0.0	0.3	0.6	0.0	0.0	0.5	0.0	0.2	2.1	0.3	0.0	0.4	0.1	0.0	2.0	0.0	0.0	0.2	0.8	0.2	0.4	0.0	0.0	0.0	4.6	10916.9	0.0	0.5	0.8	0.0	0.4	0.1	0.0	2.7	0.0	0.2	0.4	1.1	0.0	0.0	0.4	1.1	0.3	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.8	0.0	0.0	0.1	0.0	0.0	0.0	688.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	3.4	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.1	66.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.3
CPA1	CPA	ENSG00000091704	"Carboxypeptidase A1"	P15085	7	130380339-130388114	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	2324	"pancreas: 239516.8"	"Cell type enriched"	"Detected in some"	19	"Exocrine glandular cells: 10133.0"	"Cancer enriched"	"Detected in some"	639	"pancreatic cancer: 1377.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"AN3-CA: 11.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA021836, CAB025197, HPA052215"	Enhanced				"Secreted to digestive system"	NA	NA		110000000			"CAB025197: , HPA021836: AB_1846005, HPA052215: AB_2681764"	"unprognostic (8.41e-2)"			"unprognostic (9.24e-4)"	"unprognostic (5.22e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.76e-1)"		"unprognostic (2.27e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.34e-6)"	"unprognostic (4.99e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.37e-2)"	23.3	4.8	0.2	5.6	0.2	4.7	13.7	0.1	0.2	7.1	0.9	4.2	33.9	5.0	0.1	7.0	3.7	0.2	43.9	0.2	0.2	4.6	13.0	3.3	8.8	0.1	0.1	0.1	103.0	239516.8	0.0	5.1	18.5	0.2	7.0	0.0	0.2	39.9	0.1	4.7	6.6	21.0	0.4	0.2	7.8	21.5	5.5	0.1	0.1	3.0	0.4	0.0	2.8	4.0	0.4	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.7	0.0	0.2	0.0	1.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.2	0.2	0.1	0.1	0.1	0.2	0.2	0.1	0.4	0.1	3.2	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.9	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	5.9	12.0	1.9	0.0	0.1	0.1	0.0	0.0	0.0	10133.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.9	1.2	0.0	1.0	44.5	2.1	0.0	0.0	0.0	527.2	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.1	0.0	16.2	2.7	0.9	5.5	0.0	0.0	1.6	0.0	2.5	0.0	0.1
CELA2A	ELA2A	ENSG00000142615	"Chymotrypsin like elastase 2A"	P08217	1	15456728-15472091	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Diabetes mellitus, Disease variant, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	2323	"pancreas: 164113.1"	"Cell type enriched"	"Detected in some"	34	"Exocrine glandular cells: 7828.2"	"Cancer enriched"	"Detected in single"	3818	"pancreatic cancer: 463.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HMC-1: 1.2"														"Secreted to digestive system"	NA	NA		2700000				"unprognostic (9.78e-2)"	"unprognostic (3.33e-2)"		"unprognostic (5.60e-2)"	"unprognostic (5.27e-2)"	"unprognostic (3.63e-3)"		"unprognostic (2.35e-1)"	"unprognostic (4.14e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.94e-9)"	"unprognostic (4.10e-2)"		"unprognostic (3.42e-1)"	"unprognostic (3.55e-2)"	7.1	5.6	0.2	2.6	0.0	1.1	4.5	0.2	0.1	2.3	0.0	1.6	18.7	2.1	0.0	2.3	1.1	0.0	27.1	0.0	0.0	1.6	5.8	1.2	4.3	0.0	0.0	0.0	70.6	164113.1	0.0	1.3	10.3	0.0	2.8	0.0	0.0	28.2	0.0	1.6	1.8	8.8	0.0	0.0	2.3	15.5	2.0	0.0	0.0	1.1	0.0	0.0	0.9	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	5.8	0.1	0.3	0.3	0.3	0.0	0.0	1.1	7828.2	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	1.3	0.0	0.0	20.7	0.0	0.0	0.0	0.1	227.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.1
CELA3A	"ELA3, ELA3A"	ENSG00000142789	"Chymotrypsin like elastase 3A"	P09093	1	22001657-22012542	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	2214	"pancreas: 264842.4"	"Cell type enriched"	"Detected in some"	56	"Exocrine glandular cells: 34710.4"	"Cancer enriched"	"Detected in some"	2497	"pancreatic cancer: 1481.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	28	"MOLT-4: 24.9"									"HPA028086, HPA045650"	Supported		Approved	Cytosol	"Secreted to digestive system"	NA	NA			Cytosol		"HPA028086: AB_2672482, HPA045650: AB_2679407"			"unprognostic (1.27e-1)"	"unprognostic (2.71e-1)"							"unprognostic (1.79e-1)"			"unprognostic (6.32e-2)"	"unprognostic (2.67e-1)"			18.4	4.5	0.0	3.0	0.0	2.8	11.7	0.0	0.0	7.4	0.0	4.2	21.5	4.2	0.0	7.4	3.1	0.1	45.0	0.0	0.0	4.1	13.6	3.1	6.1	0.0	0.0	0.0	119.6	264842.4	0.0	6.9	15.0	0.0	8.9	0.0	0.0	44.4	0.0	3.9	4.5	12.3	0.0	0.0	6.3	48.0	3.2	0.0	0.3	3.1	0.0	0.0	2.9	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	25.5	40.7	0.1	0.0	0.6	0.0	0.0	0.1	34710.4	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	197.1	0.3	2.4	0.0	0.0	94.0	0.0	0.0	0.0	0.0	619.0	1.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.8	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CELA3B	"CBPP, ELA3B"	ENSG00000219073	"Chymotrypsin like elastase 3B"	P08861	1	21977022-21998642	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	2086	"pancreas: 50042.6"	"Cell type enriched"	"Detected in some"	45	"Exocrine glandular cells: 14881.1"	"Cancer enriched"	"Detected in single"	1218	"pancreatic cancer: 408.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA028086, HPA045650"	Supported		Approved	Cytosol	"Secreted to digestive system"	NA	NA			Cytosol		"HPA028086: AB_2672482, HPA045650: AB_2679407"			"unprognostic (2.89e-1)"	"unprognostic (4.01e-3)"						"unprognostic (6.53e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.29e-1)"		"unprognostic (6.40e-2)"				7.9	1.8	0.0	0.6	0.0	0.8	4.6	0.0	0.0	2.6	0.0	1.7	6.3	1.7	0.1	2.6	1.2	0.0	8.4	0.0	0.0	1.6	5.1	1.2	1.1	0.0	0.0	0.0	23.9	50042.6	0.0	2.2	3.5	0.0	3.1	0.1	0.0	9.6	0.0	1.6	1.6	2.7	0.0	0.0	2.3	17.4	2.5	0.0	0.0	1.2	0.0	0.0	1.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	10.4	78.6	0.3	0.0	0.6	0.0	0.0	0.2	14881.1	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	309.9	0.9	0.9	0.0	0.0	60.4	0.0	0.0	0.0	0.2	325.6	16.0	0.7	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0
PNLIP	PL	ENSG00000175535	"Pancreatic lipase"	P16233	10	116545931-116567855	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	2057	"pancreas: 448477.5"	"Cell type enriched"	"Detected in some"	8	"Exocrine glandular cells: 4086.8"	"Cancer enriched"	"Detected in some"	4854	"pancreatic cancer: 2731.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-2 OS: 1.3"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA062430, HPA062494"	Enhanced				"Secreted to digestive system"	NA	NA		14000000			"HPA062430: AB_2684761, HPA062494: AB_2684782"											"unprognostic (2.05e-2)"	"unprognostic (4.46e-2)"						13.1	3.1	0.0	10.6	0.0	1.1	8.9	0.0	0.0	4.1	0.0	3.1	65.3	9.1	0.4	4.8	1.5	0.0	78.9	0.0	0.0	3.0	10.2	2.1	17.1	0.0	0.0	0.0	218.0	448477.5	0.0	2.5	24.6	0.0	4.6	0.0	0.0	72.3	0.0	2.9	3.7	34.2	0.0	0.0	3.8	28.5	2.3	0.0	0.0	2.0	0.0	0.0	1.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.3	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.5	0.0	0.0	0.3	0.0	0.0	0.1	4086.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.0	0.0	14.5	0.0	0.0	0.5	0.1	507.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1
AMY2A	AMY2	ENSG00000243480	"Amylase alpha 2A"	P04746	1	103616811-103625780	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted secreted proteins"	"Carbohydrate metabolism"	"Glycosidase, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1982	"pancreas: 149956.9"	"Cell type enriched"	"Detected in some"	114	"Exocrine glandular cells: 1016.0"	"Cancer enriched"	"Detected in single"	2010	"pancreatic cancer: 200.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045394, HPA045399, CAB045960, HPA046980"	Enhanced				"Secreted to digestive system"	NA	NA					"CAB045960: AB_2226891, HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889"					"unprognostic (3.27e-1)"					"unprognostic (1.78e-3)"	"unprognostic (3.24e-2)"			"unprognostic (1.29e-1)"		"unprognostic (2.13e-2)"		5.3	1.3	1.3	2.9	1.5	0.3	3.9	0.8	1.4	1.9	0.8	1.4	22.7	2.9	0.1	2.3	0.8	0.0	26.9	1.3	1.2	1.5	4.7	1.0	5.5	1.0	1.0	1.3	75.6	149956.9	0.1	1.5	8.4	1.1	2.1	0.0	0.6	30.3	0.0	1.5	1.4	10.8	0.0	0.8	1.8	2.2	1.2	1.1	0.0	1.1	0.0	0.0	0.5	1.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.5	0.8	1.4	1.3	1.2	1.0	1.0	1.3	1.1	0.8	1.1	1.4	0.1	0.0	0.0	2.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.1	0.0	0.0	0.2	0.0	0.0	1.3	1016.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	4.6	0.0	0.0	0.0	0.1	8.9	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.2	0.1	0.4	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.6
CPB1		ENSG00000153002	"Carboxypeptidase B1"	P15086	3	148791102-148860187	"Enzymes, Plasma proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1969	"pancreas: 228861.2"	"Cell type enriched"	"Detected in some"	12	"Exocrine glandular cells: 7306.0"	"Group enriched"	"Detected in some"	312	"breast cancer: 293.8;pancreatic cancer: 641.4"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"basophil: 4.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.0;U-2 OS: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB026158, HPA038069, HPA046340"	Enhanced				"Secreted to digestive system"	NA	NA		88000000			"CAB026158: , HPA038069: AB_2675816, HPA046340: AB_2679628"	"unprognostic (6.90e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.27e-2)"	"unprognostic (6.26e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.59e-2)"	"unprognostic (4.51e-2)"	"unprognostic (5.50e-8)"	"unprognostic (3.08e-1)"	"unprognostic (1.60e-1)"		"unprognostic (4.93e-2)"	12.1	83.7	0.4	5.1	1.5	2.5	79.2	0.5	1.0	3.6	0.2	2.7	31.5	4.8	0.3	3.5	1.8	0.1	41.1	0.5	0.7	2.0	7.1	1.7	8.2	1.0	1.1	0.2	116.2	228861.2	0.0	2.1	13.8	1.2	4.8	4.5	0.0	36.6	0.0	2.3	2.4	17.3	0.0	0.3	19.4	28.5	2.9	0.9	0.1	1.6	0.0	0.0	1.5	2.1	3.4	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.5	0.0	0.9	0.2	0.0	0.0	0.0	4.0	0.3	0.5	1.3	0.4	0.9	0.4	0.5	1.1	0.1	0.7	0.3	1.4	1.9	1.4	0.5	0.5	0.3	0.4	0.4	1.5	0.5	1.0	0.5	0.7	1.0	1.1	0.2	1.2	0.3	0.9	3.4	2.2	0.0	0.0	1.0	0.0	0.6	0.5	0.0	0.0	0.0	8.7	1.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	11.6	11.2	0.0	0.1	1.1	164.9	1.3	0.3	7306.0	0.0	36.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.2	0.0	0.0	1.0	2.5	0.6	1.5	0.0	0.0	18.1	0.0	0.0	0.0	29.8	590.0	0.1	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	4.2	2.5	0.0	1.1	0.1	0.3	0.3	0.3	1.1	0.2	0.2
PRSS1	TRY1	ENSG00000204983	"Serine protease 1"	P07477	7	142749468-142753076	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1921	"pancreas: 344337.9"	"Cell type enriched"	"Detected in some"	28	"Exocrine glandular cells: 57138.3"	"Cancer enriched"	"Detected in many"	224	"pancreatic cancer: 1920.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	23	"OE19: 10.6;RPMI-8226: 4.5;U-2 OS: 2.8"									"CAB025487, CAB025538, HPA062452, HPA063471"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to digestive system"	NA	NA		100000000000	Vesicles	"Endoplasmic reticulum"	"CAB025487: , CAB025538: , HPA062452: AB_2684768, HPA063471: AB_2685017"	"unprognostic (6.55e-5)"	"unprognostic (5.28e-1)"	"unprognostic (7.58e-2)"	"prognostic unfavorable (6.41e-6)"				"unprognostic (8.26e-2)"		"prognostic favorable (7.05e-4)"	"unprognostic (1.35e-1)"			"unprognostic (3.93e-2)"	"unprognostic (1.96e-1)"	"prognostic favorable (4.91e-4)"	"unprognostic (3.12e-1)"	39.2	10.0	0.0	4.7	0.0	0.0	25.9	0.0	0.0	11.7	0.0	9.6	55.0	8.9	0.8	15.3	5.7	0.0	51.5	0.0	0.0	9.5	30.0	6.5	6.5	0.0	0.0	0.0	179.2	344337.9	0.1	10.4	14.0	0.0	15.3	0.0	0.0	44.6	4.3	9.0	10.1	12.8	0.0	0.0	13.5	77.7	6.9	0.0	0.0	6.4	0.0	0.0	4.7	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	100.7	0.0	0.1	0.0	3.6	0.0	0.0	0.0	57138.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	119.4	0.6	0.0	0.0	0.0	1985.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.6	0.0	0.1	0.1	0.2	0.2
GKN1	"AMP18, BRICD1, CA11"	ENSG00000169605	"Gastrokine 1"	Q9NS71	2	68974573-68980980	"Plasma proteins, Predicted secreted proteins"		Mitogen		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1842	"stomach 1: 37772.3"	"Cell type enriched"	"Detected in some"	28	"Gastric mucus-secreting cells: 9780.9"	"Cancer enriched"	"Detected in some"	116	"stomach cancer: 255.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 6.5;HMC-1: 17.2;MOLT-4: 12.4;NTERA-2: 16.0;REH: 7.2;U-2 OS: 10.1;U-266/70: 10.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA047684	Enhanced				"Secreted to digestive system"	NA	NA		18000000			"HPA047684: AB_2680120"						"unprognostic (5.40e-2)"					"prognostic unfavorable (1.54e-4)"			"unprognostic (4.54e-1)"			"prognostic favorable (4.53e-4)"	1.6	1.8	0.0	0.1	0.0	0.0	1.3	0.0	0.1	0.4	0.0	1.3	0.0	0.3	0.0	3.6	0.4	0.0	0.6	0.0	0.0	1.8	0.8	3.5	0.0	0.0	0.0	0.0	0.4	4.8	0.0	0.3	20.5	0.0	0.7	0.3	0.0	0.4	0.1	1.0	0.5	0.4	0.0	0.0	10.5	37772.3	0.4	0.0	1.1	0.2	0.2	0.1	1.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.2	0.1	0.0	6.5	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	12.4	0.0	16.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	10.1	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.3	3.3	9780.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	346.5	0.0	0.0	26.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.6	0.5	0.0	0.0
PGA4		ENSG00000229183	"Pepsinogen A4"	P0DJD7	11	61222349-61231694	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1759	"stomach 1: 67237.8"	"Cell type enriched"	"Detected in some"	8	"Exocrine glandular cells: 109.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"classical monocyte: 9.9;intermediate monocyte: 10.9;non-classical monocyte: 3.4"	"Lineage enriched"	"Detected in single"	26	"monocytes: 10.9"	"Group enriched"	"Detected in some"	6	"BJ hTERT+: 26.1;HMC-1: 9.5;THP-1: 15.7"									HPA046875	Supported				"Secreted to digestive system"	NA	NA					"HPA046875: AB_2679851"										"unprognostic (2.22e-1)"								7.8	8.4	0.0	2.1	0.0	0.0	9.0	0.0	0.2	5.5	0.0	28.4	2.5	4.6	0.0	9.1	19.2	0.3	5.0	0.1	0.0	30.6	11.8	38.2	0.0	0.0	0.0	0.0	4.1	19.0	0.0	3.6	3.8	0.1	16.4	0.4	0.3	4.6	0.7	2.5	3.8	2.9	0.8	0.1	5.2	67237.8	4.4	0.0	0.1	3.1	0.0	0.2	5.1	5.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.1	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.0	0.0	1.6	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	1.1	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.3	0.0	3.4	0.0	0.0	1.8	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	109.1	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CLPS		ENSG00000137392	Colipase	P04118	6	35794982-35797344	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Digestion, Lipid degradation, Lipid metabolism"		"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1695	"pancreas: 264335.0"	"Cell type enriched"	"Detected in some"	17	"Exocrine glandular cells: 23175.0"	"Cancer enriched"	"Detected in many"	188	"pancreatic cancer: 1726.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA010512	Enhanced				"Secreted to digestive system"	NA	NA		1600000			"HPA010512: AB_1846979"	"unprognostic (2.00e-1)"			"unprognostic (1.11e-1)"						"unprognostic (8.12e-3)"	"unprognostic (2.47e-1)"			"unprognostic (1.33e-1)"	"unprognostic (1.61e-1)"			27.2	6.1	0.5	5.8	1.5	9.1	17.9	0.1	0.7	7.8	0.2	5.7	40.6	6.1	5.7	10.0	3.9	0.0	46.8	1.1	0.0	5.4	17.8	4.1	10.6	0.5	0.3	0.6	155.9	264335.0	0.0	6.4	12.0	0.3	8.0	0.0	0.0	42.1	0.0	5.8	7.3	24.2	0.0	0.1	8.0	27.9	4.0	0.4	0.0	3.9	0.0	0.0	3.3	5.2	0.8	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.6	0.3	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.5	1.5	0.1	0.7	1.1	0.0	0.5	0.3	0.6	0.3	0.1	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	28.6	0.0	0.0	0.0	1.1	11.9	0.0	0.0	23175.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	130.8	0.0	0.0	0.0	0.0	1331.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CFHR5	"CFHL5, FHR-5, FHR5"	ENSG00000134389	"Complement factor H related 5"	Q9BXR6	1	196977556-197009678	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"			"Disease variant, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	1689	"liver: 168.8"	"Cell type enriched"	"Detected in some"	19	"Hepatocytes: 102.7"	"Cancer enriched"	"Detected in single"	396	"liver cancer: 57.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA038915, HPA040726"	Supported				"Secreted to blood"	NA	NA		1900000000			"HPA038915: AB_2676269, HPA040726: AB_2677101"							"unprognostic (9.12e-3)"											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	168.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	102.7	0.0	0.0	0.1	0.0	0.0	3.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0
CELA2B	"ELA2B, RP11-265F14.2"	ENSG00000215704	"Chymotrypsin like elastase 2B"	P08218	1	15465909-15491395	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1671	"pancreas: 20621.8"	"Cell type enriched"	"Detected in some"	73	"Exocrine glandular cells: 1227.6"	"Cancer enriched"	"Detected in single"	574	"pancreatic cancer: 69.9"	"Region enhanced"	"Detected in some"		"cerebral cortex: 3.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"U-138 MG: 3.9"														"Secreted to digestive system"	NA	NA						"unprognostic (4.36e-3)"	"unprognostic (5.45e-2)"	"unprognostic (6.66e-2)"	"unprognostic (5.31e-3)"	"unprognostic (4.47e-3)"	"unprognostic (1.37e-3)"	"unprognostic (4.66e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.94e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.22e-6)"	"unprognostic (2.47e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.80e-2)"	0.9	3.0	0.4	0.5	0.1	1.0	0.6	2.0	3.2	0.2	0.0	0.1	3.8	0.4	0.1	0.3	0.1	0.6	4.5	0.4	0.5	0.2	0.6	0.3	1.2	0.1	0.2	0.0	12.3	20621.8	0.0	0.1	1.2	0.7	0.3	0.0	1.7	3.4	0.0	0.3	1.0	2.4	0.0	0.6	0.3	1.2	0.7	0.5	0.0	0.8	0.0	0.0	0.1	0.1	0.6	0.0	0.6	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.5	0.8	0.4	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.1	0.0	0.0	3.9	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.1	2.0	3.2	0.4	0.5	0.1	0.2	0.0	0.7	0.6	0.5	0.6	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.1	0.0	0.0	0.0	0.0	1.4	1227.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.5	0.1	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0
F2		ENSG00000180210	"Coagulation factor II, thrombin"	P00734	11	46719196-46739506	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	1655	"liver: 1227.2"	"Cell type enriched"	"Detected in some"	26	"Hepatocytes: 991.0"	"Cancer enriched"	"Detected in some"	110	"liver cancer: 508.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	22	"Hep G2: 281.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB016780, HPA051476, HPA054698"	Enhanced				"Secreted to blood"	NA	NA	108000000000	41000000000			"CAB016780: , HPA051476: AB_2681498, HPA054698: AB_2682578"	"unprognostic (1.98e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.94e-2)"		"unprognostic (5.79e-2)"	"unprognostic (8.29e-2)"	"unprognostic (4.46e-2)"	"prognostic unfavorable (6.75e-12)"	"unprognostic (5.65e-3)"	"unprognostic (5.80e-2)"		"unprognostic (1.54e-3)"	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.7	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.2	1227.2	0.0	0.0	0.2	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.3	0.5	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.9	0.0	0.2	2.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.5	0.2	281.0	0.0	1.5	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.7	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.1	0.2	0.4	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	20.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.2	0.0	37.5	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.3	21.8	991.0	0.0	0.0	0.2	0.2	0.0	26.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	2.0	0.0	0.0	0.1
CUZD1	"ERG-1, UO-44"	ENSG00000138161	"CUB and zona pellucida like domains 1"	Q86UP6	10	122832158-122846175	"Predicted membrane proteins"	"Cell adhesion, Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	1632	"pancreas: 2434.7"	"Cell type enriched"	"Detected in some"	6	"Exocrine glandular cells: 266.9"	"Cancer enriched"	"Detected in some"	54	"pancreatic cancer: 32.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-HME1: 1.9;U-937: 1.2"	"Not detected"	"Not detected"							"HPA068479, HPA068660, HPA074117"	Enhanced		Approved	Nucleoli,Vesicles		No	No			Nucleoli	Vesicles	"HPA068479: AB_2685995, HPA068660: AB_2686015, HPA074117: AB_2686663"	"unprognostic (4.68e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.52e-5)"	"unprognostic (8.08e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.16e-4)"	"unprognostic (4.19e-2)"	"unprognostic (3.03e-2)"	"unprognostic (5.15e-2)"	"unprognostic (8.46e-2)"	"unprognostic (6.64e-3)"	"unprognostic (2.75e-3)"	"unprognostic (4.48e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.83e-4)"	0.4	0.2	0.4	0.2	0.4	0.8	0.4	0.4	0.5	0.6	0.4	0.5	0.5	0.4	0.4	0.5	0.5	0.0	0.4	0.5	0.4	0.8	0.2	0.5	0.2	0.5	0.4	0.4	1.0	2434.7	0.0	1.4	0.1	0.6	0.7	0.0	0.4	0.5	0.0	0.1	0.7	0.9	0.0	0.4	1.1	0.4	1.0	0.4	0.3	0.5	0.0	0.0	0.5	0.5	0.5	0.3	0.5	0.1	0.0	0.0	0.3	0.4	0.1	0.1	0.0	0.7	0.0	0.1	0.1	0.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.9	0.1	0.2	0.3	0.3	0.3	1.0	0.1	0.4	0.3	0.4	0.4	0.0	0.0	0.4	0.0	0.4	0.1	0.4	0.2	0.3	0.0	0.3	0.5	0.4	0.6	0.5	0.0	0.5	0.2	0.0	0.0	0.4	0.8	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.4	0.4	0.5	0.5	0.4	0.5	0.4	0.4	0.6	0.4	0.4	0.5	0.2	0.0	0.0	0.0	0.2	0.6	0.2	0.0	0.0	0.7	0.2	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.9	2.8	0.1	0.1	0.1	0.0	0.4	0.0	266.9	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	5.0	0.0	0.1	0.0	0.3	0.3	6.7	0.3	0.1	0.0	0.0	3.7	0.1	0.0	0.0	0.0	43.6	0.1	0.4	0.2	0.1	0.0	0.0	0.1	0.5	0.0	0.4	0.1	0.7	0.2	0.0	0.1	0.0	0.7	0.1	0.2	0.1
BPIFA2	"bA49G10.1, C20orf70, PSP, SPLUNC2"	ENSG00000131050	"BPI fold containing family A member 2"	Q96DR5	20	33161768-33181412	"Predicted secreted proteins"		"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	1618	"salivary gland: 6917.3"	"Cell type enriched"	"Detected in some"	4	"Ionocytes: 649.0"	"Group enriched"	"Detected in some"	4	"lung cancer: 2.6;pancreatic cancer: 2.9;stomach cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 1.0;RT4: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044006	Enhanced				"Secreted to digestive system"	NA	NA					"HPA044006: AB_10963580"							"unprognostic (9.10e-3)"	"unprognostic (1.22e-1)"		"unprognostic (1.95e-1)"	"unprognostic (3.56e-2)"		"unprognostic (3.03e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.14e-4)"	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.1	0.0	0.9	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.8	4.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6917.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	49.3	0.0	0.0	0.0	0.0	0.2	0.0	145.2	3.7	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	649.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	17.3	0.0	0.0	0.0	8.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5
PLA2G1B	"PLA2, PLA2A, PPLA2"	ENSG00000170890	"Phospholipase A2 group IB"	P04054	12	120322115-120327779	"Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Lipid metabolism, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1518	"pancreas: 118708.0"	"Cell type enriched"	"Detected in many"	17	"Exocrine glandular cells: 20351.4"	"Cancer enriched"	"Detected in many"	185	"pancreatic cancer: 763.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 2.5;U-2 OS: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA047822, HPA060803"	Enhanced				"Secreted to digestive system"	NA	NA		3900000			"HPA047822: AB_2680169, HPA060803: AB_2684369"	"unprognostic (1.28e-4)"	"unprognostic (6.02e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.80e-4)"	"unprognostic (2.15e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.60e-1)"	"unprognostic (8.61e-4)"	8.8	6.5	0.2	1.7	0.1	3.0	5.8	0.2	0.6	3.4	0.0	2.1	16.0	2.3	0.0	3.3	1.8	0.9	21.7	0.2	0.3	2.7	7.2	32.4	4.0	0.1	0.1	0.1	78.2	118708.0	0.0	4.5	6.1	0.2	4.4	0.3	0.7	21.5	0.0	2.0	3.4	7.8	0.1	0.2	3.0	8.7	4.3	0.1	0.3	1.5	0.0	0.0	1.3	2.0	0.1	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.4	0.1	0.6	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.0	1.9	0.2	0.2	0.0	0.5	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.6	0.2	0.3	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.0	12.8	91.5	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.8	1.3	0.4	0.0	0.8	0.0	0.0	0.0	0.2	0.2	1.9	24.3	10.6	0.4	0.1	1.1	1.2	0.0	0.1	20351.4	0.0	0.3	0.0	0.0	0.0	8.6	0.0	1.9	0.0	0.0	0.1	1.2	0.0	0.0	0.0	41.0	3.1	1.5	0.0	1.0	43.9	0.0	2.1	0.0	0.0	1142.1	1.7	3.4	0.1	0.2	4.1	7.6	1.0	0.0	0.0	0.0	3.4	0.5	0.2	0.0	0.1	0.0	0.3	12.5	1.2	0.1
A1BG		ENSG00000121410	"Alpha-1-B glycoprotein"	P04217	19	58345178-58353492	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	1492	"liver: 1234.7"	"Cell type enriched"	"Detected in many"	13	"Hepatocytes: 1548.5"	"Cancer enriched"	"Detected in single"	85	"liver cancer: 22.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 2.5;RH-30: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB016673, HPA044252"	Supported				"Secreted to blood"	NA	NA	200000000000	51000000000			"CAB016673: AB_1611892, HPA044252: AB_2678876"	"unprognostic (9.95e-2)"	"unprognostic (5.31e-2)"	"unprognostic (3.67e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.66e-2)"	"prognostic favorable (3.97e-4)"	"unprognostic (1.09e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.19e-5)"	"unprognostic (2.37e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.72e-1)"	"unprognostic (6.72e-2)"	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.0	0.0	0.8	0.1	0.2	0.1	0.0	0.1	1234.7	0.1	0.3	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.6	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.5	0.6	0.0	2.5	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.8	0.3	0.0	0.0	0.9	0.3	0.8	0.0	0.1	0.1	0.7	1.3	0.4	0.0	0.0	0.0	0.1	0.2	0.1	0.4	0.0	0.3	0.4	0.0	0.6	0.2	0.0	0.0	0.9	0.9	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	10.2	12.8	14.1	0.7	50.2	8.8	2.2	16.2	12.0	3.4	52.0	64.3	0.7	27.1	10.6	22.0	2.1	1.0	71.2	0.0	7.9	0.9	0.6	5.0	52.6	10.9	1.2	56.2	2.2	9.2	15.6	20.3	5.1	2.1	17.7	10.8	43.2	1548.5	25.1	8.4	1.7	0.1	20.3	110.9	66.0	2.1	1.2	49.4	115.6	0.0	60.8	3.1	15.5	0.0	8.7	5.4	0.0	1.2	94.4	11.1	0.0	2.0	15.0	5.5	26.3	29.2	43.8	4.1	7.9	1.5	3.7	1.9	52.6	0.7	0.2	0.6
APOA2		ENSG00000158874	"Apolipoprotein A2"	P02652	1	161222292-161223631	"Cancer-related genes, Candidate cardiovascular disease genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Host-virus interaction, Lipid transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1385	"liver: 36306.5"	"Cell type enriched"	"Detected in some"	75	"Hepatocytes: 50065.8"	"Cancer enriched"	"Detected in many"	329	"liver cancer: 11230.1"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"Hep G2: 16822.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025885, HPA072575"	Supported				"Secreted to blood"	NA	NA	115000000000	92000000000			"CAB025885: , HPA072575: "		"unprognostic (2.05e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.99e-1)"		"unprognostic (9.82e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.16e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.57e-2)"		"unprognostic (4.40e-3)"	"unprognostic (3.16e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.60e-1)"	"unprognostic (6.09e-2)"	2.1	1.1	0.6	0.7	0.5	26.2	1.8	0.4	1.1	0.7	0.8	0.7	0.0	0.7	0.1	1.0	1.9	0.0	1.7	0.5	1.7	9.6	36306.5	2.1	0.3	0.7	0.6	0.2	0.7	2.1	0.0	1.2	1.3	0.7	0.6	0.5	0.0	0.6	0.0	0.6	0.8	0.9	0.0	0.6	7.7	1.9	1.2	0.8	0.4	0.9	0.0	0.3	0.4	0.8	1.2	0.0	0.6	0.0	0.0	0.0	0.0	22.4	0.0	0.0	0.0	0.0	1814.4	0.0	3.6	0.0	0.0	0.0	2.3	1.5	0.0	0.0	0.0	0.0	5.8	10.0	16822.4	0.0	19.3	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.9	0.2	0.0	0.0	0.7	0.7	1.5	0.0	1.1	1.3	14.6	0.3	0.0	11.3	0.8	0.0	7.8	0.0	0.2	5.2	0.1	0.0	4.1	0.0	0.1	0.0	0.0	3.8	0.0	5.2	0.0	6.1	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.1	0.2	0.0	0.0	0.6	0.5	0.4	1.1	0.5	1.7	0.7	0.6	0.2	0.7	0.6	0.8	1.2	0.0	0.0	0.0	0.0	40.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	480.4	0.0	0.0	0.0	0.8	0.0	0.1	1.9	0.0	1.7	0.0	0.0	22.5	0.0	323.6	0.0	0.6	6.4	0.2	0.0	0.0	0.0	0.0	425.9	50065.8	4.7	0.0	0.0	0.2	0.0	665.8	0.0	7.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.1	9.8	0.0	0.0	0.0	0.0	0.0	1.9	0.9	0.0	0.0	5.6	26.0	0.0	0.0	0.0
SERPINC1	"AT3, ATIII, MGC22579"	ENSG00000117601	"Serpin family C member 1"	P01008	1	173903800-173917327	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"	"Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	1339	"liver: 5098.2"	"Cell type enriched"	"Detected in some"	49	"Hepatocytes: 2707.9"	"Cancer enriched"	"Detected in some"	871	"liver cancer: 1504.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	37	"Hep G2: 84.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA001816, CAB016790, HPA024007"	Supported				"Secreted to blood"	NA	NA		120000000000			"CAB016790: , HPA001816: AB_1079926, HPA024007: AB_1856732"	"unprognostic (1.28e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.83e-2)"	"unprognostic (5.98e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.93e-2)"	"prognostic favorable (3.40e-5)"	"unprognostic (1.75e-2)"	"unprognostic (8.67e-2)"	"unprognostic (3.48e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.28e-3)"	"unprognostic (5.80e-2)"	"unprognostic (6.35e-2)"	"unprognostic (8.21e-2)"	0.2	0.1	0.3	0.0	0.3	0.0	0.1	0.3	0.3	0.1	0.2	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.3	0.3	0.2	3.8	5098.2	0.3	0.1	0.3	0.3	0.2	0.1	0.2	0.0	0.2	0.2	0.3	0.1	0.0	0.7	0.1	0.0	0.3	0.1	0.2	0.0	0.3	1.6	0.2	0.4	0.2	0.1	0.2	0.1	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.2	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.6	0.1	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	84.2	0.0	1.6	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.4	0.3	0.0	0.2	1.8	0.1	0.0	0.1	0.0	0.1	1.2	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.3	0.0	1.0	0.1	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.2	0.3	0.3	0.2	0.3	0.3	0.2	0.4	0.1	3.2	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	37.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.3	0.2	0.0	1.6	0.0	34.7	0.1	0.4	0.0	0.1	0.0	0.2	0.0	0.1	42.1	2707.9	0.2	0.0	0.1	0.0	0.0	55.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	4.6	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.3	3.7	0.0	0.0	0.2
APOC4-APOC2		ENSG00000224916	"APOC4-APOC2 readthrough (NMD candidate)"		19	44942238-44949565	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in some"	1257	"liver: 2239.2"	"Cell type enriched"	"Detected in some"	12	"Hepatocytes: 147.1"	"Cancer enriched"	"Detected in some"	17	"liver cancer: 9.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"THP-1: 4.2"									HPA055877	Supported					NA	NA					"HPA055877: AB_2682953"	"unprognostic (1.45e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.01e-4)"	"unprognostic (2.28e-1)"	"unprognostic (2.88e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.68e-2)"	0.1	0.4	0.5	0.0	0.4	0.0	0.2	0.4	0.6	0.2	0.4	0.2	0.0	0.0	0.0	0.1	0.7	0.0	0.1	0.4	0.4	0.2	2239.2	1.7	0.0	0.5	0.5	0.4	0.0	0.3	0.0	0.8	0.0	0.5	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.5	1.2	0.1	0.4	0.6	0.0	0.2	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.4	0.6	0.4	0.4	0.5	0.5	0.4	0.5	0.5	0.6	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	1.1	147.1	2.2	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0
LELP1		ENSG00000203784	"Late cornified envelope like proline rich 1"	Q5T871	1	153203430-153205120	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	1197	"testis: 1126.4"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 21424.4"	"Cancer enriched"	"Detected in single"	10	"testis cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA070231	Enhanced					NA	NA					"HPA070231: AB_2686237"															"unprognostic (1.77e-1)"			0.1	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.4	0.3	0.3	0.0	0.0	0.1	0.1	1126.4	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3645.9	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21424.4	88.9	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	89.1	0.0	0.0	0.0	0.0	0.0	0.0	46.0	0.0	0.0	105.5	54.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRM1	CT94.1	ENSG00000175646	"Protamine 1"	P04553	16	11280841-11281330	"Predicted intracellular proteins"	"Differentiation, DNA condensation, Spermatogenesis"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1098	"testis: 14225.7"	"Cell type enriched"	"Detected in some"	6	"Late spermatids: 776887.9"	"Cancer enriched"	"Detected in single"	161	"testis cancer: 11.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 2.4;U-2197: 1.7"					"Not detected"	"Not detected"			"HPA055150, HPA059371"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA055150: AB_2682718, HPA059371: "															"unprognostic (2.10e-2)"			2.2	2.2	0.0	0.5	0.0	0.0	10.0	0.0	0.0	1.8	0.0	2.1	1.5	1.0	0.0	2.0	1.2	0.0	1.7	0.0	0.0	2.6	4.4	1.4	0.4	0.0	0.0	0.0	1.6	3.1	0.0	1.9	0.0	0.1	12.9	0.0	0.0	2.1	1.3	5.8	3.6	4.1	0.0	0.0	1.4	2.4	14225.7	0.0	0.0	4.4	0.0	0.1	1.5	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	126844.3	0.0	0.0	80.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	776887.9	1855.9	161.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1689.6	0.0	0.0	0.0	0.0	0.0	0.0	1157.0	0.0	0.0	2054.0	1211.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRM2	CT94.2	ENSG00000122304	"Protamine 2"	P04554	16	11275639-11276480	"Predicted intracellular proteins"	"Differentiation, DNA condensation, Spermatogenesis"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1082	"testis: 11788.4"	"Cell type enriched"	"Detected in some"	7	"Late spermatids: 506606.3"	"Cancer enriched"	"Detected in single"	187	"testis cancer: 11.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"BEWO: 1.1;NB-4: 1.3;U-2197: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB032738, HPA056386"	Enhanced					NA	NA					"CAB032738: AB_2171312, HPA056386: AB_2683111"															"unprognostic (3.88e-2)"			1.8	1.9	0.0	0.3	0.0	0.0	8.6	0.0	0.0	1.5	0.0	1.8	0.6	1.0	0.0	1.6	1.1	0.0	1.5	0.0	0.0	2.1	3.6	1.1	0.5	0.0	0.0	0.0	1.4	2.6	0.0	1.7	0.0	0.0	10.8	0.0	0.0	1.7	0.8	4.7	3.1	3.2	0.0	0.0	1.1	2.1	11788.4	0.0	0.2	3.6	0.0	0.0	1.3	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	70432.4	0.2	0.0	77.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	506606.3	1538.1	115.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1673.0	0.0	0.0	0.0	0.0	0.0	0.0	913.8	0.0	0.0	1879.2	957.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SFTPA1	"COLEC4, SFTP1, SP-A, SP-A1"	ENSG00000122852	"Surfactant protein A1"	Q8IWL2	10	79610939-79615455	"Disease related genes, Human disease related genes, Predicted secreted proteins"	"Gaseous exchange"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	1048	"lung: 7147.2"	"Cell type enriched"	"Detected in some"	11	"Alveolar cells type 2: 13480.7"	"Cancer enriched"	"Detected in some"	25	"lung cancer: 706.4"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	27	"plasmacytoid DC: 2.7"	"Lineage enriched"	"Detected in single"	27	"dendritic cells: 2.7"	"Cell line enriched"	"Detected in some"	6	"RPMI-8226: 43.2"									"CAB016793, HPA042638, HPA045752, HPA049368"	Supported				"Secreted in other tissues"	NA	NA					"CAB016793: , HPA042638: AB_2678095, HPA045752: AB_2679442, HPA049368: AB_2680731"						"unprognostic (5.83e-4)"		"unprognostic (1.17e-1)"			"unprognostic (3.38e-2)"	"unprognostic (4.24e-1)"		"unprognostic (3.47e-2)"		"unprognostic (9.09e-2)"		0.4	6.8	0.1	2.6	0.1	0.0	0.5	0.2	0.3	0.9	0.0	0.2	0.0	0.1	0.0	0.2	0.2	0.0	0.8	0.1	0.0	0.2	0.9	7147.2	0.0	0.1	0.0	0.0	6.4	0.7	0.0	0.3	1.4	0.1	1.0	0.0	0.0	0.2	4.8	0.8	0.7	0.4	0.0	0.0	4.9	3.8	0.3	0.0	1.5	0.5	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.7	0.1	0.0	0.0	0.0	0.0	43.2	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	7.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.1	0.1	0.2	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	1160.3	13480.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	183.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	18.9	0.0	0.0	0.0	0.0	0.0	19.7	0.0	0.0	454.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	85.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	64.2	0.0	0.0	0.0
SYCN	"FLJ27441, INSSA1, SYL"	ENSG00000179751	Syncollin	Q0VAF6	19	39202825-39204263	"Predicted intracellular proteins"	Exocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1004	"pancreas: 28602.4"	"Cell type enriched"	"Detected in some"	7	"Exocrine glandular cells: 4000.5"	"Cancer enriched"	"Detected in single"	842	"pancreatic cancer: 369.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA047654	Enhanced				"Intracellular and membrane"	NA	NA		920000			"HPA047654: AB_2680112"											"unprognostic (8.02e-2)"							3.8	0.8	0.0	0.4	0.0	0.0	2.5	0.0	0.1	1.4	0.0	0.8	4.0	0.9	0.2	1.6	0.6	0.0	4.5	0.0	0.0	1.0	3.0	0.5	0.6	0.0	0.0	0.0	11.3	28602.4	0.0	0.9	1.6	0.0	1.6	0.0	0.0	4.1	0.0	0.8	1.4	1.8	0.0	0.0	1.2	2.3	28.4	0.0	0.0	0.5	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	4.4	0.0	0.0	0.3	0.0	0.0	0.0	4000.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	1.2	0.5	0.0	0.0	9.8	0.0	0.0	0.0	0.0	506.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.6	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0
GP2	ZAP75	ENSG00000169347	"Glycoprotein 2"	P55259	16	20309574-20327808	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	966	"pancreas: 35681.9"	"Cell type enriched"	"Detected in some"	5	"Exocrine glandular cells: 504.1"	"Cancer enriched"	"Detected in many"	14	"pancreatic cancer: 320.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA015739, HPA016668"	Enhanced				"Secreted to digestive system"	NA	NA		41000			"HPA015739: AB_1849905, HPA016668: AB_1849907"	"unprognostic (2.14e-2)"		"unprognostic (1.97e-2)"	"unprognostic (5.68e-2)"			"unprognostic (4.29e-2)"	"unprognostic (1.63e-1)"			"unprognostic (2.84e-1)"	"unprognostic (6.35e-2)"	"unprognostic (8.17e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.36e-1)"			6.7	1.9	0.2	0.9	0.2	0.7	3.8	0.5	0.4	1.6	0.3	3.9	36.9	2.2	0.2	3.9	1.4	18.8	6.6	0.3	0.2	10.5	5.0	1.6	2.1	0.2	0.2	0.2	15.5	35681.9	0.0	2.9	2.4	0.3	33.7	6.2	0.1	7.6	0.0	1.6	1.6	10.2	0.1	0.1	2.5	27.6	1.9	0.2	0.1	1.3	0.0	0.2	1.0	1.6	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.3	0.1	0.0	0.2	0.0	0.0	0.2	0.2	0.5	0.4	0.3	0.2	0.2	0.2	0.2	0.3	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.7	0.0	0.0	0.2	1.1	0.1	0.1	87.2	0.0	0.0	0.0	0.0	0.0	1.7	9.8	1.3	7.5	0.3	0.5	0.2	0.0	0.0	0.0	504.1	0.0	0.2	0.0	2.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.1	0.0	0.0	0.3	15.6	0.3	0.4	0.0	0.0	4.2	0.2	0.0	0.0	0.0	20.7	13.9	0.4	0.0	69.7	2.0	0.0	0.0	0.3	0.0	0.5	0.2	0.4	0.1	0.0	0.0	0.0	0.1	0.1	19.9	2.1
LALBA	LYZL7	ENSG00000167531	"Lactalbumin alpha"	P00709	12	48567684-48570066	"Cancer-related genes, Metabolic proteins, Predicted secreted proteins"	"Lactose biosynthesis"	"Milk protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	928	"breast: 2211.1"	"Cell type enriched"	"Detected in some"	160	"Breast glandular cells: 48911.9"	"Cancer enriched"	"Detected in single"	599	"breast cancer: 29.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB026343, HPA029855, HPA029856"	Enhanced				"Secreted in female reproductive system"	NA	NA		91000			"CAB026343: , HPA029855: AB_2673222, HPA029856: AB_10671362"															"unprognostic (7.85e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	2211.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	166.6	0.0	0.0	0.0	46.7	0.0	0.0	0.0	0.0	0.0	48911.9	305.6	0.0	0.0	0.0	0.0	0.0	0.0	108.5	0.0	0.0	0.0	0.6	0.0	0.0	15.9	0.0	0.0	0.1	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.0	58.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.1	0.0	0.7	0.0	0.0	0.0	32.6	0.0	0.0	0.0
PGA3		ENSG00000229859	"Pepsinogen A3"	P0DJD8	11	61203307-61213098	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	924	"stomach 1: 89793.9"	"Cell type enriched"	"Detected in some"	526	"Gastric mucus-secreting cells: 3263.5"	"Cancer enriched"	"Detected in single"	498	"stomach cancer: 24.8"	"Region enhanced"	"Detected in some"		"hippocampal formation: 3.2"	"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HMC-1: 2.8;THP-1: 1.1"									"CAB026358, HPA046875"	Enhanced				"Secreted to digestive system"	NA	NA					"CAB026358: , HPA046875: AB_2679851"										"unprognostic (6.39e-2)"				"unprognostic (1.11e-1)"				41.6	10.1	0.6	0.2	0.3	0.2	18.4	0.8	1.0	8.5	0.0	78.0	1.3	3.8	0.0	97.1	4.5	0.1	7.7	3.2	0.1	5.2	16.3	6.3	0.0	0.1	0.0	0.6	5.4	13.1	0.0	13.6	0.5	0.1	5.5	0.1	0.9	6.8	0.8	4.4	5.6	5.7	0.4	0.0	6.4	89793.9	7.4	0.0	0.1	5.0	0.6	0.1	6.2	6.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.1	0.7	1.3	0.4	0.1	0.2	0.7	0.1	0.1	0.1	0.6	0.4	0.2	0.3	0.0	0.0	1.3	0.6	0.3	0.8	1.0	3.2	0.1	0.1	0.0	0.6	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.9	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	6.2	0.0	0.3	3263.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.5	0.0	0.0	0.7	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.1	0.0	0.1	0.0	3.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.0	0.1
HPX		ENSG00000110169	Hemopexin	P02790	11	6431049-6442617	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Host-virus interaction, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	908	"liver: 5485.4"	"Cell type enriched"	"Detected in some"	38	"Hepatocytes: 6095.8"	"Cancer enriched"	"Detected in many"	79	"liver cancer: 571.1"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"Hep G2: 21.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB016725, HPA065318, HPA068847"	Approved				"Secreted to blood"	NA	NA	425000000000	190000000000			"CAB016725: , HPA065318: , HPA068847: "	"unprognostic (3.39e-2)"	"unprognostic (9.26e-2)"	"unprognostic (3.88e-1)"	"unprognostic (6.19e-4)"	"unprognostic (2.05e-2)"	"unprognostic (2.41e-1)"	"prognostic favorable (2.26e-4)"	"unprognostic (6.33e-2)"	"unprognostic (5.67e-3)"	"unprognostic (3.88e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.78e-2)"	"unprognostic (5.82e-12)"	"unprognostic (2.01e-1)"	"unprognostic (4.48e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.14e-2)"	1.1	0.8	0.8	0.1	0.7	0.1	6.0	1.0	1.0	1.6	0.6	1.1	0.4	1.0	0.2	0.5	1.6	0.3	0.9	0.7	0.8	1.4	5485.4	1.2	0.3	0.7	0.7	0.8	1.6	5.6	0.1	1.2	0.3	0.8	2.4	0.6	1.7	1.1	0.6	0.3	1.6	1.1	0.3	0.7	3.9	0.9	1.1	0.8	0.1	0.9	0.0	0.1	1.1	1.2	0.7	0.2	0.1	0.4	0.2	0.0	0.6	0.0	0.0	0.1	0.1	0.3	1.3	0.0	0.8	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.2	0.2	0.6	0.2	21.3	0.0	3.0	0.0	0.8	0.6	0.1	0.0	0.5	0.1	0.2	0.4	0.1	0.1	0.4	0.0	0.0	0.3	0.9	0.0	0.1	1.3	0.2	0.0	0.1	0.2	0.0	1.0	3.0	0.2	0.2	1.1	0.0	0.5	0.3	0.2	1.0	0.1	0.4	0.2	0.9	0.2	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	1.0	1.0	0.7	0.8	0.7	0.7	0.8	0.8	0.7	0.8	0.7	0.5	3.2	0.5	0.3	15.1	0.6	0.2	0.2	0.0	1.5	19.1	7.7	0.7	80.1	0.2	0.0	2.1	0.1	0.1	0.6	0.0	0.1	2.3	0.2	0.3	6.2	0.0	157.7	0.7	0.6	0.1	0.4	0.0	1.2	0.0	1.1	132.8	6095.8	0.2	0.0	0.8	0.7	0.0	155.3	0.2	2.9	0.3	0.2	0.0	1.0	0.0	0.2	0.0	0.0	0.1	0.8	0.0	0.0	0.0	1.7	0.2	0.0	1.0	2.1	0.0	0.4	0.5	0.6	0.5	0.0	0.3	0.0	11.3	0.2	0.5	0.3
GNAT1	CSNBAD3	ENSG00000114349	"G protein subunit alpha transducin 1"	P11488	3	50191610-50197696	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"	Transducer	"Congenital stationary night blindness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	905	"retina: 1129.9"	"Cell type enriched"	"Detected in some"	5	"Rod photoreceptor cells: 2275.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	6	"hippocampal formation: 6.5"	"Not detected"	"Not detected"			HPA045393	Enhanced					NA	NA					"HPA045393: AB_2679310"	"unprognostic (3.08e-1)"	"unprognostic (1.81e-1)"		"unprognostic (8.56e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.82e-3)"		"unprognostic (6.10e-2)"				"unprognostic (1.07e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.02e-1)"	"unprognostic (9.48e-3)"	0.1	0.1	0.4	0.1	0.3	0.7	0.2	0.9	0.5	0.1	0.0	0.1	0.1	0.1	0.4	0.2	0.1	0.1	0.0	0.3	0.2	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.4	0.1	0.2	1129.9	0.0	0.0	0.1	0.4	0.1	0.1	0.1	0.1	0.1	1.2	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.6	0.1	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.1	0.1	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.9	0.5	0.3	0.2	0.2	0.2	0.1	0.4	0.1	0.2	0.6	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	222.9	0.1	0.1	0.4	0.0	0.0	0.0	241.8	0.0	0.0	0.0	0.0	0.0	14.1	0.1	0.1	13.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	90.9	0.0	0.0	0.0	0.0	0.0	38.2	0.6	0.0	0.0	0.0	0.0	397.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2275.4	0.0	0.0	0.0	4.7	2.1	0.7	0.0	0.1	0.0	0.1	0.1	0.1
SLC12A1	NKCC2	ENSG00000074803	"Solute carrier family 12 member 1"	Q13621	15	48178438-48304078	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Symport, Transport"		"Bartter syndrome, Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	878	"kidney: 712.0"	"Cell type enriched"	"Detected in some"	5	"Distal tubular cells: 209.4"	"Cancer enriched"	"Detected in single"	4	"renal cancer: 1.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	26	"RPTEC TERT1: 25.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA014967, HPA018107"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA014967: AB_1854503, HPA018107: AB_1854504"	"unprognostic (3.52e-2)"	"unprognostic (1.30e-2)"		"unprognostic (9.65e-2)"	"unprognostic (1.74e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.85e-3)"	"unprognostic (2.81e-4)"	"unprognostic (9.75e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.20e-4)"	"unprognostic (8.52e-2)"	0.1	0.0	0.2	0.1	0.2	0.2	0.1	0.5	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	712.0	0.4	0.0	0.0	0.5	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.5	0.4	0.2	0.5	0.5	0.5	0.2	0.4	0.2	0.2	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.7	0.0	0.0	38.6	0.0	0.0	0.0	0.0	209.4	0.0	13.5	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	13.2	0.3	0.1	0.0	1.0	0.0	0.0	0.0	1.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MUC7	"FLJ27047, MG2"	ENSG00000171195	"Mucin 7, secreted"	Q8TAX7	4	70430492-70482997	"Disease related genes, Predicted secreted proteins"			Asthma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	875	"salivary gland: 26231.5"	"Cell type enriched"	"Detected in some"	12	"Melanocytes: 12.4"	"Group enriched"	"Detected in some"	12	"head and neck cancer: 8.1;melanoma: 2.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA006411	Enhanced				"Secreted to digestive system"	NA	NA					"HPA006411: AB_1854204"	"unprognostic (5.49e-2)"					"unprognostic (3.20e-1)"			"unprognostic (1.06e-1)"									1.0	5.3	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.4	0.0	1.0	0.0	0.1	0.0	2.1	0.0	0.0	6.6	0.0	0.0	1.0	3.7	0.6	0.0	0.0	0.7	0.0	6.5	29.9	0.0	1.9	3.2	0.0	0.8	0.0	0.0	26231.5	0.0	2.6	3.3	1.5	0.0	0.0	1.0	1.1	1.5	0.2	0.0	1.4	0.1	0.4	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	12.4	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SFTPC	"BRICD6, PSP-C, SFTP2, SMDP2, SP-C"	ENSG00000168484	"Surfactant protein C"	P11686	8	22156913-22164479	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Gaseous exchange"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	795	"lung: 18623.0"	"Cell type enriched"	"Detected in some"	12	"Alveolar cells type 2: 107013.9"	"Cancer enriched"	"Detected in some"	218	"lung cancer: 226.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 9.5;NB-4: 12.4;SCLC-21H: 5.1;U-2197: 24.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA010928	Enhanced				"Secreted in other tissues"	NA	NA					"HPA010928: AB_1857425"		"unprognostic (1.84e-1)"			"unprognostic (1.96e-1)"	"unprognostic (1.44e-1)"		"unprognostic (1.13e-1)"	"unprognostic (2.97e-1)"		"unprognostic (4.97e-2)"	"unprognostic (1.08e-1)"		"unprognostic (1.50e-1)"		"unprognostic (1.32e-2)"		1.7	23.4	12.2	10.4	13.8	0.0	0.9	12.2	15.9	1.6	9.8	0.9	0.0	0.4	0.3	0.9	0.4	0.0	2.7	11.6	11.9	1.0	2.8	18623.0	0.0	13.3	12.6	11.1	21.7	1.7	0.0	1.1	4.8	13.3	3.1	0.0	0.0	0.8	9.0	2.1	3.1	2.3	0.0	11.9	14.1	6.5	2.8	12.1	0.0	4.3	0.1	0.2	0.1	0.9	16.8	0.0	0.1	0.0	0.0	0.5	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	12.4	0.3	0.0	0.0	0.4	0.1	0.0	0.0	0.0	5.1	0.4	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.1	0.1	24.4	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	13.8	12.2	15.9	11.6	11.9	13.3	12.6	11.1	13.3	11.9	12.1	16.8	0.0	8535.2	107013.9	0.7	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	1416.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	67.8	0.0	0.0	0.9	0.0	0.0	174.6	0.0	0.0	986.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	30.4	0.0	106.6	23.2	0.0	0.0	0.0	0.0	0.5	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	339.6	0.0	6.6	0.0	0.3	0.1	0.1	0.0	0.6	0.0	163.4	0.4	0.0	0.1
ITIH1	"H1P, IATIH, ITIH"	ENSG00000055957	"Inter-alpha-trypsin inhibitor heavy chain 1"	P19827	3	52777595-52792068	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	782	"liver: 1517.2"	"Cell type enriched"	"Detected in some"	34	"Hepatocytes: 1087.0"	"Cancer enriched"	"Detected in some"	598	"liver cancer: 329.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 5.3;Hep G2: 1.7;HL-60: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041639, HPA042049"	Approved		Approved	Vesicles	"Secreted to blood"	NA	NA	4490000	59000000000	Vesicles		"HPA041639: AB_10796349, HPA042049: AB_10797379"	"unprognostic (1.87e-4)"	"unprognostic (1.31e-3)"	"unprognostic (2.38e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.64e-3)"	"prognostic favorable (1.89e-5)"	"unprognostic (2.27e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.45e-2)"	"unprognostic (4.53e-4)"	"unprognostic (4.02e-3)"	"unprognostic (5.70e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.24e-2)"	0.7	0.3	0.0	0.5	0.0	0.0	0.3	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.4	0.0	0.0	0.2	1517.2	0.1	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.1	0.0	0.0	1.9	0.4	0.4	0.1	0.4	0.1	0.1	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	31.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.1	0.0	29.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	18.5	1087.0	0.1	0.0	0.0	0.0	0.0	20.2	0.0	1.7	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.1	1.4	0.0	0.0	0.1
C16orf82	TNT	ENSG00000234186	"Chromosome 16 open reading frame 82"		16	27066927-27069166	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in single"	700	"testis: 278.5"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 4722.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																				"unprognostic (8.18e-3)"			0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	278.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1003.4	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4722.1	23.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.9	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	35.5	16.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GNGT1	GNG1	ENSG00000127928	"G protein subunit gamma transducin 1"	P63211	7	93591573-93911265	"Predicted intracellular proteins, RAS pathway related proteins"		Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	645	"retina: 1918.8"	"Cell type enriched"	"Detected in some"	5	"Rod photoreceptor cells: 3097.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"midbrain: 1.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 9.4;HeLa: 3.4;SK-BR-3: 3.0;SuSa: 4.3;T-47d: 5.3;U-266/84: 4.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA042721	Enhanced					NA	NA					"HPA042721: AB_10806370"		"unprognostic (1.30e-1)"	"unprognostic (2.55e-4)"	"unprognostic (3.32e-4)"		"unprognostic (5.01e-2)"		"unprognostic (2.54e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.55e-1)"		"unprognostic (2.23e-4)"	"unprognostic (1.40e-2)"	"unprognostic (1.69e-1)"		"unprognostic (1.35e-1)"	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.2	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.3	0.0	0.0	0.0	0.2	1.5	0.1	0.4	0.0	0.0	0.0	2.9	0.3	0.0	0.0	1918.8	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.3	0.0	0.5	1.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	9.4	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.3	0.0	3.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.4	0.1	1.4	0.1	0.0	1.5	0.1	0.1	0.0	0.0	0.4	0.2	1.3	2.6	1.0	0.1	3.0	0.0	4.3	5.3	0.1	0.1	0.0	2.7	0.1	0.0	2.8	4.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.4	0.2	0.1	0.4	0.2	1.5	0.1	0.3	0.1	0.3	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	371.1	0.0	0.0	0.1	0.0	0.7	0.0	385.7	0.5	0.0	0.1	1.9	0.4	0.1	0.2	0.0	21.7	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.2	198.5	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	619.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.3	0.8	3097.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	7.1	0.0	0.1	0.0	0.0
OPALIN	"HTMP10, TMEM10, TMP10"	ENSG00000197430	"Oligodendrocytic myelin paranodal and inner loop protein"	Q96PE5	10	96343221-96359365	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	640	"brain: 149.9;choroid plexus: 61.5"	"Cell type enriched"	"Detected in some"	304	"Oligodendrocytes: 304.5"	"Cancer enriched"	"Detected in single"	36	"glioma: 1.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"REH: 1.0"	"Region enhanced"	"Detected in all"		"white matter: 240.1"	"Low region specificity"	"Detected in all"			HPA014372	Supported					NA	NA					"HPA014372: AB_2158172"					"unprognostic (1.18e-1)"													0.0	0.0	116.3	0.0	141.1	0.0	0.0	72.2	147.1	0.0	61.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	113.7	100.5	0.0	0.0	0.0	0.0	134.0	119.8	96.3	0.0	0.0	0.0	0.1	0.0	117.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	83.2	0.0	0.0	0.0	105.7	0.0	0.0	0.0	0.0	0.0	0.0	149.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	116.3	141.1	72.2	147.1	113.7	100.5	134.0	119.8	96.3	117.2	83.2	105.7	149.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.0	304.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLCO1B1	"LST-1, OATP-C, OATP1B1, SLC21A6"	ENSG00000134538	"Solute carrier organic anion transporter family member 1B1"	Q9Y6L6	12	21131194-21239796	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	613	"liver: 541.6"	"Cell type enriched"	"Detected in some"	9	"Hepatocytes: 83.1"	"Cancer enriched"	"Detected in some"	96	"liver cancer: 52.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 1.1;NTERA-2: 1.3;RPMI-8226: 1.8;SuSa: 2.2"									"HPA050892, HPA073093"	Supported		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA050892: AB_2681265, HPA073093: "			"unprognostic (5.45e-1)"			"unprognostic (1.82e-4)"	"unprognostic (2.43e-3)"	"unprognostic (1.96e-3)"		"unprognostic (1.80e-1)"	"unprognostic (2.41e-1)"	"unprognostic (8.82e-2)"		"unprognostic (5.63e-2)"	"unprognostic (3.86e-2)"		"unprognostic (3.49e-1)"	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	541.6	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.3	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.2	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	83.1	0.0	0.0	0.2	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0
SERPINA7	TBG	ENSG00000123561	"Serpin family A member 7"	P05543	X	106032435-106038727	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	612	"liver: 284.5"	"Cell type enriched"	"Detected in some"	27	"Hepatocytes: 182.8"	"Cancer enriched"	"Detected in single"	203	"liver cancer: 82.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	475	"Hep G2: 69.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA002803	Approved				"Secreted to blood"	NA	NA	39800000000	25000000000			"HPA002803: AB_1079915"			"unprognostic (6.22e-2)"				"unprognostic (1.63e-3)"				"unprognostic (3.34e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.15e-3)"		"unprognostic (2.95e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	284.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	182.8	0.0	0.0	0.0	0.7	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0
MYL7	"MYL2A, MYLC2A"	ENSG00000106631	"Myosin light chain 7"	Q01449	7	44138864-44141332	"Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	588	"heart muscle: 12944.8"	"Cell type enriched"	"Detected in some"	15	"Cardiomyocytes: 10772.7"	"Cancer enriched"	"Detected in some"	7	"testis cancer: 3.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	18	"BEWO: 35.6;CACO-2: 124.6;SuSa: 47.6"	"Not detected"	"Not detected"							"HPA013331, CAB033884, HPA039262"	Enhanced					NA	NA					"CAB033884: AB_2266773, HPA013331: AB_1854245, HPA039262: AB_2676418"	"unprognostic (1.00e-2)"	"unprognostic (7.99e-2)"		"unprognostic (4.36e-3)"	"unprognostic (2.31e-1)"	"unprognostic (2.51e-1)"				"unprognostic (1.28e-1)"	"unprognostic (7.85e-2)"				"unprognostic (1.67e-1)"		"unprognostic (7.28e-2)"	2.7	1.1	3.5	0.0	3.1	0.0	6.5	3.1	4.2	1.2	2.7	1.5	0.0	1.4	0.2	1.1	0.8	0.6	12944.8	2.9	3.7	1.0	2.3	22.0	0.8	3.1	3.3	3.0	4.4	18.5	0.4	9.8	2.2	3.3	2.0	0.0	0.2	11.7	0.3	3.1	2.3	2.0	0.0	2.9	0.9	1.4	1.0	3.7	0.0	3.6	0.0	0.0	0.4	1.9	3.2	0.0	0.0	0.0	0.0	0.0	0.0	35.6	0.0	0.0	0.4	0.0	124.6	0.0	0.0	1.6	0.0	0.0	0.6	0.0	0.1	0.5	0.0	0.0	0.0	0.4	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.4	0.9	0.4	0.0	47.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	3.1	3.1	4.2	2.9	3.7	3.1	3.3	3.0	3.3	2.9	3.7	3.2	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.4	30.5	10772.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	78.5	0.0	2.7	0.3	0.0	0.2	695.9	0.0	0.0	0.0	24.9	0.0	0.4	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	160.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HAO1	"GOX, GOX1"	ENSG00000101323	"Hydroxyacid oxidase 1"	Q9UJM8	20	7882985-7940458	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	582	"liver: 612.8"	"Cell type enriched"	"Detected in some"	22	"Hepatocytes: 301.4"	"Cancer enriched"	"Detected in some"	184	"liver cancer: 93.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA049552, HPA072442"	Enhanced					NA	NA		240000			"HPA049552: AB_2680814, HPA072442: "					"unprognostic (4.88e-2)"		"unprognostic (2.87e-3)"				"unprognostic (1.08e-2)"	"unprognostic (1.25e-1)"						0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	612.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	13.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	301.4	0.0	0.0	0.1	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0
CFHR3	"CFHL3, DOWN16, FHR-3, FHR3, HLF4"	ENSG00000116785	"Complement factor H related 3"	Q02985	1	196774813-196795407	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"			"Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	581	"liver: 510.0"	"Cell type enriched"	"Detected in some"	12	"Hepatocytes: 205.5"	"Cancer enriched"	"Detected in single"	80	"liver cancer: 27.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.7;SuSa: 1.5;T-47d: 3.6;U-266/70: 6.4"														"Secreted to blood"	NA	NA	582000000	3100000000				"unprognostic (1.73e-1)"	"unprognostic (2.11e-1)"	"unprognostic (7.16e-2)"	"unprognostic (6.77e-2)"	"unprognostic (4.46e-1)"	"unprognostic (4.20e-3)"	"prognostic favorable (2.86e-5)"	"unprognostic (1.78e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.19e-2)"	"unprognostic (6.11e-3)"	"unprognostic (2.06e-10)"	"unprognostic (2.67e-4)"	"unprognostic (3.00e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.32e-1)"	0.8	0.2	0.2	0.2	0.4	0.1	0.2	0.0	0.6	0.2	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.2	0.3	0.1	0.3	510.0	0.2	0.1	0.2	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.1	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.6	0.1	0.1	0.2	0.0	0.3	0.1	0.0	0.4	0.1	0.7	0.0	0.7	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.6	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.4	0.0	0.9	0.0	0.0	0.0	0.3	0.0	1.5	3.6	0.0	0.0	0.1	0.2	0.3	0.0	6.4	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.6	0.3	0.1	0.2	0.1	0.1	0.2	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.5	1.8	16.0	0.1	0.0	0.1	1.7	0.0	0.0	0.0	0.0	7.1	205.5	0.0	0.0	0.1	0.0	0.0	8.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.7	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.7
SPEM3		ENSG00000283439	"SPEM family member 3"	A0A1B0GUW6	17	7428857-7432820	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	568	"testis: 56.8"	"Cell type enriched"	"Detected in single"	18	"Distal tubular cells: 1.9"					"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
APOH	"B2G1, BG"	ENSG00000091583	"Apolipoprotein H"	P02749	17	66212033-66256525	"Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Heparin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	562	"liver: 18114.5"	"Cell type enriched"	"Detected in some"	41	"Hepatocytes: 7680.6"	"Cancer enriched"	"Detected in many"	232	"liver cancer: 2878.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	21	"Hep G2: 1253.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA001654, HPA003732, CAB022214"	Enhanced		Supported	"Golgi apparatus"	"Secreted to blood"	NA	NA	247000000000	41000000000	"Golgi apparatus"		"CAB022214: , HPA001654: AB_1078181, HPA003732: AB_1078183"			"unprognostic (2.11e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.28e-1)"		"prognostic favorable (2.39e-7)"	"unprognostic (1.26e-1)"		"unprognostic (5.99e-2)"	"unprognostic (2.88e-3)"		"prognostic unfavorable (1.10e-6)"	"unprognostic (1.26e-2)"	"unprognostic (5.76e-2)"			0.6	0.3	0.0	0.1	0.1	0.5	0.2	0.1	0.2	0.2	0.3	0.8	2.5	0.1	1.0	0.2	0.8	2.8	0.5	0.1	0.1	32.2	18114.5	5.6	0.3	0.2	0.1	0.2	0.2	11.0	0.0	0.2	0.4	0.4	0.2	0.7	0.2	0.2	0.3	0.2	0.2	1.0	0.0	0.1	4.3	3.8	0.3	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.2	0.0	33.5	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	60.8	0.0	1.4	0.1	0.0	1.7	1.1	0.0	0.0	0.0	0.4	0.0	2.6	1.4	1253.3	0.0	6.4	0.7	0.0	0.0	0.1	0.0	0.1	0.0	0.1	1.4	0.5	0.2	0.0	0.2	0.1	0.6	31.5	0.0	0.8	6.4	0.1	0.0	0.9	0.4	0.0	3.4	0.1	0.2	0.0	0.0	0.0	1.7	0.2	0.1	0.1	0.0	0.8	0.1	2.9	15.3	2.4	0.2	0.2	0.2	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.2	0.4	0.1	0.1	0.2	0.0	0.0	12.3	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	183.0	0.6	0.0	0.0	0.0	0.0	0.2	3.9	0.8	0.2	0.2	0.0	5.2	0.0	109.7	0.2	2.3	0.6	0.0	0.0	0.1	0.0	0.0	120.0	7680.6	0.5	0.0	0.2	0.4	0.0	182.4	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.2	0.8	0.0	0.0	0.0	0.4	25.6	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	8.8	0.0	0.8	0.0
FTMT	MtF	ENSG00000181867	"Ferritin mitochondrial"	Q8N4E7	5	121851882-121852833	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Iron storage"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	546	"testis: 54.5"	"Cell type enriched"	"Detected in some"	6	"Early spermatids: 761.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA																				"unprognostic (4.39e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	761.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	123.2	5.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	27.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1
BPIFA3	"bA49G10.4, C20orf71, SPLUNC3"	ENSG00000131059	"BPI fold containing family A member 3"	Q9BQP9	20	33217310-33227806	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	542	"testis: 54.1"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 3057.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA062708	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA062708: AB_2684843"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	736.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3057.9	14.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	18.2	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NPPA	"ANP, PND"	ENSG00000175206	"Natriuretic peptide A"	P01160	1	11845709-11848345	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hormone, Vasoactive, Vasodilator"	"Atrial fibrillation, Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	537	"heart muscle: 37245.5"	"Cell type enriched"	"Detected in some"	23	"Cardiomyocytes: 62235.0"	"Cancer enriched"	"Detected in some"	9	"glioma: 7.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"SCLC-21H: 9.6;SH-SY5Y: 9.5"	"Region enriched"	"Detected in some"	7	"olfactory bulb: 22.8"	"Low region specificity"	"Detected in all"			"HPA058269, HPA064007"	Enhanced				"Secreted to blood"	NA	NA		1200000			"HPA058269: AB_2683660, HPA064007: "	"unprognostic (1.27e-3)"	"unprognostic (3.12e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.25e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.21e-1)"	"unprognostic (5.93e-4)"	"unprognostic (2.31e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.70e-2)"	7.0	3.0	1.3	0.7	1.6	0.6	18.1	1.3	2.3	1.1	1.9	4.3	0.2	3.3	13.0	2.9	1.3	0.9	37245.5	1.7	1.2	2.5	5.1	58.6	1.2	1.3	1.3	1.6	12.2	69.3	0.9	4.0	5.9	1.1	5.1	0.0	0.4	28.8	0.0	9.0	5.7	6.1	0.7	1.1	3.1	3.6	3.9	1.2	0.5	7.1	0.0	0.0	1.2	3.9	1.7	0.5	0.2	0.3	0.5	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.9	0.6	0.8	0.0	0.0	0.4	1.0	0.0	0.0	0.0	0.2	0.4	1.0	0.3	1.8	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	1.2	0.0	0.3	0.3	1.0	0.2	0.0	0.3	0.1	0.1	0.0	0.0	0.6	9.6	9.5	0.0	0.0	0.5	0.3	0.3	0.1	0.0	0.4	0.7	0.6	0.1	0.4	0.8	1.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	1.6	1.3	2.3	1.7	1.2	1.3	1.3	1.6	1.1	1.1	1.2	1.7	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62235.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	339.1	0.0	0.0	0.3	0.0	0.0	2684.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	636.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMPRSS15	"ENTK, MGC133046, PRSS7"	ENSG00000154646	"Transmembrane serine protease 15"	P98073	21	18269116-18485879	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	523	"intestine: 988.7"	"Cell type enriched"	"Detected in some"	5	"Proximal enterocytes: 28.0"	"Group enriched"	"Detected in some"	12	"liver cancer: 0.7;pancreatic cancer: 1.5;stomach cancer: 1.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"U-138 MG: 50.8;U-87 MG: 141.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"olfactory bulb: 5.0;spinal cord: 1.8"	"HPA015611, HPA034857, HPA072934"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA015611: AB_1855791, HPA034857: , HPA072934: AB_2732214"					"unprognostic (9.26e-2)"	"unprognostic (4.14e-1)"		"unprognostic (3.52e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.20e-2)"	"unprognostic (4.70e-2)"		"unprognostic (6.35e-2)"	"unprognostic (5.92e-2)"			0.0	0.0	0.9	0.2	0.7	0.0	0.0	1.8	1.7	0.0	0.0	0.1	988.7	0.2	0.0	0.1	0.0	0.1	0.1	0.8	0.3	0.0	0.0	0.0	0.7	0.6	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.2	22.0	0.0	0.0	0.0	0.4	1.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.2	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.1	4.9	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.3	0.0	4.6	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.8	0.0	0.3	0.0	0.9	0.0	0.2	141.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.7	1.8	1.7	0.8	0.3	0.6	0.6	0.3	0.7	0.0	0.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	1.9	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.0	0.0	28.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	4.0	0.0
ITIH2	H2P	ENSG00000151655	"Inter-alpha-trypsin inhibitor heavy chain 2"	P19823	10	7703316-7749520	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	494	"liver: 2173.8"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 489.6"	"Cancer enriched"	"Detected in many"	279	"liver cancer: 626.9"	"Region enhanced"	"Detected in some"		"cerebral cortex: 4.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	453	"Hep G2: 1103.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA059150	Supported		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA		32000000000	"Golgi apparatus"		"HPA059150: AB_2683930"	"unprognostic (4.82e-2)"	"unprognostic (6.10e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.55e-3)"	"prognostic favorable (1.48e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.10e-8)"	"unprognostic (9.91e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.35e-1)"	"unprognostic (4.46e-4)"	0.1	0.2	0.4	0.1	0.8	0.1	3.1	1.4	4.3	0.0	2.3	0.0	0.0	0.2	0.0	0.0	0.2	0.3	0.1	0.4	1.0	0.8	2173.8	0.6	0.1	0.5	0.7	0.3	0.0	0.2	0.0	1.7	0.1	0.8	0.0	0.0	0.3	0.0	0.0	0.8	0.4	0.1	0.0	0.8	0.3	0.5	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.6	1103.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	2.4	0.0	0.1	0.7	0.0	0.4	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.8	1.4	4.3	0.4	1.0	0.5	0.7	0.3	0.8	0.8	0.7	1.3	0.1	0.0	2.2	0.7	1.0	0.0	0.0	0.0	0.0	0.0	2.8	0.3	0.4	117.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	4.1	0.0	0.0	0.6	0.0	2.7	3.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	8.2	489.6	0.1	0.0	1.4	0.0	0.0	9.4	0.0	2.1	0.0	0.0	0.0	18.7	0.0	0.0	0.0	1.5	1.8	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.5	0.0	0.0	0.0
SAG	"ARRESTIN, RP47"	ENSG00000130561	"S-antigen visual arrestin"	P10523	2	233307816-233347055	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Congenital stationary night blindness, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	475	"retina: 1478.8"	"Cell type enriched"	"Detected in some"	5	"Rod photoreceptor cells: 6946.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA004946	Enhanced					NA	NA					"HPA004946: AB_2667304"	"unprognostic (4.76e-2)"	"unprognostic (1.94e-2)"	"unprognostic (4.52e-3)"	"unprognostic (3.95e-1)"	"unprognostic (8.54e-2)"	"unprognostic (2.89e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.54e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.12e-9)"	"unprognostic (2.56e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.03e-5)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1478.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.3	1.6	0.2	0.0	651.7	0.2	0.3	1.0	0.0	0.0	0.0	869.5	1.5	0.7	0.6	0.0	0.0	40.4	0.9	0.2	41.6	0.0	0.0	0.4	0.0	0.1	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.1	338.2	0.5	0.0	0.0	1.5	2.3	121.5	0.9	0.5	0.0	0.0	0.7	1191.9	0.0	0.5	0.2	0.0	0.0	0.0	0.4	1.2	0.9	0.0	0.2	6946.1	13.1	1.7	0.4	2.1	1.6	0.0	0.6	0.4	0.9	0.1	0.2	1.2
C3orf22	MGC34728	ENSG00000180697	"Chromosome 3 open reading frame 22"	Q8N5N4	3	126526999-126558965	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	474	"testis: 48.8"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 1630.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA059199	Enhanced					NA	NA					"HPA059199: AB_2683946"	"unprognostic (2.10e-1)"			"unprognostic (5.14e-5)"	"unprognostic (2.55e-1)"		"unprognostic (9.21e-2)"			"unprognostic (2.01e-1)"		"unprognostic (2.75e-1)"	"unprognostic (1.08e-3)"		"unprognostic (1.34e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	283.2	0.0	0.0	0.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1630.9	10.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MYBPC3	"CMH4, cMyBP-C, FHC"	ENSG00000134571	"Myosin binding protein C3"	Q14896	11	47331406-47352702	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	"Actin-binding, Muscle protein"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	460	"heart muscle: 1371.4"	"Cell type enriched"	"Detected in some"	42	"Cardiomyocytes: 1876.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	17	"U-937: 6.4"	"Region enriched"	"Detected in some"	33	"cerebellum: 34.4"	"Low region specificity"	"Detected in many"			"HPA040147, HPA043898"	Enhanced					NA	NA		21000			"HPA040147: AB_2676861, HPA043898: AB_2678720"	"unprognostic (1.06e-1)"	"unprognostic (1.47e-6)"	"unprognostic (2.17e-1)"	"unprognostic (6.16e-2)"	"unprognostic (3.00e-3)"	"unprognostic (1.40e-4)"	"unprognostic (7.47e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.53e-2)"	"unprognostic (4.22e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.15e-1)"	"unprognostic (3.21e-2)"	0.4	2.9	0.0	0.7	0.0	1.5	0.8	0.2	0.4	0.1	0.0	0.2	0.1	0.1	0.0	0.1	0.2	0.4	1371.4	0.0	0.0	0.3	0.3	2.1	0.5	0.2	0.1	0.0	0.1	0.7	0.0	0.1	0.1	0.1	0.4	0.0	0.0	0.6	0.0	0.4	0.2	0.3	0.1	0.0	2.8	2.8	1.4	0.0	0.0	0.3	0.2	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.2	0.9	0.0	1.3	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1876.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	28.3	0.0	0.0	14.3	0.0	0.0	0.2	0.0	0.0	43.9	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.2	0.8	0.0	0.8	0.0	19.2	0.3	0.7	0.0	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.1	0.9	0.0	0.0	0.3	0.0	17.4	0.6	0.0
PRSS2	TRY2	ENSG00000275896	"Serine protease 2"	P07478	7	142760398-142774564	"Enzymes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	Digestion	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	452	"pancreas: 241429.6"	"Cell type enriched"	"Detected in some"	11	"Exocrine glandular cells: 108258.7"	"Cancer enriched"	"Detected in many"	72	"pancreatic cancer: 3463.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"basophil: 4.1;T-reg: 2.9"	"Group enriched"	"Detected in many"	8	"granulocytes: 4.1;T-cells: 2.9"	"Cell line enhanced"	"Detected in some"		"OE19: 21.0;RPMI-8226: 67.5;U-2 OS: 15.2"									"HPA062452, HPA063471"	Supported		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to digestive system"	NA	NA		890000000	Vesicles	"Endoplasmic reticulum"	"HPA062452: AB_2684768, HPA063471: AB_2685017"	"prognostic favorable (2.32e-4)"	"unprognostic (3.80e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.30e-3)"		"unprognostic (1.99e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.36e-1)"		"unprognostic (4.62e-3)"	"unprognostic (1.48e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.58e-2)"	"unprognostic (3.50e-1)"	"unprognostic (5.36e-3)"	"unprognostic (1.18e-1)"	50.8	12.6	0.0	0.2	0.1	3.2	25.6	0.0	0.1	16.6	0.0	11.8	361.7	11.5	0.0	18.4	9.7	0.1	25.3	0.0	0.0	9.4	32.5	8.3	1.3	0.0	0.0	0.0	65.5	241429.6	0.0	13.5	8.2	0.0	17.4	0.0	0.0	25.6	0.9	10.1	10.3	533.8	0.1	0.0	17.0	55.1	8.7	0.0	0.9	8.4	0.0	0.0	7.1	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.4	4.4	0.5	0.0	0.0	0.0	1.9	0.0	21.0	0.0	0.0	0.0	67.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.9	3.8	0.0	2.9	0.6	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.9	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	378.7	0.0	0.4	0.1	11.4	0.0	0.0	0.0	108258.7	0.0	0.3	4.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	15.5	0.0	0.0	348.9	0.0	0.0	0.0	0.0	9565.7	8.9	0.0	0.1	0.0	60.0	0.1	0.0	0.0	0.0	0.0	36.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	85.4	0.2
SUN5	"dJ726C3.1, SPAG4L, TSARG4"	ENSG00000167098	"Sad1 and UNC84 domain containing 5"	Q8TC36	20	32983773-33004433	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Spermatogenesis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	452	"testis: 45.2"	"Cell type enriched"	"Detected in some"	7	"Early spermatids: 510.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048529	Enhanced					NA	NA					"HPA048529: AB_2680428"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	510.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	68.0	2.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CFHR4	"CFHL4, FHR-4, FHR4"	ENSG00000134365	"Complement factor H related 4"	Q92496	1	196888014-196918713	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	432	"liver: 125.0"	"Cell type enriched"	"Detected in some"	28	"Hepatocytes: 62.6"	"Cancer enriched"	"Detected in single"	145	"liver cancer: 13.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-266/70: 1.3"					"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA		170000000									"unprognostic (5.97e-1)"	"prognostic favorable (1.57e-6)"	"unprognostic (1.89e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.26e-1)"				"unprognostic (1.68e-2)"			"unprognostic (4.71e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	125.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.7	0.0	1.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.3	2.2	62.6	0.0	0.0	0.5	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
TNNI3	"CMD2A, CMH7, TNNC1"	ENSG00000129991	"Troponin I3, cardiac type"	P19429	19	55151767-55157773	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	417	"heart muscle: 7330.6"	"Cell type enriched"	"Detected in many"	12	"Cardiomyocytes: 12618.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 13.0;HMC-1: 20.3;K-562: 39.1;OE19: 54.6"	"Region enhanced"	"Detected in many"		"olfactory bulb: 10.9"	"Low region specificity"	"Detected in many"			"CAB009349, HPA046428"	Enhanced		Approved	Vesicles,Cytosol		NA	NA		2400000	Cytosol	Vesicles	"CAB009349: AB_793465, HPA046428: AB_2679661"	"unprognostic (2.12e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.13e-1)"	"unprognostic (9.62e-3)"	"unprognostic (9.40e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.17e-3)"	"unprognostic (4.02e-3)"	"unprognostic (8.89e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.05e-1)"	"unprognostic (9.82e-2)"	1.1	3.0	0.8	0.0	0.6	0.0	17.5	0.6	0.4	0.7	0.6	0.6	0.0	0.3	0.1	0.8	6.3	0.9	7330.6	0.4	0.2	0.9	1.1	7.4	1.7	0.5	1.1	0.2	1.5	2.3	0.2	0.6	1.0	1.4	2.4	0.0	0.2	1.3	0.0	6.6	1.2	0.7	0.0	1.1	0.4	0.7	3.7	0.4	0.2	1.5	2.4	0.0	0.4	0.6	0.3	1.2	0.6	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.4	0.0	0.3	1.8	6.3	0.0	1.1	1.1	1.2	0.3	0.0	0.0	13.0	3.0	0.0	1.9	0.5	0.0	20.3	0.0	0.6	0.1	0.3	0.1	0.1	0.8	39.1	0.8	0.0	0.6	0.2	0.0	0.7	54.6	0.5	1.9	0.4	0.1	1.8	0.0	0.1	2.2	0.0	0.0	0.2	0.0	2.8	9.5	0.4	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.6	3.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.6	0.4	0.4	0.2	0.5	1.1	0.2	1.4	1.1	0.4	0.3	0.1	0.0	0.0	0.0	0.2	6.9	0.0	0.8	13.6	0.0	1.0	0.9	12618.4	8.6	1.8	5.5	0.0	1.4	0.1	0.4	0.0	0.7	56.2	3.5	0.1	131.3	1.8	0.0	0.0	0.2	0.5	202.7	0.0	1.3	0.0	996.2	0.0	0.0	2.2	1.7	0.2	0.4	2.0	0.3	0.7	222.9	0.3	4.6	1.8	1.9	0.0	4.2	0.0	0.0	0.1	1.0	0.0	1.9	0.0	0.0	0.0	0.1	11.2	0.5	0.0	0.4	123.6	6.4	16.1	0.7	2.8	2.5	0.6	1.2	1.0	0.1
CPA2		ENSG00000158516	"Carboxypeptidase A2"	P48052	7	130266863-130289798	"Enzymes, Metabolic proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	416	"pancreas: 45745.7"	"Cell type enriched"	"Detected in some"	10	"Exocrine glandular cells: 4973.8"	"Cancer enriched"	"Detected in many"	60	"pancreatic cancer: 411.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.2;CACO-2: 3.8;RH-30: 3.0;SCLC-21H: 1.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA020342, HPA021317"	Enhanced		Approved	"Golgi apparatus"	"Secreted to digestive system"	NA	NA		1500000	"Golgi apparatus"		"HPA020342: AB_1846007, HPA021317: AB_1846008"	"unprognostic (1.12e-1)"	"unprognostic (3.97e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.76e-2)"		"unprognostic (4.65e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.84e-5)"	"unprognostic (7.52e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.12e-2)"	"unprognostic (8.48e-2)"	4.7	1.0	0.6	0.7	1.0	0.4	2.6	1.2	0.9	1.2	0.4	1.2	17.6	0.8	0.1	1.5	0.7	0.0	8.5	0.5	0.9	0.9	2.6	0.7	1.5	2.9	1.5	0.4	19.8	45745.7	0.0	1.5	3.2	2.3	1.5	0.4	0.8	7.8	0.0	0.8	0.9	30.9	0.0	1.8	1.2	109.9	2.2	1.1	0.1	0.6	0.0	0.0	0.5	0.8	3.4	0.0	0.0	0.4	2.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.8	0.0	0.0	0.5	0.0	0.3	0.0	0.7	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.0	3.0	0.0	0.0	0.3	1.6	0.0	0.1	0.0	1.0	0.1	0.0	0.1	0.0	0.0	0.6	0.4	0.3	0.0	0.4	0.1	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.0	1.2	0.9	0.5	0.9	2.9	1.5	0.4	2.3	1.8	1.1	3.4	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.6	1.9	8.1	4.3	0.0	0.0	0.9	0.0	0.0	0.1	4973.8	0.0	0.2	4.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.0	10.5	0.3	0.5	0.0	0.0	13.9	4.6	0.0	0.5	1.0	471.3	52.9	0.0	0.0	0.0	9.9	0.0	0.0	0.3	0.0	0.0	1.3	0.4	2.0	0.0	0.1	0.3	0.0	0.2	1.5	0.2
SPACA1	SAMP32	ENSG00000118434	"Sperm acrosome associated 1"	Q9HBV2	6	88047841-88066838	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	406	"testis: 42.2"	"Cell type enriched"	"Detected in some"	11	"Early spermatids: 910.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA026744, HPA043297"	Enhanced					NA	NA					"HPA026744: AB_2194642, HPA043297: AB_2678413"															"unprognostic (4.15e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	910.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	80.5	5.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	61.3	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SFTPA2	"COLEC5, SP-A2"	ENSG00000185303	"Surfactant protein A2"	Q8IWL1	10	79555852-79560407	"Disease related genes, Human disease related genes, Predicted secreted proteins"	"Gaseous exchange"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	404	"lung: 10893.6"	"Cell type enriched"	"Detected in some"	10	"Alveolar cells type 2: 16905.3"	"Cancer enriched"	"Detected in many"	21	"lung cancer: 863.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	22	"BEWO: 7.3;NB-4: 8.3;RPMI-8226: 26.1;U-2197: 14.7"									"CAB002439, HPA042638, HPA045752, HPA049368"	Enhanced				"Secreted in other tissues"	NA	NA					"CAB002439: AB_564143, HPA042638: AB_2678095, HPA045752: AB_2679442, HPA049368: AB_2680731"	"unprognostic (2.51e-1)"	"unprognostic (4.87e-2)"	"unprognostic (4.99e-2)"	"unprognostic (4.38e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.05e-1)"		"unprognostic (5.78e-2)"	"unprognostic (5.08e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.68e-3)"	"unprognostic (3.10e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.20e-1)"		"unprognostic (1.33e-1)"	"unprognostic (4.69e-3)"	0.5	12.2	0.3	4.6	0.5	0.0	1.0	2.4	0.8	1.4	0.0	1.5	0.0	0.2	0.1	0.4	0.2	0.0	1.1	0.5	0.2	0.4	1.1	10893.6	0.0	1.1	0.3	0.3	6.6	1.3	0.0	0.4	2.3	1.2	26.9	2.6	0.2	0.4	8.4	1.0	0.9	0.6	0.1	0.0	6.8	10.6	0.5	0.2	2.8	0.8	0.0	0.1	0.4	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	8.3	0.4	0.0	0.0	0.2	0.0	26.1	0.0	0.3	0.3	0.3	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.2	14.7	0.1	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.5	2.4	0.8	0.5	0.2	1.1	0.3	0.3	1.2	0.0	0.2	0.5	0.0	1593.0	16905.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	329.9	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.2	0.0	0.0	22.3	1.8	0.0	0.3	3.1	0.0	22.0	0.0	0.2	431.4	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	33.4	0.0	0.0	0.0	0.0	0.0	0.5	0.1	1.2	2.0	0.0	0.0	1.0	0.0	0.1	135.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.7	0.0	2.4	0.1
UROC1	"FLJ31300, HMFN0320"	ENSG00000159650	"Urocanate hydratase 1"	Q96N76	3	126481166-126517773	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Histidine metabolism"	Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	391	"liver: 117.6"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 62.2"	"Cancer enriched"	"Detected in single"	100	"liver cancer: 12.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"NB-4: 4.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA069863	Enhanced					NA	NA		670000			"HPA069863: AB_2732143"	"unprognostic (1.28e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.43e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.23e-3)"	"unprognostic (2.95e-1)"	"unprognostic (2.57e-2)"	"unprognostic (7.71e-2)"	"unprognostic (9.97e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.65e-5)"	"unprognostic (3.97e-2)"	"unprognostic (2.66e-1)"		"unprognostic (5.52e-2)"	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	117.6	0.0	0.0	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	13.5	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.1	3.3	62.2	0.3	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0
FGA		ENSG00000171560	"Fibrinogen alpha chain"	P02671	4	154583128-154590745	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Adaptive immunity, Blood coagulation, Hemostasis, Immunity, Innate immunity"		"Amyloidosis, Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	387	"liver: 18550.1"	"Cell type enriched"	"Detected in some"	41	"Hepatocytes: 17365.8"	"Cancer enriched"	"Detected in many"	43	"liver cancer: 2431.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"Hep G2: 429.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB016776, HPA051370, HPA064755"	Supported		Enhanced	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	407000000	140000000000	"Endoplasmic reticulum"		"CAB016776: , HPA051370: AB_2681458, HPA064755: AB_2685345"		"unprognostic (5.95e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.02e-1)"		"unprognostic (5.68e-2)"	"prognostic favorable (7.33e-4)"	"unprognostic (1.29e-3)"			"unprognostic (1.84e-1)"		"prognostic unfavorable (4.23e-6)"	"unprognostic (4.20e-1)"	"unprognostic (1.41e-1)"			1.2	1.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.0	0.0	0.5	0.0	0.6	0.6	0.7	0.9	13.4	1.1	0.0	0.0	18.3	18550.1	5.4	0.1	0.0	0.0	0.0	0.7	18.9	0.0	0.5	0.9	0.0	0.4	0.0	0.0	0.5	0.0	0.5	0.6	0.9	0.0	0.0	10.0	47.9	3.8	0.0	0.1	0.4	0.0	0.1	0.6	0.8	0.0	0.0	28.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.1	0.0	2.7	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.4	0.1	429.3	0.0	6.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.2	0.0	0.5	0.1	0.0	0.5	6.1	0.0	0.0	0.5	0.2	0.1	3.5	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.3	0.0	0.0	1.0	0.0	1.9	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	27.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	414.6	3.2	0.0	0.0	0.0	0.0	0.0	1.9	38.6	28.3	0.1	0.2	8.1	0.0	205.9	0.0	1.8	0.1	0.1	1.1	1.3	0.0	0.0	238.8	17365.8	0.1	0.0	0.0	0.0	0.0	328.3	0.0	46.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	1.2	0.0	0.0	0.0	2.3	9.5	0.0	0.0	0.0	0.1	17.4	0.7	0.0	0.0	0.1	17.6	0.0	0.0	0.0
FGB		ENSG00000171564	"Fibrinogen beta chain"	P02675	4	154563011-154572807	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Blood coagulation, Hemostasis, Immunity, Innate immunity"		"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	387	"liver: 18093.6"	"Cell type enriched"	"Detected in some"	40	"Hepatocytes: 17273.6"	"Cancer enriched"	"Detected in many"	42	"liver cancer: 2262.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"Hep G2: 249.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA001900, HPA001901, CAB008624"	Enhanced		Enhanced	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA		110000000000	"Endoplasmic reticulum"		"CAB008624: AB_1615610, HPA001900: AB_1078865, HPA001901: AB_1078864"	"unprognostic (1.16e-1)"	"unprognostic (3.89e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.44e-1)"			"unprognostic (2.20e-3)"	"unprognostic (1.42e-2)"			"unprognostic (1.79e-1)"		"prognostic unfavorable (5.72e-5)"	"unprognostic (2.48e-2)"	"unprognostic (7.91e-2)"			1.1	0.8	0.0	0.0	0.0	0.1	2.8	0.0	0.0	0.8	0.0	0.5	0.0	0.6	0.3	0.6	0.8	0.4	1.1	0.0	0.0	46.7	18093.6	0.5	0.1	0.0	0.0	0.0	0.6	3.3	0.0	0.5	1.0	0.0	0.4	0.0	0.0	0.4	0.0	0.5	0.5	1.2	0.0	0.0	12.2	6.9	0.5	0.0	0.3	0.4	0.0	0.1	0.5	0.7	0.0	0.0	20.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	2.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.2	0.1	249.9	0.0	5.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	1.7	0.2	0.0	0.6	0.0	0.0	0.2	3.8	0.0	0.0	0.0	0.0	0.0	2.9	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.8	0.0	0.9	0.0	2.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	39.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.6	251.6	0.0	3.7	0.0	0.0	0.0	0.0	1.9	10.6	0.5	0.6	0.8	13.1	1.8	302.1	0.0	3.8	0.2	0.0	0.0	5.9	0.0	0.0	318.1	17273.6	0.3	0.0	0.0	0.0	0.0	421.7	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	24.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	23.7	0.0	0.0	0.0
CCER1	"C12orf12, MGC26598"	ENSG00000197651	"Coiled-coil glutamate rich protein 1"	Q8TC90	12	90905622-90955176	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	386	"testis: 38.5"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 480.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"													NA	NA																				"unprognostic (1.35e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	480.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	100.4	3.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.4	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC22A1	OCT1	ENSG00000175003	"Solute carrier family 22 member 1"	O15245	6	160121815-160158718	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	381	"liver: 614.5"	"Cell type enriched"	"Detected in some"	20	"Hepatocytes: 966.3"	"Cancer enriched"	"Detected in some"	81	"liver cancer: 83.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	12	"neutrophil: 3.5"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA029846	Approved					NA	NA					"HPA029846: AB_10603026"	"unprognostic (8.28e-2)"	"unprognostic (2.10e-1)"	"unprognostic (7.80e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.10e-2)"	"prognostic favorable (1.35e-5)"	"unprognostic (2.28e-1)"	"unprognostic (8.61e-2)"	"unprognostic (3.35e-1)"	"unprognostic (9.11e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.46e-7)"	"unprognostic (1.58e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.72e-2)"	"unprognostic (8.07e-4)"	0.3	0.3	0.2	0.1	0.2	0.4	0.3	0.0	0.8	0.3	0.2	0.2	0.0	0.3	0.1	0.2	0.3	0.7	0.1	0.5	0.0	0.9	614.5	0.4	0.2	0.2	0.1	0.2	0.4	0.4	0.0	0.3	0.0	0.3	0.4	0.1	0.1	0.4	0.1	1.0	0.4	0.3	0.0	0.0	1.6	0.3	0.3	0.1	0.1	0.7	0.1	0.0	0.1	0.3	0.4	0.0	0.2	0.2	0.4	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.2	0.0	0.8	0.0	0.0	0.4	0.1	0.4	0.2	0.1	0.2	0.6	0.0	0.3	0.3	0.0	0.5	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.4	0.4	0.0	0.2	0.1	0.0	0.6	0.0	0.4	0.3	0.0	0.0	0.0	0.1	0.1	0.4	0.3	0.3	0.7	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	3.5	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.0	0.8	0.5	0.0	0.2	0.1	0.2	0.3	0.0	0.1	0.4	0.2	0.0	1.3	2.0	1.4	0.0	0.1	0.0	0.0	0.0	0.5	0.3	0.5	47.1	0.0	0.0	2.1	0.0	0.4	0.1	0.0	0.5	0.3	0.5	0.1	0.9	0.0	13.5	6.1	0.2	0.1	0.2	0.0	0.7	0.0	0.2	11.4	966.3	0.1	0.0	3.7	0.1	0.0	16.3	0.0	0.2	0.3	0.4	0.0	1.0	0.0	0.9	0.0	0.0	0.9	0.1	0.0	0.7	0.1	0.3	0.1	1.8	0.1	0.0	0.0	0.7	0.3	0.0	0.4	0.0	0.3	0.1	1.2	0.3	0.1	0.2
TGM4	TGP	ENSG00000163810	"Transglutaminase 4"	P49221	3	44874608-44914990	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	376	"prostate: 438.3"	"Cell type enriched"	"Detected in some"	20	"Prostatic glandular cells: 226.6"	"Cancer enriched"	"Detected in single"	312	"prostate cancer: 75.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.9;hTERT-HME1: 1.3;NB-4: 2.7;RPMI-8226: 2.0;SH-SY5Y: 1.4"	"Not detected"	"Not detected"							"CAB033571, HPA073290"	Enhanced					NA	NA					"CAB033571: AB_2287329, HPA073290: "	"unprognostic (4.40e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.17e-3)"	"unprognostic (2.84e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.56e-3)"	"unprognostic (5.08e-2)"	"unprognostic (1.44e-8)"	"unprognostic (1.10e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.68e-1)"	"unprognostic (6.41e-2)"	0.0	1.1	0.0	0.2	0.0	0.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	438.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.3	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.5	4.2	0.7	0.0	0.0	0.1	0.1	0.9	0.0	0.2	0.0	0.0	0.5	0.2	0.1	0.0	0.0	5.7	0.8	0.6	0.4	0.0	0.0	0.2	0.0	0.3	1.3	0.0	1.5	0.0	0.0	0.4	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.0	11.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.2	0.0	0.4	0.0	226.6	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.1	0.3	0.0	0.4	1.0	0.2	0.1	0.2	2.4
TNP2	TP2	ENSG00000178279	"Transition protein 2"	Q05952	16	11267748-11269533	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	371	"testis: 49.7"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 919.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA																			"unprognostic (1.30e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	219.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	919.5	2.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC25A47	C14orf68	ENSG00000140107	"Solute carrier family 25 member 47"	Q6Q0C1	14	100323339-100330421	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	366	"liver: 539.1"	"Cell type enriched"	"Detected in some"	40	"Hepatocytes: 270.2"	"Cancer enriched"	"Detected in single"	273	"liver cancer: 56.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Hep G2: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"									NA	NA						"unprognostic (2.54e-3)"	"unprognostic (2.57e-3)"	"unprognostic (5.12e-2)"	"unprognostic (2.27e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.30e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.96e-3)"	"unprognostic (4.46e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.50e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.94e-1)"	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	1.4	539.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.5	0.0	1.8	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.2	0.0	0.1	0.0	2.7	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	2.9	270.2	0.0	0.0	0.0	0.6	0.0	6.7	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.8	0.0	0.0	0.0	3.5	3.5	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.7	0.0	0.0	0.4	0.1
CYP2C8	CPC8	ENSG00000138115	"Cytochrome P450 family 2 subfamily C member 8"	P10632	10	95036772-95069497	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	359	"liver: 2174.2"	"Cell type enriched"	"Detected in some"	12	"Hepatocytes: 1834.2"	"Cancer enriched"	"Detected in some"	82	"liver cancer: 102.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA013547, HPA013970, HPA015066, HPA074424"	Enhanced		Uncertain	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA			Vesicles	"Plasma membrane"	"HPA013547: AB_1847435, HPA013970: AB_1847434, HPA015066: AB_1847433, HPA074424: "	"unprognostic (3.33e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.80e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.38e-1)"	"prognostic favorable (9.82e-4)"	"unprognostic (2.85e-1)"	"unprognostic (1.44e-3)"	"unprognostic (2.63e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.05e-4)"	0.2	1.8	1.6	0.0	1.9	0.2	0.3	1.3	2.0	0.2	1.4	0.3	0.2	0.1	0.3	0.1	1.1	4.7	0.2	1.8	2.1	1.4	2174.2	0.4	0.1	1.7	2.1	1.6	0.1	1.7	0.5	3.1	0.1	1.7	0.6	0.0	3.1	0.2	0.3	0.2	0.1	1.1	0.0	1.3	1.0	6.0	4.0	1.9	0.2	0.9	0.0	0.1	0.2	0.2	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.5	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.9	1.3	2.0	1.8	2.1	1.7	2.1	1.6	1.7	1.3	1.9	2.6	0.0	0.0	0.0	1.6	8.9	0.0	0.1	0.0	0.0	1.1	0.1	0.0	0.2	147.3	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	7.3	0.9	0.1	2.0	1.8	57.5	4.5	0.2	0.0	0.1	0.0	0.2	0.0	0.6	52.8	1834.2	0.0	5.0	3.7	0.1	0.0	70.9	0.0	7.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	1.2	0.5	1.2	0.0	0.0	0.1	1.0	0.8	0.9	1.7	0.0	0.0	0.3	2.1	0.6	0.0	0.0	0.0	3.3	0.0	0.2	0.2
RBP2	"CRABP-II, CRBP2, CRBPII, RBPC2"	ENSG00000114113	"Retinol binding protein 2"	P50120	3	139452884-139480747	"Metabolic proteins, Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	357	"intestine: 2738.0"	"Cell type enriched"	"Detected in some"	26	"Proximal enterocytes: 6095.4"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 7.1;pancreatic cancer: 4.5;stomach cancer: 8.4;testis cancer: 2.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"CACO-2: 78.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA035866	Enhanced		Approved	"Golgi apparatus"		NA	NA		140000	"Golgi apparatus"		"HPA035866: AB_10672232"	"unprognostic (1.74e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.34e-2)"	"unprognostic (6.72e-6)"	"unprognostic (2.33e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.24e-1)"	"unprognostic (8.51e-3)"	"unprognostic (3.92e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.24e-3)"	"unprognostic (5.57e-3)"	"unprognostic (1.10e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.21e-1)"	0.4	1.1	5.2	1.2	3.3	0.7	0.5	1.3	3.8	0.1	0.0	2.7	2738.0	2.1	0.0	0.2	0.3	1.8	0.2	3.2	6.5	2.6	0.0	7.6	2.2	6.9	6.5	3.5	0.3	3.1	0.0	0.1	0.1	3.6	0.4	2.4	2.2	0.1	0.0	0.2	1.1	1902.4	1.0	5.1	0.1	3.7	1.0	7.0	0.0	0.5	0.0	0.0	0.0	0.0	5.1	0.0	0.2	0.2	0.2	0.0	0.0	7.1	0.0	0.0	0.0	0.0	78.8	0.1	0.6	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	5.9	0.1	0.2	0.1	0.1	0.0	11.7	0.0	0.0	4.0	10.1	0.0	0.1	0.0	0.5	0.4	0.0	0.0	0.0	0.2	0.5	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	3.3	1.3	3.8	3.2	6.5	6.9	6.5	3.5	3.6	5.1	7.0	5.1	0.0	9.6	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.1	12.9	8.4	0.0	0.0	14.0	0.0	0.6	0.0	0.0	0.0	0.2	1.2	0.0	1.0	6.1	0.0	3.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.1	185.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	2.5	0.9	6.1	226.3	0.0	0.0	0.0	6095.4	0.0	0.7	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	142.6	0.1
RCVRN	RCV1	ENSG00000109047	Recoverin	P35243	17	9896320-9905271	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Sensory transduction, Vision"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	338	"retina: 467.8"	"Cell type enriched"	"Detected in some"	4	"Rod photoreceptor cells: 1926.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"WM-115: 1.8"	"Region enhanced"	"Detected in single"		"hippocampal formation: 1.3"	"Low region specificity"	"Detected in many"			"HPA015783, CAB022363"	Enhanced					NA	NA					"CAB022363: , HPA015783: AB_2669298"	"unprognostic (1.65e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.95e-3)"		"unprognostic (4.82e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.94e-4)"	"unprognostic (1.62e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.41e-2)"	"unprognostic (9.23e-2)"	0.1	0.0	0.5	0.0	0.8	0.0	0.0	0.2	1.2	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	1.2	0.2	0.0	0.0	0.0	0.0	0.2	1.3	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	467.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.2	1.2	1.2	0.2	0.2	1.3	0.7	0.2	0.0	0.1	0.9	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	230.5	0.0	0.0	0.5	0.0	0.0	0.0	475.4	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.2	11.5	0.0	0.0	1.5	0.0	0.0	2.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	107.7	0.7	0.0	0.0	0.0	0.9	0.7	2.5	0.5	1.8	0.0	0.1	393.9	0.0	0.5	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1926.6	0.0	1.7	0.3	0.1	0.5	0.0	0.3	0.1	0.1	0.0	0.0	0.0
APOF		ENSG00000175336	"Apolipoprotein F"	Q13790	12	56360568-56362857	"Plasma proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	333	"liver: 420.1"	"Cell type enriched"	"Detected in some"	21	"Hepatocytes: 341.9"	"Cancer enriched"	"Detected in some"	6	"liver cancer: 34.8"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	10	"Hep G2: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	18000000000	2200000000				"unprognostic (3.55e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.48e-2)"	"unprognostic (8.99e-3)"	"unprognostic (9.84e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.08e-3)"	"unprognostic (7.84e-2)"	"unprognostic (4.22e-1)"	"unprognostic (5.69e-2)"	"unprognostic (2.68e-3)"	"unprognostic (8.55e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.77e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.87e-1)"	"unprognostic (4.43e-2)"	0.0	0.0	0.4	0.1	0.3	0.2	0.1	0.6	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	420.1	0.0	0.1	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.3	0.4	4.3	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.1	0.1	0.2	0.2	0.2	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.2	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.3	0.2	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.4	0.3	0.6	0.3	0.2	0.1	0.4	0.2	0.1	0.3	0.0	0.3	1.2	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.3	8.6	0.0	0.0	2.1	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.2	0.4	0.0	16.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	5.0	341.9	0.0	0.0	0.0	0.1	0.0	10.1	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.2	0.1	0.0	0.8	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.3
CYP4A11	"CYP4A2, CYP4AII"	ENSG00000187048	"Cytochrome P450 family 4 subfamily A member 11"	Q02928	1	46929177-46941484	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	333	"kidney: 220.8;liver: 864.1"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 563.8"	"Cancer enriched"	"Detected in some"	5	"liver cancer: 73.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA						"unprognostic (9.05e-2)"	"unprognostic (4.98e-2)"		"unprognostic (4.43e-2)"	"unprognostic (4.11e-1)"	"unprognostic (7.81e-5)"	"unprognostic (5.10e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.59e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.68e-2)"	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	1.6	0.0	1.4	0.0	0.1	1.1	0.1	0.0	0.4	220.8	864.1	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	32.9	0.0	7.3	0.0	0.0	0.0	0.0	17.6	0.0	0.5	0.8	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	563.8	0.0	0.0	0.1	0.0	0.0	7.3	0.2	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	4.1	108.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0
SPEM1	"C17orf83, FLJ40081"	ENSG00000181323	"Spermatid maturation 1"	Q8N4L4	17	7420324-7421632	"Predicted membrane proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	333	"testis: 69.2"	"Cell type enriched"	"Detected in some"	6	"Late spermatids: 5248.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"													NA	NA																				"unprognostic (1.28e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	808.7	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5248.6	11.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	13.8	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FGG		ENSG00000171557	"Fibrinogen gamma chain"	P02679	4	154604134-154612967	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"		"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	329	"liver: 16694.5"	"Cell type enriched"	"Detected in some"	16	"Hepatocytes: 10221.7"	"Cancer enriched"	"Detected in many"	19	"liver cancer: 1503.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	56	"Hep G2: 735.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA027529, CAB033120, HPA074638"	Supported		Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	267000000000	73000000000	"Endoplasmic reticulum"		"CAB033120: AB_2103818, HPA027529: AB_10601322, HPA074638: "	"unprognostic (1.26e-2)"				"unprognostic (4.77e-3)"	"unprognostic (6.33e-3)"	"unprognostic (3.69e-3)"	"unprognostic (2.18e-3)"		"unprognostic (9.63e-2)"	"unprognostic (7.57e-3)"		"prognostic unfavorable (1.00e-6)"	"unprognostic (1.75e-3)"	"unprognostic (3.21e-1)"		"unprognostic (1.14e-1)"	1.0	34.4	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.8	0.0	0.4	0.0	0.4	0.2	0.6	0.7	25.3	0.9	0.0	0.0	8.5	16694.5	50.6	0.1	0.0	0.0	0.0	1.4	15.9	0.0	0.4	6.4	0.0	0.4	0.0	0.0	0.4	0.3	0.5	0.5	0.6	0.0	0.0	9.1	8.7	3.1	0.1	0.3	0.4	0.0	0.0	0.5	0.6	0.1	0.0	13.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.2	0.0	1.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3.5	0.4	735.3	0.2	8.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.3	0.0	0.6	0.0	0.0	0.3	6.4	0.0	0.0	0.6	0.0	0.0	5.3	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.5	0.1	0.1	1.7	0.0	3.6	0.2	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	19.2	214.4	0.0	31.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.3	633.4	2.5	0.0	0.0	0.0	0.0	0.1	0.0	21.9	4.3	0.0	0.1	9.2	0.0	157.7	0.0	48.5	0.2	0.5	0.0	0.1	11.4	1.1	202.4	10221.7	0.2	0.0	0.0	0.0	0.0	289.5	0.0	0.5	0.0	0.8	0.0	0.0	2.0	0.0	0.0	0.0	0.0	161.8	0.0	0.0	0.0	0.0	0.0	1.6	1.5	0.0	0.0	0.0	0.1	2.0	0.6	0.0	0.0	0.4	17.3	0.2	0.0	0.0
ATP4B	ATP6B	ENSG00000186009	"ATPase H+/K+ transporting subunit beta"	P51164	13	113648804-113658198	"FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Hydrogen ion transport, Ion transport, Potassium transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	328	"stomach 1: 1105.7"	"Cell type enriched"	"Detected in some"	76	"Gastric mucus-secreting cells: 145.8"	"Cancer enriched"	"Detected in some"	12	"stomach cancer: 8.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA045400, HPA052649"	Enhanced		Uncertain	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA045400: AB_2679314, HPA052649: AB_2681900"	"unprognostic (9.92e-2)"	"unprognostic (2.19e-1)"		"unprognostic (2.66e-1)"	"unprognostic (4.86e-1)"			"unprognostic (6.43e-3)"	"unprognostic (7.81e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.22e-1)"	"unprognostic (6.50e-2)"	"unprognostic (6.65e-4)"	"unprognostic (2.25e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.78e-2)"		0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	2.9	0.2	0.0	0.0	0.0	0.4	3.3	0.0	0.1	0.2	0.0	0.4	0.1	0.4	0.0	0.4	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	1105.7	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.4	0.4	0.0	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	145.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1
ORM2	"AGP-B, AGP-B', AGP2"	ENSG00000228278	"Orosomucoid 2"	P19652	9	114329869-114333251	"Plasma proteins, Predicted secreted proteins"	"Acute phase, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	327	"liver: 8946.0"	"Cell type enriched"	"Detected in some"	41	"Hepatocytes: 10792.5"	"Cancer enriched"	"Detected in many"	34	"liver cancer: 873.1"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	40	"neutrophil: 12.0"	"Lineage enriched"	"Detected in single"	40	"granulocytes: 12.0"	"Cell line enriched"	"Detected in some"	232	"Hep G2: 831.1"									"HPA046438, HPA047725, HPA057726"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	422000000	41000000000	Vesicles	"Golgi apparatus"	"HPA046438: AB_2679666, HPA047725: AB_2680133, HPA057726: AB_2683512"	"unprognostic (6.77e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.18e-1)"	"unprognostic (5.61e-2)"	"unprognostic (5.66e-2)"	"unprognostic (9.70e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.99e-2)"	"unprognostic (5.76e-2)"	"prognostic unfavorable (1.23e-9)"	"unprognostic (3.23e-1)"	"unprognostic (6.80e-2)"	"unprognostic (7.62e-2)"	"unprognostic (9.15e-4)"	3.1	4.1	0.9	3.2	0.3	27.3	3.0	0.1	0.2	1.3	0.2	0.3	0.2	2.1	0.1	0.4	0.4	0.6	0.7	0.1	0.2	1.8	8946.0	5.8	1.1	0.2	0.3	0.0	0.3	2.2	0.0	0.2	0.2	0.1	23.8	0.1	3.6	0.3	0.0	0.4	0.4	0.4	0.1	0.7	7.4	22.1	1.4	0.1	0.5	0.3	0.0	0.0	0.3	0.3	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.2	0.0	831.1	0.0	3.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	1.2	0.0	0.0	0.1	1.1	0.4	2.5	0.0	0.3	1.9	0.1	0.0	0.3	0.1	0.0	2.6	2.0	0.2	0.1	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.7	0.6	2.2	0.0	0.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.1	0.0	0.0	0.1	0.9	0.3	0.1	0.2	0.1	0.2	0.2	0.3	0.0	0.1	0.7	0.1	0.2	0.0	0.0	10.5	0.0	16.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	263.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	6.6	1.1	0.1	7.0	0.0	141.7	0.0	6.0	0.0	0.0	15.8	1.3	0.0	0.0	162.8	10792.5	0.0	0.0	0.0	0.0	0.0	236.1	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.2
AGXT	"AGT, AGT1, AGXT1, PH1, SPAT, SPT"	ENSG00000172482	"Alanine--glyoxylate and serine--pyruvate aminotransferase"	P21549	2	240868824-240880502	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Aminotransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	322	"liver: 2217.2"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 2037.9"	"Cancer enriched"	"Detected in some"	425	"liver cancer: 253.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"Hep G2: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035370, HPA035371"	Enhanced		Supported	Vesicles		NA	NA		4700000	Vesicles		"HPA035370: AB_10673218, HPA035371: AB_2674593"	"unprognostic (3.14e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.37e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.56e-2)"	"prognostic favorable (5.92e-5)"	"unprognostic (8.28e-2)"	"unprognostic (2.77e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.57e-3)"	"unprognostic (2.54e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.37e-1)"		"unprognostic (3.26e-2)"	0.3	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	6.8	2217.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.3	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	44.3	0.1	7.3	0.0	0.7	0.0	7.6	23.5	0.1	0.1	0.2	0.0	2.8	9.0	128.4	0.0	1.7	26.7	0.4	0.0	0.4	0.0	0.0	52.5	2037.9	0.2	0.0	0.0	8.1	4.1	53.5	0.0	1.6	0.9	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	12.8	0.4	0.0	0.8	1.9	343.9	0.1	0.0	0.0	2.7	0.1	0.1	0.0	0.0	0.0	1.9	5.2	0.1	1.5	0.4
KLK3	"APS, PSA"	ENSG00000142515	"Kallikrein related peptidase 3"	P07288	19	50854915-50860764	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	320	"prostate: 8083.1"	"Cell type enriched"	"Detected in some"	77	"Prostatic glandular cells: 3438.6"	"Cancer enriched"	"Detected in some"	3905	"prostate cancer: 4241.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	173	"BEWO: 31.7;NB-4: 27.8;RPMI-8226: 19.3;SH-SY5Y: 10.5;U-2197: 10.7"									"CAB000070, HPA000764"	Enhanced				"Secreted in male reproductive system"	NA	NA		7000000			"CAB000070: , HPA000764: AB_1079700"	"unprognostic (5.06e-3)"	"unprognostic (5.60e-2)"	"unprognostic (9.93e-2)"	"unprognostic (3.90e-2)"		"unprognostic (1.09e-2)"				"unprognostic (1.26e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.13e-3)"	"unprognostic (1.94e-1)"	"unprognostic (4.64e-1)"	"unprognostic (3.15e-1)"		4.4	7.6	0.0	5.7	0.0	0.0	9.0	0.0	0.0	0.4	0.0	2.3	4.9	1.6	14.5	0.2	4.0	0.0	0.4	0.0	0.0	1.4	1.5	1.2	1.7	0.0	0.0	0.0	0.3	0.9	0.6	0.2	0.3	0.0	8083.1	1.2	0.0	4.5	25.2	0.3	0.4	3.8	0.0	0.0	0.2	1.0	7.0	0.0	0.0	0.8	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	31.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.8	0.0	0.0	0.0	0.0	0.0	19.3	0.1	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	39.0	0.0	0.0	0.0	12.4	1.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.0	0.0	0.4	2.6	0.0	0.0	0.2	0.0	0.0	3.4	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.1	9.0	0.0	0.0	0.0	1.8	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	3438.6	0.1	0.1	0.0	0.0	0.0	0.0	6.9	0.1	0.0	0.0	0.0	0.0	4.2	0.2	0.4	44.6
MLN		ENSG00000096395	Motilin	P12872	6	33794673-33804003	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	316	"intestine: 257.1"	"Cell type enriched"	"Detected in single"	11	"Enteroendocrine cells: 3.5"	"Cancer enriched"	"Detected in some"	6	"testis cancer: 5.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 3.0;SuSa: 1.1;TIME: 1.3"					"Low region specificity"	"Detected in many"			"HPA069392, HPA077622"	Enhanced				"Secreted to blood"	NA	NA	450000	200000			"HPA069392: AB_2686136, HPA077622: "					"unprognostic (7.70e-2)"					"unprognostic (6.70e-2)"				"unprognostic (4.44e-2)"	"unprognostic (3.14e-1)"			0.0	0.2	0.0	0.6	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.3	257.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.1	0.3	43.7	0.0	0.3	0.0	0.1	0.3	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.6	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.3	0.0	0.0	0.0	1.1	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.2	0.8	0.3	0.0	0.7	0.3	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CYP1A2	"CP12, P3-450"	ENSG00000140505	"Cytochrome P450 family 1 subfamily A member 2"	P05177	15	74748845-74756607	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Lyase, Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	311	"liver: 517.6"	"Cell type enriched"	"Detected in some"	57	"Hepatocytes: 85.7"	"Group enriched"	"Detected in some"	22	"liver cancer: 25.3;urothelial cancer: 6.5"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"SK-BR-3: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB016531	Enhanced					NA	NA					"CAB016531: AB_629359"				"unprognostic (1.54e-4)"			"unprognostic (1.29e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.59e-2)"		"unprognostic (1.76e-1)"	"unprognostic (1.17e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.33e-2)"	"unprognostic (7.41e-2)"	"unprognostic (2.53e-1)"	0.2	0.3	0.6	0.2	0.5	1.0	0.1	1.6	0.9	0.0	0.2	0.0	0.2	0.2	0.4	0.2	0.2	0.2	0.1	0.5	0.3	0.2	517.6	0.4	0.3	0.5	0.5	0.8	0.1	0.0	0.0	0.0	0.7	0.8	0.1	0.1	0.4	0.2	0.3	0.3	0.6	0.2	0.0	0.2	0.3	0.2	0.3	0.5	0.1	1.4	0.0	0.1	0.1	0.0	1.6	0.4	0.3	0.8	0.5	0.1	0.0	0.6	0.2	0.0	0.0	0.1	0.3	0.4	0.8	0.1	0.0	0.6	0.4	0.0	0.0	0.0	0.1	0.4	0.9	0.6	0.1	0.0	0.7	0.3	0.1	0.1	0.0	0.0	0.3	0.1	1.3	0.7	1.3	0.0	0.2	0.9	0.3	0.4	0.3	0.2	0.9	0.8	0.3	0.1	0.7	0.7	0.3	0.6	2.3	0.1	0.6	0.5	0.2	0.2	0.3	0.4	0.3	0.3	0.3	0.2	0.5	0.3	0.9	0.3	1.5	0.3	0.5	0.2	0.2	0.1	0.3	0.2	0.1	0.1	0.5	0.2	0.2	2.1	0.4	0.2	0.4	0.1	0.1	0.6	0.5	1.6	0.9	0.5	0.3	0.5	0.5	0.8	0.8	0.2	0.5	1.6	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	85.7	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2
CYP2E1	CYP2E	ENSG00000130649	"Cytochrome P450 family 2 subfamily E member 1"	P05181	10	133520406-133561220	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	308	"liver: 10463.6"	"Cell type enriched"	"Detected in many"	58	"Hepatocytes: 6272.7"	"Cancer enriched"	"Detected in some"	278	"liver cancer: 265.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 2.5;myeloid DC: 6.2"	"Group enriched"	"Detected in many"	16	"dendritic cells: 6.2;T-cells: 2.5"	"Cell line enhanced"	"Detected in many"		"HaCaT: 11.0;HL-60: 8.9;HMC-1: 8.9;NB-4: 24.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA009128, HPA029564"	Enhanced		Approved	"Endoplasmic reticulum,Mitochondria"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum, Mitochondria"		"HPA009128: AB_1078613, HPA029564: AB_10602213"	"unprognostic (6.32e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.83e-5)"	"unprognostic (1.27e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.92e-3)"	"unprognostic (6.36e-3)"	"unprognostic (2.41e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.70e-4)"	"unprognostic (1.72e-1)"	"unprognostic (8.36e-2)"	"unprognostic (3.78e-1)"	"unprognostic (9.59e-2)"	2.4	3.0	5.1	0.6	5.4	0.8	3.0	9.0	7.6	4.8	3.1	4.0	1.4	4.5	8.4	16.9	5.5	2.5	2.1	5.6	5.6	9.2	10463.6	2.6	2.0	6.2	5.8	4.7	4.2	12.5	0.6	4.1	1.4	6.8	5.4	1.2	11.6	3.6	6.2	2.8	14.0	2.2	2.2	5.1	7.3	6.8	3.7	6.2	1.8	4.0	0.9	33.9	3.5	3.3	7.5	0.1	0.0	0.3	1.0	3.5	1.9	0.7	1.6	4.5	0.0	0.3	0.0	2.7	1.4	0.2	0.5	0.0	11.0	0.0	0.2	0.4	0.3	1.5	1.8	0.2	1.3	0.6	8.9	8.9	1.0	0.2	0.0	0.7	1.9	0.0	3.1	0.6	0.4	1.0	0.7	0.6	24.0	6.4	4.3	0.4	0.4	6.1	0.0	2.0	0.0	0.0	0.0	4.2	0.0	0.6	0.2	0.3	0.9	0.0	1.4	0.4	2.3	1.0	2.2	1.0	3.0	1.5	7.4	0.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	1.1	0.6	6.2	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.2	5.1	5.4	9.0	7.6	5.6	5.6	6.2	5.8	4.7	6.8	5.1	6.2	7.5	0.8	0.0	1.1	5.5	9.2	2.3	0.2	0.7	0.6	5.7	0.6	0.5	2.8	48.6	1.9	0.0	2.1	0.0	0.4	0.1	0.0	1.6	2.1	0.6	0.8	4.6	0.0	67.6	6.7	1.3	0.1	1.1	1.5	0.5	1.3	0.7	67.1	6272.7	0.0	8.4	5.3	0.0	0.0	108.0	2.8	2.1	1.5	0.3	0.0	1.9	0.4	0.7	0.0	2.0	2.2	3.2	0.0	2.6	0.3	0.6	0.0	0.6	2.2	5.8	0.0	0.2	0.6	4.1	4.2	2.0	7.5	0.1	5.7	0.2	0.0	0.0
ADH1A	ADH1	ENSG00000187758	"Alcohol dehydrogenase 1A (class I), alpha polypeptide"	P07327	4	99276369-99291003	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	305	"liver: 2761.4"	"Cell type enriched"	"Detected in some"	12	"Hepatocytes: 200.9"	"Cancer enriched"	"Detected in some"	251	"liver cancer: 165.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"ASC diff: 8.2"									"CAB009562, HPA047814, HPA060902"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		38000000	"Plasma membrane, Cytosol"		"CAB009562: AB_2257984, HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (5.89e-2)"	"unprognostic (6.16e-2)"		"unprognostic (1.20e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.40e-1)"	"prognostic favorable (2.38e-4)"	"unprognostic (2.78e-3)"		"unprognostic (4.25e-1)"	"unprognostic (4.79e-3)"	"unprognostic (6.21e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.40e-1)"		"unprognostic (2.86e-2)"	7.2	1.6	0.2	0.4	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.3	9.0	0.3	0.5	0.1	0.5	6.7	0.2	0.0	0.0	0.7	2761.4	0.8	0.0	0.1	0.0	0.0	0.1	1.1	0.0	0.3	0.1	0.1	0.0	0.3	0.0	0.2	0.0	0.1	0.1	1.8	0.0	0.1	0.3	0.4	0.3	0.0	0.0	0.1	1.1	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	15.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.1	0.1	0.3	0.0	10.7	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	8.6	200.9	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.2	0.1	0.0	0.0	0.5	0.0	0.0	0.0
TMEM174	"FLJ31268, MGC13034"	ENSG00000164325	"Transmembrane protein 174"	Q8WUU8	5	73173193-73175143	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	304	"kidney: 154.6"	"Cell type enriched"	"Detected in some"	10	"Proximal tubular cells: 160.6"	"Cancer enriched"	"Detected in single"	126	"renal cancer: 6.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA037975	Enhanced					NA	NA					"HPA037975: AB_10672732"					"unprognostic (8.11e-2)"								"prognostic favorable (3.30e-6)"					0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	154.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.5	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	160.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0
AMY1A	AMY1	ENSG00000237763	"Amylase alpha 1A"	P04745	1	103655290-103664554	"Metabolic proteins, Predicted secreted proteins"	"Carbohydrate metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in some"	290	"salivary gland: 22262.5"	"Cell type enriched"	"Detected in some"	6	"Respiratory ciliated cells: 21.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB004310, HPA045394, HPA045399, HPA046980"	Enhanced				"Secreted to digestive system"	NA	NA		70000000			"CAB004310: AB_626668, HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889"																		0.0	0.0	0.0	0.0	0.0	2.7	0.5	0.0	0.0	76.7	0.0	0.0	0.0	0.0	0.0	0.0	27.8	0.0	0.7	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.9	6.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	22262.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.5	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	2.2	0.0	0.0	0.6	1.2	0.0	0.0	0.0	0.0	0.0	2.6	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	21.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5
C16orf78	MGC33367	ENSG00000166152	"Chromosome 16 open reading frame 78"	Q8WTQ4	16	49373804-49399431	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	287	"testis: 49.1"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 1738.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	316.9	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1738.4	5.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	6.7	2.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0
C9		ENSG00000113600	"Complement C9"	P02748	5	39284140-39424868	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"		"Age-related macular degeneration, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	287	"liver: 1408.7"	"Cell type enriched"	"Detected in some"	37	"Hepatocytes: 1962.3"	"Cancer enriched"	"Detected in single"	244	"liver cancer: 90.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"JURKAT: 9.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002151, HPA029577"	Uncertain				"Secreted to blood"	NA	NA	69600000000	64000000000			"CAB002151: AB_563670, HPA029577: AB_10603779"	"unprognostic (1.00e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.50e-1)"		"unprognostic (2.01e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.49e-3)"		"unprognostic (1.91e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.19e-2)"	"unprognostic (9.43e-5)"	"unprognostic (1.36e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.04e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1408.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	6.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	20.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.6	0.0	0.8	2.0	0.0	18.7	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	42.5	1962.3	1.2	0.0	0.1	0.2	0.0	52.6	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.4	0.1	3.7	1.7	0.0	0.0	0.3	3.0	0.0	0.0	0.1
KRTAP3-1	KAP3.1	ENSG00000212901	"Keratin associated protein 3-1"	Q9BYR8	17	41008521-41019324	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	285	"skin 1: 140.6"	"Cell type enriched"	"Detected in some"	4	"Basal prostatic cells: 581.4"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 2.8;urothelial cancer: 2.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.0;BJ: 4.9;CACO-2: 12.7;HaCaT: 2.4;T-47d: 2.0"	"Not detected"	"Not detected"													NA	NA									"unprognostic (4.24e-1)"				"unprognostic (3.00e-2)"				"unprognostic (7.37e-2)"						0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	140.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	581.4	0.0	4.0	0.0	0.9	0.0	0.0	0.0	3.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.1	0.3	1.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	139.6	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	1.3	0.0	1.4	11.2	0.0	0.0	71.8
CFHR1	"CFHL, CFHL1, CFHL1P, CFHR1P, FHR1, H36-1, H36-2, HFL1, HFL2"	ENSG00000244414	"Complement factor H related 1"	Q03591	1	196819731-196832189	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	276	"liver: 2098.7"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 320.0"	"Cancer enriched"	"Detected in single"	798	"liver cancer: 182.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 1.0;HeLa: 1.2;HL-60: 2.0;U-266/70: 2.4"	"Not detected"	"Not detected"							"HPA038915, HPA038922, HPA040726"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA		13000000000	Vesicles		"HPA038915: AB_2676269, HPA038922: AB_2676271, HPA040726: AB_2677101"	"unprognostic (2.28e-1)"	"unprognostic (3.18e-1)"			"unprognostic (3.50e-2)"	"unprognostic (1.88e-2)"	"prognostic favorable (8.71e-6)"	"unprognostic (3.02e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.48e-2)"		"unprognostic (7.21e-4)"	"unprognostic (7.01e-4)"	"unprognostic (1.13e-1)"		"unprognostic (6.41e-2)"	1.5	0.6	0.0	1.8	0.1	0.0	0.5	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.9	7.6	2098.7	0.1	6.7	0.1	0.8	0.1	0.3	0.3	0.0	0.1	0.1	0.2	0.2	0.2	0.2	0.1	0.0	0.2	0.1	0.8	0.2	0.1	6.1	0.2	0.1	0.2	0.0	0.1	0.2	0.0	0.4	0.2	0.1	0.0	0.0	0.1	0.1	1.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.6	1.2	0.0	0.0	2.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.1	0.9	0.3	0.0	0.6	0.0	0.3	0.0	0.0	0.3	0.8	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.5	0.3	0.1	0.1	0.0	2.4	0.0	0.4	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.9	0.1	0.8	0.1	0.2	0.1	0.2	0.1	0.5	3.2	0.0	0.0	2.2	0.4	0.1	0.0	0.0	1.2	0.0	0.1	1.8	11.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	18.7	0.0	0.0	0.0	9.9	0.0	0.0	0.0	6.0	15.0	320.0	5.6	0.0	0.4	0.0	0.0	16.9	0.4	0.2	1.2	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.0	41.0	2.1	0.3	1.5	0.0	0.0	0.3	1.4	5.6	0.1	0.1
GAGE12D		ENSG00000227488	"G antigen 12D"	A1L429	X	49541767-49549094	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	273	"testis: 27.3"	"Cell type enriched"	"Detected in single"	10	"Spermatogonia: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"U-266/84: 37.0"									HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: AB_2678376"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.4	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.1	9.1	0.0	0.0	0.0	37.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC25A31	"ANT4, DKFZP434N1235"	ENSG00000151475	"Solute carrier family 25 member 31"	Q9H0C2	4	127730400-127774292	"Predicted membrane proteins, Transporters"	"Antiport, Differentiation, Spermatogenesis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	271	"testis: 47.7"	"Cell type enriched"	"Detected in some"	8	"Spermatocytes: 198.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA015064, HPA016841, HPA046835, HPA071684"	Uncertain		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA015064: AB_1847691, HPA016841: AB_1847690, HPA046835: AB_2679831, HPA071684: AB_2686431"					"unprognostic (8.15e-2)"									"unprognostic (1.62e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.32e-1)"		0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	47.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	13.5	3.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	198.2	23.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPINT4	"C20orf137, dJ601O1.1"	ENSG00000149651	"Serine peptidase inhibitor, Kunitz type 4"	Q6UDR6	20	45722347-45725830	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	255	"epididymis: 281.3"	"Cell type enriched"	"Detected in single"	9	"Rod photoreceptor cells: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NB-4: 1.0"	"Not detected"	"Not detected"							HPA046703	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA046703: AB_2732530"														"unprognostic (3.61e-1)"				0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	281.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM187B	"FLJ25660, TMEM162"	ENSG00000177558	"Family with sequence similarity 187 member B"	Q17R55	19	35224800-35228729	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	241	"testis: 69.3"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 2682.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA079535	Enhanced					NA	NA					"HPA079535: "	"unprognostic (3.34e-1)"			"unprognostic (4.96e-1)"				"unprognostic (2.40e-1)"		"unprognostic (2.84e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.25e-3)"	"unprognostic (2.71e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.76e-2)"	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	69.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	548.1	0.0	0.0	0.5	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	2682.3	7.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADAM7	"EAPI, GP-83"	ENSG00000069206	"ADAM metallopeptidase domain 7"	Q9H2U9	8	24440930-24526970	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	237	"epididymis: 3759.0"	"Cell type enriched"	"Detected in some"	7	"Early spermatids: 128.3"	"Group enriched"	"Detected in some"	16	"prostate cancer: 1.0;renal cancer: 0.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	30	"BEWO: 2.4;NB-4: 6.1;RPMI-8226: 1.7;SH-SY5Y: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA008879	Enhanced				"Intracellular and membrane"	NA	NA					"HPA008879: AB_10601789"												"unprognostic (1.03e-3)"	"unprognostic (3.96e-4)"					0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	3759.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.6	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.1	0.3	0.1	0.6	0.2	0.0	1.2	0.0	0.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	128.3	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	16.7	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC7A13	"AGT-1, XAT2"	ENSG00000164893	"Solute carrier family 7 member 13"	Q8TCU3	8	86214063-86321146	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	234	"kidney: 42.4"	"Cell type enriched"	"Detected in some"	6	"Proximal tubular cells: 27.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (3.34e-1)"						"unprognostic (2.62e-1)"					"unprognostic (1.12e-1)"	"unprognostic (2.96e-5)"					0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	27.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
APOC4		ENSG00000267467	"Apolipoprotein C4"	P55056	19	44942237-44945496	"Plasma proteins, Predicted secreted proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	228	"liver: 634.1"	"Cell type enriched"	"Detected in single"	37	"Hepatocytes: 3.8"	"Cancer enriched"	"Detected in single"	15	"liver cancer: 0.7"	"Region enriched"	"Detected in single"	4	"white matter: 2.7"	"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 2.4;TIME: 1.2"	"Not detected"	"Not detected"							HPA062671	Approved				"Secreted to blood"	NA	NA	1000000000	980000000			"HPA062671: AB_2684828"							"unprognostic (1.82e-3)"											0.2	0.3	0.3	0.0	0.6	0.5	0.2	0.2	0.6	0.0	0.0	0.1	0.0	0.4	0.7	0.0	0.2	0.3	0.2	0.1	0.1	0.0	634.1	0.2	0.1	0.3	0.2	0.0	0.3	0.0	0.2	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.4	0.1	1.2	0.2	0.0	0.0	0.0	0.1	0.1	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.2	0.1	0.5	0.3	2.4	0.0	0.3	0.0	1.2	0.1	0.0	0.1	0.0	0.1	0.3	0.4	0.0	0.4	0.0	0.6	0.2	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	1.0	0.1	0.1	0.4	0.0	0.0	0.3	0.6	0.2	0.6	0.1	0.1	0.3	0.2	0.0	0.3	0.3	0.2	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
F12		ENSG00000131187	"Coagulation factor XII"	P00748	5	177402141-177409564	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	226	"liver: 609.5"	"Cell type enriched"	"Detected in many"	8	"Hepatocytes: 523.0"	"Cancer enriched"	"Detected in many"	21	"liver cancer: 171.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"classical monocyte: 1.2;eosinophil: 3.6"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.6;monocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.1;MCF7: 9.0;PC-3: 6.4;SH-SY5Y: 4.3;U-937: 4.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA003825	Approved				"Secreted to blood"	NA	NA	1040000	7000000000			"HPA003825: AB_1078790"	"unprognostic (9.75e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.93e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.32e-1)"	"prognostic favorable (4.63e-5)"	"unprognostic (6.97e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.96e-2)"	"unprognostic (4.41e-1)"	"unprognostic (6.54e-2)"	"prognostic unfavorable (7.09e-4)"	"unprognostic (4.11e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.40e-6)"	"unprognostic (6.48e-2)"	0.2	0.1	1.0	0.1	1.1	2.6	0.3	0.1	1.3	0.2	0.0	0.4	0.5	0.2	0.0	1.9	0.3	0.1	0.2	1.5	0.8	0.8	609.5	0.6	0.0	0.7	0.5	1.1	0.0	0.6	0.1	0.6	0.1	0.9	0.3	0.1	0.0	0.4	0.0	0.0	0.9	0.5	0.0	0.3	1.0	0.1	1.2	0.6	0.0	0.2	0.0	0.1	0.2	0.8	0.8	0.7	1.6	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	1.0	0.0	0.3	0.0	0.2	1.1	0.5	0.3	0.0	7.1	1.4	1.1	0.3	0.7	0.2	0.6	2.4	0.2	1.0	0.0	0.3	0.1	0.2	1.6	0.3	2.5	0.0	9.0	0.1	2.1	0.0	2.1	6.4	0.5	0.2	1.5	0.9	0.0	2.0	4.3	0.2	0.7	0.6	0.0	0.3	0.0	0.0	0.1	0.8	0.0	0.2	0.4	0.0	0.0	0.0	4.6	0.5	0.0	1.2	3.6	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.3	0.5	0.5	0.0	0.5	1.0	1.1	0.1	1.3	1.5	0.8	0.7	0.5	1.1	0.9	0.3	0.6	0.8	0.5	0.0	0.0	0.3	5.3	33.1	7.7	15.3	35.9	0.6	12.7	17.5	1.0	17.2	3.9	1.8	4.2	0.0	4.0	27.6	0.0	6.5	23.3	2.2	0.9	2.2	10.3	19.6	2.6	4.2	0.4	1.1	3.6	1.7	0.0	0.2	16.8	523.0	0.5	0.0	0.8	12.3	8.2	16.7	6.1	42.1	0.6	1.0	8.8	0.0	1.2	0.7	2.1	1.5	0.6	11.1	22.0	0.0	8.5	7.2	60.7	16.1	3.6	0.9	0.0	0.5	1.1	12.0	23.6	57.5	54.3	0.1	4.0	0.1	34.8	7.6
PSG2	"CEA, PSBG2, PSG1, PSGGB"	ENSG00000242221	"Pregnancy specific beta-1-glycoprotein 2"	P11465	19	43064209-43083045	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	223	"placenta: 240.7"	"Cell type enriched"	"Detected in some"	30	"Syncytiotrophoblasts: 802.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 10.8;fHDF/TERT166: 23.9;HBF TERT88: 34.8;SuSa: 9.4;U-2197: 45.7"														"Secreted in female reproductive system"	NA	NA		41000000																	"unprognostic (1.02e-2)"				0.0	0.0	0.2	0.0	0.1	0.8	0.0	1.0	0.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.0	240.7	0.6	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.9	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	1.8	1.0	4.7	0.0	0.0	0.0	0.0	23.9	1.3	0.5	0.0	0.0	34.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.1	45.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.0	0.6	0.3	0.0	0.2	0.0	0.1	0.6	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	2.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	26.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	1.8	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	802.3	0.0	0.0	0.0	0.8
CSH2	"CS-2, CSB, hCS-B"	ENSG00000213218	"Chorionic somatomammotropin hormone 2"	P0DML3	17	63872012-63873766	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	218	"placenta: 3319.6"	"Cell type enriched"	"Detected in some"	12	"Syncytiotrophoblasts: 275.5"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	27	"BEWO: 9.3;SuSa: 13.1"									HPA043715	Supported				"Secreted to blood"	NA	NA					"HPA043715: AB_2678632"		"unprognostic (1.68e-1)"								"unprognostic (1.85e-1)"					"unprognostic (1.86e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.1	1.2	0.0	2.0	3319.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	15.2	0.0	8.6	5.2	0.2	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	275.5	0.0	0.0	0.0	0.0
KRTAP3-3	KAP3.3	ENSG00000212899	"Keratin associated protein 3-3"	Q9BYR6	17	40993430-40994164	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	218	"skin 1: 77.6"	"Cell type enriched"	"Detected in single"	4	"Enteroendocrine cells: 1.8"	"Cancer enhanced"	"Detected in single"		"urothelial cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042992	Supported					NA	NA					"HPA042992: AB_2678258"																		0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	77.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
APOA5	"APOA-V, RAP3"	ENSG00000110243	"Apolipoprotein A5"	Q6Q788	11	116789367-116792420	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Lipid transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	216	"liver: 586.9"	"Cell type enriched"	"Detected in some"	88	"Hepatocytes: 1249.5"	"Cancer enriched"	"Detected in single"	489	"liver cancer: 112.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	55	"Hep G2: 35.6"	"Not detected"	"Not detected"												"Secreted to blood"	NA	NA	114000000	21000000				"unprognostic (1.57e-4)"						"unprognostic (4.67e-3)"	"unprognostic (5.57e-2)"		"unprognostic (2.60e-3)"		"unprognostic (2.40e-1)"		"unprognostic (2.31e-4)"				0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	586.9	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	35.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	10.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	11.4	1249.5	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0
TMEM270	"MGC26719, WBSCR28"	ENSG00000175877	"Transmembrane protein 270"	Q6UE05	7	73861159-73865890	"Human disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	215	"testis: 78.2"	"Cell type enriched"	"Detected in single"	7	"Endometrial ciliated cells: 2.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"MCF7: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA077196			Approved	Vesicles		NA	NA			Vesicles		"HPA077196: AB_2732334"	"unprognostic (3.84e-2)"	"unprognostic (6.91e-2)"	"unprognostic (6.87e-5)"	"unprognostic (1.38e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.81e-3)"	"unprognostic (1.34e-1)"	"unprognostic (8.31e-3)"		"unprognostic (2.07e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.69e-1)"	"unprognostic (2.56e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.23e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	78.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
F13B	FXIIIB	ENSG00000143278	"Coagulation factor XIII B chain"	P05160	1	197038741-197067260	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"		"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	211	"liver: 201.8"	"Cell type enriched"	"Detected in some"	26	"Hepatocytes: 54.9"	"Cancer enriched"	"Detected in single"	816	"liver cancer: 46.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA003827, HPA052139"	Supported				"Secreted to blood"	NA	NA		4700000000			"HPA003827: AB_1078794, HPA052139: AB_2681744"					"unprognostic (1.46e-1)"		"prognostic favorable (6.78e-5)"							"unprognostic (1.21e-2)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	201.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	54.9	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0
GIP		ENSG00000159224	"Gastric inhibitory polypeptide"	P09681	17	48958554-48968596	"Plasma proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	209	"intestine: 261.9"	"Cell type enriched"	"Detected in single"	4	"Intestinal goblet cells: 1.9"	"Cancer enriched"	"Detected in some"	63	"testis cancer: 74.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A549: 6.6;BEWO: 5.9;Hep G2: 9.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA021612, HPA064596"	Enhanced				"Secreted to blood"	NA	NA	33900	540000			"HPA021612: AB_1849506, HPA064596: "										"unprognostic (2.95e-1)"	"unprognostic (2.70e-3)"			"unprognostic (4.42e-2)"	"unprognostic (1.82e-1)"			0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	261.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.5	0.0	0.0	0.0	1.2	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.1	0.0	0.3	0.5	5.9	0.3	0.0	0.0	0.0	1.7	0.7	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.0	9.8	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.6	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0
PRH1	Pa	ENSG00000231887	"Proline rich protein HaeIII subfamily 1"		12	10824960-11171608	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in many"	204	"salivary gland: 12178.5"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 2472.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.8;OE19: 1.3"															NA	NA						"unprognostic (1.39e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.83e-3)"	"unprognostic (3.61e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.70e-1)"	"unprognostic (6.81e-2)"	"unprognostic (6.85e-2)"	"unprognostic (7.35e-3)"	"unprognostic (2.14e-1)"	"unprognostic (5.00e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.68e-1)"	0.9	1.8	0.6	0.1	0.6	0.9	1.2	0.3	1.0	1.5	0.1	0.9	0.0	1.3	0.0	11.3	0.9	0.0	1.6	0.9	0.3	1.5	2.2	1.4	0.0	1.3	1.0	0.3	1.8	6.2	0.3	4.4	1.2	1.2	1.5	0.0	0.2	12178.5	0.1	0.4	0.8	1.0	0.0	0.5	1.3	0.9	59.6	0.5	0.4	1.6	0.0	0.0	0.9	1.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.6	0.0	0.2	1.8	0.2	0.0	0.0	0.7	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.2	0.0	1.3	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.3	0.0	0.6	0.6	0.3	1.0	0.9	0.3	1.3	1.0	0.3	1.2	0.5	0.5	1.3	16.7	9.6	2.0	0.0	7.0	0.0	0.5	0.0	0.6	1.9	13.8	11.4	0.9	0.0	4.3	23.9	4.2	1.0	15.2	1.2	1.9	11.4	586.1	5.9	12.7	5.4	1.8	2.7	0.0	6.9	0.4	7.0	0.5	4.9	0.0	45.8	4.6	0.7	0.9	3.3	0.0	0.4	0.0	1.0	0.0	2472.1	7.8	6.7	0.0	0.0	10.7	2.6	1.0	0.0	0.0	15.3	0.3	6.4	3.2	0.6	0.6	3.9	0.7	1.3	0.0	0.8	8.7	7.9	4.6	0.2	0.0	0.8	8.8	46.8	1.2	0.3
C4orf17	DKFZP434G072	ENSG00000138813	"Chromosome 4 open reading frame 17"	Q53FE4	4	99511012-99542303	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	203	"testis: 20.2"	"Cell type enriched"	"Detected in some"	11	"Early spermatids: 230.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA060374, HPA060564"	Uncertain					NA	NA					"HPA060374: AB_2684268, HPA060564: AB_2684319"																"unprognostic (1.34e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	230.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	20.2	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TPTE	"CT44, PTEN2"	ENSG00000274391	"Transmembrane phosphatase with tensin homology"	P56180	21	10521553-10606140	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	201	"testis: 108.2"	"Cell type enriched"	"Detected in some"	6	"Spermatocytes: 464.7"	"Cancer enriched"	"Detected in single"	7	"testis cancer: 0.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 6.7;K-562: 8.2;Karpas-707: 6.4;MCF7: 4.9;PC-3: 4.8;RPMI-8226: 9.0;SuSa: 7.6;U-266/70: 7.7"									"HPA049690, HPA068342"	Enhanced		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA			Cytosol	"Endoplasmic reticulum"	"HPA049690: AB_2680850, HPA068342: AB_2685976"															"unprognostic (3.63e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	108.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	6.4	0.0	4.9	0.0	0.0	1.0	0.0	4.8	0.0	0.0	9.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	7.6	0.0	0.0	0.0	1.8	4.1	2.1	0.0	7.7	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	20.6	0.1	0.0	0.1	0.0	0.0	0.7	0.0	1.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.3	13.9	5.0	0.1	0.0	1.9	0.0	0.0	0.0	0.5	0.3	0.0	0.0	2.6	0.0	0.0	0.0	0.4	0.0	0.0	13.1	0.0	0.0	464.7	69.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1
AC023491.2		ENSG00000278633	"Putative POM121-like protein 1"		Unmapped	10598-13001	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in single"	200	"testis: 35.6"	"Cell type enriched"	"Detected in some"	27	"Spermatocytes: 38.3"					"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.6	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PSG3		ENSG00000221826	"Pregnancy specific beta-1-glycoprotein 3"	Q16557	19	42721638-42740481	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	199	"placenta: 142.8"	"Cell type enriched"	"Detected in some"	88	"Syncytiotrophoblasts: 1579.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-2197: 1.4"									HPA046327	Supported				"Secreted in female reproductive system"	NA	NA		67000000			"HPA046327: AB_2679624"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	142.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	7.9	0.0	0.0	0.0	3.9	11.2	0.0	0.1	0.3	0.0	0.0	0.4	0.0	17.9	0.9	0.0	0.8	0.0	0.1	0.0	0.0	3.8	0.0	0.4	0.0	0.0	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	1579.6	0.0	0.0	0.0	0.0
SMIM23	"C5orf50, LOC644994"	ENSG00000185662	"Small integral membrane protein 23"	A6NLE4	5	171782432-171796126	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	195	"testis: 25.2"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 287.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (6.47e-3)"			"unprognostic (1.71e-1)"						"unprognostic (7.80e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.79e-2)"		"unprognostic (2.72e-1)"			"unprognostic (5.36e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	25.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	287.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C8A		ENSG00000157131	"Complement C8 alpha chain"	P07357	1	56854797-56918223	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	194	"liver: 641.0"	"Cell type enriched"	"Detected in some"	36	"Hepatocytes: 296.4"	"Cancer enriched"	"Detected in single"	279	"liver cancer: 85.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"Hep G2: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA		6400000000										"unprognostic (3.73e-3)"	"unprognostic (2.44e-1)"			"unprognostic (1.28e-1)"			"unprognostic (6.40e-2)"		"unprognostic (9.82e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.1	641.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.0	5.3	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	5.3	296.4	0.0	0.0	0.1	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1
HP		ENSG00000257017	Haptoglobin	P00738	16	72054505-72061055	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Immunity"	"Antibiotic, Antimicrobial, Antioxidant, Serine protease homolog"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	194	"liver: 61616.4"	"Cell type enriched"	"Detected in many"	43	"Hepatocytes: 59512.7"	"Cancer enriched"	"Detected in many"	81	"liver cancer: 1297.4"	"Group enriched"	"Detected in all"	4	"hypothalamus: 29.8;medulla oblongata: 29.9"	"Group enriched"	"Detected in many"	5	"classical monocyte: 49.3;eosinophil: 80.2"	"Group enriched"	"Detected in many"	7	"granulocytes: 80.2;monocytes: 49.3"	"Group enriched"	"Detected in some"	5	"Hep G2: 232.2;HSkMC: 121.4"									"CAB003787, HPA047750, HPA066795"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	998000000000	100000000000	Vesicles		"CAB003787: , HPA047750: AB_2680146, HPA066795: "	"unprognostic (6.38e-3)"	"unprognostic (7.73e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.34e-3)"	"unprognostic (2.07e-1)"	"unprognostic (7.79e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.84e-1)"	"unprognostic (6.30e-2)"	"unprognostic (8.18e-2)"	"prognostic unfavorable (6.94e-13)"	"unprognostic (4.34e-4)"	"unprognostic (1.80e-1)"	"unprognostic (6.61e-2)"	"unprognostic (2.49e-2)"	318.1	11.5	2.1	27.1	2.4	233.7	34.5	2.0	2.9	72.5	3.9	3.6	1.5	3.5	3.0	5.4	75.2	1.3	86.5	2.1	29.8	19.2	61616.4	92.1	1.8	29.9	2.5	2.0	10.0	7.7	0.2	50.3	2.5	3.9	7.4	0.6	0.7	6.2	0.2	5.0	3.2	4.5	4.5	2.9	72.5	6.2	2.1	7.3	2.7	6.4	0.4	3.1	3.8	3.4	6.7	0.0	0.0	0.0	0.0	6.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	8.5	0.3	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	11.2	0.2	232.2	0.3	33.3	6.2	121.4	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	2.0	0.4	2.6	0.0	0.0	1.1	23.6	0.0	0.0	0.1	0.0	0.0	16.2	0.0	0.0	0.0	0.0	6.8	5.1	0.0	0.8	0.0	0.0	3.9	0.0	14.1	0.0	12.7	0.0	6.2	49.3	80.2	0.0	2.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	14.2	0.0	2.1	0.0	0.0	15.2	2.1	2.4	2.0	2.9	2.1	29.8	29.9	2.5	2.0	3.9	2.9	7.3	6.7	0.4	19.2	228.7	1.6	96.1	0.1	0.7	1.9	0.0	0.4	0.4	0.3	66.6	1085.2	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.1	56.7	0.0	1128.3	0.0	10.4	0.1	45.5	0.0	1.3	3.8	0.4	1038.7	59512.7	2.3	0.0	0.0	0.2	4.1	1381.4	0.0	0.5	10.2	7.8	1.8	0.0	0.3	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.8	0.0	1.5	7.5	0.2	0.0	2.6	1.8	0.0	0.0	0.1	0.3	0.1	90.3	0.0	0.3	0.1
PSG1	"CD66f, PBG1, PSBG1, PSGGA"	ENSG00000231924	"Pregnancy specific beta-1-glycoprotein 1"	P11464	19	42866464-42879822	"CD markers, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	193	"placenta: 262.1"	"Cell type enriched"	"Detected in some"	98	"Syncytiotrophoblasts: 207.0"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 0.5"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	19	"U-2197: 412.3"									HPA046327	Supported				"Secreted in female reproductive system"	NA	NA		75000000			"HPA046327: AB_2679624"					"unprognostic (2.02e-1)"	"unprognostic (3.54e-1)"							"unprognostic (2.44e-7)"			"unprognostic (2.28e-2)"		0.0	0.0	0.3	0.0	0.1	0.0	0.0	1.3	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	262.1	0.7	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.6	0.0	0.6	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.4	0.0	0.0	0.0	0.0	0.1	18.1	6.0	1.5	2.3	0.0	0.4	0.0	0.0	21.1	4.3	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	2.1	2.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.6	0.5	0.0	21.9	0.2	0.0	0.7	0.0	0.0	412.3	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	1.3	0.7	0.4	0.0	0.2	0.0	0.2	0.7	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.3	0.4	0.2	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	207.0	0.0	0.0	0.0	0.0
ORM1		ENSG00000229314	"Orosomucoid 1"	P02763	9	114323056-114326475	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Acute phase, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	192	"liver: 43326.9"	"Cell type enriched"	"Detected in some"	46	"Hepatocytes: 58657.7"	"Cancer enriched"	"Detected in many"	16	"liver cancer: 2506.9"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	47	"neutrophil: 193.9"	"Lineage enriched"	"Detected in many"	47	"granulocytes: 193.9"	"Cell line enriched"	"Detected in some"	12	"Hep G2: 1182.7"									"CAB006265, HPA046438, HPA047725, HPA057726"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	945000000000	61000000000	Vesicles	"Golgi apparatus"	"CAB006265: AB_425575, HPA046438: AB_2679666, HPA047725: AB_2680133, HPA057726: AB_2683512"	"unprognostic (3.85e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.26e-1)"		"unprognostic (1.16e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (2.35e-4)"	"unprognostic (2.10e-1)"	"unprognostic (4.38e-2)"	"unprognostic (9.32e-3)"	"unprognostic (4.51e-2)"	8.8	10.3	0.7	12.8	0.2	225.2	6.7	0.1	0.4	2.1	0.2	1.4	0.1	2.7	0.3	2.0	1.9	1.0	3.3	0.2	0.1	5.0	43326.9	24.6	0.7	0.3	0.2	0.0	1.6	8.2	0.0	1.4	1.3	0.2	58.1	0.0	1.1	1.4	0.0	2.0	1.6	2.3	0.3	0.5	51.7	19.4	2.8	0.1	1.2	2.8	0.3	0.1	1.6	2.2	0.2	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	2.1	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	3.4	0.6	1182.7	0.1	5.3	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.5	0.0	0.2	0.0	0.2	1.0	0.1	0.0	0.7	7.1	0.0	0.0	0.4	0.0	0.0	5.7	5.5	0.0	0.0	0.4	102.0	1.2	0.0	0.5	0.0	0.0	1.2	0.6	3.5	0.0	4.3	0.1	0.0	4.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	193.9	0.0	1.0	0.0	0.0	1.8	0.7	0.2	0.1	0.4	0.2	0.1	0.3	0.2	0.0	0.2	0.5	0.1	0.2	0.0	3.2	18.1	0.0	81.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1166.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	23.6	0.0	1.3	0.2	34.4	0.0	890.4	0.0	4.9	0.3	0.2	0.0	2.5	0.0	0.0	930.9	58657.7	0.1	0.0	0.0	0.0	0.0	1260.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.0	29.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	78.6	0.0	0.0	0.3
SLC22A12	"OAT4L, RST, URAT1"	ENSG00000197891	"Solute carrier family 22 member 12"	Q96S37	11	64590641-64602353	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	185	"kidney: 106.5"	"Cell type enriched"	"Detected in some"	17	"Proximal tubular cells: 173.1"	"Cancer enriched"	"Detected in some"	4	"renal cancer: 16.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA024575	Enhanced					NA	NA					"HPA024575: AB_1858650"					"unprognostic (5.88e-2)"		"unprognostic (2.33e-1)"						"prognostic favorable (2.63e-4)"	"unprognostic (6.19e-2)"	"unprognostic (3.91e-2)"			0.5	0.0	0.2	0.0	0.0	0.0	0.1	0.5	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	106.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.4	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	173.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0
C10orf62	bA548K23.1	ENSG00000203942	"Chromosome 10 open reading frame 62"	Q5T681	10	97589721-97590934	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	184	"testis: 280.1"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 9848.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA072947	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			Cytosol	"Nucleoplasm, Vesicles"	"HPA072947: AB_2686562"		"unprognostic (3.66e-2)"		"unprognostic (3.97e-2)"	"unprognostic (2.81e-1)"		"unprognostic (5.36e-2)"		"unprognostic (3.62e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.63e-2)"		"unprognostic (2.53e-2)"	"unprognostic (2.04e-2)"				0.0	0.2	0.4	0.0	0.7	0.0	0.2	1.4	0.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.3	0.4	0.7	0.7	0.0	0.0	0.9	0.9	0.1	0.0	0.3	0.1	0.2	0.0	0.9	0.3	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.5	0.0	0.0	280.1	0.7	0.0	0.1	0.3	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	1.4	0.3	0.3	0.4	0.9	0.9	0.1	0.9	0.5	0.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1711.8	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9848.3	39.4	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.2	0.0	0.0	0.0	0.3	0.0	0.0	6.6	0.0	0.0	40.7	24.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OOSP2	"FLJ36198, OOSP2A, PLAC1L, TMEM122"	ENSG00000149507	"Oocyte secreted protein 2"	Q86WS3	11	60040409-60048044	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	182	"testis: 18.1"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 7.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA050914	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA050914: AB_2681271"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TEX51		ENSG00000237524	"Testis expressed 51"	A0A1B0GUA7	2	126898864-126902097	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	182	"testis: 60.4"	"Cell type enriched"	"Detected in single"	11	"Proximal tubular cells: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TNNT2	"CMD1D, CMH2, CMPD2"	ENSG00000118194	"Troponin T2, cardiac type"	P45379	1	201359008-201377764	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Muscle protein"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	175	"heart muscle: 8893.8"	"Cell type enriched"	"Detected in many"	32	"Cardiomyocytes: 12561.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	18	"RH-30: 1077.7"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebral cortex: 3.8"	"CAB015371, HPA015774, HPA017888"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Focal adhesion sites,Microtubules"		No	No		57000	"Nucleoplasm, Nucleoli"	"Focal adhesion sites, Microtubules"	"CAB015371: AB_630390, HPA015774: AB_1858354, HPA017888: AB_1858355"	"unprognostic (1.45e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.33e-4)"	"unprognostic (1.85e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.63e-2)"	"unprognostic (5.50e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.76e-2)"	"unprognostic (9.98e-2)"	2.2	5.0	13.3	0.6	14.8	0.1	12.0	12.9	21.1	1.9	13.0	1.2	0.3	3.2	0.8	7.9	2.0	3.8	8893.8	18.1	13.0	50.7	2.3	22.2	2.7	13.7	13.3	13.9	1.3	5.0	0.0	4.5	10.4	13.8	6.2	0.1	0.4	3.7	0.7	16.6	21.8	1.6	0.1	12.8	0.7	2.0	1.7	12.8	2.1	2.0	9.5	0.5	19.4	5.1	17.0	0.0	0.0	0.8	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	2.0	0.4	0.0	0.5	0.0	0.0	6.7	0.0	0.4	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.5	0.0	44.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.1	1.1	0.0	0.0	2.2	3.3	0.0	0.0	1077.7	0.0	0.7	0.4	1.1	0.8	0.1	2.0	0.0	61.2	0.0	0.0	0.0	0.0	35.5	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	14.8	12.9	21.1	18.1	13.0	13.7	13.3	13.9	13.8	12.8	12.8	17.0	0.6	3.2	3.0	0.3	0.0	3.4	1.4	1.7	1.8	3.9	0.9	1.7	12561.8	0.0	1.1	1.8	0.0	3.5	0.0	2.3	0.0	0.4	11.6	1.2	0.2	93.3	0.0	0.0	9.4	0.4	1.2	385.3	1.1	2.4	0.0	0.0	0.0	0.0	3.1	0.0	0.5	1.7	0.0	0.0	0.8	19.3	0.6	0.3	0.0	1.9	2.6	0.0	0.0	0.5	0.7	1.2	1.4	1.2	0.0	2.1	0.8	0.9	0.7	0.6	0.0	8.7	145.8	0.5	0.2	2.5	7.2	4.2	0.1	0.8	3.2	1.5
SPATA3	TSARG1	ENSG00000173699	"Spermatogenesis associated 3"	Q8NHX4	2	230990324-231025055	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	174	"testis: 178.1"	"Cell type enriched"	"Detected in some"	6	"Late spermatids: 5258.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA018254	Enhanced					NA	NA					"HPA018254: AB_1857419"					"unprognostic (6.94e-3)"									"unprognostic (6.98e-2)"	"unprognostic (9.62e-2)"			0.0	0.0	0.5	0.0	0.5	0.1	0.1	0.3	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.5	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	178.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.3	0.4	0.5	0.5	0.5	0.7	0.2	0.5	0.2	1.0	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	783.7	0.0	0.0	1.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	5258.5	22.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.1	23.9	14.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FABP2	I-FABP	ENSG00000145384	"Fatty acid binding protein 2"	P12104	4	119317250-119322138	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	173	"intestine: 554.6"	"Cell type enriched"	"Detected in some"	10	"Proximal enterocytes: 5965.8"	"Group enriched"	"Detected in some"	9	"colorectal cancer: 3.2;pancreatic cancer: 1.6;stomach cancer: 2.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"basophil: 1.6;neutrophil: 4.2"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 4.2"	"Cell line enhanced"	"Detected in some"		"NB-4: 1.2;RPMI-8226: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA034607, CAB047325, CAB047326"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA		61000	"Actin filaments, Cytosol"	"Plasma membrane"	"CAB047325: , CAB047326: , HPA034607: AB_10601317"		"unprognostic (3.94e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-1)"				"unprognostic (4.58e-1)"		"unprognostic (1.51e-2)"	"unprognostic (2.61e-2)"		"unprognostic (1.69e-4)"	"unprognostic (1.93e-1)"	"unprognostic (1.02e-1)"			0.2	0.1	0.1	3.2	0.1	0.9	0.0	0.7	0.3	0.0	0.4	28.5	293.6	0.3	0.1	0.1	0.2	0.1	0.6	0.1	0.1	0.3	0.1	0.0	0.5	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	35.6	0.3	0.0	0.0	0.1	0.4	554.6	1.9	0.0	0.1	0.7	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	1.2	0.0	0.0	0.1	0.1	0.0	1.1	0.0	0.1	0.3	0.8	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.4	0.0	0.2	0.0	0.2	0.1	0.0	0.0	1.6	0.4	0.4	0.2	0.1	0.2	0.1	0.2	0.1	0.1	0.2	0.2	0.2	4.2	0.4	0.1	0.3	0.3	0.0	0.1	0.1	0.7	0.3	0.1	0.1	0.1	0.0	0.1	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.7	0.0	0.0	1.8	0.0	0.0	0.0	242.0	0.0	0.0	0.0	1.4	0.1	0.1	1.2	0.0	0.0	0.2	0.1	0.3	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	570.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	383.1	0.0	0.0	0.0	5965.8	17.3	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	222.5	0.0
HRG	"HPRG, HRGP"	ENSG00000113905	"Histidine rich glycoprotein"	P04196	3	186660216-186678234	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Blood coagulation, Chemotaxis, Fibrinolysis, Hemostasis"	Heparin-binding	"Disease variant, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	173	"liver: 5478.2"	"Cell type enriched"	"Detected in some"	29	"Hepatocytes: 479.7"	"Cancer enriched"	"Detected in some"	262	"liver cancer: 406.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HL-60: 2.7;RH-30: 3.0;SiHa: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA050269, HPA054598"	Supported				"Secreted to blood"	NA	NA	120000000000	28000000000			"HPA050269: AB_2681068, HPA054598: AB_2682539"		"unprognostic (2.67e-1)"		"unprognostic (1.74e-2)"		"unprognostic (7.58e-5)"	"prognostic favorable (9.64e-5)"	"unprognostic (1.44e-1)"		"unprognostic (2.98e-3)"	"unprognostic (2.22e-1)"		"unprognostic (1.55e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.46e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	31.7	5478.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	3.0	0.0	0.7	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.7	0.0	3.7	0.0	0.0	0.0	0.0	5.9	0.0	0.1	0.0	0.0	0.6	0.0	10.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.7	479.7	0.0	0.0	0.0	0.0	0.0	16.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.1
CYP2A6	"CPA6, CYP2A, CYP2A3"	ENSG00000255974	"Cytochrome P450 family 2 subfamily A member 6"	P11509	19	40843541-40850447	"Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	171	"liver: 1625.1"	"Cell type enriched"	"Detected in some"	21	"Hepatocytes: 322.3"	"Cancer enriched"	"Detected in some"	12	"liver cancer: 281.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RH-30: 1.1"									"HPA046713, HPA047262"	Supported				"Intracellular and membrane"	NA	NA					"HPA046713: AB_2679767, HPA047262: AB_2680005"	"unprognostic (5.40e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.10e-1)"	"unprognostic (5.05e-2)"	"unprognostic (2.64e-2)"	"prognostic favorable (5.38e-5)"	"unprognostic (4.98e-3)"	"unprognostic (4.86e-2)"	"unprognostic (6.23e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.25e-2)"	"unprognostic (8.83e-3)"	"unprognostic (2.46e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.55e-1)"	0.6	0.2	0.0	0.0	0.0	0.0	9.4	0.0	0.2	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	1625.1	0.3	0.0	0.2	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.2	0.0	0.3	0.2	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.2	0.0	0.0	0.4	0.3	0.2	5.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.7	0.0	8.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	11.4	322.3	0.0	0.0	0.1	0.0	0.0	14.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	5.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.7	0.0	1.5
ARR3	ARRX	ENSG00000120500	"Arrestin 3"	P36575	X	70268305-70281840	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	170	"retina: 395.6"	"Cell type enriched"	"Detected in some"	8	"Cone photoreceptor cells: 1538.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA063129	Enhanced		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA063129: AB_2732696"	"unprognostic (1.48e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.70e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.02e-3)"	"unprognostic (2.77e-7)"	"unprognostic (8.64e-2)"	"unprognostic (6.53e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.43e-1)"	0.2	0.3	0.2	0.5	0.3	0.5	0.0	0.0	0.2	0.0	0.5	0.3	0.6	0.4	0.0	0.2	0.1	0.4	0.4	0.1	0.3	0.1	0.0	0.2	0.9	0.3	0.2	0.0	0.3	0.4	0.0	0.0	0.3	0.4	0.3	0.2	395.6	0.3	0.0	0.3	2.3	0.9	0.0	0.2	0.5	0.4	0.2	0.3	0.0	0.4	0.0	0.0	0.2	0.0	0.2	0.1	0.2	1.2	0.8	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.2	0.4	0.5	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.5	1.2	0.1	0.4	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	1.3	0.0	0.4	0.1	2.2	0.0	0.2	0.4	0.2	0.3	0.2	0.2	0.4	0.2	0.0	0.0	0.5	0.1	0.3	0.2	0.0	0.0	0.7	0.0	0.1	0.9	0.5	0.7	0.5	0.0	0.5	0.3	0.3	0.5	0.7	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.2	0.1	0.3	0.3	0.2	0.0	0.4	0.2	0.3	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	46.7	0.0	0.0	0.3	0.0	0.0	0.0	1538.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.5	0.2	0.4	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	68.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	172.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GAST	GAS	ENSG00000184502	Gastrin	P01350	17	41712331-41715969	"Cancer-related genes, FDA approved drug targets, Predicted secreted proteins"		Hormone	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	167	"stomach 1: 9634.4"	"Cell type enriched"	"Detected in some"	5	"Glandular and luminal cells: 103.7"	"Group enriched"	"Detected in many"	6	"pancreatic cancer: 38.8;stomach cancer: 23.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"OE19: 34.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			CAB000038	Enhanced				"Secreted to digestive system"	NA	NA		87000			"CAB000038: "		"unprognostic (1.27e-1)"	"unprognostic (4.27e-3)"		"unprognostic (1.12e-1)"	"unprognostic (1.07e-2)"		"unprognostic (2.75e-2)"		"unprognostic (5.68e-2)"	"unprognostic (2.11e-1)"			"unprognostic (2.85e-1)"	"unprognostic (3.17e-1)"		"unprognostic (9.07e-2)"	0.0	0.0	1.0	0.0	0.5	0.0	0.7	0.3	0.9	0.2	0.3	0.0	57.8	0.1	0.0	0.0	0.0	0.0	0.0	0.4	1.8	0.1	0.0	3.7	0.0	0.7	0.7	0.4	0.0	0.0	0.0	0.1	4.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.7	9.4	9634.4	0.3	1.9	4.3	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.4	0.0	0.0	5.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	34.8	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.5	0.3	0.9	0.4	1.8	0.7	0.7	0.4	0.7	0.7	1.9	0.9	0.8	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.0	0.0	0.3	0.9	0.4	0.0	0.1	0.0	0.0	0.4	0.1	0.1	0.0	0.1	2.2	13.5	18.7	0.7	0.0	0.0	0.0	0.0	0.1	1.0	0.5	103.7	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.3	0.8	0.2	0.2	0.0	0.0	8.8	1.0	0.0	0.0	0.4
SLC17A2	NPT3	ENSG00000112337	"Solute carrier family 17 member 2"	O00624	6	25912754-25930691	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	165	"liver: 80.2"	"Cell type enriched"	"Detected in some"	20	"Hepatocytes: 30.9"	"Cancer enriched"	"Detected in some"	8	"liver cancer: 14.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	21	"Hep G2: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038270	Uncertain					NA	NA					"HPA038270: AB_10672511"							"prognostic favorable (8.54e-4)"						"unprognostic (1.90e-2)"		"unprognostic (4.14e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	80.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	30.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PLGLB2	PLGP1	ENSG00000125551	"Plasminogen like B2"	Q02325	2	87748087-87759476	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Tissue enriched"	"Detected in some"	163	"liver: 458.2"	"Cell type enriched"	"Detected in some"	17	"Hepatocytes: 76.3"	"Cancer enriched"	"Detected in single"	25	"liver cancer: 1.2"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"																"Secreted to blood"	NA	NA						"unprognostic (1.10e-2)"	"unprognostic (8.78e-2)"			"unprognostic (3.42e-2)"	"unprognostic (7.03e-4)"	"unprognostic (1.68e-2)"	"unprognostic (3.77e-1)"		"unprognostic (1.82e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.94e-1)"	"unprognostic (5.04e-4)"	"unprognostic (6.39e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.22e-2)"	"unprognostic (7.11e-2)"	0.3	0.8	1.0	0.5	0.7	0.5	0.3	1.8	0.9	0.6	0.1	0.3	0.2	0.6	0.6	0.6	0.7	0.2	0.6	0.8	0.2	0.8	458.2	0.3	0.9	0.5	0.2	0.8	0.5	1.3	0.4	0.9	0.4	1.4	0.7	0.3	2.8	0.4	0.4	0.6	1.0	0.5	0.2	0.1	0.9	0.5	1.0	0.2	0.8	0.5	0.5	0.7	0.3	0.2	1.0	0.0	0.1	1.2	0.3	0.4	0.5	0.4	0.6	0.4	0.1	0.2	0.1	0.3	0.7	0.4	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.3	0.5	1.2	0.0	0.1	0.5	0.2	0.5	0.3	0.1	0.2	1.0	0.4	0.7	0.0	0.1	0.4	0.1	0.1	0.0	0.2	0.1	0.1	0.3	0.1	0.0	0.4	0.0	0.0	0.7	0.2	0.2	0.0	0.3	0.0	0.3	0.2	0.1	0.5	0.4	0.3	0.5	1.2	0.3	0.4	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.4	0.1	0.1	0.0	0.1	0.0	1.0	0.7	1.8	0.9	0.8	0.2	0.5	0.2	0.8	1.4	0.1	0.2	1.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.5	4.3	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.0	4.4	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	76.3	0.1	0.0	0.3	0.1	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.1	0.0
MBP		ENSG00000197971	"Myelin basic protein"	P02686	18	76978827-77133683	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Autoimmune encephalomyelitis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	160	"brain: 32454.4;choroid plexus: 13028.9"	"Cell type enriched"	"Detected in many"	11	"Oligodendrocytes: 2895.5"	"Group enriched"	"Detected in all"	9	"glioma: 47.5;melanoma: 20.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 99.3;SK-MEL-30: 204.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002300, HPA049222, HPA064368"	Enhanced	Supported	Approved	"Plasma membrane"		NA	NA		54000	"Plasma membrane"		"CAB002300: AB_563893, HPA049222: AB_2680679, HPA064368: AB_2685247"	"unprognostic (9.36e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.31e-1)"	"unprognostic (9.87e-2)"	"unprognostic (2.90e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.95e-1)"	"prognostic favorable (4.48e-12)"	"unprognostic (2.90e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.03e-2)"	23.3	7.2	22176.9	21.0	23170.9	43.4	21.1	22711.2	22942.9	16.3	13028.9	17.3	18.8	13.3	8.0	20.7	31.8	17.3	24.3	16046.8	18317.0	19.6	23.7	20.2	27.2	30153.0	25169.6	14249.6	22.5	23.0	47.9	26.9	4.8	30653.3	15.4	17.0	7.5	22.2	13.2	142.1	28.3	20.9	8.8	29096.5	28.2	17.6	6.2	23715.3	12.6	22.4	82.3	28.0	19.2	20.4	32454.4	26.1	22.4	0.2	0.8	35.8	53.1	8.5	0.6	0.6	0.8	0.6	3.2	39.2	15.9	4.4	1.7	0.2	49.9	3.8	22.1	0.7	60.7	5.3	10.4	3.9	5.2	22.5	99.3	65.3	7.7	18.4	19.8	30.3	16.4	6.5	37.9	0.0	3.6	0.0	3.2	4.1	50.6	2.2	15.6	18.1	1.5	0.4	35.9	34.5	34.3	1.8	0.3	3.2	0.0	204.7	6.1	0.6	60.5	0.1	0.2	0.5	0.2	2.8	0.1	0.5	16.9	5.8	62.0	2.5	21.7	8.5	32.4	21.6	8.1	13.1	5.9	15.4	28.1	9.2	5.1	9.1	17.0	39.5	28.0	8.1	11.9	14.9	11.6	22176.9	23170.9	22711.2	22942.9	16046.8	18317.0	30153.0	25169.6	14249.6	30653.3	29096.5	23715.3	32454.4	5.5	48.1	39.5	10.7	86.8	118.8	61.1	28.1	84.2	52.8	24.2	22.7	45.0	35.8	50.3	103.0	2.1	0.7	221.8	48.7	41.1	43.7	5.9	159.8	11.2	9.4	49.8	68.8	32.4	35.8	0.8	36.2	59.1	161.1	71.5	2.1	10.0	30.2	44.4	1.7	47.1	51.4	44.7	78.3	123.1	6.3	28.3	98.2	92.5	45.0	84.4	25.7	247.2	124.7	2895.5	60.4	25.5	14.3	45.3	117.6	37.5	36.0	54.0	6.1	0.0	88.7	8.4	7.7	1.1	75.6	154.7	0.7	151.6	0.0	42.1	103.7
SSMEM1	"C7orf45, FLJ40316"	ENSG00000165120	"Serine rich single-pass membrane protein 1"	Q8WWF3	7	130206344-130216844	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	159	"testis: 32.6"	"Cell type enriched"	"Detected in some"	6	"Early spermatids: 474.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA										"unprognostic (3.08e-1)"				"unprognostic (1.79e-1)"					"unprognostic (5.24e-1)"	"unprognostic (2.24e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	474.1	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	54.3	4.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	68.2	3.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0
CD1B	CD1	ENSG00000158485	"CD1b molecule"	P29016	1	158327951-158331531	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	158	"lymphoid tissue: 533.8"	"Cell type enriched"	"Detected in some"	21	"Langerhans cells: 153.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	6	"myeloid DC: 19.2"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 19.2"	"Cell line enriched"	"Detected in some"	5	"MOLT-4: 587.9"									HPA021824	Approved		Approved	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Golgi apparatus, Vesicles"	Cytosol	"HPA021824: AB_1846262"	"unprognostic (7.72e-3)"	"unprognostic (1.55e-4)"	"unprognostic (1.66e-5)"	"unprognostic (1.04e-2)"		"unprognostic (1.06e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.89e-4)"	"unprognostic (2.27e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.53e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.53e-2)"	0.1	0.0	0.0	1.3	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.5	0.1	0.1	0.0	0.6	0.0	0.7	0.1	0.0	0.0	0.1	0.2	1.0	2.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.0	3.3	0.2	0.1	0.0	1.0	0.7	0.0	0.0	533.8	0.3	0.1	1.4	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	118.6	0.0	0.0	0.0	0.0	587.9	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	2.8	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.9	153.1	0.2	0.0	7.0	1.8	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0
FSCN3		ENSG00000106328	"Fascin actin-bundling protein 3"	Q9NQT6	7	127591409-127602144	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	158	"testis: 99.9"	"Cell type enriched"	"Detected in some"	7	"Late spermatids: 2359.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA075174	Enhanced					NA	NA					"HPA075174: "	"unprognostic (7.77e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.87e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.91e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.68e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.14e-5)"	"unprognostic (1.27e-1)"	"unprognostic (9.21e-3)"	"unprognostic (2.01e-1)"	"unprognostic (7.34e-2)"	0.1	0.0	0.1	0.0	0.1	0.4	0.1	0.6	0.4	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.2	0.0	0.1	0.2	0.2	0.0	0.1	0.2	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.2	0.0	0.1	0.1	0.2	0.1	0.3	0.1	0.0	0.2	0.1	0.1	99.9	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.4	0.2	0.2	0.1	0.2	0.1	0.2	0.2	0.1	0.1	0.4	0.0	1.1	0.0	0.0	0.8	0.4	0.3	1.2	0.0	0.4	0.4	0.5	1.5	0.0	0.0	0.0	0.3	0.4	0.2	0.0	0.3	333.6	0.2	0.5	1.4	0.0	0.0	0.2	0.2	0.3	0.3	0.0	0.5	1.3	0.2	0.0	0.1	0.1	0.0	0.2	0.2	0.0	0.3	1.3	2359.0	9.3	1.3	1.8	0.0	0.0	0.2	0.0	0.0	0.3	0.3	1.4	8.2	0.0	0.3	0.3	0.0	0.0	0.4	0.0	1.0	1.1	10.7	7.2	0.2	1.3	0.3	0.4	0.2	0.3	0.2
SLC10A1	NTCP	ENSG00000100652	"Solute carrier family 10 member 1"	Q14973	14	69775416-69797241	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction, Ion transport, Sodium transport, Symport, Transport"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	158	"liver: 430.4"	"Cell type enriched"	"Detected in some"	25	"Hepatocytes: 147.2"	"Cancer enriched"	"Detected in some"	79	"liver cancer: 65.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042727	Approved					NA	NA					"HPA042727: AB_10960691"	"unprognostic (3.42e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.93e-2)"	"unprognostic (6.51e-3)"	"prognostic favorable (9.53e-6)"	"unprognostic (6.07e-3)"	"unprognostic (8.95e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.75e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.45e-1)"	"unprognostic (5.69e-2)"	0.0	0.0	0.8	0.1	0.6	0.4	0.0	2.7	1.6	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	1.5	0.4	0.1	430.4	0.0	0.0	0.6	0.8	0.2	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.8	0.6	2.7	1.6	1.5	0.4	0.6	0.8	0.2	1.0	0.2	0.6	1.5	0.4	0.0	0.0	1.3	0.6	0.1	0.1	0.4	0.0	0.6	0.2	0.1	0.5	5.7	0.2	0.0	0.0	0.2	1.4	0.0	0.0	0.0	1.1	0.1	0.6	0.7	0.0	2.7	4.2	0.0	0.1	0.6	0.5	0.6	0.0	0.1	1.4	147.2	0.1	0.0	2.7	0.0	2.0	3.8	0.0	5.4	0.0	0.3	0.0	2.8	0.0	0.2	0.0	3.0	2.4	0.0	0.1	0.0	0.5	0.1	0.2	0.0	0.1	0.2	0.0	3.4	0.7	0.1	0.0	0.2	0.0	0.3	1.7	0.2	0.0	0.1
C8B		ENSG00000021852	"Complement C8 beta chain"	P07358	1	56929207-56966140	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	156	"liver: 847.0"	"Cell type enriched"	"Detected in some"	18	"Hepatocytes: 295.1"	"Cancer enriched"	"Detected in some"	181	"liver cancer: 107.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	22	"basophil: 2.1"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 2.1"	"Cell line enriched"	"Detected in single"	4	"Hep G2: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA023694	Supported				"Secreted to blood"	NA	NA		6700000000			"HPA023694: AB_1847128"				"unprognostic (6.65e-2)"			"prognostic favorable (9.31e-5)"	"unprognostic (2.37e-1)"			"unprognostic (2.37e-1)"			"unprognostic (1.29e-2)"	"unprognostic (6.57e-2)"	"unprognostic (5.12e-3)"		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	847.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.2	1.0	0.0	0.1	0.0	5.3	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	7.1	295.1	0.1	0.0	0.1	0.0	0.0	7.6	0.0	11.6	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0
C10orf120	bA318C4.1	ENSG00000183559	"Chromosome 10 open reading frame 120"	Q5SQS8	10	122697709-122699846	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	154	"testis: 31.2"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 592.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	592.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	123.6	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CTSG	CG	ENSG00000100448	"Cathepsin G"	P08311	14	24573518-24576250	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	153	"bone marrow: 5399.9"	"Cell type enriched"	"Detected in some"	16	"granulocytes: 534.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	7	"THP-1: 8681.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000110, HPA047737"	Enhanced				"Intracellular and membrane"	NA	NA		330000			"CAB000110: , HPA047737: AB_2680140"	"unprognostic (1.67e-1)"	"unprognostic (2.57e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.08e-1)"		"prognostic favorable (1.57e-4)"	"unprognostic (4.05e-2)"	"unprognostic (4.13e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (8.91e-4)"	18.3	0.1	0.0	13.6	0.0	5399.9	25.6	0.0	0.1	16.8	0.2	25.7	5.9	9.6	10.3	22.3	2.7	26.1	3.7	0.0	0.0	1.3	3.7	11.7	6.6	0.0	0.0	0.0	0.5	3.5	1.5	1.0	2.9	0.0	3.7	25.8	0.0	11.6	4.9	1.9	24.5	18.3	7.7	0.0	17.1	5.0	3.3	0.0	26.2	0.8	7.7	6.1	35.2	4.2	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	303.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	33.2	0.0	0.1	0.0	0.0	3.6	41.5	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	1.2	0.0	3.6	0.0	0.0	8681.4	0.0	0.0	0.3	0.0	5.3	0.0	0.8	2.8	0.0	1287.5	0.1	0.0	6.0	0.0	1.1	1.0	0.0	0.0	0.9	3.4	5.4	0.0	0.0	1.7	7.3	5.0	0.0	6.5	0.0	19.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	12.8	33.3	0.0	0.2	6.4	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.3	0.0	0.0	2.4	0.0	1.3	0.0	0.0	0.1	1.0	0.0	0.0	534.9	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.6	11.1	9.1	0.0	1.5	5.4	0.0	1.8	0.0	2.1	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.7	0.0	0.0	0.2	1.3	0.3	1.7	0.0	4.0	0.0	5.1	0.0	0.4	0.0
RDH16	"RODH-4, SDR9C8"	ENSG00000139547	"Retinol dehydrogenase 16"	O75452	12	56951431-56959374	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	152	"liver: 799.6"	"Cell type enriched"	"Detected in some"	27	"Hepatocytes: 365.1"	"Cancer enriched"	"Detected in many"	20	"liver cancer: 44.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 2.0;hTCEpi: 4.3;OE19: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA038518	Enhanced					NA	NA					"HPA038518: AB_10672713"	"unprognostic (5.42e-3)"	"unprognostic (4.20e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.92e-2)"	"prognostic favorable (2.16e-5)"	"unprognostic (8.83e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.84e-1)"	"unprognostic (6.85e-2)"	"unprognostic (6.10e-1)"	"unprognostic (7.99e-12)"	"unprognostic (2.24e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.01e-2)"	0.3	0.3	1.0	0.0	1.0	0.0	0.3	1.0	1.0	0.9	1.0	0.3	0.0	0.4	0.1	1.4	0.5	0.0	0.3	1.0	0.9	0.5	799.6	0.4	0.1	0.9	0.9	1.0	0.5	0.6	0.0	0.3	0.0	1.0	5.2	0.0	0.4	0.5	2.4	0.2	2.8	0.5	0.0	0.9	2.5	0.3	1.3	1.0	0.2	0.3	0.0	1.4	0.3	1.6	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	4.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	1.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.0	1.0	1.0	1.0	0.9	0.9	0.9	1.0	1.0	0.9	1.0	1.0	0.1	0.0	0.0	2.0	1.9	0.0	1.2	0.3	0.0	2.2	0.2	0.0	2.0	5.7	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.1	8.5	0.1	0.1	0.6	0.0	13.5	0.2	0.4	0.0	0.3	0.0	0.1	0.0	0.3	3.6	365.1	0.2	1.7	0.2	0.0	0.0	6.3	0.3	5.8	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	1.8	0.2	0.0	0.0	0.3	5.7	0.0	0.1	0.2	1.0	0.0	0.0	0.1	1.4	0.9	0.8	0.3	0.0	0.6	0.1	0.0	0.3
SI		ENSG00000090402	Sucrase-isomaltase	P14410	3	164978898-165078496	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase, Multifunctional enzyme"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	150	"intestine: 550.1"	"Cell type enriched"	"Detected in some"	8	"Proximal enterocytes: 1083.9"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 6.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.1;CACO-2: 1.5;HeLa: 1.2;NB-4: 1.3;RPMI-8226: 2.0;SH-SY5Y: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA011897	Enhanced					NA	NA					"HPA011897: AB_1856840"			"unprognostic (2.71e-2)"								"unprognostic (1.62e-2)"	"unprognostic (2.68e-1)"		"unprognostic (2.05e-1)"	"unprognostic (4.41e-2)"			0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	550.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	31.3	0.0	0.0	0.0	0.0	0.0	451.9	0.9	0.0	0.0	0.6	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	37.1	0.0	0.0	9.7	0.0	0.0	0.1	5.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	123.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	124.7	0.0	0.0	0.3	1083.9	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	77.8	0.0
UGT2B10		ENSG00000109181	"UDP glucuronosyltransferase family 2 member B10"	P36537	4	68815994-68832023	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	149	"liver: 235.6"	"Cell type enriched"	"Detected in some"	11	"Hepatocytes: 245.3"	"Cancer enriched"	"Detected in single"	296	"liver cancer: 93.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	116	"Hep G2: 12.0"									HPA045108	Uncertain					NA	NA					"HPA045108: AB_2679218"			"unprognostic (3.50e-3)"				"unprognostic (1.92e-3)"						"unprognostic (4.17e-1)"					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	235.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	21.0	0.1	0.0	0.3	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	245.3	0.0	0.0	0.0	0.3	0.0	7.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.4	0.0	0.2	0.0
GUCY2F	"CYGF, GC-F, GUC2DL, RetGC-2, ROS-GC2"	ENSG00000101890	"Guanylate cyclase 2F, retinal"	P51841	X	109372906-109482086	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"cGMP biosynthesis, Sensory transduction, Vision"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	145	"retina: 42.6"	"Cell type enriched"	"Detected in some"	26	"Rod photoreceptor cells: 31.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"THP-1: 1.0"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"									NA	NA									"unprognostic (1.91e-1)"	"unprognostic (4.45e-2)"									"unprognostic (2.96e-1)"	"unprognostic (2.23e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.1	0.4	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0
LIPF	"HGL, HLAL"	ENSG00000182333	"Lipase F, gastric type"	P07098	10	88664441-88678814	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	142	"stomach 1: 37514.0"	"Cell type enriched"	"Detected in some"	444	"Gastric mucus-secreting cells: 1509.7"	"Cancer enriched"	"Detected in some"	75	"stomach cancer: 278.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 4.1;MOLT-4: 3.4;NTERA-2: 3.4;REH: 2.1;RPMI-8226: 1.8;THP-1: 6.8;U-2 OS: 2.2;U-266/70: 3.1"	"Region enriched"	"Detected in single"	77	"olfactory bulb: 7.6"					HPA045930	Enhanced				"Secreted to digestive system"	NA	NA					"HPA045930: AB_10959518"										"unprognostic (1.53e-1)"				"unprognostic (1.83e-1)"				3.6	2.9	0.1	0.0	0.0	0.0	4.6	0.1	0.0	3.1	0.0	8.7	264.5	1.9	0.0	118.8	5.5	0.0	2.2	0.0	0.1	11.5	5.0	7.3	0.0	0.2	0.2	0.0	2.2	4.5	0.0	7.3	0.5	0.1	6.8	0.0	0.0	2.6	0.0	1.6	1.7	1.9	0.0	0.1	2.6	37514.0	2.9	0.1	0.0	1.3	0.0	0.1	2.5	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	3.4	0.0	0.0	2.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	2.2	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1509.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
ALPI	IAP	ENSG00000163295	"Alkaline phosphatase, intestinal"	P09923	2	232456125-232460753	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	138	"intestine: 142.5"	"Cell type enriched"	"Detected in some"	8	"Proximal enterocytes: 290.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.7;renal cancer: 3.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	13	"CACO-2: 4.8"									"HPA038764, HPA038765, HPA051699"	Supported		Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA		130000	"Plasma membrane"		"HPA038764: AB_2676194, HPA038765: AB_2676195, HPA051699: AB_2681577"			"unprognostic (1.01e-1)"	"unprognostic (7.71e-2)"			"unprognostic (4.14e-2)"			"unprognostic (1.47e-1)"	"unprognostic (9.57e-4)"		"unprognostic (8.07e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.99e-2)"			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	142.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	129.1	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	33.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	290.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0
C1orf185	FLJ27485	ENSG00000204006	"Chromosome 1 open reading frame 185"	Q5T7R7	1	51102221-51148086	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	138	"testis: 25.7"	"Cell type enriched"	"Detected in some"	8	"Early spermatids: 616.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA																							0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	616.4	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	71.7	4.7	0.3	0.0	0.0	0.0	0.0	0.0	7.1	0.3	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.7	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TSPY4		ENSG00000233803	"Testis specific protein Y-linked 4"	P0CV99	Y	9337464-9340284	"Predicted intracellular proteins"	"Differentiation, Gonadal differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	138	"testis: 33.0"	"Cell type enriched"	"Detected in single"	11	"Spermatogonia: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	591	"U-266/70: 1954.4;U-266/84: 2232.7"									"HPA049384, HPA067289"	Supported		Approved	Cytosol		NA	NA			Cytosol		"HPA049384: AB_2680738, HPA067289: "																		0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	33.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.7	0.0	0.0	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.1	0.0	2.4	1954.4	2232.7	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MYH1	"MGC133384, MYHa, MyHC-2X/D, MYHSA1"	ENSG00000109061	"Myosin heavy chain 1"	P12882	17	10492307-10518542	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	137	"skeletal muscle: 7957.1"	"Cell type enriched"	"Detected in some"	10	"Skeletal myocytes: 77.4"	"Cancer enriched"	"Detected in single"	45	"head and neck cancer: 8.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA001349, CAB010759"	Enhanced		Uncertain	"Focal adhesion sites"		NA	NA		98000000	"Focal adhesion sites"		"CAB010759: AB_477248, HPA001349: AB_1079437"	"unprognostic (2.87e-2)"					"unprognostic (3.27e-3)"		"unprognostic (1.91e-1)"	"unprognostic (8.95e-3)"	"unprognostic (4.49e-2)"	"unprognostic (7.31e-2)"		"unprognostic (5.63e-3)"	"unprognostic (9.85e-4)"	"unprognostic (1.92e-1)"		"unprognostic (4.58e-2)"	2.6	0.1	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	3.5	0.1	0.1	0.5	0.3	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	1.3	0.0	0.0	9.1	0.1	7957.1	0.5	0.2	0.1	0.0	0.1	0.2	1.9	0.0	0.0	0.5	58.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.5	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.6	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	77.4	0.6	0.1	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0
ALB		ENSG00000163631	Albumin	P02768	4	73397114-73421482	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	135	"liver: 214254.8"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 65190.0"	"Cancer enriched"	"Detected in many"	384	"liver cancer: 14213.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	38	"Hep G2: 4500.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB006262, HPA031024, HPA031025"	Enhanced		Enhanced	"Endoplasmic reticulum,Golgi apparatus"	"Secreted to blood"	NA	NA	40000000000000		"Golgi apparatus"	"Endoplasmic reticulum"	"CAB006262: AB_425297, HPA031024: AB_2673703, HPA031025: AB_2673704"	"unprognostic (1.38e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.44e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.53e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.43e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (7.87e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.02e-2)"	6.4	3.8	1.1	0.0	1.2	0.0	6.0	0.8	1.2	1.5	0.8	2.2	0.0	1.8	15.5	2.7	4.3	3.9	6.3	0.9	1.0	469.5	214254.8	6.7	1.3	0.9	0.9	0.9	2.5	1582.3	1.0	3.4	4.6	1.0	2.2	0.1	0.5	2.1	0.1	2.0	2.6	2.3	0.0	0.9	37.3	10.1	3.6	0.9	0.3	3.6	0.1	1.4	0.9	1.7	1.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	18.8	0.6	0.0	0.0	1.6	0.0	0.0	0.1	0.6	0.0	31.7	2.1	4500.0	0.0	117.1	3.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	17.0	0.2	0.0	0.1	2.0	0.0	4.0	0.0	0.1	2.1	95.1	0.0	0.0	3.2	0.0	0.0	52.3	0.0	0.0	0.0	0.0	0.0	13.5	0.0	1.4	0.1	0.1	7.0	0.6	32.9	0.1	33.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.2	0.8	1.2	0.9	1.0	0.9	0.9	0.9	1.0	0.9	0.9	1.0	0.1	0.0	0.0	1.0	187.5	0.0	0.0	0.0	0.0	0.0	43.4	18.9	0.1	13788.8	0.0	38.6	0.0	1.4	0.6	0.1	72.4	5.3	2.5	0.2	0.1	65.5	1.8	1133.8	0.2	273.8	11.1	0.5	4.6	0.0	0.0	0.1	1252.5	65190.0	8.5	0.0	0.2	0.0	0.0	1764.5	0.0	0.1	0.0	2.9	0.0	0.0	1.0	0.0	0.0	0.0	0.1	160.6	0.0	0.0	0.0	0.2	0.0	686.5	0.0	0.0	0.0	0.0	1.1	0.2	1.3	0.0	0.1	21.2	77.1	0.1	0.0	0.1
INS	"IDDM1, IDDM2"	ENSG00000254647	Insulin	P01308	11	2159779-2161221	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"	"Carbohydrate metabolism, Glucose metabolism"	Hormone	"Cancer-related genes, Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	135	"pancreas: 13093.3"	"Cell type enriched"	"Detected in some"	21	"Pancreatic endocrine cells: 1475.2"	"Cancer enriched"	"Detected in single"	7165	"pancreatic cancer: 1751.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"EFO-21: 268.3;U-2 OS: 376.2;U-698: 132.4"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	13	"midbrain: 1.3"	"CAB000048, HPA004932, CAB012098, CAB053843"	Enhanced				"Secreted to blood"	NA	NA	437000				"CAB000048: , CAB012098: AB_300968, CAB053843: AB_620123, HPA004932: AB_1851816"											"unprognostic (7.61e-2)"							19.4	4.0	0.1	0.2	0.1	50.3	0.6	0.0	0.0	0.4	0.0	12.9	1.5	1.4	0.0	1.9	0.3	3.7	5.6	0.1	0.1	41.0	1.4	1.7	5.4	0.2	0.5	0.0	2.7	13093.3	0.0	0.3	1.4	0.4	0.5	0.0	0.0	3.1	0.0	0.3	97.2	0.7	0.0	0.0	1.4	42.5	0.3	0.2	0.0	1.3	0.0	0.0	5.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	268.3	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	376.2	0.0	31.8	0.0	15.9	132.4	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.2	0.5	0.0	0.4	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	67.2	0.0	0.0	0.0	0.0	1475.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OPN1MW	"CBBM, CBD, COD5, GCP, OPN1MW1"	ENSG00000268221	"Opsin 1, medium wave sensitive"	P04001	X	154182596-154196861	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"	"Sensory transduction, Vision"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	135	"retina: 13.4"	"Cell type enriched"	"Detected in single"	111	"Cone photoreceptor cells: 33.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	33.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
PSG9	"PSG11, PSGII"	ENSG00000183668	"Pregnancy specific beta-1-glycoprotein 9"	Q00887	19	43211791-43269530	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	135	"placenta: 107.3"	"Cell type enriched"	"Detected in some"	60	"Syncytiotrophoblasts: 277.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 5.2;GAMG: 16.3;HBF TERT88: 9.3;SuSa: 10.7;U-2197: 9.7"									HPA046327	Supported				"Secreted in female reproductive system"	NA	NA		43000000			"HPA046327: AB_2679624"	"unprognostic (9.32e-2)"	"unprognostic (3.28e-1)"				"unprognostic (2.15e-1)"												0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.2	0.0	0.0	0.3	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	107.3	0.3	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.7	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	5.2	2.9	4.5	2.3	0.1	0.1	0.0	0.2	1.4	16.3	0.3	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.6	10.7	4.3	0.0	0.2	0.1	2.1	9.7	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	4.3	1.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	4.6	0.1	0.0	1.1	0.0	0.1	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	277.3	0.0	0.0	0.0	0.0
AIPL1	LCA4	ENSG00000129221	"Aryl hydrocarbon receptor interacting protein like 1"	Q9NZN9	17	6393693-6435199	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"		"Disease variant, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	134	"retina: 843.2"	"Cell type enriched"	"Detected in some"	4	"Rod photoreceptor cells: 1926.4"	"Cancer enriched"	"Detected in single"	12	"testis cancer: 0.5"	"Region enriched"	"Detected in single"	12	"midbrain: 6.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.5;OE19: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA026578	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA026578: AB_2671905"		"unprognostic (2.42e-2)"		"unprognostic (1.17e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.68e-3)"		"unprognostic (3.24e-1)"		"unprognostic (1.13e-3)"				"unprognostic (3.76e-1)"	"unprognostic (5.35e-2)"			0.0	0.0	0.3	0.1	0.3	0.7	0.0	0.1	0.3	0.0	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.2	6.2	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	843.2	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.6	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.3	2.8	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.3	0.1	0.3	0.1	0.5	0.2	6.2	0.1	0.3	0.0	0.3	0.4	0.0	3.2	1.1	0.0	0.0	0.8	1.0	0.0	0.0	139.2	0.1	0.0	0.6	0.0	1.4	0.0	412.8	0.1	0.1	0.2	0.0	0.0	7.8	0.4	0.2	8.5	0.0	0.0	0.3	0.0	0.1	0.3	0.0	0.4	0.0	0.1	1.4	0.0	0.1	65.6	0.2	0.2	0.0	0.3	1.1	1.3	0.0	0.3	1.8	0.0	0.0	256.1	0.0	0.5	0.1	0.1	0.0	0.4	0.0	0.7	0.0	0.0	0.0	1926.4	0.0	1.8	0.3	0.4	0.2	0.0	0.4	0.3	0.4	0.1	0.0	1.7
POM121L12	DKFZp564N2472	ENSG00000221900	"POM121 transmembrane nucleoporin like 12"	Q8N7R1	7	53035633-53036925	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	134	"testis: 13.4"	"Cell type enriched"	"Detected in some"	8	"Spermatocytes: 11.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA027836	Enhanced					NA	NA					"HPA027836: AB_10669592"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNJ1	"Kir1.1, ROMK1"	ENSG00000151704	"Potassium inwardly rectifying channel subfamily J member 1"	P48048	11	128836315-128867373	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Bartter syndrome, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	132	"kidney: 199.8"	"Cell type enriched"	"Detected in some"	5	"Distal tubular cells: 195.6"	"Cancer enriched"	"Detected in some"	7	"renal cancer: 3.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	39	"RPTEC TERT1: 116.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA026962	Enhanced					NA	NA					"HPA026962: AB_10601934"	"unprognostic (1.75e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.19e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.44e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.78e-1)"	"unprognostic (6.05e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.28e-1)"	"unprognostic (7.81e-3)"	0.2	0.1	1.0	0.1	1.3	0.1	0.1	0.1	0.3	0.0	0.1	0.1	0.0	0.0	1.5	0.1	0.1	0.0	0.1	0.4	0.3	199.8	0.1	0.2	0.1	0.3	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	1.0	0.1	0.0	0.1	0.2	0.1	0.1	0.4	0.1	0.5	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	116.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	2.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.3	0.1	0.3	0.4	0.3	0.3	0.2	0.2	0.2	0.1	0.4	0.2	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	38.6	0.0	0.0	0.1	0.0	195.6	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0
LYZL6	"LYC1, PRO1485, TKAL754"	ENSG00000275722	"Lysozyme like 6"	O75951	17	35934518-35943713	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	Fertilization	"Antimicrobial, Bacteriolytic enzyme, Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	132	"testis: 48.3"	"Cell type enriched"	"Detected in some"	6	"Early spermatids: 387.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA025734, HPA053073"	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA025734: AB_1853444, HPA053073: AB_2682034"																		0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	48.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.4	0.2	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	387.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.3	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	15.4	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NR2E3	"PNR, rd7, RP37"	ENSG00000278570	"Nuclear receptor subfamily 2 group E member 3"	Q9Y5X4	15	71792638-71818259	"Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Sensory transduction, Transcription, Transcription regulation, Vision"	"DNA-binding, Receptor, Repressor"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	131	"retina: 132.6"	"Cell type enriched"	"Detected in some"	30	"Rod photoreceptor cells: 1357.8"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (9.90e-2)"	"unprognostic (2.50e-1)"	"unprognostic (8.25e-3)"	"unprognostic (2.63e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.85e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.51e-1)"	"unprognostic (3.65e-1)"	"unprognostic (4.75e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.82e-1)"	0.1	0.2	0.1	0.0	0.1	0.1	0.3	0.1	0.4	0.4	0.0	0.1	0.0	0.2	0.3	0.4	0.4	0.1	0.1	0.1	0.0	0.3	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.1	1.0	0.1	132.6	0.4	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.6	0.7	0.0	0.0	0.6	0.0	0.0	0.2	0.3	0.4	0.0	0.5	0.0	0.8	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.3	0.3	0.0	0.7	0.6	0.2	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.1	0.4	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.8	0.0	0.4	0.1	0.0	0.3	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.0	2.0	0.0	1.2	33.1	2.1	0.5	0.7	0.0	0.0	0.0	41.7	0.0	0.1	0.7	0.0	0.3	1.1	1.4	1.5	3.9	0.0	0.0	0.3	0.2	0.3	0.3	0.0	1.8	0.0	0.2	0.0	0.4	0.1	30.3	0.2	0.0	0.0	0.3	0.0	0.3	0.6	0.1	0.0	0.0	0.0	45.0	0.0	0.5	0.0	0.6	0.3	1.9	0.0	4.3	0.2	0.0	0.0	1357.8	0.0	3.3	0.3	0.6	0.4	0.8	0.0	0.0	0.0	4.3	0.5	1.1
RTP3	"LTM1, TMEM7, Z3CXXC3"	ENSG00000163825	"Receptor transporter protein 3"	Q9BQQ7	3	46497976-46500950	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	130	"liver: 120.5"	"Cell type enriched"	"Detected in some"	40	"Hepatocytes: 89.6"	"Cancer enriched"	"Detected in some"	5	"liver cancer: 22.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"SiHa: 12.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA075932			Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA075932: "		"unprognostic (2.09e-1)"				"unprognostic (1.64e-1)"	"prognostic favorable (3.11e-6)"								"unprognostic (1.08e-1)"	"unprognostic (1.58e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	120.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.5	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.2	89.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.4	1.9	0.0	0.0	0.0	0.1	0.1	0.0	0.0
OR2H1	"OR2H6, OR2H8, OR6-2"	ENSG00000204688	"Olfactory receptor family 2 subfamily H member 1"	Q9GZK4	6	29457181-29464328	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	128	"testis: 12.7"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 65.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"									NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SUN3	"MGC33329, SUNC1"	ENSG00000164744	"Sad1 and UNC84 domain containing 3"	Q8TAQ9	7	47987148-48029119	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	126	"testis: 42.0"	"Cell type enriched"	"Detected in some"	7	"Early spermatids: 582.2"	"Cancer enriched"	"Detected in single"	4	"testis cancer: 2.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"GAMG: 7.0;U-2 OS: 20.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA008344, HPA076890"	Enhanced		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA008344: AB_1857656, HPA076890: "	"unprognostic (5.11e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.61e-4)"	"unprognostic (2.31e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.59e-5)"	"unprognostic (4.88e-1)"	"unprognostic (1.47e-1)"		"unprognostic (2.65e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.48e-1)"	"unprognostic (2.58e-1)"	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.0	3.1	0.1	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.3	0.0	1.3	20.6	0.0	0.0	0.7	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.1	0.2	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.1	0.1	1.9	0.0	582.2	0.1	0.0	0.1	0.0	0.0	3.6	0.0	25.5	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.9	0.0	3.4	0.0	0.0	0.0	0.0	79.3	2.1	0.3	0.0	1.0	0.1	0.0	0.0	1.0	0.4	0.2	0.1	1.5	0.1	0.0	0.0	0.6	0.0	0.0	6.6	0.0	0.2	19.1	7.1	0.0	0.0	0.8	0.2	0.0	0.0	0.0
TRIML1	"FLJ36180, RNF209"	ENSG00000184108	"Tripartite motif family like 1"	Q8N9V2	4	188139441-188147743	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	122	"testis: 12.1"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 138.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"BEWO: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA											"unprognostic (6.99e-2)"									"unprognostic (5.21e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	138.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	29.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	1.1	0.0	0.0	0.0	0.0
RRH	peropsin	ENSG00000180245	"Retinal pigment epithelium-derived rhodopsin homolog"	O14718	4	109827972-109849123	"G-protein coupled receptors, Predicted membrane proteins"	"Sensory transduction"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	120	"retina: 76.2"	"Cell type enriched"	"Detected in some"	4	"Muller glia cells: 40.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-266/84: 1.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.59e-1)"	"unprognostic (2.47e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.25e-2)"	"unprognostic (7.56e-2)"	"unprognostic (8.47e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.62e-3)"	"unprognostic (4.65e-1)"	"unprognostic (4.38e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.18e-2)"	0.1	0.2	0.4	0.1	0.4	0.0	0.2	0.3	0.6	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.4	0.3	0.3	0.1	0.1	0.1	0.3	0.2	0.4	0.1	0.1	0.0	0.1	0.0	0.4	0.1	0.1	76.2	0.1	0.1	0.1	0.3	0.1	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.5	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.1	0.0	0.3	0.4	0.1	0.1	0.0	0.2	0.0	0.1	0.4	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.1	1.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.4	0.3	0.6	0.4	0.3	0.3	0.2	0.4	0.4	0.2	0.2	0.5	0.1	0.0	0.0	6.2	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	8.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.3	0.0	2.5	3.7	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1
TSSK6	"CT72, FLJ24002, SSTK"	ENSG00000178093	"Testis specific serine kinase 6"	Q9BXA6	19	19512418-19515548	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	116	"testis: 168.9"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 8709.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.4;CACO-2: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (2.12e-1)"	"unprognostic (7.89e-2)"	"unprognostic (7.26e-2)"	"unprognostic (6.64e-2)"	"unprognostic (3.39e-1)"	"unprognostic (7.20e-5)"	"unprognostic (3.38e-1)"	"unprognostic (5.51e-3)"	"unprognostic (5.17e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.98e-4)"	"unprognostic (2.28e-2)"	"unprognostic (5.34e-3)"	"unprognostic (2.74e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.52e-3)"	"unprognostic (9.89e-2)"	0.5	0.7	0.4	0.0	0.6	0.1	0.7	0.4	0.5	0.4	0.1	0.6	0.5	0.8	0.0	0.7	0.6	0.0	0.3	0.2	0.3	0.9	1.2	0.4	0.3	0.7	0.5	0.0	0.5	1.0	0.0	0.7	0.0	0.7	1.0	0.0	0.0	0.6	0.0	0.3	1.4	1.0	0.0	0.6	1.2	0.9	168.9	0.5	0.1	0.9	0.0	0.1	0.6	0.6	0.7	0.0	0.6	0.0	0.0	0.0	0.1	3.4	0.1	0.2	0.0	0.1	1.7	0.0	0.7	0.1	0.0	0.0	0.4	0.1	0.6	0.0	0.5	0.0	0.4	0.4	0.0	0.4	0.4	0.7	0.3	0.1	0.2	0.5	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.3	0.7	0.3	0.0	0.0	0.6	0.0	0.5	0.0	0.2	0.2	0.4	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.5	0.2	0.9	0.2	0.8	0.6	0.0	0.7	0.4	0.9	0.0	0.1	0.3	0.1	0.0	0.1	0.7	0.0	0.2	0.0	0.1	0.8	0.4	0.1	0.0	0.0	0.2	0.1	0.2	0.4	0.6	0.4	0.5	0.2	0.3	0.7	0.5	0.0	0.7	0.6	0.5	0.7	0.2	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.3	0.1	1.7	1.5	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	1462.5	0.5	0.4	2.7	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.8	0.0	0.1	0.7	0.5	0.1	0.0	0.0	0.0	2.0	0.8	0.5	8709.8	47.8	2.2	1.8	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	57.2	0.1	0.1	0.5	0.2	0.3	0.0	19.7	1.1	0.3	57.7	25.7	0.0	0.1	0.1	0.2	0.0	0.1	0.1
TMEM207		ENSG00000198398	"Transmembrane protein 207"	Q6UWW9	3	190428655-190449901	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	115	"kidney: 17.9"	"Cell type enriched"	"Detected in some"	18	"Distal tubular cells: 68.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA014332	Uncertain					NA	NA					"HPA014332: AB_2204907"															"unprognostic (4.81e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	68.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMEM239		ENSG00000198326	"Transmembrane protein 239"	Q8WW34	20	2816302-2820284	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	115	"testis: 107.1"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 127.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"HDLM-2: 9.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA											"unprognostic (5.12e-3)"								"unprognostic (2.95e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	107.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	127.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPATA31D1	"FAM75D1, FLJ46321"	ENSG00000214929	"SPATA31 subfamily D member 1"	Q6ZQQ2	9	81988772-81995253	"Predicted membrane proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	113	"testis: 11.2"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 10.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047897	Uncertain					NA	NA					"HPA047897: AB_2680204"															"unprognostic (1.25e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NMRK2	"ITGB1BP3, MIBP, NRK2"	ENSG00000077009	"Nicotinamide riboside kinase 2"	Q9NPI5	19	3933103-3942416	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	111	"heart muscle: 1317.2;skeletal muscle: 640.8;tongue: 728.5"	"Cell type enriched"	"Detected in some"	36	"Cardiomyocytes: 995.1"	"Cancer enhanced"	"Detected in some"		"renal cancer: 32.8;testis cancer: 13.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BEWO: 29.2;NTERA-2: 24.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA049909, HPA054792, HPA072450"	Approved		Enhanced	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA049909: , HPA054792: AB_2682601, HPA072450: AB_2686522"				"unprognostic (3.61e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.18e-2)"		"unprognostic (2.54e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.61e-2)"		"unprognostic (3.30e-2)"	"prognostic favorable (1.19e-4)"	"unprognostic (1.72e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.38e-1)"		0.6	1.7	0.4	0.0	0.2	0.0	0.8	0.3	0.9	0.1	0.1	0.4	0.0	0.4	0.1	5.8	0.6	0.0	1317.2	0.6	0.3	1.8	0.3	2.1	0.0	0.5	0.3	0.0	0.5	0.6	0.0	1.7	0.1	0.5	2.6	0.1	0.0	8.0	0.9	640.8	0.5	0.5	0.0	0.3	0.1	0.6	0.5	0.2	0.0	0.6	728.5	0.0	0.4	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	29.2	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	24.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.7	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.3	0.9	0.6	0.3	0.5	0.3	0.0	0.5	0.3	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	995.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	12.4	0.0	0.0	0.2	0.0	0.6	26.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	24.6	0.0	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0
CCDC185	"C1orf65, FLJ35728"	ENSG00000178395	"Coiled-coil domain containing 185"	Q8N715	1	223393415-223395465	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	109	"testis: 35.7"	"Cell type enriched"	"Detected in some"	8	"Early spermatids: 518.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.71e-1)"	"unprognostic (1.55e-2)"		"unprognostic (2.41e-6)"	"unprognostic (9.69e-2)"	"unprognostic (1.79e-2)"		"unprognostic (1.12e-2)"		"unprognostic (1.53e-1)"	"unprognostic (4.65e-1)"	"unprognostic (2.58e-1)"		"unprognostic (1.37e-3)"		"unprognostic (3.13e-1)"	"unprognostic (2.61e-2)"	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	518.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.4	4.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1
MYLPF	"HUMMLC2B, MRLC2, MYL11"	ENSG00000180209	"Myosin light chain, phosphorylatable, fast skeletal muscle"	Q96A32	16	30370934-30377991	"Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	108	"skeletal muscle: 20095.7;tongue: 5974.2"	"Cell type enriched"	"Detected in many"	29	"Skeletal myocytes: 654.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 15.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	73	"plasmacytoid DC: 19.6"	"Lineage enriched"	"Detected in single"	73	"dendritic cells: 19.6"	"Group enriched"	"Detected in some"	18	"BEWO: 75.4;HSkMC: 166.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039262, HPA055059"	Enhanced					NA	NA		1000000			"HPA039262: AB_2676418, HPA055059: AB_2732591"	"unprognostic (8.81e-3)"	"unprognostic (7.55e-3)"	"unprognostic (1.05e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.37e-3)"	"unprognostic (8.26e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.52e-2)"	"unprognostic (4.14e-4)"	"unprognostic (1.84e-1)"	"unprognostic (3.88e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.44e-2)"	1.5	0.5	0.1	0.2	0.1	0.6	3.4	0.4	0.3	0.3	0.0	0.9	0.0	0.5	0.1	70.5	0.0	0.0	1.5	0.1	0.1	0.4	1.2	1.0	0.3	0.1	0.1	0.0	0.7	1.3	0.0	0.5	1.2	0.3	45.1	0.1	0.1	120.3	0.1	20095.7	2.0	0.7	0.2	0.0	0.5	0.7	4.9	0.0	10.1	2.1	5974.2	0.6	0.1	0.8	0.3	0.0	0.2	0.0	0.4	0.0	0.0	75.4	0.1	0.0	0.1	0.0	3.0	0.0	1.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.2	166.1	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.3	0.4	0.2	0.3	0.7	0.4	0.1	0.2	0.0	3.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	6.6	1.2	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	19.6	0.0	0.2	0.1	0.1	0.4	0.3	0.1	0.1	0.1	0.1	0.0	0.3	0.0	0.0	0.3	1.6	3.2	2.3	0.3	2.5	0.9	1.7	8.3	0.6	1.1	8.6	7.2	1.9	4.3	5.0	7.3	0.0	15.9	13.2	2.2	0.0	0.8	14.9	3.0	3.8	3.0	3.6	0.4	0.4	0.9	16.5	2.4	1.1	6.2	8.8	0.7	5.3	1.3	4.2	0.0	0.5	2.9	2.0	4.7	11.5	22.4	1.2	5.3	1.8	1.0	3.1	1.6	19.6	1.0	1.2	0.4	5.7	0.4	2.9	1.5	1.1	4.2	3.8	1.9	0.0	654.1	5.9	4.7	1.7	1.2	1.1	6.6	4.8	0.4	2.2	2.7
DMRTC2		ENSG00000142025	"DMRT like family C2"	Q8IXT2	19	41844743-41852333	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Sexual differentiation, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	106	"testis: 41.2"	"Cell type enriched"	"Detected in some"	4	"Spermatocytes: 162.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045016	Uncertain					NA	NA					"HPA045016: AB_10960404"	"unprognostic (6.80e-3)"			"unprognostic (4.38e-2)"								"unprognostic (5.36e-2)"		"unprognostic (2.69e-1)"	"unprognostic (1.02e-1)"			0.0	0.0	0.1	0.1	0.2	0.3	0.1	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	41.2	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.1	0.0	0.2	0.1	0.1	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.6	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	162.6	38.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0
FGF21		ENSG00000105550	"Fibroblast growth factor 21"	Q9NSA1	19	48755524-48758333	"Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	106	"liver: 84.8"	"Cell type enriched"	"Detected in some"	19	"Cardiomyocytes: 116.4"	"Cancer enriched"	"Detected in single"	315	"liver cancer: 33.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HHSteC: 1.4;U-2 OS: 4.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA061286	Supported				"Secreted to blood"	NA	NA	254000	73000			"HPA061286: AB_2684466"				"unprognostic (1.64e-2)"		"unprognostic (3.62e-1)"	"unprognostic (3.21e-2)"			"unprognostic (3.42e-1)"				"unprognostic (1.54e-1)"	"unprognostic (1.85e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	84.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	116.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
UGT2B4	UGT2B11	ENSG00000156096	"UDP glucuronosyltransferase family 2 member B4"	P06133	4	69480165-69526014	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	106	"liver: 1284.2"	"Cell type enriched"	"Detected in some"	22	"Hepatocytes: 883.5"	"Cancer enriched"	"Detected in some"	96	"liver cancer: 351.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"RH-30: 4.6"									"CAB033260, HPA045108"	Enhanced				"Intracellular and membrane"	NA	NA					"CAB033260: AB_2241496, HPA045108: AB_2679218"	"unprognostic (7.46e-2)"						"unprognostic (1.50e-1)"	"unprognostic (9.37e-2)"			"unprognostic (1.51e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.43e-3)"	"unprognostic (3.52e-1)"			0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.0	0.0	0.0	1.3	1284.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.4	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	10.7	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	11.7	883.5	0.1	0.0	0.1	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0
INSL5		ENSG00000172410	"Insulin like 5"	Q9Y5Q6	1	66797741-66801256	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	104	"intestine: 130.1"	"Cell type enriched"	"Detected in some"	365	"Enteroendocrine cells: 8836.2"	"Group enriched"	"Detected in some"	5	"colorectal cancer: 1.2;prostate cancer: 0.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"							"HPA030100, CAB033849"	Enhanced				"Secreted to blood"	NA	NA	38500000				"CAB033849: AB_2264904, HPA030100: AB_10601915"	"unprognostic (2.48e-1)"		"unprognostic (4.41e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.18e-1)"					"unprognostic (2.76e-2)"		"unprognostic (1.30e-1)"	"unprognostic (2.62e-2)"			"unprognostic (7.53e-2)"		0.0	0.0	1.0	0.0	0.9	0.0	0.1	0.8	1.1	0.0	1.0	76.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.8	0.9	0.3	0.0	0.0	0.0	0.9	0.8	0.8	0.0	0.0	0.0	0.2	0.0	0.8	0.1	130.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.4	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.9	0.8	1.1	0.8	0.9	0.9	0.8	0.8	0.8	1.2	0.9	0.8	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.2	0.0	0.0	0.2	0.3	0.0	0.0	8836.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	22.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	14.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	11.4	0.0
SERPINA10	"PZI, ZPI"	ENSG00000140093	"Serpin family A member 10"	Q9UK55	14	94280460-94293268	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	104	"liver: 349.8"	"Cell type enriched"	"Detected in some"	17	"Hepatocytes: 259.1"	"Cancer enriched"	"Detected in some"	51	"liver cancer: 40.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"Hep G2: 21.2"	"Not detected"	"Not detected"							HPA048739			Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA	3960000000	4700000000	Nucleoplasm	Cytosol	"HPA048739: AB_2797237"	"unprognostic (7.14e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (9.00e-4)"	"unprognostic (6.11e-2)"		"unprognostic (2.81e-4)"	"unprognostic (2.31e-4)"	"unprognostic (2.77e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.93e-3)"	0.4	0.4	0.5	0.6	0.9	3.3	0.7	3.3	1.5	0.5	0.4	0.7	0.7	0.7	0.5	0.4	0.3	0.5	0.6	0.5	0.6	0.5	349.8	0.4	0.8	1.8	0.9	0.0	0.9	0.5	0.2	0.2	0.5	1.4	0.4	0.7	3.1	0.4	0.4	0.5	1.7	0.7	0.6	0.3	0.7	0.7	0.6	0.9	1.3	0.7	0.4	0.4	0.2	0.1	2.1	0.6	0.2	1.8	0.7	0.7	0.6	0.4	0.5	0.5	0.9	0.8	2.7	0.6	2.1	0.3	0.4	0.2	0.4	2.2	0.5	1.3	0.8	1.4	2.0	0.8	21.2	0.4	1.6	1.1	0.6	0.5	0.3	0.7	1.1	1.0	1.1	0.5	1.3	1.0	0.3	1.4	0.8	0.8	0.2	0.6	0.9	1.2	0.9	0.5	0.7	0.9	0.8	0.4	0.4	0.2	1.0	0.9	0.9	0.6	0.7	0.4	0.7	0.6	1.1	0.5	0.9	0.9	1.9	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	3.3	1.5	0.5	0.6	1.8	0.9	0.0	1.4	0.3	0.9	2.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.8	2.8	0.0	0.0	14.6	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	6.6	8.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	3.3	259.1	0.0	0.0	0.0	0.4	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
PON1	"ESA, PON"	ENSG00000005421	"Paraoxonase 1"	P27169	7	95297676-95324532	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"		Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	103	"liver: 536.1"	"Cell type enriched"	"Detected in some"	23	"Hepatocytes: 440.0"	"Cancer enriched"	"Detected in some"	78	"liver cancer: 97.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA001610	Approved				"Secreted to blood"	NA	NA	96000000000	17000000000			"HPA001610: AB_1079656"	"unprognostic (2.02e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.70e-1)"		"prognostic favorable (7.24e-7)"	"unprognostic (2.24e-1)"	"unprognostic (1.95e-1)"	"unprognostic (9.02e-3)"	"unprognostic (1.76e-3)"	"unprognostic (3.97e-2)"	"unprognostic (6.74e-9)"	"unprognostic (1.09e-3)"	"unprognostic (2.29e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.54e-3)"	0.0	4.2	0.6	0.0	0.6	0.0	0.1	0.7	0.6	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.5	0.5	0.2	536.1	0.1	0.0	0.6	0.5	0.5	0.6	0.1	0.0	0.8	0.0	0.6	0.3	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.3	0.5	5.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.6	0.7	0.6	0.5	0.5	0.6	0.5	0.5	0.6	0.3	0.5	0.6	0.0	0.0	1.5	7.2	1.1	0.0	0.0	0.0	0.0	0.6	0.2	0.3	0.6	18.6	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.4	3.0	13.5	0.2	0.2	0.0	0.2	0.0	0.3	0.0	0.1	8.9	440.0	0.0	0.0	0.2	0.2	0.0	13.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	2.0	0.2	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	1.6	0.5	0.4	0.2	0.0	0.1	0.0	0.6	0.5	0.3	0.1
CSHL1	"CS-5, CSHP1, CSL, hCS-L, MGC149868"	ENSG00000204414	"Chorionic somatomammotropin hormone like 1"	Q14406	17	63909597-63918838	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	102	"placenta: 151.3"	"Cell type enriched"	"Detected in some"	12	"Syncytiotrophoblasts: 21.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB025646, HPA043715"	Enhanced				"Secreted to blood"	NA	NA					"CAB025646: , HPA043715: AB_2678632"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.4	151.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	21.6	0.0	0.0	0.0	0.0
F7		ENSG00000057593	"Coagulation factor VII"	P08709	13	113105788-113120685	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	102	"liver: 161.5"	"Cell type enriched"	"Detected in some"	18	"Hepatocytes: 149.3"	"Cancer enriched"	"Detected in some"	17	"liver cancer: 41.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"CACO-2: 11.5;Hep G2: 7.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004826			Approved	Mitochondria	"Secreted to blood"	NA	NA	351000000	1300000000	Mitochondria		"HPA004826: AB_10602805"	"unprognostic (2.06e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.50e-3)"	"unprognostic (3.81e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.19e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.35e-3)"	"unprognostic (3.36e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.47e-1)"	0.2	0.0	0.4	0.1	0.3	0.0	0.2	0.5	0.7	0.9	0.2	0.0	0.5	0.1	0.6	0.1	0.5	0.0	0.1	0.3	0.8	0.4	161.5	0.1	0.0	0.3	0.4	0.3	0.4	0.1	0.2	0.4	0.1	0.4	0.4	0.0	0.2	0.3	0.0	0.0	0.3	0.8	0.0	0.1	0.1	0.1	1.5	0.5	0.0	0.1	0.0	0.0	0.1	0.5	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.5	0.7	0.3	0.8	0.3	0.4	0.3	0.4	0.1	0.5	0.4	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.6	0.3	0.5	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.4	0.0	8.0	0.3	0.2	0.0	0.4	0.0	0.2	0.0	0.3	2.2	149.3	0.1	0.0	0.5	0.4	0.0	2.8	0.7	0.2	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	1.1	0.3	0.0	0.2	0.0	0.5	0.1	3.2	4.1	0.0	0.1	0.1	0.2	0.1	0.3	0.0
PRSS57	"PRSSL1, UNQ782"	ENSG00000185198	"Serine protease 57"	Q6UWY2	19	685546-695498	"Enzymes, Predicted secreted proteins"		"Heparin-binding, Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	102	"bone marrow: 166.6"	"Cell type enriched"	"Detected in some"	9	"Erythroid cells: 77.8"	"Cancer enriched"	"Detected in single"	10	"pancreatic cancer: 2.2"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"basophil: 5.9"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	13	"NB-4: 377.2;THP-1: 184.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA						"unprognostic (2.89e-1)"	"unprognostic (1.43e-1)"		"unprognostic (2.10e-1)"		"unprognostic (3.99e-4)"	"unprognostic (3.07e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.50e-2)"	"unprognostic (4.04e-2)"	"unprognostic (7.70e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.46e-2)"	"unprognostic (8.16e-2)"	"unprognostic (2.56e-2)"		0.1	0.0	0.0	0.0	0.0	166.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.1	0.0	0.0	0.1	7.9	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	377.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	184.4	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.0	3.2	0.0	5.9	1.1	0.0	0.4	0.2	0.0	0.0	0.0	3.1	1.5	0.0	0.0	0.5	0.7	2.5	0.0	0.1	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	77.8	0.1	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.5	0.0	0.0	0.2	0.0	0.0	2.5	1.0	8.2	0.0	0.1	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.0
CYP2A7	CYP2A	ENSG00000198077	"Cytochrome P450 family 2 subfamily A member 7"	P20853	19	40875439-40882752	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	101	"liver: 153.7"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 195.3"	"Group enriched"	"Detected in some"	238	"breast cancer: 9.2;liver cancer: 25.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB033510, HPA046713, HPA047262"	Enhanced				"Intracellular and membrane"	NA	NA					"CAB033510: AB_782366, HPA046713: AB_2679767, HPA047262: AB_2680005"	"unprognostic (2.18e-1)"				"unprognostic (3.60e-2)"		"unprognostic (2.65e-3)"	"unprognostic (8.89e-2)"		"unprognostic (1.39e-2)"	"unprognostic (3.95e-1)"	"unprognostic (9.21e-2)"	"unprognostic (8.71e-2)"	"unprognostic (3.99e-2)"		"unprognostic (1.06e-2)"		0.0	0.0	0.3	0.0	0.3	0.0	0.5	0.0	0.6	1.5	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	153.7	0.1	0.0	0.4	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.6	0.3	0.0	0.4	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	4.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	24.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.2	11.0	195.3	0.0	0.0	0.1	0.8	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.9
MS4A10	"CD20L7, MS4A9"	ENSG00000172689	"Membrane spanning 4-domains A10"	Q96PG2	11	60785333-60801305	"Predicted membrane proteins, Transporters"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	101	"intestine: 86.5"	"Cell type enriched"	"Detected in some"	25	"Proximal enterocytes: 319.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA014778	Uncertain					NA	NA					"HPA014778: AB_2669089"					"unprognostic (7.67e-3)"						"unprognostic (1.28e-1)"	"unprognostic (8.73e-3)"		"unprognostic (1.27e-1)"	"unprognostic (5.21e-2)"			0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.3	0.2	0.0	0.1	0.2	73.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.1	86.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.3	0.2	0.1	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.2	319.4	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	3.3	0.3
MUC5AC	MUC5	ENSG00000215182	"Mucin 5AC, oligomeric mucus/gel-forming"	P98088	11	1157953-1201138	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	101	"stomach 1: 186.7"	"Cell type enriched"	"Detected in some"	248	"Gastric mucus-secreting cells: 10434.9"	"Group enriched"	"Detected in many"	4	"pancreatic cancer: 25.3;stomach cancer: 61.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	16	"A549: 19.9;OE19: 13.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002774, CAB009395, HPA040615"	Enhanced				"Secreted to digestive system"	NA	NA					"CAB002774: , CAB009395: AB_2146854, HPA040615: AB_2677042"	"unprognostic (2.10e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.51e-2)"		"unprognostic (4.56e-2)"	"unprognostic (6.49e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.30e-3)"	"unprognostic (8.46e-2)"	"unprognostic (5.83e-4)"	"unprognostic (1.84e-1)"	"unprognostic (9.21e-3)"	"unprognostic (4.07e-1)"	"unprognostic (1.37e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.0	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	186.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	19.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	13.5	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	17.4	0.0	0.1	5.4	0.0	0.0	0.1	0.0	2.7	0.0	42.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.8	0.0	2.8	10434.9	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.8	4.1	0.0	0.0	0.2	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.1	0.0	30.0	8.9	0.0	0.0	10.0	0.0	0.0	0.0	1.3	0.0	0.4	0.0	0.0	0.1	7.9	0.0	0.0	28.1
PDE6G	"PDEG, RP57"	ENSG00000185527	"Phosphodiesterase 6G"	P18545	17	81650459-81663112	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase	"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	99	"retina: 2068.0"	"Cell type enriched"	"Detected in many"	6	"Rod photoreceptor cells: 4448.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 10.6"	"Region enhanced"	"Detected in single"		"midbrain: 2.1"	"Group enriched"	"Detected in many"	6	"basophil: 127.0;NK-cell: 220.2"	"Group enriched"	"Detected in all"	6	"granulocytes: 127.0;NK-cells: 220.2"	"Cell line enhanced"	"Detected in some"		"Hep G2: 5.2;NB-4: 5.8;NTERA-2: 8.9;REH: 11.9;SuSa: 6.2"	"Region enhanced"	"Detected in some"		"hippocampal formation: 4.7"	"Not detected"	"Not detected"			HPA045118	Supported		Uncertain	Vesicles		NA	NA			Vesicles		"HPA045118: AB_2732517"	"unprognostic (6.16e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.85e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.94e-2)"	"unprognostic (5.71e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.14e-1)"	1.5	0.3	0.1	4.7	0.1	7.9	1.0	0.2	0.5	1.0	0.2	1.6	0.6	0.2	0.1	0.8	0.7	2.5	0.5	0.1	0.5	1.7	4.3	3.0	20.8	0.2	2.1	0.0	0.0	0.0	0.1	0.1	12.1	0.2	0.2	1.0	2068.0	0.5	0.4	1.2	0.3	1.6	1.0	0.2	20.0	1.7	0.9	0.3	8.4	0.4	0.3	7.2	3.0	0.1	0.7	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.3	0.1	0.2	0.0	0.9	0.0	0.0	0.0	0.0	5.2	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.4	2.8	0.2	0.1	0.2	0.4	0.3	0.0	5.8	8.9	0.0	0.0	11.9	0.0	1.9	0.0	0.0	0.0	0.2	0.0	0.1	0.1	6.2	0.1	0.8	1.2	0.2	0.0	0.0	0.1	0.1	0.6	0.9	0.4	3.1	0.1	127.0	18.1	30.5	4.1	26.2	1.3	2.7	0.8	2.3	28.9	5.1	2.1	7.4	2.4	220.2	15.5	2.9	0.1	13.5	0.1	0.1	0.2	0.5	0.1	0.5	0.2	2.1	0.0	0.2	0.2	0.3	0.7	0.3	0.0	0.6	0.3	1.1	0.9	0.0	0.0	0.6	422.5	0.3	0.4	0.2	0.0	0.0	5.5	517.1	0.2	4.3	0.1	1.9	0.4	0.8	1.5	0.3	27.2	0.0	1.7	0.2	0.2	0.4	0.2	0.0	0.5	23.6	0.1	2.9	0.2	22.6	262.5	0.1	0.2	0.0	4.8	8.0	2.3	0.0	4.4	3.6	0.0	13.3	709.0	11.3	0.0	0.1	0.2	0.0	0.0	0.8	0.1	0.1	1.0	0.0	4448.6	0.0	0.1	0.1	1.1	0.2	0.3	1.4	0.3	1.7	2.1	0.0	0.1
FBXO40	"Fbx40, KIAA1195"	ENSG00000163833	"F-box protein 40"	Q9UH90	3	121593379-121630295	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	97	"heart muscle: 91.2;skeletal muscle: 163.8;tongue: 101.2"	"Cell type enriched"	"Detected in some"	33	"Cardiomyocytes: 416.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"pons and medulla: 1.7"	"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (1.67e-2)"	"unprognostic (1.23e-4)"			"unprognostic (9.17e-2)"	"unprognostic (6.65e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.14e-1)"		"unprognostic (4.30e-2)"	0.2	0.1	0.2	0.0	0.6	0.6	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.1	0.0	1.2	0.1	0.0	91.2	0.5	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.6	0.2	0.0	0.1	0.0	0.0	0.5	1.0	0.0	0.1	0.8	0.0	163.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	101.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.1	0.1	0.0	0.2	0.6	0.0	0.8	0.5	0.1	0.2	0.1	0.6	0.5	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	416.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.8	0.0	0.0	2.8	0.0	0.1	9.6	0.0	0.2	0.0	12.4	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	2.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.8	2.3	0.0	0.0	0.0	0.1	0.0	0.2	0.6	0.0	0.0
ITIH3	H3P	ENSG00000162267	"Inter-alpha-trypsin inhibitor heavy chain 3"	Q06033	3	52794768-52809009	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	97	"liver: 799.2"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 1183.8"	"Cancer enriched"	"Detected in some"	247	"liver cancer: 273.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	24	"Hep G2: 17.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA017373	Approved				"Secreted to blood"	NA	NA		9100000000			"HPA017373: AB_1851954"	"unprognostic (2.07e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.30e-4)"	"unprognostic (4.28e-2)"	"unprognostic (3.26e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (4.49e-8)"	"unprognostic (2.09e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.55e-2)"	"unprognostic (9.31e-2)"	4.3	0.7	0.4	0.9	0.5	0.0	2.2	0.4	0.8	4.5	0.7	1.0	0.3	3.6	1.7	1.3	3.5	1.3	0.7	0.4	0.3	0.7	799.2	3.0	2.5	0.4	0.4	0.4	2.8	0.3	0.1	0.4	1.7	0.4	1.1	1.0	0.1	0.4	2.4	0.6	0.9	1.3	1.2	0.3	8.2	1.2	3.5	0.4	0.2	1.2	0.4	1.8	1.4	2.3	0.5	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.4	0.8	0.4	0.3	0.4	0.4	0.4	0.4	0.3	0.4	0.5	0.1	0.0	0.0	0.0	21.6	0.1	0.0	0.0	0.0	0.5	0.1	1.4	0.8	78.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	0.1	0.1	3.5	0.0	90.9	0.0	0.0	0.1	2.1	0.0	0.0	0.0	12.3	66.4	1183.8	0.0	0.0	0.0	0.0	0.0	85.1	0.3	132.0	1.2	0.1	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	9.1	0.4	0.3	0.0	0.1	0.3	3.6	19.2	0.0	0.1
C17orf78	FLJ39647	ENSG00000278505	"Chromosome 17 open reading frame 78"	Q8N4C9	17	37375985-37392708	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	95	"intestine: 128.6"	"Cell type enriched"	"Detected in some"	18	"Proximal enterocytes: 223.7"	"Group enriched"	"Detected in some"	8	"colorectal cancer: 0.8;stomach cancer: 1.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (8.73e-3)"	"unprognostic (1.91e-1)"	"unprognostic (8.98e-2)"	"unprognostic (4.90e-3)"	"unprognostic (5.31e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.02e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.43e-1)"	"unprognostic (5.53e-6)"	"unprognostic (1.94e-2)"	"unprognostic (7.23e-3)"	"unprognostic (4.85e-2)"	"unprognostic (3.19e-2)"	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.1	128.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.1	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.1	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	7.3	0.0	0.0	0.0	1.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.4	0.0	7.5	0.0	0.0	0.0	223.7	0.3	0.0	0.0	0.0	0.0	0.0	1.5	1.0	0.0	0.0	0.0	0.0	0.1	12.1	0.0
CSN2	CASB	ENSG00000135222	"Casein beta"	P05814	4	69955256-69961007	"Predicted secreted proteins"		"Milk protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	94	"breast: 310.5"	"Cell type enriched"	"Detected in some"	97	"Breast glandular cells: 33136.9"	"Cancer enriched"	"Detected in single"	156	"breast cancer: 75.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA041036	Supported				"Secreted in female reproductive system"	NA	NA					"HPA041036: AB_10793865"																		0.0	0.0	0.0	0.0	0.0	0.0	310.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	113.1	0.0	0.0	0.0	29.8	0.0	0.0	0.0	0.0	0.0	33136.9	340.4	0.0	0.0	0.0	0.0	0.0	0.0	72.4	0.0	0.0	0.0	0.8	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	35.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.0	0.0
INHBE	"activin, MGC4638"	ENSG00000139269	"Inhibin subunit beta E"	P58166	12	57452323-57459280	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor, Hormone"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	94	"liver: 149.6"	"Cell type enriched"	"Detected in single"	43	"Hepatocytes: 35.0"	"Cancer enriched"	"Detected in some"	27	"liver cancer: 34.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HHSteC: 50.8;Karpas-707: 79.1;RH-30: 36.9;U-266/70: 263.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA016843, CAB034017"	Enhanced		Supported	Vesicles	"Secreted to blood"	NA	NA		3500000	Vesicles		"CAB034017: AB_2233745, HPA016843: AB_1851796"	"unprognostic (7.34e-2)"	"unprognostic (6.73e-2)"	"unprognostic (3.45e-1)"	"unprognostic (4.69e-5)"	"unprognostic (2.61e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.44e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (5.66e-8)"	"unprognostic (4.09e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.57e-2)"	"unprognostic (7.52e-3)"	0.0	0.0	0.0	0.1	0.1	0.3	0.0	1.5	0.3	0.2	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.3	149.6	0.1	0.1	0.9	0.3	0.1	0.0	0.9	0.1	1.0	0.0	1.2	0.3	0.0	0.1	0.0	0.0	1.5	0.1	0.2	0.0	0.0	0.3	0.0	0.2	0.1	0.0	1.4	0.5	0.0	0.2	0.1	0.2	0.2	0.4	0.3	0.5	0.0	0.5	0.3	2.9	7.8	0.2	9.2	0.4	0.1	4.0	1.9	0.7	0.2	0.4	1.8	0.0	1.2	18.3	0.2	0.1	0.3	11.9	50.8	2.3	2.4	4.9	5.3	1.2	11.4	0.4	0.0	1.8	5.0	79.1	0.0	0.0	0.2	0.2	0.5	0.1	0.3	0.2	36.9	8.8	0.0	0.1	19.5	0.9	0.0	0.0	7.6	0.3	0.6	8.7	0.3	0.2	4.0	0.1	0.6	263.5	9.2	3.8	1.5	0.4	0.3	0.9	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.7	0.1	0.1	0.2	0.0	0.0	0.0	0.1	1.5	0.3	0.1	0.1	0.9	0.3	0.1	1.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	35.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1
KRTAP19-5	KAP19.5	ENSG00000186977	"Keratin associated protein 19-5"	Q3LI72	21	30501657-30502141	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	94	"skin 1: 19.8"	"Cell type enriched"	"Detected in single"	22	"Syncytiotrophoblasts: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"HEK 293: 4.3"															NA	NA		1600000																					0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0
SAXO1	"C9orf138, FAM154A, MGC35182"	ENSG00000155875	"Stabilizer of axonemal microtubules 1"	Q8IYX7	9	18858906-19049358	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	94	"testis: 38.8"	"Cell type enriched"	"Detected in some"	8	"Early spermatids: 572.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA023899	Enhanced					NA	NA					"HPA023899: AB_1845813"	"unprognostic (4.23e-4)"	"unprognostic (1.59e-1)"	"unprognostic (3.38e-1)"	"unprognostic (3.17e-2)"	"unprognostic (5.28e-3)"	"unprognostic (8.64e-2)"	"unprognostic (3.89e-1)"	"unprognostic (2.90e-3)"	"unprognostic (1.38e-2)"	"unprognostic (4.97e-3)"	"unprognostic (1.51e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.36e-2)"	"unprognostic (5.40e-2)"	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.3	0.0	0.2	0.0	0.0	0.2	0.0	0.1	38.8	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.7	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.0	0.3	0.2	0.1	0.1	0.2	0.2	0.2	0.3	0.0	0.0	5.2	0.2	0.0	0.1	0.0	0.6	0.2	0.7	0.9	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	572.8	1.2	0.4	0.6	0.0	0.0	1.0	0.4	0.0	0.3	0.0	0.1	0.0	0.1	0.0	1.0	0.2	0.0	1.1	0.1	0.0	1.2	0.0	65.8	4.7	0.2	0.0	1.0	0.3	0.2	0.0	1.5	3.7	0.1	0.0	2.6	0.2	0.0	0.0	0.6	0.0	0.1	0.0	0.1	0.2	11.6	2.4	0.2	0.0	0.1	0.3	0.1	0.1	0.2
MS4A3	"CD20L, HTM4"	ENSG00000149516	"Membrane spanning 4-domains A3"	Q96HJ5	11	60056587-60071115	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	93	"bone marrow: 424.0"	"Cell type enriched"	"Detected in some"	5	"Erythroid cells: 19.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	1478	"basophil: 2686.3"	"Lineage enriched"	"Detected in single"	4507	"granulocytes: 2686.3"	"Cell line enhanced"	"Detected in some"		"HEL: 48.9;K-562: 94.2;NB-4: 109.8;THP-1: 319.0;U-937: 126.2"	"Not detected"	"Not detected"							HPA019210	Supported		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA019210: AB_1854134"					"unprognostic (6.37e-3)"			"unprognostic (1.25e-1)"						"unprognostic (2.67e-1)"	"unprognostic (3.77e-1)"			0.0	0.0	0.0	0.3	0.0	424.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	4.5	0.0	0.5	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	48.9	0.0	0.0	0.0	17.4	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.2	0.0	0.0	0.0	0.0	109.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	319.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	126.2	0.0	2686.3	0.1	1.8	0.1	0.1	0.3	0.2	0.4	0.0	0.3	0.2	0.2	0.4	0.9	0.1	0.5	0.2	0.1	8.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	19.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.0	0.3	0.0	0.0	0.8	0.0	3.6	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0
AQP2		ENSG00000167580	"Aquaporin 2"	P41181	12	49950737-49958878	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Diabetes insipidus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	92	"kidney: 390.4;seminal vesicle: 214.4"	"Cell type enriched"	"Detected in some"	440	"Collecting duct cells: 4143.6"	"Group enriched"	"Detected in some"	6	"renal cancer: 1.7;stomach cancer: 1.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 3.4;HEL: 1.1;HMC-1: 2.2;OE19: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA046834	Enhanced					NA	NA					"HPA046834: AB_2679830"	"unprognostic (2.10e-1)"	"unprognostic (3.77e-2)"	"unprognostic (6.96e-3)"	"unprognostic (4.48e-3)"	"unprognostic (3.60e-2)"			"unprognostic (9.51e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.65e-2)"	"unprognostic (7.38e-3)"	"unprognostic (5.92e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.11e-1)"		0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.7	0.0	0.0	0.2	0.7	0.0	0.0	390.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.4	214.4	0.0	0.2	0.0	0.0	0.0	0.0	0.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	3.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	4143.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.1	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	9.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.1	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0
SERPINA11		ENSG00000186910	"Serpin family A member 11"	Q86U17	14	94442464-94452800	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	92	"liver: 494.6"	"Cell type enriched"	"Detected in some"	46	"Hepatocytes: 278.7"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 94.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"Hep G2: 17.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA		230000000				"unprognostic (2.50e-2)"	"unprognostic (3.26e-1)"	"unprognostic (9.00e-2)"	"prognostic favorable (6.30e-4)"		"unprognostic (7.44e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.44e-1)"		"unprognostic (5.14e-2)"	"unprognostic (1.53e-1)"		"unprognostic (1.64e-1)"				0.0	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.1	5.3	0.0	0.0	0.0	0.5	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	494.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	3.9	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	1.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.3	0.0	0.0	4.3	1.8	0.0	4.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.6	278.7	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.2
CYP7A1	CYP7	ENSG00000167910	"Cytochrome P450 family 7 subfamily A member 1"	P22680	8	58490178-58500163	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	91	"liver: 49.9"	"Cell type enriched"	"Detected in single"	17	"Hepatocytes: 7.0"	"Cancer enriched"	"Detected in single"	96	"liver cancer: 28.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (5.20e-2)"			"unprognostic (1.93e-2)"	"unprognostic (1.77e-2)"		"prognostic favorable (3.19e-4)"	"unprognostic (7.60e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.64e-1)"	"unprognostic (8.43e-3)"	"unprognostic (3.01e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.51e-1)"		0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0
CLPSL1	"C6orf127, dJ510O8.6"	ENSG00000204140	"Colipase like 1"	A2RUU4	6	35781019-35793675	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	90	"epididymis: 612.9;pancreas: 179.9"	"Cell type enriched"	"Detected in some"	4	"Exocrine glandular cells: 39.0"	"Group enriched"	"Detected in some"	6	"breast cancer: 3.6;cervical cancer: 1.0;endometrial cancer: 2.8;ovarian cancer: 1.8;pancreatic cancer: 3.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	17	"T-47d: 8.4"									HPA073155	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA073155: AB_2686576"	"unprognostic (7.97e-2)"	"unprognostic (1.58e-1)"		"unprognostic (4.75e-1)"				"unprognostic (2.54e-1)"		"unprognostic (3.10e-2)"	"unprognostic (2.13e-1)"			"unprognostic (1.97e-1)"	"unprognostic (6.60e-2)"		"unprognostic (7.06e-3)"	0.1	0.3	0.8	0.0	2.2	0.0	4.3	0.3	2.3	0.0	0.2	0.0	0.0	0.0	612.9	0.0	0.0	0.0	0.0	2.9	0.4	0.0	0.0	0.0	0.0	0.8	0.5	1.2	0.1	179.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.6	2.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	8.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.2	0.3	2.3	2.9	0.4	0.8	0.5	1.2	0.6	0.3	0.4	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	1.8	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	39.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	8.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0
FAM205A	C9orf144B	ENSG00000205108	"Family with sequence similarity 205 member A"	Q6ZU69	9	34723053-34729488	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	90	"testis: 25.0"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 135.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			HPA071267	Enhanced		Uncertain	"Nucleoli fibrillar center,Plasma membrane"		NA	NA			"Plasma membrane"	"Nucleoli fibrillar center"	"HPA071267: AB_2686376"	"unprognostic (2.25e-1)"					"unprognostic (3.66e-3)"		"unprognostic (6.29e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.73e-3)"	"unprognostic (7.82e-2)"	"unprognostic (9.61e-2)"	"unprognostic (6.41e-2)"	"unprognostic (4.78e-1)"		"unprognostic (7.34e-2)"		0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	25.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	135.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.6	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPATA31A1	"C9orf36, C9orf36A, DKFZP434B204, FAM75A1, FAM75A2, SPATA31A2"	ENSG00000204849	"SPATA31 subfamily A member 1"	Q5TZJ5	9	39355669-39361962	"Predicted membrane proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	90	"testis: 9.0"	"Cell type enriched"	"Detected in some"	6	"Early spermatids: 17.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																				"unprognostic (1.40e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM24A	AC073585.4	ENSG00000203795	"Family with sequence similarity 24 member A"	A6NFZ4	10	122910610-122913111	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	89	"testis: 17.8"	"Cell type enriched"	"Detected in some"	10	"Early spermatids: 303.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA052490	Supported				"Secreted in male reproductive system"	NA	NA					"HPA052490: AB_2681851"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	303.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1
LCE1D	LEP4	ENSG00000172155	"Late cornified envelope 1D"	Q5T752	1	152796721-152798181	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	89	"skin 1: 77.7"	"Cell type enriched"	"Detected in single"	42	"Suprabasal keratinocytes: 12.6"	"Cancer enriched"	"Detected in single"	8	"melanoma: 4.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA														"unprognostic (7.67e-2)"									0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	77.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0
MYL1		ENSG00000168530	"Myosin light chain 1"	P05976	2	210290150-210315174	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	88	"skeletal muscle: 22012.9;tongue: 15729.5"	"Cell type enriched"	"Detected in some"	246	"Skeletal myocytes: 492.9"	"Group enriched"	"Detected in some"	18	"head and neck cancer: 36.0;prostate cancer: 12.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"HSkMC: 51.4"	"Region enriched"	"Detected in single"	4	"olfactory bulb: 4.0"	"Low region specificity"	"Detected in all"			"HPA046859, HPA063034, HPA073827"	Enhanced				"Intracellular and membrane"	NA	NA		21000000			"HPA046859: AB_2679842, HPA063034: AB_2684927, HPA073827: "						"prognostic unfavorable (6.59e-4)"									"unprognostic (1.88e-1)"			1.7	0.5	0.1	0.0	0.1	0.0	3.4	0.0	0.1	0.1	0.0	0.9	0.0	0.5	0.0	214.5	0.0	0.0	1.8	0.2	0.0	0.8	1.0	0.9	0.0	0.0	0.0	0.0	0.6	1.1	0.0	0.4	0.0	0.0	165.7	0.0	0.0	171.6	0.0	22012.9	2.7	0.7	0.0	0.2	0.4	0.7	0.5	0.0	7.4	2.4	15729.5	0.9	0.1	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	51.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.1	0.0	0.0	0.0	11.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	492.9	2.0	0.1	0.2	0.0	0.0	0.0	1.6	0.0	0.0	0.1
CSN1S1	"CASA, CSN1"	ENSG00000126545	"Casein alpha s1"	P47710	4	69931068-69946574	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Milk protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	87	"breast: 1406.5"	"Cell type enriched"	"Detected in some"	47	"Breast glandular cells: 8261.0"	"Cancer enriched"	"Detected in some"	10	"breast cancer: 17.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035659, HPA057031"	Enhanced				"Secreted in female reproductive system"	NA	NA					"HPA035659: AB_10696356, HPA057031: AB_2683315"					"unprognostic (1.52e-2)"										"unprognostic (1.01e-1)"			16.2	0.0	0.1	0.5	0.0	0.0	1406.5	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.4	1.2	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.3	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.6	0.1	0.0	0.0	0.1	0.0	0.3	0.1	28.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	8261.0	172.2	2.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.1	0.3	0.0	2.1	0.0	0.0	0.3	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.6	0.0	0.0	0.0	5.5	0.0	0.0	0.0
KLK2		ENSG00000167751	"Kallikrein related peptidase 2"	P20151	19	50861568-50880567	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	87	"prostate: 571.2"	"Cell type enriched"	"Detected in some"	40	"Prostatic glandular cells: 777.2"	"Cancer enriched"	"Detected in some"	1666	"prostate cancer: 989.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.5;NB-4: 5.6"									HPA000764	Supported				"Secreted in male reproductive system"	NA	NA					"HPA000764: AB_1079700"	"unprognostic (3.05e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.69e-1)"	"unprognostic (8.53e-2)"		"unprognostic (1.15e-1)"		"unprognostic (8.97e-2)"	"unprognostic (3.22e-1)"	"unprognostic (6.44e-2)"	"unprognostic (8.06e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.11e-3)"	"unprognostic (7.56e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.04e-1)"	0.7	1.2	3.8	1.2	2.8	6.5	0.5	5.1	5.0	0.1	2.4	0.4	1.5	0.6	1.1	0.5	0.3	0.2	0.3	2.8	1.8	0.4	0.8	0.5	1.0	3.1	2.2	3.1	0.4	0.0	0.8	0.0	0.2	3.7	571.2	0.3	1.8	1.9	0.4	1.0	0.8	1.0	0.1	1.5	0.7	0.5	3.0	2.2	0.0	1.9	0.0	0.2	0.2	0.0	4.1	0.9	0.6	0.3	0.7	0.0	0.4	3.5	0.2	0.1	0.1	0.1	0.3	0.4	1.0	0.1	0.0	0.3	0.9	0.1	0.0	0.1	0.9	0.6	0.0	0.7	0.0	0.0	0.1	1.7	0.2	0.1	0.1	0.2	0.2	0.0	0.6	0.7	0.9	0.2	1.0	0.6	5.6	0.5	0.9	0.0	0.4	0.0	1.6	0.0	1.1	0.5	0.5	0.1	0.7	0.6	0.1	0.5	0.2	0.4	0.6	1.0	2.6	0.9	0.8	1.8	0.4	1.0	0.6	0.7	0.4	0.6	0.5	0.3	0.3	0.2	0.3	0.2	0.3	0.1	0.6	0.2	0.4	1.7	0.4	0.2	0.5	0.1	0.2	3.8	2.8	5.1	5.0	2.8	1.8	3.1	2.2	3.1	3.7	1.5	2.2	4.1	0.0	0.0	0.6	0.0	0.2	0.3	10.2	0.0	0.0	0.0	16.1	2.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.8	1.5	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	5.2	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	777.2	0.0	0.1	0.0	0.0	0.0	0.0	1.8	19.3	7.2	0.0	0.9	0.0	0.6	1.7	0.0	12.0
PSG11	"MGC22484, PSG13, PSG14"	ENSG00000243130	"Pregnancy specific beta-1-glycoprotein 11"	Q9UQ72	19	43007656-43026474	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	87	"placenta: 53.4"	"Cell type enriched"	"Detected in some"	57	"Syncytiotrophoblasts: 161.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"U-2197: 16.4"									"HPA042240, HPA046327"	Enhanced				"Secreted in female reproductive system"	NA	NA		40000000			"HPA042240: AB_10797384, HPA046327: AB_2679624"					"unprognostic (2.58e-1)"													0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	161.9	0.0	0.1	0.0	0.0
RHOXF2B		ENSG00000203989	"Rhox homeobox family member 2B"	P0C7M4	X	120072264-120077690	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	87	"testis: 21.4"	"Cell type enriched"	"Detected in single"	6	"Spermatogonia: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HL-60: 596.6;K-562: 903.3;NB-4: 1129.0"									HPA003314	Supported		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA003314: AB_1855193"																		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	596.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	903.3	0.0	0.0	0.0	0.0	1129.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	94.3	3.0	0.0	0.0	0.6	0.2	0.0	156.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.2	0.2	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MEPE		ENSG00000152595	"Matrix extracellular phosphoglycoprotein"	Q9NQ76	4	87821411-87846817	"Predicted intracellular proteins, Predicted secreted proteins"	Biomineralization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	86	"brain: 8.6"	"Cell type enriched"	"Detected in single"	18	"Inhibitory neurons: 12.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebral cortex: 8.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA038003, HPA038004"	Uncertain				"Secreted to extracellular matrix"	NA	NA		810000			"HPA038003: AB_2675780, HPA038004: AB_10670537"	"unprognostic (2.88e-1)"				"unprognostic (8.15e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.61e-1)"		"unprognostic (4.76e-2)"	"unprognostic (1.11e-1)"		"unprognostic (3.14e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.41e-1)"		"unprognostic (5.64e-4)"	0.0	0.0	4.8	0.0	1.2	0.0	0.0	0.1	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	4.3	0.0	0.0	0.0	0.0	0.4	0.3	1.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	1.2	0.1	8.6	1.0	4.3	0.4	0.3	1.1	1.0	0.5	0.8	2.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
SPO11	"CT35, SPATA43, TOPVIA"	ENSG00000054796	"SPO11 initiator of meiotic double stranded breaks"	Q9Y5K1	20	57329803-57343994	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Meiosis	"DNA-binding, Hydrolase, Isomerase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	86	"testis: 8.5"	"Cell type enriched"	"Detected in some"	9	"Spermatocytes: 98.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"									NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	98.2	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ATP2A1	"ATP2A, SERCA1"	ENSG00000196296	"ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1"	O14983	16	28878405-28904466	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	Translocase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	85	"skeletal muscle: 8320.7;tongue: 3228.0"	"Cell type enriched"	"Detected in some"	4	"Skeletal myocytes: 65.2"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 4.7"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 1.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 30.0"	"Region enriched"	"Detected in some"	8	"thalamus: 13.1"	"Group enriched"	"Detected in some"	6	"basal ganglia: 1.3;cerebral cortex: 1.4;hippocampal formation: 1.2"	"CAB002310, CAB032706"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA		2800000	"Endoplasmic reticulum"		"CAB002310: AB_564139, CAB032706: AB_2061286"	"unprognostic (2.37e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.23e-5)"	"unprognostic (5.35e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.22e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.72e-4)"	"unprognostic (1.70e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.51e-2)"	1.3	1.1	1.3	1.6	0.8	1.9	1.8	0.9	2.6	0.8	0.0	1.2	1.6	1.5	0.4	28.0	1.4	0.5	1.1	0.8	0.6	1.3	3.1	1.3	2.9	1.2	0.6	0.3	1.6	1.0	0.5	3.2	0.7	1.4	9.6	0.4	8.0	67.8	3.5	8320.7	2.2	2.3	0.4	0.7	1.5	1.1	10.7	0.9	1.5	2.3	3228.0	0.4	1.2	1.3	2.3	7.7	8.0	14.4	8.7	0.7	2.3	13.3	3.5	2.0	0.6	0.6	4.5	6.7	11.9	4.1	0.6	4.8	7.9	3.6	0.2	1.0	5.9	30.0	4.2	19.0	14.4	0.3	1.8	3.8	5.9	1.6	0.9	0.7	7.3	0.4	21.8	8.2	9.8	0.4	15.2	17.3	9.5	14.4	2.8	11.2	26.4	10.2	9.1	0.1	0.9	9.2	7.3	5.0	6.8	5.2	5.2	5.1	4.2	3.1	4.5	9.4	8.5	4.5	14.2	9.5	12.0	8.7	23.4	4.4	0.0	0.0	0.2	0.3	0.0	0.4	0.5	0.3	0.3	0.0	0.2	0.4	0.4	0.0	1.6	0.0	1.0	0.5	0.2	1.3	0.8	0.9	2.6	0.8	0.6	1.2	0.6	0.3	1.4	0.7	0.9	2.3	0.3	0.0	0.0	0.7	0.2	0.1	0.0	0.3	0.6	2.1	0.5	0.5	0.5	0.0	0.2	0.0	14.6	0.4	0.0	0.6	0.0	0.1	1.3	0.4	0.4	0.3	0.0	0.0	2.3	0.2	0.2	0.5	1.5	0.7	0.0	0.7	0.0	0.6	0.1	0.0	2.3	0.3	0.0	0.6	0.0	3.9	0.3	0.3	0.0	1.0	0.0	0.3	0.0	0.5	2.3	0.2	1.2	0.0	0.1	0.2	0.7	0.1	0.4	4.7	0.0	65.2	0.6	5.7	3.4	0.3	0.1	0.7	0.4	0.7	0.6	0.1
SOX30		ENSG00000039600	"SRY-box transcription factor 30"	O94993	5	157625679-157671480	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	85	"testis: 81.3"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 351.1"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 1.9;CACO-2: 1.3;HDLM-2: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA006159, CAB009382"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Vesicles"	Cytosol	"CAB009382: AB_2195963, HPA006159: AB_1080062"	"unprognostic (3.51e-2)"	"unprognostic (4.72e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.70e-4)"	"unprognostic (2.53e-2)"	"unprognostic (6.12e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.22e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.73e-2)"	"unprognostic (7.85e-2)"	"unprognostic (4.64e-4)"	"unprognostic (5.88e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.72e-2)"	"unprognostic (3.45e-1)"	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.3	0.7	0.1	0.0	0.1	0.9	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.1	0.2	0.1	81.3	0.2	0.7	0.0	0.0	0.1	0.1	0.0	0.2	1.9	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	1.3	0.8	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	4.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.3	0.1	0.3	0.1	0.0	0.0	0.2	0.3	0.2	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.5	0.3	0.1	0.1	0.1	0.0	0.2	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.6	0.0	0.0	0.1	0.0	0.6	0.0	0.0	351.1	0.5	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	71.4	1.8	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.1	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	42.8	11.7	0.0	0.0	0.0	0.1	0.3	0.0	0.0
CPB2	"CPU, PCPB, TAFI"	ENSG00000080618	"Carboxypeptidase B2"	Q96IY4	13	46053186-46105033	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis"	"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	84	"liver: 1496.4"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 1332.7"	"Cancer enriched"	"Detected in some"	112	"liver cancer: 268.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	86	"Hep G2: 173.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004146	Approved				"Secreted to blood"	NA	NA		8500000000			"HPA004146: AB_1078397"	"unprognostic (3.44e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.69e-2)"	"unprognostic (1.17e-2)"	"prognostic favorable (2.06e-4)"	"unprognostic (1.89e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.17e-2)"	"unprognostic (4.83e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.10e-2)"	"unprognostic (3.34e-2)"	"unprognostic (9.61e-2)"	0.0	0.0	0.3	0.1	2.6	0.7	0.1	0.7	2.4	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	4.9	0.0	0.4	1.3	0.4	1496.4	17.7	0.1	2.6	1.8	0.3	0.0	0.5	0.0	0.0	0.0	2.5	0.1	0.0	0.4	0.1	0.2	0.2	0.1	0.1	0.0	0.5	0.4	0.1	0.2	1.6	0.0	0.1	0.0	0.0	0.0	0.0	4.9	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.6	0.3	173.2	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.2	0.0	0.1	0.2	0.2	0.2	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.1	0.1	0.0	2.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.5	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	2.6	0.7	2.4	0.4	1.3	2.6	1.8	0.3	2.5	0.5	1.6	4.9	0.0	3.2	27.0	3.9	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	190.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.1	1.0	0.0	10.7	4.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	15.7	1332.7	0.1	0.0	5.3	0.0	0.0	22.7	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	13.0	36.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0
CYP17A1	"CPT7, CYP17, P450C17, S17AH"	ENSG00000148795	"Cytochrome P450 family 17 subfamily A member 1"	P05093	10	102830531-102837472	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Steroidogenesis	"Lyase, Monooxygenase, Oxidoreductase"	"Congenital adrenal hyperplasia, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	84	"adrenal gland: 8297.2"	"Cell type enriched"	"Detected in some"	17	"Theca cells: 1871.0"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 22.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 3.0;SCLC-21H: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048533	Enhanced		Approved	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA048533: AB_2680432"	"unprognostic (1.07e-2)"	"unprognostic (8.84e-2)"	"unprognostic (3.01e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.29e-2)"	"unprognostic (2.92e-3)"	"unprognostic (2.39e-4)"	"unprognostic (8.26e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.92e-3)"	"unprognostic (1.13e-1)"	"prognostic favorable (5.43e-7)"	"unprognostic (1.07e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.94e-4)"	0.4	8297.2	0.0	2.1	0.0	0.0	0.4	0.1	0.1	0.8	0.0	0.5	0.0	0.8	0.1	0.9	1.0	0.4	0.8	0.0	0.0	53.4	6.7	1.4	0.0	0.0	0.1	0.0	16.8	1.8	10.6	0.7	0.0	0.0	0.7	0.0	0.2	3.4	0.0	1.0	0.6	0.6	0.0	0.0	0.9	1.3	99.1	0.0	0.0	2.9	0.0	0.0	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	2.2	0.1	0.4	0.1	0.0	0.5	0.0	0.1	0.7	0.0	0.0	1.8	0.0	0.4	0.1	0.1	21.5	0.0	41.6	0.1	0.0	0.7	0.0	2.7	0.1	0.2	0.0	1.3	0.0	0.1	0.0	0.1	0.4	6.1	0.1	1.7	0.1	0.0	0.0	0.6	0.7	10.6	1.8	0.9	0.0	0.0	0.1	0.2	3.1	0.5	0.1	0.7	0.0	0.0	0.0	0.3	0.0	104.3	0.0	1.2	0.0	1.2	0.6	0.3	0.1	0.0	0.0	0.3	0.4	1871.0	0.0	0.1
FABP6	"I-15P, I-BABP, I-BALB, I-BAP, ILBP, ILBP3, ILLBP"	ENSG00000170231	"Fatty acid binding protein 6"	P51161	5	160187367-160238735	"Metabolic proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	84	"intestine: 4570.5"	"Cell type enriched"	"Detected in some"	23	"Proximal enterocytes: 52213.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 31.6;EFO-21: 30.5;HDLM-2: 13.6;NB-4: 17.0;RPMI-8226: 17.2;RT4: 15.2;U-2197: 15.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA012601, CAB024713"	Enhanced				"Intracellular and membrane"	NA	NA		890000			"CAB024713: , HPA012601: AB_1848435"	"unprognostic (3.03e-2)"	"unprognostic (7.55e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.00e-3)"	"unprognostic (1.48e-2)"	"unprognostic (3.53e-1)"	"unprognostic (5.35e-7)"	"unprognostic (3.05e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (4.35e-9)"	"unprognostic (2.10e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.85e-3)"	0.0	14.5	8.2	2.5	8.4	0.1	0.2	9.0	11.7	1.8	8.5	2.5	5.0	1.9	0.0	1.2	54.3	0.2	1.3	7.7	11.7	0.2	0.1	5.4	4.2	9.0	9.3	7.2	0.1	0.1	0.0	0.7	0.1	10.1	0.2	0.0	0.9	0.2	0.2	0.0	0.4	4570.5	3.4	9.2	1.5	0.4	3.2	8.8	5.7	0.1	1.4	3.5	2.7	0.4	8.3	0.3	0.6	0.0	0.2	0.0	0.0	11.4	0.0	0.0	0.0	0.0	8.1	1.3	31.6	30.5	0.0	0.3	0.0	0.0	0.0	0.0	13.6	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.5	0.0	0.0	2.3	1.2	0.4	0.0	0.0	0.0	17.0	0.1	0.0	2.9	0.0	1.0	17.2	0.0	15.2	2.8	0.7	0.0	8.8	0.2	0.1	0.2	0.2	0.0	0.0	0.1	15.3	1.7	1.7	6.9	4.0	0.3	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	8.4	9.0	11.7	7.7	11.7	9.0	9.3	7.2	10.1	9.2	8.8	8.3	0.0	0.0	1.5	1.3	0.2	0.5	0.3	7.8	0.6	0.2	0.1	0.1	3.4	0.0	21.9	0.0	0.0	0.0	0.0	0.6	0.0	0.9	0.4	110.2	0.6	0.1	0.0	0.0	1.6	0.0	0.3	0.6	0.0	1.4	0.0	0.6	0.0	0.0	0.1	1.7	2.2	2244.4	2.0	0.0	4.2	0.2	0.3	0.4	0.0	0.0	0.6	0.2	0.0	0.0	0.9	0.3	2080.0	0.0	0.0	0.1	52213.9	0.1	134.9	0.7	0.0	0.0	1.2	0.1	2.1	2.0	0.1	0.0	0.1	1.7	1304.0	1.4
MYH2	"IBM3, MYH2A, MYHas8, MyHC-2A, MyHC-IIa, MYHSA2"	ENSG00000125414	"Myosin heavy chain 2"	Q9UKX2	17	10521148-10549700	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	84	"skeletal muscle: 12912.1;tongue: 6194.6"	"Cell type enriched"	"Detected in some"	18	"Skeletal myocytes: 129.6"	"Cancer enriched"	"Detected in single"	60	"head and neck cancer: 27.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 4.0;HSkMC: 1.9;NTERA-2: 8.3;SuSa: 1.7"									"HPA001349, CAB010760"	Enhanced		Uncertain	"Focal adhesion sites"		NA	NA		81000000	"Focal adhesion sites"		"CAB010760: AB_477190, HPA001349: AB_1079437"	"unprognostic (6.50e-2)"					"unprognostic (1.86e-2)"		"unprognostic (4.76e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.05e-4)"	"unprognostic (2.89e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.30e-2)"			0.4	0.1	0.6	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	46.9	0.3	0.0	0.5	0.4	0.0	0.2	0.2	0.4	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.1	0.0	0.0	21.7	0.0	0.0	114.0	1.0	12912.1	0.7	0.2	0.4	0.0	0.1	0.2	0.2	0.0	0.3	0.9	6194.6	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	129.6	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0
OPN1SW	"BCP, BOP, CBT"	ENSG00000128617	"Opsin 1, short wave sensitive"	P03999	7	128772485-128775794	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"	"Sensory transduction, Vision"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	84	"retina: 41.3"	"Cell type enriched"	"Detected in some"	12	"Cone photoreceptor cells: 41.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"LHCN-M2: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA013562, HPA014083"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Cytokinetic bridge,Cytosol"		Yes	NA			Nucleoplasm	"Nuclear bodies, Cytokinetic bridge, Cytosol"	"HPA013562: AB_2668850, HPA014083: AB_2668938"	"unprognostic (2.88e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (8.50e-5)"	"unprognostic (1.13e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.33e-2)"	"unprognostic (3.79e-1)"	"unprognostic (6.05e-2)"	"prognostic unfavorable (2.26e-8)"	"prognostic unfavorable (5.98e-8)"	"unprognostic (2.53e-1)"	"unprognostic (8.99e-2)"	"prognostic unfavorable (9.33e-4)"	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.3	0.0	0.4	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	41.3	0.2	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.0	0.0	41.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LUZP4	"CT-8, CT28, HOM-TES-85"	ENSG00000102021	"Leucine zipper protein 4"	Q9P127	X	115289715-115307563	"Predicted intracellular proteins"	"mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	83	"testis: 8.2"	"Cell type enriched"	"Detected in some"	4	"Spermatogonia: 35.2"	"Cancer enriched"	"Detected in some"	9	"testis cancer: 13.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046436, HPA051999"	Enhanced					NA	NA					"HPA046436: AB_10964168, HPA051999: AB_2681688"															"unprognostic (1.84e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	35.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB108B		ENSG00000184276	"Defensin beta 108B"	Q8NET1	11	71833200-71837710	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	82	"epididymis: 13.0"	"Cell type enriched"	"Detected in single"	18	"Collecting duct cells: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"								"Secreted in male reproductive system"	NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MYOZ1	"CS-2, FATZ, MYOZ"	ENSG00000177791	"Myozenin 1"	Q9NP98	10	73631612-73641474	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	82	"skeletal muscle: 7201.9;tongue: 3337.4"	"Cell type enriched"	"Detected in some"	11	"Skeletal myocytes: 144.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 7.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"BEWO: 44.6"	"Region enriched"	"Detected in single"	17	"olfactory bulb: 3.9"	"Low region specificity"	"Detected in all"			"HPA037848, HPA038437"	Enhanced					NA	NA		71000			"HPA037848: AB_10670156, HPA038437: AB_2676009"	"unprognostic (4.55e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.90e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.08e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.22e-4)"	"unprognostic (1.18e-1)"	"unprognostic (9.25e-2)"	"unprognostic (2.55e-2)"	"unprognostic (5.59e-2)"	"unprognostic (5.14e-2)"	"unprognostic (2.64e-2)"	"unprognostic (6.78e-2)"	"unprognostic (7.17e-2)"	"unprognostic (1.09e-1)"	2.6	0.7	2.7	0.2	2.8	0.0	2.7	2.7	3.9	1.4	2.7	0.7	0.0	1.0	23.4	64.4	1.5	1.4	23.9	2.4	3.9	2.6	0.6	5.1	0.4	2.8	2.6	2.1	1.8	0.6	0.2	2.7	2.2	2.7	22.3	0.3	1.2	37.2	3.5	7201.9	1.5	0.5	0.9	2.7	1.6	0.6	2.1	2.7	0.9	4.4	3337.4	0.4	0.9	1.6	2.8	0.0	0.0	0.3	0.0	0.0	0.0	44.6	0.3	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.3	0.2	7.2	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	2.8	2.7	3.9	2.4	3.9	2.8	2.6	2.1	2.7	2.7	2.7	2.8	0.2	0.0	0.0	0.3	0.0	0.3	1.6	0.3	0.6	2.7	1.0	1.9	9.3	0.0	1.3	5.5	0.0	0.4	0.0	0.0	7.9	0.1	0.1	0.0	0.3	0.6	0.0	0.0	0.1	0.2	2.5	1.5	0.0	0.0	0.0	0.9	0.0	0.0	6.3	0.0	0.1	0.0	2.0	0.0	0.8	1.2	0.9	0.7	0.0	0.0	0.0	6.1	0.0	0.5	0.1	0.0	0.0	7.5	0.0	0.3	0.0	0.4	0.1	0.6	13.1	144.4	11.6	0.4	2.2	0.1	0.3	0.1	0.6	3.0	0.0	0.3
SPATA31D3	"FAM75D3, FLJ44082"	ENSG00000186788	"SPATA31 subfamily D member 3"	P0C874	9	81943586-81950038	"Predicted membrane proteins"	"Differentiation, Spermatogenesis"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	82	"testis: 8.1"	"Cell type enriched"	"Detected in some"	17	"Early spermatids: 31.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
APOC2		ENSG00000234906	"Apolipoprotein C2"	P02655	19	44946035-44949565	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism, Lipid transport, Transport"		"Disease variant, Hyperlipidemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	79	"liver: 9720.4"	"Cell type enriched"	"Detected in some"	34	"Hepatocytes: 1170.2"	"Cancer enriched"	"Detected in some"	17	"liver cancer: 49.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	30	"NK-cell: 3.2"	"Lineage enriched"	"Detected in single"	30	"NK-cells: 3.2"	"Group enriched"	"Detected in many"	4	"Hep G2: 713.0;THP-1: 1354.4"									HPA055877	Supported				"Secreted to blood"	NA	NA	43000000000	49000000000			"HPA055877: AB_2682953"	"unprognostic (4.28e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.66e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.14e-8)"	"unprognostic (1.32e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.80e-3)"	1.0	5.5	70.1	1.7	63.9	1.1	5.4	64.5	117.2	4.5	53.6	4.4	41.8	1.2	4.9	2.4	4.3	3.8	0.8	59.1	83.1	16.5	9720.4	35.2	16.0	74.7	67.7	54.9	0.4	2.2	6.7	3.0	2.9	77.9	1.4	4.4	2.8	2.4	2.2	1.9	4.3	66.2	0.7	77.5	3.9	2.7	1.1	70.5	3.2	0.9	0.7	9.9	2.2	0.8	122.4	2.9	0.6	0.3	0.4	0.5	0.6	1.3	0.1	0.0	0.0	0.1	2.0	2.8	0.7	0.3	0.0	0.0	2.6	0.0	0.1	0.0	0.7	0.1	123.0	2.7	713.0	0.2	15.4	237.5	0.2	0.3	0.0	0.0	0.3	0.0	0.1	1.7	2.9	0.1	0.8	0.9	126.3	0.5	3.2	0.4	0.8	5.2	1.1	0.0	1.5	0.1	0.1	1.9	0.2	7.7	0.0	0.7	1354.4	0.0	0.3	0.6	0.8	0.8	2.3	0.9	2.2	0.2	3.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	70.1	63.9	64.5	117.2	59.1	83.1	74.7	67.7	54.9	77.9	77.5	70.5	122.4	0.1	0.0	2.3	0.0	1.2	0.6	0.0	0.0	0.0	0.0	0.1	0.3	0.1	11.5	0.0	3.7	0.0	0.1	0.1	0.0	3.9	0.0	0.0	0.0	0.1	0.3	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	26.0	0.0	13.6	1170.2	33.8	0.0	0.0	0.4	0.0	15.5	1.2	0.0	0.0	24.0	7.2	0.0	2.0	0.0	0.0	0.0	0.0	0.0	10.0	0.7	0.0	0.1	17.7	32.3	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.4	0.3	1.8	0.0	1.3	0.0
EPPIN-WFDC6	SPINLW1-WFDC6	ENSG00000249139	"EPPIN-WFDC6 readthrough"	O95925	20	45534196-45547662	"Predicted secreted proteins"		"Antimicrobial, Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	78	"epididymis: 64.1;testis: 54.0"	"Cell type enriched"	"Detected in single"	6	"Respiratory ciliated cells: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA067335	Supported				"Secreted in male reproductive system"	NA	NA					"HPA067335: "										"unprognostic (1.46e-3)"					"unprognostic (6.38e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	64.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
POM121L2	POM121-L	ENSG00000158553	"POM121 transmembrane nucleoporin like 2"	Q96KW2	6	27285903-27312170	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	77	"testis: 8.4"	"Cell type enriched"	"Detected in single"	6	"Spermatocytes: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA046150	Uncertain					NA	NA					"HPA046150: AB_10960993"		"unprognostic (2.45e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.22e-1)"				"unprognostic (1.43e-2)"		"unprognostic (5.88e-3)"				"unprognostic (3.48e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.51e-2)"	"unprognostic (2.03e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
APCS	"MGC88159, PTX2, SAP"	ENSG00000132703	"Amyloid P component, serum"	P02743	1	159587826-159588865	"Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	76	"liver: 3659.1"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 4141.9"	"Cancer enriched"	"Detected in some"	25	"liver cancer: 826.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RH-30: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB007817, HPA053294"	Supported				"Secreted to blood"	NA	NA	27700000000	39000000000			"CAB007817: AB_598185, HPA053294: AB_2682104"							"unprognostic (3.19e-3)"				"unprognostic (2.30e-2)"							0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	48.1	0.1	0.0	0.0	1.2	3659.1	0.1	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	388.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	198.8	0.0	0.0	0.0	2.7	0.0	45.5	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	57.8	4141.9	0.0	0.0	0.0	0.0	0.0	88.9	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0
SLC6A18	"FLJ31236, Xtrp2"	ENSG00000164363	"Solute carrier family 6 member 18"	Q96N87	5	1225381-1246189	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	76	"kidney: 8.3"	"Cell type enriched"	"Detected in some"	7	"Proximal tubular cells: 55.6"	"Cancer enriched"	"Detected in single"	44	"renal cancer: 4.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA011885	Enhanced					NA	NA					"HPA011885: AB_1857198"			"unprognostic (2.02e-1)"										"unprognostic (5.69e-3)"	"unprognostic (2.90e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	55.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0
TM4SF20	"FLJ22800, TCCE518"	ENSG00000168955	"Transmembrane 4 L six family member 20"	Q53R12	2	227362038-227381995	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Autism spectrum disorder"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	76	"intestine: 269.0"	"Cell type enriched"	"Detected in some"	4	"Proximal enterocytes: 703.0"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 5.0;liver cancer: 4.7;pancreatic cancer: 5.5;stomach cancer: 11.8"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.6;RPMI-8226: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA051838, HPA063184, HPA065531"	Uncertain		Supported	"Plasma membrane,Focal adhesion sites"		NA	NA			"Plasma membrane, Focal adhesion sites"		"HPA051838: AB_2681631, HPA063184: AB_2684958, HPA065531: AB_2685506"	"unprognostic (4.68e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.75e-2)"		"unprognostic (4.96e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.44e-3)"	"unprognostic (7.76e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.04e-3)"		0.1	0.1	0.1	0.3	0.2	0.2	0.0	1.2	0.4	0.0	0.3	3.1	269.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.1	3.9	0.3	0.0	0.0	0.0	0.3	145.7	1.6	0.0	0.1	0.5	3.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	2.6	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.0	1.7	0.0	0.1	0.2	0.6	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.7	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.2	1.2	0.4	0.1	0.1	0.1	0.1	0.1	0.5	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	48.4	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	21.4	0.0	0.0	0.0	77.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.0	0.5	0.0	157.9	0.7	0.0	0.0	703.0	0.0	0.0	0.3	0.0	0.1	0.0	0.5	0.3	0.0	0.0	0.0	0.1	0.0	18.8	0.0
NRL	"D14S46E, NRL-MAF, RP27"	ENSG00000129535	"Neural retina leucine zipper"	P54845	14	24078662-24115010	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Sensory transduction, Transcription, Transcription regulation, Vision"	"Activator, Developmental protein, DNA-binding"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	75	"retina: 320.1"	"Cell type enriched"	"Detected in many"	5	"Rod photoreceptor cells: 3720.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SuSa: 4.8"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"CAB026066, HPA064599"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB026066: , HPA064599: AB_2685295"	"unprognostic (2.71e-2)"	"unprognostic (8.17e-4)"	"unprognostic (4.60e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.99e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.88e-5)"	"unprognostic (3.59e-2)"	"unprognostic (7.84e-3)"	"unprognostic (1.75e-3)"	"unprognostic (3.49e-2)"	"unprognostic (2.38e-5)"	"unprognostic (2.56e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.35e-3)"	0.8	2.5	1.6	0.5	1.4	0.5	1.0	2.3	2.2	1.1	0.4	0.9	1.1	1.1	0.7	1.1	1.0	0.9	2.2	1.4	1.3	2.8	3.6	1.1	1.0	2.1	1.6	1.1	1.2	1.7	2.0	2.4	0.3	1.9	1.5	0.4	320.1	1.0	0.7	2.5	0.7	1.4	0.3	1.5	2.1	1.3	4.2	1.5	1.2	2.7	1.4	0.7	1.1	0.8	1.6	0.3	1.2	1.6	1.6	0.3	0.2	0.4	0.3	0.3	0.5	0.3	0.7	0.5	1.2	0.4	0.5	1.0	0.5	0.6	0.3	0.2	0.6	0.5	0.7	0.6	2.2	0.6	1.4	1.6	0.4	0.5	0.2	0.7	0.7	0.5	2.2	0.7	1.2	0.3	0.9	1.2	0.6	1.8	1.8	0.9	1.2	1.5	0.0	0.4	1.3	1.7	1.2	0.8	0.7	0.8	4.8	0.9	1.5	0.4	1.1	0.5	0.1	0.7	3.6	1.9	1.5	0.3	0.9	1.1	0.2	0.3	1.3	0.2	0.4	0.1	1.0	0.2	0.4	0.3	0.7	0.8	0.6	0.1	0.5	0.3	0.4	0.2	0.3	1.6	1.4	2.3	2.2	1.4	1.3	2.1	1.6	1.1	1.9	1.5	1.5	1.6	1.4	0.0	0.5	5.5	6.2	0.8	1.6	0.1	1.2	434.4	2.0	1.9	2.1	0.0	0.7	7.3	431.6	1.4	3.2	1.5	13.7	0.6	2.7	1.3	0.7	24.1	1.8	3.2	1.8	1.1	0.9	0.7	2.6	1.0	0.0	0.7	0.7	3.3	2.0	250.7	2.6	1.7	0.0	1.3	0.4	4.2	1.2	1.4	1.8	0.0	1.1	636.4	5.2	2.0	4.4	0.3	5.3	1.9	1.7	2.0	5.6	6.7	0.1	3720.7	0.0	1.2	0.7	9.7	4.3	2.2	0.4	2.5	2.6	2.3	1.0	2.1
CCDC105	FLJ40365	ENSG00000160994	"Coiled-coil domain containing 105"	Q8IYK2	19	15010726-15023276	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	70	"testis: 15.5"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 201.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA058585	Approved					NA	NA					"HPA058585: AB_2683763"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	201.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	33.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MYL2	CMH10	ENSG00000111245	"Myosin light chain 2"	P10916	12	110910819-110921443	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	70	"heart muscle: 26352.1;skeletal muscle: 29242.5;tongue: 19998.9"	"Cell type enriched"	"Detected in some"	80	"Cardiomyocytes: 27611.5"	"Group enriched"	"Detected in some"	46	"head and neck cancer: 31.5;prostate cancer: 25.5"	"Region enriched"	"Detected in single"	8	"hypothalamus: 5.3"	"Group enriched"	"Detected in some"	12	"memory B-cell: 1.1;naive B-cell: 1.2"	"Lineage enriched"	"Detected in single"	12	"B-cells: 1.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 4.2;HSkMC: 8.8;U-2 OS: 17.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA019763, HPA039262"	Supported		Uncertain	Microtubules		NA	NA		180000	Microtubules		"HPA019763: AB_1854243, HPA039262: AB_2676418"	"unprognostic (2.07e-2)"	"unprognostic (1.37e-1)"		"unprognostic (1.39e-1)"		"prognostic unfavorable (2.60e-4)"		"unprognostic (1.32e-1)"	"unprognostic (4.05e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.20e-1)"		"unprognostic (1.76e-1)"	"unprognostic (2.84e-1)"	"unprognostic (3.55e-1)"		6.2	4.5	0.0	0.1	0.0	0.7	29.7	0.0	0.0	1.5	0.0	3.7	0.6	2.2	0.0	360.1	0.5	9.5	26352.1	0.0	5.3	2.9	5.5	5.1	15.3	0.6	0.5	0.0	2.4	5.8	0.0	2.5	0.1	0.2	252.0	0.1	0.0	109.6	0.2	29242.5	12.6	3.2	0.3	0.1	2.1	3.5	2.1	0.0	1.0	13.5	19998.9	1.1	2.2	4.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	4.2	0.0	0.2	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.8	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	17.7	0.0	0.1	0.0	0.0	1.7	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.6	0.5	0.0	0.2	0.1	0.0	0.1	1.1	0.0	0.0	0.0	1.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	27611.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	235.7	0.0	0.0	0.0	0.0	0.0	53.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	4.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	342.2	138.8	0.1	0.1	0.0	0.0	0.0	3.3	0.0	0.1	0.0
SYCP1	"CT8, HOM-TES-14, SCP1"	ENSG00000198765	"Synaptonemal complex protein 1"	Q15431	1	114854863-114995370	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Meiosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	70	"testis: 40.5"	"Cell type enriched"	"Detected in some"	8	"Spermatocytes: 1162.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	98	"THP-1: 17.2"	"Region enriched"	"Detected in single"	51	"cerebellum: 14.7"	"Not detected"	"Not detected"			HPA021083	Enhanced		Approved	"Nuclear bodies,Cytosol"		NA	NA			"Nuclear bodies, Cytosol"		"HPA021083: AB_1857685"	"unprognostic (2.91e-1)"									"unprognostic (6.89e-3)"				"unprognostic (4.87e-1)"	"unprognostic (8.74e-3)"			0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	139.5	0.3	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	56.7	5.3	0.4	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	1162.6	32.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CD1E		ENSG00000158488	"CD1e molecule"	P15812	1	158353696-158357553	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	69	"lymphoid tissue: 971.4"	"Cell type enriched"	"Detected in some"	13	"Langerhans cells: 549.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	14	"myeloid DC: 62.5"	"Lineage enriched"	"Detected in many"	14	"dendritic cells: 62.5"	"Cell line enriched"	"Detected in some"	43	"MOLT-4: 1276.2"					"Not detected"	"Not detected"			"HPA057769, HPA070634"	Uncertain		Supported	"Nucleoli,Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Golgi apparatus"	Nucleoli	"HPA057769: AB_2683522, HPA070634: "	"unprognostic (7.94e-3)"	"unprognostic (1.85e-5)"	"unprognostic (1.47e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.60e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.50e-2)"	"unprognostic (2.45e-1)"	0.7	0.5	0.0	4.5	0.0	0.0	1.8	0.0	0.0	2.1	0.0	2.1	2.2	1.1	0.4	8.0	0.9	4.9	1.0	0.0	0.1	0.8	1.5	3.1	6.5	0.0	0.0	0.0	0.6	0.4	0.5	0.1	0.0	0.0	1.1	5.7	0.0	1.5	0.6	0.4	14.1	2.8	0.9	0.0	5.2	4.8	0.5	0.0	971.4	0.8	0.2	9.9	2.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	29.8	0.1	0.0	0.0	0.5	1276.2	0.0	0.3	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.1	2.5	0.2	0.0	0.0	0.0	62.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.2	0.5	0.0	0.8	8.4	0.0	0.0	0.6	0.0	0.1	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	1.3	0.0	0.0	0.0	0.7	0.0	0.0	1.3	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	4.8	549.5	0.0	0.0	41.7	8.8	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.0	7.1	0.1	0.7	0.0	0.0	0.0
ESX1	"ESX1L, ESXR1"	ENSG00000123576	"ESX homeobox 1"	Q8N693	X	104250038-104254933	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	69	"testis: 9.0"	"Cell type enriched"	"Detected in some"	25	"Spermatogonia: 98.0"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 0.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"TIME: 24.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA051992, HPA073330"	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA051992: AB_2681684, HPA073330: "															"unprognostic (1.87e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	24.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	98.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
NEB	"NEB177D, NEM2"	ENSG00000183091	Nebulin	P20929	2	151485336-151734487	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes, Nemaline myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	69	"skeletal muscle: 9386.7;tongue: 2517.7"	"Cell type enriched"	"Detected in many"	8	"Skeletal myocytes: 662.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 8.8;RH-30: 34.3;U-266/70: 12.8"	"Group enriched"	"Detected in some"	6	"cerebellum: 6.5;olfactory bulb: 4.0"	"Region enriched"	"Detected in some"	6	"cerebellum: 11.8"	HPA016601	Enhanced					NA	NA		120000			"HPA016601: AB_1854361"	"unprognostic (2.40e-2)"	"unprognostic (6.71e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.85e-3)"	"unprognostic (2.54e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.45e-13)"	"unprognostic (6.80e-2)"	"unprognostic (2.22e-2)"	"unprognostic (4.07e-3)"	"unprognostic (4.06e-2)"	1.9	6.4	2.3	0.7	4.7	1.3	2.9	4.3	2.7	0.5	1.5	1.0	1.1	0.6	1.7	16.3	0.5	12.8	23.6	2.3	5.0	1.8	4.9	2.3	1.3	2.7	2.8	1.8	0.9	2.0	0.1	2.6	0.8	3.1	22.3	0.1	3.6	86.6	0.2	9386.7	7.0	1.8	0.2	2.2	3.1	1.1	1.7	3.0	1.2	13.1	2517.7	0.8	0.4	1.2	2.9	0.5	0.5	0.8	0.7	0.1	0.1	2.3	0.4	0.0	0.0	0.0	6.1	0.7	1.7	1.2	0.1	0.2	1.2	0.1	0.0	0.0	0.8	0.9	0.6	1.1	2.0	0.0	1.1	1.5	5.0	0.3	0.1	0.0	0.3	0.8	0.5	1.2	8.8	0.5	0.7	0.6	1.1	1.4	3.0	1.0	1.6	34.3	0.2	0.1	1.2	2.0	0.3	0.3	0.4	0.2	1.3	0.9	1.1	0.8	0.9	1.2	0.1	1.2	12.8	2.0	0.4	0.2	0.8	1.5	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	2.3	4.7	4.3	2.7	2.3	5.0	2.7	2.8	1.8	3.1	2.2	3.0	2.9	0.3	0.0	1.1	14.0	2.0	0.8	1.2	0.2	2.8	2.4	0.5	0.4	82.6	18.6	0.7	0.0	0.0	0.5	1.2	0.0	0.0	0.5	7.6	1.4	1.5	2.1	1.8	0.0	13.1	0.0	0.4	10.6	2.0	2.5	1.3	2.2	0.7	2.4	0.7	3.3	9.2	0.0	4.1	1.3	0.7	7.6	0.6	2.7	0.0	7.5	0.2	0.4	0.0	6.0	5.2	0.1	0.0	0.0	2.0	1.1	0.3	0.4	0.1	1.7	0.0	662.8	1.9	1.4	1.6	0.2	1.3	0.8	1.1	1.5	0.0	0.2
AMBP	"EDC1, HCP, HI30, IATIL, ITI, ITIL, ITILC, UTI"	ENSG00000106927	"Alpha-1-microglobulin/bikunin precursor"	P02760	9	114060127-114078328	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Host-virus interaction"	"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	68	"liver: 11037.4"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 10517.4"	"Cancer enriched"	"Detected in many"	115	"liver cancer: 2620.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	173	"Hep G2: 1398.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA001497, CAB069436, HPA075585"	Approved		Approved	"Golgi apparatus,Vesicles,Cytosol"	"Secreted to blood"	NA	NA		47000000000	Vesicles	"Golgi apparatus, Cytosol"	"CAB069436: AB_1611916, HPA001497: AB_1078144, HPA075585: "	"unprognostic (6.92e-2)"	"unprognostic (3.61e-1)"	"unprognostic (4.95e-3)"	"prognostic favorable (1.20e-4)"	"unprognostic (9.79e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.04e-3)"	"unprognostic (7.59e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.14e-1)"	"unprognostic (7.84e-2)"	"unprognostic (4.36e-2)"	"unprognostic (2.89e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.97e-3)"	"unprognostic (9.45e-3)"	0.5	0.2	0.1	0.0	0.1	0.0	6.5	0.3	0.4	0.1	0.2	0.3	2.3	0.1	0.4	0.3	0.4	161.9	0.4	0.1	0.3	11.1	11037.4	0.3	0.1	0.1	0.1	0.1	0.2	126.4	0.0	0.2	0.4	0.1	0.2	0.5	0.2	0.1	0.0	0.2	0.2	0.7	0.0	0.1	3.1	2.6	1.0	0.1	0.1	0.4	0.0	0.2	0.1	0.2	0.1	0.0	6.7	0.1	0.0	0.2	0.1	0.0	0.0	0.5	0.0	0.0	1.8	0.0	1.8	2.1	0.2	0.9	0.5	0.0	0.0	0.0	3.2	0.0	3.0	1.0	1398.1	0.0	5.5	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.0	0.1	0.1	0.3	0.0	0.9	3.1	0.0	0.2	8.1	0.4	5.9	0.6	1.7	0.0	2.8	1.1	0.0	0.1	0.0	0.2	1.0	0.0	0.8	0.0	0.4	1.0	0.3	1.5	0.0	1.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.4	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	1.5	0.0	19.1	1.5	0.6	0.0	2.2	0.0	1.9	0.4	0.2	2585.0	0.6	1.8	0.0	0.1	0.0	0.6	3.9	216.5	30.4	0.2	0.1	10.0	2.4	219.2	0.1	28.2	0.8	0.1	0.0	1.0	0.0	0.0	181.3	10517.4	0.7	0.0	0.1	1.6	0.0	243.7	0.5	59.4	0.6	0.2	0.0	0.0	3.6	0.0	0.0	0.0	0.0	14.9	1.7	0.0	0.0	0.6	0.6	13.7	0.0	0.0	0.0	0.0	0.5	0.6	0.2	1.1	0.4	1.4	14.3	0.0	1.2	0.3
MPC1L	SLC54A3	ENSG00000238205	"Mitochondrial pyruvate carrier 1 like"	P0DKB6	X	40623566-40624136	"Metabolic proteins, Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	68	"testis: 18.5"	"Cell type enriched"	"Detected in single"	5	"Endometrial ciliated cells: 1.2"	"Cancer enriched"	"Detected in single"	9	"testis cancer: 3.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"									NA	NA																		"unprognostic (8.47e-4)"		"unprognostic (1.00e-1)"			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	18.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PDE6A	"PDEA, RP43"	ENSG00000132915	"Phosphodiesterase 6A"	P16499	5	149857953-149944793	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	68	"retina: 1129.3"	"Cell type enriched"	"Detected in many"	11	"Rod photoreceptor cells: 2946.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	5	"CACO-2: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA016970, HPA074677"	Enhanced					NA	NA					"HPA016970: AB_1855125, HPA074677: AB_2732264"	"unprognostic (6.85e-2)"	"unprognostic (8.84e-2)"	"unprognostic (1.70e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.72e-2)"	"unprognostic (4.39e-3)"	"unprognostic (8.83e-2)"	"unprognostic (6.54e-2)"	"unprognostic (5.91e-3)"	"unprognostic (1.77e-2)"	"unprognostic (9.21e-2)"	"unprognostic (7.57e-5)"	"unprognostic (9.93e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.26e-2)"	0.1	0.7	0.5	0.2	0.5	0.9	0.2	1.4	0.8	0.0	0.1	1.2	0.2	0.1	16.5	0.9	0.2	0.2	0.2	0.4	0.3	0.1	0.1	0.3	0.1	0.5	0.3	0.4	0.2	0.2	0.2	1.7	0.1	0.7	0.3	0.9	1129.3	0.4	0.2	0.3	0.6	0.1	0.1	0.2	0.2	0.2	1.5	0.4	0.0	0.4	0.0	0.2	0.0	0.1	1.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	2.5	0.2	0.3	0.4	0.0	0.4	0.2	0.0	0.1	0.1	0.1	0.0	0.2	0.4	0.2	0.0	0.2	0.1	0.0	0.3	0.3	0.2	0.2	0.0	0.0	0.1	0.4	0.4	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.3	0.2	0.3	0.0	0.2	0.0	0.1	0.3	0.1	0.4	0.2	0.4	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.1	1.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.6	0.2	0.1	0.2	0.1	0.0	0.5	0.5	1.4	0.8	0.4	0.3	0.5	0.3	0.4	0.7	0.2	0.4	1.2	0.9	0.0	5.8	0.0	0.4	1.1	0.6	0.8	0.0	150.5	0.5	0.4	6.7	0.0	2.8	0.0	244.0	1.1	1.6	14.3	0.0	0.1	18.4	1.5	0.5	11.6	0.0	0.0	1.2	0.2	2.2	1.2	0.0	2.5	3.8	1.9	2.2	0.6	0.3	75.7	0.6	0.4	2.0	1.9	0.4	5.5	1.2	1.5	0.0	0.0	1.4	263.1	5.2	0.5	0.2	0.1	2.8	0.4	0.3	0.4	0.4	0.1	3.2	2946.4	0.0	1.0	1.2	2.3	0.8	5.4	0.6	2.9	1.5	2.2	2.7	0.2
PSG5	"FL-NCA-3, PSG"	ENSG00000204941	"Pregnancy specific beta-1-glycoprotein 5"	Q15238	19	43166256-43186536	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	68	"placenta: 112.8"	"Cell type enriched"	"Detected in some"	44	"Syncytiotrophoblasts: 724.4"	"Cancer enhanced"	"Detected in single"		"urothelial cancer: 0.5"	"Region enhanced"	"Detected in single"		"cerebellum: 1.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"BJ: 427.9;fHDF/TERT166: 1485.4"									HPA046327	Supported				"Secreted in female reproductive system"	NA	NA		22000000			"HPA046327: AB_2679624"	"unprognostic (1.59e-1)"	"unprognostic (3.38e-2)"				"unprognostic (4.69e-2)"		"unprognostic (1.62e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.75e-2)"		"unprognostic (1.12e-2)"	"unprognostic (2.62e-2)"		"unprognostic (1.03e-1)"	"unprognostic (7.92e-2)"	0.1	0.0	0.1	0.0	0.1	0.0	0.0	1.6	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.1	0.3	0.0	112.8	0.8	0.0	0.0	0.3	0.1	0.1	0.1	0.6	0.0	0.9	0.0	0.3	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.3	0.3	0.0	0.0	0.2	0.6	0.1	427.9	122.3	7.0	57.8	0.0	0.3	0.0	0.0	1485.4	1.8	16.4	0.1	0.0	65.8	0.0	0.0	0.1	0.3	0.0	0.4	0.0	0.1	0.8	0.0	1.1	7.8	2.3	0.0	0.0	0.0	0.0	0.6	1.6	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	10.2	0.0	0.0	0.1	0.5	1.6	54.9	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.6	0.3	0.3	0.0	0.1	0.0	0.3	0.8	0.0	0.1	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.2	2.3	0.0	1.2	0.0	0.1	0.1	0.0	0.5	1.8	0.0	14.2	0.0	0.1	0.0	6.0	0.8	0.0	0.0	0.2	0.0	0.0	3.3	0.0	16.2	0.4	0.0	0.2	0.0	0.0	0.0	0.0	2.5	0.0	3.4	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.0	0.6	0.0	0.0	0.5	1.5	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	724.4	0.0	0.1	0.0	0.1
UGT1A4	"HUG-BR2, UGT1D"	ENSG00000244474	"UDP glucuronosyltransferase family 1 member A4"	P22310	2	233718736-233773300	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	68	"liver: 394.9"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 15.1"	"Cancer enriched"	"Detected in single"	487	"liver cancer: 24.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA												"unprognostic (9.89e-3)"						"unprognostic (6.77e-5)"	"unprognostic (2.59e-1)"			"unprognostic (3.50e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	394.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRBV15	"TCRBV15S1, TCRBV24S1A3T"	ENSG00000276819	"T cell receptor beta variable 15"		7	142592928-142593473	"Predicted intracellular proteins, T-cell receptor genes"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in single"	67	"lymphoid tissue: 47.3"	"Cell type enriched"	"Detected in single"	27	"T-cells: 2.8"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	48	"MAIT T-cell: 21.9;memory CD4 T-cell: 14.6;memory CD8 T-cell: 21.1;naive CD4 T-cell: 18.8;naive CD8 T-cell: 12.3;T-reg: 27.8"	"Lineage enriched"	"Detected in single"	158	"T-cells: 27.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"													NA	NA						"unprognostic (1.07e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.89e-3)"	"unprognostic (1.39e-3)"		"unprognostic (2.09e-4)"	"unprognostic (1.08e-2)"	"unprognostic (6.75e-2)"	"unprognostic (5.47e-3)"	"unprognostic (7.77e-2)"	"unprognostic (4.14e-2)"	"unprognostic (3.86e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.38e-1)"	"unprognostic (8.34e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.55e-2)"	0.0	0.1	0.0	1.6	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.4	0.6	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.3	3.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.8	0.4	0.1	0.0	47.3	0.1	0.0	3.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	21.9	0.0	14.6	21.1	0.0	0.0	18.8	12.3	0.1	0.0	0.0	0.0	27.8	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0
C17orf98	LOC388381	ENSG00000275489	"Chromosome 17 open reading frame 98"	A8MV24	17	38835086-38841438	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	66	"testis: 19.6"	"Cell type enriched"	"Detected in some"	8	"Early spermatids: 263.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"hTCEpi: 5.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA051696	Uncertain		Approved	"Nucleoli,Intermediate filaments"		NA	NA			"Intermediate filaments"	Nucleoli	"HPA051696: AB_2681576"	"unprognostic (2.30e-1)"			"unprognostic (3.25e-4)"	"unprognostic (1.46e-1)"					"unprognostic (3.01e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.14e-2)"	"unprognostic (8.69e-3)"	"unprognostic (2.56e-1)"	"unprognostic (7.58e-2)"	"unprognostic (9.02e-2)"		0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	19.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.2	0.1	0.2	0.0	0.0	5.6	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	3.9	0.0	263.7	0.2	0.1	0.1	0.0	0.0	0.4	0.2	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.2	29.4	1.2	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.1	3.3	1.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0
HBG1	HBG-T2	ENSG00000213934	"Hemoglobin subunit gamma 1"	P69891	11	5248269-5249857	"Human disease related genes, Predicted intracellular proteins"	"Oxygen transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	66	"placenta: 370.7"	"Cell type enriched"	"Detected in single"	76	"Macrophages: 22.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	48	"K-562: 3611.8"									HPA043234	Approved					NA	NA					"HPA043234: AB_2678378"					"unprognostic (3.17e-2)"													1.0	0.5	0.3	0.0	0.3	0.3	0.5	0.4	0.5	0.6	0.3	0.3	0.2	0.4	0.0	0.4	0.3	0.0	1.7	0.3	0.3	1.3	1.3	3.1	0.0	0.6	0.4	0.3	0.4	0.4	0.0	0.6	370.7	0.4	0.4	0.0	0.0	0.2	0.0	0.9	0.3	0.3	0.0	0.3	5.6	0.4	0.2	0.4	0.9	1.1	2.3	0.0	0.1	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	75.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3611.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.3	0.3	0.3	0.4	0.5	0.3	0.3	0.6	0.4	0.3	0.4	0.3	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
MASP2	MASP1P1	ENSG00000009724	"Mannan binding lectin serine peptidase 2"	O00187	1	11026523-11047239	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	64	"liver: 480.4"	"Cell type enriched"	"Detected in some"	52	"Hepatocytes: 658.6"	"Cancer enriched"	"Detected in some"	71	"liver cancer: 41.9"	"Group enriched"	"Detected in some"	5	"cerebellum: 5.6;pons: 2.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"Hep G2: 16.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA029313, HPA029314"	Uncertain		Supported	"Golgi apparatus"	"Secreted to blood"	NA	NA	340000000	820000000	"Golgi apparatus"		"HPA029313: AB_10669654, HPA029314: AB_10670029"	"unprognostic (7.00e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.26e-3)"	"prognostic favorable (1.60e-4)"	"unprognostic (2.92e-3)"	"unprognostic (3.13e-2)"	"unprognostic (4.04e-2)"	"unprognostic (6.90e-3)"	"unprognostic (8.30e-4)"	"unprognostic (7.14e-2)"	"unprognostic (3.91e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-4)"	1.7	1.3	0.0	1.8	0.0	7.5	2.3	5.6	0.7	2.3	0.0	2.7	1.6	2.8	0.0	1.2	2.8	1.2	1.3	0.4	0.0	1.0	480.4	1.9	2.7	0.0	0.0	0.0	2.9	2.9	0.0	2.4	0.6	2.3	1.6	0.0	7.0	2.5	0.0	5.2	5.3	3.5	0.0	0.0	2.5	2.4	1.5	0.0	0.0	1.9	0.0	0.0	2.1	1.7	0.0	0.5	0.3	2.6	1.6	0.0	0.1	0.4	0.7	0.0	0.0	0.0	1.2	1.0	2.3	0.6	0.0	0.5	0.7	0.0	0.0	0.0	0.6	2.3	1.3	2.7	16.4	0.0	2.0	1.5	0.0	0.0	0.1	0.0	1.8	0.0	1.7	0.7	0.5	0.0	0.5	0.6	1.1	0.3	0.2	0.7	1.6	0.9	0.6	0.0	1.3	1.7	0.7	0.9	0.4	0.4	1.6	0.6	1.2	1.2	0.9	0.5	0.8	0.5	0.5	0.9	1.5	0.5	1.7	0.4	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	5.6	0.7	0.4	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	4.6	1.1	0.9	0.2	0.0	0.6	0.2	0.2	0.0	0.5	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.9	0.0	5.3	9.5	0.0	0.0	0.1	0.0	0.1	1.3	0.0	8.2	658.6	0.1	0.0	8.3	0.0	0.0	12.6	0.3	0.0	0.0	0.0	1.8	1.9	0.0	0.1	0.0	8.0	10.4	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.7	0.4	0.0	0.7	0.2	0.0	0.0	0.4	0.6	0.0	0.8	0.1	0.0	0.1
NPVF	"C7orf9, RFRP"	ENSG00000105954	"Neuropeptide VF precursor"	Q9HCQ7	7	25224570-25228486	"Predicted secreted proteins"		Neuropeptide		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	64	"retina: 222.4"	"Cell type enriched"	"Detected in some"	40	"Muller glia cells: 526.1"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"hypothalamus: 3.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	18	"hypothalamus: 6.1"	"Region enriched"	"Detected in single"	8	"hypothalamus: 3.0"	HPA041733	Enhanced				"Secreted in other tissues"	NA	NA					"HPA041733: AB_10794524"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	222.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	526.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PPP1R3A	"GM, PPP1R3"	ENSG00000154415	"Protein phosphatase 1 regulatory subunit 3A"	Q16821	7	113876777-114075920	"Disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Carbohydrate metabolism, Glycogen metabolism"		"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	64	"heart muscle: 41.2;skeletal muscle: 154.4;tongue: 105.0"	"Cell type enriched"	"Detected in some"	8	"Cardiomyocytes: 157.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	67	"THP-1: 14.6"	"Region enriched"	"Detected in single"	12	"thalamus: 1.1"	"Not detected"	"Not detected"			"HPA070440, HPA073138"	Enhanced					NA	NA					"HPA070440: , HPA073138: "						"unprognostic (8.96e-3)"												0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	41.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	1.0	0.0	154.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	105.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	157.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.8	0.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GOLGA6L1		ENSG00000273976	"Golgin A6 family like 1"	Q8N7Z2	15	23127066-23136822	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	63	"testis: 28.6"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 52.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047733	Uncertain					NA	NA					"HPA047733: "																		0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.2	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AHSP	"EDRF, ERAF"	ENSG00000169877	"Alpha hemoglobin stabilizing protein"	Q9NZD4	16	31527900-31528803	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	62	"bone marrow: 1683.5"	"Cell type enriched"	"Detected in some"	296	"Erythroid cells: 8721.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTCEpi: 3.0;K-562: 1.5"					"Low region specificity"	"Detected in some"			HPA040940	Enhanced					NA	NA		5300000			"HPA040940: AB_10796231"		"unprognostic (3.00e-1)"			"unprognostic (2.01e-1)"	"unprognostic (8.44e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.53e-1)"		"unprognostic (3.10e-1)"	"unprognostic (2.16e-1)"		"unprognostic (3.70e-3)"	"unprognostic (2.04e-2)"	"unprognostic (9.02e-2)"	"unprognostic (3.25e-2)"		0.8	0.1	0.7	0.2	0.7	1683.5	0.4	0.9	2.6	0.2	1.1	0.1	0.0	0.1	0.0	0.2	0.2	0.0	1.3	0.7	0.7	1.8	4.8	4.6	0.2	0.9	1.0	0.6	0.2	0.3	0.1	1.4	27.3	0.8	0.1	0.3	0.0	0.5	0.0	0.2	1.4	0.1	0.0	0.8	23.9	0.2	4.1	0.8	2.9	0.7	9.0	0.0	0.2	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	4.7	0.7	0.7	0.9	2.6	0.7	0.7	0.9	1.0	0.6	0.8	0.8	0.8	0.9	0.1	0.0	0.0	0.0	9.7	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.5	0.0	0.0	0.6	0.0	8721.3	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	2.9	4.2	0.0	0.0	0.0	0.0	0.0	8.1	0.0	29.4	0.3	2.8	10.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	4.1	0.5	0.0	0.0	0.0	2.1	0.0	0.0	0.1
MUC17		ENSG00000169876	"Mucin 17, cell surface associated"	Q685J3	7	101020072-101058859	"Cancer-related genes, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	62	"intestine: 43.0"	"Cell type enriched"	"Detected in some"	8	"Proximal enterocytes: 320.9"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 22.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA031634	Enhanced				"Intracellular and membrane"	NA	NA					"HPA031634: AB_10603021"			"unprognostic (2.37e-2)"	"unprognostic (2.41e-1)"		"unprognostic (8.17e-3)"					"unprognostic (5.57e-3)"	"unprognostic (6.07e-2)"	"unprognostic (8.79e-8)"	"unprognostic (1.28e-1)"	"unprognostic (2.47e-2)"			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	22.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	43.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	39.8	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	22.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.9	14.8	0.0	0.0	0.1	320.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	22.0	0.0
MYH7	"CMD1S, CMH1, MPD1"	ENSG00000092054	"Myosin heavy chain 7"	P12883	14	23412740-23435660	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	62	"heart muscle: 4312.8;skeletal muscle: 14692.0;tongue: 5426.5"	"Cell type enriched"	"Detected in some"	127	"Cardiomyocytes: 10295.8"	"Group enriched"	"Detected in some"	9	"head and neck cancer: 12.2;prostate cancer: 15.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	31	"HSkMC: 11.4"	"Low region specificity"	"Detected in many"							"HPA001239, HPA001349, CAB015384"	Enhanced		Uncertain	"Focal adhesion sites"		NA	NA		43000000	"Focal adhesion sites"		"CAB015384: AB_2147279, HPA001239: AB_1079438, HPA001349: AB_1079437"	"unprognostic (6.49e-2)"	"unprognostic (8.27e-5)"	"unprognostic (1.56e-1)"	"unprognostic (3.04e-3)"	"unprognostic (4.30e-1)"	"unprognostic (7.33e-3)"		"unprognostic (8.60e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.79e-1)"	"unprognostic (5.38e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.28e-2)"	1.7	1.3	2.0	0.0	1.6	0.1	2.6	0.2	1.1	0.3	1.2	1.0	0.5	0.4	0.0	130.3	0.1	1.1	4312.8	1.2	2.1	0.9	1.4	3.2	1.5	1.1	1.4	0.8	0.7	7.8	0.0	1.5	0.0	0.7	77.5	0.0	0.0	37.3	0.0	14692.0	3.2	0.9	0.0	0.7	0.5	0.9	1.4	2.4	0.1	1.9	5426.5	0.1	0.2	1.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.6	0.2	1.1	1.2	2.1	1.1	1.4	0.8	0.7	0.7	2.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10295.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.2	0.0	80.9	0.0	0.0	0.2	3.1	0.0	70.5	0.0	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.7	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	3.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	52.2	51.2	0.1	2.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0
SPATA31D4	"FAM75D4, FLJ43859"	ENSG00000189357	"SPATA31 subfamily D member 4"	Q6ZUB0	9	81928514-81934948	"Predicted membrane proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	62	"testis: 6.1"	"Cell type enriched"	"Detected in some"	14	"Early spermatids: 57.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
XAGE1A	"CT12.1a, GAGED2, XAGE-1, XAGE1"	ENSG00000204379	"X antigen family member 1A"	Q9HD64	X	52495808-52500812	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	62	"testis: 95.4"	"Cell type enriched"	"Detected in some"	5	"Alveolar cells type 2: 14.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HMC-1: 1443.3;NB-4: 1484.7;THP-1: 1390.5;U-2 OS: 1014.9;U-266/70: 649.2;U-266/84: 1967.0;U-937: 1201.1"									HPA046363			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA046363: "																		0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.2	95.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	5.7	235.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.8	0.0	6.5	2.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	1443.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	319.6	1.9	0.0	0.0	1.3	1484.7	0.2	0.0	0.0	0.7	0.0	5.3	0.0	0.0	0.6	156.7	0.0	2.6	3.7	0.0	96.1	1390.5	1.5	0.0	1014.9	0.3	187.7	649.2	1967.0	3.3	0.7	1201.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MPO		ENSG00000005381	Myeloperoxidase	P05164	17	58269855-58280935	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Hydrogen peroxide"	"Oxidoreductase, Peroxidase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	61	"bone marrow: 4058.2"	"Cell type enriched"	"Detected in some"	30	"Erythroid cells: 87.4"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 1.1"	"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 6.2"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	94	"HL-60: 3517.4;NB-4: 4589.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000059, HPA021147, HPA061464"	Enhanced		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"	No	NA	576000000	24000000	Vesicles	Nucleoplasm	"CAB000059: AB_2335676, HPA021147: AB_1854083, HPA061464: AB_2684531"	"unprognostic (1.91e-1)"	"unprognostic (9.08e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.78e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.92e-2)"	"unprognostic (8.34e-3)"	"unprognostic (4.91e-2)"	"unprognostic (3.07e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.14e-2)"	"unprognostic (8.05e-2)"	0.4	0.4	0.7	0.7	0.6	4058.2	0.3	0.6	1.1	0.0	0.2	0.1	0.0	0.2	1.1	0.1	0.2	0.3	0.9	0.7	0.6	0.2	1.8	8.4	1.7	0.8	0.8	0.5	0.1	0.1	0.0	1.6	1.4	0.7	0.2	0.2	0.4	66.9	0.1	1.1	4.4	0.2	0.3	0.7	21.9	0.1	0.4	0.6	11.0	0.3	0.3	0.2	0.5	0.1	0.8	0.4	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	3517.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4589.9	0.0	0.0	0.0	5.3	3.2	0.6	0.0	0.0	0.0	0.5	1.1	0.0	0.0	0.0	0.0	43.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.1	0.0	4.0	0.0	0.0	6.2	0.0	0.0	3.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	1.4	0.0	0.6	0.0	0.1	7.5	0.7	0.6	0.6	1.1	0.7	0.6	0.8	0.8	0.5	0.7	0.7	0.6	0.8	0.0	0.0	0.5	0.7	0.3	0.0	0.0	0.0	0.0	0.4	0.2	0.3	0.4	0.0	0.0	0.0	0.0	0.0	1.8	0.0	1.9	0.0	0.5	0.1	0.0	0.1	0.0	87.4	0.3	0.2	0.9	0.7	0.0	0.0	0.0	0.0	0.7	0.3	0.9	0.0	0.2	0.0	0.0	1.2	0.0	1.3	0.0	2.9	0.0	0.0	2.3	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.1	0.1	0.3	0.1	0.0	0.1	0.6	0.0	0.0	0.0
VTN	VN	ENSG00000109072	Vitronectin	P04004	17	28367284-28373091	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	61	"liver: 6088.3"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 5507.4"	"Cancer enriched"	"Detected in many"	85	"liver cancer: 2216.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"CACO-2: 1748.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016695, CAB016765, HPA060933, HPA068011"	Supported		Supported	"Endoplasmic reticulum,Vesicles"	"Secreted to blood"	NA	NA	606000000000	33000000000	"Endoplasmic reticulum, Vesicles"		"CAB016695: AB_1624536, CAB016765: , HPA060933: AB_2684389, HPA068011: "	"unprognostic (1.19e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.29e-2)"	"unprognostic (6.13e-2)"	"unprognostic (9.74e-2)"	"unprognostic (8.42e-2)"	"prognostic favorable (3.74e-4)"	"unprognostic (6.20e-2)"	"unprognostic (3.97e-1)"	"unprognostic (8.95e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (4.10e-11)"	"unprognostic (8.82e-3)"	"unprognostic (2.27e-1)"	"unprognostic (4.86e-3)"	"unprognostic (7.09e-2)"	3.2	99.8	2.3	2.5	2.5	0.3	0.9	4.8	3.7	0.9	0.3	0.7	4.7	1.5	0.9	0.5	2.2	61.8	53.6	2.4	2.1	3.6	6088.3	1.8	4.3	2.2	2.6	2.5	1.9	17.8	0.1	3.0	40.9	2.8	1.3	0.3	47.8	0.6	4.4	0.4	0.8	1.3	2.8	1.3	2.9	5.1	10.1	2.0	0.1	0.8	0.5	0.4	4.2	0.7	2.3	0.0	28.4	0.7	0.4	0.2	0.3	7.3	1.8	0.8	0.9	0.9	1748.9	0.1	1.2	0.2	0.2	0.2	0.7	0.0	0.0	0.1	0.2	0.2	1.2	1.1	86.7	2.5	6.1	0.5	0.4	0.0	0.6	0.0	3.9	0.1	0.0	1.6	0.3	0.2	0.7	0.2	0.0	0.8	0.4	0.1	0.4	3.5	0.1	0.3	0.0	1.0	1.4	115.6	8.0	0.2	4.3	0.3	0.0	1.0	0.4	0.3	0.1	0.2	1.0	0.5	1.4	0.5	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	2.3	2.5	4.8	3.7	2.4	2.1	2.2	2.6	2.5	2.8	1.3	2.0	2.3	0.1	0.0	1.1	2.0	21.5	0.0	0.0	0.0	0.0	13.0	0.1	0.1	18.1	1162.4	0.0	0.0	77.2	3.7	0.0	0.0	3.9	16.8	0.0	0.0	1.2	7.3	0.0	131.0	0.9	19.7	2.8	48.1	0.0	0.0	0.0	1.8	120.3	5507.4	4.7	38.7	1.0	0.1	0.0	160.3	0.3	0.2	0.0	0.3	0.0	0.0	20.1	6.9	0.0	1.0	0.5	23.5	1.2	1.5	0.0	0.0	0.1	9.5	0.0	38.3	0.0	0.4	1.5	4.2	0.6	0.0	0.0	9.6	9.0	0.7	0.0	0.0
FMO3	FMOII	ENSG00000007933	"Flavin containing dimethylaniline monoxygenase 3"	P31513	1	171090901-171117819	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	60	"liver: 1132.4"	"Cell type enriched"	"Detected in some"	13	"Hepatocytes: 412.3"	"Cancer enriched"	"Detected in many"	13	"liver cancer: 94.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC diff: 34.6;ASC TERT1: 26.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA013750	Enhanced					NA	NA					"HPA013750: AB_1848968"	"unprognostic (1.87e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.81e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.31e-3)"	"prognostic favorable (3.46e-4)"	"prognostic favorable (5.60e-5)"	"unprognostic (2.95e-1)"	"unprognostic (9.34e-2)"	"unprognostic (3.02e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (1.84e-1)"	"unprognostic (2.59e-1)"	"unprognostic (3.45e-1)"	"unprognostic (7.27e-2)"	18.6	12.5	2.5	0.9	2.5	0.4	6.9	2.5	3.6	1.2	2.3	1.1	1.8	1.4	3.0	5.2	13.4	1.9	4.1	2.2	2.4	13.5	1132.4	18.9	5.0	4.6	2.4	1.9	0.3	4.6	4.3	4.4	0.2	2.9	1.1	0.7	0.1	5.1	0.4	4.6	3.1	2.3	1.6	3.9	0.4	3.9	0.5	3.0	1.4	2.7	3.1	9.2	1.0	0.9	2.7	0.0	0.0	0.0	0.0	34.6	26.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.4	0.0	7.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	2.5	2.5	3.6	2.2	2.4	4.6	2.4	1.9	2.9	3.9	3.0	2.7	2.7	12.8	0.5	0.0	0.7	0.4	0.4	2.7	0.0	0.0	0.1	0.3	0.4	7.2	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.2	0.0	4.7	0.0	29.5	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	6.8	412.3	0.0	0.0	0.0	0.0	4.1	9.5	0.8	0.0	0.3	0.1	1.8	1.0	0.0	0.5	0.0	7.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	22.7	0.2	6.6	1.3	6.3	0.4	0.1	0.4	0.4	0.0	0.8	0.2	0.0	0.1
SLC36A2	"PAT2, TRAMD1, tramdorin"	ENSG00000186335	"Solute carrier family 36 member 2"	Q495M3	5	151314972-151347590	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	60	"kidney: 68.2;skeletal muscle: 81.0;tongue: 30.1"	"Cell type enriched"	"Detected in some"	8	"Proximal tubular cells: 53.0"	"Cancer enriched"	"Detected in single"	9	"renal cancer: 0.5"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA044002, HPA062229"	Enhanced					NA	NA					"HPA044002: AB_10964214, HPA062229: AB_2684717"	"unprognostic (3.47e-1)"	"unprognostic (3.40e-1)"		"unprognostic (2.26e-2)"	"unprognostic (6.23e-2)"	"unprognostic (8.38e-3)"	"unprognostic (4.66e-3)"	"unprognostic (3.03e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.89e-2)"	0.1	0.1	0.2	0.1	0.1	0.3	0.1	0.8	0.6	0.0	0.1	0.0	0.0	0.0	0.5	0.8	0.0	0.0	0.1	0.2	0.1	68.2	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.3	0.3	0.0	0.2	0.9	0.0	81.0	0.2	0.0	0.0	0.0	0.1	0.0	0.9	0.1	0.0	0.0	30.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.3	0.1	0.1	0.1	0.3	0.1	0.1	0.0	0.4	0.2	0.2	1.1	0.4	0.1	0.4	0.1	0.1	0.2	0.1	0.8	0.6	0.2	0.1	0.2	0.0	0.3	0.3	0.0	0.1	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	5.9	0.0	6.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.2	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.0	0.0	0.0	0.0	1.8	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1
SLC38A4	"ATA3, NAT3, PAAT"	ENSG00000139209	"Solute carrier family 38 member 4"	Q969I6	12	46764761-46832408	"FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Symport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	60	"liver: 614.9"	"Cell type enriched"	"Detected in some"	25	"Hepatocytes: 289.5"	"Cancer enriched"	"Detected in many"	14	"liver cancer: 61.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 17.7;LHCN-M2: 43.2;RH-30: 14.6;RT4: 86.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.81e-2)"	"unprognostic (7.46e-3)"	"unprognostic (5.22e-3)"	"unprognostic (1.75e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (5.37e-4)"	"unprognostic (3.06e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.89e-2)"	"unprognostic (8.28e-2)"	"unprognostic (6.31e-3)"	"unprognostic (2.21e-2)"	0.8	1.1	0.3	0.4	0.2	0.0	1.2	0.1	0.4	0.5	0.5	5.1	0.4	2.2	0.2	1.7	0.9	0.3	0.3	0.2	0.6	4.5	614.9	0.4	0.2	0.3	0.3	0.1	0.2	6.7	0.2	0.1	2.2	0.4	1.3	1.3	0.2	0.8	0.5	10.2	2.6	0.5	5.5	0.2	1.2	0.2	0.3	0.6	1.4	0.3	2.7	0.8	2.0	0.2	0.4	0.0	0.0	0.1	0.0	17.7	2.2	3.4	2.3	5.6	2.0	1.8	1.1	4.3	0.0	3.5	7.8	0.0	1.0	0.0	0.6	1.7	0.0	0.0	0.1	0.0	0.2	0.7	0.5	0.0	4.2	0.1	0.1	1.4	0.1	0.0	0.0	0.2	0.0	43.2	0.0	0.1	0.0	1.3	0.0	0.0	0.0	14.6	0.0	0.0	86.0	0.3	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.2	0.5	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.4	0.2	0.6	0.3	0.3	0.1	0.4	0.2	0.6	0.4	0.1	0.0	0.0	2.6	0.5	0.8	0.0	2.2	3.4	0.0	0.1	0.0	1.5	11.5	0.2	1.8	0.0	2.5	0.0	1.9	0.0	0.0	0.2	0.4	0.2	1.2	0.0	5.3	0.6	0.0	0.7	1.2	0.0	0.2	0.0	1.6	3.9	289.5	0.5	0.0	2.2	0.4	2.0	6.7	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.2	1.2	0.0	0.0	0.7	0.3	0.4	0.2	0.0	0.0	0.3	0.2	0.0	0.1	2.8	0.6	0.8	0.4	2.7	1.3	0.1
SSX2	"CT5.2a, HD21, HOM-MEL-40, MGC119055, MGC15364, MGC3884, SSX"	ENSG00000241476	"SSX family member 2"	Q16385	X	52696896-52707189	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	59	"testis: 15.1"	"Cell type enriched"	"Detected in single"	4	"Spermatogonia: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045683, HPA071685"	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA045683: AB_2679418, HPA071685: "																		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GRM6	"CSNB1B, GPRC1F, mGlu6, MGLUR6"	ENSG00000113262	"Glutamate metabotropic receptor 6"	O15303	5	178977587-178996206	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"	"Sensory transduction, Vision"	"G-protein coupled receptor, Receptor, Transducer"	"Congenital stationary night blindness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	58	"retina: 43.0"	"Cell type enriched"	"Detected in some"	31	"Bipolar cells: 440.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA014511	Enhanced					NA	NA					"HPA014511: AB_2669025"	"unprognostic (1.85e-1)"	"unprognostic (1.54e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.16e-1)"	"unprognostic (2.25e-3)"	"unprognostic (7.72e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.12e-3)"	"unprognostic (6.27e-2)"	"unprognostic (3.34e-4)"	"unprognostic (2.58e-1)"	"unprognostic (3.36e-4)"	"unprognostic (1.23e-1)"	"unprognostic (6.45e-2)"	"unprognostic (7.59e-3)"	"unprognostic (1.97e-1)"	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.5	0.0	0.1	0.1	0.0	0.7	0.0	0.1	0.3	0.0	43.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.1	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.4	0.3	0.1	0.0	440.5	0.1	0.0	1.9	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	1.0	0.2	0.4	0.6	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.1	3.3	0.4	0.0	0.0	0.0	0.9	1.1	0.0	0.1	0.0	0.0	0.6	4.2	0.0	1.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	14.2	0.0	0.3	0.2	0.9	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1
RETNLB	"FIZZ2, HXCP2, RELMb"	ENSG00000163515	"Resistin like beta"	Q9BQ08	3	108743424-108757384	"Predicted secreted proteins, Transporters"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	58	"intestine: 248.0"	"Cell type enriched"	"Detected in some"	38	"Intestinal goblet cells: 210.1"	"Cancer enriched"	"Detected in some"	10	"colorectal cancer: 16.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"OE19: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049152	Enhanced				"Secreted to blood"	NA	NA	123000				"HPA049152: AB_2680655"			"prognostic favorable (6.86e-5)"			"unprognostic (1.19e-3)"		"unprognostic (3.37e-2)"		"unprognostic (4.69e-2)"				"unprognostic (2.67e-2)"	"unprognostic (5.78e-2)"		"unprognostic (4.26e-1)"	0.1	0.0	0.0	4.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	76.4	16.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	248.0	0.0	0.0	0.1	0.0	0.0	34.8	0.8	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	2.4	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	210.1	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	5.5	0.0
GKN2	"blottin, BRICD1B, GDDR, PRO813, TFIZ1, VLTI465"	ENSG00000183607	"Gastrokine 2"	Q86XP6	2	68945232-68952893	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	57	"stomach 1: 4654.7"	"Cell type enriched"	"Detected in some"	22	"Gastric mucus-secreting cells: 2770.2"	"Cancer enriched"	"Detected in some"	8	"stomach cancer: 43.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.1;HaCaT: 1.1;HMC-1: 2.0;MOLT-4: 1.6;NTERA-2: 2.3;PC-3: 4.5;U-2 OS: 1.6;U-266/70: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA057765	Enhanced				"Secreted to digestive system"	NA	NA					"HPA057765: AB_2683520"								"unprognostic (1.81e-1)"			"unprognostic (1.44e-4)"			"unprognostic (2.22e-1)"				0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.3	0.9	0.0	0.0	0.6	0.1	0.0	0.1	0.0	0.0	0.2	0.1	81.5	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.6	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	1.5	4654.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	2.3	0.0	4.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.2	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	115.4	109.3	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.9	2770.2	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.6	0.0	0.0	0.0	0.1	121.2	0.0	0.0	10.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.0
HBD		ENSG00000223609	"Hemoglobin subunit delta"	P02042	11	5232678-5243657	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Oxygen transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	57	"bone marrow: 2820.5"	"Cell type enriched"	"Detected in some"	318	"Erythroid cells: 22112.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"eosinophil: 2.1;neutrophil: 2.3;plasmacytoid DC: 1.6"	"Group enriched"	"Detected in many"	8	"dendritic cells: 1.6;granulocytes: 2.3"	"Cell line enhanced"	"Detected in some"		"HEL: 74.5;HMC-1: 22.3;U-266/70: 127.4;U-266/84: 25.5"									"CAB037087, HPA043234"	Supported					NA	NA		6600000000			"CAB037087: AB_260051, HPA043234: AB_2678378"	"unprognostic (1.32e-2)"		"unprognostic (4.87e-2)"		"unprognostic (4.14e-2)"	"unprognostic (2.26e-3)"		"unprognostic (1.52e-1)"		"unprognostic (3.56e-2)"	"unprognostic (1.04e-1)"		"unprognostic (8.67e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.17e-1)"	"unprognostic (6.24e-2)"	"unprognostic (3.17e-1)"	1.3	0.3	0.9	0.6	0.9	2820.5	0.7	1.3	3.1	0.1	1.8	0.5	0.0	0.1	0.0	0.3	2.8	0.1	2.0	0.9	0.8	3.1	7.5	6.2	0.5	1.0	1.2	0.9	0.3	0.2	4.6	2.2	19.7	1.1	0.2	0.4	0.1	2.2	0.3	0.5	0.7	0.2	0.0	1.0	49.5	0.3	0.1	0.8	4.3	1.0	11.6	0.2	0.2	0.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	74.5	0.0	0.0	0.0	0.3	22.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	127.4	25.5	0.0	0.0	0.1	0.0	0.4	0.2	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.2	0.0	1.6	0.0	105.0	0.9	0.9	1.3	3.1	0.9	0.8	1.0	1.2	0.9	1.1	1.0	0.8	1.4	0.0	0.0	0.0	0.0	11.4	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	4.3	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	22112.3	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.1	13.6	13.4	0.1	0.0	0.0	0.0	0.0	16.9	1.9	0.1	0.0	6.2	69.4	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.6	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.1	0.0	5.8	0.0	0.0	0.0
SLC22A8	OAT3	ENSG00000149452	"Solute carrier family 22 member 8"	Q8TCC7	11	62989154-63015841	"FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Detoxification, Ion transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	56	"choroid plexus: 89.8;kidney: 338.1"	"Cell type enriched"	"Detected in some"	38	"Proximal tubular cells: 347.6"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.6"	"Region enhanced"	"Detected in some"		"hippocampal formation: 3.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044174	Enhanced					NA	NA					"HPA044174: AB_10963058"							"unprognostic (5.35e-4)"					"unprognostic (4.66e-1)"	"unprognostic (6.88e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.20e-1)"			0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.7	1.6	0.0	89.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	338.1	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.7	1.6	3.8	0.0	0.1	0.9	0.0	0.3	0.0	1.0	0.1	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	1.2	0.0	0.0	5.5	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	347.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0
CA1	Car1	ENSG00000133742	"Carbonic anhydrase 1"	P00915	8	85327608-85379014	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	55	"bone marrow: 1813.7;intestine: 2128.9"	"Cell type enriched"	"Detected in some"	4	"Erythroid cells: 11487.3"	"Group enriched"	"Detected in some"	10	"colorectal cancer: 3.4;stomach cancer: 0.9"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	987	"HEL: 1022.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA006558, CAB025790"	Enhanced					NA	NA		4600000000			"CAB025790: , HPA006558: AB_1845989"	"unprognostic (1.44e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.57e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.84e-2)"	"unprognostic (2.03e-2)"		"unprognostic (1.73e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.61e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.95e-2)"	1.2	0.4	0.7	0.5	0.3	1813.7	2.1	1.0	1.7	0.2	1.0	1032.7	0.2	1.6	0.1	0.7	2.2	0.3	1.4	0.2	2.1	1.9	6.8	6.0	0.2	0.4	0.6	0.2	0.4	0.3	0.1	1.9	20.8	0.5	0.4	2128.9	0.4	1.1	1.8	1.0	1.4	1.9	31.0	0.2	35.6	2.3	0.2	0.3	0.5	0.9	3.4	0.1	0.4	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1022.7	0.0	0.5	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.8	0.7	0.3	1.0	1.7	0.2	2.1	0.4	0.6	0.2	0.5	0.2	0.3	0.8	0.0	0.0	0.0	4.2	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.8	0.0	0.0	0.0	0.0	0.0	2565.3	0.0	0.0	0.5	0.1	0.0	0.5	45.8	11487.3	11.8	0.0	0.0	0.1	0.0	0.1	22.3	0.0	4.2	4.4	0.0	0.0	12.1	159.4	0.0	11.4	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	1.0	13.0	2.2	0.0	754.9	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	3.4	0.1	298.4	0.0
CACNG1	CACNLG	ENSG00000108878	"Calcium voltage-gated channel auxiliary subunit gamma 1"	Q06432	17	67044554-67056797	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	55	"skeletal muscle: 330.4;tongue: 122.9"	"Cell type enriched"	"Detected in single"	27	"Skeletal myocytes: 8.1"	"Cancer enhanced"	"Detected in some"		"breast cancer: 1.6;head and neck cancer: 1.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HSkMC: 2.9"	"Region enriched"	"Detected in single"	6	"basal ganglia: 3.4"	"Not detected"	"Not detected"									NA	NA						"unprognostic (1.76e-1)"	"unprognostic (9.83e-3)"		"unprognostic (1.75e-5)"	"unprognostic (2.60e-1)"	"unprognostic (6.72e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.44e-2)"		"unprognostic (4.84e-3)"	"unprognostic (1.07e-1)"	"unprognostic (4.20e-2)"		"unprognostic (1.60e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.94e-1)"	0.0	1.7	0.5	0.0	0.6	0.0	0.4	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.0	3.3	0.0	330.4	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.6	0.0	122.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.1	0.6	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LRRC10	"HRLRRP, LRRC10A"	ENSG00000198812	"Leucine rich repeat containing 10"	Q5BKY1	12	69608564-69610907	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	55	"heart muscle: 40.4"	"Cell type enriched"	"Detected in some"	19	"Cardiomyocytes: 39.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA										"unprognostic (3.76e-4)"										"unprognostic (4.59e-1)"			0.1	0.0	0.1	0.3	0.2	0.2	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	40.4	0.3	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.3	0.1	0.2	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.3	0.3	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	39.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MEP1B		ENSG00000141434	"Meprin A subunit beta"	Q16820	18	32185069-32220404	"Enzymes, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	55	"intestine: 366.9"	"Cell type enriched"	"Detected in some"	42	"Proximal enterocytes: 231.8"	"Cancer enriched"	"Detected in some"	5	"pancreatic cancer: 3.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA029119	Enhanced				"Secreted to digestive system"	NA	NA		310000			"HPA029119: AB_2672913"	"unprognostic (1.33e-1)"	"unprognostic (6.72e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.50e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.74e-2)"	"unprognostic (4.30e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.31e-4)"	"unprognostic (4.74e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.39e-2)"	"unprognostic (3.75e-2)"	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.2	0.2	0.0	0.0	8.3	251.6	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	6.6	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.0	0.1	0.0	0.0	0.0	0.0	366.9	0.3	0.1	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	4.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.2	0.3	0.2	0.1	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	5.4	0.0	0.0	0.3	0.6	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.9	0.0	3.8	0.0	0.1	0.2	231.8	0.0	0.0	0.2	0.0	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	2.5	0.1
PRTN3	"ACPA, AGP7, C-ANCA, MBT, P29, PR-3"	ENSG00000196415	"Proteinase 3"	P24158	19	840999-848175	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	55	"bone marrow: 2115.4"	"Cell type enriched"	"Detected in some"	17	"Erythroid cells: 26.5"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 1.0"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	8	"neutrophil: 2.0"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 2.0"	"Cell line enriched"	"Detected in some"	6	"THP-1: 2054.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005938, CAB017558"	Enhanced		Approved	Vesicles,Cytosol	"Secreted to blood"	NA	NA		390000	Cytosol	Vesicles	"CAB017558: AB_2172317, HPA005938: AB_1855764"	"unprognostic (2.81e-2)"			"unprognostic (2.10e-1)"	"unprognostic (3.83e-3)"		"unprognostic (4.20e-1)"	"unprognostic (3.31e-2)"		"unprognostic (3.34e-1)"	"unprognostic (9.98e-3)"	"unprognostic (3.67e-2)"	"unprognostic (8.62e-6)"	"unprognostic (5.31e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.14e-2)"		0.5	0.2	0.5	0.0	0.7	2115.4	0.4	0.2	1.3	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.1	0.0	1.1	0.6	0.4	0.3	2.8	11.8	0.4	0.3	0.4	0.5	0.1	0.1	0.2	1.3	0.6	0.4	0.3	0.0	0.0	1.6	0.0	0.3	1.3	0.0	0.0	0.2	38.5	0.1	0.2	0.5	7.2	0.4	0.0	0.0	0.0	0.1	0.4	1.2	0.6	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.3	0.0	0.1	0.0	0.0	5.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	343.6	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	2054.4	0.0	0.0	0.0	0.2	0.9	0.0	0.2	0.3	0.0	14.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	9.9	0.5	0.7	0.2	1.3	0.6	0.4	0.3	0.4	0.5	0.4	0.2	0.5	0.4	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.8	1.3	0.4	1.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	26.5	0.4	0.0	0.9	0.9	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	1.5	0.0	0.1	0.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.0	0.2	0.1	0.0	0.1
CPN1		ENSG00000120054	"Carboxypeptidase N subunit 1"	P15169	10	100042193-100081869	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	54	"liver: 82.3"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 37.2"	"Group enriched"	"Detected in some"	12	"liver cancer: 26.6;melanoma: 7.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	17	"SK-MEL-30: 141.8"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA		13000000000						"unprognostic (2.97e-2)"	"unprognostic (2.23e-2)"			"unprognostic (3.93e-2)"		"unprognostic (1.64e-1)"		"unprognostic (6.75e-2)"		"unprognostic (2.93e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.63e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	82.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	141.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	37.2	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	7.6	4.4	0.0	0.0	0.1	0.1	0.0	0.2	0.0
MYH6		ENSG00000197616	"Myosin heavy chain 6"	P13533	14	23381982-23408273	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"	"Atrial septal defect, Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	54	"heart muscle: 2909.5"	"Cell type enriched"	"Detected in some"	17	"Cardiomyocytes: 8051.1"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 1.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	23	"NTERA-2: 4.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA001239, HPA001349, CAB075723, CAB075724, CAB075725"	Enhanced		Uncertain	"Focal adhesion sites"		NA	NA		25000000	"Focal adhesion sites"		"CAB075723: AB_2665728, CAB075724: AB_2665729, CAB075725: AB_2665730, HPA001239: AB_1079438, HPA001349: AB_1079437"	"unprognostic (2.09e-2)"	"unprognostic (8.53e-4)"		"unprognostic (1.80e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.66e-1)"		"unprognostic (2.09e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.44e-2)"	"unprognostic (5.34e-3)"		"unprognostic (6.90e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.22e-2)"	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	2909.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.9	5.9	0.0	0.0	0.5	0.1	0.9	0.0	0.0	1.9	0.0	53.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	51.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8051.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	31.7	0.0	2.7	0.1	0.0	0.0	449.6	0.0	0.0	0.0	0.3	1.1	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.8	60.3	0.1	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0
RHAG	"CD241, RH50A, SLC42A1"	ENSG00000112077	"Rh associated glycoprotein"	Q02094	6	49605175-49636839	"CD markers, Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ammonia transport, Transport"		"Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	54	"bone marrow: 120.5"	"Cell type enriched"	"Detected in some"	170	"Erythroid cells: 494.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	202	"HEL: 506.0;K-562: 491.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA046051, HPA055331"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA046051: , HPA055331: AB_2682785"					"unprognostic (8.16e-2)"						"unprognostic (6.86e-2)"	"unprognostic (1.25e-3)"		"unprognostic (1.65e-1)"				0.2	0.1	0.0	0.0	0.0	120.5	0.0	0.0	0.0	0.6	0.0	0.4	0.1	0.1	0.0	0.1	0.2	0.0	1.4	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.0	0.2	0.2	0.0	0.2	0.6	0.0	0.0	0.4	0.0	0.0	1.7	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	506.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	491.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.4	0.4	0.1	0.3	0.0	494.2	0.2	0.2	0.6	0.3	0.0	0.6	2.5	0.0	1.1	0.1	0.5	0.0	0.1	0.0	0.0	0.6	0.3	2.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.4	0.1	0.0	0.0
SLC34A1	"NAPI-3, NPT2, NPTIIa, SLC11, SLC17A2"	ENSG00000131183	"Solute carrier family 34 member 1"	Q06495	5	177379235-177398848	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	54	"kidney: 156.8"	"Cell type enriched"	"Detected in some"	14	"Proximal tubular cells: 143.2"	"Cancer enriched"	"Detected in single"	12	"renal cancer: 1.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"HEL: 2.4;U-937: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA051255, HPA077175"	Approved		Approved	"Nucleoplasm,Nuclear speckles,Plasma membrane,Mitotic spindle,Cytosol"		Yes	NA			"Nuclear speckles, Plasma membrane"	"Nucleoplasm, Mitotic spindle, Cytosol"	"HPA051255: AB_2681409, HPA077175: "	"unprognostic (1.17e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.49e-2)"		"unprognostic (1.56e-3)"	"unprognostic (2.28e-1)"	"unprognostic (4.50e-2)"	"unprognostic (4.43e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.66e-2)"	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	156.8	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	7.3	0.0	0.0	0.2	0.0	9.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	143.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.0	0.0	0.1
AMY1B	AMY1	ENSG00000174876	"Amylase alpha 1B"	P04745	1	103687415-103696680	"Metabolic proteins, Predicted secreted proteins"	"Carbohydrate metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in some"	53	"salivary gland: 4644.3"	"Cell type enriched"	"Detected in some"	5	"Respiratory ciliated cells: 19.1"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045394, HPA045399, HPA046980"	Supported				"Secreted to digestive system"	NA	NA		70000000			"HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889"					"unprognostic (7.34e-2)"			"unprognostic (2.59e-1)"		"unprognostic (6.05e-2)"				"unprognostic (6.08e-2)"		"unprognostic (1.96e-1)"		0.0	0.0	0.0	0.0	0.0	0.1	2.4	0.0	0.0	87.2	0.0	0.0	0.0	0.1	0.0	0.6	56.8	0.0	0.9	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.4	32.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4644.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.6	1.3	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	2.8	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.8	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	19.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0
CATSPER4		ENSG00000188782	"Cation channel sperm associated 4"	Q7RTX7	1	26190561-26202968	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Differentiation, Ion transport, Spermatogenesis, Transport"	"Calcium channel, Developmental protein, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	53	"testis: 11.3"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 65.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045257	Enhanced					NA	NA					"HPA045257: AB_10968995"	"unprognostic (7.20e-2)"	"unprognostic (2.06e-2)"		"unprognostic (4.56e-2)"		"unprognostic (2.69e-2)"		"unprognostic (3.49e-1)"		"unprognostic (3.86e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.16e-1)"		"unprognostic (3.06e-1)"	"unprognostic (6.78e-2)"	"unprognostic (6.98e-2)"	"unprognostic (6.67e-5)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MT3	GIF	ENSG00000087250	"Metallothionein 3"	P25713	16	56589074-56591088	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	53	"brain: 6495.8;choroid plexus: 3367.6"	"Cell type enriched"	"Detected in many"	5	"Astrocytes: 228.8"	"Cancer enriched"	"Detected in many"	58	"glioma: 392.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"naive CD8 T-cell: 5.0"	"Lineage enriched"	"Detected in single"	51	"T-cells: 5.0"	"Cell line enhanced"	"Detected in some"		"JURKAT: 3.4;RPMI-8226: 6.2;SCLC-21H: 11.0;U-87 MG: 18.3"					"Low region specificity"	"Detected in all"			"HPA004011, CAB017779"	Enhanced					NA	NA					"CAB017779: , HPA004011: AB_1854158"	"unprognostic (6.63e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.34e-2)"	"unprognostic (8.11e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.49e-3)"	"unprognostic (2.45e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.30e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.26e-2)"	3.8	92.5	4021.7	0.9	4018.6	0.1	2.9	4000.2	6495.8	4.6	3367.6	12.4	0.2	0.5	0.0	3.0	3.8	0.4	11.7	3909.4	3807.5	6.0	2.2	1.6	0.7	3902.4	3868.2	3892.5	4.7	1.9	2.2	40.7	1.5	3827.6	7.2	2.5	63.8	44.4	0.7	4.3	3.4	4.9	0.3	3699.1	0.9	6.5	10.1	4121.2	1.9	2.1	5.7	12.9	3.8	9.7	3970.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	3.4	0.0	1.5	0.0	0.0	0.1	0.0	0.3	0.0	0.3	0.0	0.0	6.2	0.0	0.0	11.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	1.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.4	0.0	0.0	1.2	5.0	0.0	0.0	0.0	0.0	0.0	0.5	4021.7	4018.6	4000.2	6495.8	3909.4	3807.5	3902.4	3868.2	3892.5	3827.6	3699.1	4121.2	3970.8	0.4	0.0	0.5	228.8	0.0	0.3	0.1	10.7	0.0	0.0	0.0	0.5	29.6	0.0	4.0	0.0	0.0	0.0	0.0	9.9	45.0	1.7	8.0	8.3	0.1	0.5	10.3	0.0	14.3	0.0	0.1	2.9	0.0	1.8	0.0	3.9	0.7	0.2	0.3	0.0	10.0	12.3	4.1	0.0	0.0	9.7	1.2	0.3	0.0	16.9	0.0	0.0	1.0	43.7	28.2	0.0	3.2	0.4	0.0	0.3	0.3	0.7	18.4	0.0	0.0	3.8	0.7	4.0	2.5	0.0	0.0	0.0	1.5	20.4	8.3	0.1
ANG	"RAA1, RNASE5"	ENSG00000214274	Angiogenin	P03950	14	20684177-20698971	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Differentiation, Stress response"	"Developmental protein, DNA-binding, Endonuclease, Hydrolase, Nuclease, Protein synthesis inhibitor"	"Amyotrophic lateral sclerosis, Cancer-related genes, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	52	"liver: 3042.7"	"Cell type enriched"	"Detected in many"	24	"Hepatocytes: 4816.3"	"Cancer enriched"	"Detected in all"	17	"liver cancer: 279.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 24.5;myeloid DC: 14.5"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Hep G2: 152.2;OE19: 116.1"	"Low region specificity"	"Detected in all"							HPA055896			Approved	"Nucleoli,Nucleoli rim,Mitotic chromosome,Actin filaments"	"Secreted to blood"	Yes	No	308000000	410000000	"Nucleoli, Nucleoli rim, Mitotic chromosome"	"Actin filaments"	"HPA055896: "	"unprognostic (2.50e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.77e-2)"	"prognostic favorable (6.85e-4)"	"unprognostic (5.71e-3)"	"unprognostic (6.99e-2)"	"prognostic favorable (7.83e-5)"	"unprognostic (1.16e-1)"	"unprognostic (3.20e-3)"	"unprognostic (9.19e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.69e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.09e-1)"	37.0	3.1	3.6	6.1	3.3	1.0	38.1	3.6	5.0	37.4	5.4	32.9	23.4	23.6	18.1	9.9	30.7	28.8	13.6	3.4	6.1	18.6	3042.7	18.7	3.6	4.3	3.8	2.9	58.6	31.1	5.3	5.0	3.8	4.0	33.0	46.1	2.2	53.0	13.4	6.3	27.5	27.3	10.5	4.5	7.5	58.7	10.3	3.7	1.5	8.9	10.6	4.2	25.0	31.6	4.6	3.7	9.9	2.3	0.0	23.9	27.8	0.3	4.8	8.8	1.1	4.0	5.9	5.1	0.4	1.5	12.0	8.0	3.8	2.8	3.1	1.3	18.4	3.8	0.9	5.1	152.2	5.0	4.0	0.5	22.2	2.5	1.5	5.1	11.8	5.7	4.2	0.2	27.0	3.5	0.7	0.9	1.2	0.7	116.1	10.7	0.7	3.9	11.3	2.3	2.9	0.0	0.4	4.6	1.7	6.5	5.1	4.0	0.7	6.0	1.9	2.8	1.7	0.7	5.9	4.8	0.5	3.2	2.0	5.0	0.0	24.5	0.0	0.6	2.9	0.4	5.8	1.2	1.1	14.5	4.9	0.3	0.2	0.4	0.0	0.1	2.3	0.8	7.1	3.6	3.3	3.6	5.0	3.4	6.1	4.3	3.8	2.9	4.0	4.5	3.7	4.6	9.7	28.9	17.7	0.0	9.7	27.1	43.3	39.2	14.2	0.1	33.8	24.8	0.8	194.5	24.6	11.0	0.0	1.6	0.7	32.5	11.7	40.0	1.0	6.2	9.7	11.0	71.0	27.8	0.0	31.6	5.3	48.8	56.1	24.9	0.0	10.7	62.4	4816.3	15.9	0.0	0.0	171.9	12.2	95.9	18.7	2.9	71.1	13.8	23.2	0.0	4.9	10.1	0.0	0.0	0.0	21.6	33.3	24.0	11.7	43.7	91.3	61.2	76.5	0.6	13.1	29.7	17.7	1.0	1.3	9.4	52.4	9.3	5.6	0.5	51.6	39.2
CPXCR1	CT77	ENSG00000147183	"CPX chromosome region candidate 1"	Q8N123	X	88747225-88754785	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	52	"testis: 6.5"	"Cell type enriched"	"Detected in some"	6	"Early spermatids: 80.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"													NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	80.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACTN2		ENSG00000077522	"Actinin alpha 2"	P35609	1	236664141-236764631	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		Actin-binding	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	51	"heart muscle: 780.0;skeletal muscle: 2155.0;tongue: 1273.4"	"Cell type enriched"	"Detected in some"	11	"Cardiomyocytes: 1762.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 10.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 2.0;HEK 293: 1.3;HSkMC: 5.9;hTEC/SVTERT24-B: 2.7"	"Region enhanced"	"Detected in many"		"basal ganglia: 66.6"	"Region enhanced"	"Detected in all"		"basal ganglia: 44.5"	"HPA006035, HPA008315"	Enhanced		Uncertain	"Actin filaments"		NA	NA		25000000	"Actin filaments"		"HPA006035: AB_1078095, HPA008315: AB_1844543"	"unprognostic (1.75e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.91e-1)"	"unprognostic (4.32e-3)"	"unprognostic (7.85e-2)"	"unprognostic (2.97e-3)"	"unprognostic (2.17e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.71e-11)"	"unprognostic (1.30e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.22e-1)"	0.7	0.2	11.8	0.0	27.7	0.1	0.9	8.8	19.3	0.3	11.0	0.4	0.0	0.5	0.0	22.0	0.5	0.7	780.0	13.6	13.9	0.4	0.3	3.9	0.2	13.1	10.9	13.8	1.1	1.7	0.1	0.5	0.1	13.1	16.2	0.0	1.4	18.5	0.1	2155.0	0.9	0.5	1.8	9.3	0.2	3.9	4.3	12.1	0.5	0.7	1273.4	0.1	3.5	0.4	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	1.0	2.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.1	1.3	0.0	0.0	0.2	0.0	0.0	0.2	5.9	0.0	2.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	27.7	8.8	19.3	13.6	13.9	13.1	10.9	13.8	13.1	9.3	12.1	15.3	0.3	0.0	0.6	18.6	0.0	0.3	0.4	0.0	1.2	2.6	0.4	0.5	1762.9	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	8.6	0.5	1.2	10.4	0.0	0.0	40.9	0.7	0.0	43.7	3.6	1.4	0.0	0.1	1.8	0.2	0.1	0.0	11.3	0.0	0.0	0.0	0.3	24.6	0.6	1.2	0.0	11.2	0.0	0.0	0.0	24.6	156.9	0.2	0.0	0.4	0.0	0.2	0.0	1.4	0.0	1.2	0.0	66.3	12.4	3.1	2.0	1.2	0.1	0.0	0.4	0.4	0.0	0.2
NTSR2	NTR2	ENSG00000169006	"Neurotensin receptor 2"	O95665	2	11658178-11670195	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	51	"brain: 78.8;choroid plexus: 34.6"	"Cell type enriched"	"Detected in some"	32	"Astrocytes: 32.7"	"Cancer enriched"	"Detected in single"	15	"glioma: 6.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (5.40e-2)"	"unprognostic (2.30e-2)"			"unprognostic (2.36e-2)"	"unprognostic (5.32e-2)"			"unprognostic (2.23e-1)"	"unprognostic (1.80e-1)"		"unprognostic (2.75e-1)"		"unprognostic (4.98e-1)"	"unprognostic (1.64e-1)"			0.3	0.9	67.1	0.0	68.1	0.0	0.2	59.8	78.8	0.0	34.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.1	62.6	0.0	0.0	0.0	0.0	63.6	71.8	53.2	1.1	0.2	0.0	0.2	0.0	60.9	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	49.8	0.0	0.0	0.2	66.3	0.0	0.0	0.0	0.0	0.0	0.0	52.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.1	68.1	59.8	78.8	58.1	62.6	63.6	71.8	53.2	60.9	49.8	66.3	52.1	0.0	0.0	0.0	32.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR9A2		ENSG00000179468	"Olfactory receptor family 9 subfamily A member 2"	Q8NGT5	7	143026158-143027195	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	51	"brain: 5.0"	"Cell type enriched"	"Detected in some"	40	"Oligodendrocytes: 76.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"													NA	NA																							0.0	0.0	1.1	0.0	1.9	0.0	0.0	1.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.0	0.0	0.0	3.2	2.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.9	1.2	1.0	0.2	1.2	3.2	2.0	0.0	2.8	2.5	2.0	5.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	76.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SMPX	"Chisel, Csl, DFN6, DFNX4"	ENSG00000091482	"Small muscle protein X-linked"	Q9UHP9	X	21705978-21758116	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	51	"heart muscle: 764.5;skeletal muscle: 1194.6;tongue: 1107.3"	"Cell type enriched"	"Detected in some"	22	"Cardiomyocytes: 807.6"	"Group enriched"	"Detected in many"	4	"head and neck cancer: 7.2;stomach cancer: 1.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"GAMG: 23.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA077360			Approved	"Plasma membrane"		NA	NA		62000	"Plasma membrane"		"HPA077360: AB_2732342"	"unprognostic (7.29e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (3.04e-5)"	"unprognostic (1.39e-2)"	"unprognostic (7.46e-2)"	"unprognostic (5.27e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.58e-2)"		"unprognostic (2.67e-2)"	"unprognostic (2.82e-1)"		"unprognostic (8.38e-2)"	0.2	0.1	2.7	0.5	2.3	0.1	1.1	3.9	3.8	0.3	1.3	17.0	0.7	0.4	0.0	20.2	0.7	0.5	764.5	1.8	3.8	0.1	1.2	0.5	0.2	2.0	3.5	1.8	1.1	0.3	0.0	0.2	0.0	2.0	11.2	3.4	1.7	17.9	0.8	1194.6	0.3	4.1	12.7	1.6	0.1	7.3	0.2	6.1	1.5	0.3	1107.3	0.1	3.2	0.2	2.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.2	0.0	0.0	0.0	0.3	3.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.6	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	2.3	3.9	3.8	1.8	3.8	2.0	3.5	1.8	2.0	1.6	6.1	2.5	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	807.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.6	0.0	0.0	16.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	35.6	9.5	0.1	0.3	0.0	0.0	0.3	0.1	2.1	0.1	0.0
SMTNL1	CHASM	ENSG00000214872	"Smoothelin like 1"	A8MU46	11	57542641-57550274	"Predicted intracellular proteins"		"Calmodulin-binding, Muscle protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	51	"skeletal muscle: 718.1;tongue: 194.6"	"Cell type enriched"	"Detected in some"	5	"Skeletal myocytes: 5.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"U-266/70: 1.6;U-266/84: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.35e-2)"	"unprognostic (3.90e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.79e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.22e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.53e-3)"	"unprognostic (4.04e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.04e-6)"	"unprognostic (1.21e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.49e-1)"	"unprognostic (1.44e-2)"	0.4	0.2	0.7	0.9	0.4	2.3	0.4	0.2	0.3	0.4	0.0	0.2	0.4	0.3	0.0	8.9	0.5	0.3	0.2	0.2	1.4	0.2	0.8	0.9	0.8	2.7	0.4	0.0	0.5	0.1	0.0	0.5	0.1	0.6	1.6	0.0	0.6	6.1	0.0	718.1	0.3	0.5	0.0	0.1	1.1	0.2	0.5	0.9	0.0	0.4	194.6	0.0	0.2	0.4	1.5	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.4	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.4	0.0	0.1	0.7	0.3	0.2	0.0	0.0	0.5	0.1	0.2	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	1.6	1.0	0.0	0.1	0.4	0.0	0.6	0.3	0.7	0.4	0.4	0.4	0.2	0.3	0.5	0.2	0.3	0.6	0.4	1.1	0.2	0.5	0.2	0.2	0.1	0.7	0.4	0.2	0.3	0.2	1.4	2.7	0.4	0.0	0.6	0.1	0.9	1.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.1	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPACA5B	LYZL5B	ENSG00000171478	"Sperm acrosome associated 5B"	Q96QH8	X	48130657-48132613	"Enzymes, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	51	"testis: 24.1"	"Cell type enriched"	"Detected in single"	16	"Early spermatids: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044747, HPA047149"	Supported				"Secreted in male reproductive system"	NA	NA					"HPA044747: AB_2679071, HPA047149: AB_2679955"																		0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	24.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.3	0.2	0.4	0.2	0.2	0.4	0.3	0.0	0.3	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GAGE1	CT4.1	ENSG00000205777	"G antigen 1"	P0DTW1	X	49599025-49608536	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	49	"testis: 9.1"	"Cell type enriched"	"Detected in some"	4	"Spermatogonia: 113.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"AN3-CA: 739.9"									HPA043232	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: AB_2678376"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	739.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	139.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.5	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.1	24.4	113.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC007325.1		ENSG00000276017			Unmapped	72411-74814	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in single"	48	"testis: 9.0"	"Cell type enriched"	"Detected in single"	13	"Spermatocytes: 2.7"					"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.0	0.1	0.0	0.0	0.0	0.0	0.0		0.1	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CKMT2	SMTCK	ENSG00000131730	"Creatine kinase, mitochondrial 2"	P17540	5	81233320-81266398	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	48	"heart muscle: 1102.4;skeletal muscle: 1444.3;tongue: 2345.0"	"Cell type enriched"	"Detected in many"	20	"Cardiomyocytes: 814.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	7	"NK-cell: 1.1"	"Lineage enriched"	"Detected in single"	7	"NK-cells: 1.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 3.5;T-47d: 6.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA051880	Enhanced					NA	NA		3000000			"HPA051880: AB_2681650"	"unprognostic (3.64e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.60e-2)"	"unprognostic (5.34e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.75e-3)"	18.3	33.9	11.6	0.8	13.6	0.1	4.6	16.5	12.4	8.0	20.9	2.7	1.1	6.4	11.5	20.3	6.9	8.2	1102.4	10.4	12.8	14.7	1.0	2.5	1.3	15.6	15.7	8.5	10.3	7.7	15.9	4.6	0.7	15.8	13.2	0.7	1.6	26.5	13.2	1444.3	4.0	2.8	8.8	12.3	1.8	18.0	3.6	15.0	0.8	4.9	2345.0	0.4	4.2	4.1	17.0	0.3	0.7	0.8	1.3	1.9	0.4	3.5	0.1	0.0	0.0	0.0	2.4	0.2	1.4	0.4	0.0	1.0	0.0	0.0	0.0	0.0	1.5	2.4	0.1	1.0	3.2	2.6	0.6	0.2	0.8	0.0	0.0	0.0	0.3	0.0	2.1	0.3	0.5	0.0	2.2	1.2	0.2	1.0	0.0	0.7	0.6	1.0	0.1	0.0	0.0	1.4	1.0	1.2	0.3	1.4	1.5	6.3	0.3	0.7	0.4	1.2	0.7	0.2	0.2	0.1	1.3	0.4	0.9	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	11.6	13.6	16.5	12.4	10.4	12.8	15.6	15.7	8.5	15.8	12.3	15.0	17.0	1.8	0.0	0.5	40.1	0.0	0.1	0.4	0.0	1.2	0.9	0.9	0.8	814.1	7.2	0.6	12.9	0.0	0.1	0.0	0.1	37.2	1.7	25.1	13.6	3.5	9.8	0.0	0.0	11.4	0.6	0.4	16.2	6.6	27.8	0.0	0.8	0.0	0.0	0.1	0.0	18.1	0.3	0.0	0.0	0.0	2.2	7.2	0.3	3.6	23.4	0.0	1.4	0.0	4.5	9.1	0.4	0.0	15.1	0.0	0.3	0.3	0.6	0.7	1.0	0.0	11.6	15.0	1.0	0.4	0.1	0.1	0.3	0.8	23.7	2.5	0.2
GOLGA6L22		ENSG00000277865	"Golgin A6 family like 22"	H0YM25	15	22458903-22469230	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	48	"testis: 9.3"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 58.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047733	Uncertain					NA	NA					"HPA047733: "						"unprognostic (2.71e-2)"								"unprognostic (1.08e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
INS-IGF2		ENSG00000129965	"INS-IGF2 readthrough"	F8WCM5	11	2132538-2161209	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	48	"pancreas: 9.2"	"Cell type enriched"	"Detected in single"	11	"Hepatocytes: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											CAB019430	Enhanced				"Secreted to digestive system"	NA	NA					"CAB019430: AB_10691857"					"unprognostic (1.33e-1)"						"unprognostic (2.34e-1)"							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MIOX	ALDRL6	ENSG00000100253	"Myo-inositol oxygenase"	Q9UGB7	22	50486784-50490648	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	48	"kidney: 707.3"	"Cell type enriched"	"Detected in some"	10	"Proximal tubular cells: 4564.6"	"Cancer enriched"	"Detected in many"	16	"renal cancer: 56.0"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 24.9;Hep G2: 5.7;Karpas-707: 12.8;U-266/70: 7.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA039451, HPA039562"	Enhanced					NA	NA					"HPA039451: AB_2676513, HPA039562: AB_2676574"	"unprognostic (2.11e-1)"	"unprognostic (4.32e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.30e-2)"	"unprognostic (9.83e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.84e-3)"	"unprognostic (2.84e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.85e-2)"	"unprognostic (9.83e-2)"	"prognostic favorable (2.60e-6)"	"unprognostic (1.77e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.23e-2)"	0.2	0.1	0.1	0.3	0.2	0.2	0.0	0.7	0.5	0.0	0.2	0.8	0.2	0.0	0.2	0.1	0.0	5.3	0.0	0.2	0.2	707.3	0.4	0.0	0.7	0.2	0.1	0.2	0.0	1.2	0.0	0.1	0.1	0.3	0.5	0.0	0.1	0.3	0.1	0.0	0.3	0.2	0.0	0.1	0.2	1.1	0.2	0.2	0.2	14.8	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.1	0.3	0.2	0.1	2.0	0.2	0.0	0.0	0.1	0.1	0.2	0.1	0.6	0.4	0.0	0.2	0.2	0.0	0.0	24.9	0.0	0.2	0.4	5.7	2.8	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.0	1.1	0.1	12.8	0.0	1.2	0.0	0.1	0.2	0.5	0.4	0.1	0.1	0.1	2.6	0.1	0.1	0.3	0.0	0.0	0.6	0.5	0.1	1.4	0.0	0.0	0.5	0.1	0.1	7.8	0.7	0.3	0.1	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.1	0.2	0.7	0.5	0.2	0.2	0.2	0.1	0.2	0.3	0.1	0.2	0.3	0.2	0.0	1.7	0.0	13.0	0.8	0.9	0.1	0.0	0.6	0.7	0.8	0.1	1.5	0.0	99.3	0.0	0.0	0.3	0.3	424.6	0.0	0.0	0.1	0.2	0.2	1.2	0.0	0.0	0.9	0.1	0.3	0.0	0.2	0.0	0.1	0.4	0.3	0.1	0.0	0.0	0.9	0.0	0.0	1.6	0.0	0.0	23.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	4564.6	0.0	0.5	0.0	0.2	0.1	0.1	0.3	0.0	0.1	0.3	7.8	0.0	0.1	0.9
TRBV6-1	"TCRBV13S3, TCRBV6S1, TRBV61"	ENSG00000211706	"T cell receptor beta variable 6-1"	A0A0K0K1D8	7	142328297-142328786	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	48	"lymphoid tissue: 90.0"	"Cell type enriched"	"Detected in single"	10	"T-cells: 5.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 118.0;T-reg: 74.1"	"Lineage enriched"	"Detected in single"	126	"T-cells: 118.0"	"Cell line enriched"	"Detected in single"	11	"SCLC-21H: 1.5"															NA	NA						"unprognostic (1.12e-2)"	"unprognostic (3.42e-4)"	"unprognostic (3.40e-3)"	"unprognostic (1.20e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.75e-5)"	"unprognostic (1.08e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.86e-5)"	"unprognostic (1.28e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.85e-4)"	"unprognostic (2.41e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.51e-2)"	"unprognostic (3.56e-2)"	0.2	0.1	0.0	4.9	0.0	1.0	0.4	0.0	0.0	0.4	0.0	0.9	0.7	0.1	0.1	0.2	0.2	1.7	0.2	0.0	0.0	0.1	0.3	0.8	8.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.4	0.0	0.0	0.3	1.8	0.2	0.0	2.2	1.0	0.0	0.0	90.0	0.4	0.1	10.3	1.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.0	118.0	0.0	37.7	33.2	0.1	0.1	39.0	18.5	0.9	0.0	0.1	0.1	74.1	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0
ASGR2	CLEC4H2	ENSG00000161944	"Asialoglycoprotein receptor 2"	P07307	17	7101322-7115700	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Endocytosis, Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	47	"liver: 847.6"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 878.6"	"Cancer enriched"	"Detected in many"	66	"liver cancer: 214.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"classical monocyte: 110.0;myeloid DC: 64.1"	"Group enriched"	"Detected in many"	51	"dendritic cells: 64.1;monocytes: 110.0"	"Cell line enriched"	"Detected in some"	9	"Hep G2: 528.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA014899, HPA015998"	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane"		NA	NA		14000000	"Endoplasmic reticulum, Plasma membrane"		"HPA014899: AB_1845085, HPA015998: AB_1845084"	"unprognostic (6.76e-2)"	"unprognostic (7.45e-7)"	"unprognostic (1.61e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.03e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.35e-4)"	"unprognostic (1.54e-3)"	"unprognostic (6.95e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.31e-2)"	1.2	0.3	0.8	8.0	0.9	7.0	0.5	0.8	1.5	0.4	1.5	0.5	0.3	0.3	0.1	0.5	0.6	17.8	0.4	1.1	1.2	1.2	847.6	2.5	0.9	1.1	0.9	0.7	0.2	0.5	0.1	0.2	0.5	0.9	0.4	0.4	0.0	0.5	0.2	0.2	5.3	0.6	1.3	1.0	6.9	0.5	0.5	1.2	0.5	0.3	0.1	1.1	2.0	0.4	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	62.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	528.3	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	42.3	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.0	1.0	110.0	0.8	0.1	11.2	0.2	0.0	0.0	0.0	64.1	0.0	0.1	0.0	1.7	0.1	0.1	1.6	0.3	31.8	0.8	0.9	0.8	1.5	1.1	1.2	1.1	0.9	0.7	0.9	1.0	1.2	1.5	0.0	0.0	5.1	0.3	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	150.2	0.0	0.0	0.0	0.1	0.0	0.1	1.9	0.0	0.4	0.0	0.0	1.3	7.1	19.6	1.9	0.0	0.2	0.1	0.0	0.1	2.5	0.0	16.1	878.6	8.4	0.0	0.1	0.1	0.0	41.1	7.7	0.7	0.0	19.6	0.0	0.0	15.3	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	6.6	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.3	0.4	1.4	0.0	0.0	0.1
TDO2	"TDO, TPH2"	ENSG00000151790	"Tryptophan 2,3-dioxygenase"	P48775	4	155854738-155920406	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Tryptophan catabolism"	"Dioxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	47	"liver: 804.5"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 1174.2"	"Cancer enriched"	"Detected in many"	18	"liver cancer: 35.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"EFO-21: 9.6;HDLM-2: 22.0;U-87 MG: 11.3"	"Group enriched"	"Detected in some"	7	"cerebellum: 6.3;hippocampal formation: 5.3;white matter: 1.9"	"Low region specificity"	"Detected in all"			HPA039611	Uncertain		Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA039611: "	"unprognostic (1.10e-1)"	"unprognostic (3.00e-3)"	"unprognostic (3.84e-2)"	"unprognostic (1.95e-1)"	"unprognostic (7.06e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.68e-8)"	"unprognostic (7.99e-2)"	"unprognostic (9.29e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.95e-2)"	0.2	1.6	0.5	16.9	0.6	0.0	0.1	0.4	1.4	0.2	0.4	1.2	3.6	0.4	0.7	0.7	0.3	1.9	0.0	0.7	0.5	0.4	804.5	3.3	3.1	0.5	1.3	0.5	0.1	0.3	0.1	4.1	0.6	0.6	0.2	1.4	0.0	0.4	0.2	0.2	0.0	6.0	2.6	0.5	1.9	1.6	0.4	0.5	0.2	0.2	0.0	2.6	7.7	0.1	0.9	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	9.6	0.0	0.2	0.0	0.1	0.0	0.0	22.0	0.0	0.1	0.0	0.0	0.3	0.3	0.0	1.1	0.0	0.0	0.0	0.9	0.0	0.0	0.1	3.5	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	1.6	0.0	0.3	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.2	0.0	1.2	0.4	0.5	0.0	3.4	0.0	0.0	11.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.4	1.4	0.7	0.5	0.5	1.3	0.5	0.6	0.5	0.5	0.9	0.8	0.0	0.0	0.7	2.7	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.6	158.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.5	0.1	1.1	2.4	0.0	32.0	4.1	0.0	0.0	1.7	3.6	0.1	0.0	0.0	29.6	1174.2	0.9	0.0	0.4	0.0	0.0	31.7	0.0	0.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.6	0.0	11.3	0.4	1.1	0.0	0.0	0.3	2.3	0.3	0.0	0.1
CCL16	"CKb12, HCC-4, LCC-1, LEC, LMC, Mtn-1, NCC-4, SCYA16, SCYL4"	ENSG00000275152	"C-C motif chemokine ligand 16"	O15467	17	35976493-35981497	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	46	"liver: 121.3"	"Cell type enriched"	"Detected in some"	18	"Hepatocytes: 262.0"	"Cancer enriched"	"Detected in single"	154	"liver cancer: 49.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	24	"Hep G2: 10.1"					"Low region specificity"	"Detected in some"								"Secreted to blood"	NA	NA	2780000	23000000				"unprognostic (3.85e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.75e-2)"		"unprognostic (2.72e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.91e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.66e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.08e-2)"	0.6	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.8	0.0	0.2	0.1	0.5	0.0	0.2	0.5	0.2	0.1	0.0	0.0	0.3	121.3	0.3	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.5	0.1	0.0	0.1	0.1	0.1	0.3	0.2	0.2	0.0	2.6	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	262.0	0.0	0.0	0.0	0.2	0.0	4.1	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1
CYP21A2	"CA21H, CAH1, CPS1, CYP21, CYP21B, P450c21B"	ENSG00000231852	"Cytochrome P450 family 21 subfamily A member 2"	P08686	6	32038327-32041644	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Steroidogenesis	"Monooxygenase, Oxidoreductase"	"Congenital adrenal hyperplasia, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	46	"adrenal gland: 2058.4"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 15.9"	"Cancer enhanced"	"Detected in some"		"liver cancer: 2.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HDLM-2: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA048979, HPA053371"	Enhanced					NA	NA					"HPA048979: AB_2680584, HPA053371: AB_2682131"	"unprognostic (1.03e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.02e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.76e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.67e-7)"	"unprognostic (7.39e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.82e-1)"	1.4	2058.4	0.0	0.0	0.0	0.0	1.5	0.0	0.6	1.6	0.0	1.9	0.0	1.5	0.6	0.6	2.5	0.0	2.2	0.0	0.0	6.9	45.1	0.8	0.0	0.0	0.0	0.0	4.4	0.9	0.0	1.9	0.0	0.0	1.9	0.0	0.0	4.0	0.0	0.3	0.6	1.2	0.0	0.0	5.6	0.8	0.8	0.0	0.0	2.4	0.0	0.0	2.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.4	2.4	0.5	0.3	1.5	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.1	0.8	0.9	1.8	0.0	0.1	0.0	0.0	1.6	0.0	0.2	1.3	0.4	0.0	15.9	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.1	0.6	0.1	1.8	0.0	0.0	0.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	2.0	1.2	0.6	0.0	0.3	0.6	0.6	0.4	0.0	0.0	0.0	0.3	1.0	0.0	0.0
TRBV14	"TCRBV14S1, TCRBV16S1A1N1"	ENSG00000275743	"T cell receptor beta variable 14"	A0A5B0	7	142587868-142588359	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	46	"lymphoid tissue: 45.8"	"Cell type enriched"	"Detected in single"	11	"T-cells: 8.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	10	"memory CD4 T-cell: 20.2;memory CD8 T-cell: 24.6;naive CD4 T-cell: 21.6;naive CD8 T-cell: 19.5;T-reg: 27.1"	"Lineage enriched"	"Detected in single"	60	"T-cells: 27.1"	"Not detected"	"Not detected"																	NA	NA						"unprognostic (1.70e-4)"	"unprognostic (1.68e-2)"	"unprognostic (1.99e-1)"	"unprognostic (8.53e-4)"		"unprognostic (3.16e-4)"	"unprognostic (5.12e-2)"	"unprognostic (6.14e-5)"	"unprognostic (1.77e-1)"	"unprognostic (9.00e-3)"	"unprognostic (3.05e-1)"	"unprognostic (3.30e-1)"	"unprognostic (2.09e-3)"	"unprognostic (8.25e-2)"	"unprognostic (6.65e-3)"	"unprognostic (4.82e-2)"	"unprognostic (5.44e-2)"	0.2	0.0	0.0	2.1	0.0	0.9	0.1	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.4	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.6	4.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.1	0.3	0.0	0.9	0.0	0.0	1.3	0.5	0.1	0.0	45.8	0.1	0.0	5.1	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.1	0.0	2.2	0.0	20.2	24.6	0.0	0.2	21.6	19.5	0.4	0.0	0.0	0.0	27.1	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0
GOLGA6L2	"CT105, FLJ36144"	ENSG00000174450	"Golgin A6 family like 2"	Q8N9W4	15	23439038-23447243	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	45	"testis: 54.2"	"Cell type enriched"	"Detected in some"	8	"Early spermatids: 567.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	23	"U-266/70: 5.0;U-266/84: 1.2"															NA	NA							"unprognostic (1.45e-1)"	"unprognostic (4.86e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.24e-1)"								"unprognostic (5.52e-2)"	"unprognostic (8.71e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	54.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	567.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	64.3	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.6	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0
HRC	MGC133236	ENSG00000130528	"Histidine rich calcium binding protein"	P23327	19	49151198-49155396	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	45	"heart muscle: 557.3;skeletal muscle: 457.3;tongue: 246.8"	"Cell type enriched"	"Detected in some"	17	"Cardiomyocytes: 1182.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"Hep G2: 5.8;HSkMC: 5.6;K-562: 8.0;THP-1: 13.9;U-266/84: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004833	Enhanced				"Intracellular and membrane"	NA	NA		100000			"HPA004833: AB_1079083"	"unprognostic (1.06e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.46e-2)"	"unprognostic (4.94e-2)"	"unprognostic (5.66e-2)"	"unprognostic (9.75e-3)"	"unprognostic (3.44e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.09e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.41e-3)"	"unprognostic (5.85e-3)"	"unprognostic (4.04e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.46e-1)"	8.2	3.6	2.8	0.6	2.8	0.0	5.8	3.1	4.0	5.6	2.3	2.4	0.9	6.4	5.4	4.6	9.3	2.2	557.3	2.7	2.4	3.5	1.9	2.8	0.8	2.5	2.7	2.3	4.6	1.3	1.5	1.5	2.1	3.0	4.3	0.9	0.8	8.2	2.5	457.3	2.4	2.3	2.1	2.4	0.5	1.8	1.4	2.6	0.6	4.8	246.8	0.4	3.1	3.9	2.6	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.6	5.8	0.0	0.0	1.1	5.6	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.1	0.0	0.0	0.2	0.7	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	13.9	0.2	0.0	0.0	0.3	0.0	0.0	4.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	2.8	3.1	4.0	2.7	2.4	2.5	2.7	2.3	3.0	2.4	2.6	2.6	3.7	0.0	0.0	0.0	0.3	0.3	0.2	0.0	0.0	1.0	0.8	1.0	1182.5	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.3	1.7	11.0	1.2	0.0	0.0	0.2	0.0	20.9	0.0	0.5	0.0	0.0	0.7	0.6	0.1	3.3	0.1	2.8	0.0	0.0	1.1	0.4	8.4	0.3	3.6	0.0	0.0	1.3	0.0	0.0	0.1	0.1	0.4	8.2	0.1	0.2	0.5	0.0	0.0	0.2	65.7	8.7	44.2	0.0	0.2	0.1	0.1	0.1	0.2	2.8	1.5	0.2
PGLYRP2	"PGLYRPL, PGRP-L, PGRPL, tagL, tagL-alpha, tagl-beta, TAGL-like"	ENSG00000161031	"Peptidoglycan recognition protein 2"	Q96PD5	19	15468645-15498956	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	Immunity	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	45	"liver: 260.9"	"Cell type enriched"	"Detected in some"	11	"Hepatocytes: 168.7"	"Cancer enriched"	"Detected in some"	16	"liver cancer: 42.9"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"granulocytes: 3.4;monocytes: 5.1;T-cells: 2.3"	"Group enriched"	"Detected in some"	5	"MCF7: 8.1;T-47d: 8.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB033468, HPA046311, HPA075237"	Supported		Approved	"Cell Junctions"	"Secreted to blood"	NA	NA		87000000000	"Cell Junctions"		"CAB033468: AB_1127187, HPA046311: AB_2679621, HPA075237: AB_2686739"	"unprognostic (7.39e-3)"	"unprognostic (1.52e-2)"	"unprognostic (5.22e-2)"	"unprognostic (8.79e-2)"	"unprognostic (3.97e-1)"	"unprognostic (4.88e-4)"	"unprognostic (5.93e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.18e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.66e-16)"	"unprognostic (6.35e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.81e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	260.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	5.7	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	3.4	0.4	0.2	1.6	1.7	1.6	0.2	0.9	0.8	0.1	0.0	2.2	2.3	1.6	0.5	5.1	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	4.3	0.0	0.2	0.5	0.0	0.0	4.1	1.5	0.2	4.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	3.3	0.0	0.0	0.3	0.0	0.4	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	2.9	168.7	0.3	0.0	0.4	0.0	0.0	2.2	0.0	3.1	0.3	1.9	8.8	0.0	1.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	14.1	0.8	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.4	0.7	0.1	0.1	0.0	7.6	0.0	0.0	0.1
SERPINA1	"A1A, A1AT, AAT, alpha-1-antitrypsin, alpha1AT, PI, PI1"	ENSG00000197249	"Serpin family A member 1"	P01009	14	94376747-94390693	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Blood coagulation, Hemostasis"	"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	45	"liver: 34304.0"	"Cell type enriched"	"Detected in many"	8	"Hepatocytes: 42919.3"	"Cancer enriched"	"Detected in all"	10	"liver cancer: 3850.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 2482.1;intermediate monocyte: 3411.9;neutrophil: 2823.2;non-classical monocyte: 4518.8"	"Group enriched"	"Detected in all"	5	"granulocytes: 2823.2;monocytes: 4518.8"	"Cell line enriched"	"Detected in many"	10	"Hep G2: 4769.1"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	6	"cerebellum: 130.6"	"HPA000927, HPA001292, CAB013211, CAB016648, CAB073396"	Enhanced		Enhanced	Vesicles	"Secreted to blood"	NA	NA	2070000000000	140000000000	Vesicles		"CAB013211: , CAB016648: AB_1611888, CAB073396: , HPA000927: AB_1844761, HPA001292: AB_1844762"	"prognostic favorable (1.61e-5)"	"unprognostic (3.37e-1)"	"prognostic favorable (5.86e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.50e-3)"	"unprognostic (3.81e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.54e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.96e-1)"	49.6	9.7	7.8	227.0	11.7	158.6	101.7	10.2	19.9	106.6	14.6	152.4	281.1	42.7	5.3	10.1	22.6	355.5	12.2	7.8	19.1	511.1	34304.0	575.7	37.4	22.4	13.0	6.9	5.5	202.7	5.3	9.1	26.8	16.7	12.7	180.6	2.6	33.9	141.7	3.7	6.1	767.2	76.4	14.1	316.1	284.8	3.0	20.5	15.2	23.2	12.0	25.4	56.4	9.1	29.9	25.9	0.3	0.0	0.5	1.0	0.0	1.5	0.6	1.7	0.6	1.1	187.8	500.8	2.6	15.6	0.0	1.4	1.9	0.0	10.9	1.2	70.1	0.0	4.3	2.0	4769.1	0.3	16.8	2.3	4.1	5.4	0.3	18.5	1.9	0.0	0.0	3.2	0.4	0.0	0.8	1.1	12.1	2.0	5.5	8.0	1.9	16.7	2.4	300.8	3.0	0.6	1.3	6.4	1.6	1.4	0.4	262.1	2.7	1.6	2.1	59.4	1.9	7.1	3.3	1.8	7.0	4.4	41.8	0.6	10.6	2482.1	634.3	5.5	3411.9	6.8	7.7	3.6	4.1	683.6	3.6	4.3	3.6	2823.2	5.3	4518.8	14.9	4.5	2770.7	7.8	11.7	10.2	19.9	7.8	19.1	22.4	13.0	6.9	16.7	14.1	20.5	29.9	2.2	35.3	285.9	0.0	137.4	2.3	1.0	36.3	0.0	0.2	100.8	31.5	5.3	4520.9	165.5	150.8	0.0	1.6	3.9	52.0	68.4	3787.9	0.2	70.0	2.8	57.0	12.1	1227.4	0.0	225.8	4.5	3.6	36.2	51.3	1.3	0.1	938.8	42919.3	167.6	0.0	0.0	742.4	30.5	1454.0	74.1	1.1	0.0	413.3	1.8	1.0	291.7	0.3	9.2	0.0	0.0	2161.6	137.0	0.0	1.5	6.8	5270.0	745.9	108.3	0.2	0.0	0.6	17.4	0.0	0.2	0.6	1.7	6.4	75.5	0.0	83.2	6.7
TCAP	"CMD1N, LGMD2G, T-cap, TELE, telethonin"	ENSG00000173991	Titin-cap	O15273	17	39665349-39666554	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cardiomyopathy, Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	45	"heart muscle: 4049.4;skeletal muscle: 15979.8;tongue: 5883.1"	"Cell type enriched"	"Detected in many"	7	"Cardiomyocytes: 2473.2"	"Group enriched"	"Detected in many"	8	"head and neck cancer: 20.2;prostate cancer: 11.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NB-4: 5.3;SK-BR-3: 8.4"	"Region enhanced"	"Detected in many"		"cerebral cortex: 15.8"	"Low region specificity"	"Detected in some"			"CAB004591, HPA026477"	Enhanced					NA	NA		36000			"CAB004591: AB_628340, HPA026477: AB_1857888"	"unprognostic (5.29e-2)"	"unprognostic (9.29e-2)"	"unprognostic (2.40e-3)"	"unprognostic (4.32e-3)"	"unprognostic (8.79e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.12e-4)"	"unprognostic (2.62e-1)"	"unprognostic (4.51e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.78e-1)"	"prognostic favorable (4.55e-4)"	3.5	4.2	11.9	0.8	14.2	2.9	5.8	12.8	16.2	2.9	10.2	2.6	0.7	2.2	0.0	190.5	2.6	1.9	4049.4	11.0	11.8	3.1	3.4	8.5	3.3	12.4	12.8	10.9	3.6	2.7	0.9	5.4	0.9	12.6	108.0	0.1	1.1	138.7	1.6	15979.8	4.3	2.5	0.8	11.2	3.2	2.7	3.5	12.2	1.0	5.0	5883.1	0.9	1.7	3.0	12.0	0.1	2.5	1.7	2.2	0.2	0.3	0.6	0.4	0.2	0.4	0.5	0.9	1.5	1.0	1.6	0.3	1.7	0.9	0.3	0.0	0.0	0.9	2.6	0.7	2.0	0.4	0.1	0.6	0.3	0.7	0.3	1.0	0.1	1.0	0.2	1.1	1.6	0.3	0.0	1.1	0.7	5.3	1.0	0.9	0.6	0.7	1.5	0.7	0.8	0.2	1.0	1.7	1.3	8.4	1.1	0.9	0.6	1.1	1.1	0.8	1.0	1.4	0.5	3.7	2.0	0.5	0.6	1.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	11.9	14.2	12.8	16.2	11.0	11.8	12.4	12.8	10.9	12.6	11.2	12.2	12.0	3.3	0.0	0.0	8.1	0.7	1.7	0.5	0.3	0.0	1.5	1.5	0.9	2473.2	5.7	0.3	1.8	0.0	0.1	0.3	0.4	1.9	0.3	0.4	0.9	0.5	29.0	3.0	1.3	2.2	0.0	0.0	68.5	1.5	0.6	0.0	0.8	2.2	0.0	0.4	10.1	2.7	1.1	0.0	0.6	2.0	0.1	0.3	2.9	1.8	1.0	0.1	0.8	0.0	1.0	2.6	0.5	0.6	0.4	0.9	0.7	0.5	0.3	0.6	1.7	6.6	336.9	25.4	1.0	1.2	0.0	2.0	0.4	1.9	0.5	1.2	0.7
GBX2		ENSG00000168505	"Gastrulation brain homeobox 2"	P52951	2	236165236-236168386	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	44	"brain: 11.0"	"Cell type enriched"	"Detected in single"	4	"Early spermatids: 2.8"	"Group enriched"	"Detected in some"	6	"glioma: 1.7;testis cancer: 6.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 47.5;BEWO: 8.3;PC-3: 14.2;TIME: 7.7"	"Region enhanced"	"Detected in single"		"thalamus: 1.3"	"Group enriched"	"Detected in some"	4	"midbrain: 2.5;pons: 2.7;thalamus: 6.4"	HPA067809			Approved	Nucleoplasm		Yes	NA			Nucleoplasm		"HPA067809: AB_2685900"	"unprognostic (5.30e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.91e-1)"	"unprognostic (8.13e-2)"	"unprognostic (6.99e-2)"	"unprognostic (3.55e-4)"	"unprognostic (8.69e-7)"	"unprognostic (2.08e-1)"	"unprognostic (1.01e-2)"	"unprognostic (5.47e-2)"	"unprognostic (9.39e-4)"	0.0	0.0	1.4	0.0	1.4	0.0	0.0	2.5	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	7.5	0.0	0.0	0.0	0.0	4.8	5.1	0.1	0.0	0.0	0.0	0.1	0.1	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.2	11.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	2.6	0.9	47.5	1.8	0.0	0.0	8.3	0.7	0.0	1.3	0.0	1.1	0.0	0.0	0.9	0.0	1.4	0.0	0.4	0.1	0.3	0.0	4.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	3.9	0.0	3.4	0.0	0.6	1.2	0.0	0.4	1.2	0.0	14.2	0.0	5.1	0.0	0.4	0.0	0.6	0.3	1.6	0.0	0.5	1.5	0.0	0.0	7.7	0.4	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.4	2.5	0.8	0.4	7.5	4.8	5.1	0.1	3.3	2.7	11.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0
SPTA1	EL2	ENSG00000163554	"Spectrin alpha, erythrocytic 1"	P02549	1	158610704-158686715	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell shape"	"Actin capping, Actin-binding"	"Disease variant, Elliptocytosis, Hereditary hemolytic anemia, Pyropoikilocytosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	44	"bone marrow: 76.3"	"Cell type enriched"	"Detected in some"	29	"Erythroid cells: 255.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"K-562: 38.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB016193, HPA028048, HPA028253, CAB037246"	Enhanced					NA	NA		11000000			"CAB016193: AB_669050, CAB037246: AB_261445, HPA028048: AB_10603341, HPA028253: AB_2672537"	"unprognostic (3.39e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.65e-3)"	"unprognostic (1.50e-3)"	"unprognostic (9.08e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.29e-1)"	"unprognostic (9.09e-2)"	"unprognostic (6.73e-8)"	"unprognostic (6.08e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.76e-2)"	"unprognostic (5.85e-3)"	0.1	0.0	0.0	0.0	0.0	76.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	38.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	8.7	0.0	0.0	0.3	0.0	255.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.8	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0
TMEM262		ENSG00000187066	"Transmembrane protein 262"	E9PQX1	11	65084979-65089375	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	44	"testis: 21.3"	"Cell type enriched"	"Detected in some"	11	"Early spermatids: 179.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (4.36e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.78e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.71e-4)"	"unprognostic (1.85e-5)"	"unprognostic (3.28e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.19e-3)"	"unprognostic (7.18e-3)"	"unprognostic (7.13e-9)"	"unprognostic (9.53e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.84e-3)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	21.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.4	0.2	0.0	0.0	0.0	0.1	0.3	0.1	0.3	0.0	0.3	0.2	0.0	1.4	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	179.5	0.3	0.2	0.2	0.0	0.4	0.0	0.0	0.3	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.3	16.3	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.1	0.0	0.1	0.1	0.1	0.5	0.0	0.4	0.2	1.1	1.2	0.5	0.3	0.4	0.5	0.1	0.1	0.1
TRBV12-4	"TCRBV12S4, TCRBV8S2A1T, TRBV124"	ENSG00000276953	"T cell receptor beta variable 12-4"	A0A0B4J2E0	7	142563740-142564245	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	44	"lymphoid tissue: 111.3"	"Cell type enriched"	"Detected in some"	5	"T-cells: 5.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	32	"memory CD4 T-cell: 28.6;memory CD8 T-cell: 38.8;naive CD4 T-cell: 39.7;naive CD8 T-cell: 33.7;T-reg: 54.4"	"Lineage enriched"	"Detected in single"	68	"T-cells: 54.4"	"Cell line enriched"	"Detected in some"	11	"LHCN-M2: 51.6"															NA	NA						"unprognostic (6.97e-4)"	"unprognostic (1.20e-4)"	"unprognostic (7.96e-2)"	"unprognostic (1.32e-3)"		"unprognostic (3.96e-4)"	"unprognostic (1.20e-2)"	"unprognostic (5.27e-3)"	"unprognostic (1.50e-2)"	"unprognostic (9.59e-4)"	"unprognostic (1.53e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.22e-5)"	"unprognostic (4.32e-2)"	"unprognostic (5.32e-3)"	"unprognostic (1.44e-1)"	"unprognostic (5.08e-3)"	0.5	0.0	0.0	6.3	0.0	1.3	0.7	0.0	0.2	0.4	0.1	1.2	0.3	0.4	0.0	0.2	0.3	0.5	0.0	0.0	0.0	0.1	1.2	1.1	21.7	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	1.2	0.0	0.2	0.2	0.1	0.3	2.5	0.1	0.0	2.8	2.3	0.6	0.0	111.3	0.3	0.2	2.3	1.0	0.2	0.1	0.5	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	1.1	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	4.7	0.0	4.2	1.9	0.4	1.9	0.2	0.0	0.2	51.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	3.1	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.1	0.0	28.6	38.8	0.0	0.0	39.7	33.7	0.7	0.0	0.0	0.2	54.4	10.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0
C18orf63	DKFZP781G0119	ENSG00000206043	"Chromosome 18 open reading frame 63"	Q68DL7	18	74315839-74359189	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	43	"testis: 9.9"	"Cell type enriched"	"Detected in some"	10	"Spermatocytes: 83.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042233			Approved	Mitochondria		NA	NA			Mitochondria		"HPA042233: AB_10960843"								"unprognostic (1.40e-1)"					"unprognostic (1.43e-4)"					0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	83.7	7.9	0.0	0.0	0.0	0.0	0.1	0.1	0.0
COX6A2		ENSG00000156885	"Cytochrome c oxidase subunit 6A2"	Q02221	16	31427731-31428360	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		Oxidoreductase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	43	"heart muscle: 2939.2;skeletal muscle: 6806.0;tongue: 2114.7"	"Cell type enriched"	"Detected in some"	18	"Cardiomyocytes: 4861.8"	"Group enriched"	"Detected in many"	5	"head and neck cancer: 9.3;liver cancer: 2.9;prostate cancer: 3.6"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	150	"NK-cell: 15.0"	"Lineage enriched"	"Detected in single"	150	"NK-cells: 15.0"	"Cell line enriched"	"Detected in some"	4	"U-266/84: 13.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.66e-1)"	"unprognostic (1.73e-3)"			"unprognostic (2.09e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.68e-2)"		"unprognostic (3.88e-1)"	"unprognostic (5.61e-2)"	"unprognostic (7.20e-2)"	"unprognostic (8.71e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.65e-1)"			1.5	0.9	1.6	0.1	1.0	0.0	2.9	2.1	2.3	0.4	0.2	1.1	1.1	1.1	0.0	75.5	0.9	0.0	2939.2	0.8	1.5	4.4	16.0	3.4	0.4	1.4	1.7	0.7	1.2	3.0	2.9	12.0	0.1	5.2	39.2	0.0	1.0	92.8	0.1	6806.0	2.4	1.2	0.0	0.7	0.5	1.3	1.3	2.4	0.5	2.0	2114.7	0.1	0.3	1.4	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.1	1.6	1.0	2.1	2.3	0.8	1.5	1.4	1.7	0.7	5.2	0.7	2.4	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.2	0.4	4861.8	2.8	0.0	3.7	0.0	0.0	0.4	0.0	5.9	0.0	0.0	0.0	0.1	48.8	0.0	0.0	0.0	0.4	0.0	96.2	0.0	0.1	0.0	0.2	0.4	75.7	2.9	3.3	0.0	0.1	0.0	1.6	0.0	0.8	0.3	1.3	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.1	1.3	24.9	0.0	4.2	19.7	258.0	53.7	0.2	1.2	0.0	0.0	0.0	2.1	0.0	0.0	0.0
STYXL2	DUSP27	ENSG00000198842	"Serine/threonine/tyrosine interacting like 2"	Q5VZP5	1	167094075-167129165	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	43	"heart muscle: 64.2;skeletal muscle: 115.7;tongue: 54.5"	"Cell type enriched"	"Detected in some"	7	"Cardiomyocytes: 143.6"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 12.8;stomach cancer: 3.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"RH-30: 14.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA012912			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA012912: AB_2668767"	"unprognostic (1.26e-2)"		"unprognostic (1.74e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.10e-3)"	"unprognostic (4.65e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.72e-1)"	"unprognostic (7.65e-2)"	"unprognostic (8.23e-2)"	"unprognostic (3.39e-1)"	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.9	0.1	0.1	64.2	0.3	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	1.7	0.0	0.9	1.7	0.0	115.7	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	54.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	143.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	3.6	0.0	0.0	0.0	0.0	0.0	0.0	18.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
TNNT3	"AMCD2B, DA2B, DKFZp779M2348, FSSV"	ENSG00000130595	"Troponin T3, fast skeletal type"	P45378	11	1919703-1938706	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Muscle protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	43	"skeletal muscle: 14039.2;tongue: 4547.7"	"Cell type enriched"	"Detected in many"	4	"Skeletal myocytes: 542.6"	"Group enriched"	"Detected in many"	9	"head and neck cancer: 28.8;urothelial cancer: 19.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	17	"basophil: 5.3"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 5.3"	"Cell line enriched"	"Detected in some"	21	"HSkMC: 24.0"	"Region enhanced"	"Detected in some"		"olfactory bulb: 5.1"	"Low region specificity"	"Detected in single"			"CAB002451, HPA037810, HPA056909"	Enhanced					NA	NA		470000			"CAB002451: AB_564151, HPA037810: AB_10966217, HPA056909: AB_2683273"	"unprognostic (1.01e-2)"	"prognostic favorable (7.37e-4)"	"unprognostic (2.17e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.53e-3)"	"unprognostic (1.20e-1)"	"unprognostic (5.88e-2)"	"unprognostic (4.29e-3)"	"unprognostic (3.53e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.42e-5)"	"unprognostic (2.99e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.90e-2)"	27.8	2.4	0.2	1.4	0.4	1.5	20.2	0.2	0.4	12.4	0.1	4.5	0.2	6.6	2.8	63.0	14.6	1.9	126.5	0.3	0.2	0.7	1.4	3.7	1.4	0.2	0.1	0.2	1.7	2.3	0.3	2.5	41.7	0.2	20.8	0.5	0.0	217.8	3.1	14039.2	8.5	3.1	1.3	0.1	2.9	3.3	5.3	0.1	5.5	7.7	4547.7	2.1	20.4	12.1	0.2	0.0	0.0	0.0	0.0	0.5	0.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.4	0.2	0.4	0.3	0.2	0.2	0.1	0.2	0.2	0.1	0.1	0.2	33.1	0.0	1.9	0.0	0.8	2.9	3.9	5.9	2.2	0.0	0.4	0.3	17.8	0.0	10.1	0.0	0.0	24.5	1.5	0.0	0.0	0.1	0.3	2.4	0.3	33.9	0.0	0.0	0.1	0.0	6.7	42.0	0.0	0.1	0.0	3.0	0.0	0.0	2.7	0.0	0.0	0.0	6.1	0.0	2.3	2.5	110.9	2.2	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	94.8	0.3	0.2	0.0	0.0	42.5	0.0	0.0	542.6	11.2	0.1	0.6	2.9	3.4	18.3	2.0	0.7	0.0	17.1
XKR3	"MGC57211, XTES"	ENSG00000172967	"XK related 3"	Q5GH77	22	16783412-16821699	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	43	"testis: 8.2"	"Cell type enriched"	"Detected in some"	10	"Early spermatids: 159.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.6"	"Cell line enriched"	"Detected in some"	15	"Karpas-707: 230.8"									"HPA003379, HPA035081"	Uncertain					NA	NA					"HPA003379: AB_10602682, HPA035081: AB_2674451"	"unprognostic (4.57e-1)"				"unprognostic (3.37e-1)"								"unprognostic (3.11e-2)"	"unprognostic (3.13e-2)"	"unprognostic (5.77e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.3	0.5	0.0	0.0	15.2	230.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.7	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.9	0.1	0.1	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	159.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.3	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0
CCDC166		ENSG00000255181	"Coiled-coil domain containing 166"	P0CW27	8	143706694-143708109	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	42	"testis: 4.1"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 27.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			HPA025058	Uncertain					NA	NA					"HPA025058: AB_2671717"	"unprognostic (2.65e-1)"	"unprognostic (3.64e-1)"								"unprognostic (6.18e-2)"				"unprognostic (4.97e-1)"	"unprognostic (1.67e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MYF6	"bHLHc4, MRF4"	ENSG00000111046	"Myogenic factor 6"	P23409	12	80707634-80709474	"Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Myogenesis"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	42	"skeletal muscle: 443.6;tongue: 209.5"	"Cell type enriched"	"Detected in some"	39	"Skeletal myocytes: 146.1"	"Cancer enriched"	"Detected in some"	5	"head and neck cancer: 3.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	17	"LHCN-M2: 26.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA										"unprognostic (2.20e-2)"	"prognostic unfavorable (2.05e-4)"		"unprognostic (9.88e-2)"							"unprognostic (6.64e-1)"			0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	7.8	0.0	443.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	209.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	146.1	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0
ASGR1	CLEC4H1	ENSG00000141505	"Asialoglycoprotein receptor 1"	P07306	17	7173431-7179564	"Predicted intracellular proteins, Predicted secreted proteins"	"Endocytosis, Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	41	"liver: 1101.2"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 1107.9"	"Cancer enriched"	"Detected in many"	90	"liver cancer: 131.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 115.2;intermediate monocyte: 55.5;myeloid DC: 41.2"	"Group enriched"	"Detected in many"	8	"dendritic cells: 41.2;monocytes: 115.2"	"Cell line enriched"	"Detected in some"	29	"Hep G2: 493.2"	"Region enriched"	"Detected in all"	9	"cerebellum: 44.1"	"Not detected"	"Not detected"			"HPA011954, HPA012852"	Enhanced		Supported	"Vesicles,Cell Junctions"	"Secreted to blood"	NA	NA		10000	Vesicles	"Cell Junctions"	"HPA011954: AB_1845079, HPA012852: AB_1845080"	"unprognostic (3.56e-3)"	"unprognostic (3.57e-1)"	"unprognostic (8.76e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.86e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.39e-1)"	"unprognostic (8.55e-5)"	"unprognostic (1.55e-1)"	"unprognostic (8.33e-11)"	"unprognostic (1.45e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.73e-3)"	"unprognostic (4.46e-3)"	2.1	1.5	6.6	3.7	7.0	2.5	1.9	14.5	10.2	1.6	6.0	1.2	2.3	1.3	0.6	1.7	1.8	2.9	1.0	7.5	6.9	1.2	1101.2	3.9	1.3	7.3	7.6	7.4	1.2	1.0	7.1	2.9	0.5	9.1	1.7	0.5	4.9	0.9	0.3	1.5	4.2	1.4	1.3	5.4	4.9	1.4	26.7	7.8	0.4	5.9	0.4	0.3	1.7	1.5	8.0	0.3	0.7	9.2	4.2	0.0	0.2	0.8	0.8	0.9	0.9	1.6	16.8	0.5	0.3	1.1	0.2	0.4	0.2	0.3	0.2	0.4	0.3	0.8	1.2	1.4	493.2	0.1	0.8	1.7	1.2	0.2	0.5	0.1	0.6	8.4	7.4	1.1	0.6	0.5	0.4	0.7	1.2	1.7	0.2	0.4	0.9	3.5	0.2	0.1	0.7	0.6	3.5	0.7	0.3	0.6	1.5	0.5	0.2	1.2	0.9	3.4	0.7	0.4	0.2	0.3	0.5	0.6	0.4	0.3	10.0	115.2	0.4	0.2	55.5	1.1	0.5	0.2	0.2	41.2	0.5	0.3	0.4	3.3	0.5	14.9	1.8	0.3	36.7	6.6	7.0	14.5	10.2	7.5	6.9	7.3	7.6	7.4	9.1	5.4	7.8	8.0	6.0	0.0	4.7	2.9	2.6	3.2	1.7	2.0	3.4	37.8	5.6	6.0	1.5	55.8	2.0	3.7	160.6	3.6	2.9	1.4	3.9	0.9	235.4	4.2	3.6	13.2	15.6	16.8	4.6	0.2	3.7	1.9	3.6	16.5	0.0	5.1	27.5	1107.9	39.9	15.2	4.8	2.3	2.0	97.4	11.9	115.8	2.5	52.6	0.0	1.9	77.2	3.6	0.0	2.0	0.6	0.3	1.3	1.2	0.0	0.9	0.2	6.8	1.6	42.3	0.0	0.8	1.9	6.5	9.7	9.9	4.8	12.4	1.4	1.6	1.3	2.4
BAAT	BAT	ENSG00000136881	"Bile acid-CoA:amino acid N-acyltransferase"	Q14032	9	101354182-101385400	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Hydrolase, Serine esterase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	41	"liver: 727.0"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 996.7"	"Cancer enriched"	"Detected in many"	42	"liver cancer: 181.1"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 3.4;CACO-2: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA021251, HPA021330"	Enhanced		Uncertain	Vesicles		NA	NA		520000	Vesicles		"HPA021251: AB_1845247, HPA021330: AB_2670674"	"unprognostic (2.53e-2)"	"unprognostic (1.81e-1)"	"unprognostic (9.97e-2)"	"unprognostic (9.33e-2)"	"unprognostic (7.75e-3)"	"unprognostic (4.68e-2)"	"prognostic favorable (4.97e-4)"	"unprognostic (2.14e-2)"	"unprognostic (6.19e-2)"	"unprognostic (4.43e-4)"	"unprognostic (3.65e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (4.24e-7)"	"unprognostic (1.74e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.75e-1)"	0.1	0.0	0.3	0.0	0.5	1.2	0.0	0.5	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	17.6	0.1	0.5	0.3	0.3	727.0	0.4	0.0	0.4	0.4	0.3	0.0	0.9	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.7	0.0	3.4	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.8	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.1	0.1	0.1	0.4	0.8	0.2	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.5	1.0	0.5	0.3	0.4	0.4	0.3	0.5	0.0	0.3	0.7	0.3	0.0	0.0	0.7	2.4	0.0	0.1	0.0	0.0	1.1	0.3	0.1	0.7	91.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.1	0.0	0.1	0.7	0.0	16.0	9.7	0.2	0.0	0.1	0.0	0.1	0.0	0.0	12.1	996.7	0.0	0.0	7.2	0.0	0.0	18.2	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.1	0.0	3.0	0.9	1.8	0.1	0.0	0.0	0.0	0.3	0.3	0.0	0.2	0.0	0.5	0.1	0.3	0.2	0.0	0.0	0.0	1.0	0.1	0.4	0.0
GOLGA6L6	FLJ36131	ENSG00000277322	"Golgin A6 family like 6"	A8MZA4	15	20531856-20541800	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	41	"testis: 5.2"	"Cell type enriched"	"Detected in some"	7	"Early spermatids: 27.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047733	Uncertain					NA	NA					"HPA047733: "						"unprognostic (1.10e-1)"								"unprognostic (1.67e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	27.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PROC		ENSG00000115718	"Protein C, inactivator of coagulation factors Va and VIIIa"	P04070	2	127418427-127429242	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	41	"liver: 603.4"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 432.9"	"Cancer enriched"	"Detected in many"	22	"liver cancer: 118.3"	"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in some"	9	"plasmacytoid DC: 59.7"	"Lineage enriched"	"Detected in many"	9	"dendritic cells: 59.7"	"Cell line enriched"	"Detected in some"	16	"Hep G2: 156.1"					"Low region specificity"	"Detected in all"			"HPA005550, CAB016721, CAB016792"	Approved				"Secreted to blood"	NA	NA		5200000000			"CAB016721: , CAB016792: , HPA005550: AB_1079687"	"unprognostic (2.46e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.64e-2)"	"unprognostic (3.13e-2)"	"unprognostic (4.90e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.29e-1)"	"unprognostic (3.74e-3)"	"unprognostic (2.56e-2)"	"unprognostic (8.12e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.60e-3)"	"unprognostic (8.06e-2)"	0.1	0.0	0.7	0.1	0.9	1.1	0.1	0.6	1.0	0.2	0.0	0.7	0.8	0.1	0.1	0.1	0.2	0.6	0.1	0.6	0.6	14.6	603.4	0.2	0.7	1.3	0.6	0.5	0.2	0.4	0.0	0.3	0.1	1.6	0.2	0.6	0.2	0.2	0.1	0.2	0.6	0.8	0.0	0.7	0.4	2.7	0.2	0.7	0.6	0.2	0.0	0.3	0.4	0.2	1.2	0.1	2.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	4.1	0.0	0.9	0.1	0.4	9.5	0.0	0.3	0.0	0.0	0.2	0.1	7.8	156.1	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.3	1.6	0.4	2.3	0.7	0.0	0.1	0.0	0.0	0.9	0.4	0.0	1.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.3	0.1	0.0	0.0	6.3	0.0	0.0	59.7	0.0	0.3	0.7	0.9	0.6	1.0	0.6	0.6	1.3	0.6	0.5	1.6	0.7	0.7	1.2	0.0	0.0	0.0	0.3	4.1	0.8	0.4	11.2	0.0	0.0	0.1	0.0	0.4	47.1	1.2	0.0	0.0	0.0	24.0	3.9	5.9	0.5	0.1	3.4	0.1	0.6	10.3	18.7	0.1	0.2	0.0	0.7	2.0	0.2	0.0	0.0	12.1	432.9	3.7	0.0	0.5	9.3	0.0	9.3	4.0	0.1	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	8.1	0.0	0.0	0.0	3.8	84.8	3.4	0.0	0.0	0.2	0.3	0.1	0.2	0.0	0.1	0.1	1.1	0.0	1.8	0.3
SCRT2	ZNF898B	ENSG00000215397	"Scratch family transcriptional repressor 2"	Q9NQ03	20	661596-675802	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	41	"brain: 7.2;retina: 3.9"	"Cell type enriched"	"Detected in some"	11	"Horizontal cells: 60.6"	"Cancer enriched"	"Detected in single"	5	"glioma: 1.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Karpas-707: 1.7;NTERA-2: 1.7;RPMI-8226: 3.4;SCLC-21H: 1.8;SH-SY5Y: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA067697			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA067697: AB_2685890"					"unprognostic (9.71e-2)"					"unprognostic (2.03e-1)"	"unprognostic (6.97e-2)"			"unprognostic (9.70e-2)"	"unprognostic (1.70e-1)"			0.0	0.0	0.8	0.0	1.0	0.0	0.0	5.4	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.5	0.0	0.0	0.0	0.0	4.8	3.2	0.0	0.0	0.1	0.0	0.0	0.0	3.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	5.4	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	3.4	0.0	0.0	1.8	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	1.0	5.4	7.2	1.3	0.5	4.8	3.2	0.0	3.0	0.5	5.4	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	60.6	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SMCO1	"C3orf43, DKFZp313B0440, FLJ41923"	ENSG00000214097	"Single-pass membrane protein with coiled-coil domains 1"	Q147U7	3	196506879-196515346	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	41	"heart muscle: 38.9;skeletal muscle: 150.6;tongue: 107.9"	"Cell type enriched"	"Detected in some"	34	"Cardiomyocytes: 89.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA061937			Approved	"Endoplasmic reticulum,Golgi apparatus"		NA	NA			"Golgi apparatus"	"Endoplasmic reticulum"	"HPA061937: AB_2684642"	"unprognostic (4.86e-2)"	"unprognostic (1.62e-1)"		"unprognostic (1.51e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.72e-2)"		"unprognostic (1.73e-1)"		"unprognostic (3.25e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.94e-2)"		"unprognostic (2.95e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.88e-3)"	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.6	2.4	0.0	0.0	38.9	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.7	0.0	0.1	0.7	0.0	150.6	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	107.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	89.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	1.7	0.0	0.0	0.5	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.5	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FBXO47		ENSG00000204952	"F-box protein 47"	Q5MNV8	17	38936432-38967403	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	40	"testis: 3.9"	"Cell type enriched"	"Detected in some"	6	"Spermatocytes: 74.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA057438	Uncertain					NA	NA					"HPA057438: AB_2683441"		"unprognostic (1.53e-1)"			"unprognostic (2.98e-1)"			"unprognostic (2.82e-1)"	"unprognostic (3.92e-1)"	"unprognostic (6.04e-2)"	"unprognostic (2.59e-2)"		"unprognostic (2.29e-2)"	"unprognostic (6.85e-2)"	"unprognostic (4.15e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	1.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.6	0.0	0.0	74.1	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
NUTM1	"C15orf55, DKFZp434O192, FAM22H, NUT"	ENSG00000184507	"NUT midline carcinoma family member 1"	Q86Y26	15	34343315-34357737	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	40	"testis: 19.9"	"Cell type enriched"	"Detected in some"	6	"Early spermatids: 89.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA040421	Enhanced					NA	NA					"HPA040421: AB_10793965"	"unprognostic (4.14e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.11e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.99e-1)"	"unprognostic (8.37e-2)"		"unprognostic (8.66e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.34e-1)"	"unprognostic (5.55e-2)"	"unprognostic (1.34e-2)"	"unprognostic (5.97e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.27e-2)"	"unprognostic (4.79e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	19.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	89.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SSX2B	CT5.2b	ENSG00000268447	"SSX family member 2B"	Q16385	X	52751132-52790305	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	40	"testis: 30.2"	"Cell type enriched"	"Detected in single"	9	"Spermatogonia: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 2.7;PC-3: 2.5;T-47d: 1.0;U-2197: 1.5"									"HPA045683, HPA071685"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA045683: AB_2679418, HPA071685: "																		0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.4	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.1	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	30.2	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.5	0.0	0.2	1.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.4	0.3	0.4	0.7	0.2	0.0	0.2	0.2	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
STAC3	MGC2793	ENSG00000185482	"SH3 and cysteine rich domain 3"	Q96MF2	12	57243453-57251188	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	40	"skeletal muscle: 2337.2;tongue: 1179.3"	"Cell type enriched"	"Detected in many"	7	"Skeletal myocytes: 287.7"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 11.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 5.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 3.6;monocytes: 5.8"	"Cell line enriched"	"Detected in many"	23	"RH-30: 2282.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA039285, HPA039527"			Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA039285: AB_2676427, HPA039527: AB_10673424"	"unprognostic (6.16e-2)"	"prognostic favorable (2.01e-4)"	"prognostic unfavorable (7.10e-4)"	"unprognostic (1.05e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (7.11e-6)"	"unprognostic (4.58e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.14e-3)"	2.8	2.0	3.2	7.4	3.2	18.0	2.2	5.2	5.3	1.5	2.9	2.6	2.0	0.8	2.8	31.5	1.7	2.4	1.4	3.2	3.0	1.8	4.4	6.6	8.9	3.1	3.1	3.0	1.0	1.4	2.6	2.1	2.9	3.8	23.2	3.0	3.2	44.3	1.1	2337.2	2.6	2.6	2.5	2.7	9.2	1.7	12.0	3.1	4.2	2.2	1179.3	7.5	2.5	1.3	4.0	0.6	0.8	2.1	4.0	1.3	2.2	0.8	0.5	0.5	0.5	0.7	0.5	1.9	55.0	1.1	1.2	0.0	1.0	0.9	1.1	0.2	1.4	1.0	27.9	0.3	0.6	0.5	17.2	97.1	10.0	1.6	0.4	0.6	1.3	0.9	6.1	2.9	2.2	7.5	5.4	1.6	36.3	0.1	0.8	1.0	13.0	2282.0	2.6	1.3	1.2	1.4	1.1	1.6	1.5	0.3	0.3	0.9	48.4	1.0	0.5	0.4	1.6	0.4	2.2	1.2	9.6	1.1	32.9	0.7	0.0	4.4	0.3	0.0	5.8	0.0	0.7	0.0	0.2	3.6	0.3	0.0	0.1	0.2	0.0	2.9	1.0	0.2	1.4	3.2	3.2	5.2	5.3	3.2	3.0	3.1	3.1	3.0	3.8	2.7	3.1	4.0	0.4	0.0	0.6	1.3	1.9	1.5	0.4	1.1	0.6	7.5	1.2	1.4	0.3	1.5	0.4	0.0	2.1	1.0	2.8	0.9	0.0	0.8	13.5	1.1	0.6	0.7	2.4	0.4	3.0	1.0	0.7	0.8	1.1	0.9	5.7	1.5	1.8	1.3	39.9	1.7	2.4	1.2	4.1	37.3	16.3	8.9	1.2	24.1	0.0	0.0	26.3	1.5	0.0	1.5	1.2	0.9	1.0	0.7	0.5	1.0	1.6	0.7	2.3	2.5	0.0	287.7	1.0	3.4	1.4	0.6	0.3	1.4	1.6	0.8	1.2	0.4
ANHX		ENSG00000227059	"Anomalous homeobox"	E9PGG2	12	133218312-133235877	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	39	"testis: 5.0"	"Cell type enriched"	"Detected in some"	7	"Spermatogonia: 27.8"	"Cancer enriched"	"Detected in single"	55	"testis cancer: 3.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"									NA	NA																				"unprognostic (2.28e-1)"			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	27.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BTN1A1	"BT, BTN, BTN1"	ENSG00000124557	"Butyrophilin subfamily 1 member A1"	Q13410	6	26501221-26510422	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	39	"breast: 32.8"	"Cell type enriched"	"Detected in some"	43	"Breast glandular cells: 111.9"	"Cancer enhanced"	"Detected in single"		"breast cancer: 0.6"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 2.1;naive B-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	5	"CACO-2: 4.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA011126, CAB037340"	Supported				"Intracellular and membrane"	NA	NA					"CAB037340: , HPA011126: AB_1845491"	"unprognostic (4.07e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.77e-2)"		"unprognostic (5.50e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.24e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.35e-10)"	"unprognostic (4.62e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.14e-2)"	"unprognostic (5.31e-4)"	0.0	0.0	0.0	0.3	0.0	0.0	32.8	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	2.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	111.9	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0
C12orf54	MGC35033	ENSG00000177627	"Chromosome 12 open reading frame 54"	Q6X4T0	12	48482498-48496524	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	39	"testis: 40.7"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 2541.6"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 2.9;head and neck cancer: 2.1"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HBEC3-KT: 2.7"					"Not detected"	"Not detected"			HPA073090			Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA073090: "	"unprognostic (2.59e-3)"	"unprognostic (5.49e-2)"	"unprognostic (7.94e-3)"	"unprognostic (2.60e-2)"	"unprognostic (2.48e-2)"	"unprognostic (8.99e-2)"		"unprognostic (5.96e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.36e-4)"	"unprognostic (2.37e-1)"	"unprognostic (5.06e-3)"	"unprognostic (7.53e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.92e-1)"	0.0	0.4	0.4	0.0	0.5	0.0	0.2	0.3	1.0	0.1	0.0	0.1	0.0	0.2	0.0	0.4	0.1	0.1	0.0	0.4	0.3	0.0	0.0	0.1	0.0	0.6	0.5	0.4	0.5	0.0	0.0	0.0	0.1	0.6	0.2	0.1	0.2	0.0	0.3	0.0	0.1	0.0	0.3	0.4	0.1	0.0	40.7	0.3	0.0	0.0	0.2	0.6	0.2	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.3	1.0	0.4	0.3	0.6	0.5	0.4	0.6	0.4	0.3	0.6	0.0	0.0	2.6	8.1	0.0	5.1	38.6	19.5	1.2	0.2	0.2	0.1	0.7	0.0	4.5	0.0	0.0	0.1	0.0	0.0	1.9	0.1	543.1	0.0	0.0	1.2	0.0	0.0	5.3	0.0	0.2	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	9.1	0.0	2.0	0.0	1.8	2541.6	10.8	1.4	0.0	2.8	0.0	0.3	0.0	4.5	2.5	0.0	0.0	13.2	0.0	6.4	0.0	1.9	1.9	0.2	6.6	4.3	1.0	11.5	6.5	5.9	2.3	0.0	0.5	0.4	0.0	10.8
H2AP	"CXorf27, HIP17, HYPM"	ENSG00000187516	"H2A.P histone"	O75409	X	37990779-37991314	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	39	"testis: 44.5"	"Cell type enriched"	"Detected in single"	5	"Syncytiotrophoblasts: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	4	"SuSa: 1.2"	"Not detected"	"Not detected"							HPA003356	Enhanced					NA	NA					"HPA003356: AB_1078593"															"unprognostic (2.99e-2)"			0.0	0.0	0.5	0.0	1.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.1	0.0	0.0	0.4	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	44.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.0	0.4	0.7	0.5	0.4	0.1	0.4	0.8	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0
KRT2	"KRT2A, KRTE"	ENSG00000172867	"Keratin 2"	P35908	12	52644558-52652211	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, FDA approved drug targets, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	39	"skin 1: 3251.0"	"Cell type enriched"	"Detected in some"	14	"Suprabasal keratinocytes: 265.4"	"Cancer enriched"	"Detected in some"	5	"melanoma: 23.4"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"naive CD4 T-cell: 1.4"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.4"	"Cell line enhanced"	"Detected in single"		"HEL: 2.0"	"Group enriched"	"Detected in some"	6	"amygdala: 1.7;hippocampal formation: 2.7"	"Not detected"	"Not detected"			"HPA006299, CAB037321"	Enhanced		Approved	"Golgi apparatus,Intermediate filaments,Cytosol"		NA	NA		9700000000	"Intermediate filaments, Cytosol"	"Golgi apparatus"	"CAB037321: , HPA006299: AB_1079180"	"unprognostic (1.22e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.56e-1)"	"unprognostic (8.47e-3)"	"unprognostic (1.69e-2)"		"unprognostic (1.84e-1)"	"unprognostic (3.59e-1)"		"unprognostic (2.12e-1)"	"unprognostic (4.76e-2)"	"unprognostic (3.56e-7)"	"unprognostic (6.43e-2)"	"unprognostic (5.98e-3)"	"unprognostic (6.69e-2)"	"unprognostic (3.46e-1)"	2.1	0.5	0.0	0.1	0.0	1.0	82.9	0.0	0.0	0.8	0.0	0.7	1.6	0.4	0.3	1.1	0.1	0.0	1.5	0.0	0.0	0.5	1.2	1.0	0.5	0.0	0.0	0.0	0.5	1.0	0.0	0.5	0.0	0.0	0.4	0.1	0.0	1.6	0.0	48.3	3251.0	0.8	0.0	0.0	0.5	0.7	1.0	0.0	6.9	0.8	0.0	6.1	0.1	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0	0.1	0.0	0.0	0.0	0.1	0.4	1.5	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.6	1.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.3	9.5	0.0	0.0	0.1	8.8	0.0	0.1	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.5	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	265.4	0.1	1.0	0.0	0.6	0.1
LMOD2		ENSG00000170807	"Leiomodin 2"	Q6P5Q4	7	123655866-123664290	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	39	"heart muscle: 785.5;skeletal muscle: 942.6;tongue: 800.6"	"Cell type enriched"	"Detected in some"	26	"Cardiomyocytes: 1432.4"	"Group enriched"	"Detected in some"	20	"head and neck cancer: 3.5;prostate cancer: 1.4"	"Region enhanced"	"Detected in single"		"midbrain: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HSkMC: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA046370, HPA051039"	Enhanced		Uncertain	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Plasma membrane"	"Actin filaments, Cytosol"	"HPA046370: , HPA051039: AB_2681321"	"unprognostic (2.55e-1)"			"unprognostic (1.14e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.18e-1)"	"unprognostic (5.50e-1)"	"unprognostic (5.69e-2)"	"unprognostic (6.98e-2)"		"unprognostic (2.13e-2)"	"unprognostic (1.43e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.51e-1)"		"unprognostic (1.82e-3)"	0.2	0.1	0.2	0.0	0.0	0.6	0.5	0.1	0.5	0.0	0.2	0.1	0.0	0.0	0.0	21.4	0.0	0.1	785.5	0.3	0.0	0.0	0.2	0.3	0.3	0.0	1.0	0.0	0.1	0.2	0.0	0.1	0.8	0.0	10.3	0.0	0.1	10.1	0.0	942.6	0.3	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.2	0.2	800.6	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1432.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.4	0.5	0.4	9.4	0.0	0.0	0.1	0.0	0.1	27.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.9	7.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
SRL	SAR	ENSG00000185739	Sarcalumenin	Q86TD4	16	4189374-4242080	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	39	"heart muscle: 243.4;skeletal muscle: 515.1;tongue: 385.7"	"Cell type enriched"	"Detected in some"	16	"Cardiomyocytes: 247.3"	"Group enriched"	"Detected in some"	5	"head and neck cancer: 1.5;thyroid cancer: 5.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	12	"HSkMC: 4.0"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in some"		"basal ganglia: 5.3"	"HPA041535, HPA045520"	Enhanced				"Intracellular and membrane"	NA	NA		230000			"HPA041535: AB_2677538, HPA045520: AB_2679358"	"unprognostic (1.24e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.11e-2)"	"unprognostic (2.04e-7)"	"unprognostic (1.41e-1)"	"unprognostic (8.28e-2)"	"unprognostic (7.40e-4)"	"unprognostic (4.91e-2)"	"unprognostic (8.70e-2)"	"unprognostic (7.78e-4)"	"unprognostic (3.33e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.68e-4)"	3.0	0.4	1.1	1.2	1.0	0.2	1.7	1.0	1.4	2.6	1.0	1.2	0.4	3.0	2.3	9.7	3.1	1.8	243.4	0.8	1.2	1.4	0.4	1.2	0.7	1.2	1.4	0.8	1.3	0.6	0.2	0.5	1.3	1.1	5.6	1.1	8.6	6.5	2.6	515.1	0.8	1.7	3.4	1.1	2.2	1.1	1.1	1.2	1.7	2.3	385.7	1.1	1.4	1.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	1.1	1.0	1.0	1.4	0.8	1.2	1.2	1.4	0.8	1.1	1.1	1.2	1.1	0.5	0.0	0.0	0.3	0.0	0.3	0.1	0.0	0.0	1.0	0.0	0.0	247.3	0.0	0.0	1.8	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.2	0.0	0.0	0.4	0.0	0.0	8.5	0.0	0.1	0.0	0.2	2.9	0.0	0.0	0.0	3.3	0.0	0.0	0.3	0.3	0.0	1.8	0.1	0.0	1.0	0.0	1.2	0.0	1.0	0.3	0.1	0.0	3.8	0.0	0.3	0.0	0.2	0.0	12.1	6.6	5.5	15.4	0.1	0.2	0.0	0.4	0.0	0.1	0.4	0.0	0.1
TRAV41	"TCRAV19S1, TCRAV41S1"	ENSG00000211820	"T cell receptor alpha variable 41"	A0A0B4J266	14	22320188-22320691	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	39	"lymphoid tissue: 108.8"	"Cell type enriched"	"Detected in single"	7	"T-cells: 2.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"memory CD4 T-cell: 77.1;naive CD4 T-cell: 74.1;T-reg: 71.1"	"Lineage enriched"	"Detected in many"	46	"T-cells: 77.1"	"Cell line enriched"	"Detected in some"	60	"HDLM-2: 136.5"															NA	NA						"unprognostic (1.25e-3)"	"unprognostic (1.98e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.94e-1)"	"unprognostic (8.89e-3)"	"unprognostic (1.56e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.99e-2)"	"unprognostic (6.89e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.49e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.37e-2)"	"unprognostic (8.34e-3)"	"unprognostic (1.45e-1)"	0.1	0.0	0.8	5.7	1.0	0.5	0.4	0.7	1.8	0.1	0.6	1.0	1.0	0.5	0.0	0.7	0.1	1.3	0.0	0.9	1.0	0.0	0.3	2.7	16.2	1.2	1.1	0.7	0.0	0.0	0.1	0.0	0.0	0.8	0.4	1.6	0.0	0.0	0.1	0.3	0.1	0.8	0.7	0.7	4.1	1.2	0.1	0.8	108.8	0.2	0.0	12.7	1.2	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	136.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	3.3	0.8	0.3	0.0	77.1	19.1	0.0	0.0	74.1	31.0	1.6	0.1	0.1	0.0	71.1	18.1	0.8	1.0	0.7	1.8	0.9	1.0	1.2	1.1	0.7	0.8	0.7	0.8	1.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0
DAZ4		ENSG00000205916	"Deleted in azoospermia 4"	Q86SG3	Y	24833843-24907040	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	38	"stomach 1: 23.9;testis: 11.9"	"Cell type enriched"	"Detected in single"	40	"Gastric mucus-secreting cells: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	124	"U-266/70: 153.6;U-266/84: 153.1"									HPA047113	Approved					NA	NA					"HPA047113: AB_2679936"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	23.9	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	153.6	153.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DDX53	"CAGE, CT26"	ENSG00000184735	"DEAD-box helicase 53"	Q86TM3	X	22999960-23003589	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	38	"brain: 2.2;testis: 5.4"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 62.6"	"Cancer enriched"	"Detected in single"	4	"testis cancer: 0.7"	"Region enhanced"	"Detected in single"		"cerebellum: 2.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 3.2;K-562: 4.6;RPMI-8226: 2.4;U-2197: 1.4;U-266/84: 10.5"									HPA003186			Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Nucleoplasm	"Nucleoli, Cytosol"	"HPA003186: AB_1078637"														"unprognostic (5.76e-1)"	"unprognostic (1.12e-1)"			0.0	0.0	0.3	0.0	0.2	0.0	0.0	2.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.4	0.0	0.3	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	2.2	0.3	0.1	0.3	0.1	0.3	0.0	0.5	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	10.9	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GYPA	"CD235a, GPA, MN, MNS"	ENSG00000170180	"Glycophorin A (MNS blood group)"	P02724	4	144109303-144140751	"Blood group antigen proteins, CD markers, Predicted membrane proteins"	"Host-virus interaction"	"Blood group antigen, Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	38	"bone marrow: 157.6"	"Cell type enriched"	"Detected in some"	350	"Erythroid cells: 1995.6"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	203	"HEL: 149.1;K-562: 37.7"									"CAB002658, HPA014811"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		15000000	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB002658: , HPA014811: AB_1849827"					"unprognostic (1.60e-1)"								"unprognostic (2.47e-2)"					0.0	0.1	0.2	0.0	0.3	157.6	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	2.4	0.5	0.3	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.1	4.1	0.6	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	149.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	37.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	1.9	0.4	0.4	0.0	0.0	0.8	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.9	0.0	0.7	0.0	0.0	0.0	0.0	1995.6	2.4	0.0	2.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	1.7	0.0	0.0	0.9	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.6	0.2	0.0	0.0
LCE1E	LEP5	ENSG00000186226	"Late cornified envelope 1E"	Q5T753	1	152786214-152788426	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	38	"skin 1: 61.9"	"Cell type enriched"	"Detected in some"	10	"Suprabasal keratinocytes: 18.3"	"Cancer enhanced"	"Detected in single"		"melanoma: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"HaCaT: 10.0"															NA	NA							"unprognostic (9.92e-2)"				"unprognostic (9.50e-2)"			"unprognostic (2.30e-2)"								"unprognostic (2.56e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	61.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	10.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	18.3	0.0	0.1	0.0	0.0	0.0
TRBV28	"TCRBV28S1, TCRBV3S1"	ENSG00000211753	"T cell receptor beta variable 28"	A0A5B6	7	142720660-142721160	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	38	"lymphoid tissue: 201.2"	"Cell type enriched"	"Detected in some"	12	"T-cells: 33.1"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 154.5"	"Lineage enriched"	"Detected in many"	79	"T-cells: 154.5"	"Cell line enriched"	"Detected in single"	30	"JURKAT: 23.7"	"Not detected"	"Not detected"													NA	NA						"unprognostic (1.34e-3)"	"prognostic favorable (1.52e-4)"	"unprognostic (1.94e-3)"	"prognostic favorable (2.48e-5)"	"unprognostic (5.54e-2)"	"prognostic favorable (3.62e-4)"	"unprognostic (5.76e-2)"	"unprognostic (2.33e-3)"	"prognostic favorable (1.35e-5)"	"unprognostic (2.47e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (7.48e-8)"	"unprognostic (1.27e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.94e-3)"	0.5	0.9	0.0	9.3	0.1	3.0	2.1	0.2	0.2	1.2	0.0	2.6	3.4	0.6	0.3	1.3	0.3	2.9	0.5	0.0	0.0	0.5	1.9	3.5	24.9	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.1	0.0	0.7	1.7	0.0	1.3	0.3	0.2	0.1	4.0	0.3	0.0	9.6	2.1	0.4	0.0	201.2	0.5	0.6	34.0	5.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.4	0.0	3.8	0.0	26.1	0.5	94.5	80.1	0.1	0.2	98.1	53.3	1.9	1.6	0.1	0.4	154.5	34.1	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.1	0.0	0.6	0.0
ERVV-1	"ENVV1, FLJ32214, HERV-V1"	ENSG00000269526	"Endogenous retrovirus group V member 1, envelope"	B6SEH8	19	53013921-53016122	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	37	"placenta: 16.2"	"Cell type enriched"	"Detected in some"	28	"Syncytiotrophoblasts: 260.9"	"Cancer enhanced"	"Detected in some"		"renal cancer: 0.6;urothelial cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"BEWO: 7.9;SuSa: 6.2"									HPA076115			Approved	Centrosome,Cytosol		NA	NA			Cytosol	Centrosome	"HPA076115: "	"unprognostic (1.04e-3)"			"unprognostic (7.32e-3)"	"unprognostic (2.97e-1)"	"unprognostic (2.70e-2)"		"unprognostic (1.67e-2)"		"unprognostic (9.92e-2)"		"unprognostic (6.75e-2)"	"unprognostic (4.34e-5)"	"unprognostic (3.48e-2)"	"unprognostic (5.80e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.35e-1)"	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	16.2	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	260.9	0.0	0.0	0.0	0.0
MB	PVALB	ENSG00000198125	Myoglobin	P02144	22	35606764-35637951	"Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters"	"Oxygen transport, Transport"	"Muscle protein"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	37	"heart muscle: 11523.2;skeletal muscle: 41097.5;tongue: 29343.1"	"Cell type enriched"	"Detected in many"	12	"Cardiomyocytes: 5182.1"	"Group enriched"	"Detected in many"	7	"breast cancer: 13.6;head and neck cancer: 31.1;prostate cancer: 30.4"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"NK-cell: 1.3"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 1.3"	"Cell line enriched"	"Detected in some"	4	"SK-BR-3: 175.6"	"Low region specificity"	"Detected in many"							"CAB000060, HPA003123"	Enhanced					NA	NA	13500000	140000000			"CAB000060: , HPA003123: AB_1079442"	"unprognostic (7.51e-2)"	"unprognostic (3.92e-3)"	"unprognostic (1.07e-1)"	"unprognostic (7.71e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.66e-3)"	"unprognostic (5.78e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.74e-3)"	"unprognostic (1.17e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.19e-2)"	6.6	4.6	1.0	1.5	1.0	0.3	43.9	1.0	2.3	2.9	0.7	14.7	1.9	2.3	0.3	742.4	18.8	4.1	11523.2	0.8	1.7	2.7	5.9	15.0	5.4	1.2	1.2	0.7	5.4	27.1	16.3	10.7	3.1	1.1	216.1	13.0	0.2	370.1	0.5	41097.5	16.3	11.2	1.4	0.9	2.1	3.8	4.6	1.3	0.8	8.6	29343.1	1.9	1.3	4.5	1.0	1.9	7.6	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.2	0.0	0.0	4.6	0.7	0.1	0.3	1.0	0.8	0.2	0.0	0.0	5.4	0.3	0.1	0.5	0.1	0.0	0.0	0.2	0.1	0.2	0.4	0.0	0.2	0.0	0.0	0.5	0.5	0.0	19.2	0.1	0.6	0.0	1.9	2.3	0.9	0.5	8.0	0.0	6.4	1.5	0.2	19.0	175.6	0.0	0.3	39.4	0.1	0.4	0.5	1.2	2.2	0.2	0.0	0.0	0.2	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.0	1.0	1.0	2.3	0.8	1.7	1.2	1.2	0.7	1.1	0.9	1.3	1.0	0.3	0.0	0.0	0.3	0.1	0.3	4.3	12.5	0.0	0.0	30.7	23.9	5182.1	0.0	30.8	0.0	0.0	0.1	0.5	3.8	0.0	4.7	20.1	20.2	0.1	40.7	11.5	0.0	0.0	0.2	0.0	145.2	0.0	0.2	0.0	0.8	0.0	0.4	0.0	0.0	0.1	114.6	14.2	0.0	0.4	70.0	0.0	2.1	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.8	0.7	0.0	21.8	2.6	0.1	19.9	0.0	0.0	420.9	42.0	0.3	0.7	0.6	0.1	0.3	2.8	0.1	2.9	15.1
TYR	"OCA1, OCA1A, OCAIA"	ENSG00000077498	Tyrosinase	P14679	11	89177875-89295759	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"Melanin biosynthesis"	"Monooxygenase, Oxidoreductase, Tumor antigen"	"Albinism, Deafness, Disease variant, FDA approved drug targets, Waardenburg syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	37	"skin 1: 31.8"	"Cell type enriched"	"Detected in some"	5	"Melanocytes: 184.9"	"Cancer enriched"	"Detected in single"	1755	"melanoma: 351.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	995	"SK-MEL-30: 426.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000079, HPA043241, HPA050889, HPA064583"	Enhanced		Enhanced	Vesicles		NA	NA			Vesicles		"CAB000079: AB_564045, HPA043241: AB_2678383, HPA050889: AB_2681264, HPA064583: "	"unprognostic (1.16e-1)"								"unprognostic (1.01e-1)"		"unprognostic (1.85e-3)"		"unprognostic (9.75e-3)"					0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	31.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	426.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.9	0.3	0.0	0.1	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	2.5	5.2	0.3	0.0	184.9	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	2.0	0.0	0.1	0.0	0.0	0.0
ACOT12	"Cach, STARD15, THEAL"	ENSG00000172497	"Acyl-CoA thioesterase 12"	Q8WYK0	5	81329996-81394179	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	36	"liver: 101.5"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 36.2"	"Cancer enriched"	"Detected in single"	76	"liver cancer: 13.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA037723			Approved	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	NA			Cytosol	"Nucleoplasm, Cytokinetic bridge"	"HPA037723: AB_10672606"	"unprognostic (6.06e-2)"				"unprognostic (1.39e-1)"		"prognostic favorable (5.30e-4)"		"unprognostic (7.68e-2)"	"unprognostic (8.22e-2)"	"unprognostic (5.68e-3)"	"unprognostic (2.46e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.06e-1)"		0.0	0.0	0.5	0.0	0.8	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.6	2.7	101.5	0.0	0.0	0.4	0.4	0.5	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.3	0.4	0.6	0.4	0.4	0.5	0.4	0.0	0.5	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.8	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	8.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	36.2	0.5	0.0	1.2	0.0	0.0	1.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	3.4	4.2	0.0	0.0	0.0	0.4	0.0	0.6	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0
GNG13	"G(gamma)13, h2-35"	ENSG00000127588	"G protein subunit gamma 13"	Q9P2W3	16	798041-800734	"Predicted intracellular proteins, RAS pathway related proteins"		Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	36	"brain: 46.4;retina: 56.3"	"Cell type enriched"	"Detected in some"	16	"Bipolar cells: 311.6"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"cerebellum: 46.4;pons: 12.5;thalamus: 24.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 10.4;HEK 293: 9.0;HeLa: 6.5;MCF7: 12.9"	"Region enhanced"	"Detected in all"		"cerebellum: 940.0"	"Group enriched"	"Detected in many"	6	"cerebellum: 37.7;olfactory bulb: 14.0"	HPA046272	Enhanced					NA	NA					"HPA046272: AB_10960062"	"unprognostic (1.84e-1)"	"unprognostic (2.75e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.57e-2)"	"unprognostic (5.41e-2)"		"unprognostic (8.47e-2)"	"unprognostic (9.16e-3)"	"unprognostic (4.04e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.77e-2)"		"unprognostic (7.12e-2)"	"unprognostic (1.55e-1)"		"unprognostic (3.38e-1)"	0.0	0.0	3.1	0.1	0.6	0.2	0.0	46.4	4.6	0.0	0.0	0.7	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.7	1.9	0.0	0.0	0.0	0.1	0.9	6.5	0.1	0.0	0.0	0.0	0.2	0.0	12.5	0.0	0.1	56.3	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.3	24.0	0.6	0.0	0.0	0.1	0.0	0.0	4.9	0.2	3.6	0.5	1.1	0.0	0.0	0.8	1.0	0.0	0.0	0.0	10.4	0.3	1.1	0.3	0.0	0.1	1.6	0.0	0.0	0.0	1.2	9.0	1.3	6.5	0.0	0.0	2.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.8	0.8	0.0	12.9	1.3	0.7	1.2	0.1	1.0	2.8	2.8	0.6	0.0	1.5	0.9	0.8	0.9	0.3	0.2	0.3	0.7	0.1	0.0	1.3	1.2	1.7	0.3	0.4	2.5	4.0	0.0	2.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.6	46.4	4.6	0.7	1.9	0.9	6.5	0.1	12.5	0.0	24.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	311.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	5.3	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.5	0.1	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1
RAX	RX	ENSG00000134438	"Retina and anterior neural fold homeobox"	Q9Y2V3	18	59267035-59274086	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	36	"brain: 10.4;pituitary gland: 6.6;retina: 16.1"	"Cell type enriched"	"Detected in some"	5	"Muller glia cells: 493.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	9	"hypothalamus: 10.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.8;SH-SY5Y: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA							"unprognostic (4.14e-2)"				"unprognostic (1.79e-1)"		"unprognostic (3.76e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.22e-1)"				"unprognostic (1.33e-1)"	"unprognostic (3.46e-1)"			0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	10.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	6.6	0.0	0.4	0.1	0.0	16.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	10.4	0.0	0.2	0.0	0.4	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	5.9	0.0	0.0	1.3	0.0	0.0	0.0	83.4	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	493.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	20.7	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TNNC1	TNNC	ENSG00000114854	"Troponin C1, slow skeletal and cardiac type"	P63316	3	52451100-52454041	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Muscle protein"	"Cardiomyopathy, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	36	"heart muscle: 8240.1;skeletal muscle: 21280.3;tongue: 12513.9"	"Cell type enriched"	"Detected in many"	10	"Cardiomyocytes: 3550.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 27.1"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"MAIT T-cell: 1.2"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"CACO-2: 68.2;CAPAN-2: 33.5;EFO-21: 65.2;HeLa: 49.1;Hep G2: 46.1;HSkMC: 67.2;U-2 OS: 97.7"	"Region enriched"	"Detected in all"	4	"cerebral cortex: 87.0"	"Group enriched"	"Detected in some"	6	"midbrain: 7.6;spinal cord: 7.1"	"CAB002450, HPA044848, HPA056897"	Enhanced		Approved	"Nucleoplasm,Actin filaments,Mitochondria"		NA	NA		990000	"Nucleoplasm, Actin filaments, Mitochondria"		"CAB002450: AB_564152, HPA044848: AB_2679110, HPA056897: AB_2683269"	"unprognostic (2.18e-2)"	"unprognostic (1.70e-1)"	"unprognostic (8.66e-2)"	"unprognostic (3.43e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.92e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.15e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.15e-2)"	"unprognostic (4.86e-1)"	6.5	11.0	0.8	0.8	0.8	0.7	19.3	3.1	1.1	7.7	6.4	3.9	1.1	2.8	42.1	390.7	2.8	3.3	8240.1	1.4	1.2	19.1	4.1	79.2	3.9	0.9	0.9	0.7	2.5	6.8	1.6	17.7	5.3	1.0	171.6	4.2	0.4	121.8	2.3	21280.3	16.3	3.3	0.8	0.9	2.8	5.7	10.7	1.0	4.4	14.5	12513.9	1.6	5.4	5.4	0.8	0.7	5.2	3.6	0.6	0.2	0.5	8.0	0.4	0.3	0.3	0.4	68.2	33.5	0.5	65.2	9.9	0.1	0.4	0.1	0.3	0.0	1.2	1.6	0.5	49.1	46.1	0.3	0.3	0.1	67.2	1.2	0.0	0.7	0.6	0.0	2.0	0.2	5.1	2.0	0.1	0.2	0.8	0.5	15.1	0.7	0.1	2.9	2.3	3.3	13.0	0.2	0.0	0.5	6.7	0.1	3.9	26.7	0.5	0.0	0.1	97.7	0.8	0.2	2.8	1.3	0.9	0.3	0.7	0.1	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.2	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.8	0.1	0.8	0.8	3.1	1.1	1.4	1.2	0.9	0.9	0.7	1.0	0.9	1.0	0.8	0.2	125.0	12.6	0.0	0.3	1.5	1.7	4.0	0.6	0.2	0.5	0.3	3550.1	5.7	7.9	3.7	2.1	59.0	0.1	1.6	27.4	11.8	0.7	66.4	6.7	39.8	330.7	0.4	0.0	13.0	5.1	52.7	0.5	98.8	0.0	0.8	0.7	0.7	4.9	0.0	0.0	1.7	2.0	0.0	1.4	5.8	22.4	2.6	5.4	0.0	0.1	1.2	0.0	0.0	0.0	6.5	0.3	177.6	0.1	0.8	0.5	1.3	2.8	0.1	0.0	241.8	36.0	2.1	1.0	0.1	0.9	31.1	2.8	1.3	2.0	6.8
UBL4B	FLJ25690	ENSG00000186150	"Ubiquitin like 4B"	Q8N7F7	1	110112443-110113947	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	36	"testis: 105.8"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 6512.1"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"BJ hTERT+: 20.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA031364	Enhanced					NA	NA					"HPA031364: AB_10604000"	"unprognostic (2.92e-1)"	"unprognostic (3.48e-2)"		"unprognostic (3.53e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.65e-2)"		"unprognostic (5.24e-2)"	"unprognostic (1.29e-2)"	"unprognostic (3.43e-2)"	"unprognostic (6.87e-3)"	"unprognostic (4.46e-1)"	"unprognostic (2.20e-9)"	"unprognostic (3.29e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.59e-4)"	"unprognostic (3.90e-2)"	0.3	0.0	1.0	0.0	0.6	0.0	0.6	0.4	1.3	0.1	2.9	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.6	1.1	0.0	0.0	0.0	0.1	0.5	1.6	0.5	0.1	0.0	0.0	1.1	0.0	0.6	0.2	0.0	0.1	0.4	0.0	0.1	0.2	0.0	0.1	0.3	0.0	0.0	105.8	2.2	0.0	0.0	0.7	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	20.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.6	0.4	1.3	0.6	1.1	0.5	1.6	0.5	0.6	0.3	2.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1490.4	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6512.1	29.2	3.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	22.2	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.5	0.0	51.6	18.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0
C9orf57		ENSG00000204669	"Chromosome 9 open reading frame 57"	Q5W0N0	9	72051376-72072721	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	35	"testis: 13.1"	"Cell type enriched"	"Detected in some"	6	"Spermatocytes: 13.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA								"unprognostic (3.26e-2)"				"unprognostic (1.15e-1)"							"unprognostic (5.05e-2)"				0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CLUL1		ENSG00000079101	"Clusterin like 1"	Q15846	18	596988-650334	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	35	"retina: 300.5"	"Cell type enriched"	"Detected in many"	7	"Rod photoreceptor cells: 407.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 34.3"					"Not detected"	"Not detected"			"CAB025264, HPA075240"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane"	"Secreted in other tissues"	NA	NA		11000	"Endoplasmic reticulum"	"Plasma membrane"	"CAB025264: , HPA075240: AB_2732286"	"unprognostic (1.75e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.81e-3)"	"unprognostic (3.00e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.97e-3)"	"unprognostic (8.38e-3)"	"unprognostic (3.76e-2)"	"unprognostic (4.85e-3)"	"unprognostic (4.96e-3)"	"unprognostic (6.36e-4)"	"unprognostic (1.32e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.29e-3)"	"unprognostic (2.37e-2)"	0.2	1.0	2.2	0.5	5.0	3.9	2.3	1.3	4.3	1.5	5.7	0.9	0.5	1.4	0.5	1.2	1.8	2.0	0.3	2.5	2.4	5.4	0.5	1.4	0.8	4.1	2.8	1.7	4.9	1.3	3.7	3.9	0.6	4.4	8.6	0.1	300.5	2.4	1.1	0.2	0.7	1.4	0.1	1.7	0.1	3.2	2.7	3.4	1.8	6.9	0.0	0.1	0.8	0.2	8.3	3.6	5.4	10.1	6.8	0.0	0.0	6.1	3.9	0.3	0.0	0.0	4.2	2.1	4.3	1.0	0.0	3.6	1.5	0.0	0.6	0.0	3.6	9.3	7.3	2.9	34.3	0.0	2.5	1.3	0.3	0.0	0.0	0.0	1.7	0.4	10.5	10.5	12.3	0.0	1.2	4.4	7.8	0.7	4.4	2.4	8.8	4.8	15.5	1.1	1.1	8.8	6.2	4.0	2.5	3.4	8.0	3.3	1.0	0.8	4.0	5.7	2.8	2.0	6.9	13.3	9.7	3.2	4.7	3.5	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.3	0.0	2.2	5.0	1.3	4.3	2.5	2.4	4.1	2.8	1.7	4.4	1.7	3.4	8.3	0.1	0.0	2.6	0.3	0.1	0.0	3.8	1.5	2.8	29.6	2.8	5.0	0.2	0.0	1.7	0.0	20.9	0.8	0.0	0.1	1.9	0.4	0.7	2.5	0.3	2.0	0.0	0.0	5.2	0.2	0.1	0.4	0.0	3.2	0.0	3.5	0.0	0.0	0.2	16.8	3.8	0.0	0.0	0.0	0.3	0.8	0.9	0.2	0.0	1.0	0.0	58.1	0.0	0.0	4.9	0.0	0.0	1.2	0.0	5.5	0.0	0.5	2.4	407.5	6.6	0.0	0.3	10.6	8.6	0.2	0.1	0.4	0.1	17.3	0.1	1.6
CYP2B6	"CPB6, CYP2B, CYPIIB6"	ENSG00000197408	"Cytochrome P450 family 2 subfamily B member 6"	P20813	19	40991282-41018398	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"liver: 538.2"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 420.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 28.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 2.6;OE19: 1.8"					"Region enhanced"	"Detected in single"		"spinal cord: 2.3"	"CAB033866, HPA048124, HPA062973"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Nuclear membrane"	"Nucleoplasm, Cytosol"	"CAB033866: AB_2292644, HPA048124: AB_2680274, HPA062973: AB_2684914"	"unprognostic (1.86e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.13e-2)"	"unprognostic (6.13e-2)"		"unprognostic (4.59e-2)"	"unprognostic (4.63e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.73e-1)"		"unprognostic (5.78e-2)"		"unprognostic (1.04e-3)"	"unprognostic (2.19e-1)"	"unprognostic (9.43e-2)"		"unprognostic (5.44e-1)"	0.0	0.0	0.3	0.2	0.2	0.5	0.1	0.6	0.3	0.0	0.3	4.8	5.1	0.1	0.0	0.0	0.0	0.7	0.1	0.2	0.3	15.2	538.2	0.4	0.1	0.3	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.4	0.0	1.8	0.9	0.0	0.1	0.2	0.0	6.8	0.6	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.1	0.1	0.0	2.6	0.1	0.0	0.0	0.1	0.2	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.2	0.5	0.2	1.8	0.1	0.0	0.1	0.1	0.6	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.2	0.4	0.3	0.2	0.1	0.2	0.2	0.1	0.3	0.3	0.0	0.4	0.0	0.7	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.5	0.1	0.0	0.4	0.1	0.0	0.3	0.2	0.6	0.3	0.2	0.3	0.3	0.2	0.1	0.4	0.1	0.2	0.4	0.0	0.0	1.1	0.0	0.8	0.0	0.2	0.4	0.0	0.0	0.1	0.0	0.2	7.2	1.4	1.8	0.0	0.0	0.0	6.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	16.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	11.4	420.9	0.0	0.0	0.1	1.6	0.0	11.2	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.3	0.0	0.0	0.1	38.3	16.9	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.1	4.3	0.7
DCT	TYRP2	ENSG00000080166	"Dopachrome tautomerase"	P40126	13	94436811-94479682	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Melanin biosynthesis"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"skin 1: 108.2"	"Cell type enriched"	"Detected in some"	23	"Melanocytes: 3552.1"	"Cancer enriched"	"Detected in some"	215	"melanoma: 155.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	272	"SK-MEL-30: 257.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA010742, HPA010743, HPA010800, CAB017634"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"CAB017634: AB_1130818, HPA010742: , HPA010743: AB_1847519, HPA010800: AB_1847520"	"unprognostic (5.99e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.81e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.64e-3)"	"unprognostic (1.06e-2)"	"unprognostic (6.18e-5)"	"unprognostic (6.97e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.42e-1)"	0.4	0.4	0.6	0.0	0.9	0.1	3.0	0.5	0.7	0.2	0.2	0.2	0.0	0.3	0.9	0.0	0.9	0.1	0.1	0.6	0.7	0.2	0.2	0.1	0.0	0.5	0.6	0.6	0.4	0.4	0.0	1.6	0.0	0.5	0.3	0.0	0.9	1.5	0.3	0.4	108.2	0.1	0.1	0.5	0.1	0.1	0.6	0.5	0.5	0.2	0.1	0.0	0.2	0.3	0.5	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	257.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.3	0.2	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.9	0.5	0.7	0.6	0.7	0.5	0.6	0.6	0.5	0.5	0.5	0.5	0.0	0.0	0.0	23.5	0.0	152.3	0.1	0.0	0.0	1.0	0.3	0.5	0.9	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.5	0.1	1.2	0.0	0.0	16.1	0.2	0.0	1.4	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	14.4	0.0	0.0	0.0	25.5	23.8	0.9	0.0	3552.1	1.9	0.0	3.5	0.0	6.6	2.4	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.2	0.3	0.0	0.5	1.0	0.5	0.8	0.0	33.4	0.0	0.9	0.1	0.0	0.0
FSD2	"RP11-127F21, SPRYD1"	ENSG00000186628	"Fibronectin type III and SPRY domain containing 2"	A1L4K1	15	82755362-82806070	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	35	"heart muscle: 52.8;skeletal muscle: 155.8;tongue: 44.7"	"Cell type enriched"	"Detected in some"	6	"Cardiomyocytes: 81.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 3.6;U-266/70: 4.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA046263			Approved	Cytosol		NA	NA			Cytosol		"HPA046263: AB_2679604"	"unprognostic (2.80e-1)"	"unprognostic (3.54e-1)"	"unprognostic (6.63e-2)"	"unprognostic (6.30e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.97e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.07e-1)"	"unprognostic (9.37e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.59e-2)"	0.2	0.7	0.2	0.9	0.2	0.8	0.1	0.8	0.5	0.0	0.0	0.1	0.9	0.4	0.6	2.0	0.3	0.3	52.8	0.3	0.2	0.3	0.1	0.2	1.1	0.1	0.1	0.2	0.6	0.6	0.7	0.1	0.3	0.4	1.2	0.0	2.4	0.8	0.0	155.8	1.5	0.8	0.1	0.0	0.6	0.6	0.7	0.2	0.0	0.9	44.7	0.1	0.1	0.0	0.7	0.7	0.7	1.1	1.3	0.0	0.0	0.6	0.7	0.0	0.0	0.0	0.6	1.2	2.3	0.5	0.0	0.6	2.8	0.0	0.0	0.2	0.4	3.1	1.3	3.6	1.0	0.0	0.7	0.5	0.0	0.0	0.0	0.1	0.7	0.0	1.0	1.2	2.0	0.0	0.7	0.4	1.4	1.0	0.5	0.6	0.8	0.8	0.6	0.1	1.3	1.1	0.9	0.5	0.5	0.9	0.5	0.9	1.0	0.5	1.6	0.8	0.6	1.0	4.7	2.1	0.8	1.0	2.8	0.4	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.2	0.8	0.5	0.3	0.2	0.1	0.1	0.2	0.4	0.0	0.2	0.7	0.4	0.0	2.2	1.3	0.2	0.4	1.0	0.2	0.0	2.1	0.5	0.3	81.6	1.5	0.8	0.0	6.2	0.1	0.3	0.1	0.0	0.0	4.8	1.7	0.3	1.2	1.2	0.0	3.9	0.4	0.1	3.0	0.0	1.6	1.3	0.6	0.0	0.0	0.3	11.8	3.6	0.0	2.0	0.3	2.1	6.1	0.3	0.2	0.0	1.0	0.1	0.7	0.0	4.0	3.3	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.5	4.5	0.0	4.5	0.6	0.6	0.3	0.0	0.6	0.3	0.4	0.2	0.1	0.3
ITLN2	HL-2	ENSG00000158764	"Intelectin 2"	Q8WWU7	1	160945025-160954809	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"intestine: 411.7"	"Cell type enriched"	"Detected in some"	4	"Alveolar cells type 1: 76.9"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 2.8;testis cancer: 4.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 11.9;HHSteC: 1.9;HMC-1: 3.4;SK-MEL-30: 4.0;SuSa: 3.8"					"Low region specificity"	"Detected in all"			"HPA006683, HPA067326"	Enhanced				"Secreted to digestive system"	NA	NA					"HPA006683: AB_2129681, HPA067326: AB_2732764"		"unprognostic (1.42e-1)"	"unprognostic (9.62e-3)"	"unprognostic (4.61e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.25e-1)"	"unprognostic (6.84e-4)"	"unprognostic (2.47e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.01e-1)"		"unprognostic (1.84e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.91e-2)"	3.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	240.9	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.1	0.4	11.8	0.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.1	0.0	0.2	411.7	0.0	0.0	0.0	0.1	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	1.9	0.0	3.4	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.7	0.0	0.0	4.0	3.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	76.9	5.3	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.4	0.3	1.4	0.0	0.2	0.0	0.4	11.0	0.3	0.1	0.0	0.0	5.0	0.0	0.3	0.0	0.2	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	5.3	0.0	0.6	14.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.3	6.3	17.5	0.4
PSG6		ENSG00000170848	"Pregnancy specific beta-1-glycoprotein 6"	Q00889	19	42902086-42919563	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"placenta: 49.9"	"Cell type enriched"	"Detected in some"	125	"Syncytiotrophoblasts: 363.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	16	"U-2197: 144.6"									HPA046327	Supported				"Secreted in female reproductive system"	NA	NA		65000000			"HPA046327: AB_2679624"						"unprognostic (4.23e-1)"												0.0	0.0	0.3	0.1	0.1	1.4	0.0	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	49.9	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.9	0.5	0.6	1.1	0.0	0.3	0.0	0.0	1.9	0.1	0.2	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.9	0.0	0.0	0.0	0.1	0.3	144.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.1	1.2	0.3	0.3	0.0	0.2	0.0	0.1	0.6	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.9	0.2	0.0	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	363.5	0.0	0.0	0.0	0.0
SLC24A1	"CSNB1D, HsT17412, KIAA0702, NCKX, NCKX1, RODX"	ENSG00000074621	"Solute carrier family 24 member 1"	O60721	15	65611366-65660995	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Sensory transduction, Symport, Transport, Vision"		"Congenital stationary night blindness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	35	"retina: 195.2"	"Cell type enriched"	"Detected in many"	11	"Rod photoreceptor cells: 338.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA039370	Enhanced		Approved	Microtubules		NA	NA			Microtubules		"HPA039370: AB_10960279"	"unprognostic (9.47e-2)"	"unprognostic (9.97e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.66e-3)"	"unprognostic (6.39e-3)"	"unprognostic (4.64e-1)"	"unprognostic (8.82e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.94e-1)"	"unprognostic (2.01e-1)"	"unprognostic (9.91e-2)"	"prognostic favorable (2.33e-6)"	"unprognostic (8.45e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.96e-2)"	4.0	3.1	2.1	2.0	2.4	1.9	4.9	5.5	2.6	4.9	2.6	2.6	2.3	3.8	4.7	2.4	5.2	3.8	1.5	2.2	2.5	3.8	2.9	3.1	3.3	2.4	2.1	1.9	5.4	3.0	3.8	2.7	3.6	2.8	3.3	2.5	195.2	2.7	3.1	1.0	5.1	3.0	2.9	2.4	4.0	2.6	4.2	2.2	2.4	5.2	1.3	1.9	3.0	3.2	2.6	1.5	3.0	3.2	2.9	4.7	7.9	4.0	3.7	4.2	3.7	2.4	1.4	6.5	2.1	12.4	3.7	1.3	4.1	3.9	4.2	2.1	2.2	2.8	4.6	2.5	6.8	6.8	3.1	6.0	6.7	5.9	2.1	12.3	5.1	6.4	4.8	5.0	7.0	6.0	6.4	2.0	2.8	4.1	13.5	1.2	2.0	1.0	1.4	5.6	6.0	1.5	2.1	1.0	2.8	8.0	4.4	6.0	4.2	9.3	3.7	3.7	1.4	2.6	2.8	5.5	2.4	3.9	6.4	3.1	2.6	0.4	0.7	0.4	0.4	0.5	0.4	0.4	0.4	0.3	1.0	0.3	0.4	0.6	0.8	0.2	0.8	0.1	0.1	2.1	2.4	5.5	2.6	2.2	2.5	2.4	2.1	1.9	2.8	2.4	2.2	2.6	4.0	6.4	5.1	5.2	3.4	1.5	1.4	1.2	1.8	29.8	3.5	2.8	2.3	0.0	3.8	0.0	27.1	4.2	1.6	2.9	0.0	1.5	1.6	6.3	5.4	15.6	1.8	1.7	2.2	1.3	2.7	2.6	4.1	7.9	2.5	4.7	3.6	1.4	1.9	20.2	2.0	2.5	2.0	3.1	1.6	2.5	3.1	2.7	1.8	4.7	1.2	26.1	2.1	3.0	1.4	2.6	0.5	2.2	3.3	1.4	2.6	0.7	4.1	338.3	0.0	3.4	2.5	20.3	10.1	2.9	1.0	2.5	2.5	8.3	2.6	0.9
SLC6A19		ENSG00000174358	"Solute carrier family 6 member 19"	Q695T7	5	1201595-1225111	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	35	"intestine: 143.6;kidney: 89.5"	"Cell type enriched"	"Detected in some"	5	"Proximal enterocytes: 561.5"	"Group enriched"	"Detected in many"	4	"renal cancer: 7.9;stomach cancer: 5.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BEWO: 14.3;HEL: 18.3;OE19: 5.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA037415, HPA043207"	Enhanced					NA	NA					"HPA037415: AB_10672346, HPA043207: AB_2678363"			"unprognostic (1.26e-1)"				"unprognostic (1.01e-3)"				"unprognostic (6.04e-2)"	"unprognostic (3.64e-1)"	"prognostic favorable (4.14e-6)"	"unprognostic (1.37e-1)"	"unprognostic (7.36e-2)"			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	141.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	89.5	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	5.6	0.0	0.0	0.0	0.0	0.0	143.6	0.3	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.4	0.0	5.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	64.3	0.6	1.8	0.0	0.0	0.0	104.4	1.9	0.1	0.1	0.0	0.0	0.1	4.8	2.7	0.0	0.0	14.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.1	0.0	0.0	0.0	561.5	76.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.4	0.0	8.7	0.0
UNCX	Uncx4.1	ENSG00000164853	"UNC homeobox"	A6NJT0	7	1232872-1237326	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	35	"brain: 17.4"	"Cell type enriched"	"Detected in single"	10	"Cardiomyocytes: 1.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 17.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	21	"NB-4: 98.5"	"Region enriched"	"Detected in single"	5	"cerebellum: 3.2"	"Region enriched"	"Detected in single"	8	"cerebellum: 7.5"	HPA063294			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA063294: AB_2684977"					"unprognostic (1.15e-1)"										"unprognostic (9.71e-2)"			0.0	0.0	0.7	0.0	0.3	0.0	0.0	17.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.4	0.0	0.0	0.0	1.8	3.0	0.0	0.0	0.0	0.0	0.4	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	98.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	17.4	0.6	0.0	2.8	1.8	3.0	0.0	5.4	0.7	1.8	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CA5A	"CA5, CAV, CAVA"	ENSG00000174990	"Carbonic anhydrase 5A"	P35218	16	87881546-87936580	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		Lyase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	34	"liver: 24.4"	"Cell type enriched"	"Detected in many"	6	"Hepatocytes: 39.0"	"Cancer enriched"	"Detected in single"	26	"liver cancer: 2.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	36	"Hep G2: 25.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.91e-1)"	"unprognostic (8.64e-3)"	"unprognostic (3.36e-2)"	"unprognostic (6.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (2.96e-1)"	"unprognostic (8.39e-3)"	"unprognostic (3.50e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.55e-2)"	"unprognostic (4.23e-2)"	"unprognostic (7.99e-3)"	"unprognostic (1.77e-1)"	"unprognostic (5.03e-3)"	"unprognostic (3.37e-2)"	"unprognostic (2.76e-2)"	0.0	0.0	0.5	0.1	0.4	0.1	0.1	0.5	0.7	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	24.4	0.1	0.1	0.5	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	25.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.5	0.7	0.4	0.4	0.5	0.4	0.3	0.5	0.4	0.6	0.5	0.2	0.0	3.4	0.3	0.3	0.4	2.5	0.0	0.0	1.7	0.2	0.3	2.1	0.0	1.3	1.8	4.2	0.4	0.5	0.1	0.0	0.0	0.3	0.6	0.4	5.4	0.0	2.7	0.8	0.0	0.3	1.0	0.0	0.8	6.3	0.2	1.1	39.0	0.1	3.3	0.6	0.2	0.0	1.4	1.6	0.8	0.3	1.5	0.0	2.8	0.2	0.8	2.1	0.0	0.5	0.0	0.0	1.2	0.1	1.9	0.2	0.3	1.5	3.8	0.0	4.1	1.1	0.4	0.4	0.0	0.3	0.3	1.2	1.7	0.1	1.8
MEIOB	"C16orf73, MGC35212"	ENSG00000162039	"Meiosis specific with OB-fold"	Q8N635	16	1833986-1884294	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Meiosis	"DNA-binding, Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	34	"testis: 37.4"	"Cell type enriched"	"Detected in some"	6	"Spermatocytes: 499.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HMC-1: 27.6;K-562: 92.7;THP-1: 76.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (7.18e-2)"	"unprognostic (1.91e-1)"			"unprognostic (3.04e-2)"		"unprognostic (9.73e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.68e-3)"	"unprognostic (2.00e-2)"		"unprognostic (2.68e-2)"	"unprognostic (7.30e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.80e-1)"		"unprognostic (2.18e-3)"	0.1	0.1	0.1	0.0	0.2	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.1	1.0	0.3	0.0	0.0	0.1	0.1	0.2	0.3	0.1	0.0	0.2	0.2	0.2	0.1	0.0	0.9	0.0	0.0	0.1	0.7	0.2	0.0	0.0	0.0	0.1	37.4	0.1	0.9	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.9	0.1	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	27.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	92.7	0.1	0.0	1.5	0.0	0.0	4.2	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.6	9.4	0.8	0.0	0.4	1.1	76.2	1.2	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.3	0.2	0.1	0.1	0.1	0.2	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.7	0.1	0.0	0.2	0.0	0.0	0.5	0.1	0.3	0.8	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.5	58.0	0.1	0.3	0.2	0.0	0.0	2.6	0.0	0.2	0.2	0.0	0.2	4.5	2.3	0.0	0.0	0.1	3.3	4.1	0.0	0.0	0.0	0.0	15.9	1.8	0.2	0.0	0.0	0.0	0.1	0.0	1.0	2.1	0.1	0.0	1.5	0.0	0.3	0.0	3.4	0.0	0.3	6.6	0.0	0.3	499.7	75.2	0.6	0.4	0.0	0.0	0.8	0.0	0.4
MMP10	STMY2	ENSG00000166670	"Matrix metallopeptidase 10"	P09238	11	102770502-102780628	"Cancer-related genes, Enzymes, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	34	"endometrium 1: 267.9"	"Cell type enriched"	"Detected in some"	38	"Basal respiratory cells: 3913.2"	"Group enriched"	"Detected in many"	4	"cervical cancer: 47.8;head and neck cancer: 102.2;lung cancer: 42.3"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 11.8;HUVEC TERT2: 15.1;SCLC-21H: 4.7"									CAB002159	Uncertain		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA	765000		Cytosol	"Plasma membrane"	"CAB002159: AB_564103"	"unprognostic (8.76e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.98e-3)"	"unprognostic (2.72e-3)"	"unprognostic (7.17e-3)"	"unprognostic (1.52e-2)"	"unprognostic (5.67e-8)"	"unprognostic (2.08e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.99e-5)"	"unprognostic (2.66e-2)"	"unprognostic (7.98e-2)"	"unprognostic (5.46e-2)"	"prognostic favorable (7.12e-4)"	0.1	0.0	0.1	7.7	2.2	0.1	0.1	0.0	0.7	0.7	0.0	0.3	1.1	267.9	0.0	0.2	0.0	1.3	0.0	0.2	0.4	0.0	1.0	2.0	0.1	0.3	0.3	0.0	0.2	0.2	0.0	0.0	1.3	0.4	1.4	0.3	0.0	1.6	0.0	0.0	0.0	0.8	0.2	0.0	0.0	2.9	0.5	1.8	0.6	0.0	0.2	0.7	4.5	3.2	0.2	0.0	0.1	0.8	0.2	0.0	0.0	0.2	11.8	0.6	0.1	0.1	0.3	0.0	0.0	3.3	1.8	0.2	2.7	0.0	1.3	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.5	0.0	15.1	0.0	0.7	0.0	0.0	0.0	0.0	0.3	2.8	0.5	1.6	0.0	0.0	0.0	0.0	0.6	4.7	0.0	2.4	0.0	0.0	0.8	0.0	0.0	1.9	3.5	1.2	0.4	0.5	0.0	0.0	0.1	0.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.2	0.0	0.7	0.2	0.4	0.3	0.3	0.0	0.4	0.0	1.8	0.2	0.1	0.0	0.0	0.0	0.0	0.8	51.3	3913.2	0.0	0.0	0.7	0.0	0.1	0.0	85.4	29.5	0.0	0.0	0.0	0.4	0.0	34.0	6.1	6.4	2.5	9.0	0.0	0.0	0.0	14.6	0.0	6.3	0.0	12.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.4	0.0	9.5	1.3	0.0	0.6	0.0	0.0	1.6	0.0	0.0	0.0	0.0	102.5	0.1	0.0	0.0	42.5	0.0	0.1	29.3	0.0	0.0	0.0	11.7	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	8.2
SPACA4	SAMP14	ENSG00000177202	"Sperm acrosome associated 4"	Q8TDM5	19	48606742-48607714	"Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	34	"testis: 118.7"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 1014.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041927, HPA061302"	Enhanced					NA	NA					"HPA041927: AB_10794162, HPA061302: AB_2684475"	"unprognostic (2.48e-2)"	"unprognostic (6.37e-4)"	"unprognostic (6.59e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.09e-3)"	"unprognostic (9.43e-6)"		"unprognostic (6.67e-3)"		"unprognostic (1.05e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.78e-1)"		"unprognostic (3.43e-1)"	"unprognostic (2.88e-1)"	"unprognostic (4.47e-1)"	"unprognostic (2.01e-2)"	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.3	0.4	0.0	2.1	3.1	0.0	0.0	2.0	0.3	1.1	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.9	0.0	0.1	1.4	3.1	0.0	0.0	0.0	3.5	118.7	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.5	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.6	0.0	0.2	0.6	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1014.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	185.9	4.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	9.8	3.3	0.0	1.6	0.0	0.0	0.0	0.0	0.2
TSPO2	"BZRPL1, dJ34B21.2"	ENSG00000112212	"Translocator protein 2"	Q5TGU0	6	41042467-41044337	"Predicted membrane proteins, Transporters"	Transport	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	34	"bone marrow: 50.6"	"Cell type enriched"	"Detected in some"	115	"Erythroid cells: 253.9"	"Cancer enhanced"	"Detected in some"		"liver cancer: 0.8"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"OE19: 11.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA060691, HPA066996"			Enhanced	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA060691: , HPA066996: AB_2685761"	"unprognostic (1.89e-3)"	"unprognostic (8.35e-3)"	"unprognostic (2.57e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.66e-2)"	"unprognostic (6.61e-3)"	"unprognostic (2.29e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.71e-1)"	"unprognostic (4.92e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.76e-2)"	0.0	0.0	0.2	0.1	0.5	50.6	0.0	0.0	0.5	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.1	0.5	0.6	0.2	0.1	0.5	0.2	0.0	0.1	0.1	0.0	0.0	1.2	1.3	0.0	0.0	0.4	0.0	0.0	0.1	0.5	0.7	0.0	0.1	1.3	0.6	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.1	0.4	0.0	11.0	0.0	0.3	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.5	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.5	0.0	0.1	0.5	0.2	0.0	1.3	0.1	0.7	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.9	0.3	0.1	0.0	0.0	0.0	253.9	0.2	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	2.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.3	0.0
ASB12	FLJ39577	ENSG00000198881	"Ankyrin repeat and SOCS box containing 12"	Q8WXK4	X	64224194-64230607	"Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	33	"skeletal muscle: 91.4;tongue: 52.6"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 21.1"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 1.2"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AF22: 1.2;THP-1: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049542	Uncertain					NA	NA					"HPA049542: AB_2680810"	"unprognostic (6.52e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.06e-3)"	"unprognostic (6.76e-2)"	"unprognostic (4.23e-2)"	"unprognostic (6.50e-2)"	"unprognostic (8.25e-2)"	"unprognostic (6.75e-2)"	"unprognostic (9.69e-3)"	"unprognostic (6.75e-3)"	"unprognostic (5.18e-2)"	"unprognostic (5.12e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.32e-2)"	"unprognostic (4.63e-2)"	0.2	0.3	0.3	0.1	0.3	0.2	0.2	0.3	0.4	0.3	0.3	0.4	0.0	0.4	0.5	0.9	1.4	0.2	2.1	0.3	0.3	0.3	0.1	0.2	0.1	0.3	0.2	0.3	0.6	0.2	0.3	0.2	0.0	0.3	0.4	0.5	0.2	0.7	0.6	91.4	0.3	0.2	0.3	0.2	0.2	0.3	1.7	0.2	0.1	0.2	52.6	0.2	0.6	0.3	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.7	0.6	0.0	0.0	0.0	0.7	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.1	0.3	0.0	0.0	0.2	0.7	0.7	0.2	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.3	0.3	0.4	0.3	0.3	0.3	0.2	0.3	0.3	0.2	0.2	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.2	4.6	0.2	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	21.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1
HAPLN2	BRAL1	ENSG00000132702	"Hyaluronan and proteoglycan link protein 2"	Q9GZV7	1	156619331-156625725	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	33	"brain: 276.4"	"Cell type enriched"	"Detected in some"	6	"Oligodendrocytes: 202.1"	"Cancer enriched"	"Detected in some"	10	"glioma: 7.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045765	Enhanced				"Secreted in brain"	NA	NA					"HPA045765: AB_10964781"	"unprognostic (3.19e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.04e-3)"	"unprognostic (1.31e-1)"	"unprognostic (8.25e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.72e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.17e-3)"	0.6	0.3	49.2	0.0	119.9	0.0	0.5	159.6	96.3	0.7	8.3	0.4	0.8	2.7	0.0	0.1	2.6	0.0	1.4	38.9	107.0	0.5	0.1	0.3	0.0	201.9	139.2	26.1	0.6	0.1	0.2	0.4	0.0	174.3	2.6	0.0	0.1	0.2	0.1	0.7	0.3	0.7	0.0	185.6	0.1	0.3	1.3	115.2	0.0	0.3	0.1	0.0	1.3	1.0	276.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.2	119.9	159.6	96.3	38.9	107.0	201.9	139.2	26.1	174.3	185.6	115.2	276.4	1.5	0.0	0.0	5.2	0.0	0.1	0.1	0.0	0.0	1.7	0.9	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.4	2.3	0.0	0.0	5.8	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.7	5.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.0	12.5	202.1	0.0	5.0	0.0	0.0	0.2	2.8	0.0	0.0	0.5	32.9	0.9	14.4	0.7	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1
PRM3		ENSG00000178257	"Protamine 3"	Q9NNZ6	16	11273199-11273629	"Predicted intracellular proteins"	"Differentiation, DNA condensation, Spermatogenesis"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	33	"testis: 89.6"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 3440.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"TIME: 3.6"	"Not detected"	"Not detected"													NA	NA																							0.0	0.0	0.5	0.0	0.6	2.7	0.0	2.6	1.5	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.3	0.5	0.2	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.4	0.2	0.0	0.2	0.6	0.0	0.0	0.1	0.2	0.0	89.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.1	0.2	0.0	0.0	0.0	0.1	0.0	3.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	2.6	1.5	0.9	0.0	0.5	0.2	0.2	1.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	854.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3440.3	12.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	8.9	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KLK4	"EMSP, EMSP1, KLK-L1, PRSS17, PSTS"	ENSG00000167749	"Kallikrein related peptidase 4"	Q9Y5K2	19	50906352-50910738	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	Biomineralization	"Hydrolase, Protease, Serine protease"	"Amelogenesis imperfecta, Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	32	"prostate: 288.8"	"Cell type enriched"	"Detected in some"	15	"Prostatic glandular cells: 106.1"	"Cancer enriched"	"Detected in many"	55	"prostate cancer: 463.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 6.4;HaCaT: 7.9;OE19: 7.3;SK-BR-3: 5.1"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"spinal cord: 4.5"	HPA051839	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA051839: AB_2681632"	"unprognostic (3.58e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.66e-3)"	"unprognostic (3.11e-2)"	"unprognostic (4.35e-1)"	"unprognostic (3.18e-1)"	"unprognostic (6.66e-2)"	"unprognostic (9.69e-2)"	"unprognostic (8.23e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.20e-3)"	"unprognostic (3.27e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.34e-1)"	0.4	2.9	0.6	1.5	0.3	1.1	1.7	1.6	1.1	4.6	0.0	3.0	7.3	4.4	1.1	2.1	0.6	1.0	0.1	0.3	0.3	0.6	1.2	0.3	0.8	1.5	0.7	0.1	0.1	0.9	1.0	0.0	0.3	1.4	288.8	3.7	0.5	4.9	2.7	3.5	9.0	5.1	0.3	0.4	0.3	1.9	1.2	0.5	0.1	3.9	1.3	0.8	1.2	0.2	1.1	4.1	1.6	0.2	0.2	0.0	0.0	3.5	0.0	0.0	0.0	0.0	3.5	6.4	0.4	0.3	0.1	0.2	7.9	0.0	4.2	0.0	1.1	1.1	1.3	3.8	1.4	0.0	1.4	1.7	0.0	1.9	0.0	0.0	0.2	0.0	0.3	0.7	3.3	0.0	1.0	0.1	2.0	0.1	7.3	0.3	0.3	0.4	0.9	0.0	2.6	0.0	0.4	0.3	5.1	0.0	0.2	4.0	0.3	0.9	0.2	0.2	1.0	0.2	2.0	0.9	0.4	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	1.6	1.1	0.3	0.3	1.5	0.7	0.1	1.4	0.4	0.5	1.1	0.1	0.0	0.0	0.0	0.0	0.3	3.6	0.0	0.0	0.6	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.6	0.0	2.6	0.1	0.0	0.0	0.1	0.2	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	6.7	0.0	0.0	0.0	0.4	0.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	106.1	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.3	0.0	0.6	0.0	0.0	3.3	1.0	2.6
LGALS14	"CLC2, PPL13"	ENSG00000006659	"Galectin 14"	Q8TCE9	19	39704481-39709444	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	32	"placenta: 66.1"	"Cell type enriched"	"Detected in some"	11	"Syncytiotrophoblasts: 88.7"	"Cancer enriched"	"Detected in single"	16	"liver cancer: 5.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"EFO-21: 4.3;U-266/70: 9.8"									HPA065180			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA065180: "										"unprognostic (1.95e-1)"								0.1	0.0	0.7	0.3	0.9	0.6	0.4	2.0	1.4	0.2	0.3	0.1	0.3	0.2	0.3	0.0	0.0	0.1	0.0	0.7	0.5	0.0	0.0	0.2	0.4	1.2	0.8	1.0	0.2	0.5	0.0	0.0	66.1	1.5	0.2	0.1	0.5	0.1	0.0	0.1	0.9	0.1	0.2	0.3	0.4	0.3	0.2	1.1	0.1	0.1	0.2	0.6	0.1	0.0	1.9	0.1	0.0	0.2	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	4.3	0.1	0.1	0.5	0.0	0.0	0.1	1.2	0.1	0.1	0.5	0.2	0.0	0.1	0.7	0.0	0.1	0.1	0.2	0.4	0.0	0.3	0.1	0.8	0.0	0.3	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.2	0.1	0.5	0.0	0.1	0.0	0.3	0.4	0.5	0.1	9.8	0.4	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.9	2.0	1.4	0.7	0.5	1.2	0.8	1.0	1.5	0.3	1.1	1.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	88.7	0.2	0.0	0.0	0.0
SFTPB	"SFTP3, SP-B"	ENSG00000168878	"Surfactant protein B"	P07988	2	85657314-85668741	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Gaseous exchange"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	32	"lung: 3597.3"	"Cell type enriched"	"Detected in some"	4	"Alveolar cells type 2: 15343.4"	"Cancer enriched"	"Detected in many"	5	"lung cancer: 1306.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.8;NB-4: 3.5;U-2197: 6.7;U-266/70: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002440, HPA034820, HPA062148"	Enhanced				"Secreted in other tissues"	NA	NA		80000000			"CAB002440: AB_564142, HPA034820: AB_2674347, HPA062148: AB_2684697"	"unprognostic (6.46e-3)"	"unprognostic (4.94e-2)"	"unprognostic (4.94e-2)"	"prognostic unfavorable (1.71e-6)"	"unprognostic (2.25e-3)"	"unprognostic (4.57e-3)"	"unprognostic (8.57e-3)"	"unprognostic (6.45e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (2.99e-6)"	"unprognostic (2.37e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.90e-2)"	"unprognostic (4.38e-2)"	0.7	4.4	1.8	2.2	1.7	0.4	0.5	2.0	3.0	0.5	1.3	0.5	0.4	0.2	0.7	0.4	0.3	0.2	1.3	1.7	2.0	2.1	1.2	3597.3	0.3	1.7	1.5	1.5	11.1	1.0	0.2	5.5	1.5	1.8	1.3	0.4	2.9	0.5	2.0	1.2	0.8	0.7	0.1	1.2	4.1	5.1	0.5	1.7	0.3	114.0	0.3	0.2	0.2	0.4	1.9	0.1	0.2	0.2	0.5	0.3	0.5	2.8	0.2	0.2	0.1	0.0	0.3	0.6	0.0	0.2	0.0	0.3	2.0	0.2	0.0	0.0	0.3	0.2	0.3	0.7	0.3	0.1	0.1	1.4	0.0	0.3	0.2	0.1	0.5	0.0	0.4	0.3	0.4	0.1	0.3	1.1	3.5	1.6	0.5	0.4	1.3	0.2	0.3	0.2	0.3	0.4	0.3	0.0	0.4	0.2	0.3	0.3	0.3	0.0	0.2	0.6	6.7	0.1	2.4	0.6	0.2	0.6	0.5	0.1	0.3	0.6	0.2	0.2	1.1	0.1	0.2	0.2	0.2	0.4	0.2	0.3	0.2	0.6	0.2	0.7	0.2	0.4	0.4	1.8	1.7	2.0	3.0	1.7	2.0	1.7	1.5	1.5	1.8	1.2	1.7	1.9	0.0	3650.6	15343.4	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.5	0.0	1930.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	14.4	0.0	0.0	0.2	0.2	0.0	26.9	0.0	0.0	262.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	16.2	0.0	0.3	0.0	0.0	25.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	185.9	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	36.5	0.0	0.0	0.2
SLC39A5		ENSG00000139540	"Solute carrier family 39 member 5"	Q6ZMH5	12	56230049-56237846	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	32	"intestine: 239.6;kidney: 111.0;liver: 172.5;pancreas: 309.3"	"Cell type enriched"	"Detected in some"	4	"Proximal enterocytes: 798.4"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 30.6;liver cancer: 36.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	53	"CACO-2: 39.9;Hep G2: 58.5"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.1"	"Not detected"	"Not detected"			HPA018423			Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA018423: AB_1857154"	"unprognostic (5.94e-3)"	"unprognostic (8.29e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.19e-7)"	"unprognostic (1.73e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.93e-3)"	"prognostic favorable (5.05e-4)"	"unprognostic (2.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.96e-4)"	0.3	0.1	0.2	5.6	0.2	0.1	0.3	0.4	0.3	0.3	0.1	74.4	239.6	0.4	0.0	0.1	0.3	6.5	0.1	0.1	0.1	111.0	172.5	0.2	0.4	0.2	0.1	0.0	0.4	309.3	0.0	0.2	0.1	0.2	0.3	46.3	6.4	0.1	0.3	0.1	0.3	220.8	2.6	0.0	0.3	1.4	0.2	0.1	0.0	0.3	0.3	0.0	0.2	0.2	0.3	0.0	0.3	0.1	0.2	0.2	0.3	0.5	0.0	0.0	0.1	0.0	39.9	0.4	0.1	0.1	0.1	0.0	0.2	0.0	0.3	0.0	0.6	0.1	0.2	0.2	58.5	0.2	0.1	0.2	0.2	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.3	0.0	0.2	0.0	0.8	0.0	0.9	0.1	0.2	0.2	0.3	0.5	0.1	0.3	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.3	0.1	0.1	0.2	0.1	0.0	0.2	0.0	0.1	0.3	0.1	0.0	0.0	0.0	1.4	0.6	0.1	0.0	0.0	0.9	0.1	0.3	0.2	15.7	0.0	3.7	116.7	0.0	0.0	171.9	19.6	0.3	0.6	0.0	0.1	0.2	25.3	2.7	0.2	20.6	0.0	0.1	0.0	0.0	0.0	0.0	2.2	138.9	0.1	0.0	0.2	112.7	0.0	1.6	1.2	1.4	0.0	1.3	0.0	0.0	0.6	0.6	0.0	0.0	0.1	7.4	192.8	0.0	0.0	0.1	798.4	169.9	0.0	1.8	0.0	0.2	0.2	0.0	0.0	0.0	0.4	0.0	0.8	0.0	168.7	0.0
TMEM31	MGC39655	ENSG00000179363	"Transmembrane protein 31"	Q5JXX7	X	103710909-103714032	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	32	"testis: 110.9"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 3288.8"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.8;BEWO: 4.3;MCF7: 6.4;NTERA-2: 1.8;U-937: 2.4"					"Low region specificity"	"Detected in all"			HPA052760			Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA052760: "	"unprognostic (9.42e-5)"	"unprognostic (1.46e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.51e-2)"	"unprognostic (7.75e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.39e-2)"	"unprognostic (3.77e-1)"	"unprognostic (5.91e-5)"	"unprognostic (1.75e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.72e-1)"	"unprognostic (4.68e-2)"	0.3	0.2	2.4	0.1	2.6	0.0	0.6	2.4	3.4	1.4	1.8	0.2	0.0	0.7	0.5	0.1	1.0	0.2	0.3	2.3	2.4	0.5	0.3	0.3	0.2	2.5	2.4	2.1	1.8	0.2	1.3	0.9	0.9	2.6	0.6	0.0	0.2	0.2	0.3	1.0	0.4	0.2	0.1	2.3	0.4	0.2	110.9	2.5	0.3	0.3	0.0	0.0	0.4	0.6	2.9	0.0	0.0	1.8	0.1	0.1	0.0	4.3	0.1	0.0	0.2	0.3	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.7	0.0	0.2	0.0	1.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.2	6.4	0.1	1.2	1.8	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.5	0.3	0.4	0.0	0.2	0.8	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.5	0.0	2.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	2.4	2.6	2.4	3.4	2.3	2.4	2.5	2.4	2.1	2.6	2.3	2.5	2.9	0.3	0.0	0.0	0.0	0.0	0.8	0.7	0.2	0.0	0.0	0.4	1.5	0.2	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.2	641.3	10.1	0.4	1.1	0.0	0.0	0.2	0.7	8.6	0.6	0.0	0.2	0.0	1.1	0.7	0.2	0.4	0.0	0.1	0.1	0.0	0.3	0.3	3288.8	13.4	1.2	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.1	0.0	7.5	0.0	0.3	0.0	0.2	0.0	0.0	13.1	0.3	0.3	19.6	12.1	0.0	0.3	2.9	0.0	0.2	0.0	0.2
ADH4	ADH-2	ENSG00000198099	"Alcohol dehydrogenase 4 (class II), pi polypeptide"	P08319	4	99123657-99157792	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"liver: 5193.5"	"Cell type enriched"	"Detected in some"	21	"Hepatocytes: 975.2"	"Cancer enriched"	"Detected in some"	60	"liver cancer: 230.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"Hep G2: 22.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA020525	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA		20000000	"Nucleoplasm, Cytosol"		"HPA020525: AB_1844609"	"unprognostic (2.75e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.85e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.14e-2)"	"unprognostic (1.33e-2)"	"prognostic favorable (7.08e-6)"	"unprognostic (1.49e-1)"		"unprognostic (1.39e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.34e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.20e-1)"		"unprognostic (5.89e-3)"	1.6	0.8	0.5	0.4	0.5	0.5	4.4	1.2	1.2	1.0	0.0	0.6	165.6	0.2	0.5	0.8	0.3	0.4	0.1	0.6	0.5	1.5	5193.5	0.2	0.2	0.3	0.1	0.2	0.1	0.4	0.1	0.0	0.2	0.5	0.3	0.6	0.8	2.7	0.5	0.6	0.6	23.1	0.1	0.0	0.6	0.6	1.0	0.3	0.0	0.4	2.2	0.1	0.4	3.4	0.8	0.1	0.2	0.1	0.2	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.4	0.2	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.0	0.4	0.4	22.2	0.0	1.6	0.2	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.3	0.8	0.0	0.1	0.1	0.5	0.3	0.0	0.1	0.1	1.6	0.5	0.0	0.1	0.1	0.2	1.5	0.3	0.0	0.1	0.4	0.0	0.1	0.4	0.1	0.3	0.0	0.4	0.4	0.6	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	1.2	1.2	0.6	0.5	0.3	0.1	0.2	0.5	0.0	0.3	0.8	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	21.5	0.2	1.8	0.0	0.0	0.0	0.8	0.0	0.0	26.9	0.7	0.6	1.1	0.0	45.5	0.1	0.6	0.0	1.0	0.0	0.3	0.0	0.0	16.1	975.2	0.0	0.0	0.0	1.1	0.0	27.0	0.0	3.7	0.3	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	1.9	0.0	0.8	0.0
CHIA	"AMCase, CHIT2, TSA1902"	ENSG00000134216	"Chitinase acidic"	Q9BZP6	1	111290851-111320566	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Carbohydrate metabolism, Chitin degradation, Immunity, Inflammatory response, Polysaccharide degradation"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"stomach 1: 330.2"	"Cell type enriched"	"Detected in some"	5	"Alveolar cells type 2: 34.6"	"Group enriched"	"Detected in some"	4	"lung cancer: 1.8;stomach cancer: 2.0;thyroid cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"ASC diff: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA059193	Approved				"Intracellular and membrane"	NA	NA					"HPA059193: AB_2683942"				"unprognostic (8.00e-2)"	"unprognostic (7.08e-2)"			"unprognostic (2.02e-2)"					"unprognostic (4.99e-2)"	"unprognostic (7.93e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.06e-2)"		0.3	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.3	0.2	0.0	0.0	0.0	0.6	0.5	1.6	0.3	0.0	0.0	0.1	0.2	0.1	0.2	10.7	0.3	0.1	0.1	0.1	0.1	0.2	2.0	1.9	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.1	0.0	330.2	0.5	0.1	0.0	0.5	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.0	34.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.0
NCAN	CSPG3	ENSG00000130287	Neurocan	O14594	19	19211958-19252233	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"brain: 74.2"	"Cell type enriched"	"Detected in some"	6	"Astrocytes: 195.5"	"Cancer enriched"	"Detected in some"	57	"glioma: 71.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.0;SCLC-21H: 2.3;SH-SY5Y: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036814	Enhanced				"Secreted in brain"	NA	NA		790000			"HPA036814: AB_10673666"	"unprognostic (1.02e-2)"	"unprognostic (2.84e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.58e-3)"	"unprognostic (4.38e-2)"	"unprognostic (9.09e-6)"	"unprognostic (1.10e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.58e-2)"	0.0	0.1	52.5	0.0	50.6	0.0	0.0	15.0	74.2	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.4	39.5	0.0	0.0	0.0	0.0	38.7	35.7	47.7	0.0	0.0	0.0	0.3	0.0	44.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	20.4	0.0	0.0	0.9	58.3	0.1	0.0	0.0	0.0	0.0	0.0	51.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	1.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.5	50.6	15.0	74.2	55.4	39.5	38.7	35.7	47.7	44.0	20.4	58.3	51.4	0.0	0.0	0.0	195.5	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.1	0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	15.5	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	8.4	0.0	0.5	0.0	29.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	2.4	0.0	0.1	0.0	0.0	0.3	0.0	0.0
EPB42	"MGC116735, MGC116737, PA"	ENSG00000166947	"Erythrocyte membrane protein band 4.2"	P16452	15	43197227-43221018	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell shape, Erythrocyte maturation"		"Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	30	"bone marrow: 99.8"	"Cell type enriched"	"Detected in many"	33	"Erythroid cells: 480.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	91	"HEL: 85.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA040261	Supported		Uncertain	Nucleoplasm,Cytosol		NA	NA		1400000	"Nucleoplasm, Cytosol"		"HPA040261: AB_10673441"	"unprognostic (8.45e-2)"	"unprognostic (4.66e-1)"	"unprognostic (4.15e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.95e-1)"	"unprognostic (6.05e-2)"	"unprognostic (5.27e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.48e-5)"	"unprognostic (1.70e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.88e-2)"	"unprognostic (3.47e-3)"	3.1	0.0	0.0	0.0	0.0	99.8	0.5	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.4	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	3.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	2.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	85.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	2.8	1.9	1.5	0.5	0.0	4.0	0.0	0.0	0.6	1.5	0.5	0.0	6.2	4.5	0.0	1.5	0.0	0.0	14.4	0.0	0.0	1.2	0.0	480.0	0.1	0.0	2.3	0.8	0.0	0.0	4.5	0.0	2.5	1.1	1.1	6.7	0.1	0.9	4.1	2.2	2.8	10.5	2.8	1.1	1.8	0.0	3.6	2.5	14.4	0.0	0.0	0.0	1.7	0.7	0.4	1.5	2.4	0.0	0.6	8.4	6.6	1.0	1.0	13.5	4.6	0.0	2.8	6.7	3.8	0.0	0.8	2.0
GATA1	"ERYF1, GATA-1, GF1, NF-E1, NFE1"	ENSG00000102145	"GATA binding protein 1"	P15976	X	48786562-48794311	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	30	"bone marrow: 60.4"	"Cell type enriched"	"Detected in some"	4	"Erythroid cells: 165.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	6	"eosinophil: 471.7"	"Lineage enriched"	"Detected in single"	1877	"granulocytes: 471.7"	"Group enriched"	"Detected in some"	9	"HEL: 221.5;HMC-1: 211.9;K-562: 238.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA000232, HPA000233, CAB009195"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB009195: AB_2232148, HPA000232: AB_1078949, HPA000233: AB_1078951"	"unprognostic (1.93e-1)"	"unprognostic (7.54e-2)"	"unprognostic (8.95e-3)"	"unprognostic (3.84e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.00e-4)"	"unprognostic (4.87e-2)"	"unprognostic (3.48e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.04e-2)"	"unprognostic (7.71e-3)"	"unprognostic (4.13e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.78e-1)"	"unprognostic (9.10e-2)"	"unprognostic (2.71e-2)"	0.2	0.1	0.1	0.1	0.2	60.4	0.1	0.2	0.1	0.2	0.1	0.2	0.6	0.3	0.0	0.2	0.1	0.6	0.1	0.0	0.3	0.2	0.3	2.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.2	1.0	0.3	0.3	0.3	0.4	0.1	0.1	0.0	0.2	0.5	0.3	0.2	2.0	0.5	1.4	0.2	0.1	0.1	0.4	0.0	0.4	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	221.5	0.0	0.0	0.0	0.2	211.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	238.9	0.4	0.0	0.0	0.1	26.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	83.6	0.2	471.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.2	0.0	0.0	4.4	0.1	0.2	0.2	0.1	0.0	0.3	0.3	0.3	0.0	0.3	0.2	0.2	0.6	0.0	0.0	1.3	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	165.6	0.1	0.0	0.5	0.3	0.0	0.0	37.9	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.4	31.5	0.0	9.2	0.0	0.0	0.1	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.1	1.2	0.2	0.0	0.0
GYS2		ENSG00000111713	"Glycogen synthase 2"	P54840	12	21536107-21604847	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Glycogen biosynthesis"	"Allosteric enzyme, Glycosyltransferase, Transferase"	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	30	"liver: 175.3"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 63.6"	"Cancer enriched"	"Detected in single"	29	"liver cancer: 12.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039482	Approved					NA	NA					"HPA039482: AB_10795107"	"unprognostic (7.22e-3)"	"unprognostic (2.85e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.78e-2)"	"unprognostic (5.68e-2)"	"unprognostic (3.16e-1)"	"prognostic favorable (7.62e-5)"	"unprognostic (1.06e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.22e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.66e-4)"	2.7	0.0	0.1	0.0	0.1	0.0	1.0	0.1	0.1	1.2	0.0	0.1	0.0	0.0	0.0	5.8	0.0	0.0	0.1	0.1	0.0	0.2	175.3	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	5.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.9	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.4	63.6	0.0	0.0	7.7	0.0	6.1	1.6	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	5.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1
KLHL33		ENSG00000185271	"Kelch like family member 33"	A6NCF5	14	20425852-20436166	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	30	"skeletal muscle: 74.0;tongue: 20.4"	"Cell type enriched"	"Detected in some"	19	"Cardiomyocytes: 27.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	21	"plasmacytoid DC: 5.8"	"Lineage enriched"	"Detected in single"	21	"dendritic cells: 5.8"	"Cell line enriched"	"Detected in single"	9	"REH: 4.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA049985, HPA056560"	Enhanced					NA	NA					"HPA049985: , HPA056560: AB_2683174"	"unprognostic (6.92e-2)"	"unprognostic (6.39e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.81e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.60e-1)"	"unprognostic (9.77e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.39e-2)"	"unprognostic (4.15e-2)"	"unprognostic (4.60e-2)"	"unprognostic (7.43e-3)"	"unprognostic (4.88e-3)"	"unprognostic (3.32e-5)"	"unprognostic (2.32e-1)"	0.9	0.3	0.4	0.2	0.5	0.2	0.6	1.5	0.7	1.1	0.3	0.7	0.3	1.4	1.0	0.9	0.8	0.8	0.9	0.5	0.5	0.5	0.1	0.4	0.6	0.4	0.6	0.5	1.2	0.2	0.5	0.2	0.2	0.8	1.0	0.3	0.3	0.5	1.0	74.0	0.1	0.5	0.5	0.1	0.6	0.3	0.4	0.5	1.0	0.4	20.4	0.6	0.5	1.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.1	0.0	0.0	5.8	0.0	0.1	0.4	0.5	1.5	0.7	0.5	0.5	0.4	0.6	0.5	0.8	0.1	0.5	0.8	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	27.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.7	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0
MAG	"GMA, S-MAG, SIGLEC-4A, SIGLEC4A"	ENSG00000105695	"Myelin associated glycoprotein"	P20916	19	35292125-35313807	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	30	"brain: 690.0"	"Cell type enriched"	"Detected in some"	12	"Oligodendrocytes: 267.8"	"Cancer enriched"	"Detected in some"	7	"glioma: 20.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	12	"plasmacytoid DC: 2.9"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 2.9"	"Cell line enriched"	"Detected in some"	22	"WM-115: 36.6"	"Region enhanced"	"Detected in all"		"white matter: 2742.2"	"Low region specificity"	"Detected in all"			"CAB009345, HPA012499"	Enhanced					NA	NA					"CAB009345: AB_670104, HPA012499: AB_1854238"	"unprognostic (2.70e-3)"	"unprognostic (2.70e-2)"		"unprognostic (8.06e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.93e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.00e-1)"	"unprognostic (5.62e-2)"	"unprognostic (5.18e-4)"	"unprognostic (6.29e-2)"	"unprognostic (2.19e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.66e-1)"	0.2	1.3	99.7	0.0	295.4	0.0	0.3	256.6	225.9	0.2	0.0	0.1	0.0	0.2	0.0	0.0	4.2	0.0	0.3	111.3	205.6	0.3	0.2	0.3	0.1	432.2	287.2	42.8	22.6	0.1	0.0	0.5	0.3	361.2	0.3	0.0	0.0	0.2	0.3	0.1	0.1	0.1	0.0	262.6	1.1	0.1	0.6	239.2	0.0	1.0	0.0	0.0	0.2	0.5	690.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.0	36.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	2.9	0.0	0.0	99.7	295.4	256.6	225.9	111.3	205.6	432.2	287.2	42.8	361.2	262.6	239.2	690.0	1.2	0.0	0.0	1.6	0.2	0.0	0.2	0.0	0.0	0.0	0.3	4.4	4.1	0.0	0.0	0.0	0.0	0.2	4.0	0.0	1.9	0.0	0.1	0.0	0.0	4.2	0.0	0.4	0.5	0.5	5.4	2.7	0.0	0.0	4.5	21.0	12.8	0.0	1.0	0.0	0.6	0.0	0.0	0.6	0.0	0.1	1.8	1.2	0.0	1.0	0.1	0.0	0.0	0.5	267.8	0.6	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	4.3	0.0	0.0	0.3	0.4	11.0	0.0	0.0
PSG4		ENSG00000243137	"Pregnancy specific beta-1-glycoprotein 4"	Q00888	19	43192702-43207299	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	30	"parathyroid gland: 55.9;placenta: 144.8"	"Cell type enriched"	"Detected in some"	38	"Syncytiotrophoblasts: 553.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"fHDF/TERT166: 552.6;U-2197: 147.3"									HPA046327	Supported				"Secreted in female reproductive system"	NA	NA		58000000			"HPA046327: AB_2679624"	"unprognostic (4.29e-2)"	"unprognostic (5.18e-2)"		"unprognostic (9.49e-2)"		"unprognostic (2.52e-2)"		"unprognostic (3.63e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.75e-2)"	"unprognostic (8.82e-3)"	"unprognostic (1.03e-3)"	"unprognostic (1.68e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.57e-1)"	0.1	0.1	0.1	0.0	0.0	0.0	1.1	0.8	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.5	55.9	0.1	144.8	0.4	0.2	0.0	0.0	1.2	0.2	0.0	3.3	0.0	1.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.3	0.8	0.0	1.8	0.1	0.7	0.3	0.0	2.7	0.0	1.9	552.6	4.6	0.0	0.2	0.4	5.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	8.2	53.6	3.6	0.0	0.0	0.0	0.0	4.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.3	0.4	0.0	0.0	0.0	7.1	0.9	14.5	0.0	0.0	4.4	2.1	5.5	147.3	0.1	0.2	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.2	0.1	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	3.3	0.0	1.5	0.4	0.5	0.3	0.0	0.3	0.0	0.0	4.7	0.0	0.0	0.0	14.3	0.1	0.1	0.2	0.1	0.0	0.0	1.0	0.0	11.9	0.4	0.0	2.7	0.0	0.1	0.0	0.0	2.0	0.0	1.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.5	0.3	0.7	0.0	0.0	0.0	2.7	0.0	0.0	0.2	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	553.7	0.0	0.0	0.0	0.3
PYY	PYY1	ENSG00000131096	"Peptide YY"	P10082	17	43952738-44004469	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	30	"intestine: 53.0"	"Cell type enriched"	"Detected in some"	96	"Enteroendocrine cells: 19377.2"	"Group enriched"	"Detected in many"	8	"endometrial cancer: 7.9;ovarian cancer: 15.2;testis cancer: 18.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 2.9"	"Region enriched"	"Detected in single"	14	"pons and medulla: 1.4"	"Low region specificity"	"Detected in single"			"HPA010973, CAB016734"	Enhanced				"Secreted to blood"	NA	NA	87100				"CAB016734: AB_876471, HPA010973: AB_1855194"	"unprognostic (8.17e-3)"	"unprognostic (5.41e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.81e-3)"	"unprognostic (2.48e-4)"	"unprognostic (5.26e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.69e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.20e-1)"	0.1	1.7	0.3	1.5	0.3	0.1	0.4	0.2	0.7	0.3	0.1	53.0	2.5	0.4	0.4	0.0	0.4	0.0	0.0	0.3	0.3	1.3	0.2	0.2	0.3	0.4	0.3	0.3	0.0	0.7	0.2	0.0	0.0	0.5	0.3	37.0	0.8	0.1	0.8	0.1	0.1	42.0	0.1	0.2	0.1	0.5	1.1	0.4	0.3	0.5	0.1	0.1	0.0	0.0	0.5	0.1	0.2	0.2	0.4	0.3	0.6	0.0	0.4	0.1	0.5	0.3	0.5	0.3	0.2	0.6	0.5	0.4	0.2	0.4	0.1	0.3	1.2	0.2	0.7	0.2	0.0	0.4	0.2	2.9	0.8	0.1	0.5	0.2	0.6	0.1	0.3	0.2	0.5	0.4	0.6	0.2	0.4	0.6	0.4	0.2	0.1	0.1	0.0	0.8	0.0	0.4	0.1	0.3	0.0	0.7	0.3	0.5	0.0	0.5	0.6	0.5	0.1	0.4	0.0	0.5	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.7	0.3	0.3	0.4	0.3	0.3	0.5	0.2	0.4	0.5	0.1	0.0	0.0	0.3	1.4	0.0	0.0	0.0	0.0	0.0	1.5	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	65.0	1.9	0.0	1.0	7.9	1.3	0.1	19377.2	0.0	3.5	0.0	0.1	0.0	0.0	18.9	8.9	0.1	0.0	0.0	0.0	0.0	3.3	199.9	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	35.5	0.0	0.0	0.0	20.7	0.1	0.0	0.0	0.0	0.0	0.1	2.3	4.3	0.0	0.1	0.0	1.0	0.0	36.8	0.0
TRAV26-2	"TCRAV26S2, TCRAV4S1, TRAV262"	ENSG00000211812	"T cell receptor alpha variable 26-2"	A0A0B4J265	14	22202583-22203368	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	30	"lymphoid tissue: 41.9"	"Cell type enriched"	"Detected in single"	11	"T-cells: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	35	"memory CD4 T-cell: 52.8;memory CD8 T-cell: 80.5;naive CD4 T-cell: 50.9;naive CD8 T-cell: 36.8;T-reg: 66.3"	"Lineage enriched"	"Detected in single"	121	"T-cells: 80.5"	"Cell line enriched"	"Detected in single"	122	"HDLM-2: 12.2"	"Not detected"	"Not detected"													NA	NA						"unprognostic (7.57e-5)"	"unprognostic (1.82e-1)"	"unprognostic (2.19e-1)"	"unprognostic (6.76e-4)"		"unprognostic (8.84e-5)"		"unprognostic (4.51e-2)"	"unprognostic (2.10e-2)"	"unprognostic (8.91e-3)"	"unprognostic (9.24e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.76e-3)"	"unprognostic (3.41e-1)"	"unprognostic (5.19e-2)"	0.1	0.0	0.0	4.7	0.0	0.3	0.2	0.0	0.1	0.0	0.0	1.1	0.6	0.0	0.0	0.5	0.2	1.0	0.0	0.1	0.0	0.1	0.9	1.3	10.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.3	0.1	0.0	0.0	0.9	0.3	0.0	1.9	1.0	0.1	0.2	41.9	0.1	0.6	7.5	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	1.6	0.1	0.9	0.0	52.8	80.5	0.0	0.1	50.9	36.8	0.6	0.0	0.1	0.0	66.3	18.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0
C5	"C5a, C5b, CPAMD4"	ENSG00000106804	"Complement C5"	P01031	9	120952335-121050275	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Inflammatory response, Innate immunity"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	29	"liver: 437.3"	"Cell type enriched"	"Detected in many"	16	"Hepatocytes: 538.3"	"Cancer enriched"	"Detected in many"	17	"liver cancer: 73.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 28.4;Hep G2: 30.4"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA029339	Supported				"Secreted to blood"	NA	NA	113000000000	39000000000			"HPA029339: AB_10601125"	"unprognostic (2.51e-1)"	"unprognostic (5.88e-3)"	"unprognostic (2.50e-3)"	"unprognostic (1.57e-2)"	"unprognostic (5.05e-2)"	"unprognostic (9.52e-3)"	"prognostic favorable (9.43e-4)"	"unprognostic (1.83e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.35e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.46e-5)"	"unprognostic (5.91e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.75e-1)"	3.0	1.7	2.9	1.2	3.5	2.2	2.5	2.6	2.6	3.0	3.5	2.3	3.9	2.8	2.7	1.7	3.0	1.5	1.1	2.2	3.0	4.8	437.3	7.1	2.1	3.3	2.9	2.1	3.3	15.0	2.6	3.2	0.9	3.2	3.2	1.6	3.5	1.4	2.2	0.5	3.8	4.0	2.0	2.9	1.5	5.8	1.7	2.7	1.2	2.0	1.2	1.7	2.6	2.1	4.7	1.6	28.4	6.4	11.3	8.0	9.2	0.2	3.4	3.5	0.9	2.0	0.8	2.8	4.1	0.1	1.8	3.8	11.0	0.3	0.3	1.5	0.9	0.0	1.8	1.5	30.4	1.5	1.0	0.7	4.1	0.5	2.0	3.7	1.8	1.0	1.6	0.7	3.8	2.2	5.6	0.4	0.2	1.7	7.0	10.9	2.5	2.8	0.4	1.7	0.8	1.6	6.5	1.6	0.0	2.7	4.4	2.2	3.7	1.3	2.8	0.2	7.5	3.4	2.3	1.8	1.7	2.2	3.8	6.8	0.0	0.3	0.4	0.0	0.0	0.2	0.3	0.1	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.9	3.5	2.6	2.6	2.2	3.0	3.3	2.9	2.1	3.2	2.9	2.7	4.7	0.8	6.4	28.6	30.0	3.5	1.0	1.0	0.5	1.8	4.8	2.2	1.3	0.8	32.9	7.1	1.8	0.0	0.1	0.1	0.4	1.9	0.2	1.8	1.1	2.2	1.4	0.0	12.0	7.3	0.4	0.0	2.9	2.0	0.8	0.0	3.1	7.5	538.3	1.9	6.7	9.4	1.0	0.0	16.3	1.0	2.8	3.1	3.5	0.0	6.5	2.3	3.2	2.1	25.6	25.4	0.7	3.8	9.1	0.1	0.7	1.0	6.8	3.8	2.6	0.0	4.0	1.6	7.5	2.5	2.0	1.3	0.0	1.4	2.8	2.0	0.6
FLG		ENSG00000143631	Filaggrin	P20930	1	152302165-152325239	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Developmental protein"	"Cancer-related genes, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"skin 1: 461.9"	"Cell type enriched"	"Detected in some"	13	"Suprabasal keratinocytes: 44.0"	"Cancer enriched"	"Detected in some"	7	"melanoma: 11.6"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 10.1;NTERA-2: 3.1;TIME: 2.1;U-2 OS: 2.4;U-2197: 2.6;WM-115: 2.0"	"Not detected"	"Not detected"							"CAB002210, HPA027505, HPA030188, HPA030189"	Enhanced		Enhanced	"Cytoplasmic bodies"		NA	NA		3800000	"Cytoplasmic bodies"		"CAB002210: AB_563731, HPA027505: AB_10600107, HPA030188: AB_10601749, HPA030189: AB_10601999"	"unprognostic (3.37e-2)"	"unprognostic (3.76e-1)"	"unprognostic (8.83e-2)"	"unprognostic (2.96e-3)"	"unprognostic (9.65e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.98e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.28e-2)"	"unprognostic (4.15e-2)"	"unprognostic (7.41e-3)"	0.3	0.4	1.1	0.1	0.5	0.1	15.9	0.4	0.6	3.2	0.0	0.2	0.0	0.5	0.0	12.1	0.4	0.1	0.3	0.4	0.9	0.3	0.2	0.2	0.0	1.6	0.9	0.3	0.9	0.4	0.0	0.2	0.0	1.2	0.2	0.0	0.2	2.7	0.0	1.8	461.9	0.1	0.0	0.7	0.1	0.2	0.3	0.8	0.5	0.3	0.0	0.5	0.1	4.9	2.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.5	0.0	10.1	0.0	0.0	0.0	1.1	0.0	0.8	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.1	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	2.1	0.8	2.4	2.6	1.9	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.5	0.4	0.6	0.4	0.9	1.6	0.9	0.3	1.2	0.7	0.8	2.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	1.0	0.0	0.6	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	1.0	44.0	0.0	0.1	0.1	0.0	0.0
FOXB1	"FKH5, HFKH-5"	ENSG00000171956	"Forkhead box B1"	Q99853	15	60004234-60061730	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	29	"brain: 18.9"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 32.5"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.2"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	5	"T-reg: 1.1"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.1"	"Cell line enhanced"	"Detected in some"		"AF22: 6.6;HDLM-2: 14.7;HEK 293: 10.7;JURKAT: 5.6"	"Region enhanced"	"Detected in many"		"hypothalamus: 6.6"	"Low region specificity"	"Detected in many"			HPA073369			Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA073369: AB_2686597"	"unprognostic (1.69e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.33e-3)"	"unprognostic (1.17e-2)"		"unprognostic (1.47e-2)"	"unprognostic (5.32e-4)"	"unprognostic (1.06e-1)"	"unprognostic (9.21e-2)"	"unprognostic (3.21e-1)"	"unprognostic (8.12e-9)"	"unprognostic (8.74e-2)"	"unprognostic (1.74e-1)"		"unprognostic (9.38e-2)"	0.0	0.0	4.2	0.0	2.6	0.0	0.0	6.1	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	18.9	0.0	0.0	0.0	0.2	10.1	6.6	0.1	0.0	0.0	0.0	0.0	0.2	5.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.9	0.0	0.2	0.6	11.9	0.0	0.0	0.0	0.0	0.0	0.0	4.5	2.5	0.0	6.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.7	10.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	1.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	4.2	2.6	6.1	0.7	0.1	18.9	10.1	6.6	0.1	5.5	7.9	11.9	4.5	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.0	0.0	32.5	7.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	3.6	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	6.8	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	4.8	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0
GAP43	"B-50, GAP-43, PP46"	ENSG00000172020	"Growth associated protein 43"	P17677	3	115623510-115721490	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Differentiation, Growth regulation, Neurogenesis"	"Calmodulin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	29	"brain: 289.7"	"Cell type enriched"	"Detected in some"	4	"Excitatory neurons: 270.2"	"Cancer enriched"	"Detected in many"	43	"glioma: 245.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 37.9;NTERA-2: 81.1;SCLC-21H: 52.2;SH-SY5Y: 39.6;U-87 MG: 18.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004417, HPA013392, HPA015600, CAB078783"	Enhanced	Supported	Enhanced	"Plasma membrane"		NA	NA		35000	"Plasma membrane"		"CAB004417: AB_627660, CAB078783: AB_2620096, HPA013392: AB_1849468, HPA015600: AB_1849466"	"unprognostic (1.24e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.72e-5)"	"unprognostic (7.44e-3)"	"unprognostic (2.19e-2)"	"unprognostic (3.97e-3)"	"unprognostic (3.15e-3)"	"unprognostic (6.08e-4)"	"unprognostic (3.33e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.35e-8)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.29e-3)"	0.6	6.3	105.9	7.6	160.6	0.0	0.9	51.1	289.7	0.4	4.8	8.7	2.6	0.3	0.1	1.1	0.3	4.7	4.3	142.2	160.0	0.2	0.2	0.3	0.2	70.4	121.7	154.7	0.2	0.8	0.0	10.1	1.7	101.5	0.9	4.8	8.0	2.1	0.3	0.3	0.4	5.5	4.4	50.3	0.0	2.9	0.4	150.4	0.1	0.2	0.6	0.4	1.3	1.9	136.0	0.0	0.0	37.9	0.0	0.0	0.0	0.0	0.9	0.7	0.0	0.2	0.0	0.1	0.0	0.0	0.4	0.2	0.1	0.4	0.0	0.0	0.1	0.2	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.0	8.6	0.0	0.5	0.0	0.0	0.0	9.1	0.2	0.0	0.0	0.0	81.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.2	39.6	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	1.5	0.1	0.1	0.1	0.0	0.0	18.9	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	105.9	160.6	51.1	289.7	142.2	160.0	70.4	121.7	154.7	101.5	50.3	150.4	136.0	0.1	0.0	0.0	20.9	0.0	0.3	0.0	0.0	0.0	3.7	0.0	0.0	0.5	0.0	0.0	0.0	2.1	0.1	0.4	0.0	0.0	0.0	1.0	0.0	0.8	5.1	0.0	0.0	270.2	0.0	0.1	4.5	0.0	0.0	0.0	1.5	0.0	0.0	0.8	0.0	62.5	0.0	0.0	0.0	1.2	1.8	0.0	0.0	1.8	29.0	0.0	1.4	0.0	40.2	20.2	0.8	0.0	0.0	0.4	0.0	0.0	0.2	0.0	3.5	0.0	2.0	1.1	0.9	1.7	0.0	0.1	0.0	0.1	0.3	0.0	0.0
GNAT2	ACHM4	ENSG00000134183	"G protein subunit alpha transducin 2"	P19087	1	109603091-109619929	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"	Transducer		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"retina: 79.5"	"Cell type enriched"	"Detected in some"	8	"Cone photoreceptor cells: 60.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"basophil: 2.3;eosinophil: 2.5;neutrophil: 3.7"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.7"	"Cell line enhanced"	"Detected in some"		"CACO-2: 4.5;TIME: 5.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA																							0.0	0.1	0.3	0.5	0.6	0.4	0.0	0.8	1.0	0.0	2.7	0.1	0.0	0.2	0.0	0.2	0.1	1.0	0.9	0.9	0.0	0.2	0.9	0.1	0.3	0.2	0.4	0.4	0.0	0.9	0.2	0.2	0.5	0.5	0.1	0.1	79.5	0.3	0.1	0.2	1.8	0.7	0.1	0.1	0.2	0.2	2.7	0.2	0.1	0.2	0.0	0.1	0.1	0.0	0.3	0.7	0.7	0.5	1.1	0.1	0.1	0.3	0.7	0.1	0.2	0.0	4.5	0.4	1.3	1.8	0.0	0.3	0.4	1.8	0.1	0.3	0.3	0.4	1.2	1.8	0.7	0.0	1.5	0.8	0.4	0.2	0.7	0.3	1.0	0.4	0.5	0.6	0.7	0.2	1.1	0.5	0.4	0.6	0.6	0.4	0.5	0.8	0.8	0.2	2.0	1.2	0.5	1.3	0.4	1.7	2.7	0.9	0.0	5.9	0.3	0.4	1.3	2.5	1.4	2.9	1.7	2.8	0.5	0.5	2.3	0.5	2.5	0.6	0.4	0.6	0.5	0.4	0.4	0.4	0.4	0.4	0.4	3.7	0.4	0.6	0.5	0.3	0.1	0.3	0.6	0.8	1.0	0.9	0.0	0.2	0.4	0.4	0.5	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	60.5	0.1	0.0	0.1	0.0	0.0	3.2	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.1	0.0	2.8	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0
TMEM52B	"C12orf59, FLJ31166"	ENSG00000165685	"Transmembrane protein 52B"	Q4KMG9	12	10170542-10191801	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"kidney: 177.4"	"Cell type enriched"	"Detected in some"	15	"Distal tubular cells: 712.1"	"Cancer enriched"	"Detected in some"	5	"renal cancer: 6.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"CACO-2: 95.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA058096	Enhanced		Approved	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"HPA058096: AB_2683603"	"unprognostic (1.10e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.33e-3)"	"unprognostic (1.37e-1)"	"unprognostic (8.65e-2)"	"unprognostic (7.14e-4)"	"unprognostic (2.23e-1)"	"unprognostic (6.36e-2)"	"unprognostic (7.33e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.80e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.18e-1)"	0.1	0.1	0.6	0.8	1.0	3.5	0.3	0.8	1.2	0.1	0.8	0.1	0.2	0.0	0.3	0.0	0.1	0.4	0.0	0.7	1.0	177.4	0.2	0.7	0.2	0.9	0.7	0.4	0.0	0.3	0.1	0.0	6.1	1.3	0.1	0.1	0.1	1.9	0.0	0.0	0.4	0.2	0.4	1.5	0.1	0.4	0.3	0.8	0.1	0.2	0.0	0.2	0.2	0.0	1.6	2.3	0.1	0.0	0.1	0.0	0.0	1.1	2.2	0.0	0.1	0.0	95.9	0.1	0.0	0.1	0.7	4.9	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	11.7	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	4.1	0.0	0.0	7.0	8.9	0.0	3.0	5.0	1.4	0.0	0.2	0.4	0.0	0.0	0.1	0.1	0.1	0.2	4.7	0.0	0.4	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.9	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.6	1.0	0.8	1.2	0.7	1.0	0.9	0.7	0.4	1.3	1.5	0.8	1.6	0.1	0.0	0.5	0.3	0.5	0.1	0.0	0.0	0.0	0.0	0.2	0.5	0.3	0.0	0.0	12.9	0.0	44.7	0.0	0.1	712.1	0.0	0.6	0.0	0.1	0.2	0.0	0.0	0.8	0.0	2.5	3.2	0.0	0.1	0.0	0.0	0.0	0.0	10.8	0.0	0.2	0.0	0.0	0.8	1.1	0.1	0.3	4.2	1.8	2.8	1.7	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.3	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	19.4	0.1	0.0	0.0	0.1
CYP8B1	CYP12	ENSG00000180432	"Cytochrome P450 family 8 subfamily B member 1"	Q9UNU6	3	42856005-42875898	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	28	"liver: 407.9"	"Cell type enriched"	"Detected in some"	76	"Hepatocytes: 920.2"	"Cancer enriched"	"Detected in some"	46	"liver cancer: 69.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.4;SK-BR-3: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (1.58e-2)"	"unprognostic (5.41e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.42e-3)"	"unprognostic (4.47e-3)"	"unprognostic (1.49e-1)"	"unprognostic (9.85e-2)"	"unprognostic (4.04e-3)"	"unprognostic (5.86e-3)"	"unprognostic (2.74e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.63e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.24e-1)"	0.3	0.1	0.2	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.9	0.2	0.1	0.5	0.1	0.3	0.1	14.6	407.9	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.4	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.2	1.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	8.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	5.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	7.9	920.2	0.1	0.0	0.0	0.0	0.0	10.7	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0
FEZF2	"FEZL, FKSG36, FLJ10142, TOF, Zfp312, ZNF312"	ENSG00000153266	"FEZ family zinc finger 2"	Q8TBJ5	3	62369681-62374324	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	28	"brain: 165.1"	"Cell type enriched"	"Detected in some"	4	"Bipolar cells: 51.5"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"	"Group enriched"	"Detected in all"	5	"cerebral cortex: 165.1;hippocampal formation: 50.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"AF22: 1.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 12.2;cerebral cortex: 12.1;hippocampal formation: 21.3"							NA	NA										"unprognostic (2.37e-1)"					"unprognostic (1.74e-2)"				"unprognostic (1.70e-1)"				0.1	0.0	11.6	0.0	15.3	0.0	0.0	2.7	165.1	0.0	3.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.0	4.4	0.1	0.0	0.0	0.0	19.1	4.3	9.9	0.0	0.0	0.0	0.7	0.0	10.5	0.0	0.0	5.8	0.0	0.0	0.1	0.0	0.0	0.0	4.3	0.1	0.2	0.0	3.8	2.8	0.0	0.0	0.0	0.0	0.0	20.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	15.3	2.7	165.1	50.0	4.4	19.1	4.3	9.9	10.5	4.3	3.8	20.1	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	51.5	0.9	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.8	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
HRH3	GPCR97	ENSG00000101180	"Histamine receptor H3"	Q9Y5N1	20	62214960-62220278	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	28	"brain: 57.7"	"Cell type enriched"	"Detected in some"	4	"Inhibitory neurons: 23.8"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"SCLC-21H: 15.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.56e-1)"	"unprognostic (3.22e-1)"		"unprognostic (4.15e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.77e-2)"			"unprognostic (1.62e-2)"	"unprognostic (7.30e-2)"	"unprognostic (3.17e-4)"	"unprognostic (2.40e-1)"		"unprognostic (3.66e-3)"	"unprognostic (3.30e-1)"		"unprognostic (3.59e-2)"	0.0	0.4	19.7	0.0	39.2	0.0	0.0	9.2	22.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	22.8	0.0	0.0	0.0	0.0	11.0	23.7	15.4	0.0	0.0	0.0	2.0	0.0	13.8	0.1	0.0	0.6	0.1	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.1	0.9	57.7	0.0	0.0	0.0	0.0	0.2	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.1	0.0	0.1	15.6	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.7	39.2	9.2	22.4	14.8	22.8	11.0	23.7	15.4	13.8	0.8	57.7	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.3	23.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LIPC	"HL, HTGL"	ENSG00000166035	"Lipase C, hepatic type"	P11150	15	58410569-58569844	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Heparin-binding, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	28	"liver: 172.5"	"Cell type enriched"	"Detected in some"	9	"Hepatocytes: 161.7"	"Group enriched"	"Detected in some"	14	"liver cancer: 20.4;renal cancer: 10.4"	"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	7	"granulocytes: 1.6;NK-cells: 1.5;T-cells: 1.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 8.5;EFO-21: 6.1;Hep G2: 24.4;HMC-1: 6.8;MOLT-4: 5.5;U-2197: 18.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA		5500000				"unprognostic (1.76e-2)"	"unprognostic (9.15e-3)"	"unprognostic (7.89e-2)"	"unprognostic (7.15e-4)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.93e-3)"	"unprognostic (6.25e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.10e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.27e-2)"	0.3	0.1	0.6	0.3	0.6	0.2	1.5	0.9	1.0	0.4	0.1	0.6	1.8	0.2	0.9	0.6	1.0	0.8	0.4	0.7	0.4	6.0	172.5	0.3	0.7	0.8	0.8	0.6	0.8	2.5	0.0	1.5	0.4	0.9	0.2	0.8	0.1	0.2	0.9	0.0	0.6	0.8	0.1	0.7	0.8	0.5	0.1	0.4	2.1	1.3	0.3	0.2	1.6	0.3	1.3	0.0	0.0	0.0	0.0	0.3	1.0	0.1	0.1	0.8	0.0	0.0	8.5	0.0	0.0	6.1	0.2	0.3	0.0	0.0	0.0	0.0	0.4	0.0	3.0	0.0	24.4	0.5	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.2	0.1	5.5	0.8	0.0	0.1	0.0	1.1	0.3	0.0	2.6	0.5	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	18.4	0.0	0.1	0.0	0.1	0.2	0.5	0.0	1.6	0.1	0.0	1.3	0.1	1.8	0.0	0.3	0.9	0.1	0.0	0.4	1.3	0.2	1.5	0.2	0.0	0.9	1.1	0.6	0.6	0.9	1.0	0.7	0.4	0.8	0.8	0.6	0.9	0.7	0.4	1.3	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.0	2.2	0.8	11.5	0.7	3.7	0.0	0.0	0.9	1.2	5.9	7.8	0.0	0.4	0.5	1.2	0.0	2.7	6.1	3.7	0.1	2.9	0.5	2.7	0.0	0.2	4.2	161.7	0.1	0.0	4.3	0.0	0.0	3.8	0.8	0.1	0.3	0.3	1.8	16.9	0.6	0.0	3.1	0.0	12.9	0.2	0.0	0.0	0.0	0.2	0.3	15.7	0.0	0.0	0.0	1.6	0.3	0.0	0.0	0.3	0.6	0.0	1.1	1.2	0.0	0.1
SLC22A6	"OAT1, PAHT, ROAT1"	ENSG00000197901	"Solute carrier family 22 member 6"	Q4U2R8	11	62936385-62984967	"FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	28	"kidney: 198.3"	"Cell type enriched"	"Detected in some"	17	"Proximal tubular cells: 310.4"	"Cancer enriched"	"Detected in single"	102	"renal cancer: 18.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA074559, CAB075704"	Enhanced					NA	NA					"CAB075704: , HPA074559: AB_2732260"					"unprognostic (2.42e-2)"								"unprognostic (2.25e-3)"	"unprognostic (4.43e-1)"				0.0	0.0	2.0	0.0	2.3	0.0	0.0	3.9	2.4	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	3.8	198.3	0.0	0.0	0.0	7.1	4.8	0.9	0.0	0.0	0.0	0.6	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.1	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.3	3.9	2.4	1.5	3.8	7.1	4.8	0.9	3.1	3.0	5.5	3.1	0.0	0.0	0.0	4.9	1.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	7.3	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.3	0.0	1.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	310.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0
ATP6V1G3	"ATP6G3, Vma10"	ENSG00000151418	"ATPase H+ transporting V1 subunit G3"	Q96LB4	1	198523222-198540945	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	27	"kidney: 58.0"	"Cell type enriched"	"Detected in some"	48	"Distal tubular cells: 444.1"	"Cancer enriched"	"Detected in single"	140	"renal cancer: 11.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 1.5;BJ hTERT+: 1.1;fHDF/TERT166: 4.4;hTERT-RPE1: 1.8;U-2197: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA028701	Enhanced					NA	NA					"HPA028701: AB_10611681"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	58.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.8	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.5	1.1	0.8	0.3	0.0	0.0	0.0	0.2	4.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.2	0.0	0.0	0.0	0.0	444.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2
CACNG5		ENSG00000075429	"Calcium voltage-gated channel auxiliary subunit gamma 5"	Q9UF02	17	66835117-66894751	"FDA approved drug targets, Predicted membrane proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	27	"brain: 12.5;retina: 15.9"	"Cell type enriched"	"Detected in some"	14	"Oligodendrocyte precursor cells: 74.9"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in all"		"olfactory bulb: 124.3"	"Low region specificity"	"Detected in many"			HPA050115	Uncertain					NA	NA					"HPA050115: AB_2681022"					"unprognostic (1.85e-3)"					"unprognostic (3.84e-2)"	"unprognostic (1.44e-1)"		"unprognostic (2.46e-6)"	"unprognostic (4.52e-2)"	"unprognostic (1.29e-1)"			0.0	0.0	4.6	0.0	3.1	0.1	0.0	1.0	5.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	3.3	0.1	0.0	0.0	0.4	3.3	6.4	2.4	0.0	0.1	0.0	0.1	0.0	1.9	0.0	0.0	15.9	0.0	0.0	0.1	0.1	0.0	0.0	3.7	0.2	0.0	0.1	12.5	0.1	0.0	0.0	0.3	0.0	0.0	3.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	3.1	1.0	5.3	1.9	3.3	3.3	6.4	2.4	1.9	3.7	12.5	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FETUB		ENSG00000090512	"Fetuin B"	Q9UGM5	3	186635969-186653141	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Fertilization	"Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	27	"liver: 236.5"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 47.2"	"Cancer enriched"	"Detected in some"	12	"liver cancer: 44.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035132, HPA035133"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA	47500000000	3600000000	Vesicles		"HPA035132: AB_10601650, HPA035133: "		"unprognostic (9.01e-2)"		"unprognostic (1.95e-1)"	"unprognostic (4.62e-1)"	"unprognostic (8.74e-2)"	"unprognostic (6.28e-3)"	"unprognostic (1.24e-2)"	"unprognostic (7.55e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.73e-2)"			"unprognostic (9.18e-2)"	"unprognostic (1.79e-1)"	"unprognostic (8.39e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.7	0.0	0.1	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.4	236.5	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.8	0.0	0.1	2.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	5.9	0.0	2.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	3.9	0.0	5.3	0.2	0.2	0.1	0.0	2.7	0.2	0.2	0.0	0.0	0.0	1.4	0.0	0.0	0.7	47.2	0.0	0.0	0.0	0.2	0.0	2.9	0.0	5.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0
GOLGA6C		ENSG00000167195	"Golgin A6 family member C"	A6NDK9	15	75258599-75270199	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	27	"testis: 10.0"	"Cell type enriched"	"Detected in some"	6	"Early spermatids: 9.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044978, HPA050087, HPA072134"	Supported		Approved	Nucleoplasm,Vesicles,Centrosome		NA	NA			Vesicles	"Nucleoplasm, Centrosome"	"HPA044978: AB_2679165, HPA050087: AB_2681010, HPA072134: "															"unprognostic (6.53e-3)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
GOT1L1	MGC33309	ENSG00000169154	"Glutamic-oxaloacetic transaminase 1 like 1"	Q8NHS2	8	37934281-37940124	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Aminotransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	27	"testis: 14.2"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 137.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA028778	Uncertain					NA	NA					"HPA028778: AB_10602138"														"unprognostic (6.93e-3)"	"unprognostic (5.46e-1)"			0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	137.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	24.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MYBPHL		ENSG00000221986	"Myosin binding protein H like"	A2RUH7	1	109292365-109307011	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	27	"heart muscle: 86.1"	"Cell type enriched"	"Detected in some"	6	"Cardiomyocytes: 156.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 2.5;RH-30: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA077633			Approved	Vesicles		NA	NA			Vesicles		"HPA077633: "	"unprognostic (6.07e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.53e-2)"	"unprognostic (5.89e-1)"	"unprognostic (5.22e-3)"	"unprognostic (4.10e-1)"	"unprognostic (7.05e-9)"	"unprognostic (6.01e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.64e-1)"	0.0	0.1	0.7	0.0	1.4	0.0	0.0	0.7	3.1	0.0	0.1	0.0	0.0	0.0	0.4	0.6	2.3	0.0	86.1	2.3	0.9	0.0	0.0	1.2	0.0	1.0	1.0	1.0	0.0	0.0	0.0	3.0	0.0	1.0	0.0	0.0	2.0	0.0	0.0	0.6	0.0	0.1	0.0	0.7	0.0	0.5	0.5	0.9	0.0	0.0	0.6	0.0	0.1	0.0	2.8	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.4	0.7	3.1	2.3	0.9	1.0	1.0	1.0	1.0	0.7	0.9	2.8	0.0	0.0	5.1	0.3	0.0	0.0	0.1	0.7	0.0	1.8	0.1	0.1	156.7	0.0	1.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.1	0.0	0.0	3.1	0.0	0.0	11.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.5	2.2	0.1	0.0	0.7	0.0	0.0	0.0	0.1	0.8	11.1	0.0	25.0	1.6	0.3	0.6	0.0	0.1	0.0	0.1	0.1	0.0	0.4
PDE6C	"ACHM5, COD4, PDEA2"	ENSG00000095464	"Phosphodiesterase 6C"	P51160	10	93612537-93666010	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	27	"retina: 23.3"	"Cell type enriched"	"Detected in some"	13	"Cone photoreceptor cells: 56.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (1.39e-3)"	"unprognostic (7.41e-3)"	"unprognostic (2.61e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.17e-2)"	"unprognostic (5.23e-3)"	"unprognostic (2.46e-3)"	"unprognostic (2.81e-3)"	"unprognostic (9.68e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.96e-3)"	"unprognostic (2.19e-7)"	"unprognostic (1.19e-1)"	"unprognostic (6.61e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.80e-3)"	0.1	0.1	0.1	0.0	0.2	0.2	0.1	0.8	0.3	0.3	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.0	0.2	0.0	0.3	0.2	0.0	23.3	0.1	0.0	0.5	0.5	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.5	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.8	0.3	0.2	0.1	0.1	0.1	0.0	0.3	0.0	0.1	0.5	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	56.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.0	0.0	0.7	0.0	0.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0
TRAT1	"HSPC062, TCRIM, TRIM"	ENSG00000163519	"T cell receptor associated transmembrane adaptor 1"	Q6PIZ9	3	108822770-108855005	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	27	"lymphoid tissue: 80.6"	"Cell type enriched"	"Detected in some"	10	"T-cells: 129.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"basophil: 395.1"	"Group enriched"	"Detected in many"	155	"granulocytes: 395.1;T-cells: 313.1"	"Group enriched"	"Detected in some"	25	"JURKAT: 29.9;MOLT-4: 76.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA002356, CAB026130, HPA072760"	Enhanced		Enhanced	"Plasma membrane,Mitotic spindle,Centriolar satellite"		Yes	NA			"Plasma membrane"	"Mitotic spindle, Centriolar satellite"	"CAB026130: , HPA002356: AB_1080375, HPA072760: "	"unprognostic (1.54e-4)"	"unprognostic (1.41e-3)"	"unprognostic (6.82e-2)"	"unprognostic (4.95e-3)"	"unprognostic (2.84e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.87e-3)"	"unprognostic (2.02e-2)"	"unprognostic (7.21e-3)"	"unprognostic (8.96e-3)"	"unprognostic (8.03e-2)"	"unprognostic (4.32e-1)"	"unprognostic (2.86e-5)"	"unprognostic (3.12e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.90e-4)"	"unprognostic (4.36e-2)"	0.8	0.6	0.0	11.1	0.0	2.8	0.8	0.0	0.1	0.4	0.2	1.3	1.4	0.4	0.4	1.0	0.3	2.5	0.4	0.1	0.1	0.3	1.3	2.1	24.1	0.1	0.1	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.8	1.5	0.0	0.6	0.1	0.1	0.6	3.0	0.5	0.0	8.6	2.4	0.4	0.1	80.6	0.4	0.4	12.5	2.9	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.9	0.0	2.1	0.0	0.0	76.0	0.0	0.0	0.0	0.0	0.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	395.1	0.6	0.2	57.0	0.2	116.4	1.0	229.5	119.6	0.3	0.4	313.1	77.7	3.5	2.2	0.7	0.8	111.1	139.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.5	0.0	3.2	0.0	3.3	8.4	0.1	0.0	0.0	0.0	0.4	0.3	0.3	0.0	0.0	1.8	0.0	0.0	8.9	0.1	0.0	0.0	2.3	0.1	0.1	1.1	0.0	2.7	0.1	0.0	0.0	1.7	7.7	0.1	2.5	0.0	1.8	0.6	0.2	0.0	0.2	0.0	0.0	1.0	12.2	2.2	0.0	1.8	3.6	0.0	3.2	0.0	3.1	0.0	0.2	0.0	0.0	0.0	5.1	0.2	0.0	0.5	0.0	0.0	0.0	0.3	0.8	0.0	0.1	0.0	8.0	0.1	129.3	0.6	0.0	0.2
TRBV20-1	"TCRBV20S1, TCRBV2S1, TRBV201"	ENSG00000211747	"T cell receptor beta variable 20-1"	A0A075B6N2	7	142626649-142627399	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	27	"lymphoid tissue: 162.9"	"Cell type enriched"	"Detected in some"	15	"T-cells: 26.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 351.7"	"Lineage enriched"	"Detected in many"	115	"T-cells: 351.7"	"Group enriched"	"Detected in some"	8	"Karpas-707: 2.4;MOLT-4: 5.0;REH: 2.5;RH-30: 3.0"	"Not detected"	"Not detected"													NA	NA						"unprognostic (1.25e-3)"	"prognostic favorable (4.40e-5)"	"unprognostic (1.39e-2)"	"prognostic favorable (8.49e-4)"	"unprognostic (8.83e-2)"	"unprognostic (2.69e-3)"	"unprognostic (4.34e-2)"	"unprognostic (8.75e-3)"	"prognostic favorable (1.37e-4)"	"unprognostic (1.30e-2)"	"unprognostic (8.86e-2)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (1.11e-5)"	"unprognostic (1.45e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.41e-2)"	1.7	0.2	0.1	13.8	0.0	5.1	0.6	0.1	0.2	0.6	0.0	2.4	0.5	0.3	0.0	0.7	0.7	3.3	0.1	0.1	0.1	0.5	0.6	2.7	53.7	0.2	0.2	0.1	0.5	0.2	0.0	0.8	0.0	0.3	0.9	3.1	0.0	0.5	0.2	0.1	1.9	6.0	0.9	0.1	7.3	3.7	0.3	0.2	162.9	1.0	0.0	6.0	2.3	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	5.0	0.2	0.0	0.0	0.0	2.5	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.0	0.6	0.2	4.6	0.3	231.9	1.1	192.7	76.4	0.6	0.6	144.0	58.9	2.3	0.3	0.8	0.4	351.7	50.2	0.1	0.0	0.1	0.2	0.1	0.1	0.2	0.2	0.1	0.3	0.1	0.2	0.5	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.5	0.0	0.0	0.0
TRBV4-1	"BV07S1J2.7, TCRBV4S1, TCRBV7S1A1N2T, TRBV41"	ENSG00000211710	"T cell receptor beta variable 4-1"	A0A577	7	142313184-142313666	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	27	"lymphoid tissue: 116.0"	"Cell type enriched"	"Detected in some"	7	"T-cells: 12.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 176.7"	"Lineage enriched"	"Detected in many"	89	"T-cells: 176.7"	"Cell line enriched"	"Detected in single"	8	"U-266/84: 1.5"															NA	NA						"unprognostic (1.58e-4)"	"unprognostic (3.14e-3)"	"unprognostic (1.49e-2)"	"unprognostic (5.74e-4)"	"unprognostic (1.88e-1)"	"unprognostic (6.43e-3)"	"unprognostic (5.89e-2)"	"unprognostic (2.96e-2)"	"unprognostic (6.43e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.79e-2)"	"unprognostic (6.71e-5)"	"unprognostic (1.76e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.67e-2)"	"unprognostic (8.99e-2)"	0.5	0.0	0.0	7.2	0.1	2.6	0.7	0.0	0.2	0.8	0.0	0.9	0.1	0.2	0.7	1.1	0.9	0.9	0.0	0.0	0.0	0.4	0.4	0.7	15.4	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.2	0.0	0.5	0.8	0.0	0.2	0.0	0.1	0.2	4.3	0.4	0.1	4.1	2.3	0.1	0.0	116.0	0.3	0.0	10.1	2.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	1.0	0.2	0.1	2.5	0.1	40.2	0.1	69.8	167.3	0.0	0.2	152.1	152.7	1.9	0.8	0.4	0.8	176.7	43.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.0
AADACL2	MGC72001	ENSG00000197953	"Arylacetamide deacetylase like 2"	Q6P093	3	151733916-151761339	"Predicted secreted proteins"		Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	26	"skin 1: 35.6"	"Cell type enriched"	"Detected in some"	7	"Suprabasal keratinocytes: 30.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA							"unprognostic (2.20e-2)"				"unprognostic (3.10e-3)"		"unprognostic (2.63e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.22e-1)"				"unprognostic (3.00e-1)"			"unprognostic (2.91e-4)"	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	35.6	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	30.7	0.1	0.1	0.0	0.0	0.0
ACTL8	CT57	ENSG00000117148	"Actin like 8"	Q9H568	1	17755333-17827063	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	26	"testis: 7.1"	"Cell type enriched"	"Detected in some"	6	"Spermatogonia: 50.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"U-266/84: 245.3"					"Not detected"	"Not detected"			HPA027176			Approved	Cytosol		NA	NA			Cytosol		"HPA027176: AB_1844553"	"unprognostic (1.79e-3)"	"unprognostic (3.18e-2)"	"unprognostic (4.62e-2)"	"prognostic unfavorable (1.62e-6)"	"unprognostic (6.18e-2)"	"prognostic unfavorable (7.02e-4)"	"unprognostic (1.63e-3)"	"unprognostic (2.33e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.69e-1)"	"unprognostic (4.89e-1)"		"unprognostic (1.43e-1)"	"unprognostic (5.49e-2)"		"unprognostic (4.68e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	1.4	0.0	0.1	0.2	0.0	0.2	0.1	0.0	0.2	0.0	0.2	0.0	11.0	0.3	0.2	0.6	0.0	1.5	0.0	0.0	0.1	1.4	0.0	0.5	1.4	0.0	3.3	1.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	2.5	13.3	0.0	2.4	0.0	0.0	9.2	5.9	0.1	0.0	0.0	27.5	0.0	0.0	0.4	0.0	0.0	5.2	0.5	0.0	0.5	0.4	0.0	0.0	0.1	1.9	0.2	0.1	245.3	0.1	4.9	2.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	7.8	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	1.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	50.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0
HBM	"HBAP2, HBK"	ENSG00000206177	"Hemoglobin subunit mu"	Q6B0K9	16	153892-166764	"Predicted intracellular proteins"	"Oxygen transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	26	"bone marrow: 463.6"	"Cell type enriched"	"Detected in some"	504	"Erythroid cells: 8988.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"									NA	NA		980000								"unprognostic (1.30e-1)"										"unprognostic (7.59e-2)"			0.7	0.1	0.1	0.0	0.4	463.6	0.3	0.0	1.3	0.1	1.5	0.1	0.0	0.0	0.0	0.2	0.1	0.0	1.3	0.2	0.0	1.8	3.1	3.9	0.0	0.0	0.3	0.2	0.2	0.1	0.0	1.2	6.4	0.3	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	17.6	0.1	0.2	0.0	0.2	0.7	0.9	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	6.9	0.1	0.4	0.0	1.3	0.2	0.0	0.0	0.3	0.2	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	8988.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	3.5	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.6	0.0	3.3	17.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	2.1	0.0	0.1	0.0	1.9	0.0	0.0	0.0
HSD17B6	"HSE, RODH, SDR9C6"	ENSG00000025423	"Hydroxysteroid 17-beta dehydrogenase 6"	O14756	12	56752161-56787790	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	26	"liver: 1819.2"	"Cell type enriched"	"Detected in many"	11	"Hepatocytes: 1969.3"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 170.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 13.4;U-266/84: 18.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA059141	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA059141: AB_2683922"	"unprognostic (7.70e-2)"	"unprognostic (8.76e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.79e-2)"	"prognostic favorable (6.32e-4)"	"unprognostic (1.06e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.74e-2)"	"unprognostic (2.50e-10)"	"unprognostic (1.26e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.05e-1)"	5.4	2.5	12.6	7.0	14.0	0.5	0.7	12.9	19.1	25.7	9.2	16.0	3.3	21.0	1.6	10.0	6.6	9.1	0.5	11.7	12.0	2.5	1819.2	63.7	0.8	12.2	13.5	12.0	6.0	0.6	0.5	0.7	5.4	14.0	51.7	7.6	0.8	0.4	69.8	0.4	1.0	4.8	13.2	11.5	47.9	5.8	23.5	13.2	0.9	31.7	0.5	0.9	37.0	14.7	12.2	0.3	0.8	1.9	0.4	1.9	1.4	2.3	4.1	3.5	1.9	1.9	0.4	0.4	12.0	1.7	0.5	0.5	0.3	6.1	1.1	1.1	7.7	2.2	3.7	1.2	0.6	1.2	1.9	6.0	1.0	0.4	1.2	0.6	0.6	0.0	10.3	1.1	13.4	0.9	2.4	5.6	1.3	7.5	0.7	0.7	7.4	0.8	2.9	0.2	1.4	11.0	2.3	2.0	3.6	0.9	0.7	0.6	1.5	0.3	0.9	0.8	4.0	1.0	11.7	18.0	7.8	1.3	6.9	0.6	0.0	0.0	0.0	1.0	0.2	1.2	0.7	0.8	0.8	0.2	0.3	1.1	0.7	0.0	0.0	0.5	0.7	1.0	0.3	12.6	14.0	12.9	19.1	11.7	12.0	12.2	13.5	12.0	14.0	11.5	13.2	12.2	0.4	173.1	130.6	21.2	6.1	1.3	3.1	0.6	0.6	0.4	0.7	0.6	0.2	27.1	9.3	0.0	0.0	1.4	0.4	0.0	0.0	0.1	4.6	0.7	3.5	1.3	0.0	29.5	1.4	0.0	2.6	5.0	0.0	0.1	0.0	1.6	26.0	1969.3	0.4	0.0	2.1	0.4	0.0	40.2	0.3	4.5	12.5	0.5	0.0	1.0	1.0	1.3	0.0	3.0	5.5	0.1	0.0	1.5	0.8	16.1	0.0	0.3	1.5	0.6	13.1	0.6	3.5	16.4	11.4	1.2	1.6	0.4	2.2	36.0	0.7	1.1
LDB3	"CMD1C, KIAA0613, PDLIM6, ZASP"	ENSG00000122367	"LIM domain binding 3"	O75112	10	86668507-86736072	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cardiomyopathy, Disease variant, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	26	"heart muscle: 1079.8;skeletal muscle: 2973.6;tongue: 1825.5"	"Cell type enriched"	"Detected in many"	7	"Cardiomyocytes: 1825.0"	"Group enriched"	"Detected in some"	4	"head and neck cancer: 1.7;melanoma: 2.5;prostate cancer: 3.6;stomach cancer: 1.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 3.0;hTERT-RPE1: 3.3;SCLC-21H: 4.9;SK-MEL-30: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048955	Enhanced		Supported	"Nucleoplasm,Focal adhesion sites,Cytosol"		NA	NA		750000	"Focal adhesion sites, Cytosol"	Nucleoplasm	"HPA048955: AB_2680568"	"unprognostic (1.60e-1)"	"unprognostic (9.01e-2)"	"unprognostic (4.87e-2)"	"unprognostic (6.92e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.79e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.54e-3)"	"unprognostic (3.55e-2)"	"unprognostic (4.72e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.16e-1)"	9.2	1.4	12.9	2.8	35.5	0.4	6.6	26.8	32.4	9.6	1.7	26.0	2.4	15.2	5.0	55.0	17.4	3.1	1079.8	12.5	23.2	2.0	0.8	5.2	0.5	52.7	36.0	6.5	6.4	1.3	0.5	2.4	2.8	52.5	38.5	5.4	0.7	21.0	25.4	2973.6	4.0	8.9	23.9	32.2	0.6	9.1	4.8	30.8	0.7	5.2	1825.5	0.3	7.0	10.3	76.2	0.1	0.1	0.2	1.7	0.2	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.2	0.1	0.3	0.0	0.3	0.2	0.0	0.0	0.0	0.5	0.4	0.4	0.7	0.0	0.0	0.0	0.9	3.0	0.2	0.0	0.0	3.3	0.0	0.3	0.1	1.0	0.0	0.8	0.2	0.1	0.2	0.2	0.2	0.0	1.1	0.0	0.0	0.6	4.9	0.9	0.2	0.1	2.4	0.7	0.2	0.1	0.0	0.1	0.2	0.2	0.0	0.1	0.3	0.2	0.4	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.9	35.5	26.8	32.4	12.5	23.2	52.7	36.0	6.5	52.5	32.2	30.8	76.2	1.5	0.0	0.0	1.0	0.0	1.0	0.5	0.2	0.0	1.5	0.2	0.3	1825.0	0.0	0.2	1.8	0.0	0.1	0.0	0.0	0.0	0.0	23.4	0.1	0.4	15.5	0.0	0.0	4.5	1.1	0.0	31.5	0.0	0.2	0.0	0.9	0.0	0.0	0.1	0.0	2.6	0.0	4.1	0.0	1.2	19.6	11.1	0.5	1.8	1.9	0.0	0.7	0.0	1.5	245.1	0.1	0.0	6.8	0.0	0.3	0.0	0.1	0.1	4.1	39.5	48.0	54.9	1.0	1.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2
MYL3	"CMH8, MLC1SB, MLC1V, VLC1"	ENSG00000160808	"Myosin light chain 3"	P08590	3	46835111-46882172	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	26	"heart muscle: 4888.7;skeletal muscle: 5183.9;tongue: 2092.6"	"Cell type enriched"	"Detected in some"	53	"Cardiomyocytes: 3626.2"	"Group enriched"	"Detected in many"	4	"head and neck cancer: 3.0;prostate cancer: 3.4;renal cancer: 8.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 8.6;HSkMC: 8.7;RPTEC TERT1: 34.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA016564, CAB018662, HPA046859, HPA063034"	Enhanced		Approved	Nucleoli,Mitochondria		NA	NA		7300000	"Nucleoli, Mitochondria"		"CAB018662: AB_627952, HPA016564: AB_1854244, HPA046859: AB_2679842, HPA063034: AB_2684927"	"unprognostic (3.11e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.44e-2)"	"unprognostic (9.67e-3)"	"unprognostic (3.37e-2)"	"unprognostic (4.72e-3)"	"unprognostic (3.63e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.88e-2)"	"prognostic favorable (1.22e-8)"	"unprognostic (1.16e-3)"	"unprognostic (9.45e-3)"	"unprognostic (7.18e-5)"	"unprognostic (2.53e-3)"	5.8	4.2	9.8	1.0	9.6	1.5	9.0	10.2	14.9	6.7	7.2	2.3	1.6	3.4	3.4	158.4	4.2	3.6	4888.7	9.8	11.1	49.4	4.1	5.8	3.3	13.9	11.0	8.7	5.2	2.7	1.3	1.7	4.7	11.2	25.3	0.8	1.9	19.8	1.5	5183.9	3.5	2.3	2.0	11.9	8.0	2.1	2.3	11.9	0.7	2.4	2092.6	0.6	2.4	4.8	12.1	0.5	0.7	0.4	0.3	4.4	1.5	3.6	0.7	0.4	0.4	0.6	8.6	0.8	1.6	1.4	0.1	0.2	0.5	0.4	0.1	0.7	0.3	0.1	0.8	2.6	0.3	0.7	0.9	0.8	8.7	0.2	0.3	0.1	0.2	0.1	0.5	0.4	1.2	0.2	1.2	0.3	0.5	1.0	0.4	0.4	0.9	0.3	0.1	34.2	1.3	0.6	0.4	0.3	0.7	0.1	0.7	0.3	0.5	0.2	1.0	0.8	0.6	0.3	0.5	0.4	0.7	0.3	0.8	0.8	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.4	0.1	0.1	0.3	0.0	0.1	0.4	0.0	0.0	9.8	9.6	10.2	14.9	9.8	11.1	13.9	11.0	8.7	11.2	11.9	11.9	12.1	0.7	0.0	0.0	1.0	0.0	0.8	0.2	0.0	0.0	0.2	2.3	0.1	3626.2	0.0	0.0	1.8	0.0	0.4	0.0	0.0	54.8	0.0	2.4	0.1	2.2	32.8	0.0	0.0	0.1	0.0	16.4	23.7	0.0	0.0	0.0	0.0	1.1	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.6	12.8	1.2	0.7	0.0	0.0	0.0	2.8	0.0	0.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	68.1	0.0	0.4	6.6	27.9	20.4	0.2	0.5	0.0	0.4	0.8	0.4	0.1	0.0	0.0
MYOZ3	"CS-3, CS3, FATZ-3, FRP3"	ENSG00000164591	"Myozenin 3"	Q8TDC0	5	150660882-150679368	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	26	"skeletal muscle: 236.4;tongue: 200.2"	"Cell type enriched"	"Detected in some"	6	"Peritubular cells: 44.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 5.3;NTERA-2: 9.2;REH: 14.8;SuSa: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039166	Enhanced					NA	NA					"HPA039166: AB_10671871"	"unprognostic (2.74e-1)"	"unprognostic (2.46e-3)"	"unprognostic (9.57e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.59e-2)"	"unprognostic (8.77e-2)"	"unprognostic (9.19e-4)"	"unprognostic (6.99e-2)"	"unprognostic (5.19e-2)"	"unprognostic (7.21e-3)"	"unprognostic (7.31e-9)"	"unprognostic (2.19e-2)"	"unprognostic (2.79e-1)"	"unprognostic (8.46e-2)"	"unprognostic (4.20e-2)"	0.4	0.5	1.8	0.1	2.3	1.1	0.6	1.9	1.0	1.7	0.8	0.3	0.3	1.5	1.4	5.4	0.8	1.5	5.4	1.6	2.5	0.6	0.1	0.8	0.1	8.4	2.4	0.4	0.9	0.2	0.0	1.4	0.1	2.9	4.2	0.2	0.2	3.3	1.0	236.4	0.1	0.7	0.8	5.4	0.2	0.5	3.8	3.0	0.4	0.7	200.2	0.0	0.7	0.5	3.1	0.0	0.0	2.3	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	5.3	0.0	0.2	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.5	0.7	0.0	0.0	0.1	0.0	0.7	1.4	9.2	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	2.6	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.8	2.3	1.9	1.0	1.6	2.5	8.4	2.4	0.4	2.9	5.4	3.0	3.1	3.5	0.0	0.0	1.0	0.1	0.4	0.4	0.5	0.6	1.1	1.7	1.5	2.9	0.0	0.1	0.0	0.0	0.6	0.9	0.3	0.0	0.0	0.3	0.5	0.7	2.5	0.0	0.0	0.9	0.2	0.3	1.8	0.0	1.4	0.0	4.3	2.9	0.0	0.2	0.0	3.0	0.3	2.0	0.3	1.1	1.2	3.1	0.7	0.0	1.0	0.1	0.5	1.0	0.0	0.2	0.0	0.1	44.4	0.0	0.4	0.5	0.0	0.0	0.0	0.0	7.0	0.8	0.4	1.5	0.0	0.4	0.7	0.5	0.4	0.5	0.1
POTEC	"A26B2, CT104.6, DKFZp686J0529, POTE-18, POTE18"	ENSG00000183206	"POTE ankyrin domain family member C"	B2RU33	18	14507339-14543585	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	26	"testis: 2.5"	"Cell type enriched"	"Detected in some"	8	"Spermatocytes: 40.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA						"unprognostic (1.63e-1)"									"unprognostic (9.88e-2)"				"unprognostic (8.05e-2)"	"unprognostic (1.64e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	2.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	40.1	4.9	0.0	0.0	0.3	0.0	0.0	0.1	0.1
SFTPD	"COLEC7, SFTP4, SP-D"	ENSG00000133661	"Surfactant protein D"	P35247	10	79937467-79982614	"Predicted secreted proteins"	"Gaseous exchange, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	26	"lung: 512.4"	"Cell type enriched"	"Detected in many"	4	"Alveolar cells type 2: 1863.1"	"Cancer enriched"	"Detected in many"	16	"lung cancer: 106.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"intermediate monocyte: 10.0;non-classical monocyte: 36.3"	"Lineage enriched"	"Detected in many"	18	"monocytes: 36.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.1;HaCaT: 1.0;hTCEpi: 3.2;MCF7: 1.3;U-2197: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB004578, HPA044582, HPA056768"	Enhanced				"Secreted in other tissues"	NA	NA		8200000			"CAB004578: AB_628276, HPA044582: AB_2679004, HPA056768: AB_2683232"	"unprognostic (3.81e-5)"	"unprognostic (7.00e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.66e-3)"	"unprognostic (6.83e-2)"	"unprognostic (3.85e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.29e-2)"	"unprognostic (2.57e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.86e-2)"	1.1	1.8	2.2	0.4	2.2	19.9	0.9	1.6	2.5	1.0	1.9	0.7	0.1	0.6	1.3	1.8	1.8	0.9	1.1	2.1	2.5	1.3	1.1	512.4	0.0	1.7	2.0	1.9	1.1	4.3	2.0	3.4	0.7	1.7	1.5	0.1	0.3	1.1	1.2	0.2	5.0	0.4	0.4	1.2	0.6	1.2	1.4	2.0	0.5	5.9	0.2	0.2	0.3	2.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	1.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.8	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.1	0.3	0.3	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	10.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	36.3	0.0	0.0	0.9	2.2	2.2	1.6	2.5	2.1	2.5	1.7	2.0	1.9	1.7	1.2	2.0	1.6	0.3	439.1	1863.1	1.0	0.2	0.9	1.3	7.8	1.2	1.7	1.4	1.8	0.7	0.0	38.0	5.5	0.0	0.1	0.0	0.0	1.9	1.4	7.4	0.6	0.1	1.5	0.0	0.0	4.9	5.8	3.0	4.4	0.0	0.9	20.2	1.6	0.4	0.7	0.1	0.0	3.5	0.0	0.0	0.0	2.7	12.2	1.2	2.9	0.0	1.9	0.6	2.8	0.0	0.0	0.6	2.0	0.1	0.4	0.0	0.8	0.0	0.2	9.6	0.5	0.0	1.8	0.4	0.4	0.3	0.6	1.8	0.1	4.3	0.1	0.1	0.6
TRBV5-5	"TCRBV5S3A2T, TCRBV5S5, TRBV55"	ENSG00000211725	"T cell receptor beta variable 5-5"	A0A597	7	142482548-142483019	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	26	"lymphoid tissue: 18.7"	"Cell type enriched"	"Detected in single"	23	"T-cells: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	25	"memory CD4 T-cell: 36.7;memory CD8 T-cell: 28.0;naive CD4 T-cell: 38.6;naive CD8 T-cell: 29.0;T-reg: 41.9"	"Lineage enriched"	"Detected in many"	30	"T-cells: 41.9"	"Not detected"	"Not detected"																	NA	NA						"unprognostic (4.96e-5)"	"unprognostic (4.74e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.98e-4)"		"unprognostic (2.84e-3)"	"unprognostic (9.58e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.27e-4)"	"unprognostic (7.42e-2)"	"unprognostic (8.32e-3)"	"unprognostic (9.06e-2)"		0.1	0.0	0.2	1.8	0.1	0.7	0.0	0.0	0.2	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.3	0.0	0.2	0.1	0.0	0.0	0.1	2.3	0.2	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.8	0.5	0.0	0.7	18.7	0.1	0.0	4.4	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	1.3	0.1	0.0	0.6	0.0	0.8	0.0	36.7	28.0	0.1	0.1	38.6	29.0	0.8	0.0	0.1	0.0	41.9	11.3	0.2	0.1	0.0	0.2	0.2	0.1	0.2	0.1	0.1	0.2	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0
TSPAN16	"TM-8, TM4-B, TM4SF16"	ENSG00000130167	"Tetraspanin 16"	Q9UKR8	19	11296139-11326996	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	26	"testis: 135.7"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 4868.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"basophil: 16.6;eosinophil: 19.1;neutrophil: 37.4"	"Lineage enriched"	"Detected in many"	17	"granulocytes: 37.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA076551	Enhanced		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA076551: "	"unprognostic (1.06e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.06e-3)"		"unprognostic (1.37e-1)"	"unprognostic (2.21e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.90e-1)"	"unprognostic (8.69e-4)"	"unprognostic (8.81e-8)"	"unprognostic (1.98e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.95e-3)"	"unprognostic (2.67e-1)"	0.0	0.0	0.3	0.2	0.1	5.2	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	135.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	16.6	2.2	19.1	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	37.4	0.0	0.4	0.0	0.0	0.3	0.3	0.1	0.2	0.4	0.4	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	892.5	0.0	0.1	1.6	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.2	4868.3	15.5	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.4	20.9	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT1A1	"GNT1, UGT1, UGT1A"	ENSG00000241635	"UDP glucuronosyltransferase family 1 member A1"	P22309	2	233760270-233773300	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	26	"intestine: 203.0;liver: 325.1"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 105.0"	"Cancer enriched"	"Detected in some"	19	"liver cancer: 16.4"	"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.4"	"Cell line enhanced"	"Detected in some"		"HaCaT: 14.0;OE19: 64.5;RT4: 34.7"	"Not detected"	"Not detected"													NA	NA								"unprognostic (7.28e-2)"			"unprognostic (2.49e-2)"	"unprognostic (3.60e-1)"	"unprognostic (5.69e-2)"			"unprognostic (4.17e-3)"	"unprognostic (6.31e-3)"	"unprognostic (1.94e-5)"	"unprognostic (2.78e-3)"			"unprognostic (2.99e-4)"	0.1	0.1	0.5	0.2	0.5	0.5	0.2	1.5	0.7	0.1	0.1	3.0	203.0	0.2	0.4	3.5	0.1	1.0	0.2	0.5	0.4	4.1	325.1	0.2	0.3	0.3	0.1	0.3	0.2	0.1	0.1	0.0	0.1	0.8	0.2	2.5	0.9	0.5	0.3	0.1	1.8	79.8	0.1	0.0	0.2	2.4	0.6	0.3	0.1	0.2	0.1	0.3	10.1	0.9	0.6	0.3	1.1	0.2	0.2	0.1	0.1	0.6	0.0	0.0	0.0	0.1	5.4	0.3	0.2	2.5	0.1	0.1	14.0	0.0	0.2	0.0	0.2	0.1	0.1	0.6	1.6	0.0	0.5	0.2	0.2	0.6	0.0	0.0	0.1	0.0	0.3	0.2	0.6	0.0	0.8	0.1	0.3	0.5	64.5	6.5	0.1	0.1	0.6	0.0	34.7	0.2	0.4	2.6	0.4	0.0	0.2	0.2	0.0	0.1	0.2	0.1	0.3	0.0	0.2	0.2	0.1	0.7	0.4	0.2	0.9	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.1	1.4	0.3	0.1	0.1	0.1	0.0	0.5	0.5	1.5	0.7	0.5	0.4	0.3	0.1	0.3	0.8	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.6	0.0	0.0	0.0	0.0	0.0	3.7	1.8	0.0	0.0	0.0	1.8	0.0	0.1	2.9	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.1	105.0	0.0	0.0	0.0	0.4	0.0	2.4	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.6	0.0	0.1	6.9	14.6	2.2	1.5	0.0	0.0	0.4	0.1	0.2	0.1	1.5	0.0	0.0	0.1	0.0	0.7	7.3
APOBEC1	"APOBEC-1, BEDP, CDAR1, HEPR"	ENSG00000111701	"Apolipoprotein B mRNA editing enzyme catalytic subunit 1"	P41238	12	7649400-7665908	"Enzymes, Predicted intracellular proteins"	"mRNA processing"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	25	"intestine: 29.3"	"Cell type enriched"	"Detected in some"	5	"Proximal enterocytes: 153.8"	"Group enriched"	"Detected in some"	9	"colorectal cancer: 6.2;pancreatic cancer: 6.1;stomach cancer: 3.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	25	"CAPAN-2: 1.7;OE19: 4.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA								"unprognostic (2.35e-1)"					"unprognostic (3.80e-4)"			"unprognostic (7.96e-3)"			"unprognostic (1.79e-1)"	"unprognostic (4.38e-1)"			0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	29.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	26.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.3	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.2	28.2	0.0	0.0	0.0	153.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	4.9	0.0
APOC3		ENSG00000110245	"Apolipoprotein C3"	P02656	11	116829706-116833072	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism, Lipid transport, Transport"		"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	25	"liver: 27875.1"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 84691.9"	"Cancer enriched"	"Detected in many"	643	"liver cancer: 4021.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"CACO-2: 107.3;Hep G2: 296.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA065365, HPA073918"	Supported		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"	"Secreted to blood"	NA	NA	106000000000	45000000000	Nucleoplasm	"Nucleoli, Cell Junctions"	"HPA065365: AB_2732733, HPA073918: "							"prognostic favorable (3.77e-4)"				"unprognostic (2.33e-1)"		"prognostic unfavorable (6.87e-5)"	"unprognostic (1.60e-2)"	"unprognostic (5.21e-2)"			2.2	1.2	0.0	1.0	0.0	0.0	2.5	0.0	0.1	0.3	0.0	6.0	915.3	0.5	0.0	1.1	1.9	0.0	1.6	0.0	0.0	18.4	27875.1	1.4	0.9	0.0	0.0	0.0	0.8	2.4	0.0	0.8	0.9	0.0	0.6	0.0	0.0	0.6	0.0	0.6	1.0	1115.8	0.5	0.0	8.0	1.5	1.0	0.0	0.5	0.8	0.2	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.2	0.0	0.0	0.0	0.1	107.3	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	296.2	0.0	10.7	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.2	2.3	0.2	0.0	0.0	0.0	6.3	3.9	0.0	0.1	1.1	3.8	4.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.2	0.0	3.4	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	674.9	0.0	0.0	0.0	0.2	0.0	0.0	3.9	0.0	4.2	0.0	0.0	39.7	0.0	823.7	0.0	0.4	1.5	0.1	0.0	0.0	0.0	0.3	707.9	84691.9	1.1	0.0	0.0	264.5	0.0	1107.4	0.0	12.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	224.0	0.0	0.0	0.0	10473.3	121.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	39.8	0.0	135.5	0.0
EGFL6	MAEG	ENSG00000198759	"EGF like domain multiple 6"	Q8IUX8	X	13569601-13633575	"Predicted secreted proteins"	"Cell adhesion, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	25	"placenta: 650.6"	"Cell type enriched"	"Detected in many"	8	"Fibroblasts: 214.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BJ hTERT+: 4.3;NTERA-2: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA001838	Enhanced				"Secreted to extracellular matrix"	NA	NA					"HPA001838: AB_2666457"	"unprognostic (1.66e-1)"	"unprognostic (1.32e-2)"	"unprognostic (9.15e-3)"	"unprognostic (3.76e-3)"	"unprognostic (1.77e-2)"	"prognostic favorable (9.73e-4)"	"unprognostic (4.13e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.19e-3)"	"prognostic favorable (4.95e-4)"	"unprognostic (2.39e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.14e-9)"	"unprognostic (7.10e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.82e-3)"	13.6	0.0	0.4	0.6	0.5	0.0	3.3	0.1	0.2	0.8	0.1	0.2	0.5	1.8	0.0	4.4	2.3	1.1	0.3	0.2	1.0	0.7	0.0	25.8	0.3	0.7	1.0	0.2	0.3	1.2	0.6	2.6	650.6	0.3	1.1	0.3	2.3	0.4	0.1	0.0	0.5	0.4	0.5	1.1	0.3	1.3	0.3	0.6	0.2	0.3	1.7	1.6	10.8	1.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.1	0.2	0.2	1.0	0.7	1.0	0.2	0.3	1.1	0.6	0.4	1.3	0.0	2.0	0.0	0.0	1.0	1.2	22.0	1.2	6.3	0.1	0.5	0.4	0.0	11.9	0.0	0.0	12.4	0.0	0.5	0.0	0.0	0.3	4.2	5.6	6.0	0.0	0.0	0.3	0.0	9.8	214.7	0.0	3.7	0.0	0.0	0.0	0.0	17.3	0.0	2.0	0.1	4.1	0.0	0.7	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	12.4	1.0	0.0	0.0	23.9	0.1	1.1	14.9	0.4	26.4	0.9	4.9	0.1	3.7
GABRR1		ENSG00000146276	"Gamma-aminobutyric acid type A receptor subunit rho1"	P24046	6	89177504-89231278	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	25	"retina: 24.8"	"Cell type enriched"	"Detected in some"	12	"Bipolar cells: 63.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"NTERA-2: 1.2;OE19: 2.6;SuSa: 1.6"	"Region enhanced"	"Detected in single"		"midbrain: 1.3"											NA	NA						"unprognostic (5.75e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.90e-2)"	"unprognostic (5.78e-2)"	"unprognostic (4.90e-2)"		"unprognostic (8.32e-3)"	"unprognostic (2.52e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.62e-5)"	"unprognostic (1.18e-1)"	"unprognostic (9.90e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.29e-1)"	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	24.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.6	0.0	0.3	0.1	0.0	0.0	63.1	0.0	0.0	0.3	0.0	0.0	0.0	4.2	0.4	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.1	0.0	0.0	4.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.0	4.2	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.0	1.9	0.0	0.6	0.0	3.5	3.5	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	4.5	0.0	0.0	0.4	0.0	1.8	0.0	0.0	0.3	0.0	0.0	0.0	0.2
GABRR2		ENSG00000111886	"Gamma-aminobutyric acid type A receptor subunit rho2"	P28476	6	89254464-89315299	"Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	25	"retina: 31.7"	"Cell type enriched"	"Detected in some"	18	"Bipolar cells: 30.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.2;U-266/70: 5.1;U-266/84: 1.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (2.05e-2)"	"unprognostic (1.47e-4)"	"unprognostic (1.56e-1)"	"unprognostic (1.88e-4)"	"unprognostic (4.19e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.24e-2)"	"unprognostic (9.13e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.54e-6)"	"unprognostic (3.69e-2)"	"unprognostic (7.81e-2)"	"unprognostic (5.79e-2)"	"unprognostic (7.15e-3)"	0.5	0.3	0.6	1.2	0.5	0.7	0.2	0.8	0.7	0.3	0.4	0.3	0.7	0.5	0.4	0.1	0.1	0.3	0.2	0.5	0.4	0.4	0.1	0.3	0.8	0.6	0.6	0.4	0.2	0.1	0.0	0.0	0.3	0.6	0.3	0.4	31.7	0.3	0.2	0.8	0.4	0.7	0.3	0.3	0.8	0.3	0.2	0.6	1.2	0.3	0.2	0.6	0.2	0.0	0.8	0.0	0.0	0.2	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.5	0.5	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.6	0.1	0.2	0.0	2.2	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.3	0.1	0.8	0.1	0.0	0.2	0.1	0.0	0.0	0.3	0.6	0.0	0.7	0.1	0.2	0.1	0.0	0.3	5.1	1.4	0.2	0.2	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.6	0.5	0.8	0.7	0.5	0.4	0.6	0.6	0.4	0.6	0.3	0.6	0.8	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	30.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.7	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.0	0.0	0.3	0.0	1.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KLKB1	KLK3	ENSG00000164344	"Kallikrein B1"	P03952	4	186208979-186258471	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis, Inflammatory response"	"Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	25	"liver: 331.1"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 280.5"	"Cancer enriched"	"Detected in some"	17	"liver cancer: 27.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 3.1;SCLC-21H: 2.1;U-937: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Secreted to blood"	NA	NA	28900000000	5300000000				"unprognostic (4.80e-2)"	"unprognostic (4.53e-3)"	"unprognostic (4.36e-2)"	"unprognostic (4.17e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.83e-1)"	"unprognostic (8.14e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.45e-2)"	"unprognostic (6.01e-2)"	"unprognostic (7.30e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.59e-2)"	0.5	1.8	6.7	0.3	6.8	0.0	0.6	6.4	7.6	1.3	8.8	1.9	2.9	0.6	1.0	0.4	1.3	2.6	2.5	6.7	6.4	5.7	331.1	1.0	0.7	7.2	6.7	6.5	0.7	4.8	1.0	3.6	0.2	7.2	1.7	1.4	13.3	0.7	0.6	2.4	0.2	2.6	0.7	6.7	2.4	0.8	2.0	6.4	0.4	1.9	1.8	0.4	1.5	0.9	6.6	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.1	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	6.8	6.4	7.6	6.7	6.4	7.2	6.7	6.5	7.2	6.7	6.4	6.6	0.1	0.0	0.0	48.3	0.7	0.0	0.1	0.2	0.6	5.1	0.3	0.5	4.3	14.3	0.1	1.8	16.7	0.0	0.5	0.6	0.0	1.8	2.8	0.6	0.2	1.0	3.0	2.7	10.2	0.5	0.0	0.4	0.0	0.4	0.0	0.2	5.7	280.5	0.2	0.0	15.6	0.4	0.0	4.4	0.0	2.2	0.6	0.3	0.0	6.5	0.1	10.6	2.1	8.0	7.7	0.4	1.4	0.0	0.1	0.0	2.6	1.6	1.1	5.1	0.0	0.6	0.3	1.3	1.3	0.1	0.0	0.0	0.6	0.1	0.7	0.1
CASP14	"MGC119078, MGC119079, MICE"	ENSG00000105141	"Caspase 14"	P31944	19	15049480-15058293	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Differentiation	"Hydrolase, Protease, Thiol protease"	Ichthyosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"skin 1: 489.9"	"Cell type enriched"	"Detected in some"	5	"Suprabasal keratinocytes: 96.0"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 62.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"hTCEpi: 49.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB010059, HPA027062"	Enhanced		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA		3600000	"Nucleoplasm, Cytosol"	Mitochondria	"CAB010059: AB_626800, HPA027062: AB_2672101"	"unprognostic (1.17e-2)"	"unprognostic (6.44e-3)"		"unprognostic (6.22e-2)"		"unprognostic (2.77e-1)"		"prognostic unfavorable (7.59e-4)"	"unprognostic (9.42e-2)"	"unprognostic (2.19e-2)"	"prognostic unfavorable (5.96e-4)"	"unprognostic (2.68e-1)"		"unprognostic (4.30e-2)"	"unprognostic (1.99e-1)"		"unprognostic (1.97e-1)"	0.3	0.0	0.1	0.0	0.3	0.4	7.9	0.2	0.2	1.9	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.3	0.8	0.0	0.1	1.1	4.3	1.4	489.9	0.0	0.0	0.0	0.0	0.0	0.3	0.2	1.0	0.0	0.0	0.0	0.0	20.0	0.9	1.1	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.9	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.2	0.2	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	19.1	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	2.8	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	96.0	0.7	0.1	0.0	0.0	0.8
DGKK		ENSG00000274588	"Diacylglycerol kinase kappa"	Q5KSL6	X	50365409-50470825	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	24	"adrenal gland: 3.4;brain: 8.2;pituitary gland: 6.1"	"Cell type enriched"	"Detected in some"	6	"NK-cells: 13.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"thalamus: 8.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	21	"Hep G2: 34.5"	"Region enhanced"	"Detected in many"		"hypothalamus: 19.8"	"Low region specificity"	"Detected in some"									NA	NA						"unprognostic (3.99e-1)"		"unprognostic (1.18e-1)"	"unprognostic (4.18e-3)"	"unprognostic (1.23e-1)"		"unprognostic (5.83e-3)"	"unprognostic (9.58e-2)"		"unprognostic (2.41e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.28e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.49e-2)"	"unprognostic (4.64e-3)"	0.0	3.4	1.5	0.0	5.3	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.0	0.8	0.8	0.1	0.0	0.0	0.0	6.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	5.3	0.0	2.2	0.1	3.0	0.8	0.8	0.1	1.2	0.3	8.2	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.0	0.1	0.0	13.4	2.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1
KISS1		ENSG00000170498	"KiSS-1 metastasis suppressor"	Q15726	1	204190341-204196491	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins"			"Cancer-related genes, Disease variant, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"placenta: 235.3"	"Cell type enriched"	"Detected in many"	26	"Syncytiotrophoblasts: 1336.6"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 9.2"	"Region enriched"	"Detected in some"	8	"hypothalamus: 9.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	23	"BJ: 145.5;U-2 OS: 59.4"					"Not detected"	"Not detected"			"CAB017775, HPA035542"	Enhanced		Approved	Vesicles	"Secreted in female reproductive system"	NA	NA		860000	Vesicles		"CAB017775: , HPA035542: AB_2674677"	"unprognostic (9.64e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.89e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.28e-2)"		"unprognostic (1.28e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.98e-12)"	"unprognostic (2.25e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.76e-1)"	"prognostic favorable (6.29e-6)"	0.0	0.0	0.4	0.0	0.7	0.0	0.1	0.7	0.6	0.3	0.7	0.2	0.9	0.2	0.0	0.1	0.1	0.0	0.1	0.4	9.9	2.4	4.4	1.4	0.0	1.3	0.3	0.3	0.1	1.0	0.1	3.1	235.3	0.4	0.6	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.2	0.2	2.1	3.3	5.2	0.9	0.1	0.0	0.0	0.0	0.6	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	2.4	145.5	1.8	2.5	0.7	0.0	0.7	0.0	1.4	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.9	0.2	0.0	0.2	0.1	0.0	0.0	0.9	0.2	0.1	0.0	0.7	0.0	0.8	0.2	0.3	0.0	0.1	59.4	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.7	0.6	0.4	9.9	1.3	0.3	0.3	0.4	0.2	0.9	0.4	0.3	0.0	0.0	0.3	0.0	0.0	4.0	7.5	0.0	1.0	1.2	0.6	0.0	1.5	2.2	0.0	0.0	9.3	0.0	1.5	0.0	11.3	40.2	0.2	0.0	1.4	0.0	0.0	0.1	4.9	6.9	1.9	4.1	0.5	0.0	0.4	0.7	2.8	15.1	0.0	0.0	0.6	0.0	0.0	0.0	5.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	1.5	0.0	0.1	50.1	17.0	1.4	0.4	0.0	0.0	0.0	7.1	0.6	1.1	0.0	0.0	1336.6	0.1	0.1	2.1	14.3
MYL4	"ALC1, AMLC, GT1, PRO1957"	ENSG00000198336	"Myosin light chain 4"	P12829	17	47200446-47223679	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"	"Atrial fibrillation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	24	"heart muscle: 3302.6"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 2426.3"	"Cancer enriched"	"Detected in some"	5	"thyroid cancer: 11.7"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	9	"plasmacytoid DC: 1.8"	"Lineage enriched"	"Detected in single"	9	"dendritic cells: 1.8"	"Cell line enriched"	"Detected in some"	4	"HEL: 552.8"	"Group enriched"	"Detected in all"	6	"amygdala: 25.8;cerebral cortex: 88.4;hippocampal formation: 25.2;white matter: 50.9"	"Not detected"	"Not detected"			"HPA046859, HPA051884, HPA063034"	Enhanced		Approved	"Plasma membrane"		NA	NA		3100000	"Plasma membrane"		"HPA046859: AB_2679842, HPA051884: AB_2681651, HPA063034: AB_2684927"	"unprognostic (2.43e-2)"	"unprognostic (9.57e-2)"	"unprognostic (2.25e-1)"	"unprognostic (5.51e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.12e-3)"	"unprognostic (5.06e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.10e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.00e-6)"	"unprognostic (1.92e-4)"	"unprognostic (2.54e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.50e-1)"	2.0	0.5	0.3	0.4	0.3	135.7	2.8	0.2	0.4	0.3	0.4	0.7	0.8	0.8	0.0	0.6	0.5	1.1	3302.6	0.3	0.3	1.3	1.4	9.5	0.9	0.3	1.1	0.2	0.8	8.7	0.3	0.5	9.2	0.4	1.1	0.3	42.5	3.0	0.2	3.6	1.1	1.3	0.8	0.3	3.1	3.5	15.6	0.3	2.4	11.1	6.5	0.4	0.9	0.8	0.4	0.0	0.0	0.3	0.0	0.1	0.0	0.9	0.3	0.0	0.2	0.0	0.9	0.1	1.6	0.9	0.0	0.4	0.0	0.1	0.0	0.0	3.0	0.2	552.8	0.1	0.0	0.0	0.0	0.3	21.2	0.0	0.3	0.1	0.0	1.0	1.4	133.3	0.3	0.2	0.0	10.0	0.1	0.3	0.0	0.4	0.3	12.9	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	24.3	0.0	0.2	4.5	0.0	0.3	0.1	0.0	0.3	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.2	0.3	0.3	0.2	0.4	0.3	0.3	0.3	1.1	0.2	0.4	0.3	0.3	0.4	3.2	3.2	0.0	0.0	0.7	0.8	0.0	0.0	0.0	5.5	0.0	0.0	2426.3	0.0	0.0	0.0	64.6	0.5	2.7	0.1	0.0	0.1	23.3	0.1	0.0	23.2	0.0	412.8	0.1	0.0	3.9	150.7	1.5	0.1	0.0	0.3	1.8	0.5	1.9	1.7	0.0	0.8	0.0	0.6	0.6	54.6	3.4	34.0	12.4	0.0	1.5	7.9	4.1	0.0	0.1	0.1	0.0	1.5	0.8	0.0	10.9	0.2	0.0	24.4	0.0	0.6	36.5	9.9	0.5	0.0	0.9	1.4	0.3	0.2	1.0	0.0
PSG8		ENSG00000124467	"Pregnancy specific beta-1-glycoprotein 8"	Q9UQ74	19	42752686-42855691	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	24	"placenta: 6.6"	"Cell type enriched"	"Detected in some"	11	"Syncytiotrophoblasts: 34.3"	"Cancer enriched"	"Detected in single"	17	"thyroid cancer: 0.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA046327	Supported				"Secreted in female reproductive system"	NA	NA		55000000			"HPA046327: AB_2679624"																"unprognostic (1.85e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.2	3.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	34.3	0.0	0.0	0.0	0.0
TLX3	"HOX11L2, RNX"	ENSG00000164438	"T cell leukemia homeobox 3"	O43711	5	171309248-171312139	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	24	"brain: 7.9"	"Cell type enriched"	"Detected in some"	6	"Extravillous trophoblasts: 7.7"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 1.7"	"Region enhanced"	"Detected in many"		"cerebellum: 7.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SH-SY5Y: 25.9"	"Region enriched"	"Detected in single"	7	"cerebellum: 2.2"	"Region enriched"	"Detected in some"	8	"cerebellum: 15.5"	"HPA030504, HPA060957, HPA069359"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA030504: AB_2732458, HPA060957: AB_2732655, HPA069359: AB_2732130"		"unprognostic (3.52e-2)"		"unprognostic (2.43e-2)"					"unprognostic (2.09e-1)"	"unprognostic (3.11e-1)"				"unprognostic (9.80e-2)"	"unprognostic (2.76e-2)"		"unprognostic (4.48e-2)"	0.0	0.0	0.0	0.0	0.4	0.0	0.0	7.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.3	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.4	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.2	0.0	0.0	25.9	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	7.9	0.3	0.0	0.1	2.1	0.3	0.0	1.1	2.8	0.5	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0
TMEM182	FLJ30294	ENSG00000170417	"Transmembrane protein 182"	Q6ZP80	2	102736905-103019900	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	24	"heart muscle: 98.5;skeletal muscle: 152.1;tongue: 128.8"	"Cell type enriched"	"Detected in many"	6	"Cardiomyocytes: 150.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA045861			Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA045861: AB_2679475"	"unprognostic (1.39e-1)"	"unprognostic (3.42e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.12e-4)"	"unprognostic (5.35e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.03e-3)"	"unprognostic (2.34e-1)"	"unprognostic (4.19e-2)"	"unprognostic (3.42e-2)"	"unprognostic (9.88e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.36e-2)"	2.8	1.6	2.5	0.7	2.1	0.6	2.3	2.7	2.9	2.9	2.2	1.8	1.9	1.1	5.3	4.0	2.1	1.8	98.5	2.6	2.9	2.1	2.0	1.3	1.8	2.9	2.7	2.1	1.5	2.1	3.6	2.6	1.4	3.0	4.1	2.3	1.5	2.0	2.2	152.1	0.5	1.2	1.1	2.7	1.6	2.2	1.4	2.8	1.8	3.0	128.8	1.5	2.2	0.6	3.0	4.9	3.3	2.4	7.3	2.8	2.4	6.9	2.5	2.2	2.4	4.4	10.7	7.3	4.5	9.0	1.4	6.1	3.3	2.6	3.7	5.4	11.6	3.5	6.6	1.4	6.7	3.0	6.2	4.4	3.2	7.6	4.5	5.2	1.9	0.4	6.4	5.2	1.2	3.5	4.6	3.9	5.7	4.2	5.9	3.6	3.4	6.3	3.7	5.7	6.2	5.2	1.9	4.1	3.3	10.3	3.5	3.0	3.2	0.7	4.2	3.5	2.7	3.1	3.9	13.0	5.5	3.8	8.4	6.3	0.0	0.0	0.2	2.5	0.2	2.8	3.6	1.5	1.3	0.9	1.2	2.4	2.4	0.0	2.4	0.3	2.9	0.5	1.1	2.5	2.1	2.7	2.9	2.6	2.9	2.9	2.7	2.1	3.0	2.7	2.8	3.0	0.6	22.4	12.3	1.3	3.6	0.4	1.0	1.8	1.2	0.3	8.1	2.4	150.6	0.0	15.3	3.7	0.0	2.3	4.2	0.5	0.0	1.8	0.6	2.4	1.1	2.0	6.6	3.6	6.1	3.3	2.6	6.9	4.1	1.6	3.8	1.2	0.7	2.3	1.2	0.0	10.8	2.6	2.0	0.8	0.7	0.6	0.6	1.3	7.2	6.5	0.1	2.4	1.0	8.5	3.4	2.4	1.1	0.7	2.7	1.0	1.0	2.4	12.8	0.3	0.0	4.6	2.3	1.0	2.4	2.5	0.6	1.1	2.9	1.1	1.8	2.8
CIDEA	CIDE-A	ENSG00000176194	"Cell death inducing DFFA like effector a"	O60543	18	12254361-12277595	"Disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	23	"adipose tissue: 223.3;breast: 108.9"	"Cell type enriched"	"Detected in some"	78	"Breast glandular cells: 330.6"	"Cancer enhanced"	"Detected in some"		"breast cancer: 1.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	10	"hTEC/SVTERT24-B: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.96e-2)"	"unprognostic (2.43e-2)"			"unprognostic (1.74e-1)"	"unprognostic (1.49e-1)"		"unprognostic (8.93e-3)"	"unprognostic (3.20e-2)"	"unprognostic (7.00e-2)"	"unprognostic (3.72e-2)"			"unprognostic (1.91e-3)"	"unprognostic (3.17e-2)"	"unprognostic (7.67e-3)"	"unprognostic (1.96e-1)"	223.3	3.8	2.7	0.2	3.5	0.0	108.9	3.5	4.6	1.7	2.4	1.2	0.0	0.0	0.0	4.9	0.0	1.2	1.9	3.3	2.5	0.2	0.2	0.0	0.3	3.0	2.8	3.0	0.0	0.9	0.0	0.0	0.0	3.5	0.1	0.9	0.1	4.3	0.0	1.1	7.3	2.1	0.2	2.8	0.0	1.0	0.1	2.6	0.2	0.5	4.7	0.2	1.1	5.1	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	3.5	3.5	4.6	3.3	2.5	3.0	2.8	3.0	3.5	2.8	2.6	3.7	1.9	0.0	0.0	0.7	0.5	0.1	0.1	0.3	0.0	0.2	330.6	3.8	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.3	1.0	0.0	0.2	0.3	0.0	0.0	3.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	4.2	0.6	0.6	1.8	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.4	0.3	0.7	1.0	0.0	0.3	0.5	0.0	0.8
LBP	BPIFD2	ENSG00000129988	"Lipopolysaccharide binding protein"	P18428	20	38346482-38377013	"Plasma proteins, Predicted secreted proteins, Transporters"	"Immunity, Innate immunity, Lipid transport, Transport"	"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	23	"liver: 1349.5"	"Cell type enriched"	"Detected in some"	30	"Hepatocytes: 458.3"	"Cancer enriched"	"Detected in many"	20	"liver cancer: 356.7"	"Region enhanced"	"Detected in single"		"medulla oblongata: 1.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"ASC diff: 10.7;HSkMC: 12.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001508, CAB025905"	Approved				"Secreted to blood"	NA	NA	25000000000	1300000000			"CAB025905: , HPA001508: AB_1079241"	"unprognostic (4.20e-2)"	"prognostic unfavorable (5.56e-4)"	"unprognostic (4.54e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.53e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.48e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.93e-2)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (3.62e-12)"	"prognostic unfavorable (5.76e-4)"	"unprognostic (1.69e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.67e-1)"	58.8	0.5	0.0	24.4	0.1	0.5	6.6	0.0	0.1	2.6	0.0	0.4	0.0	2.7	0.0	0.1	0.6	0.2	1.9	0.0	0.0	8.5	1349.5	1.2	2.8	1.1	0.0	0.0	0.2	1.7	0.1	0.4	0.1	0.0	0.4	0.0	0.0	0.4	0.0	23.0	0.4	0.6	1.5	0.0	0.5	0.6	0.7	0.3	0.1	4.0	2.1	0.3	0.7	0.2	0.3	0.0	0.1	0.1	0.0	10.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.1	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.5	8.6	0.7	0.0	0.0	0.1	0.0	0.0	7.9	0.8	1.0	0.1	0.2	0.5	0.0	10.7	0.3	11.0	0.1	0.8	0.0	0.7	0.0	0.0	9.7	458.3	0.3	0.0	0.3	0.0	0.0	8.5	0.0	0.3	0.6	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.2	5.1	0.0	0.0	0.0	0.1	0.0	15.2	0.1	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.0
LCE1F	LEP6	ENSG00000240386	"Late cornified envelope 1F"	Q5T754	1	152776372-152776728	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"skin 1: 211.4"	"Cell type enriched"	"Detected in some"	10	"Suprabasal keratinocytes: 18.3"	"Group enriched"	"Detected in some"	13	"head and neck cancer: 5.5;melanoma: 14.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BJ hTERT+: 6.5;hTERT-HME1: 3.0"															NA	NA											"unprognostic (2.21e-1)"			"unprognostic (8.43e-2)"									0.0	0.0	0.0	0.0	0.0	0.2	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	211.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0
LEAP2	LEAP-2	ENSG00000164406	"Liver enriched antimicrobial peptide 2"	Q969E1	5	132873444-132875046	"Plasma proteins, Predicted secreted proteins"		"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	23	"liver: 536.4"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 1650.6"	"Cancer enriched"	"Detected in many"	17	"liver cancer: 40.0"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CACO-2: 3.4;Hep G2: 4.7;U-266/84: 3.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA		790000				"unprognostic (2.14e-2)"	"unprognostic (8.78e-2)"	"unprognostic (4.75e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.78e-3)"	"unprognostic (6.53e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.62e-1)"	"unprognostic (7.08e-3)"	"unprognostic (2.91e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (2.68e-4)"	0.9	0.9	0.8	0.3	1.0	0.5	1.1	2.2	1.2	1.3	0.5	1.7	12.4	0.8	0.2	1.3	1.2	4.5	1.2	0.9	0.9	12.0	536.4	1.1	0.5	0.9	0.9	0.9	1.2	1.9	0.7	1.1	0.2	1.2	2.4	1.6	1.0	1.3	0.2	1.5	1.4	23.6	0.1	0.7	2.2	2.0	1.1	0.9	0.3	1.9	0.5	0.5	7.9	1.6	1.9	0.1	0.7	0.4	1.5	0.6	0.4	0.4	0.1	0.1	0.4	0.6	3.4	0.5	0.2	0.1	0.1	0.4	0.7	1.4	0.6	0.0	1.2	1.0	0.3	1.2	4.7	0.1	0.5	0.2	0.1	0.5	0.0	0.1	0.3	0.1	1.1	0.5	0.4	0.0	0.3	0.8	0.6	1.1	1.1	0.5	0.0	0.2	1.1	0.0	0.2	0.5	0.3	0.3	0.7	0.5	0.4	0.8	0.4	0.0	0.2	0.3	0.6	0.1	1.1	3.8	1.1	0.0	0.7	0.2	1.3	0.7	0.3	0.6	0.4	0.8	1.0	0.6	0.7	0.6	0.8	1.0	0.8	1.7	1.0	0.3	0.8	1.1	0.3	0.8	1.0	2.2	1.2	0.9	0.9	0.9	0.9	0.9	1.2	0.7	0.9	1.9	2.5	0.0	2.6	1.3	7.9	10.1	10.8	4.1	2.8	17.1	4.9	2.8	1.9	64.3	2.6	0.0	33.3	3.3	7.6	39.2	9.8	2.9	6.2	4.8	3.8	5.2	4.8	9.3	1.1	9.8	7.9	5.8	1.5	10.3	7.0	6.7	14.3	1650.6	1.4	13.5	1.4	12.1	0.0	17.3	14.1	0.5	1.5	4.2	5.4	1.0	2.2	5.2	13.4	2.0	1.8	2.9	30.9	1.9	3.1	14.0	279.9	51.8	1.7	25.2	0.0	13.5	4.8	7.0	2.9	1.4	7.7	7.3	6.2	4.1	8.0	10.2
MAT1A	"MAT, MATA1, SAMS, SAMS1"	ENSG00000151224	"Methionine adenosyltransferase 1A"	Q00266	10	80271820-80289658	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"One-carbon metabolism"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"liver: 1357.4"	"Cell type enriched"	"Detected in some"	55	"Hepatocytes: 5534.4"	"Cancer enriched"	"Detected in many"	54	"liver cancer: 209.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	14	"Hep G2: 94.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA048627	Supported					NA	NA		1900000			"HPA048627: AB_2680465"	"unprognostic (6.92e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.88e-2)"	"unprognostic (9.43e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.49e-2)"	"unprognostic (2.03e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.11e-16)"	"unprognostic (8.59e-3)"	"unprognostic (9.90e-2)"	"unprognostic (3.58e-1)"	"unprognostic (5.98e-2)"	0.5	0.5	0.6	0.1	0.6	0.0	0.4	0.2	0.4	0.1	0.8	0.2	0.2	0.1	58.0	0.1	1.2	0.0	0.2	0.1	0.6	0.9	1357.4	0.4	0.1	0.4	0.7	0.1	6.4	44.1	0.1	0.9	0.1	0.5	0.0	0.0	0.0	0.3	2.0	0.0	3.8	0.0	0.2	0.9	0.6	0.2	3.7	0.4	0.4	0.4	0.0	0.0	0.5	0.1	0.2	6.5	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.3	0.0	3.2	0.1	0.0	0.0	0.0	0.3	0.5	1.6	0.0	94.9	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.2	0.0	2.1	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.3	1.0	0.2	0.0	0.5	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.2	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.2	0.4	0.1	0.6	0.4	0.7	0.1	0.5	0.9	0.4	0.2	0.0	0.0	0.5	0.0	8.8	2.0	0.1	0.4	0.0	0.0	0.2	0.6	0.7	67.2	0.9	1.8	0.0	0.0	0.0	0.0	1.9	0.1	23.9	3.0	0.0	5.3	0.0	69.5	0.1	4.6	0.0	0.0	0.0	0.2	0.0	7.6	76.8	5534.4	0.1	0.0	0.0	0.0	0.0	100.4	0.6	5.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.4	0.0	0.1	0.0	0.6	10.2	0.0	0.0	0.0	0.2	2.7	0.3	0.0	2.7	0.0	6.0	1.0	0.0	0.0
MS4A12	"FLJ20217, Ms4a10"	ENSG00000071203	"Membrane spanning 4-domains A12"	Q9NXJ0	11	60492778-60507430	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"intestine: 256.7"	"Cell type enriched"	"Detected in some"	4	"Distal enterocytes: 1139.3"	"Cancer enriched"	"Detected in some"	8	"colorectal cancer: 6.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RH-30: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA048616, HPA057657"	Enhanced		Approved	"Nucleoli,Endoplasmic reticulum,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Nucleoli, Endoplasmic reticulum, Golgi apparatus"	"HPA048616: , HPA057657: AB_2683491"			"unprognostic (2.64e-2)"						"unprognostic (2.33e-1)"			"unprognostic (1.49e-1)"		"unprognostic (3.26e-1)"	"unprognostic (2.83e-1)"	"unprognostic (9.20e-3)"		0.2	0.0	0.0	11.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	236.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	256.7	0.0	0.0	0.5	0.0	0.0	0.3	4.8	0.0	0.0	0.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1139.3	0.0	0.0	0.4	0.1	0.0	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	255.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.7	0.0	0.0	0.0	0.6	0.1	27.8	0.0
MYF5	bHLHc2	ENSG00000111049	"Myogenic factor 5"	P13349	12	80716912-80719671	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	23	"skeletal muscle: 5.6;tongue: 8.9"	"Cell type enriched"	"Detected in single"	1159	"Skeletal myocytes: 347.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	22	"LHCN-M2: 478.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA041691			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041691: AB_10796780"						"unprognostic (2.65e-2)"												0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	478.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	347.9	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
MYH4	"MYH2B, MyHC-2B, MyHC-IIb"	ENSG00000264424	"Myosin heavy chain 4"	Q9Y623	17	10443290-10469559	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	23	"skeletal muscle: 10.7"	"Cell type enriched"	"Detected in single"	5	"Cardiomyocytes: 3.3"	"Cancer enriched"	"Detected in single"	115	"liver cancer: 9.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	25	"OE19: 9.0"									HPA001349	Supported		Uncertain	"Focal adhesion sites"		NA	NA		86000000	"Focal adhesion sites"		"HPA001349: AB_1079437"	"unprognostic (3.27e-2)"		"unprognostic (2.94e-2)"			"unprognostic (4.94e-2)"	"unprognostic (1.69e-2)"	"unprognostic (4.72e-1)"			"unprognostic (1.37e-1)"		"unprognostic (3.32e-2)"	"unprognostic (1.21e-3)"	"unprognostic (3.52e-4)"		"unprognostic (9.97e-2)"	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0
MYOM1		ENSG00000101605	"Myomesin 1"	P52179	18	3066807-3219968	"Predicted intracellular proteins"		"Muscle protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	23	"heart muscle: 416.6;skeletal muscle: 853.6;tongue: 439.4"	"Cell type enriched"	"Detected in many"	15	"Cardiomyocytes: 1346.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"HAP1: 13.5;HMC-1: 3.5;HSkMC: 6.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA014305, HPA049193"	Enhanced					NA	NA		33000			"HPA014305: AB_1854257, HPA049193: AB_2680670"	"unprognostic (2.51e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.19e-3)"	"unprognostic (8.01e-3)"	"unprognostic (8.94e-2)"	"unprognostic (4.31e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.15e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.62e-1)"	15.2	2.3	7.6	1.4	8.7	0.6	4.2	8.6	6.4	2.9	4.3	10.3	1.9	6.4	3.0	14.2	6.9	14.7	416.6	6.3	10.6	1.3	24.9	1.5	1.3	11.5	11.2	4.9	2.9	11.6	0.4	1.6	1.6	11.3	12.5	2.4	2.0	5.4	4.5	853.6	1.3	4.6	12.0	9.2	1.0	3.2	5.8	8.6	0.8	2.8	439.4	0.7	7.7	2.4	9.3	0.0	0.1	0.2	0.0	0.7	0.7	0.3	0.4	0.5	0.0	0.0	0.1	0.1	0.4	0.1	0.1	0.1	0.0	13.5	0.1	0.2	0.4	0.1	0.1	0.1	0.1	0.1	0.0	3.5	6.2	0.3	0.2	0.0	0.3	0.0	0.2	0.0	0.4	0.2	0.0	0.2	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.1	0.3	0.0	0.1	0.2	0.0	0.5	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.4	0.1	0.2	0.0	0.6	0.0	0.2	7.6	8.7	8.6	6.4	6.3	10.6	11.5	11.2	4.9	11.3	9.2	8.6	9.3	1.2	0.0	0.5	49.0	1.7	1.7	2.3	0.7	0.0	2.1	1.0	0.8	1346.0	27.1	1.2	0.0	2.1	0.9	2.7	7.4	0.0	0.6	11.7	1.1	0.4	12.0	0.0	0.8	3.5	6.3	0.1	27.4	6.6	1.0	0.0	3.4	2.5	19.1	0.3	1.7	7.1	0.7	4.1	1.3	2.1	14.1	2.1	1.3	0.0	7.5	1.5	0.2	2.1	24.6	13.5	1.5	88.9	4.1	0.1	0.8	0.5	0.3	2.1	1.6	6.6	24.6	40.8	4.4	5.4	0.1	1.3	2.2	1.3	1.3	0.6	0.6
OR2T10		ENSG00000184022	"Olfactory receptor family 2 subfamily T member 10"	Q8NGZ9	1	248590487-248597700	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	23	"kidney: 5.1"	"Cell type enriched"	"Detected in single"	8	"Proximal tubular cells: 4.9"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA052019	Uncertain					NA	NA					"HPA052019: AB_2681696"													"unprognostic (8.58e-2)"					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PAX7	Hup1	ENSG00000009709	"Paired box 7"	P23759	1	18630846-18748866	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Myogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	23	"brain: 5.1;skeletal muscle: 5.8;tongue: 4.4"	"Cell type enriched"	"Detected in some"	284	"Skeletal myocytes: 341.4"	"Group enriched"	"Detected in some"	6	"breast cancer: 0.5;cervical cancer: 1.5;lung cancer: 1.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A549: 1.4;CAPAN-2: 1.4;U-2 OS: 3.0"	"Region enriched"	"Detected in single"	17	"midbrain: 4.6"	"Region enhanced"	"Detected in some"		"thalamus: 4.3"							NA	NA						"unprognostic (8.41e-4)"	"unprognostic (2.07e-1)"			"unprognostic (5.35e-2)"	"unprognostic (3.96e-2)"		"unprognostic (4.21e-1)"						"unprognostic (1.96e-1)"	"unprognostic (1.34e-1)"			0.0	0.0	0.1	0.0	0.8	0.0	0.0	1.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	3.2	5.1	0.3	0.0	0.0	0.0	0.1	0.0	1.5	0.1	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.6	0.0	0.0	4.4	0.0	0.0	0.0	0.7	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	1.5	1.4	0.2	0.1	3.2	5.1	0.3	1.5	2.0	0.6	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	341.4	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0
PCARE	"C2orf71, FLJ34931, RP54"	ENSG00000179270	"Photoreceptor cilium actin regulator"	A6NGG8	2	29060976-29074523	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"		"Ciliopathy, Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"retina: 28.7"	"Cell type enriched"	"Detected in single"	20	"Cardiomyocytes: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (2.28e-3)"	"unprognostic (1.23e-1)"		"unprognostic (1.13e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.88e-1)"		"unprognostic (5.88e-3)"	"unprognostic (6.68e-3)"	"unprognostic (1.21e-1)"	"unprognostic (6.61e-2)"	"unprognostic (3.81e-2)"		"unprognostic (2.37e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.28e-4)"	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.4	0.4	0.0	0.1	0.0	0.2	0.8	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	28.7	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.1	0.1	0.4	0.2	0.8	0.1	0.1	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RAPSN	"CMS1D, CMS1E, RNF205"	ENSG00000165917	"Receptor associated protein of the synapse"	Q13702	11	47437764-47449143	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	23	"skeletal muscle: 89.7;tongue: 33.4"	"Cell type enriched"	"Detected in some"	4	"Skeletal myocytes: 63.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"RH-30: 238.7"	"Low region specificity"	"Detected in some"							HPA039475	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA			"Plasma membrane, Centrosome, Cytosol"		"HPA039475: AB_10794196"	"unprognostic (5.37e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.34e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.35e-1)"	"unprognostic (5.38e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.64e-4)"	"unprognostic (3.83e-1)"	"unprognostic (4.73e-3)"	"unprognostic (4.48e-2)"	0.2	1.5	0.4	0.2	0.4	0.3	0.2	0.3	1.2	0.1	0.7	0.7	0.1	0.0	0.1	1.2	0.1	0.1	2.6	0.5	0.4	0.3	0.5	0.4	0.2	0.4	0.4	0.2	0.0	0.2	0.0	0.1	2.1	0.4	0.8	0.0	0.1	1.3	0.0	89.7	0.4	0.5	0.1	0.4	0.7	0.2	0.3	0.5	0.1	0.2	33.4	0.1	0.1	0.1	0.5	0.0	0.2	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.3	0.2	0.7	0.1	0.2	1.2	4.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	59.6	0.0	0.0	0.2	0.0	0.0	0.2	0.0	238.7	0.0	0.3	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.3	0.1	0.3	0.3	0.3	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.3	1.2	0.5	0.4	0.4	0.4	0.2	0.4	0.4	0.5	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.3	0.3	1.4	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.5	2.7	0.3	0.1	0.2	0.0	0.0	0.1	0.2	0.1	1.0	0.0	0.5	0.0	0.2	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.3	0.3	13.8	0.0	0.5	0.0	0.0	0.6	1.3	0.0	0.5	0.0	0.8	0.0	0.0	0.1	0.2	0.0	0.0	1.1	0.0	0.0	63.8	0.5	0.0	0.4	0.0	0.0	0.3	0.4	0.1	0.2	0.1
THEM5	FLJ37964	ENSG00000196407	"Thioesterase superfamily member 5"	Q8N1Q8	1	151847101-151853712	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	23	"skin 1: 152.6"	"Cell type enriched"	"Detected in some"	18	"Suprabasal keratinocytes: 34.7"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"amygdala: 2.1;cerebral cortex: 3.8;hippocampal formation: 2.8;pons: 1.4;white matter: 1.3"	"Immune cell enhanced"	"Detected in single"		"MAIT T-cell: 1.7"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.7"	"Cell line enriched"	"Detected in some"	7	"HDLM-2: 57.6"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	15	"basal ganglia: 13.8"							NA	NA						"unprognostic (2.28e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.41e-2)"	"unprognostic (2.58e-3)"	"unprognostic (9.55e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.83e-1)"	"unprognostic (7.86e-3)"	"unprognostic (3.07e-3)"	"unprognostic (9.37e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.49e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.62e-2)"	0.3	1.9	2.1	2.0	0.2	0.5	4.3	0.0	3.8	0.8	0.4	0.5	1.4	0.5	0.0	6.6	0.7	3.1	1.9	2.8	0.0	1.1	0.6	1.3	6.4	0.5	0.3	0.1	0.3	1.3	0.0	0.5	0.6	1.4	0.4	0.0	0.7	3.2	0.0	1.3	152.6	0.8	0.0	0.0	1.1	1.9	1.2	0.3	0.1	1.0	0.0	0.3	1.3	3.2	1.3	6.6	0.0	0.1	0.2	0.0	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	2.3	0.0	0.0	0.0	57.6	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	2.3	0.0	1.7	0.2	0.0	7.1	1.2	0.6	0.0	0.2	0.7	0.0	0.0	0.4	0.1	8.6	2.1	1.1	1.4	1.4	2.4	0.0	0.0	0.0	1.6	0.1	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.7	0.1	1.7	0.0	0.6	0.4	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.9	1.7	2.1	0.2	0.0	3.8	2.8	0.0	0.5	0.3	0.1	1.4	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.9	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.8	34.7	1.1	0.0	0.0	0.0	0.0
TRBV2	"TCRBV22S1A2N1T, TCRBV2S1"	ENSG00000226660	"T cell receptor beta variable 2"	A0A1B0GX68	7	142300924-142301432	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	23	"lymphoid tissue: 90.1"	"Cell type enriched"	"Detected in single"	80	"T-cells: 8.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	14	"memory CD4 T-cell: 120.3;memory CD8 T-cell: 64.5;naive CD4 T-cell: 71.5;naive CD8 T-cell: 44.5;T-reg: 122.7"	"Lineage enriched"	"Detected in many"	21	"T-cells: 122.7"	"Cell line enriched"	"Detected in single"	10	"RPMI-8226: 9.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (6.62e-4)"	"unprognostic (4.94e-4)"	"unprognostic (5.79e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.09e-1)"	"unprognostic (4.71e-5)"	"unprognostic (3.60e-2)"	"unprognostic (3.74e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.70e-5)"	"unprognostic (3.83e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.41e-2)"	1.1	0.3	0.0	8.4	0.0	3.9	1.2	0.0	0.1	1.1	0.0	2.6	2.5	0.3	1.1	1.7	0.2	2.4	0.1	0.0	0.0	0.4	1.0	1.6	25.7	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.8	2.1	0.0	0.3	0.5	0.0	0.3	1.7	0.8	0.0	6.8	3.5	0.3	0.0	90.1	0.5	0.3	22.3	3.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.9	0.0	5.5	0.1	120.3	64.5	0.3	0.1	71.5	44.5	1.2	0.1	0.1	5.8	122.7	29.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0
TRBV5-1	"TCRBV5S1, TCRBV5S1A1T, TRBV51"	ENSG00000211734	"T cell receptor beta variable 5-1"	A0A578	7	142320677-142321544	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"lymphoid tissue: 44.4"	"Cell type enriched"	"Detected in some"	11	"T-cells: 13.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 211.6;T-reg: 295.5"	"Lineage enriched"	"Detected in many"	111	"T-cells: 295.5"	"Not detected"	"Not detected"																	NA	NA						"unprognostic (2.26e-4)"	"unprognostic (1.36e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.49e-3)"	"unprognostic (6.65e-2)"	"unprognostic (7.02e-5)"	"unprognostic (2.55e-2)"	"unprognostic (3.66e-2)"	"unprognostic (4.29e-3)"	"unprognostic (5.85e-4)"	"unprognostic (3.55e-2)"	"unprognostic (4.36e-1)"	"unprognostic (5.96e-7)"	"unprognostic (2.63e-1)"	"unprognostic (2.52e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.97e-2)"	0.2	0.0	0.0	4.9	0.0	1.1	0.2	0.0	0.1	0.4	0.0	0.7	1.0	0.1	0.0	0.1	0.1	0.8	0.0	0.0	0.0	0.1	0.2	0.7	10.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.2	0.0	0.0	0.3	1.9	0.1	0.0	2.6	1.6	0.2	0.0	44.4	0.2	0.0	9.0	1.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.3	2.6	0.2	11.0	0.4	166.1	65.4	0.4	0.4	211.6	128.7	2.6	0.5	0.5	0.3	295.5	82.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0
ABCA2	ABC2	ENSG00000107331	"ATP binding cassette subfamily A member 2"	Q9BZC7	9	137007234-137028922	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	22	"brain: 515.5"	"Cell type enriched"	"Detected in many"	10	"Oligodendrocytes: 388.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"T-47d: 66.4"	"Low region specificity"	"Detected in all"							HPA042886	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA042886: AB_2678213"	"unprognostic (1.01e-2)"	"unprognostic (9.21e-3)"	"unprognostic (9.59e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.74e-2)"	"unprognostic (6.78e-3)"	"unprognostic (3.14e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.36e-1)"	9.1	6.1	66.3	4.3	210.6	6.8	6.3	158.1	127.8	5.3	0.0	7.5	3.1	4.3	4.5	3.3	6.3	6.0	8.8	60.6	108.7	7.1	7.4	6.2	4.6	233.6	190.7	32.6	3.2	9.4	13.5	23.5	3.1	243.7	7.2	2.2	2.8	8.5	4.7	7.4	6.6	6.5	2.4	167.3	9.6	11.7	2.9	162.0	2.9	15.3	3.6	1.8	5.7	5.3	515.5	8.6	9.2	4.5	18.2	11.1	11.8	7.9	9.5	3.8	4.2	1.5	2.8	10.3	0.4	26.2	10.2	4.1	14.4	2.9	6.9	0.8	6.4	5.9	0.8	26.2	3.5	5.5	13.3	14.5	5.0	6.3	3.0	0.9	15.3	2.4	2.7	2.2	1.5	5.3	25.7	0.1	29.1	2.4	10.9	9.5	13.3	4.6	13.0	2.9	2.0	17.4	20.0	10.1	19.6	7.2	0.3	66.4	17.4	11.9	11.2	6.1	16.0	3.9	0.3	0.2	0.1	19.0	2.6	5.8	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.6	0.2	0.3	66.3	210.6	158.1	127.8	60.6	108.7	233.6	190.7	32.6	243.7	167.3	162.0	515.5	7.2	0.0	0.0	26.1	2.3	3.3	1.5	7.1	3.4	12.6	6.2	9.1	5.1	17.2	2.3	1.8	14.6	1.0	24.0	15.2	1.9	2.9	1.0	6.7	4.8	4.7	34.7	6.6	23.4	1.5	1.2	6.4	5.1	6.9	0.0	12.6	6.1	8.6	1.2	37.0	20.8	7.0	2.0	3.5	4.6	1.6	22.1	2.7	5.4	4.7	0.9	12.8	24.7	12.5	388.7	2.3	7.1	23.7	6.7	2.4	11.6	1.4	4.9	7.9	0.0	11.4	4.7	0.5	4.7	1.7	2.7	0.8	13.2	2.8	11.0	1.3
C2orf78	"COG5373, FLJ43987, hCG1989538"	ENSG00000187833	"Chromosome 2 open reading frame 78"	A6NCI8	2	73784189-73817147	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	22	"testis: 12.5"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 49.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"									NA	NA									"unprognostic (5.25e-2)"			"unprognostic (6.56e-3)"							"unprognostic (2.42e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CXorf66	"RP11-35F15.2, SGPX"	ENSG00000203933	"Chromosome X open reading frame 66"	Q5JRM2	X	139955728-139965521	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	22	"testis: 13.5"	"Cell type enriched"	"Detected in some"	7	"Early spermatids: 129.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA												"unprognostic (3.87e-2)"											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	129.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM170B	"AC084727.4, C10orf73"	ENSG00000172538	"Family with sequence similarity 170 member B"	A6NMN3	10	49131154-49134021	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	22	"testis: 6.5"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 80.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	20	"eosinophil: 1.9"	"Lineage enriched"	"Detected in single"	20	"granulocytes: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043899, HPA050610"	Uncertain					NA	NA					"HPA043899: AB_2678721, HPA050610: AB_2681189"													"unprognostic (8.01e-2)"					0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	80.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	19.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TAT		ENSG00000198650	"Tyrosine aminotransferase"	P17735	16	71565660-71577092	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	"Aminotransferase, Transferase"	"Disease variant, Mental retardation, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	22	"liver: 1283.0"	"Cell type enriched"	"Detected in some"	43	"Hepatocytes: 4164.8"	"Cancer enriched"	"Detected in some"	10	"liver cancer: 152.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Hep G2: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (3.66e-3)"	"unprognostic (1.29e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.01e-2)"	"prognostic favorable (6.51e-4)"	"unprognostic (1.69e-1)"	"unprognostic (9.32e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.73e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.27e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.05e-2)"	0.1	0.0	0.0	0.1	0.0	0.1	59.5	0.0	0.1	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.4	1283.0	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.2	0.6	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.8	0.1	1.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	2.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.4	0.1	0.1	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.7	6.7	0.0	0.1	0.0	0.0	0.6	95.3	18.7	0.5	72.9	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.3	1.0	0.3	0.0	3.1	0.0	45.5	0.0	0.7	0.0	0.2	0.0	0.1	0.0	0.1	49.6	4164.8	0.0	0.0	0.0	0.0	0.0	72.3	0.0	0.7	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	2.7	0.2	0.3	1.0	0.0	0.0	0.1	1.3	1.3	0.0	0.0	0.0	3.9	0.0	0.1	0.0
ZG16	"hZG16, JCLN, JCLN1, ZG16A"	ENSG00000174992	"Zymogen granule protein 16"	O60844	16	29778256-29782973	"Predicted secreted proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	22	"intestine: 484.1"	"Cell type enriched"	"Detected in some"	10	"Intestinal goblet cells: 20216.0"	"Cancer enriched"	"Detected in some"	6	"colorectal cancer: 21.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SK-BR-3: 2.3"	"Not detected"	"Not detected"							"HPA052066, HPA052512"	Enhanced				"Secreted to digestive system"	NA	NA		1300000			"HPA052066: AB_2681716, HPA052512: AB_2681857"	"unprognostic (1.64e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.60e-3)"	"unprognostic (8.20e-2)"		"unprognostic (3.50e-2)"	"unprognostic (1.93e-2)"	"unprognostic (5.14e-2)"		"unprognostic (1.65e-1)"	"unprognostic (7.77e-2)"	"unprognostic (3.27e-1)"		"unprognostic (2.56e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.42e-1)"	0.5	0.0	0.0	7.9	0.1	0.1	0.7	0.1	0.1	0.0	0.0	366.3	58.3	0.6	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.4	22.4	0.0	0.2	0.1	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.1	0.1	484.1	0.1	0.0	0.5	0.0	0.1	138.0	13.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	2.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.8	0.3	0.4	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.6	0.0	1107.2	0.0	0.0	0.0	0.1	0.0	0.1	145.5	0.0	0.1	11.9	0.0	0.1	0.0	0.2	40.1	0.0	0.4	44.6	0.0	0.0	0.1	20216.0	0.0	0.8	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	484.8	0.0	0.0	0.2	1950.6	1.6	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.5	7.1	0.0	306.7	0.3
ACTC1	"ACTC, CMD1R"	ENSG00000159251	"Actin alpha cardiac muscle 1"	P68032	15	34790230-34795549	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Muscle protein"	"Atrial septal defect, Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	21	"heart muscle: 11516.0"	"Cell type enriched"	"Detected in some"	30	"Cardiomyocytes: 9746.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 20.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 1131.8;LHCN-M2: 4544.5;RH-30: 2053.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB037330, HPA041264, HPA041271"	Enhanced					NA	NA		2400000000			"CAB037330: , HPA041264: AB_2677383, HPA041271: AB_2677386"	"unprognostic (8.18e-3)"	"unprognostic (3.74e-2)"	"unprognostic (4.82e-3)"	"unprognostic (1.19e-2)"	"unprognostic (3.04e-2)"	"prognostic unfavorable (3.72e-5)"	"unprognostic (3.26e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.26e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.10e-3)"	"unprognostic (5.68e-4)"	"unprognostic (8.79e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (9.32e-4)"	51.6	1.8	2.0	24.9	1.9	0.0	12.0	2.2	5.6	8.3	6.7	4.1	0.8	7.0	1.1	23.0	1.7	12.0	11516.0	1.9	2.4	1.5	0.6	4.0	2.6	2.7	2.9	1.8	3.2	13.0	1.0	2.3	9.0	3.2	73.7	3.6	31.8	11.6	543.1	136.3	3.3	0.6	8.9	1.4	1.3	9.4	0.6	3.4	11.4	2.4	196.8	0.2	444.1	16.3	2.8	0.0	0.2	0.1	0.0	0.2	3.3	0.2	2.2	0.7	5.2	1.3	0.0	0.0	0.0	1.3	1131.8	0.2	0.0	0.4	0.0	1.3	0.0	0.0	0.1	23.9	0.0	0.1	1.4	0.0	457.2	0.0	0.2	0.1	0.3	0.1	0.0	0.0	0.0	4544.5	0.0	0.0	0.0	3.8	0.0	0.0	0.0	2053.3	0.0	0.0	0.0	0.1	0.1	4.0	0.0	0.0	31.2	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.0	0.0	0.2	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.9	2.2	5.6	1.9	2.4	2.7	2.9	1.8	3.2	1.4	3.4	2.8	0.0	0.0	0.0	0.3	0.0	0.5	0.3	0.0	0.0	11.9	0.1	0.0	9746.1	0.0	0.0	0.0	20.9	0.1	0.0	0.0	1.9	0.0	5.0	0.0	0.1	69.2	0.0	0.0	0.2	0.2	4.3	315.2	0.0	0.0	0.0	0.1	0.4	0.4	0.1	0.0	0.4	0.0	0.0	0.0	0.0	1.9	0.0	0.2	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.2	0.0	63.4	86.5	1.0	0.7	0.0	0.4	0.3	0.1	0.1	0.0	0.0
ATF5		ENSG00000169136	"Activating transcription factor 5"	Q9Y2D1	19	49928702-49933935	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	21	"liver: 2500.3"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 1412.6"	"Cancer enriched"	"Detected in all"	7	"liver cancer: 200.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 24.0;intermediate monocyte: 22.4;myeloid DC: 14.3;plasmacytoid DC: 38.5"	"Group enriched"	"Detected in all"	9	"dendritic cells: 38.5;monocytes: 24.0"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 313.2;Karpas-707: 523.4;THP-1: 452.4;U-266/84: 715.6;U-698: 316.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030187	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA030187: AB_10601666"	"unprognostic (2.09e-2)"	"prognostic favorable (1.14e-4)"	"unprognostic (9.38e-3)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.52e-1)"	"unprognostic (6.70e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.96e-3)"	"prognostic unfavorable (3.39e-7)"	"unprognostic (3.06e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.51e-1)"	38.0	61.9	13.1	32.0	11.5	21.6	35.9	10.4	15.3	15.0	9.3	17.9	28.6	16.3	9.9	18.1	23.1	14.5	16.7	12.0	12.6	26.1	2500.3	17.2	23.5	14.6	12.7	9.3	14.2	29.4	10.1	14.8	12.4	14.6	23.4	10.4	12.6	21.3	10.4	30.8	17.7	23.4	10.3	12.9	27.5	24.7	44.7	12.3	13.2	119.7	9.6	20.2	24.6	14.4	14.9	68.5	47.3	17.8	12.0	18.3	15.5	17.8	48.6	40.8	49.4	30.2	35.7	36.5	60.7	24.3	28.6	34.0	24.2	22.7	20.0	23.5	313.2	22.6	41.7	14.8	27.4	12.5	162.7	113.6	108.3	31.5	36.5	8.5	12.2	21.4	132.6	38.1	523.4	24.7	64.3	23.5	35.9	8.8	18.6	62.6	194.2	19.1	24.9	56.6	90.9	28.2	20.1	113.2	47.8	34.9	6.6	39.2	452.4	36.6	95.5	61.3	11.3	49.8	13.8	715.6	316.2	75.1	63.6	36.4	0.4	24.0	1.0	1.4	22.4	2.0	1.6	1.4	1.7	14.3	0.8	1.2	1.8	3.6	3.2	6.0	38.5	1.9	4.7	13.1	11.5	10.4	15.3	12.0	12.6	14.6	12.7	9.3	14.6	12.9	12.3	14.9	16.3	12.8	11.9	2.6	41.7	22.6	12.3	11.1	39.9	3.8	31.9	29.3	7.4	38.6	9.4	16.5	6.2	33.9	23.5	22.0	13.7	13.1	260.8	36.5	17.4	21.1	21.5	64.2	1.2	29.8	19.4	27.3	34.1	35.3	6.3	27.1	40.0	1412.6	82.5	92.5	1.8	21.0	2.0	59.4	172.3	134.3	13.4	51.2	40.9	2.8	259.9	17.4	8.2	0.5	1.6	20.0	20.6	16.6	118.1	24.8	49.0	47.9	9.6	7.5	13.1	18.0	24.2	15.0	11.3	37.7	24.0	35.6	15.1	23.4	23.4	18.4
GPR26		ENSG00000154478	"G protein-coupled receptor 26"	Q8NDV2	10	123666355-123697399	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	21	"brain: 7.0"	"Cell type enriched"	"Detected in some"	6	"Excitatory neurons: 11.4"	"Cancer enriched"	"Detected in single"	13	"breast cancer: 0.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	11	"SCLC-21H: 1.0"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 62.7"	HPA062736	Enhanced					NA	NA					"HPA062736: AB_2684855"	"unprognostic (4.15e-2)"				"unprognostic (5.75e-2)"	"unprognostic (3.42e-1)"		"unprognostic (2.12e-1)"			"unprognostic (9.09e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.12e-1)"			0.0	0.0	1.1	0.0	1.5	0.0	0.0	0.0	4.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	2.0	0.0	0.0	0.0	0.0	2.0	7.0	1.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	3.4	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.5	0.0	4.5	5.6	2.0	2.0	7.0	1.3	1.0	0.6	3.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0
LRCOL1		ENSG00000204583	"Leucine rich colipase like 1"	A6NCL2	12	132603150-132610582	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"epididymis: 50.5"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 33.2"	"Group enriched"	"Detected in some"	4	"endometrial cancer: 0.8;liver cancer: 3.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"												"Secreted in male reproductive system"	NA	NA						"unprognostic (5.09e-3)"	"unprognostic (7.83e-3)"	"unprognostic (3.26e-1)"	"unprognostic (6.94e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.38e-2)"	"prognostic favorable (7.04e-4)"	"unprognostic (4.54e-2)"	"unprognostic (6.08e-2)"	"unprognostic (5.29e-2)"	"unprognostic (4.66e-3)"	"unprognostic (1.52e-1)"	"unprognostic (6.50e-6)"	"unprognostic (1.46e-3)"	"unprognostic (9.63e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.00e-3)"	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.1	0.0	0.2	50.5	0.1	0.4	0.0	0.0	0.0	0.0	0.1	2.3	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.3	0.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.4	0.6	1.9	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.3	0.0	0.1	3.3	33.2	0.0	0.0	0.1	0.0	0.0	1.0	0.3	0.0	1.5	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.1	0.1	0.0	0.2	0.4	0.0	0.0
LRG1	LRG	ENSG00000171236	"Leucine rich alpha-2-glycoprotein 1"	P02750	19	4536402-4540036	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	21	"liver: 952.0"	"Cell type enriched"	"Detected in many"	7	"Hepatocytes: 793.0"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 160.9"	"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in many"	19	"neutrophil: 285.2"	"Lineage enriched"	"Detected in many"	44	"granulocytes: 285.2"	"Cell line enhanced"	"Detected in many"		"Hep G2: 15.4;SK-BR-3: 15.7;THP-1: 26.2;U-937: 48.7"	"Low region specificity"	"Detected in single"							"HPA001888, HPA001889"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	21000000000	42000000000	Vesicles		"HPA001888: AB_1079276, HPA001889: AB_1079275"	"unprognostic (5.54e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.46e-3)"	"unprognostic (9.83e-2)"	"prognostic unfavorable (3.66e-6)"	"unprognostic (4.06e-2)"	"unprognostic (1.45e-1)"	"prognostic favorable (3.49e-4)"	"unprognostic (2.60e-2)"	5.5	4.6	0.6	17.9	0.5	31.7	4.3	1.1	2.3	8.7	1.2	7.4	6.8	1.9	5.9	22.9	10.1	15.6	1.1	0.6	0.6	7.9	952.0	7.9	0.8	0.7	0.6	0.5	1.6	44.5	0.1	1.6	1.9	1.9	4.4	4.7	0.2	21.1	6.2	1.0	4.3	3.4	2.2	0.4	16.4	13.8	0.3	0.8	1.2	1.3	1.4	6.5	13.4	3.8	1.3	10.8	0.1	0.0	0.0	0.0	0.1	8.0	0.0	0.0	0.0	0.0	1.0	8.0	3.6	13.3	0.0	0.5	1.4	0.0	1.7	0.1	13.4	0.4	0.3	0.2	15.4	0.0	0.4	13.9	4.1	0.0	0.0	0.0	0.0	0.1	0.0	9.6	0.2	0.0	0.6	0.0	11.3	0.2	8.2	0.0	0.1	0.3	11.3	1.0	2.0	0.0	0.0	0.1	15.7	0.1	1.3	4.8	26.2	0.3	0.0	0.2	0.1	0.2	0.1	0.1	0.2	0.0	48.7	0.0	2.4	6.4	15.0	0.1	2.0	0.1	0.4	0.3	0.1	1.6	0.4	0.1	0.1	285.2	0.2	1.3	0.2	1.1	2.2	0.6	0.5	1.1	2.3	0.6	0.6	0.7	0.6	0.5	1.9	0.4	0.8	1.3	13.4	12.8	54.3	0.0	3.3	8.0	33.1	56.8	18.2	0.1	14.2	2.5	0.5	60.1	50.2	14.7	0.0	0.8	0.5	44.7	1.9	112.7	0.0	38.0	1.8	24.7	4.9	13.2	0.0	64.1	12.4	3.0	31.6	17.3	12.0	0.2	38.2	793.0	6.7	1.7	0.0	26.3	32.6	19.9	5.0	0.0	0.0	14.7	1.8	0.0	7.3	0.1	0.0	0.0	0.0	40.6	11.9	0.0	1.7	4.5	10.8	4.9	76.1	0.1	0.0	2.3	3.3	0.0	0.2	9.0	5.8	1.4	1.9	3.4	27.6	30.2
NIBAN3	"BCNP1, FAM129C, FLJ39802"	ENSG00000167483	"Niban apoptosis regulator 3"	Q86XR2	19	17523301-17553839	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"bone marrow: 15.5;intestine: 16.8;lymphoid tissue: 35.0"	"Cell type enriched"	"Detected in some"	8	"B-cells: 11.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	379	"memory B-cell: 31.9;naive B-cell: 52.1;plasmacytoid DC: 110.7"	"Group enriched"	"Detected in many"	476	"B-cells: 52.1;dendritic cells: 110.7"	"Group enriched"	"Detected in some"	19	"Daudi: 50.1;REH: 23.8;U-698: 33.2"	"Not detected"	"Not detected"							HPA043277	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA043277: AB_10794391"	"unprognostic (6.55e-5)"	"unprognostic (3.03e-7)"	"unprognostic (3.40e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.69e-4)"	"unprognostic (3.79e-3)"	"unprognostic (1.69e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.20e-1)"	"unprognostic (9.47e-4)"	"unprognostic (8.42e-2)"	"unprognostic (5.51e-5)"	"unprognostic (3.39e-1)"	"unprognostic (9.03e-3)"	"unprognostic (6.08e-2)"	"unprognostic (7.56e-3)"	0.2	0.0	0.1	10.8	0.1	15.5	0.1	0.1	0.2	0.1	0.0	0.5	0.0	0.1	0.0	0.4	0.1	1.0	0.1	0.1	0.1	0.4	0.3	0.5	26.2	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.4	0.0	0.0	0.0	16.8	0.0	0.1	35.0	0.7	0.5	0.1	1.8	0.6	0.0	12.3	0.6	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.4	0.0	0.0	0.0	23.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.9	0.0	0.0	0.0	52.1	0.0	0.1	0.0	0.0	0.0	110.7	0.0	2.2	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.4	0.1	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
TRAV2		ENSG00000211776	"T cell receptor alpha variable 2"	A0A0B4J234	14	21712321-21712843	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	21	"lymphoid tissue: 56.8"	"Cell type enriched"	"Detected in single"	5	"T-cells: 2.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 40.9"	"Lineage enriched"	"Detected in single"	124	"T-cells: 40.9"	"Cell line enriched"	"Detected in single"	21	"Daudi: 2.1"															NA	NA						"unprognostic (1.38e-2)"	"unprognostic (6.44e-3)"	"unprognostic (7.50e-2)"	"unprognostic (1.93e-2)"		"unprognostic (1.86e-3)"	"unprognostic (3.64e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.84e-2)"	"unprognostic (9.93e-5)"	"unprognostic (1.92e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.45e-2)"	0.3	0.2	0.0	8.3	0.0	2.5	0.3	0.0	0.5	0.2	0.0	2.0	0.8	0.0	0.0	0.9	0.3	0.9	0.3	0.0	0.0	0.2	0.3	1.6	20.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.9	0.0	0.2	0.0	0.0	0.1	1.7	0.1	0.0	3.4	2.7	0.2	0.1	56.8	0.2	0.0	13.3	2.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	31.3	0.0	31.5	9.9	0.0	0.0	24.5	9.6	0.1	0.0	0.0	0.3	40.9	5.7	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0
ALLC	ALC	ENSG00000151360	Allantoicase	Q8N6M5	2	3658200-3702671	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	20	"testis: 16.6"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 140.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	19	"U-266/84: 6.1"	"Not detected"	"Not detected"													NA	NA									"unprognostic (5.47e-2)"	"unprognostic (3.24e-2)"		"unprognostic (2.91e-3)"	"unprognostic (4.75e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.83e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.74e-4)"	"unprognostic (1.01e-2)"	"unprognostic (2.73e-1)"			0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.4	0.6	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	16.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	140.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	33.2	3.4	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	22.2	0.0	0.0	0.0	0.5	0.0	0.0	13.1	0.0	0.1	5.1	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0
C5orf52		ENSG00000187658	"Chromosome 5 open reading frame 52"	A6NGY3	5	157671533-157680158	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"testis: 36.2"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 1980.5"	"Cancer enriched"	"Detected in single"	4	"colorectal cancer: 1.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"									NA	NA								"unprognostic (3.20e-2)"							"unprognostic (1.01e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.50e-1)"		"unprognostic (3.64e-1)"	"unprognostic (1.32e-1)"			0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.6	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	36.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	401.1	1.5	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1980.5	7.8	0.6	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.1	5.8	6.4	0.1	0.0	0.1	0.0	0.0	0.0	6.6	0.0	0.0	26.4	4.6	0.0	0.0	0.0	0.0	0.0	1.2	0.0
CYP2C9	"CYP2C10, P450IIC9"	ENSG00000138109	"Cytochrome P450 family 2 subfamily C member 9"	P11712	10	94938658-94990091	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"liver: 1734.1"	"Cell type enriched"	"Detected in some"	26	"Hepatocytes: 1704.9"	"Cancer enriched"	"Detected in some"	41	"liver cancer: 118.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA015066, CAB016123, HPA074424"	Enhanced		Uncertain	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA			Vesicles	"Plasma membrane"	"CAB016123: AB_629363, HPA015066: AB_1847433, HPA074424: "	"unprognostic (3.37e-1)"	"unprognostic (5.68e-2)"	"unprognostic (9.67e-2)"	"unprognostic (4.16e-2)"		"unprognostic (1.83e-2)"	"prognostic favorable (2.83e-6)"	"unprognostic (2.37e-1)"	"unprognostic (2.05e-2)"		"unprognostic (4.93e-2)"		"unprognostic (1.26e-4)"	"unprognostic (7.55e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.24e-2)"	0.1	0.0	0.0	0.4	0.0	0.2	0.1	0.1	0.1	0.6	0.0	1.5	88.6	0.0	0.0	7.7	0.0	8.0	0.0	0.0	0.0	4.2	1734.1	0.2	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.3	0.0	1.0	0.0	0.0	2.3	46.6	0.1	0.0	0.5	18.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	18.6	0.2	1.8	0.0	0.0	0.0	1.5	0.0	7.6	0.0	0.8	0.7	1.1	0.0	16.0	0.0	0.7	0.0	0.2	44.4	7.4	0.0	0.0	26.7	1704.9	0.0	0.0	0.1	1.4	0.0	34.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	2.6	0.0	0.1	0.0	65.3	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.1	1.9	0.0	2.7	0.0
LDHAL6B	"LDH6B, LDHAL6, LDHL"	ENSG00000171989	"Lactate dehydrogenase A like 6B"	Q9BYZ2	15	59206843-59208588	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"testis: 41.0"	"Cell type enriched"	"Detected in some"	13	"Spermatocytes: 101.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HeLa: 1.1"	"Region enriched"	"Detected in single"	6	"olfactory bulb: 1.3"					HPA053962	Enhanced					NA	NA					"HPA053962: AB_2682324"	"unprognostic (1.59e-1)"	"unprognostic (9.41e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.46e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.13e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.12e-7)"	"unprognostic (3.47e-2)"	"unprognostic (1.49e-2)"	"unprognostic (8.53e-2)"	"unprognostic (7.80e-2)"	0.2	0.0	0.5	0.2	0.7	0.0	0.2	0.5	0.8	0.2	2.0	0.2	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.2	0.4	0.2	0.3	0.1	0.1	0.8	0.5	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.2	0.0	0.0	0.1	0.0	0.1	0.3	0.3	0.0	0.6	0.0	0.1	41.0	0.7	0.0	0.1	0.0	0.0	0.1	0.2	1.8	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.5	0.8	0.2	0.4	0.8	0.5	0.0	1.0	0.6	0.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	101.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NUPR2	NUPR1L	ENSG00000185290	"Nuclear protein 2, transcriptional regulator"	A6NF83	7	56114681-56116417	"Predicted intracellular proteins"	"Cell cycle, Growth arrest, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	20	"testis: 357.6"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 15101.8"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 13.7"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 5.1"	"Group enriched"	"Detected in many"	4	"granulocytes: 2.0;T-cells: 5.1"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 11.9"	"Not detected"	"Not detected"													NA	NA						"unprognostic (5.81e-2)"	"unprognostic (2.01e-1)"		"unprognostic (1.10e-1)"	"unprognostic (9.52e-2)"	"unprognostic (3.25e-2)"		"unprognostic (2.46e-1)"		"unprognostic (1.34e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.50e-2)"	"prognostic favorable (9.53e-5)"	"unprognostic (1.66e-1)"	"unprognostic (8.44e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.44e-2)"	2.2	3.3	7.1	0.3	7.5	1.0	2.7	8.4	9.3	1.8	5.4	0.9	1.2	0.7	3.0	0.7	1.6	0.4	1.3	7.4	7.9	17.6	2.3	1.0	0.7	7.1	7.0	7.7	1.3	4.0	3.3	12.8	0.7	7.1	6.5	0.7	2.6	7.8	5.7	1.5	1.3	0.7	0.6	6.3	0.7	6.0	357.6	7.9	1.4	15.6	1.0	0.6	0.6	0.8	7.5	1.0	3.1	1.4	4.0	3.6	1.5	0.5	0.2	1.4	0.7	0.4	0.4	2.2	0.4	4.7	0.1	1.5	0.3	1.9	0.5	0.9	0.7	6.0	2.4	1.4	2.7	1.9	0.8	0.3	2.8	2.0	1.0	4.4	1.7	1.3	3.1	3.0	2.5	1.4	3.3	1.3	3.1	1.3	1.2	3.3	1.1	1.6	11.9	2.3	0.5	3.9	3.6	1.9	0.5	5.4	4.6	1.2	0.7	1.0	0.6	1.7	0.9	0.7	3.8	4.8	4.6	2.4	3.0	1.1	2.0	0.3	0.6	0.3	0.0	0.5	0.4	1.8	0.5	0.4	0.5	5.1	1.4	0.1	0.4	0.5	0.8	0.5	0.8	7.1	7.5	8.4	9.3	7.4	7.9	7.1	7.0	7.7	7.1	6.3	7.9	7.5	0.2	0.0	1.5	0.0	0.2	0.0	21.3	0.0	2.2	1.4	39.6	41.3	0.0	0.0	1.8	90.1	0.0	9.6	0.5	1.4	422.6	3.6	3765.4	3.9	0.1	6.7	14.6	0.0	0.0	1.8	1.7	0.9	9.7	2.4	1.3	0.1	0.0	0.0	0.6	16.8	0.0	3.0	0.0	0.0	0.0	15101.8	94.1	5.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	1.5	68.4	0.0	24.8	0.1	3.2	2.9	0.8	85.5	0.0	1.5	112.8	53.3	2.7	0.0	2.9	0.6	0.0	2.0	20.4
PON3		ENSG00000105852	"Paraoxonase 3"	Q15166	7	95359872-95396375	"Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	20	"liver: 621.9"	"Cell type enriched"	"Detected in many"	11	"Hepatocytes: 509.6"	"Group enriched"	"Detected in many"	9	"liver cancer: 30.8;lung cancer: 7.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 28.9;CACO-2: 8.6;CAPAN-2: 6.5;Hep G2: 32.6;T-47d: 17.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA014848, CAB025250"	Enhanced				"Secreted to blood"	NA	NA	1760000000	380000000			"CAB025250: , HPA014848: AB_1855540"	"unprognostic (2.67e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.28e-3)"	"unprognostic (5.52e-3)"	"unprognostic (1.36e-1)"	"unprognostic (4.87e-1)"	"unprognostic (1.44e-3)"	"unprognostic (6.32e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.44e-3)"	"unprognostic (9.14e-2)"	"unprognostic (7.18e-3)"	"unprognostic (8.30e-9)"	"unprognostic (1.66e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.29e-2)"	"unprognostic (5.12e-2)"	1.0	3.9	1.9	0.5	1.6	0.0	31.5	1.6	1.7	5.3	1.2	2.0	7.9	0.9	3.7	0.5	1.3	4.5	0.8	1.6	1.9	2.7	621.9	14.3	0.1	2.1	2.2	1.4	12.5	14.4	0.2	25.1	0.8	3.1	0.9	2.9	0.1	26.5	4.0	0.3	7.5	3.1	0.2	1.9	0.3	2.3	9.1	1.9	1.6	7.2	0.3	6.0	1.4	0.9	1.7	3.1	28.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	6.5	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.6	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	5.3	0.0	0.1	17.4	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.6	1.6	1.7	1.6	1.9	2.1	2.2	1.4	3.1	1.9	1.9	1.7	2.5	6.4	45.9	24.5	0.6	0.9	0.9	9.3	1.8	0.0	5.4	4.3	0.5	31.5	23.9	3.7	0.0	1.7	0.3	3.2	1.9	0.3	14.5	0.0	0.4	1.9	0.0	8.0	0.1	2.0	2.2	5.2	0.5	0.0	0.0	0.4	10.0	509.6	0.2	0.0	0.2	1.8	12.2	8.1	0.3	4.8	8.1	0.2	14.2	4.7	0.0	3.2	0.0	17.6	0.1	1.2	1.2	3.0	0.0	2.1	6.0	6.7	6.5	0.1	0.0	0.8	2.1	21.4	16.9	0.3	1.3	1.4	0.8	6.6	2.3	0.4
RBP4		ENSG00000138207	"Retinol binding protein 4"	P02753	10	93591687-93601744	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Sensory transduction, Transport, Vision"		"Cancer-related genes, Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	20	"liver: 12018.0"	"Cell type enriched"	"Detected in many"	12	"Hepatocytes: 12711.6"	"Cancer enriched"	"Detected in all"	27	"liver cancer: 3135.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"Hep G2: 1117.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001641, CAB004555"	Supported				"Secreted to blood"	NA	NA	46100000000	210000000000			"CAB004555: AB_670938, HPA001641: AB_1079795"	"unprognostic (9.42e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (2.60e-2)"	"unprognostic (6.69e-4)"	"prognostic favorable (1.74e-8)"	"unprognostic (2.39e-1)"	"unprognostic (5.76e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.44e-1)"	"unprognostic (7.14e-3)"	"unprognostic (9.88e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.60e-2)"	600.0	32.7	29.9	6.3	39.2	1.1	397.5	16.0	48.5	5.7	16.9	9.2	4.9	2.3	1.0	1.1	2.1	7.5	10.7	34.5	87.4	144.1	12018.0	24.7	0.6	24.4	23.1	36.7	4.1	83.0	0.1	523.9	12.5	23.9	8.7	6.8	3.0	13.8	4.7	6.3	14.6	19.3	0.8	17.8	5.6	12.0	4.7	42.9	1.5	8.0	5.3	0.1	19.2	8.9	26.4	0.0	14.7	0.0	0.0	2.9	0.0	0.1	0.3	0.1	2.5	0.4	264.9	0.5	1.5	2.7	0.3	0.2	0.8	0.0	0.0	0.3	0.2	0.2	2.2	1.1	1117.2	0.2	9.2	0.2	18.7	0.5	0.7	0.0	0.0	0.0	0.0	1.4	0.2	1.2	0.0	0.1	7.3	1.3	2.4	121.7	0.4	7.0	0.0	0.0	0.6	0.9	0.2	9.6	0.0	0.0	0.6	0.5	0.8	0.4	0.0	7.8	0.2	0.3	0.9	0.3	3.7	0.0	3.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.9	39.2	16.0	48.5	34.5	87.4	24.4	23.1	36.7	23.9	17.8	42.9	26.4	9.1	0.0	4.2	0.3	17.2	0.8	0.5	0.0	0.0	0.0	2.1	6.7	0.7	999.4	0.6	23.9	6.2	0.3	0.2	21.9	97.8	7.8	2.8	1.6	3.1	10.8	62.5	152.4	5.8	0.2	22.6	10.5	0.0	22.1	0.0	0.0	158.1	12711.6	17.8	0.0	7.2	40.7	0.0	210.4	3.0	2.4	3.1	7.8	1.8	1.0	0.0	0.8	0.0	1.0	1.1	29.2	28.0	5.7	0.3	2.1	0.8	785.3	0.7	0.5	0.0	7.3	3.8	3.1	13.9	0.0	0.9	1.4	12.3	0.0	1.7	1.4
ROS1	"c-ros-1, MCF3, ROS"	ENSG00000047936	"ROS proto-oncogene 1, receptor tyrosine kinase"	P08922	6	117287353-117425942	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	20	"epididymis: 59.1;lung: 32.0"	"Cell type enriched"	"Detected in some"	4	"Alveolar cells type 2: 78.5"	"Cancer enriched"	"Detected in some"	13	"lung cancer: 6.9"	"Region enhanced"	"Detected in single"		"cerebral cortex: 2.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"GAMG: 19.3;HSkMC: 10.1;hTCEpi: 21.7;LHCN-M2: 14.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA049098, HPA072424"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA049098: AB_2680628, HPA072424: AB_2686519"	"unprognostic (8.18e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.57e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.56e-12)"	"unprognostic (1.09e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.12e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.2	0.0	0.4	0.0	0.0	59.1	0.0	0.1	0.0	0.0	0.5	0.0	0.3	0.1	32.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.5	0.0	0.0	2.2	0.4	0.2	0.2	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	10.1	21.7	0.2	1.9	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	2.0	0.0	3.1	1.7	0.2	2.1	0.0	0.0	0.0	1.9	3.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.5	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.4	0.0	16.0	78.5	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.8	0.0	3.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.3	1.8	0.2	0.0	0.0	0.0	17.8	0.0	0.0	0.2	0.0	1.5	1.3	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	1.3	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0
SAA1	"PIG4, SAA, TP53I4"	ENSG00000173432	"Serum amyloid A1"	P0DJI8	11	18266260-18269977	"Disease related genes, Predicted secreted proteins"	"Acute phase"	Heparin-binding	Amyloidosis	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	20	"liver: 48539.6"	"Cell type enriched"	"Detected in many"	6	"Hepatocytes: 99298.7"	"Cancer enriched"	"Detected in many"	16	"liver cancer: 1249.6"	"Group enriched"	"Detected in some"	6	"hypothalamus: 41.8;white matter: 12.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"HBEC3-KT: 716.4"														"Secreted to blood"	NA	NA	300000000	11000000000				"unprognostic (2.86e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.63e-2)"	"unprognostic (7.04e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (4.57e-12)"	"unprognostic (5.15e-2)"	"unprognostic (9.78e-2)"	"unprognostic (9.23e-3)"	"unprognostic (1.64e-1)"	2058.8	54.9	0.1	163.1	0.1	0.0	1394.3	0.1	0.6	260.1	1.4	31.8	1.4	2.2	0.2	51.5	57.1	34.0	17.0	0.2	41.8	28.5	48539.6	99.4	1.2	0.8	3.0	0.1	3.3	47.1	0.5	67.1	7.2	0.3	67.1	6.5	0.0	2387.4	4.4	515.8	81.3	75.6	19.0	0.1	39.1	42.4	1.7	4.5	52.6	18.3	0.2	15.9	64.4	29.3	12.5	49.2	0.3	0.0	0.3	34.4	0.2	18.9	1.3	1.1	0.2	0.3	0.1	17.2	0.0	38.3	0.0	11.7	45.5	0.0	716.4	0.3	0.6	0.0	0.8	0.0	0.1	148.4	1.1	0.0	60.9	66.7	0.2	76.7	0.1	0.0	0.0	0.1	0.0	9.3	0.1	0.0	0.1	0.0	0.0	0.0	0.2	1.7	0.0	28.5	0.9	0.0	0.1	4.2	5.5	0.2	0.0	0.5	0.0	0.0	0.2	5.5	0.0	1.3	0.0	1.3	1.3	0.1	0.7	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.6	0.2	41.8	0.8	3.0	0.1	0.3	0.1	4.5	12.5	107.2	6.4	2.8	0.0	259.8	9.3	64.9	10039.5	10.2	0.0	210.6	1010.4	0.1	1701.5	7604.7	55.2	0.0	1.3	3.0	44.5	0.0	250.4	0.0	12.6	1.6	114.9	1.8	3543.7	0.1	81.1	34.4	8.3	0.0	14.3	2.5	0.0	2568.6	99298.7	1.0	0.0	0.1	5.2	2012.1	2454.9	0.3	0.0	0.0	2.6	51.6	0.0	2.6	0.0	1.0	0.0	0.1	68.8	5.5	0.0	0.1	185.5	3.1	0.2	15716.2	0.0	0.0	31.5	736.1	0.0	0.0	34.1	0.1	2.1	214.7	0.0	36.7	178.8
SAA2		ENSG00000134339	"Serum amyloid A2"	P0DJI9	11	18239223-18248668	"Disease related genes, Predicted secreted proteins"	"Acute phase"		Amyloidosis	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	20	"liver: 36562.7"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 55342.6"	"Cancer enriched"	"Detected in many"	22	"liver cancer: 150.5"	"Group enriched"	"Detected in some"	6	"hypothalamus: 49.8;white matter: 19.9"	"Immune cell enhanced"	"Detected in some"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 27.8;EFO-21: 20.2;GAMG: 19.6;HaCaT: 25.0;HBEC3-KT: 55.4;HSkMC: 17.6"														"Secreted to blood"	NA	NA		9200000000				"unprognostic (1.73e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.63e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.40e-3)"	"unprognostic (7.12e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.78e-2)"	"unprognostic (6.13e-2)"	"prognostic unfavorable (1.30e-8)"	"unprognostic (1.53e-1)"	"unprognostic (9.72e-2)"	"unprognostic (7.62e-3)"	"unprognostic (1.28e-1)"	567.4	17.1	0.0	139.1	0.2	0.5	324.2	0.4	0.7	279.3	0.6	7.9	0.9	1.0	0.2	22.3	21.3	14.2	6.3	0.2	49.8	12.4	36562.7	36.0	0.6	0.3	5.6	0.2	1.8	14.1	0.2	31.4	1.8	0.6	38.8	1.3	0.6	1810.9	1.6	223.0	20.6	21.1	6.6	0.0	20.2	18.3	2.1	5.9	16.4	6.7	0.2	6.9	22.6	7.9	19.9	27.8	0.1	0.2	0.2	1.0	0.0	3.6	0.1	0.8	0.1	0.3	0.0	12.1	0.1	20.2	0.2	19.6	25.0	0.0	55.4	0.1	1.2	0.0	1.0	0.5	0.0	7.8	0.8	0.1	17.6	7.4	0.0	8.9	0.6	0.2	0.0	0.0	0.9	1.5	0.0	0.2	0.0	0.5	0.4	0.0	0.2	0.7	0.0	12.4	1.3	0.3	0.0	1.7	8.5	0.1	0.5	0.4	0.5	0.2	0.2	1.2	0.5	1.2	0.5	0.3	1.7	0.1	1.1	0.3	1.0	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.4	0.1	0.1	1.1	0.1	0.2	0.2	0.2	0.1	0.0	0.2	0.4	0.7	0.2	49.8	0.3	5.6	0.2	0.6	0.0	5.9	19.9	7.6	0.0	1.5	0.0	184.4	1.0	5.6	4629.9	0.6	0.0	56.8	68.5	0.2	1052.3	4596.4	3.7	0.0	0.4	0.8	21.9	0.0	70.3	1.6	12.3	0.9	68.2	0.0	2356.0	0.0	34.4	2.3	2.0	0.0	13.5	0.0	0.0	1442.8	55342.6	0.4	0.0	0.0	1.1	1204.4	1502.7	0.0	0.5	0.0	0.6	8.8	0.0	1.0	0.0	0.0	0.0	0.0	27.3	0.0	0.0	0.1	34.5	2.9	0.1	11449.8	0.0	0.0	3.1	400.9	0.3	0.0	5.6	0.1	0.5	144.2	0.0	5.3	65.4
SCN5A	"CDCD2, CMD1E, CMPD2, HB1, HB2, HBBD, HH1, ICCD, IVF, LQT3, Nav1.5, PFHB1, SSS1"	ENSG00000183873	"Sodium voltage-gated channel alpha subunit 5"	Q14524	3	38548057-38649687	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Calmodulin-binding, Ion channel, Sodium channel, Voltage-gated channel"	"Atrial fibrillation, Brugada syndrome, Cardiomyopathy, Disease variant, FDA approved drug targets, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"heart muscle: 42.3"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 77.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"LHCN-M2: 27.6;RH-30: 22.8"	"Group enriched"	"Detected in many"	5	"amygdala: 3.1;basal ganglia: 10.1;hypothalamus: 6.0"	"Region enhanced"	"Detected in many"		"basal ganglia: 5.4"	HPA063346			Supported	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA			"Plasma membrane"	"Nucleoplasm, Nucleoli"	"HPA063346: "	"unprognostic (9.29e-4)"	"unprognostic (4.05e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.21e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.48e-1)"	"unprognostic (7.36e-2)"	"unprognostic (8.48e-2)"	"unprognostic (7.12e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.16e-4)"	"unprognostic (4.85e-3)"	"unprognostic (1.09e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.95e-3)"	0.2	0.1	1.9	0.1	1.2	0.2	0.2	0.0	0.6	1.7	0.0	0.2	0.2	0.7	0.0	0.1	0.3	0.1	42.3	0.2	1.2	0.0	0.0	0.1	0.0	0.4	0.2	0.2	0.5	0.0	0.0	0.4	0.2	0.2	0.3	0.1	2.0	0.2	0.5	1.7	0.1	0.2	0.3	0.1	0.1	0.1	0.3	1.8	0.0	0.2	1.0	0.0	0.4	0.7	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	1.1	0.4	0.1	0.0	0.2	3.6	0.0	0.0	0.0	1.0	0.5	2.7	0.0	0.4	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.4	0.0	2.1	2.8	0.4	0.0	0.0	27.6	1.4	0.0	0.0	2.6	0.0	0.0	0.0	22.8	0.0	0.0	3.2	0.4	3.1	0.0	0.0	0.0	0.8	0.0	0.0	5.7	0.0	5.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.2	0.0	0.6	0.2	1.2	0.4	0.2	0.2	0.2	0.1	1.8	0.1	0.1	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.0	2.7	0.0	0.3	77.1	0.0	0.1	0.0	14.6	0.2	0.0	0.0	0.0	0.1	1.2	0.1	3.2	2.8	0.0	0.0	0.5	0.0	0.3	3.1	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	6.3	0.3	0.6	0.2	0.0	3.7	0.0	0.6	0.0	1.5	0.1	0.1	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.9	0.0	7.3	3.1	0.2	1.0	0.0	0.0	0.0	0.1	0.1	0.0	1.4
SLCO1B3	"OATP1B3, OATP8, SLC21A8"	ENSG00000111700	"Solute carrier organic anion transporter family member 1B3"	Q9NPD5	12	20810702-20916911	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"liver: 267.3"	"Cell type enriched"	"Detected in some"	26	"Hepatocytes: 203.4"	"Cancer enriched"	"Detected in many"	4	"liver cancer: 5.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 65.3;A549: 17.5;CAPAN-2: 12.6;GAMG: 13.6;HeLa: 14.2;PC-3: 17.3;U-2 OS: 14.7"									"HPA004943, HPA050892"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA004943: AB_1854758, HPA050892: AB_2681265"		"unprognostic (5.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.95e-2)"		"unprognostic (1.63e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.09e-2)"		"unprognostic (3.08e-2)"	"unprognostic (1.54e-2)"	"unprognostic (7.37e-2)"		"unprognostic (1.50e-1)"	"unprognostic (6.61e-3)"		"unprognostic (2.36e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	13.1	13.1	0.3	0.2	0.1	0.4	0.3	0.0	0.3	0.0	0.5	0.0	0.0	267.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	1.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	65.3	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	12.6	0.0	4.3	0.0	13.6	0.1	0.0	0.5	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.9	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	14.7	0.0	1.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.2	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	203.4	0.0	0.0	0.5	0.0	0.0	1.6	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.2
TBX22	"CLPA, CPX"	ENSG00000122145	"T-box transcription factor 22"	Q9Y458	X	80014753-80031774	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Deafness, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	20	"testis: 11.2;thyroid gland: 4.8"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 4.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"HDLM-2: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA														"unprognostic (6.58e-2)"						"unprognostic (6.31e-2)"	"unprognostic (1.18e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AGER	"RAGE, SCARJ1"	ENSG00000204305	"Advanced glycosylation end-product specific receptor"	Q15109	6	32180968-32184322	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"lung: 734.6"	"Cell type enriched"	"Detected in many"	22	"Alveolar cells type 1: 2394.2"	"Cancer enhanced"	"Detected in all"		"lung cancer: 27.2;thyroid cancer: 20.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 2.5;JURKAT: 3.0;RPTEC TERT1: 2.2;U-266/70: 2.4;U-266/84: 2.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB011682, HPA064436, HPA069474"	Enhanced		Approved	"Nucleoli fibrillar center,Plasma membrane,Cell Junctions"	"Secreted in other tissues"	NA	NA	5360000	100000	"Plasma membrane, Cell Junctions"	"Nucleoli fibrillar center"	"CAB011682: AB_2258049, HPA064436: AB_2685264, HPA069474: "	"unprognostic (9.37e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.59e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (3.41e-4)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (9.01e-7)"	"unprognostic (3.57e-1)"	"unprognostic (3.70e-2)"	"unprognostic (4.44e-2)"	"prognostic favorable (2.74e-6)"	1.8	1.8	0.1	1.1	0.1	0.5	1.7	0.2	0.4	4.2	0.2	3.2	0.6	2.5	2.0	2.1	4.5	0.1	2.4	0.1	0.1	5.5	2.7	734.6	0.6	0.2	0.1	0.1	4.8	1.8	0.0	5.1	0.4	0.2	4.9	0.8	0.4	1.6	0.0	1.0	1.8	3.2	0.1	0.0	7.0	2.1	2.2	0.1	0.8	39.5	0.1	0.5	2.9	3.3	0.1	0.1	0.0	0.0	0.3	0.1	0.9	1.5	0.0	0.1	0.0	0.1	0.0	0.2	0.1	1.0	0.2	0.0	1.0	0.1	0.3	0.2	0.2	2.5	0.7	0.0	0.0	0.0	0.3	1.1	0.0	0.1	0.0	0.1	0.2	0.1	3.0	0.0	0.3	0.1	1.3	0.1	0.9	0.0	0.1	0.0	0.0	0.1	0.1	2.2	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.5	0.0	0.1	0.0	0.6	0.8	0.1	2.4	2.0	0.9	1.1	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.4	0.1	0.1	0.2	0.1	0.1	0.2	0.0	0.1	0.1	5.4	2394.2	107.9	5.9	4.9	0.9	1.5	2.0	2.8	5.1	1.5	2.9	3.0	4.3	20.9	1.8	0.0	1.1	2.7	1.1	0.0	1.5	0.4	1.1	2.6	4.1	0.0	4.4	0.5	1.0	0.9	3.0	1.5	1.9	17.7	3.1	2.9	2.0	1.3	6.7	0.6	1.3	0.0	5.3	6.5	1.2	1.8	5.3	1.8	4.7	4.8	4.6	2.1	2.5	1.3	1.1	2.7	1.2	3.3	2.6	0.8	0.3	5.6	3.4	6.6	1.2	2.6	0.1	1.2	1.6	1.8	2.2	6.2	1.7	1.2	0.9
AL451007.3		ENSG00000284188	"Novel protein"		1	244729898-244730962	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in single"	19	"testis: 8.9"	"Cell type enriched"	"Detected in single"	4	"Distal tubular cells: 3.9"					"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.1	8.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0
CALML6	CAGLP	ENSG00000169885	"Calmodulin like 6"	Q8TD86	1	1915108-1917296	"Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	19	"skeletal muscle: 156.0;tongue: 110.8"	"Cell type enriched"	"Detected in some"	22	"Skeletal myocytes: 22.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.6;BEWO: 1.3;CAPAN-2: 1.2;hTCEpi: 1.4"															NA	NA						"unprognostic (3.85e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.59e-4)"	"unprognostic (1.66e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.33e-3)"	"unprognostic (9.72e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.03e-2)"	"unprognostic (9.76e-2)"	"unprognostic (5.21e-10)"	"unprognostic (5.06e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.23e-2)"	"unprognostic (6.48e-2)"	0.4	0.3	1.4	0.2	1.5	0.2	0.6	1.4	2.9	0.7	1.3	0.3	0.1	0.3	0.8	7.0	0.3	0.0	0.2	1.4	1.4	0.7	2.0	0.3	0.2	1.4	1.4	1.4	0.3	1.6	0.2	0.7	0.1	1.4	1.5	0.3	0.2	2.9	0.4	156.0	1.7	0.3	0.2	1.3	0.5	0.5	1.3	1.4	0.2	0.5	110.8	0.4	0.3	1.1	1.5	0.0	0.0	0.1	1.6	0.7	0.3	1.3	0.3	0.0	0.1	0.1	0.0	1.2	0.4	0.1	0.5	0.1	0.7	0.0	0.1	0.0	0.2	0.1	0.0	0.2	0.0	0.1	0.0	0.3	0.3	1.4	0.1	0.1	0.1	0.1	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.2	0.5	0.4	0.1	0.8	0.2	0.1	0.0	0.1	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.6	0.1	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.5	1.4	2.9	1.4	1.4	1.4	1.4	1.4	1.4	1.3	1.4	1.5	0.0	0.0	0.0	0.3	0.0	0.3	0.2	0.1	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.1	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	22.8	1.0	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.1
EQTN	"AFAF, C9orf11, equatorin, SPACA8"	ENSG00000120160	Equatorin	Q9NQ60	9	27284654-27297150	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"testis: 38.2"	"Cell type enriched"	"Detected in some"	10	"Early spermatids: 739.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA015089, HPA015504"	Enhanced		Approved	"Plasma membrane,Actin filaments"	"Secreted in male reproductive system"	NA	NA			"Plasma membrane, Actin filaments"		"HPA015089: AB_1845795, HPA015504: AB_2067598"	"unprognostic (7.83e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.64e-2)"	"unprognostic (8.12e-3)"	"unprognostic (1.34e-3)"	"unprognostic (4.41e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.32e-1)"	"unprognostic (1.89e-1)"	"unprognostic (5.67e-2)"		"unprognostic (1.14e-1)"	"unprognostic (4.59e-2)"	"unprognostic (8.46e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.42e-1)"	0.2	0.0	0.4	0.0	1.2	0.0	0.2	0.7	0.9	0.2	0.2	0.3	0.4	0.2	0.5	0.0	0.2	0.0	0.0	0.2	0.5	0.2	0.0	0.3	0.2	1.3	1.0	0.1	0.5	0.4	0.0	0.0	0.0	1.3	0.1	0.3	0.1	0.0	0.1	0.1	0.2	0.3	0.0	0.9	0.2	0.2	38.2	1.0	0.0	0.2	0.1	0.0	0.1	0.1	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.2	0.7	0.9	0.2	0.5	1.3	1.0	0.1	1.3	0.9	1.0	2.0	0.0	0.0	0.0	1.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	739.3	0.2	0.2	0.2	0.0	0.0	0.3	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	67.8	5.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.1	0.7	0.0	0.2	0.6	0.2	0.0	0.0	0.0	0.0	0.2	16.2	2.4	0.0	0.3	0.1	0.0	0.1	0.2	0.1
ERMN	"ERMIN, JN, KIAA1189"	ENSG00000136541	Ermin	Q8TAM6	2	157318631-157327713	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	19	"brain: 533.8;choroid plexus: 175.1"	"Cell type enriched"	"Detected in some"	51	"Oligodendrocytes: 290.9"	"Cancer enriched"	"Detected in some"	4	"glioma: 9.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"HAP1: 25.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038295, HPA038296"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA038295: AB_10805353, HPA038296: AB_10796217"	"unprognostic (7.89e-2)"	"unprognostic (9.06e-3)"	"unprognostic (2.71e-2)"	"prognostic favorable (6.93e-6)"	"unprognostic (1.06e-1)"	"unprognostic (2.02e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.57e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.46e-3)"	"unprognostic (2.84e-2)"	"unprognostic (7.96e-2)"	"unprognostic (9.97e-3)"	"unprognostic (5.76e-2)"	0.7	0.2	273.7	2.3	365.4	18.9	0.5	340.6	341.5	0.4	175.1	0.8	0.5	0.4	0.1	0.5	0.4	0.8	0.3	243.3	284.7	0.5	0.5	2.4	3.4	404.1	353.9	195.2	0.2	0.3	0.0	0.4	0.1	417.0	0.3	0.9	0.6	1.7	0.3	0.4	0.7	3.8	0.3	331.8	4.8	1.3	0.5	342.4	1.6	0.4	0.0	3.1	0.7	0.3	533.8	0.1	0.3	0.3	0.2	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.2	1.3	0.0	1.9	0.0	0.3	25.3	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.0	0.7	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	3.5	0.4	0.2	0.7	2.3	0.2	0.1	0.5	0.0	0.4	0.5	0.0	1.0	0.4	0.5	0.0	0.1	0.0	0.3	0.6	1.2	0.0	0.2	0.1	0.3	0.6	3.4	2.5	0.6	1.7	0.9	0.9	0.5	0.3	0.3	0.4	0.2	0.2	0.1	0.1	0.1	0.1	0.3	0.3	0.3	0.6	0.5	0.2	0.3	0.2	0.1	273.7	365.4	340.6	341.5	243.3	284.7	404.1	353.9	195.2	417.0	331.8	342.4	533.8	0.1	0.0	1.3	1.6	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	1.3	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.4	0.0	0.2	0.0	0.8	0.2	0.0	1.2	0.9	0.1	0.0	2.2	0.0	1.9	1.1	0.0	3.1	2.0	290.9	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.5	2.7	0.0	0.0	0.0
FTHL17	CT38	ENSG00000132446	"Ferritin heavy chain like 17"	Q9BXU8	X	31071233-31072041	"Predicted intracellular proteins"	"Iron storage"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	19	"testis: 4.0"	"Cell type enriched"	"Detected in some"	6	"Spermatocytes: 18.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"									NA	NA																				"unprognostic (5.67e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GAPDHS	"GAPD2, GAPDH-2, GAPDS"	ENSG00000105679	"Glyceraldehyde-3-phosphate dehydrogenase, spermatogenic"	O14556	19	35533455-35545319	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"testis: 272.0"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 8717.5"	"Cancer enriched"	"Detected in single"	97	"melanoma: 13.3"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 22.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042666	Enhanced		Approved	Nucleoplasm,Centrosome		NA	NA		7500000	Nucleoplasm	Centrosome	"HPA042666: AB_2678104"	"unprognostic (3.74e-1)"	"unprognostic (1.59e-1)"			"unprognostic (7.41e-2)"			"unprognostic (1.56e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.81e-2)"			"unprognostic (2.96e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.37e-1)"	1.2	2.8	0.2	4.1	0.8	2.4	0.2	0.8	0.7	0.0	0.0	0.6	3.3	2.7	0.0	3.0	1.9	3.6	4.1	0.1	0.1	0.9	0.3	1.9	6.5	0.8	0.1	0.1	3.4	5.2	0.0	0.1	1.1	1.3	2.0	0.0	3.6	5.2	0.0	1.7	14.0	3.2	0.0	0.1	5.3	2.5	272.0	0.4	0.0	11.5	0.0	0.0	1.5	0.1	1.0	6.5	22.4	6.4	9.6	0.0	0.0	5.4	1.9	0.0	0.0	0.0	13.8	10.4	10.7	2.9	0.0	2.6	7.6	0.0	0.0	0.0	10.5	11.2	7.1	16.7	7.1	0.1	6.4	8.3	0.0	0.0	0.0	0.0	3.9	0.0	10.3	17.6	6.0	0.0	19.6	2.5	3.0	8.6	4.1	3.1	7.6	4.3	8.3	0.0	6.1	11.3	5.1	2.4	5.7	7.0	4.3	4.8	2.7	2.1	7.2	7.9	1.8	2.7	16.9	4.8	6.2	3.9	11.4	2.6	0.0	0.1	0.2	0.1	0.1	0.3	0.1	0.0	0.3	0.2	0.3	0.2	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.2	0.8	0.8	0.7	0.1	0.1	0.8	0.1	0.1	1.3	0.1	0.4	1.0	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1915.7	0.0	0.0	1.6	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.4	0.0	0.0	0.3	0.4	8717.5	24.8	2.4	44.4	0.0	0.2	0.0	0.0	1.0	0.5	0.0	0.0	28.6	0.0	0.0	0.0	0.1	0.0	0.0	26.3	0.0	0.1	33.4	18.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0
GCKR		ENSG00000084734	"Glucokinase regulator"		2	27496839-27523684	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in some"	19	"liver: 137.5"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 96.5"	"Cancer enriched"	"Detected in some"	8	"liver cancer: 14.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 13.4;Hep G2: 20.7;HUVEC TERT2: 6.4;TIME: 4.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB034098, HPA045855, HPA052227"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Nucleoli	"CAB034098: AB_2247323, HPA045855: , HPA052227: "	"unprognostic (3.31e-1)"	"unprognostic (2.11e-3)"	"unprognostic (2.27e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.68e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.12e-1)"	"unprognostic (2.25e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.02e-7)"	"unprognostic (6.51e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.27e-3)"	"unprognostic (1.50e-2)"	0.6	7.2	1.0	0.2	1.4	0.9	0.6	4.0	1.6	0.4	1.2	0.1	0.7	0.5	0.6	1.5	0.2	2.3	0.4	1.1	1.4	0.3	137.5	0.2	0.6	1.8	1.1	1.3	5.9	1.8	0.2	0.4	0.2	2.3	0.5	0.3	0.9	0.4	0.2	0.3	0.8	0.2	0.3	0.5	1.6	6.6	2.7	0.9	0.2	0.1	0.1	0.3	0.3	0.4	1.8	0.2	0.4	0.4	0.2	0.3	0.2	0.1	0.0	0.1	0.3	0.0	0.4	0.1	0.2	0.5	0.7	0.2	0.2	0.2	0.0	0.0	0.1	0.0	13.4	0.7	20.7	0.8	0.0	0.4	0.3	1.0	0.5	0.1	2.2	6.4	0.1	0.0	0.2	0.2	0.0	0.1	0.7	0.1	0.0	0.0	0.3	0.0	0.1	0.2	0.2	0.0	0.1	0.1	0.2	0.1	0.1	0.5	0.2	4.2	0.1	0.3	0.6	0.2	0.4	0.1	0.2	1.2	0.1	0.2	0.8	0.2	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.4	0.1	0.1	0.4	0.3	0.0	0.1	0.0	0.2	1.0	1.4	4.0	1.6	1.1	1.4	1.8	1.1	1.3	2.3	0.5	0.9	1.8	0.3	0.0	0.0	1.0	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.3	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.1	7.9	0.1	0.6	0.6	0.0	0.0	2.0	10.4	0.0	0.2	18.3	0.1	0.0	0.1	0.7	96.5	0.1	0.0	1.6	0.0	0.0	2.1	0.0	3.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	13.7	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	1.7	0.2	0.4	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0
GHRL	"ghrelin, MTLRP, obestatin"	ENSG00000157017	"Ghrelin and obestatin prepropeptide"	Q9UBU3	3	10285666-10292947	"Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"stomach 1: 359.0"	"Cell type enriched"	"Detected in many"	52	"Gastric mucus-secreting cells: 1123.8"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 3.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 17.5;classical monocyte: 11.0;eosinophil: 12.4;myeloid DC: 41.8;neutrophil: 25.7;plasmacytoid DC: 28.5"	"Group enriched"	"Detected in many"	6	"dendritic cells: 41.8;granulocytes: 25.7;monocytes: 11.0"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 14.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA014246, CAB022731"	Enhanced				"Secreted to blood"	NA	NA	2580000	350000			"CAB022731: , HPA014246: AB_1849659"	"unprognostic (1.74e-2)"	"unprognostic (3.01e-4)"	"unprognostic (3.75e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.60e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.85e-1)"	"unprognostic (5.45e-3)"	"unprognostic (1.54e-3)"	"unprognostic (2.71e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.52e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.79e-4)"	0.6	0.5	3.6	3.1	3.9	4.5	1.6	4.3	6.0	0.5	3.0	1.4	19.1	0.7	4.8	1.8	0.7	2.3	1.3	3.4	2.7	0.9	1.4	1.1	7.5	3.3	3.0	3.4	1.3	4.1	0.7	0.8	0.5	3.9	1.0	0.6	2.0	1.4	0.3	2.1	2.1	3.2	0.9	2.2	2.5	359.0	1.1	2.8	1.3	1.3	0.2	3.1	1.4	0.5	3.7	0.6	0.2	2.6	2.0	1.8	0.0	4.8	2.4	0.0	0.7	0.2	2.9	0.5	1.5	0.9	0.1	2.1	0.4	0.0	0.6	0.0	0.4	2.9	3.1	2.1	6.3	0.0	3.2	5.3	0.3	0.0	0.0	0.1	0.2	0.5	1.9	1.3	14.4	0.0	0.7	1.2	4.3	1.3	0.5	5.3	0.8	0.2	0.8	0.0	2.4	1.9	0.3	1.6	1.1	0.1	1.7	1.1	3.8	2.6	1.2	0.7	1.1	1.7	1.7	2.6	2.9	0.4	3.5	0.5	17.5	11.0	12.4	0.2	5.5	0.1	2.1	0.2	0.0	41.8	1.0	0.3	0.1	25.7	4.4	0.4	28.5	0.2	3.8	3.6	3.9	4.3	6.0	3.4	2.7	3.3	3.0	3.4	3.9	2.2	2.8	3.7	0.6	0.0	1.1	1.3	4.9	1.3	4.6	0.2	0.0	7.8	0.8	0.6	0.3	0.0	0.2	1.8	10.4	1.7	10.5	0.5	0.0	1.0	0.3	0.2	0.7	1.5	0.0	0.0	1.0	1.3	1.5	1.0	1123.8	0.8	0.0	0.6	1.8	0.1	1.8	3.3	0.6	0.1	0.0	3.8	8.8	1.0	0.3	5.7	1.8	2.8	7.4	2.2	21.6	0.0	0.7	0.9	0.1	0.4	0.7	4.9	1.5	0.2	0.2	9.1	6.6	4.0	0.9	1.7	1.3	0.0	0.6	0.3	4.0	0.7	0.8	2.2
GRK7	GPRK7	ENSG00000114124	"G protein-coupled receptor kinase 7"	Q8WTQ7	3	141778148-141818490	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	19	"retina: 11.4"	"Cell type enriched"	"Detected in some"	73	"Cone photoreceptor cells: 329.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"HPA075093, HPA078232"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA075093: , HPA078232: "	"unprognostic (1.11e-1)"	"unprognostic (1.70e-2)"	"unprognostic (3.35e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.39e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.31e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.53e-8)"	"unprognostic (3.08e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.91e-1)"	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	11.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.2	0.1	0.0	0.0	3.9	0.1	0.4	0.2	0.0	0.6	1.0	0.1	0.1	0.2	0.0	0.0	0.0	329.4	0.0	0.2	0.0	0.0	0.0	1.0	0.1	0.1	0.1	0.0	0.0	2.5	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.4	2.4	0.0	0.1	0.0	1.9	0.1	1.1	0.0	4.5	3.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.5	0.1	0.1	0.0	0.2	0.3	0.0	0.1	0.3	0.1	0.0
MUCL3	"bCX105N19.6, C6orf37, DPCR1, PBLT"	ENSG00000168631	"Mucin like 3"	Q3MIW9	6	30934523-30954221	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"stomach 1: 204.7"	"Cell type enriched"	"Detected in some"	20	"Pancreatic endocrine cells: 239.5"	"Group enriched"	"Detected in some"	9	"pancreatic cancer: 56.8;stomach cancer: 55.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"OE19: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA014036	Enhanced					NA	NA					"HPA014036: AB_1847841"	"unprognostic (2.81e-1)"	"unprognostic (4.49e-2)"	"unprognostic (9.13e-4)"	"unprognostic (6.74e-2)"	"unprognostic (4.29e-2)"	"unprognostic (8.06e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.32e-3)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (6.58e-4)"	"unprognostic (1.13e-1)"	"unprognostic (5.97e-2)"	"unprognostic (4.76e-2)"	"unprognostic (9.80e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.58e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	10.5	0.0	10.0	0.0	0.0	0.0	0.0	0.2	3.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	204.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.2	0.1	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	239.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
ODF3	"CT135, hSHIPPO, SHIPPO1"	ENSG00000177947	"Outer dense fiber of sperm tails 3"	Q96PU9	11	196761-200261	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	19	"testis: 9.5"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 95.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA038919, HPA039241"	Enhanced					NA	NA					"HPA038919: AB_2676270, HPA039241: AB_10673417"					"unprognostic (4.17e-1)"					"unprognostic (2.41e-1)"				"unprognostic (1.24e-2)"	"unprognostic (1.99e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	95.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC18A3	VACHT	ENSG00000187714	"Solute carrier family 18 member A3"	Q16572	10	49610310-49612720	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"		"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"brain: 23.7"	"Cell type enriched"	"Detected in some"	4	"Fibroblasts: 7.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SH-SY5Y: 7.2"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"spinal cord: 78.1"	CAB079011		Supported				NA	NA					"CAB079011: "				"unprognostic (2.14e-4)"	"unprognostic (1.55e-1)"			"unprognostic (1.01e-1)"		"unprognostic (9.39e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.00e-1)"		"unprognostic (5.85e-3)"	"unprognostic (7.56e-2)"	"unprognostic (1.16e-1)"		0.0	0.0	0.6	0.3	1.5	0.0	0.0	0.0	13.5	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.8	0.0	0.0	0.0	0.0	16.1	5.6	0.9	0.0	0.0	0.0	1.2	0.4	23.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	3.2	0.0	0.7	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.5	7.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	7.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.5	0.0	13.5	0.1	5.8	16.1	5.6	0.9	23.7	3.2	1.5	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0
SLC52A1	"FLJ10060, GPCR42, GPR172B, hRFT1, PAR2, RFVT1"	ENSG00000132517	"Solute carrier family 52 member 1"	Q9NWF4	17	5032600-5052009	"Disease related genes, Metabolic proteins, Predicted membrane proteins"	Transport	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	19	"intestine: 36.1;placenta: 18.5;skin 1: 11.2"	"Cell type enriched"	"Detected in some"	4	"Syncytiotrophoblasts: 820.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.4;BEWO: 1.9;EFO-21: 1.8;HMC-1: 4.6;SK-BR-3: 2.6;T-47d: 1.6"															NA	NA						"unprognostic (8.81e-3)"	"prognostic favorable (9.54e-4)"	"unprognostic (9.34e-2)"	"unprognostic (7.30e-4)"	"unprognostic (6.31e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.82e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.19e-2)"	"unprognostic (5.17e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.07e-2)"	"unprognostic (6.60e-2)"	0.1	0.1	0.2	0.1	0.2	0.5	0.5	0.6	0.4	0.5	0.1	1.0	36.1	0.2	0.3	1.0	0.9	0.3	0.1	0.4	0.0	0.1	0.1	0.4	0.2	0.2	0.0	0.3	0.1	0.3	0.6	0.1	18.5	0.3	1.0	0.5	0.2	0.4	0.6	0.3	11.2	23.7	0.1	0.1	0.4	0.3	0.5	0.2	0.6	0.3	0.0	0.2	1.1	0.7	0.5	0.1	2.4	0.0	0.1	0.1	0.1	1.9	0.0	0.0	0.3	0.3	0.0	0.1	0.1	1.8	0.0	0.3	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	4.6	0.0	0.1	0.1	0.0	0.1	0.1	0.3	0.0	0.5	0.0	0.1	0.2	0.2	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.7	0.0	0.1	0.4	2.6	0.0	0.0	1.6	0.7	0.3	0.1	0.5	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.7	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.2	0.1	0.7	0.2	0.0	0.1	0.0	0.0	0.2	0.2	0.6	0.4	0.4	0.0	0.2	0.0	0.3	0.3	0.1	0.2	0.5	0.1	0.0	0.5	0.0	0.0	1.1	1.6	2.0	0.6	0.0	0.2	0.5	0.7	0.0	0.9	0.0	0.0	185.7	0.1	4.1	0.0	0.0	0.2	1.7	0.1	0.6	1.2	0.0	0.0	0.0	15.3	1.2	0.0	0.5	0.0	0.3	2.2	0.0	15.7	0.0	0.1	6.6	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.3	76.4	0.1	7.7	0.0	0.0	0.2	0.1	2.0	2.1	2.3	1.7	820.1	0.3	0.1	2.6	1.5
TPPP2	"C14orf8, CT152, p18, p25beta"	ENSG00000179636	"Tubulin polymerization promoting protein family member 2"	P59282	14	21024109-21036276	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"testis: 256.8"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 9161.6"	"Cancer enhanced"	"Detected in single"		"liver cancer: 0.5"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004120	Enhanced					NA	NA					"HPA004120: AB_2303582"	"unprognostic (2.91e-2)"	"unprognostic (2.49e-3)"	"unprognostic (2.54e-1)"		"unprognostic (1.66e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.57e-3)"	"unprognostic (4.63e-4)"		"unprognostic (3.83e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.64e-4)"	"unprognostic (2.51e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.21e-1)"	0.1	0.4	0.7	0.1	0.7	0.0	0.5	0.7	1.1	0.2	1.0	0.1	0.1	0.2	3.5	0.0	0.2	0.3	0.6	0.7	0.7	0.9	13.4	0.1	0.0	0.8	0.7	0.4	0.8	0.2	0.2	0.1	0.1	0.7	0.4	0.3	0.3	1.4	0.2	3.2	0.1	0.3	0.0	0.8	0.1	0.1	256.8	0.7	0.0	0.1	4.8	0.0	0.1	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.7	1.1	0.7	0.7	0.8	0.7	0.4	0.7	0.8	0.7	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.3	1.9	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.1	1897.4	0.1	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	5.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	9161.6	47.5	2.7	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	35.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	52.0	30.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1
C8G		ENSG00000176919	"Complement C8 gamma chain"	P07360	9	136945185-136946975	"Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"liver: 569.1"	"Cell type enriched"	"Detected in some"	9	"Hepatocytes: 1134.7"	"Cancer enriched"	"Detected in all"	58	"liver cancer: 260.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"HMC-1: 41.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA046269	Approved				"Secreted to blood"	NA	NA		2800000000			"HPA046269: AB_2679606"	"unprognostic (5.00e-2)"	"unprognostic (4.05e-3)"	"prognostic unfavorable (2.99e-4)"	"unprognostic (3.94e-1)"	"unprognostic (4.53e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.96e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.02e-3)"	"unprognostic (2.16e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.05e-2)"	0.3	1.5	0.1	0.0	0.1	0.0	0.3	0.2	0.3	0.3	0.0	1.3	31.5	0.4	0.9	0.6	0.4	2.5	1.0	0.1	0.0	2.3	569.1	0.3	0.1	0.1	0.1	0.0	0.1	0.3	0.0	0.6	0.0	0.1	0.4	0.3	0.0	0.4	0.1	3.2	0.3	17.9	0.0	0.1	2.1	1.3	2.3	0.1	0.2	0.7	0.0	0.1	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.4	0.0	0.0	41.8	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.2	0.3	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	1.0	0.0	0.0	0.3	2.3	0.4	0.2	0.4	0.0	0.0	0.4	0.9	0.7	28.6	0.3	0.0	2.1	0.4	1.1	25.0	0.0	0.2	0.9	0.1	0.1	0.7	1.8	8.0	0.2	0.8	1.0	0.1	0.0	0.3	8.9	1.2	17.5	1134.7	0.3	0.0	0.2	5.0	0.0	25.3	0.2	1.5	0.0	0.2	0.0	0.0	0.0	1.1	4.1	0.5	0.1	0.5	4.7	0.7	0.0	0.4	122.3	6.7	0.1	0.5	0.0	0.3	0.3	0.7	0.6	0.5	0.4	3.4	1.8	0.2	2.0	0.2
EDDM3A	"FAM12A, HE3-ALPHA"	ENSG00000181562	"Epididymal protein 3A"	Q14507	14	20745887-20748380	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"epididymis: 641.7"	"Cell type enriched"	"Detected in some"	26	"Collecting duct cells: 29.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA049952	Approved				"Secreted in male reproductive system"	NA	NA					"HPA049952: AB_2680970"	"unprognostic (1.42e-1)"				"unprognostic (9.88e-2)"								"unprognostic (8.56e-3)"		"unprognostic (2.10e-1)"			0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	641.7	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	35.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.3	0.1	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	29.5	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
FXYD4	CHIF	ENSG00000150201	"FXYD domain containing ion transport regulator 4"	P59646	10	43371636-43376335	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	18	"kidney: 129.1"	"Cell type enriched"	"Detected in some"	107	"Collecting duct cells: 5039.3"	"Group enriched"	"Detected in many"	5	"renal cancer: 10.7;urothelial cancer: 20.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	29	"SuSa: 10.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA058421	Enhanced		Uncertain	Cytosol		NA	NA			Cytosol		"HPA058421: AB_2683714"	"unprognostic (2.92e-3)"	"unprognostic (5.25e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.85e-1)"		"unprognostic (2.32e-1)"		"unprognostic (2.00e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.12e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.20e-1)"	"unprognostic (2.09e-2)"	0.1	0.0	2.2	0.0	2.7	0.0	0.0	2.0	2.7	0.0	1.5	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.3	1.9	2.2	129.1	0.0	1.1	0.0	2.4	2.6	1.7	0.0	0.0	0.0	0.1	0.0	3.4	0.1	0.0	0.0	5.7	2.7	1.3	0.0	0.0	0.0	1.8	0.0	7.0	0.8	2.5	0.0	0.0	0.4	0.0	1.7	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.7	2.0	2.7	1.9	2.2	2.4	2.6	1.7	3.4	1.8	2.5	3.3	0.0	6.4	1.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.1	5039.3	0.0	0.5	0.0	0.5	46.9	0.0	2.6	6.4	2.6	0.0	0.0	0.0	0.0	0.2	0.1	0.4	9.2	15.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	11.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.2	0.1	0.1	8.0	0.0	0.0	0.0	0.0	0.1	1.4	0.1	0.0	0.0	0.4	0.3	0.1	1.0	1.4
GFI1B	ZNF163B	ENSG00000165702	"Growth factor independent 1B transcriptional repressor"	Q5VTD9	9	132944000-132991687	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"bone marrow: 39.3"	"Cell type enriched"	"Detected in some"	4	"Erythroid cells: 99.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	20	"basophil: 195.6;eosinophil: 395.8"	"Lineage enriched"	"Detected in many"	26	"granulocytes: 395.8"	"Group enriched"	"Detected in some"	5	"HEL: 168.9;HMC-1: 104.6;K-562: 53.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB004420, HPA006291"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"CAB004420: AB_2110132, HPA006291: "	"unprognostic (1.79e-2)"	"unprognostic (2.90e-4)"	"unprognostic (6.54e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.54e-2)"		"unprognostic (2.53e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.61e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.41e-1)"	0.0	0.0	0.1	0.3	0.2	39.3	0.0	0.2	0.2	0.0	0.2	0.5	0.9	0.0	0.1	0.1	0.0	0.3	0.2	0.1	0.2	0.0	0.2	1.1	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.3	0.0	0.1	0.1	0.4	0.5	1.0	0.1	0.1	1.9	0.3	2.2	0.2	0.1	0.0	0.0	0.2	0.1	0.0	0.5	0.3	0.1	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	1.9	0.3	23.8	0.0	0.0	0.0	1.5	0.0	0.6	0.0	0.0	0.0	168.9	0.2	0.1	0.0	0.1	104.6	0.0	1.4	0.0	0.2	0.0	0.0	0.0	53.0	0.2	0.0	0.0	0.1	17.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	1.5	0.0	0.0	0.0	195.6	0.3	395.8	0.1	1.9	0.1	0.1	0.1	0.0	1.9	0.2	0.5	0.1	3.9	0.5	15.1	1.0	0.0	12.5	0.1	0.2	0.2	0.2	0.1	0.2	0.3	0.1	0.1	0.2	0.1	0.2	0.5	0.2	0.0	0.6	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.2	0.0	1.3	0.0	1.8	0.0	0.0	0.1	0.1	0.8	0.0	0.1	3.8	0.0	0.3	0.4	1.2	99.1	0.4	0.0	0.2	0.3	0.0	0.1	14.5	0.4	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.3	0.0	12.9	0.0	15.8	0.0	0.0	0.6	0.0	0.0	0.5	0.2	0.0	24.2	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.4	0.0	0.0	0.3	0.2	1.0	0.6	0.1
GOLGA6A	"GLP, GOLGA6"	ENSG00000159289	"Golgin A6 family member A"	Q9NYA3	15	74069857-74082550	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"liver: 4.1;testis: 15.2"	"Cell type enriched"	"Detected in some"	8	"Early spermatids: 47.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-266/70: 1.3"									"HPA044978, HPA050087, HPA072134"	Supported		Approved	Nucleoplasm,Vesicles,Centrosome		NA	NA			Vesicles	"Nucleoplasm, Centrosome"	"HPA044978: AB_2679165, HPA050087: AB_2681010, HPA072134: "					"unprognostic (1.68e-1)"		"unprognostic (2.09e-2)"			"unprognostic (9.50e-2)"				"unprognostic (9.67e-2)"	"unprognostic (6.70e-2)"			0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	15.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MYOG	"bHLHc3, MYF4"	ENSG00000122180	Myogenin	P15173	1	203083129-203086012	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Differentiation, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"skeletal muscle: 101.8;tongue: 47.1"	"Cell type enriched"	"Detected in single"	36	"Skeletal myocytes: 11.0"	"Group enriched"	"Detected in some"	6	"head and neck cancer: 3.9;testis cancer: 1.7"	"Region enhanced"	"Detected in single"		"cerebellum: 2.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	222	"HSkMC: 29.6;RH-30: 57.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA028336			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA028336: AB_2672562"	"unprognostic (1.71e-1)"				"unprognostic (1.64e-1)"	"unprognostic (1.05e-3)"				"unprognostic (2.22e-1)"			"unprognostic (2.79e-9)"	"unprognostic (3.96e-1)"	"unprognostic (2.56e-1)"			0.0	0.0	0.6	0.0	0.3	0.0	0.0	2.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.5	0.0	0.0	0.0	0.0	0.1	0.8	2.2	0.0	0.2	4.1	0.0	101.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.6	0.0	47.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	29.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	57.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.2	0.1	0.1	0.0	0.6	0.3	2.5	0.4	0.6	0.1	0.3	0.2	0.5	0.8	0.0	0.3	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
POU3F4	"BRN4, DFN3, DFNX2, OTF9"	ENSG00000196767	"POU class 3 homeobox 4"		X	83508290-83512127	"Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in single"	18	"brain: 11.6"	"Cell type enriched"	"Detected in some"	6	"Collecting duct cells: 11.0"	"Cancer enriched"	"Detected in single"	21	"glioma: 5.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	99	"AF22: 9.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA062295			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA062295: AB_2732681"					"unprognostic (5.73e-2)"										"unprognostic (2.00e-1)"			0.0	0.0	2.2	0.0	11.6	0.0	0.0	3.1	3.9	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.4	2.6	0.6	0.0	0.0	0.0	3.5	5.3	2.2	0.1	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	11.6	3.1	3.9	1.4	2.6	3.5	5.3	2.2	5.0	2.5	3.2	1.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PROCA1	MGC39650	ENSG00000167525	"Protein interacting with cyclin A1"	Q8NCQ7	17	28703197-28711854	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"testis: 178.8"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 6882.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 5.6;NB-4: 6.0;REH: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA023648, HPA030218"	Approved		Approved	"Nuclear membrane,Golgi apparatus"		NA	NA			"Nuclear membrane"	"Golgi apparatus"	"HPA023648: AB_1855726, HPA030218: AB_10601152"	"unprognostic (5.78e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.11e-3)"	"unprognostic (3.07e-2)"	"unprognostic (2.97e-2)"	"unprognostic (7.26e-3)"	"unprognostic (6.90e-2)"	"unprognostic (7.11e-3)"	"unprognostic (2.86e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.01e-3)"	"unprognostic (6.88e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.00e-2)"	2.1	1.7	3.1	1.4	3.1	1.5	1.9	3.8	4.9	3.7	2.9	2.0	1.1	2.9	0.4	1.5	4.3	0.7	2.3	3.0	3.2	5.4	1.2	2.7	2.2	3.4	3.5	3.0	6.1	0.9	0.3	3.0	0.6	3.4	3.5	0.4	1.2	1.7	0.5	0.9	1.4	4.0	0.7	3.2	9.9	2.0	178.8	3.1	1.4	1.8	0.5	0.8	2.3	2.7	3.7	0.6	0.9	1.6	5.6	1.0	1.6	1.6	0.9	0.6	0.7	0.6	0.9	2.0	0.0	0.3	0.8	0.1	0.8	1.7	0.2	0.3	1.1	0.4	2.7	1.7	0.4	0.4	4.5	0.1	0.7	0.3	1.2	0.0	0.7	0.1	0.7	2.6	1.6	0.6	0.2	3.3	6.0	4.4	0.3	0.5	7.1	2.4	0.1	0.6	0.2	0.4	0.7	0.4	0.1	0.5	1.0	2.5	3.9	0.5	0.2	1.0	0.6	0.3	0.7	1.0	1.2	0.4	4.1	0.8	4.9	1.1	3.5	0.5	1.6	0.2	1.9	1.1	0.3	0.6	0.5	0.4	0.8	0.7	0.6	1.2	2.5	0.6	0.5	3.1	3.1	3.8	4.9	3.0	3.2	3.4	3.5	3.0	3.4	3.2	3.1	3.7	2.3	0.0	1.1	4.6	2.8	1.0	1.2	1.0	0.6	3.7	1.5	1.9	6.6	1.5	1.9	0.0	4.2	0.8	3.9	0.8	0.0	0.6	1682.9	5.3	2.4	2.7	2.4	3.0	0.8	0.2	1.9	2.7	1.1	2.4	15.2	4.2	4.2	0.2	2.8	3.3	1.1	1.5	2.0	5.3	2.9	6882.6	25.4	6.8	0.0	3.7	2.5	7.9	1.0	2.0	0.9	0.6	0.3	19.5	1.2	0.8	2.0	1.2	3.9	4.4	19.7	1.5	2.4	79.2	21.7	1.1	0.3	0.7	2.6	7.5	1.7	0.7
SERPIND1	"D22S673, HC-II, HC2, HCF2, HLS2"	ENSG00000099937	"Serpin family D member 1"	P05546	22	20774113-20787720	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Chemotaxis, Hemostasis"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"	"Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"liver: 1263.3"	"Cell type enriched"	"Detected in some"	25	"Hepatocytes: 283.7"	"Cancer enriched"	"Detected in many"	80	"liver cancer: 334.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"Hep G2: 208.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"CAB008639, HPA055767"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA		50000000000	Vesicles		"CAB008639: AB_1618010, HPA055767: AB_2682912"	"unprognostic (1.68e-1)"	"unprognostic (8.27e-2)"	"unprognostic (4.40e-2)"	"prognostic favorable (4.09e-4)"	"unprognostic (5.42e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.94e-9)"	"unprognostic (2.01e-1)"	"unprognostic (4.66e-2)"	"unprognostic (8.36e-3)"	"unprognostic (1.46e-1)"	0.2	0.2	0.1	0.0	0.9	0.2	0.4	1.6	0.9	0.9	70.3	0.0	0.0	2.0	0.0	0.1	0.9	0.4	0.6	1.8	0.2	0.3	1263.3	2.5	0.0	0.1	0.0	0.2	1.8	0.5	10.2	0.8	1.6	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.2	0.0	0.2	0.4	0.1	0.2	0.0	0.7	0.0	0.0	0.8	0.5	0.2	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.2	208.2	0.1	0.8	0.5	0.1	0.0	1.6	0.0	0.0	20.4	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.1	2.4	16.5	0.0	0.7	0.0	0.0	3.3	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.6	0.4	0.1	0.0	0.1	0.1	0.0	0.2	7.2	0.2	13.9	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.1	0.1	0.0	0.5	0.2	0.1	0.1	0.3	0.0	0.5	0.1	0.0	0.1	0.9	1.6	0.9	1.8	0.2	0.1	0.0	0.2	0.2	0.0	0.2	0.2	0.0	0.0	11.3	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	2.7	1.6	0.0	0.1	2.3	0.0	0.0	1.3	0.0	3.9	283.7	0.1	0.0	0.9	0.0	0.0	6.3	0.0	0.0	1.2	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.5	3.4	0.0	0.0
SYNPO2L	FLJ12921	ENSG00000166317	"Synaptopodin 2 like"	Q9H987	10	73644881-73663803	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"heart muscle: 264.8;skeletal muscle: 281.9;tongue: 88.0"	"Cell type enriched"	"Detected in some"	52	"Cardiomyocytes: 665.1"	"Group enriched"	"Detected in some"	6	"breast cancer: 1.5;head and neck cancer: 1.4;prostate cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CACO-2: 4.1;HSkMC: 3.2;RH-30: 3.0;SK-BR-3: 3.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA055192, HPA057142"	Enhanced		Supported	"Nuclear speckles,Cell Junctions,Cytosol"		NA	NA			"Nuclear speckles"	"Cell Junctions, Cytosol"	"HPA055192: AB_2682732, HPA057142: AB_2683348"	"unprognostic (2.75e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-3)"	"unprognostic (3.65e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.54e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.44e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.34e-1)"	0.1	0.5	0.6	0.1	0.8	0.3	3.6	0.8	0.8	0.2	0.1	0.0	0.1	0.1	0.1	11.9	0.1	0.1	264.8	0.7	0.4	0.1	0.1	1.3	0.2	0.8	0.6	0.4	0.2	0.4	0.0	0.1	0.6	0.7	3.1	0.0	0.4	4.8	0.0	281.9	0.3	0.0	0.0	0.5	0.2	0.1	0.3	0.5	0.1	0.2	88.0	0.2	0.1	1.1	0.7	0.0	0.0	0.4	0.1	0.0	0.0	0.3	0.5	0.6	0.1	0.0	4.1	0.2	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.2	0.0	0.3	0.1	0.0	3.2	0.0	0.6	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	3.0	0.1	0.0	0.1	0.1	0.1	0.0	3.2	0.0	0.1	0.1	0.1	0.0	0.2	0.4	0.0	0.1	0.5	0.0	0.0	0.0	0.2	0.0	0.6	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.2	0.0	0.0	0.6	0.8	0.8	0.8	0.7	0.4	0.8	0.6	0.4	0.7	0.5	0.5	0.7	0.5	3.2	0.0	0.3	0.9	1.5	1.4	0.0	2.2	1.9	1.0	0.8	665.1	0.0	0.7	0.0	2.1	0.2	0.5	0.0	0.0	0.0	2.6	0.1	0.4	5.0	0.0	0.0	0.3	0.0	0.2	12.6	0.0	0.3	1.3	0.3	0.0	0.4	0.2	0.0	0.9	0.0	0.0	0.6	2.1	1.1	0.9	0.8	1.8	1.0	0.3	0.4	0.0	1.5	1.1	0.0	0.0	0.4	0.3	0.9	0.0	0.2	0.7	1.2	0.0	12.0	5.2	0.8	1.3	0.4	0.4	0.0	0.7	0.2	0.0	1.0
TRAV36DV7	TRAV36/DV7	ENSG00000211815	"T cell receptor alpha variable 36/delta variable 7"	A0A075B6V5	14	22226746-22227254	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	18	"lymphoid tissue: 27.7"	"Cell type enriched"	"Detected in single"	4	"T-cells: 2.3"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	8	"memory CD4 T-cell: 29.2;memory CD8 T-cell: 21.9;naive CD4 T-cell: 37.6;naive CD8 T-cell: 23.0;T-reg: 50.1"	"Lineage enriched"	"Detected in many"	13	"T-cells: 50.1"	"Group enriched"	"Detected in some"	11	"Daudi: 1.4;HL-60: 3.3"					"Not detected"	"Not detected"									NA	NA						"unprognostic (3.67e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.74e-2)"	"unprognostic (7.69e-2)"	"unprognostic (2.39e-6)"	"unprognostic (8.10e-2)"	"unprognostic (9.54e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.45e-1)"	"unprognostic (4.62e-5)"	"unprognostic (1.52e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.17e-4)"	0.2	0.0	0.0	2.1	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.8	0.3	0.0	0.0	0.3	0.2	1.0	0.4	0.0	0.0	0.0	0.1	1.5	10.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	1.7	0.6	0.1	0.1	27.7	0.1	0.0	5.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	3.9	1.6	0.0	0.0	1.4	29.2	21.9	0.0	0.1	37.6	23.0	0.3	0.0	0.0	0.0	50.1	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0
WFDC11	WAP11	ENSG00000180083	"WAP four-disulfide core domain 11"	Q8NEX6	20	45648563-45670270	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	18	"epididymis: 94.6"	"Cell type enriched"	"Detected in some"	12	"Early spermatids: 55.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"basophil: 2.3"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.3"	"Group enriched"	"Detected in some"	5	"HeLa: 8.7;RPMI-8226: 5.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted in male reproductive system"	NA	NA																							0.0	0.4	1.0	0.2	0.5	3.0	0.3	2.9	2.4	0.1	0.7	0.2	0.0	0.2	94.6	0.2	0.2	0.5	0.1	0.6	0.4	0.2	0.3	0.2	0.2	0.5	0.5	0.1	0.2	0.2	0.1	0.0	0.2	1.3	0.4	0.0	2.0	0.7	0.1	0.1	1.5	0.2	0.1	0.0	0.2	0.3	5.1	0.6	0.0	0.3	0.0	0.1	0.2	0.0	3.1	0.1	0.7	0.0	0.1	0.4	0.5	0.8	0.7	0.1	0.0	0.0	0.5	0.2	0.4	0.2	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.5	0.8	8.7	0.5	0.0	0.4	0.4	0.2	0.0	0.0	0.1	0.1	0.0	0.3	0.4	0.1	0.0	0.1	0.3	0.7	0.7	0.2	0.4	0.1	0.3	5.3	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.6	0.0	0.7	0.0	0.1	0.4	0.2	0.1	0.3	0.3	0.0	0.0	1.4	0.2	2.3	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.2	0.3	0.3	0.0	0.2	0.0	0.0	1.0	0.5	2.9	2.4	0.6	0.4	0.5	0.5	0.1	1.3	0.0	0.6	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.8	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0
AKR1C4	"3-alpha-HSD, C11, CDR, CHDR, DD4, HAKRA, MGC22581"	ENSG00000198610	"Aldo-keto reductase family 1 member C4"	P17516	10	5195462-5218949	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"liver: 723.4"	"Cell type enriched"	"Detected in some"	16	"Hepatocytes: 613.3"	"Cancer enriched"	"Detected in some"	86	"liver cancer: 108.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HDLM-2: 6.6;OE19: 2.9"									"HPA044720, HPA068265"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		NA	NA		3800000	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"HPA044720: AB_2679058, HPA068265: AB_2685966"	"unprognostic (2.21e-1)"	"unprognostic (3.04e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.25e-1)"		"unprognostic (5.99e-2)"	"unprognostic (9.40e-2)"	"unprognostic (2.32e-1)"		"unprognostic (1.26e-1)"	"unprognostic (1.52e-2)"		"unprognostic (1.29e-1)"	"unprognostic (3.31e-1)"	"unprognostic (7.34e-2)"		"unprognostic (1.45e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.2	0.0	0.4	42.2	0.0	0.0	0.1	0.3	723.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	1.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.3	0.2	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	37.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.2	0.2	0.0	0.8	0.0	13.5	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.0	13.6	613.3	0.0	0.0	0.0	0.6	0.0	14.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.2	1.0	1.5	0.0	0.0	0.1	0.0	2.1	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.1
ANO3	"C11orf25, DYT23, GENX-3947, TMEM16C"	ENSG00000134343	"Anoctamin 3"	Q9BYT9	11	26188842-26663289	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"		"Disease variant, Dystonia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"brain: 45.9;epididymis: 57.9"	"Cell type enriched"	"Detected in some"	5	"Excitatory neurons: 201.9"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 45.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 1.9;HDLM-2: 6.8;U-2 OS: 1.6;U-2197: 4.3"	"Region enhanced"	"Detected in all"		"basal ganglia: 158.9"	"Region enriched"	"Detected in all"	7	"basal ganglia: 180.1"	HPA041629	Uncertain					NA	NA					"HPA041629: AB_10793969"	"unprognostic (7.01e-3)"	"unprognostic (4.31e-1)"	"unprognostic (2.94e-1)"	"unprognostic (9.29e-2)"	"unprognostic (9.28e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.45e-2)"	"unprognostic (7.02e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.81e-4)"	"unprognostic (9.48e-3)"	"unprognostic (3.50e-2)"	"unprognostic (4.33e-1)"	"unprognostic (4.01e-1)"	3.0	0.8	3.6	0.1	45.9	0.0	0.5	0.0	10.7	0.5	0.0	0.2	0.1	0.1	57.9	0.0	0.2	1.8	0.1	8.2	7.3	1.0	1.1	0.4	0.0	7.2	0.9	6.6	0.1	0.3	0.1	0.3	0.0	15.2	0.0	0.1	0.4	0.2	0.1	0.0	0.0	0.1	0.2	0.0	0.4	0.0	1.9	5.6	0.1	1.0	0.1	0.0	0.0	0.1	4.1	0.0	0.0	0.4	0.0	1.1	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.9	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	4.3	0.0	0.4	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	45.9	0.0	10.7	8.2	7.3	7.2	0.9	6.6	15.2	0.0	5.6	4.1	1.0	0.0	2.0	3.3	0.0	0.0	0.0	0.1	0.0	1.7	0.2	0.0	0.9	0.0	0.2	0.0	14.6	0.2	0.0	0.0	0.0	0.1	12.0	0.5	0.0	0.4	0.0	0.0	201.9	0.0	0.3	0.5	0.0	0.3	0.0	0.0	1.8	0.7	0.0	8.4	4.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	8.4	0.0	0.0	0.0	38.2	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	2.3	0.0	0.0	4.7	3.8	2.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0
C19orf84		ENSG00000262874	"Chromosome 19 open reading frame 84"	I3L1E1	19	51388289-51390591	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"testis: 22.2"	"Cell type enriched"	"Detected in some"	10	"Spermatogonia: 31.9"	"Group enriched"	"Detected in some"	5	"ovarian cancer: 1.3;testis cancer: 3.5"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"K-562: 6.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA068082	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA068082: AB_2685949"	"unprognostic (5.94e-2)"	"unprognostic (7.72e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.13e-3)"	"unprognostic (9.28e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.84e-1)"	"unprognostic (2.61e-7)"	"unprognostic (8.30e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.92e-2)"	"unprognostic (3.99e-3)"	0.0	0.0	0.4	0.2	0.4	0.7	0.0	0.4	0.7	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.4	0.0	0.0	0.1	0.3	0.5	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.4	0.0	22.2	0.4	0.1	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.4	0.4	0.7	0.5	0.4	0.5	0.4	0.2	0.4	0.4	0.4	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.6	0.0	2.2	0.3	0.3	0.0	0.0	0.2	0.0	3.1	0.0	0.0	0.0	1.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	31.9	0.0	0.0	0.0	0.1	0.1	0.0	0.0
CCDC168	"C13orf40, FLJ40176"	ENSG00000175820	"Coiled-coil domain containing 168"	Q8NDH2	13	102729367-102759072	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	17	"testis: 8.9"	"Cell type enriched"	"Detected in some"	11	"Early spermatids: 1011.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA048184, HPA058793, HPA078547"	Uncertain		Approved	Nucleoli,Centrosome,Cytosol		NA	NA			"Nucleoli, Centrosome"	Cytosol	"HPA048184: AB_2680303, HPA058793: AB_2683823, HPA078547: "	"unprognostic (2.06e-1)"	"unprognostic (7.95e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.39e-4)"	"unprognostic (2.09e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.89e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.44e-5)"	"unprognostic (2.56e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.85e-1)"	"unprognostic (6.94e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	3.2	0.0	0.3	0.3	0.0	0.7	0.0	0.0	0.0	0.7	1.8	4.5	0.0	1.8	0.0	0.0	0.3	2.3	0.1	0.0	0.3	1011.0	0.2	1.2	0.6	0.0	0.0	1.1	0.4	0.5	0.4	0.0	0.4	0.0	0.4	0.4	0.0	0.3	0.0	0.9	0.0	0.0	0.6	0.0	91.3	2.1	0.6	0.0	1.0	1.6	0.0	0.0	0.5	0.6	0.4	0.0	0.7	1.4	0.5	0.0	0.2	0.0	0.0	0.0	2.9	0.7	3.1	1.5	0.0	0.0	0.4	0.9	0.2	0.2	0.2
COX7A1	"COX7A, COX7AH"	ENSG00000161281	"Cytochrome c oxidase subunit 7A1"	P24310	19	36150922-36152449	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	17	"heart muscle: 1859.2;skeletal muscle: 7012.9;tongue: 5004.0"	"Cell type enriched"	"Detected in many"	26	"Cardiomyocytes: 21879.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 162.5;ASC TERT1: 122.3;BJ: 84.7;BJ hTERT+: 102.7;fHDF/TERT166: 178.6;HHSteC: 91.4;HSkMC: 109.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (5.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.13e-3)"	"unprognostic (6.46e-3)"	"unprognostic (5.33e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.77e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.84e-3)"	"unprognostic (7.27e-3)"	"unprognostic (9.44e-2)"	"unprognostic (6.23e-2)"	"unprognostic (1.54e-2)"	271.6	92.3	190.5	20.6	190.6	2.2	106.8	188.8	258.6	64.4	193.4	93.3	15.0	55.0	39.6	83.0	58.3	32.2	1859.2	199.0	209.6	71.1	12.0	63.9	12.1	191.3	183.4	189.1	46.4	41.0	149.1	106.4	27.6	193.9	87.3	23.9	50.1	88.8	120.2	7012.9	30.2	37.0	85.8	184.1	34.7	47.1	9.8	191.1	86.6	55.2	5004.0	7.4	89.3	50.5	210.6	0.5	5.9	0.6	0.1	162.5	122.3	0.0	84.7	102.7	3.4	0.0	0.0	1.8	1.4	13.0	178.6	0.0	0.7	0.0	0.0	0.8	0.2	1.8	0.4	2.1	0.3	91.4	0.0	0.8	109.0	0.0	0.0	0.0	0.0	11.3	0.0	0.6	0.7	0.0	0.8	0.0	0.7	1.0	0.6	1.2	0.2	0.0	0.4	0.0	1.6	0.0	0.6	0.0	0.0	0.0	0.2	0.6	0.1	20.7	0.0	1.3	0.5	0.4	0.8	1.9	0.7	0.2	0.8	1.2	0.0	0.6	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.3	0.1	0.0	0.0	190.5	190.6	188.8	258.6	199.0	209.6	191.3	183.4	189.1	193.9	184.1	191.1	210.6	309.7	0.0	5.1	2.3	2.2	26.4	1.0	28.2	2.8	80.6	25.0	89.4	21879.1	18.6	11.0	22.0	45.9	1.0	1.5	0.0	817.8	13.7	17.0	6.0	124.6	360.4	0.0	5.3	5.9	14.1	0.7	602.1	0.5	3.7	45.0	5.5	259.5	7.3	24.0	67.3	4.3	0.0	26.4	10.7	30.5	90.8	224.6	5.2	284.6	3.7	0.0	31.5	0.0	2.0	2.3	6.2	0.0	281.3	1.5	3.5	0.0	183.1	10.7	84.7	184.1	328.4	463.4	2.0	3.8	4.3	19.0	1.9	4.8	17.3	0.1	0.8
HORMAD1	"CT46, DKFZP434A1315"	ENSG00000143452	"HORMA domain containing 1"	Q86X24	1	150698060-150720895	"Predicted intracellular proteins"	"Differentiation, Meiosis, Oogenesis, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"testis: 118.8"	"Cell type enriched"	"Detected in some"	4	"Spermatocytes: 727.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 6.9"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A549: 5.6;HeLa: 4.9;hTCEpi: 19.4;SiHa: 6.1;SuSa: 6.5;THP-1: 11.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA028346, HPA037850"	Enhanced		Approved	Nucleoplasm,Nucleoli		Yes	No			Nucleoplasm	Nucleoli	"HPA028346: AB_2672564, HPA037850: AB_10696358"	"unprognostic (7.21e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.15e-2)"	"unprognostic (9.06e-2)"	"unprognostic (3.91e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.56e-2)"	"unprognostic (5.17e-3)"	"unprognostic (3.79e-9)"	"unprognostic (3.32e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.49e-2)"	0.1	0.0	0.1	0.5	0.1	0.5	0.1	0.0	0.3	0.0	0.1	0.2	0.0	0.0	0.0	3.7	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.2	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.1	0.4	0.1	0.4	0.0	0.0	6.8	0.2	0.1	0.2	0.9	0.1	118.8	0.2	0.0	0.0	0.0	0.8	0.0	0.2	0.2	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	2.6	0.0	0.0	0.0	0.1	0.0	0.1	4.9	0.0	0.0	0.1	0.1	0.0	19.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.1	0.0	0.1	6.5	0.0	11.3	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.2	0.2	0.1	0.0	0.0	0.0	0.2	5.4	0.0	1.4	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	3.4	0.0	0.3	0.0	0.1	88.3	0.5	0.1	0.5	0.0	0.0	2.7	0.0	2.1	0.4	0.0	0.1	0.0	0.1	0.4	0.0	0.8	0.0	2.0	0.0	0.0	1.3	0.9	35.1	5.3	0.8	0.0	1.0	1.5	0.0	0.0	1.0	0.1	0.0	0.1	4.9	0.0	0.0	0.0	0.0	0.5	0.0	32.9	0.0	0.4	727.7	163.5	0.0	9.2	2.2	0.0	0.3	0.2	0.1
HSPB3	HSPL27	ENSG00000169271	"Heat shock protein family B (small) member 3"	Q12988	5	54455699-54456377	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Stress response"		"Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	17	"heart muscle: 410.0;skeletal muscle: 219.2;tongue: 220.9"	"Cell type enriched"	"Detected in some"	18	"Cardiomyocytes: 398.1"	"Cancer enriched"	"Detected in many"	6	"head and neck cancer: 7.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 86.3;fHDF/TERT166: 39.1;HSkMC: 16.3;LHCN-M2: 12.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA062124			Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA062124: AB_2684690"		"unprognostic (1.44e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.78e-3)"	"unprognostic (3.06e-1)"	"unprognostic (2.25e-3)"		"unprognostic (1.13e-1)"	"unprognostic (4.41e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.70e-2)"		"unprognostic (2.73e-1)"	"unprognostic (2.82e-2)"		"unprognostic (7.15e-2)"	0.9	0.2	5.3	0.1	6.1	0.2	2.1	4.5	8.5	0.9	4.7	4.6	0.2	7.6	0.4	16.6	3.0	0.2	410.0	6.5	6.7	0.4	0.1	2.9	0.0	4.8	4.7	5.9	1.0	0.1	0.0	3.6	0.1	5.1	8.6	2.2	1.6	6.7	0.8	219.2	2.2	0.9	10.5	4.6	0.7	0.9	1.8	4.7	0.7	0.3	220.9	0.0	3.8	0.8	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	86.3	0.1	0.1	0.4	0.0	0.0	0.3	39.1	0.1	4.8	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.4	0.0	0.0	16.3	5.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	4.4	0.1	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.3	6.1	4.5	8.5	6.5	6.7	4.8	4.7	5.9	5.1	4.6	4.7	7.0	0.0	0.0	0.0	0.3	0.0	6.4	0.4	3.2	0.0	0.1	0.0	0.0	398.1	0.0	0.3	0.0	0.0	0.1	0.0	10.5	0.0	0.0	0.1	0.7	0.2	3.5	0.0	0.0	4.3	0.0	0.0	14.4	0.0	1.3	0.0	0.1	0.0	0.0	0.1	1.7	6.5	0.0	0.0	0.0	4.9	0.4	0.6	0.2	3.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.5	6.6	21.3	7.2	0.4	0.0	0.0	5.3	0.1	0.2	0.1	0.3	0.3
KLHL1	"FLJ30047, KIAA1490, MRP2"	ENSG00000150361	"Kelch like family member 1"	Q9NR64	13	69700594-70108493	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"brain: 26.3"	"Cell type enriched"	"Detected in some"	7	"Oligodendrocyte precursor cells: 206.1"	"Cancer enriched"	"Detected in single"	7	"breast cancer: 0.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	13	"HeLa: 2.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA021196	Uncertain					NA	NA					"HPA021196: AB_1852567"					"unprognostic (5.81e-2)"					"unprognostic (7.40e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.41e-1)"						0.0	0.1	3.4	0.0	2.1	0.0	0.0	2.7	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	8.9	0.0	0.0	0.0	0.0	7.6	26.3	1.5	0.0	0.0	0.0	0.4	0.0	7.3	0.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.2	18.6	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	2.1	2.7	2.3	1.1	8.9	7.6	26.3	1.5	7.3	3.8	18.6	7.9	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	206.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MSMB	"IGBF, MSP, MSPB, PN44, PRPS, PSP, PSP-94, PSP57, PSP94"	ENSG00000263639	"Microseminoprotein beta"	P08118	10	46033307-46048180	"Cancer-related genes, Disease related genes, Predicted membrane proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	17	"prostate: 9466.5"	"Cell type enriched"	"Detected in many"	4	"Prostatic glandular cells: 10715.4"	"Cancer enriched"	"Detected in many"	42	"prostate cancer: 3435.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 25.6;NB-4: 21.6;RPMI-8226: 11.3;SH-SY5Y: 6.1;SK-BR-3: 5.9;U-2197: 12.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB026357, HPA051257"	Enhanced				"Secreted in male reproductive system"	NA	NA		6000000			"CAB026357: , HPA051257: AB_2681410"	"unprognostic (6.47e-2)"	"unprognostic (7.21e-3)"		"unprognostic (1.37e-2)"		"unprognostic (8.18e-3)"	"unprognostic (4.28e-3)"	"unprognostic (9.24e-3)"	"unprognostic (1.66e-1)"	"unprognostic (8.66e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.55e-2)"		"unprognostic (2.01e-1)"	"unprognostic (7.04e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (7.19e-4)"	5.1	4.6	0.0	3.0	0.0	0.1	20.7	0.0	0.0	3.2	0.0	1.6	10.4	0.3	45.5	12.4	4.7	3.0	0.5	0.0	0.0	1.8	1.8	30.2	0.2	0.0	0.0	0.0	0.3	2.3	0.2	0.5	0.6	0.0	9466.5	0.1	0.0	32.1	0.6	0.4	36.5	2.3	0.0	0.0	0.7	557.1	10.2	0.0	1.1	0.8	0.0	10.1	7.2	2.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	25.6	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.4	21.6	0.2	0.0	0.0	0.0	0.0	11.3	0.0	1.6	1.0	6.1	0.0	5.9	0.0	0.2	0.4	0.0	0.0	0.0	0.0	12.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.3	0.0	195.9	586.4	0.0	0.0	6.4	1.3	0.0	4.3	2203.2	0.0	0.0	2.1	0.1	0.3	0.0	0.1	48.9	0.6	0.0	10.7	0.0	0.0	0.1	0.2	0.4	9.5	404.2	0.2	1.3	0.0	0.0	1.2	0.2	0.0	0.0	0.8	419.1	0.0	0.0	78.8	0.3	30.5	3.6	0.0	0.0	0.0	0.0	0.0	0.0	1.8	29.6	0.0	0.8	10715.4	0.3	0.0	570.6	0.0	0.0	0.0	271.0	0.5	1.4	0.0	0.4	1.5	14.3	0.0	0.1	192.4
PLIN1	PLIN	ENSG00000166819	"Perilipin 1"	O60240	15	89664367-89679427	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	17	"adipose tissue: 964.8;breast: 466.9"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 59.0"	"Group enriched"	"Detected in many"	5	"breast cancer: 8.4;liver cancer: 2.3;pancreatic cancer: 2.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	171	"ASC diff: 208.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA024299, CAB033821, CAB037333"	Enhanced		Uncertain	Peroxisomes		NA	NA		22000	Peroxisomes		"CAB033821: AB_2252681, CAB037333: , HPA024299: AB_1855467"	"unprognostic (4.62e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.51e-3)"	"unprognostic (9.89e-3)"	"unprognostic (3.54e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.13e-2)"	"unprognostic (8.00e-3)"	"unprognostic (2.28e-3)"	"unprognostic (2.62e-6)"	"unprognostic (5.56e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.63e-1)"	"unprognostic (4.85e-2)"	964.8	11.4	12.4	3.5	12.2	0.3	466.9	7.7	10.7	1.3	5.2	9.3	0.5	0.7	0.4	1.3	1.4	6.6	8.3	10.3	10.1	2.7	41.2	0.7	1.7	9.4	10.5	7.3	2.1	6.2	0.2	1.3	0.2	11.8	2.6	3.8	0.6	21.0	0.6	9.6	13.7	14.0	1.5	6.3	1.1	5.5	13.3	9.3	2.3	5.3	17.5	0.1	8.0	3.1	8.4	0.0	0.2	0.2	0.0	208.2	0.7	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.5	0.7	0.5	0.1	0.7	0.2	0.0	0.2	0.6	0.7	0.0	0.1	0.3	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.1	0.3	0.2	0.1	0.3	1.2	0.1	0.5	0.1	0.1	0.0	0.1	0.2	0.2	0.1	0.4	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	12.2	7.7	10.7	10.3	10.1	9.4	10.5	7.3	11.8	6.3	9.3	8.4	2.6	0.0	0.0	4.2	0.2	0.1	0.3	0.1	0.0	0.3	0.7	3.0	1.1	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.2	7.5	0.1	0.2	0.2	0.0	0.0	0.5	0.2	0.0	0.3	0.0	0.2	0.0	0.1	1.1	59.0	0.0	0.0	0.3	0.3	0.0	1.0	0.3	7.5	0.9	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.2	1.3	0.0	0.0	0.6	0.3	0.1	0.1	0.1	0.0	1.3	1.3	4.8	0.2	0.0	0.4	0.0	0.1	0.1	0.5	0.9
PRR18	MGC35308	ENSG00000176381	"Proline rich 18"	Q8N4B5	6	166305300-166308448	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"brain: 126.7"	"Cell type enriched"	"Detected in some"	5	"Oligodendrocytes: 27.3"	"Group enriched"	"Detected in some"	5	"glioma: 3.1;liver cancer: 1.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"SCLC-21H: 4.3;SH-SY5Y: 2.5"	"Low region specificity"	"Detected in all"							HPA077250	Enhanced					NA	NA					"HPA077250: AB_2732336"	"unprognostic (2.91e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.65e-2)"	"unprognostic (5.60e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.44e-3)"	"unprognostic (4.79e-3)"	"unprognostic (2.43e-1)"	"unprognostic (3.35e-3)"	"unprognostic (9.49e-2)"	"unprognostic (9.58e-2)"	"unprognostic (1.07e-1)"	0.3	0.0	28.4	0.0	73.4	0.0	0.1	35.0	71.3	0.1	7.2	0.0	0.3	0.0	0.0	0.0	2.1	0.0	0.0	29.4	37.1	0.0	3.4	0.2	0.0	90.4	59.1	17.8	0.0	0.2	1.2	0.9	0.0	101.1	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	31.2	0.0	0.1	0.0	54.7	0.0	0.1	0.0	0.0	0.0	0.0	126.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	2.5	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.4	73.4	35.0	71.3	29.4	37.1	90.4	59.1	17.8	101.1	31.2	54.7	126.7	0.0	0.0	0.0	2.3	0.0	0.0	0.2	0.0	0.0	1.1	0.1	0.0	0.6	2.8	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	3.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.5	27.3	0.1	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ROM1	"ROM, TSPAN23"	ENSG00000149489	"Retinal outer segment membrane protein 1"	Q03395	11	62611722-62615116	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Sensory transduction, Vision"		"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	17	"retina: 1197.3"	"Cell type enriched"	"Detected in many"	5	"Rod photoreceptor cells: 3239.7"	"Cancer enriched"	"Detected in all"	6	"glioma: 14.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 2.7"	"Group enriched"	"Detected in many"	4	"NK-cells: 2.7;T-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"HSkMC: 25.2;U-266/84: 31.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA028910, HPA073279"	Enhanced		Approved	"Plasma membrane,Cytosol"		No	No			"Plasma membrane, Cytosol"		"HPA028910: AB_2672824, HPA073279: "	"unprognostic (1.54e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.05e-1)"	"prognostic favorable (2.20e-4)"	"unprognostic (2.20e-1)"	"unprognostic (9.87e-2)"	"unprognostic (7.65e-3)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (2.85e-6)"	"unprognostic (2.61e-1)"	"unprognostic (4.65e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.24e-2)"	10.8	8.0	62.5	2.3	64.4	1.2	9.3	62.4	68.0	8.6	53.9	8.1	1.8	7.7	4.8	7.6	10.8	4.6	6.2	60.1	70.6	5.9	7.2	6.1	2.5	72.1	65.9	56.8	13.6	3.6	5.2	7.1	1.5	66.8	8.3	2.6	1197.3	4.3	5.0	3.3	5.4	5.4	5.4	66.2	7.5	7.1	6.2	66.6	1.6	6.0	3.7	2.5	9.7	7.4	69.3	3.2	1.9	3.1	6.6	4.5	22.0	0.6	2.1	3.7	4.3	2.8	0.9	5.3	3.0	15.9	12.2	2.0	4.1	1.5	4.2	1.1	5.3	3.0	3.1	8.6	4.0	13.0	1.1	0.9	25.2	5.9	4.5	9.1	15.1	7.0	1.2	4.0	6.5	9.1	8.3	1.7	2.3	0.8	1.7	5.9	1.6	2.6	19.1	5.0	1.8	3.3	5.1	5.0	5.8	2.5	0.5	8.1	1.4	8.3	7.2	2.7	8.3	2.5	2.9	31.9	2.4	14.2	3.1	1.5	0.0	0.4	0.3	0.3	0.1	0.9	0.2	1.2	0.3	0.2	0.3	0.5	0.6	0.1	2.7	0.4	0.3	0.4	0.5	62.5	64.4	62.4	68.0	60.1	70.6	72.1	65.9	56.8	66.8	66.2	66.6	69.3	19.9	0.0	4.4	4.9	0.6	3.7	5.7	5.0	7.4	356.6	3.8	7.2	2.5	2.8	2.3	5.5	594.2	1.0	0.6	2.4	1.9	1.6	2.0	1.0	4.1	31.3	4.2	0.0	0.2	3.1	0.2	4.1	1.1	1.0	1.3	1.2	21.8	1.7	1.1	171.6	0.5	2.8	0.0	1.9	0.8	7.9	19.0	1.2	3.6	1.9	1.3	516.9	1.0	1.0	6.5	2.1	2.5	5.7	0.6	3.1	3.1	4.7	2.7	3239.7	0.0	2.5	4.3	1.6	5.1	5.3	1.0	0.7	1.5	4.0	2.9	3.1
TM6SF2	Lpr4	ENSG00000213996	"Transmembrane 6 superfamily member 2"	Q9BZW4	19	19264364-19273391	"Predicted membrane proteins, Transporters"	"Lipid metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"intestine: 76.2;liver: 33.9"	"Cell type enriched"	"Detected in some"	6	"Proximal enterocytes: 231.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 1.4;HHSteC: 1.8;LHCN-M2: 1.5;NTERA-2: 1.0;SH-SY5Y: 1.8"	"Low region specificity"	"Detected in single"							HPA066026	Uncertain					NA	NA					"HPA066026: AB_2685598"	"unprognostic (2.41e-1)"	"unprognostic (4.81e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.15e-3)"	"unprognostic (3.29e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.39e-3)"	"unprognostic (4.00e-2)"	"unprognostic (4.15e-2)"	"unprognostic (4.53e-4)"	"unprognostic (9.55e-3)"	"unprognostic (4.37e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.15e-2)"	0.2	0.4	0.2	0.1	0.2	0.0	0.2	0.2	0.5	0.9	0.4	2.0	76.2	0.6	0.2	0.1	0.3	0.5	0.4	0.2	0.6	3.2	33.9	0.4	0.1	0.3	0.3	0.2	0.0	0.1	0.2	0.6	0.5	0.2	0.6	2.1	0.0	0.1	0.3	0.0	0.1	69.4	0.3	0.1	0.1	2.4	0.1	0.3	0.0	0.1	0.1	0.0	0.2	0.5	0.2	0.0	0.2	0.7	0.0	0.0	0.1	0.0	0.8	0.4	0.4	0.5	0.4	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	1.4	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	1.8	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.5	0.2	0.6	0.3	0.3	0.2	0.2	0.1	0.3	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	10.7	3.9	0.0	0.0	0.2	1.8	0.1	0.0	0.0	0.8	0.2	0.3	1.2	21.4	0.1	4.5	0.0	1.1	35.6	0.1	0.0	1.1	8.6	0.0	0.3	0.4	0.0	0.6	0.0	1.8	1.0	0.0	0.0	0.0	3.5	0.1	0.1	29.7	0.4	0.0	0.0	231.1	5.5	0.0	0.0	0.0	0.1	0.7	0.0	0.2	0.1	0.1	0.1	0.1	0.1	9.6	0.0
TRBV18	TCRBV18S1	ENSG00000276557	"T cell receptor beta variable 18"	A0A087X0M5	7	142615716-142616415	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	17	"lymphoid tissue: 27.8"	"Cell type enriched"	"Detected in single"	13	"T-cells: 6.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 102.0"	"Lineage enriched"	"Detected in single"	316	"T-cells: 102.0"	"Not detected"	"Not detected"																	NA	NA						"unprognostic (1.55e-2)"	"unprognostic (1.14e-3)"	"unprognostic (4.53e-3)"	"unprognostic (7.74e-4)"	"unprognostic (2.60e-2)"	"unprognostic (1.08e-4)"	"unprognostic (3.11e-1)"	"unprognostic (6.76e-3)"	"unprognostic (3.67e-2)"	"unprognostic (7.81e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.28e-6)"	"unprognostic (3.80e-1)"	"unprognostic (4.42e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.47e-2)"	0.1	0.1	0.0	0.0	0.0	0.8	0.1	0.0	0.1	0.2	0.0	0.5	0.0	0.1	0.0	0.1	0.1	0.8	0.0	0.0	0.0	0.1	0.1	0.8	8.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	1.0	0.0	0.1	0.0	0.0	0.3	1.6	0.2	0.0	1.8	0.5	0.0	0.0	27.8	0.2	0.0	2.2	0.6	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.9	0.0	3.0	0.2	46.6	10.8	0.0	0.0	49.3	16.9	0.2	0.1	0.1	0.0	102.0	14.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0
ABCB4	"GBD1, MDR2, MDR3, PFIC-3, PGY3"	ENSG00000005471	"ATP binding cassette subfamily B member 4"	P21439	7	87401696-87480435	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase	"Disease variant, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"liver: 124.2"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 256.1"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 16.3"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"memory B-cell: 4.4;naive B-cell: 8.1"	"Lineage enriched"	"Detected in many"	7	"B-cells: 8.1"	"Group enriched"	"Detected in some"	5	"SH-SY5Y: 12.9;WM-115: 25.7"	"Low region specificity"	"Detected in many"							"HPA049395, HPA053288"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA			"Nucleoplasm, Plasma membrane, Actin filaments"	"Focal adhesion sites"	"HPA049395: AB_2680745, HPA053288: AB_2682102"	"unprognostic (7.92e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.35e-3)"	"unprognostic (9.91e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.44e-3)"	"unprognostic (8.43e-2)"	"unprognostic (2.83e-2)"	"unprognostic (8.01e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.47e-1)"	0.7	7.5	1.0	2.5	0.7	0.9	0.5	0.7	1.0	0.3	0.5	0.9	0.4	0.2	0.6	0.6	0.2	0.8	6.7	0.9	0.7	0.6	124.2	0.2	5.9	0.9	0.8	0.7	0.4	0.1	0.0	0.2	0.2	1.1	0.5	1.2	0.4	0.6	0.4	7.5	1.4	2.2	0.3	0.7	5.1	0.6	1.0	0.8	0.7	0.5	4.8	5.2	1.2	0.5	0.9	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.4	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.2	12.9	0.0	0.6	2.6	0.5	0.2	0.6	0.0	0.2	1.7	0.1	0.0	0.0	0.0	3.2	0.2	0.0	25.7	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	1.2	8.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	1.0	0.7	0.7	1.0	0.9	0.7	0.9	0.8	0.7	1.1	0.7	0.8	0.9	1.3	0.0	0.5	0.3	22.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	10.2	0.0	0.0	1.8	0.0	1.1	0.1	0.2	0.0	0.1	0.6	0.2	0.2	1.0	0.0	0.4	0.6	0.0	0.3	2.0	0.0	0.2	0.0	0.0	3.3	256.1	0.5	38.7	1.8	0.0	0.0	5.0	1.2	0.4	0.0	1.0	10.6	3.7	0.1	0.0	0.0	0.5	0.0	0.1	0.1	0.4	0.3	0.0	0.5	0.7	0.0	0.2	0.0	0.6	1.2	1.2	0.2	0.0	0.4	0.1	0.7	0.0	0.2	0.0
ASCL3	"bHLHa42, HASH3, Sgn1"	ENSG00000176009	"Achaete-scute family bHLH transcription factor 3"	Q9NQ33	11	8937579-8938211	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	16	"salivary gland: 8.8"	"Cell type enriched"	"Detected in single"	923	"Ionocytes: 461.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA027032	Uncertain					NA	NA					"HPA027032: AB_10602434"											"unprognostic (8.91e-2)"	"unprognostic (1.32e-1)"		"unprognostic (3.53e-1)"				0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	8.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	461.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BLK	MGC10442	ENSG00000136573	"BLK proto-oncogene, Src family tyrosine kinase"	P51451	8	11486894-11564599	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"intestine: 39.4;lymphoid tissue: 47.1"	"Cell type enriched"	"Detected in some"	11	"B-cells: 116.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"memory B-cell: 183.4;naive B-cell: 131.5"	"Lineage enriched"	"Detected in many"	5	"B-cells: 183.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 106.6;REH: 29.9;RPMI-8226: 38.5;U-698: 48.6;U-87 MG: 22.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB005093, HPA069571"	Approved		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"CAB005093: AB_2274756, HPA069571: AB_2732137"	"unprognostic (6.50e-5)"	"unprognostic (4.22e-3)"	"unprognostic (5.64e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.45e-1)"	"unprognostic (5.98e-6)"	"unprognostic (1.59e-2)"	"unprognostic (8.94e-4)"	"unprognostic (1.02e-3)"	"unprognostic (9.83e-3)"	"unprognostic (1.22e-2)"	"unprognostic (4.66e-2)"	"unprognostic (9.05e-6)"	"unprognostic (5.62e-2)"	"unprognostic (5.43e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.16e-1)"	0.3	0.1	0.0	9.2	0.0	2.7	0.2	0.0	0.0	0.0	0.0	1.5	0.5	0.1	0.0	1.2	0.2	0.5	0.0	0.0	0.0	1.1	0.7	0.8	30.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.7	0.0	0.8	0.0	0.3	0.0	39.4	0.1	0.0	47.1	2.1	0.1	0.0	2.5	1.2	0.0	28.2	1.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	106.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	29.9	0.0	38.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	5.4	10.2	48.6	22.7	0.0	0.0	0.2	0.1	0.2	2.0	0.0	37.9	183.4	1.4	4.6	0.1	131.5	0.9	0.4	0.7	0.1	0.1	17.5	1.8	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	116.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.6	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.2	0.1	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.7	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	1.0	1.3	0.0	0.0	0.5	0.1	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	4.0	0.1	0.1	0.0
C11orf42	MGC34805	ENSG00000180878	"Chromosome 11 open reading frame 42"	Q8N5U0	11	6205557-6211135	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"testis: 25.6"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 818.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 1.3;HeLa: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA063404	Enhanced		Approved	"Nuclear membrane,Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	"Nuclear membrane, Vesicles"	"HPA063404: AB_2685006"	"unprognostic (4.79e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.39e-3)"	"unprognostic (3.49e-3)"	"unprognostic (2.05e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.50e-2)"	"unprognostic (9.30e-2)"	"unprognostic (6.47e-3)"	"unprognostic (7.02e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.07e-2)"	"unprognostic (4.74e-2)"	0.0	0.1	0.3	0.2	0.5	0.1	0.1	1.4	0.7	0.1	0.0	0.2	0.9	0.3	0.0	0.1	0.1	0.2	0.1	0.4	0.3	0.2	0.2	0.0	0.2	0.1	0.0	0.6	0.2	0.1	0.0	0.1	0.1	0.9	0.1	0.0	1.4	0.2	0.0	0.1	1.5	0.7	0.0	0.0	0.2	0.3	25.6	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.5	0.1	0.8	0.1	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.8	0.2	0.2	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.2	1.3	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.3	0.1	0.0	0.2	0.3	0.1	0.4	0.1	0.4	0.2	0.3	0.0	0.0	0.1	0.4	0.1	0.0	0.3	0.1	0.1	0.1	0.3	0.1	0.3	0.1	0.6	0.1	0.1	0.3	0.1	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	1.4	0.7	0.4	0.3	0.1	0.0	0.6	0.9	0.0	0.1	0.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	146.5	0.0	0.0	0.1	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	818.5	1.5	0.2	0.0	1.0	0.0	0.0	0.0	2.0	2.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C1orf68	"LEP7, XP32"	ENSG00000198854	"Chromosome 1 open reading frame 68"	Q5T750	1	152719522-152720470	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"skin 1: 683.7"	"Cell type enriched"	"Detected in some"	14	"Suprabasal keratinocytes: 78.3"	"Group enriched"	"Detected in some"	13	"head and neck cancer: 2.4;melanoma: 6.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"HaCaT: 1.8"	"Not detected"	"Not detected"							HPA057942			Approved	"Plasma membrane,Cytosol"		NA	NA		220000	"Plasma membrane"	Cytosol	"HPA057942: "		"unprognostic (1.73e-1)"				"unprognostic (7.46e-2)"			"unprognostic (9.34e-2)"									0.2	0.0	0.0	0.0	0.0	0.2	43.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	683.7	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.8	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	78.3	0.0	0.1	0.0	0.0	0.0
CDY2A	CDY2	ENSG00000182415	"Chromodomain Y-linked 2A"	Q9Y6F7	Y	18025787-18027746	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"epididymis: 1.1;testis: 2.0"	"Cell type enriched"	"Detected in single"	18	"Collecting duct cells: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA066682	Supported					NA	NA					"HPA066682: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CRH	"CRF, CRH1"	ENSG00000147571	"Corticotropin releasing hormone"	P06850	8	66176376-66178464	"Plasma proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"brain: 104.6"	"Cell type enriched"	"Detected in some"	5	"Syncytiotrophoblasts: 160.6"	"Cancer enriched"	"Detected in some"	28	"urothelial cancer: 34.5"	"Region enriched"	"Detected in many"	4	"medulla oblongata: 104.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SuSa: 1.3"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons: 25.1"						"Secreted to blood"	NA	NA	10000									"unprognostic (1.62e-1)"						"unprognostic (9.68e-2)"				"unprognostic (1.00e-1)"	"unprognostic (9.55e-2)"	"unprognostic (7.22e-3)"	1.5	0.2	9.7	0.0	2.8	0.1	0.0	0.1	6.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	7.5	0.0	0.0	0.0	0.0	104.6	10.7	1.9	0.0	1.6	0.7	0.2	6.6	17.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.9	24.3	0.0	0.1	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	2.8	0.1	6.4	1.4	7.5	104.6	10.7	1.9	17.0	0.3	24.3	13.1	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	31.5	0.0	0.0	0.0	0.0	18.8	0.0	0.0	0.0	2.8	0.0	0.0	0.0	1.5	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.4	0.0	0.0	160.6	0.0	0.0	0.0	0.1
FCRL1	"CD307a, FCRH1, IFGP1, IRTA5"	ENSG00000163534	"Fc receptor like 1"	Q96LA6	1	157794403-157820120	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"bone marrow: 8.1;intestine: 8.7;lymphoid tissue: 27.5"	"Cell type enriched"	"Detected in some"	26	"B-cells: 88.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	49	"memory B-cell: 39.3;naive B-cell: 68.1"	"Lineage enriched"	"Detected in many"	62	"B-cells: 68.1"	"Group enriched"	"Detected in some"	26	"Daudi: 5.4;U-698: 17.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA013323	Enhanced					NA	NA		290000			"HPA013323: AB_1848480"	"unprognostic (6.52e-4)"	"unprognostic (3.49e-3)"	"unprognostic (8.68e-3)"	"unprognostic (8.08e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.01e-5)"	"unprognostic (1.47e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.40e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.44e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.80e-2)"	"unprognostic (6.74e-2)"	0.2	0.0	0.0	10.2	0.0	8.1	0.0	0.0	0.1	0.1	0.0	0.5	0.2	0.0	0.0	0.2	0.0	0.5	0.1	0.0	0.0	0.2	0.2	0.6	27.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.5	0.0	0.6	0.0	0.0	0.0	8.7	0.0	0.0	18.0	0.8	0.0	0.0	3.0	0.4	0.0	22.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	17.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	39.3	0.0	0.0	0.0	68.1	0.0	0.1	1.1	0.2	0.5	0.0	0.3	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	88.7	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	1.3	0.0	0.0	0.6	0.0	0.0	0.5	0.1	0.0	0.0	0.0	3.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0
LGALS13	"PLAC8, PP13"	ENSG00000105198	"Galectin 13"	Q9UHV8	19	39602501-39607474	"Metabolic proteins, Predicted intracellular proteins"	Apoptosis	Hemagglutinin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	16	"placenta: 11.9"	"Cell type enriched"	"Detected in some"	17	"Syncytiotrophoblasts: 319.9"	"Cancer enriched"	"Detected in single"	4	"thyroid cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	22	"SuSa: 2.1"									HPA046803			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA046803: AB_10965990"																		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.0	0.0	0.0	11.9	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.6	0.0	0.7	0.2	0.4	0.1	0.5	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	319.9	0.0	0.0	0.0	0.0
LGALS16		ENSG00000249861	"Galectin 16"	A8MUM7	19	39655913-39660647	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	16	"placenta: 5.6"	"Cell type enriched"	"Detected in some"	66	"Syncytiotrophoblasts: 1019.7"	"Cancer enriched"	"Detected in single"	11	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	81	"BEWO: 4.2;SuSa: 11.8"															NA	NA																							0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	5.6	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1019.7	0.0	0.0	0.0	0.0
LPA	"LP, Lp(a)"	ENSG00000198670	Lipoprotein(a)	P08519	6	160531482-160664275	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid transport, Transport"	"Hydrolase, Protease, Serine protease"	Atherosclerosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"liver: 77.3"	"Cell type enriched"	"Detected in some"	28	"Hepatocytes: 80.7"	"Cancer enriched"	"Detected in single"	38	"liver cancer: 3.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"RT4: 1.0"									"CAB016072, HPA060604"	Supported				"Secreted to blood"	NA	NA	78800000000	1800000000			"CAB016072: AB_2135240, HPA060604: AB_2684330"		"unprognostic (2.16e-1)"	"unprognostic (5.10e-1)"	"unprognostic (7.75e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.59e-1)"		"unprognostic (6.38e-3)"	"unprognostic (3.63e-2)"	"unprognostic (3.18e-1)"	"unprognostic (7.45e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.72e-2)"	0.0	0.1	1.7	0.0	1.5	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.8	0.0	0.0	0.9	4.7	0.5	77.3	0.1	0.0	1.5	1.5	1.2	0.2	0.6	0.0	0.0	0.0	1.0	0.6	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	3.3	1.1	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.5	0.0	1.1	0.9	4.7	1.5	1.5	1.2	1.0	0.2	3.3	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.1	0.0	0.2	0.0	2.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	80.7	0.0	0.0	1.3	0.0	0.0	2.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3
OAZ3		ENSG00000143450	"Ornithine decarboxylase antizyme 3"	Q9UMX2	1	151762899-151771334	"Predicted intracellular proteins"	"Polyamine biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	16	"testis: 246.6"	"Cell type enriched"	"Detected in many"	5	"Late spermatids: 12007.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 3.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA030136, HPA045808"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA030136: AB_2673331, HPA045808: "	"unprognostic (2.12e-1)"	"unprognostic (3.86e-1)"	"unprognostic (1.53e-1)"	"unprognostic (5.44e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.48e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.01e-4)"	"unprognostic (1.57e-2)"	"unprognostic (2.89e-1)"	"unprognostic (8.05e-6)"	"unprognostic (3.94e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.50e-2)"	"unprognostic (8.36e-2)"	1.5	1.6	2.4	1.6	2.4	0.6	2.4	4.3	2.7	0.6	1.5	1.3	0.7	0.5	2.7	1.7	0.9	0.8	1.0	2.6	2.4	1.6	2.8	1.5	1.5	2.9	2.5	2.3	0.3	2.1	4.3	2.7	0.6	2.9	15.4	1.7	2.7	8.2	1.3	3.0	1.2	1.2	0.5	1.9	1.3	1.4	246.6	2.4	0.6	3.3	0.9	0.6	1.1	1.0	2.4	0.9	1.8	1.0	2.5	0.8	2.4	2.3	1.9	0.4	1.7	0.7	1.0	2.3	0.8	1.5	0.6	1.2	0.9	1.0	1.7	0.5	5.8	5.3	0.8	3.2	1.5	1.0	0.4	0.9	3.8	1.0	1.9	2.3	1.1	2.6	2.3	1.2	2.8	1.9	7.7	0.7	1.3	2.5	3.6	1.9	0.4	0.8	1.3	0.3	2.3	1.2	2.8	0.8	3.7	3.6	2.3	8.2	2.1	2.3	1.0	0.5	1.9	1.0	4.0	7.5	2.0	1.3	1.2	2.7	0.6	0.8	0.1	0.3	0.4	0.3	0.3	0.3	0.6	1.0	0.2	0.3	0.6	0.4	0.7	1.5	0.3	0.7	0.4	2.4	2.4	4.3	2.7	2.6	2.4	2.9	2.5	2.3	2.9	1.9	2.4	2.4	2.3	0.0	1.7	0.3	0.3	0.8	2.6	1.8	1.8	0.5	16.0	6.2	1.4	0.0	2.2	0.0	2.1	1.7	0.9	4.2	1.9	2.4	2386.5	3.4	0.6	5.3	3.6	0.4	0.4	3.1	3.0	1.0	1.5	1.5	1.3	0.5	1.8	3.1	4.8	0.0	0.3	7.4	2.0	4.2	1.6	12007.9	46.0	5.1	1.8	0.0	1.8	1.7	0.0	0.0	0.3	3.3	4.9	42.5	1.6	20.4	5.7	7.4	3.2	1.6	0.0	0.4	0.8	67.6	31.8	1.2	0.6	1.5	0.6	1.4	2.7	3.2
RAB41		ENSG00000147127	"RAB41, member RAS oncogene family"	Q5JT25	X	70282093-70285002	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"retina: 66.1"	"Cell type enriched"	"Detected in some"	19	"Cone photoreceptor cells: 533.8"	"Cancer enhanced"	"Detected in some"		"glioma: 2.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"U-2197: 3.7;U-87 MG: 4.6"									"HPA001510, HPA065289"	Uncertain		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Vesicles, Plasma membrane"	"HPA001510: AB_1079733, HPA065289: "	"unprognostic (1.32e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.36e-3)"	"unprognostic (4.25e-3)"	"unprognostic (1.18e-1)"	"unprognostic (3.46e-2)"	"unprognostic (6.33e-3)"	"unprognostic (1.85e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.04e-3)"	"unprognostic (7.63e-2)"	"unprognostic (2.39e-1)"	"unprognostic (9.78e-3)"	"unprognostic (8.42e-2)"	"unprognostic (9.89e-2)"	0.2	0.8	0.3	0.6	0.4	0.4	0.1	0.3	0.8	0.1	0.0	0.3	0.4	0.2	0.0	0.3	0.2	0.5	0.6	0.2	0.2	0.3	0.1	0.3	0.5	0.5	0.4	0.0	0.8	0.1	0.0	0.2	0.2	0.3	0.2	0.0	66.1	1.0	0.0	0.5	1.3	0.8	0.0	0.3	0.5	0.2	4.0	0.6	0.0	0.8	0.0	0.0	0.3	0.1	0.4	0.5	0.5	1.3	0.5	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.6	0.5	0.6	1.1	0.0	1.1	0.6	0.0	0.0	0.0	0.8	1.3	0.1	1.4	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	1.7	0.0	0.8	0.5	1.2	0.0	0.3	0.8	0.5	0.8	1.7	1.7	0.3	0.9	0.9	0.0	0.4	0.8	1.5	0.5	0.3	1.5	0.6	0.3	1.4	1.6	0.6	0.7	3.7	0.8	0.7	1.1	0.8	4.6	1.1	1.1	0.0	0.0	0.0	0.1	0.2	0.3	0.2	0.1	0.1	0.3	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.4	0.3	0.8	0.2	0.2	0.5	0.4	0.0	0.3	0.3	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	533.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	28.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SERPINF2	"A2AP, AAP, ALPHA-2-PI, API, PLI"	ENSG00000167711	"Serpin family F member 2"	P08697	17	1742836-1755265	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Acute phase"	"Protease inhibitor, Serine protease inhibitor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	16	"liver: 1591.4"	"Cell type enriched"	"Detected in many"	11	"Hepatocytes: 1007.7"	"Cancer enriched"	"Detected in all"	6	"liver cancer: 450.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"plasmacytoid DC: 44.7"	"Lineage enriched"	"Detected in many"	23	"dendritic cells: 44.7"	"Cell line enriched"	"Detected in some"	24	"Hep G2: 145.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA001885, CAB024863"	Approved				"Secreted to blood"	NA	NA	11900	61000000000			"CAB024863: , HPA001885: AB_1079922"	"unprognostic (2.17e-3)"	"unprognostic (2.56e-3)"	"unprognostic (2.48e-1)"	"unprognostic (7.57e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.45e-2)"	"prognostic favorable (2.26e-5)"	"unprognostic (1.44e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.88e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.09e-3)"	"unprognostic (7.05e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.68e-3)"	"unprognostic (2.93e-1)"	10.7	2.0	1.5	4.4	1.6	0.4	18.5	1.3	2.2	6.9	9.2	3.9	0.7	8.7	102.3	3.1	19.8	0.7	2.4	2.0	1.5	72.5	1591.4	13.0	3.0	1.6	1.7	1.2	7.8	9.2	0.1	1.9	0.8	2.5	21.6	0.5	0.5	6.1	32.9	4.3	5.3	11.7	1.8	2.1	7.2	3.8	12.6	1.6	2.6	8.0	0.4	3.5	7.4	5.8	2.1	1.8	6.1	0.0	0.0	0.5	0.3	0.3	0.0	0.0	0.0	0.0	0.0	3.8	0.3	0.9	0.0	0.3	0.9	0.0	3.3	0.0	0.0	0.0	0.1	0.9	145.9	1.1	0.8	0.1	1.6	1.2	0.0	0.7	0.1	0.0	0.1	0.2	0.2	0.0	0.2	0.0	0.7	0.1	0.3	0.3	0.1	0.9	1.3	0.0	0.3	0.0	0.2	0.6	0.0	1.1	0.0	0.2	0.1	0.3	0.0	0.6	0.1	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	1.9	1.4	0.0	0.8	0.0	0.5	0.0	0.0	10.7	0.5	0.0	0.0	0.0	1.2	0.0	44.7	0.0	1.2	1.5	1.6	1.3	2.2	2.0	1.5	1.6	1.7	1.2	2.5	2.1	1.6	2.1	1.6	3.2	19.6	0.3	5.3	1.5	4.9	10.3	8.0	0.2	20.5	8.8	0.7	27.1	7.0	1.8	6.2	0.2	32.1	0.7	9.8	0.0	0.6	0.1	2.7	3.4	4.2	23.6	1.6	4.9	0.3	2.7	0.0	0.3	1.3	0.3	14.6	1007.7	7.7	0.0	1.9	2.1	12.2	32.2	20.1	0.8	33.8	8.2	1.8	1.0	10.9	0.1	0.0	1.0	0.7	3.8	2.7	26.7	3.2	2.8	2.2	87.5	4.4	0.4	0.0	1.3	1.2	0.4	0.5	1.3	1.6	0.3	2.6	0.0	3.3	1.8
TRAV10	"TCRAV10S1, TCRAV24S1"	ENSG00000211784	"T cell receptor alpha variable 10"	A0A0B4J240	14	21825472-21826075	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	16	"lymphoid tissue: 16.3"	"Cell type enriched"	"Detected in single"	6	"T-cells: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	64	"MAIT T-cell: 24.7;memory CD4 T-cell: 38.3;memory CD8 T-cell: 43.3;naive CD4 T-cell: 42.5;naive CD8 T-cell: 25.0;T-reg: 59.4"	"Lineage enriched"	"Detected in single"	156	"T-cells: 59.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"													NA	NA						"unprognostic (2.58e-3)"	"unprognostic (1.27e-3)"	"unprognostic (1.74e-2)"	"unprognostic (5.74e-4)"		"unprognostic (3.80e-4)"		"unprognostic (2.97e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.63e-2)"	"unprognostic (7.70e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.67e-5)"	"unprognostic (2.49e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.66e-1)"		0.2	0.2	0.0	3.5	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.6	0.1	0.2	0.0	0.3	0.1	0.9	0.0	0.0	0.0	0.0	0.2	0.9	5.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	1.8	0.7	0.0	0.0	16.3	0.1	0.0	5.3	0.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	24.7	0.1	38.3	43.3	0.0	0.1	42.5	25.0	0.3	0.0	0.2	0.3	59.4	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0
CPN2	ACBP	ENSG00000178772	"Carboxypeptidase N subunit 2"	P22792	3	194339768-194351328	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"liver: 220.4"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 171.8"	"Cancer enriched"	"Detected in some"	32	"liver cancer: 72.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	29	"Hep G2: 61.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA004732	Uncertain				"Secreted to blood"	NA	NA		25000000000			"HPA004732: AB_1078561"	"unprognostic (4.27e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.42e-1)"			"unprognostic (4.12e-2)"	"prognostic favorable (2.05e-4)"	"unprognostic (1.27e-1)"	"unprognostic (8.65e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.64e-1)"		"prognostic unfavorable (4.59e-4)"	"unprognostic (2.91e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.90e-5)"	"unprognostic (8.42e-2)"	0.4	3.1	0.5	0.4	0.6	1.5	0.2	0.6	1.0	0.2	0.0	0.2	0.0	0.4	0.4	0.1	0.2	0.4	1.0	0.8	0.4	14.8	220.4	0.2	0.3	0.3	0.2	0.5	0.3	0.1	0.1	0.0	0.4	0.4	0.2	0.2	1.1	0.2	0.1	0.1	0.6	0.2	0.2	0.0	1.2	0.4	0.7	0.4	0.1	0.3	0.0	0.2	0.1	0.0	1.2	0.2	0.1	0.3	0.3	0.1	0.8	0.2	0.3	0.1	0.0	0.0	0.4	0.2	0.2	0.3	0.8	0.4	0.5	0.1	0.0	0.2	0.1	0.2	0.3	0.6	61.8	0.0	0.3	0.1	0.1	0.0	0.2	0.1	0.3	0.0	0.3	0.5	0.6	0.0	0.3	0.2	0.3	0.3	0.1	0.1	0.1	0.5	0.0	0.1	0.4	0.3	0.2	0.3	0.2	0.4	0.3	0.2	1.4	1.6	0.2	2.1	0.2	0.1	0.2	0.2	0.1	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.6	1.0	0.8	0.4	0.3	0.2	0.5	0.4	0.0	0.4	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	171.8	0.2	0.0	0.3	0.0	0.0	2.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
CPO		ENSG00000144410	"Carboxypeptidase O"	Q8IVL8	2	206939518-206969474	"Enzymes, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"intestine: 112.7"	"Cell type enriched"	"Detected in some"	8	"Proximal enterocytes: 349.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	30	"basophil: 12.0"	"Lineage enriched"	"Detected in single"	84	"granulocytes: 12.0"	"Cell line enhanced"	"Detected in single"		"NB-4: 1.0"					"Not detected"	"Not detected"								"Intracellular and membrane"	NA	NA						"unprognostic (9.39e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.95e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.75e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.52e-1)"	"unprognostic (6.56e-2)"	"unprognostic (4.03e-2)"	"unprognostic (4.89e-2)"	0.5	1.0	2.4	0.1	2.5	0.0	0.8	1.4	3.1	0.5	1.2	0.9	0.5	0.3	7.6	0.2	0.7	0.4	0.4	2.3	2.2	1.3	0.7	0.3	0.1	2.1	2.2	2.3	0.4	0.5	1.0	1.2	0.2	2.4	0.9	0.4	0.6	0.9	0.8	0.7	0.5	112.7	0.7	1.9	0.2	0.5	0.8	2.5	0.1	1.0	0.5	0.1	0.5	0.3	3.4	0.0	0.0	0.0	0.0	0.7	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.6	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	12.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	2.5	1.4	3.1	2.3	2.2	2.1	2.2	2.3	2.4	1.9	2.5	3.4	0.1	0.0	0.0	9.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.2	0.0	0.0	0.0	43.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	35.9	6.3	0.0	0.0	0.0	0.7	0.3	0.0	0.0	6.5	0.0	0.0	0.0	2.0	14.6	0.0	3.8	0.0	0.0	0.0	349.9	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1
FLG2	IFPS	ENSG00000143520	"Filaggrin family member 2"	Q5D862	1	152348735-152360006	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"skin 1: 487.8"	"Cell type enriched"	"Detected in some"	11	"Suprabasal keratinocytes: 24.2"	"Cancer enriched"	"Detected in some"	8	"melanoma: 7.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA028699	Approved					NA	NA		21000000			"HPA028699: AB_10601905"		"unprognostic (2.58e-1)"				"unprognostic (2.33e-1)"		"unprognostic (3.08e-1)"	"unprognostic (6.85e-2)"	"unprognostic (6.59e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.96e-1)"		0.2	0.0	0.1	0.0	0.0	0.1	32.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	487.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.3	0.0	0.9	0.4	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.2	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.1	1.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.5	0.2	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	1.1	0.0	1.0	0.2	0.1	0.2	0.0	24.2	0.0	0.0	0.1	0.0	0.3
KCNJ14	"IRK4, Kir2.4"	ENSG00000182324	"Potassium inwardly rectifying channel subfamily J member 14"	Q9UNX9	19	48455574-48466980	"FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"retina: 59.3"	"Cell type enriched"	"Detected in many"	7	"Rod photoreceptor cells: 326.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"NB-4: 7.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA071765			Approved	Nucleoli		NA	NA			Nucleoli		"HPA071765: AB_2686444"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.33e-5)"	"unprognostic (5.77e-2)"	"unprognostic (9.41e-2)"	"unprognostic (5.26e-2)"	"unprognostic (7.05e-4)"	"unprognostic (7.83e-4)"	"unprognostic (1.26e-1)"	"unprognostic (6.48e-2)"	"unprognostic (4.43e-3)"	"unprognostic (4.92e-2)"	"unprognostic (5.02e-6)"	"unprognostic (1.47e-1)"	"unprognostic (4.98e-2)"	"unprognostic (6.82e-3)"	"unprognostic (4.41e-2)"	0.7	0.3	2.1	0.3	2.9	2.1	0.7	2.9	2.3	0.8	1.7	0.5	0.3	0.6	0.6	1.3	0.9	0.4	0.4	2.0	1.9	0.7	0.9	0.7	0.5	2.8	2.9	1.8	1.0	0.6	0.2	0.9	0.3	3.8	1.4	0.3	59.3	0.6	0.2	1.6	2.2	0.6	0.3	1.9	0.7	0.5	1.2	2.9	0.3	1.2	0.3	0.3	0.6	1.0	2.6	0.9	2.3	0.4	1.5	0.9	0.9	1.5	0.3	0.2	0.5	0.7	2.2	1.2	1.1	0.4	0.3	1.1	3.2	0.7	0.4	1.2	0.8	1.2	0.6	1.5	0.6	0.5	0.9	1.8	0.9	1.6	1.1	1.3	0.6	0.3	1.0	1.0	1.1	0.3	1.4	0.4	7.6	0.8	1.2	1.1	1.5	0.9	0.2	0.3	2.7	0.8	1.0	1.0	1.5	0.9	0.8	1.0	0.8	0.5	1.5	2.0	1.6	1.8	1.2	1.9	0.7	0.4	2.4	1.6	1.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.3	0.1	0.2	0.6	0.1	0.0	0.1	0.1	0.0	2.1	2.9	2.9	2.3	2.0	1.9	2.8	2.9	1.8	3.8	1.9	2.9	2.6	3.7	0.0	3.4	5.2	1.2	4.5	3.6	1.0	1.8	17.0	4.9	2.4	0.6	2.8	0.7	1.8	41.7	1.4	0.3	1.3	0.0	1.1	4.7	4.1	2.8	2.3	0.0	0.8	2.3	1.1	2.4	1.3	0.5	5.6	0.0	2.4	0.7	0.5	0.6	15.2	3.1	1.4	0.0	0.0	0.7	0.6	1.2	1.0	0.0	1.9	0.6	24.5	0.0	0.0	0.9	3.1	0.3	0.4	0.7	4.4	0.5	0.1	1.8	326.4	0.0	6.5	1.5	3.9	3.3	2.6	5.4	1.0	0.9	1.2	1.7	2.9
SPANXN1	"CT11.6, SPANX-N1"	ENSG00000203923	"SPANX family member N1"	Q5VSR9	X	145247503-145256208	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	15	"testis: 1.5"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 8.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TEX12		ENSG00000150783	"Testis expressed 12"	Q9BXU0	11	112167372-112172556	"Predicted intracellular proteins"	Meiosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"retina: 8.7;testis: 20.9"	"Cell type enriched"	"Detected in some"	5	"Spermatocytes: 211.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-698: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA038289, HPA038290"	Enhanced					NA	NA					"HPA038289: AB_10672742, HPA038290: AB_2675934"	"unprognostic (1.49e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.93e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.91e-1)"	"unprognostic (9.20e-4)"	"unprognostic (1.71e-2)"	"unprognostic (2.97e-1)"	"unprognostic (6.54e-2)"	"unprognostic (4.10e-2)"	"unprognostic (3.16e-3)"	0.3	0.0	0.1	0.1	0.1	0.4	0.4	0.5	0.2	0.2	0.1	0.3	0.6	0.2	0.0	0.1	0.2	0.1	0.2	0.0	0.1	0.2	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.2	8.7	0.2	0.1	1.0	0.7	0.4	0.2	0.0	0.2	0.2	20.9	0.1	0.1	0.1	0.7	0.2	0.2	0.2	0.1	0.0	0.0	0.2	0.1	0.3	0.2	0.0	0.0	0.1	0.1	0.3	0.1	0.4	0.7	0.2	0.2	0.1	0.0	0.1	0.2	0.2	0.5	0.0	0.3	0.0	0.0	0.4	0.4	0.2	0.2	0.2	0.3	0.1	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.3	0.7	0.1	0.4	0.2	0.2	0.1	0.6	0.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.8	0.0	0.1	0.4	0.2	0.1	0.0	0.0	1.4	0.1	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.2	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.6	0.3	0.4	0.0	0.5	0.1	0.3	0.4	0.0	0.1	0.0	4.2	0.1	0.3	0.3	0.0	0.2	2.0	0.0	0.1	0.1	0.0	0.0	1.7	0.2	0.1	0.2	0.0	0.2	0.0	0.3	0.0	0.4	0.3	0.0	2.2	0.1	0.0	0.0	1.9	5.1	0.9	0.3	0.0	1.0	0.6	0.3	0.0	0.5	0.2	0.1	0.1	0.7	0.1	0.2	0.3	0.1	0.0	0.4	6.6	0.2	0.4	211.7	36.1	0.0	0.4	0.0	0.3	0.2	0.2	0.3
TRBV7-7	"TCRBV6S6A2T, TCRBV7S7, TRBV77"	ENSG00000253291	"T cell receptor beta variable 7-7"	A0A0K0K1E9	7	142511626-142512127	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	15	"lymphoid tissue: 8.3"	"Cell type enriched"	"Detected in single"	11	"T-cells: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"memory CD4 T-cell: 7.8;memory CD8 T-cell: 2.5;naive CD4 T-cell: 7.6;naive CD8 T-cell: 3.3;T-reg: 10.1"	"Lineage enriched"	"Detected in single"	101	"T-cells: 10.1"	"Not detected"	"Not detected"																	NA	NA						"unprognostic (2.82e-4)"							"unprognostic (2.74e-1)"		"unprognostic (1.93e-3)"	"unprognostic (2.30e-2)"		"unprognostic (1.89e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.74e-2)"		0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.2	0.1	0.0	8.3	0.0	0.0	1.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.0	7.8	2.5	0.0	0.0	7.6	3.3	0.0	0.0	0.0	0.0	10.1	2.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0
TRDC		ENSG00000211829	"T cell receptor delta constant"		14	22462932-22465787	"Predicted membrane proteins, T-cell receptor genes"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in many"	15	"lymphoid tissue: 408.1"	"Cell type enriched"	"Detected in some"	4	"NK-cells: 746.6"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 19.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	87	"gdT-cell: 5873.4;NK-cell: 2243.9"	"Group enriched"	"Detected in all"	150	"NK-cells: 2243.9;T-cells: 5873.4"	"Cell line enriched"	"Detected in some"	38	"NB-4: 356.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.21e-3)"	"unprognostic (8.15e-3)"	"unprognostic (7.03e-2)"	"prognostic favorable (8.25e-4)"	"unprognostic (2.53e-1)"	"unprognostic (2.42e-3)"	"unprognostic (2.19e-1)"	"prognostic favorable (6.13e-4)"	"unprognostic (2.76e-2)"	"unprognostic (2.19e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (7.67e-5)"	"unprognostic (1.25e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.99e-2)"	9.5	0.4	1.1	7.9	1.1	26.4	3.8	1.5	1.5	2.9	0.8	9.0	4.0	7.7	2.1	2.1	4.1	8.0	2.7	2.1	1.0	1.1	11.1	11.7	22.9	1.0	1.2	0.9	1.9	0.2	0.5	0.7	2.8	0.9	1.0	7.5	0.0	4.7	1.2	1.6	1.4	5.6	2.2	0.8	54.6	2.1	2.7	1.0	408.1	1.8	1.4	18.4	4.6	0.9	1.4	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.3	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	356.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.2	0.0	3.1	0.9	1.4	0.0	0.0	0.1	3.2	4.8	2.3	5873.4	7.9	3.8	5.7	16.7	31.7	9.2	1.9	16.2	46.6	27.0	2243.9	5.5	7.1	27.5	1292.0	1.1	1.1	1.5	1.5	2.1	1.0	1.0	1.2	0.9	0.9	0.8	1.0	1.4	1.1	3.2	5.5	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.1	0.0	0.6	0.0	0.0	0.0	165.7	0.3	0.0	0.5	0.0	0.9	0.8	0.7	0.0	1.3	0.0	0.0	0.0	1.3	0.0	1.0	0.0	0.0	4.2	0.5	0.5	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.9	0.0	0.0	5.7	0.0	746.6	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.3	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	123.5	0.0	0.0	0.0
AKNAD1	"C1orf62, MGC26989"	ENSG00000162641	"AKNA domain containing 1"	Q5T1N1	1	108815898-108963484	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	14	"testis: 4.9"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 80.6"	"Cancer enhanced"	"Detected in single"		"glioma: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 1.1;hTCEpi: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA030270, HPA030271, HPA030272"	Uncertain		Approved	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	NA			Cytosol	"Microtubules, Cytokinetic bridge"	"HPA030270: AB_10610980, HPA030271: AB_10600873, HPA030272: AB_10601342"	"unprognostic (4.93e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.52e-2)"	"unprognostic (2.00e-3)"	"unprognostic (7.22e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.09e-5)"	"unprognostic (8.15e-2)"	"unprognostic (5.95e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.00e-8)"	"unprognostic (1.08e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.75e-2)"	"unprognostic (8.22e-2)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.9	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.7	0.0	0.0	1.6	0.0	1.5	0.1	0.0	1.8	2.5	0.5	0.9	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.2	80.6	0.3	5.1	1.4	0.0	0.0	1.0	0.2	0.8	3.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	1.4	0.7	0.0	0.0	0.3	17.8	2.5	0.1	1.8	0.0	0.0	0.4	0.0	3.5	3.1	0.2	0.0	1.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	8.2	0.9	0.6	1.4	0.1	0.1	0.7	0.1	0.7	0.5	0.0
ANGPTL8	"C19orf80, RIFL, TD26"	ENSG00000130173	"Angiopoietin like 8"	Q6UXH0	19	11237450-11241943	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid metabolism"	Hormone	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	14	"liver: 413.1"	"Cell type enriched"	"Detected in some"	26	"Hepatocytes: 151.2"	"Cancer enriched"	"Detected in some"	37	"liver cancer: 84.6"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	22	"Hep G2: 37.0;MCF7: 21.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042131			Approved	"Nucleoplasm,Golgi apparatus"	"Secreted to blood"	NA	NA	836000	350000	"Golgi apparatus"	Nucleoplasm	"HPA042131: AB_10794413"	"unprognostic (2.37e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.02e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (1.84e-6)"	"unprognostic (1.09e-1)"	"unprognostic (3.55e-1)"	"unprognostic (4.57e-1)"	"unprognostic (1.75e-2)"	29.8	0.9	1.5	0.2	0.5	0.1	22.7	0.0	1.7	1.2	0.2	1.2	0.4	0.9	1.6	0.3	0.8	0.4	1.3	0.7	0.4	3.9	413.1	0.5	0.1	0.9	0.5	0.0	1.1	0.9	0.0	0.3	0.1	0.4	0.8	0.0	0.1	1.3	0.1	0.8	0.8	1.3	0.1	0.2	0.4	0.7	0.6	1.5	0.0	1.0	0.0	0.0	1.1	1.0	0.7	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.2	0.2	1.3	37.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.1	0.0	0.0	21.2	0.0	0.7	0.2	0.0	0.0	0.1	0.4	1.0	0.0	0.3	0.0	0.3	0.4	0.9	0.0	0.4	0.6	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.2	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.5	0.0	1.7	0.7	0.4	0.9	0.5	0.0	0.4	0.2	1.5	0.7	0.6	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.4	0.2	0.8	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.3	0.2	0.0	2.7	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.3	4.6	151.2	0.1	0.0	0.0	0.0	0.0	4.4	0.0	1.9	0.9	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.1	0.0	3.3	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.3	0.1	0.2	0.0	0.1
C16orf96		ENSG00000205832	"Chromosome 16 open reading frame 96"	A6NNT2	16	4556490-4600714	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	14	"testis: 10.6"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 15.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"REH: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.94e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.57e-4)"	"unprognostic (1.12e-1)"	"unprognostic (4.47e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.32e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.26e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.06e-5)"	"unprognostic (3.22e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.23e-2)"	"unprognostic (4.24e-4)"	"unprognostic (2.66e-1)"	0.0	0.1	0.4	0.0	0.6	0.1	0.0	0.5	0.5	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.5	0.1	0.3	0.1	0.0	0.7	0.5	0.2	0.1	0.4	0.0	0.2	0.0	0.6	0.1	0.0	0.4	0.1	0.1	0.1	0.3	0.1	0.0	0.5	0.1	0.0	10.6	0.5	0.1	0.2	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.5	0.5	0.3	0.5	0.7	0.5	0.2	0.6	0.5	0.5	0.6	0.1	0.0	0.0	3.6	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.1	0.1	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.0	0.0	3.8	0.6	0.0	0.0	0.0	0.0	0.2	0.0	1.5	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	1.5	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0
C2orf16	DKFZp434G118	ENSG00000221843	"Chromosome 2 open reading frame 16"	Q68DN1	2	27537386-27582721	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 21.6"	"Cell type enriched"	"Detected in some"	6	"Early spermatids: 94.1"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 2.4;SiHa: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA052136, HPA056962"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No			"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA052136: AB_2681742, HPA056962: AB_2683290"	"unprognostic (4.32e-2)"	"unprognostic (1.08e-2)"	"unprognostic (8.36e-2)"	"unprognostic (3.40e-3)"	"unprognostic (6.36e-2)"	"unprognostic (6.17e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.07e-1)"	"unprognostic (9.35e-2)"	"unprognostic (3.79e-3)"	"unprognostic (4.59e-1)"	"unprognostic (2.19e-2)"	"unprognostic (8.82e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.46e-2)"	"unprognostic (8.53e-3)"	0.1	0.4	0.1	0.2	0.1	0.0	0.2	0.0	0.3	0.2	0.0	0.2	0.1	0.2	0.0	0.3	0.2	0.2	0.3	0.1	0.1	0.1	1.2	0.1	0.1	0.3	0.0	0.1	0.5	0.3	0.0	0.5	0.0	0.5	0.3	0.0	1.5	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.4	21.6	0.1	0.0	0.4	0.0	0.0	0.2	0.2	0.2	0.6	0.6	0.9	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.8	0.3	0.8	0.0	0.6	0.2	0.0	0.0	0.0	0.6	0.1	1.2	0.5	0.6	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.4	0.1	0.3	0.5	0.8	0.0	0.1	0.0	0.3	0.1	0.3	0.0	0.5	0.5	0.2	0.0	0.6	2.4	0.4	1.8	0.4	0.2	0.1	0.4	0.4	1.1	0.5	0.8	0.3	0.4	0.1	0.0	0.7	0.2	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.1	0.3	0.0	0.1	0.5	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.7	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.4	94.1	0.3	0.2	0.1	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.3	0.2	0.0	0.0	0.0	0.0	14.4	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.1	0.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C4orf51		ENSG00000237136	"Chromosome 4 open reading frame 51"	C9J302	4	145680146-145771032	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	14	"testis: 5.8"	"Cell type enriched"	"Detected in some"	9	"Early spermatids: 82.7"	"Cancer enriched"	"Detected in single"	8	"testis cancer: 1.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.37e-2)"	"unprognostic (1.44e-1)"		"unprognostic (1.03e-1)"	"unprognostic (1.93e-2)"	"unprognostic (4.37e-1)"		"unprognostic (1.32e-1)"		"unprognostic (2.19e-3)"	"unprognostic (8.13e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.07e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	82.7	0.9	0.0	0.1	0.0	0.0	2.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	9.1	1.5	0.0	0.0	1.9	0.0	0.0	0.0	2.5	2.6	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	3.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CYP19A1	"ARO, ARO1, aromatase, CPV1, CYAR, CYP19, P-450AROM"	ENSG00000137869	"Cytochrome P450 family 19 subfamily A member 1"	P11511	15	51208057-51338601	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	14	"placenta: 125.5"	"Cell type enriched"	"Detected in some"	10	"Syncytiotrophoblasts: 2007.5"	"Cancer enhanced"	"Detected in single"		"glioma: 0.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 92.8;HDLM-2: 17.5;HSkMC: 31.4;SuSa: 16.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000355, HPA051194"	Enhanced		Uncertain	Mitochondria		NA	NA			Mitochondria		"CAB000355: , HPA051194: AB_2681381"	"unprognostic (9.41e-2)"	"unprognostic (7.44e-2)"	"unprognostic (9.52e-5)"	"unprognostic (6.81e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.25e-4)"	"unprognostic (5.18e-5)"	"unprognostic (1.54e-3)"	"unprognostic (2.38e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.97e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.54e-5)"	"unprognostic (2.52e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.11e-1)"	5.3	9.1	3.8	0.5	0.6	0.2	2.1	0.1	2.1	0.6	0.0	0.2	0.7	0.3	0.0	0.1	0.3	0.5	1.0	0.2	3.0	0.1	0.1	0.7	0.0	1.0	2.3	0.2	3.2	1.3	0.2	0.0	125.5	0.4	0.6	0.1	0.6	0.9	2.8	0.6	1.5	0.2	1.4	0.5	0.6	0.2	6.5	3.2	0.2	2.5	0.3	0.0	3.5	0.5	2.5	0.1	0.0	0.0	0.0	1.7	92.8	6.0	0.1	0.3	0.0	0.1	0.2	0.0	0.0	0.3	0.5	0.4	0.0	0.0	0.0	0.0	17.5	0.0	0.6	0.2	8.1	0.6	0.0	0.1	31.4	0.0	0.3	4.0	0.3	0.0	0.0	0.0	0.8	0.4	0.7	0.0	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	2.4	0.2	16.3	0.0	0.5	0.1	0.3	0.1	0.2	0.0	3.0	1.6	0.0	0.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.8	0.6	0.1	2.1	0.2	3.0	1.0	2.3	0.2	0.4	0.5	3.2	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	52.8	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.7	0.0	0.0	0.1	0.0	7.9	1.5	0.0	0.0	0.0	191.3	0.0	0.0	14.0	0.0	0.3	0.0	0.0	0.9	0.0	5.1	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.2	0.9	12.3	0.3	0.0	0.0	2007.5	0.0	22.2	0.0	0.0
EFCAB3	FLJ25818	ENSG00000172421	"EF-hand calcium binding domain 3"	Q8N7B9	17	62343941-62416480	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	14	"testis: 6.0"	"Cell type enriched"	"Detected in some"	8	"Early spermatids: 74.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA046862	Uncertain					NA	NA					"HPA046862: AB_2679844"													"unprognostic (2.99e-6)"					0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.3	0.2	0.0	0.0	0.3	0.0	0.2	0.1	0.1	0.1	0.4	0.0	0.3	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	1.1	0.3	0.0	0.1	0.0	0.2	0.0	0.2	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	74.6	0.2	0.4	0.4	0.0	0.0	1.3	0.0	0.2	0.4	0.0	0.3	1.3	0.3	0.4	0.3	0.0	1.7	0.9	0.0	0.0	0.0	1.1	8.4	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.1	0.0	0.4	0.0	0.1	0.0	0.1	3.1	0.3	0.0	0.2	0.1	0.1	0.5	0.0	0.0	0.4	0.1	0.0	0.0	0.1
EGR4	"NGFI-C, PAT133"	ENSG00000135625	"Early growth response 4"	Q05215	2	73290929-73293701	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 53.5"	"Cell type enriched"	"Detected in many"	6	"Enteroendocrine cells: 99.5"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebral cortex: 53.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"HMC-1: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA028983	Enhanced					NA	NA					"HPA028983: AB_10603665"	"unprognostic (7.75e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.39e-4)"	"unprognostic (2.43e-3)"	"unprognostic (2.68e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.03e-2)"	"unprognostic (5.20e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.29e-4)"	"unprognostic (2.41e-1)"	"unprognostic (1.75e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.07e-3)"	0.2	0.1	2.5	0.1	5.1	0.1	0.0	24.6	53.5	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	18.0	3.8	0.0	0.0	0.0	0.0	1.5	2.3	1.8	0.0	0.0	0.0	3.5	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.9	1.3	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	5.1	24.6	53.5	18.0	3.8	1.5	2.3	1.8	4.1	0.0	1.3	10.4	1.3	0.0	0.0	0.0	2.6	2.7	13.2	0.6	0.6	3.0	6.8	7.2	1.2	0.0	0.2	0.0	0.0	0.1	5.0	0.4	0.0	0.2	0.0	2.9	7.0	1.0	99.5	0.0	3.8	1.0	0.3	0.7	5.1	15.9	8.9	16.1	0.0	0.0	0.2	0.0	0.5	0.6	2.0	0.6	5.3	0.6	0.0	3.6	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.3	1.1	0.0	1.0	10.8	0.0	0.0	0.1	0.8	0.0	0.2	5.7	0.2	13.2	1.7	2.3	0.8	1.5	3.4	0.8	0.2
ERVV-2	ENVV2	ENSG00000268964	"Endogenous retrovirus group V member 2, envelope"	B6SEH9	19	53044740-53051680	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	14	"placenta: 8.5"	"Cell type enriched"	"Detected in single"	4	"Syncytiotrophoblasts: 3.8"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 16.9;SuSa: 10.9;T-47d: 4.6;U-266/84: 2.8"									HPA076115			Approved	Centrosome,Cytosol		NA	NA			Cytosol	Centrosome	"HPA076115: "				"unprognostic (3.14e-3)"		"unprognostic (2.06e-1)"				"unprognostic (1.31e-1)"			"unprognostic (4.33e-9)"	"unprognostic (3.01e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.60e-4)"	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	8.5	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	10.9	4.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0
GHRH	GHRF	ENSG00000118702	"Growth hormone releasing hormone"	P01286	20	37251086-37261814	"Human disease related genes, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 130.9"	"Cell type enriched"	"Detected in single"	7	"Cardiomyocytes: 5.2"	"Cancer enriched"	"Detected in some"	7	"urothelial cancer: 8.5"	"Region enriched"	"Detected in some"	12	"hypothalamus: 130.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"NTERA-2: 2.1;U-266/84: 7.9"	"Region enriched"	"Detected in many"	9	"hypothalamus: 32.9"	"Region enhanced"	"Detected in some"		"hypothalamus: 3.7"						"Secreted in other tissues"	NA	NA						"unprognostic (4.78e-2)"				"unprognostic (2.57e-2)"									"unprognostic (1.58e-1)"	"unprognostic (3.10e-1)"			0.0	1.0	0.7	0.0	0.3	0.0	0.3	0.3	0.5	0.0	0.1	0.0	3.5	0.0	0.0	0.3	0.0	0.0	6.3	0.3	130.9	0.0	0.0	0.0	0.0	0.2	0.4	0.3	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.2	0.0	0.6	0.1	11.2	9.3	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.3	0.5	0.3	130.9	0.2	0.4	0.3	0.3	0.2	11.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0
GSG1	MGC3146	ENSG00000111305	"Germ cell associated 1"	Q2KHT4	12	13083532-13103683	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 433.3"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 10812.1"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.9"	"Region enhanced"	"Detected in some"		"midbrain: 6.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 8.8;LHCN-M2: 9.8;RPTEC TERT1: 12.3;U-2 OS: 5.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Intracellular and membrane"	NA	NA						"unprognostic (1.50e-1)"	"unprognostic (2.21e-2)"		"unprognostic (6.33e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.52e-1)"	"unprognostic (6.85e-2)"	"unprognostic (8.23e-2)"	"unprognostic (5.91e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.32e-3)"	0.1	0.1	0.4	0.2	0.9	0.8	0.4	1.8	1.4	0.0	1.1	0.1	1.4	0.1	0.6	0.1	0.0	0.2	0.1	0.6	0.4	0.5	0.1	0.1	0.3	0.1	6.8	0.5	0.1	4.8	0.0	0.2	0.2	0.6	0.4	0.2	30.7	0.1	0.0	0.3	0.2	0.7	0.0	0.0	0.2	0.1	433.3	0.1	0.1	0.1	0.0	0.1	0.0	0.1	1.4	0.1	0.4	0.3	0.1	2.0	1.2	0.4	0.2	0.4	0.3	0.4	0.2	0.1	0.2	0.1	8.8	0.6	0.1	0.1	0.0	0.8	0.2	0.0	0.2	0.6	0.3	0.0	0.2	0.1	0.8	0.0	1.6	0.1	0.1	0.0	0.1	0.1	1.6	9.8	0.2	0.1	1.0	2.1	0.1	0.2	0.1	3.5	0.1	12.3	0.2	0.6	0.2	0.3	0.0	0.1	0.3	0.0	1.4	0.1	0.5	5.9	0.3	0.3	0.5	0.3	0.1	2.5	0.2	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.4	0.9	1.8	1.4	0.6	0.4	0.1	6.8	0.5	0.6	0.0	0.1	1.4	0.1	3.2	1.1	0.3	0.0	0.1	0.1	0.0	0.0	134.9	0.1	0.0	0.3	1.5	0.0	0.0	6.2	0.1	0.0	0.0	1.9	0.6	2248.2	0.1	0.2	2.8	27.5	2.7	1.8	0.0	0.1	0.7	0.0	0.1	0.0	0.0	1.4	0.0	0.6	1.7	0.8	2.0	2.0	0.3	0.0	10812.1	53.4	2.9	0.0	1.0	0.1	6.7	0.0	0.0	0.1	0.0	1.2	39.9	0.0	0.1	0.1	0.0	0.0	16.1	6.6	0.4	0.1	57.0	27.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1
INSL3	"MGC119818, MGC119819, RLF, RLNL"	ENSG00000248099	"Insulin like 3"	P51460	19	17816512-17821574	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted secreted proteins"		Hormone	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 413.0"	"Cell type enriched"	"Detected in some"	19	"Theca cells: 24080.8"	"Cancer enriched"	"Detected in many"	21	"testis cancer: 39.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 5.7;PC-3: 2.6;SCLC-21H: 5.2;SH-SY5Y: 4.7"									HPA028615	Enhanced				"Secreted to blood"	NA	NA	566000				"HPA028615: AB_10600717"	"unprognostic (3.25e-1)"	"unprognostic (2.25e-4)"	"unprognostic (3.50e-5)"	"unprognostic (7.04e-2)"	"unprognostic (1.74e-4)"	"unprognostic (4.60e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.46e-1)"	"unprognostic (4.93e-2)"	"unprognostic (9.51e-10)"	"unprognostic (6.80e-3)"	"unprognostic (1.41e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.09e-5)"	0.4	1.7	1.1	4.8	1.4	1.8	0.5	2.1	1.5	0.1	1.6	0.4	1.5	0.3	0.8	0.6	0.8	0.4	0.2	1.3	1.2	0.4	0.4	0.9	2.9	1.3	1.2	1.0	29.8	0.2	0.0	0.2	0.3	1.6	0.6	0.0	0.1	0.6	0.0	0.2	0.3	1.7	0.0	1.2	5.3	0.8	413.0	1.3	0.5	0.3	0.4	1.3	0.4	0.3	1.3	0.2	0.6	0.1	0.5	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.1	1.1	0.1	1.4	0.0	0.2	0.0	0.0	0.0	0.0	1.2	0.1	0.5	0.0	0.2	0.0	0.0	1.2	0.8	0.6	0.0	0.0	0.0	0.0	0.1	0.0	5.7	0.0	1.0	0.2	1.1	0.0	1.1	2.6	0.9	0.0	0.1	0.1	0.3	5.2	4.7	0.0	1.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.4	0.0	0.4	2.1	0.1	0.1	1.3	0.0	0.4	0.2	0.0	0.7	0.4	0.7	0.0	0.9	0.9	0.1	1.1	0.7	1.0	2.2	0.5	0.1	0.1	0.8	0.5	1.1	1.4	2.1	1.5	1.3	1.2	1.3	1.2	1.0	1.6	1.2	1.3	1.3	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.7	2.3	0.0	0.0	0.1	6.8	0.0	0.1	3.4	0.0	0.0	0.3	0.0	0.4	42.3	0.0	0.0	0.0	0.9	0.4	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	257.1	1240.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	998.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	2.9	5.7	0.0	0.0	0.5	0.8	24080.8	0.0	0.0
KLF1	EKLF	ENSG00000105610	"Kruppel like factor 1"	Q13351	19	12884422-12887201	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Congenital dyserythropoietic anemia, Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"bone marrow: 41.5"	"Cell type enriched"	"Detected in some"	199	"Erythroid cells: 519.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.9;non-classical monocyte: 1.1"	"Lineage enriched"	"Detected in single"	8	"monocytes: 1.9"	"Group enriched"	"Detected in some"	29	"HEL: 61.6;K-562: 150.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051850	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA051850: AB_2616460"	"unprognostic (1.17e-1)"	"unprognostic (1.38e-4)"	"unprognostic (2.96e-1)"	"unprognostic (1.17e-3)"	"unprognostic (7.13e-2)"	"unprognostic (3.90e-4)"	"unprognostic (3.25e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.08e-2)"	"unprognostic (6.51e-2)"	"unprognostic (7.71e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.76e-1)"	"unprognostic (2.44e-1)"	0.0	0.0	0.1	0.0	0.1	41.5	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	2.8	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	61.6	0.0	0.0	0.0	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	150.5	0.0	0.0	0.2	0.3	0.4	0.7	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.4	0.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	3.6	0.0	0.0	0.6	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.6	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	1.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	519.2	0.0	0.0	0.9	0.7	0.0	0.0	0.0	0.0	0.0	0.1	2.6	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.3	0.1	0.0	0.1	0.1
KRT10	"CK10, K10, KPP"	ENSG00000186395	"Keratin 10"	P13645	17	40818117-40822614	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	14	"skin 1: 15560.6"	"Cell type enriched"	"Detected in all"	5	"Suprabasal keratinocytes: 12515.3"	"Group enriched"	"Detected in all"	4	"head and neck cancer: 310.0;melanoma: 562.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	5	"hTCEpi: 718.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000132, HPA012014"	Enhanced				"Secreted in other tissues"	NA	NA		18000000000			"CAB000132: , HPA012014: AB_1852195"	"unprognostic (3.07e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (9.32e-5)"	"unprognostic (1.64e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.66e-2)"	"unprognostic (8.10e-2)"	64.6	48.3	9.7	7.6	10.0	13.5	436.9	10.1	15.0	289.7	10.8	44.6	8.0	55.4	5.5	79.2	45.9	2.3	93.8	10.1	10.2	57.3	65.0	40.0	6.3	10.1	10.0	9.6	52.8	69.7	8.3	77.8	3.8	10.1	60.5	3.4	7.0	165.2	5.5	124.2	15560.6	48.6	4.0	10.2	57.3	58.5	65.4	10.3	44.4	53.9	5.9	13.9	48.9	1115.1	10.7	30.3	31.2	11.0	12.2	14.4	11.5	10.4	29.9	16.5	11.4	10.6	11.2	11.7	8.7	42.0	13.1	16.2	158.5	5.4	11.3	13.4	20.1	27.0	9.2	44.7	19.4	16.4	17.1	24.9	10.1	718.0	9.0	17.3	15.0	7.4	12.3	102.1	16.0	12.2	17.3	25.5	16.2	14.6	23.1	19.1	17.8	16.7	17.7	12.3	26.3	8.9	11.1	19.9	46.0	39.0	17.3	35.5	24.3	9.3	17.6	29.5	22.5	34.4	0.4	19.8	22.4	24.5	10.4	23.4	12.8	2.6	11.1	4.8	2.3	5.4	11.2	5.4	6.8	4.1	5.6	5.8	5.9	0.8	6.9	3.2	8.1	5.5	1.9	9.7	10.0	10.1	15.0	10.1	10.2	10.1	10.0	9.6	10.1	10.2	10.3	10.7	197.8	35.3	40.0	19.2	187.5	2239.7	320.6	370.2	255.6	47.0	304.4	328.2	194.2	174.5	197.2	112.2	20.9	117.4	163.2	138.9	305.2	232.5	150.4	174.3	172.2	170.0	181.1	87.7	19.1	376.9	295.7	204.5	126.9	164.5	74.3	87.0	159.5	237.6	105.0	21.9	16.3	237.6	195.3	90.3	350.7	65.6	216.6	116.8	393.1	20.6	100.1	221.4	162.7	17.6	35.0	236.0	149.8	174.9	311.6	342.0	155.3	233.2	116.8	68.6	105.2	141.0	167.7	345.1	121.2	295.0	12515.3	160.1	164.3	131.4	173.1	515.6
LCE1C	LEP3	ENSG00000197084	"Late cornified envelope 1C"	Q5T751	1	152804835-152806628	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"skin 1: 489.0"	"Cell type enriched"	"Detected in some"	4	"Suprabasal keratinocytes: 83.0"	"Cancer enriched"	"Detected in some"	6	"melanoma: 17.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BJ hTERT+: 1.0;HBEC3-KT: 2.2;hTEC/SVTERT24-B: 1.1;hTERT-HME1: 2.8"															NA	NA							"unprognostic (3.35e-2)"			"unprognostic (5.95e-2)"	"unprognostic (3.46e-2)"			"unprognostic (3.35e-2)"									0.2	0.1	0.0	0.0	0.0	0.3	34.5	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	4.1	489.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.4	0.0	3.5	2.8	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.6	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.2	83.0	0.0	0.2	0.0	0.0	0.0
LCE2A	LEP9	ENSG00000187173	"Late cornified envelope 2A"	Q5TA79	1	152698345-152699442	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"skin 1: 119.1"	"Cell type enriched"	"Detected in single"	4	"Melanocytes: 1.8"	"Cancer enriched"	"Detected in some"	5	"melanoma: 10.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 5.6;SK-MEL-30: 2.0;U-2197: 1.4"															NA	NA											"unprognostic (3.45e-2)"			"unprognostic (6.77e-2)"									0.0	0.0	0.0	0.0	0.0	0.1	8.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	119.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.9	0.0	1.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0
NOTUM		ENSG00000185269	"Notum, palmitoleoyl-protein carboxylesterase"	Q6P988	17	81952507-81961840	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"placenta: 136.8"	"Cell type enriched"	"Detected in some"	45	"Extravillous trophoblasts: 1002.5"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 48.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"Hep G2: 428.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA022851			Approved	"Endoplasmic reticulum"	"Secreted in female reproductive system"	NA	NA		1900000	"Endoplasmic reticulum"		"HPA022851: "	"unprognostic (1.49e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.23e-2)"	"unprognostic (4.80e-3)"	"unprognostic (1.97e-1)"	"unprognostic (9.02e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.49e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.01e-2)"	"unprognostic (4.48e-6)"	"unprognostic (1.76e-1)"	"unprognostic (9.88e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.00e-1)"	0.0	0.1	1.3	0.0	1.5	0.0	0.2	0.5	1.7	0.2	0.0	0.0	1.1	2.1	0.3	0.3	0.4	0.2	0.2	0.9	0.8	0.6	10.1	2.2	0.0	2.0	2.6	0.9	0.1	0.4	0.9	0.2	136.8	1.3	0.3	0.0	0.0	0.6	0.2	8.3	1.9	0.3	0.1	0.6	0.2	2.1	2.8	1.3	0.0	0.0	0.5	0.0	1.4	0.2	1.4	0.0	1.2	0.0	0.0	0.0	0.0	1.3	0.1	0.2	0.0	0.1	10.0	0.4	0.0	1.8	0.3	0.2	0.4	2.4	0.0	0.0	0.1	1.1	2.2	2.8	428.6	0.2	0.4	0.4	0.2	0.0	0.0	0.0	0.6	0.0	0.2	11.2	0.0	0.0	0.6	0.0	0.2	0.1	67.9	0.4	0.0	0.2	0.1	0.0	0.2	15.7	1.6	4.2	1.7	6.2	2.3	0.1	4.9	0.0	0.5	6.3	0.0	0.2	0.1	0.0	1.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.5	0.5	1.7	0.9	0.8	2.0	2.6	0.9	1.3	0.6	1.3	1.4	0.0	0.0	3.7	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.6	1.3	1.2	0.0	0.0	0.0	0.0	10.0	0.0	0.1	0.0	0.0	0.4	0.1	0.1	0.8	0.0	0.0	0.6	0.0	1002.5	1.2	1.5	0.3	0.0	0.1	0.0	3.6	18.4	0.0	1.1	0.1	0.0	0.0	0.3	0.2	0.3	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.5	12.7	0.0	0.0	22.0	0.1	0.0	0.3	0.0
OIT3	"FLJ39116, LZP"	ENSG00000138315	"Oncoprotein induced transcript 3"	Q8WWZ8	10	72893584-72933036	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"liver: 111.7"	"Cell type enriched"	"Detected in some"	11	"Hepatic stellate cells: 372.3"	"Cancer enriched"	"Detected in many"	4	"liver cancer: 4.6"	"Region enhanced"	"Detected in single"		"cerebellum: 1.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"CACO-2: 2.3;Hep G2: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA		52000000				"unprognostic (2.42e-2)"	"unprognostic (6.76e-2)"	"unprognostic (7.98e-4)"	"unprognostic (9.26e-2)"	"unprognostic (9.47e-4)"	"unprognostic (3.05e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.50e-3)"	"unprognostic (1.41e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.19e-1)"	0.0	0.0	0.1	0.3	0.1	0.0	0.0	1.4	0.5	0.0	0.1	0.3	5.3	0.0	0.0	0.0	0.0	0.3	2.4	0.2	0.1	1.5	111.7	0.3	0.1	0.1	0.2	0.1	0.1	0.1	0.3	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.1	6.2	0.0	0.1	7.9	0.1	0.5	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.4	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.4	0.5	0.2	0.1	0.1	0.2	0.1	0.3	0.1	0.1	0.2	0.7	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	10.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.2	0.0	14.6	0.0	10.7	0.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	372.3	10.6	0.0	0.0	0.9	0.0	0.0	31.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.4	0.5	0.0	0.0
REG1A	"PSP, PSPS, PSPS1, PTP, REG"	ENSG00000115386	"Regenerating family member 1 alpha"	P05451	2	79120362-79123409	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	14	"pancreas: 104777.1"	"Cell type enriched"	"Detected in some"	5	"Exocrine glandular cells: 115721.8"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 1268.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 12.3;EFO-21: 18.3;HDLM-2: 15.2;NB-4: 11.0;OE19: 10.7;RPMI-8226: 32.5;SH-SY5Y: 12.5;U-2 OS: 31.1;U-251 MG: 10.8;U-266/84: 13.3"									"CAB025138, HPA045549, HPA045579"	Enhanced				"Secreted to digestive system"	NA	NA		68000000			"CAB025138: , HPA045549: AB_2679365, HPA045579: AB_2679374"			"unprognostic (1.89e-1)"	"unprognostic (2.91e-2)"	"unprognostic (3.39e-1)"		"unprognostic (1.45e-1)"	"unprognostic (2.10e-1)"		"unprognostic (1.63e-1)"	"unprognostic (5.52e-2)"		"unprognostic (3.54e-3)"	"unprognostic (5.53e-2)"	"unprognostic (5.54e-2)"			20.8	5.8	0.0	200.5	0.0	21.0	10.0	0.0	0.0	6.8	0.0	56.4	7666.5	5.4	0.0	9.4	6.4	97.5	10.3	0.0	0.0	90.6	16.0	4.5	7.6	0.0	0.0	0.0	25.8	104777.1	0.0	8.5	3.5	0.0	6.1	286.1	0.0	9.4	0.1	4.3	28.4	5685.1	179.8	0.0	8.6	954.4	3.9	0.0	0.0	4.1	0.0	0.4	3.2	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.5	10.7	0.0	0.0	0.0	32.5	0.0	0.0	1.4	12.5	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	31.1	2.0	10.8	0.0	13.3	5.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.2	0.0	0.0	0.0	0.0	0.0	25.5	1.9	1549.8	0.1	0.1	0.0	12.7	5.3	0.0	0.0	115721.8	0.0	0.9	692.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1813.1	0.0	0.0	0.0	0.1	0.0	17.0	0.0	0.0	507.5	0.0	0.0	0.0	0.0	22774.8	732.4	0.0	0.2	0.0	5100.1	20.8	0.0	0.0	0.0	0.0	51.7	0.0	0.4	0.0	0.0	0.0	0.6	0.0	5419.7	0.0
REG1B	"PSPS2, REGH, REGI-BETA, REGL"	ENSG00000172023	"Regenerating family member 1 beta"	P48304	2	79085023-79088019	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	14	"pancreas: 40077.8"	"Cell type enriched"	"Detected in some"	4	"Exocrine glandular cells: 36125.0"	"Cancer enriched"	"Detected in some"	5	"pancreatic cancer: 201.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 6.3;HDLM-2: 4.1;RPMI-8226: 3.0;U-2 OS: 15.7;U-251 MG: 3.9;U-266/84: 3.8"									"HPA045549, HPA045579"	Supported				"Secreted to digestive system"	NA	NA		32000000			"HPA045549: AB_2679365, HPA045579: AB_2679374"			"unprognostic (4.08e-1)"								"unprognostic (1.09e-1)"		"unprognostic (3.51e-3)"	"unprognostic (9.20e-2)"				10.2	2.2	0.0	36.1	0.0	9.9	3.3	0.0	0.1	2.4	0.0	11.4	744.8	2.1	0.0	3.5	2.1	0.4	2.7	0.0	0.0	2.6	5.6	1.7	1.7	0.0	0.0	0.0	2.1	40077.8	0.0	3.1	0.1	0.0	2.0	109.3	0.0	3.1	0.0	1.6	16.2	2777.0	113.2	0.0	3.3	5.0	1.5	0.0	0.0	1.7	0.0	0.0	1.4	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.3	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.1	3.9	0.0	3.8	1.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	86.7	0.0	0.0	0.0	3.3	1.8	0.0	0.0	36125.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	91.6	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	178.3	0.0	0.0	0.0	0.0	7978.5	174.7	0.0	0.0	0.0	3101.3	0.1	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	178.8	0.0
SCGB1D4	IIS	ENSG00000197745	"Secretoglobin family 1D member 4"	Q6XE38	11	62296281-62299075	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"cervix: 52.7;endometrium 1: 15.7;epididymis: 44.1;fallopian tube: 54.2"	"Cell type enriched"	"Detected in some"	6	"Endometrial ciliated cells: 3089.4"	"Cancer enriched"	"Detected in some"	57	"endometrial cancer: 100.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in female reproductive system"	NA	NA									"unprognostic (2.26e-3)"						"unprognostic (3.20e-1)"								0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	52.7	0.0	0.0	0.0	15.7	44.1	0.0	54.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	3089.4	111.9	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	457.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.6	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.2	0.0	0.0	0.0	3.9	0.0	0.0	0.0
SPRR4		ENSG00000184148	"Small proline rich protein 4"	Q96PI1	1	152970648-152972574	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"skin 1: 104.7"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 54.2"	"Cancer enriched"	"Detected in many"	5	"head and neck cancer: 17.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA055963	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Nuclear membrane"	"HPA055963: AB_2682988"		"unprognostic (4.40e-2)"				"unprognostic (7.38e-3)"			"unprognostic (1.45e-1)"								"unprognostic (6.75e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	104.7	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.9	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SYNGR4		ENSG00000105467	"Synaptogyrin 4"	O95473	19	48364367-48376377	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 54.9"	"Cell type enriched"	"Detected in some"	4	"Spermatocytes: 159.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"A549: 9.8;SCLC-21H: 24.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA030075, HPA059286"	Enhanced		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA030075: AB_10610559, HPA059286: AB_2683965"	"unprognostic (1.58e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.18e-2)"	"unprognostic (9.49e-4)"	"unprognostic (2.51e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.52e-3)"	"unprognostic (3.72e-3)"	"unprognostic (2.87e-2)"	"unprognostic (6.19e-2)"	"unprognostic (6.69e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.02e-7)"	"unprognostic (1.06e-2)"	"unprognostic (1.74e-4)"	"unprognostic (1.58e-1)"	"unprognostic (9.77e-2)"	0.0	0.0	0.3	0.0	0.3	0.1	0.0	2.9	1.0	0.0	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.6	0.0	0.1	0.0	0.0	0.3	0.6	0.3	0.0	1.0	3.9	0.3	0.0	1.7	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	54.9	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.1	9.8	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.6	0.2	0.4	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.5	3.2	0.5	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	1.2	0.1	3.6	0.1	0.3	0.5	0.2	0.0	0.7	1.8	0.7	0.0	2.8	0.0	0.0	24.1	0.6	0.1	0.4	0.0	0.0	0.4	0.1	0.1	0.0	0.8	0.0	0.0	3.2	1.1	0.8	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	2.9	1.0	0.7	0.6	0.3	0.6	0.3	1.7	0.3	0.3	0.6	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	32.6	0.0	0.1	0.1	9.1	0.0	0.3	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.2	0.0	0.0	0.0	24.6	0.9	0.1	0.0	1.0	0.0	0.0	0.0	0.5	0.3	0.4	0.0	0.0	0.0	0.5	0.2	0.1	0.0	0.0	6.6	0.0	0.0	159.5	33.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1
TMEM144	FLJ11155	ENSG00000164124	"Transmembrane protein 144"	Q7Z5S9	4	158201604-158255416	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	14	"brain: 419.0"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 994.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 2.1;plasmacytoid DC: 2.2"	"Group enriched"	"Detected in many"	10	"dendritic cells: 2.2;monocytes: 1.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 36.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063554			Approved	Mitochondria		NA	NA			Mitochondria		"HPA063554: AB_2685039"	"unprognostic (1.26e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.06e-2)"	"prognostic favorable (2.89e-4)"	"unprognostic (2.90e-1)"	"unprognostic (1.71e-5)"	"unprognostic (8.27e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.33e-2)"	"prognostic unfavorable (8.48e-4)"	"unprognostic (9.34e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.26e-2)"	"unprognostic (3.88e-2)"	"unprognostic (4.05e-2)"	8.7	13.0	85.3	3.7	217.4	3.2	15.5	156.9	157.1	7.7	23.3	14.5	29.6	6.1	15.7	5.4	6.9	12.6	15.1	97.1	137.6	3.9	3.2	6.4	2.4	221.8	161.0	58.9	13.6	7.4	4.6	1.3	6.6	200.1	9.0	16.0	0.6	5.9	11.0	2.8	3.4	20.9	7.2	139.5	4.0	11.3	27.2	158.9	1.9	17.1	2.6	1.6	6.7	2.6	419.0	4.7	12.1	0.2	2.6	8.6	11.8	36.5	1.9	3.9	1.7	2.8	15.1	17.8	0.0	2.8	0.6	10.0	2.2	5.1	16.7	2.4	0.0	5.5	8.5	3.0	13.5	2.8	10.7	2.3	8.9	20.0	7.0	3.0	0.5	9.7	1.7	5.5	0.2	12.8	5.1	0.0	0.0	3.2	15.1	2.9	0.0	0.0	0.4	4.2	12.3	1.9	0.0	0.5	19.6	4.2	7.1	12.6	2.4	1.8	3.9	2.7	0.7	2.1	0.0	1.1	0.9	5.4	1.4	3.1	0.0	1.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.3	2.2	0.0	0.3	85.3	217.4	156.9	157.1	97.1	137.6	221.8	161.0	58.9	200.1	139.5	158.9	419.0	2.9	9.6	9.1	53.2	0.3	3.1	7.7	5.2	2.8	0.9	12.4	10.7	12.7	12.8	8.4	0.0	0.0	13.7	1.5	36.6	0.0	15.4	231.8	14.5	8.6	4.8	4.9	3.0	10.9	13.3	6.5	4.4	14.8	24.5	4.5	14.6	4.6	1.2	29.0	0.0	12.5	21.4	8.2	20.8	5.0	98.2	10.5	12.9	3.6	12.2	10.6	1.3	0.0	5.5	994.4	9.0	18.9	9.1	0.2	3.5	44.1	6.4	8.8	0.2	0.0	8.5	2.6	3.0	2.2	5.8	5.1	8.8	0.9	6.8	18.6	6.4
TMEM253	"C14orf176, C14orf95, NCRNA00220"	ENSG00000232070	"Transmembrane protein 253"	P0C7T8	14	21098811-21103724	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	14	"intestine: 98.2"	"Cell type enriched"	"Detected in some"	4	"Proximal enterocytes: 201.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"HPA052329, HPA065092"	Enhanced					NA	NA					"HPA052329: AB_2681791, HPA065092: AB_2685420"	"unprognostic (7.48e-3)"	"unprognostic (1.33e-2)"	"unprognostic (7.19e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.28e-2)"	"unprognostic (5.46e-2)"	"unprognostic (9.93e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.04e-1)"	0.6	2.4	0.9	0.8	0.8	0.1	0.6	0.9	1.6	0.6	0.8	15.2	98.2	0.4	1.6	1.5	0.5	0.9	0.4	0.8	1.0	0.8	1.1	0.5	0.1	0.8	0.9	0.7	0.5	1.3	0.4	0.6	0.4	0.9	0.7	12.9	0.2	6.9	1.3	0.1	1.2	89.5	0.8	0.8	0.5	0.7	0.4	0.9	0.4	5.8	0.0	0.3	0.5	1.0	1.1	0.1	0.4	0.7	0.9	0.7	0.0	1.7	0.4	0.7	0.1	0.4	0.9	0.5	1.5	0.2	0.0	0.0	1.7	0.3	1.4	0.0	0.9	0.1	0.7	1.4	1.0	0.0	0.0	0.0	0.2	1.0	0.2	0.9	0.6	0.1	0.5	0.5	0.0	0.3	0.0	0.0	0.1	0.6	1.6	0.0	0.3	0.2	0.8	0.7	0.6	0.3	0.6	0.5	0.3	0.8	0.5	0.3	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.2	0.0	0.1	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.8	0.9	1.6	0.8	1.0	0.8	0.9	0.7	0.9	0.8	0.9	1.1	0.0	0.0	0.0	2.0	0.5	0.8	1.0	1.3	2.2	0.9	0.7	1.3	0.2	1.5	0.3	0.0	0.0	1.1	0.1	45.3	0.0	0.3	0.1	0.0	0.2	0.4	3.6	0.0	0.1	0.0	0.2	0.2	2.0	0.2	0.0	0.6	0.0	0.2	0.2	0.0	0.2	11.2	0.0	0.3	0.3	0.0	0.0	0.2	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.1	8.8	0.0	0.1	0.2	201.8	0.7	0.1	0.5	0.0	0.4	0.4	0.0	0.3	1.6	0.6	1.0	0.1	0.2	23.4	0.8
TRBV19	"TCRBV17S1A1T, TCRBV19S1"	ENSG00000211746	"T cell receptor beta variable 19"	A0A075B6N1	7	142618849-142619532	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"lymphoid tissue: 53.9"	"Cell type enriched"	"Detected in some"	5	"T-cells: 11.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"memory CD4 T-cell: 50.8;memory CD8 T-cell: 40.2;naive CD4 T-cell: 71.1;naive CD8 T-cell: 53.5;T-reg: 88.5"	"Lineage enriched"	"Detected in single"	191	"T-cells: 88.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.62e-3)"	"unprognostic (8.91e-4)"	"unprognostic (1.14e-2)"	"unprognostic (5.81e-3)"	"unprognostic (2.38e-2)"	"unprognostic (2.29e-4)"	"unprognostic (3.96e-3)"	"unprognostic (3.62e-3)"	"unprognostic (4.51e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (8.59e-4)"	"unprognostic (9.78e-2)"	"unprognostic (4.14e-2)"	"unprognostic (3.57e-2)"	"unprognostic (3.27e-2)"	0.4	0.1	0.0	5.7	0.0	0.7	0.7	0.1	0.2	0.8	0.0	1.2	0.6	0.5	0.0	0.4	0.3	3.8	0.0	0.0	0.0	0.2	0.7	1.1	28.7	0.0	0.0	0.0	0.4	0.1	0.3	0.1	0.0	0.1	0.4	2.2	0.0	0.3	0.3	0.1	0.4	3.0	0.2	0.0	3.8	3.0	0.1	0.0	53.9	0.5	0.2	2.0	0.5	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	1.4	0.1	13.5	0.4	50.8	40.2	0.1	0.0	71.1	53.5	0.4	0.1	0.2	0.0	88.5	15.5	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0
TRBV27	"TCRBV14S1, TCRBV27S1"	ENSG00000211752	"T cell receptor beta variable 27"	A0A0K0K1C4	7	142715346-142715861	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	14	"lymphoid tissue: 82.3"	"Cell type enriched"	"Detected in some"	4	"T-cells: 6.1"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	8	"memory CD4 T-cell: 61.1;memory CD8 T-cell: 112.2;naive CD4 T-cell: 48.2;naive CD8 T-cell: 75.8;T-reg: 94.7"	"Lineage enriched"	"Detected in single"	137	"T-cells: 112.2"	"Group enriched"	"Detected in some"	4	"HAP1: 2.9;JURKAT: 3.3;U-937: 3.6"					"Not detected"	"Not detected"									NA	NA						"unprognostic (3.08e-2)"	"unprognostic (2.10e-2)"	"unprognostic (5.66e-2)"			"unprognostic (5.85e-4)"	"unprognostic (8.84e-2)"	"unprognostic (7.89e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.28e-4)"	"unprognostic (1.49e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.91e-7)"	"unprognostic (4.03e-1)"	"unprognostic (3.91e-2)"	"unprognostic (8.10e-2)"	"unprognostic (6.43e-2)"	0.4	0.5	0.0	3.5	0.5	1.9	0.8	0.0	0.3	0.7	0.0	1.2	1.0	0.9	0.1	0.8	0.2	1.8	0.2	0.0	0.0	0.4	0.5	1.7	19.9	0.0	0.3	0.0	0.5	0.2	0.0	0.1	0.1	0.1	0.5	1.7	0.0	1.7	0.0	0.3	0.2	2.8	0.2	0.0	4.8	1.9	5.8	0.1	82.3	0.6	0.9	10.7	1.6	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.6	0.0	0.4	0.1	0.6	3.3	0.0	10.4	0.1	61.1	112.2	0.1	0.1	48.2	75.8	0.8	0.1	0.2	0.1	94.7	27.3	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0
UGT2B28		ENSG00000135226	"UDP glucuronosyltransferase family 2 member B28"	Q9BY64	4	69280475-69295050	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"breast: 200.4"	"Cell type enriched"	"Detected in single"	16	"Cholangiocytes: 10.0"	"Cancer enriched"	"Detected in single"	8	"breast cancer: 1.9"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 1.3"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.3"	"Group enriched"	"Detected in some"	10	"Daudi: 2.9;NB-4: 2.7"									HPA045108	Uncertain				"Intracellular and membrane"	NA	NA					"HPA045108: AB_2679218"	"unprognostic (1.81e-1)"						"unprognostic (1.40e-1)"	"unprognostic (7.20e-3)"				"unprognostic (1.51e-2)"	"unprognostic (4.37e-5)"				"unprognostic (9.79e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	200.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADIG	"MGC39724, RP5-1100H13.2, SMAF1"	ENSG00000182035	Adipogenin	Q0VDE8	20	38581195-38588463	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	13	"testis: 53.9"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 1714.0"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA041124	Uncertain					NA	NA					"HPA041124: AB_10795534"					"unprognostic (2.97e-2)"		"unprognostic (7.69e-3)"					"unprognostic (2.27e-1)"	"unprognostic (4.52e-3)"			"unprognostic (1.34e-2)"		0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	53.9	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.3	0.2	0.4	0.1	0.2	0.1	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	409.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1714.0	3.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	1.2	0.0	0.0	6.6	0.0	0.0	5.3	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ALAS2	ASB	ENSG00000158578	"5'-aminolevulinate synthase 2"	P22557	X	55009055-55030977	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis"	"Acyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"bone marrow: 611.2"	"Cell type enriched"	"Detected in some"	166	"Erythroid cells: 2366.7"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.6"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"plasmacytoid DC: 1.6"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 1.6"	"Group enriched"	"Detected in some"	93	"HEL: 71.7;K-562: 85.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (7.82e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.98e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.68e-2)"	"unprognostic (4.07e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.32e-2)"	"unprognostic (6.63e-3)"	"unprognostic (4.39e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.89e-1)"	1.2	0.5	1.1	0.4	1.7	611.2	0.6	1.6	8.5	0.2	11.8	0.5	0.6	0.1	0.0	0.8	1.1	0.8	2.5	0.9	1.3	2.4	3.3	5.2	0.3	2.3	2.4	0.7	0.4	0.3	0.0	1.2	45.2	2.0	0.2	0.0	0.2	1.0	0.2	0.5	0.6	0.3	0.1	1.8	25.4	0.2	0.2	1.7	1.0	1.2	18.4	0.0	0.6	0.7	3.0	0.1	0.0	0.0	0.8	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.6	71.7	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	85.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.2	0.2	0.1	0.4	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.6	0.4	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	1.6	0.0	5.9	1.1	1.7	1.6	8.5	0.9	1.3	2.3	2.4	0.7	2.0	1.8	1.7	3.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	4.8	0.0	0.1	0.0	0.3	1.8	2366.7	0.0	0.2	1.8	0.3	0.0	0.1	0.0	0.0	1.4	1.3	2.1	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	7.3	14.2	1.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.7	1.1	0.0	0.0	0.1
ATOH1	"bHLHa14, HATH1, MATH-1, Math1"	ENSG00000172238	"Atonal bHLH transcription factor 1"	Q92858	4	93828753-93830964	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"intestine: 20.2"	"Cell type enriched"	"Detected in some"	30	"Intestinal goblet cells: 226.1"	"Cancer enriched"	"Detected in some"	4	"colorectal cancer: 9.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049400			Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			Mitochondria	"Nucleoplasm, Cytosol"	"HPA049400: "			"prognostic favorable (3.26e-5)"								"unprognostic (5.20e-1)"	"unprognostic (2.69e-1)"		"unprognostic (1.26e-1)"	"unprognostic (2.70e-1)"			0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.2	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.0	0.1	20.2	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	226.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.0	0.0
CKM	CKMM	ENSG00000104879	"Creatine kinase, M-type"	P06732	19	45306413-45322875	"Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"skeletal muscle: 74254.4;tongue: 26289.9"	"Cell type enriched"	"Detected in some"	8	"Cardiomyocytes: 5353.0"	"Cancer enriched"	"Detected in many"	4	"head and neck cancer: 64.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 68.8"	"Region enriched"	"Detected in single"	15	"olfactory bulb: 1.5"	"Low region specificity"	"Detected in many"			HPA047859	Enhanced					NA	NA		170000000			"HPA047859: AB_2680186"	"unprognostic (3.51e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.61e-2)"	"unprognostic (4.14e-1)"	"unprognostic (7.68e-3)"	"unprognostic (4.04e-3)"	"unprognostic (1.85e-2)"	"unprognostic (4.23e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.00e-1)"	"unprognostic (9.46e-3)"	"unprognostic (9.67e-8)"	"unprognostic (3.23e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.95e-1)"	6.8	2.7	0.6	0.0	0.2	0.7	12.5	0.2	0.4	0.7	0.0	5.3	0.1	1.8	0.0	516.9	0.4	0.2	3834.2	0.4	0.0	2.1	5.3	8.7	0.5	1.0	0.0	0.0	2.8	5.3	0.0	2.1	0.3	1.1	136.0	0.1	0.2	343.7	2.1	74254.4	15.3	4.3	2.4	0.3	2.5	23.7	10.0	0.5	2.5	8.6	26289.9	0.4	1.5	3.9	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.4	0.0	5.8	0.0	0.3	16.3	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	2.0	0.0	0.0	0.0	6.3	0.2	0.2	0.0	0.0	68.8	0.0	0.0	0.1	0.1	0.0	0.1	16.3	0.1	0.0	0.1	0.1	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.2	0.2	0.4	0.4	0.0	1.0	0.0	0.0	1.1	0.3	0.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	5353.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	11.7	0.1	15.3	0.8	0.9	51.2	0.0	0.0	0.4	0.0	0.7	141.8	0.0	0.1	1.3	0.4	0.4	0.0	6.6	0.0	0.5	0.0	0.0	0.9	0.3	53.2	1.5	3.2	0.0	0.0	0.9	0.0	0.0	0.5	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.8	0.0	0.0	639.9	47.3	16.5	1.6	0.0	0.1	0.3	2.6	3.6	0.0	0.1
CLCA1	"CaCC, CLCRG1"	ENSG00000016490	"Chloride channel accessory 1"	A8K7I4	1	86468368-86500259	"Predicted secreted proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"intestine: 1411.7"	"Cell type enriched"	"Detected in some"	16	"Intestinal goblet cells: 3524.6"	"Group enriched"	"Detected in some"	9	"colorectal cancer: 86.8;pancreatic cancer: 27.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.1;NB-4: 2.5;RPMI-8226: 2.9;SH-SY5Y: 1.8;U-2197: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA052787, HPA059301"	Enhanced				"Secreted to digestive system"	NA	NA		77000			"HPA052787: AB_2681947, HPA059301: AB_2683971"			"prognostic favorable (2.98e-4)"								"unprognostic (3.42e-1)"			"unprognostic (8.61e-2)"	"unprognostic (1.06e-1)"			1.2	0.0	0.0	110.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	746.9	917.9	1.2	0.0	0.3	0.1	0.7	0.0	0.0	0.0	0.6	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	1072.4	0.0	0.0	0.5	0.0	0.0	1411.7	15.6	0.0	0.0	3.2	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	24.1	0.0	0.0	0.1	0.0	0.0	0.0	6.7	0.0	0.3	0.0	0.0	0.1	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.3	3524.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	54.8	0.0	0.0	0.0	213.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	68.3	0.1
DNAJB7	HSC3	ENSG00000172404	"DnaJ heat shock protein family (Hsp40) member B7"	Q7Z6W7	22	40859549-40862113	"Predicted intracellular proteins"		Chaperone		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	13	"testis: 10.4"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 553.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA000534	Approved					NA	NA					"HPA000534: AB_1078693"	"unprognostic (3.89e-2)"	"unprognostic (1.12e-2)"	"unprognostic (9.61e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.16e-2)"	"unprognostic (5.56e-3)"	"unprognostic (1.62e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.81e-2)"	"unprognostic (4.46e-4)"	"unprognostic (3.32e-3)"	"unprognostic (3.06e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.45e-2)"	0.1	0.1	0.2	0.1	0.2	0.5	0.1	0.7	0.7	0.3	0.3	0.1	0.4	0.2	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.2	0.3	0.2	0.0	0.2	0.0	0.4	0.2	0.1	0.8	0.2	0.0	0.4	0.1	0.5	0.0	0.0	0.1	0.1	10.4	0.2	0.0	0.3	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.2	0.3	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.0	0.1	0.4	0.4	0.2	0.1	0.0	0.2	0.2	0.1	0.0	0.1	0.3	0.1	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.2	0.3	0.3	0.1	0.3	0.2	0.2	0.0	0.1	0.3	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.7	0.7	0.1	0.1	0.2	0.2	0.2	0.4	0.0	0.2	0.6	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.0	3.4	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.1	0.4	0.8	0.0	0.0	553.5	1.5	0.8	0.4	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.4	4.5	0.2	0.0	0.0	0.1	1.7	0.5	0.4	0.0	0.0	0.0	98.5	2.8	0.2	0.0	0.0	0.0	0.9	0.0	1.0	0.7	0.0	0.0	2.6	0.1	0.1	6.0	0.0	0.0	11.2	0.0	0.3	0.1	2.9	1.5	0.0	0.0	0.3	0.2	0.2	0.9	0.1
GCG	"GLP-1, GLP1, GLP2, GRPP"	ENSG00000115263	Glucagon	P01275	2	162142882-162152404	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"pancreas: 1959.8"	"Cell type enriched"	"Detected in some"	23	"Enteroendocrine cells: 5457.0"	"Cancer enriched"	"Detected in some"	209	"pancreatic cancer: 428.4"	"Group enriched"	"Detected in some"	27	"basal ganglia: 2.3;medulla oblongata: 4.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 133.4;U-2 OS: 186.8;U-698: 44.5"	"Region enriched"	"Detected in single"	10	"pons and medulla: 3.5"	"Region enriched"	"Detected in some"	5	"spinal cord: 13.7"	"CAB000040, HPA036760, HPA036761"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to blood"	NA	NA	127000	420000	"Endoplasmic reticulum"	Vesicles	"CAB000040: AB_10013726, HPA036760: AB_2675296, HPA036761: AB_2675297"			"unprognostic (3.13e-3)"								"unprognostic (9.99e-2)"	"unprognostic (1.16e-2)"		"unprognostic (1.26e-2)"				20.5	0.1	0.0	3.1	2.3	20.2	0.0	0.0	0.0	0.0	0.0	85.2	3.5	0.6	0.0	5.3	0.0	4.2	2.5	0.0	0.0	42.3	0.0	0.2	3.6	4.6	0.0	0.0	0.1	1959.8	0.0	0.0	0.1	0.0	0.8	153.3	0.0	0.3	0.0	0.0	37.5	131.3	0.8	0.0	0.2	41.6	0.0	0.1	0.4	0.6	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	133.4	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	186.8	0.2	12.1	0.0	5.6	44.5	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	18.7	0.0	0.2	0.0	0.0	0.3	0.1	5457.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	91.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	230.9	8.5	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	22.9	0.0
GYPB	"CD235b, GPB, MNS, SS"	ENSG00000250361	"Glycophorin B (MNS blood group)"	P06028	4	143996104-144019380	"Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins"		"Blood group antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"bone marrow: 63.7"	"Cell type enriched"	"Detected in some"	450	"Erythroid cells: 1351.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"HEL: 159.0"														"Intracellular and membrane"	NA	NA																							0.1	0.0	0.1	0.0	0.6	63.7	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.2	0.3	0.5	0.5	0.1	0.1	0.0	0.7	0.0	0.0	0.0	0.2	4.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.1	0.4	0.1	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	159.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.6	0.0	1.0	0.5	0.2	0.1	0.0	0.7	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.9	0.0	0.0	0.2	0.1	0.1	0.0	1351.4	3.0	0.0	1.2	0.2	0.0	0.0	0.0	2.1	0.0	0.9	1.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.1	0.0	0.0
HSD11B1	"HSD11, HSD11B, SDR26C1"	ENSG00000117594	"Hydroxysteroid 11-beta dehydrogenase 1"	P28845	1	209686178-209734949	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"liver: 976.2"	"Cell type enriched"	"Detected in many"	9	"Hepatocytes: 646.2"	"Cancer enriched"	"Detected in all"	28	"liver cancer: 197.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory CD4 T-cell: 5.6"	"Lineage enriched"	"Detected in single"	17	"T-cells: 5.6"	"Cell line enriched"	"Detected in some"	5	"ASC diff: 989.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047729	Enhanced					NA	NA		110000			"HPA047729: AB_2680135"	"unprognostic (1.08e-3)"	"unprognostic (2.13e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.63e-2)"	"unprognostic (8.35e-3)"	"unprognostic (8.69e-2)"	"prognostic unfavorable (1.97e-10)"	"unprognostic (3.41e-2)"	"unprognostic (3.91e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.59e-2)"	18.5	7.8	10.2	14.7	15.6	0.3	12.1	23.2	22.2	2.3	9.3	3.9	1.2	4.3	15.9	2.1	5.1	8.1	6.8	11.5	16.0	10.8	976.2	40.2	4.3	14.8	22.5	9.5	60.4	3.3	0.2	8.9	73.1	16.8	28.0	3.3	0.7	2.5	13.1	5.5	30.5	5.1	13.0	9.7	7.3	7.1	7.2	13.2	0.7	5.3	10.7	1.9	28.2	6.3	17.9	0.4	0.0	0.0	0.0	989.2	102.8	0.0	0.1	36.0	0.0	0.1	0.0	0.2	0.0	0.2	0.3	0.1	0.1	0.0	43.9	0.0	0.0	0.0	0.0	0.0	0.0	206.6	0.2	0.1	5.4	0.0	6.9	0.4	0.9	0.0	0.0	0.0	51.2	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.7	16.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	34.9	8.4	4.0	0.2	0.2	0.3	1.4	0.3	0.3	5.7	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	5.6	1.2	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	1.7	0.4	10.2	15.6	23.2	22.2	11.5	16.0	14.8	22.5	9.5	16.8	9.7	13.2	17.9	0.4	3.2	0.0	1.3	0.8	0.1	0.4	4.8	0.6	0.5	0.2	0.0	1.4	30.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.2	0.9	0.6	1.0	0.0	5.3	3.3	0.0	0.1	66.4	0.5	2.8	0.0	0.0	7.5	646.2	8.3	0.0	2.8	0.0	0.0	7.9	2.3	2.8	29.2	3.7	0.0	28.1	0.6	16.2	0.0	0.5	55.7	0.4	0.0	7.9	0.0	0.9	0.0	0.2	0.1	0.5	0.0	2.6	5.5	0.0	0.2	0.1	0.1	0.3	1.1	0.3	0.0	1.7
KPRP	C1orf45	ENSG00000203786	"Keratinocyte proline rich protein"	Q5T749	1	152759561-152762052	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"skin 1: 259.2"	"Cell type enriched"	"Detected in some"	11	"Suprabasal keratinocytes: 20.0"	"Group enriched"	"Detected in some"	22	"head and neck cancer: 6.9;melanoma: 13.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 1.9;U-2197: 1.1"	"Not detected"	"Not detected"							"HPA031988, HPA031990"	Enhanced					NA	NA		27000000			"HPA031988: AB_10671582, HPA031990: AB_2674102"		"unprognostic (1.03e-1)"				"unprognostic (2.67e-2)"			"unprognostic (1.22e-1)"								"unprognostic (1.03e-1)"	0.1	0.0	0.0	0.0	0.7	0.1	10.4	0.0	0.1	6.7	0.0	0.0	0.0	0.0	0.0	20.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.2	0.0	1.7	259.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	4.1	0.0	7.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.9	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.0	0.0	0.0	0.0	0.0	0.0
KRT77	KRT1B	ENSG00000189182	"Keratin 77"	Q7Z794	12	52689626-52703524	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"skin 1: 257.0"	"Cell type enriched"	"Detected in some"	8	"Suprabasal keratinocytes: 20.2"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	36	"HaCaT: 3.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA045934	Enhanced		Approved	"Nuclear membrane,Plasma membrane"		NA	NA		1200000000	"Nuclear membrane, Plasma membrane"		"HPA045934: AB_10960065"	"unprognostic (3.52e-2)"	"unprognostic (1.54e-1)"				"unprognostic (1.41e-1)"		"unprognostic (3.79e-1)"	"unprognostic (2.61e-1)"						"unprognostic (2.11e-1)"		"unprognostic (2.06e-1)"	0.3	0.0	0.0	0.0	0.0	0.1	19.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	257.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	20.2	0.0	0.0	0.0	0.0	0.0
LCE2B	"LEP10, SPRL1B, XP5"	ENSG00000159455	"Late cornified envelope 2B"	O14633	1	152686123-152687397	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"skin 1: 572.7"	"Cell type enriched"	"Detected in some"	17	"Suprabasal keratinocytes: 31.5"	"Cancer enriched"	"Detected in some"	5	"melanoma: 11.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA											"unprognostic (3.04e-2)"			"unprognostic (1.36e-1)"									0.3	0.1	0.0	0.0	0.0	0.0	42.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	6.2	572.7	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.1	0.0	0.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	31.5	0.0	0.1	0.0	0.0	0.0
LCE6A	C1orf44	ENSG00000235942	"Late cornified envelope 6A"	A0A183	1	152842856-152843983	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"skin 1: 248.6"	"Cell type enriched"	"Detected in single"	8	"Suprabasal keratinocytes: 2.6"	"Cancer enriched"	"Detected in some"	5	"melanoma: 5.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA046376	Enhanced					NA	NA					"HPA046376: AB_10965998"						"unprognostic (4.25e-2)"			"unprognostic (8.73e-2)"									0.0	0.0	0.0	0.0	0.0	0.0	19.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	248.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0
LEMD1	"CT50, LEMP-1"	ENSG00000186007	"LEM domain containing 1"	Q68G75	1	205381378-205455954	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"epididymis: 14.9;testis: 55.5"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 4203.7"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 10.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"CAPAN-2: 39.6"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in single"	6	"cerebellum: 3.9"	HPA045425			Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA045425: AB_10960538"	"unprognostic (1.78e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.88e-2)"	"unprognostic (4.20e-3)"	"unprognostic (7.27e-2)"	"unprognostic (1.48e-1)"		"unprognostic (2.72e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (1.26e-4)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (3.31e-1)"	"unprognostic (5.66e-6)"	"unprognostic (2.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.38e-2)"	0.0	0.3	0.3	0.0	0.2	0.0	0.3	2.6	0.6	0.2	0.0	0.0	0.7	0.3	14.9	0.8	1.6	0.1	0.0	0.1	0.4	1.0	0.0	0.4	0.0	1.9	1.3	0.1	0.6	0.0	0.0	0.5	0.1	2.7	0.2	0.0	1.4	1.9	0.4	0.0	0.3	0.2	0.1	0.2	0.0	0.9	55.5	2.7	0.0	0.6	0.0	0.8	0.1	0.6	1.4	4.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	39.6	0.0	3.7	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.3	0.0	0.0	0.1	0.3	0.0	0.0	0.3	0.0	0.0	0.0	2.4	1.3	0.0	0.0	0.0	0.0	2.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.2	2.6	0.6	0.1	0.4	1.9	1.3	0.1	2.7	0.2	2.7	1.4	0.0	0.0	2.6	1.0	0.0	0.0	1.2	8.4	4.6	12.1	1.6	0.9	0.0	0.0	6.4	0.0	4.2	0.1	0.0	0.0	0.0	1.9	968.7	0.8	0.1	0.7	0.0	0.0	1.4	0.7	0.1	0.2	0.0	1.1	0.0	0.6	1.1	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	4203.7	12.8	1.1	0.0	0.0	0.0	1.3	0.0	1.0	0.5	6.8	0.1	13.9	0.0	8.5	0.3	4.3	1.6	0.7	6.6	0.0	0.4	15.6	9.7	0.7	0.0	0.4	0.1	0.1	0.3	4.4
LIPM	"bA304I5.1, LIPL3"	ENSG00000173239	"Lipase family member M"	Q5VYY2	10	88802730-88820546	"Predicted intracellular proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"skin 1: 28.2"	"Cell type enriched"	"Detected in single"	11	"Suprabasal keratinocytes: 1.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA071276			Approved	"Endoplasmic reticulum"	"Secreted in other tissues"	NA	NA			"Endoplasmic reticulum"		"HPA071276: "	"unprognostic (7.72e-2)"	"unprognostic (8.49e-4)"	"unprognostic (1.42e-2)"	"unprognostic (2.23e-4)"	"unprognostic (6.70e-3)"	"unprognostic (3.01e-3)"	"unprognostic (5.75e-2)"	"unprognostic (6.63e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.45e-2)"	"prognostic unfavorable (6.47e-4)"	"unprognostic (1.59e-2)"	"unprognostic (5.93e-2)"	"unprognostic (7.05e-3)"	"unprognostic (4.17e-2)"	"unprognostic (9.02e-2)"	"unprognostic (9.70e-6)"	0.0	0.0	0.0	0.2	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	28.2	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0
MYBPC2	"fsMyBP-C, MGC163408, MYBPCF"	ENSG00000086967	"Myosin binding protein C2"	Q14324	19	50432892-50466321	"Predicted intracellular proteins"	"Cell adhesion"	"Actin-binding, Muscle protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"skeletal muscle: 4380.5;tongue: 1209.8"	"Cell type enriched"	"Detected in some"	29	"Skeletal myocytes: 56.9"	"Cancer enriched"	"Detected in some"	9	"head and neck cancer: 9.9"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	16	"HDLM-2: 58.7;Karpas-707: 143.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA042991	Enhanced					NA	NA		420000			"HPA042991: AB_2678257"	"unprognostic (6.48e-3)"	"unprognostic (2.65e-3)"	"unprognostic (6.25e-2)"	"unprognostic (3.26e-3)"	"unprognostic (1.91e-3)"	"unprognostic (2.15e-2)"	"unprognostic (6.22e-3)"	"unprognostic (2.46e-1)"	"unprognostic (5.38e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.19e-8)"	"unprognostic (1.85e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.73e-3)"	"unprognostic (2.73e-1)"	0.2	0.0	0.2	1.1	0.2	0.3	0.4	0.2	0.4	0.0	0.1	0.4	0.0	0.0	0.0	4.2	0.1	0.0	0.2	0.2	0.3	0.3	0.1	0.2	1.1	0.3	0.4	0.2	0.1	0.3	213.9	0.2	0.0	0.4	6.7	0.2	0.0	12.6	0.0	4380.5	0.5	0.4	0.0	0.2	0.3	0.2	0.3	0.3	1.4	1.0	1209.8	1.1	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	58.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	143.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.4	0.2	0.3	0.3	0.4	0.2	0.4	0.2	0.3	1.0	0.0	0.0	0.5	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.7	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.1	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	56.9	0.5	0.2	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0
PDIA2	"PDA2, PDI, PDIP, PDIR"	ENSG00000185615	"Protein disulfide isomerase family A member 2"	Q13087	16	283164-287215	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Chaperone, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"pancreas: 2531.2"	"Cell type enriched"	"Detected in some"	4	"Exocrine glandular cells: 294.9"	"Cancer enriched"	"Detected in many"	5	"pancreatic cancer: 28.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 3.9;HEK 293: 7.9;Hep G2: 6.7;Karpas-707: 2.9;MCF7: 4.6;SH-SY5Y: 3.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA051692, HPA053492"	Enhanced				"Intracellular and membrane"	NA	NA					"HPA051692: AB_2681575, HPA053492: AB_2682169"	"unprognostic (3.46e-2)"	"unprognostic (7.98e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.17e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.58e-14)"	"unprognostic (3.06e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.87e-2)"	1.8	0.6	67.0	0.4	71.9	0.6	0.8	83.0	96.8	0.6	64.2	2.5	24.1	0.3	0.9	0.9	0.7	0.1	3.9	67.0	71.4	0.6	0.6	0.7	0.2	78.9	76.3	67.9	1.5	2531.2	0.0	7.6	2.5	78.7	1.0	0.3	2.4	1.0	0.1	0.6	0.3	7.2	0.0	72.1	0.3	193.2	1.0	71.5	0.0	0.4	0.0	0.5	0.5	0.6	87.5	0.0	1.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.1	0.1	3.9	0.1	0.5	0.0	7.9	0.0	0.3	6.7	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.1	0.0	0.3	2.9	0.1	4.6	0.1	0.4	0.2	1.6	0.0	0.1	0.0	0.9	0.0	0.0	1.6	3.7	0.0	0.1	0.0	0.5	1.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.0	71.9	83.0	96.8	67.0	71.4	78.9	76.3	67.9	78.7	72.1	71.5	87.5	0.0	0.0	0.5	1.6	1.9	0.5	0.0	0.0	0.0	4.2	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.7	0.0	0.1	0.3	0.1	0.0	0.0	12.4	294.9	1.3	5.5	65.7	0.1	0.0	0.1	0.0	0.0	0.4	0.0	14.0	1.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.9	1.6	0.6	0.0	2.0	22.2	25.5	1.4	0.4	0.2	0.0	3.9	1.1	0.0	0.5	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.5	0.0	0.0	1.4	0.0
PSAPL1		ENSG00000178597	"Prosaposin like 1"	Q6NUJ1	4	7430285-7434930	"Predicted secreted proteins"	"Lipid metabolism, Sphingolipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"skin 1: 93.8;stomach 1: 38.9"	"Cell type enriched"	"Detected in some"	13	"Gastric mucus-secreting cells: 41.8"	"Group enriched"	"Detected in some"	5	"head and neck cancer: 0.7;melanoma: 2.5;pancreatic cancer: 2.0;stomach cancer: 3.0;urothelial cancer: 1.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CACO-2: 16.6;OE19: 32.2;RPMI-8226: 24.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA038013, HPA038482"	Approved		Enhanced	Cytosol	"Secreted - unknown location"	NA	NA		31000	Cytosol		"HPA038013: AB_10673652, HPA038482: AB_2676037"		"unprognostic (2.64e-2)"				"unprognostic (2.40e-1)"		"unprognostic (9.33e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.61e-1)"	"unprognostic (7.90e-3)"	"unprognostic (2.52e-1)"		"unprognostic (2.08e-2)"	"unprognostic (2.75e-1)"		"unprognostic (2.63e-3)"	0.2	0.0	0.0	0.0	0.2	0.0	5.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	93.8	0.0	0.0	0.0	0.0	38.9	3.5	0.1	0.2	0.0	0.0	3.1	0.0	0.2	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.2	0.0	0.0	0.0	24.7	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.2	0.1	0.0	0.6	0.0	0.1	0.7	0.0	0.0	0.0	0.3	0.2	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	41.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0
RAD51AP2	FLJ17540	ENSG00000214842	"RAD51 associated protein 2"	Q09MP3	2	17510584-17518439	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	13	"testis: 9.5"	"Cell type enriched"	"Detected in some"	8	"Spermatocytes: 457.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (3.87e-2)"	"unprognostic (3.31e-2)"	"unprognostic (9.98e-2)"	"unprognostic (3.12e-2)"	"unprognostic (4.61e-1)"	"unprognostic (3.51e-1)"	"unprognostic (9.80e-2)"	"unprognostic (4.84e-3)"		"unprognostic (2.64e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.71e-1)"		"unprognostic (6.26e-3)"	"unprognostic (3.82e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.15e-1)"	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.7	0.2	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.7	0.2	0.5	1.5	0.9	1.2	0.1	0.7	2.8	0.9	0.0	0.2	0.0	2.1	0.0	0.0	6.0	0.0	0.0	12.8	0.0	0.1	0.2	0.0	0.0	8.0	0.0	0.0	0.2	2.0	0.0	0.0	0.1	0.0	1.7	0.1	0.0	4.1	0.7	0.0	0.0	0.2	5.7	0.9	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.3	0.1	0.1	0.4	0.1	1.1	0.0	0.1	0.2	0.2	26.3	0.1	0.4	457.6	51.7	0.6	0.6	0.0	0.0	0.5	1.6	0.9
RLBP1	CRALBP	ENSG00000140522	"Retinaldehyde binding protein 1"	P12271	15	89209869-89221614	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Sensory transduction, Transport, Vision"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"retina: 268.0"	"Cell type enriched"	"Detected in some"	34	"Muller glia cells: 3148.2"	"Group enriched"	"Detected in some"	30	"glioma: 3.7;melanoma: 7.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	53	"SK-MEL-30: 22.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042051, HPA044083"	Enhanced	Approved	Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			Cytosol	"Nucleoplasm, Centrosome"	"HPA042051: AB_2732495, HPA044083: AB_2678802"	"unprognostic (3.19e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.76e-1)"		"unprognostic (8.24e-3)"	"unprognostic (5.21e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.76e-1)"		"unprognostic (2.78e-1)"	"unprognostic (1.13e-1)"		"unprognostic (8.42e-2)"	0.0	0.2	13.6	0.1	15.3	0.1	0.0	13.6	21.0	0.0	14.8	1.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	14.3	13.0	0.0	0.0	0.0	0.0	13.6	13.0	13.5	0.0	0.0	0.0	2.6	0.0	13.6	0.0	0.1	268.0	0.0	0.0	0.1	0.0	0.4	0.1	12.5	0.0	0.2	0.9	13.0	0.0	0.0	0.2	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	13.6	15.3	13.6	21.0	14.3	13.0	13.6	13.0	13.5	13.6	12.5	13.0	13.4	0.0	0.0	0.0	19.6	0.0	0.0	0.0	0.0	0.0	21.4	0.0	0.0	0.3	0.0	0.0	0.0	39.6	4.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.5	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	5.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.9	2.0	3148.2	0.0	5.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	90.9	0.0	0.0	0.0	0.2	0.2	0.0	0.0	20.0	0.0	0.0	0.0	0.0
SLC2A2	GLUT2	ENSG00000163581	"Solute carrier family 2 member 2"	P11168	3	170996347-171026743	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"liver: 842.9"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 457.6"	"Cancer enriched"	"Detected in some"	12	"liver cancer: 105.2"	"Region enhanced"	"Detected in single"		"white matter: 2.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	55	"CACO-2: 7.7;Hep G2: 27.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB010444, HPA028997"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB010444: AB_641068, HPA028997: AB_2672860"			"unprognostic (9.56e-2)"		"unprognostic (1.24e-1)"		"prognostic favorable (2.63e-5)"				"unprognostic (3.10e-1)"		"unprognostic (1.02e-1)"	"unprognostic (2.95e-2)"	"unprognostic (6.31e-2)"			0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.2	0.4	0.0	0.1	0.0	66.7	0.0	0.0	0.0	0.0	5.3	0.0	0.2	0.2	31.1	842.9	0.0	0.0	0.5	0.4	0.0	0.0	2.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.4	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	27.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.2	0.4	0.2	0.2	0.5	0.4	0.0	0.6	0.3	0.3	2.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	90.1	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.2	6.7	0.0	0.0	0.1	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	457.6	0.0	0.0	0.1	3.0	0.0	10.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	2.5	0.0	0.0	0.0	105.4	63.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	1.8	0.0
SPATA31A6	FAM75A6	ENSG00000185775	"SPATA31 subfamily A member 6"	Q5VVP1	9	42183659-42189887	"Predicted membrane proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	13	"testis: 2.0"	"Cell type enriched"	"Detected in single"	4	"Early spermatids: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																				"unprognostic (2.23e-2)"			0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRAV1-1	"TCRAV1S1, TCRAV7S1, TRAV11"	ENSG00000255569	"T cell receptor alpha variable 1-1"	A0A0B4J248	14	21621838-21622567	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	13	"lymphoid tissue: 18.1"	"Cell type enriched"	"Detected in single"	10	"T-cells: 5.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	18	"MAIT T-cell: 26.0;memory CD4 T-cell: 11.8;memory CD8 T-cell: 27.1;naive CD4 T-cell: 17.7;naive CD8 T-cell: 25.7;T-reg: 30.6"	"Lineage enriched"	"Detected in many"	23	"T-cells: 30.6"	"Cell line enriched"	"Detected in single"	160	"MOLT-4: 30.7"															NA	NA						"unprognostic (1.56e-1)"	"unprognostic (6.87e-2)"	"unprognostic (5.07e-1)"			"unprognostic (6.72e-4)"	"unprognostic (2.62e-3)"	"unprognostic (6.08e-3)"	"unprognostic (2.29e-1)"	"unprognostic (6.56e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.96e-1)"	"unprognostic (9.40e-5)"	"unprognostic (3.51e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.40e-1)"		0.2	0.0	0.0	2.7	0.0	0.7	0.1	0.0	0.1	0.6	0.0	0.6	0.7	0.2	0.0	0.2	0.1	1.1	0.0	0.0	0.0	0.0	0.1	0.2	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.0	0.1	1.1	0.0	0.0	1.9	1.4	0.1	0.0	18.1	0.1	0.0	3.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	26.0	0.0	11.8	27.1	0.2	0.0	17.7	25.7	0.0	0.0	0.0	0.0	30.6	6.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0
TRAV27		ENSG00000211809	"T cell receptor alpha variable 27"	A0A087WT01	14	22147995-22148633	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"lymphoid tissue: 20.0"	"Cell type enriched"	"Detected in some"	4	"T-cells: 4.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	19	"memory CD4 T-cell: 51.6;memory CD8 T-cell: 58.9;naive CD4 T-cell: 60.4;naive CD8 T-cell: 59.1;T-reg: 81.9"	"Lineage enriched"	"Detected in many"	63	"T-cells: 81.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"													NA	NA						"unprognostic (3.86e-3)"	"unprognostic (1.66e-2)"	"unprognostic (4.15e-2)"	"unprognostic (2.78e-4)"	"unprognostic (1.61e-1)"	"unprognostic (2.21e-3)"	"unprognostic (3.13e-1)"	"unprognostic (8.30e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.75e-4)"	"unprognostic (3.45e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.12e-3)"	0.1	0.0	0.0	2.3	0.0	0.4	0.2	0.0	0.2	0.6	0.0	0.6	0.3	0.2	0.0	0.4	0.3	0.2	0.1	0.0	0.0	0.1	0.1	0.7	5.0	0.1	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	1.5	0.0	0.2	0.0	0.2	0.2	0.7	0.0	0.0	1.7	0.9	0.0	0.1	20.0	0.1	0.0	5.7	1.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.5	0.0	3.2	0.2	51.6	58.9	0.0	0.0	60.4	59.1	1.0	1.3	0.1	0.3	81.9	19.9	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0
TRAV29DV5	TRAV29/DV5	ENSG00000211810	"T cell receptor alpha variable 29/delta variable 5"	P04437	14	22163238-22163870	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"lymphoid tissue: 26.8"	"Cell type enriched"	"Detected in some"	5	"T-cells: 13.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	20	"memory CD4 T-cell: 99.2;memory CD8 T-cell: 126.3;naive CD4 T-cell: 105.5;naive CD8 T-cell: 66.4;T-reg: 123.9"	"Lineage enriched"	"Detected in single"	129	"T-cells: 126.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"													NA	NA						"unprognostic (7.25e-4)"	"unprognostic (3.20e-3)"	"unprognostic (4.50e-2)"	"unprognostic (8.49e-4)"		"unprognostic (3.24e-3)"	"unprognostic (9.16e-2)"	"unprognostic (2.73e-1)"	"unprognostic (4.17e-3)"	"unprognostic (4.47e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.11e-4)"	"unprognostic (7.53e-2)"	"unprognostic (4.69e-2)"	"unprognostic (9.86e-2)"	"unprognostic (7.28e-2)"	0.1	0.0	0.0	4.7	0.0	0.8	0.3	0.0	0.1	0.2	0.0	1.3	1.7	0.1	0.4	0.8	0.5	0.9	0.3	0.0	0.0	0.2	0.5	1.3	11.9	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.6	0.0	0.3	0.2	0.0	0.0	1.8	0.2	0.0	4.8	2.0	0.1	0.1	26.8	0.1	0.0	11.8	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.1	5.1	0.2	2.5	0.1	99.2	126.3	0.1	0.2	105.5	66.4	0.9	0.2	0.2	0.2	123.9	35.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.0
TRBV10-1	"TCRBV10S1, TCRBV12S2, TCRBV12S2A1T, TRBV101"	ENSG00000211717	"T cell receptor beta variable 10-1"	A0A0K0K1A3	7	142399860-142400377	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	13	"lymphoid tissue: 4.5"	"Cell type enriched"	"Detected in single"	4	"T-cells: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	10	"MAIT T-cell: 3.2;memory CD4 T-cell: 4.7;memory CD8 T-cell: 3.0;naive CD4 T-cell: 6.2;naive CD8 T-cell: 2.6;T-reg: 9.5"	"Lineage enriched"	"Detected in single"	18	"T-cells: 9.5"	"Not detected"	"Not detected"																	NA	NA															"unprognostic (1.41e-2)"				"unprognostic (3.88e-1)"	"unprognostic (2.85e-3)"			0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.1	0.0	4.5	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	4.7	3.0	0.0	0.0	6.2	2.6	0.5	0.0	0.0	0.0	9.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0
TRBV4-2	"TCRBV4S2, TCRBV7S3A2T, TRBV42"	ENSG00000211745	"T cell receptor beta variable 4-2"	A0A539	7	142345421-142345985	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	13	"lymphoid tissue: 21.2"	"Cell type enriched"	"Detected in some"	8	"T-cells: 23.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 100.2"	"Lineage enriched"	"Detected in single"	293	"T-cells: 100.2"	"Not detected"	"Not detected"																	NA	NA						"unprognostic (2.89e-3)"	"unprognostic (4.65e-4)"	"unprognostic (1.28e-3)"	"unprognostic (1.06e-2)"	"unprognostic (4.60e-2)"	"unprognostic (7.05e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.32e-2)"	"unprognostic (6.75e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.82e-4)"	"unprognostic (5.50e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.48e-2)"	0.2	0.0	0.0	1.4	0.0	0.6	0.1	0.0	0.1	0.3	0.0	0.3	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.1	0.2	0.5	5.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.0	1.6	0.1	0.0	2.3	0.3	0.5	0.0	21.2	0.3	0.0	4.8	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	100.2	0.0	25.6	27.8	0.1	0.0	23.9	14.4	0.1	0.0	0.2	0.3	44.8	8.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	23.9	0.0	0.0	0.0
AC092143.1		ENSG00000198211	"Novel protein (MC1R-TUBB3 readthrough)"		16	89919165-89936092	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in single"	12	"testis: 6.6"	"Cell type enriched"	"Detected in single"	15	"Fibroblasts: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"SK-MEL-30: 10.7"									"CAB011512, HPA043640, HPA046280"	Uncertain		Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA			Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB011512: AB_444319, HPA043640: AB_2678594, HPA046280: AB_2679612"					"unprognostic (2.90e-4)"				"unprognostic (6.87e-2)"									0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	6.6	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.2	0.0	0.3	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AFM	"ALB2, ALBA"	ENSG00000079557	Afamin	P43652	4	73481745-73504001	"Plasma proteins, Predicted secreted proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"liver: 969.5"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 300.4"	"Cancer enriched"	"Detected in single"	167	"liver cancer: 62.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"CACO-2: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA017006, HPA052437"	Enhanced				"Secreted to blood"	NA	NA	54900000000	8700000000			"HPA017006: AB_1844635, HPA052437: AB_2732575"							"prognostic favorable (1.80e-4)"				"unprognostic (5.73e-2)"		"unprognostic (4.24e-2)"					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	80.4	969.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.1	0.0	0.0	0.0	0.0	0.3	0.2	4.3	0.0	1.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.7	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	4.2	300.4	0.1	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	42.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.1	0.0	0.0
APOA4		ENSG00000110244	"Apolipoprotein A4"	P06727	11	116820700-116823304	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"intestine: 3138.1"	"Cell type enriched"	"Detected in some"	44	"Proximal enterocytes: 10311.5"	"Cancer enriched"	"Detected in some"	29	"liver cancer: 291.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 7.7;CACO-2: 8.0;Hep G2: 7.7;NB-4: 7.3;RPMI-8226: 12.5;SH-SY5Y: 10.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001352, HPA002549, CAB068250, CAB068251, CAB068252"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	61200000000	74000000000	Vesicles		"CAB068250: AB_2665657, CAB068251: AB_2665659, CAB068252: AB_2665658, HPA001352: AB_1078179, HPA002549: AB_1078177"							"unprognostic (8.81e-2)"				"unprognostic (2.12e-2)"			"unprognostic (1.75e-2)"	"unprognostic (7.91e-2)"			0.1	0.0	0.0	2.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	6.3	2224.9	1.8	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	259.4	0.0	2.5	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	3138.1	3.1	0.0	0.1	4.7	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	3.1	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	77.5	0.0	0.0	0.0	234.3	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	221.5	0.0	0.0	0.0	10311.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	87.7	0.0
ARMH2	C6orf229	ENSG00000260286	"Armadillo like helical domain containing 2"	H3BNL8	6	24797335-24798917	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"testis: 13.5"	"Cell type enriched"	"Detected in single"	9	"Endometrial ciliated cells: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 2.5"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA												"unprognostic (1.28e-1)"							"unprognostic (1.16e-1)"				0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.0	0.0	1.1	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.6	0.0	13.5	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.3	0.1	0.3	0.1	0.7	0.5	0.3	0.5	0.2	0.7	0.5	0.3	2.5	0.2	0.1	0.2	0.2	0.0	0.1	0.2	0.4	0.2	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ATP2A2	"ATP2B, DAR, SERCA2"	ENSG00000174437	"ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2"	P16615	12	110280756-110351093	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	Translocase	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	12	"heart muscle: 1015.1;skeletal muscle: 2883.7;tongue: 2793.4"	"Cell type enriched"	"Detected in all"	7	"Cardiomyocytes: 2119.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062605	Enhanced					NA	NA		2500000			"HPA062605: AB_2684805"	"unprognostic (4.81e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.50e-1)"	"unprognostic (3.98e-3)"	"unprognostic (1.91e-2)"	"unprognostic (6.20e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.26e-1)"	"unprognostic (5.62e-2)"	"unprognostic (9.93e-2)"	61.0	50.1	27.9	58.3	29.2	46.4	34.4	34.9	24.9	43.7	18.3	64.8	48.0	47.0	39.4	182.8	67.6	61.1	1015.1	33.7	26.8	34.8	55.2	49.4	36.3	29.6	42.4	20.6	42.4	38.5	56.5	24.7	55.8	29.4	94.2	69.7	19.2	93.0	70.7	2883.7	46.2	56.9	75.0	30.2	30.8	47.6	74.8	51.1	36.6	74.0	2793.4	48.5	91.8	58.4	34.2	129.7	305.7	135.4	106.5	95.3	111.7	185.1	154.9	197.2	163.6	102.1	229.1	131.3	155.4	129.2	165.4	115.4	185.0	215.9	264.4	157.3	130.0	127.2	148.0	115.6	121.5	164.7	151.1	130.6	130.3	170.7	202.3	190.1	165.4	134.9	82.6	162.9	74.9	118.6	131.3	76.0	53.2	139.7	126.6	134.8	96.8	130.2	128.6	59.5	279.2	138.2	101.5	207.8	151.1	87.0	113.9	213.7	95.6	159.8	147.8	69.3	93.9	127.4	140.6	189.5	169.0	152.3	70.9	168.8	0.0	0.6	0.0	0.5	1.3	0.2	0.1	0.3	0.2	0.5	0.2	0.3	0.3	0.0	0.3	0.6	0.5	0.3	0.2	27.9	29.2	34.9	24.9	33.7	26.8	29.6	42.4	20.6	29.4	30.2	51.1	34.2	48.9	44.8	57.5	85.5	26.3	114.5	95.2	134.5	68.9	63.6	70.2	64.6	2119.9	41.5	103.5	51.5	64.6	33.4	37.4	155.1	1.9	43.7	14.8	291.6	90.8	59.7	137.3	14.1	161.0	71.0	37.6	104.2	49.5	258.1	45.0	47.3	40.7	122.2	64.3	84.1	146.1	109.6	65.1	54.6	64.9	13.4	30.4	65.3	67.6	63.7	33.8	27.5	15.5	119.6	96.4	98.0	89.4	83.1	56.8	117.4	78.0	25.3	176.4	42.9	52.6	88.0	110.2	80.3	47.7	142.3	109.0	30.6	32.7	40.0	97.7	126.4
ATP8B4	"ATPIM, KIAA1939"	ENSG00000104043	"ATPase phospholipid transporting 8B4 (putative)"	Q8TF62	15	49858238-50182817	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"bone marrow: 78.8"	"Cell type enriched"	"Detected in many"	6	"Microglial cells: 248.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 15.2;NK-cell: 11.0"	"Group enriched"	"Detected in many"	5	"granulocytes: 15.2;NK-cells: 11.0"	"Cell line enhanced"	"Detected in some"		"HMC-1: 40.2;NB-4: 19.2;THP-1: 26.7;U-937: 103.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA040254	Approved		Uncertain	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Vesicles"	Cytosol	"HPA040254: AB_10673028"	"unprognostic (6.45e-3)"	"unprognostic (3.83e-2)"	"unprognostic (5.39e-2)"	"unprognostic (2.96e-3)"	"unprognostic (3.25e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.87e-3)"	"unprognostic (1.64e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.99e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.08e-1)"	1.4	1.1	2.2	2.5	2.3	78.8	0.7	3.5	6.7	1.0	2.4	1.1	0.7	6.5	4.2	0.5	3.1	2.2	0.4	4.6	2.2	1.2	1.6	1.1	1.0	2.1	2.2	1.5	0.4	0.5	0.2	0.3	3.6	2.5	0.6	1.7	0.1	0.6	0.9	0.1	0.3	1.3	3.2	3.5	2.6	0.6	0.4	1.5	0.5	0.1	0.1	1.0	1.4	0.4	4.3	0.1	0.6	0.0	0.0	0.0	0.7	0.2	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.5	0.5	0.2	0.0	0.2	12.2	0.0	7.3	1.7	0.1	0.0	13.6	40.2	0.7	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	19.2	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.1	1.5	0.1	1.2	0.0	0.0	0.1	0.0	26.7	0.0	0.0	0.3	1.0	0.0	0.1	0.0	0.0	1.3	103.7	0.0	15.2	2.0	3.8	0.4	1.2	0.1	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.8	11.0	0.4	0.0	0.0	0.9	2.2	2.3	3.5	6.7	4.6	2.2	2.1	2.2	1.5	2.5	3.5	1.5	4.3	1.7	0.0	1.9	1.6	0.8	1.5	0.1	0.2	0.6	0.6	0.2	0.6	1.3	0.0	0.1	0.0	0.0	5.4	12.5	0.3	0.0	0.0	27.6	0.3	1.7	1.0	0.0	12.2	20.3	0.0	1.8	8.1	3.1	0.2	19.7	0.0	1.1	3.7	16.4	0.0	17.5	0.3	2.0	37.0	17.7	25.3	1.8	27.0	1.8	248.3	6.3	0.5	15.5	1.0	2.1	0.0	0.1	0.7	4.8	2.3	0.7	1.2	0.7	0.2	0.0	1.0	7.0	0.5	0.6	0.6	0.3	2.9	13.4	1.1	0.2	0.3
CD1A	CD1	ENSG00000158477	"CD1a molecule"	P06126	1	158254424-158258269	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"lymphoid tissue: 320.9"	"Cell type enriched"	"Detected in some"	20	"Langerhans cells: 151.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	25	"classical monocyte: 6.4;intermediate monocyte: 4.2;memory B-cell: 10.1;myeloid DC: 11.4;naive B-cell: 5.3"	"Group enriched"	"Detected in many"	37	"B-cells: 10.1;dendritic cells: 11.4;monocytes: 6.4"	"Group enriched"	"Detected in some"	81	"JURKAT: 41.4;MOLT-4: 66.4"					"Not detected"	"Not detected"			"CAB000009, HPA010734"	Enhanced					NA	NA					"CAB000009: AB_2073290, HPA010734: AB_1078452"	"unprognostic (7.21e-5)"	"prognostic favorable (6.37e-4)"	"unprognostic (1.37e-5)"	"unprognostic (2.55e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.16e-2)"	"unprognostic (9.93e-4)"	"unprognostic (1.49e-2)"	"unprognostic (3.12e-1)"	"unprognostic (3.86e-2)"	"unprognostic (6.99e-2)"	"unprognostic (5.12e-2)"	"unprognostic (5.49e-5)"	"unprognostic (5.58e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.76e-1)"	"unprognostic (8.81e-2)"	0.1	0.0	0.0	1.6	0.0	0.0	1.4	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.0	10.5	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.8	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.4	0.0	0.1	27.3	0.2	0.0	0.0	1.3	0.8	0.1	0.0	320.9	0.2	0.0	3.9	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	41.4	0.0	0.0	0.0	0.0	66.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	6.4	0.0	0.0	4.2	0.2	10.1	0.0	0.0	11.4	5.3	0.1	0.0	0.0	0.0	0.2	0.3	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.2	151.7	0.0	0.0	4.0	1.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	7.0	0.0	0.2	0.0	0.0	0.0
CLPB	"ANKCLB, FLJ13152, HSP78, SKD3"	ENSG00000162129	"Caseinolytic mitochondrial matrix peptidase chaperone subunit B"	Q9H078	11	72285495-72434680	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Hydrolase	"Cataract, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"testis: 145.8"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 5136.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 25.5"	"Group enriched"	"Detected in all"	5	"dendritic cells: 25.5;granulocytes: 7.7;monocytes: 15.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039005, HPA039006, HPA064571"	Enhanced					NA	NA					"HPA039005: AB_2676305, HPA039006: AB_10672767, HPA064571: AB_2685290"	"unprognostic (9.36e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.99e-1)"	"unprognostic (2.05e-2)"	"unprognostic (8.22e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (8.36e-8)"	"unprognostic (9.29e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.28e-2)"	6.0	7.2	3.7	6.7	4.1	11.8	3.5	6.2	7.7	2.7	0.2	3.8	3.9	3.4	2.0	4.0	3.2	3.1	6.2	3.9	6.0	9.1	11.3	3.5	3.8	6.9	5.2	3.8	3.0	6.0	9.4	2.2	6.1	8.0	2.3	3.4	6.8	5.9	3.8	8.9	2.3	2.7	6.4	4.5	3.9	3.9	145.8	6.6	4.1	5.8	7.3	3.4	3.8	2.6	6.4	12.7	39.4	9.5	20.5	12.2	9.8	28.8	12.9	8.9	21.8	15.5	55.5	19.1	28.6	30.5	13.0	35.0	26.5	30.6	31.0	23.0	26.3	24.0	23.5	38.3	28.4	10.1	28.0	45.3	14.6	7.7	37.7	33.2	6.4	23.3	26.9	39.7	20.3	12.7	33.0	26.7	23.3	10.5	40.4	35.4	22.2	16.6	14.3	9.9	22.6	27.7	16.9	16.8	39.9	30.8	11.5	22.4	22.0	16.9	29.0	18.0	27.4	25.9	9.9	16.6	18.4	14.6	22.2	19.5	7.7	15.7	0.8	3.0	13.5	3.1	1.9	1.6	2.8	25.5	1.8	2.1	1.8	1.1	2.6	7.8	4.3	1.1	7.8	3.7	4.1	6.2	7.7	3.9	6.0	6.9	5.2	3.8	8.0	4.5	6.6	6.4	9.0	16.0	9.7	4.6	6.1	0.4	5.3	5.9	2.2	4.1	7.7	5.0	3.7	2.8	8.6	9.2	4.2	13.0	3.2	3.9	5.9	13.7	1135.5	7.2	13.4	8.0	0.0	11.4	9.8	16.3	17.1	5.5	7.1	9.7	3.8	9.2	1.4	10.7	21.6	3.3	9.8	1.8	10.2	5.9	4.2	5136.8	25.1	13.2	1.8	14.0	8.8	1.9	2.1	11.1	10.4	10.4	1.4	18.4	14.2	6.3	4.3	24.3	5.3	5.5	13.1	3.5	8.1	40.9	22.9	6.0	1.1	33.1	3.6	16.7	2.6	6.6
DMKN	ZD52F10	ENSG00000161249	Dermokine	Q6E0U4	19	35497220-35513658	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"skin 1: 4714.4"	"Cell type enriched"	"Detected in many"	5	"Suprabasal keratinocytes: 8514.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 11.7"	"Group enriched"	"Detected in many"	5	"NK-cells: 11.7;T-cells: 6.4"	"Cell line enhanced"	"Detected in many"		"A-431: 150.1;CACO-2: 182.0;CAPAN-2: 153.9;HBEC3-KT: 236.4;RPTEC TERT1: 232.2"	"Region enhanced"	"Detected in all"		"basal ganglia: 51.9"	"Low region specificity"	"Detected in all"			HPA029406	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted in other tissues"	NA	NA		47000000	"Nucleoplasm, Cytosol"		"HPA029406: AB_10603661"	"unprognostic (5.70e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.48e-2)"	"unprognostic (3.82e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.82e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.93e-2)"	"prognostic favorable (5.37e-6)"	"unprognostic (3.50e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.08e-1)"	11.7	9.4	6.2	1.1	9.7	1.7	197.6	6.9	7.6	134.9	13.5	9.6	5.6	16.3	14.6	223.3	74.6	1.8	11.3	5.3	8.0	37.7	4.7	22.5	1.2	16.2	9.2	4.8	35.3	60.2	87.9	58.5	2.2	18.3	19.4	5.0	1.9	70.0	14.7	20.3	4714.4	8.4	4.2	5.7	2.9	20.0	4.1	6.4	12.3	60.5	0.2	51.1	14.2	381.6	14.7	150.1	24.0	0.0	0.1	5.7	8.7	40.5	0.5	19.6	1.0	1.4	182.0	153.9	0.0	57.5	1.4	7.3	81.8	44.5	236.4	1.9	0.7	43.0	0.0	0.0	41.3	6.8	0.0	0.5	77.6	62.3	4.2	133.2	13.4	0.0	0.0	0.8	0.2	0.5	130.2	0.1	0.0	129.2	107.9	9.7	0.2	0.0	6.2	232.2	97.4	0.4	0.0	35.6	0.1	14.9	36.7	58.5	0.0	0.3	22.3	67.1	0.8	0.6	0.9	0.3	1.1	18.8	0.3	1.4	0.0	0.0	0.0	6.4	0.0	5.5	1.7	0.5	3.1	0.0	0.1	0.1	2.0	0.0	11.7	0.0	0.2	0.0	1.3	6.2	9.7	6.9	7.6	5.3	8.0	16.2	9.2	4.8	18.3	5.7	6.4	14.7	13.9	105.8	115.3	1.0	5.9	1623.7	143.2	169.9	39.3	1.7	71.8	164.3	20.4	100.1	107.6	204.1	0.0	1.0	6.7	6.0	230.9	138.0	15.9	181.5	9.0	27.7	49.3	2.7	6.9	140.2	1.5	47.1	27.0	107.8	7.6	2.4	12.1	4.0	1.0	0.0	5.3	8.0	46.8	0.3	287.0	98.0	13.1	2.8	305.9	0.0	2.6	15.1	28.8	0.0	0.4	146.1	9.3	15.8	3.4	94.0	0.2	7.6	270.2	0.8	0.0	0.9	22.9	7.6	31.4	34.0	8514.1	2.3	15.0	0.2	14.2	77.4
FABP4	"A-FABP, aP2"	ENSG00000170323	"Fatty acid binding protein 4"	P15090	8	81478419-81483236	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"adipose tissue: 3821.0;breast: 2214.1"	"Cell type enriched"	"Detected in many"	17	"Adipocytes: 24359.7"	"Group enriched"	"Detected in all"	7	"breast cancer: 42.1;cervical cancer: 141.7;head and neck cancer: 133.8;urothelial cancer: 65.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	171	"ASC diff: 4051.5;RT4: 2107.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA002188, CAB024961"	Enhanced					NA	NA		22000000			"CAB024961: , HPA002188: AB_1078822"	"unprognostic (4.81e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.64e-3)"	"unprognostic (2.63e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.70e-3)"	"unprognostic (1.78e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.36e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.13e-3)"	"unprognostic (4.48e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.39e-1)"	3821.0	42.6	0.8	47.1	0.9	2.8	2214.1	0.9	1.6	10.0	29.3	53.4	2.8	4.7	0.6	15.3	11.0	68.8	93.4	1.2	0.9	7.0	5.2	114.5	13.7	0.9	0.8	0.7	4.2	16.7	59.6	1.5	188.5	0.9	4.3	33.8	2.6	59.2	5.1	67.2	57.7	45.1	14.3	0.8	6.7	26.7	1.1	3.1	30.1	83.7	168.2	2.0	245.2	19.1	0.9	0.0	0.0	0.0	0.0	4051.5	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	17.9	0.0	0.1	1.3	0.0	0.4	0.0	0.0	2.0	0.7	0.0	0.0	0.0	0.8	1.2	0.1	3.0	0.0	9.4	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	2107.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.3	0.2	5.7	0.0	0.2	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.9	0.9	1.6	1.2	0.9	0.9	0.8	0.7	0.9	0.8	3.1	0.9	24359.7	35.3	64.3	0.0	19.4	14.4	1.1	0.9	4.6	0.5	71.7	196.2	42.1	0.0	26.7	0.0	0.0	0.5	73.6	0.0	0.0	0.2	1.6	0.4	8.8	1132.7	0.0	0.0	0.0	5.6	0.7	53.1	1.1	0.2	27.8	0.1	23.2	0.4	114.2	0.0	0.0	0.0	0.0	50.4	15.7	10.9	1.5	192.7	16.0	0.0	0.6	0.9	0.0	0.0	0.0	0.2	2.2	1.2	2.7	0.5	0.0	0.3	21.9	2.4	716.6	62.2	1364.8	0.0	0.1	1.2	13.9	0.7	18.7	2.3	0.0	55.3
FAM186A	LOC121006	ENSG00000185958	"Family with sequence similarity 186 member A"	A6NE01	12	50326230-50396622	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"testis: 14.3"	"Cell type enriched"	"Detected in some"	8	"Early spermatids: 521.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA047128, HPA064735"	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Nucleoplasm, Vesicles"	"Plasma membrane"	"HPA047128: AB_10967726, HPA064735: "	"unprognostic (1.01e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.69e-2)"	"unprognostic (3.48e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.30e-2)"	"unprognostic (6.96e-2)"	"unprognostic (4.65e-5)"	"unprognostic (1.93e-1)"	"unprognostic (2.42e-5)"	"unprognostic (1.65e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.51e-2)"	"unprognostic (3.22e-3)"	0.1	0.3	0.1	0.2	0.4	0.5	0.1	0.5	0.3	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.4	0.2	0.1	0.3	0.3	0.1	0.2	0.2	0.1	0.1	0.2	0.3	0.0	0.9	0.0	0.2	0.3	0.1	0.7	0.2	0.0	1.1	0.3	0.2	0.0	0.0	0.4	0.1	14.3	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.3	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.6	0.3	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.6	0.3	0.1	0.1	0.0	0.0	0.1	0.4	0.5	0.3	0.2	0.1	0.2	0.1	0.1	0.2	0.0	0.1	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	521.1	0.1	0.2	0.1	0.0	0.0	2.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	64.7	0.6	0.1	0.0	2.8	0.0	0.6	0.0	1.5	3.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	1.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGFN1	"DKFZp434B1231, EEF1A2BP1"	ENSG00000163395	"Immunoglobulin like and fibronectin type III domain containing 1"	Q86VF2	1	201190824-201228952	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"skeletal muscle: 188.1"	"Cell type enriched"	"Detected in some"	4	"Skeletal myocytes: 103.8"	"Cancer enriched"	"Detected in some"	4	"thyroid cancer: 8.1"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"HeLa: 76.6"	"Group enriched"	"Detected in many"	7	"amygdala: 3.3;basal ganglia: 1.2;cerebral cortex: 2.9;hippocampal formation: 1.9"	"Low region specificity"	"Detected in some"			HPA050415	Enhanced		Approved	"Midbody ring"		Yes	NA			"Midbody ring"		"HPA050415: AB_2681120"	"unprognostic (2.09e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.82e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.00e-2)"	"unprognostic (9.80e-3)"	"unprognostic (1.73e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.80e-2)"	"prognostic unfavorable (1.27e-8)"	"unprognostic (3.55e-4)"	"unprognostic (6.06e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.42e-2)"	0.6	0.1	0.3	0.1	0.1	0.0	0.2	0.0	0.3	0.8	0.6	0.1	0.0	10.5	15.2	0.0	0.9	0.2	0.3	1.0	0.5	0.1	0.1	0.5	0.1	0.1	0.2	0.1	0.2	7.0	0.0	0.1	0.0	0.3	0.7	0.2	0.0	0.0	0.3	188.1	0.2	0.0	0.8	0.0	0.0	0.1	2.6	0.4	0.0	14.7	0.2	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	76.6	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.8	0.0	4.9	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.3	1.0	0.5	0.1	0.2	0.1	0.3	0.0	0.4	0.1	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.4	0.1	0.0	0.0	0.1	1.5	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	22.1	0.4	1.8	1.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	9.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	103.8	0.7	0.6	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0
LHX1	"LIM-1, LIM1"	ENSG00000273706	"LIM homeobox 1"	P48742	17	36936785-36944612	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	12	"kidney: 10.7"	"Cell type enriched"	"Detected in some"	8	"Horizontal cells: 361.7"	"Group enriched"	"Detected in some"	4	"ovarian cancer: 8.1;testis cancer: 2.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 3.8;HMC-1: 1.6;WM-115: 7.0"	"Region enhanced"	"Detected in many"		"cerebellum: 19.1"	"Region enriched"	"Detected in many"	4	"cerebellum: 15.7"	"HPA044307, HPA073521, HPA074382"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Golgi apparatus"		NA	NA			Nucleoplasm	"Nuclear membrane, Golgi apparatus"	"HPA044307: , HPA073521: AB_2732226, HPA074382: "	"unprognostic (3.86e-5)"	"unprognostic (1.64e-1)"		"prognostic unfavorable (3.63e-5)"	"unprognostic (3.85e-2)"	"unprognostic (1.06e-4)"		"unprognostic (2.67e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.20e-3)"		"unprognostic (1.74e-5)"	"unprognostic (1.33e-1)"	"unprognostic (8.62e-2)"		"unprognostic (3.05e-2)"	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	10.7	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.1	0.0	3.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	1.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.8	0.4	0.2	0.0	0.5	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.4	2.1	0.0	0.0	42.3	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.6	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	361.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	13.0	0.0	1.6	0.0	0.0	0.2	1.1	2.3	0.0	0.0	0.4	0.3	0.0	0.2	0.0
MCHR2	"GPR145, MCH2, MCH2R, SLT"	ENSG00000152034	"Melanin concentrating hormone receptor 2"	Q969V1	6	99918519-99994247	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"brain: 3.3;testis: 1.5"	"Cell type enriched"	"Detected in some"	27	"Excitatory neurons: 44.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"									NA	NA										"unprognostic (5.76e-2)"													0.0	0.0	1.0	0.0	2.6	0.1	0.0	0.0	3.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	1.7	0.0	0.0	0.0	0.0	0.4	0.1	2.4	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	2.6	0.0	3.3	2.7	1.7	0.4	0.1	2.4	1.4	0.0	0.1	1.9	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	44.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MMP13	CLG3	ENSG00000137745	"Matrix metallopeptidase 13"	P45452	11	102942995-102955732	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"urinary bladder: 13.0"	"Cell type enriched"	"Detected in some"	12	"Basal respiratory cells: 426.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 70.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HaCaT: 17.9;PC-3: 6.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB002742	Supported				"Secreted to extracellular matrix"	NA	NA					"CAB002742: "	"unprognostic (8.98e-3)"	"unprognostic (1.54e-1)"	"unprognostic (4.75e-2)"	"unprognostic (4.57e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.59e-3)"		"unprognostic (1.32e-1)"	"unprognostic (6.35e-3)"	"unprognostic (1.69e-1)"	"unprognostic (7.55e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.73e-8)"	"unprognostic (2.12e-2)"	"unprognostic (3.14e-1)"	"unprognostic (4.14e-2)"	"unprognostic (4.33e-2)"	0.0	0.0	0.1	0.2	0.1	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	13.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	17.9	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.1	0.0	0.0	0.0	6.7	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.0	2.4	1.3	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.3	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	8.7	426.0	0.0	0.0	0.0	0.0	0.2	0.0	33.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	6.8	0.0	0.0	0.0	2.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	15.8
MS4A15		ENSG00000166961	"Membrane spanning 4-domains A15"	Q8N5U1	11	60756867-60776733	"Predicted membrane proteins"		Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	12	"lung: 44.3"	"Cell type enriched"	"Detected in some"	15	"Alveolar cells type 1: 96.1"	"Cancer enhanced"	"Detected in many"		"lung cancer: 6.3"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"T-reg: 3.2"	"Lineage enriched"	"Detected in single"	12	"T-cells: 3.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.2;HEL: 3.6;JURKAT: 1.6;MOLT-4: 1.6;U-266/70: 4.0;U-266/84: 2.1"	"Region enriched"	"Detected in some"	28	"olfactory bulb: 166.8"	"Region enriched"	"Detected in single"	26	"olfactory bulb: 20.2"	HPA054563			Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA054563: "	"unprognostic (1.85e-1)"	"unprognostic (4.31e-3)"	"unprognostic (8.59e-2)"	"unprognostic (5.89e-4)"	"unprognostic (4.49e-1)"	"unprognostic (1.09e-3)"		"unprognostic (3.92e-3)"	"unprognostic (5.43e-3)"	"unprognostic (1.20e-1)"	"unprognostic (7.30e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.04e-9)"	"unprognostic (7.02e-2)"	"unprognostic (8.63e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.47e-1)"	0.3	0.2	0.3	0.4	0.3	0.1	2.2	0.3	0.4	0.3	0.2	0.3	1.0	1.3	0.3	0.4	1.0	0.2	0.3	0.7	0.2	0.1	0.0	44.3	0.5	0.3	0.2	0.3	1.8	0.1	0.0	0.0	0.7	0.5	0.3	0.7	0.4	0.1	1.3	0.0	0.0	2.2	1.6	0.1	0.3	0.4	0.6	0.2	3.8	0.3	0.0	1.8	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	3.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.5	1.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.3	0.0	0.0	4.0	2.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.0	0.5	0.2	0.0	0.2	0.0	0.0	3.2	0.2	0.3	0.3	0.3	0.4	0.7	0.2	0.3	0.2	0.3	0.5	0.1	0.2	0.4	0.2	96.1	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	6.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.1	0.0	0.0	1.3	0.1	0.0	0.0	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.4	0.0	0.0	2.5	0.0	1.5	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	2.1	0.2	0.1	0.0	0.0
MUC2		ENSG00000198788	"Mucin 2, oligomeric mucus/gel-forming"		11	1074875-1110511	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in some"	12	"intestine: 135.1"	"Cell type enriched"	"Detected in some"	12	"Intestinal goblet cells: 745.0"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 93.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			CAB016275	Enhanced				"Intracellular and membrane"	NA	NA					"CAB016275: AB_627970"	"unprognostic (6.37e-2)"	"unprognostic (8.32e-2)"	"unprognostic (5.76e-3)"	"unprognostic (5.09e-2)"	"unprognostic (6.18e-3)"	"unprognostic (3.39e-2)"	"unprognostic (1.71e-2)"	"unprognostic (5.76e-3)"	"unprognostic (7.87e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.37e-3)"	"unprognostic (4.20e-2)"	"unprognostic (3.64e-5)"	"unprognostic (1.38e-1)"	"unprognostic (1.22e-1)"		"unprognostic (3.10e-2)"	0.6	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	135.1	31.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	92.6	0.0	0.0	0.5	0.0	0.0	80.6	4.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	18.0	0.0	0.4	0.0	0.0	0.0	0.0	60.3	0.0	0.3	0.0	0.1	0.0	0.6	14.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	8.9	0.0	0.0	0.0	0.0	0.0	0.0	745.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	31.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.8	0.0	34.3	0.0
MYLK2	"KMLC, MLCK2, skMLCK"	ENSG00000101306	"Myosin light chain kinase 2"	Q9H1R3	20	31819308-31834689	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"skeletal muscle: 739.1"	"Cell type enriched"	"Detected in some"	5	"Skeletal myocytes: 15.9"	"Cancer enhanced"	"Detected in some"		"glioma: 1.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 4.1;RH-30: 10.5;RPMI-8226: 8.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA059704, HPA059890"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA059704: AB_2684108, HPA059890: AB_2684153"	"unprognostic (1.74e-2)"	"unprognostic (1.87e-1)"	"unprognostic (8.84e-2)"	"unprognostic (5.27e-2)"	"prognostic favorable (4.00e-4)"	"unprognostic (5.58e-2)"	"unprognostic (1.38e-7)"	"unprognostic (2.29e-1)"	"unprognostic (2.60e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.73e-2)"	"unprognostic (7.25e-11)"	"unprognostic (2.01e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.70e-2)"	0.1	0.0	0.6	0.1	0.5	0.4	0.1	0.5	0.7	0.0	0.4	0.2	0.0	0.1	0.1	4.8	0.1	0.0	0.3	0.6	0.6	0.0	0.0	0.1	0.0	0.6	0.6	0.5	0.1	5.5	0.0	0.1	0.0	0.6	1.1	0.0	0.0	2.5	0.0	739.1	0.3	0.1	0.1	0.6	0.3	0.2	0.2	0.6	0.2	0.2	60.9	0.0	0.0	0.0	0.6	0.3	0.0	0.7	0.6	0.0	0.0	0.4	0.1	0.0	0.3	0.0	0.2	0.2	0.5	0.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.6	0.3	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.0	1.3	0.8	0.5	0.1	4.1	0.1	0.6	0.5	0.3	0.5	0.0	0.3	0.6	10.5	8.8	0.0	0.1	0.5	0.5	2.7	0.1	0.0	0.1	0.1	0.1	2.1	0.2	0.7	0.4	2.4	0.0	0.8	0.2	0.1	2.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.5	0.7	0.6	0.6	0.6	0.6	0.5	0.6	0.6	0.6	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	1.2	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0
ODF3L2	"C19orf19, FLJ40059"	ENSG00000181781	"Outer dense fiber of sperm tails 3 like 2"	Q3SX64	19	463346-474983	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"skeletal muscle: 8.3;testis: 23.6"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 1184.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA067065, HPA067973"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		NA	NA			Nucleoli	"Nucleoplasm, Golgi apparatus"	"HPA067065: , HPA067973: AB_2685937"	"unprognostic (3.75e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.83e-3)"	"unprognostic (9.69e-3)"	"unprognostic (5.88e-2)"	"unprognostic (5.65e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.13e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.02e-5)"	"unprognostic (3.13e-3)"	"unprognostic (8.99e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.99e-1)"	0.3	0.3	0.7	0.0	0.7	0.0	0.3	0.4	0.9	0.1	0.2	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.3	0.5	0.5	0.2	0.3	0.2	0.0	0.7	0.6	0.4	0.1	0.1	0.0	0.1	0.2	1.3	0.2	0.0	0.1	0.0	0.0	8.3	0.1	0.2	0.0	0.4	0.7	0.1	23.6	0.7	0.0	0.3	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.4	0.9	0.5	0.5	0.7	0.6	0.4	1.3	0.4	0.7	0.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	212.8	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	5.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1184.9	8.4	0.6	0.0	1.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	7.6	5.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0
SERPINA12	"OL-64, Vaspin"	ENSG00000165953	"Serpin family A member 12"	Q8IW75	14	94487274-94517844	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"skin 1: 344.3"	"Cell type enriched"	"Detected in some"	4	"Suprabasal keratinocytes: 20.9"	"Group enriched"	"Detected in some"	5	"liver cancer: 1.8;melanoma: 2.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"Hep G2: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA		6500000				"unprognostic (1.82e-3)"				"unprognostic (6.44e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.00e-2)"		"unprognostic (5.98e-2)"	"unprognostic (2.97e-2)"	"unprognostic (7.64e-3)"				"unprognostic (6.67e-2)"			0.2	0.0	0.0	0.0	0.0	0.1	28.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	4.4	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	344.3	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	20.9	0.0	0.0	0.0	0.0	0.0
SHISA8	"C22orf17, Orf26"	ENSG00000234965	"Shisa family member 8"	B8ZZ34	22	41909554-41914667	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"adrenal gland: 14.0;brain: 45.7"	"Cell type enriched"	"Detected in some"	18	"Horizontal cells: 477.8"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	7	"cerebellum: 45.7;pons: 20.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"HEK 293: 19.3"	"Group enriched"	"Detected in many"	4	"cerebellum: 7.8;olfactory bulb: 15.7;white matter: 4.0"	"Low region specificity"	"Detected in all"			HPA059173	Uncertain					NA	NA					"HPA059173: AB_2683938"	"unprognostic (8.76e-2)"	"unprognostic (2.98e-4)"	"unprognostic (1.03e-1)"	"prognostic favorable (2.76e-4)"	"unprognostic (4.42e-2)"	"unprognostic (1.45e-3)"	"unprognostic (4.40e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.45e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.59e-2)"	"unprognostic (2.60e-2)"	"unprognostic (6.22e-4)"	"unprognostic (7.84e-2)"	0.0	14.0	1.7	0.5	0.5	0.1	0.0	45.7	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	1.2	0.5	0.9	0.4	0.0	0.1	1.2	0.9	4.0	0.3	0.0	0.0	0.1	1.7	0.0	20.2	0.1	0.0	0.3	0.8	0.0	0.3	0.3	1.6	0.0	2.4	2.5	0.2	0.2	4.9	0.0	0.1	0.1	0.7	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	2.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.5	45.7	3.2	0.5	0.9	0.9	4.0	0.3	20.2	2.4	4.9	0.8	0.1	0.0	0.0	0.3	10.8	0.0	0.0	0.0	0.0	11.5	22.7	0.0	3.7	0.0	0.0	0.0	4.2	0.0	0.5	0.0	1.9	0.0	1.1	5.2	0.5	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	7.9	0.0	0.1	0.0	0.0	0.0	477.8	25.9	0.0	0.0	0.3	0.0	1.1	0.0	0.1	0.0	0.0	0.0	1.5	0.0	1.0	1.6	0.0	0.0	0.4	0.1	0.2	0.0	0.1	0.0	4.5	0.0	0.0	0.1	1.9	2.3	0.0	0.0	0.0	0.3	0.0	0.0	0.1
SLC13A4	"SUT-1, SUT1"	ENSG00000164707	"Solute carrier family 13 member 4"	Q9UKG4	7	135681237-135729258	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"choroid plexus: 659.0"	"Cell type enriched"	"Detected in some"	4	"Syncytiotrophoblasts: 786.0"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.3"	"Region enhanced"	"Detected in many"		"hippocampal formation: 49.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HDLM-2: 30.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048582	Enhanced					NA	NA					"HPA048582: AB_2680450"	"unprognostic (2.40e-1)"	"unprognostic (2.51e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.78e-1)"	"unprognostic (7.69e-2)"	"unprognostic (3.96e-6)"	"unprognostic (3.33e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.56e-3)"	"unprognostic (9.23e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.30e-6)"	"unprognostic (1.53e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.73e-2)"	0.0	0.0	2.3	0.0	0.6	0.0	0.0	9.4	14.3	0.3	659.0	0.0	0.0	0.0	0.0	2.4	0.5	0.0	0.1	49.0	0.9	0.0	0.0	0.0	0.0	0.9	8.6	0.2	0.0	0.2	0.0	1.4	54.9	3.1	0.0	0.0	2.4	0.5	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	3.9	10.5	0.0	0.0	0.0	2.0	0.0	1.1	0.7	0.0	0.0	0.0	0.0	0.0	0.4	5.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	30.3	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.1	0.0	2.4	0.1	0.1	2.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.6	9.4	14.3	49.0	0.9	0.9	8.6	0.2	3.1	0.6	10.5	0.7	0.0	0.0	0.0	3.3	0.0	0.0	0.5	0.1	0.0	3.4	0.1	0.1	1.9	0.0	0.1	0.0	4.2	189.9	0.0	0.0	0.0	0.2	0.6	0.5	0.5	1.0	0.0	0.0	2.7	0.0	9.5	1.2	0.0	0.1	0.0	0.1	0.0	0.0	14.9	3.3	3.0	0.0	0.0	0.0	0.3	0.5	0.3	0.4	0.0	1.0	0.0	2.1	0.0	3.5	2.5	0.1	0.0	0.0	0.1	0.5	0.0	0.1	4.3	14.9	0.0	0.6	0.3	0.3	0.5	0.0	0.1	786.0	0.1	0.1	0.0	0.4
SLC2A14	"GLUT14, SLC2A3P3"	ENSG00000173262	"Solute carrier family 2 member 14"	Q8TDB8	12	7812512-7891148	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Spermatogenesis, Sugar transport, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"testis: 82.0"	"Cell type enriched"	"Detected in many"	5	"Spermatocytes: 65.7"	"Cancer enriched"	"Detected in single"	35	"testis cancer: 7.1"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 3.7;neutrophil: 3.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 18.4;CACO-2: 31.0;SuSa: 35.5"									HPA006539	Supported		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA006539: AB_1078984"	"unprognostic (2.52e-1)"	"unprognostic (4.74e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.82e-3)"	"unprognostic (8.62e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.91e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.46e-4)"	"unprognostic (3.92e-2)"	"unprognostic (3.41e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.22e-2)"	0.6	5.7	0.8	0.3	1.1	6.3	0.9	4.2	1.2	0.2	1.5	0.9	0.2	0.3	0.2	1.5	0.4	0.9	0.7	1.7	0.7	0.6	3.0	0.5	0.6	0.3	0.4	1.0	2.7	6.7	0.0	0.4	1.1	1.8	1.3	0.5	1.4	0.1	0.1	0.5	0.7	0.5	0.5	0.0	0.3	0.2	82.0	1.1	0.2	0.2	0.1	0.2	1.0	0.3	1.0	0.4	1.5	0.7	0.4	0.3	0.8	18.4	0.2	0.0	0.0	0.5	31.0	0.2	0.1	0.8	0.0	0.3	0.2	0.1	0.0	0.0	0.7	0.2	3.3	1.2	8.1	0.1	2.0	4.5	0.0	0.2	0.2	0.0	0.1	0.0	1.1	3.6	0.8	0.0	0.7	0.4	1.6	3.6	0.1	0.0	0.2	0.1	1.1	0.0	0.5	0.6	0.2	0.5	0.7	0.1	35.5	0.1	2.7	0.5	0.1	3.0	0.5	0.5	3.0	1.3	0.6	0.9	0.1	0.6	3.7	0.4	1.0	0.6	0.1	0.6	0.3	0.5	0.4	0.2	0.3	0.3	0.4	3.4	0.6	0.1	0.2	1.0	0.2	0.8	1.1	4.2	1.2	1.7	0.7	0.3	0.4	1.0	1.8	0.0	1.1	1.0	2.1	0.0	1.1	0.0	0.9	0.6	0.0	0.0	0.0	0.1	0.1	0.3	2.4	0.0	0.0	0.0	4.2	0.4	0.5	0.1	0.0	0.0	8.9	0.1	1.3	3.2	0.0	6.9	1.9	1.5	1.5	1.9	0.0	0.2	9.5	6.4	5.3	0.5	0.2	0.0	2.2	0.0	0.0	2.5	12.2	5.4	0.3	1.4	1.8	1.9	0.0	0.1	0.0	0.5	0.4	0.3	5.7	2.6	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.2	2.7	65.7	3.1	0.0	0.1	0.4	3.6	4.2	0.1	0.0
SMIM32		ENSG00000271824	"Small integral membrane protein 32"	A0A1B0GUA5	5	136191468-136193162	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	12	"brain: 14.4;intestine: 13.0;kidney: 48.4"	"Cell type enriched"	"Detected in some"	11	"Proximal tubular cells: 394.0"	"Cancer enhanced"	"Detected in many"		"renal cancer: 12.4"	"Region enhanced"	"Detected in many"		"basal ganglia: 14.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (2.35e-5)"	"unprognostic (3.08e-1)"	"unprognostic (7.74e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.11e-2)"	"unprognostic (9.13e-2)"	"prognostic favorable (1.63e-4)"	"unprognostic (1.86e-2)"		"unprognostic (1.75e-2)"	"prognostic favorable (6.13e-4)"	"unprognostic (1.51e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.85e-3)"	"unprognostic (8.05e-2)"	0.0	0.0	1.0	0.2	14.4	0.0	0.0	1.9	2.5	0.0	0.0	3.6	13.0	0.0	0.0	0.0	0.0	2.0	0.0	1.2	0.8	48.4	0.3	0.0	0.0	4.4	1.0	4.1	0.0	0.4	0.0	0.0	0.0	1.2	0.4	1.6	0.0	0.1	0.0	0.6	0.0	6.2	0.0	0.7	0.0	1.4	0.3	0.9	0.0	1.2	0.6	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	14.4	1.9	2.5	1.2	0.8	4.4	1.0	4.1	1.2	0.7	0.9	2.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.4	0.0	0.0	0.0	0.0	33.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	394.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.0
TRAV17	"TCRAV17S1, TCRAV3S1"	ENSG00000211797	"T cell receptor alpha variable 17"	A0A0B4J275	14	21997539-21998168	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	12	"lymphoid tissue: 28.1"	"Cell type enriched"	"Detected in some"	5	"T-cells: 6.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	19	"memory CD4 T-cell: 81.4;memory CD8 T-cell: 63.7;naive CD4 T-cell: 61.8;naive CD8 T-cell: 53.2;T-reg: 116.3"	"Lineage enriched"	"Detected in single"	226	"T-cells: 116.3"	"Cell line enriched"	"Detected in single"	221	"JURKAT: 22.0"	"Not detected"	"Not detected"													NA	NA						"unprognostic (8.22e-4)"	"unprognostic (4.50e-3)"	"unprognostic (1.37e-3)"	"unprognostic (2.06e-2)"		"unprognostic (2.72e-6)"	"unprognostic (6.44e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.67e-3)"	"unprognostic (8.23e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.58e-5)"	"unprognostic (1.73e-1)"	"unprognostic (8.43e-3)"	"unprognostic (8.53e-2)"	"unprognostic (2.21e-1)"	0.1	0.0	0.0	6.0	0.0	0.5	0.2	0.0	0.2	0.5	0.0	1.2	1.8	0.3	0.8	0.7	0.6	1.4	0.1	0.0	0.1	0.2	0.4	1.4	13.3	0.1	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.6	1.6	0.0	0.1	0.0	0.0	0.1	1.5	0.3	0.1	3.3	2.3	0.1	0.1	28.1	0.3	0.0	10.2	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.7	0.0	3.9	0.2	81.4	63.7	0.0	0.2	61.8	53.2	0.5	0.1	0.1	0.3	116.3	22.3	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0
TRAV23DV6	"TCRAV17S1, TRAV23/DV6"	ENSG00000211803	"T cell receptor alpha variable 23/delta variable 6"	A0A075B6W5	14	22086407-22086961	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	12	"lymphoid tissue: 26.5"	"Cell type enriched"	"Detected in single"	20	"T-cells: 4.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"memory CD4 T-cell: 79.3;naive CD4 T-cell: 85.6;T-reg: 65.6"	"Lineage enriched"	"Detected in many"	56	"T-cells: 85.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (7.79e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.69e-1)"		"unprognostic (2.66e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.19e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.56e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.47e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.33e-1)"	0.5	0.1	0.0	6.4	0.0	1.1	0.5	0.0	0.0	0.5	0.0	1.2	2.1	0.2	0.0	1.0	0.5	1.3	0.3	0.0	0.0	0.0	0.5	1.8	10.4	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.6	1.8	0.0	0.5	0.1	0.1	0.1	1.0	0.6	0.0	3.3	2.2	0.0	0.0	26.5	0.6	0.0	10.9	1.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	2.0	0.0	3.2	0.0	79.3	19.6	0.0	0.1	85.6	21.4	1.5	0.1	0.0	0.0	65.6	20.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0
TRAV8-4		ENSG00000211790	"T cell receptor alpha variable 8-4"	P01737	14	21894433-21895030	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	12	"lymphoid tissue: 21.0"	"Cell type enriched"	"Detected in single"	15	"T-cells: 4.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"memory CD4 T-cell: 184.9;memory CD8 T-cell: 101.6;naive CD4 T-cell: 154.6;naive CD8 T-cell: 74.5;T-reg: 235.1"	"Lineage enriched"	"Detected in many"	49	"T-cells: 235.1"	"Cell line enriched"	"Detected in single"	1440	"JURKAT: 405.7"															NA	NA						"unprognostic (3.41e-4)"	"unprognostic (1.74e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.14e-4)"		"unprognostic (3.47e-4)"	"unprognostic (5.06e-2)"	"unprognostic (1.42e-2)"	"unprognostic (5.10e-4)"	"unprognostic (4.24e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.51e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.60e-1)"	"unprognostic (5.58e-2)"	0.3	0.0	0.0	6.5	0.0	0.6	0.5	0.0	0.1	0.3	0.3	1.0	0.8	0.0	0.2	0.1	0.2	0.8	0.2	0.0	0.0	0.1	0.3	0.8	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.3	0.1	0.1	0.6	1.7	0.3	0.0	2.9	1.5	0.2	0.0	21.0	0.2	0.1	7.7	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	405.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.1	1.4	0.2	24.1	1.9	184.9	101.6	0.1	0.2	154.6	74.5	4.7	0.3	0.3	0.3	235.1	45.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.7	0.0	0.0	0.0
UGT1A7	UGT1G	ENSG00000244122	"UDP glucuronosyltransferase family 1 member A7"	Q9HAW7	2	233681938-233773299	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"esophagus: 84.4"	"Cell type enriched"	"Detected in some"	4	"Squamous epithelial cells: 40.7"	"Group enriched"	"Detected in some"	10	"cervical cancer: 1.2;head and neck cancer: 2.3;lung cancer: 3.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"SiHa: 112.2"															NA	NA							"unprognostic (6.27e-2)"	"unprognostic (1.02e-1)"			"unprognostic (7.76e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.09e-1)"			"unprognostic (7.92e-2)"		"unprognostic (1.71e-7)"	"unprognostic (2.14e-1)"			"unprognostic (4.57e-2)"	0.1	1.3	0.3	0.0	0.1	0.0	0.4	0.6	0.9	0.6	0.3	0.1	0.2	0.0	0.0	84.4	0.0	0.0	0.0	0.3	0.1	0.6	4.3	0.0	0.0	0.4	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.2	5.7	0.0	0.0	3.4	0.1	0.0	0.2	0.0	0.1	0.0	0.5	0.0	0.0	0.0	5.3	0.4	7.1	0.9	0.0	1.8	0.1	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	112.2	7.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.6	0.9	0.3	0.1	0.4	0.3	0.3	0.5	0.2	0.5	0.9	0.0	0.0	0.0	0.0	0.0	0.4	2.3	1.3	4.6	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.8	0.7	0.3	0.2	0.0	0.0	0.0	0.2	0.0	0.0	40.7	1.7	0.0	0.0	0.0	0.5	8.5
ACSM5	FLJ20581	ENSG00000183549	"Acyl-CoA synthetase medium chain family member 5"	Q6NUN0	16	20409534-20441336	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"liver: 278.8"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 237.8"	"Group enriched"	"Detected in some"	7	"liver cancer: 20.5;renal cancer: 9.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC diff: 5.3;ASC TERT1: 11.5;HSkMC: 13.8;U-87 MG: 8.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA041435	Uncertain		Uncertain	Vesicles		NA	NA			Vesicles		"HPA041435: AB_10961121"	"unprognostic (1.01e-1)"	"unprognostic (1.61e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.11e-3)"	"unprognostic (2.09e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.57e-1)"	25.8	2.5	6.4	0.7	4.7	0.6	10.7	4.6	4.7	2.1	2.8	2.9	0.8	1.2	7.1	1.0	1.7	2.3	2.5	5.2	6.6	25.6	278.8	2.2	1.9	7.1	5.9	3.2	0.8	0.6	1.0	0.5	1.4	6.5	0.6	1.3	0.5	0.9	0.9	14.0	2.1	2.0	1.0	6.2	4.6	3.4	0.9	7.5	0.7	4.3	1.7	0.7	1.1	2.2	8.4	0.0	0.0	0.1	0.1	5.3	11.5	0.0	0.1	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	13.8	0.0	0.8	0.1	0.2	0.0	0.0	0.1	0.5	1.6	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	2.2	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	8.5	0.1	0.0	0.1	0.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	6.4	4.7	4.6	4.7	5.2	6.6	7.1	5.9	3.2	6.5	6.2	7.5	8.4	0.4	0.0	0.0	1.0	0.5	0.0	0.1	0.0	0.0	0.0	0.8	0.4	3.8	1.5	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.5	0.5	0.0	0.3	1.2	0.0	13.5	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.3	6.1	237.8	3.7	0.0	0.2	0.0	0.0	11.7	1.5	0.8	9.3	3.5	0.0	7.5	1.3	0.9	0.0	1.5	0.1	0.0	0.0	6.0	0.0	0.2	0.0	52.1	0.0	0.1	0.0	11.3	0.3	0.2	0.3	0.1	0.6	0.0	0.7	0.9	0.1	0.2
ANKRD1	"ALRP, C-193, CARP, CVARP, MCARP"	ENSG00000148677	"Ankyrin repeat domain 1"	Q15327	10	90912096-90921087	"Metabolic proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"heart muscle: 6603.1"	"Cell type enriched"	"Detected in some"	15	"Cardiomyocytes: 13820.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 7.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 474.5;EFO-21: 1248.9;hTERT-RPE1: 679.8;LHCN-M2: 1573.6;SuSa: 469.1;TIME: 2206.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038736	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	Yes			"Nucleoli fibrillar center"	Nucleoplasm	"HPA038736: AB_2676184"	"unprognostic (2.45e-1)"	"unprognostic (6.14e-3)"	"unprognostic (2.24e-1)"	"unprognostic (4.39e-1)"	"unprognostic (9.14e-3)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (1.28e-2)"	"unprognostic (6.63e-3)"	"unprognostic (2.19e-1)"	"unprognostic (3.27e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.40e-1)"	"unprognostic (2.72e-5)"	"unprognostic (3.40e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.16e-3)"	0.9	0.7	0.0	0.4	0.1	0.0	1.9	0.2	0.2	0.4	0.7	0.6	0.0	0.4	0.0	0.6	0.1	1.3	6603.1	0.0	0.9	0.6	1.6	49.0	2.6	0.2	0.2	0.0	0.8	4.8	0.2	1.2	4.2	0.2	6.8	0.0	0.0	8.8	0.1	575.7	1.6	0.6	2.1	0.0	0.6	1.0	0.9	0.7	1.5	1.8	20.7	0.0	1.2	0.5	0.1	37.2	10.8	6.6	0.3	5.8	6.7	0.5	21.5	2.2	6.0	10.8	474.5	17.9	0.3	1248.9	1.8	48.5	13.3	2.3	3.1	15.7	1.4	1.2	0.2	2.9	148.5	27.7	0.0	0.0	44.2	0.1	9.5	21.6	679.8	437.8	0.0	0.3	0.0	1573.6	0.4	0.0	0.0	1.3	2.7	0.3	0.0	104.3	0.0	3.9	0.5	0.1	0.0	0.3	0.4	1.2	469.1	0.3	1.9	2206.7	4.1	163.9	3.2	175.0	0.0	1.2	3.0	0.9	0.6	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.9	0.2	0.2	0.0	0.2	0.0	0.7	0.1	0.0	913.5	42.0	0.0	0.0	0.0	3.5	18.5	0.0	0.0	0.0	0.0	13820.4	7.2	6.6	0.0	0.0	0.6	0.0	0.0	0.0	66.3	5.7	9.4	0.2	83.6	0.0	0.0	0.0	0.2	0.2	243.5	0.0	4.6	3.8	1.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.4	0.0	0.1	1.0	0.0	0.0	74.5	100.9	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.1
C4BPB	C4BP	ENSG00000123843	"Complement component 4 binding protein beta"	P20851	1	207088860-207099993	"Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"liver: 475.2"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 597.6"	"Cancer enriched"	"Detected in many"	19	"liver cancer: 83.7"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	16	"CACO-2: 116.4;HeLa: 46.2;Hep G2: 151.6;OE19: 57.1"					"Not detected"	"Not detected"			"HPA000925, HPA051620"	Approved		Uncertain	"Golgi apparatus"	"Secreted to blood"	NA	NA	265000000000	1100000000	"Golgi apparatus"		"HPA000925: , HPA051620: AB_2681554"	"unprognostic (1.73e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.26e-1)"	"unprognostic (2.07e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.54e-2)"	"unprognostic (4.58e-3)"	"unprognostic (9.49e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.25e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.05e-2)"	"unprognostic (8.25e-2)"	3.1	0.1	0.0	3.4	0.0	0.0	1.9	0.0	0.1	2.8	0.0	2.8	3.8	0.1	0.0	0.2	0.5	3.1	0.0	0.0	0.0	0.4	475.2	1.5	0.4	0.0	0.0	0.0	44.6	9.2	0.0	0.0	6.3	0.1	0.0	1.8	0.0	0.5	0.0	0.1	0.1	4.4	0.7	0.0	0.4	8.5	0.7	0.0	0.1	0.0	0.1	0.2	0.4	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	116.4	5.8	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	46.2	151.6	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.6	0.3	0.0	0.0	2.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	12.8	2.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	7.3	2.2	0.5	54.3	3.2	0.0	0.0	1.0	0.2	10.2	1.9	11.4	4.1	0.7	0.1	0.8	1.8	8.0	0.1	88.8	0.3	3.4	5.6	0.8	0.0	0.3	9.7	597.6	2.1	0.0	0.2	5.6	0.0	13.1	0.3	2.8	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.1	69.2	15.9	0.0	0.1	0.2	4.3	0.0	2.2	0.0	0.0	1.1	0.4	0.1	0.4	0.0	0.0	0.1	1.1	143.8	4.8	0.1
CCDC17	FLJ33084	ENSG00000159588	"Coiled-coil domain containing 17"	Q96LX7	1	45620044-45624057	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"fallopian tube: 36.3"	"Cell type enriched"	"Detected in many"	5	"Respiratory ciliated cells: 374.1"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA028338	Enhanced					NA	NA					"HPA028338: AB_10669641"	"unprognostic (3.53e-5)"	"unprognostic (7.40e-2)"	"unprognostic (3.08e-3)"	"unprognostic (3.55e-3)"	"unprognostic (3.31e-1)"	"unprognostic (9.21e-3)"	"unprognostic (6.97e-2)"	"unprognostic (1.30e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.46e-3)"	"unprognostic (2.91e-1)"	"unprognostic (8.37e-7)"	"unprognostic (1.20e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.92e-1)"	"unprognostic (5.91e-3)"	0.0	0.1	0.2	0.1	0.2	0.4	0.0	0.2	0.8	1.1	0.1	0.1	0.2	0.1	0.0	0.0	36.3	0.0	0.1	0.1	0.2	0.1	0.2	3.4	0.1	0.6	0.4	0.1	0.0	0.1	0.0	0.0	0.2	0.5	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.1	0.2	0.2	0.1	0.1	0.1	0.3	0.0	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.3	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.8	0.1	0.2	0.6	0.4	0.1	0.5	0.2	0.3	0.2	3.1	3.2	4.1	1.0	0.4	1.1	0.3	14.2	0.6	0.1	2.4	1.7	1.6	0.0	23.4	0.0	0.0	0.6	2.0	4.6	5.9	0.5	0.0	74.5	1.1	2.1	1.2	0.4	0.1	0.9	0.2	1.9	1.1	3.2	1.3	0.3	1.1	0.9	0.6	0.0	0.1	2.3	10.2	0.6	1.4	0.4	1.2	1.8	0.0	1.0	1.0	0.4	0.0	0.0	1.7	1.3	3.2	2.2	0.3	0.6	4.2	1.1	374.1	0.5	0.0	0.9	5.2	0.8	0.7	0.9	0.6	0.5	0.8	0.7	2.6	0.4
CD1C	CD1	ENSG00000158481	"CD1c molecule"	P29017	1	158289923-158294774	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"lymphoid tissue: 131.6"	"Cell type enriched"	"Detected in some"	6	"Langerhans cells: 551.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"memory B-cell: 84.1;myeloid DC: 324.9"	"Group enriched"	"Detected in many"	8	"B-cells: 84.1;dendritic cells: 324.9"	"Group enriched"	"Detected in some"	10	"JURKAT: 14.8;MOLT-4: 49.4"									HPA068359			Approved	"Endoplasmic reticulum,Golgi apparatus,Vesicles"		NA	NA		200000	"Golgi apparatus, Vesicles"	"Endoplasmic reticulum"	"HPA068359: "	"unprognostic (2.55e-3)"	"prognostic favorable (1.79e-5)"	"unprognostic (1.75e-5)"	"unprognostic (3.09e-5)"	"unprognostic (3.12e-2)"	"unprognostic (8.13e-3)"	"unprognostic (2.01e-1)"	"unprognostic (3.80e-3)"	"unprognostic (7.11e-3)"	"unprognostic (1.87e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.99e-1)"	2.7	0.8	0.0	17.5	0.0	1.2	5.1	0.0	0.3	2.3	0.0	3.5	2.0	2.4	0.6	4.6	1.9	7.8	2.1	0.0	0.1	1.3	4.2	6.5	26.4	0.0	0.0	0.0	0.9	0.7	0.6	0.2	0.1	0.0	1.8	9.5	0.0	2.9	1.3	1.0	12.3	12.1	3.1	0.0	23.2	3.7	1.0	0.0	131.6	0.7	1.1	38.5	4.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.0	0.0	0.0	49.4	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.9	0.0	0.6	26.8	0.1	0.1	24.7	0.3	84.1	0.1	0.0	324.9	49.1	0.2	0.0	1.1	4.1	3.7	1.5	0.5	15.4	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	5.2	0.0	26.6	13.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	4.1	0.0	0.1	1.5	0.0	0.8	0.0	0.0	0.1	1.4	0.0	0.0	3.8	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	7.1	551.4	4.5	0.0	91.2	19.6	0.0	11.8	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	1.5	0.0	0.0	0.2	0.4	0.1	0.3	0.0	7.4	0.0	1.9	0.0	0.0	0.0
CDRT15L2		ENSG00000214819	"CMT1A duplicated region transcript 15 like 2"	A8MXV6	17	20579724-20580911	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"testis: 15.7"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 120.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hippocampal formation: 1.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	120.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.4	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CGB1		ENSG00000267631	"Chorionic gonadotropin subunit beta 1"	A6NKQ9	19	49035569-49036895	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"pancreas: 2.8;pituitary gland: 4.3"	"Cell type enriched"	"Detected in single"	77	"Syncytiotrophoblasts: 69.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HMC-1: 17.7"									"HPA038925, HPA038934"	Uncertain		Approved	Cytosol	"Secreted to blood"	NA	NA			Cytosol		"HPA038925: AB_2676272, HPA038934: AB_2676277"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.8	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	17.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.4	0.0	3.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	69.9	0.0	0.0	0.0	0.0
CHGB	"SCG1, SgI"	ENSG00000089199	"Chromogranin B"	P05060	20	5911510-5925353	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"adrenal gland: 3499.0;pituitary gland: 1436.4"	"Cell type enriched"	"Detected in many"	5	"Enteroendocrine cells: 1036.1"	"Cancer enriched"	"Detected in many"	6	"pancreatic cancer: 154.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	23	"SCLC-21H: 355.0;SH-SY5Y: 541.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008759, CAB009403, HPA012602"	Enhanced	Supported	Enhanced	Vesicles	"Intracellular and membrane"	NA	NA		6500000	Vesicles		"CAB009403: AB_2081255, HPA008759: AB_1846704, HPA012602: AB_1846706"	"unprognostic (1.79e-3)"	"unprognostic (7.72e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.68e-2)"	"prognostic unfavorable (1.89e-4)"	"unprognostic (7.96e-3)"	"unprognostic (2.86e-1)"	"unprognostic (6.18e-3)"	"unprognostic (7.93e-2)"	"prognostic favorable (9.96e-4)"	"unprognostic (8.56e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.81e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.01e-2)"	27.8	3499.0	25.1	5.4	19.8	0.8	2.2	137.0	102.7	0.4	0.0	8.0	60.8	1.6	4.2	0.6	13.8	0.4	38.6	113.7	77.4	8.3	0.7	2.4	3.1	72.8	104.5	20.4	26.1	93.6	6.4	1436.4	0.7	138.1	5.4	14.3	57.4	6.2	3.9	11.1	1.7	31.8	1.0	6.4	0.4	134.4	15.0	35.0	4.0	9.9	0.9	1.4	0.4	2.3	218.1	0.0	7.9	0.9	0.0	0.2	0.2	0.4	0.2	0.0	0.1	0.0	1.9	0.0	0.0	4.3	0.0	4.9	0.1	0.0	0.1	0.1	0.6	0.1	2.6	0.0	1.6	0.1	4.2	0.2	1.5	0.0	0.0	2.1	0.1	0.1	0.2	0.4	0.1	1.0	0.0	0.1	0.9	19.7	1.3	0.0	0.1	0.0	0.4	0.5	0.2	355.0	541.8	0.0	0.5	0.4	2.1	0.3	0.4	0.3	0.1	6.4	0.4	3.3	0.0	0.7	2.7	0.5	3.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	25.1	19.8	137.0	102.7	113.7	77.4	72.8	104.5	20.4	138.1	6.4	35.0	218.1	0.0	3.2	2.4	7.5	0.3	4.2	9.9	0.8	0.0	93.3	0.1	0.3	114.4	0.0	0.7	69.9	20.9	0.1	0.0	1.6	1.9	0.5	7.1	0.2	0.7	3.0	1036.1	0.0	31.6	0.4	0.0	18.9	4.1	0.3	0.0	202.8	0.0	0.3	0.1	75.7	28.8	61.9	65.1	0.3	9.5	8.3	0.9	1.6	7.2	9.4	1.1	13.7	1.0	7.5	5.2	22.9	17.7	0.4	0.0	3.3	3.2	0.3	4.4	75.6	13.1	3.0	1.6	76.6	41.8	0.0	3.7	0.3	1.0	3.0	2.2	4.2
CLC	"Gal-10, LGALS10, MGC149659"	ENSG00000105205	"Charcot-Leyden crystal galectin"	Q05315	19	39731255-39738029	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"bone marrow: 456.3"	"Cell type enriched"	"Detected in some"	15	"Erythroid cells: 127.8"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 3.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in all"	312	"basophil: 28756.2;eosinophil: 21481.0"	"Lineage enriched"	"Detected in all"	2254	"granulocytes: 28756.2"	"Cell line enriched"	"Detected in some"	12	"HMC-1: 7553.4"					"Not detected"	"Not detected"			HPA041751	Enhanced					NA	NA		400000			"HPA041751: AB_10793973"		"unprognostic (4.53e-2)"	"unprognostic (3.04e-2)"		"unprognostic (4.09e-2)"	"unprognostic (1.45e-1)"		"unprognostic (2.72e-1)"		"unprognostic (1.34e-2)"	"unprognostic (6.60e-2)"		"unprognostic (2.21e-1)"	"unprognostic (4.28e-2)"	"unprognostic (5.74e-2)"		"unprognostic (1.24e-1)"	2.0	0.1	0.0	30.3	0.0	456.3	0.3	0.2	0.4	0.3	0.0	10.3	25.6	0.3	0.1	0.9	1.8	16.7	0.5	0.0	0.3	0.3	4.9	6.3	1.8	0.1	0.0	0.0	0.1	0.4	0.2	0.4	1.4	0.0	0.1	8.2	0.0	0.9	0.2	0.2	1.5	41.9	24.7	0.1	11.4	15.8	0.6	0.6	7.3	0.3	0.2	0.2	24.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	4.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	619.0	7553.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	3.5	0.7	0.9	0.0	0.0	0.6	0.3	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	2.3	0.0	0.0	3.8	0.0	2.4	28756.2	5.0	21481.0	2.5	11.1	6.0	4.8	6.9	1.7	5.3	6.2	3.1	9.2	80.3	2.5	12.7	7.8	4.0	100.3	0.0	0.0	0.2	0.4	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	127.8	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.2	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.3	0.2	0.0	0.0	0.0
CLEC18C	"MGC34761, MRCL3"	ENSG00000157335	"C-type lectin domain family 18 member C"	Q8NCF0	16	70173322-70187361	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"kidney: 17.2;testis: 4.3"	"Cell type enriched"	"Detected in single"	46	"Proximal tubular cells: 23.3"	"Cancer enriched"	"Detected in single"	9	"renal cancer: 1.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA048976	Uncertain				"Secreted to blood"	NA	NA					"HPA048976: AB_2680582"		"unprognostic (3.90e-1)"		"unprognostic (3.03e-1)"	"unprognostic (1.20e-4)"					"unprognostic (5.55e-2)"	"unprognostic (5.72e-3)"	"unprognostic (2.92e-1)"	"unprognostic (7.64e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.61e-3)"		"unprognostic (6.98e-2)"	0.0	0.1	0.3	0.0	0.3	0.0	0.0	0.9	0.4	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.2	17.2	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.9	0.4	0.3	0.2	0.2	0.1	0.1	0.4	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
CNGA1	"CNCG, CNCG1, CNG1, RCNC1, RCNCa, RP49"	ENSG00000198515	"Cyclic nucleotide gated channel subunit alpha 1"	P29973	4	47935977-48016681	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sensory transduction, Transport, Vision"	"Ion channel, Ligand-gated ion channel"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"retina: 266.7"	"Cell type enriched"	"Detected in many"	6	"Rod photoreceptor cells: 1139.7"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 4.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 9.2;RT4: 7.2;U-2 OS: 3.0"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.0"	"Not detected"	"Not detected"			HPA076168			Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"	Nucleoplasm	"HPA076168: AB_2686781"	"unprognostic (2.68e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.59e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.48e-6)"	"unprognostic (1.86e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.66e-2)"	"unprognostic (8.23e-2)"	3.3	0.4	0.5	0.8	1.3	0.3	1.5	1.6	0.9	1.0	0.6	3.6	2.3	0.4	9.4	9.1	4.1	1.1	0.4	0.8	0.7	2.4	23.7	0.3	0.1	0.6	0.5	0.6	0.1	0.8	4.2	0.3	1.0	0.8	2.6	2.4	266.7	4.4	1.7	5.1	5.2	6.3	0.3	0.1	3.4	2.8	0.4	0.7	0.3	0.7	1.3	0.5	3.7	1.9	0.7	2.3	0.9	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.2	2.0	9.2	0.1	0.5	0.0	2.7	1.4	0.2	0.3	0.1	0.0	0.6	0.0	0.2	0.8	0.0	0.1	0.2	0.0	0.4	0.0	0.0	0.9	0.0	0.8	0.7	0.5	0.2	0.9	0.0	0.1	0.4	1.1	2.2	0.1	0.0	0.1	0.4	7.2	0.3	0.0	0.2	0.5	0.1	0.2	0.9	0.0	0.3	0.2	3.0	0.1	0.1	0.7	0.8	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.2	0.3	0.0	0.5	0.0	0.0	0.5	1.3	1.6	0.9	0.8	0.7	0.6	0.5	0.6	0.8	0.1	0.7	0.7	7.3	0.0	0.0	0.7	0.1	0.1	1.8	0.5	0.6	97.7	8.7	1.8	0.7	5.7	3.4	62.5	91.8	0.0	0.0	10.6	0.0	10.1	0.4	2.5	0.4	8.7	0.0	2.7	1.2	6.6	0.0	0.3	0.0	3.6	0.0	0.0	0.0	38.0	1.7	45.4	1.1	4.0	0.0	0.8	0.0	0.1	0.3	0.5	0.0	7.5	0.0	163.9	0.0	0.0	0.2	2.1	16.4	0.0	0.0	3.7	24.5	0.4	0.8	1139.7	0.0	0.6	17.1	0.6	1.3	10.3	2.7	0.3	0.2	0.1	4.7	35.1
DHH	"HHG-3, MGC35145"	ENSG00000139549	"Desert hedgehog signaling molecule"	O43323	12	49086656-49094801	"Disease related genes, Human disease related genes, Predicted secreted proteins"		"Developmental protein, Hydrolase, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"testis: 16.8"	"Cell type enriched"	"Detected in some"	7	"Granulosa cells: 17.1"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"AN3-CA: 1.8;EFO-21: 2.3;HUVEC TERT2: 1.5;K-562: 5.6;TIME: 2.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	6	"spinal cord: 8.2"						"Secreted in male reproductive system"	NA	NA						"unprognostic (7.56e-2)"	"unprognostic (2.05e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.93e-3)"	"unprognostic (2.36e-4)"	"unprognostic (1.29e-1)"	"unprognostic (7.22e-3)"	"unprognostic (8.21e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.97e-2)"	0.7	0.2	0.3	0.5	0.3	0.0	0.7	0.7	1.4	0.4	0.8	0.3	0.0	0.6	0.2	0.3	0.4	0.3	0.6	0.3	0.3	0.2	0.1	0.5	0.1	0.5	0.4	0.1	0.3	0.1	0.0	0.6	0.6	0.4	0.4	0.1	0.0	0.3	0.3	0.1	0.3	0.4	0.4	0.6	0.2	0.3	16.8	0.4	0.0	0.3	0.4	0.0	0.7	0.5	1.1	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.7	1.4	0.3	0.3	0.5	0.4	0.1	0.4	0.6	0.4	1.1	1.6	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	2.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	17.1	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.3	1.0	0.7	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0
DHODH		ENSG00000102967	"Dihydroorotate dehydrogenase (quinone)"	Q02127	16	72008588-72027664	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Pyrimidine biosynthesis"	Oxidoreductase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	11	"liver: 106.7"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 124.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010123, HPA011942"	Approved		Enhanced	Nucleoplasm,Mitochondria,Cytosol		NA	NA			Mitochondria	"Nucleoplasm, Cytosol"	"HPA010123: AB_1847648, HPA011942: AB_1847649"	"unprognostic (4.88e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.10e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.40e-2)"	"unprognostic (9.26e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.81e-1)"	7.5	4.9	2.9	4.3	3.3	3.9	5.9	3.2	3.3	4.1	3.4	5.5	3.9	5.5	2.9	4.2	6.1	2.3	9.7	2.6	2.1	8.0	106.7	4.0	4.2	3.2	3.0	2.1	5.0	4.2	6.3	2.6	2.7	3.1	4.0	5.8	3.2	5.5	4.5	10.1	4.5	3.2	5.7	1.9	4.1	4.2	3.7	2.6	3.9	4.1	8.2	5.5	4.0	3.4	5.0	12.5	25.7	6.9	12.1	3.8	5.0	13.9	10.5	4.2	15.6	11.6	20.4	11.1	27.8	13.6	5.7	8.6	12.5	13.7	11.4	18.2	6.0	13.3	15.4	12.6	20.3	10.6	21.4	10.8	4.9	11.3	18.6	19.7	4.7	11.3	18.3	23.9	4.4	9.7	32.7	20.2	17.0	15.9	21.1	10.0	24.9	9.6	29.4	9.4	7.8	8.5	10.2	14.1	14.8	6.8	8.7	13.0	10.3	5.1	14.1	8.3	13.1	15.2	8.8	18.7	46.3	7.1	22.4	12.8	6.1	8.4	1.0	9.4	8.8	12.9	12.0	8.5	9.3	14.5	11.7	11.7	12.6	2.1	10.1	6.3	13.5	8.0	7.2	2.9	3.3	3.2	3.3	2.6	2.1	3.2	3.0	2.1	3.1	1.9	2.6	5.0	6.3	3.2	13.1	1.6	7.1	5.6	7.8	11.2	6.8	5.6	6.6	7.1	14.8	15.7	5.5	7.3	4.2	12.3	6.9	1.6	5.9	10.3	2.9	3.8	6.3	9.1	1.2	7.8	2.0	5.1	12.4	7.4	2.6	3.2	8.2	10.2	5.3	124.1	7.9	3.3	2.3	6.6	10.2	6.0	3.1	3.6	2.8	3.3	12.4	1.0	3.8	5.2	8.2	4.0	4.4	5.9	2.4	2.2	4.6	11.2	1.0	20.8	8.1	5.2	0.0	9.7	9.1	6.8	8.1	5.0	3.8	2.9	4.3	13.5	6.7	4.2
DYNAP	"C18orf26, FLJ39106"	ENSG00000178690	"Dynactin associated protein"	Q8N1N2	18	54587757-54599493	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"esophagus: 29.6"	"Cell type enriched"	"Detected in single"	4	"Squamous epithelial cells: 1.7"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"Karpas-707: 12.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA011148	Uncertain					NA	NA					"HPA011148: AB_1845609"		"unprognostic (9.88e-2)"		"unprognostic (2.51e-2)"		"unprognostic (1.75e-3)"				"unprognostic (1.45e-1)"					"unprognostic (8.09e-3)"			0.8	0.4	1.7	0.6	1.4	2.2	0.6	2.3	2.6	0.4	0.0	0.6	0.6	1.0	2.1	29.6	0.5	0.7	1.0	1.6	1.0	0.9	0.8	0.5	1.1	0.9	0.4	0.7	0.8	0.5	0.3	0.0	0.4	1.2	0.3	0.7	2.6	2.0	0.5	0.9	1.1	0.5	0.8	0.1	2.4	0.4	1.0	1.0	0.3	0.5	0.4	1.9	0.3	0.2	2.5	0.5	0.2	1.3	0.6	0.6	1.4	1.3	0.3	0.5	1.0	1.0	0.7	0.5	0.7	0.5	0.6	1.1	0.5	0.9	0.0	0.5	0.2	0.2	0.2	0.9	0.4	0.5	0.7	0.6	0.6	0.1	0.9	0.3	0.3	0.2	0.6	1.0	12.9	0.1	0.2	0.5	0.4	2.0	0.2	0.3	0.5	1.5	0.6	0.3	0.7	0.5	0.7	0.2	0.3	2.4	0.9	0.4	0.8	2.2	0.4	2.4	0.5	0.4	0.5	0.4	1.0	0.6	0.3	0.3	0.3	0.3	0.6	0.2	0.3	0.1	0.2	0.1	0.1	0.1	0.4	0.1	0.1	0.8	0.2	0.8	0.2	0.0	0.0	1.7	1.4	2.3	2.6	1.6	1.0	0.9	0.4	0.7	1.2	0.1	1.0	2.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0
GNB1		ENSG00000078369	"G protein subunit beta 1"	P62873	1	1785285-1891117	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins, Transporters"		Transducer	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	11	"retina: 2652.0"	"Cell type enriched"	"Detected in all"	5	"Rod photoreceptor cells: 1373.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040736	Supported		Approved	"Golgi apparatus,Plasma membrane"		NA	NA		1900000	"Plasma membrane"	"Golgi apparatus"	"HPA040736: AB_2677106"	"unprognostic (9.49e-2)"	"unprognostic (4.91e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.34e-1)"	"unprognostic (9.07e-3)"	"prognostic unfavorable (3.61e-6)"	"unprognostic (1.99e-2)"	"unprognostic (3.60e-1)"	"unprognostic (7.27e-2)"	"unprognostic (8.47e-3)"	"unprognostic (1.95e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.90e-2)"	179.7	125.0	162.0	181.5	210.6	149.0	120.8	149.3	232.6	125.3	95.1	167.3	175.2	128.1	91.6	127.8	115.4	111.9	120.7	210.7	187.4	126.2	104.1	147.9	161.3	155.8	164.2	191.2	131.4	106.8	149.4	107.6	142.3	176.5	119.4	124.2	2652.0	121.6	120.0	67.4	112.7	209.9	157.5	136.4	143.9	130.8	99.9	168.3	168.8	114.6	97.9	146.8	154.0	103.6	202.4	373.2	344.2	400.2	280.4	222.4	242.4	154.4	515.4	339.9	456.2	355.2	282.8	361.8	385.5	369.3	522.5	258.6	192.0	405.5	373.5	411.4	595.9	199.2	375.0	308.2	325.6	279.1	227.7	394.4	216.4	256.6	437.2	402.9	306.1	376.8	298.8	236.8	337.8	440.0	230.3	501.9	177.4	230.8	190.0	275.0	482.9	308.7	306.4	310.8	227.5	489.9	556.5	477.1	306.6	420.5	272.8	214.8	305.9	579.4	399.3	267.5	314.8	379.1	227.1	432.8	888.7	341.4	470.1	230.5	11.4	13.3	21.9	9.9	16.4	9.1	9.0	9.9	11.2	13.3	9.6	6.7	7.2	22.1	12.8	17.5	22.7	12.5	8.2	162.0	210.6	149.3	232.6	210.7	187.4	155.8	164.2	191.2	176.5	136.4	168.3	202.4	172.0	70.5	42.6	57.5	67.9	86.3	51.6	47.4	33.0	149.8	65.3	57.8	60.6	52.9	42.4	75.4	175.2	44.2	124.4	140.9	46.9	88.0	29.1	93.3	112.9	131.6	122.9	40.3	102.4	100.5	99.4	77.8	52.0	121.6	53.8	101.9	95.3	60.3	100.8	180.0	101.9	95.5	40.7	152.7	114.6	33.8	76.1	128.0	53.4	115.2	119.5	250.3	73.2	70.9	110.1	175.4	91.0	88.0	75.3	100.5	167.6	67.4	41.1	1373.7	78.9	71.0	105.9	68.8	67.1	51.6	101.7	36.4	74.5	83.7	83.0	94.1
GPR179	"CSNB1E, GPR158L1"	ENSG00000277399	"G protein-coupled receptor 179"		17	38324571-38343956	"Human disease related genes, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in some"	11	"retina: 14.0"	"Cell type enriched"	"Detected in some"	11	"Bipolar cells: 25.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA017885	Uncertain					NA	NA					"HPA017885: AB_2279357"	"unprognostic (1.65e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.24e-4)"	"unprognostic (8.89e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.04e-2)"	"unprognostic (4.76e-2)"	"unprognostic (2.34e-2)"	"unprognostic (6.57e-3)"	"unprognostic (5.31e-2)"	"unprognostic (5.09e-10)"	"unprognostic (6.18e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.41e-4)"	0.0	0.0	0.9	0.0	0.7	0.0	0.0	0.3	0.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.1	1.2	0.0	0.0	0.0	0.0	0.3	0.8	0.5	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.0	14.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.4	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.3	0.8	1.1	1.2	0.3	0.8	0.5	0.5	0.8	1.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.1	0.0	0.0	0.7	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HAL	HIS	ENSG00000084110	"Histidine ammonia-lyase"	P42357	12	95972662-95996365	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Histidine metabolism"	Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"liver: 199.8;skin 1: 61.6"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 129.6"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 23.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"basophil: 56.9;neutrophil: 73.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 73.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.2;NB-4: 2.8;THP-1: 11.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA038547, HPA038548"	Enhanced		Approved	Cytosol		NA	NA		280000	Cytosol		"HPA038547: AB_10669541, HPA038548: AB_10673175"	"unprognostic (3.39e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.41e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.89e-2)"	"unprognostic (3.74e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.87e-2)"	1.4	0.3	0.1	3.0	0.1	11.6	2.2	0.2	0.4	0.8	0.3	0.4	0.6	0.4	0.0	1.0	0.7	0.6	0.3	0.1	0.1	0.3	199.8	2.3	0.5	0.1	0.1	0.0	0.2	0.9	0.1	3.0	0.4	0.1	0.2	0.4	0.0	0.6	0.1	0.2	61.6	0.8	0.5	0.1	7.7	0.4	0.1	0.1	0.5	0.2	0.6	1.4	0.5	1.4	0.1	0.4	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.1	0.0	0.1	0.6	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.3	0.3	0.1	0.0	0.0	0.4	0.4	0.0	0.6	0.3	0.2	0.1	0.2	0.3	0.0	0.1	0.1	0.0	0.1	2.8	0.9	0.1	0.4	0.2	0.1	0.0	0.1	0.6	0.1	0.3	0.3	0.0	0.0	0.0	0.0	11.4	0.1	0.1	0.1	0.1	0.1	0.4	0.5	0.1	0.0	1.7	0.0	56.9	15.1	2.4	0.0	5.7	0.0	0.0	0.0	0.0	3.4	0.1	0.0	0.0	73.3	0.7	13.6	0.3	0.2	4.4	0.1	0.1	0.2	0.4	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.0	1.1	0.0	0.6	0.1	0.1	0.1	0.0	0.0	0.1	0.3	0.7	2.8	0.3	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.1	3.2	2.0	0.4	0.0	9.7	0.2	0.2	0.7	0.1	0.5	15.0	0.0	0.1	2.5	129.6	0.3	0.0	0.1	0.1	0.0	7.7	0.8	0.0	0.0	3.5	0.0	0.0	6.3	0.0	1.0	0.0	0.0	0.0	1.3	0.0	0.4	0.2	1.2	0.7	0.1	0.0	0.0	0.2	0.2	0.1	0.0	0.0	2.8	0.0	0.6	0.0	0.3	0.1
IGFALS	ALS	ENSG00000099769	"Insulin like growth factor binding protein acid labile subunit"	P35858	16	1790413-1794971	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"liver: 117.6"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 85.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 11.1"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 1.9;U-266/70: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA040692, HPA040948"	Supported				"Secreted to blood"	NA	NA	14700000000	26000000000			"HPA040692: AB_10794067, HPA040948: AB_10794999"	"unprognostic (2.74e-3)"	"unprognostic (1.95e-1)"	"unprognostic (9.13e-2)"	"prognostic unfavorable (6.06e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.37e-2)"	"prognostic favorable (5.97e-4)"	"unprognostic (5.54e-4)"	"unprognostic (3.00e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.39e-1)"	"unprognostic (5.51e-2)"	0.2	0.2	0.6	0.3	0.8	0.4	0.4	1.4	0.7	0.4	0.7	0.6	0.3	0.3	0.1	0.1	0.7	1.6	0.2	0.3	0.3	1.0	117.6	0.8	0.0	0.7	0.6	0.2	0.7	2.5	0.0	0.7	0.0	0.9	0.5	0.1	0.2	0.8	0.1	0.5	0.8	0.6	0.0	0.4	0.3	11.0	2.0	0.4	0.9	0.9	0.0	0.0	0.4	0.2	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.9	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.5	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.0	0.7	0.0	0.0	0.1	0.5	0.0	0.0	1.7	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	1.4	0.7	0.3	0.3	0.7	0.6	0.2	0.9	0.4	0.4	1.9	0.1	0.0	0.0	1.6	0.1	0.1	0.2	0.2	0.0	0.5	0.9	0.6	1.6	14.3	0.2	0.0	6.2	0.0	0.0	0.6	0.0	2.7	1.1	0.4	0.0	0.2	0.0	0.0	0.5	0.6	0.0	0.4	8.2	0.1	0.0	0.2	2.9	85.2	0.0	0.0	0.6	14.6	0.0	1.3	0.3	1.7	0.0	0.0	1.8	0.0	0.0	0.3	1.0	0.0	0.7	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.9	0.0	0.2	0.1	0.4	0.4	0.0	0.3	0.0	0.2	0.1	0.7	0.1
INSL4	EPIL	ENSG00000120211	"Insulin like 4"	Q14641	9	5231419-5235304	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"placenta: 16.0"	"Cell type enriched"	"Detected in some"	10	"Syncytiotrophoblasts: 3575.7"	"Cancer enhanced"	"Detected in some"		"lung cancer: 1.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"A549: 24.6"									HPA065145			Approved	Vesicles	"Secreted to blood"	NA	NA			Vesicles		"HPA065145: "		"unprognostic (9.77e-2)"						"unprognostic (2.02e-1)"		"unprognostic (4.66e-1)"				"unprognostic (7.74e-2)"				0.0	0.0	0.1	0.1	0.2	0.3	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	16.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	24.6	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.4	0.0	2.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.3	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	325.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.4	0.0	0.0	0.0	0.0	26.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	38.2	0.0	0.0	0.0	0.0	0.0	1.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3575.7	0.0	0.0	0.0	0.0
KRT75	K6HF	ENSG00000170454	"Keratin 75"	O95678	12	52424070-52434371	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"skin 1: 19.5"	"Cell type enriched"	"Detected in some"	7	"Ductal cells: 20.4"	"Cancer enriched"	"Detected in many"	4	"head and neck cancer: 36.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"PC-3: 38.5;U-2 OS: 50.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA019367, HPA076201"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		1500000000	Cytosol	"Plasma membrane"	"HPA019367: AB_1852239, HPA076201: AB_2686786"	"unprognostic (2.83e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.79e-2)"	"unprognostic (8.85e-3)"	"unprognostic (2.67e-1)"		"unprognostic (2.17e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.60e-2)"	"unprognostic (9.20e-2)"	"unprognostic (5.19e-2)"		"unprognostic (2.45e-1)"	"unprognostic (8.98e-2)"		"unprognostic (1.94e-1)"	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	50.0	0.0	0.1	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	1.6	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	20.4	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2
LCE1A	LEP1	ENSG00000186844	"Late cornified envelope 1A"	Q5T7P2	1	152827473-152828097	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"skin 1: 257.7"	"Cell type enriched"	"Detected in some"	14	"Suprabasal keratinocytes: 40.3"	"Cancer enriched"	"Detected in some"	6	"melanoma: 14.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA											"unprognostic (3.82e-2)"			"unprognostic (1.70e-1)"									0.1	0.0	0.0	0.0	0.0	0.0	23.5	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	257.7	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	40.3	0.0	0.1	0.0	0.0	0.0
LCE2C	LEP11	ENSG00000187180	"Late cornified envelope 2C"	Q5TA81	1	152675295-152676574	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"skin 1: 255.1"	"Cell type enriched"	"Detected in single"	35	"Suprabasal keratinocytes: 14.2"	"Cancer enriched"	"Detected in some"	5	"melanoma: 9.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA											"unprognostic (1.47e-2)"			"unprognostic (7.00e-2)"									0.1	0.0	0.0	0.0	0.0	0.1	22.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	255.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	1.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0
MCEMP1	"C19orf59, MGC132456"	ENSG00000183019	"Mast cell expressed membrane protein 1"	Q8IX19	19	7676628-7679826	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"bone marrow: 66.5;lung: 74.9;lymphoid tissue: 35.4"	"Cell type enriched"	"Detected in some"	4	"Macrophages: 147.5"	"Cancer enhanced"	"Detected in many"		"lung cancer: 3.7"	"Region enhanced"	"Detected in single"		"cerebral cortex: 2.0"	"Group enriched"	"Detected in some"	5	"classical monocyte: 102.1;neutrophil: 45.9"	"Group enriched"	"Detected in many"	5	"granulocytes: 45.9;monocytes: 102.1"	"Group enriched"	"Detected in some"	6	"THP-1: 53.7;U-937: 166.6"	"Region enhanced"	"Detected in single"		"cerebellum: 1.3"	"Not detected"	"Not detected"			HPA014731	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA014731: AB_1845619"	"unprognostic (4.84e-2)"	"unprognostic (9.81e-4)"	"unprognostic (2.41e-1)"	"unprognostic (4.36e-2)"	"unprognostic (8.85e-3)"	"unprognostic (2.62e-3)"	"unprognostic (5.57e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.77e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.69e-5)"	"unprognostic (1.15e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.93e-2)"	"unprognostic (7.95e-2)"	4.1	0.5	0.0	19.9	0.0	66.5	0.5	0.0	2.0	0.1	0.1	0.4	0.2	0.1	0.0	0.5	1.7	0.6	1.1	0.0	0.1	0.7	1.5	74.9	0.1	0.0	0.1	0.0	0.2	0.7	0.0	0.2	1.8	0.9	0.5	0.1	0.0	0.8	0.0	0.3	0.1	0.6	5.1	0.0	35.4	0.9	0.2	0.5	0.9	0.4	1.5	0.1	4.8	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	1.4	17.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	53.7	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	166.6	0.0	0.0	102.1	2.8	0.2	6.0	0.0	0.0	0.3	0.0	14.9	0.0	0.0	0.3	45.9	0.6	0.4	0.9	0.2	38.3	0.0	0.0	0.0	2.0	0.0	0.1	0.0	0.1	0.0	0.9	0.0	0.5	0.1	0.4	19.2	34.5	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	11.2	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.1	0.0	0.0	2.2	0.0	3.6	0.0	0.0	1.0	2.9	0.0	0.0	7.6	0.0	0.0	0.3	28.8	0.0	0.0	0.0	0.0	28.3	0.0	0.1	0.0	147.5	0.0	0.0	26.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.2	5.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.8	2.9	0.0	0.0	0.1
NLRP10	"CLR11.1, NALP10, NOD8, PAN5, Pynod"	ENSG00000182261	"NLR family pyrin domain containing 10"	Q86W26	11	7957537-7965426	"Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"breast: 1.4;skin 1: 5.3"	"Cell type enriched"	"Detected in single"	5	"Microglial cells: 1.0"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 22.3;BJ: 5.9;HBF TERT88: 7.7;LHCN-M2: 3.7"	"Region enhanced"	"Detected in some"		"olfactory bulb: 2.1"					"HPA039498, HPA040101"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			Nucleoplasm	"Nuclear membrane"	"HPA039498: AB_10795679, HPA040101: AB_10795519"						"unprognostic (4.06e-1)"			"unprognostic (4.34e-1)"						"unprognostic (9.78e-3)"		"unprognostic (2.87e-2)"	0.0	0.0	0.1	0.0	0.1	0.1	1.4	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.1	5.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	22.3	0.0	0.0	0.1	0.0	0.3	0.1	5.9	2.8	1.3	2.8	0.1	0.0	0.0	0.1	1.8	0.0	0.0	0.0	1.0	7.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.3	0.1	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.9	2.8	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
PLG		ENSG00000122194	Plasminogen	P00747	6	160702238-160754097	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis, Tissue remodeling"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"liver: 2688.2"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 1772.7"	"Cancer enriched"	"Detected in some"	84	"liver cancer: 180.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"CAB000668, CAB016678, HPA021602, HPA048823"	Supported				"Secreted to blood"	NA	NA	140000000000	45000000000			"CAB000668: , CAB016678: AB_1621208, HPA021602: AB_1855453, HPA048823: AB_2680532"		"unprognostic (1.70e-1)"		"unprognostic (2.16e-3)"	"unprognostic (2.44e-1)"		"unprognostic (8.54e-3)"	"unprognostic (1.41e-1)"		"unprognostic (1.76e-3)"	"unprognostic (6.28e-2)"	"unprognostic (7.25e-2)"	"prognostic favorable (4.22e-4)"	"unprognostic (3.97e-3)"	"unprognostic (5.21e-2)"		"unprognostic (2.33e-2)"	0.4	0.4	0.2	0.2	0.4	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.3	0.2	0.0	0.1	2.4	0.5	0.0	0.3	0.2	243.2	2688.2	0.4	0.7	0.1	0.0	0.4	0.3	0.0	0.0	0.0	0.4	0.1	0.6	0.0	0.1	0.9	0.0	0.1	0.2	0.1	0.0	0.0	0.5	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.5	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.3	0.2	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.4	0.3	0.2	0.1	0.0	0.4	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.3	5.4	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.6	30.0	0.0	1.8	0.0	0.0	0.3	0.0	19.6	0.0	0.2	3.0	0.1	1.2	0.0	24.0	0.6	0.0	0.0	0.0	0.0	0.1	1.3	0.0	28.5	1772.7	0.1	0.0	0.5	0.0	0.0	35.4	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	235.7	1.5	0.1	0.0	0.4	0.2	0.4	0.4	0.0	0.0	0.0	2.3	0.1	0.0	0.0
SLC13A5	"INDY, NACT"	ENSG00000141485	"Solute carrier family 13 member 5"	Q86YT5	17	6684719-6713377	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Amelogenesis imperfecta, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"liver: 417.4"	"Cell type enriched"	"Detected in some"	15	"Hepatocytes: 381.0"	"Cancer enriched"	"Detected in some"	15	"liver cancer: 27.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	79	"Hep G2: 58.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044343	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA044343: AB_10961771"	"unprognostic (8.46e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.79e-2)"	"unprognostic (8.79e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.30e-3)"	"unprognostic (3.78e-11)"	"unprognostic (2.42e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.04e-1)"	0.2	2.8	4.8	0.0	6.2	0.0	0.3	4.9	8.0	0.3	2.8	0.0	0.0	0.3	0.0	1.1	2.1	0.0	0.0	5.4	6.5	0.7	417.4	0.0	0.2	6.8	5.5	4.7	0.6	0.3	0.0	0.8	0.0	6.8	0.0	0.0	1.7	38.3	0.0	0.0	0.0	0.0	0.0	4.4	3.4	0.0	2.3	6.8	0.0	0.0	0.0	0.0	0.0	0.2	4.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	58.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	6.2	4.9	8.0	5.4	6.5	6.8	5.5	4.7	6.8	4.4	6.8	4.2	0.4	0.0	0.0	24.8	4.8	0.5	0.6	0.6	1.2	0.6	0.1	0.1	0.9	7.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.1	1.9	0.0	24.0	0.3	0.5	0.1	0.4	0.0	0.1	0.0	0.9	16.8	381.0	0.0	0.0	0.2	0.0	0.0	23.2	1.1	0.4	0.6	0.3	0.0	1.9	0.0	7.0	0.0	1.5	0.1	16.9	0.0	0.0	0.0	0.3	0.0	0.0	0.1	1.6	0.0	0.5	0.5	2.4	2.8	1.2	0.4	0.1	1.0	7.8	0.0	0.3
SMYD1	"BOP, KMT3D, ZMYND22"	ENSG00000115593	"SET and MYND domain containing 1"	Q8NB12	2	88067825-88113384	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"heart muscle: 157.9;skeletal muscle: 498.3;tongue: 304.0"	"Cell type enriched"	"Detected in some"	27	"Cardiomyocytes: 208.0"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 0.9;stomach cancer: 1.6"	"Region enhanced"	"Detected in some"		"basal ganglia: 3.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"HSkMC: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA062282	Enhanced					NA	NA					"HPA062282: AB_2684736"	"unprognostic (1.93e-2)"		"unprognostic (2.49e-1)"		"unprognostic (4.09e-2)"	"unprognostic (8.51e-3)"			"unprognostic (2.74e-1)"		"unprognostic (3.91e-1)"			"unprognostic (8.81e-3)"	"unprognostic (1.40e-1)"			0.0	0.0	0.2	0.2	3.1	0.0	5.4	0.1	1.0	0.0	0.0	12.0	2.0	0.0	0.0	7.4	0.0	0.0	157.9	0.4	0.1	0.0	0.0	0.1	0.0	1.3	0.2	0.7	0.0	0.3	2.5	0.0	0.0	0.3	4.1	1.9	0.0	4.0	0.0	498.3	0.1	7.0	28.3	0.1	0.0	7.4	0.3	0.1	0.4	0.1	304.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.1	0.1	1.0	0.4	0.1	1.3	0.2	0.7	0.3	0.1	0.1	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.7	208.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.5	0.0	0.0	0.3	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	1.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPINK4	"MGC133107, PEC-60"	ENSG00000122711	"Serine peptidase inhibitor Kazal type 4"	O60575	9	33218365-33248567	"Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"intestine: 991.0"	"Cell type enriched"	"Detected in some"	14	"Intestinal goblet cells: 8017.1"	"Group enriched"	"Detected in many"	20	"colorectal cancer: 237.5;pancreatic cancer: 269.7;stomach cancer: 111.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	6	"basophil: 1.8"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.8"	"Group enriched"	"Detected in some"	12	"HMC-1: 175.7;OE19: 480.7"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.1"	"Low region specificity"	"Detected in single"			HPA007286	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"	"Secreted to digestive system"	NA	NA			"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA007286: AB_1080083"	"unprognostic (3.49e-2)"	"unprognostic (2.32e-1)"	"prognostic favorable (8.85e-5)"	"unprognostic (3.09e-4)"		"unprognostic (1.49e-1)"		"unprognostic (1.00e-1)"		"unprognostic (9.66e-2)"	"unprognostic (2.43e-1)"			"unprognostic (1.24e-1)"	"unprognostic (3.25e-1)"		"unprognostic (2.42e-3)"	1.4	0.6	0.0	85.0	0.1	0.6	0.1	0.6	0.3	0.0	0.1	645.5	265.8	1.8	0.0	0.1	0.0	0.6	0.0	0.0	0.0	1.4	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.9	2.2	0.9	0.0	0.1	0.0	991.0	92.9	0.1	0.5	0.3	0.0	643.6	42.6	0.0	0.2	1.5	0.3	0.0	0.1	0.0	0.0	0.0	17.6	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.4	0.0	0.0	0.0	3.5	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	11.7	27.8	1.1	0.0	0.0	175.7	0.0	0.0	0.0	0.4	0.5	0.0	0.1	4.1	0.3	0.0	3.9	0.4	2.3	0.0	480.7	0.4	0.0	0.0	0.2	0.0	0.5	0.4	1.4	15.2	3.1	0.0	0.1	14.2	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.3	0.1	1.4	0.3	0.0	1.8	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	5.0	0.3	0.0	0.0	0.0	21.7	0.1	0.0	0.0	0.0	0.0	5.5	12.5	0.1	0.0	56.5	0.0	0.2	1.0	0.1	0.0	0.6	88.2	0.0	0.0	0.0	0.0	0.0	43.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8017.1	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	23.9	0.0	0.5	0.1	0.1	106.8	0.0	0.1	0.2	541.4	0.0	0.0	129.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.1	191.5	0.2
TMEM151A	"MGC33486, TMEM151"	ENSG00000179292	"Transmembrane protein 151A"	Q8N4L1	11	66291894-66296664	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"brain: 111.8"	"Cell type enriched"	"Detected in some"	4	"Oligodendrocytes: 70.1"	"Cancer enhanced"	"Detected in some"		"glioma: 4.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 15.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041035	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA041035: AB_10794404"	"unprognostic (1.20e-1)"	"unprognostic (8.24e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.44e-1)"	"unprognostic (7.60e-2)"	"unprognostic (9.48e-3)"	"unprognostic (8.57e-2)"	"unprognostic (8.73e-4)"	"unprognostic (2.41e-3)"	"unprognostic (2.02e-2)"	"unprognostic (6.11e-3)"	"unprognostic (1.69e-3)"	"unprognostic (2.80e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.67e-2)"	1.4	1.4	44.7	0.0	60.2	0.0	0.0	67.0	54.5	0.0	3.3	0.3	0.1	0.0	0.0	0.0	0.1	0.8	0.4	45.0	52.2	0.1	0.2	0.1	0.0	82.3	67.9	38.4	0.2	1.1	0.3	9.7	0.0	75.1	0.1	0.0	1.6	0.2	0.0	0.0	0.0	0.1	0.0	72.2	0.0	5.4	0.3	57.9	0.0	0.0	0.0	0.0	0.0	0.1	111.8	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.5	0.0	1.1	0.0	3.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.0	0.0	15.3	3.5	0.5	0.0	0.2	0.0	0.1	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.7	60.2	67.0	54.5	45.0	52.2	82.3	67.9	38.4	75.1	72.2	57.9	111.8	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	9.6	0.0	0.0	0.7	4.3	0.0	0.0	2.1	0.0	0.1	0.1	0.0	0.2	0.3	0.0	0.1	0.0	7.7	0.0	11.6	0.4	0.0	1.0	9.2	0.1	0.0	0.0	0.0	0.0	0.1	15.2	11.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.8	0.0	2.5	0.0	2.0	70.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.4	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0
TOMM20L	UNQ9438	ENSG00000196860	"Translocase of outer mitochondrial membrane 20 like"	Q6UXN7	14	58395928-58408702	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"testis: 11.0"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 154.1"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA076397	Enhanced					NA	NA					"HPA076397: "	"unprognostic (1.72e-1)"	"unprognostic (2.34e-4)"	"unprognostic (8.13e-2)"	"unprognostic (7.80e-3)"	"unprognostic (5.08e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.28e-2)"	"unprognostic (4.93e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.06e-2)"	"unprognostic (5.66e-3)"	"unprognostic (4.57e-6)"	"unprognostic (8.75e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.66e-3)"	0.3	0.1	0.1	0.1	0.1	0.1	0.3	0.3	0.1	0.0	0.0	0.3	0.0	0.2	1.0	0.0	0.2	0.0	0.2	0.1	0.0	0.4	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.5	0.1	0.2	0.1	0.5	0.3	0.4	0.2	0.3	0.0	0.2	0.3	0.1	0.0	0.2	0.4	11.0	0.0	0.0	0.6	0.0	0.1	0.1	0.0	0.2	0.5	0.0	0.1	0.5	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.1	0.0	0.1	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.3	0.4	0.1	0.2	0.1	0.4	0.5	0.2	0.1	0.1	0.1	1.0	0.7	0.1	0.1	0.2	0.3	0.4	0.8	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.4	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	1.3	0.2	0.0	0.2	0.0	0.0	0.0	0.6	0.9	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	154.1	0.8	0.2	0.1	0.0	0.0	2.5	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	2.6	0.1	0.0	0.0	0.0	28.6	0.9	0.2	0.0	0.0	0.0	0.8	0.0	4.5	2.1	0.1	0.3	0.7	0.0	0.2	0.1	0.8	0.0	0.0	0.0	0.4	0.1	27.6	1.6	0.0	0.4	0.0	0.1	0.2	0.2	0.2
TRAV4	"TCRAV20S1, TCRAV4S1"	ENSG00000211778	"T cell receptor alpha variable 4"	A0A0B4J268	14	21736152-21736982	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"lymphoid tissue: 38.2"	"Cell type enriched"	"Detected in some"	8	"T-cells: 8.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	70	"MAIT T-cell: 66.1;memory CD4 T-cell: 81.9;memory CD8 T-cell: 124.0;naive CD4 T-cell: 77.1;naive CD8 T-cell: 81.0;T-reg: 167.9"	"Lineage enriched"	"Detected in many"	118	"T-cells: 167.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.13e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.39e-4)"	"unprognostic (5.20e-3)"	"unprognostic (1.18e-4)"	"unprognostic (1.34e-2)"	"unprognostic (5.48e-2)"	"unprognostic (7.19e-3)"	"unprognostic (2.48e-3)"	"unprognostic (8.68e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.37e-4)"	"unprognostic (1.65e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.89e-1)"	"unprognostic (6.49e-2)"	0.3	0.3	0.0	7.7	0.1	1.3	1.1	0.0	0.4	1.1	0.0	1.8	1.7	0.3	0.0	1.1	0.6	2.8	0.5	0.0	0.0	0.2	0.6	2.4	17.5	0.3	0.4	0.0	0.2	0.5	0.1	0.0	0.1	0.2	1.2	2.1	0.0	0.8	0.1	0.0	0.4	3.3	0.4	0.1	5.4	2.5	0.3	0.2	38.2	0.3	0.0	14.3	2.8	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.1	0.6	0.1	66.1	0.1	81.9	124.0	0.1	0.1	77.1	81.0	1.4	0.4	0.5	0.4	167.9	25.2	0.0	0.1	0.0	0.4	0.0	0.0	0.3	0.4	0.0	0.2	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0
TRBV6-5	"TCRBV13S1, TCRBV6S5, TRBV65"	ENSG00000211721	"T cell receptor beta variable 6-5"	A0A0K0K1A5	7	142450947-142451448	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"lymphoid tissue: 83.0"	"Cell type enriched"	"Detected in single"	121	"T-cells: 12.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"naive CD8 T-cell: 133.8;T-reg: 137.9"	"Lineage enriched"	"Detected in many"	54	"T-cells: 137.9"	"Cell line enriched"	"Detected in some"	8	"HL-60: 61.1"															NA	NA						"unprognostic (6.42e-3)"	"unprognostic (7.43e-4)"	"unprognostic (1.11e-2)"	"unprognostic (2.20e-3)"	"unprognostic (1.38e-1)"	"unprognostic (8.63e-5)"	"unprognostic (1.55e-2)"	"unprognostic (1.51e-3)"	"unprognostic (8.72e-3)"	"unprognostic (2.11e-3)"	"unprognostic (7.03e-2)"	"unprognostic (4.82e-1)"	"prognostic unfavorable (5.40e-5)"	"unprognostic (3.12e-2)"	"unprognostic (4.17e-2)"	"unprognostic (7.43e-3)"	"unprognostic (3.06e-2)"	0.2	0.2	0.0	4.2	0.0	2.3	0.5	0.0	0.1	0.4	0.0	0.9	1.1	0.2	0.0	0.2	0.3	1.6	0.1	0.0	0.0	0.1	0.3	2.5	16.2	0.0	0.0	0.0	0.3	7.4	0.0	0.0	0.1	0.0	0.3	1.2	0.2	0.4	0.1	0.0	0.3	2.0	0.3	0.0	3.4	1.7	0.1	0.0	83.0	0.4	0.8	12.1	1.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	61.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.5	0.2	0.2	1.0	0.1	32.8	0.3	78.7	76.2	0.1	0.4	92.0	133.8	2.5	0.2	0.4	0.4	137.9	59.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.1
TSPY10		ENSG00000236424	"Testis specific protein Y-linked 10"	P0CW01	Y	9527880-9530682	"Predicted intracellular proteins"	"Differentiation, Gonadal differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	11	"testis: 1.7"	"Cell type enriched"	"Detected in some"	10	"Spermatogonia: 10.3"	"Cancer enriched"	"Detected in single"	13	"testis cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-266/84: 63.8"									"HPA049384, HPA067289"	Supported		Approved	Cytosol		NA	NA			Cytosol		"HPA049384: AB_2680738, HPA067289: "															"unprognostic (5.36e-1)"			0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	11.8	63.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BHLHA15	"BHLHB8, MIST1"	ENSG00000180535	"Basic helix-loop-helix family member a15"	Q7RTS1	7	98211439-98215457	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"pancreas: 507.1;salivary gland: 147.1"	"Cell type enriched"	"Detected in single"	25	"Plasma cells: 12.6"	"Cancer enriched"	"Detected in many"	4	"prostate cancer: 16.2"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Karpas-707: 53.5;RPMI-8226: 72.0;U-266/70: 67.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB034083, HPA047834"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"CAB034083: AB_2065216, HPA047834: AB_2680172"	"unprognostic (2.80e-2)"	"unprognostic (9.45e-3)"	"unprognostic (8.10e-2)"	"unprognostic (6.66e-2)"	"unprognostic (4.33e-3)"	"unprognostic (1.10e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.60e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.70e-4)"	"unprognostic (3.36e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.95e-1)"	"unprognostic (8.25e-3)"	0.1	0.1	0.7	3.7	0.6	0.3	1.5	0.1	2.1	1.9	0.0	4.1	4.0	0.1	0.8	1.0	0.1	0.8	0.2	1.3	0.8	0.4	5.2	0.9	3.9	0.5	0.4	0.7	0.4	507.1	0.1	1.5	0.1	0.6	8.6	1.6	0.0	147.1	4.0	0.2	0.5	3.4	0.0	0.7	5.1	31.6	0.2	1.1	0.7	1.9	0.0	4.7	2.5	0.2	0.4	0.3	0.1	0.0	0.0	0.0	0.3	0.4	0.1	0.0	0.3	0.1	0.8	0.9	0.0	1.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	2.8	0.0	0.6	6.7	5.9	0.0	0.1	0.0	0.4	0.4	0.2	0.0	0.2	0.0	0.0	53.5	0.0	0.9	0.0	0.0	0.8	6.2	0.8	0.4	0.0	72.0	0.3	0.0	4.3	1.2	0.0	11.2	0.0	0.0	0.7	0.1	0.0	0.0	0.7	0.1	0.1	67.6	5.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.6	0.1	2.1	1.3	0.8	0.5	0.4	0.7	0.6	0.7	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
BTBD17	"BTBD17A, LGALS3BPL, TANGO10A"	ENSG00000204347	"BTB domain containing 17"	A6NE02	17	74356416-74361868	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	10	"brain: 5.1"	"Cell type enriched"	"Detected in some"	6	"Horizontal cells: 28.6"	"Cancer enriched"	"Detected in some"	5	"glioma: 9.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	20	"AF22: 2.9;NTERA-2: 3.8;SCLC-21H: 11.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA025022	Approved				"Secreted in brain"	NA	NA					"HPA025022: AB_2067352"					"unprognostic (2.63e-1)"					"unprognostic (2.77e-1)"	"unprognostic (4.82e-5)"			"unprognostic (3.89e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.89e-3)"		0.0	0.5	2.6	0.0	2.5	0.0	0.0	1.8	3.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.1	4.4	0.0	0.0	0.0	0.0	2.3	3.0	1.6	0.0	0.2	0.0	0.2	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.4	0.3	5.1	0.0	0.2	0.0	0.0	0.0	0.0	2.2	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.5	1.8	3.3	2.1	4.4	2.3	3.0	1.6	2.9	1.5	5.1	2.2	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	4.2	0.0	0.0	0.0	4.2	0.0	0.6	0.0	0.0	0.0	0.9	0.0	0.0	0.1	4.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.6	0.1	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	1.3	0.0	3.5	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.6	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0
C10orf90	"bA422P15.2, FATS, FLJ32938"	ENSG00000154493	"Chromosome 10 open reading frame 90"	Q96M02	10	126424997-126798708	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"brain: 109.1"	"Cell type enriched"	"Detected in some"	4	"Oligodendrocytes: 819.4"	"Cancer enriched"	"Detected in some"	5	"melanoma: 4.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 118.8;U-2197: 36.1;U-266/84: 27.2;U-87 MG: 37.0;WM-115: 29.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038648, HPA075229"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane, Cytosol"		"HPA038648: AB_10672721, HPA075229: "	"unprognostic (1.21e-2)"	"unprognostic (3.34e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.98e-3)"	"unprognostic (5.06e-2)"	"unprognostic (9.34e-3)"	"unprognostic (3.73e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.06e-11)"	"unprognostic (2.69e-3)"	"unprognostic (9.91e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.88e-1)"	0.6	0.0	28.2	0.1	61.1	0.0	4.7	35.2	32.9	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	22.5	34.2	0.1	0.1	0.0	0.0	53.2	50.1	11.6	0.1	0.2	0.0	0.3	0.3	84.9	0.0	0.1	0.0	10.7	0.0	0.1	0.9	0.1	0.0	34.7	0.0	0.0	6.5	53.9	1.2	0.3	0.4	0.7	0.0	0.0	109.1	0.3	0.1	0.0	0.0	0.8	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	2.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	2.3	0.0	1.6	0.0	0.9	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	2.6	0.0	0.0	0.0	0.0	118.8	0.0	0.0	0.2	0.0	4.7	0.0	36.1	0.7	0.0	27.2	0.0	37.0	0.0	29.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.2	61.1	35.2	32.9	22.5	34.2	53.2	50.1	11.6	84.9	34.7	53.9	109.1	0.2	0.0	0.0	24.5	0.1	0.0	0.0	0.0	0.0	0.0	3.0	2.7	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	120.5	0.0	0.0	0.1	0.0	0.0	2.2	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	1.6	0.0	0.0	0.0	0.0	142.7	0.3	0.0	0.0	3.7	0.0	0.0	0.0	181.0	819.4	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.1	1.3	0.5	0.0	0.0	4.2	0.1	0.0	0.0	0.0
DEFB132	"DEFB32, RP5-1103G7.6"	ENSG00000186458	"Defensin beta 132"	Q7Z7B7	20	257724-261096	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"epididymis: 273.5"	"Cell type enriched"	"Detected in some"	7	"Collecting duct cells: 11.0"	"Group enriched"	"Detected in some"	4	"liver cancer: 0.8;prostate cancer: 1.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA046399	Approved				"Secreted in male reproductive system"	NA	NA					"HPA046399: AB_10960992"	"unprognostic (9.27e-3)"						"unprognostic (1.61e-2)"					"unprognostic (2.54e-2)"						26.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	273.5	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	20.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	1.5	0.0	11.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
FAM209B	"C20orf107, dJ1153D9.4"	ENSG00000213714	"Family with sequence similarity 209 member B"	Q5JX69	20	56533246-56536520	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 115.3"	"Cell type enriched"	"Detected in some"	7	"Early spermatids: 1680.6"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"U-266/70: 2.0;U-266/84: 2.2"									HPA042144	Enhanced					NA	NA					"HPA042144: AB_10794414"	"unprognostic (2.93e-1)"	"unprognostic (6.90e-2)"	"unprognostic (9.49e-3)"	"unprognostic (4.96e-3)"	"unprognostic (1.72e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.72e-1)"	"unprognostic (7.77e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.59e-4)"	"unprognostic (3.47e-1)"	"unprognostic (2.02e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.55e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.48e-4)"	0.7	0.2	0.6	0.6	0.6	11.9	0.8	0.6	0.9	0.5	0.7	0.5	0.2	0.4	0.0	0.5	0.6	0.3	0.4	0.6	0.6	0.5	0.8	1.0	1.3	0.6	0.6	0.5	0.2	0.7	0.3	0.9	0.1	0.6	0.7	0.4	0.2	0.7	0.3	0.9	1.1	0.9	0.2	0.6	2.6	0.6	115.3	0.6	0.6	0.4	0.4	0.9	0.5	0.5	0.7	0.0	1.0	0.2	0.0	0.0	0.1	0.1	0.4	0.7	0.9	0.3	0.7	0.0	0.1	0.7	0.4	0.2	0.6	0.5	0.3	0.8	0.2	0.4	0.4	0.0	0.2	0.1	1.1	1.6	0.6	0.9	0.1	0.5	0.0	0.0	0.7	0.0	0.9	0.0	1.1	0.4	1.0	0.2	0.0	0.5	0.3	0.2	0.0	0.6	0.3	0.6	0.1	0.3	1.4	0.2	0.2	0.6	0.2	0.0	0.1	0.2	0.6	0.0	2.0	2.2	0.3	0.1	0.4	0.1	0.0	0.3	1.0	0.6	0.1	0.0	0.0	0.0	0.3	0.2	0.2	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.6	0.6	0.6	0.9	0.6	0.6	0.6	0.6	0.5	0.6	0.6	0.6	0.7	0.3	0.0	1.9	0.0	0.1	0.1	0.5	0.4	0.0	0.0	0.3	0.3	0.3	0.0	0.3	0.0	0.0	0.3	0.5	0.3	0.0	0.9	1680.6	0.2	0.1	0.9	1.2	0.0	0.6	1.6	0.5	0.1	0.0	0.3	1.3	0.1	0.4	0.2	0.6	0.0	0.4	0.2	0.0	1.6	0.7	238.2	11.5	1.0	0.0	0.0	0.9	0.0	2.1	0.0	0.9	0.8	0.1	8.2	0.0	0.3	0.4	1.0	1.1	0.0	0.0	0.1	0.4	12.8	7.1	0.0	0.0	0.0	0.4	0.1	0.1	0.6
GRPR	"BB2, BB2R"	ENSG00000126010	"Gastrin releasing peptide receptor"	P30550	X	16123565-16153518	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"pancreas: 20.4"	"Cell type enriched"	"Detected in single"	15	"Inhibitory neurons: 6.3"	"Cancer enriched"	"Detected in some"	4	"breast cancer: 6.6"	"Region enhanced"	"Detected in single"		"hypothalamus: 1.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"PC-3: 29.2;T-47d: 38.2;U-138 MG: 51.5"	"Region enhanced"	"Detected in single"		"hypothalamus: 2.0"	"Low region specificity"	"Detected in all"			HPA069604			Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA069604: AB_2686158"	"unprognostic (3.32e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.72e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.87e-1)"	"unprognostic (9.17e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.68e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.92e-1)"	"unprognostic (2.86e-2)"	0.1	0.1	0.1	0.2	0.2	0.1	1.9	0.0	0.2	0.4	0.1	0.3	0.1	0.5	1.9	0.0	0.1	0.1	0.2	0.2	1.6	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.0	20.4	0.2	0.0	0.1	0.2	0.5	0.3	0.1	0.0	0.1	0.2	0.0	0.1	0.8	0.6	0.1	1.2	0.0	0.2	0.0	0.1	0.2	0.1	0.1	0.0	0.3	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.3	0.0	0.9	0.1	4.0	1.6	0.4	0.1	0.0	0.1	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.2	0.5	0.0	0.0	0.0	0.5	0.0	29.2	0.0	0.1	0.1	0.1	0.0	0.8	0.1	0.0	0.1	0.1	1.5	38.2	0.1	0.2	51.5	1.9	0.0	1.6	0.3	0.2	0.2	0.0	0.1	0.8	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.2	1.6	0.2	0.1	0.1	0.2	0.6	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HAMP	"HEPC, HFE2B, LEAP-1, LEAP1"	ENSG00000105697	"Hepcidin antimicrobial peptide"	P81172	19	35280716-35285143	"Disease related genes, Human disease related genes, Potential drug targets, Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial, Fungicide, Hormone"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"liver: 2071.6"	"Cell type enriched"	"Detected in many"	17	"Hepatocytes: 3227.7"	"Group enriched"	"Detected in many"	12	"glioma: 6.5;liver cancer: 16.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"myeloid DC: 1.5;plasmacytoid DC: 4.6"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 4.6"	"Cell line enriched"	"Detected in some"	440	"Hep G2: 448.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	1900000	10000000				"unprognostic (5.53e-2)"	"unprognostic (5.02e-4)"	"unprognostic (2.10e-3)"	"unprognostic (4.69e-3)"	"unprognostic (5.35e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.92e-2)"	"unprognostic (9.36e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.61e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.68e-7)"	"unprognostic (4.11e-2)"	"unprognostic (3.93e-2)"	"unprognostic (4.08e-2)"	"unprognostic (7.77e-2)"	0.8	1.3	16.5	2.1	18.9	5.4	1.5	16.8	30.7	1.4	19.3	0.5	0.9	0.3	0.6	0.5	2.8	0.6	211.1	17.1	70.1	0.3	2071.6	3.2	4.0	48.6	22.6	17.3	3.2	88.7	0.4	5.9	2.3	24.5	2.8	0.0	4.3	1.2	1.3	1.2	1.0	0.5	1.0	19.1	1.1	1.1	0.7	22.3	0.1	0.4	0.2	4.4	1.6	0.2	26.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.7	448.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.7	1.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.4	0.0	4.6	0.0	0.0	16.5	18.9	16.8	30.7	17.1	70.1	48.6	22.6	17.3	24.5	19.1	22.3	26.8	0.8	0.0	0.0	0.0	5.7	0.5	1.5	0.0	0.0	0.0	26.2	8.0	1.7	30.0	0.6	0.0	0.0	0.9	0.6	0.1	0.0	0.4	0.0	1.9	1.0	13.7	0.0	89.7	0.2	99.0	1.2	0.4	10.7	1.8	75.7	0.7	45.3	3227.7	187.9	0.0	0.0	0.7	0.0	63.2	1.2	0.0	0.0	28.4	0.0	0.0	0.0	0.6	0.0	0.0	0.1	22.6	0.1	0.0	0.1	4.2	0.0	0.1	0.0	0.6	0.0	0.2	0.6	0.0	0.0	0.0	18.6	0.7	4.3	0.5	0.2	2.2
HBB	"beta-globin, CD113t-C"	ENSG00000244734	"Hemoglobin subunit beta"	P68871	11	5225464-5229395	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Oxygen transport, Transport"	"Hypotensive agent, Vasoactive"	"Congenital dyserythropoietic anemia, Disease variant, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	10	"bone marrow: 134386.5"	"Cell type enriched"	"Detected in many"	24	"Erythroid cells: 672352.3"	"Group enriched"	"Detected in all"	4	"cervical cancer: 66.4;glioma: 244.6;renal cancer: 65.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"neutrophil: 658.1;plasmacytoid DC: 379.7"	"Group enriched"	"Detected in all"	11	"dendritic cells: 379.7;granulocytes: 658.1"	"Cell line enhanced"	"Detected in some"		"HEL: 6.0;SCLC-21H: 5.0;SH-SY5Y: 6.4;U-266/70: 23.1;U-266/84: 4.2"									"CAB009526, HPA043234"	Enhanced					NA	NA		10000000000			"CAB009526: AB_2143058, HPA043234: AB_2678378"	"unprognostic (2.41e-1)"	"unprognostic (8.55e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.22e-1)"	"unprognostic (4.88e-2)"	"unprognostic (7.46e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.91e-1)"	"unprognostic (8.11e-3)"	"unprognostic (2.40e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.87e-3)"	"unprognostic (6.41e-2)"	1042.1	486.0	418.9	219.2	731.0	134386.5	644.6	502.4	2433.0	349.2	2881.9	255.8	29.1	79.5	46.0	510.2	836.8	799.5	2206.8	384.6	499.0	2306.6	1922.8	4075.1	27.0	534.9	824.6	366.6	291.5	159.9	50.9	814.5	6397.9	921.5	314.8	150.2	31.3	552.9	293.3	584.6	126.3	171.3	66.9	587.8	9299.9	271.4	172.0	936.9	198.6	1161.7	13016.8	40.6	323.4	638.9	1021.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	2.2	0.0	0.0	0.0	0.8	0.2	0.4	0.0	0.0	0.4	0.3	0.0	0.0	5.0	6.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	23.1	4.2	0.0	0.0	0.0	0.0	99.5	25.3	73.7	37.8	1.3	4.0	21.5	6.8	1.1	35.2	13.8	13.7	39.9	658.1	47.9	5.0	379.7	1.4	22388.9	418.9	731.0	502.4	2433.0	384.6	499.0	534.9	824.6	366.6	921.5	587.8	936.9	1021.6	441.7	3.2	8.4	0.0	280.5	157.0	2.3	5.1	0.0	4.0	54.7	72.0	3.4	217.3	4.5	7.3	4.2	2.2	369.9	5.2	50.9	0.0	0.0	6.8	6.6	151.7	3.6	672352.3	0.0	0.0	11.3	276.1	0.0	5.1	0.0	4.6	443.4	420.5	7.3	3.3	0.0	7.2	6.1	1452.1	702.6	0.0	0.0	1091.0	27383.1	0.0	72.7	9.7	38.1	0.0	0.0	0.1	3.5	0.0	1.9	0.0	0.1	272.4	84.9	117.8	0.0	126.0	396.8	0.0	0.0	0.0	252.5	2.2	769.8	0.3	3.0	0.1
HEPHL1	DKFZp686F22190	ENSG00000181333	"Hephaestin like 1"	Q6MZM0	11	94021354-94114208	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters"	"Copper transport, Ion transport, Transport"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"esophagus: 4.5;lymphoid tissue: 9.6;skin 1: 2.4;vagina: 4.6"	"Cell type enriched"	"Detected in some"	5	"Basal keratinocytes: 10.5"	"Cancer enriched"	"Detected in some"	5	"head and neck cancer: 20.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HaCaT: 1.4;HBEC3-KT: 2.6"	"Region enriched"	"Detected in single"	12	"olfactory bulb: 1.2"	"Not detected"	"Not detected"			HPA031517	Uncertain					NA	NA		260000000			"HPA031517: AB_10603769"	"unprognostic (9.16e-2)"	"prognostic unfavorable (4.94e-4)"	"unprognostic (2.40e-1)"	"unprognostic (3.26e-6)"	"unprognostic (3.17e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.72e-2)"	"unprognostic (6.71e-2)"	"unprognostic (5.34e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.25e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	9.6	0.0	4.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.4	0.0	2.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	10.5	0.0	0.6	0.0	0.0	0.1	0.0	0.3	0.0	0.0	1.8	0.0	0.6	0.0	0.1	0.0	0.0	1.4	0.0	0.1	0.1	0.0	0.4	1.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.3	0.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.5	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0
KRT1	"EHK1, KRT1A"	ENSG00000167768	"Keratin 1"	P04264	12	52674736-52680407	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Ichthyosis, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"skin 1: 13111.3"	"Cell type enriched"	"Detected in some"	5	"Suprabasal keratinocytes: 10030.4"	"Group enriched"	"Detected in many"	5	"head and neck cancer: 313.8;melanoma: 478.9"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"memory CD4 T-cell: 2.3"	"Lineage enriched"	"Detected in single"	23	"T-cells: 2.3"	"Group enriched"	"Detected in some"	14	"HaCaT: 94.9;hTCEpi: 39.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB002153, HPA017917, HPA062908"	Enhanced					NA	NA		35000000000			"CAB002153: AB_563790, HPA017917: AB_1852192, HPA062908: AB_2684901"	"unprognostic (8.05e-2)"	"unprognostic (8.49e-3)"	"unprognostic (5.06e-3)"	"unprognostic (6.44e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.16e-1)"	"unprognostic (9.24e-2)"	"unprognostic (6.63e-2)"	"unprognostic (3.23e-4)"	"unprognostic (1.58e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.09e-2)"	6.9	1.4	0.0	0.1	0.0	7.7	469.4	0.0	0.1	226.7	0.0	2.2	0.2	1.3	0.4	31.0	0.4	0.3	4.1	0.0	0.0	1.2	3.6	2.7	0.0	0.0	0.0	0.0	1.4	3.7	0.0	1.4	1.6	0.0	1.6	0.1	0.0	272.2	0.1	48.2	13111.3	2.1	0.2	0.0	1.6	2.1	1.9	0.0	77.5	2.0	0.8	0.5	0.9	1267.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.7	0.0	39.3	0.0	0.0	0.0	0.0	4.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.8	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	1681.6	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	19.1	0.0	22.3	0.0	0.0	0.0	17.4	0.0	0.0	234.7	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.0	0.0	267.0	0.0	0.0	0.3	265.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	10.5	0.0	0.0	1.1	10030.4	0.0	7.8	0.0	0.3	0.4
LACTBL1		ENSG00000215906	"Lactamase beta like 1"	A8MY62	1	22953043-22965338	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	10	"retina: 3.0"	"Cell type enriched"	"Detected in single"	10	"Bipolar cells: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA066810			Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA066810: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LCE1B	"LEP2, SPRL2A"	ENSG00000196734	"Late cornified envelope 1B"	Q5T7P3	1	152811971-152813108	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"skin 1: 159.2"	"Cell type enriched"	"Detected in some"	18	"Suprabasal keratinocytes: 18.9"	"Cancer enriched"	"Detected in some"	10	"melanoma: 6.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"hTCEpi: 2.0"															NA	NA							"unprognostic (1.79e-1)"				"unprognostic (1.24e-2)"			"unprognostic (6.43e-2)"									0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	159.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	18.9	0.0	0.0	0.0	0.0	0.0
MS4A6E		ENSG00000166926	"Membrane spanning 4-domains A6E"	Q96DS6	11	60334831-60396596	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 35.9"	"Cell type enriched"	"Detected in some"	10	"Early spermatids: 1211.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA076623			Approved	Vesicles		NA	NA			Vesicles		"HPA076623: AB_2686809"					"unprognostic (2.58e-1)"	"unprognostic (3.35e-1)"		"unprognostic (3.47e-1)"			"unprognostic (6.81e-3)"		"unprognostic (4.55e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.76e-1)"		1.4	0.0	0.0	1.1	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	3.6	0.0	35.9	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1211.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	114.8	6.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0
MST1	"D3F15S2, DNF15S2, HGFL, MSP, NF15S2"	ENSG00000173531	"Macrophage stimulating 1"		3	49683947-49689501	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in all"	10	"liver: 935.5"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 362.8"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 42.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 84.6;NB-4: 17.3;U-266/70: 21.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA024036	Approved				"Secreted to blood"	NA	NA					"HPA024036: AB_1854147"	"unprognostic (5.13e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.16e-2)"	"unprognostic (9.42e-3)"	"unprognostic (8.24e-2)"	"unprognostic (2.97e-1)"	"prognostic favorable (7.14e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.48e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.68e-3)"	16.7	28.2	11.2	1.1	11.2	6.3	8.2	11.7	13.0	10.7	11.0	4.7	51.0	8.9	11.4	7.4	10.6	7.5	4.6	11.0	11.9	95.4	935.5	5.9	3.7	11.2	11.3	11.1	12.6	16.6	9.5	29.5	5.9	11.3	13.0	2.1	5.3	8.1	5.2	3.6	15.0	31.4	2.2	11.2	14.0	8.8	35.1	11.1	2.2	36.7	2.9	1.7	6.1	6.9	11.2	0.2	0.4	1.2	2.0	3.7	7.6	3.7	1.1	1.4	0.6	0.8	3.9	1.2	0.3	2.6	1.3	0.5	0.8	0.6	1.5	0.6	1.3	0.7	0.6	2.6	84.6	5.8	0.0	1.6	10.2	2.6	0.7	2.1	14.1	1.4	3.5	0.7	9.9	1.9	0.6	0.5	17.3	0.2	1.1	1.0	0.4	0.5	2.2	4.2	0.6	0.2	2.8	0.0	1.6	0.4	2.5	1.5	5.7	0.9	1.9	0.6	0.1	0.2	21.8	2.9	0.5	2.2	3.2	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.2	11.2	11.7	13.0	11.0	11.9	11.2	11.3	11.1	11.3	11.2	11.1	11.2	3.1	6.4	3.9	10.1	3.5	2.9	4.6	5.8	6.8	8.2	6.1	10.2	2.2	45.8	5.4	27.6	8.4	4.8	1.0	5.1	62.6	6.9	7.6	2.3	3.5	3.4	8.3	29.7	1.1	3.9	19.7	5.2	9.2	3.2	1.3	36.9	10.0	362.8	1.4	1.7	2.0	8.9	6.1	10.7	1.4	2.6	3.1	1.2	3.6	2.8	0.1	8.9	0.0	3.0	2.9	2.1	7.2	1.9	1.6	1.3	57.0	61.9	6.7	6.9	0.0	2.3	10.9	21.8	9.2	2.6	4.7	5.1	2.1	22.8	13.7	3.4
MUC6		ENSG00000184956	"Mucin 6, oligomeric mucus/gel-forming"	Q6W4X9	11	1012823-1036718	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"pancreas: 172.7;stomach 1: 413.2"	"Cell type enriched"	"Detected in some"	4	"Gastric mucus-secreting cells: 278.8"	"Group enriched"	"Detected in many"	4	"pancreatic cancer: 42.9;stomach cancer: 58.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"OE19: 1.7"	"Not detected"	"Not detected"							CAB002165	Enhanced				"Secreted to digestive system"	NA	NA		75000			"CAB002165: AB_442114"	"unprognostic (1.90e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.56e-3)"	"unprognostic (1.04e-1)"	"unprognostic (5.17e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.63e-1)"	"unprognostic (9.46e-2)"	"unprognostic (8.62e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.39e-1)"	"unprognostic (4.72e-2)"	"unprognostic (5.23e-2)"	0.2	0.2	1.5	0.0	0.6	0.0	0.9	0.4	0.7	14.1	0.0	1.6	15.8	2.1	0.9	5.3	2.5	0.3	0.1	1.0	0.0	2.5	5.4	0.2	0.0	0.2	0.0	0.8	0.2	172.7	0.0	0.2	0.0	0.9	4.4	0.0	0.0	0.1	28.2	0.1	0.1	0.1	0.0	0.0	0.3	413.2	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.6	0.4	0.7	1.0	0.0	0.2	0.0	0.8	0.9	0.0	0.1	0.4	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	11.3	2.8	1.7	54.3	0.0	9.2	0.0	0.0	0.2	0.1	0.0	12.2	0.1	0.5	0.1	0.1	0.0	0.0	1.2	19.1	0.0	0.1	278.8	0.5	0.0	0.1	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	59.1	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
NAPSA	"KAP, Kdap, NAP1, NAPA"	ENSG00000131400	"Napsin A aspartic peptidase"	O96009	19	50358477-50365830	"Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"		"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"lung: 1085.0"	"Cell type enriched"	"Detected in many"	5	"Alveolar cells type 2: 3072.3"	"Cancer enriched"	"Detected in many"	18	"lung cancer: 249.9"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 8.7"	"Group enriched"	"Detected in many"	7	"B-cells: 4.3;dendritic cells: 8.7"	"Cell line enriched"	"Detected in some"	31	"U-698: 42.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB009591, HPA045280, HPA047236, HPA047744"	Enhanced				"Secreted in other tissues"	NA	NA		1500000			"CAB009591: , HPA045280: AB_2679283, HPA047236: AB_2679993, HPA047744: AB_2680143"	"unprognostic (5.36e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.30e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.76e-3)"	"unprognostic (7.67e-3)"	"prognostic favorable (1.21e-4)"	"unprognostic (4.08e-4)"	"unprognostic (3.29e-1)"	"unprognostic (9.83e-3)"	"unprognostic (7.26e-5)"	0.4	0.9	1.0	1.6	0.9	0.1	0.5	0.9	0.9	0.7	0.7	0.6	0.4	0.5	2.0	0.4	1.0	0.1	0.4	0.8	0.9	107.3	1.2	1085.0	1.2	0.9	0.9	0.8	2.2	1.0	0.2	0.6	0.4	0.9	1.0	0.4	0.4	0.6	1.0	0.2	1.0	1.6	0.1	0.8	1.1	0.9	1.9	0.9	0.4	1.7	0.0	0.5	0.4	0.7	1.1	0.2	0.4	0.0	0.2	0.2	0.2	0.2	0.1	0.0	0.0	0.1	0.1	0.3	0.2	0.3	0.2	0.0	0.5	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.2	0.0	0.2	0.4	1.3	0.1	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.7	0.2	0.5	0.2	0.3	0.4	0.6	0.0	0.2	1.1	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.1	0.4	0.2	0.0	0.1	1.0	0.0	0.2	0.4	42.1	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.9	0.0	4.3	0.2	0.3	2.6	1.7	0.4	0.4	0.5	0.4	0.7	8.7	0.0	1.1	1.0	0.9	0.9	0.9	0.8	0.9	0.9	0.9	0.8	0.9	0.8	0.9	1.1	0.3	522.4	3072.3	0.3	3.8	0.1	0.5	0.2	0.0	1.3	0.8	0.9	0.4	1.5	45.9	46.0	4.2	0.5	0.4	0.8	9.8	0.6	47.2	12.6	0.4	6.2	0.0	0.4	0.5	0.8	0.3	5.8	0.5	1.5	69.4	1.0	0.4	0.4	0.3	0.0	0.5	1.0	0.0	1.6	5.3	9.1	0.9	7.9	0.0	1.9	0.2	1.5	1.0	0.0	1.4	0.1	2.3	0.4	0.6	0.4	2.0	276.1	16.4	0.9	0.0	0.3	0.3	1.4	1.4	0.0	0.6	0.1	12.9	0.4	0.9	0.1
PRAME	"CT130, MAPE"	ENSG00000185686	"PRAME nuclear receptor transcriptional regulator"	P78395	22	22547701-22559361	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Differentiation, Growth regulation, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 105.9"	"Cell type enriched"	"Detected in some"	4	"Spermatogonia: 249.0"	"Cancer enhanced"	"Detected in many"		"melanoma: 139.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"K-562: 834.1"					"Not detected"	"Not detected"			"HPA045153, HPA068562"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA045153: AB_10797259, HPA068562: "	"unprognostic (9.36e-3)"	"unprognostic (9.74e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.87e-2)"	"unprognostic (5.20e-2)"	"prognostic unfavorable (3.41e-4)"	"unprognostic (3.43e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.52e-3)"	"unprognostic (9.68e-3)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (7.48e-9)"	"unprognostic (1.95e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.26e-1)"	0.1	3.8	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.8	0.0	0.1	0.0	3.4	10.1	0.0	0.5	0.0	0.2	0.0	0.1	1.8	0.1	0.2	0.1	0.1	0.0	0.0	4.8	0.1	0.0	0.3	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.3	0.1	0.3	0.2	0.1	0.1	0.1	105.9	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.2	0.9	53.3	0.0	126.0	0.0	0.0	33.4	0.0	0.0	0.0	0.0	0.4	0.7	3.5	88.8	0.0	0.5	0.1	4.3	0.0	0.0	61.5	14.8	36.0	21.7	0.6	0.0	2.9	172.6	0.0	0.0	0.0	0.0	0.0	0.0	14.9	834.1	15.6	0.0	8.1	0.3	0.2	0.0	27.2	3.5	5.0	0.0	0.2	0.0	0.2	1.1	185.0	0.0	0.6	0.2	0.0	27.8	24.3	5.0	0.1	159.6	0.0	0.2	3.0	14.6	1.3	0.2	0.8	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	37.8	22.3	1.1	0.3	0.0	0.0	0.0	0.0	0.9	2.0	0.0	13.0	0.0	60.9	0.0	0.0	0.1	10.1	0.0	0.0	0.0	0.0	0.0	41.4	5.6	0.4	0.0	0.0	3.1	0.2	0.0	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.0	1.8	0.0	0.4	6.6	0.0	2.7	41.8	249.0	0.0	0.0	0.0	0.1	14.2	0.1	0.0
PRR32	CXorf64	ENSG00000183631	"Proline rich 32"	B1ATL7	X	126819729-126821786	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"tongue: 22.6"	"Cell type enriched"	"Detected in single"	13	"Cardiomyocytes: 1.3"	"Cancer enriched"	"Detected in single"	5	"glioma: 0.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"basal ganglia: 3.5;hippocampal formation: 10.7;pons and medulla: 13.5;thalamus: 8.2"	"Not detected"	"Not detected"			HPA048386	Uncertain		Approved	"Nuclear speckles,Plasma membrane,Centrosome"		NA	NA			"Plasma membrane"	"Nuclear speckles, Centrosome"	"HPA048386: AB_2680380"					"unprognostic (7.10e-3)"	"unprognostic (7.97e-2)"				"unprognostic (3.79e-1)"						"unprognostic (2.98e-2)"		0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.5	0.0	2.2	0.1	0.2	0.0	0.2	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	22.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PSMA8	"MGC26605, PSMA7L"	ENSG00000154611	"Proteasome 20S subunit alpha 8"	Q8TAA3	18	26133852-26193355	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 17.1"	"Cell type enriched"	"Detected in some"	6	"Spermatocytes: 229.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	72	"Daudi: 25.5;JURKAT: 7.1;U-266/70: 15.9;U-266/84: 17.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (5.39e-3)"	"unprognostic (7.45e-5)"			"unprognostic (2.94e-1)"	"unprognostic (3.04e-2)"		"unprognostic (1.59e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.30e-2)"		"unprognostic (7.54e-4)"	"unprognostic (4.80e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.56e-1)"		0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.1	17.1	0.0	0.5	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	17.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	1.4	0.8	1.2	0.0	1.2	0.9	1.9	0.1	0.4	0.0	0.7	1.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.5	0.4	0.1	0.0	0.0	10.3	0.0	0.0	0.1	0.0	0.4	0.6	0.0	2.8	0.1	0.0	0.0	0.0	0.3	0.7	0.1	0.2	0.0	0.4	0.0	0.0	0.0	0.2	6.9	1.2	0.3	1.8	1.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	1.5	2.4	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	229.1	37.2	0.0	0.0	1.0	0.7	0.5	0.0	0.0
SAGE1	"CT14, SAGE"	ENSG00000181433	"Sarcoma antigen 1"	Q9NXZ1	X	135889205-135913061	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	10	"testis: 4.9"	"Cell type enriched"	"Detected in some"	9	"Spermatogonia: 9.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 20.5;K-562: 15.6;Karpas-707: 25.5;U-2 OS: 7.0;U-266/70: 8.9;U-266/84: 23.8"									"HPA003033, HPA003208"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA003033: AB_1079865, HPA003208: AB_1079863"				"unprognostic (1.11e-1)"	"unprognostic (5.26e-2)"			"unprognostic (1.15e-1)"		"unprognostic (1.02e-2)"	"unprognostic (2.37e-1)"		"unprognostic (7.12e-4)"	"unprognostic (1.45e-2)"	"unprognostic (1.10e-1)"			0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.4	0.4	0.1	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	4.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.6	25.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	8.9	23.8	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.2	0.3	0.4	0.4	0.1	0.4	0.3	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SEPTIN14	"FLJ44060, SEPT14"	ENSG00000154997	"Septin 14"	Q6ZU15	7	55793540-55862755	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"testis: 22.7"	"Cell type enriched"	"Detected in single"	5	"Extravillous trophoblasts: 1.1"	"Cancer enriched"	"Detected in some"	10	"glioma: 6.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 6.2;U-266/84: 5.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA073255	Enhanced					NA	NA					"HPA073255: AB_2686590"					"unprognostic (1.29e-1)"					"unprognostic (3.50e-1)"				"unprognostic (1.98e-2)"	"unprognostic (1.57e-1)"			0.9	0.6	1.1	1.4	1.2	2.3	1.0	1.5	1.5	0.7	0.4	0.6	0.5	1.0	1.0	0.7	0.7	0.9	0.6	1.1	1.0	1.1	2.3	0.7	1.0	1.0	0.8	1.0	1.1	0.6	1.2	1.4	1.1	1.4	1.2	0.8	2.0	0.8	0.5	0.6	1.4	0.5	0.7	0.6	1.2	0.9	22.7	1.0	1.3	1.2	0.6	0.9	0.8	0.0	1.7	1.2	0.3	1.3	2.9	1.3	1.0	6.2	0.8	0.7	0.6	0.9	0.2	0.8	0.9	0.2	0.5	1.3	1.1	1.4	1.0	1.7	1.6	0.7	0.6	2.3	2.3	2.8	1.3	1.4	1.1	1.8	0.8	1.5	1.2	0.7	2.2	2.3	1.3	1.0	0.6	1.8	1.7	1.1	2.0	0.2	0.7	1.2	1.4	1.0	0.9	1.0	1.3	0.3	0.7	1.2	1.4	0.8	1.8	0.6	0.8	0.8	0.9	0.6	1.7	5.7	1.3	0.7	4.6	1.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	1.1	1.2	1.5	1.5	1.1	1.0	1.0	0.8	1.0	1.4	0.6	1.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SGCG	"A4, DAGA4, DMDA, DMDA1, LGMD2C, MAM, MGC130048, SCARMD2, SCG3, TYPE"	ENSG00000102683	"Sarcoglycan gamma"	Q13326	13	23180979-23325162	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"			"Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"heart muscle: 119.9;skeletal muscle: 159.5;tongue: 145.3"	"Cell type enriched"	"Detected in some"	10	"Cardiomyocytes: 134.3"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"cerebral cortex: 1.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"fHDF/TERT166: 66.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA007476	Enhanced					NA	NA					"HPA007476: AB_1079946"	"unprognostic (5.19e-2)"	"unprognostic (8.28e-2)"	"unprognostic (5.15e-3)"	"unprognostic (1.64e-4)"	"unprognostic (3.00e-3)"	"unprognostic (3.61e-2)"		"unprognostic (8.14e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.49e-1)"	"unprognostic (6.05e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.98e-3)"	"unprognostic (1.07e-1)"	14.4	0.6	0.0	0.1	0.0	0.0	2.2	0.0	1.8	0.3	0.0	0.9	0.1	0.1	8.0	3.3	1.1	0.8	119.9	0.3	0.0	0.3	0.0	4.9	0.0	0.3	0.0	0.0	0.2	0.1	2.1	0.3	0.0	0.3	3.2	0.6	0.3	4.3	0.4	159.5	3.4	0.6	0.1	0.0	0.1	0.9	1.6	0.2	0.1	0.1	145.3	0.1	3.0	1.4	0.3	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	66.6	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	12.2	0.0	0.2	0.7	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.5	0.0	0.5	0.4	0.0	0.1	0.0	0.2	0.4	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.3	0.0	0.3	0.0	0.0	0.3	0.0	0.2	0.3	0.2	0.0	0.0	0.3	0.0	3.3	0.1	0.0	0.0	0.0	0.0	0.1	134.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	1.3	0.0	0.0	12.5	0.0	0.0	11.2	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	1.6	0.0	0.0	0.0	3.4	3.0	7.5	0.2	5.4	1.0	0.0	0.0	0.0	0.5	1.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	1.2	3.8	13.2	0.0	1.0	0.0	0.1	0.0	0.0	0.0
SLC35G6	"AMAC1L3, TMEM21B"	ENSG00000259224	"Solute carrier family 35 member G6"	P0C7Q6	17	7481332-7483496	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	10	"testis: 5.2"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 31.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"													NA	NA						"unprognostic (3.81e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.11e-3)"		"unprognostic (1.37e-2)"	"unprognostic (1.65e-3)"	"unprognostic (3.29e-1)"	"unprognostic (9.19e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.13e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.01e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	1.6	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0
SLC5A1	"D22S675, NAGT, SGLT1"	ENSG00000100170	"Solute carrier family 5 member 1"	P13866	22	32043261-32113029	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Sugar transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"intestine: 532.9"	"Cell type enriched"	"Detected in many"	6	"Proximal enterocytes: 768.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 20.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"OE19: 34.2"	"Region enriched"	"Detected in single"	26	"cerebellum: 7.6"	"Low region specificity"	"Detected in many"			"CAB015467, HPA051805, HPA055106"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Golgi apparatus"	"Nuclear membrane, Cytosol"	"CAB015467: , HPA051805: AB_2681618, HPA055106: AB_2682695"	"unprognostic (1.96e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.24e-2)"	"prognostic favorable (2.59e-4)"	"unprognostic (3.85e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.22e-2)"	"unprognostic (4.83e-2)"	"unprognostic (6.21e-2)"	"unprognostic (9.53e-2)"	"prognostic favorable (6.97e-7)"	"unprognostic (4.68e-3)"	"unprognostic (1.98e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.45e-2)"	0.1	0.0	0.1	4.2	0.1	0.0	9.8	0.2	0.2	12.4	0.0	10.1	532.9	0.5	3.5	5.1	1.1	27.1	52.7	0.1	0.1	6.7	1.7	2.2	0.3	0.1	0.0	0.1	0.0	1.7	0.3	1.0	0.0	0.2	3.0	9.8	0.2	19.2	2.4	0.3	13.3	304.9	0.7	0.0	2.9	7.3	2.3	0.4	0.1	0.0	0.0	4.1	0.0	6.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.6	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	34.2	0.0	0.0	0.0	2.1	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.0	0.1	0.2	0.0	0.4	0.2	0.1	0.0	0.0	0.3	0.2	0.6	1.7	4.2	0.0	0.0	11.6	6.5	115.2	115.8	8.2	0.0	0.0	0.0	0.2	19.8	0.0	3.0	38.4	2.4	1.4	1.0	25.4	0.0	0.4	1.4	0.0	1.4	5.6	10.3	0.0	0.0	0.0	0.3	0.0	0.0	0.3	34.1	0.0	0.0	0.0	71.3	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	32.6	1.5	0.0	17.6	768.7	6.4	2.0	0.0	0.0	0.0	0.7	10.1	4.2	2.0	5.5	0.0	0.1	0.1	41.2	6.7
SPDYE4		ENSG00000183318	"Speedy/RINGO cell cycle regulator family member E4"	A6NLX3	17	8753106-8758559	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	10	"testis: 7.9"	"Cell type enriched"	"Detected in some"	6	"Early spermatids: 22.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.6;HeLa: 1.7;NB-4: 1.0"					"Not detected"	"Not detected"			"HPA025704, HPA051750"	Enhanced					NA	NA					"HPA025704: AB_1853093, HPA051750: AB_2681590"										"unprognostic (3.20e-1)"	"unprognostic (7.16e-4)"		"unprognostic (3.15e-3)"			"unprognostic (2.79e-1)"		0.0	0.1	0.6	0.2	0.1	0.8	0.0	0.3	0.7	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.1	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.2	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.2	7.9	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.7	0.3	1.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.7	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.5	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.2	0.1	0.2	0.3	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.4	0.3	0.2	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.1	0.3	0.7	0.2	0.2	0.1	0.1	0.0	0.2	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
STAR	STARD1	ENSG00000147465	"Steroidogenic acute regulatory protein"	P49675	8	38142700-38150992	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Lipid transport, Steroidogenesis, Transport"		"Congenital adrenal hyperplasia, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"adrenal gland: 5115.5"	"Cell type enriched"	"Detected in some"	44	"Theca cells: 2243.4"	"Group enriched"	"Detected in some"	4	"head and neck cancer: 1.0;lung cancer: 0.8;ovarian cancer: 1.4;testis cancer: 3.0"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	7	"basophil: 2.4"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 2.4"	"Cell line enriched"	"Detected in some"	5	"K-562: 436.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023644, HPA027318, CAB032598"	Enhanced					NA	NA					"CAB032598: AB_2115937, HPA023644: AB_10598916, HPA027318: AB_10601574"	"unprognostic (1.60e-4)"	"unprognostic (3.20e-2)"	"unprognostic (9.17e-2)"	"unprognostic (3.28e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.96e-2)"	"unprognostic (2.12e-5)"	"unprognostic (3.30e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.77e-3)"	"unprognostic (6.65e-2)"	"unprognostic (4.75e-9)"	"unprognostic (1.58e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.48e-2)"	"unprognostic (6.16e-2)"	1.7	5115.5	2.3	3.2	1.9	2.1	0.4	1.7	3.4	0.7	0.8	0.4	0.2	0.5	0.6	2.2	6.4	0.2	0.7	1.5	3.8	0.4	1.2	0.5	1.0	3.6	2.6	2.0	501.3	0.9	0.0	2.2	0.5	4.6	0.5	0.1	0.6	1.8	0.3	0.4	4.5	0.6	0.4	1.6	1.0	0.7	89.0	3.2	3.1	0.4	0.0	1.9	0.5	3.3	3.6	0.1	0.0	0.8	0.2	0.3	3.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.7	0.1	0.1	0.0	0.1	0.1	0.5	0.0	0.1	0.0	88.9	0.8	5.3	1.3	3.8	0.1	12.4	0.3	0.1	0.1	0.8	0.0	0.3	436.1	0.2	0.0	0.0	0.4	43.7	9.6	0.1	0.1	0.0	0.0	0.0	0.0	0.2	1.2	1.2	0.2	0.0	0.2	0.0	0.1	43.0	1.5	0.1	0.0	0.2	0.1	0.2	0.2	0.0	0.3	9.3	0.2	2.4	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.3	0.1	0.0	0.0	0.2	0.0	2.3	1.9	1.7	3.4	1.5	3.8	3.6	2.6	2.0	4.6	1.6	3.2	3.6	0.0	0.0	0.0	0.7	0.1	9.4	0.7	0.8	4.0	1.1	0.1	1.1	0.6	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.1	1.9	10.7	0.6	0.0	0.0	1.4	0.0	0.0	25.7	0.0	0.3	0.0	1.4	0.0	0.0	0.2	0.0	2.8	0.0	0.0	0.0	0.7	10.2	50.1	0.2	3.6	0.0	0.0	0.6	0.0	0.5	0.3	0.1	0.0	4.1	0.0	0.2	0.0	0.0	0.4	0.6	0.0	0.2	3.0	4.8	0.8	1.7	11.2	0.1	0.1	2243.4	0.0	0.1
TECRL	"DKFZp313B2333, DKFZp313D0829, GPSN2L, SRD5A2L2, TERL"	ENSG00000205678	"Trans-2,3-enoyl-CoA reductase like"	Q5HYJ1	4	64275257-64409468	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"heart muscle: 559.4"	"Cell type enriched"	"Detected in some"	35	"Cardiomyocytes: 1775.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA																							0.0	0.3	0.1	0.1	0.3	1.0	0.6	0.8	0.4	0.0	0.2	0.0	0.0	0.2	0.0	0.4	0.1	0.1	559.4	0.1	0.5	0.0	0.0	0.2	0.4	0.2	0.2	0.0	0.1	0.5	0.1	0.0	0.1	0.4	1.7	0.0	0.5	0.3	0.0	56.8	1.0	0.0	0.0	0.1	0.1	0.1	0.1	0.3	0.0	0.7	2.0	0.0	0.3	0.0	1.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.8	0.4	0.1	0.5	0.2	0.2	0.0	0.4	0.1	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1775.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.2	0.0	0.0	50.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.6	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRAV14DV4	"hADV14S1, TCRAV6S1-hDV104S1, TRAV14/DV4"	ENSG00000211792	"T cell receptor alpha variable 14/delta variable 4"	A0A0A6YYC5	14	21924063-21924651	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"lymphoid tissue: 25.9"	"Cell type enriched"	"Detected in single"	12	"T-cells: 6.2"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"memory CD4 T-cell: 38.2;memory CD8 T-cell: 78.1;naive CD4 T-cell: 30.7;naive CD8 T-cell: 122.3;T-reg: 42.6"	"Lineage enriched"	"Detected in single"	176	"T-cells: 122.3"	"Cell line enhanced"	"Detected in single"		"JURKAT: 1.6"															NA	NA						"unprognostic (6.82e-3)"	"unprognostic (1.00e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.06e-3)"		"unprognostic (3.00e-5)"	"unprognostic (2.52e-1)"	"unprognostic (7.61e-4)"	"unprognostic (3.77e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.62e-5)"	"unprognostic (3.01e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.60e-2)"	0.6	0.1	0.0	4.2	0.1	1.5	0.6	0.0	0.1	0.5	0.0	0.8	2.0	0.3	0.0	0.6	0.7	1.6	0.2	0.0	0.0	0.2	1.1	2.5	12.8	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	1.2	0.0	0.2	0.1	0.0	0.2	1.7	0.1	0.0	3.5	1.4	0.0	0.1	25.9	0.2	0.0	8.1	1.7	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.2	9.9	0.1	38.2	78.1	0.0	0.2	30.7	122.3	0.3	0.4	0.3	0.0	42.6	21.3	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0
TRAV24		ENSG00000211805	"T cell receptor alpha variable 24"	A0A0B4J272	14	22105343-22105846	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"lymphoid tissue: 21.6"	"Cell type enriched"	"Detected in single"	11	"T-cells: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	24	"memory CD4 T-cell: 24.4;memory CD8 T-cell: 47.5;naive CD4 T-cell: 22.4;naive CD8 T-cell: 66.5;T-reg: 40.9"	"Lineage enriched"	"Detected in single"	244	"T-cells: 66.5"	"Not detected"	"Not detected"																	NA	NA						"unprognostic (1.96e-3)"	"unprognostic (2.05e-3)"	"unprognostic (3.76e-2)"			"unprognostic (1.79e-4)"		"unprognostic (5.42e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.79e-3)"	"unprognostic (3.31e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.47e-5)"	"unprognostic (3.62e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.44e-2)"		0.2	0.0	0.1	3.8	0.2	0.4	0.2	0.0	0.2	0.2	0.0	0.6	1.0	0.2	0.0	0.0	0.6	0.9	0.0	0.0	0.1	0.0	1.0	1.4	7.4	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	2.1	0.0	0.6	0.0	0.0	0.0	1.2	0.7	0.0	2.3	1.7	0.0	0.6	21.6	0.1	0.5	4.6	1.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.6	0.0	0.7	0.1	24.4	47.5	0.0	0.0	22.4	66.5	0.2	0.0	0.1	0.2	40.9	10.0	0.1	0.2	0.0	0.2	0.0	0.1	0.2	0.5	0.0	0.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0
TRIM72	MG53	ENSG00000177238	"Tripartite motif containing 72"	Q6ZMU5	16	31214091-31231537	"Predicted intracellular proteins, Transporters"	"Exocytosis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"skeletal muscle: 153.3;tongue: 43.4"	"Cell type enriched"	"Detected in many"	5	"Skeletal myocytes: 45.6"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 0.9"	"Group enriched"	"Detected in many"	5	"cerebellum: 9.4;pons: 3.2"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HL-60: 7.2;LHCN-M2: 12.6;RH-30: 29.7;U-266/70: 17.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA054909	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA054909: AB_2682639"	"unprognostic (2.61e-1)"	"unprognostic (3.21e-3)"	"unprognostic (5.07e-2)"	"unprognostic (9.77e-2)"	"unprognostic (3.71e-1)"	"unprognostic (3.13e-1)"	"unprognostic (2.01e-3)"	"unprognostic (2.80e-1)"	"unprognostic (6.57e-2)"	"unprognostic (4.90e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.24e-10)"	"unprognostic (7.70e-2)"	"unprognostic (6.72e-2)"	"unprognostic (4.15e-1)"	"unprognostic (4.30e-4)"	0.2	0.2	0.9	0.2	0.8	0.8	0.2	9.4	1.1	0.1	0.4	0.2	0.2	0.2	0.3	1.0	0.1	0.2	0.7	0.7	0.5	0.1	0.1	0.2	0.3	1.1	0.8	0.6	0.2	0.3	0.1	0.0	0.2	3.2	1.9	0.1	0.8	2.5	0.1	153.3	0.5	0.2	0.1	0.2	0.3	0.3	0.3	0.6	0.1	0.2	43.4	0.2	0.1	0.0	1.3	0.1	0.1	0.2	0.4	0.2	0.1	0.3	0.3	0.1	0.0	0.0	0.2	0.4	0.2	0.1	0.1	0.2	0.2	0.1	0.0	0.0	0.3	0.1	0.2	0.7	0.2	0.2	7.2	0.3	1.2	0.1	0.0	0.1	0.1	0.0	0.2	0.3	0.8	12.6	0.1	0.1	0.5	0.2	0.2	0.2	0.3	29.7	4.1	0.0	0.2	2.6	0.2	0.1	0.3	0.1	0.3	0.2	2.6	0.1	0.2	0.2	0.2	0.1	17.9	1.7	0.2	0.2	0.4	0.2	1.9	0.3	0.5	0.3	0.3	0.3	0.4	0.3	0.2	0.3	0.6	0.4	0.3	1.5	0.6	0.4	0.6	0.2	0.1	0.9	0.8	9.4	1.1	0.7	0.5	1.1	0.8	0.6	3.2	0.2	0.6	1.3	4.7	3.2	3.8	0.0	0.8	0.1	3.1	0.0	0.0	1.0	3.1	8.0	3.0	0.0	2.5	0.0	2.1	0.3	2.4	0.0	0.0	0.0	0.3	1.5	4.7	1.5	0.0	0.0	0.2	0.0	0.3	2.5	0.0	4.0	1.3	0.8	0.4	0.0	0.2	0.0	0.1	0.2	0.0	1.2	0.3	0.0	0.0	3.1	0.0	0.0	0.6	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.3	1.9	0.1	0.1	0.0	0.9	0.0	45.6	2.2	0.1	0.2	0.8	0.3	0.1	2.2	1.2	0.9	1.5
ADSS1	"ADSSL1, FLJ38602"	ENSG00000185100	"Adenylosuccinate synthase 1"	Q8N142	14	104724229-104747325	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Purine biosynthesis"	Ligase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"skeletal muscle: 1285.2;tongue: 615.2"	"Cell type enriched"	"Detected in some"	20	"Cardiomyocytes: 137.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 15.2;MCF7: 14.2;OE19: 23.2;SiHa: 23.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052621	Enhanced					NA	NA		290000			"HPA052621: "	"unprognostic (2.23e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.72e-3)"	"unprognostic (5.14e-2)"	"unprognostic (2.81e-3)"	"unprognostic (3.46e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.35e-1)"	"prognostic unfavorable (4.99e-4)"	"unprognostic (2.33e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.78e-2)"	8.2	5.1	4.4	1.0	6.8	0.9	4.4	7.1	5.5	3.6	7.5	2.8	2.7	3.3	4.5	18.6	6.5	5.7	101.2	4.1	6.9	15.0	29.1	3.1	1.1	8.6	6.5	3.4	2.7	8.0	7.4	10.1	7.4	8.0	7.7	1.4	10.2	10.8	4.1	1285.2	5.5	2.8	2.3	5.8	2.0	6.5	18.6	6.9	1.0	7.5	615.2	0.8	6.6	5.4	8.3	0.1	3.2	2.4	7.1	1.7	1.1	0.8	0.9	1.3	0.2	0.7	0.2	2.5	0.0	15.2	0.8	0.5	1.3	0.2	0.5	0.6	1.0	0.5	0.1	7.9	1.1	1.8	0.0	6.0	3.2	2.3	0.0	2.6	2.7	0.4	0.3	2.9	0.1	1.2	14.2	0.0	0.7	2.1	23.2	1.3	0.2	0.3	0.9	0.5	1.7	2.0	4.2	23.1	1.0	3.3	1.8	7.1	2.1	0.8	0.1	0.6	1.6	0.1	4.4	3.5	0.0	2.2	1.0	1.5	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	4.4	6.8	7.1	5.5	4.1	6.9	8.6	6.5	3.4	8.0	5.8	6.9	8.3	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	137.4	0.0	0.0	0.0	0.0	3.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.7	6.6	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0
AMZ1	KIAA1950	ENSG00000174945	"Archaelysin family metallopeptidase 1"	Q400G9	7	2679522-2775500	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	9	"brain: 7.8"	"Cell type enriched"	"Detected in some"	5	"Oligodendrocyte precursor cells: 104.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 7.0;MCF7: 7.5;SK-BR-3: 5.2;T-47d: 27.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020233	Uncertain					NA	NA					"HPA020233: AB_1844818"	"unprognostic (9.08e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.81e-1)"	"unprognostic (5.72e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.16e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.64e-9)"	"unprognostic (1.60e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.13e-1)"	0.0	0.0	7.8	0.2	6.3	0.4	0.1	3.7	4.8	0.9	0.0	0.0	0.1	0.9	0.0	0.0	0.3	0.1	0.1	3.9	2.0	0.0	0.8	0.5	0.2	3.9	3.9	5.4	0.2	0.1	0.0	0.6	0.8	4.2	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.7	0.8	0.4	0.0	0.6	6.5	0.0	0.0	0.0	0.3	0.1	0.3	2.1	0.0	0.0	0.0	0.0	0.0	0.0	7.0	2.3	3.4	1.6	2.2	0.0	1.0	0.6	0.2	2.2	0.2	0.0	0.0	0.0	1.6	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	1.5	0.0	7.5	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	5.2	0.0	0.1	27.7	0.0	0.0	0.1	0.1	0.1	0.1	1.0	0.2	0.0	0.6	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	7.8	6.3	3.7	4.8	3.9	2.0	3.9	3.9	5.4	4.2	0.8	6.5	2.1	0.1	0.0	0.5	14.4	0.9	0.0	0.1	0.0	0.0	0.8	0.3	0.3	3.3	0.0	0.0	0.0	4.2	0.3	1.6	0.0	0.0	0.0	18.8	0.5	1.6	0.4	0.0	0.0	6.1	0.0	9.8	0.3	0.0	0.3	0.0	0.0	0.0	0.0	1.8	0.0	10.6	0.2	0.0	0.0	1.9	9.9	0.0	1.7	1.8	5.6	0.0	0.0	0.0	104.5	20.7	0.4	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.7	0.0	0.2	0.4	0.0	0.3	0.0	0.1	0.1	0.8	0.0	0.0	0.1
BARHL2		ENSG00000143032	"BarH like homeobox 2"	Q9NY43	1	90711539-90717302	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 27.2"	"Cell type enriched"	"Detected in some"	4	"Horizontal cells: 23.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"cerebellum: 27.2;pons: 8.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 1.0;HEK 293: 3.7;HMC-1: 1.0"	"Region enriched"	"Detected in many"	5	"cerebellum: 12.9"	"Region enriched"	"Detected in some"	20	"cerebellum: 24.6"							NA	NA										"unprognostic (1.83e-1)"				"unprognostic (1.73e-1)"	"unprognostic (6.80e-2)"				"unprognostic (3.10e-1)"	"unprognostic (1.60e-1)"			0.0	0.0	0.3	0.0	0.1	0.0	0.0	27.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.5	2.7	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	3.7	0.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	27.2	0.6	0.0	1.3	0.5	2.7	0.0	8.6	0.2	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	4.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BTLA	"BTLA1, CD272"	ENSG00000186265	"B and T lymphocyte associated"	Q7Z6A9	3	112463966-112499472	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"lymphoid tissue: 28.9"	"Cell type enriched"	"Detected in some"	4	"B-cells: 66.2"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"memory B-cell: 65.0;naive B-cell: 96.5;plasmacytoid DC: 24.9"	"Group enriched"	"Detected in many"	4	"B-cells: 96.5;dendritic cells: 24.9"	"Cell line enhanced"	"Detected in single"		"U-698: 2.0"	"Not detected"	"Not detected"							"HPA047211, HPA062029"	Enhanced					NA	NA					"HPA047211: AB_2679983, HPA062029: AB_2684665"	"unprognostic (1.13e-3)"	"unprognostic (2.13e-3)"	"unprognostic (5.79e-4)"	"unprognostic (1.01e-4)"	"unprognostic (7.08e-2)"	"unprognostic (7.74e-6)"	"unprognostic (6.20e-3)"	"unprognostic (7.59e-3)"	"unprognostic (5.98e-2)"	"unprognostic (1.53e-5)"	"unprognostic (2.33e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.57e-5)"	"unprognostic (2.57e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.42e-2)"	0.4	0.3	0.0	11.3	0.0	2.1	2.0	0.1	0.4	0.5	0.1	1.7	1.6	0.3	0.1	0.6	0.3	1.1	0.3	0.1	0.0	0.3	0.6	0.9	26.6	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.1	0.4	1.7	0.2	1.4	0.1	0.1	0.1	3.1	0.4	0.0	10.9	3.0	0.1	0.1	7.8	0.3	0.1	28.9	2.0	0.1	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.2	0.1	0.0	11.2	0.0	8.3	65.0	13.6	6.5	4.6	96.5	12.7	12.6	0.5	0.3	0.1	24.9	3.4	6.5	0.0	0.0	0.1	0.4	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.5	0.0	66.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	2.3	0.8	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	1.5	1.3	0.0	0.4	0.2	0.1	0.0	0.4	0.0	0.0	1.3	4.7	3.6	0.0	1.6	7.2	0.0	1.9	0.0	0.0	1.0	0.3	0.0	0.0	0.0	15.9	0.0	0.0	0.2	0.7	0.0	0.0	0.3	0.1	0.2	0.3	0.0	0.3	0.1	8.6	0.0	0.0	0.1
C3	"ARMD9, C3a, C3b, CPAMD1"	ENSG00000125730	"Complement C3"	P01024	19	6677704-6730562	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Fatty acid metabolism, Immunity, Inflammatory response, Innate immunity, Lipid metabolism"		"Age-related macular degeneration, Disease variant, FDA approved drug targets, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	9	"liver: 4800.7"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 4512.2"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 1213.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"non-classical monocyte: 13.3"	"Lineage enriched"	"Detected in many"	4	"monocytes: 13.3"	"Group enriched"	"Detected in many"	7	"BJ hTERT+: 357.8;EFO-21: 738.6;Hep G2: 795.3;HSkMC: 534.8;SiHa: 209.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003563, CAB004209, HPA020432"	Enhanced				"Secreted to blood"	NA	NA	1260000000000	200000000000			"CAB004209: AB_627277, HPA003563: AB_1847117, HPA020432: AB_1847118"	"unprognostic (3.26e-3)"	"unprognostic (3.91e-1)"	"unprognostic (3.92e-1)"	"unprognostic (5.98e-3)"	"unprognostic (3.31e-1)"	"unprognostic (1.04e-1)"	"prognostic favorable (8.11e-4)"	"unprognostic (1.99e-1)"	"unprognostic (9.26e-2)"	"unprognostic (5.80e-2)"	"unprognostic (8.12e-3)"	"unprognostic (5.48e-2)"	"prognostic unfavorable (1.09e-5)"	"unprognostic (2.63e-2)"	"unprognostic (2.49e-2)"	"unprognostic (6.03e-3)"	"unprognostic (3.88e-1)"	532.8	288.8	38.7	196.1	49.2	1.5	215.8	48.9	44.2	239.5	34.6	119.9	23.1	83.6	41.4	77.1	353.4	358.2	161.1	33.4	208.8	50.0	4800.7	177.5	68.7	146.6	73.5	21.3	230.0	184.2	18.0	21.9	17.8	107.3	35.7	77.3	11.8	156.9	57.9	36.9	50.8	157.8	124.2	85.4	7.2	108.8	41.5	84.8	34.4	93.2	52.4	127.5	366.8	102.1	170.5	65.0	23.0	0.0	0.1	10.8	36.0	74.7	5.2	357.8	6.8	12.6	3.6	49.5	1.9	738.6	0.3	54.2	46.6	0.2	43.1	6.9	24.0	0.5	3.1	31.2	795.3	16.3	6.2	9.1	534.8	12.8	60.8	27.3	9.5	0.0	0.0	2.1	0.8	0.2	1.0	0.6	1.6	1.5	0.7	0.1	0.4	5.0	0.3	32.1	6.2	0.5	0.5	209.5	0.1	0.5	0.1	17.2	8.8	3.5	5.7	7.4	4.8	3.6	1.6	4.8	4.5	75.1	4.5	0.3	1.7	1.3	0.6	0.3	2.5	0.2	0.5	0.2	0.1	0.7	0.5	0.2	0.2	3.0	1.3	13.3	0.5	0.1	0.9	38.7	49.2	48.9	44.2	33.4	208.8	146.6	73.5	21.3	107.3	85.4	84.8	170.5	36.4	76.9	473.9	0.7	29.4	27.5	14.7	141.5	0.6	0.7	19.5	23.4	14.5	783.5	422.5	16.5	0.0	1.4	2.0	0.2	5.9	494.1	45.9	23.0	63.5	26.2	0.0	209.9	0.4	136.7	1.4	482.2	17.9	57.7	5.1	0.1	124.9	4512.2	34.4	0.0	0.5	0.9	20.3	164.5	44.8	97.5	226.2	45.1	35.6	70.3	14.6	1.2	0.0	0.5	0.6	376.4	0.2	10.9	3.9	13.3	1.9	53.6	177.5	4.6	6.6	20.1	49.1	4.0	7.7	5.2	21.9	2.7	15.0	0.1	0.4	38.2
CABP2	DFNB93	ENSG00000167791	"Calcium binding protein 2"	Q9NPB3	11	67518912-67524517	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Hearing, Sensory transduction, Vision"		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	9	"retina: 7.4"	"Cell type enriched"	"Detected in some"	14	"Bipolar cells: 100.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	22	"cerebellum: 9.3"	"Not detected"	"Not detected"									NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	100.2	0.0	0.0	0.1	0.0	0.0	0.0	4.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CAPN8	nCL-2	ENSG00000203697	"Calpain 8"	A6NHC0	1	223538007-223665723	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"stomach 1: 293.7"	"Cell type enriched"	"Detected in many"	6	"Gastric mucus-secreting cells: 910.8"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 28.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"OE19: 125.9;RT4: 76.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA073939			Approved	"Nucleoplasm,Nuclear membrane,Vesicles"		No	NA			"Nucleoplasm, Nuclear membrane, Vesicles"		"HPA073939: AB_2686646"	"unprognostic (4.87e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.97e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.72e-3)"	"unprognostic (3.55e-1)"	"unprognostic (4.12e-6)"	"unprognostic (6.95e-2)"	"unprognostic (5.59e-2)"	"unprognostic (3.83e-2)"	"unprognostic (5.44e-3)"	0.3	0.2	4.6	6.3	1.1	0.1	15.1	0.1	3.0	1.0	1.6	23.8	8.1	0.1	11.2	0.6	1.3	14.4	0.0	2.3	3.1	1.6	0.3	21.5	0.1	2.2	1.3	0.6	0.2	3.0	0.0	0.1	0.3	1.0	2.9	33.3	0.3	8.6	1.4	0.8	1.7	4.6	1.1	1.3	0.3	293.7	0.6	1.7	0.0	0.2	0.0	0.4	12.4	0.7	2.3	1.5	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.8	0.0	4.6	0.0	0.1	0.0	0.2	8.3	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	1.0	0.2	0.0	0.2	125.9	3.8	0.1	0.0	0.0	1.3	76.8	1.2	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	4.6	1.1	0.1	3.0	2.3	3.1	2.2	1.3	0.6	1.0	1.3	1.7	2.3	0.4	28.9	131.7	1.6	1.8	0.1	6.5	1.9	0.0	0.0	19.9	7.9	2.6	10.0	55.9	25.8	0.0	0.2	0.2	90.9	0.0	3.8	2.3	2.0	0.3	0.7	3.0	0.0	0.6	21.6	0.0	0.3	910.8	2.1	10.8	5.2	0.0	0.3	0.6	0.0	0.1	61.9	4.1	0.0	0.8	6.7	1.8	1.8	0.0	0.0	0.0	0.0	1.0	0.0	0.1	36.1	42.6	3.4	3.5	4.0	2.1	1.5	15.0	0.0	0.0	0.3	0.8	0.4	1.0	0.0	0.0	0.1	1.4	2.9	21.2	31.2
CCM2L	"C20orf160, dJ310O13.5"	ENSG00000101331	"CCM2 like scaffold protein"	Q9NUG4	20	32010438-32032180	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"lymphoid tissue: 142.7"	"Cell type enriched"	"Detected in some"	5	"Theca cells: 248.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 8.2;HUVEC TERT2: 9.0;NTERA-2: 4.6;RH-30: 3.2;SCLC-21H: 7.7;TIME: 4.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA008434, HPA071063"	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA008434: AB_1845671, HPA071063: AB_2686339"	"unprognostic (1.71e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.43e-3)"	"unprognostic (5.84e-3)"	"unprognostic (1.91e-1)"	"unprognostic (3.09e-3)"	"unprognostic (1.27e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.00e-3)"	"unprognostic (7.84e-2)"	"unprognostic (4.66e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-1)"	15.6	5.4	7.1	1.6	6.5	0.0	15.1	9.0	6.9	8.3	4.3	4.4	1.3	9.0	0.6	3.7	7.8	2.5	16.5	5.6	5.4	9.5	2.3	11.9	1.5	6.2	6.0	5.5	3.7	2.7	1.4	4.2	7.9	6.6	5.9	1.1	0.4	3.4	1.8	4.8	3.8	5.4	3.3	5.2	142.7	4.3	1.6	6.5	0.8	10.3	4.9	0.9	6.4	6.4	6.2	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	9.0	0.9	0.0	0.0	0.0	2.4	0.0	0.0	4.6	0.1	0.0	0.6	3.2	0.1	0.0	0.0	7.7	0.9	0.2	0.0	0.0	1.1	2.5	0.0	4.8	0.0	1.3	0.0	0.0	0.1	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	6.5	9.0	6.9	5.6	5.4	6.2	6.0	5.5	6.6	5.2	6.5	6.2	45.8	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.6	0.5	0.6	4.6	2.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.2	32.1	0.0	0.0	2.9	0.2	0.0	1.0	0.0	0.2	0.0	4.3	24.3	0.0	0.0	3.3	2.4	0.0	0.0	0.3	0.3	0.4	0.0	0.2	0.0	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.6	1.8	0.3	0.6	0.1	0.3	0.0	0.1	248.7	0.0	0.1
CEACAM3	"CD66d, CGM1"	ENSG00000170956	"CEA cell adhesion molecule 3"	P40198	19	41796587-41811554	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"bone marrow: 44.7"	"Cell type enriched"	"Detected in some"	13	"Paneth cells: 56.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	6	"neutrophil: 289.3"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 289.3"	"Not detected"	"Not detected"											HPA011041	Approved					NA	NA					"HPA011041: AB_1078481"	"unprognostic (1.60e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.19e-1)"	"unprognostic (8.09e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.68e-2)"	"unprognostic (8.44e-2)"	"unprognostic (2.83e-1)"	0.9	0.1	0.1	5.2	0.1	44.7	0.1	0.1	0.8	0.1	0.5	0.2	0.0	0.2	0.0	0.4	0.3	0.3	0.3	0.1	0.1	0.1	0.6	1.9	0.2	0.1	0.1	0.1	0.0	0.3	0.0	0.0	0.3	0.4	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.2	0.2	0.0	5.1	0.1	0.0	0.1	0.6	0.1	1.3	0.4	1.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	4.2	0.0	0.0	19.3	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	289.3	0.0	45.8	0.0	0.0	3.2	0.1	0.1	0.1	0.8	0.1	0.1	0.1	0.1	0.1	0.4	0.0	0.1	0.2	0.0	3.2	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.1	0.8	0.0	0.0	0.3	0.0	3.3	0.0	1.4	0.0	4.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	56.4	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.4	0.4
CGB5	HCG	ENSG00000189052	"Chorionic gonadotropin subunit beta 5"	P0DN86	19	49043848-49045311	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"pituitary gland: 8.7;placenta: 25.8"	"Cell type enriched"	"Detected in some"	4	"Syncytiotrophoblasts: 19.7"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 10.0;testis cancer: 5.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	25	"BEWO: 120.1;U-251 MG: 53.2"									"HPA038925, HPA038934"	Supported		Approved	Cytosol	"Secreted to blood"	NA	NA			Cytosol		"HPA038925: AB_2676272, HPA038934: AB_2676277"		"unprognostic (1.38e-1)"				"unprognostic (1.68e-1)"					"unprognostic (1.51e-3)"			"prognostic unfavorable (1.18e-5)"	"unprognostic (1.07e-1)"		"prognostic unfavorable (9.47e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.8	0.1	8.7	25.8	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.8	0.4	0.0	0.0	0.0	0.0	120.1	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	3.5	0.0	0.0	0.0	0.1	2.2	0.0	53.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.7	0.0	0.0	0.0	0.0
CHRM5		ENSG00000184984	"Cholinergic receptor muscarinic 5"	P08912	15	33968497-34067458	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 14.3"	"Cell type enriched"	"Detected in some"	9	"Oligodendrocytes: 178.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.6;HMC-1: 10.4;NB-4: 1.9"	"Region enhanced"	"Detected in many"		"hypothalamus: 13.2"	"Low region specificity"	"Detected in many"			HPA013172	Uncertain					NA	NA					"HPA013172: AB_1854212"	"unprognostic (8.19e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.67e-2)"	"unprognostic (4.32e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.27e-2)"	"unprognostic (4.61e-4)"	"unprognostic (7.95e-2)"	"unprognostic (1.33e-6)"	"unprognostic (1.42e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.38e-1)"	"unprognostic (9.07e-2)"	0.1	0.1	2.9	0.3	6.0	0.4	0.3	3.6	5.8	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.1	0.1	0.0	1.7	6.5	0.1	0.6	0.1	0.3	10.7	7.9	1.1	0.1	0.3	0.0	0.2	1.5	8.5	0.1	0.0	1.3	0.1	0.0	0.2	0.4	0.5	0.0	3.9	0.2	0.1	1.5	13.9	0.0	0.6	0.0	0.1	0.0	0.1	14.3	0.1	0.1	0.5	0.2	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.2	0.6	0.2	0.2	0.0	0.4	10.4	0.3	0.0	0.1	0.0	0.1	0.0	0.3	0.5	1.0	0.0	0.1	0.2	1.9	0.1	0.2	0.1	0.1	0.2	0.1	0.0	0.3	0.2	0.2	0.2	0.6	0.2	0.1	0.1	1.0	0.1	0.1	0.2	0.2	0.1	0.7	0.2	0.3	0.0	0.2	0.3	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.2	0.0	0.0	2.9	6.0	3.6	5.8	1.7	6.5	10.7	7.9	1.1	8.5	3.9	13.9	14.3	0.1	0.0	0.0	3.3	0.0	0.0	0.1	0.0	0.0	3.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	1.5	0.2	0.0	1.9	0.0	5.9	0.2	0.1	0.0	0.0	0.0	8.7	0.0	18.9	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	12.6	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	2.8	0.1	0.2	1.0	2.5	178.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.8	0.0	0.1	0.0	0.4	0.9	0.0	0.0	0.8	0.0	0.2	0.0	0.0
CR1L		ENSG00000197721	"Complement C3b/C4b receptor 1 like"	Q2VPA4	1	207645113-207738416	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	9	"bone marrow: 1.5"	"Cell type enriched"	"Detected in some"	18	"Erythroid cells: 128.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HEL: 1.3;HMC-1: 2.9;K-562: 1.6"									HPA049348	Approved				"Secreted in other tissues"	NA	NA					"HPA049348: AB_2680723"	"unprognostic (2.35e-2)"	"unprognostic (8.27e-2)"	"unprognostic (1.99e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.01e-1)"	"unprognostic (7.45e-2)"	"unprognostic (5.27e-2)"	"unprognostic (8.21e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.02e-1)"	"unprognostic (6.33e-2)"	"unprognostic (2.02e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.31e-2)"	"unprognostic (9.68e-2)"	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.0	0.0	0.1	0.5	0.5	0.0	0.3	1.8	0.0	0.1	0.0	0.0	5.9	0.4	0.2	6.9	0.2	1.8	0.0	128.6	0.4	0.0	0.1	0.2	0.0	1.0	0.0	0.0	3.6	0.2	1.2	0.0	0.4	0.0	2.0	0.3	0.3	0.4	0.0	0.5	0.0	1.0	1.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.4	0.0	0.2	3.3	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.3	0.3	0.1	0.1	0.0	0.2
DAZ1	"DAZ, SPGY"	ENSG00000188120	"Deleted in azoospermia 1"	Q9NQZ3	Y	23129355-23199094	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	9	"testis: 2.0"	"Cell type enriched"	"Detected in single"	38	"Gastric mucus-secreting cells: 23.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	18	"U-266/70: 15.3;U-266/84: 24.5"									HPA047113	Supported					NA	NA					"HPA047113: AB_2679936"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.3	24.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ERICH2		ENSG00000204334	"Glutamate rich 2"	A1L162	2	170783786-170798971	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"testis: 165.2"	"Cell type enriched"	"Detected in many"	7	"Early spermatids: 2216.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	4	"hTCEpi: 61.5"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"olfactory bulb: 33.1"	HPA061010			Approved	"Nucleoli fibrillar center,Vesicles"		NA	NA			"Nucleoli fibrillar center"	Vesicles	"HPA061010: "	"unprognostic (1.02e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.26e-1)"	"prognostic favorable (9.49e-4)"	"unprognostic (7.57e-3)"	"unprognostic (6.61e-2)"	"unprognostic (9.62e-3)"	"unprognostic (6.96e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (8.98e-7)"	"unprognostic (1.03e-1)"	"unprognostic (5.28e-3)"	"unprognostic (7.35e-2)"	"unprognostic (2.76e-1)"	1.4	1.8	6.0	0.2	6.0	0.0	4.4	5.7	7.3	6.3	13.1	0.6	0.1	4.9	3.6	0.7	9.5	1.8	3.9	5.2	6.1	3.6	5.5	12.2	0.3	5.0	5.3	4.8	2.2	2.9	8.0	1.4	0.4	5.0	2.3	0.7	6.9	2.5	2.2	1.1	0.6	0.3	1.3	4.7	0.1	3.9	165.2	5.4	0.3	18.8	3.5	0.6	1.1	0.9	5.1	9.5	0.0	0.1	7.7	0.0	0.0	0.4	0.0	0.0	1.5	3.1	7.9	1.9	0.0	0.3	0.0	3.4	0.2	2.0	0.7	0.1	1.3	2.0	4.1	0.0	0.1	7.8	0.4	0.5	1.2	61.5	0.0	14.1	0.2	0.0	1.5	9.2	0.0	0.0	3.3	0.0	0.8	9.5	11.3	1.6	0.0	1.5	0.0	4.4	0.2	1.1	2.0	5.6	0.1	2.4	1.8	1.3	1.3	0.0	2.0	1.7	0.0	0.9	0.0	0.0	0.0	7.7	3.8	6.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	6.0	5.7	7.3	5.2	6.1	5.0	5.3	4.8	5.0	4.7	5.4	5.1	0.2	6.4	24.4	8.1	0.1	0.3	0.6	1.7	0.0	1.6	1.0	2.0	2.0	2.8	2.3	1.8	0.0	0.0	0.0	0.1	13.7	0.9	2216.6	25.7	3.6	0.9	7.7	0.0	4.4	1.8	0.2	1.0	0.0	1.3	0.0	0.7	0.0	2.5	0.0	0.0	12.7	1.6	2.0	0.0	0.0	302.9	9.6	0.9	0.0	1.9	0.0	2.0	0.0	6.6	4.0	1.3	0.0	7.5	0.0	0.2	0.0	0.7	21.5	0.5	6.6	0.8	1.0	39.1	10.8	0.0	0.1	0.0	0.1	0.2	0.4	0.1
FAM71F2	FAM137B	ENSG00000205085	"Family with sequence similarity 71 member F2"	Q6NXP2	7	128672288-128687872	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"testis: 26.3"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 611.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA020513, HPA024248"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA020513: AB_1853077, HPA024248: AB_2671497"	"unprognostic (1.01e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.83e-2)"	"unprognostic (8.29e-3)"	"unprognostic (6.22e-2)"	"unprognostic (2.67e-2)"	"unprognostic (6.13e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.65e-4)"	"unprognostic (3.17e-2)"	"unprognostic (3.85e-4)"	"unprognostic (3.00e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.40e-4)"	"unprognostic (2.47e-2)"	1.4	2.0	2.3	0.4	2.1	1.1	1.3	1.5	2.5	1.2	1.1	0.9	0.3	0.9	0.9	0.9	0.9	0.5	2.0	2.1	1.1	1.7	1.0	0.8	0.4	2.0	1.2	2.3	1.2	1.3	0.2	2.9	0.3	1.7	1.3	0.4	2.7	1.7	0.4	1.3	1.0	0.9	0.5	0.6	1.7	1.1	26.3	1.6	0.2	1.4	0.1	0.3	1.0	0.8	2.7	0.2	0.3	0.4	0.6	0.4	0.6	0.2	0.2	0.1	0.1	0.1	0.1	0.4	0.3	0.1	0.5	0.1	0.5	0.0	0.2	0.2	0.1	0.1	0.2	0.9	0.0	0.2	0.2	0.6	0.5	0.2	0.4	0.1	0.6	0.1	0.2	0.1	0.4	0.2	0.4	0.1	0.4	0.3	0.0	0.2	0.2	0.0	0.1	0.3	1.1	0.3	0.2	0.2	0.2	0.4	0.5	0.2	0.1	1.3	0.5	0.1	0.8	0.3	0.9	0.4	0.3	0.3	0.2	0.3	1.6	0.2	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.3	0.1	0.1	1.1	0.4	0.1	0.4	0.1	0.0	2.3	2.1	1.5	2.5	2.1	1.1	2.0	1.2	2.3	1.7	0.6	1.6	2.7	0.5	3.2	2.2	17.0	0.4	0.0	1.8	0.3	0.6	12.2	1.3	0.8	1.4	2.8	0.2	3.7	52.1	0.6	0.1	0.5	0.0	1.5	138.7	2.1	2.0	1.5	1.2	0.0	11.9	0.7	0.7	1.4	3.1	5.6	2.5	2.0	2.2	0.8	0.9	0.0	10.2	1.1	0.0	1.3	0.4	611.8	4.1	1.4	0.0	2.8	1.1	2.7	1.0	6.6	10.6	1.6	1.8	3.0	2.0	2.5	0.5	0.3	0.2	19.0	0.0	6.5	1.4	13.1	4.0	0.4	0.1	2.5	1.1	4.0	1.4	1.1
FCN3	"FCNH, HAKA1"	ENSG00000142748	"Ficolin 3"	O75636	1	27369110-27374824	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement activation lectin pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"liver: 280.5;lung: 730.9"	"Cell type enriched"	"Detected in some"	16	"Hepatic stellate cells: 2828.6"	"Cancer enhanced"	"Detected in many"		"renal cancer: 7.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											CAB025945	Approved				"Secreted to blood"	NA	NA	22800000000	14000000000			"CAB025945: "	"unprognostic (1.59e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.55e-2)"	"unprognostic (8.27e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.21e-1)"	"unprognostic (6.28e-4)"	"unprognostic (7.07e-2)"	"unprognostic (2.86e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.87e-3)"	"unprognostic (4.14e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.61e-2)"	44.5	36.2	1.1	5.8	1.0	0.0	41.1	1.1	1.6	1.8	8.5	3.3	0.8	3.9	0.1	2.9	3.1	1.6	45.0	1.3	2.5	53.5	280.5	730.9	4.3	1.2	1.1	0.9	2.4	12.6	2.7	6.7	22.8	1.2	5.3	0.5	0.0	2.6	0.5	9.0	1.7	6.8	1.8	1.2	11.4	8.5	2.4	1.2	0.4	20.6	7.6	0.3	3.0	1.9	1.2	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.0	1.1	1.6	1.3	2.5	1.2	1.1	0.9	1.2	1.2	1.2	1.2	94.1	0.0	9.3	0.0	16.6	0.8	0.6	0.5	0.6	0.0	0.8	2.8	2.4	52.9	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.1	1.5	0.4	0.2	155.1	0.0	136.4	0.1	0.0	0.0	3.8	0.5	0.2	3.8	0.0	2828.6	31.8	0.3	0.0	0.1	0.0	2.0	168.6	0.3	2.7	3.4	2.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.6	0.0	0.1	5.1	0.0	0.0	1.0	2.7	0.5	0.5	1.0	1.1	0.0	4.9	0.5	0.0	0.3
GNMT		ENSG00000124713	"Glycine N-methyltransferase"	Q14749	6	42960754-42963880	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"liver: 298.9;pancreas: 605.1"	"Cell type enriched"	"Detected in many"	10	"Hepatocytes: 842.9"	"Group enriched"	"Detected in many"	20	"liver cancer: 69.6;prostate cancer: 49.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 8.5;SCLC-21H: 9.5;T-47d: 6.1"	"Region enriched"	"Detected in some"	4	"cerebellum: 15.7"	"Low region specificity"	"Detected in many"			HPA027501	Enhanced		Approved	Cytosol		NA	NA		390000	Cytosol		"HPA027501: AB_1849879"	"unprognostic (1.53e-2)"	"unprognostic (8.02e-4)"	"unprognostic (3.11e-2)"	"unprognostic (4.24e-3)"	"unprognostic (3.91e-2)"	"unprognostic (6.40e-4)"	"prognostic favorable (1.86e-4)"	"unprognostic (4.08e-6)"	"unprognostic (1.01e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.52e-1)"	"unprognostic (3.50e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.92e-2)"	0.8	0.9	2.8	1.3	2.9	3.9	7.1	3.1	2.8	0.8	2.3	0.6	0.2	0.9	2.2	0.6	1.4	0.5	3.2	2.9	2.5	0.9	298.9	2.0	1.0	2.2	1.7	2.8	1.9	605.1	0.2	8.5	0.4	2.4	20.5	0.3	2.2	9.8	1.2	1.9	0.9	1.6	0.5	1.8	2.9	51.2	0.7	2.2	1.8	1.9	0.4	1.2	0.8	0.7	2.8	0.4	0.3	1.4	3.9	0.4	0.1	0.2	0.3	1.6	0.6	0.9	0.0	0.1	1.3	0.1	0.3	0.7	0.4	0.2	0.2	0.2	1.6	1.2	1.0	0.9	8.5	0.0	0.9	1.8	0.3	0.0	0.3	0.1	0.9	0.0	3.0	1.2	1.5	0.2	1.8	1.6	3.0	0.1	0.4	0.4	1.4	1.3	0.8	0.6	0.2	9.5	1.3	0.1	1.3	0.6	0.4	6.1	2.8	0.3	0.7	0.7	0.4	0.8	1.0	1.0	1.1	0.1	1.6	0.8	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.2	0.5	0.0	0.0	0.7	0.0	0.1	2.8	2.9	3.1	2.8	2.9	2.5	2.2	1.7	2.8	2.4	1.8	2.2	2.8	0.3	0.0	2.2	5.5	2.8	0.3	5.2	0.7	0.0	1.7	10.2	14.7	5.4	24.3	0.2	1.8	0.0	0.1	1.7	0.0	3.9	0.5	0.2	1.6	0.2	2.2	0.0	77.9	18.4	0.9	0.1	0.3	0.5	0.8	0.0	2.6	24.3	842.9	0.7	1.7	18.2	0.0	6.1	28.9	0.7	0.1	0.9	1.1	0.0	11.2	0.3	0.2	0.0	7.1	4.7	0.6	0.0	2.6	0.5	17.9	0.3	3.4	4.6	0.3	0.0	0.2	0.6	0.6	0.7	0.0	0.1	0.1	3.0	0.0	0.2	1.9
HTRA4	FLJ90724	ENSG00000169495	"HtrA serine peptidase 4"	P83105	8	38974228-38988663	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"placenta: 67.5"	"Cell type enriched"	"Detected in some"	10	"Extravillous trophoblasts: 444.0"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	24	"BEWO: 233.6"	"Region enhanced"	"Detected in single"		"hippocampal formation: 2.1"	"Low region specificity"	"Detected in all"			HPA045402	Enhanced				"Secreted in female reproductive system"	NA	NA		23000			"HPA045402: AB_2679316"	"unprognostic (1.20e-1)"	"unprognostic (5.83e-4)"	"unprognostic (8.02e-2)"	"unprognostic (2.13e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.40e-1)"	"unprognostic (5.14e-4)"	"unprognostic (1.01e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.58e-1)"	"unprognostic (5.19e-3)"	"unprognostic (2.39e-3)"	"unprognostic (1.19e-3)"	0.6	0.5	1.1	0.9	1.2	7.3	1.2	3.3	5.0	0.9	0.0	0.5	0.3	0.9	0.9	0.1	0.3	0.5	0.3	1.3	0.5	0.4	0.6	2.0	2.6	0.8	0.5	0.6	0.6	0.8	0.5	0.1	67.5	1.2	0.6	0.7	1.9	0.3	1.1	1.0	0.8	0.4	0.7	0.2	1.2	0.4	0.9	0.7	0.5	0.5	0.1	1.7	0.4	0.1	2.3	0.4	0.3	0.2	0.4	0.8	0.4	233.6	0.6	0.4	0.3	0.4	0.4	0.5	0.5	0.2	0.2	0.4	0.4	0.2	0.2	0.1	0.2	0.4	0.4	0.7	0.3	0.2	0.6	0.6	0.7	0.2	0.2	0.5	0.3	0.2	0.2	0.4	1.3	0.2	0.5	0.4	0.3	0.3	0.1	0.2	0.2	0.2	0.4	0.2	0.7	0.4	0.6	0.5	0.3	0.1	9.6	0.5	0.7	0.0	0.7	0.5	0.3	0.3	0.5	0.2	0.2	0.2	0.7	0.2	0.3	0.1	0.4	0.2	0.1	0.3	0.2	0.2	0.2	0.1	0.5	0.2	0.2	0.5	0.2	0.2	0.5	0.3	0.0	1.1	1.2	3.3	5.0	1.3	0.5	0.8	0.5	0.6	1.2	0.2	0.7	2.3	0.1	0.0	0.0	0.0	1.0	0.1	1.7	0.1	1.2	0.5	0.1	0.3	0.7	0.0	0.0	0.0	2.1	2.8	1.1	0.1	0.0	0.0	0.1	0.2	0.7	0.3	0.0	0.0	0.4	0.0	444.0	1.2	0.0	0.5	0.0	0.7	1.4	0.0	11.6	1.7	0.2	0.0	0.0	0.6	0.3	0.0	0.0	3.8	1.8	1.0	0.0	0.4	1.0	1.5	0.2	0.3	0.0	0.0	0.5	1.5	0.0	0.2	0.1	0.2	0.0	3.5	0.2	0.0	0.1	0.0	0.1	40.4	0.7	0.2	0.2	1.1
IFIT1B	"bA149I23.6, IFIT1L"	ENSG00000204010	"Interferon induced protein with tetratricopeptide repeats 1B"	Q5T764	10	89378056-89385205	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"bone marrow: 25.9"	"Cell type enriched"	"Detected in single"	320	"Erythroid cells: 96.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA062924	Approved					NA	NA					"HPA062924: AB_2684906"	"unprognostic (2.59e-1)"	"unprognostic (3.13e-1)"			"unprognostic (6.62e-3)"	"unprognostic (4.55e-2)"			"unprognostic (4.11e-2)"	"unprognostic (9.34e-2)"			"unprognostic (1.76e-1)"	"unprognostic (6.86e-2)"				0.0	0.0	0.0	0.0	0.0	25.9	0.0	0.4	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	2.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	96.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNG4	Kv6.4	ENSG00000168418	"Potassium voltage-gated channel modifier subfamily G member 4"	Q8TDN1	16	84218667-84239750	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 3.4;retina: 4.3"	"Cell type enriched"	"Detected in some"	14	"Bipolar cells: 56.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in all"	4	"cerebellum: 90.5;pons and medulla: 27.0"	"Low region specificity"	"Detected in many"			HPA063516			Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA063516: "					"unprognostic (3.54e-1)"									"unprognostic (6.67e-2)"				0.1	0.4	0.6	0.0	0.8	0.3	0.0	3.3	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.1	3.4	1.5	0.3	0.1	0.0	0.0	0.0	0.0	2.5	0.0	0.0	4.3	0.0	0.0	0.1	0.3	0.0	0.0	1.3	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.2	0.0	0.1	0.0	0.0	0.6	0.8	3.3	0.6	0.5	0.6	3.4	1.5	0.3	2.5	1.3	0.7	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	56.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	4.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1
KRT4	"CK4, CYK4, K4"	ENSG00000170477	"Keratin 4"	P19013	12	52806549-52814116	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"esophagus: 19918.5"	"Cell type enriched"	"Detected in some"	18	"Squamous epithelial cells: 5828.7"	"Group enriched"	"Detected in many"	5	"cervical cancer: 94.3;head and neck cancer: 151.8;stomach cancer: 73.1;urothelial cancer: 38.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	33	"HaCaT: 734.9;SK-BR-3: 361.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002154, HPA034881"	Enhanced		Supported	"Intermediate filaments"		NA	NA		600000000	"Intermediate filaments"		"CAB002154: AB_563803, HPA034881: AB_2674370"	"unprognostic (4.04e-1)"	"unprognostic (3.22e-3)"	"unprognostic (5.16e-3)"	"unprognostic (8.52e-3)"		"unprognostic (1.20e-1)"		"unprognostic (2.64e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (2.85e-3)"	"unprognostic (2.84e-2)"	"unprognostic (2.58e-11)"	"unprognostic (1.64e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (6.26e-4)"	1.3	1.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	246.0	0.0	1.0	0.0	1.2	0.0	19918.5	9.6	3.2	7.2	0.0	0.0	0.9	2.6	17.5	0.0	0.0	0.0	0.0	1.8	2.8	0.0	8.9	0.0	0.0	4.4	0.0	0.0	2140.9	0.0	2.6	3.2	1.7	0.9	0.0	1.6	8.7	0.8	0.0	2.0	1.0	0.1	1430.5	4.4	1048.7	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	1.8	0.0	0.1	0.0	734.9	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.5	1.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	1.9	0.3	0.0	1.4	0.0	0.2	0.0	15.5	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	1.0	361.6	0.0	0.0	2.0	0.0	2.0	0.0	0.2	0.0	0.0	0.0	1.0	0.9	0.5	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.4	3.3	0.0	0.0	0.0	6.5	36.9	23.3	0.0	0.5	2.9	0.5	0.0	308.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.6	0.2	2.9	0.0	0.0	0.0	0.0	0.0	2.6	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	28.5	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.9	6.9	0.0	0.1	53.7	0.0	0.0	0.0	5.3	0.0	0.1	5828.7	0.0	0.0	2.0	0.0	0.0	54.4
KRT74	"K6IRS4, KRT5C, KRT6IRS4"	ENSG00000170484	"Keratin 74"	Q7RTS7	12	52565782-52573843	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Ectodermal dysplasia, Hypotrichosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"epididymis: 5.6;skin 1: 10.0"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"HPA040655, HPA048596"	Enhanced		Approved	"Nucleoli,Intermediate filaments,Cytosol"		NA	NA		130000000	"Intermediate filaments"	"Nucleoli, Cytosol"	"HPA040655: , HPA048596: AB_2680457"		"unprognostic (6.75e-3)"		"unprognostic (3.93e-1)"		"unprognostic (1.60e-1)"		"unprognostic (2.49e-2)"		"unprognostic (9.46e-2)"		"unprognostic (2.29e-1)"			"unprognostic (8.54e-2)"		"unprognostic (1.02e-1)"	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
KRTAP5-4	KRTAP5.4	ENSG00000241598	"Keratin associated protein 5-4"		11	1620958-1622138	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in single"	9	"skin 1: 2.9"	"Cell type enriched"	"Detected in single"	10	"Cardiomyocytes: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA								"unprognostic (6.52e-2)"	"unprognostic (4.04e-4)"						"unprognostic (1.80e-1)"	"unprognostic (7.83e-2)"			"unprognostic (2.00e-2)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRTDAP	"KDAP, UNQ467"	ENSG00000188508	"Keratinocyte differentiation associated protein"	P60985	19	35487324-35495558	"Plasma proteins, Predicted secreted proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"skin 1: 5823.9;vagina: 1749.8"	"Cell type enriched"	"Detected in some"	15	"Suprabasal keratinocytes: 5277.0"	"Group enriched"	"Detected in many"	7	"head and neck cancer: 486.4;melanoma: 207.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	56	"hTCEpi: 100.2"	"Region enriched"	"Detected in single"	6	"white matter: 1.6"	"Not detected"	"Not detected"			HPA063474	Enhanced				"Secreted in other tissues"	NA	NA		34000000			"HPA063474: AB_2685019"	"unprognostic (4.55e-2)"	"unprognostic (2.46e-1)"		"unprognostic (1.64e-1)"		"unprognostic (6.11e-2)"		"unprognostic (1.59e-1)"	"unprognostic (8.80e-2)"	"unprognostic (7.13e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.16e-2)"	3.8	1.0	1.0	0.0	1.4	1.8	411.0	0.9	1.9	404.4	0.9	1.5	0.1	0.8	0.7	111.9	1.4	0.0	2.3	0.9	0.9	0.8	3.1	1.7	0.0	1.1	0.9	0.8	1.7	3.4	0.7	1.3	0.0	1.3	1.6	0.0	0.1	206.9	0.3	22.7	5823.9	1.3	0.1	0.9	0.8	1.5	3.3	0.9	20.2	2.5	0.3	90.9	0.7	1749.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.4	0.1	0.2	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.8	0.2	0.0	0.0	0.4	100.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.4	0.9	1.9	0.9	0.9	1.1	0.9	0.8	1.3	0.9	0.9	0.9	0.3	0.0	0.0	0.0	0.0	348.5	0.8	0.4	0.0	0.0	0.5	1.5	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	18.4	0.2	0.1	3.6	0.0	0.0	0.1	0.2	0.0	4.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.7	63.4	0.9	0.1	42.7	0.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	2.4	42.9	19.1	0.0	5277.0	0.0	1.5	0.0	0.0	0.5
LBX1	"HPX6, LBX1H"	ENSG00000138136	"Ladybird homeobox 1"	P52954	10	101226195-101229794	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Myogenesis, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"skeletal muscle: 26.7"	"Cell type enriched"	"Detected in single"	5	"Skeletal myocytes: 3.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HEK 293: 3.4;RH-30: 4.3;SCLC-21H: 9.1"	"Group enriched"	"Detected in some"	24	"cerebellum: 1.6;pons and medulla: 3.0"	"Group enriched"	"Detected in some"	18	"cerebellum: 1.2;medulla oblongata: 2.0;spinal cord: 2.0"	"HPA002016, HPA002086, CAB079927"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"		NA	NA			Nucleoplasm	"Nucleoli, Nuclear bodies, Cytosol"	"CAB079927: , HPA002016: AB_2666518, HPA002086: AB_1079242"		"unprognostic (4.13e-1)"			"unprognostic (3.86e-2)"	"unprognostic (2.25e-2)"		"unprognostic (2.29e-1)"	"unprognostic (7.28e-3)"	"unprognostic (3.31e-1)"				"unprognostic (9.76e-2)"	"unprognostic (1.45e-1)"			0.0	0.0	0.6	0.0	0.4	0.0	0.0	1.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	26.7	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.7	0.0	0.0	3.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.3	0.0	0.0	0.0	9.1	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	1.9	0.3	0.0	0.0	2.7	0.1	0.0	1.8	2.8	0.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MLANA	MART1	ENSG00000120215	Melan-A	Q16655	9	5890889-5910606	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"skin 1: 43.3"	"Cell type enriched"	"Detected in some"	23	"Melanocytes: 1718.2"	"Cancer enriched"	"Detected in single"	556	"melanoma: 277.0"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	406	"SK-MEL-30: 703.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000057, HPA048662"	Enhanced					NA	NA					"CAB000057: AB_442107, HPA048662: AB_2680485"	"unprognostic (2.52e-2)"	"unprognostic (6.87e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.61e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.53e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.71e-3)"	"unprognostic (3.60e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.01e-2)"	"unprognostic (5.78e-2)"	"unprognostic (9.43e-2)"	0.1	0.2	0.2	0.4	0.5	0.7	1.4	1.9	0.6	0.0	4.7	0.1	0.1	0.1	0.0	0.2	0.0	0.2	0.1	0.2	0.1	0.3	0.5	0.1	0.4	0.5	0.3	0.2	0.1	0.1	0.0	0.1	0.1	0.7	0.1	0.0	0.3	1.1	0.0	0.3	43.3	0.1	0.0	0.1	0.2	0.2	0.3	0.6	0.1	0.2	0.0	0.0	0.2	0.3	0.6	0.8	0.6	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.8	0.2	0.0	0.2	0.1	0.0	0.0	0.0	1.0	0.2	1.7	1.3	1.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.9	0.0	0.3	0.1	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.4	0.1	0.4	0.1	703.0	0.1	0.1	0.3	0.6	0.2	0.4	0.1	0.7	0.2	0.7	0.3	0.2	0.4	0.1	0.8	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.1	0.0	0.3	0.1	0.2	0.4	0.2	0.1	0.2	0.1	0.0	0.2	0.5	1.9	0.6	0.2	0.1	0.5	0.3	0.2	0.7	0.1	0.6	0.6	0.0	0.0	0.0	0.3	0.0	73.7	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.2	0.9	0.0	0.0	1.3	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	15.5	0.9	0.0	0.2	1718.2	0.0	0.0	0.0	0.0	1.5	1.8	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.3	14.5	0.0	0.5	0.1	0.0	0.0
NAT8	"ATase2, GLA, Hcml1, TSC501"	ENSG00000144035	"N-acetyltransferase 8 (putative)"	Q9UHE5	2	73640723-73642422	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"kidney: 739.2"	"Cell type enriched"	"Detected in some"	13	"Proximal tubular cells: 2565.5"	"Cancer enriched"	"Detected in some"	5	"renal cancer: 242.1"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	15	"Hep G2: 10.7"					"Low region specificity"	"Detected in all"			"HPA067855, HPA074519"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA067855: AB_2732774, HPA074519: AB_2686699"	"unprognostic (4.51e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.98e-1)"	"unprognostic (4.95e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.90e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.13e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.07e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.13e-2)"	"unprognostic (8.36e-5)"	0.1	0.3	1.3	0.1	0.7	0.1	0.2	0.2	0.9	0.2	0.0	1.1	4.7	0.1	0.0	0.0	1.2	0.6	0.0	1.1	0.6	739.2	83.3	0.2	0.0	0.6	0.2	1.0	1.3	0.2	0.0	0.6	0.0	0.5	0.2	0.1	1.8	0.1	0.1	0.0	0.0	7.3	0.1	0.0	1.1	0.6	0.5	0.7	0.0	0.1	0.0	0.0	0.1	0.1	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	10.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.7	0.2	0.9	1.1	0.6	0.6	0.2	1.0	0.5	0.0	0.7	1.1	0.0	0.0	0.0	0.0	19.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	36.8	0.0	0.0	0.0	0.3	187.9	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	22.9	51.1	0.0	0.0	0.0	1.1	0.0	1.0	0.4	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	61.3	2565.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.6	0.1
ODF2	"CT134, ODF84"	ENSG00000136811	"Outer dense fiber of sperm tails 2"	Q5BJF6	9	128455186-128501292	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	9	"testis: 320.1"	"Cell type enriched"	"Detected in all"	4	"Late spermatids: 8228.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001874, HPA048841"	Enhanced		Supported	Vesicles,Centrosome		NA	NA			Centrosome	Vesicles	"HPA001874: AB_1079522, HPA048841: AB_2680536"	"unprognostic (4.54e-3)"	"unprognostic (9.91e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.57e-3)"	"unprognostic (6.11e-2)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.28e-2)"	"prognostic unfavorable (1.72e-4)"	"unprognostic (1.93e-2)"	"unprognostic (9.23e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.65e-2)"	14.3	11.9	12.1	22.3	11.2	31.3	14.3	19.5	14.8	19.9	36.1	14.5	10.4	22.1	11.1	12.5	22.8	13.4	14.5	12.4	12.6	11.2	16.5	14.6	25.8	13.1	14.6	9.5	15.2	13.3	15.4	31.0	16.0	14.7	16.2	15.3	15.0	13.0	14.9	9.0	19.5	13.8	20.7	11.2	20.7	13.8	320.1	13.1	35.1	13.3	5.4	26.8	17.2	14.6	12.0	44.2	52.2	85.3	97.7	33.3	39.6	68.6	72.3	33.7	58.9	30.8	51.8	31.6	78.6	26.7	59.2	45.7	112.7	62.9	43.1	59.4	52.2	29.3	69.8	84.9	43.8	19.3	76.2	84.5	32.8	26.9	62.6	43.9	36.5	52.0	58.8	83.9	42.9	56.3	134.9	81.5	92.7	33.4	89.7	37.2	73.6	82.0	60.9	30.7	33.6	51.2	43.6	67.8	64.0	22.9	38.3	59.8	54.8	49.9	73.1	44.6	84.9	71.7	79.6	123.9	55.9	33.4	68.4	64.8	21.6	9.2	10.3	11.4	13.4	13.6	8.2	10.2	12.2	8.8	7.0	7.2	9.3	3.0	12.0	17.8	8.3	8.1	10.1	12.1	11.2	19.5	14.8	12.4	12.6	13.1	14.6	9.5	14.7	11.2	13.1	12.0	14.2	6.4	6.8	9.8	14.4	16.7	16.7	7.4	19.9	9.8	11.2	9.5	10.6	11.5	8.5	7.3	10.4	13.1	13.7	4.6	11.7	10.6	1914.4	39.4	16.3	18.3	3.6	29.8	18.5	9.0	16.8	14.0	10.2	13.4	19.6	10.1	8.2	9.6	12.4	8.4	16.6	10.9	12.2	10.2	14.9	8228.0	42.6	12.9	10.6	12.2	11.1	8.6	9.2	14.1	9.8	7.4	3.2	33.8	16.1	16.1	3.0	6.9	46.6	8.9	13.1	11.1	16.7	268.1	58.3	13.8	13.2	33.2	16.8	11.4	7.6	12.9
PDE6B	"CSNB3, CSNBAD2, PDEB, rd1, RP40"	ENSG00000133256	"Phosphodiesterase 6B"	P35913	4	625573-670782	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase	"Congenital stationary night blindness, Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"retina: 388.3"	"Cell type enriched"	"Detected in many"	5	"Rod photoreceptor cells: 460.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"EFO-21: 11.5;JURKAT: 17.3;MOLT-4: 31.3;REH: 16.8;SCLC-21H: 20.2;SH-SY5Y: 11.9;U-266/84: 24.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA054148, HPA059929"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA054148: AB_2682401, HPA059929: AB_2684166"	"unprognostic (2.43e-2)"	"unprognostic (1.33e-4)"	"unprognostic (2.45e-4)"	"unprognostic (7.18e-3)"	"unprognostic (1.88e-2)"	"unprognostic (5.04e-3)"	"unprognostic (7.32e-3)"	"prognostic favorable (5.34e-4)"	"unprognostic (9.70e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.41e-3)"	"unprognostic (1.85e-1)"	1.9	2.2	12.0	5.6	23.4	8.5	4.2	9.6	21.7	2.5	2.1	1.7	1.2	2.8	4.1	1.7	10.3	3.7	5.9	11.3	17.4	5.0	1.0	4.7	14.5	24.6	20.7	7.9	2.8	1.8	8.3	4.2	3.1	31.3	2.8	1.3	388.3	3.8	3.0	1.1	2.2	3.1	2.5	10.8	10.2	2.9	4.4	26.6	12.3	12.1	0.1	9.3	3.8	1.4	41.1	0.1	0.0	1.2	0.5	0.3	0.4	0.4	0.0	0.1	0.8	2.0	0.0	0.1	0.3	11.5	0.3	0.9	0.1	2.5	0.6	0.0	0.1	0.0	1.0	0.3	0.1	5.8	0.2	0.4	0.7	0.0	3.5	0.0	0.8	1.1	17.3	0.1	1.0	0.1	0.3	31.3	0.1	9.4	0.7	0.0	16.8	0.2	0.2	2.1	1.3	20.2	11.9	0.0	0.3	0.1	4.2	0.6	0.0	0.4	0.2	1.2	0.2	0.4	7.7	24.0	0.3	0.3	0.3	0.2	16.8	5.4	0.9	14.0	7.7	12.6	12.8	9.3	9.8	8.5	21.4	14.6	15.8	1.4	14.4	8.1	18.2	15.5	9.4	12.0	23.4	9.6	21.7	11.3	17.4	24.6	20.7	7.9	31.3	10.8	26.6	41.1	0.5	3.2	5.0	4.2	6.4	0.4	2.1	1.2	2.8	20.7	3.9	2.4	4.4	0.0	3.5	0.0	83.4	0.1	8.4	0.2	1.9	6.9	0.4	7.0	2.2	2.9	1.8	7.4	40.3	0.6	0.3	1.3	1.5	2.5	3.8	5.4	2.2	0.0	11.3	11.8	27.3	0.5	4.1	5.1	1.4	0.3	1.5	3.3	3.6	4.7	6.2	31.1	7.2	10.1	33.9	0.8	0.2	1.5	7.5	1.9	0.0	8.4	11.2	460.1	0.0	1.6	1.1	4.3	11.0	1.9	0.3	0.3	5.9	3.5	0.4	1.3
POTEB3		ENSG00000278522	"POTE ankyrin domain family member B3"	A0JP26	15	21405401-21440499	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	9	"testis: 5.7"	"Cell type enriched"	"Detected in single"	5	"Spermatocytes: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 1.5;RPMI-8226: 1.9"															NA	NA																							0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.3	0.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.7	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.2	0.3	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.4	0.0	0.1	0.0	0.2	0.4	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.5	0.8	0.0	0.1	0.0	0.9	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.5	0.1	0.1	0.1	0.2	0.0	0.2	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
REXO5	NEF-sp	ENSG00000005189	"RNA exonuclease 5"	Q96IC2	16	20806429-20849665	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"testis: 346.9"	"Cell type enriched"	"Detected in some"	5	"Granulosa cells: 26.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	15	"basophil: 86.7"	"Lineage enriched"	"Detected in many"	39	"granulocytes: 86.7"	"Cell line enhanced"	"Detected in many"		"K-562: 44.7;U-266/70: 42.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA040755, HPA040868, HPA066145"	Approved		Approved	"Nuclear membrane,Nucleoli,Endoplasmic reticulum"		NA	NA			"Nuclear membrane"	"Nucleoli, Endoplasmic reticulum"	"HPA040755: AB_10965790, HPA040868: AB_10963549, HPA066145: "	"unprognostic (2.39e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.68e-1)"	"unprognostic (5.63e-2)"	"unprognostic (9.15e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.80e-2)"	"unprognostic (8.24e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.42e-4)"	"unprognostic (1.01e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.93e-2)"	2.4	1.8	1.1	1.8	1.2	11.7	3.6	1.3	1.6	1.7	0.3	2.1	3.0	2.3	1.2	2.3	4.2	1.6	3.5	1.1	1.2	1.2	1.8	1.0	2.9	1.7	1.0	1.3	1.9	1.8	40.4	0.9	1.5	1.3	5.4	3.1	4.3	1.7	1.3	1.0	2.2	2.1	2.7	0.5	1.1	5.0	346.9	1.4	7.4	0.9	1.3	2.6	2.0	1.6	1.9	11.3	6.5	10.1	4.5	4.2	7.5	3.4	7.6	8.4	8.2	8.9	4.7	10.0	7.0	11.5	6.7	5.7	5.7	7.7	3.4	8.5	6.5	4.9	11.7	10.2	6.7	0.8	17.2	16.4	3.8	1.5	9.7	12.4	3.5	2.8	0.0	44.7	29.8	20.5	15.1	2.8	13.5	5.5	4.6	6.6	14.0	18.8	12.6	2.5	4.0	8.6	9.7	7.3	9.6	2.4	2.9	16.2	14.8	1.4	6.1	5.4	8.2	9.3	42.5	31.1	2.7	12.6	22.3	5.6	86.7	0.4	5.7	0.3	0.1	0.4	0.0	0.4	0.4	0.7	0.0	0.1	0.3	0.4	2.2	0.2	0.2	1.8	0.4	1.1	1.2	1.3	1.6	1.1	1.2	1.7	1.0	1.3	1.3	0.5	1.4	1.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	3.4	0.0	0.0	1.3	0.0	0.0	3.2	0.8	0.0	0.0	1.6	0.0	2.8	1.6	0.6	0.0	0.0	0.0	1.5	2.4	1.5	0.0	1.7	1.3	26.4	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.6	1.5	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.5	0.5	4.7	0.0	0.0
RGR	RP44	ENSG00000148604	"Retinal G protein coupled receptor"	P47804	10	84230666-84259960	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Sensory transduction, Vision"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"retina: 140.2"	"Cell type enriched"	"Detected in some"	29	"Muller glia cells: 1475.8"	"Cancer enriched"	"Detected in single"	4	"glioma: 0.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"midbrain: 23.4;olfactory bulb: 49.7;thalamus: 27.3"	HPA059149			Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			Vesicles	"Plasma membrane, Cytosol"	"HPA059149: "	"unprognostic (9.28e-2)"		"unprognostic (1.05e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.53e-2)"				"unprognostic (4.57e-2)"	"unprognostic (1.57e-1)"				"unprognostic (1.59e-1)"	"unprognostic (1.97e-1)"			0.1	0.0	11.0	0.0	10.9	0.0	0.1	3.4	14.7	0.0	12.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.4	6.4	6.9	0.0	0.0	0.2	0.0	4.1	6.5	7.5	0.0	0.0	0.0	0.4	0.0	5.8	0.0	0.0	140.2	0.1	0.0	0.0	0.1	0.1	0.0	1.7	0.0	0.2	0.9	8.6	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	10.9	3.4	14.7	6.4	6.9	4.1	6.5	7.5	5.8	1.7	8.6	5.0	0.0	0.0	0.0	6.8	0.0	0.0	0.1	0.0	0.0	20.6	0.1	0.1	0.4	0.0	0.0	0.0	31.3	0.0	0.0	0.1	0.0	0.0	8.6	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.0	0.0	0.0	10.6	0.3	0.0	0.0	0.0	0.0	1475.8	0.0	2.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.6	0.0	2.8	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RHCE	"CD240CE, RH"	ENSG00000188672	"Rh blood group CcEe antigens"	P18577	1	25362249-25430192	"Blood group antigen proteins, CD markers, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"bone marrow: 48.8"	"Cell type enriched"	"Detected in some"	67	"Erythroid cells: 511.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"HEL: 81.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA060951, HPA077385"	Supported		Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA060951: , HPA077385: "	"unprognostic (1.37e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.91e-2)"	"unprognostic (7.01e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.08e-2)"	"unprognostic (4.61e-2)"	"unprognostic (5.77e-5)"	"unprognostic (1.38e-1)"	"unprognostic (3.94e-2)"	"unprognostic (7.15e-3)"	"unprognostic (1.63e-1)"	0.2	0.6	1.9	0.1	2.4	48.8	0.3	2.1	3.3	0.3	1.6	0.2	0.2	0.2	4.3	0.6	1.0	0.3	1.1	2.0	2.1	0.4	1.7	0.4	0.5	2.3	2.0	1.9	0.5	1.2	0.1	3.4	1.1	2.2	1.0	0.3	2.3	5.5	0.2	1.5	0.6	0.1	0.0	2.1	1.1	0.4	2.2	2.0	0.8	0.6	0.9	0.3	0.1	0.5	2.8	0.2	0.1	0.2	0.5	0.9	0.6	0.1	0.3	0.3	0.4	0.1	0.1	1.5	0.7	1.1	1.0	0.1	0.3	0.0	0.2	0.2	0.4	0.1	81.3	0.0	0.0	1.1	0.0	0.6	1.9	1.5	0.6	0.5	0.0	0.0	0.6	17.5	0.4	0.5	0.8	0.0	0.6	1.7	0.7	0.5	0.2	0.2	2.6	0.0	0.0	0.7	0.8	0.3	0.3	1.0	0.8	0.5	0.0	0.1	0.2	0.0	0.9	0.0	5.1	1.4	1.0	2.9	0.9	0.5	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.9	2.4	2.1	3.3	2.0	2.1	2.3	2.0	1.9	2.2	2.1	2.0	2.8	0.8	0.0	0.0	5.5	0.8	0.5	0.5	0.3	0.6	4.2	1.1	2.5	0.7	1.5	0.2	0.0	0.0	0.8	1.2	0.5	0.0	0.3	1.1	1.2	0.7	0.4	0.0	511.8	2.9	0.2	0.7	0.4	3.6	0.8	4.5	0.6	0.0	0.7	0.2	6.7	2.3	0.0	0.0	0.6	0.4	0.5	0.6	1.7	0.0	0.0	0.0	4.7	1.0	2.0	2.7	0.5	0.0	0.7	3.0	0.3	0.1	0.0	0.9	2.4	6.6	0.5	0.5	3.0	7.6	0.6	1.4	0.8	0.8	0.7	0.3	0.7
SCGB1A1	"CC10, CC16, CCSP, UGB"	ENSG00000149021	"Secretoglobin family 1A member 1"	P11684	11	62405103-62423195	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Phospholipase A2 inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"lung: 3106.6"	"Cell type enriched"	"Detected in some"	4	"Club cells: 43564.7"	"Cancer enriched"	"Detected in many"	8	"lung cancer: 215.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	71	"HaCaT: 1977.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025686, HPA031828"	Enhanced				"Secreted in other tissues"	NA	NA		13000000			"CAB025686: , HPA031828: AB_2674061"		"unprognostic (2.40e-3)"		"unprognostic (1.55e-2)"	"unprognostic (5.46e-2)"	"unprognostic (2.70e-2)"		"unprognostic (4.69e-3)"		"unprognostic (2.12e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.31e-2)"		"unprognostic (2.63e-2)"	"unprognostic (1.63e-1)"		"unprognostic (2.40e-2)"	0.6	2.1	0.8	0.9	0.9	0.2	0.3	1.6	1.2	0.7	0.6	0.2	0.4	0.2	0.7	11.1	337.0	0.2	0.5	0.8	0.8	0.2	0.4	3106.6	0.2	0.8	1.2	0.7	2.1	1.9	0.0	2.4	1.7	1.1	85.9	0.0	0.2	0.5	0.9	0.4	0.2	1.6	0.0	0.7	7.3	4.3	0.2	1.0	2.8	0.4	0.0	6.0	0.2	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.3	1977.1	0.0	0.3	0.0	0.0	0.0	0.8	0.8	0.0	0.0	0.3	27.9	0.0	0.0	0.0	0.0	0.1	0.2	0.8	0.0	1.1	0.0	0.0	0.6	1.4	0.4	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.1	0.4	0.0	0.0	1.0	2.0	0.0	1.0	0.0	0.0	1.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.9	1.6	1.2	0.8	0.8	0.8	1.2	0.7	1.1	0.7	1.0	0.9	0.0	1125.0	2573.3	0.0	0.0	0.0	71.4	3938.5	0.0	0.0	0.0	0.0	0.0	0.0	43564.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	113.5	0.0	0.0	0.1	0.0	0.0	304.5	0.0	0.5	691.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	4534.8	0.0	0.0	0.7	0.0	128.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.8	0.0	0.0	0.0	134.7	0.0	0.0	9997.0	0.0	0.0	0.0	850.3	0.0	0.0	3.9	0.0	0.0	83.7	0.0	0.0	800.2
SLC1A2	"EAAT2, GLT-1"	ENSG00000110436	"Solute carrier family 1 member 2"	P43004	11	35251205-35420063	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"brain: 830.5;choroid plexus: 249.5"	"Cell type enriched"	"Detected in many"	7	"Astrocytes: 4607.2"	"Cancer enriched"	"Detected in some"	5	"glioma: 28.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.3"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.3"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 2.1;BJ hTERT+: 2.4;fHDF/TERT166: 1.7;Hep G2: 2.9;NTERA-2: 3.1;SCLC-21H: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002574, HPA009172, HPA067499"	Enhanced					NA	NA					"CAB002574: AB_564087, HPA009172: AB_1849764, HPA067499: "	"unprognostic (8.00e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.65e-3)"	"unprognostic (1.39e-2)"	"unprognostic (9.27e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.35e-1)"	"unprognostic (8.33e-4)"	"unprognostic (6.34e-2)"	"unprognostic (8.06e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.49e-2)"	0.4	4.7	595.4	0.6	634.7	0.4	3.9	425.9	830.5	0.9	249.5	0.2	0.5	1.0	0.3	0.2	0.3	0.2	0.9	682.6	430.9	0.2	35.2	0.6	1.9	525.7	520.3	562.1	0.1	9.5	0.1	2.6	1.1	594.6	0.3	0.1	60.6	4.7	0.1	0.3	1.3	0.2	0.3	415.4	0.5	2.1	1.7	506.0	0.2	0.3	0.5	1.7	0.3	0.7	549.0	0.0	0.1	0.5	0.0	0.2	2.1	0.0	0.5	2.4	0.1	0.1	0.0	0.0	0.0	0.0	1.7	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.3	2.9	0.1	0.3	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.2	0.0	1.1	0.0	0.1	0.5	0.0	0.3	0.1	0.1	0.2	0.0	0.3	0.0	0.0	0.5	0.0	0.1	1.3	0.1	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.2	0.1	0.5	0.2	0.1	0.1	0.1	0.1	595.4	634.7	425.9	830.5	682.6	430.9	525.7	520.3	562.1	594.6	415.4	506.0	549.0	0.4	3.2	4.8	4607.2	0.4	2.9	0.0	0.0	0.0	109.9	8.1	2.4	3.1	0.0	0.0	0.0	148.0	25.6	0.3	0.1	0.0	0.1	96.6	1.8	11.7	1.6	0.0	0.0	83.7	3.4	1.0	3.1	1.1	1.5	0.0	0.7	0.0	6.7	3.3	6.7	81.5	0.0	0.0	0.0	3.0	97.9	0.0	0.6	1.8	194.9	31.6	10.1	0.0	634.9	12.3	0.4	0.0	0.0	0.1	0.3	0.0	0.1	0.8	161.2	0.0	0.3	1.8	0.5	1.3	0.0	1.1	269.4	0.2	0.0	0.0	0.1
SLC26A3	"CLD, DRA"	ENSG00000091138	"Solute carrier family 26 member 3"	P40879	7	107765467-107803225	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Transport"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"intestine: 1130.8"	"Cell type enriched"	"Detected in some"	4	"Distal enterocytes: 2328.4"	"Cancer enriched"	"Detected in many"	14	"colorectal cancer: 52.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RPMI-8226: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036055	Approved					NA	NA					"HPA036055: AB_10602401"	"unprognostic (1.26e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.02e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.05e-3)"	"unprognostic (6.31e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.05e-2)"	"unprognostic (8.85e-2)"	"unprognostic (8.01e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.54e-2)"	"unprognostic (3.58e-3)"	1.1	0.0	0.0	19.9	0.0	0.0	60.1	0.2	0.1	0.2	0.0	1130.8	582.1	0.9	15.4	0.5	0.8	17.9	0.0	0.0	0.0	0.8	0.5	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	1.1	887.2	0.1	0.0	131.1	0.0	0.1	119.5	15.1	0.0	0.0	1.3	0.9	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	165.9	4.2	0.0	0.3	0.0	0.0	0.0	51.4	41.7	0.3	34.3	0.0	0.0	0.0	0.0	0.0	2328.4	0.0	0.0	6.4	1.8	0.1	0.3	14.3	0.0	110.2	0.0	0.0	0.1	0.0	0.2	26.7	0.2	0.0	0.1	0.0	0.0	114.3	32.5	0.0	0.0	0.0	0.6	0.3	0.1	0.0	89.9	0.0	0.0	0.0	101.6	182.1	0.0	503.4	0.0	0.0	0.3	388.9	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	2.2	0.0	86.0	0.1
SPDYE3		ENSG00000214300	"Speedy/RINGO cell cycle regulator family member E3"	A6NKU9	7	100307702-100322196	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	9	"testis: 2.5"	"Cell type enriched"	"Detected in many"	4	"Early spermatids: 181.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA051750	Supported					NA	NA					"HPA051750: AB_2681590"	"prognostic favorable (8.73e-4)"	"unprognostic (6.27e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (2.00e-6)"	"unprognostic (1.06e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.90e-1)"	"unprognostic (6.91e-2)"	"unprognostic (3.99e-2)"	"unprognostic (7.32e-2)"	"unprognostic (5.25e-2)"	"unprognostic (9.08e-2)"	"unprognostic (5.06e-2)"	"unprognostic (9.17e-2)"	"unprognostic (3.58e-1)"	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.5	8.1	0.5	1.7	0.7	1.2	0.0	5.2	0.4	0.0	2.3	1.5	1.0	0.0	10.4	0.1	1.5	0.0	0.0	0.0	181.7	1.2	1.7	0.9	0.0	0.4	13.6	0.0	0.2	0.8	0.0	0.9	0.0	1.1	0.0	0.2	0.2	0.0	11.5	0.3	4.1	0.3	0.8	44.4	2.1	0.4	0.0	3.7	0.0	0.7	0.0	11.6	8.1	0.0	0.0	1.9	0.0	0.6	0.0	0.2	1.0	3.7	0.0	1.1	0.9	3.4	1.1	0.0	1.7	0.1	0.9	0.6	0.0	0.7
ST18	"KIAA0535, NZF-3, NZF3, ZC2H2C3, ZC2HC10, ZNF387"	ENSG00000147488	"ST18 C2H2C-type zinc finger transcription factor"	O60284	8	52110839-52460959	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 81.8"	"Cell type enriched"	"Detected in some"	39	"Oligodendrocytes: 4055.3"	"Cancer enhanced"	"Detected in single"		"pancreatic cancer: 0.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 2.7;SCLC-21H: 9.6;U-87 MG: 1.5"	"Region enhanced"	"Detected in all"		"cerebellum: 40.2"	"Low region specificity"	"Detected in all"			HPA044919	Uncertain					NA	NA					"HPA044919: AB_10959756"	"unprognostic (3.66e-1)"	"unprognostic (4.34e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.55e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.53e-5)"	"unprognostic (3.29e-1)"	"unprognostic (1.35e-1)"	"unprognostic (9.34e-2)"	"unprognostic (9.84e-3)"	0.0	0.9	20.4	0.1	43.1	0.0	0.0	42.8	28.1	0.0	2.4	0.1	0.5	0.0	0.0	0.0	0.0	0.2	0.0	16.6	25.5	0.3	0.1	0.1	0.0	39.9	37.7	9.3	0.0	1.9	0.0	4.4	0.1	44.0	0.1	0.3	8.6	0.0	0.0	0.0	0.0	0.5	0.0	29.7	0.0	1.5	0.3	32.8	0.1	0.0	0.0	0.1	0.0	0.0	81.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	43.1	42.8	28.1	16.6	25.5	39.9	37.7	9.3	44.0	29.7	32.8	81.8	0.0	0.0	0.0	4.9	0.6	0.1	0.1	0.0	0.0	101.5	0.0	0.0	1.1	4.3	0.0	0.0	14.6	0.0	0.0	0.1	0.0	0.0	7.4	0.0	0.0	0.2	49.6	1.3	3.4	0.0	0.4	0.2	5.1	0.0	0.0	0.0	0.0	0.2	1.3	1.7	8.5	0.8	10.2	1.6	11.0	1.7	0.0	3.4	0.0	0.0	0.7	2.4	0.0	13.0	4055.3	0.3	0.0	0.0	0.1	0.3	0.1	0.8	0.0	4.5	0.0	0.0	0.1	0.3	0.3	0.0	0.3	0.1	0.1	0.0	0.3	0.0
TRAV25	"TCRAV25S1, TCRAV32S1"	ENSG00000211806	"T cell receptor alpha variable 25"	A0A0B4J276	14	22112347-22113031	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	9	"lymphoid tissue: 15.4"	"Cell type enriched"	"Detected in single"	6	"T-cells: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	63	"memory CD4 T-cell: 33.5;memory CD8 T-cell: 20.9;naive CD4 T-cell: 32.6;naive CD8 T-cell: 22.5;T-reg: 49.4"	"Lineage enriched"	"Detected in single"	404	"T-cells: 49.4"	"Not detected"	"Not detected"																	NA	NA						"unprognostic (9.50e-3)"	"unprognostic (1.49e-2)"	"unprognostic (7.22e-2)"			"unprognostic (2.89e-5)"		"unprognostic (6.65e-3)"	"unprognostic (7.53e-3)"	"unprognostic (7.30e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.52e-3)"	"unprognostic (9.55e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.74e-1)"	0.1	0.0	0.0	2.7	0.1	0.3	0.5	0.0	0.2	0.1	0.0	0.8	0.8	0.3	0.6	0.2	0.2	0.5	0.0	0.0	0.0	0.2	0.1	1.5	8.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.0	0.0	0.0	0.0	0.2	0.1	0.7	0.3	0.0	2.3	1.7	0.0	0.1	15.4	0.1	0.0	7.8	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	33.5	20.9	0.0	0.0	32.6	22.5	0.1	0.0	0.0	0.0	49.4	7.4	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0
TRAV8-2		ENSG00000211786	"T cell receptor alpha variable 8-2"	A0A0B4J237	14	21846537-21847221	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	9	"lymphoid tissue: 24.3"	"Cell type enriched"	"Detected in some"	9	"T-cells: 10.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	99	"MAIT T-cell: 59.1;memory CD4 T-cell: 143.4;memory CD8 T-cell: 81.1;naive CD4 T-cell: 143.2;naive CD8 T-cell: 80.1;T-reg: 190.6"	"Lineage enriched"	"Detected in many"	184	"T-cells: 190.6"	"Cell line enriched"	"Detected in single"	6	"JURKAT: 1.9"															NA	NA						"unprognostic (5.88e-3)"	"unprognostic (9.98e-4)"	"unprognostic (2.31e-2)"	"unprognostic (2.23e-2)"		"unprognostic (9.88e-5)"	"unprognostic (1.94e-3)"	"unprognostic (7.22e-3)"	"unprognostic (9.30e-3)"	"unprognostic (2.82e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.57e-5)"	"unprognostic (1.86e-1)"	"unprognostic (5.00e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.02e-1)"	0.2	0.1	0.0	3.2	0.0	2.0	0.2	0.0	0.0	0.2	0.0	0.7	1.1	0.2	1.6	0.5	0.2	1.4	0.1	0.0	0.0	2.7	0.2	1.2	14.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.2	0.0	0.4	0.0	0.0	0.4	1.3	0.1	0.0	4.2	1.3	0.3	0.0	24.3	0.3	0.0	6.0	1.7	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.3	1.0	1.1	0.1	59.1	0.2	143.4	81.1	0.3	0.3	143.2	80.1	0.7	0.2	0.2	0.1	190.6	40.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	10.7	0.0	0.0	0.0
TRAV9-2		ENSG00000211793	"T cell receptor alpha variable 9-2"	A0A087WT02	14	21941128-21941657	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	9	"lymphoid tissue: 28.1"	"Cell type enriched"	"Detected in single"	6	"T-cells: 5.6"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"memory CD4 T-cell: 178.3;naive CD4 T-cell: 172.2;T-reg: 350.8"	"Lineage enriched"	"Detected in many"	78	"T-cells: 350.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"													NA	NA						"unprognostic (2.02e-3)"	"unprognostic (2.04e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.25e-4)"		"unprognostic (1.14e-5)"	"unprognostic (1.37e-2)"	"unprognostic (2.23e-2)"	"unprognostic (5.98e-4)"	"unprognostic (9.53e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.51e-1)"	"unprognostic (9.00e-4)"	"unprognostic (2.49e-1)"	"unprognostic (4.28e-2)"	"unprognostic (3.38e-1)"	"unprognostic (2.56e-2)"	0.2	0.0	0.0	5.7	0.0	0.1	0.4	0.0	0.2	0.7	0.0	1.9	0.8	0.2	0.0	0.4	0.4	1.7	0.2	0.0	0.0	0.2	1.1	1.8	19.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.5	0.0	0.1	0.4	0.2	0.2	2.1	0.5	0.0	5.0	3.1	0.1	0.0	28.1	0.2	0.2	16.4	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.2	0.8	0.0	14.3	0.6	178.3	43.4	0.2	0.3	172.2	42.5	4.4	0.3	0.2	1.1	350.8	40.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0
TSSK4	"C14orf20, STK22E"	ENSG00000139908	"Testis specific serine kinase 4"	Q6SA08	14	24205696-24208362	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"testis: 38.4"	"Cell type enriched"	"Detected in some"	9	"Early spermatids: 253.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA060660, HPA077103"	Approved		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA060660: AB_2684339, HPA077103: AB_2732332"	"unprognostic (1.95e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.69e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.38e-5)"	"unprognostic (1.06e-1)"	"unprognostic (6.25e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.39e-1)"	"unprognostic (7.03e-3)"	"unprognostic (1.27e-3)"	"unprognostic (3.42e-1)"	"unprognostic (4.30e-2)"	"unprognostic (6.28e-2)"	"unprognostic (8.98e-2)"	"unprognostic (7.26e-2)"	0.9	1.1	0.8	2.0	0.6	3.5	1.0	0.9	0.4	1.3	0.0	1.3	1.6	1.1	0.3	1.3	1.2	1.7	0.7	0.7	0.1	0.8	0.6	1.0	2.7	0.5	0.3	0.1	1.1	1.5	0.0	0.9	0.4	0.6	0.9	0.0	3.1	1.5	0.0	1.3	4.2	1.7	0.0	0.2	1.8	1.2	38.4	0.4	0.0	1.5	0.0	0.0	1.1	1.1	0.7	0.6	2.3	2.2	0.8	0.0	0.0	2.4	0.9	0.0	0.0	0.0	1.3	2.2	1.8	0.5	0.1	0.4	2.1	0.0	0.1	0.0	0.9	1.7	2.0	3.4	1.7	0.0	1.0	2.1	0.0	0.0	0.0	0.3	1.9	0.0	2.1	0.8	1.2	0.0	2.2	2.1	1.1	0.4	0.5	1.8	1.8	0.8	1.5	0.0	3.0	1.2	1.2	1.7	1.4	0.4	0.9	1.0	1.0	0.9	1.6	1.0	2.1	0.7	2.3	3.0	2.6	0.5	1.6	0.5	0.0	0.2	0.4	0.4	0.2	0.1	0.3	0.3	0.3	0.1	0.3	0.3	0.3	0.3	0.5	0.1	0.3	0.1	0.1	0.8	0.6	0.9	0.4	0.7	0.1	0.5	0.3	0.1	0.6	0.2	0.4	0.7	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	253.7	0.3	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	26.5	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.1	0.1	0.3	0.1	0.8	0.0	0.0	0.2	0.1	6.8	0.8	0.0	0.0	0.1	0.1	0.1	0.0	0.0
ADGRV1	"DKFZp761P0710, FEB4, GPR98, KIAA0686, MASS1, USH2C, VLGR1"	ENSG00000164199	"Adhesion G protein-coupled receptor V1"	Q8WXG9	5	90529344-91164437	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sensory transduction, Vision"	"G-protein coupled receptor, Hydrolase, Receptor, Transducer"	"Deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"adrenal gland: 537.4"	"Cell type enriched"	"Detected in many"	8	"Astrocytes: 2207.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 15.5;HAP1: 23.0;K-562: 9.8;NTERA-2: 11.6;SCLC-21H: 11.1;SuSa: 15.0;U-266/70: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067503	Approved		Approved	"Lipid droplets"		NA	NA			"Lipid droplets"		"HPA067503: AB_2685856"	"unprognostic (1.29e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.95e-3)"	"unprognostic (7.50e-3)"	"unprognostic (9.73e-7)"	"unprognostic (1.87e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.48e-2)"	"unprognostic (7.14e-2)"	0.0	537.4	36.2	0.0	41.1	0.6	3.6	10.6	39.8	0.5	19.4	1.0	0.3	0.1	0.7	2.4	0.2	12.4	0.1	39.8	68.3	21.7	42.6	2.2	0.0	17.2	10.9	33.4	0.2	1.5	0.8	15.2	4.1	19.6	1.3	1.1	18.3	2.4	0.2	0.2	2.1	0.5	0.0	5.1	0.3	1.1	1.4	7.8	0.9	17.6	0.0	0.4	10.5	1.9	29.8	0.5	2.1	15.5	0.0	0.0	0.1	0.2	0.3	0.1	0.0	0.0	1.7	0.2	0.3	0.4	0.0	0.4	0.2	23.0	0.2	0.0	1.0	4.3	4.1	2.0	1.4	0.0	0.3	0.1	0.0	4.8	0.0	0.1	0.1	0.0	0.1	9.8	2.6	0.0	2.1	0.1	0.2	11.6	2.9	4.2	0.0	0.4	2.1	0.0	0.5	11.1	2.7	3.4	2.2	0.2	15.0	5.9	0.0	0.8	0.4	1.9	0.5	1.1	13.4	4.1	0.6	0.7	0.2	0.0	3.2	0.9	2.8	1.0	0.7	1.7	1.5	1.1	1.4	0.5	2.9	1.7	0.9	4.6	1.1	0.5	1.2	1.6	0.2	36.2	41.1	10.6	39.8	39.8	68.3	17.2	10.9	33.4	19.6	5.1	7.8	29.8	0.4	25.6	26.5	2207.3	0.0	0.0	6.1	0.0	1.8	28.0	15.5	7.4	2.4	2.8	5.6	5.5	264.8	3.0	0.4	0.6	1.9	1.9	43.5	3.3	0.3	1.1	7.3	0.0	54.0	4.2	2.6	1.1	4.6	1.9	0.0	6.7	0.0	12.4	0.2	10.1	21.9	0.4	0.0	0.8	0.0	54.8	0.6	0.5	0.0	51.5	1.2	8.9	1.0	40.2	7.4	1.7	1.2	0.4	0.1	2.1	0.1	24.2	7.3	84.4	0.0	0.3	0.4	3.6	4.5	2.9	0.0	4.1	0.6	0.2	1.2	9.0
APOC1		ENSG00000130208	"Apolipoprotein C1"	P02654	19	44914247-44919349	"Cancer-related genes, Candidate cardiovascular disease genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Lipid transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"liver: 16364.8"	"Cell type enriched"	"Detected in many"	6	"Hepatocytes: 33405.9"	"Cancer enriched"	"Detected in all"	21	"liver cancer: 3253.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	9	"myeloid DC: 5.6"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 5.6"	"Cell line enhanced"	"Detected in many"		"Hep G2: 576.4;HSkMC: 332.9;K-562: 151.6;SK-MEL-30: 268.0"	"Low region specificity"	"Detected in all"							HPA051518	Supported				"Secreted to blood"	NA	NA	20300000000	15000000000			"HPA051518: AB_2681519"	"unprognostic (3.51e-2)"	"unprognostic (3.31e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.59e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (1.15e-7)"	"unprognostic (9.51e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.52e-1)"	"unprognostic (7.13e-3)"	"unprognostic (3.48e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.65e-1)"	57.2	2014.5	109.4	28.3	147.7	52.6	87.8	109.9	340.9	24.0	103.7	28.6	13.2	11.1	42.3	6.0	21.4	31.3	9.9	98.2	181.1	14.4	16364.8	292.4	141.3	156.0	163.0	91.5	56.9	21.6	16.4	23.8	42.0	130.9	14.5	16.8	15.3	35.8	2.2	22.5	49.1	49.5	4.0	135.3	257.0	22.9	18.8	152.6	37.8	36.6	6.2	34.2	23.7	11.4	149.3	2.7	26.5	12.0	5.0	37.1	38.2	111.5	1.3	1.7	4.8	7.3	55.6	49.9	8.4	9.4	1.0	3.2	1.8	15.6	1.9	2.3	0.4	63.5	36.8	4.2	576.4	32.9	27.5	18.1	332.9	2.8	4.8	1.8	9.2	1.3	1.8	151.6	0.8	1.7	3.6	1.5	2.0	112.4	10.4	5.6	6.2	16.0	0.8	7.3	2.0	5.3	3.3	18.9	0.3	268.0	37.7	2.2	98.4	4.2	0.4	1.7	0.2	1.7	4.5	5.4	8.2	0.7	7.4	2.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	5.6	0.1	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.3	109.4	147.7	109.9	340.9	98.2	181.1	156.0	163.0	91.5	130.9	135.3	152.6	149.3	22.9	115.4	214.4	2.3	40.6	17.0	4.1	5.8	6.2	2.5	49.8	92.8	0.8	453.2	55.8	1.8	0.0	31.7	1.6	2.4	49.0	4.6	1.2	6.6	128.4	68.9	2.4	768.8	0.3	4.0	341.3	93.0	19.4	5.0	142.6	30.6	432.6	33405.9	4789.8	0.0	0.5	3.2	4.1	867.7	27.3	22.8	270.9	620.5	30.2	3.7	124.5	276.0	0.0	0.0	0.0	3.2	0.3	259.5	1.3	4.2	0.6	16.6	24.4	9.9	19.7	1628.8	24.4	2.0	3.2	3.7	17.8	71.6	46.7	1226.7	2.1	5.0
ARRDC5		ENSG00000205784	"Arrestin domain containing 5"	A6NEK1	19	4890437-4902896	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 17.1"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 292.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in single"	18	"REH: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (2.85e-2)"	"unprognostic (3.83e-5)"	"unprognostic (2.53e-1)"	"unprognostic (7.22e-5)"	"unprognostic (1.70e-1)"	"unprognostic (7.16e-5)"	"unprognostic (1.65e-2)"	"unprognostic (1.18e-2)"	"unprognostic (8.00e-2)"	"unprognostic (9.03e-2)"	"unprognostic (8.76e-2)"	"unprognostic (6.45e-2)"	"unprognostic (7.18e-8)"	"unprognostic (1.76e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.79e-2)"	0.1	0.1	0.4	0.6	0.3	1.6	0.1	0.2	0.6	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.0	0.4	0.4	0.1	0.1	0.5	1.7	0.6	0.4	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.1	0.2	0.1	0.0	0.0	0.1	0.9	0.1	0.3	2.1	0.2	17.1	0.5	1.6	0.1	0.0	0.6	0.2	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	1.2	1.1	0.3	0.6	1.0	0.2	0.8	0.5	0.7	1.0	1.1	0.0	0.6	0.1	1.4	0.5	0.3	0.4	0.3	0.2	0.6	0.4	0.4	0.6	0.4	0.1	1.0	0.3	0.5	0.8	0.0	0.0	0.0	0.3	2.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	8.4	0.1	0.0	0.0	292.2	0.3	0.0	0.2	0.0	0.0	0.5	0.2	0.0	0.3	0.5	0.1	0.0	0.0	0.0	0.3	1.0	0.0	0.4	0.0	0.0	3.5	0.6	61.0	1.2	2.2	0.0	13.1	3.0	0.0	15.5	0.0	0.3	0.1	0.0	0.7	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	5.9	1.0	0.0	0.1	0.0	4.1	0.0	0.0	0.4
CCL7	"FIC, MARC, MCP-3, MCP3, NC28, SCYA6, SCYA7"	ENSG00000108688	"C-C motif chemokine ligand 7"	P80098	17	34270221-34272242	"Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	"Cytokine, Heparin-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"bone marrow: 26.1"	"Cell type enriched"	"Detected in some"	4	"Hofbauer cells: 56.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"thalamus: 1.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 11.5;BJ hTERT+ SV40 Large T+: 2.3;BJ hTERT+ SV40 Large T+ RasG12V: 2.8;HSkMC: 3.3"	"Not detected"	"Not detected"												"Secreted to blood"	NA	NA	29700					"unprognostic (7.66e-2)"	"unprognostic (1.05e-2)"	"unprognostic (8.53e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.54e-2)"	"unprognostic (9.54e-2)"		"unprognostic (4.18e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.27e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.99e-8)"	"unprognostic (2.83e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.79e-2)"	0.8	0.3	0.0	2.5	0.0	26.1	0.1	0.0	0.3	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.7	0.2	0.0	0.9	0.2	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.2	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.2	0.0	1.7	0.3	0.0	0.0	0.0	3.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	1.7	0.0	1.3	11.5	2.3	2.8	0.0	0.0	0.0	0.4	0.8	0.0	1.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	3.3	0.0	0.9	0.0	0.0	1.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.3	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.5	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.2	0.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	56.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5
CGB8		ENSG00000213030	"Chorionic gonadotropin subunit beta 8"	P0DN86	19	49047638-49049106	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"placenta: 19.0"	"Cell type enriched"	"Detected in some"	6	"Syncytiotrophoblasts: 44.3"	"Cancer enriched"	"Detected in some"	4	"testis cancer: 5.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"BEWO: 157.9;U-251 MG: 57.2"									"HPA038925, HPA038934"	Supported		Approved	Cytosol	"Secreted to blood"	NA	NA			Cytosol		"HPA038925: AB_2676272, HPA038934: AB_2676277"		"unprognostic (3.35e-2)"				"unprognostic (1.72e-1)"					"unprognostic (7.44e-3)"				"unprognostic (4.70e-1)"		"unprognostic (1.67e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	19.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	1.2	0.0	0.0	0.0	0.0	157.9	0.0	0.0	0.6	0.0	0.0	5.3	0.0	0.1	1.0	4.0	1.3	0.0	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	10.1	0.2	0.6	0.0	2.8	7.1	0.7	57.2	0.1	0.2	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.3	0.0	0.0	0.0	0.0
CHRNA1	CHRNA	ENSG00000138435	"Cholinergic receptor nicotinic alpha 1 subunit"	P02708	2	174747592-174787935	"Disease related genes, Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skeletal muscle: 171.4"	"Cell type enriched"	"Detected in some"	48	"Skeletal myocytes: 193.5"	"Cancer enhanced"	"Detected in many"		"glioma: 5.8"	"Group enriched"	"Detected in some"	12	"cerebral cortex: 13.1;hippocampal formation: 5.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"LHCN-M2: 445.4;RH-30: 360.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA071554	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA071554: AB_2686416"	"unprognostic (1.49e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.22e-3)"	"unprognostic (2.28e-2)"	"unprognostic (2.96e-1)"	"unprognostic (8.55e-3)"	"unprognostic (5.34e-2)"	"unprognostic (5.29e-3)"	"unprognostic (9.59e-2)"	"unprognostic (9.64e-2)"	"unprognostic (9.66e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.18e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-1)"	"unprognostic (7.18e-2)"	0.1	0.0	0.3	0.2	0.4	0.0	0.5	0.2	13.1	0.6	0.3	1.5	0.2	0.0	0.2	0.6	0.0	0.0	0.3	5.6	0.3	0.0	0.2	0.6	0.8	0.4	0.3	0.4	0.0	0.0	0.0	3.4	0.2	0.6	2.1	0.9	0.0	3.2	0.0	171.4	0.3	0.0	0.0	0.4	0.0	0.1	0.4	0.3	1.2	0.0	20.6	1.2	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	21.5	0.0	0.2	0.0	0.0	1.4	0.0	0.1	0.2	445.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	360.2	0.0	0.0	0.3	2.9	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.4	0.2	13.1	5.6	0.3	0.4	0.3	0.4	0.6	0.4	0.3	0.8	0.1	0.0	0.0	0.0	2.8	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.3	4.0	0.0	0.0	1.7	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.1	0.5	0.0	0.6	0.4	1.7	0.3	0.4	1.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	193.5	0.3	0.1	0.2	0.0	0.0	0.0	1.8	0.0	0.2	0.0
CHRNE	ACHRE	ENSG00000108556	"Cholinergic receptor nicotinic epsilon subunit"	Q04844	17	4897771-4934438	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"heart muscle: 53.0;pituitary gland: 27.8"	"Cell type enriched"	"Detected in many"	5	"Late spermatids: 161.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 2.5"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"HEL: 5.0;HMC-1: 11.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	14	"basal ganglia: 6.3"							NA	NA						"unprognostic (2.00e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.94e-2)"	"unprognostic (4.35e-3)"	"unprognostic (6.55e-2)"	"unprognostic (2.27e-3)"	"unprognostic (7.80e-4)"	"unprognostic (7.75e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.69e-2)"	"unprognostic (6.58e-2)"	"unprognostic (8.42e-4)"	"unprognostic (1.39e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.83e-2)"	"unprognostic (5.70e-2)"	0.6	0.4	0.1	0.4	0.1	0.7	0.7	0.5	0.5	0.7	0.0	0.3	0.3	0.4	1.3	0.5	0.6	1.1	53.0	0.2	0.1	0.8	3.5	0.8	0.5	0.2	0.1	0.0	0.8	1.7	0.2	27.8	0.6	0.2	0.6	0.0	5.2	0.8	0.2	1.8	2.1	0.8	0.2	0.0	1.8	0.5	0.8	0.1	0.1	0.5	2.1	0.2	0.3	0.5	0.2	0.0	0.0	0.4	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	5.0	0.0	0.8	0.4	0.0	11.5	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.2	1.3	2.5	0.4	0.0	0.0	0.1	0.8	0.2	0.4	0.1	0.7	1.1	0.8	0.6	0.1	0.0	0.7	0.1	0.1	0.5	0.5	0.2	0.1	0.2	0.1	0.0	0.2	0.0	0.1	0.2	4.9	0.0	0.0	0.3	4.2	1.7	1.4	0.8	1.2	5.0	1.6	2.0	6.5	1.5	0.6	1.8	4.2	0.6	10.2	0.0	1.9	0.3	27.8	0.6	1.1	3.3	0.0	0.0	0.5	0.9	7.3	2.3	1.1	0.8	8.2	1.4	2.9	7.4	3.4	3.3	0.4	0.1	2.0	1.3	13.0	161.5	0.9	9.9	0.0	2.8	5.3	1.1	8.2	0.5	0.7	0.7	0.0	0.4	3.5	1.1	0.0	2.9	0.6	10.0	0.0	0.9	1.1	5.6	8.4	0.2	1.1	11.1	3.5	6.2	0.2	0.7
CLDN19		ENSG00000164007	"Claudin 19"	Q8N6F1	1	42733093-42740254	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Vision"		"Disease variant, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"choroid plexus: 15.7;kidney: 16.8;placenta: 9.8"	"Cell type enriched"	"Detected in some"	6	"Extravillous trophoblasts: 221.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.6"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CACO-2: 3.0;Hep G2: 6.3;SuSa: 3.5"	"Region enhanced"	"Detected in many"		"olfactory bulb: 5.4"	"Region enriched"	"Detected in many"	6	"spinal cord: 41.8"							NA	NA						"unprognostic (6.23e-4)"	"unprognostic (1.80e-1)"		"unprognostic (1.85e-6)"	"unprognostic (5.30e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.22e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.22e-2)"	"unprognostic (8.76e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.12e-1)"		"unprognostic (3.29e-3)"	0.4	0.1	0.1	0.0	0.1	0.1	1.2	0.5	0.5	0.0	15.7	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.1	1.3	0.1	16.8	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	9.8	0.5	0.3	0.0	0.0	0.8	0.8	0.2	0.4	0.1	0.0	0.1	0.0	0.3	0.0	0.1	1.6	0.0	0.9	0.0	0.4	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.5	1.3	0.1	0.1	0.2	0.1	0.5	0.1	0.1	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.3	0.2	8.3	0.3	0.0	0.6	12.9	0.0	12.5	0.0	0.0	33.2	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	221.6	0.7	0.0	0.2	0.0	0.0	0.7	0.0	5.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.3	0.0	1.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	3.7	0.0	0.2	0.0	0.3	0.1	0.1	0.1	0.0	0.0	12.4	0.1	0.2	0.1	0.0
CLTRN	"NX17, TMEM27"	ENSG00000147003	"Collectrin, amino acid transport regulator"	Q9HBJ8	X	15627318-15675012	"Metabolic proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"kidney: 490.8"	"Cell type enriched"	"Detected in some"	16	"Proximal tubular cells: 885.4"	"Cancer enriched"	"Detected in many"	35	"renal cancer: 106.2"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 8.5;hTERT-HME1: 5.2;RPTEC TERT1: 8.5;SuSa: 5.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA048543	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"		NA	NA			"Endoplasmic reticulum, Vesicles"		"HPA048543: AB_2680436"	"unprognostic (1.27e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.66e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.50e-2)"	"unprognostic (1.90e-2)"	"prognostic favorable (5.65e-4)"	"unprognostic (1.05e-2)"	"unprognostic (3.03e-1)"	"prognostic favorable (6.78e-9)"	"unprognostic (1.77e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.33e-2)"	0.5	0.8	0.6	0.0	0.6	0.3	2.0	0.7	0.8	1.0	13.6	0.6	1.4	1.6	3.1	0.6	2.4	3.8	1.1	0.7	0.5	490.8	62.0	1.8	0.4	0.7	0.8	0.5	3.2	5.4	10.6	0.6	0.5	0.7	1.5	0.3	1.2	0.8	1.3	0.1	1.2	0.4	0.4	0.5	0.2	11.0	1.1	0.6	0.8	4.1	0.1	0.3	0.8	0.4	1.0	2.3	1.8	1.1	0.3	0.7	1.0	0.7	0.0	0.0	0.1	0.1	0.1	0.5	0.1	1.6	0.2	0.2	8.5	0.7	2.3	0.0	0.3	0.7	0.2	0.0	0.8	1.0	0.0	0.0	0.2	2.0	0.3	5.2	0.6	0.0	2.1	0.5	0.4	0.2	2.8	0.1	0.3	2.9	0.8	2.6	0.2	0.3	0.9	8.5	0.1	1.1	1.0	0.6	0.1	1.8	5.1	0.6	0.2	0.0	0.2	0.4	0.3	0.0	0.4	0.2	0.3	0.6	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.2	0.1	0.1	0.2	0.6	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.6	0.7	0.8	0.7	0.5	0.7	0.8	0.5	0.7	0.5	0.6	1.0	0.1	0.0	4.1	0.0	5.7	0.0	0.0	0.0	0.0	0.0	3.0	3.2	0.0	0.0	1.8	27.6	0.0	2.1	0.0	0.0	54.8	25.1	0.0	2.8	0.6	0.1	0.0	0.0	0.0	0.6	0.5	0.3	0.0	3.3	0.0	1.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	885.4	2.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.0	3.7	0.5	0.0	0.0
CORIN	"ATC2, CRN, Lrp4, PRSC, TMPRSS10"	ENSG00000145244	"Corin, serine peptidase"	Q9Y5Q5	4	47593999-47838106	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"heart muscle: 57.5"	"Cell type enriched"	"Detected in some"	6	"Cardiomyocytes: 69.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"ASC TERT1: 44.0"	"Region enhanced"	"Detected in some"		"basal ganglia: 2.6"	"Low region specificity"	"Detected in some"			HPA070941			Approved	"Nuclear bodies,Plasma membrane,Actin filaments"	"Intracellular and membrane"	Yes	No			"Plasma membrane"	"Nuclear bodies, Actin filaments"	"HPA070941: AB_2686324"	"unprognostic (1.05e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.58e-4)"	"unprognostic (3.19e-1)"	"unprognostic (3.67e-2)"	"unprognostic (8.22e-2)"	"unprognostic (9.78e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.86e-2)"	"unprognostic (5.18e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.33e-2)"	0.3	0.1	0.2	0.1	0.1	0.0	1.0	0.1	0.2	2.1	0.6	0.3	0.1	4.5	0.6	0.9	1.5	4.6	57.5	0.1	0.8	0.7	0.1	1.9	0.0	0.7	0.6	0.1	0.5	0.2	1.2	1.9	0.4	0.2	2.4	0.0	0.3	0.4	6.1	0.1	7.5	0.3	0.7	0.1	1.1	0.5	2.5	0.4	0.1	0.1	0.1	0.1	1.2	4.0	0.2	0.0	0.0	0.1	0.3	10.3	44.0	0.0	2.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	2.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.9	1.4	0.0	0.3	0.2	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.1	0.8	0.7	0.6	0.1	0.2	0.1	0.4	0.2	0.3	0.0	7.5	1.0	0.0	3.8	0.3	0.0	0.0	1.0	8.3	0.3	69.4	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.1	1.3	1.0	0.0	0.0	6.5	0.0	0.0	9.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	10.8	0.0	0.0	0.6	5.5	2.0	4.7	0.1	5.4	1.0	0.0	0.7	0.0	2.0	3.9	0.0	0.0	2.6	0.0	0.6	0.0	0.2	0.0	0.3	0.0	0.3	2.3	4.6	4.4	0.1	2.7	0.0	0.6	0.1	0.0	0.3
CRYAA	"CRYA1, HSPB4"	ENSG00000160202	"Crystallin alpha A"	P02489	21	43169008-43172805	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Chaperone, Eye lens protein"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"kidney: 50.7;retina: 56.0"	"Cell type enriched"	"Detected in single"	5	"Muller glia cells: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	148	"Hep G2: 38.0"	"Region enhanced"	"Detected in some"		"hippocampal formation: 3.9"					"HPA037737, HPA038430"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA037737: AB_2675639, HPA038430: AB_2732478"							"unprognostic (3.68e-3)"											0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	50.7	6.7	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	56.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	38.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.5	0.3	0.3	0.2	0.1	0.2	0.2	0.2	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DSC1	CDHF1	ENSG00000134765	"Desmocollin 1"	Q08554	18	31129236-31162856	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skin 1: 230.7"	"Cell type enriched"	"Detected in some"	5	"Suprabasal keratinocytes: 166.5"	"Group enriched"	"Detected in some"	17	"head and neck cancer: 7.3;melanoma: 4.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"naive CD4 T-cell: 2.7;naive CD8 T-cell: 2.6"	"Lineage enriched"	"Detected in single"	8	"T-cells: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA075379	Enhanced					NA	NA		27000000			"HPA075379: AB_2732290"	"unprognostic (1.41e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.48e-2)"	"unprognostic (3.71e-2)"	"unprognostic (8.19e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.65e-6)"	"unprognostic (5.08e-2)"	"unprognostic (2.91e-1)"	"unprognostic (6.99e-2)"	"unprognostic (4.74e-5)"	0.1	0.0	0.0	0.1	0.0	0.2	9.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.0	27.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.3	0.1	0.0	0.1	0.2	0.0	0.7	230.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	2.7	2.6	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	14.1	0.3	0.0	2.2	0.9	0.1	0.4	29.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.3	0.4	0.0	0.0	3.6	0.0	0.1	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.5	166.5	0.4	0.6	0.0	0.0	0.3
GABRG1		ENSG00000163285	"Gamma-aminobutyric acid type A receptor subunit gamma1"	Q8N1C3	4	46035769-46124054	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 37.3;choroid plexus: 9.6"	"Cell type enriched"	"Detected in some"	8	"Astrocytes: 135.5"	"Cancer enriched"	"Detected in single"	8	"glioma: 0.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-266/70: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035622, HPA058102"	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA035622: AB_10603669, HPA058102: "	"unprognostic (2.50e-1)"				"unprognostic (2.20e-1)"		"unprognostic (6.06e-2)"			"unprognostic (1.46e-2)"	"unprognostic (7.39e-4)"		"unprognostic (1.23e-1)"		"unprognostic (1.28e-1)"	"unprognostic (1.99e-1)"		0.1	0.1	26.3	0.0	20.4	0.0	0.0	21.0	27.5	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	20.0	28.3	0.0	0.0	0.0	0.0	26.4	37.3	16.6	1.2	0.0	0.0	0.6	0.0	23.4	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	22.6	0.1	0.0	0.2	32.2	0.0	0.1	0.0	0.0	0.0	0.0	23.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.3	20.4	21.0	27.5	20.0	28.3	26.4	37.3	16.6	23.4	22.6	32.2	23.7	0.3	0.0	0.0	135.5	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.3	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	11.2	0.0	15.4	0.0	2.5	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	6.6	0.0	1.8	0.1	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0
GUCA2B		ENSG00000044012	"Guanylate cyclase activator 2B"	Q16661	1	42153410-42155820	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"intestine: 144.2"	"Cell type enriched"	"Detected in some"	7	"Paneth cells: 18841.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 5.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"A549: 1.4;CACO-2: 3.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.0"						"Secreted to blood"	NA	NA	77700	1200000						"unprognostic (2.59e-2)"				"unprognostic (1.44e-2)"				"unprognostic (1.34e-1)"		"unprognostic (6.22e-2)"	"unprognostic (1.86e-1)"				0.2	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	90.2	36.9	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	5.5	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	23.5	0.0	0.0	0.6	0.0	0.1	144.2	0.6	0.0	0.0	18.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	1098.8	0.0	0.9	1.0	0.0	0.0	0.0	22.8	0.0	0.0	47.9	0.3	0.0	0.0	0.0	22.3	0.0	0.4	3.1	0.1	0.0	0.0	107.2	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	18841.5	0.0	0.0	0.0	2568.9	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	1.3	0.0	55.3	0.9
IL37	"FIL1, FIL1(ZETA), FIL1Z, IL-1F7, IL-1H4, IL-1RP1, IL1F7"	ENSG00000125571	"Interleukin 37"	Q9NZH6	2	112912971-112918882	"Predicted intracellular proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skin 1: 137.9"	"Cell type enriched"	"Detected in some"	26	"Ionocytes: 73.2"	"Cancer enriched"	"Detected in some"	6	"lung cancer: 6.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 2.7;PC-3: 5.9;RT4: 3.2"									"HPA054371, HPA057950"	Uncertain		Supported	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA	76700		"Nucleoplasm, Vesicles"		"HPA054371: AB_2682465, HPA057950: AB_2683561"	"unprognostic (1.79e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.71e-5)"	"unprognostic (1.11e-1)"	"unprognostic (2.58e-2)"		"unprognostic (1.09e-2)"	"unprognostic (1.28e-2)"	"unprognostic (9.54e-2)"	"unprognostic (8.26e-3)"			"unprognostic (3.95e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.35e-2)"	0.1	0.0	0.0	0.2	0.0	0.2	16.9	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.1	0.4	137.9	0.1	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.1	0.0	0.0	0.1	0.2	2.7	0.2	0.2	0.2	0.3	0.0	0.2	0.1	0.2	0.1	0.1	0.4	0.8	0.1	0.0	1.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.3	0.6	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.8	0.2	0.2	5.9	0.0	0.0	0.0	0.0	3.2	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	73.2	0.0	0.4	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.1	0.0	2.8	0.0	0.1	0.0	0.0	0.0
KRT73	"K6IRS3, KRT6IRS3"	ENSG00000186049	"Keratin 73"	Q86Y46	12	52607570-52618559	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skin 1: 16.4"	"Cell type enriched"	"Detected in some"	5	"NK-cells: 7.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"naive CD4 T-cell: 8.8;naive CD8 T-cell: 3.1"	"Lineage enriched"	"Detected in single"	13	"T-cells: 8.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA044031	Enhanced					NA	NA					"HPA044031: AB_10963434"		"unprognostic (2.23e-3)"				"unprognostic (6.54e-2)"					"unprognostic (3.05e-1)"	"unprognostic (2.12e-3)"	"unprognostic (2.11e-3)"		"unprognostic (4.94e-1)"			0.2	0.0	0.0	0.7	0.0	1.3	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	16.4	0.9	0.0	0.0	0.6	0.0	0.1	0.0	0.4	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.2	0.0	0.0	8.8	3.1	0.0	0.6	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	7.2	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0
LHFPL3	LHFPL4	ENSG00000187416	"LHFPL tetraspan subfamily member 3"	Q86UP9	7	104328700-104907232	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 34.1;retina: 23.8"	"Cell type enriched"	"Detected in some"	19	"Oligodendrocyte precursor cells: 4790.3"	"Cancer enriched"	"Detected in some"	12	"glioma: 27.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 1.6;SH-SY5Y: 2.1;SK-BR-3: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069691			Approved	Vesicles		No	NA			Vesicles		"HPA069691: AB_2686171"		"unprognostic (1.20e-2)"	"unprognostic (6.91e-2)"	"unprognostic (4.59e-3)"	"unprognostic (5.03e-2)"			"unprognostic (2.27e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.96e-2)"	"unprognostic (5.81e-2)"	"unprognostic (5.99e-3)"	"unprognostic (8.50e-3)"	"unprognostic (3.07e-1)"		"unprognostic (1.33e-1)"	0.0	0.1	18.2	0.1	10.8	0.0	0.0	13.2	7.1	3.4	0.0	0.4	1.4	0.6	0.0	0.0	0.3	0.0	0.0	5.9	12.9	1.1	0.0	1.6	0.0	7.6	13.6	7.4	0.1	0.9	0.0	0.0	0.0	7.0	0.2	0.1	23.8	0.0	0.0	0.0	0.2	1.2	0.0	7.6	0.4	0.3	0.1	34.1	0.0	0.0	0.0	0.1	0.0	0.2	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.1	0.0	1.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.2	10.8	13.2	7.1	5.9	12.9	7.6	13.6	7.4	7.0	7.6	34.1	10.5	0.0	0.0	0.5	3.6	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.3	0.2	7.7	0.1	0.0	0.0	31.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	245.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.8	0.0	1.3	0.0	4790.3	13.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	7.3	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0
LILRA4	"CD85g, ILT7"	ENSG00000239961	"Leukocyte immunoglobulin like receptor A4"	P59901	19	54333185-54339162	"CD markers, Predicted membrane proteins"	"Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"lymphoid tissue: 11.0"	"Cell type enriched"	"Detected in some"	26	"dendritic cells: 336.0"	"Cancer enhanced"	"Detected in many"		"glioma: 2.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	21	"plasmacytoid DC: 176.1"	"Lineage enriched"	"Detected in many"	21	"dendritic cells: 176.1"	"Not detected"	"Not detected"											HPA049418	Approved					NA	NA		12000000			"HPA049418: AB_2680756"	"unprognostic (5.11e-2)"	"unprognostic (1.21e-4)"	"unprognostic (2.65e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.19e-3)"	"unprognostic (7.62e-2)"	"unprognostic (1.36e-3)"	"unprognostic (1.08e-1)"	"unprognostic (9.46e-2)"	"unprognostic (4.90e-2)"	"unprognostic (9.30e-2)"	"unprognostic (8.28e-7)"	"unprognostic (2.12e-2)"	"unprognostic (1.17e-3)"	"unprognostic (4.53e-1)"	"unprognostic (5.86e-2)"	0.0	0.0	0.2	0.5	0.3	0.0	0.0	0.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.7	0.7	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.5	11.0	0.0	0.1	0.4	0.0	0.0	0.0	2.6	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.3	0.0	0.0	1.1	3.9	0.0	0.0	0.0	0.4	0.0	176.1	0.0	1.1	0.2	0.3	0.3	0.3	0.2	0.3	0.7	0.5	0.1	0.6	0.5	0.4	0.7	0.0	0.0	0.6	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	336.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	4.0	1.6	0.0	0.0	5.9	0.0	1.9	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	1.3	0.0	0.0	0.1
LRTM1	HT017	ENSG00000144771	"Leucine rich repeats and transmembrane domains 1"	Q9HBL6	3	54918231-54967088	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"retina: 79.6;skeletal muscle: 26.1"	"Cell type enriched"	"Detected in some"	12	"Bipolar cells: 389.8"	"Cancer enhanced"	"Detected in single"		"urothelial cancer: 0.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HEL: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA										"unprognostic (2.28e-1)"	"unprognostic (1.58e-2)"								"unprognostic (9.56e-2)"	"unprognostic (2.16e-1)"		"unprognostic (1.87e-3)"	0.1	0.0	1.4	0.0	3.0	0.1	0.5	0.5	3.5	0.2	2.7	0.4	0.0	0.0	0.3	4.0	0.1	0.0	0.1	2.2	3.3	0.0	0.3	0.2	0.1	1.0	5.8	2.4	0.0	0.1	0.1	0.0	0.6	1.7	1.1	0.1	79.6	1.0	0.5	26.1	0.0	0.2	0.0	0.1	6.7	0.1	0.5	1.1	0.1	0.3	2.5	0.1	0.1	0.0	3.0	0.1	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.4	0.0	0.3	0.0	0.1	0.1	0.0	0.2	0.0	0.4	0.1	0.2	0.0	1.1	0.3	0.2	0.0	0.0	0.2	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.3	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.1	0.1	0.0	0.5	0.0	0.1	0.2	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.5	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.3	0.0	0.1	0.1	1.4	3.0	0.5	3.5	2.2	3.3	1.0	5.8	2.4	1.7	0.1	1.1	3.0	0.2	0.0	0.0	5.9	0.0	0.4	0.6	0.1	0.0	389.8	0.0	0.0	0.5	0.0	0.0	1.8	16.7	9.3	0.0	0.1	0.0	0.0	3.0	0.1	0.2	1.0	0.0	0.0	27.1	0.4	1.3	1.2	0.0	0.3	0.0	0.2	0.0	0.0	0.7	1.7	10.9	0.0	0.0	0.0	0.6	0.7	5.9	0.1	0.0	1.9	0.1	17.2	0.0	4.0	0.5	2.0	0.0	4.5	0.0	0.6	0.0	0.0	0.0	30.8	0.0	3.2	1.6	3.1	3.7	0.0	0.4	22.2	0.1	0.5	0.0	0.4
MARCHF11	"MARCH-XI, MARCH11, RNF226"	ENSG00000183654	"Membrane associated ring-CH-type finger 11"	A6NNE9	5	16067139-16180762	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 83.0"	"Cell type enriched"	"Detected in single"	30	"Cardiomyocytes: 6.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"SH-SY5Y: 83.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (9.91e-3)"				"unprognostic (1.08e-1)"					"unprognostic (2.98e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.54e-1)"			"unprognostic (1.52e-1)"	"unprognostic (3.55e-2)"		0.1	0.7	4.3	0.0	4.7	0.0	0.3	5.0	6.8	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	5.7	6.9	0.2	0.1	0.0	0.0	5.3	4.6	4.7	0.3	1.3	0.0	10.0	0.0	5.1	0.3	0.0	3.6	1.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.1	83.0	4.8	0.0	0.0	0.0	0.0	0.0	0.1	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	83.8	0.0	0.0	0.0	7.5	0.0	0.0	0.0	1.5	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	4.7	5.0	6.8	5.7	6.9	5.3	4.6	4.7	5.1	3.6	4.8	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MC4R		ENSG00000166603	"Melanocortin 4 receptor"	P32245	18	60371062-60372775	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, FDA approved drug targets, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 3.2;fallopian tube: 3.1;retina: 3.9"	"Cell type enriched"	"Detected in some"	7	"Bipolar cells: 7.3"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	70	"fHDF/TERT166: 94.7"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 10.2"	HPA016719	Uncertain					NA	NA					"HPA016719: AB_1853617"	"unprognostic (2.29e-1)"			"unprognostic (5.31e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.41e-1)"		"unprognostic (1.35e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.48e-1)"			"unprognostic (2.49e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.59e-1)"		0.0	0.2	1.9	0.0	2.7	0.0	0.2	0.4	1.6	0.0	0.4	0.0	0.1	0.0	0.3	0.0	3.1	0.0	0.0	1.9	3.2	0.0	0.0	0.0	0.0	1.3	1.5	2.3	0.1	0.0	0.0	0.1	0.0	1.0	0.0	0.0	3.9	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.1	0.1	2.5	0.3	0.0	0.0	0.3	0.0	0.0	1.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	94.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.7	0.4	1.6	1.9	3.2	1.3	1.5	2.3	1.0	0.7	2.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MYOM3	FLJ35961	ENSG00000142661	"Myomesin 3"	Q5VTT5	1	24056035-24112135	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"heart muscle: 177.1;skeletal muscle: 324.2;tongue: 258.1"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 198.3"	"Cancer enhanced"	"Detected in some"		"renal cancer: 6.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"A549: 4.6;Hep G2: 18.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA028132, HPA028340"			Approved	"Golgi apparatus,Vesicles,Cytokinetic bridge"		Yes	No		830000	Vesicles	"Golgi apparatus, Cytokinetic bridge"	"HPA028132: AB_10599293, HPA028340: "	"unprognostic (8.59e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.39e-1)"	"unprognostic (8.60e-3)"	"unprognostic (1.52e-2)"	"unprognostic (7.31e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.66e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.73e-4)"	"unprognostic (2.09e-1)"	"prognostic favorable (4.28e-6)"	"unprognostic (2.77e-2)"	"unprognostic (1.60e-3)"	"unprognostic (7.75e-2)"	"unprognostic (1.68e-1)"	0.4	0.2	0.0	0.2	0.1	0.0	0.7	0.2	0.3	0.2	0.4	0.5	1.1	0.3	0.0	6.1	0.9	0.4	177.1	0.1	0.1	31.7	0.2	0.3	0.1	0.2	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.1	4.6	0.7	1.2	7.1	0.0	324.2	2.0	5.2	0.2	0.0	0.0	0.2	9.0	0.1	1.7	0.3	258.1	0.1	0.1	0.4	0.2	0.1	4.6	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	1.3	0.0	1.9	0.6	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.8	18.1	0.0	0.1	0.1	0.5	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.4	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.2	0.2	0.1	1.0	0.2	0.5	0.6	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	1.0	0.6	0.2	0.1	0.6	0.0	0.1	0.6	198.3	0.0	0.0	3.7	0.0	0.0	0.1	3.6	1.9	0.1	16.2	0.4	0.0	1.6	1.2	0.0	0.4	0.4	0.0	6.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.3	1.7	0.0	0.0	0.7	10.3	0.6	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.2	2.5	2.4	0.0	0.0	0.2	13.0	33.2	0.0	2.5	6.6	10.0	1.3	0.0	0.2	0.0	0.6	0.0	0.3	2.3	2.2	0.3
NOX4	"KOX, KOX-1"	ENSG00000086991	"NADPH oxidase 4"	Q9NPH5	11	89324353-89498187	"Predicted membrane proteins, Transporters"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"kidney: 139.3"	"Cell type enriched"	"Detected in many"	5	"Proximal tubular cells: 164.0"	"Cancer enhanced"	"Detected in many"		"renal cancer: 5.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 14.3;HUVEC TERT2: 27.7;TIME: 70.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (2.91e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.74e-3)"	"unprognostic (6.58e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.33e-1)"	"unprognostic (8.83e-3)"	"unprognostic (8.95e-3)"	"unprognostic (3.80e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (6.14e-4)"	"unprognostic (1.99e-4)"	"unprognostic (9.71e-2)"	"unprognostic (5.69e-2)"	"unprognostic (3.03e-3)"	6.0	0.7	0.7	0.7	1.1	0.2	3.8	0.9	1.9	1.5	1.4	1.0	0.2	4.9	0.4	0.4	1.3	2.4	5.5	0.5	0.8	139.3	0.3	1.5	0.2	1.3	0.8	0.4	0.8	0.3	3.6	0.9	3.1	0.9	1.0	0.3	17.3	3.0	1.3	1.7	1.1	0.6	3.5	1.3	0.4	0.5	0.3	0.8	0.1	2.1	3.6	0.5	1.4	1.1	1.9	0.0	0.0	1.9	0.0	0.0	0.0	0.0	3.5	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.7	0.1	0.0	0.1	14.3	27.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	6.1	0.0	0.0	0.3	7.1	0.4	0.0	70.6	0.2	5.0	0.0	5.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.7	1.1	0.9	1.9	0.5	0.8	1.3	0.8	0.4	0.9	1.3	0.8	1.9	4.4	0.0	0.0	2.9	1.0	0.6	0.1	0.4	0.0	7.5	0.2	0.3	1.0	0.0	0.0	11.0	6.2	2.2	0.2	0.1	15.6	0.0	0.8	1.0	1.4	5.9	0.0	0.0	30.0	0.0	0.8	9.2	0.0	3.0	0.0	0.6	2.5	0.1	0.2	0.0	21.1	0.0	0.0	0.0	0.5	0.7	0.3	1.3	0.0	6.5	0.1	4.5	0.0	7.1	28.4	0.1	0.0	1.2	0.3	0.1	0.0	164.0	0.0	27.1	0.0	1.2	1.0	0.6	0.7	0.1	0.3	2.5	1.1	0.1	0.0	0.1
ODF3L1	MGC48986	ENSG00000182950	"Outer dense fiber of sperm tails 3 like 1"	Q8IXM7	15	75724041-75727688	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"testis: 22.8"	"Cell type enriched"	"Detected in some"	9	"Early spermatids: 111.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.0;HeLa: 1.2;U-87 MG: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (6.24e-2)"	"unprognostic (1.97e-2)"	"unprognostic (4.58e-2)"	"unprognostic (8.42e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.74e-1)"	"unprognostic (7.55e-4)"	"unprognostic (9.65e-2)"	"unprognostic (9.96e-3)"	"unprognostic (6.40e-2)"	"unprognostic (4.14e-2)"	"unprognostic (8.94e-3)"	"unprognostic (1.45e-2)"	1.4	0.1	0.6	0.3	0.3	0.3	1.1	1.4	0.5	0.6	0.4	1.1	0.5	1.2	0.1	1.2	1.0	2.6	0.7	0.5	0.4	0.2	1.2	1.6	0.1	0.2	0.3	0.2	0.2	0.4	0.1	1.1	0.2	0.6	0.4	0.4	0.0	0.1	0.1	0.1	1.5	0.9	0.9	0.0	0.3	1.7	22.8	0.2	0.6	1.4	0.0	0.1	0.9	0.2	0.7	0.0	1.0	0.3	0.0	0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.2	0.9	0.0	0.0	0.1	0.0	0.9	0.0	0.6	0.0	0.7	0.4	0.0	1.2	0.2	0.2	0.0	0.0	0.6	0.0	0.2	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.4	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	1.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	1.4	0.5	0.5	0.4	0.2	0.3	0.2	0.6	0.0	0.2	0.7	0.1	0.0	1.1	0.0	0.4	6.1	9.7	0.9	0.0	0.0	0.6	0.3	0.0	0.0	2.5	0.0	0.0	1.6	0.1	0.7	0.0	0.3	111.2	2.7	0.5	0.3	0.0	0.0	0.1	0.0	0.9	2.1	1.5	1.8	0.0	0.2	1.1	0.3	0.4	0.0	0.0	1.2	0.0	0.0	2.7	11.9	0.0	1.3	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.2	0.7	0.8	0.9	1.6	0.7	0.3	0.0	6.6	2.7	1.0	8.0	0.4	0.0	6.5	1.9	0.4	0.1	0.5	4.1
OR14A2	"OR5AX1, OR5AX1P"	ENSG00000241128	"Olfactory receptor family 14 subfamily A member 2"	Q96R54	1	247722957-247724043	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	8	"testis: 2.4"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 14.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	51	"GAMG: 5.0"									HPA052685	Uncertain					NA	NA					"HPA052685: AB_2681914"																		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PIEZO2	"C18orf30, C18orf58, FAM38B, FAM38B2, FLJ23144, FLJ23403, FLJ34907, HsT748, HsT771"	ENSG00000154864	"Piezo type mechanosensitive ion channel component 2"	Q9H5I5	18	10666483-11149569	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Transport"	"Ion channel"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 56.6"	"Cell type enriched"	"Detected in many"	10	"Oligodendrocytes: 399.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 15.1;BJ hTERT+ SV40 Large T+: 16.9;BJ hTERT+ SV40 Large T+ RasG12V: 23.1;HeLa: 38.1;U-266/70: 23.0;U-698: 16.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA015986, HPA031974, HPA040616"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA015986: AB_1848395, HPA031974: AB_10603675, HPA040616: AB_2677043"	"unprognostic (1.36e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.21e-2)"	"unprognostic (2.53e-2)"	"unprognostic (7.84e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.87e-2)"	"unprognostic (4.34e-3)"	"unprognostic (6.55e-2)"	"unprognostic (3.89e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (9.57e-7)"	"unprognostic (1.12e-3)"	"unprognostic (1.09e-1)"	"unprognostic (9.04e-2)"	"unprognostic (1.83e-2)"	1.1	0.5	7.3	1.3	15.9	0.4	1.8	12.0	14.4	1.1	0.0	2.9	0.4	0.7	1.6	5.1	1.1	5.3	0.2	5.6	10.5	1.1	4.1	6.7	0.9	14.1	13.4	2.4	0.7	1.8	0.5	0.9	0.0	18.0	3.0	1.4	0.1	0.3	3.0	0.1	1.1	1.1	2.1	10.6	2.7	1.6	1.2	13.4	0.8	1.5	0.2	0.6	5.4	0.7	56.6	0.0	1.8	15.1	0.0	0.0	0.0	0.0	0.8	4.4	16.9	23.1	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	10.6	0.0	0.5	0.0	38.1	8.8	5.2	0.0	0.1	0.1	0.3	4.3	1.2	0.1	5.2	0.6	0.0	0.3	2.7	0.0	0.3	0.0	4.5	6.7	0.0	0.0	0.0	7.0	0.0	5.3	12.7	0.0	0.1	0.0	0.8	6.7	0.0	4.5	0.0	0.0	5.8	0.3	0.9	23.0	0.2	16.2	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	15.9	12.0	14.4	5.6	10.5	14.1	13.4	2.4	18.0	10.6	13.4	56.6	3.3	0.0	5.3	2.0	0.0	0.8	0.3	0.0	0.0	0.0	2.3	0.8	1.6	10.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.3	31.7	0.2	0.2	9.9	0.0	0.0	2.5	0.2	0.0	11.2	2.6	0.0	5.1	0.1	17.2	5.9	1.0	0.0	37.0	0.0	0.0	3.2	0.8	11.9	0.0	0.6	0.0	9.4	0.0	0.0	0.0	2.0	399.6	0.1	0.0	0.0	0.4	0.1	0.0	0.1	7.3	0.0	6.6	0.9	4.5	0.3	1.4	0.2	0.9	0.4	0.6	32.9	0.0	0.1
PLAAT1	"A-C1, H-REV107, HRASLS, HRASLS1, PLA/AT1, PLAAT-1"	ENSG00000127252	"Phospholipase A and acyltransferase 1"	Q9HDD0	3	193241128-193277738	"Enzymes, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"skeletal muscle: 90.9;testis: 74.2;tongue: 44.9"	"Cell type enriched"	"Detected in some"	11	"Cardiomyocytes: 12.5"	"Cancer enhanced"	"Detected in many"		"glioma: 8.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 12.9;NTERA-2: 11.0;PC-3: 23.8;RH-30: 10.7;SCLC-21H: 22.0;U-2 OS: 13.3;U-251 MG: 18.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051179	Uncertain		Approved	"Focal adhesion sites,Cytosol"		No	No			"Focal adhesion sites"	Cytosol	"HPA051179: AB_2681375"	"unprognostic (3.01e-2)"	"unprognostic (4.21e-2)"	"unprognostic (7.93e-3)"	"unprognostic (4.82e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.87e-1)"	"unprognostic (9.97e-3)"	"unprognostic (9.68e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.77e-4)"	"unprognostic (5.09e-2)"	"unprognostic (1.38e-5)"	"unprognostic (1.61e-2)"	"prognostic favorable (4.36e-4)"	"unprognostic (2.98e-3)"	"unprognostic (1.13e-2)"	0.9	2.5	4.7	0.2	5.0	0.1	1.8	3.6	5.8	0.4	0.8	0.4	0.0	0.9	5.9	6.6	0.5	0.2	8.8	5.1	5.5	0.5	0.1	0.2	0.0	4.4	4.2	5.1	0.2	1.4	2.1	2.2	0.1	3.9	0.1	0.1	9.1	2.1	0.7	90.9	3.2	0.3	1.3	2.0	0.2	0.8	74.2	4.0	2.3	7.1	44.9	0.3	0.3	0.4	5.4	0.0	0.1	2.6	0.0	0.0	0.0	0.0	0.2	0.0	2.3	0.4	0.0	0.1	0.0	0.2	0.0	5.3	0.0	12.9	0.4	0.6	0.0	5.6	6.9	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	11.0	0.4	23.8	0.0	10.7	0.0	3.7	0.0	22.0	4.1	1.5	3.3	0.0	2.1	6.5	0.1	0.1	0.0	13.3	0.0	18.6	0.1	0.0	0.0	7.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.4	4.7	5.0	3.6	5.8	5.1	5.5	4.4	4.2	5.1	3.9	2.0	4.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0
RGS13		ENSG00000127074	"Regulator of G protein signaling 13"	O14921	1	192636138-192660311	"Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"lymphoid tissue: 48.4"	"Cell type enriched"	"Detected in some"	16	"granulocytes: 520.0"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 0.6"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	39	"basophil: 6.8"	"Lineage enriched"	"Detected in single"	39	"granulocytes: 6.8"	"Cell line enriched"	"Detected in some"	20	"Daudi: 47.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA076656	Enhanced					NA	NA					"HPA076656: "	"unprognostic (1.99e-2)"	"unprognostic (6.08e-3)"	"unprognostic (3.25e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.37e-5)"	"unprognostic (1.93e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.65e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.35e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.96e-1)"	0.5	0.0	0.0	9.6	0.0	0.7	2.3	0.0	0.0	1.6	0.0	2.3	3.1	1.0	0.7	1.7	0.3	3.7	0.1	0.0	0.0	0.0	0.0	4.0	48.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.2	1.6	0.0	0.3	0.6	0.0	0.3	5.7	1.2	0.0	0.3	2.1	0.1	0.0	1.3	0.0	0.2	35.4	2.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	30.8	0.0	4.8	1.9	2.1	0.0	0.0	0.0	0.1	0.3	0.3	0.0	1.3	0.0	0.0	0.0	2.9	0.1	0.0	0.1	0.0	0.0	0.0	0.3	7.1	0.0	0.2	0.0	0.0	0.9	12.2	0.0	520.0	0.0	0.0	0.0	0.3	0.0	0.6	0.6	0.0	0.6	7.1	0.0	0.0	3.8	7.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	3.9	1.7	0.2	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	1.3	0.0	7.9	0.5	1.6	0.1
RIDA	"HRSP12, P14.5, PSP, UK114"	ENSG00000132541	"Reactive intermediate imine deaminase A homolog"	P52758	8	98102344-98117171	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"kidney: 500.8;liver: 1549.6"	"Cell type enriched"	"Detected in many"	5	"Proximal tubular cells: 1579.1"	"Group enriched"	"Detected in all"	5	"liver cancer: 162.2;renal cancer: 42.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 191.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022856, HPA023489"	Enhanced					NA	NA		5000000			"HPA022856: AB_1858253, HPA023489: AB_1858252"	"unprognostic (1.67e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.16e-1)"	"unprognostic (2.20e-2)"	"prognostic favorable (9.61e-6)"	"unprognostic (6.08e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.81e-1)"	"unprognostic (4.46e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.51e-2)"	50.6	48.8	92.0	11.5	95.0	7.6	19.2	95.1	132.8	11.3	82.8	24.7	30.8	8.4	22.9	14.4	9.5	22.9	32.6	88.7	93.9	500.8	1549.6	9.6	10.2	96.5	94.5	87.4	23.6	27.2	24.8	10.1	10.9	93.7	19.5	24.9	26.8	16.5	11.7	40.4	10.7	22.0	10.9	91.4	7.5	25.0	17.3	97.4	11.3	16.0	41.3	12.4	15.6	8.0	90.3	44.0	37.5	29.3	36.6	65.5	50.4	33.0	39.7	28.0	26.4	31.0	51.4	28.4	62.5	49.6	29.4	34.5	30.8	65.4	56.9	52.5	22.3	28.6	45.0	25.6	55.6	29.9	17.6	7.0	44.4	19.5	36.6	39.9	32.4	34.2	65.3	82.7	12.9	35.5	57.8	35.6	50.1	47.0	191.4	67.8	41.0	21.7	18.4	64.6	31.6	32.2	15.7	25.5	17.4	29.2	37.4	44.5	23.5	20.9	20.6	12.5	33.7	16.3	31.2	46.1	30.9	35.0	39.0	13.2	0.2	9.0	5.6	6.6	7.8	8.7	13.8	9.4	10.1	11.1	11.5	12.0	13.0	1.9	10.3	8.3	8.5	13.9	8.1	92.0	95.0	95.1	132.8	88.7	93.9	96.5	94.5	87.4	93.7	91.4	97.4	90.3	7.8	25.6	22.4	0.0	7.4	0.0	0.0	0.0	0.0	0.0	13.8	15.1	0.0	0.0	1.8	47.8	0.0	31.1	3.2	0.0	285.7	19.7	0.0	25.1	12.3	5.0	0.0	0.0	0.0	8.5	29.9	7.9	0.0	9.4	2.5	17.7	0.0	0.0	24.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	5.7	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.8	0.0	0.0	1579.1	5.8	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	14.4	6.3	22.3	0.0	0.0
SLC18A1	"CGAT, VAT1, VMAT1"	ENSG00000036565	"Solute carrier family 18 member A1"	P54219	8	20144855-20183206	"FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"adrenal gland: 25.3"	"Cell type enriched"	"Detected in some"	27	"Enteroendocrine cells: 139.0"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 0.8"	"Region enriched"	"Detected in single"	4	"midbrain: 1.7"	"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 2.8"	"Lineage enriched"	"Detected in single"	19	"monocytes: 2.8"	"Cell line enriched"	"Detected in some"	8	"SH-SY5Y: 67.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA006877, HPA063797"	Enhanced					NA	NA					"HPA006877: AB_2667690, HPA063797: AB_2685125"	"unprognostic (8.03e-4)"	"unprognostic (1.02e-1)"	"unprognostic (3.75e-3)"	"unprognostic (3.50e-1)"	"unprognostic (6.61e-2)"	"unprognostic (3.09e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.48e-2)"	"unprognostic (8.25e-2)"	"unprognostic (4.41e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.05e-1)"	0.1	25.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	3.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.3	1.2	0.1	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	3.8	67.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.1	1.7	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	139.0	0.0	0.0	0.0	0.0	3.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	3.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.9	1.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1
SLC25A4	"ANT1, PEO2, PEO3, T1"	ENSG00000151729	"Solute carrier family 25 member 4"	P12235	4	185143266-185150382	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Antiport, Host-virus interaction, Transport"		"Cardiomyopathy, Disease variant, FDA approved drug targets, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"heart muscle: 201.5;skeletal muscle: 192.6;tongue: 349.7"	"Cell type enriched"	"Detected in all"	4	"Cardiomyocytes: 4722.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046835, HPA071684"	Approved		Supported	Mitochondria		NA	NA		380000	Mitochondria		"HPA046835: AB_2679831, HPA071684: AB_2686431"	"unprognostic (4.19e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.11e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.90e-3)"	"unprognostic (8.25e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (3.41e-4)"	"unprognostic (2.05e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.28e-3)"	4.7	5.7	11.9	1.6	16.6	0.4	4.6	24.1	31.3	3.4	7.1	15.9	3.0	5.9	3.5	10.1	5.8	3.9	201.5	16.1	15.2	10.4	7.3	4.6	1.6	12.7	13.0	15.3	5.0	5.3	7.8	9.6	1.8	14.9	9.0	3.9	20.1	9.1	12.7	192.6	3.1	6.9	8.1	9.9	3.1	15.8	4.7	12.7	1.5	5.2	349.7	1.2	9.9	3.6	19.3	0.7	3.1	2.5	5.1	2.7	0.3	4.6	2.6	0.8	3.1	3.0	6.8	1.7	2.3	1.8	3.1	2.4	2.5	9.8	2.7	2.0	3.9	8.4	1.6	4.7	8.1	5.5	1.4	1.5	2.0	6.6	4.7	1.3	7.2	2.3	4.0	3.8	1.7	1.9	5.0	1.6	3.1	4.1	2.2	6.6	2.5	1.3	3.2	6.9	4.8	8.1	6.2	3.1	1.3	12.5	4.5	2.4	1.1	1.7	0.2	1.4	1.5	3.4	7.3	3.5	2.9	2.2	0.3	2.8	0.0	0.0	0.0	1.7	0.0	1.3	1.5	0.5	1.4	0.0	1.0	0.4	1.2	0.1	0.3	0.0	1.3	0.5	0.6	11.9	16.6	24.1	31.3	16.1	15.2	12.7	13.0	15.3	14.9	9.9	12.7	19.3	37.5	86.6	76.4	22.9	37.9	44.1	159.0	119.9	30.1	180.6	42.9	53.5	4722.0	115.8	80.0	71.7	104.3	69.2	41.1	44.4	988.0	75.3	20.6	77.8	7.4	80.1	53.8	3.0	35.1	74.1	56.5	120.1	54.0	33.6	12.0	18.6	27.5	92.1	65.9	159.9	43.7	40.6	215.7	8.5	13.8	16.7	46.6	6.8	190.3	19.7	9.0	541.2	16.5	26.7	29.2	51.4	28.5	112.8	76.4	59.1	113.8	178.3	144.0	221.0	105.2	134.5	402.7	28.0	34.0	33.2	18.2	40.5	27.7	23.7	54.2	50.7
SLC25A41	"APC4, FLJ40442, MGC34725"	ENSG00000181240	"Solute carrier family 25 member 41"	Q8N5S1	19	6426037-6433779	"Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 6.4;choroid plexus: 3.9;testis: 2.1"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 92.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 3.0;U-937: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA043591	Uncertain					NA	NA					"HPA043591: AB_10964585"	"unprognostic (1.87e-3)"	"unprognostic (2.52e-3)"	"unprognostic (6.81e-2)"	"unprognostic (8.75e-2)"	"unprognostic (2.67e-1)"	"unprognostic (8.29e-4)"	"unprognostic (4.43e-3)"	"unprognostic (2.81e-2)"	"unprognostic (9.26e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.19e-3)"	"unprognostic (3.11e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.63e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.24e-1)"	0.0	0.1	4.3	0.0	4.8	0.0	0.0	4.2	6.4	0.2	3.9	0.5	0.0	0.1	0.0	0.3	0.2	0.0	0.3	4.4	4.0	0.1	0.3	0.0	0.0	4.4	4.1	4.0	0.3	0.1	0.0	0.2	0.0	4.4	0.4	0.0	0.3	0.1	0.1	0.3	0.2	0.2	0.1	3.9	0.1	0.2	2.1	4.2	0.0	0.2	0.0	0.0	0.3	0.2	4.3	0.1	0.1	0.4	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.9	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	3.0	0.2	0.6	0.0	0.0	0.1	0.0	0.2	0.8	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	4.8	4.2	6.4	4.4	4.0	4.4	4.1	4.0	4.4	3.9	4.2	4.3	0.0	0.0	0.0	2.0	0.1	0.0	0.1	0.3	0.0	1.0	0.2	0.3	0.5	0.0	0.0	0.0	2.1	0.4	0.1	0.4	0.0	0.3	92.2	0.1	0.1	0.0	0.0	0.0	5.0	0.0	0.1	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.1	3.3	4.5	0.4	0.0	0.0	0.0	20.6	0.9	0.1	0.0	0.0	0.0	1.1	0.0	1.0	1.6	0.6	0.2	0.0	0.0	0.2	0.2	0.2	0.1	1.2	0.0	0.1	0.1	0.3	0.6	0.0	0.3	0.5	0.0	0.0	0.4	0.1
SPIB	SPI-B	ENSG00000269404	"Spi-B transcription factor"	Q01892	19	50418938-50431314	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"intestine: 28.1;lymphoid tissue: 100.2"	"Cell type enriched"	"Detected in many"	4	"Paneth cells: 787.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	54	"memory B-cell: 307.8;naive B-cell: 260.6;plasmacytoid DC: 572.6"	"Group enriched"	"Detected in many"	106	"B-cells: 307.8;dendritic cells: 572.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 166.3;HDLM-2: 107.3;Karpas-707: 52.8;U-698: 238.2"									HPA018523	Uncertain					NA	NA					"HPA018523: AB_1857443"	"prognostic favorable (4.76e-5)"	"unprognostic (1.06e-5)"	"unprognostic (9.15e-3)"	"unprognostic (3.70e-2)"	"unprognostic (9.72e-3)"	"prognostic favorable (2.14e-5)"	"unprognostic (2.33e-1)"	"unprognostic (4.79e-3)"	"unprognostic (1.18e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.96e-8)"	"unprognostic (1.43e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.33e-2)"	1.2	0.1	0.4	42.1	0.4	6.1	0.2	1.1	0.6	0.1	0.5	22.4	13.2	0.4	0.2	0.7	0.8	1.7	0.2	0.4	0.7	0.6	0.5	1.1	87.7	1.4	0.4	0.5	0.1	1.5	0.0	0.1	0.2	0.5	1.2	18.4	0.3	2.8	0.2	1.3	0.5	28.1	0.8	0.1	29.5	8.3	0.4	0.4	7.6	0.8	0.2	100.2	4.2	0.3	1.3	0.4	1.1	0.1	0.1	0.0	0.0	0.7	0.1	0.0	0.1	0.2	3.1	0.2	166.3	0.2	0.1	0.0	0.2	1.4	0.0	0.0	107.3	0.3	0.7	0.3	0.1	0.0	0.5	0.3	0.0	0.1	0.1	0.1	0.1	0.0	0.8	4.6	52.8	0.1	0.5	0.1	0.6	1.5	0.1	0.0	11.6	0.9	2.0	0.0	0.2	0.1	0.1	0.1	0.2	0.2	0.2	0.3	5.4	0.8	0.1	3.0	0.1	0.3	5.0	3.5	238.2	0.1	2.6	0.2	4.1	0.5	0.8	0.5	0.2	0.4	307.8	0.3	0.3	6.9	260.6	0.4	0.3	2.6	3.9	0.3	572.6	0.6	14.8	0.4	0.4	1.1	0.6	0.4	0.7	1.4	0.4	0.5	0.5	0.1	0.4	1.3	0.5	0.0	1.8	0.3	162.7	1.8	2.1	0.0	0.0	0.7	0.6	0.9	0.4	0.0	0.0	0.0	0.0	0.3	192.8	28.3	0.0	0.7	0.0	1.1	0.3	0.8	19.8	0.4	0.3	1.1	0.2	1.1	2.6	0.5	4.5	0.2	0.0	0.5	1.4	0.0	0.3	18.4	0.0	0.6	38.0	0.0	0.0	13.0	7.2	0.0	1.6	0.6	1.0	0.0	0.2	0.0	787.8	0.4	2.0	1.4	5.0	0.3	0.7	1.0	0.0	1.3	0.8	0.2	1.1	0.0	1.3	0.3	2.7	0.1	37.6	1.3
TNFRSF13C	"BAFFR, CD268"	ENSG00000159958	"TNF receptor superfamily member 13C"	Q96RJ3	22	41922032-41926806	"CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"intestine: 34.0;lymphoid tissue: 58.6"	"Cell type enriched"	"Detected in some"	10	"B-cells: 194.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	36	"memory B-cell: 22.5;naive B-cell: 29.1"	"Lineage enriched"	"Detected in single"	40	"B-cells: 29.1"	"Group enriched"	"Detected in some"	6	"REH: 21.0;U-698: 10.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA003246, CAB008380"	Enhanced					NA	NA					"CAB008380: AB_590602, HPA003246: AB_1078264"	"unprognostic (3.43e-4)"	"prognostic favorable (4.44e-7)"	"unprognostic (6.52e-2)"	"unprognostic (9.10e-2)"	"unprognostic (7.64e-3)"	"unprognostic (4.83e-3)"	"unprognostic (2.89e-2)"	"unprognostic (3.78e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.79e-8)"	"unprognostic (2.21e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.77e-1)"	"unprognostic (9.44e-2)"	0.8	0.8	2.0	17.9	1.4	6.0	0.5	1.3	1.6	0.2	0.6	1.3	1.2	0.3	0.3	1.5	0.4	1.0	0.4	1.9	1.6	0.8	0.3	1.0	39.3	3.5	2.8	1.2	0.1	0.1	0.1	0.2	0.3	2.5	0.5	1.1	0.4	1.7	0.1	2.3	3.3	34.0	0.1	2.8	58.6	2.5	0.7	1.8	3.4	1.1	0.5	55.0	1.8	0.5	1.9	0.3	0.2	1.1	2.3	0.0	0.0	0.4	0.2	0.1	0.2	0.8	0.9	0.5	1.9	0.4	0.2	0.2	0.4	0.7	0.0	0.3	0.4	2.3	0.2	0.4	0.2	0.1	1.7	0.4	0.1	0.0	0.4	0.1	0.1	0.0	0.7	0.4	1.9	0.2	0.7	1.6	1.8	0.7	0.1	0.1	21.0	2.4	1.6	0.0	0.2	1.3	0.3	0.1	0.4	0.3	0.2	0.4	2.2	0.2	0.5	2.5	0.9	0.3	2.0	1.1	10.9	0.1	1.8	0.5	0.7	0.1	0.2	0.2	0.2	0.3	22.5	0.3	0.2	0.1	29.1	0.4	0.4	0.3	0.3	0.3	0.4	0.2	1.1	2.0	1.4	1.3	1.6	1.9	1.6	3.5	2.8	1.2	2.5	2.8	1.8	1.9	0.1	0.0	1.1	0.0	194.5	0.1	0.4	0.0	1.2	1.0	1.6	1.3	1.4	0.0	0.0	0.0	0.0	0.2	2.6	0.3	0.0	0.0	0.1	2.6	0.5	0.3	1.2	0.4	0.0	0.0	0.2	0.7	0.5	4.3	0.0	1.5	0.0	0.2	0.1	8.4	0.1	0.1	0.0	0.6	0.0	0.0	0.0	1.3	0.0	6.5	0.3	0.0	0.0	0.0	0.0	0.1	0.3	0.0	18.0	0.3	0.1	0.2	0.0	0.4	0.0	0.5	0.4	1.5	1.4	0.3	0.0	0.1	3.4	0.2	0.4	0.2
TRAV13-1		ENSG00000211788	"T cell receptor alpha variable 13-1"	A0A0B4J241	14	21868839-21869365	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"lymphoid tissue: 63.1"	"Cell type enriched"	"Detected in single"	26	"T-cells: 15.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 329.3"	"Lineage enriched"	"Detected in many"	28	"T-cells: 329.3"	"Cell line enriched"	"Detected in single"	20	"JURKAT: 1.9"															NA	NA						"unprognostic (1.10e-3)"	"unprognostic (9.80e-3)"	"unprognostic (1.60e-2)"	"unprognostic (3.04e-3)"	"unprognostic (5.71e-2)"	"unprognostic (3.30e-5)"	"unprognostic (7.68e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.67e-3)"	"unprognostic (3.30e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.16e-5)"	"unprognostic (1.03e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.59e-2)"	1.2	0.3	0.0	13.8	0.1	2.2	1.1	0.0	0.2	0.2	0.1	3.8	3.7	0.7	0.3	0.8	0.9	3.7	0.5	0.0	0.1	0.4	1.0	4.4	29.4	0.1	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.1	1.1	3.1	0.0	1.2	0.4	0.2	0.2	7.6	0.4	0.0	8.5	3.8	0.2	0.0	63.1	0.6	0.7	30.2	5.8	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.7	0.4	1.4	0.4	62.6	0.4	203.8	179.6	0.5	0.6	232.3	292.5	6.2	0.5	0.5	0.9	329.3	80.2	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	15.6	0.0	0.0	0.0
TRAV20		ENSG00000211800	"T cell receptor alpha variable 20"	A0A0B4J274	14	22040594-22041153	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"lymphoid tissue: 14.7"	"Cell type enriched"	"Detected in single"	6	"T-cells: 4.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	8	"memory CD4 T-cell: 124.2;memory CD8 T-cell: 94.6;naive CD4 T-cell: 124.6;naive CD8 T-cell: 98.0;T-reg: 152.3"	"Lineage enriched"	"Detected in many"	60	"T-cells: 152.3"	"Not detected"	"Not detected"																	NA	NA						"unprognostic (1.70e-2)"	"unprognostic (3.31e-3)"	"unprognostic (6.84e-2)"	"unprognostic (2.90e-3)"		"unprognostic (1.14e-2)"	"unprognostic (1.93e-3)"	"unprognostic (2.21e-2)"	"unprognostic (4.70e-2)"	"unprognostic (8.88e-2)"	"unprognostic (7.00e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.16e-4)"	"unprognostic (1.80e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.11e-2)"	0.0	0.1	0.0	3.3	0.0	0.2	0.3	0.0	0.0	0.5	0.0	0.7	0.5	0.2	0.0	0.2	0.1	1.7	0.1	0.0	0.0	0.1	0.6	1.4	9.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.7	0.0	0.7	0.2	0.1	0.0	0.8	0.5	0.0	2.4	0.8	0.0	0.0	14.7	0.3	0.0	7.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.2	0.5	0.1	15.6	1.6	124.2	94.6	0.0	0.1	124.6	98.0	2.5	0.2	0.4	0.4	152.3	40.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0
TRAV26-1		ENSG00000211807	"T cell receptor alpha variable 26-1"	A0A087WT03	14	22123318-22124285	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"lymphoid tissue: 14.1"	"Cell type enriched"	"Detected in single"	5	"T-cells: 3.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"memory CD4 T-cell: 37.4;naive CD4 T-cell: 39.7;T-reg: 55.8"	"Lineage enriched"	"Detected in single"	69	"T-cells: 55.8"	"Not detected"	"Not detected"																	NA	NA						"unprognostic (1.36e-3)"	"unprognostic (1.33e-5)"	"unprognostic (1.21e-2)"	"unprognostic (3.60e-2)"		"unprognostic (1.50e-3)"	"unprognostic (1.08e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.67e-4)"	"unprognostic (3.93e-3)"	"unprognostic (3.28e-1)"	"unprognostic (4.01e-5)"	"unprognostic (1.63e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.73e-2)"	0.0	0.1	0.0	3.0	0.0	0.3	0.4	0.0	0.1	0.0	0.0	0.8	0.5	0.1	0.0	0.4	0.1	0.9	0.0	0.0	0.0	0.1	0.2	1.0	8.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.2	0.0	0.0	0.1	1.1	0.0	0.0	2.6	1.6	0.0	0.0	14.1	0.1	0.0	6.2	1.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.1	0.0	1.2	0.0	37.4	9.6	0.0	0.0	39.7	12.5	0.4	0.0	0.1	0.0	55.8	7.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0
TRIL	KIAA0644	ENSG00000255690	"TLR4 interactor with leucine rich repeats"	Q7L0X0	7	28953358-28958330	"Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 62.3"	"Cell type enriched"	"Detected in many"	4	"Astrocytes: 72.1"	"Cancer enhanced"	"Detected in many"		"glioma: 20.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 22.2;SH-SY5Y: 40.0;SK-BR-3: 35.7;T-47d: 15.8"	"Low region specificity"	"Detected in all"													NA	NA						"unprognostic (1.26e-3)"	"unprognostic (3.29e-2)"	"unprognostic (5.89e-2)"	"prognostic unfavorable (3.23e-4)"	"unprognostic (2.66e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.58e-2)"	"unprognostic (8.77e-2)"	"prognostic unfavorable (8.52e-4)"	"unprognostic (4.27e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.07e-2)"	3.6	2.3	40.0	0.6	51.6	0.0	4.2	62.3	32.2	2.6	8.0	1.9	2.1	3.6	1.7	2.4	2.3	1.0	3.5	33.9	39.8	5.3	0.6	2.6	0.4	61.7	62.3	20.7	1.6	0.6	0.8	1.6	1.1	52.1	1.9	1.9	1.0	8.2	1.5	3.2	1.6	2.4	3.4	46.7	2.7	2.4	0.5	59.4	0.4	3.0	0.8	0.3	2.3	3.5	40.7	0.0	0.0	22.2	0.0	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	6.1	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.8	40.0	0.1	35.7	0.0	3.2	15.8	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.0	51.6	62.3	32.2	33.9	39.8	61.7	62.3	20.7	52.1	46.7	59.4	40.7	7.0	12.8	5.3	72.1	0.0	0.0	0.2	0.0	4.0	0.4	7.4	11.0	2.7	0.0	0.6	1.8	0.0	0.2	0.0	0.1	3.9	0.1	0.0	0.4	0.2	4.3	0.0	0.0	0.7	0.0	1.9	15.9	0.0	1.1	0.0	0.2	2.5	0.4	0.1	6.7	0.6	0.4	0.0	0.0	0.0	0.2	1.2	0.5	0.0	5.6	0.0	17.1	0.0	13.0	0.4	0.0	0.2	0.0	0.0	0.0	0.1	1.8	0.0	0.8	13.1	15.2	4.9	0.5	0.7	2.2	0.0	0.1	0.1	2.0	0.8	0.1
UGT8	CGT	ENSG00000174607	"UDP glycosyltransferase 8"	Q16880	4	114598770-114678225	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 263.0"	"Cell type enriched"	"Detected in many"	8	"Oligodendrocytes: 821.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"memory B-cell: 6.9;naive B-cell: 10.7"	"Lineage enriched"	"Detected in single"	12	"B-cells: 10.7"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 58.4;OE19: 123.7;RPTEC TERT1: 55.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014405, HPA065785"	Enhanced		Approved	Mitochondria		No	No			Mitochondria		"HPA014405: AB_1858606, HPA065785: AB_2685559"	"unprognostic (7.38e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.56e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.76e-1)"	"prognostic favorable (8.55e-5)"	"unprognostic (2.80e-1)"	"unprognostic (1.78e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.49e-1)"	0.6	0.6	67.4	4.7	134.5	1.1	4.7	153.4	106.2	7.0	9.3	27.1	30.6	3.8	0.3	1.5	4.4	11.1	0.3	60.4	99.0	31.3	0.2	1.1	5.0	194.5	130.6	40.1	0.4	8.6	0.2	0.2	0.2	178.3	0.5	28.0	2.2	7.3	0.7	0.5	2.2	27.9	1.6	161.8	1.7	16.9	5.1	119.8	0.6	13.6	0.4	5.1	0.6	0.6	263.0	0.6	0.2	4.4	0.6	0.3	0.0	0.7	0.2	0.0	0.1	3.4	17.7	58.4	17.6	1.2	0.2	13.8	25.8	0.0	0.1	0.1	0.3	14.3	0.3	24.6	0.0	0.0	0.4	0.4	0.0	0.0	0.1	0.0	5.4	0.1	0.2	16.1	3.0	0.1	0.3	0.3	1.7	6.4	123.7	8.8	1.6	28.9	0.3	55.2	0.6	31.4	4.6	0.2	5.4	0.8	1.1	0.9	5.4	1.0	1.1	19.2	0.7	19.6	6.3	0.8	0.6	29.2	0.9	17.9	0.2	0.0	0.8	0.0	0.0	0.6	6.9	0.0	0.0	0.0	10.7	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.3	67.4	134.5	153.4	106.2	60.4	99.0	194.5	130.6	40.1	178.3	161.8	119.8	263.0	0.1	6.4	1.5	1.0	22.0	0.0	1.8	0.3	6.8	0.0	5.7	6.1	0.8	8.6	3.9	25.8	0.0	0.0	0.1	19.0	9.8	1.4	9.2	9.6	1.7	0.5	48.4	0.0	1.0	13.1	0.0	0.6	19.4	21.4	0.0	0.2	0.0	0.0	0.0	0.0	3.7	27.9	0.0	0.0	0.0	3.5	1.2	0.5	1.8	2.8	0.0	0.0	0.0	98.5	821.1	10.8	14.6	0.0	4.0	0.7	24.2	1.4	1.5	0.0	0.0	0.0	0.4	20.9	34.0	5.9	0.1	0.0	0.4	0.1	26.9	0.9
VSX1	"PPCD, PPCD1, PPD"	ENSG00000100987	"Visual system homeobox 1"	Q9NZR4	20	25070885-25082141	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Sensory transduction, Transcription, Transcription regulation, Vision"	"Developmental protein, DNA-binding"	"Corneal dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 14.4;retina: 35.8"	"Cell type enriched"	"Detected in some"	23	"Bipolar cells: 465.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"Karpas-707: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA079607			Approved	Nucleoli		NA	NA			Nucleoli		"HPA079607: "	"unprognostic (1.93e-1)"	"unprognostic (6.63e-2)"		"unprognostic (9.68e-3)"	"unprognostic (4.33e-2)"		"unprognostic (2.27e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.01e-1)"	"unprognostic (8.64e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.31e-9)"	"unprognostic (1.53e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.07e-4)"	"unprognostic (2.38e-1)"	0.0	0.9	3.4	0.0	3.3	0.5	0.1	14.4	2.9	0.1	1.7	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.2	2.8	3.6	0.0	0.2	0.0	0.1	3.2	3.5	2.6	1.5	0.4	0.7	2.9	0.0	7.6	0.2	0.1	35.8	0.1	0.3	0.5	0.2	0.1	0.0	3.0	0.1	0.1	0.2	3.4	0.7	0.2	0.2	0.0	0.2	0.0	3.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	4.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.3	0.0	0.0	3.4	3.3	14.4	2.9	2.8	3.6	3.2	3.5	2.6	7.6	3.0	3.4	3.5	0.0	0.0	0.0	6.5	0.1	0.0	0.0	0.0	0.0	465.9	0.1	0.0	1.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.0	0.0	5.3	0.0	19.6	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.9	0.0	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
YJEFN3	"FLJ44968, hYjeF_N3-19p13.11"	ENSG00000250067	"YjeF N-terminal domain containing 3"	A6XGL0	19	19528861-19537581	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 41.5;testis: 24.5"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 605.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 10.3;HEK 293: 12.1"									HPA060789	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA060789: AB_2684366"	"unprognostic (2.59e-2)"	"unprognostic (2.50e-1)"	"unprognostic (5.99e-6)"	"unprognostic (1.65e-1)"	"unprognostic (3.16e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.37e-4)"	"unprognostic (2.38e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (7.25e-4)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (1.30e-7)"	"unprognostic (1.17e-2)"	"unprognostic (8.26e-2)"	"unprognostic (2.48e-1)"	"unprognostic (9.49e-3)"	0.3	0.4	19.3	0.4	40.0	0.0	0.3	0.2	39.2	0.4	0.4	0.6	0.1	0.3	2.7	0.3	0.8	0.1	1.3	41.5	14.9	2.2	0.9	0.4	0.4	10.8	7.1	29.1	0.7	0.6	0.1	4.4	0.3	10.2	1.9	0.4	0.5	0.2	0.3	0.5	1.3	0.5	0.2	0.3	0.9	0.6	24.5	5.4	0.2	1.0	0.1	0.3	0.6	0.4	12.6	0.2	0.8	1.7	0.7	0.2	0.4	10.3	0.6	0.1	0.4	0.6	0.8	0.6	0.5	1.4	0.1	0.1	1.1	0.2	0.2	0.0	0.1	12.1	0.0	1.8	0.0	0.1	0.2	0.5	0.1	0.5	0.2	0.4	0.1	0.0	0.7	0.8	0.6	0.0	0.9	0.0	0.1	3.3	0.0	2.5	1.9	0.4	0.3	0.0	0.1	0.2	2.8	0.2	0.0	0.3	0.5	1.2	1.4	0.7	0.3	0.8	3.2	0.8	2.7	2.2	0.6	0.2	1.6	0.3	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.2	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.4	0.0	19.3	40.0	0.2	39.2	41.5	14.9	10.8	7.1	29.1	10.2	0.3	5.4	12.6	2.7	9.6	0.5	11.8	2.3	2.0	2.2	1.8	0.6	19.7	3.2	3.2	1.9	1.5	4.4	0.0	10.4	1.6	2.3	6.2	1.9	1.8	136.4	2.6	4.0	2.5	5.4	4.4	22.4	0.6	1.1	2.4	5.6	5.5	1.3	4.0	1.4	1.8	1.1	10.1	29.0	6.7	0.0	0.6	2.0	605.2	3.7	2.0	1.8	5.6	1.4	5.1	3.1	3.5	6.3	0.7	2.6	1.9	0.7	2.4	4.4	0.5	2.3	17.2	6.6	7.5	3.8	16.1	13.2	0.7	4.1	1.8	2.8	0.9	6.0	1.2
ZP2	ZPA	ENSG00000103310	"Zona pellucida glycoprotein 2"	Q05996	16	21197450-21214510	"Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"	Fertilization	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	8	"brain: 4.9"	"Cell type enriched"	"Detected in single"	15	"Proximal enterocytes: 7.6"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"cerebellum: 4.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	37	"HDLM-2: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA011296	Enhanced				"Secreted in female reproductive system"	NA	NA					"HPA011296: AB_1859485"	"unprognostic (2.35e-2)"		"unprognostic (3.12e-2)"			"unprognostic (6.60e-2)"		"unprognostic (9.83e-2)"			"unprognostic (3.44e-3)"	"unprognostic (3.12e-1)"		"unprognostic (1.66e-1)"	"unprognostic (4.41e-2)"			0.0	0.0	0.0	0.0	0.1	0.0	0.1	4.9	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.5	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.9	0.2	0.1	0.1	0.0	0.2	0.0	0.9	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1
ABHD12B	"BEM46L3, C14orf29"	ENSG00000131969	"Abhydrolase domain containing 12B"	Q7Z5M8	14	50872053-50904970	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 6.2;retina: 15.7;skin 1: 10.6"	"Cell type enriched"	"Detected in some"	7	"Muller glia cells: 188.1"	"Cancer enriched"	"Detected in many"	5	"testis cancer: 7.6"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 1.0;neutrophil: 2.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.1"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"thalamus: 2.1"	"Low region specificity"	"Detected in many"			HPA002873	Uncertain		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA002873: AB_2220573"	"unprognostic (6.61e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.92e-3)"	"unprognostic (1.99e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.31e-2)"	"unprognostic (6.27e-2)"	"unprognostic (3.30e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.70e-3)"	"unprognostic (3.16e-2)"	"unprognostic (9.62e-2)"	"unprognostic (3.18e-3)"	"unprognostic (1.68e-1)"	0.5	0.0	2.5	0.1	4.9	1.6	1.3	0.1	2.6	0.0	0.7	0.7	0.0	0.3	0.0	0.2	1.0	0.1	0.1	1.2	1.8	0.2	0.0	0.3	0.1	0.7	4.9	1.8	0.0	0.0	0.2	0.1	0.1	1.5	0.0	1.0	15.7	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.6	6.2	0.3	0.1	0.0	0.0	0.0	0.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	2.5	4.9	0.1	2.6	1.2	1.8	0.7	4.9	1.8	1.5	0.0	6.2	3.5	2.4	0.0	0.0	0.3	0.1	0.4	0.1	1.5	0.0	3.4	0.1	0.1	1.9	0.0	5.0	1.8	2.1	0.1	0.0	2.2	0.0	0.0	7.7	2.5	0.2	0.7	0.0	0.0	9.9	0.0	0.0	0.7	0.0	0.6	1.3	0.0	0.0	0.0	0.1	0.0	0.7	1.0	4.1	0.0	0.0	5.8	1.2	0.1	0.0	0.0	0.0	188.1	0.0	1.0	4.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	26.4	18.1	0.0	0.1	1.2	0.3	0.2	0.0	1.4	0.3	0.1	0.0	1.8	0.2
C17orf99	"GLPG464, UNQ464"	ENSG00000187997	"Chromosome 17 open reading frame 99"	Q6UX52	17	78146353-78166177	"Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"bone marrow: 9.1"	"Cell type enriched"	"Detected in some"	29	"Erythroid cells: 52.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"HaCaT: 3.5;HMC-1: 7.1;K-562: 4.2"	"Not detected"	"Not detected"							HPA029655	Uncertain				"Secreted to blood"	NA	NA					"HPA029655: AB_10601691"	"unprognostic (3.55e-5)"	"unprognostic (1.87e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.47e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.86e-1)"	"unprognostic (9.77e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.38e-4)"	"unprognostic (6.58e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.78e-3)"	0.0	0.0	0.0	0.1	0.0	9.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.4	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	7.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	1.8	0.4	0.6	1.1	0.1	0.3	0.5	0.0	0.7	1.8	0.0	0.2	0.1	0.6	0.0	0.1	0.0	0.1	0.2	0.5	0.0	52.6	0.3	0.4	0.4	0.4	0.0	0.3	0.0	0.1	0.4	0.2	0.5	0.0	0.3	0.7	0.0	0.0	0.7	0.1	0.6	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.7	0.2	0.1	0.2	0.1	0.0	1.1	0.6	0.1	0.1	0.6	0.9	0.3	0.2	0.9	0.4	0.8
CAMK2A	"CAMKA, CaMKII, CaMKIINalpha, KIAA0968"	ENSG00000070808	"Calcium/calmodulin dependent protein kinase II alpha"	Q9UQM7	5	150219491-150290291	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 697.8"	"Cell type enriched"	"Detected in some"	4	"Excitatory neurons: 245.8"	"Cancer enriched"	"Detected in single"	13	"glioma: 6.0"	"Region enhanced"	"Detected in many"		"cerebral cortex: 697.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.3;SCLC-21H: 3.0;SuSa: 1.4;U-87 MG: 3.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebral cortex: 1071.1"	"CAB004330, HPA051783, HPA051785, HPA053973"	Supported		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		66000	"Plasma membrane"	"Cell Junctions, Cytosol"	"CAB004330: AB_626788, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (7.20e-3)"	"unprognostic (6.47e-3)"	"unprognostic (6.16e-3)"	"unprognostic (4.85e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.13e-1)"	"unprognostic (6.19e-3)"	"unprognostic (3.07e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.00e-8)"	"unprognostic (2.71e-4)"	"unprognostic (1.68e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.36e-3)"	0.2	0.9	166.6	0.2	233.1	0.1	0.1	0.0	697.8	1.2	0.0	0.8	0.1	2.8	0.3	1.3	1.5	0.3	4.9	492.9	76.7	0.7	0.2	0.9	0.0	15.2	8.0	257.3	0.4	0.1	0.0	3.6	0.3	107.2	0.8	0.2	1.9	0.7	0.4	95.9	0.7	0.4	2.4	0.0	0.3	0.5	0.1	9.0	0.0	0.1	35.0	0.0	2.0	0.7	131.4	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.8	0.5	0.3	0.0	0.0	0.0	0.0	0.4	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.9	0.0	0.7	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	3.0	0.0	0.1	0.0	0.1	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	3.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	166.6	233.1	0.0	697.8	492.9	76.7	15.2	8.0	257.3	107.2	0.0	9.0	131.4	0.0	0.0	0.0	12.1	0.0	3.4	0.0	0.0	0.0	5.1	0.0	0.0	14.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.2	0.2	0.0	0.0	245.8	0.0	0.1	2.2	0.0	0.2	0.0	0.0	0.0	0.0	2.1	0.0	55.5	0.0	0.0	0.0	0.8	0.3	0.0	0.0	3.6	9.4	0.0	0.4	0.0	8.5	8.1	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.1	0.0	3.6	1.8	0.0	0.3	0.0	1.4	0.3	0.2	0.0	0.0	0.0
CBLN2		ENSG00000141668	"Cerebellin 2 precursor"	Q8IUK8	18	72536680-72638521	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 36.2"	"Cell type enriched"	"Detected in some"	13	"Excitatory neurons: 508.3"	"Cancer enriched"	"Detected in single"	7	"breast cancer: 3.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"SH-SY5Y: 54.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted in brain"	NA	NA		1400000				"unprognostic (2.03e-2)"	"unprognostic (3.52e-1)"	"unprognostic (1.13e-3)"	"unprognostic (9.09e-5)"	"unprognostic (7.10e-2)"	"unprognostic (6.27e-3)"		"unprognostic (7.39e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.37e-4)"	"unprognostic (5.01e-4)"	"unprognostic (8.15e-2)"	"unprognostic (6.07e-4)"	"unprognostic (7.19e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.93e-2)"	0.2	0.2	5.1	0.3	19.4	0.0	0.1	0.0	36.2	0.3	0.0	1.8	1.5	0.0	0.0	0.0	0.1	0.0	0.0	5.4	12.9	0.7	0.4	0.0	0.0	7.9	5.1	15.6	0.1	0.0	0.0	0.2	0.0	12.0	0.9	1.5	5.2	0.0	5.2	0.0	0.5	2.5	0.8	0.0	0.0	0.1	0.2	16.8	0.0	0.0	0.0	0.7	0.1	0.0	15.8	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	54.9	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	19.4	0.0	36.2	5.4	12.9	7.9	5.1	15.6	12.0	0.0	16.8	15.8	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.7	0.3	37.8	0.0	508.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	20.6	0.0	0.0	0.0	0.3	0.6	0.6	0.0	0.0	10.3	0.0	0.5	0.0	9.5	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.3	0.1	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0
CCDC103	"CILD17, FLJ13094, FLJ34211, PR46b"	ENSG00000167131	"Coiled-coil domain containing 103"	Q8IW40	17	44899142-44905390	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"fallopian tube: 15.3;testis: 27.5"	"Cell type enriched"	"Detected in some"	5	"Respiratory ciliated cells: 7.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 14.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA043131			Approved	Cytosol		NA	NA			Cytosol		"HPA043131: AB_10796686"	"unprognostic (9.40e-3)"	"unprognostic (1.75e-1)"			"unprognostic (5.60e-2)"	"unprognostic (1.99e-2)"		"unprognostic (4.50e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.35e-2)"		"unprognostic (4.69e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.60e-1)"	0.3	1.2	2.2	0.5	1.5	0.4	0.5	1.6	1.4	1.1	2.1	0.5	0.3	1.2	1.5	0.2	15.3	0.8	0.2	1.1	3.0	1.7	0.4	1.5	0.2	2.5	2.2	1.1	0.9	0.5	1.4	0.9	0.3	2.0	0.4	0.4	1.9	0.3	1.1	0.3	0.3	0.2	0.9	2.3	0.2	0.6	27.5	1.6	0.4	1.8	0.0	0.2	0.3	0.3	1.7	2.5	14.4	1.4	2.4	2.3	1.6	1.3	1.0	2.5	1.3	0.8	2.9	3.3	0.3	2.0	0.7	5.7	3.5	0.5	1.7	0.6	6.9	4.9	0.8	3.3	0.1	1.2	1.7	0.4	1.1	3.2	1.6	0.6	2.4	1.1	1.1	1.9	0.2	0.3	2.0	0.3	0.6	0.5	1.8	2.3	0.5	0.7	0.7	6.6	1.3	4.1	1.0	0.6	0.3	1.8	1.3	3.7	1.4	1.6	0.8	2.8	0.8	2.0	0.6	0.7	0.7	7.0	0.8	0.7	0.4	1.6	1.3	0.2	0.9	0.1	0.1	0.0	0.3	1.1	0.3	0.1	0.1	0.2	0.4	0.8	0.4	0.0	1.0	2.2	1.5	1.6	1.4	1.1	3.0	2.5	2.2	1.1	2.0	2.3	1.6	1.7	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	7.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CDH15	"CDH14, CDH3"	ENSG00000129910	"Cadherin 15"	P55291	16	89171748-89195492	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Cell adhesion"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 23.1;skeletal muscle: 57.5"	"Cell type enriched"	"Detected in some"	13	"Skeletal myocytes: 76.1"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in some"	13	"cerebellum: 23.1;pons: 9.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RH-30: 145.8"	"Region enriched"	"Detected in many"	7	"cerebellum: 15.7"	"Region enriched"	"Detected in some"	17	"cerebellum: 18.7"	"HPA009139, HPA070961"	Enhanced	Supported	Enhanced	"Golgi apparatus,Plasma membrane"		NA	NA		870000	"Golgi apparatus, Plasma membrane"		"HPA009139: AB_1078372, HPA070961: AB_2686328"	"unprognostic (1.26e-1)"	"unprognostic (7.70e-3)"	"unprognostic (6.64e-3)"	"unprognostic (2.81e-1)"	"unprognostic (7.79e-3)"	"unprognostic (2.70e-3)"	"unprognostic (2.84e-3)"	"unprognostic (4.37e-2)"	"unprognostic (2.30e-3)"	"unprognostic (7.66e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.14e-7)"	"unprognostic (3.09e-2)"	"unprognostic (3.13e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.64e-2)"	0.0	0.2	0.0	0.0	0.2	0.0	0.0	23.1	0.6	0.9	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.1	0.1	1.3	0.4	0.0	0.1	1.2	0.0	0.2	1.5	0.0	0.1	0.8	9.6	0.4	0.0	0.0	0.9	0.0	57.5	0.1	0.0	0.0	0.2	1.2	0.2	0.6	0.1	0.0	0.0	5.4	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.8	0.7	0.0	0.1	4.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	31.5	0.1	0.0	0.1	0.0	0.2	0.3	0.0	145.8	0.3	0.0	0.0	0.8	0.5	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	23.1	0.6	0.0	0.1	0.1	1.2	0.0	9.6	0.2	0.1	0.6	0.2	0.0	2.0	0.0	0.7	0.0	0.2	0.0	0.0	0.1	0.1	0.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.1	1.0	0.1	1.2	0.0	0.1	0.0	0.3	0.7	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.2	1.8	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.2	0.0	0.2	0.0	76.1	0.4	1.5	5.5	0.0	0.0	0.1	0.2	0.8	0.1	0.1
CDH16		ENSG00000166589	"Cadherin 16"	O75309	16	66908122-66918917	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"kidney: 251.5"	"Cell type enriched"	"Detected in some"	4	"Collecting duct cells: 617.9"	"Cancer enriched"	"Detected in many"	15	"renal cancer: 96.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	99	"RPTEC TERT1: 225.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB013526, HPA036260"	Enhanced					NA	NA		130000			"CAB013526: , HPA036260: AB_2675027"		"unprognostic (1.07e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.96e-1)"		"unprognostic (9.81e-2)"	"unprognostic (4.24e-3)"	"unprognostic (5.81e-2)"	"unprognostic (5.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.23e-2)"		"prognostic favorable (1.02e-7)"	"unprognostic (2.19e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.36e-3)"	"unprognostic (2.34e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	1.4	0.3	4.7	0.3	11.1	0.3	0.1	0.0	0.0	251.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	3.9	0.4	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	35.6	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	225.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.4	6.7	0.0	0.0	617.9	0.0	0.1	0.0	0.4	74.3	0.1	2.9	18.0	2.1	0.2	0.0	0.0	0.0	0.0	0.2	0.7	0.0	34.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	14.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.4	1.9	124.4	0.0	0.0	0.0	0.6	0.9	0.0	0.2	1.9	0.0	1.0	0.8	0.0	0.7	0.0
CIB4		ENSG00000157884	"Calcium and integrin binding family member 4"	A0PJX0	2	26581205-26641366	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 17.5"	"Cell type enriched"	"Detected in some"	7	"Early spermatids: 181.0"	"Cancer enhanced"	"Detected in some"		"renal cancer: 0.7;thyroid cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA036130, HPA036131"	Uncertain					NA	NA					"HPA036130: AB_10670709, HPA036131: AB_2674959"	"unprognostic (3.63e-3)"		"unprognostic (1.78e-1)"	"unprognostic (2.61e-4)"	"unprognostic (1.63e-1)"			"unprognostic (1.66e-1)"		"unprognostic (1.27e-1)"	"unprognostic (4.29e-4)"	"unprognostic (1.57e-1)"	"unprognostic (3.19e-5)"	"unprognostic (1.20e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.76e-3)"	"unprognostic (3.50e-1)"	0.0	0.8	0.4	0.0	0.1	0.0	0.0	0.5	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.2	0.0	0.5	0.2	0.1	0.0	0.1	0.2	0.0	0.8	0.8	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	17.5	0.3	0.0	2.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.5	0.2	0.1	0.2	0.5	0.2	0.1	0.8	0.1	0.3	0.6	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	14.6	0.0	0.0	5.5	2.1	0.0	0.0	0.0	0.0	0.0	181.0	0.0	0.3	0.3	1.8	0.0	0.6	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.0	24.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	11.9	0.7	0.0	0.0	0.8	0.0	0.5	0.0	0.0
CIDEC	"CIDE-3, FLJ20871, Fsp27"	ENSG00000187288	"Cell death inducing DFFA like effector c"	Q96AQ7	3	9866711-9880255	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adipose tissue: 738.8;breast: 497.0"	"Cell type enriched"	"Detected in some"	7	"Proximal enterocytes: 219.4"	"Group enriched"	"Detected in many"	5	"breast cancer: 4.5;colorectal cancer: 1.4;liver cancer: 2.4;pancreatic cancer: 4.6;stomach cancer: 2.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"ASC diff: 1683.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA018837, HPA020553"	Uncertain					NA	NA					"HPA018837: AB_1846767, HPA020553: AB_1846769"	"unprognostic (1.83e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.26e-5)"	"unprognostic (9.03e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.48e-3)"	"unprognostic (8.14e-2)"	"unprognostic (5.37e-5)"	"unprognostic (9.47e-3)"	"unprognostic (2.02e-1)"	"unprognostic (7.46e-3)"	"unprognostic (2.94e-2)"	738.8	5.6	0.2	1.1	0.3	0.0	497.0	0.1	0.4	0.9	0.0	11.6	69.6	4.7	0.3	0.7	2.2	5.0	7.0	0.1	0.2	2.1	10.1	0.2	1.2	0.2	0.1	0.0	0.4	7.4	0.1	0.2	0.0	0.1	2.3	3.9	0.0	16.3	3.8	6.2	15.5	90.6	1.6	0.1	0.2	7.5	0.9	0.1	1.5	3.9	11.7	0.0	13.4	4.9	0.3	0.0	0.2	0.0	0.0	1683.2	376.0	1.2	0.1	0.0	0.0	0.0	7.5	9.1	0.0	0.2	0.6	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	19.1	2.8	0.0	0.0	228.9	0.4	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.1	0.6	0.0	0.3	0.0	0.6	1.6	0.0	0.0	1.0	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.3	0.1	0.4	0.1	0.2	0.2	0.1	0.0	0.1	0.1	0.1	0.3	2.3	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	2.0	0.2	0.0	0.0	0.0	0.0	0.0	1.5	30.0	1.9	0.0	0.5	0.2	0.1	0.1	3.5	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.1	8.4	0.0	0.0	0.4	1.0	2.5	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	14.5	0.4	0.0	0.4	219.4	1.1	0.0	0.0	0.0	0.5	0.6	0.6	0.4	0.0	0.0	0.0	0.2	0.1	3.8	0.3
CLDN16	"HOMG3, PCLN1"	ENSG00000113946	"Claudin 16"	Q9Y5I7	3	190322541-190412138	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"Disease variant, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"kidney: 64.2"	"Cell type enriched"	"Detected in some"	8	"Distal tubular cells: 187.9"	"Group enriched"	"Detected in many"	15	"ovarian cancer: 39.8;thyroid cancer: 29.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	153	"EFO-21: 691.6;RPTEC TERT1: 233.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA056020	Enhanced					NA	NA					"HPA056020: AB_2683011"	"unprognostic (5.01e-2)"	"unprognostic (7.83e-3)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (1.99e-5)"	"unprognostic (6.06e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.20e-1)"	"unprognostic (2.76e-3)"	"unprognostic (3.70e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.76e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.15e-1)"	0.1	0.7	0.3	0.2	0.4	0.0	0.2	0.0	0.5	0.0	1.3	0.0	0.0	0.3	0.6	0.5	2.9	0.7	0.0	0.2	0.3	64.2	2.2	0.4	1.5	0.2	0.2	0.3	0.0	0.2	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.4	0.9	0.0	3.2	0.0	0.4	0.0	0.1	0.1	0.1	0.2	0.3	9.8	0.0	1.0	0.3	0.2	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	691.6	0.0	0.3	0.7	0.0	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.8	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	233.2	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.0	2.2	0.0	0.3	1.4	1.2	3.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.5	0.2	0.3	0.2	0.2	0.3	0.2	0.0	0.2	0.5	0.1	0.0	0.0	0.3	0.0	7.0	5.8	2.6	0.6	0.3	0.8	0.3	0.4	4.3	1.6	9.2	0.0	0.4	0.0	0.0	187.9	3.4	2.0	3.0	0.1	0.2	0.0	0.0	5.0	0.4	0.2	0.9	0.0	0.5	1.3	0.3	0.0	1.6	0.1	3.3	3.6	0.0	0.0	0.3	1.2	0.2	0.0	0.4	5.4	2.8	0.0	0.2	0.0	4.0	0.1	0.5	0.0	0.4	0.0	6.7	0.0	0.9	22.1	0.2	0.0	0.8	0.6	0.3	0.3	0.9	12.6	6.2	0.2	0.2	0.0	3.1
CLEC18A	MRCL	ENSG00000157322	"C-type lectin domain family 18 member A"	A5D8T8	16	69950705-69964452	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"kidney: 23.2"	"Cell type enriched"	"Detected in some"	23	"Proximal tubular cells: 78.0"	"Cancer enriched"	"Detected in single"	7	"renal cancer: 1.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA048976	Uncertain				"Secreted to blood"	NA	NA					"HPA048976: AB_2680582"	"unprognostic (1.68e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.14e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.40e-2)"	"unprognostic (6.77e-4)"	"unprognostic (6.73e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.03e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.53e-2)"	0.2	0.9	0.1	0.0	0.3	0.3	0.3	0.7	0.5	0.2	2.3	0.3	0.0	0.1	0.0	0.1	0.3	0.1	0.1	0.2	0.3	23.2	0.2	0.4	0.1	0.3	0.3	0.0	0.2	0.4	0.1	0.4	0.0	0.4	0.3	0.1	0.1	0.6	0.0	0.2	0.3	0.7	0.0	0.3	1.2	0.5	3.2	0.2	0.3	0.4	0.1	0.1	0.3	0.1	0.4	0.0	0.1	0.7	0.0	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.2	0.4	0.0	0.3	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.2	0.0	0.0	0.1	0.1	0.4	0.0	0.1	0.4	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.7	0.5	0.2	0.3	0.3	0.3	0.0	0.4	0.3	0.2	0.4	0.3	0.0	1.1	0.0	0.9	0.1	0.0	0.2	0.0	1.6	0.3	0.4	0.5	2.8	0.4	0.0	2.1	0.1	0.3	3.3	1.9	0.3	0.4	0.4	0.1	0.4	0.0	0.0	0.3	0.2	0.1	0.3	2.0	0.5	0.0	0.6	2.5	0.4	0.4	3.3	0.4	1.0	0.0	0.6	0.3	0.8	0.3	1.1	0.0	0.0	0.9	0.9	1.0	0.0	0.0	0.5	0.4	0.0	0.2	0.2	1.5	78.0	0.7	1.3	0.0	0.7	1.3	0.5	0.2	0.0	0.0	0.3	0.6	0.6	1.3	0.2
CLEC1B	CLEC2	ENSG00000165682	"C-type lectin domain family 1 member B"	Q9P126	12	9985642-10013424	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"liver: 65.8"	"Cell type enriched"	"Detected in some"	8	"Hepatic stellate cells: 535.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"basophil: 13.8"	"Group enriched"	"Detected in many"	4	"granulocytes: 13.8;monocytes: 5.0"	"Group enriched"	"Detected in some"	6	"Karpas-707: 11.3;U-266/84: 28.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051108	Approved					NA	NA					"HPA051108: "	"unprognostic (2.03e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.45e-1)"		"unprognostic (4.63e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.26e-2)"	"unprognostic (7.71e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.49e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.91e-2)"	0.1	0.4	0.0	0.9	0.2	9.3	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.2	0.1	65.8	2.2	0.7	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.1	2.9	0.2	2.2	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	2.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	28.8	0.0	0.0	3.3	0.0	13.8	5.0	7.5	0.0	4.4	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	3.3	0.1	4.1	1.2	0.0	13.8	0.0	0.2	0.1	0.2	0.0	0.2	0.3	0.1	0.0	0.3	0.1	0.4	0.4	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	7.4	0.0	53.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	535.8	5.0	0.1	0.0	0.0	0.0	0.0	49.9	0.0	0.3	0.0	64.6	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	1.6	0.0	0.0	0.0	1.1	0.6	0.0	0.0
CLRN1	"RP61, USH3, USH3A"	ENSG00000163646	"Clarin 1"	P58418	3	150926163-150972727	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hearing, Sensory transduction, Vision"		"Deafness, Disease variant, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"adrenal gland: 5.0;retina: 12.9"	"Cell type enriched"	"Detected in some"	6	"Muller glia cells: 165.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	30	"NTERA-2: 3.3"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.00e-3)"				"unprognostic (1.26e-1)"					"unprognostic (5.54e-1)"					"unprognostic (9.68e-2)"			0.0	5.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	165.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CNDP1	"CN1, CPGL2, HsT2308, MGC10825"	ENSG00000150656	"Carnosine dipeptidase 1"	Q96KN2	18	74534500-74587212	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 97.4"	"Cell type enriched"	"Detected in some"	10	"Oligodendrocytes: 361.7"	"Cancer enhanced"	"Detected in some"		"glioma: 4.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	38	"U-266/84: 15.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA008933, HPA073283"	Enhanced				"Secreted to blood"	NA	NA		2100000000			"HPA008933: AB_1847033, HPA073283: "	"unprognostic (7.43e-3)"	"unprognostic (6.00e-2)"	"unprognostic (8.55e-3)"	"unprognostic (3.93e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.17e-2)"	"unprognostic (8.04e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.90e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.28e-1)"	0.0	0.0	34.5	0.0	63.1	0.2	0.0	74.5	39.0	0.0	5.5	0.0	1.3	0.0	0.7	0.0	0.0	0.1	0.0	27.7	53.9	0.6	13.0	0.0	0.0	79.6	76.2	17.7	0.0	0.0	0.0	0.2	0.0	97.2	0.1	0.0	0.1	0.0	0.1	1.4	0.1	0.2	0.0	45.8	0.0	0.0	0.3	71.5	0.0	0.2	0.0	0.0	0.0	0.0	97.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	15.4	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	34.5	63.1	74.5	39.0	27.7	53.9	79.6	76.2	17.7	97.2	45.8	71.5	97.4	0.2	0.0	0.0	0.3	0.2	0.1	0.4	0.2	0.0	0.6	0.5	0.3	0.7	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	8.6	0.5	0.2	0.2	0.0	2.7	1.2	0.2	0.0	0.3	0.0	1.5	0.0	0.2	0.7	35.1	0.1	0.0	1.5	0.7	0.0	1.2	1.1	3.1	0.0	0.2	0.0	1.0	0.0	0.5	0.0	3.0	361.7	0.2	0.1	0.0	0.0	0.4	0.4	24.5	0.0	1.0	0.0	0.6	0.2	1.0	0.4	0.0	0.3	0.0	0.4	0.0	0.5	0.2
CNTN2	"AXT, TAG-1, TAX, TAX1"	ENSG00000184144	"Contactin 2"	Q02246	1	205042937-205078289	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Cell adhesion"		Epilepsy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 251.1"	"Cell type enriched"	"Detected in some"	11	"Oligodendrocytes: 335.5"	"Cancer enriched"	"Detected in some"	9	"glioma: 6.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"NTERA-2: 3.9;SCLC-21H: 9.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001397, HPA012497"	Approved				"Secreted in brain"	NA	NA		58000			"HPA001397: AB_1847146, HPA012497: AB_1847147"	"unprognostic (1.90e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.87e-2)"	"unprognostic (4.52e-3)"	"unprognostic (2.98e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.43e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.44e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.73e-7)"	"unprognostic (9.82e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.07e-2)"	0.3	0.5	90.3	0.4	135.7	0.0	0.1	120.8	113.0	0.5	36.8	1.7	0.1	0.0	0.0	0.2	0.1	0.1	0.4	83.6	103.0	0.0	0.0	0.0	0.0	143.1	132.4	63.5	0.0	0.1	0.0	8.0	0.0	145.4	0.3	0.5	1.2	0.4	0.6	0.0	0.5	0.9	0.2	128.4	0.1	0.5	6.2	122.8	0.1	0.1	0.0	0.3	0.2	0.7	251.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	90.3	135.7	120.8	113.0	83.6	103.0	143.1	132.4	63.5	145.4	128.4	122.8	251.1	0.4	0.0	0.6	1.3	0.1	0.0	0.0	0.0	0.0	2.4	0.9	1.3	3.7	0.0	0.6	1.8	0.0	0.0	1.2	0.0	0.0	0.6	13.7	0.6	0.5	0.5	0.0	0.0	18.4	0.6	0.0	0.4	0.0	1.2	0.0	2.6	0.0	0.0	0.0	3.3	16.0	0.0	0.0	0.0	0.0	29.0	0.6	0.5	0.0	4.7	0.0	0.2	0.0	9.5	335.5	0.6	0.0	0.0	0.4	0.0	0.0	0.3	1.5	0.8	0.0	0.0	0.3	3.2	0.6	0.0	0.0	0.0	0.5	0.2	0.0	0.2
CPNE4	"COPN4, CPN4"	ENSG00000196353	"Copine 4"	Q96A23	3	131533555-132285410	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 26.1;prostate: 25.5"	"Cell type enriched"	"Detected in some"	10	"Excitatory neurons: 351.2"	"Cancer enriched"	"Detected in some"	6	"prostate cancer: 22.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 6.2;AF22: 5.7;Karpas-707: 1.7;RT4: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA032036, HPA078300"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA032036: AB_10600898, HPA078300: AB_2732377"	"unprognostic (7.38e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.22e-4)"	"unprognostic (2.53e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.81e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.29e-2)"	"unprognostic (9.10e-3)"	"unprognostic (1.18e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.51e-1)"	0.6	0.5	3.9	0.1	26.1	0.0	0.2	0.0	14.0	0.2	0.0	0.3	0.7	0.2	0.6	0.3	0.4	0.0	0.9	15.8	5.8	1.0	0.1	0.4	0.0	8.5	5.1	15.4	0.0	0.2	1.9	3.0	0.0	1.9	25.5	0.2	2.0	0.4	3.8	0.0	0.3	0.5	0.3	0.0	0.9	0.6	1.4	14.2	0.0	0.3	0.1	0.0	0.1	0.4	7.0	0.0	6.2	5.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	1.7	0.8	0.4	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.3	1.9	0.8	0.4	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.7	1.4	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3.9	26.1	0.0	14.0	15.8	5.8	8.5	5.1	15.4	1.9	0.0	14.2	7.0	0.9	0.0	0.0	8.8	0.0	0.3	0.4	0.1	0.0	0.8	0.0	0.0	17.5	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.6	0.1	0.6	4.9	0.0	351.2	0.0	0.0	0.6	3.6	0.6	0.0	0.2	0.0	0.0	0.1	1.7	33.0	0.1	0.0	0.0	0.3	5.6	0.3	1.1	0.0	8.4	0.6	0.3	0.0	8.5	7.1	0.1	0.0	0.0	0.0	17.0	0.0	2.6	0.3	0.6	0.0	0.0	0.4	1.4	1.1	0.3	0.1	0.0	0.0	0.1	0.0	0.9
CTNNA3	"MGC26194, VR22"	ENSG00000183230	"Catenin alpha 3"	Q9UI47	10	65912523-67696195	"Disease related genes, Predicted intracellular proteins"	"Cell adhesion"		"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 172.3"	"Cell type enriched"	"Detected in some"	14	"Oligodendrocytes: 4054.6"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 2.4;Karpas-707: 1.5;NTERA-2: 1.7;RPMI-8226: 2.4;SCLC-21H: 1.5;U-266/70: 6.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA061818	Enhanced					NA	NA					"HPA061818: AB_2684618"	"unprognostic (2.19e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.64e-4)"	"unprognostic (8.13e-3)"	"unprognostic (6.43e-3)"	"unprognostic (9.90e-2)"	"unprognostic (2.60e-4)"	"unprognostic (8.27e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.09e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.67e-3)"	"unprognostic (7.93e-5)"	"unprognostic (6.43e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.24e-1)"	0.7	0.5	30.4	0.6	81.7	0.1	0.5	43.3	50.6	1.4	0.0	1.5	0.3	1.3	0.1	1.5	0.7	0.6	18.8	24.1	40.2	0.3	8.5	0.1	0.2	74.3	67.7	10.6	1.8	0.1	0.2	0.2	0.4	85.1	0.4	0.6	0.4	0.3	0.2	12.2	0.2	0.8	2.6	65.8	0.3	1.2	2.2	59.0	0.1	0.3	23.6	0.3	0.6	0.6	172.3	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	2.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	1.7	0.6	0.7	0.1	0.0	2.4	0.0	0.0	1.5	0.0	0.1	0.0	0.0	1.4	0.1	0.0	0.0	0.1	0.4	0.0	0.0	6.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	30.4	81.7	43.3	50.6	24.1	40.2	74.3	67.7	10.6	85.1	65.8	59.0	172.3	0.4	0.0	0.0	24.5	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.3	75.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	217.8	0.0	1.5	1.2	0.0	0.0	49.8	0.0	0.0	2.5	0.0	0.1	0.0	2.6	0.4	5.7	0.0	0.0	50.6	0.0	0.0	0.8	0.3	275.5	4.4	0.3	0.0	30.0	0.0	1.4	0.0	50.3	4054.6	0.0	0.1	4.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.7	9.3	4.0	1.6	0.0	0.1	0.0	0.1	4.6	0.1	0.0
CUTC	CGI-32	ENSG00000119929	"CutC copper transporter"	Q9NTM9	10	99702558-99756134	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	7	"skeletal muscle: 389.2;tongue: 206.1"	"Cell type enriched"	"Detected in all"	4	"Spermatocytes: 163.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038619, HPA058231"	Enhanced		Enhanced	Nucleoplasm,Nucleoli,Cytosol		No	No			"Nucleoplasm, Cytosol"	Nucleoli	"HPA038619: AB_10672649, HPA058231: "	"unprognostic (1.25e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.70e-1)"	"unprognostic (8.66e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.55e-3)"	"unprognostic (8.67e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (3.81e-7)"	"unprognostic (1.00e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.97e-1)"	32.6	15.6	22.0	14.7	24.5	23.8	27.6	23.6	25.1	16.7	20.4	18.4	11.2	14.9	11.1	16.1	17.2	12.2	36.5	21.4	22.8	13.3	30.4	15.2	22.5	23.7	23.5	21.1	12.7	14.3	8.7	7.8	11.4	24.0	16.2	16.0	28.5	17.0	11.3	389.2	17.9	21.1	14.6	23.2	28.9	18.7	43.7	22.9	24.1	13.3	206.1	19.8	44.2	16.8	28.0	27.4	57.7	19.9	60.7	71.8	32.8	10.8	22.0	28.0	21.6	24.2	26.7	20.5	98.9	19.1	37.5	10.6	22.9	40.8	36.6	23.9	29.5	39.0	32.9	26.1	42.7	33.2	61.5	15.5	34.0	22.3	34.5	71.1	26.8	37.8	56.2	29.6	21.4	16.4	19.4	55.7	63.2	20.0	27.7	21.4	37.5	23.3	38.3	22.8	11.2	6.5	14.8	10.1	15.9	28.9	27.1	25.3	34.7	21.2	9.0	12.2	9.9	29.5	34.7	48.5	69.6	29.4	130.0	8.2	70.6	42.6	111.7	56.9	35.2	60.0	73.4	53.9	54.9	47.1	66.5	74.4	57.2	68.6	63.1	46.0	54.2	57.0	45.3	22.0	24.5	23.6	25.1	21.4	22.8	23.7	23.5	21.1	24.0	23.2	22.9	28.0	26.3	9.6	12.5	15.3	32.8	12.1	14.7	23.1	5.7	18.7	12.6	15.2	40.6	14.3	14.9	5.5	8.4	18.6	23.2	4.6	21.5	16.9	12.6	11.4	12.0	19.8	12.1	28.2	8.5	17.4	13.5	32.8	10.7	8.3	30.4	14.4	27.5	23.4	20.9	11.8	9.0	7.4	12.2	17.0	11.7	10.8	13.1	16.6	30.2	7.5	28.0	25.9	21.6	8.0	26.9	10.5	7.4	16.1	27.2	16.1	19.2	34.8	21.5	33.0	19.7	27.1	15.5	163.3	36.7	14.3	10.9	13.5	25.6	36.3	9.6	11.6
CYP4A22		ENSG00000162365	"Cytochrome P450 family 4 subfamily A member 22"	Q5TCH4	1	47137435-47149735	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"liver: 216.0"	"Cell type enriched"	"Detected in some"	9	"Hepatocytes: 143.0"	"Cancer enriched"	"Detected in some"	13	"liver cancer: 20.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RH-30: 1.2"															NA	NA						"unprognostic (5.34e-2)"	"unprognostic (1.24e-1)"		"unprognostic (3.19e-2)"			"unprognostic (2.88e-3)"	"unprognostic (2.76e-3)"		"unprognostic (1.50e-3)"	"unprognostic (2.21e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.93e-2)"	"unprognostic (5.29e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.71e-1)"	"unprognostic (8.59e-4)"	0.4	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.1	0.0	3.7	0.0	0.0	0.0	0.1	0.2	0.0	33.2	216.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.1	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	143.0	0.0	0.0	0.2	0.0	0.0	1.9	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
DLX1		ENSG00000144355	"Distal-less homeobox 1"	P56177	2	172084740-172089677	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 9.0"	"Cell type enriched"	"Detected in some"	23	"Inhibitory neurons: 30.4"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 11.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 134.5;U-138 MG: 36.9;WM-115: 42.1"	"Group enriched"	"Detected in many"	5	"basal ganglia: 28.6;olfactory bulb: 82.6"	"Region enriched"	"Detected in many"	4	"olfactory bulb: 48.8"	"HPA007175, HPA045884"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"HPA007175: , HPA045884: AB_10960361"	"unprognostic (2.14e-2)"	"unprognostic (5.09e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.89e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.92e-3)"	"unprognostic (8.86e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.40e-9)"	"unprognostic (2.22e-1)"	"unprognostic (9.19e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.91e-3)"	0.0	1.3	5.3	0.2	5.1	0.0	0.1	0.0	4.4	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	3.2	9.0	0.0	0.0	0.0	0.0	0.3	0.2	3.0	0.0	0.0	0.0	0.1	0.0	1.1	0.7	0.2	0.0	0.1	0.0	0.1	0.4	0.2	0.1	0.0	0.0	0.1	0.0	4.4	0.0	1.0	0.2	0.3	0.1	0.2	2.7	2.4	0.6	0.6	134.5	2.0	4.5	0.3	3.2	6.5	7.7	4.1	1.0	0.2	0.0	7.8	7.2	7.5	9.4	7.4	1.2	5.2	0.3	33.3	21.1	14.4	5.7	0.1	7.9	15.9	0.0	2.2	1.9	3.2	5.4	0.0	6.7	12.4	0.0	6.3	8.1	0.1	1.9	0.1	0.0	22.9	0.4	15.8	0.0	0.9	4.5	11.3	0.0	6.1	0.8	17.5	0.4	5.2	9.5	7.1	36.9	0.2	16.4	16.4	0.2	0.0	0.1	15.2	21.4	42.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.3	5.1	0.0	4.4	3.2	9.0	0.3	0.2	3.0	1.1	0.0	4.4	2.7	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	30.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FITM1	FIT1	ENSG00000139914	"Fat storage inducing transmembrane protein 1"	A5D6W6	14	24130659-24132849	"Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"heart muscle: 144.1;skeletal muscle: 225.9"	"Cell type enriched"	"Detected in some"	4	"Cardiomyocytes: 281.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 2.0;HMC-1: 1.2;RH-30: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA019842	Uncertain					NA	NA					"HPA019842: AB_1853025"	"unprognostic (1.81e-2)"	"unprognostic (4.29e-7)"	"unprognostic (2.77e-1)"	"unprognostic (2.02e-3)"	"unprognostic (2.24e-2)"	"unprognostic (6.68e-2)"	"prognostic favorable (1.00e-3)"	"unprognostic (1.20e-4)"	"unprognostic (4.57e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.86e-2)"	"unprognostic (5.62e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.12e-3)"	1.0	7.3	0.7	0.2	0.8	1.7	1.2	1.1	1.1	0.9	0.5	1.0	0.9	0.8	0.5	1.3	0.8	0.2	144.1	0.6	0.6	1.9	27.2	1.4	0.5	0.8	0.7	0.6	1.4	15.6	0.2	1.6	0.1	0.7	3.3	0.3	0.8	7.5	0.4	225.9	1.6	2.3	0.0	0.7	10.3	1.3	2.3	0.7	0.4	2.1	1.7	0.2	0.7	0.9	1.0	0.0	0.0	0.1	0.2	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.3	0.3	0.1	0.2	2.0	0.2	0.0	1.2	0.2	0.2	0.0	0.2	0.0	0.0	0.7	0.0	0.3	0.2	0.2	0.2	0.6	0.0	0.0	0.3	0.3	2.0	0.0	0.1	0.3	0.2	0.3	0.1	0.2	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.2	0.0	0.5	0.2	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	1.1	1.1	0.6	0.6	0.8	0.7	0.6	0.7	0.7	0.7	1.0	2.7	0.0	0.0	0.0	0.6	0.1	0.3	0.4	0.0	1.8	1.3	0.9	281.6	1.5	0.2	0.0	0.0	0.2	1.1	1.9	0.0	1.0	2.2	0.5	0.3	5.0	1.2	0.0	0.3	3.0	0.2	12.2	1.1	0.9	0.0	0.6	1.1	37.4	0.2	0.0	0.2	1.1	0.0	0.8	0.3	3.9	0.0	0.4	0.0	0.0	0.9	0.9	2.1	0.0	0.4	0.8	0.3	0.7	0.2	0.3	3.8	0.6	0.3	0.7	0.0	56.8	7.5	1.5	0.3	0.7	0.6	0.7	0.8	12.3	0.9	0.2
GAGE12E		ENSG00000216649	"G antigen 12E"	A1L429	X	49551333-49558649	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	7	"testis: 1.8"	"Cell type enriched"	"Detected in some"	4	"Spermatogonia: 11.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 1.4;U-266/84: 2.1"									HPA043232	Supported		Uncertain	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: AB_2678376"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.3	2.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GFAP	FLJ45472	ENSG00000131095	"Glial fibrillary acidic protein"	P14136	17	44903159-44916937	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 12855.4"	"Cell type enriched"	"Detected in some"	7	"Astrocytes: 381.9"	"Cancer enriched"	"Detected in some"	368	"glioma: 2468.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 6.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 6.2;NK-cells: 1.7"	"Cell line enhanced"	"Detected in many"		"U-87 MG: 6.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000039, HPA056030, HPA063513"	Enhanced	Supported	Supported	"Intermediate filaments"		No	No		170000000	"Intermediate filaments"		"CAB000039: AB_10013382, HPA056030: AB_2683015, HPA063513: AB_2685027"	"unprognostic (1.79e-2)"	"unprognostic (2.74e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.12e-5)"	"unprognostic (4.08e-1)"	"unprognostic (5.09e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.53e-2)"	"unprognostic (6.57e-3)"	"unprognostic (7.35e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.75e-5)"	"unprognostic (1.49e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.64e-1)"	1.8	1.8	4351.8	2.2	4622.7	14.3	3.5	5816.3	4926.6	1.3	1892.6	1.4	0.4	0.9	1.5	3.8	2.2	1.6	8.2	4465.1	8932.7	1.5	1.7	1.4	1.9	12855.4	6807.2	2981.1	2.1	1.6	1.6	34.2	0.7	8213.5	1.3	1.0	118.7	2.0	1.0	2.1	2.6	0.7	0.9	9813.6	1.5	1.5	1.4	8782.5	0.4	1.7	0.3	1.1	1.4	0.9	11334.3	1.0	0.7	1.2	2.3	0.0	0.4	0.2	1.0	1.2	1.5	1.2	1.3	1.5	2.2	1.9	0.5	0.9	2.7	1.4	0.4	1.8	3.0	1.1	1.4	2.1	0.9	0.0	0.2	2.2	0.1	0.8	1.0	0.0	1.7	0.0	2.3	0.7	5.3	0.8	1.3	1.9	2.6	1.6	0.1	3.3	0.7	0.7	1.2	0.7	0.6	1.6	1.8	0.1	1.7	0.2	1.0	1.2	1.2	0.7	1.2	0.9	1.1	2.0	0.7	1.6	1.6	6.1	2.0	2.7	1.5	0.8	0.3	0.3	0.6	0.2	0.2	0.2	0.4	0.1	0.5	0.3	0.4	6.2	1.7	0.5	0.5	0.2	0.2	4351.8	4622.7	5816.3	4926.6	4465.1	8932.7	12855.4	6807.2	2981.1	8213.5	9813.6	8782.5	11334.3	0.0	0.0	0.0	381.9	0.1	0.0	0.1	0.0	0.0	0.8	1.3	0.6	5.2	0.0	0.0	0.0	6.2	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.1	0.8	0.0	0.0	0.5	0.2	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	3.7	0.0	53.5	0.0	10.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	4.4	0.0	0.2	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1
GLYATL1B	GLYATL1P3	ENSG00000255151	"Glycine-N-acyltransferase like 1B"	A0A0U1RQE8	11	59086307-59094786	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"breast: 7.4;lymphoid tissue: 2.8"	"Cell type enriched"	"Detected in single"	57	"Proximal tubular cells: 5.8"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 0.7"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.5"	"Lineage enriched"	"Detected in single"	15	"B-cells: 1.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.8;T-47d: 1.2;U-266/70: 1.8"									HPA039501	Uncertain		Uncertain	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA039501: AB_2676545"	"unprognostic (1.39e-1)"	"unprognostic (3.46e-1)"						"unprognostic (1.44e-1)"			"unprognostic (1.25e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.21e-4)"	"unprognostic (3.45e-1)"		0.0	0.0	0.0	0.8	0.0	0.0	7.4	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.9	0.0	1.8	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GUCA1C	GCAP3	ENSG00000138472	"Guanylate cyclase activator 1C"	O95843	3	108907792-108953879	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"retina: 299.3"	"Cell type enriched"	"Detected in some"	4	"Cone photoreceptor cells: 125.1"	"Cancer enriched"	"Detected in single"	7	"pancreatic cancer: 0.5"	"Group enriched"	"Detected in some"	5	"hippocampal formation: 1.1;midbrain: 4.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	85	"RPTEC TERT1: 14.0"									HPA041597	Uncertain		Approved	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"HPA041597: AB_10795501"						"unprognostic (7.56e-2)"					"unprognostic (6.56e-2)"							0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	1.1	0.5	0.6	0.0	0.0	0.0	0.1	4.1	0.3	0.4	41.9	0.0	0.4	0.0	0.1	0.0	0.0	299.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.4	1.3	0.1	0.0	0.0	0.0	0.0	4.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.3	1.1	0.5	0.1	4.1	0.3	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	14.5	0.0	0.0	0.0	125.1	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.3	0.0	0.0	0.7	0.6	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.5	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	1.0	0.0	9.7	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	29.6	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	17.5	0.0	0.0
HSPB7	cvHSP	ENSG00000173641	"Heat shock protein family B (small) member 7"	Q9UBY9	1	16014028-16019594	"Predicted intracellular proteins"	"Stress response"	Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"heart muscle: 2988.1;skeletal muscle: 2437.7;tongue: 1240.4"	"Cell type enriched"	"Detected in some"	32	"Cardiomyocytes: 2389.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"fHDF/TERT166: 315.1"	"Not detected"	"Not detected"							HPA027639	Approved		Approved	Nucleoplasm		NA	NA		130000	Nucleoplasm		"HPA027639: AB_10601756"	"unprognostic (1.11e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.28e-3)"	"unprognostic (7.44e-3)"	"unprognostic (8.35e-2)"	"prognostic unfavorable (5.29e-4)"	"unprognostic (1.02e-1)"	"unprognostic (5.32e-2)"	"unprognostic (2.47e-3)"	"unprognostic (3.19e-3)"	"unprognostic (6.94e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.51e-2)"	"unprognostic (9.98e-2)"	"prognostic unfavorable (1.26e-4)"	309.6	124.4	4.5	32.4	3.7	0.2	120.7	8.5	5.1	49.8	8.6	101.7	5.2	181.0	7.6	44.5	65.4	18.8	2988.1	3.6	8.5	13.4	3.2	22.3	1.7	10.2	5.6	2.5	25.6	9.3	39.1	5.4	7.1	14.1	43.3	8.1	3.1	35.4	24.6	2437.7	14.5	34.3	191.0	4.9	4.5	72.0	20.3	4.6	0.6	14.2	1240.4	0.7	100.0	30.8	6.5	0.0	0.0	0.0	1.5	70.7	3.2	1.8	18.4	1.1	0.0	0.2	0.0	0.1	0.0	0.0	315.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	3.4	0.0	0.0	2.1	0.0	0.0	0.0	7.9	0.0	0.0	0.1	0.0	4.3	0.0	0.0	0.6	0.1	0.1	0.0	0.1	5.3	3.3	0.0	0.0	0.0	1.3	0.0	11.8	0.0	1.3	0.1	1.1	0.0	14.1	0.6	1.9	0.0	10.3	0.2	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	3.7	8.5	5.1	3.6	8.5	10.2	5.6	2.5	14.1	4.9	4.6	6.5	0.5	0.0	0.0	0.0	0.0	3.2	0.2	0.0	0.0	0.8	0.2	0.4	2389.7	0.0	0.0	3.7	0.0	2.8	0.0	0.0	13.7	1.4	55.5	0.1	0.7	26.6	0.0	0.0	0.0	0.2	1.4	46.3	0.0	0.1	0.0	0.4	0.0	0.0	1.6	1.7	0.1	0.0	0.0	0.0	4.6	74.2	14.3	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.2	0.0	0.0	6.8	0.0	0.5	0.0	0.2	0.0	0.6	0.0	20.2	42.6	1.9	0.9	0.1	2.6	3.3	0.5	3.0	0.0	0.1
ICOS	"AILIM, CD278"	ENSG00000163600	"Inducible T cell costimulator"	Q9Y6W8	2	203936763-203961577	"CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"bone marrow: 16.6;lymphoid tissue: 20.4"	"Cell type enriched"	"Detected in some"	12	"T-cells: 81.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 29.1"	"Lineage enriched"	"Detected in single"	54	"T-cells: 29.1"	"Group enriched"	"Detected in some"	8	"HEL: 4.6;MOLT-4: 12.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB032575, HPA034865"	Approved		Approved	"Plasma membrane,Actin filaments"	"Intracellular and membrane"	NA	NA			"Plasma membrane"	"Actin filaments"	"CAB032575: AB_2122593, HPA034865: "	"unprognostic (2.66e-2)"	"unprognostic (2.13e-3)"	"unprognostic (4.19e-4)"	"unprognostic (2.35e-5)"	"unprognostic (1.07e-1)"	"prognostic favorable (1.80e-4)"	"unprognostic (9.38e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.51e-4)"	"unprognostic (7.50e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.86e-5)"	"unprognostic (7.05e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.82e-3)"	0.5	0.1	0.0	7.8	0.0	16.6	0.3	0.0	0.0	0.2	0.0	0.7	0.7	0.2	0.1	0.5	0.3	1.5	0.2	0.0	0.0	0.2	0.4	2.6	14.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.5	1.3	0.0	0.4	0.0	0.0	0.2	2.3	0.4	0.0	3.3	1.3	0.2	0.0	20.4	0.4	0.0	16.3	2.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	4.2	0.0	15.1	6.8	0.0	0.0	15.7	7.2	0.1	0.5	0.0	0.0	29.1	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	1.3	0.0	3.1	2.9	0.0	0.0	0.0	0.0	1.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.1	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	1.1	2.0	0.2	6.3	0.0	0.4	0.1	0.1	0.0	0.0	0.2	0.0	0.8	4.7	0.1	0.0	3.1	3.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.3	0.0	1.8	0.1	81.2	0.0	0.0	0.1
IGHV2-70		ENSG00000274576	"Immunoglobulin heavy variable 2-70"	P01814	14	106770577-106771020	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"lymphoid tissue: 733.7;stomach 1: 506.6"	"Cell type enriched"	"Detected in single"	5	"Plasma cells: 2.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	24	"cerebral cortex: 3.5;hypothalamus: 3.5;midbrain: 7.3;spinal cord: 2.1"	"Group enriched"	"Detected in some"	241	"memory B-cell: 24.6;naive B-cell: 23.5"	"Lineage enriched"	"Detected in single"	247	"B-cells: 24.6"	"Cell line enriched"	"Detected in some"	8	"U-698: 12.4"														"Immunoglobulin genes"	NA	NA		170000000				"unprognostic (8.01e-3)"	"unprognostic (2.93e-2)"	"unprognostic (3.56e-3)"	"unprognostic (2.38e-2)"		"unprognostic (1.12e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.14e-1)"	"unprognostic (8.29e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (9.44e-6)"	"unprognostic (9.10e-2)"	"unprognostic (2.50e-1)"	"unprognostic (8.93e-2)"	"unprognostic (2.91e-1)"	7.4	26.0	0.0	97.1	0.0	69.9	87.0	0.1	3.5	62.8	0.0	87.6	53.7	4.1	0.0	44.7	8.2	37.9	2.1	0.0	3.5	4.8	13.4	70.5	83.4	0.1	7.3	0.0	5.0	1.0	0.9	0.4	0.2	0.0	6.8	83.7	0.0	95.4	14.2	0.1	0.9	42.4	2.5	2.1	157.7	506.6	1.2	0.0	60.0	8.6	0.0	733.7	50.8	4.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.4	0.8	0.0	0.0	0.8	0.6	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.1	0.7	0.0	0.1	0.0	12.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.6	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	3.5	0.0	3.5	0.1	7.3	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKV6D-21	"A10, IGKV6D21"	ENSG00000225523	"Immunoglobulin kappa variable 6D-21 (non-functional)"	A0A0A0MT36	2	90021567-90022185	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in many"	7	"intestine: 67.7;lymphoid tissue: 154.1;urinary bladder: 229.5"	"Cell type enriched"	"Detected in some"	7	"Plasma cells: 234.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	154	"memory B-cell: 14.2;naive B-cell: 16.5"	"Lineage enriched"	"Detected in single"	166	"B-cells: 16.5"	"Not detected"	"Not detected"																"Immunoglobulin genes"	NA	NA						"prognostic favorable (1.95e-4)"	"unprognostic (5.47e-3)"	"unprognostic (2.85e-3)"			"prognostic favorable (5.25e-5)"		"unprognostic (1.51e-1)"		"unprognostic (1.86e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.10e-2)"	"prognostic unfavorable (3.45e-7)"	"unprognostic (7.23e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.07e-1)"	0.5	0.4	0.0	17.4	0.2	17.3	11.9	0.0	0.1	5.4	0.0	67.7	39.2	1.6	0.0	22.3	0.8	2.7	2.2	0.1	0.0	1.6	2.5	6.3	20.0	0.4	0.0	0.0	1.2	1.1	0.0	0.0	0.0	0.1	0.8	32.1	0.0	21.2	17.4	0.0	1.2	38.1	1.1	0.0	45.7	13.5	3.4	0.0	9.2	1.4	0.0	154.1	229.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	234.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0
IGLV10-54		ENSG00000211642	"Immunoglobulin lambda variable 10-54"	A0A075B6I4	22	22038643-22215270	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"breast: 123.2;intestine: 327.8;lymphoid tissue: 332.4;salivary gland: 255.9;stomach 1: 196.3"	"Cell type enriched"	"Detected in some"	17	"Plasma cells: 358.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	32	"memory B-cell: 60.0;naive B-cell: 35.2"	"Lineage enriched"	"Detected in many"	41	"B-cells: 60.0"	"Cell line enhanced"	"Detected in single"		"TIME: 2.3"														"Immunoglobulin genes"	NA	NA		54000000				"prognostic favorable (9.35e-5)"	"unprognostic (2.65e-2)"	"unprognostic (9.06e-2)"	"unprognostic (8.71e-3)"	"unprognostic (1.29e-1)"	"prognostic favorable (8.30e-5)"	"unprognostic (1.40e-1)"	"unprognostic (1.83e-1)"	"unprognostic (5.62e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.00e-1)"	"prognostic unfavorable (1.48e-5)"	"unprognostic (3.33e-1)"	"unprognostic (5.57e-2)"	"unprognostic (5.17e-2)"	"unprognostic (3.86e-1)"	3.7	1.9	0.1	97.3	0.6	34.1	123.2	0.1	2.2	2.0	0.7	327.8	297.4	1.5	0.0	22.7	24.6	22.1	12.1	0.1	0.1	2.1	7.0	22.5	65.2	1.5	0.7	0.1	2.6	11.7	0.0	0.4	0.4	0.4	6.5	156.5	0.0	255.9	2.3	0.1	1.0	140.1	12.8	0.2	156.5	196.3	0.4	0.3	23.1	2.5	0.0	332.4	22.0	4.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	60.0	0.0	0.0	0.0	35.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.1	0.6	0.1	2.2	0.1	0.1	1.5	0.7	0.1	0.4	0.2	0.3	0.8	0.0	0.0	0.0	0.0	20.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	358.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
IGLV3-27		ENSG00000211658	"Immunoglobulin lambda variable 3-27"	P01718	22	22668288-22668806	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"lymphoid tissue: 405.0"	"Cell type enriched"	"Detected in some"	135	"Plasma cells: 1406.5"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	719	"memory B-cell: 194.0;naive B-cell: 367.8"	"Lineage enriched"	"Detected in single"	941	"B-cells: 367.8"	"Not detected"	"Not detected"																"Immunoglobulin genes"	NA	NA		720000000				"unprognostic (3.45e-2)"	"unprognostic (1.87e-3)"	"unprognostic (5.44e-2)"	"unprognostic (4.30e-3)"		"prognostic favorable (3.60e-7)"	"unprognostic (8.55e-2)"	"unprognostic (2.16e-1)"	"unprognostic (5.91e-2)"	"unprognostic (9.56e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (4.95e-9)"	"unprognostic (1.82e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.07e-1)"	8.9	1.8	0.2	16.5	0.1	29.7	30.0	0.0	0.6	23.9	0.1	57.3	19.4	2.2	0.0	10.4	5.2	10.6	3.2	0.0	0.0	3.6	3.8	29.5	64.8	0.3	0.0	0.0	3.0	0.3	0.2	0.4	0.0	0.1	2.4	27.1	0.0	40.9	0.8	0.0	0.5	24.6	0.7	0.0	104.8	60.4	24.4	0.0	48.1	2.8	0.0	405.0	27.7	2.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.1	194.0	0.2	0.0	0.3	367.8	0.0	0.0	0.2	0.0	0.1	0.1	0.1	11.8	0.2	0.1	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1406.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
KASH5	"CCDC155, FLJ32658"	ENSG00000161609	"KASH domain containing 5"	Q8N6L0	19	49388219-49417990	"Predicted intracellular proteins, Predicted membrane proteins"	Meiosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 54.9"	"Cell type enriched"	"Detected in single"	18	"Cardiomyocytes: 1.9"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Group enriched"	"Detected in some"	7	"cerebellum: 3.8;pons: 1.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 1.3;U-266/70: 3.6;U-698: 1.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA019937, HPA019940"	Enhanced					NA	NA					"HPA019937: AB_1848877, HPA019940: AB_1848879"	"unprognostic (1.31e-1)"	"unprognostic (4.23e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.99e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.41e-2)"	"unprognostic (5.31e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.11e-9)"	"unprognostic (6.50e-2)"	"unprognostic (4.18e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.20e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	2.0	0.0	0.0	0.0	1.5	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.7	0.0	0.3	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.6	0.6	1.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.1	0.0	0.1	0.0	0.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNJ12	"hIRK1, IRK2, KCNJN1, Kir2.2, Kir2.2v"	ENSG00000184185	"Potassium inwardly rectifying channel subfamily J member 12"	Q14500	17	21376357-21419870	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 24.7;skeletal muscle: 69.8;tongue: 26.0"	"Cell type enriched"	"Detected in many"	6	"Horizontal cells: 89.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 24.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.3;HeLa: 3.9;PC-3: 4.3;SCLC-21H: 4.8;SiHa: 2.5;SuSa: 5.2;U-2197: 4.2"									HPA027021	Approved		Uncertain	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA027021: AB_10602912"	"unprognostic (3.81e-3)"	"unprognostic (2.69e-2)"	"unprognostic (8.60e-2)"	"prognostic unfavorable (7.84e-5)"	"unprognostic (2.29e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.39e-2)"	"unprognostic (4.91e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.90e-2)"	"unprognostic (9.70e-3)"	1.0	1.1	3.6	0.6	2.1	0.4	0.8	24.7	3.1	1.1	0.0	0.9	0.1	0.5	0.6	1.4	2.1	0.4	6.1	1.5	2.7	1.2	0.1	1.9	0.1	3.3	7.4	1.9	0.4	0.2	5.6	0.8	0.4	9.1	0.6	0.3	1.3	0.7	0.6	69.8	3.0	0.4	0.6	0.9	1.2	1.1	0.8	12.1	0.1	1.1	26.0	1.0	0.8	0.5	2.8	0.0	0.7	0.3	1.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	2.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	1.0	0.0	4.3	0.0	0.6	1.1	0.0	0.0	4.8	0.2	2.5	0.0	1.1	5.2	0.0	0.0	2.0	0.0	0.3	4.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	2.1	24.7	3.1	1.5	2.7	3.3	7.4	1.9	9.1	0.9	12.1	2.8	1.4	0.0	0.0	0.7	0.0	1.5	0.0	2.3	0.0	2.9	0.0	0.3	14.3	0.0	1.2	1.8	0.0	0.0	0.1	1.1	1.9	0.0	0.5	0.4	0.5	3.4	1.2	0.0	2.8	0.0	0.0	3.4	0.5	1.8	0.0	0.0	6.8	0.1	0.2	89.2	5.7	1.4	4.1	0.0	1.2	0.5	7.5	0.1	0.0	2.8	0.0	10.2	0.0	0.0	0.2	0.0	0.5	4.1	0.0	0.2	0.0	0.8	0.1	1.5	0.0	3.0	0.7	0.6	2.5	0.0	2.3	0.1	0.5	0.0	1.8	0.2
LCE5A	"LEP18, SPRL5A"	ENSG00000186207	"Late cornified envelope 5A"	Q5TCM9	1	152510803-152512177	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"skin 1: 77.9"	"Cell type enriched"	"Detected in some"	4	"Suprabasal keratinocytes: 7.4"	"Cancer enhanced"	"Detected in single"		"melanoma: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"									NA	NA							"unprognostic (2.51e-1)"				"unprognostic (7.27e-3)"			"unprognostic (9.27e-2)"				"unprognostic (1.89e-1)"					0.0	0.0	0.0	0.0	0.0	0.1	11.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	77.9	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0
MTRNR2L10		ENSG00000256045	"MT-RNR2 like 10"	P0CJ77	X	55181392-55182442	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in many"	7	"brain: 1176.5"	"Cell type enriched"	"Detected in many"	9	"Cardiomyocytes: 9177.9"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 0.6"	"Region enriched"	"Detected in all"	43	"cerebral cortex: 1176.5"	"Group enriched"	"Detected in all"	5	"basophil: 171.3;eosinophil: 137.1;neutrophil: 395.3"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 395.3"	"Cell line enhanced"	"Detected in many"		"A549: 178.6;HeLa: 834.8;Hep G2: 578.6"														"Secreted to blood"	NA	NA						"unprognostic (4.42e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.10e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.71e-2)"	"unprognostic (8.42e-2)"	"unprognostic (1.58e-2)"	"unprognostic (9.01e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.01e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.97e-2)"	"unprognostic (4.99e-2)"	"unprognostic (3.97e-4)"	38.6	32.5	14.4	5.8	14.5	8.3	3.8	14.4	1176.5	0.7	14.4	39.3	11.4	12.1	38.8	23.3	17.1	10.7	162.7	27.1	14.4	123.1	80.2	3.4	2.6	24.8	14.4	14.3	15.0	24.0	5.2	0.0	6.7	16.9	8.4	66.7	2.5	28.0	3.5	129.1	12.8	10.6	24.8	15.9	8.5	10.8	22.7	14.5	1.0	5.7	15.1	21.4	4.4	0.0	14.8	10.5	178.6	2.4	49.1	4.5	2.2	12.8	16.1	0.8	0.9	0.5	12.1	25.7	24.2	3.4	1.1	2.1	36.6	0.1	1.2	0.5	7.0	36.4	12.3	834.8	578.6	1.1	4.1	6.5	6.2	2.7	0.3	2.0	42.0	0.7	18.4	21.8	13.7	1.9	67.9	3.8	28.8	1.1	0.9	14.0	9.2	9.9	11.3	4.0	111.5	2.5	10.2	4.7	4.3	18.1	23.2	14.4	21.1	25.7	18.0	3.8	6.2	1.6	4.4	3.1	2.0	11.2	5.3	4.0	171.3	50.3	137.1	9.5	25.1	11.4	38.2	14.8	12.7	21.7	36.5	19.1	22.3	395.3	22.8	24.5	26.2	16.2	63.8	14.4	14.5	14.4	1176.5	27.1	14.4	24.8	14.4	14.3	16.9	15.9	14.5	14.8	3.8	0.0	0.0	0.0	4.9	8.2	411.9	1.0	0.0	0.0	15.8	6.6	9177.9	2.8	0.6	42.3	0.0	0.3	1.3	0.0	84.1	0.0	0.3	11.5	6.5	296.2	0.0	0.0	0.0	0.0	0.3	289.5	0.0	16.0	0.0	4.0	1.8	6.2	0.6	0.0	0.0	0.0	2.0	5.5	23.2	1.1	0.6	75.9	16.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.5	222.0	0.0	611.6	0.6	0.0	0.0	995.2	385.1	0.6	0.9	0.0	9.1	0.3	70.1	4.3	0.0	449.2
MUC22	PBMUCL1	ENSG00000261272	"Mucin 22"	E2RYF6	6	31010474-31035402	"Human disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"esophagus: 18.0"	"Cell type enriched"	"Detected in single"	6	"Microglial cells: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA							"unprognostic (2.38e-1)"			"unprognostic (1.57e-1)"	"unprognostic (1.46e-1)"		"unprognostic (1.91e-1)"		"unprognostic (4.03e-1)"			"unprognostic (1.46e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.65e-1)"	"unprognostic (1.35e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MYZAP	"GCOM1, Gup, Gup1, MYOZAP"	ENSG00000263155	"Myocardial zonula adherens protein"	P0CAP1	15	57591904-57685364	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"heart muscle: 594.4"	"Cell type enriched"	"Detected in many"	7	"Cardiomyocytes: 481.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 3.4;naive CD4 T-cell: 2.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 137.3;hTERT-HME1: 24.0;HUVEC TERT2: 28.3;OE19: 47.5;RT4: 25.1;TIME: 33.1"									HPA039827	Approved					NA	NA					"HPA039827: AB_10673364"	"unprognostic (1.30e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.26e-3)"	"unprognostic (1.49e-1)"	"unprognostic (6.10e-3)"	"unprognostic (5.19e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.77e-2)"	65.8	55.1	2.3	2.6	2.0	4.1	22.5	6.0	2.4	11.3	1.5	13.8	17.0	29.7	1.8	41.7	4.7	4.8	594.4	1.7	2.9	5.2	2.4	32.0	6.0	6.0	3.4	1.4	5.1	35.4	0.6	1.8	57.0	8.0	20.0	11.9	1.3	18.4	38.5	11.8	8.3	15.6	17.3	1.5	12.5	23.6	2.5	3.0	1.4	3.8	15.6	8.6	84.7	27.1	3.0	6.0	1.7	0.0	10.5	2.3	0.1	3.2	0.9	8.6	1.4	1.7	7.3	4.1	0.1	0.7	0.0	8.9	2.6	0.0	4.4	1.7	0.0	0.2	137.3	1.7	0.1	0.4	0.0	0.1	0.0	3.1	0.3	24.0	0.1	28.3	0.2	1.9	0.0	0.7	2.3	0.0	0.1	0.1	47.5	2.4	0.0	11.4	0.3	0.0	25.1	0.0	4.1	0.6	5.9	0.0	1.2	7.9	0.1	33.1	0.1	2.6	0.4	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.4	0.4	0.0	0.0	3.4	2.0	0.0	0.5	0.0	0.8	0.0	0.2	2.4	2.3	2.0	6.0	2.4	1.7	2.9	6.0	3.4	1.4	8.0	1.5	3.0	3.0	22.9	9.6	0.6	0.0	0.3	0.0	10.2	0.0	0.0	0.3	3.0	1.0	481.4	5.7	0.6	25.8	0.0	4.4	0.0	26.9	7.9	32.5	0.1	1.1	3.0	15.1	1.8	1.3	0.0	18.9	2.4	9.8	7.1	3.5	0.0	65.1	4.6	0.2	1.4	0.0	0.0	7.9	0.0	7.9	0.0	0.7	4.7	8.7	0.0	0.0	3.4	0.6	0.0	0.0	0.0	21.5	24.9	17.0	0.0	11.0	18.1	0.3	0.7	0.2	0.0	0.2	8.1	0.0	1.6	0.0	0.0	1.2	0.2	13.2	6.6	22.4
NAT16	"C7orf52, FLJ39237"	ENSG00000167011	"N-acetyltransferase 16 (putative)"	Q8N8M0	7	101170496-101180293	"Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 2.6;pancreas: 2.3;pituitary gland: 3.6;retina: 6.9;thyroid gland: 1.8"	"Cell type enriched"	"Detected in some"	36	"Horizontal cells: 292.7"	"Cancer enhanced"	"Detected in some"		"glioma: 1.3;melanoma: 2.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPMI-8226: 2.4;SH-SY5Y: 3.4;SK-MEL-30: 2.7;U-2 OS: 2.9;U-87 MG: 1.7"									HPA021918	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA021918: AB_1848922"	"unprognostic (4.32e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.69e-3)"	"unprognostic (4.58e-3)"	"unprognostic (2.93e-2)"	"unprognostic (2.61e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.35e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.62e-2)"	"unprognostic (5.53e-5)"	"unprognostic (7.65e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.02e-5)"	"unprognostic (1.59e-1)"	0.0	0.1	1.5	0.0	1.2	0.2	0.0	0.5	2.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	1.7	0.0	0.1	0.0	0.0	0.7	1.1	1.7	0.0	2.3	0.3	3.6	0.0	0.7	0.0	0.0	6.9	0.1	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.4	0.1	1.7	0.0	1.8	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.4	0.0	0.3	0.1	0.0	2.4	0.0	0.2	0.0	3.4	0.0	0.1	2.7	0.2	0.1	0.0	0.0	0.1	2.9	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	1.5	1.2	0.5	2.6	0.9	1.7	0.7	1.1	1.7	0.7	0.3	1.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.1	0.1	0.7	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	292.7	2.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	5.5	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1
NEUROD6	"Atoh2, bHLHa2, Math-2, Nex1, NEX1M"	ENSG00000164600	"Neuronal differentiation 6"	Q96NK8	7	31337465-31340726	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 24.5"	"Cell type enriched"	"Detected in some"	10	"Excitatory neurons: 20.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	66	"SCLC-21H: 6.5"	"Region enhanced"	"Detected in all"		"hippocampal formation: 225.0"	"Group enriched"	"Detected in many"	9	"cerebral cortex: 20.9;hippocampal formation: 81.8"	HPA074530	Enhanced					NA	NA					"HPA074530: AB_2732257"					"unprognostic (3.68e-2)"													0.0	0.0	7.3	0.0	12.9	0.0	0.0	4.6	13.5	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.5	6.1	0.0	0.0	0.0	0.0	4.5	3.8	10.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	12.9	4.6	13.5	24.5	6.1	4.5	3.8	10.0	6.3	3.8	3.6	10.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NEXN	"NELIN, nexilin"	ENSG00000162614	"Nexilin F-actin binding protein"	Q0ZGT2	1	77888513-77943895	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Actin-binding	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"heart muscle: 408.5;skeletal muscle: 683.2;tongue: 553.8"	"Cell type enriched"	"Detected in many"	6	"Cardiomyocytes: 2329.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 152.2;LHCN-M2: 135.1;RH-30: 108.5"	"Region enhanced"	"Detected in all"		"basal ganglia: 40.4"	"Group enriched"	"Detected in all"	4	"basal ganglia: 9.0;midbrain: 13.4;pons: 10.0;thalamus: 25.2"	"HPA011185, HPA011904"	Approved		Supported	"Plasma membrane,Actin filaments"		NA	NA		2900000	"Plasma membrane, Actin filaments"		"HPA011185: AB_1854409, HPA011904: "	"unprognostic (9.73e-2)"	"unprognostic (6.72e-2)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (1.72e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.25e-1)"	"unprognostic (5.41e-2)"	"unprognostic (5.60e-2)"	"unprognostic (2.48e-1)"	"unprognostic (9.65e-3)"	"unprognostic (3.68e-2)"	43.2	22.6	2.2	24.8	2.6	0.6	16.3	1.8	1.9	21.7	3.8	67.4	10.3	79.7	10.8	49.8	47.9	29.0	408.5	1.4	2.1	8.1	5.7	25.4	5.6	1.6	3.3	0.9	15.3	10.0	1.5	1.5	10.7	1.9	63.0	15.8	0.6	11.6	70.4	683.2	5.5	26.9	71.2	1.1	8.6	44.5	5.8	5.1	2.1	10.4	553.8	1.8	50.1	19.7	2.0	26.0	1.5	4.5	0.2	79.5	75.3	12.3	152.2	65.5	29.8	20.2	4.6	0.2	0.0	8.6	54.7	34.4	3.4	3.3	14.3	53.3	0.7	3.4	6.2	7.5	1.5	59.3	1.3	0.2	56.6	3.3	40.7	23.8	65.2	22.8	6.0	0.3	0.0	135.1	0.0	29.9	1.8	23.8	0.0	18.6	24.3	108.5	0.2	35.5	1.2	0.1	1.1	13.3	0.0	1.0	29.9	0.0	3.5	23.4	71.7	53.6	31.2	76.1	0.2	0.2	0.1	4.0	2.8	0.2	0.0	1.7	0.0	0.2	1.0	0.0	0.7	0.1	0.2	0.9	0.5	0.3	0.1	1.4	0.3	0.8	0.6	0.0	3.6	2.2	2.6	1.8	1.9	1.4	2.1	1.6	3.3	0.9	1.9	1.1	5.1	2.0	8.3	105.8	4.9	11.4	2.1	1.8	0.9	4.6	1.2	2.7	1.4	33.1	2329.6	0.0	5.4	0.0	4.2	0.8	4.1	0.4	1.9	15.3	24.0	2.6	24.2	17.4	0.0	1.7	26.6	32.4	4.0	93.2	1.1	3.2	1.3	29.7	38.6	1.5	1.2	1.7	27.6	0.5	0.0	4.4	2.2	9.0	73.3	44.9	0.0	16.9	5.8	0.7	0.0	24.6	27.3	21.8	0.1	346.1	0.3	1.3	5.3	0.7	0.4	3.8	216.9	70.4	177.2	0.7	3.6	0.8	0.9	0.3	2.3	13.0	2.1	0.4
NKX6-3	FLJ25169	ENSG00000165066	"NK6 homeobox 3"	A6NJ46	8	41645177-41650817	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 10.9;stomach 1: 28.2"	"Cell type enriched"	"Detected in single"	5	"Gastric mucus-secreting cells: 2.6"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 3.1;stomach cancer: 3.9"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Daudi: 4.9;THP-1: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.87e-1)"	"unprognostic (9.91e-3)"		"unprognostic (4.04e-1)"	"unprognostic (5.73e-2)"			"unprognostic (1.98e-1)"		"unprognostic (1.65e-1)"	"unprognostic (6.36e-2)"	"unprognostic (1.13e-1)"		"unprognostic (2.17e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.78e-1)"		0.0	0.0	0.4	0.1	0.6	0.1	0.0	2.6	1.1	0.0	0.4	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	1.5	0.5	1.1	0.5	0.0	0.9	1.8	0.0	0.0	1.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.5	0.3	28.2	0.1	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	2.6	1.1	0.5	0.5	0.5	1.1	0.5	1.3	0.5	0.4	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PCDHAC1		ENSG00000248383	"Protocadherin alpha subfamily C, 1"	Q9H158	5	140926299-141012347	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	7	"parathyroid gland: 30.0"	"Cell type enriched"	"Detected in some"	4	"Alveolar cells type 1: 6.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 5.7;EFO-21: 2.5;hTCEpi: 5.9;PC-3: 4.2;SCLC-21H: 2.9"	"Low region specificity"	"Detected in all"							HPA052775			Approved	Nucleoplasm,Nucleoli,Vesicles		No	No			"Nucleoplasm, Nucleoli"	Vesicles	"HPA052775: AB_2681942"	"unprognostic (2.52e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.32e-3)"	"unprognostic (9.52e-3)"	"unprognostic (1.36e-1)"	"unprognostic (9.63e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.64e-3)"	"unprognostic (1.04e-3)"	"unprognostic (3.25e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.29e-2)"	0.4	0.4	0.4	0.5	0.7	0.0	0.1	4.4	1.0	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.1	1.0	0.0	0.5	0.6	0.2	0.1	0.7	1.2	1.8	0.9	0.6	0.0	1.2	30.0	0.7	0.0	2.2	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.1	0.7	1.0	0.0	0.9	0.0	0.6	0.1	0.0	1.2	0.0	5.7	0.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.7	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	4.2	0.0	0.0	0.0	0.1	0.3	2.9	1.7	0.0	0.4	0.0	0.5	0.3	0.0	0.0	0.3	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	4.4	1.0	0.5	0.6	1.8	0.9	0.6	2.2	0.1	1.0	1.2	0.1	6.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.9	1.2	0.0	0.2	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PDILT	PDIA7	ENSG00000169340	"Protein disulfide isomerase like, testis expressed"	Q8N807	16	20359175-20404737	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Chaperone, Developmental protein, Isomerase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"stomach 1: 123.7"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 136.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 2.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AF22: 1.0;HBEC3-KT: 3.0;hTCEpi: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA041913	Approved				"Intracellular and membrane"	NA	NA					"HPA041913: AB_10795644"							"unprognostic (1.99e-1)"					"unprognostic (6.09e-2)"	"unprognostic (2.05e-3)"	"unprognostic (2.63e-1)"				0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.1	123.7	18.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	1.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	3.0	0.0	0.1	0.0	0.3	0.3	0.0	0.0	0.0	0.2	0.2	3.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.1	0.1	0.1	0.0	0.5	0.2	0.2	0.0	0.3	0.1	0.2	0.5	0.7	0.1	2.8	0.0	0.2	0.1	0.1	0.1	0.2	0.2	0.1	0.2	0.0	0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	136.9	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	23.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1
PDLIM5	"Enh, LIM"	ENSG00000163110	"PDZ and LIM domain 5"	Q96HC4	4	94451857-94668227	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	7	"heart muscle: 635.2;skeletal muscle: 1174.5;tongue: 581.1"	"Cell type enriched"	"Detected in all"	4	"Cardiomyocytes: 1844.2"	"Cancer enriched"	"Detected in all"	8	"prostate cancer: 132.0"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"basophil: 219.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 219.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013511, HPA016740, HPA020026"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		NA	NA		1200000	"Plasma membrane"	"Nucleoplasm, Focal adhesion sites"	"CAB013511: AB_2533388, HPA016740: AB_1855153, HPA020026: AB_1855154"	"unprognostic (6.20e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.46e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.04e-1)"	42.1	26.3	21.2	25.8	24.1	60.2	39.9	23.9	22.6	27.5	79.3	34.4	33.6	95.6	11.4	73.0	40.9	47.9	635.2	21.6	94.7	35.2	83.4	22.2	16.4	31.7	27.7	16.1	27.4	30.4	12.3	17.7	68.3	24.6	89.3	31.0	18.3	40.5	69.5	1174.5	20.8	34.7	106.8	22.6	24.3	31.3	12.8	23.8	11.0	25.7	581.1	21.3	46.3	27.8	22.1	31.4	87.2	33.6	13.0	71.7	51.3	13.0	71.6	59.9	40.1	32.6	80.8	66.3	12.0	72.0	72.3	21.0	31.8	46.5	68.2	65.9	24.1	19.3	43.7	53.8	32.2	103.7	14.6	38.3	66.4	58.4	96.1	74.0	177.9	93.5	13.2	19.2	12.5	86.2	29.8	15.0	4.8	11.4	66.7	36.6	7.2	24.7	11.1	45.0	94.6	16.5	21.8	38.9	88.7	20.3	26.7	10.3	5.2	113.7	103.7	17.3	46.1	44.1	9.5	13.0	12.7	56.5	10.3	24.9	219.7	23.4	21.0	12.1	40.6	9.7	10.5	12.0	12.8	19.5	7.6	7.9	10.4	22.6	9.2	44.6	6.6	11.8	15.2	21.2	24.1	23.9	22.6	21.6	94.7	31.7	27.7	16.1	24.6	22.6	23.8	22.1	107.4	44.8	23.6	184.1	22.1	194.4	380.3	92.1	63.7	4.7	90.2	67.4	1844.2	62.9	82.9	49.7	31.3	13.7	18.5	180.0	13.7	95.0	19.2	68.7	11.8	117.2	109.4	27.6	4.9	95.1	96.5	97.8	84.6	108.7	52.0	29.1	137.8	207.0	38.8	1.7	20.7	107.4	36.7	60.6	75.3	9.1	41.3	59.8	62.2	104.0	41.6	86.2	12.3	181.5	43.1	139.2	166.8	66.5	23.2	300.7	117.5	73.6	70.0	35.8	78.9	96.7	134.7	23.8	34.4	107.3	157.0	23.8	31.1	6.8	74.0	217.5
PHOX2A	"ARIX, CFEOM2, FEOM2, PMX2A"	ENSG00000165462	"Paired like homeobox 2A"	O14813	11	72239077-72245664	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"adrenal gland: 20.1;brain: 10.2"	"Cell type enriched"	"Detected in single"	4	"Spermatogonia: 2.9"	"Cancer enriched"	"Detected in some"	9	"ovarian cancer: 9.3"	"Region enhanced"	"Detected in some"		"pons: 10.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	226	"SH-SY5Y: 569.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA053810, HPA065621, HPA078004"	Enhanced		Supported	Nucleoplasm		No	NA			Nucleoplasm		"HPA053810: , HPA065621: AB_2685522, HPA078004: AB_2732367"			"unprognostic (5.84e-2)"		"unprognostic (8.51e-2)"					"unprognostic (5.07e-2)"	"unprognostic (2.19e-1)"		"unprognostic (2.13e-1)"	"unprognostic (9.92e-4)"	"unprognostic (3.03e-2)"			0.4	20.1	0.1	1.3	0.1	0.0	0.0	0.0	0.2	0.0	0.1	2.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.6	4.4	0.0	0.0	0.2	0.0	0.5	0.0	10.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.2	0.0	1.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.4	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	569.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.8	1.6	4.4	0.0	10.2	0.2	0.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PITX3	ASMD	ENSG00000107859	"Paired like homeodomain 3"	O75364	10	102230186-102241512	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 5.0;skeletal muscle: 16.7;tongue: 6.0"	"Cell type enriched"	"Detected in some"	4	"Skeletal myocytes: 22.1"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	11	"midbrain: 5.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	16	"RH-30: 30.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"midbrain: 9.1"							NA	NA						"unprognostic (8.13e-2)"	"unprognostic (4.07e-1)"		"unprognostic (5.15e-3)"	"unprognostic (6.30e-2)"	"unprognostic (1.06e-1)"		"unprognostic (6.04e-5)"	"unprognostic (6.30e-3)"	"unprognostic (2.02e-1)"	"unprognostic (6.36e-2)"		"unprognostic (2.67e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.76e-2)"	"unprognostic (6.76e-3)"	"unprognostic (4.13e-2)"	1.2	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.1	0.0	0.1	0.0	0.0	0.0	0.1	5.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	6.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	30.3	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.1	5.0	0.1	0.0	0.0	0.3	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	5.2	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	22.1	0.3	1.4	1.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0
PMEL	"D12S53E, gp100, Pmel17, SI, SIL, SILV"	ENSG00000185664	"Premelanosome protein"	P40967	12	55954105-55973317	"Predicted intracellular proteins, Predicted membrane proteins"	"Melanin biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"cervix: 39.8;endometrium 1: 32.5;skin 1: 116.1"	"Cell type enriched"	"Detected in many"	32	"Melanocytes: 1472.7"	"Cancer enriched"	"Detected in many"	500	"melanoma: 2481.9"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	68	"SK-MEL-30: 8590.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA031649	Enhanced		Supported	"Endoplasmic reticulum,Golgi apparatus"	"Intracellular and membrane"	NA	NA		11000000	"Endoplasmic reticulum"	"Golgi apparatus"	"HPA031649: AB_2673976"	"unprognostic (4.63e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.90e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.46e-3)"	"unprognostic (6.44e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.12e-2)"	"unprognostic (3.98e-1)"	"prognostic favorable (3.70e-4)"	"unprognostic (2.86e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.04e-1)"	2.8	0.8	0.2	0.8	0.2	1.8	8.4	0.7	0.6	39.8	0.5	1.3	1.6	32.5	1.5	0.7	1.3	1.6	0.5	0.2	0.1	2.1	5.1	0.9	5.7	0.3	1.0	0.2	4.3	2.4	1.7	0.7	2.8	0.1	0.9	1.2	0.5	3.6	0.8	0.3	116.1	2.1	3.6	0.0	0.5	1.1	4.9	0.0	0.7	1.1	0.2	2.2	1.3	4.0	0.3	14.8	1.1	5.6	0.2	83.6	0.6	126.2	0.9	0.8	1.9	2.0	12.8	6.0	2.6	6.1	0.8	0.3	2.5	0.6	1.0	1.6	3.0	2.1	2.4	2.5	0.7	0.3	1.0	1.4	0.5	1.0	1.2	0.6	1.3	1.0	1.1	0.5	1.8	0.5	2.7	0.4	1.0	17.1	2.8	0.3	1.6	3.5	1.5	1.4	2.7	0.5	2.6	0.3	2.5	8590.9	4.6	4.4	8.8	1.4	0.9	6.5	0.7	7.9	2.1	10.4	3.2	1.0	2.7	0.3	0.0	0.3	0.1	0.0	0.0	0.4	0.3	0.1	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.0	0.4	0.0	0.1	0.2	0.2	0.7	0.6	0.2	0.1	0.3	1.0	0.2	0.1	0.0	0.0	0.3	0.8	0.0	0.5	0.0	0.1	45.9	0.8	1.1	2.8	0.0	1.0	0.9	0.4	1.5	2.2	0.0	0.0	12.1	0.0	1.5	0.0	2.1	8.0	0.7	0.2	1.2	0.0	0.8	0.1	2.3	12.4	1.6	1.1	0.5	0.0	11.1	0.0	2.9	1.7	0.0	0.1	1.6	0.0	0.3	14.6	5.3	12.2	0.6	1472.7	1.0	0.6	0.2	0.0	0.0	0.1	1.0	0.6	0.7	1.2	0.5	2.4	2.8	1.0	0.0	0.0	0.2	1.7	3.9	2.6	1.0	10.2	24.9	0.4	1.3	1.6	0.4
RPL3L		ENSG00000140986	"Ribosomal protein L3 like"	Q92901	16	1943974-1957606	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"skeletal muscle: 952.6;tongue: 426.4"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 134.5"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.4"	"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CACO-2: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049136	Enhanced		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA049136: AB_2680648"	"unprognostic (2.53e-1)"	"unprognostic (2.63e-2)"	"unprognostic (9.27e-4)"	"unprognostic (6.38e-4)"	"unprognostic (4.36e-2)"	"unprognostic (3.48e-3)"	"unprognostic (3.46e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.46e-2)"	"unprognostic (4.53e-3)"	"unprognostic (3.32e-1)"	"unprognostic (4.24e-1)"	"unprognostic (8.32e-3)"	"unprognostic (4.60e-2)"	0.3	0.4	0.7	0.2	0.8	1.8	1.5	1.7	1.0	0.0	0.9	0.2	0.6	0.3	0.4	8.5	0.1	0.5	100.5	0.7	0.3	0.4	0.3	0.2	0.4	0.2	0.1	0.4	0.3	11.6	0.0	0.1	0.2	1.0	4.2	0.0	1.3	7.0	0.1	952.6	0.7	0.5	0.0	0.0	0.4	0.2	6.5	0.2	0.1	0.4	426.4	0.1	0.2	0.1	1.2	1.1	1.2	0.3	1.1	0.0	0.0	0.7	0.5	0.0	0.0	0.0	4.0	2.1	0.6	0.7	0.0	1.0	1.1	0.1	0.1	0.0	0.5	0.6	0.4	0.9	1.4	0.0	0.3	0.4	0.1	0.1	0.1	0.1	0.7	0.0	0.7	0.4	2.8	0.0	0.6	0.8	1.0	0.6	1.2	2.5	0.4	0.3	0.9	0.1	0.4	1.6	0.5	0.5	1.4	0.6	0.7	0.7	0.6	0.6	0.6	1.4	0.8	0.4	1.2	0.6	0.5	0.8	0.2	0.2	0.5	0.2	0.3	0.3	0.3	0.2	0.4	0.2	0.3	0.1	0.4	0.3	0.3	1.2	0.2	0.3	0.4	0.1	0.1	0.7	0.8	1.7	1.0	0.7	0.3	0.2	0.1	0.4	1.0	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.6	0.9	0.2	0.0	0.0	0.1	0.6	134.5	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	7.9	0.0	0.1	1.3	0.0	5.3	0.1	0.0	0.2	2.9	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	7.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	23.7	2.2	0.7	2.4	0.0	0.4	0.0	0.2	0.1	0.1	0.5
SEPTIN3	"SEP3, SEPT3"	ENSG00000100167	"Septin 3"	Q9UH03	22	41969475-41998221	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 232.2"	"Cell type enriched"	"Detected in some"	5	"Extravillous trophoblasts: 27.9"	"Group enriched"	"Detected in many"	5	"glioma: 24.6;melanoma: 11.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 26.6;Daudi: 22.3;SCLC-21H: 71.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003548, CAB017633"	Supported	Supported	Approved	"Nucleoplasm,Plasma membrane,Actin filaments"		NA	NA			"Nucleoplasm, Plasma membrane"	"Actin filaments"	"CAB017633: AB_2301476, HPA003548: AB_1079908"	"unprognostic (2.10e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (1.78e-4)"	"unprognostic (4.56e-2)"	"unprognostic (1.13e-1)"	"unprognostic (7.07e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.67e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.30e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.15e-2)"	"unprognostic (6.68e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.04e-1)"	0.2	4.6	129.5	0.4	160.6	0.1	1.3	86.3	232.2	0.2	33.7	0.7	0.3	0.2	1.5	0.2	0.1	0.5	0.1	166.8	111.7	0.3	0.1	0.7	0.5	88.6	77.0	154.3	0.2	1.2	18.7	7.8	5.7	100.4	1.3	0.5	28.6	0.4	0.0	0.1	1.6	0.4	0.3	54.9	0.2	0.7	2.1	93.2	0.9	0.8	0.2	0.5	0.3	0.4	150.2	1.5	1.7	26.6	20.1	0.3	0.0	13.3	0.3	0.3	1.8	0.8	0.4	3.1	22.3	0.7	0.2	11.4	0.1	14.0	0.1	0.7	9.2	4.6	0.1	0.5	0.0	0.2	0.0	0.9	0.2	1.0	0.1	0.0	0.0	0.0	12.1	0.0	3.4	0.0	2.4	3.7	0.2	18.2	0.2	0.7	17.9	0.0	1.3	0.0	2.7	71.4	14.8	10.9	0.1	18.2	2.5	2.6	6.7	0.0	0.0	9.2	0.9	1.0	14.1	13.1	0.2	0.3	9.0	2.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	129.5	160.6	86.3	232.2	166.8	111.7	88.6	77.0	154.3	100.4	54.9	93.2	150.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0
SERPINE2	"GDN, nexin, PI7, PN1, PNI"	ENSG00000135919	"Serpin family E member 2"	P07093	2	223975045-224039318	"Plasma proteins, Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Heparin-binding, Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"placenta: 1101.0"	"Cell type enriched"	"Detected in many"	8	"Granulosa cells: 4466.0"	"Cancer enriched"	"Detected in all"	9	"melanoma: 271.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"naive CD4 T-cell: 12.9;naive CD8 T-cell: 6.8;NK-cell: 23.2"	"Group enriched"	"Detected in many"	15	"NK-cells: 23.2;T-cells: 12.9"	"Cell line enhanced"	"Detected in many"		"BJ: 1492.9;fHDF/TERT166: 6425.1;SK-MEL-30: 2966.9;WM-115: 2183.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000277			Approved	"Golgi apparatus"	"Secreted in female reproductive system"	NA	NA		910000	"Golgi apparatus"		"HPA000277: "	"unprognostic (1.73e-1)"	"unprognostic (7.08e-3)"	"unprognostic (8.49e-2)"	"unprognostic (7.78e-3)"	"unprognostic (2.57e-3)"	"unprognostic (5.57e-2)"	"unprognostic (1.49e-2)"	"unprognostic (7.43e-3)"	"unprognostic (4.41e-1)"	"unprognostic (7.12e-2)"	"unprognostic (7.56e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.97e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.18e-2)"	"prognostic unfavorable (6.48e-5)"	28.2	20.0	126.6	76.4	119.9	6.5	14.5	134.8	159.9	28.4	78.3	22.8	28.5	17.6	5.7	36.5	20.9	46.4	74.6	117.1	140.7	36.3	10.9	14.6	31.1	161.1	149.1	116.3	146.9	8.6	3.4	8.8	1101.0	131.6	26.6	22.0	5.4	12.7	7.6	6.7	11.3	27.3	120.8	144.2	31.2	9.0	58.1	143.1	17.2	26.3	10.9	44.3	148.3	27.9	134.7	3.1	83.8	29.4	32.6	1172.5	438.7	4.4	1492.9	851.5	118.1	112.7	4.8	7.0	0.4	32.5	6425.1	188.0	5.0	3.5	102.5	101.0	0.6	26.8	16.6	49.9	22.7	57.7	12.8	1.5	128.3	68.5	342.0	505.6	304.6	9.0	5.4	0.5	1.9	412.1	4.5	2.3	3.9	56.2	31.8	92.3	10.3	25.2	64.5	1100.2	97.5	43.0	7.1	284.4	0.5	2966.9	385.2	1.2	6.4	1056.5	692.5	96.6	214.4	72.7	6.3	13.3	0.8	443.5	11.1	2183.6	0.0	0.0	0.0	0.7	0.0	0.5	0.8	0.6	0.6	0.0	1.2	12.9	6.8	0.5	23.2	0.0	0.2	0.7	2.7	126.6	119.9	134.8	159.9	117.1	140.7	161.1	149.1	116.3	131.6	144.2	143.1	134.7	13.5	0.0	1.1	233.1	3.1	23.3	16.0	132.2	351.7	5.3	7.9	8.5	5.3	0.0	4.6	7.3	0.0	106.1	11.3	19.5	11.7	13.0	2.6	5.3	17.7	20.9	24.0	23.1	86.1	33.2	524.3	556.7	5.6	5.9	2.5	4466.0	23.2	0.0	45.5	0.0	11.4	4.7	0.0	0.8	26.9	9.9	401.4	9.7	142.3	23.4	3.5	2.5	2.1	199.6	13.5	22.1	14.9	98.9	5.6	27.2	2.0	146.2	1.7	3.5	13.1	5.2	146.6	4.2	70.9	34.8	14.5	133.9	10.7	18.9	3.1	7.2
SLAIN1	"C13orf32, FLJ30046"	ENSG00000139737	"SLAIN motif family member 1"	Q8ND83	13	77697687-77764242	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"brain: 414.4"	"Cell type enriched"	"Detected in many"	5	"Oligodendrocytes: 1081.8"	"Cancer enhanced"	"Detected in many"		"glioma: 25.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEK 293: 58.1;HL-60: 78.8;MOLT-4: 90.5;REH: 62.1;SCLC-21H: 58.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (8.76e-5)"	"unprognostic (1.78e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.25e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.39e-2)"	"unprognostic (6.20e-2)"	"prognostic favorable (9.07e-4)"	"unprognostic (4.80e-3)"	"unprognostic (3.83e-3)"	"unprognostic (2.16e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.97e-2)"	2.6	10.4	210.4	5.5	301.9	17.8	7.1	227.0	215.6	5.6	53.0	4.2	3.1	7.5	12.9	4.3	18.4	4.0	6.7	163.3	213.3	9.0	8.2	10.9	11.5	272.3	287.1	122.5	7.9	11.8	20.8	8.3	3.9	288.9	7.5	3.0	60.1	10.7	6.1	3.3	2.8	4.0	5.3	254.8	8.8	12.3	34.3	245.9	27.5	11.5	5.0	11.3	5.3	2.3	414.4	0.3	3.5	41.1	0.9	0.0	0.0	7.1	0.2	0.0	0.1	0.0	4.0	8.6	32.8	2.1	0.1	0.1	0.2	39.3	0.0	0.0	41.4	58.1	28.0	7.6	0.7	1.1	78.8	2.0	0.0	0.1	0.0	0.0	4.6	1.6	45.0	0.8	41.9	0.0	1.1	90.5	7.8	15.7	28.4	12.9	62.1	3.6	0.1	19.3	3.3	58.6	29.7	0.0	11.4	7.9	13.5	0.0	35.1	0.5	0.5	1.7	0.4	11.2	41.3	20.2	38.9	4.5	9.1	2.5	0.0	0.0	0.0	0.8	0.1	1.2	0.3	1.0	0.9	0.1	0.2	1.1	1.8	0.0	0.3	0.1	0.9	2.3	0.5	210.4	301.9	227.0	215.6	163.3	213.3	272.3	287.1	122.5	288.9	254.8	245.9	414.4	0.7	12.8	10.8	27.7	5.5	0.8	3.0	0.0	2.8	7.9	5.4	2.8	4.7	8.6	1.9	3.7	16.7	1.8	8.8	0.1	1.9	2.1	79.0	14.8	2.3	3.4	9.0	3.0	72.7	2.6	0.2	1.5	7.1	23.0	0.0	5.2	3.6	5.7	0.3	3.3	91.9	0.8	0.0	1.2	0.8	18.0	1.5	1.7	7.2	30.0	0.8	95.5	6.2	209.1	1081.8	2.3	0.0	0.7	4.1	5.0	0.1	4.4	0.0	4.0	0.0	5.5	2.3	3.1	2.1	2.5	1.3	0.4	6.0	0.7	0.4	3.2
SLC13A1	"NAS1, NaSi-1"	ENSG00000081800	"Solute carrier family 13 member 1"	Q9BZW2	7	123113531-123199972	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Sulfate transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"kidney: 82.6"	"Cell type enriched"	"Detected in some"	6	"Proximal tubular cells: 452.1"	"Cancer enriched"	"Detected in single"	219	"renal cancer: 10.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA053615, HPA062714"	Enhanced					NA	NA					"HPA053615: AB_2682207, HPA062714: AB_2684846"											"unprognostic (1.86e-1)"		"prognostic favorable (8.95e-5)"	"unprognostic (1.71e-1)"	"unprognostic (3.76e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	82.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	7.3	0.0	0.0	0.0	0.1	27.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.1	0.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	75.3	452.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	4.1	0.0
SLC35G3	"AMAC1, FLJ40154, TMEM21A"	ENSG00000164729	"Solute carrier family 35 member G3"	Q8N808	17	35192520-35194523	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	7	"testis: 2.3"	"Cell type enriched"	"Detected in some"	9	"Early spermatids: 30.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA							"unprognostic (1.88e-1)"		"unprognostic (2.67e-1)"		"unprognostic (6.17e-3)"				"unprognostic (3.83e-1)"				"unprognostic (6.24e-2)"	"unprognostic (3.06e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0
SLC5A5	NIS	ENSG00000105641	"Solute carrier family 5 member 5"	Q92911	19	17871945-17895174	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Congenital hypothyroidism, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"choroid plexus: 132.1;salivary gland: 65.0;stomach 1: 59.3"	"Cell type enriched"	"Detected in some"	40	"Gastric mucus-secreting cells: 244.7"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 3.7"	"Region enhanced"	"Detected in many"		"hippocampal formation: 11.1"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"BEWO: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB022364, HPA049055"	Enhanced					NA	NA					"CAB022364: , HPA049055: AB_2680614"	"unprognostic (2.72e-2)"	"unprognostic (8.94e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.03e-1)"	"unprognostic (3.93e-2)"	"unprognostic (5.51e-8)"	"unprognostic (1.07e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.54e-2)"	"unprognostic (3.23e-1)"	0.0	0.0	0.5	0.2	0.2	0.3	0.1	5.4	3.0	5.6	132.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	11.1	0.2	0.0	0.0	0.1	0.3	0.2	3.1	0.2	0.0	0.0	0.0	0.3	0.0	1.3	0.1	0.0	0.1	65.0	0.0	0.4	0.2	0.2	0.0	0.1	0.2	59.3	0.4	2.7	0.0	12.1	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.3	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.3	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.6	0.0	1.1	0.1	0.1	0.3	0.4	0.4	0.3	0.9	0.1	0.2	0.3	1.2	0.9	0.6	0.2	0.1	0.1	0.6	0.3	0.5	0.2	5.4	3.0	11.1	0.2	0.2	3.1	0.2	1.3	0.1	2.7	0.3	0.0	0.0	0.6	0.3	1.1	0.4	0.0	0.0	0.0	0.0	1.7	0.0	0.8	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.2	0.2	0.0	0.0	0.5	0.6	1.3	0.1	244.7	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.3	0.6	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.9	0.1	0.0	0.0	2.9	0.0	0.0	1.2	0.2	0.1	6.1	0.2	0.3	0.0	0.9	0.0	0.0	0.2
SLC7A10	asc-1	ENSG00000130876	"Solute carrier family 7 member 10"	Q9NS82	19	33208664-33225850	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"adipose tissue: 29.5;brain: 11.2;breast: 12.8"	"Cell type enriched"	"Detected in some"	4	"Astrocytes: 40.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BEWO: 1.9;HHSteC: 1.1;HSkMC: 1.6;THP-1: 3.9;U-2 OS: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041884, HPA057036"	Uncertain		Uncertain	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA041884: AB_10794494, HPA057036: AB_2683317"	"unprognostic (1.85e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.79e-6)"	"unprognostic (1.16e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.98e-3)"	"unprognostic (4.64e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.28e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.34e-3)"	"unprognostic (8.91e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.18e-2)"	29.5	0.3	7.5	0.2	7.8	0.0	12.8	10.0	11.2	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.9	8.4	0.5	0.0	0.0	0.2	8.7	10.8	5.4	0.0	0.2	0.0	0.0	0.2	10.1	0.0	0.0	0.5	0.8	0.0	0.1	0.2	0.5	0.0	4.9	0.0	0.1	0.5	9.8	0.0	0.5	0.4	0.3	0.3	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	3.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	7.8	10.0	11.2	6.9	8.4	8.7	10.8	5.4	10.1	4.9	9.8	7.0	0.1	0.0	0.0	40.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.8	0.0	2.4	0.0	9.5	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.4	0.0	0.1	0.1	0.1	0.0	0.0	0.0
SOAT2	ACAT2	ENSG00000167780	"Sterol O-acyltransferase 2"	O75908	12	53103486-53124535	"Enzymes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"intestine: 19.6"	"Cell type enriched"	"Detected in some"	5	"Proximal enterocytes: 14.3"	"Group enriched"	"Detected in some"	8	"liver cancer: 5.2;testis cancer: 5.5"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"MAIT T-cell: 1.1"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.1"	"Group enriched"	"Detected in some"	5	"CACO-2: 9.5;Hep G2: 22.6;U-266/70: 7.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (2.53e-1)"	"unprognostic (2.72e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.30e-4)"	"unprognostic (3.88e-3)"	"unprognostic (9.26e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.83e-2)"	"unprognostic (9.05e-2)"	"unprognostic (2.37e-1)"	"unprognostic (7.58e-3)"	"unprognostic (3.28e-1)"	0.3	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.1	0.7	0.0	0.2	11.7	0.4	0.3	0.1	0.6	0.4	0.1	0.0	0.0	0.4	2.9	0.2	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.4	0.1	0.0	0.4	0.1	0.0	0.2	19.6	0.0	0.0	2.1	0.2	0.2	0.0	0.1	0.3	0.1	0.2	0.3	0.6	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.3	0.4	9.5	0.1	0.0	0.0	0.5	0.0	0.8	0.0	0.0	0.7	0.0	0.0	1.0	0.0	22.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.4	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	7.2	1.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.7	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	1.5	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	1.3	0.0	0.0	0.0	0.2	0.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	2.5	0.0	0.0	0.0	14.3	0.8	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.6	0.0	0.3	0.0
TBX5	HOS	ENSG00000089225	"T-box transcription factor 5"	Q99593	12	114353911-114408442	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Atrial fibrillation, Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"heart muscle: 58.2;lung: 21.0;placenta: 28.9"	"Cell type enriched"	"Detected in some"	9	"Cardiomyocytes: 104.7"	"Cancer enhanced"	"Detected in some"		"lung cancer: 1.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 18.9;BJ hTERT+: 41.5;BJ hTERT+ SV40 Large T+: 9.2;BJ hTERT+ SV40 Large T+ RasG12V: 12.2;HAP1: 16.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA008786, HPA064683"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA008786: AB_10601720, HPA064683: AB_2685320"	"unprognostic (3.09e-2)"	"unprognostic (1.53e-1)"			"unprognostic (3.79e-2)"	"unprognostic (2.75e-1)"		"unprognostic (1.62e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.67e-2)"	"unprognostic (3.36e-7)"	"unprognostic (2.29e-2)"	"unprognostic (1.68e-2)"	"unprognostic (7.34e-2)"	"unprognostic (4.38e-3)"	3.4	0.0	0.1	0.0	0.0	0.0	4.5	0.2	0.4	0.3	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	58.2	0.8	0.0	0.0	0.0	21.0	0.6	0.3	0.1	0.0	0.0	0.0	1.3	0.0	28.9	0.3	3.4	0.0	0.3	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	5.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	18.9	41.5	9.2	12.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	16.3	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.8	0.0	0.3	0.1	0.0	0.3	0.0	0.0	0.2	2.9	0.0	0.6	1.6	0.0	0.1	0.0	0.0	0.0	4.5	0.1	0.1	104.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.7	0.1	0.0	0.0	0.0	2.1	0.3	0.0	0.1	0.0	0.0	0.0	6.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	7.0	0.0	0.0	0.3	0.1	0.1	0.2	0.0	0.0	0.0
TMPRSS11F	"FLJ16046, HATL4"	ENSG00000198092	"Transmembrane serine protease 11F"	Q6ZWK6	4	68053198-68129869	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	7	"esophagus: 15.3;lymphoid tissue: 4.1;skin 1: 9.3;vagina: 4.8"	"Cell type enriched"	"Detected in some"	4	"Squamous epithelial cells: 6.9"	"Group enriched"	"Detected in some"	7	"cervical cancer: 1.6;head and neck cancer: 2.1;lung cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"K-562: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA026911	Uncertain					NA	NA					"HPA026911: AB_2205589"		"unprognostic (9.46e-2)"			"unprognostic (5.30e-1)"	"unprognostic (7.16e-2)"		"unprognostic (8.79e-3)"	"unprognostic (1.09e-1)"			"unprognostic (2.40e-1)"			"unprognostic (1.22e-1)"	"unprognostic (5.08e-2)"		0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.5	0.1	0.0	0.1	1.0	0.0	0.1	9.3	0.0	0.0	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	4.1	0.0	4.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.3	0.3	0.0	0.5	0.1	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	6.9	0.0	0.3	0.0	0.1	0.0	0.5
TRAV3		ENSG00000211777	"T cell receptor alpha variable 3"	A0A0B4J244	14	21723713-21724321	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 10.2"	"Cell type enriched"	"Detected in some"	4	"T-cells: 6.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"memory CD4 T-cell: 48.8;memory CD8 T-cell: 33.6;naive CD4 T-cell: 51.2;naive CD8 T-cell: 47.8;T-reg: 112.7"	"Lineage enriched"	"Detected in single"	144	"T-cells: 112.7"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.32e-3)"	"unprognostic (4.61e-4)"	"unprognostic (2.50e-1)"	"unprognostic (6.25e-3)"	"unprognostic (7.75e-2)"	"unprognostic (8.35e-4)"	"unprognostic (8.65e-3)"	"unprognostic (4.31e-3)"	"unprognostic (2.88e-3)"	"unprognostic (4.24e-3)"	"unprognostic (5.27e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.91e-4)"	"unprognostic (1.67e-1)"	"unprognostic (6.61e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.08e-1)"	0.2	0.2	0.0	2.9	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.5	0.1	0.2	0.6	0.6	0.0	0.0	0.1	0.2	0.8	7.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.8	0.0	0.2	0.0	0.0	0.3	1.4	0.0	0.0	2.0	1.0	0.3	0.3	10.2	0.1	0.1	5.8	1.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	14.3	0.0	48.8	33.6	0.1	0.1	51.2	47.8	0.7	0.1	0.0	0.0	112.7	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.5	0.0	0.0	0.0	6.7	0.0	0.0	0.0
TRAV8-1		ENSG00000211782	"T cell receptor alpha variable 8-1"	A0A0A6YYK1	14	21797287-21797886	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 11.9"	"Cell type enriched"	"Detected in single"	9	"T-cells: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	43	"MAIT T-cell: 14.2;memory CD4 T-cell: 39.5;memory CD8 T-cell: 20.6;naive CD4 T-cell: 37.6;naive CD8 T-cell: 16.3;T-reg: 54.4"	"Lineage enriched"	"Detected in single"	77	"T-cells: 54.4"	"Not detected"	"Not detected"																	NA	NA						"unprognostic (8.53e-3)"	"unprognostic (1.98e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.34e-2)"		"unprognostic (4.86e-4)"	"unprognostic (2.84e-3)"	"unprognostic (8.19e-3)"	"unprognostic (1.90e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.54e-5)"	"unprognostic (2.60e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.86e-1)"	"unprognostic (5.72e-2)"	0.1	0.0	0.0	3.7	0.0	0.4	0.2	0.0	0.2	0.0	0.0	0.7	0.6	0.2	0.2	0.7	0.1	0.4	0.1	0.0	0.0	0.0	0.1	0.8	6.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.6	0.0	0.1	0.2	0.7	0.0	0.0	1.7	0.5	0.2	0.0	11.9	0.0	0.0	4.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.2	14.2	0.0	39.5	20.6	0.1	0.1	37.6	16.3	0.7	0.0	0.0	0.1	54.4	8.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0
TRBV6-6	"TCRBV13S6A2T, TCRBV6S6, TRBV66"	ENSG00000211724	"T cell receptor beta variable 6-6"	A0A0A6YYG2	7	142469537-142470013	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 14.8"	"Cell type enriched"	"Detected in single"	37	"T-cells: 3.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 81.4"	"Lineage enriched"	"Detected in single"	98	"T-cells: 81.4"	"Cell line enriched"	"Detected in some"	10	"HL-60: 10.4"															NA	NA						"unprognostic (1.69e-4)"	"unprognostic (3.82e-4)"	"unprognostic (3.66e-2)"	"unprognostic (2.55e-2)"	"unprognostic (8.55e-2)"	"unprognostic (9.93e-5)"	"unprognostic (4.36e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.42e-2)"	"unprognostic (5.90e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.78e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.22e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.01e-2)"	0.1	0.0	0.0	2.8	0.0	0.8	0.5	0.0	0.1	0.1	0.0	0.8	0.9	0.1	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.1	0.0	0.9	5.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.2	0.8	0.1	1.6	0.0	0.0	0.1	1.2	0.1	0.0	2.9	0.8	0.0	0.0	14.8	0.2	0.0	10.7	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.5	0.3	14.7	0.0	34.6	47.9	0.0	0.1	48.9	21.3	0.8	0.1	0.2	0.2	81.4	12.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0
TTLL7	FLJ23033	ENSG00000137941	"Tubulin tyrosine ligase like 7"	Q6ZT98	1	83865024-83999150	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Ligase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 56.6"	"Cell type enriched"	"Detected in many"	6	"Oligodendrocytes: 1558.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 28.4;RH-30: 22.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052249	Approved					NA	NA					"HPA052249: AB_2681773"	"unprognostic (9.68e-2)"	"unprognostic (3.78e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.82e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.63e-2)"	"unprognostic (7.93e-4)"	"unprognostic (4.34e-1)"	"unprognostic (1.84e-3)"	"unprognostic (3.32e-1)"	"unprognostic (2.67e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.04e-3)"	4.2	1.5	14.8	1.3	30.9	0.0	1.4	13.0	27.9	2.3	0.0	3.3	1.7	4.5	1.4	3.2	5.9	4.1	2.6	15.1	18.3	0.8	1.1	3.1	0.1	20.7	21.6	11.2	1.3	4.4	1.4	7.8	0.0	27.2	5.5	2.2	8.3	2.7	2.7	3.5	0.7	1.8	7.5	10.1	0.4	3.7	5.0	18.3	0.1	1.6	1.7	0.2	5.4	2.5	56.6	3.4	0.2	2.5	4.5	2.1	5.0	0.0	7.1	2.8	2.5	4.7	0.0	0.5	0.0	2.1	6.6	10.2	0.1	5.0	2.5	3.8	28.4	3.6	4.1	5.5	0.1	1.1	0.2	0.5	1.5	0.2	3.9	0.1	7.4	2.8	0.1	0.0	10.3	10.3	0.0	0.0	0.0	2.0	0.0	3.5	0.0	22.1	0.0	0.4	1.8	13.9	8.9	3.8	2.2	2.3	4.6	3.1	0.2	0.4	3.8	1.5	0.6	7.7	3.5	6.6	0.2	5.2	0.0	5.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	30.9	13.0	27.9	15.1	18.3	20.7	21.6	11.2	27.2	10.1	18.3	56.6	3.9	67.3	7.5	12.4	3.9	3.2	18.8	2.1	0.6	138.6	6.9	4.8	16.8	17.2	7.7	7.3	73.0	0.7	0.9	1.8	1.9	18.2	211.6	36.3	6.8	6.1	27.6	0.0	230.3	7.6	0.2	14.2	10.2	1.7	25.3	2.7	3.9	2.4	0.5	95.9	216.6	5.3	4.1	0.3	7.7	38.6	10.8	2.6	17.8	16.9	0.6	19.1	2.1	113.6	1558.6	4.3	4.7	84.7	12.5	22.5	0.4	13.8	30.8	118.4	19.7	68.0	44.9	68.2	45.7	2.7	2.0	0.7	3.0	1.1	1.3	26.5
VAX1		ENSG00000148704	"Ventral anterior homeobox 1"	Q5SQQ9	10	117128521-117138301	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	7	"brain: 3.7"	"Cell type enriched"	"Detected in some"	4	"Inhibitory neurons: 7.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"A-431: 3.1;WM-115: 2.3"	"Group enriched"	"Detected in some"	6	"basal ganglia: 5.6;hypothalamus: 3.2;olfactory bulb: 1.5"	"Low region specificity"	"Detected in some"			HPA028946	Uncertain		Approved	"Nucleoplasm,Nucleoli rim"		Yes	NA			"Nucleoli rim"	Nucleoplasm	"HPA028946: AB_10602679"		"unprognostic (1.08e-2)"		"unprognostic (1.92e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.96e-2)"		"unprognostic (5.77e-3)"	"unprognostic (2.19e-1)"			"unprognostic (1.17e-1)"		"unprognostic (5.72e-2)"	"unprognostic (2.09e-1)"		"unprognostic (2.99e-1)"	0.0	0.0	3.1	0.0	2.8	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.7	0.0	0.0	0.0	0.0	1.2	0.4	0.6	0.0	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.6	0.0	0.0	0.0	0.0	0.0	0.0	2.8	3.1	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	2.8	0.0	2.2	0.2	3.7	1.2	0.4	0.6	1.4	0.0	2.6	2.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
WFDC6	"C20orf171, dJ461P17.11, WAP6"	ENSG00000243543	"WAP four-disulfide core domain 6"	Q9BQY6	20	45534196-45539482	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"epididymis: 253.1"	"Cell type enriched"	"Detected in some"	4	"Respiratory ciliated cells: 34.2"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 0.9;testis cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"U-87 MG: 2.6"														"Secreted in male reproductive system"	NA	NA						"unprognostic (3.68e-3)"			"unprognostic (2.21e-3)"				"unprognostic (1.26e-2)"		"unprognostic (8.74e-2)"					"unprognostic (2.91e-2)"			0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.3	0.7	0.0	0.0	0.0	0.2	253.1	0.1	7.8	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	1.9	0.0	0.3	0.1	0.0	0.0	0.0	0.0	37.8	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	6.8	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	34.2	0.0	0.0	0.0	0.2	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1
XPNPEP2		ENSG00000122121	"X-prolyl aminopeptidase 2"	O43895	X	129738949-129769536	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"intestine: 168.0;kidney: 157.4"	"Cell type enriched"	"Detected in some"	6	"Proximal enterocytes: 475.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 18.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"gdT-cell: 4.3;intermediate monocyte: 1.4;MAIT T-cell: 1.2;memory CD4 T-cell: 1.3;memory CD8 T-cell: 2.8;naive CD8 T-cell: 2.0;non-classical monocyte: 2.8;T-reg: 1.4"	"Group enriched"	"Detected in many"	7	"monocytes: 2.8;T-cells: 4.3"	"Cell line enhanced"	"Detected in some"		"ASC diff: 8.2;ASC TERT1: 40.1;HSkMC: 21.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA000339, CAB025136, CAB025269, HPA064568"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		13000000	"Plasma membrane, Cytosol"		"CAB025136: , CAB025269: , HPA000339: AB_1858894, HPA064568: "	"unprognostic (7.95e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.21e-3)"	"unprognostic (3.54e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.26e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.07e-1)"	"unprognostic (9.28e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.53e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.26e-3)"	6.9	0.9	0.2	3.7	0.1	0.2	3.0	0.1	0.1	3.7	0.1	4.9	99.9	2.5	0.1	2.2	6.3	4.4	3.3	0.1	0.1	157.4	23.2	2.1	0.5	0.2	0.1	0.1	1.8	0.3	0.3	0.1	1.2	0.1	1.8	6.4	0.0	1.5	0.4	0.5	3.9	168.0	6.0	0.1	0.3	3.4	0.1	0.1	1.0	1.4	2.4	0.4	7.8	4.0	0.1	0.0	0.0	0.5	0.0	8.2	40.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.2	0.0	0.0	21.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	4.3	1.4	1.2	0.0	1.3	2.8	0.2	0.2	0.4	2.0	0.1	0.0	2.8	0.4	1.4	0.9	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	1.2	0.0	0.0	0.0	0.5	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.8	0.0	0.2	0.5	11.4	5.9	0.0	0.0	0.0	0.1	0.3	1.2	0.0	0.2	0.0	0.0	10.0	1.1	0.0	0.0	0.0	0.4	18.5	0.8	0.0	0.3	12.8	0.0	1.0	3.6	0.0	0.0	1.0	1.8	1.0	0.0	0.0	3.1	0.0	0.1	0.0	21.0	0.0	0.1	0.0	475.9	75.1	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	1.0	1.2	0.9	0.0	8.4	0.0
AATK	"AATYK, AATYK1, KIAA0641, LMR1, LMTK1, PPP1R77"	ENSG00000181409	"Apoptosis associated tyrosine kinase"	Q6ZMQ8	17	81110487-81166221	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 179.1"	"Cell type enriched"	"Detected in many"	5	"Oligodendrocytes: 243.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	11	"neutrophil: 2.0"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 2.0"	"Group enriched"	"Detected in some"	6	"CACO-2: 60.1;SH-SY5Y: 17.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009073	Enhanced		Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA009073: AB_1078076"	"unprognostic (3.47e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.95e-4)"	"unprognostic (1.96e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.29e-2)"	"unprognostic (9.85e-2)"	"unprognostic (6.09e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.88e-3)"	"unprognostic (2.48e-1)"	"unprognostic (4.28e-6)"	"unprognostic (1.58e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.57e-2)"	2.8	4.2	32.2	3.2	64.4	3.7	2.3	31.6	57.7	2.5	0.0	6.3	31.2	0.9	0.5	1.8	2.9	2.7	3.4	22.8	36.1	0.9	0.9	9.6	0.9	89.4	62.1	13.9	0.9	20.8	3.0	17.5	2.0	100.5	5.2	0.5	2.1	5.9	3.3	0.6	4.6	23.9	0.8	39.5	9.7	5.8	0.7	58.6	0.1	2.9	1.1	0.2	2.8	4.2	179.1	0.3	0.5	0.7	4.9	0.0	0.0	0.7	0.1	0.0	0.0	0.0	60.1	0.2	0.0	0.3	0.0	0.0	1.2	0.6	0.0	0.0	0.0	2.0	2.2	3.2	2.8	0.1	0.0	3.9	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	1.4	0.0	6.6	0.0	0.2	0.7	0.6	0.3	2.1	4.1	0.6	0.0	0.2	4.5	17.1	0.2	0.4	2.3	0.2	1.1	2.2	2.1	0.4	0.5	0.4	0.0	0.1	0.0	0.0	0.2	1.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.0	32.2	64.4	31.6	57.7	22.8	36.1	89.4	62.1	13.9	100.5	39.5	58.6	179.1	6.3	32.1	20.3	17.0	0.3	0.3	1.0	1.9	0.6	43.0	1.3	5.1	2.2	2.8	0.1	0.0	4.2	0.1	0.5	6.8	0.0	0.6	0.0	0.4	0.2	1.8	1.8	0.0	34.6	1.8	0.1	0.5	7.1	0.6	6.3	2.0	1.1	0.1	2.1	21.9	36.0	4.6	0.0	2.8	0.4	0.0	1.5	8.2	5.4	2.8	1.5	9.6	4.1	21.1	243.2	1.1	4.2	2.6	0.1	0.9	34.1	0.9	0.0	4.4	0.0	4.3	0.8	0.4	0.5	0.0	0.3	2.3	1.4	0.4	7.0	0.2
AC006059.2		ENSG00000280571	"Novel protein"		3	42705756-42804518	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in some"	6	"brain: 2.3;retina: 7.7"	"Cell type enriched"	"Detected in single"	4	"Alveolar cells type 1: 3.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047429			Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Centriolar satellite"	"Nucleoplasm, Cytosol"	"HPA047429: AB_2680043"	"unprognostic (1.72e-1)"	"unprognostic (4.20e-1)"			"unprognostic (8.65e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.02e-2)"	"unprognostic (8.28e-2)"	"unprognostic (1.40e-1)"		"unprognostic (1.72e-1)"	"unprognostic (4.32e-2)"	"unprognostic (5.96e-2)"	"unprognostic (6.09e-3)"		"unprognostic (2.99e-2)"	"unprognostic (3.01e-2)"	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.5	0.0	0.0	0.0	0.0	0.8	0.7	0.1	0.0	0.1	0.0		0.0	0.8	0.0	0.0	7.7	0.1	0.0	0.8	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0		2.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.2	0.6	0.5	0.5	0.8	0.7	0.1	0.8	0.6	0.8	2.3	0.0	3.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ANKRD62	DKFZp779B1634	ENSG00000181626	"Ankyrin repeat domain 62"	A6NC57	18	12093843-12129764	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	6	"brain: 1.1;pancreas: 1.0;testis: 1.6"	"Cell type enriched"	"Detected in some"	5	"Spermatocytes: 92.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA059835	Enhanced		Uncertain	"Nucleoplasm,Nuclear bodies,Actin filaments"		NA	NA			"Nucleoplasm, Nuclear bodies"	"Actin filaments"	"HPA059835: AB_2684136"	"unprognostic (2.45e-2)"	"unprognostic (1.18e-1)"		"unprognostic (2.37e-3)"	"unprognostic (9.46e-2)"	"unprognostic (3.01e-1)"		"unprognostic (1.98e-1)"		"unprognostic (6.61e-2)"	"unprognostic (7.95e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.55e-4)"	"unprognostic (1.13e-1)"	"unprognostic (3.28e-2)"	"unprognostic (4.52e-3)"	"unprognostic (8.70e-2)"	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.4	0.1	0.6	0.3	0.0	0.8	0.0	0.0	0.6	0.1	0.0	1.3	0.3	0.1	0.4	0.3	0.0	0.0	1.7	0.4	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	2.2	0.1	0.2	0.5	0.0	0.0	16.5	1.7	0.6	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.6	0.8	2.6	0.6	0.2	0.0	1.0	0.0	0.1	1.0	1.0	0.2	0.5	1.1	0.4	0.0	0.8	0.2	0.0	0.0	0.9	0.0	1.3	0.3	92.8	15.8	0.5	1.1	0.0	0.2	0.1	0.2	0.5
ANPEP	"CD13, gp150, LAP1, p150, PEPN"	ENSG00000166825	"Alanyl aminopeptidase, membrane"	P15144	15	89784895-89815401	"CD markers, Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Differentiation, Host-virus interaction"	"Aminopeptidase, Developmental protein, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"intestine: 2405.7;pancreas: 680.7"	"Cell type enriched"	"Detected in many"	14	"Proximal enterocytes: 6315.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"neutrophil: 227.1"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 227.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 613.7;ASC TERT1: 764.2;BJ: 738.4;BJ hTERT+: 1135.6;fHDF/TERT166: 703.8;HMC-1: 660.3;HSkMC: 670.0;HUVEC TERT2: 874.8;TIME: 815.1;U-2197: 891.4"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"spinal cord: 14.8"	"CAB002417, HPA004625"	Enhanced		Supported	"Plasma membrane"		NA	NA		1200000000	"Plasma membrane"		"CAB002417: AB_563491, HPA004625: AB_2667199"	"unprognostic (6.31e-2)"	"unprognostic (7.94e-3)"	"unprognostic (6.91e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.50e-1)"	"unprognostic (7.73e-2)"	"unprognostic (5.28e-3)"	"unprognostic (3.96e-1)"	"unprognostic (4.04e-3)"	"unprognostic (3.20e-2)"	"unprognostic (2.01e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.99e-2)"	41.7	7.1	1.8	37.0	1.8	104.4	56.4	1.5	8.2	41.7	3.8	269.3	2405.7	3.6	1.7	4.9	8.1	121.4	6.6	1.5	5.0	252.0	274.0	34.6	12.9	1.7	1.9	1.3	1.9	680.7	0.8	1.9	33.4	2.7	94.9	60.5	0.0	42.4	5.6	2.5	30.0	1986.9	30.0	1.4	26.1	8.1	2.1	13.4	7.2	8.3	3.8	4.7	17.0	15.1	4.1	0.1	45.6	0.0	0.5	613.7	764.2	6.2	738.4	1135.6	95.3	81.6	5.8	0.4	0.2	8.4	703.8	0.0	0.6	5.6	0.2	38.6	0.1	0.1	137.3	4.6	122.8	352.0	11.4	660.3	670.0	1.4	302.3	0.3	4.4	874.8	0.0	3.8	0.8	37.8	0.1	0.6	355.4	1.9	0.0	49.9	0.3	0.1	9.5	449.2	0.0	1.2	7.2	0.1	1.3	0.1	1.8	0.5	72.1	815.1	385.3	0.6	891.4	0.1	0.4	0.1	0.1	0.9	0.9	20.5	22.2	56.3	41.1	0.1	27.4	0.0	0.2	0.0	0.0	26.2	0.2	0.0	0.0	227.1	0.0	49.7	0.7	0.0	25.7	1.8	1.8	1.5	8.2	1.5	5.0	1.7	1.9	1.3	2.7	1.4	13.4	4.1	2.4	0.0	3.0	0.0	5.2	9.9	2.8	1.4	0.6	0.0	35.7	12.8	1.2	391.7	19.7	20.2	0.0	13.0	0.7	429.8	43.0	15.4	0.2	0.5	10.1	8.4	3.0	6.6	0.3	386.2	16.3	31.0	0.0	0.4	24.1	0.3	79.2	192.4	37.5	0.0	0.3	199.6	2.0	54.1	63.2	0.2	2.8	71.9	3.6	0.0	38.3	0.0	0.0	0.0	0.1	75.5	316.9	1.5	2.1	20.9	6315.2	435.0	3.3	0.0	26.3	0.8	8.1	0.3	0.5	0.2	5.8	6.4	3.7	187.8	290.9	1.4
AOX1	"AO, AOH1"	ENSG00000138356	"Aldehyde oxidase 1"	Q06278	2	200586014-200677064	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adrenal gland: 303.4;liver: 898.3"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 749.1"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 122.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 377.3;ASC TERT1: 191.5;HSkMC: 78.2;hTERT-HME1: 81.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA040199, HPA040215"	Enhanced					NA	NA		3300000			"HPA040199: AB_10795273, HPA040215: AB_10795360"	"unprognostic (4.39e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.17e-4)"	"unprognostic (1.92e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.93e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.00e-2)"	"prognostic favorable (6.05e-5)"	"unprognostic (1.33e-2)"	"unprognostic (8.16e-3)"	"unprognostic (3.38e-2)"	"unprognostic (4.99e-3)"	74.9	303.4	0.2	3.2	2.3	0.5	50.6	0.1	1.4	15.9	3.8	11.9	0.8	10.9	12.4	8.3	48.6	9.9	9.6	0.6	0.5	104.2	898.3	19.7	4.8	2.7	0.7	0.3	48.4	85.7	1.3	2.9	1.7	4.9	22.5	4.5	0.5	15.5	28.5	13.0	19.6	12.8	7.2	0.1	4.1	14.4	19.6	3.0	2.0	17.8	11.1	1.5	38.9	17.8	2.8	0.6	0.2	0.0	0.0	377.3	191.5	0.2	6.6	12.2	5.4	9.7	0.0	0.1	0.1	0.5	8.4	2.3	0.2	0.1	18.6	22.0	0.2	0.6	0.0	4.6	20.7	25.4	0.9	0.0	78.2	4.6	26.1	81.2	5.4	0.2	0.2	0.2	0.1	18.3	0.5	0.0	0.1	8.0	0.1	5.2	0.0	0.5	0.1	0.2	0.2	0.4	0.3	4.8	0.0	0.3	0.4	0.1	0.2	31.9	13.8	11.2	0.2	2.5	0.2	0.1	2.6	10.7	0.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.3	0.1	1.4	0.6	0.5	2.7	0.7	0.3	4.9	0.1	3.0	2.8	1.0	3.2	1.1	0.7	3.6	1.8	0.5	1.2	1.2	0.1	0.2	0.3	0.9	17.2	0.1	3.7	0.0	0.1	0.0	0.1	11.7	0.7	0.8	0.4	3.0	2.6	3.0	37.5	0.9	26.2	0.2	22.9	0.0	8.2	0.0	0.1	15.4	749.1	0.4	0.0	2.5	0.1	2.0	19.8	3.6	4.4	74.0	1.7	3.6	1.0	0.0	0.6	0.0	5.0	6.9	11.5	0.0	82.0	0.0	7.5	0.1	162.2	0.1	0.1	0.0	5.3	3.0	0.8	1.3	0.1	1.6	0.0	2.0	2.3	0.1	0.4
BBOX1	"BBH, BBOX, G-BBH, gamma-BBH"	ENSG00000129151	"Gamma-butyrobetaine hydroxylase 1"	O75936	11	27040725-27127809	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carnitine biosynthesis"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"kidney: 472.3;liver: 133.0"	"Cell type enriched"	"Detected in many"	7	"Proximal tubular cells: 1623.0"	"Group enriched"	"Detected in many"	6	"glioma: 23.7;renal cancer: 59.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"hTCEpi: 13.7;RPTEC TERT1: 7.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA007600, HPA027823"	Enhanced	Approved	Uncertain	"Vesicles,Actin filaments"		NA	NA		35000	Vesicles	"Actin filaments"	"HPA007600: AB_1845284, HPA027823: AB_10602394"	"unprognostic (9.96e-3)"	"unprognostic (1.80e-2)"	"unprognostic (8.17e-2)"	"prognostic unfavorable (6.65e-4)"	"unprognostic (7.03e-2)"	"unprognostic (6.66e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.13e-2)"	"unprognostic (3.03e-1)"	"unprognostic (6.89e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (1.45e-5)"	"unprognostic (1.71e-2)"	"unprognostic (2.70e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.73e-3)"	1.4	0.0	23.8	0.0	22.3	0.0	25.3	29.8	34.2	2.7	16.9	0.2	0.0	0.1	8.1	17.7	9.0	9.7	0.0	22.4	24.7	472.3	133.0	0.3	0.1	28.0	28.7	20.9	0.0	0.8	0.0	7.0	0.3	32.7	0.6	0.0	0.4	6.2	4.1	0.9	52.3	0.0	0.0	27.9	0.0	0.2	0.1	26.8	1.1	9.7	0.0	0.6	0.1	11.4	26.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.9	13.7	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.2	2.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	22.3	29.8	34.2	22.4	24.7	28.0	28.7	20.9	32.7	27.9	26.8	26.3	0.1	0.0	0.6	66.3	5.3	8.2	9.0	80.9	0.6	0.0	16.3	11.0	0.0	15.7	18.1	46.0	0.0	0.3	0.2	0.0	223.0	0.7	1.1	10.3	0.1	0.3	0.0	0.0	1.1	0.0	0.0	0.4	0.0	0.9	0.0	0.1	0.4	27.9	0.0	0.0	0.8	0.0	12.2	0.6	1.1	1.1	0.0	7.1	1.8	4.7	0.0	13.8	0.0	2.0	0.3	0.1	0.0	0.4	0.0	0.2	0.0	1623.0	9.4	0.4	0.0	0.0	1.4	0.0	0.6	16.9	35.8	0.3	5.0	0.0	0.0	2.6
C11orf71	FLJ20010	ENSG00000180425	"Chromosome 11 open reading frame 71"	Q6IPW1	11	114391443-114400511	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"testis: 140.1"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 2360.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 23.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063943, HPA074787"			Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA063943: AB_2685157, HPA074787: AB_2686712"	"unprognostic (1.24e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.42e-2)"	"prognostic favorable (6.94e-4)"	"unprognostic (7.35e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.30e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.04e-3)"	"unprognostic (1.39e-2)"	"unprognostic (2.85e-2)"	"prognostic favorable (7.01e-9)"	"unprognostic (5.68e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.17e-2)"	5.4	10.7	12.5	5.1	13.8	3.8	7.7	12.7	13.9	5.5	11.2	6.9	7.7	5.1	22.8	4.3	7.2	4.4	8.4	12.1	14.9	14.0	22.3	6.0	6.7	14.4	13.7	12.3	7.2	8.8	9.0	13.5	3.7	13.8	8.6	6.3	16.1	9.9	5.8	15.2	8.9	7.6	2.9	12.2	9.4	7.4	140.1	13.1	9.0	12.5	15.3	4.8	4.6	4.1	16.5	1.2	3.9	4.2	13.6	6.2	3.6	2.9	0.6	1.7	1.7	1.5	3.0	23.6	6.8	7.8	1.0	8.1	6.3	2.8	2.9	2.1	7.5	1.6	5.1	3.2	6.9	5.9	3.0	5.5	5.9	3.2	2.2	6.7	1.9	2.1	10.8	5.1	6.0	3.2	5.5	5.5	4.6	2.2	5.5	2.5	3.9	3.4	17.3	3.8	3.0	11.6	4.6	15.3	1.8	2.4	4.4	11.5	1.6	2.1	0.4	5.9	4.6	1.2	5.8	10.1	5.2	0.9	6.9	1.7	15.9	15.4	10.3	8.8	9.8	5.5	5.9	5.7	6.0	9.3	8.3	9.5	9.9	12.3	12.1	11.9	12.0	7.1	10.1	12.5	13.8	12.7	13.9	12.1	14.9	14.4	13.7	12.3	13.8	12.2	13.1	16.5	12.7	3.2	13.4	5.2	8.0	2.7	15.7	6.3	8.6	10.3	18.3	15.9	19.0	0.0	6.2	5.5	4.2	16.1	6.4	15.0	82.2	15.7	589.6	21.2	8.1	8.7	18.1	7.2	4.7	18.9	3.4	9.5	18.8	12.8	6.3	14.1	0.0	0.0	11.5	13.5	5.6	16.7	10.2	0.0	4.1	2360.8	13.1	13.6	5.4	2.8	11.2	31.5	7.2	4.0	18.5	10.5	15.5	9.1	17.2	9.2	33.0	78.6	18.9	14.1	6.6	7.6	8.0	70.6	9.9	10.4	2.6	14.6	7.4	19.6	12.7	11.4
C22orf15	"FLJ36561, N27C7-3"	ENSG00000169314	"Chromosome 22 open reading frame 15"	Q8WYQ4	22	23762990-23765863	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"fallopian tube: 18.4"	"Cell type enriched"	"Detected in some"	5	"Respiratory ciliated cells: 198.2"	"Cancer enriched"	"Detected in single"	4	"endometrial cancer: 1.7"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AF22: 1.2;BJ: 1.2;BJ hTERT+: 2.3;hTERT-RPE1: 3.2;MOLT-4: 1.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"								"Secreted in female reproductive system"	NA	NA						"unprognostic (2.37e-2)"	"unprognostic (3.28e-3)"	"unprognostic (1.28e-1)"	"prognostic favorable (8.53e-5)"	"unprognostic (1.86e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.38e-2)"	"unprognostic (6.14e-2)"	"unprognostic (3.60e-2)"	"unprognostic (7.70e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.79e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.08e-3)"	0.0	0.0	0.8	0.0	0.2	0.3	0.1	0.4	0.2	0.4	0.4	0.1	0.0	0.2	0.0	0.0	18.4	0.2	0.0	0.2	1.1	0.1	0.0	1.8	0.1	1.0	1.1	0.1	0.5	0.0	0.0	1.1	0.2	1.0	0.3	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.1	1.1	0.2	0.1	2.8	0.5	1.1	0.0	0.0	0.2	0.2	0.1	0.3	0.0	0.1	1.2	0.0	0.0	0.0	0.0	1.2	2.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	3.2	0.3	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.1	0.3	0.2	0.1	0.1	0.5	0.2	0.0	0.0	0.0	1.0	0.0	0.1	0.8	0.2	0.4	0.2	0.2	1.1	1.0	1.1	0.1	1.0	1.1	0.5	0.3	0.0	0.0	1.8	1.3	0.0	0.1	0.0	9.1	0.0	0.5	0.0	0.5	0.1	0.0	15.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	6.0	35.8	0.2	0.2	0.0	0.4	2.3	0.0	0.0	1.4	0.0	0.3	2.5	0.1	0.7	0.1	0.0	0.0	2.0	0.0	16.2	0.3	0.4	3.5	0.0	0.3	0.0	1.0	0.1	0.2	0.0	0.5	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	198.2	1.9	0.0	0.1	3.5	10.9	4.2	0.0	0.3	0.0	1.0	0.5	0.0	0.1
C2CD6	"ALS2CR11, FLJ25351"	ENSG00000155754	"C2 calcium dependent domain containing 6"	Q53TS8	2	201487421-201619178	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 40.2"	"Cell type enriched"	"Detected in some"	21	"Theca cells: 41.0"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.9;HSkMC: 2.0;hTEC/SVTERT24-B: 2.0;SCLC-21H: 2.3;THP-1: 2.0;U-2197: 7.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.64e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.77e-3)"	"unprognostic (7.13e-6)"	"unprognostic (1.33e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.81e-2)"	"unprognostic (3.15e-2)"	"unprognostic (6.53e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.10e-1)"	"unprognostic (5.13e-10)"	"unprognostic (1.95e-1)"	"unprognostic (6.35e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.18e-1)"	0.6	0.7	2.3	0.0	2.1	0.0	0.3	2.2	1.0	0.1	0.7	0.1	0.1	0.2	0.1	0.2	0.1	0.4	1.2	0.6	2.0	0.1	0.1	0.3	0.2	4.6	2.5	0.1	0.7	0.0	0.0	0.7	0.1	4.1	0.3	0.0	0.9	0.1	0.1	0.1	0.1	0.1	0.2	5.2	0.1	0.0	40.2	2.9	0.0	0.1	0.0	0.0	0.1	0.1	6.5	0.0	0.0	0.0	0.0	0.2	1.9	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	2.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.1	0.2	0.1	0.0	2.0	0.0	0.0	0.5	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.3	2.1	2.2	1.0	0.6	2.0	4.6	2.5	0.1	4.1	5.2	2.9	6.5	0.3	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.0	1.9	0.0	0.0	0.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	41.0	0.0	0.0
CABP7	MGC57793	ENSG00000100314	"Calcium binding protein 7"	Q86V35	22	29720003-29731833	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 35.2"	"Cell type enriched"	"Detected in some"	19	"Cardiomyocytes: 28.6"	"Group enriched"	"Detected in some"	4	"glioma: 2.3;ovarian cancer: 1.0;pancreatic cancer: 3.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"HEL: 10.3;SCLC-21H: 9.7;SH-SY5Y: 3.1;U-2 OS: 3.1"	"Group enriched"	"Detected in all"	4	"cerebellum: 74.4;hippocampal formation: 204.8;midbrain: 60.3;pons and medulla: 110.0"	"Region enhanced"	"Detected in all"		"hippocampal formation: 51.0"	HPA016439	Uncertain					NA	NA					"HPA016439: AB_2669357"	"unprognostic (1.88e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.55e-1)"	"unprognostic (2.29e-4)"	"unprognostic (2.05e-3)"	"unprognostic (7.96e-2)"	"unprognostic (8.69e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.44e-7)"	"unprognostic (1.25e-4)"	"unprognostic (3.60e-2)"	"unprognostic (2.71e-1)"	"unprognostic (4.72e-3)"	0.1	5.6	4.6	0.0	4.2	0.2	0.1	18.8	35.2	0.1	0.6	0.6	0.4	0.1	0.0	0.1	0.1	0.0	0.1	34.2	3.6	0.1	0.3	0.1	0.1	26.1	10.6	3.4	0.1	3.2	0.0	0.4	0.0	27.0	0.4	0.0	1.0	0.2	0.0	0.1	0.2	1.5	0.0	20.4	0.4	0.3	0.6	4.8	0.0	0.3	0.0	0.0	0.1	0.1	18.5	0.1	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.5	10.3	0.3	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.3	0.0	0.0	9.7	3.1	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.1	3.1	0.1	0.2	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.0	0.0	0.1	4.6	4.2	18.8	35.2	34.2	3.6	26.1	10.6	3.4	27.0	20.4	4.8	18.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.1	28.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.8	0.0	0.0	1.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	1.1	0.5	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	1.5	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.1	0.0
CASQ2	PDIB2	ENSG00000118729	"Calsequestrin 2"	O14958	1	115700021-115768714	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Muscle protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"heart muscle: 1066.4"	"Cell type enriched"	"Detected in some"	8	"Cardiomyocytes: 777.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 5.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	19	"HSkMC: 13.6"	"Region enriched"	"Detected in all"	6	"cerebellum: 43.1"	"Low region specificity"	"Detected in all"			"HPA027285, HPA055298"	Enhanced				"Intracellular and membrane"	NA	NA					"HPA027285: AB_1845933, HPA055298: AB_2682777"	"unprognostic (1.13e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.41e-2)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (1.03e-4)"	"unprognostic (1.78e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.34e-1)"	"unprognostic (8.92e-2)"	"unprognostic (7.20e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (2.25e-5)"	32.1	3.1	3.8	6.4	2.3	0.0	9.0	3.1	3.6	7.2	3.8	40.8	3.4	17.3	6.6	38.8	14.8	6.7	1066.4	2.0	3.7	3.4	0.6	5.4	0.8	2.1	5.0	1.8	5.3	1.2	1.6	1.0	1.6	2.3	13.9	17.2	0.3	7.7	20.4	183.8	3.7	9.2	39.5	2.1	0.8	14.3	1.5	7.8	1.6	4.1	166.5	1.3	44.3	7.0	2.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	2.3	3.1	3.6	2.0	3.7	2.1	5.0	1.8	2.3	2.1	7.8	2.2	2.7	0.0	0.0	0.3	0.0	0.6	0.3	0.0	0.6	0.2	0.1	0.4	777.8	0.0	0.0	1.8	0.0	0.4	0.1	0.0	0.0	0.0	15.5	0.3	0.0	4.8	0.0	0.0	0.7	0.0	0.3	17.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	20.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.0	1.3	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	92.1	11.0	73.4	0.1	0.4	0.2	0.3	0.0	0.1	0.0	0.0	0.0
CCDC89	FLJ38159	ENSG00000179071	"Coiled-coil domain containing 89"	Q8N998	11	85683848-85686195	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 44.0"	"Cell type enriched"	"Detected in some"	9	"Early spermatids: 434.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"LHCN-M2: 3.1;SCLC-21H: 3.9;U-2197: 4.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040628	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA040628: AB_2677053"	"unprognostic (5.81e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.04e-2)"	"unprognostic (5.37e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.92e-2)"	"unprognostic (8.22e-2)"	"unprognostic (2.87e-1)"	"unprognostic (9.16e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.41e-3)"	"unprognostic (7.75e-3)"	"unprognostic (5.10e-2)"	"unprognostic (8.47e-2)"	"unprognostic (3.52e-1)"	0.6	0.9	1.2	0.3	0.7	0.0	1.3	1.5	0.7	1.0	0.9	0.6	0.3	2.6	1.0	0.3	7.9	1.0	1.0	0.5	1.5	1.1	0.2	1.1	0.3	1.5	1.2	0.5	4.8	0.1	1.3	1.3	0.7	1.5	1.3	0.7	1.6	0.3	1.5	0.4	0.4	0.5	1.5	1.6	0.5	1.1	44.0	0.8	0.4	0.2	0.4	0.1	0.8	0.6	1.2	0.0	0.0	0.0	0.0	2.3	2.6	0.1	0.7	0.0	0.0	0.0	0.1	0.0	0.1	2.5	2.1	2.5	0.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	1.1	0.0	0.0	1.5	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	2.2	0.0	0.1	1.3	3.9	0.9	0.0	0.4	0.0	0.0	0.3	0.0	0.0	2.1	0.0	4.8	1.7	0.0	2.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.7	1.5	0.7	0.5	1.5	1.5	1.2	0.5	1.5	1.6	0.8	1.2	0.1	0.0	0.6	1.0	0.0	0.3	0.1	1.0	0.0	0.3	0.4	0.4	0.1	0.0	1.8	0.0	0.0	0.0	0.2	0.2	0.0	0.1	434.9	7.3	2.0	0.4	0.0	0.0	0.5	0.0	0.1	1.7	0.0	0.2	0.0	0.4	0.4	0.0	1.7	6.7	0.6	0.1	2.0	0.8	0.0	43.1	3.1	0.2	0.0	1.9	0.0	1.0	0.0	0.5	0.5	0.0	0.0	4.5	0.4	0.0	0.0	1.5	30.2	0.8	0.0	1.7	1.4	45.9	1.4	0.0	0.3	0.0	0.2	0.8	0.0	0.1
CERS1	"LAG1, LASS1, UOG1"	ENSG00000223802	"Ceramide synthase 1"	P27544	19	18868545-18896727	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase	"Disease variant, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 288.3;choroid plexus: 74.8"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 126.6"	"Group enriched"	"Detected in many"	5	"glioma: 13.5;melanoma: 4.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 32.1;HEK 293: 34.7;NB-4: 39.3;NTERA-2: 25.2"									HPA045724	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA045724: AB_10969762"	"unprognostic (8.25e-2)"	"unprognostic (8.91e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.59e-2)"	"unprognostic (6.47e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.02e-1)"	"unprognostic (7.04e-3)"	"unprognostic (3.52e-3)"	"unprognostic (1.92e-1)"	"unprognostic (4.59e-2)"	"unprognostic (2.99e-2)"	"unprognostic (3.15e-2)"	"unprognostic (9.15e-2)"	"unprognostic (3.49e-1)"	0.9	3.1	190.1	0.8	203.8	0.2	0.6	242.3	218.3	2.0	74.8	2.6	0.1	0.7	0.5	1.0	0.7	2.5	2.9	196.1	177.3	0.3	0.2	0.5	0.0	288.3	211.2	151.5	2.8	0.9	2.9	12.9	0.3	226.5	1.5	0.3	4.9	0.9	0.5	21.5	0.6	1.0	1.5	230.7	0.2	1.3	29.6	221.9	0.3	1.1	12.4	0.1	1.7	1.7	238.2	0.2	3.3	19.1	32.1	1.1	0.4	0.8	2.2	0.1	5.4	3.9	15.7	1.2	0.1	22.0	1.4	4.4	0.3	13.8	0.6	2.1	0.0	34.7	0.2	0.7	11.7	2.4	3.4	0.5	1.2	0.2	1.7	0.6	6.0	1.3	0.2	2.2	0.2	3.7	8.4	0.3	39.3	25.2	0.1	0.7	0.2	0.6	0.7	4.1	0.0	17.8	15.8	0.8	0.1	14.1	6.0	5.5	20.5	0.5	0.1	4.3	3.4	4.8	0.7	0.5	0.1	0.2	1.2	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	190.1	203.8	242.3	218.3	196.1	177.3	288.3	211.2	151.5	226.5	230.7	221.9	238.2	0.2	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	3.6	0.6	1.3	0.6	0.0	0.0	0.0	2.1	0.0	0.1	0.2	0.0	0.0	21.1	0.3	0.4	0.6	0.0	0.0	0.0	0.2	0.0	1.0	0.0	1.1	0.0	1.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	126.6	1.2	0.2	1.8	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.1	0.0	1.6	0.0	1.0	0.4	1.4	2.9	0.0	0.4	0.3	0.1	0.4	0.0	0.0
CGA	"FSHA, GPA1, GPHa, GPHA1, HCG, LHA, TSHA"	ENSG00000135346	"Glycoprotein hormones, alpha polypeptide"	P01215	6	87085498-87095106	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"pituitary gland: 4423.7"	"Cell type enriched"	"Detected in some"	15	"Syncytiotrophoblasts: 85317.2"	"Cancer enhanced"	"Detected in many"		"breast cancer: 10.9;testis cancer: 13.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	28	"BEWO: 776.1;SuSa: 1437.9"	"Region enriched"	"Detected in many"	6	"hypothalamus: 22.2"	"Region enriched"	"Detected in many"	40	"hypothalamus: 82.2"	"CAB023350, HPA029698"	Enhanced				"Secreted to blood"	NA	NA					"CAB023350: AB_617281, HPA029698: AB_2673153"	"unprognostic (1.66e-1)"	"unprognostic (2.10e-1)"		"unprognostic (3.22e-5)"	"unprognostic (1.46e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.69e-2)"	"unprognostic (3.17e-1)"			"unprognostic (7.04e-3)"	"unprognostic (1.51e-1)"		"unprognostic (2.85e-1)"	"unprognostic (4.32e-2)"	"unprognostic (8.32e-2)"	"unprognostic (9.15e-3)"	0.5	4.1	0.2	0.1	0.5	2.0	0.1	0.5	0.6	0.0	0.3	0.3	0.5	1.0	1.2	1.2	0.1	0.2	1.2	0.2	0.6	2.7	2.0	0.7	0.3	1.6	1.0	0.3	0.5	1.3	19.0	4423.7	732.2	1.0	2.7	0.3	0.3	0.5	1.1	3.3	1.9	0.3	3.4	0.2	1.1	38.4	0.5	0.6	0.8	0.5	0.0	0.3	0.4	0.2	1.3	0.0	1.0	0.0	0.1	0.0	0.0	776.1	0.7	0.6	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.9	4.2	1.8	0.3	40.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.2	0.1	0.0	0.3	0.0	0.1	1.0	0.6	0.1	22.6	0.0	1437.9	0.1	0.0	0.0	0.9	0.2	0.4	0.3	3.1	0.4	0.5	0.2	0.0	0.1	0.7	0.2	0.1	0.3	0.0	0.1	0.2	0.1	0.3	0.1	0.4	0.2	0.4	0.6	0.2	0.3	0.4	0.1	0.0	0.2	0.5	0.5	0.6	0.2	0.6	1.6	1.0	0.3	1.0	0.2	0.6	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.9	1.9	0.0	0.0	7.3	0.0	1414.2	0.1	0.0	0.0	0.0	0.2	20.2	1.1	22.9	1.8	0.0	0.2	0.0	5400.7	65.5	0.0	28.4	0.0	0.0	0.0	0.0	625.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.4	0.0	0.0	85317.2	6.0	0.0	0.2	9.9
CHRNA3		ENSG00000080644	"Cholinergic receptor nicotinic alpha 3 subunit"	P32297	15	78593052-78621295	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"adrenal gland: 39.6;lymphoid tissue: 66.4;retina: 53.9"	"Cell type enriched"	"Detected in some"	19	"Cone photoreceptor cells: 164.7"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SH-SY5Y: 356.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA029430	Enhanced		Supported	"Nuclear speckles,Plasma membrane"		NA	NA			"Plasma membrane"	"Nuclear speckles"	"HPA029430: AB_10603785"	"unprognostic (2.28e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.16e-3)"	"unprognostic (1.97e-1)"	"unprognostic (4.28e-2)"	"unprognostic (7.20e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.86e-4)"	"unprognostic (2.65e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.48e-1)"	0.4	39.6	3.9	5.2	2.0	0.0	0.1	6.2	2.3	0.6	0.7	6.5	1.5	0.5	0.0	0.1	0.0	0.3	0.3	0.8	2.0	0.0	0.0	0.2	0.3	3.0	6.7	0.5	0.1	0.2	0.0	1.2	0.1	6.6	0.2	4.1	53.9	0.1	0.0	0.1	0.5	3.0	3.8	0.3	0.1	2.8	1.0	9.1	66.4	0.2	0.0	0.9	0.2	0.7	1.1	0.1	0.3	0.7	0.6	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.0	1.5	0.0	8.8	0.0	0.0	0.3	1.4	0.5	0.4	0.1	0.0	0.1	4.0	0.0	0.3	0.0	0.0	0.0	0.0	22.6	0.2	0.0	0.0	0.3	7.1	0.0	1.6	0.1	0.2	0.4	0.3	0.1	0.0	0.4	67.7	356.1	0.3	0.1	0.1	0.5	0.4	0.0	0.0	0.1	1.7	0.1	0.4	0.2	0.7	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	2.0	6.2	2.3	0.8	2.0	3.0	6.7	0.5	6.6	0.3	9.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.8	0.0	0.0	0.0	164.7	0.0	0.0	0.2	1.9	0.0	3.7	0.1	1.2	0.4	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.2	1.7	0.4	3.6	0.0	0.0	0.0	3.5	0.0	0.2	0.0	0.0	0.0	3.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.1	0.1	0.3	2.1	0.0	0.0	0.0	0.0	2.6	0.1	0.1
CHST4	"HEC-GLCNAC-6-ST, LSST"	ENSG00000140835	"Carbohydrate sulfotransferase 4"	Q8NCG5	16	71525233-71538748	"Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Inflammatory response"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"gallbladder: 70.0"	"Cell type enriched"	"Detected in some"	24	"Cholangiocytes: 165.8"	"Cancer enriched"	"Detected in many"	6	"pancreatic cancer: 10.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 8.6;HL-60: 2.7;NB-4: 5.0;NTERA-2: 7.5;SCLC-21H: 3.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA021955	Enhanced				"Intracellular and membrane"	NA	NA					"HPA021955: AB_1846723"	"unprognostic (2.22e-3)"	"unprognostic (1.41e-1)"	"unprognostic (8.87e-2)"	"unprognostic (3.35e-2)"	"unprognostic (4.76e-3)"	"unprognostic (6.86e-2)"	"prognostic unfavorable (9.24e-4)"	"unprognostic (1.26e-1)"		"unprognostic (1.70e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.27e-6)"	"unprognostic (1.46e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.73e-1)"	0.2	1.3	0.2	0.2	0.1	0.0	0.2	0.1	0.1	2.5	1.4	0.0	0.0	0.1	0.0	0.2	5.4	70.0	0.0	0.1	0.2	0.0	4.4	0.2	1.3	0.3	0.3	0.0	0.0	12.5	0.0	0.5	0.0	0.4	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.0	0.1	0.2	0.0	0.0	2.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.3	0.1	0.0	0.3	0.1	0.0	0.6	0.1	0.0	0.2	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	7.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	2.1	0.1	1.5	0.0	0.0	1.6	0.0	0.1	0.1	0.0	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.2	0.3	0.3	0.0	0.4	0.3	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.0	0.1	165.8	6.7	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	3.7	0.4	0.0	0.0	0.0	0.4	0.7	0.0	0.3	0.0	3.8	0.0	0.1	0.0	0.3	0.0	0.0	0.2	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
CLDN15		ENSG00000106404	"Claudin 15"	P56746	7	101232092-101238820	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"intestine: 262.2"	"Cell type enriched"	"Detected in many"	4	"Proximal enterocytes: 594.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (8.85e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.79e-1)"	"prognostic favorable (2.56e-4)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (5.31e-5)"	"unprognostic (9.98e-2)"	"unprognostic (2.89e-2)"	"unprognostic (9.64e-2)"	"prognostic favorable (3.30e-4)"	42.1	3.9	8.8	7.4	9.4	13.7	20.4	8.3	11.1	14.8	5.8	15.8	262.2	11.2	2.3	7.3	16.5	7.4	7.7	7.2	7.5	15.2	22.4	10.8	9.9	10.0	8.7	6.5	18.7	7.8	2.0	6.9	6.0	10.0	11.5	7.9	8.9	6.5	2.6	3.6	11.0	185.5	4.5	8.0	22.8	10.1	8.3	8.6	8.8	9.3	1.3	7.1	9.9	11.7	17.4	3.3	10.1	5.3	8.4	8.1	6.5	3.6	3.2	4.0	3.9	5.6	7.3	3.8	11.0	5.6	2.1	6.4	6.1	8.8	1.8	3.8	13.8	18.5	5.1	6.9	9.0	7.1	5.7	10.6	6.2	8.8	5.1	6.7	8.3	3.3	10.9	24.3	17.4	3.0	11.7	9.1	32.6	4.1	4.9	6.9	12.3	4.5	9.3	2.3	4.1	5.1	18.1	2.9	5.5	16.4	7.2	5.1	11.4	4.7	12.8	11.0	19.5	3.9	18.3	24.9	11.7	3.6	14.9	7.5	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.3	0.0	0.1	0.1	0.2	0.2	0.2	0.1	0.1	0.3	0.1	0.2	8.8	9.4	8.3	11.1	7.2	7.5	10.0	8.7	6.5	10.0	8.0	8.6	17.4	27.3	3.2	1.1	4.9	5.2	6.8	5.4	12.9	5.2	20.4	7.5	6.1	1.2	18.6	8.2	22.0	31.3	5.1	6.3	18.9	13.7	5.6	17.1	8.6	3.8	22.4	12.1	16.8	1.5	6.5	3.8	17.2	9.2	7.1	0.0	5.2	7.5	10.6	2.7	15.2	1.4	55.7	16.2	4.6	7.5	4.1	15.2	4.0	7.2	4.7	5.1	4.4	10.3	0.5	10.5	6.6	93.1	2.2	1.2	6.1	594.4	3.5	10.1	20.2	6.6	6.4	5.1	5.8	7.2	3.4	5.3	5.1	5.5	3.2	120.6	3.9
CNP		ENSG00000173786	"2',3'-cyclic nucleotide 3' phosphodiesterase"	P09543	17	41966763-41977740	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"brain: 1435.7"	"Cell type enriched"	"Detected in all"	4	"Oligodendrocytes: 555.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 149.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"white matter: 1789.4"	"Low region specificity"	"Detected in all"			"CAB002672, HPA023266, HPA023278, HPA023280, HPA023338"	Enhanced	Supported	Supported	"Plasma membrane"		NA	NA		46000	"Plasma membrane"		"CAB002672: , HPA023266: AB_1847058, HPA023278: AB_1847060, HPA023280: AB_1847061, HPA023338: AB_1847062"	"unprognostic (2.17e-1)"	"unprognostic (4.48e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.09e-1)"	"unprognostic (9.71e-2)"	"unprognostic (2.58e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.76e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.10e-3)"	32.2	33.8	516.4	31.5	867.4	23.6	29.8	717.0	656.9	38.7	236.8	46.4	21.6	33.8	37.0	63.9	29.2	32.9	24.6	510.3	646.1	42.9	45.2	21.9	36.0	983.4	801.8	404.4	32.5	28.1	23.9	28.3	23.7	889.5	41.9	18.6	20.7	47.6	37.5	26.6	34.6	31.7	30.5	735.6	26.0	30.1	16.8	717.3	31.4	24.9	22.4	35.4	37.6	40.8	1435.7	56.9	92.4	85.8	106.6	71.7	67.2	38.5	70.1	102.5	171.1	191.5	73.0	49.6	59.0	54.3	88.5	88.1	95.0	58.3	44.6	59.0	59.7	76.8	56.7	59.3	127.7	76.9	56.7	49.6	111.0	31.5	94.1	22.8	61.9	79.4	58.0	42.4	46.4	60.6	35.1	148.5	50.9	20.7	29.8	66.5	91.4	126.7	58.7	45.7	55.7	50.9	69.5	85.7	127.0	155.5	41.6	57.2	82.3	80.2	66.6	73.7	92.3	81.9	53.4	66.6	47.5	66.1	42.9	266.4	18.7	38.2	23.4	21.5	40.7	17.2	28.0	18.8	17.4	33.8	19.2	16.6	19.6	7.7	23.5	34.0	149.4	22.4	33.0	516.4	867.4	717.0	656.9	510.3	646.1	983.4	801.8	404.4	889.5	735.6	717.3	1435.7	26.6	16.0	12.7	14.4	19.0	16.7	17.5	10.4	16.5	22.0	29.5	24.0	13.0	20.0	19.5	35.0	6.2	30.6	53.2	39.9	125.2	46.3	1.3	19.1	27.1	24.8	19.7	25.2	6.8	41.7	50.2	27.7	17.9	21.3	9.5	20.2	20.3	32.3	39.8	50.5	9.5	16.2	18.3	17.0	14.5	4.0	38.8	20.3	55.2	14.0	25.0	84.7	23.7	45.2	555.6	35.5	19.0	36.1	27.8	21.7	19.0	80.5	12.8	25.4	32.9	36.6	29.4	5.1	16.0	30.9	18.9	13.0	16.9	33.3	20.6	17.4
CRYGD	CRYG4	ENSG00000118231	"Crystallin gamma D"	P07320	2	208121607-208124524	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Eye lens protein"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"ovary: 8.1"	"Cell type enriched"	"Detected in some"	4	"Granulosa cells: 140.2"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	20	"HEL: 10.0"					"Not detected"	"Not detected"			"HPA041269, HPA043386"	Supported		Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA041269: AB_2732491, HPA043386: "					"unprognostic (4.49e-2)"						"unprognostic (2.64e-1)"				"unprognostic (3.62e-1)"			0.0	0.0	0.5	0.0	0.4	1.3	0.0	0.2	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.4	0.6	0.0	0.0	0.0	0.0	0.5	0.7	0.4	8.1	0.0	0.0	0.4	0.0	0.6	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	1.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.2	0.8	0.4	0.6	0.5	0.7	0.4	0.6	0.3	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.1	0.0	4.6	0.3	0.0	0.1	0.9	0.0	0.0	0.0	140.2	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	4.2	0.0	0.4	0.0	0.0	0.0	34.5	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.9	0.1	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
CTLA4	"CD, CD152, CELIAC3, CTLA-4, GSE, IDDM12"	ENSG00000163599	"Cytotoxic T-lymphocyte associated protein 4"	P16410	2	203867771-203873965	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"		"Diabetes mellitus, Disease variant, FDA approved drug targets, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 37.7"	"Cell type enriched"	"Detected in some"	8	"T-cells: 41.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in some"	7	"T-reg: 44.5"	"Lineage enriched"	"Detected in single"	445	"T-cells: 44.5"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.5;SK-MEL-30: 3.0;U-266/70: 4.3;U-266/84: 13.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Intracellular and membrane"	NA	NA						"unprognostic (1.92e-2)"	"unprognostic (9.13e-3)"	"unprognostic (1.47e-3)"	"unprognostic (9.89e-6)"	"unprognostic (1.86e-1)"	"prognostic favorable (4.48e-5)"	"unprognostic (1.02e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.65e-3)"	"unprognostic (2.77e-1)"	"unprognostic (3.76e-1)"	"unprognostic (9.86e-10)"	"unprognostic (4.13e-2)"	"unprognostic (7.45e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.19e-2)"	1.1	0.2	0.6	18.6	0.5	6.1	1.1	0.5	0.7	0.6	0.6	1.2	0.3	0.3	0.0	1.6	0.6	5.3	0.5	0.5	2.0	0.6	0.7	2.9	37.7	1.2	0.6	0.4	0.1	0.4	0.5	0.3	0.3	1.6	1.5	3.2	0.0	0.5	1.0	0.1	0.7	6.2	0.9	0.6	3.9	2.9	1.1	0.5	10.2	1.1	0.2	17.1	5.9	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	4.3	13.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	6.2	0.8	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.0	44.5	0.6	0.6	0.5	0.5	0.7	0.5	2.0	1.2	0.6	0.4	1.6	0.6	0.5	0.5	0.4	0.0	3.2	0.0	1.6	0.5	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.2	4.1	0.0	1.3	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.2	0.0	3.3	0.0	2.8	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	5.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	1.0	0.2	0.9	0.1	41.9	0.0	0.0	0.1
CTXN3		ENSG00000205279	"Cortexin 3"	Q4LDR2	5	127649044-127658630	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"kidney: 80.6"	"Cell type enriched"	"Detected in some"	8	"Proximal tubular cells: 201.3"	"Cancer enriched"	"Detected in single"	8	"renal cancer: 1.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"													NA	NA										"unprognostic (7.32e-2)"	"unprognostic (9.88e-2)"		"unprognostic (1.19e-1)"				"unprognostic (1.29e-1)"	"unprognostic (6.20e-3)"					0.0	0.0	4.9	0.0	5.4	0.0	0.0	3.6	9.3	0.0	4.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.0	6.8	80.6	0.0	0.1	0.0	9.3	13.0	5.0	0.0	0.0	0.2	5.4	0.0	12.3	0.5	0.0	0.2	0.2	0.0	13.0	0.0	0.0	0.0	4.2	0.0	0.0	0.1	7.3	0.1	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	5.4	3.6	9.3	7.0	6.8	9.3	13.0	5.0	12.3	4.2	7.3	12.2	0.0	0.0	0.0	1.0	1.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	23.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	201.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0
CYP4F3	"CYP4F, LTB4H"	ENSG00000186529	"Cytochrome P450 family 4 subfamily F member 3"	Q08477	19	15640897-15662825	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 81.0;liver: 237.7"	"Cell type enriched"	"Detected in many"	8	"Hepatocytes: 562.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 30.6"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	63	"neutrophil: 84.1"	"Lineage enriched"	"Detected in single"	177	"granulocytes: 84.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 33.0;HaCaT: 14.9;Hep G2: 18.3;OE19: 49.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA058960	Approved					NA	NA					"HPA058960: AB_2683862"	"unprognostic (1.73e-2)"	"unprognostic (9.70e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.16e-3)"	"unprognostic (5.40e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.15e-3)"	"unprognostic (5.19e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.07e-1)"	1.6	0.1	0.9	1.2	3.0	81.0	0.2	2.7	1.5	3.4	0.5	2.1	9.5	0.1	0.8	26.9	1.1	15.6	0.2	1.9	2.0	27.6	237.7	2.3	0.1	2.4	2.1	0.7	0.1	0.6	0.0	0.5	0.4	2.6	0.6	1.8	0.1	3.5	0.6	0.1	3.9	15.1	0.3	2.0	7.8	5.2	0.3	1.7	0.7	0.1	0.6	0.7	2.9	9.0	4.3	0.3	7.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	33.0	0.1	0.2	0.0	0.1	14.9	0.0	0.2	0.0	0.6	0.0	0.1	3.5	18.3	0.0	0.2	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	49.3	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.2	0.4	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	84.1	0.0	0.1	0.0	0.0	0.1	0.9	3.0	2.7	1.5	1.9	2.0	2.4	2.1	0.7	2.6	2.0	1.7	4.3	0.0	9.6	3.7	0.7	2.0	1.0	2.1	2.5	1.2	0.0	0.1	0.1	0.9	62.9	5.0	0.0	0.0	0.0	1.4	10.0	0.0	2.3	0.1	0.9	0.2	0.7	53.1	17.3	0.0	0.2	0.2	0.8	7.7	3.1	1.3	0.0	8.2	562.4	0.0	0.0	0.0	14.4	8.2	11.4	0.3	0.7	0.0	1.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	4.0	7.4	0.0	0.0	3.2	69.9	32.1	1.9	0.0	0.0	0.7	1.3	0.0	0.3	25.7	6.5	0.0	1.1	0.0	10.9	13.1
DAND5	"CER2, CKTSF1B3, Coco, DANTE, DTE, FLJ38607, GREM3"	ENSG00000179284	"DAN domain BMP antagonist family member 5"	Q8N907	19	12965159-12974760	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"heart muscle: 8.6"	"Cell type enriched"	"Detected in some"	7	"Cardiomyocytes: 17.1"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	16	"SH-SY5Y: 19.8"	"Not detected"	"Not detected"							"HPA043493, HPA049472"	Uncertain		Approved	Mitochondria	"Secreted in other tissues"	NA	NA			Mitochondria		"HPA043493: AB_2732505, HPA049472: AB_2680781"	"unprognostic (1.18e-2)"	"unprognostic (4.63e-2)"	"unprognostic (7.51e-2)"	"unprognostic (4.63e-2)"	"unprognostic (3.82e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.95e-3)"	"unprognostic (7.27e-3)"	"unprognostic (8.17e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.48e-10)"	"unprognostic (4.43e-1)"	"unprognostic (2.48e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.37e-1)"	0.1	0.9	0.4	0.1	0.4	0.7	0.3	0.8	0.6	0.1	1.3	1.4	0.2	0.1	0.2	0.1	0.1	0.3	8.6	0.4	0.2	0.1	0.0	0.1	0.1	0.5	0.3	0.3	0.1	0.2	0.8	0.1	0.0	0.7	0.1	0.3	0.7	0.4	0.0	0.1	0.3	0.3	0.3	0.2	0.0	0.3	0.3	0.3	0.1	0.2	0.2	0.0	0.1	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.1	0.4	0.0	0.8	0.3	0.0	0.0	0.2	0.2	0.0	0.3	0.0	0.2	0.0	0.7	0.4	1.2	0.0	0.4	0.3	0.1	0.2	0.0	0.1	0.2	0.0	0.1	0.1	0.0	1.0	19.8	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.2	0.2	0.0	0.2	0.4	0.0	0.1	0.0	0.2	0.1	1.2	0.1	0.4	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.3	0.2	0.4	1.5	0.4	0.1	0.4	0.0	0.1	0.4	0.4	0.8	0.6	0.4	0.2	0.5	0.3	0.3	0.7	0.2	0.3	0.8	0.5	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.7	1.3	17.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.1	0.4	0.5	0.0	0.0	0.1	0.4	0.1	0.4	0.0	0.3	0.0	2.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.3	0.3	0.3	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.2	0.1	0.0	0.6	0.0	2.1	0.5	0.1	0.2	0.3	0.3	0.0	0.1	0.1	0.5	0.1
DBH	DBM	ENSG00000123454	"Dopamine beta-hydroxylase"	P09172	9	133636363-133659329	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Catecholamine biosynthesis"	"Monooxygenase, Oxidoreductase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"adrenal gland: 275.3;brain: 130.0"	"Cell type enriched"	"Detected in some"	6	"Hepatic stellate cells: 10.0"	"Cancer enhanced"	"Detected in some"		"liver cancer: 1.7"	"Group enriched"	"Detected in many"	7	"midbrain: 48.9;pons: 130.0;white matter: 35.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	346	"SH-SY5Y: 1826.4"	"Region enriched"	"Detected in some"	6	"pons and medulla: 22.1"	"Region enriched"	"Detected in single"	26	"pons: 18.5"	"HPA002130, HPA005960, HPA070789"	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	NA	NA		1600000000	Vesicles	"Endoplasmic reticulum"	"HPA002130: AB_2666554, HPA005960: AB_1078628, HPA070789: AB_2686312"	"unprognostic (1.93e-3)"	"unprognostic (7.52e-3)"	"unprognostic (8.53e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.18e-3)"	"unprognostic (3.38e-3)"	"unprognostic (3.39e-3)"	"unprognostic (3.97e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.99e-2)"	"unprognostic (5.80e-2)"	"unprognostic (7.69e-2)"	"unprognostic (2.81e-7)"	"unprognostic (9.31e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.06e-3)"	2.8	275.3	1.2	1.1	1.8	0.2	0.1	0.0	3.5	0.4	0.0	0.1	0.4	0.3	0.2	0.1	0.3	0.4	0.3	0.3	0.3	1.3	36.4	0.8	2.3	9.7	48.9	0.1	0.4	4.3	0.0	1.4	1.4	130.0	0.4	0.0	0.1	0.7	0.2	0.1	0.2	0.6	0.0	0.1	0.9	0.4	0.2	0.6	0.2	0.4	0.0	0.0	0.4	1.1	35.7	0.0	0.0	0.1	0.9	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.2	3.2	0.9	0.1	0.0	0.0	0.3	5.2	4.7	0.0	0.0	2.1	1826.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.8	0.0	3.5	0.3	0.3	9.7	48.9	0.1	130.0	0.1	0.6	35.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	10.0	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0
DCD	"AIDD, DCD-1, DSEP, HCAP, PIF"	ENSG00000161634	Dermcidin	P81605	12	54644589-54648493	"Plasma proteins, Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial, Fungicide, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"skin 1: 2047.6"	"Cell type enriched"	"Detected in some"	355	"Melanocytes: 8167.8"	"Cancer enriched"	"Detected in some"	9	"breast cancer: 91.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.0"									HPA063967	Enhanced				"Secreted in other tissues"	NA	NA		410000000			"HPA063967: AB_2685163"	"unprognostic (3.55e-2)"													"unprognostic (1.61e-1)"				56.1	0.4	3.3	0.3	3.1	1.1	358.3	3.2	5.4	0.3	3.6	0.7	0.2	0.7	0.9	0.5	0.2	0.8	1.2	3.3	3.0	0.2	1.0	0.6	0.2	3.0	3.3	3.1	0.4	1.1	0.0	0.5	0.1	3.3	0.4	0.2	0.5	0.5	0.1	14.1	2047.6	0.7	0.1	2.9	0.4	0.7	1.1	2.9	0.3	0.5	0.0	0.2	0.2	0.7	3.9	0.2	0.3	0.4	0.4	0.3	0.4	0.4	0.5	0.1	0.0	0.2	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.6	0.4	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.2	1.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.5	0.2	0.0	0.2	0.1	0.3	0.2	0.2	0.0	0.2	0.2	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.1	1.9	0.4	0.5	0.4	0.3	0.6	0.5	0.4	0.3	0.2	0.4	0.5	0.5	1.1	0.9	0.7	0.5	0.6	0.2	3.3	3.1	3.2	5.4	3.3	3.0	3.0	3.3	3.1	3.3	2.9	2.9	3.9	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.1	0.0	0.0	8167.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.5	0.4	0.2	0.0	23.0	0.0	1.0	0.0	0.0	0.0
DCUN1D1	"DCUN1L1, RP42, SCCRO, SCRO, Tes3"	ENSG00000043093	"Defective in cullin neddylation 1 domain containing 1"	Q96GG9	3	182938074-182985953	"Predicted intracellular proteins"	"Ubl conjugation pathway"		Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"testis: 248.1"	"Cell type enriched"	"Detected in all"	5	"Late spermatids: 13031.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA035911	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		130000	Nucleoplasm	Cytosol	"HPA035911: AB_10673489"	"unprognostic (2.13e-1)"	"unprognostic (2.36e-1)"	"unprognostic (4.83e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.44e-3)"	"unprognostic (6.06e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.72e-2)"	"unprognostic (9.34e-2)"	"unprognostic (9.25e-3)"	"unprognostic (4.98e-3)"	"unprognostic (7.26e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.12e-1)"	"unprognostic (5.01e-2)"	"unprognostic (3.52e-1)"	14.9	12.4	12.4	12.5	15.7	22.6	13.1	15.1	16.5	11.7	7.0	14.1	13.8	13.0	9.5	18.3	10.5	12.9	15.8	11.8	12.2	19.4	31.7	10.7	15.5	13.0	14.2	9.8	12.5	10.3	12.1	8.5	12.7	15.1	13.7	13.2	11.4	11.1	14.1	34.8	14.5	14.5	15.5	13.6	12.6	11.5	248.1	14.1	13.8	17.9	38.5	17.7	15.1	10.3	20.1	54.3	23.5	31.0	13.1	32.4	30.8	26.3	33.9	37.8	37.4	36.2	34.9	39.0	63.6	72.5	32.2	56.4	29.4	27.6	28.5	49.8	52.2	14.3	61.1	17.2	14.8	20.2	36.6	44.3	23.3	32.6	22.3	20.7	28.3	26.7	38.0	20.6	32.6	27.9	28.8	36.2	19.0	25.3	40.4	21.7	27.9	32.4	41.6	27.5	37.6	22.4	22.3	59.7	41.9	33.1	32.6	86.0	29.0	25.6	22.9	22.2	31.7	40.3	26.5	53.3	64.0	29.0	33.8	33.8	10.2	8.5	16.3	6.7	9.2	6.6	6.4	5.6	6.6	10.0	4.1	6.2	6.8	13.7	10.5	6.2	7.5	7.4	5.5	12.4	15.7	15.1	16.5	11.8	12.2	13.0	14.2	9.8	15.1	13.6	14.1	20.1	23.5	22.4	29.5	54.2	22.3	43.3	26.0	28.3	23.3	13.2	26.6	15.4	32.5	21.5	30.1	47.8	10.4	18.8	36.3	29.1	37.2	28.3	2437.8	24.0	29.9	23.7	26.9	98.1	52.7	30.5	18.7	29.0	18.3	26.3	29.8	22.1	17.9	52.6	28.6	18.5	40.9	19.6	30.5	45.9	54.2	13031.2	86.6	39.5	12.4	30.0	45.9	18.1	20.6	37.7	91.9	31.9	24.1	64.3	20.2	42.0	27.3	42.3	24.0	22.6	78.9	35.9	37.4	124.6	58.7	25.7	42.5	20.0	27.1	15.3	20.7	43.6
DEFA1B		ENSG00000240247	"Defensin alpha 1B"	P59665	8	6996766-6999195	"Cancer-related genes, Plasma proteins, Predicted secreted proteins, Transporters"	"Antiviral defense"	"Antibiotic, Antimicrobial, Defensin, Fungicide"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"bone marrow: 878.7"	"Cell type enriched"	"Detected in single"	37	"T-cells: 3.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 2.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA052517	Supported				"Secreted to blood"	NA	NA					"HPA052517: AB_2681860"																		1.9	0.3	0.1	0.8	0.1	878.7	1.1	0.1	2.0	0.0	0.1	0.1	0.0	0.9	0.0	0.1	0.1	0.0	2.9	0.2	0.1	0.9	9.2	52.6	0.0	0.2	0.6	0.1	0.3	0.1	0.0	1.4	7.3	0.4	0.1	0.0	0.1	9.5	0.0	0.8	0.2	0.2	0.0	0.1	151.6	0.6	0.1	0.3	28.0	1.2	5.8	1.4	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	2.0	0.2	0.1	0.2	0.6	0.1	0.4	0.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0
DNAJC6	"KIAA0473, PARK19"	ENSG00000116675	"DnaJ heat shock protein family (Hsp40) member C6"	O75061	1	65248219-65415871	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Chaperone, Hydrolase, Protein phosphatase"	"Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 103.0;retina: 53.3"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 1038.1"	"Cancer enriched"	"Detected in many"	4	"glioma: 5.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 62.1;HEL: 165.8;K-562: 65.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031182, HPA054917"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Plasma membrane"	"HPA031182: AB_10611957, HPA054917: AB_2682641"	"unprognostic (6.99e-2)"	"unprognostic (2.00e-3)"	"unprognostic (3.19e-1)"	"unprognostic (7.94e-7)"	"unprognostic (1.59e-1)"	"unprognostic (7.61e-3)"	"unprognostic (1.87e-4)"	"unprognostic (2.98e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.14e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.53e-1)"	"prognostic favorable (2.81e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.67e-3)"	1.3	11.2	22.9	0.9	35.0	4.8	1.1	23.6	55.5	0.8	0.0	1.8	1.0	0.6	0.4	0.3	1.1	1.0	9.0	39.4	44.1	7.7	0.4	1.5	0.2	52.2	48.4	29.5	0.5	2.2	1.0	12.7	7.4	60.3	1.1	1.7	53.3	0.7	0.7	0.4	1.0	1.0	0.9	20.5	2.1	1.7	2.2	47.3	0.8	1.7	0.8	0.3	1.1	0.9	103.0	10.4	2.8	0.1	4.4	2.1	0.5	23.4	20.1	33.1	32.6	31.7	2.7	0.5	9.9	1.7	8.3	8.0	2.5	14.6	3.3	25.8	62.1	6.9	165.8	5.1	0.6	0.2	5.6	3.9	2.7	2.2	3.3	13.8	6.0	0.7	8.0	65.5	1.2	6.6	1.9	2.1	0.0	6.5	0.0	2.2	0.0	4.9	0.4	23.7	0.0	39.4	27.0	11.9	15.5	5.4	37.4	7.5	0.3	6.5	4.8	3.3	0.6	5.9	6.0	4.1	3.0	13.4	4.1	8.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.9	35.0	23.6	55.5	39.4	44.1	52.2	48.4	29.5	60.3	20.5	47.3	103.0	0.8	0.0	0.5	49.3	0.5	1.3	0.4	0.5	0.0	30.4	0.6	0.3	28.0	2.8	0.2	0.0	14.6	8.9	1.5	0.4	1.9	0.8	2.0	1.8	0.5	3.7	7.2	19.4	237.4	0.7	2.1	5.8	1.5	3.0	0.0	0.6	0.4	0.1	1.2	52.2	237.6	1.9	2.0	0.0	0.8	1.9	0.0	0.7	7.2	18.7	1.1	4.1	0.0	136.7	1038.1	0.4	0.2	0.0	0.9	1.7	0.0	7.2	1.2	21.6	0.0	0.2	8.5	1.7	2.5	0.0	0.3	7.4	0.6	6.9	0.6	0.2
DNASE1L3	"DNAS1L3, LSD"	ENSG00000163687	"Deoxyribonuclease 1 like 3"	Q13609	3	58192257-58214697	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Necrosis"	"Endonuclease, Hydrolase, Nuclease"	"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"liver: 273.6;lymphoid tissue: 265.7"	"Cell type enriched"	"Detected in many"	6	"Hepatic stellate cells: 1670.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in some"	10	"plasmacytoid DC: 424.7"	"Lineage enriched"	"Detected in many"	20	"dendritic cells: 424.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.9;Karpas-707: 1.1;RPMI-8226: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA019955	Approved				"Secreted to blood"	NA	NA					"HPA019955: AB_1847805"	"unprognostic (7.49e-3)"	"unprognostic (3.08e-3)"	"unprognostic (9.75e-3)"	"unprognostic (3.92e-3)"	"unprognostic (2.93e-3)"	"unprognostic (1.01e-2)"	"prognostic favorable (1.20e-6)"	"unprognostic (4.74e-4)"	"unprognostic (2.10e-1)"	"unprognostic (9.71e-2)"	"unprognostic (1.91e-3)"	"unprognostic (6.95e-2)"	"prognostic favorable (1.06e-7)"	"unprognostic (7.57e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.64e-3)"	20.8	41.3	0.5	38.4	0.5	3.0	10.4	1.2	0.7	4.2	4.2	31.7	30.0	1.7	1.5	17.1	2.8	8.0	12.1	0.5	1.0	36.6	273.6	18.2	39.1	0.6	0.4	0.6	1.1	1.1	1.7	20.4	7.2	0.8	1.8	42.5	0.5	8.8	1.4	1.0	4.6	42.9	3.5	0.4	265.7	6.0	3.9	0.5	22.8	16.7	0.3	54.4	12.1	9.5	0.8	0.0	0.2	0.1	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.7	0.0	0.3	0.1	0.0	0.3	0.0	0.1	0.0	0.7	0.0	0.2	1.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	2.1	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.3	0.2	0.2	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.2	20.4	0.1	0.1	40.4	20.7	0.1	0.0	0.6	0.5	0.2	424.7	0.0	3.4	0.5	0.5	1.2	0.7	0.5	1.0	0.6	0.4	0.6	0.8	0.4	0.5	0.8	126.6	0.0	9.8	0.3	25.7	9.2	0.3	1.1	12.0	0.1	0.9	1.4	1.2	35.8	2.0	0.0	0.0	0.1	76.3	0.5	3.9	0.0	1.9	0.4	0.2	239.9	0.0	85.5	0.1	0.4	1.2	6.1	0.0	0.8	1.3	0.1	1670.9	27.1	0.5	1.7	0.1	0.2	0.0	127.1	144.3	3.2	4.1	18.6	3.6	0.0	35.3	0.0	0.0	0.0	0.0	0.0	0.0	25.6	0.2	0.3	0.1	3.3	0.0	0.2	0.0	0.3	1.3	0.3	0.2	59.3	16.3	0.3	3.8	2.6	0.0	1.0
FABP7	"B-FABP, BLBP"	ENSG00000164434	"Fatty acid binding protein 7"	O15540	6	122779716-122784074	"Metabolic proteins, Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 369.2;choroid plexus: 148.8;retina: 176.8;tongue: 201.1"	"Cell type enriched"	"Detected in some"	6	"Muller glia cells: 1407.3"	"Group enriched"	"Detected in many"	6	"glioma: 139.3;renal cancer: 51.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"AF22: 105.5;U-251 MG: 28.8;WM-115: 63.7"	"Region enriched"	"Detected in all"	5	"olfactory bulb: 1195.2"	"Low region specificity"	"Detected in all"			"CAB025488, HPA028825, CAB058697"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			Nucleoplasm	"Golgi apparatus, Cytosol"	"CAB025488: , CAB058697: AB_2665600, HPA028825: AB_10602130"	"prognostic favorable (2.49e-4)"	"unprognostic (1.56e-2)"		"unprognostic (2.53e-3)"	"unprognostic (5.80e-2)"	"unprognostic (2.29e-1)"		"unprognostic (1.14e-1)"	"unprognostic (7.11e-2)"		"unprognostic (2.09e-2)"	"unprognostic (3.42e-2)"	"prognostic unfavorable (1.65e-6)"	"unprognostic (9.83e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.50e-1)"	"unprognostic (8.66e-2)"	1.9	0.4	165.3	0.1	191.2	0.3	38.3	209.6	369.2	1.0	148.8	0.7	0.1	0.1	0.2	0.8	0.1	0.1	0.2	176.3	161.0	0.8	0.3	0.0	0.1	164.8	153.6	173.2	0.1	0.1	0.0	8.1	0.4	160.3	0.3	0.1	176.8	8.9	3.9	8.9	36.9	0.1	0.0	150.6	0.0	0.4	0.2	151.9	1.8	0.0	201.1	0.1	0.2	0.4	163.3	0.0	0.1	105.5	0.0	0.0	0.0	3.8	0.0	0.9	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	8.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.0	0.1	0.2	0.1	0.2	0.0	0.1	28.8	0.0	0.0	0.0	1.2	0.1	63.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	165.3	191.2	209.6	369.2	176.3	161.0	164.8	153.6	173.2	160.3	150.6	151.9	163.3	0.1	0.0	0.0	14.0	0.0	12.2	0.3	0.0	0.0	11.6	44.5	38.9	1.3	0.0	0.0	0.0	12.5	4.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	2.9	0.0	228.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.9	5.0	1.1	0.0	0.0	0.0	1.4	0.0	0.0	0.1	30.2	0.0	0.0	1407.3	0.0	41.7	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	48.0	0.0	0.5	0.3	0.0	0.3	0.0	18.9	7.1	0.3	0.0	0.0	0.0
FAM209A	"C20orf106, dJ1153D9.3"	ENSG00000124103	"Family with sequence similarity 209 member A"	Q5JX71	20	56517187-56526152	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 105.0"	"Cell type enriched"	"Detected in some"	8	"Early spermatids: 2173.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 2.5;Karpas-707: 1.0;U-266/84: 1.5"									HPA079442			Uncertain	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"		"HPA079442: "	"unprognostic (1.03e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.75e-1)"	"unprognostic (8.58e-3)"	"unprognostic (1.06e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.10e-1)"	"unprognostic (9.83e-2)"	"unprognostic (5.56e-3)"	"unprognostic (7.68e-2)"	"unprognostic (1.86e-9)"	"unprognostic (2.98e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.22e-2)"	0.6	0.2	0.1	0.9	0.2	16.8	0.5	0.2	0.4	0.4	0.1	0.4	0.3	0.3	0.4	0.3	0.5	0.5	0.2	0.2	0.2	0.3	0.6	0.8	1.6	0.1	0.1	0.1	0.2	1.0	0.0	0.7	0.0	0.2	0.6	0.4	0.1	0.5	0.3	0.2	1.2	1.1	0.2	0.1	2.3	0.5	105.0	0.1	0.2	0.3	0.0	1.3	0.3	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.8	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.3	0.0	0.3	0.0	0.4	2.5	0.0	0.7	0.0	0.1	0.1	0.1	0.5	0.0	1.0	0.0	0.4	0.1	0.7	0.0	0.0	0.1	0.2	0.3	0.2	0.0	0.4	0.1	0.0	0.0	0.8	0.1	0.0	0.1	0.5	0.0	0.0	0.1	0.2	0.1	0.5	1.5	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.4	0.2	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.3	0.0	2.3	0.0	0.4	0.1	0.2	0.1	0.0	0.0	0.2	0.3	0.7	0.0	0.7	0.0	0.0	0.1	2.0	0.4	0.0	0.0	2173.4	0.2	0.2	1.1	1.2	0.4	0.0	0.0	0.2	0.2	0.0	0.5	1.3	0.1	1.1	0.2	0.1	0.0	0.0	0.2	0.0	0.6	0.0	266.1	8.7	1.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.0	6.4	0.0	0.1	0.2	0.0	0.8	0.0	0.0	0.3	0.2	10.4	5.9	0.1	0.0	0.3	0.5	0.1	0.1	0.2
FGL1	"HFREP-1, HPS"	ENSG00000104760	"Fibrinogen like 1"	Q08830	8	17864380-17910365	"Plasma proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 4198.1"	"Cell type enriched"	"Detected in many"	27	"Hepatocytes: 8261.7"	"Cancer enriched"	"Detected in some"	40	"liver cancer: 399.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"A549: 55.4;Hep G2: 131.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA		57000000				"unprognostic (3.62e-2)"	"unprognostic (1.14e-2)"		"unprognostic (1.75e-5)"	"unprognostic (3.00e-1)"	"unprognostic (3.54e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.62e-1)"		"unprognostic (2.71e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.86e-7)"	"prognostic unfavorable (5.38e-4)"	"unprognostic (3.62e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.35e-1)"	0.5	0.4	1.0	0.0	1.2	0.0	1.0	0.8	1.7	0.3	0.7	0.2	0.0	0.7	0.8	0.2	0.2	0.1	0.3	1.1	2.4	0.5	4198.1	1.2	0.0	1.1	1.3	1.0	0.3	665.7	0.0	0.2	6.3	1.1	3.8	0.1	0.2	0.2	0.0	0.1	0.1	0.3	0.2	0.9	3.8	0.7	4.3	1.1	0.0	0.3	0.0	0.0	0.1	0.1	2.1	0.0	55.4	0.0	6.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.1	131.9	0.0	1.0	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.2	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.1	0.0	1.3	0.8	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.2	0.8	1.7	1.1	2.4	1.1	1.3	1.0	1.1	0.9	1.1	2.1	0.0	0.0	1.9	12.4	24.6	0.0	0.2	0.0	0.0	0.0	1.3	0.9	2.1	301.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	8.3	42.9	5.4	1.0	7.6	0.0	176.4	0.1	71.2	0.4	0.1	0.0	7.8	0.0	0.0	173.8	8261.7	20.4	0.0	0.3	0.0	0.0	231.6	0.0	32.7	0.6	0.2	0.0	14.0	1.6	0.0	0.0	2.5	0.0	74.1	0.0	0.4	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.7	0.0	0.0	1.0	12.8	0.1	0.3	0.2
GAD2	GAD65	ENSG00000136750	"Glutamate decarboxylase 2"	Q05329	10	26216665-26304558	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Neurotransmitter biosynthesis"	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 36.4;retina: 9.6"	"Cell type enriched"	"Detected in some"	13	"Inhibitory neurons: 293.9"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 3.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"SCLC-21H: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044637, CAB078177"	Enhanced					NA	NA					"CAB078177: AB_2665779, HPA044637: AB_10794053"		"unprognostic (8.67e-2)"			"unprognostic (1.11e-1)"						"unprognostic (4.93e-2)"		"unprognostic (2.52e-5)"	"unprognostic (5.44e-2)"	"unprognostic (8.08e-2)"			0.0	0.0	12.0	0.0	36.4	0.0	0.0	7.3	15.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.4	29.2	0.0	0.0	0.0	0.0	10.5	13.9	7.3	0.0	3.6	0.0	0.4	0.0	7.4	0.0	0.0	9.6	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.1	0.4	15.3	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	36.4	7.3	15.6	5.4	29.2	10.5	13.9	7.3	7.4	1.8	15.3	5.2	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	1.8	0.0	1.6	0.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	293.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	5.6	0.0	0.3	0.0	2.0	6.1	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GOLGA6D		ENSG00000140478	"Golgin A6 family member D"	P0CG33	15	75282835-75295807	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 12.2"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 12.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044978, HPA050087, HPA072134"	Supported		Approved	Nucleoplasm,Vesicles,Centrosome		NA	NA			Vesicles	"Nucleoplasm, Centrosome"	"HPA044978: AB_2679165, HPA050087: AB_2681010, HPA072134: "															"unprognostic (7.95e-3)"			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	2.1	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.8	0.1	0.0	0.0	0.1	0.0	0.0	12.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.2	0.2	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0
HMBS	"PBGD, PORC, UPS"	ENSG00000256269	"Hydroxymethylbilane synthase"	P08397	11	119084866-119093549	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"bone marrow: 172.2"	"Cell type enriched"	"Detected in many"	15	"Erythroid cells: 935.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006114, HPA050659"	Supported		Approved	"Lipid droplets"		NA	NA		21000000	"Lipid droplets"		"HPA006114: AB_1079067, HPA050659: AB_2681206"	"unprognostic (6.24e-2)"	"unprognostic (9.10e-3)"	"unprognostic (1.42e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.29e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.13e-2)"	"unprognostic (6.83e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.90e-3)"	"unprognostic (3.91e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.11e-2)"	9.4	16.0	9.3	9.4	10.1	172.2	9.5	11.2	10.5	7.7	9.6	13.8	12.6	10.2	12.0	14.6	7.7	4.1	15.6	8.9	9.7	12.3	23.0	8.9	9.3	10.6	10.1	8.3	3.9	16.3	9.3	8.5	10.7	10.3	8.7	15.0	6.0	10.0	8.7	30.7	10.0	10.2	10.6	10.7	15.3	11.8	5.7	10.6	7.7	9.0	24.1	11.9	9.7	8.1	12.7	40.0	59.9	27.7	47.5	21.6	27.2	41.7	31.1	34.8	45.0	38.2	74.4	60.2	59.4	68.3	40.1	42.0	53.7	41.6	60.1	28.2	42.0	42.4	97.2	22.5	55.0	40.8	37.6	31.2	29.8	38.0	71.5	53.1	18.7	21.5	55.9	154.6	25.7	35.9	158.4	36.3	72.6	32.1	72.8	36.5	41.9	27.8	59.5	45.3	36.2	31.1	41.4	24.6	38.4	29.3	19.3	64.7	52.3	20.0	33.0	25.5	32.9	36.0	14.2	16.7	36.6	22.7	47.4	40.0	48.5	38.5	4.4	13.6	35.2	17.8	21.4	12.5	15.1	52.8	24.4	19.7	14.7	1.3	11.5	22.2	35.1	14.2	26.6	9.3	10.1	11.2	10.5	8.9	9.7	10.6	10.1	8.3	10.3	10.7	10.6	12.7	5.2	9.6	9.0	4.2	12.1	7.9	11.0	26.7	13.6	5.6	14.5	16.8	13.7	18.6	12.8	11.0	27.1	57.8	12.1	12.4	19.6	25.6	1.7	5.8	10.4	6.2	13.2	935.9	3.8	31.2	61.1	9.0	5.6	5.8	2.5	6.3	4.6	23.7	29.1	10.1	5.7	19.1	14.2	13.0	10.4	3.0	5.9	9.5	14.2	1.9	15.3	7.5	8.2	4.5	8.6	23.3	13.0	8.6	25.0	14.5	9.2	24.5	13.6	25.9	0.0	8.6	11.7	1.7	32.0	18.8	8.1	23.3	6.1	16.7	31.0	10.5
HMX3	NKX5-1	ENSG00000188620	"H6 family homeobox 3"	A6NHT5	10	123135970-123139423	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"brain: 5.8"	"Cell type enriched"	"Detected in single"	10	"Cardiomyocytes: 1.0"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 0.5"	"Region enhanced"	"Detected in many"		"hypothalamus: 5.8"	"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HAP1: 8.1;HEL: 6.1;HeLa: 7.0;K-562: 17.9;NB-4: 13.4;SiHa: 7.0;THP-1: 5.7"	"Region enriched"	"Detected in single"	4	"hypothalamus: 1.1"	"Group enriched"	"Detected in some"	5	"basal ganglia: 1.4;hypothalamus: 4.8"	HPA069659			Approved	"Nucleoplasm,Centriolar satellite"		Yes	No			Nucleoplasm	"Centriolar satellite"	"HPA069659: AB_2686165"			"unprognostic (1.79e-1)"								"unprognostic (9.65e-2)"			"unprognostic (6.07e-2)"				0.9	0.1	0.6	0.1	0.2	0.1	0.0	0.2	0.2	0.0	0.2	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.1	0.0	0.0	0.1	1.4	2.0	0.1	0.0	0.1	0.0	0.2	0.0	1.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.1	0.2	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.1	0.0	8.1	0.0	0.0	0.7	0.4	6.1	7.0	0.2	0.1	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	2.9	17.9	0.1	0.0	0.0	0.0	13.4	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.4	0.2	0.0	7.0	0.0	0.1	0.0	0.0	5.7	0.1	0.0	0.8	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.4	1.6	0.3	0.4	0.2	0.2	0.2	0.3	0.2	0.2	0.1	0.5	0.2	0.3	0.9	0.4	0.2	0.4	0.2	0.1	0.6	0.2	0.2	0.2	0.0	5.8	1.4	2.0	0.1	1.0	0.1	2.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGFBP1	"AFBP, hIGFBP-1, IBP1, IGF-BP25, PP12"	ENSG00000146678	"Insulin like growth factor binding protein 1"	P08833	7	45888360-45893660	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 1208.7"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 994.8"	"Cancer enriched"	"Detected in many"	29	"liver cancer: 385.9"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"Hep G2: 54.7;U-2197: 84.9;U-87 MG: 145.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB004445, HPA046972, HPA050640"	Enhanced		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	28100000	25000000	"Golgi apparatus"		"CAB004445: AB_627782, HPA046972: AB_2679884, HPA050640: AB_2681197"	"unprognostic (8.66e-3)"	"unprognostic (1.45e-1)"	"unprognostic (9.41e-2)"	"unprognostic (7.80e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (1.89e-2)"	"unprognostic (2.09e-3)"	"unprognostic (8.95e-2)"		"prognostic unfavorable (6.90e-11)"	"prognostic unfavorable (6.64e-4)"	"unprognostic (7.20e-2)"	"unprognostic (7.98e-2)"	"unprognostic (3.43e-1)"	1.2	0.1	0.3	0.0	0.2	0.0	2.4	0.3	0.3	0.2	0.1	0.0	0.3	80.3	0.1	0.0	4.1	0.3	0.3	0.2	0.3	1.6	1208.7	0.1	0.1	0.8	0.4	0.2	46.6	0.5	0.0	0.5	206.2	1.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.3	0.5	0.1	0.1	0.4	1.1	0.3	0.0	0.0	0.0	0.2	0.7	0.2	6.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.6	0.3	1.4	0.1	1.6	0.3	0.0	0.0	0.7	0.0	0.0	0.3	0.5	54.7	0.3	1.1	0.1	0.1	0.7	11.3	0.1	0.6	0.3	0.0	0.2	0.1	1.3	0.0	0.0	0.2	0.0	0.0	2.8	0.0	0.3	0.0	2.2	0.0	0.3	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	84.9	0.0	0.0	0.0	0.2	145.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.3	0.3	0.2	0.3	0.8	0.4	0.2	1.0	0.3	0.4	0.7	0.4	0.0	0.5	0.0	0.9	0.0	0.0	0.6	0.0	0.0	0.0	5.7	1.0	35.8	0.7	0.0	0.0	0.9	0.0	0.0	0.0	11.0	0.1	4.7	94.3	0.9	3.5	10.7	0.1	0.0	1.6	1.8	0.0	15.9	0.0	2.1	6.8	994.8	1.7	0.0	0.1	0.0	0.0	14.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	10.7	0.1	0.5	0.0	0.0	3.4	0.8	0.0	0.0	0.0
IGHJ2		ENSG00000211904	"Immunoglobulin heavy joining 2"		14	105865199-105865250	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in many"	6	"cervix: 49.1;intestine: 128.5;lymphoid tissue: 176.3"	"Cell type enriched"	"Detected in single"	6	"Plasma cells: 3.0"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"hypothalamus: 4.7"	"Group enriched"	"Detected in some"	18	"MAIT T-cell: 49.0;naive B-cell: 12.6"	"Group enriched"	"Detected in many"	45	"B-cells: 12.6;T-cells: 49.0"	"Group enriched"	"Detected in some"	25	"Daudi: 3.8;K-562: 1.1"															NA	NA						"unprognostic (1.03e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.27e-2)"		"prognostic favorable (1.05e-4)"		"unprognostic (7.40e-2)"	"unprognostic (6.38e-2)"		"unprognostic (1.82e-1)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (5.33e-6)"	"unprognostic (4.31e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.48e-2)"	"unprognostic (4.60e-1)"	2.0	0.0	0.1	0.0	0.4	13.4	20.8	0.0	1.7	49.1	0.1	88.1	0.0	5.5	18.1	18.2	2.1	0.8	0.1	0.2	4.7	1.2	12.1	0.0	7.7	2.6	2.0	0.0	7.8	19.1	0.6	0.0	0.0	0.4	15.1	128.5	0.0	0.0	7.1	0.0	0.0	0.0	5.9	0.2	19.0	18.4	0.1	0.4	19.7	5.2	0.0	176.3	6.8	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	49.0	1.3	0.4	1.6	0.4	12.6	0.0	0.2	0.2	0.0	0.6	0.0	0.0	17.1	0.1	0.4	0.0	1.7	0.2	4.7	2.6	2.0	0.0	0.4	0.2	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKV3D-15		ENSG00000224041	"Immunoglobulin kappa variable 3D-15"	A0A087WSY6	2	90114838-90115402	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"intestine: 127.9;lymphoid tissue: 204.7;salivary gland: 54.6;stomach 1: 88.2;urinary bladder: 58.5"	"Cell type enriched"	"Detected in some"	622	"Plasma cells: 3673.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	191	"memory B-cell: 181.1;naive B-cell: 155.6"	"Lineage enriched"	"Detected in single"	206	"B-cells: 181.1"	"Cell line enhanced"	"Detected in some"		"HaCaT: 1.0;HL-60: 2.6;SiHa: 1.7"									HPA047702	Approved				"Immunoglobulin genes"	NA	NA		4800000000			"HPA047702: "	"prognostic favorable (6.11e-4)"	"prognostic favorable (7.46e-4)"	"unprognostic (9.16e-3)"	"unprognostic (1.74e-1)"		"unprognostic (1.90e-3)"	"unprognostic (7.20e-2)"	"unprognostic (9.19e-2)"	"unprognostic (4.93e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.97e-1)"	"prognostic unfavorable (1.82e-6)"	"unprognostic (8.99e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.04e-1)"	3.0	4.4	0.1	94.4	0.3	11.2	17.3	0.1	0.5	5.9	0.3	112.6	63.6	1.0	0.0	16.5	5.2	10.2	2.3	0.1	0.1	3.5	2.0	18.2	44.0	0.4	0.3	0.1	18.1	4.0	0.3	0.1	0.0	0.2	1.7	127.9	0.0	54.6	1.2	0.1	0.6	47.1	4.3	0.4	56.7	88.2	0.2	0.1	13.2	4.5	0.0	204.7	58.5	2.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.3	1.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.6	0.0	0.6	0.0	0.1	0.8	0.0	0.0	0.0	0.0	181.1	0.0	0.0	0.1	155.6	0.0	0.0	0.0	0.1	0.1	0.0	0.1	27.5	0.1	0.3	0.1	0.5	0.1	0.1	0.4	0.3	0.1	0.2	0.4	0.1	0.3	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3673.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
ITLN1	"FLJ20022, hIntL, HL-1, ITLN, LFR"	ENSG00000179914	"Intelectin 1"	Q8WWA0	1	160876540-160885180	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 343.5;intestine: 1260.1"	"Cell type enriched"	"Detected in many"	14	"Intestinal goblet cells: 1818.6"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 61.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"intermediate monocyte: 9.2;non-classical monocyte: 24.1"	"Lineage enriched"	"Detected in many"	17	"monocytes: 24.1"	"Group enriched"	"Detected in some"	4	"HEL: 2.6;HL-60: 1.9;OE19: 7.2;U-937: 7.1"	"Not detected"	"Not detected"							"CAB012652, HPA063275, HPA067326"	Enhanced				"Secreted to blood"	NA	NA	294000000	6400000			"CAB012652: , HPA063275: AB_2684974, HPA067326: AB_2732764"	"unprognostic (9.69e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.31e-3)"	"unprognostic (2.28e-1)"		"unprognostic (1.79e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.66e-2)"	"unprognostic (4.38e-1)"	"unprognostic (9.96e-2)"	"unprognostic (3.67e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.34e-2)"	343.5	0.3	0.0	26.7	0.0	2.6	0.5	0.0	0.0	0.3	0.0	448.3	275.1	0.5	2.2	0.4	6.2	0.8	125.0	0.0	0.0	3.4	3.2	40.7	0.3	0.0	0.0	0.0	9.8	3.3	0.0	0.4	1.3	0.0	0.6	1260.1	0.0	25.1	3.3	0.7	0.2	418.9	7.8	0.0	2.5	16.0	2.1	0.0	0.7	0.6	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	1.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	7.2	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	7.1	0.0	0.0	0.5	0.0	0.0	9.2	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.2	0.0	24.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.1	0.0	4.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	26.6	71.4	2.1	3.7	0.0	0.1	0.1	46.4	0.0	37.7	0.8	0.0	0.0	4.3	18.0	4.0	0.0	3.6	1.4	87.8	8.6	0.0	1.3	1.4	60.7	1.9	0.8	0.0	0.0	1818.6	0.0	124.7	0.0	0.7	14.6	1.8	0.0	0.0	0.3	0.0	1.0	0.0	0.0	7.3	17.7	3.0	0.0	0.3	15.4	0.1	0.8	0.0	0.0	0.0	10.8	0.1	0.9	0.0	0.0	0.3	2.1	15.3	59.4	0.1
KIF2C	"CT139, KNSL6, MCAK"	ENSG00000142945	"Kinesin family member 2C"	Q99661	1	44739818-44767767	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 33.3;lymphoid tissue: 37.8;testis: 77.1"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 1860.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"T-reg: 2.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"white matter: 2.1"	"Not detected"	"Not detected"			"HPA006219, HPA079172"	Enhanced		Supported	Nucleoplasm,Midbody,Centrosome		Yes	Yes			"Nucleoplasm, Centrosome"	Midbody	"HPA006219: AB_2667540, HPA079172: "	"unprognostic (3.29e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.77e-1)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (3.07e-7)"	"unprognostic (7.49e-3)"	"unprognostic (3.33e-3)"	"unprognostic (3.66e-1)"	"prognostic unfavorable (6.86e-4)"	"unprognostic (4.27e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.41e-1)"	0.8	0.8	1.1	7.1	0.6	33.3	1.6	1.9	0.6	1.2	0.8	6.3	5.5	1.8	0.7	7.3	0.9	1.3	1.3	0.5	0.7	0.6	0.7	1.3	16.6	0.9	1.0	0.3	0.7	0.5	1.3	0.4	5.5	1.3	0.8	7.7	0.8	1.3	0.7	0.9	6.1	5.1	3.2	0.9	3.7	3.5	77.1	0.8	37.8	1.1	0.7	19.4	2.1	2.7	1.8	119.7	45.8	99.6	79.8	5.3	11.6	66.6	86.9	62.1	175.0	151.3	77.6	84.2	136.2	41.3	43.2	121.7	55.2	102.8	59.6	158.2	89.1	44.4	162.1	83.3	65.5	0.6	121.5	71.8	2.7	5.8	125.0	60.3	16.5	57.6	95.4	130.4	113.1	112.4	46.5	127.5	72.9	97.1	58.4	56.5	101.1	149.3	86.4	29.6	42.8	68.3	48.5	116.1	81.6	71.5	71.9	47.2	90.7	34.7	62.9	124.2	69.0	155.6	59.4	65.0	195.3	40.3	115.4	123.9	0.0	0.0	0.0	0.9	0.0	0.0	0.6	1.7	1.2	0.1	0.1	0.3	0.2	0.0	2.0	0.1	0.8	2.9	0.5	1.1	0.6	1.9	0.6	0.5	0.7	0.9	1.0	0.3	1.3	0.9	0.8	1.8	0.1	0.0	0.5	1.6	1.3	1.8	0.5	2.4	0.0	1.0	0.9	0.9	1.6	0.0	1.7	1.8	2.1	12.2	1.9	2.9	1.9	0.3	461.1	1.2	1.4	1.6	0.0	34.5	0.8	0.4	23.4	3.2	3.1	2.1	0.0	13.0	2.9	0.2	9.2	0.0	1.0	3.5	0.0	1.9	1.5	1860.6	9.3	3.4	0.0	1.0	4.3	0.4	0.0	0.5	0.2	0.1	0.2	6.8	7.8	0.8	0.3	0.2	0.3	0.2	6.6	0.8	3.4	60.6	36.8	4.6	0.4	3.7	2.7	0.8	7.4	0.7
KIRREL2	"DKFZp564A1164, FILTRIN, MGC15718, NEPH3, NLG1"	ENSG00000126259	"Kirre like nephrin family adhesion molecule 2"	Q6UWL6	19	35855861-35867136	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"pancreas: 70.6"	"Cell type enriched"	"Detected in some"	9	"Bipolar cells: 58.6"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.6"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 21.5;HMC-1: 33.0;JURKAT: 19.5;U-937: 7.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA071587, HPA074326"	Enhanced		Supported	"Centriolar satellite"	"Intracellular and membrane"	NA	NA			"Centriolar satellite"		"HPA071587: AB_2732182, HPA074326: AB_2732251"	"unprognostic (1.28e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.16e-3)"	"unprognostic (2.05e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.72e-3)"	"unprognostic (3.30e-2)"	"unprognostic (5.56e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.43e-6)"	"unprognostic (1.72e-1)"	"unprognostic (4.44e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.62e-2)"	0.2	0.0	0.4	0.2	1.1	0.1	0.0	0.3	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	1.0	0.0	0.0	0.8	0.5	0.5	0.7	0.0	70.6	0.0	0.9	0.1	0.5	0.0	0.1	11.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.6	0.2	0.6	0.0	0.0	0.6	0.0	0.0	0.6	0.0	0.7	1.1	0.0	0.0	0.0	1.6	0.1	0.0	0.1	0.0	1.1	0.7	0.0	0.1	0.0	3.6	0.1	2.9	0.0	0.1	21.5	0.1	0.0	0.0	0.3	0.0	0.0	33.0	0.2	0.0	0.0	0.0	0.0	0.0	19.5	0.2	0.3	0.0	0.2	0.6	0.1	0.2	0.1	0.0	5.5	0.0	0.0	0.0	0.0	4.1	1.3	0.0	0.0	0.0	0.1	0.0	5.3	0.0	0.8	1.3	0.3	0.0	0.0	0.0	0.4	0.0	7.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.3	1.0	0.8	0.2	0.5	0.5	0.7	0.5	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.6	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	1.8	0.1	0.2	0.1	0.0	0.0	0.4	6.0	0.1	0.1	0.0	1.0	0.0	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.7	5.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.0	0.7	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0
LCAT		ENSG00000213398	"Lecithin-cholesterol acyltransferase"	P04180	16	67939750-67944131	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Acyltransferase, Hydrolase, Transferase"	"Corneal dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"liver: 285.3"	"Cell type enriched"	"Detected in many"	8	"Hepatocytes: 219.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 76.5;Hep G2: 62.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 29.2"	HPA044767			Approved	Nucleoplasm	"Secreted to blood"	NA	NA	6470000000	6400000000	Nucleoplasm		"HPA044767: AB_2756312"	"unprognostic (3.34e-2)"	"unprognostic (3.56e-2)"	"prognostic unfavorable (8.50e-4)"	"unprognostic (5.43e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.16e-1)"	"prognostic favorable (4.21e-8)"	"unprognostic (6.42e-2)"	"unprognostic (4.26e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.50e-2)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (9.93e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.90e-3)"	27.7	20.9	24.3	8.4	23.7	4.2	27.5	51.6	37.8	40.1	30.8	24.7	5.0	28.9	9.2	13.5	26.3	11.6	35.3	23.5	26.8	24.9	285.3	36.4	7.6	38.3	27.1	20.8	28.8	17.9	8.1	17.6	17.9	31.8	40.4	4.8	2.8	17.1	18.8	13.3	32.3	18.0	12.4	26.8	23.5	16.6	11.4	26.8	9.5	43.5	9.0	4.4	27.7	27.5	27.9	5.7	9.0	13.0	14.8	11.1	15.6	76.5	21.9	9.3	14.5	10.2	29.5	6.8	3.1	4.0	31.9	5.3	19.4	3.1	30.0	8.9	1.5	7.9	3.9	22.8	62.9	15.2	0.7	10.3	27.1	27.9	30.0	10.4	19.5	10.8	8.7	8.7	1.2	10.5	9.1	3.7	9.5	8.6	1.1	5.0	4.0	14.1	3.3	4.1	9.6	0.5	6.7	33.1	1.6	3.9	26.5	18.6	6.0	20.6	18.5	28.8	20.7	8.1	17.7	5.2	8.3	8.9	2.5	16.5	0.9	0.4	1.9	0.3	0.0	0.4	0.4	0.2	0.3	0.1	0.6	0.4	0.1	1.0	0.4	0.1	0.3	0.0	0.0	24.3	23.7	51.6	37.8	23.5	26.8	38.3	27.1	20.8	31.8	26.8	26.8	27.9	16.5	9.6	4.8	27.4	1.1	9.4	4.1	4.6	6.8	0.4	1.9	5.5	7.9	5.7	3.3	3.7	2.1	7.7	1.3	0.1	0.0	1.7	0.2	2.1	6.0	8.0	1.2	14.3	0.1	1.0	3.4	7.3	1.1	1.6	1.3	5.4	10.8	219.5	2.4	0.0	0.1	0.0	4.1	6.6	3.8	1.3	8.7	2.4	7.2	6.5	3.0	7.7	1.0	4.5	1.4	2.1	0.0	8.6	1.9	4.3	0.0	0.4	4.4	0.6	13.1	7.6	10.4	0.9	1.4	0.9	2.6	12.2	1.6	4.1	0.1	1.7
LIPJ	"bA425M17.2, LIPL1"	ENSG00000204022	"Lipase family member J"	Q5W064	10	88586753-88606976	"Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	6	"testis: 7.0"	"Cell type enriched"	"Detected in some"	7	"Early spermatids: 67.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA048594	Uncertain		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA048594: AB_2680456"	"unprognostic (4.79e-3)"	"unprognostic (6.77e-2)"	"unprognostic (4.80e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.70e-2)"	"unprognostic (9.33e-2)"	"unprognostic (2.90e-3)"	"unprognostic (7.50e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.73e-2)"	"unprognostic (6.21e-4)"	"unprognostic (9.87e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.88e-1)"	0.2	0.0	0.5	0.1	0.3	0.0	0.2	1.1	0.3	0.1	0.3	0.1	0.3	0.1	0.9	0.0	0.7	0.1	0.2	0.3	0.3	0.2	0.5	0.1	0.3	1.2	0.8	0.2	0.1	0.4	0.0	0.1	0.0	0.5	0.3	0.2	0.1	0.3	0.1	0.3	0.1	0.1	0.2	0.5	0.1	0.2	7.0	0.3	0.4	0.6	0.0	0.3	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	1.1	0.3	0.3	0.3	1.2	0.8	0.2	0.5	0.5	0.3	0.3	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.1	67.6	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.5	0.0	0.0	0.6	0.0	9.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0
LIX1	"C5orf11, Lft"	ENSG00000145721	"Limb and CNS expressed 1"	Q8N485	5	97091867-97142753	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 34.3;retina: 43.0"	"Cell type enriched"	"Detected in some"	13	"Muller glia cells: 289.4"	"Cancer enhanced"	"Detected in many"		"glioma: 13.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 2.2"	"Lineage enriched"	"Detected in single"	6	"B-cells: 2.2"	"Group enriched"	"Detected in some"	13	"RPTEC TERT1: 53.5;SuSa: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA058426	Uncertain		Approved	"Vesicles,Cytokinetic bridge,Cytosol"		Yes	NA			Cytosol	"Vesicles, Cytokinetic bridge"	"HPA058426: AB_2683715"	"unprognostic (3.18e-1)"	"unprognostic (4.53e-2)"	"unprognostic (9.46e-2)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (8.96e-2)"	"unprognostic (6.60e-2)"		"unprognostic (1.34e-1)"	"unprognostic (4.70e-1)"	"unprognostic (7.63e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.26e-1)"	"unprognostic (9.61e-2)"	0.0	0.3	22.6	0.2	19.4	0.3	0.0	26.2	17.6	0.0	6.8	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.0	25.3	34.3	3.1	0.0	0.0	0.5	29.8	26.9	13.1	0.0	0.0	0.0	1.5	0.4	23.1	1.6	0.3	43.0	0.0	5.8	0.0	0.1	0.2	0.2	28.4	0.1	0.4	0.1	24.3	0.0	4.7	0.0	0.0	0.0	0.0	28.1	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	53.5	0.0	0.1	0.0	0.0	0.0	0.0	31.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	2.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	22.6	19.4	26.2	17.6	25.3	34.3	29.8	26.9	13.1	23.1	28.4	24.3	28.1	0.0	0.0	0.0	21.2	1.3	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.7	0.0	0.1	12.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.0	0.0	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.1	3.3	1.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	289.4	0.0	0.5	1.4	0.0	0.0	0.0	0.1	0.1	0.0	2.3	0.0	9.4	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LRRC53		ENSG00000162621	"Leucine rich repeat containing 53"	A6NM62	1	74469376-74512611	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	6	"brain: 1.1"	"Cell type enriched"	"Detected in single"	8	"Enteroendocrine cells: 6.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA054062	Uncertain					NA	NA					"HPA054062: AB_2682364"					"unprognostic (3.67e-1)"													0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.5	0.2	0.2	0.2	0.1	0.4	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MEF2B	RSRFR2	ENSG00000213999	"Myocyte enhancer factor 2B"	Q02080	19	19145567-19192131	"Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 39.6"	"Cell type enriched"	"Detected in some"	4	"Plasma cells: 29.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	10	"Daudi: 223.4;U-266/70: 217.6;U-698: 299.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA004734	Supported		Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Cell Junctions"	"HPA004734: AB_10963939"	"unprognostic (7.31e-3)"	"unprognostic (4.06e-2)"	"unprognostic (9.44e-5)"	"unprognostic (5.07e-2)"	"unprognostic (2.01e-1)"	"unprognostic (7.19e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.98e-2)"	"unprognostic (8.66e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.56e-11)"	"unprognostic (2.40e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.68e-1)"	"unprognostic (8.98e-3)"	3.0	1.8	4.2	14.0	4.2	2.3	2.6	3.6	6.2	4.0	3.4	2.8	1.8	2.3	0.7	2.2	3.5	1.4	2.0	3.4	3.7	2.7	3.8	2.6	39.6	4.6	3.9	2.7	3.9	1.5	0.4	2.6	1.0	4.2	4.5	1.1	1.0	2.7	1.4	1.0	2.8	5.0	1.3	3.6	8.8	2.6	3.2	3.8	1.8	3.5	0.7	31.7	2.4	3.3	5.3	2.3	0.5	1.5	2.1	1.3	2.5	2.2	1.3	0.9	1.8	2.2	0.0	3.2	223.4	1.0	0.9	0.5	2.0	0.3	0.8	0.3	1.0	5.1	1.4	0.6	1.1	2.8	1.2	2.0	1.0	1.8	1.1	1.6	1.0	0.1	4.2	0.9	3.9	0.8	3.9	1.6	1.8	0.2	0.2	12.8	4.6	0.9	5.2	0.5	0.3	0.3	1.8	2.5	0.3	1.7	0.0	0.0	2.5	0.7	1.1	4.0	6.9	1.8	217.6	24.0	299.5	2.6	3.9	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	4.2	4.2	3.6	6.2	3.4	3.7	4.6	3.9	2.7	4.2	3.6	3.8	5.3	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	29.3	0.0	0.0	0.0	0.0	0.0	6.6	0.0	1.4	0.1	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0
MOBP		ENSG00000168314	"Myelin associated oligodendrocyte basic protein"	Q13875	3	39467198-39529479	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 933.7"	"Cell type enriched"	"Detected in some"	14	"Oligodendrocytes: 1607.0"	"Cancer enriched"	"Detected in single"	63	"glioma: 4.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	50	"HAP1: 18.6"	"Low region specificity"	"Detected in all"							HPA035152	Enhanced		Supported	"Cytoplasmic bodies"		NA	NA			"Cytoplasmic bodies"		"HPA035152: AB_10603020"	"unprognostic (1.76e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.53e-2)"	"unprognostic (7.35e-2)"	"unprognostic (5.67e-2)"	"unprognostic (3.60e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.04e-5)"	"unprognostic (2.28e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-2)"	0.1	0.1	471.7	0.1	548.1	0.0	0.1	472.4	448.0	0.1	168.7	0.7	0.0	0.5	0.0	0.0	1.5	0.1	0.2	340.0	446.2	0.1	0.1	0.7	0.0	838.5	614.4	252.2	0.8	0.1	2.5	0.4	0.0	711.3	0.1	0.2	0.2	0.3	0.0	0.2	0.1	0.1	0.1	693.8	0.1	0.1	5.5	586.0	0.0	0.1	0.0	0.0	0.3	0.1	933.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	471.7	548.1	472.4	448.0	340.0	446.2	838.5	614.4	252.2	711.3	693.8	586.0	933.7	0.1	0.0	0.0	3.3	0.0	0.6	0.1	0.0	0.0	0.1	0.2	0.3	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	105.1	1.5	0.1	0.2	0.0	0.0	6.1	0.0	0.0	0.2	0.0	0.8	11.4	40.9	0.0	0.0	0.0	0.0	3.8	0.2	0.0	0.0	1.6	113.0	1.5	0.2	0.0	1.0	0.0	0.2	0.0	4.0	1607.0	0.1	0.4	0.7	0.0	0.1	0.0	0.0	1.1	0.4	0.0	0.1	0.5	41.8	6.1	0.0	0.4	0.0	0.1	0.0	0.4	0.0
MT4	MTIV	ENSG00000102891	"Metallothionein 4"	P47944	16	56565073-56568957	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	6	"skin 1: 116.0"	"Cell type enriched"	"Detected in some"	4	"Suprabasal keratinocytes: 19.7"	"Group enriched"	"Detected in many"	6	"cervical cancer: 6.7;endometrial cancer: 11.6"	"Region enriched"	"Detected in single"	9	"cerebral cortex: 2.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"									NA	NA																				"unprognostic (8.81e-2)"			0.8	0.0	0.2	0.0	0.1	0.0	0.0	0.0	2.1	1.9	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.6	116.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	6.3	0.0	0.0	0.0	0.0	18.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	2.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.8	19.7	0.0	0.0	0.0	0.0	0.0
NEUROD4	"ATH-3, Atoh3, bHLHa4, MATH-3"	ENSG00000123307	"Neuronal differentiation 4"	Q9HD90	12	55019974-55030017	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"pituitary gland: 8.2;retina: 30.5"	"Cell type enriched"	"Detected in some"	21	"Bipolar cells: 217.6"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	9	"midbrain: 3.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AF22: 1.3;SCLC-21H: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA015545	Enhanced					NA	NA					"HPA015545: AB_2669215"					"unprognostic (1.78e-2)"													0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	30.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	217.6	0.0	0.0	2.6	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NFE2	NF-E2	ENSG00000123405	"Nuclear factor, erythroid 2"	Q16621	12	54292111-54301015	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 113.4;lymphoid tissue: 45.7"	"Cell type enriched"	"Detected in some"	5	"Erythroid cells: 265.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"basophil: 1489.2;neutrophil: 810.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 1489.2"	"Group enriched"	"Detected in some"	5	"HEL: 376.9;K-562: 168.1;NB-4: 118.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA001914	Enhanced		Approved	"Nucleoplasm,Actin filaments"		NA	NA			"Nucleoplasm, Actin filaments"		"HPA001914: AB_1079475"	"unprognostic (2.68e-4)"	"unprognostic (2.93e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.55e-2)"	"unprognostic (4.12e-1)"	"unprognostic (4.55e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.57e-3)"	"unprognostic (9.90e-6)"	"unprognostic (1.81e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.46e-2)"	3.5	0.3	0.6	6.3	0.6	113.4	0.6	0.5	1.4	1.4	2.1	0.4	0.5	0.3	0.1	0.8	2.4	1.2	1.6	0.5	0.5	1.3	2.6	13.1	0.3	0.7	0.6	0.4	0.2	0.7	1.1	0.9	4.0	0.7	0.5	0.2	0.0	0.5	0.1	1.4	4.9	0.6	1.9	0.5	45.7	0.8	1.2	0.7	1.4	1.4	3.7	0.1	2.3	0.5	0.6	0.3	0.3	0.0	0.0	0.0	0.5	1.4	1.1	6.9	0.7	0.9	5.5	10.0	0.1	0.9	0.9	0.4	0.3	0.0	0.0	0.3	0.0	0.1	376.9	0.9	9.1	0.0	5.8	48.5	0.5	0.1	0.3	0.2	4.4	0.0	0.1	168.1	0.1	0.0	0.1	15.3	118.8	0.1	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	2.6	0.2	0.6	1.8	1.0	18.9	0.3	0.2	0.4	1.1	0.1	0.0	0.0	0.1	0.4	23.4	0.0	1489.2	241.7	232.3	0.6	66.7	1.0	0.3	0.8	0.5	156.7	0.5	1.0	0.7	810.6	1.1	42.0	2.7	0.2	160.2	0.6	0.6	0.5	1.4	0.5	0.5	0.7	0.6	0.4	0.7	0.5	0.7	0.6	0.0	0.0	3.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	1.5	0.1	0.0	0.0	0.2	1.3	0.0	0.0	0.1	5.9	0.1	0.0	0.0	0.0	265.6	0.0	0.0	0.5	0.4	0.0	0.1	3.8	0.1	0.4	0.2	1.0	0.0	0.0	0.0	0.0	22.8	0.2	19.0	0.0	44.3	1.8	0.0	33.9	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.8	0.0	0.0	0.1	0.0	0.3	1.3	0.0	0.3	1.2	1.1	0.0	0.1	0.1
NKX2-5	"CSX, CSX1, NKX2.5, NKX2E, NKX4-1"	ENSG00000183072	"NK2 homeobox 5"	P52952	5	173232109-173235311	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Atrial septal defect, Congenital hypothyroidism, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"heart muscle: 204.3"	"Cell type enriched"	"Detected in some"	26	"Cardiomyocytes: 68.4"	"Cancer enhanced"	"Detected in many"		"glioma: 3.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 32.9;NTERA-2: 11.4;SK-MEL-30: 15.2;U-2 OS: 25.4;U-251 MG: 20.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA065034			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA065034: AB_2685409"	"unprognostic (3.81e-1)"	"unprognostic (8.53e-2)"		"unprognostic (2.62e-2)"	"unprognostic (9.57e-3)"	"unprognostic (3.22e-3)"		"unprognostic (6.63e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.31e-1)"			"unprognostic (5.80e-2)"	"unprognostic (2.19e-1)"		"unprognostic (1.77e-2)"	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	204.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	35.1	0.0	0.1	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.0	5.0	1.7	0.1	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	7.6	32.9	0.0	0.3	2.7	0.0	0.0	0.0	0.0	0.2	0.2	0.0	2.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.1	0.5	6.3	0.0	15.2	4.2	0.0	0.1	0.0	5.9	25.4	7.8	20.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	68.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.1	0.0	0.1	0.1	0.0	0.7	0.0	0.0
PCDHA5	"CNR6, CNRN6, CNRS6, CRNR6, PCDH-ALPHA5"	ENSG00000204965	"Protocadherin alpha 5"	Q9Y5H7	5	140821604-141012347	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"brain: 3.4"	"Cell type enriched"	"Detected in some"	4	"Horizontal cells: 6.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebellum: 3.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.3;EFO-21: 3.4;T-47d: 3.7;WM-115: 1.3"	"Low region specificity"	"Detected in many"							HPA044557	Approved		Approved	"Nuclear speckles,Plasma membrane,Mitochondria"		NA	NA			"Plasma membrane"	"Nuclear speckles, Mitochondria"	"HPA044557: AB_10970597"	"unprognostic (4.95e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.81e-4)"	"unprognostic (5.10e-2)"	"unprognostic (6.25e-3)"	"unprognostic (6.74e-2)"	"unprognostic (9.79e-2)"	"unprognostic (2.46e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.10e-4)"	"unprognostic (9.30e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.17e-5)"	"unprognostic (2.11e-1)"	0.1	0.1	0.3	0.0	1.0	0.0	0.1	3.4	1.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.8	0.3	0.1	0.0	0.1	0.0	0.1	0.2	0.8	0.1	0.2	0.0	0.5	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	1.3	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	3.7	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	1.0	3.4	1.1	0.8	0.3	0.1	0.2	0.8	1.0	0.3	0.1	0.8	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PDE1C	Hcam3	ENSG00000154678	"Phosphodiesterase 1C"	Q14123	7	31751179-32428131	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 68.8;heart muscle: 59.1"	"Cell type enriched"	"Detected in many"	5	"Oligodendrocytes: 1071.4"	"Cancer enhanced"	"Detected in some"		"glioma: 1.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 44.4;fHDF/TERT166: 148.3;hTERT-RPE1: 44.9;U-251 MG: 77.9;WM-115: 105.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052375			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA052375: AB_2681802"	"unprognostic (1.29e-2)"	"unprognostic (2.20e-5)"	"unprognostic (1.68e-2)"	"unprognostic (1.20e-3)"	"unprognostic (2.29e-1)"	"unprognostic (5.65e-2)"	"unprognostic (4.06e-3)"	"unprognostic (2.75e-1)"	"unprognostic (6.79e-3)"	"unprognostic (6.49e-2)"	"unprognostic (3.88e-5)"	"unprognostic (7.03e-2)"	"unprognostic (3.09e-3)"	"unprognostic (5.76e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.06e-3)"	2.2	1.8	16.4	2.5	41.5	0.0	4.4	19.9	32.1	0.6	0.1	2.7	1.4	2.5	6.1	6.4	10.6	1.5	59.1	17.9	27.0	4.1	0.1	5.0	0.6	29.6	28.7	16.0	3.9	2.6	0.3	1.3	3.3	34.2	2.0	1.8	7.4	1.8	3.3	0.6	0.4	3.3	5.1	16.8	0.6	4.0	3.8	29.8	1.6	3.2	4.0	0.1	9.9	1.4	68.8	0.3	5.8	15.5	0.0	0.6	0.4	0.2	44.4	18.3	20.8	17.1	0.0	0.0	0.0	0.2	148.3	0.0	1.2	0.0	0.0	27.1	0.0	0.0	1.3	1.4	0.0	0.1	0.0	31.9	1.9	0.0	4.3	0.2	44.9	7.1	0.0	0.1	0.1	1.7	0.0	0.1	0.0	0.0	0.0	13.7	0.0	0.0	0.0	22.5	0.0	6.8	0.0	0.0	0.0	0.0	1.3	0.0	0.3	0.2	22.8	8.6	0.4	77.9	0.4	0.0	0.0	2.4	0.5	105.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.4	41.5	19.9	32.1	17.9	27.0	29.6	28.7	16.0	34.2	16.8	29.8	68.8	1.2	0.0	0.0	7.5	0.1	0.0	0.7	0.1	1.2	69.5	2.8	17.1	136.0	0.0	0.7	1.8	52.1	0.0	0.1	0.0	0.0	4.8	53.4	0.2	0.1	3.9	0.0	0.0	70.8	0.4	0.0	8.7	0.0	0.4	8.8	0.2	0.0	0.0	0.1	3.3	169.2	0.0	59.0	0.0	0.2	50.3	0.3	0.5	0.0	15.9	0.0	0.9	0.0	196.6	1071.4	0.2	0.0	0.4	0.1	0.2	0.0	0.0	2.2	4.7	0.0	0.9	9.4	1.3	1.2	0.2	0.0	0.0	0.1	1.2	0.0	0.0
PFKFB1	PFRX	ENSG00000158571	"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1"	P16118	X	54932961-54998534	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Kinase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"adipose tissue: 28.6;liver: 50.7;skeletal muscle: 112.6;tongue: 41.1"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 15.9"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 7.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC diff: 8.5;Hep G2: 3.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (2.51e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.64e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.33e-1)"	"unprognostic (3.26e-3)"	"unprognostic (2.88e-1)"	"unprognostic (5.36e-3)"	"unprognostic (5.06e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.16e-4)"	"unprognostic (1.96e-3)"	28.6	0.5	0.4	0.1	0.5	0.4	9.3	0.4	0.5	0.1	0.2	0.4	0.1	0.1	0.6	1.1	0.1	0.3	0.2	0.4	0.4	1.1	50.7	0.2	0.5	0.5	0.5	0.3	0.0	1.3	0.3	0.5	0.2	0.5	0.3	0.5	0.4	0.7	0.2	112.6	0.8	0.5	0.1	0.4	0.3	0.4	0.4	0.4	0.4	1.0	41.1	0.6	0.2	0.2	0.6	0.2	0.1	0.2	0.4	8.5	0.1	0.6	0.0	0.1	0.1	0.0	0.5	0.1	0.4	0.1	0.0	0.4	0.3	0.1	0.2	0.3	0.3	0.7	0.2	0.1	3.2	0.0	0.0	0.3	0.1	0.4	0.0	0.2	0.0	0.0	0.8	0.1	1.4	0.1	0.5	0.4	0.2	0.2	0.2	0.2	0.3	0.1	0.1	0.0	0.2	0.2	0.1	0.3	1.0	0.1	0.7	0.2	0.0	0.1	0.1	0.3	0.2	0.1	0.7	1.2	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.5	0.4	0.5	0.4	0.4	0.5	0.5	0.3	0.5	0.4	0.4	0.6	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	15.9	0.1	0.0	1.5	0.1	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	3.1	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.5	0.3	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0
PGLYRP3	"PGLYRPIalpha, PGRP-Ialpha, PGRPIA"	ENSG00000159527	"Peptidoglycan recognition protein 3"	Q96LB9	1	153297862-153310718	"Metabolic proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 39.3;skin 1: 74.3;vagina: 21.6"	"Cell type enriched"	"Detected in single"	12	"Squamous epithelial cells: 4.9"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 8.9;head and neck cancer: 16.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"HaCaT: 3.8;HDLM-2: 1.6;hTCEpi: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA030369	Uncertain				"Secreted in other tissues"	NA	NA					"HPA030369: AB_10603984"		"unprognostic (6.34e-2)"	"unprognostic (1.60e-1)"			"unprognostic (7.09e-2)"		"unprognostic (2.24e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.88e-3)"			"unprognostic (1.28e-1)"	"unprognostic (1.82e-1)"		"unprognostic (2.25e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	39.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.1	74.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	7.7	0.0	21.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.4	0.0	0.0	0.0	0.0	0.0
PIP4K2A	"PIP5K2A, PIP5KIIA, PIP5KIIalpha"	ENSG00000150867	"Phosphatidylinositol-5-phosphate 4-kinase type 2 alpha"	P48426	10	22534854-22714578	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"brain: 510.5"	"Cell type enriched"	"Detected in many"	6	"Oligodendrocytes: 1585.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065440, HPA068771"	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA		4900000	"Golgi apparatus"	"Plasma membrane, Cytosol"	"HPA065440: AB_2685490, HPA068771: AB_2686030"	"unprognostic (1.11e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.57e-3)"	"unprognostic (4.20e-3)"	"unprognostic (1.55e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.56e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (1.52e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.92e-3)"	28.6	15.6	177.0	48.3	322.2	45.2	15.1	248.1	229.0	26.7	78.1	18.0	13.3	21.3	11.9	20.0	15.3	33.2	13.4	179.7	220.5	16.7	18.8	26.1	81.9	260.2	291.8	130.5	8.9	11.0	24.9	8.6	23.8	291.0	9.4	19.3	15.5	7.9	13.1	5.2	7.9	20.7	31.8	213.5	63.2	19.5	12.6	253.1	60.9	12.9	11.0	89.2	24.3	10.6	510.5	30.2	29.2	33.4	10.8	52.3	70.6	25.3	55.0	58.1	29.1	35.7	27.6	47.2	63.2	19.4	111.0	63.7	10.4	29.2	15.4	29.2	140.5	30.4	118.7	21.6	60.9	92.5	23.1	89.1	35.6	13.7	39.7	38.2	44.6	43.7	83.5	67.4	119.1	54.5	12.5	92.3	20.5	13.7	14.5	20.7	36.9	47.8	86.3	43.0	5.8	6.1	13.9	17.7	9.0	86.4	37.6	7.6	39.1	53.0	22.3	32.8	41.7	33.9	75.1	46.3	45.0	60.5	68.3	17.6	72.6	32.6	104.0	119.5	57.9	164.0	52.1	94.2	139.9	43.7	33.1	62.8	118.2	40.5	144.2	67.3	44.8	75.9	183.4	177.0	322.2	248.1	229.0	179.7	220.5	260.2	291.8	130.5	291.0	213.5	253.1	510.5	22.5	3.2	6.7	84.9	43.2	17.6	4.0	2.0	3.4	5.7	12.9	5.5	8.1	14.3	5.6	18.4	2.1	8.6	196.9	3.4	11.7	9.7	22.9	7.4	15.7	29.2	4.9	236.9	65.6	10.7	5.4	19.6	6.6	24.8	22.8	13.4	62.4	8.7	31.8	13.5	62.0	2.9	0.0	98.6	80.0	34.5	16.8	82.8	104.9	142.4	81.3	5.0	159.6	167.9	1585.0	22.1	3.7	10.1	36.4	7.1	1.0	15.6	2.2	9.1	19.7	14.1	30.6	6.1	7.9	3.3	16.9	12.4	130.7	8.5	2.8	6.6
PLGLB1	"PLGL, PRP-B"	ENSG00000183281	"Plasminogen like B1"	Q02325	2	87002559-87021852	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Tissue enriched"	"Detected in all"	6	"liver: 236.8"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 95.9"	"Cancer enriched"	"Detected in single"	7	"liver cancer: 0.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"																"Secreted to blood"	NA	NA						"unprognostic (7.25e-2)"	"unprognostic (7.25e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.39e-5)"	"unprognostic (7.04e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.53e-4)"	"unprognostic (1.60e-1)"	"unprognostic (4.56e-4)"	"unprognostic (9.90e-3)"	"unprognostic (2.96e-5)"	"unprognostic (1.02e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.32e-2)"	"unprognostic (3.98e-5)"	3.5	5.5	20.4	4.6	21.2	8.6	3.6	32.9	26.7	6.4	21.5	4.5	3.9	6.0	8.2	4.0	4.4	4.8	4.8	20.4	19.7	6.1	236.8	3.3	8.0	18.4	19.3	21.6	6.7	4.1	2.3	9.6	2.3	23.0	6.6	2.7	42.8	4.9	3.2	8.9	14.3	5.4	2.4	15.8	9.5	4.0	4.3	19.6	7.3	5.7	4.4	4.3	4.9	4.9	23.4	2.7	3.7	4.6	2.6	3.6	5.2	4.5	3.2	2.3	1.7	2.6	2.9	6.9	7.3	3.3	1.3	1.3	2.4	1.2	0.5	1.8	8.2	3.1	5.8	6.6	3.1	2.5	3.5	1.5	4.0	4.2	4.7	4.8	7.9	0.8	8.0	3.0	5.9	2.2	3.9	13.3	11.5	5.9	2.4	2.4	3.1	1.7	3.9	4.5	2.9	3.6	4.0	2.9	2.5	2.7	4.6	1.3	7.6	5.0	3.3	2.3	2.3	2.0	6.7	5.1	2.9	1.9	4.7	1.9	1.9	0.3	0.4	0.7	0.1	0.6	1.2	0.7	0.5	0.1	0.8	0.9	0.5	1.0	0.4	0.3	0.6	1.1	0.1	20.4	21.2	32.9	26.7	20.4	19.7	18.4	19.3	21.6	23.0	15.8	19.6	23.4	1.3	0.0	3.4	0.7	1.0	1.1	0.3	0.4	1.2	10.3	1.1	1.0	2.6	1.5	1.5	0.0	6.2	0.2	1.5	0.7	0.0	1.1	0.8	1.0	1.0	1.6	1.2	4.0	0.9	0.2	0.2	1.6	0.5	0.9	0.0	1.0	1.8	95.9	0.2	5.0	1.1	2.5	0.0	1.3	0.4	0.3	1.2	1.1	3.6	0.0	1.6	2.7	1.0	0.0	0.8	0.3	0.3	1.9	0.9	0.5	0.7	1.8	2.3	18.2	0.0	2.5	1.0	0.7	0.5	1.5	1.3	0.0	1.4	0.9	0.9	0.3
PRAP1	UPA	ENSG00000165828	"Proline rich acidic protein 1"	Q96NZ9	10	133347368-133352683	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"intestine: 1144.8;liver: 680.6"	"Cell type enriched"	"Detected in some"	9	"Proximal enterocytes: 17736.9"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 348.8"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"CACO-2: 34.2;Hep G2: 128.3"									"HPA038713, HPA052451"	Supported				"Secreted to digestive system"	NA	NA		210000000			"HPA038713: AB_10673117, HPA052451: AB_2681839"	"unprognostic (1.63e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.89e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.90e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.30e-1)"	"unprognostic (4.35e-3)"	"unprognostic (4.91e-2)"	"unprognostic (8.23e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.22e-3)"	0.6	0.5	0.7	4.2	0.7	0.5	0.3	0.4	0.7	0.2	5.3	75.3	1063.3	0.8	0.1	0.4	0.7	2.7	0.3	0.6	0.4	146.7	680.6	0.3	1.5	1.2	0.5	0.4	0.4	0.1	0.1	0.8	0.1	1.3	0.3	36.0	0.0	1.7	0.3	0.2	1.4	1144.8	1.7	0.6	0.8	2.8	12.3	0.6	0.4	0.2	0.3	0.1	0.3	0.2	0.6	0.2	0.5	0.1	1.2	0.1	0.0	14.6	0.0	0.0	0.0	0.0	34.2	0.6	0.5	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.3	0.5	128.3	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.6	0.0	3.5	0.4	5.0	0.0	0.2	0.9	2.9	0.0	0.0	0.9	4.6	0.4	0.0	0.0	0.8	0.0	0.2	0.0	0.0	1.4	1.3	0.0	1.4	0.1	0.4	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.7	0.7	0.4	0.7	0.6	0.4	1.2	0.5	0.4	1.3	0.6	0.6	0.6	0.0	0.0	0.0	0.0	7.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	8.6	0.0	9.2	0.0	0.2	0.0	773.7	33.2	0.1	1.9	0.6	0.0	0.6	18.4	13.5	0.1	0.2	0.2	0.2	1.5	0.1	8.9	0.0	12.5	1021.3	0.2	0.0	0.0	676.2	0.0	20.9	0.0	7.3	1.2	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1815.7	1.5	0.0	0.1	17736.9	412.0	0.1	0.0	0.0	0.0	0.1	140.2	38.2	0.0	0.0	0.3	3.5	0.0	607.1	0.1
RBM24	"dJ259A10.1, FLJ30829, RNPC6"	ENSG00000112183	"RNA binding motif protein 24"	Q9BX46	6	17281361-17293871	"Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"heart muscle: 143.4;skeletal muscle: 316.0;tongue: 106.6"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 193.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 58.7;RH-30: 59.7;T-47d: 28.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA066927, HPA067231"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA066927: AB_2685750, HPA067231: AB_2685808"	"unprognostic (9.05e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.67e-3)"	"unprognostic (1.53e-1)"	"unprognostic (4.54e-4)"	"unprognostic (3.34e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.97e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.33e-4)"	4.3	0.5	4.4	1.8	5.0	0.1	3.8	0.6	6.1	12.4	2.7	6.8	1.6	31.5	16.9	7.4	24.2	2.7	143.4	4.6	5.0	0.7	1.2	1.3	0.5	3.0	1.7	5.0	2.2	0.2	2.1	5.6	0.6	1.5	10.0	7.5	0.4	4.1	5.8	316.0	1.2	3.7	29.5	1.4	1.2	2.2	4.2	2.8	0.8	2.1	106.6	0.3	8.8	3.6	3.0	1.5	9.3	12.0	0.0	0.0	0.0	0.0	18.7	6.8	12.4	13.0	0.0	1.1	0.0	5.7	13.4	19.5	0.0	11.5	0.4	22.3	0.0	0.4	0.0	1.0	6.4	0.5	0.0	1.1	6.4	0.0	2.4	0.5	15.8	1.6	0.0	0.0	0.0	58.7	2.8	0.0	0.2	4.1	0.0	1.4	0.1	59.7	0.0	0.0	0.0	7.8	0.9	0.2	0.0	0.2	9.3	28.2	0.4	0.0	4.2	10.0	0.0	16.2	0.0	0.0	0.1	0.3	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	5.0	0.6	6.1	4.6	5.0	3.0	1.7	5.0	1.5	1.4	2.8	3.0	1.1	0.0	0.0	0.0	0.0	1.1	0.2	1.1	0.0	2.3	3.2	0.8	193.2	0.0	1.8	0.0	0.0	0.1	0.1	4.3	0.0	0.0	0.6	33.5	13.6	1.5	4.8	0.0	11.6	0.0	13.4	6.4	0.0	9.9	1.3	0.5	0.4	0.0	0.3	1.7	6.6	4.5	0.0	0.0	0.7	1.9	0.0	0.3	1.8	1.9	0.0	0.7	0.0	0.5	0.4	0.3	2.2	0.7	0.0	0.3	0.0	0.6	21.9	0.0	6.6	23.9	19.7	0.4	7.3	0.2	1.0	0.8	0.5	0.0	3.0	0.1
SARDH	"DMGDHL1, SDH"	ENSG00000123453	"Sarcosine dehydrogenase"	Q9UL12	9	133663560-133739955	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"epididymis: 48.3;liver: 115.3;pancreas: 43.6"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 120.6"	"Cancer enriched"	"Detected in many"	8	"liver cancer: 18.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 3.3;naive CD4 T-cell: 6.7;T-reg: 8.8"	"Lineage enriched"	"Detected in single"	16	"T-cells: 8.8"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 17.4;Hep G2: 31.1;MOLT-4: 22.5;RH-30: 18.5;RPMI-8226: 39.1;SH-SY5Y: 14.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA057267, HPA058086"	Approved		Approved	Mitochondria		NA	NA		230000	Mitochondria		"HPA057267: AB_2683388, HPA058086: AB_2683601"	"unprognostic (3.64e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (4.62e-4)"	"unprognostic (5.83e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.74e-3)"	"unprognostic (2.78e-1)"	"unprognostic (3.48e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.30e-2)"	1.0	2.2	3.6	2.5	3.3	0.9	0.8	1.8	4.0	2.3	0.6	1.0	1.8	2.1	48.3	0.6	1.9	1.3	1.6	3.1	2.9	12.2	115.3	2.7	4.1	4.2	2.7	2.9	3.1	43.6	2.1	4.1	0.9	2.9	2.3	0.4	0.6	5.3	1.8	0.6	0.4	1.3	0.9	2.6	1.3	3.0	0.7	3.7	4.3	1.6	0.3	2.4	1.1	1.0	2.8	0.0	0.1	1.4	17.4	0.1	0.5	2.3	0.1	0.7	0.9	1.1	0.3	0.2	0.0	2.4	0.3	2.2	0.1	0.0	0.3	0.7	0.0	0.3	2.5	0.0	31.1	1.9	0.1	0.3	4.2	0.0	2.0	0.1	0.4	0.2	13.1	0.1	0.4	11.1	3.2	22.5	2.4	2.8	1.7	0.2	1.6	18.5	39.1	0.0	0.1	1.7	14.7	0.0	0.4	3.9	0.8	2.4	0.2	0.1	3.3	3.0	0.3	0.0	0.3	0.0	1.3	2.1	1.4	0.1	0.3	0.1	0.1	0.3	0.0	0.8	0.0	3.3	0.8	0.0	0.3	6.7	1.2	0.5	0.1	0.0	0.3	8.8	1.4	3.6	3.3	1.8	4.0	3.1	2.9	4.2	2.7	2.9	2.9	2.6	3.7	2.8	0.1	0.0	1.9	6.8	0.4	0.3	0.4	0.0	1.2	0.1	0.2	0.8	0.8	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	1.0	0.8	1.2	5.7	1.5	1.1	0.1	2.3	0.0	0.3	1.3	0.8	2.9	120.6	0.1	0.0	0.7	0.0	0.0	1.6	0.6	0.8	4.7	0.2	0.0	1.9	0.0	4.2	1.0	0.5	0.3	0.1	0.0	3.0	0.7	0.3	0.0	21.3	0.0	0.3	0.0	1.6	3.5	0.1	0.8	0.0	0.1	0.0	4.2	1.6	0.0	0.2
SCN4A	"HYKPP, HYPP, Nav1.4, SkM1"	ENSG00000007314	"Sodium voltage-gated channel alpha subunit 4"	P35499	17	63938554-63972918	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Congenital myasthenic syndrome, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"skeletal muscle: 138.7;tongue: 54.5"	"Cell type enriched"	"Detected in some"	6	"Adipocytes: 46.4"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"REH: 15.0;RH-30: 45.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053992			Approved	"Nucleoplasm,Centriolar satellite"		NA	NA			Nucleoplasm	"Centriolar satellite"	"HPA053992: AB_2797249"	"unprognostic (2.47e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.87e-4)"	"unprognostic (3.84e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.59e-3)"	"unprognostic (3.15e-2)"	"unprognostic (2.70e-2)"	"unprognostic (4.38e-3)"	"unprognostic (3.46e-1)"	"unprognostic (4.15e-1)"	"unprognostic (6.45e-2)"	14.7	0.7	0.0	0.2	0.1	0.0	16.2	0.2	0.1	0.1	0.0	0.8	0.0	0.1	0.0	1.1	0.2	0.3	0.8	0.0	0.0	0.4	0.1	0.0	0.4	0.0	0.0	0.0	0.2	0.2	0.7	1.5	0.1	0.1	0.5	0.1	0.0	1.8	0.0	138.7	0.7	0.3	0.0	0.0	0.9	0.5	1.7	0.0	0.2	4.3	54.5	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	1.5	0.0	0.0	15.0	45.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	2.8	1.4	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	46.4	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.2	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.5	0.0	0.0	2.3	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.1	0.0	1.1	2.2	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	4.6	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.1	5.9	0.3	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0
SLC24A2	NCKX2	ENSG00000155886	"Solute carrier family 24 member 2"	Q9UI40	9	19507452-19786928	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Potassium transport, Sensory transduction, Sodium transport, Symport, Transport, Vision"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 108.6"	"Cell type enriched"	"Detected in some"	4	"Oligodendrocytes: 2710.1"	"Group enriched"	"Detected in some"	4	"breast cancer: 0.5;glioma: 1.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 2.6;SCLC-21H: 2.2;U-87 MG: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA079359			Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA079359: "	"unprognostic (1.30e-1)"	"unprognostic (8.57e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.48e-2)"		"unprognostic (8.46e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.50e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.08e-4)"	"unprognostic (1.58e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.51e-2)"	0.1	6.0	21.1	0.0	49.8	0.1	0.0	29.1	62.5	0.1	0.0	0.1	0.0	2.1	0.0	0.0	0.5	0.1	0.0	19.6	28.7	0.1	0.0	0.0	0.0	69.7	37.7	4.5	0.0	0.0	0.0	0.8	0.1	77.8	0.1	0.0	18.9	0.0	0.0	0.1	0.1	0.0	0.0	14.7	0.1	0.1	0.2	59.0	0.0	0.0	0.3	0.0	0.0	0.0	108.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.1	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.2	0.2	0.1	0.1	0.0	21.1	49.8	29.1	62.5	19.6	28.7	69.7	37.7	4.5	77.8	14.7	59.0	108.6	0.0	0.0	0.0	18.9	0.1	0.0	0.0	0.0	0.0	58.7	0.0	0.0	2.3	0.0	0.0	0.0	273.1	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.1	0.1	0.0	0.0	668.6	0.0	0.1	0.9	0.0	0.1	0.0	0.0	1.4	0.0	0.1	97.6	637.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	25.3	0.0	4.1	0.0	217.6	2710.1	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	10.4	0.0	3.2	0.2	0.2	0.7	0.0	0.1	0.3	0.0	0.0	0.1	0.0
SLC4A1	"AE1, CD233, DI, EPB3, FR, RTA1A, SW, WD, WR"	ENSG00000004939	"Solute carrier family 4 member 1 (Diego blood group)"	P02730	17	44248390-44268141	"Blood group antigen proteins, CD markers, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Ion transport, Transport"	"Blood group antigen"	"Disease variant, Elliptocytosis, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"bone marrow: 410.5"	"Cell type enriched"	"Detected in some"	80	"Erythroid cells: 1629.2"	"Cancer enriched"	"Detected in single"	91	"renal cancer: 16.3"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"basophil: 3.0;neutrophil: 2.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in single"		"K-562: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA015584, CAB034438, HPA063911"	Enhanced					NA	NA		22000000			"CAB034438: AB_2123479, HPA015584: AB_1844824, HPA063911: AB_2685151"	"unprognostic (1.36e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.44e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.72e-3)"	"unprognostic (1.19e-1)"	"unprognostic (9.28e-3)"	"unprognostic (1.93e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.13e-1)"	0.3	0.3	0.7	0.3	0.6	410.5	0.2	2.0	1.1	0.0	2.3	0.2	0.3	0.1	0.3	0.3	0.1	0.3	0.6	0.5	0.7	71.8	2.2	1.8	0.4	0.8	0.6	0.5	0.1	0.2	0.0	0.6	11.0	0.9	0.1	0.1	0.7	0.4	0.1	2.2	0.5	0.2	0.0	0.3	12.9	0.3	0.3	0.9	0.7	0.3	1.5	0.1	0.1	0.1	1.3	0.2	0.0	0.3	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.6	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.2	0.4	0.4	0.0	0.2	0.6	0.1	0.1	0.0	0.0	0.1	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.8	0.2	0.2	0.1	0.6	0.0	0.3	0.1	0.1	0.4	0.2	0.3	0.3	0.1	0.1	0.6	0.6	0.1	0.3	0.3	0.2	0.2	0.1	0.2	0.1	0.4	0.5	0.2	3.0	0.3	0.5	0.2	0.3	0.2	0.3	0.2	0.2	0.1	0.5	0.2	0.2	2.7	1.1	0.4	0.3	0.1	0.2	0.7	0.6	2.0	1.1	0.5	0.7	0.8	0.6	0.5	0.9	0.3	0.9	1.3	0.8	6.4	0.6	0.3	2.0	0.0	1.3	0.0	0.0	0.4	1.0	1.1	0.7	0.0	0.6	20.2	0.0	0.4	0.1	0.2	3.9	0.1	0.8	0.2	0.4	0.7	0.0	1629.2	0.2	0.0	1.6	0.5	0.0	0.5	0.0	0.1	0.7	0.9	1.4	0.0	0.2	0.1	0.0	1.0	0.0	0.0	0.0	1.9	0.0	1.0	0.6	0.2	2.1	0.0	0.0	0.0	0.0	0.4	0.3	0.9	0.2	0.4	0.0	0.2	0.0	1.2	0.2	0.7	0.5	0.0	0.0	0.8	1.5	0.7	0.1	0.6
SLC6A7	PROT	ENSG00000011083	"Solute carrier family 6 member 7"	Q99884	5	150190062-150222788	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 22.4"	"Cell type enriched"	"Detected in some"	4	"Excitatory neurons: 41.5"	"Cancer enhanced"	"Detected in single"		"colorectal cancer: 0.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA028907	Uncertain					NA	NA					"HPA028907: AB_10602404"	"unprognostic (3.01e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.82e-4)"	"unprognostic (6.42e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.50e-1)"	"unprognostic (3.73e-4)"	"unprognostic (8.11e-2)"	"unprognostic (5.46e-2)"	"unprognostic (2.73e-1)"	"unprognostic (3.70e-3)"	0.1	0.0	7.3	0.3	14.2	0.0	0.1	15.4	22.4	0.0	0.4	3.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	11.7	6.3	0.0	0.0	0.1	0.1	3.0	6.5	12.8	0.0	0.0	0.0	0.1	0.0	10.6	0.0	4.0	0.1	0.2	0.0	0.0	0.0	3.3	0.1	2.1	0.0	0.0	0.1	8.0	0.0	0.0	0.0	0.1	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	14.2	15.4	22.4	11.7	6.3	3.0	6.5	12.8	10.6	2.1	8.0	16.7	0.0	0.0	0.0	2.9	0.0	0.3	0.0	0.1	0.0	0.3	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.1	0.0	0.0	0.0	0.2	3.6	0.0	41.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	2.6	5.4	0.0	0.0	0.4	0.0	0.3	0.5	0.0	2.8	0.0	0.0	0.0	0.5	1.6	0.1	8.7	0.0	0.0	0.1	1.9	0.0	0.1	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.7	0.1
SLC7A9	CSNU3	ENSG00000021488	"Solute carrier family 7 member 9"	P82251	19	32830509-32869767	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Cystinuria, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 125.6;kidney: 68.8"	"Cell type enriched"	"Detected in some"	7	"Proximal enterocytes: 772.0"	"Group enriched"	"Detected in some"	7	"liver cancer: 6.6;renal cancer: 5.2;stomach cancer: 1.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	16	"BEWO: 3.4;CACO-2: 8.2;Hep G2: 8.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042591	Enhanced					NA	NA					"HPA042591: AB_10962500"	"unprognostic (4.12e-2)"	"unprognostic (5.40e-2)"	"unprognostic (6.19e-2)"	"unprognostic (3.37e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.39e-1)"	"unprognostic (9.69e-2)"	"unprognostic (5.97e-2)"	"unprognostic (3.20e-1)"	"unprognostic (4.94e-3)"	"unprognostic (5.10e-5)"	0.2	0.1	0.8	0.1	0.8	0.0	0.3	0.8	0.9	0.6	0.6	0.7	79.0	0.4	1.5	0.2	0.5	0.2	0.1	0.7	0.8	68.8	17.4	0.2	0.1	0.7	0.7	0.7	0.6	0.3	0.0	0.7	0.1	0.9	1.0	0.2	1.0	0.2	0.2	0.0	0.2	125.6	0.2	0.7	0.3	0.2	0.4	0.7	0.2	0.8	0.0	0.0	0.3	0.5	0.9	0.0	0.1	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.8	0.9	0.7	0.8	0.7	0.7	0.7	0.9	0.7	0.7	0.9	0.1	0.0	0.0	2.3	0.5	0.0	0.1	0.0	0.0	1.3	0.2	0.6	0.4	0.0	0.0	5.5	4.2	0.2	0.1	0.0	1.9	0.1	1.6	0.3	0.2	0.1	0.0	0.0	3.1	7.2	8.8	0.2	0.0	0.2	0.0	0.4	0.0	12.2	0.2	0.0	3.0	18.2	0.0	0.0	0.0	0.1	0.6	0.5	0.0	2.8	0.0	0.2	0.0	0.0	1.7	0.6	27.5	0.0	0.0	0.0	772.0	97.8	1.8	1.2	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.5	0.1	11.7	0.0
SOHLH1	"bA100C15.3, bHLHe80, C9orf157, NOHLH, SPATA27, TEB2"	ENSG00000165643	"Spermatogenesis and oogenesis specific basic helix-loop-helix 1"	Q5JUK2	9	135693407-135704498	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 29.1;choroid plexus: 12.1;testis: 17.0"	"Cell type enriched"	"Detected in some"	4	"Spermatogonia: 78.3"	"Group enriched"	"Detected in some"	5	"cervical cancer: 2.3;endometrial cancer: 0.6;head and neck cancer: 2.3;lung cancer: 2.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"CACO-2: 20.9;U-266/84: 39.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA059439			Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA059439: AB_2684017"	"unprognostic (2.93e-1)"			"unprognostic (1.23e-3)"	"unprognostic (9.85e-3)"	"unprognostic (2.84e-2)"		"unprognostic (3.55e-1)"		"unprognostic (2.59e-3)"				"unprognostic (4.98e-3)"	"unprognostic (2.17e-1)"		"unprognostic (1.63e-1)"	0.1	0.0	13.4	0.0	15.7	0.0	0.0	12.8	29.1	0.0	12.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	15.1	12.7	0.0	0.0	0.0	0.0	16.4	13.4	14.5	0.1	0.0	0.1	3.2	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	12.3	0.1	0.1	17.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	20.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	39.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	15.7	12.8	29.1	15.1	12.7	16.4	13.4	14.5	16.8	12.3	12.8	18.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.1	0.0	0.0	15.9	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.5	0.0	0.0	0.0	0.0	5.1	0.6	0.0	0.0	3.7	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.5	78.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0
STRA8		ENSG00000146857	"Stimulated by retinoic acid 8"	Q7Z7C7	7	135231979-135258492	"Predicted intracellular proteins"	"Differentiation, DNA replication, Meiosis, Oogenesis, Spermatogenesis, Transcription, Transcription regulation"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"choroid plexus: 5.3"	"Cell type enriched"	"Detected in some"	6	"Spermatogonia: 10.8"	"Cancer enhanced"	"Detected in many"		"renal cancer: 2.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.5;THP-1: 2.4;U-266/84: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA078044			Approved	Cytosol		NA	NA			Cytosol		"HPA078044: "		"unprognostic (2.84e-1)"		"unprognostic (4.86e-2)"	"unprognostic (3.89e-2)"	"unprognostic (9.67e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.25e-1)"		"unprognostic (8.55e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.69e-1)"			0.1	0.0	0.6	0.0	0.4	0.0	0.0	0.2	0.4	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.2	0.3	0.0	0.1	0.0	0.4	0.4	0.2	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.1	0.0	0.2	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	2.4	0.1	0.1	0.0	0.0	0.0	0.2	1.5	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.2	0.4	0.9	0.2	0.4	0.4	0.2	0.6	0.2	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.8	10.8	0.0	0.0	0.8	0.0	0.0	0.0	0.0
TEX101	"CT131, MGC4766, SGRG, SPATA44, TES101RP"	ENSG00000131126	"Testis expressed 101"	Q9BY14	19	43401496-43418597	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 118.6"	"Cell type enriched"	"Detected in some"	6	"Spermatocytes: 909.7"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	4	"cerebral cortex: 20.2"	"Immune cell enriched"	"Detected in single"	557	"basophil: 55.7"	"Lineage enriched"	"Detected in single"	557	"granulocytes: 55.7"	"Cell line enhanced"	"Detected in single"		"THP-1: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA041915, HPA042513"	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA041915: AB_10795268, HPA042513: AB_10795507"	"unprognostic (2.50e-2)"	"unprognostic (5.67e-4)"	"unprognostic (2.64e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.78e-4)"		"unprognostic (1.70e-1)"	"unprognostic (2.84e-2)"	"unprognostic (6.54e-2)"	"unprognostic (4.06e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.67e-7)"	"unprognostic (8.83e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.49e-2)"	"unprognostic (7.04e-2)"	0.1	0.4	0.3	0.3	0.3	0.1	0.2	0.3	20.2	0.3	0.3	0.5	0.4	0.5	0.2	1.3	0.3	0.2	0.5	2.4	0.3	0.2	0.5	0.2	0.2	4.5	0.2	0.3	0.5	1.6	0.1	0.0	0.2	1.5	0.3	0.5	0.0	1.1	0.2	0.6	1.5	0.5	0.3	1.0	0.1	0.2	118.6	0.3	1.0	0.1	0.0	1.3	0.1	1.0	0.5	0.2	0.0	0.3	0.1	0.2	0.6	0.1	0.1	0.1	0.2	0.2	0.0	0.1	0.1	0.2	0.4	0.3	0.1	0.1	0.2	0.1	0.3	0.0	0.1	0.4	0.1	0.5	0.1	0.2	0.3	0.4	0.0	0.2	0.2	0.4	0.2	0.1	0.2	0.3	0.0	0.1	0.2	0.1	0.2	0.1	0.7	0.0	0.2	0.5	0.0	0.2	0.0	0.1	0.2	0.6	0.1	0.0	1.3	0.1	0.2	0.1	0.1	0.3	0.2	0.3	0.1	0.2	0.1	0.1	55.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	20.2	2.4	0.3	4.5	0.2	0.3	1.5	1.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.0	0.2	0.1	0.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	10.2	0.0	0.0	31.5	6.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	32.9	0.0	0.0	909.7	151.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMEM235		ENSG00000204278	"Transmembrane protein 235"	A6NFC5	17	78231310-78240987	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	6	"brain: 108.5"	"Cell type enriched"	"Detected in some"	23	"Oligodendrocytes: 107.8"	"Cancer enriched"	"Detected in single"	15	"glioma: 0.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053939	Uncertain					NA	NA					"HPA053939: AB_2682316"					"unprognostic (1.47e-1)"	"unprognostic (6.91e-3)"								"unprognostic (3.92e-2)"	"unprognostic (1.71e-1)"			0.0	0.0	44.3	0.0	67.7	0.0	0.0	44.8	48.7	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.8	44.6	0.0	0.0	0.0	0.0	62.9	58.7	30.5	0.0	0.0	0.0	0.3	0.0	57.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.8	0.0	0.0	0.0	51.5	0.3	0.0	0.0	0.0	0.0	0.0	108.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.3	67.7	44.8	48.7	36.8	44.6	62.9	58.7	30.5	57.3	38.8	51.5	108.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	107.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRAV1-2		ENSG00000256553	"T cell receptor alpha variable 1-2"	A0A0B4J238	14	21642889-21643578	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	6	"lymphoid tissue: 19.5"	"Cell type enriched"	"Detected in single"	6	"T-cells: 4.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	7	"MAIT T-cell: 2027.8"	"Lineage enriched"	"Detected in many"	507	"T-cells: 2027.8"	"Not detected"	"Not detected"																	NA	NA						"unprognostic (1.19e-3)"	"unprognostic (1.29e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.84e-3)"		"unprognostic (5.87e-3)"	"unprognostic (1.55e-3)"	"unprognostic (3.56e-2)"	"unprognostic (8.90e-2)"	"unprognostic (6.50e-4)"	"unprognostic (3.16e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.99e-2)"	"unprognostic (8.30e-2)"	0.3	0.7	0.0	4.5	0.0	1.3	0.4	0.0	0.4	0.6	0.0	1.2	1.6	0.3	0.3	0.5	0.8	3.1	0.1	0.0	0.1	0.2	1.1	2.0	7.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.8	1.2	0.0	0.3	0.0	0.0	0.4	1.3	0.3	0.1	4.6	1.5	0.1	0.0	19.5	0.5	0.0	7.3	2.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.3	0.7	1.0	0.6	2027.8	0.4	44.9	311.2	0.8	0.2	40.9	70.0	3.9	0.3	1.3	1.7	79.5	40.4	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0
TRAV30		ENSG00000259092	"T cell receptor alpha variable 30"	A0A087WSZ9	14	22168429-22168988	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	6	"lymphoid tissue: 13.8"	"Cell type enriched"	"Detected in single"	11	"T-cells: 2.2"	"Cancer enriched"	"Detected in many"	6	"renal cancer: 11.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	19	"memory CD4 T-cell: 23.4;memory CD8 T-cell: 21.4;naive CD4 T-cell: 35.5;naive CD8 T-cell: 22.8;T-reg: 42.3"	"Lineage enriched"	"Detected in many"	28	"T-cells: 42.3"	"Group enriched"	"Detected in some"	14	"HDLM-2: 13.7;HHSteC: 11.4"															NA	NA						"unprognostic (1.98e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.37e-2)"		"unprognostic (3.75e-3)"	"unprognostic (3.51e-1)"	"unprognostic (2.35e-2)"		"unprognostic (3.56e-2)"	"unprognostic (2.29e-1)"		"unprognostic (1.16e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.85e-3)"	"unprognostic (8.04e-3)"	0.1	0.0	0.0	1.5	0.1	0.4	0.0	0.1	0.0	0.1	0.0	0.8	1.4	0.8	0.0	0.2	1.7	0.4	0.0	0.1	0.0	2.2	2.0	0.9	6.5	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.5	0.0	0.4	0.8	0.0	0.0	1.1	0.0	0.0	1.6	0.5	0.0	0.0	13.8	0.0	0.3	3.7	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.8	0.0	0.2	0.1	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.5	1.1	0.0	0.8	0.0	23.4	21.4	0.2	0.0	35.5	22.8	1.4	0.0	0.0	0.2	42.3	11.6	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0
TRBV7-2	"TCRBV6S5A1N1, TCRBV7S2, TRBV72"	ENSG00000282939	"T cell receptor beta variable 7-2"	A0A1B0GXF2	7	142352819-142353358	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	6	"epididymis: 35.9;lymphoid tissue: 86.3"	"Cell type enriched"	"Detected in some"	5	"T-cells: 33.0"					"Region enriched"	"Detected in single"	18	"midbrain: 10.9"	"Immune cell enhanced"	"Detected in many"		"memory CD4 T-cell: 397.4;T-reg: 570.3"	"Lineage enriched"	"Detected in many"	79	"T-cells: 570.3"	"Group enriched"	"Detected in some"	9	"JURKAT: 55.7;MOLT-4: 93.6;U-937: 49.0"															NA	NA																							0.6	0.1	0.0	15.1	0.1	0.0	2.2	0.0	0.2	2.2	0.0	1.2	1.7	0.0	35.9	0.6	0.6	0.0	0.1	0.0	0.6	0.4	0.3	5.6	49.4	0.2	10.9	0.0	0.1	0.2	0.0	1.0	0.1	0.0	0.3	4.6	0.0	0.4	0.4	0.0	0.2	4.7	1.1	0.0	5.8	4.8	0.0	0.1	86.3	0.7	0.0	43.3	2.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.7	0.0	0.0	0.0	0.0	93.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	1.4	0.3	0.0	0.0	49.0	0.0	1.1	2.3	0.7	11.9	1.2	55.5	0.7	397.4	178.6	2.7	0.7	302.2	110.6	1.2	0.5	1.9	7.2	570.3	104.9	0.0	0.1	0.0	0.2	0.0	0.6	0.2	10.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.3	0.0	0.0	0.0	0.2	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	33.0	0.0	0.0	0.0
XIRP2	CMYA3	ENSG00000163092	"Xin actin binding repeat containing 2"	A4UGR9	2	166888480-167259753	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"skeletal muscle: 1042.6;tongue: 548.0"	"Cell type enriched"	"Detected in some"	19	"Cardiomyocytes: 1907.2"	"Cancer enriched"	"Detected in some"	5	"head and neck cancer: 3.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.6;HUVEC TERT2: 4.2;U-2197: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA034813, HPA074599"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA034813: AB_10602588, HPA074599: "					"unprognostic (5.27e-4)"	"unprognostic (5.96e-3)"		"unprognostic (7.42e-2)"	"unprognostic (2.42e-1)"					"unprognostic (1.74e-1)"	"unprognostic (2.56e-1)"			0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.0	140.3	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	6.0	0.0	0.0	8.0	0.0	1042.6	0.7	0.1	0.0	0.0	0.5	0.1	3.1	0.0	0.1	0.3	548.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.1	0.3	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1907.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.5	0.0	0.0	10.1	0.0	0.0	1.9	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	23.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	2.5	1.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	98.4	5.8	1.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0
ZSCAN5B	"ZNF371, ZNF495B"	ENSG00000197213	"Zinc finger and SCAN domain containing 5B"	A6NJL1	19	56189570-56197920	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"testis: 1.3"	"Cell type enriched"	"Detected in single"	8	"Spermatogonia: 6.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA043123, HPA046836, HPA059494, HPA060667"	Uncertain		Uncertain	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA043123: AB_2678328, HPA046836: AB_2679832, HPA059494: AB_2684038, HPA060667: "	"unprognostic (4.73e-2)"	"unprognostic (9.73e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.06e-2)"	"unprognostic (5.79e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.15e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.83e-2)"	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC008687.4		ENSG00000268655	"Novel protein"		19	49017496-49020523	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in some"	5	"pancreas: 8.5;testis: 2.7"	"Cell type enriched"	"Detected in single"	20	"Pancreatic endocrine cells: 4.1"	"Cancer enhanced"	"Detected in some"		"melanoma: 1.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HEK 293: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.06e-1)"	"unprognostic (7.61e-3)"	"unprognostic (7.17e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.23e-1)"		"unprognostic (5.63e-2)"	"unprognostic (4.91e-2)"	"unprognostic (3.85e-1)"	"unprognostic (7.96e-4)"	"unprognostic (9.37e-3)"	"unprognostic (4.19e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.46e-1)"	0.0	0.2	0.3	0.0	0.1	0.0	0.1	0.2	0.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	8.5	0.1	0.4	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.1	1.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.4	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.8	1.2	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.4	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.9	0.0	0.8	0.3	0.7	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.5	0.3	0.0	0.2	0.0	0.0	0.3	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACSBG1	"BG1, BGM, FLJ30320, hBG1, hsBG, KIAA0631, MGC14352"	ENSG00000103740	"Acyl-CoA synthetase bubblegum family member 1"	Q96GR2	15	78167468-78245688	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 62.5"	"Cell type enriched"	"Detected in some"	5	"Astrocytes: 158.0"	"Cancer enriched"	"Detected in some"	4	"glioma: 3.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 3.1;SK-MEL-30: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041642, CAB045955, HPA058869"	Approved		Approved	Vesicles		NA	NA			Vesicles		"CAB045955: AB_11124196, HPA041642: AB_2677593, HPA058869: AB_2683840"	"unprognostic (1.28e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.29e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.96e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.42e-2)"	0.1	5.6	24.3	0.4	36.6	2.4	1.6	32.2	25.4	0.4	0.0	0.9	0.4	0.2	0.7	0.4	2.8	0.2	0.6	20.1	32.5	0.4	0.4	0.5	0.4	47.9	38.9	13.0	0.3	0.2	0.0	0.5	0.1	46.3	0.8	0.1	0.6	0.3	0.2	0.2	11.5	0.5	0.2	51.0	0.3	0.3	3.7	39.1	3.5	0.2	0.0	0.1	0.3	0.5	62.5	0.3	0.0	0.6	0.9	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.3	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.1	0.5	0.3	0.6	0.3	0.0	0.2	0.6	0.2	0.0	0.1	0.1	0.2	0.0	0.4	0.2	0.4	0.0	0.1	0.2	0.5	3.1	0.2	0.1	0.1	0.4	0.2	0.0	0.4	0.2	0.3	0.1	0.4	1.5	0.3	0.1	0.2	0.4	0.2	0.2	0.1	0.1	0.3	0.1	0.3	0.1	0.2	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	1.0	0.0	0.3	24.3	36.6	32.2	25.4	20.1	32.5	47.9	38.9	13.0	46.3	51.0	39.1	62.5	0.1	0.0	2.0	158.0	0.6	1.1	0.6	0.3	0.6	1.9	0.2	0.1	3.0	0.0	2.7	0.0	4.2	0.2	0.5	0.3	0.0	0.0	1.8	4.4	0.3	0.2	0.0	4.6	0.7	0.0	0.2	0.7	0.5	0.3	0.0	0.1	0.0	0.0	0.1	0.0	1.0	0.2	0.0	0.0	0.0	1.7	0.3	4.0	1.8	2.8	0.1	0.2	1.0	7.5	26.9	0.2	0.0	0.0	0.9	0.3	0.1	0.2	19.1	3.3	0.0	0.3	1.0	2.0	10.0	0.4	0.6	0.4	0.5	1.6	0.1	0.7
ACTRT3	ARPM1	ENSG00000184378	"Actin related protein T3"	Q9BYD9	3	169766921-169769561	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 47.8"	"Cell type enriched"	"Detected in many"	6	"Early spermatids: 1021.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 18.1;HSkMC: 11.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA035817, HPA035818"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA035817: AB_10671938, HPA035818: AB_2674801"	"unprognostic (2.35e-1)"	"unprognostic (9.39e-2)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (4.11e-4)"	"unprognostic (1.89e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.31e-4)"	"unprognostic (2.64e-1)"	"unprognostic (9.16e-2)"	"unprognostic (4.41e-2)"	"unprognostic (8.03e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.25e-3)"	"unprognostic (2.22e-1)"	1.6	1.0	3.6	0.7	1.8	0.4	1.1	2.4	9.7	1.5	2.2	0.9	1.1	1.1	0.8	1.0	2.1	0.9	1.0	5.5	1.7	2.5	2.7	1.2	0.8	3.0	1.8	1.5	1.6	0.6	1.2	1.4	1.0	2.8	1.2	0.8	0.8	0.6	1.9	0.7	0.4	0.8	1.6	3.1	0.4	1.3	47.8	3.2	0.8	1.5	0.7	0.9	1.7	0.7	6.4	4.0	2.5	0.2	1.1	18.1	5.5	0.0	4.7	3.0	3.1	2.6	0.0	5.2	0.0	6.5	5.9	2.0	2.5	1.5	2.5	3.3	2.9	1.7	9.3	1.9	0.5	3.0	1.1	0.9	11.8	0.6	3.8	0.7	2.0	5.8	0.9	0.0	0.0	5.7	2.0	0.2	0.1	4.5	3.5	5.3	0.6	0.0	0.1	3.3	1.0	3.1	2.1	5.9	1.4	0.1	0.6	2.5	4.1	2.4	0.0	0.0	2.5	0.0	0.4	0.2	0.2	1.1	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.9	0.3	0.0	0.3	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	3.6	1.8	2.4	9.7	5.5	1.7	3.0	1.8	1.5	2.8	3.1	3.2	6.4	0.9	0.0	1.5	0.3	0.1	0.4	1.3	1.6	1.2	1.6	0.4	0.4	0.7	0.0	2.0	0.0	2.1	1.7	0.1	0.2	1.9	2.3	1021.8	1.1	0.6	1.8	0.0	0.4	0.2	2.1	1.3	1.7	0.5	0.9	1.3	1.3	2.2	2.1	1.5	3.3	0.2	1.3	0.0	0.8	0.7	161.0	9.6	2.2	1.8	0.0	0.0	1.5	0.0	0.0	0.0	2.1	0.1	5.7	0.2	0.7	0.5	2.8	2.1	1.3	13.1	1.1	1.4	24.6	4.6	1.2	0.0	0.8	1.3	3.8	1.2	0.4
AGPAT4	"dJ473J16.2, LPAAT-delta"	ENSG00000026652	"1-acylglycerol-3-phosphate O-acyltransferase 4"	Q9NRZ5	6	161129967-161274061	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 54.4"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 407.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 25.5;HEL: 19.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053287, HPA060525"	Approved		Approved	"Nucleoli,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	"Nucleoli, Vesicles"	"HPA053287: AB_2682101, HPA060525: AB_2684306"	"unprognostic (5.69e-2)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (1.73e-1)"	"unprognostic (3.43e-2)"	"unprognostic (4.14e-2)"	"unprognostic (6.67e-3)"	"unprognostic (1.94e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (4.08e-4)"	"unprognostic (1.82e-2)"	"unprognostic (8.87e-2)"	"unprognostic (3.63e-4)"	"unprognostic (5.51e-2)"	4.7	2.1	17.9	1.8	30.6	5.3	4.5	25.2	25.5	7.1	6.9	5.1	1.2	7.8	2.2	3.7	6.1	4.3	2.4	17.2	22.9	3.4	0.8	6.8	0.9	41.9	28.6	16.3	7.5	2.1	0.3	11.5	8.8	35.4	3.7	2.2	2.2	2.7	2.4	1.0	2.1	2.6	4.7	31.8	4.6	2.4	2.8	27.2	1.3	4.1	1.0	1.0	3.1	5.1	54.4	0.5	1.0	25.5	5.1	4.7	9.5	1.1	0.9	0.3	1.9	3.2	1.5	4.6	0.7	1.8	4.2	11.8	0.5	4.8	4.0	1.8	2.9	8.1	19.4	4.9	0.1	3.7	0.2	2.8	11.4	1.9	5.0	2.7	9.1	6.1	3.1	9.8	8.9	2.4	0.0	1.4	2.2	6.2	0.0	9.7	0.0	1.1	0.5	5.6	0.4	14.8	5.6	4.0	2.1	1.1	9.9	1.1	1.2	6.8	2.6	3.3	1.8	4.4	0.7	1.0	0.0	9.9	1.0	1.6	0.0	1.8	0.0	3.4	1.5	1.1	0.2	1.6	2.1	1.0	0.5	0.8	1.2	0.3	2.9	1.3	0.8	1.7	1.3	17.9	30.6	25.2	25.5	17.2	22.9	41.9	28.6	16.3	35.4	31.8	27.2	54.4	12.0	3.2	5.5	7.5	4.5	3.2	5.5	9.7	6.2	2.4	3.5	2.7	5.6	5.7	6.9	5.5	0.0	20.3	31.1	6.1	0.0	5.2	52.1	23.8	12.5	13.5	1.8	31.5	87.9	8.2	12.0	17.8	4.6	5.1	11.4	20.6	10.4	0.2	18.2	0.0	95.8	0.7	10.2	7.2	16.4	72.8	5.9	17.0	3.6	23.4	9.4	4.0	9.2	56.3	407.6	5.5	18.7	8.6	15.7	1.3	0.0	0.6	21.4	1.2	19.7	5.3	6.9	4.9	2.8	1.1	2.6	22.2	14.1	3.7	1.4	3.6
AMH	MIS	ENSG00000104899	"Anti-Mullerian hormone"	P03971	19	2249309-2252073	"Disease related genes, Human disease related genes, Predicted secreted proteins"	"Differentiation, Gonadal differentiation"	"Growth factor"	"Disease variant, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"pituitary gland: 3.9;testis: 10.5"	"Cell type enriched"	"Detected in many"	61	"Granulosa cells: 1567.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 16.9;NTERA-2: 6.4;REH: 7.0;SH-SY5Y: 7.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA066973			Approved	Vesicles,Aggresome	"Secreted to blood"	NA	NA	1580000	280000	"Vesicles, Aggresome"		"HPA066973: AB_2732754"	"unprognostic (8.10e-5)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (9.21e-5)"	"unprognostic (8.73e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.32e-1)"	"unprognostic (8.03e-2)"	"unprognostic (8.99e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.53e-1)"	"unprognostic (5.95e-3)"	"unprognostic (1.34e-2)"	"unprognostic (8.73e-8)"	"unprognostic (4.64e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.76e-1)"	0.1	0.2	0.5	0.0	0.8	0.0	0.2	1.1	1.3	0.3	0.0	0.6	0.0	0.3	0.0	0.3	0.4	0.0	0.2	0.2	0.4	0.5	0.3	0.3	0.0	0.5	0.4	0.3	1.1	1.3	0.0	3.9	0.0	0.6	0.5	0.0	0.0	0.2	0.0	1.5	0.2	0.4	0.0	0.2	0.2	0.2	10.5	0.4	0.0	0.3	0.0	0.0	0.2	0.3	0.5	2.8	0.2	0.1	0.4	0.0	0.0	4.3	0.6	0.0	0.0	0.0	0.1	0.2	0.5	1.7	0.0	0.0	0.0	0.0	0.0	0.0	3.0	16.9	0.1	0.8	0.0	0.0	0.2	2.7	0.0	0.0	0.0	0.0	0.0	0.0	1.0	2.6	0.4	0.0	0.5	0.1	1.3	6.4	0.0	1.5	7.0	1.4	0.9	0.0	0.2	0.4	7.7	0.1	0.0	1.7	0.0	0.8	0.0	0.7	0.6	1.3	0.9	2.5	4.7	3.7	0.8	0.3	1.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	1.1	1.3	0.2	0.4	0.5	0.4	0.3	0.6	0.2	0.4	0.5	0.3	0.0	0.0	2.0	0.0	0.1	0.2	0.1	0.6	12.1	1.6	2.2	1.1	1.5	0.0	0.0	2.1	0.3	0.4	1.1	0.0	0.3	2.0	0.7	0.8	0.5	1.2	0.4	1.6	0.2	0.3	0.4	0.0	1.5	0.0	1567.5	0.7	0.3	0.1	8.4	11.5	1.0	0.0	0.0	0.0	9.2	1.5	2.3	0.0	1.9	0.1	6.3	0.0	1.0	2.2	0.0	0.0	0.4	0.1	0.1	0.9	0.2	0.1	2.3	0.0	9.2	25.6	8.1	0.6	0.7	0.1	0.0	0.4	0.0	0.8	0.2
ANXA8L1	"ANXA8L2, bA145E20.2, bA301J7.3"	ENSG00000264230	"Annexin A8 like 1"	Q5VT79	10	46375627-46391784	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 196.8;skin 1: 328.0;vagina: 101.3"	"Cell type enriched"	"Detected in many"	4	"Squamous epithelial cells: 118.7"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 5.2;head and neck cancer: 5.6"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.2;myeloid DC: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HaCaT: 374.5;HBEC3-KT: 485.0;hTCEpi: 140.1;SiHa: 116.6"									"HPA045246, HPA047451"			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045246: AB_2679271, HPA047451: AB_2680052"	"unprognostic (3.67e-3)"	"unprognostic (4.56e-3)"	"unprognostic (9.14e-3)"	"unprognostic (3.92e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.08e-2)"	"unprognostic (8.05e-2)"	"unprognostic (6.94e-3)"	"unprognostic (8.33e-5)"	"unprognostic (3.43e-1)"	"unprognostic (8.26e-10)"	"unprognostic (1.39e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.32e-1)"	18.3	0.2	0.0	0.0	0.0	1.2	22.1	0.0	0.1	22.8	0.0	0.2	0.0	0.1	0.0	196.8	6.2	0.1	1.6	0.0	0.0	0.0	1.1	16.7	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.2	24.3	0.0	6.8	0.0	0.0	41.1	4.6	1.1	328.0	0.1	0.0	0.0	0.1	0.3	0.8	0.0	4.3	0.1	0.0	35.4	37.7	101.3	0.0	70.1	18.2	0.0	0.0	0.0	0.0	24.8	0.9	0.1	0.0	0.0	1.9	12.6	0.0	0.6	0.3	0.5	374.5	0.0	485.0	0.0	28.9	0.0	0.0	33.3	0.0	9.3	0.0	0.7	0.0	140.1	0.2	58.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	70.2	0.2	0.7	0.0	0.0	0.8	0.0	0.0	76.0	0.1	0.0	116.6	12.0	0.0	7.2	0.0	0.7	0.0	0.1	12.2	0.1	0.3	0.0	0.1	0.0	2.8	0.1	0.2	0.0	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.9	1.1	0.0	0.0	0.0	3.0	0.2	11.4	1.6	2.3	2.4	3.7	18.6	19.9	0.0	0.0	14.8	0.0	3.0	0.0	0.7	0.4	1.0	0.0	0.9	0.0	0.0	0.0	0.2	11.4	12.8	5.6	0.1	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.5	0.0	0.0	0.0	1.6	0.3	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	9.7	1.4	0.0	1.2	2.5	5.2	0.0	10.9	0.2	13.1	0.0	1.5	0.3	2.4	118.7	1.1	6.3	0.6	0.0	0.2	5.9
ATG4C	"APG4C, AUTL1, AUTL3, FLJ14867"	ENSG00000125703	"Autophagy related 4C cysteine peptidase"	Q96DT6	1	62784132-62865516	"Enzymes, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"brain: 62.8"	"Cell type enriched"	"Detected in all"	7	"Oligodendrocytes: 449.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007049	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA007049: AB_1845159"	"unprognostic (1.28e-1)"	"unprognostic (2.69e-1)"	"prognostic favorable (9.83e-4)"	"unprognostic (7.43e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.76e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.19e-1)"	8.0	8.0	25.8	10.4	40.1	5.8	7.9	25.7	27.8	8.6	9.1	8.4	6.8	8.1	5.9	7.3	6.6	8.8	6.0	20.5	26.8	11.3	11.2	8.1	13.4	28.6	31.9	16.3	8.4	7.6	10.9	3.3	13.0	33.9	6.6	8.8	6.7	9.9	6.2	5.2	5.5	6.7	9.5	28.7	12.2	7.7	8.1	29.2	13.9	10.0	5.3	11.0	8.4	4.0	62.8	11.5	8.9	13.5	11.9	17.4	18.5	13.5	16.6	11.3	15.7	17.5	6.5	8.8	23.9	12.5	8.5	18.3	8.6	16.1	12.7	22.5	18.0	15.0	27.2	9.3	8.7	12.4	22.2	17.4	15.5	8.9	16.7	7.9	15.1	19.1	26.3	23.4	19.1	13.4	5.4	22.5	8.5	19.8	16.2	14.5	26.5	32.2	17.2	11.2	8.1	18.2	9.1	11.0	20.6	22.1	23.2	10.0	10.3	7.6	12.5	12.2	21.3	18.4	16.3	24.0	20.0	14.3	21.5	15.4	32.6	17.4	14.1	7.2	14.1	10.1	34.3	10.2	8.9	31.9	30.8	14.1	12.0	2.5	12.5	8.6	19.0	9.8	11.5	25.8	40.1	25.7	27.8	20.5	26.8	28.6	31.9	16.3	33.9	28.7	29.2	62.8	12.6	6.4	10.6	50.3	29.7	5.0	6.2	9.9	6.8	5.2	5.8	5.8	10.0	5.7	9.7	7.3	2.1	37.7	14.1	3.7	19.6	7.2	8.1	5.5	10.2	12.8	6.0	15.8	42.0	8.1	30.7	12.2	8.2	4.9	12.0	7.8	12.8	10.0	36.5	5.0	40.8	4.3	4.1	17.9	7.3	3.0	8.7	25.1	8.8	58.1	29.7	10.5	9.2	57.8	449.9	4.8	4.2	9.8	24.2	3.5	4.8	24.8	4.8	5.2	6.6	8.3	8.3	37.2	14.6	6.6	4.0	29.0	9.2	9.1	6.6	3.6
BANK1	"BANK, FLJ20706"	ENSG00000153064	"B cell scaffold protein with ankyrin repeats 1"	Q8NDB2	4	101411286-102074812	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"B-cell activation"		"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 24.4;lymphoid tissue: 97.2"	"Cell type enriched"	"Detected in many"	10	"B-cells: 455.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 6.9"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	14	"memory B-cell: 310.4;naive B-cell: 253.0"	"Lineage enriched"	"Detected in many"	16	"B-cells: 310.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 13.6;HEL: 10.6;HL-60: 9.6;U-266/70: 31.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA037002	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		19000	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA037002: AB_10672383"	"unprognostic (1.59e-2)"	"unprognostic (2.08e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.73e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.97e-2)"	"unprognostic (4.25e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.75e-2)"	"unprognostic (6.09e-3)"	"unprognostic (1.75e-1)"	8.6	3.6	0.6	35.4	0.5	6.3	2.2	1.5	0.9	2.4	0.3	2.8	2.4	0.8	3.3	0.9	2.3	3.0	0.6	0.5	1.3	3.2	0.3	8.1	82.9	0.7	0.9	0.4	0.1	0.5	0.4	1.5	0.8	0.9	5.8	3.3	0.3	2.4	4.8	0.1	0.7	24.4	1.0	0.7	56.6	7.5	3.0	0.8	9.8	13.0	0.2	97.2	7.6	0.7	0.7	0.0	3.0	0.0	0.0	3.4	1.4	0.1	0.1	0.1	0.4	0.6	0.1	4.6	13.6	1.2	0.0	0.0	0.2	0.1	1.5	0.4	0.0	0.0	10.6	2.6	0.0	0.1	9.6	0.0	0.6	0.4	0.0	0.0	1.2	0.1	0.0	0.1	4.0	0.6	0.5	0.0	0.6	0.0	0.4	5.7	0.2	0.6	0.0	0.4	6.1	2.6	0.0	0.3	0.2	0.0	0.1	0.5	2.5	1.3	0.0	0.6	0.0	0.0	31.0	0.0	2.2	0.1	5.3	0.0	10.8	1.7	19.7	0.4	0.5	0.1	310.4	0.1	0.2	10.5	253.0	0.1	0.1	0.9	1.5	0.2	5.2	0.2	11.3	0.6	0.5	1.5	0.9	0.5	1.3	0.7	0.9	0.4	0.9	0.7	0.8	0.7	3.5	44.8	27.1	6.8	455.9	0.1	2.2	0.5	0.0	0.2	1.7	0.4	0.5	0.0	10.0	3.7	0.0	2.1	5.8	0.0	0.0	0.2	2.8	13.1	1.0	1.3	0.0	6.1	7.3	0.2	0.6	1.4	6.1	15.2	1.3	0.1	0.0	0.1	1.5	0.0	1.6	0.4	2.0	2.9	25.1	2.0	0.0	13.0	5.4	4.7	2.8	1.8	1.0	1.0	1.3	4.1	1.3	0.4	13.7	4.4	0.2	4.2	2.2	0.1	0.0	0.1	0.8	1.9	5.6	0.8	1.1	0.3	12.9	2.1	1.1	4.3
BEST4	VMD2L2	ENSG00000142959	"Bestrophin 4"	Q8NFU0	1	44783585-44788170	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"choroid plexus: 13.4;fallopian tube: 8.3;intestine: 21.3"	"Cell type enriched"	"Detected in some"	25	"Paneth cells: 1290.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 2.5;U-698: 1.8"					"Low region specificity"	"Detected in many"			HPA058564	Uncertain					NA	NA					"HPA058564: AB_2683759"	"unprognostic (5.76e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.15e-2)"	"unprognostic (6.20e-2)"	"unprognostic (6.51e-3)"	"unprognostic (1.09e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.04e-1)"	"unprognostic (8.97e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.69e-5)"	"unprognostic (1.43e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.13e-3)"	0.2	1.9	2.5	0.7	1.1	0.7	0.5	2.3	1.3	1.0	13.4	21.3	9.2	0.7	3.0	0.2	8.3	0.2	0.2	0.9	1.5	0.5	0.6	1.9	0.6	1.5	2.1	1.0	0.5	0.3	0.3	2.7	0.2	2.3	0.4	16.2	1.1	0.3	0.5	0.5	2.2	8.1	0.5	1.7	0.5	0.4	0.7	1.4	0.5	0.6	0.1	0.4	0.3	0.3	1.4	0.0	0.2	0.3	0.4	0.1	0.1	1.1	0.2	0.1	0.1	0.0	0.1	0.5	0.1	0.5	0.1	0.3	0.5	0.1	0.0	0.1	0.3	0.2	0.0	0.8	2.5	0.1	0.0	0.3	0.2	0.3	0.1	0.2	0.6	0.3	0.4	0.1	0.2	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.8	0.3	0.1	0.1	0.1	0.2	0.4	0.0	0.5	0.1	0.1	0.1	0.2	0.4	0.1	1.8	0.4	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.6	0.8	0.6	0.7	0.0	0.5	0.2	0.5	0.1	0.3	0.0	0.3	0.6	0.1	2.5	1.1	2.3	1.3	0.9	1.5	1.5	2.1	1.0	2.3	1.7	1.4	1.4	0.2	0.0	0.0	0.0	0.8	0.3	0.8	3.4	0.0	0.8	0.4	1.0	0.5	0.0	4.2	5.5	0.0	0.3	0.4	31.2	1.9	0.7	0.0	26.7	0.5	0.2	2.4	0.0	1.9	0.8	0.2	0.6	0.5	1.2	0.0	0.3	0.4	0.0	0.3	0.0	4.3	3.2	0.0	0.0	0.9	0.2	0.9	0.2	0.0	0.0	0.1	1.2	0.0	0.0	0.1	0.6	1290.4	0.4	0.4	0.7	6.1	1.0	50.1	0.2	0.0	1.2	0.8	0.7	1.6	0.0	0.6	0.3	1.4	0.4	9.1	0.5
BHLHE22	"Beta3, BHLHB5, CAGL85, TNRC20"	ENSG00000180828	"Basic helix-loop-helix family member e22"	Q8NFJ8	8	64580365-64583627	"Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 23.0"	"Cell type enriched"	"Detected in some"	14	"Bipolar cells: 64.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	23	"THP-1: 78.4"	"Group enriched"	"Detected in all"	5	"amygdala: 30.7;cerebellum: 30.7;cerebral cortex: 22.7;hippocampal formation: 46.3;white matter: 13.1"					"HPA064128, HPA064872, HPA067500"	Enhanced		Approved	"Nucleoplasm,Nuclear speckles,Centrosome,Cytosol"		NA	NA			"Nucleoplasm, Nuclear speckles"	"Centrosome, Cytosol"	"HPA064128: AB_2685195, HPA064872: AB_2685377, HPA067500: AB_2685855"	"unprognostic (9.17e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.28e-5)"	"unprognostic (7.22e-3)"	"unprognostic (6.47e-4)"	"unprognostic (2.41e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.71e-2)"	"unprognostic (2.86e-7)"	"unprognostic (3.20e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.72e-3)"	"unprognostic (1.86e-1)"	1.6	0.5	8.9	1.5	6.8	0.0	1.5	12.7	23.0	1.8	0.7	1.2	0.4	0.3	0.1	1.0	0.8	0.4	0.3	19.9	2.0	0.1	0.5	2.0	0.7	4.4	1.6	4.1	0.2	0.7	0.1	1.4	0.0	4.3	0.4	0.5	4.5	0.5	2.4	0.1	0.7	1.5	0.4	1.6	1.4	0.5	0.2	1.7	0.3	0.7	0.0	0.6	1.2	2.9	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	78.4	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	6.8	12.7	23.0	19.9	2.0	4.4	1.6	4.1	4.3	1.6	1.7	2.8	0.3	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	64.7	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	1.2	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.1	0.0	3.4	0.2	0.0	0.0	0.6	1.5	0.0	1.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	3.0	0.0	0.2	2.9	0.0	0.4	0.1	1.6	0.0	0.1	0.0	0.0	0.0
C1QL1	"C1QRF, C1QTNF14, CRF, CTRP14"	ENSG00000131094	"Complement C1q like 1"	O75973	17	44959693-44968303	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 108.9"	"Cell type enriched"	"Detected in some"	7	"Horizontal cells: 673.0"	"Cancer enriched"	"Detected in all"	7	"glioma: 116.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 34.8;SH-SY5Y: 24.8;U-2 OS: 89.0;U-251 MG: 28.1;U-87 MG: 27.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted in brain"	NA	NA						"unprognostic (6.37e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.63e-3)"	"unprognostic (3.15e-2)"	"unprognostic (2.05e-2)"	"unprognostic (7.65e-2)"	"unprognostic (3.40e-3)"	"unprognostic (2.34e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.49e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (1.31e-8)"	"unprognostic (2.67e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.04e-1)"	3.7	0.8	33.0	0.4	14.6	0.0	0.9	26.4	23.0	2.7	10.4	4.4	2.0	13.1	0.3	1.9	4.4	0.3	3.4	12.4	24.7	20.4	0.7	0.2	0.0	108.9	37.4	11.5	0.7	4.6	0.0	2.1	0.0	31.0	7.4	0.3	8.2	0.7	0.0	0.1	0.5	6.2	0.6	31.4	0.1	3.9	0.8	27.3	0.1	0.3	0.2	0.0	6.4	1.2	26.2	4.6	5.1	1.1	17.8	0.3	0.0	0.3	0.8	0.7	0.5	1.6	0.7	0.6	0.2	3.0	0.4	5.3	0.6	2.8	0.2	0.2	12.7	7.5	0.0	7.9	0.1	2.1	0.0	2.2	0.4	0.0	0.7	0.2	6.2	0.0	3.1	0.1	0.2	0.5	1.1	4.0	0.1	3.1	0.5	10.7	6.7	0.2	0.3	0.1	0.4	34.8	24.8	15.6	1.3	1.3	0.9	4.1	0.2	0.1	1.4	89.0	0.9	28.1	1.0	0.0	0.1	27.8	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.0	14.6	26.4	23.0	12.4	24.7	108.9	37.4	11.5	31.0	31.4	27.3	26.2	0.1	0.0	0.0	4.2	0.0	0.3	0.2	1.0	0.0	22.3	0.4	3.2	1.1	5.7	0.0	0.0	10.4	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.5	0.4	5.3	0.0	0.5	0.0	0.1	1.9	0.0	0.5	0.0	0.3	1.1	0.1	0.0	673.0	11.7	0.0	0.0	0.3	0.0	0.2	0.3	0.1	0.0	1.0	0.0	17.6	0.0	84.4	0.8	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.5	0.0	0.0	0.7	0.2	1.0	0.2	0.0	0.0	0.2	0.1	0.0	0.1
C4orf54	"FOPV, LOC285556"	ENSG00000248713	"Chromosome 4 open reading frame 54"	D6RIA3	4	99636529-99654648	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skeletal muscle: 73.4"	"Cell type enriched"	"Detected in single"	17	"Endometrial ciliated cells: 14.3"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.6"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RH-30: 1.6;SK-BR-3: 1.1"	"Low region specificity"	"Detected in single"							HPA079091			Approved	"Nuclear bodies,Cytosol"		NA	NA			"Nuclear bodies"	Cytosol	"HPA079091: "	"unprognostic (3.91e-2)"	"unprognostic (3.76e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.00e-3)"	"unprognostic (2.31e-3)"	"unprognostic (1.50e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.20e-1)"		"unprognostic (2.42e-3)"	"unprognostic (1.89e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.20e-3)"	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	5.1	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.4	0.0	73.4	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.7	0.0	14.5	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
CA7		ENSG00000168748	"Carbonic anhydrase 7"	P43166	16	66844414-66854153	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 57.5"	"Cell type enriched"	"Detected in some"	40	"Paneth cells: 3026.3"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 0.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"REH: 1.1;THP-1: 1.9"	"Region enhanced"	"Detected in all"		"cerebellum: 67.2"	"Low region specificity"	"Detected in many"			HPA047237	Uncertain					NA	NA					"HPA047237: AB_2679994"	"unprognostic (8.77e-4)"	"unprognostic (5.23e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.16e-2)"		"unprognostic (7.90e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.84e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.69e-2)"	"unprognostic (7.12e-3)"	"unprognostic (8.47e-2)"	"unprognostic (5.20e-1)"	"unprognostic (1.90e-2)"	"unprognostic (6.46e-2)"	0.0	0.0	5.0	0.2	6.3	0.0	0.1	5.0	10.8	0.0	2.6	57.5	6.9	0.1	0.9	0.1	0.0	0.0	0.0	8.1	4.3	0.0	0.0	0.0	0.0	4.5	4.0	6.7	0.0	0.0	0.0	0.1	0.0	5.5	0.0	49.1	0.0	0.0	0.2	0.0	0.0	10.1	1.1	3.0	0.0	0.0	0.6	5.2	0.1	0.0	0.2	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	1.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	6.3	5.0	10.8	8.1	4.3	4.5	4.0	6.7	5.5	3.0	5.2	5.9	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	74.2	0.0	0.0	0.0	0.0	0.0	0.0	16.3	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.1	16.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	3026.3	0.0	0.0	0.5	23.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.3	0.0	39.9	0.1
CARNS1	"ATPGD1, KIAA1394"	ENSG00000172508	"Carnosine synthase 1"	A5YM72	11	67414968-67425607	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 295.2;skeletal muscle: 76.3"	"Cell type enriched"	"Detected in some"	19	"Oligodendrocytes: 447.9"	"Group enriched"	"Detected in many"	5	"glioma: 4.1;thyroid cancer: 10.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	12	"RPMI-8226: 7.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			HPA038569	Enhanced				"Intracellular and membrane"	NA	NA					"HPA038569: AB_2676089"	"unprognostic (1.07e-4)"	"unprognostic (4.33e-3)"	"unprognostic (2.00e-2)"	"unprognostic (6.15e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.28e-2)"	"unprognostic (7.54e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.19e-3)"	"unprognostic (1.00e-1)"	"unprognostic (6.14e-6)"	"unprognostic (3.44e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.83e-3)"	"unprognostic (8.33e-2)"	5.7	0.3	81.2	0.4	155.2	0.5	0.7	139.2	116.3	0.6	39.9	0.7	0.4	0.5	1.4	0.9	1.3	0.5	8.6	78.7	109.4	0.8	0.5	0.9	1.2	215.4	158.7	59.8	0.9	1.3	0.9	0.6	0.0	208.2	0.7	0.2	0.0	1.3	0.2	76.3	0.5	0.9	0.2	134.6	2.1	7.6	0.2	128.8	0.4	5.6	30.3	0.5	0.5	0.6	295.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.2	0.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.4	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.6	0.3	0.1	0.1	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.4	0.5	0.3	1.0	0.0	0.6	0.4	1.0	0.0	0.5	0.0	0.0	0.2	0.3	81.2	155.2	139.2	116.3	78.7	109.4	215.4	158.7	59.8	208.2	134.6	128.8	295.2	0.6	3.2	0.5	1.0	3.5	0.3	0.2	0.2	0.0	0.0	0.3	0.4	13.5	7.2	0.7	0.0	0.0	0.1	6.1	0.6	0.0	0.5	0.0	0.3	0.2	1.0	3.0	0.0	1.2	0.0	0.1	1.5	23.0	0.5	0.0	0.1	0.4	0.4	0.2	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	4.1	2.5	447.9	0.1	0.1	0.4	4.0	0.2	0.2	0.3	0.9	0.5	0.0	3.5	3.0	0.0	0.3	0.1	0.9	0.0	2.3	0.3	0.2	0.1
CCL17	"ABCD-2, SCYA17, TARC"	ENSG00000102970	"C-C motif chemokine ligand 17"	Q92583	16	57404767-57416063	"Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 21.3"	"Cell type enriched"	"Detected in some"	55	"monocytes: 12161.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	640	"HDLM-2: 2395.1"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"basal ganglia: 4.3"	CAB002583	Uncertain				"Secreted to blood"	NA	NA	248000				"CAB002583: AB_564022"	"unprognostic (4.62e-3)"	"prognostic favorable (1.91e-5)"	"unprognostic (5.83e-2)"	"unprognostic (3.52e-4)"	"unprognostic (4.51e-2)"	"unprognostic (1.78e-3)"	"unprognostic (4.44e-1)"	"unprognostic (3.41e-2)"	"unprognostic (6.36e-2)"	"unprognostic (4.28e-2)"	"unprognostic (4.11e-1)"	"unprognostic (2.91e-2)"	"unprognostic (6.04e-2)"	"unprognostic (2.35e-1)"	"unprognostic (7.72e-3)"	"unprognostic (4.14e-3)"	"prognostic favorable (5.80e-4)"	1.2	0.1	0.2	8.4	0.2	0.0	1.9	0.2	0.4	1.4	0.0	1.5	0.1	0.1	0.0	3.1	0.6	2.9	1.3	0.3	0.1	0.6	0.3	4.6	8.5	0.2	0.1	0.1	0.2	0.5	0.1	0.0	0.1	0.3	0.3	2.8	0.0	2.6	0.2	0.1	2.5	3.7	2.6	0.2	0.8	0.7	0.5	0.2	21.3	0.8	0.2	5.7	3.4	0.9	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	3.3	0.0	0.0	0.0	2395.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.2	0.0	0.0	0.0	0.0	3.7	0.2	0.0	0.0	2.9	1.5	0.1	0.1	2.0	0.0	0.0	0.1	0.0	1.0	0.0	1.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.4	0.3	0.1	0.2	0.1	0.1	0.3	0.2	0.2	0.3	1.3	0.0	5.1	0.0	0.4	10.8	0.1	3.4	0.0	0.0	1.1	1.5	0.0	0.0	3.8	0.0	0.0	0.0	0.3	0.0	0.0	4.2	0.3	0.1	0.0	0.6	0.0	0.0	0.2	37.4	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	2.0	1.0	217.9	0.3	0.0	48.7	0.0	0.0	12161.5	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.1	0.0	0.4	2.1	0.0	0.0	0.0	12.0	0.0	0.5	0.0	2.7	0.0	0.4	0.0	0.0	0.7
CCL21	"6Ckine, CKb9, ECL, exodus-2, SCYA21, SLC, TCA4"	ENSG00000137077	"C-C motif chemokine ligand 21"	O00585	9	34709005-34710136	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 2748.4"	"Cell type enriched"	"Detected in many"	8	"Endothelial cells: 1213.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 1.1;K-562: 1.2"					"Low region specificity"	"Detected in some"			HPA051210	Enhanced				"Secreted to blood"	NA	NA	198000	920000			"HPA051210: AB_2681390"	"unprognostic (3.06e-3)"	"unprognostic (7.19e-3)"	"unprognostic (9.89e-2)"	"unprognostic (5.50e-2)"		"unprognostic (4.51e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.04e-2)"	"unprognostic (8.07e-2)"	"unprognostic (4.15e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.70e-1)"	"unprognostic (8.99e-3)"	"unprognostic (3.50e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.66e-2)"	"unprognostic (8.91e-2)"	175.3	47.4	0.1	272.1	0.2	0.0	182.5	0.1	0.3	155.9	0.7	109.8	46.7	76.3	34.4	129.2	255.5	81.5	33.5	0.2	0.1	74.3	66.6	198.1	2748.4	0.4	0.1	0.2	34.1	15.4	0.9	2.5	1.8	0.2	38.5	137.0	0.0	21.7	19.2	6.9	45.9	503.0	69.6	0.0	339.8	61.4	10.4	0.1	29.1	523.8	30.9	1007.3	74.7	51.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.2	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.3	0.7	0.2	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.3	0.2	0.1	0.4	0.1	0.2	0.2	0.0	0.1	0.2	58.4	22.4	53.3	0.0	1.9	145.3	2.4	3.8	1.8	0.0	13.5	4.3	10.1	0.0	13.0	1.8	0.0	0.2	1.4	0.2	0.0	10.0	5.7	0.1	0.3	1213.6	0.0	2.7	0.0	3.6	0.2	22.9	0.0	0.2	11.4	0.0	107.1	0.5	0.6	0.0	0.0	2.1	0.0	1.8	148.8	11.0	0.6	6.5	144.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.4	29.6	1.5	0.0	0.0	10.2	0.0	0.0	3.4	120.0	0.2	0.3	11.5	137.7	0.3	9.2	0.0	0.0	0.4
CDH22	"C20orf25, dJ998H6.1"	ENSG00000149654	"Cadherin 22"	Q9UJ99	20	46173739-46308498	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 18.8"	"Cell type enriched"	"Detected in some"	4	"Excitatory neurons: 48.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	18	"SCLC-21H: 3.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA012164, HPA012715"	Uncertain	Supported				NA	NA					"HPA012164: AB_1845902, HPA012715: "	"unprognostic (2.41e-4)"	"unprognostic (1.72e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.32e-3)"	"unprognostic (3.39e-2)"	"unprognostic (4.73e-1)"	"unprognostic (4.32e-1)"	"unprognostic (2.54e-2)"	"unprognostic (5.54e-2)"	"unprognostic (4.50e-4)"	"unprognostic (2.62e-1)"	"unprognostic (3.09e-1)"	"unprognostic (7.26e-3)"	"unprognostic (5.93e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.92e-2)"	"unprognostic (9.83e-2)"	0.1	1.5	10.7	0.0	5.8	0.0	0.1	18.8	15.3	0.2	0.0	0.0	0.0	0.0	0.0	0.9	1.4	0.0	0.6	6.3	2.2	0.2	0.0	0.0	0.0	1.1	2.5	7.4	0.3	1.7	0.0	1.4	0.0	6.5	1.1	0.0	1.2	0.2	0.5	0.5	4.1	0.1	0.0	0.7	0.0	0.2	1.1	3.0	0.0	0.1	0.0	0.0	0.0	0.8	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	5.8	18.8	15.3	6.3	2.2	1.1	2.5	7.4	6.5	0.7	3.0	3.4	0.0	0.0	0.0	1.3	0.0	0.8	1.3	0.0	1.8	9.3	0.0	0.0	3.5	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.4	4.0	0.0	0.0	0.3	7.1	0.0	48.5	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.4	7.2	0.3	0.0	0.0	4.7	0.0	0.8	0.0	12.1	1.7	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	1.4	0.0	0.1	0.1	0.3	0.6	0.3	0.0	0.1	0.0	0.1	0.0	0.0
CDIN1	"C15orf41, FLJ22851, HH114, MGC11326"	ENSG00000186073	"CDAN1 interacting nuclease 1"	Q9Y2V0	15	36579626-36810248	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Congenital dyserythropoietic anemia, Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"heart muscle: 79.3;tongue: 34.8"	"Cell type enriched"	"Detected in some"	9	"Cardiomyocytes: 97.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061023	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA061023: AB_2684417"	"unprognostic (1.82e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.10e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.93e-3)"	"unprognostic (2.27e-2)"	"unprognostic (2.37e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.59e-3)"	"unprognostic (9.14e-2)"	"unprognostic (3.74e-6)"	"unprognostic (1.22e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.62e-4)"	"unprognostic (1.58e-1)"	2.7	5.1	2.8	2.4	6.8	0.7	2.9	4.3	3.6	5.1	1.4	4.4	6.7	6.9	1.8	9.5	4.1	4.1	79.3	2.4	3.5	2.8	3.7	2.5	2.4	3.9	3.1	2.4	4.4	2.2	2.4	2.4	2.1	4.3	6.0	3.2	9.7	5.0	6.6	12.1	5.6	3.4	9.6	2.6	2.3	3.3	7.1	3.7	4.2	2.5	34.8	3.6	9.6	8.3	4.9	19.0	10.0	12.4	4.7	13.5	15.6	5.1	8.9	4.5	11.1	9.1	13.9	7.4	3.0	8.8	22.1	8.1	33.8	13.0	7.7	12.7	1.5	9.1	9.9	9.0	10.3	11.8	8.4	7.1	12.0	8.3	9.5	5.2	8.5	10.7	9.6	12.9	3.1	15.4	8.6	2.6	4.9	6.8	8.6	5.1	7.9	3.5	2.0	7.4	25.8	7.1	4.4	5.7	5.5	4.8	9.0	5.5	13.1	7.6	10.8	5.9	7.3	2.5	7.2	11.2	13.7	13.7	15.0	10.2	0.0	0.5	0.3	2.5	1.3	2.2	2.1	1.9	2.4	1.4	2.2	2.3	1.9	0.0	3.3	0.4	1.1	5.1	1.1	2.8	6.8	4.3	3.6	2.4	3.5	3.9	3.1	2.4	4.3	2.6	3.7	4.9	1.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	97.6	0.0	0.0	0.0	0.0	8.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	6.6	1.4	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	10.8	0.2	0.0	0.0	0.0
CFAP299	C4orf22	ENSG00000197826	"Cilia and flagella associated protein 299"	Q6V702	4	80335730-80963750	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"fallopian tube: 20.0;testis: 27.6"	"Cell type enriched"	"Detected in some"	54	"Endometrial ciliated cells: 54.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 1.4;BJ: 1.6;hTERT-RPE1: 2.5;LHCN-M2: 1.0;SCLC-21H: 1.1;U-251 MG: 1.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA043383	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA043383: AB_10797140"	"unprognostic (4.77e-4)"	"unprognostic (1.52e-1)"		"unprognostic (4.06e-2)"	"unprognostic (1.45e-2)"			"unprognostic (7.24e-2)"		"unprognostic (3.27e-1)"	"unprognostic (6.93e-2)"	"unprognostic (5.90e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.61e-2)"	0.1	0.0	1.6	0.0	1.0	0.0	0.1	1.5	0.6	0.4	2.1	0.0	0.1	0.2	0.0	0.0	20.0	0.1	0.0	0.7	1.1	0.3	0.0	1.4	0.1	4.4	3.3	0.0	0.1	0.0	0.0	0.1	0.0	2.3	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	27.6	1.3	0.1	0.6	0.0	0.0	0.0	0.0	1.1	1.4	0.0	0.0	0.0	0.1	0.7	0.0	1.6	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.5	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	1.0	1.5	0.6	0.7	1.1	4.4	3.3	0.0	2.3	4.1	1.3	1.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	54.5	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0
CHGA		ENSG00000100604	"Chromogranin A"	P10645	14	92923150-92935285	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, Fungicide"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"parathyroid gland: 6618.5"	"Cell type enriched"	"Detected in many"	7	"Enteroendocrine cells: 6553.1"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 114.8"	"Group enriched"	"Detected in many"	9	"cerebral cortex: 319.5;white matter: 124.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	151	"SCLC-21H: 489.5;SH-SY5Y: 1339.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000023, HPA017369, CAB040544, CAB055506, CAB058688"	Enhanced		Supported	Vesicles	"Intracellular and membrane"	NA	NA	295000000	100000000	Vesicles		"CAB000023: , CAB040544: , CAB055506: AB_2081135, CAB058688: AB_2665574, HPA017369: AB_1846698"	"prognostic favorable (7.85e-5)"	"unprognostic (4.89e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.43e-2)"	"unprognostic (5.95e-2)"	"prognostic unfavorable (2.40e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.56e-2)"	"prognostic favorable (4.07e-4)"	"unprognostic (1.85e-1)"	"unprognostic (8.81e-13)"	"unprognostic (1.07e-2)"	"unprognostic (1.77e-1)"	"unprognostic (9.17e-2)"	"prognostic unfavorable (3.99e-4)"	14.6	1260.4	6.7	9.5	14.2	0.2	0.3	0.6	319.5	8.4	0.0	92.8	244.9	0.4	0.3	1.0	1.1	0.2	0.2	24.3	12.7	1.0	0.4	1.6	0.1	16.6	8.8	8.3	0.2	103.4	6618.5	449.7	0.0	21.1	12.4	106.1	11.1	0.2	0.3	0.1	0.6	181.4	0.9	0.0	0.2	367.5	78.3	6.9	0.6	24.8	0.0	0.0	1.3	1.2	124.7	0.0	0.5	2.4	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.8	2.7	0.0	0.0	0.2	0.0	1.4	0.0	0.0	489.5	1339.4	0.0	0.4	0.1	0.0	0.1	0.1	0.0	0.0	4.2	0.3	0.4	0.0	0.0	0.8	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	14.2	0.6	319.5	24.3	12.7	16.6	8.8	8.3	21.1	0.0	6.9	124.7	0.1	0.0	0.0	11.1	1.0	0.9	0.4	0.0	0.0	17.3	0.2	0.3	2.9	0.0	0.0	0.0	29.2	0.3	0.0	9.8	0.0	0.1	1.3	6.0	2.3	0.8	6553.1	0.0	59.5	0.4	0.1	4.1	195.7	0.5	0.0	0.5	0.0	0.0	1.5	16.8	37.7	820.4	14.2	0.0	0.0	7.9	39.7	0.1	7.2	15.9	2.0	3.7	0.0	10.6	12.8	46.5	137.8	137.3	0.0	6.6	36.7	0.0	0.0	16.2	0.0	0.0	0.2	4.7	2.2	0.0	0.0	0.3	0.2	0.4	25.9	5.1
CIBAR2	"FAM92B, FLJ44299"	ENSG00000153789	"CBY1 interacting BAR domain containing 2"	Q6ZTR7	16	85098358-85112472	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"fallopian tube: 86.3"	"Cell type enriched"	"Detected in single"	8	"Plasma cells: 2.4"	"Group enriched"	"Detected in some"	5	"endometrial cancer: 5.4;lung cancer: 1.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 2.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA041022	Enhanced					NA	NA					"HPA041022: AB_10795500"	"unprognostic (1.77e-4)"	"unprognostic (7.44e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.11e-3)"	"unprognostic (5.09e-3)"	"unprognostic (1.14e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.28e-1)"	"unprognostic (9.81e-2)"	"unprognostic (3.70e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.10e-13)"	"unprognostic (2.76e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.29e-1)"	0.1	1.3	7.9	1.3	1.9	0.4	0.3	2.2	1.2	1.9	9.3	0.7	1.3	1.4	0.2	0.1	86.3	0.2	0.0	1.4	4.7	0.2	0.0	10.3	0.6	6.9	7.7	0.2	0.1	0.1	0.0	16.3	0.0	5.2	0.1	0.4	0.4	0.5	0.1	0.0	0.4	0.7	0.0	6.9	2.6	0.4	0.4	3.4	0.2	0.0	0.0	1.9	1.2	0.0	2.7	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	2.5	0.3	0.0	0.0	0.0	0.1	0.2	0.2	0.8	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	7.9	1.9	2.2	1.2	1.4	4.7	6.9	7.7	0.2	5.2	6.9	3.4	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CLDN17	"MGC126552, MGC126554"	ENSG00000156282	"Claudin 17"	P56750	21	30165565-30166805	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"esophagus: 6.2;salivary gland: 6.5;vagina: 7.3"	"Cell type enriched"	"Detected in single"	4	"Early spermatids: 4.4"	"Cancer enriched"	"Detected in single"	5	"head and neck cancer: 2.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045903	Enhanced					NA	NA					"HPA045903: AB_2679491"						"unprognostic (2.41e-1)"												0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.3	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
CLEC12B		ENSG00000256660	"C-type lectin domain family 12 member B"	Q2HXU8	12	10010627-10018796	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 5.2;skin 1: 4.3;testis: 13.2"	"Cell type enriched"	"Detected in some"	5	"Melanocytes: 80.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"GAMG: 2.8;U-937: 6.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (2.08e-2)"	"unprognostic (4.81e-2)"	"unprognostic (3.60e-1)"		"unprognostic (1.81e-1)"	"unprognostic (3.76e-1)"	"unprognostic (3.36e-3)"	"unprognostic (4.14e-4)"	"unprognostic (7.69e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.02e-5)"	"unprognostic (1.41e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.48e-1)"	"unprognostic (8.95e-4)"	0.4	0.0	0.0	0.5	0.1	5.2	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.8	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	4.3	0.1	0.1	0.0	1.6	0.1	13.2	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	6.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	15.4	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.8	0.8	9.5	0.3	2.2	80.0	0.0	2.7	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.4	0.0	0.9	0.0	0.1	0.0	0.0	0.0
CLEC4M	"CD209L, CD299, DC-SIGN2, DC-SIGNR, DCSIGNR, HP10347, LSIGN"	ENSG00000104938	"C-type lectin domain family 4 member M"	Q9H2X3	19	7763210-7769605	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Endocytosis, Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"liver: 63.1;lymphoid tissue: 16.6"	"Cell type enriched"	"Detected in some"	11	"Hepatic stellate cells: 270.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB033689, CAB033691, HPA042661"	Supported				"Intracellular and membrane"	NA	NA		3400000			"CAB033689: AB_831088, CAB033691: AB_2081354, HPA042661: AB_2678101"	"unprognostic (1.56e-1)"				"unprognostic (3.03e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.58e-2)"		"unprognostic (1.27e-1)"	"unprognostic (4.58e-3)"	"unprognostic (4.60e-2)"	"unprognostic (5.15e-2)"		"unprognostic (1.43e-1)"	1.4	1.1	0.5	0.3	0.1	0.1	0.2	0.3	0.4	0.0	0.0	0.1	0.0	0.7	0.0	0.0	1.2	0.0	0.0	0.1	0.1	0.1	63.1	3.2	16.6	0.9	0.5	0.1	3.0	0.1	0.0	0.1	7.4	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.4	0.4	0.0	2.2	0.3	0.0	0.1	0.0	0.3	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.3	0.4	0.1	0.1	0.9	0.5	0.1	0.6	0.4	0.3	0.5	0.0	0.0	0.0	0.0	1.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.5	2.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.0	3.5	0.0	18.7	0.1	0.0	0.0	1.3	0.0	0.0	0.0	15.7	270.2	2.8	0.7	0.0	0.2	0.0	0.0	14.8	2.3	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.8	1.4	0.1	0.0	0.0	0.3	0.3	23.4	0.0	0.2
CMYA5	"C5orf10, DKFZp451G223, SPRYD2, TRIM76"	ENSG00000164309	"Cardiomyopathy associated 5"	Q8N3K9	5	79689836-79800240	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"skeletal muscle: 628.6;tongue: 806.6"	"Cell type enriched"	"Detected in many"	15	"Cardiomyocytes: 3425.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 1.3;RT4: 1.5;THP-1: 5.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA074081, HPA077831"	Enhanced		Approved	"Nuclear speckles,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Nuclear speckles, Cytosol"	"Vesicles, Plasma membrane"	"HPA074081: , HPA077831: "	"unprognostic (5.53e-2)"	"unprognostic (9.91e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.49e-2)"	"unprognostic (9.01e-4)"	"unprognostic (7.00e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.04e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.93e-2)"	"unprognostic (6.30e-3)"	"unprognostic (3.88e-2)"	"unprognostic (7.69e-2)"	"unprognostic (9.74e-2)"	0.7	0.1	1.6	0.2	1.6	0.0	3.9	1.4	2.2	1.6	2.7	0.9	0.1	5.9	4.7	6.7	2.2	0.9	157.3	1.0	4.3	2.5	1.3	0.5	0.0	1.9	1.6	0.2	14.8	0.3	3.7	2.1	1.1	1.6	6.2	0.2	1.8	6.2	2.2	628.6	2.3	0.4	4.6	1.4	0.0	0.6	0.5	1.6	0.9	2.4	806.6	0.1	2.1	1.2	3.6	0.0	0.0	0.0	0.1	0.5	0.4	0.6	0.2	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	1.0	5.4	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.6	1.4	2.2	1.0	4.3	1.9	1.6	0.2	1.6	1.4	1.6	3.6	2.7	9.6	2.8	69.5	0.4	1.3	17.9	2.9	4.6	2.0	24.4	46.6	3425.2	5.7	12.2	25.8	0.0	21.4	1.3	0.4	17.6	0.7	0.3	29.3	7.2	19.7	1.8	0.0	32.9	0.4	2.9	113.7	3.6	55.2	1.3	2.5	0.4	2.3	2.1	217.0	10.7	0.2	8.2	0.6	1.6	2.3	14.9	1.4	0.0	6.5	0.1	8.8	2.1	156.3	2.9	0.6	0.2	13.5	0.6	4.8	0.0	15.4	6.2	3.0	0.0	165.6	23.1	2.5	2.0	2.2	5.4	32.8	1.2	1.7	0.2	18.1
CPS1		ENSG00000021826	"Carbamoyl-phosphate synthase 1"	P31327	2	210477682-210679107	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Urea cycle"	"Allosteric enzyme, Ligase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 1071.9"	"Cell type enriched"	"Detected in many"	19	"Hepatocytes: 2075.1"	"Cancer enriched"	"Detected in many"	8	"liver cancer: 136.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 347.6;SiHa: 65.1;SK-BR-3: 98.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB003781, HPA021400"	Enhanced		Supported	"Nucleoli,Nucleoli rim"		NA	NA		8300000	"Nucleoli, Nucleoli rim"		"CAB003781: , HPA021400: AB_1847197"	"unprognostic (1.67e-2)"	"unprognostic (3.72e-2)"	"unprognostic (4.02e-2)"	"unprognostic (7.21e-7)"	"unprognostic (3.81e-2)"	"unprognostic (2.52e-1)"	"prognostic favorable (6.93e-5)"	"unprognostic (1.23e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.94e-3)"	"unprognostic (2.38e-4)"	"unprognostic (5.90e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.14e-2)"	"unprognostic (3.74e-2)"	2.6	0.4	1.1	0.4	9.0	0.1	1.5	5.1	4.1	0.9	0.2	0.8	213.7	1.6	2.8	1.5	0.9	1.6	1.1	0.8	3.3	1.9	1071.9	1.1	0.3	7.3	6.2	0.7	3.0	0.8	0.1	0.9	2.5	7.0	0.8	0.4	0.3	0.5	0.8	0.6	1.3	124.4	2.2	3.7	1.2	0.6	6.0	5.8	0.3	1.8	0.5	0.2	0.6	0.7	6.7	0.9	9.7	14.0	11.7	11.6	16.5	18.0	6.1	6.4	6.3	9.2	1.8	0.0	2.7	0.4	5.3	9.6	3.0	0.5	10.8	15.9	0.0	4.5	10.0	347.6	15.2	2.8	4.0	0.0	9.2	6.2	12.8	13.0	18.7	0.4	4.2	10.3	0.8	10.4	2.8	0.3	0.7	6.3	0.0	1.8	0.7	14.6	1.6	13.2	0.2	0.5	1.1	65.1	98.9	8.1	20.0	0.1	1.6	7.7	17.5	5.8	5.9	13.0	0.0	0.7	0.0	12.5	11.6	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	9.0	5.1	4.1	0.8	3.3	7.3	6.2	0.7	7.0	3.7	5.8	6.7	0.4	12.8	8.4	6.2	3.6	2.2	0.6	0.9	1.2	1.4	1.3	1.5	1.1	15.7	3.9	1.8	8.4	0.4	0.4	0.1	0.0	0.2	35.5	1.0	2.1	2.0	0.0	18.7	12.1	0.2	0.4	2.6	0.0	1.6	3.8	0.3	16.8	2075.1	0.2	0.0	6.2	13.5	0.0	27.2	2.9	6.5	2.5	0.8	1.8	3.7	0.2	0.7	0.0	3.0	8.8	0.0	2.5	1.2	0.1	1.1	105.6	1.0	1.3	2.3	0.0	1.8	2.3	0.6	1.8	1.5	1.8	20.8	1.8	3.5	41.2	0.4
CSN3	CSN10	ENSG00000171209	"Casein kappa"	P07498	4	70242588-70251428	"Predicted secreted proteins"		"Milk protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"breast: 382.2"	"Cell type enriched"	"Detected in some"	48	"Breast glandular cells: 2554.0"	"Cancer enriched"	"Detected in some"	5	"breast cancer: 35.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035953, HPA035954"	Enhanced				"Secreted in female reproductive system"	NA	NA					"HPA035953: AB_10673226, HPA035954: AB_2674884"																		0.0	0.0	0.0	0.0	0.0	0.0	382.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	10.3	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	2554.0	52.2	0.1	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.1	3.7	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.9	0.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0
CT45A10		ENSG00000269586	"Cancer/testis antigen family 45 member A10"	P0DMU9	X	135881063-135889086	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 9.3"	"Cell type enriched"	"Detected in some"	4	"Spermatogonia: 47.9"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 1.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 85.4;K-562: 26.9;Karpas-707: 94.7;U-266/84: 88.6"									"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893"					"unprognostic (3.55e-1)"					"unprognostic (7.08e-3)"					"unprognostic (2.08e-1)"			0.0	0.0	0.6	0.1	0.6	0.0	0.0	0.5	1.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.5	0.0	0.0	0.1	0.0	1.3	0.8	0.3	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	9.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	85.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.9	94.7	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	18.4	0.0	0.0	18.5	88.6	0.1	10.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.5	1.3	1.2	1.5	1.3	0.8	0.3	2.0	0.6	1.3	0.8	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	47.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CYP2W1	"FLJ20359, MGC34287"	ENSG00000073067	"Cytochrome P450 family 2 subfamily W member 1"	Q8TAV3	7	983181-989640	"Predicted intracellular proteins"	"Lipid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 19.2;intestine: 6.2;skin 1: 9.2"	"Cell type enriched"	"Detected in some"	7	"Enteroendocrine cells: 98.5"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 25.3;stomach cancer: 15.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"CACO-2: 13.5;Hep G2: 49.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Intracellular and membrane"	NA	NA						"unprognostic (7.09e-3)"	"unprognostic (1.94e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.28e-1)"	"unprognostic (6.26e-2)"	"unprognostic (2.72e-5)"	"unprognostic (7.52e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (5.85e-4)"	0.1	19.2	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.2	0.0	0.9	6.2	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.3	0.0	0.3	1.0	0.1	2.1	0.5	0.2	0.3	0.2	0.0	9.2	1.0	0.0	0.0	0.4	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.7	1.0	0.1	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.3	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.2	0.0	0.2	49.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	2.2	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.6	4.3	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.0	4.0	2.3	1.5	0.0	0.6	0.0	0.0	0.5	0.0	2.6	0.0	0.0	1.1	0.0	3.7	0.0	0.1	0.1	0.1	0.0	0.3	98.5	0.0	0.0	0.9	0.6	10.2	0.0	0.1	0.0	0.3	0.0	0.0	1.1	0.0	0.0	13.6	0.0	0.0	0.9	0.0	1.8	0.3	0.0	0.0	0.1	10.5	0.0	0.0	0.0	0.1	3.3	0.0	0.1	1.2	1.1	0.0	3.3	0.6	0.0	0.8	0.3	0.2	0.1	0.0	4.4	1.9	0.2	4.4	11.4	3.7
DEFB1	"BD1, DEFB-1, DEFB101, HBD-1, HBD1, MGC51822"	ENSG00000164825	"Defensin beta 1"	P60022	8	6870592-6877936	"Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 1745.1;pancreas: 754.1;salivary gland: 1991.2"	"Cell type enriched"	"Detected in many"	6	"Distal tubular cells: 13300.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 522.9"	"Group enriched"	"Detected in many"	4	"amygdala: 1.1;cerebellum: 1.5;hypothalamus: 1.1;midbrain: 2.3;thalamus: 2.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 43.3"					"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA		2500000				"unprognostic (2.31e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.16e-3)"	"unprognostic (4.41e-2)"	"prognostic unfavorable (5.62e-4)"	"unprognostic (2.77e-1)"	"unprognostic (2.38e-2)"	"prognostic unfavorable (5.94e-4)"	"unprognostic (3.24e-1)"	"prognostic favorable (1.90e-5)"	"unprognostic (9.62e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.16e-1)"	8.3	0.7	1.1	1.5	0.0	5.3	41.9	1.5	0.4	307.9	0.3	18.7	5.1	6.3	16.5	192.2	21.4	55.4	1.1	0.0	1.1	1745.1	250.5	5.8	0.0	0.1	2.3	0.3	0.5	754.1	7.0	12.8	2.1	0.1	38.2	11.6	2.0	1991.2	24.7	2.9	206.5	8.7	0.3	0.0	0.3	33.6	0.4	2.3	3.1	3.6	0.0	9.1	11.7	153.5	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.2	0.0	0.5	0.0	2.2	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.5	4.2	0.0	0.1	0.3	0.0	2.7	1.2	43.3	0.3	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.2	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.5	0.4	0.0	1.1	0.1	2.3	0.3	0.1	0.0	2.3	0.2	0.7	3.2	4.5	0.0	6.8	90.1	641.5	210.5	134.9	0.4	46.9	26.9	0.1	1976.0	57.2	982.1	0.0	11.8	0.4	117.6	13300.4	1860.0	0.0	339.5	223.6	8.8	15.7	0.0	0.0	295.4	0.9	19.0	1.5	1529.3	0.0	0.0	3.3	319.3	3.6	0.0	0.0	8.6	46.8	4.4	7.3	0.1	17.4	17.0	7.2	0.0	15.3	0.6	0.0	0.0	0.0	156.9	91.2	0.0	1.2	537.6	59.1	218.9	9.5	0.7	0.0	1.4	14.3	0.0	0.0	237.0	537.6	3.7	13.8	0.0	15.4	257.0
DPEP2NB		ENSG00000263201	"DPEP2 neighbor"	A0A0U1RQF7	16	68013436-68015911	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5	"testis: 4.0"	"Cell type enriched"	"Detected in some"	54	"Syncytiotrophoblasts: 65.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 1.0"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA											"unprognostic (1.91e-1)"											"unprognostic (3.22e-2)"	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.7	0.0	0.0	0.0	0.0
DRD2		ENSG00000149295	"Dopamine receptor D2"	P14416	11	113409605-113475691	"FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 64.1;pituitary gland: 60.0"	"Cell type enriched"	"Detected in some"	12	"Horizontal cells: 60.6"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"basal ganglia: 64.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"SCLC-21H: 88.3"	"Region enriched"	"Detected in many"	10	"basal ganglia: 205.3"	"Region enriched"	"Detected in many"	4	"basal ganglia: 146.3"	"HPA015139, HPA015691"	Supported	Supported				NA	NA					"HPA015139: , HPA015691: AB_1847834"	"unprognostic (8.49e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.29e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.15e-1)"		"unprognostic (1.97e-2)"	"unprognostic (5.89e-2)"	"unprognostic (4.40e-2)"	"unprognostic (8.33e-4)"	"unprognostic (1.10e-1)"	"unprognostic (6.65e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.82e-2)"	"unprognostic (8.49e-3)"	0.2	8.5	5.1	0.1	64.1	0.0	1.3	0.1	15.0	1.0	0.0	0.3	0.0	1.1	0.1	0.5	1.3	0.2	0.1	1.5	7.1	1.2	0.0	0.2	0.0	15.0	36.5	3.8	0.2	0.2	0.0	60.0	0.0	16.5	0.9	0.3	11.8	12.0	0.7	0.8	0.8	0.2	1.5	0.5	0.0	0.1	1.0	14.1	0.0	0.0	0.3	0.0	0.2	0.6	7.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	7.6	0.2	0.0	0.0	0.0	6.1	0.0	0.0	0.1	0.1	4.9	0.1	0.0	0.0	0.0	0.0	0.0	10.0	0.0	1.6	0.0	1.1	0.0	0.0	0.0	0.0	0.0	3.1	0.4	0.0	0.0	1.0	0.1	0.0	0.0	9.6	0.0	0.0	0.1	88.3	10.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	2.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	64.1	0.1	15.0	1.5	7.1	15.0	36.5	3.8	16.5	0.5	14.1	7.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	4.7	0.1	2.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	60.6	1.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DSCAM	"CHD2-42, CHD2-52"	ENSG00000171587	"DS cell adhesion molecule"	O60469	21	40010999-40847158	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Neurogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 6.9;pituitary gland: 4.2;retina: 1.9"	"Cell type enriched"	"Detected in some"	4	"Oligodendrocyte precursor cells: 4376.6"	"Cancer enriched"	"Detected in single"	14	"glioma: 3.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 3.6;MCF7: 8.3;NTERA-2: 2.2;SCLC-21H: 3.3;T-47d: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019324, HPA057493"	Enhanced		Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Golgi apparatus"		"HPA019324: AB_2670118, HPA057493: "	"unprognostic (1.47e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.99e-2)"	"unprognostic (9.98e-2)"	"unprognostic (5.49e-4)"	"unprognostic (1.78e-1)"	"unprognostic (9.58e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.85e-3)"	"unprognostic (2.12e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.17e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.75e-2)"	"unprognostic (5.46e-3)"	0.0	0.0	5.2	0.0	6.0	0.0	0.1	0.2	6.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	5.8	3.4	0.0	0.1	0.0	0.0	2.6	2.0	4.1	0.0	0.1	0.0	4.2	0.7	5.5	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.8	0.0	0.4	4.7	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	2.2	0.0	0.0	0.0	0.0	1.2	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.3	2.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	6.0	0.2	6.9	5.8	3.4	2.6	2.0	4.1	5.5	2.5	4.7	5.9	0.0	0.0	0.0	19.9	0.0	0.0	0.1	0.0	0.0	19.6	0.0	0.4	1.1	1.5	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.4	0.0	0.0	1083.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.2	16.8	649.1	0.0	0.0	2.4	0.0	4.2	0.0	0.0	0.0	200.5	0.0	0.7	0.0	4376.6	21.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	2.0	0.1	1.7	1.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0
ECT2L	"ARHGEF32, C6orf91, FBXO49, LFDH"	ENSG00000203734	"Epithelial cell transforming 2 like"	Q008S8	6	138795911-138904070	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"fallopian tube: 8.7"	"Cell type enriched"	"Detected in some"	6	"Respiratory ciliated cells: 91.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HEL: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA035488	Uncertain					NA	NA					"HPA035488: AB_10672865"	"unprognostic (2.88e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.53e-3)"	"unprognostic (3.48e-2)"	"unprognostic (8.45e-3)"	"unprognostic (9.42e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.03e-2)"	"unprognostic (5.90e-4)"	"unprognostic (2.32e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.27e-2)"	"unprognostic (7.07e-3)"	"unprognostic (2.65e-3)"	0.0	0.3	1.2	0.1	0.4	0.3	0.3	0.8	0.9	0.4	1.3	0.0	0.0	0.2	0.0	0.1	8.7	0.0	1.7	1.2	0.5	0.0	0.0	1.5	0.1	1.6	1.3	0.2	0.1	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.4	0.2	0.0	0.2	0.4	0.0	0.1	1.6	0.1	0.1	0.4	0.5	0.0	0.1	0.0	0.0	0.3	0.1	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.4	0.8	0.9	1.2	0.5	1.6	1.3	0.2	0.6	1.6	0.5	0.7	0.2	0.0	1.1	2.3	0.1	0.5	0.7	1.6	0.0	2.1	0.3	0.1	2.3	0.0	12.7	0.0	2.1	0.1	0.6	0.1	0.0	0.0	5.1	15.0	0.5	0.8	0.0	0.0	6.1	0.0	0.0	0.9	0.0	1.4	0.0	0.3	0.0	0.0	0.1	0.0	6.7	0.0	0.0	0.0	0.4	5.4	0.0	0.1	0.0	1.0	0.0	2.0	0.0	2.0	3.2	0.0	0.0	0.0	0.4	0.3	0.0	0.0	91.4	3.2	0.0	1.2	0.5	0.5	0.1	0.0	0.0	0.3	0.6	0.2	0.0	0.3
ERVFRD-1	"envFRD, ERVFRDE1, HERV-FRD, HERV-W/FRD, syncytin-2"	ENSG00000244476	"Endogenous retrovirus group FRD member 1, envelope"	P60508	6	11102489-11111725	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"placenta: 37.3"	"Cell type enriched"	"Detected in some"	56	"Syncytiotrophoblasts: 575.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SuSa: 38.8"									HPA011812			Uncertain	"Nucleoplasm,Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Plasma membrane, Actin filaments"	"Nucleoplasm, Cytosol"	"HPA011812: AB_1857702"	"unprognostic (1.99e-1)"	"unprognostic (3.29e-4)"	"unprognostic (4.75e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.19e-3)"	"unprognostic (3.35e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.78e-3)"	"unprognostic (5.80e-4)"	"unprognostic (3.40e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.37e-2)"	0.3	0.4	0.6	0.1	0.5	0.2	0.4	1.8	0.5	0.4	0.0	0.3	0.5	0.3	1.0	0.3	0.2	0.4	0.1	0.6	0.3	0.4	0.2	0.6	0.0	0.6	0.4	0.4	0.0	0.0	7.5	0.0	37.3	0.9	0.3	0.2	0.2	0.2	0.3	0.0	0.5	0.5	0.2	0.1	0.0	0.3	0.1	0.5	0.5	0.0	0.4	0.0	0.5	0.2	0.6	0.0	0.1	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	38.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.5	1.8	0.5	0.6	0.3	0.6	0.4	0.4	0.9	0.1	0.5	0.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.6	0.0	0.6	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.1	0.3	0.0	0.0	10.1	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.1	0.0	0.0	0.0	575.5	0.4	0.5	0.0	0.0
FAM178B	LOC51252	ENSG00000168754	"Family with sequence similarity 178 member B"	Q8IXR5	2	96875882-96986580	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 19.0;brain: 10.4;epididymis: 5.6;lymphoid tissue: 12.2;testis: 8.2"	"Cell type enriched"	"Detected in many"	4	"Erythroid cells: 88.3"	"Cancer enriched"	"Detected in many"	5	"melanoma: 8.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 25.7;OE19: 7.0;RPMI-8226: 28.0;WM-115: 27.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"spinal cord: 2.4"	"HPA042516, HPA062110"	Uncertain		Uncertain	"Nuclear speckles,Golgi apparatus"		NA	NA			"Nuclear speckles"	"Golgi apparatus"	"HPA042516: AB_10806241, HPA062110: "	"unprognostic (2.47e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.04e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.28e-2)"	"unprognostic (9.02e-4)"	"unprognostic (4.70e-2)"	"unprognostic (8.55e-2)"	"unprognostic (6.49e-3)"	"unprognostic (1.49e-1)"	"unprognostic (5.13e-2)"	"unprognostic (9.82e-11)"	"unprognostic (6.93e-2)"	"unprognostic (1.57e-1)"	"unprognostic (9.63e-3)"	"unprognostic (1.08e-1)"	1.4	0.0	4.9	0.0	7.6	19.0	0.9	5.8	7.4	0.4	2.3	1.5	0.0	1.6	5.6	0.7	1.3	0.1	0.4	4.6	5.0	0.1	0.0	0.4	0.1	7.5	7.9	3.6	0.5	0.0	0.0	0.1	0.9	9.6	1.1	0.1	0.1	0.3	0.8	0.2	1.1	0.5	0.4	6.5	12.2	0.3	8.2	7.2	0.1	0.1	0.0	0.0	2.1	0.8	10.4	6.2	0.0	0.0	2.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.7	0.0	0.5	2.5	0.0	0.0	0.2	7.0	0.0	0.0	6.7	28.0	0.0	0.0	0.8	0.0	0.0	4.3	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	27.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.1	0.0	0.1	4.9	7.6	5.8	7.4	4.6	5.0	7.5	7.9	3.6	9.6	6.5	7.2	10.4	0.2	0.0	0.0	1.0	1.2	0.8	0.6	0.4	0.0	0.2	0.5	1.4	0.4	0.0	0.0	0.0	2.1	3.2	0.5	0.1	0.0	0.0	3.6	0.1	0.3	0.2	0.0	88.3	7.2	0.0	7.1	3.0	0.0	0.1	0.0	0.2	0.4	0.0	1.2	1.7	1.1	0.0	10.2	0.0	0.9	7.8	0.9	1.0	3.6	1.0	0.2	2.9	1.0	1.0	20.7	0.2	0.1	0.0	0.1	0.3	0.0	0.0	0.4	0.2	0.0	2.8	1.6	3.2	20.1	0.6	1.7	2.5	0.2	0.3	0.1	0.4
FEV	Pet-1	ENSG00000163497	"FEV transcription factor, ETS family member"	Q99581	2	218981087-218985184	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 21.6"	"Cell type enriched"	"Detected in some"	32	"Enteroendocrine cells: 744.9"	"Group enriched"	"Detected in some"	10	"pancreatic cancer: 3.0;prostate cancer: 9.9;stomach cancer: 2.4"	"Region enhanced"	"Detected in many"		"midbrain: 21.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HMC-1: 35.5;SH-SY5Y: 43.8"	"Region enhanced"	"Detected in single"		"midbrain: 1.9"	"Group enriched"	"Detected in some"	5	"midbrain: 4.8;pons: 2.7"	HPA067679		Supported	Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA067679: AB_2685884"			"unprognostic (4.58e-1)"		"unprognostic (1.60e-1)"					"unprognostic (7.21e-2)"	"prognostic favorable (4.85e-4)"	"unprognostic (2.87e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.15e-1)"			0.1	2.3	0.3	0.0	1.4	0.0	0.0	0.1	0.8	0.0	0.0	1.2	4.3	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	6.2	21.6	0.0	0.0	1.3	0.0	2.6	0.0	10.4	2.2	1.8	0.4	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	3.2	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	35.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.1	43.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.4	0.1	0.8	0.5	0.2	6.2	21.6	0.0	10.4	0.1	5.6	5.2	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.2	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	744.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.2	6.0	0.0	0.0	3.4	1.2	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.1
FLNC	"ABP-280, ABPL, FLN2"	ENSG00000128591	"Filamin C"	Q14315	7	128830406-128859274	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		Actin-binding	"Cardiomyopathy, Disease variant, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"heart muscle: 474.0;skeletal muscle: 1396.2;tongue: 446.5"	"Cell type enriched"	"Detected in many"	26	"Cardiomyocytes: 1892.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 393.6;fHDF/TERT166: 180.2;hTEC/SVTERT24-B: 190.6;U-2 OS: 163.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA006135, HPA071007"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		26000000	"Plasma membrane, Cytosol"		"HPA006135: AB_1848602, HPA071007: "	"unprognostic (1.25e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.40e-2)"	"prognostic unfavorable (2.80e-4)"	"unprognostic (1.64e-3)"	"unprognostic (4.42e-3)"	"prognostic unfavorable (2.17e-5)"	"unprognostic (1.03e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.37e-2)"	"prognostic unfavorable (5.69e-4)"	"unprognostic (5.68e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.52e-3)"	"prognostic unfavorable (3.73e-5)"	13.1	3.5	6.6	26.1	10.0	0.0	6.0	12.3	9.1	16.3	5.7	153.0	9.5	97.4	4.6	40.6	35.7	13.9	474.0	4.8	18.7	2.8	1.1	12.7	0.6	50.9	10.2	1.9	9.4	2.1	3.3	1.6	2.4	24.9	71.7	9.9	0.5	16.6	101.7	1396.2	7.5	40.6	115.4	57.0	0.7	66.2	2.3	14.6	0.3	4.4	446.5	0.2	164.1	21.5	56.8	0.1	0.8	4.2	0.1	34.4	41.2	4.1	393.6	73.6	109.2	52.3	124.0	1.0	0.1	64.7	180.2	44.9	0.1	23.7	0.9	64.4	0.2	13.1	0.1	20.2	0.1	43.2	0.0	0.2	78.0	0.1	190.6	0.1	44.2	69.0	0.3	49.0	0.2	75.8	0.0	0.0	1.5	64.5	0.1	22.6	0.1	127.5	1.0	0.1	0.0	2.1	7.0	0.7	0.1	0.3	88.0	0.4	1.6	144.6	38.2	163.5	10.1	0.2	0.1	0.0	0.3	129.0	0.1	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	10.0	12.3	9.1	4.8	18.7	50.9	10.2	1.9	24.9	57.0	14.6	56.8	3.6	3.2	0.5	0.7	0.0	3.7	0.3	0.1	1.2	0.6	0.3	1.3	1892.3	0.0	1.9	1.8	0.0	0.4	0.2	0.5	0.0	0.7	0.4	1.8	5.0	31.4	0.0	0.0	0.2	0.2	3.0	31.6	0.0	2.9	0.0	0.6	1.8	0.0	0.9	0.0	1.1	0.3	0.0	0.0	6.9	0.9	5.3	0.5	5.4	0.0	0.0	0.1	0.0	0.0	5.8	2.6	0.1	10.5	1.2	2.7	0.0	1.1	0.0	0.2	0.0	71.8	38.1	0.3	1.0	0.2	4.5	1.9	1.0	0.1	0.2	1.0
FRMD7	"FLJ43346, NYS, NYS1"	ENSG00000165694	"FERM domain containing 7"	Q6ZUT3	X	132076990-132128020	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Neurogenesis		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"endometrium 1: 2.9;kidney: 2.8;smooth muscle: 2.3"	"Cell type enriched"	"Detected in single"	19	"Distal tubular cells: 9.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-87 MG: 1.5"	"Region enriched"	"Detected in many"	28	"olfactory bulb: 65.7"	"Region enriched"	"Detected in single"	86	"olfactory bulb: 21.3"	HPA000886	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA000886: AB_1079269"	"unprognostic (3.08e-2)"	"unprognostic (1.27e-1)"			"unprognostic (1.36e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.54e-2)"			"unprognostic (3.00e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	2.9	0.5	0.0	0.5	0.0	0.1	0.1	0.1	2.8	0.4	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.1	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GBP6	DKFZp686G0786	ENSG00000183347	"Guanylate binding protein family member 6"	Q6ZN66	1	89364059-89388160	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"esophagus: 329.9"	"Cell type enriched"	"Detected in some"	25	"Squamous epithelial cells: 325.0"	"Group enriched"	"Detected in many"	7	"cervical cancer: 21.7;head and neck cancer: 38.1;lung cancer: 14.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"A-431: 5.4;HaCaT: 11.3"					"Low region specificity"	"Detected in all"			HPA027744	Enhanced					NA	NA					"HPA027744: AB_10602809"	"unprognostic (7.60e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.05e-3)"	"unprognostic (5.85e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.34e-1)"	"unprognostic (7.99e-4)"	"unprognostic (1.63e-1)"	"unprognostic (2.04e-6)"	"unprognostic (1.43e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.41e-1)"	"unprognostic (3.91e-3)"	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.3	0.3	12.4	0.1	0.0	0.0	0.1	0.1	329.9	0.3	0.2	0.1	0.3	0.3	0.0	0.1	0.3	0.1	0.4	0.2	0.2	0.4	0.1	0.0	0.8	0.0	0.5	0.1	0.0	0.1	63.3	0.1	0.2	0.9	0.0	0.0	0.3	0.2	0.3	0.0	0.4	1.1	0.2	0.2	55.5	0.1	32.3	0.4	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	11.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.5	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.2	0.0	0.1	0.3	0.3	0.7	0.2	0.1	0.1	0.6	0.1	0.2	0.2	0.3	0.3	0.3	0.3	0.4	0.2	0.2	0.5	0.3	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.8	5.2	12.5	0.1	0.0	0.0	0.2	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.3	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.5	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.4	0.0	0.0	12.8	0.0	0.0	0.0	1.2	0.0	0.1	325.0	0.0	0.0	0.2	1.2	0.0	1.2
GCGR	GGR	ENSG00000215644	"Glucagon receptor"	P47871	17	81804132-81814008	"FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Diabetes mellitus, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 171.0"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 74.6"	"Cancer enriched"	"Detected in many"	4	"liver cancer: 10.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 1.0;MCF7: 1.4;SK-BR-3: 1.2;U-87 MG: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA071228			Uncertain	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA071228: AB_2686368"	"unprognostic (3.28e-4)"	"unprognostic (9.30e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.53e-4)"	"unprognostic (1.11e-1)"	"unprognostic (2.30e-3)"	"unprognostic (4.38e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.61e-1)"	"unprognostic (6.42e-2)"	"unprognostic (5.99e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.17e-3)"	"unprognostic (8.36e-3)"	0.2	2.6	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.0	0.7	0.2	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.4	35.7	171.0	0.0	0.1	0.2	0.1	0.0	0.0	1.5	6.3	0.2	0.0	0.2	0.2	0.0	0.7	0.1	0.0	0.0	1.2	0.6	0.0	0.1	0.1	0.1	0.9	0.0	0.0	0.2	0.1	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.2	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.9	0.0	0.6	0.0	0.5	0.0	0.3	0.6	0.0	0.3	3.7	2.1	0.0	0.0	0.1	3.9	0.2	0.1	0.4	0.0	0.2	0.0	5.3	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	1.4	74.6	0.1	0.0	0.5	0.0	0.0	1.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.1	0.6	0.4	0.0	0.0	0.0	0.2	0.4	0.5	0.4	0.0	0.2	0.0	0.1	0.0
GGACT	A2LD1	ENSG00000134864	"Gamma-glutamylamine cyclotransferase"	Q9BVM4	13	100530164-100589528	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"kidney: 76.2"	"Cell type enriched"	"Detected in many"	6	"Proximal tubular cells: 152.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	5	"SCLC-21H: 133.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065320	Enhanced					NA	NA		110000			"HPA065320: AB_2685466"	"unprognostic (1.93e-1)"	"unprognostic (5.33e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.30e-3)"	"unprognostic (9.12e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.07e-2)"	"unprognostic (7.41e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.37e-2)"	"unprognostic (2.57e-1)"	5.9	6.1	3.2	3.8	3.7	1.6	5.0	3.8	4.8	2.6	3.1	7.7	8.8	3.2	2.1	2.7	3.1	3.0	1.7	2.9	3.6	76.2	16.9	3.0	3.4	4.7	3.9	2.6	2.8	15.3	3.0	1.5	3.0	4.9	3.5	5.0	6.9	9.0	3.2	2.4	4.8	6.2	2.4	4.0	4.1	7.2	6.7	3.7	3.7	3.6	4.2	5.9	3.4	2.5	4.6	14.2	1.7	11.3	12.2	9.4	14.3	4.9	8.8	2.3	1.5	3.8	0.2	12.6	1.4	4.9	6.4	0.2	0.7	1.8	2.6	0.5	20.1	7.6	6.0	1.1	0.7	13.4	8.6	19.1	17.3	9.8	0.2	0.8	0.1	5.7	6.6	3.1	0.3	2.3	0.9	1.4	1.1	0.6	27.4	3.8	0.9	2.8	1.8	14.1	2.4	133.3	5.0	2.8	6.2	6.6	10.5	5.9	28.0	5.5	0.0	0.1	3.0	2.4	7.3	4.4	0.5	0.7	6.4	6.2	0.0	4.1	0.8	5.8	5.9	5.5	3.9	4.8	6.4	3.3	4.3	2.9	4.3	0.0	7.0	6.2	2.4	5.4	3.4	3.2	3.7	3.8	4.8	2.9	3.6	4.7	3.9	2.6	4.9	4.0	3.7	4.6	3.2	0.0	1.5	7.5	7.2	2.7	3.0	1.1	5.2	1.7	4.4	3.2	0.9	1.5	2.1	7.3	14.6	13.4	2.6	4.6	7.9	8.7	4.7	2.6	2.1	3.4	7.8	1.7	2.7	10.0	11.8	3.6	3.1	4.2	5.7	4.1	4.2	14.0	12.1	1.7	3.2	4.7	2.0	9.8	1.4	10.3	2.8	6.2	0.0	4.7	10.0	6.8	19.6	3.5	8.0	9.1	4.5	3.8	2.1	2.3	10.5	152.0	0.1	3.3	6.6	4.3	1.8	22.5	10.9	3.9	2.0	4.4	6.1	12.4	7.7	2.5
GLB1L2		ENSG00000149328	"Galactosidase beta 1 like 2"	Q8IW92	11	134331874-134378341	"Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"retina: 162.0"	"Cell type enriched"	"Detected in many"	4	"Rod photoreceptor cells: 182.0"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 21.0"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 3.2;NK-cell: 3.1"	"Group enriched"	"Detected in many"	24	"NK-cells: 3.1;T-cells: 3.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 49.9;HaCaT: 52.6;OE19: 123.6;SCLC-21H: 34.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA054808, HPA059955"	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"	NA	NA			Nucleoplasm	Vesicles	"HPA054808: AB_2682608, HPA059955: AB_2684178"	"unprognostic (2.63e-2)"	"unprognostic (9.77e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.01e-1)"	1.4	2.1	3.4	2.6	2.2	0.3	7.1	0.2	8.5	5.3	12.2	21.8	5.8	34.2	2.2	3.6	25.9	2.8	0.9	9.3	0.6	20.8	0.6	3.6	0.6	1.4	1.2	2.1	13.9	10.7	25.2	14.2	1.5	1.6	34.8	11.8	162.0	9.2	25.4	1.0	9.5	4.0	4.4	0.1	0.6	9.1	8.4	1.0	0.6	22.9	0.2	0.6	6.8	5.1	1.5	16.0	1.6	8.2	4.7	0.0	0.0	5.5	0.0	0.0	0.0	0.0	13.3	49.9	0.0	16.3	0.0	6.8	52.6	25.2	0.4	0.0	0.0	23.9	0.0	6.7	0.6	2.2	0.0	28.4	0.3	0.7	0.0	0.0	0.0	0.1	7.6	26.3	0.0	0.0	15.3	4.4	3.0	4.7	123.6	18.2	0.0	0.0	1.5	14.1	11.0	34.9	13.1	11.4	14.2	0.0	1.2	18.4	0.2	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	4.1	0.0	3.1	0.0	0.0	0.0	3.2	0.0	1.2	0.0	0.6	1.2	0.0	0.1	0.9	1.4	0.0	3.1	0.0	0.0	0.0	0.5	3.4	2.2	0.2	8.5	9.3	0.6	1.4	1.2	2.1	1.6	0.1	1.0	1.5	0.2	0.0	1.8	0.3	0.4	2.2	5.2	1.0	1.8	6.2	7.2	7.9	1.6	1.5	2.5	0.0	41.7	0.2	3.4	19.5	0.0	2.5	2.1	7.9	22.1	1.2	9.0	0.0	1.6	2.4	1.0	3.6	4.1	2.2	0.0	41.9	0.0	0.2	0.2	5.0	1.2	5.9	0.0	0.0	0.3	6.8	1.2	0.3	5.4	1.0	0.0	10.8	1.0	1.0	0.3	2.2	6.3	0.7	2.2	8.1	3.0	8.4	10.1	182.0	0.0	3.7	2.3	2.6	4.6	1.9	0.9	0.1	2.5	3.4	11.5	2.7
GLDN	"CLOM, COLM, colmedin, CRG-L2, UNC-122"	ENSG00000186417	Gliomedin	Q6ZMI3	15	51341655-51408005	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 83.0"	"Cell type enriched"	"Detected in many"	5	"Oligodendrocytes: 510.8"	"Cancer enhanced"	"Detected in many"		"glioma: 4.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 2.7;MCF7: 1.3;SuSa: 1.8;U-266/70: 3.3;U-266/84: 2.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA050873, HPA059441"	Uncertain		Supported	"Vesicles,Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		410000	"Vesicles, Plasma membrane"		"HPA050873: , HPA059441: AB_2684018"	"unprognostic (5.04e-2)"	"unprognostic (2.57e-2)"	"unprognostic (5.15e-5)"	"unprognostic (3.21e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.07e-4)"	"unprognostic (2.02e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.14e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.80e-3)"	"unprognostic (1.37e-1)"	15.3	2.3	25.8	1.7	44.9	0.7	9.8	33.1	30.6	1.4	0.0	3.6	0.2	0.5	0.6	0.5	1.2	3.4	5.1	13.6	28.6	0.4	0.1	8.8	0.2	45.0	45.9	3.7	0.6	0.5	0.4	0.6	4.0	57.3	2.5	6.5	1.4	1.4	0.7	1.0	4.8	0.6	0.6	32.2	3.0	2.1	0.3	36.6	0.1	0.9	0.9	0.2	1.5	1.5	83.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	2.7	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.1	0.0	0.1	0.5	0.8	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	1.0	0.0	1.8	0.0	0.5	0.0	0.0	0.0	0.1	0.0	3.3	2.9	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	25.8	44.9	33.1	30.6	13.6	28.6	45.0	45.9	3.7	57.3	32.2	36.6	83.0	40.1	0.0	2.6	2.0	0.0	6.2	0.0	0.3	0.0	9.2	0.2	0.3	8.4	0.0	0.1	0.0	0.0	5.2	0.0	47.0	0.0	0.0	0.0	0.0	0.1	3.7	1.2	0.0	7.4	0.0	0.6	7.9	4.6	0.2	0.0	4.5	0.0	0.2	4.9	0.0	17.2	1.7	0.0	14.9	9.5	0.0	0.3	16.1	3.6	42.2	0.0	0.3	0.0	2.0	510.8	0.1	28.6	0.0	0.0	0.1	0.0	0.1	0.9	0.8	0.0	4.7	9.8	0.1	0.1	0.0	4.0	100.4	0.6	0.4	5.1	1.6
GOLGA8K		ENSG00000249931	"Golgin A8 family member K"	D6RF30	15	32392782-32403292	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	5	"testis: 6.6"	"Cell type enriched"	"Detected in some"	6	"Early spermatids: 16.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 1.0;JURKAT: 1.0;THP-1: 1.7;U-937: 2.4"															NA	NA						"unprognostic (2.47e-1)"	"unprognostic (3.27e-1)"			"unprognostic (4.01e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.62e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.86e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.97e-1)"	"unprognostic (7.00e-3)"	"unprognostic (4.81e-2)"	"unprognostic (1.18e-2)"	"unprognostic (9.81e-2)"	0.6	0.2	0.1	0.1	0.6	0.6	0.4	0.2	0.6	0.4	0.1	0.4	0.0	0.3	0.0	0.3	0.3	0.0	0.3	0.1	0.4	0.2	0.1	0.5	0.0	0.6	0.2	0.0	0.4	0.9	0.1	0.5	0.0	0.6	0.3	0.0	0.2	0.3	0.1	0.1	0.3	0.4	0.1	0.1	0.3	0.2	6.6	0.1	0.0	1.3	0.0	0.2	0.5	0.4	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.5	1.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.1	0.0	0.3	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.2	0.6	0.1	0.4	0.6	0.2	0.0	0.6	0.1	0.1	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
GOLGA8T		ENSG00000261247	"Golgin A8 family member T"	H3BQL2	15	30135149-30145567	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 7.0"	"Cell type enriched"	"Detected in single"	6	"Early spermatids: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA						"unprognostic (1.01e-1)"				"unprognostic (1.38e-1)"			"unprognostic (2.05e-1)"	"unprognostic (2.41e-1)"		"unprognostic (1.22e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.20e-2)"		"unprognostic (5.37e-2)"	"unprognostic (2.10e-2)"		0.4	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.1	0.2	0.0	0.4	0.0	0.2	0.4	0.0	0.6	0.0	0.0	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.7	1.1	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.2	0.3	0.0	0.0	0.2	0.2	7.0	0.0	0.0	1.2	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPR149	"IEDA, PGR10, R35"	ENSG00000174948	"G protein-coupled receptor 149"	Q86SP6	3	154334943-154430190	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 6.6"	"Cell type enriched"	"Detected in some"	22	"Inhibitory neurons: 48.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 15.0"	"Low region specificity"	"Detected in many"			HPA018020	Uncertain					NA	NA					"HPA018020: AB_1849334"																		0.0	0.0	0.6	0.0	6.6	0.0	0.0	1.2	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	1.5	1.4	0.7	0.0	0.0	0.0	0.9	0.0	2.6	0.0	0.0	0.8	0.0	1.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	4.8	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	6.6	1.2	1.9	0.1	2.0	1.5	1.4	0.7	2.6	0.4	4.8	2.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	48.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
HAP1	"HAP2, hHLP1, HIP5, HLP"	ENSG00000173805	"Huntingtin associated protein 1"	P54257	17	41717742-41734644	"Predicted intracellular proteins"	"Autophagy, Cilium biogenesis/degradation, Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 53.1"	"Cell type enriched"	"Detected in many"	4	"Glandular and luminal cells: 66.5"	"Cancer enhanced"	"Detected in many"		"glioma: 6.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"REH: 96.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA023394, HPA076992"	Enhanced		Supported	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"HPA023394: AB_1850492, HPA076992: AB_2686822"	"unprognostic (2.84e-3)"	"unprognostic (3.74e-3)"	"unprognostic (2.42e-2)"	"unprognostic (2.30e-1)"	"unprognostic (7.53e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.11e-2)"	"unprognostic (8.76e-2)"	"prognostic favorable (4.26e-4)"	"unprognostic (1.38e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.99e-2)"	"unprognostic (9.29e-2)"	0.3	1.5	27.3	0.3	18.5	0.1	1.0	14.2	21.8	10.3	9.6	1.7	2.8	3.5	1.6	1.1	2.6	1.5	0.0	17.8	42.2	1.9	0.4	1.0	0.2	26.3	21.8	16.1	1.2	1.0	0.0	11.6	1.5	23.1	1.9	0.5	0.8	1.5	1.3	0.2	1.3	1.5	0.6	20.1	3.5	11.1	2.2	53.1	2.8	5.1	0.1	0.2	0.5	1.9	26.4	0.2	3.1	1.4	3.1	0.0	0.0	0.3	0.3	0.1	0.6	0.1	1.9	0.2	0.2	1.1	0.2	0.5	13.1	6.7	0.5	0.0	0.0	3.4	0.0	1.8	0.1	0.3	0.0	0.6	0.0	1.6	0.1	0.7	0.2	0.0	0.0	0.0	0.1	0.0	1.5	0.1	0.2	1.6	18.7	0.8	96.0	0.0	3.7	0.6	1.0	0.4	0.1	0.7	0.4	0.1	1.5	2.4	0.0	0.0	0.0	1.3	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0.0	27.3	18.5	14.2	21.8	17.8	42.2	26.3	21.8	16.1	23.1	20.1	53.1	26.4	1.1	0.0	1.7	3.3	0.3	3.1	7.3	1.0	6.8	1.6	1.6	6.7	3.6	0.0	1.9	0.0	2.1	1.5	0.5	1.1	0.0	0.3	0.5	11.5	7.6	3.2	0.0	0.0	1.0	0.9	0.7	3.4	7.7	66.5	0.0	0.2	1.4	0.8	0.5	0.0	5.4	0.6	4.1	0.6	2.2	0.6	0.3	1.2	0.0	0.0	0.4	0.6	2.1	14.6	0.3	1.5	0.2	0.7	0.3	5.3	0.2	0.2	1.7	1.8	0.0	10.6	2.3	0.1	4.7	8.4	3.1	15.7	0.9	0.1	1.1	3.5
HBA2	HBA-T2	ENSG00000188536	"Hemoglobin subunit alpha 2"	P69905	16	172876-173710	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Oxygen transport, Transport"		"Disease variant, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"bone marrow: 38528.1"	"Cell type enriched"	"Detected in many"	22	"Erythroid cells: 198314.0"	"Cancer enhanced"	"Detected in all"		"glioma: 59.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 315.1;neutrophil: 955.3;plasmacytoid DC: 486.7"	"Group enriched"	"Detected in all"	7	"dendritic cells: 486.7;granulocytes: 955.3"	"Group enriched"	"Detected in some"	18	"HEL: 1196.2;K-562: 328.3"									"CAB038417, HPA043780"	Enhanced					NA	NA		14000000000			"CAB038417: , HPA043780: AB_2678667"	"unprognostic (1.57e-1)"	"unprognostic (7.02e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.59e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.99e-2)"	"unprognostic (4.43e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.73e-2)"	"unprognostic (8.92e-2)"	1006.7	325.2	160.4	187.9	285.2	38528.1	550.0	276.4	1058.3	361.2	3417.4	238.4	21.8	86.6	5.9	436.0	575.4	148.9	2186.1	104.8	185.3	2287.2	1868.7	4241.2	9.8	263.7	502.8	81.6	291.0	142.5	11.5	814.1	3649.4	321.6	305.4	26.9	4.1	308.1	133.1	574.0	189.2	155.6	13.0	320.5	8190.8	266.3	186.5	360.5	34.9	1202.5	1760.1	10.1	328.1	638.2	487.2	0.0	0.2	0.0	0.0	0.0	0.7	0.4	0.4	0.1	0.0	0.0	3.2	0.0	1.9	4.9	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.6	1196.2	0.5	0.0	0.0	0.2	1.7	0.4	0.1	0.4	0.0	0.0	0.0	0.1	328.3	0.0	0.1	0.6	0.0	0.3	0.1	0.5	0.0	0.0	0.0	43.4	0.0	0.9	11.9	9.7	1.1	0.0	0.0	0.1	1.4	0.2	5.6	0.0	0.3	0.4	0.0	0.4	0.0	0.0	0.3	0.6	0.2	119.6	28.1	315.1	99.6	1.7	3.7	39.2	8.5	7.1	42.5	19.1	22.8	73.9	955.3	49.5	3.3	486.7	1.0	15003.3	160.4	285.2	276.4	1058.3	104.8	185.3	263.7	502.8	81.6	321.6	320.5	360.5	487.2	184.7	3.2	1.5	0.0	97.6	44.4	0.4	0.1	0.6	1.7	20.2	22.2	6.8	70.1	0.7	0.0	0.0	0.0	162.2	6.9	54.8	0.0	3.4	0.6	0.8	50.9	3.0	198314.0	0.0	0.0	0.0	241.0	4.1	0.9	1.3	0.3	142.8	131.2	0.0	0.0	0.0	7.5	4.1	770.6	149.6	16.9	0.0	402.9	8790.3	0.0	37.5	2.3	954.7	0.0	0.0	0.0	3.6	0.0	0.3	0.2	0.1	29.6	2.5	58.6	0.0	25.2	171.5	1.0	9.9	1.1	44.6	0.0	306.3	0.1	5.0	0.1
HBQ1	HBQ	ENSG00000086506	"Hemoglobin subunit theta 1"	P09105	16	180459-181179	"Predicted intracellular proteins"	"Oxygen transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"bone marrow: 25.8"	"Cell type enriched"	"Detected in some"	9	"Erythroid cells: 399.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"granulocytes: 1.3;T-cells: 1.3"	"Group enriched"	"Detected in some"	8	"HEL: 22.4;Hep G2: 15.8;K-562: 56.5"					"Low region specificity"	"Detected in all"			HPA062473	Enhanced		Approved	"Lipid droplets"		NA	NA		160000	"Lipid droplets"		"HPA062473: AB_2684774"		"unprognostic (4.24e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.30e-1)"		"unprognostic (1.28e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.33e-1)"	"unprognostic (8.92e-2)"	"unprognostic (2.02e-3)"	"unprognostic (8.24e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.55e-1)"	0.2	0.1	3.0	0.0	2.5	25.8	0.1	0.7	4.7	0.0	0.8	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.5	2.4	1.8	0.5	0.4	0.9	0.0	0.8	0.8	2.4	0.1	0.0	0.0	0.7	0.8	1.5	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.4	3.7	0.1	1.9	2.0	0.0	0.2	0.0	0.0	0.0	0.2	2.0	0.0	1.3	0.4	4.1	0.0	0.0	0.7	0.1	0.0	0.0	0.2	3.8	0.0	0.0	0.5	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	22.4	1.0	15.8	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.1	1.3	56.5	0.0	0.0	0.2	2.5	0.0	2.9	0.0	0.2	0.2	0.0	0.4	0.8	0.0	0.5	2.9	0.0	0.0	0.7	0.0	0.1	0.9	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.3	0.2	0.4	0.9	0.0	0.0	0.2	0.6	1.3	0.0	0.0	0.1	0.0	4.3	3.0	2.5	0.7	4.7	2.4	1.8	0.8	0.8	2.4	1.5	0.4	2.0	2.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.5	0.3	0.0	0.0	0.0	0.0	0.1	1.0	0.1	0.0	0.1	1.1	0.0	0.0	0.0	0.0	399.8	0.0	0.0	2.2	0.3	0.0	0.0	0.0	0.7	0.7	0.3	0.4	0.0	0.0	0.0	0.0	0.9	0.0	4.1	0.3	7.6	3.6	0.0	0.6	0.0	41.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	6.0	36.1	0.0	0.1	0.3	0.6	1.2	0.3	0.0
HDC		ENSG00000140287	"Histidine decarboxylase"	P19113	15	50241947-50265965	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Catecholamine biosynthesis"	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 87.6;epididymis: 46.5"	"Cell type enriched"	"Detected in some"	12	"granulocytes: 596.0"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.9;testis cancer: 2.7"	"Group enriched"	"Detected in many"	5	"hypothalamus: 87.6;pons: 36.0"	"Immune cell enriched"	"Detected in single"	2140	"basophil: 686.2"	"Lineage enriched"	"Detected in single"	2140	"granulocytes: 686.2"	"Group enriched"	"Detected in some"	4	"HEL: 460.8;HMC-1: 1051.3"	"Region enriched"	"Detected in many"	5	"hypothalamus: 43.9"	"Group enriched"	"Detected in some"	10	"hypothalamus: 16.5;midbrain: 4.2"	HPA038891	Enhanced		Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA038891: AB_10673231"	"unprognostic (4.97e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.43e-4)"	"unprognostic (1.08e-1)"	"unprognostic (6.16e-2)"	"unprognostic (3.93e-7)"	"unprognostic (4.18e-5)"	"unprognostic (8.79e-3)"	"unprognostic (1.48e-1)"	"unprognostic (8.46e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.53e-1)"	"unprognostic (7.20e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.50e-1)"	2.0	0.4	0.2	3.5	3.6	4.7	1.4	0.0	0.2	2.3	0.6	3.8	4.1	2.6	46.5	4.9	0.8	11.3	0.7	0.2	87.6	0.4	0.5	7.0	0.9	0.0	8.1	0.0	0.1	1.2	0.5	0.4	0.4	36.0	1.8	3.6	0.8	1.3	1.0	0.3	2.0	4.6	2.5	0.0	0.5	13.0	1.3	12.9	0.9	0.1	0.8	1.0	3.8	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	460.8	0.2	0.0	0.0	1.2	1051.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.5	181.8	0.3	0.0	0.0	0.2	0.4	0.4	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.5	0.2	0.4	686.2	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.0	1.6	0.2	3.6	0.0	0.2	0.2	87.6	0.0	8.1	0.0	36.0	0.0	12.9	0.1	0.0	12.8	47.5	0.3	0.0	0.8	0.0	0.0	0.0	2.6	0.0	0.0	0.5	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	10.9	0.3	0.0	0.0	2.3	9.2	0.0	596.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	1.8	0.4	0.0	1.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	3.8	0.0	0.0	0.0	4.5	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.0	3.5	0.0	0.1	0.1
HSFX2		ENSG00000268738	"Heat shock transcription factor family, X-linked 2"	Q9UBD0	X	149592512-149595314	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 12.4"	"Cell type enriched"	"Detected in single"	16	"Cardiomyocytes: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.1;HEK 293: 1.1;hTCEpi: 1.5;MCF7: 1.4;U-138 MG: 1.5"									"HPA051700, HPA063040"	Supported		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA051700: AB_2681578, HPA063040: AB_2732695"					"unprognostic (7.64e-2)"					"unprognostic (6.92e-3)"				"unprognostic (2.00e-1)"				0.3	0.4	0.5	0.2	1.0	0.0	0.6	0.9	2.2	0.4	0.8	0.5	0.5	0.6	0.2	0.4	1.0	0.0	1.1	0.8	0.2	0.5	0.5	0.6	0.1	0.5	0.4	0.7	1.1	0.4	1.3	0.4	0.4	0.8	0.9	0.5	1.0	1.0	1.4	0.7	1.2	0.3	0.7	0.1	1.1	0.4	12.4	0.6	0.6	0.5	2.1	0.2	0.4	0.5	2.6	0.5	0.0	1.1	0.6	0.0	0.2	0.0	0.2	0.5	0.2	0.6	0.0	0.0	0.1	0.2	0.3	0.0	1.0	0.0	0.3	0.1	0.0	1.1	0.0	0.4	0.0	0.0	0.1	0.3	0.5	1.5	0.6	0.0	0.2	0.0	0.7	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.3	0.1	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.9	2.2	0.8	0.2	0.5	0.4	0.7	0.8	0.1	0.6	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHJ6		ENSG00000211900	"Immunoglobulin heavy joining 6"		14	105863198-105863258	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in many"	5	"cervix: 143.6;intestine: 38.9;lung: 47.4;testis: 152.5;urinary bladder: 114.3"	"Cell type enriched"	"Detected in single"	56	"Plasma cells: 39.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	14	"memory B-cell: 316.2;naive B-cell: 112.7"	"Lineage enriched"	"Detected in many"	21	"B-cells: 316.2"	"Cell line enhanced"	"Detected in some"		"U-266/84: 1.3;U-937: 1.2"															NA	NA																							0.0	0.0	0.0	0.0	0.0	1.1	0.7	0.1	0.9	143.6	0.0	2.6	38.9	1.0	0.0	0.0	2.2	0.5	0.9	0.3	0.0	3.1	2.5	47.4	0.4	0.4	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.3	3.7	0.0	0.0	0.0	18.4	0.0	0.0	0.0	0.0	0.0	0.6	0.7	152.5	0.3	0.0	0.7	0.0	10.8	114.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	1.2	0.0	3.5	3.5	0.8	0.3	0.0	0.2	316.2	0.5	0.6	0.5	112.7	0.6	0.3	14.8	0.2	1.0	0.0	0.1	89.2	0.0	0.0	0.1	0.9	0.3	0.0	0.4	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHV3-15		ENSG00000211943	"Immunoglobulin heavy variable 3-15"	A0A0B4J1V0	14	106153624-106154163	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 185.1;lymphoid tissue: 383.3;salivary gland: 179.2;stomach 1: 113.8;urinary bladder: 174.0"	"Cell type enriched"	"Detected in some"	112	"Plasma cells: 6281.5"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in some"		"white matter: 2.3"	"Group enriched"	"Detected in some"	9	"MAIT T-cell: 21.6;memory B-cell: 24.4"	"Group enriched"	"Detected in many"	9	"B-cells: 24.4;T-cells: 21.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.2;Daudi: 1.9;HL-60: 2.1;K-562: 2.0;NB-4: 2.4;RH-30: 1.9;RPMI-8226: 4.1;SH-SY5Y: 3.7"														"Immunoglobulin genes"	NA	NA		20000000000				"prognostic favorable (8.85e-5)"	"unprognostic (2.07e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.62e-2)"	"prognostic favorable (3.34e-5)"	"unprognostic (5.20e-2)"	"unprognostic (2.44e-1)"	"unprognostic (9.67e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (1.49e-7)"	"unprognostic (6.85e-2)"	"unprognostic (6.92e-2)"	"unprognostic (7.12e-2)"	"unprognostic (3.63e-1)"	7.1	37.2	0.1	25.0	0.6	1.8	23.4	0.0	1.2	13.1	0.2	185.1	4.5	5.0	0.9	11.8	16.5	29.9	1.1	0.1	0.1	8.9	10.7	40.4	0.0	1.5	0.2	0.0	5.9	19.2	0.4	1.3	0.4	0.4	9.6	14.7	0.0	179.2	23.2	0.8	4.3	108.1	0.3	0.0	383.3	113.8	0.5	0.1	0.0	15.0	0.0	10.5	174.0	9.8	2.3	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.8	2.4	0.7	0.0	0.0	0.0	1.9	4.1	0.0	0.0	0.0	3.7	0.4	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.6	0.1	0.4	1.6	0.0	0.2	0.0	0.3	0.0	0.2	0.2	0.1	0.1	0.0	21.6	24.4	0.1	0.2	0.2	0.0	0.2	0.1	2.5	0.0	0.0	0.2	0.1	1.8	0.1	0.6	0.0	1.2	0.1	0.1	1.5	0.2	0.0	0.4	0.0	0.1	2.3	0.0	0.0	0.0	0.0	56.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.0	1.1	8.2	0.0	0.0	0.1	1.1	0.6	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6281.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.3	0.0
IGHV4-28		ENSG00000211952	"Immunoglobulin heavy variable 4-28"	A0A0C4DH34	14	106324254-106324760	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 45.3;lymphoid tissue: 88.1;salivary gland: 40.2;stomach 1: 31.0;urinary bladder: 123.7"	"Cell type enriched"	"Detected in some"	230	"Plasma cells: 346.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"spinal cord: 1.3"	"Group enriched"	"Detected in some"	206	"memory B-cell: 28.7;naive B-cell: 12.5"	"Lineage enriched"	"Detected in single"	288	"B-cells: 28.7"	"Not detected"	"Not detected"																"Immunoglobulin genes"	NA	NA		2500000000				"unprognostic (3.14e-3)"	"unprognostic (1.32e-2)"	"unprognostic (8.05e-2)"	"unprognostic (6.64e-3)"		"prognostic favorable (2.63e-4)"	"unprognostic (1.58e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.74e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (4.79e-6)"	"unprognostic (1.45e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.75e-1)"	1.2	11.4	0.0	41.3	0.0	6.0	13.1	0.0	0.2	3.3	0.0	45.3	45.3	1.0	0.0	12.6	1.9	7.7	1.2	0.0	0.7	1.8	2.4	9.0	10.1	0.0	0.1	0.0	3.6	0.4	0.0	0.2	0.0	0.0	0.8	44.5	0.0	40.2	1.8	0.0	0.5	30.5	2.0	1.3	42.7	31.0	0.5	0.0	5.9	4.4	0.0	88.1	123.7	1.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.6	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.7	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.1	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	346.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
IGHV6-1		ENSG00000211933	"Immunoglobulin heavy variable 6-1"	A0A0B4J1U7	14	105939756-105940253	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 445.6;lymphoid tissue: 160.3"	"Cell type enriched"	"Detected in some"	175	"Plasma cells: 2295.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.1"	"Immune cell enriched"	"Detected in some"	6	"naive B-cell: 19.7"	"Lineage enriched"	"Detected in single"	53	"B-cells: 19.7"	"Not detected"	"Not detected"																"Immunoglobulin genes"	NA	NA		930000000				"prognostic favorable (1.35e-4)"	"unprognostic (9.66e-2)"	"unprognostic (4.55e-3)"	"unprognostic (1.26e-1)"		"prognostic favorable (1.85e-5)"		"unprognostic (1.84e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.89e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.95e-1)"	"prognostic unfavorable (2.48e-6)"	"unprognostic (3.69e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.30e-1)"	9.0	2.1	0.3	0.0	0.1	0.0	7.6	0.0	0.4	3.1	0.2	445.6	0.0	1.2	0.0	18.0	4.3	1.5	1.5	0.0	1.1	3.2	6.2	13.7	0.0	0.3	0.1	0.0	0.9	11.6	0.0	0.3	0.0	0.1	1.6	0.0	0.0	57.2	8.7	0.1	2.0	41.3	11.3	0.2	160.3	19.6	0.3	0.1	0.0	6.8	0.0	0.0	3.7	1.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.7	0.7	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.1	19.7	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.4	0.0	1.1	0.3	0.1	0.0	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	5.1	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2295.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0
IGKV1-39		ENSG00000242371	"Immunoglobulin kappa variable 1-39"	P01597	2	89319625-89320146	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 75.0;lymphoid tissue: 256.9;salivary gland: 152.5;stomach 1: 83.9"	"Cell type enriched"	"Detected in some"	151	"Plasma cells: 16225.1"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 13.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	388	"memory B-cell: 1069.8;naive B-cell: 935.1"	"Lineage enriched"	"Detected in many"	415	"B-cells: 1069.8"	"Cell line enriched"	"Detected in some"	21	"Daudi: 194.2"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		8000000000			"HPA048721: "	"prognostic favorable (1.76e-4)"	"unprognostic (5.10e-3)"	"unprognostic (4.71e-2)"			"prognostic favorable (1.70e-5)"		"unprognostic (2.38e-1)"		"unprognostic (7.33e-2)"	"unprognostic (1.78e-1)"		"unprognostic (6.62e-6)"	"unprognostic (1.19e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.27e-1)"	"unprognostic (2.25e-1)"	6.0	9.2	0.0	55.2	0.0	14.3	17.8	0.0	0.1	13.9	0.0	62.9	71.1	5.7	0.0	11.7	12.6	14.4	1.6	0.2	0.0	10.7	6.8	27.4	36.8	0.1	0.0	0.0	1.8	3.2	0.0	0.5	0.0	0.1	4.3	13.5	0.0	152.5	1.0	0.2	0.8	75.0	1.2	0.0	256.9	83.9	0.3	0.0	6.0	31.3	0.0	42.8	17.7	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	194.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	1.8	0.0	9.0	0.0	0.0	0.0	0.9	1.0	0.7	0.3	0.3	0.3	1069.8	0.5	0.4	1.1	935.1	0.3	0.6	2.5	0.4	0.6	1.3	0.8	136.4	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	107.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	10.7	0.0	0.0	0.0	0.4	3.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16225.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	4.9	0.0	0.3	0.0
IGKV1-8	"IGKV18, L9"	ENSG00000240671	"Immunoglobulin kappa variable 1-8"	A0A0C4DH67	2	88992409-88992931	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 30.0;lymphoid tissue: 55.5;salivary gland: 21.3;stomach 1: 18.8;urinary bladder: 42.1"	"Cell type enriched"	"Detected in some"	40	"Plasma cells: 622.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	311	"memory B-cell: 131.0;naive B-cell: 136.4"	"Lineage enriched"	"Detected in single"	317	"B-cells: 136.4"	"Not detected"	"Not detected"											HPA048721	Approved				"Immunoglobulin genes"	NA	NA		6100000000			"HPA048721: "	"prognostic favorable (1.64e-4)"	"unprognostic (1.56e-2)"	"unprognostic (8.07e-2)"	"unprognostic (6.41e-3)"		"prognostic favorable (5.13e-4)"	"unprognostic (6.87e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (4.14e-7)"	"unprognostic (6.94e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.98e-1)"	1.1	2.5	0.0	13.7	0.0	7.2	6.8	0.0	0.1	2.0	0.0	30.0	12.1	1.3	0.0	2.9	1.5	5.5	0.8	0.0	0.0	3.2	2.1	4.8	13.8	0.0	0.0	0.0	0.5	0.9	0.0	0.1	0.0	0.0	1.4	19.5	0.0	21.3	0.7	0.0	0.0	14.0	0.6	0.0	51.7	18.8	0.3	0.0	7.1	3.4	0.0	55.5	42.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	131.0	0.0	0.4	0.1	136.4	0.1	0.0	0.1	0.1	0.1	0.0	0.1	12.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	622.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0
IGLC7		ENSG00000211685	"Immunoglobulin lambda constant 7"		22	22922594-22923034	"Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in many"	5	"intestine: 88.9;lymphoid tissue: 108.6;salivary gland: 70.8;stomach 1: 114.1"	"Cell type enriched"	"Detected in some"	10	"B-cells: 109.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	341	"memory B-cell: 128.8;naive B-cell: 133.0"	"Lineage enriched"	"Detected in single"	346	"B-cells: 133.0"	"Cell line enriched"	"Detected in some"	913	"Karpas-707: 122629.0"														"Immunoglobulin genes"	NA	NA						"unprognostic (1.20e-3)"	"unprognostic (5.94e-2)"	"unprognostic (3.91e-1)"	"unprognostic (2.16e-2)"		"prognostic favorable (2.03e-4)"	"unprognostic (2.11e-1)"	"unprognostic (9.60e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.74e-1)"	"unprognostic (4.11e-1)"	"prognostic unfavorable (1.61e-6)"	"unprognostic (2.86e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.62e-2)"	5.7	4.7	0.0	28.2	0.1	20.1	15.7	0.0	0.4	5.1	0.1	54.6	88.9	4.5	0.5	8.4	4.3	10.8	1.4	0.0	0.4	2.3	3.5	8.4	41.2	0.3	0.0	0.0	2.5	1.7	0.1	0.2	0.0	0.2	4.5	23.3	0.0	70.8	0.6	0.1	0.2	23.3	0.9	0.0	108.6	114.1	0.8	0.1	20.2	5.8	0.0	105.0	19.2	2.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	85.8	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.2	112.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	122629.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	134.3	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	2.7	3.0	0.6	111.2	0.0	47.3	0.3	0.1	0.0	0.0	0.1	0.0	128.8	0.0	0.0	0.1	133.0	0.0	0.2	0.1	0.0	0.1	0.3	0.1	25.5	0.0	0.1	0.0	0.4	0.0	0.4	0.3	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	109.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.5	0.0	0.4	3.7	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0
IL1RL1	"DER4, FIT-1, IL33R, ST2, ST2L, ST2V, T1"	ENSG00000115602	"Interleukin 1 receptor like 1"	Q01638	2	102311502-102352037	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 124.7;lung: 163.4;placenta: 201.5"	"Cell type enriched"	"Detected in many"	9	"granulocytes: 501.5"	"Cancer enriched"	"Detected in many"	5	"thyroid cancer: 7.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	64	"basophil: 38.3;eosinophil: 29.3"	"Lineage enriched"	"Detected in single"	72	"granulocytes: 38.3"	"Group enriched"	"Detected in some"	6	"HHSteC: 245.1;HMC-1: 373.7;HUVEC TERT2: 185.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA007406, HPA007917"	Uncertain		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"	"Secreted to blood"	NA	NA	19100000	3100000	"Plasma membrane"	"Focal adhesion sites, Cytosol"	"HPA007406: AB_1079128, HPA007917: AB_1079129"	"unprognostic (7.25e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.28e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.25e-3)"	"unprognostic (2.07e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.50e-2)"	"unprognostic (8.58e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.60e-3)"	16.8	30.5	7.1	3.1	8.2	0.7	14.8	7.2	11.0	3.7	10.8	4.1	1.7	2.5	0.6	4.4	2.6	14.8	21.8	7.5	7.0	124.7	16.1	163.4	0.7	7.8	7.3	5.7	1.1	4.9	0.8	5.7	201.5	8.6	5.0	3.4	2.9	1.8	4.7	2.5	3.9	8.0	3.8	7.5	1.4	25.3	0.5	8.3	1.3	4.1	0.7	0.8	6.6	4.0	8.6	0.9	0.2	0.7	0.1	15.1	0.6	0.3	0.5	0.7	0.4	0.6	0.3	0.5	0.5	0.7	0.2	0.2	1.4	0.2	6.3	0.4	0.2	0.1	45.7	0.8	0.8	245.1	1.9	373.7	5.1	1.5	6.2	40.0	0.6	185.5	0.2	0.9	0.8	0.7	0.4	0.6	8.7	0.3	0.4	0.7	0.3	0.2	0.2	1.0	0.3	0.6	0.4	0.5	0.3	0.2	0.4	0.3	0.1	15.4	0.5	0.5	3.5	0.5	0.1	0.3	0.4	0.7	0.6	0.5	38.3	0.0	29.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	7.1	8.2	7.2	11.0	7.5	7.0	7.8	7.3	5.7	8.6	7.5	8.3	8.6	22.6	9.6	13.1	0.0	0.1	8.5	20.3	0.4	0.0	0.0	0.3	0.1	2.7	0.0	7.7	1.8	0.0	0.0	3.3	0.1	0.0	3.2	0.4	1.1	14.8	49.7	0.0	1.3	0.2	0.5	0.1	54.5	0.0	2.5	501.5	0.0	26.4	0.7	0.0	0.0	0.2	0.0	0.0	0.3	19.1	1.3	0.9	3.0	3.6	0.0	0.0	0.0	0.0	0.5	0.1	37.2	0.0	0.0	3.2	15.7	0.0	0.0	6.6	0.3	39.5	1.5	37.7	0.0	0.0	0.0	5.1	0.0	31.5	0.0	0.0	16.4
INSIG1	"CL-6, MGC1405"	ENSG00000186480	"Insulin induced gene 1"	O15503	7	155297776-155310235	"Plasma proteins, Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 568.2"	"Cell type enriched"	"Detected in all"	4	"Langerhans cells: 4121.3"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 142.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"intermediate monocyte: 272.8;non-classical monocyte: 500.8"	"Lineage enriched"	"Detected in all"	6	"monocytes: 500.8"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 1228.9;RPMI-8226: 605.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071524			Uncertain	Vesicles		NA	NA			Vesicles		"HPA071524: "	"unprognostic (8.11e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.47e-1)"	"unprognostic (9.23e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (9.62e-4)"	"unprognostic (4.97e-2)"	80.0	37.6	31.1	35.7	38.6	45.9	37.7	46.3	43.3	18.9	54.1	30.1	53.5	19.7	32.0	40.4	17.7	31.9	19.9	31.5	38.8	32.2	568.2	43.6	31.1	60.9	55.1	26.5	24.2	112.6	17.5	19.0	34.4	64.1	63.1	26.6	40.9	71.6	11.4	9.1	35.5	35.5	20.5	40.8	19.1	61.6	34.7	41.8	40.7	12.6	12.1	25.5	37.0	23.4	88.6	158.9	29.0	76.8	48.1	200.6	265.5	41.9	12.5	179.1	36.9	242.6	18.1	225.2	104.0	35.7	98.2	282.2	83.9	53.1	92.6	43.3	32.3	155.5	28.6	51.7	0.0	99.0	49.3	448.7	165.6	50.4	281.8	25.8	27.3	49.8	202.8	53.2	1228.9	47.9	82.2	238.7	128.6	80.0	30.4	20.4	43.5	0.2	605.1	291.6	77.8	57.2	45.5	41.6	29.9	67.8	28.7	29.0	162.0	56.3	40.5	11.8	77.2	33.3	296.8	57.4	93.3	177.6	187.2	38.2	21.3	29.7	13.4	49.3	272.8	25.5	46.5	32.8	41.9	78.5	60.2	32.6	36.7	62.6	27.5	500.8	44.7	77.0	85.2	31.1	38.6	46.3	43.3	31.5	38.8	60.9	55.1	26.5	64.1	40.8	41.8	88.6	91.4	41.7	121.5	39.8	100.5	140.2	59.4	148.2	74.6	16.5	58.0	31.6	43.6	35.8	114.4	40.5	10.4	47.7	79.0	129.1	17.6	52.0	21.2	30.8	11.6	135.6	126.8	38.3	11.1	140.4	189.0	120.4	57.6	67.4	60.4	18.1	33.2	828.9	46.9	38.7	16.9	91.5	185.1	63.6	4121.3	9.7	15.8	381.0	247.3	7.5	29.6	88.7	34.0	17.1	61.8	53.6	86.6	18.4	100.1	180.4	29.1	9.4	68.3	18.1	19.7	36.3	62.0	33.6	45.0	135.8	155.3	130.4	108.2	20.6	48.0	158.5
KCNK7	K2p7.1	ENSG00000173338	"Potassium two pore domain channel subfamily K member 7"	Q9Y2U2	11	65592836-65595996	"Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skin 1: 85.8"	"Cell type enriched"	"Detected in some"	5	"Suprabasal keratinocytes: 103.7"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 4.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	15	"basophil: 2.1;naive B-cell: 2.2;neutrophil: 1.5"	"Group enriched"	"Detected in many"	16	"B-cells: 2.2;granulocytes: 2.1"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 6.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA077577			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA077577: AB_2686845"	"unprognostic (1.12e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.08e-2)"	"unprognostic (5.71e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.68e-3)"	"unprognostic (8.53e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.87e-1)"	"unprognostic (6.90e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.11e-2)"	1.7	0.7	3.4	0.2	3.3	5.5	3.0	3.8	5.7	3.1	2.3	1.7	0.4	1.4	0.1	18.1	2.3	0.3	1.3	3.4	2.9	0.7	0.9	1.7	0.3	3.3	3.3	2.8	1.8	0.4	0.0	1.3	0.4	3.5	1.5	0.0	0.7	2.5	0.3	2.6	85.8	1.2	0.2	3.4	2.0	1.3	1.1	3.2	0.4	0.6	0.5	1.0	1.7	9.6	3.9	0.3	1.6	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.1	1.0	0.4	0.4	0.1	0.2	2.2	0.0	0.0	0.0	0.5	1.1	0.5	0.9	0.6	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.8	0.6	1.3	0.4	1.0	0.5	0.4	0.6	0.6	0.6	0.9	0.0	0.2	0.6	0.1	6.8	1.5	0.3	0.4	0.7	0.0	0.4	1.1	0.0	0.3	1.1	1.0	0.1	0.9	0.7	0.2	0.5	0.6	0.6	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.2	0.0	0.0	1.5	0.1	0.1	0.0	0.0	0.0	3.4	3.3	3.8	5.7	3.4	2.9	3.3	3.3	2.8	3.5	3.4	3.2	3.9	1.1	0.0	0.5	0.3	0.8	19.1	0.4	0.7	0.6	2.1	0.7	1.8	0.2	0.0	0.7	0.0	0.0	0.1	1.6	1.0	0.0	0.1	0.7	0.7	0.3	1.2	1.2	0.0	0.9	0.0	0.1	0.4	0.0	1.7	0.0	0.2	0.7	0.3	0.5	0.0	0.9	0.4	0.0	1.3	4.0	1.8	0.6	0.7	3.6	0.0	0.4	0.1	0.0	1.0	1.8	0.1	4.8	0.0	0.0	0.3	0.3	0.1	1.1	1.1	6.6	0.4	0.8	0.1	1.3	16.3	103.7	0.0	0.6	0.1	0.8	1.3
KRT84	"Hb-4, KRTHB4"	ENSG00000161849	"Keratin 84"	Q9NSB2	12	52377812-52385652	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"lymphoid tissue: 1.5;skin 1: 1.1"	"Cell type enriched"	"Detected in single"	22	"Cardiomyocytes: 2.2"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039714	Supported					NA	NA		67000000			"HPA039714: AB_2676641"		"unprognostic (1.08e-1)"				"unprognostic (1.65e-2)"		"unprognostic (1.65e-1)"	"unprognostic (3.47e-1)"					"unprognostic (1.59e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.5	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LCN1	"MGC71975, PMFA, TLC, TP, VEGP"	ENSG00000160349	"Lipocalin 1"	P31025	9	135521438-135526540	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Sensory transduction, Taste, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"esophagus: 12.9;seminal vesicle: 8.0"	"Cell type enriched"	"Detected in some"	8	"Basal prostatic cells: 8.2"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 3.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA		3800000				"unprognostic (5.50e-3)"		"unprognostic (1.10e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.99e-1)"	"unprognostic (1.08e-2)"		"unprognostic (1.11e-4)"	"unprognostic (1.22e-1)"	"unprognostic (7.84e-2)"	"unprognostic (9.47e-2)"		"unprognostic (3.94e-8)"	"unprognostic (2.07e-3)"	"unprognostic (3.03e-2)"		"unprognostic (5.83e-2)"	0.0	0.0	0.3	0.2	0.3	0.0	0.0	0.3	0.9	0.0	0.3	0.0	0.0	0.0	0.0	12.9	1.9	0.0	0.5	0.9	0.3	0.0	0.0	0.1	0.0	0.3	0.3	0.3	0.0	0.1	0.0	1.9	0.2	0.3	0.0	0.0	0.0	0.3	8.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.9	0.9	0.3	0.3	0.3	0.3	0.3	0.3	0.4	0.5	0.5	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1
LIME1	"dJ583P15.4, FLJ20406, LIME"	ENSG00000203896	"Lck interacting transmembrane adaptor 1"	Q9H400	20	63736283-63739103	"Predicted intracellular proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 244.7"	"Cell type enriched"	"Detected in some"	5	"Plasma cells: 210.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"gdT-cell: 314.8;MAIT T-cell: 285.2;memory CD4 T-cell: 437.6;memory CD8 T-cell: 412.5;naive CD4 T-cell: 289.4;naive CD8 T-cell: 319.4;plasmacytoid DC: 749.3;T-reg: 689.4"	"Group enriched"	"Detected in all"	8	"dendritic cells: 749.3;T-cells: 689.4"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 33.9;MOLT-4: 37.9;RPMI-8226: 144.4;U-266/70: 71.1"	"Low region specificity"	"Detected in many"							CAB015363	Approved				"Intracellular and membrane"	NA	NA					"CAB015363: AB_629890"	"unprognostic (1.16e-1)"	"unprognostic (2.35e-1)"	"unprognostic (5.95e-3)"	"unprognostic (3.01e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.85e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.51e-3)"	"prognostic unfavorable (5.04e-5)"	"unprognostic (2.39e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.67e-1)"	"prognostic favorable (6.92e-6)"	6.7	5.7	1.7	5.7	4.3	4.7	5.9	1.9	7.1	8.3	0.4	9.6	2.2	6.0	0.0	11.3	6.9	0.0	4.6	2.2	1.1	53.2	244.7	9.1	10.8	3.2	1.1	1.4	9.7	5.2	0.1	11.4	0.1	2.5	13.5	0.3	0.0	12.6	0.4	4.0	11.9	18.9	0.0	0.7	43.5	18.5	5.9	1.2	6.1	11.3	0.0	1.2	7.7	9.2	3.7	2.0	0.6	0.1	0.4	0.0	0.0	4.9	2.6	0.2	0.3	0.0	1.1	2.1	5.7	3.8	0.1	0.0	5.1	0.0	0.3	0.3	2.5	4.8	1.1	2.3	25.4	0.0	1.5	2.1	0.2	0.7	0.0	0.0	0.0	0.0	16.4	2.1	33.9	0.0	1.1	37.9	10.7	2.0	1.3	6.6	25.9	0.8	144.4	0.4	0.3	2.0	2.9	1.3	1.3	2.8	0.0	1.1	0.8	0.5	1.8	2.8	1.9	1.5	71.1	3.0	12.7	1.5	1.1	0.7	1.9	1.5	1.8	314.8	1.0	285.2	76.4	437.6	412.5	2.4	37.2	289.4	319.4	10.6	85.5	1.7	749.3	689.4	193.8	1.7	4.3	1.9	7.1	2.2	1.1	3.2	1.1	1.4	2.5	0.7	1.2	3.7	0.0	0.0	0.0	21.5	7.2	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.8	7.7	0.0	0.0	0.3	22.4	0.0	0.0	0.0	0.4	3.1	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	5.6	0.1	0.0	0.0	9.0	9.6	0.0	0.0	0.0	210.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	5.8	0.1	0.0	36.7	0.0	0.1	0.0
LRRC2		ENSG00000163827	"Leucine rich repeat containing 2"	Q9BYS8	3	46515385-46580099	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"heart muscle: 45.7;skeletal muscle: 166.6;tongue: 94.9"	"Cell type enriched"	"Detected in many"	6	"Cardiomyocytes: 198.4"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 5.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 7.2;HEL: 4.2;LHCN-M2: 4.1;TIME: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039138, HPA064844"			Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA039138: AB_10795461, HPA064844: "	"unprognostic (1.32e-4)"	"unprognostic (3.44e-3)"	"unprognostic (2.29e-2)"	"unprognostic (3.38e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.38e-3)"	"unprognostic (1.61e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.72e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.24e-1)"	2.4	0.7	1.2	0.7	4.0	0.8	2.0	1.2	2.8	3.4	0.3	1.6	0.7	4.8	2.4	1.5	2.4	3.0	45.7	2.7	1.5	4.5	5.6	1.2	0.6	0.7	0.6	2.7	5.2	1.1	0.9	1.3	1.0	0.8	2.1	1.6	0.3	2.2	0.3	166.6	1.8	0.8	4.1	0.8	2.8	1.8	0.8	0.3	3.2	22.3	94.9	0.7	2.3	2.1	1.6	0.1	0.0	0.1	0.1	0.6	1.4	0.1	0.5	1.0	0.3	0.5	0.0	0.1	0.2	0.1	7.2	0.0	0.1	2.5	0.0	0.9	0.3	0.0	4.2	0.3	0.0	0.1	0.1	0.0	0.1	0.0	2.8	0.0	2.3	0.1	0.5	0.0	0.2	4.1	0.0	0.5	0.1	1.0	0.3	0.1	0.1	0.0	0.2	0.0	0.2	0.3	0.8	0.5	0.1	1.0	0.7	0.1	0.5	3.2	0.1	0.3	1.6	1.1	0.2	0.2	1.9	0.1	0.1	0.9	0.6	0.1	0.1	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.1	0.1	0.5	0.2	0.1	0.1	0.5	0.1	1.2	4.0	1.2	2.8	2.7	1.5	0.7	0.6	2.7	0.8	0.8	0.3	1.6	1.6	9.6	1.1	2.0	0.2	1.9	1.1	0.6	0.6	0.1	0.8	1.3	198.4	7.2	0.0	1.8	0.0	0.1	0.0	0.2	9.8	0.6	2.3	0.3	1.6	4.0	3.0	0.0	12.5	1.0	0.0	11.9	3.1	0.4	10.2	2.5	5.0	10.2	2.0	0.0	11.2	1.8	0.0	0.8	5.7	2.9	0.6	0.6	10.6	3.7	0.0	0.4	0.0	3.5	0.7	1.0	0.4	0.0	3.0	0.6	0.0	0.8	0.7	0.2	0.0	32.7	2.6	0.6	0.7	0.0	2.4	0.1	2.1	7.9	1.9	0.4
LRRC26	bA350O14.10	ENSG00000184709	"Leucine rich repeat containing 26"	Q2I0M4	9	137168758-137170051	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"salivary gland: 292.4"	"Cell type enriched"	"Detected in many"	5	"Intestinal goblet cells: 598.0"	"Cancer enriched"	"Detected in many"	5	"prostate cancer: 47.6"	"Region enhanced"	"Detected in single"		"cerebellum: 2.5"	"Immune cell enriched"	"Detected in single"	1177	"plasmacytoid DC: 117.6"	"Lineage enriched"	"Detected in single"	1177	"dendritic cells: 117.6"	"Cell line enriched"	"Detected in some"	6	"RPMI-8226: 130.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA056312	Approved		Supported	"Nucleoli fibrillar center,Plasma membrane"		NA	NA			"Plasma membrane"	"Nucleoli fibrillar center"	"HPA056312: AB_2683098"	"unprognostic (1.75e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.04e-2)"	"prognostic favorable (4.82e-6)"	"unprognostic (3.39e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.13e-2)"		"unprognostic (1.98e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.75e-1)"		"prognostic favorable (3.48e-4)"	"unprognostic (3.27e-1)"		"unprognostic (2.29e-1)"	0.0	0.0	0.1	0.3	0.3	0.0	7.4	2.5	0.5	0.4	0.0	10.3	1.7	1.1	0.0	2.8	1.1	0.0	0.0	0.5	0.4	0.0	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.6	0.0	0.1	0.0	0.8	53.6	0.5	0.0	292.4	0.5	0.0	4.8	7.2	0.0	0.1	0.1	5.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	5.4	0.7	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.9	0.1	0.3	0.7	20.8	0.1	130.9	0.0	0.0	1.0	0.2	0.5	6.0	0.0	0.0	2.7	0.5	0.1	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	117.6	0.0	0.5	0.1	0.3	2.5	0.5	0.5	0.4	0.2	0.1	0.1	0.8	0.1	0.1	0.1	0.6	0.0	0.0	0.3	1.2	1.0	1.7	0.5	0.0	0.0	101.2	64.4	0.4	4.3	1.0	0.0	0.0	0.1	81.8	15.2	1.9	0.1	0.5	13.0	1.6	1.0	9.0	0.0	0.1	0.4	0.0	0.4	9.2	21.3	0.0	0.0	0.0	0.0	0.1	0.0	0.3	598.0	4.1	0.0	0.9	1.1	0.0	1.4	56.9	0.0	0.6	0.0	0.0	0.0	0.1	0.2	11.8	0.0	0.6	28.4	28.8	0.1	0.4	0.0	0.0	0.0	0.4	0.2	2.8	3.5	0.3	0.0	0.6	0.0	24.3	3.7
MLC1	"KIAA0027, LVM, MLC, VL"	ENSG00000100427	"Modulator of VRAC current 1"	Q15049	22	50059391-50085426	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 263.9;choroid plexus: 119.2"	"Cell type enriched"	"Detected in some"	6	"Astrocytes: 115.6"	"Cancer enriched"	"Detected in some"	69	"glioma: 122.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 20.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HL-60: 228.2;NB-4: 219.8;THP-1: 401.5;U-266/70: 131.6;U-266/84: 120.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003040	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"HPA003040: AB_1079387"	"unprognostic (2.68e-2)"	"unprognostic (5.46e-6)"	"unprognostic (5.41e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.42e-3)"	"unprognostic (9.54e-3)"	"unprognostic (7.21e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.51e-3)"	"unprognostic (8.39e-4)"	"unprognostic (1.40e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.92e-1)"	0.3	0.1	211.8	0.7	202.2	36.7	0.1	190.1	263.9	1.9	119.2	0.1	0.4	0.3	1.0	0.1	1.8	1.0	0.4	198.6	208.3	0.1	0.4	1.6	0.3	235.6	205.3	171.2	0.3	0.1	0.0	1.1	2.3	192.5	4.9	0.0	4.2	0.1	1.4	0.1	1.0	0.1	0.2	200.2	2.2	0.2	3.8	201.2	0.5	0.1	0.0	0.5	0.4	12.0	188.7	0.4	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	68.1	0.0	0.0	0.1	228.2	68.4	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	1.8	219.8	0.3	0.0	0.1	24.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	401.5	0.0	0.0	0.2	0.1	0.3	131.6	120.2	0.4	0.3	35.7	2.2	0.0	1.1	0.0	3.9	6.8	0.1	0.1	0.3	1.6	0.9	0.0	0.1	1.8	0.1	20.2	9.2	0.2	0.1	4.0	211.8	202.2	190.1	263.9	198.6	208.3	235.6	205.3	171.2	192.5	200.2	201.2	188.7	0.0	0.0	0.5	115.6	0.3	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.6	0.0	0.0	0.1	17.2	0.0	0.0	0.0	1.1	0.1	0.4	0.1	0.0	7.8	0.4	0.0	0.1	2.4	0.0	0.1	1.3	4.4	0.4	0.0	3.5	0.0	0.5	0.0	0.0	0.3	0.0	0.7	0.0	0.6	1.8	7.5	0.6	16.3	18.6	0.5	0.8	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.3	2.7	0.1	0.0	0.0
MS4A1	"B1, Bp35, CD20, MS4A2"	ENSG00000156738	"Membrane spanning 4-domains A1"	P11836	11	60455846-60470752	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"B-cell activation"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 678.9"	"Cell type enriched"	"Detected in some"	35	"B-cells: 970.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	96	"memory B-cell: 625.4;naive B-cell: 627.0"	"Lineage enriched"	"Detected in many"	96	"B-cells: 627.0"	"Group enriched"	"Detected in some"	26	"Daudi: 731.3;U-698: 364.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000015, HPA014341, HPA014391"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB000015: AB_2282030, HPA014341: AB_1846265, HPA014391: AB_1846264"	"prognostic favorable (4.34e-5)"	"unprognostic (4.45e-4)"	"unprognostic (1.19e-4)"	"unprognostic (2.04e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.53e-7)"	"unprognostic (2.46e-3)"	"unprognostic (1.85e-3)"	"unprognostic (3.06e-2)"	"unprognostic (2.89e-4)"	"unprognostic (6.96e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.96e-5)"	"unprognostic (2.23e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.30e-1)"	3.6	0.4	0.0	151.1	0.0	19.3	0.8	0.0	0.2	0.5	0.3	9.1	3.1	2.2	1.0	4.2	0.5	8.5	1.8	0.0	0.1	3.4	2.2	4.0	504.4	0.2	0.2	0.0	0.3	0.2	7.4	0.3	0.9	0.1	5.2	10.7	0.0	9.0	0.3	0.8	0.1	124.5	1.2	0.1	256.0	18.6	1.2	0.1	51.0	6.7	0.1	678.9	16.4	1.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	731.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.3	0.5	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.5	0.2	0.0	0.1	0.0	364.1	0.0	0.2	0.0	0.8	0.5	0.3	2.4	0.1	3.7	625.4	2.8	5.5	0.5	627.0	0.5	2.1	2.0	6.5	0.6	0.5	0.8	32.1	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.2	0.0	0.1	0.1	0.1	0.1	0.3	0.0	3.8	0.0	970.5	0.1	0.1	0.0	0.0	0.0	0.4	0.3	0.4	0.0	0.0	0.0	0.0	0.0	14.5	0.3	0.0	0.0	4.5	0.7	0.1	0.3	0.0	7.0	0.0	0.0	0.1	1.8	2.0	0.1	2.5	0.0	1.1	0.3	0.1	0.0	0.0	0.2	0.0	0.6	0.3	2.0	0.0	4.6	7.2	0.0	2.5	0.0	2.1	0.0	0.0	0.0	0.3	0.0	9.1	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.5	0.2	0.1	0.8	0.1	0.0	27.3	0.7	0.2	0.0
MTRNR2L3		ENSG00000256222	"MT-RNR2 like 3"	P0CJ70	20	57358447-57359498	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	5	"brain: 3.3;skeletal muscle: 1.0"	"Cell type enriched"	"Detected in some"	49	"Cardiomyocytes: 3203.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"cerebral cortex: 3.3"	"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in single"		"HeLa: 1.1"														"Secreted - unknown location"	NA	NA						"unprognostic (1.55e-4)"	"unprognostic (2.65e-1)"	"unprognostic (2.59e-1)"	"unprognostic (8.34e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.80e-2)"	"unprognostic (9.44e-6)"	"unprognostic (2.56e-1)"	"unprognostic (6.68e-2)"	"unprognostic (5.35e-3)"	"unprognostic (1.52e-3)"	"unprognostic (7.52e-2)"	"unprognostic (5.36e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.94e-3)"	0.0	0.1	0.2	0.0	0.3	0.2	0.0	0.5	3.3	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.3	0.2	0.2	0.0	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.1	1.1	0.0	0.1	0.0	0.1	0.1	0.2	0.3	0.5	3.3	0.4	0.3	0.2	0.3	0.2	0.4	0.2	0.3	0.5	0.7	0.0	0.0	0.0	1.0	3.2	32.3	0.3	0.0	0.0	2.4	1.3	3203.4	1.5	0.1	0.0	0.0	0.4	0.2	0.0	1.9	0.0	0.1	0.3	0.3	58.4	0.0	2.7	0.0	0.0	0.4	64.9	0.0	0.7	0.0	0.2	2.2	2.6	0.7	0.0	0.0	0.0	0.0	3.9	12.0	0.5	1.5	1.8	7.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	17.7	0.0	10.6	0.1	0.0	0.0	9.2	60.8	0.3	0.7	0.0	3.1	0.5	1.2	0.1	0.0	18.1
NACC2	"BEND9, BTBD14A, BTBD31, MGC23427"	ENSG00000148411	"NACC family member 2"	Q96BF6	9	136006537-136095289	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"brain: 131.0"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 305.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 49.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047924, HPA052962"	Approved		Approved	Nucleoli,Mitochondria		NA	NA			"Nucleoli, Mitochondria"		"HPA047924: AB_2680212, HPA052962: AB_2681998"	"unprognostic (1.13e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.90e-2)"	"unprognostic (8.73e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.25e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.92e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.23e-1)"	"prognostic favorable (8.28e-5)"	"prognostic favorable (8.63e-4)"	"unprognostic (1.71e-1)"	"unprognostic (4.98e-2)"	"unprognostic (4.12e-2)"	12.4	11.5	92.6	8.8	88.9	2.0	8.0	113.9	77.2	8.9	25.1	24.8	6.3	21.0	4.1	8.6	12.9	7.2	14.6	53.1	73.3	7.6	9.7	9.6	3.4	124.4	101.7	46.6	7.7	7.7	4.6	6.5	2.7	131.0	11.9	3.8	5.0	8.0	17.4	17.2	4.3	10.0	15.7	90.4	8.1	13.7	6.6	107.8	1.0	5.8	6.8	2.0	23.4	7.4	123.8	6.1	32.7	3.6	49.0	15.4	8.6	4.5	14.6	9.7	4.6	1.6	14.0	10.6	0.0	17.1	23.2	7.4	23.3	7.9	7.9	1.5	18.6	7.1	4.1	33.3	17.6	15.6	0.0	7.4	14.4	7.2	4.3	4.3	18.8	13.0	0.0	12.8	0.1	9.0	20.5	0.0	11.6	11.0	9.7	20.2	0.0	3.8	10.0	19.2	6.9	1.2	1.5	20.6	17.0	18.2	16.2	17.4	37.9	21.6	12.3	13.9	10.5	10.1	0.1	0.0	0.3	16.2	1.4	25.2	1.9	2.2	0.8	0.8	1.7	0.3	0.0	0.3	0.7	1.2	0.0	0.2	0.2	2.7	0.2	1.7	0.1	0.2	0.8	92.6	88.9	113.9	77.2	53.1	73.3	124.4	101.7	46.6	131.0	90.4	107.8	123.8	14.3	12.8	5.0	69.9	0.8	4.6	4.9	9.0	3.4	3.4	6.7	5.6	28.5	7.2	7.9	5.5	0.0	0.7	7.0	12.4	0.0	12.6	76.2	18.9	9.8	18.5	2.4	1.7	2.5	13.4	2.1	10.9	7.7	6.0	2.5	1.5	17.9	33.2	7.8	3.3	21.1	4.4	0.0	38.4	8.0	305.5	18.0	16.6	5.4	21.5	45.3	17.1	12.3	40.7	45.1	18.3	9.2	19.2	2.1	11.8	6.7	13.6	12.5	1.9	26.3	14.0	15.8	2.4	12.6	6.8	5.1	0.4	5.7	1.4	5.3	7.6
NANOS2	"NOS2, ZC2HC12B"	ENSG00000188425	"Nanos C2HC-type zinc finger 2"	P60321	19	45913214-45914778	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Translation regulation"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5	"testis: 3.6"	"Cell type enriched"	"Detected in single"	16	"Spermatogonia: 8.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA014190	Approved					NA	NA					"HPA014190: AB_2668950"					"unprognostic (2.65e-1)"					"unprognostic (1.01e-1)"					"unprognostic (3.69e-1)"			0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.3	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.5	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.3	0.6	0.4	0.3	0.5	0.3	0.2	0.6	0.3	0.4	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NCCRP1	"FBXO50, LOC342897, NCCRP-1"	ENSG00000188505	"NCCRP1, F-box associated domain containing"	Q6ZVX7	19	39196964-39201884	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 457.0;lymphoid tissue: 126.0;skin 1: 257.3;vagina: 183.2"	"Cell type enriched"	"Detected in some"	12	"monocytes: 563.9"	"Group enriched"	"Detected in many"	4	"cervical cancer: 42.8;head and neck cancer: 48.5;melanoma: 28.3;urothelial cancer: 33.9"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.1"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.1"	"Cell line enriched"	"Detected in some"	10	"SK-BR-3: 30.8"	"Region enhanced"	"Detected in single"		"olfactory bulb: 1.6"	"Low region specificity"	"Detected in some"			HPA052812	Approved					NA	NA		400000			"HPA052812: AB_2681960"	"unprognostic (3.56e-3)"	"unprognostic (3.69e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (4.59e-3)"	"unprognostic (3.73e-3)"	"unprognostic (2.78e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.53e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.37e-6)"	"unprognostic (2.12e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.57e-1)"	0.3	0.2	1.8	2.1	1.1	1.0	6.3	1.8	1.9	46.5	0.0	0.4	2.0	0.6	0.8	457.0	1.1	0.8	0.4	1.2	1.0	2.8	0.2	0.4	2.8	1.2	1.1	0.8	0.4	8.9	1.4	0.4	1.1	1.6	1.4	1.9	1.7	54.4	1.2	0.9	257.3	0.7	0.5	0.9	1.4	0.5	0.5	1.1	4.2	0.6	0.0	126.0	5.2	183.2	1.6	0.2	0.2	1.1	0.2	0.1	0.7	2.4	0.1	0.0	0.1	0.2	0.5	0.5	0.7	2.3	0.4	0.2	1.0	1.7	0.7	0.5	0.0	0.4	0.2	0.9	0.1	0.2	0.5	0.3	0.5	0.5	0.1	0.3	0.3	0.3	0.5	0.4	0.2	0.3	0.1	0.2	0.2	0.7	0.2	0.2	0.2	0.4	0.4	0.1	0.6	0.6	1.0	2.9	30.8	0.2	0.9	0.4	0.9	0.2	0.2	0.2	0.2	0.5	0.2	0.2	0.6	0.6	0.2	0.5	1.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.0	1.8	1.1	1.8	1.9	1.2	1.0	1.2	1.1	0.8	1.6	0.9	1.1	1.6	0.0	0.0	0.0	0.0	0.0	0.6	1.6	8.5	0.0	0.3	4.7	2.4	0.3	0.0	30.8	3.7	0.0	0.4	0.2	0.1	0.0	2.7	0.0	0.7	0.4	0.2	0.0	0.0	0.0	2.3	3.1	1.0	0.0	2.5	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	6.1	0.0	4.7	0.2	0.0	0.7	1.8	0.0	563.9	0.3	0.0	0.0	0.0	4.2	0.7	0.0	1.2	1.1	0.0	0.1	1.6	0.0	0.0	0.1	2.0	0.1	0.5	7.3	7.1	11.1	0.2	0.1	0.0	46.4
NEUROG1	"AKA, bHLHa6, Math4C, NEUROD3, ngn1"	ENSG00000181965	"Neurogenin 1"	Q92886	5	135534282-135535964	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5	"brain: 4.2"	"Cell type enriched"	"Detected in single"	15	"Bipolar cells: 9.1"	"Cancer enriched"	"Detected in single"	12	"testis cancer: 1.1"	"Region enriched"	"Detected in single"	10	"midbrain: 4.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA072232			Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA072232: "															"unprognostic (3.04e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NKAIN1	"FAM77C, FLJ12650"	ENSG00000084628	"Sodium/potassium transporting ATPase interacting 1"	Q4KMZ8	1	31179745-31239887	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 24.4;brain: 18.6;skeletal muscle: 19.6;tongue: 12.0"	"Cell type enriched"	"Detected in some"	12	"Oligodendrocytes: 43.9"	"Group enriched"	"Detected in many"	5	"breast cancer: 17.2;glioma: 4.6;prostate cancer: 10.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 21.2;AN3-CA: 35.8;NTERA-2: 92.7;SCLC-21H: 27.3;SH-SY5Y: 43.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006873	Uncertain					NA	NA					"HPA006873: AB_1848410"	"unprognostic (1.58e-2)"	"unprognostic (7.99e-2)"	"unprognostic (8.54e-2)"	"unprognostic (6.11e-5)"	"unprognostic (6.59e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.30e-4)"	"unprognostic (1.04e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.01e-2)"	"unprognostic (8.07e-2)"	"unprognostic (6.31e-9)"	"unprognostic (1.00e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.62e-4)"	"unprognostic (5.50e-2)"	0.1	24.4	8.6	0.2	14.2	0.0	0.4	16.5	10.8	0.2	3.2	0.2	0.1	0.6	3.5	0.6	0.1	0.0	0.0	11.7	11.5	0.2	0.0	0.0	0.0	17.7	16.4	7.4	0.1	0.2	0.6	2.2	0.3	18.6	1.0	0.1	1.5	0.4	0.3	19.6	1.7	0.1	0.2	5.8	0.0	0.1	0.3	12.1	0.2	0.0	12.0	0.0	0.0	0.5	13.7	0.0	0.4	21.2	35.8	0.2	0.0	0.3	0.1	0.0	0.4	0.1	0.4	0.2	0.0	0.7	0.4	0.4	0.0	5.3	0.0	0.1	0.0	1.5	0.0	0.3	0.3	0.2	0.4	0.1	0.1	0.1	0.4	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.3	0.8	92.7	0.0	0.9	0.0	0.3	0.1	0.1	3.6	27.3	43.9	1.0	0.3	2.5	2.4	9.6	0.4	0.0	0.0	0.5	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	14.2	16.5	10.8	11.7	11.5	17.7	16.4	7.4	18.6	5.8	12.1	13.7	0.0	0.0	0.0	0.3	0.0	0.4	0.1	0.2	0.0	0.5	0.5	0.1	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.0	1.9	0.2	0.0	0.1	1.1	0.0	0.0	0.0	3.6	0.0	0.3	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	3.3	0.0	2.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.5	43.9	0.1	0.0	0.0	0.0	0.3	0.0	0.8	0.1	0.5	0.0	0.3	0.3	0.8	1.2	0.3	1.4	0.4	0.0	0.1	0.0	0.2
NLRP3	"AGTAVPRL, AII, AVP, C1orf7, CIAS1, CLR1.1, DFNA34, FCAS, FCU, MWS, NALP3, PYPAF1"	ENSG00000162711	"NLR family pyrin domain containing 3"	Q96P20	1	247416156-247449108	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation"	Activator	"Amyloidosis, Cancer-related genes, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"bone marrow: 54.3"	"Cell type enriched"	"Detected in many"	6	"Macrophages: 254.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"basophil: 129.4"	"Group enriched"	"Detected in many"	23	"dendritic cells: 37.3;granulocytes: 129.4;monocytes: 35.6"	"Cell line enriched"	"Detected in some"	4	"THP-1: 78.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA012878	Uncertain				"Intracellular and membrane"	NA	NA					"HPA012878: AB_1846752"	"unprognostic (3.56e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.23e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.69e-1)"	"unprognostic (7.86e-2)"	"unprognostic (4.46e-2)"	"unprognostic (3.84e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.52e-2)"	"unprognostic (4.88e-3)"	"unprognostic (2.17e-4)"	"unprognostic (1.10e-1)"	"unprognostic (6.10e-2)"	8.4	1.4	1.0	10.1	0.7	54.3	3.5	0.9	0.8	1.8	1.1	1.5	0.8	0.9	0.4	2.7	1.4	6.5	0.8	0.8	1.6	0.6	2.1	4.6	2.5	1.8	1.1	0.3	0.7	1.6	0.9	0.5	3.4	1.8	0.8	1.8	0.3	0.8	0.7	0.5	0.4	2.4	4.8	2.2	4.6	1.4	0.3	1.2	1.7	1.0	0.5	1.7	6.4	0.4	2.5	7.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.9	0.2	0.4	0.0	0.3	0.0	0.3	0.0	0.5	0.0	0.0	2.2	2.9	0.5	0.0	1.3	0.2	0.0	0.0	5.3	0.0	0.0	0.0	0.5	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	13.8	0.0	0.0	0.4	0.4	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	78.4	0.1	3.2	2.5	0.0	0.2	0.0	0.0	0.0	7.2	18.9	2.4	129.4	35.6	0.2	0.6	21.7	1.7	0.0	2.9	1.2	37.3	0.1	1.1	0.7	8.6	0.0	11.5	1.8	0.1	12.2	1.0	0.7	0.9	0.8	0.8	1.6	1.8	1.1	0.3	1.8	2.2	1.2	2.5	2.2	0.0	0.5	0.3	2.6	1.0	0.1	0.0	0.6	0.3	0.6	1.1	0.6	0.0	0.0	0.0	0.0	0.7	6.0	0.0	0.0	0.0	0.3	0.1	0.5	2.3	0.0	1.7	2.6	0.0	0.4	1.2	1.5	0.1	2.5	0.2	0.4	0.3	16.2	0.0	1.2	0.2	0.0	35.4	41.4	0.2	0.0	254.2	0.0	17.8	14.5	0.7	1.0	1.0	0.4	0.1	0.0	0.4	4.0	0.0	0.0	0.2	0.0	0.4	0.0	1.0	1.1	0.4	0.4	1.3	0.6	1.4	10.2	0.1	0.0	0.0
NR5A2	"B1F2, FTF, FTZ-F1, FTZ-F1beta, hB1F, hB1F-2, LRH-1, LRH1"	ENSG00000116833	"Nuclear receptor subfamily 5 group A member 2"	O00482	1	200027614-200177420	"Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 18.0;liver: 38.9;pancreas: 61.7"	"Cell type enriched"	"Detected in many"	5	"Granulosa cells: 276.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.6"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"basophil: 3.2;neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.2"	"Cell line enhanced"	"Detected in some"		"A549: 25.0;CACO-2: 6.2;HAP1: 14.9;HMC-1: 6.4;HUVEC TERT2: 20.4"	"Region enhanced"	"Detected in single"		"hypothalamus: 1.2"	"Not detected"	"Not detected"			"HPA005455, HPA017067"	Approved		Uncertain	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA005455: AB_1078140, HPA017067: AB_1844767"	"unprognostic (7.47e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.19e-2)"	"unprognostic (6.63e-3)"	"unprognostic (4.46e-2)"	"unprognostic (3.78e-2)"	"unprognostic (3.34e-1)"	"unprognostic (8.50e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.00e-7)"	"unprognostic (5.48e-2)"	"unprognostic (5.07e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.37e-1)"	5.4	0.4	0.4	2.6	0.3	0.9	3.8	0.5	0.3	3.5	0.3	12.0	17.5	3.3	1.4	0.9	2.2	8.0	1.1	0.3	2.3	0.5	38.9	2.7	2.1	0.6	0.8	0.1	1.0	61.7	0.4	0.1	0.4	0.8	1.6	13.2	0.2	0.5	0.8	1.1	1.1	18.0	4.4	0.3	0.2	1.3	0.8	0.7	0.6	0.9	0.7	1.4	1.8	1.2	0.6	0.0	25.0	0.0	0.1	0.0	0.2	0.6	0.0	0.4	0.0	0.0	6.2	0.1	0.0	0.0	0.0	0.7	0.7	14.9	0.0	0.0	3.3	1.1	0.0	0.3	2.7	0.5	0.1	6.4	0.1	0.0	0.0	0.1	0.0	20.4	0.1	0.0	0.3	0.0	0.6	0.0	0.4	0.9	0.0	0.3	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.1	1.7	4.7	0.3	0.1	1.0	0.2	0.1	0.2	3.4	2.3	2.6	0.3	0.2	0.1	3.2	0.4	0.4	0.2	0.2	0.2	0.3	0.3	0.3	0.1	0.4	0.4	0.3	1.5	0.5	0.2	0.5	0.4	0.1	0.4	0.3	0.5	0.3	0.3	2.3	0.6	0.8	0.1	0.8	0.3	0.7	0.6	23.7	0.0	1.7	0.3	0.2	1.9	0.1	0.0	0.0	0.2	0.2	0.0	9.9	32.9	0.0	0.0	0.0	0.0	0.3	37.5	0.0	38.2	0.4	0.3	0.3	32.4	4.9	2.7	0.4	54.5	0.0	0.8	0.0	0.2	13.3	276.2	38.6	38.5	0.1	0.0	0.6	13.8	0.0	4.9	1.5	0.3	0.6	0.6	0.0	0.0	3.1	0.0	0.0	1.0	0.3	22.0	21.8	0.0	1.2	0.3	49.9	0.0	0.8	0.3	0.0	0.5	6.1	0.1	0.1	0.0	1.4	0.0	0.3	0.1	32.3	0.2
NRAP		ENSG00000197893	"Nebulin related anchoring protein"	Q86VF7	10	113588714-113664070	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"skeletal muscle: 2386.3;tongue: 1155.0"	"Cell type enriched"	"Detected in some"	9	"Cardiomyocytes: 534.1"	"Group enriched"	"Detected in some"	7	"head and neck cancer: 8.2;prostate cancer: 3.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA037953, HPA037954, HPA075074"	Enhanced		Approved	"Vesicles,Intermediate filaments,Cytosol"		NA	NA			"Intermediate filaments"	"Vesicles, Cytosol"	"HPA037953: AB_2675755, HPA037954: AB_10672394, HPA075074: "	"unprognostic (1.13e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.75e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.03e-3)"	"unprognostic (3.72e-2)"	"unprognostic (4.20e-2)"	"unprognostic (6.40e-2)"	"unprognostic (2.88e-1)"	"unprognostic (5.39e-4)"	"unprognostic (8.21e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.16e-1)"		0.3	0.1	0.1	0.0	0.3	0.0	0.4	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	25.0	0.0	0.2	331.9	0.1	0.1	0.1	0.5	0.4	0.1	0.4	0.2	0.3	0.1	0.4	0.0	0.3	0.0	0.1	20.6	1.0	0.0	22.2	0.0	2386.3	0.6	0.1	0.0	0.0	0.1	0.3	0.6	0.2	0.0	0.4	1155.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.3	0.1	0.1	0.4	0.2	0.3	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.0	534.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	1.4	0.1	0.0	3.7	0.0	0.0	0.3	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	4.8	0.0	0.0	0.3	2.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	57.3	3.3	1.0	2.3	0.0	0.1	0.0	0.2	0.0	0.5	0.0
NTS		ENSG00000133636	Neurotensin	P30990	12	85874295-85882992	"Predicted secreted proteins"		Vasoactive		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 167.2"	"Cell type enriched"	"Detected in some"	13	"Intestinal goblet cells: 1683.2"	"Cancer enhanced"	"Detected in many"		"lung cancer: 155.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SuSa: 205.5"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"basal ganglia: 154.3"	"HPA026664, HPA071012"	Enhanced		Supported	Vesicles	"Secreted to digestive system"	NA	NA		1600000	Vesicles		"HPA026664: AB_2671936, HPA071012: "	"unprognostic (3.63e-1)"	"prognostic favorable (9.94e-5)"	"unprognostic (8.18e-2)"	"prognostic unfavorable (5.10e-4)"	"unprognostic (1.99e-2)"	"unprognostic (3.04e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.53e-3)"	"unprognostic (8.83e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.30e-6)"	"unprognostic (2.94e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.17e-1)"	"unprognostic (7.48e-2)"	6.2	1.2	8.1	3.6	2.1	0.0	5.3	1.2	9.7	0.7	0.5	1.8	6.7	0.3	0.7	5.6	0.9	1.3	0.5	2.4	13.6	1.7	1.5	1.2	11.8	11.1	8.9	0.2	0.6	0.4	0.1	32.6	0.5	6.2	0.3	1.5	0.0	0.1	0.6	0.0	0.1	167.2	1.1	4.2	0.1	36.7	0.3	16.8	0.5	0.9	0.2	1.0	3.1	0.3	4.6	0.0	5.0	0.3	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.1	0.0	0.0	0.0	0.0	0.0	1.0	50.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	10.7	0.0	4.1	0.0	1.7	0.0	0.0	0.0	5.4	1.6	0.0	0.0	0.0	205.5	0.4	0.0	0.0	0.1	0.0	0.4	0.0	2.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	2.1	1.2	9.7	2.4	13.6	11.1	8.9	0.2	6.2	4.2	16.8	4.6	3.6	0.0	0.5	0.0	0.0	1.3	0.7	22.6	0.0	0.0	10.1	0.0	0.3	0.0	27.0	9.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	68.4	2.4	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	44.3	0.0	0.2	0.0	1.2	1683.2	2.0	0.3	2.6	0.0	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.5	15.0	0.0	0.0	2.5	120.8	0.0	3.5	0.0	0.0	0.0	0.9	0.8	0.1	1.2	2.3	0.1	1.3	0.0	8.1	60.4
ONECUT1	"HNF-6, HNF6, HNF6A"	ENSG00000169856	"One cut homeobox 1"	Q9UBC0	15	52755053-52791078	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"gallbladder: 6.0;liver: 13.0;pancreas: 13.7;retina: 4.7"	"Cell type enriched"	"Detected in some"	16	"Horizontal cells: 647.8"	"Group enriched"	"Detected in some"	7	"liver cancer: 2.9;pancreatic cancer: 0.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.8;Hep G2: 1.4;MCF7: 1.3;NTERA-2: 1.8;SuSa: 1.9;WM-115: 1.2"	"Region enhanced"	"Detected in single"		"hypothalamus: 1.0"	"Low region specificity"	"Detected in many"			HPA003457	Enhanced					NA	NA					"HPA003457: AB_1079525"		"unprognostic (5.12e-2)"		"unprognostic (2.45e-2)"	"unprognostic (2.64e-2)"	"unprognostic (4.82e-2)"	"unprognostic (9.19e-2)"	"unprognostic (7.05e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.03e-1)"		"unprognostic (1.70e-7)"	"unprognostic (9.76e-3)"	"unprognostic (2.11e-1)"		"unprognostic (1.17e-1)"	0.0	0.0	1.0	0.0	0.7	0.5	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.4	1.0	0.0	13.0	0.0	0.0	1.8	1.9	0.1	0.0	13.7	0.0	0.0	0.0	1.8	0.0	0.0	4.7	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	1.9	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.4	1.8	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	1.3	0.0	0.0	1.8	0.1	0.1	0.3	0.0	0.0	0.0	0.8	0.4	0.0	0.1	0.0	0.2	1.9	0.3	0.0	0.0	0.6	0.8	0.0	0.1	0.1	0.0	0.0	0.2	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.7	0.4	0.3	0.4	1.0	1.8	1.9	0.1	1.8	0.7	0.7	1.7	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	1.3	40.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	21.1	1.4	0.1	0.0	0.3	0.0	0.0	0.4	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	647.8	0.2	0.0	0.0	0.3	0.0	3.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	15.6	0.2	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.2	3.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR51E2	PSGR	ENSG00000167332	"Olfactory receptor family 51 subfamily E member 2"	Q9H255	11	4680171-4697854	"Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 8.5;prostate: 29.2"	"Cell type enriched"	"Detected in some"	6	"Enteroendocrine cells: 77.4"	"Cancer enriched"	"Detected in some"	274	"prostate cancer: 217.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.9;BJ hTERT+: 1.1;hTERT-RPE1: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.98e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.09e-3)"	"unprognostic (1.57e-2)"	"unprognostic (8.00e-4)"	"unprognostic (3.61e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.61e-1)"	"unprognostic (5.04e-5)"	"unprognostic (3.34e-2)"	"unprognostic (4.66e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.29e-1)"	0.7	0.2	0.3	1.0	0.4	0.1	0.5	0.4	0.5	0.5	0.6	8.5	0.2	1.3	0.3	0.0	0.5	0.3	0.1	0.5	0.3	0.2	0.0	0.0	0.0	0.4	0.3	0.4	0.6	0.1	0.0	0.0	4.0	0.5	29.2	2.2	0.1	0.0	2.3	0.4	0.2	0.8	2.1	0.1	0.0	0.4	0.3	0.4	0.0	0.1	0.4	0.0	0.4	0.2	0.6	0.0	0.0	0.0	0.0	0.2	1.9	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.4	0.5	0.5	0.3	0.4	0.3	0.4	0.5	0.1	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	77.4	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1
OTOP2		ENSG00000183034	"Otopetrin 2"	Q7RTS6	17	74922950-74933912	"Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 20.3"	"Cell type enriched"	"Detected in some"	20	"Paneth cells: 627.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	41	"HDLM-2: 10.1"	"Region enriched"	"Detected in some"	12	"olfactory bulb: 12.7"	"Low region specificity"	"Detected in many"			"HPA024524, HPA053090"	Uncertain		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA024524: AB_2671592, HPA053090: AB_2682041"		"unprognostic (1.62e-2)"	"unprognostic (1.45e-1)"			"unprognostic (7.25e-2)"		"unprognostic (3.21e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.30e-1)"			"unprognostic (2.85e-2)"	"unprognostic (3.81e-1)"	"unprognostic (9.04e-2)"		"unprognostic (2.04e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	20.3	0.3	0.2	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.1	0.0	0.1	1.4	0.3	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	30.0	0.0	0.0	9.3	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.0	19.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	627.4	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	4.1	0.0
PAEP	"GD, GdA, GdF, GdS, MGC138509, MGC142288, PAEG, PEP, PP14"	ENSG00000122133	"Progestagen associated endometrial protein"	P09466	9	135561756-135566955	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"endometrium 1: 258.4"	"Cell type enriched"	"Detected in some"	10	"Glandular and luminal cells: 10785.5"	"Cancer enriched"	"Detected in many"	8	"melanoma: 275.3"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"basophil: 3.1;neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.1"	"Cell line enriched"	"Detected in some"	7	"SK-MEL-30: 21.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB016762, HPA020108, HPA029473"	Enhanced				"Secreted in female reproductive system"	NA	NA		120000			"CAB016762: , HPA020108: AB_1855595, HPA029473: AB_10610147"	"unprognostic (3.39e-2)"	"unprognostic (8.47e-3)"	"unprognostic (6.84e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (6.61e-6)"	"unprognostic (1.27e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.93e-3)"		"prognostic unfavorable (0.00e+0)"	"prognostic unfavorable (5.46e-4)"	"unprognostic (4.24e-1)"		"unprognostic (4.98e-2)"	0.1	0.2	0.3	1.1	0.4	1.7	0.5	0.8	0.7	49.9	1.7	0.1	1.0	258.4	0.9	0.2	4.8	0.4	0.1	0.5	0.4	0.1	0.1	0.5	0.6	0.3	0.2	0.4	0.8	0.0	0.0	0.0	27.4	0.3	2.7	0.1	0.4	0.4	45.3	0.7	2.1	0.8	0.1	0.2	0.3	6.0	0.7	0.3	0.0	0.3	0.0	0.1	0.3	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.5	0.4	0.3	0.0	0.9	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.6	1.6	2.2	0.0	0.5	0.0	0.1	0.0	0.0	0.2	0.0	0.2	2.9	0.2	0.0	0.3	0.0	0.7	0.5	0.0	0.0	0.2	0.2	0.3	0.0	0.2	0.4	0.2	0.1	0.2	21.0	0.6	0.3	0.2	0.0	0.0	1.0	0.2	0.1	0.8	2.2	0.1	0.2	0.2	0.2	3.1	0.3	0.2	0.2	0.2	0.1	0.2	0.3	0.2	0.1	0.4	0.3	0.3	1.4	0.3	0.3	0.5	0.1	0.1	0.3	0.4	0.8	0.7	0.5	0.4	0.3	0.2	0.4	0.3	0.2	0.3	1.1	0.0	0.0	0.5	0.0	0.2	0.0	3.4	0.0	0.0	0.0	0.9	0.6	0.3	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	613.5	1008.8	67.9	0.0	0.0	0.0	0.2	0.0	1.6	0.0	10785.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	106.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	144.0	0.0	0.0	0.0	0.0	0.0	86.5	0.0	0.0	0.0
PAX1		ENSG00000125813	"Paired box 1"	P15863	20	21705659-21718486	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Deafness, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"parathyroid gland: 163.4"	"Cell type enriched"	"Detected in some"	4	"Skeletal myocytes: 7.7"	"Cancer enriched"	"Detected in single"	7	"head and neck cancer: 1.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"SCLC-21H: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (9.74e-2)"				"unprognostic (3.45e-2)"	"unprognostic (3.01e-1)"		"unprognostic (2.64e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.12e-1)"		"unprognostic (1.21e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.08e-2)"		0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	163.4	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	35.4	0.9	0.0	19.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.2	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.5	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0
PDZK1IP1	"DD96, MAP17, SPAP"	ENSG00000162366	"PDZK1 interacting protein 1"	Q13113	1	47183582-47191044	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"kidney: 1056.7"	"Cell type enriched"	"Detected in many"	4	"Proximal tubular cells: 5516.6"	"Cancer enhanced"	"Detected in all"		"renal cancer: 340.7"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 6.6"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"EFO-21: 148.8;RPTEC TERT1: 501.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA014907	Enhanced		Approved	"Nuclear speckles,Cytosol"		NA	NA			Cytosol	"Nuclear speckles"	"HPA014907: AB_1855166"	"unprognostic (2.97e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.16e-2)"	"prognostic unfavorable (6.92e-4)"	"unprognostic (8.14e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (3.45e-4)"	"unprognostic (2.64e-2)"	"unprognostic (7.90e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.89e-1)"	10.2	8.3	0.6	24.8	0.9	43.5	36.8	0.4	1.6	17.9	1.5	42.8	21.8	10.8	2.9	207.5	26.0	199.4	1.0	0.5	1.1	1056.7	6.9	29.7	0.4	0.5	0.6	0.3	0.7	100.8	0.0	1.1	3.9	0.6	12.2	31.2	0.0	205.1	8.7	1.6	144.1	66.9	3.1	0.4	3.7	64.0	1.4	0.7	1.9	1.5	0.6	60.7	20.1	67.2	0.9	54.8	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	41.5	0.0	148.8	0.0	0.0	0.7	0.0	0.5	0.0	0.6	0.0	0.6	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	2.9	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	2.6	501.3	0.0	0.0	0.0	0.5	4.3	0.0	0.0	1.4	0.0	0.0	0.1	1.2	0.1	0.4	0.3	0.6	0.3	0.1	0.1	0.0	0.0	3.4	0.3	0.6	1.1	0.2	0.0	0.0	0.0	1.7	0.4	0.2	0.0	6.6	0.7	0.1	1.5	1.1	144.5	0.6	0.9	0.4	1.6	0.5	1.1	0.5	0.6	0.3	0.6	0.4	0.7	0.9	1.6	76.9	47.4	0.0	31.2	14.1	13.3	489.8	7.4	0.0	152.9	105.5	0.1	303.1	413.3	233.6	0.0	0.1	1.7	118.8	414.8	1175.8	0.0	6.1	3.3	4.5	39.6	148.4	0.0	760.0	0.0	6.6	36.7	38.1	10.8	0.2	5.0	1.7	0.3	0.0	0.0	143.3	52.9	0.3	2.1	0.0	3.4	59.3	8.8	0.0	13.6	0.6	2.1	0.0	0.0	1115.2	91.0	0.0	0.1	38.9	106.2	5516.6	147.6	0.0	0.0	0.1	28.7	0.0	0.1	30.7	54.0	0.8	22.0	0.0	150.5	68.5
PF4	"CXCL4, SCYB4"	ENSG00000163737	"Platelet factor 4"	P02776	4	73980811-73982027	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	Chemotaxis	"Cytokine, Heparin-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 67.1;lymphoid tissue: 31.8"	"Cell type enriched"	"Detected in some"	23	"Macrophages: 1360.7"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 4.4"	"Region enhanced"	"Detected in single"		"cerebral cortex: 2.3"	"Group enriched"	"Detected in many"	12	"basophil: 85.2;neutrophil: 43.0"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 85.2"	"Cell line enriched"	"Detected in some"	10	"HEL: 29.8"									"CAB026008, HPA052485"	Enhanced				"Secreted to blood"	NA	NA	7700000				"CAB026008: , HPA052485: AB_2681847"		"unprognostic (4.14e-4)"	"unprognostic (1.00e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.96e-4)"	"unprognostic (7.58e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.02e-3)"	"unprognostic (1.84e-2)"	"unprognostic (3.03e-2)"	"unprognostic (9.54e-5)"	"unprognostic (2.55e-1)"	"unprognostic (8.77e-2)"	"unprognostic (9.69e-2)"	"unprognostic (4.81e-2)"	0.6	0.2	0.1	0.7	0.2	67.1	0.3	0.1	2.3	0.1	1.1	1.0	0.0	0.1	0.0	0.1	0.3	0.7	0.8	0.1	0.2	0.6	2.2	10.6	0.3	0.4	0.6	0.1	0.1	0.3	0.0	0.3	3.0	0.3	0.1	0.8	0.0	0.4	0.1	1.0	0.0	0.2	0.1	0.4	31.8	0.9	0.1	0.2	0.0	0.6	2.6	0.0	0.1	0.1	0.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	29.8	0.0	0.0	1.5	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	85.2	3.8	1.4	0.8	1.2	0.8	0.0	0.2	0.0	1.5	0.7	0.7	0.3	43.0	0.1	3.9	5.4	0.6	148.4	0.1	0.2	0.1	2.3	0.1	0.2	0.4	0.6	0.1	0.3	0.4	0.2	0.3	0.7	0.0	0.0	0.0	10.8	0.0	0.2	0.4	0.0	0.0	0.1	0.3	0.0	2.8	1.5	1.8	0.0	0.0	4.1	5.3	0.0	6.0	0.0	0.0	0.0	7.1	13.3	0.0	0.0	0.2	0.3	0.5	0.0	0.0	0.0	0.0	24.7	0.2	0.3	0.0	0.0	1.8	0.0	9.5	0.0	0.1	0.0	1360.7	0.0	0.0	59.0	0.0	57.7	0.0	0.0	7.6	0.7	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	1.1	0.2	0.0	0.4	0.0	0.0	0.3	5.8	0.0	7.4	0.2
PHOSPHO1		ENSG00000173868	"Phosphoethanolamine/phosphocholine phosphatase 1"	Q8TCT1	17	49223366-49230787	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Mineral balance"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 103.8"	"Cell type enriched"	"Detected in some"	6	"Late spermatids: 1499.6"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	160	"eosinophil: 171.1;neutrophil: 426.7"	"Lineage enriched"	"Detected in many"	228	"granulocytes: 426.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 5.7;EFO-21: 3.2;HDLM-2: 4.1;SuSa: 5.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA065025			Approved	"Plasma membrane,Actin filaments"		NA	NA			"Actin filaments"	"Plasma membrane"	"HPA065025: AB_2732727"	"unprognostic (1.37e-1)"	"unprognostic (3.01e-3)"	"unprognostic (7.53e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.57e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.04e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.87e-1)"	2.5	1.3	2.3	3.4	3.1	19.1	0.5	6.4	4.3	0.4	1.1	0.7	2.9	0.7	0.2	1.0	1.3	2.2	1.4	2.1	6.1	1.3	1.0	2.3	1.6	9.1	5.6	0.4	0.3	1.2	0.2	0.6	6.4	8.9	0.8	0.0	0.7	1.2	0.3	3.4	1.3	3.0	0.4	5.4	14.3	0.9	103.8	4.9	0.3	0.7	3.3	0.2	0.9	0.5	10.0	0.0	1.0	0.0	0.8	0.1	0.1	0.0	0.2	0.2	0.0	0.1	1.5	0.0	5.7	3.2	0.0	2.1	0.0	0.9	0.3	0.1	4.1	0.1	0.7	0.7	0.2	0.0	0.0	0.6	0.2	0.0	0.3	0.0	0.4	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.2	0.7	1.2	2.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	5.4	0.1	0.1	2.2	0.3	1.7	1.1	0.0	0.1	0.2	0.3	1.5	2.0	0.1	0.2	0.6	171.1	0.4	1.5	0.3	0.1	0.1	0.2	0.4	0.0	0.0	0.2	426.7	0.5	1.8	0.0	0.1	1.1	2.3	3.1	6.4	4.3	2.1	6.1	9.1	5.6	0.4	8.9	5.4	4.9	10.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	1.2	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	10.1	0.3	0.0	0.0	0.0	205.8	0.0	0.0	1.4	0.0	8.6	0.7	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.4	0.0	2.6	0.0	1.4	0.0	0.0	0.3	0.0	1499.6	7.8	0.6	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	11.2	4.5	0.0	0.0	237.6	0.1	0.0	0.1	0.1
PHOX2B	"NBPhox, PMX2B"	ENSG00000109132	"Paired like homeobox 2B"	Q99453	4	41744082-41748725	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 8.7;brain: 8.8"	"Cell type enriched"	"Detected in single"	10	"Cardiomyocytes: 1.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"medulla oblongata: 8.4;midbrain: 3.0;pons: 8.8;white matter: 5.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	89	"SH-SY5Y: 132.7"	"Region enriched"	"Detected in single"	17	"pons and medulla: 5.6"	"Group enriched"	"Detected in some"	18	"medulla oblongata: 1.4;pons: 2.0"	"HPA074325, HPA074941"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA074325: AB_2686678, HPA074941: AB_2732272"			"unprognostic (1.01e-1)"								"unprognostic (2.47e-1)"			"unprognostic (5.27e-2)"				0.0	8.7	0.3	0.4	1.5	0.0	0.0	0.0	1.0	0.0	0.0	1.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	3.0	0.0	0.0	0.1	0.0	0.0	0.0	8.8	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.2	0.3	0.2	0.0	0.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	132.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.5	0.0	1.0	0.0	0.0	8.4	3.0	0.0	8.8	0.2	1.4	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PLB1	"FLJ30866, PLB"	ENSG00000163803	"Phospholipase B1"	Q6P1J6	2	28457145-28644142	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 39.4"	"Cell type enriched"	"Detected in many"	4	"Proximal enterocytes: 112.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"classical monocyte: 3.0;eosinophil: 3.0;intermediate monocyte: 4.4;myeloid DC: 5.7;neutrophil: 8.8;non-classical monocyte: 5.0"	"Group enriched"	"Detected in many"	40	"dendritic cells: 5.7;granulocytes: 8.8;monocytes: 5.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.6;OE19: 7.8;RT4: 2.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"									NA	NA						"unprognostic (2.18e-2)"	"unprognostic (2.49e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.91e-3)"	"unprognostic (4.74e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.61e-9)"	"unprognostic (2.48e-2)"	"unprognostic (2.19e-2)"	"unprognostic (4.99e-2)"	"unprognostic (8.03e-2)"	1.6	5.8	3.4	1.8	3.1	5.0	1.8	1.1	3.0	1.8	2.7	1.5	0.7	1.7	1.7	1.0	1.3	1.5	1.0	2.7	2.5	0.5	0.5	1.6	0.4	2.2	2.0	2.6	0.9	0.6	0.3	1.6	2.2	1.8	2.1	1.8	0.1	1.4	1.5	2.0	8.0	39.4	2.8	1.7	4.1	0.9	2.6	2.3	0.6	2.0	0.6	0.3	1.8	1.3	2.1	0.4	0.0	2.4	0.0	0.5	0.3	3.6	0.1	1.0	0.2	0.2	2.5	0.2	0.2	0.2	0.4	1.0	0.5	0.0	1.9	0.2	0.1	0.0	0.2	0.4	0.4	0.8	0.4	0.1	0.4	1.1	0.4	0.5	0.4	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.1	7.8	0.5	0.0	0.4	0.0	1.1	2.7	1.0	0.2	0.1	0.1	0.2	0.2	0.0	1.3	0.2	0.2	0.7	0.1	0.1	0.5	0.1	0.0	0.8	1.8	0.0	0.0	3.0	3.0	0.0	4.4	0.0	0.0	0.1	0.0	5.7	0.0	0.0	0.0	8.8	0.0	5.0	0.3	0.1	1.1	3.4	3.1	1.1	3.0	2.7	2.5	2.2	2.0	2.6	1.8	1.7	2.3	2.1	0.6	0.0	0.6	0.7	0.3	0.4	1.0	0.6	0.6	0.1	1.6	1.5	1.6	0.0	1.5	0.0	0.0	0.5	2.1	6.5	1.9	1.6	27.0	2.4	1.0	1.5	1.2	0.0	3.2	0.9	23.2	0.6	0.0	1.1	5.7	0.1	1.1	0.0	12.5	0.0	3.4	5.4	0.0	17.4	10.1	18.3	1.2	12.5	0.0	15.0	4.8	0.3	0.0	1.5	0.4	1.0	2.6	0.7	0.5	0.4	112.6	0.0	1.5	0.0	0.0	1.1	0.3	1.0	0.9	0.3	0.4	8.2	1.5	0.6	2.5	1.6
PLP1	"GPM6C, PLP, SPG2"	ENSG00000123560	"Proteolipid protein 1"	P60201	X	103773718-103792619	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted membrane proteins"			"Cancer-related genes, Disease variant, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 7049.5"	"Cell type enriched"	"Detected in some"	12	"Oligodendrocytes: 4822.5"	"Group enriched"	"Detected in many"	22	"glioma: 160.5;melanoma: 75.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"SK-MEL-30: 241.0;WM-115: 139.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004128	Enhanced					NA	NA					"HPA004128: AB_1079635"	"unprognostic (5.72e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.95e-2)"		"unprognostic (2.57e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.92e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.62e-5)"	"unprognostic (4.91e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.16e-2)"	7.4	15.9	2495.4	4.2	4076.4	0.1	5.5	4190.6	3190.4	15.0	1305.5	54.6	6.4	6.9	6.7	10.0	7.4	9.7	18.8	2415.6	3200.5	1.5	2.0	1.3	0.4	5172.3	3764.4	1867.1	5.8	2.5	83.7	6.5	0.0	5014.7	21.2	15.0	7.5	6.7	30.3	2.4	24.6	22.6	22.9	4863.3	0.5	15.6	33.8	3716.8	3.8	3.5	6.8	0.4	13.0	22.0	7049.5	0.2	0.0	20.7	0.1	0.0	0.3	0.0	0.0	0.4	0.0	0.8	1.9	0.0	0.0	0.2	0.7	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	4.0	0.0	0.2	0.0	0.9	0.0	0.1	0.0	2.8	0.0	0.0	0.1	0.0	37.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	241.0	6.3	0.1	0.2	0.0	0.1	0.4	0.1	0.2	0.0	0.3	0.2	4.0	0.0	139.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2495.4	4076.4	4190.6	3190.4	2415.6	3200.5	5172.3	3764.4	1867.1	5014.7	4863.3	3716.8	7049.5	0.5	0.0	0.0	23.8	0.1	15.9	0.3	0.0	6.2	1.7	0.2	0.5	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.6	0.0	0.0	9.7	0.0	0.0	13.3	0.0	0.0	0.0	188.3	3.3	0.0	0.1	0.0	11.2	0.0	0.0	0.0	5.8	3.1	7.5	0.8	396.6	17.8	0.0	30.7	0.0	31.2	4822.5	0.0	0.0	3.0	0.0	0.8	0.0	0.0	0.0	1.1	0.0	3.1	2.4	0.6	0.3	0.8	2.6	0.0	0.2	5.6	0.0	0.1
PLPPR3	"FLJ11535, LPPR3, PRG-2, PRG2"	ENSG00000129951	"Phospholipid phosphatase related 3"	Q6T4P5	19	812488-821955	"Enzymes, Metabolic proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 9.9;brain: 23.5;fallopian tube: 11.2"	"Cell type enriched"	"Detected in some"	7	"Endometrial ciliated cells: 37.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 4.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"NB-4: 61.8;THP-1: 128.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052293, HPA057034"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA052293: AB_2681787, HPA057034: AB_2683316"	"unprognostic (7.65e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.32e-1)"	"unprognostic (4.51e-4)"	"unprognostic (8.06e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.72e-12)"	"unprognostic (1.21e-2)"	"unprognostic (6.82e-2)"	"unprognostic (8.50e-2)"	"unprognostic (2.91e-1)"	0.0	0.0	19.2	0.2	16.7	9.9	2.2	0.0	21.3	0.3	0.0	0.1	0.0	0.2	0.0	0.0	11.2	0.1	0.0	15.7	8.4	0.0	0.0	2.3	0.1	5.9	7.4	23.5	0.3	0.0	0.2	0.4	0.0	6.0	0.3	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.7	0.2	0.1	3.2	9.5	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.3	1.5	12.2	0.0	0.0	0.0	6.9	0.2	0.1	0.0	0.0	0.7	0.1	0.1	8.4	0.1	0.1	0.3	2.3	0.0	0.0	0.0	5.2	0.0	1.6	0.0	0.5	4.4	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.1	12.0	0.3	0.0	1.1	0.0	61.8	9.5	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.3	15.5	0.3	0.0	0.0	6.3	5.4	128.9	0.1	0.2	0.2	0.3	0.1	0.2	0.5	0.2	0.0	10.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	16.7	0.0	21.3	15.7	8.4	5.9	7.4	23.5	6.0	0.7	9.5	7.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	3.7	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	37.2	0.6	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.4	0.0	1.2	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.9	0.1	5.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0
POU4F1	"BRN3A, RDC-1"	ENSG00000152192	"POU class 4 homeobox 1"	Q01851	13	78598362-78603552	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 7.9;retina: 2.6"	"Cell type enriched"	"Detected in some"	10	"Skeletal myocytes: 28.6"	"Low cancer specificity"	"Detected in single"			"Region enhanced"	"Detected in many"		"medulla oblongata: 7.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 14.1;HEL: 15.5;JURKAT: 12.2;REH: 10.9;RH-30: 17.9;SCLC-21H: 17.1;U-266/70: 16.1"	"Group enriched"	"Detected in some"	23	"midbrain: 2.5;pons and medulla: 2.1;thalamus: 2.2"	"Region enhanced"	"Detected in some"		"medulla oblongata: 4.1"	HPA068024	Enhanced	Approved				NA	NA					"HPA068024: AB_2685943"	"unprognostic (6.70e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.27e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.05e-3)"		"unprognostic (1.32e-1)"	"unprognostic (6.30e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.17e-2)"	"unprognostic (8.98e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.53e-1)"		"unprognostic (4.75e-3)"	0.0	0.0	2.0	0.1	0.7	0.3	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.5	7.9	4.6	0.1	0.0	0.0	0.0	0.0	0.2	2.2	0.0	0.0	2.6	0.0	0.0	0.4	0.0	0.0	0.0	1.7	0.0	0.0	0.9	1.5	0.7	0.0	0.1	0.8	0.0	0.0	1.0	0.0	0.7	2.7	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.6	0.0	5.1	0.0	0.0	0.0	14.1	15.5	0.0	2.0	0.0	7.7	4.4	0.0	0.1	0.0	0.0	0.0	0.0	12.2	3.1	0.0	0.7	0.0	1.2	1.4	0.0	2.1	0.0	10.9	17.9	0.0	0.0	0.0	17.1	0.2	0.0	0.0	0.7	0.2	0.0	1.5	0.2	0.0	0.0	0.3	0.0	16.1	5.1	0.0	0.0	8.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.7	0.4	0.3	0.3	0.7	7.9	4.6	0.1	2.2	1.7	1.5	1.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.2	0.1	0.3	1.0	0.0	0.0	0.0	0.0	0.1	2.8	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.8	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	2.0	0.0	28.6	0.1	2.5	2.7	0.0	0.4	0.0	0.1	0.0	0.1	0.0
PRSS35	"C6orf158, dJ223E3.1, MGC46520"	ENSG00000146250	"Serine protease 35"	Q8N3Z0	6	83512534-83525704	"Enzymes, Predicted secreted proteins"		"Serine protease homolog"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"retina: 50.9"	"Cell type enriched"	"Detected in some"	36	"Muller glia cells: 410.9"	"Group enriched"	"Detected in some"	4	"glioma: 2.8;testis cancer: 4.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	9	"MAIT T-cell: 19.5"	"Lineage enriched"	"Detected in single"	195	"T-cells: 19.5"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 10.4;CACO-2: 86.3;HAP1: 12.8;RPTEC TERT1: 24.6;SuSa: 17.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"amygdala: 2.9;cerebellum: 3.6;cerebral cortex: 5.8;hippocampal formation: 5.3;olfactory bulb: 2.7"	"HPA038787, HPA038788"	Uncertain				"Secreted in female reproductive system"	NA	NA					"HPA038787: AB_10675951, HPA038788: AB_2676208"	"unprognostic (6.17e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.70e-4)"	"unprognostic (6.08e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.33e-2)"	"unprognostic (7.01e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.88e-6)"	"unprognostic (7.15e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.54e-4)"	1.3	2.4	3.0	0.1	3.8	0.0	0.3	1.7	6.8	2.9	1.7	0.1	0.3	1.4	1.1	0.3	1.4	4.2	2.7	3.3	2.6	3.2	0.4	1.3	0.7	2.2	2.0	3.6	10.3	0.3	0.3	1.1	3.7	2.8	1.2	0.3	50.9	0.3	0.4	0.1	0.2	0.1	1.5	1.8	0.7	0.3	3.1	2.0	0.1	0.4	0.1	0.1	1.3	0.5	2.9	0.0	0.5	1.9	0.0	0.1	0.0	0.0	0.3	10.4	1.0	2.0	86.3	0.0	0.0	0.1	0.4	0.0	0.0	12.8	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	3.1	0.0	1.2	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.1	1.6	0.4	8.2	0.0	0.0	0.0	24.6	0.0	0.0	1.0	0.0	0.0	0.0	17.9	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	19.5	0.0	0.3	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.0	3.8	1.7	6.8	3.3	2.6	2.2	2.0	3.6	2.8	1.8	2.0	2.9	0.3	3.2	0.5	8.1	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.1	1.5	0.0	0.0	1.8	0.0	0.3	0.0	0.1	9.8	0.1	0.1	0.0	0.3	0.8	1.8	0.0	0.2	0.0	0.0	4.4	0.0	0.0	0.0	0.9	0.0	0.3	0.4	6.7	0.2	0.0	0.0	0.0	0.0	0.2	1.2	0.1	0.0	1.0	0.0	410.9	0.0	1.0	0.1	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	11.4	6.6	0.1	3.7	0.1	0.5	0.0	0.0	0.1	0.7	5.1	0.0	0.0
PSCA		ENSG00000167653	"Prostate stem cell antigen"	O43653	8	142670308-142682725	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"stomach 1: 3043.6"	"Cell type enriched"	"Detected in many"	4	"Gastric mucus-secreting cells: 5332.3"	"Cancer enriched"	"Detected in many"	6	"urothelial cancer: 785.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 22.4;HeLa: 45.7;OE19: 17.6;RT4: 61.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	8	"spinal cord: 38.2"	"HPA030783, HPA056418"	Approved		Supported	"Plasma membrane"		NA	NA		18000	"Plasma membrane"		"HPA030783: AB_2673611, HPA056418: AB_2683123"	"unprognostic (1.21e-3)"	"unprognostic (1.76e-3)"	"unprognostic (3.20e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.77e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.93e-2)"	"unprognostic (7.81e-3)"	"unprognostic (8.25e-3)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (5.60e-5)"	"unprognostic (6.82e-2)"	"unprognostic (2.38e-3)"	"unprognostic (4.93e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.06e-3)"	2.7	0.4	0.4	0.5	0.4	0.2	1.9	0.2	0.9	33.4	0.1	5.0	4.0	0.4	0.6	336.7	8.0	10.1	0.3	0.5	0.2	5.7	0.7	6.4	0.1	0.4	0.2	0.3	0.6	3.2	0.0	0.6	2.4	0.4	232.6	4.8	0.0	23.6	2.0	0.3	10.2	2.5	0.1	0.1	0.4	3043.6	1.4	0.3	0.4	0.4	0.0	15.2	634.3	169.1	0.4	10.7	0.7	0.0	0.0	2.1	6.8	10.6	4.9	1.1	2.1	1.8	0.1	22.4	0.0	0.4	0.4	8.1	2.1	0.0	0.4	1.3	0.6	0.0	0.0	45.7	0.0	0.1	0.0	1.5	6.0	7.8	4.6	0.0	0.6	0.0	0.0	0.0	0.0	1.7	5.8	1.7	0.6	1.2	17.6	1.2	0.7	0.0	0.9	1.0	61.7	0.2	0.5	5.1	15.6	3.5	0.3	0.2	0.2	1.0	1.5	1.7	2.7	0.0	1.9	0.1	0.0	2.9	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.2	0.9	0.5	0.2	0.4	0.2	0.3	0.4	0.1	0.3	0.4	0.2	3.2	1.5	1.6	7.7	0.9	26.0	120.0	0.0	0.0	3.9	2.7	1.2	71.4	894.2	1.8	0.0	2.3	0.0	1.9	7.9	3.2	0.3	1.3	0.1	1.1	275.1	0.0	0.3	1.2	5.0	3.3	5332.3	0.3	0.0	0.3	0.0	0.0	0.6	0.0	0.2	12.9	179.0	0.6	1.0	0.4	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	57.1	0.2	0.0	13.4	238.7	0.3	0.4	994.9	0.0	0.0	0.0	48.9	0.0	0.5	13.1	1.3	28.5	4.6	0.0	0.9	1241.5
PSD2	"DKFZp761B0514, EFA6C"	ENSG00000146005	"Pleckstrin and Sec7 domain containing 2"	Q9BQI7	5	139795808-139844466	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 104.2"	"Cell type enriched"	"Detected in some"	4	"Astrocytes: 229.9"	"Cancer enriched"	"Detected in single"	43	"glioma: 19.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"THP-1: 1.1;U-2 OS: 1.1;U-698: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054625			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA054625: "	"unprognostic (3.76e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.34e-3)"	"unprognostic (2.48e-3)"	"unprognostic (1.34e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.22e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.53e-1)"	"unprognostic (4.02e-1)"	"unprognostic (4.16e-3)"	"unprognostic (3.40e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.12e-3)"	0.1	0.3	70.4	0.3	81.6	0.2	0.5	92.6	63.9	0.8	20.8	0.1	0.1	0.2	1.6	0.0	0.4	0.2	0.2	58.0	72.1	0.1	0.1	0.1	0.0	89.7	94.7	50.0	0.1	0.4	0.0	1.0	0.0	94.2	0.2	0.1	4.1	1.7	0.4	0.3	0.1	0.1	0.1	63.6	0.2	0.1	1.1	104.2	1.0	0.1	0.0	0.1	0.1	0.2	67.9	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.5	0.9	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.3	1.1	0.0	0.0	0.2	0.0	1.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	70.4	81.6	92.6	63.9	58.0	72.1	89.7	94.7	50.0	94.2	63.6	104.2	67.9	0.0	0.0	0.0	229.9	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.0	9.1	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	6.5	0.0	2.6	0.0	52.8	24.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.6	0.0	1.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
R3HDML	dJ881L22.3	ENSG00000101074	"R3H domain containing like"	Q9H3Y0	20	44337043-44351238	"Predicted secreted proteins"		"Protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	5	"intestine: 2.4"	"Cell type enriched"	"Detected in single"	5	"Microglial cells: 1.0"	"Cancer enriched"	"Detected in single"	5	"colorectal cancer: 1.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.0;OE19: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA070264	Enhanced				"Secreted - unknown location"	NA	NA					"HPA070264: AB_2686244"	"unprognostic (1.89e-1)"		"unprognostic (2.23e-1)"				"unprognostic (9.86e-2)"	"unprognostic (9.12e-2)"	"unprognostic (6.06e-3)"		"unprognostic (2.64e-1)"			"unprognostic (6.32e-2)"	"unprognostic (4.95e-3)"			0.0	0.0	0.3	0.3	0.1	0.1	0.0	0.1	0.2	0.0	0.0	0.7	2.2	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.2	0.2	0.1	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.4	0.0	0.0	0.0	0.4	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.2	0.2	0.2	0.2	0.1	0.0	0.2	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
RAB42	MGC45806	ENSG00000188060	"RAB42, member RAS oncogene family"	Q8N4Z0	1	28592200-28595449	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 24.7"	"Cell type enriched"	"Detected in many"	7	"Hofbauer cells: 91.3"	"Cancer enhanced"	"Detected in many"		"renal cancer: 10.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 10.0;Hep G2: 14.3;HSkMC: 8.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050290			Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA050290: AB_2681075"	"unprognostic (1.10e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.25e-2)"	"unprognostic (7.59e-2)"	"unprognostic (2.00e-4)"	"unprognostic (8.81e-2)"	"unprognostic (2.39e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.52e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.83e-2)"	"unprognostic (2.07e-3)"	2.6	0.7	1.1	1.7	1.6	0.8	2.2	1.3	3.1	2.2	1.4	1.8	1.5	1.7	0.6	0.7	1.0	1.7	0.8	0.9	1.5	0.9	1.2	2.9	6.7	1.7	0.9	0.6	0.4	0.5	2.7	0.3	4.6	2.3	0.7	2.4	1.0	2.6	0.6	0.3	0.6	1.6	1.5	1.4	3.5	1.3	1.4	2.5	24.7	0.6	0.6	3.6	1.9	1.1	3.6	0.1	0.7	0.9	0.0	4.1	10.0	0.0	0.4	3.8	4.1	5.3	2.0	1.5	0.2	2.0	4.3	0.4	0.2	4.1	0.0	2.7	0.1	0.0	0.3	6.8	14.3	1.7	1.1	0.0	8.8	0.1	2.2	0.0	0.4	1.2	0.1	0.1	0.1	0.9	0.0	0.1	2.2	4.8	0.0	0.0	6.5	0.0	1.7	1.8	0.0	0.3	1.5	3.7	0.1	0.0	0.6	0.2	1.8	0.4	0.0	1.2	3.9	0.0	0.3	2.1	0.2	0.1	3.9	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	1.1	1.6	1.3	3.1	0.9	1.5	1.7	0.9	0.6	2.3	1.4	2.5	3.6	0.5	0.0	0.0	0.0	0.7	0.1	0.2	0.7	0.0	0.5	1.2	1.0	0.4	1.5	1.0	0.0	0.0	0.6	0.1	0.2	0.0	8.5	5.3	3.4	3.9	0.3	0.0	0.4	0.1	0.0	0.8	3.4	0.0	3.2	0.0	0.5	2.5	0.0	91.3	0.0	0.1	0.1	0.0	3.5	1.7	12.2	1.5	11.7	0.0	1.0	1.1	1.0	0.0	0.0	0.1	2.9	1.2	0.0	1.2	0.2	0.3	0.5	0.4	0.9	0.0	4.5	0.9	2.5	1.8	0.4	0.4	0.4	0.3	0.2	0.1	0.1
RAB6D	"RAB6CL, WTH3DI"	ENSG00000233087	"RAB6D, member RAS oncogene family"	Q53S08	2	131361111-131364142	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	5	"parathyroid gland: 7.5"	"Cell type enriched"	"Detected in single"	15	"Respiratory ciliated cells: 1.5"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"MOLT-4: 2.2"									HPA059131	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA059131: AB_2683916"	"unprognostic (4.19e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.03e-2)"	"unprognostic (4.08e-1)"	"unprognostic (4.79e-2)"		"unprognostic (4.41e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.55e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.12e-1)"	0.0	0.2	0.4	0.1	0.6	0.0	0.0	0.0	0.9	0.0	0.0	1.0	0.2	0.1	0.3	0.0	0.1	0.2	0.0	0.7	0.7	0.1	0.0	0.0	0.0	0.4	0.3	0.4	0.1	0.0	7.5	0.0	0.0	0.6	1.4	0.8	0.1	0.0	0.0	0.0	0.0	0.7	0.2	0.2	0.0	0.0	1.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.2	0.0	0.3	0.9	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.9	0.7	0.7	0.4	0.3	0.4	0.6	0.2	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RASGEF1C	FLJ35841	ENSG00000146090	"RasGEF domain family member 1C"	Q8N431	5	180100795-180209211	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 20.6;testis: 5.8"	"Cell type enriched"	"Detected in some"	9	"Microglial cells: 188.3"	"Cancer enhanced"	"Detected in some"		"glioma: 2.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.2;HEK 293: 1.7;MCF7: 2.2;SCLC-21H: 7.6;U-2 OS: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028242	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA028242: AB_10602294"	"unprognostic (2.21e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.75e-4)"	"unprognostic (4.65e-2)"	"unprognostic (4.04e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.02e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.65e-4)"	"unprognostic (5.89e-2)"	"unprognostic (8.25e-3)"	"unprognostic (3.70e-1)"	"unprognostic (1.77e-2)"	0.2	0.2	3.7	0.2	12.9	0.0	0.4	20.6	8.6	1.0	0.0	2.4	0.1	0.0	0.1	0.3	0.5	0.3	0.8	6.7	2.5	0.1	0.0	0.0	0.0	6.8	4.1	6.9	0.1	0.1	0.0	0.1	0.1	7.5	0.9	0.2	0.3	1.1	0.9	0.0	0.5	0.8	0.1	4.5	0.0	0.7	5.8	2.9	0.0	1.2	0.0	0.0	0.7	1.1	7.3	0.0	0.0	0.2	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.0	2.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	2.4	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	12.9	20.6	8.6	6.7	2.5	6.8	4.1	6.9	7.5	4.5	2.9	7.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.2	1.8	1.1	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	3.4	0.2	0.0	0.5	0.0	0.0	20.2	0.0	0.6	0.1	0.0	0.5	0.0	1.5	0.0	0.0	0.1	0.0	12.5	0.0	0.0	0.0	0.0	3.8	0.0	0.1	0.0	188.3	0.0	0.2	0.0	15.1	19.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	16.7	1.0	0.0	0.0	1.9	0.0	0.5	0.0	0.0
REG4	"GISP, REG-IV, RELP"	ENSG00000134193	"Regenerating family member 4"	Q9BYZ8	1	119794017-119811580	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 668.2"	"Cell type enriched"	"Detected in some"	7	"Intestinal goblet cells: 3458.1"	"Group enriched"	"Detected in many"	21	"colorectal cancer: 180.6;pancreatic cancer: 215.1;stomach cancer: 162.9"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	6	"naive CD8 T-cell: 24.6"	"Lineage enriched"	"Detected in single"	101	"T-cells: 24.6"	"Cell line enriched"	"Detected in some"	60	"OE19: 6164.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025867, HPA046555"	Enhanced				"Secreted to digestive system"	NA	NA		460000			"CAB025867: , HPA046555: AB_2679696"	"unprognostic (3.22e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.86e-3)"	"unprognostic (2.57e-1)"	"unprognostic (6.52e-2)"	"unprognostic (6.20e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.64e-2)"		"unprognostic (7.10e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.99e-1)"	"unprognostic (5.12e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.10e-1)"		"unprognostic (1.32e-3)"	0.7	0.0	0.2	34.7	0.1	0.3	0.0	0.1	0.2	0.4	0.1	238.3	266.8	0.5	0.0	1.5	0.0	0.5	0.0	0.2	0.1	0.7	0.3	0.0	1.6	0.2	0.1	0.1	0.0	134.8	0.0	0.0	0.0	0.2	2.6	317.4	0.0	2.3	0.2	0.0	0.0	668.2	8.6	0.1	0.2	19.2	2.4	0.2	0.4	0.0	0.0	0.8	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.3	2.3	0.1	6164.0	102.7	0.0	0.0	0.8	0.0	29.2	0.2	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	3.8	24.6	0.2	0.0	0.0	0.0	0.0	2.5	0.2	0.1	0.1	0.2	0.2	0.1	0.2	0.1	0.1	0.2	0.1	0.2	0.4	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	20.6	0.0	0.0	10.8	0.0	0.0	0.0	441.8	0.0	0.0	1.0	0.0	0.0	33.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3458.1	0.0	0.0	0.0	25.9	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	140.0	0.0	0.1	3.8	178.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	2.9	0.1	52.0	0.2
RFLNA	"Cfm2, FAM101A, FLJ44614, RefilinA"	ENSG00000178882	"Refilin A"	Q6ZTI6	12	123973241-124316024	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"stomach 1: 95.5"	"Cell type enriched"	"Detected in some"	22	"Pancreatic endocrine cells: 113.9"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 19.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"hTEC/SVTERT24-B: 13.8;HUVEC TERT2: 19.8;LHCN-M2: 34.8;OE19: 37.0;RH-30: 11.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA058911, HPA078021"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA058911: AB_2683853, HPA078021: AB_2732368"	"unprognostic (1.71e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.15e-2)"	"unprognostic (8.78e-4)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (3.16e-5)"	"unprognostic (8.87e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.71e-3)"	"unprognostic (1.15e-3)"	"unprognostic (1.77e-8)"	"unprognostic (2.48e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.37e-2)"	1.8	1.1	4.0	2.3	3.7	0.0	1.8	5.2	5.4	9.4	6.0	15.4	14.1	1.7	0.4	0.6	3.0	0.6	0.4	3.1	5.2	1.4	0.1	1.2	0.2	15.6	6.6	2.2	2.9	0.3	0.3	2.1	0.6	19.1	4.3	10.5	0.3	2.3	0.3	5.5	1.3	15.3	0.5	3.3	0.1	95.5	0.2	4.0	0.2	0.1	3.2	0.1	0.5	1.3	11.9	0.0	0.0	2.7	0.0	0.0	0.0	3.5	0.0	0.0	0.4	0.4	1.8	1.3	0.0	0.1	4.9	0.2	0.0	2.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.2	0.8	0.0	13.8	0.1	0.8	19.8	2.1	0.0	0.0	34.8	0.0	0.1	0.0	2.9	37.0	0.0	0.0	11.1	0.2	0.0	0.0	1.4	0.9	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	3.7	5.2	5.4	3.1	5.2	15.6	6.6	2.2	19.1	3.3	4.0	11.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	5.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.5	0.0	0.1	0.5	0.1	0.0	0.0	0.0	2.6	0.1	0.6	0.0	0.2	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	113.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
RHCG	"C15orf6, PDRC2, RHGK, SLC42A3"	ENSG00000140519	"Rh family C glycoprotein"	Q9UBD6	15	89471398-89496589	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ammonia transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 4054.6;vagina: 1743.1"	"Cell type enriched"	"Detected in many"	21	"Squamous epithelial cells: 1544.7"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 152.9;head and neck cancer: 154.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 3.8;hTCEpi: 2.0;RT4: 1.2"	"Region enriched"	"Detected in many"	5	"olfactory bulb: 8.4"	"Low region specificity"	"Detected in some"			"HPA041874, HPA043317"	Enhanced					NA	NA					"HPA041874: AB_2677719, HPA043317: AB_2678424"	"unprognostic (1.60e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.86e-3)"	"unprognostic (1.98e-2)"	"unprognostic (9.39e-3)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (3.80e-4)"	"unprognostic (1.07e-1)"	"unprognostic (9.82e-2)"	"unprognostic (1.39e-2)"	"unprognostic (4.84e-2)"	"unprognostic (2.55e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.45e-3)"	1.3	2.1	4.8	0.0	5.0	0.0	0.8	4.6	6.9	393.6	3.5	0.5	0.0	0.6	0.0	4054.6	0.7	0.7	1.2	4.9	5.0	115.0	3.5	0.3	0.0	4.9	4.6	4.6	0.8	3.2	0.0	4.3	0.1	4.6	3.4	0.0	2.6	598.3	0.8	1.0	14.7	0.9	0.3	4.8	0.6	3.5	1.3	4.5	0.8	0.5	0.0	465.6	3.8	1743.1	4.6	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.3	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	5.0	4.6	6.9	4.9	5.0	4.9	4.6	4.6	4.6	4.8	4.5	4.6	0.0	0.0	0.0	2.0	0.3	1.3	28.9	22.9	6.2	1.0	0.9	0.5	0.7	0.0	47.6	14.7	0.0	0.0	0.0	0.6	15.6	1.5	2.0	0.0	0.1	0.7	0.0	0.0	6.0	0.4	0.0	2.6	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	2.0	0.0	0.7	1.4	0.0	1.5	0.0	0.0	0.0	64.4	0.0	4.0	0.3	0.7	4.8	0.0	0.0	34.8	0.0	0.0	1.6	2.8	0.0	0.0	5.4	1.5	0.1	1544.7	17.8	0.0	0.3	0.0	0.2	70.5
RND2	"ARHN, Rho7, RhoN"	ENSG00000108830	"Rho family GTPase 2"	P52198	17	43025231-43032041	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 56.7;choroid plexus: 16.5;testis: 37.5"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 590.2"	"Group enriched"	"Detected in many"	5	"glioma: 44.4;testis cancer: 11.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 12.0;AN3-CA: 15.5;HAP1: 12.1;NTERA-2: 17.2;SH-SY5Y: 10.4;SuSa: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077757	Approved					NA	NA					"HPA077757: AB_2732361"	"unprognostic (2.19e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.02e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.44e-3)"	"unprognostic (4.55e-2)"	"unprognostic (7.44e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.22e-4)"	"unprognostic (7.85e-2)"	"unprognostic (8.17e-2)"	"unprognostic (6.13e-3)"	"unprognostic (9.92e-2)"	"unprognostic (7.52e-2)"	"unprognostic (5.57e-2)"	0.6	3.1	31.2	0.2	36.8	0.2	1.0	47.1	26.1	2.1	16.5	3.0	0.4	3.7	2.6	1.1	2.0	0.8	1.4	22.6	41.7	0.8	4.1	0.5	0.2	56.7	53.9	18.4	3.8	0.6	5.6	7.0	0.1	51.3	2.7	0.4	3.9	0.8	3.7	0.5	2.0	1.2	2.4	47.0	0.1	1.4	37.5	44.2	0.4	6.6	0.2	0.3	2.1	1.6	40.2	0.0	0.3	12.0	15.5	0.9	0.6	0.3	0.5	0.7	2.1	1.6	1.9	0.2	0.1	2.8	1.6	0.7	0.1	12.1	0.2	1.8	0.0	6.2	0.0	0.2	0.2	0.9	0.1	0.1	0.8	0.1	2.4	0.1	0.3	0.2	1.3	3.1	0.1	0.0	0.5	4.9	0.2	17.2	0.0	0.1	0.9	0.0	0.1	0.2	0.0	3.3	10.4	0.0	0.2	0.1	7.9	2.3	0.0	0.1	0.3	0.4	0.1	0.0	1.1	3.3	0.2	1.9	0.0	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	31.2	36.8	47.1	26.1	22.6	41.7	56.7	53.9	18.4	51.3	47.0	44.2	40.2	1.5	0.0	1.5	2.0	0.1	1.3	4.8	0.6	6.8	2.8	2.0	3.3	2.1	1.5	2.0	3.7	0.0	2.1	0.0	0.1	5.9	1.2	136.3	1.9	12.6	1.2	0.0	0.0	2.2	0.8	1.9	3.2	0.0	1.0	1.3	10.5	1.4	3.3	0.6	5.0	7.2	0.0	0.0	0.6	0.7	590.2	5.0	0.8	1.8	1.0	0.0	27.2	1.0	11.6	1.6	0.3	0.1	4.5	0.1	1.6	0.0	2.3	6.5	3.7	0.0	6.2	2.9	38.3	6.1	0.8	1.8	1.6	0.6	2.6	0.1	1.6
RNF148	MGC35222	ENSG00000235631	"Ring finger protein 148"	Q8N7C7	7	122701668-122702922	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 49.6"	"Cell type enriched"	"Detected in some"	6	"Early spermatids: 405.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebellum: 9.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.8;MCF7: 1.1"	"Not detected"	"Not detected"							HPA045587			Approved	Cytosol		NA	NA			Cytosol		"HPA045587: AB_10963695"	"unprognostic (1.75e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.85e-1)"	"unprognostic (3.23e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.81e-2)"	"unprognostic (8.48e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.09e-1)"	0.2	0.2	0.0	0.0	0.2	0.0	0.2	9.7	1.6	0.2	0.4	0.1	0.0	0.6	0.1	0.0	0.2	0.1	0.2	0.3	0.1	0.3	0.3	0.4	0.0	0.1	0.5	0.0	0.1	0.3	0.0	0.2	0.0	3.6	0.4	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	49.6	0.2	0.0	0.2	0.0	0.0	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	2.8	0.0	1.1	0.0	0.0	0.3	0.6	0.3	0.0	0.0	0.7	0.0	0.2	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	9.7	1.6	0.3	0.1	0.1	0.5	0.0	3.6	0.0	0.2	0.8	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.1	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	405.2	0.5	0.5	0.5	0.0	0.0	0.0	1.0	0.1	0.1	0.0	0.8	0.0	0.1	1.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	62.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	1.9	0.0	0.1	0.0	0.2	0.0	0.0	6.6	0.2	0.1	3.9	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.1
RNF220	"C1orf164, FLJ10597"	ENSG00000187147	"Ring finger protein 220"	Q5VTB9	1	44405194-44651724	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"brain: 118.6"	"Cell type enriched"	"Detected in all"	7	"Oligodendrocytes: 2136.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-937: 69.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027577, HPA027578"	Approved		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA027577: AB_2672339, HPA027578: AB_10601482"	"unprognostic (3.12e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.94e-2)"	"unprognostic (6.96e-3)"	"prognostic unfavorable (2.35e-6)"	"unprognostic (1.55e-1)"	"unprognostic (8.47e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.14e-3)"	"unprognostic (2.96e-2)"	"prognostic unfavorable (5.12e-4)"	"unprognostic (1.51e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.37e-3)"	"unprognostic (6.46e-2)"	7.5	6.0	35.7	7.4	59.3	10.9	6.9	44.1	50.2	7.4	1.3	8.4	7.9	9.0	5.9	6.7	8.2	2.9	8.3	31.6	41.8	6.6	5.3	5.7	6.0	58.4	51.4	18.5	7.6	7.1	5.8	7.1	6.2	69.8	6.0	3.9	7.5	7.4	4.6	24.5	8.4	7.7	5.5	45.9	6.9	6.7	8.2	67.1	7.1	6.3	10.2	5.9	7.1	7.0	118.6	11.6	5.4	22.9	7.8	8.7	7.9	17.1	13.4	12.3	10.1	14.9	9.3	11.2	22.3	11.6	10.8	14.4	7.5	25.8	11.0	13.7	28.0	22.9	30.9	17.9	16.3	14.1	22.0	15.2	8.7	24.7	11.3	17.9	8.4	5.9	11.6	23.1	10.7	6.3	8.1	21.8	16.7	24.9	12.6	12.2	18.3	13.5	15.9	6.5	7.1	10.3	12.7	11.4	7.8	17.4	7.9	5.8	38.1	9.1	10.7	11.4	10.2	25.1	24.4	25.2	16.0	8.7	69.5	6.5	0.9	0.8	1.2	1.2	0.7	0.9	0.8	0.3	1.6	1.3	1.2	0.7	0.6	0.6	0.8	0.5	2.5	1.3	0.6	35.7	59.3	44.1	50.2	31.6	41.8	58.4	51.4	18.5	69.8	45.9	67.1	118.6	16.2	9.6	13.4	66.3	26.9	15.2	13.4	13.2	30.1	25.1	24.7	20.8	22.0	25.8	10.4	23.9	25.0	17.3	33.7	29.0	17.6	17.9	13.1	23.4	20.7	17.2	18.0	41.9	21.9	28.7	24.5	16.7	19.4	20.5	10.8	18.8	17.9	31.4	25.7	23.5	12.9	24.3	22.4	29.3	9.8	16.2	19.3	21.3	12.4	298.9	23.9	19.2	15.5	7.1	2136.9	25.3	20.9	13.9	26.1	22.5	26.5	35.6	8.2	18.3	6.6	23.5	14.8	30.6	31.3	25.1	17.5	10.1	26.1	17.6	26.7	20.5
RYR3		ENSG00000198838	"Ryanodine receptor 3"	Q15413	15	33310962-33866121	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 42.1;choroid plexus: 30.6;skeletal muscle: 24.4;tongue: 44.6"	"Cell type enriched"	"Detected in many"	4	"Astrocytes: 788.8"	"Cancer enriched"	"Detected in single"	4	"glioma: 1.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	19	"basophil: 1.9"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 1.9"	"Cell line enhanced"	"Detected in some"		"A549: 4.4;RH-30: 6.5;RPTEC TERT1: 3.1;SuSa: 2.8"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 23.4"	HPA062004			Approved	Vesicles		NA	NA			Vesicles		"HPA062004: AB_2797267"	"unprognostic (5.85e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.26e-2)"	"unprognostic (8.03e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.85e-2)"	"unprognostic (7.10e-2)"	"unprognostic (8.25e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.91e-1)"	1.3	0.7	35.4	0.2	42.1	1.4	2.1	34.3	40.0	4.0	30.6	7.0	0.5	7.2	0.1	1.3	5.4	0.5	0.2	33.9	26.7	2.0	0.0	0.3	0.1	35.7	28.5	31.1	0.9	0.1	6.1	1.4	0.1	32.9	1.4	1.3	2.2	0.5	2.0	24.4	1.0	1.8	4.4	23.1	0.6	2.1	0.5	36.4	0.6	0.3	44.6	0.4	4.0	2.8	29.4	0.2	4.4	0.9	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	1.1	0.1	0.2	0.4	0.0	1.4	0.1	0.0	0.0	0.0	0.2	0.1	0.9	0.1	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	1.6	0.0	0.2	0.1	0.1	0.7	0.2	0.1	0.3	6.5	0.1	3.1	0.3	0.1	0.3	0.4	0.0	0.1	2.8	0.0	0.2	0.5	0.1	0.1	0.0	0.4	0.2	0.9	0.4	0.3	1.4	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.4	42.1	34.3	40.0	33.9	26.7	35.7	28.5	31.1	32.9	23.1	36.4	29.4	2.9	0.0	1.1	788.8	0.2	0.4	0.0	0.0	0.0	8.0	0.2	2.5	2.2	0.0	0.6	0.0	0.0	0.6	0.5	0.0	0.0	0.0	15.5	7.7	1.4	1.8	0.0	8.4	162.5	0.0	0.7	0.6	0.0	8.0	14.0	0.2	0.0	0.0	1.0	69.0	115.2	0.0	0.0	0.0	1.0	41.9	0.3	0.3	0.0	36.5	0.6	0.3	0.0	22.1	5.9	0.0	0.0	0.0	0.1	0.0	0.0	0.3	5.9	0.8	0.0	51.3	0.4	0.1	1.5	0.0	0.6	0.1	0.4	2.5	0.0	0.0
SAA2-SAA4		ENSG00000255071	"SAA2-SAA4 readthrough"		11	18231423-18248635	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in some"	5	"liver: 128.0"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 20.7"	"Cancer enriched"	"Detected in many"	13	"liver cancer: 39.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 2.6;EFO-21: 1.5;GAMG: 1.1;HaCaT: 1.0"									HPA060139	Uncertain					NA	NA					"HPA060139: AB_2684210"	"prognostic favorable (4.56e-4)"	"unprognostic (1.48e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.23e-3)"	"unprognostic (9.41e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.96e-1)"		"unprognostic (8.27e-3)"	"unprognostic (3.17e-2)"	"unprognostic (7.30e-2)"	"prognostic unfavorable (2.92e-8)"	"unprognostic (1.92e-1)"			"unprognostic (2.72e-1)"	23.9	1.5	0.0	1.5	0.0	0.0	5.2	0.0	0.3	15.4	0.0	0.1	0.0	0.0	0.1	0.5	0.3	0.6	0.0	0.0	0.4	0.2	128.0	1.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.5	0.0	0.0	18.9	0.2	5.3	0.3	0.2	0.1	0.0	0.1	0.2	0.2	0.1	0.6	0.0	0.0	0.6	0.3	0.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.5	0.0	1.5	0.0	1.1	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	20.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SH3TC2	"CMT4C, KIAA1985"	ENSG00000169247	"SH3 domain and tetratricopeptide repeats 2"	Q8TF17	5	148923639-149063163	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 12.8;retina: 3.9"	"Cell type enriched"	"Detected in many"	10	"Oligodendrocytes: 270.4"	"Cancer enhanced"	"Detected in some"		"melanoma: 1.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 2.6;HBEC3-KT: 2.2;RT4: 3.6;SK-MEL-30: 5.2;WM-115: 3.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA037683, HPA037684"	Uncertain		Approved	Nucleoplasm,Cytosol		No	No			"Nucleoplasm, Cytosol"		"HPA037683: AB_2675608, HPA037684: AB_10672603"	"unprognostic (6.30e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.22e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.17e-4)"	"unprognostic (2.18e-2)"	"unprognostic (4.53e-1)"	"unprognostic (6.21e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.21e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.40e-1)"	0.1	0.0	5.4	0.0	7.7	0.1	0.1	5.0	4.9	0.1	0.8	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.3	3.5	4.8	0.0	0.0	0.0	0.0	6.9	7.2	2.1	0.0	0.0	0.0	0.0	0.4	7.9	0.0	0.0	3.9	0.1	0.1	0.2	0.1	0.0	0.0	6.5	0.0	0.0	1.5	6.2	0.0	0.0	0.1	0.0	0.1	0.0	12.8	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.3	0.1	2.6	1.5	0.0	1.8	0.1	0.6	1.9	0.0	2.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.4	0.2	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	1.1	1.6	0.0	1.3	0.0	0.7	3.6	0.0	0.0	0.0	0.0	5.2	0.1	0.0	0.0	0.2	0.1	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.4	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	7.7	5.0	4.9	3.5	4.8	6.9	7.2	2.1	7.9	6.5	6.2	12.8	1.9	3.2	3.7	0.3	0.1	0.9	0.8	1.0	0.0	1.4	0.7	0.4	1.7	1.5	3.8	0.0	4.2	0.8	0.0	0.6	0.0	0.6	6.4	0.3	0.1	2.8	0.0	0.0	0.4	0.2	0.4	0.5	0.0	0.5	2.5	0.1	1.4	0.3	0.4	0.0	0.4	0.0	2.0	1.8	0.7	2.3	0.3	2.2	0.0	4.7	0.1	2.3	0.0	0.0	270.4	1.6	0.0	0.0	0.1	1.2	0.0	0.1	4.1	25.4	0.0	0.3	0.4	2.3	0.9	1.0	0.9	11.9	0.3	0.1	0.2	8.8
SHOX2	"OG12, OG12X, SHOT"	ENSG00000168779	"Short stature homeobox 2"	O60902	3	158095905-158106420	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 25.5"	"Cell type enriched"	"Detected in some"	6	"Early spermatids: 90.3"	"Cancer enhanced"	"Detected in many"		"glioma: 3.4"	"Region enhanced"	"Detected in many"		"thalamus: 25.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 24.2;THP-1: 38.7"	"Group enriched"	"Detected in many"	5	"midbrain: 36.0;thalamus: 54.8"	"Group enriched"	"Detected in some"	6	"midbrain: 10.6;pons: 16.3;thalamus: 32.1"							NA	NA						"unprognostic (2.62e-1)"	"unprognostic (6.32e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.69e-3)"	"unprognostic (2.28e-3)"	"unprognostic (7.66e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.31e-2)"	"unprognostic (8.75e-3)"	"unprognostic (0.00e+0)"	"unprognostic (4.20e-3)"	"unprognostic (2.12e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.76e-3)"	4.4	0.1	7.7	0.0	2.2	0.1	5.5	0.3	0.9	3.7	0.0	0.1	0.0	0.4	0.1	0.0	0.3	0.2	2.0	0.1	4.9	0.0	0.0	0.2	1.7	10.1	12.5	0.1	0.2	0.2	0.3	0.2	0.2	7.0	0.1	0.0	0.0	2.3	0.4	1.3	1.8	0.1	0.0	0.5	0.0	0.2	3.5	25.5	0.0	0.5	0.4	0.3	0.4	1.1	2.8	5.5	0.6	0.3	8.1	24.2	15.3	1.5	8.9	3.4	4.8	8.2	1.8	0.7	1.2	0.2	12.8	9.5	0.1	10.1	0.0	1.9	5.1	2.9	13.7	2.7	0.0	0.0	1.2	10.7	6.9	0.3	4.4	0.5	14.8	0.0	0.7	3.8	0.9	2.1	0.3	0.0	0.7	0.0	0.1	0.5	6.2	7.4	1.4	0.0	0.0	2.7	20.5	1.0	0.2	5.2	0.1	0.2	38.7	0.5	15.0	3.1	16.6	14.8	1.1	2.9	0.9	14.5	7.3	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	7.7	2.2	0.3	0.9	0.1	4.9	10.1	12.5	0.1	7.0	0.5	25.5	2.8	3.0	0.0	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.2	0.5	2.4	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	90.3	0.1	1.7	0.9	0.0	0.0	0.0	0.2	0.7	9.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.0	0.0	1.9	1.2	13.9	2.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	13.1	1.1	8.5	5.7	2.8	0.0	0.4	0.3	0.1	0.0	0.2	0.0
SLC10A2	"ASBT, ISBT"	ENSG00000125255	"Solute carrier family 10 member 2"	Q12908	13	103043998-103066417	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 81.5"	"Cell type enriched"	"Detected in some"	29	"Proximal enterocytes: 371.2"	"Cancer enriched"	"Detected in single"	11	"renal cancer: 4.3"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004795	Approved					NA	NA					"HPA004795: AB_1856953"											"unprognostic (2.82e-2)"		"prognostic favorable (5.78e-5)"	"unprognostic (1.64e-2)"	"unprognostic (1.29e-1)"			0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.2	0.3	0.0	0.0	0.2	24.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	17.1	0.0	0.1	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	81.5	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.3	0.0	0.2	0.4	0.3	0.0	0.6	0.2	0.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	371.2	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.1
SLC15A1	"HPECT1, HPEPT1, PEPT1"	ENSG00000088386	"Solute carrier family 15 member 1"	P46059	13	98683801-98752672	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Peptide transport, Protein transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 204.7"	"Cell type enriched"	"Detected in some"	5	"Proximal enterocytes: 414.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 55.5;SK-BR-3: 54.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA002827	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA002827: AB_1856974"	"unprognostic (8.76e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.76e-3)"	"unprognostic (6.26e-2)"	"unprognostic (7.83e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.37e-1)"	"unprognostic (6.79e-2)"	"unprognostic (6.88e-4)"	"unprognostic (2.11e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.64e-1)"	"unprognostic (9.01e-2)"	"unprognostic (3.87e-2)"	0.1	0.0	0.4	0.4	0.3	0.5	1.1	0.6	0.4	2.4	1.3	2.7	153.0	5.6	5.9	2.1	0.1	43.5	0.0	0.3	0.4	6.0	18.4	0.1	0.3	0.3	0.6	0.3	0.1	8.3	20.8	0.3	0.1	0.6	1.5	2.7	0.0	0.5	0.5	0.7	23.4	204.7	0.4	0.2	0.1	1.2	0.2	1.0	0.2	0.3	0.0	0.6	2.6	3.9	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	9.2	55.5	0.0	2.3	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.5	12.8	0.0	0.1	0.1	3.3	3.2	1.2	0.1	0.6	0.1	54.7	0.0	2.6	0.2	0.0	0.0	0.4	0.1	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.1	0.4	0.3	0.6	0.4	0.3	0.4	0.3	0.6	0.3	0.6	0.2	1.0	0.6	0.6	3.2	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.5	50.1	2.4	1.8	0.0	0.0	0.0	33.0	1.9	10.7	0.0	8.2	9.9	0.4	3.6	0.0	0.3	0.9	0.0	0.2	0.0	77.6	0.0	7.2	0.4	32.4	0.1	0.0	0.2	12.0	0.0	0.8	0.0	0.0	0.0	0.4	1.8	0.0	0.0	0.0	0.0	0.5	0.3	2.2	13.8	0.0	0.0	0.6	414.1	10.4	1.7	0.0	0.0	1.3	0.8	0.0	0.3	0.0	0.9	0.1	0.4	0.0	5.8	0.5
SLC38A8		ENSG00000166558	"Solute carrier family 38 member 8"	A6NNN8	16	84009667-84042795	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5	"brain: 3.7"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 16.1"	"Cancer enriched"	"Detected in single"	14	"melanoma: 6.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 2.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"									NA	NA						"unprognostic (9.69e-2)"	"unprognostic (6.16e-2)"		"unprognostic (8.00e-3)"	"unprognostic (6.40e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.20e-3)"	"unprognostic (1.89e-1)"	"unprognostic (7.70e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.16e-2)"		"unprognostic (3.54e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.45e-1)"			0.0	0.1	3.7	0.0	3.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	1.2	0.7	0.0	0.1	0.0	0.0	1.4	1.6	1.2	0.0	0.2	0.1	0.7	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.4	2.0	0.5	0.0	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	3.0	0.0	1.3	1.2	0.7	1.4	1.6	1.2	1.3	0.4	2.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.2	0.0	0.1	0.0	0.0	0.6	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	1.4	0.0	0.0	0.0	0.0	16.1	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.2	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC5A11	"KST1, SGLT6, SMIT2"	ENSG00000158865	"Solute carrier family 5 member 11"	Q8WWX8	16	24845841-24911628	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Ion transport, Sodium transport, Sugar transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 46.1"	"Cell type enriched"	"Detected in some"	19	"Oligodendrocytes: 677.9"	"Cancer enhanced"	"Detected in some"		"glioma: 1.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Hep G2: 8.3;Karpas-707: 2.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035331	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA035331: AB_10601489"	"unprognostic (2.57e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.90e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.85e-3)"	"unprognostic (6.68e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.45e-3)"	0.1	0.1	11.9	0.0	24.6	0.0	0.6	23.9	21.4	0.0	8.7	0.2	3.3	0.0	0.0	0.0	0.1	0.2	0.0	11.8	20.5	3.0	0.8	0.1	0.0	26.1	24.8	9.9	0.1	0.3	0.0	0.3	0.0	29.4	0.1	0.0	0.0	0.1	0.0	0.0	0.1	8.2	0.0	23.3	0.2	0.1	0.4	23.5	0.0	0.1	0.2	0.0	0.1	0.1	46.1	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	24.6	23.9	21.4	11.8	20.5	26.1	24.8	9.9	29.4	23.3	23.5	46.1	0.0	0.0	0.0	2.9	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	2.3	0.0	0.8	0.0	0.0	0.1	0.0	0.1	0.0	0.6	0.1	0.0	2.0	1.5	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.5	677.9	0.0	2.4	0.0	0.1	0.0	35.2	7.2	0.2	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.1	0.0	0.2	0.6	0.0
SLC6A20	"IMINO, SIT1, XT3, Xtrp3"	ENSG00000163817	"Solute carrier family 6 member 20"	Q9NP91	3	45755449-45796536	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"choroid plexus: 49.3;intestine: 24.5"	"Cell type enriched"	"Detected in some"	4	"Proximal enterocytes: 74.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.7;OE19: 3.9;SuSa: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.57e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.43e-3)"	"unprognostic (3.26e-2)"	"unprognostic (4.33e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.55e-5)"	"unprognostic (2.87e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.09e-2)"	0.2	0.1	1.1	0.7	1.1	0.4	0.4	1.8	4.0	1.0	49.3	0.5	24.5	0.8	0.1	0.1	0.2	7.0	0.2	2.1	0.4	1.8	0.2	2.0	0.3	0.6	1.0	0.4	0.1	3.0	0.1	1.3	0.1	0.8	0.5	0.2	0.5	0.7	0.1	0.8	0.7	17.7	0.3	0.4	0.1	5.2	0.4	0.7	0.9	0.2	0.5	0.1	0.0	0.1	0.7	0.1	0.1	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.7	0.1	0.5	0.0	0.2	1.7	0.0	0.0	0.1	0.0	0.1	0.2	0.7	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.0	0.2	0.2	0.1	0.4	3.9	0.1	0.2	0.0	0.2	0.1	0.1	0.1	0.2	0.8	0.1	0.0	1.1	0.1	0.0	0.0	0.2	0.2	0.2	0.1	0.4	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	1.1	1.1	1.8	4.0	2.1	0.4	0.6	1.0	0.4	0.8	0.4	0.7	0.7	0.1	0.0	5.0	0.0	0.1	0.5	0.6	0.6	0.0	0.3	0.7	0.4	1.2	17.2	2.7	0.0	0.0	0.1	0.2	3.5	0.0	13.7	0.6	1.7	0.5	0.1	0.0	0.0	1.4	0.2	0.1	0.7	17.9	2.1	0.0	0.2	0.4	0.0	0.0	0.0	0.2	4.8	0.0	0.0	0.0	1.7	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.1	9.4	1.2	1.2	0.4	2.3	74.7	3.5	1.4	0.3	0.0	0.6	0.3	0.2	0.2	0.0	0.3	0.0	0.3	0.1	7.0	4.2
SMIM2	"C13orf44, MGC5590"	ENSG00000139656	"Small integral membrane protein 2"	Q9BVW6	13	44143150-44161257	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 23.6"	"Cell type enriched"	"Detected in some"	6	"Early spermatids: 53.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 2.5;OE19: 4.8"					"Low region specificity"	"Detected in single"			"HPA026891, HPA077071"	Enhanced		Uncertain	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA026891: AB_10602924, HPA077071: "	"unprognostic (4.34e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.87e-5)"	"unprognostic (2.40e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.75e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.10e-1)"	"unprognostic (4.80e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.05e-2)"	0.2	0.2	0.8	0.1	0.9	0.0	0.0	0.2	1.9	0.0	0.5	0.8	0.8	0.0	2.9	0.3	0.2	0.3	1.0	0.6	0.6	0.8	0.4	0.2	0.0	0.4	0.5	0.7	0.1	0.6	0.0	0.2	0.4	0.6	0.2	0.0	0.3	0.6	0.1	0.9	0.3	1.9	0.5	0.2	0.2	0.5	23.6	0.3	5.0	0.3	0.0	0.0	0.3	0.0	0.6	0.4	0.2	0.4	0.0	0.0	0.0	0.4	0.0	2.5	0.5	0.0	0.5	0.1	0.7	0.4	0.0	0.4	1.2	0.0	1.0	0.7	0.0	0.7	0.0	0.8	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.4	0.0	0.3	4.8	0.4	0.4	0.0	0.0	0.0	0.1	1.1	0.5	1.3	0.5	0.9	0.9	0.0	0.0	0.2	0.0	0.5	0.7	0.1	0.0	0.0	0.2	0.6	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.9	0.2	1.9	0.6	0.6	0.4	0.5	0.7	0.6	0.2	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.5	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	8.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0
SOX14	SOX28	ENSG00000168875	"SRY-box transcription factor 14"	O95416	3	137764315-137766334	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 8.8"	"Cell type enriched"	"Detected in some"	5	"Cytotrophoblasts: 18.4"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 2.8"	"Region enhanced"	"Detected in many"		"thalamus: 8.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"hypothalamus: 1.7;midbrain: 4.9"	"Group enriched"	"Detected in some"	6	"midbrain: 7.1;pons: 4.5;thalamus: 11.8"							NA	NA								"unprognostic (1.43e-1)"	"unprognostic (1.63e-1)"								"unprognostic (1.88e-2)"		"unprognostic (2.49e-3)"	"unprognostic (5.08e-1)"			0.0	0.0	1.6	0.0	0.3	0.0	0.0	1.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.5	4.1	0.0	0.0	0.0	0.0	0.0	1.7	1.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	1.5	0.4	0.0	1.5	0.5	4.1	0.0	1.5	0.1	8.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	18.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0
SPRR2F		ENSG00000244094	"Small proline rich protein 2F"	Q96RM1	1	153112121-153113516	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"esophagus: 266.8;lymphoid tissue: 70.8;ovary: 113.4"	"Cell type enriched"	"Detected in some"	29	"Granulosa cells: 681.7"	"Group enriched"	"Detected in many"	5	"cervical cancer: 16.0;head and neck cancer: 53.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"K-562: 2.7"															NA	NA							"unprognostic (7.40e-2)"		"unprognostic (1.14e-2)"		"unprognostic (1.48e-2)"		"unprognostic (2.41e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.57e-1)"				"unprognostic (2.54e-1)"	"unprognostic (2.96e-1)"		"unprognostic (1.78e-3)"	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.2	0.0	0.0	0.0	0.1	0.0	266.8	1.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	113.4	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	26.2	0.0	0.2	2.4	0.0	0.0	0.0	0.0	0.4	6.7	0.0	0.1	0.0	0.1	70.8	0.1	30.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.1	18.8	0.0	0.0	0.0	681.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	10.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	23.0	0.0	0.7	0.0	0.0	0.0	0.2	4.5	0.0	0.3
STON2	"STN2, STNB2"	ENSG00000140022	"Stonin 2"	Q8WXE9	14	81260656-81436465	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 81.3"	"Cell type enriched"	"Detected in many"	4	"Astrocytes: 253.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"intermediate monocyte: 1.2"	"Lineage enriched"	"Detected in single"	4	"monocytes: 1.2"	"Cell line enhanced"	"Detected in many"		"HEL: 113.4;HMC-1: 60.9;Karpas-707: 58.3;RT4: 46.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003086	Enhanced		Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA003086: AB_2302748"	"unprognostic (5.28e-2)"	"unprognostic (9.83e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (4.96e-4)"	"unprognostic (2.50e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.30e-1)"	"unprognostic (9.88e-2)"	"unprognostic (9.19e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.37e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.44e-1)"	3.5	0.8	68.7	1.2	67.7	5.6	9.7	38.4	52.1	3.1	14.6	4.5	4.0	1.2	5.2	14.4	10.8	5.9	2.5	66.2	81.3	14.4	3.0	5.0	1.1	43.0	61.2	43.6	2.8	0.9	0.3	10.1	2.5	49.5	2.1	5.0	10.3	5.6	2.7	13.3	8.1	4.3	1.7	25.0	16.5	5.8	3.4	55.5	2.6	10.9	17.5	2.9	6.4	9.6	56.8	4.7	3.1	12.1	0.2	0.0	0.1	13.4	0.0	0.1	0.0	0.3	10.0	4.2	0.0	5.5	0.0	3.4	30.6	16.5	39.8	0.0	0.8	5.5	113.4	19.9	4.2	0.0	0.0	60.9	1.7	33.5	0.0	11.0	0.0	0.0	6.1	40.2	58.3	1.2	6.8	5.4	0.0	11.9	11.5	2.4	0.1	17.6	3.4	8.4	46.0	28.1	1.7	13.7	0.6	0.0	9.9	1.7	0.3	0.3	2.4	8.8	9.7	2.6	6.0	11.9	0.1	8.4	0.4	2.6	0.0	0.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	1.1	68.7	67.7	38.4	52.1	66.2	81.3	43.0	61.2	43.6	49.5	25.0	55.5	56.8	6.3	3.2	0.5	253.4	0.1	13.6	13.2	20.5	30.7	0.6	11.8	8.1	1.1	2.8	6.8	18.4	12.5	1.4	0.1	4.8	7.9	0.6	0.4	56.0	1.2	5.0	0.0	12.2	0.9	0.5	0.4	8.3	7.1	16.1	0.0	12.5	4.2	0.9	3.4	3.3	4.4	3.2	14.2	18.0	6.1	1.6	10.2	13.5	1.8	23.4	2.3	23.9	0.0	12.1	15.2	3.2	2.7	8.6	1.0	6.8	4.6	20.6	5.8	6.1	0.0	36.1	3.2	1.0	5.9	24.3	8.8	15.5	0.9	6.3	2.7	33.2
SULT2A1	"DHEA-ST, STD"	ENSG00000105398	"Sulfotransferase family 2A member 1"	Q06520	19	47870467-47886315	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Bile acid catabolism, Lipid degradation, Lipid metabolism, Steroid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 1081.0"	"Cell type enriched"	"Detected in some"	9	"Hepatocytes: 1578.7"	"Cancer enriched"	"Detected in some"	52	"liver cancer: 244.3"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.9"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.9"	"Group enriched"	"Detected in some"	34	"Hep G2: 39.6;RT4: 26.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB018755, HPA041487, HPA063633"	Enhanced		Supported	Cytosol		NA	NA		1200000	Cytosol		"CAB018755: AB_650242, HPA041487: AB_2677507, HPA063633: AB_2685066"			"unprognostic (2.14e-1)"				"unprognostic (6.79e-3)"							"unprognostic (6.82e-2)"	"unprognostic (1.36e-1)"		"unprognostic (1.31e-2)"	0.1	237.6	0.3	0.1	0.2	0.4	0.0	0.5	0.5	0.0	0.4	0.6	60.1	0.1	0.4	0.0	0.0	0.1	0.0	0.2	0.1	0.2	1081.0	0.0	0.2	0.1	0.2	0.3	0.1	0.1	37.2	0.0	0.1	0.3	0.1	0.9	1.0	0.1	3.1	0.1	0.3	87.3	0.0	0.0	0.4	24.6	4.2	0.3	0.0	0.1	0.0	0.1	2.0	0.1	0.6	0.1	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.9	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.3	39.6	0.0	0.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.1	0.3	0.1	0.1	0.1	0.0	0.5	0.3	0.0	26.7	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.2	0.1	0.2	0.1	0.2	0.0	0.2	0.1	2.9	0.2	0.2	0.2	0.1	0.2	0.2	0.3	0.2	0.1	0.4	0.4	0.3	0.8	0.5	0.1	0.3	0.2	0.2	0.3	0.2	0.5	0.5	0.2	0.1	0.1	0.2	0.3	0.3	0.0	0.3	0.6	0.0	0.0	0.0	0.3	2.9	0.1	0.6	0.0	0.0	1.3	0.0	0.0	0.6	18.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.3	0.0	18.7	0.3	0.0	0.0	0.3	5.1	0.1	0.0	0.1	30.0	1578.7	0.0	0.0	0.3	2.8	0.0	31.8	0.4	0.2	3.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	8.8	0.4	0.0	0.3	171.7	0.1	0.0	2.7	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.5	1.8	81.7	2.2	0.3
SUV39H2	"FLJ23414, KMT1B"	ENSG00000152455	"Suppressor of variegation 3-9 homolog 2"	Q9H5I1	10	14878820-14904315	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Differentiation, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 39.6"	"Cell type enriched"	"Detected in many"	4	"Early spermatids: 421.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045901, HPA057554"	Enhanced		Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA045901: AB_10960702, HPA057554: AB_2683466"	"prognostic unfavorable (5.55e-4)"	"unprognostic (1.45e-1)"	"unprognostic (2.98e-2)"	"unprognostic (8.78e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.23e-3)"	"prognostic unfavorable (2.01e-6)"	"unprognostic (1.06e-1)"	"unprognostic (9.15e-2)"	"unprognostic (3.59e-3)"	"unprognostic (2.42e-1)"	"unprognostic (4.13e-3)"	"prognostic unfavorable (5.71e-5)"	"unprognostic (2.71e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.55e-2)"	"unprognostic (1.39e-1)"	2.2	1.5	1.7	2.4	1.8	4.7	3.9	8.2	3.3	1.5	1.6	3.0	2.1	2.0	1.6	3.2	2.1	1.7	1.0	2.6	1.4	2.3	3.2	1.3	2.5	1.6	1.7	1.4	2.5	1.9	1.9	1.3	3.9	3.2	2.7	3.5	3.4	1.8	2.3	1.4	1.9	2.6	2.4	1.3	1.5	1.9	39.6	1.4	6.1	1.5	1.3	3.1	3.1	1.4	3.4	28.6	20.8	40.8	24.1	7.5	10.7	16.9	14.8	8.1	24.1	34.6	29.5	15.2	22.4	13.4	5.8	22.6	21.3	27.7	16.4	31.6	22.9	15.1	29.4	14.0	21.5	4.3	14.8	16.2	4.1	5.3	24.2	5.4	6.4	19.0	37.4	41.9	15.2	20.3	19.3	31.3	4.4	28.8	26.6	5.9	38.4	28.1	20.7	10.9	11.0	13.8	16.8	23.9	16.6	11.1	23.8	24.6	11.0	11.6	21.4	31.7	22.9	23.1	9.5	36.1	47.9	12.1	14.8	13.5	0.2	0.3	0.2	1.5	1.1	1.9	0.4	1.1	1.7	1.1	0.3	1.8	1.8	0.3	3.0	0.4	1.8	2.0	0.5	1.7	1.8	8.2	3.3	2.6	1.4	1.6	1.7	1.4	3.2	1.3	1.4	3.4	2.0	0.0	1.5	4.2	2.6	8.3	10.2	6.7	9.1	7.5	4.0	3.7	2.9	2.8	7.5	1.8	10.4	13.9	1.7	1.1	5.9	4.4	421.0	3.4	5.1	4.3	3.5	16.2	8.0	2.2	25.6	5.1	4.1	4.0	2.5	7.8	1.8	3.0	5.0	11.8	7.9	3.1	6.1	1.6	2.8	104.4	4.7	1.8	1.8	2.8	0.7	4.2	3.1	4.5	4.5	2.1	1.7	2.6	7.1	14.5	1.0	7.4	3.5	10.2	6.6	5.8	6.6	47.5	46.6	8.3	8.8	8.9	3.4	8.7	4.5	10.9
SYNPR	"MGC26651, SPO"	ENSG00000163630	Synaptoporin	Q8TBG9	3	63228315-63616924	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 101.6;retina: 39.1"	"Cell type enriched"	"Detected in some"	6	"Inhibitory neurons: 641.5"	"Cancer enhanced"	"Detected in some"		"glioma: 1.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.0"	"Region enhanced"	"Detected in all"		"olfactory bulb: 743.6"	"Low region specificity"	"Detected in all"			"HPA051368, HPA061671"	Enhanced					NA	NA					"HPA051368: AB_2681456, HPA061671: AB_2684582"			"unprognostic (1.69e-1)"		"unprognostic (3.77e-2)"			"unprognostic (3.14e-3)"	"unprognostic (3.02e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.50e-1)"		"unprognostic (5.32e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.89e-1)"		0.0	0.3	36.1	0.1	101.6	0.0	0.0	61.9	61.3	0.0	12.9	0.1	0.2	0.0	0.0	0.0	0.0	0.0	4.6	52.3	37.6	0.0	0.0	0.0	0.0	44.5	33.4	70.1	0.0	0.1	0.0	1.2	0.0	26.9	0.0	0.1	39.1	0.6	0.0	0.0	0.0	0.1	0.0	20.2	0.0	0.5	0.0	49.2	0.0	0.2	0.0	0.0	0.0	0.0	47.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.1	101.6	61.9	61.3	52.3	37.6	44.5	33.4	70.1	26.9	20.2	49.2	47.7	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	23.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	5.3	0.0	72.4	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	106.0	641.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	45.0	0.0	8.0	7.6	0.1	1.1	0.0	0.0	0.0	0.0	0.1	0.0	7.4	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0
TAC1	"NKNA, NPK, TAC2"	ENSG00000006128	"Tachykinin precursor 1"	P20366	7	97732084-97740472	"Predicted secreted proteins"		"Neuropeptide, Neurotransmitter"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 58.9;lymphoid tissue: 46.5"	"Cell type enriched"	"Detected in some"	7	"Inhibitory neurons: 99.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	16	"U-266/70: 22.8"	"Region enhanced"	"Detected in all"		"basal ganglia: 560.0"	"Region enriched"	"Detected in all"	10	"basal ganglia: 388.8"	HPA014429	Enhanced				"Secreted to blood"	NA	NA					"HPA014429: AB_1857722"	"unprognostic (9.24e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.92e-1)"					"unprognostic (2.08e-1)"	"unprognostic (7.95e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.70e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.86e-2)"	2.1	8.6	11.2	11.0	27.1	0.0	2.1	4.2	14.2	0.4	4.0	7.6	8.3	0.8	1.6	0.1	1.0	6.7	0.9	8.5	58.9	3.7	0.3	0.5	0.0	56.3	39.7	10.5	0.2	0.6	0.5	1.6	0.0	24.1	1.3	3.6	3.5	6.8	2.2	0.3	1.2	10.4	7.6	13.3	46.5	3.0	0.4	37.2	0.2	7.5	0.0	0.0	1.5	0.8	11.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	22.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	27.1	4.2	14.2	8.5	58.9	56.3	39.7	10.5	24.1	13.3	37.2	11.3	0.1	0.0	0.0	2.9	0.5	0.4	0.1	0.0	0.0	0.0	0.4	0.6	0.3	7.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	2.0	1.0	0.0	0.0	0.0	1.2	0.0	0.0	13.2	0.0	9.7	0.0	0.0	0.0	0.0	0.1	0.0	99.4	5.4	0.0	0.0	0.4	0.1	0.3	0.1	0.0	1.9	0.0	0.0	0.0	1.5	3.4	0.5	0.0	0.0	0.0	4.2	0.3	9.1	0.0	0.0	0.0	1.1	1.3	0.2	2.1	0.0	0.1	0.0	0.4	0.0	0.5	0.9
TLCD4	"FLJ31842, TMEM56"	ENSG00000152078	"TLC domain containing 4"	Q96MV1	1	95117355-95197607	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 131.0"	"Cell type enriched"	"Detected in some"	9	"Cardiomyocytes: 77.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 13.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 22.4;RH-30: 35.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046762			Approved	"Nuclear speckles"		No	No			"Nuclear speckles"		"HPA046762: AB_2679792"	"unprognostic (1.51e-3)"	"unprognostic (1.54e-1)"	"unprognostic (2.98e-3)"	"unprognostic (2.79e-1)"	"unprognostic (3.30e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.82e-3)"	"unprognostic (3.63e-2)"	"unprognostic (4.42e-3)"	"unprognostic (2.69e-2)"	"unprognostic (4.99e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.10e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.15e-2)"	5.4	10.0	10.9	2.2	10.6	20.7	2.6	21.7	15.0	2.4	2.3	13.7	5.5	3.5	2.6	2.3	2.5	4.3	26.0	11.2	9.7	5.8	131.0	3.7	0.4	7.0	7.5	10.2	1.7	7.5	6.4	3.4	4.5	7.6	5.4	10.3	3.1	8.3	2.9	13.1	1.1	8.6	3.6	9.7	0.7	5.1	4.9	8.0	0.3	7.4	9.8	0.5	4.7	1.3	14.1	22.4	12.6	1.7	2.6	0.8	0.0	2.9	0.8	0.5	2.8	6.5	9.1	10.4	0.0	10.7	0.4	20.0	0.2	7.4	1.1	4.8	15.5	4.1	0.5	9.2	2.0	0.8	0.4	0.6	1.2	0.4	2.1	0.0	4.4	0.0	1.2	19.8	1.2	0.6	1.9	1.3	0.1	1.7	0.7	6.9	0.0	35.7	0.6	12.0	14.4	4.5	3.6	15.6	10.8	6.7	1.8	11.7	0.4	0.2	0.3	9.0	1.1	7.9	3.8	8.0	0.0	1.5	0.1	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	10.9	10.6	21.7	15.0	11.2	9.7	7.0	7.5	10.2	7.6	9.7	8.0	14.1	5.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	77.9	0.0	0.0	0.0	0.0	8.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.5	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0
TMTC2	DKFZp762A217	ENSG00000179104	"Transmembrane O-mannosyltransferase targeting cadherins 2"	Q8N394	12	82686880-83134870	"Enzymes, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 59.5"	"Cell type enriched"	"Detected in many"	5	"Oligodendrocytes: 2152.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 32.0;WM-115: 80.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026954, HPA026955"	Uncertain		Approved	"Plasma membrane,Actin filaments"		No	No			"Plasma membrane"	"Actin filaments"	"HPA026954: AB_2256025, HPA026955: AB_10602282"	"unprognostic (1.56e-1)"	"unprognostic (5.62e-2)"	"unprognostic (9.61e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.73e-3)"	"unprognostic (5.06e-2)"	"prognostic favorable (2.84e-5)"	"unprognostic (1.10e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.06e-2)"	"unprognostic (8.06e-2)"	3.7	0.8	10.5	4.8	32.9	2.1	4.6	17.6	16.8	4.8	0.0	9.0	2.8	5.4	4.5	9.9	10.1	7.9	1.9	7.9	18.7	6.6	1.2	6.5	1.9	25.6	27.8	3.7	2.0	4.5	2.9	3.5	3.4	29.8	6.2	5.7	5.6	6.9	11.3	1.2	4.9	4.7	6.9	13.4	1.3	10.3	3.0	21.8	1.5	6.4	1.7	2.2	7.6	7.4	59.5	1.7	6.4	32.0	0.2	4.3	3.9	2.9	2.1	0.7	1.7	0.3	0.3	3.4	0.0	0.5	11.9	1.2	2.8	9.7	4.9	0.5	7.5	5.8	0.0	5.2	0.2	0.4	2.2	1.0	1.1	4.3	0.2	1.6	3.4	2.7	3.5	0.0	4.2	0.4	3.4	1.6	8.8	1.1	6.0	5.3	0.0	1.3	0.6	2.9	14.1	8.3	15.1	2.9	4.6	21.0	5.4	4.9	0.5	1.7	5.3	1.8	7.2	2.7	7.8	5.7	1.2	1.2	3.8	80.2	0.0	0.9	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	10.5	32.9	17.6	16.8	7.9	18.7	25.6	27.8	3.7	29.8	13.4	21.8	59.5	10.7	9.6	8.9	333.3	2.0	14.4	15.5	12.0	18.2	38.1	8.9	5.5	1.8	11.5	18.4	14.7	8.4	13.6	3.1	3.6	0.0	5.4	12.9	13.5	7.5	10.3	2.4	0.8	117.1	8.2	1.7	9.8	12.8	13.1	0.0	0.2	2.5	1.4	1.9	8.4	377.0	9.8	2.0	6.6	9.6	5.0	5.9	6.2	32.0	86.2	9.3	13.9	1.0	38.7	2152.4	9.4	3.3	1.2	7.3	11.9	2.7	2.1	17.0	1.6	6.6	0.8	2.2	0.6	2.2	16.2	11.5	4.1	2.8	1.0	5.9	14.5
TPSG1	"PRSS31, TMT"	ENSG00000116176	"Tryptase gamma 1"	Q9NRR2	16	1221651-1225257	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 14.8"	"Cell type enriched"	"Detected in some"	6	"Intestinal goblet cells: 278.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 5.2"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"HMC-1: 23.2;MCF7: 7.9"	"Not detected"	"Not detected"							HPA060458	Enhanced					NA	NA					"HPA060458: AB_2684283"	"unprognostic (1.86e-1)"	"unprognostic (3.46e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.27e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.45e-2)"	"unprognostic (4.60e-2)"	"unprognostic (9.97e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.92e-2)"	"unprognostic (6.39e-2)"	"prognostic unfavorable (1.76e-8)"	"unprognostic (2.19e-1)"	"unprognostic (1.70e-1)"	"unprognostic (8.65e-4)"	"unprognostic (5.70e-2)"	0.6	1.0	0.4	1.5	1.3	0.0	3.2	0.1	0.4	0.7	0.0	14.8	14.2	1.3	0.1	0.8	0.7	1.0	0.2	0.2	0.4	0.5	0.4	0.8	0.0	0.4	0.1	0.2	2.1	0.2	0.0	3.1	0.0	0.3	1.1	9.1	0.1	0.3	0.2	0.2	1.1	9.4	0.3	0.0	0.0	1.1	1.6	0.3	0.0	0.1	0.0	0.0	1.8	0.8	0.1	0.0	1.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	23.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.7	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.3	0.1	0.4	0.2	0.4	0.4	0.1	0.2	0.3	0.0	0.3	0.1	0.0	0.0	0.6	0.0	0.2	0.1	0.0	0.0	0.0	0.0	1.2	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.9	0.0	0.0	0.4	0.0	0.0	0.0	278.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.3	0.1	5.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	4.7	0.0
TRAV12-2		ENSG00000211789	"T cell receptor alpha variable 12-2"	A0A075B6T6	14	21887857-21888502	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 22.6"	"Cell type enriched"	"Detected in some"	6	"T-cells: 6.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	17	"memory CD4 T-cell: 101.9;memory CD8 T-cell: 87.7;naive CD4 T-cell: 90.3;naive CD8 T-cell: 65.2;T-reg: 143.3"	"Lineage enriched"	"Detected in many"	77	"T-cells: 143.3"	"Not detected"	"Not detected"																	NA	NA						"unprognostic (1.73e-3)"	"unprognostic (6.86e-3)"	"unprognostic (1.74e-2)"	"unprognostic (4.98e-3)"	"unprognostic (4.75e-2)"	"unprognostic (2.41e-4)"	"unprognostic (2.22e-2)"	"unprognostic (7.44e-2)"	"unprognostic (5.23e-4)"	"unprognostic (1.73e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.03e-3)"	"unprognostic (3.69e-1)"	"unprognostic (3.34e-3)"	"unprognostic (9.87e-2)"	"unprognostic (3.01e-2)"	0.8	0.9	0.0	7.6	0.0	0.9	1.0	0.0	0.1	1.1	0.0	1.6	4.1	0.8	0.5	0.8	1.2	2.5	0.3	0.0	0.0	0.3	0.6	2.5	15.8	0.1	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.1	0.8	2.1	0.0	1.7	0.1	0.2	0.5	2.9	0.5	0.0	5.9	2.3	0.0	0.1	22.6	0.6	0.0	13.7	3.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.5	1.2	0.0	5.7	0.1	101.9	87.7	0.2	0.1	90.3	65.2	1.8	0.1	0.2	0.1	143.3	27.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0
TRAV5		ENSG00000211779	"T cell receptor alpha variable 5"	A0A0B4J249	14	21749178-21749705	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 13.0"	"Cell type enriched"	"Detected in some"	5	"T-cells: 7.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	52	"MAIT T-cell: 24.7;memory CD4 T-cell: 49.5;memory CD8 T-cell: 77.3;naive CD4 T-cell: 39.9;naive CD8 T-cell: 74.0;T-reg: 81.4"	"Lineage enriched"	"Detected in many"	73	"T-cells: 81.4"	"Not detected"	"Not detected"																	NA	NA						"unprognostic (1.04e-3)"	"unprognostic (2.62e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.69e-2)"		"unprognostic (6.26e-5)"	"unprognostic (3.58e-1)"	"unprognostic (8.15e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.11e-2)"	"unprognostic (8.38e-6)"	"unprognostic (2.28e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.70e-2)"	0.1	0.4	0.0	3.6	0.1	0.5	0.7	0.0	0.3	0.3	0.4	1.0	0.5	0.7	0.0	0.3	0.1	2.7	0.2	0.1	0.0	0.2	0.8	1.1	13.0	0.3	0.2	0.0	0.3	0.6	0.0	0.0	0.0	0.1	2.2	1.6	0.0	2.6	0.3	0.0	0.0	2.7	0.8	0.0	4.6	1.8	0.1	0.2	11.6	0.8	0.8	7.7	0.7	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	1.0	0.5	24.7	0.2	49.5	77.3	0.1	0.1	39.9	74.0	1.1	0.0	0.2	0.3	81.4	17.9	0.0	0.1	0.0	0.3	0.1	0.0	0.3	0.2	0.0	0.1	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.7	0.0	0.0	0.0
TRBV29-1	"TCRBV29S1, TCRBV4S1A1T, TRBV291"	ENSG00000232869	"T cell receptor beta variable 29-1"	A0A5B7	7	142740206-142740894	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 99.4"	"Cell type enriched"	"Detected in single"	11	"T-cells: 4.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	44	"MAIT T-cell: 45.1;memory CD4 T-cell: 128.6;memory CD8 T-cell: 83.2;naive CD4 T-cell: 137.8;naive CD8 T-cell: 110.8;T-reg: 178.2"	"Lineage enriched"	"Detected in many"	69	"T-cells: 178.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"													NA	NA						"prognostic favorable (1.23e-4)"	"unprognostic (9.31e-4)"	"unprognostic (1.29e-1)"	"unprognostic (8.13e-3)"	"unprognostic (3.28e-2)"	"unprognostic (3.47e-4)"	"unprognostic (6.84e-3)"	"unprognostic (1.71e-2)"	"unprognostic (9.15e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (6.74e-5)"	"unprognostic (1.45e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.05e-1)"	0.6	0.3	0.0	6.6	0.0	4.4	1.2	0.3	0.2	1.5	0.1	2.0	2.7	0.6	0.0	1.0	0.3	2.6	0.1	0.1	0.0	0.4	1.2	1.5	21.9	0.1	0.0	0.0	0.6	21.4	0.0	0.1	0.0	0.1	0.7	2.1	0.0	0.7	0.6	0.1	0.4	3.9	1.3	0.0	5.5	2.4	0.1	0.0	99.4	0.7	0.5	23.6	2.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.1	0.7	0.1	45.1	2.0	128.6	83.2	0.1	1.8	137.8	110.8	2.5	0.2	0.3	0.7	178.2	51.1	0.0	0.0	0.3	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0
TRBV6-2	"TCRBV13S2A1T, TCRBV6S2, TRBV62"	ENSG00000283063	"T cell receptor beta variable 6-2"	"A0A0J9YXY3, P0DPF7"	7	142349152-142349664	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 8.3"	"Cell type enriched"	"Detected in single"	10	"T-cells: 6.2"					"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 92.1"	"Lineage enriched"	"Detected in single"	175	"T-cells: 92.1"	"Not detected"	"Not detected"																	NA	NA																							0.2	0.0	0.0	2.4	0.0	0.7	0.1	0.0	0.0	0.1	0.0	0.1	0.7	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.2	0.5	8.3	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	1.5	0.1	0.0	2.3	0.2	0.0	0.0	4.7	0.3	0.0	5.9	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	92.1	0.2	24.0	26.4	0.0	0.0	21.7	17.5	0.5	0.0	0.1	0.1	40.3	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0
TRGV2	"TCRGV2, VIS2"	ENSG00000233306	"T cell receptor gamma variable 2"	A0A075B6R0	7	38362864-38363518	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 6.6"	"Cell type enriched"	"Detected in some"	5	"T-cells: 19.2"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"memory CD8 T-cell: 147.8"	"Lineage enriched"	"Detected in many"	22	"T-cells: 147.8"	"Cell line enriched"	"Detected in some"	4	"Karpas-707: 17.4"															NA	NA						"unprognostic (1.51e-3)"	"unprognostic (8.88e-5)"	"unprognostic (1.77e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.31e-4)"	"unprognostic (1.50e-3)"	"unprognostic (1.13e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.48e-2)"	"unprognostic (3.02e-1)"	"unprognostic (4.21e-5)"	"unprognostic (1.43e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.87e-3)"	0.2	0.6	0.1	1.6	0.2	0.9	0.1	0.0	0.2	0.2	0.4	0.8	0.8	0.3	0.1	0.2	0.3	1.0	0.2	0.0	0.1	0.1	0.4	0.9	5.0	0.5	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.2	1.3	0.6	0.1	0.9	0.1	0.1	0.2	1.4	0.4	0.2	6.6	0.7	0.3	0.3	4.8	0.3	0.0	0.7	0.6	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.2	2.4	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	1.0	17.4	0.0	0.0	0.5	0.8	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.7	1.7	0.1	0.0	3.8	0.0	0.2	0.4	0.0	59.4	0.2	58.4	0.1	29.7	147.8	1.4	0.2	7.0	54.9	0.9	6.8	0.1	1.5	0.6	22.0	0.1	0.2	0.0	0.2	0.0	0.1	0.5	0.3	0.0	0.2	0.2	0.3	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.8	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0
TRIM63	"IRF, MURF-1, RNF28, SMRZ"	ENSG00000158022	"Tripartite motif containing 63"	Q969Q1	1	26051301-26068436	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Muscle protein, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 1951.6"	"Cell type enriched"	"Detected in some"	7	"Cardiomyocytes: 272.2"	"Cancer enriched"	"Detected in some"	10	"melanoma: 31.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	40	"ASC diff: 16.1;SK-MEL-30: 55.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebellum: 5.1"							NA	NA						"unprognostic (1.10e-1)"	"unprognostic (4.80e-4)"	"unprognostic (1.45e-2)"	"unprognostic (7.52e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.16e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.32e-1)"	"unprognostic (5.58e-2)"	0.9	0.2	0.0	0.0	0.1	0.0	0.8	0.0	0.1	1.5	0.0	0.6	0.3	8.9	0.3	7.2	0.6	2.7	195.8	0.0	0.0	1.5	0.4	1.3	0.0	0.2	0.1	0.0	0.2	0.8	0.0	0.2	4.0	0.0	1.5	0.2	0.1	9.7	0.5	1951.6	3.0	0.9	3.5	0.0	0.2	0.8	0.2	0.2	0.3	0.5	391.0	0.2	9.0	1.1	0.1	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.9	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.6	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.4	0.0	272.2	5.7	0.0	1.8	0.0	0.5	0.0	0.0	1.9	1.8	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.1	8.1	0.0	0.1	10.1	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	12.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	3.3	29.7	0.0	0.0	0.0	34.7	1.4	0.0	0.0	0.0	0.1	1.6	6.1	0.0	0.1	0.1
TSPY3	CT78	ENSG00000228927	"Testis specific protein Y-linked 3"	P0CV98	Y	9398421-9401223	"Predicted intracellular proteins"	"Differentiation, Gonadal differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5	"testis: 3.0"	"Cell type enriched"	"Detected in some"	5	"Spermatogonia: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	75	"U-266/70: 148.5;U-266/84: 145.3"									"HPA049384, HPA067289"	Supported		Approved	Cytosol		NA	NA			Cytosol		"HPA049384: AB_2680738, HPA067289: "															"unprognostic (4.19e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	148.5	145.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TTN	"CMD1G, CMH9, CMPD4, FLJ32040, LGMD2J, MYLK5, TMD"	ENSG00000155657	Titin	Q8WZ42	2	178525989-178830802	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cardiomyopathy, Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"skeletal muscle: 929.2;tongue: 372.8"	"Cell type enriched"	"Detected in many"	16	"Cardiomyocytes: 24394.9"	"Cancer enriched"	"Detected in single"	4	"head and neck cancer: 1.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RH-30: 1.9"	"Not detected"	"Not detected"							"HPA007042, CAB022682, HPA030048"	Enhanced					NA	NA		16000000			"CAB022682: , HPA007042: AB_1080292, HPA030048: AB_2732451"	"unprognostic (1.00e-2)"	"unprognostic (3.92e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.11e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.49e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.49e-4)"	"unprognostic (1.99e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.34e-2)"	0.7	0.4	3.2	0.5	5.5	4.3	0.5	3.5	5.2	0.3	0.0	0.3	0.4	0.4	0.2	2.7	0.3	0.7	140.0	2.7	2.0	0.2	0.3	1.3	1.4	11.7	4.8	1.5	0.7	1.8	0.0	0.8	0.5	7.8	2.8	0.0	1.9	7.0	0.0	929.2	0.8	0.6	0.0	4.3	0.7	0.4	1.6	4.4	0.7	0.6	372.8	0.4	0.2	0.3	6.8	0.3	0.1	0.7	0.4	0.0	0.0	1.4	0.2	0.0	0.0	0.0	0.7	0.1	1.0	0.2	0.0	0.7	0.7	0.0	0.0	0.0	1.0	0.8	1.5	1.3	0.4	0.0	0.1	0.3	0.9	0.0	0.0	0.0	0.7	0.6	0.7	0.9	0.5	0.1	0.2	0.7	1.0	0.2	0.1	0.7	0.5	1.9	0.6	0.0	0.2	0.4	0.7	0.1	0.5	0.0	0.6	0.3	1.0	0.7	0.0	0.0	0.3	0.2	1.4	0.2	1.4	0.0	0.5	0.3	1.8	0.2	0.5	0.4	0.2	0.1	6.1	0.9	0.7	0.1	5.7	2.0	2.6	1.0	3.6	0.2	0.2	6.0	0.1	3.2	5.5	3.5	5.2	2.7	2.0	11.7	4.8	1.5	7.8	4.3	4.4	6.8	10.9	16.0	173.4	43.8	32.1	0.9	1.6	0.0	2.8	102.7	1.7	0.5	24394.9	30.0	6.2	0.0	20.9	0.7	6.8	0.1	1.9	14.1	43.2	3.4	6.8	99.1	4.2	3.0	25.1	28.3	0.3	502.5	3.6	7.2	10.1	0.7	2.5	0.6	0.3	16.8	31.3	0.1	0.0	0.8	0.8	6.4	1.2	26.2	0.0	25.3	0.6	12.0	2.1	11.6	4.9	0.5	0.1	4.5	10.6	0.2	0.3	0.4	2.9	27.8	0.0	1466.9	104.7	9.3	1.5	2.3	0.1	0.4	24.3	2.8	0.5	0.1
TTR	"CTS, CTS1, HsT2651, PALB"	ENSG00000118271	Transthyretin	P02766	18	31557009-31598833	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Transport	"Hormone, Thyroid hormone"	"Amyloidosis, Cancer-related genes, Disease variant, FDA approved drug targets, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"choroid plexus: 113301.2"	"Cell type enriched"	"Detected in many"	30	"Hepatocytes: 23659.3"	"Group enriched"	"Detected in many"	28	"liver cancer: 928.2;pancreatic cancer: 666.0"	"Region enhanced"	"Detected in all"		"hippocampal formation: 1942.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 160.1;EFO-21: 39.6;Hep G2: 249.0;U-2 OS: 57.0"	"Group enriched"	"Detected in all"	5	"basal ganglia: 1538.3;hippocampal formation: 4891.0;pons and medulla: 5758.5;thalamus: 3400.4"	"Region enhanced"	"Detected in all"		"medulla oblongata: 1381.8"	"CAB002517, HPA002550, CAB062567, CAB073406"	Supported		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	345000000000	99000000000	"Golgi apparatus"		"CAB002517: AB_563965, CAB062567: AB_2665620, CAB073406: , HPA002550: AB_1080419"	"unprognostic (6.79e-3)"		"unprognostic (3.38e-2)"	"unprognostic (4.10e-1)"	"unprognostic (1.74e-1)"		"unprognostic (1.84e-2)"	"unprognostic (8.15e-2)"	"unprognostic (3.74e-2)"		"unprognostic (9.66e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.23e-2)"	"unprognostic (8.35e-3)"	"unprognostic (5.26e-1)"		"unprognostic (3.52e-2)"	4.2	0.6	128.7	0.5	52.0	9.7	0.4	721.6	513.1	2.0	113301.2	6.1	15.1	1.3	0.9	2.3	0.8	51.7	3.0	1942.6	44.9	18.6	21460.6	0.9	2.4	103.8	810.7	6.3	1.1	1800.0	188.4	6.1	2.7	259.3	1.6	4.5	80.7	1.8	0.4	1.1	15.7	6.8	0.3	9.7	3.9	50.3	2.3	568.1	1.1	1.3	0.0	0.1	2.3	0.6	108.9	1.6	0.4	0.6	0.5	0.8	0.1	1.0	0.8	0.3	0.0	0.0	160.1	0.0	2.9	39.6	0.5	0.6	0.4	0.0	0.3	0.0	5.9	0.8	5.2	1.8	249.0	0.4	11.2	1.0	0.1	0.1	0.1	0.0	0.7	0.0	0.3	2.8	0.4	0.0	0.5	0.4	0.7	0.6	4.5	0.3	0.3	7.4	0.2	0.3	1.6	0.9	1.1	5.8	0.0	0.2	1.7	0.6	0.2	1.7	2.4	57.0	0.5	4.3	1.0	2.6	17.6	0.7	4.3	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.4	0.1	0.0	0.1	0.0	0.0	128.7	52.0	721.6	513.1	1942.6	44.9	103.8	810.7	6.3	259.3	9.7	568.1	108.9	0.0	0.0	0.0	0.0	15.1	0.5	0.0	0.0	0.0	144.8	0.0	0.0	1.8	779.2	0.0	5.5	162.6	0.3	0.0	1.5	5.9	3.1	6.8	0.5	0.5	14.1	356.2	192.5	0.0	2.0	3.6	0.7	13.3	0.0	0.0	0.2	192.4	23659.3	2.4	26.9	0.1	19.6	0.0	313.7	0.0	8.7	0.3	1.2	0.0	0.0	0.0	24.9	0.0	0.0	0.0	130.5	5.2	0.0	0.0	0.2	1.3	26.9	0.0	56.0	0.0	0.0	0.3	3.3	1.1	0.0	0.1	4.0	10.9	0.0	1.7	0.0
UGT2A1		ENSG00000173610	"UDP glucuronosyltransferase family 2 member A1 complex locus"	P0DTE4	4	69588417-69653249	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"choroid plexus: 2.9;kidney: 2.2;liver: 3.7;pituitary gland: 5.6"	"Cell type enriched"	"Detected in some"	18	"Proximal tubular cells: 107.9"	"Cancer enhanced"	"Detected in some"		"liver cancer: 0.7;lung cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA017261, HPA045108"	Uncertain					NA	NA					"HPA017261: AB_10963582, HPA045108: AB_2679218"							"unprognostic (3.93e-3)"	"unprognostic (5.62e-1)"					"unprognostic (1.28e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.76e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.2	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	3.7	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	107.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
WDR74	"FLJ10439, Nsa1"	ENSG00000133316	"WD repeat domain 74"	Q6RFH5	11	62832342-62841809	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"brain: 563.1;choroid plexus: 634.2"	"Cell type enriched"	"Detected in all"	5	"Early spermatids: 616.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037795, HPA038419"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA037795: AB_10671380, HPA038419: AB_2676006"	"unprognostic (5.52e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.35e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.97e-3)"	"unprognostic (6.58e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.46e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.29e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.35e-1)"	21.4	21.9	304.3	20.7	261.2	128.2	21.4	480.5	302.4	18.9	634.2	19.6	17.3	21.0	14.7	26.0	22.5	11.5	19.5	252.0	157.1	17.9	28.7	15.0	30.9	210.7	221.9	145.1	25.8	31.1	15.2	11.5	18.5	335.4	19.7	16.6	33.9	25.2	13.9	59.8	31.4	17.8	17.2	261.5	30.3	22.2	15.5	270.7	62.9	28.7	25.6	24.1	25.1	19.1	563.1	64.2	76.2	28.8	49.4	22.9	31.4	85.9	35.8	37.5	73.6	49.1	108.8	77.0	111.6	97.6	28.5	59.0	84.1	88.8	69.0	56.8	72.7	64.2	55.5	84.1	97.5	65.9	112.3	36.0	30.9	75.7	47.8	153.9	24.8	36.1	80.5	126.1	32.5	33.7	120.6	106.7	178.7	117.1	70.9	96.7	108.9	49.9	193.6	52.7	35.6	65.7	72.1	40.8	84.1	115.4	27.8	58.8	83.1	28.0	44.4	52.4	98.3	88.2	81.0	120.3	137.1	47.5	68.3	57.2	40.1	140.9	11.7	40.2	61.4	49.7	66.0	42.1	38.6	105.0	121.5	56.8	52.0	51.0	93.2	44.9	154.3	52.4	47.8	304.3	261.2	480.5	302.4	252.0	157.1	210.7	221.9	145.1	335.4	261.5	270.7	563.1	36.8	38.5	67.9	1.6	112.5	104.5	47.2	45.7	60.9	15.2	37.6	57.0	2.0	40.0	108.7	16.5	16.7	55.2	57.9	32.0	43.0	42.8	616.0	22.4	34.0	41.7	41.0	26.5	3.6	40.5	53.8	39.1	65.2	32.4	43.6	23.5	20.7	34.0	37.9	3.3	3.0	32.1	20.3	33.1	69.2	97.1	32.9	45.0	30.2	1.0	22.4	15.4	45.3	2.0	2.8	39.8	24.2	21.4	74.3	50.3	44.8	54.0	32.0	11.4	19.7	53.0	89.3	19.4	31.4	50.3	109.3	34.8	66.3	30.4	41.5	39.8
XIRP1	"CMYA1, DKFZp451D042, Xin"	ENSG00000168334	"Xin actin binding repeat containing 1"	Q702N8	3	39183210-39192596	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"heart muscle: 601.1;skeletal muscle: 386.6"	"Cell type enriched"	"Detected in some"	15	"Cardiomyocytes: 850.5"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 4.4;LHCN-M2: 1.1;RH-30: 3.0"	"Not detected"	"Not detected"							"HPA016750, HPA018458, CAB026391"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Actin filaments"		NA	NA			"Plasma membrane, Actin filaments"	Nucleoplasm	"CAB026391: , HPA016750: AB_1858884, HPA018458: AB_1858885"	"unprognostic (2.19e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.75e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.43e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.66e-3)"	"unprognostic (1.66e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.30e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.02e-5)"	"unprognostic (2.08e-2)"	"unprognostic (2.78e-2)"	"unprognostic (6.86e-4)"	"unprognostic (4.12e-2)"	1.1	0.3	0.3	1.2	0.0	0.0	0.2	1.6	0.7	0.0	0.0	0.7	0.0	0.2	0.0	5.6	0.0	1.0	601.1	1.1	0.2	0.1	0.1	1.7	0.0	0.6	0.2	0.0	0.1	1.2	0.0	0.5	0.7	0.3	3.4	0.0	0.0	5.1	0.0	386.6	0.4	0.5	0.4	0.3	0.6	0.3	0.0	0.2	0.5	0.2	97.3	0.0	3.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.6	0.7	1.1	0.2	0.6	0.2	0.0	0.3	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	850.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.2	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.4	3.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0
ZMYND15	DKFZp434N127	ENSG00000141497	"Zinc finger MYND-type containing 15"	Q9H091	17	4739833-4746119	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 28.5"	"Cell type enriched"	"Detected in many"	6	"Early spermatids: 191.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 2.1;CAPAN-2: 1.9;HaCaT: 1.6;T-47d: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA023286			Uncertain	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA023286: AB_1859076"	"unprognostic (2.30e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.61e-2)"	"unprognostic (7.49e-3)"	"unprognostic (3.62e-2)"	"unprognostic (7.86e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.49e-1)"	"unprognostic (6.72e-3)"	"unprognostic (4.02e-1)"	"unprognostic (5.47e-2)"	"unprognostic (4.62e-2)"	"unprognostic (9.24e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.07e-1)"	1.8	1.4	1.7	2.4	1.6	1.0	1.7	1.8	2.5	0.9	1.8	0.8	4.0	0.6	0.5	0.9	1.1	2.9	0.6	1.7	2.1	2.0	3.1	4.7	1.7	2.1	1.9	1.2	0.7	1.2	5.5	1.4	1.2	2.6	1.7	0.7	0.3	3.1	0.9	0.4	1.4	3.1	0.7	2.4	5.5	1.9	28.5	2.0	0.8	1.1	0.1	0.4	1.8	0.7	2.6	2.1	0.3	0.0	0.9	0.0	0.1	0.1	0.0	0.5	0.5	1.1	0.9	1.9	0.0	0.0	0.0	0.2	1.6	0.4	0.1	0.0	0.2	0.7	0.0	0.2	0.5	0.3	0.0	0.6	0.1	0.2	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.7	0.2	0.2	0.0	0.0	0.6	0.6	0.9	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.7	1.6	1.8	2.5	1.7	2.1	2.1	1.9	1.2	2.6	2.4	2.0	2.6	0.8	0.0	2.0	1.3	0.6	0.9	8.0	1.8	0.6	0.3	4.4	3.7	0.7	2.8	3.1	1.8	0.0	0.1	0.2	3.3	0.0	1.6	191.4	2.8	0.3	1.4	1.2	0.0	0.0	3.9	0.0	0.7	4.6	2.7	0.0	0.3	3.9	0.6	5.2	0.0	0.1	2.9	0.0	11.9	7.3	30.9	0.6	12.9	1.8	1.9	21.9	2.0	0.0	1.0	0.5	3.5	1.4	2.2	0.1	6.7	3.8	0.8	3.7	0.3	0.0	0.2	1.0	24.3	2.0	0.5	0.9	0.0	0.2	0.3	1.3	8.5
AGMAT	FLJ23384	ENSG00000116771	Agmatinase	Q9BSE5	1	15571699-15585051	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Putrescine biosynthesis, Spermidine biosynthesis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 135.1;liver: 62.6;skeletal muscle: 34.5"	"Cell type enriched"	"Detected in many"	7	"Proximal tubular cells: 306.8"	"Group enriched"	"Detected in all"	5	"colorectal cancer: 18.5;liver cancer: 25.3;renal cancer: 11.2;stomach cancer: 11.1"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 4.1;T-cells: 8.4"	"Cell line enhanced"	"Detected in many"		"CACO-2: 36.7;Hep G2: 92.6;RPMI-8226: 22.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA026443, HPA028321"	Enhanced					NA	NA		240000			"HPA026443: AB_1844644, HPA028321: AB_10600779"	"unprognostic (2.27e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.79e-3)"	"unprognostic (3.60e-2)"	"unprognostic (8.72e-2)"	"unprognostic (6.66e-3)"	"unprognostic (9.48e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.35e-1)"	"prognostic favorable (5.13e-4)"	"unprognostic (4.43e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.45e-2)"	0.4	1.1	1.3	3.2	1.2	1.0	0.3	1.4	1.5	0.5	0.9	9.3	18.0	0.5	0.3	0.5	0.3	0.5	0.1	1.0	0.9	135.1	62.6	0.2	4.0	0.8	0.7	1.5	0.1	0.6	2.2	0.3	0.2	1.1	0.5	6.9	0.4	4.6	0.1	34.5	0.4	13.5	0.7	0.4	1.6	1.8	0.8	0.8	2.2	0.5	6.2	4.2	0.8	0.1	1.5	7.7	6.3	0.5	0.3	0.1	0.8	0.2	1.3	1.4	0.8	0.5	36.7	5.1	0.1	0.2	0.9	0.2	0.2	0.0	0.0	0.9	7.6	0.1	5.2	5.1	92.6	0.9	4.0	0.2	0.9	0.4	2.4	0.0	0.6	0.7	0.1	0.1	10.3	1.9	8.6	0.2	4.0	8.1	6.5	3.7	0.1	0.0	22.3	0.2	2.2	1.5	1.1	10.9	0.4	1.3	0.4	1.5	8.2	1.1	0.3	0.3	2.1	0.1	0.3	6.1	5.0	0.4	0.1	0.2	1.2	0.3	0.2	2.1	0.3	2.6	4.1	4.5	2.4	0.2	2.7	8.4	5.0	1.4	0.5	0.2	0.4	6.4	2.0	1.3	1.2	1.4	1.5	1.0	0.9	0.8	0.7	1.5	1.1	0.4	0.8	1.5	0.2	0.0	0.0	1.0	5.9	0.3	1.7	0.5	0.0	1.3	0.5	0.9	0.6	2.8	0.3	3.7	0.0	0.9	0.5	7.4	31.3	1.1	9.4	1.2	1.1	0.6	1.2	2.1	1.9	0.9	0.8	0.7	5.1	2.1	0.0	1.4	1.8	42.5	1.1	3.3	2.2	9.6	2.0	2.9	0.8	4.2	0.3	2.0	1.8	3.7	1.9	1.0	5.2	0.5	0.4	2.3	6.0	0.0	2.0	1.7	27.0	306.8	1.4	2.4	0.0	4.7	0.5	1.6	3.5	1.2	0.6	0.8	5.0	3.4	18.9	3.0
ANKLE1	"ANKRD41, FLJ39369, LEMD6"	ENSG00000160117	"Ankyrin repeat and LEM domain containing 1"	Q8NAG6	19	17281645-17287646	"Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 25.8;brain: 9.2"	"Cell type enriched"	"Detected in some"	10	"Erythroid cells: 70.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 77.2;HL-60: 34.6;NB-4: 41.7;U-937: 57.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA026789, HPA073498"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA026789: AB_10611675, HPA073498: AB_2686612"	"unprognostic (5.66e-2)"	"unprognostic (2.21e-1)"	"unprognostic (6.90e-2)"	"prognostic unfavorable (4.86e-5)"	"unprognostic (2.73e-1)"	"unprognostic (1.72e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.28e-1)"	"unprognostic (7.89e-4)"	"unprognostic (5.86e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.03e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.00e-3)"	"unprognostic (4.30e-2)"	0.7	0.9	5.0	2.3	3.2	25.8	0.6	9.2	6.2	0.6	0.6	0.5	0.9	1.0	1.3	0.7	0.6	0.7	1.0	3.7	1.7	0.4	0.6	0.8	4.1	2.4	1.4	3.9	1.5	1.7	0.4	0.5	1.2	4.1	0.7	0.5	3.7	1.5	0.6	0.3	2.4	0.8	0.8	0.4	2.2	0.8	1.5	2.4	1.3	0.9	0.5	3.1	0.7	0.5	4.3	0.9	0.8	3.7	1.7	0.4	0.6	3.2	1.1	0.3	0.6	0.6	17.1	1.5	77.2	0.7	0.5	0.6	1.5	28.4	0.4	0.6	22.3	3.4	29.1	13.1	0.6	0.3	34.6	12.5	0.3	1.0	2.7	0.2	0.9	0.6	6.4	4.2	9.2	0.4	0.9	24.2	41.7	10.2	0.3	2.6	17.3	1.0	8.7	0.4	1.7	1.2	7.1	6.8	0.9	0.7	1.5	0.6	20.1	1.4	1.0	1.2	1.4	1.0	1.3	0.9	27.8	0.7	57.2	1.3	0.9	0.9	0.6	0.5	1.9	0.3	1.6	0.4	0.5	1.1	0.9	0.5	0.4	1.5	0.3	1.4	0.9	0.4	0.6	5.0	3.2	9.2	6.2	3.7	1.7	2.4	1.4	3.9	4.1	0.4	2.4	4.3	0.4	0.0	0.5	0.7	1.1	0.8	0.8	0.3	0.0	1.9	0.5	0.6	0.8	0.0	0.1	0.0	0.0	1.6	0.4	0.4	0.0	0.2	0.3	0.2	0.4	0.4	0.0	70.7	1.4	0.2	0.7	0.6	0.0	0.8	1.3	1.1	0.0	0.1	0.8	0.0	1.6	0.5	0.0	0.9	1.3	0.0	1.8	1.1	0.0	1.0	3.0	0.5	1.0	1.0	1.6	0.3	0.1	1.5	0.9	0.5	0.0	0.1	0.9	1.5	6.6	0.6	0.4	0.5	1.0	0.0	0.4	0.4	0.5	0.3	0.3	0.2
APOBEC3A	"ARP3, PHRBN"	ENSG00000128383	"Apolipoprotein B mRNA editing enzyme catalytic subunit 3A"	P31941	22	38952741-38992778	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 94.8;lymphoid tissue: 48.7;urinary bladder: 24.6"	"Cell type enriched"	"Detected in many"	4	"Urothelial cells: 426.0"	"Group enriched"	"Detected in many"	4	"cervical cancer: 11.3;head and neck cancer: 15.8"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 1014.5"	"Lineage enriched"	"Detected in many"	8	"monocytes: 1014.5"	"Not detected"	"Not detected"											"HPA043237, HPA056980, HPA066719"	Approved		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043237: AB_10795980, HPA056980: AB_2683298, HPA066719: AB_2685711"	"unprognostic (6.45e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.52e-1)"	"unprognostic (2.59e-3)"	"unprognostic (9.01e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.91e-1)"	7.9	0.4	0.5	21.1	0.5	94.8	0.8	0.6	1.0	1.2	1.0	1.5	1.4	0.4	0.3	12.3	4.3	6.4	1.3	0.8	0.4	0.7	2.0	13.5	1.1	0.6	0.5	0.4	0.2	1.6	0.4	0.3	3.6	0.5	0.4	0.6	0.2	6.8	0.3	0.5	0.6	0.9	1.7	0.3	48.7	1.1	0.2	0.4	2.4	1.0	3.7	21.3	24.6	10.4	1.0	0.1	0.0	0.1	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.5	0.1	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.3	0.6	0.3	34.7	223.9	8.4	0.7	1014.5	1.5	3.1	0.6	0.7	10.4	0.8	0.7	0.7	121.7	0.9	298.5	1.3	1.0	149.1	0.5	0.5	0.6	1.0	0.8	0.4	0.6	0.5	0.4	0.5	0.3	0.4	1.0	0.7	28.9	33.6	0.0	0.5	1.3	16.0	1.8	0.0	0.6	0.7	0.3	0.1	0.0	24.1	1.8	4.2	0.3	0.2	17.5	0.0	0.1	0.6	0.5	0.2	1.4	0.0	8.0	0.0	0.2	0.3	6.3	0.0	0.6	25.9	0.3	0.7	0.4	14.9	0.0	0.0	0.0	2.0	18.8	41.4	0.1	0.3	91.3	16.0	0.0	17.9	0.8	2.1	0.0	0.0	1.3	27.4	0.4	15.6	6.7	4.5	0.2	10.7	0.8	0.0	1.0	1.2	0.1	0.4	48.7	6.8	0.3	3.1	0.2	1.7	426.0
ARG1		ENSG00000118520	"Arginase 1"	P05089	6	131470832-131584332	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Adaptive immunity, Arginine metabolism, Immunity, Innate immunity, Urea cycle"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 1213.5"	"Cell type enriched"	"Detected in some"	22	"Hepatocytes: 991.4"	"Cancer enriched"	"Detected in some"	45	"liver cancer: 167.7"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in some"	5	"neutrophil: 44.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 44.9"	"Cell line enhanced"	"Detected in single"		"HL-60: 1.4"	"Region enhanced"	"Detected in single"		"cerebellum: 2.4"	"Low region specificity"	"Detected in all"			"HPA003595, CAB009434, HPA024006, CAB056159, CAB080011"	Enhanced					NA	NA		9500000			"CAB009434: AB_2058955, CAB056159: AB_2665582, CAB080011: , HPA003595: AB_1078190, HPA024006: AB_1844987"	"unprognostic (2.00e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.95e-2)"	"unprognostic (7.96e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.56e-2)"	"unprognostic (7.55e-3)"	"unprognostic (8.35e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.79e-2)"	2.2	0.2	0.2	0.3	0.1	294.9	4.9	1.0	0.4	0.2	0.3	0.2	0.0	0.1	0.0	2.2	1.9	0.0	0.8	0.2	0.2	0.3	1213.5	6.6	0.3	0.5	0.2	0.1	0.2	0.4	0.0	0.2	1.7	0.6	0.3	0.0	0.3	0.9	0.0	0.5	74.8	0.3	0.2	0.0	20.8	0.4	0.1	0.1	1.3	0.5	0.6	0.7	0.2	2.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.0	1.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	1.0	0.1	0.0	0.2	0.7	0.3	44.9	0.0	0.9	0.2	9.3	0.4	0.2	0.1	1.0	0.4	0.2	0.2	0.5	0.2	0.1	0.6	0.0	0.1	0.3	0.0	0.0	0.0	0.3	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	17.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.1	0.1	1.5	0.0	43.6	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	23.2	991.4	0.0	0.0	0.1	0.1	0.0	27.6	0.0	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1
ASB10	GLC1F	ENSG00000146926	"Ankyrin repeat and SOCS box containing 10"	Q8WXI3	7	151175698-151187832	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease variant, Glaucoma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"skeletal muscle: 78.6"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 12.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA079685	Enhanced					NA	NA					"HPA079685: "						"unprognostic (6.72e-3)"				"unprognostic (1.96e-1)"								0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.0	0.0	78.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ATP6V0D2	"ATP6D2, FLJ38708, VMA6"	ENSG00000147614	"ATPase H+ transporting V0 subunit d2"	Q8N8Y2	8	85987323-86154225	"Metabolic proteins, Predicted intracellular proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"kidney: 61.0"	"Cell type enriched"	"Detected in some"	6	"Distal tubular cells: 209.4"	"Cancer enriched"	"Detected in many"	9	"renal cancer: 36.7"	"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 3.3;SuSa: 5.8;U-87 MG: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA055327, HPA058496"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA055327: AB_2682784, HPA058496: "	"unprognostic (3.79e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.50e-2)"	"unprognostic (8.43e-3)"	"unprognostic (5.36e-5)"	"unprognostic (4.02e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.75e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.61e-1)"	"prognostic favorable (2.20e-6)"	"unprognostic (8.58e-2)"	"unprognostic (1.77e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.97e-2)"	0.1	0.0	0.5	0.7	1.0	1.9	0.8	0.2	0.6	0.4	0.2	3.1	1.6	0.3	1.4	0.7	0.1	0.5	0.4	0.5	0.5	61.0	0.4	2.6	1.3	0.4	0.8	0.3	0.0	0.4	1.3	0.0	0.8	0.5	1.4	3.6	14.1	1.1	2.5	0.0	1.8	1.3	0.4	0.2	1.1	0.3	0.2	0.8	0.5	1.0	0.0	1.1	0.5	0.0	1.2	0.4	0.6	0.3	0.4	0.0	0.3	1.3	0.0	0.0	0.6	0.1	0.0	0.2	0.1	0.1	0.0	1.4	1.2	0.4	0.9	0.2	0.2	0.0	0.5	0.7	0.1	0.0	0.4	0.6	0.3	0.0	0.2	0.4	1.1	0.0	0.1	0.2	0.3	0.3	0.0	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.6	2.0	0.1	0.0	0.4	3.3	5.8	0.9	0.0	0.2	0.3	0.4	0.2	0.3	0.2	0.1	0.3	5.1	0.3	0.4	0.7	0.2	0.1	0.2	0.1	0.1	0.2	0.2	0.1	0.1	0.4	0.2	0.2	1.0	0.5	0.2	0.4	0.2	0.1	0.5	1.0	0.2	0.6	0.5	0.5	0.4	0.8	0.3	0.5	0.2	0.8	1.2	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.1	0.0	0.4	0.1	0.0	0.4	0.0	0.1	7.3	31.3	0.0	0.0	0.0	209.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.0	0.0	0.2	0.0	30.5	0.0	1.1	0.0	0.0	6.9	0.0	0.0	0.0	1.5	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.3	0.0	1.0	0.0	11.4	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.2
AWAT2	"DGAT2L4, MFAT"	ENSG00000147160	"Acyl-CoA wax alcohol acyltransferase 2"	Q6E213	X	70040542-70049938	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"skin 1: 7.1"	"Cell type enriched"	"Detected in some"	6	"Spermatocytes: 8.3"	"Cancer enriched"	"Detected in single"	7	"testis cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA062748	Approved					NA	NA					"HPA062748: AB_2684862"	"unprognostic (3.41e-2)"			"unprognostic (1.06e-1)"	"unprognostic (2.99e-2)"			"unprognostic (4.11e-2)"		"unprognostic (1.11e-1)"					"unprognostic (8.60e-2)"	"unprognostic (4.55e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	8.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1
BEST2	"FLJ20132, VMD2L1"	ENSG00000039987	"Bestrophin 2"	Q8NFU1	19	12751702-12758458	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 26.0;skin 1: 17.0"	"Cell type enriched"	"Detected in some"	36	"Intestinal goblet cells: 136.4"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 1.1"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 1.7"	HPA046229	Approved					NA	NA					"HPA046229: AB_10966140"	"unprognostic (3.19e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.74e-2)"	"unprognostic (4.02e-3)"		"unprognostic (2.77e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.46e-3)"	"unprognostic (9.18e-6)"	"unprognostic (3.45e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.64e-5)"	0.2	0.2	0.7	0.7	0.7	2.3	0.5	2.6	0.8	0.2	0.4	26.0	0.1	0.5	0.7	0.2	0.3	0.6	0.4	0.6	1.4	0.2	0.3	0.4	0.5	0.9	0.7	0.4	0.5	0.3	0.3	0.0	0.4	1.3	0.3	14.1	1.5	1.0	0.3	0.3	17.0	15.6	0.7	0.6	0.5	0.3	0.4	0.7	0.2	0.6	0.1	4.9	0.2	1.4	1.6	0.3	0.2	0.7	1.3	0.0	0.0	0.6	0.3	0.0	0.2	0.1	0.8	1.3	1.1	0.3	0.0	0.2	0.7	0.0	0.2	0.2	1.3	0.6	0.9	1.2	0.3	0.1	0.4	1.9	0.1	0.1	0.1	0.1	0.4	0.1	0.2	0.2	0.5	0.2	1.1	0.3	0.6	1.0	0.1	0.7	0.1	0.4	0.2	0.3	0.3	0.7	0.7	0.5	0.0	0.1	0.8	0.6	0.1	1.0	0.3	0.3	0.6	0.7	0.3	0.5	0.3	0.5	1.0	0.7	0.5	0.1	0.1	0.3	0.1	0.2	0.5	0.2	0.1	0.0	0.7	0.5	0.4	0.4	0.4	0.1	0.6	0.1	0.2	0.7	0.7	2.6	0.8	0.6	1.4	0.9	0.7	0.4	1.3	0.6	0.7	1.6	0.1	0.0	0.0	0.3	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.1	0.0	0.0	0.2	0.1	3.7	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	136.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.5	0.0	0.1	0.3	0.1	0.0	1.8	0.1
BHLHE23	"bA305P22.3, Beta4, BHLHB4"	ENSG00000125533	"Basic helix-loop-helix family member e23"	Q8NDY6	20	63005927-63007035	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	4	"brain: 1.0"	"Cell type enriched"	"Detected in single"	32	"Cardiomyocytes: 3.3"	"Cancer enriched"	"Detected in single"	11	"testis cancer: 0.5"	"Region enriched"	"Detected in single"	5	"medulla oblongata: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	21	"MOLT-4: 13.9"	"Not detected"	"Not detected"							HPA030575	Uncertain					NA	NA					"HPA030575: AB_10601459"															"unprognostic (1.74e-1)"			0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	13.9	0.5	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	1.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C10orf71	FLJ45913	ENSG00000177354	"Chromosome 10 open reading frame 71"	Q711Q0	10	49299170-49327492	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"skeletal muscle: 282.8;tongue: 82.7"	"Cell type enriched"	"Detected in some"	15	"Cardiomyocytes: 56.0"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	22	"K-562: 6.9;RH-30: 9.9"	"Not detected"	"Not detected"							HPA057556			Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA057556: AB_2683467"				"unprognostic (1.25e-2)"		"unprognostic (3.97e-2)"		"unprognostic (4.16e-2)"		"unprognostic (5.58e-2)"		"unprognostic (1.66e-1)"		"unprognostic (1.17e-1)"	"unprognostic (1.81e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	44.8	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	22.1	0.0	0.0	0.1	1.3	0.0	0.0	1.2	0.0	282.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	82.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
C6orf15	STG	ENSG00000204542	"Chromosome 6 open reading frame 15"	Q6UXA7	6	31111223-31112575	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"cervix: 5.6;lymphoid tissue: 3.5;skin 1: 5.8"	"Cell type enriched"	"Detected in some"	14	"Breast glandular cells: 73.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"RH-30: 13.4;U-2 OS: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA001436	Uncertain				"Secreted to extracellular matrix"	NA	NA					"HPA001436: AB_2243752"	"unprognostic (2.73e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.56e-1)"		"unprognostic (1.77e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.71e-2)"			"unprognostic (1.72e-1)"		"unprognostic (1.90e-1)"	"unprognostic (1.34e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	3.5	0.0	0.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	73.3	2.8	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	2.3	0.0	1.3	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
CACNA1G	"Cav3.1, NBR13"	ENSG00000006283	"Calcium voltage-gated channel subunit alpha1 G"	O43497	17	50560715-50627474	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease variant, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 38.3"	"Cell type enriched"	"Detected in some"	7	"Bipolar cells: 176.7"	"Cancer enhanced"	"Detected in some"		"glioma: 1.6;testis cancer: 1.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 9.2;GAMG: 3.2;HeLa: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004714	Uncertain					NA	NA					"HPA004714: AB_1078368"	"unprognostic (1.90e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.00e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.02e-4)"	"unprognostic (1.47e-2)"	"unprognostic (2.16e-2)"	"unprognostic (9.76e-2)"	"unprognostic (4.87e-12)"	"unprognostic (3.34e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.56e-3)"	"unprognostic (6.63e-2)"	0.8	0.2	7.2	0.2	5.6	0.3	1.0	18.9	8.9	9.3	0.0	0.3	0.2	2.9	0.1	0.4	3.5	0.2	1.9	2.8	8.2	0.0	0.0	0.3	0.3	4.4	19.3	2.7	5.4	0.1	0.0	0.2	0.4	6.2	1.1	0.1	8.9	0.3	0.4	0.1	1.4	0.1	0.7	6.1	0.1	0.2	0.6	38.3	0.1	0.3	0.1	0.2	0.1	3.8	6.6	0.0	9.2	2.1	2.4	0.6	0.1	0.1	0.1	0.0	0.0	0.1	1.8	0.2	0.0	0.6	0.1	3.2	0.3	1.1	0.0	0.2	1.1	0.4	0.6	3.2	0.3	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.7	0.5	0.4	1.0	0.8	0.0	0.0	0.1	2.7	1.1	1.8	0.1	0.0	1.5	0.0	0.1	0.2	0.8	2.5	0.3	0.1	0.6	0.0	0.0	0.4	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.2	5.6	18.9	8.9	2.8	8.2	4.4	19.3	2.7	6.2	6.1	38.3	6.6	0.2	0.0	0.0	0.3	0.0	1.9	0.2	0.0	0.6	176.7	0.3	0.5	4.5	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	1.6	0.6	11.2	0.6	0.0	0.0	16.0	0.0	0.6	4.5	0.0	0.6	0.0	0.1	0.0	0.0	0.4	5.0	21.5	0.0	0.0	0.0	5.7	0.2	0.0	0.9	3.6	1.0	0.0	2.3	0.0	22.6	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	5.9	0.0	0.3	3.7	0.7	0.9	0.8	2.8	0.1	0.3	0.0	0.1	0.1
CALCA	"CALC1, CGRP, CGRP-alpha"	ENSG00000110680	"Calcitonin related polypeptide alpha"	"P01258, P06881"	11	14966668-14972351	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins, Transporters"		Hormone	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"parathyroid gland: 179.4;thyroid gland: 155.5"	"Cell type enriched"	"Detected in some"	64	"Ionocytes: 2368.1"	"Cancer enriched"	"Detected in many"	7	"lung cancer: 64.7"	"Group enriched"	"Detected in many"	4	"hypothalamus: 11.7;medulla oblongata: 14.7;pons: 34.8;white matter: 11.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	5	"pons and medulla: 57.9"					"HPA059886, HPA064453"	Enhanced	Supported			"Secreted to blood"	NA	NA	51500				"HPA059886: , HPA064453: "			"unprognostic (1.97e-1)"	"prognostic unfavorable (4.49e-5)"	"unprognostic (5.99e-2)"		"unprognostic (2.42e-1)"	"unprognostic (1.17e-1)"		"unprognostic (6.45e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.33e-2)"	"unprognostic (7.49e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.53e-3)"	"unprognostic (1.02e-2)"	0.7	0.2	0.6	1.6	0.6	0.0	0.2	0.6	3.9	0.2	0.1	0.4	0.0	0.2	0.0	0.1	0.3	0.2	0.9	0.3	11.7	7.2	37.8	2.4	0.1	14.7	4.5	0.1	0.1	0.4	179.4	0.8	0.0	34.8	2.5	0.1	0.0	0.1	0.0	0.5	0.0	0.1	1.5	1.9	3.0	0.2	0.2	0.5	0.3	155.5	0.0	0.0	4.4	0.4	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.6	3.9	0.3	11.7	14.7	4.5	0.1	34.8	1.9	0.5	11.6	0.1	0.0	0.0	0.0	0.2	0.3	0.4	35.4	0.0	0.0	0.0	0.1	0.4	0.0	0.3	36.8	0.0	0.0	0.0	0.0	5.9	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	1.9	0.0	0.6	0.0	0.3	0.0	0.0	0.7	4.4	0.3	0.0	0.0	0.0	2368.1	0.0	4.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.2	0.0	0.0	0.4	5.5	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.4
CCL22	"A-152E5.1, ABCD-1, DC/B-CK, MDC, MGC34554, SCYA22, STCP-1"	ENSG00000102962	"C-C motif chemokine ligand 22"	O00626	16	57358783-57366189	"Predicted secreted proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 5.2;lymphoid tissue: 15.0;skin 1: 6.6;urinary bladder: 4.5"	"Cell type enriched"	"Detected in some"	27	"monocytes: 5366.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	18	"HDLM-2: 49.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	617000					"unprognostic (2.67e-2)"	"unprognostic (7.68e-3)"	"prognostic favorable (2.98e-4)"	"prognostic favorable (2.23e-6)"	"unprognostic (8.87e-2)"	"prognostic favorable (9.17e-5)"	"unprognostic (1.20e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.15e-2)"	"unprognostic (7.71e-2)"	"unprognostic (3.43e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.88e-2)"	0.5	0.3	0.2	13.6	0.2	0.6	1.4	0.6	0.3	0.7	0.4	1.6	1.2	0.3	0.1	1.8	0.3	1.8	0.1	0.2	0.1	0.2	0.7	1.8	5.9	0.2	0.1	0.1	0.2	0.3	0.1	0.0	0.1	0.3	0.4	5.2	0.2	0.7	0.4	0.4	6.6	3.1	0.9	0.0	2.0	1.5	0.4	0.2	15.0	0.3	0.3	14.6	4.5	0.6	0.7	0.5	0.2	0.2	0.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.5	0.7	0.3	0.1	0.1	0.0	1.2	0.1	0.1	0.1	49.6	0.1	0.2	0.3	0.5	0.0	0.2	1.4	0.1	0.0	0.1	0.0	0.1	0.1	0.2	0.3	0.3	0.0	0.1	0.2	0.4	0.4	0.2	0.0	0.1	0.2	1.8	0.0	2.7	0.3	0.2	0.2	2.1	0.0	0.2	0.2	2.4	0.4	0.2	0.2	0.1	0.2	0.2	0.1	0.4	0.0	0.2	0.1	1.6	0.2	0.2	0.2	0.1	0.1	1.0	0.1	0.1	0.9	0.4	0.1	0.2	1.2	0.4	0.1	0.3	0.1	0.1	0.2	0.2	0.6	0.3	0.2	0.1	0.2	0.1	0.1	0.3	0.0	0.2	0.7	0.1	3.2	1.1	0.0	4.2	6.6	0.3	0.6	0.0	0.0	1.3	0.6	0.4	0.0	1.2	0.0	0.0	0.0	0.1	0.1	1.9	5.9	0.0	0.3	0.1	0.8	0.0	0.0	0.0	21.1	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	3.7	0.0	0.1	0.0	0.0	0.0	194.6	0.0	0.0	10.4	3.6	0.0	5366.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.2	0.0	0.1	0.8	0.0	0.0	0.1	3.9	0.0	0.0	0.0	8.0	0.1	1.2	0.0	0.1	0.4
CCN6	"WISP-3, WISP3"	ENSG00000112761	"Cellular communication network factor 6"	O95389	6	112054075-112069686	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"epididymis: 10.3"	"Cell type enriched"	"Detected in single"	7	"Cardiomyocytes: 2.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	49	"RT4: 12.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA064196			Supported	Mitochondria	"Secreted to extracellular matrix"	NA	NA			Mitochondria		"HPA064196: AB_2685209"	"unprognostic (2.13e-2)"	"unprognostic (7.90e-3)"	"unprognostic (5.00e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.76e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.98e-3)"	"unprognostic (4.07e-3)"	"unprognostic (1.82e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.02e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.11e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.93e-2)"	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	10.3	0.0	2.3	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.2	0.2	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
CD79B	"B29, IGB"	ENSG00000007312	"CD79b molecule"	P40259	17	63928740-63932336	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins"	"Adaptive immunity, Immunity"		"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 268.9"	"Cell type enriched"	"Detected in many"	4	"B-cells: 491.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in all"	4	"memory B-cell: 1132.1;naive B-cell: 1505.8"	"Lineage enriched"	"Detected in all"	5	"B-cells: 1505.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 1060.0;REH: 350.2;U-698: 1475.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA009178, CAB009751, HPA044107"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nucleoplasm, Cytosol"	"CAB009751: AB_2275844, HPA009178: AB_1078483, HPA044107: "	"unprognostic (3.90e-3)"	"unprognostic (1.61e-3)"	"unprognostic (5.21e-2)"	"unprognostic (3.45e-3)"	"unprognostic (4.22e-3)"	"prognostic favorable (2.35e-4)"	"unprognostic (1.82e-1)"	"unprognostic (9.25e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.28e-2)"	"unprognostic (2.75e-1)"	4.9	1.7	0.9	71.1	0.9	55.0	3.4	0.9	1.4	1.9	1.7	7.8	4.7	1.5	1.6	2.6	1.6	6.8	7.5	0.8	0.9	4.7	3.5	5.0	268.9	1.0	0.9	0.8	0.6	0.7	0.7	25.5	3.8	1.5	2.5	7.3	0.0	7.9	0.8	3.5	1.9	66.7	2.6	0.9	148.9	10.8	1.0	0.9	27.4	4.1	5.8	210.1	13.5	2.2	1.0	1.8	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.4	0.0	0.0	1060.0	7.8	0.0	0.4	0.3	0.0	0.0	0.0	0.5	0.0	2.7	0.0	0.4	0.6	0.6	0.5	0.0	0.0	0.1	0.0	0.0	1.2	0.4	1.2	56.9	0.0	0.0	0.6	23.0	0.3	0.0	0.0	350.2	0.9	4.4	0.0	0.0	0.5	0.0	1.7	0.0	0.7	5.8	0.0	16.2	1.7	0.1	3.7	0.3	0.6	51.3	54.4	1475.5	0.0	2.2	0.0	6.2	13.0	1.1	44.9	192.2	51.3	1132.1	57.1	30.1	47.0	1505.8	38.4	23.2	5.8	42.4	304.3	6.7	107.9	112.1	0.9	0.9	0.9	1.4	0.8	0.9	1.0	0.9	0.8	1.5	0.9	0.9	1.0	24.9	0.0	1.3	0.0	491.9	4.5	0.4	0.0	1.8	0.0	1.1	4.4	1.4	1.5	0.0	0.0	0.0	0.2	24.2	0.3	0.0	0.1	0.6	0.3	1.0	25.2	1.2	8.6	0.0	0.0	0.4	3.3	0.5	0.3	15.2	0.0	51.4	1.3	5.8	0.0	0.0	0.4	0.0	14.8	5.1	1.4	1.2	13.4	21.4	0.0	14.3	0.0	36.0	0.0	0.0	0.0	0.1	1.9	99.6	0.4	0.0	1.0	0.0	0.0	0.0	4.4	5.4	1.2	0.3	0.7	3.1	0.4	27.0	0.5	0.8	0.2
CEACAM20	UNQ9366	ENSG00000273777	"CEA cell adhesion molecule 20"	Q6UY09	19	44501677-44529788	"Predicted membrane proteins"	Immunity			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"intestine: 38.0"	"Cell type enriched"	"Detected in single"	97	"Proximal enterocytes: 39.0"	"Cancer enriched"	"Detected in some"	4	"prostate cancer: 5.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"U-266/70: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.04e-2)"	"unprognostic (5.03e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.92e-1)"			"unprognostic (1.23e-2)"	"unprognostic (3.75e-1)"		"unprognostic (9.89e-2)"	"unprognostic (1.07e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.14e-5)"	"unprognostic (7.13e-2)"	"unprognostic (2.51e-2)"		"unprognostic (1.44e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.5	0.1	0.1	0.0	0.0	0.0	0.0	38.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	39.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0
CFL2	NEM7	ENSG00000165410	"Cofilin 2"	Q9Y281	14	34709113-34714823	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease variant, Nemaline myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"heart muscle: 376.3;skeletal muscle: 726.7;tongue: 692.4"	"Cell type enriched"	"Detected in many"	4	"Cardiomyocytes: 522.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037078, HPA045599"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		47000000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB037078: AB_259128, HPA045599: AB_2679383"	"unprognostic (1.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.80e-3)"	"unprognostic (3.82e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.65e-2)"	"unprognostic (3.13e-3)"	"unprognostic (9.59e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (2.16e-5)"	49.1	52.9	78.4	28.9	103.7	18.3	24.8	95.5	111.6	40.1	64.8	68.3	14.4	74.0	19.6	69.7	42.9	24.4	376.3	78.3	93.6	31.7	126.9	25.1	10.7	98.2	94.0	65.3	41.5	9.5	24.6	11.0	35.6	98.1	76.1	28.4	41.4	17.2	108.4	726.7	7.2	24.2	116.0	86.5	12.8	36.4	21.9	89.7	10.5	29.7	692.4	10.0	57.3	24.5	138.8	87.1	77.7	49.5	32.0	51.1	185.6	27.9	146.6	170.5	145.6	151.4	61.9	38.5	30.6	58.5	245.2	104.9	17.1	107.4	32.5	268.6	4.2	45.0	6.6	87.4	144.5	81.6	8.2	5.3	139.3	12.4	122.2	67.7	96.8	145.9	4.5	9.9	26.8	186.9	25.5	6.3	4.3	16.3	15.4	118.9	5.4	158.1	4.7	55.1	17.7	10.3	41.7	96.6	21.5	51.2	36.2	47.8	7.5	124.6	140.9	93.0	66.1	72.9	34.3	22.8	11.7	51.7	11.4	34.5	1.8	1.0	1.3	1.9	1.0	3.1	4.9	2.2	2.1	1.6	3.0	1.7	1.8	0.3	1.8	0.4	1.6	2.1	0.9	78.4	103.7	95.5	111.6	78.3	93.6	98.2	94.0	65.3	98.1	86.5	89.7	138.8	39.6	105.8	41.6	6.2	17.0	20.0	88.6	31.3	23.9	62.8	19.6	16.6	522.2	22.8	26.3	22.0	20.9	32.2	11.5	0.9	60.7	45.2	2.6	40.3	60.5	45.1	9.5	11.4	9.6	39.7	60.5	69.9	6.1	56.2	5.7	25.8	47.2	112.0	15.6	77.4	14.2	2.4	57.0	15.7	14.4	10.1	57.2	10.6	30.2	11.2	5.7	112.9	15.5	8.0	93.8	24.7	4.0	98.6	60.4	84.0	1.0	101.9	24.7	57.8	32.9	83.9	115.8	49.3	51.9	16.1	19.5	21.3	21.1	47.9	4.6	58.5
CGB3	CGB	ENSG00000104827	"Chorionic gonadotropin subunit beta 3"	P0DN86	19	49022869-49024333	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"placenta: 9.9"	"Cell type enriched"	"Detected in some"	7	"Syncytiotrophoblasts: 865.9"	"Group enriched"	"Detected in some"	5	"pancreatic cancer: 2.9;testis cancer: 4.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	20	"BEWO: 65.8"									"CAB000042, CAB010884, HPA038925, HPA038934"	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	NA			Cytosol		"CAB000042: , CAB010884: AB_259037, HPA038925: AB_2676272, HPA038934: AB_2676277"									"unprognostic (1.39e-1)"		"unprognostic (7.88e-2)"				"unprognostic (6.92e-2)"		"unprognostic (1.04e-2)"	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.3	0.0	2.1	9.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.3	0.0	0.0	65.8	0.0	0.0	0.0	0.0	0.0	1.1	0.3	0.1	0.2	0.1	0.0	0.1	0.0	0.0	1.4	0.6	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.6	0.5	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.3	0.2	0.3	0.0	0.3	0.2	0.1	0.4	0.0	0.0	2.1	0.7	0.0	0.0	0.1	0.4	0.0	3.3	1.3	0.9	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.4	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	118.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	865.9	0.0	0.0	0.0	0.0
CLCN1	"ClC-1, CLC1"	ENSG00000188037	"Chloride voltage-gated channel 1"	P35523	7	143316111-143352083	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"skeletal muscle: 66.5"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 149.6"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in single"		"HSkMC: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (5.16e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.53e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.56e-4)"	"unprognostic (8.71e-3)"	"unprognostic (2.35e-1)"	"unprognostic (2.90e-3)"	"unprognostic (3.12e-1)"	"unprognostic (2.35e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.55e-3)"	"unprognostic (3.57e-2)"	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.6	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.0	66.5	0.0	1.0	0.0	0.0	0.1	0.2	1.0	0.0	0.2	0.0	16.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.3	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.6	1.2	0.0	0.0	0.1	0.8	0.6	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	32.9	0.0	0.2	0.1	0.0	0.0	0.4	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.1	0.0	0.0	0.8	149.6	0.0	0.7	0.0	1.0	0.6	0.0	0.0	0.0	0.7	5.7	15.0	0.0	0.0	0.2	0.4	0.1	0.3	0.0	0.0	1.4	0.3	0.1	2.2	0.7	0.1	0.0	0.1	0.1	0.2	2.1
CLCN5	"ClC-5, CLC5, DENTS, hCIC-K2, hClC-K2, NPHL1, NPHL2, XLRH, XRN"	ENSG00000171365	"Chloride voltage-gated channel 5"	P51795	X	49922596-50099235	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Antiport, Ion transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"epididymis: 23.9;kidney: 46.6;liver: 17.0"	"Cell type enriched"	"Detected in many"	4	"Skeletal myocytes: 214.4"	"Cancer enhanced"	"Detected in all"		"renal cancer: 9.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 2.6;plasmacytoid DC: 2.8"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in all"	4	"CACO-2: 49.0;RH-30: 66.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000401, HPA003213"	Uncertain		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Golgi apparatus, Plasma membrane"	Cytosol	"HPA000401: AB_1078531, HPA003213: AB_2666843"	"unprognostic (3.33e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.54e-1)"	"unprognostic (8.08e-3)"	"unprognostic (1.60e-1)"	"unprognostic (5.21e-2)"	"prognostic favorable (5.20e-4)"	"unprognostic (3.59e-2)"	"prognostic favorable (2.05e-8)"	"unprognostic (7.87e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.60e-2)"	2.0	2.5	2.1	1.7	1.7	1.5	1.6	3.6	1.6	1.7	2.5	2.4	5.0	4.0	23.9	2.4	3.1	3.9	1.3	1.3	6.8	46.6	17.0	2.8	1.3	3.1	2.7	1.2	7.1	2.2	1.4	2.3	5.9	3.2	1.7	2.8	3.4	2.5	1.0	4.0	4.8	3.9	2.9	2.3	1.8	2.9	2.2	2.6	1.1	2.2	2.8	1.2	1.4	2.1	2.7	2.9	5.4	4.2	5.5	12.8	7.5	7.9	2.8	1.2	1.6	1.9	49.0	3.0	3.5	1.2	2.5	9.7	2.8	9.9	1.7	2.2	1.1	7.5	3.3	2.7	12.8	7.2	4.1	5.7	4.9	1.6	3.7	5.9	1.2	5.8	4.0	4.3	4.7	5.3	3.2	1.6	1.4	5.7	7.4	2.4	1.9	66.0	5.2	6.0	5.5	7.2	5.2	3.3	3.0	5.1	14.1	3.0	2.1	3.8	1.6	3.7	12.7	1.4	3.6	11.9	7.3	2.8	6.6	8.5	0.0	0.9	0.0	0.1	0.9	0.1	0.1	0.2	0.2	2.6	0.1	0.0	0.0	0.2	0.1	0.1	2.8	0.0	0.3	2.1	1.7	3.6	1.6	1.3	6.8	3.1	2.7	1.2	3.2	2.3	2.6	2.7	4.3	9.6	8.4	20.5	2.1	7.1	1.8	1.6	5.2	27.4	1.8	1.4	1.9	2.8	2.3	12.9	2.1	6.2	17.7	11.3	11.7	4.1	2.0	8.0	10.0	5.5	0.0	3.4	11.5	3.5	2.6	7.9	8.6	22.8	2.5	0.8	1.4	35.2	11.1	8.4	15.6	6.6	4.1	17.6	19.8	0.6	5.3	10.9	3.6	46.9	10.1	2.7	2.1	20.6	9.6	7.7	7.3	13.2	2.2	4.0	20.4	38.8	4.2	4.3	0.0	214.4	4.8	0.9	2.3	8.1	9.5	5.1	1.9	9.3	7.0	4.8
CLSTN2	"CDHR13, CS2, CSTN2, FLJ39113"	ENSG00000158258	"Calsyntenin 2"	Q9H4D0	3	139935185-140577397	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 18.4;brain: 25.4;ovary: 65.2"	"Cell type enriched"	"Detected in many"	4	"Excitatory neurons: 552.2"	"Cancer enriched"	"Detected in many"	7	"breast cancer: 15.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 32.7;SCLC-21H: 14.5;SuSa: 42.7;THP-1: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031342, HPA061800"	Approved		Uncertain	"Vesicles,Cytokinetic bridge"		Yes	No		130000	Vesicles	"Cytokinetic bridge"	"HPA031342: AB_10602800, HPA061800: AB_2684615"	"unprognostic (7.58e-2)"	"unprognostic (2.64e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.51e-3)"	"unprognostic (5.52e-3)"	"unprognostic (8.35e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.58e-1)"	"unprognostic (6.25e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.52e-2)"	"unprognostic (3.16e-2)"	"unprognostic (7.63e-5)"	"unprognostic (7.22e-5)"	18.4	4.9	10.2	0.3	15.1	0.0	8.9	0.0	25.4	3.6	0.0	1.3	0.5	5.1	0.7	1.0	4.7	2.1	5.5	24.4	3.9	4.4	0.8	1.1	2.7	14.4	3.5	9.3	65.2	1.7	0.8	0.9	0.9	10.7	5.4	0.8	2.8	1.3	1.1	1.6	1.8	1.3	6.9	0.0	0.1	1.0	0.6	2.3	0.7	2.8	2.2	0.3	1.6	3.2	14.5	0.0	0.0	5.1	0.0	2.2	0.6	0.0	0.7	0.0	0.0	0.0	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	1.8	0.3	0.0	0.0	0.0	0.0	0.0	0.1	2.5	0.0	0.1	0.0	32.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	2.1	0.0	0.0	0.0	42.7	2.2	9.4	0.0	1.0	0.5	1.4	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	15.1	0.0	25.4	24.4	3.9	14.4	3.5	9.3	10.7	0.0	2.3	14.5	2.1	0.0	0.0	18.3	0.0	0.5	0.3	0.0	8.6	1.8	10.9	2.2	8.0	0.0	0.6	3.7	0.0	0.2	0.1	0.0	1.9	0.2	39.8	0.5	8.9	0.8	0.0	0.0	552.2	0.2	0.0	9.1	0.0	0.2	0.0	25.0	2.2	0.0	0.1	0.0	111.5	0.0	0.0	0.3	1.5	31.1	28.0	0.8	0.0	5.6	0.0	0.8	0.0	108.6	29.4	0.0	0.0	0.7	0.0	5.0	0.0	32.3	3.0	3.8	0.0	28.3	13.7	0.8	0.8	0.4	0.0	0.0	0.7	0.5	0.0	0.3
CPLX3	CPX-III	ENSG00000213578	"Complexin 3"	Q8WVH0	15	74826627-74831802	"Predicted intracellular proteins"	"Exocytosis, Neurotransmitter transport, Sensory transduction, Transport, Vision"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"lymphoid tissue: 111.2;prostate: 123.4;retina: 99.4"	"Cell type enriched"	"Detected in some"	6	"Bipolar cells: 496.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 2.4;Karpas-707: 2.0;SK-BR-3: 1.1;U-266/84: 1.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB079003		Supported				NA	NA					"CAB079003: "																		0.1	7.2	10.4	0.2	9.6	0.1	0.2	16.5	10.3	0.2	4.2	0.3	0.1	0.0	0.1	0.8	0.1	0.0	25.5	18.1	7.1	0.0	0.1	0.1	0.2	8.1	12.9	8.9	0.1	0.1	0.1	5.4	0.0	12.6	123.4	0.1	99.4	18.1	0.0	0.0	0.3	0.3	0.0	6.2	111.2	15.0	6.4	20.5	0.1	0.0	0.0	0.2	0.1	0.3	10.5	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	1.1	0.5	0.1	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.5	1.4	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	9.6	16.5	10.3	18.1	7.1	8.1	12.9	8.9	12.6	6.2	20.5	10.5	0.0	0.0	0.0	2.6	0.1	0.0	0.1	0.0	0.0	496.1	0.1	0.0	0.0	0.0	0.0	0.0	77.2	0.0	0.1	0.5	0.0	0.0	3.9	0.1	0.0	0.5	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	15.2	6.9	0.0	0.0	0.0	0.0	4.9	0.0	0.1	0.0	0.0	0.0	19.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	9.9	0.0	0.0	0.0	56.0	0.0	0.0	0.0	8.9	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2
CXCR5	"BLR1, CD185, MDR15"	ENSG00000160683	"C-X-C motif chemokine receptor 5"	P32302	11	118883892-118897787	"CD markers, G-protein coupled receptors, Predicted membrane proteins"	"B-cell activation"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 10.7;intestine: 10.3;lymphoid tissue: 29.1"	"Cell type enriched"	"Detected in some"	13	"B-cells: 83.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"memory B-cell: 67.7;naive B-cell: 92.4"	"Lineage enriched"	"Detected in many"	8	"B-cells: 92.4"	"Group enriched"	"Detected in some"	11	"Daudi: 18.9;U-698: 65.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB026149, HPA042432"	Enhanced					NA	NA					"CAB026149: , HPA042432: AB_2677995"	"unprognostic (8.51e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.19e-1)"		"unprognostic (4.02e-5)"		"unprognostic (2.08e-2)"	"unprognostic (3.23e-3)"	"unprognostic (1.19e-2)"	"unprognostic (3.66e-1)"	"unprognostic (2.41e-3)"	"unprognostic (1.52e-5)"	"unprognostic (4.21e-1)"	"unprognostic (2.03e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.90e-1)"	0.3	1.9	0.3	11.4	0.4	10.7	0.2	0.6	0.3	2.5	0.1	2.8	0.5	0.3	0.1	2.6	0.1	1.0	0.6	0.4	0.2	0.5	1.5	1.4	29.1	0.3	0.5	0.1	0.7	0.9	0.0	1.0	0.2	0.3	3.7	0.5	0.6	1.3	0.0	2.1	1.9	10.3	0.0	0.1	21.3	2.0	0.3	0.4	1.9	0.8	0.0	16.1	2.3	1.4	0.3	0.1	0.0	0.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	18.9	0.5	0.0	0.7	2.1	0.0	0.0	0.0	0.4	0.3	3.9	0.0	0.0	0.0	0.5	1.4	0.0	0.0	0.0	0.0	1.0	0.0	0.9	0.0	0.6	0.0	1.1	0.8	1.6	0.0	0.7	0.0	0.8	0.1	0.3	0.0	0.0	0.6	0.5	0.0	0.1	0.9	0.2	0.4	0.8	0.0	0.6	0.9	0.0	0.2	0.3	0.0	65.2	0.1	0.7	0.0	0.1	0.1	0.0	1.0	0.0	0.9	67.7	10.9	3.0	0.1	92.4	1.1	1.0	0.1	0.2	0.1	0.1	1.7	6.2	0.3	0.4	0.6	0.3	0.4	0.2	0.3	0.5	0.1	0.3	0.1	0.4	0.3	0.1	0.0	1.8	0.0	83.0	0.1	0.0	0.0	1.2	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.7	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.5	1.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.8	0.2	1.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.9	0.6	0.3	6.1	0.1	0.1	0.1
DGCR6		ENSG00000183628	"DiGeorge syndrome critical region gene 6"	Q14129	22	18906028-18914238	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"heart muscle: 46.5;skeletal muscle: 185.0"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 1045.2"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 4.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 10.3"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	8	"OE19: 46.5"															NA	NA						"unprognostic (9.80e-3)"	"unprognostic (2.12e-3)"	"unprognostic (1.51e-1)"	"unprognostic (3.93e-3)"	"unprognostic (2.41e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.42e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.23e-2)"	"unprognostic (3.38e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.28e-1)"	13.4	10.1	6.8	0.7	6.5	2.0	15.1	8.3	7.4	5.6	7.3	3.8	1.4	2.1	2.3	7.3	4.0	1.1	46.5	6.7	6.4	9.7	27.3	9.7	1.7	7.3	6.1	7.0	2.2	13.2	1.8	20.1	1.3	8.0	6.9	0.9	4.6	12.7	1.5	185.0	25.0	5.0	0.8	5.2	4.2	5.5	26.4	7.2	1.4	22.0	7.0	1.4	4.8	8.0	7.3	0.7	2.5	3.8	2.9	1.7	1.5	0.8	0.9	0.8	1.4	0.9	0.6	1.5	0.3	1.2	1.4	0.8	1.7	2.9	1.5	1.0	1.2	5.6	0.6	3.1	0.6	1.2	1.5	0.5	1.0	2.1	1.1	0.4	1.2	0.6	1.9	3.9	1.8	1.3	1.7	1.3	2.2	1.5	46.5	1.7	2.2	3.3	0.2	0.7	0.2	3.5	1.7	1.2	0.5	0.5	2.8	1.9	0.3	0.3	2.5	2.1	0.7	0.7	1.8	0.3	0.4	1.6	2.5	1.8	10.3	1.1	1.9	0.4	1.8	1.1	0.3	1.2	1.0	3.0	0.1	1.8	1.5	0.4	0.4	1.1	0.2	1.2	2.4	6.8	6.5	8.3	7.4	6.7	6.4	7.3	6.1	7.0	8.0	5.2	7.2	7.3	3.8	9.6	5.1	17.3	1.4	16.4	10.2	19.6	0.0	6.0	6.9	17.8	60.4	7.2	15.2	7.3	4.2	2.3	2.0	1.5	23.5	1.3	245.4	3.8	1.8	3.9	1.8	0.0	6.3	2.6	2.7	8.9	0.5	1.1	8.9	0.6	1.8	16.3	2.6	30.3	5.4	3.9	14.2	4.6	16.3	1045.2	4.4	2.3	80.0	3.7	2.5	11.3	0.0	10.6	5.4	1.9	0.1	8.2	1.1	2.9	10.5	4.9	46.4	2.7	6.6	11.0	11.6	5.1	3.2	0.0	31.7	2.3	2.9	0.9	1.6	8.5
DOCK5	FLJ21034	ENSG00000147459	"Dedicator of cytokinesis 5"	Q9H7D0	8	25184689-25418082	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 84.3"	"Cell type enriched"	"Detected in many"	7	"Oligodendrocytes: 789.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 30.7"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 30.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017719, HPA056837"	Approved		Enhanced	Cytosol		No	No			Cytosol		"HPA017719: AB_1847820, HPA056837: AB_2683253"	"unprognostic (2.16e-1)"	"unprognostic (3.55e-3)"	"unprognostic (1.25e-2)"	"prognostic favorable (1.91e-4)"	"unprognostic (8.44e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.61e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.69e-2)"	"unprognostic (4.21e-2)"	"unprognostic (4.18e-3)"	"unprognostic (3.00e-1)"	"prognostic unfavorable (1.18e-6)"	"unprognostic (2.81e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.25e-1)"	4.2	3.4	14.6	7.6	47.9	17.2	4.8	29.0	27.3	4.2	20.3	8.2	10.7	4.1	5.2	3.5	6.2	5.8	6.4	15.3	28.9	4.2	15.3	9.4	1.8	34.6	37.3	8.5	6.9	4.7	2.6	8.3	10.3	42.0	7.9	9.5	2.5	6.7	5.6	2.6	5.2	13.0	3.4	20.2	19.4	6.7	6.3	36.0	1.9	15.6	2.8	1.6	4.1	4.9	84.3	19.8	43.2	4.1	0.3	9.8	10.6	14.2	45.5	26.5	12.4	9.6	6.3	15.5	0.4	4.0	40.3	13.7	34.6	4.9	32.5	19.9	6.2	6.1	20.2	40.5	15.8	11.1	5.0	21.6	7.3	12.9	13.6	20.3	13.6	10.7	0.8	0.3	0.8	12.2	11.5	0.7	9.5	4.1	24.4	11.9	0.3	9.0	0.5	9.1	12.0	3.0	1.4	24.0	14.5	4.7	3.4	4.5	4.0	32.1	21.1	13.6	25.5	17.1	0.7	0.2	0.3	27.4	10.2	27.4	14.6	2.5	3.8	0.4	5.5	0.1	0.0	0.1	0.0	2.3	0.0	0.0	0.3	30.7	0.4	6.8	0.4	0.0	0.3	14.6	47.9	29.0	27.3	15.3	28.9	34.6	37.3	8.5	42.0	20.2	36.0	84.3	2.7	44.8	41.5	96.6	2.2	18.5	13.2	30.5	2.2	9.6	12.8	5.8	13.4	31.5	31.4	14.7	2.1	28.3	20.1	50.6	0.0	10.3	0.9	16.3	10.0	10.6	17.5	9.9	4.9	12.0	100.2	28.1	32.1	53.1	31.0	52.8	8.2	35.0	13.3	1.7	3.6	26.7	8.2	60.3	51.0	5.6	28.9	41.3	85.4	38.4	24.5	20.0	22.6	61.3	789.8	48.9	27.4	48.2	13.4	36.0	60.0	6.2	20.9	2.3	13.1	4.0	12.1	0.9	5.6	5.8	7.2	20.5	10.8	25.1	27.7	16.8
ETNPPL	AGXT2L1	ENSG00000164089	"Ethanolamine-phosphate phospho-lyase"	Q8TBG4	4	108742048-108763054	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 156.3;liver: 192.6"	"Cell type enriched"	"Detected in some"	8	"Astrocytes: 219.4"	"Group enriched"	"Detected in some"	23	"glioma: 7.9;liver cancer: 21.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 5.7;Hep G2: 2.3;NTERA-2: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044546, HPA072938"	Supported		Approved	Nucleoplasm		Yes	NA			Nucleoplasm		"HPA044546: AB_10962867, HPA072938: AB_2686560"	"unprognostic (5.20e-3)"	"unprognostic (1.33e-1)"		"unprognostic (3.93e-1)"	"prognostic favorable (9.52e-5)"		"unprognostic (5.93e-3)"	"unprognostic (3.91e-2)"	"unprognostic (2.82e-1)"	"unprognostic (6.32e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.42e-2)"	"unprognostic (9.48e-2)"	0.1	5.5	156.0	0.1	126.1	0.0	0.1	93.8	145.6	0.1	41.2	0.0	0.2	0.3	0.0	0.1	0.0	0.2	7.5	124.7	122.9	9.2	192.6	0.1	0.0	145.7	115.9	103.7	0.1	0.0	2.9	1.9	0.0	156.3	0.0	0.0	1.7	34.7	0.1	2.5	0.0	0.0	0.0	79.0	0.7	18.4	0.5	110.6	0.1	1.1	1.5	0.0	0.0	0.0	109.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.0	5.7	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	156.0	126.1	93.8	145.6	124.7	122.9	145.7	115.9	103.7	156.3	79.0	110.6	109.3	0.0	0.0	0.0	219.4	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	14.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.4	0.0	0.0	0.4	0.0	0.0	0.5	1.5	0.4	0.0	0.0	0.7	26.8	0.0	0.0	0.6	0.0	0.0	1.6	0.0	1.7	0.0	0.0	0.0	7.5	0.0	8.5	0.0	1.5	0.7	0.0	0.0	0.0	0.1	0.0	0.0	7.9	0.0	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1
FAM124A	FLJ30707	ENSG00000150510	"Family with sequence similarity 124 member A"	Q86V42	13	51222334-51284239	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 59.2;choroid plexus: 21.9;retina: 26.0"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 232.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"HAP1: 18.0;HUVEC TERT2: 10.6;NTERA-2: 35.1;SH-SY5Y: 13.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048182	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA048182: AB_2680301"	"unprognostic (3.94e-3)"	"unprognostic (8.76e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.34e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.38e-3)"	"unprognostic (4.51e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.05e-2)"	4.0	1.8	13.2	2.7	28.8	0.2	2.9	22.0	24.1	2.2	21.9	6.1	0.6	3.1	4.7	1.2	3.1	2.4	4.3	13.5	19.0	3.7	0.7	1.9	0.8	28.6	27.0	10.3	0.8	1.4	0.6	1.3	3.6	33.7	4.6	1.3	26.0	7.3	4.4	1.0	0.9	2.0	5.3	22.1	8.4	3.3	1.3	25.1	3.2	2.4	1.3	0.5	4.6	1.6	59.2	0.0	1.7	1.2	1.1	0.3	0.1	0.1	0.2	0.6	0.2	0.2	0.1	0.6	0.6	0.0	0.0	2.2	0.1	18.0	0.2	0.1	0.1	2.7	0.1	0.5	0.0	1.4	0.9	1.1	0.4	0.2	0.5	0.0	0.0	10.6	4.8	0.1	0.1	0.0	0.3	4.6	0.3	35.1	0.3	2.8	1.0	0.1	2.6	0.0	0.1	2.5	13.3	0.6	2.2	2.0	2.6	0.3	1.1	0.2	0.1	1.2	0.9	1.3	0.3	0.0	0.0	1.6	3.2	1.5	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.4	0.2	0.1	0.1	0.1	0.0	13.2	28.8	22.0	24.1	13.5	19.0	28.6	27.0	10.3	33.7	22.1	25.1	59.2	8.5	0.0	0.0	17.6	0.4	0.8	2.1	0.0	0.6	10.2	1.1	1.8	10.8	0.0	0.0	1.8	50.1	0.0	0.8	0.2	3.9	2.6	4.7	0.8	3.5	9.3	0.0	0.0	12.0	0.8	0.0	2.2	0.0	1.6	1.3	0.6	8.6	0.1	0.2	6.7	4.8	0.0	0.0	0.6	0.3	5.8	0.6	1.4	3.6	9.4	0.0	3.6	0.0	10.6	232.9	0.7	0.0	0.4	0.0	2.3	0.0	11.7	1.5	43.6	0.0	1.8	2.0	1.7	1.6	0.1	0.1	0.0	0.6	0.7	0.1	0.5
FAM155B	"CXorf63, TED, TMEM28"	ENSG00000130054	"Family with sequence similarity 155 member B"	O75949	X	69504326-69532508	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"heart muscle: 33.2"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 23.7"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 8.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 7.4;HAP1: 16.2;Hep G2: 6.1;NTERA-2: 24.3;OE19: 6.5;SCLC-21H: 11.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036093	Uncertain					NA	NA					"HPA036093: AB_10673613"	"prognostic unfavorable (4.61e-5)"	"unprognostic (1.17e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.14e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.09e-4)"	"unprognostic (7.07e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.67e-2)"	"unprognostic (4.94e-3)"	"prognostic unfavorable (1.83e-4)"	"prognostic favorable (6.63e-4)"	"unprognostic (1.46e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.21e-2)"	0.1	0.8	2.4	0.0	2.2	0.0	0.3	3.1	2.6	0.2	0.6	0.2	0.1	0.3	0.4	0.1	0.7	0.2	33.2	2.2	2.6	0.9	0.2	0.1	0.1	2.6	3.2	2.1	0.1	1.8	3.1	2.4	0.0	3.2	0.9	0.2	0.4	1.1	4.9	0.1	0.0	0.2	0.1	1.8	0.7	1.1	1.6	3.2	0.1	8.0	0.0	0.1	0.2	0.1	2.5	0.0	2.7	0.2	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.7	0.0	5.2	0.0	0.0	0.0	16.2	0.6	0.0	0.0	5.0	0.0	0.0	6.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	5.2	0.0	0.0	24.3	6.5	0.0	0.0	0.0	0.0	0.2	0.0	11.3	0.8	0.1	0.0	0.0	0.7	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	2.2	3.1	2.6	2.2	2.6	2.6	3.2	2.1	3.2	1.8	3.2	2.5	0.2	0.0	0.0	1.3	0.0	0.0	0.3	1.6	0.0	0.4	0.6	0.1	23.7	0.0	0.8	1.8	0.0	0.0	0.0	0.5	0.0	0.5	0.0	2.0	0.5	0.7	1.2	0.0	0.8	1.2	0.0	0.4	0.0	4.4	0.0	0.0	0.4	0.3	0.1	0.0	0.9	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.1	0.8	0.2	0.0	0.0	1.2	0.0	0.5	0.3	0.8	0.0	0.1	0.2	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.3
FBXO2	"Fbg1, Fbs1, FBX2, Nfb42, OCP1"	ENSG00000116661	"F-box protein 2"	Q9UK22	1	11637018-11655785	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 217.9;choroid plexus: 103.6;pancreas: 87.6;pituitary gland: 119.3"	"Cell type enriched"	"Detected in many"	4	"Exocrine glandular cells: 685.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CACO-2: 113.4;HBEC3-KT: 96.9;Hep G2: 239.8;SiHa: 440.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005472	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA005472: AB_2667332"	"unprognostic (2.02e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.10e-1)"	"unprognostic (8.13e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.68e-2)"	"prognostic favorable (3.45e-6)"	"unprognostic (5.26e-2)"	"unprognostic (5.21e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.64e-1)"	3.6	25.5	197.0	1.8	146.7	0.0	13.6	148.2	217.9	6.6	103.6	4.1	16.5	2.3	6.7	9.0	6.0	2.6	7.5	172.5	197.9	19.0	28.3	5.8	2.0	182.9	171.6	147.3	3.6	87.6	30.0	119.3	0.1	190.8	15.3	0.4	7.6	25.4	7.6	4.8	17.3	5.3	0.7	156.1	3.7	9.7	12.1	180.4	10.7	8.4	1.0	3.6	5.1	13.2	176.7	35.7	10.8	0.4	35.1	0.7	0.0	5.3	1.5	3.0	1.1	0.2	113.4	10.0	0.0	40.6	0.3	8.3	0.1	3.6	96.9	0.1	0.8	1.0	0.0	1.7	239.8	4.6	0.1	0.0	3.0	17.0	0.0	0.9	1.1	0.4	0.1	0.3	0.1	0.0	0.5	0.0	0.0	1.3	14.3	1.3	0.1	0.1	0.2	8.2	3.0	3.6	4.7	440.5	0.1	3.9	3.5	21.1	0.0	0.0	0.3	3.1	0.0	0.0	2.4	2.1	1.7	0.7	0.0	1.0	0.0	0.0	0.0	0.9	0.0	1.3	0.7	0.5	1.2	0.0	0.5	0.8	1.1	0.0	0.0	0.0	0.0	0.4	0.2	197.0	146.7	148.2	217.9	172.5	197.9	182.9	171.6	147.3	190.8	156.1	180.4	176.7	1.2	0.0	1.5	40.8	8.4	19.6	62.3	149.9	90.5	11.3	15.0	75.4	3.7	15.7	33.5	47.8	2.1	0.8	5.9	0.2	86.1	23.2	2.1	1.2	0.7	1.8	1.2	0.0	16.5	685.9	3.9	8.7	6.6	0.7	4.5	0.2	2.5	102.0	0.4	28.6	16.7	0.7	38.7	2.2	2.6	2.4	34.8	1.1	44.4	5.6	3.2	106.6	7.2	6.6	10.4	132.1	2.2	40.6	3.3	39.2	2.0	7.2	44.4	15.8	0.0	1.1	7.7	18.4	12.1	10.0	9.9	1.0	13.0	0.5	0.4	25.0
FCAMR	"CD351, FCA/MR, FKSG87"	ENSG00000162897	"Fc fragment of IgA and IgM receptor"	Q8WWV6	1	206957965-206970625	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"kidney: 38.4;lymphoid tissue: 26.4"	"Cell type enriched"	"Detected in some"	8	"Proximal tubular cells: 32.9"	"Group enriched"	"Detected in some"	5	"liver cancer: 2.4;renal cancer: 5.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA056505	Enhanced					NA	NA		5300000			"HPA056505: AB_2732604"	"unprognostic (2.94e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.53e-2)"	"unprognostic (2.92e-1)"	"unprognostic (7.44e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.69e-3)"	"unprognostic (1.08e-4)"	"unprognostic (3.61e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.26e-1)"	0.2	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	1.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	38.4	8.0	0.0	24.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.0	1.0	0.0	0.0	2.4	0.6	0.0	0.0	1.0	0.0	0.0	26.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.9	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	32.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.1
FCER2	"CD23, CD23A, CLEC4J, FCE2"	ENSG00000104921	"Fc fragment of IgE receptor II"	P06734	19	7688758-7702146	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"IgE-binding protein, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"lymphoid tissue: 42.6"	"Cell type enriched"	"Detected in some"	16	"B-cells: 157.6"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 2.1"	"Region enriched"	"Detected in single"	9	"cerebral cortex: 2.7"	"Group enriched"	"Detected in many"	24	"memory B-cell: 200.9;naive B-cell: 496.2"	"Lineage enriched"	"Detected in many"	34	"B-cells: 496.2"	"Cell line enriched"	"Detected in some"	14	"HDLM-2: 449.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB002624, HPA008928, HPA067430"	Enhanced				"Secreted to blood"	NA	NA		240000			"CAB002624: , HPA008928: AB_1846285, HPA067430: "	"unprognostic (3.20e-4)"	"unprognostic (1.87e-3)"	"unprognostic (1.95e-2)"	"unprognostic (2.44e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.89e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.04e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.46e-4)"	"unprognostic (2.99e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.89e-2)"	"unprognostic (5.17e-2)"	4.9	0.1	0.0	17.6	0.0	5.2	1.2	0.2	2.7	0.4	0.1	1.8	2.8	0.1	0.1	0.4	0.3	1.1	0.5	0.3	0.0	0.3	0.5	0.6	39.8	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.5	0.2	0.1	1.9	0.0	1.9	0.1	0.3	0.4	9.7	0.2	0.0	38.7	2.2	0.4	0.0	6.4	0.7	0.1	42.6	1.6	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	449.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.6	0.0	0.2	0.0	0.1	0.0	0.1	32.7	0.0	0.5	4.2	0.3	0.0	14.7	0.1	200.9	0.2	0.0	4.4	496.2	0.3	0.1	1.5	0.3	4.4	0.6	0.2	21.6	0.0	0.0	0.2	2.7	0.3	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.6	0.0	157.6	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.7	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.1	1.1	0.0	1.2	0.0	0.1	0.0	0.0	1.3	1.7	0.0	0.0	9.4	1.8	1.0	0.9	0.0	2.1	0.0	0.1	0.0	0.0	0.0	4.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	1.2	1.2	0.0	0.0
FCN2	"EBP-37, FCNL, ficolin-2, P35"	ENSG00000160339	"Ficolin 2"	Q15485	9	134880810-134887523	"Plasma proteins, Predicted secreted proteins"	"Complement activation lectin pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"liver: 100.5"	"Cell type enriched"	"Detected in some"	18	"Hepatic stellate cells: 1192.6"	"Group enriched"	"Detected in some"	8	"breast cancer: 1.0;liver cancer: 2.0;prostate cancer: 1.1;renal cancer: 0.5"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 5.5;intermediate monocyte: 4.6"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							"Region enriched"	"Detected in some"	23	"spinal cord: 38.6"						"Secreted to blood"	NA	NA	8100000000	1400000000				"unprognostic (1.91e-1)"	"unprognostic (1.07e-1)"			"unprognostic (6.96e-4)"		"unprognostic (3.73e-2)"	"unprognostic (2.09e-2)"		"unprognostic (3.81e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.06e-2)"		"unprognostic (1.05e-1)"	"unprognostic (3.07e-1)"		4.7	24.8	0.3	0.0	0.3	0.1	7.7	0.2	0.5	0.3	0.4	0.0	0.1	0.1	0.2	0.1	0.3	0.1	0.2	0.5	0.3	6.2	100.5	0.1	0.1	0.3	0.5	0.2	0.5	0.5	0.2	3.1	0.0	0.3	3.2	0.0	0.0	3.2	0.4	0.1	0.2	0.1	0.0	0.2	3.1	0.2	0.2	0.3	0.0	2.1	0.1	0.0	0.4	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	5.5	0.0	0.0	4.6	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	1.1	0.0	2.2	0.0	0.0	9.0	0.3	0.3	0.2	0.5	0.5	0.3	0.3	0.5	0.2	0.3	0.2	0.3	0.3	0.1	0.0	0.0	0.7	3.8	0.0	0.1	0.0	0.0	0.0	3.8	0.4	0.1	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.6	0.0	34.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1192.6	12.6	0.0	0.0	0.1	0.0	0.0	64.1	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1
FNDC9	"C5orf40, MGC27121"	ENSG00000172568	"Fibronectin type III domain containing 9"	Q8TBE3	5	157341598-157345677	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 27.6;pituitary gland: 11.8"	"Cell type enriched"	"Detected in some"	5	"Bipolar cells: 5.8"	"Cancer enriched"	"Detected in single"	16	"glioma: 0.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA						"unprognostic (2.35e-3)"	"unprognostic (3.80e-2)"	"unprognostic (2.93e-1)"		"unprognostic (3.53e-3)"	"unprognostic (4.90e-3)"		"unprognostic (3.40e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.35e-6)"	"unprognostic (3.63e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.12e-3)"	0.0	4.8	5.3	0.3	5.8	0.7	0.0	6.5	14.6	0.0	0.3	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.0	27.6	0.1	0.1	0.1	0.1	6.7	6.1	4.7	0.0	0.0	0.0	11.8	0.0	4.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.1	0.1	0.0	14.8	0.0	0.0	0.0	0.0	0.1	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.3	5.8	6.5	14.6	5.0	27.6	6.7	6.1	4.7	4.0	1.2	14.8	5.7	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0
GPR15		ENSG00000154165	"G protein-coupled receptor 15"	P49685	3	98531978-98534681	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"intestine: 31.6"	"Cell type enriched"	"Detected in some"	8	"Plasma cells: 31.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"memory B-cell: 3.6;memory CD4 T-cell: 10.8;memory CD8 T-cell: 5.1;T-reg: 12.1"	"Group enriched"	"Detected in many"	26	"B-cells: 3.6;T-cells: 12.1"	"Group enriched"	"Detected in some"	5	"HDLM-2: 4.6;U-266/70: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA013775	Approved					NA	NA					"HPA013775: AB_1849264"	"unprognostic (8.03e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.72e-3)"	"unprognostic (5.66e-2)"	"unprognostic (9.48e-3)"	"unprognostic (5.60e-5)"	"unprognostic (5.17e-1)"	"unprognostic (6.77e-3)"	"unprognostic (3.96e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.83e-1)"	"unprognostic (4.04e-3)"	"unprognostic (4.23e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.54e-1)"	0.3	0.0	0.0	4.6	0.2	0.2	3.9	0.0	0.2	0.3	0.0	20.2	2.8	0.2	0.0	2.5	0.1	2.3	0.0	0.0	0.1	0.2	0.3	1.9	2.4	0.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.4	31.6	0.0	5.0	0.2	0.0	0.2	10.3	0.9	0.2	5.3	1.6	0.0	0.2	2.0	0.5	0.0	5.4	7.3	1.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.3	3.6	10.8	5.1	0.0	0.6	0.5	0.8	0.3	0.0	0.0	0.2	12.1	2.1	0.0	0.2	0.0	0.2	0.0	0.1	0.5	0.2	0.0	0.4	0.2	0.2	0.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0
GREB1	KIAA0575	ENSG00000196208	"Growth regulating estrogen receptor binding 1"	Q4ZG55	2	11482341-11642788	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"ovary: 280.7"	"Cell type enriched"	"Detected in many"	9	"Granulosa cells: 545.2"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 17.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 40.3;Hep G2: 39.6;MCF7: 61.8;SH-SY5Y: 40.5;SK-MEL-30: 30.4;T-47d: 138.0"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA024616, HPA027843, HPA028416"	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"		"HPA024616: AB_10599728, HPA027843: AB_10601103, HPA028416: AB_10601344"	"unprognostic (1.52e-2)"	"unprognostic (4.63e-1)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.05e-4)"	"unprognostic (1.23e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.68e-1)"	"unprognostic (3.63e-2)"	"unprognostic (7.51e-4)"	"unprognostic (2.42e-2)"	"unprognostic (3.34e-1)"	"unprognostic (2.46e-3)"	"unprognostic (4.80e-2)"	1.8	3.4	8.3	0.7	8.8	0.4	13.8	2.3	10.5	49.7	0.7	0.9	0.7	61.8	7.0	0.6	53.9	2.8	4.5	8.0	16.4	1.8	3.1	1.4	0.6	8.9	7.6	5.5	280.7	7.7	0.7	9.0	3.0	5.0	64.0	0.2	1.5	1.1	3.8	4.0	2.6	0.9	12.9	3.4	0.2	3.0	15.1	9.0	0.3	0.6	4.8	0.3	1.7	21.7	7.0	0.1	1.0	40.3	0.5	0.2	0.2	1.8	0.0	0.1	0.1	0.3	0.3	0.2	2.5	0.3	0.0	6.9	0.2	3.1	0.2	0.1	5.1	3.6	0.4	0.3	39.6	0.5	0.3	2.1	0.5	2.2	0.6	0.4	0.4	0.0	3.9	0.5	1.0	0.3	61.8	1.2	2.0	13.0	0.1	0.1	29.1	0.0	1.9	0.1	0.0	11.8	40.5	0.9	1.1	30.4	5.2	138.0	0.7	0.0	4.1	2.0	0.4	0.1	6.0	4.4	24.7	6.8	11.9	1.2	0.6	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.1	0.1	0.1	0.1	0.0	8.3	8.8	2.3	10.5	8.0	16.4	8.9	7.6	5.5	5.0	3.4	9.0	7.0	0.4	0.0	0.5	20.2	0.7	0.8	1.9	0.0	0.6	4.8	24.7	13.7	8.3	5.7	0.6	0.0	2.1	0.2	0.1	0.1	0.0	0.3	0.8	35.7	36.0	1.3	0.0	0.0	15.0	0.2	3.6	16.9	0.0	23.4	3.8	545.2	0.7	8.9	3.2	3.3	46.9	0.0	0.0	0.0	1.2	2.5	20.2	1.4	5.4	1.0	0.0	0.2	0.0	11.6	20.9	0.4	0.0	55.3	5.0	14.3	0.0	2.5	2.9	0.5	0.0	7.2	14.8	1.1	2.9	0.3	0.3	0.3	1.1	33.1	0.0	2.5
GYPE	"GPE, MNS"	ENSG00000197465	"Glycophorin E (MNS blood group)"	P15421	4	143870864-143905563	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	4	"bone marrow: 13.4"	"Cell type enriched"	"Detected in some"	11	"Erythroid cells: 188.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	12	"HEL: 120.9;K-562: 39.8"															NA	NA						"unprognostic (2.17e-1)"	"unprognostic (6.03e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.00e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.09e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.81e-3)"	"unprognostic (1.10e-4)"	"unprognostic (7.81e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.97e-1)"	"unprognostic (3.49e-2)"	1.1	0.3	0.1	1.4	1.0	13.4	0.7	0.0	1.6	0.7	0.0	0.2	0.0	0.3	0.7	0.3	0.2	0.7	0.9	0.6	0.4	0.4	0.1	2.9	1.1	0.1	0.0	1.2	0.0	0.1	0.2	0.2	0.8	0.4	0.3	0.4	0.2	0.3	0.6	0.1	0.3	0.9	0.4	0.0	3.2	0.3	0.5	0.0	1.1	0.8	0.0	2.6	0.7	0.2	0.3	0.0	0.0	0.0	0.0	6.8	6.6	0.0	2.8	6.4	1.4	1.8	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.2	0.0	1.6	0.0	0.0	120.9	0.0	0.0	1.3	0.0	0.0	0.8	0.0	0.0	0.0	1.5	0.0	0.0	39.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.9	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	1.0	0.0	1.6	0.6	0.4	0.1	0.0	1.2	0.4	0.0	0.0	0.3	0.2	16.0	1.5	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	1.0	0.1	0.0	188.4	5.3	0.0	0.2	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	1.3	0.0	0.0	0.8	0.5	0.3	0.0	0.3	3.6	1.0	0.0	0.0	1.0	6.0	1.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.8	0.3	0.0	0.0	0.1	0.3	0.7	0.0	0.0
HBA1	HBA-T3	ENSG00000206172	"Hemoglobin subunit alpha 1"	P69905	16	176680-177522	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Oxygen transport, Transport"		"Disease variant, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"bone marrow: 24541.9"	"Cell type enriched"	"Detected in many"	51	"Erythroid cells: 224916.4"	"Group enriched"	"Detected in many"	4	"endometrial cancer: 2.6;glioma: 6.3;ovarian cancer: 2.6;stomach cancer: 2.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 142.6;plasmacytoid DC: 101.1"	"Group enriched"	"Detected in all"	5	"dendritic cells: 101.1;granulocytes: 142.6"	"Group enriched"	"Detected in some"	36	"HEL: 3355.8;K-562: 2416.8"									"CAB032534, HPA043780"	Enhanced					NA	NA		14000000000			"CAB032534: AB_2294993, HPA043780: AB_2678667"	"unprognostic (1.16e-1)"	"unprognostic (1.45e-2)"	"unprognostic (8.87e-2)"	"unprognostic (9.78e-3)"	"unprognostic (3.02e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.21e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.59e-2)"	"unprognostic (3.79e-1)"	"unprognostic (6.61e-2)"	"unprognostic (2.67e-2)"	"unprognostic (9.56e-2)"	563.6	184.5	89.5	82.7	213.9	24541.9	319.3	152.8	802.0	157.9	2244.8	128.0	10.7	41.8	2.4	246.9	353.9	60.6	1410.3	51.0	108.5	1386.9	1109.3	2221.0	5.0	164.5	327.4	35.4	161.1	101.4	5.2	469.4	2009.5	282.8	171.6	11.6	3.1	139.4	44.1	235.9	193.3	85.8	7.1	198.0	5572.2	137.1	105.6	283.2	20.9	614.3	1133.1	3.6	168.6	354.2	403.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	58.1	0.0	5.7	2.1	0.0	0.4	0.0	3.5	0.0	0.0	0.0	0.2	3355.8	0.0	37.1	0.0	1.3	0.0	0.3	0.0	0.0	0.7	0.0	0.0	1.7	2416.8	0.0	0.0	14.7	0.5	0.3	0.4	1.0	0.0	0.1	1.4	79.1	0.0	1.0	7.4	5.3	2.8	0.0	0.0	0.0	1.1	0.0	8.3	0.0	0.0	0.9	0.0	0.0	0.4	0.8	0.0	0.2	0.0	8.5	7.4	48.2	26.3	0.2	0.7	7.5	3.1	8.7	10.0	4.5	8.3	25.7	142.6	13.4	0.8	101.1	0.3	2806.3	89.5	213.9	152.8	802.0	51.0	108.5	164.5	327.4	35.4	282.8	198.0	283.2	403.4	72.7	0.0	0.0	0.0	56.8	10.6	0.1	0.0	0.0	0.4	11.3	12.3	1.8	55.8	0.1	0.0	0.0	0.0	93.2	3.2	7.9	0.0	6.0	0.5	0.5	20.4	1.2	224916.4	0.0	0.0	0.0	57.9	0.0	0.4	0.0	0.1	151.0	78.8	0.0	0.0	0.0	5.7	0.0	436.7	64.1	22.4	0.0	234.0	4338.2	0.0	12.7	1.3	1166.9	0.0	0.0	0.1	2.8	0.4	0.5	0.2	0.2	11.1	0.0	16.5	0.0	8.7	58.7	1.5	7.6	0.0	13.2	0.0	155.7	0.0	3.2	0.0
HLA-G		ENSG00000204632	"Major histocompatibility complex, class I, G"	P17693	6	29826967-29831125	"Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins"	Immunity		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"pituitary gland: 13.9;placenta: 11.2"	"Cell type enriched"	"Detected in many"	45	"Extravillous trophoblasts: 1850.2"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"											CAB016158	Enhanced				"Secreted to blood"	NA	NA	32800000	67000000			"CAB016158: AB_627938"	"unprognostic (1.13e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.40e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.51e-1)"	"prognostic favorable (3.91e-5)"	"unprognostic (6.34e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.03e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.19e-3)"	0.4	0.3	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.7	0.7	0.2	0.0	0.3	0.3	0.1	0.3	0.0	0.0	0.5	0.4	2.8	0.0	0.0	0.0	0.0	0.2	1.2	0.0	13.9	11.2	0.0	0.3	0.0	0.0	0.6	0.0	0.2	0.4	0.7	0.0	0.0	1.3	0.7	2.7	0.0	0.4	0.6	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.9	1.4	0.8	0.6	1.0	0.7	0.6	0.9	0.4	0.5	0.5	1.3	2.1	0.8	0.6	0.1	1.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.6	0.0	1.2	22.8	7.3	7.1	1.2	0.0	0.2	0.0	0.8	4.3	1.8	0.0	0.0	10.7	2.7	28.1	0.0	4.5	20.1	0.9	1.3	8.8	17.5	2.7	0.0	5.6	1850.2	5.5	1.5	2.6	0.0	0.7	6.4	1.2	25.5	0.0	0.0	34.3	2.0	8.1	27.3	13.0	2.5	4.8	12.4	0.0	1.4	0.0	3.1	0.0	0.0	24.9	19.9	2.6	0.9	14.3	0.2	0.3	0.6	0.0	0.0	4.8	3.8	5.9	2.8	0.1	35.2	40.5	6.8	1.9	18.2	15.0
HOATZ	"C11orf88, FLJ46266"	ENSG00000183644	"HOATZ cilia and flagella associated protein"	Q6PI97	11	111514785-111537031	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"choroid plexus: 27.2;fallopian tube: 89.7;testis: 29.4"	"Cell type enriched"	"Detected in single"	28	"Cardiomyocytes: 5.8"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.6;Karpas-707: 1.7;SuSa: 1.2"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 8.9"							NA	NA						"unprognostic (2.25e-1)"	"unprognostic (3.07e-5)"	"unprognostic (3.85e-4)"	"unprognostic (4.16e-2)"	"unprognostic (4.44e-5)"	"unprognostic (2.56e-3)"	"unprognostic (6.91e-2)"	"unprognostic (5.49e-3)"	"unprognostic (2.86e-1)"	"unprognostic (9.96e-3)"	"unprognostic (2.70e-1)"	"unprognostic (4.40e-2)"	"unprognostic (6.80e-3)"	"unprognostic (7.57e-2)"	"unprognostic (6.22e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.11e-1)"	0.0	0.0	8.1	0.1	2.3	0.1	0.0	3.2	2.1	4.2	27.2	0.0	0.2	3.1	0.4	0.0	89.7	0.2	0.0	1.2	5.5	0.0	0.0	11.8	0.1	8.8	7.1	0.1	0.1	0.0	0.0	0.4	0.3	7.0	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.0	8.4	0.2	0.1	29.4	3.5	0.1	0.8	0.0	0.0	0.0	0.0	5.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.3	0.0	0.0	0.2	0.2	0.1	0.3	0.9	0.1	0.0	0.1	0.1	0.2	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	8.1	2.3	3.2	2.1	1.2	5.5	8.8	7.1	0.1	7.0	8.4	3.5	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHJ1		ENSG00000211905	"Immunoglobulin heavy joining 1"	A0A0C4DH62	14	105865407-105865458	"Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in many"	4	"intestine: 358.1;lymphoid tissue: 417.5;salivary gland: 121.2;stomach 1: 308.2"	"Cell type enriched"	"Detected in single"	18	"Plasma cells: 1.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebral cortex: 1.9"	"Group enriched"	"Detected in some"	72	"memory B-cell: 276.3;naive B-cell: 180.8;plasmacytoid DC: 99.0"	"Group enriched"	"Detected in many"	73	"B-cells: 276.3;dendritic cells: 99.0"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 2.7;U-698: 1.8"														"Immunoglobulin genes"	NA	NA						"unprognostic (5.28e-3)"	"unprognostic (2.05e-2)"	"unprognostic (6.81e-2)"	"unprognostic (9.53e-2)"		"prognostic favorable (3.55e-4)"		"unprognostic (2.51e-1)"			"unprognostic (2.45e-1)"			"unprognostic (3.00e-2)"	"unprognostic (2.90e-2)"			8.7	5.3	0.1	198.7	0.4	35.9	73.6	0.0	1.9	18.8	0.2	262.6	358.1	3.4	0.0	15.8	5.2	12.7	1.4	0.1	0.0	2.3	6.2	28.7	47.2	1.0	0.0	0.0	8.3	3.1	0.4	0.0	0.7	0.4	4.4	184.4	0.0	121.2	0.5	0.0	0.0	172.6	12.1	0.3	101.1	308.2	1.0	0.2	14.8	2.9	0.0	417.5	61.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.6	0.1	0.2	0.0	0.2	276.3	0.6	2.5	0.2	180.8	0.3	0.3	0.0	0.1	0.1	99.0	0.2	29.1	0.1	0.4	0.0	1.9	0.1	0.0	1.0	0.0	0.0	0.4	0.3	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHV3-30		ENSG00000270550	"Immunoglobulin heavy variable 3-30"	"P01768, P0DP03"	14	106335082-106335613	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 539.1;lymphoid tissue: 1305.5;salivary gland: 463.6;stomach 1: 577.9;urinary bladder: 382.2"	"Cell type enriched"	"Detected in some"	184	"Plasma cells: 14426.7"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in single"	5	"cerebral cortex: 4.8"	"Group enriched"	"Detected in some"	409	"memory B-cell: 164.0;naive B-cell: 136.6"	"Lineage enriched"	"Detected in single"	446	"B-cells: 164.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.1;Daudi: 1.7;NB-4: 2.3;RPMI-8226: 1.7;SCLC-21H: 1.7;SH-SY5Y: 3.0;U-266/70: 1.3"														"Immunoglobulin genes"	NA	NA		8500000000				"unprognostic (2.12e-3)"	"unprognostic (5.51e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.81e-3)"	"unprognostic (1.72e-2)"	"prognostic favorable (3.23e-5)"	"unprognostic (7.43e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (1.65e-7)"	"unprognostic (1.32e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.01e-1)"	"unprognostic (6.96e-2)"	17.2	38.8	0.1	323.5	0.2	120.8	145.4	0.0	4.8	42.0	0.7	539.1	267.9	13.4	0.0	135.9	45.2	147.9	30.6	0.4	0.2	28.5	25.3	129.3	378.0	0.9	0.4	0.1	23.2	12.4	0.7	3.4	0.7	0.2	18.8	257.3	0.0	463.6	20.6	0.9	2.8	298.6	23.8	0.1	803.8	577.9	6.0	0.2	159.7	77.3	0.1	1305.5	382.2	35.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.3	2.3	0.0	0.0	0.0	0.0	1.0	1.7	0.0	0.0	1.7	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	1.3	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.1	164.0	0.2	0.0	0.1	136.6	0.3	0.1	0.3	0.0	0.0	0.2	0.0	24.4	0.1	0.2	0.0	4.8	0.4	0.2	0.9	0.4	0.1	0.2	0.1	0.2	0.3	0.0	0.0	0.0	0.0	78.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	5.4	16.3	0.0	1.3	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14426.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.4	0.0
IGLV4-3		ENSG00000211672	"Immunoglobulin lambda variable 4-3"	A0A075B6K6	22	22871507-22872035	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"lymphoid tissue: 15.9;stomach 1: 29.2"	"Cell type enriched"	"Detected in some"	23	"Plasma cells: 50.3"	"Cancer enhanced"	"Detected in many"		"lung cancer: 4.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	98	"memory B-cell: 11.7;naive B-cell: 7.8"	"Lineage enriched"	"Detected in single"	118	"B-cells: 11.7"	"Cell line enriched"	"Detected in single"	5	"Daudi: 1.3"														"Immunoglobulin genes"	NA	NA		1600000				"unprognostic (7.22e-2)"	"unprognostic (5.51e-3)"	"unprognostic (2.71e-1)"			"unprognostic (4.37e-4)"		"unprognostic (1.87e-1)"			"unprognostic (2.74e-1)"			"unprognostic (1.49e-1)"	"unprognostic (1.36e-1)"			0.2	0.0	0.0	2.2	0.2	1.5	1.6	0.0	0.2	0.2	0.0	5.2	4.5	0.3	0.0	0.3	0.1	0.4	0.0	0.0	0.0	0.1	0.1	1.0	10.2	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.1	3.3	0.0	2.8	0.0	0.0	0.0	3.1	0.0	0.0	5.3	29.2	0.2	0.0	1.5	0.4	0.0	15.9	0.8	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGLV4-69		ENSG00000211637	"Immunoglobulin lambda variable 4-69"	A0A075B6H9	22	22030934-22031472	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 434.2;lymphoid tissue: 465.1;salivary gland: 117.7;stomach 1: 288.1;urinary bladder: 205.7"	"Cell type enriched"	"Detected in some"	140	"Plasma cells: 4593.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in single"		"medulla oblongata: 1.2"	"Group enriched"	"Detected in some"	302	"memory B-cell: 331.7;naive B-cell: 224.0"	"Lineage enriched"	"Detected in single"	361	"B-cells: 331.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.0;NB-4: 1.0;REH: 1.3;RPMI-8226: 5.4;SH-SY5Y: 1.3"														"Immunoglobulin genes"	NA	NA		320000000				"prognostic favorable (1.02e-4)"	"unprognostic (1.32e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.34e-3)"	"unprognostic (2.67e-2)"	"prognostic favorable (4.04e-5)"	"unprognostic (2.59e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (1.89e-5)"	"unprognostic (9.74e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.08e-2)"	15.7	9.8	0.1	174.0	0.4	43.6	64.7	0.1	0.3	28.1	0.1	328.9	434.2	5.7	0.2	52.7	5.5	44.5	15.3	0.0	0.1	6.1	14.6	72.8	454.3	1.2	0.0	0.0	10.7	8.5	0.3	1.1	0.1	0.2	6.4	211.5	0.0	117.7	6.4	0.2	0.5	221.4	3.4	0.0	308.4	288.1	1.4	0.2	82.9	9.9	0.1	465.1	205.7	5.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	1.0	0.1	0.0	0.0	1.3	0.0	5.4	0.0	0.0	0.7	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.3	0.6	0.0	0.6	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.1	331.7	0.2	0.1	0.2	224.0	0.0	0.1	0.9	0.1	0.1	0.1	0.2	32.3	0.1	0.4	0.1	0.3	0.0	0.1	1.2	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	32.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.5	11.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4593.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.0
IGLV5-45		ENSG00000211650	"Immunoglobulin lambda variable 5-45"	A0A087WSX0	22	22375986-22376505	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 40.9;intestine: 42.5;lymphoid tissue: 98.3;salivary gland: 49.4"	"Cell type enriched"	"Detected in some"	116	"Plasma cells: 6697.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"memory B-cell: 1.2;naive B-cell: 1.1"	"Lineage enriched"	"Detected in single"	11	"B-cells: 1.2"	"Not detected"	"Not detected"																"Immunoglobulin genes"	NA	NA		160000000				"prognostic favorable (4.62e-4)"	"unprognostic (6.18e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.29e-1)"	"prognostic favorable (2.70e-5)"	"unprognostic (1.58e-3)"	"unprognostic (2.77e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.16e-2)"	"unprognostic (3.08e-1)"	"prognostic unfavorable (5.95e-6)"	"unprognostic (6.14e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.36e-2)"	1.9	0.3	0.0	0.0	0.0	0.4	5.6	0.0	0.5	2.3	0.0	25.4	0.0	0.7	0.0	40.9	2.0	0.0	0.2	0.0	0.0	2.6	3.1	9.7	0.0	0.0	0.0	0.0	0.6	0.6	0.0	0.2	0.0	0.1	1.1	0.2	0.0	49.4	0.0	0.1	0.4	42.5	0.0	0.0	98.3	14.2	0.4	0.1	0.0	4.1	0.0	1.4	14.1	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.8	57.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6697.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.1	0.0
KCNA5	"HK2, HPCN1, Kv1.5"	ENSG00000130037	"Potassium voltage-gated channel subfamily A member 5"	P22460	12	5043879-5046788	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Atrial fibrillation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"choroid plexus: 43.1;heart muscle: 24.8"	"Cell type enriched"	"Detected in some"	4	"Bipolar cells: 143.1"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.2"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	122	"plasmacytoid DC: 12.2"	"Lineage enriched"	"Detected in single"	122	"dendritic cells: 12.2"	"Cell line enriched"	"Detected in single"	13	"NTERA-2: 4.2"	"Low region specificity"	"Detected in many"							"HPA021516, CAB022562"	Approved					NA	NA					"CAB022562: , HPA021516: AB_2670732"	"unprognostic (3.87e-1)"	"unprognostic (9.91e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.64e-1)"	"unprognostic (7.06e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.61e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.37e-2)"	"unprognostic (5.08e-3)"	"unprognostic (6.73e-4)"	"unprognostic (1.92e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.08e-2)"	2.3	0.5	3.4	0.2	4.9	0.1	1.4	2.9	3.5	0.7	43.1	3.1	0.3	1.5	0.4	4.9	1.9	0.8	24.8	6.3	7.3	1.1	0.2	2.8	0.2	3.5	5.4	2.4	2.4	1.3	0.0	7.2	2.0	2.8	0.6	0.5	7.6	0.3	0.9	3.9	0.3	1.2	0.5	4.4	0.5	3.7	0.2	4.4	0.1	1.3	4.8	0.4	3.6	1.1	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	3.4	4.9	2.9	3.5	6.3	7.3	3.5	5.4	2.4	2.8	4.4	4.4	4.6	0.7	0.0	0.0	0.3	1.6	0.9	0.0	0.0	0.0	143.1	0.0	0.0	20.9	0.0	0.0	0.0	2.1	0.1	10.7	0.0	0.0	0.0	0.0	0.0	0.1	2.9	3.5	0.0	0.3	0.0	0.0	3.7	0.0	0.0	0.0	4.2	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.0	1.4	0.0	0.0	0.3	0.0	3.7	0.1	1.9	0.0	1.5	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	4.0	13.1	3.5	29.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.1
KISS1R	"AXOR12, GPR54, HOT7T175"	ENSG00000116014	"KISS1 receptor"	Q969F8	19	917287-921005	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 5.7"	"Cell type enriched"	"Detected in some"	9	"Extravillous trophoblasts: 41.9"	"Cancer enhanced"	"Detected in many"		"renal cancer: 3.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 15.7;RPMI-8226: 37.4;SCLC-21H: 7.4;SH-SY5Y: 20.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA007156, HPA071913"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"HPA007156: , HPA071913: AB_2686471"	"unprognostic (1.54e-1)"	"unprognostic (3.01e-2)"	"unprognostic (9.42e-2)"	"unprognostic (2.15e-1)"	"unprognostic (8.46e-3)"	"unprognostic (9.23e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.17e-2)"	"prognostic unfavorable (3.33e-6)"	"unprognostic (1.87e-1)"	"unprognostic (8.09e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.05e-2)"	0.0	0.0	2.3	0.1	1.9	0.0	0.0	0.9	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.4	3.4	0.2	0.1	0.1	0.1	3.4	1.8	3.3	0.0	1.4	0.3	1.1	0.1	4.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.0	0.4	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.1	0.1	5.1	0.0	0.7	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.3	4.1	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	15.7	0.0	0.0	0.3	0.1	0.0	0.6	1.2	0.4	1.0	0.0	37.4	0.0	0.0	7.4	20.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	2.3	1.9	0.9	1.9	1.4	3.4	3.4	1.8	3.3	4.1	1.0	5.7	5.1	0.1	0.0	0.0	0.0	1.0	0.1	0.1	0.5	0.0	1.1	1.2	1.4	0.5	0.0	0.2	0.0	0.0	0.4	0.2	0.1	0.0	0.7	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.2	41.9	0.1	0.0	0.4	0.0	0.1	0.0	0.1	0.7	0.0	0.7	0.0	0.0	0.0	1.5	0.0	0.0	0.3	1.8	0.0	0.0	0.2	1.0	0.0	0.0	0.1	0.0	0.0	4.2	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.4	0.0	0.3	0.3	0.3	1.6	0.9	0.2	0.1	0.2
KRT6B	KRTL1	ENSG00000185479	"Keratin 6B"	P04259	12	52446651-52452146	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Ectodermal dysplasia, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"esophagus: 942.0"	"Cell type enriched"	"Detected in some"	4	"Squamous epithelial cells: 217.5"	"Group enriched"	"Detected in many"	5	"head and neck cancer: 1424.3;melanoma: 472.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"OE19: 148.7"									"CAB000130, HPA045697, HPA061168"	Supported		Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"CAB000130: , HPA045697: AB_2679422, HPA061168: AB_2684440"	"prognostic favorable (9.44e-4)"	"unprognostic (3.27e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.28e-1)"		"unprognostic (1.21e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.07e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.77e-2)"		"unprognostic (9.63e-2)"		"unprognostic (3.29e-1)"	"prognostic unfavorable (9.52e-4)"	0.5	0.2	0.0	2.0	0.0	0.1	16.4	0.0	0.0	109.0	0.0	0.3	0.0	0.1	0.0	942.0	0.2	0.2	0.3	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.3	0.0	0.0	0.2	0.0	0.0	169.9	0.0	0.3	208.9	0.2	0.0	0.0	0.1	0.7	0.2	0.0	2.1	0.1	0.0	74.9	0.2	231.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.9	0.0	27.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	29.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	148.7	1.1	0.0	0.1	13.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	20.6	1.8	40.4	0.0	0.0	28.7	16.8	0.1	0.0	16.3	0.0	0.0	0.0	0.9	0.3	0.0	46.2	1.8	0.0	0.0	0.9	0.0	0.0	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.0	0.0	1.7	1.3	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	5.6	0.0	0.0	2.8	0.0	0.0	0.0	1.4	0.0	0.2	217.5	32.7	0.0	0.3	0.0	0.6	5.9
LCN10		ENSG00000187922	"Lipocalin 10"	Q6JVE6	9	136738167-136743356	"Predicted secreted proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"epididymis: 32.6"	"Cell type enriched"	"Detected in single"	32	"B-cells: 6.4"	"Cancer enriched"	"Detected in single"	8	"thyroid cancer: 1.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	18	"memory B-cell: 6.5;naive B-cell: 6.4"	"Lineage enriched"	"Detected in single"	18	"B-cells: 6.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055919	Approved				"Secreted in male reproductive system"	NA	NA					"HPA055919: AB_2682969"	"unprognostic (2.02e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.89e-1)"	"unprognostic (5.85e-2)"	"unprognostic (6.54e-3)"	"unprognostic (2.22e-4)"	"unprognostic (4.54e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.14e-3)"	"unprognostic (2.96e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.52e-1)"	"unprognostic (8.32e-2)"	"unprognostic (3.86e-1)"	3.0	0.1	1.4	1.1	1.3	0.8	2.8	1.2	1.9	5.6	1.3	1.5	0.1	7.8	32.6	1.2	7.9	0.4	5.5	1.3	1.3	0.1	0.1	0.9	1.4	1.3	1.3	1.1	2.1	1.0	0.3	0.1	0.0	1.3	2.7	0.7	0.0	1.6	1.0	0.8	0.7	2.7	3.1	1.3	1.6	2.2	1.2	1.5	0.3	2.1	2.0	1.1	3.2	2.4	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	6.4	0.2	0.0	0.0	0.2	0.0	0.0	0.3	0.3	1.4	1.3	1.2	1.9	1.3	1.3	1.3	1.3	1.1	1.3	1.3	1.5	1.6	0.2	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1
LPAR1	"edg-2, EDG2, Gpcr26, GPR26, LPA1, Mrec1.3, rec.1.3, vzg-1"	ENSG00000198121	"Lysophosphatidic acid receptor 1"	Q92633	9	110873263-111038458	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 339.6;choroid plexus: 153.0"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 626.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 9.1;eosinophil: 19.0"	"Group enriched"	"Detected in many"	6	"granulocytes: 19.0;monocytes: 9.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 582.0;ASC TERT1: 337.0;BJ hTERT+: 426.7;HSkMC: 246.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050667			Approved	"Nuclear speckles,Plasma membrane"		NA	NA			"Nuclear speckles"	"Plasma membrane"	"HPA050667: "	"unprognostic (1.35e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.79e-2)"	"unprognostic (6.08e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.29e-3)"	"unprognostic (2.12e-2)"	"unprognostic (5.42e-3)"	"unprognostic (2.78e-2)"	"unprognostic (9.97e-3)"	"unprognostic (1.65e-1)"	27.3	13.5	306.6	19.0	318.5	0.2	26.1	235.1	274.8	58.2	153.0	21.8	14.0	17.2	17.3	15.3	15.9	14.3	16.7	220.9	231.0	7.8	2.6	16.5	17.8	300.0	304.1	187.2	12.2	6.6	2.2	5.0	39.1	310.8	21.1	18.5	0.8	16.8	23.8	6.7	19.1	18.4	20.7	262.5	14.9	11.9	6.9	276.0	6.8	16.6	17.7	17.4	27.9	31.9	339.6	11.7	22.2	30.4	0.1	582.0	337.0	0.0	151.6	426.7	104.1	46.8	3.0	1.8	0.0	0.1	157.7	18.6	45.5	0.4	118.5	85.0	0.0	4.1	0.0	1.1	0.0	157.1	0.1	0.2	246.6	6.8	51.4	96.9	62.3	1.8	0.2	0.0	0.2	80.8	0.1	0.0	0.1	5.9	0.0	121.6	0.1	22.4	0.0	23.5	20.6	0.9	7.2	3.1	0.0	0.0	6.2	10.4	0.5	0.1	48.9	1.3	35.3	0.1	1.5	0.0	0.0	7.4	0.0	54.9	1.5	9.1	19.0	0.0	3.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	1.9	2.1	1.3	0.2	0.0	2.1	306.6	318.5	235.1	274.8	220.9	231.0	300.0	304.1	187.2	310.8	262.5	276.0	339.6	1.9	0.0	1.1	6.2	0.2	13.0	15.5	8.5	4.0	0.0	3.4	6.0	1.4	1.5	9.1	0.0	0.0	0.5	0.3	6.6	1.9	1.8	1.4	3.6	40.4	1.9	0.0	0.0	1.0	2.9	0.4	61.4	6.1	8.7	0.0	0.0	2.5	0.0	3.3	0.0	15.6	3.7	4.1	4.1	15.1	2.7	38.8	3.6	14.2	141.5	12.0	1.0	1.0	1.0	626.8	2.0	2.9	70.7	0.7	12.7	4.5	0.2	3.0	0.2	0.0	13.3	6.3	0.3	2.4	15.2	9.2	0.8	1.2	0.2	4.2	6.7
LRRC4C	"KIAA1580, NGL-1"	ENSG00000148948	"Leucine rich repeat containing 4C"	Q9HCJ2	11	40114203-41459773	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 16.8;retina: 17.3"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocyte precursor cells: 5497.5"	"Cancer enhanced"	"Detected in some"		"glioma: 3.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AF22: 19.1;U-2 OS: 20.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054800, HPA075816"	Supported		Approved	Cytosol		NA	NA			Cytosol		"HPA054800: AB_2682603, HPA075816: "	"unprognostic (4.86e-3)"	"unprognostic (3.43e-2)"	"unprognostic (7.62e-3)"	"unprognostic (4.87e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.84e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.90e-13)"	"unprognostic (5.05e-4)"	"unprognostic (5.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.45e-3)"	0.7	3.5	12.1	0.8	15.5	0.0	1.4	1.4	16.8	3.1	0.0	1.9	0.4	1.2	0.3	0.4	0.5	0.8	1.5	14.5	10.2	0.3	1.1	0.8	0.7	9.0	10.1	15.6	0.6	0.3	1.7	4.1	0.0	7.9	0.6	0.7	17.3	0.7	1.6	0.3	0.2	0.8	1.3	4.1	0.6	0.5	0.2	8.6	0.6	2.4	0.7	0.8	0.7	2.0	12.0	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	20.9	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	15.5	1.4	16.8	14.5	10.2	9.0	10.1	15.6	7.9	4.1	8.6	12.0	0.2	0.0	1.3	498.2	0.2	0.1	0.0	1.4	0.0	35.5	4.2	3.0	1.2	0.0	1.4	0.0	6.2	0.0	0.0	0.0	1.9	0.0	0.9	0.3	10.5	1.4	0.0	0.0	1171.8	0.0	0.0	5.6	0.0	0.9	0.0	0.1	0.0	0.0	0.1	8.4	1274.6	0.0	0.0	0.0	1.9	0.2	2.1	0.4	1.8	49.6	0.0	93.6	0.0	5497.5	221.3	0.3	0.0	1.5	0.1	0.1	0.0	0.7	0.0	99.7	0.0	2.0	0.7	0.3	0.5	0.0	0.0	0.0	0.0	2.3	0.0	0.0
LRRC52	FLJ25811	ENSG00000162763	"Leucine rich repeat containing 52"	Q8N7C0	1	165544000-165563957	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"testis: 16.8"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 185.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (9.09e-2)"			"unprognostic (1.76e-2)"	"unprognostic (6.48e-2)"			"unprognostic (3.79e-2)"	"unprognostic (8.45e-2)"	"unprognostic (6.70e-4)"						"unprognostic (6.05e-4)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	4.1	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	185.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LTF	HLF2	ENSG00000012223	Lactotransferrin	P02788	3	46435645-46485234	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Ion transport, Iron transport, Osteogenesis, Transcription, Transcription regulation, Transport"	"Antibiotic, Antimicrobial, DNA-binding, Heparin-binding, Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 4295.9;salivary gland: 1172.0"	"Cell type enriched"	"Detected in many"	5	"Breast glandular cells: 1519.6"	"Group enriched"	"Detected in all"	5	"breast cancer: 239.0;endometrial cancer: 170.3;glioma: 152.6;prostate cancer: 195.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	23	"neutrophil: 5.4;non-classical monocyte: 17.0"	"Group enriched"	"Detected in many"	23	"granulocytes: 5.4;monocytes: 17.0"	"Group enriched"	"Detected in some"	11	"RPMI-8226: 43.2;TIME: 14.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB008646, CAB016201, HPA057177, HPA059976"	Enhanced				"Secreted to blood"	NA	NA		350000000			"CAB008646: AB_1618695, CAB016201: AB_629860, HPA057177: AB_2683361, HPA059976: AB_2684185"	"unprognostic (7.24e-3)"	"unprognostic (2.43e-1)"	"unprognostic (5.94e-2)"	"unprognostic (3.41e-2)"	"unprognostic (7.14e-3)"	"unprognostic (3.45e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.21e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.04e-1)"	"prognostic favorable (6.30e-5)"	"unprognostic (1.66e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.09e-3)"	4.9	1.2	2.3	36.4	3.2	4295.9	336.8	6.5	4.2	663.9	2.5	2.8	1.2	4.2	158.8	23.2	4.4	7.6	4.2	3.0	6.8	102.3	3.3	29.7	8.7	4.6	20.2	0.7	0.5	18.8	6.2	7.0	3.1	10.5	155.5	2.2	0.9	1172.0	382.4	1.7	11.9	5.2	1.9	7.2	71.0	334.6	0.4	16.1	30.0	10.2	1.7	348.4	2.4	1.2	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.7	0.1	0.0	0.0	1.9	0.5	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.7	0.1	0.1	0.0	0.1	0.6	43.2	0.2	0.2	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.0	14.3	0.0	0.3	1.2	0.1	0.6	0.0	0.1	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	17.0	0.4	0.0	29.5	2.3	3.2	6.5	4.2	3.0	6.8	4.6	20.2	0.7	10.5	7.2	16.1	9.6	15.5	0.0	2.8	0.7	4.3	1.1	8.6	82.8	0.0	0.0	1519.6	198.4	1.0	2.8	298.0	71.7	0.0	0.0	6.2	0.1	0.0	1.4	1.2	0.3	0.2	8.8	0.0	3.0	0.1	0.9	0.2	2.5	56.1	2.3	1.3	0.1	5.0	0.0	0.0	0.0	0.0	0.2	14.2	0.0	0.7	1.5	5.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.1	0.0	0.1	78.6	0.0	18.6	14.9	0.0	0.0	0.3	9.9	0.2	0.1	15.4	0.1	0.1	4.0	0.1	0.1	101.7
LUZP2		ENSG00000187398	"Leucine zipper protein 2"	Q86TE4	11	24496970-25082638	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 29.2"	"Cell type enriched"	"Detected in some"	5	"Oligodendrocyte precursor cells: 1890.0"	"Group enriched"	"Detected in some"	7	"glioma: 3.5;prostate cancer: 4.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 10.9;HAP1: 4.4;HeLa: 1.9;hTERT-RPE1: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039007, HPA046161"	Enhanced	Supported	Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted in brain"	NA	NA			"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA039007: AB_2676307, HPA046161: AB_2679564"	"unprognostic (4.49e-2)"	"unprognostic (2.74e-2)"	"unprognostic (8.63e-2)"	"unprognostic (3.50e-1)"	"unprognostic (5.22e-3)"	"unprognostic (3.38e-1)"	"unprognostic (4.88e-2)"	"unprognostic (5.67e-4)"	"unprognostic (2.40e-1)"	"unprognostic (5.66e-2)"	"unprognostic (6.16e-3)"	"unprognostic (4.09e-2)"	"unprognostic (5.18e-3)"	"unprognostic (9.41e-3)"	"unprognostic (4.18e-2)"	"unprognostic (2.17e-1)"	"unprognostic (9.64e-2)"	0.3	6.5	8.2	0.1	8.7	0.1	0.5	13.2	7.2	0.1	1.0	0.8	0.1	0.2	0.0	0.1	0.0	0.1	0.1	6.2	13.7	0.2	0.9	0.2	0.0	12.1	29.2	6.1	0.0	0.0	0.0	0.6	0.0	14.1	2.4	0.6	1.1	0.1	0.1	0.0	0.1	0.2	0.3	17.4	0.1	0.1	0.5	16.0	0.0	0.0	0.6	0.0	0.3	0.1	17.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	10.9	4.4	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.1	0.2	0.0	1.1	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.2	8.7	13.2	7.2	6.2	13.7	12.1	29.2	6.1	14.1	17.4	16.0	17.4	0.3	0.0	0.0	11.4	0.0	0.6	0.1	0.0	1.8	6.9	0.3	1.7	0.6	0.0	0.0	3.7	0.0	0.0	0.1	1.2	0.0	0.0	33.7	0.6	0.7	0.1	0.0	0.0	149.4	0.0	0.1	2.6	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	371.4	1.7	0.0	0.0	0.0	6.4	0.9	0.1	0.0	4.7	0.0	0.3	0.0	1890.0	9.1	0.2	23.9	0.0	0.0	4.5	0.0	0.7	0.0	0.8	0.0	0.4	0.3	0.3	0.6	0.9	0.3	0.1	0.0	2.4	1.5	1.6
MEX3D	"KIAA2031, OK/SW-cl.4, RKHD1, RNF193, Tino"	ENSG00000181588	"Mex-3 RNA binding family member D"	Q86XN8	19	1554669-1568058	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 78.9"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 340.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"REH: 67.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065385	Approved					NA	NA					"HPA065385: AB_2685482"	"unprognostic (2.71e-1)"	"unprognostic (9.01e-2)"	"unprognostic (3.90e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.80e-2)"	"unprognostic (9.35e-3)"	"unprognostic (3.58e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.85e-1)"	"unprognostic (3.74e-1)"	"unprognostic (9.37e-3)"	"unprognostic (2.75e-3)"	"unprognostic (5.13e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.36e-2)"	7.7	3.9	10.3	2.6	9.0	0.4	8.1	8.6	9.4	8.9	0.6	7.7	4.7	12.7	5.9	9.6	7.8	2.8	6.1	7.7	6.5	4.9	5.5	7.8	1.2	15.9	9.9	6.5	12.4	6.3	2.3	4.9	6.9	16.4	6.9	2.7	0.8	9.3	2.7	1.7	10.8	5.2	3.6	10.7	2.7	6.9	78.9	10.2	1.6	6.2	1.5	2.1	7.8	9.3	17.8	40.6	3.1	17.5	20.3	6.4	6.1	43.2	24.9	5.4	9.6	10.0	9.9	6.9	12.9	27.5	9.3	2.4	20.5	7.7	6.2	11.7	21.2	9.5	3.1	3.3	12.2	5.1	9.4	8.5	4.6	9.0	5.2	4.1	7.6	15.4	6.7	18.7	12.2	11.4	8.1	22.2	10.0	36.5	8.8	11.6	67.4	18.5	10.0	8.7	6.1	26.2	29.6	20.3	11.1	15.2	14.6	14.2	10.4	28.0	19.6	27.4	30.4	32.3	13.6	5.8	13.5	8.3	13.8	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	9.0	8.6	9.4	7.7	6.5	15.9	9.9	6.5	16.4	10.7	10.2	17.8	18.1	12.8	8.4	2.0	0.6	14.8	3.5	3.8	6.2	2.4	23.4	13.2	7.3	8.6	4.2	9.2	0.0	5.2	3.4	10.8	0.0	11.9	73.8	15.6	15.6	10.5	18.6	4.0	0.9	9.6	12.8	11.0	2.6	19.9	1.3	8.2	12.5	13.6	2.4	1.7	0.6	7.3	6.1	2.5	8.1	340.7	14.9	3.3	7.2	0.0	1.2	6.0	1.0	3.0	3.5	20.9	6.4	9.4	0.8	8.9	6.2	2.7	1.7	1.7	0.0	5.9	13.6	3.7	4.3	10.1	17.6	16.6	2.5	2.6	9.6	5.1
MOG	"BTN6, BTNL11"	ENSG00000204655	"Myelin oligodendrocyte glycoprotein"	Q16653	6	29657002-29672372	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 66.1"	"Cell type enriched"	"Detected in some"	49	"Oligodendrocytes: 472.3"	"Cancer enriched"	"Detected in single"	45	"glioma: 15.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in all"		"white matter: 1396.5"	"Low region specificity"	"Detected in all"			HPA021873	Enhanced					NA	NA					"HPA021873: AB_1854055"	"unprognostic (1.33e-1)"				"unprognostic (1.32e-1)"				"unprognostic (1.03e-1)"	"unprognostic (1.05e-2)"		"unprognostic (7.87e-2)"	"unprognostic (3.00e-4)"	"unprognostic (4.89e-2)"	"unprognostic (4.90e-2)"			0.0	0.0	17.7	0.0	23.1	0.0	0.0	20.9	66.1	0.0	15.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.4	19.0	21.9	0.0	0.0	0.0	0.0	27.8	21.4	17.2	0.1	0.0	0.0	0.3	0.0	53.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	20.1	0.0	0.0	0.0	21.6	0.0	0.0	0.0	0.0	0.0	0.0	35.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	23.1	20.9	66.1	19.0	21.9	27.8	21.4	17.2	53.2	20.1	21.6	35.2	0.0	0.0	1.1	0.7	0.1	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.8	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.8	0.0	0.0	0.3	0.7	0.0	0.0	0.2	0.0	1.0	0.1	0.0	0.0	9.5	472.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.1	0.1	0.0	0.9	0.0	0.3	0.0	0.0	0.3
MTRNR2L4		ENSG00000232196	"MT-RNR2 like 4"	P0CJ71	16	3370979-3372668	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in many"	4	"skeletal muscle: 296.3"	"Cell type enriched"	"Detected in some"	14	"Cardiomyocytes: 154.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 168.2"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 168.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 48.8;HaCaT: 51.3;HeLa: 88.0"														"Secreted to blood"	NA	NA						"unprognostic (8.53e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.66e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.81e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.19e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.65e-1)"	18.1	53.2	17.3	10.9	17.3	9.5	2.5	18.4	39.3	1.1	17.3	14.8	20.9	4.7	2.2	10.9	2.4	3.4	66.6	19.6	17.2	32.1	17.2	5.8	3.9	19.5	17.1	17.2	4.9	14.0	1.7	0.3	6.4	18.8	7.4	9.1	7.4	17.2	2.9	296.3	9.7	21.9	3.4	17.3	9.2	19.3	12.3	17.3	0.2	1.8	3.2	3.3	1.4	0.1	18.7	13.8	8.8	2.6	48.8	1.1	1.6	15.0	7.3	0.4	0.9	0.7	4.2	28.7	10.2	14.5	0.4	0.3	51.3	0.1	0.5	0.4	7.8	5.0	9.0	88.0	36.6	0.2	3.0	23.5	1.0	0.7	0.2	0.5	1.1	0.1	1.1	6.9	13.6	1.5	3.0	6.4	23.8	4.0	0.5	1.7	11.6	6.9	9.2	2.1	10.2	5.7	13.0	4.6	11.6	19.1	0.8	16.1	22.7	6.6	15.4	13.5	18.0	5.3	7.1	2.5	9.7	10.6	22.8	3.7	62.3	25.6	72.1	4.9	12.9	5.5	14.3	6.2	6.4	11.1	16.5	6.9	8.7	168.2	8.6	13.4	13.4	7.7	23.3	17.3	17.3	18.4	39.3	19.6	17.2	19.5	17.1	17.2	18.8	17.3	17.3	18.7	0.2	0.0	0.0	0.0	0.1	0.1	2.5	0.0	0.0	0.0	0.2	0.1	154.2	2.8	0.0	1.8	0.0	0.1	0.1	0.0	3.9	0.0	0.0	0.1	0.2	3.1	0.0	0.0	0.1	0.2	0.0	3.3	0.0	0.2	0.0	0.1	0.4	0.2	0.1	0.0	0.0	0.5	0.0	0.6	0.7	0.0	0.0	0.6	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	1.8	0.0	10.4	0.0	0.0	0.0	2.5	3.3	1.0	0.3	0.0	0.3	0.1	0.4	0.1	0.0	1.4
MTRNR2L7		ENSG00000256892	"MT-RNR2 like 7"	P0CJ74	10	37601440-37602974	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	4	"brain: 1.7"	"Cell type enriched"	"Detected in some"	26	"Cardiomyocytes: 188.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted - unknown location"	NA	NA															"unprognostic (2.28e-1)"				"unprognostic (5.87e-2)"				0.0	0.1	0.4	0.0	0.4	0.1	0.0	0.4	1.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.4	0.1	0.1	0.0	0.0	0.4	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	1.7	0.4	0.4	0.4	0.4	0.3	0.4	0.4	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	188.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.6	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4
NAALADL1		ENSG00000168060	"N-acetylated alpha-linked acidic dipeptidase like 1"	Q9UQQ1	11	65044818-65058553	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"intestine: 100.1"	"Cell type enriched"	"Detected in many"	11	"Proximal enterocytes: 588.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 182.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 5.8;fHDF/TERT166: 7.8;HHSteC: 20.2;HSkMC: 13.5;SCLC-21H: 10.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA047123	Enhanced		Uncertain	Cytosol		NA	NA			Cytosol		"HPA047123: AB_2679942"	"unprognostic (2.98e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.75e-4)"	"unprognostic (2.10e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.80e-2)"	12.5	3.2	3.7	6.7	3.5	21.3	12.2	3.9	6.0	22.7	5.9	16.7	20.0	18.9	4.6	7.3	15.4	9.4	9.3	3.3	3.7	7.4	2.6	11.0	11.0	3.9	3.5	3.0	16.8	2.3	2.0	6.1	2.3	3.8	14.0	7.2	2.0	5.0	11.6	2.8	5.3	100.1	10.6	3.7	15.4	8.2	8.7	3.9	3.5	5.7	4.2	7.0	12.8	14.6	4.4	0.0	0.0	0.1	0.2	0.5	5.8	1.0	2.3	0.0	2.8	1.3	0.0	0.0	0.1	0.0	7.8	0.0	0.0	0.0	0.2	0.1	0.9	0.4	0.0	0.2	3.5	20.2	0.0	0.0	13.5	0.0	2.7	0.0	0.1	3.6	0.1	0.0	0.3	0.0	0.2	0.2	0.7	0.0	0.1	0.1	0.1	0.0	1.0	0.2	0.0	10.5	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.8	0.0	0.1	0.1	182.0	21.2	35.9	29.6	14.6	15.8	25.7	23.8	14.8	16.3	29.8	27.0	15.0	3.7	80.2	8.8	0.7	45.2	24.6	3.7	3.5	3.9	6.0	3.3	3.7	3.9	3.5	3.0	3.8	3.7	3.9	4.4	19.1	0.0	0.0	0.0	8.0	3.6	3.4	5.6	6.2	2.0	0.8	9.1	1.8	1.5	0.4	0.0	0.0	0.2	9.8	31.3	3.9	0.1	0.8	0.4	5.8	11.1	1.2	2.5	0.3	0.8	0.3	11.4	1.1	0.2	19.7	4.3	16.8	0.4	2.8	10.1	0.4	21.0	2.0	5.6	5.7	2.6	11.8	5.2	16.0	1.0	17.3	12.2	41.2	1.0	0.1	0.2	50.0	18.0	1.1	0.5	588.6	0.5	0.5	0.9	0.0	8.3	11.1	1.6	3.5	1.3	3.3	0.4	11.1	3.9	11.8	0.4
NECTIN4	"LNIR, nectin-4, PRR4, PVRL4"	ENSG00000143217	"Nectin cell adhesion molecule 4"	Q96NY8	1	161070998-161089558	"Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 99.7;salivary gland: 33.8;skin 1: 112.6;vagina: 57.8"	"Cell type enriched"	"Detected in some"	5	"Syncytiotrophoblasts: 384.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 56.5;HaCaT: 37.0;MCF7: 24.0;OE19: 24.6;SK-BR-3: 47.8;T-47d: 31.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA010775	Enhanced		Supported	"Plasma membrane"	"Secreted in other tissues"	No	No		170000	"Plasma membrane"		"HPA010775: AB_1079720"	"unprognostic (1.09e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.11e-2)"	"unprognostic (5.69e-3)"	"unprognostic (2.09e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.24e-8)"	"unprognostic (2.98e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.68e-2)"	"unprognostic (4.97e-2)"	0.3	0.1	0.1	0.5	0.1	0.7	13.8	0.3	0.2	13.5	0.0	1.5	0.7	1.3	7.0	99.7	2.9	3.8	0.1	0.1	0.1	3.1	0.1	3.5	0.1	0.1	0.1	0.1	0.0	4.5	0.4	0.6	12.3	0.2	9.5	1.7	0.1	33.8	4.4	0.6	112.6	0.6	0.1	0.1	0.0	8.9	0.6	0.2	0.8	0.2	0.0	14.6	17.0	57.8	0.4	10.9	0.4	0.0	0.1	0.0	0.1	56.5	0.1	0.1	0.1	0.2	0.0	14.6	0.0	0.2	0.0	0.1	37.0	0.0	1.2	0.2	0.0	0.5	0.0	0.8	11.1	0.0	0.1	0.7	0.0	14.6	3.0	3.6	0.1	0.0	0.0	0.0	0.1	0.1	24.0	0.1	0.1	0.1	24.6	0.0	0.0	0.0	0.1	0.0	17.5	0.0	0.2	0.2	47.8	0.0	6.4	31.1	0.0	0.0	0.1	2.4	0.5	0.2	0.2	0.1	0.1	0.1	0.0	0.2	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.4	0.2	6.4	9.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	41.6	17.8	0.0	0.0	8.1	16.5	0.0	39.4	0.4	0.0	0.0	41.7	0.0	28.1	2.9	0.6	0.0	0.0	0.0	30.0	67.1	1.2	0.0	43.1	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	67.1	0.0	0.0	0.0	0.0	0.0	0.1	10.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	384.2	0.4	0.1	0.0	0.0
OBSCN	"ARHGEF30, KIAA1556, KIAA1639, UNC89"	ENSG00000154358	"Obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF"	Q5VST9	1	228208044-228378876	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Differentiation	"Calmodulin-binding, Developmental protein, Kinase, Muscle protein, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"skeletal muscle: 485.2"	"Cell type enriched"	"Detected in many"	6	"Cardiomyocytes: 155.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 10.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA021186, HPA065801"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		4500000	"Plasma membrane, Cytosol"		"HPA021186: AB_1854761, HPA065801: "	"unprognostic (8.47e-3)"	"unprognostic (1.56e-1)"	"unprognostic (9.99e-2)"	"prognostic unfavorable (1.64e-4)"	"unprognostic (5.30e-3)"	"unprognostic (6.36e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.82e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.16e-2)"	2.4	2.5	1.7	1.4	14.8	1.6	3.7	9.3	3.2	7.3	14.2	5.0	0.7	3.7	1.8	4.6	5.1	1.1	58.7	0.9	2.7	6.6	1.3	8.9	2.1	5.5	2.4	0.9	8.7	5.4	1.1	13.7	0.9	7.3	10.0	0.5	0.8	9.4	1.7	485.2	4.1	5.5	0.5	0.7	9.3	5.3	1.9	4.6	5.0	7.5	113.8	1.3	3.2	7.5	2.7	1.7	2.8	3.6	3.7	0.2	0.2	4.6	1.6	0.7	1.7	1.4	2.1	1.3	3.2	5.4	0.7	0.7	2.1	1.3	2.2	0.3	2.0	3.4	1.7	10.5	0.1	1.2	2.4	2.2	1.4	0.6	0.4	0.5	5.1	0.5	7.0	3.2	0.0	0.3	1.8	3.3	3.5	4.9	0.6	2.1	4.4	0.0	1.9	1.8	1.4	1.7	6.3	0.6	3.9	1.0	0.8	3.4	4.0	1.0	0.0	5.1	0.3	0.5	2.5	0.5	4.7	0.0	0.8	2.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.1	0.1	1.7	14.8	9.3	3.2	0.9	2.7	5.5	2.4	0.9	7.3	0.7	4.6	2.7	1.5	0.0	5.5	1.6	2.4	2.2	6.6	7.7	23.9	4.2	7.3	11.9	155.8	4.3	4.5	5.5	10.4	0.1	1.9	0.7	11.7	3.6	4.9	3.9	3.7	3.1	0.0	3.0	3.9	0.5	0.5	5.7	3.1	11.3	7.0	1.8	1.4	0.5	0.1	0.0	5.3	2.7	4.1	0.3	1.0	4.5	3.1	1.1	1.8	5.6	0.5	7.9	4.1	1.5	1.7	0.8	1.1	4.5	1.5	3.8	0.6	4.1	1.3	3.2	0.0	22.9	6.1	1.0	4.1	9.4	1.7	1.2	5.4	6.2	1.2	3.6
PAX5	BSAP	ENSG00000196092	"Paired box 5"	Q02548	9	36833269-37034268	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"lymphoid tissue: 40.0"	"Cell type enriched"	"Detected in some"	29	"B-cells: 91.3"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"medulla oblongata: 4.4;midbrain: 4.9;pons: 3.7;thalamus: 3.6;white matter: 1.3"	"Group enriched"	"Detected in some"	43	"memory B-cell: 39.0;naive B-cell: 26.0"	"Lineage enriched"	"Detected in single"	52	"B-cells: 39.0"	"Group enriched"	"Detected in some"	9	"Daudi: 66.6;REH: 194.1;U-698: 87.1"	"Region enriched"	"Detected in single"	11	"midbrain: 3.9"	"Low region specificity"	"Detected in all"			"CAB026269, CAB026869, HPA056394, HPA068498"	Enhanced	Supported	Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center, Vesicles, Cytosol"	"CAB026269: , CAB026869: , HPA056394: AB_2683116, HPA068498: AB_2685997"	"unprognostic (4.69e-4)"	"unprognostic (3.83e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.11e-3)"	"unprognostic (3.15e-1)"	"unprognostic (8.96e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.01e-1)"	0.3	0.1	0.3	15.1	0.3	9.5	0.1	0.3	0.7	0.0	0.2	0.9	0.5	0.2	0.1	0.2	0.0	0.8	0.2	0.3	0.5	0.1	0.2	0.3	40.0	4.4	4.9	0.3	0.0	0.0	0.0	0.2	0.1	3.7	0.3	0.8	0.5	1.0	0.0	3.2	0.0	6.7	0.0	0.7	18.8	1.7	0.6	3.6	2.8	0.2	0.0	36.5	1.1	0.0	1.3	0.1	0.3	5.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	66.6	0.1	0.0	0.1	0.2	0.1	0.0	0.0	3.5	0.1	0.0	0.0	0.0	0.0	2.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.5	0.1	0.3	1.9	0.3	0.4	194.1	0.4	0.3	0.0	0.0	13.2	2.9	0.1	0.7	0.0	0.0	0.0	7.5	0.2	0.0	0.2	0.1	0.0	0.2	0.1	87.1	0.0	1.5	0.1	0.7	0.0	0.1	0.0	0.1	0.1	39.0	0.0	0.0	0.1	26.0	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.7	0.3	0.3	0.3	0.7	0.3	0.5	4.4	4.9	0.3	3.7	0.7	3.6	1.3	0.0	0.0	0.0	0.7	91.3	0.0	0.3	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.4	0.6	0.0	0.0	0.4	0.0	0.0	1.3	0.0	0.0	0.4	0.0	0.0	0.5	0.1	0.0	0.3	0.0	3.1	0.0	0.9	0.0	0.0	0.2	0.5	0.0	0.0	0.3	0.0	0.1	0.0	2.7	0.4	0.0	0.1	0.0	0.1	0.0	0.8	0.1	0.6	0.2	0.2	0.0	0.0	2.0	0.0	0.0	0.3
PCDH15	"CDHR15, DFNB23, USH1F"	ENSG00000150275	"Protocadherin related 15"	Q96QU1	10	53802771-55627942	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Hearing"		"Deafness, Disease variant, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adrenal gland: 19.2;brain: 17.1;retina: 62.2"	"Cell type enriched"	"Detected in some"	13	"Oligodendrocyte precursor cells: 2965.2"	"Cancer enriched"	"Detected in single"	9	"glioma: 0.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"U-2 OS: 1.1;U-266/70: 3.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA074437		Supported			"Intracellular and membrane"	NA	NA		22000			"HPA074437: "	"unprognostic (1.38e-1)"	"unprognostic (3.39e-1)"		"unprognostic (8.15e-5)"	"unprognostic (3.07e-3)"	"unprognostic (2.79e-1)"		"unprognostic (9.15e-4)"	"unprognostic (2.02e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.12e-3)"		"unprognostic (1.31e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.27e-1)"	"unprognostic (7.66e-3)"	0.2	19.2	14.2	0.3	9.7	0.1	0.0	3.3	10.6	0.2	0.0	0.2	0.2	0.1	0.5	0.1	0.1	0.1	0.3	15.4	14.2	8.1	0.0	2.5	0.4	13.9	11.4	10.2	0.0	0.0	0.5	4.7	0.2	10.6	0.2	0.0	62.2	0.1	0.0	0.0	0.0	0.2	0.0	7.7	0.7	0.3	3.3	17.1	0.1	0.0	0.0	0.5	0.5	0.0	10.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	1.1	0.0	0.0	3.3	0.3	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	9.7	3.3	10.6	15.4	14.2	13.9	11.4	10.2	10.6	7.7	17.1	10.1	0.0	0.0	0.0	14.4	0.0	0.3	0.0	0.0	0.0	5.1	0.6	0.0	4.8	0.0	0.0	0.0	87.6	0.0	0.0	0.0	0.0	0.0	26.1	0.0	0.1	0.3	0.0	0.0	27.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	216.2	0.1	0.0	0.0	0.0	7.5	0.0	0.1	0.0	3.7	0.0	4.4	0.0	2965.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	92.8	0.0	0.0	0.2	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0
PCP2	"GPSM4, MGC41903"	ENSG00000174788	"Purkinje cell protein 2"	Q8IVA1	19	7631611-7633719	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 52.8;retina: 33.6;testis: 113.3"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 4139.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 52.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 8.4;Karpas-707: 4.2;NB-4: 17.7"	"Region enriched"	"Detected in many"	44	"cerebellum: 2160.4"	"Region enriched"	"Detected in all"	28	"cerebellum: 552.9"	HPA057428			Approved	"Nuclear speckles,Vesicles"		Yes	NA			"Nuclear speckles"	Vesicles	"HPA057428: AB_2683436"	"prognostic favorable (7.93e-4)"	"unprognostic (6.06e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.79e-4)"	"unprognostic (1.19e-1)"	"unprognostic (4.88e-5)"	"unprognostic (1.11e-1)"	"unprognostic (6.23e-2)"	"unprognostic (9.15e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.70e-2)"	"prognostic favorable (2.76e-5)"	0.3	1.7	0.4	1.1	0.6	3.8	5.6	52.8	1.9	2.1	0.0	0.5	1.4	0.9	3.3	2.1	2.4	2.3	1.3	0.5	0.1	8.0	3.7	2.3	3.0	0.3	2.6	0.0	0.1	5.4	1.1	1.4	0.4	12.9	5.9	0.3	33.6	16.5	1.9	0.2	7.1	1.6	0.0	0.1	3.0	3.1	113.3	0.1	3.1	5.7	0.0	1.5	0.9	1.6	16.6	1.8	0.4	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.7	1.6	0.7	1.1	0.0	0.0	1.3	0.0	0.2	0.0	0.8	0.6	2.6	2.8	0.1	0.0	0.3	8.4	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.2	4.2	0.0	0.3	0.3	17.7	0.4	0.3	0.0	0.8	0.2	0.7	0.8	0.1	0.1	0.0	1.4	1.4	0.0	0.4	3.7	3.4	0.2	0.0	0.5	0.4	0.0	1.4	0.7	0.2	0.0	2.0	0.0	0.0	0.1	0.0	0.3	0.0	0.4	0.1	0.1	0.1	0.2	0.3	0.2	0.3	0.8	0.2	0.0	0.6	0.0	1.7	0.4	0.6	52.8	1.9	0.5	0.1	0.3	2.6	0.0	12.9	0.1	0.1	16.6	0.1	0.0	2.3	0.0	0.2	0.8	1.1	1.4	0.0	734.7	7.7	5.8	0.0	2.8	1.8	5.5	22.9	0.2	2.7	0.7	9.8	0.8	836.5	1.0	0.1	2.6	0.0	0.0	0.0	0.2	0.1	0.1	0.0	1.5	1.3	1.3	0.0	0.5	0.4	23.5	0.0	0.4	0.0	0.8	1.3	4139.3	10.5	7.1	1.8	1.0	1.5	40.7	2.1	0.0	0.0	0.4	0.1	13.2	0.3	1.0	1.3	0.5	0.4	100.3	19.7	0.0	0.1	14.5	9.0	0.0	1.1	0.0	1.0	0.0	0.6	0.6
PHKA1	PHKA	ENSG00000067177	"Phosphorylase kinase regulatory subunit alpha 1"	P46020	X	72578814-72714319	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Calmodulin-binding, Muscle protein"	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"parathyroid gland: 32.2;skeletal muscle: 103.6;tongue: 90.0"	"Cell type enriched"	"Detected in many"	4	"Astrocytes: 85.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 39.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001081, HPA075355"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA001081: AB_1079607, HPA075355: "	"unprognostic (3.68e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (6.84e-4)"	"unprognostic (3.52e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.23e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.76e-1)"	"unprognostic (9.45e-3)"	"unprognostic (9.94e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.12e-1)"	3.2	17.8	7.1	1.0	10.6	0.7	4.9	9.4	6.3	2.4	15.1	3.3	1.1	3.3	6.6	5.7	3.8	3.2	7.6	6.2	11.5	2.7	2.4	2.1	1.1	8.8	10.9	4.5	8.4	7.7	32.2	9.9	1.8	8.5	6.0	3.3	3.9	7.1	6.4	103.6	3.4	2.1	3.4	7.3	3.4	7.0	2.1	9.9	4.0	6.9	90.0	1.4	4.8	3.5	6.8	15.3	21.2	1.2	12.4	7.2	6.8	12.9	2.8	2.6	0.5	0.1	6.2	13.3	0.0	8.2	0.3	15.1	5.9	24.9	10.3	0.8	39.2	25.1	7.0	17.4	5.7	7.5	0.0	0.0	9.1	10.0	2.4	16.7	12.5	14.5	12.7	11.0	0.0	13.6	11.0	11.1	0.7	16.5	25.2	28.0	0.0	0.0	0.0	3.7	7.2	12.9	15.3	13.4	17.3	0.2	15.4	6.2	0.6	7.5	0.0	6.2	2.7	7.3	17.1	17.1	0.0	5.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	10.6	9.4	6.3	6.2	11.5	8.8	10.9	4.5	8.5	7.3	9.9	6.8	5.8	0.0	3.7	85.2	0.5	2.4	6.5	2.3	4.0	2.4	5.2	3.7	6.6	1.5	3.5	11.0	8.4	1.0	0.1	0.8	0.0	1.6	0.4	4.8	1.4	3.5	2.4	4.0	5.3	2.7	1.1	2.5	3.6	2.9	6.3	3.4	5.7	1.9	1.6	3.3	16.0	1.8	4.1	10.4	0.7	0.1	3.1	0.6	1.8	6.5	0.0	1.5	0.0	18.6	0.5	5.4	0.4	8.6	1.3	9.0	0.4	1.6	6.6	3.3	0.0	7.1	1.9	0.4	1.0	5.6	3.4	0.5	0.3	1.9	2.6	8.9
PLEKHH1	KIAA1200	ENSG00000054690	"Pleckstrin homology, MyTH4 and FERM domain containing H1"	Q9ULM0	14	67533290-67589612	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 150.2;thyroid gland: 39.2"	"Cell type enriched"	"Detected in many"	8	"Oligodendrocytes: 607.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 10.2;BEWO: 9.7;RT4: 10.2;SK-MEL-30: 12.0;T-47d: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047707, HPA051964"	Uncertain		Approved	Centrosome		NA	NA			Centrosome		"HPA047707: AB_2680126, HPA051964: AB_2681675"	"unprognostic (2.47e-2)"	"unprognostic (9.57e-2)"	"unprognostic (3.94e-2)"	"prognostic favorable (8.03e-5)"	"unprognostic (4.74e-1)"	"unprognostic (9.15e-3)"	"unprognostic (8.43e-5)"	"unprognostic (1.54e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.14e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.85e-1)"	"prognostic favorable (4.03e-7)"	"unprognostic (1.49e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (2.26e-4)"	0.9	4.0	12.5	1.3	55.5	0.0	2.6	32.6	33.3	2.9	0.0	6.8	11.8	1.4	8.3	1.2	3.4	2.1	0.7	14.3	31.0	2.1	0.4	0.7	0.1	68.4	51.9	5.6	0.2	7.7	9.6	4.4	1.1	71.4	10.3	6.8	7.3	23.0	2.3	0.9	4.1	9.4	0.8	39.1	0.9	6.4	1.9	43.1	1.1	39.2	0.4	0.3	1.4	0.9	150.2	5.3	1.2	2.0	10.2	0.2	0.0	9.7	0.0	0.0	0.1	0.1	3.2	1.6	0.0	1.6	0.0	0.9	2.3	3.6	0.9	0.1	0.3	3.5	0.0	1.8	2.1	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.0	0.0	1.3	4.0	0.0	0.0	7.6	0.0	0.2	3.0	6.0	0.6	0.1	0.3	1.5	1.1	10.2	2.7	2.5	0.9	1.9	12.0	4.7	9.7	2.1	0.0	0.8	3.6	1.0	0.6	0.0	0.0	0.0	0.5	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	55.5	32.6	33.3	14.3	31.0	68.4	51.9	5.6	71.4	39.1	43.1	150.2	0.1	3.2	6.4	19.9	0.7	0.1	0.7	3.1	1.2	16.7	5.8	6.0	3.6	2.8	3.4	9.2	39.6	3.0	1.4	21.2	3.9	2.2	0.6	19.1	2.0	0.7	7.3	0.0	13.4	4.0	0.3	0.6	29.0	18.0	0.0	67.7	0.0	0.2	0.8	3.3	21.9	16.9	0.0	0.6	0.3	0.7	0.3	1.5	3.6	12.2	0.0	4.6	0.0	34.2	607.7	2.9	7.7	0.4	0.0	4.1	12.8	1.7	3.9	36.6	0.0	1.5	1.0	0.7	1.6	2.3	2.3	10.7	0.3	2.0	16.4	1.2
PLN	"CMD1P, PLB"	ENSG00000198523	Phospholamban	P26678	6	118548296-118561716	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"heart muscle: 1578.1;skeletal muscle: 512.0"	"Cell type enriched"	"Detected in some"	8	"Cardiomyocytes: 2452.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							"CAB005597, HPA026900"	Enhanced					NA	NA					"CAB005597: AB_2252716, HPA026900: AB_1855314"	"unprognostic (2.49e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.96e-3)"	"unprognostic (4.81e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.35e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.97e-1)"	"unprognostic (8.98e-2)"	"unprognostic (8.98e-2)"	"unprognostic (3.28e-1)"	"prognostic unfavorable (4.11e-4)"	"unprognostic (2.98e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (5.59e-4)"	40.5	12.5	1.5	12.5	2.2	0.6	16.0	2.8	3.5	31.1	3.7	110.8	13.8	122.7	22.0	44.3	82.6	93.0	1578.1	1.6	2.0	15.1	1.2	15.6	2.7	2.0	1.9	1.2	20.6	3.3	1.3	1.5	0.3	2.0	35.4	24.6	0.2	5.3	37.4	512.0	6.4	41.9	129.5	1.5	3.0	34.3	4.3	2.1	1.0	12.8	232.3	0.9	44.5	23.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.2	2.8	3.5	1.6	2.0	2.0	1.9	1.2	2.0	1.5	2.1	2.1	4.5	0.0	0.0	0.3	0.2	4.2	0.2	0.0	1.2	1.8	0.4	0.6	2452.8	0.0	0.0	0.0	2.1	0.0	0.2	0.0	0.0	0.0	108.2	0.2	0.7	21.4	0.0	0.0	1.0	0.0	0.0	49.1	0.5	0.1	0.0	0.1	0.7	0.1	0.1	0.0	0.9	0.0	0.0	0.0	4.7	25.0	0.9	0.4	3.6	1.0	0.0	0.0	0.0	2.0	1.1	0.1	0.0	11.7	0.0	0.7	0.0	0.0	0.0	0.3	276.1	16.7	248.0	9.2	0.8	0.3	1.6	0.0	0.8	0.0	0.0	0.4
POU2AF1	"BOB1, OBF1"	ENSG00000110777	"POU class 2 homeobox associating factor 1"	Q16633	11	111352255-111455630	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 38.9;lymphoid tissue: 120.4;stomach 1: 40.4"	"Cell type enriched"	"Detected in many"	4	"Plasma cells: 566.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"memory B-cell: 33.5;naive B-cell: 24.0"	"Lineage enriched"	"Detected in many"	9	"B-cells: 33.5"	"Group enriched"	"Detected in many"	4	"Daudi: 307.2;Karpas-707: 339.3;U-266/70: 326.6;U-266/84: 159.9;U-698: 610.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB011193	Enhanced					NA	NA					"CAB011193: AB_532299"	"prognostic favorable (1.68e-4)"	"prognostic favorable (1.63e-4)"	"unprognostic (1.04e-2)"	"unprognostic (5.50e-3)"	"unprognostic (1.88e-1)"	"prognostic favorable (3.59e-4)"	"unprognostic (2.09e-1)"	"unprognostic (3.63e-3)"	"unprognostic (7.15e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.81e-2)"	"unprognostic (8.51e-8)"	"unprognostic (2.35e-1)"	"unprognostic (3.90e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.23e-1)"	2.0	1.2	6.5	49.4	5.5	8.2	5.6	4.1	7.4	1.7	16.5	15.9	22.4	1.6	1.3	2.9	1.3	4.8	1.4	5.8	2.6	1.4	1.4	3.3	100.1	7.0	5.8	4.3	1.2	0.6	0.3	0.1	2.8	7.3	1.9	13.5	6.6	13.0	1.9	1.8	1.1	38.9	1.2	2.6	80.1	40.4	1.7	5.7	9.7	2.8	0.3	120.4	9.4	1.9	7.2	0.9	0.9	0.3	0.4	5.6	5.2	1.0	0.2	0.1	0.1	0.1	1.1	0.3	307.2	0.7	0.3	0.2	0.8	0.9	0.4	0.1	0.9	0.2	0.5	1.0	1.1	0.1	0.6	1.7	0.2	0.3	0.3	0.6	0.5	0.3	3.4	11.8	339.3	0.3	0.8	1.5	1.6	0.4	0.5	0.5	65.3	0.7	83.0	0.2	0.8	0.6	6.1	0.7	0.3	0.2	2.4	1.3	0.9	2.7	0.5	3.1	0.6	0.5	326.6	159.9	610.8	0.4	0.7	0.5	3.8	0.2	0.6	0.3	0.2	0.2	33.5	0.5	0.2	0.1	24.0	0.4	0.2	1.6	0.5	0.4	0.3	1.2	1.2	6.5	5.5	4.1	7.4	5.8	2.6	7.0	5.8	4.3	7.3	2.6	5.7	7.2	0.0	0.0	3.6	0.3	131.3	0.3	7.1	12.3	0.0	0.0	0.0	0.9	1.9	10.0	20.1	0.0	0.0	0.0	0.1	0.2	0.0	0.1	8.4	24.9	0.6	0.2	3.0	6.6	0.1	5.7	0.0	0.8	4.6	0.5	0.0	0.1	0.7	2.4	0.1	0.0	0.1	0.7	2.0	0.6	0.4	10.9	0.3	0.8	8.8	1.0	0.3	0.0	1.0	0.0	4.6	0.4	1.2	0.4	566.8	1.2	0.0	0.4	65.0	0.0	0.0	0.1	1.0	6.3	1.8	0.8	0.0	0.0	4.2	0.0	0.8	8.4
PROB1	C5orf65	ENSG00000228672	"Proline rich basic protein 1"	E7EW31	5	139390592-139395104	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"skeletal muscle: 81.8"	"Cell type enriched"	"Detected in some"	4	"Cardiomyocytes: 29.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	7	"HDLM-2: 104.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA053354, HPA060103"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053354: , HPA060103: AB_2684205"	"unprognostic (4.14e-2)"	"prognostic favorable (9.26e-4)"	"unprognostic (2.60e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.53e-2)"	"unprognostic (9.27e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.28e-3)"	"unprognostic (3.21e-2)"	"unprognostic (4.84e-4)"	"unprognostic (7.10e-2)"	"unprognostic (1.75e-2)"	"unprognostic (9.05e-2)"	"unprognostic (3.62e-2)"	"unprognostic (5.89e-2)"	"unprognostic (8.24e-2)"	1.4	4.9	4.1	0.9	3.2	0.4	1.5	4.6	2.6	1.3	1.9	1.3	1.2	1.7	0.4	1.0	2.1	0.4	16.8	2.9	5.3	1.7	0.6	0.9	1.0	5.3	6.2	1.7	0.6	0.4	2.4	3.0	0.6	4.9	3.3	0.1	0.3	2.4	1.3	81.8	0.6	1.6	0.5	6.3	1.6	1.2	0.8	4.8	0.7	1.0	18.5	0.6	1.6	1.0	3.6	1.5	0.6	0.3	0.3	0.1	0.3	0.5	1.2	0.3	1.3	1.1	4.3	2.6	5.7	1.1	3.9	0.1	0.7	0.5	0.1	0.3	104.7	1.4	1.4	2.7	0.5	3.0	0.0	3.2	0.9	0.7	2.8	0.6	0.7	0.1	3.7	0.5	5.7	4.1	1.2	4.9	2.6	1.4	0.6	2.7	15.4	0.4	12.5	0.2	0.1	1.3	0.7	6.0	4.5	0.2	1.3	2.1	3.0	0.4	0.1	0.4	0.2	0.4	1.0	1.8	9.2	0.1	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.1	3.2	4.6	2.6	2.9	5.3	5.3	6.2	1.7	4.9	6.3	4.8	3.6	2.4	0.0	0.0	0.0	0.7	0.0	0.3	0.0	1.2	0.0	0.4	0.1	29.7	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.1	0.2	2.4	1.5	2.5	0.0	0.4	0.0	0.0	0.3	1.2	1.1	0.9	0.0	0.7	2.9	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.3	0.1	1.2	3.0	0.3	0.0	2.4	0.0	0.2	6.6	5.6	2.9	0.4	0.8	0.3	0.0	2.6	0.4	2.4	0.6	0.3
PRR35	C16orf11	ENSG00000161992	"Proline rich 35"	P0CG20	16	560394-565529	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 44.7"	"Cell type enriched"	"Detected in some"	9	"Collecting duct cells: 36.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	12	"cerebellum: 44.7;pons: 17.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebellum: 4.5"	"Not detected"	"Not detected"			HPA069297	Uncertain		Approved	"Nucleoli,Cytokinetic bridge,Cytosol"		Yes	NA			Nucleoli	"Cytokinetic bridge, Cytosol"	"HPA069297: AB_2686113"		"unprognostic (6.96e-2)"		"unprognostic (3.08e-2)"	"unprognostic (5.25e-1)"	"unprognostic (8.11e-2)"				"unprognostic (2.56e-1)"				"unprognostic (3.38e-2)"	"unprognostic (1.17e-1)"			0.0	0.1	0.0	0.0	0.3	0.0	0.0	44.7	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	10.5	0.0	0.0	0.0	0.2	2.6	0.0	0.0	1.1	0.0	0.0	0.0	17.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	44.7	1.4	0.2	0.2	0.2	2.6	0.0	17.5	0.2	0.4	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.9	0.1	0.0	1.3	0.0	0.0	36.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PSG7		ENSG00000221878	"Pregnancy specific beta-1-glycoprotein 7"	Q13046	19	42924132-42937207	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"			"Group enriched"	"Detected in some"	4	"placenta: 4.2;skin 1: 1.2"	"Cell type enriched"	"Detected in some"	95	"Syncytiotrophoblasts: 162.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 1.6;fHDF/TERT166: 1.1;HBF TERT88: 2.3;U-2197: 1.8"									HPA046327	Supported				"Secreted in female reproductive system"	NA	NA					"HPA046327: AB_2679624"																		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.1	0.5	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	162.0	0.0	0.0	0.0	0.0
PXK	"FLJ20335, Slob"	ENSG00000168297	"PX domain containing serine/threonine kinase like"	Q7Z7A4	3	58332880-58426127	"Enzymes, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 314.9"	"Cell type enriched"	"Detected in all"	9	"Oligodendrocytes: 732.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-937: 159.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024068	Supported		Supported	"Plasma membrane,Centriolar satellite,Cytosol"		NA	NA			Cytosol	"Plasma membrane, Centriolar satellite"	"HPA024068: AB_1855967"	"unprognostic (2.98e-2)"	"unprognostic (3.29e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.62e-3)"	"unprognostic (5.03e-3)"	"prognostic favorable (5.68e-4)"	"unprognostic (3.90e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.38e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.86e-2)"	20.0	16.8	73.8	31.8	145.8	73.8	15.9	101.1	120.2	45.7	20.6	20.5	10.7	23.7	8.5	11.4	17.7	15.6	15.4	76.9	105.1	17.1	11.7	20.7	43.4	138.9	130.3	52.9	18.4	15.8	21.3	13.5	29.9	149.7	12.9	10.6	35.9	14.9	11.8	18.9	14.1	19.4	18.9	94.5	25.4	16.4	12.5	114.3	13.8	63.7	14.4	45.3	19.6	30.4	314.9	13.7	6.9	6.8	12.0	79.7	70.0	17.8	22.6	42.5	19.7	27.3	4.0	3.1	74.7	5.1	33.6	28.4	4.2	18.7	13.2	21.8	18.5	12.5	13.1	11.3	5.8	87.5	112.8	22.5	57.4	31.6	24.6	42.0	72.5	17.8	49.1	15.7	26.1	35.7	5.3	26.2	122.2	7.8	4.1	19.7	40.7	9.4	13.4	12.6	8.0	6.0	4.0	14.2	11.0	19.0	10.7	34.8	122.9	17.9	24.9	11.0	48.5	23.9	19.4	21.6	73.7	36.2	159.3	10.7	39.5	44.6	69.1	23.8	37.2	20.7	62.6	17.1	20.3	41.8	69.6	15.3	17.5	73.5	21.6	57.1	32.1	21.1	32.0	73.8	145.8	101.1	120.2	76.9	105.1	138.9	130.3	52.9	149.7	94.5	114.3	314.9	20.1	9.6	6.3	28.4	59.8	14.1	5.8	5.6	7.4	31.0	5.9	7.1	13.1	7.2	6.0	23.9	20.9	19.7	31.7	8.3	33.2	7.1	69.7	9.1	33.0	14.2	7.8	19.3	33.8	5.7	6.8	41.5	6.1	16.0	19.7	15.2	16.4	7.5	13.6	20.2	53.7	5.0	2.0	24.5	31.1	38.3	30.7	25.2	17.8	30.0	28.6	32.7	30.9	79.4	732.6	3.0	5.5	25.2	17.6	6.0	8.7	12.2	6.4	22.2	19.7	18.7	18.2	16.8	21.9	10.1	13.1	35.2	16.9	18.3	5.0	3.9
RALYL	HNRPCL3	ENSG00000184672	"RALY RNA binding protein like"	Q86SE5	8	84182787-84921844	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 20.0;brain: 73.6;kidney: 19.3"	"Cell type enriched"	"Detected in some"	5	"Excitatory neurons: 2828.9"	"Cancer enhanced"	"Detected in single"		"glioma: 1.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"OE19: 31.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055868, HPA059112"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA055868: AB_2682950, HPA059112: AB_2683908"				"unprognostic (1.13e-5)"	"unprognostic (1.62e-1)"		"unprognostic (7.48e-2)"		"unprognostic (1.36e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.82e-5)"	"unprognostic (2.74e-2)"	"unprognostic (2.52e-1)"			0.1	20.0	26.1	0.2	37.6	0.2	0.1	73.6	45.4	0.0	1.6	0.5	0.4	0.1	0.7	0.0	0.6	5.1	2.4	27.5	33.0	19.3	0.3	0.1	0.1	15.2	22.4	33.9	0.0	2.4	0.0	6.2	1.2	33.0	0.2	0.4	9.1	0.6	2.0	0.2	0.2	0.7	0.1	10.9	2.5	0.5	0.4	25.0	0.0	0.1	0.3	0.1	0.1	0.1	33.2	0.1	0.0	4.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	31.5	0.2	0.0	0.4	0.0	0.0	0.0	0.7	0.1	0.1	0.2	0.1	0.2	0.1	0.0	0.4	0.2	0.0	0.2	0.1	0.2	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.1	37.6	73.6	45.4	27.5	33.0	15.2	22.4	33.9	33.0	10.9	25.0	33.2	0.0	0.0	0.0	50.6	0.0	0.0	0.0	0.0	0.0	38.5	1.0	0.6	5.0	21.5	0.0	7.3	2.1	0.0	0.0	0.0	178.1	1.0	2.2	0.0	0.0	0.9	1.8	0.0	2828.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	33.7	531.4	0.6	0.0	0.0	0.0	1.5	0.3	0.0	0.0	68.4	0.0	32.8	0.0	495.6	36.3	0.1	0.0	0.0	0.0	0.0	11.7	19.4	0.0	5.2	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	4.0	0.1	0.1
RBP7	CRBPIV	ENSG00000162444	"Retinol binding protein 7"	Q96R05	1	9997206-10016021	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"adipose tissue: 349.2;breast: 398.0;lymphoid tissue: 113.0"	"Cell type enriched"	"Detected in many"	7	"Adipocytes: 3631.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 311.5;neutrophil: 344.7"	"Group enriched"	"Detected in many"	31	"granulocytes: 344.7;monocytes: 311.5"	"Group enriched"	"Detected in some"	4	"EFO-21: 13.0;SK-MEL-30: 9.8;T-47d: 34.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			HPA034749	Enhanced		Uncertain	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles, Cytosol"		"HPA034749: AB_10602084"	"unprognostic (1.93e-3)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (9.59e-2)"	"unprognostic (2.31e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.05e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.46e-2)"	"unprognostic (7.90e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.61e-2)"	349.2	15.1	26.1	8.9	31.2	28.9	398.0	28.8	33.5	21.0	28.2	13.9	2.7	20.5	4.2	34.7	14.8	52.1	71.4	25.4	27.9	33.0	9.7	8.9	8.4	28.3	29.5	24.2	12.8	12.0	69.4	16.8	16.0	30.2	18.8	4.4	5.0	22.5	8.2	16.1	33.9	11.6	15.0	28.5	113.0	17.4	9.3	28.9	12.7	36.5	25.2	5.7	23.8	28.1	42.2	0.0	0.6	0.3	0.0	0.0	0.5	0.0	0.0	0.0	2.5	0.9	2.5	3.2	0.0	13.0	1.3	0.0	0.0	0.1	1.0	4.4	0.0	2.8	0.0	0.1	1.3	1.6	0.0	0.0	0.0	2.0	2.1	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	3.4	0.0	0.0	0.0	0.7	0.0	0.2	0.5	2.6	0.2	9.8	3.5	34.8	2.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.4	311.5	2.8	0.4	138.4	0.2	0.1	0.0	0.1	10.6	0.2	0.2	0.1	344.7	0.0	68.3	2.0	0.7	96.8	26.1	31.2	28.8	33.5	25.4	27.9	28.3	29.5	24.2	30.2	28.5	28.9	42.2	3631.8	0.0	1.3	0.7	9.5	20.6	9.5	2.6	9.1	0.2	43.0	73.9	22.9	10.0	1.2	1.8	0.0	5.0	16.2	0.1	23.5	2.0	3.2	2.5	15.8	349.2	0.0	5.7	0.4	2.8	1.9	36.1	0.0	4.8	3.8	7.1	69.7	3.7	63.7	0.0	0.4	0.4	2.0	502.5	14.1	6.1	6.2	42.5	21.4	1.0	149.7	2.1	3.1	0.0	13.4	2.7	0.1	0.7	2.7	20.7	0.0	1.4	0.9	1.5	0.0	3.9	20.5	1.8	2.8	26.2	17.6	6.2	3.8	3.6	0.6	6.3
RFPL4B	RNF211	ENSG00000251258	"Ret finger protein like 4B"	Q6ZWI9	6	112347330-112351294	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	4	"testis: 1.7"	"Cell type enriched"	"Detected in some"	5	"Extravillous trophoblasts: 15.7"	"Group enriched"	"Detected in some"	7	"liver cancer: 0.6;testis cancer: 1.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 1.9;RPTEC TERT1: 2.3;U-266/70: 1.0;U-266/84: 8.0"									"HPA059324, HPA066464"	Uncertain					NA	NA					"HPA059324: , HPA066464: "	"unprognostic (4.26e-1)"				"unprognostic (1.45e-1)"						"unprognostic (6.66e-2)"	"unprognostic (3.78e-1)"	"unprognostic (2.80e-3)"		"unprognostic (3.73e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	15.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	3.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0
RFX6	"dJ955L16.1, MGC33442, RFXDC1"	ENSG00000185002	"Regulatory factor X6"	Q8HWS3	6	116877212-116932161	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adrenal gland: 4.6;intestine: 2.2;pancreas: 2.3;stomach 1: 6.5"	"Cell type enriched"	"Detected in some"	14	"Enteroendocrine cells: 68.6"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HEK 293: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA037696	Approved					NA	NA					"HPA037696: AB_2675616"	"unprognostic (2.92e-1)"		"unprognostic (4.66e-2)"				"unprognostic (2.49e-2)"	"unprognostic (1.55e-1)"			"prognostic favorable (3.59e-4)"	"unprognostic (2.59e-2)"		"unprognostic (1.63e-1)"	"unprognostic (1.25e-1)"			0.0	4.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.6	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.7	0.0	0.1	1.3	0.0	0.3	0.0	0.0	0.0	1.3	0.0	0.0	0.0	6.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.3	0.0	0.0	0.0	0.0	4.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	68.6	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	3.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.3	0.0	0.0	0.4	0.0
RHD	"CD240D, DIIIc, RH, Rh30a, Rh4, RhII, RhPI"	ENSG00000187010	"Rh blood group D antigen"	Q02161	1	25272393-25330445	"Blood group antigen proteins, CD markers, Predicted membrane proteins, Transporters"		"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"bone marrow: 15.9"	"Cell type enriched"	"Detected in some"	21	"Erythroid cells: 153.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 6.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.3"	"Group enriched"	"Detected in some"	7	"HEL: 43.0;K-562: 13.0"									"HPA060951, HPA077385"	Supported		Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA060951: , HPA077385: "	"unprognostic (4.75e-3)"	"unprognostic (7.70e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.96e-3)"	"unprognostic (1.93e-1)"	"unprognostic (8.09e-2)"	"unprognostic (5.53e-2)"	"unprognostic (4.92e-3)"	0.1	0.4	0.8	0.6	1.5	15.9	0.1	1.6	1.2	0.2	0.2	0.1	0.3	0.4	0.1	0.3	0.2	0.4	0.3	0.9	0.3	0.1	0.1	0.2	0.7	1.0	0.6	0.7	0.5	0.4	0.0	0.2	0.3	1.5	0.3	0.1	1.9	2.5	0.0	3.9	2.1	0.3	0.0	0.1	0.6	0.2	0.5	0.6	0.1	0.3	0.0	0.1	0.1	0.1	1.5	0.2	0.0	0.3	0.3	0.1	0.0	0.5	0.0	0.1	0.1	0.0	0.1	0.3	0.6	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.7	0.2	43.0	1.0	0.2	0.0	0.3	0.4	0.0	0.1	0.1	0.1	0.2	0.1	0.2	13.0	0.9	0.1	0.2	0.2	0.3	4.0	0.0	0.2	0.3	0.2	0.1	0.0	0.1	0.6	0.4	0.1	0.2	0.1	0.1	0.2	0.6	0.4	0.7	0.2	0.5	0.2	0.4	0.2	0.2	0.6	0.2	0.2	4.3	0.9	2.0	0.6	0.4	0.7	1.0	0.8	0.5	0.1	1.3	0.9	0.8	6.3	1.0	0.6	0.4	0.7	0.6	0.8	1.5	1.6	1.2	0.9	0.3	1.0	0.6	0.7	1.5	0.1	0.6	1.5	0.2	0.0	0.5	1.0	0.6	0.1	0.2	0.0	0.0	0.3	0.1	0.1	1.0	0.0	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.1	0.3	1.0	0.0	153.0	5.2	0.2	0.0	0.2	0.0	0.3	0.0	0.2	0.4	0.0	0.1	0.0	4.3	0.0	0.0	0.3	0.3	0.0	0.0	3.0	0.0	3.7	0.0	0.4	0.0	7.1	6.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.0	1.2	0.4	0.1	0.6	0.0	0.0	0.0	0.7	0.2	0.0	0.1
RHOXF1	"OTEX, PEPP1"	ENSG00000101883	"Rhox homeobox family member 1"	Q8NHV9	X	120109051-120115913	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 15.2"	"Cell type enriched"	"Detected in some"	14	"Spermatogonia: 123.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"T-reg: 4.9"	"Lineage enriched"	"Detected in single"	33	"T-cells: 4.9"	"Cell line enhanced"	"Detected in single"		"HEK 293: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA052560, HPA056506"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA052560: , HPA056506: AB_2683157"	"unprognostic (5.03e-3)"	"unprognostic (1.22e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.31e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.46e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.89e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.50e-4)"	"unprognostic (1.97e-1)"	"unprognostic (5.85e-4)"	"unprognostic (3.00e-1)"	"unprognostic (7.96e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.73e-3)"	1.7	1.2	2.5	0.1	2.1	0.1	1.4	3.5	3.5	1.3	2.4	1.3	0.0	0.8	0.0	0.5	2.4	0.2	0.5	2.1	2.6	1.8	0.9	0.5	0.3	2.4	2.6	2.1	3.6	0.3	0.1	1.8	0.0	3.0	1.4	0.0	2.6	0.6	0.2	0.2	1.2	1.0	0.1	2.2	1.3	0.7	15.2	2.4	0.2	1.1	0.0	0.1	1.1	0.8	2.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	4.9	0.0	2.5	2.1	3.5	3.5	2.1	2.6	2.4	2.6	2.1	3.0	2.2	2.4	2.7	0.2	0.0	0.0	0.0	0.1	0.4	0.1	0.2	0.0	1.3	0.3	0.5	1.3	0.0	0.0	0.0	4.2	0.1	0.2	0.1	1.9	0.2	1.5	0.2	0.1	0.5	0.0	0.0	0.8	0.4	0.4	0.2	0.0	0.1	0.0	8.3	0.0	0.2	0.1	0.0	1.5	0.3	0.0	0.0	0.0	3.8	0.6	0.2	0.0	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.0	1.5	0.1	0.1	0.0	0.1	2.4	1.3	0.0	0.0	0.3	3.3	123.8	0.0	0.3	0.0	0.2	0.7	0.2	0.0
SCGN	"CALBL, DJ501N12.8, SECRET, SEGN"	ENSG00000079689	"Secretagogin, EF-hand calcium binding protein"	O76038	6	25652201-25701783	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 34.7;intestine: 19.4;pancreas: 67.6;pituitary gland: 38.8;stomach 1: 19.0"	"Cell type enriched"	"Detected in some"	5	"Enteroendocrine cells: 600.1"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 38.2;renal cancer: 22.6"	"Region enhanced"	"Detected in many"		"hypothalamus: 34.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.4;CACO-2: 6.4;HEL: 4.6;Hep G2: 3.6;SCLC-21H: 24.7"	"Region enriched"	"Detected in many"	16	"olfactory bulb: 82.0"	"Region enriched"	"Detected in some"	9	"olfactory bulb: 137.1"	"CAB004005, HPA006641, CAB044060, CAB062563, CAB068232"	Enhanced	Supported	Supported	Cytosol	"Intracellular and membrane"	NA	NA			Cytosol		"CAB004005: , CAB044060: , CAB062563: AB_2665612, CAB068232: AB_2665613, HPA006641: AB_1079874"	"unprognostic (8.15e-2)"		"unprognostic (4.31e-3)"		"unprognostic (1.46e-1)"		"unprognostic (1.25e-2)"	"unprognostic (4.70e-1)"			"unprognostic (1.78e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.14e-2)"	"unprognostic (5.41e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.19e-1)"		3.4	3.5	2.8	3.4	1.3	0.2	3.3	20.7	3.2	0.1	0.3	17.0	12.5	0.0	0.0	0.2	0.1	0.9	8.0	13.9	34.7	1.4	4.2	0.8	0.1	1.6	6.5	0.6	0.3	67.6	0.1	38.8	3.3	6.0	2.0	19.4	1.0	2.5	0.1	0.0	0.6	11.6	1.2	1.1	0.0	19.0	0.6	7.5	0.4	1.9	0.0	0.0	0.1	0.1	1.4	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	4.6	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	24.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	1.3	20.7	3.2	13.9	34.7	1.6	6.5	0.6	6.0	1.1	7.5	1.4	1.9	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	1.0	0.6	0.5	107.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.1	0.0	0.0	2.2	600.1	0.0	0.2	0.4	0.2	0.3	9.2	0.0	0.0	0.9	3.3	0.5	0.1	0.0	1.8	14.3	4.1	0.0	0.0	0.2	0.6	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.1	4.8	3.7	0.0	0.0	3.7	1.1	3.1	0.0	0.0	13.1	0.0	9.1	0.2	1.1	0.0	0.0	0.0	0.1	0.5	2.2	0.3
SLC10A4	MGC29802	ENSG00000145248	"Solute carrier family 10 member 4"	Q96EP9	4	48483343-48489526	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 27.6"	"Cell type enriched"	"Detected in some"	4	"Inhibitory neurons: 16.2"	"Group enriched"	"Detected in many"	4	"endometrial cancer: 1.8;glioma: 5.9"	"Region enhanced"	"Detected in many"		"midbrain: 27.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 9.2;HEL: 5.3;K-562: 13.1;SH-SY5Y: 32.1"	"Group enriched"	"Detected in many"	4	"basal ganglia: 26.2;hypothalamus: 10.7;midbrain: 26.5;pons and medulla: 13.2;thalamus: 8.4"	"Group enriched"	"Detected in many"	5	"basal ganglia: 14.2;midbrain: 56.7;pons: 23.5;spinal cord: 44.7"	HPA028835	Uncertain	Supported				NA	NA					"HPA028835: AB_10603025"	"unprognostic (4.06e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.49e-1)"	"unprognostic (3.46e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.08e-3)"	"unprognostic (9.98e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.50e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.73e-2)"	0.1	2.7	0.6	0.2	1.7	1.1	0.1	0.0	3.6	0.6	0.0	0.9	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.1	7.2	0.1	0.1	0.2	0.0	6.4	27.6	0.3	0.1	0.1	0.0	6.8	0.0	15.5	0.2	0.1	0.1	1.4	0.0	0.1	0.1	0.4	0.1	1.1	0.1	0.5	0.4	8.9	0.0	0.4	0.0	0.0	0.1	0.6	5.4	0.0	3.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	1.0	0.0	9.2	0.0	0.1	0.0	2.8	5.3	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.9	32.1	0.4	0.0	0.1	0.3	0.0	4.3	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.7	0.0	3.6	0.1	7.2	6.4	27.6	0.3	15.5	1.1	8.9	5.4	0.4	0.0	3.2	0.0	0.0	0.4	0.1	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.1	1.7	0.1	0.2	0.4	0.0	3.0	0.6	0.0	0.3	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	16.2	0.0	0.0	0.0	0.4	2.4	0.3	0.0	0.0	1.0	0.1	0.0	0.0	4.0	0.5	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.2	0.5	0.7	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0
SLC17A3	NPT4	ENSG00000124564	"Solute carrier family 17 member 3"	O00476	6	25833066-25882286	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"kidney: 165.8"	"Cell type enriched"	"Detected in some"	13	"Proximal tubular cells: 197.8"	"Cancer enriched"	"Detected in some"	17	"renal cancer: 57.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	210	"RPTEC TERT1: 114.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (5.31e-3)"				"unprognostic (1.56e-2)"		"unprognostic (2.51e-1)"	"unprognostic (4.65e-2)"			"unprognostic (5.05e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.49e-1)"		0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	165.8	37.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	114.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.0	1.8	0.0	0.0	0.2	0.1	7.9	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.1	15.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	197.8	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.8	0.2	0.0	0.1
SLC6A13	GAT2	ENSG00000010379	"Solute carrier family 6 member 13"	Q9NSD5	12	220621-262873	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"kidney: 154.5"	"Cell type enriched"	"Detected in some"	6	"Proximal tubular cells: 324.9"	"Cancer enriched"	"Detected in some"	18	"renal cancer: 32.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"RPTEC TERT1: 4.6;SuSa: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036449, HPA052726"			Supported	Nucleoplasm,Nucleoli,Mitochondria,Cytosol		NA	NA			Mitochondria	"Nucleoplasm, Nucleoli, Cytosol"	"HPA036449: AB_2675130, HPA052726: AB_2681927"	"unprognostic (8.45e-3)"	"unprognostic (4.20e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.64e-5)"	"unprognostic (1.13e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.21e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.25e-3)"	"unprognostic (3.79e-2)"	"unprognostic (2.62e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.91e-1)"	0.2	0.3	14.5	0.0	17.0	0.1	0.1	11.4	18.5	0.1	14.7	0.1	2.6	0.1	0.3	0.0	7.1	0.0	2.5	12.7	12.0	154.5	37.1	0.9	0.0	12.7	13.0	12.0	0.2	0.0	0.0	3.0	0.0	13.5	0.5	0.0	1.1	0.1	0.1	0.5	0.2	0.6	0.0	12.5	0.3	0.1	3.1	13.7	0.1	6.4	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.4	1.6	0.0	0.0	0.1	0.0	0.5	0.0	0.2	0.6	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	17.0	11.4	18.5	12.7	12.0	12.7	13.0	12.0	13.5	12.5	13.7	13.0	0.0	0.0	0.6	1.3	1.9	0.0	0.0	0.4	0.0	0.4	0.1	0.1	1.5	0.0	0.1	18.4	2.1	0.0	0.1	0.0	49.0	0.0	1.4	0.6	0.1	0.2	0.0	5.3	3.6	0.0	0.0	0.3	0.0	0.6	0.0	0.0	1.8	27.0	0.0	0.0	1.2	0.0	2.0	1.6	0.0	0.6	0.3	1.7	0.0	17.8	0.0	0.0	0.0	1.5	1.3	0.0	0.0	0.0	0.0	0.1	0.5	324.9	0.7	0.7	0.0	0.4	0.1	0.6	0.4	0.0	0.0	0.3	0.9	0.0	0.0	0.0
SLCO1C1	"OATP-F, OATP1, OATP1C1, SLC21A14"	ENSG00000139155	"Solute carrier organic anion transporter family member 1C1"	Q9NYB5	12	20695332-20753386	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 43.5;choroid plexus: 26.6"	"Cell type enriched"	"Detected in some"	12	"Astrocytes: 292.2"	"Cancer enriched"	"Detected in single"	17	"glioma: 4.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	15	"HeLa: 4.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (1.15e-1)"	"unprognostic (8.18e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.64e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.32e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.37e-4)"	"unprognostic (1.56e-3)"	"unprognostic (1.51e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.76e-2)"	1.6	0.1	15.3	0.1	17.4	0.0	0.4	14.1	23.3	0.0	26.6	0.2	0.1	0.0	0.2	0.1	0.0	0.7	0.4	17.3	43.5	0.1	0.0	0.1	0.2	13.2	14.8	15.5	0.0	0.1	0.2	8.2	0.0	14.2	0.1	0.2	2.8	0.1	0.0	0.0	0.2	0.3	0.1	12.5	0.0	0.1	1.5	16.4	0.1	0.7	0.5	0.2	0.2	0.0	15.6	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.3	17.4	14.1	23.3	17.3	43.5	13.2	14.8	15.5	14.2	12.5	16.4	15.6	2.4	0.0	0.0	292.2	0.0	0.1	0.0	0.0	0.0	1.4	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	9.5	0.0	0.1	1.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	2.8	0.1	0.0	0.0	0.0	13.4	1.8	0.0	0.0	23.4	0.1	4.8	0.0	3.5	0.5	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.2	0.0	1.0	5.3	0.5	0.2	0.0	0.0	0.0	0.0	1.2	0.4	0.0
SPATC1	"MGC61633, SPATA15, SPERIOLIN"	ENSG00000186583	"Spermatogenesis and centriole associated 1"	Q76KD6	8	144012280-144047114	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"testis: 37.8"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 358.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	10	"U-937: 7.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"cerebellum: 13.9"							NA	NA						"unprognostic (2.96e-1)"	"unprognostic (1.41e-3)"	"unprognostic (3.34e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.59e-3)"	"unprognostic (6.96e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.77e-1)"	"unprognostic (4.12e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.34e-3)"	"unprognostic (2.74e-1)"	"unprognostic (5.81e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.74e-1)"	0.2	0.1	0.2	1.8	0.2	8.5	0.1	1.2	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.2	0.2	0.3	0.8	0.6	1.6	0.3	0.0	0.0	0.1	0.0	0.0	0.2	1.7	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.7	0.1	0.0	2.0	0.2	37.8	0.3	0.1	0.0	0.0	0.5	0.1	0.0	0.9	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.4	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.2	1.2	0.4	0.1	0.2	1.6	0.3	0.0	1.7	0.0	0.3	0.9	0.0	0.0	0.5	5.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	76.3	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	358.1	2.5	0.5	0.0	0.0	4.3	0.0	0.0	1.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPINK7	"ECG2, ECRG2"	ENSG00000145879	"Serine peptidase inhibitor Kazal type 7"	P58062	5	148312419-148315922	"Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"esophagus: 625.4;vagina: 619.0"	"Cell type enriched"	"Detected in some"	7	"Squamous epithelial cells: 49.2"	"Group enriched"	"Detected in many"	6	"cervical cancer: 4.5;head and neck cancer: 15.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"hTCEpi: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036294	Enhanced				"Secreted in other tissues"	NA	NA		230000			"HPA036294: AB_10671243"		"unprognostic (2.82e-1)"				"unprognostic (8.99e-3)"		"unprognostic (8.52e-3)"	"unprognostic (1.81e-1)"		"unprognostic (1.12e-2)"	"unprognostic (3.37e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.86e-2)"	"unprognostic (7.24e-2)"	"unprognostic (4.22e-2)"	0.1	0.1	0.1	0.0	0.2	0.0	0.2	0.2	0.2	122.6	0.1	0.0	0.0	0.1	0.1	625.4	0.1	0.1	0.2	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.1	0.2	0.1	0.5	0.0	0.7	0.0	0.2	0.1	0.0	0.0	141.2	0.0	0.2	7.4	0.1	0.1	0.1	0.1	4.2	0.1	0.1	4.8	0.1	0.1	117.0	0.6	619.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.0	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.2	0.0	0.0	0.0	0.0	0.0	4.5
SPRR3		ENSG00000163209	"Small proline rich protein 3"	Q9UBC9	1	153001747-153003856	"Cancer-related genes, Predicted intracellular proteins"	Keratinization		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 19659.3;vagina: 6111.4"	"Cell type enriched"	"Detected in some"	11	"Squamous epithelial cells: 987.1"	"Group enriched"	"Detected in many"	4	"cervical cancer: 206.3;head and neck cancer: 423.4;stomach cancer: 113.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 3.5;CAPAN-2: 5.8;hTCEpi: 9.7;OE19: 4.4;RT4: 12.6;TIME: 3.4"	"Not detected"	"Not detected"							HPA044467	Enhanced					NA	NA		5200			"HPA044467: AB_2678952"		"unprognostic (2.78e-2)"	"unprognostic (3.54e-1)"	"unprognostic (8.77e-2)"		"unprognostic (7.50e-3)"		"unprognostic (9.67e-3)"	"unprognostic (2.36e-1)"		"prognostic unfavorable (6.27e-5)"			"unprognostic (9.70e-2)"	"unprognostic (4.66e-2)"		"unprognostic (1.58e-2)"	3.7	3.5	0.0	0.1	0.0	0.0	3.0	0.0	0.0	2034.4	0.0	2.4	0.1	3.5	0.0	19659.3	3.4	38.5	7.4	0.0	0.0	2.5	5.8	1.7	0.0	0.0	0.1	0.0	4.4	8.8	0.0	11.1	0.7	0.0	3.4	0.1	0.0	3182.9	0.0	5.0	5.2	4.3	1.7	0.0	3.4	15.3	2.1	0.0	1.4	2.3	0.0	2420.4	65.8	6111.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	5.8	3.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.1	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.3	0.0	0.0	0.0	4.4	0.0	0.0	1.1	0.0	0.0	12.6	0.0	0.0	0.3	2.7	0.0	0.5	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	1.5	1.2	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	4.0	7.4	0.0	0.0	0.0	0.1	0.0	41.3	0.0	0.0	5.9	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	4.2	1.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.3	0.0	0.0	0.0	0.4	0.0	0.1	2.1	0.0	0.0	0.0	1.0	0.0	0.0	987.1	0.0	7.5	0.4	0.1	0.0	89.6
ST6GALNAC1	"SIAT7A, ST6GalNAcI"	ENSG00000070526	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1"	Q9NSC7	17	76624761-76643786	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"cervix: 61.6;intestine: 197.8;stomach 1: 65.5"	"Cell type enriched"	"Detected in many"	5	"Intestinal goblet cells: 801.0"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 41.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 8.9;naive CD4 T-cell: 3.4"	"Lineage enriched"	"Detected in single"	32	"T-cells: 8.9"	"Group enriched"	"Detected in some"	4	"K-562: 65.5;OE19: 107.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA014767, HPA014975"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		3500000	"Golgi apparatus"	Nucleoplasm	"HPA014767: , HPA014975: AB_1857529"	"unprognostic (4.59e-2)"	"unprognostic (8.60e-3)"	"unprognostic (5.32e-3)"	"unprognostic (1.86e-3)"	"unprognostic (6.31e-3)"	"prognostic favorable (2.54e-5)"	"unprognostic (1.39e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.58e-2)"	"unprognostic (8.64e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.87e-3)"	"unprognostic (5.58e-2)"	1.7	0.1	5.1	12.7	5.0	2.8	2.1	5.0	7.4	61.6	4.2	156.8	63.0	5.1	3.9	24.6	3.8	18.4	2.2	4.8	5.3	0.4	0.1	5.7	1.2	5.8	5.3	4.3	0.8	0.7	0.1	0.0	2.1	5.5	7.0	197.8	1.0	26.5	0.5	1.4	1.0	76.4	5.4	5.1	14.8	65.5	3.1	5.7	0.2	0.3	0.9	2.4	3.1	4.5	4.9	0.2	2.4	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	3.4	0.2	11.9	0.0	0.0	12.4	0.0	2.9	0.0	0.0	0.0	19.5	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.3	65.5	0.0	0.0	0.0	0.2	0.2	0.0	107.5	0.4	0.0	0.0	0.4	0.1	0.7	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.3	0.6	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.9	0.1	0.0	0.0	3.4	0.0	0.2	0.0	0.0	0.0	1.3	0.9	5.1	5.0	5.0	7.4	4.8	5.3	5.8	5.3	4.3	5.5	5.1	5.7	4.9	8.6	16.0	7.5	0.7	0.3	0.1	5.7	90.2	12.0	0.1	0.1	0.0	2.0	17.2	143.4	0.0	0.0	0.3	0.0	133.3	0.0	1.4	0.3	85.1	7.6	27.2	33.0	6.7	0.4	18.2	0.1	1.3	65.7	77.6	0.0	0.3	8.6	0.0	0.3	0.0	0.3	801.0	50.8	0.0	0.0	0.9	1.5	1.1	0.0	18.7	0.0	0.0	0.0	1.5	0.3	42.8	76.1	0.0	0.0	2.4	51.6	0.0	117.4	1.2	0.0	0.3	5.3	0.4	0.1	12.8	0.1	0.1	1.8	63.3	123.1	24.5
STAB2	"DKFZP434E0321, FEEL-2, FELL, HARE, SCARH1, STAB-2"	ENSG00000136011	"Stabilin 2"	Q8WWQ8	12	103587273-103766719	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Endocytosis	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"lymphoid tissue: 66.4"	"Cell type enriched"	"Detected in some"	11	"Hepatic stellate cells: 145.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BEWO: 11.5;HaCaT: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA026871, HPA072699"	Enhanced		Supported	Cytosol		NA	NA		1200000	Cytosol		"HPA026871: AB_1857536, HPA072699: "	"unprognostic (5.66e-3)"	"unprognostic (7.51e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.84e-2)"	"unprognostic (8.47e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.81e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.05e-1)"	"unprognostic (9.72e-4)"	"unprognostic (1.37e-2)"	"unprognostic (5.00e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.06e-1)"	0.9	0.2	0.9	0.9	0.6	0.7	0.9	0.2	0.7	1.0	0.0	2.1	0.3	0.9	1.5	0.8	1.3	1.0	0.3	1.2	0.1	0.2	14.8	0.5	3.9	0.4	0.2	0.4	0.6	0.3	0.0	0.3	0.3	0.6	0.4	0.4	0.3	0.4	0.0	0.2	0.3	0.6	0.2	0.2	66.4	0.4	2.2	0.4	0.0	1.1	0.0	0.4	0.8	0.5	0.3	0.2	0.5	0.5	0.1	0.0	0.0	11.5	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	3.2	0.0	0.0	0.0	0.0	0.8	0.3	0.7	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.4	0.1	1.8	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.6	0.2	0.0	0.4	0.6	0.3	0.0	0.8	0.1	0.1	0.0	0.2	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.6	0.2	0.7	1.2	0.1	0.4	0.2	0.4	0.6	0.2	0.4	0.3	0.2	0.0	0.0	0.7	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.8	4.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	6.1	0.0	0.0	4.0	0.0	0.0	2.7	0.0	0.6	0.2	0.0	0.0	0.0	0.0	145.6	4.1	0.1	0.0	1.9	0.0	0.0	11.6	0.7	12.2	0.3	0.0	0.0	1.0	0.0	0.0	0.0	2.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.0	0.0	0.0
TBC1D3I		ENSG00000274933	"TBC1 domain family member 3I"	A0A087WXS9	17	36253456-36264553	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"testis: 7.1"	"Cell type enriched"	"Detected in some"	12	"Early spermatids: 38.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"CAPAN-2: 5.3"									"HPA046969, HPA047745, HPA052553"	Approved		Uncertain	Vesicles		NA	NA			Vesicles		"HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869"																		0.1	0.2	0.7	0.0	0.8	0.0	0.1	0.8	1.5	0.2	0.6	0.1	0.0	0.1	0.0	0.3	0.3	0.0	0.1	0.8	0.8	0.2	0.3	0.1	0.1	1.1	0.8	0.9	0.2	0.2	0.0	0.3	0.0	1.7	0.3	0.0	0.0	0.2	0.1	0.1	0.2	0.2	0.0	0.3	0.3	0.1	7.1	0.7	0.0	0.1	0.0	0.0	0.2	0.2	0.9	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	5.3	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.4	0.3	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.8	1.5	0.8	0.8	1.1	0.8	0.9	1.7	0.3	0.7	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TFF3	"HITF, ITF"	ENSG00000160180	"Trefoil factor 3"	Q07654	21	42311667-42315651	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"cervix: 308.4;intestine: 358.6;salivary gland: 343.0;thyroid gland: 420.1"	"Cell type enriched"	"Detected in many"	10	"Intestinal goblet cells: 33890.3"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 765.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	9	"eosinophil: 1.8"	"Lineage enriched"	"Detected in single"	18	"granulocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"MCF7: 58.7;OE19: 126.6;T-47d: 27.8;TIME: 105.0"									"CAB020681, HPA035464"	Enhanced		Approved	Nucleoplasm,Nucleoli	"Secreted to blood"	No	NA	151000000	6500000	Nucleoplasm	Nucleoli	"CAB020681: , HPA035464: AB_2674636"	"unprognostic (2.84e-2)"	"unprognostic (3.61e-3)"	"unprognostic (1.07e-1)"	"prognostic favorable (5.60e-6)"	"unprognostic (1.28e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.71e-1)"	"unprognostic (6.90e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.86e-2)"	8.7	6.0	0.1	28.0	0.1	2.2	26.5	0.3	0.2	308.4	0.2	358.6	209.9	2.8	0.5	22.9	50.2	83.5	3.1	0.1	0.1	3.4	6.6	10.0	3.5	0.1	0.8	0.0	3.5	6.2	0.0	1.4	0.1	0.2	9.9	308.6	0.1	343.0	1.6	0.9	6.6	293.1	8.5	0.1	23.3	7.4	0.5	0.2	1.8	420.1	1.7	0.9	3.6	4.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	58.7	0.0	0.7	0.1	126.6	12.1	0.0	9.0	0.3	0.1	0.0	16.1	0.1	0.0	1.7	0.0	0.0	27.8	0.0	105.0	0.0	0.0	0.7	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0.8	0.0	0.2	0.1	0.2	0.1	36.9	16.0	25.3	0.0	15.4	41.6	15.1	196.3	3.4	0.1	804.5	444.7	21.6	919.3	595.9	22.0	0.0	0.6	3.4	2188.7	0.0	9.4	0.5	29.3	1.4	322.8	770.9	0.0	0.0	67.8	0.7	21.5	71.4	11.4	59.2	2.0	170.3	5.8	2.1	5.0	0.0	33890.3	3263.2	3.4	42.4	9.0	2.5	2.8	96.0	0.0	0.0	0.0	0.0	0.0	0.0	45.2	1855.5	7.9	6.1	73.0	2788.7	0.1	453.2	0.1	0.0	1.1	28.2	1.0	0.3	4.3	38.6	0.8	14.9	0.6	1376.3	107.7
TLL1		ENSG00000038295	"Tolloid like 1"	O43897	4	165873237-166104457	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Differentiation	"Developmental protein, Hydrolase, Metalloprotease, Protease"	"Atrial septal defect, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 19.8;placenta: 6.4"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocyte precursor cells: 115.1"	"Cancer enhanced"	"Detected in some"		"renal cancer: 1.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 6.0;Karpas-707: 9.6;PC-3: 3.3"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	8	"cerebellum: 45.8"	HPA060767			Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		560000	Vesicles		"HPA060767: AB_2684357"	"unprognostic (2.17e-1)"	"unprognostic (6.45e-4)"	"unprognostic (8.60e-2)"	"unprognostic (2.65e-5)"	"unprognostic (9.85e-2)"	"unprognostic (2.51e-4)"	"unprognostic (3.37e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.07e-4)"	"unprognostic (2.86e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.13e-3)"	"unprognostic (7.76e-2)"	"unprognostic (6.91e-3)"	"unprognostic (1.21e-5)"	3.0	0.5	0.7	1.0	5.0	0.0	2.7	19.8	8.9	1.7	0.0	1.1	0.7	1.2	0.3	0.7	1.3	2.4	0.7	10.1	3.8	1.6	0.1	1.2	1.1	3.0	8.4	1.5	0.3	2.3	0.8	0.9	6.4	5.9	0.9	0.9	1.8	0.8	0.8	0.4	1.3	1.8	1.4	0.0	0.0	0.7	0.4	3.3	0.3	1.4	0.4	0.8	1.6	1.5	3.9	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.3	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.6	0.0	0.1	0.0	6.0	0.0	0.0	0.0	0.0	0.3	1.1	0.0	1.3	0.0	0.9	0.0	0.0	9.6	0.0	0.0	0.0	0.1	0.9	0.0	3.3	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	5.0	19.8	8.9	10.1	3.8	3.0	8.4	1.5	5.9	0.0	3.3	3.9	10.2	0.0	0.6	0.0	0.0	1.8	0.3	1.3	0.6	14.1	0.2	0.1	7.1	1.5	1.8	0.0	0.0	4.4	0.0	0.0	0.0	1.5	0.1	0.0	2.0	18.9	0.0	0.0	24.9	2.0	1.4	2.4	0.0	0.1	0.0	0.0	2.5	0.0	0.3	8.4	8.0	0.1	0.0	0.0	1.0	0.0	3.1	0.1	1.8	10.3	0.0	0.1	0.0	115.1	0.5	0.1	0.0	4.5	0.0	1.1	4.0	1.1	0.8	0.7	0.0	0.2	0.3	0.1	0.2	0.1	1.7	1.9	0.8	0.0	0.6	0.2
TMCC2	"FLJ38497, HUCEP11"	ENSG00000133069	"Transmembrane and coiled-coil domain family 2"	O75069	1	205227946-205285632	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 88.8;brain: 43.7"	"Cell type enriched"	"Detected in many"	8	"Erythroid cells: 622.1"	"Cancer enhanced"	"Detected in many"		"melanoma: 10.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 32.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014254	Approved					NA	NA					"HPA014254: AB_1851326"	"unprognostic (2.59e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.61e-2)"	"unprognostic (4.18e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.46e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.05e-5)"	"unprognostic (3.17e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.99e-3)"	"unprognostic (3.06e-2)"	"unprognostic (4.01e-1)"	"unprognostic (3.43e-3)"	1.2	2.6	21.8	0.4	17.2	88.8	0.9	14.7	43.7	1.7	0.0	1.9	0.3	1.6	0.0	0.7	2.1	0.3	2.5	22.1	11.1	1.4	0.7	3.1	0.3	31.4	22.6	4.6	3.1	0.5	3.1	5.0	5.4	37.4	1.1	0.1	8.5	0.9	0.3	3.6	1.7	0.9	0.5	20.9	16.2	0.9	2.0	21.4	0.7	1.3	1.6	0.2	1.2	1.6	29.8	1.9	0.9	1.7	3.8	0.7	0.2	0.9	2.4	1.0	2.3	1.8	0.3	0.2	1.8	0.4	0.6	6.3	3.2	1.1	0.5	0.7	5.7	4.2	7.5	0.5	0.1	0.3	0.3	3.5	0.4	0.1	1.2	0.0	2.0	0.3	1.7	4.0	2.4	0.9	0.1	0.0	0.9	4.1	0.0	5.2	2.8	4.3	9.1	0.4	0.1	32.0	4.3	0.2	0.0	8.0	1.5	0.7	0.4	0.8	1.5	2.5	3.9	2.7	4.9	2.1	1.2	1.3	0.6	9.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	21.8	17.2	14.7	43.7	22.1	11.1	31.4	22.6	4.6	37.4	20.9	21.4	29.8	1.9	0.0	0.0	6.2	0.4	1.0	0.4	1.2	0.0	34.4	0.2	0.0	4.6	0.0	0.3	1.8	10.4	0.1	0.3	0.0	0.0	1.6	1.5	3.7	0.8	2.5	3.5	622.1	7.9	0.0	0.2	1.0	0.0	1.9	0.0	7.4	3.9	0.0	0.9	40.4	10.1	0.1	0.0	0.6	6.1	0.8	1.2	13.1	3.6	2.8	7.8	17.7	0.0	2.5	73.0	0.2	0.0	0.4	0.8	0.1	0.0	0.2	0.9	43.2	0.0	1.8	2.8	1.1	4.8	0.4	0.9	0.0	0.7	0.8	0.1	0.1
TMEM63A	KIAA0792	ENSG00000196187	"Transmembrane protein 63A"	O94886	1	225845536-225882380	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel"	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"brain: 353.4;salivary gland: 122.1"	"Cell type enriched"	"Detected in many"	5	"Oligodendrocytes: 323.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 112.2;SK-BR-3: 119.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066504, HPA066936, HPA068918"			Enhanced	"Vesicles,Centriolar satellite"		NA	NA			"Vesicles, Centriolar satellite"		"HPA066504: AB_2685680, HPA066936: AB_2685751, HPA068918: AB_2686057"	"unprognostic (5.31e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.14e-2)"	"prognostic favorable (8.79e-4)"	"unprognostic (2.05e-1)"	"unprognostic (7.16e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.92e-2)"	23.3	18.1	43.8	27.3	132.7	43.1	29.3	108.8	99.0	30.4	10.8	30.4	26.5	26.0	22.9	15.3	28.4	27.6	20.9	48.6	86.3	32.9	40.6	31.5	35.9	159.4	118.7	24.0	28.6	57.2	18.0	11.9	24.4	199.4	58.1	37.3	3.7	122.1	37.6	16.7	21.6	34.8	18.3	103.7	31.9	48.1	5.3	107.4	28.0	19.1	13.8	27.2	26.6	23.4	353.4	27.6	8.3	7.0	20.2	54.1	18.7	47.7	20.6	22.2	22.5	22.6	29.7	20.0	7.7	37.1	25.2	13.3	41.4	7.5	12.5	10.3	25.8	13.4	33.4	21.0	18.0	12.6	12.5	84.1	19.5	7.8	13.5	8.1	31.1	14.8	17.0	28.2	6.3	18.0	17.4	11.2	12.7	37.8	87.5	13.2	11.1	21.3	112.2	34.1	71.8	0.6	3.7	15.2	119.3	14.5	16.0	27.7	11.9	17.8	12.9	8.9	12.1	18.9	2.5	10.4	2.0	11.9	7.0	24.3	6.3	3.9	3.6	10.3	3.1	11.4	5.8	13.1	9.8	2.9	5.5	11.4	6.9	5.5	10.2	5.3	11.5	19.8	6.9	43.8	132.7	108.8	99.0	48.6	86.3	159.4	118.7	24.0	199.4	103.7	107.4	353.4	11.0	6.4	9.2	45.7	23.3	3.3	24.9	5.7	2.2	0.8	30.0	16.8	6.5	34.3	14.0	20.2	2.1	38.7	37.0	34.7	1.9	36.3	9.1	43.1	10.6	8.6	19.2	6.3	1.0	25.5	6.6	8.9	48.9	49.8	17.2	44.8	10.8	22.2	16.7	0.0	1.7	35.0	24.4	11.7	5.3	13.5	18.3	14.2	3.6	26.2	10.4	12.9	40.2	5.5	323.2	18.4	29.0	13.2	9.1	41.6	13.0	14.8	23.1	1.8	26.3	8.8	10.8	0.6	5.3	4.2	4.1	22.4	23.3	7.2	57.6	35.1
TMPRSS11A	"ECRG1, HATL1, HESP"	ENSG00000187054	"Transmembrane serine protease 11A"	Q6ZMR5	4	67909395-67964140	"Enzymes, Predicted membrane proteins, Transporters"	"Cell cycle"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"esophagus: 86.9;lymphoid tissue: 28.7;vagina: 42.0"	"Cell type enriched"	"Detected in some"	7	"Squamous epithelial cells: 50.7"	"Group enriched"	"Detected in some"	9	"cervical cancer: 14.4;head and neck cancer: 11.6;lung cancer: 4.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA078316	Enhanced					NA	NA					"HPA078316: "	"unprognostic (1.63e-1)"	"unprognostic (4.60e-2)"				"unprognostic (1.76e-2)"		"unprognostic (6.98e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.66e-1)"		"unprognostic (4.58e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.33e-2)"	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	1.2	9.5	0.0	0.0	0.0	0.0	0.0	86.9	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.3	0.0	0.4	12.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.7	0.1	0.0	0.0	28.7	0.3	42.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	1.2	0.2	0.5	0.8	0.7	0.0	1.0	0.1	0.7	1.8	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.5	1.2	0.6	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	3.5	0.7	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.9	0.0	0.3	0.1	0.1	0.2	50.7	0.0	0.0	0.0	0.0	0.0	7.2
TPH1	"TPH, TPRH"	ENSG00000129167	"Tryptophan hydroxylase 1"	P17752	11	18017564-18042426	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Serotonin biosynthesis"	"Monooxygenase, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 21.5;intestine: 19.5;stomach 1: 15.1"	"Cell type enriched"	"Detected in many"	30	"Enteroendocrine cells: 1466.7"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.4"	"Region enriched"	"Detected in some"	10	"midbrain: 21.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HL-60: 1.5"	"Low region specificity"	"Detected in some"							"CAB010767, HPA022483"	Uncertain		Uncertain	Cytosol		NA	NA			Cytosol		"CAB010767: AB_261587, HPA022483: AB_1858378"	"unprognostic (2.14e-4)"	"unprognostic (9.97e-2)"	"unprognostic (6.92e-2)"	"unprognostic (6.78e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.26e-5)"	"unprognostic (1.73e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.19e-4)"	"unprognostic (6.72e-2)"	"unprognostic (5.40e-8)"	"unprognostic (3.76e-2)"	"unprognostic (7.42e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.46e-5)"	0.5	0.1	0.3	1.2	0.4	1.1	1.3	0.3	0.4	0.5	4.2	9.1	10.2	0.9	0.9	0.2	0.9	0.1	0.3	0.4	2.1	0.3	0.2	0.8	0.5	0.3	21.5	0.3	0.7	0.5	0.1	3.1	0.2	0.5	1.5	19.5	1.8	0.5	0.1	0.4	1.5	11.3	0.2	0.2	0.7	15.1	0.9	0.6	0.4	0.5	0.1	0.7	0.4	0.4	0.4	0.1	0.0	0.5	0.4	0.0	0.0	0.2	0.1	0.1	0.0	0.3	0.6	0.0	0.4	0.1	0.0	0.0	0.2	0.1	0.5	0.2	0.4	1.0	0.7	0.3	1.1	0.0	1.5	0.3	0.0	0.6	0.0	0.2	0.1	0.2	0.8	0.3	0.2	0.0	0.1	0.3	0.2	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.3	0.4	0.3	0.0	0.1	0.2	0.0	0.0	0.9	0.0	0.1	0.4	0.1	0.5	0.0	0.1	0.3	0.0	0.3	0.4	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.3	0.4	0.3	0.4	0.4	2.1	0.3	21.5	0.3	0.5	0.2	0.6	0.4	1.4	0.0	0.0	1.0	1.1	0.4	0.4	0.5	0.0	14.9	1.9	1.0	0.8	0.0	0.1	5.5	2.1	0.2	0.6	1.7	0.0	0.2	0.8	0.1	0.6	0.7	1466.7	0.4	0.5	0.6	0.0	1.2	2.0	0.2	0.0	5.6	0.4	0.2	0.2	1.7	0.4	48.2	0.0	0.3	1.4	0.8	0.9	0.5	0.0	0.0	0.1	1.4	1.0	0.0	0.6	0.4	13.4	1.2	0.3	2.3	1.5	0.3	0.9	5.6	6.6	1.3	1.3	2.8	3.7	0.0	1.4	0.0	1.2	0.0	2.7	0.4
TPM1	"C15orf13, CMH3"	ENSG00000140416	"Tropomyosin 1"	P09493	15	63042632-63071915	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes, Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"heart muscle: 9637.8;skeletal muscle: 12799.1;tongue: 5229.5"	"Cell type enriched"	"Detected in all"	4	"Cardiomyocytes: 13012.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 48.7"	"Group enriched"	"Detected in all"	4	"dendritic cells: 14.1;granulocytes: 48.7;monocytes: 19.2"	"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 3141.3;SuSa: 3810.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000261, HPA009066, CAB017698, HPA047089, HPA053624"	Supported		Approved	"Actin filaments,Cytosol"		NA	NA		120000000	"Actin filaments"	Cytosol	"CAB017698: AB_2272017, HPA000261: AB_1080339, HPA009066: AB_1080342, HPA047089: AB_2679928, HPA053624: AB_2682210"	"unprognostic (1.07e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.00e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.66e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.53e-2)"	"prognostic unfavorable (7.30e-4)"	346.6	104.6	48.9	235.0	47.1	21.7	351.9	51.1	57.2	563.8	73.6	2128.0	292.3	1580.2	252.7	645.0	831.0	290.6	9637.8	51.0	42.8	210.7	95.5	249.2	48.5	41.7	42.5	45.7	323.0	386.7	37.8	71.1	208.2	43.4	816.7	528.0	84.6	260.3	1560.2	12799.1	146.6	686.6	1770.5	43.4	135.4	984.8	52.7	46.7	21.3	158.1	5229.5	29.7	1523.6	429.4	43.5	554.5	357.3	418.1	20.9	143.1	89.9	1335.5	1509.1	552.8	905.9	669.2	253.9	107.6	1.7	677.7	1517.1	602.7	295.9	361.8	243.4	597.0	14.5	50.9	81.2	376.3	124.5	403.3	3.8	17.9	125.7	138.0	742.1	198.2	3141.3	243.2	14.7	8.7	20.4	695.3	286.4	25.6	7.1	496.0	129.0	61.1	9.0	146.5	15.8	1308.7	298.8	101.1	71.7	180.9	284.4	65.1	3810.3	204.8	15.3	1095.8	1178.8	572.0	181.6	1094.8	5.9	4.3	7.8	335.9	22.4	842.1	48.7	9.9	4.8	4.0	19.2	3.1	5.5	3.6	4.3	14.1	5.6	4.0	3.6	10.7	1.9	14.3	2.4	6.3	15.6	48.9	47.1	51.1	57.2	51.0	42.8	41.7	42.5	45.7	43.4	43.4	46.7	43.5	542.3	57.7	86.3	19.9	12.1	71.9	202.0	344.1	18.2	49.0	450.1	953.1	13012.4	346.0	147.0	318.2	383.7	212.1	20.6	561.3	187.9	2502.6	6.5	147.2	614.4	294.3	267.7	137.0	44.2	1671.1	3094.8	557.1	279.3	211.2	52.0	85.3	175.6	138.1	201.5	52.2	53.2	964.7	183.1	42.5	72.1	27.3	205.0	114.3	81.8	111.5	47.5	47.4	28.8	36.2	6.0	2372.3	623.4	1130.3	8.8	244.3	724.7	361.1	104.2	447.5	1038.7	484.0	1685.9	27.4	82.2	29.4	50.4	103.0	29.0	130.7	385.3	198.2
TRAV8-3		ENSG00000211787	"T cell receptor alpha variable 8-3"	A0A0A6YYJ7	14	21852558-21853006	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 71.7"	"Cell type enriched"	"Detected in single"	7	"T-cells: 3.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 138.2;T-reg: 153.1"	"Lineage enriched"	"Detected in many"	47	"T-cells: 153.1"	"Cell line enriched"	"Detected in single"	6	"JURKAT: 2.9"					"Low region specificity"	"Detected in single"									NA	NA						"unprognostic (7.74e-4)"	"unprognostic (5.25e-5)"	"unprognostic (8.88e-4)"	"unprognostic (1.12e-2)"	"unprognostic (2.69e-1)"	"unprognostic (9.64e-5)"	"unprognostic (8.20e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.38e-2)"	"unprognostic (6.44e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.66e-5)"	"unprognostic (2.99e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.26e-2)"	0.6	0.0	0.4	6.6	0.7	3.9	2.9	0.2	1.6	2.3	0.3	3.0	2.4	0.8	17.0	1.6	9.0	5.7	0.4	0.6	0.3	0.7	1.2	3.8	40.5	0.2	0.3	0.4	0.5	0.0	0.1	0.0	0.6	0.4	1.9	4.7	0.0	2.0	0.7	0.3	0.8	2.8	1.0	0.3	9.1	2.7	3.1	0.3	71.7	0.9	1.1	30.5	6.9	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.4	1.2	0.1	29.7	0.1	106.6	48.4	0.3	0.6	138.2	77.0	3.2	0.2	0.3	0.9	153.1	34.6	0.4	0.7	0.2	1.6	0.6	0.3	0.2	0.3	0.4	0.4	0.3	0.3	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0
TRIM58	BIA2	ENSG00000162722	"Tripartite motif containing 58"	Q8NG06	1	247857187-247880138	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 32.5;thyroid gland: 15.3"	"Cell type enriched"	"Detected in many"	23	"Erythroid cells: 456.4"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 2.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 18.3;HEL: 40.7;K-562: 21.8;PC-3: 37.0;U-2 OS: 29.0;WM-115: 42.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA023637	Uncertain					NA	NA					"HPA023637: AB_1858309"	"unprognostic (3.85e-1)"	"unprognostic (5.24e-3)"	"unprognostic (7.00e-2)"	"unprognostic (6.52e-4)"	"unprognostic (1.46e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.14e-5)"	"unprognostic (3.59e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.00e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.57e-2)"	0.5	0.6	1.4	0.6	0.8	32.5	0.5	0.2	1.4	0.4	1.3	1.2	0.1	0.2	0.1	0.1	1.3	0.3	0.2	0.6	2.8	0.2	0.2	1.3	0.2	3.0	3.2	0.7	0.0	0.2	0.1	0.2	5.8	3.6	1.5	0.9	0.6	0.3	0.2	0.2	0.9	0.3	0.6	1.1	2.4	0.4	2.7	2.7	0.3	15.3	1.6	0.1	0.2	0.2	3.3	0.0	0.0	0.0	0.0	0.7	2.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.4	1.7	18.3	0.0	0.0	0.0	1.3	40.7	0.0	0.0	0.0	5.5	2.4	0.0	0.0	0.2	0.0	0.0	0.0	1.4	21.8	0.1	0.0	0.0	0.2	0.3	2.7	0.0	37.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.2	4.7	0.0	0.0	29.0	0.0	0.0	6.3	0.0	0.0	0.0	13.0	42.1	0.7	0.1	0.3	0.0	0.1	0.0	0.8	0.0	0.0	0.2	0.2	0.0	0.0	0.6	0.3	0.1	0.1	0.0	0.6	1.4	0.8	0.2	1.4	0.6	2.8	3.0	3.2	0.7	3.6	1.1	2.7	3.3	0.6	3.2	3.0	0.3	1.7	1.0	1.4	0.0	0.6	3.4	1.1	0.3	0.5	0.0	5.6	1.8	12.5	3.3	0.4	0.8	0.0	0.1	4.3	2.5	0.7	1.7	1.2	456.4	3.7	0.0	4.6	3.0	0.0	2.1	8.2	0.4	1.8	0.1	2.4	0.0	1.8	0.4	0.0	3.2	1.4	1.2	0.9	19.4	1.8	0.0	1.0	2.7	2.1	0.5	0.3	0.2	0.7	0.7	0.3	4.0	0.0	0.2	3.7	3.7	0.0	0.9	0.7	2.8	9.7	0.1	0.9	4.9	1.7	0.3	0.8	0.8
TRPV5	"CaT2, ECAC1"	ENSG00000127412	"Transient receptor potential cation channel subfamily V member 5"	Q9NQA5	7	142908101-142933746	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	4	"kidney: 4.3"	"Cell type enriched"	"Detected in some"	8	"Oligodendrocytes: 15.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA063175	Uncertain					NA	NA					"HPA063175: AB_2684954"	"unprognostic (7.44e-2)"	"unprognostic (3.93e-2)"		"unprognostic (1.22e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.98e-1)"		"unprognostic (3.26e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.95e-2)"	"unprognostic (7.73e-4)"	"unprognostic (4.87e-2)"	"unprognostic (3.41e-1)"	"unprognostic (4.58e-1)"	"unprognostic (7.76e-3)"	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.7	0.9	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	4.3	0.0	0.0	0.0	0.8	0.8	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.7	0.9	0.6	0.7	0.8	0.8	0.6	0.8	0.7	0.9	0.9	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UPK3B	"FLJ32198, MGC10902, p35, UPIIIb"	ENSG00000243566	"Uroplakin 3B"	Q9BT76	7	76510525-76516522	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 55.2;esophagus: 65.3;lung: 50.4;urinary bladder: 42.6"	"Cell type enriched"	"Detected in some"	5	"Alveolar cells type 1: 121.8"	"Group enriched"	"Detected in many"	12	"ovarian cancer: 64.6;urothelial cancer: 78.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 13.2;CAPAN-2: 48.2;HaCaT: 10.0;RT4: 34.7;T-47d: 27.1"	"Not detected"	"Not detected"							HPA010506	Approved					NA	NA					"HPA010506: AB_1080479"	"unprognostic (8.33e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.62e-3)"	"unprognostic (2.26e-3)"	"unprognostic (7.87e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.03e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.06e-2)"	"unprognostic (8.37e-9)"	"unprognostic (3.56e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.34e-2)"	55.2	0.7	0.1	0.1	0.4	0.1	1.5	0.0	0.3	4.6	0.8	1.0	0.0	0.7	0.2	65.3	10.1	0.1	5.8	0.0	0.2	0.6	1.0	50.4	0.1	0.1	0.2	0.0	7.0	1.3	0.0	1.8	0.0	0.1	2.7	0.0	0.2	8.3	0.0	0.5	4.1	1.0	0.0	0.0	2.1	2.9	4.3	0.6	0.0	1.4	0.0	1.9	42.6	12.2	0.1	1.1	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	48.2	0.0	0.4	0.0	0.1	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.1	0.0	2.9	0.1	0.0	0.0	0.0	0.0	34.7	0.0	0.0	0.3	3.9	0.0	0.1	27.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.3	0.0	0.2	0.1	0.2	0.0	0.1	0.0	0.6	0.1	0.3	121.8	3.3	0.0	0.3	1.7	0.4	18.3	4.6	0.4	0.2	0.0	0.3	20.0	20.4	3.7	4.2	0.1	0.0	0.2	0.0	0.1	0.0	0.5	0.0	0.9	0.0	0.0	0.0	0.0	0.0	13.9	1.1	0.5	1.3	0.1	0.7	0.1	0.1	1.7	0.0	0.0	6.1	0.3	2.5	0.0	12.2	0.3	3.6	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.7	0.1	0.0	11.1	0.2	0.0	0.0	1.1	0.0	0.1	2.1	2.8	0.1	0.4	0.0	0.2	14.2
VSIG1	"GPA34, MGC44287"	ENSG00000101842	"V-set and immunoglobulin domain containing 1"	Q86XK7	X	108044970-108079184	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"stomach 1: 195.3"	"Cell type enriched"	"Detected in some"	10	"Gastric mucus-secreting cells: 333.8"	"Group enriched"	"Detected in many"	17	"lung cancer: 8.7;pancreatic cancer: 17.7;stomach cancer: 31.2"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 12.0;T-reg: 12.9"	"Lineage enriched"	"Detected in many"	4	"T-cells: 12.9"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 3.5;HUVEC TERT2: 7.4;PC-3: 2.3;TIME: 1.7"	"Not detected"	"Not detected"							"HPA001445, HPA036310, HPA036311"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA001445: AB_10669749, HPA036310: AB_10670795, HPA036311: AB_10673350"	"unprognostic (4.33e-3)"	"unprognostic (4.60e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.80e-2)"	"unprognostic (3.25e-2)"	"unprognostic (9.79e-2)"	"unprognostic (4.58e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.31e-7)"	"unprognostic (1.48e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.23e-3)"	0.0	0.1	0.3	1.3	0.4	0.5	0.1	0.2	0.3	0.0	0.3	0.2	1.3	0.1	0.3	0.2	0.0	8.5	0.0	0.2	0.2	0.1	0.1	1.0	1.9	0.1	0.1	0.2	0.0	0.2	0.0	2.6	0.3	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.4	0.5	0.0	0.1	0.8	195.3	48.1	0.2	0.8	0.1	0.0	1.6	9.0	0.1	0.2	0.1	0.6	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.3	0.0	3.5	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.2	0.6	0.0	1.1	0.0	7.4	0.0	0.0	0.1	0.0	0.2	0.2	0.1	0.2	0.6	2.3	0.2	0.0	0.0	0.3	0.6	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	1.7	0.1	0.5	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.1	1.0	0.0	3.8	2.8	8.1	3.6	0.0	1.3	12.0	5.8	0.3	0.1	0.1	0.1	12.9	2.6	0.3	0.4	0.2	0.3	0.2	0.2	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.2	25.6	11.0	1.0	2.4	0.6	0.9	0.7	0.0	0.9	0.2	0.1	0.5	1.5	0.7	0.0	0.0	0.0	0.1	0.4	0.0	2.9	6.1	1.1	0.1	1.0	0.0	0.0	4.1	4.6	0.0	0.6	333.8	0.2	2.5	0.0	0.0	0.0	0.1	0.0	1.4	0.3	0.0	0.0	0.4	10.8	0.6	0.7	0.0	0.0	0.3	0.1	1.0	0.0	0.1	32.9	0.0	0.0	1.0	0.6	0.0	0.0	0.9	0.8	0.0	1.1	0.2	1.0	0.6	0.0	0.0	0.1	4.5	0.2	0.1	3.8
ZNF829	DKFZp779O175	ENSG00000185869	"Zinc finger protein 829"	Q3KNS6	19	36888124-36916291	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 10.5"	"Cell type enriched"	"Detected in many"	4	"Early spermatids: 278.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/84: 13.0"					"Low region specificity"	"Detected in all"			HPA073073			Approved	"Nucleoplasm,Nuclear bodies"		No	No			Nucleoplasm	"Nuclear bodies"	"HPA073073: AB_2686567"	"unprognostic (4.55e-2)"	"unprognostic (2.34e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.44e-4)"	"unprognostic (1.32e-1)"	"unprognostic (6.46e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.33e-2)"	"unprognostic (9.35e-4)"	"unprognostic (1.20e-2)"	"unprognostic (3.57e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.48e-4)"	"unprognostic (5.47e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.92e-4)"	1.1	0.9	0.6	1.2	0.7	1.1	2.1	1.9	1.0	1.1	0.1	0.8	0.9	1.6	1.0	0.9	1.3	0.9	1.2	0.7	0.5	1.2	0.8	1.0	1.5	0.6	0.6	0.6	2.4	0.9	1.9	0.5	1.5	0.8	1.4	0.7	2.0	1.1	1.2	0.5	1.9	0.7	1.4	0.3	1.6	0.9	10.5	0.7	1.6	1.7	0.8	1.5	1.0	0.9	1.1	0.0	0.8	2.9	0.1	1.5	2.2	1.2	3.3	1.9	3.9	5.5	0.0	0.5	0.1	3.9	2.1	3.7	0.6	0.0	2.3	4.6	0.0	4.1	1.6	0.1	0.1	1.6	0.0	4.2	2.3	2.1	4.3	0.0	1.3	0.4	1.2	0.0	0.1	3.9	0.7	0.7	0.8	5.1	0.0	0.0	0.0	3.7	1.5	1.1	4.5	3.2	4.7	0.1	0.0	2.8	3.8	3.0	0.2	1.1	2.4	3.4	3.3	3.4	7.9	13.0	5.0	0.0	0.0	6.1	1.4	0.2	0.9	0.9	0.1	1.4	0.8	1.0	1.4	0.3	1.2	1.4	1.5	0.4	0.7	0.2	0.5	1.0	0.3	0.6	0.7	1.9	1.0	0.7	0.5	0.6	0.6	0.6	0.8	0.3	0.7	1.1	3.0	0.0	3.4	2.0	4.7	1.5	1.9	1.2	1.2	6.8	2.5	2.0	5.6	2.8	3.7	3.7	4.2	4.0	5.5	0.6	0.0	2.7	278.1	3.1	4.4	3.7	0.0	1.3	4.2	1.0	2.5	3.9	0.5	3.1	1.3	5.5	2.9	0.6	1.5	11.8	3.8	1.0	0.0	1.0	4.6	58.9	5.9	1.4	3.6	1.0	1.7	2.6	5.2	6.0	4.1	0.8	0.1	7.2	1.3	1.9	0.3	1.3	1.6	11.1	0.0	5.9	4.6	10.6	11.2	1.1	2.7	4.2	3.8	3.1	0.5	1.1
A2ML1	"CPAMD9, FLJ25179, p170"	ENSG00000166535	"Alpha-2-macroglobulin like 1"	A8K2U0	12	8822621-8887001	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 560.7;vagina: 206.4"	"Cell type enriched"	"Detected in some"	6	"Squamous epithelial cells: 127.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 39.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 10.9;hTCEpi: 5.5;SK-BR-3: 13.9"					"Low region specificity"	"Detected in many"			"HPA038847, HPA038848"	Enhanced				"Secreted in other tissues"	NA	NA		10000000			"HPA038847: AB_2676236, HPA038848: AB_10672654"	"unprognostic (1.13e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.46e-3)"	"unprognostic (2.14e-1)"	"unprognostic (5.54e-3)"	"unprognostic (4.59e-2)"	"unprognostic (7.58e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.15e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.06e-9)"	"unprognostic (2.28e-1)"	"unprognostic (3.07e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.42e-2)"	0.2	0.1	2.5	0.0	2.0	0.2	4.2	1.3	2.5	55.8	0.4	0.1	0.0	0.5	0.4	560.7	0.7	0.2	0.4	2.0	1.7	0.1	0.3	0.1	0.2	2.0	2.1	1.6	0.4	0.2	0.9	1.4	0.7	1.6	0.6	0.0	0.7	99.8	0.0	0.3	72.6	0.1	0.1	1.5	0.1	0.7	5.0	2.8	3.0	0.1	0.0	51.9	1.2	206.4	1.3	0.1	0.0	0.1	0.1	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.1	0.1	0.2	0.1	0.2	0.0	2.5	10.9	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	13.9	0.0	1.0	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.3	0.1	0.0	0.0	2.5	2.0	1.3	2.5	2.0	1.7	2.0	2.1	1.6	1.6	1.5	2.8	1.3	0.0	0.0	0.0	20.2	0.0	0.4	0.5	1.0	1.8	0.7	0.3	0.1	0.7	0.0	2.2	0.0	0.0	0.3	0.0	0.0	1.9	0.0	0.4	4.4	0.9	0.3	0.0	0.0	4.9	0.0	0.5	0.4	0.0	11.9	0.0	0.8	0.0	0.0	0.1	0.0	4.6	0.0	0.0	0.0	0.0	0.6	0.3	0.2	0.0	0.0	0.0	1.2	0.0	2.0	0.5	0.0	0.0	0.0	0.0	2.6	0.0	0.1	0.2	0.3	0.0	0.4	0.3	1.0	0.4	127.6	12.6	0.1	0.1	1.9	0.0	8.2
AANAT	SNAT	ENSG00000129673	"Aralkylamine N-acetyltransferase"	Q16613	17	76453351-76470117	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Biological rhythms, Melatonin biosynthesis"	"Acyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"retina: 11.1;testis: 4.7"	"Cell type enriched"	"Detected in some"	10	"Bipolar cells: 302.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.5;Daudi: 2.0;SCLC-21H: 3.2;U-266/70: 2.3;U-266/84: 2.7;U-698: 3.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA054321			Supported	Cytosol	"Intracellular and membrane"	NA	NA			Cytosol		"HPA054321: AB_2682449"	"unprognostic (7.89e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.61e-1)"	"unprognostic (9.30e-2)"	"unprognostic (4.19e-1)"	"unprognostic (2.81e-7)"	"unprognostic (1.04e-1)"	"unprognostic (6.00e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.34e-2)"	0.1	0.2	0.5	1.6	0.6	1.3	0.1	0.7	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.2	0.7	0.1	0.7	0.5	0.2	0.0	0.2	1.5	1.9	3.0	0.1	0.2	0.2	0.0	0.3	0.0	1.8	0.1	0.0	11.1	0.1	0.0	0.1	1.4	0.4	0.0	0.9	1.0	0.2	4.7	1.6	0.0	0.4	0.0	0.1	0.2	0.1	1.9	0.5	2.5	0.3	0.2	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	1.7	2.0	0.3	0.0	0.3	0.6	0.0	0.0	0.1	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.6	0.2	0.0	1.0	0.2	0.3	0.0	0.1	0.6	0.8	0.2	0.1	0.1	1.1	0.0	0.0	3.2	0.2	0.0	0.1	0.8	0.3	1.5	0.3	0.0	0.0	0.9	0.1	0.0	2.3	2.7	3.6	0.6	0.2	0.4	0.7	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.3	0.0	0.0	0.5	0.6	0.7	0.7	0.7	0.5	1.9	3.0	0.1	1.8	0.9	1.6	1.9	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	302.1	0.1	0.4	0.3	0.0	0.0	0.0	12.5	0.3	0.2	0.0	0.0	0.0	7.5	0.2	0.1	0.6	1.2	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	6.7	0.6	0.1	0.0	0.3	0.0	19.4	0.3	0.1	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.4	0.0	30.2	0.0	0.0	0.0	3.1	1.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1
AASDHPPT	"AASD-PPT, ACPS, CGI-80, LYS5"	ENSG00000149313	"Aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase"	Q9NRN7	11	106075501-106098699	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Early spermatids: 388.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026687	Approved					NA	NA					"HPA026687: AB_1844414"	"unprognostic (1.96e-2)"	"unprognostic (4.40e-1)"	"unprognostic (8.71e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.11e-1)"	"unprognostic (9.04e-3)"	"unprognostic (2.82e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.44e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.32e-1)"	"prognostic favorable (4.27e-4)"	"unprognostic (2.13e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.43e-1)"	17.1	23.7	33.0	18.5	37.4	15.9	21.4	34.7	44.5	17.7	27.2	13.7	13.7	20.5	26.0	21.3	20.8	13.5	28.0	37.3	39.8	34.4	33.9	15.6	22.8	35.1	34.7	37.1	21.1	33.5	20.2	11.5	28.1	34.0	19.1	14.2	32.6	24.7	17.2	33.1	17.2	12.0	18.5	33.5	17.4	13.7	37.8	34.4	21.5	22.3	32.7	24.1	18.6	11.7	41.8	29.6	28.2	84.7	63.5	41.4	54.6	34.3	43.1	36.7	58.7	45.0	61.2	53.3	91.4	98.2	28.2	57.2	37.8	77.0	57.6	59.0	55.8	39.3	84.6	19.5	45.0	64.3	73.5	35.2	53.8	72.8	47.0	63.8	40.5	49.6	39.8	95.2	22.2	57.6	16.7	79.8	63.6	36.9	40.2	39.4	55.7	81.3	103.7	70.4	32.5	63.0	58.3	47.5	45.8	43.6	49.1	60.2	50.0	41.9	49.7	47.6	35.3	45.6	30.7	53.7	90.0	22.4	100.0	57.9	63.2	21.6	23.9	20.6	27.9	29.2	26.7	23.9	22.7	21.8	20.8	27.4	26.4	6.9	31.9	28.1	19.2	30.6	18.2	33.0	37.4	34.7	44.5	37.3	39.8	35.1	34.7	37.1	34.0	33.5	34.4	41.8	32.4	32.1	31.7	18.3	33.8	20.0	28.2	39.4	56.3	35.0	23.4	31.9	24.1	34.3	29.8	18.4	2.1	78.4	27.7	7.3	39.2	33.5	388.5	31.6	42.2	23.9	18.6	47.9	36.0	24.3	63.8	33.9	23.4	29.4	29.8	41.9	17.2	36.5	39.0	21.9	34.8	12.6	30.5	24.9	13.0	70.2	32.3	27.9	32.0	15.0	29.9	67.4	19.6	32.6	43.4	22.6	10.2	26.7	45.1	23.5	11.1	81.4	47.6	20.0	13.1	30.8	38.2	47.8	37.5	46.2	24.4	39.4	33.1	62.9	13.5	19.6
ABCA3	"ABC-C, ABC3, EST111653, LBM180"	ENSG00000167972	"ATP binding cassette subfamily A member 3"	Q99758	16	2275881-2340746	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport	Translocase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 92.0"	"Cell type enriched"	"Detected in many"	6	"Alveolar cells type 2: 427.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 34.6;SCLC-21H: 45.9;T-47d: 76.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007884	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA007884: AB_1078077"	"unprognostic (2.64e-1)"	"unprognostic (2.19e-2)"	"unprognostic (6.09e-3)"	"unprognostic (2.61e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.58e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.22e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.32e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.30e-1)"	6.9	8.8	15.8	3.0	18.1	0.7	6.8	7.9	25.7	2.6	0.0	6.1	2.0	3.7	3.6	3.0	4.4	2.7	5.6	20.7	11.6	6.5	1.1	92.0	3.7	16.5	11.7	19.4	3.4	13.2	11.3	11.1	4.4	17.9	5.0	1.2	7.4	9.2	4.3	6.3	4.3	3.9	4.7	8.8	3.4	4.9	9.0	16.6	11.4	24.8	3.8	6.6	4.6	2.3	17.3	0.7	21.6	4.1	33.1	0.8	0.0	0.3	5.8	1.4	2.3	2.4	3.0	3.4	0.2	8.4	2.7	2.1	0.6	19.2	0.3	0.8	34.6	12.9	2.2	2.5	0.5	2.9	0.4	3.6	0.3	0.5	0.3	1.1	13.4	32.4	0.2	24.0	0.0	0.1	29.3	0.1	2.4	4.4	5.2	10.4	5.4	0.7	3.8	18.7	0.7	45.9	33.0	4.1	23.4	0.6	1.6	76.5	2.0	9.3	0.2	1.1	9.0	9.8	6.1	2.9	0.1	4.7	11.7	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.0	0.4	0.1	0.0	0.0	0.1	15.8	18.1	7.9	25.7	20.7	11.6	16.5	11.7	19.4	17.9	8.8	16.6	17.3	4.3	70.5	427.4	30.0	1.1	0.6	0.5	0.2	2.2	20.7	8.4	6.7	6.7	4.3	9.5	18.4	12.5	0.0	2.1	0.3	0.0	5.7	7.7	1.3	0.3	6.3	5.4	0.0	60.3	3.8	0.0	2.7	0.0	2.9	29.7	7.7	5.3	0.7	1.0	18.5	58.6	0.8	4.1	1.2	1.8	3.8	1.8	3.1	1.8	13.1	2.2	7.1	2.1	32.2	37.2	1.9	0.4	3.4	3.6	1.5	0.4	2.0	2.4	12.5	6.6	7.2	2.9	5.1	15.0	1.2	1.6	0.0	3.9	1.3	0.4	0.2
ABCB10	"EST20237, M-ABC2, MTABC2"	ENSG00000135776	"ATP binding cassette subfamily B member 10"	Q9NRK6	1	229516582-229558707	"Plasma proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 60.7"	"Cell type enriched"	"Detected in many"	5	"Erythroid cells: 170.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"HL-60: 101.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB044063, CAB044065, HPA055175"	Uncertain					NA	NA					"CAB044063: AB_353262, CAB044065: AB_2220666, HPA055175: AB_2682727"	"unprognostic (1.00e-1)"	"unprognostic (1.29e-2)"	"unprognostic (5.56e-3)"	"unprognostic (5.64e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.06e-3)"	"unprognostic (9.38e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.15e-2)"	"unprognostic (5.61e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.13e-1)"	"unprognostic (8.32e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.83e-1)"	"unprognostic (5.29e-2)"	"unprognostic (3.37e-2)"	9.0	6.0	5.0	9.0	5.4	60.7	8.0	7.2	6.5	6.8	5.4	11.2	17.3	6.9	4.7	8.4	8.0	6.8	7.9	4.9	5.1	9.9	19.1	8.9	11.1	5.3	5.4	5.2	5.5	7.4	9.5	3.5	11.4	5.6	8.5	11.4	6.4	6.8	7.4	13.0	8.2	14.0	9.3	4.9	8.7	10.2	3.8	5.8	8.2	7.6	11.0	9.7	8.5	6.4	6.3	25.1	14.6	11.9	9.8	19.9	17.1	51.6	22.5	16.8	20.0	18.1	15.1	18.7	27.3	20.1	20.7	8.2	21.1	25.8	18.6	20.1	18.7	32.5	30.0	12.2	19.3	14.2	101.9	16.1	11.8	15.7	12.2	14.1	12.1	21.9	47.9	65.2	61.0	20.8	7.9	26.1	57.9	15.9	28.8	12.3	23.4	23.5	29.0	16.2	15.9	8.8	13.3	17.6	19.4	28.6	7.3	15.0	35.0	17.0	21.5	13.5	13.5	31.2	14.9	11.9	23.7	11.3	17.5	13.8	0.5	0.6	0.8	0.7	0.8	1.0	0.5	0.9	1.1	0.8	0.6	0.8	1.0	0.1	0.4	0.6	0.9	0.8	0.3	5.0	5.4	7.2	6.5	4.9	5.1	5.3	5.4	5.2	5.6	4.9	5.8	6.3	6.9	9.6	2.0	16.0	3.8	3.2	2.7	4.3	3.4	6.8	6.4	4.2	11.5	5.7	5.5	0.0	12.5	6.5	7.9	13.5	1.9	4.6	0.2	6.3	8.7	6.5	10.2	170.0	21.9	5.3	10.4	5.0	6.1	6.0	5.7	3.5	8.6	19.2	9.1	10.1	27.3	10.6	2.0	13.3	6.6	0.5	5.0	8.3	8.8	10.3	16.8	3.6	4.1	31.2	30.3	4.7	8.8	4.5	5.5	8.4	13.5	4.9	12.1	4.8	6.6	5.4	6.8	4.2	4.5	8.3	5.1	3.6	5.9	2.8	11.5	3.7
ABCC2	"CMOAT, cMRP, DJS, MRP2"	ENSG00000023839	"ATP binding cassette subfamily C member 2"	Q92887	10	99782640-99852594	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	Transport	Translocase	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 40.6;liver: 122.7"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 70.7"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 24.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"A549: 204.4;Hep G2: 208.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA071145	Enhanced					NA	NA					"HPA071145: "	"unprognostic (1.49e-3)"	"unprognostic (5.92e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.93e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.15e-3)"	"unprognostic (5.68e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.30e-1)"	"unprognostic (1.40e-3)"	"prognostic unfavorable (1.93e-5)"	"unprognostic (1.31e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.26e-2)"	1.3	0.4	0.3	0.7	0.4	0.8	3.1	0.5	0.4	0.5	0.2	0.5	39.4	0.4	0.2	0.3	0.7	24.6	0.2	0.3	0.3	18.7	122.7	0.5	0.7	0.4	0.3	0.2	0.3	1.1	0.1	0.1	0.5	0.4	0.4	0.4	3.9	0.5	0.2	1.1	1.7	40.6	0.2	0.3	1.4	0.7	0.7	0.3	0.8	0.4	0.8	0.5	1.3	0.5	0.6	0.3	204.4	3.5	10.2	15.3	12.0	3.4	0.5	1.3	0.5	0.6	44.6	0.3	0.4	0.3	0.7	0.5	1.3	0.3	0.4	0.6	0.5	0.3	0.0	1.0	208.7	0.5	0.3	0.7	1.9	13.9	1.5	1.4	0.2	0.4	0.6	0.0	0.3	0.2	1.0	0.2	1.4	0.3	39.8	0.3	0.3	0.2	0.4	1.4	0.3	0.1	0.2	0.5	3.4	25.9	0.4	0.1	0.4	0.7	0.6	0.6	0.9	0.6	0.8	0.1	0.2	16.1	1.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.5	0.4	0.3	0.3	0.4	0.3	0.2	0.4	0.3	0.3	0.6	0.7	0.0	0.0	2.3	0.4	0.0	0.2	0.2	0.0	0.3	0.1	0.0	0.5	1.5	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.2	2.6	2.9	0.2	0.3	0.0	0.4	1.0	0.4	0.0	1.7	0.0	0.6	1.3	0.1	1.4	70.7	0.2	0.0	1.3	0.6	0.0	1.0	0.0	1.1	0.3	0.4	5.4	1.9	0.3	0.1	0.0	1.0	2.2	0.1	0.0	0.0	0.1	0.2	15.5	10.7	2.8	1.5	0.0	0.4	0.5	1.2	0.7	0.1	0.0	1.6	0.4	0.1	0.4	0.0
AC005154.5		ENSG00000281039	"Novel protein"		7	30497077-30550761	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"Cardiomyocytes: 9.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-266/70: 21.4"									HPA020735	Uncertain					NA	NA					"HPA020735: AB_1845754"	"unprognostic (1.15e-2)"	"unprognostic (5.67e-3)"			"unprognostic (1.07e-2)"			"unprognostic (8.33e-2)"	"unprognostic (3.92e-2)"		"unprognostic (6.95e-3)"	"unprognostic (1.57e-1)"	"unprognostic (6.37e-4)"		"unprognostic (2.55e-2)"	"unprognostic (4.34e-3)"	"unprognostic (1.50e-4)"	12.9	9.3	22.9	7.0	22.2	29.0	9.7	20.2	26.3	3.9	22.9	8.2	11.0	8.3	25.1	2.9	6.1	7.7	4.5	21.8	21.0	4.4	6.3	12.9	14.2	20.0	20.9	21.6	9.3	2.6	7.8	3.1	6.2	20.9	7.8	8.7	20.8	7.0	8.5	11.0	15.3	6.9	5.4	19.5	12.4	9.0	5.3	21.6	9.0	8.3	4.0	11.5	5.8	0.7	22.4	2.0	0.0	7.4	7.5	5.1	11.7	2.8	5.0	5.4	2.8	2.0	1.2	0.7	2.6	1.5	4.1	3.6	5.4	1.0	2.3	2.8	3.3	1.4	2.6	6.2	2.4	4.7	5.9	11.6	8.0	7.0	2.1	4.1	5.8	2.8	5.7	2.2	12.0	4.3	0.4	2.3	7.6	1.6	1.2	0.7	2.2	0.5	4.7	4.5	3.3	1.7	2.7	2.6	1.6	3.6	8.6	4.0	8.2	2.8	2.0	1.5	2.0	1.1	21.4	5.2	2.5	3.5	7.2	6.3	0.0	0.2	0.4	0.5	0.1	0.1	0.0	0.1	0.4	0.4	0.3	0.3	0.0	0.1	0.1	0.2	0.1	0.1	0.0	22.9	22.2	20.2	26.3	21.8	21.0	20.0	20.9	21.6	20.9	19.5	21.6	22.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC007040.2		ENSG00000258881	"Novel protein"		2	70939318-70995336	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"brain: 1.3;retina: 1.4"	"Cell type enriched"	"Detected in single"	4	"Cytotrophoblasts: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 3.1;JURKAT: 2.4;U-2 OS: 2.1"															NA	NA						"unprognostic (1.86e-1)"	"unprognostic (2.94e-1)"	"unprognostic (7.99e-4)"	"unprognostic (1.36e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.53e-9)"	"unprognostic (6.54e-2)"	"unprognostic (7.86e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.32e-1)"	0.1	0.0	0.7	0.1	0.6	0.2	0.1	1.3	1.1	0.0	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.7	0.4	0.1	0.0	0.0	0.1	0.7	0.5	0.6	0.0	0.1	0.0	0.0	0.0	0.9	0.1	0.0	1.4	0.3	0.0	0.2	0.5	0.0	0.0	0.2	0.1	0.0	0.8	0.5	0.0	0.1	0.0	0.0	0.0	0.0	1.0	1.1	0.1	0.1	0.6	0.1	0.1	0.4	0.0	0.0	0.2	0.2	0.1	0.1	1.6	0.1	0.2	3.1	0.2	0.4	0.0	0.3	1.3	1.0	1.0	0.1	0.3	0.0	0.0	0.3	0.1	0.0	0.3	0.0	0.1	0.6	2.4	0.1	0.4	0.2	0.3	0.1	0.1	0.1	0.2	0.1	1.3	0.4	0.0	0.3	0.1	0.1	0.1	0.2	0.2	0.5	0.0	0.3	0.0	0.4	1.2	2.1	0.3	1.0	0.1	0.0	0.0	1.3	0.5	1.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.6	1.3	1.1	0.7	0.4	0.7	0.5	0.6	0.9	0.2	0.5	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0
AC011479.1		ENSG00000267748	"Novel protein"		19	38289151-38304910	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"salivary gland: 11.7"	"Cell type enriched"	"Detected in some"	5	"Alveolar cells type 1: 28.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 2.1;CAPAN-2: 1.6;REH: 1.7;SK-BR-3: 3.5;U-266/84: 2.7"															NA	NA						"unprognostic (1.48e-2)"	"unprognostic (7.63e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.31e-1)"		"unprognostic (7.07e-2)"		"unprognostic (1.36e-1)"		"unprognostic (4.78e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.66e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.94e-2)"	"unprognostic (4.41e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.56e-1)"	0.1	0.5	0.4	0.0	0.3	0.3	1.0	0.3	0.6	0.8	0.4	1.1	1.7	0.4	1.2	1.7	0.3	0.2	0.1	0.3	0.5	2.1	0.2	1.1	0.4	0.4	0.3	0.3	2.2	5.2	0.2	1.8	1.1	0.4	1.9	0.6	0.0	11.7	0.8	0.2	2.0	1.1	0.0	0.3	0.5	2.1	0.8	0.3	0.3	2.3	0.0	0.1	0.5	1.2	0.4	2.1	1.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.6	0.0	1.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.0	1.5	0.0	0.3	0.3	0.9	0.3	1.7	0.0	0.0	0.4	0.8	0.0	0.0	0.3	3.5	0.0	0.2	0.5	1.4	0.6	0.0	0.0	0.0	0.0	0.5	2.7	0.0	0.0	0.0	0.3	19.8	4.5	22.8	0.2	2.6	0.3	4.9	2.0	0.7	17.9	7.1	4.0	3.6	2.4	0.5	2.6	22.5	0.6	8.8	0.4	0.3	0.3	0.6	0.3	0.5	0.4	0.3	0.3	0.4	0.3	0.3	0.4	0.0	28.9	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.9	0.0	0.0	4.3	0.0	0.0	1.5	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.2	1.1	0.0	0.5	2.5	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0
AC012184.2		ENSG00000260537	"Novel protein, DDX19B and DDX19A readthrough"		16	70299194-70372582	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	15	"Respiratory ciliated cells: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 34.2;U-698: 35.1"									"HPA046380, HPA066668"	Approved		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA046380: AB_2679645, HPA066668: "																		3.4	1.8	0.0	4.3	0.0	4.5	1.3	0.0	0.2	0.5	0.0	3.1	4.0	0.5	0.0	4.0	0.5	2.8	4.7	0.0	0.0	2.3	1.9	1.2	4.0	0.0	0.0	0.0	0.2	6.4	1.6	0.0	1.3	0.0	0.9	2.6	0.8	2.2	0.2	6.1	3.0	2.8	1.0	0.0	1.1	3.0	0.0	0.0	1.3	3.1	2.1	5.9	4.4	0.7	0.0	2.2	7.6	5.5	14.4	0.0	6.4	12.7	6.6	7.9	11.8	12.6	14.0	19.2	13.1	8.7	6.4	1.4	7.2	0.0	5.0	6.6	3.9	9.6	8.7	4.5	0.9	7.3	12.2	6.2	4.3	1.1	11.5	0.0	2.3	7.7	3.3	5.3	3.5	4.8	4.8	0.1	0.0	6.7	0.6	1.8	34.2	2.7	22.9	3.6	9.2	7.3	8.1	18.1	3.2	3.2	0.9	5.4	3.0	7.8	8.1	7.6	3.2	4.8	11.0	8.0	35.1	1.0	9.0	13.8	22.4	16.1	11.6	15.5	19.8	12.8	10.4	13.3	15.3	18.2	11.5	11.3	11.3	2.2	15.9	14.8	3.8	22.1	14.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC026464.6		ENSG00000272617	"Novel protein, COG8-PDF readthrough"		16	69328644-69334871	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"Cardiomyocytes: 3.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"																	NA	NA																							8.1	9.3	9.4	8.8	9.6	6.4	7.7	9.7	13.8	6.5	9.3	9.1	9.0	5.9	9.6	6.0	5.9	3.8	5.3	9.6	10.7	21.7	23.2	7.2	7.7	9.5	9.4	9.1	5.4	7.0	18.1	4.2	6.6	9.8	7.0	8.8	4.9	8.4	6.4	12.7	5.4	8.0	7.6	8.9	6.2	6.0	21.4	9.4	9.7	7.1	12.2	9.7	8.8	3.0	10.1	24.1	31.8	23.8	28.3	27.3	17.6	18.6	24.3	23.5	35.2	35.2	35.9	34.2	33.3	17.3	26.1	20.7	31.9	38.3	32.1	27.9	8.3	19.1	20.0	27.7	65.2	25.5	38.4	17.7	18.3	35.4	35.9	26.3	17.1	21.2	37.8	34.4	15.0	27.0	51.9	34.5	45.4	34.0	37.0	10.9	48.0	10.4	56.6	52.3	21.4	30.7	25.2	41.0	17.3	25.3	23.4	62.5	34.9	12.5	24.7	22.1	19.6	26.9	24.3	26.2	63.2	21.1	25.0	29.0	0.7	5.2	4.1	3.7	4.3	4.7	4.3	6.4	7.4	6.7	7.4	7.1	5.8	1.3	6.7	4.6	3.0	5.8	4.5	9.4	9.6	9.7	13.8	9.6	10.7	9.5	9.4	9.1	9.8	8.9	9.4	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC069444.2		ENSG00000285585	"Novel protein"		3	119703076-119807570	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	15	"Respiratory ciliated cells: 9.5"					"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA074084	Uncertain					NA	NA					"HPA074084: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC091167.6		ENSG00000275674	"Novel protein"		15	90266317-90314499	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"brain: 1.4;intestine: 1.2;pancreas: 1.1"	"Cell type enriched"	"Detected in single"	5	"Alveolar cells type 2: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.9;CACO-2: 1.0;U-266/84: 1.1"															NA	NA						"unprognostic (1.02e-1)"	"unprognostic (6.86e-2)"	"unprognostic (7.11e-2)"	"unprognostic (9.39e-2)"	"unprognostic (4.70e-2)"			"unprognostic (2.50e-2)"		"unprognostic (6.17e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.18e-2)"	"unprognostic (4.73e-2)"		"unprognostic (1.52e-1)"	"unprognostic (3.05e-2)"	0.0	0.0	0.7	0.0	0.5	0.0	0.1	0.2	0.8	0.1	0.0	0.2	1.2	0.1	0.1	0.0	0.2	0.0	0.0	0.9	0.5	0.1	0.1	0.1	0.0	0.6	0.1	0.3	0.1	1.1	0.3	0.2	0.0	1.4	0.1	0.0	0.3	0.5	0.2	0.1	0.0	0.7	0.3	0.2	0.0	0.4	0.2	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.3	0.3	0.3	0.2	0.0	0.0	1.9	0.1	0.0	0.1	0.1	1.0	0.3	0.0	0.4	0.0	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.1	0.5	0.1	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.4	0.3	0.2	0.1	0.1	0.4	1.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.7	0.5	0.2	0.8	0.9	0.5	0.6	0.1	0.3	1.4	0.2	0.4	0.7	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC093155.3		ENSG00000267561	"Novel protein"		1	86993009-87169204	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"adipose tissue: 19.5"	"Cell type enriched"	"Detected in single"	6	"granulocytes: 5.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 1.7"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.7"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 9.4;HEL: 14.7;HMC-1: 17.9;THP-1: 12.7"									"HPA043069, HPA043603"	Approved		Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA043069: AB_10964127, HPA043603: AB_10963432"	"unprognostic (4.41e-1)"				"unprognostic (3.13e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.85e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.51e-2)"	"unprognostic (5.19e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.14e-1)"			"unprognostic (2.54e-1)"	19.5	1.8	2.5	3.1	3.6	0.3	7.1	1.9	5.0	4.5	2.2	3.7	2.4	2.6	2.2	3.2	1.5	4.9	8.4	2.9	2.8	1.9	1.7	5.6	2.2	2.1	2.1	2.9	6.9	1.1	0.8	0.0	6.0	2.1	0.8	3.4	0.3	2.9	2.4	1.3	0.4	3.1	4.6	2.2	2.7	1.2	3.9	2.0	1.2	1.9	3.7	1.0	4.7	0.0	2.7	0.0	0.1	0.9	2.2	2.5	9.4	0.3	0.0	0.1	0.0	0.4	0.7	0.9	0.1	0.2	0.0	0.2	0.2	0.3	0.2	0.4	0.1	0.5	14.7	0.4	0.1	0.1	0.3	17.9	1.6	0.3	0.2	0.0	0.0	0.1	0.2	0.2	0.4	0.2	0.0	0.2	0.2	0.4	1.2	0.0	0.2	0.3	0.0	0.4	0.4	0.2	0.4	0.3	0.0	0.5	0.9	0.2	12.7	0.0	0.3	0.7	0.1	1.5	1.0	4.0	0.0	0.7	0.1	0.4	0.6	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	2.5	3.6	1.9	5.0	2.9	2.8	2.1	2.1	2.9	2.1	2.2	2.0	2.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0
AC099811.2		ENSG00000267261	"Novel protein"		17	42119674-42154916	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	32	"Alveolar cells type 1: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MOLT-4: 2.9;REH: 2.1;SK-BR-3: 2.3;U-87 MG: 2.0"					"Low region specificity"	"Detected in all"									NA	NA																							0.1	0.0	0.3	0.5	0.2	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.1	0.3	0.2	0.0	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.1	0.4	0.3	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.3	1.1	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.1	0.3	0.0	0.9	1.1	0.0	0.3	0.0	0.9	0.5	0.6	0.5	0.7	0.0	0.0	0.0	0.9	0.2	0.6	0.0	0.0	0.0	0.3	0.1	0.4	0.0	0.0	2.9	0.0	0.5	1.1	0.0	2.1	0.5	0.0	0.0	0.6	0.2	0.9	0.0	2.3	0.1	0.5	0.0	0.0	0.0	0.4	0.5	0.0	0.7	1.1	0.3	0.0	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.4	0.2	0.1	0.1	0.3	0.2	0.4	0.4	0.6	0.3	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC107959.5		ENSG00000284956	"Novel protein"		8	23084403-23115536	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"gallbladder: 1.6;testis: 1.8"	"Cell type enriched"	"Detected in single"	13	"granulocytes: 1.3"					"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	7	"neutrophil: 221.6"	"Lineage enriched"	"Detected in many"	142	"granulocytes: 221.6"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 18.5;HDLM-2: 22.7"															NA	NA																							0.2	1.0	0.7	0.5	0.6	1.3	0.0	0.5	0.7	0.1	0.9	0.1	0.2	0.0	0.1	0.1	0.0	1.6	0.0	0.6	0.7	1.0	0.0	0.1	0.0	0.7	0.6	0.5	0.1	0.0	0.0		0.0	0.8	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.5	0.3	0.1	1.8	0.6	0.0	0.2	0.2	0.1	0.0		0.8	3.4	5.6	1.0	18.5	0.0	3.6	3.7	0.0	0.7	0.4	3.4	0.7	1.3	3.7	5.0	1.6	1.2	0.1	0.8	0.8	2.7	22.7	1.9	0.0	2.4	11.5	2.0	0.6	7.5	2.0	2.6	1.1	0.9	4.5	3.6	0.5	0.9	0.0	0.8	0.3	0.0	1.1	4.2	4.4	0.8	0.1	1.1	0.4	1.0	0.2	0.3	0.1	0.4	2.3	5.7	1.3	2.2	0.4	1.4	5.9	7.8	8.2	0.9	7.7	6.6	0.4	7.5	1.7	5.6	2.4	1.5	31.4	0.0	0.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	221.6	0.2	1.4	0.0	0.0	0.4	0.7	0.6	0.5	0.7	0.6	0.7	0.7	0.6	0.5	0.8	0.5	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC233755.1		ENSG00000275063	"Immunoglobulin heavy variable 4-38-2-like"	P0DP08	Unmapped	41444-41876	"Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 630.3;lymphoid tissue: 775.3;urinary bladder: 438.4"	"Cell type enriched"	"Detected in some"	196	"Plasma cells: 4861.5"					"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	368	"memory B-cell: 403.0;naive B-cell: 259.1"	"Lineage enriched"	"Detected in single"	447	"B-cells: 403.0"	"Cell line enriched"	"Detected in some"	7	"REH: 141.7"														"Secreted to blood"	NA	NA																							34.1	2.2	0.3	335.5	0.0	87.2	76.9	0.0	1.0	194.9	0.6	630.3	468.4	6.0	0.0	102.7	3.7	40.9	1.7	0.0	0.9	2.4	21.4	37.5	127.6	0.2	0.5	0.0	12.0	1.4	0.0		1.1	0.0	4.4	224.0	0.0	190.4	21.7	0.2	0.7	137.2	30.6	0.1	213.5	244.1	7.9	0.0	34.6	3.3	0.0	775.3	438.4		0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.1	1.0	0.0	0.0	0.0	19.1	0.4	0.4	0.0	0.0	141.7	1.6	3.2	0.0	0.0	0.2	9.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.3	0.0	3.6	0.0	0.7	0.0	0.3	0.2	0.1	0.1	0.0	0.5	403.0	0.2	0.2	0.2	259.1	0.2	0.1	0.6	0.1	0.1	0.9	0.2	34.3	0.3	0.0	0.0	1.0	0.0	0.9	0.2	0.5	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	24.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.7	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4861.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0
AC233755.2		ENSG00000277856			Unmapped	26241-26534	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"intestine: 101.2;lymphoid tissue: 226.6;stomach 1: 94.2"	"Cell type enriched"	"Detected in some"	136	"Plasma cells: 369.2"					"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	309	"memory B-cell: 27.4;naive B-cell: 34.3"	"Lineage enriched"	"Detected in single"	344	"B-cells: 34.3"	"Cell line enhanced"	"Detected in some"		"JURKAT: 7.7;MOLT-4: 7.6;REH: 2.3;SH-SY5Y: 2.4;TIME: 1.6"															NA	NA																							7.4	2.4	0.0	36.3	0.2	28.6	13.7	0.0	0.2	9.3	0.0	101.2	94.7	3.7	0.0	18.1	0.4	4.2	1.6	0.0	0.0	0.3	4.3	6.4	101.5	0.4	0.0	0.0	2.7	0.0	0.1		0.1	0.0	1.7	20.5	0.0	36.3	3.2	0.0	0.4	33.6	2.5	0.4	37.9	94.2	1.6	0.0	17.3	1.0	0.0	226.6	39.6		0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.1	0.0	0.0	0.0	7.6	0.4	0.0	0.0	0.0	2.3	1.1	0.0	0.0	0.0	0.4	2.4	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.4	0.0	0.0	0.0	34.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.2	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	369.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
AC240274.1		ENSG00000271254	"Neuroblastoma breakpoint family member 1"		Unmapped	4612-29626	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Spermatocytes: 186.6"					"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA038748, HPA038752, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Uncertain		Approved	Microtubules,Cytosol		NA	NA			Cytosol	Microtubules	"HPA038748: AB_2676188, HPA038752: , HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "																		12.1	29.3	16.5	10.5	19.0	9.5	11.1	20.0	16.7	12.8	14.4	21.3	17.2	18.3	13.4	9.7	18.8	12.5	8.0	14.8	17.5	15.1	8.2	12.9	6.6	22.8	21.7	14.0	29.9	5.7	18.2		14.7	27.1	11.7	22.0	13.9	11.3	9.3	11.0	11.9	25.2	16.5	20.0	13.0	8.6	40.9	19.2	6.9	12.1	6.9	7.5	8.6		23.4	25.6	33.3	36.9	26.2	12.1	13.2	8.4	37.6	22.7	34.4	28.8	12.2	9.7	20.0	2.9	34.8	11.9	14.0	14.3	7.0	46.2	13.4	29.2	5.4	19.6	16.7	16.4	17.5	11.4	8.7	10.0	19.6	15.6	22.3	9.8	32.6	24.4	6.7	13.5	35.0	21.5	7.5	5.8	3.6	79.2	38.4	23.5	2.9	8.3	14.0	27.3	44.2	37.2	31.0	16.0	10.8	28.1	5.2	13.3	21.2	21.5	53.0	17.1	7.8	28.3	16.1	5.2	26.3	7.6	1.5	0.8	1.1	0.6	0.8	1.1	0.6	0.4	0.4	0.3	0.9	0.6	0.7	0.7	2.3	0.6	0.5	0.0	0.4	16.5	19.0	20.0	16.7	14.8	17.5	22.8	21.7	14.0	27.1	20.0	19.2	23.4	2.5	22.4	11.6	0.0	1.4	0.0	1.6	0.0	6.8	2.0	4.3	4.8	0.0	1.5	4.3	0.0	4.2	9.5	0.7	12.9	1.9	2.5	46.1	2.1	3.6	4.4	0.0	5.2	0.0	2.7	12.8	6.4	3.6	1.6	15.2	14.3	2.5	2.7	6.9	0.0	0.0	4.3	0.0	4.2	0.0	11.0	16.8	5.2	0.0	0.0	4.0	2.4	2.1	0.0	0.0	2.8	3.4	18.4	0.6	0.9	5.7	1.6	10.9	1.4	6.6	6.1	2.3	186.6	46.2	5.9	0.0	2.6	1.6	33.3	3.6	0.9
ACAP1	"CENTB1, KIAA0050"	ENSG00000072818	"ArfGAP with coiled-coil, ankyrin repeat and PH domains 1"	Q15027	17	7336529-7351477	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	"GTPase activation"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 41.4;intestine: 43.7;lymphoid tissue: 96.8"	"Cell type enriched"	"Detected in many"	6	"Late spermatids: 3430.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 23.3;HDLM-2: 31.0;JURKAT: 42.4;Karpas-707: 29.4;NB-4: 37.9;U-937: 24.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA075570	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA075570: AB_2732295"	"unprognostic (1.20e-2)"	"prognostic favorable (3.66e-4)"	"unprognostic (2.49e-1)"	"prognostic favorable (2.97e-5)"	"unprognostic (4.43e-4)"	"prognostic favorable (4.17e-5)"	"unprognostic (5.66e-3)"	"unprognostic (1.11e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (1.65e-10)"	"unprognostic (1.14e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.90e-1)"	"unprognostic (8.61e-3)"	4.1	1.1	0.5	19.1	0.5	41.4	2.1	0.5	0.6	2.2	0.7	4.8	4.2	1.5	0.3	4.2	4.0	3.6	1.8	0.3	0.5	4.5	5.2	16.2	39.9	0.6	0.5	0.3	0.9	1.2	0.1	1.3	0.5	0.5	3.8	2.1	0.2	3.6	0.4	0.9	2.2	43.7	0.9	0.6	96.8	5.1	0.8	0.7	26.0	5.2	0.8	22.8	4.3	3.8	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.1	0.1	0.0	23.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	31.0	0.0	8.8	0.1	0.0	0.1	11.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	42.4	0.0	29.4	0.0	0.0	14.5	37.9	0.4	0.0	0.0	15.1	0.2	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	8.9	0.0	0.0	0.1	0.0	0.0	9.1	8.2	10.9	0.1	24.9	0.0	28.8	7.9	30.8	29.6	2.4	33.3	20.2	31.5	32.1	13.7	21.3	26.7	27.5	22.6	32.5	0.4	17.3	39.0	22.3	0.5	0.5	0.5	0.6	0.3	0.5	0.6	0.5	0.3	0.5	0.6	0.7	0.6	3.8	9.6	5.5	1.6	150.9	8.3	7.6	25.1	2.8	15.8	7.0	8.1	32.9	7.2	12.3	5.5	18.8	3.9	160.7	2.0	7.9	3.9	498.1	8.3	5.4	5.0	3.6	22.9	0.3	3.7	3.2	8.0	5.6	3.4	40.5	1.8	7.1	5.3	7.5	0.0	1.9	2.7	8.2	26.2	39.5	3430.7	20.2	27.9	24.9	2.8	38.3	11.7	332.7	0.5	1.0	5.5	0.0	15.4	68.0	4.6	1.3	3.8	44.6	20.4	19.7	7.5	8.1	15.6	10.5	1.5	7.4	4.4	268.3	0.9	1.6	3.5
ACBD7	"bA455B2.2, FLJ38219"	ENSG00000176244	"Acyl-CoA binding domain containing 7"	Q8N6N7	10	15075475-15088776	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 42.6;choroid plexus: 16.3"	"Cell type enriched"	"Detected in some"	5	"Astrocytes: 28.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"JURKAT: 28.7;MOLT-4: 29.2;U-698: 21.8"	"Region enriched"	"Detected in all"	5	"olfactory bulb: 17.6"	"Low region specificity"	"Detected in all"			"HPA043326, HPA062478"			Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA043326: AB_2678429, HPA062478: AB_2684777"	"unprognostic (2.15e-1)"	"unprognostic (8.94e-2)"	"unprognostic (7.79e-3)"	"unprognostic (6.53e-3)"	"unprognostic (7.30e-2)"	"unprognostic (6.89e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.34e-2)"	"unprognostic (3.59e-3)"	"unprognostic (3.06e-1)"	"unprognostic (2.18e-4)"	"unprognostic (9.72e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.90e-2)"	0.3	0.3	34.5	0.4	33.1	1.4	4.3	29.0	35.7	0.2	16.3	0.4	0.9	0.3	0.8	0.4	1.9	0.4	0.2	31.8	28.4	0.4	0.4	0.4	0.7	42.6	32.8	26.3	0.4	0.4	0.3	0.6	0.3	38.0	0.4	0.4	7.8	2.4	0.5	0.9	1.3	0.5	0.2	22.9	0.4	0.5	3.0	32.6	6.8	1.7	0.0	0.5	0.3	0.1	25.9	3.4	0.8	12.7	7.0	1.0	0.6	1.8	0.8	0.7	1.9	3.0	3.8	4.2	2.9	4.3	2.5	2.6	0.6	6.9	1.8	2.9	6.0	10.2	3.4	1.1	2.3	0.1	0.4	1.3	0.3	0.1	1.0	0.1	3.2	2.9	28.7	2.4	3.6	2.5	10.5	29.2	4.5	6.3	1.0	2.0	16.4	4.3	6.9	1.6	1.0	9.7	6.6	2.7	8.6	1.1	4.7	10.9	0.6	1.6	0.7	6.6	1.3	2.8	10.4	19.1	21.8	2.1	0.5	0.7	0.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.8	0.3	0.1	0.3	0.1	0.0	34.5	33.1	29.0	35.7	31.8	28.4	42.6	32.8	26.3	38.0	22.9	32.6	25.9	0.1	0.0	0.6	28.1	0.1	0.1	0.1	0.0	0.6	0.2	0.5	0.6	0.0	0.0	0.0	0.0	2.1	0.0	0.5	0.2	0.0	0.0	5.3	2.6	0.1	0.4	1.8	0.0	0.3	0.0	0.1	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	2.3	0.0	0.1	0.0	1.0	0.0	0.6	0.0	1.5	0.1	0.0	1.1	0.0	0.0	0.1	0.0	0.1	1.6	0.8	0.0	0.3	0.3	2.9	0.4	0.5	0.0	0.1	0.2	0.1	0.1	0.1
ACE2		ENSG00000130234	"Angiotensin I converting enzyme 2"	Q9BYF1	X	15494566-15607236	"Enzymes, Metabolic proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Host-virus interaction"	"Carboxypeptidase, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 66.1;intestine: 244.2;kidney: 88.4"	"Cell type enriched"	"Detected in many"	5	"Proximal enterocytes: 294.8"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 13.9;renal cancer: 26.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 1.2;NTERA-2: 1.2;SuSa: 1.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA000288, CAB026174, CAB026213, CAB080024, CAB080025, CAB080027, CAB080028"	Enhanced				"Secreted to blood"	NA	NA		400000			"CAB026174: , CAB026213: , CAB080024: AB_10864415, CAB080025: AB_2809589, CAB080027: AB_2665870, CAB080028: AB_2665871, HPA000288: AB_1078160"	"unprognostic (1.40e-1)"	"unprognostic (7.26e-2)"	"unprognostic (2.76e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.26e-2)"	"prognostic favorable (4.21e-4)"	"unprognostic (2.34e-2)"	"unprognostic (6.74e-3)"	"unprognostic (2.54e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (2.12e-5)"	"unprognostic (1.94e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.11e-1)"	"unprognostic (7.10e-2)"	6.1	0.5	0.2	1.4	0.2	0.6	4.4	0.5	0.3	0.6	1.7	10.0	184.9	0.5	0.6	1.8	1.6	66.1	43.1	0.2	0.3	88.4	5.8	0.8	0.4	0.3	0.2	0.1	1.9	2.5	1.5	0.1	1.2	0.3	0.4	6.0	0.3	1.4	4.1	0.7	0.3	244.2	0.5	0.2	0.1	2.7	50.2	0.2	0.5	4.5	0.5	0.2	0.8	1.2	0.3	0.0	0.0	0.3	0.0	0.2	0.0	0.8	0.1	0.0	0.2	0.2	0.2	0.3	0.4	0.3	0.0	0.3	0.7	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.5	1.2	1.2	0.0	0.0	0.3	0.2	0.5	0.2	0.4	0.2	0.9	0.0	0.4	0.0	1.9	0.4	0.4	0.1	0.0	0.0	0.3	0.4	0.1	0.5	0.5	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.2	0.2	0.5	0.3	0.2	0.3	0.3	0.2	0.1	0.3	0.2	0.2	0.3	0.4	0.0	0.5	1.3	1.4	0.1	0.5	5.0	0.0	0.0	1.6	0.0	11.2	55.8	2.6	0.0	0.0	4.2	0.1	22.9	3.9	1.2	0.5	1.1	0.3	1.0	7.2	0.0	0.8	0.8	0.3	4.6	0.0	0.6	0.0	3.9	0.0	0.9	0.8	0.0	0.8	8.2	0.0	0.0	0.0	1.4	8.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.9	5.1	6.0	0.0	1.0	294.8	48.8	2.0	0.0	19.7	0.0	8.9	1.1	1.0	0.0	0.1	12.7	0.3	0.1	10.6	2.2
ACOXL	FLJ11042	ENSG00000153093	"Acyl-CoA oxidase like"	Q9NUZ1	2	110732539-111120610	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"epididymis: 7.3;lung: 9.3"	"Cell type enriched"	"Detected in some"	5	"Alveolar cells type 2: 41.9"	"Group enriched"	"Detected in some"	6	"lung cancer: 0.6;prostate cancer: 1.1;testis cancer: 2.1;urothelial cancer: 2.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A-431: 12.1;RPMI-8226: 22.0;RT4: 29.3;U-266/70: 18.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA035392, HPA035393"			Supported	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"HPA035392: AB_2674604, HPA035393: AB_2674605"	"unprognostic (1.62e-1)"	"unprognostic (7.30e-2)"	"unprognostic (6.77e-4)"	"unprognostic (2.93e-7)"	"unprognostic (1.32e-2)"	"unprognostic (7.84e-5)"	"unprognostic (1.28e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.31e-2)"	"unprognostic (7.24e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.72e-1)"	"prognostic favorable (6.48e-4)"	1.1	0.6	0.6	0.5	0.7	1.5	0.1	0.2	0.5	0.4	0.1	0.5	0.5	0.5	7.3	0.4	0.3	0.6	1.2	0.4	0.1	0.5	0.3	9.3	0.9	0.4	0.3	0.5	0.2	1.0	2.9	0.3	0.7	0.5	3.2	0.3	0.7	0.6	0.0	1.3	0.7	0.6	0.1	0.0	0.6	0.5	3.2	0.3	0.3	0.8	0.0	1.2	4.7	0.1	0.6	12.1	0.2	0.3	0.2	0.1	0.0	0.8	0.1	0.0	0.0	0.0	0.9	0.7	0.3	0.5	0.1	0.3	1.3	0.0	0.1	0.0	0.3	3.5	0.2	0.5	0.5	0.0	0.0	0.3	0.1	1.2	0.0	0.1	0.3	0.0	0.6	1.8	1.8	0.1	4.4	0.9	0.4	4.2	0.0	0.3	0.6	0.2	22.0	0.0	29.3	2.5	1.0	0.3	0.5	0.1	0.6	0.4	1.2	0.3	0.2	1.0	0.2	0.1	18.7	4.8	0.7	0.0	0.1	0.1	0.7	0.3	0.3	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.0	0.9	0.2	0.2	0.2	0.1	0.1	0.6	0.7	0.2	0.5	0.4	0.1	0.4	0.3	0.5	0.5	0.0	0.3	0.6	0.3	0.0	41.9	0.0	1.0	0.3	0.3	0.0	0.0	0.6	0.1	0.3	0.5	0.0	0.7	0.0	0.0	0.0	0.1	1.3	0.0	0.2	5.4	0.2	0.1	0.2	1.2	0.0	2.2	0.0	0.0	0.4	0.0	0.8	0.0	5.9	0.0	0.0	0.1	0.0	2.0	0.3	0.0	0.0	0.8	8.1	0.0	0.2	0.0	0.0	0.0	0.1	1.0	1.0	1.3	0.1	2.3	0.0	7.5	0.8	0.0	0.1	0.1	0.3	0.0	0.2	0.3	1.6	2.7	0.0	0.3	0.0	1.1	0.0	0.2	0.8
ADAMTS7	"ADAM-TS7, DKFZp434H204"	ENSG00000136378	"ADAM metallopeptidase with thrombospondin type 1 motif 7"	Q9UKP4	15	78759206-78811464	"Plasma proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 21.2"	"Cell type enriched"	"Detected in some"	4	"Theca cells: 44.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	9	"HMC-1: 259.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA045284, HPA048453"	Uncertain		Supported	Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles		"HPA045284: AB_2679285, HPA048453: AB_2680399"	"unprognostic (5.94e-3)"	"unprognostic (9.94e-3)"	"unprognostic (2.76e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.88e-4)"	"unprognostic (3.34e-3)"	"unprognostic (2.89e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.34e-2)"	"prognostic unfavorable (9.53e-4)"	"unprognostic (1.59e-1)"	"unprognostic (2.66e-2)"	"unprognostic (8.86e-2)"	6.2	5.3	0.4	1.8	0.3	0.1	3.9	0.2	0.5	6.0	0.5	3.5	1.1	7.2	0.1	0.9	2.3	2.3	21.2	0.3	0.5	2.2	1.1	6.4	0.9	0.4	0.4	0.1	6.2	0.6	0.4	0.8	2.1	0.4	1.8	0.2	0.5	1.3	0.5	1.1	1.6	2.7	1.4	0.1	5.2	2.2	4.1	0.5	0.2	2.1	0.5	0.2	3.0	2.6	0.4	0.0	1.1	16.5	7.5	6.9	8.2	20.9	3.7	1.3	1.0	0.6	0.0	0.1	0.0	4.8	0.4	1.0	0.4	0.4	2.0	0.0	0.3	0.6	2.1	0.5	0.1	6.9	0.0	259.9	3.3	2.0	1.9	1.0	5.3	24.0	0.0	0.3	0.7	5.6	0.0	0.1	4.9	4.7	0.0	1.4	17.3	7.7	0.3	0.5	0.9	0.3	23.9	4.8	0.0	0.6	4.0	3.2	0.4	29.8	9.4	1.0	3.3	0.0	0.1	0.0	0.0	1.6	0.1	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.2	0.5	0.3	0.5	0.4	0.4	0.1	0.4	0.1	0.5	0.4	7.5	0.0	0.0	3.6	0.3	0.4	0.2	0.7	0.0	0.3	0.1	0.5	9.8	0.0	0.3	0.0	0.0	0.3	0.2	0.1	0.0	0.1	4.9	0.8	7.5	10.5	0.0	0.0	0.1	0.0	0.3	10.1	0.5	0.9	3.8	7.2	2.9	0.3	0.7	0.0	0.2	0.0	2.0	0.0	0.8	2.7	1.5	0.1	1.8	1.0	0.1	1.3	0.0	9.5	1.4	0.3	0.0	1.9	0.0	0.3	0.0	0.1	0.3	0.1	0.0	3.7	5.0	2.6	2.0	0.2	0.1	0.3	0.5	44.9	0.1	0.3
ADAMTSL1	"ADAMTSR1, C9orf94, FLJ35283"	ENSG00000178031	"ADAMTS like 1"	Q8N6G6	9	17906563-18910950	"Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 13.4"	"Cell type enriched"	"Detected in some"	6	"Excitatory neurons: 245.4"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 2.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 118.3;HSkMC: 61.2;hTEC/SVTERT24-B: 64.3;hTERT-RPE1: 55.8;LHCN-M2: 64.3;TIME: 207.9;U-138 MG: 96.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA057437, HPA074973"	Uncertain		Approved	Vesicles	"Secreted in other tissues"	NA	NA		28000000	Vesicles		"HPA057437: AB_2683440, HPA074973: "	"unprognostic (4.64e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.95e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.52e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.01e-4)"	"unprognostic (3.66e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.41e-2)"	"unprognostic (7.29e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.50e-2)"	3.9	5.6	0.9	1.9	0.8	0.0	2.4	1.6	0.8	3.9	0.0	3.1	1.8	13.4	1.2	5.5	4.1	5.0	1.0	3.5	8.1	2.1	0.9	1.2	0.8	2.1	3.4	0.9	1.6	1.4	0.2	1.8	0.6	0.5	8.2	2.9	0.4	1.3	1.6	0.4	0.9	1.8	11.3	0.8	0.7	5.2	1.0	6.3	0.5	0.9	0.8	0.9	2.6	2.0	1.1	6.4	0.5	1.2	0.0	17.5	118.3	0.0	3.6	16.3	14.8	33.3	0.0	0.1	0.1	0.1	44.1	5.5	0.0	6.6	1.1	41.7	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	61.2	0.0	64.3	0.2	55.8	27.1	0.0	0.1	0.3	64.3	0.0	0.2	0.1	5.6	0.0	0.3	0.0	10.1	0.2	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	207.9	96.9	2.5	2.6	15.8	0.0	0.0	0.0	31.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.8	1.6	0.8	3.5	8.1	2.1	3.4	0.9	0.5	0.8	6.3	1.1	1.6	0.0	0.0	5.2	0.0	0.1	0.1	0.3	0.0	0.0	0.1	0.4	1.4	0.0	0.6	0.0	0.0	0.0	0.0	3.1	0.0	0.1	7.2	0.3	1.1	8.9	0.0	0.0	245.4	0.0	0.0	15.1	0.5	0.5	0.0	0.1	1.1	0.0	0.1	0.0	39.5	0.4	0.0	0.0	0.8	2.9	5.0	0.1	0.0	1.9	0.0	0.0	0.0	9.0	5.7	0.0	0.4	1.2	0.0	0.6	0.2	0.4	0.0	0.0	0.0	0.1	1.2	2.9	1.6	0.1	0.1	0.1	0.0	0.1	1.7	0.1
ADH1B	ADH2	ENSG00000196616	"Alcohol dehydrogenase 1B (class I), beta polypeptide"	P00325	4	99304971-99352760	"Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 1514.9;liver: 5906.7"	"Cell type enriched"	"Detected in many"	6	"Hepatocytes: 4153.7"	"Cancer enriched"	"Detected in many"	31	"liver cancer: 223.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"ASC diff: 6574.3"									"HPA047814, HPA060902"	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA		39000000	"Plasma membrane, Cytosol"		"HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (5.13e-2)"	"unprognostic (9.80e-3)"	"unprognostic (6.59e-2)"	"unprognostic (5.56e-2)"	"unprognostic (9.49e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.04e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.47e-3)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (7.87e-4)"	"unprognostic (4.60e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.60e-2)"	1514.9	141.5	2.7	36.7	3.0	0.1	932.4	2.3	8.1	40.9	17.5	197.2	38.8	162.8	75.5	106.6	388.3	146.5	146.7	2.2	2.1	67.3	5906.7	376.5	26.0	5.1	3.0	2.1	118.7	49.5	7.9	24.4	6.8	4.2	27.0	115.8	0.1	68.5	26.9	67.1	147.3	239.2	74.0	4.7	73.3	142.3	2.8	2.5	20.0	95.3	230.2	16.1	290.3	119.7	2.8	0.0	0.0	0.0	0.0	6574.3	956.7	0.2	0.0	2.0	0.0	0.0	0.0	0.0	0.7	0.1	1.1	0.0	0.0	0.5	1.4	0.0	0.1	0.0	1.1	0.1	0.0	26.9	3.0	0.0	216.8	0.1	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.5	0.1	0.0	0.0	0.1	3.2	0.1	0.0	0.0	0.1	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.2	0.2	0.3	1.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	3.0	2.3	8.1	2.2	2.1	5.1	3.0	2.1	4.2	4.7	2.5	2.8	29.0	0.0	3.4	0.0	8.1	22.3	0.5	0.1	6.8	0.1	1.1	2.5	12.2	110.1	2.3	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.6	0.1	0.9	14.7	0.0	115.0	0.0	0.0	0.1	633.1	11.2	0.0	1.3	0.0	96.8	4153.7	0.1	0.0	0.0	0.0	0.0	98.8	25.4	0.6	55.3	3.5	28.4	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	7.1	0.7	0.0	0.1	0.2	0.1	6.6	15.0	47.9	0.0	0.1	10.4	13.1	0.1	8.9	0.1	0.0	0.2
ADIRF	"AFRO, APM2, C10orf116"	ENSG00000148671	"Adipogenesis regulatory factor"	Q15847	10	86968432-86983934	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 1249.9"	"Cell type enriched"	"Detected in many"	4	"Proximal enterocytes: 12067.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 2.5;naive CD8 T-cell: 1.9"	"Lineage enriched"	"Detected in single"	8	"T-cells: 2.5"	"Cell line enhanced"	"Detected in many"		"HaCaT: 847.5;PC-3: 680.7;RT4: 1035.2"					"Low region specificity"	"Detected in all"			HPA026810	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		760000	"Nucleoplasm, Cytosol"		"HPA026810: AB_2672003"																		1249.9	59.3	198.2	51.3	182.0	1.0	248.6	170.8	383.2	189.9	183.8	115.2	481.2	115.0	49.6	115.2	237.9	47.2	91.4	198.2	245.5	148.6	83.1	211.3	15.6	205.1	183.0	180.4	254.9	73.8	27.1	55.5	28.6	186.5	315.3	48.6	29.3	299.3	235.9	88.3	104.4	495.7	76.4	188.8	74.2	75.8	27.4	195.0	26.0	117.5	133.0	45.1	245.1	172.5	191.8	259.8	4.9	0.1	0.1	123.3	224.9	16.1	97.0	166.9	1.7	0.4	6.5	29.5	0.0	3.4	209.9	8.4	847.5	0.0	39.7	1.0	9.1	0.0	0.0	22.5	1.8	19.9	0.2	3.4	1.9	132.0	0.6	70.1	6.7	50.4	3.6	0.3	36.3	4.0	130.4	0.6	6.5	0.0	6.4	680.7	0.5	0.0	3.4	14.6	1035.2	11.8	3.0	36.0	222.0	1.7	0.0	270.7	2.7	132.6	3.4	17.4	13.2	0.6	4.0	3.3	0.4	6.3	0.0	5.1	0.0	0.2	0.0	0.0	0.0	0.6	0.0	1.0	0.0	0.3	0.0	2.5	1.9	0.0	0.0	0.0	0.0	0.5	0.3	198.2	182.0	170.8	383.2	198.2	245.5	205.1	183.0	180.4	186.5	188.8	195.0	191.8	1215.2	1842.9	476.5	3.9	15.0	528.4	141.9	309.7	39.9	5.4	651.4	253.2	0.0	58.6	614.4	187.6	2.1	299.2	14.3	658.7	1352.0	29.9	9.6	55.7	63.9	944.9	30.0	37.5	0.1	272.1	16.9	508.0	121.3	195.1	48.9	11.7	1691.7	257.4	26.4	0.0	0.3	418.7	128.1	17.3	492.0	48.4	1309.5	25.3	610.1	10.3	99.9	703.9	0.0	1.0	0.2	336.8	1115.3	469.8	3.4	481.9	12067.2	1144.8	88.2	16.5	1472.6	705.4	2422.0	3.2	6.2	35.0	438.6	166.8	40.7	2.4	443.5	1160.7
ADRA2C	"ADRA2L2, ADRA2RL2, ADRARL2"	ENSG00000184160	"Adrenoceptor alpha 2C"	P18825	4	3766348-3768526	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 67.9;endometrium 1: 58.1"	"Cell type enriched"	"Detected in some"	5	"Endometrial stromal cells: 135.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 22.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 13.3;MCF7: 21.9;NTERA-2: 7.4;OE19: 8.6;SCLC-21H: 8.0;SH-SY5Y: 9.7"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"basal ganglia: 34.3"	HPA057688	Uncertain					NA	NA					"HPA057688: AB_2683503"	"unprognostic (1.44e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.02e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.12e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.71e-1)"	"unprognostic (3.24e-2)"	"unprognostic (9.08e-3)"	"unprognostic (1.01e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.72e-1)"	"unprognostic (6.48e-2)"	14.8	3.7	7.0	0.5	17.6	0.0	8.3	3.3	7.8	67.9	3.3	2.8	0.4	58.1	2.2	2.0	22.9	0.4	5.5	6.3	7.9	22.9	0.6	4.1	0.8	12.2	5.2	7.6	8.3	3.9	0.2	4.8	3.7	10.8	22.6	0.2	0.8	1.2	18.8	3.5	6.2	3.2	2.2	3.5	22.1	2.4	3.8	6.9	0.4	1.4	1.8	0.1	4.3	14.2	5.9	0.0	4.6	0.1	0.1	0.5	0.0	0.2	0.5	0.0	0.1	0.0	2.4	1.4	0.0	2.3	0.4	0.8	0.0	0.2	0.0	0.0	0.0	6.6	0.0	0.0	13.3	0.6	0.0	0.9	1.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	3.2	21.9	0.0	0.0	7.4	8.6	0.0	0.0	6.8	0.0	0.0	0.4	8.0	9.7	3.0	0.0	0.1	1.9	7.0	0.1	0.0	0.0	5.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	17.6	3.3	7.8	6.3	7.9	12.2	5.2	7.6	10.8	3.5	6.9	5.9	26.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	2.2	1.7	0.8	0.9	1.0	2.8	0.0	12.9	0.0	0.9	0.1	0.1	3.9	0.4	0.0	4.7	135.9	5.4	0.0	0.0	1.2	0.0	0.2	1.4	0.0	2.4	0.0	10.7	1.1	0.0	0.3	3.3	0.6	0.2	0.0	0.0	0.7	0.4	1.5	0.6	0.0	1.0	0.0	5.8	0.0	0.0	0.2	0.1	0.0	3.8	0.0	0.3	0.0	2.4	0.0	0.1	0.0	0.9	5.8	0.1	1.6	0.0	0.0	1.6	0.6	0.0	0.1	0.2
AGAP5	"CTGLF2, Em:AC073389.1"	ENSG00000172650	"ArfGAP with GTPase domain, ankyrin repeat and PH domain 5"	A6NIR3	10	73674287-73697881	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Early spermatids: 79.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											HPA042490	Uncertain					NA	NA					"HPA042490: AB_2678022"	"unprognostic (1.84e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.52e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.98e-2)"	"unprognostic (4.04e-3)"	"unprognostic (4.33e-3)"	"unprognostic (5.83e-5)"	"unprognostic (3.33e-2)"	"unprognostic (2.87e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.17e-2)"	3.2	5.1	2.7	3.8	3.0	3.2	4.4	4.1	3.8	3.9	4.0	3.3	3.6	3.4	4.2	3.3	3.4	2.6	5.2	2.6	3.0	4.5	6.9	3.6	4.4	3.0	2.9	2.3	4.9	9.9	1.9	4.8	2.7	3.3	4.7	3.1	5.4	6.4	2.5	8.8	6.6	4.0	2.2	2.1	5.0	4.3	8.4	3.0	3.1	4.0	2.2	2.8	3.4	3.5	4.5	2.4	2.9	3.8	4.2	3.0	2.3	5.7	2.9	2.1	2.0	1.7	3.9	3.3	2.9	2.4	2.3	0.8	5.9	2.8	2.4	1.3	3.4	3.3	2.3	6.7	4.5	2.5	5.9	3.7	2.4	2.6	2.3	6.2	5.2	1.6	4.2	3.0	5.8	1.8	2.3	2.3	7.7	1.1	2.6	7.9	3.1	1.6	2.2	2.0	2.3	1.7	1.5	1.7	6.2	3.5	2.7	3.5	4.7	2.9	2.5	3.4	2.5	3.8	6.9	3.7	1.7	2.6	6.7	1.1	0.6	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	2.7	3.0	4.1	3.8	2.6	3.0	3.0	2.9	2.3	3.3	2.1	3.0	4.5	2.1	0.0	9.0	4.2	1.5	1.9	0.3	0.8	0.0	2.4	2.4	1.7	0.0	1.5	3.7	3.7	6.2	1.7	2.1	1.0	0.0	1.6	79.9	2.6	2.3	2.1	0.0	2.7	6.4	2.2	0.7	1.7	4.6	1.5	3.8	2.5	3.9	3.5	1.5	3.3	6.3	2.0	0.0	1.3	2.2	18.9	1.2	1.9	1.8	1.9	2.4	1.7	2.1	4.5	8.4	2.7	0.5	3.8	1.6	1.1	3.2	0.6	6.6	2.7	0.0	0.9	0.9	4.2	2.4	0.9	1.3	0.7	1.8	1.3	2.1	0.7
AGAP9	"bA301J7.2, CTGLF6, FLJ00312"	ENSG00000204172	"ArfGAP with GTPase domain, ankyrin repeat and PH domain 9"	Q5VTM2	10	47501854-47523638	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Early spermatids: 109.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											HPA042490	Uncertain					NA	NA					"HPA042490: AB_2678022"	"unprognostic (6.26e-2)"	"unprognostic (5.74e-2)"	"prognostic unfavorable (9.98e-5)"	"unprognostic (1.85e-1)"	"unprognostic (6.80e-2)"	"unprognostic (9.89e-4)"	"unprognostic (1.13e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.85e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.14e-2)"	"prognostic unfavorable (3.02e-5)"	"unprognostic (9.44e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.70e-3)"	"prognostic favorable (7.04e-4)"	12.4	14.6	7.8	5.3	8.2	8.5	14.5	9.4	9.5	16.3	8.9	13.8	15.8	12.3	6.8	13.6	15.0	5.7	12.2	7.6	7.7	22.1	40.2	12.3	5.4	9.2	8.1	7.4	18.8	32.4	3.1	26.3	2.3	9.2	18.1	3.5	12.0	14.3	4.8	10.0	19.9	19.4	3.5	6.9	14.7	18.5	27.5	8.4	4.9	19.9	2.3	3.3	12.4	14.9	9.7	4.4	6.6	5.7	5.8	5.1	4.2	6.8	4.2	1.9	2.0	1.5	7.9	6.9	0.9	5.2	2.9	1.2	12.9	2.3	3.0	1.5	8.5	12.4	2.5	2.6	9.4	4.5	9.3	7.4	2.9	5.8	5.1	14.2	2.2	1.0	0.5	4.0	3.5	1.3	7.3	1.6	11.9	3.1	3.2	1.3	3.4	3.2	2.8	4.1	5.0	0.7	4.1	3.4	7.0	0.9	5.4	9.3	5.1	5.3	4.3	7.1	5.0	7.8	4.8	3.7	4.3	4.3	9.7	1.7	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	7.8	8.2	9.4	9.5	7.6	7.7	9.2	8.1	7.4	9.2	6.9	8.4	9.7	3.8	3.2	9.9	0.0	1.6	0.0	1.6	0.0	2.8	6.6	5.3	5.0	1.6	7.2	3.1	11.0	18.8	3.1	3.0	0.2	1.9	1.8	109.7	12.3	4.7	2.7	1.2	2.7	0.0	2.2	0.7	3.6	20.4	4.1	7.6	7.1	2.2	7.2	2.1	11.8	0.0	1.5	0.0	3.0	0.0	21.5	3.4	3.3	0.0	0.0	1.7	4.3	1.0	0.0	0.0	6.0	0.8	6.0	2.1	2.6	6.7	1.0	6.6	8.7	0.0	3.2	2.9	12.4	4.8	1.8	0.0	1.0	2.3	4.0	2.0	1.8
AGTR2	"AT2, MRX88"	ENSG00000180772	"Angiotensin II receptor type 2"	P50052	X	116170744-116174974	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"endometrium 1: 8.9;lung: 8.9;smooth muscle: 13.3"	"Cell type enriched"	"Detected in some"	15	"Alveolar cells type 2: 20.4"	"Group enriched"	"Detected in some"	12	"endometrial cancer: 3.0;lung cancer: 1.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	8	"cerebellum: 2.0"							NA	NA									"unprognostic (2.13e-1)"				"unprognostic (1.71e-1)"			"unprognostic (3.22e-2)"				"unprognostic (4.37e-2)"			0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	5.1	0.0	0.1	0.0	8.9	0.8	0.0	2.7	0.1	1.7	0.0	0.0	0.6	0.0	8.9	0.0	0.1	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0
AL132671.2		ENSG00000282218	"Novel protein, GOPC-ROS1 readthrough"		6	117318211-117573571	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	15	"Alveolar cells type 2: 1.5"					"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	36	"U-138 MG: 8.9"	"Low region specificity"	"Detected in all"							HPA019477	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA019477: AB_1849890"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL132780.3		ENSG00000259132	"Novel protein"		14	22946270-22982258	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	32	"Alveolar cells type 1: 3.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 38.9;MCF7: 23.7"									HPA029803	Approved					NA	NA					"HPA029803: AB_10601428"																		3.0	4.9	10.1	2.8	9.9	4.7	2.6	9.7	14.0	3.8	9.5	5.7	4.0	2.6	6.8	4.2	4.8	4.2	6.9	10.2	9.9	6.8	7.0	4.0	6.4	10.7	9.9	9.8	7.0	12.9	2.3	3.1	2.8	10.4	4.7	4.0	2.0	3.8	2.1	5.9	6.2	4.2	1.8	10.0	10.2	5.4	3.5	10.4	4.7	3.4	1.5	2.6	3.6	3.0	10.9	4.0	13.0	4.4	0.8	7.1	7.1	6.1	0.0	5.6	3.7	4.1	2.9	0.0	0.0	1.9	9.4	1.3	0.6	2.9	3.9	2.1	0.0	1.6	0.0	7.7	38.9	4.1	4.2	0.1	4.3	8.1	3.5	8.3	8.5	6.9	12.7	0.0	5.6	3.4	23.7	6.2	16.8	2.2	6.4	5.1	5.7	3.9	4.4	14.1	10.8	4.4	1.9	0.0	2.8	1.4	4.7	4.6	7.9	0.1	5.4	2.6	0.6	4.4	4.7	9.4	7.1	0.4	1.7	3.1	0.3	2.8	1.2	1.7	2.5	0.6	1.6	1.0	1.0	2.8	2.3	1.8	1.0	5.8	0.5	1.6	1.4	2.4	1.5	10.1	9.9	9.7	14.0	10.2	9.9	10.7	9.9	9.8	10.4	10.0	10.4	10.9	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ALKAL1	"AUGB, FAM150A, UNQ9433"	ENSG00000196711	"ALK and LTK ligand 1"	Q6UXT8	8	52534037-52565430	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 2.4;thyroid gland: 2.4;urinary bladder: 1.6"	"Cell type enriched"	"Detected in some"	4	"Distal tubular cells: 5.9"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 2.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"CAPAN-2: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA027368	Uncertain				"Secreted - unknown location"	NA	NA					"HPA027368: AB_10602317"			"unprognostic (1.18e-1)"	"unprognostic (1.13e-4)"				"unprognostic (9.47e-2)"		"unprognostic (9.64e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.60e-2)"	"unprognostic (1.70e-4)"	"unprognostic (4.48e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.58e-3)"	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	1.2	0.0	0.8	0.6	0.0	0.0	0.0	0.2	2.4	0.0	0.0	0.1	0.1	0.2	0.3	0.0	0.4	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.5	0.1	0.0	0.8	0.0	0.0	0.0	0.5	0.7	0.2	0.0	0.4	0.1	0.1	0.0	2.4	0.0	0.0	1.6	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.4	0.2	0.0	0.5	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	5.9	0.1	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ALOX12	12S-LOX	ENSG00000108839	"Arachidonate 12-lipoxygenase, 12S type"	P18054	17	6996049-7010754	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Dioxygenase, Hydrolase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 49.8;vagina: 106.5"	"Cell type enriched"	"Detected in some"	6	"Macrophages: 17.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.5"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"A-431: 25.5;HEL: 40.4"	"Region enriched"	"Detected in single"	5	"olfactory bulb: 4.4"					"HPA010691, CAB019287, HPA064819"	Enhanced		Supported	"Nuclear speckles,Vesicles,Cytosol"		NA	NA		49000	Cytosol	"Nuclear speckles, Vesicles"	"CAB019287: , HPA010691: AB_1844756, HPA064819: "	"unprognostic (3.61e-3)"	"unprognostic (6.93e-2)"	"unprognostic (7.17e-5)"	"unprognostic (9.43e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.45e-1)"	"unprognostic (3.16e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.96e-5)"	"unprognostic (4.01e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.47e-2)"	1.0	1.6	0.9	3.3	1.2	4.7	0.3	0.1	1.0	16.6	0.4	0.4	1.9	2.2	0.0	49.8	1.2	3.2	1.4	0.3	0.3	0.6	0.2	1.2	3.9	1.0	0.5	0.0	1.3	1.9	0.0	0.1	1.1	1.1	0.8	0.1	3.1	20.3	0.0	1.6	21.9	2.0	0.2	0.1	3.3	1.1	1.3	0.8	0.0	1.9	0.1	3.9	1.5	106.5	3.3	25.5	4.2	1.9	1.4	0.0	0.0	1.7	1.6	0.0	0.0	0.0	3.7	0.9	1.3	0.9	0.0	1.4	3.2	0.0	0.1	0.0	2.8	3.2	40.4	6.8	2.8	0.1	0.4	6.5	0.0	0.1	0.0	0.0	2.4	0.0	2.8	2.7	1.4	0.0	0.3	0.5	0.9	1.3	0.2	0.8	1.4	0.8	0.7	0.0	3.2	0.1	0.9	0.7	0.8	0.4	2.4	1.5	1.1	4.6	2.2	1.2	2.1	1.1	0.8	0.3	0.7	1.2	3.0	1.0	2.1	0.9	1.8	0.7	0.4	0.5	1.1	0.5	0.7	0.7	0.6	0.2	0.3	4.5	0.7	0.4	1.3	0.3	13.6	0.9	1.2	0.1	1.0	0.3	0.3	1.0	0.5	0.0	1.1	0.1	0.8	3.3	0.0	0.0	0.0	2.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	1.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	17.3	0.0	1.0	0.8	0.0	0.0	2.5	2.4	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	2.5	1.1	0.0	0.1	0.1	0.0	2.0
ALX1	CART1	ENSG00000180318	"ALX homeobox 1"	Q15699	12	85280220-85301784	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 4.0;kidney: 3.0"	"Cell type enriched"	"Detected in some"	5	"Melanocytes: 32.0"	"Cancer enriched"	"Detected in some"	10	"melanoma: 16.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 10.4;HEK 293: 23.3;HUVEC TERT2: 17.2;SK-MEL-30: 29.5;THP-1: 18.0;WM-115: 14.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001598, HPA018905"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		NA	NA			"Nuclear bodies"	"Nucleoplasm, Golgi apparatus"	"HPA001598: AB_1078400, HPA018905: AB_1844783"	"unprognostic (4.92e-3)"	"unprognostic (8.09e-2)"		"unprognostic (1.09e-3)"	"unprognostic (1.84e-1)"	"unprognostic (6.24e-2)"		"unprognostic (2.05e-2)"	"unprognostic (9.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.55e-5)"		"unprognostic (8.97e-2)"		"unprognostic (1.43e-1)"	0.2	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.3	0.8	0.4	0.0	0.0	0.7	4.0	0.0	2.3	0.0	0.0	0.2	0.2	3.0	0.0	0.0	0.0	0.1	0.1	0.1	1.7	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.2	1.9	0.9	0.0	1.6	0.0	0.3	0.2	0.0	0.0	0.8	0.1	0.0	0.0	0.8	0.0	0.4	0.3	0.1	0.0	6.0	0.0	0.0	0.7	0.7	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.5	0.0	3.6	0.0	10.4	0.5	0.0	0.0	23.3	0.0	4.1	0.0	0.3	0.0	0.0	0.0	0.0	3.1	0.0	9.3	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	2.7	5.8	0.0	0.0	29.5	4.1	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	6.3	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.2	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	5.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.1	0.0	0.0	32.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	2.2	0.2	1.0	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.0
AMDHD1	MGC35366	ENSG00000139344	"Amidohydrolase domain containing 1"	Q96NU7	12	95943331-95968720	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Histidine metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 61.2;skeletal muscle: 27.6"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 132.5"	"Cancer enriched"	"Detected in many"	14	"liver cancer: 23.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 46.6;HMC-1: 47.7;Karpas-707: 61.2;SiHa: 40.5;SK-BR-3: 46.1;U-266/70: 49.1;U-266/84: 62.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA039720, HPA040149"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	NA		1400000	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA039720: AB_10672967, HPA040149: "	"unprognostic (4.81e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.33e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.06e-1)"	"unprognostic (7.01e-2)"	"unprognostic (3.35e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.63e-3)"	"unprognostic (3.98e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.61e-1)"	1.8	11.8	8.0	6.5	9.9	6.2	0.4	5.6	10.1	0.3	7.3	1.5	5.2	3.0	0.4	2.7	0.7	1.8	1.7	8.3	6.1	5.9	61.2	2.4	4.4	15.5	9.1	5.2	1.4	3.4	0.7	0.5	2.0	9.6	2.8	0.2	1.8	2.1	0.2	27.6	5.9	5.1	0.6	3.2	6.0	4.8	13.2	9.2	0.6	0.9	0.9	0.4	0.3	0.2	16.2	46.6	9.5	0.8	5.8	0.0	0.0	10.0	1.5	0.5	0.7	1.4	3.9	5.8	4.0	4.2	0.0	2.6	8.2	0.3	0.0	0.3	16.0	1.7	4.2	7.9	9.4	0.0	5.9	47.7	0.0	0.4	0.8	0.1	0.2	0.3	3.9	2.7	61.2	0.0	6.8	3.7	10.8	4.4	1.8	2.2	7.8	0.3	5.3	0.0	4.3	4.9	6.9	40.5	46.1	5.2	0.2	4.6	8.4	0.0	5.8	19.1	8.0	5.4	49.1	62.8	6.3	3.8	12.2	6.9	0.2	0.6	1.7	0.5	0.6	0.4	0.6	0.2	0.6	0.5	0.3	0.3	0.4	0.4	2.3	1.8	0.2	0.1	0.5	8.0	9.9	5.6	10.1	8.3	6.1	15.5	9.1	5.2	9.6	3.2	9.2	16.2	1.1	0.0	0.5	0.3	2.0	0.4	0.2	0.0	0.0	0.1	1.1	1.0	0.6	1.5	0.6	3.7	0.0	0.9	1.7	0.0	3.9	0.2	0.9	0.1	0.0	0.8	1.8	8.0	0.7	1.1	0.1	0.1	0.0	0.0	0.0	0.2	8.6	132.5	4.4	1.7	0.3	0.1	0.0	5.7	1.3	0.1	0.3	1.8	3.6	0.0	0.7	1.8	2.1	4.0	2.0	0.2	0.0	0.0	0.7	0.0	0.4	31.0	0.0	0.0	0.0	0.8	0.0	1.5	1.9	0.0	0.3	0.3	1.4	0.3	0.4	0.1
ANKRD2	ARPP	ENSG00000165887	"Ankyrin repeat domain 2"	Q9GZV1	10	97572499-97583884	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 238.3;skeletal muscle: 989.2;tongue: 831.1"	"Cell type enriched"	"Detected in some"	6	"Cardiomyocytes: 218.3"	"Cancer enhanced"	"Detected in many"		"renal cancer: 4.9;testis cancer: 5.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 17.6;BJ hTERT+ SV40 Large T+: 7.3;HaCaT: 13.0;RPTEC TERT1: 17.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA040842, HPA040884"	Enhanced		Enhanced	Vesicles		NA	NA		110000	Vesicles		"HPA040842: AB_10963794, HPA040884: AB_10969453"	"unprognostic (1.27e-2)"	"unprognostic (9.99e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.60e-3)"	"unprognostic (2.17e-1)"	"unprognostic (3.12e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.69e-3)"	"unprognostic (4.56e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.13e-1)"	0.4	0.8	2.6	0.1	2.4	0.0	0.5	2.6	3.8	0.2	2.0	0.2	0.0	0.3	0.3	1.0	0.1	0.3	238.3	2.5	2.7	5.6	0.3	0.8	0.2	2.6	2.5	2.4	0.1	0.9	0.0	0.6	0.0	2.6	2.9	0.0	0.3	3.4	1.0	989.2	1.9	0.2	0.2	2.2	0.1	0.2	0.5	2.9	0.0	0.5	831.1	0.1	0.1	0.4	3.1	17.6	5.4	0.0	0.0	0.2	0.0	0.4	0.9	0.0	7.3	4.7	0.3	5.3	0.0	0.6	0.2	0.4	13.0	0.0	4.7	5.0	0.2	0.2	0.0	0.3	0.0	0.5	0.0	0.0	0.8	2.1	4.3	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	17.4	0.8	0.0	0.0	0.0	4.4	0.0	0.4	2.1	0.3	0.0	0.1	1.5	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.6	2.4	2.6	3.8	2.5	2.7	2.6	2.5	2.4	2.6	2.2	2.9	3.1	0.1	0.0	0.0	1.3	0.0	0.1	0.7	1.7	1.2	0.0	0.2	0.4	218.3	2.8	0.2	3.7	0.0	0.2	0.0	0.0	31.3	1.2	0.6	0.1	0.3	1.6	0.0	0.0	1.3	0.2	0.4	1.0	0.0	0.1	0.0	0.7	0.4	0.2	0.1	0.0	1.5	0.0	0.0	0.0	0.4	0.2	0.0	0.3	0.0	0.0	1.6	0.0	0.0	0.5	0.4	0.9	0.0	1.9	0.0	0.1	0.0	19.1	0.0	0.1	0.0	13.6	1.1	2.5	3.5	0.6	0.3	0.3	0.2	0.1	0.0	0.5
ANKRD20A2P	ANKRD20A2	ENSG00000183148	"Ankyrin repeat domain 20 family member A2, pseudogene"	Q5SQ80	9	40223285-40266845	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"brain: 2.5;testis: 3.3"	"Cell type enriched"	"Detected in single"	6	"Cardiomyocytes: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"HDLM-2: 10.5"									"HPA043239, HPA047112, HPA047167, HPA047766, HPA051753"	Uncertain					NA	NA					"HPA043239: , HPA047112: , HPA047167: , HPA047766: , HPA051753: AB_2681592"					"unprognostic (4.24e-3)"									"unprognostic (9.19e-2)"				0.3	0.1	0.7	0.0	2.3	0.0	0.3	0.1	2.5	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.2	0.0	0.7	1.5	1.1	0.1	0.1	0.8	0.0	2.2	1.2	1.8	0.1	0.9	0.0	0.5	0.0	1.6	0.2	0.1	0.2	0.4	0.1	0.1	0.2	0.1	0.0	0.3	0.3	0.1	3.3	1.5	0.1	0.3	0.0	0.0	0.0	0.4	2.5	0.1	1.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.0	10.5	0.0	0.5	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	1.4	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.1	2.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.3	0.1	2.5	1.5	1.1	2.2	1.2	1.8	1.6	0.3	1.5	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
ANKRD20A3P	ANKRD20A3	ENSG00000276203	"Ankyrin repeat domain 20 family member A3, pseudogene"	Q5VUR7	9	66106815-66179474	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in single"		"testis: 2.0"	"Cell type enriched"	"Detected in single"	15	"Cardiomyocytes: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"Karpas-707: 9.5;U-266/84: 3.7"									"HPA043239, HPA047112, HPA047167, HPA047766, HPA051753"	Uncertain					NA	NA					"HPA043239: , HPA047112: , HPA047167: , HPA047766: , HPA051753: AB_2681592"					"unprognostic (4.27e-2)"													0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.7	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.5	0.3	0.1	0.0	0.1	0.0	0.2	0.0	0.2	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ANKRD20A4P	ANKRD20A4	ENSG00000172014	"Ankyrin repeat domain 20 family member A4, pseudogene"	Q4UJ75	9	64369394-64413142	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"brain: 1.5"	"Cell type enriched"	"Detected in some"	9	"Cardiomyocytes: 9.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 1.0;Karpas-707: 1.4"									"HPA043239, HPA047112, HPA047167, HPA047766, HPA051753"	Uncertain					NA	NA					"HPA043239: , HPA047112: , HPA047167: , HPA047766: , HPA051753: AB_2681592"	"unprognostic (3.40e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.69e-2)"		"unprognostic (2.56e-1)"		"unprognostic (9.24e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.97e-3)"	"unprognostic (8.99e-2)"	"unprognostic (2.88e-1)"	"unprognostic (4.12e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.10e-2)"	"unprognostic (5.84e-2)"	0.5	0.2	0.1	0.1	0.1	1.1	0.2	0.1	1.5	0.1	0.0	0.3	0.2	0.1	0.1	0.5	0.1	0.1	0.3	0.9	0.0	0.2	0.1	0.3	0.1	0.3	0.0	0.0	0.4	0.7	0.1	0.2	0.3	0.6	0.1	0.4	0.5	0.3	0.0	0.2	0.2	0.3	0.0	0.0	0.3	0.3	0.6	0.5	0.2	0.2	0.1	0.1	0.1	0.2	0.5	0.2	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	0.1	0.6	0.1	0.0	0.2	0.5	0.4	0.1	0.2	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.1	0.2	0.9	1.0	1.4	0.0	0.0	0.3	0.0	0.1	0.8	0.3	0.0	0.3	0.2	0.2	0.2	0.6	0.2	0.0	0.0	0.7	0.1	0.7	0.0	0.3	0.0	0.7	0.1	0.0	0.2	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.1	1.5	0.9	0.0	0.3	0.0	0.0	0.6	0.0	0.5	0.5	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
ANOS1	"ADMLX, KAL, KAL1, KALIG-1, WFDC19"	ENSG00000011201	"Anosmin 1"	P23352	X	8528874-8732137	"Disease related genes, Human disease related genes, Predicted secreted proteins"	"Cell adhesion, Chemotaxis"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 43.5"	"Cell type enriched"	"Detected in many"	11	"Alveolar cells type 1: 240.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"hTERT-RPE1: 40.4;NTERA-2: 37.0;U-2 OS: 17.6"					"Low region specificity"	"Detected in all"								"Secreted in brain"	NA	NA						"unprognostic (2.93e-1)"	"unprognostic (5.33e-2)"	"unprognostic (9.54e-2)"	"unprognostic (4.16e-3)"	"unprognostic (7.77e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.17e-3)"	"unprognostic (4.53e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.09e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.71e-2)"	"unprognostic (9.38e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.56e-2)"	6.6	4.0	8.9	1.1	9.4	0.3	3.7	6.7	7.4	4.4	1.2	0.7	0.3	0.5	3.1	1.3	1.1	1.7	5.1	7.8	11.2	0.8	0.8	43.5	1.9	13.4	11.3	6.7	0.3	0.4	15.2	0.5	1.2	13.9	4.2	1.0	19.8	2.4	4.4	10.6	3.1	0.6	0.7	19.0	0.8	0.8	3.9	10.6	4.0	9.4	6.9	0.9	1.2	1.2	18.1	0.1	0.0	1.9	0.0	0.0	0.0	2.2	0.8	0.1	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.7	4.0	0.2	5.5	0.5	5.6	0.0	0.0	0.0	1.5	0.1	3.1	0.3	0.1	40.4	0.0	0.1	0.0	0.0	0.5	0.4	0.3	0.0	37.0	0.0	0.0	0.0	0.0	0.0	2.1	0.7	2.1	0.1	1.9	0.5	0.0	4.8	0.0	1.0	0.0	0.0	17.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	9.4	6.7	7.4	7.8	11.2	13.4	11.3	6.7	13.9	19.0	10.6	18.1	1.7	240.4	12.6	0.0	0.0	0.0	4.7	0.0	13.1	20.5	6.2	3.4	6.2	0.0	19.8	0.0	4.2	0.1	0.0	0.0	0.0	0.9	0.2	0.4	1.5	1.6	0.0	0.0	0.0	0.0	0.3	10.9	0.0	0.1	1.3	2.2	6.1	0.0	5.1	0.0	0.0	0.0	0.0	2.9	0.0	0.3	0.6	3.0	0.0	0.0	0.2	17.8	0.0	0.0	0.0	1.5	0.1	1.2	0.0	3.1	0.0	0.2	3.6	1.6	0.0	8.7	3.3	0.6	1.6	1.5	0.0	0.1	0.3	0.8	0.4	1.1
AOC2	"DAO2, RAO"	ENSG00000131480	"Amine oxidase copper containing 2"	O75106	17	42844580-42850707	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Catecholamine metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"Early spermatids: 29.5"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 11.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA057779	Uncertain				"Intracellular and membrane"	NA	NA					"HPA057779: "	"unprognostic (3.79e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.10e-4)"	"unprognostic (1.90e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.16e-2)"	"unprognostic (8.27e-3)"	"unprognostic (4.55e-5)"	"unprognostic (3.55e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.63e-2)"	"prognostic favorable (2.47e-4)"	5.9	1.1	2.0	0.6	2.2	0.9	2.6	2.1	2.9	1.3	1.0	1.1	0.3	1.0	0.5	0.7	1.6	0.7	0.6	2.6	1.9	1.2	3.4	2.3	0.5	2.3	1.8	2.3	1.1	0.7	0.2	2.0	0.4	2.8	1.5	0.2	1.5	0.6	0.5	1.6	1.3	0.8	0.6	1.4	1.7	0.8	4.9	2.1	0.3	0.9	0.6	0.6	1.8	1.2	2.8	0.2	2.3	0.5	2.5	11.2	1.1	6.0	0.8	0.7	1.6	2.2	1.8	0.2	0.9	1.1	0.2	0.7	1.0	2.2	0.6	3.2	2.0	6.0	0.3	1.3	1.9	0.7	0.3	2.2	1.7	2.0	1.5	2.3	0.4	0.4	3.1	0.6	2.1	0.4	0.3	0.5	0.9	0.8	0.2	0.7	1.1	2.3	1.9	0.3	3.6	0.8	0.5	0.1	0.8	3.4	4.6	0.4	0.2	0.4	1.5	3.2	2.0	1.0	4.6	4.9	0.9	0.4	2.2	0.8	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	2.0	2.2	2.1	2.9	2.6	1.9	2.3	1.8	2.3	2.8	1.4	2.1	2.8	1.1	0.0	0.5	1.6	0.3	1.0	0.5	0.1	0.0	0.5	0.9	0.9	0.4	0.0	0.7	0.0	2.1	0.1	0.4	0.0	0.0	0.3	29.5	1.4	0.7	1.4	0.0	0.0	1.8	0.4	0.1	0.2	0.0	2.8	0.0	0.5	0.4	0.7	0.1	0.0	1.2	0.2	0.0	0.3	0.6	5.0	0.3	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.2	0.1	0.0	0.0	1.2	0.1	0.2	0.4	0.8	0.0	0.5	1.0	2.3	2.1	0.4	1.6	0.0	0.2	0.4	0.2	0.6
AP000781.2		ENSG00000254979	"Novel protein"		11	57387365-57424059	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"bone marrow: 13.4;liver: 7.3;placenta: 7.1"	"Cell type enriched"	"Detected in single"	10	"granulocytes: 6.3"	"Cancer enhanced"	"Detected in single"		"melanoma: 0.5"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	9	"basophil: 3.5"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 3.5"	"Cell line enriched"	"Detected in some"	7	"HMC-1: 186.9"									HPA038515	Supported					NA	NA					"HPA038515: AB_10675800"	"unprognostic (1.12e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.55e-4)"	"unprognostic (2.16e-1)"	"unprognostic (4.01e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.51e-10)"	"unprognostic (4.86e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.59e-2)"	"unprognostic (3.10e-1)"	4.2	0.2	0.0	0.6	0.0	13.4	2.6	0.0	0.3	0.5	0.0	0.5	0.7	0.4	0.0	1.1	0.2	1.1	0.6	0.0	0.0	0.3	7.3	1.0	1.0	0.1	0.0	0.0	0.3	2.9	0.0	0.2	7.1	0.1	0.3	0.4	0.0	1.4	0.0	1.0	5.0	0.5	0.3	0.0	0.5	0.3	0.1	0.0	0.4	1.2	0.1	0.9	1.0	0.7	0.0	0.7	0.0	0.1	0.0	0.0	0.9	0.8	0.0	0.3	0.2	0.6	0.0	0.2	0.8	0.0	0.1	0.0	1.3	0.0	0.0	0.6	0.0	0.0	4.2	0.0	0.0	0.8	28.6	186.9	1.7	0.0	0.6	0.0	0.0	0.4	0.7	0.4	1.6	0.0	0.0	1.1	9.1	0.3	0.0	0.0	4.0	0.0	8.7	0.2	0.0	1.0	0.3	0.2	0.4	2.9	0.0	0.0	0.9	0.1	0.2	0.5	3.3	0.0	0.3	0.0	1.0	0.9	1.1	1.3	3.5	0.2	0.2	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AP001273.2		ENSG00000284057	"Novel protein, C11orf54-MED17 readthrough"		11	93741664-93812378	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"kidney: 9.5"	"Cell type enriched"	"Detected in single"	7	"Respiratory ciliated cells: 4.4"					"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA040511, HPA046619"	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA040511: AB_10795369, HPA046619: "																		1.3	2.1	0.6	2.1	0.6	0.0	1.1	0.6	1.0	1.5	0.4	1.9	4.9	1.2	0.4	0.3	1.4	2.0	1.5	0.5	0.6	9.5	4.6	1.1	0.8	0.7	0.6	0.4	2.3	0.3	2.0	0.5	1.7	0.8	2.4	1.6	1.4	1.6	1.0	1.1	1.6	3.4	0.5	0.6	0.8	1.8	1.3	0.6	1.6	1.5	1.8	1.2	0.9	0.2	0.8	0.6	0.0	3.3	0.6	1.9	0.0	1.9	0.0	1.0	0.7	1.3	0.6	1.4	2.2	4.0	2.5	1.0	2.2	4.0	0.9	0.4	3.3	0.3	0.7	1.4	0.0	1.4	0.0	0.7	1.4	0.6	0.0	1.5	2.9	1.0	1.7	1.3	0.5	3.9	0.0	2.6	2.2	1.4	6.0	0.1	0.8	2.3	1.3	3.5	0.0	0.7	0.3	2.1	2.4	4.9	2.8	2.5	0.9	2.8	0.3	0.8	0.4	1.3	0.6	1.3	2.9	0.2	1.8	1.3	1.9	1.2	1.8	1.1	1.2	1.3	1.0	1.1	1.4	1.5	0.4	1.1	1.4	1.8	1.2	1.4	0.8	2.1	1.2	0.6	0.6	0.6	1.0	0.5	0.6	0.7	0.6	0.4	0.8	0.6	0.6	0.8	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
APLN	"apelin, XNPEP2"	ENSG00000171388	Apelin	Q9ULZ1	X	129645259-129654956	"Predicted secreted proteins"	"Angiogenesis, Gastrulation, Host-virus interaction"	"Developmental protein, Hormone"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.6;placenta: 54.5"	"Cell type enriched"	"Detected in some"	7	"Endothelial cells: 68.2"	"Group enriched"	"Detected in all"	6	"glioma: 44.2;renal cancer: 21.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	6	"HUVEC TERT2: 502.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"	NA	NA						"unprognostic (1.50e-1)"	"prognostic unfavorable (2.92e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.50e-2)"	"unprognostic (5.94e-2)"	"prognostic unfavorable (9.32e-4)"	"prognostic unfavorable (6.09e-4)"	"unprognostic (4.71e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.30e-1)"	"unprognostic (9.12e-2)"	"prognostic unfavorable (9.61e-5)"	"unprognostic (1.55e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.42e-2)"	4.0	9.3	19.8	2.3	19.0	0.0	3.0	20.6	20.5	0.4	7.3	1.0	0.8	0.7	0.3	0.6	1.2	0.4	10.2	15.8	22.0	7.3	1.4	13.6	0.1	29.5	25.2	12.6	2.4	0.3	1.0	5.5	54.5	33.6	1.1	0.3	0.3	0.6	0.5	3.8	1.2	0.8	2.0	29.4	0.7	1.2	1.2	29.9	0.3	0.9	1.1	0.2	3.4	0.4	37.6	0.2	0.6	58.5	0.5	1.9	3.6	0.0	0.2	0.0	1.1	1.8	0.0	0.0	0.0	6.2	0.2	2.5	0.0	1.4	14.1	1.0	0.0	0.1	0.0	0.6	0.1	0.2	3.3	1.4	7.7	0.1	7.2	0.0	0.0	502.1	1.7	0.1	1.9	2.6	0.0	0.2	0.7	1.5	0.0	26.8	0.3	0.5	0.9	0.0	0.0	2.0	6.2	0.2	0.1	0.0	0.1	0.1	0.9	86.2	2.1	0.2	36.5	2.1	0.8	0.0	0.0	34.0	0.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	19.0	20.6	20.5	15.8	22.0	29.5	25.2	12.6	33.6	29.4	29.9	37.6	3.0	0.0	1.3	8.1	0.0	0.1	0.1	0.6	0.0	0.0	0.2	9.4	6.8	0.0	0.1	0.0	0.0	0.9	0.0	0.1	0.0	0.2	0.0	0.1	0.1	68.2	0.0	0.0	0.1	0.0	0.7	1.0	0.0	0.2	1.3	0.0	0.0	0.3	0.3	0.0	0.4	0.1	0.0	0.0	0.4	0.0	0.0	0.2	1.8	1.9	0.0	0.0	0.0	0.0	3.6	0.1	0.0	0.0	0.0	0.9	0.0	1.0	0.0	0.0	0.0	0.4	0.6	0.0	0.2	0.0	0.1	1.2	0.2	2.9	0.0	0.0
APOLD1	"DKFZP434F0318, FLJ25138"	ENSG00000178878	"Apolipoprotein L domain containing 1"	Q96LR9	12	12725917-12829975	"Predicted membrane proteins"	"Angiogenesis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 125.6"	"Cell type enriched"	"Detected in many"	4	"Adipocytes: 781.6"	"Cancer enhanced"	"Detected in all"		"renal cancer: 24.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 36.7;HDLM-2: 19.3;hTERT-RPE1: 15.1"	"Group enriched"	"Detected in all"	4	"basal ganglia: 5.7;olfactory bulb: 20.1"	"Low region specificity"	"Detected in all"			"HPA052462, HPA058882"	Approved		Approved	"Nucleoplasm,Plasma membrane"		No	No			"Nucleoplasm, Plasma membrane"		"HPA052462: AB_2681841, HPA058882: AB_2683844"	"unprognostic (1.98e-1)"	"unprognostic (8.36e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.58e-3)"	"unprognostic (8.07e-2)"	"unprognostic (3.46e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.23e-2)"	"unprognostic (4.30e-3)"	"unprognostic (3.42e-3)"	"unprognostic (1.81e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.15e-2)"	125.6	15.8	42.2	15.5	31.1	0.3	91.4	32.4	38.8	44.2	25.3	11.7	3.9	15.9	2.4	35.6	30.7	34.7	42.5	29.4	33.1	13.1	17.8	17.2	5.7	40.2	37.7	25.3	7.0	24.3	28.2	10.6	87.3	40.8	12.9	12.1	5.8	10.4	5.7	34.6	15.3	10.8	52.9	32.5	6.1	12.2	3.0	39.9	10.7	65.4	29.0	3.3	28.5	18.3	37.5	6.4	0.2	36.7	1.2	1.1	2.1	0.3	6.0	9.9	6.0	8.7	2.4	6.5	2.0	0.5	2.3	2.1	2.0	1.4	0.3	10.1	19.3	1.4	0.5	2.0	0.0	2.2	1.0	0.6	1.4	1.7	2.1	4.7	15.1	4.6	3.5	0.5	2.5	3.1	1.3	1.0	1.1	0.2	1.5	1.1	2.9	0.8	0.9	0.7	0.6	3.1	3.4	5.7	0.5	13.6	0.6	0.2	3.1	5.6	1.3	2.0	8.1	5.5	1.8	0.9	1.4	2.0	4.0	6.9	2.2	0.3	0.2	0.3	0.1	0.4	1.0	0.7	0.5	0.2	0.8	0.5	0.3	1.6	0.3	0.2	0.6	1.1	0.1	42.2	31.1	32.4	38.8	29.4	33.1	40.2	37.7	25.3	40.8	32.5	39.9	37.5	781.6	6.4	5.3	17.3	15.9	18.1	2.5	1.4	6.8	4.4	5.4	5.8	11.9	4.3	5.9	0.0	4.2	2.9	13.3	5.3	0.0	1.1	2.9	0.7	7.2	169.4	3.6	18.9	5.3	0.4	1.4	25.0	1.1	1.3	7.6	5.8	62.4	3.8	6.6	3.3	7.0	6.3	2.0	14.2	27.1	2.1	4.4	6.6	28.4	32.8	5.9	39.6	29.9	5.0	28.5	1.2	0.6	0.4	5.7	2.9	2.3	0.5	5.4	4.8	111.7	17.5	193.5	5.5	1.0	2.3	15.5	1.0	18.3	1.1	9.3	3.7
ARPP19	"ARPP-16, ARPP-19, ARPP16, ENSAL"	ENSG00000128989	"CAMP regulated phosphoprotein 19"	P56211	15	52547045-52569883	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Late spermatids: 3587.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA056851	Approved					NA	NA		270000			"HPA056851: AB_2683255"	"unprognostic (2.83e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.44e-1)"	"unprognostic (8.09e-2)"	"unprognostic (1.58e-1)"	"unprognostic (6.14e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.33e-2)"	"unprognostic (7.21e-2)"	"unprognostic (5.67e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.15e-1)"	"prognostic favorable (1.72e-4)"	"unprognostic (1.40e-2)"	"unprognostic (4.82e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.27e-1)"	61.7	52.2	128.7	39.0	241.9	104.2	46.7	117.9	169.9	38.4	80.7	36.9	29.2	48.3	36.7	52.6	33.7	39.6	82.1	163.0	139.9	57.0	42.6	45.5	48.7	132.1	123.6	150.2	46.6	46.7	110.1	39.0	57.5	144.7	39.8	36.2	57.9	32.0	41.2	242.6	30.7	30.9	58.6	141.8	44.1	38.9	85.4	144.6	53.4	57.9	172.1	52.1	55.9	30.3	157.6	115.1	126.3	178.2	81.3	69.8	77.6	91.7	103.8	88.7	75.9	76.9	111.7	56.6	120.2	110.3	75.0	110.3	100.4	126.1	116.7	98.2	412.3	59.9	138.0	126.0	99.9	59.4	131.8	99.3	74.0	116.1	78.5	128.2	90.0	119.8	115.3	86.2	224.4	113.9	129.0	126.4	51.6	110.1	81.0	63.8	134.1	102.6	243.3	108.2	146.7	179.4	145.2	76.6	99.2	102.6	194.4	99.2	89.0	109.4	120.3	86.1	87.0	151.1	104.4	289.8	154.8	84.9	116.8	116.7	53.5	38.5	88.1	47.7	44.5	47.4	69.9	50.0	57.4	32.5	50.8	47.9	53.1	63.8	65.6	55.6	41.5	80.2	53.9	128.7	241.9	117.9	169.9	163.0	139.9	132.1	123.6	150.2	144.7	141.8	144.6	157.6	90.8	64.1	59.4	33.6	93.9	215.7	190.7	142.2	55.8	54.3	107.3	72.5	156.5	61.5	96.1	62.5	20.9	75.7	100.3	46.2	135.0	88.9	743.5	66.3	60.4	83.0	84.6	63.3	133.2	67.9	94.2	73.7	43.3	104.4	62.1	58.5	80.7	93.1	72.3	85.8	33.9	45.6	81.4	81.7	211.9	3587.2	70.8	73.4	165.4	32.8	144.5	105.5	65.9	24.6	54.3	117.0	38.1	108.3	94.8	174.0	37.0	129.4	62.7	59.4	72.3	78.7	131.1	154.9	196.1	82.0	222.8	87.7	95.0	40.3	43.4	262.9
ARTN	"ENOVIN, EVN, NBN"	ENSG00000117407	Artemin	Q5T4W7	1	43933320-43937240	"Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"Urothelial cells: 51.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"A-431: 61.9;HaCaT: 62.8;HBEC3-KT: 57.0;hTCEpi: 22.7;hTERT-HME1: 15.9"	"Region enriched"	"Detected in single"	9	"olfactory bulb: 3.3"	"Region enhanced"	"Detected in single"		"olfactory bulb: 1.0"						"Secreted in other tissues"	NA	NA						"unprognostic (1.98e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.18e-1)"	"unprognostic (3.08e-1)"	"prognostic favorable (8.18e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.59e-6)"	"unprognostic (2.35e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.48e-3)"	"unprognostic (1.53e-1)"	1.8	0.9	1.9	0.9	1.4	0.8	1.8	3.4	2.3	4.1	1.3	2.1	0.4	3.2	3.4	3.8	2.8	0.9	1.6	1.6	1.5	4.1	0.7	2.4	0.3	4.2	2.6	1.3	2.1	2.8	6.7	6.7	7.5	4.9	8.3	1.6	1.8	1.5	8.2	0.7	1.0	1.2	1.3	1.3	0.7	1.8	2.4	4.2	0.3	1.4	0.3	0.3	2.4	4.7	2.1	61.9	1.5	1.2	0.9	0.2	0.3	0.2	2.8	0.5	2.3	2.5	0.4	1.4	0.8	0.4	0.9	0.8	62.8	0.0	57.0	0.6	0.2	2.1	1.0	7.6	0.1	0.0	0.4	1.3	0.0	22.7	1.1	15.9	10.6	0.0	1.1	0.7	2.1	0.2	4.3	0.2	4.0	5.4	0.0	2.6	1.4	0.0	0.9	0.3	1.3	1.4	0.5	0.4	0.1	1.4	1.1	10.2	10.4	0.6	1.2	0.5	0.5	2.8	6.7	5.5	0.9	8.8	3.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.4	3.4	2.3	1.6	1.5	4.2	2.6	1.3	4.9	1.3	4.2	2.1	0.1	0.0	0.0	0.0	0.1	0.0	4.3	2.3	0.0	1.8	2.3	0.5	0.8	0.0	2.8	0.0	0.0	0.1	0.3	2.8	3.9	0.1	8.4	1.6	0.3	0.2	0.0	0.0	0.7	0.2	0.0	0.3	0.0	1.9	0.0	3.2	0.0	0.0	0.1	0.0	1.2	1.0	0.0	0.0	0.5	2.6	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	1.1	0.4	0.0	12.1	0.0	1.6	0.7	4.6	0.0	0.0	4.0	4.3	0.0	0.0	0.0	0.0	0.1	0.8	0.7	51.5
ASCL2	"ASH2, bHLHa45, HASH2"	ENSG00000183734	"Achaete-scute family bHLH transcription factor 2"	Q99929	11	2268498-2270588	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 7.0;salivary gland: 8.1;skin 1: 6.7"	"Cell type enriched"	"Detected in many"	9	"Extravillous trophoblasts: 1042.9"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 76.1;stomach cancer: 23.1"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 7.9"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"BEWO: 25.1;NB-4: 8.1;OE19: 14.2;SCLC-21H: 20.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (2.71e-3)"	"prognostic favorable (5.11e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.93e-2)"	"unprognostic (7.88e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.22e-2)"	"prognostic favorable (4.73e-4)"	"unprognostic (5.85e-2)"	"unprognostic (1.45e-6)"	"unprognostic (8.86e-3)"	"unprognostic (5.48e-2)"	"unprognostic (6.12e-4)"	"unprognostic (1.07e-3)"	0.3	0.2	1.0	1.3	0.9	0.9	0.7	0.6	0.9	1.7	0.5	3.9	7.0	2.2	0.5	1.7	0.4	0.1	0.1	0.9	0.5	1.3	0.8	0.6	0.7	1.2	2.1	0.7	0.1	0.7	0.1	0.1	5.5	1.0	2.4	2.5	0.0	8.1	1.6	0.2	6.7	5.6	0.1	1.3	2.4	2.1	0.8	1.8	0.5	0.5	0.0	0.6	1.5	1.9	2.0	0.0	0.0	0.4	0.0	0.0	0.0	25.1	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	2.7	0.0	8.1	0.6	14.2	0.0	0.0	0.0	0.0	0.0	0.6	20.5	0.1	0.0	0.5	0.0	0.0	2.5	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	3.9	1.2	7.9	2.2	1.7	0.1	0.0	0.5	1.3	0.8	0.0	0.1	1.3	0.9	0.0	1.4	0.0	0.0	0.4	1.0	0.9	0.6	0.9	0.9	0.5	1.2	2.1	0.7	1.0	1.3	1.8	2.0	1.2	0.0	0.0	0.0	1.4	13.6	14.1	3.3	23.3	0.0	7.2	3.3	0.9	1.5	0.7	20.2	0.0	18.7	29.2	14.4	7.9	0.2	0.1	1.4	4.7	2.6	78.2	4.4	0.0	0.0	1042.9	1.5	10.2	3.5	0.0	0.0	23.2	0.5	31.1	0.0	0.0	31.4	2.0	22.0	7.0	0.2	1.8	14.3	1.8	3.7	22.6	0.0	110.2	0.0	0.0	0.0	3.6	1.5	1.3	6.5	9.1	0.4	1.0	0.1	0.0	0.1	0.3	0.3	13.7	9.1	4.7	23.3	8.9	0.1	112.1	9.4
ATP10A	"ATP10C, ATPVA, ATPVC, KIAA0566"	ENSG00000206190	"ATPase phospholipid transporting 10A (putative)"	O60312	15	25677271-25865184	"Enzymes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.9"	"Cell type enriched"	"Detected in many"	6	"Microglial cells: 216.4"	"Cancer enhanced"	"Detected in all"		"melanoma: 7.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 23.0;fHDF/TERT166: 22.9;HMC-1: 19.4;SK-MEL-30: 21.9;U-2197: 12.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041496, HPA042509"	Uncertain					NA	NA					"HPA041496: AB_2677513, HPA042509: AB_2678032"	"unprognostic (3.70e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.30e-4)"	"unprognostic (1.18e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.67e-1)"	"unprognostic (4.95e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (6.60e-5)"	"unprognostic (1.30e-1)"	"unprognostic (1.38e-2)"	"unprognostic (4.89e-2)"	"unprognostic (9.42e-2)"	5.2	8.8	14.9	2.7	8.1	2.5	5.3	5.8	9.0	2.1	1.6	2.9	0.8	1.5	0.1	1.9	2.3	3.7	1.8	5.7	5.2	5.7	0.6	7.1	1.9	11.5	9.5	3.1	1.1	1.4	3.5	2.1	1.8	10.3	2.2	0.8	0.1	8.0	0.7	0.6	2.3	3.0	2.9	5.1	1.5	3.2	4.3	12.9	1.1	2.5	0.7	1.1	2.5	1.4	8.1	0.0	5.7	1.3	0.0	2.2	2.8	0.0	23.0	9.3	6.1	9.9	0.0	0.0	0.0	1.6	22.9	0.0	0.0	9.3	1.2	0.4	0.0	0.2	0.0	0.0	0.1	0.1	0.0	19.4	0.9	0.0	0.6	0.0	2.5	0.0	1.2	0.0	0.0	3.3	0.0	1.2	0.0	1.5	0.0	1.5	4.4	4.6	2.8	9.9	0.0	0.0	0.1	0.0	0.0	21.9	0.0	7.4	1.2	0.0	8.9	0.2	12.7	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.6	0.1	0.5	0.0	0.3	0.5	0.1	0.0	0.7	0.6	0.0	1.2	0.0	1.0	0.1	0.3	14.9	8.1	5.8	9.0	5.7	5.2	11.5	9.5	3.1	10.3	5.1	12.9	8.1	0.3	32.1	8.6	2.0	0.8	1.0	0.0	2.7	0.6	0.2	2.6	1.8	1.7	1.5	5.3	0.0	0.0	0.0	11.1	0.1	0.0	0.5	23.2	2.8	2.8	4.2	0.0	0.0	4.5	0.0	0.1	5.0	3.1	7.9	15.2	0.0	0.4	0.1	2.5	0.0	2.1	0.2	0.0	2.5	5.2	21.8	4.1	4.5	17.8	216.4	2.3	0.0	14.4	1.5	2.7	0.8	0.0	17.7	1.7	0.7	0.0	0.1	4.2	0.1	0.0	4.7	9.1	0.4	1.2	0.0	0.4	0.0	8.6	0.1	0.0	0.0
ATP8A1	ATPIA	ENSG00000124406	"ATPase phospholipid transporting 8A1"	Q9Y2Q0	4	42408373-42657105	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 82.3"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 1218.1"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 13.5"	"Region enhanced"	"Detected in all"		"white matter: 82.3"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 27.5;Daudi: 46.3;HEL: 16.4;REH: 16.1;SH-SY5Y: 14.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052935	Enhanced		Supported	Vesicles		NA	NA			Vesicles		"HPA052935: AB_2681992"	"unprognostic (8.63e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.61e-2)"	"unprognostic (6.59e-2)"	"unprognostic (6.82e-3)"	"unprognostic (7.69e-2)"	"unprognostic (2.02e-3)"	"unprognostic (3.99e-1)"	"unprognostic (2.99e-3)"	"unprognostic (4.39e-2)"	"unprognostic (9.71e-2)"	"prognostic favorable (5.54e-10)"	"unprognostic (2.43e-1)"	"unprognostic (3.25e-1)"	"unprognostic (8.21e-2)"	"unprognostic (2.25e-1)"	2.8	9.0	2.5	9.6	26.9	23.7	3.7	5.9	23.9	2.2	0.0	12.9	4.3	2.4	12.3	2.3	2.4	2.5	8.5	13.5	17.7	3.8	1.7	12.0	15.1	8.4	8.3	4.9	16.4	7.1	36.3	2.2	2.4	13.2	8.3	11.8	19.5	4.4	5.3	10.1	1.7	8.9	2.8	8.1	9.1	12.6	2.1	11.3	10.0	40.1	15.7	11.9	2.5	1.5	82.3	0.0	0.1	0.4	27.5	0.1	0.1	0.1	0.1	0.0	0.0	0.0	3.0	0.4	46.3	12.6	0.2	0.0	2.4	6.5	0.1	0.0	7.4	4.5	16.4	1.6	0.7	0.1	4.0	0.3	0.4	0.0	0.0	0.0	0.6	0.2	10.3	0.0	5.1	0.0	2.0	6.0	1.4	2.0	1.9	0.6	16.1	0.0	5.3	9.5	0.6	4.9	14.8	0.3	9.4	0.0	1.1	3.1	0.0	0.4	0.0	2.0	0.5	0.0	1.7	0.0	9.4	0.7	5.6	0.2	0.0	0.6	0.6	3.7	0.2	1.9	1.5	1.1	4.1	0.6	2.5	1.7	4.4	0.5	2.2	2.5	2.4	1.0	0.6	2.5	26.9	5.9	23.9	13.5	17.7	8.4	8.3	4.9	13.2	8.1	11.3	82.3	26.1	28.9	80.1	136.1	23.3	1.5	1.8	0.6	2.2	19.7	4.0	1.5	14.4	0.0	5.3	5.5	81.3	0.0	52.9	48.4	3.9	0.2	4.6	1.3	1.3	13.6	84.6	13.9	295.9	2.5	0.1	4.8	19.9	4.2	8.2	26.5	16.8	1.1	1.6	62.2	255.9	28.6	0.0	8.8	4.6	2.9	3.4	8.9	3.6	31.9	5.1	2.2	33.0	144.8	1218.1	0.6	10.2	1.9	37.6	9.6	45.6	2.0	0.3	38.1	0.0	6.3	2.7	1.5	3.6	5.0	1.4	0.0	51.6	8.6	25.0	3.0
ATXN1L	BOAT1	ENSG00000224470	"Ataxin 1 like"	P0C7T5	16	71845976-71885268	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Late spermatids: 263.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062596, HPA062789"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA062596: AB_2684802, HPA062789: AB_2684868"	"unprognostic (1.51e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.99e-1)"	"prognostic favorable (5.33e-8)"	"unprognostic (1.61e-1)"	"unprognostic (1.42e-1)"	"unprognostic (5.30e-2)"	"prognostic unfavorable (8.42e-4)"	14.1	8.1	12.0	10.0	12.8	39.9	11.0	9.4	9.6	11.2	6.3	9.8	8.3	12.5	7.4	9.8	11.0	9.0	9.6	9.8	9.6	18.9	6.6	12.1	10.0	11.2	12.1	8.6	12.8	12.6	16.6	5.3	10.9	12.7	8.2	9.3	8.0	9.5	10.5	10.5	12.1	9.4	13.0	10.8	11.9	10.1	12.3	12.7	12.9	12.0	13.8	10.6	9.0	7.4	11.2	11.8	15.7	15.7	11.5	18.1	8.9	18.4	9.8	10.8	17.4	13.2	22.6	12.9	13.2	15.0	15.4	8.0	20.3	13.4	14.9	18.9	3.6	11.9	9.7	17.7	15.9	13.5	11.9	19.0	12.8	18.6	19.8	14.2	11.4	16.0	17.0	11.1	10.2	10.4	33.6	20.2	11.7	14.3	9.3	7.4	21.4	15.9	15.8	12.1	16.4	8.3	14.2	19.5	10.2	11.9	16.4	16.0	12.5	19.4	19.0	19.9	12.1	13.3	23.0	20.8	30.7	11.8	7.9	16.3	0.6	0.3	0.3	0.4	0.4	0.3	0.3	0.3	0.4	0.2	0.2	0.5	0.5	0.4	0.4	0.2	0.1	0.7	0.3	12.0	12.8	9.4	9.6	9.8	9.6	11.2	12.1	8.6	12.7	10.8	12.7	11.2	11.1	0.0	10.6	4.2	14.9	22.8	15.3	11.4	14.2	11.2	16.0	10.2	15.7	14.3	9.5	14.7	14.6	8.3	19.9	15.2	17.6	11.9	44.2	19.1	15.0	14.2	7.8	5.7	6.8	11.8	7.9	11.0	5.6	35.4	12.7	8.0	14.3	12.3	8.5	15.2	5.7	8.7	8.2	14.3	25.2	263.0	14.9	11.8	12.4	5.6	16.9	6.3	29.9	3.5	9.1	14.4	19.6	12.8	16.0	18.3	13.3	15.8	9.9	17.2	13.1	15.5	14.3	22.4	21.1	13.1	24.9	11.5	15.8	8.0	10.6	28.4
B3GALNT2	MGC39558	ENSG00000162885	"Beta-1,3-N-acetylgalactosaminyltransferase 2"	Q8NCR0	1	235447190-235504452	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Cone photoreceptor cells: 252.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007846, HPA050662"	Approved		Uncertain	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Golgi apparatus"		"HPA007846: , HPA050662: AB_2681209"	"unprognostic (5.50e-2)"	"unprognostic (3.16e-3)"	"unprognostic (6.60e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.59e-3)"	"unprognostic (1.96e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.38e-1)"	"unprognostic (7.19e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.52e-2)"	"unprognostic (3.40e-1)"	"unprognostic (3.53e-3)"	"unprognostic (8.34e-3)"	4.8	5.4	2.5	2.8	2.4	1.6	4.1	2.7	2.5	5.1	5.2	7.2	3.2	7.3	4.8	9.0	5.6	5.3	6.1	2.5	4.6	3.3	3.2	3.4	2.2	2.5	2.8	2.3	5.2	22.5	6.8	3.8	4.4	2.5	7.4	5.4	3.9	6.1	6.6	23.5	6.2	5.2	10.6	2.6	2.7	9.0	5.9	2.7	3.6	7.3	16.8	3.4	7.9	5.4	2.5	15.0	10.4	11.1	16.2	14.2	15.7	21.6	14.1	11.8	9.8	10.0	7.7	13.1	8.2	15.3	15.5	7.0	17.3	21.3	14.8	12.5	14.5	11.7	5.8	12.7	9.3	10.0	17.9	4.3	9.9	9.5	10.4	21.5	7.0	14.1	19.2	10.9	10.9	9.2	7.3	10.0	8.8	15.7	7.9	3.1	10.6	19.9	18.8	6.4	21.1	14.2	16.8	23.7	7.8	12.2	3.9	18.5	15.6	13.1	9.7	13.3	16.6	18.1	11.3	14.8	5.0	6.7	12.1	21.7	1.1	1.1	0.5	0.6	1.6	0.8	0.6	0.6	0.7	2.3	0.5	0.5	0.9	0.2	1.2	1.4	1.9	0.3	0.4	2.5	2.4	2.7	2.5	2.5	4.6	2.5	2.8	2.3	2.5	2.6	2.7	2.5	9.6	9.6	5.0	38.8	7.8	31.2	39.0	15.1	36.5	33.1	8.9	6.7	6.7	1.5	9.5	5.5	252.3	20.3	14.6	5.2	0.0	6.9	26.7	20.2	14.8	7.0	9.0	5.0	38.4	7.2	7.0	11.5	10.7	19.9	5.7	11.9	4.6	4.7	3.9	28.6	56.2	6.2	4.1	3.0	16.3	7.3	10.5	6.9	1.8	23.4	11.5	11.2	7.2	29.1	21.7	9.2	5.4	16.1	14.0	27.6	9.7	2.3	8.1	18.4	0.0	21.0	20.5	35.8	40.3	28.5	29.7	22.4	9.0	17.6	7.0	33.1
B3GAT2	GlcAT-S	ENSG00000112309	"Beta-1,3-glucuronyltransferase 2"	Q9NPZ5	6	70856679-70957060	"Enzymes, Metabolic proteins, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.2;retina: 18.5"	"Cell type enriched"	"Detected in many"	8	"Horizontal cells: 319.7"	"Group enriched"	"Detected in some"	20	"glioma: 4.7;testis cancer: 1.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	19	"SCLC-21H: 21.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012059	Uncertain					NA	NA					"HPA012059: AB_2061050"	"unprognostic (7.10e-3)"	"unprognostic (7.81e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.10e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.88e-2)"	"unprognostic (4.22e-2)"	"unprognostic (9.16e-4)"	"unprognostic (8.09e-2)"	"unprognostic (7.43e-3)"	"unprognostic (6.88e-7)"	"unprognostic (2.72e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.53e-2)"	"unprognostic (3.45e-3)"	1.2	0.4	15.9	0.5	18.3	0.4	1.1	13.4	14.7	1.2	6.2	0.8	0.7	0.7	0.1	1.0	0.7	0.2	0.8	26.1	14.1	0.6	0.9	1.0	0.5	19.8	18.4	11.5	0.8	1.5	0.0	0.8	0.1	23.8	0.9	0.0	18.5	1.2	0.0	0.8	1.5	1.0	0.1	22.3	0.7	1.1	1.0	15.3	0.6	1.0	0.0	0.0	1.1	1.4	30.2	0.3	0.0	0.6	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.2	1.1	0.1	0.3	0.2	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.1	0.5	0.0	0.2	0.0	0.5	0.7	0.1	0.1	0.1	0.2	0.2	0.0	0.2	21.8	0.2	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.1	0.2	0.1	0.3	0.5	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.3	0.0	0.1	0.2	0.2	0.3	0.1	0.1	0.1	0.3	0.0	15.9	18.3	13.4	14.7	26.1	14.1	19.8	18.4	11.5	23.8	22.3	15.3	30.2	4.5	0.0	2.2	23.8	9.7	25.5	11.9	19.4	0.0	16.5	7.2	1.7	1.0	11.5	9.0	16.5	22.9	6.0	10.0	13.0	0.0	5.6	9.7	3.6	5.4	7.7	0.0	3.2	2.5	3.9	3.9	6.9	2.0	6.0	0.0	2.5	9.3	10.7	7.5	319.7	8.2	4.9	16.2	10.0	27.0	6.0	19.9	5.1	14.2	0.0	11.6	15.2	30.9	32.2	0.2	9.1	15.5	13.5	3.7	16.9	23.3	1.4	3.4	22.5	13.1	5.8	5.8	18.7	36.7	1.2	19.9	7.1	15.1	2.1	6.2	12.2
BCORL1	"CXorf10, FLJ11362"	ENSG00000085185	"BCL6 corepressor like 1"	Q5H9F3	X	129981107-130058071	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Autism spectrum disorder, Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	6	"Syncytiotrophoblasts: 93.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 29.6;HAP1: 44.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031775, HPA031777, HPA068568"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA031775: AB_10602332, HPA031777: AB_10671578, HPA068568: AB_2686007"	"unprognostic (8.07e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.09e-2)"	"prognostic unfavorable (2.20e-5)"	"unprognostic (4.58e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.96e-3)"	"unprognostic (5.56e-3)"	"unprognostic (2.39e-1)"	"unprognostic (8.02e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (5.00e-4)"	"unprognostic (9.18e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.41e-2)"	3.5	3.1	2.3	2.7	2.2	5.6	2.2	4.0	2.6	3.5	0.4	2.6	2.6	4.5	2.2	2.6	4.3	2.0	2.8	2.3	4.4	2.6	2.0	2.9	1.7	2.8	2.1	1.4	5.6	4.6	5.9	2.6	11.4	2.3	3.3	2.1	2.0	3.4	3.8	3.3	2.9	2.9	4.4	1.3	2.8	2.2	6.6	1.9	2.3	4.5	3.3	1.7	2.7	2.6	1.9	3.4	8.0	18.7	29.6	10.6	8.0	5.3	4.5	5.2	5.7	6.5	9.6	2.2	1.5	9.9	8.8	5.5	2.0	44.2	1.8	5.2	3.4	6.7	16.2	3.9	3.1	5.2	3.8	4.8	4.9	3.6	11.0	0.6	8.3	6.8	5.2	7.7	16.4	3.6	1.9	6.0	11.3	5.2	2.6	5.9	12.6	7.5	2.2	3.0	0.4	3.2	10.9	2.3	0.7	3.0	9.4	6.7	5.9	5.9	4.5	6.0	5.7	4.5	5.1	10.1	2.5	2.9	7.8	2.2	0.0	0.3	0.6	0.2	0.0	0.2	0.2	0.2	0.1	0.3	0.2	0.1	0.1	0.7	0.2	0.1	0.1	0.0	0.2	2.3	2.2	4.0	2.6	2.3	4.4	2.8	2.1	1.4	2.3	1.3	1.9	1.9	5.4	0.0	2.8	6.8	2.9	11.9	2.8	2.2	10.8	1.7	12.5	7.5	7.1	4.3	1.9	7.3	0.0	14.1	6.1	3.7	0.0	3.0	0.5	3.7	7.0	7.9	12.0	2.5	4.6	1.1	4.8	6.9	2.6	4.7	7.0	4.3	4.6	2.8	3.2	8.4	4.4	2.4	2.0	2.2	5.9	1.2	4.7	2.7	7.2	5.6	3.0	2.3	4.1	4.5	8.5	2.6	1.9	3.8	3.2	3.8	4.2	2.3	2.9	1.3	6.6	8.0	6.1	3.4	6.9	9.2	11.5	93.4	4.9	0.9	3.6	2.8
BEGAIN	KIAA1446	ENSG00000183092	"Brain enriched guanylate kinase associated"	Q9BUH8	14	100537147-100587413	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.4;pancreas: 24.0;pituitary gland: 19.8"	"Cell type enriched"	"Detected in many"	7	"Horizontal cells: 143.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 3.4"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.4"	"Group enriched"	"Detected in some"	7	"HeLa: 56.6;SH-SY5Y: 129.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002899			Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA002899: AB_1078277"	"unprognostic (2.98e-4)"	"unprognostic (2.75e-3)"	"unprognostic (2.66e-2)"	"unprognostic (2.66e-4)"	"unprognostic (2.77e-3)"	"unprognostic (1.93e-2)"	"unprognostic (5.16e-2)"	"unprognostic (6.35e-2)"	"unprognostic (3.83e-1)"	"unprognostic (4.33e-2)"	"unprognostic (4.15e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.01e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.60e-1)"	1.2	3.2	14.4	0.4	14.4	4.0	1.7	13.6	27.4	2.8	0.0	1.1	2.6	2.5	0.8	1.0	6.0	1.2	1.9	20.9	4.7	1.0	0.7	1.4	0.6	6.5	2.6	15.4	4.8	24.0	4.6	19.8	1.6	6.3	4.1	0.2	2.2	1.5	1.3	0.7	1.1	2.7	0.8	0.4	5.8	1.2	2.8	2.4	1.0	1.0	0.1	0.5	1.5	1.3	11.4	0.8	3.3	1.8	11.1	0.0	0.0	0.3	0.3	0.0	0.5	0.1	0.0	1.1	0.3	0.5	0.5	2.5	0.4	0.5	0.0	0.0	0.0	1.1	5.1	56.6	0.0	0.1	0.2	0.3	0.3	0.2	0.9	1.2	0.0	0.1	0.7	0.6	0.1	0.0	4.4	0.4	1.6	1.3	0.3	1.9	0.1	0.3	7.0	0.0	0.2	2.9	129.7	3.0	0.1	3.0	0.0	0.9	13.7	0.0	0.4	3.8	0.1	0.0	0.0	0.0	0.2	9.2	2.5	0.3	0.8	0.1	3.4	0.0	0.7	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.4	0.0	0.1	14.4	14.4	13.6	27.4	20.9	4.7	6.5	2.6	15.4	6.3	0.4	2.4	11.4	0.8	0.0	0.6	18.6	0.3	2.4	1.8	0.3	0.0	3.7	0.5	1.1	2.3	0.0	0.7	0.0	0.0	0.1	0.2	0.3	0.0	1.4	0.4	0.1	0.1	0.6	0.0	0.0	18.4	8.0	0.2	1.5	0.0	0.1	9.5	0.1	1.4	0.0	0.3	143.0	10.9	0.0	0.0	0.0	0.8	0.8	1.8	0.3	1.8	4.7	1.1	0.8	0.0	15.6	0.8	2.9	1.1	6.8	0.3	1.6	2.7	0.1	0.1	2.3	0.0	1.7	0.7	0.9	1.5	0.3	2.0	0.1	0.3	0.4	0.4	0.4
BMERB1	"C16orf45, FLJ32618"	ENSG00000166780	"BMERB domain containing 1"	Q96MC5	16	15434475-15625028	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 135.6"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 57.0"	"Cancer enhanced"	"Detected in all"		"glioma: 30.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 8.7"	"Lineage enriched"	"Detected in many"	4	"T-cells: 8.7"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 101.8;U-2197: 81.3;U-87 MG: 124.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041114, HPA063757"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA041114: AB_10794542, HPA063757: "	"unprognostic (1.02e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.67e-2)"	"unprognostic (6.96e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (1.53e-4)"	"unprognostic (3.23e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.64e-2)"	"unprognostic (5.28e-2)"	"prognostic favorable (1.75e-4)"	"unprognostic (3.79e-3)"	"unprognostic (8.31e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.58e-1)"	29.7	15.6	94.4	10.6	104.0	1.1	21.7	72.0	115.5	46.0	53.5	36.4	8.4	40.9	19.9	21.6	38.8	24.1	47.4	112.3	90.1	22.5	22.0	13.5	6.5	124.8	91.2	93.0	41.3	18.8	3.9	41.1	1.4	128.3	32.7	9.4	41.0	12.7	27.9	87.6	11.8	19.2	35.9	68.4	9.3	21.8	40.6	88.0	4.0	13.6	41.7	4.0	44.7	25.5	135.6	1.4	31.5	12.8	1.5	56.7	50.7	0.3	18.1	62.6	15.5	8.4	0.0	0.9	0.1	4.0	101.8	37.5	0.2	4.1	5.3	7.9	0.4	0.7	6.7	11.9	1.5	19.4	0.1	13.6	24.5	5.2	33.8	0.5	25.8	25.2	14.5	0.4	0.5	24.2	21.6	5.1	0.9	17.2	0.4	10.7	1.0	16.3	0.1	8.8	4.6	26.2	27.6	0.9	8.3	5.5	2.1	0.4	0.4	8.9	34.2	17.6	81.3	9.4	5.7	12.5	0.2	124.3	0.2	7.1	0.1	0.1	0.1	8.7	0.0	1.7	2.1	2.0	5.2	0.5	1.3	1.5	2.8	0.6	0.2	0.1	0.2	2.6	1.1	94.4	104.0	72.0	115.5	112.3	90.1	124.8	91.2	93.0	128.3	68.4	88.0	135.6	7.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0
BMPR1B	"ALK6, CDw293"	ENSG00000138696	"Bone morphogenetic protein receptor type 1B"	O00238	4	94757955-95158448	"CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Chondrogenesis	"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.0;cervix: 24.9;prostate: 22.6"	"Cell type enriched"	"Detected in many"	7	"Astrocytes: 480.6"	"Cancer enhanced"	"Detected in many"		"breast cancer: 32.4;prostate cancer: 24.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 22.0;MCF7: 11.1;SH-SY5Y: 18.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.25e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.40e-3)"	"prognostic favorable (2.84e-4)"	"unprognostic (1.57e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.62e-3)"	"unprognostic (7.89e-4)"	"unprognostic (6.22e-2)"	"unprognostic (3.81e-3)"	"unprognostic (2.63e-2)"	0.6	4.6	16.6	0.3	14.0	0.1	1.0	15.1	15.1	24.9	2.8	0.8	0.1	4.4	2.4	0.2	12.6	2.7	0.7	13.4	22.0	7.8	0.8	1.7	0.0	20.2	17.5	10.2	6.2	1.1	0.1	1.9	0.7	16.8	22.6	0.2	8.2	1.0	14.3	3.0	0.8	0.1	0.6	14.8	0.9	2.4	3.7	15.1	6.5	0.5	1.1	0.0	0.2	0.5	12.9	0.0	22.0	5.6	0.0	2.3	4.8	0.2	0.1	0.0	0.1	0.5	0.0	0.1	0.0	0.2	1.0	0.0	1.3	3.6	8.4	0.1	0.0	4.9	0.0	1.4	0.0	0.6	0.5	0.1	2.7	9.0	2.8	6.2	0.4	0.1	0.0	0.0	0.0	7.1	11.1	0.6	0.1	2.1	0.1	3.2	0.2	3.4	0.1	4.3	0.1	0.2	18.8	0.3	3.2	3.2	0.8	1.7	0.0	0.0	4.0	3.8	0.2	4.3	0.0	0.0	0.0	1.5	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.0	16.6	14.0	15.1	15.1	13.4	22.0	20.2	17.5	10.2	16.8	14.8	15.1	12.9	0.0	6.4	0.0	480.6	0.0	2.7	1.3	13.1	1.2	0.4	3.8	1.0	3.4	2.8	33.4	60.7	0.0	0.0	0.0	0.0	1.9	3.0	1.4	28.5	1.4	1.1	18.4	0.0	51.0	0.4	0.3	1.5	0.0	20.8	0.0	38.6	2.9	0.0	0.1	0.0	2.5	0.0	8.2	0.0	1.2	1.4	3.1	0.4	28.4	22.5	0.0	38.5	0.0	10.1	2.8	0.7	0.0	3.8	0.0	28.5	0.0	0.2	15.7	1.6	0.0	1.7	2.9	1.2	10.6	0.4	2.3	0.0	0.5	4.4	0.0	1.6
BPIFA1	"bA49G10.5, LUNX, PLUNC, SPLUNC1"	ENSG00000198183	"BPI fold containing family A member 1"	Q9NP55	20	33235995-33243311	"Plasma proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix: 6.2;lung: 18.5;pituitary gland: 12.2"	"Cell type enriched"	"Detected in some"	6	"Club cells: 1205.8"	"Cancer enriched"	"Detected in many"	27	"lung cancer: 262.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	10	"cerebellum: 2.0"	"Not detected"	"Not detected"			CAB025669	Supported				"Secreted in other tissues"	NA	NA		1200000			"CAB025669: "						"unprognostic (1.06e-1)"		"unprognostic (1.53e-1)"						"unprognostic (3.65e-1)"		"unprognostic (1.80e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.8	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	1.1	0.0	0.0	0.0	0.0	129.5	0.0	0.0	0.0	0.0	0.0	0.0	1205.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	126.1	0.0	0.0	3.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	198.0	0.0	0.0	0.0	80.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1
BPIFB1	"bA49G10.6, C20orf114, dJ1187J4.1, LPLUNC1, MGC14597, VEMSGP"	ENSG00000125999	"BPI fold containing family B member 1"	Q8TDL5	20	33273480-33309871	"Plasma proteins, Predicted secreted proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 571.7;salivary gland: 273.3;stomach 1: 516.9"	"Cell type enriched"	"Detected in many"	5	"Club cells: 5748.4"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 75.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.7;OE19: 3.8;RT4: 2.2;SK-BR-3: 4.3"	"Region enriched"	"Detected in single"	6	"olfactory bulb: 4.8"	"Low region specificity"	"Detected in many"			HPA024256	Enhanced				"Secreted in other tissues"	NA	NA		2700000			"HPA024256: AB_1845664"	"unprognostic (2.42e-1)"	"unprognostic (5.41e-2)"		"unprognostic (3.67e-2)"	"unprognostic (3.09e-1)"	"unprognostic (6.72e-2)"	"unprognostic (3.43e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.82e-1)"	"unprognostic (4.00e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.36e-7)"	"unprognostic (3.30e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.55e-2)"	0.1	0.1	0.1	0.0	0.3	0.0	0.9	0.0	0.2	571.7	0.0	0.2	25.9	0.0	0.0	47.5	0.1	3.5	0.0	0.4	0.0	0.0	0.1	113.5	0.2	0.2	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.1	1.2	0.0	0.0	273.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	516.9	3.5	0.0	0.2	0.0	0.0	1.2	8.3	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	3.8	0.0	0.4	0.0	0.1	0.0	2.2	0.0	0.0	0.0	4.3	0.0	0.0	0.3	0.0	0.3	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.2	0.4	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.6	22.7	0.0	0.0	1.3	1.4	614.0	0.0	0.0	2.0	1.3	0.4	2.8	5748.4	0.0	0.0	0.2	0.0	0.0	0.0	0.3	63.6	0.4	0.1	1.1	0.0	0.0	0.2	0.2	0.1	3.0	31.1	0.6	3.8	0.0	0.4	0.1	0.2	0.0	0.1	0.0	1021.3	0.0	1.9	82.9	0.3	1.5	1.8	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.7	0.0	2.0	0.0	0.0	1027.4	0.0	0.0	0.4	305.5	5.8	0.8	11.6	0.4	0.1	1.0	0.0	0.0	95.9
BTBD11	"ABTB2B, FLJ33957"	ENSG00000151136	"BTB domain containing 11"	A6QL63	12	107318421-107659642	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.5;parathyroid gland: 101.1"	"Cell type enriched"	"Detected in many"	9	"Inhibitory neurons: 266.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 3.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 25.0;Hep G2: 13.6;MOLT-4: 17.9;PC-3: 12.3;RT4: 11.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055898, HPA061334"			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA055898: AB_2682964, HPA061334: "	"unprognostic (3.40e-2)"	"unprognostic (4.06e-1)"	"unprognostic (2.37e-1)"	"unprognostic (7.85e-2)"	"unprognostic (8.78e-3)"	"unprognostic (4.82e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.92e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.92e-8)"	"unprognostic (2.66e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.33e-2)"	"unprognostic (9.07e-3)"	0.4	0.7	8.3	2.8	4.4	4.5	2.9	5.5	11.1	8.2	5.0	0.6	0.7	0.9	1.2	29.6	0.3	0.9	0.6	2.9	12.6	4.2	1.1	0.6	2.9	20.7	14.7	3.2	0.1	0.8	101.1	3.5	2.0	25.4	3.4	0.6	1.9	5.7	1.3	0.5	10.6	1.4	0.5	9.4	1.4	0.6	0.7	25.6	17.3	19.0	0.2	3.3	1.7	11.2	33.5	0.1	25.0	5.0	0.0	1.8	0.5	0.0	0.6	0.0	0.2	0.0	0.3	4.0	0.0	6.1	0.1	2.4	9.2	5.1	9.5	0.3	0.0	1.6	0.0	0.1	13.6	0.0	0.2	0.1	2.0	4.0	0.0	2.9	3.8	0.7	10.5	0.0	0.0	0.2	0.9	17.9	2.0	5.3	0.5	12.3	0.0	8.1	0.0	0.0	11.4	6.8	2.5	0.0	0.2	0.0	0.4	0.5	0.7	1.0	0.1	0.2	0.0	2.0	0.1	0.0	0.1	6.4	2.6	0.0	0.9	0.4	0.5	1.0	0.1	3.5	0.0	1.1	0.6	0.7	0.1	1.4	1.3	1.3	0.1	0.3	0.1	0.6	0.6	8.3	4.4	5.5	11.1	2.9	12.6	20.7	14.7	3.2	25.4	9.4	25.6	33.5	0.3	0.0	0.0	17.3	0.3	5.2	3.7	2.5	6.8	3.5	0.7	3.2	2.9	0.0	3.0	0.0	0.0	0.2	1.2	0.0	0.0	0.8	0.0	1.2	1.9	0.3	3.5	1.3	8.7	0.0	0.0	1.5	0.0	2.3	0.0	0.0	0.0	0.9	0.3	1.7	266.4	0.4	0.0	0.6	4.3	0.0	0.6	1.7	0.0	1.0	1.8	0.2	3.1	12.5	1.9	0.3	0.0	4.1	0.7	2.8	0.2	0.9	0.3	0.4	0.0	0.0	1.1	0.1	0.2	27.5	7.7	0.4	4.5	3.4	0.4	3.4
BTNL9	"BTN8, FLJ32535"	ENSG00000165810	"Butyrophilin like 9"	Q6UXG8	5	181040225-181061521	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 203.4;breast: 201.7"	"Cell type enriched"	"Detected in many"	6	"Adipocytes: 900.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"OE19: 9.9;U-698: 37.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043429			Approved	"Nuclear membrane,Vesicles"		NA	NA			"Nuclear membrane"	Vesicles	"HPA043429: AB_10961264"	"unprognostic (2.69e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.76e-2)"	"prognostic unfavorable (7.51e-4)"	"unprognostic (2.07e-1)"	"unprognostic (1.43e-1)"	"prognostic favorable (1.55e-9)"	"unprognostic (2.15e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.71e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.56e-2)"	203.4	13.4	20.1	3.0	15.1	1.0	201.7	16.4	20.7	9.7	12.5	10.3	1.9	11.1	5.4	6.0	20.2	9.4	68.9	21.2	15.1	22.1	7.9	103.2	7.2	21.4	16.8	13.0	5.4	12.0	6.0	4.8	10.6	23.6	8.4	3.7	1.2	7.0	2.7	47.1	11.5	10.9	4.0	13.9	57.8	12.9	4.5	32.8	9.9	29.8	20.9	13.9	10.6	10.4	20.6	0.0	0.2	0.1	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	3.4	0.1	0.2	1.4	0.0	0.0	0.2	0.7	0.1	0.0	0.2	3.7	1.5	0.4	0.2	0.0	0.7	4.2	0.0	0.1	0.0	0.0	0.0	0.0	3.6	0.9	0.3	0.0	0.1	0.1	0.2	0.1	9.9	2.3	0.0	0.1	0.1	0.1	0.6	0.2	0.1	0.2	0.1	0.0	0.2	0.6	0.0	0.0	0.1	5.5	0.1	0.0	0.3	0.1	37.1	0.1	0.1	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	20.1	15.1	16.4	20.7	21.2	15.1	21.4	16.8	13.0	23.6	13.9	32.8	20.6	900.4	0.0	3.8	1.3	9.8	2.3	0.6	0.1	0.6	0.6	2.4	3.6	40.6	0.0	0.8	0.0	0.0	0.1	3.9	1.0	3.9	0.0	0.7	1.1	0.5	127.0	4.2	0.4	8.4	0.2	0.1	10.2	0.5	3.4	1.3	7.0	144.9	0.6	0.1	0.0	1.2	3.5	0.0	8.3	1.1	1.4	2.1	1.7	3.6	54.4	0.1	0.3	0.0	1.0	0.6	0.1	1.2	0.4	1.2	0.4	0.0	0.1	2.4	0.3	13.1	8.4	37.5	4.0	9.8	5.5	2.3	0.1	2.2	88.9	1.5	0.5
BZW1	"BZAP45, KIAA0005"	ENSG00000082153	"Basic leucine zipper and W2 domains 1"	Q7L1Q6	2	200810594-200827338	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Late spermatids: 3845.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047288, HPA053272"	Uncertain		Approved	Vesicles		NA	NA		34000	Vesicles		"HPA047288: , HPA053272: "	"unprognostic (2.45e-2)"	"prognostic unfavorable (4.28e-4)"	"unprognostic (2.08e-3)"	"unprognostic (1.56e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.31e-3)"	"unprognostic (3.98e-3)"	"prognostic unfavorable (5.10e-4)"	"unprognostic (4.49e-3)"	"unprognostic (7.93e-3)"	"unprognostic (1.08e-3)"	"unprognostic (8.97e-3)"	"unprognostic (4.38e-2)"	"unprognostic (3.04e-1)"	"unprognostic (7.61e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.24e-1)"	131.8	130.4	32.1	98.4	35.2	221.6	89.6	39.4	40.8	66.1	51.9	99.3	65.2	67.2	58.9	121.9	53.8	93.9	53.0	35.0	51.3	89.3	228.9	74.2	98.7	38.4	38.6	28.8	62.8	63.1	73.0	31.0	106.1	37.5	100.5	91.5	46.2	61.7	62.3	102.5	48.3	72.0	80.8	42.8	63.3	69.7	172.5	39.1	124.2	75.0	75.9	110.3	166.2	62.0	47.0	296.6	230.1	309.4	187.1	305.2	353.3	221.6	425.2	501.8	281.2	244.5	360.7	195.3	142.5	144.7	339.7	186.1	159.8	284.9	512.6	521.8	154.6	151.3	370.8	453.9	280.1	244.5	420.9	199.6	205.3	233.5	373.2	398.9	244.6	495.4	132.3	328.5	234.0	379.3	236.6	387.9	201.3	392.4	120.1	575.4	293.1	333.4	148.6	256.1	435.2	188.9	218.7	325.5	120.9	226.1	255.5	126.6	216.7	555.0	416.8	242.9	255.2	276.6	286.1	428.6	377.8	341.2	209.3	312.1	236.7	140.7	168.5	177.9	173.4	207.2	102.0	126.0	167.5	162.6	87.1	112.4	156.7	117.0	218.5	195.1	75.5	171.5	294.6	32.1	35.2	39.4	40.8	35.0	51.3	38.4	38.6	28.8	37.5	42.8	39.1	47.0	207.3	86.6	108.1	31.3	148.5	198.5	318.5	310.7	125.7	37.1	159.0	89.8	18.1	82.9	290.3	90.1	18.8	115.4	263.2	127.5	138.9	250.2	927.0	108.3	145.3	149.0	96.7	72.8	28.7	233.1	164.3	181.2	72.4	150.0	196.9	72.7	99.2	262.4	114.1	58.9	32.1	113.3	183.1	88.6	194.0	3845.6	102.2	169.1	124.5	15.0	308.1	119.6	170.0	24.6	36.6	464.4	106.5	95.9	132.7	242.3	68.2	163.3	121.7	33.4	98.6	159.4	179.8	175.2	169.2	133.2	196.1	195.2	200.3	103.3	106.1	370.9
C12orf60	MGC47869	ENSG00000182993	"Chromosome 12 open reading frame 60"	Q5U649	12	14803666-14906586	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 14.8"	"Cell type enriched"	"Detected in many"	6	"Early spermatids: 452.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							HPA043911			Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA043911: AB_10963941"	"unprognostic (3.71e-2)"	"unprognostic (7.02e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.39e-2)"	"unprognostic (4.01e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.09e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.25e-3)"	"unprognostic (9.42e-2)"	"unprognostic (2.17e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.75e-2)"	0.8	4.7	1.1	0.5	1.3	0.8	0.8	1.3	1.5	0.6	1.8	0.5	0.1	0.4	1.4	0.4	1.4	0.8	3.1	1.0	1.1	2.6	6.0	1.0	1.8	1.3	1.3	1.0	0.5	1.0	1.1	0.7	0.7	1.4	0.9	0.4	6.5	0.8	0.5	1.3	0.5	0.5	0.2	1.4	3.3	0.9	14.8	1.3	0.8	1.3	0.8	1.0	0.5	0.4	1.7	1.8	1.9	1.9	5.5	2.0	1.4	1.7	1.3	0.7	1.3	1.6	0.8	1.9	1.5	1.5	0.4	2.0	2.0	2.1	4.3	1.8	3.6	2.2	1.2	0.5	1.3	1.7	1.8	0.6	0.7	2.6	1.3	2.9	1.8	2.6	2.5	2.0	0.3	1.9	0.6	0.7	1.1	6.6	2.7	1.1	2.2	3.3	2.3	2.5	0.5	1.4	1.7	2.8	0.7	2.6	5.6	2.2	0.8	2.0	1.2	1.3	0.9	1.5	0.9	0.7	5.1	1.5	1.7	1.7	0.1	0.5	1.7	0.9	0.6	1.5	1.6	0.7	1.3	0.5	1.0	1.8	1.5	0.1	1.6	0.3	0.4	1.6	0.4	1.1	1.3	1.3	1.5	1.0	1.1	1.3	1.3	1.0	1.4	1.4	1.3	1.7	0.9	0.0	0.0	6.8	3.3	0.3	0.5	3.9	0.0	4.0	1.2	1.7	3.6	0.0	3.0	5.5	20.9	1.8	0.9	0.3	7.9	1.8	452.6	3.6	0.6	1.8	0.0	11.6	3.1	1.1	1.6	2.2	0.0	1.1	0.0	1.0	0.0	1.1	1.3	1.7	3.7	0.4	8.2	0.9	0.8	72.6	3.1	1.0	0.0	1.0	2.8	2.8	5.2	10.6	10.8	0.8	0.2	2.6	1.2	0.5	0.3	3.4	8.0	17.0	19.7	2.0	1.6	31.9	8.9	0.2	1.0	0.3	2.8	0.5	0.5	0.3
C12orf71	LOC728858	ENSG00000214700	"Chromosome 12 open reading frame 71"	A8MTZ7	12	27081057-27082578	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 1.4;testis: 3.3"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 19.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	10	"NK-cell: 1.0"	"Lineage enriched"	"Detected in single"	10	"NK-cells: 1.0"	"Cell line enhanced"	"Detected in single"		"HDLM-2: 1.4"	"Not detected"	"Not detected"							"HPA038359, HPA058728"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA038359: , HPA058728: AB_2683800"	"unprognostic (1.14e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.78e-3)"	"unprognostic (9.90e-2)"	"unprognostic (3.13e-1)"	"unprognostic (7.12e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.73e-3)"	"unprognostic (1.96e-1)"	"unprognostic (4.15e-8)"	"unprognostic (4.85e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.01e-2)"	0.1	0.1	0.3	0.1	0.3	1.4	0.1	0.0	0.3	0.2	0.1	0.1	0.0	0.1	0.0	0.2	0.2	0.0	0.1	0.3	0.1	0.0	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.2	0.0	0.2	0.7	0.3	0.0	0.0	0.2	0.1	3.3	0.4	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.3	0.3	0.1	0.2	0.1	0.1	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.9	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2
C14orf39	SIX6OS1	ENSG00000179008	"Chromosome 14 open reading frame 39"	Q8N1H7	14	60396469-60515543	"Plasma proteins, Predicted intracellular proteins"	"DNA recombination, Meiosis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pituitary gland: 4.9;salivary gland: 4.7;testis: 10.9"	"Cell type enriched"	"Detected in some"	4	"Spermatocytes: 92.5"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Group enriched"	"Detected in some"	11	"hypothalamus: 2.3;thalamus: 1.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 6.2;JURKAT: 28.3;MOLT-4: 23.9;RH-30: 6.2;U-2 OS: 12.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA059518	Uncertain		Approved	Nucleoplasm,Nucleoli		Yes	No			"Nucleoplasm, Nucleoli"		"HPA059518: AB_2684049"	"unprognostic (6.17e-2)"	"unprognostic (1.73e-3)"		"unprognostic (3.00e-6)"	"unprognostic (2.78e-1)"	"unprognostic (6.97e-2)"		"unprognostic (7.55e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.78e-1)"		"unprognostic (7.46e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.09e-1)"	0.2	1.9	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.7	0.4	0.2	0.5	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.2	0.0	0.5	4.9	0.0	0.1	1.1	0.0	2.7	4.7	0.1	3.0	0.0	0.1	0.1	0.0	0.0	0.3	10.9	1.7	0.1	0.2	3.7	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.8	6.2	0.0	0.0	0.0	0.0	0.3	4.5	0.0	0.7	0.0	0.1	0.0	28.3	0.0	0.0	2.0	0.0	23.9	0.3	3.0	0.0	1.4	0.0	6.2	0.0	0.4	1.7	0.1	2.6	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	12.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.3	0.1	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.6	0.5	0.0	0.9	0.0	0.1	0.7	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.2	0.0	0.0	2.8	0.0	0.0	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	3.3	0.9	0.0	0.0	0.0	0.0	6.8	0.3	0.0	0.0	1.0	0.0	12.3	0.0	1.0	0.7	0.0	0.0	0.7	0.0	0.8	0.0	0.0	1.2	1.1	0.0	10.0	0.2	92.5	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2
C17orf107		ENSG00000205710	"Chromosome 17 open reading frame 107"	Q6ZR85	17	4899418-4902934	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 27.2"	"Cell type enriched"	"Detected in many"	5	"Late spermatids: 288.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	7	"neutrophil: 2.9"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 2.9"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 2.6;HMC-1: 3.2;hTCEpi: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA069713	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA069713: AB_2686181"	"prognostic favorable (5.06e-5)"	"unprognostic (1.63e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.13e-3)"	"unprognostic (9.61e-2)"	"unprognostic (5.03e-2)"	"unprognostic (4.15e-1)"	"unprognostic (2.05e-1)"	"prognostic favorable (8.61e-4)"	"unprognostic (1.17e-1)"	"prognostic favorable (2.68e-4)"	"unprognostic (9.29e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.12e-1)"	1.4	1.8	0.8	1.1	1.0	2.1	2.0	7.4	3.7	2.0	0.0	0.9	1.0	1.5	3.4	1.1	1.8	1.5	8.8	1.7	2.5	2.1	5.7	2.0	0.5	1.3	0.6	1.1	4.2	5.0	3.6	27.2	0.6	1.5	3.4	0.4	1.7	13.3	2.0	0.5	3.3	1.0	0.4	0.0	2.0	3.3	4.6	1.2	0.3	1.3	0.0	0.6	1.0	1.6	1.5	0.3	0.4	0.5	0.1	1.0	0.8	0.7	1.9	0.2	0.1	0.3	0.3	0.3	0.2	0.3	2.6	0.0	0.7	0.0	0.2	0.1	0.0	0.4	0.8	0.4	0.4	1.4	0.0	3.2	0.8	3.3	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.9	0.4	0.1	0.1	1.4	0.1	0.1	0.0	0.2	0.2	1.0	0.1	0.2	0.3	0.5	0.2	0.1	0.3	0.2	0.2	0.2	0.3	0.0	0.2	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.3	2.9	0.0	0.0	0.0	0.0	0.1	0.8	1.0	7.4	3.7	1.7	2.5	1.3	0.6	1.1	1.5	0.0	1.2	1.5	1.7	0.0	1.3	1.6	9.7	1.8	2.8	0.4	6.8	1.2	3.5	1.7	14.4	0.0	1.1	0.0	0.0	0.4	4.5	0.1	1.9	0.4	53.3	0.8	0.4	1.5	0.0	0.0	0.7	1.3	2.3	2.3	2.0	1.2	11.4	0.9	0.4	3.1	1.0	5.0	0.8	1.5	2.0	1.9	10.7	288.4	1.5	6.3	1.8	0.0	0.1	0.0	0.0	0.0	0.2	0.7	0.0	1.2	8.1	2.3	0.2	1.9	0.6	0.8	0.0	0.5	2.0	1.5	1.2	1.2	1.3	5.2	4.0	1.1	0.2	1.1
C19orf18	MGC41906	ENSG00000177025	"Chromosome 19 open reading frame 18"	Q8NEA5	19	57958437-57974534	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 12.5"	"Cell type enriched"	"Detected in many"	5	"Early spermatids: 131.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.0;HEK 293: 3.0;RT4: 2.0;U-266/84: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA014527, HPA079195"	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA014527: AB_1845612, HPA079195: "	"unprognostic (5.38e-2)"	"unprognostic (6.36e-3)"	"unprognostic (3.70e-2)"	"prognostic favorable (5.07e-4)"	"unprognostic (4.85e-2)"	"unprognostic (9.50e-2)"	"unprognostic (2.75e-1)"	"unprognostic (5.40e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.08e-5)"	"unprognostic (1.11e-2)"	"unprognostic (8.75e-5)"	"unprognostic (1.53e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.05e-3)"	1.2	1.9	4.9	0.4	5.1	0.6	2.7	4.5	6.9	1.3	7.3	1.6	0.8	1.3	4.0	0.6	2.3	1.2	4.0	4.5	7.1	1.5	1.8	1.0	0.6	6.5	4.9	3.7	1.8	1.1	0.9	3.9	0.8	5.8	3.4	0.8	5.2	1.2	1.3	3.6	1.3	1.2	0.9	5.2	1.3	1.1	12.5	4.8	0.6	1.7	0.6	0.7	1.6	0.9	5.0	0.1	0.0	0.8	2.0	0.4	0.6	0.6	1.0	0.2	0.2	0.6	0.0	0.2	0.2	0.4	0.2	0.2	0.0	0.0	0.0	0.6	0.0	3.0	0.1	0.0	0.7	0.7	0.0	0.5	0.7	1.2	0.0	0.2	0.7	0.1	0.4	0.1	0.0	1.4	0.0	0.4	0.0	0.0	0.0	0.2	0.6	0.0	0.5	0.5	2.0	0.8	0.2	0.4	0.0	0.3	0.6	0.7	0.6	0.4	0.1	0.2	0.2	0.2	0.4	1.8	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.2	0.1	0.3	0.2	0.1	0.2	0.1	0.1	0.2	0.2	0.0	0.0	4.9	5.1	4.5	6.9	4.5	7.1	6.5	4.9	3.7	5.8	5.2	4.8	5.0	1.9	3.2	2.2	17.9	0.8	0.4	0.3	0.6	0.0	0.9	2.2	1.8	3.6	1.5	2.1	0.0	0.0	0.5	0.6	0.8	0.0	2.0	131.6	5.7	0.9	2.1	0.0	2.7	2.5	0.2	0.6	0.7	0.0	1.4	0.0	0.7	4.6	1.9	0.4	0.0	3.2	1.9	0.0	0.8	1.4	24.2	2.1	0.4	1.8	1.0	0.6	1.5	0.0	8.5	8.0	1.0	0.3	0.7	0.2	0.6	0.5	0.3	4.0	3.4	6.6	0.9	1.2	5.3	2.2	0.2	0.6	0.3	0.6	1.2	1.1	0.5
C1orf105		ENSG00000180999	"Chromosome 1 open reading frame 105"	O95561	1	172420685-172468831	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 15.5;testis: 26.6"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 193.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"BEWO: 27.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.50e-2)"	"unprognostic (2.48e-4)"	"unprognostic (7.11e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.07e-4)"	"unprognostic (1.27e-3)"	"unprognostic (3.02e-2)"	"unprognostic (1.47e-2)"		"unprognostic (8.22e-2)"	"unprognostic (1.92e-1)"		"unprognostic (1.18e-1)"	"unprognostic (7.65e-4)"	"unprognostic (3.85e-1)"		"unprognostic (1.94e-1)"	0.0	0.2	0.5	0.0	0.8	2.1	0.0	1.4	0.6	0.0	0.1	0.0	0.1	0.0	5.5	0.5	0.0	0.1	15.5	0.5	0.6	0.2	0.2	0.0	0.1	0.6	0.4	0.4	0.0	0.5	0.0	0.0	0.6	0.7	1.3	0.0	0.2	1.2	0.1	1.4	0.6	0.6	0.0	0.2	0.1	0.1	26.6	0.6	0.4	0.2	3.3	0.0	0.0	0.0	1.5	0.0	0.3	0.3	0.1	0.0	0.0	27.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.4	0.3	0.1	0.0	0.0	0.0	0.1	0.4	0.1	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	3.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.8	1.4	0.6	0.5	0.6	0.6	0.4	0.4	0.7	0.2	0.6	1.5	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	193.9	0.0	0.0	0.3	0.0	0.0	0.5	0.6	13.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.8	0.0	0.0	0.0	0.0	24.6	1.8	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.9	0.0	0.0	1.2	0.0	0.0	3.8	1.9	0.0	0.0	0.0	0.5	2.7	45.6	3.2	0.0	0.0	1.8	0.0	0.1	0.1	0.0
C1orf127	FLJ37118	ENSG00000175262	"Chromosome 1 open reading frame 127"		1	10946471-10982037	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"pancreas: 4.4;skeletal muscle: 16.7"	"Cell type enriched"	"Detected in some"	9	"Enteroendocrine cells: 20.4"	"Cancer enriched"	"Detected in single"	9	"pancreatic cancer: 2.8"	"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in single"		"myeloid DC: 1.3"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.3"	"Cell line enriched"	"Detected in single"	4	"THP-1: 2.6"	"Not detected"	"Not detected"							HPA027654	Uncertain		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles, Cytosol"		"HPA027654: AB_10611814"	"unprognostic (1.82e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.03e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.32e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.82e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.03e-1)"	0.2	0.6	0.3	0.1	0.3	0.1	0.1	1.2	0.7	0.1	0.3	0.3	0.7	0.0	0.1	0.6	0.0	0.3	0.6	0.2	0.3	0.0	0.2	0.4	0.6	0.2	0.5	0.2	0.0	4.4	0.1	0.2	0.2	0.3	0.1	0.6	0.0	0.2	0.0	16.7	0.0	0.4	0.0	0.2	0.6	1.9	0.5	0.6	0.1	0.2	3.8	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.1	0.0	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.3	1.2	0.7	0.2	0.3	0.2	0.5	0.2	0.3	0.2	0.6	0.3	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.3	0.8	0.0	0.8	0.6	0.1	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C1QTNF6	"CTRP6, ZACRP6"	ENSG00000133466	"C1q and TNF related 6"	Q9BXI9	22	37180166-37199385	"Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 32.0;placenta: 29.9"	"Cell type enriched"	"Detected in many"	11	"Extravillous trophoblasts: 398.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 114.2;RT4: 50.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002042	Enhanced		Approved	Nucleoplasm	"Secreted to blood"	No	No	354000000		Nucleoplasm		"HPA002042: AB_1078342"	"unprognostic (9.65e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.23e-3)"	"unprognostic (1.25e-3)"	"unprognostic (3.01e-2)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (9.60e-6)"	"unprognostic (6.96e-2)"	"unprognostic (5.11e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.61e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.52e-2)"	4.6	6.8	4.7	6.7	4.5	1.6	4.0	4.4	5.4	9.5	4.4	4.7	1.6	32.0	1.4	2.7	7.0	8.9	3.3	4.4	4.3	5.9	13.2	5.2	5.1	5.0	5.0	4.1	5.5	3.5	2.2	2.5	29.9	5.4	6.8	3.6	0.5	3.2	2.9	1.5	4.8	5.4	8.3	4.5	6.5	3.5	6.3	4.9	2.5	3.8	0.7	2.3	5.7	4.4	6.4	17.7	20.5	10.7	3.6	1.8	21.3	32.6	3.4	6.8	2.8	2.0	3.8	24.7	0.1	14.1	6.0	1.5	34.9	0.4	8.4	1.2	4.9	2.6	2.8	8.3	3.8	7.1	0.1	2.3	29.2	4.9	2.3	0.6	7.3	25.5	0.8	0.1	7.7	1.1	114.2	0.0	0.5	7.1	2.5	0.3	0.2	0.1	2.8	24.5	50.7	1.8	14.6	1.0	19.7	2.8	5.5	7.0	0.5	9.4	1.1	5.6	0.4	0.1	15.5	0.4	0.1	2.1	2.0	3.2	0.4	0.1	0.5	0.2	0.2	0.2	0.2	0.4	0.3	0.1	0.7	0.9	0.7	0.5	1.5	0.1	0.3	1.4	0.3	4.7	4.5	4.4	5.4	4.4	4.3	5.0	5.0	4.1	5.4	4.5	4.9	6.4	3.2	0.0	0.0	13.7	2.9	1.5	2.1	1.9	0.6	1.0	8.6	4.2	1.8	1.5	2.2	1.8	0.0	8.1	1.5	7.9	1.9	3.4	2.0	4.8	30.8	6.8	0.0	0.8	3.3	1.1	398.9	7.6	2.0	9.6	1.3	19.8	10.0	7.2	9.3	0.0	4.3	3.1	0.0	1.9	1.4	8.9	0.6	1.2	5.4	3.7	1.1	4.5	1.0	4.0	7.8	2.7	2.8	0.4	3.4	0.8	2.0	1.6	2.7	0.9	0.0	2.2	7.5	7.2	4.5	1.0	0.3	34.5	3.1	7.6	4.4	1.5
C2CD4A	"FAM148A, NLF1"	ENSG00000198535	"C2 calcium dependent domain containing 4A"	Q8NCU7	15	62066977-62070917	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pituitary gland: 13.6"	"Cell type enriched"	"Detected in many"	5	"Glandular and luminal cells: 107.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"OE19: 34.4;RPTEC TERT1: 29.9"									HPA078864			Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA078864: "	"unprognostic (3.85e-2)"	"unprognostic (6.68e-2)"	"unprognostic (5.00e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.38e-3)"	"unprognostic (5.49e-3)"	"unprognostic (3.85e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.21e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (4.72e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.35e-1)"	0.2	0.4	0.2	0.6	0.2	0.2	0.2	0.1	1.9	0.4	0.3	0.5	1.0	1.3	0.0	0.1	0.0	0.4	0.1	0.3	1.7	2.0	2.5	0.5	0.2	0.9	0.2	0.2	0.1	4.0	0.0	13.6	0.1	0.7	0.6	0.6	0.2	1.2	0.1	0.3	0.5	0.5	0.0	0.1	0.1	2.0	0.1	0.3	2.1	0.2	0.0	0.5	3.7	0.0	0.9	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	1.6	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.4	0.1	0.2	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.1	34.4	0.2	0.1	0.0	0.2	29.9	0.7	1.3	0.0	0.1	0.3	0.0	0.0	0.2	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.1	0.2	0.0	0.2	0.2	0.1	1.9	0.3	1.7	0.9	0.2	0.2	0.7	0.1	0.3	0.9	0.6	0.0	0.0	0.3	0.3	0.5	1.8	3.8	0.0	0.9	4.3	6.2	1.4	0.0	2.7	0.0	0.0	0.0	0.0	1.2	1.9	2.8	0.0	11.7	14.6	3.9	20.8	0.0	0.0	6.6	0.0	1.2	3.6	107.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	5.2	14.2	0.0	0.8	0.0	0.0	0.8	0.0	0.0	1.0	0.3	0.0	0.0	0.0	3.7	0.0	0.0	0.8	2.2	0.3	0.0	1.1	0.2	0.0	1.0	1.4	0.0	0.0	0.0	1.1	0.0	1.1	0.1	1.0	1.1
C2orf66	UNQ6411	ENSG00000187944	"Chromosome 2 open reading frame 66"		2	196804417-196809355	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"adrenal gland: 4.0;brain: 5.9;pituitary gland: 3.8"	"Cell type enriched"	"Detected in some"	7	"Early spermatids: 36.9"	"Cancer enhanced"	"Detected in single"		"glioma: 0.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 9.0;RT4: 2.2;TIME: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA020869	Uncertain		Uncertain	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA			Nucleoplasm	Cytosol	"HPA020869: AB_1851545"	"unprognostic (1.19e-1)"	"unprognostic (4.85e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.61e-2)"	"unprognostic (6.80e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.10e-3)"	"unprognostic (4.54e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.75e-5)"	"unprognostic (1.84e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.86e-2)"	2.8	4.0	2.1	0.2	1.8	0.1	0.5	1.4	2.2	0.0	1.5	0.2	0.0	0.1	0.4	0.2	0.6	0.3	0.4	2.0	5.9	0.2	0.1	0.3	0.0	2.2	2.4	1.8	0.3	0.5	0.1	3.8	0.0	2.4	0.3	0.1	1.9	0.1	0.1	0.0	1.2	0.3	0.0	1.7	0.1	0.2	1.5	2.7	0.1	0.1	0.0	0.1	0.3	0.2	2.3	0.0	0.1	0.2	0.8	0.2	0.2	0.0	0.3	0.2	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.2	0.4	9.0	0.3	0.1	0.0	0.1	0.8	0.2	1.2	0.2	0.0	0.1	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.4	2.2	0.3	0.0	0.0	0.0	0.2	0.3	0.0	0.1	2.1	0.1	0.1	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.8	1.4	2.2	2.0	5.9	2.2	2.4	1.8	2.4	1.7	2.7	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.9	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	4.9	0.3	0.1	0.0	0.0	0.0	0.0	0.0	2.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1
C3orf85	FLJ22763	ENSG00000241224	"Chromosome 3 open reading frame 85"	A0A1B0GTC6	3	109118252-109151401	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 71.1;kidney: 14.1;liver: 20.0"	"Cell type enriched"	"Detected in some"	9	"Proximal tubular cells: 169.0"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 1.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA		2900000						"unprognostic (9.10e-2)"				"unprognostic (9.48e-3)"						"unprognostic (3.80e-4)"	"unprognostic (1.15e-1)"	"unprognostic (6.70e-2)"			0.1	0.0	0.2	0.4	0.4	0.0	0.0	0.4	0.3	0.0	0.0	5.4	71.1	0.1	1.6	0.0	0.0	0.0	0.0	0.1	0.1	14.1	20.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	5.3	0.1	0.0	0.0	0.0	0.0	65.2	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.4	0.3	0.1	0.1	0.2	0.2	0.0	0.3	0.0	0.2	0.5	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	169.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0
C8orf34	"vest-1, VEST1"	ENSG00000165084	"Chromosome 8 open reading frame 34"	Q49A92	8	68330955-68819023	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 8.9;fallopian tube: 9.2;parathyroid gland: 7.4"	"Cell type enriched"	"Detected in some"	5	"Inhibitory neurons: 396.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 2.3;HEK 293: 2.3;LHCN-M2: 2.7;RH-30: 2.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044420, HPA053065"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus"		No	NA			"Nucleoplasm, Nucleoli"	"Golgi apparatus"	"HPA044420: AB_10963791, HPA053065: AB_2682030"	"unprognostic (1.75e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.30e-2)"	"unprognostic (5.59e-3)"	"unprognostic (3.07e-1)"	"unprognostic (2.85e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.55e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.80e-4)"	"unprognostic (5.21e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.84e-4)"	"unprognostic (1.33e-1)"	2.7	0.3	8.9	0.2	6.3	0.5	0.7	4.4	4.8	2.1	2.0	0.2	0.2	0.6	0.6	1.0	9.2	0.6	0.6	7.1	7.9	0.3	0.2	2.5	0.2	6.4	6.6	2.8	0.4	1.1	7.4	1.7	0.3	5.5	2.1	0.3	1.0	0.6	1.0	0.3	0.9	0.2	0.1	5.8	0.2	0.8	0.7	4.4	0.8	0.4	0.9	0.2	0.4	0.2	6.6	0.1	0.0	0.3	0.1	0.6	1.0	0.1	0.9	2.3	0.3	0.3	0.1	0.2	0.1	0.3	0.5	0.1	0.1	0.1	0.3	0.1	0.0	2.3	0.3	0.5	0.2	0.1	0.0	0.2	0.1	0.3	0.4	0.8	0.1	0.0	0.3	0.1	0.4	2.7	0.3	0.0	0.2	1.0	0.0	0.0	0.1	2.7	0.0	0.2	0.2	0.5	0.0	0.1	0.1	0.0	0.2	1.4	0.1	0.0	0.4	0.2	1.6	0.0	0.4	0.0	0.0	0.1	0.1	0.4	0.5	0.1	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.3	0.2	0.3	0.5	0.2	0.1	0.4	0.1	0.1	8.9	6.3	4.4	4.8	7.1	7.9	6.4	6.6	2.8	5.5	5.8	4.4	6.6	0.2	16.0	18.7	9.4	0.0	1.7	0.8	0.2	0.0	1.5	0.2	0.0	1.2	0.0	3.9	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.5	26.4	0.7	0.5	0.0	0.0	79.2	0.0	0.3	1.9	0.0	4.3	1.3	0.1	0.0	0.0	0.3	0.0	396.6	0.1	0.0	0.0	1.2	1.3	0.3	0.4	1.8	3.7	0.1	0.0	0.0	9.5	10.1	0.5	0.0	0.4	0.0	0.8	0.0	0.0	20.8	0.7	0.0	0.6	1.7	0.6	0.4	0.1	0.9	0.4	0.4	0.2	0.0	0.4
CA10	"CA-RPX, CARPX, HUCEP-15"	ENSG00000154975	"Carbonic anhydrase 10"	Q9NS85	17	51630313-52160017	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 56.1;cervix: 22.0;retina: 44.9"	"Cell type enriched"	"Detected in some"	4	"Oligodendrocyte precursor cells: 1607.5"	"Cancer enriched"	"Detected in some"	4	"glioma: 4.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 1.2;RT4: 2.1;SCLC-21H: 6.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054825, HPA057837"	Supported		Approved	Vesicles	"Secreted in brain"	NA	NA			Vesicles		"HPA054825: AB_2682617, HPA057837: AB_2683542"		"unprognostic (2.66e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.43e-1)"	"unprognostic (8.22e-2)"	"unprognostic (4.43e-3)"	"unprognostic (1.02e-3)"	"unprognostic (1.01e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.21e-3)"	"unprognostic (9.18e-5)"	"unprognostic (1.60e-1)"	"unprognostic (1.51e-1)"		0.0	3.2	24.3	0.0	22.4	0.0	0.0	56.1	27.4	22.0	9.6	0.3	0.3	0.2	0.0	0.0	0.4	0.1	0.0	23.4	24.5	7.3	0.0	0.0	0.0	31.7	22.6	22.7	1.9	0.2	0.0	4.0	1.0	35.2	0.0	0.1	44.9	1.2	0.0	0.0	0.0	0.5	0.1	19.5	0.0	0.1	10.3	27.8	0.0	0.0	0.0	0.0	0.1	0.1	34.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.2	2.1	6.2	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.3	22.4	56.1	27.4	23.4	24.5	31.7	22.6	22.7	35.2	19.5	27.8	34.1	0.0	0.0	0.0	8.8	0.2	0.0	0.0	0.0	0.0	211.9	0.0	0.0	0.4	0.0	0.0	3.7	4.2	0.0	0.1	0.0	15.6	0.0	134.5	0.0	0.0	0.3	0.0	0.0	343.6	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.0	17.0	0.0	0.0	0.0	0.2	84.4	1.2	0.1	0.0	14.0	0.0	5.1	0.0	1607.5	4.2	0.0	0.0	0.7	0.1	0.2	0.0	0.2	0.0	11.9	0.0	0.1	0.0	1.5	1.3	0.0	0.0	0.1	2.2	0.0	0.0	0.1
CACHD1	"KIAA1573, VWCD1"	ENSG00000158966	"Cache domain containing 1"	Q5VU97	1	64470129-64693058	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Astrocytes: 283.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 41.3;NTERA-2: 56.5;SuSa: 35.4;U-2197: 29.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017202	Uncertain		Uncertain	Nucleoplasm,Nucleoli		NA	NA		310000	"Nucleoplasm, Nucleoli"		"HPA017202: AB_1852423"	"unprognostic (2.92e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.75e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.82e-2)"	"unprognostic (4.32e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.89e-1)"	"unprognostic (3.65e-1)"	"unprognostic (2.13e-1)"	11.0	13.2	18.4	2.0	17.3	0.1	11.9	8.4	11.4	12.0	20.5	2.9	1.6	10.9	9.2	3.8	14.5	4.5	3.4	13.9	15.6	6.4	1.9	9.0	2.0	13.8	17.9	12.0	22.8	7.3	7.0	9.2	10.2	8.9	8.2	2.7	6.4	8.2	7.6	2.9	7.6	3.5	9.7	7.3	4.5	6.7	2.3	21.3	5.1	6.4	5.4	1.6	6.0	10.7	7.5	0.3	1.7	41.3	6.1	16.1	5.6	0.0	5.9	7.8	10.0	9.7	24.8	0.2	0.0	16.8	9.7	8.0	3.1	23.4	5.0	10.4	4.6	12.2	8.9	2.9	0.0	0.0	3.8	0.1	5.0	3.4	1.2	6.2	6.0	5.7	6.0	0.0	0.0	0.0	0.7	0.8	0.0	56.5	0.3	4.2	5.2	4.2	0.0	0.0	1.3	2.1	23.5	12.7	0.0	5.2	35.4	1.7	0.5	3.7	1.0	7.3	29.1	5.3	0.0	0.0	0.0	1.0	0.7	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	18.4	17.3	8.4	11.4	13.9	15.6	13.8	17.9	12.0	8.9	7.3	21.3	7.5	25.2	6.4	49.9	283.7	0.1	17.3	7.5	6.1	6.8	15.5	8.3	7.0	1.3	0.0	11.5	3.7	0.0	0.0	0.2	0.1	0.0	2.3	9.5	14.0	8.1	20.2	0.0	0.0	19.4	2.7	0.1	11.1	5.6	16.9	2.5	26.0	4.2	1.3	0.2	0.0	6.9	0.2	4.1	0.3	6.1	4.1	14.3	0.8	1.8	24.4	0.2	6.4	0.0	57.8	1.8	1.2	0.1	3.0	0.0	2.0	0.5	4.2	10.2	1.3	6.6	25.2	6.4	0.5	0.8	2.9	14.8	0.0	0.9	0.8	0.5	5.1
CACNG4	"MGC11138, MGC24983"	ENSG00000075461	"Calcium voltage-gated channel auxiliary subunit gamma 4"	Q9UBN1	17	66964707-67033398	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 33.4;prostate: 11.8"	"Cell type enriched"	"Detected in some"	6	"Oligodendrocyte precursor cells: 145.3"	"Group enriched"	"Detected in many"	5	"breast cancer: 30.3;glioma: 35.8;ovarian cancer: 14.8;prostate cancer: 10.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	6	"SH-SY5Y: 387.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 118.1"	"HPA005803, HPA065370"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA005803: AB_2667439, HPA065370: AB_2685480"	"unprognostic (1.27e-1)"	"unprognostic (3.16e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.42e-2)"	"unprognostic (8.64e-3)"	"unprognostic (2.91e-1)"	"unprognostic (7.08e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.85e-2)"	"unprognostic (6.03e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.38e-10)"	"unprognostic (8.57e-3)"	"unprognostic (1.23e-1)"	"unprognostic (8.71e-2)"	"unprognostic (4.28e-1)"	0.2	0.8	26.4	0.1	33.4	0.0	5.4	6.0	22.6	0.4	3.3	0.5	0.2	0.5	0.1	0.2	4.2	0.4	0.1	13.0	15.4	0.1	0.0	5.8	0.0	15.7	15.1	15.8	0.1	0.4	1.2	0.3	0.7	21.4	11.8	0.1	0.8	1.7	1.3	0.1	0.4	0.1	1.1	10.0	0.0	1.5	0.2	21.1	0.0	0.1	0.0	0.0	0.4	0.7	10.6	6.4	4.1	15.6	0.0	0.0	0.0	4.4	0.0	0.0	1.4	0.0	4.6	0.2	0.0	0.2	0.0	41.2	64.1	0.1	0.0	0.0	0.0	0.3	0.0	1.8	3.7	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	34.5	0.1	0.3	15.7	7.3	0.0	0.0	0.4	8.7	0.0	11.1	15.8	387.4	3.6	10.4	0.0	38.1	38.5	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.4	33.4	6.0	22.6	13.0	15.4	15.7	15.1	15.8	21.4	10.0	21.1	10.6	0.0	3.2	1.3	0.0	0.0	0.0	1.1	0.3	0.0	0.2	6.4	3.4	1.3	0.0	1.4	0.0	0.0	0.3	0.1	0.6	0.0	0.1	2.6	1.0	0.2	0.1	7.7	0.0	1.8	0.2	0.2	0.2	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	20.8	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.7	0.0	3.4	0.0	145.3	0.3	0.7	0.2	0.0	0.0	2.6	0.0	0.0	1.9	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.7
CALCOCO2	"MGC17318, NDP52"	ENSG00000136436	"Calcium binding and coiled-coil domain 2"	Q13137	17	48831018-48866522	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Early spermatids: 1127.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA022989, HPA023019, HPA023195"	Enhanced		Supported	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA022989: AB_1845914, HPA023019: AB_1845915, HPA023195: AB_1845916"	"unprognostic (3.71e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.84e-2)"	"unprognostic (3.37e-2)"	"unprognostic (4.90e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.88e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.80e-2)"	"unprognostic (7.57e-2)"	"unprognostic (5.65e-2)"	119.0	59.7	36.1	55.8	43.4	63.4	96.1	42.6	51.2	80.0	72.0	102.0	68.7	69.8	61.6	89.4	82.9	66.8	127.1	34.8	56.7	76.4	121.3	92.2	53.6	49.4	46.0	30.3	87.3	57.1	77.4	47.0	63.8	48.3	56.1	102.5	77.1	53.0	73.1	159.7	66.8	76.1	88.6	41.3	69.4	72.1	137.5	42.4	75.1	76.0	171.9	67.7	81.6	77.6	52.9	126.0	79.4	33.1	64.0	241.2	173.7	95.0	120.2	160.0	135.9	151.3	150.8	80.6	42.5	117.0	146.5	115.9	68.2	81.4	101.7	162.6	193.3	66.9	40.7	48.0	59.1	276.8	137.4	196.8	258.1	148.1	144.3	103.9	129.0	101.3	130.7	74.9	124.3	119.2	36.8	119.5	73.6	10.3	278.9	97.7	77.8	161.7	81.0	52.2	39.2	13.1	27.9	37.6	24.3	106.0	66.6	154.2	76.5	97.7	147.1	44.9	91.0	85.8	110.4	165.1	30.0	89.2	69.0	61.4	108.9	115.1	115.5	56.6	121.5	54.2	54.1	49.9	58.9	67.1	46.7	50.5	55.8	132.8	105.0	132.3	33.6	107.2	89.7	36.1	43.4	42.6	51.2	34.8	56.7	49.4	46.0	30.3	48.3	41.3	42.4	52.9	166.2	115.4	98.1	20.5	42.1	36.6	73.3	40.9	40.9	16.8	34.7	32.4	169.1	37.1	48.4	33.1	50.1	50.2	48.6	124.5	37.2	47.2	1127.4	37.4	89.7	104.6	50.4	40.8	31.0	42.2	45.3	79.1	31.6	44.0	100.0	29.8	110.3	58.9	27.6	8.4	21.2	44.7	24.4	119.2	54.3	233.3	70.2	70.7	26.6	28.1	57.4	45.9	64.9	26.7	27.3	37.7	54.6	74.1	56.2	57.6	81.5	48.9	28.4	72.7	72.3	69.6	76.2	152.5	32.7	55.6	46.9	81.3	54.6	96.3	66.1	66.1
CALHM6	"C6orf187, dJ93H18.5, FAM26F, INAM, OTTHUMP00000017061, OTTHUMP00000017062, RP1-93H18.5"	ENSG00000188820	"Calcium homeostasis modulator family member 6"	Q5R3K3	6	116461370-116463771	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 137.7"	"Cell type enriched"	"Detected in some"	5	"Hofbauer cells: 138.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"intermediate monocyte: 724.6;non-classical monocyte: 861.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 28.0;Karpas-707: 45.1;RPMI-8226: 159.8;U-937: 59.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.14e-2)"	"unprognostic (2.31e-2)"	"unprognostic (6.46e-3)"	"unprognostic (7.15e-3)"	"unprognostic (9.53e-3)"	"unprognostic (4.10e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.68e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.19e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (9.31e-10)"	"unprognostic (1.69e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.85e-3)"	"unprognostic (9.25e-3)"	6.1	7.3	4.9	60.7	5.3	41.8	10.1	4.5	6.6	4.4	5.5	10.5	12.3	2.4	3.6	4.1	4.1	7.2	3.8	4.8	5.7	4.1	24.9	10.9	73.6	7.1	4.8	4.6	4.6	1.8	1.7	4.9	12.6	5.4	5.5	7.1	1.1	5.7	3.0	1.6	1.9	21.1	11.9	5.0	137.7	7.9	8.2	5.2	14.2	2.5	2.6	23.2	11.5	3.0	5.9	6.4	0.0	0.6	0.4	0.5	2.0	11.7	0.2	1.3	2.0	1.3	0.0	1.0	0.2	3.5	1.5	0.0	0.0	0.3	0.2	4.2	0.7	0.4	28.0	0.0	0.0	2.8	0.1	0.1	2.2	0.0	0.2	0.2	0.5	0.7	0.0	0.0	45.1	5.5	0.0	2.7	4.8	3.6	0.0	0.0	2.4	0.0	159.8	2.2	0.3	2.7	0.1	14.9	0.1	11.7	1.6	0.2	7.3	0.1	0.0	0.2	0.1	0.9	11.4	0.2	0.0	0.3	59.7	3.9	22.0	205.7	50.1	16.6	724.6	16.6	231.8	23.0	15.5	193.8	308.9	28.9	15.2	115.8	27.4	861.9	86.5	2.7	175.6	4.9	5.3	4.5	6.6	4.8	5.7	7.1	4.8	4.6	5.4	5.0	5.2	5.9	0.6	0.0	1.7	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.8	3.2	0.0	0.0	0.0	0.0	0.0	1.7	2.7	0.0	0.0	0.6	0.0	0.2	0.3	0.8	0.0	0.0	0.0	10.0	9.0	0.7	0.0	0.1	0.0	1.4	0.0	0.0	138.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	0.0	0.0	10.3	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	2.2	1.2	1.8	0.0	0.0
CALML3	CLP	ENSG00000178363	"Calmodulin like 3"	P27482	10	5524961-5526771	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 511.2;skin 1: 152.9;vagina: 202.4"	"Cell type enriched"	"Detected in some"	8	"Squamous epithelial cells: 1257.1"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 150.9;head and neck cancer: 196.3"	"Region enhanced"	"Detected in single"		"cerebellum: 1.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"A-431: 21.5;hTCEpi: 8.6;RPMI-8226: 6.0"	"Not detected"	"Not detected"							"CAB010070, HPA044999"	Approved					NA	NA		1200000			"CAB010070: , HPA044999: AB_2679177"	"unprognostic (1.02e-3)"	"unprognostic (1.18e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.37e-1)"		"unprognostic (1.29e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.02e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.43e-3)"	0.3	0.1	0.2	0.0	0.1	0.0	5.4	1.5	0.1	51.5	0.0	0.1	0.0	0.1	0.1	511.2	1.2	0.0	0.1	0.0	0.4	17.5	1.6	0.0	0.0	0.5	0.4	0.0	0.1	0.2	0.0	0.3	0.0	0.2	3.0	0.0	0.0	121.9	0.1	1.1	152.9	0.2	0.0	0.0	0.1	0.3	1.7	0.6	80.2	0.1	0.0	40.2	0.2	202.4	0.0	21.5	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	8.6	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.5	0.1	0.0	0.4	0.5	0.4	0.0	0.2	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	28.4	29.8	6.3	157.1	2.2	13.3	22.4	0.4	0.0	1.1	0.0	0.0	0.0	0.0	0.0	5.9	0.0	4.3	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	28.5	0.0	1.4	8.3	0.3	0.8	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	6.5	0.0	59.6	0.7	0.3	0.0	0.0	0.9	6.7	0.1	1257.1	55.0	0.0	0.7	0.0	0.2	30.6
CAMK2B	"CAM2, CAMK2, CAMKB, CaMKII"	ENSG00000058404	"Calcium/calmodulin dependent protein kinase II beta"	Q13554	7	44217150-44334577	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Actin-binding, Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 253.4;skeletal muscle: 133.8"	"Cell type enriched"	"Detected in many"	7	"Bipolar cells: 857.4"	"Cancer enhanced"	"Detected in many"		"glioma: 6.0;thyroid cancer: 6.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 75.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006849, HPA026307, HPA051783, HPA051785, HPA053973"	Enhanced	Supported	Supported	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		600000	"Plasma membrane"	"Cell Junctions, Cytosol"	"CAB006849: , HPA026307: AB_1845941, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (1.88e-3)"	"unprognostic (4.49e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.36e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.90e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.23e-7)"	"unprognostic (7.04e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.15e-2)"	"unprognostic (3.95e-2)"	0.5	11.4	65.8	0.6	93.8	0.1	1.5	113.3	253.4	0.1	0.0	0.8	1.0	0.2	28.6	1.4	1.1	0.2	66.0	197.6	35.1	1.6	7.8	0.3	1.3	32.1	19.6	77.3	0.3	3.8	6.1	51.7	0.1	42.2	3.2	0.4	21.6	1.4	1.6	133.8	1.2	0.9	0.1	1.6	0.3	2.3	2.2	24.0	0.8	20.5	59.7	1.6	0.0	0.3	83.6	0.0	0.8	0.4	0.6	0.0	0.4	0.4	0.3	0.1	0.3	0.0	0.3	0.1	0.2	1.6	0.4	0.1	0.3	0.4	1.4	0.1	2.0	4.5	0.1	0.2	0.2	0.1	0.0	0.9	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.8	0.1	10.1	0.0	0.4	0.2	0.1	4.4	0.2	1.7	0.3	0.0	0.0	75.5	4.0	0.4	0.0	0.0	0.1	3.5	0.3	0.4	0.5	0.7	0.4	0.1	0.9	0.8	0.2	0.2	0.0	0.5	1.0	0.1	0.2	0.1	0.2	0.2	0.2	0.2	0.1	0.1	0.3	0.2	0.2	0.4	0.7	0.3	0.2	0.2	0.2	65.8	93.8	113.3	253.4	197.6	35.1	32.1	19.6	77.3	42.2	1.6	24.0	83.6	0.1	0.0	0.0	67.3	0.2	1.1	21.5	0.0	10.8	857.4	3.1	17.5	88.9	2.8	0.0	0.0	45.9	0.1	0.0	0.5	9.8	0.0	0.9	2.3	0.4	1.6	40.7	0.0	111.4	0.0	0.2	2.9	4.1	5.6	4.5	15.4	0.0	4.3	0.2	60.6	90.9	1.5	2.0	0.6	0.4	2.9	1.8	0.5	1.8	5.6	0.0	23.2	0.0	19.6	5.4	0.1	1.2	0.0	0.1	3.3	0.1	1.9	0.0	53.1	0.0	6.9	1.7	0.2	7.8	0.9	0.4	0.3	0.2	0.2	0.3	6.6
CAND2	"KIAA0667, TIP120B, Tp120b"	ENSG00000144712	"Cullin associated and neddylation dissociated 2 (putative)"	O75155	3	12796472-12871916	"Predicted intracellular proteins"	"Transcription, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 136.1"	"Cell type enriched"	"Detected in many"	4	"Early spermatids: 120.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 19.4;REH: 12.4;U-266/84: 9.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005777	Approved		Approved	"Nuclear bodies,Cytosol"		NA	NA			"Nuclear bodies"	Cytosol	"HPA005777: AB_2667431"	"unprognostic (6.11e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.52e-3)"	"unprognostic (6.09e-2)"	"unprognostic (4.22e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.00e-2)"	"unprognostic (9.03e-2)"	"unprognostic (6.36e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.78e-5)"	"unprognostic (1.31e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.96e-3)"	3.0	3.3	7.5	0.5	7.8	1.0	1.9	6.2	7.7	4.4	7.1	4.9	0.9	6.4	2.2	2.4	6.2	1.8	24.5	7.7	9.1	2.4	1.6	2.4	0.8	7.8	7.4	8.4	5.0	2.4	5.5	8.4	0.8	8.2	3.6	0.7	2.2	3.3	3.0	136.1	1.2	2.3	3.4	6.3	2.2	3.3	15.9	7.8	0.8	3.2	36.5	0.6	4.4	2.8	7.7	0.8	1.6	5.6	0.2	0.2	0.1	0.3	1.4	0.6	3.4	4.1	0.9	0.3	1.0	1.9	0.9	0.9	0.2	6.4	0.1	2.6	1.8	19.4	1.5	2.9	1.4	5.2	0.2	0.1	1.2	0.3	3.1	0.1	3.3	0.7	7.2	5.3	1.0	1.0	3.3	2.6	0.8	3.8	0.4	2.0	12.4	1.2	1.0	0.2	1.5	3.9	4.6	0.1	0.9	1.2	1.1	1.6	6.3	0.4	1.0	0.9	1.0	1.4	1.3	9.9	8.4	0.6	1.2	2.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.1	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.3	0.1	7.5	7.8	6.2	7.7	7.7	9.1	7.8	7.4	8.4	8.2	6.3	7.8	7.7	0.9	3.2	1.1	5.9	0.2	0.4	0.8	0.6	1.8	16.0	0.4	0.5	4.8	1.5	0.7	1.8	10.4	0.2	0.2	0.1	0.0	0.9	120.6	0.4	1.4	1.8	0.0	0.4	19.3	0.0	0.2	2.6	0.5	0.3	0.0	5.6	3.3	2.0	4.2	13.5	25.3	0.0	0.0	0.0	0.8	23.2	4.7	0.4	0.0	4.7	0.0	2.9	1.0	12.1	7.2	0.0	0.0	10.1	0.2	0.5	0.0	0.7	0.3	3.1	0.0	4.1	4.0	1.4	5.3	0.4	0.1	0.1	1.0	9.2	0.0	0.4
CARNMT1	"C9orf41, FLJ25795"	ENSG00000156017	"Carnosine N-methyltransferase 1"	Q8N4J0	9	74980790-75028423	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	5	"Early spermatids: 256.8"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 25.9"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026756	Uncertain					NA	NA					"HPA026756: AB_1845824"	"unprognostic (1.59e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.99e-2)"	"unprognostic (4.81e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.22e-2)"	"unprognostic (4.92e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.62e-2)"	5.2	6.2	2.8	7.0	11.3	8.4	7.0	25.9	5.9	5.8	0.5	9.3	12.8	6.2	8.4	10.1	6.3	6.9	5.5	4.2	2.7	12.3	17.2	5.4	9.8	2.9	3.9	2.7	6.2	9.1	11.3	3.9	5.4	7.1	6.5	8.5	7.9	9.2	5.3	8.7	8.5	12.5	6.1	0.8	6.8	7.8	16.6	2.2	8.5	13.7	8.6	8.6	9.2	5.2	4.6	27.6	16.1	6.6	17.0	10.3	22.4	24.6	24.4	10.0	9.0	8.2	4.1	17.9	43.7	12.9	17.4	19.2	26.7	20.0	25.3	25.5	40.0	17.4	22.3	15.5	18.4	12.6	40.7	21.2	15.0	12.4	17.0	17.3	13.3	18.6	15.6	19.1	36.9	17.4	7.3	29.8	10.8	31.4	33.0	14.7	14.4	20.2	25.4	23.5	19.0	6.5	3.6	18.7	46.2	9.2	11.8	23.5	11.7	14.8	14.8	19.9	18.2	21.3	28.2	38.3	13.1	22.9	27.6	9.8	0.0	0.4	1.0	1.3	0.8	1.9	1.7	1.3	2.0	0.6	0.9	1.6	1.5	0.1	1.5	0.4	0.6	2.0	0.7	2.8	11.3	25.9	5.9	4.2	2.7	2.9	3.9	2.7	7.1	0.8	2.2	4.6	8.5	6.4	11.7	0.0	10.2	0.0	11.6	0.0	21.6	14.5	16.6	8.0	0.0	11.5	6.8	27.6	10.4	7.0	18.6	4.5	25.4	7.5	256.8	11.2	19.6	9.4	7.3	6.3	0.0	11.9	13.0	6.6	13.7	14.8	2.5	8.7	8.9	29.8	8.1	20.2	0.0	12.8	0.0	9.1	0.0	44.3	7.5	8.5	0.0	0.0	8.9	5.6	17.5	0.0	0.0	9.3	8.8	10.9	17.4	17.7	22.6	37.3	4.4	10.4	0.0	9.3	5.6	17.7	10.3	33.5	0.0	5.1	17.1	16.2	13.2	15.0
CC2D2A	"JBTS9, KIAA1345, MKS6"	ENSG00000048342	"Coiled-coil and C2 domain containing 2A"	Q9P2K1	4	15469865-15601552	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Joubert syndrome, Meckel syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 85.5"	"Cell type enriched"	"Detected in many"	4	"Cone photoreceptor cells: 569.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044124	Approved					NA	NA					"HPA044124: AB_10969197"	"unprognostic (1.88e-1)"	"unprognostic (2.05e-3)"	"unprognostic (6.01e-3)"	"unprognostic (4.23e-3)"	"unprognostic (2.13e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.63e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.23e-2)"	"unprognostic (7.33e-2)"	"prognostic favorable (3.42e-9)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (1.19e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.18e-2)"	8.4	9.4	13.9	2.8	13.2	2.7	8.9	14.2	16.7	14.4	20.4	13.1	5.0	12.9	11.2	8.3	34.5	12.5	7.0	13.5	14.4	23.8	2.9	10.8	2.0	13.8	13.6	12.1	11.9	5.1	10.1	12.8	8.6	13.0	10.0	6.0	85.5	3.3	12.6	2.5	2.2	5.1	15.6	12.3	3.3	8.2	4.9	13.3	1.2	8.3	11.2	1.4	9.4	6.5	16.6	5.4	11.3	15.6	7.0	18.4	34.4	3.8	6.8	11.5	12.7	15.5	5.1	13.2	0.5	7.3	13.1	27.7	3.4	13.1	8.7	15.9	0.0	7.3	5.5	10.1	7.1	13.5	0.5	0.1	25.0	22.8	20.7	15.5	23.3	5.9	0.2	14.7	0.4	24.4	3.9	0.2	0.9	25.9	0.2	23.3	3.5	4.9	1.1	32.1	2.6	9.7	11.1	4.3	3.1	32.2	14.6	4.9	1.3	2.2	20.2	12.0	8.6	14.4	0.4	0.5	0.3	24.3	0.3	13.1	1.9	2.4	0.2	0.4	1.6	0.6	0.3	0.3	0.1	3.8	0.3	0.2	0.4	4.8	0.9	0.8	0.2	0.9	0.6	13.9	13.2	14.2	16.7	13.5	14.4	13.8	13.6	12.1	13.0	12.3	13.3	16.6	8.4	12.8	14.6	39.8	0.7	2.2	5.6	5.7	14.2	15.1	6.5	9.0	22.9	10.0	23.5	25.8	569.2	10.2	0.3	0.8	33.2	6.6	12.0	96.8	14.0	7.0	6.0	2.7	20.9	0.9	3.1	18.7	4.1	9.0	0.0	15.2	8.9	1.6	5.0	8.4	43.4	0.9	8.2	5.7	4.6	6.7	9.3	4.4	12.4	16.9	1.2	18.4	0.0	62.8	19.5	1.0	0.5	16.6	1.3	4.4	2.1	57.1	128.4	136.4	6.6	14.7	17.7	2.6	0.7	6.4	1.3	1.5	1.9	12.9	2.9	4.0
CCDC121	"FLJ13646, FLJ43364"	ENSG00000176714	"Coiled-coil domain containing 121"	Q6ZUS5	2	27625638-27629012	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 25.6"	"Cell type enriched"	"Detected in many"	4	"Early spermatids: 186.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 10.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA051791	Uncertain		Approved	"Actin filaments,Cytosol"		NA	NA			"Actin filaments, Cytosol"		"HPA051791: AB_2681611"	"unprognostic (1.52e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.93e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.71e-3)"	"prognostic favorable (4.12e-4)"	"unprognostic (4.03e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.65e-4)"	"unprognostic (7.78e-2)"	"prognostic favorable (1.87e-5)"	"unprognostic (2.50e-1)"	"unprognostic (1.72e-1)"	"unprognostic (7.86e-2)"	"unprognostic (5.42e-2)"	4.0	3.1	6.5	1.8	5.6	1.3	5.2	6.4	6.5	3.9	4.7	3.1	2.4	4.9	4.5	2.8	7.2	2.6	6.0	5.6	10.0	5.4	3.0	4.0	2.3	8.6	5.6	4.1	10.0	2.4	7.8	2.5	3.4	6.0	4.3	3.0	7.3	5.3	5.7	3.6	3.0	2.2	3.5	8.4	4.1	3.5	25.6	7.6	2.4	7.2	5.7	2.3	2.3	1.9	8.0	3.3	3.8	5.1	5.7	9.1	4.0	6.4	1.7	0.8	1.7	0.8	2.9	3.0	1.7	2.6	1.1	4.9	3.1	3.8	1.4	1.8	2.4	4.1	1.0	2.1	3.8	1.7	1.5	2.9	1.3	4.5	0.9	2.4	2.8	3.4	0.8	4.6	2.3	2.4	2.8	1.2	1.6	5.3	4.2	1.9	5.7	12.4	3.0	3.5	2.6	6.6	7.6	1.4	6.3	2.2	4.1	5.2	3.6	1.8	1.5	5.5	1.3	4.7	1.4	1.5	2.5	3.6	2.1	1.8	1.8	1.9	10.8	0.4	2.9	1.3	2.3	1.4	0.5	1.4	1.9	2.3	1.6	4.2	2.3	3.4	0.4	0.3	1.0	6.5	5.6	6.4	6.5	5.6	10.0	8.6	5.6	4.1	6.0	8.4	7.6	8.0	7.3	6.4	2.6	1.6	2.9	0.6	1.7	0.8	0.6	5.1	2.4	3.2	3.2	4.3	1.9	0.0	20.9	3.1	1.3	1.9	7.9	3.6	186.5	17.1	5.2	5.8	1.2	1.7	0.7	1.1	2.0	4.2	2.6	7.6	0.0	2.8	5.3	2.0	1.9	3.3	1.1	1.3	2.0	1.6	2.1	44.7	8.7	2.2	1.8	0.0	0.8	12.7	0.0	1.5	2.9	2.0	0.8	6.8	0.3	1.2	1.4	3.9	21.2	12.4	13.1	5.6	3.2	31.0	10.0	1.4	1.1	1.8	1.7	4.9	2.1	0.8
CCDC154	"C16orf29, LOC645811"	ENSG00000197599	"Coiled-coil domain containing 154"		16	1434383-1444556	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"testis: 11.7"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 51.6"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 4.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 9.5;NB-4: 4.7;SCLC-21H: 33.2;U-266/70: 5.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 1.9"	"HPA041158, HPA043535, HPA048237"	Uncertain		Approved	"Golgi apparatus,Plasma membrane"		NA	NA			"Plasma membrane"	"Golgi apparatus"	"HPA041158: , HPA043535: AB_2678536, HPA048237: AB_2680323"	"unprognostic (2.40e-1)"	"unprognostic (1.42e-2)"	"unprognostic (5.97e-4)"	"unprognostic (3.28e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.76e-3)"	"unprognostic (7.96e-2)"	"unprognostic (3.01e-3)"	"unprognostic (1.67e-1)"	"unprognostic (5.34e-2)"	"unprognostic (4.19e-5)"	"unprognostic (2.35e-2)"	"unprognostic (8.02e-6)"	"unprognostic (9.33e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.33e-1)"	"unprognostic (9.35e-5)"	0.6	0.8	1.8	0.9	1.6	1.0	0.8	1.6	2.2	1.7	0.5	0.9	1.4	1.0	0.3	0.4	1.9	0.5	0.6	1.4	1.1	1.3	0.7	0.8	1.5	1.7	1.3	1.0	1.5	1.2	0.1	3.8	0.4	2.1	1.6	0.1	0.8	0.7	0.4	0.8	1.6	1.2	0.2	1.0	2.2	2.0	11.7	1.6	0.4	2.8	0.1	0.4	0.8	0.9	2.4	9.5	0.4	0.3	0.6	0.4	0.2	0.4	0.1	0.0	0.0	0.0	0.3	0.8	0.1	0.3	0.0	0.4	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.3	0.4	0.3	0.1	0.5	0.1	0.3	0.1	0.0	0.1	0.0	0.1	1.2	0.5	0.0	0.7	0.0	4.7	0.2	0.0	0.1	2.8	0.1	0.2	0.0	0.2	33.2	0.5	0.1	0.2	1.4	0.1	1.0	2.4	0.0	0.4	0.1	0.4	0.0	5.8	1.6	0.1	0.0	4.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.6	1.6	2.2	1.4	1.1	1.7	1.3	1.0	2.1	1.0	1.6	2.4	0.2	0.0	0.0	9.8	1.4	0.0	0.5	0.2	0.0	3.2	0.5	0.6	0.6	1.5	0.1	3.7	8.4	0.0	0.4	0.1	0.0	0.1	51.6	0.3	0.3	0.1	0.0	0.0	3.9	0.4	0.0	0.3	1.1	0.3	1.3	1.5	0.4	0.2	0.8	6.7	4.8	0.5	0.0	0.3	0.8	11.1	1.5	0.6	1.8	7.5	0.8	2.4	0.0	2.0	3.8	0.0	0.0	0.4	0.0	0.1	0.2	0.2	0.8	4.2	0.0	0.3	0.6	10.1	1.2	0.0	0.4	0.0	0.7	0.4	0.0	0.2
CCDC187	MGC50722	ENSG00000260220	"Coiled-coil domain containing 187"	A0A096LP49	9	136249973-136306901	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 11.1;pituitary gland: 7.2;testis: 29.9"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 446.1"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"RPMI-8226: 10.4;SCLC-21H: 3.1"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"midbrain: 3.2"							NA	NA						"unprognostic (1.11e-1)"	"unprognostic (9.60e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.31e-2)"		"unprognostic (6.18e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.15e-2)"	"unprognostic (5.54e-2)"	"unprognostic (8.93e-4)"	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.8	0.3	0.0	0.0	0.1	2.8	0.0	11.1	0.0	0.0	0.0	0.5	0.2	0.0	2.0	0.0	0.1	0.2	0.0	0.0	0.4	0.0	7.2	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.5	29.9	0.3	0.0	4.9	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	10.4	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.5	0.1	0.2	0.0	0.1	0.1	0.3	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	107.8	49.7	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	446.1	3.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.1	0.0	0.1	22.6	0.0	0.0	0.0	0.0	2.1	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1
CCDC190	"C1orf110, MGC48998"	ENSG00000185860	"Coiled-coil domain containing 190"	Q86UF4	1	162824458-162868815	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 5.6;esophagus: 3.3"	"Cell type enriched"	"Detected in some"	4	"Respiratory ciliated cells: 26.2"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 3.9;hTERT-RPE1: 4.8;HUVEC TERT2: 4.8;LHCN-M2: 7.3;TIME: 16.7;U-2197: 8.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028579, HPA028584, HPA028592"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA028579: AB_10610978, HPA028584: AB_10599423, HPA028592: AB_10601001"	"unprognostic (4.29e-1)"	"unprognostic (8.37e-2)"		"unprognostic (1.75e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.68e-2)"		"unprognostic (8.33e-3)"		"unprognostic (3.04e-2)"	"unprognostic (3.09e-2)"	"unprognostic (6.41e-2)"	"unprognostic (7.41e-5)"	"unprognostic (2.64e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.26e-1)"	"unprognostic (1.70e-1)"	0.1	0.1	1.5	0.0	1.1	0.0	0.0	1.0	1.1	0.1	0.9	0.0	0.0	0.1	0.3	3.3	0.5	0.4	0.5	1.4	5.6	0.0	0.0	1.8	0.0	1.6	2.0	0.4	0.0	0.0	0.0	0.1	0.0	1.1	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.7	0.0	0.1	0.3	2.5	0.0	0.1	0.1	0.4	0.1	0.0	2.4	0.1	0.0	0.0	0.0	0.1	1.7	0.0	0.2	0.2	0.3	0.2	0.0	0.0	0.0	0.3	0.2	0.1	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	3.9	2.4	4.8	4.8	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.7	0.4	0.0	8.8	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.1	1.0	1.1	1.4	5.6	1.6	2.0	0.4	1.1	0.7	2.5	2.4	0.0	0.0	0.5	0.0	0.2	0.0	0.7	0.0	0.6	0.0	0.2	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	2.5	0.6	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	26.2	0.0	0.0	0.4	0.5	0.1	0.2	5.8	0.0	0.0	0.0	0.0	0.0	0.5
CCDC57	"FLJ00130, FLJ23754"	ENSG00000176155	"Coiled-coil domain containing 57"	Q2TAC2	17	82101460-82212830	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	6	"Late spermatids: 729.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"naive CD4 T-cell: 3.7;naive CD8 T-cell: 7.6"	"Lineage enriched"	"Detected in many"	6	"T-cells: 7.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA023315, HPA023326, HPA023342, HPA023344"	Approved		Approved	"Microtubules,Centriolar satellite,Cytosol"		NA	NA			Microtubules	"Centriolar satellite, Cytosol"	"HPA023315: AB_1846159, HPA023326: AB_1846160, HPA023342: AB_2275460, HPA023344: AB_1846162"	"unprognostic (2.51e-3)"	"unprognostic (8.22e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.92e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.19e-2)"	"unprognostic (2.16e-1)"	"prognostic favorable (5.55e-5)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (2.28e-6)"	"unprognostic (5.19e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.80e-3)"	5.3	8.5	3.7	5.8	4.7	8.4	8.4	6.0	8.7	10.4	5.6	7.6	7.3	9.5	6.5	3.5	11.1	6.7	3.9	4.3	1.6	12.4	7.4	8.2	5.4	2.9	1.7	3.4	12.4	10.6	7.9	17.0	3.5	3.7	14.5	3.0	9.1	9.1	5.9	4.0	5.6	6.7	3.6	0.0	6.3	7.8	12.3	1.5	8.2	17.8	1.1	2.9	7.0	6.6	3.7	5.2	10.4	5.4	6.9	3.1	5.8	6.0	3.9	3.9	2.8	2.5	3.0	7.9	2.7	3.7	3.2	2.9	12.0	1.6	7.2	1.6	2.8	10.6	4.5	20.3	6.7	4.0	4.5	5.6	5.9	5.5	5.3	6.9	6.5	3.4	3.9	5.8	1.5	2.0	7.5	8.8	8.5	1.7	3.0	4.1	4.7	2.4	3.8	5.5	6.2	18.5	11.3	3.4	17.3	6.7	3.4	9.9	5.3	3.7	11.0	10.0	4.8	8.2	11.0	1.2	0.9	8.5	5.1	4.5	0.5	0.4	0.5	0.6	0.1	0.2	0.4	0.5	0.8	0.4	0.3	3.7	7.6	1.3	0.3	0.1	1.2	0.2	1.0	3.7	4.7	6.0	8.7	4.3	1.6	2.9	1.7	3.4	3.7	0.0	1.5	3.7	5.9	25.6	62.7	19.6	35.8	11.7	22.7	23.7	19.4	22.5	82.3	66.2	5.3	17.2	41.9	29.5	41.7	36.2	45.4	27.6	9.8	15.8	116.1	44.9	15.9	6.9	42.7	14.1	72.8	17.1	34.2	9.8	36.2	19.2	34.9	33.2	7.1	101.0	29.9	25.2	54.4	46.9	30.5	42.1	35.8	729.3	8.1	28.7	33.8	13.1	39.6	10.0	48.4	16.1	10.6	18.1	26.9	10.1	36.5	20.4	31.6	13.2	52.3	66.3	6.6	14.3	9.9	13.6	6.9	21.2	18.3	12.4	40.2	10.5	37.2	23.1
CCDC82	FLJ23518	ENSG00000149231	"Coiled-coil domain containing 82"	Q8N4S0	11	96349241-96389956	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Early spermatids: 493.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038704, HPA070631"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA038704: AB_10674835, HPA070631: "	"unprognostic (3.04e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.37e-1)"	"unprognostic (9.94e-3)"	"unprognostic (5.94e-2)"	"unprognostic (3.68e-1)"	"unprognostic (3.41e-1)"	"unprognostic (7.68e-3)"	"unprognostic (1.42e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.31e-2)"	21.9	15.3	21.2	19.7	24.6	17.3	17.7	36.7	30.3	15.5	12.8	16.7	13.1	18.5	14.0	10.5	16.1	17.0	13.3	22.5	19.6	16.8	22.3	18.1	23.6	25.6	26.0	15.1	18.4	13.9	11.9	18.3	17.5	24.9	13.1	13.5	43.5	12.9	15.9	14.5	14.4	17.0	14.0	16.2	20.5	16.9	23.9	21.5	22.5	18.1	15.1	20.3	16.8	14.6	36.4	12.9	17.9	52.4	21.0	35.9	30.0	20.8	47.0	28.0	29.9	42.4	31.1	41.3	26.1	42.8	23.1	50.5	29.1	17.5	14.7	42.5	44.5	11.7	49.1	42.7	26.0	25.6	41.5	33.2	18.3	9.2	58.9	22.8	28.0	35.9	25.3	31.4	28.1	40.5	1.1	34.9	40.2	12.0	21.6	12.7	23.7	44.2	21.0	22.6	32.9	9.6	22.7	26.6	2.7	23.0	35.5	5.0	19.5	42.6	50.1	28.1	43.7	25.3	9.5	29.9	36.0	16.2	30.7	38.6	59.4	12.5	25.1	23.7	15.2	24.5	22.5	24.7	23.6	14.0	19.3	26.9	25.5	17.9	35.7	16.2	18.7	28.5	17.9	21.2	24.6	36.7	30.3	22.5	19.6	25.6	26.0	15.1	24.9	16.2	21.5	36.4	57.9	19.2	31.4	30.7	32.9	30.5	27.0	31.5	19.4	58.9	14.0	18.5	37.2	18.6	28.9	31.3	100.1	16.6	55.1	10.7	27.4	34.6	493.8	57.6	37.0	53.6	19.8	16.4	67.0	17.5	20.5	44.9	13.7	26.4	40.4	36.4	38.6	32.1	25.2	32.0	67.0	9.0	24.4	27.4	38.4	76.8	43.8	32.5	26.6	23.4	37.2	41.6	42.2	54.3	119.7	32.3	12.2	42.9	27.2	14.5	8.8	40.1	71.8	50.6	32.9	45.4	48.4	85.4	57.0	13.0	20.5	8.2	40.7	24.9	10.3	18.7
CCER2		ENSG00000262484	"Coiled-coil glutamate rich protein 2"	I3L3R5	19	38908980-38912158	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 4.9"	"Cell type enriched"	"Detected in some"	8	"Melanocytes: 617.2"	"Group enriched"	"Detected in many"	5	"glioma: 5.1;testis cancer: 1.9;urothelial cancer: 5.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.4;THP-1: 1.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA069716	Uncertain				"Secreted - unknown location"	NA	NA		8800			"HPA069716: AB_2686183"	"unprognostic (6.58e-2)"	"unprognostic (2.24e-2)"	"unprognostic (5.03e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.76e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.16e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.08e-3)"	"unprognostic (3.82e-2)"	"unprognostic (1.01e-9)"	"unprognostic (1.75e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.61e-1)"	"prognostic favorable (2.32e-4)"	0.5	0.6	2.2	0.2	2.3	0.7	0.8	2.2	3.4	0.9	1.8	0.8	0.3	0.7	0.3	1.2	1.1	0.1	0.6	2.2	2.1	1.3	3.0	0.5	0.3	2.8	2.2	2.1	0.8	0.5	0.2	2.5	0.1	2.4	1.4	0.1	1.0	0.9	0.2	2.3	3.9	0.9	0.1	2.0	1.1	0.6	4.9	2.2	0.4	1.2	0.0	0.1	0.9	0.8	2.3	0.1	1.4	0.3	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.5	1.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.4	0.0	0.3	0.0	0.0	0.6	0.5	0.1	0.2	0.1	0.0	0.0	0.0	0.9	0.2	0.9	0.0	0.9	0.2	0.4	0.3	0.0	0.2	0.7	0.1	0.2	0.1	0.6	0.4	0.2	0.1	0.1	0.0	0.1	1.0	1.4	0.0	0.0	0.7	0.0	0.0	0.6	0.5	0.2	0.1	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.3	2.2	3.4	2.2	2.1	2.8	2.2	2.1	2.4	2.0	2.2	2.3	0.1	3.2	0.0	3.9	0.1	76.9	0.1	0.1	0.0	2.5	0.4	0.5	0.4	1.5	0.1	1.8	4.2	0.4	0.4	0.3	0.0	0.0	1.4	0.3	0.2	0.6	1.2	0.4	2.3	0.0	0.1	0.8	0.0	0.5	0.0	0.3	0.0	0.6	0.2	0.0	3.3	0.2	0.0	0.3	7.2	4.9	0.3	0.2	617.2	0.0	0.0	1.3	0.0	3.5	2.2	0.1	0.2	0.0	0.0	0.1	0.2	0.2	0.4	3.8	0.0	0.4	0.7	1.1	2.1	0.0	3.0	0.3	0.4	0.2	0.6	0.1
CCL11	"eotaxin, MGC22554, SCYA11"	ENSG00000172156	"C-C motif chemokine ligand 11"	P51671	17	34285742-34288334	"Cancer-related genes, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 36.1;lymphoid tissue: 31.7;stomach 1: 35.4;urinary bladder: 41.4"	"Cell type enriched"	"Detected in some"	15	"Fibroblasts: 38.9"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 12.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	21	"BJ hTERT+: 9.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA	88500					"unprognostic (4.61e-2)"	"unprognostic (1.45e-1)"	"prognostic favorable (8.70e-4)"	"unprognostic (8.18e-2)"		"prognostic favorable (1.99e-4)"	"unprognostic (9.91e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.64e-8)"	"unprognostic (2.66e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.72e-2)"	1.7	0.8	0.0	31.7	0.0	0.0	0.2	0.0	0.0	2.4	0.0	32.1	33.5	1.7	0.0	12.5	0.7	4.8	9.8	0.0	0.0	4.2	0.6	9.2	0.0	0.0	0.0	0.0	0.3	2.9	1.7	1.0	0.0	0.0	2.7	14.9	0.0	0.1	1.0	0.0	0.0	36.1	20.7	0.0	2.8	35.4	0.0	0.0	0.3	0.0	0.0	0.7	41.4	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	9.7	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	38.9	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.1	1.9	0.0	0.0	1.4	0.0	0.0	0.8	0.0	0.0	0.1
CCL14	"CKb1, HCC-1, HCC-3, MCIF, NCC-2, SCYA14, SCYL2"	ENSG00000276409	"C-C motif chemokine ligand 14"	Q16627	17	35983288-35987004	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 637.8"	"Cell type enriched"	"Detected in many"	5	"Hepatic stellate cells: 1156.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	41	"HUVEC TERT2: 92.1"					"Low region specificity"	"Detected in all"			"CAB004423, HPA030268"	Uncertain				"Secreted to blood"	NA	NA	5200000	37000000			"CAB004423: AB_627716, HPA030268: AB_10603782"	"unprognostic (4.13e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.55e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.99e-2)"	"unprognostic (8.79e-5)"	"unprognostic (1.44e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.10e-2)"	"unprognostic (6.33e-3)"	"unprognostic (3.00e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.36e-2)"	"unprognostic (3.95e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.14e-1)"	397.9	103.5	0.5	6.5	0.3	3.3	404.1	0.3	1.7	191.6	2.6	57.9	2.9	199.7	59.9	62.5	235.5	69.9	62.1	0.3	1.5	67.3	83.3	67.0	49.3	0.5	0.5	0.3	44.5	22.7	12.5	39.9	0.9	0.6	98.2	9.9	0.0	62.5	50.0	56.4	90.2	50.9	95.1	0.4	637.8	68.1	16.1	0.5	34.7	124.9	24.8	28.4	117.8	179.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	92.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.5	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.3	1.7	0.3	1.5	0.5	0.5	0.3	0.6	0.4	0.5	1.2	136.5	0.0	8.2	0.0	2.2	1.9	0.1	0.0	3.4	0.0	0.6	1.1	0.2	18.6	0.6	0.0	0.0	0.0	0.1	2.0	0.0	0.0	24.2	0.4	0.3	203.8	0.0	26.7	0.0	0.0	0.0	9.4	0.0	0.2	1.3	0.0	1156.5	11.0	0.3	0.0	0.0	1.0	0.0	58.8	3.1	63.8	1.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.2	2.3	1.1	2.6	0.0	0.0	0.3	2.3	0.0	0.0	2.0	1.4	0.0	1.8	0.1	0.6	0.2
CCL23	"Ckb-8, CKb8, MIP-3, MPIF-1, SCYA23"	ENSG00000274736	"C-C motif chemokine ligand 23"	P55773	17	36013056-36017972	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	"Cytokine, Heparin-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"Hepatic stellate cells: 243.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	163	"eosinophil: 183.7"	"Lineage enriched"	"Detected in many"	163	"granulocytes: 183.7"	"Group enriched"	"Detected in some"	4	"HEL: 17.6;THP-1: 37.4"									HPA042015	Uncertain				"Secreted to blood"	NA	NA	937000	130000			"HPA042015: AB_10794039"	"unprognostic (1.65e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.50e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.20e-4)"	"unprognostic (2.17e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.05e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.35e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.95e-1)"	7.6	6.7	0.0	7.1	0.0	3.7	7.4	0.0	0.2	18.7	0.1	3.6	0.3	14.9	1.6	4.8	12.0	3.3	0.6	0.0	0.0	11.6	7.6	21.6	1.6	0.0	0.0	0.0	2.9	1.0	0.0	0.3	0.3	0.0	8.6	8.8	0.0	3.5	0.3	0.5	3.5	9.4	10.9	0.0	14.2	3.4	0.6	0.1	0.8	3.1	0.1	1.3	5.5	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	2.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	1.0	0.7	183.7	0.1	0.7	0.0	1.0	0.0	0.4	0.7	0.0	0.0	0.4	0.7	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	9.5	3.2	2.3	0.0	0.9	1.7	0.4	0.0	0.0	0.0	0.1	0.3	0.2	1.5	0.6	0.0	0.0	0.0	0.7	1.6	0.0	0.0	1.6	0.0	0.2	44.6	0.0	5.7	0.0	0.0	0.0	0.7	0.0	0.0	10.1	0.0	243.8	2.6	7.0	0.0	0.0	0.5	0.0	14.7	2.7	0.1	0.0	3.7	1.8	0.0	0.0	0.0	2.1	0.0	0.0	0.0	21.4	0.0	0.1	0.1	0.5	0.1	1.5	0.0	0.0	0.0	0.5	0.0	0.1	0.1	2.7	0.3	0.6	0.0	4.2	0.2
CCL8	"HC14, MCP-2, SCYA8"	ENSG00000108700	"C-C motif chemokine ligand 8"	P80075	17	34319435-34321402	"Cancer-related genes, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	"Cytokine, Heparin-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"Smooth muscle cells: 104.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	6	"classical monocyte: 3.4"	"Lineage enriched"	"Detected in single"	6	"monocytes: 3.4"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 1.1;BJ hTERT+ SV40 Large T+ RasG12V: 1.0;EFO-21: 2.1;HSkMC: 3.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA	32000					"unprognostic (7.51e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.90e-2)"	"unprognostic (4.03e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.65e-1)"	"unprognostic (9.97e-2)"	"unprognostic (1.67e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (1.05e-7)"	"unprognostic (1.39e-1)"	"unprognostic (1.88e-2)"	"unprognostic (5.65e-2)"	"unprognostic (3.41e-2)"	17.7	4.7	0.4	5.1	0.4	1.8	6.2	0.4	0.9	1.5	1.1	18.3	14.2	7.3	1.9	3.5	1.4	8.8	2.7	0.4	0.6	5.1	3.2	7.2	4.0	0.7	0.4	0.4	1.4	1.1	4.9	0.5	7.2	0.4	2.3	16.6	0.0	1.9	1.4	0.4	0.5	17.1	9.4	0.4	3.0	3.0	3.2	0.9	12.6	2.3	7.1	0.5	13.8	0.3	1.9	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	1.1	0.0	1.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.4	0.4	0.9	0.4	0.6	0.7	0.4	0.4	0.4	0.4	0.9	1.9	21.5	0.0	0.0	0.0	0.1	4.2	0.3	0.5	0.0	0.0	0.9	1.1	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	10.5	0.9	7.5	9.6	0.0	0.0	0.0	2.0	0.0	16.4	0.0	1.6	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	3.5	18.6	2.2	0.0	12.7	5.4	0.0	0.1	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	1.3	104.3	0.0	0.0	0.0	5.4	0.1	0.8	0.7	0.0	0.1
CCN5	"CT58, CTGF-L, WISP-2, WISP2"	ENSG00000064205	"Cellular communication network factor 5"	O76076	20	44714844-44728509	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 253.2;cervix: 321.0"	"Cell type enriched"	"Detected in some"	6	"Fibroblasts: 165.2"	"Cancer enhanced"	"Detected in many"		"melanoma: 8.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 42.6;ASC TERT1: 113.8;HeLa: 62.7;HSkMC: 46.5;U-2197: 375.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			CAB019273	Approved				"Secreted to extracellular matrix"	NA	NA		1200000			"CAB019273: "	"unprognostic (1.87e-1)"	"unprognostic (2.64e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.53e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.95e-3)"	"unprognostic (1.76e-10)"	"unprognostic (1.55e-3)"	"unprognostic (7.21e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.28e-1)"	253.2	41.9	1.5	0.7	1.5	0.2	117.5	0.7	2.9	321.0	0.8	18.4	0.7	35.5	0.7	25.6	39.4	7.7	96.8	1.3	0.9	0.7	5.6	137.6	1.9	1.4	1.3	1.3	148.4	4.4	0.6	0.8	1.5	1.2	37.3	1.6	0.1	30.9	25.7	39.5	163.6	11.6	6.5	0.7	4.0	11.5	33.4	1.2	1.3	14.4	5.2	0.4	37.0	112.5	1.4	0.0	3.7	0.1	0.0	42.6	113.8	0.0	0.2	1.2	0.1	0.2	0.0	0.0	0.1	0.5	0.7	3.1	0.3	0.0	0.0	0.0	0.0	0.3	0.0	62.7	0.0	0.1	0.1	0.1	46.5	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.7	1.1	0.3	0.0	1.9	0.2	0.0	0.1	0.2	375.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.5	0.7	2.9	1.3	0.9	1.4	1.3	1.3	1.2	0.7	1.2	1.4	25.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	165.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CCNB1	CCNB	ENSG00000134057	"Cyclin B1"	P14635	5	69167135-69178245	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 53.3;lymphoid tissue: 76.9"	"Cell type enriched"	"Detected in many"	6	"Extravillous trophoblasts: 723.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basal ganglia: 3.0;white matter: 8.3"	"Not detected"	"Not detected"			"CAB000115, CAB003804, HPA030741, HPA061448"	Enhanced		Enhanced	Cytosol		Yes	Yes			Cytosol		"CAB000115: , CAB003804: AB_562272, HPA030741: AB_2673586, HPA061448: AB_2684522"	"unprognostic (4.12e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.91e-3)"	"unprognostic (4.08e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (1.54e-7)"	"prognostic unfavorable (3.38e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.49e-3)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.11e-16)"	"unprognostic (2.44e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.15e-3)"	4.0	5.1	4.1	26.2	4.3	53.3	10.1	6.4	5.0	5.8	3.2	22.4	21.1	7.7	5.4	36.2	8.3	4.0	3.1	4.0	4.8	4.8	4.3	3.9	55.0	6.1	5.1	4.3	5.0	4.3	5.8	2.7	20.9	7.0	3.8	29.8	5.8	6.5	3.9	3.5	14.7	19.6	14.5	4.0	11.2	10.9	33.2	5.3	76.9	9.4	2.0	67.6	8.5	10.5	6.4	466.0	317.1	423.5	377.1	22.2	37.1	980.2	201.3	150.8	521.3	437.0	471.2	423.9	285.2	239.1	187.6	594.2	284.2	432.4	442.8	577.2	281.4	217.2	181.6	243.2	323.2	6.8	160.5	197.7	16.6	27.7	300.5	207.2	47.7	282.8	274.2	223.5	217.9	430.2	441.4	220.5	184.7	236.7	153.3	199.3	228.4	305.2	288.2	192.6	168.2	212.7	133.5	347.7	160.3	141.9	236.4	306.4	162.5	119.8	114.4	368.5	207.6	510.2	109.2	216.6	399.8	158.8	271.9	358.6	3.1	2.0	1.5	3.2	5.1	4.5	15.4	8.3	7.4	6.0	11.1	2.7	2.6	1.3	8.2	2.4	5.0	17.6	6.2	4.1	4.3	6.4	5.0	4.0	4.8	6.1	5.1	4.3	7.0	4.0	5.3	6.4	4.0	0.0	0.5	2.0	11.8	11.5	7.2	32.1	4.6	4.8	9.8	12.3	1.9	1.5	8.8	5.5	2.1	108.2	8.3	9.5	1.9	6.5	110.2	15.2	7.4	6.6	1.2	76.2	2.7	1.4	723.1	18.3	21.4	13.0	2.5	63.0	8.9	3.2	60.2	0.0	2.1	13.8	73.2	12.0	7.2	17.8	3.1	9.7	3.6	1.0	2.7	3.9	2.1	0.5	1.0	2.4	1.5	2.6	24.1	4.5	2.5	5.6	13.1	4.1	6.6	4.9	18.5	74.3	62.2	37.4	7.2	41.5	8.0	11.8	33.4	7.8
CCNE1	CCNE	ENSG00000105173	"Cyclin E1"	P24864	19	29811991-29824312	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 36.1;placenta: 31.1"	"Cell type enriched"	"Detected in many"	14	"Extravillous trophoblasts: 1756.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"BEWO: 293.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000308, CAB016682, HPA018169"	Approved		Enhanced	Nucleoplasm		Yes	Yes			Nucleoplasm		"CAB000308: , CAB016682: AB_1614564, HPA018169: AB_1847384"	"unprognostic (2.90e-3)"	"unprognostic (1.33e-2)"	"unprognostic (1.47e-3)"	"prognostic unfavorable (6.35e-6)"	"unprognostic (5.78e-2)"	"unprognostic (4.77e-2)"	"prognostic unfavorable (3.89e-5)"	"unprognostic (1.26e-3)"	"unprognostic (3.14e-3)"	"prognostic unfavorable (2.97e-4)"	"unprognostic (3.29e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.11e-16)"	"unprognostic (5.61e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.46e-1)"	1.2	5.7	1.9	4.4	1.9	36.1	0.8	2.8	2.7	0.8	1.0	3.9	3.0	1.4	0.6	4.5	0.9	1.0	2.3	2.1	2.3	0.9	0.7	1.1	6.2	1.9	2.2	1.9	0.8	1.8	2.9	0.9	31.1	2.2	1.0	4.7	2.0	1.6	1.4	2.1	3.9	2.5	2.2	1.6	4.2	2.1	12.2	2.4	4.5	1.6	1.8	7.9	3.0	1.9	2.3	15.6	31.8	24.3	34.0	5.2	6.0	293.1	24.7	5.3	10.8	13.2	33.0	31.2	13.3	55.9	11.1	14.0	4.9	28.8	12.8	15.2	41.9	17.7	11.2	30.0	34.5	4.1	44.0	28.7	6.2	7.1	14.8	1.9	3.4	13.3	13.2	45.6	5.8	16.8	24.4	24.5	13.0	40.1	36.2	7.2	36.2	28.6	10.1	8.4	24.6	20.5	17.4	35.4	42.7	3.9	35.4	9.5	32.7	8.0	25.0	92.8	14.9	16.9	24.1	18.2	91.6	13.8	5.6	13.7	0.0	0.0	0.0	0.1	0.5	0.3	0.6	0.1	0.0	0.4	0.0	0.0	0.2	0.4	0.0	0.5	0.0	0.3	0.1	1.9	1.9	2.8	2.7	2.1	2.3	1.9	2.2	1.9	2.2	1.6	2.4	2.3	3.1	0.0	0.6	0.7	4.8	4.8	1.5	0.3	2.2	2.9	8.2	11.3	3.1	0.0	1.4	0.0	0.0	122.4	3.7	3.5	0.0	0.4	14.6	7.5	4.1	1.9	3.0	30.7	2.9	0.7	1756.5	6.0	5.6	20.1	0.0	4.6	1.4	0.2	43.4	3.3	5.1	3.3	0.0	1.0	2.5	3.6	1.2	4.2	1.8	0.0	0.2	1.7	0.0	2.5	1.3	1.4	2.2	2.2	18.4	2.2	1.0	0.4	0.1	1.1	6.6	4.1	3.4	25.0	17.6	8.5	6.0	115.7	4.5	6.9	4.9	3.5
CCNY	"C10orf9, CBCP1, CFP1"	ENSG00000108100	"Cyclin Y"	Q8ND76	10	35247025-35572669	"Predicted intracellular proteins"	"Cell cycle, Cell division, Wnt signaling pathway"	Cyclin		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"Late spermatids: 3651.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 26.4"	"Group enriched"	"Detected in all"	5	"dendritic cells: 7.8;granulocytes: 26.4;monocytes: 23.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036290	Approved					NA	NA					"HPA036290: AB_10600860"	"unprognostic (1.25e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.23e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.65e-1)"	"prognostic unfavorable (6.75e-5)"	"unprognostic (3.37e-2)"	"unprognostic (6.15e-3)"	"unprognostic (4.06e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.80e-1)"	28.3	22.1	35.3	21.4	37.1	36.2	23.9	32.9	35.4	21.9	26.0	25.4	21.7	28.7	27.2	20.6	22.4	22.9	30.7	38.0	33.0	25.0	31.3	26.1	23.6	33.9	35.0	34.4	25.4	20.8	18.1	15.6	39.1	33.4	18.5	20.2	19.5	17.2	20.3	25.7	18.9	22.4	25.9	33.8	24.6	26.5	81.8	34.9	22.7	29.9	23.1	21.2	25.6	17.5	34.9	52.3	22.2	29.3	28.2	41.6	56.5	38.2	27.4	27.7	26.0	24.9	32.4	51.7	33.2	38.1	44.1	22.7	27.1	26.3	34.6	27.7	105.0	17.3	62.0	16.0	42.4	45.8	22.7	28.3	40.3	48.1	39.9	27.1	57.6	63.3	38.3	49.1	27.3	51.6	33.2	39.9	19.6	11.2	29.6	46.2	33.0	54.4	20.7	33.2	24.6	25.8	39.3	21.5	42.7	38.6	25.4	36.9	41.8	75.5	32.1	38.6	49.4	23.9	18.3	16.6	24.4	56.0	46.6	15.1	1.7	23.4	5.2	3.3	6.5	3.6	3.1	3.2	3.5	7.8	2.4	3.2	3.6	26.4	2.9	3.4	4.0	2.3	7.6	35.3	37.1	32.9	35.4	38.0	33.0	33.9	35.0	34.4	33.4	33.8	34.9	34.9	102.2	32.1	25.9	91.1	23.4	26.9	14.1	29.0	13.6	43.5	30.2	28.7	33.1	41.5	32.1	38.6	20.9	12.0	35.2	25.8	5.9	16.5	709.0	29.5	37.2	59.8	52.8	12.4	205.5	27.8	18.1	34.4	20.4	33.4	16.5	35.3	32.5	85.3	28.9	48.8	130.0	29.0	26.4	80.4	46.9	3651.5	41.3	56.6	16.0	192.0	89.3	62.4	24.7	167.9	445.2	27.9	19.2	38.7	11.7	27.7	31.5	23.1	28.5	39.6	6.6	56.0	26.5	33.8	40.2	17.1	29.5	9.4	26.2	43.2	28.6	20.9
CD14		ENSG00000170458	"CD14 molecule"	P08571	5	140631728-140633701	"Cancer-related genes, CD markers, Human disease related genes, Plasma proteins, Predicted secreted proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 406.7"	"Cell type enriched"	"Detected in many"	4	"Hofbauer cells: 2809.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"classical monocyte: 3697.0"	"Group enriched"	"Detected in all"	5	"granulocytes: 942.3;monocytes: 3697.0"	"Cell line enhanced"	"Detected in many"		"A549: 10.1;CACO-2: 17.0;SiHa: 21.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001887, HPA002127, CAB033631, CAB072865, CAB072866"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	2750000000	10000000000	Vesicles		"CAB033631: AB_781932, CAB072865: AB_2665714, CAB072866: AB_2665715, HPA001887: AB_1078442, HPA002127: AB_1078440"	"unprognostic (1.92e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.42e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.71e-3)"	"unprognostic (4.88e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (6.80e-5)"	"unprognostic (1.20e-2)"	"unprognostic (6.87e-3)"	"unprognostic (8.12e-2)"	"unprognostic (6.92e-2)"	135.7	152.8	14.5	238.1	20.3	69.4	51.0	14.6	38.9	28.1	29.7	56.4	31.7	23.8	21.2	24.1	40.9	80.5	31.6	13.1	63.4	27.2	406.7	92.4	108.8	33.8	20.5	12.6	21.6	27.2	16.8	35.8	184.5	26.6	18.4	48.0	4.0	122.9	30.7	10.7	12.3	38.4	112.8	23.9	88.3	34.2	26.9	28.8	21.1	23.2	17.6	23.2	103.4	12.7	37.2	0.1	10.1	0.1	0.8	1.3	0.3	0.5	0.9	4.7	1.9	2.1	17.0	3.1	0.4	1.0	5.9	1.4	4.9	0.0	2.6	0.5	0.1	1.4	0.3	1.1	2.0	5.1	1.1	0.3	4.8	0.3	0.3	1.5	0.4	0.0	0.3	0.3	0.3	1.7	0.3	0.1	1.2	0.4	0.3	0.3	0.4	0.6	1.8	0.2	0.1	3.6	1.3	21.1	0.5	0.5	0.2	0.3	2.1	0.6	0.4	0.4	1.9	2.1	0.8	1.6	0.8	0.4	0.5	0.1	13.5	3697.0	21.7	6.8	677.3	8.7	12.1	3.7	3.9	440.4	1.9	5.2	3.6	942.3	3.8	95.1	25.2	3.7	3034.0	14.5	20.3	14.6	38.9	13.1	63.4	33.8	20.5	12.6	26.6	23.9	28.8	37.2	17.9	9.6	27.6	0.7	9.0	5.1	3.4	5.2	6.2	7.2	164.9	23.4	2.6	22.8	18.3	1.8	0.0	18.1	5.3	77.2	1.9	5.1	2.3	0.6	1.7	46.5	7.2	29.5	0.7	1.8	16.3	19.7	1.1	1.0	8.8	0.6	340.2	348.0	2809.2	33.7	0.9	5.9	4.1	668.4	75.9	6.1	5.0	652.8	8.8	23.4	285.3	30.0	11.3	0.5	0.4	1.8	35.3	5.3	1.8	1.7	5.0	7.0	9.8	5.1	32.9	25.8	9.7	1.5	2.0	4.4	4.3	46.1	5.5	2.1	7.4	4.9
CD160	"BY55, NK1, NK28"	ENSG00000117281	"CD160 molecule"	O95971	1	145719471-145739288	"CD markers, Predicted secreted proteins"	"Adaptive immunity, Angiogenesis, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 13.6"	"Cell type enriched"	"Detected in some"	6	"NK-cells: 410.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"gdT-cell: 107.6;MAIT T-cell: 44.5;memory CD8 T-cell: 72.9;naive CD8 T-cell: 82.8;NK-cell: 85.9"	"Group enriched"	"Detected in all"	8	"NK-cells: 85.9;T-cells: 107.6"	"Cell line enhanced"	"Detected in some"		"HeLa: 2.2"	"Not detected"	"Not detected"												"Secreted to blood"	NA	NA						"unprognostic (6.54e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.25e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.33e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.25e-3)"	"unprognostic (5.76e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.49e-3)"	"unprognostic (3.48e-5)"	"unprognostic (4.05e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.92e-4)"	0.4	0.3	1.1	1.0	1.1	5.2	0.6	3.1	0.9	0.8	0.9	1.6	4.7	0.7	0.4	0.4	0.6	1.0	1.0	0.9	0.5	0.4	5.1	1.4	3.6	0.5	0.8	0.6	0.4	0.5	0.0	0.5	0.4	1.2	0.5	1.0	1.4	1.5	0.5	0.8	1.1	4.6	0.1	0.3	13.6	0.8	0.5	0.7	0.3	0.4	0.1	1.5	0.9	0.5	0.7	0.5	0.4	0.6	0.3	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.6	0.5	0.0	0.0	0.6	0.0	0.1	0.0	1.3	0.6	1.2	2.2	0.5	0.0	0.8	1.2	0.0	0.1	0.0	0.1	0.2	0.0	0.6	0.3	0.5	0.0	0.6	0.4	1.5	0.4	0.3	1.1	0.1	0.0	0.4	0.0	0.2	0.4	0.6	0.3	0.5	0.2	0.4	0.5	0.8	0.6	0.5	0.2	0.3	1.1	0.8	0.6	0.2	0.2	0.9	0.1	12.7	0.3	0.3	107.6	0.6	44.5	1.1	1.2	72.9	0.2	1.2	0.7	82.8	5.6	85.9	1.7	1.2	0.0	81.3	1.1	1.1	3.1	0.9	0.9	0.5	0.5	0.8	0.6	1.2	0.3	0.7	0.7	1.1	0.0	0.0	0.7	1.0	0.1	0.2	0.1	0.0	1.8	0.6	0.4	0.5	0.0	0.0	0.0	10.4	0.1	59.8	3.1	0.0	0.1	4.4	0.7	0.5	1.0	0.0	6.6	0.5	0.4	0.0	0.9	3.1	0.8	2.5	0.3	3.9	0.4	0.0	6.7	0.4	0.5	0.0	4.6	0.4	11.1	0.0	0.9	0.0	0.0	1.3	0.9	410.9	0.5	0.2	0.0	0.1	0.0	2.7	0.4	0.3	0.2	0.0	2.9	0.0	1.1	0.4	0.1	0.2	0.0	0.1	0.1	44.0	0.3	1.0	0.2
CD163	"M130, MM130, SCARI1"	ENSG00000177575	"CD163 molecule"	Q86VB7	12	7470811-7503893	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Acute phase, Inflammatory response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 242.4"	"Cell type enriched"	"Detected in many"	4	"Kupffer cells: 1756.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"classical monocyte: 76.1;myeloid DC: 65.2"	"Group enriched"	"Detected in many"	40	"dendritic cells: 65.2;monocytes: 76.1"	"Cell line enhanced"	"Detected in some"		"GAMG: 1.8;HSkMC: 1.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"CAB002432, HPA046404, HPA051974"	Enhanced		Supported	"Plasma membrane"	"Secreted to blood"	NA	NA	903000000	1600000000	"Plasma membrane"		"CAB002432: AB_563510, HPA046404: AB_2679655, HPA051974: AB_2681678"	"unprognostic (1.13e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.02e-3)"	"unprognostic (2.72e-1)"	"unprognostic (6.17e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (7.27e-4)"	"unprognostic (1.04e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.84e-2)"	"unprognostic (8.77e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.20e-2)"	173.4	86.3	5.9	153.8	11.0	17.8	51.3	5.2	23.0	25.0	30.7	45.6	12.5	27.5	3.7	16.6	68.8	43.9	40.7	5.1	50.8	26.7	90.4	132.8	54.8	15.8	8.1	4.4	23.3	21.6	8.9	11.5	110.4	7.7	15.6	21.8	4.4	26.2	7.2	11.5	13.9	53.4	131.7	6.7	242.4	35.9	9.8	38.9	18.8	17.4	17.8	7.3	69.2	16.4	11.8	0.0	0.0	0.0	0.0	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	1.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	76.1	0.5	0.1	6.4	0.0	0.0	0.0	0.1	65.2	0.0	0.0	0.0	1.7	0.0	0.0	1.0	0.1	20.1	5.9	11.0	5.2	23.0	5.1	50.8	15.8	8.1	4.4	7.7	6.7	38.9	11.8	2.7	3.2	8.3	0.0	3.8	1.5	0.2	0.0	0.0	0.1	0.1	0.3	4.6	7.2	5.0	0.0	2.1	1.5	0.5	0.0	0.0	0.0	4.3	0.0	0.1	13.9	0.0	3.6	0.4	0.0	1.9	3.0	0.5	0.0	5.1	0.1	17.9	13.9	269.9	0.0	0.5	0.0	0.0	1756.1	30.9	6.4	5.0	387.9	0.0	2.8	41.1	0.9	1.0	0.0	0.0	0.0	0.0	1.2	1.0	0.1	0.0	0.2	1.6	0.2	118.3	1.7	4.0	3.9	2.6	0.5	1.0	3.0	1.3	0.0	0.0	0.1
CD300LG	"CLM9, Trem4"	ENSG00000161649	"CD300 molecule like family member g"	Q6UXG3	17	43847148-43863639	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	Immunity	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 134.8;breast: 112.8;placenta: 59.1"	"Cell type enriched"	"Detected in some"	11	"Adipocytes: 567.9"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA		1400000				"unprognostic (2.38e-2)"	"unprognostic (2.06e-3)"	"unprognostic (2.63e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.40e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.01e-2)"	"unprognostic (4.08e-3)"	"unprognostic (8.69e-4)"	"unprognostic (2.12e-5)"	"unprognostic (1.30e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.57e-1)"	134.8	2.5	0.2	1.5	0.2	0.2	112.8	0.2	0.2	3.6	0.0	2.4	0.1	4.2	12.8	1.9	4.4	4.6	27.4	0.1	0.1	2.1	1.2	11.4	1.8	0.3	0.2	0.0	1.9	2.1	1.1	0.2	59.1	0.3	1.7	0.5	0.0	1.9	2.1	22.3	7.5	2.3	1.1	0.1	2.8	3.1	20.1	0.1	3.5	3.1	47.6	0.2	2.6	3.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.1	0.1	0.3	0.2	0.0	0.3	0.1	0.1	0.1	567.9	0.0	0.0	0.0	0.7	0.1	0.1	0.0	0.6	0.0	1.8	2.3	3.3	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.6	0.0	0.0	50.2	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	5.3	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.3	1.6	13.1	0.6	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	30.9	0.3	0.0	0.0	0.0	0.7	0.0	13.1	2.3	2.9	0.3	0.7	0.1	0.4	0.0	0.3	0.2	0.0	0.0
CD38		ENSG00000004468	"CD38 molecule"	P28907	4	15778275-15853232	"Cancer-related genes, CD markers, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Receptor, Transferase"	"Cancer-related genes, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 63.9"	"Cell type enriched"	"Detected in many"	4	"Plasma cells: 378.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 18.3"	"Group enriched"	"Detected in all"	5	"B-cells: 9.9;dendritic cells: 5.8;NK-cells: 18.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 128.0;Karpas-707: 34.7;MOLT-4: 32.6;REH: 26.0;RPMI-8226: 20.9;U-266/70: 26.9;U-698: 24.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002493, HPA022132, CAB025255, HPA052381"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB002493: AB_563556, CAB025255: , HPA022132: AB_1846300, HPA052381: AB_2681807"	"unprognostic (1.27e-2)"	"unprognostic (8.06e-3)"	"unprognostic (1.06e-2)"	"prognostic favorable (9.68e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.82e-3)"	"unprognostic (2.74e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.87e-2)"	"unprognostic (6.15e-6)"	"unprognostic (5.23e-1)"	"unprognostic (4.34e-1)"	"unprognostic (6.63e-6)"	"unprognostic (1.79e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.13e-1)"	3.1	2.4	3.2	13.2	3.6	13.8	2.0	3.1	2.9	0.6	1.0	4.5	5.8	0.9	1.3	1.1	3.0	1.9	3.7	3.4	5.5	0.7	3.3	6.4	23.6	4.9	5.3	1.3	0.7	0.3	0.1	1.8	0.5	4.7	13.3	3.6	0.2	2.6	19.8	21.6	0.3	5.3	1.4	2.5	17.1	3.0	1.0	4.1	63.9	2.1	3.5	18.2	6.9	0.5	4.8	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	128.0	0.0	0.0	0.4	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	17.0	0.2	34.7	0.0	0.0	32.6	7.9	0.2	0.0	0.0	26.0	0.1	20.9	0.0	0.0	0.2	1.5	0.0	0.2	0.5	0.3	0.1	5.7	0.5	0.0	0.1	0.1	0.0	26.9	0.2	24.3	0.4	6.2	0.3	0.1	1.9	0.1	1.2	2.4	0.3	9.9	1.5	1.2	4.7	7.7	2.4	1.9	1.4	18.3	1.9	5.8	2.4	4.4	3.2	3.6	3.1	2.9	3.4	5.5	4.9	5.3	1.3	4.7	2.5	4.1	4.8	0.8	3.2	15.1	86.5	59.7	0.0	0.4	0.6	0.6	0.1	0.1	0.0	1.0	0.0	11.6	0.0	10.4	0.2	33.8	0.2	0.0	0.0	2.5	4.0	1.4	2.7	0.0	78.6	0.4	0.0	0.2	2.7	2.0	0.3	38.2	0.8	2.9	4.3	4.4	0.0	0.4	1.3	0.0	44.3	0.8	0.7	0.0	17.7	7.2	5.6	3.1	0.0	79.3	1.0	1.8	0.0	0.3	0.0	378.4	8.1	0.2	0.1	42.5	0.1	13.1	1.5	7.6	2.9	1.7	1.6	0.0	0.5	26.5	0.0	1.6	0.2
CD40LG	"CD154, CD40L, gp39, hCD40L, HIGM1, IMD3, TNFSF5, TRAP"	ENSG00000102245	"CD40 ligand"	P29965	X	136648158-136660390	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 15.6"	"Cell type enriched"	"Detected in some"	8	"T-cells: 76.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"gdT-cell: 26.3;MAIT T-cell: 64.1;memory CD4 T-cell: 80.5;naive CD4 T-cell: 76.1"	"Lineage enriched"	"Detected in many"	39	"T-cells: 80.5"	"Cell line enriched"	"Detected in some"	15	"MOLT-4: 23.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA045827, HPA072480"	Enhanced		Approved	"Golgi apparatus,Plasma membrane"	"Secreted to blood"	NA	NA	776000	20000	"Golgi apparatus, Plasma membrane"		"HPA045827: AB_10959606, HPA072480: "	"unprognostic (1.94e-5)"	"unprognostic (1.24e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.27e-3)"	"unprognostic (4.71e-2)"	"unprognostic (3.56e-5)"	"unprognostic (3.66e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.14e-4)"	"unprognostic (1.87e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.70e-4)"	"unprognostic (2.15e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.36e-3)"	"unprognostic (2.92e-2)"	0.6	0.3	0.1	8.0	0.0	1.9	1.1	0.2	0.2	0.9	0.3	1.9	1.9	0.3	0.2	1.0	0.5	2.1	0.2	0.2	0.1	0.4	1.0	2.4	15.6	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.8	3.1	0.0	0.7	0.3	0.1	0.6	3.9	0.6	0.1	5.0	2.0	0.3	0.1	15.6	0.5	0.2	14.9	2.5	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.3	26.3	0.1	64.1	0.1	80.5	11.7	0.2	0.0	76.1	0.7	1.3	0.8	0.1	0.1	10.5	13.6	0.1	0.0	0.2	0.2	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.6	0.0	2.4	0.0	2.4	1.3	0.0	0.0	0.0	0.0	0.4	0.5	0.3	0.0	0.6	0.0	0.0	0.0	4.5	0.0	0.0	0.0	3.9	0.0	0.0	0.6	0.0	1.7	0.0	0.0	0.0	0.6	2.6	0.0	1.3	0.0	1.1	0.3	0.1	0.0	0.0	0.0	0.0	0.6	4.0	8.9	0.0	2.9	1.8	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.7	0.0	0.0	0.1	2.0	0.0	76.6	0.0	0.0	0.1
CD70	"CD27L, CD27LG, TNFSF7"	ENSG00000125726	"CD70 molecule"	P32970	19	6583183-6604103	"Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Cytokine	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 3.4"	"Cell type enriched"	"Detected in some"	4	"monocytes: 239.4"	"Cancer enriched"	"Detected in many"	4	"renal cancer: 24.7"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 44.2"	"Group enriched"	"Detected in many"	35	"B-cells: 24.2;T-cells: 44.2"	"Cell line enhanced"	"Detected in many"		"SiHa: 189.2;THP-1: 157.3;U-251 MG: 234.2;U-266/70: 399.5;U-266/84: 312.7;U-698: 138.1"	"Region enriched"	"Detected in single"	25	"cerebellum: 11.3"	"Low region specificity"	"Detected in all"			HPA046582			Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA046582: "	"unprognostic (8.71e-2)"	"unprognostic (9.91e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.33e-4)"	"unprognostic (1.73e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (6.29e-4)"	"unprognostic (1.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (3.22e-4)"	"unprognostic (2.57e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.08e-1)"	1.6	0.1	0.1	3.2	0.1	0.8	1.1	0.4	0.3	0.3	0.4	2.3	0.5	0.1	0.0	0.7	0.2	0.4	0.1	0.2	0.3	0.5	0.2	0.9	3.4	0.2	0.1	0.1	0.1	0.3	0.0	0.1	0.1	0.2	0.2	1.5	0.0	0.2	0.0	0.3	1.0	2.2	0.1	0.1	2.9	1.0	0.3	0.1	1.5	0.3	0.9	1.9	1.1	0.5	0.4	1.3	39.1	0.1	75.6	1.7	1.0	0.1	0.0	0.3	0.3	2.6	0.1	0.5	74.2	4.1	0.4	81.8	53.2	46.5	3.6	0.0	0.2	1.6	0.0	56.8	0.1	0.0	0.0	2.2	0.5	0.4	43.9	31.1	12.2	0.3	0.1	1.3	2.5	1.1	0.2	1.3	94.3	0.9	0.0	70.0	20.3	0.1	16.3	24.6	0.2	0.0	0.0	189.2	0.0	0.8	0.2	0.5	157.3	1.0	0.6	32.6	0.0	234.2	399.5	312.7	138.1	41.0	23.8	14.8	0.8	0.1	0.1	3.3	0.0	8.1	24.2	5.3	8.8	0.1	9.9	0.7	2.1	0.2	0.9	0.0	0.3	44.2	1.6	0.1	0.1	0.4	0.3	0.2	0.3	0.2	0.1	0.1	0.2	0.1	0.1	0.4	0.6	0.0	0.0	0.0	50.9	5.7	0.1	11.1	0.0	0.0	0.1	0.3	0.2	0.0	0.3	1.8	0.0	0.0	2.3	0.0	0.0	0.3	0.0	0.4	0.0	1.6	1.8	0.0	0.1	0.7	0.0	11.3	0.5	0.2	1.3	0.1	0.7	0.3	0.4	0.0	0.7	0.0	18.3	0.6	14.6	0.0	0.0	3.0	3.6	0.0	239.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0	24.9	0.2	0.0	0.2	0.7	0.0	0.0	0.4	0.9	0.2	0.6	0.4	5.4	0.0	14.1	0.0	0.4	0.0
CDK18	"PCTAIRE3, PCTK3"	ENSG00000117266	"Cyclin dependent kinase 18"	Q07002	1	205504596-205532793	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 188.2;heart muscle: 109.9"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 462.9"	"Cancer enhanced"	"Detected in all"		"renal cancer: 32.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 38.5;HeLa: 35.3;hTERT-RPE1: 32.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045429	Approved		Approved	"Actin filaments"		No	No			"Actin filaments"		"HPA045429: AB_10961257"	"unprognostic (7.95e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.30e-1)"	"unprognostic (7.06e-3)"	"unprognostic (2.93e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.89e-2)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (5.07e-6)"	"unprognostic (6.07e-2)"	"unprognostic (1.45e-1)"	"unprognostic (6.12e-2)"	"prognostic favorable (2.81e-5)"	4.6	9.1	77.0	4.2	114.0	1.1	5.1	131.9	86.3	11.0	39.0	11.8	29.1	8.7	3.5	5.7	8.7	10.5	109.9	56.1	93.1	26.2	10.7	11.1	2.8	150.4	144.3	52.0	12.7	17.0	7.9	11.6	16.3	157.1	9.3	9.3	13.4	29.4	23.8	6.2	3.3	25.1	7.0	139.4	9.6	36.1	1.7	116.3	3.6	9.5	5.3	3.7	5.8	7.6	188.2	22.2	1.4	0.2	1.3	0.0	0.0	22.6	0.4	4.1	1.0	5.5	9.4	17.8	12.4	3.2	0.2	1.9	21.2	4.9	38.5	0.9	3.4	3.8	3.0	35.3	10.5	4.0	0.1	0.2	2.5	1.9	0.1	0.8	32.2	0.0	18.4	0.1	15.2	0.3	17.7	1.2	0.6	18.4	6.1	0.9	1.6	0.1	16.6	3.6	13.5	7.9	2.8	6.4	3.2	14.2	24.5	15.3	6.2	0.0	0.0	8.1	0.1	0.1	4.1	2.1	2.5	0.2	9.4	3.7	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	77.0	114.0	131.9	86.3	56.1	93.1	150.4	144.3	52.0	157.1	139.4	116.3	188.2	4.6	0.0	0.5	12.4	1.0	3.4	6.9	17.4	11.4	7.0	4.6	5.6	29.6	5.7	6.8	73.5	0.0	5.7	0.2	12.1	7.9	18.5	2.4	2.1	0.7	2.9	6.0	1.3	12.0	6.7	2.3	3.8	15.8	4.6	0.0	13.3	2.5	3.7	5.3	0.0	4.5	12.9	2.0	3.8	4.5	4.0	0.9	3.8	3.6	12.2	4.4	28.2	1.0	4.5	462.9	6.5	111.2	1.5	0.9	10.8	35.6	18.7	3.3	1.2	6.6	5.8	12.8	6.6	17.0	5.3	1.3	1.9	1.4	22.7	13.7	9.2
CEACAM21	"FLJ13540, R29124_1"	ENSG00000007129	"CEA cell adhesion molecule 21"	Q3KPI0	19	41549518-41586844	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 17.6;lymphoid tissue: 10.3"	"Cell type enriched"	"Detected in some"	10	"Granulosa cells: 150.8"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.2"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"HMC-1: 8.6;Karpas-707: 6.1;THP-1: 3.3;U-266/70: 5.8;U-937: 5.8"									HPA043411	Uncertain					NA	NA					"HPA043411: AB_10794886"	"unprognostic (2.55e-1)"	"unprognostic (1.61e-3)"	"unprognostic (5.73e-2)"	"prognostic favorable (1.89e-5)"	"unprognostic (2.57e-1)"	"unprognostic (8.02e-4)"	"unprognostic (3.04e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.51e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.37e-6)"	"unprognostic (2.09e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.37e-1)"	1.1	0.7	1.4	2.2	0.9	17.6	0.8	0.9	1.3	2.2	0.7	0.7	0.6	2.7	0.3	0.5	0.7	0.5	0.5	0.9	2.3	0.7	1.2	3.8	5.3	1.9	2.5	0.8	0.4	0.2	0.1	0.4	1.5	1.9	0.6	0.6	0.0	0.5	3.6	0.1	0.1	2.6	0.5	1.5	10.3	0.9	1.1	3.1	2.2	0.6	0.1	3.5	0.8	0.3	1.7	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	6.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	5.8	1.0	1.0	0.0	5.8	0.0	0.1	6.0	27.3	29.7	11.7	20.1	10.8	25.6	20.8	6.9	15.1	21.3	21.0	30.2	19.2	7.0	12.4	26.6	17.9	1.4	0.9	0.9	1.3	0.9	2.3	1.9	2.5	0.8	1.9	1.5	3.1	1.7	1.5	0.0	0.0	0.3	5.2	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.6	1.8	0.0	0.1	7.2	0.0	0.0	0.0	5.4	7.3	0.1	2.0	0.0	5.7	0.1	0.0	0.1	0.3	0.0	2.2	4.5	150.8	10.0	0.3	9.4	0.0	0.7	0.0	0.0	9.0	0.6	10.3	0.0	6.2	1.8	15.0	1.0	0.0	9.2	0.0	0.1	0.0	0.0	0.4	10.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.6	0.6	0.0	0.0	0.3	8.8	0.0	0.0	0.0
CEP104	"CFAP256, GlyBP, JBTS25, KIAA0562, ROC22, RP1-286D6.4"	ENSG00000116198	"Centrosomal protein 104"	O60308	1	3812086-3857396	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Ciliopathy, Joubert syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"Cone photoreceptor cells: 458.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010126	Approved					NA	NA					"HPA010126: AB_10601583"	"unprognostic (3.60e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.83e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.49e-3)"	"unprognostic (8.35e-2)"	"unprognostic (4.85e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.90e-1)"	"unprognostic (2.89e-1)"	"prognostic favorable (1.70e-5)"	"unprognostic (7.06e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.55e-1)"	9.1	9.2	8.5	6.7	10.0	3.1	6.5	9.2	7.0	7.0	10.4	7.7	5.2	7.2	4.3	7.7	8.0	6.3	7.6	5.3	8.0	11.4	8.8	7.5	7.1	11.7	11.5	3.9	7.5	8.9	14.1	8.1	6.7	13.7	7.7	6.7	9.1	7.9	8.6	9.6	7.1	7.2	9.4	8.0	6.6	7.7	9.7	10.2	8.4	10.0	7.0	8.8	8.2	6.7	9.1	13.4	10.8	8.8	11.8	20.9	15.9	6.8	14.0	11.2	19.5	12.8	8.0	11.4	15.7	17.6	14.8	14.0	12.8	20.3	13.1	23.1	22.1	15.5	15.8	12.7	10.2	13.5	15.5	13.3	8.0	13.0	17.9	28.0	13.6	16.6	17.3	19.6	15.7	18.3	6.2	22.8	6.3	6.3	18.9	20.2	14.1	12.3	17.1	12.7	7.8	22.1	8.8	21.7	23.8	15.0	10.8	10.2	8.0	19.1	14.0	6.5	23.6	11.4	13.0	20.6	22.5	7.9	17.4	5.6	0.3	0.1	1.5	0.6	0.2	0.5	0.2	0.4	0.6	0.3	0.7	0.7	0.1	0.2	0.7	0.4	0.9	0.2	0.1	8.5	10.0	9.2	7.0	5.3	8.0	11.7	11.5	3.9	13.7	8.0	10.2	9.1	13.7	25.6	25.9	15.7	14.7	15.9	14.2	9.2	12.0	24.8	12.8	9.1	14.1	12.8	13.9	25.8	458.7	16.3	18.6	16.2	7.9	26.0	74.9	34.3	14.4	15.4	11.3	10.7	23.7	19.6	24.4	12.9	12.2	18.9	10.8	12.6	8.9	18.4	13.2	58.9	24.6	13.5	4.1	14.6	7.8	91.7	12.5	14.3	19.6	12.2	21.0	13.8	22.6	12.1	34.1	24.3	11.7	20.7	23.2	19.2	16.6	18.5	28.7	55.2	19.7	19.8	16.1	63.7	23.5	15.0	20.0	11.4	17.2	18.2	12.7	13.7
CEP72	"FLJ10565, KIAA1519"	ENSG00000112877	"Centrosomal protein 72"	Q9P209	5	612340-667168	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 7.3"	"Cell type enriched"	"Detected in many"	4	"Melanocytes: 135.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 4.5"	"Group enriched"	"Detected in many"	4	"B-cells: 1.6;NK-cells: 4.5;T-cells: 1.7"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 46.0;HeLa: 40.0"	"Region enriched"	"Detected in many"	8	"cerebellum: 14.1"	"Not detected"	"Not detected"			"HPA058235, HPA074879"	Approved		Approved	Nucleoplasm,Centrosome,Mitochondria		NA	NA			Centrosome	"Nucleoplasm, Mitochondria"	"HPA058235: AB_2683649, HPA074879: AB_2686720"	"unprognostic (2.06e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (8.50e-2)"	"unprognostic (9.74e-2)"	"unprognostic (2.94e-3)"	"unprognostic (3.20e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.38e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.81e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.93e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.24e-2)"	1.1	0.9	1.1	1.9	1.1	3.1	1.4	1.3	1.3	1.6	0.8	1.1	1.4	1.3	1.0	2.2	1.6	1.5	0.8	1.4	0.9	1.1	2.1	1.4	2.7	0.9	0.8	1.0	2.8	2.0	1.2	1.5	0.7	1.0	1.3	0.9	1.1	1.7	0.8	0.7	2.4	1.6	0.9	0.5	1.8	1.9	7.3	0.9	3.1	1.8	0.6	1.4	1.3	1.7	1.8	7.5	11.9	10.6	15.0	0.9	1.0	19.1	3.2	1.4	7.1	6.2	10.8	11.2	8.8	8.2	1.4	13.2	7.1	7.5	5.4	2.8	46.0	11.8	9.7	40.0	4.3	1.3	11.3	6.3	1.1	2.3	6.1	4.1	1.4	2.8	17.0	10.1	10.1	3.5	5.7	17.1	9.8	7.0	6.4	11.1	12.8	6.1	12.2	2.3	5.8	8.1	6.2	23.3	7.6	2.0	3.3	7.6	8.7	0.9	6.8	9.9	6.5	4.6	6.3	6.4	8.8	4.2	15.7	7.3	0.0	0.3	0.3	1.3	0.1	1.7	1.4	1.1	1.2	0.1	1.6	1.6	1.6	0.0	4.5	0.6	0.4	1.5	0.8	1.1	1.1	1.3	1.3	1.4	0.9	0.9	0.8	1.0	1.0	0.5	0.9	1.8	0.7	3.2	1.5	1.3	2.9	5.7	0.9	2.4	0.6	2.5	1.1	1.8	2.2	2.8	1.0	0.0	0.0	1.2	1.1	1.1	0.0	2.5	4.0	2.4	1.5	1.1	0.0	4.2	2.5	0.9	5.1	1.0	3.6	1.9	0.0	3.8	0.4	1.7	1.4	3.3	1.3	0.7	4.1	0.8	2.9	2.2	1.2	0.7	135.2	1.0	1.4	0.9	2.1	2.0	3.9	2.3	0.5	2.6	4.7	1.1	0.1	0.5	3.4	2.0	0.0	1.3	1.1	30.7	10.1	2.8	3.7	1.6	1.9	0.9	1.3	2.5
CERCAM	"CEECAM1, GLT25D3"	ENSG00000167123	"Cerebral endothelial cell adhesion molecule"	Q5T4B2	9	128411751-128437351	"Metabolic proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 566.7"	"Cell type enriched"	"Detected in many"	7	"Oligodendrocytes: 626.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 280.5;ASC TERT1: 284.1;fHDF/TERT166: 271.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021657, HPA051595"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Nucleoli"	"Cell Junctions"	"HPA021657: AB_1846507, HPA051595: AB_2681545"	"unprognostic (2.87e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.89e-3)"	"unprognostic (2.19e-1)"	"unprognostic (4.68e-3)"	"unprognostic (7.79e-3)"	"unprognostic (3.29e-3)"	"unprognostic (5.68e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (5.22e-4)"	"unprognostic (1.59e-1)"	"unprognostic (5.93e-2)"	"prognostic unfavorable (3.33e-16)"	"unprognostic (1.34e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.05e-3)"	"prognostic unfavorable (3.30e-5)"	24.1	9.0	244.5	12.4	399.8	2.6	24.7	257.1	340.0	39.8	155.3	18.9	8.0	35.3	9.8	13.2	23.6	31.5	27.5	260.2	324.4	16.1	3.8	17.0	4.2	388.4	359.4	217.8	31.4	30.3	31.2	107.3	49.8	475.4	28.2	7.8	1.0	21.6	23.0	7.1	15.1	12.4	47.8	249.2	10.9	16.0	11.2	373.1	2.4	23.6	7.0	4.0	30.2	31.1	566.7	44.7	26.0	35.2	38.2	280.5	284.1	27.4	145.5	149.7	41.2	32.0	10.3	2.4	0.0	58.3	271.9	33.5	33.8	14.7	22.2	13.9	11.7	25.6	2.9	24.1	15.5	89.7	5.4	84.4	171.6	11.7	48.4	10.5	157.7	44.3	3.0	13.0	36.5	51.8	82.3	2.3	55.7	1.8	2.3	25.4	4.7	23.6	7.3	18.4	15.5	4.9	8.5	33.8	43.1	16.7	10.1	34.4	13.7	48.2	103.5	27.3	138.1	23.2	42.2	35.0	0.8	99.7	17.1	21.0	0.1	0.6	0.0	1.8	0.7	0.1	0.1	0.1	2.1	0.7	0.0	0.0	2.3	0.0	0.6	0.0	1.0	0.0	1.3	244.5	399.8	257.1	340.0	260.2	324.4	388.4	359.4	217.8	475.4	249.2	373.1	566.7	8.5	6.4	10.3	7.2	3.5	8.9	6.5	7.0	10.8	1.7	8.7	6.9	3.9	0.0	13.6	11.0	0.0	18.4	5.8	0.0	0.0	11.6	2.7	3.1	18.7	7.7	0.0	2.5	2.9	3.4	61.1	82.3	3.6	6.7	8.8	9.8	16.8	0.1	6.2	6.7	3.3	0.0	2.0	0.8	10.4	2.3	24.2	2.9	40.9	3.7	1.3	0.1	17.5	11.6	626.9	4.5	0.0	26.4	17.9	5.0	0.0	0.9	3.9	0.9	6.6	27.8	26.4	8.6	22.2	2.4	4.1	19.6	3.3	5.9	0.0	2.8
CETN3	CEN3	ENSG00000153140	"Centrin 3"	O15182	5	90392257-90409766	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 131.5"	"Cell type enriched"	"Detected in all"	4	"Spermatocytes: 469.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035608, HPA063704"	Enhanced		Supported	Centrosome		NA	NA			Centrosome		"HPA035608: AB_10601098, HPA063704: AB_2685097"	"unprognostic (2.08e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.58e-2)"	"prognostic unfavorable (2.22e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.18e-2)"	"unprognostic (8.77e-2)"	"unprognostic (5.03e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.53e-1)"	"unprognostic (5.21e-2)"	"unprognostic (2.35e-1)"	17.6	21.8	20.1	14.8	21.5	7.7	24.3	20.5	26.5	20.8	20.0	17.1	9.7	20.2	22.0	13.6	22.8	10.4	22.3	19.3	19.9	20.0	13.6	13.5	19.3	21.8	22.3	18.4	31.2	9.3	24.6	16.9	19.4	22.3	19.2	19.8	35.6	15.3	14.9	14.5	15.5	10.7	14.0	20.6	15.2	13.0	131.5	21.3	20.8	15.3	14.2	21.1	11.4	11.8	28.8	38.4	18.7	66.2	13.4	38.8	49.2	39.5	41.2	25.4	39.7	47.1	25.5	45.3	71.7	40.4	20.2	76.9	26.2	58.5	57.4	63.5	59.6	27.2	36.4	26.9	32.6	27.3	26.9	22.2	32.7	36.6	29.4	49.1	42.5	24.1	56.8	47.2	30.9	44.3	26.5	46.2	42.6	23.2	14.0	42.6	40.6	45.7	37.0	35.1	14.5	36.0	37.2	40.2	19.9	31.7	59.1	37.7	36.6	28.0	22.6	32.7	32.0	55.7	28.6	55.5	63.6	26.9	60.5	23.3	19.7	9.9	14.8	12.9	13.1	13.7	27.3	14.3	14.6	11.3	21.8	20.4	16.3	1.2	17.3	16.6	30.6	13.3	6.9	20.1	21.5	20.5	26.5	19.3	19.9	21.8	22.3	18.4	22.3	20.6	21.3	28.8	19.5	19.2	38.7	13.4	17.8	14.3	34.3	70.3	22.2	19.3	23.5	25.7	53.0	27.1	37.5	36.8	18.8	69.4	13.4	11.9	95.9	21.8	20.2	41.4	26.6	22.4	24.0	54.1	8.4	10.0	69.5	33.0	6.1	24.4	6.3	19.6	48.5	42.2	26.0	21.9	12.6	21.2	48.8	19.2	5.1	38.5	44.1	10.3	19.6	8.4	19.6	84.0	17.5	15.1	34.1	12.8	21.4	32.4	8.4	16.5	8.5	46.2	75.9	24.4	59.2	14.2	23.8	469.5	66.3	19.6	15.8	41.7	15.0	17.2	24.8	21.6
CFAP300	"C11orf70, FBB5, MGC13040"	ENSG00000137691	"Cilia and flagella associated protein 300"	Q9BRQ4	11	102047437-102084554	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 29.5;testis: 30.5"	"Cell type enriched"	"Detected in some"	4	"Endometrial ciliated cells: 142.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 17.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038585	Enhanced		Approved	Centrosome		NA	NA			Centrosome		"HPA038585: AB_10795357"	"unprognostic (9.70e-2)"	"unprognostic (3.18e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.77e-6)"	"unprognostic (1.76e-2)"	"unprognostic (8.68e-3)"	"unprognostic (2.94e-2)"	"unprognostic (6.73e-3)"	2.8	3.5	5.0	0.4	2.5	0.0	2.6	2.9	2.1	5.5	9.2	1.1	0.8	4.3	10.8	1.8	29.5	3.3	1.1	2.1	7.2	1.7	0.1	3.0	0.9	5.2	4.6	1.4	4.2	0.8	2.7	4.1	3.4	4.8	4.0	0.8	1.4	0.8	6.7	0.2	1.2	0.8	2.9	5.7	0.1	1.9	30.5	3.3	0.6	3.7	0.0	0.5	3.1	1.9	4.0	0.1	8.5	8.5	0.0	7.5	17.9	0.2	3.4	8.6	4.6	6.5	0.6	11.1	0.0	2.0	6.7	2.3	2.1	2.1	1.0	3.3	0.0	1.3	0.0	1.3	0.0	5.3	0.0	0.0	7.8	10.5	11.9	8.0	8.9	0.1	0.1	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.2	3.5	0.0	0.0	0.0	12.6	2.4	9.4	0.0	11.0	0.1	0.0	0.0	9.6	0.0	1.3	1.1	3.5	11.2	2.8	0.1	0.0	0.0	3.7	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.0	2.5	2.9	2.1	2.1	7.2	5.2	4.6	1.4	4.8	5.7	3.3	4.0	0.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.4	3.8	0.0	0.0	0.0	29.5	0.0	7.1	0.1	0.0	1.9	4.0	0.0	142.5	9.8	0.2	0.0	0.0	0.0	0.0	0.5	3.4	0.0	2.1	0.0	2.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.9	0.2	6.0	0.0	0.0
CFAP73	"CCDC42B, MIA2"	ENSG00000186710	"Cilia and flagella associated protein 73"	A6NFT4	12	113149858-113159276	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.0;choroid plexus: 23.3;fallopian tube: 42.6"	"Cell type enriched"	"Detected in some"	4	"Endometrial ciliated cells: 110.3"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 5.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 4.3;REH: 2.2;T-47d: 2.5;U-698: 9.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA048539	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"		NA	NA			"Nucleoli fibrillar center"	"Nucleoplasm, Vesicles"	"HPA048539: AB_2680434"	"unprognostic (2.42e-2)"	"prognostic favorable (1.29e-4)"	"unprognostic (1.90e-3)"	"prognostic favorable (5.52e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.18e-3)"	"unprognostic (6.49e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.14e-1)"	"unprognostic (5.68e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.62e-4)"	"unprognostic (2.03e-4)"	"unprognostic (1.60e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.55e-2)"	0.2	0.4	15.7	0.4	5.5	2.1	0.3	5.4	2.4	2.1	23.3	0.2	0.3	0.5	0.3	0.5	42.6	0.2	0.1	4.0	14.3	1.0	0.5	7.2	0.7	13.8	14.6	0.8	0.4	0.4	0.1	1.2	0.0	11.7	0.6	0.0	0.2	2.3	0.7	0.3	4.8	0.5	0.0	19.0	0.6	4.0	0.5	6.2	0.0	0.8	0.0	1.2	0.2	0.2	3.7	0.2	0.0	0.2	0.3	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.3	2.0	4.3	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.3	0.2	1.7	0.1	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.3	0.0	0.0	0.7	0.2	0.7	0.3	0.8	0.1	2.2	0.0	0.3	0.5	0.5	0.4	0.1	0.0	0.6	0.0	0.2	2.5	0.0	0.1	0.1	0.7	0.2	0.1	0.4	0.1	9.2	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	5.5	5.4	2.4	4.0	14.3	13.8	14.6	0.8	11.7	19.0	6.2	3.7	0.0	0.0	1.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.4	0.0	0.0	6.2	3.7	0.0	0.1	0.1	0.2	0.0	0.0	0.4	110.3	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.6	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.3	0.3	0.3	0.0	0.0	0.0	0.8	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.2	0.1	23.3	0.2	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.1	0.1	0.2
CFC1B		ENSG00000152093	"Cripto, FRL-1, cryptic family 1B"	P0CG36	2	130521197-130528604	"Predicted secreted proteins"	Gastrulation	"Developmental protein"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"pituitary gland: 2.4"	"Cell type enriched"	"Detected in single"	9	"Bipolar cells: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA041773	Approved				"Secreted - unknown location"	NA	NA					"HPA041773: AB_2677664"																		0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	2.4	0.0	0.3	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CGB2		ENSG00000104818	"Chorionic gonadotropin subunit beta 2"	Q6NT52	19	49031890-49033238	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 1.6"	"Cell type enriched"	"Detected in some"	6	"Syncytiotrophoblasts: 40.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HMC-1: 29.9;U-266/70: 12.1;U-266/84: 15.6"									"HPA038925, HPA038934"	Supported		Approved	Cytosol	"Secreted in other tissues"	NA	NA			Cytosol		"HPA038925: AB_2676272, HPA038934: AB_2676277"										"unprognostic (3.05e-2)"								0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.6	0.2	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.3	1.8	0.7	0.0	0.2	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	4.1	0.0	0.5	0.0	0.1	0.3	0.0	29.9	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.3	0.1	0.0	0.0	0.3	0.8	0.0	3.9	12.1	15.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.1	0.2	0.1	0.0	0.6	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	1.5	1.8	0.0	0.0	40.0	0.0	0.0	0.0	0.0
CHIT1	"CHI3, CHIT"	ENSG00000133063	"Chitinase 1"	Q13231	1	203212827-203273641	"Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Carbohydrate metabolism, Chitin degradation, Polysaccharide degradation"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 50.3;lung: 36.7;lymphoid tissue: 21.9"	"Cell type enriched"	"Detected in some"	10	"Hofbauer cells: 40.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 31.9"	"Region enriched"	"Detected in some"	5	"cerebral cortex: 12.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA010575, HPA074844"	Enhanced				"Secreted to blood"	NA	NA	26400000	57000000			"HPA010575: AB_1078512, HPA074844: "	"unprognostic (5.80e-3)"	"prognostic favorable (2.02e-4)"	"unprognostic (2.58e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.87e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.55e-2)"	"unprognostic (6.36e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.56e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.95e-1)"	8.7	0.3	0.4	0.4	0.5	50.3	8.3	0.2	12.5	8.2	0.4	1.2	0.0	3.6	0.1	0.0	0.1	0.4	0.2	0.4	0.2	0.1	0.8	36.7	21.9	0.5	0.4	0.3	0.5	2.1	0.0	0.0	0.7	1.4	1.0	1.0	0.0	0.4	0.0	0.2	0.3	0.8	0.0	0.6	5.7	0.5	0.0	0.4	3.5	1.3	0.0	1.1	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.4	0.4	0.5	0.2	12.5	0.4	0.2	0.5	0.4	0.3	1.4	0.6	0.4	2.3	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.2	0.0	0.0	0.2	0.3	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.4	0.0	0.1	0.0	0.0	0.0	0.0	40.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	3.9	0.0	0.0	0.6	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0
CLCNKA	hClC-Ka	ENSG00000186510	"Chloride voltage-gated channel Ka"	P51800	1	16018875-16034050	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"	"Bartter syndrome, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 96.7;parathyroid gland: 49.3"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 271.5"	"Group enriched"	"Detected in some"	7	"renal cancer: 4.4;thyroid cancer: 1.6"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"U-266/70: 7.4"									HPA057717	Approved					NA	NA					"HPA057717: AB_2683509"	"unprognostic (2.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.02e-1)"	"unprognostic (2.76e-3)"	"unprognostic (8.20e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.18e-2)"	"unprognostic (6.92e-3)"	"unprognostic (3.49e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.13e-3)"	"unprognostic (1.36e-1)"	"unprognostic (9.13e-2)"	"unprognostic (4.37e-3)"	"unprognostic (1.28e-1)"	0.6	2.9	0.3	0.0	0.3	0.0	0.9	2.1	0.4	0.5	3.9	0.4	0.0	0.6	0.5	0.0	0.5	0.1	0.5	0.7	0.6	96.7	0.2	0.3	0.0	0.4	0.6	0.3	0.9	3.5	49.3	18.4	0.0	0.9	0.8	0.0	2.3	7.0	0.2	0.5	0.7	0.1	0.2	0.3	0.1	3.9	4.5	0.4	0.0	21.8	0.3	0.0	0.2	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.2	1.6	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	2.1	0.4	0.7	0.6	0.4	0.6	0.3	0.9	0.3	0.4	0.3	0.0	3.2	0.5	0.3	0.0	0.1	0.1	0.0	0.0	3.9	0.4	0.1	3.8	0.0	0.7	25.8	0.0	0.4	0.0	0.1	25.4	0.3	40.2	0.1	0.0	0.1	1.2	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	4.5	0.0	0.0	0.1	13.5	0.2	0.1	67.1	0.0	0.0	271.5	0.3	0.0	1.8	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.3	0.0	0.7	0.0	0.0	0.1	1.9	1.2	0.0	0.0	0.7	0.1	0.0	0.3	0.2
CLDN12		ENSG00000157224	"Claudin 12"	P56749	7	90383721-90513402	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"Early spermatids: 354.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA026945	Approved					NA	NA					"HPA026945: AB_10603786"	"unprognostic (1.45e-2)"	"prognostic unfavorable (6.36e-4)"	"unprognostic (3.84e-2)"	"unprognostic (4.87e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.86e-2)"	"unprognostic (6.47e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.67e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.19e-2)"	"unprognostic (7.66e-2)"	"unprognostic (2.37e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.30e-1)"	8.4	22.2	17.2	7.1	18.2	3.2	21.3	19.7	20.6	13.8	16.7	22.4	18.9	14.2	20.0	12.0	15.5	19.2	18.5	16.9	19.6	24.3	52.4	12.2	2.0	17.8	17.2	16.0	20.7	14.7	21.8	22.7	10.2	16.4	24.3	24.1	31.6	19.8	12.5	17.5	8.4	21.5	13.3	15.5	4.6	21.8	12.9	19.8	5.8	17.3	23.2	5.1	15.9	10.5	19.7	25.5	22.6	26.3	17.8	27.1	22.2	14.3	30.3	33.6	19.9	33.2	21.7	65.0	4.1	24.1	18.2	43.9	21.2	23.4	27.9	39.8	6.0	22.1	2.5	19.9	23.8	26.8	5.1	2.8	27.8	29.7	33.3	52.3	35.9	10.5	5.0	14.8	14.3	30.0	12.1	6.8	12.0	44.7	32.6	14.4	3.4	37.9	6.2	31.0	17.0	21.4	39.1	16.8	15.6	51.7	42.1	18.2	16.4	25.8	46.6	29.2	36.6	33.5	7.8	8.1	0.6	33.1	3.6	24.0	0.0	0.2	0.0	0.3	0.3	0.3	0.3	0.6	0.1	1.0	0.1	0.2	0.3	0.0	0.0	0.0	0.3	0.5	0.2	17.2	18.2	19.7	20.6	16.9	19.6	17.8	17.2	16.0	16.4	15.5	19.8	19.7	3.6	32.1	10.3	21.2	0.9	9.8	14.8	23.5	8.6	34.5	21.8	10.9	15.7	20.0	23.4	18.4	20.9	8.7	0.7	19.1	7.9	18.9	354.5	13.4	9.5	4.8	16.7	1.3	35.9	41.0	10.0	13.8	10.7	18.1	0.0	5.7	8.6	51.2	7.2	20.2	33.4	18.8	18.3	0.8	5.7	31.2	10.5	2.8	19.6	9.4	2.7	49.6	1.0	28.1	3.9	32.3	13.0	10.5	3.3	48.7	13.4	26.4	36.3	20.9	13.1	8.4	10.1	22.3	6.7	11.9	10.9	5.1	1.6	5.0	18.7	51.8
CLDND2	MGC33839	ENSG00000160318	"Claudin domain containing 2"	Q8NHS1	19	51367098-51369003	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 45.3"	"Cell type enriched"	"Detected in many"	9	"Early spermatids: 344.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 11.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA056971	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA056971: AB_2683294"	"unprognostic (2.86e-1)"	"unprognostic (4.29e-5)"	"unprognostic (2.29e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.19e-1)"	"unprognostic (9.42e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.94e-9)"	"unprognostic (4.00e-2)"	"unprognostic (3.95e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.70e-2)"	5.0	4.6	9.6	2.0	9.1	9.7	4.2	10.5	12.3	3.7	7.9	4.3	4.6	2.7	0.1	2.7	3.7	1.6	3.1	9.8	9.4	3.8	4.7	3.3	2.0	9.8	9.3	8.9	4.4	5.3	1.0	3.4	0.9	10.1	4.3	1.2	1.9	4.4	1.5	2.5	1.8	4.4	0.6	8.8	6.6	2.9	45.3	9.4	1.0	3.5	2.7	0.5	4.9	3.3	10.7	2.0	5.5	2.0	2.7	2.8	2.5	1.1	0.9	0.4	0.9	1.2	0.6	6.4	5.1	1.1	0.5	0.6	2.5	0.6	0.3	0.2	3.6	8.6	4.5	9.1	11.0	1.1	1.3	1.3	1.9	0.9	0.2	0.5	1.3	0.6	2.5	3.0	3.7	0.8	1.2	1.1	7.5	0.8	5.6	6.9	1.0	4.5	2.1	1.5	1.4	1.1	1.3	2.3	0.5	1.8	1.0	1.4	0.3	1.2	1.9	3.9	2.0	0.8	3.4	3.9	2.0	4.7	5.1	1.2	3.0	0.4	2.1	1.7	1.0	0.9	0.8	0.4	2.2	0.7	0.4	0.3	0.7	0.2	2.9	0.4	1.5	0.6	0.3	9.6	9.1	10.5	12.3	9.8	9.4	9.8	9.3	8.9	10.1	8.8	9.4	10.7	4.3	0.0	3.7	8.5	3.1	1.7	5.6	1.3	5.7	5.4	7.8	8.3	6.9	12.8	1.2	16.5	0.0	1.8	8.1	4.9	3.9	1.0	344.4	0.9	3.0	2.4	10.3	8.2	2.1	0.7	1.7	3.4	6.6	1.5	15.8	1.8	5.3	17.4	2.6	3.3	4.3	16.8	4.1	4.1	4.0	36.1	6.2	3.7	1.8	4.7	2.4	2.5	9.2	0.5	3.2	0.7	5.8	6.4	3.7	3.4	13.3	5.5	6.0	2.3	0.0	5.4	5.4	23.5	1.3	7.5	2.7	0.8	4.4	1.4	12.3	5.5
CLEC18B	MRCL2	ENSG00000140839	"C-type lectin domain family 18 member B"	Q6UXF7	16	74408270-74421953	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 32.7;testis: 11.9"	"Cell type enriched"	"Detected in some"	14	"Proximal tubular cells: 26.8"	"Cancer enhanced"	"Detected in some"		"glioma: 2.7;renal cancer: 5.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.1;JURKAT: 1.6;K-562: 3.1;U-266/70: 1.1"									HPA048976	Uncertain				"Secreted to blood"	NA	NA					"HPA048976: AB_2680582"	"unprognostic (5.69e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.30e-3)"	"unprognostic (9.37e-2)"	"prognostic unfavorable (2.07e-4)"	"unprognostic (7.15e-2)"	"unprognostic (7.51e-2)"	"unprognostic (4.49e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.91e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.31e-2)"	"unprognostic (5.87e-2)"	"unprognostic (5.43e-2)"	"unprognostic (4.27e-2)"	0.1	1.9	3.8	0.4	3.9	0.1	0.2	4.7	4.8	0.4	2.5	0.2	0.4	0.1	0.6	2.7	0.3	0.3	0.2	3.8	6.0	32.7	0.6	0.2	0.1	4.1	3.6	3.2	0.2	0.6	0.0	0.8	0.1	3.9	0.5	0.1	2.3	0.7	0.0	0.2	0.2	0.3	0.1	3.8	0.6	0.3	11.9	3.5	0.3	0.6	0.0	0.0	0.1	1.7	5.5	0.0	0.6	1.1	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.2	0.2	0.4	0.4	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.0	0.1	0.6	0.1	0.0	0.0	0.2	0.0	1.6	3.1	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.3	0.1	0.0	0.6	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.3	1.1	0.7	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	3.9	4.7	4.8	3.8	6.0	4.1	3.6	3.2	3.9	3.8	3.5	5.5	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.3	0.0	0.4	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.5	1.9	0.1	0.1	0.1	0.1	0.1	1.2	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.4	0.4	0.0	0.0	0.0	1.6	0.3	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.6	0.5	0.1	0.0	0.0	0.0	0.4	26.8	0.0	1.4	0.0	0.0	0.2	0.5	0.2	0.0	0.1	0.0	0.1	0.0	0.3	0.0
CLEC3A	CLECSF1	ENSG00000166509	"C-type lectin domain family 3 member A"	O75596	16	78022515-78066761	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.1;breast: 9.5;urinary bladder: 5.9"	"Cell type enriched"	"Detected in single"	7	"Prostatic glandular cells: 4.7"	"Cancer enriched"	"Detected in some"	102	"breast cancer: 78.5"	"Region enriched"	"Detected in single"	6	"midbrain: 4.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"SK-BR-3: 7.4;T-47d: 21.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051511	Uncertain				"Secreted to extracellular matrix"	NA	NA					"HPA051511: AB_2681514"	"prognostic unfavorable (1.61e-4)"				"unprognostic (1.60e-1)"							"unprognostic (2.42e-1)"		"unprognostic (1.25e-1)"	"unprognostic (4.95e-2)"		"unprognostic (3.80e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.0	5.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	4.1	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
CLEC4C	"BDCA2, CD303, CLECSF11, CLECSF7, DLEC, HECL"	ENSG00000198178	"C-type lectin domain family 4 member C"	Q8WTT0	12	7729383-7751605	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 5.5"	"Cell type enriched"	"Detected in some"	21	"dendritic cells: 107.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	16	"plasmacytoid DC: 468.0"	"Lineage enriched"	"Detected in many"	16	"dendritic cells: 468.0"	"Cell line enriched"	"Detected in single"	5	"HDLM-2: 2.1"									HPA029432	Approved					NA	NA					"HPA029432: AB_10601259"	"unprognostic (3.55e-3)"	"unprognostic (3.01e-2)"		"unprognostic (1.03e-1)"	"unprognostic (3.70e-2)"	"unprognostic (7.37e-5)"		"unprognostic (2.36e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.55e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.88e-3)"	"unprognostic (2.82e-2)"	"unprognostic (3.18e-3)"	"unprognostic (2.36e-2)"	"unprognostic (1.25e-1)"	0.3	0.1	0.0	1.4	0.1	1.6	1.4	0.4	0.2	0.1	0.6	0.1	0.0	0.1	0.0	0.2	0.1	1.2	0.0	0.1	0.0	0.1	0.2	0.6	5.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.2	0.2	0.0	3.8	0.2	0.9	0.0	2.1	0.1	0.0	5.3	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	5.3	0.7	30.0	0.1	0.1	0.1	0.6	0.1	0.1	4.1	2.6	0.1	0.0	14.7	2.9	0.0	468.0	0.2	3.0	0.0	0.1	0.4	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	107.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	4.0	0.1	0.0	1.9	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.8	4.9	0.0	0.3	0.0	0.8	0.0	0.0	0.0
CLEC4G	"LSECtin, UNQ431"	ENSG00000182566	"C-type lectin domain family 4 member G"	Q6UXB4	19	7728958-7733906	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 15.1;liver: 53.7;lymphoid tissue: 15.2"	"Cell type enriched"	"Detected in some"	15	"Hepatic stellate cells: 730.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 18.8;myeloid DC: 15.1"	"Group enriched"	"Detected in many"	4	"dendritic cells: 15.1;monocytes: 18.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB003789, HPA014044"	Enhanced					NA	NA					"CAB003789: , HPA014044: AB_1846916"	"unprognostic (7.20e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.64e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.29e-2)"	"unprognostic (7.45e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.13e-8)"	"unprognostic (5.21e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.65e-2)"	15.1	0.5	2.2	2.4	2.0	1.2	2.6	3.7	3.0	0.1	2.0	1.2	0.4	0.1	0.3	0.4	4.8	1.6	1.0	2.5	2.1	0.4	53.7	1.0	15.2	2.4	2.2	1.9	0.5	0.3	0.0	0.1	1.0	2.4	0.3	0.9	0.0	1.1	0.3	0.4	1.0	2.1	1.0	2.2	3.4	0.9	0.4	3.5	0.2	0.5	0.0	0.3	7.8	0.4	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	18.8	0.0	0.0	4.2	0.0	0.3	0.0	0.0	15.1	4.2	0.1	0.0	0.4	0.5	0.5	0.7	0.0	4.5	2.2	2.0	3.7	3.0	2.5	2.1	2.4	2.2	1.9	2.4	2.2	3.5	2.6	0.1	0.0	0.0	0.3	3.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	7.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.0	0.0	18.7	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	730.3	7.1	0.8	0.0	1.1	0.0	0.0	46.7	2.9	0.0	0.3	2.6	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.7	0.0	0.3	0.3	1.1	0.8	0.0	0.1
CLNK	MIST	ENSG00000109684	"Cytokine dependent hematopoietic cell linker"	Q7Z7G1	4	10486395-10684768	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 6.1"	"Cell type enriched"	"Detected in many"	5	"Ionocytes: 73.2"	"Cancer enriched"	"Detected in single"	13	"renal cancer: 3.3"	"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"HDLM-2: 4.1;U-937: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035671, HPA035672"	Uncertain		Uncertain	Vesicles		NA	NA			Vesicles		"HPA035671: AB_10669673, HPA035672: AB_10669775"	"unprognostic (2.47e-3)"	"unprognostic (4.74e-4)"	"unprognostic (1.99e-4)"	"unprognostic (2.24e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.23e-6)"	"unprognostic (2.05e-2)"	"unprognostic (5.37e-4)"	"unprognostic (9.87e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.55e-1)"	"unprognostic (7.74e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.05e-3)"	"unprognostic (6.65e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.99e-2)"	0.3	0.2	0.5	0.9	0.4	0.4	0.6	1.4	0.8	0.2	0.5	0.3	0.6	0.4	1.2	0.4	0.2	0.5	0.2	0.5	0.4	6.1	0.9	0.6	3.0	0.6	0.3	0.6	0.4	0.1	0.1	1.3	1.0	0.9	0.4	0.4	0.3	0.5	0.3	0.2	0.9	0.9	0.1	0.2	1.6	1.1	0.8	0.4	1.4	0.3	0.0	2.0	0.3	0.0	0.8	0.0	0.2	0.2	0.1	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	4.1	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.2	0.3	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.4	0.0	0.1	0.2	0.1	0.2	0.0	0.1	0.2	2.2	0.1	0.5	0.1	0.2	0.2	0.1	0.1	1.4	0.4	0.1	2.6	1.1	0.1	0.1	0.4	2.0	0.0	0.6	1.8	0.2	0.5	0.4	1.4	0.8	0.5	0.4	0.6	0.3	0.6	0.9	0.2	0.4	0.8	0.1	3.2	3.0	1.0	12.9	0.8	0.8	0.0	0.0	1.3	0.3	0.3	0.7	0.0	0.9	0.0	2.1	0.3	4.6	0.1	13.7	0.0	5.3	0.7	0.2	0.4	0.0	5.3	1.7	0.0	2.2	0.5	0.5	0.9	11.4	0.2	0.7	0.3	0.3	0.0	1.6	0.2	73.2	1.9	5.5	5.4	0.3	3.5	1.8	1.9	0.5	0.4	0.0	1.0	0.7	0.1	0.0	2.2	1.1	0.7	0.0	0.2	0.2	1.0	0.0	1.1	0.5	1.9	0.8	0.0	0.4	0.1	6.0	1.3	0.0	0.7
CMA1		ENSG00000092009	"Chymase 1"	P23946	14	24505353-24508265	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 18.7"	"Cell type enriched"	"Detected in some"	28	"granulocytes: 53.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000363, HPA052634"	Enhanced		Supported	"Cytosol,Cytoplasmic bodies"	"Secreted to blood"	NA	NA	3000000		"Cytoplasmic bodies"	Cytosol	"CAB000363: AB_2083616, HPA052634: AB_2681892"	"unprognostic (1.37e-1)"	"unprognostic (2.27e-3)"	"unprognostic (2.04e-1)"			"unprognostic (7.07e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.91e-3)"	"unprognostic (4.19e-3)"	"unprognostic (1.29e-4)"	"unprognostic (2.52e-3)"	"unprognostic (7.78e-2)"	"unprognostic (7.37e-2)"	"unprognostic (4.98e-3)"	6.6	0.0	0.2	3.7	0.1	0.2	18.7	0.1	0.2	4.6	0.2	8.8	0.6	3.2	4.3	10.3	0.9	7.4	1.6	0.1	0.7	0.2	0.5	1.5	1.8	0.4	0.2	0.0	0.1	1.6	0.6	0.2	0.1	0.3	1.0	8.4	0.0	4.7	1.3	0.9	8.1	5.8	2.3	0.3	0.2	1.5	0.9	0.3	3.0	0.4	3.0	2.4	11.2	0.9	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.1	0.2	0.1	0.7	0.4	0.2	0.0	0.3	0.3	0.3	0.3	0.0	0.0	1.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	53.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.1	0.0
CMPK2	"NDK, TYKi, UMP-CMPK2"	ENSG00000134326	"Cytidine/uridine monophosphate kinase 2"	Q5EBM0	2	6840570-6866635	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Pyrimidine biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.6;salivary gland: 8.6"	"Cell type enriched"	"Detected in many"	4	"Erythroid cells: 86.3"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"white matter: 14.6"	"Immune cell enhanced"	"Detected in many"		"eosinophil: 4.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 12.8;BJ hTERT+ SV40 Large T+ RasG12V: 11.9;HEL: 20.3;MOLT-4: 11.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041430	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA041430: AB_10796674"	"unprognostic (2.37e-1)"	"unprognostic (6.07e-2)"	"unprognostic (5.71e-2)"	"prognostic unfavorable (4.71e-4)"	"unprognostic (1.82e-1)"	"unprognostic (5.08e-2)"	"unprognostic (3.80e-2)"	"unprognostic (8.93e-2)"	"unprognostic (6.63e-2)"	"unprognostic (4.54e-3)"	"unprognostic (7.39e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.77e-2)"	"unprognostic (7.69e-2)"	"unprognostic (4.32e-2)"	2.0	1.4	1.7	1.4	3.3	6.5	1.8	0.6	1.9	1.0	1.6	1.3	1.6	0.9	0.3	0.7	0.7	0.8	1.6	1.2	1.9	1.1	0.9	2.8	1.3	6.3	2.4	1.1	0.4	1.3	0.9	1.1	1.7	3.2	0.7	0.6	0.1	8.6	0.7	1.1	0.4	2.2	0.9	1.7	3.5	2.9	2.0	2.1	1.9	1.2	1.6	0.7	0.9	0.6	14.6	0.3	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.2	12.8	11.9	0.0	1.4	3.1	0.8	0.0	3.3	0.2	0.0	0.0	0.0	0.3	0.2	20.3	0.0	0.0	0.0	0.6	1.8	0.1	0.0	0.2	0.0	0.0	0.0	2.0	5.8	0.1	0.0	0.1	11.8	3.6	0.3	0.0	1.0	3.6	0.0	0.0	0.0	0.4	0.4	0.5	0.2	0.0	1.9	0.0	0.0	1.3	0.0	0.0	0.2	0.0	0.0	3.3	0.4	0.0	0.0	3.6	0.8	3.1	1.6	4.9	0.3	3.9	0.2	1.1	0.2	0.2	1.1	0.1	0.2	0.3	1.1	0.5	2.0	0.1	0.4	0.7	1.7	3.3	0.6	1.9	1.2	1.9	6.3	2.4	1.1	3.2	1.7	2.1	14.6	20.8	3.2	7.5	0.0	1.9	0.4	0.9	0.5	0.0	1.5	1.7	1.3	1.6	0.0	0.5	1.8	0.0	3.0	3.4	10.0	1.9	2.6	4.0	5.4	0.8	11.7	7.2	86.3	1.9	6.6	2.9	2.7	11.2	1.0	2.5	1.7	7.1	1.4	19.5	0.0	2.5	2.5	0.0	12.3	2.8	1.6	1.5	11.3	0.0	9.4	11.9	5.3	3.1	1.5	0.2	6.2	8.4	5.7	2.1	1.0	8.4	0.7	4.1	0.2	0.0	2.2	2.0	2.7	4.4	0.7	0.4	0.8	4.5	1.6	1.6	2.0
CNGA3	"ACHM2, CCNC1, CCNCa, CNCG3, CNG3"	ENSG00000144191	"Cyclic nucleotide gated channel subunit alpha 3"	Q16281	2	98346188-98398601	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sensory transduction, Transport, Vision"	"Ion channel, Ligand-gated ion channel"	"Disease variant, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.7;pituitary gland: 10.2;retina: 5.9"	"Cell type enriched"	"Detected in some"	14	"Cone photoreceptor cells: 43.8"	"Cancer enriched"	"Detected in some"	9	"glioma: 7.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"U-87 MG: 6.8"	"Group enriched"	"Detected in some"	6	"basal ganglia: 1.8;hypothalamus: 1.9"	"Not detected"	"Not detected"			"HPA049378, CAB079025"	Approved	Approved				NA	NA					"CAB079025: , HPA049378: AB_2732551"	"unprognostic (2.34e-2)"	"unprognostic (1.83e-2)"	"unprognostic (4.96e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.18e-1)"		"unprognostic (4.17e-4)"		"unprognostic (4.65e-2)"	"unprognostic (1.86e-3)"	"unprognostic (2.88e-1)"		"unprognostic (3.85e-3)"	"unprognostic (8.98e-2)"	"unprognostic (5.90e-2)"	"unprognostic (3.71e-2)"	0.1	0.0	1.0	0.5	0.8	0.0	0.2	0.7	0.7	0.0	2.3	3.1	1.0	0.0	0.0	1.5	0.4	0.0	0.0	0.7	4.4	0.0	0.0	0.1	0.0	3.6	1.6	0.2	0.0	0.3	0.0	10.2	0.0	3.4	0.0	1.2	5.9	0.2	0.2	0.0	0.0	1.4	0.8	5.7	0.0	0.9	0.5	1.0	0.0	0.0	0.0	0.0	0.6	0.1	4.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.8	0.7	0.7	0.7	4.4	3.6	1.6	0.2	3.4	5.7	1.0	4.8	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.7	0.0	0.0	0.0	43.8	0.0	0.0	0.0	0.0	0.0	1.3	0.4	0.0	0.1	0.0	0.0	3.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.9	0.3	0.1	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	1.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0
CNGB3	"ACHM1, ACHM3, RMCH"	ENSG00000170289	"Cyclic nucleotide gated channel subunit beta 3"	Q9NQW8	8	86553977-86743675	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Sensory transduction, Transport, Vision"	"Ion channel, Ligand-gated ion channel"	"Disease variant, Stargardt disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 4.2;retina: 13.2"	"Cell type enriched"	"Detected in some"	13	"Cone photoreceptor cells: 158.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"midbrain: 2.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	14	"SCLC-21H: 18.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA057244	Enhanced					NA	NA					"HPA057244: AB_2683380"	"unprognostic (5.35e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.58e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.17e-1)"	"unprognostic (3.82e-1)"	"unprognostic (9.28e-2)"	"unprognostic (2.77e-4)"	"unprognostic (1.40e-4)"	"unprognostic (1.66e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.84e-1)"	0.0	0.0	0.0	0.3	0.2	4.2	0.0	1.0	0.3	0.1	1.2	0.1	0.5	0.2	0.1	0.0	0.9	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.2	0.1	2.0	0.0	0.4	0.6	0.0	0.0	0.1	0.4	0.1	0.0	13.2	0.3	0.0	0.1	1.2	0.1	0.0	0.0	0.1	0.3	2.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	1.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	1.3	0.1	0.0	0.0	0.5	0.3	0.0	0.0	0.3	0.0	1.0	18.9	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.3	0.1	0.1	0.1	2.0	0.0	0.4	0.0	0.1	0.3	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.0	0.0	0.0	0.0	158.4	0.1	1.3	0.0	0.0	0.0	5.6	0.1	0.6	0.2	0.0	0.0	2.4	0.0	0.0	1.3	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	11.4	0.0	0.1	0.0	1.0	0.2	1.5	0.0	1.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.1	0.1	1.6	0.2	0.0	0.3	0.0	0.1	0.1	0.0	0.0
CNR2	CB2	ENSG00000188822	"Cannabinoid receptor 2"	P34972	1	23870515-23913362	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Inflammatory response"	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 3.4;lymphoid tissue: 8.8"	"Cell type enriched"	"Detected in some"	5	"B-cells: 27.8"	"Cancer enriched"	"Detected in single"	6	"testis cancer: 2.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	8	"basophil: 49.3;eosinophil: 35.1;memory B-cell: 29.6;naive B-cell: 27.9;NK-cell: 19.4"	"Group enriched"	"Detected in many"	9	"B-cells: 29.6;granulocytes: 49.3;NK-cells: 19.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 5.3;HEL: 4.4;HMC-1: 19.7;U-698: 13.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB009719	Uncertain					NA	NA					"CAB009719: AB_2082784"	"unprognostic (9.45e-4)"	"unprognostic (5.40e-3)"	"unprognostic (8.50e-3)"	"unprognostic (8.19e-3)"	"unprognostic (3.55e-3)"	"unprognostic (9.34e-6)"	"unprognostic (5.58e-3)"	"unprognostic (6.96e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.04e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.75e-2)"	"unprognostic (4.91e-2)"	0.1	0.0	0.2	2.4	0.1	1.5	0.0	0.4	0.3	0.0	0.2	0.3	0.2	0.1	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.2	7.4	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.3	0.2	0.1	0.0	1.6	0.2	3.4	0.1	0.0	8.8	0.4	0.1	0.1	1.0	0.2	0.0	7.5	0.4	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.4	0.2	0.0	0.0	0.0	19.7	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	13.4	0.0	0.1	0.0	49.3	0.1	35.1	3.2	0.1	3.8	29.6	0.1	3.0	0.4	27.9	0.2	1.8	1.2	19.4	0.2	1.7	0.2	2.0	0.2	0.1	0.4	0.3	0.2	0.0	0.1	0.0	0.2	0.2	0.0	0.1	0.3	0.1	3.2	3.9	0.3	27.8	0.6	0.8	0.0	0.0	0.8	0.2	0.0	0.3	0.0	1.8	0.0	0.0	0.1	2.1	0.5	0.0	0.0	0.2	0.1	0.3	0.3	0.0	3.2	0.4	0.0	0.0	0.9	0.0	0.2	3.8	0.1	0.4	0.3	0.2	0.0	0.4	0.0	0.0	0.6	0.9	0.0	0.0	0.8	0.0	0.0	0.5	0.2	5.2	0.0	0.5	0.1	2.0	0.0	0.5	0.5	0.0	0.1	0.7	0.7	0.0	0.9	0.4	0.3	0.2	0.0	0.3	0.3	2.4	0.2	0.0	0.8
COL24A1		ENSG00000171502	"Collagen type XXIV alpha 1 chain"	Q17RW2	1	85729233-86156943	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 9.3"	"Cell type enriched"	"Detected in some"	4	"Excitatory neurons: 167.1"	"Low cancer specificity"	"Detected in single"			"Region enhanced"	"Detected in many"		"cerebral cortex: 9.3"	"Immune cell enriched"	"Detected in single"	9	"plasmacytoid DC: 2.7"	"Lineage enriched"	"Detected in single"	9	"dendritic cells: 2.7"	"Cell line enhanced"	"Detected in some"		"ASC diff: 2.1;Karpas-707: 3.7;NTERA-2: 1.9;RH-30: 2.7;SuSa: 2.8;U-266/70: 6.9"														"Secreted to extracellular matrix"	NA	NA		52000				"unprognostic (3.00e-1)"	"unprognostic (6.19e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.76e-3)"	"unprognostic (1.82e-3)"	"unprognostic (2.45e-2)"	"unprognostic (2.44e-5)"	"unprognostic (1.37e-1)"	"unprognostic (4.08e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.48e-6)"	"unprognostic (2.79e-5)"	"unprognostic (5.07e-1)"	"unprognostic (1.19e-1)"	"unprognostic (9.90e-2)"	0.4	0.0	0.6	0.8	2.9	0.9	0.3	0.0	9.3	5.9	0.0	4.9	1.5	1.3	0.8	0.7	0.1	1.6	1.4	7.1	1.0	0.7	0.0	0.7	0.3	0.8	0.0	2.1	2.4	0.0	0.0	1.2	0.1	1.2	1.1	0.8	5.5	0.4	1.5	0.5	0.5	1.7	0.9	0.1	0.3	1.7	0.8	0.3	0.2	0.4	1.7	0.3	5.0	3.0	2.4	0.0	0.0	0.9	0.0	2.1	0.3	0.0	0.4	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.6	0.0	0.9	0.0	0.5	0.0	0.7	0.0	0.1	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.7	0.5	0.0	0.0	0.1	1.9	0.0	0.0	0.0	2.7	0.3	0.3	0.7	0.0	0.0	0.0	0.1	0.3	2.8	0.0	0.6	0.0	1.2	0.1	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.7	0.0	0.0	0.6	2.9	0.0	9.3	7.1	1.0	0.8	0.0	2.1	1.2	0.1	0.3	2.4	0.0	0.0	0.6	6.8	1.1	0.4	0.0	0.2	0.0	1.9	0.5	0.0	2.1	0.0	0.5	5.5	0.0	0.0	11.1	0.0	0.0	0.0	0.1	0.2	3.7	0.4	0.0	2.5	167.1	0.0	0.0	2.8	0.0	0.1	1.3	0.5	0.0	0.0	2.4	0.0	12.9	0.0	0.0	0.0	0.4	0.2	0.9	0.9	10.6	7.5	0.0	40.4	0.0	11.1	6.5	0.0	0.0	0.7	3.3	0.0	0.0	0.1	2.4	1.7	0.0	0.5	1.3	1.0	0.9	0.0	0.1	0.0	0.3	2.8	0.0	0.0
COL4A5	"ASLN, ATS"	ENSG00000188153	"Collagen type IV alpha 5 chain"	P29400	X	108439838-108697545	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Alport syndrome, Cancer-related genes, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 108.6"	"Cell type enriched"	"Detected in many"	9	"Oligodendrocytes: 713.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 87.7;HHSteC: 95.0;HUVEC TERT2: 92.8;TIME: 88.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077177			Approved	"Vesicles,Plasma membrane"	"Secreted to extracellular matrix"	NA	NA			"Plasma membrane"	Vesicles	"HPA077177: "	"unprognostic (2.58e-2)"	"unprognostic (2.57e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.97e-2)"	"unprognostic (7.27e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (2.41e-5)"	"unprognostic (2.10e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.06e-1)"	6.9	5.6	27.3	2.3	55.5	0.0	8.1	40.2	41.2	36.7	22.7	5.4	3.8	59.7	25.6	9.7	37.8	18.3	8.9	28.4	40.3	12.2	2.5	8.6	1.2	61.1	48.7	22.4	23.1	3.9	17.0	19.8	14.6	58.6	37.3	5.6	6.2	7.4	33.2	7.7	26.6	6.4	47.6	40.1	5.6	34.7	6.0	42.7	2.7	10.6	4.4	1.0	48.0	22.9	108.6	4.5	26.7	47.2	14.9	18.0	10.6	0.3	2.8	11.7	14.2	23.2	24.0	1.9	4.2	0.0	2.0	8.6	21.7	13.2	45.2	17.8	6.7	11.7	3.4	87.7	2.9	95.0	0.0	13.5	49.2	53.6	17.4	37.2	45.2	92.8	0.0	0.2	0.1	13.9	2.0	0.1	0.5	14.0	0.0	16.0	0.1	0.0	0.2	35.9	26.7	0.0	0.0	70.2	2.2	6.0	65.6	12.9	0.0	88.8	9.5	2.8	6.4	4.0	1.9	0.0	0.0	8.2	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.3	55.5	40.2	41.2	28.4	40.3	61.1	48.7	22.4	58.6	40.1	42.7	108.6	1.0	6.4	7.3	72.5	0.0	26.9	29.7	29.4	17.1	0.5	14.8	14.7	10.0	2.8	14.2	20.2	0.0	0.7	0.0	0.0	0.0	0.4	0.1	7.4	45.4	4.6	0.0	0.0	1.1	0.9	0.4	12.3	3.1	5.7	1.3	2.0	4.2	0.5	0.4	0.0	1.5	0.2	6.1	0.3	2.1	1.7	20.2	0.6	1.8	20.6	0.0	11.1	0.0	3.5	713.9	0.4	0.0	36.9	0.0	18.1	0.0	0.1	8.2	0.6	6.6	2.4	18.3	0.4	0.9	4.2	15.9	0.7	1.1	21.5	0.1	24.7
COL5A3		ENSG00000080573	"Collagen type V alpha 3 chain"	P25940	19	9959561-10010504	"Cancer-related genes, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	5	"Astrocytes: 510.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 38.9;BJ: 23.6;BJ hTERT+: 26.2;BJ hTERT+ SV40 Large T+: 14.4;HSkMC: 28.2;WM-115: 26.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA041695, HPA048256"	Approved		Approved	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		330000	"Plasma membrane"		"HPA041695: , HPA048256: AB_2680330"	"unprognostic (1.17e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.63e-2)"	"unprognostic (3.24e-2)"	"unprognostic (6.84e-3)"	"unprognostic (3.01e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (7.17e-8)"	"unprognostic (3.25e-2)"	"unprognostic (7.31e-3)"	"unprognostic (6.00e-2)"	"prognostic unfavorable (6.87e-5)"	42.8	5.1	31.0	9.9	31.5	0.1	32.6	29.7	46.2	43.9	37.9	15.8	3.8	27.5	1.9	9.1	23.0	4.2	27.8	31.2	23.5	3.3	13.5	14.3	3.2	34.4	26.4	26.1	6.3	5.2	3.0	3.5	33.1	29.0	16.8	2.0	21.3	7.4	9.0	15.4	21.9	11.8	10.4	28.5	1.7	10.0	4.7	28.9	4.6	12.8	6.1	3.9	12.7	26.6	26.9	0.0	0.0	0.5	0.0	12.4	38.9	0.0	23.6	26.2	14.4	5.7	0.0	0.0	0.0	0.2	4.4	0.3	2.3	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	28.2	0.6	5.2	5.5	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	1.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	6.6	0.1	0.0	0.0	0.0	11.6	5.5	0.5	0.0	0.0	0.0	0.0	1.5	0.0	26.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.0	31.5	29.7	46.2	31.2	23.5	34.4	26.4	26.1	29.0	28.5	28.9	26.9	13.7	0.0	0.0	510.3	0.0	4.2	0.1	0.2	2.2	65.1	0.3	0.9	6.4	0.0	0.1	0.0	6.2	0.1	0.3	1.3	0.0	0.2	6.9	0.4	12.0	8.1	0.0	0.0	15.6	0.0	0.2	17.5	0.5	0.4	0.0	0.0	3.9	22.9	0.6	3.3	3.4	0.0	0.0	0.0	3.2	2.1	17.4	0.4	14.2	36.5	0.1	2.6	0.0	73.9	2.5	0.3	0.1	8.2	0.0	0.3	0.2	0.1	0.9	28.3	92.1	8.5	58.0	0.3	0.3	3.2	7.1	0.1	1.9	0.9	0.0	0.3
COL9A1		ENSG00000112280	"Collagen type IX alpha 1 chain"	P20849	6	70216040-70303084	"Disease related genes, Human disease related genes, Predicted secreted proteins"			"Deafness, Stickler syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 57.0;prostate: 15.4"	"Cell type enriched"	"Detected in some"	4	"Oligodendrocyte precursor cells: 310.1"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 3.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"AF22: 25.7;NTERA-2: 8.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA074749	Enhanced				"Secreted to extracellular matrix"	NA	NA		120000			"HPA074749: AB_2732266"	"unprognostic (2.18e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.48e-3)"	"unprognostic (5.72e-2)"	"unprognostic (5.32e-4)"	"unprognostic (3.24e-3)"	"unprognostic (8.79e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.68e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.62e-2)"	0.1	0.0	5.1	0.1	5.0	0.0	0.1	4.4	5.6	0.4	57.0	1.0	0.8	0.3	0.1	0.1	0.2	0.4	5.0	5.5	4.9	0.3	0.0	0.0	0.0	6.8	5.3	3.8	0.0	0.3	0.1	5.2	0.0	6.1	15.4	0.5	9.6	1.5	0.3	0.0	0.0	0.9	0.2	4.8	0.0	1.5	4.1	5.2	0.1	0.4	0.3	0.0	1.3	2.9	6.0	0.0	0.0	25.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	5.0	4.4	5.6	5.5	4.9	6.8	5.3	3.8	6.1	4.8	5.2	6.0	0.6	0.0	0.0	2.3	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.1	3.7	0.0	0.0	0.0	4.2	0.0	0.0	1.0	1.9	0.0	21.4	1.2	0.1	0.8	1.2	0.0	1.4	0.2	0.0	0.5	0.0	1.7	0.0	1.0	0.0	0.0	0.1	35.3	6.7	0.5	0.0	0.0	0.0	11.6	0.0	0.1	0.0	2.8	0.1	68.5	0.0	310.1	0.6	0.0	0.8	0.4	0.0	2.3	0.0	0.1	0.0	3.2	0.0	0.3	4.2	0.6	2.3	0.1	0.0	0.0	0.0	0.1	0.8	0.1
CPA3		ENSG00000163751	"Carboxypeptidase A3"	P15088	3	148865296-148897203	"Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 113.0;lung: 87.1"	"Cell type enriched"	"Detected in some"	26	"granulocytes: 4422.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	1534	"basophil: 1115.4"	"Lineage enriched"	"Detected in single"	5518	"granulocytes: 1115.4"	"Cell line enriched"	"Detected in some"	45	"HEL: 303.3"	"Not detected"	"Not detected"							"HPA006479, HPA008689, CAB020712"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"	"Secreted to blood"	NA	NA			"Golgi apparatus"	Nucleoplasm	"CAB020712: , HPA006479: AB_1078396, HPA008689: AB_1846009"	"unprognostic (1.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.66e-3)"	"unprognostic (9.13e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.14e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.30e-3)"	"unprognostic (3.50e-3)"	"unprognostic (5.18e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.69e-3)"	16.2	2.7	0.0	20.0	0.3	25.9	21.2	0.0	0.0	59.9	0.2	39.6	27.6	26.3	19.5	41.5	6.6	113.0	6.3	0.0	0.0	3.3	2.8	87.1	11.3	0.0	0.0	0.0	0.9	21.2	2.8	0.9	1.7	0.0	18.7	57.2	0.0	12.2	15.2	1.6	16.8	46.3	25.9	0.0	1.1	45.7	3.8	0.0	15.0	1.0	10.3	15.3	54.5	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.6	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	303.3	0.0	0.0	0.2	0.2	6.7	0.2	0.0	0.1	0.3	0.5	3.8	0.0	0.1	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1115.4	0.0	0.7	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	2.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.1	163.9	0.0	0.5	1.7	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.7	0.0	16.0	0.0	1.6	0.0	3.5	0.5	0.0	4422.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	5.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	6.7	0.3	0.0	0.0	8.7	0.0	0.0	0.2	0.3	0.0	0.0	0.0	1.3	0.0	41.7	0.0	0.0	0.3
CRABP1	"CRABP, CRABP-I, CRABPI, RBP5"	ENSG00000166426	"Cellular retinoic acid binding protein 1"	P29762	15	78340353-78348225	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 548.8;thyroid gland: 174.9"	"Cell type enriched"	"Detected in some"	24	"Muller glia cells: 4845.4"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 117.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"AF22: 1022.7;NTERA-2: 307.4"	"Group enriched"	"Detected in many"	5	"amygdala: 6.4;basal ganglia: 23.4;hypothalamus: 13.3;olfactory bulb: 12.8;pons and medulla: 7.4"	"Low region specificity"	"Detected in all"			HPA017203	Enhanced	Supported				NA	NA					"HPA017203: AB_1846512"	"unprognostic (1.23e-1)"	"unprognostic (3.76e-3)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (2.01e-1)"	"unprognostic (4.35e-2)"		"unprognostic (1.05e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.45e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.79e-2)"	"unprognostic (9.37e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.69e-1)"	0.6	1.7	18.7	2.5	26.0	0.2	56.7	26.2	26.6	1.3	26.7	6.4	0.8	2.4	2.0	0.6	0.3	1.6	0.4	9.6	40.4	15.1	0.0	0.7	0.2	59.1	49.5	11.3	0.4	0.7	0.0	27.8	15.1	54.2	2.6	1.7	548.8	1.1	47.9	0.2	26.9	5.0	1.8	24.5	75.8	7.2	0.5	52.7	1.7	174.9	0.2	1.2	0.6	2.5	95.4	0.0	0.2	1022.7	0.1	0.0	0.0	0.3	0.1	0.3	0.0	0.0	65.3	0.9	0.0	6.3	0.0	0.3	0.0	9.3	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	57.9	0.4	307.4	1.0	0.8	0.0	0.0	0.0	0.0	1.5	85.5	58.0	0.0	0.2	0.1	24.8	1.4	35.9	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.7	26.0	26.2	26.6	9.6	40.4	59.1	49.5	11.3	54.2	24.5	52.7	95.4	1.0	0.0	0.0	0.3	0.8	9.7	0.1	0.0	0.0	31.1	112.6	199.0	0.0	0.0	0.0	0.0	33.3	1.1	2.9	1.1	70.5	0.0	0.0	0.1	0.1	4.8	0.0	0.0	0.2	0.0	0.8	11.3	0.0	0.1	0.0	4.2	0.0	0.0	1.5	10.1	1.5	0.4	0.0	0.0	5.3	0.0	0.0	0.5	192.1	0.0	0.0	4845.4	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.4	0.5	0.0	91.2	0.0	0.0	1.0	0.1	2.2	0.0	2.6	1.4	0.9	0.0	1.6	0.1
CRACD	"CRAD, KIAA1211"	ENSG00000109265	"Capping protein inhibiting regulator of actin dynamics"	Q6ZU35	4	56049073-56328625	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.3;intestine: 19.8;testis: 29.8"	"Cell type enriched"	"Detected in single"	11	"Cardiomyocytes: 3.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 26.7;SH-SY5Y: 56.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043249, HPA048148"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		59000	Nucleoplasm	"Golgi apparatus"	"HPA043249: AB_2678388, HPA048148: AB_2680286"	"unprognostic (1.65e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.74e-3)"	"unprognostic (1.31e-1)"	"unprognostic (6.04e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.05e-6)"	"unprognostic (1.02e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.93e-1)"	0.5	2.3	6.7	3.1	7.8	4.0	0.3	8.8	6.9	1.6	0.0	9.5	13.9	3.5	4.2	0.5	3.0	11.4	0.7	5.3	11.2	0.7	0.7	1.0	2.2	15.7	12.0	2.6	1.2	1.8	6.4	0.9	0.6	19.3	1.7	8.2	4.2	1.0	3.6	0.0	0.5	19.8	4.4	8.6	2.6	2.7	29.8	11.0	0.6	0.1	0.2	1.9	1.3	1.2	15.6	0.0	2.9	11.2	0.9	0.3	0.0	4.1	0.1	0.4	0.5	1.2	3.4	0.4	10.2	0.3	0.0	9.1	0.0	9.6	0.2	0.3	0.9	5.6	5.7	5.1	0.5	1.6	4.8	0.8	0.4	0.2	0.0	0.1	3.6	5.3	9.1	0.0	9.8	0.1	1.4	7.1	0.4	6.0	8.7	7.2	6.8	6.1	0.2	0.1	2.6	26.7	56.7	1.0	0.3	6.9	9.4	2.4	0.5	2.1	0.3	2.8	0.7	2.6	9.7	6.9	0.1	2.8	0.2	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	7.8	8.8	6.9	5.3	11.2	15.7	12.0	2.6	19.3	8.6	11.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
CRACDL	"C2orf55, KIAA1211L, MGC42367"	ENSG00000196872	"CRACD like"	Q6NV74	2	98793846-98936259	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.3;epididymis: 31.9"	"Cell type enriched"	"Detected in some"	9	"Adipocytes: 35.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 41.0;HDLM-2: 61.7;Karpas-707: 17.4;MCF7: 16.3;SiHa: 17.3;SK-BR-3: 22.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	16	"amygdala: 19.1;basal ganglia: 45.5;cerebral cortex: 36.9;hippocampal formation: 54.9;olfactory bulb: 15.9"	"HPA051082, HPA061678"	Enhanced		Approved	"Microtubules,Cytokinetic bridge,Centrosome"		Yes	No			"Microtubules, Centrosome"	"Cytokinetic bridge"	"HPA051082: AB_2681337, HPA061678: AB_2684584"	"unprognostic (3.56e-3)"	"unprognostic (1.23e-3)"	"unprognostic (5.88e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.67e-3)"	"unprognostic (2.12e-1)"	"unprognostic (5.10e-2)"	"unprognostic (7.65e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.61e-2)"	"prognostic favorable (1.13e-5)"	"unprognostic (1.22e-1)"	"unprognostic (3.34e-1)"	"prognostic favorable (1.33e-5)"	"unprognostic (2.22e-2)"	4.4	0.9	14.8	1.5	21.1	0.5	5.2	0.0	33.3	5.2	0.0	6.0	8.1	2.1	31.9	11.3	22.8	2.9	2.8	31.8	7.5	2.9	0.3	6.1	0.8	8.3	1.6	26.0	0.6	4.8	7.8	6.6	4.6	10.6	2.3	4.6	0.1	11.1	4.6	1.7	6.3	7.5	2.3	0.0	1.3	8.3	6.2	1.9	1.0	5.0	1.5	1.8	2.2	5.5	13.4	8.4	0.4	0.2	3.2	0.0	0.0	41.0	0.0	0.0	0.0	0.0	0.4	4.9	0.0	10.4	0.0	0.2	7.4	0.3	0.4	0.0	61.7	1.2	0.0	0.5	0.5	0.0	0.0	0.1	0.3	2.3	0.1	1.2	0.1	2.5	0.0	0.0	17.4	0.0	16.3	0.2	1.3	0.1	8.3	0.9	0.0	0.0	0.8	3.2	6.5	5.8	0.9	17.3	22.5	0.1	0.0	8.7	1.4	10.7	0.0	1.3	0.0	0.1	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	14.8	21.1	0.0	33.3	31.8	7.5	8.3	1.6	26.0	10.6	0.0	1.9	13.4	35.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0
CREB1		ENSG00000118260	"CAMP responsive element binding protein 1"	P16220	2	207529737-207605988	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Differentiation, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"Early spermatids: 417.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003803, HPA019150"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB003803: AB_562092, HPA019150: AB_1847220"	"unprognostic (1.20e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.30e-2)"	"unprognostic (2.69e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (2.77e-5)"	"unprognostic (8.41e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.53e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.74e-2)"	"unprognostic (4.82e-3)"	"unprognostic (5.53e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.45e-2)"	13.1	8.7	10.8	15.5	11.4	22.6	14.9	17.7	12.4	15.9	12.8	11.5	10.1	15.8	10.9	15.1	13.2	14.1	11.7	10.7	13.3	12.5	11.7	13.8	22.3	10.8	10.2	8.9	17.3	8.8	15.7	7.0	18.2	12.1	13.1	14.1	18.0	9.0	12.7	6.7	11.6	10.7	16.5	10.8	17.3	12.2	32.7	11.4	29.0	18.3	14.7	25.2	17.0	9.6	14.6	24.9	20.9	38.6	15.6	22.9	22.4	21.8	15.9	23.5	26.6	26.5	21.6	22.9	15.4	19.8	21.1	29.8	19.5	34.8	20.4	37.7	25.1	13.2	29.2	18.9	23.0	18.7	27.7	20.0	16.0	16.3	21.1	31.1	25.4	34.9	28.9	20.5	22.5	30.4	16.8	41.0	16.1	27.8	24.2	13.1	31.4	22.1	20.2	25.1	24.6	27.1	23.4	21.6	16.2	18.1	35.5	16.5	30.1	18.5	21.8	22.6	22.1	20.5	19.6	27.5	36.4	25.2	25.3	22.0	33.6	28.2	28.2	27.0	29.2	23.7	36.7	25.3	26.2	34.1	34.8	30.0	20.7	56.1	45.6	34.9	18.6	38.6	26.7	10.8	11.4	17.7	12.4	10.7	13.3	10.8	10.2	8.9	12.1	10.8	11.4	14.6	46.7	19.2	18.2	47.0	52.3	70.9	47.1	33.3	34.1	38.9	25.3	18.5	26.3	17.2	29.0	12.9	33.3	29.1	35.5	25.3	23.5	23.6	417.8	19.6	39.2	47.2	32.4	54.7	56.1	20.3	24.9	35.8	18.8	21.0	43.7	41.5	35.7	15.8	29.4	40.4	51.1	28.2	30.5	48.8	75.9	47.2	26.1	35.8	44.4	68.4	60.9	42.1	33.0	66.9	70.7	26.4	27.5	29.3	29.1	56.5	22.8	19.7	18.9	40.2	39.5	37.4	40.7	44.5	29.4	33.5	57.8	18.6	42.6	19.6	25.7	62.6
CRLF2	"CRL2, TSLPR"	ENSG00000205755	"Cytokine receptor like factor 2"	Q9HC73	X	1187549-1212723	"Cancer-related genes, Human disease related genes, Predicted membrane proteins"		Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 1.8;gallbladder: 1.3;lymphoid tissue: 1.5"	"Cell type enriched"	"Detected in some"	4	"monocytes: 100.2"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 1.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	13	"plasmacytoid DC: 1.2"	"Lineage enriched"	"Detected in single"	13	"dendritic cells: 1.2"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 16.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"								"Intracellular and membrane"	NA	NA						"unprognostic (7.84e-2)"	"unprognostic (7.99e-4)"	"unprognostic (6.02e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.15e-3)"	"unprognostic (2.31e-6)"	"unprognostic (1.72e-1)"	"unprognostic (5.10e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.46e-2)"	"unprognostic (9.72e-3)"	"unprognostic (6.88e-5)"	"unprognostic (7.09e-3)"	"unprognostic (4.81e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.62e-1)"	0.2	0.0	0.0	1.5	0.0	1.8	0.2	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.1	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.2	0.3	0.2	0.0	0.2	0.3	0.0	0.0	0.3	0.0	0.1	0.5	0.6	0.1	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.5	0.8	0.1	0.3	2.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.3	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.6	0.9	3.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.3	0.0	0.0	20.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.1	0.0	0.0	1.8	0.0	1.0	100.2	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1
CRNN	"C1orf10, SEP53"	ENSG00000143536	Cornulin	Q9UBG3	1	152409243-152414263	"Disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 5389.2;vagina: 1705.5"	"Cell type enriched"	"Detected in some"	24	"Squamous epithelial cells: 79.9"	"Group enriched"	"Detected in many"	18	"cervical cancer: 19.3;head and neck cancer: 74.0;stomach cancer: 22.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA024343, CAB026182"	Enhanced					NA	NA		100000			"CAB026182: , HPA024343: AB_1847162"		"unprognostic (1.96e-2)"		"unprognostic (1.74e-6)"		"unprognostic (4.20e-2)"			"unprognostic (3.43e-1)"	"unprognostic (6.43e-3)"								1.0	0.9	0.1	0.0	0.1	0.0	0.7	0.0	0.2	413.5	0.0	0.6	0.0	0.8	0.0	5389.2	0.7	1.1	1.8	0.1	0.1	0.6	1.5	0.4	0.0	0.1	0.1	0.0	1.2	3.0	0.0	3.5	0.0	0.1	0.8	0.0	0.0	914.1	0.0	1.4	7.5	1.2	0.1	0.1	0.9	5.0	0.8	0.1	0.0	0.6	0.0	252.0	1.2	1705.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	79.9	0.0	0.0	0.0	0.0	0.0	0.0
CRYBA2		ENSG00000163499	"Crystallin beta A2"	P53672	2	218990189-218993422	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Eye lens protein"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pancreas: 16.7;pituitary gland: 13.8"	"Cell type enriched"	"Detected in some"	34	"Enteroendocrine cells: 860.9"	"Cancer enriched"	"Detected in some"	15	"pancreatic cancer: 16.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"BEWO: 69.6"	"Region enhanced"	"Detected in some"		"pons and medulla: 4.3"	"Low region specificity"	"Detected in some"			HPA062293	Supported					NA	NA					"HPA062293: AB_2732680"	"unprognostic (5.29e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.15e-1)"	"unprognostic (4.19e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.66e-2)"	"unprognostic (3.75e-1)"		"prognostic favorable (7.62e-4)"	"unprognostic (2.91e-1)"		"unprognostic (1.90e-1)"	"unprognostic (2.19e-1)"			0.3	3.6	0.5	0.0	0.8	0.0	0.0	0.6	0.8	0.0	0.2	2.1	2.8	0.0	0.2	0.2	0.0	0.0	0.1	0.5	0.8	0.2	0.0	0.0	0.0	1.7	4.3	0.4	0.0	16.7	1.4	13.8	0.0	3.0	0.8	2.2	0.2	0.1	0.0	0.1	0.2	2.7	0.0	0.3	0.0	4.6	2.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.0	69.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.2	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	10.3	2.5	2.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	1.9	0.1	0.2	0.1	0.1	1.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.6	0.8	0.5	0.8	1.7	4.3	0.4	3.0	0.3	1.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.2	0.5	0.4	0.0	0.0	0.0	0.0	0.3	0.0	3.6	0.0	0.0	3.8	0.0	0.0	0.1	860.9	0.0	0.1	1.3	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	25.0	0.0	0.0	0.4	10.0	0.0	0.1	1.8	0.0	0.0	0.1	0.0	0.0	0.0	7.5	17.5	0.0	0.0	1.0	3.9	0.0	0.0	0.9	0.0	0.0	0.0	0.6	4.5	0.0	0.3	0.3	0.1	0.0	1.7	0.0
CRYBB1		ENSG00000100122	"Crystallin beta B1"	P53674	22	26599278-26618027	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Eye lens protein"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 9.7"	"Cell type enriched"	"Detected in some"	21	"Hofbauer cells: 82.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"intermediate monocyte: 10.3;non-classical monocyte: 7.5"	"Lineage enriched"	"Detected in many"	7	"monocytes: 10.3"	"Group enriched"	"Detected in some"	5	"Karpas-707: 43.3;RPMI-8226: 82.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA003448, CAB010058"	Supported					NA	NA		89000			"CAB010058: AB_668166, HPA003448: AB_2732396"	"unprognostic (1.31e-1)"	"unprognostic (5.56e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.18e-1)"	"unprognostic (7.89e-3)"	"unprognostic (1.51e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.88e-4)"	"unprognostic (2.62e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.76e-2)"	1.3	1.6	1.4	0.9	1.5	0.6	0.6	1.5	2.5	0.6	1.3	0.5	0.4	0.3	9.7	0.4	0.4	1.2	0.4	1.5	2.1	0.2	0.4	0.5	1.2	2.0	1.7	1.3	0.2	0.2	0.3	0.5	3.3	2.3	0.2	0.4	0.0	0.4	0.2	0.1	0.1	0.4	0.9	1.8	1.6	0.3	0.3	1.9	0.4	0.2	0.2	0.5	1.1	0.2	2.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	1.5	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	43.3	0.0	0.0	0.0	0.3	1.8	0.0	0.0	0.8	0.0	82.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	4.6	0.0	0.2	0.5	0.0	0.0	0.7	0.2	1.8	0.0	2.2	0.0	0.0	1.0	0.0	0.0	10.3	0.0	0.2	0.0	0.0	1.5	0.0	0.0	0.0	0.4	0.5	7.5	0.0	0.0	0.6	1.4	1.5	1.5	2.5	1.5	2.1	2.0	1.7	1.3	2.3	1.8	1.9	2.0	0.1	0.0	0.0	0.7	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.1	1.3	0.0	0.0	0.9	0.0	0.5	0.2	0.0	0.1	1.3	0.0	0.0	0.2	82.6	0.0	0.2	0.0	0.0	3.5	0.8	0.6	0.0	2.8	1.8	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.7	0.1	0.2	0.0	0.0
CRYBG2	"AIM1L, FLJ38020"	ENSG00000176092	"Crystallin beta-gamma domain containing 2"	Q8N1P7	1	26321698-26360080	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 48.6;skin 1: 19.1;vagina: 20.7"	"Cell type enriched"	"Detected in some"	4	"Syncytiotrophoblasts: 48.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 11.4;BEWO: 23.2;CACO-2: 39.3;CAPAN-2: 25.7;HaCaT: 9.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA029629			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA029629: AB_10601331"	"unprognostic (2.20e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (5.11e-6)"	"unprognostic (1.45e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.39e-4)"	"unprognostic (1.88e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (3.53e-4)"	"unprognostic (2.94e-2)"	"unprognostic (4.83e-9)"	"unprognostic (9.12e-3)"	"unprognostic (3.40e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.63e-2)"	0.0	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.0	4.9	0.0	2.7	6.6	0.0	0.9	48.6	0.3	1.2	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	6.0	0.0	0.4	1.9	0.0	6.2	0.0	0.0	19.1	5.9	0.0	0.0	0.0	1.4	1.5	0.0	0.1	0.0	0.0	4.2	8.5	20.7	0.0	11.4	0.0	0.0	0.0	0.0	0.0	23.2	0.0	0.0	0.1	0.1	39.3	25.7	0.3	7.7	0.0	0.1	9.7	0.1	6.9	0.0	0.0	0.2	0.0	0.1	1.6	0.0	0.0	0.0	0.0	8.6	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.5	0.0	0.0	1.9	6.3	0.0	0.0	0.0	0.2	0.4	2.5	0.4	0.0	0.0	4.5	0.0	1.7	6.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.0	0.0	1.8	0.0	6.7	0.9	0.0	1.9	2.1	0.0	2.4	0.1	0.1	0.0	0.0	0.0	1.4	4.4	0.1	0.0	2.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	48.6	1.2	0.0	0.0	0.0
CRYGB	CRYG2	ENSG00000182187	"Crystallin gamma B"	P07316	2	208142573-208146158	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Eye lens protein"	Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"Early spermatids: 1.1"	"Group enriched"	"Detected in some"	6	"ovarian cancer: 1.1;testis cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"hippocampal formation: 3.3;hypothalamus: 2.2;thalamus: 2.0"					HPA043386	Supported		Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA043386: "										"unprognostic (6.73e-2)"					"unprognostic (1.31e-1)"			0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.3	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.4	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.6	0.3	0.3	0.4	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CSRP3	"CLP, CMD1M, MLP"	ENSG00000129170	"Cysteine and glycine rich protein 3"	P50461	11	19182030-19210571	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Myogenesis, Transcription, Transcription regulation"	"Actin-binding, Developmental protein"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 2637.7;skeletal muscle: 1664.9;tongue: 584.1"	"Cell type enriched"	"Detected in some"	35	"Cardiomyocytes: 3433.6"	"Cancer enriched"	"Detected in some"	6	"head and neck cancer: 18.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HSkMC: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042581	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA		250000	Cytosol	Nucleoplasm	"HPA042581: AB_2678061"				"unprognostic (1.62e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.55e-2)"				"unprognostic (4.72e-2)"				"unprognostic (5.99e-2)"	"unprognostic (1.08e-1)"			0.3	0.2	0.2	0.0	0.1	0.1	2.8	0.5	0.3	0.0	0.0	0.1	0.0	0.1	0.0	39.9	0.0	0.5	2637.7	0.2	0.2	0.2	0.2	1.3	1.2	0.2	0.1	0.1	0.5	2.7	0.0	0.1	0.1	0.3	33.1	0.0	0.0	25.0	0.0	1664.9	0.3	0.2	0.0	0.0	0.0	0.2	0.2	0.1	0.1	0.7	584.1	0.2	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.2	0.2	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.5	0.3	0.2	0.2	0.2	0.1	0.1	0.3	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	3433.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	28.8	0.0	0.0	0.3	6.0	0.0	79.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	95.5	32.7	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0
CST3		ENSG00000101439	"Cystatin C"	P01034	20	23626706-23638473	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"	"Age-related macular degeneration, Amyloidosis, Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 4252.1"	"Cell type enriched"	"Detected in all"	4	"Langerhans cells: 18746.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"classical monocyte: 4967.5;intermediate monocyte: 6424.5;myeloid DC: 7959.0;non-classical monocyte: 4297.7;plasmacytoid DC: 4427.4"	"Group enriched"	"Detected in all"	9	"dendritic cells: 7959.0;monocytes: 6424.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 1733.4;ASC TERT1: 1179.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000118, HPA013143"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	1040000000	2800000000	"Golgi apparatus, Vesicles"		"CAB000118: , HPA013143: AB_1847417"	"unprognostic (3.89e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (1.83e-4)"	"unprognostic (8.53e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.29e-3)"	"unprognostic (3.51e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.97e-1)"	"unprognostic (5.01e-2)"	"prognostic favorable (8.77e-4)"	1020.0	713.4	2674.6	264.7	2597.5	172.2	908.0	2549.1	4252.1	571.0	2576.7	745.5	393.1	714.2	883.6	561.6	809.7	588.3	1151.6	2598.4	2545.6	515.2	840.5	601.0	467.4	2816.0	2595.9	2125.6	580.6	952.1	322.7	675.3	167.3	2567.8	780.5	420.8	47.3	2025.7	445.6	755.1	492.3	807.0	370.8	2560.5	729.6	988.0	767.2	2942.4	422.8	664.3	522.0	209.8	708.9	623.7	2490.1	155.2	328.2	75.4	175.8	1733.4	1179.8	145.3	261.4	350.7	170.3	137.7	625.1	219.7	0.8	241.0	345.2	221.3	496.2	69.6	499.9	51.9	0.9	253.5	157.6	61.1	1082.9	621.2	7.5	251.0	919.0	415.9	226.6	241.5	352.5	268.5	18.5	147.6	4.0	239.5	234.4	1.5	162.2	103.5	461.9	752.2	5.7	96.4	215.2	708.0	328.3	84.7	98.2	191.1	54.6	343.3	107.7	156.5	548.2	702.0	163.4	119.0	231.6	97.7	157.1	6.2	1.8	138.0	339.5	184.0	48.1	4967.5	33.2	66.9	6424.5	25.5	23.1	18.3	45.8	7959.0	13.6	16.9	31.1	809.3	191.4	4297.7	4427.4	13.6	4250.8	2674.6	2597.5	2549.1	4252.1	2598.4	2545.6	2816.0	2595.9	2125.6	2567.8	2560.5	2942.4	2490.1	662.4	115.4	168.8	849.5	93.8	942.9	571.1	568.2	213.9	152.4	660.2	512.1	240.7	1361.2	514.5	641.9	29.2	476.8	603.3	1889.9	414.8	489.9	46.2	441.1	795.0	728.2	882.1	252.1	4.5	783.6	308.7	3026.2	981.7	631.0	359.9	687.0	491.9	2563.0	1816.7	48.8	11.2	1360.6	691.7	4301.1	18746.6	184.3	2132.6	4542.6	1563.5	87.1	2025.6	248.7	99.9	263.9	6.0	1458.5	2342.1	1790.4	67.9	786.0	4301.1	1098.6	364.4	36.3	2195.7	1417.0	846.2	125.5	400.6	461.5	822.0	469.0	117.4	208.1	1039.4	1079.7
CTAG2	"CAMEL, CT6.2a, CT6.2b, ESO2, LAGE-1, LAGE-1a, LAGE-1b, LAGE1, MGC138724, MGC3803"	ENSG00000126890	"Cancer/testis antigen 2"	O75638	X	154651972-154653579	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 5.4;testis: 10.5"	"Cell type enriched"	"Detected in some"	4	"Spermatogonia: 77.3"	"Cancer enhanced"	"Detected in many"		"melanoma: 12.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 104.1;K-562: 140.6;OE19: 203.6;RPMI-8226: 311.3;SK-BR-3: 195.4;U-266/84: 356.9"									"HPA071467, HPA076586"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA			"Nucleoplasm, Vesicles"	"Nuclear bodies"	"HPA071467: AB_2686402, HPA076586: "							"prognostic unfavorable (2.35e-4)"		"unprognostic (3.87e-1)"						"unprognostic (1.00e-1)"		"unprognostic (1.25e-2)"	0.3	0.8	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.3	0.0	0.1	0.0	0.8	1.6	0.0	5.4	0.0	0.1	0.4	0.7	0.3	0.0	0.2	0.1	0.0	0.5	2.0	0.0	0.3	2.6	0.1	0.3	0.0	0.0	0.1	0.0	3.3	0.4	0.2	0.0	0.0	0.4	0.5	10.5	0.0	3.0	0.1	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	104.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	140.6	2.9	0.0	0.0	0.2	0.0	0.0	203.6	0.0	0.0	0.0	311.3	0.0	0.0	0.4	0.0	0.0	195.4	0.3	0.0	0.2	0.6	0.3	6.3	0.2	0.7	0.2	2.6	356.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.2	0.0	2.1	0.0	0.0	1.2	0.9	0.0	3.9	0.0	0.2	0.0	1.8	0.2	0.0	0.0	0.5	0.0	11.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	3.1	0.3	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	3.7	1.2	0.5	0.0	0.0	0.6	18.5	77.3	0.0	0.0	1.1	0.1	0.0	0.0	0.0
CTXN1	FLJ25968	ENSG00000178531	"Cortexin 1"	P60606	19	7924491-7926135	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"brain: 226.7;endometrium 1: 86.4"	"Cell type enriched"	"Detected in many"	4	"Endometrial ciliated cells: 127.7"	"Group enriched"	"Detected in all"	4	"endometrial cancer: 69.5;glioma: 56.3;ovarian cancer: 138.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 96.4;HEK 293: 67.5;NTERA-2: 72.4;REH: 57.3;SCLC-21H: 56.2;SH-SY5Y: 94.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016669	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			Nucleoplasm	"Plasma membrane, Cell Junctions"	"HPA016669: AB_1847330"	"unprognostic (1.49e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.82e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.69e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.56e-3)"	"unprognostic (4.84e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.76e-2)"	"unprognostic (9.41e-2)"	4.0	12.6	171.8	0.9	226.7	0.1	3.2	0.0	174.4	32.8	0.0	39.6	0.9	86.4	2.9	2.6	43.4	0.2	1.0	201.2	27.3	10.7	0.4	7.0	0.0	91.0	17.7	137.0	6.3	2.2	1.1	57.4	0.3	150.1	16.4	0.4	0.2	6.5	12.5	0.5	4.0	4.8	4.9	0.0	1.4	8.9	28.0	43.6	0.3	2.8	0.1	0.0	21.4	13.3	52.9	33.5	8.1	20.5	96.4	0.0	0.3	4.8	8.5	2.3	4.1	2.4	2.4	5.0	0.2	16.2	2.0	2.2	35.9	4.7	0.9	0.2	3.0	67.5	0.7	5.3	1.5	0.9	1.8	1.9	0.0	2.7	1.4	0.9	9.8	5.4	9.1	21.3	0.3	0.5	40.5	18.5	13.6	72.4	2.4	34.1	57.3	0.0	6.4	15.0	1.4	56.2	94.5	5.2	2.8	9.9	1.7	21.2	0.6	8.3	2.1	33.1	3.9	4.8	0.7	1.0	4.8	8.0	3.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	171.8	226.7	0.0	174.4	201.2	27.3	91.0	17.7	137.0	150.1	0.0	43.6	52.9	0.6	0.0	0.0	3.3	0.7	1.1	4.1	1.5	2.2	0.3	15.3	6.7	0.4	1.5	1.0	9.2	4.2	0.2	0.2	0.5	3.9	7.8	9.5	127.7	22.4	1.6	9.1	0.0	20.6	0.4	0.4	3.0	0.0	7.9	0.0	13.3	0.7	0.1	0.3	0.0	3.5	0.5	2.0	0.3	0.5	27.1	1.2	0.5	1.8	4.7	0.0	0.6	0.0	1.5	2.9	1.7	1.2	1.9	0.0	19.9	0.0	11.9	21.0	0.4	0.0	0.2	17.7	6.0	16.0	0.3	2.0	0.3	0.6	3.2	0.2	6.4
CXCL16	"CXCLG16, SR-PSOX, SRPSOX"	ENSG00000161921	"C-X-C motif chemokine ligand 16"	Q9H2A7	17	4733533-4739928	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Late spermatids: 4051.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 63.3;intermediate monocyte: 107.5;myeloid DC: 38.2;neutrophil: 103.2;non-classical monocyte: 141.6"	"Group enriched"	"Detected in many"	7	"dendritic cells: 38.2;granulocytes: 103.2;monocytes: 141.6"	"Cell line enhanced"	"Detected in many"		"A-431: 86.5;CACO-2: 63.5;CAPAN-2: 58.4;HaCaT: 97.9;T-47d: 57.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA053253, HPA066315"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	1100000	6800000	"Golgi apparatus"	Vesicles	"HPA053253: AB_2682091, HPA066315: AB_2685657"	"unprognostic (4.64e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.05e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.08e-1)"	"unprognostic (4.78e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.37e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.60e-1)"	27.8	18.2	18.0	56.5	19.7	71.0	29.6	20.9	31.0	19.9	22.0	22.1	46.1	11.8	15.5	24.8	24.2	54.5	7.9	17.4	28.1	19.7	53.1	106.9	23.9	28.0	20.5	13.5	10.6	21.0	62.2	14.6	31.4	26.8	16.4	26.1	10.3	47.5	14.5	2.6	22.0	39.6	17.8	25.1	44.2	41.5	113.4	23.8	12.7	10.6	3.3	18.0	61.2	14.4	30.8	86.5	12.4	0.4	44.7	0.7	3.1	11.5	1.1	8.9	11.2	15.6	63.5	58.4	0.1	10.0	1.5	8.6	97.9	20.0	14.1	5.3	8.9	14.8	0.4	1.7	29.5	8.5	0.1	15.8	0.7	26.6	5.9	1.3	7.4	3.1	0.9	0.4	0.7	0.8	20.9	0.3	1.8	0.4	42.1	7.2	1.2	0.0	13.2	30.4	15.8	0.4	1.4	17.6	11.3	5.5	2.3	57.4	1.4	0.4	1.5	6.8	2.2	5.3	3.0	3.9	0.1	0.5	2.9	2.4	0.6	63.3	16.7	0.5	107.5	0.7	9.5	1.1	0.8	38.2	13.0	0.8	1.2	103.2	0.6	141.6	16.0	0.1	29.2	18.0	19.7	20.9	31.0	17.4	28.1	28.0	20.5	13.5	26.8	25.1	23.8	30.8	9.7	73.7	46.6	1.6	17.4	70.1	130.4	133.4	40.5	2.6	64.8	50.3	0.8	58.6	132.4	40.5	2.1	3.4	11.1	28.1	3.9	151.0	795.4	22.1	4.1	25.4	30.9	2.7	0.1	145.9	2.5	14.2	36.7	32.7	74.1	2.3	132.1	9.0	196.4	3.3	0.3	32.2	44.7	231.6	406.3	4051.5	24.5	270.6	26.6	15.0	556.1	13.2	1.0	5.0	1.2	188.1	44.5	30.1	2.2	277.2	51.3	17.4	62.4	1.3	19.7	3.4	14.4	22.7	11.5	33.7	76.4	2.9	11.7	1.6	23.7	272.7
CYP2F1	CYP2F	ENSG00000197446	"Cytochrome P450 family 2 subfamily F member 1"	P24903	19	41114432-41128381	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lung: 1.4;salivary gland: 1.0;testis: 2.1"	"Cell type enriched"	"Detected in some"	4	"Club cells: 67.4"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"HMC-1: 2.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA						"unprognostic (2.04e-1)"	"unprognostic (8.79e-2)"	"unprognostic (4.63e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.54e-1)"	"unprognostic (7.29e-3)"		"unprognostic (6.23e-3)"		"unprognostic (2.87e-2)"	"unprognostic (3.91e-2)"		"unprognostic (1.58e-6)"	"unprognostic (1.59e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.50e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.5	0.0	67.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.1	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	16.5	0.0	0.0	0.0	1.6	8.0	5.3	1.5	0.0	0.0	0.6	0.0	0.0	0.1
DCAF12L2	WDR40C	ENSG00000198354	"DDB1 and CUL4 associated factor 12 like 2"	Q5VW00	X	126163499-126166289	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.0;epididymis: 21.6"	"Cell type enriched"	"Detected in some"	7	"Granulosa cells: 11.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HAP1: 2.6;NTERA-2: 2.2;U-2 OS: 3.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA044737, HPA048981, HPA053138"	Approved		Uncertain	Cytosol		NA	NA			Cytosol		"HPA044737: AB_2679067, HPA048981: AB_2680586, HPA053138: AB_2682054"	"unprognostic (1.16e-4)"			"unprognostic (8.83e-3)"	"unprognostic (2.93e-1)"	"unprognostic (2.52e-2)"		"unprognostic (2.72e-1)"		"unprognostic (3.02e-1)"	"unprognostic (3.34e-3)"	"unprognostic (1.16e-1)"	"unprognostic (8.47e-4)"	"unprognostic (1.56e-2)"	"unprognostic (4.05e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.51e-1)"	0.5	0.9	1.7	0.0	2.1	0.0	0.4	0.2	2.3	1.4	0.0	0.5	0.0	2.4	21.6	0.1	2.3	0.1	0.0	2.5	2.6	0.2	0.0	0.0	0.1	10.0	1.6	1.7	1.4	0.0	2.5	1.3	0.0	3.0	1.5	0.0	0.2	0.3	4.3	0.1	0.2	0.2	1.3	1.5	0.0	0.3	5.5	2.5	0.0	0.1	0.9	0.2	1.2	0.5	1.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	2.1	0.2	2.3	2.5	2.6	10.0	1.6	1.7	3.0	1.5	2.5	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.7	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
DCANP1	"C5orf20, DCNP1"	ENSG00000251380	"Dendritic cell associated nuclear protein"	Q8TF63	5	135444214-135447348	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"Microglial cells: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	4	"THP-1: 1.8"									HPA048308	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA048308: AB_2680349"																		0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DCLK3	"DCAMKL3, DCDC3C, KIAA1765"	ENSG00000163673	"Doublecortin like kinase 3"	Q9C098	3	36712422-36764349	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.9;testis: 2.8"	"Cell type enriched"	"Detected in some"	6	"Early spermatids: 53.8"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 1.2"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA040685, HPA053234"	Approved		Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA040685: AB_2732487, HPA053234: "	"unprognostic (9.09e-3)"	"unprognostic (1.41e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.07e-2)"	"unprognostic (6.11e-5)"	"unprognostic (7.94e-3)"	"unprognostic (5.80e-2)"	"unprognostic (3.25e-3)"	"unprognostic (1.36e-2)"	0.4	0.1	1.0	0.4	3.9	0.1	0.2	0.2	1.5	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.3	0.8	1.5	0.0	0.0	0.0	0.0	0.7	0.2	0.9	0.0	0.1	0.2	1.0	0.3	0.7	0.0	0.1	1.5	0.1	0.0	0.9	0.1	0.1	0.3	0.7	0.0	0.0	2.8	0.5	1.3	0.3	0.9	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	3.9	0.2	1.5	0.8	1.5	0.7	0.2	0.9	0.7	0.7	0.5	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	53.8	0.1	0.1	0.5	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.0	2.0	0.0	0.9	0.0	0.0	0.0	0.4	8.9	0.3	0.1	0.0	0.0	0.0	0.9	0.0	0.5	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.1	3.3	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DERL3	"C22orf14, derlin-3, FLJ43842, IZP6, MGC71803"	ENSG00000099958	"Derlin 3"	Q96Q80	22	23834503-23839128	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 62.1;pancreas: 61.3;salivary gland: 51.5"	"Cell type enriched"	"Detected in many"	6	"Plasma cells: 1428.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	14	"plasmacytoid DC: 187.4"	"Lineage enriched"	"Detected in many"	14	"dendritic cells: 187.4"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 26.9;RPMI-8226: 23.6;U-266/70: 48.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB037234, HPA049306"	Approved		Uncertain	Vesicles		NA	NA			Vesicles		"CAB037234: AB_1840802, HPA049306: "	"unprognostic (2.01e-3)"	"prognostic favorable (8.70e-5)"	"unprognostic (9.72e-3)"	"unprognostic (7.47e-2)"	"unprognostic (9.77e-3)"	"prognostic favorable (8.01e-4)"	"unprognostic (2.23e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.66e-3)"	"unprognostic (4.74e-2)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (7.76e-13)"	"unprognostic (1.53e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.95e-1)"	1.7	3.2	1.5	4.3	1.6	1.8	5.5	1.4	2.2	4.2	1.8	17.4	10.1	3.7	0.2	4.4	7.1	2.3	5.4	1.3	1.5	5.6	9.2	9.3	9.2	1.5	1.8	1.3	2.1	61.3	0.8	8.2	0.8	1.7	3.4	11.0	0.2	51.5	3.9	2.7	0.8	33.9	0.7	1.8	62.1	29.6	25.0	1.8	1.6	14.7	0.2	17.8	3.7	2.4	1.7	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	4.5	4.8	0.9	0.0	1.4	0.0	1.1	1.3	0.0	0.5	4.8	0.4	4.6	0.0	0.7	3.2	0.6	0.0	0.2	0.5	0.0	0.1	0.1	0.5	0.8	26.9	0.0	0.0	1.3	2.2	1.0	2.3	0.3	4.2	0.0	23.6	0.9	0.3	0.6	0.1	0.1	0.0	0.2	0.7	0.0	1.5	0.0	0.0	0.0	0.4	0.1	48.5	6.3	8.3	0.8	6.2	0.1	0.0	0.0	0.0	0.2	0.1	0.2	13.8	0.0	0.0	0.0	12.4	0.1	0.0	0.1	0.0	0.0	187.4	0.0	1.3	1.5	1.6	1.4	2.2	1.3	1.5	1.5	1.8	1.3	1.7	1.8	1.8	1.7	0.5	0.0	1.1	0.3	183.8	1.8	1.5	3.7	0.6	1.1	19.3	1.8	3.5	1.5	4.1	0.0	2.1	0.8	141.7	2.7	0.0	0.5	113.2	33.8	0.9	1.1	1.8	8.2	0.3	5.8	6.2	2.2	7.7	1.7	2.5	15.7	4.6	7.8	3.4	0.0	1.7	7.9	4.1	2.2	2.1	158.2	2.5	5.4	224.1	1.9	0.5	0.8	0.0	1.0	0.5	1.1	0.5	4.1	1428.8	2.5	0.8	0.5	30.3	0.6	0.0	0.8	2.6	67.0	32.9	1.3	2.0	15.5	17.9	2.1	10.7	2.0
DES	"CMD1I, CSM1, CSM2"	ENSG00000175084	Desmin	P17661	2	219418377-219426734	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Muscle protein"	"Cancer-related genes, Cardiomyopathy, Desmin-related myopathy, Disease variant, Limb-girdle muscular dystrophy, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 9831.5;skeletal muscle: 16668.0"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 2531.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 562.1;stomach cancer: 400.2"	"Region enhanced"	"Detected in all"		"cerebral cortex: 13.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 70.2;LHCN-M2: 145.3;NB-4: 39.5;RH-30: 333.1"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"midbrain: 29.5"	"CAB000034, HPA018803"	Enhanced		Supported	"Intermediate filaments"		NA	NA		1600000	"Intermediate filaments"		"CAB000034: , HPA018803: AB_1847616"	"unprognostic (1.75e-1)"	"unprognostic (1.95e-3)"	"unprognostic (3.43e-2)"	"unprognostic (8.76e-2)"	"unprognostic (7.75e-3)"	"unprognostic (6.61e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.72e-2)"	"unprognostic (4.67e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.43e-2)"	"prognostic unfavorable (5.08e-4)"	"unprognostic (3.49e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.25e-3)"	170.8	57.6	1.7	440.0	3.3	1.1	51.7	1.8	13.7	490.7	19.3	5828.2	293.9	3040.5	86.7	1494.9	1094.5	456.2	9831.5	2.0	2.0	17.0	15.6	175.5	7.3	4.2	2.6	1.8	173.3	14.7	0.5	8.5	53.2	2.0	2237.7	247.9	0.0	257.4	2274.3	16668.0	123.2	1355.1	2581.7	2.0	25.4	1982.2	16.2	2.0	3.2	66.7	5804.8	1.2	4801.7	675.1	2.5	0.0	0.0	0.1	0.0	0.0	2.2	5.3	0.2	0.0	0.1	0.1	0.5	0.0	0.0	9.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.2	17.0	0.1	1.3	70.2	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	145.3	0.0	0.0	39.5	0.5	0.0	0.0	0.0	333.1	2.1	0.0	0.0	0.2	1.2	0.0	0.0	0.0	9.2	0.0	5.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	1.7	3.3	1.8	13.7	2.0	2.0	4.2	2.6	1.8	2.0	2.0	2.0	2.5	0.4	0.0	0.0	0.0	0.0	4.1	2.7	0.0	0.0	0.0	0.1	0.0	2531.9	1.5	0.0	0.0	0.0	1.9	0.0	0.4	0.0	0.0	90.6	0.5	6.7	22.7	0.0	0.0	0.1	0.0	5.2	104.6	0.0	0.1	0.0	0.0	1.8	0.0	5.6	0.0	0.0	0.9	0.0	0.0	10.7	71.6	28.9	2.8	12.4	0.0	0.6	0.0	0.0	0.5	0.0	0.5	0.0	50.4	0.0	8.7	0.0	0.1	0.0	0.0	46.0	497.8	210.5	5.0	5.1	0.1	9.8	8.5	2.4	0.0	0.2	2.9
DGCR6L	FLJ10666	ENSG00000128185	"DiGeorge syndrome critical region gene 6 like"	Q9BY27	22	20314238-20320080	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"Late spermatids: 2787.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"																	NA	NA						"unprognostic (1.91e-1)"	"prognostic favorable (3.82e-5)"	"unprognostic (2.74e-2)"	"unprognostic (4.61e-3)"	"unprognostic (3.97e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.61e-1)"	"prognostic favorable (5.37e-4)"	"unprognostic (1.44e-1)"	"unprognostic (4.39e-2)"	"unprognostic (3.29e-3)"	"unprognostic (9.07e-3)"	"unprognostic (6.72e-3)"	"unprognostic (4.37e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.97e-1)"	33.9	45.2	65.7	15.5	63.5	31.2	36.6	59.0	96.5	37.9	61.6	39.9	20.0	33.9	24.0	41.6	32.0	18.9	63.2	63.1	61.2	57.7	153.8	28.8	24.9	62.7	62.1	64.5	36.6	43.5	42.4	43.7	12.6	62.2	51.5	11.5	8.7	45.6	29.3	81.8	54.3	30.0	15.5	60.5	34.1	41.3	133.1	63.8	27.9	46.2	44.5	14.7	40.2	35.6	60.8	34.0	38.0	25.5	64.5	36.6	36.6	26.7	32.4	37.7	58.7	42.6	19.7	16.4	9.1	41.4	35.9	23.7	33.8	19.3	39.0	9.6	43.7	97.6	21.7	26.6	36.8	43.3	46.6	21.0	41.0	35.4	23.0	24.7	22.7	41.4	42.3	99.9	39.4	38.3	79.2	35.1	42.4	18.7	67.2	56.1	61.0	58.5	17.7	31.1	26.3	50.4	36.9	53.3	34.7	60.6	10.3	50.3	37.0	32.5	69.4	80.3	37.1	32.1	34.9	39.5	20.9	56.1	58.5	47.5	115.6	102.0	145.5	104.6	93.3	104.0	81.7	130.7	117.7	93.9	73.5	119.9	113.9	34.0	139.1	92.7	88.2	129.8	120.4	65.7	63.5	59.0	96.5	63.1	61.2	62.7	62.1	64.5	62.2	60.5	63.8	60.8	43.6	28.9	30.2	4.9	29.7	43.7	34.2	53.4	33.0	18.6	79.4	106.3	80.3	57.2	41.1	35.0	4.2	67.7	43.1	65.2	133.1	72.2	529.8	28.0	23.2	40.2	52.8	37.2	6.3	63.0	86.4	43.3	26.0	17.5	39.3	38.5	62.4	166.9	80.2	28.6	7.3	64.4	34.6	78.3	52.9	2787.0	70.2	41.7	56.9	1.9	55.5	58.2	95.8	6.0	7.9	51.7	58.5	70.7	44.2	26.2	166.0	164.5	42.5	24.9	46.0	23.6	47.2	117.3	91.0	62.3	60.9	21.9	56.7	36.2	69.0	33.9
DHRS7C	SDR32C2	ENSG00000184544	"Dehydrogenase/reductase 7C"	A6NNS2	17	9771434-9791592	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 311.0;tongue: 370.7"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 87.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA										"unprognostic (6.83e-2)"													0.1	0.1	0.5	0.0	0.6	0.0	0.1	0.4	1.1	0.0	0.4	0.4	0.2	0.0	0.0	4.0	0.0	0.0	85.4	0.7	0.5	0.0	0.1	0.1	0.0	0.5	0.5	0.5	0.0	0.1	0.0	0.2	0.0	0.5	0.5	1.1	0.0	3.0	0.0	311.0	0.0	0.2	0.0	0.5	0.0	0.0	0.6	0.5	0.0	0.0	370.7	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.4	1.1	0.7	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	14.9	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DIAPH3	"AN, AUNA1, DRF3, FLJ34705, NSDAN"	ENSG00000139734	"Diaphanous related formin 3"	Q9NSV4	13	59665583-60163928	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Deafness, Neuropathy, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 7.1;testis: 19.1"	"Cell type enriched"	"Detected in many"	5	"Early spermatids: 414.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA032151			Supported	"Plasma membrane,Microtubules"		NA	Yes			"Plasma membrane, Microtubules"		"HPA032151: AB_2674181"	"unprognostic (3.78e-2)"	"unprognostic (1.28e-2)"	"prognostic favorable (9.04e-4)"	"prognostic unfavorable (4.18e-4)"	"unprognostic (2.78e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.27e-4)"	"prognostic unfavorable (3.72e-4)"	"unprognostic (1.74e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.22e-5)"	"unprognostic (3.59e-3)"	"unprognostic (5.31e-5)"	"unprognostic (4.30e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.07e-1)"	"unprognostic (2.74e-3)"	0.4	0.1	0.1	1.7	0.2	7.1	0.8	0.3	0.3	0.3	0.2	1.9	1.9	0.6	0.0	2.2	0.1	0.4	0.1	0.1	0.2	0.8	0.2	1.2	2.4	0.2	0.2	0.1	0.1	0.2	0.1	0.0	3.5	0.4	0.1	2.1	0.0	0.5	0.0	0.0	1.3	1.7	2.6	0.1	0.5	1.6	19.1	0.3	5.5	0.1	0.0	2.4	0.6	0.7	0.5	47.7	15.6	15.8	9.1	2.7	7.1	26.9	65.0	28.7	64.2	55.6	41.7	31.4	15.9	5.2	33.4	16.7	31.7	26.0	25.5	96.9	18.0	17.9	22.7	37.6	9.5	4.1	31.2	17.4	2.8	0.6	39.2	26.3	16.3	29.2	14.0	17.8	21.9	61.8	6.9	28.0	10.2	14.7	22.5	8.9	18.8	38.9	12.9	19.9	9.6	8.3	14.3	33.2	22.8	9.5	33.8	16.7	16.8	29.3	40.5	25.9	13.7	54.5	14.7	17.1	24.4	10.9	15.2	31.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.3	0.3	0.1	0.2	0.2	0.2	0.1	0.4	0.1	0.3	0.5	0.6	54.5	3.4	39.8	1.9	3.7	0.8	2.1	2.8	0.0	3.9	1.5	1.0	2.8	1.8	0.0	0.0	21.1	1.1	3.8	5.9	1.3	414.4	2.5	3.5	2.1	0.0	26.7	5.6	4.0	30.7	5.8	9.7	9.3	0.0	78.8	1.8	0.4	6.1	0.0	3.3	2.6	2.0	1.0	1.2	56.0	0.6	1.5	0.0	5.6	0.1	3.5	2.1	19.1	1.8	1.5	0.2	0.0	18.9	0.4	1.1	5.4	0.2	0.0	0.0	0.0	7.9	39.2	17.8	11.6	1.1	7.3	2.2	2.8	5.6	1.5
DIPK1C	"C18orf51, FAM69C"	ENSG00000187773	"Divergent protein kinase domain 1C"	Q0P6D2	18	74434775-74457944	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 31.5;choroid plexus: 13.9;retina: 16.7"	"Cell type enriched"	"Detected in single"	27	"Cardiomyocytes: 22.1"	"Group enriched"	"Detected in some"	18	"glioma: 11.1;melanoma: 6.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"SK-MEL-30: 5.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048928	Enhanced					NA	NA					"HPA048928: AB_2680560"	"unprognostic (6.35e-2)"	"unprognostic (1.13e-2)"	"unprognostic (8.09e-2)"	"unprognostic (3.32e-2)"	"unprognostic (4.08e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.31e-1)"	"unprognostic (8.97e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.91e-4)"	"unprognostic (2.16e-1)"	"unprognostic (6.73e-2)"	"unprognostic (3.23e-2)"	"unprognostic (4.40e-3)"	0.3	0.1	21.3	0.0	27.5	0.0	0.3	24.3	24.1	1.7	13.9	1.0	0.0	0.2	0.1	0.1	0.2	0.4	7.0	20.5	22.7	0.1	0.3	0.0	0.0	25.4	26.7	18.8	0.0	0.1	0.0	0.3	0.1	29.9	0.4	0.1	16.7	0.3	0.6	1.1	4.2	0.3	0.1	18.5	0.1	1.5	6.9	27.7	0.7	0.0	2.0	0.0	0.1	0.4	31.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.3	27.5	24.3	24.1	20.5	22.7	25.4	26.7	18.8	29.9	18.5	27.7	31.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DIPK2B	"CXorf36, DIA1R, FLJ14103"	ENSG00000147113	"Divergent protein kinase domain 2B"	Q9H7Y0	X	45148373-45200901	"Disease related genes, Predicted secreted proteins"			"Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"Adipocytes: 96.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	57	"HUVEC TERT2: 81.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA002806	Uncertain				"Secreted - unknown location"	NA	NA		940000			"HPA002806: AB_1078595"	"unprognostic (2.12e-1)"	"unprognostic (1.32e-2)"	"unprognostic (8.51e-3)"	"unprognostic (2.05e-1)"	"unprognostic (4.65e-2)"	"unprognostic (4.07e-3)"	"unprognostic (7.30e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.39e-1)"	"unprognostic (6.06e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.75e-3)"	"unprognostic (3.79e-3)"	"unprognostic (1.98e-1)"	"unprognostic (8.47e-2)"	"unprognostic (3.11e-2)"	38.8	5.4	14.4	6.1	13.9	0.8	37.3	10.9	14.0	19.7	7.4	8.2	2.6	20.6	7.0	6.5	18.2	8.8	18.9	10.8	11.0	6.7	1.4	14.2	5.7	13.9	13.6	8.8	6.9	3.5	4.7	3.4	40.9	13.6	11.4	3.8	1.4	6.9	7.2	16.7	7.1	7.8	20.9	11.6	3.1	6.3	1.5	14.6	2.8	18.6	16.8	3.4	14.4	14.0	14.9	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	81.7	0.1	0.0	0.5	0.0	0.1	0.0	0.3	0.1	1.4	0.5	0.1	0.1	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.5	0.1	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	14.4	13.9	10.9	14.0	10.8	11.0	13.9	13.6	8.8	13.6	11.6	14.6	14.9	96.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
DISC1		ENSG00000162946	"DISC1 scaffold protein"	Q9NRI5	1	231626790-232041272	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Neurogenesis, Wnt signaling pathway"	"Developmental protein"	Schizophrenia	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 21.9"	"Cell type enriched"	"Detected in many"	4	"Rod photoreceptor cells: 113.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"THP-1: 11.4;TIME: 8.7;WM-115: 8.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA048911			Supported	"Intermediate filaments,Cytosol"		NA	NA			"Intermediate filaments, Cytosol"		"HPA048911: AB_2732549"	"unprognostic (1.08e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.57e-2)"	"unprognostic (3.36e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.41e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.89e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.31e-4)"	"unprognostic (1.74e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.94e-1)"	2.3	1.4	5.3	3.2	5.1	2.6	1.9	4.0	5.4	2.1	4.5	1.5	1.1	1.5	0.5	1.3	1.2	2.6	9.1	4.4	7.1	1.1	1.4	1.8	2.4	6.9	5.3	2.9	4.5	0.8	1.1	1.0	7.3	6.9	1.2	1.2	21.9	2.0	0.9	1.4	1.1	1.4	1.5	6.1	2.9	1.0	0.9	6.1	3.1	1.8	1.1	1.7	1.6	1.3	9.3	0.0	0.4	4.0	0.1	0.1	0.3	2.8	1.6	3.6	4.1	3.5	1.4	0.8	0.1	4.8	1.3	1.0	0.0	0.3	0.1	3.7	2.6	1.7	2.2	0.3	4.0	0.5	3.7	5.1	2.2	0.7	1.4	1.2	2.8	3.8	2.7	0.0	1.4	4.6	0.4	1.1	5.6	2.0	0.0	1.5	2.7	1.1	0.4	0.1	0.0	0.7	2.2	1.4	0.0	2.4	1.0	0.0	11.4	8.7	2.1	2.3	1.0	0.9	0.9	0.7	0.0	1.7	5.6	8.8	0.1	0.8	0.0	0.2	0.8	0.1	0.0	0.4	0.0	1.0	0.1	0.4	0.1	0.7	0.2	0.4	0.6	0.1	0.2	5.3	5.1	4.0	5.4	4.4	7.1	6.9	5.3	2.9	6.9	6.1	6.1	9.3	6.7	0.0	1.1	0.0	2.1	0.9	0.5	0.7	3.4	23.3	2.0	1.8	7.2	0.0	1.2	3.7	8.4	8.0	2.0	0.5	0.0	0.6	16.6	3.4	2.1	6.7	0.0	2.1	0.0	1.1	0.8	3.0	0.0	4.5	7.0	8.0	10.0	0.0	11.3	0.0	0.0	0.1	0.0	13.0	12.6	23.2	0.9	13.7	3.6	0.0	5.6	2.4	2.1	0.0	0.0	2.0	0.3	1.5	2.1	0.7	0.0	0.2	2.5	113.1	0.0	4.6	2.7	1.4	1.6	0.5	1.1	2.5	5.8	8.1	0.7	0.6
DLX4	"BP1, DLX7, DLX8, DLX9"	ENSG00000108813	"Distal-less homeobox 4"	Q92988	17	49968970-49974959	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"placenta: 3.8;skin 1: 3.0"	"Cell type enriched"	"Detected in some"	4	"Extravillous trophoblasts: 77.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 22.9;CACO-2: 16.8;GAMG: 15.3;HAP1: 11.2;K-562: 13.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA059933	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA059933: AB_2684169"	"unprognostic (8.12e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.29e-3)"	"unprognostic (7.49e-2)"	"unprognostic (2.71e-1)"	"unprognostic (9.35e-3)"	"unprognostic (2.85e-2)"	"unprognostic (8.73e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.88e-13)"	"unprognostic (8.79e-3)"	"unprognostic (2.77e-1)"	"unprognostic (5.00e-2)"	"unprognostic (6.86e-2)"	0.2	0.2	0.3	0.2	0.2	0.2	0.3	0.2	0.7	0.2	0.1	0.1	0.1	0.0	0.2	0.7	0.2	0.0	0.1	0.2	0.2	0.1	0.0	0.6	0.2	0.3	0.6	0.1	0.0	0.3	0.2	0.1	3.8	0.5	0.2	0.1	0.0	1.1	0.2	0.0	3.0	0.3	0.0	0.3	0.4	0.1	0.3	0.4	0.1	0.3	0.0	0.5	0.2	0.5	0.3	0.5	1.4	0.0	0.1	0.1	0.0	22.9	0.1	0.1	0.1	0.3	16.8	1.0	0.7	3.3	0.3	15.3	2.3	11.2	0.4	0.1	4.5	5.9	0.4	5.7	1.7	0.0	0.9	3.7	0.0	2.8	0.1	0.0	0.2	0.0	3.5	13.5	0.0	0.0	2.9	0.4	6.0	0.2	3.1	0.0	0.0	5.1	0.6	0.1	0.8	1.9	0.1	0.4	1.9	1.1	3.4	4.1	4.0	0.0	0.0	1.0	0.2	0.0	0.9	0.2	0.0	0.4	3.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.3	0.2	0.2	0.7	0.2	0.2	0.3	0.6	0.1	0.5	0.3	0.4	0.3	0.0	6.4	0.0	0.0	0.2	2.5	0.4	1.0	2.2	0.0	0.5	0.3	1.9	0.0	0.1	0.0	0.0	12.7	0.1	0.1	0.0	0.3	0.1	1.5	0.1	0.2	0.0	0.0	0.3	0.2	77.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	1.0	1.1	0.4	0.6	16.8	0.1	0.2	0.2	0.3
DMTN	"DMT, EPB49"	ENSG00000158856	"Dematin actin binding protein"	Q08495	8	22048995-22082527	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 194.1"	"Cell type enriched"	"Detected in many"	5	"Erythroid cells: 248.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"gdT-cell: 1.7;MAIT T-cell: 1.7;memory CD4 T-cell: 3.8;memory CD8 T-cell: 1.6;naive CD4 T-cell: 1.5;naive CD8 T-cell: 1.5;neutrophil: 1.2;T-reg: 3.3"	"Group enriched"	"Detected in many"	7	"granulocytes: 1.2;T-cells: 3.8"	"Cell line enhanced"	"Detected in many"		"A549: 68.9;HEL: 225.9;Hep G2: 63.9;HMC-1: 65.6;OE19: 67.3;RPTEC TERT1: 87.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024290, HPA058487"	Uncertain					NA	NA		2400000			"HPA024290: AB_1847601, HPA058487: "	"unprognostic (6.74e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.24e-3)"	"prognostic unfavorable (7.92e-5)"	"unprognostic (2.88e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.25e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.97e-1)"	"prognostic favorable (3.85e-9)"	"unprognostic (3.14e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.86e-1)"	"unprognostic (8.07e-2)"	36.0	30.1	108.1	6.1	136.9	137.8	22.0	0.0	194.1	12.5	0.0	30.3	9.3	15.4	14.5	19.1	30.6	13.6	72.1	132.3	67.2	66.0	28.4	20.2	3.4	35.0	20.7	134.9	3.5	29.9	55.4	110.5	7.5	63.0	25.2	15.3	23.2	23.1	20.6	67.1	24.2	14.1	14.1	0.0	19.4	24.0	11.7	30.8	3.1	39.5	41.8	3.7	13.0	12.5	95.4	44.1	68.9	0.5	1.4	1.1	0.3	5.4	4.6	4.3	14.5	4.3	29.9	26.7	0.4	43.8	0.8	0.9	14.8	2.1	2.7	6.5	0.4	13.0	225.9	5.3	63.9	1.3	0.1	65.6	0.7	29.3	0.2	0.3	8.5	14.7	2.0	21.7	2.2	0.1	18.9	5.7	0.5	1.8	67.3	6.1	0.0	0.6	3.1	87.2	12.3	15.6	21.8	7.3	0.9	3.2	3.5	11.2	2.2	26.1	0.0	22.0	0.3	24.0	0.1	0.2	0.7	0.3	0.2	15.4	0.0	0.1	0.2	1.7	0.0	1.7	0.0	3.8	1.6	0.1	0.0	1.5	1.5	1.2	0.0	0.0	0.3	3.3	9.3	108.1	136.9	0.0	194.1	132.3	67.2	35.0	20.7	134.9	63.0	0.0	30.8	95.4	9.3	3.2	10.7	10.7	1.5	2.3	4.0	3.9	1.2	34.6	9.9	5.7	37.8	0.0	5.1	7.3	12.5	0.1	2.7	15.3	19.6	11.4	12.7	11.2	1.7	10.2	20.5	248.6	45.7	11.4	1.7	2.4	7.7	12.7	0.0	4.1	3.9	15.8	0.5	28.6	29.7	8.7	0.0	1.0	1.6	7.7	0.3	44.5	14.2	5.6	1.3	2.6	0.0	1.5	4.3	18.2	10.0	2.6	1.4	3.7	1.8	29.6	9.3	7.3	0.0	1.4	5.7	1.4	2.4	3.8	5.7	0.1	6.4	0.3	13.3	4.8
DNAI4	"DIC4, FLJ23129, WDR78"	ENSG00000152763	"Dynein axonemal intermediate chain 4"	Q5VTH9	1	66812885-66924856	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 28.0;testis: 35.5"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 8.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"NK-cell: 3.8"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 3.8"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 7.0;RPTEC TERT1: 11.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (4.26e-2)"	"unprognostic (4.04e-1)"	"unprognostic (1.58e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.19e-2)"	"unprognostic (4.00e-1)"	"unprognostic (1.68e-3)"	"unprognostic (2.08e-2)"	"prognostic favorable (9.60e-5)"	"unprognostic (1.98e-1)"	"unprognostic (5.79e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.69e-1)"	1.5	1.7	10.0	0.5	3.3	0.1	3.0	4.2	2.3	4.0	16.5	5.5	0.7	3.0	5.1	0.5	28.0	2.5	1.1	2.2	11.6	6.4	1.2	4.2	1.0	12.4	8.7	1.0	3.0	1.4	7.0	2.8	2.1	7.3	1.8	4.1	4.1	1.1	2.0	0.5	1.0	0.6	1.3	12.7	0.9	0.8	35.5	4.3	2.3	5.9	0.3	0.7	0.9	0.9	9.1	2.9	1.2	1.6	2.1	4.8	7.0	0.6	1.3	2.2	1.6	1.7	0.3	2.4	1.5	0.3	1.3	5.0	0.2	1.1	0.3	2.5	0.2	0.4	0.4	0.7	0.2	1.6	0.1	0.0	3.3	3.5	6.0	1.2	5.8	0.6	1.5	0.4	0.1	2.8	1.1	0.7	0.5	2.1	1.0	0.6	0.7	0.0	0.0	11.4	0.0	1.9	0.9	1.4	0.5	1.1	1.7	0.5	1.0	0.2	0.7	0.0	4.7	0.7	0.5	0.0	3.2	1.4	0.3	1.7	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.3	0.1	0.0	0.9	0.5	0.2	0.1	3.8	0.0	0.0	0.1	0.1	10.0	3.3	4.2	2.3	2.2	11.6	12.4	8.7	1.0	7.3	12.7	4.3	9.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0
DNAJC4	"HSPF2, MCG18"	ENSG00000110011	"DnaJ heat shock protein family (Hsp40) member C4"	Q9NNZ3	11	64230278-64234286	"Predicted intracellular proteins, Predicted membrane proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 242.7"	"Cell type enriched"	"Detected in all"	5	"Late spermatids: 3342.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA011947	Uncertain					NA	NA					"HPA011947: AB_1847803"	"unprognostic (8.99e-3)"	"unprognostic (2.28e-2)"	"prognostic unfavorable (3.12e-4)"	"unprognostic (2.95e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.20e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.56e-2)"	"unprognostic (7.69e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.73e-3)"	"unprognostic (1.07e-1)"	"prognostic favorable (6.21e-4)"	"unprognostic (2.47e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.69e-1)"	38.6	81.2	47.6	25.2	46.3	43.5	39.1	47.7	51.4	49.8	49.8	53.3	39.3	38.2	36.0	44.4	40.5	24.1	83.7	44.0	46.6	66.7	72.4	38.9	35.3	50.0	46.7	40.1	62.0	99.3	33.6	55.1	16.6	50.1	59.0	23.1	11.4	60.4	23.4	64.7	53.6	54.1	16.3	45.9	71.0	62.8	242.7	51.8	29.3	57.7	49.6	33.6	43.4	40.7	49.8	12.4	11.6	26.9	39.9	32.0	56.0	18.8	17.9	30.2	10.9	15.0	11.6	17.6	14.9	57.6	32.1	6.4	9.7	13.5	16.2	6.3	31.6	15.9	18.5	12.2	31.8	39.0	13.9	42.3	58.4	42.9	17.3	20.2	51.5	26.1	16.4	12.7	76.2	7.1	30.4	5.6	33.2	7.8	29.1	22.3	38.7	7.1	101.1	45.4	8.2	23.4	37.9	18.0	20.2	68.8	25.6	48.8	24.6	24.3	12.6	12.6	19.4	10.2	74.8	32.8	18.6	11.1	17.3	36.8	48.2	57.6	42.7	21.9	52.2	27.7	47.6	21.8	25.6	80.4	49.1	30.9	24.8	31.2	41.6	42.7	129.8	22.4	36.4	47.6	46.3	47.7	51.4	44.0	46.6	50.0	46.7	40.1	50.1	45.9	51.8	49.8	29.8	12.8	30.5	11.4	69.5	43.7	58.2	54.5	95.0	21.1	93.8	119.9	22.3	34.3	37.8	27.6	8.4	80.1	58.1	47.6	160.4	37.6	667.3	22.1	27.3	35.1	81.3	28.2	5.0	38.5	60.2	34.4	45.9	24.9	46.3	41.6	43.2	32.4	53.0	25.2	6.9	74.1	69.2	69.5	63.8	3342.9	62.7	66.0	48.0	4.7	112.4	35.0	55.6	3.0	5.5	28.7	55.6	46.6	96.3	43.4	115.0	101.7	15.1	14.5	19.7	29.0	30.3	28.4	28.8	60.1	51.1	54.5	46.6	61.9	68.9	64.9
DNASE1	DNL1	ENSG00000213918	"Deoxyribonuclease 1"	P24855	16	3611728-3680143	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	Apoptosis	"Actin-binding, Endonuclease, Hydrolase, Nuclease"	"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 34.8"	"Cell type enriched"	"Detected in many"	11	"Proximal enterocytes: 715.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA010703	Enhanced		Supported	Vesicles	"Secreted in other tissues"	NA	NA		420000	Vesicles		"HPA010703: AB_10600806"	"unprognostic (5.18e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.90e-2)"	"unprognostic (3.73e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.20e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.69e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (1.14e-4)"	4.3	5.0	5.7	6.7	5.8	4.4	4.6	12.5	6.2	8.8	6.8	6.0	29.9	5.2	5.0	7.2	6.9	2.7	5.3	5.7	5.4	21.2	6.0	4.9	10.1	5.9	5.3	4.6	7.5	23.8	2.7	16.4	4.3	8.4	11.7	5.1	4.4	5.0	2.5	3.8	7.9	34.8	2.7	3.4	9.3	11.3	9.2	5.3	9.5	7.4	1.3	8.7	6.0	8.6	9.7	2.9	6.5	11.4	5.9	3.3	2.8	5.2	4.7	0.8	3.7	5.3	8.0	6.9	12.3	3.6	0.7	7.8	4.8	4.2	1.3	3.9	5.5	6.4	4.4	11.3	5.4	1.7	2.9	9.6	2.3	4.8	5.0	1.2	5.8	2.5	10.3	11.2	5.0	3.2	12.3	6.3	13.6	6.9	8.7	3.6	14.9	5.3	5.7	3.1	2.5	8.1	7.6	3.5	10.5	1.9	5.7	10.4	7.7	3.4	6.8	5.0	4.3	2.5	4.8	7.5	21.4	1.7	5.7	6.6	2.7	1.1	3.2	1.5	0.7	1.0	1.4	1.2	1.3	0.6	2.1	1.3	1.8	5.0	1.0	0.7	1.1	1.4	0.5	5.7	5.8	12.5	6.2	5.7	5.4	5.9	5.3	4.6	8.4	3.4	5.3	9.7	4.9	9.6	10.3	27.1	9.1	2.7	8.6	3.1	10.8	27.3	5.5	4.8	6.0	4.3	9.7	16.5	22.9	8.6	9.3	11.8	56.7	5.3	19.3	9.8	10.0	7.7	14.3	7.6	20.5	11.0	4.1	7.4	13.3	8.4	2.5	23.3	7.5	1.8	3.9	25.2	22.0	38.6	20.3	5.0	4.2	52.4	8.4	4.4	1.8	15.9	13.2	8.6	30.9	22.1	20.6	5.3	61.4	7.9	7.2	12.4	715.5	2.4	9.1	17.9	0.0	13.6	6.3	28.5	24.5	5.8	3.8	6.2	12.2	10.4	33.4	6.3
DOCK10	"KIAA0694, ZIZ3"	ENSG00000135905	"Dedicator of cytokinesis 10"	Q96BY6	2	224765090-225042468	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 83.9;lymphoid tissue: 32.4"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 1806.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 45.5;GAMG: 73.4;HDLM-2: 52.7;TIME: 48.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058106	Enhanced	Supported	Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA058106: AB_2683606"	"unprognostic (6.95e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.92e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.80e-1)"	"unprognostic (3.22e-3)"	"unprognostic (3.39e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.54e-1)"	"unprognostic (7.72e-2)"	4.4	8.3	24.3	19.0	44.8	10.3	3.9	31.6	32.8	8.7	10.1	6.4	4.1	3.2	1.1	3.2	2.4	6.4	1.5	26.7	32.4	3.2	5.6	7.7	28.1	42.1	38.9	15.8	17.8	1.7	2.0	1.0	2.3	44.5	1.7	6.6	5.7	2.5	1.7	1.2	5.1	12.6	4.4	31.6	30.0	6.7	2.2	35.9	32.4	2.8	0.8	20.1	6.5	4.4	83.9	0.0	21.4	6.7	0.0	8.5	17.9	0.0	45.5	36.8	21.3	15.8	0.0	0.0	0.6	0.1	28.9	73.4	0.5	0.0	0.1	16.9	52.7	0.0	0.6	4.5	0.0	0.3	4.4	2.1	4.3	0.4	31.0	12.0	8.3	21.4	7.0	0.1	42.1	36.4	2.1	8.0	6.1	2.6	0.0	5.0	10.5	9.8	6.2	1.1	0.1	0.4	5.5	0.0	0.0	4.8	1.2	1.4	20.0	48.2	22.8	5.7	10.9	15.6	0.0	0.0	0.0	32.2	29.6	10.1	3.0	3.3	0.2	6.5	9.2	6.6	7.2	10.9	9.1	6.9	4.5	10.5	9.3	0.1	14.3	11.8	2.8	8.4	4.5	24.3	44.8	31.6	32.8	26.7	32.4	42.1	38.9	15.8	44.5	31.6	35.9	83.9	3.7	3.2	9.1	4.2	47.1	4.7	0.6	0.3	8.0	7.9	0.8	4.3	1.2	0.0	2.5	5.5	0.0	0.3	39.5	0.8	1.9	0.1	3.2	0.2	2.3	3.2	2.4	5.5	8.0	0.0	0.2	4.9	5.1	0.5	36.7	64.0	2.5	1.4	30.6	97.6	244.2	3.8	0.0	54.2	39.7	2.8	0.6	51.0	8.8	201.4	38.3	1.2	38.1	400.6	1806.0	0.2	0.3	0.0	43.5	0.5	0.2	0.3	2.6	1.8	13.1	2.5	18.9	0.3	1.1	2.1	4.1	0.8	75.1	31.4	2.5	0.7
DPYD	DPD	ENSG00000188641	"Dihydropyrimidine dehydrogenase"	Q12882	1	97077743-97995000	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 69.0"	"Cell type enriched"	"Detected in many"	6	"Oligodendrocytes: 1712.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033241, HPA045210"	Uncertain					NA	NA		1600000			"CAB033241: AB_2094323, HPA045210: AB_2679256"	"unprognostic (2.33e-2)"	"unprognostic (1.69e-1)"	"unprognostic (9.82e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.13e-2)"	"unprognostic (8.81e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.56e-1)"	"unprognostic (9.29e-2)"	"prognostic unfavorable (6.27e-4)"	"unprognostic (6.54e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.43e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.25e-1)"	22.4	13.3	6.5	22.8	12.0	10.4	16.8	5.2	8.8	19.0	3.5	10.3	22.1	15.0	8.4	17.3	14.4	25.9	8.6	7.3	18.0	12.7	69.0	29.8	16.7	11.9	9.5	6.0	24.2	11.9	9.3	6.2	4.6	12.0	10.0	10.2	3.3	15.1	13.6	5.8	7.2	19.6	18.4	7.4	24.9	8.5	3.7	11.0	17.2	10.4	10.1	12.1	18.4	14.3	24.5	22.2	6.2	7.8	0.2	42.4	72.5	0.1	35.2	31.9	32.1	23.6	0.0	9.2	11.7	50.6	32.9	5.1	5.2	0.0	8.3	58.7	11.6	7.3	10.0	11.1	0.2	18.8	4.5	0.6	57.5	3.0	25.7	29.3	67.7	26.8	6.8	0.4	36.4	17.0	0.0	23.6	6.4	0.9	0.2	7.5	0.1	37.1	18.6	39.4	0.1	11.1	8.8	30.1	2.5	0.3	0.8	0.0	10.2	30.9	69.2	5.0	56.4	70.6	3.0	0.1	0.2	10.2	12.6	56.2	18.2	61.1	4.1	11.6	29.5	14.8	2.2	13.3	11.0	32.7	4.9	12.5	11.1	59.8	13.3	27.1	0.9	15.8	21.9	6.5	12.0	5.2	8.8	7.3	18.0	11.9	9.5	6.0	12.0	7.4	11.0	24.5	25.5	16.0	39.1	23.8	15.4	7.6	8.8	9.4	18.8	2.5	8.4	8.3	5.3	40.0	11.5	7.3	0.0	0.2	19.2	3.3	5.9	2.5	7.0	1.5	15.2	14.7	3.0	13.3	258.6	6.4	0.2	30.0	10.7	1.7	9.5	4.5	17.2	54.2	17.1	0.0	30.5	5.5	6.1	130.4	27.0	4.0	33.5	73.7	3.6	105.9	98.1	4.8	27.8	34.2	1712.3	5.3	2.1	18.8	17.0	4.9	21.0	6.6	8.6	0.1	13.1	16.0	17.7	1.2	3.1	19.7	5.5	0.1	31.4	5.1	6.8	9.3
DUSP13	"BEDP, DUSP13A, DUSP13B, FLJ32450, TMDP"	ENSG00000079393	"Dual specificity phosphatase 13"	"Q6B8I1, Q9UII6"	10	75094432-75109221	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 249.5;testis: 54.2;tongue: 123.6"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 428.1"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	10	"neutrophil: 1.0"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 1.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.3;EFO-21: 5.0;Hep G2: 11.0;K-562: 4.3;LHCN-M2: 9.5;RH-30: 8.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.79e-1)"	"unprognostic (2.39e-2)"		"unprognostic (2.39e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.47e-3)"	"unprognostic (8.63e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.92e-1)"	"unprognostic (2.22e-7)"	"unprognostic (1.93e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.81e-1)"	"unprognostic (2.09e-2)"	0.1	0.0	0.1	0.0	0.1	5.9	0.1	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.3	3.8	0.1	0.0	16.8	0.1	0.2	0.1	0.1	0.3	0.0	0.1	0.6	0.1	0.0	0.0	0.2	0.1	0.0	0.8	1.0	0.0	0.0	3.5	0.0	249.5	0.5	0.0	0.0	0.1	0.5	0.0	54.2	0.2	0.2	0.1	123.6	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	11.0	0.0	0.0	0.0	0.9	0.9	0.0	0.0	0.0	0.0	0.0	4.3	0.0	9.5	0.5	0.0	0.0	0.6	0.1	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.6	0.1	0.8	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	1.7	0.3	1.1	3.4	0.0	0.0	0.1	12.2	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	428.1	0.0	0.0	0.6	0.0	0.0	0.1	0.2	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	94.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.9	0.1	0.1	0.0	0.0	0.2	0.0	0.0	21.7	0.6	10.4	3.3	6.3	2.0	3.0	0.1	0.0	0.0	0.2
DYTN		ENSG00000232125	Dystrotelin	A2CJ06	2	206651621-206721570	"Predicted intracellular proteins"				"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"Erythroid cells: 5.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA															"unprognostic (3.23e-3)"		"unprognostic (8.52e-2)"						0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ELK1		ENSG00000126767	"ETS transcription factor ELK1"	P19419	X	47635521-47650604	"Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Granulosa cells: 251.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB003808, HPA036084, HPA064381"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB003808: AB_562282, HPA036084: AB_2674931, HPA064381: AB_2685250"	"unprognostic (2.25e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.17e-1)"	"unprognostic (8.39e-2)"	"prognostic unfavorable (3.25e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.67e-2)"	14.4	30.9	74.1	12.5	56.3	13.9	12.1	39.2	63.3	14.2	23.6	12.4	9.1	17.1	17.6	15.1	18.7	10.2	17.4	60.5	35.4	12.2	26.6	16.3	12.4	33.3	28.3	58.5	54.7	13.0	17.1	12.8	9.3	41.4	15.6	9.7	7.8	13.2	11.3	33.1	15.1	13.0	11.0	24.6	19.1	13.7	21.4	44.9	13.0	10.6	18.7	12.4	14.9	12.0	42.6	35.6	27.2	14.3	39.1	23.3	26.5	19.8	31.1	34.9	34.8	34.5	19.3	26.4	29.0	16.1	31.0	59.9	21.2	37.6	31.7	31.5	31.1	34.8	23.4	25.0	17.9	49.3	26.3	39.4	27.9	27.2	53.4	33.5	28.8	20.8	40.4	47.9	32.9	27.8	46.5	28.2	30.8	33.7	16.7	59.1	30.0	36.0	45.8	19.7	15.3	31.0	25.6	48.5	17.8	43.4	31.8	44.7	16.7	16.1	39.5	41.2	53.9	29.2	53.5	83.2	27.8	44.5	45.3	25.0	1.7	6.3	2.8	5.3	7.2	6.4	5.2	6.8	6.3	9.5	4.6	5.7	5.0	3.1	3.4	6.5	6.5	9.8	5.6	74.1	56.3	39.2	63.3	60.5	35.4	33.3	28.3	58.5	41.4	24.6	44.9	42.6	10.1	0.0	6.7	4.2	12.0	16.8	14.3	7.5	15.9	15.2	15.0	10.4	9.0	5.7	5.3	7.3	4.2	7.7	6.3	7.5	5.9	7.6	4.0	8.0	13.3	9.8	10.2	14.9	7.7	7.3	9.6	18.0	6.6	9.2	8.2	251.8	20.3	14.6	10.3	5.0	5.7	7.8	4.1	9.5	19.0	3.3	14.0	15.0	7.2	2.8	16.8	9.0	6.2	5.0	2.9	7.1	5.6	29.7	10.3	12.8	4.6	6.3	2.1	7.2	6.6	18.7	20.0	2.6	11.1	12.3	15.9	8.9	11.1	48.8	10.0	11.8
ENPP2	"ATX, PD-IALPHA, PDNP2"	ENSG00000136960	"Ectonucleotide pyrophosphatase/phosphodiesterase 2"	Q13822	8	119557086-119673453	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Chemotaxis, Lipid degradation, Lipid metabolism"	Hydrolase	"Cancer-related genes, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 382.3;choroid plexus: 615.9"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 1041.6"	"Cancer enhanced"	"Detected in all"		"renal cancer: 46.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"basophil: 53.8"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 53.8"	"Cell line enhanced"	"Detected in many"		"AF22: 111.4;ASC diff: 147.7;ASC TERT1: 312.5;BJ: 103.2;BJ hTERT+: 188.9;fHDF/TERT166: 124.2;HSkMC: 144.7;U-2197: 108.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023700, HPA053652"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Actin filaments"	"Secreted to blood"	NA	NA		1200000000	"Nucleoplasm, Golgi apparatus"	"Actin filaments"	"HPA023700: AB_1848170, HPA053652: AB_2682218"	"unprognostic (1.17e-2)"	"unprognostic (6.29e-2)"	"unprognostic (3.63e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.70e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.26e-1)"	"prognostic favorable (2.07e-5)"	"unprognostic (5.54e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.37e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.50e-1)"	99.3	47.1	95.6	62.6	193.1	2.7	90.5	180.3	157.8	49.9	615.9	27.3	68.1	140.5	20.4	9.1	56.2	40.3	10.0	109.2	142.0	77.3	28.7	43.1	110.7	229.1	168.0	78.0	15.3	16.1	20.4	11.9	254.4	220.6	26.6	32.6	7.0	10.0	27.6	9.0	17.7	46.2	85.9	163.5	51.9	27.2	31.6	155.9	21.0	10.9	24.1	86.5	45.5	18.2	382.3	0.0	0.0	111.4	0.0	147.7	312.5	0.4	103.2	188.9	43.9	42.1	0.0	0.0	0.1	1.3	124.2	0.1	0.3	2.3	0.0	31.3	8.7	3.4	0.0	0.2	3.1	67.0	0.0	0.5	144.7	1.3	89.3	4.3	0.6	0.5	0.1	0.1	18.1	2.5	0.0	0.1	0.7	4.4	0.0	0.5	0.1	0.1	0.6	0.3	0.0	1.1	2.2	0.1	0.4	0.2	4.2	0.1	0.0	0.0	89.6	1.9	108.6	0.9	0.9	0.0	0.0	75.0	0.8	2.4	53.8	0.2	9.5	0.0	0.1	0.1	0.4	0.5	0.0	1.0	0.1	3.0	1.1	0.5	0.4	0.2	6.8	0.0	0.6	95.6	193.1	180.3	157.8	109.2	142.0	229.1	168.0	78.0	220.6	163.5	155.9	382.3	231.4	12.8	3.6	2.0	1.8	10.6	0.5	0.0	19.9	1.9	2.1	2.8	1.8	35.8	0.6	1.8	0.0	5.2	4.9	0.3	1.9	0.1	83.9	12.7	8.8	79.9	54.0	0.8	2.5	0.0	2.2	76.9	3.6	1.4	6.3	0.4	31.1	0.8	65.8	0.0	4.2	3.3	0.0	18.6	14.9	9.5	3.1	16.2	46.2	6.5	0.1	6.4	0.0	16.6	1041.6	0.7	2.6	3.4	1.9	0.1	4.2	47.6	3.7	1.2	0.0	3.1	9.6	1.7	0.4	7.8	5.3	6.4	1.7	1.1	2.8	1.4
ENTPD3	"CD39L3, HB6, NTPDase-3"	ENSG00000168032	"Ectonucleoside triphosphate diphosphohydrolase 3"	O75355	3	40387184-40428744	"Enzymes, Metabolic proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 21.5;salivary gland: 22.6"	"Cell type enriched"	"Detected in many"	4	"Inhibitory neurons: 92.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	7	"plasmacytoid DC: 3.5"	"Lineage enriched"	"Detected in single"	7	"dendritic cells: 3.5"	"Cell line enhanced"	"Detected in some"		"HaCaT: 3.6;HBEC3-KT: 13.0;hTCEpi: 8.4;RT4: 18.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.00e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.75e-2)"	"unprognostic (9.84e-3)"	"unprognostic (2.27e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.18e-2)"	"unprognostic (8.40e-2)"	"unprognostic (9.88e-3)"	"unprognostic (4.72e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.25e-1)"	"unprognostic (6.53e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.23e-1)"	4.3	1.4	3.2	1.1	16.5	0.1	2.4	2.4	6.7	21.5	0.8	3.0	1.3	3.2	2.4	6.5	0.9	2.0	0.6	4.7	4.9	2.6	0.1	3.9	0.4	6.9	4.3	4.9	1.7	16.0	0.5	2.9	0.5	6.6	3.5	2.9	2.6	22.6	4.1	1.2	2.7	1.4	1.9	2.2	4.3	6.8	0.5	5.5	0.9	5.5	2.6	1.8	13.1	3.6	6.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	3.6	0.0	13.0	0.3	0.4	0.4	0.5	0.2	0.0	0.0	0.0	0.0	0.1	8.4	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.5	0.0	0.1	0.1	0.2	1.0	0.0	0.0	0.0	1.5	18.4	1.8	0.2	0.4	1.1	0.2	0.3	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.1	0.5	0.1	0.0	0.5	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.2	0.0	0.4	0.0	3.5	0.2	0.0	3.2	16.5	2.4	6.7	4.7	4.9	6.9	4.3	4.9	6.6	2.2	5.5	6.3	5.5	3.2	4.2	4.9	0.2	2.3	1.3	2.3	8.0	0.7	6.1	0.3	0.5	0.0	5.1	0.0	0.0	0.0	1.3	1.0	0.0	2.7	0.4	7.6	2.5	0.7	2.4	0.0	22.6	22.5	0.0	0.4	2.6	14.9	0.0	0.0	0.0	0.0	0.1	0.0	92.6	0.1	0.0	0.0	0.8	0.0	0.3	0.3	0.0	1.9	0.0	3.7	0.0	7.1	5.9	6.9	0.0	0.7	0.1	1.4	0.0	0.0	1.9	0.8	19.7	0.6	19.9	0.2	0.1	14.5	2.3	0.0	0.2	0.1	0.2	4.7
EPHA4	"Hek8, TYRO1"	ENSG00000116106	"EPH receptor A4"	P54764	2	221418027-221574202	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 32.0"	"Cell type enriched"	"Detected in many"	4	"Excitatory neurons: 317.9"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 14.9"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"basophil: 1.6;gdT-cell: 1.7;MAIT T-cell: 1.7;memory B-cell: 1.3;memory CD4 T-cell: 2.5;memory CD8 T-cell: 1.7;naive B-cell: 1.2;naive CD4 T-cell: 1.0;NK-cell: 3.5;T-reg: 1.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 77.0;ASC diff: 33.9;CACO-2: 59.3;U-2197: 38.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB028368	Enhanced					NA	NA		9300000			"CAB028368: AB_2099353"	"unprognostic (1.28e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.46e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.05e-4)"	"unprognostic (1.80e-2)"	"unprognostic (2.40e-1)"	"prognostic unfavorable (9.56e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.85e-2)"	"prognostic favorable (5.67e-4)"	"unprognostic (3.12e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.36e-1)"	"unprognostic (8.66e-2)"	7.9	1.6	1.5	1.9	4.8	3.7	4.0	0.0	22.6	4.6	32.0	4.0	1.0	6.4	2.8	4.8	4.9	3.1	17.5	18.0	15.5	4.9	0.8	3.7	2.7	0.0	2.1	4.9	11.2	1.1	1.9	0.6	1.6	2.8	5.4	4.5	4.3	2.6	6.1	2.8	13.0	2.8	8.0	0.0	3.4	2.4	11.8	2.4	3.9	9.6	4.0	3.2	3.6	3.5	0.6	2.6	2.4	77.0	0.0	33.9	20.9	0.1	18.2	8.3	16.9	6.2	59.3	0.9	0.0	0.1	26.7	0.0	7.0	12.3	0.1	7.0	9.7	6.4	0.0	0.9	0.0	0.9	0.0	1.4	8.5	4.2	5.3	0.1	10.3	14.9	0.0	0.0	0.0	4.4	9.5	0.2	0.0	5.6	5.9	1.7	0.1	8.5	0.0	25.8	4.3	13.2	0.0	6.2	1.3	1.3	6.2	2.9	0.0	0.0	1.7	3.2	38.4	1.0	0.0	0.1	0.0	6.9	0.0	3.6	1.6	0.0	0.0	1.7	0.0	1.7	1.3	2.5	1.7	0.0	1.2	1.0	0.2	0.1	3.5	0.0	0.1	1.2	0.4	1.5	4.8	0.0	22.6	18.0	15.5	0.0	2.1	4.9	2.8	0.0	2.4	0.6	36.3	0.0	6.4	51.9	8.2	6.1	0.7	9.7	2.8	9.8	4.3	6.0	31.6	7.2	13.7	9.2	0.0	0.1	12.2	4.7	7.9	0.2	3.9	1.9	5.7	26.3	3.5	0.0	317.9	0.2	0.0	5.1	4.6	5.2	1.3	9.0	20.0	0.4	0.3	1.7	68.8	12.8	8.2	0.0	1.5	5.8	1.2	0.9	7.2	70.3	0.2	7.2	3.1	8.0	7.9	30.9	3.6	8.6	2.1	1.4	0.1	1.7	4.5	3.2	0.0	3.6	10.2	10.0	1.9	4.1	12.5	0.0	5.4	11.3	6.6	2.4
ERI3	"FLJ22943, PINT1, PRNPIP"	ENSG00000117419	"ERI1 exoribonuclease family member 3"	O43414	1	44221070-44355260	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Late spermatids: 943.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027147, HPA029895"	Approved		Approved	Nucleoplasm,Cytosol		Yes	No			"Nucleoplasm, Cytosol"		"HPA027147: AB_1855725, HPA029895: AB_2673239"	"unprognostic (1.31e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.26e-1)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (5.94e-2)"	"unprognostic (6.21e-2)"	"prognostic unfavorable (2.04e-6)"	"unprognostic (6.48e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.70e-3)"	"unprognostic (5.30e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.07e-3)"	30.1	35.1	100.2	15.7	101.2	24.8	30.8	88.2	141.4	30.4	84.6	32.0	20.8	33.6	34.5	28.1	37.5	20.7	46.8	107.2	96.1	59.5	42.1	25.8	19.4	95.2	104.5	102.9	32.7	35.3	45.5	45.5	23.5	106.9	39.1	23.4	22.6	28.0	25.5	77.9	35.8	22.9	28.9	92.2	26.6	29.1	63.8	100.1	24.3	31.4	60.7	20.5	32.5	27.4	99.0	73.6	56.5	69.3	77.7	44.9	55.5	46.0	44.0	61.4	82.1	75.1	37.8	78.3	52.3	76.4	58.7	42.2	41.2	62.6	80.6	55.9	56.9	115.8	60.0	90.2	52.0	67.9	59.3	32.8	57.9	76.9	66.2	91.3	61.0	57.3	59.5	56.4	43.9	55.2	51.2	68.7	57.0	82.2	72.2	83.7	62.6	62.4	75.3	65.2	38.9	120.5	54.9	52.5	71.3	87.7	55.1	46.6	50.1	34.1	54.3	56.5	60.7	72.0	37.7	50.1	56.4	67.7	52.4	70.4	17.6	25.8	15.8	25.5	36.4	27.2	30.8	21.1	24.5	40.3	30.9	24.8	26.0	2.4	26.1	37.3	30.3	29.4	26.2	100.2	101.2	88.2	141.4	107.2	96.1	95.2	104.5	102.9	106.9	92.2	100.1	99.0	35.4	25.6	16.5	74.4	26.2	31.6	36.5	64.7	27.3	22.6	36.2	51.3	15.1	15.7	26.2	29.5	2.1	93.2	19.3	31.2	97.8	56.9	202.7	35.3	30.7	27.4	118.3	26.5	36.7	62.5	85.9	39.8	25.0	23.1	15.2	62.8	18.9	22.3	45.0	25.2	34.0	99.1	46.8	19.2	27.2	943.6	36.4	20.1	48.0	38.4	27.9	42.6	15.5	66.4	54.5	37.7	22.2	36.5	28.3	51.0	17.0	167.3	20.4	16.4	6.6	28.5	52.0	68.0	51.4	29.4	34.5	61.6	20.2	54.0	37.1	30.7
ESM1		ENSG00000164283	"Endothelial cell specific molecule 1"	Q9NQ30	5	54977867-55022671	"Predicted secreted proteins"	Angiogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 20.1;thyroid gland: 17.5"	"Cell type enriched"	"Detected in some"	8	"Endothelial cells: 142.4"	"Cancer enriched"	"Detected in all"	8	"renal cancer: 65.8"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"HUVEC TERT2: 302.2;TIME: 568.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			CAB047364	Approved				"Secreted to blood"	NA	NA	1540000	340000			"CAB047364: "	"unprognostic (4.70e-2)"	"prognostic unfavorable (2.11e-7)"	"unprognostic (2.63e-3)"	"unprognostic (2.31e-3)"	"unprognostic (4.68e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.85e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.78e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.46e-2)"	"prognostic unfavorable (4.00e-4)"	"unprognostic (7.77e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.84e-2)"	"unprognostic (2.94e-1)"	0.9	4.2	0.4	0.7	0.5	0.6	0.5	0.2	1.4	2.1	2.2	0.2	0.7	3.6	0.4	0.2	0.2	1.3	3.6	0.3	1.2	20.1	2.7	11.4	1.2	0.5	2.5	0.4	0.7	2.3	6.1	2.2	0.4	0.3	3.5	0.0	0.1	6.4	3.8	0.2	0.1	0.8	0.8	0.8	0.9	0.3	0.6	1.8	0.2	17.5	0.2	0.6	1.3	0.1	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	79.8	9.5	4.1	1.0	0.0	0.0	0.1	7.4	5.7	2.3	0.0	0.0	1.0	14.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.7	0.4	8.5	302.2	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	568.0	4.7	13.7	39.2	21.3	0.1	0.0	0.0	1.7	0.0	3.8	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.8	0.5	0.0	0.0	0.0	0.4	0.0	1.4	0.0	0.0	0.0	0.1	0.4	0.5	0.2	1.4	0.3	1.2	0.5	2.5	0.4	0.3	0.8	1.8	0.4	6.3	0.0	0.6	0.0	0.5	0.1	0.2	0.0	0.0	0.0	0.4	0.5	0.1	0.0	0.3	0.0	0.0	0.1	0.7	0.0	0.0	16.1	0.0	0.1	0.1	142.4	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.2	0.0	0.0	1.4	0.0	0.1	0.0	0.7	0.0	2.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.1	1.5	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	1.5	1.7	0.1	0.3	0.0	0.1	0.1	0.6	1.1	0.0	0.7
EXOC1L		ENSG00000250821	"Exocyst complex component 1 like"	A0A1B0GW35	4	55819790-55837489	"Predicted intracellular proteins"				"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	8	"Theca cells: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	20	"NK-cell: 1.9"	"Lineage enriched"	"Detected in single"	20	"NK-cells: 1.9"	"Cell line enhanced"	"Detected in single"		"HEK 293: 1.5"	"Region enriched"	"Detected in single"	4	"pons and medulla: 2.8"	"Not detected"	"Not detected"									NA	NA																							0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.4	0.0	0.2	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.0
EYA1	BOR	ENSG00000104313	"EYA transcriptional coactivator and phosphatase 1"	Q99502	8	71197433-71592025	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase"	"Deafness, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 16.2;parathyroid gland: 23.9"	"Cell type enriched"	"Detected in some"	11	"Astrocytes: 214.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 27.6;RH-30: 21.3;RPMI-8226: 9.5;SH-SY5Y: 51.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 20.7"	HPA028917			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA028917: AB_2672826"	"unprognostic (3.74e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.72e-3)"	"unprognostic (5.95e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.91e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.22e-12)"	"unprognostic (1.06e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.81e-4)"	"unprognostic (1.25e-2)"	0.6	0.6	2.4	0.1	7.6	0.0	0.2	0.6	2.1	3.0	16.2	0.1	0.1	0.1	0.1	0.4	2.1	0.3	4.6	1.3	1.9	0.1	0.0	0.4	0.0	2.3	3.9	0.0	0.2	0.0	23.9	10.9	0.0	3.2	12.1	0.2	0.4	0.8	4.1	2.8	0.0	0.2	0.2	0.0	0.1	0.9	0.9	4.6	11.8	0.6	2.5	0.1	2.6	4.3	1.8	0.2	0.0	6.4	27.6	0.0	0.0	0.0	0.2	2.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.9	1.6	0.0	0.0	4.7	0.0	2.2	0.0	0.0	0.5	0.0	6.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	1.0	0.0	0.0	0.0	2.0	0.0	1.5	0.0	21.3	9.5	0.0	0.0	2.2	51.4	0.0	0.0	1.6	5.9	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	6.3	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	7.6	0.6	2.1	1.3	1.9	2.3	3.9	0.0	3.2	0.0	4.6	1.8	0.2	0.0	0.0	214.5	0.0	0.1	0.0	6.4	0.6	0.1	0.0	0.1	8.8	0.0	7.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	4.4	3.1	0.1	0.2	0.0	0.0	1.3	0.0	0.5	1.3	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	13.5	0.0	2.0	0.0	0.0	6.4	0.3	0.0	0.0	11.2	0.0	0.1	0.0	18.6	0.6	0.0	0.0	0.4	0.0	0.1	0.0	0.3	10.5	0.2	0.0	0.2	0.5	0.8	1.0	1.1	0.1	0.5	0.0	1.4	0.0	0.1
F2R	"CF2R, PAR-1, PAR1, TR"	ENSG00000181104	"Coagulation factor II thrombin receptor"	P25116	5	76716126-76735770	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Blood coagulation, Hemostasis"	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 70.1"	"Cell type enriched"	"Detected in many"	5	"Hepatic stellate cells: 307.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 25.4"	"Group enriched"	"Detected in many"	14	"NK-cells: 7.0;T-cells: 25.4"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 196.9;HUVEC TERT2: 366.2;WM-115: 345.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008973, CAB012962"	Approved					NA	NA					"CAB008973: , CAB012962: AB_2533198"	"unprognostic (3.03e-1)"	"unprognostic (7.76e-2)"	"unprognostic (5.55e-2)"	"unprognostic (7.76e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.46e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.75e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (2.21e-7)"	"unprognostic (2.72e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.74e-3)"	12.3	13.7	1.7	12.2	1.4	4.1	18.5	1.9	2.7	15.5	2.7	10.1	14.4	23.4	4.3	11.2	3.9	39.9	30.7	1.2	2.1	19.2	24.1	23.0	16.3	2.6	2.5	0.9	2.9	10.0	7.4	4.4	10.6	1.9	7.3	11.8	0.7	30.7	12.1	3.6	46.0	19.0	19.0	1.8	70.1	10.4	8.8	1.7	4.9	15.3	12.0	8.6	15.5	4.5	1.5	5.7	17.5	53.3	8.8	98.4	170.5	2.6	30.3	102.5	19.5	69.8	3.9	47.0	0.1	50.1	13.0	88.1	13.2	23.1	18.1	36.6	4.4	19.3	120.2	3.8	14.7	147.7	0.6	4.9	96.9	60.2	37.2	10.5	196.9	366.2	21.4	22.8	22.1	40.1	2.4	9.6	0.4	17.0	0.3	93.5	17.1	31.9	4.3	91.2	0.8	6.3	28.7	8.9	0.2	45.2	48.0	0.7	1.3	169.0	121.8	26.7	1.3	56.7	59.0	18.5	0.2	32.4	2.3	345.5	1.1	0.2	0.4	25.4	0.5	6.5	0.6	5.7	17.7	0.0	0.2	0.9	12.7	1.1	7.0	0.1	0.3	0.6	11.2	1.7	1.4	1.9	2.7	1.2	2.1	2.6	2.5	0.9	1.9	1.8	1.7	1.5	25.8	0.0	9.2	1.6	4.4	17.2	0.7	9.3	1.2	3.5	3.4	2.4	2.6	7.2	4.5	7.3	0.0	0.2	56.2	0.3	0.0	2.0	10.7	2.8	47.1	51.8	6.6	11.6	1.0	2.2	0.4	39.5	8.2	5.4	6.3	13.0	307.0	4.3	2.1	0.0	3.3	3.9	16.2	16.6	10.7	6.0	0.9	5.4	12.4	5.6	1.1	0.1	54.6	0.5	0.1	10.8	0.2	10.5	35.8	1.4	0.5	3.4	4.2	1.4	0.0	8.1	24.9	12.7	5.4	1.5	40.1	0.3	40.1	9.5	1.3	0.4
F2RL3	PAR4	ENSG00000127533	"F2R like thrombin or trypsin receptor 3"	Q96RI0	19	16888999-16892606	"G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Blood coagulation, Hemostasis"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 18.5;lung: 33.7;thyroid gland: 19.4"	"Cell type enriched"	"Detected in some"	4	"Adipocytes: 110.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"HEL: 30.7;HMC-1: 11.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA031401, HPA042340"			Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA031401: , HPA042340: "	"unprognostic (6.17e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.64e-2)"	"unprognostic (3.83e-1)"	"unprognostic (3.27e-1)"	"unprognostic (8.31e-3)"	"unprognostic (2.97e-1)"	"unprognostic (3.28e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.30e-2)"	"unprognostic (3.00e-3)"	"prognostic favorable (6.25e-4)"	"unprognostic (2.37e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.11e-2)"	18.5	2.6	0.7	1.5	0.8	1.3	18.1	1.6	0.9	1.1	1.1	3.3	1.6	1.6	1.6	1.5	1.5	2.8	3.9	0.7	0.5	9.7	0.5	33.7	2.3	0.5	0.5	0.6	0.8	9.4	1.1	2.7	1.1	1.0	1.4	1.3	1.3	1.3	0.5	3.2	2.7	4.9	1.0	0.0	1.3	5.1	1.7	1.0	0.4	19.4	0.6	0.9	2.0	1.3	1.4	0.3	0.3	0.8	0.4	0.1	0.2	0.9	0.4	0.1	0.2	0.2	0.5	0.8	0.6	0.6	0.3	0.3	0.6	0.2	0.3	0.3	0.4	0.4	30.7	1.3	0.5	0.2	0.3	11.6	0.0	0.1	0.3	0.2	0.4	0.9	0.6	2.5	1.1	0.2	0.5	0.4	2.9	0.4	0.4	0.3	0.3	0.2	1.0	0.3	0.6	0.5	0.3	0.3	0.2	0.1	0.7	0.6	2.0	1.2	0.6	0.6	0.4	0.3	0.5	0.4	0.6	0.3	0.5	0.4	3.3	0.9	0.7	0.9	0.4	0.8	1.6	1.0	0.8	0.3	1.8	1.4	1.3	2.2	1.8	0.6	1.7	0.8	1.4	0.7	0.8	1.6	0.9	0.7	0.5	0.5	0.5	0.6	1.0	0.0	1.0	1.4	110.4	0.0	1.1	0.0	0.3	0.4	0.3	0.3	0.0	0.0	0.3	0.3	0.7	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.9	27.5	0.0	0.8	0.0	0.5	0.0	2.7	0.0	0.2	7.0	0.3	1.4	0.0	0.3	0.0	0.0	0.0	0.0	0.3	1.0	0.4	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	2.0	0.6	0.0	0.1	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.1	0.4	0.5	0.1	0.3	0.2	0.3
FADS6		ENSG00000172782	"Fatty acid desaturase 6"		17	74877302-74893781	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"brain: 10.9;epididymis: 18.3;intestine: 14.9"	"Cell type enriched"	"Detected in some"	13	"Proximal enterocytes: 72.2"	"Cancer enhanced"	"Detected in some"		"liver cancer: 2.6"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016802	Uncertain					NA	NA					"HPA016802: AB_2669448"	"unprognostic (2.41e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.68e-3)"	"unprognostic (4.73e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.41e-2)"	"unprognostic (6.98e-4)"	"unprognostic (3.38e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.14e-2)"	"unprognostic (6.71e-2)"	"unprognostic (2.27e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.79e-1)"	0.2	7.1	3.2	0.5	3.5	1.5	0.5	5.4	9.0	0.2	0.0	0.6	7.6	0.2	18.3	3.2	0.1	0.0	0.2	2.1	2.3	1.1	6.2	0.2	0.6	8.8	2.5	3.5	0.3	0.4	0.6	0.1	0.2	10.9	0.1	0.7	1.2	0.3	0.3	0.5	7.5	14.9	0.2	0.8	4.2	0.2	0.7	6.4	0.4	0.4	0.2	0.8	1.2	1.1	10.7	0.2	0.3	0.5	0.4	0.0	1.0	0.7	0.5	0.0	0.1	0.2	0.8	0.3	0.3	0.1	0.5	0.3	0.3	0.7	0.0	0.2	0.1	0.0	0.5	1.6	0.6	0.3	0.4	0.4	0.3	0.0	1.1	0.4	0.2	0.0	0.4	0.4	1.4	0.6	0.6	0.3	1.1	0.3	0.2	0.5	0.2	0.1	0.5	0.3	0.3	0.4	0.4	0.5	0.2	0.1	0.5	0.2	0.5	0.3	0.3	0.7	0.6	0.5	0.5	0.2	0.3	1.0	0.3	0.5	1.1	0.6	0.4	0.2	0.6	0.2	0.3	0.3	0.3	0.1	0.5	0.3	0.4	2.0	0.8	1.5	0.5	0.2	0.0	3.2	3.5	5.4	9.0	2.1	2.3	8.8	2.5	3.5	10.9	0.8	6.4	10.7	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	1.8	1.5	0.1	0.0	1.1	0.0	0.0	0.0	0.0	2.1	0.0	3.7	0.0	0.0	0.8	0.0	0.1	0.3	0.0	0.0	5.2	0.2	0.1	0.3	0.0	0.2	0.0	1.1	0.4	4.0	0.3	1.7	5.4	1.1	0.0	0.0	0.4	0.2	0.0	0.1	0.0	1.0	0.0	0.1	0.0	0.0	0.2	0.0	5.1	0.0	0.0	1.1	72.2	1.9	0.0	0.5	0.0	1.1	0.4	0.0	2.0	1.7	0.6	3.8	0.2	0.4	0.7	1.3
FAM13C	FAM13C1	ENSG00000148541	"Family with sequence similarity 13 member C"	Q8NE31	10	59246130-59363181	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 69.7"	"Cell type enriched"	"Detected in many"	6	"Oligodendrocytes: 477.1"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 3.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 4.1;HSkMC: 5.1;hTERT-RPE1: 3.4;NTERA-2: 4.5;SCLC-21H: 8.6;SH-SY5Y: 5.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037888	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA037888: AB_10962981"	"unprognostic (3.68e-1)"	"unprognostic (6.10e-2)"	"unprognostic (2.46e-1)"	"unprognostic (6.69e-5)"	"unprognostic (8.54e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.06e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.00e-3)"	"unprognostic (3.27e-1)"	"unprognostic (4.51e-6)"	"unprognostic (1.02e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.94e-3)"	"unprognostic (4.66e-3)"	12.5	16.3	21.3	3.9	44.0	0.0	9.4	32.3	38.2	8.8	4.4	6.6	4.2	8.8	8.1	13.9	14.7	11.6	8.2	21.9	33.6	3.4	2.2	10.0	4.8	42.5	37.7	20.5	21.4	2.3	4.7	4.8	2.6	40.6	17.4	6.3	10.0	5.7	8.0	17.3	7.3	6.0	12.3	37.4	5.2	3.8	5.3	36.5	5.2	6.3	23.1	2.3	4.4	8.0	69.7	0.0	0.1	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	1.3	0.2	0.1	0.0	1.2	0.0	4.1	1.9	0.1	0.0	0.0	5.1	0.6	0.2	0.0	3.4	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.0	4.5	0.0	0.4	0.0	0.8	0.0	0.0	1.3	8.6	5.0	0.0	0.2	0.0	0.3	0.7	0.0	0.0	2.5	2.2	0.1	2.1	0.0	0.0	0.1	3.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.3	44.0	32.3	38.2	21.9	33.6	42.5	37.7	20.5	40.6	37.4	36.5	69.7	47.8	0.0	0.0	33.6	0.1	4.8	9.3	0.3	8.0	10.5	0.7	2.7	2.5	0.0	0.7	0.0	6.2	0.0	0.4	0.1	7.9	0.0	49.0	18.6	1.5	35.2	0.0	0.0	66.8	0.0	0.0	19.8	0.5	5.3	0.0	26.9	3.9	0.5	0.0	3.3	73.2	0.2	20.3	0.0	2.5	22.1	23.0	0.7	3.6	7.5	0.0	8.8	0.0	56.8	477.1	0.0	0.0	21.1	0.1	5.4	0.0	0.6	20.7	13.6	39.5	23.4	36.2	1.4	0.7	2.4	6.3	0.0	1.2	17.4	0.2	1.1
FAM156B	TMEM29B	ENSG00000179304	"Family with sequence similarity 156 member B"	Q8NDB6	X	52891306-52908560	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"Cardiomyocytes: 10.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 80.8"									"HPA056640, HPA056643"	Uncertain					NA	NA					"HPA056640: AB_2683200, HPA056643: AB_2683201"		"unprognostic (2.91e-1)"			"unprognostic (1.31e-1)"					"unprognostic (2.66e-1)"			"unprognostic (3.24e-5)"	"unprognostic (2.97e-1)"				26.9	40.0	33.8	12.1	34.3	13.7	25.9	34.4	38.5	22.3	37.6	19.7	18.6	17.6	18.7	17.7	22.7	17.3	24.3	33.6	33.6	31.1	27.5	19.1	20.6	34.9	33.1	34.9	23.7	23.4	10.6	48.5	50.4	33.9	26.0	18.9	14.4	15.8	20.1	8.0	49.4	18.5	18.1	31.4	32.2	19.9	24.4	35.3	10.7	22.6	5.7	13.3	22.7	17.9	34.5	5.0	8.4	11.9	29.1	14.2	29.2	37.2	10.5	16.5	13.0	18.4	10.9	18.9	4.4	3.5	35.1	11.5	9.2	25.3	19.5	16.6	3.7	10.6	3.4	80.8	18.0	26.9	8.0	8.6	37.5	15.3	20.3	13.1	43.0	12.4	16.0	10.8	19.5	32.9	10.2	8.3	33.3	13.8	8.4	14.2	14.4	9.9	13.4	14.3	9.6	10.2	12.6	3.3	22.7	9.4	31.8	9.5	11.2	15.8	47.7	8.5	20.1	12.0	5.5	8.4	13.2	21.6	29.3	8.2	0.0	4.0	1.0	0.9	5.5	1.3	0.8	0.6	0.9	6.1	1.6	1.8	0.6	0.8	2.5	5.4	3.5	2.0	2.7	33.8	34.3	34.4	38.5	33.6	33.6	34.9	33.1	34.9	33.9	31.4	35.3	34.5	0.0	0.0	1.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.2	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0
FAM187A		ENSG00000214447	"Family with sequence similarity 187 member A"	A6NFU0	17	44899712-44905390	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 15.1;testis: 16.1"	"Cell type enriched"	"Detected in single"	36	"Respiratory ciliated cells: 3.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 13.7;U-87 MG: 16.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA043131			Approved	Cytosol		NA	NA			Cytosol		"HPA043131: AB_10796686"																		0.5	1.9	2.6	0.4	2.2	0.5	1.2	1.7	3.0	1.5	2.7	0.7	0.1	0.8	2.3	0.4	15.1	0.8	0.3	1.8	3.2	2.8	0.3	1.1	0.5	2.1	2.5	1.7	1.3	1.3	1.7	2.2	0.1	2.2	0.6	0.7	5.4	0.5	1.0	0.2	0.4	0.3	0.5	2.3	0.2	0.4	16.1	1.9	0.4	3.4	0.1	0.4	0.6	0.3	1.7	1.2	5.6	2.3	1.5	2.5	3.2	1.3	0.5	4.9	2.5	3.3	2.4	4.8	0.2	1.4	1.6	4.6	5.4	0.7	1.9	1.3	5.9	1.4	0.8	2.8	0.7	1.3	1.1	0.7	0.7	2.5	4.5	1.0	4.8	1.2	1.0	1.4	0.2	0.6	1.3	0.1	1.3	0.9	3.0	1.1	0.9	0.1	0.4	13.7	0.7	6.9	1.3	0.5	0.1	1.0	1.1	5.8	1.1	0.5	1.0	1.4	1.3	1.1	0.1	0.2	0.5	16.0	0.8	1.1	0.0	0.8	0.5	0.0	0.2	0.0	0.0	0.0	0.2	0.5	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.5	2.6	2.2	1.7	3.0	1.8	3.2	2.1	2.5	1.7	2.2	2.3	1.9	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM8A1	AHCP	ENSG00000137414	"Family with sequence similarity 8 member A1"	Q9UBU6	6	17600302-17611715	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Early spermatids: 759.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 5.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044698, HPA073675"	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA044698: AB_2679051, HPA073675: AB_2732236"	"unprognostic (4.06e-1)"	"unprognostic (2.32e-1)"	"unprognostic (9.11e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.99e-2)"	"unprognostic (5.17e-3)"	"unprognostic (6.13e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.09e-3)"	"unprognostic (4.44e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.71e-1)"	"unprognostic (7.59e-2)"	"unprognostic (2.98e-1)"	18.8	16.3	17.8	10.8	18.6	31.9	19.3	20.5	19.7	20.6	16.9	20.1	17.1	27.6	19.1	14.0	20.7	21.3	14.9	18.9	20.4	24.2	78.6	19.1	10.5	20.1	18.7	16.3	28.0	15.1	22.5	13.1	15.0	19.8	21.0	23.0	27.3	23.2	22.5	19.1	13.8	16.8	25.0	20.2	14.4	12.9	17.3	20.9	17.2	23.4	21.9	8.3	14.6	12.7	22.3	9.5	3.7	13.5	32.3	45.6	42.6	11.1	15.0	20.4	7.6	13.1	21.4	3.1	8.1	35.2	25.6	8.3	7.6	20.5	13.0	9.9	6.9	29.1	9.8	12.5	46.2	20.1	6.2	9.6	22.6	20.7	8.7	6.0	24.2	17.0	8.9	20.2	16.2	12.0	11.7	4.6	19.2	5.6	11.6	5.6	12.1	13.0	25.0	25.6	7.5	4.1	21.4	11.7	25.0	23.7	23.1	29.0	9.5	13.3	9.7	3.4	14.9	5.5	13.4	12.0	8.0	8.8	7.1	13.4	2.6	0.3	1.0	1.1	0.4	1.2	0.0	0.5	1.0	0.2	0.1	0.7	1.1	5.5	1.5	0.2	0.2	0.4	0.3	17.8	18.6	20.5	19.7	18.9	20.4	20.1	18.7	16.3	19.8	20.2	20.9	22.3	16.8	19.2	27.1	8.8	7.0	13.4	9.7	6.6	14.2	27.6	15.1	13.5	15.3	21.5	12.1	29.5	14.6	10.0	15.7	63.4	5.9	9.2	759.2	26.4	24.0	14.1	12.0	4.2	17.1	7.9	12.0	23.0	10.7	20.6	1.3	8.6	25.4	77.5	6.2	15.2	17.9	10.8	8.2	24.4	6.4	187.8	36.7	8.6	5.4	3.7	8.7	19.3	14.4	8.0	13.8	7.5	25.7	30.9	12.8	7.5	30.4	12.4	20.5	16.7	32.9	20.3	18.7	46.6	18.0	14.3	15.9	12.2	14.0	9.7	16.7	7.8
FCER1A	FCE1A	ENSG00000179639	"Fc fragment of IgE receptor Ia"	P12319	1	159289714-159308224	"FDA approved drug targets, Predicted membrane proteins"		"IgE-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 33.9"	"Cell type enriched"	"Detected in many"	7	"Langerhans cells: 1962.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	8	"basophil: 21557.7"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 21557.7"	"Cell line enriched"	"Detected in some"	99	"HEL: 447.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB022102, HPA036051, CAB055526"	Approved					NA	NA					"CAB022102: , CAB055526: , HPA036051: AB_2674919"	"unprognostic (1.78e-2)"	"unprognostic (2.26e-2)"	"unprognostic (7.32e-2)"	"unprognostic (7.51e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.44e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.44e-1)"	"unprognostic (7.20e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.74e-1)"	"prognostic favorable (1.20e-4)"	"unprognostic (1.68e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.39e-2)"	3.9	1.7	0.4	5.8	0.4	14.4	17.5	0.4	0.8	10.7	0.7	7.1	7.2	7.2	5.5	23.2	3.0	15.1	3.2	0.4	0.5	4.7	4.4	14.6	2.5	0.5	0.6	0.3	0.7	1.3	2.6	0.8	0.2	0.6	6.0	10.8	0.1	4.1	9.1	2.9	33.9	8.9	7.5	0.3	8.1	3.5	2.4	0.5	4.8	1.2	3.9	11.0	12.0	2.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	447.9	0.0	0.0	0.0	0.5	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21557.7	14.4	36.4	0.4	4.1	4.4	2.8	4.4	1.5	2645.6	3.1	2.3	3.4	17.2	14.6	11.0	361.0	2.8	132.1	0.4	0.4	0.4	0.8	0.4	0.5	0.5	0.6	0.3	0.6	0.3	0.5	0.5	1.6	6.4	33.1	0.3	5.5	37.7	0.1	0.0	0.6	0.0	0.6	1.8	0.6	0.0	1.8	0.0	0.0	0.0	76.8	0.0	0.0	0.0	0.3	0.1	0.0	3.4	0.0	37.8	0.0	0.0	0.1	4.2	0.0	0.1	270.7	0.0	0.0	0.0	6.4	0.0	0.1	0.0	0.0	4.0	1962.9	1.1	0.0	169.1	46.2	0.0	46.8	0.0	3.1	0.0	0.0	0.0	0.1	0.0	1.3	0.1	0.0	0.0	1.5	0.0	13.1	0.1	2.6	0.1	0.3	0.2	34.1	0.0	6.8	0.0	0.0	0.0
FCGBP	FC(GAMMA)BP	ENSG00000275395	"Fc fragment of IgG binding protein"		19	39863323-39934626	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"intestine: 199.2;salivary gland: 86.1;stomach 1: 86.3;thyroid gland: 100.7"	"Cell type enriched"	"Detected in many"	9	"Intestinal goblet cells: 6081.9"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 63.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 4.6;Daudi: 1.8;JURKAT: 1.7;MOLT-4: 1.8;RH-30: 7.1"									"HPA003517, HPA003564"	Enhanced		Approved	"Golgi apparatus,Plasma membrane,Cytokinetic bridge"	"Secreted in other tissues"	Yes	NA			"Plasma membrane"	"Golgi apparatus, Cytokinetic bridge"	"HPA003517: AB_1078838, HPA003564: AB_2231648"	"unprognostic (1.65e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.77e-2)"	"unprognostic (2.04e-2)"	"prognostic favorable (1.28e-5)"	"prognostic unfavorable (4.74e-5)"	"unprognostic (1.36e-2)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (9.70e-6)"	"unprognostic (9.44e-2)"	"unprognostic (3.03e-2)"	"unprognostic (5.92e-3)"	"unprognostic (8.60e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (2.08e-1)"	5.7	10.1	5.1	14.1	7.5	0.4	3.2	3.4	11.6	56.9	15.7	199.2	69.3	1.2	0.6	4.6	9.9	49.7	2.0	5.3	40.6	5.5	1.0	2.0	0.9	21.0	8.1	4.0	3.8	4.9	0.5	3.4	2.9	7.1	3.9	68.3	0.6	86.1	1.4	0.4	14.9	150.0	2.6	12.0	1.5	86.3	2.9	11.7	1.5	100.7	0.0	0.7	3.5	1.6	27.7	0.0	4.6	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.2	0.0	0.1	1.8	0.6	0.1	1.5	0.3	0.1	7.1	1.6	0.1	0.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.2	0.4	0.1	0.1	0.5	0.0	0.3	0.1	0.0	0.0	0.1	5.1	7.5	3.4	11.6	5.3	40.6	21.0	8.1	4.0	7.1	12.0	11.7	27.7	0.6	3.2	5.1	2.6	4.6	3.7	1.9	15.8	1.2	1.1	1.3	3.4	2.8	70.1	60.0	25.8	0.0	0.7	1.8	622.2	0.0	5.2	7.2	4.2	0.3	26.7	81.1	0.0	0.6	0.9	0.4	1.9	552.0	4.0	15.9	0.4	0.7	1.3	44.0	0.0	0.4	6081.9	2.0	30.2	12.6	9.2	0.9	21.6	8.8	15.9	0.9	0.4	1.0	0.5	0.2	3.9	253.6	0.0	2.1	13.8	413.5	1.2	11.0	2.0	59.2	0.5	1.1	0.5	2.4	0.4	6.8	0.4	5.6	0.9	191.4	164.1
FFAR4	"GPR120, GPR129, O3FAR1, PGR4"	ENSG00000186188	"Free fatty acid receptor 4"	Q5NUL3	10	93566665-93604480	"FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"	"Differentiation, Inflammatory response"	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 11.5;pituitary gland: 11.1"	"Cell type enriched"	"Detected in some"	4	"Intestinal goblet cells: 125.7"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 4.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"OE19: 12.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042563			Uncertain	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA042563: AB_10794762"	"unprognostic (1.96e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.14e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.98e-4)"	"unprognostic (1.41e-3)"	"unprognostic (1.20e-2)"	"unprognostic (2.34e-2)"	"unprognostic (7.87e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.85e-2)"	"unprognostic (5.32e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.49e-1)"	4.1	0.4	1.0	0.7	1.3	0.1	1.3	0.6	1.1	0.1	0.4	8.4	0.5	0.0	0.0	0.2	1.0	0.5	0.3	1.0	1.4	0.1	0.4	3.6	0.2	0.6	0.7	1.1	0.0	0.6	0.1	11.1	0.1	0.7	0.1	11.5	0.2	0.1	0.0	0.3	0.9	0.6	0.2	0.6	0.1	0.5	1.5	1.9	0.3	0.1	0.1	0.1	0.1	0.0	0.9	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.1	12.9	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.9	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.2	1.0	1.3	0.6	1.1	1.0	1.4	0.6	0.7	1.1	0.7	0.6	1.9	0.9	0.2	0.0	0.5	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.2	0.8	0.4	7.2	0.6	0.0	0.0	0.2	0.0	28.1	0.0	0.8	27.8	0.1	0.0	0.3	20.9	0.0	3.2	0.0	0.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	7.4	0.0	2.0	125.7	0.0	7.2	4.4	16.7	0.6	7.6	1.8	3.7	0.5	0.0	0.0	0.0	0.3	0.9	23.0	0.0	0.0	0.3	0.3	0.0	0.0	0.2	0.0	0.5	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	5.9	0.3
FGF13	"FGF2, FHF2, FLJ30672, LINC00889"	ENSG00000129682	"Fibroblast growth factor 13"	Q92913	X	138614727-139222777	"Predicted intracellular proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 49.8;skeletal muscle: 67.9;tongue: 52.8"	"Cell type enriched"	"Detected in many"	6	"Inhibitory neurons: 432.5"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 2.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 3.7"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 3.7"	"Cell line enhanced"	"Detected in many"		"AF22: 43.0;fHDF/TERT166: 38.1;HAP1: 39.8;RPMI-8226: 34.4;U-2197: 69.3;WM-115: 37.5"					"Low region specificity"	"Detected in all"			HPA002809			Supported	Cytosol		NA	NA			Cytosol		"HPA002809: AB_1078855"	"unprognostic (3.23e-1)"	"unprognostic (3.13e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.87e-3)"	"unprognostic (9.92e-3)"	"unprognostic (2.97e-3)"	"unprognostic (4.92e-2)"	"unprognostic (5.90e-3)"	"unprognostic (5.22e-3)"	"unprognostic (6.79e-2)"	"unprognostic (4.96e-4)"	"unprognostic (4.36e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.27e-1)"	"unprognostic (7.48e-2)"	18.7	2.6	20.3	2.9	21.1	4.1	6.6	6.4	33.3	11.4	8.0	5.7	4.0	10.8	3.4	6.7	3.7	6.1	1.9	38.6	23.1	7.5	1.8	2.3	5.4	15.5	22.2	21.2	8.9	1.1	49.8	4.2	13.4	34.9	17.7	4.8	11.4	11.3	4.9	67.9	1.6	4.7	6.7	9.4	6.2	5.3	4.1	20.9	0.9	5.3	52.8	2.2	6.1	4.3	28.0	0.1	0.5	43.0	0.1	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.2	0.3	0.7	38.1	0.3	2.7	39.8	0.1	0.0	0.3	11.1	0.2	0.3	1.6	1.5	0.3	0.5	0.6	1.0	0.1	0.0	0.2	0.0	2.5	1.8	12.4	4.4	0.3	0.1	0.3	4.4	0.1	14.3	6.6	2.8	34.4	6.3	0.2	0.1	0.2	0.0	0.3	26.8	21.0	0.1	0.2	0.8	1.3	1.8	69.3	19.1	16.2	9.8	0.1	15.3	12.8	37.5	1.6	0.2	0.8	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	3.7	0.1	0.2	0.4	0.1	0.0	20.3	21.1	6.4	33.3	38.6	23.1	15.5	22.2	21.2	34.9	9.4	20.9	28.0	9.7	0.0	0.0	12.7	0.1	0.4	3.0	0.3	2.8	3.6	18.3	4.1	2.6	10.0	3.0	7.3	0.0	0.2	0.0	0.5	17.6	4.2	0.0	7.7	5.0	3.6	2.4	0.0	43.5	5.8	0.3	6.1	3.1	20.5	0.0	1.4	1.4	0.1	29.3	0.0	432.5	0.8	6.1	3.7	1.4	1.4	26.1	0.6	1.8	62.8	0.6	44.8	0.0	14.1	2.4	3.8	6.7	24.5	0.1	16.9	0.0	2.9	1.8	4.2	32.9	18.0	13.7	0.0	3.7	0.1	0.9	0.1	0.3	0.8	0.3	1.0
FGF20		ENSG00000078579	"Fibroblast growth factor 20"	Q9NP95	8	16992181-17002345	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.5"	"Cell type enriched"	"Detected in some"	7	"Microglial cells: 8.4"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 2.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 1.6;CAPAN-2: 5.3;OE19: 1.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"cerebellum: 1.8"						"Secreted in other tissues"	NA	NA						"unprognostic (1.93e-2)"		"unprognostic (2.19e-1)"	"unprognostic (5.57e-3)"	"unprognostic (3.95e-2)"			"unprognostic (1.59e-3)"		"unprognostic (1.40e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.65e-2)"	"unprognostic (9.32e-2)"	"unprognostic (9.95e-2)"	"unprognostic (3.92e-1)"	"unprognostic (4.08e-2)"		0.1	0.6	0.8	0.0	0.9	0.0	0.2	2.5	1.3	1.0	0.5	0.0	0.1	0.0	0.6	0.0	0.2	0.3	0.1	0.8	1.1	0.0	0.0	0.1	0.1	1.0	1.2	0.6	0.6	0.1	0.0	0.4	0.1	1.2	0.2	0.0	0.1	1.1	0.1	0.0	0.0	0.1	0.0	1.2	1.0	0.6	0.2	1.1	0.2	0.2	0.0	0.4	0.1	0.1	1.6	0.0	0.0	0.1	0.0	0.4	0.6	0.0	0.6	1.6	0.2	0.8	0.0	5.3	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.9	2.5	1.3	0.8	1.1	1.0	1.2	0.6	1.2	1.2	1.1	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	1.0	0.0	0.0	0.0	1.2	0.0	8.4	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0
FIGNL2		ENSG00000261308	"Fidgetin like 2"	A6NMB9	12	51817899-51848718	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 2.2;parathyroid gland: 2.2"	"Cell type enriched"	"Detected in some"	6	"Proximal tubular cells: 10.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 17.4;BEWO: 11.4;NTERA-2: 7.0;SuSa: 12.7"	"Not detected"	"Not detected"													NA	NA						"unprognostic (1.83e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.26e-2)"	"unprognostic (7.36e-4)"	"unprognostic (1.99e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.57e-3)"	"unprognostic (2.71e-2)"	"unprognostic (4.75e-2)"	"unprognostic (6.40e-2)"	"unprognostic (9.78e-6)"	"unprognostic (7.95e-3)"	"unprognostic (9.65e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.48e-2)"	0.5	0.0	0.6	0.2	0.8	0.0	0.2	1.1	1.0	0.2	0.0	0.1	0.1	0.4	0.2	0.0	0.1	0.2	0.1	0.8	0.6	2.2	0.5	0.3	0.3	0.9	0.6	1.0	0.0	0.1	2.2	0.4	0.8	0.7	0.2	0.1	0.4	0.7	0.2	0.2	0.1	0.2	0.1	0.2	0.4	0.4	0.5	0.7	0.1	0.1	0.1	0.2	0.1	0.1	0.6	0.0	0.1	17.4	0.0	0.2	0.1	11.4	0.0	0.0	0.0	0.0	3.5	0.0	0.0	1.7	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.3	0.0	7.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.5	2.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	1.1	1.0	0.8	0.6	0.9	0.6	1.0	0.7	0.2	0.7	0.6	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.4	0.4	0.0	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0
FILIP1	"FILIP, KIAA1275"	ENSG00000118407	"Filamin A interacting protein 1"	Q7Z7B0	6	75291859-75493800	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 54.3;skeletal muscle: 36.1;tongue: 49.3"	"Cell type enriched"	"Detected in many"	4	"Cardiomyocytes: 582.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 6.9;HUVEC TERT2: 1.7;RPTEC TERT1: 1.9;U-266/70: 6.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA053564	Enhanced		Approved	"Plasma membrane,Actin filaments"		No	NA			"Plasma membrane, Actin filaments"		"HPA053564: AB_2682192"	"unprognostic (4.90e-2)"	"unprognostic (3.77e-2)"	"unprognostic (9.77e-3)"	"unprognostic (3.83e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.98e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.17e-3)"	"unprognostic (3.29e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.30e-3)"	"unprognostic (3.97e-3)"	"unprognostic (2.34e-1)"	"unprognostic (4.65e-2)"	"unprognostic (7.66e-3)"	6.9	1.5	1.3	3.0	1.8	0.2	2.4	0.2	2.5	1.5	1.1	8.5	1.8	8.6	0.9	9.6	4.8	5.8	54.3	4.1	1.5	1.8	3.2	7.7	1.3	0.3	0.4	1.3	1.3	1.4	12.5	1.4	5.1	0.4	3.9	3.3	0.4	1.2	3.5	36.1	0.5	2.6	13.3	0.5	0.3	3.3	2.1	0.7	1.2	2.3	49.3	0.9	11.0	1.6	1.5	0.0	1.3	0.2	0.1	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.1	6.9	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.1	0.2	0.0	0.0	0.1	0.1	0.9	0.0	0.1	0.0	0.0	1.7	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.4	0.1	0.1	0.0	0.1	0.0	1.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.9	0.7	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	1.3	1.8	0.2	2.5	4.1	1.5	0.3	0.4	1.3	0.4	0.5	0.7	1.5	82.1	128.2	82.6	5.9	0.5	0.6	0.5	2.8	0.0	3.5	0.5	0.8	582.5	0.0	9.1	0.0	0.0	0.8	0.5	0.1	1.9	0.1	54.2	18.2	1.7	45.9	0.0	2.7	9.7	0.4	0.3	60.3	0.0	19.2	1.3	1.7	72.1	0.7	1.3	0.0	12.8	0.1	8.2	1.9	1.2	17.6	2.5	1.8	1.8	5.6	0.0	2.5	1.0	6.0	10.0	0.0	0.0	4.5	0.0	0.8	0.4	0.1	62.4	3.5	92.1	70.2	114.2	7.1	7.9	0.7	0.9	0.8	1.8	11.9	0.1	0.4
FITM2	"C20orf142, dJ881L22.2, FIT2"	ENSG00000197296	"Fat storage inducing transmembrane protein 2"	Q8N6M3	20	44302840-44311202	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid metabolism"	Hydrolase	"Deafness, Disease variant, Dystonia, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 59.8"	"Cell type enriched"	"Detected in many"	9	"Cardiomyocytes: 153.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.92e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.57e-3)"	"unprognostic (1.63e-2)"	"unprognostic (3.90e-2)"	"unprognostic (8.43e-2)"	"unprognostic (5.19e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.19e-1)"	"prognostic favorable (8.98e-12)"	"unprognostic (2.07e-1)"	"unprognostic (2.54e-1)"	"unprognostic (3.38e-3)"	"unprognostic (2.49e-3)"	11.5	11.2	4.5	3.0	4.9	1.2	7.1	5.7	6.3	4.2	5.1	5.2	4.4	4.0	8.8	3.4	3.7	3.2	59.8	4.5	5.6	7.9	6.4	4.1	2.3	6.4	5.9	4.7	4.7	7.5	13.7	5.2	1.9	6.9	6.5	6.0	6.7	6.5	4.4	9.3	5.6	4.0	5.3	4.3	2.6	4.6	3.9	5.2	1.7	6.3	16.9	2.6	4.6	3.1	6.8	7.2	10.9	4.5	6.6	31.4	12.8	4.6	11.5	8.4	8.9	4.9	13.5	5.1	4.9	6.5	13.0	14.3	15.8	5.7	7.7	9.6	1.4	2.7	1.6	6.5	22.9	6.6	3.1	4.0	9.7	17.2	6.2	4.7	4.9	6.4	3.1	2.7	14.2	9.1	22.4	1.2	3.4	1.1	10.8	13.9	1.9	8.4	4.9	5.1	6.7	2.7	3.2	24.4	13.5	10.3	2.0	16.5	2.4	7.9	28.2	12.6	16.6	6.8	5.2	14.4	1.3	12.6	4.9	14.4	0.7	1.0	0.6	1.1	1.0	1.2	0.6	1.2	0.9	1.0	0.6	2.0	1.6	0.4	1.4	0.8	0.6	1.2	0.9	4.5	4.9	5.7	6.3	4.5	5.6	6.4	5.9	4.7	6.9	4.3	5.2	6.8	2.8	6.4	9.7	1.3	3.6	6.9	3.5	2.8	1.2	6.4	5.0	3.4	153.9	11.5	4.3	5.5	6.2	2.0	1.0	5.1	1.9	5.2	4.6	2.2	5.0	4.4	9.1	0.8	2.3	8.6	3.5	9.4	4.1	2.1	0.0	4.4	8.2	14.1	3.4	6.7	2.1	4.8	0.0	3.8	2.2	1.2	7.8	1.7	7.2	1.0	2.3	6.6	2.1	4.0	0.9	5.7	4.1	7.5	3.1	3.1	5.9	6.2	4.0	5.9	0.0	5.6	6.3	9.1	6.0	2.7	8.1	1.5	2.1	16.3	9.2	2.2
FKBP11	FKBP19	ENSG00000134285	"FKBP prolyl isomerase 11"	Q9NYL4	12	48921518-48926474	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 499.2"	"Cell type enriched"	"Detected in many"	4	"Plasma cells: 1153.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"MAIT T-cell: 188.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 332.6;Karpas-707: 315.1;OE19: 527.2"	"Low region specificity"	"Detected in all"							HPA041709	Enhanced		Approved	Centrosome		NA	NA		170000	Centrosome		"HPA041709: AB_10794487"	"unprognostic (7.45e-3)"	"unprognostic (8.62e-2)"	"unprognostic (2.40e-1)"	"prognostic favorable (7.09e-4)"	"unprognostic (1.70e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.64e-2)"	"unprognostic (3.49e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.15e-1)"	"unprognostic (4.51e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.54e-1)"	19.3	17.7	4.2	60.7	4.1	34.8	34.9	3.5	5.0	42.7	5.4	57.8	71.4	17.5	87.1	16.3	19.3	25.7	10.5	3.7	10.5	13.9	59.9	24.1	55.9	4.8	4.7	4.1	13.9	499.2	4.7	47.6	15.7	4.8	29.1	53.8	2.1	161.6	33.0	2.4	7.4	56.3	26.4	3.5	77.0	71.3	6.2	8.5	16.6	23.1	0.5	78.0	49.7	17.5	4.8	13.6	24.7	3.0	4.5	116.0	141.3	3.8	123.2	183.3	128.0	154.5	78.3	88.3	192.8	2.2	226.8	1.1	60.6	31.6	60.4	77.0	39.1	7.7	6.6	24.7	0.3	332.6	3.2	3.3	165.0	109.8	99.2	171.4	67.2	75.4	53.1	3.0	315.1	49.9	44.7	26.3	5.1	7.4	527.2	33.9	76.5	3.3	280.7	21.0	2.3	35.0	10.6	36.6	66.5	24.4	4.0	2.0	7.0	49.2	21.0	2.8	2.1	2.3	132.3	122.2	108.1	16.1	3.9	33.0	6.0	1.0	2.8	115.7	1.3	188.3	50.5	80.5	92.7	1.9	25.7	38.8	69.9	4.1	26.7	1.1	39.3	33.4	36.3	4.2	4.1	3.5	5.0	3.7	10.5	4.8	4.7	4.1	4.8	3.5	8.5	4.8	22.3	16.0	19.1	5.2	229.8	28.3	56.0	48.6	39.3	5.5	45.0	43.3	2.3	30.0	42.8	9.2	39.6	21.5	130.9	23.1	7.9	23.7	18.4	19.2	117.8	32.3	25.1	20.6	5.3	171.7	80.7	64.1	31.6	31.0	12.7	34.0	40.4	96.6	10.9	1.7	3.7	227.7	16.2	15.1	26.1	17.4	27.7	10.1	272.1	0.0	8.0	1.8	158.6	1.5	1.8	59.8	14.3	13.9	1153.9	111.8	14.1	18.0	43.3	14.6	6.6	10.8	88.7	12.0	9.8	23.0	21.3	42.3	145.3	37.5	49.7	45.0
FLACC1	ALS2CR12	ENSG00000155749	"Flagellum associated containing coiled-coil domains 1"	Q96Q35	2	201288271-201357398	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 17.2"	"Cell type enriched"	"Detected in single"	8	"Cardiomyocytes: 6.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 3.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 3.4;U-2197: 5.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA035793			Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA035793: AB_10602429"	"unprognostic (1.45e-1)"	"unprognostic (1.91e-1)"	"unprognostic (9.72e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.40e-3)"	"unprognostic (1.40e-5)"	"unprognostic (1.37e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.25e-2)"	0.9	1.1	6.7	1.0	3.9	5.0	0.5	2.8	4.0	0.6	8.2	0.8	0.5	0.7	1.1	1.2	8.4	1.1	4.5	4.6	3.1	1.3	0.7	2.5	1.6	5.7	5.4	3.2	0.4	0.9	0.7	1.1	0.8	3.2	0.5	1.0	3.4	1.1	0.8	1.8	1.2	1.0	0.6	5.4	0.8	0.5	17.2	3.2	0.7	1.6	0.4	0.5	0.6	0.4	4.2	0.1	0.2	1.1	0.7	2.7	1.1	0.0	0.8	0.3	0.7	0.4	0.0	0.3	0.2	0.6	1.2	0.4	1.1	0.4	0.1	0.3	0.7	0.1	0.1	1.7	0.4	0.6	1.2	1.0	0.5	0.3	0.7	0.1	0.8	0.1	1.2	0.5	1.6	0.6	0.0	0.6	1.0	0.3	0.4	0.6	0.3	0.5	0.7	0.4	0.2	0.2	0.7	0.7	0.0	3.4	1.0	0.4	1.4	0.9	1.5	0.7	5.9	0.5	0.8	1.8	0.5	1.2	0.6	0.7	3.1	0.4	0.4	0.7	0.3	0.3	0.3	0.4	0.4	0.2	0.7	0.6	0.7	3.6	1.3	0.3	0.2	0.3	0.2	6.7	3.9	2.8	4.0	4.6	3.1	5.7	5.4	3.2	3.2	5.4	3.2	4.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FMC1-LUC7L2	C7orf55-LUC7L2	ENSG00000269955	"FMC1-LUC7L2 readthrough"		7	139341360-139422599	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"Cardiomyocytes: 26.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA045663, HPA051631"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045663: AB_2679410, HPA051631: AB_2681558"	"unprognostic (2.54e-1)"	"unprognostic (5.27e-2)"			"unprognostic (3.21e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.68e-2)"		"unprognostic (4.48e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.76e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.12e-2)"	"unprognostic (6.42e-3)"		16.3	17.9	1.9	8.9	3.6	6.4	16.3	3.3	9.9	15.2	3.1	18.8	11.1	22.0	1.1	13.5	18.3	2.7	21.6	1.6	3.5	14.5	19.5	14.9	6.2	4.3	2.5	0.9	20.6	12.4	12.4	14.2	7.0	3.8	15.4	4.1	14.0	18.3	8.7	57.5	12.9	16.2	6.7	3.6	12.8	16.6	11.8	3.2	14.2	24.9	30.7	4.9	17.9	15.1	4.1	32.6	46.2	55.1	31.7	23.3	16.2	20.8	25.2	17.0	29.9	23.8	36.5	35.8	36.5	44.3	18.6	40.1	25.5	59.7	21.3	9.4	25.2	6.3	48.6	45.9	27.8	21.7	60.2	38.2	12.7	15.3	28.8	18.4	16.9	20.9	19.1	62.1	47.4	18.7	45.6	88.9	3.2	44.5	44.2	9.7	57.5	41.6	48.5	4.8	22.3	45.7	47.5	33.9	26.4	33.8	10.4	20.2	25.1	24.0	21.5	20.2	22.5	38.8	44.4	40.3	70.5	39.9	37.8	40.1	14.6	15.7	22.3	22.2	16.1	21.3	22.2	21.3	23.0	22.8	23.0	23.9	21.7	5.6	24.6	20.4	17.9	25.8	16.4	1.9	3.6	3.3	9.9	1.6	3.5	4.3	2.5	0.9	3.8	3.6	3.2	4.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FOLH1	"FOLH, GCP2, GCPII, NAALAD1, NAALAdase, PSM, PSMA"	ENSG00000086205	"Folate hydrolase 1"	Q04609	11	49145092-49208638	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Carboxypeptidase, Dipeptidase, Hydrolase, Metalloprotease, Multifunctional enzyme, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 268.8;prostate: 76.7"	"Cell type enriched"	"Detected in some"	8	"Oligodendrocytes: 367.6"	"Cancer enriched"	"Detected in many"	27	"prostate cancer: 142.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 2.3;RPMI-8226: 1.7;SK-BR-3: 1.8;TIME: 1.3;WM-115: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001451, HPA010593"	Enhanced					NA	NA					"CAB001451: AB_563979, HPA010593: AB_1079685"	"unprognostic (1.33e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (5.24e-5)"	"unprognostic (2.55e-1)"	"unprognostic (8.31e-2)"	"prognostic favorable (4.25e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.67e-3)"	"unprognostic (2.13e-2)"	"unprognostic (2.72e-1)"	"prognostic unfavorable (1.30e-6)"	"unprognostic (4.81e-2)"	"unprognostic (7.27e-2)"	"unprognostic (4.74e-3)"	"unprognostic (4.04e-1)"	1.9	1.2	18.9	0.9	34.0	0.7	4.8	25.8	24.0	1.9	7.5	0.7	268.8	1.7	0.9	1.5	3.6	10.3	0.5	17.5	24.7	13.6	35.8	1.3	0.9	32.5	28.6	13.0	1.0	0.4	0.2	0.0	0.3	31.5	76.7	0.5	4.0	53.3	0.6	0.2	1.7	83.6	1.0	26.4	2.4	1.1	0.8	27.2	0.1	1.0	0.2	0.6	1.4	0.3	60.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.1	0.1	2.3	0.2	0.0	0.5	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.1	0.1	1.7	0.0	0.0	0.2	0.7	0.0	1.8	0.3	0.2	0.3	0.0	1.3	0.1	0.9	0.2	0.1	0.0	0.2	0.0	0.0	0.4	2.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	18.9	34.0	25.8	24.0	17.5	24.7	32.5	28.6	13.0	31.5	26.4	27.2	60.0	0.5	0.0	0.6	0.0	0.0	0.3	0.7	0.1	0.6	0.0	8.2	7.0	0.3	0.0	1.9	0.0	0.0	0.0	0.5	0.0	7.9	0.0	5.2	2.1	0.5	5.0	0.0	0.0	0.5	0.0	0.0	2.2	0.0	2.8	0.0	0.0	2.9	25.9	0.1	0.0	1.0	1.1	0.0	0.3	0.0	1.4	1.5	0.2	3.6	1.0	0.0	17.4	0.0	0.0	367.6	0.0	1.2	0.4	0.0	43.0	0.8	32.4	0.1	0.6	0.0	0.0	0.4	1.1	1.5	1.5	0.9	0.0	0.2	0.5	0.2	0.6
FOLR2	FR	ENSG00000165457	"Folate receptor beta"	P14207	11	72216601-72221950	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Transport	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 169.9"	"Cell type enriched"	"Detected in many"	4	"Hofbauer cells: 1114.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 64.2;intermediate monocyte: 50.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 18.7;monocytes: 64.2"	"Cell line enriched"	"Detected in some"	5	"U-698: 18.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA		15000000				"unprognostic (2.03e-1)"	"unprognostic (6.58e-3)"	"prognostic unfavorable (8.42e-4)"	"unprognostic (1.47e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.36e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.51e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.91e-3)"	"unprognostic (6.16e-3)"	"unprognostic (1.14e-1)"	"prognostic favorable (8.41e-4)"	"unprognostic (7.98e-3)"	120.1	55.6	10.0	28.5	9.7	10.9	32.0	6.7	18.7	28.1	18.3	36.4	19.6	13.7	12.5	31.9	16.9	80.8	38.9	9.7	16.0	10.9	45.2	40.0	79.1	8.4	8.3	8.4	16.1	7.2	7.9	6.1	169.9	8.7	6.1	47.2	0.2	12.9	16.8	6.0	8.9	29.8	46.7	7.4	27.9	21.2	13.1	11.2	29.0	9.2	26.5	29.2	82.0	6.3	12.9	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.7	0.2	0.2	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.2	0.0	0.2	0.0	18.6	0.5	0.8	0.0	0.0	64.2	0.0	0.3	50.6	0.0	9.5	0.0	0.0	18.7	4.0	0.0	0.0	1.1	1.8	13.7	0.2	0.0	20.4	10.0	9.7	6.7	18.7	9.7	16.0	8.4	8.3	8.4	8.7	7.4	11.2	12.9	3.4	0.0	0.6	0.0	8.0	7.9	0.1	0.0	1.2	0.0	0.1	1.1	2.2	1.5	0.0	0.0	0.0	7.6	0.6	0.0	0.0	0.0	0.9	0.3	0.1	2.3	0.0	0.0	0.0	0.0	6.0	2.4	0.0	0.5	2.5	0.0	2.2	1.7	1114.8	0.0	0.0	0.0	0.0	229.3	98.8	2.5	1.5	199.4	0.0	15.9	5.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	2.1	0.1	0.0	0.2	0.0	0.3	0.0	2.5	1.2	0.6	0.7	1.3	5.1	16.0	1.2	0.1	0.0	0.1
FOXD3	"Genesis, HFH2"	ENSG00000187140	"Forkhead box D3"	Q9UJU5	1	63322567-63325128	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 3.7"	"Cell type enriched"	"Detected in some"	5	"Melanocytes: 5.4"	"Group enriched"	"Detected in some"	6	"melanoma: 9.9;testis cancer: 3.5"	"Region enriched"	"Detected in single"	5	"medulla oblongata: 1.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"NTERA-2: 13.1;SK-MEL-30: 11.2;WM-115: 15.7"	"Region enriched"	"Detected in single"	13	"olfactory bulb: 3.4"	"Group enriched"	"Detected in some"	13	"olfactory bulb: 8.6;spinal cord: 2.2"	CAB022455	Uncertain					NA	NA					"CAB022455: "	"unprognostic (1.39e-1)"	"unprognostic (3.23e-3)"	"unprognostic (2.33e-3)"		"unprognostic (4.63e-2)"	"unprognostic (7.79e-2)"		"unprognostic (8.22e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.92e-2)"	"unprognostic (3.28e-1)"		"unprognostic (3.00e-2)"	"unprognostic (8.56e-2)"		"unprognostic (5.83e-2)"	0.3	0.3	0.3	0.2	0.1	0.0	0.3	0.0	0.0	1.4	0.0	3.7	0.2	0.2	0.0	0.4	0.4	0.1	1.0	0.0	0.0	0.1	0.1	0.0	0.0	1.6	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.3	1.4	0.2	0.0	0.4	0.5	1.4	0.5	1.3	0.1	0.2	0.0	1.1	1.5	0.2	0.0	0.2	0.2	0.0	1.5	1.5	0.3	0.1	0.2	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.2	0.0	0.0	0.4	3.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.1	0.0	0.0	0.3	0.0	0.0	13.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	2.7	0.0	11.2	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.3	0.2	0.2	0.3	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.6	0.0	0.7	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	1.0	0.3	0.2	0.3	0.0	0.0	0.0	0.2	0.0
FOXD4L1	FOXD5	ENSG00000184492	"Forkhead box D4 like 1"	Q9NU39	2	113498665-113501155	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 1.2"	"Cell type enriched"	"Detected in some"	11	"monocytes: 31.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RH-30: 1.5"									"HPA012836, HPA069839"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA012836: AB_2105429, HPA069839: "	"unprognostic (3.48e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.02e-2)"	"unprognostic (6.61e-2)"	"unprognostic (3.22e-1)"	"unprognostic (6.41e-4)"	"unprognostic (2.54e-1)"	"unprognostic (5.77e-3)"	"unprognostic (5.93e-2)"	"unprognostic (4.21e-2)"	"unprognostic (9.54e-4)"	"unprognostic (3.98e-2)"	"unprognostic (1.18e-8)"	"unprognostic (1.57e-2)"	"unprognostic (4.14e-2)"	"unprognostic (9.57e-2)"	"unprognostic (5.91e-4)"	0.0	0.1	0.2	0.1	0.1	0.5	0.0	0.3	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.2	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.1	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.4	0.2	0.3	0.2	0.0	0.5	0.4	0.0	0.2	0.0	0.0	0.2	0.0	0.3	0.3	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.2	1.5	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.5	0.5	0.1	0.3	0.4	0.4	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.5	0.5	0.1	0.1	0.1	0.1	0.3	0.1	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	31.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1
FOXD4L3	FOXD6	ENSG00000187559	"Forkhead box D4 like 3"	Q6VB84	9	68302867-68305084	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 1.6"	"Cell type enriched"	"Detected in single"	5	"monocytes: 1.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"hippocampal formation: 1.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA012836	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA012836: AB_2105429"		"unprognostic (7.93e-4)"			"unprognostic (8.71e-2)"					"unprognostic (7.04e-2)"				"unprognostic (4.75e-2)"				0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	1.2	1.6	0.1	0.2	0.0	0.2	0.3	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FOXI1	"FKHL10, FREAC6"	ENSG00000168269	"Forkhead box I1"	Q12951	5	170105897-170109734	"Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 43.3;salivary gland: 11.5"	"Cell type enriched"	"Detected in some"	4	"Ionocytes: 132.2"	"Group enriched"	"Detected in many"	7	"breast cancer: 5.8;renal cancer: 23.1"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	16	"eosinophil: 1.5"	"Lineage enriched"	"Detected in single"	16	"granulocytes: 1.5"	"Group enriched"	"Detected in some"	5	"MCF7: 1.4;SuSa: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA071469	Enhanced		Supported	Nucleoli,Vesicles		NA	NA			Nucleoli	Vesicles	"HPA071469: AB_2686403"	"unprognostic (3.06e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.48e-2)"		"unprognostic (8.06e-2)"		"unprognostic (7.47e-2)"		"unprognostic (2.73e-1)"	"unprognostic (1.52e-2)"	"unprognostic (9.71e-3)"	"unprognostic (4.88e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.34e-2)"		"unprognostic (2.22e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	43.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.5	0.1	0.0	0.1	3.0	0.0	0.0	11.5	1.5	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.0	1.5	0.2	0.0	0.0	7.6	6.5	0.3	0.0	0.3	1.8	0.0	0.0	0.1	0.0	27.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	132.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.0	0.2	0.0	0.0	0.0
FOXL2	"BPES, BPES1"	ENSG00000183770	"Forkhead box L2"	P58012	3	138944224-138947137	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease variant, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"ovary: 45.2;parathyroid gland: 12.6"	"Cell type enriched"	"Detected in some"	4	"Granulosa cells: 208.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 4.9;fHDF/TERT166: 5.6;HEL: 8.1;hTCEpi: 7.1;K-562: 8.4;SiHa: 5.6;THP-1: 5.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA069613	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA069613: AB_2686160"	"unprognostic (1.46e-1)"	"unprognostic (3.28e-2)"		"unprognostic (4.76e-3)"	"unprognostic (2.05e-1)"	"unprognostic (5.16e-4)"		"unprognostic (3.55e-2)"	"unprognostic (2.35e-3)"	"unprognostic (5.08e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.19e-1)"	"unprognostic (9.63e-8)"	"unprognostic (2.16e-2)"	"unprognostic (4.65e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.61e-2)"	0.0	2.6	1.2	0.0	0.6	0.0	0.0	0.6	0.8	11.4	0.3	0.0	0.0	7.4	0.4	0.0	12.0	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.8	0.7	0.2	45.2	0.1	12.6	10.0	0.1	0.7	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.8	0.7	0.0	0.0	0.8	1.5	0.0	0.0	0.1	0.0	0.0	2.1	0.8	4.9	1.8	0.2	3.4	0.0	0.0	1.4	0.1	0.0	0.4	0.0	0.0	0.3	0.0	2.2	5.6	0.2	1.1	0.0	0.0	0.1	0.0	0.0	8.1	0.9	0.0	0.0	0.1	0.0	0.0	7.1	0.0	0.0	1.1	0.0	0.0	8.4	0.0	2.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	1.6	0.0	0.0	5.6	0.0	0.0	0.3	0.0	5.9	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.6	0.6	0.8	0.6	0.6	0.8	0.7	0.2	0.7	0.7	1.5	0.8	0.2	0.0	0.0	0.0	0.1	0.5	0.1	0.1	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	41.8	1.6	0.0	0.0	0.0	0.2	0.3	20.9	0.0	1.0	0.0	208.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	6.2	1.8	1.4	0.0	1.0	0.0	0.3	48.4	0.0	0.0
FP565260.3		ENSG00000277117	"ICOS ligand"		21	5022493-5040666	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"brain: 16.8"	"Cell type enriched"	"Detected in single"	6	"monocytes: 4.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 22.8;REH: 18.5;SiHa: 15.6"									HPA029179			Approved	"Plasma membrane,Cytoplasmic bodies"		NA	NA			"Plasma membrane, Cytoplasmic bodies"		"HPA029179: AB_2732445"	"unprognostic (3.34e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.58e-4)"	"unprognostic (6.66e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.46e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.43e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.17e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.09e-1)"	2.1	1.5	9.0	4.7	10.9	3.7	2.4	7.5	6.4	2.9	2.2	2.9	4.9	1.4	0.7	3.4	2.5	3.2	3.6	5.0	10.9	4.7	2.9	1.9	5.5	11.4	9.9	3.1	0.3	1.3	0.4	1.2	2.5	14.0	2.1	2.1	0.0	2.2	1.5	0.7	3.8	3.5	1.4	7.4	3.2	4.9	0.8	9.0	1.9	2.2	1.1	6.4	3.1	2.6	16.8	0.3	0.8	0.0	1.5	0.4	0.9	22.8	1.8	1.4	0.2	0.1	5.5	0.9	12.7	3.8	0.1	2.8	4.2	1.4	1.9	0.3	0.4	1.3	0.0	0.6	2.9	0.2	9.7	8.8	0.2	2.2	1.2	1.1	0.0	1.2	0.0	1.5	0.5	0.1	3.1	0.0	5.6	0.9	15.1	7.6	18.5	0.6	12.7	0.5	7.6	1.0	0.0	15.6	12.9	0.3	0.8	4.4	12.5	0.4	0.0	3.4	0.0	0.3	8.9	9.5	8.2	9.0	5.6	2.0	0.0	0.3	0.0	0.0	1.2	0.1	1.2	0.2	0.0	0.3	2.1	0.0	0.2	0.0	0.0	0.2	0.4	0.5	0.5	9.0	10.9	7.5	6.4	5.0	10.9	11.4	9.9	3.1	14.0	7.4	9.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
FRG2	FRG2A	ENSG00000205097	"FSHD region gene 2"	Q64ET8	4	190024367-190027257	"Predicted intracellular proteins"				"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	9	"Distal tubular cells: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA039264, HPA047769"	Uncertain					NA	NA					"HPA039264: AB_2676420, HPA047769: AB_2680149"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FRG2B		ENSG00000225899	"FSHD region gene 2 family member B"	Q96QU4	10	133623895-133626795	"Predicted intracellular proteins"				"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	39	"Distal tubular cells: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	15	"HDLM-2: 4.3"									"HPA039264, HPA047769"	Uncertain					NA	NA					"HPA039264: AB_2676420, HPA047769: AB_2680149"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.3	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FRMD4B	"GRSP1, KIAA1013"	ENSG00000114541	"FERM domain containing 4B"	Q9Y2L6	3	69168782-69542583	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 83.2"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 1209.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 39.8;hTERT-HME1: 52.7;HUVEC TERT2: 55.1;TIME: 47.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009705	Uncertain	Supported	Approved	"Nucleoplasm,Golgi apparatus,Centriolar satellite"		NA	NA		17000	"Centriolar satellite"	"Nucleoplasm, Golgi apparatus"	"HPA009705: AB_1849147"	"unprognostic (1.36e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.59e-2)"	"unprognostic (9.73e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.09e-2)"	"unprognostic (8.23e-2)"	"prognostic favorable (5.01e-4)"	"unprognostic (1.49e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.39e-3)"	11.1	4.8	15.7	12.4	42.2	15.7	16.3	23.3	28.2	25.1	10.1	12.9	9.2	11.5	9.4	27.0	13.3	19.3	17.5	16.5	27.1	16.4	34.8	25.1	11.0	33.6	34.9	8.0	11.0	8.3	3.7	4.0	25.7	38.0	17.0	13.0	22.1	37.5	10.6	2.3	22.1	12.6	10.6	20.1	32.6	15.2	4.7	33.5	14.2	27.3	4.7	11.3	13.8	16.0	83.2	6.7	1.8	10.4	0.3	0.2	1.5	11.3	0.5	1.7	0.8	0.5	39.8	11.3	0.8	3.5	0.5	1.0	25.9	4.9	35.3	1.2	2.2	3.3	20.4	2.6	2.3	0.7	5.2	10.2	1.7	35.2	1.0	52.7	1.6	55.1	4.7	1.6	5.8	3.0	7.7	0.5	0.8	5.6	8.9	8.5	32.2	2.8	1.0	14.8	4.6	12.1	15.6	1.7	12.2	35.5	9.3	4.6	6.8	47.1	0.6	4.3	0.4	1.8	0.6	0.3	1.2	0.4	13.5	13.5	18.3	27.6	2.3	1.9	13.8	7.0	1.6	6.3	2.8	16.9	2.0	1.9	1.8	7.1	3.8	2.3	16.8	15.4	7.7	15.7	42.2	23.3	28.2	16.5	27.1	33.6	34.9	8.0	38.0	20.1	33.5	83.2	20.6	41.7	83.6	2.9	3.6	60.7	33.4	57.8	69.4	13.8	34.4	21.7	33.4	41.5	58.5	14.7	218.9	49.9	20.3	74.4	33.2	32.6	18.9	207.9	49.3	64.3	24.5	8.6	4.2	17.3	19.7	32.1	75.4	282.6	34.7	97.5	89.3	53.6	92.6	0.0	92.7	42.1	36.7	138.7	112.7	4.0	6.5	105.2	28.4	93.7	26.3	13.5	1.0	129.2	1209.1	24.5	67.0	18.4	6.9	61.1	10.7	55.6	38.2	109.2	6.6	11.8	21.0	0.0	3.5	79.9	51.4	58.3	44.6	32.1	32.2	172.8
FRYL	"AF4p12, DKFZp686E205, KIAA0826, MOR2"	ENSG00000075539	"FRY like transcription coactivator"	O94915	4	48497357-48780322	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 79.8"	"Cell type enriched"	"Detected in all"	5	"Oligodendrocytes: 1148.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 13.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 13.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031106, HPA031107"	Supported		Approved	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	No			Cytosol	"Microtubules, Cytokinetic bridge"	"HPA031106: AB_10600660, HPA031107: AB_10600536"	"unprognostic (7.50e-2)"	"unprognostic (9.72e-3)"	"unprognostic (6.68e-3)"	"unprognostic (3.22e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.03e-2)"	"unprognostic (3.59e-2)"	"unprognostic (4.80e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.41e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.29e-2)"	8.9	5.4	9.9	13.4	37.3	15.2	8.0	22.9	26.4	8.5	2.3	38.3	10.4	8.5	3.7	6.7	6.2	8.3	8.7	9.6	19.2	8.5	5.8	9.7	13.5	28.1	21.8	5.7	7.9	5.6	20.5	2.7	10.6	28.3	6.6	37.1	29.5	6.8	6.7	4.5	10.2	12.9	9.3	23.4	10.9	10.8	6.4	25.2	16.9	8.0	12.1	13.2	10.3	3.4	79.8	19.7	11.6	26.8	16.4	11.3	16.1	14.5	18.1	17.4	17.6	21.2	9.4	14.7	25.0	14.3	19.3	32.9	11.8	17.8	28.1	37.9	14.3	6.1	45.6	11.3	4.3	7.0	31.6	16.8	11.6	10.5	24.0	24.9	16.4	26.4	21.3	14.8	9.2	22.9	9.6	34.5	10.9	4.6	8.9	9.8	25.4	35.0	4.7	15.7	20.8	23.1	9.9	17.7	5.2	9.9	12.8	6.8	19.6	40.3	19.8	25.5	10.1	35.3	12.4	17.5	22.1	16.6	20.6	19.8	13.5	0.9	1.8	2.0	1.4	1.6	1.5	1.8	1.7	1.0	1.2	2.0	1.9	2.8	2.7	1.0	1.7	1.3	0.7	9.9	37.3	22.9	26.4	9.6	19.2	28.1	21.8	5.7	28.3	23.4	25.2	79.8	87.1	38.5	33.1	92.1	50.1	47.3	24.3	32.0	38.7	45.3	23.7	17.0	33.5	18.6	28.9	16.5	135.5	23.6	59.9	122.8	3.9	13.8	11.6	48.2	29.0	74.8	79.5	80.6	110.1	11.6	21.5	23.7	128.4	56.8	46.9	25.6	48.9	15.2	19.4	47.1	172.5	195.1	38.7	30.1	34.0	3.9	17.1	40.1	26.6	214.5	35.1	32.8	63.8	146.8	1148.7	28.8	87.3	18.4	38.6	43.4	50.4	8.4	21.0	105.6	19.7	31.2	37.3	12.8	10.9	37.3	49.3	10.8	54.4	15.6	93.9	53.3
FRZB	"FRE, FRITZ, FRP-3, FRZB-1, FRZB-PEN, FRZB1, FZRB, hFIZ, SFRP3, SRFP3"	ENSG00000162998	"Frizzled related protein"	Q92765	2	182833275-182866637	"Disease related genes, Predicted secreted proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 339.8"	"Cell type enriched"	"Detected in many"	13	"Muller glia cells: 3633.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"hypothalamus: 73.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 19.2;ASC diff: 9.4;NTERA-2: 7.4;SH-SY5Y: 6.5"	"Region enhanced"	"Detected in all"		"olfactory bulb: 56.9"	"Low region specificity"	"Detected in all"								"Secreted in other tissues"	NA	NA		44000				"unprognostic (5.39e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.64e-2)"	"unprognostic (2.38e-2)"	"unprognostic (4.67e-2)"	"unprognostic (8.58e-2)"	"unprognostic (5.41e-2)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (8.97e-6)"	"unprognostic (3.53e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.04e-2)"	"unprognostic (3.21e-1)"	10.0	5.8	12.3	6.2	11.9	0.7	12.8	11.0	16.9	19.1	51.8	16.3	14.5	17.3	11.5	12.5	7.2	39.3	20.1	10.3	73.7	16.4	3.4	9.2	18.9	14.3	10.9	9.5	13.6	7.2	6.8	18.7	30.8	15.6	13.0	20.0	339.8	4.8	16.8	26.8	8.7	14.6	31.4	11.8	89.7	22.1	14.4	11.8	4.9	10.9	117.3	12.0	10.4	12.4	11.5	0.0	0.0	19.2	0.2	9.4	0.2	0.2	0.0	0.9	3.2	2.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.4	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.0	0.8	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	7.4	0.0	0.0	0.6	0.8	0.0	0.0	0.0	1.0	6.5	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	11.9	11.0	16.9	10.3	73.7	14.3	10.9	9.5	15.6	11.8	11.8	11.5	13.8	0.0	0.5	1.0	0.8	8.2	0.4	0.2	0.6	39.8	7.8	18.7	2.9	0.0	1.4	0.0	33.3	5.3	0.5	2.1	0.0	0.1	0.3	0.5	1.4	18.5	1.2	0.0	2.7	8.2	3.8	97.8	9.7	0.9	0.0	0.5	3.6	1.0	7.8	26.9	7.7	137.4	0.0	0.8	3.7	2.8	3.7	0.5	245.5	25.3	0.0	3633.8	0.0	8.5	1.7	0.2	0.8	14.7	5.8	1.8	1.3	0.2	0.2	124.4	276.1	41.9	157.1	0.2	0.1	0.6	3.1	12.4	1.5	22.9	3.4	0.6
FST	FS	ENSG00000134363	Follistatin	P19883	5	53480626-53487134	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 69.2"	"Cell type enriched"	"Detected in many"	6	"Granulosa cells: 700.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 45.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 351.1;HaCaT: 292.3;HBEC3-KT: 191.3;HMC-1: 206.5;PC-3: 558.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA016612, CAB026025"	Approved		Approved	Vesicles	"Secreted to blood"	NA	NA		1800000	Vesicles		"CAB026025: , HPA016612: "	"unprognostic (1.43e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.73e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.50e-3)"	"unprognostic (8.02e-2)"	"unprognostic (2.32e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (4.44e-5)"	"unprognostic (1.21e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.18e-1)"	21.9	6.3	0.8	3.0	0.7	0.4	15.3	0.4	0.8	6.2	0.7	8.4	1.8	4.3	3.7	6.6	11.9	7.2	7.7	1.9	1.5	2.8	69.2	8.3	1.6	1.9	1.0	0.7	10.0	2.6	0.5	5.9	24.3	1.0	15.7	3.0	0.3	11.4	10.9	9.2	17.5	8.8	4.8	0.6	0.3	11.2	5.0	1.1	2.3	4.1	7.8	13.0	40.8	7.6	0.9	20.0	1.8	33.7	0.0	38.6	13.5	55.4	76.3	351.1	46.4	45.4	0.3	0.2	0.0	0.6	19.9	2.3	292.3	0.0	191.3	32.7	0.8	0.2	4.0	1.7	31.3	20.4	0.3	206.5	31.0	0.5	84.5	55.0	31.3	40.0	0.0	0.0	0.6	29.7	0.1	0.1	1.6	52.1	0.0	558.2	4.2	43.6	0.0	0.0	31.9	0.5	0.1	3.1	0.2	2.0	83.9	0.3	0.3	0.2	124.1	35.3	13.2	11.1	0.4	0.1	0.1	14.8	4.1	116.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.7	0.4	0.8	1.9	1.5	1.9	1.0	0.7	1.0	0.6	1.1	0.9	5.2	0.0	1.1	0.0	1.0	20.0	31.5	64.4	13.1	0.0	0.9	23.4	11.4	0.0	8.3	0.0	0.0	0.6	0.0	0.0	0.0	1.6	0.4	0.1	3.4	2.9	0.0	0.0	0.1	4.6	14.8	107.7	3.6	0.1	0.0	700.1	1.1	57.2	1.8	0.0	0.7	0.0	2.0	0.8	16.4	1.5	3.1	1.5	5.4	0.0	0.0	0.0	0.0	0.0	0.0	16.6	0.0	11.3	0.2	37.1	0.0	0.1	1.6	0.0	13.1	29.6	33.3	0.3	12.2	4.0	4.7	6.0	2.0	0.3	0.0	51.8
FSTL3	"FLRG, FSRP"	ENSG00000070404	"Follistatin like 3"	O95633	19	676392-683392	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Osteogenesis, Transcription, Transcription regulation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Extravillous trophoblasts: 3647.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"BEWO: 164.7;hTCEpi: 181.2;SiHa: 341.5;U-2197: 173.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB024899, HPA045378"	Approved		Supported	Nucleoplasm	"Secreted in other tissues"	NA	Yes		7000000	Nucleoplasm		"CAB024899: , HPA045378: AB_2679300"	"unprognostic (9.86e-3)"	"unprognostic (1.32e-3)"	"prognostic unfavorable (3.01e-4)"	"prognostic unfavorable (3.03e-4)"	"unprognostic (2.19e-3)"	"unprognostic (1.51e-3)"	"unprognostic (8.64e-3)"	"prognostic unfavorable (4.61e-7)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (1.65e-4)"	"unprognostic (3.50e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.03e-3)"	"unprognostic (7.22e-3)"	"unprognostic (3.07e-1)"	"unprognostic (3.75e-1)"	"unprognostic (5.89e-3)"	80.9	164.6	15.2	24.4	14.2	13.5	62.9	12.4	20.0	74.8	15.3	64.3	7.7	62.5	6.1	22.1	70.8	16.6	125.1	15.1	18.6	45.8	26.4	133.9	5.5	21.0	14.0	12.5	64.3	49.7	3.2	29.1	180.8	18.0	75.5	6.0	2.4	21.3	22.3	11.7	31.1	36.8	42.8	15.6	22.8	43.5	75.8	15.9	2.3	38.2	4.9	1.6	71.1	63.7	17.1	9.5	74.0	5.1	3.7	22.3	56.4	164.7	126.1	18.5	30.7	11.3	27.1	14.4	4.1	49.4	84.7	17.6	65.2	4.1	106.4	10.1	7.8	8.7	3.5	110.2	22.4	95.6	6.7	12.0	70.7	181.2	34.0	140.2	79.3	5.5	3.9	8.2	5.3	46.7	33.1	2.4	4.0	6.2	62.0	26.2	7.2	3.4	8.7	43.1	1.7	3.3	5.7	341.5	6.9	4.3	6.4	6.2	3.5	75.5	30.6	106.6	173.4	46.9	8.5	4.4	2.3	4.7	20.0	14.2	0.0	1.9	0.0	0.4	1.8	0.0	0.1	0.6	0.4	0.9	0.3	1.0	0.6	0.0	0.2	1.4	0.3	0.0	0.9	15.2	14.2	12.4	20.0	15.1	18.6	21.0	14.0	12.5	18.0	15.6	15.9	17.1	4.6	19.2	1.9	40.5	1.5	14.5	31.0	11.7	1.8	1.3	11.3	7.9	16.7	32.9	4.4	9.2	0.0	53.9	1.0	1.1	7.9	86.1	8.8	6.4	14.8	8.7	1.2	1.7	9.8	64.3	3647.6	59.6	2.0	18.3	0.0	5.7	16.4	1.9	77.1	3.3	8.4	1.0	0.0	3.7	4.8	7.6	61.2	7.4	5.4	2.8	10.6	6.6	1.0	6.0	5.5	306.5	0.2	26.7	1.0	78.0	1.2	17.7	3.1	1.1	46.0	22.4	57.0	4.6	5.6	4.3	7.7	792.0	2.0	3.6	2.5	30.7
FSTL4	KIAA1061	ENSG00000053108	"Follistatin like 4"	Q6MZW2	5	133196455-133612541	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.1"	"Cell type enriched"	"Detected in many"	6	"Excitatory neurons: 390.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 57.2;U-266/70: 19.3;U-266/84: 20.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045920	Uncertain		Uncertain	Mitochondria	"Secreted to blood"	NA	NA			Mitochondria		"HPA045920: AB_10965844"	"unprognostic (5.52e-2)"	"unprognostic (2.54e-1)"	"unprognostic (5.74e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.97e-2)"	"unprognostic (6.35e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.74e-2)"	"unprognostic (8.66e-2)"	"unprognostic (3.73e-4)"	"unprognostic (2.02e-2)"	"unprognostic (9.91e-3)"	"unprognostic (1.03e-2)"	"unprognostic (4.25e-2)"	0.1	1.3	4.7	0.6	4.7	1.9	0.6	8.4	11.1	0.2	0.0	1.1	0.7	0.2	1.5	1.9	1.0	0.5	0.4	2.7	3.1	2.9	0.1	1.2	0.3	1.6	6.3	3.0	0.4	1.9	3.1	2.3	3.8	3.9	1.6	1.1	3.9	0.7	0.0	0.9	3.4	0.8	0.2	0.0	0.4	1.4	1.8	21.1	1.3	0.8	0.5	1.1	6.1	0.9	7.7	7.5	13.1	1.4	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	12.5	1.7	0.7	10.5	0.0	1.3	0.2	1.7	0.5	0.0	0.9	0.6	0.6	13.9	1.1	0.0	0.0	0.7	0.3	1.8	0.0	0.1	0.3	0.0	0.5	5.9	7.0	0.0	12.7	1.5	0.6	14.4	14.2	1.6	0.6	1.3	14.1	0.0	15.0	57.2	1.6	2.9	2.4	0.3	12.2	4.6	0.5	0.3	0.6	2.4	0.8	0.4	19.3	20.7	0.5	0.2	0.1	0.4	1.1	0.2	0.1	0.2	0.0	0.5	0.6	0.4	0.3	0.1	0.5	0.4	0.2	0.5	0.2	0.2	0.3	0.3	0.3	4.7	4.7	8.4	11.1	2.7	3.1	1.6	6.3	3.0	3.9	0.0	21.1	7.7	0.0	0.0	3.1	21.5	1.0	1.7	2.5	0.2	4.0	10.1	0.6	0.3	9.6	0.0	4.4	0.0	14.6	0.4	0.1	0.0	0.0	0.2	35.9	1.2	0.2	0.6	9.0	0.0	390.3	0.0	0.0	0.4	0.0	0.1	0.0	1.4	0.0	0.0	0.1	1.7	57.9	0.4	0.0	0.0	0.0	20.4	0.3	1.2	10.6	8.4	0.0	3.0	0.0	21.1	4.5	0.6	0.0	0.7	0.0	0.4	0.2	2.5	3.7	2.6	6.6	0.0	1.1	0.5	0.7	3.3	1.6	0.0	0.4	0.9	0.1	2.9
FUNDC2	"DC44, HCBP6"	ENSG00000165775	"FUN14 domain containing 2"	Q9BWH2	X	155025980-155060304	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 18.4;tongue: 19.6"	"Cell type enriched"	"Detected in all"	4	"Late spermatids: 1375.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059129	Approved					NA	NA					"HPA059129: AB_2683915"	"unprognostic (2.23e-1)"	"prognostic favorable (9.20e-4)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (7.26e-4)"	"unprognostic (2.07e-2)"	"unprognostic (6.20e-2)"	"prognostic unfavorable (3.78e-5)"	"unprognostic (6.56e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.49e-3)"	"unprognostic (3.14e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.74e-1)"	"unprognostic (5.67e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.81e-1)"	3.7	3.6	3.3	1.6	3.6	3.3	3.3	4.4	3.5	3.6	3.6	3.3	2.0	3.3	3.5	2.4	3.8	2.8	10.5	3.4	3.6	4.4	2.5	2.6	2.5	3.9	3.6	2.9	6.6	7.8	4.4	3.0	2.5	4.0	3.3	2.5	3.1	3.3	2.9	18.4	1.4	2.2	4.0	3.7	1.9	3.3	2.5	3.7	2.9	3.2	19.6	2.3	3.0	2.5	3.7	5.3	2.7	4.9	3.7	6.5	5.0	3.7	3.1	3.6	3.8	7.7	2.8	2.1	7.0	7.7	4.0	2.9	2.2	5.3	4.3	2.6	3.6	6.2	2.2	3.8	1.6	2.9	4.6	2.8	5.6	6.5	3.1	2.7	2.5	2.6	3.0	2.9	4.9	4.0	2.4	3.4	2.6	3.3	4.3	6.4	2.9	3.5	7.0	3.9	2.1	2.6	5.5	2.6	2.7	3.9	2.4	2.8	4.4	2.7	2.8	4.0	5.1	4.9	3.0	5.4	7.3	2.8	5.7	2.3	1.5	2.1	2.1	2.5	2.3	2.3	2.5	2.3	2.4	2.7	2.2	2.4	2.6	0.1	1.7	2.8	2.4	2.6	3.3	3.3	3.6	4.4	3.5	3.4	3.6	3.9	3.6	2.9	4.0	3.7	3.7	3.7	92.7	44.8	43.5	8.8	77.4	72.3	109.7	85.1	68.3	39.6	65.1	77.8	141.8	85.8	46.8	64.4	6.2	71.1	67.4	28.7	223.0	116.3	297.0	43.4	49.9	73.8	47.8	84.6	5.5	113.7	95.3	109.2	35.7	45.2	68.9	69.8	48.9	76.1	81.8	45.4	7.1	48.8	61.1	55.4	52.6	1375.2	107.8	66.2	67.6	5.6	60.0	109.3	64.9	7.5	12.8	104.9	35.4	76.3	104.7	142.4	78.2	193.0	39.5	49.2	26.3	141.6	90.9	31.6	46.2	54.6	60.1	79.9	69.4	54.3	51.1	85.8
FUT8		ENSG00000033170	"Fucosyltransferase 8"	Q9BYC5	14	65410592-65744121	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 65.3"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 1019.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 15.6;NK-cells: 14.8;T-cells: 10.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017129, HPA043410"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Cytosol"	"CAB017129: , HPA043410: AB_2678467"	"unprognostic (1.67e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.65e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.81e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.33e-3)"	"unprognostic (8.09e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.28e-3)"	8.0	8.2	22.2	12.0	36.3	3.6	10.6	44.5	28.2	6.9	2.1	11.5	17.6	9.1	5.4	6.9	15.8	11.2	4.8	19.7	27.4	6.9	3.4	8.2	11.7	30.0	30.4	15.5	7.3	10.0	9.7	4.6	17.5	32.4	5.8	11.7	8.3	43.0	10.6	2.5	5.4	17.6	11.1	31.6	10.3	32.1	16.5	29.2	11.4	8.5	6.4	18.8	13.4	4.5	65.3	115.9	22.5	12.6	110.6	49.5	38.4	61.6	35.9	64.8	30.3	32.6	16.9	44.8	30.7	29.2	40.1	79.4	9.0	29.9	11.4	45.6	124.2	11.0	33.5	7.2	23.0	26.8	7.6	23.9	96.0	6.8	39.3	19.4	124.4	69.6	17.1	14.1	28.8	20.8	60.8	36.6	16.7	14.7	59.6	66.6	26.9	10.3	17.2	46.5	33.1	23.4	16.6	20.8	9.8	8.0	70.6	10.2	12.9	141.8	34.5	36.0	15.3	30.5	47.3	18.5	74.3	68.6	13.6	11.1	0.7	2.0	0.7	3.6	0.9	3.8	15.6	6.2	5.6	2.6	8.3	6.6	6.6	0.3	14.8	1.4	2.6	10.0	2.9	22.2	36.3	44.5	28.2	19.7	27.4	30.0	30.4	15.5	32.4	31.6	29.2	65.3	19.0	12.8	32.5	227.5	43.1	12.1	7.4	11.5	17.1	10.1	18.3	11.7	5.9	8.6	18.9	12.9	4.2	45.5	8.3	5.9	0.0	9.1	37.9	9.9	14.6	16.0	5.4	15.8	169.0	31.7	28.1	22.7	78.0	10.2	7.6	3.3	14.6	3.5	13.0	8.4	166.4	26.5	2.0	12.2	8.6	15.3	12.8	10.2	1.8	70.3	3.6	27.8	9.2	138.7	1019.1	54.7	10.3	13.5	124.3	8.8	24.5	8.4	15.3	9.1	0.0	14.3	13.2	34.6	26.8	7.4	9.8	14.1	18.9	10.6	21.7	7.2
FXYD6-FXYD2		ENSG00000255245	"FXYD6-FXYD2 readthrough"		11	117820163-117876667	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"kidney: 4.5;salivary gland: 4.5"	"Cell type enriched"	"Detected in some"	6	"Distal tubular cells: 97.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"MOLT-4: 6.5;RPTEC TERT1: 7.3"									"HPA068838, HPA075209"	Approved		Approved	"Nuclear membrane,Vesicles"		NA	NA			"Nuclear membrane, Vesicles"		"HPA068838: AB_2686047, HPA075209: AB_2732285"																		0.2	0.2	0.2	0.0	0.3	0.0	0.2	0.4	0.5	0.4	0.1	0.6	0.1	1.0	0.9	0.1	0.6	0.9	0.5	0.3	0.3	4.5	0.2	0.4	0.0	0.3	0.2	0.2	1.3	1.9	0.0	0.3	0.2	0.2	0.3	0.0	0.0	4.5	0.1	0.2	0.1	0.4	0.3	0.2	0.9	0.3	0.3	0.2	0.4	0.3	0.2	0.1	0.4	0.2	0.3	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.5	0.0	0.4	0.0	0.0	0.0	0.2	0.0	7.3	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.4	0.5	0.3	0.3	0.3	0.2	0.2	0.2	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.6	0.0	11.0	0.0	0.0	0.0	0.0	97.8	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.3	2.5	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	15.8	0.0	0.0	6.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0
G0S2		ENSG00000123689	"G0/G1 switch 2"	P27469	1	209675412-209676390	"Metabolic proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 803.6;bone marrow: 1357.0;liver: 670.2"	"Cell type enriched"	"Detected in many"	4	"Langerhans cells: 5188.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	60	"neutrophil: 549.5"	"Lineage enriched"	"Detected in many"	213	"granulocytes: 549.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 460.8;HBEC3-KT: 726.2;PC-3: 180.6;RPMI-8226: 242.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.67e-3)"	"unprognostic (1.99e-3)"	"prognostic unfavorable (7.72e-4)"	"unprognostic (1.54e-2)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (3.82e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.04e-3)"	"unprognostic (3.03e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.32e-2)"	"unprognostic (8.12e-2)"	"prognostic unfavorable (3.14e-4)"	"unprognostic (7.57e-3)"	"unprognostic (1.53e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.64e-1)"	803.6	195.9	11.2	96.6	7.7	1357.0	523.8	8.1	45.7	7.7	8.7	19.3	7.6	34.6	11.8	8.7	27.0	15.8	158.0	17.6	9.6	184.4	670.2	321.3	7.7	11.2	7.6	6.5	47.8	31.2	0.8	9.5	13.9	10.3	38.7	4.0	0.7	60.3	14.9	657.5	22.7	31.9	11.0	9.9	49.7	64.3	30.3	9.3	5.9	23.9	306.1	5.4	137.5	17.4	14.9	0.0	4.3	0.0	0.0	460.8	16.1	0.3	0.7	1.4	1.9	1.8	19.3	14.8	0.0	4.1	3.4	2.5	0.0	0.0	726.2	4.4	0.7	1.2	0.0	1.5	0.6	37.5	0.2	0.1	47.8	1.6	32.4	0.0	15.8	0.0	0.0	0.2	0.0	0.2	0.0	0.2	15.7	1.3	0.0	180.6	0.0	0.0	242.8	1.7	0.3	0.9	1.4	16.3	0.0	4.0	0.0	0.2	56.7	73.6	0.0	4.9	0.2	0.1	0.0	1.1	0.1	13.1	0.1	0.0	0.0	1.0	9.1	0.0	1.1	0.4	0.1	2.5	0.1	0.3	0.3	0.0	0.0	549.5	0.0	0.2	0.0	0.0	0.4	11.2	7.7	8.1	45.7	17.6	9.6	11.2	7.6	6.5	10.3	9.9	9.3	14.9	52.3	9.6	59.5	5.9	16.1	232.4	654.8	760.7	124.1	0.6	295.2	43.3	359.1	14.3	111.6	11.0	0.0	1.8	5.0	16.6	299.3	52.3	25.3	42.7	12.0	264.5	29.3	6.9	0.9	148.2	3.6	730.2	11.7	112.0	39.1	34.7	12.1	179.4	174.2	0.0	3.1	32.6	22.4	78.2	5188.4	12.3	114.6	1060.3	327.3	2.8	30.7	23.1	1.0	11.1	0.9	736.5	42.9	71.5	10.3	416.7	41.1	304.9	42.3	0.3	32.9	56.4	60.1	52.1	1.1	35.2	161.4	4.2	33.3	7.5	52.5	513.7
GADD45G	"CR6, DDIT2, GADD45gamma, GRP17"	ENSG00000130222	"Growth arrest and DNA damage inducible gamma"	O95257	9	89605012-89606555	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Differentiation"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 369.0"	"Cell type enriched"	"Detected in many"	7	"Syncytiotrophoblasts: 1609.4"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 79.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"eosinophil: 4.9"	"Lineage enriched"	"Detected in single"	24	"granulocytes: 4.9"	"Group enriched"	"Detected in many"	4	"HDLM-2: 116.8;SCLC-21H: 58.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023606	Approved					NA	NA					"HPA023606: AB_1849409"	"unprognostic (5.84e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.08e-2)"	"prognostic favorable (7.06e-4)"	"unprognostic (4.45e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.77e-3)"	"unprognostic (3.75e-2)"	"unprognostic (7.65e-3)"	"unprognostic (4.16e-3)"	"prognostic favorable (3.80e-5)"	"unprognostic (1.11e-1)"	"unprognostic (1.63e-2)"	"unprognostic (4.95e-1)"	"unprognostic (3.88e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.22e-1)"	18.3	144.6	9.9	3.9	14.6	14.8	24.8	18.5	19.6	114.1	7.4	24.8	6.0	53.6	1.9	13.2	26.7	2.9	212.1	9.2	16.9	24.5	369.0	27.1	1.6	11.1	12.9	7.5	74.9	79.1	28.8	128.5	25.5	10.8	75.0	1.5	3.1	19.9	10.5	140.1	32.8	19.8	7.4	10.4	6.7	44.8	30.1	13.7	2.4	20.8	23.7	0.6	30.9	39.1	11.2	3.1	0.0	16.0	0.0	0.0	0.0	21.1	1.1	0.0	0.1	0.0	2.6	0.3	0.0	2.5	0.0	0.8	2.3	5.3	0.1	0.0	116.8	1.0	0.3	0.3	0.0	0.8	0.0	0.4	0.4	2.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	4.9	0.2	1.1	14.7	2.7	0.2	1.2	4.7	1.2	0.2	0.7	58.6	13.4	1.1	6.3	0.1	3.0	2.5	0.1	2.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	9.9	14.6	18.5	19.6	9.2	16.9	11.1	12.9	7.5	10.8	10.4	13.7	11.2	124.2	6.4	53.7	4.6	15.4	28.6	50.9	9.9	40.5	43.9	118.2	215.3	196.8	62.9	22.5	11.0	6.2	80.7	46.6	21.6	92.0	18.3	2.1	40.7	98.3	48.8	54.8	6.6	1.1	43.4	12.1	138.9	97.3	29.3	19.6	24.7	11.0	215.2	57.0	3.3	2.2	55.9	50.8	12.4	121.1	9.0	84.5	77.6	35.6	2.8	11.7	35.7	0.0	0.0	1.1	20.4	11.1	45.5	13.2	88.9	24.9	40.6	23.5	22.0	131.5	90.9	144.4	3.6	2.0	95.5	19.6	1609.4	57.5	165.8	20.0	12.4
GATB	"PET112, PET112L"	ENSG00000059691	"Glutamyl-tRNA amidotransferase subunit B"	O75879	4	151670504-151761007	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	Ligase	"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Muller glia cells: 333.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042610	Uncertain		Supported	Mitochondria		NA	NA			Mitochondria		"HPA042610: AB_10797502"	"unprognostic (2.52e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.01e-3)"	"unprognostic (5.08e-2)"	"unprognostic (2.31e-1)"	"unprognostic (6.91e-2)"	"unprognostic (2.24e-1)"	"unprognostic (5.77e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.76e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.17e-2)"	"prognostic favorable (1.20e-10)"	"unprognostic (1.91e-1)"	"unprognostic (8.39e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.46e-1)"	11.9	15.8	15.6	5.6	17.2	9.6	8.4	18.0	20.6	6.7	14.2	9.9	5.9	5.6	8.4	10.3	8.8	5.5	33.7	15.9	16.4	21.8	22.4	5.4	7.6	17.1	16.6	15.9	11.4	5.4	18.5	5.2	8.6	16.9	5.5	9.7	17.2	8.0	6.5	23.2	9.4	6.5	8.1	17.6	6.5	8.2	8.1	16.7	12.3	7.5	40.7	9.8	7.0	6.2	20.2	14.9	11.6	16.1	15.7	22.9	21.7	13.9	19.3	24.9	33.3	25.8	19.5	23.8	20.2	5.0	20.1	20.3	13.7	34.5	36.6	35.3	11.4	21.1	9.4	15.2	40.7	22.4	19.1	9.0	22.8	23.1	32.0	11.2	19.2	25.1	28.0	36.8	17.1	26.0	16.7	24.1	20.8	16.6	12.4	21.1	20.4	15.5	16.1	30.2	12.3	16.5	18.5	15.8	21.1	23.1	15.4	17.9	13.7	14.1	16.8	9.1	11.7	13.4	20.3	28.2	16.8	23.7	16.9	12.5	0.9	11.6	2.0	4.5	16.9	7.3	11.4	6.1	6.5	20.9	9.9	7.8	7.3	1.1	8.7	12.1	8.1	7.0	10.8	15.6	17.2	18.0	20.6	15.9	16.4	17.1	16.6	15.9	16.9	17.6	16.7	20.2	4.3	9.6	4.8	11.4	6.7	0.0	6.0	0.0	5.7	9.8	6.3	7.1	64.8	1.5	3.7	11.0	8.4	23.4	2.9	3.2	27.4	11.2	8.0	6.7	7.3	4.4	2.4	15.6	28.4	7.4	16.6	8.8	6.6	7.1	1.3	12.3	2.5	17.2	17.1	10.1	16.4	4.2	0.0	7.3	0.0	10.6	5.3	7.6	0.0	15.9	10.8	333.3	1.0	14.1	27.5	6.9	4.9	4.5	5.6	3.1	6.3	22.7	1.5	17.1	6.6	6.5	5.9	14.3	14.0	10.6	0.0	13.4	3.6	12.5	7.1	4.5
GCSAML	"C1orf150, FLJ44728"	ENSG00000169224	"Germinal center associated signaling and motility like"	Q5JQS6	1	247507058-247577690	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.2;prostate: 5.5"	"Cell type enriched"	"Detected in some"	24	"granulocytes: 223.3"	"Cancer enriched"	"Detected in single"	13	"prostate cancer: 1.9"	"Region enhanced"	"Detected in some"		"cerebellum: 5.2"	"Immune cell enriched"	"Detected in single"	661	"basophil: 227.7"	"Lineage enriched"	"Detected in single"	661	"granulocytes: 227.7"	"Group enriched"	"Detected in some"	71	"HEL: 151.8;HMC-1: 564.8"					"Low region specificity"	"Detected in all"			"HPA027507, HPA027510"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA027507: AB_10600756, HPA027510: AB_2672309"	"unprognostic (5.68e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.07e-3)"	"unprognostic (3.48e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.76e-4)"	"unprognostic (3.21e-1)"	"unprognostic (6.14e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.51e-3)"	"unprognostic (3.13e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.40e-2)"	0.4	0.2	0.4	0.8	0.4	1.8	1.1	5.2	0.7	0.7	0.4	1.2	1.5	0.8	0.5	1.1	0.3	1.4	0.2	0.3	0.4	0.1	0.2	2.2	0.3	0.4	0.8	0.4	0.1	0.4	0.1	0.0	0.3	3.5	5.5	1.5	1.2	0.3	0.4	0.2	0.7	1.4	0.6	0.1	0.4	1.0	3.4	0.4	0.7	0.3	0.7	0.3	0.7	0.3	1.2	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.8	0.8	0.2	0.1	0.0	0.1	151.8	0.2	0.0	0.0	0.3	564.8	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	1.0	0.1	0.3	0.3	5.0	0.2	0.1	0.0	0.2	0.1	0.3	0.0	0.1	0.1	0.4	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.5	0.4	0.0	0.0	0.3	0.2	0.0	2.3	0.1	0.4	227.7	0.1	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.1	0.3	0.3	0.2	0.2	0.2	0.2	0.1	0.2	0.5	0.4	0.4	5.2	0.7	0.3	0.4	0.4	0.8	0.4	3.5	0.1	0.4	1.2	0.0	0.0	4.4	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	1.9	0.0	9.1	0.0	0.1	0.6	0.0	5.0	0.4	0.0	0.0	0.3	0.0	0.0	223.3	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.7	7.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.3	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	8.3	1.7	0.0	0.6	0.0	1.4	0.1	0.0	0.2
GDF3		ENSG00000184344	"Growth differentiation factor 3"	Q9NR23	12	7689784-7695775	"Disease related genes, Human disease related genes, Predicted secreted proteins"		"Cytokine, Developmental protein, Growth factor"	"Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"kidney: 1.0"	"Cell type enriched"	"Detected in some"	25	"Granulosa cells: 30.2"	"Cancer enriched"	"Detected in some"	422	"testis cancer: 383.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"NTERA-2: 452.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA018468	Uncertain				"Secreted to blood"	NA	NA					"HPA018468: AB_1849586"	"unprognostic (9.48e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.51e-1)"	"unprognostic (5.40e-2)"		"unprognostic (3.09e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.25e-3)"	"unprognostic (8.00e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.03e-1)"	0.3	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	1.0	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	36.8	0.0	0.0	0.0	0.6	2.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.2	0.0	0.0	0.0	0.1	0.0	452.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	77.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	30.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GDPD3	MGC4171	ENSG00000102886	"Glycerophosphodiester phosphodiesterase domain containing 3"	Q7L5L3	16	30104810-30113537	"Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 46.0"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 447.4"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 21.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 2.4"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 2.4"	"Cell line enhanced"	"Detected in many"		"Hep G2: 32.1;MCF7: 50.6;OE19: 53.3;SK-BR-3: 165.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA041148, HPA041470"	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	NA			Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA041148: AB_10794545, HPA041470: AB_10795121"	"unprognostic (4.12e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.53e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.53e-1)"	"unprognostic (8.86e-3)"	"unprognostic (6.59e-3)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (5.89e-9)"	"unprognostic (3.11e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.79e-3)"	6.5	2.4	6.4	6.1	6.4	1.8	5.4	7.0	11.5	13.5	6.4	26.1	8.5	5.4	9.4	46.0	5.8	2.5	4.7	6.2	6.4	18.1	2.1	6.5	4.3	7.7	6.3	6.1	6.8	2.2	0.4	4.8	11.5	8.2	5.7	17.3	6.6	9.1	2.2	2.1	10.2	10.2	5.3	6.5	9.1	18.9	1.8	6.4	4.2	4.8	0.9	21.1	5.5	19.3	7.1	21.8	0.3	5.2	1.5	1.6	5.5	5.5	0.6	1.3	1.8	1.7	1.0	15.2	0.6	2.9	1.5	0.6	1.8	1.6	0.5	1.8	2.5	4.0	0.2	1.0	32.1	1.0	0.7	1.3	0.2	1.6	4.5	0.3	4.1	5.1	4.2	1.0	2.3	2.2	50.6	1.5	2.0	2.6	53.3	0.6	6.3	1.4	7.1	2.6	7.4	1.1	2.2	0.2	165.0	0.5	1.6	3.0	2.7	2.7	0.9	1.1	1.9	1.8	2.7	0.9	1.5	4.2	2.7	0.7	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.1	0.0	6.4	6.4	7.0	11.5	6.2	6.4	7.7	6.3	6.1	8.2	6.5	6.4	7.1	5.9	6.4	1.1	1.6	1.0	1.3	0.9	4.4	1.2	1.6	4.1	3.0	1.5	0.0	22.2	5.5	0.0	24.2	1.2	98.2	5.9	0.9	67.8	2.6	3.8	4.3	3.5	0.0	0.6	1.3	71.9	2.1	30.1	4.1	0.0	2.0	3.9	0.3	3.1	1.7	0.8	34.2	6.1	1.9	1.0	447.4	3.4	1.4	1.8	1.9	1.2	0.6	0.0	1.5	1.2	19.2	36.7	3.0	0.1	1.1	46.0	100.6	9.0	1.7	6.6	0.6	2.7	1.4	1.3	5.1	2.0	9.3	1.9	1.3	13.9	4.8
GJA10	CX62	ENSG00000135355	"Gap junction protein alpha 10"	Q969M2	6	89894469-89921760	"Predicted membrane proteins"				"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	92	"Horizontal cells: 18.5"	"Cancer enriched"	"Detected in single"	7	"testis cancer: 1.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA021145	Uncertain					NA	NA					"HPA021145: AB_2670600"															"unprognostic (1.09e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GJA3	"CX46, CZP3"	ENSG00000121743	"Gap junction protein alpha 3"	Q9Y6H8	13	20138255-20161052	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 7.8;parathyroid gland: 4.1;placenta: 2.5"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 13.6"	"Group enriched"	"Detected in some"	4	"head and neck cancer: 1.3;melanoma: 3.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 4.4;CAPAN-2: 7.7;HL-60: 6.6;U-266/84: 4.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA014821	Supported					NA	NA					"HPA014821: AB_2669097"	"unprognostic (2.32e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.58e-3)"	"unprognostic (2.98e-2)"	"unprognostic (1.04e-2)"	"unprognostic (6.87e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.52e-2)"	"unprognostic (7.70e-2)"	"unprognostic (4.02e-2)"	"unprognostic (9.65e-8)"	"unprognostic (2.87e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.55e-2)"	"unprognostic (8.04e-3)"	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	7.8	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	4.1	0.0	2.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.1	0.0	1.1	0.0	0.2	0.1	4.4	0.2	0.0	3.7	0.1	1.1	0.0	0.5	3.5	0.6	0.7	0.4	7.7	0.0	0.1	1.3	1.2	0.1	2.5	2.1	0.5	0.2	1.9	1.8	0.0	0.0	0.0	6.6	0.0	0.2	1.2	0.1	0.3	0.0	0.0	2.8	0.5	0.0	0.1	0.0	0.0	0.0	0.5	0.1	1.5	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	3.7	0.1	0.8	1.4	0.0	0.0	0.0	1.5	0.2	1.7	4.7	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	1.2	0.0	0.0	0.0	13.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	2.7	0.3	0.0	0.0	0.1	0.0	0.0	0.1
GLI3	"ACLS, GCPS, PAP-A, PAPA, PAPA1, PAPB, PHS, PPDIV"	ENSG00000106571	"GLI family zinc finger 3"	P10071	7	41960949-42264100	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	8	"Astrocytes: 301.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 47.1;WM-115: 34.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005534	Approved		Supported	Nucleoplasm,Nucleoli,Vesicles		NA	NA			Nucleoplasm	"Nucleoli, Vesicles"	"HPA005534: AB_1078973"	"unprognostic (2.53e-1)"	"unprognostic (2.41e-2)"	"unprognostic (7.58e-2)"	"unprognostic (8.22e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.35e-3)"	"unprognostic (2.24e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.03e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.48e-5)"	"unprognostic (9.13e-3)"	"unprognostic (5.41e-2)"	"unprognostic (3.21e-3)"	"unprognostic (7.00e-2)"	6.0	1.9	9.4	3.7	8.9	0.1	9.0	1.4	5.6	6.8	0.0	8.5	1.3	11.9	2.8	3.8	8.3	3.9	1.6	6.6	5.4	1.7	0.3	3.4	1.0	3.3	9.0	2.6	13.3	0.7	0.5	1.1	12.0	7.0	5.6	2.9	1.8	2.8	8.3	1.1	8.3	3.4	10.8	0.3	1.1	2.6	1.7	13.8	3.0	4.7	2.3	1.7	4.9	7.4	2.4	0.0	0.0	47.1	0.4	16.9	23.6	3.5	3.1	9.0	9.3	12.8	0.0	0.0	0.0	1.7	22.1	22.7	10.1	8.7	8.9	10.8	0.0	7.0	0.0	6.0	0.0	9.0	0.0	0.1	21.0	12.9	10.6	6.8	5.7	10.6	5.4	0.0	0.2	5.6	5.6	0.4	0.0	20.9	0.0	21.2	12.4	0.1	1.4	0.2	6.4	1.5	0.0	6.3	7.0	4.1	23.8	8.0	0.1	11.3	13.6	18.8	16.0	6.0	0.1	0.0	0.0	7.3	0.2	34.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	8.9	1.4	5.6	6.6	5.4	3.3	9.0	2.6	7.0	0.3	13.8	2.4	2.9	0.0	7.7	301.3	0.2	23.5	7.2	8.5	31.9	1.6	20.5	27.1	1.8	0.0	2.3	1.8	0.0	21.1	0.5	0.0	0.0	0.0	16.6	2.4	12.6	3.4	0.0	0.0	0.8	0.0	13.6	25.9	0.0	4.6	1.3	10.5	3.9	0.0	3.3	0.0	3.6	0.1	6.1	0.3	6.3	5.4	19.3	0.4	8.8	22.5	0.0	13.6	0.0	8.5	0.7	0.1	0.0	3.4	1.2	6.6	0.0	3.8	1.5	1.1	13.1	17.0	12.1	0.3	2.2	7.9	15.5	34.2	0.7	5.2	0.1	5.0
GLIS3	"MGC33662, ZNF515"	ENSG00000107249	"GLIS family zinc finger 3"	Q8NEA6	9	3824127-4348392	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Congenital hypothyroidism, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.8"	"Cell type enriched"	"Detected in many"	7	"Astrocytes: 649.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 21.5;HSkMC: 29.5;RPTEC TERT1: 20.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA056426	Approved		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA056426: AB_2683128"	"unprognostic (6.24e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.63e-3)"	"unprognostic (4.10e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.81e-2)"	"unprognostic (7.14e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.91e-3)"	"unprognostic (6.88e-3)"	"unprognostic (8.54e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.35e-2)"	3.6	1.6	8.1	2.1	5.2	0.2	1.9	7.9	5.3	7.9	16.8	1.9	0.7	3.4	2.8	0.5	8.8	6.6	2.3	5.2	21.9	7.2	3.3	3.8	1.1	24.8	12.7	2.3	6.6	9.7	2.4	2.4	1.4	9.7	3.3	2.1	1.3	3.1	8.3	1.3	0.7	1.5	2.2	14.8	2.0	1.9	2.8	7.5	0.2	18.8	0.8	0.7	4.0	2.5	14.3	1.0	8.5	2.5	0.0	3.7	9.5	0.4	5.9	21.5	3.1	4.4	1.3	3.4	0.0	4.3	5.5	9.6	0.0	2.0	0.0	6.7	2.5	1.2	0.0	0.4	0.0	11.0	0.9	0.0	29.5	0.0	9.8	1.1	5.8	0.4	0.1	0.0	0.2	2.9	0.4	0.0	1.5	0.2	0.0	0.8	0.0	5.2	0.0	20.8	0.0	0.0	0.0	0.8	0.0	0.0	1.1	0.0	0.0	5.5	3.4	0.9	3.2	13.3	0.0	0.0	0.0	8.1	0.0	3.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	8.1	5.2	7.9	5.3	5.2	21.9	24.8	12.7	2.3	9.7	14.8	7.5	14.3	8.1	9.6	24.0	649.7	1.0	1.9	9.3	17.1	0.6	1.0	4.6	1.3	1.6	75.8	34.5	69.9	0.0	3.2	0.3	3.7	0.0	51.0	5.2	79.6	17.5	11.2	43.7	0.0	18.3	22.6	3.2	21.9	4.1	82.3	1.3	1.6	6.8	8.3	2.4	0.0	54.2	1.6	12.2	0.8	4.0	2.4	13.7	3.4	3.6	86.2	2.2	15.6	0.0	26.7	4.1	49.1	3.9	11.3	0.0	16.5	2.4	16.4	35.7	0.4	0.0	34.4	19.0	1.3	7.4	0.6	1.3	4.2	1.2	8.8	6.6	6.1
GLRA2	GLR	ENSG00000101958	"Glycine receptor alpha 2"	P23416	X	14529298-14731812	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 18.4;intestine: 3.8;retina: 5.0"	"Cell type enriched"	"Detected in some"	5	"Inhibitory neurons: 74.3"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 0.6;glioma: 0.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	34	"AN3-CA: 17.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB070422	Approved					NA	NA					"CAB070422: AB_11153055"	"unprognostic (2.52e-1)"	"unprognostic (3.13e-1)"	"unprognostic (5.52e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.74e-2)"			"unprognostic (1.81e-2)"	"unprognostic (3.39e-1)"	"unprognostic (5.82e-2)"	"unprognostic (7.95e-3)"		"unprognostic (1.13e-1)"	"unprognostic (2.76e-1)"	"unprognostic (6.69e-2)"			0.0	0.0	4.7	0.1	3.3	0.1	0.0	8.3	3.1	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.1	0.1	0.0	3.9	18.4	0.0	0.0	0.0	0.0	4.8	12.6	4.3	0.1	0.0	0.0	0.3	0.1	9.0	0.0	3.8	5.0	0.1	0.0	0.0	0.1	0.1	0.1	3.4	0.0	0.0	0.2	13.4	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.1	17.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	3.3	8.3	3.1	3.9	18.4	4.8	12.6	4.3	9.0	3.4	13.4	4.8	0.0	0.0	0.0	0.7	0.1	0.1	0.0	0.0	0.0	2.6	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.4	0.0	7.6	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.0	8.7	0.0	0.0	0.1	0.0	0.1	0.0	1.9	0.0	0.0	0.0	1.7	74.3	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.0	1.0	0.0	0.3	0.0	2.0	12.4	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.2	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.5	1.1	0.0
GNA13	"G13, MGC46138"	ENSG00000120063	"G protein subunit alpha 13"	Q14344	17	65009289-65056740	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Transducer	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 145.9"	"Cell type enriched"	"Detected in all"	4	"Langerhans cells: 537.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010087	Approved		Supported	Cytosol		NA	NA		320000	Cytosol		"HPA010087: AB_10601478"	"unprognostic (2.55e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.23e-3)"	"unprognostic (8.21e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.77e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.59e-1)"	23.9	22.7	21.3	41.9	24.2	145.9	16.0	26.8	22.7	17.8	23.5	27.9	21.2	18.0	10.6	18.3	16.1	26.7	12.5	20.2	36.7	17.8	27.3	27.3	47.2	28.1	21.5	14.4	22.8	15.4	15.9	8.3	39.6	28.9	15.3	26.5	17.3	10.5	16.3	37.1	12.0	23.5	23.1	28.5	33.8	18.2	15.6	25.1	50.4	18.0	39.0	45.0	30.7	12.4	36.5	33.3	36.9	32.6	21.6	31.8	29.5	32.2	25.3	28.7	35.0	39.7	20.7	23.0	130.0	16.1	26.6	42.0	22.5	35.0	29.4	51.5	35.4	19.5	69.0	20.7	38.7	45.7	54.2	45.5	23.9	43.8	32.2	42.0	29.1	48.6	33.6	29.7	82.3	36.9	29.3	88.9	18.8	19.4	30.2	25.7	49.0	64.8	47.2	32.0	53.3	24.5	48.8	19.7	34.8	43.8	62.1	40.7	50.0	37.9	58.4	48.8	25.0	33.2	57.3	79.4	151.4	20.1	32.2	30.4	7.3	6.0	7.6	5.6	12.5	5.7	4.5	6.8	6.8	5.2	4.0	3.9	4.4	13.8	6.8	8.5	2.1	9.7	4.0	21.3	24.2	26.8	22.7	20.2	36.7	28.1	21.5	14.4	28.9	28.5	25.1	36.5	34.5	12.8	13.0	68.9	80.9	67.8	27.8	13.1	42.1	5.3	21.0	13.0	11.7	18.6	10.1	9.2	4.2	16.6	60.5	82.2	7.9	11.8	4.5	25.3	23.6	35.4	16.8	21.2	20.7	11.6	15.1	24.3	23.9	49.9	30.4	21.9	32.5	13.8	57.4	6.7	27.3	11.6	12.2	57.9	537.6	8.0	11.5	123.8	69.4	44.0	44.1	34.4	29.9	29.1	36.7	13.4	30.7	24.0	45.9	28.3	23.5	16.4	13.8	6.1	32.9	19.2	19.9	6.7	13.6	33.7	65.9	14.0	66.5	15.4	13.7	36.2
GOLGA6L10	GOLGA6L18	ENSG00000278662	"Golgin A6 family like 10"	A6NI86	15	82339993-82349475	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"testis: 16.8"	"Cell type enriched"	"Detected in many"	5	"Early spermatids: 175.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 3.3;K-562: 1.1;SuSa: 1.2"															NA	NA						"unprognostic (8.06e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.51e-1)"	"unprognostic (8.31e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.43e-1)"	"unprognostic (7.37e-2)"	"unprognostic (6.12e-2)"	"unprognostic (7.01e-2)"	"unprognostic (4.10e-1)"	"unprognostic (2.36e-4)"	"unprognostic (8.30e-2)"	"unprognostic (6.06e-6)"	"unprognostic (4.13e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.16e-1)"	"unprognostic (5.34e-2)"	1.3	1.9	0.4	0.1	0.4	0.3	1.5	0.3	0.4	3.3	1.1	2.1	0.1	2.1	0.1	6.3	3.3	0.3	1.5	0.3	0.3	1.5	1.3	1.6	0.1	0.3	0.2	0.3	3.6	3.0	0.2	2.1	0.1	0.4	2.2	0.1	0.6	4.7	0.1	1.8	2.3	1.6	0.2	0.2	1.4	2.8	16.8	0.2	0.1	2.0	0.2	0.1	2.6	5.5	0.3	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.4	0.2	0.1	0.3	0.6	0.1	0.0	0.0	0.0	3.3	0.0	0.7	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.5	1.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.3	0.7	0.1	0.2	0.0	1.0	1.2	0.2	0.1	0.0	0.4	0.1	0.1	0.0	1.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.3	0.4	0.3	0.3	0.3	0.2	0.3	0.4	0.2	0.2	0.3	1.4	6.4	5.5	2.3	0.9	0.0	4.4	0.0	1.2	6.1	2.2	2.0	2.2	2.8	3.1	5.5	4.2	2.6	2.3	1.0	0.0	2.8	175.7	11.2	3.0	1.1	4.9	0.0	1.9	2.9	0.6	2.6	5.1	6.0	1.3	6.7	2.5	2.0	0.8	3.3	1.5	2.4	0.0	0.3	0.0	26.5	3.7	0.8	0.0	1.0	0.1	4.5	1.0	2.0	0.4	4.8	3.3	1.5	0.7	2.9	2.5	0.5	2.2	7.5	0.0	1.6	1.2	34.0	12.4	3.1	0.0	0.3	0.7	4.6	3.5	3.3
GOLGA6L4		ENSG00000184206	"Golgin A6 family like 4"	A6NEF3	15	84235773-84245368	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	5	"Early spermatids: 118.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"basophil: 1.1;NK-cell: 2.3"	"Group enriched"	"Detected in many"	7	"granulocytes: 1.1;NK-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"HEK 293: 4.3;U-266/70: 5.7"															NA	NA						"unprognostic (7.35e-3)"	"unprognostic (6.23e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.74e-1)"	"unprognostic (3.53e-1)"	"unprognostic (6.83e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.23e-2)"	"unprognostic (6.23e-2)"	"unprognostic (1.72e-3)"	"unprognostic (4.70e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.44e-1)"	5.9	7.1	1.7	1.3	1.8	2.2	6.3	1.3	2.8	8.7	2.1	5.0	0.8	5.9	3.6	4.2	5.5	1.7	4.3	1.9	1.8	4.8	4.9	4.7	1.3	1.8	1.6	1.8	15.2	6.3	0.9	4.9	1.3	1.7	5.9	1.9	3.1	4.5	1.3	2.9	4.4	4.0	1.8	1.5	3.3	4.3	10.3	1.7	0.7	6.4	1.1	0.7	5.6	7.7	2.0	0.2	0.1	1.4	1.6	1.7	1.6	0.1	1.3	0.5	0.0	0.4	0.0	0.3	1.1	1.3	1.1	0.5	0.3	1.1	0.4	0.3	0.7	4.3	0.7	1.4	1.1	0.4	1.5	2.1	0.6	0.7	0.2	0.4	2.1	2.1	1.7	2.6	1.8	0.8	1.0	0.1	1.3	0.6	0.0	0.5	0.3	0.3	1.0	1.3	1.4	0.6	1.1	0.8	0.6	0.9	2.9	0.6	1.0	1.6	0.4	1.0	1.2	1.3	5.7	1.8	0.5	0.6	0.7	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.2	0.0	0.1	0.0	2.3	0.0	0.2	0.0	0.0	1.7	1.8	1.3	2.8	1.9	1.8	1.8	1.6	1.8	1.7	1.5	1.7	2.0	5.0	0.0	2.0	0.0	0.9	3.6	1.6	2.1	1.2	7.8	2.1	2.8	1.2	1.5	3.8	1.8	12.5	1.1	1.7	0.6	0.0	4.3	118.3	2.8	6.6	5.0	1.2	0.8	0.2	4.4	0.1	5.9	5.6	4.9	5.1	8.3	4.6	3.9	1.8	0.0	0.1	0.4	0.0	1.6	7.7	17.1	6.8	2.2	7.2	0.0	0.7	3.0	2.1	0.0	0.0	11.2	2.7	5.7	1.7	1.5	0.4	0.6	2.3	8.7	13.1	6.0	5.9	22.8	4.7	2.7	4.5	0.8	3.4	10.9	1.2	0.7
GOLGA8N		ENSG00000232653	"Golgin A8 family member N"	F8WBI6	15	32593456-32607310	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Early spermatids: 92.7"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 0.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"gdT-cell: 1.1;NK-cell: 2.3"	"Group enriched"	"Detected in many"	7	"NK-cells: 2.3;T-cells: 1.1"	"Group enriched"	"Detected in some"	4	"HEL: 61.6;THP-1: 38.1;U-937: 33.2"															NA	NA						"unprognostic (2.12e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.55e-3)"	"unprognostic (5.11e-3)"	"unprognostic (1.78e-2)"	"unprognostic (5.67e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.93e-1)"	"unprognostic (8.26e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.16e-1)"	10.5	6.7	1.9	1.9	2.7	6.4	9.8	1.9	3.4	12.8	3.2	8.9	1.2	10.3	5.0	6.0	12.7	0.7	10.9	1.6	2.0	8.0	12.1	8.6	1.9	3.3	3.1	1.0	19.5	31.6	3.1	23.1	0.5	3.4	8.8	0.5	2.4	8.0	2.4	6.8	7.0	8.6	1.3	1.6	9.7	8.3	16.3	2.2	0.9	34.5	1.9	1.2	10.1	10.3	3.0	0.0	0.0	0.1	0.5	2.2	3.0	0.1	1.0	0.5	0.2	0.3	0.0	0.8	0.8	0.3	0.7	0.2	0.0	0.4	0.1	0.4	0.1	0.5	61.6	0.0	0.0	0.6	1.0	0.1	0.9	1.2	0.0	0.8	3.1	0.0	0.0	0.2	0.0	0.3	1.0	0.0	10.9	0.1	0.1	0.0	0.1	1.5	0.0	0.1	0.1	0.0	0.3	0.6	0.1	0.0	0.0	0.0	38.1	1.5	1.2	0.2	0.0	0.0	3.1	3.2	0.5	0.3	33.2	0.4	0.0	0.0	0.0	1.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.2	0.0	2.3	0.0	0.2	0.0	0.1	1.9	2.7	1.9	3.4	1.6	2.0	3.3	3.1	1.0	3.4	1.6	2.2	3.0	7.4	19.2	18.6	6.2	1.6	0.0	0.4	0.0	0.0	1.8	0.9	1.4	10.9	1.5	6.2	1.8	0.0	0.2	8.3	1.3	0.0	0.4	92.7	15.9	3.7	3.6	3.5	4.2	2.9	2.0	0.0	4.9	3.6	6.5	6.3	3.3	2.2	5.3	0.6	13.5	3.3	1.1	0.0	1.3	0.0	10.1	5.6	6.2	0.0	1.9	3.2	1.8	15.5	4.5	5.4	0.6	0.8	2.2	2.5	0.3	1.4	0.8	6.6	1.9	0.0	3.4	5.6	11.5	0.9	2.0	0.0	0.1	5.4	1.4	1.3	0.2
GP9	"CD42a, GPIX"	ENSG00000169704	"Glycoprotein IX platelet"	P14770	3	129060779-129062406	"CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins"	"Blood coagulation, Cell adhesion, Hemostasis"		"Bernard Soulier syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.2;lung: 3.3;lymphoid tissue: 9.0"	"Cell type enriched"	"Detected in some"	8	"Macrophages: 151.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"basophil: 29.5;neutrophil: 13.9"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 29.5"	"Cell line enriched"	"Detected in some"	14	"HEL: 85.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA063182	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		2600000	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA063182: AB_2684956"			"unprognostic (1.70e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.10e-1)"			"unprognostic (3.80e-2)"		"unprognostic (2.50e-2)"		"unprognostic (3.24e-1)"	"unprognostic (2.53e-2)"	"unprognostic (8.47e-2)"		"unprognostic (8.70e-2)"		0.1	0.0	0.1	0.0	0.0	5.2	0.1	0.0	0.3	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.3	3.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.0	0.1	1.8	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	85.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.5	1.2	0.2	0.2	0.7	0.3	0.0	0.0	0.3	0.6	0.1	0.1	0.0	13.9	0.0	0.2	3.0	0.0	51.9	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.1	0.0	0.0	14.4	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	2.9	0.1	1.7	0.0	0.0	0.6	0.0	1.3	0.0	18.3	0.0	151.9	0.0	0.0	4.1	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.4	0.7	0.3	0.0
GPC5		ENSG00000179399	"Glypican 5"	P78333	13	91398621-92873682	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 21.6;kidney: 7.4;testis: 6.1"	"Cell type enriched"	"Detected in some"	20	"Astrocytes: 3868.1"	"Cancer enhanced"	"Detected in some"		"glioma: 2.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"CACO-2: 49.9;HeLa: 27.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040152, HPA044081"	Enhanced		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			Nucleoplasm	Cytosol	"HPA040152: AB_2676863, HPA044081: AB_2678801"	"unprognostic (4.99e-3)"	"unprognostic (2.20e-2)"	"unprognostic (1.00e-1)"	"unprognostic (9.93e-5)"	"prognostic unfavorable (4.37e-4)"	"unprognostic (4.46e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.80e-2)"	"unprognostic (9.49e-3)"	"unprognostic (3.52e-2)"	"unprognostic (1.21e-5)"	"unprognostic (2.19e-2)"	"unprognostic (1.82e-6)"	"unprognostic (3.03e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.69e-3)"	0.1	1.7	11.3	0.3	15.1	0.1	0.0	7.7	11.2	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.1	0.5	1.0	9.6	9.4	7.4	1.3	3.3	0.2	16.9	12.6	7.7	0.4	0.1	0.0	1.7	0.4	21.6	0.1	0.5	0.5	0.1	0.5	0.0	0.1	0.1	0.1	5.1	0.0	0.1	6.1	17.9	0.1	1.1	0.0	0.0	0.0	0.1	12.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.9	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.4	0.0	27.4	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.3	0.6	0.0	1.7	0.0	0.8	0.0	0.2	0.0	0.0	1.0	0.1	0.1	0.1	0.0	0.0	3.4	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.0	0.0	0.0	11.3	15.1	7.7	11.2	9.6	9.4	16.9	12.6	7.7	21.6	5.1	17.9	12.4	0.0	0.0	2.7	3868.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.3	0.0	0.0	0.1	0.0	0.1	64.6	0.0	1.6	0.0	0.0	0.1	0.0	0.0	116.6	0.0	0.0	0.4	0.0	0.1	0.0	7.9	0.0	0.0	0.1	0.0	190.6	0.1	0.0	0.0	0.4	1.0	0.3	0.1	0.0	118.0	0.6	0.0	0.0	127.2	20.9	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.7	0.8	0.3	0.1	0.0	0.0	0.1	0.1	0.5	0.0	0.1
GPIHBP1	"GPI-HBP1, LOC338328"	ENSG00000277494	"Glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1"	Q8IV16	8	143213218-143217170	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 91.5;brain: 55.8;breast: 54.9"	"Cell type enriched"	"Detected in some"	4	"Adipocytes: 356.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"Karpas-707: 3.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA066302	Enhanced				"Intracellular and membrane"	NA	NA					"HPA066302: AB_2685654"	"unprognostic (2.05e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.43e-3)"	"unprognostic (1.58e-1)"	"unprognostic (9.50e-2)"	"unprognostic (1.75e-3)"	"unprognostic (8.01e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.31e-2)"	"unprognostic (8.69e-2)"	"unprognostic (5.06e-3)"	"unprognostic (9.65e-3)"	"unprognostic (1.41e-1)"	"unprognostic (5.96e-2)"	"unprognostic (2.85e-3)"	91.5	4.9	16.3	0.4	25.0	0.1	54.9	24.6	23.3	7.8	11.1	4.7	0.6	11.5	0.2	3.5	11.8	6.6	23.8	15.8	21.3	7.9	1.6	27.6	2.5	47.4	24.2	13.0	6.7	1.8	1.1	3.4	6.6	33.7	3.9	0.5	0.1	4.2	1.7	30.5	7.1	3.8	2.4	24.8	19.4	4.1	2.1	25.3	1.9	5.5	29.9	1.0	10.6	8.0	55.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	25.0	24.6	23.3	15.8	21.3	47.4	24.2	13.0	33.7	24.8	25.3	55.8	356.5	0.0	3.2	0.0	0.5	1.5	0.1	0.0	1.2	0.0	1.0	0.6	4.3	0.0	0.6	0.0	0.0	0.0	1.3	0.0	1.9	0.0	0.1	0.0	0.0	77.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	1.3	0.0	35.7	0.4	0.0	0.0	0.1	0.0	0.0	0.8	2.1	0.6	1.5	0.4	0.0	8.4	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	5.4	3.0	0.0	0.7	0.2	1.1	0.0	0.4	1.1	0.0	0.2
GPR161	RE2	ENSG00000143147	"G protein-coupled receptor 161"	Q8N6U8	1	168079543-168137667	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 41.9;smooth muscle: 27.8"	"Cell type enriched"	"Detected in many"	8	"Horizontal cells: 158.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 44.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA015576, HPA072047"	Uncertain		Uncertain	Nucleoplasm,Nucleoli		Yes	No			Nucleoplasm	Nucleoli	"HPA015576: AB_1849283, HPA072047: AB_2686484"	"unprognostic (1.45e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.04e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.57e-6)"	"unprognostic (3.93e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.34e-2)"	3.5	1.1	3.5	5.4	2.7	0.2	2.7	3.2	3.7	6.3	1.6	6.3	1.5	41.9	3.6	9.9	10.8	5.7	2.7	3.7	2.1	1.3	0.4	4.2	1.0	3.6	8.9	2.2	7.3	11.8	5.5	1.7	2.2	3.2	9.6	3.2	2.1	1.8	11.9	1.0	2.1	3.3	27.8	2.6	2.0	3.0	1.7	4.2	2.0	1.7	2.0	1.3	4.6	5.4	2.7	11.7	7.1	28.0	18.1	6.6	11.7	0.0	11.1	11.9	9.2	9.7	44.9	1.8	0.0	6.0	16.6	17.2	33.9	6.9	10.7	5.3	4.4	8.8	4.2	5.8	0.1	2.8	1.2	2.8	4.2	6.9	7.9	12.7	21.3	18.7	3.6	3.9	0.1	14.2	1.0	1.3	0.2	11.5	19.4	11.0	3.4	12.1	0.0	4.9	3.1	5.7	24.6	12.0	0.4	32.2	10.6	6.3	1.4	25.4	18.9	9.7	25.6	12.7	0.0	0.0	0.0	5.0	0.0	4.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.5	2.7	3.2	3.7	3.7	2.1	3.6	8.9	2.2	3.2	2.6	4.2	2.7	5.8	3.2	1.1	13.7	0.1	2.2	5.7	2.5	5.2	2.2	2.2	4.2	3.6	0.0	1.4	0.0	0.0	0.5	0.0	2.8	0.0	4.1	0.4	1.3	19.4	9.1	0.0	0.0	10.8	8.0	0.4	12.3	1.1	1.8	0.0	15.3	8.9	0.1	0.8	158.2	10.9	1.5	0.0	2.5	6.3	0.9	7.5	2.0	1.8	3.7	1.1	3.2	0.0	9.5	0.4	2.6	2.4	17.0	0.0	10.9	0.0	0.1	1.1	2.1	19.7	8.8	15.1	0.3	3.3	2.7	1.4	0.4	1.0	0.7	2.5	2.7
GPR17		ENSG00000144230	"G protein-coupled receptor 17"	Q13304	2	127645864-127652639	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	58	"Oligodendrocyte precursor cells: 58.3"	"Cancer enriched"	"Detected in some"	32	"glioma: 16.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	19	"naive B-cell: 1.9"	"Lineage enriched"	"Detected in single"	19	"B-cells: 1.9"	"Cell line enhanced"	"Detected in some"		"HeLa: 3.1;REH: 4.4;TIME: 4.3;U-2 OS: 1.7;U-2197: 2.0;U-251 MG: 2.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029766	Enhanced	Supported	Approved	Vesicles		NA	NA			Vesicles		"HPA029766: AB_10612114"	"unprognostic (8.10e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.77e-5)"	"unprognostic (8.40e-3)"	"unprognostic (2.92e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.61e-3)"	"unprognostic (6.60e-2)"	"unprognostic (2.11e-3)"	"unprognostic (3.33e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.31e-1)"	8.5	1.2	9.6	3.4	6.9	0.1	7.9	5.8	9.8	3.4	5.0	17.3	1.5	14.9	1.4	2.4	5.4	2.1	16.6	7.1	6.2	3.0	2.6	9.3	1.1	10.0	8.5	5.2	1.8	2.2	0.0	0.7	1.2	10.6	5.5	0.1	0.1	2.0	0.0	7.6	3.4	6.0	0.0	7.6	7.6	5.9	0.9	8.1	0.1	3.8	0.2	0.0	8.9	5.0	7.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.1	0.3	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.1	0.5	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.1	4.4	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	1.2	0.1	0.0	4.3	0.0	1.7	2.0	2.6	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	6.9	5.8	9.8	7.1	6.2	10.0	8.5	5.2	10.6	7.6	8.1	7.8	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	58.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
GPR171	H963	ENSG00000174946	"G protein-coupled receptor 171"	O14626	3	151197832-151203216	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 21.5"	"Cell type enriched"	"Detected in some"	4	"T-cells: 107.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 110.3"	"Lineage enriched"	"Detected in many"	15	"T-cells: 110.3"	"Cell line enriched"	"Detected in some"	25	"U-266/70: 27.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA067323	Supported					NA	NA					"HPA067323: "	"unprognostic (6.82e-6)"	"unprognostic (4.90e-3)"	"unprognostic (7.10e-2)"	"unprognostic (6.85e-4)"	"unprognostic (2.80e-3)"	"unprognostic (1.04e-3)"	"unprognostic (4.19e-4)"	"unprognostic (6.09e-2)"	"unprognostic (4.93e-3)"	"unprognostic (1.01e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.72e-6)"	"unprognostic (1.31e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.02e-2)"	2.8	1.6	0.6	21.5	1.5	1.2	1.9	1.6	3.8	4.4	9.9	4.4	4.6	1.5	0.5	2.5	3.0	6.3	0.7	1.1	1.3	1.3	4.4	6.5	17.6	2.6	0.6	1.1	0.9	0.7	0.2	0.5	0.5	0.8	1.9	4.6	0.0	1.8	0.8	0.2	0.9	13.0	1.1	0.0	13.1	6.0	0.3	1.2	13.2	1.8	0.1	11.4	9.4	2.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.2	0.1	0.0	0.0	0.2	0.0	0.2	0.3	3.5	27.9	0.2	110.3	0.0	40.2	53.5	2.3	0.5	24.1	21.1	0.8	7.3	0.5	2.2	21.4	9.4	0.6	1.5	1.6	3.8	1.1	1.3	2.6	0.6	1.1	0.8	0.0	1.2	2.4	0.4	0.0	2.2	0.3	2.3	1.1	0.4	0.0	0.6	4.8	0.3	0.3	1.0	0.0	1.3	0.0	2.1	0.4	25.8	0.1	0.0	0.0	0.2	0.1	0.6	0.5	0.0	2.7	0.8	0.0	0.0	2.3	4.6	0.1	2.5	0.0	1.8	1.6	0.1	21.9	0.3	0.5	0.0	2.2	8.1	0.1	0.0	4.8	0.0	0.0	14.0	5.7	6.2	0.5	0.0	0.0	0.0	0.0	14.9	0.2	0.0	0.5	0.0	0.1	0.0	0.5	1.2	0.8	0.7	0.1	0.6	0.7	107.6	0.1	0.0	0.3
GPR20		ENSG00000204882	"G protein-coupled receptor 20"	Q99678	8	141356470-141367286	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	4	"Sertoli cells: 72.3"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	18	"intermediate monocyte: 2.6;non-classical monocyte: 4.3"	"Lineage enriched"	"Detected in single"	22	"monocytes: 4.3"	"Cell line enriched"	"Detected in single"	6	"EFO-21: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA071337			Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA071337: "	"unprognostic (4.47e-2)"	"unprognostic (2.64e-3)"	"unprognostic (5.18e-2)"	"unprognostic (2.00e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.01e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-2)"	"unprognostic (7.41e-2)"	"unprognostic (5.50e-2)"	"unprognostic (6.23e-2)"	"unprognostic (4.07e-1)"	0.8	0.2	0.0	0.2	0.0	0.0	0.6	0.0	0.4	1.7	0.1	1.3	0.4	1.9	0.7	0.6	1.5	0.7	1.0	0.0	0.0	0.3	0.2	1.5	0.0	0.0	0.1	0.0	1.2	0.2	0.1	0.2	1.2	0.1	0.9	0.3	0.0	0.2	0.8	0.3	0.4	2.1	1.8	0.0	0.2	1.7	0.1	0.0	0.0	0.5	0.4	0.0	0.7	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.1	0.1	0.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.3	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.9	0.0	0.2	1.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	72.3	0.3	16.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1
GPR78		ENSG00000155269	"G protein-coupled receptor 78"	Q96P69	4	8558725-8619761	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 1.4;placenta: 3.1"	"Cell type enriched"	"Detected in some"	4	"Extravillous trophoblasts: 5.2"	"Cancer enhanced"	"Detected in single"		"urothelial cancer: 1.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"BEWO: 25.8"									HPA013209	Uncertain					NA	NA					"HPA013209: AB_10601657"	"unprognostic (6.41e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.70e-2)"		"unprognostic (3.82e-4)"	"unprognostic (6.46e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.29e-1)"	"unprognostic (4.88e-15)"	"unprognostic (5.55e-3)"	"unprognostic (3.93e-2)"	"unprognostic (9.90e-3)"	"unprognostic (8.15e-2)"	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	4.9	0.0	0.0	0.0	0.0	0.0	25.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.8	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	5.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0
GPX3		ENSG00000211445	"Glutathione peroxidase 3"	P22352	5	151020438-151028992	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 11782.1"	"Cell type enriched"	"Detected in many"	4	"Proximal tubular cells: 20125.9"	"Cancer enhanced"	"Detected in all"		"renal cancer: 605.6;thyroid cancer: 856.0"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"neutrophil: 20.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 20.7"	"Cell line enriched"	"Detected in many"	12	"ASC diff: 7677.4"	"Region enhanced"	"Detected in all"		"hypothalamus: 239.5"	"Low region specificity"	"Detected in all"			CAB069456	Approved				"Secreted to blood"	NA	NA	5090000000	6200000000			"CAB069456: AB_1616682"	"unprognostic (4.03e-1)"	"unprognostic (7.35e-2)"	"unprognostic (5.05e-3)"	"unprognostic (9.01e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.75e-3)"	"unprognostic (2.70e-3)"	"unprognostic (8.17e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.95e-1)"	"prognostic unfavorable (1.65e-4)"	"unprognostic (2.14e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.26e-1)"	4266.6	447.5	63.5	76.1	66.1	8.0	3215.4	61.2	74.4	820.7	500.4	713.7	89.1	419.5	91.5	573.2	1047.5	137.6	1882.5	67.6	307.8	11782.1	994.4	2493.3	134.4	333.5	98.9	53.6	522.2	259.1	113.4	799.9	597.1	107.0	562.2	94.3	4241.6	485.3	141.3	854.8	569.4	726.7	61.6	68.9	560.1	646.5	81.0	120.1	27.0	3657.3	463.0	45.3	1206.7	899.3	74.9	2.2	10.0	8.5	2.7	7677.4	6.7	9.2	3.5	0.8	7.9	2.4	177.5	3.9	1.1	214.1	5.6	3.2	2.8	39.6	433.2	6.0	6.1	2.5	1.9	4.3	195.0	294.7	0.5	4.3	649.1	41.2	0.2	1.0	10.6	11.3	1.2	1.2	0.3	11.0	31.4	0.5	1.2	13.8	0.8	0.2	1.0	5.2	1.7	74.1	4.3	11.3	11.4	1.2	31.6	1.9	33.6	43.5	2.1	2.5	2.3	19.6	3.7	1.0	2.7	15.6	2.5	7.0	3.0	0.6	0.0	4.3	0.1	0.0	1.6	0.3	0.0	0.0	0.0	4.2	0.0	0.0	0.0	20.7	0.0	0.2	0.0	0.0	1.6	63.5	66.1	61.2	74.4	67.6	307.8	333.5	98.9	53.6	107.0	68.9	120.1	74.9	353.6	9.6	33.7	1.0	106.8	18.5	86.9	94.8	1.2	26.3	31.7	5.5	639.8	18.6	58.3	649.2	43.8	713.8	2.2	2.3	1772.6	5.5	2.9	48.1	71.1	144.6	45.6	24.0	4.0	48.2	1191.3	514.0	50.0	627.9	11.4	274.9	735.3	228.4	151.5	16.8	0.4	5.9	91.6	47.9	86.7	17.5	446.7	160.2	23.2	3.7	0.7	5019.8	0.0	0.0	0.3	9.9	13.8	41.0	2.2	141.8	0.5	20125.9	39.1	86.8	683.7	131.6	264.6	7.1	10.3	13.9	21.6	1767.7	68.3	1.0	1.3	34.3
GPX4	"MCSP, PHGPx"	ENSG00000167468	"Glutathione peroxidase 4"	P36969	19	1103926-1106791	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Developmental protein, Oxidoreductase, Peroxidase"	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Late spermatids: 18580.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008630, HPA047224, HPA058546"	Enhanced		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA		150000	"Nucleoplasm, Mitochondria"		"CAB008630: AB_1616685, HPA047224: AB_2679990, HPA058546: AB_2683749"	"unprognostic (8.42e-3)"	"prognostic favorable (7.18e-4)"	"unprognostic (8.14e-3)"	"prognostic favorable (1.84e-5)"	"unprognostic (1.00e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.53e-3)"	"unprognostic (8.49e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (7.72e-4)"	"unprognostic (1.29e-1)"	"prognostic favorable (8.61e-4)"	"unprognostic (1.61e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.67e-3)"	"unprognostic (2.96e-2)"	852.5	539.6	395.8	128.6	401.2	179.5	739.5	417.5	523.2	280.1	435.1	229.7	261.3	190.0	321.7	222.1	200.9	198.4	427.3	389.3	422.0	535.8	693.4	310.6	218.2	405.7	420.0	376.2	262.5	159.3	288.0	401.5	148.4	417.2	324.9	112.0	168.9	307.4	195.6	677.9	285.5	238.2	88.6	398.6	214.9	220.8	1414.5	410.8	160.1	293.9	403.2	184.1	321.7	247.3	406.7	258.1	286.8	405.8	863.0	1202.1	706.0	449.3	199.3	713.5	371.1	375.9	590.5	339.8	92.8	211.8	405.8	313.5	283.1	239.7	289.3	180.5	522.3	436.5	175.0	246.9	849.2	697.4	207.6	269.4	707.3	432.1	188.3	314.7	665.9	527.1	317.5	249.4	225.7	311.1	660.4	353.8	354.9	386.2	569.7	458.9	482.8	55.3	271.3	408.9	629.9	348.3	220.6	390.5	366.1	422.1	246.7	358.1	498.0	450.9	392.3	257.4	680.6	254.6	786.5	582.0	224.3	369.4	412.2	230.9	578.9	539.6	564.4	219.8	405.4	256.9	352.7	319.7	230.7	404.0	309.9	339.4	245.0	265.1	196.6	462.2	278.8	310.3	841.7	395.8	401.2	417.5	523.2	389.3	422.0	405.7	420.0	376.2	417.2	398.6	410.8	406.7	415.9	179.5	189.7	21.2	281.7	510.0	525.8	1188.1	512.2	332.2	845.1	868.2	264.6	316.0	600.6	472.6	98.0	562.5	231.3	479.1	1592.6	515.8	4209.7	546.8	326.3	268.7	397.1	215.0	24.5	368.7	1327.3	536.1	99.9	442.3	346.1	242.6	322.0	826.2	1184.1	208.6	33.1	328.7	671.4	583.1	1304.8	18580.2	384.9	735.2	677.7	21.5	1786.8	502.6	192.6	13.6	35.4	484.0	507.9	312.9	189.2	694.7	1861.9	3024.7	800.9	246.0	243.3	244.6	587.1	1310.8	202.4	357.7	467.0	978.1	281.0	186.7	336.4	662.6
GREM2	"CKTSF1B2, DAND3, FLJ21195, Prdc"	ENSG00000180875	"Gremlin 2, DAN family BMP antagonist"	Q9H772	1	240489573-240612155	"Disease related genes, Human disease related genes, Predicted secreted proteins"		"Cytokine, Developmental protein, Heparin-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 31.6;liver: 26.5"	"Cell type enriched"	"Detected in many"	9	"Syncytiotrophoblasts: 298.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"fHDF/TERT166: 32.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB009920	Approved				"Secreted to blood"	NA	NA		12000			"CAB009920: AB_2279266"	"unprognostic (2.01e-1)"	"unprognostic (2.49e-1)"	"unprognostic (7.41e-2)"	"unprognostic (7.58e-3)"	"unprognostic (2.82e-3)"	"unprognostic (1.34e-1)"	"unprognostic (8.18e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.31e-2)"	"unprognostic (6.40e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.07e-8)"	"unprognostic (1.22e-1)"	"unprognostic (2.36e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.38e-2)"	0.8	1.7	1.7	9.8	2.5	0.1	3.4	0.2	6.3	0.5	0.0	17.2	10.9	9.7	2.2	17.3	1.4	31.6	0.0	1.9	1.4	0.7	26.5	1.2	0.2	2.4	2.0	1.5	6.7	0.2	23.1	2.1	4.0	1.8	2.6	20.3	5.8	4.2	1.8	7.3	3.6	15.1	6.5	1.0	3.2	9.4	0.3	3.0	0.3	0.5	0.7	0.2	3.8	0.6	4.0	0.0	0.0	0.1	0.0	1.9	2.4	0.0	6.1	6.5	0.0	0.0	0.0	0.0	0.0	0.0	32.3	0.0	0.0	1.7	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.3	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	2.2	0.0	2.8	1.3	0.0	0.0	3.9	0.5	0.8	0.4	1.0	0.0	0.0	3.3	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.7	2.5	0.2	6.3	1.9	1.4	2.4	2.0	1.5	1.8	1.0	3.0	4.0	0.2	0.0	0.0	0.3	0.2	4.7	0.0	0.0	0.6	20.8	14.0	0.1	0.6	0.0	0.0	0.0	12.5	7.4	0.6	0.6	0.0	0.0	0.0	2.3	1.2	0.6	1.2	0.0	28.6	0.0	1.7	17.4	0.0	13.7	0.0	0.1	0.7	20.4	1.5	0.0	30.5	0.1	0.0	0.3	6.2	0.2	0.0	0.2	1.8	3.7	0.0	0.4	1.0	1.5	1.2	0.1	0.1	4.5	0.1	0.6	0.0	0.0	0.7	6.7	0.0	0.2	1.4	2.4	2.7	0.6	3.7	298.0	1.6	2.3	0.6	0.1
GRIN2C	"GluN2C, NMDAR2C"	ENSG00000161509	"Glutamate ionotropic receptor NMDA type subunit 2C"	Q14957	17	74842023-74861504	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 53.6;thyroid gland: 16.8"	"Cell type enriched"	"Detected in some"	6	"Astrocytes: 138.7"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 6.3;RPMI-8226: 2.3;SCLC-21H: 2.8"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	14	"cerebellum: 43.2"							NA	NA						"unprognostic (7.21e-3)"	"unprognostic (4.68e-2)"	"unprognostic (9.38e-3)"	"unprognostic (2.24e-5)"	"unprognostic (3.42e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.95e-2)"	"unprognostic (3.31e-3)"	"unprognostic (3.25e-1)"	"unprognostic (1.14e-3)"	"unprognostic (4.20e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.14e-1)"	0.6	2.4	24.4	0.2	23.5	0.6	0.2	53.6	27.2	0.4	7.8	0.5	0.2	0.2	0.2	0.2	0.2	0.2	9.7	21.5	15.2	0.1	0.2	0.1	0.1	29.0	20.6	17.5	0.3	0.2	0.1	0.7	1.8	34.4	0.2	0.1	3.3	10.6	0.2	0.4	0.2	0.4	0.2	12.3	0.2	0.3	3.8	24.6	0.0	16.8	0.2	0.0	0.3	0.3	25.0	0.0	0.2	0.2	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.8	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.2	0.1	0.2	0.2	0.0	0.4	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.1	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.2	0.5	2.3	0.0	0.1	2.8	0.2	1.2	0.1	0.4	0.4	0.4	0.0	0.1	0.2	1.1	0.2	0.1	0.6	0.0	0.1	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	24.4	23.5	53.6	27.2	21.5	15.2	29.0	20.6	17.5	34.4	12.3	24.6	25.0	0.5	0.0	0.0	138.7	0.0	0.1	0.1	0.0	0.0	6.9	0.2	0.0	16.6	1.5	0.2	1.8	0.0	0.2	0.7	0.0	0.0	0.1	1.1	0.7	0.4	0.4	0.0	0.0	0.4	0.2	0.2	0.9	0.0	3.4	0.0	21.5	0.7	0.1	12.5	1.7	1.3	0.4	0.0	0.6	0.3	6.5	0.0	0.5	1.8	11.2	0.1	20.7	2.1	4.5	0.5	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.1	2.4	0.0	0.9	2.8	5.8	3.4	0.0	0.0	0.7	0.6	8.5	0.1	0.1
GRIN3A	GluN3A	ENSG00000198785	"Glutamate ionotropic receptor NMDA type subunit 3A"	Q8TCU5	9	101569352-101738647	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.3"	"Cell type enriched"	"Detected in some"	5	"Inhibitory neurons: 220.7"	"Cancer enriched"	"Detected in single"	7	"prostate cancer: 3.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"SCLC-21H: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.29e-1)"	"unprognostic (7.10e-3)"	"unprognostic (3.01e-5)"	"unprognostic (3.39e-2)"	"unprognostic (6.32e-2)"	"unprognostic (7.06e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.56e-2)"	"unprognostic (7.34e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.87e-1)"	"unprognostic (9.41e-2)"	0.1	0.1	2.5	0.2	4.3	0.1	0.2	0.0	3.1	1.5	0.0	0.3	0.1	0.3	0.3	0.1	0.1	0.0	0.4	2.7	2.0	0.1	0.2	0.2	0.4	1.2	1.8	3.6	0.8	0.1	0.0	0.1	0.0	1.5	0.6	0.2	0.9	0.2	0.9	0.2	0.3	0.2	0.1	0.4	0.7	0.1	0.3	3.6	0.1	0.1	0.1	0.2	0.1	0.1	3.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	1.8	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.3	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	2.5	4.3	0.0	3.1	2.7	2.0	1.2	1.8	3.6	1.5	0.4	3.6	3.1	0.2	0.0	0.0	5.2	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	1.0	0.0	0.0	0.0	4.2	0.0	0.0	0.1	0.0	0.0	1.8	0.2	0.1	0.6	0.0	0.0	37.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	220.7	0.0	0.0	2.4	1.1	0.8	0.9	0.2	0.0	0.0	0.1	0.1	0.0	1.5	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	6.6	0.0	0.8	0.2	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0
GRIP1		ENSG00000155974	"Glutamate receptor interacting protein 1"	Q9Y3R0	12	66347431-67069162	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 16.5"	"Cell type enriched"	"Detected in many"	7	"Inhibitory neurons: 2829.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	5	"myeloid DC: 4.9"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 4.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 44.4;HaCaT: 48.7;REH: 30.7;RT4: 31.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038856	Uncertain					NA	NA					"HPA038856: AB_10673297"	"unprognostic (6.25e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.52e-2)"	"unprognostic (8.25e-2)"	"unprognostic (1.50e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.21e-3)"	"unprognostic (4.25e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.00e-2)"	"unprognostic (4.14e-1)"	"unprognostic (2.82e-3)"	"unprognostic (7.44e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.27e-4)"	"unprognostic (8.57e-3)"	0.3	4.4	4.1	2.7	6.6	0.5	3.0	0.0	14.4	1.2	0.0	2.5	1.1	3.6	4.8	7.4	4.3	1.6	2.7	4.6	7.9	3.4	0.3	0.8	0.7	0.6	4.7	4.5	1.2	2.0	16.5	3.3	8.3	1.2	4.6	1.7	4.8	6.1	9.4	1.0	9.9	1.9	2.9	0.0	2.6	0.8	6.2	2.9	0.7	5.1	0.6	1.3	2.6	2.0	3.2	11.1	10.1	17.7	2.1	0.0	0.0	44.4	3.2	0.0	5.4	2.5	0.3	3.3	1.4	4.2	0.0	9.5	48.7	4.9	3.3	2.4	0.0	12.0	0.0	0.1	0.3	0.0	1.2	0.1	0.0	8.0	0.0	0.8	8.3	0.0	8.0	0.0	0.1	0.0	4.0	0.4	0.4	16.1	1.4	3.6	30.7	0.1	0.6	5.6	31.0	10.8	1.4	14.8	7.1	1.4	11.3	8.7	1.8	0.0	0.0	12.7	0.1	9.0	1.5	0.3	1.0	12.0	0.7	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.9	0.1	0.1	0.2	0.0	1.0	0.0	0.3	0.0	0.1	4.1	6.6	0.0	14.4	4.6	7.9	0.6	4.7	4.5	1.2	0.0	2.9	3.2	0.1	0.0	1.1	74.7	0.1	13.3	2.3	2.9	2.2	5.5	4.1	2.4	3.4	1.5	1.7	7.3	0.0	7.8	0.7	0.3	0.0	2.2	38.5	8.1	2.2	0.4	1.8	0.0	390.2	1.5	4.3	1.1	0.0	13.7	0.0	2.3	0.0	0.0	1.0	47.1	2829.7	0.7	0.0	2.4	1.6	34.0	0.6	2.1	7.2	20.6	1.0	0.5	0.0	158.3	44.4	1.9	0.5	0.7	0.1	3.8	0.2	0.4	1.1	1.8	0.0	1.0	0.6	0.3	1.2	2.3	17.8	16.6	0.8	1.2	0.7	3.1
GRIP2	KIAA1719	ENSG00000144596	"Glutamate receptor interacting protein 2"	Q9C0E4	3	14489107-14556075	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 13.4;skeletal muscle: 36.1;tongue: 12.6"	"Cell type enriched"	"Detected in many"	4	"Inhibitory neurons: 89.0"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 3.1;BJ hTERT+ SV40 Large T+ RasG12V: 1.9;NTERA-2: 2.1;PC-3: 6.1;SCLC-21H: 3.4;U-2 OS: 2.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035673			Approved	Cytosol		NA	NA			Cytosol		"HPA035673: AB_10669776"	"unprognostic (1.48e-1)"	"unprognostic (6.26e-3)"	"unprognostic (2.43e-2)"	"unprognostic (3.13e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.87e-1)"	"unprognostic (8.19e-2)"	"unprognostic (9.14e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.90e-1)"	"unprognostic (5.82e-1)"	"unprognostic (4.01e-1)"	1.0	1.1	3.1	0.7	2.8	0.0	1.0	0.0	6.7	0.9	0.0	0.8	0.4	1.1	0.4	2.2	0.8	1.2	13.4	0.3	3.0	2.2	0.3	0.4	0.4	3.0	3.8	0.9	3.4	0.5	0.3	1.0	3.9	1.3	0.9	1.0	0.3	0.9	0.4	36.1	2.0	1.0	1.0	0.5	1.6	4.6	0.7	7.4	0.3	0.8	12.6	0.7	1.1	1.2	2.1	0.1	0.9	0.0	0.0	0.3	0.2	0.0	0.3	3.1	0.3	1.9	1.2	0.0	0.0	0.7	0.2	0.5	0.2	0.7	0.0	0.0	0.0	0.2	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.1	1.5	6.1	0.0	0.0	0.0	0.0	0.0	3.4	0.6	0.3	0.0	1.0	1.1	0.0	0.0	0.0	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	2.8	0.0	6.7	0.3	3.0	3.0	3.8	0.9	1.3	0.5	7.4	2.1	2.3	0.0	0.5	2.3	0.1	0.0	0.1	0.0	1.2	14.9	0.1	1.3	8.5	0.0	0.6	0.0	14.6	0.0	0.7	0.1	0.0	0.0	3.0	2.1	1.4	0.8	4.2	0.0	3.0	0.2	0.0	2.0	2.0	4.9	0.0	0.0	1.1	0.0	0.1	0.0	89.0	0.1	0.0	0.0	0.0	5.2	4.1	0.7	0.0	2.8	0.0	0.5	0.0	0.5	0.9	0.0	0.0	2.2	0.3	0.1	0.0	0.2	0.0	21.9	19.7	4.3	14.7	0.1	0.8	0.2	0.0	0.1	0.3	1.1	0.0	0.0
GSTA5		ENSG00000182793	"Glutathione S-transferase alpha 5"	Q7RTV2	6	52831655-52840843	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	10	"Smooth muscle cells: 23.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							"HPA004342, HPA048934, HPA053817"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367"							"unprognostic (1.97e-2)"			"unprognostic (2.83e-1)"								0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	2.2	0.4	0.0	0.0	0.0	23.6	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1
H2AC19	"H2A/r, HIST2H2AA4"	ENSG00000272196	"H2A clustered histone 19"	Q6FI13	1	149851061-149851624	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"Cardiomyocytes: 26.6"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"neutrophil: 1820.8"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 1820.8"	"Cell line enhanced"	"Detected in many"		"SiHa: 98.8;U-266/70: 270.8;U-266/84: 249.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA041189	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041189: AB_2677357"					"unprognostic (1.63e-1)"					"unprognostic (1.77e-1)"		"unprognostic (1.76e-1)"		"unprognostic (8.47e-2)"				40.5	28.0	41.6	10.2	33.1	21.1	40.5	56.9	31.6	101.1	39.2	36.2	10.9	10.1	0.0	67.3	45.6	6.9	29.0	29.0	49.8	52.3	58.8	141.7	3.8	53.1	29.4	17.5	53.7	13.8	3.0	27.5	4.8	32.2	157.6	1.0	6.2	41.5	0.0	30.5	81.2	32.2	0.0	45.0	125.6	64.9	110.8	41.6	9.7	29.3	2.6	1.4	47.8	125.3	114.2	14.9	41.0	4.2	9.4	0.0	0.0	12.9	31.6	0.0	0.0	0.0	26.4	13.9	0.0	36.4	0.0	10.0	23.0	0.0	0.0	0.0	20.4	53.9	5.4	35.5	15.5	0.0	5.2	27.4	0.0	0.0	0.0	0.0	9.7	0.0	18.7	32.9	61.2	0.0	85.0	18.5	5.6	15.7	75.7	31.8	14.3	6.4	20.1	0.0	5.9	37.8	16.1	98.8	21.2	9.1	5.3	38.5	8.9	0.0	6.9	71.4	14.1	4.5	270.8	249.5	20.8	0.0	26.9	11.6	314.7	206.9	388.5	34.8	121.2	35.8	72.9	30.4	32.6	135.6	93.1	22.8	21.6	1820.8	41.6	151.6	193.3	48.3	215.9	41.6	33.1	56.9	31.6	29.0	49.8	53.1	29.4	17.5	32.2	45.0	41.6	114.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.6	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.4	5.6	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0
H2BC4	"H2B.1, H2B/l, H2BFL, HIST1H2BC"	ENSG00000180596	"H2B clustered histone 4"	P62807	6	26114873-26123926	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"Syncytiotrophoblasts: 42.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	18	"neutrophil: 923.6"	"Lineage enriched"	"Detected in all"	26	"granulocytes: 923.6"	"Cell line enhanced"	"Detected in all"		"K-562: 39.8;SiHa: 75.8;U-2 OS: 51.9;U-266/70: 42.8;U-266/84: 57.1"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (8.30e-3)"	"unprognostic (2.60e-2)"	"unprognostic (2.37e-2)"	"unprognostic (9.26e-2)"	"unprognostic (3.20e-2)"	"unprognostic (5.08e-2)"	"unprognostic (4.72e-1)"	"unprognostic (6.45e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (9.01e-4)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (1.75e-5)"	"unprognostic (5.41e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.49e-1)"	"unprognostic (6.60e-3)"	3.3	3.4	10.4	6.1	18.3	25.2	6.8	11.2	11.2	6.2	9.4	3.1	3.3	1.2	3.6	14.8	7.1	4.7	3.7	8.8	20.5	5.4	13.2	8.1	2.9	17.1	10.0	6.2	2.6	2.6	0.9	5.9	7.3	14.9	22.0	2.3	1.5	7.5	0.9	14.6	5.2	3.0	1.2	22.0	5.2	7.1	6.4	16.6	15.0	3.6	8.1	2.3	3.5	10.3	28.0	7.0	4.0	2.1	2.0	1.9	1.1	2.6	6.8	2.5	4.5	3.7	5.6	4.1	2.7	12.5	2.3	3.3	5.2	2.8	2.8	2.2	6.3	2.3	2.2	6.1	9.6	2.6	3.4	8.4	27.3	1.7	1.9	1.1	2.2	1.8	2.1	39.8	21.1	8.6	8.0	7.5	7.2	2.2	7.4	12.4	3.3	3.0	16.3	7.8	1.7	9.4	3.0	75.8	5.8	2.6	5.5	31.8	3.1	5.6	5.5	51.9	3.4	2.8	42.8	57.1	13.2	2.3	8.6	3.8	52.5	9.3	49.9	9.2	10.5	12.4	19.1	13.3	13.0	6.6	35.1	10.3	7.7	923.6	10.5	10.4	22.0	9.3	19.2	10.4	18.3	11.2	11.2	8.8	20.5	17.1	10.0	6.2	14.9	22.0	16.6	28.0	1.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	5.2	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	7.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	42.8	0.4	0.0	0.0	0.0
H2BC9	"H2B/j, H2BFJ, HIST1H2BH"	ENSG00000275713	"H2B clustered histone 9"	Q93079	6	26251651-26253710	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 4.2;vagina: 4.4"	"Cell type enriched"	"Detected in some"	4	"Extravillous trophoblasts: 29.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	4	"basophil: 3.7;neutrophil: 3.0"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 3.7"	"Cell line enhanced"	"Detected in many"		"U-266/70: 16.9"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (5.83e-2)"	"unprognostic (6.27e-3)"	"unprognostic (4.50e-2)"	"unprognostic (9.18e-2)"	"unprognostic (5.52e-2)"	"prognostic unfavorable (7.52e-4)"	"unprognostic (5.06e-3)"	"unprognostic (3.08e-3)"	"unprognostic (1.58e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.96e-8)"	"unprognostic (1.60e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.95e-3)"	0.2	0.2	0.4	0.6	0.5	1.4	0.6	0.4	0.5	1.2	0.8	1.2	3.0	0.4	0.8	4.2	0.8	0.3	0.1	0.3	1.0	0.7	0.2	1.6	0.8	0.7	0.5	0.2	0.1	0.0	0.1	0.1	0.2	0.7	3.6	0.8	0.0	1.3	0.0	0.0	0.4	1.7	0.1	0.6	3.8	0.7	0.6	0.8	2.9	1.0	0.1	0.5	0.4	4.4	1.2	1.8	0.1	7.0	0.0	0.0	0.1	1.1	0.9	0.3	1.2	0.6	2.4	1.1	0.0	1.7	0.1	1.8	3.4	0.0	0.6	1.7	0.9	0.1	1.3	6.1	0.4	0.0	0.0	4.0	0.3	0.3	0.4	0.5	0.0	0.3	1.0	2.7	6.2	0.1	2.0	3.8	2.7	1.6	0.0	1.8	4.0	0.0	0.9	0.0	2.7	3.2	2.9	4.2	1.4	0.6	0.3	2.0	3.3	0.0	0.6	0.0	0.7	3.1	16.9	4.5	0.0	0.5	1.5	3.8	3.7	0.2	0.6	0.3	0.0	0.1	0.6	0.2	0.4	0.6	0.3	0.0	0.1	3.0	0.8	0.1	0.2	0.4	5.2	0.4	0.5	0.4	0.5	0.3	1.0	0.7	0.5	0.2	0.7	0.6	0.8	1.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	29.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.2	0.0	0.0	0.0
H2BS1	H2BFS	ENSG00000234289	"H2B.S histone 1"	P57053	21	43565182-43565648	"Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	5	"Syncytiotrophoblasts: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.4;K-562: 1.0;U-2 OS: 1.6"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"					"unprognostic (1.29e-1)"					"unprognostic (4.33e-3)"				"unprognostic (2.06e-2)"				0.7	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.7	0.1	0.7	0.0	0.9	0.0	1.3	0.7	0.0	0.5	0.1	0.1	0.2	2.0	1.0	0.1	0.1	0.1	0.0	0.6	1.0	0.0	0.3	0.0	0.2	1.4	0.0	0.0	0.7	0.0	0.1	0.6	0.8	0.0	0.0	1.6	0.6	1.1	0.1	0.0	0.7	0.0	0.0	0.4	0.9	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0
H4C12	"dJ160A22.1, H4/d, H4F2iii, H4FD, HIST1H4K"	ENSG00000273542	"H4 clustered histone 12"	P62805	6	27831174-27831560	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 22.4;brain: 20.6"	"Cell type enriched"	"Detected in single"	6	"Cardiomyocytes: 2.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"basophil: 160.3"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 160.3"	"Cell line enhanced"	"Detected in many"		"Hep G2: 63.7;MCF7: 63.3"									HPA042201	Supported					NA	NA		25000000			"HPA042201: AB_2677898"	"unprognostic (3.19e-1)"	"unprognostic (9.09e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.84e-3)"	"unprognostic (9.63e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.58e-1)"	"unprognostic (7.39e-2)"	"unprognostic (5.79e-2)"	"unprognostic (3.13e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.45e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.02e-1)"	4.2	5.6	4.7	2.8	9.6	22.4	2.1	2.8	15.7	3.8	0.0	7.6	6.2	3.1	1.0	1.4	3.4	3.7	0.5	17.6	20.6	1.1	8.1	1.2	4.7	0.0	3.4	6.3	0.9	1.0	7.1	0.4	1.5	17.9	5.2	3.4	0.4	1.1	2.0	0.4	0.7	5.8	1.2	2.4	5.8	6.0	1.4	7.8	8.9	2.7	2.0	2.2	2.9	0.4	9.0	8.0	9.9	21.0	35.4	13.3	5.0	12.4	8.9	4.4	8.7	5.6	17.2	2.6	12.6	16.4	3.7	2.1	19.4	0.5	13.1	2.7	18.5	3.7	8.4	19.0	63.7	7.5	12.4	10.8	15.9	3.5	5.4	2.9	1.2	7.8	7.1	16.5	26.6	0.3	63.3	22.8	13.0	13.3	13.3	20.3	9.2	1.5	9.1	1.5	3.6	11.7	15.8	16.3	9.0	12.1	2.9	12.4	6.1	7.9	4.4	21.0	2.3	0.1	14.3	16.7	23.0	5.6	9.2	8.7	160.3	9.4	40.4	29.8	21.3	25.8	33.8	29.0	31.6	18.2	37.1	17.4	22.1	22.9	28.0	26.3	20.0	38.9	24.6	4.7	9.6	2.8	15.7	17.6	20.6	0.0	3.4	6.3	17.9	2.4	7.8	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H4C14	"H4/n, H4F2, H4FN, HIST2H4, HIST2H4A"	ENSG00000270882	"H4 clustered histone 14"	P62805	1	149832659-149839767	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 46.3"	"Cell type enriched"	"Detected in single"	21	"Cardiomyocytes: 14.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SiHa: 61.9;U-2 OS: 52.8;U-266/70: 50.6"									HPA042201	Approved					NA	NA		25000000			"HPA042201: AB_2677898"	"unprognostic (1.90e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.50e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.99e-2)"	"unprognostic (6.99e-2)"	"unprognostic (8.36e-2)"	"unprognostic (4.66e-2)"	"unprognostic (3.44e-1)"	"unprognostic (4.91e-2)"	"unprognostic (8.70e-2)"	"unprognostic (6.78e-4)"	"unprognostic (6.15e-2)"	"unprognostic (3.63e-3)"	"unprognostic (1.62e-2)"	"unprognostic (5.99e-2)"	3.1	5.3	13.9	2.8	11.2	7.4	4.1	46.3	7.2	5.5	6.6	6.3	3.3	4.0	0.0	5.1	8.0	6.6	5.4	8.5	26.1	5.0	5.9	4.8	7.9	14.1	12.1	6.4	4.4	6.9	1.3	7.2	2.9	19.7	12.1	0.2	0.5	4.7	4.6	2.6	5.0	5.4	0.6	8.8	7.3	5.3	1.6	22.9	10.3	6.8	2.5	0.5	5.2	6.8	9.0	7.1	41.9	2.2	7.4	8.4	2.7	3.2	3.4	2.8	11.0	5.2	8.3	11.1	2.7	11.9	1.1	3.5	19.8	0.0	7.4	0.4	16.0	23.4	3.0	33.6	3.3	7.7	2.8	2.5	12.5	9.5	3.7	5.7	0.3	1.9	3.2	13.3	27.8	0.6	38.4	10.5	6.9	9.9	12.8	15.9	9.0	5.7	24.1	1.2	2.8	39.5	11.5	61.9	5.9	9.0	1.3	25.7	5.4	0.0	5.1	52.8	7.1	5.7	50.6	46.6	15.7	5.1	8.2	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	11.2	46.3	7.2	8.5	26.1	14.1	12.1	6.4	19.7	8.8	22.9	9.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0
HACD1	"CAP, PTPLA"	ENSG00000165996	"3-hydroxyacyl-CoA dehydratase 1"	B0YJ81	10	17589032-17617374	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	"Developmental protein, Lyase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 64.8"	"Cell type enriched"	"Detected in many"	4	"Cardiomyocytes: 143.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	11	"T-reg: 55.7"	"Lineage enriched"	"Detected in many"	12	"T-cells: 55.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.73e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.62e-2)"	"unprognostic (4.10e-1)"	"unprognostic (5.67e-3)"	"unprognostic (4.21e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.49e-2)"	9.3	7.1	3.6	5.1	3.8	8.1	8.9	10.5	4.7	6.2	3.5	22.6	2.9	22.3	3.3	7.9	10.4	3.6	64.8	3.4	5.6	3.1	1.6	9.8	1.3	5.3	4.9	3.7	4.3	2.7	0.5	3.8	1.6	5.8	12.0	3.9	2.3	2.7	16.9	36.8	3.1	7.0	25.6	3.0	1.7	15.2	3.6	5.3	2.6	7.7	16.6	1.3	18.2	6.9	8.8	29.3	24.6	6.8	33.4	30.1	5.8	0.6	40.5	24.4	51.9	48.5	16.4	34.6	0.2	5.9	66.4	74.5	7.1	17.3	12.3	28.6	19.1	10.4	67.1	18.4	45.6	39.0	0.3	4.8	14.0	17.2	29.9	11.6	39.8	10.1	35.1	0.6	1.3	69.0	21.0	50.4	6.7	14.6	2.2	6.6	44.7	7.1	0.8	20.5	5.6	7.5	19.1	34.6	0.6	58.9	21.2	24.2	16.7	9.8	30.3	17.4	18.7	18.8	0.9	0.8	0.3	22.3	7.7	4.3	4.7	0.9	0.7	1.2	0.1	0.3	0.4	5.0	1.0	3.0	1.3	0.9	0.7	2.6	3.3	0.3	1.5	55.7	1.3	3.6	3.8	10.5	4.7	3.4	5.6	5.3	4.9	3.7	5.8	3.0	5.3	8.8	2.4	28.9	15.0	0.3	0.4	0.0	23.1	0.0	8.0	0.8	6.9	21.6	143.7	10.0	2.5	31.3	0.0	0.5	4.4	0.4	3.9	16.5	11.1	5.6	8.0	5.4	3.6	29.2	10.4	8.0	1.9	7.1	8.2	12.4	6.3	17.5	20.7	1.0	5.4	0.0	11.7	2.5	0.0	2.2	0.0	2.7	1.8	3.6	0.0	5.6	0.8	0.5	1.0	2.5	31.8	15.6	0.8	0.7	0.6	23.9	0.5	2.3	0.7	0.6	0.0	5.7	32.5	7.4	5.2	17.7	0.0	3.0	2.9	10.8	3.5	6.2
HAND1	"bHLHa27, eHand, Hxt, Thing1"	ENSG00000113196	"Heart and neural crest derivatives expressed 1"	O96004	5	154474972-154478227	"Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 13.9;intestine: 46.0;smooth muscle: 12.4"	"Cell type enriched"	"Detected in some"	8	"Cardiomyocytes: 15.2"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 2.8"	"Region enhanced"	"Detected in single"		"thalamus: 1.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"SH-SY5Y: 119.5;SuSa: 212.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA040925, HPA075313"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear membrane, Nuclear bodies"	"HPA040925: AB_10796563, HPA075313: "			"unprognostic (2.37e-2)"					"unprognostic (8.29e-2)"		"unprognostic (2.46e-3)"	"unprognostic (7.23e-2)"				"unprognostic (5.21e-2)"		"unprognostic (6.38e-3)"	0.1	4.8	0.0	2.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	46.0	3.7	0.0	0.0	0.0	0.0	0.5	13.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	14.5	12.4	0.0	0.0	0.0	0.3	1.3	0.1	0.0	0.0	0.0	7.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	119.5	0.0	0.0	0.0	212.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.5	15.2	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.1	0.0	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.6	1.7	0.0	0.8	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.1	1.1	0.0	0.0	0.2	0.0
HAPLN3	"EXLD1, HsT19883"	ENSG00000140511	"Hyaluronan and proteoglycan link protein 3"	Q96S86	15	88877294-88895597	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	9	"Extravillous trophoblasts: 966.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 50.9"	"Lineage enriched"	"Detected in all"	5	"T-cells: 50.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 34.7;U-2 OS: 31.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039237	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA			"Plasma membrane, Cytosol"		"HPA039237: AB_10805357"	"unprognostic (1.67e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.21e-1)"	"unprognostic (3.82e-1)"	"unprognostic (3.37e-3)"	"unprognostic (7.37e-3)"	"unprognostic (1.13e-3)"	"unprognostic (4.30e-1)"	"prognostic unfavorable (4.18e-13)"	"unprognostic (1.95e-1)"	"unprognostic (3.01e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.12e-1)"	10.4	1.9	1.9	11.6	1.7	3.1	8.6	1.6	3.0	5.0	3.3	3.1	0.6	4.3	0.1	6.1	6.3	2.8	4.4	1.8	2.1	3.0	0.9	9.7	11.8	2.0	1.8	1.5	2.7	1.4	0.5	2.2	1.4	2.0	5.8	0.4	4.2	6.1	0.7	3.6	5.7	4.7	2.7	2.1	5.8	3.5	1.0	2.3	2.9	4.7	0.6	3.3	6.9	5.6	2.0	2.0	7.0	1.3	15.4	4.4	4.2	4.7	4.4	1.0	1.6	2.0	4.4	6.4	0.0	11.9	5.4	2.5	1.7	14.7	1.9	0.0	34.7	12.9	4.9	0.3	0.0	0.6	0.0	0.1	1.6	0.8	3.0	0.2	0.2	7.1	0.6	0.1	9.3	0.8	0.2	0.1	0.0	11.2	0.0	0.2	0.0	0.6	11.5	2.9	0.1	0.1	4.2	0.9	0.7	6.1	1.9	0.0	0.6	1.3	10.8	31.2	8.1	0.7	1.1	0.1	0.1	3.8	0.0	9.3	1.4	1.1	0.0	1.2	0.8	5.4	0.2	18.3	7.4	2.2	1.5	18.3	8.6	0.3	10.1	0.2	0.8	50.9	5.9	1.9	1.7	1.6	3.0	1.8	2.1	2.0	1.8	1.5	2.0	2.1	2.3	2.0	16.0	0.0	3.4	1.3	4.0	32.0	10.8	13.5	4.6	2.5	47.1	42.4	9.3	1.5	10.4	1.8	10.4	5.8	3.2	0.5	0.0	5.3	0.0	6.3	3.7	29.4	0.0	0.0	1.3	2.0	966.2	8.5	1.5	12.1	1.3	2.5	3.3	0.1	19.3	0.0	0.1	0.9	6.1	0.3	22.0	0.2	0.9	3.0	17.8	2.8	9.7	3.8	3.1	0.5	0.1	9.9	0.1	0.7	0.5	10.4	0.0	0.2	2.7	103.8	13.1	7.2	24.5	0.3	2.1	6.3	24.2	20.4	9.4	0.2	0.5	7.8
HBE1	HBE	ENSG00000213931	"Hemoglobin subunit epsilon 1"	P02100	11	5268345-5505652	"Plasma proteins, Predicted intracellular proteins"	"Oxygen transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	5	"Hofbauer cells: 174.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"K-562: 10059.8"	"Not detected"	"Not detected"							HPA043234	Approved					NA	NA		510000000			"HPA043234: AB_2678378"	"unprognostic (7.59e-2)"			"unprognostic (6.70e-2)"	"unprognostic (3.76e-2)"	"unprognostic (4.25e-1)"		"unprognostic (1.64e-1)"	"unprognostic (9.03e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.32e-2)"	"unprognostic (1.02e-3)"		"unprognostic (2.14e-1)"	"unprognostic (5.80e-2)"	"unprognostic (7.34e-2)"	0.3	0.3	0.2	0.0	0.6	0.3	0.2	0.0	1.1	0.4	0.0	0.2	0.0	0.3	0.4	0.1	0.4	0.0	0.3	0.3	0.3	0.3	1.3	0.3	0.0	0.7	0.1	0.7	0.6	0.2	0.0	0.3	0.8	0.4	0.4	0.0	0.2	0.1	0.1	0.4	0.2	0.2	0.2	0.0	0.4	0.2	0.6	0.3	0.2	0.3	0.0	0.0	0.2	0.3	0.6	1.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	12.5	0.3	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.1	649.4	0.0	5.8	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	10059.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.1	0.4	0.7	0.7	0.0	0.0	31.9	0.1	0.9	19.4	0.1	0.8	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.6	0.0	1.1	0.3	0.3	0.7	0.1	0.7	0.4	0.0	0.3	0.6	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.2	0.0	0.2	0.0	0.0	0.9	0.0	0.3	4.3	0.0	16.0	0.5	0.0	31.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	174.7	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.3	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.6	0.2	0.0	0.0	14.8	0.1	0.0	0.9	0.1
HEBP1	"HBP, HEBP"	ENSG00000013583	"Heme binding protein 1"	Q9NRV9	12	12974870-13000265	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 245.1"	"Cell type enriched"	"Detected in many"	4	"Proximal enterocytes: 837.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056417, HPA075277"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA		290000	Vesicles	Nucleoplasm	"HPA056417: AB_2683122, HPA075277: AB_2686741"	"unprognostic (1.65e-1)"	"unprognostic (2.31e-2)"	"unprognostic (9.28e-2)"	"unprognostic (5.67e-3)"	"unprognostic (4.45e-3)"	"unprognostic (5.42e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.44e-1)"	"unprognostic (6.04e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.94e-3)"	"unprognostic (6.19e-2)"	"unprognostic (2.28e-3)"	"unprognostic (5.71e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.02e-2)"	"unprognostic (4.43e-2)"	72.2	109.0	41.8	21.2	49.2	58.4	67.2	47.2	46.3	51.9	47.5	44.0	245.1	44.2	17.5	43.0	50.4	41.7	58.2	39.9	46.4	65.4	147.0	55.1	28.5	50.2	45.6	39.9	80.6	76.5	50.7	28.0	34.9	48.3	42.8	22.0	15.3	44.1	37.1	39.6	60.1	167.1	39.0	49.0	59.0	45.4	30.0	47.0	19.7	123.7	38.0	21.6	51.6	50.7	53.7	74.2	46.2	29.3	54.8	229.6	167.6	20.5	65.0	91.0	60.2	79.7	29.8	26.6	21.2	25.2	128.8	51.9	64.7	37.6	54.2	69.1	3.0	30.0	12.0	51.0	74.2	159.1	22.3	11.3	134.7	47.9	80.7	101.9	187.0	124.3	25.1	13.6	19.4	103.9	48.1	18.3	34.9	42.5	71.5	30.0	40.2	85.3	22.1	50.8	74.1	16.6	14.8	85.6	41.1	86.5	84.2	21.3	33.6	140.2	45.7	53.1	72.6	36.2	16.4	14.4	7.9	73.2	38.5	18.8	15.6	65.7	17.2	9.6	49.4	13.5	11.5	16.5	10.4	51.2	11.8	20.6	12.1	21.0	18.7	69.8	25.3	9.7	25.9	41.8	49.2	47.2	46.3	39.9	46.4	50.2	45.6	39.9	48.3	49.0	47.0	53.7	120.1	54.5	21.3	2.0	14.9	37.5	56.2	38.3	39.9	43.0	73.3	95.8	26.7	115.8	19.8	57.0	4.2	36.2	14.5	56.5	99.7	89.5	33.8	8.6	27.4	80.4	20.4	174.4	1.5	100.3	27.1	68.6	28.5	14.6	1.3	31.6	162.4	121.7	82.0	6.7	1.7	45.3	18.3	85.4	43.1	13.0	89.2	53.7	62.2	0.0	78.1	44.2	10.3	4.5	3.5	71.1	90.5	94.0	8.0	79.8	837.6	93.0	7.0	6.7	52.6	35.7	40.8	13.8	7.5	44.5	36.1	26.3	14.5	84.3	93.6	54.3
HELT	"bHLHb44, HCM1228, HESL, MEGANE, Mgn"	ENSG00000187821	"Helt bHLH transcription factor"	A6NFD8	4	185018841-185020804	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"Distal tubular cells: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HAP1: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA036188, HPA036189"	Uncertain					NA	NA					"HPA036188: AB_10672237, HPA036189: AB_2674997"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1
HESX1	"ANF, RPX"	ENSG00000163666	"HESX homeobox 1"	Q9UBX0	3	57197838-57227606	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Spermatocytes: 36.3"	"Cancer enriched"	"Detected in many"	4	"testis cancer: 6.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 73.5;U-266/84: 23.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA024187	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA024187: AB_1850620"	"unprognostic (6.47e-2)"	"unprognostic (1.66e-3)"	"unprognostic (5.50e-2)"	"unprognostic (1.19e-3)"	"unprognostic (5.04e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.96e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.46e-3)"	"unprognostic (9.48e-2)"	"unprognostic (2.79e-3)"	"unprognostic (1.39e-3)"	"unprognostic (4.17e-2)"	"unprognostic (3.15e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.14e-1)"	1.4	1.8	1.8	1.0	1.8	6.0	2.6	2.3	2.2	1.2	1.5	1.1	1.1	0.9	3.4	1.0	1.1	1.6	1.2	1.8	2.0	2.1	3.8	1.4	1.8	2.1	1.9	1.8	1.4	1.8	1.6	1.8	1.2	1.9	1.5	0.8	2.0	1.1	2.0	0.9	4.3	1.0	0.6	1.6	2.2	2.0	6.3	1.8	1.3	2.5	0.6	1.3	0.9	1.1	1.9	1.3	1.2	2.6	4.3	0.4	1.6	0.8	0.1	0.5	0.8	1.4	0.6	3.9	3.4	0.6	0.1	1.0	0.2	1.2	1.4	1.0	2.0	2.9	5.0	1.8	0.4	2.9	1.6	0.5	4.1	1.2	0.4	2.8	2.1	0.7	7.2	0.8	4.3	0.3	0.3	2.2	9.1	73.5	1.1	0.8	0.8	1.6	1.7	3.6	0.7	1.1	3.5	1.0	1.4	2.7	1.2	1.0	7.0	0.5	3.3	1.3	1.0	1.4	12.2	23.7	10.1	1.2	3.1	1.6	0.5	0.8	0.4	0.2	1.6	0.0	0.6	0.2	0.1	0.5	0.5	0.2	0.1	1.4	0.7	0.2	1.8	0.0	0.2	1.8	1.8	2.3	2.2	1.8	2.0	2.1	1.9	1.8	1.9	1.6	1.8	1.9	1.0	0.0	0.5	6.5	0.9	0.4	0.6	1.4	0.0	0.3	1.3	1.8	0.8	1.5	0.4	1.8	0.0	1.5	1.7	0.9	0.0	0.4	0.5	1.7	0.7	1.2	0.0	0.0	1.7	0.2	1.1	0.6	0.5	0.4	0.0	1.0	1.4	1.0	2.1	1.7	1.5	0.1	2.0	1.6	0.6	0.4	0.9	2.0	0.0	6.5	1.1	1.6	0.0	3.0	5.1	0.5	0.2	0.4	0.2	0.7	0.7	1.2	0.9	2.6	0.0	0.8	0.5	36.3	7.6	0.3	1.1	0.5	0.7	2.7	0.7	0.4
HHLA1	PLA2L	ENSG00000132297	"HERV-H LTR-associating 1"	C9JL84	8	132061486-132111159	"Predicted secreted proteins"				"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"Alveolar cells type 2: 19.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NTERA-2: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted - unknown location"	NA	NA											"unprognostic (5.15e-2)"								"unprognostic (1.19e-1)"	"unprognostic (2.15e-1)"			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	2.5	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.4	0.1	0.0	0.3	0.0	0.0	0.9	0.0	0.0	0.6	0.0	0.2	3.8	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0
HIP1	ILWEQ	ENSG00000127946	"Huntingtin interacting protein 1"	O00291	7	75533298-75738962	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Apoptosis, Differentiation, Endocytosis, Transcription, Transcription regulation"	"Actin-binding, Activator"	"Cancer-related genes, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 50.9"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 1373.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 9.5;eosinophil: 6.8;neutrophil: 6.8;NK-cell: 3.0;plasmacytoid DC: 3.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 55.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013606, CAB015334, CAB016402, HPA017964"	Enhanced		Supported	Vesicles		NA	NA			Vesicles		"CAB015334: AB_2117565, CAB016402: AB_627725, HPA013606: AB_1850717, HPA017964: AB_1850719"	"unprognostic (8.23e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.73e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.70e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.73e-3)"	"unprognostic (9.67e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.09e-1)"	16.9	8.0	24.3	7.4	35.0	5.5	13.3	28.3	23.8	11.8	16.9	5.6	2.7	9.8	9.3	5.3	13.0	8.4	9.1	19.9	24.8	13.3	9.4	18.7	4.8	32.4	34.4	14.8	8.0	3.8	4.2	3.5	19.9	32.7	6.9	4.2	4.6	4.1	11.3	4.2	10.7	5.0	12.3	25.6	11.3	4.8	30.7	31.4	3.1	15.4	8.5	4.5	9.1	8.0	50.9	5.2	55.9	37.1	35.2	15.3	20.8	11.1	9.7	6.3	6.2	4.6	3.2	5.0	3.8	11.2	24.2	21.6	6.3	38.1	8.0	8.3	3.1	7.1	3.0	6.6	5.3	15.2	0.8	14.8	16.0	4.8	20.4	4.2	11.4	26.3	4.2	4.0	3.6	10.1	21.6	2.5	22.2	40.5	0.5	6.6	4.4	15.5	0.3	4.7	20.0	1.8	16.2	9.0	5.6	12.5	32.8	34.6	13.9	9.4	18.0	13.7	6.2	13.6	4.0	0.4	8.9	18.1	8.0	12.4	9.5	0.9	6.8	0.9	0.9	0.7	0.3	0.1	0.7	1.4	0.4	0.1	0.5	6.8	3.0	0.7	3.3	1.4	0.3	24.3	35.0	28.3	23.8	19.9	24.8	32.4	34.4	14.8	32.7	25.6	31.4	50.9	54.0	60.9	37.5	43.8	7.8	17.6	6.2	7.1	20.5	12.0	14.8	10.7	14.3	11.5	12.2	27.6	12.5	2.1	27.2	2.2	13.7	14.4	256.9	15.5	24.2	54.3	4.8	7.8	16.3	6.0	10.0	17.1	6.1	25.5	14.0	25.9	36.8	22.5	14.9	23.5	19.0	3.0	6.1	18.5	49.1	1373.3	22.4	24.1	10.6	45.9	9.4	14.3	21.6	336.3	313.7	3.1	7.7	24.8	18.4	4.2	0.3	2.6	1.3	9.4	85.5	25.9	44.8	12.1	5.6	5.6	9.1	0.8	13.5	7.7	3.3	3.5
HLA-DQA1	"CELIAC1, HLA-DQA"	ENSG00000196735	"Major histocompatibility complex, class II, DQ alpha 1"	P01909	6	32628179-32647062	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 336.9;lymphoid tissue: 338.7"	"Cell type enriched"	"Detected in many"	4	"Langerhans cells: 4114.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 666.6"	"Group enriched"	"Detected in all"	19	"B-cells: 287.6;dendritic cells: 666.6;monocytes: 257.6"	"Cell line enriched"	"Detected in some"	7	"HDLM-2: 1419.1"									HPA012315	Enhanced					NA	NA		200000			"HPA012315: AB_1853930"	"unprognostic (4.24e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.43e-2)"	"unprognostic (7.94e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.07e-2)"	"unprognostic (3.26e-1)"	"unprognostic (5.81e-3)"	"unprognostic (2.84e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.36e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.57e-1)"	47.7	46.2	1.9	112.0	2.1	7.2	42.0	2.0	3.2	50.3	6.6	77.6	0.1	27.9	32.5	32.4	29.4	128.5	20.9	1.8	9.1	31.4	95.9	336.9	338.7	3.7	4.1	1.1	18.8	15.1	2.6	15.3	13.8	3.8	15.2	117.0	1.9	35.2	7.9	7.6	29.7	74.6	19.4	4.6	181.5	104.2	12.3	2.4	236.5	26.3	0.0	324.8	177.5	16.4	10.6	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	213.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1419.1	0.9	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	4.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	2.4	0.4	0.0	0.1	0.6	0.6	63.2	1.5	156.1	24.4	0.0	0.0	1.9	105.8	0.5	2.4	257.6	1.0	287.6	3.3	16.5	666.6	274.1	0.4	4.3	3.0	8.2	68.3	162.7	21.6	129.0	1.9	2.1	2.0	3.2	1.8	9.1	3.7	4.1	1.1	3.8	4.6	2.4	10.6	67.9	12.8	86.3	0.0	972.8	50.2	0.4	4.3	4.6	0.1	9.8	28.6	2.1	7.2	19.4	0.0	2.1	0.8	179.8	0.9	1.9	4.6	0.6	0.5	0.4	97.4	0.0	38.3	0.1	4.6	2.4	14.7	10.7	0.9	50.4	0.8	12.8	0.6	381.0	0.0	0.1	0.4	2.0	518.6	4114.3	1.3	3.1	874.3	71.2	12.2	957.1	1.0	4.1	0.0	0.2	2.1	0.1	0.0	96.1	1.5	1.8	6.5	27.3	2.5	6.6	1.2	5.3	0.0	0.7	2.5	41.6	2.1	56.0	1.2	2.7	7.6
HLA-DQA2	HLA-DXA	ENSG00000237541	"Major histocompatibility complex, class II, DQ alpha 2"	P01906	6	32741391-32747198	"Human disease related genes, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 21.0;lymphoid tissue: 27.3"	"Cell type enriched"	"Detected in many"	4	"Langerhans cells: 1196.5"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA						"unprognostic (4.06e-3)"	"unprognostic (2.46e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.57e-2)"	"unprognostic (8.85e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.19e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.48e-2)"	8.4	4.6	0.0	0.0	0.0	0.0	7.3	0.0	0.0	2.3	0.0	3.0	0.0	2.1	0.0	3.1	2.8	0.1	2.1	0.0	0.0	5.7	1.7	21.0	0.0	0.0	0.0	0.0	0.9	1.3	0.0	2.5	0.0	0.0	2.5	0.0	0.0	3.4	0.0	1.4	8.0	11.7	0.0	0.0	27.3	2.9	0.6	0.0	0.3	3.7	0.0	0.3	3.1	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.1	3.2	3.6	0.0	179.2	23.5	0.3	1.8	1.2	0.0	2.5	1.3	0.5	0.0	7.5	3.7	0.0	0.2	144.1	0.1	0.0	0.2	0.7	0.1	0.2	20.6	2.4	0.4	0.0	0.0	0.8	1.6	0.0	0.3	0.0	0.8	2.2	0.3	110.0	0.0	0.0	0.0	0.0	78.9	1196.5	2.0	1.2	243.1	24.9	0.0	125.3	0.0	8.2	0.0	0.0	0.2	0.0	0.0	9.5	0.0	0.0	11.2	12.4	0.0	6.6	0.7	1.2	0.1	0.3	0.1	23.3	0.4	13.8	0.0	0.0	0.7
HLA-DQB2	HLA-DXB	ENSG00000232629	"Major histocompatibility complex, class II, DQ beta 2"	P05538	6	32756098-32763532	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 14.8;skin 1: 46.8"	"Cell type enriched"	"Detected in some"	33	"Langerhans cells: 1010.0"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.3"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073187	Enhanced					NA	NA					"HPA073187: "	"prognostic favorable (5.55e-4)"	"unprognostic (3.75e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.10e-1)"	"unprognostic (6.60e-2)"	"unprognostic (8.15e-2)"	"unprognostic (3.73e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.94e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.92e-2)"	3.9	1.9	0.0	0.0	0.0	0.1	3.8	0.0	0.0	2.3	0.1	1.4	0.3	0.9	0.1	7.3	1.5	0.5	1.2	0.0	0.1	2.3	0.6	14.8	0.7	0.1	0.0	0.0	0.4	0.6	0.0	1.9	0.0	0.0	1.5	1.0	0.0	2.5	0.0	0.8	46.8	6.6	0.0	0.0	12.9	1.3	0.6	0.0	0.2	2.4	0.0	0.4	1.4	4.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	1.3	0.0	0.0	1.1	0.8	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.1	3.2	13.0	0.0	5.9	28.4	0.0	0.1	0.0	0.0	0.4	1.7	0.4	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.2	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	2.5	0.1	0.0	0.0	2.4	0.0	0.1	0.0	0.0	6.2	1010.0	0.5	0.9	30.5	26.6	1.0	4.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.6	0.2	0.6	0.1	27.6	0.1	2.7	0.0	0.0	0.4
HLA-DRB5		ENSG00000198502	"Major histocompatibility complex, class II, DR beta 5"	Q30154	6	32517353-32530287	"Human disease related genes, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 359.3;lymphoid tissue: 427.0"	"Cell type enriched"	"Detected in many"	4	"Langerhans cells: 4068.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 61.9"	"Group enriched"	"Detected in all"	10	"B-cells: 26.1;dendritic cells: 61.9;monocytes: 35.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 641.1;HMC-1: 154.2;U-698: 189.9;U-87 MG: 238.6"									HPA043151	Supported					NA	NA					"HPA043151: AB_2678342"	"unprognostic (1.97e-3)"	"unprognostic (4.74e-2)"	"unprognostic (3.30e-2)"	"prognostic favorable (7.89e-4)"	"unprognostic (2.28e-2)"	"unprognostic (4.68e-3)"	"unprognostic (9.09e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.06e-2)"	"unprognostic (5.40e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.60e-3)"	"unprognostic (9.72e-2)"	"unprognostic (5.48e-2)"	97.6	63.5	1.0	140.3	1.4	23.3	83.3	1.0	2.8	50.2	2.6	70.7	13.3	40.1	110.7	49.0	61.5	2.5	42.7	0.9	6.2	65.2	42.9	359.3	427.0	1.2	5.2	0.6	25.6	28.1	0.0	27.4	6.7	6.6	32.9	53.5	3.0	27.8	0.0	22.5	48.3	186.2	0.2	8.7	230.3	216.0	11.9	2.6	167.3	46.5	0.0	164.1	56.6	29.2	1.6	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.4	0.0	0.0	0.7	0.0	0.0	0.0	641.1	6.2	0.0	0.0	0.0	0.0	0.6	154.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.6	0.0	0.2	0.2	1.3	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.0	6.6	0.0	0.0	56.0	0.1	3.3	0.8	1.9	0.4	41.4	0.8	189.9	238.6	1.8	0.1	0.2	28.6	3.8	0.9	35.2	0.1	23.0	0.8	2.4	61.9	26.1	0.1	1.1	0.7	2.1	20.3	13.3	4.1	51.9	1.0	1.4	1.0	2.8	0.9	6.2	1.2	5.2	0.6	6.6	8.7	2.6	1.6	467.2	16.0	84.9	0.0	632.7	104.3	3.1	9.3	23.9	0.6	9.9	15.2	9.5	88.6	35.6	14.7	4.2	1.4	140.9	17.5	1.9	2.8	2.7	1.5	1.1	285.3	1.8	72.3	0.1	8.1	2.9	30.3	75.4	2.0	60.1	1.5	88.5	3.4	475.2	0.0	0.1	35.4	12.2	516.2	4068.5	7.4	15.8	978.8	120.9	8.4	246.9	0.5	9.2	0.0	0.1	31.5	52.3	34.3	46.2	6.7	661.5	37.0	71.6	1.8	19.7	8.9	17.3	0.8	1.3	11.2	90.6	3.1	68.0	0.3	50.8	65.7
HMCN2	"DKFZp434P0216, FLJ23816"	ENSG00000148357	"Hemicentin 2"	Q8NDA2	9	130265882-130434123	"Predicted intracellular proteins, Predicted secreted proteins"	"Sensory transduction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 34.2;intestine: 38.1"	"Cell type enriched"	"Detected in many"	8	"Skeletal myocytes: 283.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 7.8;RH-30: 18.0;SCLC-21H: 2.6;SH-SY5Y: 4.1;U-138 MG: 2.9;U-87 MG: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA053903, HPA070647"	Enhanced		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		27000000	Vesicles		"HPA053903: AB_2682301, HPA070647: AB_2686290"	"unprognostic (1.61e-1)"	"unprognostic (8.05e-3)"	"unprognostic (1.69e-1)"	"unprognostic (5.53e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.78e-3)"	"unprognostic (3.23e-1)"	"unprognostic (3.97e-4)"	"unprognostic (3.36e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.53e-2)"	"unprognostic (3.62e-2)"	"unprognostic (8.96e-3)"	"unprognostic (8.63e-2)"	9.9	1.3	0.4	1.5	0.5	0.0	3.9	0.0	0.6	17.2	0.2	38.1	5.3	34.2	0.1	4.9	10.2	0.7	10.0	0.1	0.6	1.6	1.2	3.8	1.2	2.0	1.8	0.0	2.6	0.9	0.1	0.3	0.2	2.2	9.3	1.9	0.0	2.3	2.3	25.2	3.8	21.7	4.3	1.0	0.4	4.9	5.7	0.8	1.2	4.8	6.3	0.2	9.3	12.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.4	0.2	0.5	0.0	18.0	0.1	0.0	0.1	2.6	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.2	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.6	0.1	0.6	2.0	1.8	0.0	2.2	1.0	0.8	1.0	1.2	3.2	7.5	2.3	0.5	0.9	0.4	0.0	0.0	1.1	0.2	0.3	4.8	0.0	3.7	0.0	0.0	0.1	0.1	22.9	1.9	0.0	17.0	0.0	0.2	5.0	0.0	0.0	1.3	0.0	0.1	24.8	0.0	0.1	7.6	0.1	0.7	2.3	0.4	1.7	5.8	3.6	2.0	0.8	0.8	10.6	0.0	2.3	1.8	1.0	0.0	0.0	0.0	0.5	0.7	0.1	8.3	0.0	0.1	0.8	34.1	1.2	4.0	0.7	0.0	283.7	4.5	0.9	1.1	0.0	0.6	0.3	1.6	2.9	5.5	4.7
HOXA11	"HOX1, HOX1I"	ENSG00000005073	"Homeobox A11"	P31270	7	27181157-27185232	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 37.4;endometrium 1: 97.6;smooth muscle: 41.6"	"Cell type enriched"	"Detected in some"	19	"Endometrial stromal cells: 116.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 32.5;HEK 293: 44.0;THP-1: 34.7;U-937: 43.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	36	"spinal cord: 3.5"	"HPA006770, HPA035623"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA006770: AB_2667672, HPA035623: AB_10601576"	"unprognostic (5.95e-2)"	"unprognostic (9.23e-2)"	"unprognostic (3.07e-2)"	"unprognostic (2.70e-2)"	"unprognostic (6.29e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.82e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (2.57e-5)"	"unprognostic (2.17e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.56e-1)"	2.2	0.7	0.0	1.5	0.0	0.0	0.4	0.0	0.0	37.4	0.0	20.0	0.0	97.6	0.0	0.0	1.3	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	10.1	0.0	14.8	3.9	0.0	0.1	9.7	8.0	1.3	0.2	41.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	17.2	10.5	0.0	4.8	0.3	0.0	13.1	15.2	11.1	0.0	26.8	32.5	18.9	13.8	0.3	1.7	0.0	6.1	23.5	0.1	3.2	16.3	0.0	14.7	1.6	44.0	5.7	11.2	0.7	0.9	12.5	1.7	6.5	0.6	0.1	0.0	0.0	14.1	1.1	0.4	0.0	2.2	0.4	0.0	9.4	0.0	4.4	13.1	0.7	0.0	0.3	9.6	8.1	5.6	0.0	6.7	0.0	2.0	3.6	1.2	34.7	0.0	0.2	12.9	3.2	1.5	0.0	0.0	0.0	0.2	43.4	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	2.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.8	0.0	0.1	0.3	1.1	5.9	0.0	0.8	4.0	116.8	1.3	5.3	0.0	0.0	0.0	0.1	3.6	0.0	1.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.1	0.0	0.0	0.3	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	2.8	0.2	0.2	0.0	0.0	0.0	0.9	5.8	1.2	0.1	0.0	0.0	0.0	0.6	0.1	1.1	1.3
HOXA13	"HOX1, HOX1J"	ENSG00000106031	"Homeobox A13"	P31271	7	27193503-27200091	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix: 22.5;placenta: 17.2;prostate: 22.5;seminal vesicle: 23.5"	"Cell type enriched"	"Detected in some"	4	"Distal enterocytes: 41.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 10.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 26.9;HEK 293: 37.3;PC-3: 18.4;RT4: 42.1;THP-1: 18.2;U-937: 20.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA046098, HPA069061"			Supported	"Nucleoplasm,Mitotic chromosome,Intermediate filaments"		Yes	NA			Nucleoplasm	"Mitotic chromosome, Intermediate filaments"	"HPA046098: AB_2679536, HPA069061: "	"unprognostic (7.20e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.04e-4)"	"unprognostic (1.06e-3)"	"unprognostic (2.24e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.40e-2)"	"unprognostic (9.22e-3)"	"unprognostic (7.30e-3)"	"unprognostic (8.39e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.42e-11)"	"unprognostic (2.58e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.36e-2)"	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	22.5	0.0	10.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.2	0.0	22.5	12.0	0.0	0.0	23.5	2.1	0.3	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.2	14.3	0.0	2.2	1.6	0.0	2.5	0.2	0.0	0.1	13.2	14.4	5.1	3.3	2.8	0.2	0.0	1.6	6.2	0.7	0.0	26.9	0.0	4.3	0.0	37.3	1.9	6.9	0.2	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.1	0.0	8.7	0.0	11.8	18.4	2.7	0.6	0.0	0.1	42.1	0.7	0.0	3.3	0.0	0.3	2.0	0.0	18.2	0.0	0.5	4.5	0.3	0.1	0.0	0.0	0.0	0.0	20.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	41.3	0.0	0.0	0.6	0.1	4.0	1.1	8.4	0.0	0.0	0.0	0.1	2.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.6	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	5.5	0.0	0.1	0.0	0.0	0.0	0.1	2.8	0.5	0.0	0.0	0.1	0.1	0.1	0.0	10.3	3.1
HOXD12	HOX4H	ENSG00000170178	"Homeobox D12"	P35452	2	176099795-176102489	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 1.5;seminal vesicle: 1.5"	"Cell type enriched"	"Detected in single"	12	"Cardiomyocytes: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 1.7;REH: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA059444	Uncertain					NA	NA					"HPA059444: AB_2684020"		"unprognostic (1.00e-1)"	"unprognostic (2.40e-3)"		"unprognostic (1.32e-2)"	"unprognostic (3.53e-2)"		"unprognostic (1.71e-2)"	"unprognostic (1.36e-2)"			"unprognostic (7.11e-2)"		"unprognostic (4.54e-2)"	"unprognostic (7.29e-2)"		"unprognostic (1.44e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.5	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.3	0.0	0.4	0.2	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HPSE2	"HPA2, HPR2, UFS"	ENSG00000172987	"Heparanase 2 (inactive)"	Q8WWQ2	10	98457077-99235862	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.5;cervix: 33.3;vagina: 27.8"	"Cell type enriched"	"Detected in some"	9	"Astrocytes: 900.7"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 4.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	16	"BJ hTERT+: 10.2;HEL: 20.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA044603	Uncertain				"Secreted to extracellular matrix"	NA	NA					"HPA044603: AB_10794051"	"unprognostic (2.44e-1)"	"unprognostic (4.28e-3)"	"unprognostic (4.83e-3)"	"unprognostic (6.00e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.82e-2)"	"unprognostic (4.03e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.86e-4)"	"unprognostic (5.79e-2)"	"unprognostic (2.51e-1)"	"unprognostic (9.39e-3)"	"unprognostic (6.13e-3)"	1.8	0.0	10.6	2.0	19.2	0.0	5.2	17.1	9.1	33.3	3.4	2.9	2.8	4.5	0.0	14.4	1.8	1.4	0.0	5.8	19.8	1.1	0.0	2.2	0.0	23.6	24.3	4.1	0.2	0.0	0.0	0.3	1.5	23.0	11.2	3.0	0.0	2.4	4.3	0.3	3.0	5.3	1.7	15.1	0.0	4.6	2.7	27.5	0.1	0.1	3.1	0.4	18.5	27.8	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	10.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	20.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	10.6	19.2	17.1	9.1	5.8	19.8	23.6	24.3	4.1	23.0	15.1	27.5	13.8	0.3	0.0	0.0	900.7	0.0	0.0	4.8	0.0	0.0	0.0	0.2	0.8	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.3	0.4	24.8	0.3	0.0	0.0	6.4	0.0	0.0	4.2	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	97.3	0.2	0.0	0.0	0.0	48.6	0.3	0.0	0.0	40.3	0.0	0.0	0.0	16.6	4.6	0.0	0.0	0.4	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.9	1.9	11.5	2.1	0.0	0.1	0.0	0.2	0.8	0.0	0.7
HSP90B1	"GP96, GRP94, TRA1"	ENSG00000166598	"Heat shock protein 90 beta family member 1"	P14625	12	103930107-103953931	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Plasma cells: 4874.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003901, CAB005224, HPA008424, CAB078151"	Enhanced		Enhanced	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		330000000	"Endoplasmic reticulum"		"CAB005224: AB_2119181, CAB078151: AB_2665765, HPA003901: AB_1851181, HPA008424: AB_1851184"	"unprognostic (1.03e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.17e-2)"	"unprognostic (7.14e-3)"	"unprognostic (3.00e-2)"	"unprognostic (7.22e-2)"	"unprognostic (8.77e-2)"	"unprognostic (8.30e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (1.03e-10)"	"unprognostic (2.95e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.28e-2)"	333.4	343.8	178.8	427.3	185.3	442.7	345.4	189.8	205.9	366.3	229.4	343.7	263.8	305.0	1041.5	158.7	308.1	220.9	279.1	167.8	222.3	320.0	742.5	273.4	248.0	210.9	184.8	158.3	305.3	400.5	338.6	249.1	525.4	203.9	363.4	391.3	187.3	257.1	386.4	88.2	116.1	271.8	389.1	200.1	325.0	300.3	182.3	209.3	230.3	1424.6	92.0	330.7	359.9	166.0	254.2	856.5	459.9	926.2	940.0	960.1	897.5	1229.9	1449.4	1133.4	776.0	1038.1	839.1	805.3	243.8	1102.2	1579.2	995.1	583.2	934.6	1578.9	1063.2	607.3	307.4	684.5	447.6	861.0	1457.4	702.1	514.6	519.6	690.9	920.0	1342.8	2643.7	1513.9	293.8	560.0	914.8	1039.9	314.7	409.2	768.3	756.9	925.5	544.5	372.2	597.1	1079.2	1064.3	527.1	271.5	645.7	889.2	912.0	932.7	1468.4	743.9	1016.2	854.4	566.1	476.0	462.8	607.9	945.5	949.0	455.6	1106.9	494.7	904.5	113.8	81.3	30.3	199.7	88.6	244.9	108.5	118.5	187.8	111.8	71.1	75.9	133.8	18.7	199.3	83.3	322.7	81.1	188.5	178.8	185.3	189.8	205.9	167.8	222.3	210.9	184.8	158.3	203.9	200.1	209.3	254.2	507.5	237.2	373.8	28.7	646.0	309.3	905.1	743.6	196.9	50.3	261.4	334.0	687.8	235.9	475.3	257.5	156.4	568.4	480.6	424.0	56.7	471.2	89.6	570.8	751.1	439.6	406.6	213.5	34.0	250.4	1081.0	714.0	390.9	690.9	405.3	500.6	446.9	891.9	553.1	77.4	41.9	631.5	238.0	300.1	309.8	47.0	563.2	378.4	421.6	52.5	240.5	141.0	199.8	30.2	61.3	321.8	419.1	337.7	4874.6	760.6	246.1	271.4	404.2	111.6	216.9	325.7	569.3	489.0	154.4	196.3	260.7	921.0	316.0	542.6	494.6	620.0
HTR2A	"5-HT2A, HTR2"	ENSG00000102468	"5-hydroxytryptamine receptor 2A"	P28223	13	46831546-46897076	"FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"	"Behavior, Host-virus interaction"	"G-protein coupled receptor, Host cell receptor for virus entry, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 15.4;choroid plexus: 4.6"	"Cell type enriched"	"Detected in some"	8	"Excitatory neurons: 81.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 1.8;ASC TERT1: 4.6;BEWO: 1.4;HEL: 1.5;U-138 MG: 2.3;U-2 OS: 1.4;U-87 MG: 1.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014011	Enhanced					NA	NA					"HPA014011: AB_1856709"	"unprognostic (8.01e-2)"	"unprognostic (2.71e-2)"	"unprognostic (9.49e-2)"	"unprognostic (7.40e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.70e-2)"	"unprognostic (4.31e-2)"	"unprognostic (5.27e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.90e-1)"	"unprognostic (9.94e-5)"	"unprognostic (4.78e-3)"	"unprognostic (2.54e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.28e-2)"	0.9	0.3	4.0	0.8	9.6	0.1	0.5	0.0	15.4	0.6	4.6	0.5	0.4	0.5	0.0	0.5	0.3	1.6	0.7	10.1	8.1	0.1	0.1	0.3	0.0	0.9	2.2	8.5	0.3	0.0	0.0	0.2	0.0	3.0	0.2	0.7	0.8	0.0	0.6	0.3	0.1	0.4	2.6	0.0	0.0	0.2	0.6	1.0	0.7	0.1	0.6	0.2	0.8	0.5	9.5	0.0	0.0	0.0	0.0	1.8	4.6	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.3	1.4	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	4.0	9.6	0.0	15.4	10.1	8.1	0.9	2.2	8.5	3.0	0.0	1.0	9.5	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.5	0.2	1.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.2	8.6	0.1	0.0	0.0	81.7	0.0	0.0	1.9	0.0	0.2	0.0	0.0	0.4	0.1	0.1	0.0	10.1	0.0	0.0	0.3	0.0	2.2	0.9	1.9	0.0	3.7	0.0	4.6	0.0	2.5	3.2	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.3	0.0	1.0	1.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.1	0.1
HUNK		ENSG00000142149	"Hormonally up-regulated Neu-associated kinase"	P57058	21	31873020-32044633	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 9.9"	"Cell type enriched"	"Detected in many"	5	"Inhibitory neurons: 109.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 13.2;BEWO: 16.3;RH-30: 18.1;SCLC-21H: 14.8;SiHa: 13.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA027295, HPA027372"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA027295: AB_2672203, HPA027372: AB_2672239"	"unprognostic (9.09e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.95e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.12e-4)"	"unprognostic (4.00e-2)"	"unprognostic (6.90e-2)"	"unprognostic (5.07e-1)"	"unprognostic (2.27e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (7.48e-5)"	"unprognostic (8.84e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.69e-2)"	0.7	1.0	1.1	1.3	1.5	0.2	1.2	0.6	5.2	0.3	0.1	3.7	1.4	4.1	1.9	0.4	1.9	0.6	0.3	5.3	5.7	2.9	0.5	1.0	0.4	0.5	0.2	1.0	0.6	9.9	0.1	1.2	4.7	1.4	0.9	3.8	3.1	0.6	2.2	0.3	3.0	2.7	2.4	0.3	0.1	1.3	1.0	0.9	0.7	0.6	0.2	0.6	1.5	0.7	1.8	0.0	3.9	13.2	0.1	0.0	0.0	16.3	1.3	0.0	0.2	0.0	5.3	0.1	0.0	0.5	6.2	0.2	0.0	7.7	0.0	0.1	0.1	3.9	0.0	3.7	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	1.1	0.2	1.1	10.2	0.1	0.1	0.1	18.1	0.1	1.3	0.0	14.8	9.8	13.2	1.0	0.5	9.3	5.5	1.4	0.0	0.1	9.3	0.1	0.0	0.1	0.0	1.8	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	1.5	0.6	5.2	5.3	5.7	0.5	0.2	1.0	1.4	0.3	0.9	1.8	0.2	6.4	9.1	7.5	0.0	5.1	2.6	0.2	0.6	8.1	0.5	2.8	3.5	14.3	3.0	7.3	2.1	9.2	0.0	4.6	0.0	5.3	0.2	1.2	1.3	0.8	4.9	0.0	19.0	3.3	13.9	7.9	0.5	3.4	0.0	4.3	0.4	1.0	2.7	3.3	109.6	5.1	0.0	0.0	4.2	0.1	0.3	0.4	3.6	1.0	0.1	8.1	0.0	10.1	1.5	1.6	4.4	0.0	0.0	2.1	1.8	1.9	0.8	1.2	0.0	6.3	2.2	0.7	1.1	0.7	5.8	6.2	0.5	0.0	10.6	0.9
HUWE1	"Ib772, KIAA0312, UREB1"	ENSG00000086758	"HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1"	Q7Z6Z7	X	53532096-53686728	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, Differentiation, DNA damage, DNA repair, Ubl conjugation pathway"	"DNA-binding, Transferase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Granulosa cells: 507.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002548, CAB022718"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA		73000	"Nucleoplasm, Cytosol"		"CAB022718: , HPA002548: AB_1080489"	"unprognostic (4.73e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.59e-2)"	"unprognostic (6.64e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.56e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.89e-2)"	"unprognostic (8.10e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.45e-1)"	37.5	46.5	57.8	21.2	59.8	26.9	37.7	59.1	70.5	39.6	40.2	45.2	17.8	46.0	53.0	48.8	41.1	18.7	51.4	61.1	57.8	40.0	42.1	36.5	26.8	58.1	67.7	54.3	54.4	46.3	43.6	54.6	24.2	67.2	38.7	22.9	40.4	39.2	28.9	101.8	59.7	40.6	29.0	49.3	42.8	45.9	43.4	62.3	41.6	43.2	58.6	30.6	45.0	40.6	58.1	166.8	100.4	64.0	45.4	109.2	64.8	78.5	48.8	62.6	50.2	52.3	77.0	52.2	86.6	32.3	89.4	90.4	77.8	145.6	81.8	68.3	125.6	64.6	69.1	91.9	60.5	100.2	104.5	40.6	62.4	59.8	120.8	137.6	49.7	88.3	66.4	70.3	54.5	66.3	102.4	57.0	58.2	87.7	45.4	71.3	52.0	87.9	52.8	84.0	113.3	53.1	38.4	137.7	60.5	44.1	118.7	87.0	50.1	113.8	46.0	65.8	66.5	62.9	47.3	50.2	73.1	49.2	100.1	67.6	2.8	2.3	4.3	3.3	1.9	4.0	2.4	3.1	3.5	3.3	2.4	2.2	2.2	1.9	3.5	3.8	3.5	2.9	1.9	57.8	59.8	59.1	70.5	61.1	57.8	58.1	67.7	54.3	67.2	49.3	62.3	58.1	41.4	51.3	46.1	70.2	41.9	30.1	32.6	30.4	44.9	57.8	37.0	35.6	110.4	37.1	35.4	40.5	50.1	31.0	40.0	29.2	1.9	42.8	28.6	45.6	59.8	38.3	47.6	47.7	94.4	35.4	34.8	38.6	57.1	69.6	22.1	507.7	32.9	48.1	24.8	82.4	85.8	28.1	18.3	31.4	30.8	32.8	28.3	34.1	26.6	59.0	43.7	22.6	35.0	83.9	95.3	49.3	20.5	39.1	50.9	44.1	27.1	14.7	35.7	33.3	13.1	69.6	56.4	34.5	44.6	53.3	41.6	37.9	46.7	114.1	31.7	42.0
IBSP	"BSP, BSP-II, SP-II"	ENSG00000029559	"Integrin binding sialoprotein"	P21815	4	87799554-87812435	"Cancer-related genes, Predicted secreted proteins"	"Biomineralization, Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.4;pituitary gland: 2.0"	"Cell type enriched"	"Detected in some"	4	"Hofbauer cells: 5.8"	"Group enriched"	"Detected in many"	4	"breast cancer: 3.8;glioma: 12.2"	"Region enhanced"	"Detected in some"		"hypothalamus: 3.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-138 MG: 7.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA						"unprognostic (2.53e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.93e-1)"	"unprognostic (3.75e-2)"	"unprognostic (9.48e-3)"	"unprognostic (1.03e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.02e-3)"		"unprognostic (5.81e-11)"	"unprognostic (6.20e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.30e-3)"	"unprognostic (2.11e-1)"	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.3	0.2	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	3.4	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.1	2.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.2	0.0	0.2	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	1.0	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.2	0.1	3.4	0.3	0.6	0.0	0.3	0.2	1.7	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
IDO1	"IDO, INDO"	ENSG00000131203	"Indoleamine 2,3-dioxygenase 1"	P14902	8	39902275-39928790	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Immunity, Tryptophan catabolism"	"Dioxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 59.2;placenta: 111.8"	"Cell type enriched"	"Detected in many"	11	"monocytes: 2612.3"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	14	"eosinophil: 465.0"	"Lineage enriched"	"Detected in many"	18	"granulocytes: 465.0"	"Cell line enriched"	"Detected in some"	7	"EFO-21: 61.8"	"Region enriched"	"Detected in many"	12	"basal ganglia: 34.1"	"Low region specificity"	"Detected in all"			"HPA023072, HPA023149, HPA027772, CAB072820"	Enhanced		Supported	Nucleoplasm,Vesicles,Mitochondria,Cytosol		NA	NA			Cytosol	"Nucleoplasm, Vesicles, Mitochondria"	"CAB072820: , HPA023072: AB_1846220, HPA023149: AB_1846221, HPA027772: AB_1846222"	"unprognostic (1.68e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.08e-3)"	"unprognostic (7.21e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.06e-2)"	"prognostic favorable (5.27e-4)"	"prognostic favorable (3.32e-4)"	"unprognostic (3.59e-2)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (1.12e-7)"	"unprognostic (4.18e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.97e-2)"	5.0	0.7	0.5	40.9	0.4	0.7	2.0	0.4	0.8	7.3	0.9	5.3	10.4	10.3	1.2	1.4	2.7	6.2	1.1	0.3	0.6	1.7	2.4	26.1	59.2	0.6	0.4	0.3	1.2	1.2	0.2	0.1	111.8	0.5	2.1	8.3	1.3	1.9	3.0	8.2	1.3	8.5	2.5	0.4	23.2	5.9	1.1	0.6	31.5	4.0	0.6	31.8	9.2	0.5	0.6	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.9	7.6	4.8	0.3	0.8	0.0	61.8	0.0	3.3	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.1	0.4	0.1	0.0	0.0	0.2	0.0	0.3	0.4	0.1	0.0	0.1	0.0	0.1	0.0	0.1	8.4	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	2.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	9.1	0.2	0.2	0.0	0.3	0.0	32.5	1.3	465.0	0.1	1.4	0.1	0.2	0.1	0.0	26.4	0.3	0.1	0.2	4.9	0.1	0.1	0.3	0.1	1.2	0.5	0.4	0.4	0.8	0.3	0.6	0.6	0.4	0.3	0.5	0.4	0.6	0.6	24.9	0.0	0.5	0.7	4.4	0.4	0.2	18.3	0.0	0.0	0.5	0.1	0.3	0.0	76.0	0.0	0.0	0.0	0.3	8.3	0.0	4.4	3.7	70.1	23.0	6.9	0.0	0.0	0.2	8.1	0.0	0.3	0.0	223.3	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	2.0	3.7	28.1	1.8	0.0	13.6	0.0	0.0	2612.3	3.0	0.0	0.0	0.1	0.4	0.0	0.4	2.4	0.5	0.0	0.0	33.3	0.2	0.0	1.2	8.4	0.0	0.1	0.1	0.6	0.0	1.3	0.0	1.3	2.0
IFNA13		ENSG00000233816	"Interferon alpha 13"	P01562	9	21367424-21368962	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Antiviral defense"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 1.3"	"Cell type enriched"	"Detected in single"	17	"Granulosa cells: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047557	Uncertain				"Secreted to blood"	NA	NA					"HPA047557: AB_2680087"																		0.0	0.0	0.5	0.0	1.3	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.8	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.3	0.1	1.0	0.5	0.3	0.8	0.6	0.4	0.9	0.0	1.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNL2	"IL-28A, IL28A"	ENSG00000183709	"Interferon lambda 2"	Q8IZJ0	19	39268396-39270188	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	15	"Breast myoepithelial cells: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	17	"HDLM-2: 10.9"									CAB025489	Uncertain				"Secreted to blood"	NA	NA					"CAB025489: "	"unprognostic (1.37e-1)"	"unprognostic (2.84e-1)"				"unprognostic (1.05e-1)"				"unprognostic (2.11e-2)"	"unprognostic (1.08e-1)"			"unprognostic (6.96e-2)"				0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHE		ENSG00000211891	"Immunoglobulin heavy constant epsilon"	P01854	14	105597691-105601728	"Immunoglobulin genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 1.9;lymphoid tissue: 4.6;thyroid gland: 2.7"	"Cell type enriched"	"Detected in some"	50	"Plasma cells: 462.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"U-266/70: 3818.2"	"Not detected"	"Not detected"												"Immunoglobulin genes"	NA	NA		77000000				"unprognostic (3.18e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.54e-3)"	"unprognostic (4.99e-1)"		"unprognostic (4.87e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.36e-2)"	"unprognostic (2.40e-2)"	"unprognostic (8.04e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.01e-3)"	"unprognostic (1.07e-2)"	"unprognostic (3.98e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.63e-1)"	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	1.9	0.0	0.0	4.6	1.5	0.0	0.0	0.2	2.7	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.6	0.0	0.0	0.6	0.0	0.6	3818.2	371.6	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	462.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0
IGHJ3		ENSG00000242887	"Immunoglobulin heavy joining 3"		14	105864587-105864635	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"esophagus: 36.8;intestine: 58.4;pancreas: 62.2"	"Cell type enriched"	"Detected in single"	48	"Plasma cells: 24.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"basophil: 9.0;naive B-cell: 29.1"	"Group enriched"	"Detected in many"	7	"B-cells: 29.1;granulocytes: 9.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.5;RPMI-8226: 6.1;TIME: 8.0;U-251 MG: 2.6"															NA	NA						"prognostic favorable (8.67e-4)"	"unprognostic (8.67e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.42e-2)"		"prognostic favorable (3.86e-5)"	"unprognostic (3.12e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.82e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.70e-2)"	"prognostic unfavorable (3.24e-4)"	"unprognostic (8.47e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.30e-1)"	16.3	3.0	0.7	0.0	0.9	0.0	0.0	0.2	2.2	1.9	0.5	0.0	0.0	0.0	0.0	36.8	0.7	9.1	0.0	0.5	0.7	1.0	10.3	17.5	0.0	1.6	3.3	0.0	11.4	62.2	0.0	0.0	0.0	1.5	7.6	58.4	0.1	0.0	4.3	0.0	2.4	0.0	0.0	0.3	0.0	0.0	0.3	0.8	0.0	2.4	0.0	0.0	5.3	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.4	0.2	0.0	0.9	0.0	0.7	1.1	2.6	29.1	1.5	1.2	0.0	0.4	0.7	0.0	1.2	0.0	0.7	0.9	0.2	2.2	0.5	0.7	1.6	3.3	0.0	1.5	0.3	0.8	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
IGHJ4		ENSG00000240041	"Immunoglobulin heavy joining 4"		14	105864215-105864260	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"intestine: 421.2;lymphoid tissue: 1582.1;urinary bladder: 556.5"	"Cell type enriched"	"Detected in single"	148	"Plasma cells: 103.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	187	"memory B-cell: 6029.7;naive B-cell: 2618.0"	"Lineage enriched"	"Detected in all"	261	"B-cells: 6029.7"	"Cell line enriched"	"Detected in some"	87	"U-698: 3990.3"															NA	NA																							0.0	0.0	7.1	0.0	3.5	0.0	242.7	0.9	10.9	0.0	2.8	381.0	0.0	0.0	0.0	201.9	7.4	4.1	12.5	1.1	32.2	0.0	39.4	0.0	0.0	6.8	38.0	0.8	0.0	0.0	13.7	0.0	2.5	21.5	7.1	421.2	0.0	0.0	0.0	0.0	20.8	0.0	0.0	2.0	45.8	7.3	3.7	2.0	32.6	3.9	0.0	1582.1	556.5	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	19.9	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	14.0	17.5	0.0	0.0	0.0	0.0	6.8	3.6	0.0	0.0	0.0	0.0	0.0	8.9	0.0	45.8	0.0	0.0	6.2	0.0	3990.3	0.0	12.2	0.0	13.9	3.6	5.4	5.0	1.3	3.0	6029.7	13.2	4.0	23.1	2618.0	1.5	6.0	20.1	3.3	6.0	0.0	6.6	1048.2	7.1	3.5	0.9	10.9	1.1	32.2	6.8	38.0	0.8	21.5	2.0	2.0	5.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	103.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHJ5		ENSG00000242472	"Immunoglobulin heavy joining 5"		14	105863814-105863862	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"breast: 74.0;intestine: 73.0"	"Cell type enriched"	"Detected in single"	397	"Plasma cells: 39.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	4	"hypothalamus: 28.0"	"Immune cell enriched"	"Detected in many"	263	"memory B-cell: 1081.0"	"Lineage enriched"	"Detected in many"	263	"B-cells: 1081.0"	"Group enriched"	"Detected in some"	11	"HL-60: 10.5;REH: 14.0;RH-30: 18.0"															NA	NA																							33.8	0.0	1.2	0.0	3.0	0.0	74.0	1.2	6.7	0.0	2.1	73.0	0.0	0.0	0.0	0.2	0.0	0.0	1.6	1.5	28.0	4.6	29.7	17.2	0.0	3.7	4.0	0.6	0.0	4.8	0.0	0.0	0.0	2.5	33.0	0.2	0.2	0.0	0.0	0.0	7.9	0.0	0.0	1.4	0.0	0.0	0.4	1.9	0.0	4.9	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.6	2.1	1.2	0.7	1081.0	0.4	0.6	4.1	0.0	2.6	0.9	2.3	0.7	0.6	0.0	1.1	316.0	1.2	3.0	1.2	6.7	1.5	28.0	3.7	4.0	0.6	2.5	1.4	1.9	6.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHV1-18		ENSG00000211945	"Immunoglobulin heavy variable 1-18"	A0A0C4DH31	14	106184901-106185394	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 490.6;salivary gland: 236.2"	"Cell type enriched"	"Detected in some"	259	"Plasma cells: 13773.3"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	21	"memory B-cell: 73.2"	"Lineage enriched"	"Detected in many"	21	"B-cells: 73.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.6;HL-60: 3.0;RPMI-8226: 2.9;TIME: 1.6"														"Immunoglobulin genes"	NA	NA		4700000000				"prognostic favorable (3.47e-4)"	"unprognostic (2.53e-2)"	"unprognostic (8.73e-3)"	"unprognostic (2.56e-2)"	"unprognostic (9.67e-3)"	"prognostic favorable (8.27e-4)"	"unprognostic (5.47e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.50e-2)"	"unprognostic (3.60e-1)"	"unprognostic (4.26e-1)"	"prognostic unfavorable (5.84e-7)"	"unprognostic (3.22e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.44e-2)"	11.5	3.5	0.1	0.0	0.2	0.0	23.1	0.0	0.4	33.0	0.0	128.5	0.0	9.0	4.5	164.0	24.5	7.7	1.6	0.0	0.0	15.9	14.4	58.8	0.0	0.4	0.0	0.0	8.6	3.2	2.0	1.3	0.2	0.1	10.9	0.0	0.0	236.2	0.0	0.4	0.9	104.1	2.6	0.1	490.6	84.7	0.5	0.1	0.0	34.1	0.2	0.0	157.6	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	1.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	3.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.9	0.0	0.0	0.0	0.6	0.5	0.8	0.0	0.0	1.1	1.2	2.9	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.5	0.4	1.0	0.5	0.0	0.3	0.0	1.4	0.0	3.4	0.0	0.1	0.0	0.0	0.1	73.2	0.0	0.0	0.1	0.0	0.1	0.0	1.0	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	50.6	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.5	53.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	13773.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	3.2	0.0	0.1	0.0
IGHV1-2	V35	ENSG00000211934	"Immunoglobulin heavy variable 1-2"	P23083	14	105986582-105987083	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 467.1;lymphoid tissue: 1167.1"	"Cell type enriched"	"Detected in some"	38	"Plasma cells: 609.0"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	52	"memory B-cell: 285.2;naive B-cell: 347.4"	"Lineage enriched"	"Detected in many"	57	"B-cells: 347.4"	"Cell line enriched"	"Detected in some"	8	"U-266/70: 14302.7"														"Immunoglobulin genes"	NA	NA		4000000000				"unprognostic (1.63e-3)"	"unprognostic (1.09e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.46e-2)"	"unprognostic (5.78e-2)"	"prognostic favorable (1.67e-5)"	"unprognostic (9.05e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.20e-2)"	"prognostic unfavorable (2.02e-4)"	"unprognostic (2.17e-2)"	"unprognostic (8.59e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.17e-2)"	16.8	43.5	0.2	367.6	0.2	76.7	84.9	0.0	0.9	41.9	0.4	467.1	225.7	13.3	1.3	34.8	59.0	54.9	26.4	0.0	0.0	13.5	19.0	61.3	408.3	0.5	0.3	0.0	36.8	3.0	0.6	1.3	0.6	0.2	23.5	286.4	0.0	224.2	53.0	0.4	4.5	122.9	7.6	0.0	396.3	218.1	35.2	0.0	72.8	34.0	0.0	1167.1	257.7	9.0	0.6	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	4.3	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.8	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	2.6	0.0	0.0	2.3	0.4	2.8	0.0	0.0	3.1	0.6	0.5	0.0	0.0	1.3	1.8	0.1	0.0	0.6	0.0	0.0	0.2	0.3	0.0	1.5	0.0	1.3	14302.7	1755.5	0.5	0.0	0.4	0.0	0.3	0.6	0.1	0.3	0.0	0.2	285.2	1.6	0.7	0.2	347.4	1.5	0.6	6.1	0.2	0.3	0.5	1.1	34.0	0.2	0.2	0.0	0.9	0.0	0.0	0.5	0.3	0.0	0.2	0.0	0.0	0.6	0.0	0.0	1.3	0.0	15.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.1	4.6	0.0	0.0	0.2	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	609.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0
IGHV1-24		ENSG00000211950	"Immunoglobulin heavy variable 1-24"	A0A0C4DH33	14	106276548-106277043	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 188.3;salivary gland: 76.9"	"Cell type enriched"	"Detected in some"	4	"Plasma cells: 231.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	4	"medulla oblongata: 1.2"	"Immune cell enhanced"	"Detected in single"		"naive B-cell: 2.8"	"Lineage enriched"	"Detected in single"	9	"B-cells: 2.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.0;HL-60: 1.8;JURKAT: 1.3;RH-30: 1.4"														"Immunoglobulin genes"	NA	NA		3100000000				"prognostic favorable (9.01e-4)"	"unprognostic (2.67e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.93e-3)"		"prognostic favorable (3.61e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.10e-1)"	"prognostic unfavorable (2.07e-7)"	"unprognostic (5.43e-2)"	"unprognostic (3.14e-2)"	"unprognostic (3.17e-1)"	"unprognostic (4.78e-2)"	4.4	1.4	0.0	34.1	0.0	0.0	8.6	0.0	0.2	56.8	0.2	17.8	0.0	5.7	0.0	46.7	6.6	4.7	1.0	0.0	0.1	7.0	6.5	17.8	0.0	1.2	0.2	0.0	19.7	1.4	0.1	0.4	0.3	0.0	3.1	14.1	0.0	76.9	0.0	0.1	0.8	24.2	2.1	0.0	188.3	37.3	14.3	0.0	0.4	14.6	0.0	18.6	63.9	6.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.6	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.8	0.1	0.0	0.0	2.8	0.1	0.2	0.0	0.0	0.0	0.0	0.1	3.6	0.0	0.0	0.0	0.2	0.0	0.1	1.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	19.9	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	19.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	231.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	5.7	0.0	0.0	0.0	0.2	0.0	0.2	0.0
IGHV1-3	VI-3B	ENSG00000211935	"Immunoglobulin heavy variable 1-3"	A0A0C4DH29	14	106005095-106005574	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 225.4;lymphoid tissue: 634.5"	"Cell type enriched"	"Detected in some"	335	"Plasma cells: 13473.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"memory B-cell: 52.8;naive B-cell: 27.8"	"Lineage enriched"	"Detected in many"	9	"B-cells: 52.8"	"Cell line enriched"	"Detected in some"	11	"Karpas-707: 148.5"														"Immunoglobulin genes"	NA	NA		2600000000				"unprognostic (1.39e-2)"	"unprognostic (3.81e-3)"	"unprognostic (2.96e-2)"	"unprognostic (4.93e-2)"		"unprognostic (7.41e-3)"		"unprognostic (2.42e-1)"	"unprognostic (7.85e-2)"	"unprognostic (5.60e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.58e-1)"	"prognostic unfavorable (5.67e-7)"	"unprognostic (7.02e-2)"	"unprognostic (4.31e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.26e-1)"	10.7	59.9	0.0	209.7	0.0	36.7	47.1	0.0	0.5	42.0	0.2	195.2	220.5	4.8	15.5	45.9	6.6	86.2	1.8	0.0	0.0	7.6	8.9	41.3	173.2	0.2	0.0	0.0	8.4	7.1	0.3	0.6	0.1	0.1	6.1	225.4	0.0	121.6	23.7	0.6	0.9	142.1	11.4	0.1	248.6	190.8	0.4	0.2	58.3	24.4	0.0	634.5	92.9	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	14.1	1.0	148.5	0.0	0.0	0.8	1.1	0.1	0.0	0.0	0.0	0.7	0.7	0.0	0.0	10.0	8.9	0.1	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.7	0.0	2.8	1.4	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	52.8	0.6	0.2	0.0	27.8	1.6	0.5	0.0	0.0	0.0	5.8	1.7	6.1	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	40.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	27.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13473.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	4.5	0.0	0.0	0.0
IGHV1-45		ENSG00000211961	"Immunoglobulin heavy variable 1-45"	A0A0A0MS14	14	106506996-106507491	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 19.1;lymphoid tissue: 30.5;stomach 1: 17.6"	"Cell type enriched"	"Detected in single"	20	"Plasma cells: 2.0"	"Cancer enriched"	"Detected in many"	7	"lung cancer: 15.4"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"U-266/70: 1.2;U-266/84: 1.3"														"Immunoglobulin genes"	NA	NA		380000000				"prognostic favorable (5.57e-4)"	"unprognostic (5.07e-3)"	"unprognostic (2.12e-3)"	"unprognostic (1.46e-1)"		"unprognostic (7.64e-3)"	"unprognostic (2.90e-1)"	"unprognostic (3.50e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.05e-1)"	"unprognostic (1.28e-3)"	"unprognostic (2.94e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.16e-1)"	0.2	0.1	0.0	3.7	0.0	1.8	19.1	0.0	0.0	0.3	0.0	4.6	1.1	0.5	0.0	6.5	0.2	0.6	0.1	0.0	0.0	0.2	0.2	3.6	7.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.3	6.2	0.0	11.6	0.0	0.0	0.1	2.3	0.7	0.0	6.9	17.6	0.1	0.0	3.0	0.3	0.0	30.5	4.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	1.1	0.6	0.3	0.0	1.1	0.7	0.7	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHV1-46		ENSG00000211962	"Immunoglobulin heavy variable 1-46"	P01743	14	106511117-106511856	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 45.5;lymphoid tissue: 126.7;salivary gland: 67.9"	"Cell type enriched"	"Detected in some"	201	"Plasma cells: 8432.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.7;RPMI-8226: 1.2;SH-SY5Y: 1.2;TIME: 2.3;U-266/70: 1.1;U-266/84: 1.2"														"Immunoglobulin genes"	NA	NA		2900000000				"prognostic favorable (6.28e-4)"	"unprognostic (2.49e-2)"	"prognostic favorable (7.34e-4)"	"unprognostic (1.10e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.80e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.76e-2)"	"unprognostic (8.11e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.27e-1)"	"prognostic unfavorable (1.56e-6)"	"unprognostic (6.19e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.13e-1)"	2.9	1.3	0.0	0.0	0.0	0.0	7.2	0.0	0.2	6.3	0.1	38.7	0.0	2.5	1.0	5.0	3.5	0.7	4.7	0.0	0.0	3.2	4.2	15.4	0.0	0.1	0.0	0.0	3.0	5.4	0.1	0.4	0.4	0.1	1.9	45.5	0.0	67.9	0.0	0.1	0.7	34.5	0.0	0.0	126.7	25.3	0.2	0.0	0.0	10.6	0.2	0.0	5.2	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.3	1.2	0.0	0.0	0.5	1.2	0.2	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.3	0.0	0.1	1.1	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.7	0.0	0.0	0.0	1.9	41.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8432.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0
IGHV1-69	IGHV1-E	ENSG00000211973	"Immunoglobulin heavy variable 1-69"	P01742	14	106714684-106715181	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 140.3;lymphoid tissue: 171.6;urinary bladder: 164.1"	"Cell type enriched"	"Detected in some"	85	"Plasma cells: 231.0"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"medulla oblongata: 2.5;pons: 2.4"	"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.5;plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 1.4;HMC-1: 1.0;MOLT-4: 6.2;SCLC-21H: 1.1;U-698: 1.9"														"Immunoglobulin genes"	NA	NA		2700000000				"unprognostic (3.51e-3)"	"unprognostic (7.03e-2)"	"prognostic favorable (9.56e-5)"	"prognostic favorable (8.32e-4)"		"unprognostic (1.06e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.91e-1)"	"prognostic unfavorable (2.77e-7)"	"unprognostic (1.28e-1)"	"unprognostic (2.95e-1)"	"unprognostic (8.20e-2)"	"unprognostic (6.82e-2)"	4.0	1.4	0.0	0.0	0.2	0.1	6.6	0.0	0.5	21.5	0.3	32.6	0.0	7.0	0.0	7.0	5.7	78.2	0.5	0.0	0.2	6.8	4.9	18.1	0.0	2.5	0.0	0.0	2.0	0.8	1.8	0.5	0.0	2.4	4.7	140.3	0.0	56.4	13.2	0.1	0.3	31.9	6.8	0.0	171.6	31.2	0.1	0.3	0.0	25.4	0.0	0.0	164.1	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.1	0.1	0.9	0.0	0.0	1.3	0.0	0.5	0.0	0.2	0.0	0.5	0.0	0.2	2.5	0.0	0.0	2.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	231.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0
IGHV1-69-2	IGHV1-F	ENSG00000281990	"Immunoglobulin heavy variable 1-69-2"	A0A0G2JMI3	14	106737110-106737547	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 22.3;lymphoid tissue: 47.5;salivary gland: 16.5"	"Cell type enriched"	"Detected in some"	226	"Plasma cells: 10423.1"					"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"memory B-cell: 6.7;naive B-cell: 5.5"	"Lineage enriched"	"Detected in many"	6	"B-cells: 6.7"	"Cell line enriched"	"Detected in some"	6	"MOLT-4: 11.2"														"Immunoglobulin genes"	NA	NA		1100000000																					2.9	0.3	0.0	5.9	0.0	2.5	3.7	0.0	0.0	1.4	0.0	12.1	22.3	1.1	0.2	2.1	1.2	14.7	1.6	0.0	0.0	2.6	0.9	4.5	13.6	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.5	14.5	0.0	16.5	0.9	0.0	0.0	18.2	0.2	0.0	47.5	10.0	0.2	0.0	3.8	1.1	0.0	36.8	4.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	6.7	0.5	0.9	0.0	5.5	0.6	1.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.0	1.4	23.0	0.0	0.0	0.0	1.1	1.2	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10423.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0
IGHV2-5		ENSG00000211937	"Immunoglobulin heavy variable 2-5"	P01817	14	106037902-106038365	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 470.2;lymphoid tissue: 1438.6;stomach 1: 714.4"	"Cell type enriched"	"Detected in some"	333	"Plasma cells: 9414.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	22	"memory B-cell: 66.7;naive B-cell: 67.3"	"Lineage enriched"	"Detected in many"	22	"B-cells: 67.3"	"Cell line enriched"	"Detected in some"	5	"Karpas-707: 8.8"														"Immunoglobulin genes"	NA	NA		700000000				"unprognostic (1.38e-2)"	"unprognostic (4.10e-3)"	"unprognostic (2.51e-2)"	"unprognostic (6.62e-3)"		"prognostic favorable (1.41e-4)"	"unprognostic (1.66e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.45e-2)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (2.09e-6)"	"unprognostic (2.74e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.15e-1)"	"unprognostic (1.56e-1)"	17.0	5.0	0.0	184.7	0.2	113.9	107.1	0.0	0.4	45.4	0.3	470.2	269.0	7.6	2.5	28.1	10.8	65.6	5.8	0.0	0.1	20.3	16.5	84.7	189.6	0.6	0.1	0.0	13.9	9.4	1.0	1.1	0.3	0.6	9.4	299.1	0.0	203.1	8.9	0.4	1.6	178.5	17.6	0.3	353.8	714.4	2.3	0.1	122.6	27.9	0.0	1438.6	251.7	12.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	8.8	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.2	1.6	0.4	0.0	0.1	1.2	1.8	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.3	0.4	0.6	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	66.7	0.0	0.0	0.1	67.3	0.1	0.1	3.0	0.0	0.0	0.0	0.0	10.5	0.0	0.2	0.0	0.4	0.0	0.1	0.6	0.1	0.0	0.6	0.3	0.1	0.4	0.0	0.0	0.0	0.0	28.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.1	27.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	3.4	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9414.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	3.2	0.0	0.0	0.0
IGHV2-70D		ENSG00000211974	"Immunoglobulin heavy variable 2-70D"	A0A0C4DH43	14	106723574-106724093	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 37.1;lymphoid tissue: 91.7;stomach 1: 47.4"	"Cell type enriched"	"Detected in single"	10	"B-cells: 1.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	68	"memory B-cell: 9.7;naive B-cell: 3.7"	"Lineage enriched"	"Detected in single"	97	"B-cells: 9.7"	"Cell line enriched"	"Detected in single"	7	"MOLT-4: 1.7"														"Immunoglobulin genes"	NA	NA		110000000				"unprognostic (5.57e-2)"	"unprognostic (9.48e-3)"	"prognostic favorable (3.34e-4)"	"unprognostic (4.34e-2)"		"unprognostic (8.37e-3)"		"unprognostic (2.34e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.13e-2)"	"unprognostic (6.01e-2)"	"prognostic unfavorable (3.09e-4)"	"unprognostic (6.70e-2)"	"unprognostic (3.83e-1)"	"unprognostic (3.66e-2)"	"unprognostic (8.11e-2)"	1.7	0.7	0.0	16.7	0.0	4.2	7.1	0.0	0.1	5.6	0.1	37.1	14.3	1.9	0.0	5.3	4.5	21.1	1.7	0.0	0.1	2.4	2.3	6.3	4.7	0.0	0.0	0.0	0.8	0.3	0.1	0.1	0.0	0.0	0.7	33.5	0.0	30.5	0.1	0.0	0.1	21.9	0.6	0.0	41.7	47.4	0.0	0.0	4.6	2.6	0.0	91.7	3.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHV3-11		ENSG00000211941	"Immunoglobulin heavy variable 3-11"	P01762	14	106116635-106117204	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 222.2;lymphoid tissue: 618.3;stomach 1: 208.5"	"Cell type enriched"	"Detected in some"	142	"Plasma cells: 1655.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	445	"memory B-cell: 43.1;naive B-cell: 45.7"	"Lineage enriched"	"Detected in single"	458	"B-cells: 45.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.1;SH-SY5Y: 1.2"														"Immunoglobulin genes"	NA	NA		18000000000				"unprognostic (2.07e-3)"	"unprognostic (4.84e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.04e-2)"	"prognostic favorable (3.42e-5)"	"unprognostic (4.12e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.44e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (1.52e-5)"	"unprognostic (1.43e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.30e-1)"	8.4	26.2	0.0	176.6	0.1	38.3	66.7	0.0	0.5	35.0	0.2	222.2	195.1	6.9	12.4	38.9	6.7	44.1	8.7	0.0	0.0	6.7	10.6	29.4	124.7	0.7	0.1	0.0	7.9	2.0	0.2	0.8	0.0	0.1	4.1	169.5	0.0	120.7	3.8	0.3	0.7	117.8	11.3	0.1	220.9	208.5	1.3	0.5	45.3	17.1	0.0	618.3	110.4	8.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.1	0.7	0.7	0.0	0.0	0.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.1	0.0	0.0	0.0	45.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.1	0.0	0.5	0.0	0.0	0.7	0.1	0.0	0.1	0.1	0.5	0.2	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.6	0.0	0.0	0.0	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1655.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0
IGHV3-20		ENSG00000211946	"Immunoglobulin heavy variable 3-20"	A0A0C4DH32	14	106210936-106211453	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 100.1;lymphoid tissue: 218.5;stomach 1: 123.6;urinary bladder: 82.6"	"Cell type enriched"	"Detected in some"	24	"Plasma cells: 142.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	242	"memory B-cell: 28.5;naive B-cell: 19.8"	"Lineage enriched"	"Detected in single"	286	"B-cells: 28.5"	"Cell line enhanced"	"Detected in single"		"Daudi: 1.2"														"Immunoglobulin genes"	NA	NA		2200000000				"prognostic favorable (2.56e-5)"	"unprognostic (2.30e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.45e-2)"		"prognostic favorable (2.93e-4)"	"unprognostic (1.35e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.93e-1)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (2.09e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.76e-1)"	1.9	2.2	0.0	36.6	0.2	22.8	23.9	0.0	0.1	17.5	0.2	65.4	100.1	1.8	0.0	10.2	2.3	20.9	3.1	0.0	0.0	1.5	4.7	10.6	58.4	0.1	0.0	0.0	2.8	0.4	0.1	0.2	0.0	0.0	1.3	63.1	0.0	43.5	1.4	0.0	0.3	38.0	2.0	0.0	60.1	123.6	1.2	0.0	16.8	2.8	0.0	218.5	82.6	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.5	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	142.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0
IGHV3-21		ENSG00000211947	"Immunoglobulin heavy variable 3-21"	A0A0B4J1V1	14	106235064-106235594	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 401.3;salivary gland: 215.0"	"Cell type enriched"	"Detected in some"	86	"Plasma cells: 3885.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 2.1;NB-4: 2.1;NTERA-2: 1.2;RH-30: 2.3;TIME: 1.9"														"Immunoglobulin genes"	NA	NA		37000000000				"prognostic favorable (1.30e-4)"	"unprognostic (1.21e-2)"	"unprognostic (7.19e-3)"	"unprognostic (1.51e-2)"	"unprognostic (9.16e-3)"	"prognostic favorable (9.34e-4)"	"unprognostic (3.15e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.05e-1)"	"prognostic unfavorable (9.31e-8)"	"unprognostic (1.73e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.77e-1)"	10.5	2.7	0.3	0.0	0.2	0.0	25.0	0.2	1.2	13.6	0.2	120.6	0.0	7.1	0.9	17.5	31.2	0.0	1.4	0.3	0.2	15.0	10.8	55.7	0.0	0.4	0.2	0.2	2.9	16.3	2.4	1.3	0.6	0.4	7.3	0.0	0.0	215.0	0.3	0.4	4.3	112.2	0.8	0.3	401.3	83.6	0.4	0.3	0.0	25.8	0.0	0.0	28.0	10.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	2.1	1.2	0.0	0.0	0.7	2.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.3	0.2	0.2	1.2	0.3	0.2	0.4	0.2	0.2	0.4	0.3	0.3	1.0	0.0	0.0	0.0	0.0	44.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	1.0	21.4	0.0	0.0	0.1	0.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3885.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.2	0.0
IGHV3-23		ENSG00000211949	"Immunoglobulin heavy variable 3-23"	P01764	14	106268606-106269140	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1699.2;lymphoid tissue: 3014.7"	"Cell type enriched"	"Detected in some"	139	"Plasma cells: 15979.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	406	"memory B-cell: 548.5;naive B-cell: 336.7"	"Lineage enriched"	"Detected in many"	503	"B-cells: 548.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.4;HL-60: 3.3;NB-4: 4.1;RH-30: 3.0;RPMI-8226: 9.0;SH-SY5Y: 5.8"														"Immunoglobulin genes"	NA	NA		42000000000				"unprognostic (1.17e-3)"	"unprognostic (5.43e-2)"	"unprognostic (9.68e-3)"	"unprognostic (3.31e-3)"	"unprognostic (1.34e-2)"	"prognostic favorable (3.85e-4)"	"unprognostic (3.26e-1)"	"unprognostic (4.79e-1)"	"unprognostic (7.26e-2)"	"unprognostic (6.52e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (1.79e-7)"	"unprognostic (6.22e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.42e-2)"	67.1	191.1	0.5	920.7	0.6	187.2	346.7	0.2	2.0	80.8	1.5	1699.2	1655.6	37.3	9.9	345.7	30.4	233.3	46.7	0.2	0.3	26.8	56.9	250.9	866.7	1.1	0.6	0.2	43.0	31.3	1.5	2.7	0.9	0.6	35.6	1097.7	0.1	704.2	54.0	0.9	15.1	894.2	40.4	0.8	809.1	1068.3	35.3	0.4	199.3	52.7	0.1	3014.7	1001.7	27.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.2	4.1	0.7	0.0	0.0	0.6	3.0	9.0	0.0	0.0	2.7	5.8	0.8	0.1	0.0	0.0	0.0	0.0	1.8	0.0	1.3	1.3	1.1	1.5	0.0	0.3	0.0	0.9	0.0	0.4	0.4	0.1	0.2	0.0	0.1	548.5	0.2	0.3	0.3	336.7	0.1	0.2	1.0	0.2	0.2	0.2	0.8	62.4	0.5	0.6	0.2	2.0	0.2	0.3	1.1	0.6	0.2	0.6	0.8	0.4	1.3	0.1	0.0	0.0	0.0	114.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	12.0	0.0	0.0	0.0	1.6	19.4	0.0	1.3	0.0	1.8	2.0	0.2	0.0	0.0	0.1	0.0	4.1	0.0	0.0	0.0	3.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15979.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	3.9	0.0	0.1	0.0
IGHV3-33		ENSG00000211955	"Immunoglobulin heavy variable 3-33"	P01772	14	106359793-106360324	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1076.9;lymphoid tissue: 2391.5;stomach 1: 1794.9"	"Cell type enriched"	"Detected in some"	26	"Plasma cells: 556.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	101	"memory B-cell: 378.9;naive B-cell: 364.1"	"Lineage enriched"	"Detected in many"	103	"B-cells: 378.9"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 5.4;HL-60: 5.3;RPMI-8226: 7.7;SH-SY5Y: 3.8;U-266/70: 8.1"														"Immunoglobulin genes"	NA	NA		7500000000				"unprognostic (1.04e-3)"	"unprognostic (2.38e-2)"	"unprognostic (8.95e-3)"	"prognostic favorable (6.36e-4)"	"unprognostic (6.84e-2)"	"prognostic favorable (7.19e-5)"	"unprognostic (1.80e-1)"	"unprognostic (1.95e-1)"	"unprognostic (7.31e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.18e-1)"	"prognostic unfavorable (4.10e-6)"	"unprognostic (6.23e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.26e-1)"	"unprognostic (5.92e-2)"	21.9	68.0	1.1	518.6	0.7	118.7	292.5	0.2	3.0	54.1	2.1	1076.9	890.1	16.4	14.7	128.7	19.0	143.2	33.1	0.3	0.2	15.2	42.1	212.0	801.9	1.3	0.9	0.2	110.9	29.6	2.0	1.8	0.8	0.6	23.4	782.9	0.0	625.3	39.9	0.5	3.6	346.7	37.7	0.4	479.9	1794.9	29.6	0.7	299.5	42.6	0.1	2391.5	383.1	18.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	5.4	0.0	0.5	0.0	0.0	0.0	5.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.1	0.8	0.0	0.0	0.5	0.2	0.3	0.0	0.0	0.8	2.9	7.7	0.0	0.0	1.4	3.8	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.3	0.7	8.1	0.0	0.2	0.0	0.8	0.0	0.2	0.6	0.1	1.1	0.0	1.9	378.9	3.6	0.9	0.3	364.1	1.4	0.6	1.0	0.2	0.1	0.2	0.5	44.6	1.1	0.7	0.2	3.0	0.3	0.2	1.3	0.9	0.2	0.6	0.4	0.7	1.0	0.0	0.0	0.6	0.0	20.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	10.0	2.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	556.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0
IGHV3-43		ENSG00000232216	"Immunoglobulin heavy variable 3-43"	A0A0B4J1X8	14	106470264-106470800	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 213.9;stomach 1: 315.0;urinary bladder: 154.3"	"Cell type enriched"	"Detected in some"	28	"Plasma cells: 557.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	321	"memory B-cell: 29.4;naive B-cell: 39.0"	"Lineage enriched"	"Detected in single"	366	"B-cells: 39.0"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 1.8;SH-SY5Y: 2.3"														"Immunoglobulin genes"	NA	NA		4000000000				"prognostic favorable (2.31e-4)"	"unprognostic (2.22e-2)"	"prognostic favorable (1.46e-4)"	"unprognostic (4.87e-3)"		"prognostic favorable (8.20e-4)"	"unprognostic (2.36e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.63e-1)"	"unprognostic (7.27e-3)"	"unprognostic (4.50e-2)"	"unprognostic (8.73e-2)"	"prognostic unfavorable (2.40e-5)"	"unprognostic (1.60e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.75e-2)"	9.4	2.3	0.0	23.9	0.3	11.6	44.2	0.0	0.3	46.4	0.0	102.7	103.4	2.0	0.0	10.3	3.6	10.8	0.3	0.0	0.0	2.6	9.9	10.9	4.3	0.9	0.1	0.0	4.2	2.2	1.0	0.3	0.1	0.1	2.7	66.7	0.0	58.6	5.5	0.1	1.1	48.8	4.4	0.0	84.4	315.0	0.2	0.1	0.0	3.8	0.0	213.9	154.3	4.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.2	1.8	0.0	0.0	0.5	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	29.4	0.0	0.0	0.0	39.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.3	0.0	0.3	0.0	0.0	0.9	0.1	0.0	0.1	0.0	0.1	0.9	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	557.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0
IGHV3-48		ENSG00000211964	"Immunoglobulin heavy variable 3-48"	P01763	14	106537810-106538344	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 521.1;lymphoid tissue: 866.0;stomach 1: 408.5"	"Cell type enriched"	"Detected in some"	100	"Plasma cells: 5878.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebral cortex: 1.3"	"Group enriched"	"Detected in some"	527	"memory B-cell: 187.1;naive B-cell: 97.5"	"Lineage enriched"	"Detected in single"	693	"B-cells: 187.1"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 1.5;SH-SY5Y: 1.6"														"Immunoglobulin genes"	NA	NA		49000000000				"unprognostic (9.19e-3)"	"unprognostic (1.87e-2)"	"unprognostic (5.12e-2)"	"unprognostic (9.07e-3)"	"unprognostic (1.77e-1)"	"prognostic favorable (1.56e-5)"	"unprognostic (1.23e-1)"	"unprognostic (9.59e-2)"	"unprognostic (2.65e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.44e-1)"	"prognostic unfavorable (4.88e-8)"	"unprognostic (1.89e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.15e-1)"	6.9	23.1	0.0	234.8	0.1	81.9	56.9	0.0	1.3	26.1	0.5	438.3	521.1	8.2	0.1	33.7	12.2	39.0	6.9	0.0	0.0	10.6	18.7	32.6	126.3	0.4	0.1	0.0	12.3	8.9	0.9	0.9	0.1	1.3	6.9	255.6	0.0	166.1	16.2	0.6	1.6	135.5	17.8	0.2	273.3	408.5	28.1	0.1	36.6	16.1	0.0	866.0	250.8	7.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.9	0.4	0.0	0.0	0.0	0.8	0.9	0.0	0.0	1.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.5	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	187.1	0.0	0.0	0.1	97.5	0.0	0.1	0.1	0.0	0.0	0.0	0.2	22.0	0.0	0.1	0.0	1.3	0.0	0.0	0.4	0.1	0.0	1.3	0.2	0.1	0.2	0.0	0.0	0.0	0.0	58.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.0	0.7	17.9	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5878.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0
IGHV3-49		ENSG00000211965	"Immunoglobulin heavy variable 3-49"	A0A0A0MS15	14	106556936-106557477	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 212.7;lymphoid tissue: 376.7;stomach 1: 183.9"	"Cell type enriched"	"Detected in some"	46	"Plasma cells: 717.7"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in single"		"medulla oblongata: 1.0"	"Group enriched"	"Detected in some"	187	"memory B-cell: 59.4;naive B-cell: 42.2"	"Lineage enriched"	"Detected in single"	219	"B-cells: 59.4"	"Cell line enhanced"	"Detected in single"		"RPMI-8226: 1.0"														"Immunoglobulin genes"	NA	NA		1600000000				"prognostic favorable (7.16e-4)"	"unprognostic (7.91e-3)"	"unprognostic (2.50e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.12e-1)"	"prognostic favorable (2.34e-6)"	"unprognostic (4.47e-2)"	"unprognostic (4.30e-2)"	"unprognostic (7.00e-3)"	"unprognostic (9.17e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.20e-2)"	"prognostic unfavorable (1.43e-6)"	"unprognostic (7.42e-2)"	"unprognostic (2.79e-1)"	"unprognostic (8.96e-2)"	"unprognostic (3.00e-1)"	21.0	7.2	0.1	113.3	0.3	46.1	42.9	0.0	0.5	11.6	0.2	212.7	186.0	4.7	3.9	20.2	5.1	11.0	9.4	0.0	0.1	4.9	12.9	43.6	109.5	1.0	0.1	0.0	26.8	1.8	0.2	0.4	0.0	0.3	3.0	140.6	0.0	89.2	12.2	0.2	0.3	88.9	11.6	0.1	184.7	183.9	1.8	0.1	21.6	9.8	0.0	376.7	100.9	3.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.4	1.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.4	0.0	0.0	0.0	42.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	8.8	0.1	0.3	0.0	0.5	0.0	0.1	1.0	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.4	1.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	4.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	717.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0
IGHV3-53		ENSG00000211967	"Immunoglobulin heavy variable 3-53"	P01767	14	106592676-106593347	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 82.2;lymphoid tissue: 130.6;stomach 1: 43.7"	"Cell type enriched"	"Detected in some"	22	"Plasma cells: 176.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	99	"memory B-cell: 54.7;naive B-cell: 52.7"	"Lineage enriched"	"Detected in single"	101	"B-cells: 54.7"	"Not detected"	"Not detected"																"Immunoglobulin genes"	NA	NA		4300000000				"unprognostic (1.41e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.46e-3)"	"prognostic favorable (5.66e-4)"		"prognostic favorable (3.95e-4)"	"unprognostic (3.91e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.51e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.36e-2)"	"prognostic unfavorable (2.04e-5)"	"unprognostic (1.79e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.72e-1)"	2.9	0.8	0.0	37.5	0.0	8.0	15.7	0.0	0.1	4.7	0.0	67.2	82.2	1.0	0.3	4.2	2.0	6.7	1.4	0.0	0.0	1.8	2.8	7.8	38.9	0.0	0.0	0.0	3.3	1.3	0.1	0.1	0.0	0.0	1.1	74.7	0.0	32.5	2.0	0.0	0.2	34.1	2.3	0.0	67.4	43.7	1.6	0.0	8.2	4.6	0.0	130.6	10.3	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	54.7	0.0	0.0	0.0	52.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	176.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
IGHV3-64		ENSG00000223648	"Immunoglobulin heavy variable 3-64"	A0A075B6Q5	14	106657725-106658258	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 32.4;salivary gland: 21.2"	"Cell type enriched"	"Detected in some"	38	"Plasma cells: 88.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	19	"memory B-cell: 11.1"	"Lineage enriched"	"Detected in single"	111	"B-cells: 11.1"	"Cell line enhanced"	"Detected in single"		"HL-60: 1.1"														"Immunoglobulin genes"	NA	NA		4300000000				"prognostic favorable (6.09e-6)"	"unprognostic (6.52e-2)"	"unprognostic (2.11e-3)"	"unprognostic (3.10e-2)"		"unprognostic (1.39e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.01e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.52e-1)"	"prognostic unfavorable (3.93e-5)"	"unprognostic (1.58e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.07e-2)"	0.9	0.1	0.0	2.0	0.0	8.7	7.2	0.0	0.4	0.5	0.0	11.8	7.0	0.9	0.0	1.2	1.9	4.2	1.2	0.0	0.0	0.7	2.3	4.3	0.0	0.0	0.0	0.0	3.3	3.6	0.0	0.1	0.0	0.0	0.6	1.2	0.0	21.2	0.4	0.0	0.0	11.4	1.3	0.0	32.4	6.1	0.0	0.0	0.0	1.5	0.0	0.0	3.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	88.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0
IGHV3-66		ENSG00000211972	"Immunoglobulin heavy variable 3-66"	A0A0C4DH42	14	106675017-106675544	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 47.7;intestine: 60.1;urinary bladder: 104.9"	"Cell type enriched"	"Detected in some"	107	"Plasma cells: 958.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	137	"memory B-cell: 39.7"	"Lineage enriched"	"Detected in single"	137	"B-cells: 39.7"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 1.7;U-2 OS: 2.3"														"Immunoglobulin genes"	NA	NA		7200000000				"prognostic favorable (2.43e-6)"	"unprognostic (2.48e-2)"	"unprognostic (5.05e-3)"	"unprognostic (1.31e-3)"		"unprognostic (2.20e-3)"	"unprognostic (8.65e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.83e-2)"	"unprognostic (1.87e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (2.89e-6)"	"unprognostic (3.87e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.19e-1)"	3.9	0.9	0.0	0.0	0.0	11.2	3.9	0.0	0.4	15.5	0.2	60.1	0.0	1.4	1.2	27.3	3.3	47.7	0.2	0.0	0.0	1.3	3.6	13.2	41.5	0.1	0.0	0.0	5.7	0.4	0.0	0.1	0.0	0.0	3.9	32.6	0.0	16.3	5.7	0.0	1.5	10.2	1.3	0.0	32.0	6.4	0.6	0.0	0.0	2.5	0.0	40.0	104.9	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	39.7	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	958.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
IGHV3-7		ENSG00000211938	"Immunoglobulin heavy variable 3-7"	P01780	14	106062151-106062683	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 465.8;lymphoid tissue: 979.9"	"Cell type enriched"	"Detected in some"	255	"Plasma cells: 20463.1"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 18.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	147	"memory B-cell: 134.0;naive B-cell: 107.0"	"Lineage enriched"	"Detected in single"	163	"B-cells: 134.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 7.6;HL-60: 3.1;K-562: 3.0;NB-4: 3.0;RPMI-8226: 5.8;SH-SY5Y: 4.8;TIME: 2.9"														"Immunoglobulin genes"	NA	NA		39000000000				"unprognostic (1.29e-2)"	"unprognostic (5.57e-3)"	"unprognostic (1.37e-2)"			"prognostic favorable (1.47e-6)"	"unprognostic (1.00e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (4.35e-5)"	"unprognostic (5.18e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.70e-2)"	48.2	10.2	0.8	50.5	0.8	71.8	204.9	0.6	3.3	88.1	0.8	465.8	155.4	38.1	8.3	17.9	13.6	37.3	2.1	0.3	0.3	17.4	20.5	56.9	103.4	2.0	1.9	0.3	24.9	4.8	2.9	1.9	0.3	3.5	9.2	306.6	0.0	267.6	23.2	1.3	9.7	207.7	3.6	3.7	615.3	232.6	13.3	0.4	0.0	21.3	0.1	979.9	43.3	15.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	3.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.0	0.0	0.0	0.0	0.0	3.0	0.5	0.0	0.0	0.4	2.6	5.8	0.0	0.0	2.3	4.8	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.7	0.0	1.2	1.6	0.0	0.1	0.0	0.6	0.0	0.4	0.8	0.2	0.1	0.0	0.2	134.0	0.2	0.2	0.3	107.0	0.1	0.1	0.1	0.1	0.2	0.6	0.2	12.6	0.8	0.8	0.6	3.3	0.3	0.3	2.0	1.9	0.3	3.5	3.7	0.4	1.4	0.0	0.0	0.0	0.0	80.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	30.5	0.0	5.3	0.0	0.0	0.0	4.4	31.1	0.0	0.0	0.0	2.2	1.9	0.0	0.0	0.0	0.2	0.0	1.6	0.0	0.3	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20463.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.0	0.0	0.0	7.4	0.0	0.5	0.0
IGHV3-72		ENSG00000225698	"Immunoglobulin heavy variable 3-72"	A0A0B4J1Y9	14	106790691-106791233	"Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 58.7;lymphoid tissue: 122.6;urinary bladder: 102.0"	"Cell type enriched"	"Detected in some"	271	"Plasma cells: 3507.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	5	"memory B-cell: 52.4"	"Lineage enriched"	"Detected in many"	50	"B-cells: 52.4"	"Cell line enhanced"	"Detected in some"		"NB-4: 1.3;RH-30: 1.3;RPMI-8226: 1.2;TIME: 2.2;U-698: 5.8"														"Immunoglobulin genes"	NA	NA		9600000000				"prognostic favorable (9.10e-6)"	"unprognostic (2.18e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.93e-2)"		"prognostic favorable (8.57e-5)"	"unprognostic (9.14e-3)"	"unprognostic (3.98e-2)"	"unprognostic (1.86e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.27e-2)"	"prognostic unfavorable (4.40e-4)"	"unprognostic (9.29e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.32e-1)"	4.8	2.6	0.1	18.5	0.0	15.6	7.1	0.0	0.6	5.2	0.2	56.3	28.7	3.0	2.9	17.6	3.4	0.3	0.3	0.0	0.0	1.9	5.4	8.7	2.7	0.3	0.1	0.0	2.3	3.4	0.1	0.2	0.1	0.1	1.9	48.2	0.0	46.9	0.9	0.1	0.3	58.7	5.5	0.0	122.6	29.7	0.0	0.0	2.6	2.3	0.5	12.3	102.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	1.3	0.2	0.0	0.0	0.1	1.3	1.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.2	0.1	0.0	0.3	0.0	5.8	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	52.4	0.1	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.4	0.1	0.0	0.0	0.6	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.0	0.1	7.1	0.0	0.0	0.0	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3507.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0
IGHV3-74		ENSG00000224650	"Immunoglobulin heavy variable 3-74"	A0A0B4J1X5	14	106810442-106811131	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 88.1;lymphoid tissue: 329.7;salivary gland: 103.4"	"Cell type enriched"	"Detected in some"	454	"Plasma cells: 19404.3"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.5"	"Immune cell enhanced"	"Detected in single"		"naive CD8 T-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	861	"Daudi: 2948.0"														"Immunoglobulin genes"	NA	NA		27000000000				"prognostic favorable (2.47e-4)"	"unprognostic (9.70e-2)"	"prognostic favorable (8.33e-4)"	"unprognostic (6.96e-3)"	"unprognostic (1.42e-1)"	"prognostic favorable (7.79e-4)"	"unprognostic (1.06e-1)"	"unprognostic (7.06e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.85e-2)"	"prognostic unfavorable (4.70e-6)"	"unprognostic (1.14e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.12e-1)"	11.4	1.2	0.1	0.0	0.2	0.0	12.7	0.0	1.5	9.4	0.0	58.9	0.0	2.1	1.9	88.1	2.7	1.3	0.7	0.0	0.1	4.6	6.7	22.4	0.0	0.5	0.4	0.0	2.5	1.9	0.6	0.8	0.1	0.2	6.6	0.0	0.0	103.4	0.0	0.5	3.3	74.7	0.0	0.1	329.7	27.7	0.2	0.1	0.0	7.7	0.0	0.0	46.9	5.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.2	2948.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.1	1.1	0.2	0.0	0.0	0.1	1.2	0.0	0.1	0.1	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.1	0.7	0.3	0.4	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	1.2	0.9	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	1.5	0.0	0.1	0.5	0.4	0.0	0.2	0.1	0.1	0.4	0.0	0.0	0.0	0.0	42.7	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	1.4	27.5	0.2	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.6	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	19404.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	2.3	0.0	0.1	0.3
IGHV3OR15-7	IGHV3/OR15-7	ENSG00000259490	"Immunoglobulin heavy variable 3/OR15-7 (pseudogene)"		15	19987656-19988117	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"intestine: 2.0;stomach 1: 1.9"	"Cell type enriched"	"Detected in single"	104	"Plasma cells: 10.4"	"Cancer enhanced"	"Detected in many"		"lung cancer: 3.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA						"unprognostic (1.08e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.07e-1)"		"prognostic favorable (1.43e-5)"		"unprognostic (4.56e-1)"			"unprognostic (3.12e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.07e-4)"	"unprognostic (7.46e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.24e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.5	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHV4-31		ENSG00000231475	"Immunoglobulin heavy variable 4-31"	A0A087WSY4	14	106349283-106349792	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 471.6;urinary bladder: 192.5"	"Cell type enriched"	"Detected in some"	183	"Plasma cells: 1651.6"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"hypothalamus: 4.8;midbrain: 4.5;spinal cord: 1.5"	"Group enriched"	"Detected in some"	48	"memory B-cell: 43.6;naive B-cell: 19.4"	"Lineage enriched"	"Detected in single"	66	"B-cells: 43.6"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 1.4;SH-SY5Y: 1.0"														"Immunoglobulin genes"	NA	NA		710000000				"unprognostic (1.53e-3)"	"unprognostic (9.05e-2)"	"unprognostic (1.12e-1)"	"prognostic favorable (5.74e-4)"		"prognostic favorable (4.64e-5)"	"unprognostic (1.16e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.72e-2)"	"unprognostic (9.75e-2)"	"prognostic unfavorable (6.38e-6)"	"unprognostic (2.00e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.09e-1)"	2.6	1.8	0.0	48.5	0.0	5.4	38.0	0.1	0.7	15.5	0.0	104.8	72.7	6.6	1.5	32.5	5.4	106.1	11.8	0.0	4.8	3.8	6.4	19.3	104.8	0.2	4.5	0.0	58.5	4.8	0.2	0.5	0.0	0.2	11.5	25.1	0.0	53.7	8.4	0.1	1.3	91.1	3.1	1.5	139.7	88.6	1.3	0.2	76.8	15.9	0.0	471.6	192.5	4.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.4	1.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.6	0.1	0.0	0.0	19.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.5	0.0	0.0	0.1	0.7	0.0	4.8	0.2	4.5	0.0	0.2	1.5	0.2	0.1	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1651.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
IGHV4-34		ENSG00000211956	"Immunoglobulin heavy variable 4-34"	P06331	14	106373663-106374145	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 285.6;urinary bladder: 281.2"	"Cell type enriched"	"Detected in some"	197	"Plasma cells: 15696.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	602	"U-698: 5353.4"														"Immunoglobulin genes"	NA	NA		4300000000				"unprognostic (5.34e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.25e-2)"	"unprognostic (5.34e-3)"	"unprognostic (6.12e-2)"	"prognostic favorable (2.77e-4)"	"unprognostic (8.06e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.27e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (2.55e-6)"	"unprognostic (2.61e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.75e-1)"	"unprognostic (7.51e-2)"	4.6	3.0	0.2	0.0	0.3	0.0	9.9	0.2	1.6	7.7	0.3	48.4	0.0	5.6	0.9	7.3	22.7	0.0	1.5	0.3	0.8	7.1	7.0	33.7	0.0	0.7	0.2	0.1	22.2	1.3	0.4	0.9	0.3	0.4	3.8	2.2	0.0	82.8	0.0	0.3	2.8	54.6	0.3	0.2	285.6	48.4	0.3	0.3	0.0	19.4	0.0	0.0	281.2	4.0	1.5	3.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.5	2.6	3.2	0.0	0.0	1.4	0.0	4.1	0.0	0.3	0.0	0.6	3.7	0.0	0.1	8.8	0.4	1.8	0.0	0.8	5353.4	0.0	3.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.1	0.0	0.1	0.5	0.0	0.8	0.2	0.3	0.2	1.6	0.3	0.8	0.7	0.2	0.1	0.4	0.2	0.3	1.5	0.0	0.0	0.0	0.0	79.4	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	53.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15696.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	5.6	0.0	0.0	0.0
IGHV4-39		ENSG00000211959	"Immunoglobulin heavy variable 4-39"	P01824	14	106421711-106422218	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 478.7;salivary gland: 249.1;urinary bladder: 546.5"	"Cell type enriched"	"Detected in some"	432	"Plasma cells: 48104.6"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.6;naive B-cell: 1.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.3;Daudi: 1.8;HL-60: 2.4;NB-4: 2.2;RH-30: 2.1;RPMI-8226: 1.4;U-266/70: 2.1;U-698: 2.0"														"Immunoglobulin genes"	NA	NA		5000000000				"unprognostic (1.18e-3)"	"unprognostic (2.99e-3)"	"unprognostic (5.95e-3)"	"unprognostic (1.46e-2)"	"unprognostic (5.65e-2)"	"unprognostic (2.38e-3)"	"unprognostic (4.48e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (2.60e-6)"	"unprognostic (2.04e-2)"	"unprognostic (2.77e-1)"	"unprognostic (7.68e-2)"	"unprognostic (8.33e-2)"	9.6	6.6	0.5	381.7	0.3	14.6	33.5	0.1	0.8	24.2	1.2	142.9	4.4	12.6	2.6	19.2	17.9	0.0	6.2	0.2	0.1	13.8	13.9	55.4	0.0	0.5	0.8	0.1	17.8	3.7	1.2	1.4	0.0	0.6	7.2	5.1	0.0	249.1	9.6	0.5	12.2	144.8	2.0	0.1	478.7	109.0	1.3	0.2	2.8	37.6	0.0	5.4	546.5	13.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	2.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.3	0.0	0.0	1.1	2.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.6	0.0	0.2	0.2	0.0	2.1	0.0	2.0	0.0	0.3	0.0	0.4	0.1	0.0	0.0	0.0	0.2	1.6	0.1	0.1	0.1	1.7	0.5	0.1	1.1	0.1	0.1	0.2	0.1	0.0	0.5	0.3	0.1	0.8	0.2	0.1	0.5	0.8	0.1	0.6	0.1	0.2	0.3	0.0	0.0	0.0	0.0	89.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	111.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48104.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.3	0.0	0.3	0.0
IGHV4-4		ENSG00000276775	"Immunoglobulin heavy variable 4-4"	A0A075B6R2	14	106011922-106012420	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 572.4;urinary bladder: 774.2"	"Cell type enriched"	"Detected in some"	285	"Plasma cells: 2624.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"midbrain: 3.0"	"Group enriched"	"Detected in some"	23	"memory B-cell: 56.6;naive B-cell: 31.2"	"Lineage enriched"	"Detected in many"	30	"B-cells: 56.6"	"Cell line enriched"	"Detected in some"	18	"Karpas-707: 34.5"														"Immunoglobulin genes"	NA	NA		3800000000				"unprognostic (1.03e-3)"	"unprognostic (1.93e-2)"	"unprognostic (1.50e-1)"			"prognostic favorable (1.60e-6)"		"unprognostic (2.24e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.45e-2)"	"prognostic unfavorable (1.69e-5)"	"unprognostic (3.16e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.05e-1)"	9.5	2.5	0.0	132.7	0.0	18.0	64.2	0.0	0.2	37.9	0.1	207.1	161.3	3.8	0.8	60.3	53.9	105.9	0.8	0.0	0.6	5.4	6.7	37.2	174.6	0.3	3.0	0.0	10.1	6.1	0.4	0.4	0.0	0.1	4.0	141.6	0.0	78.8	15.1	0.3	3.9	79.3	13.5	0.4	187.9	176.6	1.6	0.1	32.1	16.8	0.0	572.4	774.2	5.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.5	34.5	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.1	0.8	0.2	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	56.6	0.2	0.2	0.0	31.2	0.6	0.0	0.0	0.0	0.0	1.9	0.6	4.1	0.0	0.0	0.0	0.2	0.0	0.6	0.3	3.0	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2624.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0
IGHV4-59		ENSG00000224373	"Immunoglobulin heavy variable 4-59"	P01825	14	106627249-106627825	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 530.9;lymphoid tissue: 918.7;urinary bladder: 708.4"	"Cell type enriched"	"Detected in some"	301	"Plasma cells: 12374.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	37	"memory B-cell: 169.0;naive B-cell: 77.2"	"Lineage enriched"	"Detected in many"	51	"B-cells: 169.0"	"Cell line enhanced"	"Detected in some"		"MOLT-4: 8.1;SCLC-21H: 2.0;SH-SY5Y: 4.2"														"Immunoglobulin genes"	NA	NA		5500000000				"prognostic favorable (1.62e-5)"	"unprognostic (3.95e-2)"	"unprognostic (7.25e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.13e-2)"	"prognostic favorable (9.18e-5)"	"unprognostic (2.88e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.68e-1)"	"prognostic unfavorable (1.41e-7)"	"unprognostic (6.04e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.76e-1)"	21.6	3.3	0.0	263.0	0.3	96.4	90.2	0.0	1.1	40.8	0.7	530.9	303.7	12.3	2.7	90.4	18.1	169.6	28.1	0.0	2.0	13.7	20.8	90.7	149.2	0.5	1.6	0.0	23.7	10.4	1.7	1.5	0.3	0.2	12.7	460.2	0.0	227.5	8.9	0.5	3.6	224.5	19.7	1.9	469.1	262.8	15.1	0.3	87.2	44.5	0.0	918.7	708.4	10.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	1.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.8	0.0	0.0	0.0	8.1	1.0	0.3	0.3	0.0	0.8	1.0	0.7	0.0	0.0	2.0	4.2	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.4	0.4	0.1	1.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	169.0	0.0	0.2	1.4	77.2	0.1	0.0	0.0	0.0	0.1	3.3	0.1	11.9	0.0	0.3	0.0	1.1	0.0	2.0	0.5	1.6	0.0	0.2	1.9	0.3	0.3	0.0	0.0	0.6	0.0	41.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	11.2	0.0	0.0	0.0	0.7	1.2	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12374.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	3.6	0.0	0.5	0.0
IGHV4-61		ENSG00000211970	"Immunoglobulin heavy variable 4-61"	A0A0C4DH41	14	106639119-106639657	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"intestine: 208.7;lymphoid tissue: 388.4;stomach 1: 144.3"	"Cell type enriched"	"Detected in some"	98	"Plasma cells: 2432.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	43	"memory B-cell: 39.0;naive B-cell: 25.5"	"Lineage enriched"	"Detected in single"	52	"B-cells: 39.0"	"Cell line enriched"	"Detected in single"	11	"MOLT-4: 8.7"														"Immunoglobulin genes"	NA	NA		4400000000				"unprognostic (2.11e-3)"	"unprognostic (6.59e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.12e-2)"		"prognostic favorable (3.71e-6)"	"unprognostic (6.96e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.72e-2)"	"unprognostic (9.95e-2)"	"unprognostic (9.02e-2)"	"prognostic unfavorable (4.13e-6)"	"unprognostic (3.55e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.24e-1)"	"unprognostic (2.32e-2)"	6.4	44.9	0.1	98.4	0.2	31.1	56.6	0.0	1.4	10.1	0.1	208.7	187.4	5.8	0.0	15.7	5.1	22.6	3.1	0.0	0.3	5.4	10.6	28.5	54.8	0.2	1.1	0.0	10.5	1.4	0.2	0.7	0.1	0.2	4.1	122.9	0.0	105.2	7.1	0.2	0.6	87.2	8.1	0.3	182.8	144.3	1.0	0.2	30.3	23.2	0.0	388.4	44.3	5.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.4	0.0	0.0	8.7	0.8	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.4	0.5	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.5	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	39.0	0.0	0.1	0.0	25.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	4.6	0.1	0.2	0.0	1.4	0.0	0.3	0.2	1.1	0.0	0.2	0.3	0.2	0.2	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.8	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2432.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0
IGHV5-10-1	IGHV5-A	ENSG00000282651	"Immunoglobulin heavy variable 5-10-1"	A0A0J9YXX1	14	106107972-106108464	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 319.6;lymphoid tissue: 572.2"	"Cell type enriched"	"Detected in single"	36	"B-cells: 3.6"					"Region enriched"	"Detected in single"	6	"cerebral cortex: 1.2"	"Group enriched"	"Detected in some"	15	"memory B-cell: 74.8;naive B-cell: 66.7"	"Lineage enriched"	"Detected in many"	16	"B-cells: 74.8"	"Group enriched"	"Detected in some"	6	"Daudi: 9.4;U-698: 4.8"									HPA006014	Approved				"Immunoglobulin genes"	NA	NA		1200000000			"HPA006014: "																		3.0	28.7	0.0	232.0	0.0	39.0	103.0	0.0	1.2	69.4	0.0	276.7	1.0	10.9	0.0	112.5	20.1	93.3	6.2	0.0	0.0	5.5	7.4	129.5	122.1	0.1	0.0	0.0	54.5	5.8	0.4	0.3	0.2	0.1	7.0	319.6	0.0	76.1	19.1	0.1	1.6	52.1	11.0	0.0	205.6	149.6	0.1	0.0	39.7	7.4	0.0	572.2	198.5	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.4	0.0	4.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.8	0.0	0.0	0.0	66.7	0.0	0.0	4.6	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHV5-51		ENSG00000211966	"Immunoglobulin heavy variable 5-51"	A0A0C4DH38	14	106578744-106579236	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 551.4;salivary gland: 226.3;urinary bladder: 356.7"	"Cell type enriched"	"Detected in some"	87	"Plasma cells: 5993.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.8;Daudi: 3.7;K-562: 2.4;NB-4: 1.7;TIME: 3.3"									HPA006014	Approved				"Immunoglobulin genes"	NA	NA		2700000000			"HPA006014: "	"unprognostic (2.03e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.21e-2)"	"unprognostic (7.65e-3)"	"unprognostic (1.80e-2)"	"prognostic favorable (5.47e-4)"	"unprognostic (2.40e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.92e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (3.31e-7)"	"unprognostic (1.11e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.70e-1)"	"unprognostic (1.17e-1)"	10.6	4.9	0.3	0.0	0.5	0.0	26.2	0.1	1.4	14.6	0.7	142.0	0.0	8.7	6.4	19.2	15.4	27.3	1.5	0.1	0.3	15.1	15.1	56.7	0.0	0.6	0.0	0.0	8.9	17.2	1.0	2.3	0.6	0.6	11.3	0.0	0.0	226.3	0.0	0.7	3.2	146.0	1.7	0.2	551.4	100.7	4.8	0.2	0.0	25.8	0.0	0.0	356.7	14.8	1.4	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	1.3	0.8	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.3	1.3	1.2	0.8	0.0	0.1	0.0	0.7	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.3	0.5	0.1	1.4	0.1	0.3	0.6	0.0	0.0	0.6	0.2	0.2	1.4	0.0	0.0	0.0	0.0	68.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	1.8	44.9	0.0	0.0	0.0	0.7	1.0	0.1	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5993.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0
IGHV7-4-1		ENSG00000282122	"Immunoglobulin heavy variable 7-4-1"	A0A0J9YVY3	14	106025145-106025630	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 98.3;lymphoid tissue: 135.0"	"Cell type enriched"	"Detected in some"	4	"Plasma cells: 4.7"					"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	109	"memory B-cell: 8.3;naive B-cell: 13.5"	"Lineage enriched"	"Detected in single"	136	"B-cells: 13.5"	"Cell line enriched"	"Detected in some"	5	"Karpas-707: 5.4"														"Immunoglobulin genes"	NA	NA		560000000																					3.9	3.0	0.3	58.8	0.0	39.3	21.3	0.0	0.5	7.8	0.2	61.3	8.4	0.5	0.0	4.8	0.8	3.1	0.4	0.0	0.0	2.1	2.8	49.6	7.6	0.0	0.1	0.0	0.9	0.7	0.0	0.2	0.0	0.0	2.6	98.3	0.0	42.5	8.8	0.3	0.1	43.3	0.2	0.1	69.0	24.4	0.2	0.0	46.0	5.9	0.0	135.0	10.4	2.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.2	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKJ5		ENSG00000211593	"Immunoglobulin kappa joining 5"		2	88860568-88860605	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"intestine: 1232.4;lymphoid tissue: 1378.5;stomach 1: 1076.4"	"Cell type enriched"	"Detected in single"	13	"B-cells: 1.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	24	"memory B-cell: 9254.1;naive B-cell: 8737.5"	"Lineage enriched"	"Detected in all"	25	"B-cells: 9254.1"	"Cell line enriched"	"Detected in some"	24	"U-698: 3392.4"															NA	NA						"unprognostic (4.92e-2)"	"unprognostic (2.57e-2)"	"unprognostic (3.68e-2)"	"unprognostic (9.30e-3)"		"prognostic favorable (1.83e-4)"		"unprognostic (1.12e-1)"			"unprognostic (3.22e-1)"		"prognostic unfavorable (5.49e-6)"	"unprognostic (2.00e-2)"	"unprognostic (4.25e-1)"		"unprognostic (2.02e-1)"	25.5	42.6	0.6	1378.5	0.8	165.9	238.9	0.7	4.5	74.4	1.1	1205.8	1232.4	13.6	5.8	131.9	8.9	79.2	26.3	0.9	6.7	18.1	31.0	159.0	534.1	2.0	3.4	0.1	63.9	29.5	6.6	0.0	4.1	1.0	23.0	1182.7	0.0	649.6	17.3	0.0	5.9	1087.7	41.0	4.6	678.6	1076.4	12.5	0.8	62.1	4.4	0.0	1224.0	440.4	0.0	1.9	17.7	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	0.0	0.0	0.0	0.0	0.0	0.0	142.3	0.0	0.0	0.0	0.0	0.0	7.2	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	58.5	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	133.3	3.5	11.4	3.2	1.9	3392.4	0.0	8.1	0.0	3.3	10.1	10.2	3.8	1.3	2.2	9254.1	18.4	3.5	7.4	8737.5	9.5	3.4	9.4	7.6	3.4	373.6	8.8	1167.3	0.6	0.8	0.7	4.5	0.9	6.7	2.0	3.4	0.1	1.0	4.6	0.8	1.9	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKV1-12	"IGKV112, L19"	ENSG00000243290	"Immunoglobulin kappa variable 1-12"	A0A0C4DH73	2	89040224-89040745	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"intestine: 399.6;lymphoid tissue: 795.5"	"Cell type enriched"	"Detected in some"	92	"Plasma cells: 12442.9"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 17.2"	"Region enhanced"	"Detected in some"		"midbrain: 3.1"	"Group enriched"	"Detected in some"	820	"memory B-cell: 259.8;naive B-cell: 164.2"	"Lineage enriched"	"Detected in single"	1005	"B-cells: 259.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.5;Daudi: 2.1;RPMI-8226: 1.9;SH-SY5Y: 1.9"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		13000000000			"HPA048721: "	"prognostic favorable (6.09e-4)"	"prognostic favorable (1.59e-4)"	"unprognostic (7.33e-2)"	"unprognostic (3.74e-2)"		"prognostic favorable (3.85e-5)"		"unprognostic (5.89e-2)"	"unprognostic (5.74e-1)"	"unprognostic (7.13e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.90e-1)"	"prognostic unfavorable (6.59e-8)"	"unprognostic (1.18e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.71e-1)"	10.3	146.2	0.1	203.6	0.2	73.7	118.0	0.0	0.3	51.2	0.2	399.6	242.8	7.3	0.0	57.6	16.3	70.2	10.0	0.1	1.1	13.6	18.0	65.9	240.6	0.7	3.1	0.0	18.3	7.3	0.2	1.4	0.0	1.0	7.3	281.3	0.0	220.8	5.4	0.4	2.8	233.1	11.3	0.9	363.3	257.1	6.8	0.1	70.2	33.0	0.0	795.5	245.3	9.7	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	1.9	0.0	0.0	0.5	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.1	0.1	0.0	0.0	259.8	0.0	0.1	0.1	164.2	0.0	0.1	0.2	0.1	0.1	0.1	0.1	24.3	0.1	0.2	0.0	0.3	0.1	1.1	0.7	3.1	0.0	1.0	0.9	0.1	1.4	0.0	0.0	0.0	0.0	134.3	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.2	1.3	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	20.4	0.0	0.0	0.0	1.8	1.6	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.3	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12442.9	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.3	0.0	0.3	5.0	0.0	0.0	0.0
IGKV1-16	"IGKV116, L1"	ENSG00000240864	"Immunoglobulin kappa variable 1-16"	P04430	2	89099859-89100361	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 282.4;lymphoid tissue: 602.8;urinary bladder: 262.5"	"Cell type enriched"	"Detected in some"	559	"Plasma cells: 18463.6"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	523	"memory B-cell: 164.7;naive B-cell: 112.8"	"Lineage enriched"	"Detected in single"	621	"B-cells: 164.7"	"Cell line enhanced"	"Detected in single"		"RPMI-8226: 1.0"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		10000000000			"HPA048721: "	"prognostic favorable (2.63e-4)"	"unprognostic (7.81e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.61e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.87e-1)"	"unprognostic (8.35e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (1.06e-5)"	"unprognostic (2.84e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.84e-2)"	"unprognostic (5.82e-2)"	10.6	4.8	0.1	160.6	0.1	40.4	76.6	0.0	0.8	76.7	0.5	282.4	201.2	6.3	0.5	34.6	6.7	99.9	11.5	0.0	0.2	9.2	15.1	40.9	156.3	0.1	0.1	0.0	17.9	2.0	0.1	3.6	0.1	0.1	5.7	237.9	0.0	127.9	31.1	0.8	0.5	144.8	11.9	0.1	317.9	160.3	2.0	0.1	46.1	18.5	0.0	602.8	262.5	5.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.1	0.2	1.0	0.0	0.0	0.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	164.7	0.0	0.0	0.1	112.8	0.0	0.1	0.2	0.0	0.0	0.0	0.0	16.9	0.1	0.1	0.0	0.8	0.0	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	33.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.6	21.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18463.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.2	0.0
IGKV1-17	"A30, IGKV117"	ENSG00000240382	"Immunoglobulin kappa variable 1-17"	P01599	2	89117342-89117844	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 378.6;lymphoid tissue: 458.2"	"Cell type enriched"	"Detected in some"	113	"Plasma cells: 4510.1"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	425	"memory B-cell: 105.7;naive B-cell: 82.2"	"Lineage enriched"	"Detected in single"	478	"B-cells: 105.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.9;K-562: 1.2;RPMI-8226: 2.0;SH-SY5Y: 1.4"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		8400000000			"HPA048721: "	"unprognostic (7.72e-3)"	"unprognostic (1.60e-1)"	"unprognostic (7.37e-3)"	"unprognostic (1.78e-2)"	"unprognostic (5.08e-3)"	"prognostic favorable (4.11e-4)"	"unprognostic (8.04e-2)"	"unprognostic (1.00e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.76e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (3.44e-7)"	"unprognostic (3.12e-3)"	"unprognostic (8.83e-2)"	"unprognostic (3.80e-1)"	"unprognostic (7.28e-2)"	11.5	26.8	0.1	185.4	0.2	27.9	87.9	0.0	0.7	9.0	0.4	362.0	297.5	6.6	4.2	55.2	12.5	56.2	11.0	0.0	0.1	10.1	14.3	36.8	96.4	0.5	0.3	0.0	12.5	3.3	1.1	1.0	0.1	0.2	5.5	378.6	0.0	135.4	31.3	1.3	0.8	154.0	4.7	0.1	308.5	161.1	2.5	0.2	46.0	26.0	0.0	458.2	184.3	6.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.8	2.0	0.0	0.0	0.5	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	105.7	0.0	0.0	0.1	82.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	12.6	0.1	0.2	0.0	0.7	0.0	0.1	0.5	0.3	0.0	0.2	0.1	0.2	0.3	0.0	0.0	0.0	0.0	39.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	11.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4510.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0
IGKV1-27	"A20, IGKV127"	ENSG00000244575	"Immunoglobulin kappa variable 1-27"	A0A075B6S5	2	89213423-89213928	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 270.6;lymphoid tissue: 350.0;salivary gland: 179.1"	"Cell type enriched"	"Detected in some"	126	"Plasma cells: 4951.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in single"	6	"midbrain: 5.0"	"Group enriched"	"Detected in some"	683	"memory B-cell: 152.7;naive B-cell: 185.3"	"Lineage enriched"	"Detected in single"	748	"B-cells: 185.3"	"Cell line enhanced"	"Detected in single"		"BEWO: 1.8"					"Not detected"	"Not detected"			HPA048721	Approved				"Immunoglobulin genes"	NA	NA		8300000000			"HPA048721: "	"prognostic favorable (2.56e-5)"	"unprognostic (6.50e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.72e-2)"	"prognostic favorable (8.14e-4)"	"unprognostic (9.60e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.41e-1)"	"unprognostic (6.99e-3)"	"unprognostic (9.31e-2)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (8.84e-5)"	"unprognostic (3.23e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.67e-2)"	8.9	9.3	0.1	134.7	0.1	28.8	70.7	0.0	0.3	16.9	0.2	270.6	185.0	6.2	7.8	30.7	6.9	37.8	10.8	0.1	0.8	11.6	9.8	55.7	125.7	0.6	5.0	0.0	8.8	4.9	0.2	1.0	0.0	0.1	6.5	214.3	0.0	179.1	8.9	0.6	0.6	201.9	5.2	0.2	279.1	92.7	1.0	0.1	47.3	19.5	0.0	350.0	88.5	6.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.4	0.6	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.7	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.1	152.7	0.1	0.1	0.1	185.3	0.0	0.0	0.1	0.1	0.1	0.0	0.0	15.8	0.1	0.1	0.0	0.3	0.1	0.8	0.6	5.0	0.0	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.0	39.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.3	12.2	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4951.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0
IGKV1-33	"IGKV133, O18"	ENSG00000242076	"Immunoglobulin kappa variable 1-33"	P01594	2	89266494-89268506	"Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	"Bence-Jones protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 1742.2;stomach 1: 633.2;urinary bladder: 629.1"	"Cell type enriched"	"Detected in some"	131	"Plasma cells: 2044.1"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 5.5"	"Group enriched"	"Detected in many"	11	"hypothalamus: 9.0;midbrain: 14.7;spinal cord: 11.3"	"Group enriched"	"Detected in some"	378	"memory B-cell: 369.6;naive B-cell: 441.5"	"Lineage enriched"	"Detected in many"	411	"B-cells: 441.5"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 2.7;SCLC-21H: 9.1;SH-SY5Y: 8.8;U-251 MG: 3.5"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA					"HPA048721: "	"unprognostic (1.76e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.52e-2)"			"prognostic favorable (4.58e-5)"		"unprognostic (5.06e-2)"		"unprognostic (8.55e-3)"	"unprognostic (2.31e-1)"			"unprognostic (1.63e-2)"	"unprognostic (2.57e-1)"		"unprognostic (4.66e-1)"	51.0	22.1	0.2	268.7	0.5	140.8	323.7	0.8	1.0	130.9	0.4	476.0	298.9	20.9	2.8	107.2	33.7	189.0	23.4	0.3	9.0	36.3	38.2	131.5	533.9	0.5	14.7	0.1	37.4	8.4	1.9	2.7	0.4	0.7	18.9	516.7	0.2	480.4	129.0	0.7	2.1	177.4	14.6	11.3	827.4	633.2	13.7	0.2	385.5	54.4	0.2	1742.2	629.1	26.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.1	0.7	0.0	0.0	0.2	0.1	1.9	2.7	0.0	0.0	9.1	8.8	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.4	3.5	0.7	0.0	0.2	0.0	0.6	0.0	0.4	0.3	0.4	0.1	0.0	0.1	369.6	0.2	0.1	0.3	441.5	0.2	0.1	1.0	0.2	0.3	0.3	0.2	39.5	0.2	0.5	0.8	1.0	0.3	9.0	0.5	14.7	0.1	0.7	11.3	0.2	1.0	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2044.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0
IGKV1-37	"IGKV137, O14"	ENSG00000239862	"Immunoglobulin kappa variable 1-37 (non-functional)"	A0A075B6S9	2	89297264-89297785	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 8.2;lymphoid tissue: 17.4;urinary bladder: 5.6"	"Cell type enriched"	"Detected in some"	24	"Plasma cells: 73.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	247	"memory B-cell: 21.2;naive B-cell: 28.2"	"Lineage enriched"	"Detected in single"	283	"B-cells: 28.2"	"Not detected"	"Not detected"											HPA048721	Approved				"Immunoglobulin genes"	NA	NA					"HPA048721: "								"unprognostic (3.47e-1)"						"unprognostic (1.17e-1)"				0.1	0.2	0.0	2.9	0.0	0.8	2.4	0.0	0.0	0.5	0.0	4.5	3.1	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.4	1.2	2.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	2.6	0.6	0.0	0.0	2.0	0.2	0.0	3.7	1.5	0.0	0.0	0.9	0.1	0.0	17.4	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.2	0.0	0.0	0.0	28.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	73.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKV1-5		ENSG00000243466	"Immunoglobulin kappa variable 1-5"	P01602	2	88947301-88947957	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 784.5;lymphoid tissue: 1471.3;urinary bladder: 953.4"	"Cell type enriched"	"Detected in some"	240	"Plasma cells: 39194.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	364	"memory B-cell: 859.0;naive B-cell: 860.5"	"Lineage enriched"	"Detected in many"	364	"B-cells: 860.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 4.0;HL-60: 2.4;RPMI-8226: 5.0;SCLC-21H: 2.9;SH-SY5Y: 4.5"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		8400000000			"HPA048721: "	"prognostic favorable (1.19e-4)"	"unprognostic (1.26e-2)"	"unprognostic (3.12e-3)"	"unprognostic (5.00e-3)"	"unprognostic (1.59e-2)"	"prognostic favorable (3.47e-4)"	"unprognostic (7.60e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.32e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.58e-1)"	"prognostic unfavorable (4.36e-8)"	"unprognostic (1.14e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.27e-2)"	"unprognostic (3.17e-2)"	27.0	82.8	0.2	645.8	0.6	116.4	236.2	0.2	1.9	116.8	0.6	784.5	533.5	17.3	2.1	147.5	87.7	125.9	18.8	0.1	1.4	35.6	32.3	126.4	390.4	1.0	1.8	0.2	61.3	10.9	0.5	3.0	0.4	0.3	16.9	752.3	0.0	395.4	35.1	0.9	3.3	433.3	24.6	1.3	922.7	460.4	11.6	0.4	156.7	58.9	0.0	1471.3	953.4	28.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.4	1.6	0.5	0.0	0.0	0.3	1.0	5.0	0.0	0.0	2.9	4.5	0.2	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.4	0.7	0.4	0.6	0.1	0.4	0.0	0.6	0.0	0.7	1.2	1.3	0.5	0.2	0.4	859.0	2.3	0.3	1.0	860.5	0.2	0.3	1.4	0.4	0.6	0.7	0.6	113.5	0.2	0.6	0.2	1.9	0.1	1.4	1.0	1.8	0.2	0.3	1.3	0.4	1.1	0.0	0.0	0.6	0.0	163.2	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.7	0.0	0.0	0.0	7.0	89.7	0.0	0.0	0.0	0.7	3.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39194.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.0	11.8	0.0	0.2	0.0
IGKV1-6		ENSG00000239855	"Immunoglobulin kappa variable 1-6"	A0A0C4DH72	2	88966262-88966767	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 157.0;lymphoid tissue: 611.3"	"Cell type enriched"	"Detected in some"	33	"Plasma cells: 877.6"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in single"	5	"cerebral cortex: 1.5"	"Group enriched"	"Detected in some"	801	"memory B-cell: 123.6;naive B-cell: 85.7"	"Lineage enriched"	"Detected in single"	946	"B-cells: 123.6"	"Not detected"	"Not detected"											HPA048721	Approved				"Immunoglobulin genes"	NA	NA		12000000000			"HPA048721: "	"prognostic favorable (3.44e-5)"	"unprognostic (5.25e-3)"	"unprognostic (3.78e-2)"	"unprognostic (8.68e-3)"	"unprognostic (3.23e-2)"	"prognostic favorable (1.81e-4)"	"unprognostic (3.86e-3)"	"unprognostic (3.86e-2)"	"unprognostic (3.00e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.12e-1)"	"prognostic unfavorable (4.37e-6)"	"unprognostic (5.23e-3)"	"unprognostic (3.02e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.54e-1)"	4.5	1.7	0.1	84.9	0.0	37.4	50.8	0.0	1.5	16.7	0.1	157.0	111.5	4.1	4.1	23.7	5.1	18.3	5.4	0.0	0.2	7.7	6.3	20.2	82.9	0.1	0.1	0.0	4.1	1.8	0.0	1.1	0.0	0.0	4.3	147.2	0.0	95.8	2.3	0.2	0.5	59.6	5.2	0.2	211.2	131.6	0.7	0.1	23.0	16.6	0.0	611.3	146.1	8.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	123.6	0.0	0.0	0.1	85.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	14.1	0.1	0.0	0.0	1.5	0.0	0.2	0.1	0.1	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	26.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	877.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0
IGKV1-9	"IGKV19, L8"	ENSG00000241755	"Immunoglobulin kappa variable 1-9"	A0A0C4DH69	2	89009982-89010515	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 432.1;lymphoid tissue: 676.7;stomach 1: 286.2"	"Cell type enriched"	"Detected in some"	116	"Plasma cells: 7178.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	705	"memory B-cell: 300.5;naive B-cell: 296.8"	"Lineage enriched"	"Detected in single"	709	"B-cells: 300.5"	"Cell line enhanced"	"Detected in some"		"HL-60: 1.2;NB-4: 1.0;RPMI-8226: 2.9;TIME: 1.2"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		4500000000			"HPA048721: "	"prognostic favorable (2.10e-7)"	"unprognostic (1.30e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.55e-3)"	"unprognostic (4.70e-2)"	"prognostic favorable (4.91e-4)"	"unprognostic (3.30e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.09e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (6.04e-8)"	"unprognostic (4.03e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.40e-1)"	12.7	12.7	0.2	186.1	0.2	54.1	204.8	0.0	1.3	11.6	0.4	432.1	269.4	8.3	0.8	53.3	79.1	30.3	14.0	0.3	1.1	15.1	18.1	40.4	203.4	0.3	0.6	0.0	20.9	2.5	0.5	1.3	0.1	0.2	12.9	351.9	0.0	223.3	13.5	0.5	1.0	184.4	13.4	0.3	315.6	286.2	35.4	0.1	85.8	34.4	0.0	676.7	189.3	8.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	1.0	0.3	0.0	0.0	0.0	0.9	2.9	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.1	0.0	0.5	0.0	0.2	0.0	0.2	0.0	0.2	0.4	0.1	0.2	0.0	0.1	300.5	0.1	0.0	0.3	296.8	0.0	0.1	0.3	0.2	0.2	0.1	0.3	34.5	0.2	0.2	0.0	1.3	0.3	1.1	0.3	0.6	0.0	0.2	0.3	0.1	0.3	0.0	0.0	0.0	0.0	61.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	10.7	0.0	0.0	0.0	1.8	0.7	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7178.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0
IGKV1D-12		ENSG00000278857	"Immunoglobulin kappa variable 1D-12"	P01611	2	90159840-90160335	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 22.9;lymphoid tissue: 47.9;salivary gland: 34.9"	"Cell type enriched"	"Detected in some"	178	"Plasma cells: 232.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	34	"memory B-cell: 13.0;naive B-cell: 12.2"	"Lineage enriched"	"Detected in single"	35	"B-cells: 13.0"	"Cell line enhanced"	"Detected in single"		"RH-30: 2.2"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		12000000000			"HPA048721: "	"unprognostic (1.94e-4)"	"unprognostic (9.04e-4)"	"unprognostic (3.42e-2)"			"prognostic favorable (3.23e-4)"		"unprognostic (3.09e-2)"		"unprognostic (4.66e-2)"	"unprognostic (1.34e-1)"		"unprognostic (1.33e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.25e-1)"	0.9	0.3	0.0	9.7	0.0	0.9	7.7	0.0	0.2	2.4	0.0	17.7	1.6	1.3	0.0	2.2	1.8	0.0	0.2	0.0	0.0	1.7	1.1	11.8	12.6	0.0	0.0	0.0	0.2	0.4	0.0	0.2	0.1	0.1	1.1	9.2	0.0	34.9	0.3	0.1	0.2	22.9	5.6	0.0	47.9	9.6	0.2	0.0	1.4	4.0	0.0	9.5	2.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.4	0.4	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.1	12.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	232.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKV1D-13		ENSG00000276566	"Immunoglobulin kappa variable 1D-13"	"A0A0B4J2D9, P0DP09"	2	90154073-90154574	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 104.6;lymphoid tissue: 320.4"	"Cell type enriched"	"Detected in some"	141	"Plasma cells: 6195.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	733	"memory B-cell: 480.8;naive B-cell: 331.6"	"Lineage enriched"	"Detected in single"	868	"B-cells: 480.8"	"Cell line enhanced"	"Detected in single"		"Daudi: 1.0"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		370000000			"HPA048721: "	"prognostic favorable (4.68e-6)"	"unprognostic (4.10e-2)"	"unprognostic (2.16e-1)"	"unprognostic (5.71e-3)"		"unprognostic (3.01e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.84e-2)"	"unprognostic (8.14e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.68e-3)"	"unprognostic (4.68e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.60e-2)"	2.7	0.4	0.0	102.1	0.0	35.1	34.6	0.0	0.0	47.1	0.0	86.4	21.9	5.4	0.0	18.0	10.3	2.5	1.9	0.0	0.0	8.2	6.4	39.8	320.4	0.0	0.0	0.0	1.0	2.0	0.0	0.4	0.0	0.1	3.1	79.1	0.0	54.7	1.4	0.0	1.1	104.6	6.9	0.0	103.7	20.5	2.7	0.0	29.2	7.3	0.0	225.1	46.3	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.4	0.3	0.1	0.1	0.2	480.8	0.2	0.1	0.5	331.6	0.0	0.0	0.4	0.1	0.1	0.2	0.1	42.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.1	0.0	43.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6195.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKV1D-16		ENSG00000241244	"Immunoglobulin kappa variable 1D-16"	P01601	2	90100236-90100738	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 79.8;intestine: 92.9;lymphoid tissue: 166.8"	"Cell type enriched"	"Detected in some"	249	"Plasma cells: 1994.1"	"Cancer enhanced"	"Detected in many"		"lung cancer: 17.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	327	"memory B-cell: 57.6;naive B-cell: 120.1"	"Lineage enriched"	"Detected in single"	442	"B-cells: 120.1"	"Not detected"	"Not detected"											HPA048721	Approved				"Immunoglobulin genes"	NA	NA		9000000000			"HPA048721: "	"prognostic favorable (2.41e-4)"	"unprognostic (4.41e-3)"	"unprognostic (3.96e-3)"	"unprognostic (5.39e-2)"		"unprognostic (1.35e-3)"	"unprognostic (8.61e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.54e-2)"	"unprognostic (6.61e-3)"	"unprognostic (3.25e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (4.37e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.84e-1)"	2.4	0.4	0.0	30.5	0.0	15.1	19.1	0.0	0.4	11.1	0.1	92.9	39.3	1.6	0.0	14.0	2.5	79.8	1.3	0.0	0.0	1.6	3.9	10.1	27.8	0.0	0.5	0.0	2.5	1.0	0.6	0.1	0.0	0.1	3.6	50.7	0.0	30.6	0.9	0.0	0.1	34.7	1.0	0.1	57.1	26.9	0.4	0.0	10.0	2.8	0.0	166.8	23.8	1.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	57.6	0.0	0.0	0.1	120.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1994.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0
IGKV1D-17		ENSG00000242766	"Immunoglobulin kappa variable 1D-17"	A0A075B6S4	2	90082635-90083291	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 4.8;lymphoid tissue: 12.6;salivary gland: 5.8"	"Cell type enriched"	"Detected in some"	13	"Plasma cells: 36.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	60	"memory B-cell: 7.7;naive B-cell: 4.1"	"Lineage enriched"	"Detected in single"	78	"B-cells: 7.7"	"Not detected"	"Not detected"											HPA048721	Approved				"Immunoglobulin genes"	NA	NA		1000000000			"HPA048721: "	"prognostic favorable (1.47e-4)"	"unprognostic (4.23e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.44e-1)"		"prognostic favorable (5.68e-4)"		"unprognostic (1.19e-1)"		"unprognostic (6.18e-2)"	"unprognostic (2.27e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.74e-5)"	"unprognostic (1.38e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.04e-3)"	0.6	0.1	0.1	5.1	0.2	0.9	0.8	0.0	0.3	0.3	0.6	3.7	1.5	0.2	0.0	0.5	0.8	0.6	0.0	0.1	0.1	0.3	0.4	1.5	0.8	0.5	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.3	0.1	2.2	0.0	5.8	0.3	0.0	0.4	4.8	0.4	0.1	12.6	2.0	0.0	0.1	0.3	0.5	0.0	4.6	1.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.2	0.0	0.3	0.1	0.1	0.5	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKV1D-33		ENSG00000239975	"Immunoglobulin kappa variable 1D-33"	P01593	2	89913982-89916052	"Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 63.5;salivary gland: 73.9"	"Cell type enriched"	"Detected in some"	410	"Plasma cells: 5131.4"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 5.0"	"Region enriched"	"Detected in single"	11	"midbrain: 6.9"	"Group enriched"	"Detected in some"	116	"memory B-cell: 6.3;naive B-cell: 16.8"	"Lineage enriched"	"Detected in single"	169	"B-cells: 16.8"	"Not detected"	"Not detected"											HPA048721	Approved				"Immunoglobulin genes"	NA	NA		4900000000			"HPA048721: "	"unprognostic (5.10e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.11e-2)"			"unprognostic (2.03e-4)"		"unprognostic (7.90e-2)"		"unprognostic (6.50e-2)"	"unprognostic (6.82e-2)"			"unprognostic (4.54e-2)"	"unprognostic (4.23e-2)"			1.8	0.5	0.0	3.9	0.1	2.3	8.4	0.0	0.1	2.3	0.1	18.6	1.4	1.4	0.0	4.7	2.8	2.7	0.2	0.1	0.6	3.9	2.2	18.0	6.8	0.1	6.9	0.0	0.4	0.5	0.0	0.1	0.0	0.0	1.6	2.1	0.0	73.9	8.6	0.0	0.3	19.3	0.0	0.4	63.5	21.4	0.1	0.0	4.8	3.3	0.2	9.1	16.9	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.1	0.1	0.6	0.1	6.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5131.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0
IGKV1D-37	"IGKV1D37, O4"	ENSG00000250036	"Immunoglobulin kappa variable 1D-37 (non-functional)"	P0DSN7	2	89884740-89885216	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 12.8;stomach 1: 15.2;urinary bladder: 20.3"	"Cell type enriched"	"Detected in single"	11	"Plasma cells: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	209	"memory B-cell: 13.6;naive B-cell: 29.1"	"Lineage enriched"	"Detected in single"	284	"B-cells: 29.1"	"Cell line enriched"	"Detected in single"	5	"HDLM-2: 2.5"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		6700000000			"HPA048721: "														"unprognostic (2.68e-1)"				0.1	0.0	0.0	4.2	0.0	3.3	2.5	0.0	0.0	0.8	0.0	8.7	12.8	0.1	0.4	2.1	0.2	0.5	0.3	0.4	0.0	0.1	0.4	0.8	4.1	0.0	0.0	0.0	0.4	1.2	0.0	0.0	0.1	0.0	0.7	1.0	0.0	7.2	0.0	0.2	0.0	6.1	0.2	0.0	6.6	15.2	0.2	0.0	1.2	0.1	0.0	2.5	20.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	13.6	0.0	0.0	0.0	29.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKV1D-39		ENSG00000251546	"Immunoglobulin kappa variable 1D-39"	P04432	2	89862482-89862981	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 2950.1;lymphoid tissue: 6546.1;stomach 1: 2280.3"	"Cell type enriched"	"Detected in some"	298	"Plasma cells: 7890.2"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 12.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	226	"memory B-cell: 470.5;naive B-cell: 733.0"	"Lineage enriched"	"Detected in many"	275	"B-cells: 733.0"	"Group enriched"	"Detected in some"	36	"Daudi: 731.4;U-698: 516.7"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA					"HPA048721: "	"prognostic favorable (1.88e-4)"	"unprognostic (4.70e-2)"	"unprognostic (2.14e-3)"			"prognostic favorable (5.99e-5)"		"unprognostic (3.84e-1)"		"unprognostic (4.34e-2)"	"unprognostic (1.28e-1)"			"unprognostic (9.06e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.92e-1)"	"unprognostic (1.84e-1)"	148.7	182.8	0.7	1625.0	1.4	470.4	1000.3	0.7	4.6	372.1	2.9	2950.1	2073.9	80.8	52.9	616.8	133.3	635.6	88.2	0.5	5.8	81.0	173.3	691.4	1985.4	2.5	7.4	0.5	216.7	26.8	3.5	5.5	1.3	3.1	81.6	2282.9	0.4	1240.9	149.9	2.3	33.4	1266.3	89.5	4.0	1725.6	2280.3	27.8	1.6	777.6	211.1	0.0	6546.1	1831.8	47.3	2.4	0.3	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	731.4	0.5	0.0	0.0	2.1	0.0	0.0	0.0	0.3	0.0	3.2	0.0	0.0	0.0	5.9	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	2.3	6.6	2.4	0.0	0.0	1.0	2.9	10.3	0.0	0.0	11.1	17.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	1.8	2.5	0.0	0.1	516.7	0.0	1.6	0.0	0.5	0.4	0.8	0.6	0.2	0.4	470.5	0.3	0.3	0.4	733.0	0.5	0.2	2.6	0.8	0.4	0.4	0.3	47.6	0.7	1.4	0.7	4.6	0.5	5.8	2.5	7.4	0.5	3.1	4.0	1.6	2.4	0.0	0.0	0.0	0.0	26.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7890.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	14.0	0.0	0.0	0.0
IGKV1D-42		ENSG00000211633	"Immunoglobulin kappa variable 1D-42 (non-functional)"	A0A075B6H8	2	90190193-90190681	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 48.2;lymphoid tissue: 25.5"	"Cell type enriched"	"Detected in single"	93	"Plasma cells: 9.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	36	"memory B-cell: 5.6;naive B-cell: 1.6"	"Lineage enriched"	"Detected in single"	57	"B-cells: 5.6"	"Cell line enriched"	"Detected in single"	5	"RPMI-8226: 2.6"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		41000000			"HPA048721: "	"unprognostic (8.08e-6)"	"unprognostic (4.83e-2)"	"unprognostic (2.22e-2)"			"unprognostic (2.51e-3)"		"unprognostic (1.84e-1)"			"unprognostic (2.10e-2)"		"unprognostic (1.66e-5)"	"unprognostic (1.00e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.39e-1)"	0.1	0.0	0.0	7.6	0.0	6.7	10.9	0.0	0.0	0.8	0.0	18.9	7.6	0.2	0.3	1.4	0.2	1.7	0.1	0.0	0.0	0.0	0.3	2.9	2.6	0.1	0.0	0.0	4.1	1.1	0.0	0.0	0.0	0.0	0.1	48.2	0.0	8.6	0.0	0.0	0.1	7.9	0.0	0.0	4.3	14.1	0.0	0.0	0.6	0.3	0.0	25.5	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKV1D-43		ENSG00000242580	"Immunoglobulin kappa variable 1D-43"	A0A0B4J1Z2	2	90209873-90210529	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 2.9;lymphoid tissue: 4.9;stomach 1: 3.7"	"Cell type enriched"	"Detected in some"	86	"Plasma cells: 695.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	152	"memory B-cell: 13.3;naive B-cell: 17.0"	"Lineage enriched"	"Detected in single"	171	"B-cells: 17.0"	"Cell line enriched"	"Detected in single"	310	"RPMI-8226: 79.1"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		380000000			"HPA048721: "	"prognostic favorable (3.32e-5)"	"unprognostic (6.71e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.27e-2)"		"unprognostic (4.57e-3)"		"unprognostic (1.37e-3)"		"unprognostic (3.15e-1)"	"unprognostic (2.67e-2)"		"unprognostic (3.82e-5)"	"unprognostic (3.96e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.06e-1)"	0.2	0.0	0.0	2.8	0.0	1.3	1.4	0.0	0.0	0.0	0.0	2.7	1.9	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	1.1	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	2.0	0.2	0.0	0.0	2.9	0.0	0.0	1.8	3.7	0.0	0.0	0.5	0.1	0.0	4.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	79.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	17.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	695.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
IGKV1D-8		ENSG00000239819	"Immunoglobulin kappa variable 1D-8"	A0A087WSZ0	2	90220727-90221384	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 14.3;salivary gland: 5.7"	"Cell type enriched"	"Detected in some"	29	"Plasma cells: 338.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	323	"memory B-cell: 32.7;naive B-cell: 31.8"	"Lineage enriched"	"Detected in single"	328	"B-cells: 32.7"	"Cell line enriched"	"Detected in some"	26	"RPMI-8226: 38.3"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		1900000000			"HPA048721: "	"prognostic favorable (2.93e-4)"	"unprognostic (1.03e-3)"	"unprognostic (2.23e-2)"	"unprognostic (2.76e-3)"		"prognostic favorable (8.80e-5)"	"unprognostic (6.07e-2)"	"unprognostic (9.76e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (2.12e-6)"	"unprognostic (1.35e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.32e-1)"	0.3	0.0	0.0	5.4	0.0	0.7	1.2	0.0	0.0	0.5	0.0	2.4	1.6	0.1	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.3	0.3	1.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	2.6	0.0	5.7	0.0	0.0	0.0	2.9	0.0	0.0	8.3	1.9	0.0	0.0	1.2	0.6	0.0	14.3	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.3	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.7	0.0	0.0	0.0	31.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	338.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
IGKV1OR2-108	"IGKV1/OR2-108, IGKV1OR2108, IGO1"	ENSG00000231292	"Immunoglobulin kappa variable 1/OR2-108 (non-functional)"		2	113406396-113406872	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"intestine: 38.6;lymphoid tissue: 57.2"	"Cell type enriched"	"Detected in single"	652	"Plasma cells: 65.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	55	"memory B-cell: 13.5;naive B-cell: 12.2"	"Lineage enriched"	"Detected in single"	58	"B-cells: 13.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 6.6;HBEC3-KT: 7.2;hTEC/SVTERT24-B: 4.1;REH: 4.1"	"Not detected"	"Not detected"							HPA048721	Approved					NA	NA					"HPA048721: "	"prognostic favorable (1.53e-6)"	"unprognostic (2.73e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.37e-1)"		"unprognostic (3.64e-3)"	"unprognostic (3.57e-2)"	"unprognostic (3.20e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (9.96e-6)"	"unprognostic (6.95e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.95e-1)"	0.5	1.4	0.1	23.5	0.3	11.3	16.9	0.0	0.2	4.8	4.5	38.6	22.0	0.3	0.0	6.9	0.4	5.6	0.2	0.9	0.3	0.1	1.5	6.9	14.1	0.1	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.9	22.3	0.1	15.4	0.5	0.1	4.8	14.1	0.8	0.0	12.8	17.0	0.0	0.0	3.8	1.3	0.0	57.2	21.9	0.1	0.1	2.1	0.7	0.3	0.0	0.0	0.0	0.4	0.0	2.2	0.3	1.5	3.0	1.2	6.6	0.0	0.9	1.1	0.3	0.0	7.2	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	4.1	2.4	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.6	0.4	0.0	1.6	4.1	0.6	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.6	0.0	1.3	0.2	0.2	0.1	1.2	0.1	0.4	0.4	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	13.5	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.5	0.1	0.3	0.0	0.2	0.9	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKV2-24		ENSG00000241294	"Immunoglobulin kappa variable 2-24"	A0A0C4DH68	2	89176328-89177160	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 275.3;lymphoid tissue: 478.7;urinary bladder: 942.3"	"Cell type enriched"	"Detected in some"	252	"Plasma cells: 5620.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in some"		"hypothalamus: 3.9"	"Immune cell enriched"	"Detected in some"	4	"memory B-cell: 48.1"	"Lineage enriched"	"Detected in single"	482	"B-cells: 48.1"	"Cell line enhanced"	"Detected in single"		"NB-4: 1.3"														"Immunoglobulin genes"	NA	NA		840000000				"prognostic favorable (5.74e-6)"	"unprognostic (4.92e-3)"	"unprognostic (1.04e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.79e-3)"	"prognostic favorable (1.59e-4)"	"unprognostic (5.02e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (2.82e-5)"	"unprognostic (1.03e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.65e-1)"	13.8	14.7	0.1	66.4	0.2	27.6	92.7	0.1	0.7	11.6	0.4	275.3	253.1	3.2	1.1	82.7	6.6	24.4	14.8	0.2	3.9	7.7	8.7	30.2	132.8	0.5	2.6	0.1	6.4	5.7	0.2	0.9	0.2	0.2	5.4	182.4	0.0	221.3	3.4	0.3	3.3	99.3	8.0	1.2	478.7	107.8	1.2	0.4	24.0	11.2	0.0	237.6	942.3	14.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.1	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.1	0.2	0.1	0.7	0.2	3.9	0.5	2.6	0.1	0.2	1.2	0.4	0.4	0.0	0.0	0.0	0.0	22.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	3.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5620.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0
IGKV2-28		ENSG00000244116	"Immunoglobulin kappa variable 2-28"	A0A075B6P5	2	89221698-89222461	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1054.5;lymphoid tissue: 1749.9"	"Cell type enriched"	"Detected in some"	92	"Plasma cells: 1868.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	13	"naive B-cell: 11.1"	"Lineage enriched"	"Detected in single"	13	"B-cells: 11.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.4;Daudi: 2.8;HL-60: 3.6;K-562: 2.0;NB-4: 2.7;RPMI-8226: 4.5;SCLC-21H: 2.1;SH-SY5Y: 1.7"														"Immunoglobulin genes"	NA	NA						"unprognostic (1.03e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.34e-1)"			"prognostic favorable (3.32e-4)"		"unprognostic (2.12e-2)"		"unprognostic (6.32e-3)"	"unprognostic (3.14e-1)"			"unprognostic (3.71e-2)"	"unprognostic (5.21e-2)"		"unprognostic (2.64e-2)"	24.2	40.6	0.2	406.2	0.2	181.8	429.6	0.1	1.1	57.0	0.8	1054.5	763.5	38.6	5.0	668.8	29.3	132.0	22.4	0.1	0.9	45.5	40.5	159.0	589.5	0.4	0.7	0.0	88.7	19.7	3.8	3.3	0.5	0.3	21.2	716.4	0.1	739.1	95.9	1.8	7.2	429.2	24.1	0.7	1217.4	534.7	163.0	0.5	169.1	85.5	0.0	1749.9	498.3	31.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	2.7	0.4	0.0	0.0	0.0	1.1	4.5	0.0	0.4	2.1	1.7	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.9	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.4	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.2	11.1	0.2	0.1	0.8	0.1	0.0	0.4	0.1	0.0	0.2	0.2	0.1	1.1	0.1	0.9	0.4	0.7	0.0	0.3	0.7	0.5	0.8	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1868.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	20.3	0.0	0.0	0.0
IGKV2-30		ENSG00000243238	"Immunoglobulin kappa variable 2-30"	P06310	2	89244781-89245596	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 637.0;lymphoid tissue: 675.5;stomach 1: 326.0"	"Cell type enriched"	"Detected in some"	365	"Plasma cells: 25365.6"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 26.0"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	316	"memory B-cell: 561.0;naive B-cell: 325.4"	"Lineage enriched"	"Detected in many"	400	"B-cells: 561.0"	"Cell line enriched"	"Detected in some"	388	"U-698: 8426.0"														"Immunoglobulin genes"	NA	NA		6800000000				"prognostic favorable (6.84e-5)"	"unprognostic (1.26e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.41e-1)"		"prognostic favorable (6.78e-5)"	"unprognostic (6.92e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.45e-2)"	"unprognostic (9.82e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.07e-1)"	"prognostic unfavorable (4.53e-6)"	"unprognostic (1.74e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.50e-1)"	15.2	9.5	0.1	162.2	0.3	76.6	239.4	0.1	1.3	14.1	0.6	637.0	397.9	5.7	0.8	38.2	11.6	35.4	18.0	0.1	0.3	15.0	29.9	67.9	178.1	1.3	0.4	0.1	15.9	7.8	0.1	2.4	0.2	0.2	7.9	327.5	0.0	222.3	23.5	0.6	1.2	262.3	19.3	0.4	675.5	326.0	21.4	0.2	41.3	19.0	0.0	605.4	209.4	21.6	1.5	5.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	13.1	4.6	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	1.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.8	0.3	0.0	0.0	0.1	2.7	1.9	0.0	0.4	0.0	0.9	3.8	0.0	2.6	0.0	0.0	5.6	0.0	0.0	21.7	0.1	2.6	0.3	1.7	8426.0	0.0	2.7	0.0	0.5	0.4	0.2	0.2	0.0	0.2	561.0	0.1	0.2	0.4	325.4	0.0	0.2	1.4	0.2	0.3	0.7	0.3	53.3	0.1	0.3	0.1	1.3	0.1	0.3	1.3	0.4	0.1	0.2	0.4	0.2	1.5	0.0	0.0	0.0	0.0	69.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	1.3	30.5	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25365.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.2	0.0	0.3	0.0
IGKV2D-24		ENSG00000241566	"Immunoglobulin kappa variable 2D-24 (non-functional)"	A0A075B6R9	2	90004797-90005629	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 19.8;lymphoid tissue: 25.8;urinary bladder: 15.4"	"Cell type enriched"	"Detected in single"	207	"Plasma cells: 165.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"hippocampal formation: 1.6"	"Group enriched"	"Detected in some"	48	"memory B-cell: 6.7;naive B-cell: 2.7"	"Lineage enriched"	"Detected in single"	68	"B-cells: 6.7"	"Cell line enriched"	"Detected in single"	8	"U-937: 1.0"														"Immunoglobulin genes"	NA	NA						"prognostic favorable (1.21e-4)"	"unprognostic (1.78e-1)"	"prognostic favorable (8.07e-4)"	"unprognostic (2.09e-2)"		"prognostic favorable (2.11e-4)"		"unprognostic (2.33e-1)"		"unprognostic (2.29e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.74e-5)"	"unprognostic (7.60e-2)"	"unprognostic (1.57e-2)"	"unprognostic (3.85e-1)"	"unprognostic (3.47e-1)"	0.7	0.8	0.1	4.3	0.0	2.7	6.2	0.0	0.6	0.3	0.0	16.9	19.8	0.1	0.0	1.5	0.4	3.5	0.1	1.6	0.2	0.6	0.5	1.8	6.1	0.0	1.2	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.3	7.3	0.0	9.7	0.5	0.0	0.3	7.0	0.1	0.1	25.2	5.2	0.1	0.1	1.7	0.4	0.0	25.8	15.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6	1.6	0.2	0.0	1.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	165.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKV2D-28		ENSG00000242534	"Immunoglobulin kappa variable 2D-28"	P01615	2	89959979-89960754	"Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 223.6;lymphoid tissue: 466.4;salivary gland: 261.9"	"Cell type enriched"	"Detected in some"	98	"Plasma cells: 4332.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	224	"memory B-cell: 3054.0;naive B-cell: 2203.9"	"Lineage enriched"	"Detected in all"	260	"B-cells: 3054.0"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 5.0;RPMI-8226: 2.0;SCLC-21H: 1.9;SH-SY5Y: 4.3;U-698: 4.4"														"Immunoglobulin genes"	NA	NA		3500000000				"unprognostic (3.88e-3)"	"unprognostic (2.68e-2)"				"unprognostic (2.51e-3)"		"unprognostic (1.22e-1)"		"unprognostic (1.13e-1)"	"unprognostic (4.17e-1)"			"unprognostic (1.13e-1)"	"unprognostic (2.66e-1)"			7.9	4.8	0.1	163.5	0.3	23.5	35.5	0.1	1.5	7.2	0.4	205.7	223.6	8.4	1.2	114.5	14.1	26.3	4.9	0.4	2.0	11.5	13.4	41.0	168.0	0.7	0.4	0.2	2.9	1.9	0.1	0.9	0.4	0.5	11.2	66.5	0.0	261.9	19.4	0.3	0.9	144.5	8.8	0.2	466.4	188.0	5.7	0.3	41.3	38.1	0.3	193.6	159.2	8.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	1.1	0.0	0.0	0.0	5.0	0.0	1.4	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.4	0.1	0.0	0.0	0.7	0.0	2.0	0.0	0.0	1.9	4.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.6	1.3	0.0	4.4	0.0	1.1	0.0	11.7	7.8	1.2	1.2	0.5	1.3	3054.0	1.3	0.9	2.0	2203.9	0.2	0.9	2.2	1.0	1.5	1.4	1.3	248.7	0.1	0.3	0.1	1.5	0.4	2.0	0.7	0.4	0.2	0.5	0.2	0.3	0.4	0.0	0.0	0.0	0.0	44.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4332.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	31.5	0.0	0.1	0.0
IGKV2D-29		ENSG00000243264	"Immunoglobulin kappa variable 2D-29"	A0A075B6S2	2	89947512-89948279	"Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 254.7;lymphoid tissue: 468.7"	"Cell type enriched"	"Detected in some"	8	"Plasma cells: 184.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	253	"memory B-cell: 360.5;naive B-cell: 489.4"	"Lineage enriched"	"Detected in many"	292	"B-cells: 489.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 8.5;HDLM-2: 1.2;TIME: 2.1;U-698: 2.2"														"Immunoglobulin genes"	NA	NA		1500000000				"prognostic favorable (3.31e-4)"	"unprognostic (2.43e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.76e-2)"		"prognostic favorable (8.34e-4)"	"unprognostic (4.43e-3)"	"unprognostic (1.54e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.47e-2)"	"unprognostic (5.09e-2)"	"unprognostic (8.87e-2)"	"prognostic unfavorable (2.97e-4)"	"unprognostic (9.46e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.61e-1)"	"unprognostic (7.80e-2)"	6.9	1.1	0.1	74.4	0.2	29.7	49.9	0.3	1.3	12.7	0.9	254.7	97.9	3.9	0.0	9.6	6.6	14.4	3.8	0.2	0.2	3.4	8.5	41.8	140.6	0.4	0.6	0.1	9.9	2.8	0.2	0.3	0.0	0.2	3.6	111.9	0.0	107.8	10.4	0.4	3.0	68.4	2.9	0.5	171.6	127.1	1.0	0.2	38.3	7.9	0.0	468.7	35.4	2.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.2	0.7	0.3	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.1	0.2	0.1	0.0	2.2	0.0	0.1	0.0	0.3	0.4	0.2	0.1	0.0	0.2	360.5	0.2	0.1	0.6	489.4	0.0	0.1	1.6	0.2	0.4	0.2	0.2	42.2	0.1	0.2	0.3	1.3	0.2	0.2	0.4	0.6	0.1	0.2	0.5	0.2	0.2	0.0	0.0	0.0	0.0	22.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	184.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0
IGKV2D-30		ENSG00000239571	"Immunoglobulin kappa variable 2D-30"	A0A075B6S6	2	89936859-89937679	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 15.5;lymphoid tissue: 33.8;stomach 1: 22.4"	"Cell type enriched"	"Detected in some"	222	"Plasma cells: 1314.8"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 2.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	379	"memory B-cell: 124.9;naive B-cell: 164.0"	"Lineage enriched"	"Detected in single"	430	"B-cells: 164.0"	"Cell line enriched"	"Detected in some"	6	"U-698: 51.7"														"Immunoglobulin genes"	NA	NA						"unprognostic (1.17e-3)"	"unprognostic (6.82e-2)"	"unprognostic (1.58e-1)"			"unprognostic (2.98e-4)"		"unprognostic (5.74e-3)"		"unprognostic (3.19e-2)"	"unprognostic (1.10e-1)"			"unprognostic (4.12e-2)"	"unprognostic (3.55e-1)"			0.3	0.4	0.0	6.4	0.0	4.3	6.0	0.0	0.1	0.8	0.0	15.5	11.9	0.4	0.0	1.0	0.4	0.8	0.8	0.1	0.0	1.3	0.7	2.9	6.8	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.5	11.3	0.0	13.1	4.6	0.0	1.3	8.6	2.0	0.0	29.6	22.4	0.1	0.0	1.6	0.8	0.0	33.8	5.6	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	51.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	124.9	0.0	0.1	0.1	164.0	0.0	0.0	0.3	0.1	0.1	0.0	0.1	19.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1314.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0
IGKV2D-40		ENSG00000251039	"Immunoglobulin kappa variable 2D-40"	P01614	2	89851791-89852497	"Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 124.3"	"Cell type enriched"	"Detected in some"	489	"Plasma cells: 1517.1"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 30.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	494	"memory B-cell: 134.9;naive B-cell: 96.8"	"Lineage enriched"	"Detected in single"	575	"B-cells: 134.9"	"Cell line enhanced"	"Detected in single"		"Daudi: 3.7"														"Immunoglobulin genes"	NA	NA		1900000000				"prognostic favorable (5.01e-4)"	"unprognostic (1.16e-2)"	"unprognostic (8.37e-2)"	"unprognostic (6.04e-2)"		"prognostic favorable (9.78e-7)"		"unprognostic (1.87e-1)"		"unprognostic (2.29e-1)"	"unprognostic (2.32e-2)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (3.59e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.25e-1)"	1.7	1.5	0.0	21.2	0.0	14.9	13.6	0.0	0.1	10.1	0.0	16.8	7.0	3.1	0.0	35.9	14.5	7.8	2.0	0.0	0.0	1.0	2.9	19.7	66.3	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.6	22.0	0.0	32.6	21.9	0.0	0.0	31.4	1.6	0.0	45.2	38.9	0.4	0.0	26.6	5.7	0.0	124.3	34.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	134.9	0.0	0.0	0.0	96.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1517.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
IGKV3-11		ENSG00000241351	"Immunoglobulin kappa variable 3-11"	P04433	2	89027171-89027731	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1386.5;lymphoid tissue: 2836.4;urinary bladder: 1837.9"	"Cell type enriched"	"Detected in some"	129	"Plasma cells: 27475.3"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"hypothalamus: 6.1;spinal cord: 19.9"	"Group enriched"	"Detected in many"	292	"memory B-cell: 1729.8;naive B-cell: 1401.2"	"Lineage enriched"	"Detected in many"	323	"B-cells: 1729.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.0;Daudi: 2.0;SCLC-21H: 3.7;SH-SY5Y: 4.6"									HPA047702	Approved				"Immunoglobulin genes"	NA	NA		18000000000			"HPA047702: "	"unprognostic (3.97e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.70e-2)"	"prognostic favorable (1.36e-5)"	"unprognostic (2.02e-1)"	"unprognostic (3.20e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (2.26e-8)"	"unprognostic (5.93e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.07e-1)"	42.3	61.1	0.4	740.1	0.4	190.8	389.1	0.3	2.1	137.4	0.5	1386.5	707.9	32.4	11.6	144.8	34.3	255.9	19.0	0.2	6.1	43.5	55.7	229.6	580.5	0.5	1.6	0.2	121.9	13.8	1.9	3.3	0.9	0.8	30.4	1101.3	0.1	500.0	61.5	1.2	14.3	540.5	60.0	19.9	1108.8	795.9	22.4	0.3	264.3	89.6	0.9	2836.4	1837.9	33.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.2	0.4	0.0	0.0	0.4	1.8	1.5	0.0	0.0	3.7	4.6	0.4	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.7	0.7	0.6	1.8	0.3	0.1	0.0	1.4	0.0	1.9	1.3	1.2	2.0	0.2	0.7	1729.8	0.8	0.6	1.6	1401.2	0.8	0.8	5.3	0.9	1.1	1.2	1.3	186.7	0.4	0.4	0.3	2.1	0.2	6.1	0.5	1.6	0.2	0.8	19.9	0.3	1.0	0.0	0.0	0.5	0.0	211.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	82.6	0.0	0.0	0.0	2.5	1.9	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.7	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27475.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.0	62.0	0.0	0.3	0.0
IGKV3-15		ENSG00000244437	"Immunoglobulin kappa variable 3-15"	P01624	2	89085177-89085787	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 793.4;lymphoid tissue: 2012.9;urinary bladder: 791.3"	"Cell type enriched"	"Detected in some"	85	"Plasma cells: 22923.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	561	"memory B-cell: 2243.8;naive B-cell: 1651.4"	"Lineage enriched"	"Detected in all"	646	"B-cells: 2243.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.7;K-562: 1.3;NB-4: 1.9;RH-30: 1.2;RPMI-8226: 2.2;SCLC-21H: 1.4;SH-SY5Y: 2.5"									HPA047702	Approved				"Immunoglobulin genes"	NA	NA		7200000000			"HPA047702: "	"prognostic favorable (1.57e-4)"	"unprognostic (1.29e-2)"	"unprognostic (7.02e-3)"	"unprognostic (3.89e-3)"	"unprognostic (9.06e-3)"	"unprognostic (2.06e-3)"	"unprognostic (5.36e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.82e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (3.15e-7)"	"unprognostic (2.00e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.17e-1)"	24.9	115.6	0.1	609.5	0.2	132.2	176.0	0.1	1.5	143.0	0.6	793.4	435.3	19.6	35.0	121.0	30.3	145.7	14.9	0.1	1.8	34.6	37.0	186.5	505.1	0.5	2.2	0.1	55.9	9.4	2.5	3.0	0.5	0.2	18.5	655.6	0.0	402.6	115.3	1.1	1.8	338.6	29.8	1.4	1028.9	635.5	65.4	0.2	252.5	78.3	0.0	2012.9	791.3	28.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.4	1.9	0.6	0.0	0.0	0.0	1.2	2.2	0.0	0.0	1.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.4	0.7	0.5	0.0	0.0	0.0	1.0	0.0	1.8	3.4	0.8	1.0	0.4	0.8	2243.8	1.0	1.1	1.8	1651.4	1.0	1.1	1.9	1.0	1.3	1.7	1.5	193.1	0.1	0.2	0.1	1.5	0.1	1.8	0.5	2.2	0.1	0.2	1.4	0.2	1.0	0.0	0.0	0.0	0.0	269.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	2.6	73.4	0.0	0.0	0.0	1.4	1.1	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.1	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	22923.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	252.5	0.0	0.0	0.2	0.0	0.0	28.2	0.0	0.0	0.0
IGKV3-20		ENSG00000239951	"Immunoglobulin kappa variable 3-20"	P01619	2	89142574-89143160	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 3110.0;lymphoid tissue: 5290.0"	"Cell type enriched"	"Detected in some"	138	"Plasma cells: 52154.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	329	"memory B-cell: 1602.7;naive B-cell: 1222.4"	"Lineage enriched"	"Detected in many"	373	"B-cells: 1602.7"	"Group enriched"	"Detected in many"	215	"U-266/70: 3769.9;U-266/84: 1732.3"									HPA047702	Approved				"Immunoglobulin genes"	NA	NA		20000000000			"HPA047702: "	"prognostic favorable (1.86e-4)"	"unprognostic (4.16e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (9.01e-4)"	"unprognostic (1.43e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.93e-3)"	"unprognostic (8.44e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (1.07e-6)"	"unprognostic (7.35e-2)"	"unprognostic (5.08e-1)"	"unprognostic (6.64e-2)"	"unprognostic (2.70e-2)"	81.9	56.9	0.9	1808.2	1.2	383.7	743.7	0.6	4.2	329.7	2.7	3110.0	1729.8	59.6	7.8	304.8	106.1	643.2	56.1	0.6	11.7	104.6	114.5	458.1	2840.2	2.2	5.9	0.5	154.8	33.1	5.9	9.7	1.8	1.8	56.6	2757.4	0.2	1282.2	226.7	3.3	13.5	1367.1	83.5	10.0	2720.7	1425.6	24.9	1.4	677.6	226.2	1.8	5290.0	1657.9	70.6	1.4	2.5	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.5	0.0	0.0	2.3	0.0	0.0	0.0	0.5	0.0	2.1	0.0	0.0	0.0	6.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	2.0	5.9	2.8	0.0	0.0	3.0	6.0	10.4	0.0	0.0	7.7	12.8	1.4	0.0	0.1	0.0	0.0	0.8	4.4	0.0	2.0	1.5	4.3	3769.9	1732.3	1.8	0.0	2.3	0.0	4.0	1.2	0.7	0.7	0.4	0.8	1602.7	0.8	0.6	3.5	1222.4	0.4	0.7	4.2	0.8	1.0	0.9	0.8	196.9	0.9	1.2	0.6	4.2	0.6	11.7	2.2	5.9	0.5	1.8	10.0	1.4	1.4	0.1	3.2	1.3	0.0	376.9	0.0	0.0	0.0	5.2	0.0	0.1	0.1	0.0	4.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	9.4	0.0	0.0	0.0	55.3	124.4	0.0	1.3	0.0	3.6	5.0	0.1	0.0	0.0	0.1	0.0	5.3	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	52154.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	3.0	0.0	0.0	26.7	0.0	0.2	0.0
IGKV3D-11		ENSG00000211632	"Immunoglobulin kappa variable 3D-11"	A0A0A0MRZ8	2	90172802-90173414	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"intestine: 38.9;lymphoid tissue: 59.0;stomach 1: 28.0"	"Cell type enriched"	"Detected in some"	34	"Plasma cells: 196.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	468	"memory B-cell: 152.5;naive B-cell: 146.1"	"Lineage enriched"	"Detected in single"	478	"B-cells: 152.5"	"Cell line enhanced"	"Detected in single"		"U-266/70: 2.1"									HPA047702	Approved				"Immunoglobulin genes"	NA	NA		6700000000			"HPA047702: "	"prognostic favorable (6.40e-5)"	"unprognostic (7.90e-3)"	"unprognostic (1.91e-2)"	"unprognostic (2.24e-3)"		"prognostic favorable (5.58e-5)"	"unprognostic (2.65e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.78e-1)"	"unprognostic (6.31e-2)"	"unprognostic (3.49e-1)"	"unprognostic (3.61e-1)"	"prognostic unfavorable (2.20e-6)"	"unprognostic (1.12e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.24e-2)"	1.2	0.7	0.2	36.3	0.2	8.9	6.4	0.0	0.1	1.8	0.0	38.9	32.5	0.8	0.0	2.4	2.1	2.7	0.5	0.0	0.3	2.1	1.4	12.5	13.1	0.1	0.2	0.0	1.5	0.5	0.0	0.1	0.0	0.1	0.7	26.9	0.0	18.9	0.3	0.0	0.0	23.8	0.7	0.2	30.2	28.0	0.2	0.1	4.3	2.3	0.0	59.0	17.2	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.8	0.4	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	152.5	0.0	0.0	0.1	146.1	0.0	0.1	0.1	0.0	0.0	0.0	0.3	30.2	0.2	0.2	0.0	0.1	0.0	0.3	0.1	0.2	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	196.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0
IGKV3D-20		ENSG00000211625	"Immunoglobulin kappa variable 3D-20"	A0A0C4DH25	2	90038848-90039479	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 133.1;lymphoid tissue: 277.7"	"Cell type enriched"	"Detected in some"	38	"Plasma cells: 289.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	1042	"memory B-cell: 197.3;naive B-cell: 99.0"	"Lineage enriched"	"Detected in single"	1388	"B-cells: 197.3"	"Cell line enriched"	"Detected in some"	4	"U-266/70: 19.5"									HPA047702	Approved				"Immunoglobulin genes"	NA	NA		11000000000			"HPA047702: "	"prognostic favorable (6.82e-4)"	"unprognostic (4.70e-3)"	"unprognostic (3.16e-2)"	"unprognostic (8.10e-3)"	"unprognostic (2.05e-1)"	"unprognostic (2.60e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.68e-1)"	"unprognostic (5.15e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (3.56e-6)"	"unprognostic (7.10e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.73e-1)"	4.1	6.3	0.0	81.9	0.0	16.2	32.7	0.0	0.4	12.3	0.0	133.1	56.4	2.7	0.0	15.4	4.2	16.4	6.5	0.0	0.6	2.9	6.5	20.8	74.1	0.1	0.1	0.0	7.2	3.3	0.0	0.3	0.1	0.1	3.7	89.0	0.0	64.6	3.4	0.1	2.6	78.3	6.1	0.3	89.1	83.2	1.2	0.0	16.3	5.2	0.0	277.7	38.4	2.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	19.5	4.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	197.3	0.0	0.1	0.1	99.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	34.1	0.0	0.0	0.0	0.4	0.0	0.6	0.1	0.1	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	289.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0
IGKV3D-7		ENSG00000228325	"Immunoglobulin kappa variable 3D-7"	A0A0C4DH55	2	90234812-90235370	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 4.6;lymphoid tissue: 5.6;stomach 1: 4.5;urinary bladder: 5.5"	"Cell type enriched"	"Detected in single"	415	"Plasma cells: 207.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	36	"memory B-cell: 2.8;naive B-cell: 4.3"	"Lineage enriched"	"Detected in single"	44	"B-cells: 4.3"	"Cell line enriched"	"Detected in some"	12	"RPMI-8226: 48.7"									HPA047702	Approved				"Immunoglobulin genes"	NA	NA		3700000000			"HPA047702: "		"unprognostic (2.74e-1)"				"unprognostic (8.62e-3)"		"unprognostic (6.59e-2)"			"unprognostic (2.14e-1)"			"unprognostic (3.05e-1)"	"unprognostic (4.02e-1)"			0.1	0.0	0.0	5.6	0.2	1.3	0.1	0.0	0.1	0.2	0.0	4.1	4.6	0.0	0.0	1.9	0.1	1.6	0.0	0.1	0.2	0.0	0.2	0.5	1.4	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	2.1	0.1	0.0	0.0	4.5	0.0	0.0	3.8	4.5	0.0	0.1	0.3	0.6	0.0	4.4	5.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	207.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKV3OR2-268	"IGKV268, IGKV3/OR2-268, IGKV3/OR2-268A, IGKV3OR2-268A"	ENSG00000233999	"Immunoglobulin kappa variable 3/OR2-268 (non-functional)"		2	87338511-87339035	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"intestine: 101.3;lymphoid tissue: 86.4"	"Cell type enriched"	"Detected in some"	302	"Plasma cells: 2604.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"memory B-cell: 220.0;naive B-cell: 78.9"	"Lineage enriched"	"Detected in many"	7	"B-cells: 220.0"	"Group enriched"	"Detected in some"	71	"U-266/70: 183.9;U-266/84: 593.2"									HPA047702	Approved					NA	NA					"HPA047702: "	"prognostic favorable (8.06e-4)"	"unprognostic (1.69e-3)"	"unprognostic (1.19e-1)"			"prognostic favorable (1.41e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.10e-1)"	"unprognostic (8.68e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (1.12e-6)"	"unprognostic (2.80e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.41e-1)"	0.3	1.3	0.2	46.2	0.3	11.9	28.8	0.1	0.8	3.4	0.1	101.3	34.2	0.9	0.0	1.3	0.7	24.9	1.4	0.3	0.4	0.6	2.6	7.6	24.0	0.2	1.2	0.2	3.3	1.2	0.0	0.0	0.1	0.2	1.6	60.1	0.0	29.6	1.7	0.0	0.6	28.0	4.1	0.0	19.4	34.3	0.4	0.2	10.4	1.2	0.0	86.4	24.6	0.9	0.4	0.5	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.5	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.4	3.8	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.5	0.2	183.9	593.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.3	220.0	2.8	0.1	0.1	78.9	0.0	0.1	0.1	0.1	0.0	0.2	30.0	32.7	0.2	0.3	0.1	0.8	0.3	0.4	0.2	1.2	0.2	0.2	0.0	0.2	0.4	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2604.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0
IGKV4-1	"B3, IGKV41"	ENSG00000211598	"Immunoglobulin kappa variable 4-1"	P06312	2	88885397-88886153	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1823.0;lymphoid tissue: 3195.0"	"Cell type enriched"	"Detected in some"	219	"Plasma cells: 46306.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	588	"memory B-cell: 3036.3;naive B-cell: 3070.9"	"Lineage enriched"	"Detected in all"	591	"B-cells: 3070.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 14.9;RPMI-8226: 10.4;SH-SY5Y: 6.9;U-266/70: 7.5"														"Immunoglobulin genes"	NA	NA		8500000000				"prognostic favorable (6.41e-5)"	"unprognostic (9.19e-2)"	"unprognostic (4.29e-3)"	"unprognostic (5.42e-3)"	"unprognostic (2.08e-2)"	"prognostic favorable (8.25e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.32e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.29e-1)"	"prognostic unfavorable (2.52e-6)"	"unprognostic (1.99e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.19e-1)"	56.4	299.2	0.5	1064.0	1.0	345.3	671.9	0.5	3.4	146.4	2.5	1823.0	1785.8	47.3	19.6	197.5	41.6	189.9	52.3	0.6	7.8	34.8	76.7	305.1	823.4	1.8	7.3	0.4	87.3	28.6	2.5	2.9	1.0	3.1	44.3	1330.7	0.1	708.3	90.4	1.0	8.7	1031.5	67.0	3.5	980.1	1135.9	126.7	0.7	408.8	51.4	0.1	3195.0	764.7	19.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.9	0.0	1.7	0.0	0.0	0.0	3.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.6	3.6	0.3	0.0	0.0	1.4	2.2	10.4	0.0	0.0	4.0	6.9	2.3	0.0	0.0	0.0	0.0	0.7	2.6	0.0	0.8	1.1	1.0	7.5	0.2	0.8	0.0	1.2	0.0	3.9	3.2	5.1	1.6	0.9	1.7	3036.3	1.9	1.1	2.8	3070.9	2.1	1.3	2.4	1.6	2.4	2.3	1.7	344.9	0.5	1.0	0.5	3.4	0.6	7.8	1.8	7.3	0.4	3.1	3.5	0.7	1.5	0.0	0.0	0.0	0.0	210.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	8.0	0.0	0.0	0.0	17.0	40.2	0.0	0.0	0.0	2.2	2.8	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	3.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	46306.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	15.7	0.0	0.1	0.0
IGKV5-2	"B2, IGKV52"	ENSG00000211599	"Immunoglobulin kappa variable 5-2"	P06315	2	88897232-88897784	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 36.2;lymphoid tissue: 83.8"	"Cell type enriched"	"Detected in some"	193	"Plasma cells: 1664.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"memory B-cell: 21.4;naive B-cell: 17.2"	"Lineage enriched"	"Detected in many"	21	"B-cells: 21.4"	"Group enriched"	"Detected in some"	19	"Daudi: 4.2;HDLM-2: 1.8;RPMI-8226: 2.3"					"Low region specificity"	"Detected in all"								"Immunoglobulin genes"	NA	NA		4700000				"unprognostic (1.77e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.49e-2)"		"prognostic favorable (2.12e-4)"		"unprognostic (2.37e-1)"		"unprognostic (2.26e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (8.62e-6)"	"unprognostic (2.60e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.85e-2)"	0.5	0.0	0.0	10.4	0.0	6.5	19.8	0.0	0.0	5.3	0.0	23.5	36.2	0.8	0.0	4.1	0.9	0.9	0.1	0.0	0.0	0.9	1.0	6.3	17.5	0.0	0.0	0.0	0.4	0.4	0.5	0.0	0.0	0.0	0.6	11.2	0.0	15.0	1.9	0.0	0.5	14.4	0.2	0.0	23.7	15.4	0.0	0.0	3.0	1.0	0.0	83.8	4.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.4	0.0	0.0	0.0	17.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1664.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0
IGKV6-21	"A26, IGKV621"	ENSG00000211611	"Immunoglobulin kappa variable 6-21 (non-functional)"	A0A0C4DH24	2	89159751-89160366	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 98.2;lymphoid tissue: 142.1"	"Cell type enriched"	"Detected in some"	142	"Plasma cells: 1715.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	194	"memory B-cell: 28.8;naive B-cell: 9.8"	"Lineage enriched"	"Detected in single"	289	"B-cells: 28.8"	"Cell line enriched"	"Detected in some"	6	"U-266/70: 10.5"														"Immunoglobulin genes"	NA	NA		250000000				"prognostic favorable (1.82e-4)"	"unprognostic (1.80e-2)"	"unprognostic (4.99e-3)"	"unprognostic (2.32e-2)"		"unprognostic (1.51e-3)"	"unprognostic (1.93e-1)"	"unprognostic (6.32e-2)"		"unprognostic (4.74e-2)"	"unprognostic (8.91e-2)"	"unprognostic (7.31e-2)"	"prognostic unfavorable (5.05e-4)"	"unprognostic (1.45e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.14e-1)"	1.1	0.4	0.0	42.0	0.1	12.1	37.7	0.0	0.1	2.2	0.0	98.2	39.2	1.8	0.6	8.5	2.0	5.9	0.5	0.0	0.7	2.7	2.6	12.0	65.0	0.2	0.3	0.0	2.2	0.9	0.0	0.1	0.0	0.0	1.5	80.0	0.0	43.9	9.1	0.0	0.4	38.8	5.0	0.1	64.3	36.6	0.9	0.0	10.3	3.6	0.0	142.1	37.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	1.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.8	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.1	0.0	0.1	0.0	0.7	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	6.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1715.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0
IGLJ2		ENSG00000211676	"Immunoglobulin lambda joining 2"		22	22899481-22899655	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"intestine: 263.2;lymphoid tissue: 191.4;stomach 1: 214.6"	"Cell type enriched"	"Detected in single"	5	"Plasma cells: 1.7"	"Group enriched"	"Detected in many"	8	"colorectal cancer: 12.9;endometrial cancer: 21.6"	"Region enhanced"	"Detected in single"		"pons: 1.3"	"Group enriched"	"Detected in many"	12	"memory B-cell: 876.1;naive B-cell: 864.5"	"Lineage enriched"	"Detected in many"	12	"B-cells: 876.1"	"Cell line enhanced"	"Detected in some"		"Daudi: 10.8;HMC-1: 34.1;RH-30: 89.7;U-698: 19.8"															NA	NA						"unprognostic (6.99e-3)"	"unprognostic (5.36e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.13e-2)"		"unprognostic (5.94e-7)"		"unprognostic (1.51e-2)"			"unprognostic (3.63e-2)"			"unprognostic (3.66e-2)"	"unprognostic (5.17e-2)"		"unprognostic (2.92e-1)"	8.5	55.5	0.2	174.6	0.0	25.6	11.3	0.1	0.8	6.1	0.2	135.8	263.2	3.0	4.2	13.6	1.0	12.6	2.9	0.1	0.0	2.1	6.9	21.7	95.3	0.3	0.1	0.0	4.8	6.0	0.1	0.0	0.0	1.3	4.0	31.4	0.0	76.3	4.3	0.0	0.2	207.7	1.9	0.0	129.5	214.6	2.4	0.1	15.7	0.3	0.0	191.4	61.3	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	34.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.0	0.0	0.7	89.7	1.3	0.0	0.0	0.8	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	1.0	0.0	0.6	19.8	0.0	0.5	0.0	1.4	1.9	0.6	0.4	0.2	0.7	876.1	0.3	0.3	0.9	864.5	0.2	0.4	9.3	0.7	0.8	71.8	0.5	136.5	0.2	0.0	0.1	0.8	0.1	0.0	0.3	0.1	0.0	1.3	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGLL5		ENSG00000254709	"Immunoglobulin lambda like polypeptide 5"	B9A064	22	22887780-22896111	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 412.1;lymphoid tissue: 679.7;stomach 1: 310.9"	"Cell type enriched"	"Detected in some"	55	"Melanocytes: 93931.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	226	"memory B-cell: 515.9;naive B-cell: 615.5"	"Lineage enriched"	"Detected in many"	246	"B-cells: 615.5"	"Group enriched"	"Detected in some"	7	"Daudi: 637.2;U-266/70: 386.4;U-698: 441.1"														"Secreted to blood"	NA	NA		53000000000				"prognostic favorable (6.10e-4)"	"unprognostic (7.64e-3)"	"unprognostic (4.33e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.82e-2)"	"prognostic favorable (3.41e-5)"	"unprognostic (1.76e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.73e-1)"	"prognostic unfavorable (5.94e-8)"	"unprognostic (1.85e-1)"	"unprognostic (4.63e-1)"	"unprognostic (8.52e-2)"	"unprognostic (6.50e-2)"	10.7	25.3	0.4	166.3	0.3	95.2	140.6	0.2	1.2	33.1	0.6	409.4	412.1	7.9	0.0	50.8	14.8	67.9	11.3	0.3	0.3	16.7	16.1	66.3	311.1	0.5	0.4	0.2	18.8	11.1	1.5	1.5	0.2	0.3	8.4	251.7	0.1	281.9	22.4	0.5	2.7	183.1	8.8	0.4	462.5	310.9	4.3	0.3	124.8	26.5	0.2	679.7	225.5	10.1	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	637.2	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.3	3.6	0.9	0.0	0.0	0.6	1.0	0.4	0.0	0.1	0.0	0.0	0.9	1.4	0.0	1.9	0.1	0.2	386.4	68.5	441.1	0.0	0.3	0.0	0.4	0.7	0.2	0.3	0.1	0.2	515.9	0.2	0.2	0.8	615.5	0.1	0.2	1.0	0.2	0.4	2.5	0.3	68.1	0.4	0.3	0.2	1.2	0.3	0.3	0.5	0.4	0.2	0.3	0.4	0.3	0.5	0.0	3.2	30.9	0.0	222.5	108.6	0.0	0.0	0.0	0.0	1.4	0.1	0.0	1.5	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.7	0.0	0.0	12.7	1.2	5.7	0.0	0.0	0.0	7.7	3.1	0.0	11.4	0.1	1.1	4.2	0.0	0.0	0.0	0.1	0.0	0.8	113.1	3.8	0.0	0.9	93931.2	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.1	0.0	1680.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	93.5	0.0	49.3	0.0	2.4	0.0
IGLV1-36		ENSG00000211655	"Immunoglobulin lambda variable 1-36"	A0A0B4J1U3	22	22431958-22432465	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 271.0;stomach 1: 123.5;urinary bladder: 87.2"	"Cell type enriched"	"Detected in some"	13	"Plasma cells: 59.2"	"Cancer enhanced"	"Detected in many"		"lung cancer: 33.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	625	"memory B-cell: 60.9;naive B-cell: 85.8"	"Lineage enriched"	"Detected in single"	731	"B-cells: 85.8"	"Not detected"	"Not detected"																"Immunoglobulin genes"	NA	NA		980000000				"prognostic favorable (1.55e-4)"	"unprognostic (5.15e-2)"	"unprognostic (2.04e-2)"	"prognostic favorable (2.60e-4)"		"unprognostic (1.11e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.51e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (1.64e-5)"	"unprognostic (2.99e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.07e-1)"	1.0	0.3	0.0	19.8	0.0	14.6	23.9	0.0	0.4	6.1	0.0	28.5	21.8	0.7	0.6	10.6	9.2	7.3	3.0	0.0	0.0	3.2	3.4	8.8	16.7	0.0	0.1	0.0	1.7	1.1	0.0	0.1	0.0	0.1	1.6	45.2	0.0	37.6	3.1	0.0	0.6	12.4	0.8	0.0	109.0	123.5	0.3	0.0	30.7	2.8	0.0	271.0	87.2	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	60.9	0.0	0.0	0.0	85.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
IGLV1-40		ENSG00000211653	"Immunoglobulin lambda variable 1-40"	P01703	22	22409766-22410282	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 1302.2;stomach 1: 1299.3"	"Cell type enriched"	"Detected in some"	358	"Plasma cells: 43406.7"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in some"		"cerebral cortex: 3.1"	"Group enriched"	"Detected in some"	496	"memory B-cell: 666.4;naive B-cell: 576.7"	"Lineage enriched"	"Detected in many"	532	"B-cells: 666.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 3.5;RPMI-8226: 2.2;SH-SY5Y: 3.4;TIME: 2.3"														"Immunoglobulin genes"	NA	NA		2300000000				"unprognostic (1.64e-3)"	"unprognostic (4.68e-3)"	"unprognostic (3.88e-2)"	"unprognostic (3.37e-3)"	"unprognostic (9.60e-3)"	"prognostic favorable (5.74e-6)"	"unprognostic (2.39e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.43e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (5.44e-6)"	"unprognostic (1.51e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.57e-2)"	25.3	13.1	0.8	205.4	0.4	115.4	139.9	0.1	3.1	68.7	1.0	559.0	556.6	15.0	0.6	126.5	21.7	238.2	15.3	0.3	0.2	28.4	28.5	116.4	284.7	0.5	0.9	0.2	57.1	10.1	1.1	3.4	0.6	0.5	46.5	339.8	4.3	417.2	19.9	1.2	2.3	289.6	14.5	0.2	1038.0	1299.3	7.3	0.3	180.9	61.8	0.0	1302.2	468.7	19.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.3	1.0	1.1	0.0	0.0	0.2	0.8	2.2	0.0	0.0	1.3	3.4	0.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.4	0.7	0.7	1.1	1.1	0.8	0.0	0.3	0.0	0.4	0.7	0.2	0.3	0.1	0.6	666.4	0.3	0.3	0.6	576.7	0.1	0.2	1.2	0.3	0.3	0.6	0.4	53.7	0.8	0.4	0.1	3.1	0.3	0.2	0.5	0.9	0.2	0.5	0.2	0.3	1.0	0.0	0.0	0.0	0.0	121.0	0.0	0.0	0.0	2.2	0.0	0.4	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	1.2	8.0	0.0	0.0	0.0	28.6	64.2	0.0	0.0	0.0	1.8	0.9	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.7	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	43406.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	7.4	0.0	0.1	0.0
IGLV1-44		ENSG00000211651	"Immunoglobulin lambda variable 1-44"	P01699	22	22380766-22381347	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 595.1;lymphoid tissue: 1935.1;stomach 1: 539.1"	"Cell type enriched"	"Detected in some"	108	"Plasma cells: 12023.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	840	"memory B-cell: 968.8;naive B-cell: 850.4"	"Lineage enriched"	"Detected in many"	894	"B-cells: 968.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 21.3;RPMI-8226: 5.5;SCLC-21H: 4.1;U-698: 15.2"														"Immunoglobulin genes"	NA	NA		4000000000				"unprognostic (1.88e-3)"	"unprognostic (1.51e-2)"	"unprognostic (2.40e-2)"	"unprognostic (7.23e-3)"	"unprognostic (4.81e-3)"	"prognostic favorable (4.71e-5)"	"unprognostic (2.18e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (6.55e-8)"	"unprognostic (1.85e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.48e-2)"	"unprognostic (5.49e-2)"	16.9	2.0	0.0	300.0	0.5	134.7	111.4	0.0	2.0	10.8	0.0	382.3	595.1	12.0	0.0	80.8	19.7	79.4	17.6	0.0	0.0	18.5	17.3	123.3	524.0	1.6	0.7	0.0	15.4	3.6	0.0	2.6	0.0	0.3	13.9	265.6	0.0	275.3	9.5	0.7	1.6	238.5	21.6	0.0	613.6	539.1	11.7	0.4	119.0	35.4	0.0	1935.1	242.6	16.3	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	5.5	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	968.8	0.0	0.0	0.7	850.4	0.0	0.0	0.0	0.0	0.1	1.0	0.1	100.0	0.0	0.5	0.0	2.0	0.0	0.0	1.6	0.7	0.0	0.3	0.0	0.4	1.9	0.0	0.0	0.6	0.0	111.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	2.7	0.0	0.0	0.0	3.5	48.4	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12023.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.3	0.0
IGLV1-47		ENSG00000211648	"Immunoglobulin lambda variable 1-47"	P01700	22	22357739-22358260	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 713.3;lymphoid tissue: 1819.2;stomach 1: 631.2"	"Cell type enriched"	"Detected in some"	114	"Plasma cells: 10777.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	638	"memory B-cell: 1518.1;naive B-cell: 819.6"	"Lineage enriched"	"Detected in many"	828	"B-cells: 1518.1"	"Cell line enhanced"	"Detected in some"		"HL-60: 2.1;RH-30: 2.1;RPMI-8226: 4.2;SCLC-21H: 2.7;SH-SY5Y: 2.4;U-698: 7.1"														"Immunoglobulin genes"	NA	NA		3000000000				"unprognostic (5.19e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.26e-1)"	"prognostic favorable (2.66e-4)"	"unprognostic (4.44e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (5.12e-8)"	"unprognostic (5.00e-3)"	"unprognostic (1.62e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.15e-2)"	36.3	218.1	0.6	326.1	1.8	163.8	202.5	0.5	2.3	82.8	0.7	713.3	711.1	24.0	3.0	165.1	21.5	113.8	27.4	0.3	0.3	23.4	32.1	127.8	695.1	2.9	0.4	0.2	43.9	9.0	4.9	2.1	0.5	1.0	22.7	536.4	0.2	531.4	70.8	0.7	4.7	335.6	35.0	0.5	820.3	631.2	9.9	0.7	262.5	34.4	0.0	1819.2	370.1	10.3	2.4	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	1.4	0.4	0.0	0.0	0.7	2.1	4.2	0.0	0.0	2.7	2.4	0.5	0.0	0.0	0.1	0.0	0.3	0.9	0.0	0.0	0.0	0.1	0.6	0.0	7.1	0.0	0.9	0.0	0.7	1.2	0.5	0.7	0.1	0.5	1518.1	0.7	0.6	1.0	819.6	0.3	0.6	0.6	0.5	0.5	1.8	0.6	159.6	0.6	1.8	0.5	2.3	0.3	0.3	2.9	0.4	0.2	1.0	0.5	0.7	2.4	0.0	0.0	0.0	0.0	94.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.7	0.0	0.0	0.0	1.7	29.0	0.0	0.0	0.0	0.7	1.7	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	10777.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.3	0.0
IGLV1-50		ENSG00000211645	"Immunoglobulin lambda variable 1-50 (non-functional)"	A0A075B6I6	22	22327300-22327814	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 16.5;lymphoid tissue: 14.8;stomach 1: 20.6"	"Cell type enriched"	"Detected in single"	2575	"Plasma cells: 1545.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	21	"memory B-cell: 11.0;naive B-cell: 2.9"	"Lineage enriched"	"Detected in single"	33	"B-cells: 11.0"	"Cell line enhanced"	"Detected in single"		"HEK 293: 1.1"														"Immunoglobulin genes"	NA	NA						"unprognostic (1.75e-4)"	"unprognostic (8.01e-2)"	"unprognostic (1.28e-3)"	"unprognostic (6.91e-2)"	"unprognostic (2.10e-1)"	"prognostic favorable (7.08e-4)"	"unprognostic (2.81e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.83e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.58e-4)"	"unprognostic (4.89e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.59e-2)"	0.5	0.6	0.3	6.1	0.3	3.4	6.8	1.6	2.2	0.5	0.0	5.4	16.5	0.6	1.2	2.4	0.5	0.8	0.0	0.7	0.1	0.2	0.2	4.5	1.9	0.7	0.1	0.0	0.9	0.1	0.1	0.1	0.0	1.9	0.3	4.5	0.7	4.7	0.3	0.4	0.0	9.5	0.2	0.0	4.0	20.6	0.4	0.2	0.6	0.2	0.0	14.8	9.4	0.1	1.3	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.3	0.5	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.1	0.0	0.3	0.1	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	11.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.3	1.6	2.2	0.7	0.1	0.7	0.1	0.0	1.9	0.0	0.2	1.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1545.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGLV1-51		ENSG00000211644	"Immunoglobulin lambda variable 1-51"	P01701	22	22322472-22322969	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 1331.3;lymphoid tissue: 3052.4;urinary bladder: 1598.3"	"Cell type enriched"	"Detected in some"	312	"Plasma cells: 34336.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"memory B-cell: 275.9;naive B-cell: 178.3"	"Lineage enriched"	"Detected in many"	10	"B-cells: 275.9"	"Cell line enhanced"	"Detected in many"		"HEK 293: 17.9"														"Immunoglobulin genes"	NA	NA		1700000000				"prognostic favorable (1.85e-4)"	"unprognostic (1.71e-2)"	"unprognostic (3.12e-3)"	"unprognostic (1.76e-3)"	"unprognostic (1.61e-1)"	"prognostic favorable (1.95e-5)"	"unprognostic (3.55e-3)"	"unprognostic (3.78e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.86e-1)"	"prognostic unfavorable (1.40e-5)"	"unprognostic (1.21e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.07e-1)"	43.9	321.8	1.2	489.3	1.8	276.7	632.9	4.5	6.9	73.8	1.6	1331.3	1149.4	38.4	17.0	290.0	53.2	240.2	70.7	1.4	1.3	32.0	53.8	180.7	345.7	3.7	1.9	1.1	186.6	39.3	5.8	4.1	1.6	5.7	34.7	938.6	3.2	701.6	50.0	1.9	13.2	708.0	50.3	1.9	942.0	965.3	11.8	1.8	276.5	63.5	1.7	3052.4	1598.3	17.9	2.5	1.3	0.6	1.6	3.8	3.5	1.7	5.9	1.4	3.2	3.1	2.0	2.3	1.0	8.8	1.6	0.8	1.1	3.1	1.9	3.8	2.2	1.4	17.9	3.9	4.5	2.4	0.7	3.4	1.7	5.2	1.0	2.7	0.3	0.4	3.1	0.9	3.9	0.9	3.0	1.6	2.6	3.8	3.0	2.8	4.1	2.3	2.7	8.8	3.6	1.4	8.3	4.9	2.0	1.4	1.8	0.9	2.7	0.3	4.3	4.4	9.2	1.0	1.2	2.0	2.0	2.0	0.4	2.8	0.8	0.1	0.5	0.0	0.2	0.2	26.3	275.9	0.2	0.3	0.1	178.3	0.7	0.5	0.4	0.1	0.3	0.2	0.2	26.4	1.2	1.8	4.5	6.9	1.4	1.3	3.7	1.9	1.1	5.7	1.9	1.8	2.5	0.0	0.0	0.5	0.0	109.8	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	4.8	35.7	0.1	0.0	0.0	0.7	1.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	34336.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.1	19.3	0.0	0.0	9.4	0.0	0.0	0.0
IGLV2-11		ENSG00000211668	"Immunoglobulin lambda variable 2-11"	P01706	22	22792491-22793007	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1556.6;lymphoid tissue: 2951.9"	"Cell type enriched"	"Detected in some"	85	"Plasma cells: 7693.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	37	"memory B-cell: 1402.5;naive B-cell: 850.1"	"Lineage enriched"	"Detected in many"	46	"B-cells: 1402.5"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 75.0;U-266/70: 20.9;U-266/84: 15.3"														"Immunoglobulin genes"	NA	NA		980000000				"unprognostic (9.76e-3)"	"unprognostic (6.86e-2)"	"unprognostic (3.46e-3)"	"unprognostic (7.67e-3)"	"unprognostic (2.82e-3)"	"prognostic favorable (4.74e-5)"	"unprognostic (1.18e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.19e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.72e-1)"	"prognostic unfavorable (1.38e-7)"	"unprognostic (3.93e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.27e-1)"	33.9	7.4	0.6	347.9	0.7	158.7	452.2	0.2	2.2	28.0	0.8	1469.8	1556.6	18.6	0.5	213.9	30.3	193.0	45.0	0.2	0.6	22.0	41.5	181.4	685.9	1.5	0.5	0.2	30.7	22.6	0.6	2.2	0.5	1.0	17.1	876.1	0.0	428.8	36.3	1.7	3.0	719.8	21.5	0.3	642.8	883.9	76.0	0.6	289.1	62.7	0.0	2951.9	666.7	14.9	2.2	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	3.4	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	75.0	0.0	0.0	0.9	4.6	1.1	0.0	0.0	0.8	2.8	8.3	0.0	0.0	2.9	4.8	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	1.1	0.3	1.6	20.9	15.3	0.0	0.3	1.1	0.0	1.2	1.0	0.7	11.5	0.2	1.4	1402.5	1.5	5.9	0.9	850.1	1.0	4.6	30.2	11.1	0.8	0.9	0.8	149.8	0.6	0.7	0.2	2.2	0.2	0.6	1.5	0.5	0.2	1.0	0.3	0.6	2.2	0.0	0.0	0.0	0.0	89.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	15.8	0.0	0.0	0.0	1.4	11.7	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7693.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0
IGLV2-14		ENSG00000211666	"Immunoglobulin lambda variable 2-14"	P01704	22	22758700-22759218	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 2647.3;lymphoid tissue: 5420.7;stomach 1: 2553.5"	"Cell type enriched"	"Detected in some"	179	"Plasma cells: 58316.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	50	"memory B-cell: 3655.3;naive B-cell: 2657.4"	"Lineage enriched"	"Detected in all"	58	"B-cells: 3655.3"	"Cell line enriched"	"Detected in many"	5	"RPMI-8226: 22672.4"														"Immunoglobulin genes"	NA	NA		2200000000				"prognostic favorable (3.23e-4)"	"unprognostic (9.05e-3)"	"unprognostic (1.18e-2)"	"unprognostic (7.20e-3)"	"unprognostic (2.00e-2)"	"prognostic favorable (2.21e-4)"	"unprognostic (3.69e-1)"	"unprognostic (1.97e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.83e-2)"	"unprognostic (9.11e-2)"	"unprognostic (4.97e-1)"	"prognostic unfavorable (5.74e-7)"	"unprognostic (1.15e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.87e-2)"	84.6	194.0	0.8	761.9	1.2	361.0	757.3	0.5	6.4	120.7	4.2	2647.3	2493.0	48.2	20.9	247.4	49.4	446.2	45.6	0.6	0.8	53.8	103.0	402.9	3348.5	2.2	2.8	0.5	76.0	52.5	4.5	5.7	1.2	1.5	71.6	1084.4	0.1	804.6	120.6	2.7	21.5	1273.3	62.5	0.7	1593.2	2553.5	14.0	1.6	591.5	117.5	0.5	5420.7	1174.6	35.3	2.5	0.2	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.4	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	5.8	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	4453.2	0.0	0.0	8.7	8.0	1.7	0.0	0.0	4.9	3.7	22672.4	0.0	0.0	11.8	11.1	0.4	17.3	0.0	0.0	7.1	0.0	5.1	0.0	4.1	5.7	1.1	20.4	37.7	1.4	12.1	1.7	5.0	3.9	5.3	1.7	47.1	1.0	28.8	3655.3	9.6	53.9	3.3	2657.4	1.4	12.7	11.6	62.5	2.4	2.2	2.1	451.3	0.8	1.2	0.5	6.4	0.6	0.8	2.2	2.8	0.5	1.5	0.7	1.6	2.5	0.0	0.0	0.0	0.0	324.1	0.0	0.0	0.0	1.2	0.0	0.3	0.3	0.0	2.8	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	14.7	0.0	0.0	0.0	9.9	121.8	0.0	0.0	0.0	1.4	1.7	0.0	0.0	0.0	0.3	0.0	3.5	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	58316.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	36.6	0.0	0.8	0.0
IGLV2-18		ENSG00000211664	"Immunoglobulin lambda variable 2-18"	A0A075B6J9	22	22734607-22735089	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 274.0;lymphoid tissue: 226.2"	"Cell type enriched"	"Detected in some"	210	"Plasma cells: 2488.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	44	"memory B-cell: 321.2;naive B-cell: 126.9"	"Lineage enriched"	"Detected in many"	64	"B-cells: 321.2"	"Group enriched"	"Detected in some"	7	"RPMI-8226: 13.4;U-266/70: 22.3;U-266/84: 7.2"														"Immunoglobulin genes"	NA	NA		570000000				"prognostic favorable (6.06e-5)"	"unprognostic (2.81e-2)"	"unprognostic (7.47e-3)"	"unprognostic (1.13e-2)"		"prognostic favorable (7.75e-4)"	"unprognostic (1.44e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.58e-2)"	"unprognostic (2.41e-2)"	"prognostic unfavorable (1.86e-7)"	"unprognostic (1.95e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.27e-2)"	3.4	0.3	0.0	73.7	0.0	23.9	67.8	0.0	0.3	6.8	0.1	274.0	264.4	4.3	0.0	40.0	10.9	36.6	6.3	0.0	0.0	2.0	2.9	12.8	37.9	0.1	0.0	0.0	4.1	1.1	2.1	0.2	0.1	0.3	1.7	139.8	0.0	64.9	5.0	0.1	0.3	151.4	6.5	0.0	96.6	73.1	0.5	0.1	22.3	2.9	0.0	226.2	18.5	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	13.4	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	22.3	7.2	0.1	0.1	0.1	0.0	0.2	1.8	0.0	1.6	0.0	0.8	321.2	0.3	1.3	0.1	126.9	0.7	0.6	0.5	5.0	0.1	0.2	0.1	69.7	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	7.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2488.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
IGLV2-23		ENSG00000211660	"Immunoglobulin lambda variable 2-23"	P01705	22	22697789-22698407	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 697.4;lymphoid tissue: 1611.5;stomach 1: 678.8"	"Cell type enriched"	"Detected in some"	132	"Plasma cells: 12487.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	369	"memory B-cell: 2072.7;naive B-cell: 2596.0"	"Lineage enriched"	"Detected in all"	410	"B-cells: 2596.0"	"Cell line enriched"	"Detected in some"	10	"Karpas-707: 85411.7"														"Immunoglobulin genes"	NA	NA		540000000				"prognostic favorable (3.43e-5)"	"unprognostic (7.99e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.35e-3)"	"unprognostic (2.73e-2)"	"unprognostic (1.30e-2)"	"unprognostic (9.33e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (1.50e-7)"	"unprognostic (8.20e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.42e-2)"	13.0	39.3	0.7	309.6	0.5	104.5	186.6	0.2	1.5	45.6	0.7	640.1	697.4	16.3	1.3	79.3	25.7	67.5	20.1	0.2	0.2	18.3	26.4	162.2	628.5	0.9	0.3	0.1	16.5	8.3	0.6	1.7	0.6	0.5	10.9	461.3	0.0	360.0	38.4	0.5	2.1	521.7	16.3	0.3	534.8	678.8	6.0	0.5	280.3	39.5	0.4	1611.5	276.8	12.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.2	0.0	0.0	65.3	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	1.3	82.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	85411.7	0.0	0.0	2.2	4.2	0.5	0.0	0.0	0.7	1.9	8843.9	0.0	0.0	2.1	4.5	0.0	4.7	0.0	0.0	1.9	0.0	1.0	0.0	1.1	3.4	0.7	213.9	81.1	0.5	92.6	0.2	35.5	1.8	3.1	1.0	1.6	0.9	1.3	2072.7	1.6	0.8	2.6	2596.0	0.6	0.9	6.3	1.6	1.7	0.9	1.3	231.7	0.7	0.5	0.2	1.5	0.2	0.2	0.9	0.3	0.1	0.5	0.3	0.5	0.5	0.0	0.0	0.0	0.0	94.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	13.7	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12487.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	39.5	0.0	0.2	0.0
IGLV2-8		ENSG00000278196	"Immunoglobulin lambda variable 2-8"	P01709	22	22822658-22823289	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1152.7;lymphoid tissue: 1021.0"	"Cell type enriched"	"Detected in some"	80	"Plasma cells: 5288.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	125	"memory B-cell: 1439.0;naive B-cell: 2097.3"	"Lineage enriched"	"Detected in all"	149	"B-cells: 2097.3"	"Group enriched"	"Detected in many"	617	"U-266/70: 64161.5;U-266/84: 56786.5"														"Immunoglobulin genes"	NA	NA		1500000000				"prognostic favorable (2.92e-4)"	"unprognostic (1.29e-1)"	"unprognostic (7.17e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.65e-1)"	"prognostic favorable (5.07e-5)"	"unprognostic (2.74e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.34e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.55e-2)"	"prognostic unfavorable (3.00e-5)"	"unprognostic (2.04e-2)"	"unprognostic (2.67e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.62e-1)"	18.8	7.0	1.1	328.1	0.6	96.8	156.7	0.2	2.4	26.2	1.4	1152.7	985.9	9.5	3.6	92.3	8.0	133.6	30.7	0.2	0.3	15.1	24.5	59.7	230.1	1.0	1.1	0.3	57.7	30.6	1.4	1.4	0.2	0.8	9.0	253.0	0.0	257.8	60.8	0.6	1.9	455.2	20.2	0.4	441.2	437.7	3.4	0.5	91.4	23.9	0.0	1021.0	261.4	10.4	1.2	62.7	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.7	7.6	0.0	0.0	23.1	0.0	0.0	0.0	22.3	0.0	0.5	0.0	0.0	0.0	0.7	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.3	0.0	0.0	11.3	1.9	14.8	0.0	0.0	97.9	0.9	10.1	0.0	0.0	1.4	2.8	0.2	0.0	9.3	0.0	0.0	29.5	0.9	0.0	9.8	0.6	38.9	64161.5	56786.5	20.4	0.0	10.1	0.0	1.2	2.4	0.6	2.1	0.7	0.9	1439.0	1.3	1.5	1.9	2097.3	0.4	1.0	14.1	1.3	1.4	0.6	0.7	174.0	1.1	0.6	0.2	2.4	0.2	0.3	1.0	1.1	0.3	0.8	0.4	0.5	1.2	0.0	3.2	0.0	0.0	65.3	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	2.5	0.0	0.7	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5288.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.2	0.0
IGLV3-1		ENSG00000211673	"Immunoglobulin lambda variable 3-1"	P01715	22	22880706-22881396	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1246.6;lymphoid tissue: 3353.5;stomach 1: 1473.5"	"Cell type enriched"	"Detected in some"	321	"Plasma cells: 56277.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	725	"memory B-cell: 779.5;naive B-cell: 1038.5"	"Lineage enriched"	"Detected in many"	828	"B-cells: 1038.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 14.4;RPMI-8226: 4.5;SCLC-21H: 9.1;SH-SY5Y: 9.9"									HPA003285	Approved				"Immunoglobulin genes"	NA	NA		4300000000			"HPA003285: AB_1079122"	"prognostic favorable (9.70e-5)"	"unprognostic (9.06e-2)"	"unprognostic (5.39e-3)"	"unprognostic (2.37e-2)"	"unprognostic (8.13e-2)"	"prognostic favorable (1.13e-4)"	"unprognostic (2.30e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (9.06e-9)"	"unprognostic (2.70e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.69e-1)"	44.9	71.6	0.4	489.8	0.5	335.4	320.3	0.3	2.1	193.6	0.9	1246.6	649.2	39.6	0.0	219.6	19.3	313.3	28.3	0.2	0.5	25.8	70.7	177.8	1126.4	1.5	0.4	0.2	34.4	7.6	2.8	2.0	0.7	0.5	22.1	690.9	0.2	632.9	19.8	1.2	4.1	485.8	37.6	0.4	659.5	1473.5	56.4	1.0	338.6	36.2	0.0	3353.5	685.5	30.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.1	0.0	0.0	1.1	0.0	0.0	0.0	1.9	0.0	0.6	0.0	0.0	0.0	2.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.2	2.4	0.8	0.0	0.0	0.5	3.0	4.5	0.0	0.0	9.1	9.9	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.6	0.6	1.7	1.8	1.2	2.8	0.0	0.3	0.0	0.7	1.1	0.5	0.3	0.4	0.4	779.5	0.6	0.2	1.2	1038.5	0.2	0.3	0.6	0.4	0.8	0.5	0.5	52.3	0.4	0.5	0.3	2.1	0.2	0.5	1.5	0.4	0.2	0.5	0.4	1.0	0.9	0.0	3.2	0.0	0.0	111.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	122.5	0.0	0.0	0.0	0.0	0.0	10.7	174.8	0.0	0.0	0.0	1.1	1.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56277.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	11.7	0.0	0.2	0.0
IGLV3-10		ENSG00000211669	"Immunoglobulin lambda variable 3-10"	A0A075B6K4	22	22811747-22812281	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 319.9;lymphoid tissue: 713.6;stomach 1: 291.3"	"Cell type enriched"	"Detected in some"	52	"Plasma cells: 1090.2"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in some"		"cerebral cortex: 3.4"	"Group enriched"	"Detected in some"	786	"memory B-cell: 548.7;naive B-cell: 315.0"	"Lineage enriched"	"Detected in single"	998	"B-cells: 548.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 4.9;HL-60: 1.0;RH-30: 1.6"									HPA003285	Approved				"Immunoglobulin genes"	NA	NA		2000000000			"HPA003285: AB_1079122"	"unprognostic (6.00e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.73e-2)"	"unprognostic (6.99e-2)"	"prognostic favorable (1.27e-4)"	"unprognostic (7.40e-3)"	"unprognostic (2.44e-2)"	"unprognostic (9.91e-2)"	"unprognostic (9.55e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.55e-1)"	"prognostic unfavorable (6.95e-8)"	"unprognostic (9.23e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.04e-2)"	33.6	114.0	0.5	145.3	0.3	66.1	112.2	0.2	3.4	41.7	1.1	311.0	177.9	7.7	4.6	56.7	8.0	43.9	20.7	0.2	0.2	11.9	21.0	48.4	232.5	1.8	0.2	0.1	14.7	10.9	0.9	0.8	0.4	0.7	11.0	319.9	0.0	140.8	10.9	0.2	8.1	95.6	5.8	0.1	218.8	291.3	98.2	0.2	26.2	8.7	0.0	713.6	141.5	7.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	1.6	0.4	0.0	0.0	0.2	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.4	0.3	0.0	0.0	0.0	0.0	0.5	0.3	0.3	0.2	0.0	0.2	548.7	0.1	0.2	0.2	315.0	0.0	0.2	0.3	0.1	0.1	0.3	0.1	43.2	0.5	0.3	0.2	3.4	0.2	0.2	1.8	0.2	0.1	0.7	0.1	0.2	0.2	0.0	0.0	0.6	0.0	20.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	7.1	0.0	1.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1090.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.2	0.0
IGLV3-19		ENSG00000211663	"Immunoglobulin lambda variable 3-19"	P01714	22	22720623-22721145	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1036.4;lymphoid tissue: 1996.1;stomach 1: 1252.0"	"Cell type enriched"	"Detected in some"	61	"Plasma cells: 3121.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	355	"memory B-cell: 618.3;naive B-cell: 503.7"	"Lineage enriched"	"Detected in many"	391	"B-cells: 618.3"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 6.2;SCLC-21H: 9.4;SH-SY5Y: 10.7;U-251 MG: 4.2"														"Immunoglobulin genes"	NA	NA		1200000000				"prognostic favorable (5.92e-5)"	"unprognostic (1.52e-2)"	"unprognostic (1.60e-3)"	"prognostic favorable (6.11e-5)"	"unprognostic (1.14e-1)"	"unprognostic (1.24e-3)"	"unprognostic (9.58e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.03e-1)"	"prognostic unfavorable (9.37e-10)"	"unprognostic (2.10e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.44e-1)"	"unprognostic (8.52e-2)"	49.5	20.3	0.1	406.0	0.4	186.9	316.6	0.1	2.4	69.8	0.3	1036.4	720.1	19.2	265.7	155.4	66.3	184.1	37.2	0.1	0.1	25.6	58.0	194.0	468.6	1.7	0.5	0.1	45.3	11.6	1.3	2.7	0.4	0.4	17.3	920.8	0.0	307.7	63.0	0.9	4.8	388.4	35.2	0.2	719.9	1252.0	6.1	0.2	439.0	55.8	0.0	1996.1	648.2	13.7	1.6	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	2.7	0.3	0.0	0.0	0.1	0.9	6.2	0.0	0.0	9.4	10.7	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.4	0.0	4.2	0.8	0.5	0.7	0.0	0.5	0.0	0.4	0.4	1.0	0.5	0.3	0.7	618.3	0.2	0.3	0.5	503.7	0.4	0.3	1.5	0.3	0.4	0.6	0.4	36.2	0.1	0.4	0.1	2.4	0.1	0.1	1.7	0.5	0.1	0.4	0.2	0.2	1.6	0.0	0.0	0.0	0.0	51.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	1.4	15.8	0.0	1.3	0.0	2.2	1.8	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3121.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0
IGLV3-21		ENSG00000211662	"Immunoglobulin lambda variable 3-21"	P80748	22	22711689-22713203	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 1827.4;urinary bladder: 781.1"	"Cell type enriched"	"Detected in some"	59	"Plasma cells: 5013.0"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in some"		"cerebral cortex: 4.3"	"Group enriched"	"Detected in some"	339	"memory B-cell: 432.0;naive B-cell: 224.7"	"Lineage enriched"	"Detected in single"	445	"B-cells: 432.0"	"Cell line enriched"	"Detected in some"	103	"REH: 282.7"														"Immunoglobulin genes"	NA	NA		4700000000				"unprognostic (1.75e-3)"	"unprognostic (6.04e-3)"	"unprognostic (4.21e-2)"	"unprognostic (2.59e-3)"	"unprognostic (4.06e-3)"	"prognostic favorable (3.26e-7)"	"unprognostic (1.63e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.53e-1)"	"unprognostic (5.30e-2)"	"unprognostic (3.86e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (9.54e-8)"	"unprognostic (7.83e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.67e-1)"	"unprognostic (7.52e-2)"	17.8	64.0	0.3	325.0	0.3	250.3	122.0	0.1	4.3	111.0	1.8	360.8	353.6	13.0	0.5	63.7	10.3	121.6	10.9	0.1	0.2	21.1	36.7	109.6	274.9	0.7	0.4	0.1	36.0	5.7	0.7	1.4	0.4	0.3	16.9	233.0	0.0	263.1	20.4	0.5	2.4	152.0	9.1	0.2	424.3	509.1	14.5	0.3	173.2	20.1	0.0	1827.4	781.1	17.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	2.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.4	0.5	0.2	0.0	0.0	282.7	1.8	2.0	0.0	0.0	1.6	1.8	0.1	0.3	0.0	0.0	0.0	0.0	2.2	0.0	0.3	0.5	0.5	0.5	0.1	0.2	0.0	0.2	0.0	0.2	0.2	0.1	0.1	0.0	0.1	432.0	0.1	0.1	0.3	224.7	0.1	0.1	0.9	0.1	0.1	0.2	0.1	36.6	0.3	0.3	0.1	4.3	0.1	0.2	0.7	0.4	0.1	0.3	0.2	0.3	1.3	0.0	0.0	0.0	0.0	84.4	0.0	0.0	0.0	4.6	0.0	0.1	0.0	0.1	2.8	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	4.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	20.4	0.0	0.0	0.0	3.3	2.5	0.1	0.0	0.0	0.0	0.0	1.3	0.0	4.7	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5013.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	1.2	0.0	0.0	1.8	0.0	0.2	0.0
IGLV3-25		ENSG00000211659	"Immunoglobulin lambda variable 3-25"	P01717	22	22686726-22687271	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 2460.5;stomach 1: 1024.7"	"Cell type enriched"	"Detected in some"	41	"Plasma cells: 17441.3"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in some"		"cerebral cortex: 3.4"	"Group enriched"	"Detected in some"	45	"memory B-cell: 545.0;naive B-cell: 794.2"	"Lineage enriched"	"Detected in many"	53	"B-cells: 794.2"	"Cell line enhanced"	"Detected in some"		"HL-60: 2.6;RPMI-8226: 2.7;SCLC-21H: 4.6;SH-SY5Y: 5.1"									HPA003285	Approved				"Immunoglobulin genes"	NA	NA		3200000000			"HPA003285: AB_1079122"	"prognostic favorable (5.55e-4)"	"unprognostic (8.28e-2)"	"unprognostic (4.28e-3)"	"unprognostic (2.89e-2)"	"unprognostic (2.88e-2)"	"prognostic favorable (1.43e-4)"	"unprognostic (1.92e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.98e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.45e-1)"	"prognostic unfavorable (3.78e-7)"	"unprognostic (1.25e-1)"	"unprognostic (4.78e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.72e-1)"	57.4	164.8	0.3	296.0	0.6	245.4	435.3	0.3	3.4	153.2	1.3	855.4	342.0	21.0	2.1	162.9	50.2	178.7	30.1	0.7	0.4	16.8	46.0	877.3	1033.5	1.7	0.3	0.3	22.0	14.6	1.7	1.7	0.5	0.8	19.1	471.7	0.0	537.1	117.6	0.7	2.4	230.8	34.4	0.3	547.8	1024.7	60.3	0.6	157.3	23.3	0.0	2460.5	786.6	21.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.6	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	1.7	0.4	1.7	0.0	0.0	1.6	1.5	2.7	0.0	0.0	4.6	5.1	0.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	1.0	0.1	0.8	1.8	0.2	0.7	0.0	1.3	0.0	0.8	0.4	0.3	0.7	0.1	0.2	545.0	0.4	0.1	0.5	794.2	0.2	0.1	14.9	0.3	0.6	0.3	0.3	76.5	0.3	0.6	0.3	3.4	0.7	0.4	1.7	0.3	0.3	0.8	0.3	0.6	0.8	0.0	0.0	0.0	0.0	84.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.7	0.0	0.0	0.0	1.9	40.8	0.0	0.0	0.0	0.4	1.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17441.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	417.4	0.0	0.0	0.1	0.0	0.0	3.5	0.0	0.0	0.0
IGLV3-9		ENSG00000211670	"Immunoglobulin lambda variable 3-9"	A0A075B6K5	22	22819010-22819756	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 316.5;stomach 1: 118.3"	"Cell type enriched"	"Detected in some"	9	"Plasma cells: 13.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.8"	"Group enriched"	"Detected in many"	51	"memory B-cell: 64.7;naive B-cell: 168.7"	"Lineage enriched"	"Detected in many"	74	"B-cells: 168.7"	"Cell line enriched"	"Detected in some"	5	"U-266/70: 41.3"									HPA003285	Approved				"Immunoglobulin genes"	NA	NA		1500000000			"HPA003285: AB_1079122"	"prognostic favorable (2.59e-4)"	"unprognostic (6.52e-3)"	"unprognostic (1.95e-1)"	"unprognostic (5.40e-2)"		"prognostic favorable (9.80e-5)"	"unprognostic (1.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.52e-2)"	"unprognostic (3.29e-1)"	"prognostic unfavorable (6.00e-7)"	"unprognostic (3.47e-2)"	"unprognostic (4.58e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.22e-1)"	1.8	23.8	0.1	85.4	0.0	28.1	15.0	0.0	1.8	7.4	0.1	87.9	59.2	2.1	0.0	21.0	1.8	18.7	7.6	0.0	0.0	3.1	6.2	17.2	141.0	0.7	0.0	0.0	3.9	2.4	0.2	0.1	0.0	0.1	1.4	64.6	0.0	46.6	3.1	0.1	1.5	60.8	5.2	0.0	65.1	118.3	1.6	0.1	35.4	3.8	0.0	316.5	73.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	2.1	0.1	0.3	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.9	0.3	0.0	41.3	5.8	0.7	0.0	3.9	0.0	0.0	0.1	0.0	1.2	0.0	2.2	64.7	1.3	1.4	0.0	168.7	0.4	1.8	0.1	0.5	0.1	0.0	0.1	6.5	0.1	0.0	0.0	1.8	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.4	0.0	13.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0
IGLV4-60		ENSG00000211639	"Immunoglobulin lambda variable 4-60"	A0A075B6I1	22	22162199-22162681	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 194.8;lymphoid tissue: 117.3;urinary bladder: 186.6"	"Cell type enriched"	"Detected in some"	152	"Plasma cells: 1125.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	78	"memory B-cell: 79.4;naive B-cell: 48.9"	"Lineage enriched"	"Detected in single"	96	"B-cells: 79.4"	"Group enriched"	"Detected in some"	4	"Daudi: 7.8;HEL: 13.3;U-698: 3.9"														"Immunoglobulin genes"	NA	NA		120000000				"prognostic favorable (2.57e-4)"	"unprognostic (5.46e-3)"	"unprognostic (9.43e-3)"	"unprognostic (1.26e-2)"		"prognostic favorable (1.89e-4)"	"unprognostic (3.06e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (1.87e-6)"	"unprognostic (1.78e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.19e-1)"	"unprognostic (2.60e-1)"	1.8	1.9	0.0	33.2	0.0	18.2	37.0	0.0	0.2	3.3	0.1	71.4	194.8	1.5	0.0	12.4	1.9	3.4	11.5	0.0	0.0	1.5	3.9	43.9	117.3	0.0	0.0	0.0	4.7	1.1	0.4	0.2	0.2	0.1	1.1	74.1	0.0	38.2	0.8	0.1	0.1	87.5	2.1	0.0	81.0	38.1	1.7	0.0	18.5	1.7	0.0	112.9	186.6	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	3.9	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	79.4	0.1	0.0	0.0	48.9	0.0	0.0	0.8	0.0	0.0	0.0	0.4	3.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1125.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
IGLV5-48		ENSG00000211647	"Immunoglobulin lambda variable 5-48 (non-functional)"	A0A075B6I7	22	22352940-22353433	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 3.3;lymphoid tissue: 5.5;urinary bladder: 2.7"	"Cell type enriched"	"Detected in some"	8	"Plasma cells: 19.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	61	"memory B-cell: 5.4;naive B-cell: 6.7"	"Lineage enriched"	"Detected in single"	68	"B-cells: 6.7"	"Not detected"	"Not detected"																"Immunoglobulin genes"	NA	NA						"unprognostic (3.76e-3)"	"unprognostic (1.91e-2)"	"unprognostic (9.43e-2)"			"unprognostic (3.36e-4)"		"unprognostic (1.38e-1)"			"unprognostic (1.90e-1)"			"unprognostic (1.74e-2)"	"unprognostic (2.97e-1)"			0.0	0.0	0.0	0.9	0.0	1.4	0.9	0.0	0.6	0.4	0.0	3.3	3.3	0.0	0.0	0.3	0.1	0.3	0.1	0.0	0.0	0.1	0.1	0.3	3.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	1.5	0.0	0.0	0.0	1.3	0.2	0.0	5.5	0.7	0.0	0.0	2.6	0.1	0.0	5.3	2.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGLV5-52		ENSG00000211643	"Immunoglobulin lambda variable 5-52"	A0A0A0MRZ9	22	22318727-22319226	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"B-cells: 1.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"memory B-cell: 11.7;naive B-cell: 10.3"	"Lineage enriched"	"Detected in many"	6	"B-cells: 11.7"	"Low cell line specificity"	"Detected in all"																"Immunoglobulin genes"	NA	NA		1200000				"unprognostic (7.26e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.86e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.61e-5)"		"unprognostic (1.22e-1)"	"unprognostic (1.89e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.25e-3)"	"unprognostic (7.75e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.46e-2)"	11.6	10.5	11.0	18.2	11.6	14.7	24.0	15.6	14.2	16.6	12.4	26.9	20.3	28.6	44.6	22.7	22.9	22.7	16.8	12.3	11.9	11.6	9.6	15.0	44.4	10.4	11.7	11.0	21.8	8.1	14.0	8.6	11.3	11.4	16.0	23.7	22.7	18.1	15.1	10.2	38.0	15.5	22.5	8.5	22.0	29.5	13.1	11.3	17.9	21.6	15.7	53.9	31.4	6.3	14.2	12.1	7.7	18.8	29.2	22.3	25.1	14.4	7.7	19.0	17.3	22.0	15.6	5.0	38.4	8.5	22.5	10.1	16.9	36.0	25.6	24.0	9.4	27.3	13.4	21.4	14.8	8.7	20.8	22.9	24.0	24.0	19.5	34.5	14.2	35.2	13.9	40.7	3.3	32.3	14.5	7.0	13.9	10.5	22.5	5.7	9.4	9.4	6.4	22.6	16.1	21.2	13.2	9.9	10.6	10.9	15.7	21.0	4.8	21.0	40.9	25.7	4.2	9.0	6.7	21.9	18.2	14.0	15.4	12.2	0.0	1.3	1.9	1.1	0.7	1.3	11.7	1.2	1.3	1.5	10.3	0.8	0.8	0.7	0.7	0.8	1.4	0.6	3.1	11.0	11.6	15.6	14.2	12.3	11.9	10.4	11.7	11.0	11.4	8.5	11.3	14.2	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0
IGLV6-57		ENSG00000211640	"Immunoglobulin lambda variable 6-57"	P01721	22	22195799-22196276	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 1829.2;urinary bladder: 681.3"	"Cell type enriched"	"Detected in some"	72	"Plasma cells: 10791.0"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"memory B-cell: 353.9;naive B-cell: 292.4"	"Lineage enriched"	"Detected in many"	13	"B-cells: 353.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 148.0;RPMI-8226: 40.6;U-266/70: 21.6;U-698: 47.3"														"Immunoglobulin genes"	NA	NA		1900000000				"prognostic favorable (1.92e-6)"	"unprognostic (5.73e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.14e-2)"	"prognostic favorable (1.36e-5)"	"unprognostic (1.87e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.55e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (2.30e-6)"	"unprognostic (2.82e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.11e-1)"	15.7	9.1	0.1	222.9	0.2	193.4	217.7	0.0	0.8	83.0	0.4	489.6	354.4	19.3	4.5	173.0	38.5	76.5	39.5	0.1	0.1	10.5	27.0	97.9	239.4	0.6	0.2	0.1	20.5	7.7	17.9	1.1	0.4	0.5	17.3	321.7	0.0	251.8	12.8	0.3	3.2	175.7	11.7	0.1	278.8	441.5	16.1	0.1	141.0	15.4	0.0	1829.2	681.3	8.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	148.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	2.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.9	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.2	1.0	40.6	0.0	0.0	2.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.7	0.2	0.4	21.6	15.2	47.3	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.0	2.3	353.9	0.1	0.1	0.2	292.4	0.1	0.1	27.9	0.1	0.1	1.2	0.2	27.6	0.1	0.2	0.0	0.8	0.1	0.1	0.6	0.2	0.1	0.5	0.1	0.1	0.3	0.0	0.0	0.6	0.0	148.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.8	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.3	1.8	26.7	0.0	0.0	0.0	4.4	67.8	0.0	0.0	0.0	3.6	2.8	0.0	0.0	0.0	0.1	0.0	2.8	0.0	0.2	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10791.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.1	0.0	0.0	6.2	0.0	0.5	0.0
IGLV7-43		ENSG00000211652	"Immunoglobulin lambda variable 7-43"	P04211	22	22395018-22395489	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 163.5;lymphoid tissue: 240.7;stomach 1: 116.9"	"Cell type enriched"	"Detected in some"	57	"Plasma cells: 1304.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	325	"memory B-cell: 132.0;naive B-cell: 54.2"	"Lineage enriched"	"Detected in single"	461	"B-cells: 132.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.9;RPMI-8226: 1.4;U-698: 1.5"									HPA003182	Approved				"Immunoglobulin genes"	NA	NA		130000000			"HPA003182: "	"prognostic favorable (6.49e-6)"	"unprognostic (7.85e-3)"	"prognostic favorable (7.00e-4)"	"unprognostic (5.57e-2)"	"unprognostic (3.62e-2)"	"prognostic favorable (3.08e-5)"	"unprognostic (7.63e-3)"	"unprognostic (8.20e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (6.29e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.29e-1)"	8.1	0.8	0.0	31.5	0.1	16.0	46.2	0.0	0.5	4.9	0.0	163.5	134.0	3.6	0.5	8.0	3.3	22.3	3.5	0.0	0.1	3.1	4.2	13.1	59.5	0.0	0.0	0.0	4.2	2.2	0.0	1.0	0.2	0.0	2.3	130.6	0.0	73.1	4.7	0.1	0.3	57.5	17.9	0.0	170.0	116.9	0.5	0.0	31.6	6.4	0.7	240.7	31.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.4	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	132.0	0.0	0.0	0.0	54.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	10.2	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1304.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.2	0.0
IGLV7-46		ENSG00000211649	"Immunoglobulin lambda variable 7-46"	A0A075B6I9	22	22369614-22370087	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 404.4;lymphoid tissue: 463.0;stomach 1: 252.8;urinary bladder: 447.4"	"Cell type enriched"	"Detected in some"	180	"Plasma cells: 6758.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	377	"memory B-cell: 183.6;naive B-cell: 82.3"	"Lineage enriched"	"Detected in single"	521	"B-cells: 183.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 8.0;RPMI-8226: 2.8;U-698: 6.6"									HPA003182	Approved				"Immunoglobulin genes"	NA	NA		270000000			"HPA003182: "	"prognostic favorable (3.34e-6)"	"unprognostic (1.21e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.94e-3)"	"unprognostic (4.25e-3)"	"unprognostic (4.68e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.77e-2)"	"unprognostic (7.47e-3)"	"unprognostic (2.17e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (2.78e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.99e-1)"	"unprognostic (2.02e-1)"	15.3	3.8	0.1	60.3	0.2	44.6	173.5	0.1	0.9	3.8	0.1	404.4	163.9	4.4	0.0	44.1	3.1	56.5	5.2	0.1	1.1	5.5	7.8	45.3	82.9	0.4	0.1	0.0	9.1	6.3	0.1	0.8	0.1	0.3	2.5	301.6	0.0	108.2	5.3	0.5	0.8	134.2	12.2	0.1	250.1	252.8	0.7	0.2	57.8	8.7	0.0	463.0	447.4	3.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.9	0.3	0.0	0.0	0.0	0.1	2.8	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.3	0.0	6.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	183.6	0.1	0.0	0.1	82.3	0.3	0.0	0.2	0.0	0.0	0.0	0.0	15.2	0.1	0.2	0.1	0.9	0.1	1.1	0.4	0.1	0.0	0.3	0.1	0.2	0.4	0.0	0.0	0.0	0.0	37.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	12.8	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6758.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.0
IGLV8-61		ENSG00000211638	"Immunoglobulin lambda variable 8-61"	A0A075B6I0	22	22098700-22099212	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 813.1;lymphoid tissue: 992.0"	"Cell type enriched"	"Detected in some"	4	"B-cells: 25.3"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in some"		"cerebral cortex: 3.5"	"Group enriched"	"Detected in some"	630	"memory B-cell: 257.8;naive B-cell: 529.3"	"Lineage enriched"	"Detected in single"	848	"B-cells: 529.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.2;RPMI-8226: 3.6;SH-SY5Y: 1.8;U-266/70: 6.6"					"Low region specificity"	"Detected in all"								"Immunoglobulin genes"	NA	NA		620000000				"unprognostic (1.07e-3)"	"unprognostic (2.73e-2)"	"prognostic favorable (3.84e-4)"	"unprognostic (1.07e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.04e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.75e-3)"	"unprognostic (2.05e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (1.83e-4)"	"unprognostic (8.14e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.90e-1)"	9.5	5.0	0.4	126.7	0.4	64.5	79.0	0.3	3.5	43.9	1.1	203.0	813.1	22.9	0.8	10.7	5.6	46.9	11.8	0.3	0.4	5.4	13.8	82.9	259.5	0.4	1.3	0.3	9.3	13.5	1.3	0.8	0.0	0.8	10.6	192.7	0.0	109.6	1.0	0.2	4.0	162.9	13.1	0.3	277.9	180.8	3.3	0.4	16.6	11.6	0.0	992.0	250.1	3.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.9	0.4	0.0	0.0	0.0	0.2	3.6	0.0	0.0	1.0	1.8	0.2	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.3	0.0	0.3	6.6	1.0	0.3	0.0	0.0	0.0	0.2	0.6	0.0	0.2	0.2	0.1	257.8	0.3	0.0	0.4	529.3	0.0	0.0	0.2	0.1	0.4	0.1	0.2	32.7	0.4	0.4	0.3	3.5	0.3	0.4	0.4	1.3	0.3	0.8	0.3	0.4	1.4	0.0	0.0	0.0	0.0	25.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	1.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
IGLV9-49		ENSG00000223350	"Immunoglobulin lambda variable 9-49"	A0A0B4J1Y8	22	22343187-22343732	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 126.7;lymphoid tissue: 119.0"	"Cell type enriched"	"Detected in some"	20	"Plasma cells: 46.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	672	"memory B-cell: 70.3;naive B-cell: 88.1"	"Lineage enriched"	"Detected in single"	747	"B-cells: 88.1"	"Not detected"	"Not detected"																"Immunoglobulin genes"	NA	NA		43000000				"prognostic favorable (3.04e-5)"	"unprognostic (4.30e-3)"	"unprognostic (1.83e-2)"	"unprognostic (5.61e-2)"		"prognostic favorable (2.00e-5)"	"unprognostic (6.29e-2)"	"unprognostic (2.69e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (1.12e-8)"	"unprognostic (1.66e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.90e-2)"	"unprognostic (7.16e-2)"	2.2	126.7	0.0	14.8	0.0	9.8	6.1	0.1	0.5	3.3	0.0	33.9	36.8	2.2	0.0	6.1	3.3	1.1	1.2	0.2	0.1	1.0	4.5	44.2	119.0	0.2	0.0	0.0	3.3	1.4	0.0	0.1	0.1	0.2	0.9	15.2	0.0	30.0	1.0	0.1	0.1	28.5	0.4	0.0	66.4	46.7	2.0	0.0	14.2	3.4	0.2	98.7	39.5	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	70.3	0.0	0.0	0.1	88.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.1	0.5	0.2	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGSF5	JAM4	ENSG00000183067	"Immunoglobulin superfamily member 5"	Q9NSI5	21	39745407-39802096	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	8	"Syncytiotrophoblasts: 114.1"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"T-47d: 5.8"									HPA057282	Uncertain		Approved	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"HPA057282: AB_2683395"	"unprognostic (1.06e-1)"	"unprognostic (2.53e-1)"	"unprognostic (7.06e-2)"	"unprognostic (9.73e-5)"	"unprognostic (1.56e-2)"	"unprognostic (3.15e-1)"		"unprognostic (1.41e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.09e-1)"	"unprognostic (8.35e-2)"	"unprognostic (9.61e-2)"	"unprognostic (4.01e-1)"	"unprognostic (4.18e-1)"	"unprognostic (3.75e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.07e-2)"	0.3	1.3	2.2	0.2	2.4	0.4	0.9	0.4	1.5	0.7	1.8	0.4	0.3	0.7	1.9	0.2	0.7	0.4	3.4	1.3	1.8	0.4	0.4	0.3	0.4	1.3	1.2	0.8	1.0	1.5	0.2	0.6	2.6	1.7	1.4	0.7	1.2	0.5	0.4	0.2	0.6	0.3	0.4	0.6	0.4	0.5	1.1	2.4	0.6	0.7	0.1	0.4	0.4	0.1	1.2	0.7	0.4	2.4	0.6	2.3	1.8	0.6	0.4	0.6	0.6	1.0	0.4	0.7	0.8	0.6	0.9	0.9	0.6	0.8	1.6	1.3	1.3	1.1	0.7	1.9	0.3	1.4	1.0	0.3	1.7	2.9	1.5	1.7	1.2	0.3	0.3	1.4	0.5	0.9	0.9	0.2	0.3	1.3	0.6	0.4	0.4	1.1	0.4	1.0	1.0	1.1	0.3	0.6	1.6	1.0	1.0	5.8	0.6	0.2	1.0	1.2	0.5	1.0	0.5	0.4	0.5	0.6	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.2	2.4	0.4	1.5	1.3	1.8	1.3	1.2	0.8	1.7	0.6	2.4	1.2	0.0	0.0	0.0	8.5	0.0	0.0	0.2	0.0	0.0	1.2	1.0	0.8	9.7	0.0	0.1	1.8	0.0	1.6	0.0	0.6	5.9	0.6	12.8	0.0	0.4	0.2	0.0	0.0	2.9	0.2	1.7	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	4.1	0.4	0.0	0.0	0.0	4.8	0.3	0.1	0.0	0.0	0.0	1.0	0.0	5.0	1.0	0.2	0.2	0.4	0.0	1.4	0.0	6.8	0.1	0.2	0.0	0.0	0.2	0.5	0.2	0.0	0.0	114.1	0.1	1.1	0.4	2.0
IL12B	"CLMF, CLMF2, IL-12B, NKSF, NKSF2"	ENSG00000113302	"Interleukin 12B"	P29460	5	159314780-159330487	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"		Cytokine	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"lymphoid tissue: 1.4"	"Cell type enriched"	"Detected in some"	4	"monocytes: 6.7"	"Cancer enriched"	"Detected in single"	20	"testis cancer: 3.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA040970	Supported				"Secreted to blood"	NA	NA	140000				"HPA040970: AB_10796234"	"unprognostic (5.96e-5)"	"unprognostic (4.59e-5)"	"unprognostic (1.05e-1)"	"unprognostic (3.40e-1)"		"unprognostic (9.13e-4)"	"unprognostic (6.89e-2)"	"unprognostic (2.58e-4)"	"unprognostic (6.69e-3)"	"unprognostic (3.83e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.53e-1)"	"unprognostic (7.15e-3)"	"unprognostic (9.25e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.02e-2)"	0.1	0.0	0.0	0.2	0.1	0.3	0.0	0.4	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.2	0.1	0.1	0.0	0.1	0.3	0.1	0.0	0.0	0.4	0.2	0.1	0.0	1.4	0.1	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.3	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IL13RA2	"CD213a2, CT19, IL-13R, IL13BP"	ENSG00000123496	"Interleukin 13 receptor subunit alpha 2"	Q14627	X	115003975-115019977	"Cancer-related genes, CD markers, Predicted membrane proteins"		Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.4;pituitary gland: 12.1;testis: 30.3"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 322.4"	"Cancer enhanced"	"Detected in many"		"glioma: 17.2"	"Region enhanced"	"Detected in many"		"hypothalamus: 12.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"PC-3: 133.0;U-2197: 425.6;U-251 MG: 297.4;U-87 MG: 167.9"	"Region enhanced"	"Detected in many"		"olfactory bulb: 7.0"	"Low region specificity"	"Detected in some"			"HPA045831, HPA067363"			Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"	"Nucleoplasm, Vesicles"	"HPA045831: , HPA067363: "	"unprognostic (1.97e-1)"	"unprognostic (2.83e-1)"	"unprognostic (6.62e-4)"	"unprognostic (7.39e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (3.55e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.20e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.53e-5)"	"unprognostic (1.58e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.20e-1)"	0.5	4.8	1.8	4.1	2.1	0.0	0.4	0.7	1.1	1.1	1.5	0.4	0.3	0.8	4.4	0.6	0.1	0.8	0.4	1.4	12.4	3.7	10.1	1.4	0.1	2.7	2.8	1.2	0.1	0.1	0.5	12.1	0.4	1.9	4.2	0.7	0.0	0.9	3.6	0.0	0.2	0.3	0.3	0.6	0.2	0.1	30.3	4.4	2.1	1.2	0.1	0.1	4.5	0.2	1.6	0.4	0.0	4.6	0.1	0.7	3.6	0.0	29.2	28.0	0.1	0.1	0.0	0.0	0.0	0.5	14.6	46.6	0.1	0.0	5.2	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.1	4.8	0.8	4.6	26.9	0.4	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.1	133.0	0.0	0.0	0.0	2.4	0.2	0.0	6.8	2.1	0.3	0.4	0.0	0.1	0.4	0.0	14.7	0.4	425.6	297.4	0.0	0.2	0.1	167.9	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.1	0.7	1.1	1.4	12.4	2.7	2.8	1.2	1.9	0.6	4.4	1.6	0.3	0.0	0.0	0.0	0.1	0.1	4.7	0.3	0.0	0.0	0.0	0.0	0.2	1.5	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	322.4	0.4	0.3	1.3	4.2	0.0	0.4	0.0	0.0	10.3	0.0	0.4	0.0	0.0	46.4	0.4	0.0	0.0	0.6	0.0	0.0	2.8	0.3	58.6	2.8	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.2	8.5	0.0	4.9	0.1	10.9	0.0	0.0	2.9	0.0	0.0	0.0	3.4	63.1	4.0	0.0	0.0	0.0	0.1	0.0	0.0	2.3
IL17A	"CTLA8, IL-17, IL-17A, IL17"	ENSG00000112115	"Interleukin 17A"	Q16552	6	52186375-52190638	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity, Inflammatory response, Innate immunity"	Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"lymphoid tissue: 1.4"	"Cell type enriched"	"Detected in single"	14	"T-cells: 8.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	23	"Karpas-707: 2.7;U-266/84: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052258	Uncertain				"Secreted to blood"	NA	NA	9920				"HPA052258: "		"unprognostic (5.55e-1)"	"unprognostic (2.18e-4)"			"unprognostic (3.05e-4)"		"unprognostic (1.41e-2)"						"unprognostic (2.22e-2)"				0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.2
IL17REL	FLJ41993	ENSG00000188263	"Interleukin 17 receptor E like"	Q6ZVW7	22	49994513-50012659	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 4.3;stomach 1: 2.3"	"Cell type enriched"	"Detected in single"	21	"Gastric mucus-secreting cells: 12.8"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			HPA045546	Supported					NA	NA					"HPA045546: AB_10963836"	"unprognostic (3.33e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.38e-1)"	"unprognostic (6.33e-2)"	"unprognostic (4.65e-4)"	"unprognostic (2.72e-2)"	"unprognostic (1.01e-3)"	"unprognostic (4.45e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.94e-1)"	"unprognostic (3.02e-2)"	"unprognostic (4.60e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.77e-2)"	"unprognostic (6.31e-3)"	"unprognostic (8.31e-2)"	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.7	0.0	0.2	1.0	2.3	0.1	0.8	3.9	0.0	0.0	4.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.7	0.0	0.4	0.2	0.2	0.0	0.2	0.2	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IL20	"IL-20, IL10D, ZCYTO10"	ENSG00000162891	"Interleukin 20"	Q9NYY1	1	206865623-206869223	"Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	4	"Basal keratinocytes: 69.6"	"Cancer enhanced"	"Detected in some"		"breast cancer: 3.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SiHa: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB025802	Uncertain				"Secreted to blood"	NA	NA	109000				"CAB025802: "	"unprognostic (3.08e-2)"	"unprognostic (1.91e-1)"		"unprognostic (1.82e-1)"		"unprognostic (1.16e-2)"		"unprognostic (6.45e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.60e-1)"		"unprognostic (3.38e-2)"	"unprognostic (1.67e-1)"		"unprognostic (1.71e-1)"	0.8	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.6	0.0	0.9	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.6	6.6	15.1	0.0	0.0	9.4	3.7	0.1	0.0	2.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.3	0.1	0.3	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.1	0.0	2.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.5	0.3	0.0	9.9	0.0	0.1	0.0	0.1	7.3
IL25	"IL-17E, IL-25, IL17E"	ENSG00000166090	"Interleukin 25"	Q9H293	14	23372809-23376403	"Predicted intracellular proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	22	"Cardiomyocytes: 19.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB024864	Uncertain				"Secreted to blood"	NA	NA	4230000				"CAB024864: "	"unprognostic (1.49e-1)"				"unprognostic (6.82e-2)"													0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1
IL31	IL-31	ENSG00000204671	"Interleukin 31"	Q6EBC2	12	122172029-122174221	"Predicted secreted proteins"	Immunity	Cytokine		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"Early spermatids: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB025657	Uncertain				"Secreted to blood"	NA	NA	37800				"CAB025657: "														"unprognostic (1.70e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IL4	"BCGF-1, BCGF1, BSF1, IL-4, MGC79402"	ENSG00000113520	"Interleukin 4"	P05112	5	132673986-132682678	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"B-cell activation"	"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"T-cells: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	861	"basophil: 474.9"	"Lineage enriched"	"Detected in single"	861	"granulocytes: 474.9"	"Cell line enriched"	"Detected in some"	5	"MOLT-4: 21.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA072995, CAB078477"	Approved				"Secreted to blood"	NA	NA	13600				"CAB078477: AB_417057, HPA072995: AB_2732215"	"unprognostic (3.40e-2)"	"unprognostic (9.19e-2)"		"unprognostic (1.41e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.02e-1)"		"unprognostic (1.96e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.47e-10)"	"unprognostic (9.21e-3)"	"unprognostic (2.88e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.24e-2)"	0.1	0.3	0.2	0.4	0.1	0.3	0.1	0.5	0.2	0.0	0.2	0.0	0.0	0.3	0.0	0.2	0.2	0.3	0.0	0.1	0.1	0.0	0.0	0.3	0.3	0.2	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.1	0.0	0.5	0.2	0.1	0.0	0.5	0.3	0.0	0.1	0.2	0.1	0.3	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	474.9	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.2	0.1	0.5	0.2	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.0	2.2	0.0	0.0	0.0
IL5	"EDF, IL-5, TRF"	ENSG00000113525	"Interleukin 5"	P05113	5	132541445-132556838	"Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Cytokine, Growth factor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.4;testis: 5.1"	"Cell type enriched"	"Detected in some"	7	"Spermatocytes: 19.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in single"	8	"memory B-cell: 1.4"	"Lineage enriched"	"Detected in single"	8	"B-cells: 1.4"	"Cell line enhanced"	"Detected in some"		"Hep G2: 2.8;TIME: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			CAB010304	Approved				"Secreted to blood"	NA	NA	4130				"CAB010304: AB_2296159"	"unprognostic (1.66e-1)"	"unprognostic (4.76e-2)"	"unprognostic (5.30e-3)"	"unprognostic (2.35e-1)"	"unprognostic (9.07e-2)"		"unprognostic (7.98e-2)"	"unprognostic (2.03e-2)"		"unprognostic (3.51e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.27e-2)"	"unprognostic (5.84e-3)"	"unprognostic (1.91e-1)"	0.1	0.0	0.4	0.1	0.1	0.0	0.0	1.3	1.1	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.3	0.5	0.2	1.4	0.0	0.0	0.2	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.9	0.1	0.1	0.0	0.2	5.1	0.2	0.0	0.4	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	2.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.1	0.3	0.1	0.4	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	1.3	1.1	1.4	0.0	0.9	0.5	0.0	0.7	0.1	0.2	1.2	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	1.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.7	1.2	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.1	0.0	0.1	0.0	19.5	1.2	0.0	0.1	0.0	1.6	0.0	0.0	0.0
INKA2	"C1orf183, FAM212B, FLJ31105"	ENSG00000197852	"Inka box actin regulator 2"	Q9NTI7	1	111680630-111755824	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	8	"Hofbauer cells: 4.0"	"Cancer enhanced"	"Detected in many"		"glioma: 6.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	13	"neutrophil: 25.2"	"Lineage enriched"	"Detected in many"	13	"granulocytes: 25.2"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 35.6;U-87 MG: 73.0;WM-115: 28.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027809, HPA027810, HPA027811"	Approved		Supported	Nucleoplasm,Nucleoli,Vesicles		NA	NA			Nucleoplasm	"Nucleoli, Vesicles"	"HPA027809: AB_10599616, HPA027810: , HPA027811: AB_10600872"	"unprognostic (1.92e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.81e-2)"	"prognostic favorable (4.51e-5)"	"unprognostic (9.96e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.36e-2)"	"unprognostic (9.50e-3)"	"unprognostic (9.92e-5)"	"unprognostic (8.66e-2)"	"unprognostic (1.31e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.03e-3)"	"unprognostic (5.07e-2)"	7.4	1.1	9.5	3.1	11.8	2.9	4.1	5.4	16.8	2.3	3.1	2.9	1.2	4.0	1.7	6.7	5.1	2.9	12.4	15.3	5.6	2.7	0.9	4.8	1.0	5.9	5.3	12.6	2.1	1.3	2.3	0.7	6.2	7.1	3.0	2.4	1.4	2.3	4.0	7.8	5.5	2.5	5.9	4.0	5.4	3.9	2.6	5.1	2.1	2.6	9.0	1.8	2.8	3.4	10.6	2.5	2.3	5.1	3.2	20.5	7.3	1.7	1.8	4.0	3.3	7.8	4.1	0.1	2.0	0.9	1.8	1.6	2.2	2.2	4.9	3.2	4.6	1.9	15.0	1.8	4.0	8.1	1.1	2.3	6.0	20.9	35.6	1.6	0.9	8.9	2.6	0.1	3.3	5.3	2.8	1.1	1.2	1.2	2.4	2.0	2.2	19.4	0.7	0.9	3.5	10.2	3.4	1.1	0.1	9.8	5.6	2.8	3.3	3.5	7.1	11.4	3.9	1.5	20.7	3.8	2.1	73.0	4.5	28.0	0.2	1.8	1.4	0.0	1.4	0.0	0.2	0.1	0.1	1.0	0.4	0.0	0.0	25.2	0.6	2.0	0.5	0.0	0.6	9.5	11.8	5.4	16.8	15.3	5.6	5.9	5.3	12.6	7.1	4.0	5.1	10.6	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0
INSM1	"IA-1, IA1"	ENSG00000173404	"INSM transcriptional repressor 1"	Q01101	20	20368104-20370949	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 13.3;pituitary gland: 29.5"	"Cell type enriched"	"Detected in some"	42	"Enteroendocrine cells: 506.7"	"Cancer enhanced"	"Detected in many"		"glioma: 9.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	19	"SCLC-21H: 370.4"	"Low region specificity"	"Detected in many"													NA	NA						"unprognostic (1.86e-2)"	"unprognostic (5.25e-4)"	"unprognostic (7.59e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-3)"		"unprognostic (4.34e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.23e-1)"	"unprognostic (1.22e-1)"	0.2	7.2	2.1	0.6	4.7	0.0	0.0	13.3	3.2	0.0	0.1	1.3	3.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	4.5	0.0	0.0	0.0	0.5	3.1	2.5	2.5	0.0	3.0	0.0	29.5	0.0	4.1	0.2	1.9	0.1	0.0	0.2	0.0	0.1	2.1	0.0	0.5	0.2	5.2	0.4	2.9	2.8	0.0	0.0	0.3	0.1	0.0	2.2	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.1	3.2	19.4	0.0	0.0	370.4	0.3	0.0	0.3	0.0	1.1	0.9	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	4.7	13.3	3.2	2.5	4.5	3.1	2.5	2.5	4.1	0.5	2.9	2.2	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.4	1.9	0.0	0.0	0.2	0.1	0.1	506.7	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	1.4	10.8	0.0	0.0	0.7	0.0	0.0	0.2	3.6	0.0	11.9	0.0	0.0	0.5	3.1	1.5	2.3	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	2.1	0.0
INSYN1	"C15orf59, LOC388135, MGC131524"	ENSG00000205363	"Inhibitory synaptic factor 1"	Q2T9L4	15	73735458-73753351	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 50.0;heart muscle: 41.7"	"Cell type enriched"	"Detected in single"	24	"Cardiomyocytes: 14.7"	"Cancer enhanced"	"Detected in many"		"glioma: 5.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 8.7;fHDF/TERT166: 5.8;HEK 293: 3.9;NTERA-2: 3.4;SK-BR-3: 4.7;U-2 OS: 4.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041563	Approved		Approved	Nucleoplasm,Cytosol		No	NA			"Nucleoplasm, Cytosol"		"HPA041563: AB_10794670"	"unprognostic (2.28e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.71e-1)"	"unprognostic (9.36e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.36e-2)"	"unprognostic (2.67e-4)"	"unprognostic (2.67e-2)"	"prognostic favorable (5.38e-9)"	"unprognostic (4.98e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.46e-4)"	"unprognostic (1.20e-3)"	3.0	2.6	28.9	0.9	26.1	0.1	1.9	24.5	40.7	5.4	1.0	4.9	0.8	4.2	3.4	12.1	7.9	1.9	41.7	35.8	23.5	15.2	0.4	2.7	0.2	24.5	50.0	26.7	13.6	1.5	2.9	5.2	0.5	29.5	10.7	0.6	3.9	3.4	11.1	4.7	12.9	2.5	3.2	17.2	0.7	3.8	4.6	40.5	0.2	2.1	2.7	0.9	6.4	17.0	32.4	0.0	0.0	1.8	1.2	8.7	0.1	0.0	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.5	5.8	1.0	2.1	1.9	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.5	0.0	0.0	0.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.7	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.5	0.4	4.7	0.4	1.3	2.0	0.1	0.0	1.3	4.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	28.9	26.1	24.5	40.7	35.8	23.5	24.5	50.0	26.7	29.5	17.2	40.5	32.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IRF7		ENSG00000185507	"Interferon regulatory factor 7"	Q92985	11	612553-615983	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 38.5;lymphoid tissue: 33.5"	"Cell type enriched"	"Detected in many"	7	"dendritic cells: 576.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in all"	12	"plasmacytoid DC: 596.9"	"Lineage enriched"	"Detected in all"	12	"dendritic cells: 596.9"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 15.5;BJ hTERT+ SV40 Large T+ RasG12V: 9.6;Karpas-707: 6.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017694, HPA052757"	Approved		Supported	Nucleoplasm,Cytosol		No	NA			Nucleoplasm	Cytosol	"CAB017694: AB_2280489, HPA052757: AB_2681937"	"unprognostic (1.39e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.45e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.16e-1)"	"unprognostic (7.08e-2)"	"unprognostic (8.13e-2)"	"prognostic unfavorable (1.71e-10)"	"unprognostic (2.50e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.58e-1)"	"unprognostic (4.71e-2)"	8.4	2.7	1.2	1.6	1.2	1.6	7.6	1.0	2.1	8.5	1.5	6.9	0.0	3.5	0.0	12.8	4.7	2.2	7.1	1.0	1.3	12.2	38.5	14.5	0.9	2.2	1.5	0.8	4.7	5.9	0.2	6.3	0.7	1.5	9.3	0.3	0.3	8.9	0.8	11.4	7.6	15.4	0.9	0.8	33.5	8.6	1.9	1.6	1.4	10.8	1.3	2.2	5.1	7.4	4.2	0.0	0.0	0.7	0.1	0.0	0.6	0.0	0.4	3.9	15.5	9.6	2.2	0.1	0.0	3.7	0.6	3.7	0.5	0.2	0.1	1.0	0.2	0.0	0.1	0.0	0.2	0.8	0.0	0.0	1.6	0.6	0.0	0.6	0.7	0.1	1.9	0.0	6.5	0.1	0.0	0.7	0.0	0.0	3.1	1.3	0.1	0.2	0.0	0.2	0.1	3.1	0.0	0.6	1.8	0.4	0.3	0.0	1.5	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	12.7	20.4	30.6	8.1	46.1	7.8	16.5	6.7	7.0	24.3	20.8	7.5	8.5	12.9	18.7	49.5	596.9	13.5	19.7	1.2	1.2	1.0	2.1	1.0	1.3	2.2	1.5	0.8	1.5	0.8	1.6	4.2	65.0	16.0	19.0	2.9	59.2	34.4	32.3	19.6	18.8	0.4	27.7	20.2	4.3	18.6	18.2	20.2	0.0	6.1	576.1	70.1	9.8	29.9	5.9	20.1	6.3	33.0	26.3	4.8	0.0	16.9	39.0	19.3	40.8	21.2	31.7	20.1	17.9	31.7	37.3	0.0	0.1	42.5	22.4	23.2	65.4	28.9	12.2	67.4	37.4	3.7	65.2	2.7	40.2	1.0	1.3	29.9	73.8	4.9	65.1	24.8	37.6	6.3	25.5	4.6	13.1	8.8	19.8	0.4	5.9	8.0	28.4	24.1	42.7	4.6	18.9	34.6
ISL2	FLJ10160	ENSG00000159556	"ISL LIM homeobox 2"	Q96A47	15	76336773-76342475	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pituitary gland: 2.6;prostate: 2.3;vagina: 3.5"	"Cell type enriched"	"Detected in some"	7	"Cone photoreceptor cells: 27.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 9.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 15.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	10	"spinal cord: 1.8"	HPA075192			Approved	"Rods & Rings"		NA	NA			"Rods & Rings"		"HPA075192: AB_2686738"	"unprognostic (7.30e-2)"	"unprognostic (7.96e-2)"	"unprognostic (9.01e-3)"	"unprognostic (4.44e-3)"	"unprognostic (1.44e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.84e-1)"	"unprognostic (9.03e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.55e-15)"	"unprognostic (1.78e-1)"	"unprognostic (4.19e-1)"	"unprognostic (4.07e-1)"	"unprognostic (2.26e-1)"	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.4	0.0	1.6	0.8	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.8	0.3	0.0	0.0	0.0	0.0	2.6	0.0	0.2	2.3	0.0	1.4	1.8	0.0	0.0	0.2	1.2	0.0	0.1	0.5	1.6	0.8	0.0	0.0	0.0	0.0	0.1	0.0	3.5	0.8	1.5	1.8	0.0	1.7	0.1	0.1	1.5	4.5	2.1	1.2	1.5	3.4	0.7	3.3	2.1	0.0	1.1	1.9	6.4	0.1	0.2	3.2	15.4	1.6	4.0	4.1	1.4	3.6	4.3	0.0	0.8	0.0	0.0	0.0	0.0	4.8	5.1	2.6	0.3	0.1	4.4	8.4	0.0	0.6	2.8	2.7	2.0	4.4	0.0	0.6	4.9	5.0	3.0	0.0	0.0	0.9	0.3	8.2	0.0	1.5	3.2	0.6	4.3	3.8	4.1	2.0	1.1	2.5	0.0	0.0	0.8	0.0	0.1	0.9	0.0	0.8	0.0	0.5	0.1	1.7	0.1	0.0	9.5	0.0	3.5	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.1	0.8	0.3	0.0	0.2	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.6	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	27.1	0.1	0.2	0.2	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.3	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.6	0.0	0.0	0.0	3.5	0.6	0.0	0.0	0.0	2.1	0.0	0.2	0.5	1.5	1.0	0.0	0.0	0.3	0.2	0.0	0.0	3.0
ITGB1BP2	CHORDC3	ENSG00000147166	"Integrin subunit beta 1 binding protein 2"	Q9UKP3	X	71301750-71305371	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 83.6;skeletal muscle: 46.5;tongue: 53.4"	"Cell type enriched"	"Detected in some"	9	"Cardiomyocytes: 80.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HMC-1: 9.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA040721			Approved	Cytosol		NA	NA			Cytosol		"HPA040721: AB_10805827"	"unprognostic (1.87e-1)"	"unprognostic (2.65e-2)"	"unprognostic (6.91e-5)"	"unprognostic (1.95e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.81e-2)"	"unprognostic (9.02e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.85e-2)"	"unprognostic (3.17e-1)"	"unprognostic (3.08e-11)"	"unprognostic (4.38e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.64e-1)"	0.8	0.6	0.8	1.5	0.7	1.6	0.5	1.1	0.9	2.3	0.6	4.9	1.0	16.7	3.0	4.1	3.3	2.5	83.6	0.8	0.6	0.8	1.4	1.0	0.9	0.7	0.7	0.5	1.7	0.5	0.0	0.5	0.3	0.9	6.1	1.8	1.8	1.3	10.4	46.5	0.6	2.1	16.5	0.7	1.2	2.0	1.4	0.7	1.0	0.7	53.4	0.6	5.6	1.6	1.2	0.5	1.4	2.1	1.8	0.1	0.1	0.4	0.7	1.0	0.5	0.5	0.9	1.1	2.1	0.2	1.1	0.5	0.9	1.9	0.6	1.1	0.7	0.9	1.3	1.5	0.4	0.2	0.4	9.3	1.1	0.7	0.2	0.3	0.4	0.8	2.2	1.0	0.5	1.1	0.4	0.8	2.3	3.1	1.4	0.9	1.4	1.6	0.8	1.0	1.3	1.0	0.3	0.5	0.1	0.6	1.4	0.5	0.3	0.0	0.9	1.8	0.1	0.4	1.8	2.8	3.1	0.2	1.6	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	1.1	0.9	0.8	0.6	0.7	0.7	0.5	0.9	0.7	0.7	1.2	0.2	0.0	0.0	0.3	0.0	0.3	0.1	0.0	0.0	1.7	0.3	0.3	80.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.6	0.1	0.2	0.2	0.8	0.0	0.4	0.2	0.0	0.1	2.3	0.0	0.2	0.0	0.4	1.1	0.8	0.2	0.0	0.3	0.1	0.0	0.0	0.3	0.0	0.3	0.2	0.0	0.0	0.3	0.1	1.0	0.0	0.5	0.2	0.1	8.6	0.0	0.3	0.1	0.5	0.3	1.1	0.0	0.6	2.5	0.5	0.4	0.0	0.3	0.0	0.1	0.6	0.3	0.1
JAM3	"JAM-C, JAMC"	ENSG00000166086	"Junctional adhesion molecule 3"	Q9BX67	11	134069071-134152001	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Angiogenesis, Cell adhesion, Differentiation, Spermatogenesis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 342.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 5.3"	"Group enriched"	"Detected in many"	7	"B-cells: 5.3;T-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 99.5;RH-30: 122.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003417, HPA050434"	Approved		Enhanced	"Golgi apparatus"	"Secreted to blood"	NA	NA		44000	"Golgi apparatus"		"HPA003417: AB_1851981, HPA050434: AB_2681126"	"unprognostic (1.04e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.06e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (3.23e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.06e-3)"	"prognostic unfavorable (2.68e-4)"	21.0	18.8	60.6	10.2	86.6	1.3	19.3	72.3	72.8	32.1	58.0	41.8	6.7	41.2	17.7	21.7	29.0	24.7	31.3	60.1	68.1	10.8	3.2	29.9	7.9	78.7	82.1	55.1	49.1	5.2	17.9	33.5	103.6	80.0	32.8	13.0	47.7	13.4	44.9	7.1	12.3	22.7	43.2	69.6	13.6	22.6	36.0	73.7	17.7	16.0	14.7	7.5	42.0	23.6	121.1	0.0	1.0	87.9	42.5	85.3	62.7	75.4	37.0	49.1	15.1	14.8	0.3	0.6	0.0	38.7	53.3	56.2	0.5	70.0	0.7	28.2	0.2	29.6	0.3	0.0	6.9	24.9	0.4	36.2	43.2	0.0	10.7	9.6	35.8	99.5	40.8	0.3	0.2	64.5	1.0	27.5	0.2	18.9	0.6	2.9	0.5	122.8	0.0	0.9	0.2	57.5	32.2	0.0	0.2	1.0	35.3	0.2	0.2	0.6	25.1	18.4	40.3	24.7	0.1	0.1	0.4	27.6	1.2	48.0	0.0	0.0	0.1	1.3	0.0	1.6	5.3	1.6	0.9	0.0	3.1	2.3	1.7	0.5	0.0	0.0	0.0	0.0	1.8	60.6	86.6	72.3	72.8	60.1	68.1	78.7	82.1	55.1	80.0	69.6	73.7	121.1	22.2	0.0	6.0	12.7	10.9	5.1	5.6	0.9	0.0	21.7	0.3	9.3	15.7	0.0	0.7	5.5	8.4	6.0	1.2	0.1	1.9	0.4	2.1	0.8	23.3	35.5	0.0	0.4	84.3	0.2	71.2	29.6	1.5	0.5	1.3	11.7	12.5	0.0	8.6	8.4	44.2	0.0	12.2	0.6	4.2	4.9	42.9	10.9	17.8	24.4	0.2	20.2	1.0	76.4	342.8	0.3	0.0	64.3	0.9	2.2	0.0	0.2	1.5	75.6	26.3	19.0	24.3	15.5	19.2	0.2	3.8	6.2	3.5	9.7	0.0	1.0
JCHAIN	"IGCJ, IGJ, JCH"	ENSG00000132465	"Joining chain of multimeric IgA and IgM"	P01591	4	70655541-70681817	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 3057.6;intestine: 8055.6;stomach 1: 5969.9"	"Cell type enriched"	"Detected in many"	16	"Plasma cells: 101294.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	121	"memory B-cell: 4173.0;naive B-cell: 2555.1;plasmacytoid DC: 3578.1"	"Group enriched"	"Detected in all"	137	"B-cells: 4173.0;dendritic cells: 3578.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 3953.8;Karpas-707: 2117.6;RPMI-8226: 4469.2;U-266/70: 8794.0;U-266/84: 3519.2;U-698: 4949.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB034436, HPA044132"	Enhanced				"Secreted to blood"	NA	NA		2200000000			"CAB034436: AB_2233368, HPA044132: AB_2678826"	"prognostic favorable (1.81e-6)"	"unprognostic (1.45e-3)"	"unprognostic (7.44e-3)"	"unprognostic (1.82e-2)"	"unprognostic (4.23e-2)"	"prognostic favorable (7.56e-7)"	"unprognostic (2.37e-2)"	"unprognostic (2.70e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.64e-3)"	"unprognostic (3.36e-1)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (3.43e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.96e-1)"	131.4	77.3	0.9	1099.1	1.1	77.0	3057.6	0.6	3.0	207.0	3.1	8055.6	6201.6	95.2	25.2	660.3	116.0	497.0	45.9	0.6	6.5	43.6	117.8	625.7	1042.2	2.3	4.5	0.6	185.1	79.0	2.1	2.0	2.4	1.1	91.0	6487.5	0.3	2442.5	260.9	4.2	13.3	4312.7	202.2	6.8	826.5	5969.9	40.3	1.2	156.6	19.6	0.8	1761.7	1068.3	11.7	2.9	8.9	0.0	0.0	0.0	0.0	0.0	15.5	8.2	1.5	0.1	0.1	0.0	0.0	3953.8	3.3	12.7	0.1	6.6	0.0	0.0	0.6	2.1	0.0	3.3	0.0	0.0	0.0	3.3	9.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	5.4	2117.6	0.1	0.0	6.1	14.9	4.9	0.0	0.0	4.8	2.6	4469.2	0.0	0.0	3.3	15.7	3.7	2.6	2.7	0.0	0.8	6.8	3.9	9.9	11.8	4.9	6.3	8794.0	3519.2	4949.0	2.1	5.2	1.2	25.1	7.5	2.6	4.0	1.5	19.1	4173.0	2.5	3.8	6.6	2555.1	2.1	2.1	28.3	4.5	2.5	3578.1	2.6	1310.4	0.9	1.1	0.6	3.0	0.6	6.5	2.3	4.5	0.6	1.1	6.8	1.2	2.9	3.0	22.4	101.3	0.0	6154.9	0.0	28.2	0.0	8.6	0.0	11.7	1.9	2.2	15.7	8.1	0.0	0.0	0.1	700.0	5.1	0.0	0.0	0.5	0.0	0.1	38.1	7.3	139.0	0.0	0.0	0.1	48.8	228.8	0.0	79.5	0.1	66.4	24.6	0.3	0.0	0.0	5.3	0.0	35.8	0.0	0.3	0.0	42.0	0.0	0.0	3.9	0.0	6.2	0.0	0.0	0.0	5.1	0.0	101294.9	32.7	0.0	5.4	3.6	0.0	0.0	0.6	88.4	1.4	0.3	24.3	0.0	0.3	1487.8	0.0	3.5	0.6
JPH2	JP-2	ENSG00000149596	"Junctophilin 2"	Q9BR39	20	44106590-44187188	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 69.5;skeletal muscle: 121.5"	"Cell type enriched"	"Detected in some"	4	"Cardiomyocytes: 64.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 15.3;EFO-21: 15.0;fHDF/TERT166: 19.1;HeLa: 12.6;SiHa: 12.9"	"Low region specificity"	"Detected in some"							HPA052646	Approved					NA	NA					"HPA052646: AB_2681899"	"unprognostic (1.57e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.61e-4)"	"unprognostic (4.71e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.45e-3)"	"unprognostic (6.87e-2)"	"unprognostic (9.16e-2)"	"unprognostic (2.57e-2)"	"unprognostic (9.73e-2)"	"unprognostic (4.76e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.10e-2)"	5.4	1.9	0.6	4.5	0.5	0.1	5.8	0.4	0.9	14.4	1.3	44.0	2.1	52.1	3.0	12.0	30.3	3.5	69.5	0.4	0.4	1.4	0.3	5.3	0.2	1.2	0.9	0.4	3.9	0.4	0.1	1.2	3.8	0.8	24.0	4.5	0.2	5.8	22.3	121.5	3.3	11.9	27.8	0.8	1.3	16.2	0.8	0.7	0.1	1.5	48.7	0.1	40.8	10.7	0.6	7.5	0.8	0.4	0.0	0.3	0.4	1.5	2.2	4.1	5.4	2.3	15.3	5.9	0.0	15.0	19.1	6.1	10.5	0.0	0.5	2.1	0.0	0.0	0.0	12.6	0.1	0.1	0.3	0.0	0.7	1.1	2.7	3.7	3.3	0.0	0.0	0.0	0.0	7.3	4.3	0.0	0.2	0.3	0.0	0.9	1.7	3.4	0.0	0.4	0.1	0.0	0.1	12.9	3.1	0.1	8.6	10.8	0.1	0.3	2.4	2.7	0.5	4.7	0.1	0.0	0.0	0.2	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.4	0.9	0.4	0.4	1.2	0.9	0.4	0.8	0.8	0.7	0.6	0.2	0.0	0.0	0.3	0.0	6.6	0.5	0.9	0.0	0.0	0.4	5.1	64.6	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.9	0.0	0.0	0.8	0.0	0.5	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.1	0.2	0.2	0.0	6.6	15.9	12.8	0.0	1.5	0.0	2.0	0.5	0.1	0.0	0.2	0.1
KCNJ5	"CIR, GIRK4, KATP1, Kir3.4, LQT13"	ENSG00000120457	"Potassium inwardly rectifying channel subfamily J member 5"	P48544	11	128891356-128921163	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Cancer-related genes, Disease variant, Long QT syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 64.9;pancreas: 20.6"	"Cell type enriched"	"Detected in many"	4	"Hofbauer cells: 48.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"HBEC3-KT: 13.3"	"Group enriched"	"Detected in many"	6	"basal ganglia: 2.9;hypothalamus: 6.8;midbrain: 1.9;thalamus: 3.6"	"Low region specificity"	"Detected in all"			"HPA014722, HPA017353, CAB022569"	Approved					NA	NA					"CAB022569: , HPA014722: AB_1852133, HPA017353: AB_1852135"	"unprognostic (2.01e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.56e-3)"	"unprognostic (5.81e-2)"	"unprognostic (4.24e-2)"	"unprognostic (3.60e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.54e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.17e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.81e-2)"	"unprognostic (6.82e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.23e-2)"	1.5	64.9	1.1	0.6	1.6	0.4	0.9	0.5	3.1	1.3	0.5	0.6	0.8	0.3	0.9	1.0	0.9	2.2	8.6	0.6	2.8	2.9	0.5	6.0	1.6	2.9	1.6	0.6	1.0	20.6	1.3	12.0	7.3	4.0	1.3	0.7	1.0	0.9	9.7	0.4	0.4	0.5	0.6	1.6	13.7	2.3	1.1	5.1	5.8	0.5	0.4	0.5	1.5	0.4	2.9	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.2	0.1	0.3	13.3	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.3	0.1	0.0	0.0	1.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	1.1	1.6	0.5	3.1	0.6	2.8	2.9	1.6	0.6	4.0	1.6	5.1	2.9	0.2	0.0	10.0	0.3	0.2	1.5	2.2	4.7	0.0	2.7	0.2	1.4	7.6	0.0	0.3	1.8	0.0	0.8	0.1	0.0	0.0	0.1	2.3	0.2	0.2	0.6	0.0	0.0	0.2	3.9	0.7	1.1	0.0	0.3	0.0	0.2	0.4	0.1	48.3	1.7	3.1	0.0	0.0	2.2	2.9	7.8	0.9	10.9	3.6	3.7	1.2	0.3	3.1	0.5	0.1	0.8	0.0	0.7	0.3	0.6	0.0	0.1	0.3	1.4	0.0	0.9	0.2	0.9	0.5	0.5	1.7	1.2	0.6	2.3	0.0	0.6
KCNK13	"K2p13.1, THIK-1, THIK1"	ENSG00000152315	"Potassium two pore domain channel subfamily K member 13"	Q9HB14	14	90061994-90185853	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 4.6;parathyroid gland: 6.1;testis: 9.3"	"Cell type enriched"	"Detected in some"	4	"Microglial cells: 41.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"myeloid DC: 1.2"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.2"	"Cell line enhanced"	"Detected in some"		"GAMG: 1.0;RT4: 1.9;SuSa: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA003514	Approved		Approved	"Nuclear speckles,Cell Junctions"		NA	NA			"Nuclear speckles, Cell Junctions"		"HPA003514: AB_2666978"	"unprognostic (1.40e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.17e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.55e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.04e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.65e-2)"	0.3	0.8	1.7	1.7	1.5	0.0	0.2	1.0	1.9	0.1	4.6	0.4	0.5	0.2	1.0	0.2	0.3	0.4	1.3	1.7	1.7	3.2	0.5	0.4	0.6	1.3	2.1	1.8	0.1	0.3	6.1	0.3	0.2	1.4	0.1	0.5	0.0	0.2	0.4	0.0	0.1	0.5	0.3	2.4	0.6	0.4	9.3	2.0	1.1	1.9	0.0	0.5	0.5	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.4	0.0	0.0	0.3	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.1	1.9	0.7	0.2	0.0	0.7	0.5	2.9	0.0	0.7	0.0	0.0	0.8	0.0	0.3	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	1.7	1.5	1.0	1.9	1.7	1.7	1.3	2.1	1.8	1.4	2.4	2.0	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.8	0.4	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	6.3	0.0	0.4	0.0	0.0	6.0	0.0	4.4	0.0	0.0	4.0	8.1	0.6	0.0	3.2	0.0	41.2	9.0	0.0	0.0	3.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.6	0.0	0.3	0.1	0.1	0.4	0.0	0.1
KCNMB1	hslo-beta	ENSG00000145936	"Potassium calcium-activated channel subfamily M regulatory beta subunit 1"	Q16558	5	170374671-170389634	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 59.7;intestine: 53.6;seminal vesicle: 51.1;smooth muscle: 53.6"	"Cell type enriched"	"Detected in many"	6	"Peritubular cells: 354.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 6.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 5.7;monocytes: 5.9"	"Cell line enhanced"	"Detected in some"		"REH: 8.8;SK-BR-3: 2.1;U-937: 3.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (2.06e-2)"	"unprognostic (2.70e-4)"	"unprognostic (1.69e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.37e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.46e-1)"	"unprognostic (2.28e-1)"	"unprognostic (4.68e-2)"	"unprognostic (5.37e-1)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (4.13e-6)"	"unprognostic (1.08e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.04e-2)"	5.8	1.8	2.6	10.6	2.5	1.7	7.0	2.4	3.5	14.8	1.7	53.6	4.3	59.7	6.2	16.8	20.8	7.3	4.2	1.9	1.8	1.2	0.7	4.0	1.7	5.3	3.2	1.5	4.1	0.7	0.3	0.5	1.1	6.2	24.7	9.0	1.1	6.9	51.1	1.1	2.6	14.4	53.6	3.6	2.3	21.6	2.8	4.0	1.0	1.4	1.1	1.4	32.8	11.2	5.6	0.1	0.1	1.5	0.3	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.3	0.1	1.0	0.1	0.4	0.1	0.0	0.0	0.0	0.3	0.1	1.2	0.6	0.2	0.0	0.4	0.2	0.2	0.0	0.1	0.2	0.1	0.1	0.4	0.3	0.7	0.1	0.7	0.0	0.8	0.3	0.0	0.1	8.8	0.0	0.2	0.0	0.2	0.4	0.2	0.1	2.1	0.0	0.7	0.1	1.0	0.5	0.2	0.3	0.3	0.0	0.4	0.2	0.1	0.1	3.8	0.1	1.3	3.3	0.3	0.1	5.9	0.1	0.2	0.2	0.1	5.7	0.3	0.1	0.1	0.9	0.4	5.1	2.0	0.2	1.0	2.6	2.5	2.4	3.5	1.9	1.8	5.3	3.2	1.5	6.2	3.6	4.0	5.6	1.3	0.0	6.3	0.3	1.2	2.0	1.2	0.4	0.0	1.6	2.5	55.1	3.7	4.3	4.5	1.8	6.2	0.5	1.7	0.1	0.0	0.1	0.6	0.6	14.4	3.6	0.0	1.3	0.1	0.4	0.6	9.8	0.0	0.6	19.7	0.4	1.8	0.4	7.4	1.7	0.3	0.2	0.0	18.9	10.9	4.5	38.5	15.6	3.6	4.7	27.8	0.6	2.1	0.0	0.1	0.0	0.0	354.3	0.3	1.3	0.0	0.1	4.5	2.3	46.0	2.2	43.6	0.7	1.2	0.1	1.7	0.5	1.7	1.4	0.0	0.7
KIF25	KNSL3	ENSG00000125337	"Kinesin family member 25"	Q9UIL4	6	167996241-168045095	"Predicted intracellular proteins"		"Motor protein"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 4.5;retina: 2.6"	"Cell type enriched"	"Detected in some"	4	"Adipocytes: 165.2"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HDLM-2: 2.0"					"Not detected"	"Not detected"			HPA046153	Uncertain					NA	NA					"HPA046153: AB_10960550"	"unprognostic (1.11e-1)"	"unprognostic (9.32e-3)"	"unprognostic (1.39e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.66e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.45e-1)"	"unprognostic (7.08e-5)"	"unprognostic (1.55e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.77e-3)"	2.1	0.1	1.6	0.2	1.8	0.1	1.3	4.5	3.8	0.3	0.5	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.4	1.4	1.8	0.2	0.6	0.4	0.5	2.7	2.0	1.6	0.5	0.0	0.1	0.0	0.4	4.4	0.3	0.1	2.6	0.2	0.0	1.3	0.4	0.3	0.0	1.6	0.2	0.3	0.5	2.1	0.1	0.1	0.0	0.1	0.2	0.1	2.6	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.5	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.8	4.5	3.8	1.4	1.8	2.7	2.0	1.6	4.4	1.6	2.1	2.6	165.2	0.0	0.0	0.7	0.0	0.4	0.1	0.0	0.0	4.2	1.3	1.1	1.0	0.0	0.0	3.7	0.0	1.1	0.3	0.1	0.0	0.2	0.0	0.1	0.4	9.3	0.0	0.0	6.0	0.0	0.3	0.6	0.0	0.3	4.5	0.1	0.7	0.1	0.1	3.3	4.7	0.3	0.0	0.0	0.0	0.5	0.0	0.1	1.8	1.0	0.0	0.7	0.0	3.5	34.4	0.0	0.1	0.4	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.3	1.0	0.3	3.2	0.0	0.4	0.0	0.1	0.1	0.0	0.2
KIF6	"C6orf102, dJ1043E3.1, dJ137F1.4, dJ188D3.1, DKFZp451I2418, MGC33317"	ENSG00000164627	"Kinesin family member 6"	Q6ZMV9	6	39329990-39725408	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 18.6;testis: 5.3"	"Cell type enriched"	"Detected in many"	5	"Oligodendrocytes: 220.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 22.1;RPMI-8226: 9.2;SCLC-21H: 12.2;SK-MEL-30: 5.0"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"midbrain: 1.7"	"HPA038811, HPA058624"	Enhanced		Approved	Centrosome		NA	NA			Centrosome		"HPA038811: AB_10795140, HPA058624: AB_2683781"	"unprognostic (4.94e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.25e-4)"	"unprognostic (3.12e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.48e-2)"	"unprognostic (9.12e-4)"	"unprognostic (1.08e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.10e-2)"	"unprognostic (5.09e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.99e-1)"	0.3	0.3	8.2	0.1	14.1	0.1	0.5	10.6	7.5	0.3	1.5	0.2	0.5	0.2	0.5	0.3	3.8	0.4	0.3	6.8	7.8	0.3	0.3	0.8	0.3	10.3	9.4	4.1	0.2	0.5	0.3	1.2	0.3	11.9	0.2	0.1	3.1	0.1	0.1	0.4	0.2	0.2	0.1	8.2	0.2	0.2	5.3	9.8	0.1	0.6	0.2	0.1	0.0	0.0	18.6	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.1	1.0	0.3	0.5	0.1	0.0	0.0	0.1	1.0	22.1	0.2	0.1	0.0	0.2	0.0	0.3	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.3	0.0	0.6	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.6	0.0	0.0	0.5	9.2	0.2	0.0	12.2	0.1	0.0	0.1	5.0	0.3	0.1	0.1	0.1	0.0	0.1	2.9	0.7	0.2	0.0	0.0	0.7	0.0	1.5	0.5	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.5	0.2	0.1	0.6	0.0	0.0	8.2	14.1	10.6	7.5	6.8	7.8	10.3	9.4	4.1	11.9	8.2	9.8	18.6	0.2	0.0	0.6	31.3	0.1	0.1	0.7	1.0	0.0	3.9	0.5	0.5	1.3	0.0	2.2	0.0	10.4	0.3	0.0	0.0	1.9	1.5	9.1	23.9	1.0	0.8	2.4	0.0	8.6	0.9	0.5	2.7	0.0	1.0	0.0	0.4	0.0	0.0	0.3	3.3	15.6	0.0	0.0	0.0	1.5	10.3	0.3	0.3	0.0	1.9	0.1	12.9	0.0	5.0	220.3	0.1	0.1	0.0	0.1	0.3	0.0	3.5	40.0	16.3	0.0	3.1	0.8	17.0	3.1	0.1	0.4	0.3	0.2	2.2	0.0	0.4
KL		ENSG00000133116	Klotho	Q9UEF7	13	33016423-33066143	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Glycosidase, Hormone, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 129.9;parathyroid gland: 136.2"	"Cell type enriched"	"Detected in some"	7	"Proximal tubular cells: 123.3"	"Group enriched"	"Detected in many"	6	"prostate cancer: 5.9;renal cancer: 17.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HMC-1: 2.4;SK-BR-3: 4.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basal ganglia: 13.3;cerebral cortex: 6.7;hippocampal formation: 7.4;medulla oblongata: 4.2"						"Secreted to blood"	NA	NA	510000					"unprognostic (1.32e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.73e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.15e-4)"	"unprognostic (3.06e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.60e-1)"	"prognostic favorable (4.44e-4)"	"unprognostic (9.46e-2)"	"prognostic favorable (1.29e-9)"	"unprognostic (4.76e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.07e-1)"	3.0	1.4	0.9	0.8	3.0	0.1	2.5	0.8	1.2	1.8	38.0	1.6	2.8	1.2	8.8	1.1	0.8	1.3	1.1	4.2	1.2	129.9	0.4	3.6	1.0	0.7	0.9	0.6	0.1	1.2	136.2	0.3	30.7	0.6	8.1	0.9	0.0	0.8	2.5	0.7	0.6	2.6	1.2	0.5	2.5	2.1	0.5	1.2	0.5	1.3	1.6	0.5	1.6	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	3.0	0.8	1.2	4.2	1.2	0.7	0.9	0.6	0.6	0.5	1.2	0.7	15.8	0.0	0.5	0.0	0.6	0.1	0.2	0.0	0.0	0.0	0.6	0.3	1.0	0.0	0.7	12.9	0.0	0.2	0.0	0.4	5.9	0.0	1.8	0.1	2.5	10.2	16.3	0.4	1.2	0.0	0.1	1.6	0.0	0.1	0.0	0.1	1.1	0.2	2.8	0.0	0.5	1.1	0.0	0.9	1.0	0.8	0.3	1.9	0.0	6.5	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	3.6	1.8	123.3	0.7	0.0	0.0	1.1	2.3	1.4	0.5	0.0	0.1	0.1	1.1	0.1	1.9	0.1
KLHL31	"bA345L23.2, BKLHD6, KBTBD1"	ENSG00000124743	"Kelch like family member 31"	Q9H511	6	53647916-53665756	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 44.2;skeletal muscle: 147.4;tongue: 35.1"	"Cell type enriched"	"Detected in some"	33	"Cardiomyocytes: 248.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (7.27e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.67e-4)"	"unprognostic (2.23e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.98e-2)"	"unprognostic (5.50e-2)"	"unprognostic (4.24e-1)"	"unprognostic (1.09e-4)"	"unprognostic (8.73e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.40e-1)"	8.7	0.8	0.2	0.2	0.5	0.0	3.1	0.2	0.2	0.1	0.6	0.2	0.4	0.3	0.8	0.7	0.8	0.2	44.2	0.1	0.6	0.2	0.4	0.2	0.1	0.4	0.2	0.2	0.3	0.4	0.0	0.4	0.1	0.3	1.3	0.2	0.4	1.2	0.1	147.4	1.3	0.3	0.0	0.3	0.1	0.3	0.3	0.3	0.1	0.9	35.1	0.2	0.3	0.4	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.2	0.5	0.2	0.1	0.0	0.0	0.3	0.1	0.6	0.4	0.0	0.1	0.0	0.5	0.7	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.4	0.2	0.0	0.8	0.0	0.2	0.2	1.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.2	0.2	0.1	0.6	0.4	0.2	0.2	0.3	0.3	0.3	0.3	0.2	0.0	0.0	0.7	0.0	0.6	0.8	0.7	0.0	0.5	0.9	0.9	248.9	0.0	0.5	0.0	0.0	1.0	0.1	0.6	0.0	0.1	0.4	2.0	0.3	1.7	0.0	3.2	0.2	0.4	0.2	7.5	0.5	3.1	0.0	0.9	0.0	0.2	0.2	0.0	0.2	0.1	2.0	0.3	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.2	1.0	0.0	0.5	0.0	0.2	0.0	0.1	0.6	0.0	0.2	0.2	0.1	0.0	3.7	2.2	0.0	0.2	0.0	0.4	0.8	0.3	0.4	0.3	0.4
KLHL38	C8ORFK36	ENSG00000175946	"Kelch like family member 38"	Q2WGJ6	8	123645527-123652950	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 57.2;skeletal muscle: 270.9;tongue: 77.6"	"Cell type enriched"	"Detected in single"	10	"Cardiomyocytes: 1.0"	"Group enriched"	"Detected in some"	5	"breast cancer: 1.3;melanoma: 1.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 1.7;SK-BR-3: 2.8;U-2197: 4.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA024770, HPA027115"	Uncertain		Approved	Nucleoplasm,Cytosol		Yes	NA			Nucleoplasm	Cytosol	"HPA024770: AB_10599286, HPA027115: AB_10599950"	"unprognostic (8.62e-3)"	"unprognostic (3.86e-3)"	"unprognostic (1.02e-2)"	"unprognostic (8.94e-2)"	"unprognostic (4.68e-1)"	"unprognostic (2.09e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.77e-2)"	"unprognostic (5.73e-6)"	"unprognostic (8.46e-3)"	"unprognostic (3.82e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.84e-2)"	0.1	0.0	0.1	0.2	0.2	0.0	0.2	0.0	0.5	0.2	0.1	0.7	0.1	1.3	0.0	2.5	0.7	0.7	57.2	0.2	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.5	0.1	1.3	0.0	1.5	0.2	0.8	0.1	0.0	0.7	0.1	270.9	0.2	0.2	2.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	77.6	0.0	0.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.9	0.0	0.5	0.0	0.0	0.0	0.1	4.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KLHL8	KIAA1378	ENSG00000145332	"Kelch like family member 8"	Q9P2G9	4	87160103-87240314	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 61.0"	"Cell type enriched"	"Detected in all"	4	"Muller glia cells: 216.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013856, HPA017762"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA013856: AB_1852594, HPA017762: AB_2669660"	"unprognostic (2.93e-2)"	"unprognostic (4.91e-3)"	"unprognostic (3.44e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.46e-3)"	"unprognostic (3.27e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.46e-1)"	"prognostic favorable (1.53e-5)"	"unprognostic (4.24e-3)"	"unprognostic (3.05e-1)"	"unprognostic (3.57e-3)"	"unprognostic (1.57e-3)"	6.8	7.4	4.8	6.2	4.9	3.2	9.5	7.4	4.9	8.8	2.3	8.0	7.8	6.9	61.0	4.8	5.4	5.0	4.6	4.4	5.7	12.1	11.3	5.2	5.9	4.5	5.7	3.7	6.0	5.3	8.6	3.6	4.3	4.1	5.6	8.9	27.4	7.2	7.5	13.8	4.1	7.7	6.7	5.2	6.4	4.2	4.3	5.5	8.6	19.0	9.8	4.9	6.1	4.2	4.9	9.9	8.5	15.1	6.8	13.5	9.8	8.1	12.4	6.6	8.1	9.5	13.8	7.3	14.3	9.8	9.2	6.6	4.1	16.2	12.2	17.4	13.7	10.1	17.4	6.0	8.1	11.5	28.9	10.5	12.4	8.6	12.4	12.4	7.9	9.7	10.6	22.8	12.7	8.5	10.9	34.8	14.4	3.8	22.1	3.4	12.9	12.9	8.7	13.7	10.1	31.6	11.0	8.1	19.6	9.2	5.6	6.8	21.0	9.2	10.2	12.6	10.9	10.4	18.7	13.1	25.1	7.7	13.5	11.4	2.0	12.2	7.6	2.9	9.2	4.6	3.2	2.2	2.4	10.4	3.5	4.0	4.0	8.6	8.4	9.8	2.6	0.9	5.0	4.8	4.9	7.4	4.9	4.4	5.7	4.5	5.7	3.7	4.1	5.2	5.5	4.9	9.5	3.2	22.9	29.4	14.3	13.8	10.8	10.1	13.6	22.8	11.1	7.7	15.4	5.7	11.6	44.1	41.7	4.1	12.1	21.4	11.7	5.2	4.0	8.3	21.4	12.8	9.0	12.4	44.6	4.5	6.9	10.4	3.1	9.8	7.6	16.8	8.6	20.0	9.7	23.5	41.5	10.8	4.1	38.8	12.0	3.5	9.6	23.3	10.6	24.4	22.1	216.0	11.3	47.3	35.7	4.9	12.2	8.2	6.4	13.8	14.5	19.2	10.1	47.0	13.1	20.1	9.2	32.5	22.5	12.9	14.8	23.8	9.9	4.4	15.2	11.4
KRT13	"CK13, K13, MGC161462, MGC3781"	ENSG00000171401	"Keratin 13"	P13646	17	41500981-41505705	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 41253.5;vagina: 13518.8"	"Cell type enriched"	"Detected in many"	4	"Squamous epithelial cells: 16844.0"	"Group enriched"	"Detected in many"	5	"cervical cancer: 899.2;head and neck cancer: 758.7;urothelial cancer: 504.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	93	"A-431: 2462.5;HaCaT: 1626.2"									"CAB000133, HPA030877, HPA069771"	Enhanced		Enhanced	"Intermediate filaments"		NA	NA		680000000	"Intermediate filaments"		"CAB000133: , HPA030877: AB_2673641, HPA069771: AB_2732141"	"unprognostic (1.45e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.19e-2)"	"unprognostic (9.30e-5)"	"unprognostic (7.30e-3)"		"unprognostic (1.95e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.81e-3)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (1.45e-6)"	"unprognostic (1.80e-1)"	"unprognostic (2.76e-1)"	"unprognostic (3.04e-2)"	"unprognostic (4.33e-1)"	6.8	7.5	0.0	0.0	0.1	6.9	5.2	0.0	0.0	3290.9	0.0	4.9	0.1	10.3	0.0	41253.5	7.1	8.9	9.3	0.0	0.1	5.5	12.9	6.0	0.3	0.0	0.0	0.0	9.9	17.3	0.0	27.1	0.0	0.0	116.2	0.0	0.0	6935.6	3.9	9.9	13.5	8.6	14.3	0.0	7.8	31.5	7.0	0.0	13.7	6.1	0.0	1871.4	933.9	13518.8	0.0	2462.5	0.6	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.6	0.8	7.1	0.6	0.0	0.0	1626.2	0.0	0.4	0.0	1.4	0.0	4.5	21.8	0.0	0.0	1.7	1.3	0.0	0.8	0.0	0.0	0.3	0.0	0.0	5.4	1.2	0.0	1.3	0.1	0.1	0.1	14.8	0.3	0.2	1.2	0.3	0.0	10.7	0.0	0.0	1.9	2.0	7.7	0.0	2.3	6.4	5.1	0.0	0.4	0.0	6.6	0.3	6.3	5.8	1.9	4.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	16.0	1.1	0.0	0.9	2.8	545.6	17.1	146.8	0.0	2.3	4.6	0.6	1.5	94.5	0.0	0.0	0.1	0.2	0.6	0.0	0.0	1.2	2.7	0.2	11.4	1.2	5.5	0.0	0.0	0.5	12.6	0.0	4.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	8.2	0.0	0.0	3.2	55.9	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.7	286.6	27.1	227.9	0.1	0.1	3.3	0.0	0.0	0.0	16.9	0.2	0.6	16844.0	1.6	0.4	8.8	0.0	0.4	3645.4
KRT6C	KRT6E	ENSG00000170465	"Keratin 6C"	P48668	12	52468516-52473805	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 805.9;vagina: 336.2"	"Cell type enriched"	"Detected in some"	60	"Squamous epithelial cells: 234.3"	"Group enriched"	"Detected in many"	5	"head and neck cancer: 564.7;melanoma: 242.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"RPMI-8226: 94.1"									"HPA045697, HPA061168"	Supported		Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA045697: AB_2679422, HPA061168: AB_2684440"	"unprognostic (3.18e-2)"	"unprognostic (6.26e-3)"	"unprognostic (6.63e-2)"	"unprognostic (1.54e-3)"		"unprognostic (6.97e-2)"		"prognostic unfavorable (1.23e-5)"	"unprognostic (1.83e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.24e-1)"		"unprognostic (2.84e-1)"			"unprognostic (4.50e-2)"	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	101.1	0.0	0.0	0.0	0.1	0.0	805.9	0.2	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	145.5	0.0	0.1	23.3	0.1	0.0	0.0	0.1	0.4	0.0	0.0	1.0	0.1	0.0	9.6	0.1	336.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	94.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	1.2	1.3	2.2	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	234.3	2.4	0.0	0.0	0.0	0.2	3.9
KRTAP21-2	KAP21.2	ENSG00000187026	"Keratin associated protein 21-2"	Q3LI59	21	30746794-30747259	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 1.7"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 7.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	10	"HEK 293: 1.7"															NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KYAT1	"CCBL1, GTK, KATI"	ENSG00000171097	"Kynurenine aminotransferase 1"	Q16773	9	128832942-128882494	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Aminotransferase, Lyase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"Granulosa cells: 45.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA021176, HPA021177, HPA027736"	Approved		Supported	Cytosol		NA	NA		22000	Cytosol		"HPA021176: AB_1846120, HPA021177: AB_1846119, HPA027736: AB_10611818"	"unprognostic (6.51e-2)"	"unprognostic (8.67e-3)"	"unprognostic (1.05e-2)"	"unprognostic (5.98e-3)"	"unprognostic (2.15e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.47e-1)"	"unprognostic (8.60e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.65e-2)"	"unprognostic (3.10e-2)"	"unprognostic (5.79e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.98e-1)"	3.2	4.7	13.7	3.6	14.3	2.4	4.1	13.9	15.7	6.6	11.4	4.0	2.6	5.9	3.0	5.3	6.5	2.7	9.6	13.2	13.4	7.8	12.8	3.7	5.0	14.3	13.5	13.3	6.3	3.1	5.5	8.8	2.5	13.9	7.5	1.3	7.5	4.2	4.4	12.8	7.8	4.2	3.1	13.5	5.4	4.9	5.6	14.0	8.9	6.2	8.8	4.8	7.3	6.7	19.0	4.8	9.8	9.3	10.6	6.9	11.4	3.0	5.5	8.0	6.2	8.0	3.9	9.7	8.3	2.9	4.6	7.0	14.9	13.9	11.1	9.3	10.0	7.3	5.7	27.7	9.6	7.7	5.0	1.9	4.5	7.1	7.1	7.7	21.8	11.3	22.7	8.2	9.0	8.5	3.1	14.0	3.4	15.2	18.3	7.6	16.4	6.4	18.9	8.7	1.7	10.5	7.4	9.9	2.9	6.2	12.8	6.6	1.6	7.0	4.6	7.9	7.1	5.0	15.2	11.0	11.6	9.6	8.3	3.2	0.1	1.4	2.9	5.1	1.8	4.5	7.7	5.7	6.0	5.5	3.3	5.9	6.7	0.9	3.3	2.9	2.4	7.0	3.3	13.7	14.3	13.9	15.7	13.2	13.4	14.3	13.5	13.3	13.9	13.5	14.0	19.0	2.6	0.0	1.5	0.0	1.5	0.0	0.0	0.0	0.0	0.0	2.0	1.5	0.0	0.0	0.6	0.0	0.0	5.0	0.9	0.0	3.9	1.6	0.0	2.6	3.3	0.7	0.0	0.0	0.0	0.2	2.4	0.7	0.0	4.2	0.0	45.1	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.0	0.0	7.3	2.9	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.1	1.3	1.3	0.0	0.0
LAIR2	CD306	ENSG00000167618	"Leukocyte associated immunoglobulin like receptor 2"	Q6ISS4	19	54497879-54510687	"CD markers, Predicted intracellular proteins, Predicted secreted proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 1.7;pituitary gland: 2.6"	"Cell type enriched"	"Detected in some"	7	"Extravillous trophoblasts: 696.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	9	"gdT-cell: 14.0;memory CD4 T-cell: 13.8;memory CD8 T-cell: 19.5;naive CD8 T-cell: 13.2;T-reg: 49.5"	"Lineage enriched"	"Detected in many"	40	"T-cells: 49.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.3;Hep G2: 1.0"					"Low region specificity"	"Detected in some"								"Secreted to blood"	NA	NA						"unprognostic (1.99e-3)"	"unprognostic (7.49e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.86e-4)"	"unprognostic (1.06e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.93e-1)"	"unprognostic (2.21e-1)"	"unprognostic (9.52e-2)"	"unprognostic (3.68e-9)"	"unprognostic (1.21e-2)"	"unprognostic (3.15e-3)"	"unprognostic (3.40e-5)"	"unprognostic (6.71e-2)"	0.2	0.0	0.2	0.4	0.3	0.8	0.1	0.3	0.7	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.5	1.1	0.1	0.1	0.7	1.7	0.4	0.3	0.3	0.0	0.1	0.0	2.6	0.2	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.2	1.1	0.3	0.3	0.5	0.6	0.1	0.2	0.3	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.5	0.0	0.1	0.1	0.0	14.0	0.1	0.4	0.0	13.8	19.5	0.1	0.1	2.4	13.2	0.2	1.2	0.3	0.1	49.5	7.8	0.2	0.3	0.3	0.7	0.5	1.1	0.4	0.3	0.3	0.5	0.2	0.5	0.6	0.8	0.0	0.5	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.0	0.0	0.0	10.7	95.4	0.9	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.4	0.0	0.2	696.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	23.2	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.8	1.8	0.0	0.5	0.0	46.4	0.0	0.1	0.6	0.0	0.0	4.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.1	32.2	23.2	0.0	0.0	0.0
LAMC2	"BM600-100kDa, EBR2, EBR2A, kalinin-105kDa, LAMB2T, LAMNB2, nicein-100kDa"	ENSG00000058085	"Laminin subunit gamma 2"	Q13753	1	183186238-183245127	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding	"Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"urinary bladder: 39.7"	"Cell type enriched"	"Detected in many"	5	"Pancreatic endocrine cells: 1531.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 231.3"	"Region enhanced"	"Detected in some"		"cerebellum: 2.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 574.7;CAPAN-2: 501.6;HBEC3-KT: 2492.2;hTERT-HME1: 1487.5;RPTEC TERT1: 579.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004257, HPA024638, HPA046539, CAB078165"	Enhanced		Uncertain	"Endoplasmic reticulum,Golgi apparatus"	"Secreted to extracellular matrix"	No	No		130000	"Endoplasmic reticulum, Golgi apparatus"		"CAB004257: AB_627873, CAB078165: AB_2665800, HPA024638: AB_1852689, HPA046539: "	"unprognostic (7.27e-3)"	"unprognostic (7.21e-3)"	"unprognostic (3.24e-1)"	"unprognostic (6.20e-3)"	"unprognostic (9.43e-2)"	"unprognostic (4.94e-3)"	"unprognostic (4.12e-2)"	"prognostic unfavorable (4.20e-6)"	"unprognostic (1.25e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (7.11e-5)"	"unprognostic (2.77e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.26e-1)"	3.2	0.1	0.2	16.4	1.9	0.1	21.1	2.4	0.5	15.2	0.2	12.2	2.7	12.4	2.2	7.8	35.2	13.2	2.5	0.2	0.4	9.9	0.7	25.1	8.0	0.1	0.2	0.2	1.0	3.3	0.0	4.3	11.0	0.7	5.4	13.0	0.1	13.0	6.2	1.7	16.5	15.1	3.3	0.0	0.9	15.0	2.8	0.1	11.4	18.7	2.3	12.4	39.7	6.4	0.2	574.7	25.4	0.0	0.7	4.9	11.9	40.2	4.3	4.7	2.1	0.7	41.4	501.6	0.0	207.9	1.4	16.4	252.4	0.1	2492.2	2.7	0.7	0.2	0.0	0.5	0.1	1.2	0.0	0.2	6.1	189.7	6.0	1487.5	2.3	32.6	0.0	0.0	0.2	2.5	1.1	0.0	0.1	4.5	206.7	35.2	0.1	1.2	0.0	579.4	147.1	30.5	0.1	14.7	0.4	0.9	14.9	2.0	2.7	3.8	2.2	30.2	15.0	7.8	0.9	0.7	0.7	4.1	0.2	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.9	2.4	0.5	0.2	0.4	0.1	0.2	0.2	0.7	0.0	0.1	0.2	0.5	218.0	17.8	0.0	0.2	86.3	227.1	232.7	105.3	0.0	8.2	26.2	2.3	10.0	56.8	23.9	0.0	30.7	0.4	74.4	0.0	183.4	19.6	68.9	3.6	7.8	9.0	0.0	0.4	94.0	11.7	17.2	59.7	97.4	0.0	0.0	0.0	0.0	2.5	0.0	0.3	34.1	14.2	0.0	4.9	11.8	3.4	3.1	8.8	1.0	2.6	0.0	0.0	0.0	0.3	1531.1	91.2	0.4	0.3	302.0	16.7	0.2	69.3	0.0	0.0	3.4	9.6	3.6	1.0	60.3	29.7	83.3	5.3	0.1	15.3	169.9
LAYN	"FLJ30977, FLJ31092"	ENSG00000204381	Layilin	Q6UX15	11	111540280-111561745	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Prostatic glandular cells: 233.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	22	"myeloid DC: 11.2;T-reg: 13.4"	"Group enriched"	"Detected in many"	123	"dendritic cells: 11.2;T-cells: 13.4"	"Cell line enhanced"	"Detected in many"		"BJ: 150.7;BJ hTERT+: 153.7;BJ hTERT+ SV40 Large T+ RasG12V: 96.7;fHDF/TERT166: 95.1;HSkMC: 88.8;hTERT-RPE1: 94.0;U-138 MG: 108.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA040087	Approved		Approved	Cytosol		NA	NA		340000	Cytosol		"HPA040087: AB_10793927"	"unprognostic (2.27e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.83e-2)"	"unprognostic (5.62e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.75e-3)"	"unprognostic (4.47e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.61e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.35e-2)"	7.4	2.0	16.9	5.8	20.7	1.0	8.6	16.4	19.8	14.7	14.2	21.4	3.9	16.0	10.2	4.7	17.9	17.1	6.1	16.6	18.7	4.2	0.9	11.4	7.2	20.0	20.2	12.8	39.5	2.0	6.5	6.2	14.2	18.2	14.7	3.4	0.8	5.5	17.2	6.2	2.5	10.7	22.7	15.1	8.3	13.2	4.5	17.9	10.4	27.6	6.2	5.0	8.9	12.3	24.7	0.4	3.9	0.8	0.0	25.4	48.0	7.6	150.7	153.7	71.0	96.7	0.2	0.1	0.0	1.4	95.1	18.7	3.2	9.9	0.7	74.2	0.2	0.5	0.8	0.0	0.2	41.7	0.0	0.2	88.8	0.0	30.8	0.2	94.0	0.9	0.0	0.0	0.1	29.4	0.0	0.1	0.1	4.8	0.0	0.0	0.0	11.4	0.2	0.6	0.0	4.9	18.9	0.5	0.2	0.4	34.9	0.1	0.7	0.6	108.8	81.2	1.0	74.3	0.0	0.0	0.2	14.4	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	11.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	13.4	0.4	16.9	20.7	16.4	19.8	16.6	18.7	20.0	20.2	12.8	18.2	15.1	17.9	24.7	22.2	19.2	2.8	0.3	0.3	2.2	48.8	44.8	0.6	0.4	0.7	15.0	2.7	2.8	23.3	0.0	0.0	1.6	2.6	0.0	0.0	6.5	2.5	3.9	7.7	50.9	0.0	2.7	0.3	0.2	2.1	13.1	0.0	0.9	1.3	9.6	6.8	0.1	0.7	0.0	1.4	0.0	6.1	0.6	13.6	1.8	22.7	1.2	0.0	2.8	0.6	0.2	0.0	4.0	30.1	0.8	0.0	55.3	2.8	233.0	0.0	0.2	32.0	0.2	32.9	2.6	17.3	0.1	2.3	0.1	2.3	0.5	14.5	11.2	0.0	50.3
LCE3D	"LEP16, SPRL6A, SPRL6B"	ENSG00000163202	"Late cornified envelope 3D"	Q9BYE3	1	152579381-152580516	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix: 130.1;lymphoid tissue: 85.5;vagina: 231.6"	"Cell type enriched"	"Detected in some"	5	"Pancreatic endocrine cells: 8.2"	"Group enriched"	"Detected in many"	9	"head and neck cancer: 126.9;melanoma: 47.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"hTCEpi: 4.3;hTERT-HME1: 3.9"															NA	NA							"unprognostic (1.34e-1)"				"unprognostic (1.09e-1)"			"unprognostic (2.87e-1)"									0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	130.1	0.0	0.0	0.0	0.0	0.0	41.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.9	0.0	0.0	64.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	85.5	0.0	231.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LCN15	"PRO6093, UNQ2541"	ENSG00000177984	"Lipocalin 15"	Q6UWW0	9	136759634-136766255	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 12.0;seminal vesicle: 3.3"	"Cell type enriched"	"Detected in some"	4	"Enteroendocrine cells: 391.5"	"Cancer enriched"	"Detected in some"	19	"colorectal cancer: 23.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"Hep G2: 17.7"					"Low region specificity"	"Detected in all"			HPA060584	Enhanced				"Secreted in other tissues"	NA	NA					"HPA060584: AB_2684327"			"unprognostic (5.24e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.14e-1)"					"unprognostic (3.67e-1)"		"unprognostic (3.45e-2)"		"unprognostic (3.28e-2)"	"unprognostic (2.39e-1)"		"unprognostic (1.83e-1)"	0.0	0.0	1.9	0.0	1.9	0.0	0.1	1.9	2.3	0.0	1.9	3.0	12.0	0.0	1.4	0.0	0.0	0.0	0.9	1.9	1.9	0.0	0.0	0.0	0.0	1.9	1.9	1.9	0.0	0.0	0.0	0.0	0.1	1.9	0.3	1.9	0.0	0.0	3.3	0.6	0.0	3.7	0.0	1.9	0.1	0.0	0.1	1.9	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	17.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.9	1.9	2.3	1.9	1.9	1.9	1.9	1.9	1.9	1.9	1.9	1.9	1.0	0.0	0.0	0.0	0.1	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.1	0.2	0.0	0.6	391.5	0.0	2.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.0	0.3	96.9	24.4	0.3	0.4	2.8	0.0	0.1	1.8	0.0	0.0	0.0	0.0	1.0	0.8	0.0	14.7	0.0	0.0	0.2	5.5	0.1	0.0	0.9	0.0	0.3	0.1	0.1	0.4	0.0	0.1	0.0	0.1	0.1	0.9	0.4
LENG8	"KIAA1932, MGC40108, pp13842"	ENSG00000167615	"Leukocyte receptor cluster member 8"	Q96PV6	19	54448887-54462016	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Rod photoreceptor cells: 598.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEK 293: 479.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042004, HPA061571"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042004: AB_10794642, HPA061571: AB_2684562"	"unprognostic (2.09e-2)"	"unprognostic (3.24e-3)"	"unprognostic (5.14e-3)"	"unprognostic (2.19e-1)"	"unprognostic (4.42e-2)"	"prognostic favorable (7.59e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.92e-2)"	"unprognostic (4.45e-3)"	"unprognostic (5.11e-3)"	"unprognostic (8.85e-3)"	"prognostic unfavorable (3.30e-7)"	"unprognostic (3.64e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.71e-1)"	"prognostic favorable (2.73e-6)"	236.1	245.5	42.7	85.1	48.8	80.2	267.2	44.4	95.2	321.2	55.9	302.9	113.6	320.9	40.9	200.6	387.6	25.7	230.1	41.7	42.5	298.7	194.8	295.6	71.4	54.4	38.5	33.4	428.6	550.1	15.8	383.5	31.1	65.9	356.6	29.2	225.6	269.2	28.3	135.3	230.3	339.1	41.5	26.1	389.9	302.5	240.4	54.7	38.7	377.9	10.4	34.8	286.3	282.2	67.2	70.5	57.6	68.0	37.1	20.7	33.6	37.8	58.1	8.9	11.2	21.7	45.3	100.8	55.9	24.6	46.5	2.7	91.0	21.7	27.0	8.2	93.9	479.3	84.0	179.4	32.0	24.4	12.9	68.5	74.9	39.5	6.7	26.4	91.4	17.2	42.6	66.7	84.1	14.0	24.6	53.1	66.8	17.6	17.5	11.9	84.3	20.5	78.6	27.1	19.4	54.4	29.9	6.3	42.7	15.1	34.1	42.7	18.1	81.7	47.2	48.3	7.6	63.0	77.7	38.4	25.7	40.7	89.9	32.4	3.2	1.0	1.4	0.8	0.7	0.9	0.7	0.5	0.9	0.6	2.5	0.8	0.7	4.5	0.9	0.5	3.1	0.9	0.4	42.7	48.8	44.4	95.2	41.7	42.5	54.4	38.5	33.4	65.9	26.1	54.7	67.2	46.7	19.2	30.7	77.1	50.2	28.8	21.3	26.4	35.9	122.7	57.2	47.1	2.2	44.3	35.7	40.5	112.6	20.2	57.5	73.5	1.9	18.5	35.4	52.4	33.8	32.5	105.0	43.3	62.8	31.6	11.9	35.3	128.4	64.8	11.4	67.4	35.3	39.2	25.3	95.9	53.4	84.9	42.7	48.2	28.0	12.4	43.5	59.6	24.9	52.5	45.9	36.1	25.7	64.3	86.5	30.8	52.2	36.9	48.2	39.9	74.2	9.8	68.9	598.6	19.7	25.6	44.3	23.7	13.9	40.5	38.5	21.1	37.6	45.7	59.5	43.1
LEO1		ENSG00000166477	"LEO1 homolog, Paf1/RNA polymerase II complex component"	Q8WVC0	15	51938025-51971778	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	7	"granulocytes: 272.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040741, HPA040941"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Centrosome"		No	No			"Nucleoplasm, Nucleoli fibrillar center"	Centrosome	"HPA040741: AB_10794859, HPA040941: AB_10805832"	"unprognostic (2.76e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.81e-3)"	"unprognostic (2.85e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.48e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.08e-1)"	10.3	11.5	9.3	14.0	9.7	9.1	15.6	16.0	13.0	11.7	7.6	17.2	13.4	10.5	10.1	20.0	8.8	13.3	8.2	9.1	9.5	13.8	22.4	9.8	18.1	9.3	9.3	8.0	8.6	8.2	19.0	9.1	12.2	10.7	12.4	19.4	12.1	18.6	8.6	14.1	20.9	14.6	11.8	8.2	10.5	13.3	9.4	9.3	22.3	11.2	11.8	18.1	19.5	14.1	11.2	28.0	63.9	40.3	32.6	40.7	35.0	28.8	44.4	36.6	37.3	33.9	44.3	17.9	56.2	25.3	45.8	41.3	53.2	54.2	39.6	35.8	37.5	24.5	88.5	50.6	78.5	32.0	80.7	118.2	37.9	30.5	29.2	37.6	35.2	37.0	46.5	54.6	30.1	44.9	118.7	43.0	61.1	17.4	82.6	27.0	47.6	69.7	58.9	32.8	77.0	28.5	43.4	33.9	51.5	36.5	43.8	42.8	72.6	44.4	36.8	25.5	34.3	53.7	23.4	78.2	50.7	32.2	113.1	40.0	11.5	14.5	15.7	27.4	23.3	25.7	18.7	27.2	22.3	23.8	16.4	27.9	25.2	3.3	30.9	26.0	17.8	31.7	16.3	9.3	9.7	16.0	13.0	9.1	9.5	9.3	9.3	8.0	10.7	8.2	9.3	11.2	16.2	35.3	24.6	10.1	15.2	26.1	16.8	33.4	18.2	38.2	11.8	10.2	21.2	17.2	37.0	7.3	10.4	24.9	24.8	24.6	15.6	26.3	2.4	19.5	38.8	18.0	7.7	12.4	16.5	24.2	26.7	19.9	15.8	29.8	272.8	16.2	10.0	18.0	19.5	26.9	16.9	17.9	26.4	14.8	6.0	2.7	8.1	13.0	3.6	5.6	12.8	23.1	22.6	13.0	13.3	18.2	14.7	13.5	11.0	9.0	20.5	23.3	31.4	23.2	6.6	18.5	29.3	21.5	11.0	19.5	24.7	17.6	25.0	23.8	17.0	21.2
LHCGR	"HHG, LCGR, LGR2, LHR, ULG5"	ENSG00000138039	"Luteinizing hormone/choriogonadotropin receptor"	P22888	2	48686774-48755730	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.3;ovary: 2.2;testis: 2.2"	"Cell type enriched"	"Detected in some"	22	"Theca cells: 143.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB009814	Uncertain					NA	NA					"CAB009814: AB_2135467"	"unprognostic (8.57e-2)"				"unprognostic (1.08e-1)"			"unprognostic (1.54e-1)"		"unprognostic (1.41e-1)"			"unprognostic (3.14e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.24e-2)"	"unprognostic (5.22e-2)"		1.3	0.8	0.9	0.0	0.4	0.0	0.7	1.0	0.5	0.0	0.7	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.2	0.7	0.2	0.0	0.1	0.0	3.3	0.9	0.0	2.2	0.0	0.0	0.5	0.0	1.9	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	1.6	0.0	0.2	2.2	1.0	0.2	0.6	0.1	0.0	0.3	0.0	2.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.4	1.0	0.5	0.2	0.7	3.3	0.9	0.0	1.9	1.6	1.0	2.6	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.8	0.0	0.0	1.4	0.0	0.0	0.0	5.3	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	1.3	1.0	1.2	0.1	0.0	6.5	0.0	0.0	0.0	2.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.4	0.0	0.0	143.2	0.0	0.0
LIM2	"MP17, MP19"	ENSG00000105370	"Lens intrinsic membrane protein 2"	P55344	19	51379909-51387974	"Disease related genes, Human disease related genes, Predicted membrane proteins"		"Eye lens protein"	"Cataract, Disease variant"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	4	"NK-cells: 20.6"	"Cancer enriched"	"Detected in single"	40	"testis cancer: 18.3"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	7	"gdT-cell: 11.3"	"Lineage enriched"	"Detected in many"	7	"T-cells: 11.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA											"unprognostic (5.25e-2)"							"unprognostic (1.09e-3)"		"unprognostic (1.21e-1)"			0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.2	1.4	0.0	0.0	0.3	0.0	0.0	0.0	1.3	0.0	1.5	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	20.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0
LMBR1L	"FLJ10494, KIAA1174"	ENSG00000139636	"Limb development membrane protein 1 like"	Q6UX01	12	49097136-49110900	"Predicted membrane proteins"	"Endocytosis, Wnt signaling pathway"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Granulosa cells: 722.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.25e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.62e-1)"	"unprognostic (6.56e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.59e-1)"	"prognostic favorable (3.50e-4)"	"unprognostic (2.72e-2)"	"prognostic unfavorable (4.45e-7)"	"unprognostic (2.48e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.52e-3)"	5.6	9.5	14.0	4.0	14.6	4.4	4.4	15.7	18.3	6.1	13.8	7.7	6.5	7.7	6.7	8.9	7.3	5.2	9.3	14.1	14.4	7.8	6.2	5.5	7.3	15.1	14.1	14.0	8.7	5.9	5.0	8.5	11.1	14.6	6.6	4.5	6.0	5.7	7.0	6.1	5.3	8.9	7.0	13.8	7.6	5.9	25.9	14.0	11.1	3.9	6.1	6.6	8.8	6.3	15.0	7.5	10.5	13.3	13.7	9.3	13.4	14.5	7.0	11.1	9.3	8.5	10.7	5.9	3.2	5.5	14.4	5.9	3.6	9.8	5.0	5.7	12.3	15.6	7.5	6.1	9.8	17.9	5.3	11.7	15.3	6.8	13.3	7.9	25.4	29.5	13.0	19.7	4.9	8.9	3.3	9.3	14.8	6.2	20.1	7.6	6.5	5.5	3.7	6.9	15.1	7.4	6.5	5.9	5.8	13.4	11.7	5.0	7.0	28.6	6.0	3.7	4.0	2.7	8.9	5.9	4.6	8.8	4.8	3.5	24.1	19.7	51.7	12.9	16.4	11.0	17.3	13.2	14.7	14.1	18.8	18.1	15.4	9.6	6.0	21.1	10.1	22.0	17.4	14.0	14.6	15.7	18.3	14.1	14.4	15.1	14.1	14.0	14.6	13.8	14.0	15.0	26.5	6.4	20.0	16.6	26.9	15.4	13.0	13.1	23.9	37.0	14.2	10.9	7.5	7.2	9.9	9.2	20.9	14.8	29.9	15.0	3.9	16.1	104.8	6.1	11.1	27.6	47.1	11.6	14.9	10.2	39.3	21.1	9.7	9.0	17.7	722.7	17.9	8.6	16.7	32.0	14.8	12.5	16.2	13.2	41.5	156.3	13.7	23.4	21.4	14.0	27.6	9.3	27.8	8.5	13.0	17.5	15.5	6.8	36.3	14.0	51.2	3.4	6.8	31.1	13.1	17.6	24.1	14.7	12.5	15.0	14.8	22.3	33.0	18.2	13.2	18.3
LMOD3		ENSG00000163380	"Leiomodin 3"	Q0VAK6	3	69106065-69123032	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Nemaline myopathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 112.2;skeletal muscle: 464.1;tongue: 230.2"	"Cell type enriched"	"Detected in many"	7	"Cardiomyocytes: 278.1"	"Cancer enriched"	"Detected in single"	6	"head and neck cancer: 1.6"	"Region enhanced"	"Detected in single"		"midbrain: 2.1"	"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	4	"HSkMC: 2.9"	"Not detected"	"Not detected"							HPA036034	Uncertain					NA	NA					"HPA036034: AB_10673494"	"unprognostic (1.66e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.96e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.57e-2)"	"unprognostic (3.63e-1)"	"unprognostic (4.33e-1)"	"unprognostic (2.98e-4)"	"unprognostic (3.67e-3)"	"unprognostic (1.29e-1)"	"unprognostic (8.86e-2)"	"unprognostic (2.96e-1)"	0.2	0.1	0.3	0.2	0.4	0.2	0.1	0.4	0.5	0.1	0.3	0.1	0.2	0.0	0.2	6.5	0.0	0.3	112.2	0.3	0.3	0.1	0.1	0.5	0.2	0.3	2.1	0.3	0.0	0.4	0.0	0.9	0.5	0.4	3.9	0.1	1.3	9.1	0.4	464.1	0.1	0.2	0.1	0.2	0.7	0.4	0.1	0.3	0.1	0.1	230.2	0.0	0.8	0.1	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.1	0.0	0.0	0.3	2.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.2	0.3	0.0	0.1	0.1	0.2	1.6	0.2	0.4	0.2	0.2	0.2	0.3	0.4	0.3	0.1	0.3	0.3	0.4	0.4	0.2	0.4	0.2	0.4	0.1	0.3	0.4	0.4	0.5	0.3	0.3	0.3	2.1	0.3	0.4	0.2	0.3	0.4	0.5	0.0	0.0	0.3	6.2	2.3	1.5	2.1	0.0	5.0	2.4	1.8	278.1	5.7	1.3	0.0	39.6	0.8	10.0	2.4	0.0	1.0	1.6	3.4	1.2	2.4	0.0	0.0	0.1	0.0	2.1	8.2	0.0	10.0	17.8	0.5	0.7	1.2	0.7	6.7	2.0	1.9	6.1	2.2	28.1	0.5	0.3	2.2	12.4	0.0	3.9	1.0	13.4	0.0	0.3	1.1	0.2	1.2	0.9	2.6	6.1	0.4	0.3	18.1	0.0	33.1	3.4	0.6	0.1	0.8	1.4	0.4	8.2	0.9	1.1	2.5
LOXL4	"FLJ21889, LOXC"	ENSG00000138131	"Lysyl oxidase like 4"	Q96JB6	10	98247690-98268194	"Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Basal respiratory cells: 141.0"	"Cancer enhanced"	"Detected in all"		"melanoma: 44.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"BJ hTERT+: 249.7;CAPAN-2: 301.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB033876, HPA037609"	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles		"CAB033876: AB_2135101, HPA037609: AB_2675579"	"unprognostic (9.91e-3)"	"unprognostic (3.97e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (7.71e-2)"	"unprognostic (1.75e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (9.57e-4)"	"unprognostic (2.51e-1)"	"unprognostic (4.97e-2)"	"unprognostic (5.25e-2)"	"unprognostic (5.77e-3)"	"unprognostic (1.28e-1)"	"unprognostic (6.10e-2)"	"unprognostic (7.40e-3)"	6.2	2.4	0.8	1.6	0.9	0.5	12.0	1.1	0.7	11.9	2.0	7.6	1.9	7.0	3.0	2.0	7.8	1.9	2.2	0.7	1.3	4.7	6.1	4.4	0.4	1.2	1.0	0.6	7.2	6.6	1.2	1.9	5.8	1.2	6.6	1.8	2.7	19.8	10.9	8.4	3.7	3.3	7.7	0.9	2.7	2.9	5.5	0.9	1.4	7.1	1.5	0.7	5.0	7.5	1.0	0.0	1.6	0.1	0.3	6.9	29.5	0.9	32.1	249.7	2.6	26.6	5.4	301.6	0.1	28.4	25.1	1.1	0.3	0.1	0.0	2.2	0.0	0.2	0.0	4.4	13.3	6.7	0.0	0.0	3.3	0.0	4.4	0.0	0.4	0.1	0.0	0.3	0.0	0.4	0.0	0.0	2.3	0.6	0.1	0.5	0.1	2.9	0.0	0.0	0.0	0.1	1.0	0.1	0.0	0.0	8.7	0.2	0.7	0.7	0.2	53.7	3.2	1.1	0.0	0.0	0.2	0.5	0.0	35.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.8	0.9	1.1	0.7	0.7	1.3	1.2	1.0	0.6	1.2	0.9	0.9	1.0	0.3	6.4	1.5	0.7	0.3	0.9	2.1	141.0	0.0	0.4	6.5	6.5	1.6	4.3	17.5	31.3	0.0	0.2	1.7	0.1	0.0	11.1	0.3	1.5	1.2	0.9	0.0	0.0	0.1	0.5	0.4	6.0	0.0	4.2	1.3	1.1	2.2	0.4	0.2	0.0	0.1	0.2	8.2	0.0	2.1	0.4	4.1	0.2	0.0	9.4	0.0	5.4	0.0	0.0	0.0	3.0	0.0	1.5	0.3	7.9	0.0	0.4	6.3	0.1	0.0	5.2	2.2	0.1	0.2	0.1	0.9	0.4	0.2	0.7	0.0	3.4
LPIN1	KIAA0188	ENSG00000134324	"Lipin 1"	Q14693	2	11677595-11827409	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Transcription, Transcription regulation"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 195.1;tongue: 138.5"	"Cell type enriched"	"Detected in all"	5	"Late spermatids: 1705.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024591, HPA038021"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA024591: , HPA038021: AB_10669514"	"unprognostic (1.97e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.87e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.69e-2)"	"unprognostic (8.20e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.45e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.25e-1)"	"unprognostic (9.60e-2)"	"unprognostic (4.02e-1)"	36.3	15.1	29.4	15.0	29.7	8.7	37.0	24.0	25.2	21.0	19.0	15.8	12.0	16.7	19.1	40.9	15.8	13.1	18.0	21.0	28.7	11.0	27.2	16.3	22.5	30.6	30.1	21.9	31.7	10.0	23.3	34.5	11.8	33.3	13.9	8.5	15.0	27.5	14.2	195.1	13.4	19.9	13.1	13.8	14.9	15.0	57.8	39.1	16.2	14.7	138.5	26.5	20.1	23.3	31.4	16.2	18.0	15.9	34.9	71.4	77.9	7.8	22.2	38.7	14.0	24.3	6.9	15.4	8.2	2.9	18.6	41.6	17.3	17.4	49.2	12.8	32.9	9.8	20.3	11.5	9.7	25.1	14.1	90.1	71.1	21.7	57.9	22.6	41.7	28.0	19.6	27.4	68.3	10.4	6.4	13.5	12.0	16.2	5.5	18.9	18.1	28.6	52.0	36.9	10.0	42.8	33.6	8.0	19.7	51.9	15.0	4.9	7.9	19.5	22.1	19.9	14.4	19.0	108.0	92.0	15.2	31.3	24.7	16.6	11.2	2.9	13.4	10.3	2.3	11.2	7.3	9.9	10.1	2.7	5.1	8.6	7.2	1.1	9.5	2.3	10.3	12.2	3.7	29.4	29.7	24.0	25.2	21.0	28.7	30.6	30.1	21.9	33.3	13.8	39.1	31.4	15.6	22.4	56.8	167.8	46.1	19.1	45.1	12.6	18.8	48.6	32.8	22.9	59.6	31.5	43.9	11.0	85.5	8.7	68.0	21.2	7.9	23.0	338.4	27.8	44.4	25.8	36.2	9.7	55.7	28.0	6.0	28.8	19.4	76.5	35.4	13.1	17.5	48.7	8.9	48.8	71.7	25.2	22.4	15.7	39.4	1705.8	119.0	25.5	17.8	21.5	15.4	14.7	66.9	41.7	43.5	36.5	29.7	179.8	76.0	34.9	5.4	4.8	52.0	49.0	32.9	32.4	18.4	20.6	19.7	5.5	11.9	12.3	73.2	26.6	16.3	31.3
LRAT	LCA14	ENSG00000121207	"Lecithin retinol acyltransferase"	O95237	4	154626945-154753120	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Sensory transduction, Vision"	"Acyltransferase, Transferase"	"Disease variant, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.6"	"Cell type enriched"	"Detected in many"	6	"Granulosa cells: 104.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.9"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	11	"NTERA-2: 15.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA070726			Uncertain	"Endoplasmic reticulum,Golgi apparatus"		NA	NA			"Golgi apparatus"	"Endoplasmic reticulum"	"HPA070726: "	"unprognostic (3.64e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.75e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.38e-1)"	"unprognostic (9.15e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.65e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.03e-4)"	"unprognostic (4.49e-6)"	"unprognostic (6.11e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.98e-1)"	0.3	0.2	1.0	0.2	0.8	0.6	0.4	0.9	2.6	0.2	1.5	0.3	1.2	0.1	0.3	0.0	0.2	0.5	0.0	0.8	1.8	0.1	2.2	0.3	0.1	1.2	1.1	0.7	0.3	0.8	0.2	0.2	0.1	1.8	0.4	0.1	1.0	0.1	0.5	0.8	0.4	1.6	0.1	0.8	0.1	0.3	0.9	0.9	0.0	1.5	0.0	0.1	0.1	0.1	1.1	0.5	0.4	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.3	0.2	0.2	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.3	15.3	0.0	0.0	0.0	0.0	0.1	1.4	0.4	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.3	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.6	1.9	0.1	0.1	0.6	0.1	0.1	0.1	0.1	1.5	0.2	0.1	0.1	0.8	0.2	0.2	0.2	0.1	2.2	1.0	0.8	0.9	2.6	0.8	1.8	1.2	1.1	0.7	1.8	0.8	0.9	1.1	0.2	0.0	4.4	4.6	0.1	1.1	4.4	4.0	0.6	0.5	8.6	9.1	0.3	11.5	1.7	0.0	0.0	0.1	0.3	0.8	3.9	1.2	15.2	0.9	0.5	0.3	0.0	0.0	2.2	0.8	0.1	1.5	2.0	2.2	0.0	104.4	1.4	2.2	0.1	0.0	0.6	0.9	2.0	0.8	2.8	3.2	0.0	0.3	5.4	0.0	0.0	3.9	0.0	1.0	2.2	1.2	0.0	0.0	0.0	2.4	12.3	1.0	0.9	0.8	0.0	1.4	8.1	10.5	4.7	1.4	1.1	0.3	0.6	0.0	1.2	0.6
LRIG1	"DKFZP586O1624, LIG-1, LIG1"	ENSG00000144749	"Leucine rich repeats and immunoglobulin like domains 1"	Q96JA1	3	66378797-66501263	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 145.6"	"Cell type enriched"	"Detected in many"	5	"Astrocytes: 331.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 79.7;hTEC/SVTERT24-B: 55.2;U-698: 59.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011846	Approved		Approved	Cytosol		NA	NA		78000	Cytosol		"HPA011846: AB_2668545"	"unprognostic (6.41e-2)"	"unprognostic (4.18e-2)"	"unprognostic (4.35e-3)"	"unprognostic (4.58e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.32e-1)"	"prognostic favorable (3.01e-5)"	"unprognostic (5.12e-1)"	"unprognostic (7.86e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.12e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (1.50e-4)"	31.3	1.8	29.5	17.2	24.3	4.0	27.5	15.6	21.1	30.1	2.2	29.6	17.0	22.1	3.0	13.6	27.0	21.0	37.4	21.0	24.2	3.7	11.3	17.7	8.0	24.2	36.7	11.0	17.3	145.6	5.3	6.6	4.7	21.7	25.0	14.8	5.0	19.4	7.3	37.6	11.8	13.5	30.8	13.2	4.0	36.9	12.6	40.6	3.5	16.4	33.2	9.7	6.0	5.2	18.8	1.4	1.3	27.6	0.5	7.6	4.8	2.8	4.9	26.6	4.6	14.0	23.6	0.3	79.7	13.1	2.2	6.1	0.0	5.5	10.0	10.1	0.0	16.8	0.0	4.1	2.0	1.8	0.7	16.7	6.0	5.4	55.2	9.0	18.8	24.3	0.3	0.3	0.0	1.0	3.6	0.0	0.1	22.8	2.3	0.0	14.1	8.7	3.7	5.1	0.0	3.9	1.0	4.6	4.1	0.2	4.6	25.6	6.7	8.2	13.9	6.3	27.9	12.9	6.2	3.2	59.5	24.3	0.0	5.0	0.0	0.0	0.3	0.1	0.0	0.6	0.1	0.4	0.4	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	1.1	0.1	29.5	24.3	15.6	21.1	21.0	24.2	24.2	36.7	11.0	21.7	13.2	40.6	18.8	12.5	38.5	50.2	331.1	4.3	11.3	7.8	8.0	14.2	2.1	51.9	35.8	32.0	11.5	25.0	0.0	8.4	0.2	5.8	9.6	1.9	5.6	1.6	29.1	9.7	9.2	26.5	0.0	10.6	17.1	0.1	17.1	19.9	58.8	1.3	14.9	6.4	20.7	2.0	8.4	15.6	26.2	12.2	1.9	7.7	2.1	11.5	2.4	10.6	57.1	1.7	39.8	0.0	37.7	58.3	6.0	10.2	17.3	8.7	15.6	5.7	1.2	33.7	6.8	0.0	65.5	19.9	1.6	20.0	8.9	11.5	0.1	15.2	2.1	22.8	5.0
LRRC3	"C21orf102, C21orf30, DKFZP434C128, LRRC3DN"	ENSG00000160233	"Leucine rich repeat containing 3"	Q9BY71	21	44455510-44462196	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 15.6"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 30.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	5	"hypothalamus: 5.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 8.7;U-2 OS: 6.3"	"Low region specificity"	"Detected in all"							HPA017975	Uncertain					NA	NA					"HPA017975: AB_1853307"	"unprognostic (1.36e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.49e-2)"	"unprognostic (2.10e-4)"	"unprognostic (1.55e-1)"	"unprognostic (1.74e-2)"	"unprognostic (7.20e-3)"	"unprognostic (2.59e-1)"	"unprognostic (4.61e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.74e-5)"	"unprognostic (6.44e-2)"	"unprognostic (2.01e-1)"	"unprognostic (7.51e-2)"	"unprognostic (6.66e-3)"	1.9	1.4	0.7	0.8	0.5	0.6	1.5	0.1	0.6	1.4	0.3	5.1	1.7	1.3	0.4	1.1	1.5	2.2	1.7	0.5	5.7	0.6	15.6	1.6	0.5	0.6	0.5	0.5	3.4	0.8	0.3	1.3	0.9	0.5	0.8	0.8	0.3	1.1	0.6	0.5	1.8	1.6	1.5	0.2	1.1	3.9	1.7	1.0	0.5	0.6	1.0	0.3	2.0	1.3	0.6	0.5	0.4	3.5	2.9	0.0	0.0	8.7	1.5	0.0	0.1	0.0	1.3	1.2	0.0	2.6	0.7	1.9	0.1	1.7	0.0	0.0	0.2	3.8	0.0	0.4	4.0	0.6	0.0	2.3	1.1	1.4	0.0	0.0	0.0	1.4	0.6	0.3	4.5	0.0	1.3	0.5	0.2	0.9	4.5	1.4	1.9	0.0	1.5	0.1	0.1	2.8	3.2	1.3	0.3	0.6	1.9	0.8	1.9	2.8	0.0	6.3	0.0	0.0	2.5	5.2	0.0	0.0	1.6	0.5	0.3	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.7	0.5	0.1	0.6	0.5	5.7	0.6	0.5	0.5	0.5	0.2	1.0	0.6	2.6	0.0	1.5	0.0	0.8	0.6	1.1	0.0	3.4	1.1	0.6	0.9	2.0	1.5	0.0	1.8	0.0	0.2	0.3	1.6	0.0	0.3	0.3	0.2	0.4	0.6	4.2	2.7	0.0	0.4	6.6	2.5	1.5	0.9	1.3	2.4	1.1	30.7	2.5	0.0	0.1	1.8	0.0	2.5	0.5	1.5	0.6	1.1	0.0	0.0	3.2	1.4	1.0	0.0	0.1	1.7	0.3	0.7	0.2	1.3	1.8	0.0	0.0	0.0	0.0	0.8	1.4	0.9	2.0	0.6	0.6	0.3	0.8	0.3	1.7	0.7
LRRC63	RP11-139H14.4	ENSG00000173988	"Leucine rich repeat containing 63"		13	46211940-46277366	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"brain: 10.2;testis: 3.4"	"Cell type enriched"	"Detected in some"	7	"Oligodendrocytes: 255.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 2.1;HDLM-2: 1.7;JURKAT: 3.0;Karpas-707: 1.6;U-87 MG: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA039318, HPA039763"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA039318: AB_10796224, HPA039763: AB_10795408"	"unprognostic (3.40e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.33e-1)"	"unprognostic (2.12e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.06e-2)"	"unprognostic (7.28e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.39e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.18e-6)"	"unprognostic (1.27e-1)"	"unprognostic (2.98e-1)"	"unprognostic (4.57e-2)"	"unprognostic (7.31e-2)"	0.1	0.3	2.1	0.1	4.6	0.3	0.1	4.9	3.4	0.2	1.0	0.1	0.0	0.0	2.4	0.0	1.1	0.1	0.1	1.8	3.0	0.1	0.1	0.4	0.2	6.7	4.1	1.4	0.0	0.0	0.1	0.0	0.1	5.8	0.5	0.0	2.4	0.3	0.1	0.0	0.0	0.0	0.1	5.9	0.1	0.1	3.4	4.3	1.3	0.0	0.1	0.1	0.0	0.0	10.2	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.1	0.4	0.7	0.6	0.0	2.1	0.0	0.2	0.0	0.1	1.7	0.5	0.7	0.0	0.0	0.1	0.4	1.1	0.4	0.0	0.2	0.0	0.0	0.0	3.0	0.0	1.6	0.0	0.0	1.0	0.3	0.1	0.0	0.2	0.2	0.0	0.2	0.3	0.0	0.5	0.6	0.0	0.0	0.7	0.8	0.0	0.5	0.3	0.2	0.1	0.0	0.3	0.6	1.3	0.1	2.0	1.0	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.5	0.1	0.1	2.1	4.6	4.9	3.4	1.8	3.0	6.7	4.1	1.4	5.8	5.9	4.3	10.2	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.1	0.0	0.0	0.0	6.2	0.0	0.1	0.0	0.0	0.0	34.1	3.1	0.1	0.1	0.0	1.3	0.9	0.0	0.1	0.0	0.0	0.1	1.3	0.1	0.0	0.0	0.5	0.0	5.2	0.0	0.0	0.8	0.3	8.4	0.0	0.2	0.0	1.9	0.0	0.1	0.0	4.0	255.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.4	2.8	0.0	0.0	0.2	3.8	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0
LRRN1	FIGLER3	ENSG00000175928	"Leucine rich repeat neuronal 1"	Q6UXK5	3	3799431-3849834	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.3"	"Cell type enriched"	"Detected in many"	6	"Oligodendrocyte precursor cells: 418.2"	"Cancer enhanced"	"Detected in many"		"glioma: 20.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 106.6;CAPAN-2: 37.9;HAP1: 32.3;NTERA-2: 62.7;SuSa: 104.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011071	Enhanced					NA	NA		2400000			"HPA011071: AB_1853355"	"unprognostic (1.27e-2)"	"unprognostic (4.87e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.30e-3)"	"unprognostic (2.01e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.34e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.86e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.75e-1)"	"unprognostic (7.25e-2)"	0.4	0.1	7.4	0.4	10.7	1.2	4.2	6.4	6.6	3.6	0.0	0.2	0.9	2.4	1.1	0.8	1.3	2.4	0.1	6.4	4.7	0.5	0.2	1.0	0.3	12.9	13.9	5.6	5.4	1.9	4.5	2.0	0.2	13.2	4.0	0.3	1.3	5.2	4.2	5.8	1.2	1.3	1.5	5.7	1.2	1.3	6.1	13.1	2.9	2.4	2.8	0.8	3.7	0.8	16.3	0.0	0.0	106.6	0.1	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	37.9	0.0	0.0	0.0	0.0	0.0	32.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	19.9	0.0	4.7	0.0	8.1	0.0	0.0	1.1	0.0	62.7	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	7.0	0.0	0.0	0.0	104.4	4.0	0.0	0.0	0.0	12.5	0.0	1.2	11.1	23.3	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	7.4	10.7	6.4	6.6	6.4	4.7	12.9	13.9	5.6	13.2	5.7	13.1	16.3	0.4	3.2	0.0	63.0	3.5	2.2	1.8	8.7	1.8	3.0	7.6	13.3	0.4	10.0	6.6	0.0	0.0	0.1	0.7	0.4	0.0	1.6	3.2	0.5	1.5	1.0	0.0	0.4	52.7	2.2	0.2	3.0	2.0	1.2	2.5	1.1	0.0	0.0	0.1	0.0	48.1	1.0	0.0	0.0	0.8	1.1	2.5	0.3	1.8	1.9	0.0	3.4	1.0	418.2	5.3	9.9	2.5	0.7	2.9	2.4	0.3	0.7	3.0	0.5	0.0	14.9	0.9	0.0	0.9	0.5	0.3	0.0	0.6	0.1	1.4	1.0
LSMEM2	"C3orf45, FLJ38608"	ENSG00000179564	"Leucine rich single-pass membrane protein 2"	Q8N112	3	50279087-50288114	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 24.1;skeletal muscle: 16.7"	"Cell type enriched"	"Detected in some"	6	"Late spermatids: 283.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA079523			Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA079523: "	"unprognostic (2.84e-3)"	"unprognostic (6.54e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.30e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.48e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.71e-1)"	0.4	0.4	2.9	0.1	4.5	0.4	0.3	2.9	3.7	1.2	1.7	0.4	0.3	0.7	0.2	0.5	0.7	0.2	24.1	2.9	2.9	0.5	0.2	0.4	0.0	3.5	3.7	2.5	1.2	0.2	0.0	0.1	0.1	3.5	0.4	0.1	0.3	0.2	0.4	16.7	0.2	0.3	0.4	2.8	0.2	0.3	3.9	3.3	0.0	0.2	5.5	0.0	0.4	0.8	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.1	0.1	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	4.5	2.9	3.7	2.9	2.9	3.5	3.7	2.5	3.5	2.8	3.3	6.0	1.0	0.0	0.6	0.7	0.3	1.0	0.2	0.2	0.0	0.2	1.5	0.9	4.4	0.0	0.8	1.8	0.0	0.1	0.3	0.9	0.0	0.1	40.5	3.3	0.6	0.8	0.0	0.0	0.2	0.2	0.1	0.4	0.0	10.1	5.1	0.2	0.0	0.3	0.1	0.0	0.2	0.3	0.0	0.3	0.4	283.1	1.2	0.3	1.8	0.0	0.0	0.5	0.0	0.0	2.8	0.2	0.0	0.7	0.0	0.4	1.5	0.1	0.2	0.2	0.0	1.4	4.7	1.8	1.1	0.4	1.3	0.1	0.2	0.1	0.7	0.1
LTC4S	MGC33147	ENSG00000213316	"Leukotriene C4 synthase"	Q16873	5	179793980-179796647	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Leukotriene biosynthesis, Lipid biosynthesis, Lipid metabolism"	"Lyase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"granulocytes: 327.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 20.2;eosinophil: 63.1"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 63.1"	"Cell line enriched"	"Detected in some"	11	"HMC-1: 102.0"					"Low region specificity"	"Detected in many"			HPA044688			Approved	"Nucleoplasm,Endoplasmic reticulum,Cytosol"		NA	NA			Nucleoplasm	"Endoplasmic reticulum, Cytosol"	"HPA044688: "	"unprognostic (8.94e-2)"	"unprognostic (2.40e-2)"			"unprognostic (9.35e-3)"		"unprognostic (3.57e-2)"	"unprognostic (1.24e-2)"		"unprognostic (9.40e-2)"	"unprognostic (4.53e-5)"	"unprognostic (2.27e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.98e-2)"	"unprognostic (4.62e-1)"	7.1	6.9	0.8	0.5	0.9	2.3	5.6	1.4	1.5	4.0	1.8	3.2	0.7	5.7	0.0	3.1	11.9	0.3	9.3	0.8	1.5	7.1	1.9	7.8	0.2	1.8	1.4	0.2	5.8	2.0	0.2	3.6	0.4	2.0	4.8	0.2	0.0	4.3	0.8	1.0	2.9	3.3	0.4	2.7	6.1	3.0	1.5	1.7	0.0	5.9	0.0	0.1	4.8	4.1	3.8	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.9	8.9	0.2	0.4	0.3	0.6	102.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.1	6.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	3.2	0.5	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.3	1.0	0.1	20.2	0.5	63.1	0.8	0.6	3.0	0.3	2.1	1.5	8.6	0.2	0.4	1.0	0.3	4.7	0.0	0.4	0.2	0.6	0.8	0.9	1.4	1.5	0.8	1.5	1.8	1.4	0.2	2.0	2.7	1.7	3.8	32.3	0.0	3.2	2.9	2.3	9.9	9.6	11.2	14.8	0.4	26.4	38.6	0.0	14.3	6.2	14.7	0.0	10.4	5.0	0.6	1.9	5.9	0.3	4.0	1.5	49.5	3.0	2.1	0.8	2.4	1.9	8.3	3.1	5.6	327.4	0.5	72.1	0.9	41.5	0.0	0.7	1.7	0.0	20.8	46.3	0.9	16.4	53.9	1.8	28.1	2.0	0.1	2.1	1.0	1.5	1.9	0.5	47.4	10.0	3.7	2.2	54.8	5.8	0.5	0.0	0.8	1.6	0.1	0.7	5.2	7.0	3.0	10.0	1.5	3.1	10.0
LY6G6F	"C6orf21, G6f, LY6G6D, NG32"	ENSG00000204424	"Lymphocyte antigen 6 family member G6F"	Q5SQ64	6	31706866-31710679	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 3.8;lymphoid tissue: 1.2;skin 1: 1.3"	"Cell type enriched"	"Detected in some"	9	"Macrophages: 9.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	5	"neutrophil: 2.6"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.6"	"Cell line enriched"	"Detected in single"	379	"HEL: 37.8"	"Low region specificity"	"Detected in many"							HPA008053	Uncertain					NA	NA		380000			"HPA008053: AB_1840160"			"unprognostic (3.77e-1)"							"unprognostic (7.01e-2)"						"unprognostic (2.66e-3)"		0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.2	0.0	0.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	2.6	0.0	0.0	0.5	0.0	17.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	9.1	0.0	0.0	0.2	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
LYG1	SALW1939	ENSG00000144214	"Lysozyme g1"	Q8N1E2	2	99284238-99304742	"Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 23.6"	"Cell type enriched"	"Detected in some"	7	"Proximal tubular cells: 161.4"	"Cancer enriched"	"Detected in many"	15	"renal cancer: 31.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"												"Secreted in other tissues"	NA	NA						"unprognostic (1.53e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.53e-2)"	"unprognostic (3.73e-1)"	"unprognostic (9.74e-2)"	"unprognostic (3.76e-4)"	"unprognostic (6.94e-4)"	"unprognostic (2.58e-2)"	"unprognostic (4.72e-2)"	"unprognostic (9.74e-3)"	"unprognostic (5.01e-2)"	"unprognostic (1.06e-2)"	"prognostic favorable (8.44e-4)"	"unprognostic (1.31e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.31e-3)"	1.6	1.6	3.4	1.2	3.6	0.9	2.1	6.3	4.4	3.5	2.2	2.2	1.3	2.3	1.8	1.3	2.3	0.8	1.8	3.3	3.0	23.6	5.9	1.9	1.7	3.5	3.3	3.3	2.4	1.7	0.2	2.0	0.7	4.0	3.3	1.1	2.6	1.7	0.7	2.2	1.6	2.8	0.9	2.9	4.8	1.7	5.6	3.4	2.5	2.6	0.4	1.3	2.5	2.3	4.4	0.3	2.3	1.7	2.8	3.9	2.2	1.9	0.9	1.0	0.9	1.5	0.4	2.0	0.5	1.5	0.4	0.2	1.0	2.3	0.3	1.1	1.6	1.4	1.3	2.0	0.7	0.7	0.4	3.1	1.8	2.4	1.4	0.6	2.0	0.5	3.0	0.7	1.5	1.0	0.5	1.2	4.0	0.4	1.2	2.1	2.9	1.0	0.8	3.9	0.9	1.0	0.6	0.3	0.7	0.6	2.0	0.3	0.4	1.3	1.2	1.4	2.0	1.0	1.7	1.0	0.3	0.3	2.4	0.5	0.0	0.1	0.2	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.5	0.1	3.4	3.6	6.3	4.4	3.3	3.0	3.5	3.3	3.3	4.0	2.9	3.4	4.4	0.6	0.0	0.0	3.6	1.5	0.0	0.2	0.6	0.0	1.0	0.8	0.8	0.5	1.5	1.5	1.8	2.1	0.3	0.5	0.5	21.5	0.7	10.8	0.2	0.3	0.5	0.0	0.0	4.6	0.2	0.2	0.4	0.0	0.2	4.5	0.8	1.1	0.5	0.3	0.0	4.2	0.3	0.0	0.3	0.3	4.8	0.3	1.4	0.0	2.8	0.8	0.2	0.0	2.0	5.6	0.6	0.1	0.4	0.0	0.6	0.2	161.4	0.2	0.6	0.0	0.1	0.5	2.4	1.1	0.0	0.0	0.5	0.6	0.3	0.4	0.2
LYNX1-SLURP2		ENSG00000284505	"LYNX1-SLURP2 readthrough"		8	142764334-142778224	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"esophagus: 6.3"	"Cell type enriched"	"Detected in single"	12	"Pancreatic endocrine cells: 10.1"					"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.4"	"Lineage enriched"	"Detected in single"	8	"monocytes: 1.4"	"Cell line enhanced"	"Detected in single"		"BJ: 1.0"														"Intracellular and membrane"	NA	NA																							1.5	1.0	0.4	0.2	0.3	0.0	0.5	1.0	2.3	1.5	0.1	4.8	0.3	2.0	0.4	6.3	1.4	0.3	1.3	0.6	0.0	0.3	0.9	0.4	0.1	1.0	0.2	0.2	0.6	0.2	0.5	1.0	0.1	1.3	1.8	0.2	0.2	0.7	1.7	0.8	3.4	1.0	0.4	0.3	0.3	2.3	0.6	0.6	0.0	0.4	0.2	0.3	3.8	2.5	1.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.4	0.3	1.0	2.3	0.6	0.0	1.0	0.2	0.2	1.3	0.3	0.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAB21L4	"C2orf54, FLJ22671"	ENSG00000172478	"Mab-21 like 4"	Q08AI8	2	240886048-240896889	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 264.7;vagina: 81.1"	"Cell type enriched"	"Detected in single"	7	"Cytotrophoblasts: 2.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"CACO-2: 45.9;HaCaT: 34.3;SK-BR-3: 117.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052722			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA052722: "	"unprognostic (5.86e-3)"	"unprognostic (4.17e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (2.77e-4)"		"unprognostic (1.43e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.08e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.05e-1)"	0.2	0.1	0.4	1.0	0.6	0.0	1.8	0.6	1.4	17.5	0.0	3.0	11.6	0.2	0.1	264.7	0.9	0.5	0.1	0.9	0.2	13.2	13.1	10.1	0.3	0.4	0.0	0.5	0.1	1.2	0.0	0.2	0.8	0.7	1.5	2.5	0.3	29.4	0.2	0.3	59.5	5.0	0.1	0.0	0.2	5.8	0.3	0.2	1.1	0.1	0.0	23.7	2.0	81.1	0.3	0.5	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	45.9	2.7	0.3	0.3	0.0	0.0	34.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	6.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.0	5.7	0.1	0.1	0.2	7.3	0.0	0.1	0.0	11.4	0.3	5.9	2.3	0.0	0.0	117.0	0.0	0.2	0.9	0.7	0.0	0.0	1.2	0.1	0.0	0.6	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.4	0.6	0.6	1.4	0.9	0.2	0.4	0.0	0.5	0.7	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
MACIR	"C5orf30, FLJ25291"	ENSG00000181751	"Macrophage immunometabolism regulator"	Q96GV9	5	103258763-103278660	"Predicted intracellular proteins"	"Cilium biogenesis/degradation, Inflammatory response, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 36.5"	"Cell type enriched"	"Detected in some"	4	"Extravillous trophoblasts: 103.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"basophil: 37.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 37.6"	"Cell line enhanced"	"Detected in many"		"BJ: 177.1;fHDF/TERT166: 108.5;U-138 MG: 115.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043434	Uncertain					NA	NA					"HPA043434: AB_2678480"	"unprognostic (1.18e-1)"	"unprognostic (1.49e-1)"	"unprognostic (6.59e-3)"	"prognostic unfavorable (2.66e-4)"	"unprognostic (1.85e-1)"	"unprognostic (2.69e-1)"	"prognostic unfavorable (1.78e-5)"	"unprognostic (1.15e-1)"	"unprognostic (3.85e-2)"	"unprognostic (8.76e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.29e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.83e-2)"	7.8	4.2	26.0	4.4	27.3	31.7	10.0	25.1	33.3	3.5	20.7	22.8	9.6	2.2	3.1	4.8	6.1	8.2	4.0	26.9	24.9	5.8	1.0	3.8	2.7	25.8	27.1	27.1	4.7	8.0	11.3	4.1	7.7	26.5	6.6	21.9	20.9	3.2	5.0	8.5	5.9	11.8	3.4	25.1	4.4	13.3	5.9	27.6	4.1	5.2	3.5	2.6	2.9	2.7	36.5	10.6	22.2	21.8	12.9	12.0	14.2	13.9	177.1	50.1	21.4	19.5	1.4	23.2	0.1	17.1	108.5	12.6	12.2	12.6	15.1	33.5	30.1	20.6	18.0	28.3	7.1	6.1	9.1	11.4	10.9	19.5	8.7	17.1	38.3	12.8	13.2	9.1	24.2	24.8	13.5	5.2	13.2	14.9	5.7	13.6	26.4	14.5	38.7	9.2	10.1	23.0	21.2	6.3	11.7	45.2	15.4	24.3	10.3	33.6	115.6	9.5	24.8	29.9	13.6	22.6	19.6	14.5	5.1	45.7	37.6	3.6	6.2	3.4	3.2	2.9	4.1	2.8	3.6	3.5	2.0	2.5	2.4	3.2	7.3	3.7	2.0	7.3	3.0	26.0	27.3	25.1	33.3	26.9	24.9	25.8	27.1	27.1	26.5	25.1	27.6	36.5	2.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	22.5	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	103.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	21.5	0.5	0.0	0.0	0.0
MAGEB18	MGC33889	ENSG00000176774	"MAGE family member B18"	Q96M61	X	26138343-26140736	"Predicted intracellular proteins"	"Ubl conjugation pathway"	"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"Spermatocytes: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	28	"Karpas-707: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA046141	Enhanced					NA	NA					"HPA046141: AB_2679554"															"unprognostic (1.66e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAGED2	"11B6, BCG1, HCA10, JCL-1, MAGE-D2, MAGED, MGC8386"	ENSG00000102316	"MAGE family member D2"	Q9UNF1	X	54807599-54816015	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Tumor antigen"	"Bartter syndrome, Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"Granulosa cells: 1684.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA031572, HPA031573"	Approved		Enhanced	Nucleoplasm,Nucleoli,Cytosol		No	No		120000	"Nucleoplasm, Nucleoli, Cytosol"		"HPA031572: AB_10599819, HPA031573: AB_10602181"	"unprognostic (1.33e-1)"	"unprognostic (8.60e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.79e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.41e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.97e-1)"	"prognostic favorable (2.88e-4)"	"prognostic favorable (2.82e-4)"	"unprognostic (6.34e-2)"	"unprognostic (3.55e-3)"	"prognostic unfavorable (9.43e-4)"	"unprognostic (1.58e-1)"	"unprognostic (9.77e-2)"	"unprognostic (3.58e-1)"	79.1	126.3	97.5	53.3	90.3	32.1	164.2	98.2	113.1	176.0	103.7	89.4	54.8	135.5	102.8	68.0	150.3	95.1	143.5	89.0	106.1	135.0	58.0	86.6	48.4	112.3	99.6	89.5	258.2	76.1	149.3	196.8	178.6	121.8	210.6	54.0	75.1	104.2	171.5	89.6	57.1	63.0	141.8	96.7	61.3	78.3	63.6	101.2	69.4	150.6	92.2	46.6	112.7	96.5	113.9	34.0	61.4	373.7	111.0	171.6	229.5	66.8	137.9	243.7	106.4	187.5	62.3	84.4	47.1	361.2	279.0	88.5	45.2	106.5	104.2	76.1	84.5	87.0	100.0	68.6	122.1	145.5	25.4	71.8	310.4	43.0	109.3	55.5	223.6	209.9	55.2	24.5	55.7	207.6	94.0	57.0	41.9	134.7	59.1	72.4	37.4	132.9	68.2	148.5	25.3	56.6	149.5	54.7	62.4	330.6	437.5	263.1	42.9	185.0	90.4	141.3	135.9	39.5	35.7	32.7	34.5	132.0	66.7	477.6	178.5	31.9	132.1	119.1	80.0	91.7	59.2	98.1	112.1	41.1	63.9	97.3	112.0	11.8	108.6	140.8	25.8	108.9	127.4	97.5	90.3	98.2	113.1	89.0	106.1	112.3	99.6	89.5	121.8	96.7	101.2	113.9	77.9	44.8	42.8	17.6	37.4	42.4	96.4	198.6	43.3	69.8	123.3	97.8	60.5	44.3	175.4	77.3	29.2	231.5	36.9	11.9	246.5	107.4	3.4	42.4	96.8	116.4	58.3	10.3	12.9	53.7	133.7	151.7	20.9	57.1	102.1	1684.0	79.9	16.2	69.1	138.0	20.3	48.8	173.0	19.5	47.4	17.4	233.3	41.1	158.3	21.5	42.1	175.9	44.3	17.6	20.4	47.9	33.7	320.4	46.7	75.2	25.5	149.3	119.9	66.0	157.8	77.7	236.3	12.8	13.7	15.3	34.9	169.2	51.4	58.6	25.3	76.6
MAN2A1	"GOLIM7, MANA2"	ENSG00000112893	"Mannosidase alpha class 2A member 1"	Q16706	5	109689927-109869625	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 107.9"	"Cell type enriched"	"Detected in many"	9	"Oligodendrocytes: 2117.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022377, HPA026896"	Enhanced		Supported	"Golgi apparatus"		NA	NA		110000000	"Golgi apparatus"		"CAB022377: , HPA026896: AB_1853512"	"unprognostic (1.62e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.25e-2)"	"unprognostic (6.96e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.80e-2)"	"unprognostic (4.20e-2)"	"unprognostic (3.91e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.77e-3)"	"unprognostic (2.03e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.11e-3)"	"unprognostic (5.31e-3)"	11.3	17.1	33.2	14.0	57.4	12.8	11.4	38.6	29.2	13.9	2.9	20.9	30.4	12.1	4.3	8.6	9.1	18.2	3.8	18.3	29.7	17.6	42.8	10.2	15.9	54.5	47.9	8.9	9.8	22.4	20.9	0.9	15.5	64.2	9.2	21.0	1.7	6.6	10.2	6.0	7.5	26.0	18.5	46.1	14.2	15.8	9.6	44.1	22.9	14.9	11.6	14.8	16.3	2.7	107.9	23.1	18.6	26.5	11.0	56.2	42.2	97.5	49.3	78.0	26.1	46.7	23.2	37.0	17.4	30.7	63.3	18.5	26.5	14.5	56.0	59.7	16.3	9.7	32.6	13.5	30.7	34.6	15.9	15.5	39.7	25.0	43.4	61.4	37.3	54.5	16.9	8.8	87.0	70.5	13.8	27.6	9.1	20.4	17.9	7.3	10.8	40.0	78.5	34.1	32.8	3.7	3.3	22.6	24.9	16.1	29.1	20.5	17.1	56.4	53.7	21.3	30.1	32.9	48.7	58.7	13.6	41.8	22.4	30.3	4.1	2.0	0.6	1.6	2.8	1.3	1.9	2.8	2.8	1.8	1.6	3.3	2.7	1.6	0.5	4.4	2.0	2.8	1.1	33.2	57.4	38.6	29.2	18.3	29.7	54.5	47.9	8.9	64.2	46.1	44.1	107.9	20.9	6.4	8.4	100.9	41.1	17.8	15.8	12.7	29.6	0.6	20.0	9.5	7.6	34.3	14.7	31.3	0.0	19.4	28.9	65.8	1.9	27.1	13.7	10.2	35.8	21.6	24.7	29.2	220.8	35.3	98.0	32.3	45.3	33.3	15.2	19.2	36.8	130.3	18.0	0.0	115.2	35.2	22.4	74.8	24.6	8.3	9.9	47.4	26.6	102.1	39.6	5.9	13.4	46.8	2117.7	28.8	28.4	6.8	84.0	39.8	60.6	24.7	12.1	0.2	19.7	52.6	16.5	16.5	19.9	33.6	23.7	23.7	34.7	14.2	49.6	24.2
MAP6D1	"FLJ12748, SL21"	ENSG00000180834	"MAP6 domain containing 1"	Q9H9H5	3	183815922-183825594	"Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 112.7;choroid plexus: 36.3;skeletal muscle: 27.2"	"Cell type enriched"	"Detected in some"	13	"Oligodendrocytes: 101.3"	"Cancer enhanced"	"Detected in many"		"glioma: 9.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	4	"T-47d: 63.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037991	Enhanced	Supported	Approved	Cytosol		NA	NA			Cytosol		"HPA037991: AB_10672503"	"unprognostic (9.23e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.28e-2)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (8.81e-12)"	"unprognostic (1.08e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.86e-1)"	"unprognostic (5.72e-2)"	0.8	1.0	49.8	0.3	72.6	0.2	0.9	68.0	72.0	1.1	36.3	1.1	0.7	1.0	0.9	1.4	1.1	0.4	1.5	51.1	61.1	0.8	1.2	0.7	0.7	77.5	71.5	47.6	1.1	4.8	0.5	2.2	0.3	78.2	3.4	0.3	1.0	1.2	0.7	27.2	3.6	1.0	0.4	67.8	1.3	0.7	1.4	66.7	3.7	1.0	14.4	0.4	1.0	1.2	112.7	3.5	2.1	3.6	0.7	0.9	1.2	2.8	4.2	0.8	7.3	5.3	2.5	0.1	0.3	5.4	6.1	3.6	2.7	6.9	1.6	4.5	2.3	11.8	0.5	0.0	0.0	2.3	4.5	1.5	0.5	0.6	1.7	0.8	0.4	1.7	5.5	0.5	0.0	0.7	14.8	10.0	5.8	2.2	2.0	6.7	5.0	5.7	0.0	0.4	0.0	11.7	2.1	2.9	2.2	4.4	2.5	63.9	4.2	0.8	1.8	2.5	2.7	6.1	2.4	1.6	1.4	0.6	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	49.8	72.6	68.0	72.0	51.1	61.1	77.5	71.5	47.6	78.2	67.8	66.7	112.7	0.0	0.0	0.0	4.9	0.1	1.1	0.7	0.9	0.6	2.5	0.0	0.0	2.4	0.0	0.4	0.0	2.1	0.3	0.0	0.9	0.0	0.0	3.4	0.0	0.0	0.3	2.4	0.4	7.4	0.0	0.5	0.4	1.1	0.0	0.0	0.0	0.7	0.4	0.9	1.7	3.5	0.4	4.1	0.0	0.7	2.2	0.9	0.3	0.0	0.0	0.5	0.8	1.0	7.1	101.3	0.0	0.1	0.0	0.2	2.4	0.2	0.0	0.3	1.9	0.0	1.6	0.4	2.9	2.1	1.0	1.4	0.7	0.3	0.0	0.3	0.7
MAP7	E-MAP-115	ENSG00000135525	"Microtubule associated protein 7"	Q14244	6	136342281-136550819	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 134.8"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 1501.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 12.2"	"Group enriched"	"Detected in many"	4	"dendritic cells: 5.7;granulocytes: 12.2;monocytes: 3.1"	"Cell line enhanced"	"Detected in many"		"CACO-2: 59.8;HeLa: 69.2;MCF7: 88.5;OE19: 55.3;RT4: 68.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029712, HPA029713"	Enhanced		Supported	Microtubules,Cytosol		NA	NA			Cytosol	Microtubules	"HPA029712: AB_10600303, HPA029713: AB_10601339"	"unprognostic (8.68e-3)"	"prognostic unfavorable (9.70e-5)"	"unprognostic (2.33e-3)"	"unprognostic (4.35e-3)"	"unprognostic (6.95e-2)"	"unprognostic (3.35e-1)"	"prognostic favorable (9.22e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.61e-2)"	"unprognostic (3.33e-1)"	"prognostic favorable (5.07e-7)"	"unprognostic (1.62e-3)"	"unprognostic (7.84e-2)"	"unprognostic (3.62e-1)"	"unprognostic (6.51e-2)"	2.7	8.5	42.0	4.9	78.4	4.9	13.2	52.8	62.4	6.1	1.1	24.8	29.2	2.4	19.6	15.9	10.0	8.3	1.4	42.0	45.3	32.9	17.4	7.1	1.5	71.1	70.5	25.4	1.5	25.4	25.1	12.1	6.9	79.6	20.1	23.4	57.8	20.4	6.5	0.8	17.3	26.9	2.4	59.1	1.8	18.9	27.6	65.7	5.1	16.3	0.2	5.1	12.1	9.7	134.8	25.6	39.2	0.3	0.1	0.2	0.2	40.4	0.7	1.2	0.4	0.7	59.8	26.3	0.1	5.3	0.8	6.7	38.2	11.1	34.6	0.7	0.2	24.6	26.6	69.2	0.5	0.3	26.1	3.0	0.1	31.5	0.2	2.4	1.0	0.2	2.0	18.4	0.6	0.1	88.5	0.2	2.6	5.2	55.3	5.7	0.1	1.0	4.8	23.6	68.4	24.4	5.2	27.4	51.7	0.6	9.1	20.5	2.6	0.5	0.1	1.9	0.4	1.7	4.6	6.4	0.2	0.5	10.1	0.7	2.8	2.3	0.0	0.0	1.6	0.3	1.4	0.5	0.0	5.7	1.6	0.1	0.0	12.2	0.7	3.1	0.0	0.2	0.7	42.0	78.4	52.8	62.4	42.0	45.3	71.1	70.5	25.4	79.6	59.1	65.7	134.8	4.0	57.7	51.4	117.2	1.9	28.2	48.7	21.7	33.6	367.0	29.5	18.4	3.0	28.6	42.9	18.4	146.0	33.1	0.7	67.9	31.3	35.8	293.9	30.4	5.9	4.9	117.7	35.1	217.1	49.0	23.1	4.4	42.8	60.8	0.0	1.2	0.7	37.0	16.3	304.5	258.6	81.5	22.4	3.2	8.5	53.1	6.8	6.2	17.8	15.0	3.2	50.9	0.0	26.2	1501.2	37.2	51.9	3.4	4.4	56.6	60.7	81.8	56.0	104.7	19.7	2.0	5.2	37.5	23.4	49.0	30.4	76.2	3.4	2.8	64.2	62.8
MARCHF8	"c-MIR, CMIR, MARCH-VIII, MARCH8, MIR, RNF178"	ENSG00000165406	"Membrane associated ring-CH-type finger 8"	Q5T0T0	10	45454585-45594906	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"Cardiomyocytes: 26.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014597	Approved					NA	NA					"HPA014597: AB_1853580"	"unprognostic (1.38e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.04e-1)"	"prognostic favorable (2.71e-4)"	"unprognostic (1.28e-1)"	"prognostic favorable (6.64e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.12e-2)"	14.4	19.4	10.9	12.5	16.4	49.5	17.0	18.1	10.5	13.9	11.4	21.5	14.4	14.5	10.5	10.7	15.4	13.5	20.7	9.3	13.6	15.7	17.0	15.1	17.0	16.6	13.3	7.5	19.7	26.7	19.9	16.2	12.4	15.2	11.6	18.5	18.3	14.9	15.4	14.9	10.0	22.6	13.9	15.5	18.9	14.5	57.6	14.4	18.0	16.5	15.6	20.5	11.5	9.1	25.9	16.6	16.4	13.7	12.4	19.4	24.2	10.1	7.5	35.0	13.6	14.8	4.2	16.8	23.8	12.6	21.9	12.3	3.0	15.2	12.4	12.6	36.3	16.7	9.2	7.4	10.0	13.6	11.3	39.1	19.8	16.3	6.8	17.9	13.4	22.5	22.4	26.5	23.2	10.5	5.8	11.5	7.1	4.5	2.4	5.3	12.7	13.7	7.0	10.2	9.5	12.2	17.0	14.7	3.5	14.0	13.3	21.2	5.2	15.1	10.6	13.6	15.6	12.0	39.8	34.2	10.5	21.0	15.5	2.9	13.9	1.1	10.8	3.0	1.9	4.5	3.5	3.4	3.3	1.6	5.4	2.5	3.2	14.1	8.5	0.9	1.6	3.6	2.5	10.9	16.4	18.1	10.5	9.3	13.6	16.6	13.3	7.5	15.2	15.5	14.4	25.9	6.1	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.6	0.0	0.0	0.0	0.0	2.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	1.7	2.8	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	1.6	1.3	0.0	0.0	0.0
MARCO	"SCARA2, SR-A6"	ENSG00000019169	"Macrophage receptor with collagenous structure"	Q9UEW3	2	118942194-118994660	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 95.7;lung: 201.4;lymphoid tissue: 88.7"	"Cell type enriched"	"Detected in many"	6	"Kupffer cells: 1269.8"	"Cancer enhanced"	"Detected in many"		"lung cancer: 21.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"classical monocyte: 33.7;intermediate monocyte: 56.5"	"Lineage enriched"	"Detected in many"	5	"monocytes: 56.5"	"Cell line enhanced"	"Detected in some"		"HaCaT: 1.7;THP-1: 2.5;U-2 OS: 2.6;U-266/70: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA063793	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA		30000000	"Golgi apparatus"	Vesicles	"HPA063793: AB_2685123"	"unprognostic (1.30e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.96e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.83e-1)"	"unprognostic (6.27e-3)"	"unprognostic (5.13e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.55e-2)"	65.3	31.3	0.7	88.7	0.9	3.5	7.5	0.7	5.2	0.5	9.5	5.3	2.0	0.7	1.3	2.5	25.7	2.5	11.2	0.7	6.1	1.6	95.7	201.4	17.9	1.1	1.5	0.4	7.6	0.8	0.3	1.5	2.8	0.8	1.8	2.1	0.0	4.5	2.4	1.5	2.3	3.1	30.1	1.1	37.4	3.5	2.1	9.5	1.4	1.5	5.0	1.1	25.5	1.2	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.0	0.0	2.6	0.4	0.0	1.6	0.0	0.0	0.0	0.5	0.0	0.0	33.7	0.0	0.0	56.5	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.7	0.0	7.2	1.0	0.0	9.2	0.7	0.9	0.7	5.2	0.7	6.1	1.1	1.5	0.4	0.8	1.1	9.5	3.1	0.7	25.6	45.1	0.0	1.0	1.1	0.1	0.0	0.0	0.0	3.4	1.8	0.4	1.5	16.7	3.7	0.0	0.7	1.4	0.1	0.0	3.9	0.0	0.0	0.0	5.2	0.0	8.0	0.0	0.2	1.1	2.6	0.0	0.0	12.6	0.0	11.4	3.4	169.6	0.0	0.0	0.0	0.0	1269.8	46.4	0.1	0.0	199.3	0.0	2.8	23.2	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.5	0.1	0.0	0.2	13.1	0.0	0.0	0.5	0.2	0.0	0.3	0.0	0.9	1.9	4.1	0.0	0.0	0.1
MAS1L	"dJ994E9.2, MAS-L, MRG"	ENSG00000204687	"MAS1 proto-oncogene like, G protein-coupled receptor"	P35410	6	29486697-29487956	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"cervix: 3.2;epididymis: 1.9"	"Cell type enriched"	"Detected in single"	62	"granulocytes: 6.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA017983	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA017983: AB_1849332"	"unprognostic (3.66e-2)"										"unprognostic (2.51e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.65e-1)"				0.3	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	3.2	0.0	0.7	0.3	0.7	1.9	1.1	0.2	0.7	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.3	0.2	0.0	0.3	0.7	0.6	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.6	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MC5R		ENSG00000176136	"Melanocortin 5 receptor"	P33032	18	13824149-13827323	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 2.4;lymphoid tissue: 1.0"	"Cell type enriched"	"Detected in single"	17	"Squamous epithelial cells: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-138 MG: 1.8"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA042365, HPA058088"	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA042365: AB_2677961, HPA058088: "	"unprognostic (1.57e-2)"				"unprognostic (1.37e-1)"			"unprognostic (8.77e-2)"	"unprognostic (7.10e-2)"		"unprognostic (2.64e-2)"	"unprognostic (1.30e-2)"		"unprognostic (9.04e-3)"	"unprognostic (1.54e-1)"			0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	2.4	0.5	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.2	1.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.2	0.2	0.1	0.1	0.2	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0
MDC1	"Em:AB023051.5, KIAA0170, NFBD1"	ENSG00000137337	"Mediator of DNA damage checkpoint 1"	Q14676	6	30699807-30717447	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Spermatocytes: 74.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"NK-cell: 3.2"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 3.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006915	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Focal adhesion sites"		No	No			"Nucleoplasm, Nuclear bodies"	"Focal adhesion sites"	"HPA006915: AB_1853669"	"unprognostic (8.52e-2)"	"unprognostic (4.32e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.09e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.99e-1)"	"unprognostic (4.39e-3)"	"unprognostic (3.23e-1)"	9.9	7.1	2.5	8.6	3.0	13.1	11.0	4.0	5.6	12.1	2.8	10.1	5.0	13.8	8.6	6.3	12.4	4.6	9.1	2.3	3.2	8.2	9.8	9.5	10.3	4.3	3.2	1.6	17.0	10.9	8.6	12.9	7.5	4.0	10.2	6.9	14.2	9.2	8.2	11.0	9.1	11.0	9.0	1.8	11.3	8.5	28.4	3.1	14.6	16.5	5.9	11.4	10.8	9.3	4.5	36.7	11.1	47.4	34.8	6.3	10.0	23.0	14.8	10.0	25.2	21.3	22.7	8.5	37.7	17.5	17.0	23.5	20.2	63.0	28.6	34.9	29.9	65.6	43.4	28.7	12.5	4.1	27.1	16.9	7.9	9.2	48.6	27.3	9.0	11.5	25.7	61.0	36.7	19.1	14.7	14.6	20.0	20.6	8.4	7.8	33.2	24.7	37.4	11.0	10.7	39.9	23.2	11.5	26.2	13.5	29.1	21.8	16.8	13.8	24.8	26.4	19.2	26.3	19.3	21.6	34.5	7.8	63.9	34.3	0.1	0.1	0.1	0.6	0.1	0.3	0.4	0.4	0.5	0.1	0.7	0.5	0.5	0.0	3.2	0.1	0.7	0.0	0.3	2.5	3.0	4.0	5.6	2.3	3.2	4.3	3.2	1.6	4.0	1.8	3.1	4.5	9.7	16.0	13.0	10.1	13.4	4.5	5.5	5.6	15.9	11.5	6.8	8.6	7.6	7.2	5.7	5.5	8.4	7.9	11.0	2.5	3.9	5.3	4.7	8.0	8.7	9.7	6.7	14.5	8.3	6.2	11.4	11.2	4.1	13.7	17.1	12.8	6.1	12.0	6.7	5.0	8.1	3.3	12.2	6.0	5.7	3.9	7.8	7.3	1.8	11.2	5.9	10.6	14.4	12.5	9.9	5.2	1.1	6.0	16.9	2.9	1.2	3.0	8.0	17.1	13.1	16.2	8.3	74.5	18.0	8.7	3.7	1.9	12.1	7.7	6.0	1.9
MEI4		ENSG00000269964	"Meiotic double-stranded break formation protein 4"	A8MW99	6	77650274-77927028	"Predicted intracellular proteins"	"DNA recombination, Meiosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 4.0;testis: 3.7;thyroid gland: 2.2"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 86.1"	"Cancer enhanced"	"Detected in some"		"renal cancer: 0.9;testis cancer: 1.3"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (3.47e-1)"				"unprognostic (9.76e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.62e-2)"	"unprognostic (9.70e-4)"	"unprognostic (3.16e-1)"	"unprognostic (2.86e-4)"	"unprognostic (3.35e-2)"	"unprognostic (4.17e-2)"	"unprognostic (4.85e-2)"	0.1	0.7	0.4	0.0	0.4	0.0	0.0	0.3	0.3	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.5	0.2	0.7	4.0	0.9	0.0	0.0	0.9	0.5	0.1	0.0	2.0	0.1	1.0	0.0	1.2	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	3.7	0.5	0.0	2.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.3	0.3	0.2	0.7	0.9	0.5	0.1	1.2	0.5	0.5	0.7	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	86.1	0.0	0.0	0.1	0.0	0.0	4.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	3.0	0.0	0.0	0.0	0.0	21.3	0.3	0.0	0.0	9.4	0.0	0.6	0.0	2.0	2.5	0.1	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.1	0.0	0.0	0.0	3.6	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
METAP1	"KIAA0094, MAP1A, MetAP1A"	ENSG00000164024	"Methionyl aminopeptidase 1"	P53582	4	98995659-99062809	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Late spermatids: 1627.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025485, HPA037997, HPA037998"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		8900	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB025485: , HPA037997: AB_2675777, HPA037998: AB_2675778"	"unprognostic (1.79e-1)"	"unprognostic (3.39e-1)"	"prognostic favorable (7.22e-4)"	"unprognostic (1.58e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (3.08e-5)"	"unprognostic (1.09e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (2.28e-5)"	"unprognostic (2.00e-1)"	"prognostic favorable (1.72e-4)"	"unprognostic (5.50e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.15e-3)"	"prognostic favorable (9.31e-4)"	14.9	9.6	11.0	20.7	12.9	25.3	29.0	11.8	14.0	19.4	10.2	32.1	24.3	26.0	44.1	52.8	24.5	15.2	41.5	12.0	11.6	25.0	24.2	15.7	25.1	10.8	11.4	11.1	14.1	19.7	14.1	11.7	17.0	11.2	29.4	33.9	11.4	23.3	29.9	34.1	28.9	23.6	25.9	10.6	17.7	19.8	52.0	11.7	42.3	19.0	28.9	31.5	34.8	31.1	11.5	57.6	55.9	47.7	51.7	37.2	59.1	52.9	80.3	51.5	67.1	63.7	62.9	83.3	84.1	31.3	65.5	40.3	56.1	84.8	80.5	92.9	59.2	39.9	75.6	37.8	68.2	40.2	103.6	60.8	42.8	57.5	57.0	60.4	52.4	56.3	46.9	60.0	49.7	73.2	44.0	90.9	49.3	58.7	97.7	44.3	58.9	74.5	45.4	109.2	73.6	64.7	38.5	27.0	82.5	32.8	53.1	31.6	39.3	46.1	53.9	68.0	49.9	70.9	35.5	53.5	66.2	46.5	51.9	54.8	19.1	11.6	5.7	17.7	14.6	23.1	16.0	18.0	17.6	14.9	11.4	17.4	15.8	2.9	17.7	14.7	7.2	17.7	14.1	11.0	12.9	11.8	14.0	12.0	11.6	10.8	11.4	11.1	11.2	10.6	11.7	11.5	16.1	41.7	14.6	20.2	19.8	42.4	47.5	26.2	51.2	5.2	21.0	24.9	57.0	17.2	19.5	14.7	2.1	24.4	17.4	36.7	13.7	28.4	330.3	45.4	30.0	17.3	7.8	24.2	22.6	29.4	70.5	15.3	22.4	60.9	3.8	16.9	12.8	21.4	17.2	3.3	15.0	23.3	24.4	20.2	16.2	1627.3	19.3	17.4	16.0	14.0	13.9	10.6	25.7	17.6	22.3	28.0	30.8	22.6	17.8	34.4	25.3	31.6	17.2	3.7	26.3	11.5	21.7	15.7	41.6	54.3	38.8	7.7	23.6	18.1	36.2	46.9
METRN	"C16orf23, MGC2601"	ENSG00000103260	"Meteorin, glial cell differentiation regulator"	Q9UJH8	16	715118-719655	"Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 301.7;choroid plexus: 180.5"	"Cell type enriched"	"Detected in many"	5	"Muller glia cells: 1153.9"	"Cancer enhanced"	"Detected in all"		"glioma: 69.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"MCF7: 178.2;PC-3: 133.1;SK-MEL-30: 93.5"	"Region enhanced"	"Detected in all"		"cerebellum: 612.9"					HPA051164	Approved		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"	"Secreted in brain"	NA	NA			"Nuclear membrane"	"Nucleoplasm, Cytosol"	"HPA051164: AB_2681369"	"unprognostic (1.60e-2)"	"unprognostic (3.49e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.59e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.32e-1)"	"unprognostic (5.03e-3)"	"unprognostic (3.62e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.17e-2)"	14.1	36.6	198.3	4.0	188.3	1.5	14.2	174.4	301.7	14.2	180.5	24.6	4.2	17.4	3.0	10.5	37.4	2.5	50.4	167.3	216.1	29.2	50.4	17.0	2.1	267.9	188.0	143.1	5.2	46.5	5.5	88.7	3.8	201.2	25.6	1.2	3.0	25.4	13.2	23.5	11.9	12.1	2.9	207.8	12.4	22.4	15.5	207.7	2.5	30.9	5.2	1.8	20.7	11.4	204.4	8.9	73.4	14.2	72.4	24.6	13.8	22.9	17.5	8.7	6.9	4.4	11.0	21.5	1.5	39.6	12.4	26.3	32.6	2.1	17.0	1.1	4.7	32.0	2.9	13.3	57.1	15.1	6.5	9.2	33.3	18.3	2.1	4.2	21.3	2.3	20.3	5.3	1.7	5.2	178.2	2.4	22.0	5.2	9.8	133.1	24.3	16.4	24.4	18.4	2.6	22.5	28.5	6.9	18.9	93.5	1.6	28.6	12.6	8.0	19.4	36.8	22.7	15.4	11.0	3.3	1.7	30.3	4.8	46.6	0.0	0.1	0.2	0.8	0.3	0.5	1.2	0.4	0.8	0.0	0.1	0.2	0.5	0.0	0.5	0.3	0.2	1.0	0.1	198.3	188.3	174.4	301.7	167.3	216.1	267.9	188.0	143.1	201.2	207.8	207.7	204.4	46.7	0.0	2.2	91.4	8.5	3.8	17.1	3.3	0.0	45.5	79.5	75.8	16.3	48.6	1.8	16.5	14.6	0.6	26.7	29.0	50.9	8.4	8.0	230.7	54.8	21.5	27.4	2.7	6.6	5.1	2.1	15.1	5.6	14.4	0.0	2.7	20.0	39.5	6.4	70.7	5.7	10.7	2.0	7.8	6.5	25.8	11.1	6.6	10.6	8.4	1.1	1153.9	23.7	44.2	57.6	5.3	26.7	9.4	7.9	27.7	6.2	55.6	9.5	37.9	26.3	11.8	26.7	4.6	11.7	1.4	3.0	0.4	12.7	5.2	9.2	16.2
METTL3	"M6A, MT-A70, Spo8"	ENSG00000165819	"Methyltransferase like 3"	Q86U44	14	21498133-21511342	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Differentiation, DNA damage, Immunity, Innate immunity, Oogenesis, Spermatogenesis"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Early spermatids: 188.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.62e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.19e-5)"	"unprognostic (1.02e-3)"	"unprognostic (1.85e-1)"	"prognostic favorable (2.78e-4)"	"prognostic favorable (2.72e-4)"	"unprognostic (4.52e-2)"	"unprognostic (4.64e-3)"	"unprognostic (2.98e-2)"	"unprognostic (7.14e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.22e-1)"	11.9	18.7	11.8	11.4	12.4	5.9	16.1	12.3	13.1	12.9	12.1	11.4	7.7	13.3	18.2	11.8	19.0	9.9	16.9	11.9	17.2	12.7	11.8	13.0	19.2	13.6	12.5	11.4	15.1	11.6	19.2	13.1	15.3	13.1	17.5	13.0	8.7	14.3	16.9	16.9	16.7	10.7	16.4	12.9	14.0	11.3	20.0	13.2	17.9	17.0	18.7	21.4	14.6	12.5	13.1	39.6	57.7	55.0	22.2	40.5	33.4	27.5	35.9	26.0	41.7	48.5	22.0	46.4	40.8	22.6	22.3	54.2	41.6	66.4	35.2	65.7	39.1	39.8	25.9	31.9	88.1	16.6	34.8	28.2	25.0	30.3	26.0	30.2	18.6	54.8	20.8	32.0	23.5	55.9	29.1	31.0	28.6	46.4	66.1	70.7	30.7	42.6	36.5	38.8	26.6	33.4	36.6	38.7	50.6	37.5	42.7	39.8	22.8	36.6	15.0	24.8	27.6	24.9	24.9	32.5	29.0	18.2	27.7	32.0	6.5	8.9	8.9	8.0	11.5	12.4	14.3	10.0	9.4	10.9	10.8	10.3	9.3	0.9	15.7	9.6	13.0	15.5	8.4	11.8	12.4	12.3	13.1	11.9	17.2	13.6	12.5	11.4	13.1	12.9	13.2	13.1	12.5	12.8	20.1	15.7	16.2	14.9	23.3	21.2	21.1	23.4	15.1	16.5	30.6	12.8	13.6	12.9	14.6	31.1	16.2	5.4	3.9	14.5	188.2	11.7	11.4	14.7	10.8	20.4	15.0	10.0	15.7	15.3	7.1	10.0	8.8	20.4	9.7	9.5	16.6	21.9	13.7	8.7	14.2	10.0	9.9	24.3	17.1	10.8	16.0	10.3	17.9	14.9	15.5	19.1	21.7	10.8	6.5	19.9	14.9	18.8	5.5	9.1	15.3	21.0	32.9	16.4	17.5	42.4	20.3	12.4	12.4	25.3	13.2	13.2	13.4	19.0
MFAP3L	"KIAA0626, NYD-sp9"	ENSG00000198948	"Microfibril associated protein 3 like"	O75121	4	169986597-170033031	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 66.9;choroid plexus: 73.5"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 1840.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 5.7;eosinophil: 1.8;neutrophil: 3.5"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 5.7"	"Cell line enhanced"	"Detected in many"		"HMC-1: 22.5;RT4: 38.0;SK-BR-3: 34.3;SuSa: 19.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017986, HPA062306, HPA077490"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Cell Junctions"	"HPA017986: AB_1853842, HPA062306: , HPA077490: AB_2686842"	"unprognostic (8.04e-3)"	"unprognostic (8.67e-3)"	"unprognostic (3.74e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.51e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.96e-1)"	"unprognostic (7.58e-2)"	"prognostic favorable (1.42e-8)"	"unprognostic (6.59e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.62e-4)"	"unprognostic (2.40e-3)"	2.1	3.4	34.3	0.9	57.2	3.2	12.2	50.2	36.3	13.1	73.5	2.2	0.6	5.1	39.2	0.8	4.3	2.6	1.7	35.5	38.9	30.3	37.7	2.7	0.9	51.2	57.3	24.4	0.6	1.5	6.5	4.1	3.0	55.1	2.8	2.0	25.2	2.1	12.9	5.1	24.7	1.0	4.1	40.4	1.5	1.3	46.7	48.0	0.6	2.8	2.3	0.5	10.2	1.9	66.9	0.4	5.7	3.0	3.1	2.6	1.3	1.1	6.2	0.9	2.8	2.5	1.9	0.4	0.0	0.2	9.6	5.4	2.9	10.9	1.4	1.2	0.0	4.7	0.0	6.7	2.4	1.4	0.0	22.5	1.8	3.4	0.3	1.0	1.5	0.3	3.5	0.9	1.1	5.8	3.4	1.0	0.8	3.1	0.7	4.7	0.0	1.8	0.0	8.1	38.0	2.5	5.5	5.1	34.3	11.6	19.1	1.9	0.0	0.2	2.9	11.2	5.5	11.9	0.6	0.0	0.0	7.5	1.2	11.4	5.7	0.1	1.8	0.6	0.7	0.3	0.0	0.5	0.1	0.2	0.0	0.2	0.1	3.5	0.0	0.0	0.5	0.1	4.6	34.3	57.2	50.2	36.3	35.5	38.9	51.2	57.3	24.4	55.1	40.4	48.0	66.9	1.0	0.0	5.6	112.6	0.6	2.5	0.4	0.1	2.8	12.2	8.5	9.7	3.4	0.0	0.2	36.8	20.9	3.1	0.2	0.6	5.9	0.5	417.5	8.5	1.1	2.0	2.4	11.2	36.3	1.1	1.0	0.6	0.0	12.4	4.5	11.0	3.3	49.1	1.2	3.3	25.0	0.3	0.0	1.0	0.7	1840.0	5.3	13.5	7.2	3.7	1.5	2.9	2.1	53.8	127.6	1.4	0.3	9.1	0.5	0.9	0.3	24.0	0.3	15.8	19.7	1.7	4.2	17.6	13.2	0.3	8.4	9.4	0.6	1.4	0.8	2.2
MFN2	"CMT2A2, CPRP1, KIAA0214, MARF"	ENSG00000116688	"Mitofusin 2"	O95140	1	11980181-12015211	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Autophagy, Unfolded protein response"	Hydrolase	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 272.9;skeletal muscle: 313.5;tongue: 340.6"	"Cell type enriched"	"Detected in all"	7	"Cardiomyocytes: 336.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030554, CAB079902"	Uncertain		Supported	Mitochondria		NA	NA			Mitochondria		"CAB079902: AB_2724683, HPA030554: AB_10603018"	"unprognostic (9.52e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.38e-2)"	"unprognostic (8.36e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.55e-1)"	"prognostic favorable (2.36e-8)"	"unprognostic (4.69e-2)"	"unprognostic (2.76e-1)"	"unprognostic (8.84e-3)"	"unprognostic (2.12e-1)"	35.0	31.7	42.0	21.1	38.6	26.9	32.1	39.0	40.7	27.2	16.6	53.3	42.3	37.3	12.8	57.7	26.4	22.0	272.9	33.3	41.6	36.8	58.9	31.4	20.0	41.9	43.7	26.6	27.2	22.7	77.3	28.9	27.8	42.7	36.6	38.5	35.3	32.4	62.9	313.5	58.6	46.6	41.6	41.4	31.7	45.2	25.6	45.3	26.4	56.6	340.6	30.7	51.7	36.5	41.2	93.6	54.0	52.6	72.7	59.7	47.2	58.8	76.0	66.1	96.5	72.6	88.7	51.8	68.8	74.8	92.6	60.6	80.5	101.7	156.1	90.6	60.6	75.4	94.5	81.8	54.2	53.8	114.2	51.9	57.0	105.1	133.1	124.5	40.1	66.2	26.4	106.1	53.6	69.7	30.2	60.2	15.2	39.7	57.8	77.4	68.2	95.8	58.5	44.9	61.4	68.2	44.6	88.4	81.0	74.6	41.4	43.8	49.2	71.2	63.1	58.3	88.4	71.2	59.0	86.4	120.7	69.0	99.6	69.8	10.4	11.5	7.6	8.9	14.0	10.2	6.7	6.7	7.9	9.7	4.8	5.0	6.2	16.2	6.2	18.3	4.2	8.1	15.7	42.0	38.6	39.0	40.7	33.3	41.6	41.9	43.7	26.6	42.7	41.4	45.3	41.2	18.1	22.4	15.8	16.6	10.2	22.8	9.4	18.9	19.9	26.7	17.4	16.4	336.9	7.2	14.9	14.7	12.5	15.1	12.5	39.2	21.5	13.6	4.7	8.9	12.1	18.5	18.0	32.4	21.5	20.4	15.5	17.3	17.3	12.8	10.8	12.8	11.7	46.3	16.0	30.3	24.5	22.2	18.3	23.9	9.7	8.0	7.2	19.1	17.8	8.4	17.3	14.6	8.2	11.1	16.7	18.5	16.8	15.1	10.9	13.9	41.8	14.3	12.9	21.0	13.1	16.0	16.5	25.9	15.6	25.1	30.1	25.2	10.3	12.5	26.4	16.6
MINPP1	MIPP	ENSG00000107789	"Multiple inositol-polyphosphate phosphatase 1"	Q9UNW1	10	87504875-87553461	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Erythroid cells: 288.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026859	Approved				"Intracellular and membrane"	NA	NA		370000000			"HPA026859: AB_1853961"	"unprognostic (9.15e-2)"	"unprognostic (8.76e-3)"	"unprognostic (2.08e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.20e-3)"	"unprognostic (3.47e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.55e-1)"	"unprognostic (2.07e-2)"	"unprognostic (6.54e-2)"	"unprognostic (6.50e-3)"	"prognostic unfavorable (6.98e-5)"	"unprognostic (2.43e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.01e-2)"	8.5	21.5	7.3	7.3	7.4	31.3	9.5	7.6	9.1	8.9	9.8	12.7	17.8	7.0	10.1	3.6	8.6	8.5	5.8	7.4	8.1	17.7	29.3	8.4	7.8	7.2	7.3	7.3	8.9	12.0	9.1	8.2	19.1	7.3	11.8	13.0	12.1	7.0	7.7	4.9	9.2	13.7	7.7	7.5	6.9	8.6	7.9	8.0	8.2	11.7	5.7	7.0	8.7	5.7	8.1	18.6	28.1	28.1	40.9	46.4	38.1	23.2	29.5	51.1	28.8	38.3	15.0	35.5	16.4	27.0	35.9	19.4	28.2	29.9	27.1	33.2	37.1	35.7	41.1	10.4	55.7	34.6	18.0	36.0	33.7	34.7	32.6	19.5	52.5	37.0	14.3	24.5	75.9	34.4	13.8	11.9	25.6	20.0	14.2	20.2	0.0	15.8	11.0	38.5	10.4	10.2	31.5	28.1	5.9	51.5	31.5	16.7	14.7	32.4	18.3	21.9	22.1	28.7	24.5	27.1	4.2	29.3	26.8	13.7	10.5	10.8	4.9	11.5	13.8	10.1	8.7	10.8	13.0	14.3	8.2	10.2	11.4	0.7	11.7	12.5	8.2	17.3	10.5	7.3	7.4	7.6	9.1	7.4	8.1	7.2	7.3	7.3	7.3	7.5	8.0	8.1	11.7	6.4	12.8	9.1	8.1	2.8	8.3	25.5	8.0	14.4	9.0	4.3	4.9	15.7	16.2	7.3	2.1	20.4	4.9	14.0	5.9	17.2	15.9	7.1	13.4	10.5	13.1	288.9	18.3	16.7	19.2	17.9	7.1	6.7	24.7	17.8	16.4	58.3	12.9	10.1	20.8	25.5	20.3	16.0	5.8	4.0	9.3	8.7	10.6	7.5	11.7	11.1	10.3	25.6	19.1	10.5	17.2	8.2	18.6	6.8	17.1	26.0	19.0	14.8	0.0	4.8	11.1	10.6	12.1	4.0	3.4	8.1	8.2	13.7	11.6	4.4
MIXL1	"MILD1, MIXL"	ENSG00000185155	"Mix paired-like homeobox"	Q9H2W2	1	226223618-226227060	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 3.4"	"Cell type enriched"	"Detected in some"	5	"Plasma cells: 18.5"	"Cancer enriched"	"Detected in some"	9	"testis cancer: 6.3"	"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HAP1: 1.7;Hep G2: 9.0;SuSa: 1.9;U-698: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA005662			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA005662: AB_2667382"	"unprognostic (4.09e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.18e-2)"	"unprognostic (5.66e-2)"	"unprognostic (5.05e-2)"	"unprognostic (7.40e-3)"	"unprognostic (2.78e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.71e-13)"	"unprognostic (1.54e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.47e-2)"	0.0	0.1	0.2	1.0	0.2	0.2	0.2	1.1	0.3	0.1	0.2	0.7	1.3	0.2	0.1	0.0	0.0	0.2	0.2	0.2	0.2	0.0	0.1	0.2	2.4	0.2	0.2	0.2	0.2	0.1	0.6	0.0	0.2	0.5	0.1	0.6	0.1	0.2	0.2	0.1	0.2	0.7	0.1	0.1	1.0	0.8	0.4	0.2	0.2	0.1	0.0	3.4	0.6	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.0	1.7	0.0	0.1	0.0	0.1	0.1	0.2	9.0	0.4	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	1.2	0.0	0.1	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	1.9	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.0	2.4	0.0	0.0	0.0	49.7	6.5	13.0	6.4	10.0	12.6	11.3	7.3	7.3	7.2	10.4	9.6	9.7	18.2	19.6	19.5	11.0	10.3	6.2	0.2	0.2	1.1	0.3	0.2	0.2	0.2	0.2	0.2	0.5	0.1	0.2	0.6	0.6	0.0	0.0	0.0	3.2	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.3	0.2	0.1	1.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.3	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	18.5	0.1	0.1	0.1	0.0	0.5	0.0	0.3	0.1	0.1	1.5	0.0	0.0	0.3	0.1	0.1	0.0	0.1
MMP1	CLG	ENSG00000196611	"Matrix metallopeptidase 1"	P03956	11	102789401-102798160	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Collagen degradation, Host-virus interaction"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 76.3;stomach 1: 48.0;urinary bladder: 52.7"	"Cell type enriched"	"Detected in many"	10	"Pancreatic endocrine cells: 2239.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 344.2"	"Region enriched"	"Detected in single"	9	"cerebral cortex: 1.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 1139.1;HBF TERT88: 1094.4;HUVEC TERT2: 2954.4;WM-115: 1454.1"	"Not detected"	"Not detected"							HPA004920			Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA	7730000	55000	Vesicles		"HPA004920: AB_2667293"	"unprognostic (4.11e-3)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (4.20e-3)"	"unprognostic (1.19e-3)"	"unprognostic (6.46e-2)"	"unprognostic (6.50e-2)"	"prognostic unfavorable (4.22e-6)"	"unprognostic (7.83e-3)"	"unprognostic (2.94e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.11e-3)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (9.86e-10)"	"unprognostic (1.67e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.26e-2)"	"unprognostic (5.11e-2)"	0.3	0.1	0.0	26.9	0.0	0.3	0.2	0.0	1.1	0.1	0.0	4.1	8.0	10.8	0.0	4.3	0.1	76.3	0.3	0.0	0.1	0.9	0.8	6.8	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.1	7.2	0.0	0.4	6.9	0.0	6.9	0.2	0.0	0.6	13.1	1.2	0.0	2.1	48.0	0.1	0.1	0.3	0.2	0.0	1.7	52.7	0.2	0.0	0.0	0.0	0.0	1.0	0.0	1.1	0.0	517.1	1139.1	456.6	118.2	9.1	1.0	0.0	5.2	275.5	175.2	4.6	0.0	160.0	1094.4	0.0	1.0	0.0	0.0	0.0	2.9	0.0	0.5	0.3	0.8	470.1	39.6	0.1	2954.4	0.0	1.5	0.5	0.3	0.0	0.0	0.0	0.4	189.3	20.8	0.0	0.1	0.0	0.7	2.2	0.0	0.1	4.8	0.0	1.6	0.1	0.5	0.0	155.0	374.1	0.6	16.8	1.3	0.1	0.0	0.0	8.8	0.0	1454.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	3.2	2.6	0.0	0.2	2.3	22.4	90.4	0.0	0.0	0.0	0.0	0.1	30.0	15.8	3.7	0.0	0.0	0.0	0.2	0.0	143.7	0.0	0.1	0.2	113.2	0.0	0.0	0.1	204.8	0.1	11.5	25.5	2.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.0	1.9	0.4	0.0	0.0	15.5	0.0	0.0	4.2	0.0	0.0	0.0	0.0	2239.5	1.2	0.0	0.0	30.9	0.7	0.2	1.3	0.0	0.0	1.8	10.5	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.1	44.3
MMP12	HME	ENSG00000262406	"Matrix metallopeptidase 12"	P39900	11	102862736-102874982	"Cancer-related genes, Enzymes, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 15.9;lymphoid tissue: 40.7;urinary bladder: 16.1"	"Cell type enriched"	"Detected in some"	9	"Extravillous trophoblasts: 303.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"BJ: 3.3;fHDF/TERT166: 11.4;hTEC/SVTERT24-B: 6.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to extracellular matrix"	NA	NA						"unprognostic (7.33e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (1.42e-4)"	"unprognostic (1.69e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.52e-3)"	"unprognostic (5.45e-2)"	"unprognostic (3.05e-6)"	"unprognostic (1.08e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.92e-2)"	0.4	0.0	0.0	40.7	0.1	0.0	0.4	0.0	0.0	0.1	0.0	13.6	6.9	0.6	0.0	0.4	0.0	2.6	0.0	0.0	0.2	0.8	0.1	0.6	7.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	7.4	0.1	1.3	15.9	0.0	2.4	0.0	0.0	0.5	7.9	2.2	0.1	3.7	3.5	0.0	0.1	3.9	0.0	0.0	19.6	16.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	11.4	0.1	0.4	0.0	0.0	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.4	0.4	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	3.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.7	0.0	0.0	0.0	18.6	303.4	0.4	0.0	0.2	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.5	0.1	0.0	0.0	2.2
MMP16	"C8orf57, DKFZp761D112, MT3-MMP"	ENSG00000156103	"Matrix metallopeptidase 16"	P51512	8	88032011-88328025	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.4"	"Cell type enriched"	"Detected in many"	5	"Oligodendrocyte precursor cells: 2402.1"	"Cancer enhanced"	"Detected in many"		"glioma: 4.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 29.4;HUVEC TERT2: 12.8;SH-SY5Y: 16.2;U-138 MG: 13.7;WM-115: 28.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023693	Uncertain		Approved	Vesicles,Cytosol	"Secreted to extracellular matrix"	NA	NA			Cytosol	Vesicles	"HPA023693: AB_1854025"	"unprognostic (2.58e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.09e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.39e-3)"	"unprognostic (1.45e-3)"	"unprognostic (2.46e-1)"	"unprognostic (2.61e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.09e-8)"	"unprognostic (6.90e-3)"	"unprognostic (1.16e-1)"	"unprognostic (3.62e-1)"	"unprognostic (2.19e-3)"	0.7	0.3	4.0	0.3	6.4	0.0	1.8	2.9	5.6	1.7	0.0	0.6	0.1	1.6	0.6	0.4	0.6	2.6	0.8	5.3	3.9	0.1	0.1	0.2	0.2	2.1	2.0	5.0	1.0	0.6	0.2	0.5	1.0	3.0	1.0	0.4	0.4	0.3	0.7	0.1	0.2	0.3	1.3	1.4	0.4	0.3	0.4	2.8	0.4	1.0	0.5	0.2	0.9	0.5	4.4	0.0	0.2	7.9	29.4	1.0	2.0	0.0	10.9	1.6	3.0	1.8	0.0	0.1	0.0	0.0	4.9	1.8	0.0	5.8	0.0	3.7	0.0	3.4	0.0	0.0	0.0	2.4	0.0	0.5	1.4	0.0	4.4	1.3	5.4	12.8	0.1	0.0	1.1	1.7	0.0	0.0	0.0	1.7	0.0	3.0	0.3	0.6	0.0	0.6	0.1	0.2	16.2	0.0	0.0	0.2	2.2	1.1	0.0	7.1	13.7	7.7	0.2	4.2	0.0	0.0	0.0	5.7	0.0	28.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	6.4	2.9	5.6	5.3	3.9	2.1	2.0	5.0	3.0	1.4	2.8	4.4	2.2	0.0	0.0	20.5	0.1	1.1	0.0	0.0	0.6	4.4	0.8	1.4	1.0	0.0	0.0	0.0	2.1	0.1	0.1	0.0	1.9	0.0	6.5	0.5	15.9	5.2	0.0	0.0	443.4	0.0	0.1	16.0	0.0	0.4	0.0	1.9	1.4	0.0	0.4	1.7	300.3	0.0	0.0	0.0	1.6	6.5	0.9	0.4	1.8	10.3	0.0	3.0	0.0	2402.1	13.0	0.1	0.0	1.2	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.7	2.9	0.0	1.1	0.2	0.1	0.0	0.2	3.4	0.0	0.1
MMP20		ENSG00000137674	"Matrix metallopeptidase 20"	O60882	11	102576832-102625332	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Amelogenesis imperfecta"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	7	"Early spermatids: 91.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"OE19: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to extracellular matrix"	NA	NA						"unprognostic (4.62e-3)"		"unprognostic (2.61e-2)"	"unprognostic (1.68e-3)"		"unprognostic (1.75e-1)"		"unprognostic (2.13e-1)"		"unprognostic (3.06e-1)"	"unprognostic (2.97e-2)"	"unprognostic (6.75e-2)"	"unprognostic (9.58e-5)"	"unprognostic (6.10e-2)"		"unprognostic (2.35e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	91.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	12.0	0.3	0.0	0.0	1.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	6.6	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.4
MMP7	"MPSL1, PUMP-1"	ENSG00000137673	"Matrix metallopeptidase 7"	P09237	11	102520508-102530750	"Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 514.6;salivary gland: 270.1;urinary bladder: 213.2"	"Cell type enriched"	"Detected in many"	8	"Ductal cells: 8176.2"	"Cancer enhanced"	"Detected in all"		"pancreatic cancer: 352.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 145.9;CAPAN-2: 815.9;EFO-21: 189.8;RPTEC TERT1: 350.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025869, HPA051358"	Supported		Approved	Nucleoplasm,Vesicles	"Secreted to extracellular matrix"	NA	NA	2810000	35000	"Nucleoplasm, Vesicles"		"CAB025869: , HPA051358: AB_2681452"	"unprognostic (1.06e-3)"	"unprognostic (9.51e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.70e-3)"	"unprognostic (7.28e-2)"	"prognostic unfavorable (2.53e-4)"	"prognostic unfavorable (3.38e-4)"	"unprognostic (3.96e-2)"	"unprognostic (5.63e-2)"	"unprognostic (6.59e-3)"	"unprognostic (1.51e-1)"	"unprognostic (6.36e-3)"	"unprognostic (1.42e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.46e-1)"	2.4	0.1	0.0	2.0	0.0	0.3	170.3	0.0	0.3	13.4	0.0	1.6	0.6	98.3	28.2	21.5	92.0	514.6	0.2	0.0	0.1	138.6	3.5	31.9	1.9	0.1	0.0	0.0	0.7	85.9	0.0	0.3	0.8	0.0	54.5	1.1	0.0	270.1	35.2	0.1	32.2	0.7	4.9	0.0	0.2	7.4	0.6	0.3	3.4	0.4	0.0	29.5	213.2	1.7	0.1	0.2	145.9	0.0	0.4	0.0	0.0	0.2	0.0	2.1	0.1	0.1	1.9	815.9	0.0	189.8	0.0	0.0	1.1	0.0	0.1	0.1	0.7	0.0	0.0	0.0	0.6	1.0	0.1	0.2	0.7	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.5	11.8	0.0	0.0	0.0	0.0	350.1	1.0	0.0	0.0	0.0	0.0	0.0	3.9	0.3	0.1	0.0	0.7	3.0	0.0	1.6	0.1	0.6	0.4	1.0	5.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.7	86.6	43.3	0.0	1.5	1.0	382.2	135.4	1.2	0.0	124.2	93.7	0.7	100.1	401.2	1017.0	0.0	0.7	2.9	1.2	0.0	8176.2	6.1	62.1	3.3	8.8	0.0	0.0	0.0	209.4	0.3	3.4	0.0	124.6	2.5	0.0	0.0	0.0	98.0	0.0	0.0	0.0	38.7	0.6	0.3	10.3	11.8	12.6	0.0	0.0	65.2	0.0	0.0	0.0	0.0	850.9	0.0	0.0	0.1	603.3	0.0	33.9	72.6	0.0	0.0	0.0	31.4	0.1	0.2	17.0	2.4	0.8	3.6	0.0	2.3	840.8
MOB3B	"C9orf35, FLJ13204, MOB1D, MOBKL2B"	ENSG00000120162	"MOB kinase activator 3B"	Q86TA1	9	27325209-27529814	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.2"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 431.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 2.5;myeloid DC: 2.7;naive B-cell: 2.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 16.0;HAP1: 16.7;K-562: 49.9;SK-BR-3: 19.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057744			Uncertain	"Intermediate filaments,Cytosol"		NA	NA			"Intermediate filaments, Cytosol"		"HPA057744: "	"unprognostic (6.96e-3)"	"unprognostic (9.60e-2)"	"unprognostic (5.10e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.42e-1)"	"unprognostic (7.57e-3)"	"unprognostic (1.28e-1)"	"unprognostic (9.45e-2)"	"prognostic favorable (2.33e-10)"	"unprognostic (1.55e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (7.99e-2)"	5.8	1.7	10.3	3.9	24.1	0.7	6.2	19.0	12.2	6.9	11.0	12.2	17.7	9.7	5.1	3.6	8.0	5.0	1.2	8.3	14.3	7.5	1.4	6.8	4.0	21.6	19.8	6.0	26.2	3.6	0.5	1.1	4.6	21.1	2.3	13.3	7.4	3.4	2.9	5.9	6.3	15.8	6.4	22.1	8.2	5.6	3.2	18.3	3.6	5.5	5.3	5.6	3.6	4.7	31.2	3.4	2.5	7.6	0.0	1.9	0.1	16.0	0.0	0.1	0.1	0.1	1.9	0.0	0.1	3.2	0.0	0.0	10.9	16.7	13.2	0.0	7.7	2.6	4.9	9.8	0.1	0.0	0.0	1.0	3.4	13.7	0.0	2.5	0.0	0.0	0.0	49.9	0.1	0.0	0.0	0.0	0.0	9.8	6.3	0.9	3.3	0.7	0.1	4.6	6.4	0.1	2.4	2.7	19.8	4.7	9.9	1.3	0.0	0.1	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	3.1	0.5	0.0	0.5	0.0	0.0	0.8	0.0	2.5	0.0	0.0	2.7	2.9	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.3	10.3	24.1	19.0	12.2	8.3	14.3	21.6	19.8	6.0	21.1	22.1	18.3	31.2	6.9	3.2	4.1	13.7	22.1	22.7	7.7	7.6	40.9	2.1	6.7	12.6	1.5	27.1	4.3	11.0	0.0	22.1	0.4	83.3	9.8	16.4	1.0	6.5	20.1	8.7	2.4	1.7	81.7	21.0	56.0	20.8	21.4	9.2	1.3	1.9	4.6	3.1	5.4	1.7	88.9	26.9	12.2	13.2	30.6	3.1	15.8	20.4	16.0	76.8	10.8	65.3	2.1	79.4	431.9	10.6	26.1	16.1	1.2	6.5	50.3	10.5	2.7	1.3	0.0	4.5	19.2	2.2	5.0	8.4	9.5	11.8	1.6	7.7	36.8	6.9
MORN3		ENSG00000139714	"MORN repeat containing 3"	Q6PF18	12	121648742-121672631	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 3.9;testis: 4.5"	"Cell type enriched"	"Detected in many"	6	"Late spermatids: 2271.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	9	"BEWO: 13.6;CACO-2: 8.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA038709, HPA038710"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA038709: AB_2676164, HPA038710: AB_2676165"	"prognostic favorable (1.16e-4)"	"unprognostic (2.70e-3)"	"unprognostic (5.56e-2)"	"unprognostic (5.13e-2)"	"unprognostic (7.38e-3)"	"unprognostic (3.46e-3)"	"unprognostic (7.44e-2)"	"unprognostic (3.70e-2)"	"unprognostic (4.31e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.65e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.18e-1)"	0.2	0.3	1.6	0.5	1.5	0.9	0.4	1.2	1.6	0.3	3.5	0.2	0.3	0.3	0.5	0.1	3.9	0.4	0.1	1.4	1.7	0.5	0.1	1.0	1.2	1.4	1.6	1.4	0.3	0.3	2.4	1.3	0.8	1.2	0.2	0.2	0.6	0.4	0.3	0.2	2.0	0.4	0.2	1.3	0.7	0.7	4.5	1.2	0.9	0.6	0.0	0.6	0.2	0.2	1.3	0.2	0.1	0.4	0.2	0.0	0.3	13.6	0.2	0.1	0.0	0.1	8.3	0.4	0.2	0.2	0.1	0.2	0.5	0.1	0.2	0.1	0.1	0.1	0.6	0.5	0.5	0.2	0.5	0.9	0.1	0.3	0.4	0.0	0.1	0.3	1.0	0.2	0.3	0.1	0.3	0.9	0.7	0.3	0.0	0.1	0.4	0.0	0.1	0.5	0.2	1.2	1.1	0.1	0.2	0.0	0.6	1.1	0.1	0.2	0.2	0.2	0.4	0.2	0.2	0.1	0.4	1.0	0.4	0.2	1.3	0.3	0.1	0.7	0.1	0.8	0.3	0.8	0.4	0.1	0.5	0.7	0.5	1.2	0.9	0.3	0.5	0.8	0.2	1.6	1.5	1.2	1.6	1.4	1.7	1.4	1.6	1.4	1.2	1.3	1.2	1.3	1.1	3.2	1.3	0.0	1.6	3.2	1.2	3.3	0.0	1.3	2.5	1.8	1.4	4.3	8.2	1.8	0.0	0.5	6.6	0.0	7.9	4.4	352.0	34.1	1.2	2.1	0.0	0.0	2.7	1.4	0.7	1.4	0.0	3.0	2.5	2.5	0.7	0.0	0.9	0.0	2.3	0.0	4.1	0.0	0.3	2271.5	9.3	1.7	0.0	0.0	1.8	5.4	5.2	0.0	0.1	2.2	0.0	9.4	3.5	0.7	0.1	1.1	51.7	2.2	0.0	1.5	1.4	8.7	6.7	0.0	4.0	7.3	6.7	3.4	0.2	1.1
MOSPD3	"CDS3, NET30"	ENSG00000106330	"Motile sperm domain containing 3"	O75425	7	100612102-100615384	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Late spermatids: 1472.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-937: 69.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041137, HPA048240"	Uncertain		Approved	Nucleoplasm,Cytosol		No	No			"Nucleoplasm, Cytosol"		"HPA041137: AB_10803996, HPA048240: AB_2680325"	"unprognostic (1.24e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.94e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.46e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.24e-2)"	"unprognostic (7.55e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.20e-2)"	16.5	36.9	12.8	5.7	11.1	13.9	16.9	10.5	19.2	20.9	8.7	16.1	6.9	18.8	3.1	33.8	16.4	8.4	15.1	11.2	11.1	21.1	39.3	13.7	8.0	13.3	11.1	9.5	19.3	18.6	7.9	15.7	4.2	12.7	18.2	3.0	2.1	19.7	7.1	10.7	39.7	12.9	5.2	10.7	16.5	19.7	58.4	12.4	7.2	15.1	5.5	5.4	17.5	23.6	10.7	12.6	16.2	13.0	22.9	6.6	4.9	9.3	9.3	10.7	9.3	9.3	15.4	16.1	7.7	20.2	8.3	13.3	9.5	7.5	12.9	1.7	20.4	9.9	8.0	12.1	23.2	8.5	6.1	30.0	13.8	10.8	7.9	4.6	8.2	15.8	12.7	19.2	15.4	9.4	35.9	17.4	47.4	11.9	16.0	24.9	16.4	13.6	18.9	14.8	17.9	7.1	42.8	17.5	26.3	9.8	5.3	16.2	18.3	19.0	18.5	28.3	38.2	9.2	12.2	12.4	5.5	18.3	69.5	22.7	38.7	29.1	40.3	31.3	22.7	36.9	21.7	36.0	36.7	31.7	22.4	21.3	22.2	21.3	37.5	15.9	21.1	57.2	14.8	12.8	11.1	10.5	19.2	11.2	11.1	13.3	11.1	9.5	12.7	10.7	12.4	10.7	18.5	9.6	7.0	4.6	10.9	12.1	20.0	31.0	21.1	5.7	28.0	25.8	3.6	21.5	16.9	20.2	6.2	6.6	19.8	9.3	43.0	43.2	324.0	15.7	12.8	16.4	21.6	21.7	4.7	42.8	26.3	16.4	12.8	11.2	3.8	11.5	23.6	31.3	29.8	6.7	7.6	14.2	22.4	25.1	14.8	1472.9	27.7	15.6	26.6	1.9	17.4	19.0	25.7	8.5	4.9	43.9	17.3	21.8	7.8	16.2	15.1	48.7	15.9	4.0	13.1	10.7	17.5	20.3	31.1	26.7	19.6	6.2	24.4	16.7	17.0	25.3
MPIG6B	"C6orf25, G6b, G6b-B, NG31"	ENSG00000204420	"Megakaryocyte and platelet inhibitory receptor G6b"	O95866	6	31718594-31726714	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Heparin-binding, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lung: 3.6;lymphoid tissue: 4.8;skin 1: 8.2"	"Cell type enriched"	"Detected in single"	14	"granulocytes: 10.1"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	14	"HEL: 6.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA054404, HPA073017"			Approved	"Nucleoplasm,Endoplasmic reticulum,Golgi apparatus,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		330000	"Golgi apparatus"	"Nucleoplasm, Endoplasmic reticulum, Plasma membrane, Cytosol"	"HPA054404: , HPA073017: AB_2686566"	"unprognostic (1.45e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.53e-2)"	"unprognostic (3.53e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.71e-2)"	0.5	0.0	0.0	0.1	0.0	1.2	0.4	0.1	0.2	0.7	0.1	0.3	0.1	0.4	0.0	1.6	0.5	0.2	0.7	0.0	0.1	0.1	0.3	3.6	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.6	0.0	0.2	8.2	0.4	0.0	0.0	4.8	0.3	2.3	0.1	0.0	0.5	0.0	0.0	0.5	1.3	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.6	0.0	0.8	0.0	2.2	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0
MRGPRX3	MRGX3	ENSG00000179826	"MAS related GPR family member X3"	Q96LB0	11	18120955-18138488	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 1.0;salivary gland: 2.7"	"Cell type enriched"	"Detected in some"	24	"Basal respiratory cells: 53.8"	"Group enriched"	"Detected in some"	4	"head and neck cancer: 1.3;melanoma: 2.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"HBEC3-KT: 13.8"															NA	NA						"unprognostic (1.54e-3)"	"unprognostic (5.07e-2)"			"unprognostic (1.61e-1)"	"unprognostic (1.50e-1)"		"unprognostic (7.65e-2)"	"unprognostic (1.74e-1)"					"unprognostic (4.75e-2)"	"unprognostic (2.09e-1)"			0.0	0.0	0.5	0.3	0.5	0.2	0.6	0.5	0.7	0.0	0.3	0.0	0.1	0.1	0.0	1.0	0.0	0.1	0.0	0.5	0.5	0.0	0.0	0.1	0.1	0.5	0.4	0.4	0.0	0.2	0.0	0.0	0.0	0.5	0.1	0.0	0.1	2.7	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.1	0.3	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.7	0.5	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	1.8	0.3	0.0	13.8	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.5	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.0	0.5	0.2	0.2	0.3	0.3	0.1	0.1	1.4	0.9	0.3	0.1	0.5	0.1	0.1	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.5	0.7	0.5	0.5	0.5	0.4	0.4	0.5	0.0	0.5	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	53.8	0.0	0.0	0.0	0.9	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MS4A2	"APY, FCER1B, IGER, MS4A1"	ENSG00000149534	"Membrane spanning 4-domains A2"	Q01362	11	60088261-60098467	"FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"IgE-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 12.7"	"Cell type enriched"	"Detected in some"	20	"granulocytes: 967.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	908	"basophil: 275.5"	"Lineage enriched"	"Detected in single"	1467	"granulocytes: 275.5"	"Cell line enhanced"	"Detected in some"		"HEL: 2.7;THP-1: 1.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in all"		"spinal cord: 15.3"	HPA059967	Enhanced					NA	NA					"HPA059967: AB_2684183"	"unprognostic (7.28e-2)"	"unprognostic (9.21e-2)"	"unprognostic (2.50e-4)"	"unprognostic (4.97e-2)"	"unprognostic (4.47e-1)"	"unprognostic (2.40e-6)"	"unprognostic (1.88e-2)"	"unprognostic (6.21e-3)"	"unprognostic (3.96e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.63e-3)"	"unprognostic (6.49e-3)"	"unprognostic (9.95e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.74e-1)"	2.2	0.2	0.3	2.5	0.4	0.9	2.8	0.5	0.5	6.4	0.5	5.0	5.6	4.3	3.7	4.8	0.9	8.3	0.6	0.4	0.4	0.5	0.4	12.7	1.1	0.4	0.3	0.4	0.1	0.5	0.4	0.1	0.3	0.4	3.0	5.5	0.0	1.8	2.4	2.9	2.3	6.8	4.1	0.3	0.2	5.4	1.0	0.3	1.2	0.1	1.2	1.8	3.8	2.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.7	0.2	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	275.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.1	0.1	0.1	0.0	0.4	0.3	0.4	0.5	0.5	0.4	0.4	0.4	0.3	0.4	0.4	0.3	0.3	0.5	0.1	0.0	30.9	0.0	0.3	0.0	0.9	0.0	0.0	0.3	0.1	0.1	0.5	0.0	6.8	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.4	0.1	0.1	0.3	0.0	46.7	0.1	0.0	0.1	1.1	0.0	0.1	967.4	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.3	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.5	0.0	0.0	0.7	0.4	0.0	0.7	0.2	0.1	0.1	0.0	0.0	0.0	12.2	0.0	0.0	0.2
MSGN1	pMesogenin1	ENSG00000151379	"Mesogenin 1"	A6NI15	2	17816460-17817798	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	26	"Basal squamous epithelial cells: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA							"unprognostic (3.63e-2)"				"unprognostic (3.25e-2)"									"unprognostic (1.66e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
MSRB3	"DFNB74, DKFZp686C1178, FLJ36866"	ENSG00000174099	"Methionine sulfoxide reductase B3"	Q8IXL7	12	65278643-65491430	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	12	"Cardiomyocytes: 2801.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 41.6"	"Lineage enhanced"	"Detected in many"		"granulocytes: 41.6"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 126.1;hTERT-RPE1: 110.6;U-937: 106.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014432	Enhanced				"Intracellular and membrane"	NA	NA					"HPA014432: AB_1854146"	"unprognostic (1.40e-2)"	"prognostic unfavorable (3.84e-4)"	"unprognostic (2.86e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.33e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (8.85e-8)"	"unprognostic (3.29e-3)"	"unprognostic (7.80e-2)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (2.17e-4)"	45.3	10.8	12.9	21.1	12.9	21.4	26.5	12.0	13.5	28.9	20.1	79.1	12.0	86.5	20.3	63.5	41.8	33.5	91.7	11.8	22.7	10.0	3.9	30.9	5.7	16.3	14.3	9.9	17.1	5.9	3.2	6.8	25.4	13.4	53.2	28.0	12.6	10.9	104.0	105.0	8.9	25.8	124.9	14.2	13.7	36.5	5.9	17.4	4.1	14.6	69.8	4.0	61.4	23.9	13.4	8.8	19.2	16.4	75.9	71.6	63.0	0.5	87.0	92.9	33.2	19.8	0.7	1.0	0.0	18.3	126.1	10.5	1.9	7.7	22.1	30.0	0.2	15.9	0.0	16.7	0.9	46.6	47.1	0.3	33.4	11.9	28.1	39.0	110.6	68.2	0.1	0.3	0.3	76.8	2.9	0.0	11.0	5.4	0.2	10.4	0.2	22.0	0.5	7.5	1.0	0.4	7.9	30.0	1.8	21.9	16.8	14.1	44.5	78.9	42.3	22.8	19.5	34.2	8.0	6.7	0.2	11.5	106.7	26.9	15.0	0.6	41.6	0.2	0.9	0.1	0.1	0.1	0.1	0.2	0.3	0.2	0.2	6.8	8.3	0.4	10.8	0.1	1.4	12.9	12.9	12.0	13.5	11.8	22.7	16.3	14.3	9.9	13.4	14.2	17.4	13.4	55.3	12.8	3.4	76.7	0.8	6.4	16.4	11.4	4.0	22.7	2.2	45.3	2801.7	4.3	1.2	3.7	0.0	0.4	8.3	0.0	0.0	9.3	5.7	0.9	16.7	154.2	0.0	17.4	37.1	1.0	0.4	108.8	1.1	0.4	2.5	7.4	28.2	0.2	0.5	21.9	56.6	0.0	0.0	0.0	13.7	2.2	12.5	4.0	10.6	62.8	1.6	44.4	2.1	37.7	1.4	1.6	0.0	116.6	0.3	14.8	0.0	0.4	6.8	10.6	105.2	37.7	218.7	4.2	4.7	0.8	4.5	0.7	2.4	10.3	0.0	2.9
MSTO1	"FLJ10504, LST005, misato, MST"	ENSG00000125459	"Misato mitochondrial distribution and morphology regulator 1"	Q9BUK6	1	155610205-155614951	"Disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Late spermatids: 1482.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005899, HPA005914, HPA006075"	Approved		Enhanced	Cytosol		NA	NA			Cytosol		"HPA005899: AB_2667460, HPA005914: AB_2667466, HPA006075: "	"unprognostic (1.80e-2)"	"unprognostic (3.43e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.46e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (9.63e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.28e-2)"	"unprognostic (3.73e-2)"	"unprognostic (3.67e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.56e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.28e-1)"	18.1	18.4	8.3	10.3	8.6	7.4	19.0	9.4	9.5	16.8	7.6	11.4	8.8	16.3	18.1	14.8	16.9	7.3	13.7	9.3	8.7	18.0	32.0	12.8	11.5	10.2	9.7	7.7	17.2	25.3	15.0	24.5	8.7	10.6	20.9	9.1	7.9	14.5	15.0	6.9	11.7	15.8	11.9	8.0	21.4	14.8	23.3	9.8	8.7	18.7	4.7	10.8	16.0	12.9	8.9	23.0	31.1	26.7	41.1	21.9	18.5	33.3	28.8	24.5	35.1	27.9	30.8	14.3	39.5	26.1	25.9	22.6	24.7	40.2	38.8	24.2	15.3	33.6	34.1	29.5	17.8	34.8	36.7	26.4	19.2	19.4	38.8	55.7	15.6	29.2	28.5	28.4	17.3	29.3	37.7	24.7	24.9	35.4	38.6	40.8	21.2	25.0	35.4	29.6	23.1	22.0	26.7	20.2	60.6	26.3	31.2	33.5	49.2	19.5	22.2	24.3	24.0	44.9	36.4	33.8	29.3	25.0	35.6	30.9	3.5	5.9	0.4	10.0	8.3	11.2	7.4	9.4	9.1	8.4	5.5	9.8	6.2	0.7	9.6	5.5	8.4	7.5	6.8	8.3	8.6	9.4	9.5	9.3	8.7	10.2	9.7	7.7	10.6	8.0	9.8	8.9	4.6	6.4	6.0	3.9	8.8	2.7	6.1	8.6	5.2	9.1	6.6	4.4	9.7	2.8	7.2	7.3	22.9	7.9	5.8	2.9	3.9	9.6	324.5	4.2	8.2	6.1	5.4	3.8	2.0	13.4	23.7	6.3	12.8	4.7	14.5	9.5	2.2	7.1	8.7	11.8	2.1	4.9	2.0	2.6	3.5	1482.8	9.0	5.5	3.6	1.0	6.3	4.6	3.1	2.5	2.2	8.0	0.9	11.3	17.0	5.5	2.8	9.9	10.9	9.7	0.0	6.7	6.4	23.0	12.6	6.3	1.4	6.6	7.2	7.1	4.6	2.8
MT-ATP6	"ATP6, ATPase-6, MTATP6, RP, Su6m"	ENSG00000198899	"Mitochondrially encoded ATP synthase membrane subunit 6"	P00846	MT	8527-9207	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"		"Cardiomyopathy, Disease variant, Leber hereditary optic neuropathy, Leigh syndrome, Neuropathy, Primary mitochondrial disease, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 172223.8"	"Cell type enriched"	"Detected in many"	6	"Cardiomyocytes: 183462.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 15099.8"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 15099.8"	"Cell line enriched"	"Detected in all"	4	"HeLa: 81002.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.97e-1)"	"unprognostic (4.16e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.55e-2)"	"unprognostic (8.45e-3)"	"unprognostic (1.66e-1)"	"prognostic favorable (3.79e-4)"	"unprognostic (6.47e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.44e-2)"	"prognostic favorable (7.64e-4)"	"unprognostic (6.01e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.56e-1)"	"unprognostic (2.52e-3)"	26129.7	50311.0	77728.6	5809.7	78792.2	5307.7	24910.8	72560.4	112900.1	10565.3	83902.2	30700.9	16104.6	12754.9	6279.1	19134.0	12236.5	5261.4	172223.8	72883.3	66558.6	96709.9	109278.1	13366.0	4651.1	94216.9	72799.7	60937.8	11094.0	26955.6	15420.6	17626.3	7398.6	90587.5	26760.3	12112.4	12790.0	19834.7	7128.3	111829.2	20121.2	29802.0	5877.4	63727.6	15614.0	42731.3	15126.7	82041.6	2907.2	17218.3	67707.6	4381.2	21390.0	13077.2	75847.4	5618.9	8971.4	6145.8	9667.8	11469.9	2606.5	4002.9	8017.4	1465.1	1068.3	1770.2	10629.5	5953.7	9842.8	3325.6	4356.6	1640.3	11849.7	653.2	6255.4	1954.9	7091.2	5605.0	8645.7	81002.5	18778.0	1945.0	5183.5	10726.9	4289.5	5409.3	1909.8	1824.4	7406.7	1920.7	5418.1	5810.5	6963.2	4174.7	15671.4	3204.2	13620.4	1620.4	4244.5	3674.4	3985.7	2622.4	6104.2	10727.8	13879.3	3495.2	4452.8	2870.3	6024.9	6026.0	10017.9	6477.5	17539.6	10178.1	4280.9	6317.4	7166.3	5880.9	3051.9	4303.3	7137.5	3739.9	10744.5	2455.0	15099.8	2475.3	4245.7	1346.3	1650.5	1689.2	2678.1	1534.6	1712.3	1211.4	2550.5	1774.0	2220.6	2427.2	1828.9	1841.1	1470.9	1232.4	1223.2	77728.6	78792.2	72560.4	112900.1	72883.3	66558.6	94216.9	72799.7	60937.8	90587.5	63727.6	82041.6	75847.4	4123.3	1487.2	1804.3	0.0	6867.9	2903.0	6184.5	4172.7	7102.6	0.0	4343.1	7054.0	183462.2	11539.8	3367.8	6422.4	0.0	0.0	6110.1	15211.0	1880.2	2059.0	908.9	7527.8	6522.7	7371.6	3995.8	17562.3	0.0	3405.9	0.0	6067.7	6569.9	13453.0	2064.3	20320.2	9969.1	26635.5	0.0	0.0	0.0	10468.7	2803.5	16148.3	2386.4	4627.8	7672.0	5539.3	2534.6	0.0	4773.4	0.0	4080.4	0.0	0.0	2818.6	9241.3	4966.1	7780.1	4657.8	24094.7	14129.0	3106.0	0.0	6304.4	11559.3	7641.7	5682.1	5225.7	5947.3	3034.9	0.0	6304.5	12298.1	10197.0	7899.3
MT-ATP8	"A6L, ATP8, MTATP8"	ENSG00000228253	"Mitochondrially encoded ATP synthase membrane subunit 8"	P03928	MT	8366-8572	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"		"Cardiomyopathy, Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 254447.9"	"Cell type enriched"	"Detected in many"	7	"Cardiomyocytes: 29301.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"basophil: 10572.1"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 10572.1"	"Cell line enhanced"	"Detected in all"		"HeLa: 50977.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.54e-1)"	"unprognostic (4.12e-2)"	"unprognostic (3.95e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (7.56e-5)"	"unprognostic (5.17e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.52e-3)"	"unprognostic (8.26e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.63e-2)"	53012.1	73645.3	90600.2	6396.5	88959.1	4624.3	40301.3	84683.9	135906.4	14884.5	105942.0	46699.8	21094.4	18977.5	2127.4	28593.3	17393.7	3597.6	254447.9	84346.3	77576.9	120819.3	156462.7	20504.9	3699.0	109730.5	83733.5	73633.9	16809.2	41389.0	34682.7	26230.8	5141.8	112044.6	39707.2	6830.0	18664.9	30912.9	4395.9	193712.5	32365.0	47507.3	2697.9	74560.9	20481.5	64344.9	22441.4	90221.8	4597.6	27373.9	94318.9	2419.3	29700.0	19955.8	93381.6	9856.9	3525.9	11216.6	2135.1	11962.8	1899.3	5504.5	19957.4	1175.7	896.0	1537.1	4090.3	6356.6	24786.3	4872.4	4328.0	3394.0	16426.4	706.7	6608.9	1397.3	11058.2	4500.9	18761.8	50977.1	9430.6	2174.3	11096.3	15424.0	4128.5	3403.9	1971.6	1680.6	12377.4	1285.7	9692.8	10174.9	7582.9	2738.5	5189.9	6492.1	16113.6	2467.4	5471.7	2512.1	5306.1	5447.4	5282.8	6499.8	9510.1	3516.6	6319.5	7567.6	6909.7	7767.4	17681.0	6781.8	22941.8	18909.8	4285.7	9562.3	9574.5	9412.0	5112.9	9201.9	14522.4	4225.0	18954.8	2666.9	10572.1	1775.5	2174.2	955.4	1388.5	1410.8	1767.9	1079.8	1154.3	992.0	1612.2	1301.2	1614.6	968.7	1526.5	1514.0	1189.7	924.2	673.4	90600.2	88959.1	84683.9	135906.4	84346.3	77576.9	109730.5	83733.5	73633.9	112044.6	74560.9	90221.8	93381.6	76.9	189.1	178.7	0.0	1182.0	11.6	7.0	9.5	3775.0	0.0	104.1	150.4	29301.8	225.9	340.8	12.9	0.0	0.0	78.7	124.2	3.9	13.4	7.3	182.9	170.7	625.6	29.2	733.7	0.0	30.7	0.0	771.2	3726.9	282.0	295.9	161.6	219.2	729.6	0.0	0.0	0.0	59.9	0.0	344.8	8.0	42.1	40.7	539.8	12.4	0.0	23.5	0.0	21.6	0.0	0.0	20.3	98.8	25.2	1785.2	4.5	63.6	21.3	363.2	0.0	39.5	113.1	718.6	23.9	30.7	2607.0	9.1	0.0	731.3	62.3	52.8	6.7
MT-CO2	"CO2, COX2, MTCO2"	ENSG00000198712	"Mitochondrially encoded cytochrome c oxidase II"	P00403	MT	7586-8269	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Electron transport, Respiratory chain, Transport"	Translocase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 161733.2"	"Cell type enriched"	"Detected in many"	13	"Cardiomyocytes: 709929.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 73985.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016243, HPA051505, HPA054758"	Enhanced					NA	NA		240000			"CAB016243: AB_2066366, HPA051505: AB_2681511, HPA054758: AB_2682595"	"unprognostic (2.67e-1)"	"unprognostic (5.72e-2)"	"unprognostic (4.57e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.96e-2)"	"prognostic favorable (2.89e-4)"	"unprognostic (1.06e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.72e-3)"	"prognostic favorable (7.10e-4)"	"unprognostic (1.25e-1)"	"unprognostic (9.30e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.50e-2)"	"unprognostic (3.72e-3)"	23809.4	50528.2	113718.8	6015.2	115560.3	9289.0	23308.7	103093.1	161733.2	8633.9	116564.9	39379.1	18405.0	10129.1	10907.7	24728.2	11110.3	5966.5	141681.1	108498.6	100947.0	110468.7	106309.0	14153.9	6365.2	128597.3	109871.0	94676.1	8017.4	24721.3	30045.5	16993.0	10484.6	134367.9	25907.3	25229.1	9061.9	21555.4	13030.0	94136.6	21618.8	36423.0	9779.8	99835.0	18340.6	45780.6	14629.6	122532.6	6089.9	17016.6	110904.6	7955.3	21246.9	13295.2	112398.4	6276.2	9796.4	12777.6	12396.3	25548.5	9745.3	9393.2	7927.6	6429.8	4420.4	6584.3	10616.0	13681.5	12924.1	6467.6	11751.8	4522.1	23074.6	1724.1	16319.1	5925.8	10089.3	8726.0	9297.7	73985.8	20756.8	5543.0	7919.2	9987.0	14433.8	23568.7	2276.3	8072.8	14337.8	4979.3	12668.7	8862.9	12216.0	12212.6	13490.3	5804.8	22519.7	3353.4	12256.7	6160.6	5998.2	3899.6	10866.7	17578.2	17096.2	4758.2	7830.6	6527.3	15842.4	11881.3	18742.2	11084.6	31596.4	12345.0	10576.0	9043.3	10116.0	5740.6	6151.2	6563.0	7590.8	5638.0	15586.1	7129.7	20953.0	13541.7	15753.7	5586.8	8887.6	6782.0	11844.8	6189.5	6338.9	6316.7	10947.0	6386.1	7947.1	5329.9	6846.5	10055.3	8426.1	5367.4	7670.7	113718.8	115560.3	103093.1	161733.2	108498.6	100947.0	128597.3	109871.0	94676.1	134367.9	99835.0	122532.6	112398.4	4337.7	1445.5	1999.8	0.0	11825.3	6754.0	8961.4	22171.6	22140.9	0.0	11994.6	16742.4	709929.9	18464.2	10323.3	18597.6	0.0	0.0	7569.1	29582.2	3709.5	3684.4	1119.7	12108.5	6979.9	16215.0	6396.9	27238.9	0.0	4873.7	0.0	10942.5	19089.4	20683.3	2144.6	17185.5	15141.7	53416.5	0.0	0.0	0.0	17158.1	14290.0	26774.7	4814.0	5284.9	7663.3	9292.7	5140.4	0.0	7967.0	0.0	6828.1	0.0	0.0	4709.1	15133.6	5123.0	14109.6	5949.4	40280.5	22569.2	7617.1	0.0	7060.4	9361.8	14171.2	7120.5	8965.1	26952.2	6702.8	0.0	8863.0	13639.8	19371.4	14261.8
MT-ND1	"MTND1, NAD1, ND1"	ENSG00000198888	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1"	P03886	MT	3307-4262	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"	Translocase	"Alzheimer disease, Amyloidosis, Diabetes mellitus, Disease variant, Epilepsy, FDA approved drug targets, Leber hereditary optic neuropathy, MELAS syndrome, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 112263.5;heart muscle: 90921.1"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 101184.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 9432.2"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 9432.2"	"Cell line enhanced"	"Detected in all"		"HeLa: 28480.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033779, HPA066847"	Approved					NA	NA					"CAB033779: AB_2149736, HPA066847: "	"prognostic favorable (3.63e-4)"	"unprognostic (3.55e-1)"	"unprognostic (3.77e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.95e-3)"	"unprognostic (5.84e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.05e-2)"	"prognostic favorable (3.26e-4)"	"unprognostic (8.67e-2)"	"unprognostic (8.66e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.85e-2)"	18998.0	25141.1	73075.3	2707.2	73846.7	3486.3	18053.2	69171.1	112263.5	4392.8	72811.1	16638.9	6474.6	5979.3	6485.1	8432.9	6172.3	2871.9	90921.1	69327.8	65582.2	47460.2	45392.3	7945.4	2264.2	88943.4	69300.5	60576.1	4675.4	15652.8	12630.0	8056.0	5206.6	81982.0	11455.3	8875.7	6512.4	11523.4	7113.9	69755.1	14410.3	17076.6	3882.9	62244.9	8294.5	26245.9	12318.7	76272.4	2178.7	7290.5	62005.3	3011.5	10421.0	5489.5	75875.4	3533.6	3499.2	2812.3	2571.1	10434.4	1879.8	3604.8	2946.1	872.8	805.7	835.0	6132.0	3710.1	4259.8	1831.7	2239.3	810.9	2285.7	316.3	1774.7	1592.0	3064.7	2432.6	4755.7	28480.4	8841.6	2231.9	2279.1	4495.2	4494.5	4734.4	1241.1	1773.2	3240.7	877.2	1226.5	2235.4	2580.5	2400.4	4813.7	1841.1	9325.6	757.8	2191.3	2603.6	1916.7	1277.6	2295.7	4312.3	5574.2	1165.0	1844.2	1632.5	2572.1	2943.6	3403.7	2306.2	7771.2	4632.1	2652.3	2396.0	3427.2	2511.3	2841.3	1883.7	2015.4	1784.6	3937.3	744.7	9432.2	1265.2	2347.3	512.4	662.6	732.0	1155.4	614.6	683.5	439.9	1185.3	800.8	960.2	3270.7	759.6	733.2	677.2	480.0	507.7	73075.3	73846.7	69171.1	112263.5	69327.8	65582.2	88943.4	69300.5	60576.1	81982.0	62244.9	76272.4	75875.4	1754.9	1352.6	1511.3	0.0	3159.5	2265.8	3355.3	1632.2	2928.1	0.0	3174.3	3513.1	101184.9	9771.1	1985.3	4610.8	0.0	0.0	2175.7	12456.8	1033.1	1511.9	1087.5	3160.1	1985.1	4881.6	3135.6	8308.9	0.0	3595.1	0.0	2970.8	2347.6	5039.6	1402.2	7165.4	7745.2	16276.4	0.0	0.0	0.0	10835.1	927.7	12435.2	1651.4	5233.2	7049.5	2982.5	1497.7	0.0	4450.1	0.0	2385.2	0.0	0.0	2180.4	8080.9	3546.9	2046.0	3735.0	18353.7	8183.6	1760.8	0.0	6409.6	6534.6	4075.7	4806.0	5071.3	2061.1	2073.2	0.0	2839.0	4329.0	10735.4	5236.0
MT-ND4	"LHON, MTND4, NAD4, ND4"	ENSG00000198886	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4"	P03905	MT	10760-12137	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"	Translocase	"Disease variant, Dystonia, Leber hereditary optic neuropathy, MELAS syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 137287.9"	"Cell type enriched"	"Detected in many"	7	"Cardiomyocytes: 253563.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 13456.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 41594.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053928	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA053928: AB_2682313"	"unprognostic (8.39e-2)"	"unprognostic (1.83e-1)"	"unprognostic (7.29e-2)"	"unprognostic (9.54e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.50e-3)"	"unprognostic (8.16e-2)"	"unprognostic (1.45e-1)"	"prognostic favorable (1.76e-4)"	"unprognostic (1.01e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.14e-2)"	"unprognostic (4.24e-2)"	20658.1	43922.2	86296.9	4231.6	84800.0	3683.9	19527.9	76338.0	120140.6	8424.5	91101.6	26265.1	11121.8	10854.6	6855.4	16014.7	10715.8	4663.8	137287.9	78671.7	72792.5	75146.2	102227.7	11958.7	3851.1	100889.9	79118.2	67242.3	9032.7	21656.0	15848.4	12934.0	7756.8	98820.8	22403.6	15152.1	14235.8	17652.8	11801.9	62065.6	16809.5	25255.8	7178.8	71321.8	12885.4	39917.5	13676.8	89007.8	3263.7	14907.0	71231.6	4954.5	19582.1	10396.1	90827.3	4251.7	4285.9	5449.6	8075.1	12523.6	3123.1	3808.6	4184.0	1603.2	958.4	1834.2	6555.4	4688.4	7428.4	3608.7	3590.8	1396.3	7685.0	496.1	6777.9	1691.7	4330.2	2654.6	4592.7	41594.9	11166.3	1884.9	4672.8	5223.9	5330.2	7007.6	1403.3	4977.9	8925.4	2344.4	3683.1	3908.9	8930.2	3461.9	9508.0	1848.1	10481.0	1551.2	3650.3	2876.4	2481.0	1712.1	4518.2	6770.1	8938.3	1999.0	2694.8	2434.3	7967.3	4267.8	9600.3	5601.2	10888.7	6532.2	3851.7	3726.9	5232.7	3330.8	5307.6	2292.6	3407.7	2514.1	7881.4	2100.8	13456.8	3334.1	7103.1	1902.0	2192.8	2614.3	3555.5	2129.5	2285.7	1616.0	3624.4	2452.9	3095.1	2513.1	2106.5	2329.2	2112.6	1668.2	1840.0	86296.9	84800.0	76338.0	120140.6	78671.7	72792.5	100889.9	79118.2	67242.3	98820.8	71321.8	89007.8	90827.3	3065.0	1269.2	1516.1	0.0	6183.3	4404.5	9073.3	7719.8	2713.0	0.0	6210.4	6965.6	253563.4	15377.3	4975.3	12806.1	0.0	0.0	4005.7	20185.0	2435.8	2924.2	1109.7	6731.7	4298.6	9316.2	5090.0	20898.0	0.0	4058.3	0.0	5843.3	5601.5	11920.4	2188.6	15486.9	13931.3	35046.7	0.0	0.0	0.0	14557.8	5771.7	22254.8	3452.7	5132.5	8834.9	4749.3	3799.3	0.0	6280.7	0.0	4212.2	0.0	0.0	3710.0	12363.2	5788.3	3409.4	5872.9	28978.7	17714.1	4527.9	0.0	6310.9	8264.3	7732.9	6461.4	6003.0	3008.8	4937.6	0.0	5125.3	7671.5	15595.2	11405.7
MT-ND4L	"MTND4L, NAD4L, ND4L"	ENSG00000212907	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L"	P03901	MT	10470-10766	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"	Translocase	"Disease variant, Leber hereditary optic neuropathy, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 134041.0"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 30444.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 50775.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075648			Approved	Centrosome,Mitochondria		NA	NA			Mitochondria	Centrosome	"HPA075648: AB_2686760"	"unprognostic (5.81e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.76e-2)"	"unprognostic (7.91e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (4.47e-4)"	"unprognostic (1.97e-1)"	"unprognostic (4.04e-2)"	"unprognostic (4.63e-3)"	"unprognostic (6.61e-2)"	"unprognostic (7.38e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.09e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.97e-2)"	"unprognostic (5.68e-2)"	20284.3	30118.1	82919.4	4159.7	82861.5	3141.7	15057.0	80554.6	134041.0	6937.8	87207.2	18576.1	9108.0	7744.1	6029.0	10908.0	7818.9	4404.5	101941.2	81380.5	78950.0	46194.6	75538.8	8535.5	2809.8	92169.1	80564.4	73967.3	6785.7	16172.4	20594.0	9306.1	5889.2	88098.2	16578.2	14178.9	15885.7	13020.1	12836.1	59551.4	12235.3	17158.2	7041.9	75680.3	7344.0	28422.9	9635.9	85447.3	4476.2	11363.4	103996.2	4893.3	15242.1	7500.1	91212.5	4598.0	4121.5	7308.1	7468.2	25088.0	5217.1	3223.3	9523.0	2384.3	1468.4	2651.9	6894.3	4080.7	11229.9	3809.7	6497.0	2387.4	8496.5	1155.8	10210.3	2895.1	4454.2	4711.8	8095.9	50775.4	13024.1	3671.8	8429.4	6965.0	9229.0	10159.4	2792.9	9675.2	10923.1	2983.6	5697.7	4556.7	7771.2	5412.1	8124.5	3199.8	10639.4	1846.3	4811.8	4953.4	1842.5	3155.8	5025.1	7636.0	9464.9	2208.4	2971.3	4666.2	7283.7	3197.8	15599.0	5199.9	10420.1	9592.2	3792.1	4708.5	5630.1	3738.0	6985.1	3552.9	6053.5	2725.1	11018.8	1816.1	16170.2	4327.0	8286.8	2536.0	2849.6	3435.6	4233.2	2723.9	2939.9	2282.7	4618.7	3206.8	4006.1	2010.3	2906.4	2817.9	2884.1	2096.4	2551.4	82919.4	82861.5	80554.6	134041.0	81380.5	78950.0	92169.1	80564.4	73967.3	88098.2	75680.3	85447.3	91212.5	503.6	224.4	217.6	0.0	2303.6	228.5	254.2	170.4	5991.6	0.0	764.0	886.3	30444.3	1464.1	438.4	323.7	0.0	0.0	449.8	1428.3	90.1	152.9	52.8	870.1	618.8	942.3	256.6	3302.0	0.0	342.2	0.0	1129.2	5335.9	1186.3	479.3	1394.0	1520.3	4413.7	0.0	0.0	0.0	727.8	99.7	1977.9	193.5	286.1	417.2	1043.8	256.1	0.0	312.9	0.0	133.9	0.0	0.0	284.5	867.0	230.9	4395.8	129.7	1228.2	589.4	582.7	0.0	348.4	711.2	1052.8	247.0	207.4	5256.4	242.2	0.0	1387.0	308.6	573.4	207.9
MT-ND5	"MTND5, NAD5, ND5"	ENSG00000198786	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5"	P03915	MT	12337-14148	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"	Translocase	"Disease variant, Leber hereditary optic neuropathy, Leigh syndrome, MELAS syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 26244.7;skeletal muscle: 25940.2"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 35040.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 10198.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.87e-1)"	"unprognostic (3.18e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.07e-3)"	"unprognostic (5.09e-3)"	"unprognostic (1.06e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.29e-3)"	"unprognostic (4.78e-2)"	"prognostic favorable (7.31e-5)"	"unprognostic (9.93e-3)"	"unprognostic (8.75e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.68e-2)"	5336.1	4816.9	20153.2	1757.9	19867.7	1538.5	2477.7	15855.2	21563.1	1426.2	20703.9	3747.8	4172.7	1989.2	2530.1	2742.9	3056.5	2058.5	20920.1	17658.5	15492.0	7914.0	10123.6	2706.6	1190.0	26244.7	17622.9	12481.6	1902.9	2653.6	4854.7	1540.7	1705.7	25702.0	2837.5	2905.7	3293.5	2843.6	2184.3	25940.2	6710.7	4820.6	2667.0	13941.7	2030.5	6728.6	1693.7	22479.6	802.1	2076.0	19616.6	1554.7	3587.2	1550.6	20825.5	1615.8	1671.5	1998.7	1937.9	5903.9	1530.3	1075.8	3208.3	492.5	355.1	583.1	2472.6	2051.0	3865.3	1590.5	1510.4	397.3	3350.6	191.2	1685.7	583.4	2182.3	1281.4	2840.4	10198.2	4239.2	678.8	2010.7	2824.3	2305.4	1315.5	401.6	951.8	1933.5	725.2	1233.3	1056.8	1794.8	1216.3	3046.1	757.3	2453.4	397.5	910.2	903.0	1432.9	938.2	1668.7	2083.2	3132.2	595.0	904.1	1496.1	2636.3	894.4	3001.9	1927.1	2979.2	5094.9	2013.2	1403.2	2409.7	1271.9	678.8	1246.0	1066.9	1077.4	1780.4	897.7	2851.8	1521.7	874.2	771.4	980.3	922.8	979.1	753.9	839.2	746.5	1096.6	729.2	869.0	446.2	785.1	1039.5	890.3	628.6	492.0	20153.2	19867.7	15855.2	21563.1	17658.5	15492.0	26244.7	17622.9	12481.6	25702.0	13941.7	22479.6	20825.5	773.3	628.2	594.2	0.0	1707.9	895.1	1050.1	1005.5	3261.6	0.0	1003.4	1025.1	35040.8	2566.4	934.5	1156.8	0.0	0.0	977.0	3181.2	283.7	804.1	109.5	3130.4	2025.6	1614.3	782.9	3776.6	0.0	936.6	0.0	1437.2	3609.6	5212.8	862.1	2987.5	2623.3	6597.7	0.0	0.0	0.0	1776.8	583.9	3664.2	661.9	528.9	1057.5	1364.5	608.3	0.0	1303.9	0.0	756.0	0.0	0.0	1327.8	2211.7	848.6	2674.2	753.3	4484.5	2410.8	1282.0	0.0	696.8	1941.5	1558.6	652.2	521.9	3002.4	973.6	0.0	1527.8	1560.9	1650.5	1506.6
MT-ND6	"MTND6, NAD6, ND6"	ENSG00000198695	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6"	P03923	MT	14149-14673	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"	Translocase	"Disease variant, Dystonia, Leber hereditary optic neuropathy, Leigh syndrome, MELAS syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 36141.3;skeletal muscle: 58428.6"	"Cell type enriched"	"Detected in many"	13	"Cardiomyocytes: 15756.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 20826.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.96e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.03e-3)"	"unprognostic (6.02e-3)"	"unprognostic (1.68e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.06e-3)"	"unprognostic (2.91e-1)"	"prognostic favorable (8.91e-6)"	"unprognostic (3.64e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.92e-2)"	8016.0	6362.1	7658.3	3215.6	7735.1	3280.3	3122.5	3655.9	8795.7	1760.9	11735.7	5344.7	7912.0	3171.3	55.0	5876.4	5494.9	3464.6	36141.3	5505.2	4454.4	9498.0	11793.1	4637.9	2523.5	17376.5	4986.4	1025.0	2144.9	4187.6	69.8	1383.5	961.1	17708.2	2530.8	98.7	4351.6	4119.9	41.0	58428.6	15347.2	8073.3	52.3	1809.8	4239.4	10112.5	2011.3	12608.0	41.3	2583.4	245.7	43.5	5279.8	1913.2	10185.4	3305.7	2595.3	2255.7	2869.4	371.0	34.6	1614.6	4329.1	8.9	13.9	14.2	3553.8	3233.4	6999.5	2873.3	117.5	423.7	4781.1	25.1	79.1	23.3	4178.5	1966.3	4217.6	20826.9	10361.0	29.7	2704.1	3805.1	64.4	103.3	103.9	86.4	2123.1	23.2	1445.3	1855.2	2671.0	94.5	6976.5	836.0	3680.9	492.5	1868.7	1267.3	2002.7	1440.3	3034.3	60.9	9493.6	926.2	1476.3	2250.2	3898.6	1876.3	3559.0	3037.2	5182.3	8822.6	2473.6	2088.6	3550.5	1766.8	906.6	2600.9	1705.0	1682.9	2680.8	1473.8	2089.0	1092.3	645.1	733.4	881.5	840.2	1047.3	776.1	800.0	582.8	1016.1	760.2	870.6	453.3	752.2	963.0	790.6	635.2	365.4	7658.3	7735.1	3655.9	8795.7	5505.2	4454.4	17376.5	4986.4	1025.0	17708.2	1809.8	12608.0	10185.4	31.2	83.3	62.2	0.0	328.4	16.8	55.8	75.1	1210.0	0.0	52.2	31.2	15756.5	273.1	107.1	128.8	0.0	0.0	78.9	125.6	17.6	32.6	8.2	154.1	132.5	478.6	30.1	797.7	0.0	35.3	0.0	396.2	886.9	247.7	98.0	130.6	385.8	699.5	0.0	0.0	0.0	59.8	44.7	518.3	20.1	33.4	62.4	214.3	33.8	0.0	66.3	0.0	48.4	0.0	0.0	25.6	69.9	45.1	1055.4	152.0	76.1	175.7	111.0	0.0	59.2	121.6	423.9	31.7	60.5	1160.0	20.5	0.0	266.3	58.1	78.4	117.0
MT1F	MT1	ENSG00000198417	"Metallothionein 1F"	P04733	16	56657731-56660698	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 590.1;kidney: 579.1;liver: 566.6;thyroid gland: 1194.1"	"Cell type enriched"	"Detected in many"	5	"Proximal tubular cells: 10399.1"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 61.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 55.6;classical monocyte: 30.2;gdT-cell: 47.0;MAIT T-cell: 41.8;memory B-cell: 25.7;memory CD4 T-cell: 48.9;memory CD8 T-cell: 80.3;naive CD4 T-cell: 49.4;naive CD8 T-cell: 85.5;T-reg: 89.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 143.4;NB-4: 238.9;NTERA-2: 137.1;RPTEC TERT1: 754.6;THP-1: 131.9;U-937: 126.2"															NA	NA		160000				"unprognostic (4.15e-2)"	"unprognostic (3.60e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.88e-3)"	"unprognostic (2.70e-1)"	"unprognostic (4.08e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.53e-1)"	"prognostic unfavorable (2.02e-7)"	"unprognostic (2.78e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.85e-1)"	28.7	60.9	318.7	30.2	324.1	10.3	16.6	374.2	590.1	8.1	283.4	159.8	82.9	8.7	2.7	10.7	20.0	19.3	7.9	307.5	310.0	579.1	566.6	11.6	23.6	362.4	332.2	300.1	2.8	315.0	5.1	23.4	4.0	339.8	71.1	124.1	52.9	18.5	14.1	2.9	8.3	224.0	16.7	318.6	20.7	89.1	4.5	349.8	6.4	1194.1	1.8	14.7	14.9	6.1	326.4	4.9	7.4	0.0	0.2	0.4	0.3	10.0	6.1	15.6	5.6	9.5	2.0	29.5	0.1	19.3	1.3	8.8	26.5	51.5	6.0	5.8	143.4	7.1	8.9	1.4	2.6	3.7	0.2	100.9	1.5	1.7	6.1	1.7	2.5	0.8	2.1	0.4	0.1	0.3	14.7	0.4	238.9	137.1	1.2	12.9	0.0	0.6	4.4	754.6	5.3	75.1	8.3	6.1	2.4	2.6	19.8	3.5	131.9	0.0	0.0	1.7	0.9	0.7	0.4	0.0	0.0	87.5	126.2	1.1	55.6	30.2	8.9	47.0	2.8	41.8	25.7	48.9	80.3	8.2	10.7	49.4	85.5	4.8	8.1	1.4	3.3	89.2	64.1	318.7	324.1	374.2	590.1	307.5	310.0	362.4	332.2	300.1	339.8	318.6	349.8	326.4	25.9	0.0	9.3	18.6	55.4	8.5	28.1	18.6	18.2	0.0	42.0	77.1	9.5	181.6	15.1	327.4	0.0	6.7	27.5	652.8	1119.2	194.4	0.6	376.6	79.5	16.8	170.9	95.6	0.1	123.2	379.6	22.5	57.1	946.3	11.4	77.8	48.9	1365.5	29.6	0.0	0.0	631.0	4.1	70.3	9.4	1.9	31.4	115.6	92.5	2.8	53.4	0.0	27.8	1.0	0.3	126.5	1252.2	5.3	65.9	107.0	2028.8	10399.1	22.6	0.0	6.6	26.4	41.6	3.2	1.5	3.9	8.0	19.4	68.6	6.9	851.3	19.2
MT1G	"MT1, MT1K"	ENSG00000125144	"Metallothionein 1G"	P13640	16	56666730-56668065	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 3506.9;liver: 7016.2;thyroid gland: 2912.8"	"Cell type enriched"	"Detected in many"	4	"Proximal tubular cells: 77919.3"	"Group enriched"	"Detected in all"	4	"liver cancer: 320.1;ovarian cancer: 106.9;prostate cancer: 103.9;testis cancer: 269.9;thyroid cancer: 369.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	4	"U-937: 1103.8"														"Intracellular and membrane"	NA	NA						"unprognostic (1.62e-1)"	"unprognostic (4.21e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.97e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.21e-1)"	"prognostic unfavorable (1.67e-7)"	"unprognostic (1.42e-1)"	"unprognostic (3.50e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.26e-2)"	124.7	21.7	342.2	106.7	413.9	2.9	28.3	393.5	919.5	12.4	301.5	828.7	518.4	8.4	2.4	257.4	76.2	12.1	6.8	338.0	346.5	3506.9	7016.2	50.3	5.6	403.6	361.9	358.6	3.2	1822.1	0.3	21.8	2.1	372.5	428.9	521.1	43.0	44.5	5.9	8.5	56.7	1105.7	77.0	331.0	3.9	1272.7	4.0	363.1	0.9	2912.8	1.0	2.6	14.3	26.1	402.5	0.4	0.0	0.0	0.0	0.0	0.0	4.4	8.6	1.7	1.1	0.4	0.0	0.0	0.1	16.2	0.0	0.1	1.8	0.2	1.2	0.9	0.8	0.0	4.3	0.0	3.5	4.5	1.0	0.6	1.7	0.0	11.4	0.0	0.1	0.0	0.0	0.3	1.2	0.7	0.0	3.7	251.3	0.5	0.0	0.0	0.0	0.8	70.8	40.8	0.0	21.8	3.0	0.5	1.3	1.1	10.8	0.0	107.8	0.0	0.0	0.8	1.7	0.3	0.6	1.9	0.6	2.0	1103.8	0.0	0.2	0.3	0.1	0.3	0.3	0.3	0.0	0.4	0.6	0.3	0.0	0.4	0.7	0.0	0.0	0.1	0.1	0.7	0.5	342.2	413.9	393.5	919.5	338.0	346.5	403.6	361.9	358.6	372.5	331.0	363.1	402.5	10.6	28.9	8.7	38.5	338.7	57.9	26.0	4.5	46.1	0.0	87.0	116.2	11.7	330.3	9.1	2302.6	0.0	3.9	9.8	3657.8	6849.7	74.4	0.3	2960.7	777.1	49.2	246.7	878.6	0.1	283.4	403.2	50.7	443.9	8167.8	17.2	16.8	310.2	16307.3	26.3	0.0	0.1	3688.0	0.0	379.5	4.9	0.9	23.3	765.6	30.2	2.8	10.6	0.0	2.1	2.0	0.1	339.8	10431.2	2.2	26.3	823.7	8631.3	77919.3	3.9	0.0	0.0	25.1	42.9	0.3	0.8	42.2	77.9	132.7	247.5	4.7	3786.7	21.1
MT1H	MT1	ENSG00000205358	"Metallothionein 1H"	P80294	16	56669814-56671129	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 845.9;liver: 1146.3"	"Cell type enriched"	"Detected in many"	5	"Proximal tubular cells: 18797.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 173.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"EFO-21: 3.6;SuSa: 8.9"															NA	NA						"unprognostic (1.32e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.51e-1)"	"unprognostic (8.65e-2)"	"prognostic unfavorable (2.37e-7)"	"unprognostic (8.48e-3)"	"unprognostic (6.26e-2)"	"unprognostic (7.44e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (5.44e-5)"	"unprognostic (5.77e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.34e-1)"	3.9	0.2	30.6	6.8	43.0	0.0	0.8	32.7	98.9	1.9	27.5	120.3	51.6	1.7	0.7	29.4	2.1	1.1	0.6	31.2	31.3	845.9	1146.3	1.9	0.8	39.9	32.6	35.8	0.1	206.2	0.0	0.4	0.9	35.7	22.2	61.8	5.6	4.1	0.0	0.2	6.5	300.5	8.1	28.7	0.4	76.9	0.3	31.1	0.1	328.3	0.0	0.6	3.5	2.6	31.5	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	1.3	0.1	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.9	0.6	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	30.6	43.0	32.7	98.9	31.2	31.3	39.9	32.6	35.8	35.7	28.7	31.1	31.5	0.1	0.0	0.0	1.0	73.2	12.2	1.4	0.9	1.2	0.0	0.4	0.5	2.2	42.9	0.7	535.2	0.0	3.1	0.0	1181.8	1668.9	1.8	0.0	668.1	153.9	9.3	43.6	133.7	0.0	47.9	543.9	2.7	28.5	1793.8	4.5	0.4	54.7	3439.8	19.3	0.0	0.0	767.4	0.0	55.1	0.8	0.0	0.3	195.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	43.3	3282.6	0.0	0.1	27.8	3229.9	18797.6	0.0	0.0	0.0	1.6	5.5	0.1	0.4	5.5	18.9	66.9	55.5	0.0	851.8	1.3
MTARC2	"FLJ20605, MARC2, MOSC2"	ENSG00000117791	"Mitochondrial amidoxime reducing component 2"	Q969Z3	1	220748225-220784815	"Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 133.7;liver: 225.4"	"Cell type enriched"	"Detected in some"	4	"Cardiomyocytes: 29.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 35.9"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"basophil: 14.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 14.1"	"Cell line enhanced"	"Detected in many"		"T-47d: 36.0;TIME: 33.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015085, HPA017572"	Enhanced					NA	NA					"HPA015085: AB_1848780, HPA017572: AB_1848778"	"unprognostic (8.17e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.20e-2)"	"prognostic favorable (1.40e-10)"	"unprognostic (4.78e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.05e-2)"	"prognostic favorable (3.09e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.39e-2)"	"unprognostic (6.23e-2)"	30.7	18.0	10.5	6.2	12.1	0.6	16.6	8.8	15.6	11.7	47.7	18.0	59.7	6.8	15.7	9.8	10.9	21.8	25.3	11.2	10.0	133.7	225.4	31.5	7.4	9.0	10.8	11.0	22.1	30.2	125.9	9.6	12.8	8.7	20.4	20.7	3.0	36.7	12.6	34.8	4.6	58.7	9.6	8.0	11.7	28.1	11.1	10.8	3.1	42.5	21.5	8.3	12.6	10.5	10.1	9.5	7.8	4.1	5.4	10.1	4.6	3.2	6.7	11.7	8.0	8.1	5.3	11.9	0.0	4.6	6.5	4.3	1.3	0.0	9.4	7.5	0.0	15.7	0.0	16.5	11.0	9.3	4.5	0.0	8.0	14.1	3.0	0.0	12.1	22.2	0.0	6.3	0.1	5.1	2.3	0.0	15.7	6.6	3.2	7.8	0.0	13.0	0.2	28.2	10.3	2.3	6.1	10.6	0.1	15.2	4.5	36.0	5.6	33.9	0.0	4.8	10.6	12.0	2.0	0.1	0.0	1.7	0.0	0.1	14.1	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.5	12.1	8.8	15.6	11.2	10.0	9.0	10.8	11.0	8.7	8.0	10.8	10.1	7.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.7	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0
MTPAP	"FLJ10486, PAPD1, SPAX4, TENT6"	ENSG00000107951	"Mitochondrial poly(A) polymerase"	Q9NVV4	10	30309801-30374448	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, Transcription"	"Nucleotidyltransferase, RNA-binding, Transferase"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 37.1"	"Cell type enriched"	"Detected in many"	7	"Early spermatids: 240.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038620, HPA058232"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA038620: AB_10673015, HPA058232: AB_2683646"	"unprognostic (2.76e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.43e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (4.20e-6)"	"unprognostic (1.16e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.56e-2)"	"unprognostic (9.02e-2)"	"unprognostic (6.28e-3)"	"unprognostic (3.77e-1)"	"unprognostic (1.14e-2)"	"unprognostic (4.39e-2)"	9.0	7.5	3.2	10.3	4.4	37.1	9.8	12.4	6.3	6.2	2.4	9.7	10.7	9.1	6.3	8.4	6.7	5.2	8.9	4.2	4.2	9.7	10.7	6.4	10.7	3.4	3.8	4.3	8.3	10.0	8.5	2.8	9.7	4.8	7.3	11.2	7.1	8.1	5.0	13.3	8.4	9.0	9.2	2.9	9.4	7.2	5.1	3.3	9.3	10.3	12.1	10.4	8.2	5.3	5.3	26.0	25.3	15.8	23.0	15.2	14.2	20.6	17.6	6.2	17.7	18.4	27.0	35.4	36.9	12.3	11.7	16.3	29.7	31.1	20.7	21.6	18.7	24.0	37.3	23.7	27.5	16.0	24.6	28.2	14.3	19.0	19.9	11.7	9.8	19.6	34.0	41.2	28.1	13.5	21.8	29.8	21.8	10.8	19.5	13.3	29.6	27.9	34.4	16.2	17.1	25.9	20.8	16.0	16.4	24.7	14.8	15.8	15.6	18.7	18.4	23.8	26.0	19.8	6.2	16.3	50.8	15.9	44.5	6.6	27.4	25.2	27.3	21.7	35.0	23.0	20.8	20.4	21.1	33.0	17.1	21.6	22.0	4.2	25.1	27.9	17.3	23.1	13.1	3.2	4.4	12.4	6.3	4.2	4.2	3.4	3.8	4.3	4.8	2.9	3.3	5.3	12.2	9.6	7.4	9.1	11.2	25.2	13.9	7.4	4.6	0.0	9.8	9.8	16.7	15.7	9.2	3.7	0.0	13.1	13.9	8.1	19.6	9.6	240.7	9.9	14.8	12.9	4.2	16.6	12.7	9.1	12.0	12.7	7.7	12.5	5.1	18.8	12.5	14.6	14.7	0.0	14.5	15.6	6.1	15.8	13.6	34.3	12.2	10.8	8.8	8.4	14.8	0.0	5.2	4.5	14.4	8.9	5.2	16.6	5.3	14.1	8.7	14.2	8.6	0.0	13.1	14.7	10.8	25.3	19.5	11.4	24.9	11.5	8.8	12.6	18.4	16.6
MTRNR2L1		ENSG00000256618	"MT-RNR2 like 1"	P0CJ68	17	22523415-22524663	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"brain: 18493.0;choroid plexus: 7037.0"	"Cell type enriched"	"Detected in many"	11	"Cardiomyocytes: 16283.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 4804.8"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 4804.8"	"Cell line enhanced"	"Detected in all"		"HeLa: 3045.1;Hep G2: 1708.1"														"Secreted to blood"	NA	NA						"unprognostic (2.31e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.41e-3)"	"unprognostic (2.99e-2)"	"unprognostic (9.82e-3)"	"prognostic favorable (8.99e-4)"	"unprognostic (2.14e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.56e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.49e-2)"	"unprognostic (5.21e-3)"	719.4	1005.9	7037.8	175.1	7037.6	276.7	265.0	7037.0	18493.0	112.7	7037.0	631.7	361.3	132.1	206.6	377.1	140.6	198.4	2333.2	7321.5	7036.9	1199.8	949.4	144.2	126.6	7378.2	7037.3	7036.7	140.0	407.7	621.5	0.0	186.0	7144.3	235.2	541.5	638.8	444.9	283.6	3673.5	421.6	405.2	205.8	7054.4	218.4	449.4	373.0	7038.7	120.9	101.4	3357.2	194.7	178.7	0.0	7055.1	268.9	621.7	231.5	771.3	365.2	150.1	292.9	243.5	59.4	57.5	66.0	386.2	417.6	362.9	260.2	130.7	40.4	685.1	18.1	90.8	71.0	214.7	441.0	331.6	3045.1	1708.1	118.5	77.8	376.1	338.0	191.1	63.1	152.7	407.1	62.9	232.2	276.6	211.5	172.8	222.1	121.7	528.1	65.0	208.0	138.3	196.3	145.4	186.7	321.5	380.3	121.8	215.0	119.2	217.6	376.5	222.6	205.9	551.4	118.8	302.6	251.1	364.1	156.7	196.5	68.6	174.1	169.9	483.3	67.0	2097.9	721.0	1313.4	204.5	325.1	248.2	597.3	255.0	225.8	245.8	585.3	331.9	301.3	4804.8	301.1	339.6	428.7	248.4	677.0	7037.8	7037.6	7037.0	18493.0	7321.5	7036.9	7378.2	7037.3	7036.7	7144.3	7054.4	7038.7	7055.1	16.2	131.4	117.3	0.0	16.2	84.4	1432.1	2.8	0.0	0.0	54.3	88.4	16283.9	5.7	145.5	77.3	0.0	0.8	3.0	4.0	111.6	0.6	6.6	23.4	4.5	460.8	1.8	0.0	0.0	0.7	0.7	591.3	0.0	56.4	166.5	128.9	4.2	11.9	0.8	0.0	0.0	6.5	0.0	7.2	56.2	17.8	15.5	71.6	62.2	0.0	1.3	0.0	0.0	0.0	0.1	0.3	2.7	4.1	0.5	261.1	1.0	1169.4	101.8	0.0	0.0	346.1	450.7	10.2	18.2	0.0	171.3	1.0	79.5	34.6	2.2	749.7
MTRNR2L12		ENSG00000269028	"MT-RNR2 like 12"	P0DMP1	3	96617188-96618236	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"brain: 101422.8;choroid plexus: 51606.2"	"Cell type enriched"	"Detected in many"	11	"Cardiomyocytes: 34487.4"	"Cancer enhanced"	"Detected in all"		"stomach cancer: 14.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 23357.3"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 23357.3"	"Cell line enhanced"	"Detected in all"		"HeLa: 19226.4"														"Secreted to blood"	NA	NA						"unprognostic (3.79e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.76e-3)"	"unprognostic (1.69e-3)"	"unprognostic (1.81e-2)"	"unprognostic (7.77e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.08e-2)"	"unprognostic (4.90e-2)"	"unprognostic (9.59e-3)"	"unprognostic (1.81e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.85e-2)"	7120.5	9579.0	51610.0	1624.6	51611.2	2421.9	2927.0	51618.4	101422.8	1327.3	51606.2	7196.9	3229.9	1509.9	1904.2	3978.8	1605.5	2160.6	24920.5	53545.8	51603.5	11585.0	11053.5	1417.5	1120.3	54530.7	51614.8	51605.7	1484.0	3730.2	5549.5	0.9	1878.1	52543.9	2615.5	5726.5	5562.2	4112.2	3351.7	37038.2	4056.6	3660.9	2302.8	51767.6	2007.2	5188.3	3883.1	51612.3	1103.2	1317.5	22800.5	2003.2	1757.2	0.7	51668.4	3129.7	3743.3	2766.3	9914.1	4165.4	2220.4	2507.6	3970.8	808.2	749.3	954.5	2070.2	4888.5	6887.0	3132.2	1502.3	436.5	8365.9	196.7	1668.9	1010.6	2008.1	3570.2	7299.3	19226.4	8838.4	1579.3	1469.9	3824.2	4061.3	1945.5	784.9	2127.7	4578.8	844.6	3040.7	5258.3	2276.0	2553.9	1634.8	1252.5	4510.6	808.3	1892.5	1113.4	1992.1	2667.8	2102.8	4420.6	2269.6	1246.8	2408.9	2618.4	2595.6	3524.2	2439.6	2667.3	4152.9	3817.7	3062.1	2505.1	3462.1	1143.3	1197.9	802.7	3365.5	1896.5	8908.3	850.3	10533.0	3473.8	6467.2	1043.1	1696.3	1353.8	2636.4	1309.8	1129.5	1256.2	2611.9	1648.9	1580.6	23357.3	1490.6	1781.5	2078.4	1275.7	2740.2	51610.0	51611.2	51618.4	101422.8	53545.8	51603.5	54530.7	51614.8	51605.7	52543.9	51767.6	51612.3	51668.4	1081.2	2705.1	2934.5	0.0	291.8	112.5	420.7	10.3	3.4	0.0	702.7	1431.3	34487.4	147.3	1441.4	84.6	0.0	8.4	394.0	24.5	62.6	1.1	19.7	1096.7	707.4	1236.7	4.9	182.7	0.0	1.8	8.6	1698.5	29.6	1465.4	1715.6	334.8	100.3	171.7	12.3	0.0	0.0	7.1	4.1	126.9	333.5	49.0	42.9	633.1	193.9	0.0	29.8	0.0	28.8	0.0	0.0	1.4	8.4	23.0	213.1	337.3	6.6	521.0	1431.8	0.0	46.0	2907.6	1520.5	36.3	39.6	3.3	80.7	10.5	625.8	220.9	5.2	397.1
MTRNR2L13		ENSG00000270394	"MT-RNR2 like 13"	S4R3P1	4	116298876-116300320	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 2.4;choroid plexus: 1.3;skeletal muscle: 1.5"	"Cell type enriched"	"Detected in some"	20	"Cardiomyocytes: 176.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 1.5"	"Group enriched"	"Detected in some"	6	"HeLa: 4.3;Hep G2: 1.8"														"Secreted - unknown location"	NA	NA										"unprognostic (6.40e-2)"					"unprognostic (2.88e-1)"			"unprognostic (2.49e-1)"	"unprognostic (1.99e-1)"				0.2	0.6	1.4	0.0	1.4	0.1	0.0	1.4	2.4	0.0	1.3	0.3	0.1	0.1	0.0	0.1	0.0	0.1	0.9	1.4	1.4	0.6	0.3	0.1	0.0	1.4	1.4	1.4	0.0	0.1	0.1	0.0	0.0	1.4	0.0	0.2	0.0	0.1	0.0	1.5	0.1	0.2	0.0	1.4	0.0	0.1	0.1	1.4	0.0	0.0	1.0	0.0	0.0	0.0	1.5	0.1	0.4	0.0	0.4	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	4.3	1.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.1	1.4	1.4	1.4	2.4	1.4	1.4	1.4	1.4	1.4	1.4	1.4	1.4	1.5	0.0	0.0	0.0	0.0	0.0	0.1	8.4	0.0	0.0	0.0	0.0	0.0	176.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	3.8	0.0	0.0	0.0	0.8	4.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	3.7
MTRNR2L5		ENSG00000249860	"MT-RNR2 like 5"	P0CJ72	10	55599042-55600728	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"brain: 1.6"	"Cell type enriched"	"Detected in some"	18	"Cardiomyocytes: 27.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basophil: 1.2;neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.2"	"Not detected"	"Not detected"																"Secreted - unknown location"	NA	NA															"unprognostic (2.11e-2)"				"unprognostic (1.20e-1)"				0.0	0.1	1.2	0.1	0.9	0.3	0.0	0.4	1.2	0.0	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.2	1.2	1.6	0.1	0.1	0.0	0.2	1.1	1.0	1.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.2	0.0	0.7	0.2	0.1	0.0	0.4	0.2	0.1	0.0	1.6	0.0	0.1	0.1	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.6	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.3	0.2	0.1	0.0	0.1	0.1	1.2	0.2	0.3	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.1	1.2	0.2	0.1	0.1	0.0	0.1	1.2	0.9	0.4	1.2	1.2	1.6	1.1	1.0	1.0	0.9	0.4	1.6	1.1	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	27.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1
MTRNR2L8		ENSG00000255823	"MT-RNR2 like 8"	P0CJ75	11	10507894-10509186	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"brain: 15956.5;choroid plexus: 6507.5;skeletal muscle: 7622.1"	"Cell type enriched"	"Detected in many"	11	"Cardiomyocytes: 32407.2"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 6.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 3689.6;eosinophil: 2784.3;neutrophil: 9219.1"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 9219.1"	"Cell line enhanced"	"Detected in all"		"HeLa: 3532.5;Hep G2: 1873.3"														"Secreted to blood"	NA	NA						"unprognostic (6.19e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.66e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.71e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.45e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.59e-2)"	"unprognostic (4.59e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.96e-2)"	1009.0	1793.9	6511.6	333.8	6511.8	484.6	252.0	6510.4	15956.5	106.7	6507.5	914.8	618.2	225.0	266.1	648.5	202.7	303.4	3901.3	6888.0	6511.1	1796.8	1291.3	191.9	200.2	7062.6	6512.3	6503.2	241.3	618.4	514.2	1.3	238.5	6699.1	345.4	748.5	872.2	749.3	274.4	7622.1	626.6	729.9	288.4	6567.0	378.9	687.7	604.5	6511.8	97.7	150.8	1913.9	269.2	203.4	0.6	6538.8	527.3	715.6	334.3	1521.1	294.0	151.4	438.7	562.6	61.4	61.1	75.9	427.1	742.2	698.2	544.0	91.4	54.0	1407.6	10.0	103.2	66.3	307.0	613.3	685.6	3532.5	1873.3	109.4	143.3	625.4	277.5	137.1	58.0	141.0	578.3	54.0	412.8	543.6	353.2	180.7	260.8	202.2	910.4	124.0	222.2	194.5	333.0	287.7	352.4	328.7	447.0	186.5	418.8	248.4	399.0	703.2	282.9	418.6	836.4	416.2	433.8	414.5	508.2	189.6	213.6	116.4	414.1	313.4	1053.0	125.3	3689.6	1275.5	2784.3	319.4	577.0	409.2	944.6	407.8	353.4	445.8	957.8	509.9	480.1	9219.1	466.8	613.2	688.5	439.4	1155.3	6511.6	6511.8	6510.4	15956.5	6888.0	6511.1	7062.6	6512.3	6503.2	6699.1	6567.0	6511.8	6538.8	649.6	830.1	866.0	0.0	131.5	471.7	1069.8	27.1	1.2	0.0	599.2	1010.1	32407.2	124.4	492.7	57.0	0.0	6.9	118.0	2.1	72.4	0.0	23.1	785.5	473.5	1034.0	0.0	139.8	0.0	0.0	6.9	1450.7	3.1	916.4	543.7	140.3	119.2	384.5	12.8	0.0	0.0	0.5	4.1	129.6	1091.1	52.7	65.6	420.6	723.9	0.0	14.5	0.0	8.2	0.0	0.3	0.1	0.3	44.8	92.0	618.5	0.3	770.4	481.4	0.0	65.7	2750.1	1533.4	30.9	38.2	0.8	488.9	11.2	370.6	42.0	0.5	1232.9
MTSS2	"ABBA, ABBA-1, LOC92154, MTSS1L"	ENSG00000132613	"MTSS I-BAR domain containing 2"	Q765P7	16	70661204-70686053	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 419.2"	"Cell type enriched"	"Detected in some"	5	"Extravillous trophoblasts: 48.0"	"Cancer enhanced"	"Detected in all"		"glioma: 26.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 299.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048531, HPA066469"	Approved		Supported	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"HPA048531: AB_2680430, HPA066469: AB_2685671"	"prognostic unfavorable (2.85e-4)"	"unprognostic (8.85e-2)"	"unprognostic (7.01e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.21e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.59e-3)"	"unprognostic (3.88e-1)"	"unprognostic (2.92e-3)"	"unprognostic (9.87e-2)"	"unprognostic (9.92e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.25e-2)"	32.0	40.8	291.8	21.0	247.2	9.5	27.1	278.1	281.2	64.9	78.7	66.2	14.4	79.6	6.2	51.2	47.8	29.3	33.6	289.7	278.5	25.0	106.8	47.7	10.2	419.2	257.5	160.8	35.9	13.8	12.9	25.2	36.3	288.0	42.4	8.3	25.8	30.9	37.4	81.9	32.1	27.7	60.5	246.5	58.8	30.1	10.9	318.9	42.9	21.4	30.1	8.0	47.0	46.4	268.6	67.2	157.4	38.9	40.4	31.6	31.2	146.4	98.8	122.0	83.0	68.5	63.8	41.9	0.8	34.6	155.5	33.0	136.9	42.5	43.2	31.5	1.2	56.9	23.2	137.7	299.9	278.1	35.0	1.1	129.3	92.6	38.6	133.0	35.7	27.6	35.0	88.8	1.4	74.8	164.1	33.4	177.8	34.2	22.6	33.1	70.6	72.5	0.4	72.4	99.0	91.1	61.0	210.5	90.6	27.2	36.6	69.9	67.2	41.9	64.3	72.6	59.0	62.7	23.4	6.4	1.2	58.3	1.0	22.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	291.8	247.2	278.1	281.2	289.7	278.5	419.2	257.5	160.8	288.0	246.5	318.9	268.6	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	4.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	48.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0
MVB12B	"C9orf28, FAM125B, FLJ00001"	ENSG00000196814	"Multivesicular body subunit 12B"	Q9H7P6	9	126326829-126507041	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 100.8"	"Cell type enriched"	"Detected in many"	6	"Oligodendrocytes: 505.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 2.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 34.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043683, HPA049383"			Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA043683: AB_2678616, HPA049383: AB_2680737"	"unprognostic (3.50e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.82e-2)"	"unprognostic (9.59e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.22e-2)"	"unprognostic (4.45e-3)"	"unprognostic (4.33e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (7.89e-4)"	"unprognostic (2.82e-1)"	"unprognostic (1.66e-3)"	"unprognostic (3.06e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.79e-2)"	"unprognostic (1.12e-3)"	5.8	5.2	36.9	4.6	59.8	12.5	4.9	57.7	38.9	6.1	27.0	7.7	3.8	6.9	3.1	4.2	10.0	3.8	5.1	30.5	40.3	4.0	4.2	18.1	6.9	71.1	59.3	23.3	6.5	3.2	7.8	8.4	15.1	64.2	6.6	6.2	6.3	3.1	8.4	24.8	4.8	5.6	6.5	68.2	11.2	6.4	5.7	56.5	8.5	5.8	13.1	2.6	7.9	5.1	100.8	4.8	6.5	34.6	19.1	1.2	0.4	20.4	4.0	3.1	7.0	1.3	5.6	0.3	0.0	2.4	3.8	10.3	2.1	10.7	1.9	4.3	8.0	6.7	1.7	1.1	24.6	2.7	3.2	1.5	2.6	3.5	1.4	0.1	5.8	5.4	25.5	0.0	0.0	5.2	3.9	5.3	10.0	7.6	0.8	8.6	7.6	18.9	0.0	0.3	19.5	8.7	15.9	6.4	4.6	4.1	14.4	4.6	19.2	7.9	7.8	5.8	4.4	8.2	0.1	0.0	1.9	2.2	14.2	4.2	0.0	0.8	0.1	1.4	0.2	2.5	0.1	0.6	2.3	1.0	0.2	0.1	1.0	0.0	0.0	0.2	0.0	0.0	0.9	36.9	59.8	57.7	38.9	30.5	40.3	71.1	59.3	23.3	64.2	68.2	56.5	100.8	6.3	6.4	7.3	75.4	1.8	3.6	3.2	1.0	6.8	9.4	3.3	3.6	3.6	4.3	1.3	1.8	4.2	12.4	4.7	8.8	0.0	1.6	0.8	6.2	3.0	5.8	2.4	1.7	64.5	1.4	2.6	3.1	2.6	2.4	7.0	5.5	2.2	6.2	1.6	10.1	58.2	2.5	6.1	23.3	6.2	2.7	2.8	10.2	0.0	74.9	3.9	9.1	2.1	56.8	505.6	1.0	5.5	6.4	2.2	1.2	0.9	0.3	6.9	5.3	0.0	2.6	2.7	3.4	6.4	2.9	2.6	3.4	10.9	0.8	3.0	1.6
MYEOV	OCIM	ENSG00000172927	"Myeloma overexpressed"	Q96EZ4	11	69294151-69367726	"Predicted membrane proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 5.3;esophagus: 9.7;stomach 1: 6.1"	"Cell type enriched"	"Detected in many"	5	"Pancreatic endocrine cells: 199.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 172.8;A549: 83.5;CAPAN-2: 24.3;U-2 OS: 36.1"									HPA012949	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA012949: AB_1854241"	"unprognostic (1.42e-2)"	"unprognostic (8.56e-2)"	"unprognostic (7.07e-2)"	"unprognostic (3.36e-1)"	"unprognostic (5.60e-2)"	"unprognostic (7.28e-3)"	"unprognostic (7.58e-3)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (3.49e-1)"	"unprognostic (6.33e-2)"	"prognostic unfavorable (1.54e-7)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (1.48e-5)"	"unprognostic (2.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.69e-2)"	3.8	0.1	0.0	0.6	0.0	0.1	5.3	0.0	0.0	0.9	0.0	0.5	0.3	0.0	0.7	9.7	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.1	0.1	0.1	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.7	0.0	0.0	3.8	0.2	0.0	0.0	0.2	6.1	0.0	0.0	0.0	0.1	0.0	1.0	0.1	4.0	0.0	172.8	83.5	0.0	0.0	0.0	0.0	2.5	0.2	0.1	0.0	0.0	0.5	24.3	0.5	6.3	0.0	0.1	2.5	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.4	0.0	0.0	6.4	0.0	0.0	0.1	0.0	0.1	8.5	0.0	2.4	0.2	0.1	3.8	0.1	0.1	0.2	3.4	6.8	0.0	0.1	3.5	0.6	0.2	0.0	0.0	0.0	2.4	0.6	0.0	2.9	0.7	1.6	0.1	36.1	0.0	1.4	0.3	1.7	0.2	0.2	0.5	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	1.0	0.8	0.8	3.8	0.0	0.0	30.7	37.7	0.4	0.0	17.6	3.7	0.0	0.0	0.9	7.8	0.0	12.6	12.7	1.2	0.1	0.5	0.0	0.0	0.0	9.4	0.4	3.4	23.9	1.5	0.0	0.1	0.0	0.2	2.4	0.0	0.0	1.3	2.0	0.0	0.0	6.9	0.3	4.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	199.3	22.3	0.0	3.9	1.4	0.0	0.0	1.5	0.0	0.0	0.1	2.9	0.0	0.4	3.4	1.3	0.1	0.4	0.0	2.7	8.5
MYH13	MyHC-eo	ENSG00000006788	"Myosin heavy chain 13"	Q9UKX3	17	10300865-10373130	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 1.5;stomach 1: 1.6"	"Cell type enriched"	"Detected in some"	4	"Cardiomyocytes: 9.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	4	"U-2 OS: 2.8"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"									NA	NA		29000000				"unprognostic (8.86e-2)"	"unprognostic (2.45e-2)"	"unprognostic (7.81e-2)"	"unprognostic (3.95e-1)"		"unprognostic (8.35e-2)"		"unprognostic (1.42e-2)"	"unprognostic (7.50e-3)"	"unprognostic (3.15e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.40e-9)"	"unprognostic (2.44e-2)"	"unprognostic (1.08e-1)"		"unprognostic (2.06e-2)"	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.2	0.0	0.0	0.1	1.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	1.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.3	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MYH3	"HEMHC, MYHC-EMB, MYHSE1, SMHCE"	ENSG00000109063	"Myosin heavy chain 3"	P11055	17	10628526-10657309	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 29.3;seminal vesicle: 18.5;skeletal muscle: 20.8"	"Cell type enriched"	"Detected in many"	7	"Early spermatids: 411.9"	"Group enriched"	"Detected in many"	4	"head and neck cancer: 3.3;prostate cancer: 4.6;testis cancer: 2.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	26	"HSkMC: 59.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			HPA021808	Enhanced					NA	NA		29000000			"HPA021808: AB_1854242"	"unprognostic (1.70e-2)"	"unprognostic (1.10e-3)"	"unprognostic (4.19e-4)"	"unprognostic (3.35e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.54e-1)"	"unprognostic (7.84e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.24e-4)"	"unprognostic (1.91e-2)"	"unprognostic (6.17e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.49e-1)"	1.4	0.9	2.0	1.1	2.0	0.8	1.5	1.7	1.8	3.0	1.7	4.8	1.1	3.4	1.2	9.2	2.6	0.5	1.0	1.8	1.7	1.8	3.4	1.2	1.3	2.0	2.1	1.6	2.3	2.5	0.3	1.5	0.4	2.1	29.3	1.0	1.8	1.5	18.5	20.8	2.4	2.5	1.7	1.6	2.7	1.7	4.6	2.0	3.1	3.5	6.1	0.6	4.5	3.8	1.9	0.2	1.1	0.8	1.1	1.0	0.3	1.0	0.8	0.4	0.5	0.5	1.0	0.1	0.7	0.3	0.4	0.2	1.1	0.5	0.2	1.0	0.7	0.9	1.0	0.3	1.6	0.3	0.6	1.4	59.6	0.4	0.6	0.8	0.1	0.1	1.3	0.4	0.1	0.2	0.7	1.0	2.3	0.9	0.3	0.6	0.8	0.8	0.3	0.3	0.3	0.0	0.4	0.4	0.0	0.3	0.7	0.3	0.3	0.3	0.1	1.0	0.3	0.1	1.3	1.1	0.3	0.3	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.0	1.7	1.8	1.8	1.7	2.0	2.1	1.6	2.1	1.6	2.0	1.9	0.5	0.0	9.8	4.6	0.7	2.9	0.9	0.1	0.6	4.9	0.7	1.8	3.6	1.5	0.7	0.0	6.2	0.4	0.8	0.9	0.0	0.6	411.9	0.5	0.8	1.4	0.0	2.7	3.9	0.6	0.8	1.1	1.1	0.5	7.6	0.8	0.4	0.6	0.1	0.0	3.4	0.5	0.0	0.8	0.3	56.0	2.8	1.2	1.8	1.9	0.2	1.8	0.0	7.5	5.4	0.7	0.2	2.6	0.0	1.5	1.8	0.3	0.3	4.6	0.0	5.5	0.8	10.7	4.2	0.3	1.6	0.5	1.4	0.2	0.8	0.3
MYOC	"GLC1A, JOAG1, TIGR"	ENSG00000034971	Myocilin	Q99972	1	171635417-171652688	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"			"Disease variant, Glaucoma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 111.8"	"Cell type enriched"	"Detected in some"	6	"Fibroblasts: 244.4"	"Cancer enriched"	"Detected in many"	6	"melanoma: 13.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA027364	Uncertain				"Secreted to extracellular matrix"	NA	NA		25000000			"HPA027364: AB_10602036"	"unprognostic (2.02e-2)"	"unprognostic (4.65e-2)"		"unprognostic (4.44e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.43e-1)"		"unprognostic (2.33e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.94e-4)"	"unprognostic (5.35e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.24e-1)"	46.0	1.1	0.0	0.0	0.0	0.0	19.4	0.2	0.0	1.7	0.0	11.1	3.5	16.6	5.0	19.8	15.5	1.5	18.4	0.0	0.1	0.2	0.1	7.5	0.1	0.4	0.1	0.0	1.4	3.0	0.1	0.2	0.2	0.3	5.3	3.5	0.0	14.1	6.4	34.2	3.6	4.8	2.9	0.1	0.0	50.6	1.4	0.1	14.2	28.9	111.8	0.2	22.8	9.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.4	0.1	0.0	0.3	0.1	0.1	0.1	12.7	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.3	0.1	3.1	0.0	0.0	0.1	0.0	0.0	244.4	11.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.1	1.0	8.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.6	2.4	0.1	0.0	0.0	0.0	0.0	0.0	15.1	6.3	0.1	0.1	1.1	0.0	0.0	1.1	0.2	0.0	0.0
MYOZ2	"C4orf5, CS-1, FATZ-2"	ENSG00000172399	"Myozenin 2"	Q9NPC6	4	119135832-119187789	"Disease related genes, Predicted intracellular proteins"			"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 778.5;skeletal muscle: 227.3;tongue: 175.0"	"Cell type enriched"	"Detected in some"	51	"Cardiomyocytes: 2275.3"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 2.0;HSkMC: 2.3;SK-MEL-30: 6.2;U-87 MG: 6.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA035763, HPA035764"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA035763: AB_2674770, HPA035764: AB_10696509"	"unprognostic (2.53e-1)"	"unprognostic (9.20e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.34e-2)"	"unprognostic (5.71e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.77e-2)"	"unprognostic (4.04e-1)"	"unprognostic (8.25e-2)"	"unprognostic (5.07e-2)"	"unprognostic (6.19e-7)"	"unprognostic (6.66e-4)"	"unprognostic (2.43e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.83e-2)"	0.5	0.3	0.2	0.0	0.3	0.0	2.1	0.1	0.5	0.6	0.1	0.7	0.0	2.0	0.3	1.0	1.0	0.3	778.5	0.3	0.3	0.7	0.1	0.9	0.3	0.2	0.2	0.1	0.6	0.1	0.0	0.2	0.2	0.1	4.8	0.1	0.0	1.8	0.3	227.3	0.3	0.4	0.8	0.3	0.6	0.6	1.0	0.3	0.3	0.3	175.0	0.1	0.4	0.4	0.3	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	2.3	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	6.2	1.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	6.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.5	0.3	0.3	0.2	0.2	0.1	0.1	0.3	0.3	0.3	0.1	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	2275.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.4	20.8	0.0	0.0	3.4	2.2	0.0	44.1	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.3	0.1	0.0	3.7	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.7	0.0	0.2	0.0	2.9	0.0	0.0	6.6	6.9	22.3	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MYPN	MYOP	ENSG00000138347	Myopalladin	Q86TC9	10	68106117-68212017	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Actin-binding	"Cardiomyopathy, Disease variant, Nemaline myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 64.7;skeletal muscle: 286.3;tongue: 174.3"	"Cell type enriched"	"Detected in some"	4	"Cardiomyocytes: 114.2"	"Cancer enriched"	"Detected in single"	7	"head and neck cancer: 0.9"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	6	"basophil: 1.4"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 1.4"	"Cell line enhanced"	"Detected in many"		"BJ: 39.8;fHDF/TERT166: 112.3;HBF TERT88: 25.6;LHCN-M2: 47.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA036299, HPA061494"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		No	No			"Nucleoplasm, Vesicles"	Cytosol	"HPA036299: , HPA061494: AB_2684539"	"unprognostic (4.75e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.14e-3)"	"unprognostic (8.62e-3)"	"unprognostic (3.91e-1)"	"unprognostic (3.36e-3)"	"unprognostic (4.62e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.26e-3)"	"unprognostic (3.94e-3)"	"unprognostic (3.10e-1)"	"unprognostic (2.88e-8)"	"unprognostic (4.63e-5)"	"unprognostic (9.94e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.47e-1)"	0.1	0.3	0.2	0.2	0.1	0.6	0.1	0.5	0.3	0.0	0.0	0.3	0.1	0.1	0.1	2.2	0.0	0.1	64.7	0.7	0.5	0.0	0.0	0.0	0.2	0.6	0.3	0.2	0.1	0.6	0.0	0.0	0.1	0.2	1.7	0.1	1.7	2.7	0.0	286.3	0.1	0.1	0.2	0.0	0.1	0.8	0.9	0.1	0.1	0.1	174.3	0.0	0.1	0.0	0.3	2.9	1.3	0.0	0.0	0.7	4.1	0.1	39.8	19.7	14.4	5.4	0.0	0.1	0.1	0.0	112.3	20.5	0.7	0.0	0.2	25.6	0.4	0.0	0.0	14.6	0.0	0.3	0.0	0.1	1.6	0.0	7.9	0.9	3.6	0.4	0.0	0.0	0.2	47.6	8.6	0.0	0.1	0.0	0.0	1.3	0.0	2.2	0.0	0.1	0.1	0.1	0.0	5.7	0.9	0.2	0.1	0.0	0.0	1.1	0.7	0.2	4.1	0.1	0.1	0.0	0.0	4.6	0.1	4.2	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.5	0.3	0.7	0.5	0.6	0.3	0.2	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.6	0.2	0.0	114.2	0.0	0.0	0.0	25.0	0.0	0.0	1.8	0.0	0.0	1.0	1.5	0.1	0.7	0.0	0.0	0.5	0.2	0.0	1.8	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.0	0.4	0.6	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	8.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.1	0.1
MZB1	"HSPC190, MEDA-7, MGC29506, PACAP, pERp1"	ENSG00000170476	"Marginal zone B and B1 cell specific protein"	Q8WU39	5	139387467-139390081	"Predicted secreted proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 90.6;lymphoid tissue: 274.4"	"Cell type enriched"	"Detected in many"	6	"Plasma cells: 4000.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"memory B-cell: 160.4;plasmacytoid DC: 569.3"	"Group enriched"	"Detected in many"	116	"B-cells: 160.4;dendritic cells: 569.3"	"Group enriched"	"Detected in some"	5	"Karpas-707: 581.5;RPMI-8226: 2193.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043745, HPA052694"	Enhanced		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA		350000	"Golgi apparatus"		"HPA043745: AB_10960359, HPA052694: AB_2681919"	"unprognostic (4.97e-3)"	"unprognostic (1.75e-2)"	"unprognostic (4.23e-2)"	"prognostic favorable (7.27e-4)"	"unprognostic (2.21e-2)"	"prognostic favorable (4.60e-5)"	"unprognostic (6.57e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.45e-3)"	"unprognostic (7.10e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (1.15e-8)"	"unprognostic (7.22e-2)"	"unprognostic (3.14e-1)"	"unprognostic (9.46e-2)"	"unprognostic (7.36e-2)"	3.7	9.2	0.1	88.2	0.1	33.3	21.2	0.1	0.7	18.5	0.3	70.8	90.6	1.8	0.4	10.2	5.8	14.4	2.3	0.1	0.1	5.9	5.8	16.0	124.2	0.2	0.4	0.1	5.0	1.3	0.0	0.7	0.0	0.2	5.1	40.2	0.0	57.2	4.9	0.1	0.4	48.2	2.1	0.4	274.4	67.2	2.4	0.2	148.6	9.1	0.0	118.7	59.2	3.6	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	256.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	144.6	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	128.5	0.5	581.5	0.0	0.0	227.8	2.2	0.0	0.0	0.0	90.1	0.3	2193.9	0.0	0.0	0.3	0.8	0.0	11.4	0.0	0.0	3.1	0.1	0.6	0.0	1.8	0.1	0.0	262.0	16.7	223.0	0.1	0.4	0.0	0.0	0.1	0.1	1.5	0.1	3.0	160.4	0.6	1.1	0.5	75.6	0.1	0.2	3.1	2.7	0.0	569.3	0.2	26.1	0.1	0.1	0.1	0.7	0.1	0.1	0.2	0.4	0.1	0.2	0.4	0.2	0.3	0.4	6.4	10.1	0.0	665.7	2.5	1.3	0.1	0.0	0.0	3.7	3.2	1.1	4.3	2.0	0.0	0.0	0.1	235.0	0.9	0.0	0.1	0.1	1.8	0.4	2.0	1.2	49.3	0.0	0.0	0.1	2.0	6.1	0.4	2.5	0.1	11.4	14.0	0.1	0.0	0.0	1.1	0.0	7.1	3.4	1.1	0.0	4.7	540.7	0.0	1.0	0.0	4.1	0.0	0.0	0.1	0.4	0.0	4000.1	3.0	1.2	1.9	1.2	0.0	0.0	1.7	2.1	0.1	0.1	0.4	2.4	2.2	100.7	0.5	9.7	0.4
NBEAL2	KIAA0540	ENSG00000160796	"Neurobeachin like 2"	Q6ZNJ1	3	46979666-47009704	"Disease related genes, Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 104.0"	"Cell type enriched"	"Detected in many"	4	"Gastric mucus-secreting cells: 144.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	7	"neutrophil: 4.4"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 4.4"	"Cell line enhanced"	"Detected in many"		"HEL: 69.1;SK-BR-3: 64.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051969	Approved					NA	NA		31000			"HPA051969: "	"unprognostic (3.83e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.37e-2)"	"unprognostic (5.99e-3)"	"prognostic favorable (4.60e-4)"	"unprognostic (1.71e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.17e-1)"	"unprognostic (6.27e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.06e-3)"	"unprognostic (3.75e-1)"	"unprognostic (6.63e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.34e-2)"	15.6	16.2	3.7	23.5	3.1	93.0	19.4	2.8	5.0	22.9	5.1	17.1	13.0	10.6	4.7	104.0	14.8	11.1	13.0	2.7	3.4	32.1	11.3	54.5	21.0	3.6	2.8	2.4	7.9	41.0	6.7	11.4	4.8	4.0	21.7	8.4	0.8	35.9	8.4	6.6	82.0	31.3	5.6	3.0	70.5	42.8	6.4	4.2	11.3	14.8	2.9	15.9	16.8	57.3	4.3	20.2	22.1	4.0	11.3	2.3	0.8	12.9	2.8	1.7	3.8	2.5	19.4	14.2	17.4	7.7	2.4	3.7	13.0	8.3	9.0	1.9	15.4	12.4	69.1	27.8	12.2	2.2	11.9	48.5	1.9	14.8	3.9	6.0	4.6	34.2	36.2	14.6	26.3	1.9	31.2	20.5	32.7	10.6	31.9	10.0	21.6	0.5	23.0	9.1	41.1	6.1	9.9	2.4	64.4	5.7	4.9	31.5	19.9	25.3	0.3	11.7	5.1	8.9	20.1	20.7	16.3	5.1	55.0	2.9	0.2	0.6	0.4	0.5	0.6	0.1	0.0	0.2	0.5	0.1	0.0	0.1	0.1	4.4	0.4	0.4	0.1	0.2	0.3	3.7	3.1	2.8	5.0	2.7	3.4	3.6	2.8	2.4	4.0	3.0	4.2	4.3	15.0	12.8	9.4	7.8	10.0	3.3	5.5	2.4	5.7	1.3	16.3	18.2	4.3	8.6	9.3	33.1	18.8	2.2	30.8	15.1	1.9	22.9	1.4	20.0	4.1	9.8	7.2	10.3	4.0	23.1	1.1	3.0	144.3	23.9	6.3	5.1	11.7	1.2	11.1	0.0	1.5	11.5	4.1	12.9	8.3	1.0	1.2	27.9	0.0	6.5	14.6	1.5	26.8	1.0	1.4	31.4	5.6	0.0	14.2	6.2	3.4	1.3	6.6	1.9	13.1	3.4	3.5	0.5	2.4	33.6	8.0	1.9	26.3	4.5	15.1	21.0
NCBP2L		ENSG00000170935	"Nuclear cap binding protein subunit 2 like"	A6PVI3	X	107774899-107795829	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 1.1;testis: 2.6"	"Cell type enriched"	"Detected in some"	7	"Early spermatids: 40.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	79	"basophil: 8.3"	"Lineage enriched"	"Detected in single"	79	"granulocytes: 8.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA010664	Uncertain					NA	NA					"HPA010664: AB_1079451"	"unprognostic (3.22e-1)"				"unprognostic (8.00e-2)"						"unprognostic (5.64e-2)"	"unprognostic (7.29e-2)"				"unprognostic (2.64e-1)"		0.0	1.1	0.2	0.0	0.1	0.0	0.3	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.6	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	2.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.3	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	40.8	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	3.1	0.0	0.0	0.0	0.1	1.3	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0
NDUFS1	CI-75k	ENSG00000023228	"NADH:ubiquinone oxidoreductase core subunit S1"	P28331	2	206114817-206159509	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	"Oxidoreductase, Translocase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 223.4;tongue: 227.2"	"Cell type enriched"	"Detected in all"	4	"Cardiomyocytes: 582.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064605, CAB070844"	Enhanced		Supported	Mitochondria		NA	NA		48000	Mitochondria		"CAB070844: , HPA064605: AB_2685297"	"prognostic unfavorable (3.85e-4)"	"unprognostic (1.76e-1)"	"unprognostic (9.22e-3)"	"unprognostic (5.01e-2)"	"unprognostic (8.63e-3)"	"unprognostic (3.75e-1)"	"unprognostic (3.72e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.30e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.28e-1)"	"prognostic favorable (1.47e-12)"	"unprognostic (1.17e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.76e-2)"	"unprognostic (4.73e-2)"	26.5	62.1	8.8	13.4	10.1	13.3	24.0	14.7	15.8	17.2	32.5	31.2	30.2	19.5	10.9	36.5	16.4	10.6	141.1	9.6	12.4	48.5	52.2	18.5	12.7	10.2	10.7	8.6	14.7	19.4	47.6	20.4	14.5	11.2	16.0	30.3	24.6	27.9	15.7	223.4	26.4	26.3	16.6	7.6	17.0	37.4	21.0	12.8	15.7	18.1	227.2	17.0	22.6	22.6	12.9	28.3	27.6	39.2	28.6	35.8	28.9	45.4	40.4	43.4	66.0	47.6	72.0	32.1	31.7	34.8	50.8	65.5	38.5	52.9	39.2	58.2	14.6	24.9	63.5	65.1	64.9	37.0	46.2	27.5	35.3	22.5	51.9	40.4	29.6	52.3	39.3	69.8	31.1	43.6	35.2	38.5	30.7	36.5	47.2	48.6	38.3	54.7	55.1	54.7	50.7	38.1	29.8	46.7	45.1	67.1	53.3	39.8	44.2	40.1	36.2	32.0	35.8	39.1	29.8	38.4	46.9	36.3	37.5	37.8	14.1	12.9	15.7	12.4	15.2	9.6	9.6	10.8	11.8	14.7	9.0	9.6	11.1	9.2	12.5	22.5	7.8	15.9	9.5	8.8	10.1	14.7	15.8	9.6	12.4	10.2	10.7	8.6	11.2	7.6	12.8	12.9	32.4	60.9	33.0	45.1	23.8	16.2	21.7	40.8	30.1	97.1	19.3	14.0	582.5	48.6	42.8	38.6	120.9	48.4	18.8	74.5	93.9	44.2	14.5	49.8	49.8	36.6	51.0	42.0	67.8	28.2	33.7	42.3	48.4	54.5	37.3	42.3	29.3	94.5	34.0	117.8	72.8	47.9	54.9	31.2	10.7	7.0	33.5	27.7	30.2	28.1	37.2	62.7	27.8	45.2	41.6	32.1	46.4	44.8	31.0	19.9	77.8	102.3	53.5	81.5	32.9	55.2	60.8	58.2	49.5	40.8	16.6	52.5	23.7	71.5	69.9	26.6
NELL2	NRP2	ENSG00000184613	"Neural EGFL like 2"	Q99435	12	44508275-44921848	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 115.4;fallopian tube: 60.6;retina: 85.9"	"Cell type enriched"	"Detected in many"	6	"Excitatory neurons: 652.4"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 33.3"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 70.4;naive CD8 T-cell: 111.1"	"Lineage enriched"	"Detected in many"	10	"T-cells: 111.1"	"Cell line enhanced"	"Detected in some"		"AF22: 104.6;HEK 293: 27.5;NTERA-2: 41.2;SCLC-21H: 75.6;U-266/70: 27.5;U-266/84: 29.5;U-698: 40.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035714, HPA035715"	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA		6400000	Vesicles		"HPA035714: AB_2674746, HPA035715: AB_10669602"	"unprognostic (4.25e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.10e-2)"	"unprognostic (3.01e-2)"	"unprognostic (7.18e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.80e-1)"	"prognostic favorable (5.56e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.71e-5)"	"unprognostic (8.45e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.60e-3)"	"unprognostic (3.75e-2)"	2.5	17.1	30.7	11.0	63.7	7.4	1.9	3.1	115.4	23.3	53.3	2.0	26.5	2.2	0.4	1.2	60.6	1.9	0.4	95.8	47.1	1.2	1.0	5.1	20.9	2.3	2.6	60.5	0.8	0.9	0.2	34.8	0.3	10.5	27.5	2.2	85.9	1.4	2.0	0.3	9.4	15.4	2.8	0.0	6.2	2.9	3.0	3.7	8.8	6.6	0.6	15.9	4.1	4.2	46.8	0.3	0.1	104.6	3.5	0.2	0.0	0.5	0.0	0.1	0.0	0.0	0.4	0.0	8.3	12.4	0.0	0.0	0.2	25.3	0.2	0.0	0.0	27.5	0.4	8.7	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.1	1.6	0.2	0.4	0.0	0.4	0.2	0.4	41.2	0.0	14.0	0.2	12.7	0.2	0.0	0.0	75.6	1.8	0.0	0.4	0.0	1.3	0.1	0.7	0.0	0.4	3.8	0.1	2.1	27.5	29.5	40.3	0.2	0.2	0.4	0.2	0.2	0.0	5.0	0.1	24.9	0.2	30.3	52.9	0.1	0.1	70.4	111.1	0.5	11.0	0.1	0.1	0.4	26.7	30.7	63.7	3.1	115.4	95.8	47.1	2.3	2.6	60.5	10.5	0.0	3.7	46.8	0.3	0.0	1.3	48.0	1.0	1.1	0.0	0.0	5.7	35.4	0.4	0.6	0.5	2.8	6.2	0.0	33.3	0.1	2.5	5.8	0.0	0.0	0.4	0.7	0.8	0.7	0.0	0.0	652.4	0.2	0.3	3.7	0.0	0.3	0.0	49.4	0.0	0.0	0.1	1.7	108.4	0.9	0.0	0.0	1.5	1.0	0.0	0.4	0.0	18.7	1.3	7.9	1.0	74.4	16.5	0.4	0.4	0.4	0.5	0.3	18.5	0.2	21.9	58.3	0.0	4.1	4.6	1.9	4.2	0.2	1.1	0.1	23.4	0.1	2.9	0.1
NFYB	"CBF-A, HAP3, NF-YB"	ENSG00000120837	"Nuclear transcription factor Y subunit beta"	P25208	12	104117086-104138241	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Syncytiotrophoblasts: 433.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 132.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004211, HPA065646"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB004211: AB_628018, HPA065646: "	"unprognostic (5.82e-2)"	"unprognostic (2.44e-3)"	"unprognostic (4.90e-2)"	"unprognostic (7.10e-3)"	"unprognostic (2.67e-1)"	"unprognostic (4.65e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.44e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.63e-1)"	"unprognostic (9.39e-2)"	"unprognostic (8.51e-2)"	"prognostic unfavorable (9.28e-5)"	"unprognostic (1.62e-3)"	"unprognostic (4.98e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.81e-3)"	32.1	41.2	41.7	15.3	41.6	14.8	27.4	38.4	46.1	27.1	34.8	45.5	15.1	30.7	33.4	16.2	30.3	18.7	34.5	38.8	39.1	21.7	30.8	29.2	24.9	41.3	41.7	36.6	23.4	21.4	21.9	17.6	23.8	44.2	39.3	18.6	21.4	20.8	68.6	36.5	18.3	21.9	21.3	42.4	19.5	26.5	22.8	40.9	26.5	22.9	36.6	23.0	38.4	24.1	44.3	30.1	25.3	55.3	35.7	34.2	35.6	48.6	31.5	27.2	37.2	25.6	21.2	14.0	44.4	15.1	30.3	22.9	22.0	46.5	20.9	37.4	28.9	14.7	27.4	31.0	19.7	31.0	35.0	17.6	49.3	25.6	14.5	25.5	62.0	24.0	40.1	27.1	16.2	31.6	29.6	53.2	40.5	52.8	22.1	26.0	43.5	30.9	18.8	27.3	25.3	31.3	26.2	58.0	132.5	19.3	36.8	53.1	42.9	15.2	21.3	13.1	17.5	24.0	28.5	29.5	42.0	12.5	23.7	22.8	18.0	5.7	18.5	12.1	7.8	16.6	12.3	12.1	12.5	5.7	8.5	13.0	13.7	7.2	13.5	9.0	5.0	16.9	9.1	41.7	41.6	38.4	46.1	38.8	39.1	41.3	41.7	36.6	44.2	42.4	40.9	44.3	42.5	54.5	26.7	8.8	21.1	37.3	106.8	42.9	15.9	22.7	24.3	31.8	39.5	12.8	30.3	18.4	4.2	58.8	24.5	13.3	37.2	24.2	6.2	20.4	36.4	36.5	12.0	39.4	13.1	18.3	86.3	43.0	11.2	17.5	21.5	30.8	77.1	31.2	23.1	15.2	13.7	15.4	30.5	14.4	29.8	5.4	34.2	19.2	28.4	8.4	20.2	43.3	22.6	11.1	25.3	27.3	16.9	30.5	17.1	54.5	12.6	42.5	26.7	27.2	19.7	35.4	40.0	90.0	32.4	18.0	37.1	433.2	25.6	18.8	18.3	55.7
NHS		ENSG00000188158	"NHS actin remodeling regulator"	Q6T4R5	X	17375200-17735994	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	6	"Inhibitory neurons: 264.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"EFO-21: 12.7;RPTEC TERT1: 19.2;RT4: 12.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031497, HPA076257"	Uncertain		Supported	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA031497: AB_10610144, HPA076257: AB_2686789"	"unprognostic (1.39e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (1.68e-4)"	"unprognostic (2.58e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.92e-3)"	"unprognostic (3.27e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.61e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.83e-3)"	2.6	4.2	3.0	1.3	2.7	0.4	2.8	0.0	4.6	6.1	5.9	3.2	0.8	4.8	2.9	1.8	2.7	1.6	0.8	2.2	4.7	5.1	0.2	1.1	0.5	3.6	2.7	1.6	3.6	0.5	0.3	2.8	2.7	2.3	3.4	1.6	7.8	2.0	2.7	0.4	2.3	1.5	2.5	0.9	1.0	2.2	2.5	3.2	2.2	2.6	0.7	0.5	4.1	3.7	1.7	7.9	3.1	5.5	0.0	0.1	0.2	8.7	3.5	2.4	1.5	0.8	0.3	1.5	0.5	12.7	2.4	7.5	6.8	3.5	4.4	2.2	0.1	1.1	0.0	5.4	0.0	0.0	0.0	0.0	0.7	3.1	0.1	6.8	6.7	0.0	0.0	0.0	0.0	0.8	3.8	0.0	0.0	6.7	3.6	2.0	0.0	0.0	0.3	19.2	12.0	1.4	2.8	9.6	0.0	0.0	3.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	8.0	0.1	8.4	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.1	3.0	2.7	0.0	4.6	2.2	4.7	3.6	2.7	1.6	2.3	0.9	3.2	1.7	0.6	3.2	0.0	22.5	0.0	8.3	10.6	4.6	8.6	11.4	2.0	2.4	1.7	0.0	14.7	1.8	22.9	6.0	0.1	1.3	5.9	0.8	0.9	12.4	20.1	3.5	4.2	0.0	40.1	2.2	5.4	6.1	3.6	25.0	0.0	0.2	0.7	0.0	1.4	3.3	264.4	1.9	2.0	4.6	2.6	2.3	16.8	2.4	3.6	40.3	5.0	11.9	0.0	14.1	8.1	6.8	2.4	31.2	0.0	7.0	0.9	7.8	8.2	18.9	6.6	2.0	11.9	0.3	0.6	5.1	3.8	2.6	0.9	4.5	4.3	12.8
NHSL1	"bA43P8.1, C6orf63, KIAA1357"	ENSG00000135540	"NHS like 1"	Q5SYE7	6	138422043-138692571	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 23.4"	"Cell type enriched"	"Detected in many"	4	"Astrocytes: 502.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.6;non-classical monocyte: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Hep G2: 46.2;TIME: 64.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029966, HPA029967"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nuclear membrane"	Nucleoplasm	"HPA029966: AB_10601972, HPA029967: AB_2673271"	"unprognostic (1.85e-1)"	"unprognostic (9.71e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.27e-1)"	"unprognostic (8.34e-2)"	"unprognostic (5.21e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.00e-2)"	"unprognostic (4.19e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.55e-2)"	"unprognostic (4.06e-2)"	4.1	1.2	15.8	2.4	14.3	0.3	2.5	11.3	10.5	1.6	14.8	13.3	16.0	1.2	4.7	10.4	1.0	3.0	15.8	15.1	10.6	5.9	15.0	12.9	1.0	16.3	14.1	4.7	0.6	3.3	2.1	1.1	4.3	16.5	0.8	11.5	2.7	3.5	0.5	0.5	11.5	23.4	3.3	8.5	2.6	7.9	0.4	14.8	0.6	1.4	0.8	2.1	2.7	4.5	6.6	5.5	4.7	32.8	13.8	9.4	11.4	12.2	4.8	2.3	1.7	1.6	6.2	3.1	0.0	6.0	4.1	3.1	12.3	20.0	12.5	0.9	0.4	13.4	3.4	2.2	46.2	13.8	12.4	2.3	16.7	7.0	0.9	14.1	1.8	23.3	1.9	0.0	1.8	7.2	10.7	1.3	1.0	13.1	3.1	8.8	14.1	3.4	1.0	11.2	13.7	12.4	0.0	5.1	10.3	33.4	21.5	3.3	3.9	64.3	4.6	4.5	4.6	13.3	1.2	2.7	0.0	0.4	5.0	25.5	0.4	1.2	0.2	0.0	1.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.0	0.2	15.8	14.3	11.3	10.5	15.1	10.6	16.3	14.1	4.7	16.5	8.5	14.8	6.6	6.2	60.9	66.9	502.1	0.5	42.8	3.1	6.6	4.0	0.6	4.1	6.0	22.7	15.7	9.9	29.5	29.2	14.2	0.1	84.1	9.8	3.7	1.1	19.0	1.8	9.3	20.3	2.7	3.3	3.6	3.5	15.6	16.8	16.9	8.8	1.5	26.4	38.1	4.5	37.0	2.9	32.3	6.1	9.4	7.1	0.4	0.6	7.5	21.4	104.0	0.6	15.4	0.0	79.9	2.3	3.9	43.0	0.0	0.1	5.4	87.3	15.8	22.0	1.4	6.6	2.3	4.7	0.0	1.1	7.7	49.2	43.4	1.8	0.8	45.4	10.5
NIBAN1	"C1orf24, FAM129A, GIG39, NIBAN"	ENSG00000135842	"Niban apoptosis regulator 1"	Q9BZQ8	1	184790724-184974508	"Cancer-related genes, Predicted intracellular proteins"	"Stress response, Translation regulation"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 165.7"	"Cell type enriched"	"Detected in some"	13	"Cardiomyocytes: 692.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 72.1"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 72.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 83.8;Karpas-707: 85.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028172, HPA028231, HPA028657"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		120000	"Plasma membrane, Cytosol"		"HPA028172: AB_10599602, HPA028231: AB_10601886, HPA028657: AB_10601680"	"unprognostic (4.61e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.64e-3)"	"unprognostic (9.46e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.87e-1)"	"unprognostic (3.23e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.32e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.94e-3)"	"unprognostic (9.01e-3)"	"unprognostic (4.38e-2)"	"unprognostic (3.73e-2)"	"prognostic unfavorable (4.52e-4)"	18.3	7.9	1.5	39.2	2.0	8.9	24.3	1.7	3.0	14.9	4.9	71.0	8.6	24.4	6.2	61.8	22.3	28.0	165.7	1.6	3.5	3.3	2.8	18.2	11.4	4.0	2.0	1.4	4.9	86.4	4.3	2.1	6.3	3.0	60.1	16.0	0.8	101.4	43.5	61.5	7.9	18.7	41.4	2.6	12.4	59.4	1.9	2.5	12.3	15.4	41.6	17.4	106.7	14.7	3.9	42.0	0.5	0.2	0.1	28.0	42.2	1.6	21.1	42.9	17.7	22.3	0.0	17.3	0.0	13.6	54.2	4.6	46.0	2.4	1.5	28.4	83.8	3.2	17.5	8.2	0.0	65.2	57.2	19.1	39.1	65.3	52.1	62.4	12.6	0.1	6.3	4.2	85.5	0.5	0.2	1.9	10.0	11.1	0.0	4.3	13.3	9.9	0.8	24.5	0.8	2.3	2.1	0.4	0.1	29.9	7.0	9.0	17.9	3.3	35.0	0.1	6.3	43.5	71.1	30.2	8.7	68.8	23.4	35.3	20.4	3.6	10.9	5.1	2.1	4.4	1.0	4.7	5.0	5.2	0.3	0.4	1.8	72.1	5.7	0.8	0.5	11.9	2.2	1.5	2.0	1.7	3.0	1.6	3.5	4.0	2.0	1.4	3.0	2.6	2.5	3.9	20.1	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	692.7	0.0	0.0	0.0	0.0	0.4	52.8	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	1.2	24.7	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.0	0.0	0.0	0.0	0.0	0.4	27.4	0.0	0.0	0.0
NLRP8	"CLR19.2, NALP8, NOD16, PAN4"	ENSG00000179709	"NLR family pyrin domain containing 8"	Q86W28	19	55947832-55988629	"Predicted intracellular proteins"				"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	8	"Cardiomyocytes: 15.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA056989	Uncertain					NA	NA					"HPA056989: AB_2683301"	"unprognostic (2.43e-2)"											"unprognostic (3.35e-1)"		"unprognostic (3.13e-1)"	"unprognostic (6.96e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.3	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1
NLRP9	"CLR19.1, NALP9, NOD6, PAN12"	ENSG00000185792	"NLR family pyrin domain containing 9"	Q7RTR0	19	55708438-55738402	"Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	40	"Extravillous trophoblasts: 61.2"	"Cancer enriched"	"Detected in single"	59	"testis cancer: 14.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA042623	Uncertain					NA	NA					"HPA042623: AB_10965692"	"unprognostic (2.50e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.82e-2)"	"unprognostic (6.53e-2)"	"unprognostic (9.92e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.55e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.56e-3)"	"unprognostic (2.73e-1)"	"unprognostic (3.46e-1)"	"unprognostic (9.56e-2)"	"unprognostic (8.09e-3)"	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.0	61.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0
NOG	"SYM1, SYNS1"	ENSG00000183691	Noggin	Q13253	17	56593699-56595611	"Disease related genes, Human disease related genes, Predicted secreted proteins"	"Chondrogenesis, Differentiation"	"Developmental protein"	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.5;placenta: 10.7"	"Cell type enriched"	"Detected in some"	4	"Extravillous trophoblasts: 12.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"naive CD4 T-cell: 72.8;naive CD8 T-cell: 34.9"	"Lineage enriched"	"Detected in single"	78	"T-cells: 72.8"	"Cell line enhanced"	"Detected in many"		"EFO-21: 123.3;LHCN-M2: 38.1;NB-4: 28.8;PC-3: 37.9;U-2 OS: 38.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061318	Approved				"Secreted to blood"	NA	NA					"HPA061318: AB_2684478"	"unprognostic (1.49e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.49e-5)"	"prognostic favorable (6.66e-4)"	"unprognostic (4.69e-2)"	"unprognostic (5.23e-3)"		"unprognostic (1.26e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (6.86e-5)"	"unprognostic (2.88e-1)"	"unprognostic (1.14e-6)"	"unprognostic (8.39e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.00e-1)"	"unprognostic (1.65e-1)"	0.5	0.1	5.6	0.6	4.4	0.2	0.3	1.9	4.2	4.1	0.4	0.2	0.1	0.3	0.1	0.2	0.5	0.0	0.3	4.0	3.6	0.4	0.1	0.7	1.8	2.5	4.5	2.3	0.0	0.1	0.0	0.7	10.7	2.1	0.8	0.0	0.0	0.3	1.4	3.5	0.3	0.5	0.1	2.0	0.8	0.9	0.7	9.5	0.6	0.4	0.8	0.4	0.8	2.7	2.0	6.3	0.2	0.2	0.0	0.2	0.0	0.0	3.2	3.5	1.2	1.3	0.4	1.2	0.0	123.3	1.5	4.8	0.5	2.2	0.3	3.4	0.1	2.2	0.0	5.2	0.0	0.0	0.9	0.0	0.5	0.7	0.0	0.5	0.4	0.1	0.1	0.0	0.0	38.1	0.2	1.1	28.8	2.6	0.0	37.9	17.0	11.6	0.0	2.9	0.0	0.2	0.0	6.5	0.1	0.0	9.9	0.1	0.5	0.7	2.3	38.5	0.2	2.7	0.0	0.1	0.4	0.0	3.2	0.0	0.9	0.1	0.2	0.6	0.2	0.2	0.1	4.3	0.5	0.1	0.1	72.8	34.9	0.8	0.4	0.3	0.3	3.4	3.1	5.6	4.4	1.9	4.2	4.0	3.6	2.5	4.5	2.3	2.1	2.0	9.5	2.0	0.4	0.0	0.0	2.0	0.3	0.0	0.4	0.0	0.6	0.0	0.1	0.9	1.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.5	0.1	0.6	1.5	0.3	0.0	2.5	0.2	0.0	12.2	1.0	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	1.0	1.5	0.1	0.6	0.0	0.0	0.3	0.3	0.0	0.4	0.0	0.0	0.0	2.3	0.4	0.0	1.7	0.4	0.1	0.8	2.0	0.0	0.0	0.1
NOMO2	"NOMO, PM5"	ENSG00000185164	"NODAL modulator 2"	Q5JPE7	16	18417325-18562211	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 302.9"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 124.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA046697, HPA061174"	Approved					NA	NA					"HPA046697: AB_2679758, HPA061174: AB_2684444"	"unprognostic (2.58e-3)"	"unprognostic (4.11e-3)"	"unprognostic (2.58e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.85e-2)"	"unprognostic (4.80e-2)"	"unprognostic (9.37e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.78e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.42e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.54e-2)"	55.2	66.7	111.1	27.9	130.6	31.3	55.1	108.4	142.5	53.4	106.8	65.7	35.1	60.3	54.0	57.7	48.6	22.6	176.3	129.9	123.8	77.0	97.4	74.4	24.1	112.3	110.2	117.1	48.8	302.9	77.4	105.1	49.5	122.1	60.0	36.0	42.7	63.8	32.0	127.2	60.3	57.2	41.9	102.3	62.3	89.2	50.8	113.8	23.3	56.4	52.7	29.8	61.8	50.9	129.5	71.1	101.3	37.5	104.5	141.0	85.9	110.3	122.1	144.6	101.5	125.4	87.7	108.6	83.0	433.3	213.4	71.0	80.5	81.2	84.8	88.1	67.7	64.5	37.0	98.2	313.5	195.5	88.7	252.1	91.2	112.6	117.2	106.8	107.9	113.1	70.3	52.3	185.4	120.6	213.9	33.2	197.2	72.9	107.0	42.3	71.1	50.8	230.1	150.9	63.6	52.6	44.2	94.4	128.5	82.4	75.2	99.6	185.8	106.1	60.7	47.0	127.4	86.8	95.6	112.0	44.6	135.3	92.9	85.1	21.8	12.6	11.8	14.3	11.9	11.6	10.8	14.0	14.5	14.1	9.8	9.3	11.8	13.8	8.3	15.4	22.8	22.4	17.5	111.1	130.6	108.4	142.5	129.9	123.8	112.3	110.2	117.1	122.1	102.3	113.8	129.5	0.5	6.4	2.8	2.0	3.8	0.4	0.4	0.6	2.8	0.9	0.5	0.3	124.4	0.0	1.4	0.0	4.2	0.4	1.3	0.4	1.9	0.2	0.2	0.3	0.8	3.2	0.0	2.5	6.4	0.7	0.3	9.1	4.1	0.6	0.0	0.7	0.7	0.8	0.1	0.0	5.1	0.2	0.0	0.8	0.2	0.4	0.0	1.2	0.0	5.6	0.2	0.3	2.1	8.5	7.6	0.4	0.1	0.4	22.7	0.4	0.6	0.1	1.9	0.6	6.6	0.6	4.8	1.2	1.3	3.3	0.6	0.4	3.2	1.1	0.4	0.1
NPAP1	C15orf2	ENSG00000185823	"Nuclear pore associated protein 1"	Q9NZP6	15	24675775-24683393	"Predicted intracellular proteins, Transporters"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.5;testis: 2.9"	"Cell type enriched"	"Detected in some"	5	"Granulosa cells: 125.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA018828, HPA019562"	Uncertain		Supported	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			Nucleoplasm	"Vesicles, Plasma membrane"	"HPA018828: AB_2669941, HPA019562: AB_2670190"										"unprognostic (4.40e-2)"	"unprognostic (1.85e-2)"		"unprognostic (6.98e-3)"	"unprognostic (7.45e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.11e-3)"	0.0	0.0	0.7	0.0	1.5	0.4	0.1	0.1	1.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.5	1.1	0.3	0.0	0.0	0.1	0.8	0.4	0.6	0.5	0.4	0.0	0.5	0.0	1.2	0.1	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.1	0.1	2.9	1.1	0.0	0.5	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.7	1.5	0.1	1.0	0.5	1.1	0.8	0.4	0.6	1.2	0.2	1.1	1.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.1	0.2	0.7	0.1	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.1	0.0	125.9	0.0	0.0	0.1	0.0	3.5	0.0	0.0	0.0	0.0	0.8	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.3	24.1	12.7	0.0	0.0	0.0	0.0	0.5	0.0	0.2
NPIPB7	"LOC440350, NPIPL1"	ENSG00000233232	"Nuclear pore complex interacting protein family member B7"	O75200	16	28456372-28471175	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"testis: 22.4"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 152.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											"HPA011188, HPA053611"	Approved		Approved	Nucleoplasm	"Secreted in male reproductive system"	NA	NA			Nucleoplasm		"HPA011188: AB_2668455, HPA053611: AB_2682206"	"unprognostic (1.18e-1)"	"unprognostic (1.35e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.94e-1)"		"unprognostic (7.43e-2)"	"unprognostic (3.07e-3)"	"unprognostic (3.35e-2)"	"unprognostic (3.44e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.62e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.40e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.73e-2)"	"unprognostic (2.03e-2)"	1.4	1.0	4.0	1.4	3.0	2.6	1.0	5.3	8.1	0.5	0.0	1.4	1.0	1.3	2.1	0.2	0.7	0.3	0.4	4.1	0.9	0.6	1.3	0.8	1.5	2.7	0.8	0.9	1.6	1.7	0.4	0.3	0.7	3.7	1.0	1.4	4.6	0.8	1.1	5.0	3.2	1.3	0.7	0.0	1.3	2.4	22.4	2.1	1.1	0.6	1.0	0.6	0.5	0.1	3.3	0.6	4.1	3.0	2.0	1.3	1.3	6.3	1.5	0.1	0.3	0.5	1.5	1.8	3.2	0.9	1.0	0.3	2.0	0.9	0.6	0.2	1.1	1.5	1.2	4.5	3.1	0.6	2.8	6.3	1.4	3.1	1.0	0.9	1.6	0.1	1.9	1.0	2.2	0.7	5.4	0.7	2.9	1.9	0.2	0.2	2.6	1.8	1.6	0.2	1.5	1.6	0.8	1.3	0.5	0.6	2.8	2.2	1.2	2.2	1.1	2.8	1.5	1.0	4.4	2.2	3.1	0.4	1.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	3.0	5.3	8.1	4.1	0.9	2.7	0.8	0.9	3.7	0.0	2.1	3.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	1.8	0.0	0.2	0.0	0.1	0.0	0.0	152.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	32.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.8	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0
NT5DC1	"dJ486I3.1, MGC24302, NT5C2L1"	ENSG00000178425	"5'-nucleotidase domain containing 1"	Q5TFE4	6	116100851-116249497	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 95.8"	"Cell type enriched"	"Detected in all"	4	"Oligodendrocytes: 429.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030352, HPA079264"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		140000	Nucleoplasm	Cytosol	"HPA030352: AB_2154066, HPA079264: "	"unprognostic (1.30e-1)"	"unprognostic (2.92e-1)"	"prognostic favorable (2.61e-4)"	"unprognostic (1.14e-1)"	"unprognostic (3.13e-2)"	"unprognostic (7.80e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.61e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (7.49e-7)"	"unprognostic (1.41e-1)"	"unprognostic (8.53e-2)"	"unprognostic (2.79e-1)"	"unprognostic (9.63e-2)"	19.6	24.2	10.3	12.8	23.7	10.1	19.4	21.1	17.0	10.5	95.8	20.0	29.7	9.2	22.6	16.7	20.8	15.8	26.1	10.2	15.4	28.4	43.0	16.9	21.5	24.9	20.7	7.9	13.4	22.4	24.0	9.7	8.3	23.1	28.5	20.1	11.3	22.9	16.7	21.7	10.8	27.0	11.4	20.8	13.6	21.8	10.7	20.1	14.6	28.5	23.5	22.6	15.9	9.5	40.2	24.7	20.3	17.7	23.7	19.2	11.6	31.0	17.7	40.3	27.4	32.2	29.4	24.8	50.3	37.4	15.9	29.7	38.7	12.1	28.1	23.8	78.4	26.7	21.0	16.7	31.0	20.9	46.8	1.9	21.7	22.2	17.6	15.0	59.2	24.7	30.0	26.6	27.5	34.8	25.3	9.0	16.3	16.2	54.1	27.0	52.3	48.3	27.2	25.5	29.2	11.8	17.6	37.9	28.7	26.5	19.4	26.6	9.3	21.6	12.3	20.8	23.7	35.6	40.2	59.2	39.8	29.3	31.0	22.4	14.5	18.2	33.2	20.2	10.5	31.4	41.3	29.8	25.4	24.6	30.1	28.2	24.3	12.9	23.1	12.7	12.4	32.4	19.7	10.3	23.7	21.1	17.0	10.2	15.4	24.9	20.7	7.9	23.1	20.8	20.1	40.2	15.4	64.1	45.7	62.3	37.9	26.1	37.9	66.5	29.6	14.0	30.3	23.6	44.2	25.8	44.5	18.4	27.1	41.6	24.9	19.1	64.6	39.6	19.8	32.9	10.7	21.7	26.5	16.2	96.1	40.8	30.4	14.0	26.5	19.0	23.5	16.2	33.5	49.3	31.8	45.4	70.1	30.6	30.5	29.2	14.2	8.3	19.0	18.5	19.6	54.4	49.6	19.8	10.3	29.7	429.4	28.8	19.6	20.7	25.3	28.0	54.6	57.4	76.7	20.2	32.9	29.2	23.9	17.2	28.5	27.4	21.5	25.6	23.8	18.3	35.9	31.5
NTHL1	"NTH1, OCTS3"	ENSG00000065057	"Nth like DNA glycosylase 1"	P78549	16	2039815-2047866	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Glycosidase, Hydrolase, Lyase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	10	"Hepatocytes: 866.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB025152	Supported					NA	NA					"CAB025152: "	"unprognostic (1.06e-1)"	"unprognostic (9.71e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.54e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.46e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.77e-2)"	"unprognostic (6.78e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.34e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.62e-2)"	10.9	9.4	12.3	6.2	12.7	4.8	11.1	12.9	19.9	15.0	9.5	16.2	6.6	15.5	3.2	11.4	14.0	6.1	12.7	11.7	12.2	9.8	22.1	10.8	8.4	13.6	12.1	11.3	16.2	10.0	4.9	11.5	5.7	13.9	11.3	5.7	1.8	16.2	11.6	9.8	9.2	11.2	5.3	11.7	16.8	13.3	8.8	13.2	7.7	9.6	6.8	6.0	11.9	12.7	12.8	29.8	74.2	20.8	32.2	8.5	15.9	22.8	12.1	13.2	23.1	14.6	53.0	28.8	63.0	25.2	10.7	15.1	26.2	26.1	29.0	4.0	28.9	63.3	19.5	47.7	60.9	11.5	22.4	22.3	13.2	14.9	12.3	13.2	15.4	33.4	37.0	22.2	22.6	9.0	34.9	33.9	88.3	46.2	37.3	47.3	80.8	22.0	103.5	17.2	10.7	43.9	43.5	13.2	41.0	25.4	7.6	29.6	23.5	12.9	19.9	21.5	17.5	23.1	30.3	38.0	26.9	8.8	31.7	24.9	4.2	15.0	3.4	14.4	26.0	16.2	37.5	17.3	16.7	25.7	32.8	12.8	15.4	0.7	19.1	22.5	26.3	34.0	14.4	12.3	12.7	12.9	19.9	11.7	12.2	13.6	12.1	11.3	13.9	11.7	13.2	12.8	47.2	28.9	27.5	2.9	12.9	8.7	16.4	21.6	8.0	8.8	18.9	23.4	14.1	44.3	28.3	3.7	0.0	10.5	8.1	75.6	17.6	16.3	8.1	20.4	19.5	36.5	67.4	26.7	3.0	9.1	18.3	17.6	16.3	23.3	5.7	20.5	51.0	866.4	13.4	6.7	3.6	85.3	54.9	25.5	17.6	23.8	33.8	9.3	21.4	2.8	9.7	10.7	18.6	3.0	4.9	12.1	81.6	25.2	16.0	6.4	12.8	28.8	23.5	8.1	13.1	8.1	23.6	5.4	32.0	11.7	10.1	2.7	12.2	20.6	56.8	21.0
NTN1	NTN1L	ENSG00000065320	"Netrin 1"	O95631	17	9021510-9244000	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	Apoptosis		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.8;heart muscle: 35.8"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocyte precursor cells: 137.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 27.5;T-47d: 16.6;U-2 OS: 14.4;U-251 MG: 22.1;WM-115: 12.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056419	Approved		Approved	"Nucleoplasm,Actin filaments,Cytosol"	"Secreted to extracellular matrix"	NA	NA		110000	Cytosol	"Nucleoplasm, Actin filaments"	"HPA056419: AB_2683124"	"unprognostic (2.72e-1)"	"unprognostic (2.59e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.51e-1)"	"unprognostic (9.33e-3)"	"unprognostic (9.42e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.07e-3)"	"unprognostic (8.31e-3)"	4.4	0.5	8.0	3.6	5.5	0.1	5.4	10.5	5.0	8.1	3.4	12.6	6.8	9.7	3.5	19.1	10.4	7.4	35.8	3.8	11.2	1.9	7.0	4.3	0.2	12.8	31.8	2.7	0.9	2.3	4.4	3.0	0.9	10.8	4.0	4.0	0.4	11.0	2.0	2.1	7.3	10.6	6.0	14.9	0.1	17.6	3.2	8.7	2.9	2.0	2.6	2.1	10.3	5.5	14.0	0.1	0.0	1.3	4.6	4.2	0.1	27.5	0.3	0.4	0.3	0.5	0.1	5.7	0.0	6.2	0.0	9.0	0.1	1.2	0.9	0.0	6.4	10.4	1.4	0.0	0.0	0.1	0.5	0.1	0.1	2.1	0.8	0.0	0.0	0.0	1.0	0.0	0.0	0.1	5.6	0.1	0.6	1.8	0.0	0.0	3.4	4.8	0.0	0.0	0.3	0.0	0.0	0.1	4.7	1.1	4.5	16.6	0.3	0.0	6.7	14.4	0.0	22.1	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	5.5	10.5	5.0	3.8	11.2	12.8	31.8	2.7	10.8	14.9	8.7	14.0	0.7	0.0	0.0	10.7	0.3	3.3	6.6	21.8	9.6	2.9	4.7	4.4	28.1	0.0	23.9	1.8	0.0	0.3	0.2	0.5	0.0	3.1	9.3	5.8	2.0	3.1	0.0	0.0	4.8	1.7	1.2	9.7	1.1	7.9	0.0	0.0	2.2	12.4	0.1	0.0	7.1	1.4	24.4	0.6	5.9	4.6	0.3	0.1	1.8	9.4	0.6	0.3	0.0	137.2	1.0	1.4	0.1	0.0	0.0	4.0	0.7	0.2	11.1	0.2	0.0	3.9	6.8	1.6	2.0	12.7	2.8	0.5	0.5	0.0	0.6	3.5
NWD2	KIAA1239	ENSG00000174145	"NACHT and WD repeat domain containing 2"	Q9ULI1	4	37244743-37449463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 1.4;brain: 5.0"	"Cell type enriched"	"Detected in some"	4	"Excitatory neurons: 91.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046911	Uncertain					NA	NA					"HPA046911: AB_2679861"	"unprognostic (1.14e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.53e-1)"		"unprognostic (5.47e-2)"	"unprognostic (9.42e-2)"	"unprognostic (2.55e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.63e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.00e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.86e-2)"	"unprognostic (7.65e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.26e-2)"	1.4	0.0	0.6	0.0	5.0	0.0	1.1	0.2	3.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.9	0.0	0.1	0.0	0.0	1.2	4.7	2.4	0.0	0.1	0.0	0.1	0.0	2.3	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.9	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	5.0	0.2	3.0	1.6	0.9	1.2	4.7	2.4	2.3	0.0	0.2	2.3	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	91.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.1	0.0	4.5	1.9	0.1	2.5	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1
NXPH2	NPH2	ENSG00000144227	"Neurexophilin 2"	O95156	2	138669157-138780390	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 13.5;kidney: 4.1;ovary: 8.1"	"Cell type enriched"	"Detected in some"	6	"Inhibitory neurons: 156.1"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 3.4;SiHa: 3.0;SuSa: 2.1;U-2 OS: 4.7;U-251 MG: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA034759	Approved				"Secreted in brain"	NA	Yes					"HPA034759: AB_10669732"	"unprognostic (5.83e-2)"				"unprognostic (8.83e-2)"			"unprognostic (1.41e-1)"		"unprognostic (2.72e-1)"	"unprognostic (1.80e-1)"							0.0	0.0	1.6	0.1	2.0	0.0	0.1	1.3	3.2	0.1	0.4	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	1.2	1.1	4.1	0.0	0.0	0.0	10.1	2.9	1.3	8.1	0.0	0.0	0.1	0.1	13.5	0.0	0.0	2.3	0.0	0.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	3.6	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.1	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.6	3.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	4.7	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.0	1.3	3.2	1.2	1.1	10.1	2.9	1.3	13.5	2.0	3.6	8.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	156.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.5	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NYX	"CLRP, CSNB1, CSNB1A, CSNB4"	ENSG00000188937	Nyctalopin	Q9GZU5	X	41447343-41475710	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"		"Congenital stationary night blindness, Disease variant"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	7	"Bipolar cells: 13.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	4	"HDLM-2: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Intracellular and membrane"	NA	NA									"unprognostic (3.27e-2)"	"unprognostic (6.72e-2)"				"unprognostic (4.21e-2)"	"unprognostic (4.10e-4)"			"unprognostic (1.83e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.80e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.5	0.0	0.0	1.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.6	0.0	0.0	0.0	0.5	1.7	0.0	0.0	0.3	0.0	0.1	0.0	0.0
OGFOD2	"FLJ13491, FLJ37501"	ENSG00000111325	"2-oxoglutarate and iron dependent oxygenase domain containing 2"	Q6N063	12	122974580-122980043	"Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Late spermatids: 431.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039448, HPA040306"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA039448: AB_10795035, HPA040306: AB_10794026"	"unprognostic (2.14e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.86e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.14e-1)"	"unprognostic (8.44e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.07e-3)"	"unprognostic (2.48e-3)"	"unprognostic (1.13e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.13e-1)"	6.3	15.1	10.3	7.8	10.5	8.5	7.6	10.4	14.1	8.8	11.1	9.0	13.9	6.9	5.9	10.7	10.3	4.9	9.5	9.7	10.1	14.1	21.4	7.8	11.1	11.6	10.5	9.7	9.4	21.1	6.5	13.3	5.7	11.2	12.1	5.6	4.9	14.8	7.9	11.0	12.0	12.9	3.4	10.6	14.5	13.1	29.3	10.8	9.4	11.9	4.5	6.7	7.8	8.4	12.9	11.7	18.6	7.6	12.4	5.2	5.5	20.4	6.9	7.1	9.5	8.6	17.6	10.2	13.0	14.1	6.0	5.6	16.5	5.5	9.5	3.6	9.1	12.0	20.6	17.8	18.3	11.1	20.7	15.5	8.1	14.0	8.8	7.8	13.7	10.1	24.7	24.4	9.3	4.8	22.4	17.6	39.0	4.6	8.0	23.5	19.2	7.3	23.2	7.2	10.4	9.7	8.8	9.4	13.4	13.8	5.0	34.0	17.6	6.5	13.0	13.2	15.5	7.3	23.4	15.1	12.4	17.9	10.7	12.8	18.7	11.7	18.9	9.1	12.9	7.8	15.9	7.5	9.0	13.1	11.3	8.1	7.7	9.6	9.7	18.2	7.8	16.0	9.0	10.3	10.5	10.4	14.1	9.7	10.1	11.6	10.5	9.7	11.2	10.6	10.8	12.9	4.1	0.0	7.0	4.6	10.0	2.9	6.5	10.3	8.0	3.6	9.2	8.6	0.4	10.0	8.6	12.9	2.1	25.9	5.6	9.2	9.8	11.8	97.3	13.0	5.2	5.9	2.4	17.2	3.2	15.0	14.0	5.4	8.6	5.3	0.0	8.6	7.9	21.1	12.5	11.8	3.6	8.0	16.2	11.9	3.4	431.0	8.7	6.4	7.2	1.0	7.7	7.8	10.3	3.0	2.6	12.7	7.8	4.5	18.4	4.6	32.4	34.1	30.5	6.4	13.1	4.1	5.7	36.8	16.2	7.3	4.5	16.4	7.2	11.5	10.1	4.3
OLAH	"FLJ11106, SAST, THEDC1"	ENSG00000152463	"Oleoyl-ACP hydrolase"	Q9NV23	10	15032227-15073853	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 9.0;testis: 27.2"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 537.8"	"Cancer enriched"	"Detected in some"	4	"testis cancer: 3.6"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 2.6"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.6"	"Cell line enhanced"	"Detected in some"		"HSkMC: 3.6;hTCEpi: 4.8;LHCN-M2: 3.6;SK-BR-3: 5.3;SuSa: 2.6;U-266/70: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA037947, HPA037948"	Enhanced					NA	NA					"HPA037947: AB_10795028, HPA037948: AB_10805352"	"unprognostic (2.01e-1)"	"unprognostic (6.12e-2)"	"unprognostic (8.20e-3)"	"unprognostic (4.04e-3)"	"unprognostic (1.92e-1)"	"unprognostic (8.09e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.12e-2)"	"unprognostic (4.55e-1)"	"unprognostic (3.74e-2)"	"unprognostic (4.70e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.22e-10)"	"unprognostic (4.55e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.11e-2)"	"unprognostic (9.78e-2)"	1.2	0.9	1.1	0.2	0.7	1.1	5.5	0.5	1.5	0.8	0.6	0.2	0.1	0.4	0.4	3.0	1.7	1.0	0.2	1.2	0.1	1.1	0.3	1.8	0.3	0.6	0.2	0.6	0.2	0.1	0.3	1.0	3.2	0.4	0.3	0.0	0.7	2.7	0.1	0.2	0.5	0.5	0.2	0.2	9.0	0.3	27.2	0.5	0.1	0.4	0.3	0.0	0.2	0.8	1.2	0.0	0.0	0.1	0.2	0.2	0.7	1.2	0.3	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.4	0.1	0.1	0.2	0.1	0.0	0.5	0.0	0.4	3.6	4.8	0.5	0.0	0.0	0.4	0.1	0.2	0.1	3.6	0.0	0.3	0.2	0.2	0.0	0.3	0.4	0.7	0.2	0.0	0.0	0.0	0.1	0.1	5.3	0.0	2.6	0.1	0.1	0.2	0.0	1.8	0.1	0.1	3.1	0.7	0.2	1.1	0.2	0.0	0.8	0.1	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.1	2.6	0.4	0.0	0.5	0.2	0.0	1.1	0.7	0.5	1.5	1.2	0.1	0.6	0.2	0.6	0.4	0.2	0.5	1.2	0.7	3.2	0.6	0.3	0.1	0.3	0.5	0.0	0.0	0.1	131.3	0.9	0.4	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	2.7	537.8	0.1	0.2	0.3	0.0	0.0	0.1	0.0	1.7	0.3	0.0	0.2	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.0	2.2	0.3	66.1	4.4	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	8.2	0.0	0.4	0.0	0.0	0.8	0.7	6.6	0.5	1.0	2.8	1.9	0.0	0.3	11.4	0.9	0.1	0.0	0.1
ONECUT2	OC-2	ENSG00000119547	"One cut homeobox 2"	O95948	18	57435374-57491298	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 7.1;gallbladder: 10.2;intestine: 10.2;liver: 8.5;retina: 5.5"	"Cell type enriched"	"Detected in many"	5	"Horizontal cells: 964.0"	"Group enriched"	"Detected in many"	7	"liver cancer: 4.3;pancreatic cancer: 4.3;stomach cancer: 5.4"	"Region enhanced"	"Detected in many"		"basal ganglia: 7.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 20.3;HeLa: 14.1;RT4: 6.7;SCLC-21H: 10.1"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"basal ganglia: 8.7;cerebellum: 4.7;cerebral cortex: 5.6;hippocampal formation: 3.2;hypothalamus: 2.5"	HPA057058	Enhanced		Supported	"Nucleoplasm,Actin filaments"		NA	NA			Nucleoplasm	"Actin filaments"	"HPA057058: AB_2683323"	"unprognostic (3.02e-2)"	"unprognostic (5.36e-2)"	"unprognostic (9.06e-3)"	"unprognostic (3.79e-5)"	"unprognostic (1.13e-2)"	"unprognostic (4.48e-4)"	"unprognostic (2.10e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.56e-3)"	"unprognostic (8.66e-3)"	"unprognostic (1.16e-2)"	"unprognostic (5.34e-4)"	"unprognostic (3.83e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.21e-1)"	0.0	0.1	0.2	0.0	7.1	0.0	0.0	0.6	1.9	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	10.2	0.0	0.3	4.2	0.0	8.5	0.0	0.0	2.2	0.3	0.1	0.0	2.4	0.8	0.8	0.0	2.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	1.0	1.2	3.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	1.4	0.0	3.4	0.0	0.1	20.3	3.1	0.7	14.1	3.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	2.3	4.0	0.7	0.0	0.5	1.9	0.0	0.1	1.6	0.7	0.0	1.2	0.0	1.6	6.7	10.1	1.7	0.1	0.0	0.2	0.1	0.5	0.7	0.0	1.0	1.3	0.2	0.2	0.3	3.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.1	0.6	1.9	0.3	4.2	2.2	0.3	0.1	2.0	0.0	1.0	0.3	0.3	0.0	0.0	2.3	0.0	0.1	0.2	0.0	0.0	4.5	0.4	1.1	2.8	184.5	0.0	7.3	14.6	0.0	0.0	2.0	0.0	79.7	4.9	0.2	0.1	0.5	8.9	0.0	38.7	8.8	0.1	0.3	0.0	0.3	0.0	0.5	5.3	47.0	1.0	964.0	1.8	0.6	0.0	1.3	0.0	3.2	0.3	0.1	0.0	1.0	0.0	3.0	0.0	3.5	1.0	38.7	3.3	0.0	0.0	0.4	0.1	0.1	0.0	5.6	0.0	0.9	0.7	1.9	2.0	0.0	0.1	0.0	0.1	0.2	0.5	0.0
OPN1MW3		ENSG00000269433	"Opsin 1, medium wave sensitive 3"	P0DN78	X	154257538-154271805	"Predicted membrane proteins"	"Sensory transduction, Vision"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"		"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	11	"Cone photoreceptor cells: 18.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR10G6	"OR10G6P, OR10G6Q"	ENSG00000198674	"Olfactory receptor family 10 subfamily G member 6"	Q8NH81	11	123994163-123995161	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	18	"Distal tubular cells: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR14I1	"OR5BU1, OR5BU1P"	ENSG00000189181	"Olfactory receptor family 14 subfamily I member 1"	A6ND48	1	248681322-248682328	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	17	"Excitatory neurons: 29.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																	"unprognostic (3.68e-1)"	"unprognostic (1.63e-1)"					0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.8	0.5	0.0	0.2	0.0	0.5	0.1	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	29.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR1D2	"OLFR1, OR17-4"	ENSG00000184166	"Olfactory receptor family 1 subfamily D member 2"	P34982	17	3088484-3104422	"G-protein coupled receptors, Predicted membrane proteins"	"Chemotaxis, Fertilization, Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.9"	"Cell type enriched"	"Detected in single"	13	"granulocytes: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"													NA	NA																							0.5	0.4	2.7	0.5	2.8	1.5	0.5	3.3	3.9	0.2	1.1	0.2	0.4	0.4	1.0	0.2	0.5	0.5	0.4	2.7	1.6	0.7	0.7	0.4	0.8	2.6	1.9	2.3	0.7	0.3	0.2	0.0	0.4	2.7	0.5	0.4	2.5	0.6	0.3	0.6	1.1	0.4	0.2	1.1	0.8	0.4	0.6	2.3	0.4	1.3	0.3	0.5	0.3	0.0	3.7	0.4	0.3	0.5	0.7	0.2	0.2	1.1	0.3	0.1	0.2	0.3	1.4	0.6	0.6	0.7	0.3	0.8	0.7	0.2	0.1	0.3	0.7	0.6	1.8	1.0	0.2	0.2	0.6	1.2	0.1	0.4	0.2	0.1	0.5	0.2	0.6	0.7	1.9	0.1	0.5	0.4	1.1	0.7	0.2	0.1	0.4	0.3	0.5	0.4	0.8	1.0	0.5	0.4	0.2	0.4	1.3	0.6	0.6	0.5	0.5	1.3	0.4	0.3	0.9	0.5	0.5	0.4	0.5	0.7	0.2	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.2	0.1	0.1	0.6	0.1	0.1	0.1	0.0	0.0	2.7	2.8	3.3	3.9	2.7	1.6	2.6	1.9	2.3	2.7	1.1	2.3	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
OR1J2	"OR1J3, OR1J5, OST044"	ENSG00000197233	"Olfactory receptor family 1 subfamily J member 2"	Q8NGS2	9	122510802-122511743	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	9	"Excitatory neurons: 14.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"									NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR1Q1	"HSTPCR106, OR1Q2, OR1Q3, OR9-A, OST226, OST226OR9-A, TPCR106"	ENSG00000165202	"Olfactory receptor family 1 subfamily Q member 1"	Q15612	9	122614738-122615682	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"retina: 1.2"	"Cell type enriched"	"Detected in some"	8	"Excitatory neurons: 8.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044828	Uncertain					NA	NA					"HPA044828: AB_10960565"										"unprognostic (5.41e-2)"				"unprognostic (2.00e-1)"			"unprognostic (1.98e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2G2		ENSG00000177489	"Olfactory receptor family 2 subfamily G member 2"	Q8NGZ5	1	247588360-247589313	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	45	"granulocytes: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"									NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2H2	hs6M1-12	ENSG00000204657	"Olfactory receptor family 2 subfamily H member 2"	O95918	6	29585121-29590500	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"epididymis: 4.8;testis: 2.3"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 15.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"													NA	NA						"unprognostic (2.95e-1)"	"unprognostic (3.76e-1)"			"unprognostic (2.33e-2)"			"unprognostic (2.42e-1)"	"unprognostic (2.34e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.76e-1)"	"unprognostic (3.20e-1)"		"unprognostic (1.34e-1)"	"unprognostic (2.04e-1)"			0.0	0.0	0.6	0.1	1.6	0.7	0.0	1.1	0.8	0.2	0.0	0.1	0.0	0.1	4.8	0.1	0.2	0.0	0.3	0.6	0.1	0.0	0.0	0.1	0.2	1.0	0.2	0.5	0.3	0.0	0.0	0.5	0.0	0.5	0.3	0.0	1.5	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.1	0.1	2.3	0.2	0.0	0.1	0.0	0.1	0.1	0.2	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.6	1.1	0.8	0.6	0.1	1.0	0.2	0.5	0.5	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2M3	"OR2M3P, OR2M6, OST003"	ENSG00000228198	"Olfactory receptor family 2 subfamily M member 3"	Q8NG83	1	248197265-248212925	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 5.7"	"Cell type enriched"	"Detected in single"	13	"Club cells: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"																	NA	NA																							0.6	0.6	2.1	0.7	2.0	2.6	0.6	4.7	5.7	0.3	0.6	1.0	0.8	0.6	1.3	0.6	0.4	0.7	0.5	1.7	0.7	1.2	1.2	0.5	0.9	1.7	1.4	0.5	0.8	0.8	0.2	0.0	0.6	2.2	0.6	1.1	3.8	1.2	0.3	1.0	1.7	0.7	0.2	0.4	0.9	0.8	1.2	0.8	0.4	0.9	0.2	0.3	0.3	0.0	5.3	1.3	0.7	1.1	1.1	0.4	0.4	1.0	0.9	0.1	0.1	0.2	2.8	1.6	1.5	1.0	0.2	1.5	1.1	0.4	0.3	0.3	1.4	0.9	0.7	2.7	0.9	0.1	1.0	0.9	0.3	0.4	0.2	0.3	0.7	0.2	1.0	1.7	2.9	0.2	1.0	0.8	1.1	1.7	1.0	0.6	0.9	1.2	1.4	0.4	0.9	1.1	0.9	1.3	0.6	0.7	1.3	1.2	0.8	1.4	1.3	1.6	1.3	0.9	1.8	1.1	1.1	1.0	0.9	1.1	1.0	0.3	0.2	0.2	0.4	0.2	0.2	0.2	0.1	0.1	0.3	0.2	0.2	0.7	0.2	0.3	0.3	0.2	0.1	2.1	2.0	4.7	5.7	1.7	0.7	1.7	1.4	0.5	2.2	0.4	0.8	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2T2	OR2T2P	ENSG00000196240	"Olfactory receptor family 2 subfamily T member 2"	Q6IF00	1	248445512-248455725	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	17	"Proximal tubular cells: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2T33		ENSG00000177212	"Olfactory receptor family 2 subfamily T member 33"	Q8NG76	1	248269917-248277976	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"Alveolar cells type 2: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA															"unprognostic (5.79e-2)"						"unprognostic (2.22e-1)"		0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
OR4M1		ENSG00000176299	"Olfactory receptor family 4 subfamily M member 1"	Q8NGD0	14	19773504-19783696	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"Early spermatids: 48.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA058889	Uncertain					NA	NA					"HPA058889: AB_2683845"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR4M2		ENSG00000274102	"Olfactory receptor family 4 subfamily M member 2"	Q8NGB6	15	22070241-22083221	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	6	"Sertoli cells: 6.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA058889	Uncertain					NA	NA					"HPA058889: AB_2683845"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR51C1P	"OR51C2P, OR51C3P, OST734"	ENSG00000197674	"Olfactory receptor family 51 subfamily C member 1 pseudogene"		11	4690423-4697831	"Predicted membrane proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	18	"Enteroendocrine cells: 1.8"	"Cancer enriched"	"Detected in single"	65	"prostate cancer: 3.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA																	"unprognostic (1.82e-1)"						0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR52N5	OR52N5Q	ENSG00000181009	"Olfactory receptor family 52 subfamily N member 5"	Q8NH56	11	5776165-5783355	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"Adipocytes: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA																							0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR56A4		ENSG00000183389	"Olfactory receptor family 56 subfamily A member 4"	Q8NGH8	11	5999445-6006946	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"granulocytes: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"													NA	NA																							0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.4	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.4	0.2	0.3	0.1	0.1	0.3	0.2	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR5M11	OR11-199	ENSG00000255223	"Olfactory receptor family 5 subfamily M member 11"	Q96RB7	11	56542262-56543281	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"Late spermatids: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"													NA	NA																						"unprognostic (2.95e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR5P2	JCG3	ENSG00000183303	"Olfactory receptor family 5 subfamily P member 2"	Q8WZ92	11	7795905-7796973	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	4	"Rod photoreceptor cells: 19.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"													NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.0	3.7	4.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR6N1		ENSG00000197403	"Olfactory receptor family 6 subfamily N member 1"	Q8NGY5	1	158747814-158772195	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"Distal tubular cells: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	25	"basophil: 5.1"	"Lineage enriched"	"Detected in single"	52	"granulocytes: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"													NA	NA																							0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
OR7D2	"FLJ38149, HTPCRH03, OR19-4"	ENSG00000188000	"Olfactory receptor family 7 subfamily D member 2"	Q96RA2	19	9178979-9188818	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	5	"Early spermatids: 7.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HEL: 1.7"					"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (5.00e-4)"	"unprognostic (2.03e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.84e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.56e-2)"	"unprognostic (3.40e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.09e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.63e-1)"	"unprognostic (4.08e-2)"	"unprognostic (4.92e-4)"	0.2	0.2	0.6	0.3	0.5	0.7	0.1	1.1	1.1	0.1	0.2	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.2	0.6	0.4	0.1	0.1	0.1	0.6	0.4	0.2	0.6	0.1	0.2	0.0	0.2	0.1	0.5	0.2	0.1	0.6	0.2	0.4	0.3	0.5	0.2	0.2	0.1	0.5	0.4	1.1	0.5	0.1	0.2	0.1	0.3	0.2	0.1	1.1	0.1	0.1	0.2	0.7	0.2	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.3	0.3	0.0	0.2	0.3	0.0	0.1	0.0	0.2	0.1	1.7	0.3	0.2	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.4	0.5	0.7	0.0	0.1	0.3	0.4	0.1	0.0	0.1	0.3	0.3	0.0	0.0	0.5	0.2	0.1	0.1	0.2	0.0	0.3	0.2	0.0	0.0	0.2	0.2	0.1	0.1	0.3	0.2	0.2	0.1	0.1	0.0	0.7	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.6	0.2	0.1	0.2	0.0	0.0	0.6	0.5	1.1	1.1	0.6	0.4	0.4	0.2	0.6	0.5	0.1	0.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	7.2	0.1	0.1	0.1	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.5	0.2	0.1	0.0	0.0	0.0	0.4	0.1	0.2	0.2	0.0	0.0	0.3	0.1	0.0	0.2	0.3
OR8D4		ENSG00000181518	"Olfactory receptor family 8 subfamily D member 4"	Q8NGM9	11	123902167-123909229	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"Granulosa cells: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA																							0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.2	0.1	0.1	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0
OXGR1	"aKGR, GPR80, GPR99, P2RY15, P2Y15"	ENSG00000165621	"Oxoglutarate receptor 1"	Q96P68	13	96985719-96994730	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	13	"Extravillous trophoblasts: 49.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"myeloid DC: 1.2;plasmacytoid DC: 2.1"	"Lineage enriched"	"Detected in single"	7	"dendritic cells: 2.1"	"Cell line enhanced"	"Detected in some"		"RT4: 3.3;SK-BR-3: 1.4;U-2 OS: 1.6"	"Not detected"	"Not detected"							HPA067673			Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA067673: AB_2685883"	"unprognostic (1.83e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.97e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.52e-1)"		"unprognostic (8.38e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.22e-2)"	"unprognostic (4.14e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.68e-2)"	1.0	0.0	1.2	1.3	0.8	0.1	4.2	0.5	1.4	1.0	0.5	2.0	0.2	0.5	2.5	2.2	1.6	0.1	0.1	0.8	1.9	4.1	0.0	0.4	0.1	1.2	1.3	0.9	0.1	0.6	0.3	0.3	0.9	0.9	0.5	1.6	0.0	3.0	0.4	0.2	2.5	0.4	0.5	0.7	0.4	0.2	0.1	2.7	0.3	0.5	0.3	0.8	1.8	0.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	3.3	0.0	0.1	0.0	1.4	0.0	0.0	0.7	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	1.2	0.8	0.5	1.4	0.8	1.9	1.2	1.3	0.9	0.9	0.7	2.7	1.1	0.8	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.6	0.0	1.7	1.4	0.2	0.0	0.0	0.0	0.0	2.4	0.1	0.2	1.9	0.0	0.2	0.7	0.1	0.8	1.2	0.0	0.6	0.0	49.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.6	0.5	0.0	0.0	0.4	0.1	0.0	0.3	3.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.9	0.0	0.0	2.2	0.0	3.7	0.0	0.0	1.2	0.0
P2RX1	P2X1	ENSG00000108405	"Purinergic receptor P2X 1"	P51575	17	3896592-3916476	"Predicted membrane proteins"	"Apoptosis, Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 42.4;pancreas: 65.7;urinary bladder: 76.1"	"Cell type enriched"	"Detected in some"	5	"granulocytes: 185.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 46.3"	"Group enriched"	"Detected in many"	30	"dendritic cells: 15.1;granulocytes: 23.5;monocytes: 46.3"	"Cell line enhanced"	"Detected in some"		"HEL: 13.8;HMC-1: 8.4;Karpas-707: 16.8;THP-1: 14.7;U-937: 7.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"midbrain: 1.3"	HPA057678			Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA057678: "	"unprognostic (1.27e-3)"	"unprognostic (1.61e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.54e-2)"	"unprognostic (7.34e-3)"	"unprognostic (9.89e-5)"	"unprognostic (1.77e-2)"	"unprognostic (6.15e-3)"	"unprognostic (2.98e-1)"	"unprognostic (2.52e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.47e-3)"	"unprognostic (2.60e-1)"	"unprognostic (5.58e-2)"	"unprognostic (4.29e-1)"	"unprognostic (1.09e-2)"	6.4	2.0	0.7	4.4	0.8	42.4	1.5	1.1	0.8	7.7	0.8	9.6	9.3	7.4	1.8	23.2	3.9	2.0	1.6	0.7	0.8	0.9	0.7	4.8	3.0	0.9	1.0	0.6	2.1	65.7	0.1	0.3	3.9	1.0	10.8	9.3	0.1	1.6	34.4	0.5	4.2	9.1	6.1	0.8	13.1	2.8	2.6	0.8	2.0	0.4	0.3	3.2	76.1	8.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	0.2	0.1	1.1	1.8	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	0.0	0.0	0.1	3.3	0.0	0.4	0.0	2.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.1	7.4	0.0	0.0	10.8	11.9	0.0	20.4	0.0	0.4	0.0	0.0	5.9	0.9	0.0	0.0	23.5	0.0	46.3	15.1	0.0	8.2	0.7	0.8	1.1	0.8	0.7	0.8	0.9	1.0	0.6	1.0	0.8	0.8	1.2	0.1	3.2	4.2	0.7	15.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.3	0.0	0.0	0.1	8.9	0.0	0.0	0.1	0.1	0.0	0.0	0.7	0.0	18.5	0.3	2.0	0.1	0.9	0.5	0.0	185.4	0.0	0.0	0.0	3.6	0.0	0.2	0.1	0.0	5.1	2.4	0.2	0.0	22.5	0.0	1.0	7.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	36.0	0.0	0.0	0.1	0.7	0.0	0.0	0.4	3.4	0.0	0.1	0.1	0.9	0.0	1.8	0.5	0.3	0.0
P2RY12	"HORK3, P2Y12, SP1999"	ENSG00000169313	"Purinergic receptor P2Y12"	Q9H244	3	151336843-151384753	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"	"Blood coagulation, Hemostasis"	"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.1;lymphoid tissue: 9.9"	"Cell type enriched"	"Detected in some"	27	"Microglial cells: 421.6"	"Cancer enriched"	"Detected in many"	14	"glioma: 17.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 8.3"	"Group enriched"	"Detected in many"	11	"dendritic cells: 3.2;monocytes: 8.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013796, HPA014518"	Enhanced					NA	NA					"HPA013796: AB_1854884, HPA014518: AB_2669027"	"unprognostic (2.39e-2)"	"unprognostic (1.60e-3)"	"unprognostic (5.93e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.52e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.72e-3)"	"unprognostic (6.46e-2)"	"unprognostic (8.64e-4)"	"unprognostic (4.84e-2)"	"unprognostic (5.96e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.52e-2)"	"unprognostic (4.04e-1)"	8.6	4.1	4.6	2.0	6.4	0.5	3.8	5.3	6.2	1.3	2.6	1.6	1.2	0.7	0.6	1.2	2.6	2.2	1.3	5.5	7.8	0.6	2.5	2.5	9.9	8.4	7.2	3.8	1.6	0.9	1.6	0.3	2.3	11.5	0.9	1.4	0.3	2.9	2.1	0.1	0.4	2.8	1.6	12.0	5.5	1.1	0.2	8.0	1.0	0.5	0.6	8.7	1.2	0.4	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	8.3	0.0	0.3	0.0	0.0	3.2	0.5	0.0	0.0	0.3	0.0	2.2	0.3	0.0	1.3	4.6	6.4	5.3	6.2	5.5	7.8	8.4	7.2	3.8	11.5	12.0	8.0	14.1	0.2	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.5	0.0	0.0	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.0	2.1	0.0	0.0	2.6	0.0	0.0	0.0	3.1	0.0	421.6	0.7	0.4	0.0	15.6	4.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0
PALD1	"KIAA1274, PALD"	ENSG00000107719	"Phosphatase domain containing paladin 1"	Q9ULE6	10	70478767-70568450	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"Microglial cells: 129.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	15	"plasmacytoid DC: 5.0"	"Lineage enriched"	"Detected in single"	27	"dendritic cells: 5.0"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 21.5;Daudi: 26.7;NB-4: 25.7;RPMI-8226: 32.8;U-698: 26.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015696, HPA017343"	Uncertain					NA	NA					"HPA015696: AB_1852399, HPA017343: AB_1852397"	"unprognostic (1.11e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.94e-2)"	"unprognostic (2.52e-3)"	"unprognostic (4.52e-3)"	"unprognostic (3.55e-2)"	"unprognostic (4.96e-2)"	"unprognostic (3.34e-2)"	"unprognostic (6.56e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.20e-3)"	"unprognostic (2.73e-2)"	"unprognostic (9.27e-2)"	"unprognostic (2.46e-1)"	"unprognostic (8.81e-3)"	6.9	4.5	14.5	5.2	14.4	2.5	5.4	15.7	15.7	5.2	10.7	10.3	2.7	4.9	1.3	4.7	5.8	4.6	6.1	14.2	15.5	5.1	1.6	20.0	9.3	22.4	15.6	10.2	5.6	7.3	1.6	5.4	7.7	21.0	6.0	2.2	1.0	4.0	2.1	5.6	5.2	8.2	4.8	18.3	14.8	7.6	3.7	18.9	4.6	8.3	3.1	8.1	5.3	3.7	18.4	0.0	6.4	7.2	21.5	0.0	0.0	0.0	0.0	0.0	1.8	0.4	2.7	0.2	26.7	5.5	0.0	0.3	0.1	11.9	0.0	0.5	0.1	13.6	0.0	0.9	0.5	2.2	9.0	0.0	0.0	0.0	0.7	0.0	1.9	3.1	8.2	1.4	3.6	0.2	2.2	4.6	25.7	7.6	0.0	0.0	13.5	0.1	32.8	1.9	0.0	7.1	5.3	0.3	0.1	0.6	0.9	0.0	1.9	0.6	0.0	9.7	0.0	0.8	0.3	0.0	26.3	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	5.0	0.0	0.0	14.5	14.4	15.7	15.7	14.2	15.5	22.4	15.6	10.2	21.0	18.3	18.9	18.4	15.0	0.0	1.1	4.6	3.2	1.3	0.1	0.1	4.0	0.5	1.3	2.2	3.6	1.5	0.0	1.8	0.0	0.0	11.4	0.0	0.0	1.7	0.9	1.1	0.6	20.3	0.0	0.0	4.9	0.2	0.1	3.5	0.0	1.8	1.3	0.7	12.5	0.2	7.4	0.0	2.2	0.0	0.0	10.8	3.3	0.5	1.8	12.2	1.8	129.3	0.3	3.0	0.0	6.6	0.9	0.1	0.0	0.7	5.1	0.3	0.0	0.1	0.0	0.4	0.0	3.0	5.1	0.2	2.7	0.5	1.3	0.0	0.6	1.2	0.0	0.0
PAMR1	"DKFZP586H2123, RAMP"	ENSG00000149090	"Peptidase domain containing associated with muscle regeneration 1"	Q6UXH9	11	35431823-35530300	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Serine protease homolog"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	7	"Astrocytes: 380.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 86.9;ASC TERT1: 354.7;BJ hTERT+: 357.7;fHDF/TERT166: 86.7;HSkMC: 123.1;U-87 MG: 82.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted - unknown location"	NA	NA		5600000				"unprognostic (3.38e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.00e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.07e-2)"	"unprognostic (6.92e-2)"	"unprognostic (3.32e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (5.08e-5)"	"prognostic unfavorable (6.29e-4)"	"unprognostic (2.08e-1)"	"unprognostic (9.98e-2)"	"unprognostic (8.25e-2)"	20.4	15.0	24.4	0.6	24.6	0.0	15.6	24.0	23.6	60.4	14.2	13.5	4.5	58.8	18.5	10.1	22.8	20.5	18.8	22.5	25.1	4.1	12.7	6.0	1.3	36.8	30.1	19.7	3.4	5.3	1.7	6.5	56.4	30.2	21.4	6.6	0.9	5.7	18.1	2.7	20.0	10.0	15.0	44.1	5.8	5.4	0.2	30.8	2.8	7.0	9.1	1.8	28.3	41.6	37.5	0.0	0.0	0.1	0.0	86.9	354.7	0.1	42.8	357.7	4.9	8.3	32.7	0.0	0.0	0.0	86.7	0.1	0.1	0.0	0.0	3.3	0.0	0.8	0.0	0.0	0.0	50.1	0.0	0.0	123.1	1.8	9.7	1.3	0.1	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.1	0.7	0.0	0.2	0.0	0.2	0.2	0.0	8.4	0.1	0.0	0.0	0.0	0.0	14.3	2.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.1	0.0	82.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.4	24.6	24.0	23.6	22.5	25.1	36.8	30.1	19.7	30.2	44.1	30.8	37.5	2.5	0.0	0.0	380.3	0.0	19.1	1.4	14.8	1.2	0.1	0.7	19.7	1.3	0.0	2.4	1.8	0.0	2.2	0.0	0.0	0.0	1.4	0.1	4.5	26.2	1.1	0.0	0.0	13.1	0.0	1.4	50.2	1.1	0.8	0.0	0.6	0.0	0.0	2.0	0.0	8.2	0.2	0.0	0.0	5.5	0.1	0.3	0.5	1.8	28.1	0.6	0.0	0.0	9.5	1.4	0.1	0.0	0.0	0.0	0.4	0.2	0.0	1.8	0.2	0.0	1.6	5.8	0.0	0.2	0.1	9.2	3.4	0.6	0.2	0.0	0.2
PAQR7	"MPRA, mSR"	ENSG00000182749	"Progestin and adipoQ receptor family member 7"	Q86WK9	1	25861484-25875708	"Predicted membrane proteins"	"Differentiation, Oogenesis"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Late spermatids: 1939.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 75.5;HaCaT: 62.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046936	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA046936: AB_2679869"	"unprognostic (1.12e-1)"	"unprognostic (2.08e-2)"	"unprognostic (8.03e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.41e-1)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (1.47e-1)"	"unprognostic (4.59e-3)"	"unprognostic (7.79e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.31e-1)"	"prognostic favorable (1.05e-5)"	"unprognostic (1.60e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.54e-2)"	4.9	24.1	9.6	4.4	8.9	5.2	5.2	8.5	9.4	11.1	10.2	5.6	21.1	11.2	28.4	17.8	20.2	7.9	3.0	8.4	10.8	35.7	7.4	5.6	4.4	9.9	10.1	8.8	35.6	6.7	13.8	6.7	21.6	9.8	8.0	2.9	1.5	5.4	24.6	3.0	31.7	19.1	9.6	9.7	10.3	8.2	46.5	10.0	3.5	5.2	1.9	5.0	13.7	13.6	10.4	30.7	6.0	5.8	18.9	7.1	14.8	20.4	19.9	17.5	19.2	17.0	9.8	75.5	0.3	13.6	19.2	6.3	62.6	3.2	33.0	11.4	12.1	3.4	25.6	8.4	12.1	12.0	0.4	3.1	14.9	43.3	13.7	10.2	16.9	7.5	2.8	2.8	2.1	14.4	7.0	0.2	1.9	9.3	3.1	10.3	2.1	0.6	3.8	39.3	22.9	3.1	11.5	32.1	40.7	14.8	7.9	11.6	4.6	8.1	3.1	9.7	10.2	5.4	0.4	0.4	1.3	14.5	0.7	6.6	5.4	7.3	15.7	1.4	13.9	1.4	4.0	0.8	1.0	7.6	1.7	1.3	1.9	3.7	3.4	17.5	0.8	0.2	1.4	9.6	8.9	8.5	9.4	8.4	10.8	9.9	10.1	8.8	9.8	9.7	10.0	10.4	4.9	0.0	3.1	11.4	2.2	18.1	4.3	4.6	4.6	2.1	9.4	9.5	1.9	17.2	5.1	77.3	0.0	52.8	1.3	0.7	21.5	5.6	350.9	23.4	11.5	5.9	4.8	0.0	11.9	13.9	12.3	7.8	0.5	9.0	7.0	4.6	10.4	5.5	11.0	3.3	11.2	2.2	0.0	10.3	14.9	1939.3	19.9	7.8	21.4	7.5	7.6	1.6	0.0	8.5	4.0	6.4	3.0	15.1	0.7	3.1	27.9	70.2	8.6	0.6	13.1	4.3	4.7	11.6	10.0	4.7	13.1	35.7	1.6	5.8	3.7	3.1
PARD6A	"PAR-6, PAR-6A, PAR6alpha, TAX40, TIP-40"	ENSG00000102981	"Par-6 family cell polarity regulator alpha"	Q9NPB6	16	67660946-67662774	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.8;testis: 43.2"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 266.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 27.9;RPMI-8226: 24.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009733, HPA041551"	Approved		Supported	"Cell Junctions,Actin filaments,Cytosol"		No	No			"Cell Junctions, Actin filaments"	Cytosol	"CAB009733: AB_2159676, HPA041551: AB_2677545"	"prognostic favorable (5.40e-4)"	"unprognostic (6.18e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.33e-2)"	"unprognostic (7.63e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.59e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.98e-3)"	"unprognostic (9.13e-2)"	"prognostic favorable (3.08e-7)"	"unprognostic (9.22e-3)"	"unprognostic (6.69e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.39e-2)"	3.0	8.1	23.4	2.4	23.1	1.3	2.8	30.9	38.8	2.0	17.6	6.1	1.1	2.6	2.1	2.0	2.7	1.9	3.5	26.7	21.0	7.2	6.6	3.1	3.1	23.3	22.2	23.2	3.9	28.1	6.7	30.4	0.7	25.3	3.6	1.0	2.7	2.7	2.7	8.8	1.7	4.1	1.6	20.0	4.9	6.0	43.2	24.4	3.5	2.4	5.3	2.2	3.8	1.7	24.1	8.9	9.4	2.6	23.5	1.7	0.4	4.7	0.2	1.1	3.4	3.2	4.7	3.6	14.8	4.3	0.3	1.2	7.0	5.2	1.1	0.7	6.9	5.0	6.0	4.1	5.5	2.4	2.5	13.5	0.1	0.5	3.2	1.3	2.1	1.7	21.7	0.6	3.4	0.6	8.7	15.6	3.2	3.3	12.0	6.0	27.9	1.7	24.5	8.8	5.1	21.8	11.7	1.4	3.2	3.7	0.7	19.9	0.9	1.4	0.3	0.8	2.1	4.6	3.5	12.1	13.5	2.6	5.3	1.0	2.1	0.9	0.4	4.3	0.6	7.8	10.9	5.9	5.4	1.1	8.3	2.8	2.2	3.4	1.3	0.1	5.1	6.3	2.0	23.4	23.1	30.9	38.8	26.7	21.0	23.3	22.2	23.2	25.3	20.0	24.4	24.1	4.4	3.2	5.8	2.0	17.0	0.9	2.2	1.6	1.2	11.1	7.7	6.7	1.7	10.0	2.6	20.2	4.2	5.7	8.2	3.5	33.2	7.2	61.0	4.1	0.5	3.2	34.0	4.0	7.2	15.0	0.4	3.3	6.1	2.7	5.7	5.2	3.9	4.6	4.3	32.0	7.3	3.3	0.0	4.1	5.7	266.5	3.7	4.7	5.4	3.7	2.2	19.1	1.0	2.0	2.2	6.0	2.1	1.5	12.1	2.1	2.9	16.3	3.4	10.1	0.0	8.0	9.7	5.5	3.9	1.4	1.6	2.9	15.0	1.9	4.7	2.4
PAX4	MODY9	ENSG00000106331	"Paired box 4"	O43316	7	127610292-127618142	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"intestine: 1.0"	"Cell type enriched"	"Detected in some"	7	"Enteroendocrine cells: 85.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	49	"SCLC-21H: 10.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA								"unprognostic (1.52e-1)"								"unprognostic (9.71e-2)"			"unprognostic (4.86e-3)"	"unprognostic (1.21e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	2.9	0.0	0.0	0.0	85.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0
PCDHB6	PCDH-BETA6	ENSG00000113211	"Protocadherin beta 6"	Q9Y5E3	5	141150057-141153287	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	5	"Spermatocytes: 7.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 16.6;SH-SY5Y: 7.1;T-47d: 5.4;U-2197: 7.6;WM-115: 10.5"	"Low region specificity"	"Detected in many"							"HPA029566, HPA075308"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA029566: AB_10601385, HPA075308: "	"unprognostic (3.25e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.81e-1)"	"unprognostic (8.05e-2)"	"unprognostic (7.65e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.73e-3)"	"unprognostic (9.64e-3)"	"unprognostic (8.62e-2)"	"unprognostic (1.54e-3)"	"unprognostic (2.28e-2)"	"unprognostic (6.33e-2)"	"prognostic unfavorable (5.52e-4)"	"unprognostic (8.60e-4)"	"unprognostic (2.31e-2)"	"unprognostic (7.08e-3)"	"unprognostic (6.52e-2)"	0.7	0.7	0.9	0.2	0.9	0.0	1.1	0.5	1.6	1.1	0.0	0.6	0.0	1.9	1.1	0.2	1.0	0.3	0.7	1.5	0.4	0.4	0.1	0.7	0.1	0.8	0.6	0.8	1.3	0.5	1.9	1.0	0.4	0.8	0.5	0.1	0.9	0.7	0.3	0.4	0.7	0.3	0.9	0.6	0.2	0.4	1.9	0.7	0.1	0.4	0.3	0.1	0.7	0.7	1.3	0.0	0.4	0.3	0.1	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	16.6	0.2	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.3	7.1	0.0	0.1	3.7	0.4	5.4	2.3	0.0	0.6	1.2	7.6	0.0	0.0	0.0	0.0	3.8	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.9	0.5	1.6	1.5	0.4	0.8	0.6	0.8	0.8	0.6	0.7	1.3	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.6	0.4	0.6	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.1	1.0	0.7	0.0	0.0	0.0	0.8	0.0	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.2	0.0	1.5	0.8	7.6	0.1	0.0	0.4	0.0	0.0	0.2	0.0	0.0
PCSK1	"NEC1, PC1, PC3, SPC3"	ENSG00000175426	"Proprotein convertase subtilisin/kexin type 1"	P29120	5	96390333-96434143	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Disease variant, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 44.8"	"Cell type enriched"	"Detected in some"	4	"Enteroendocrine cells: 224.6"	"Cancer enhanced"	"Detected in many"		"breast cancer: 12.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"SCLC-21H: 22.6;U-138 MG: 19.0;U-87 MG: 15.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA048564, HPA079656"	Approved				"Secreted in other tissues"	NA	NA					"HPA048564: AB_2680444, HPA079656: "	"unprognostic (1.86e-2)"	"unprognostic (2.13e-2)"	"unprognostic (4.66e-3)"	"unprognostic (8.20e-5)"	"prognostic unfavorable (9.13e-5)"	"unprognostic (8.47e-4)"	"unprognostic (1.46e-1)"	"unprognostic (5.84e-3)"	"unprognostic (4.71e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.89e-3)"	"unprognostic (1.01e-1)"	"unprognostic (7.90e-6)"	"unprognostic (5.25e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.33e-3)"	"unprognostic (9.37e-3)"	1.6	6.3	8.8	4.7	4.1	0.1	1.5	1.0	36.9	0.8	0.0	2.4	5.3	0.1	0.0	0.1	0.2	0.2	0.5	4.7	44.8	0.2	0.0	0.4	0.1	4.8	6.6	2.9	0.4	7.7	0.0	12.2	0.0	20.0	0.4	2.4	8.8	2.7	0.1	0.3	1.1	3.6	0.6	1.6	0.1	5.8	0.1	8.9	0.2	1.9	0.0	0.0	2.1	0.5	16.0	0.0	0.0	0.3	0.0	2.3	0.7	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.1	1.0	3.8	0.0	0.0	0.1	0.0	0.1	0.1	0.8	2.4	0.0	0.0	0.0	0.0	2.0	1.0	0.4	0.1	0.2	0.9	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.6	0.0	3.3	0.0	0.0	0.4	0.0	0.0	1.2	19.0	0.6	0.3	0.2	0.0	0.0	0.1	15.8	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	4.1	1.0	36.9	4.7	44.8	4.8	6.6	2.9	20.0	1.6	8.9	16.0	0.0	0.0	0.0	3.6	0.0	0.0	0.1	0.0	1.8	13.2	0.0	0.0	0.7	0.0	0.0	0.0	2.1	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.2	0.2	224.6	0.0	54.5	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	4.0	10.7	2.0	0.0	0.4	1.6	0.0	0.0	0.0	4.7	0.0	0.5	0.0	3.5	4.9	1.5	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.9	0.0	1.7	1.0	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.7	0.0
PDE11A		ENSG00000284741	"Phosphodiesterase 11A"		2	177628069-178108339	"Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	9	"Cardiomyocytes: 1.9"					"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA034560	Uncertain					NA	NA					"HPA034560: AB_10602140"																		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5		0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PDE8A	HsT19550	ENSG00000073417	"Phosphodiesterase 8A"	O60658	15	84980440-85139145	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"Oligodendrocytes: 968.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"RT4: 89.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007722	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA007722: AB_1855130"	"unprognostic (1.68e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.81e-2)"	"unprognostic (4.97e-2)"	"unprognostic (6.25e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.97e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.99e-3)"	"unprognostic (2.75e-2)"	"unprognostic (3.42e-1)"	"unprognostic (3.72e-1)"	"unprognostic (4.26e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.94e-2)"	16.9	16.8	21.9	8.6	30.3	3.3	10.6	21.9	21.1	11.7	15.5	24.2	15.4	9.2	7.3	6.4	9.1	15.9	8.1	17.2	22.1	24.5	30.2	10.9	5.6	24.8	29.0	13.4	12.8	14.7	17.0	6.8	11.5	39.2	7.0	22.1	14.6	6.4	9.6	5.9	6.3	13.7	10.7	22.1	6.3	11.1	11.1	27.5	4.6	12.4	6.5	5.1	17.9	7.1	45.8	29.0	48.4	7.9	5.4	32.7	17.2	9.6	19.4	21.1	16.6	18.9	10.9	16.9	5.8	14.6	25.9	19.7	20.2	33.8	14.9	22.0	10.8	20.2	7.7	30.3	15.6	23.5	4.5	11.3	17.4	9.1	19.6	18.6	14.3	21.6	6.4	15.6	18.3	15.2	24.5	2.6	4.5	3.8	9.5	8.6	3.6	6.5	8.1	13.2	89.0	18.3	14.1	18.9	20.3	55.5	8.7	6.7	8.7	17.1	38.4	13.6	13.9	31.6	8.9	16.7	6.2	26.1	18.1	11.0	0.0	0.9	0.6	0.3	0.7	0.6	0.2	0.5	0.6	0.5	0.3	0.7	0.3	0.0	0.2	1.6	0.0	1.1	0.2	21.9	30.3	21.9	21.1	17.2	22.1	24.8	29.0	13.4	39.2	22.1	27.5	45.8	30.7	6.4	26.5	83.9	14.8	11.3	11.1	13.9	18.2	13.0	6.6	5.2	6.8	41.5	15.4	7.3	12.5	8.0	5.5	58.7	7.9	11.3	6.4	12.5	21.6	24.3	14.5	0.8	60.8	9.6	7.1	16.2	26.5	20.6	22.1	17.9	14.3	23.3	10.8	10.1	126.2	19.0	4.1	12.3	18.9	5.6	10.8	19.2	10.6	85.3	9.0	2.6	10.3	119.1	968.6	11.5	31.8	11.3	7.2	25.4	22.1	21.1	10.5	31.2	39.5	17.8	24.5	25.6	17.3	7.5	10.4	4.5	10.8	25.3	28.5	26.4
PDGFRB	"CD140b, JTK12, PDGFR, PDGFR1"	ENSG00000113721	"Platelet derived growth factor receptor beta"	P09619	5	150113839-150155872	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	Chemotaxis	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Sertoli cells: 1288.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.6"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"ASC diff: 1350.1;ASC TERT1: 462.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003842, CAB018144, HPA028499"	Enhanced		Supported	"Golgi apparatus,Vesicles"		NA	NA		39000000	Vesicles	"Golgi apparatus"	"CAB003842: AB_562328, CAB018144: AB_2162497, HPA028499: AB_10602018"	"unprognostic (4.75e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.27e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.57e-3)"	"unprognostic (6.72e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (5.87e-8)"	"unprognostic (3.13e-3)"	"unprognostic (1.25e-2)"	"unprognostic (5.47e-2)"	"prognostic unfavorable (8.11e-4)"	149.7	25.3	23.0	27.7	26.1	0.7	107.2	19.3	33.5	153.8	43.1	38.1	12.0	101.9	24.4	24.3	90.4	125.6	66.9	20.9	20.8	49.5	13.5	99.1	27.7	23.1	22.9	19.6	106.4	21.0	22.1	23.1	114.2	25.2	56.7	14.3	6.3	34.8	43.7	38.4	53.4	38.2	69.5	17.3	41.8	28.1	18.6	24.2	8.8	67.0	44.5	13.9	58.8	99.5	20.9	0.1	0.3	8.3	0.4	1350.1	462.7	3.0	48.9	202.3	33.5	56.4	5.4	0.0	0.0	6.4	142.0	19.0	0.1	0.1	0.4	15.8	0.0	0.0	0.1	3.3	3.5	190.7	0.0	0.4	210.0	0.0	46.3	0.6	106.6	0.1	0.1	0.1	5.5	5.5	0.0	0.1	0.6	9.0	0.2	0.2	3.7	2.5	0.2	0.0	0.0	0.1	24.8	0.5	0.1	0.0	38.2	0.1	0.6	0.4	53.7	17.2	23.1	2.8	0.4	0.0	0.3	33.4	0.1	1.5	0.0	0.0	0.0	0.9	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.0	0.2	23.0	26.1	19.3	33.5	20.9	20.8	23.1	22.9	19.6	25.2	17.3	24.2	20.9	50.8	0.0	1.1	81.9	0.5	24.0	0.5	0.0	2.2	6.6	1.4	3.3	17.3	1.5	0.0	1.8	4.2	0.6	6.0	0.3	0.0	0.8	1.6	2.8	99.5	32.2	0.0	0.0	7.9	0.0	1.1	123.5	2.0	2.3	0.0	2.5	6.4	1.9	1.5	0.0	1.3	0.7	0.0	0.0	35.6	10.9	165.3	3.1	24.9	45.0	0.7	50.7	23.7	10.1	3.3	0.1	0.1	203.8	2.3	0.7	0.3	0.1	0.7	2.9	1288.5	6.6	288.3	1.9	1.6	0.8	15.3	0.8	4.8	4.0	0.4	1.1
PEX5	"PTS1R, PXR1"	ENSG00000139197	"Peroxisomal biogenesis factor 5"	P50542	12	7188685-7218574	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease variant, Peroxisome biogenesis disorder, Rhizomelic chondrodysplasia punctata, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	6	"Early spermatids: 277.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 156.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039259, HPA039260"	Enhanced		Supported	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus, Cytosol"		"HPA039259: AB_10673419, HPA039260: AB_2676417"	"unprognostic (7.44e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.46e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.20e-2)"	"unprognostic (5.14e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.92e-1)"	"unprognostic (5.70e-2)"	"unprognostic (7.31e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.13e-1)"	33.0	28.0	42.8	13.3	41.3	8.9	34.5	37.9	42.7	25.0	31.8	23.8	12.2	26.2	11.0	19.0	23.4	13.7	20.5	38.6	64.6	24.6	38.1	22.2	18.8	40.1	40.9	36.0	29.4	30.6	19.1	44.4	10.1	40.4	19.8	12.0	13.7	22.3	13.8	74.7	25.9	20.5	15.3	42.3	16.2	22.4	51.3	42.4	39.7	20.2	28.7	20.9	21.9	21.4	39.9	14.7	24.7	13.0	34.2	29.1	19.9	24.3	14.0	16.6	16.2	17.2	36.9	21.8	156.1	8.3	16.2	23.6	18.2	22.1	19.5	16.8	20.8	18.2	13.8	19.0	25.7	15.4	21.3	13.6	22.2	35.2	11.1	34.5	22.0	14.2	75.0	28.2	5.3	14.7	20.0	49.7	18.5	38.6	28.0	13.1	23.7	28.1	21.4	13.0	21.4	10.9	22.6	20.9	45.4	20.1	26.2	10.2	12.5	12.7	18.2	29.9	15.8	17.2	9.5	11.6	53.4	18.0	22.8	12.2	0.0	1.6	2.1	2.9	1.4	3.6	1.9	2.0	2.9	2.6	1.4	2.6	2.6	1.2	2.8	4.1	4.6	0.9	2.2	42.8	41.3	37.9	42.7	38.6	64.6	40.1	40.9	36.0	40.4	42.3	42.4	39.9	8.6	12.8	20.1	11.4	5.6	14.5	7.2	5.2	8.0	7.8	9.2	8.5	13.7	14.3	5.6	7.3	8.4	11.3	5.1	9.9	9.8	10.1	277.8	7.0	13.6	10.3	7.2	4.6	31.5	14.9	6.4	7.8	4.1	5.2	3.8	7.2	5.7	17.6	4.7	13.5	22.1	7.2	4.1	5.4	5.0	43.7	14.3	5.2	5.4	1.0	4.6	12.7	5.2	16.1	13.3	10.2	14.2	13.9	2.9	14.1	9.9	19.3	9.8	7.0	19.7	12.0	10.2	32.2	16.6	7.4	15.3	7.7	5.8	9.6	10.4	5.7
PGAP4	"C9orf125, MGC12992, TMEM246"	ENSG00000165152	"Post-GPI attachment to proteins GalNAc transferase 4"	Q9BRR3	9	101473170-101533537	"Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	16	"Cardiomyocytes: 52.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 25.5;hTERT-RPE1: 28.8;OE19: 48.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011318, HPA054041"	Uncertain		Approved	Mitochondria		NA	Yes			Mitochondria		"HPA011318: AB_2668482, HPA054041: AB_2682353"	"unprognostic (2.58e-2)"	"unprognostic (4.76e-2)"	"unprognostic (5.52e-1)"	"unprognostic (2.81e-3)"	"unprognostic (2.72e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.20e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.24e-1)"	"unprognostic (3.51e-2)"	"unprognostic (2.09e-1)"	"prognostic favorable (1.55e-8)"	"unprognostic (1.62e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.50e-1)"	"unprognostic (9.16e-2)"	3.4	10.4	19.7	2.2	23.1	0.5	2.5	20.7	27.5	16.7	5.4	13.5	8.5	7.2	3.7	14.5	13.8	6.9	30.7	23.9	25.8	4.3	2.4	5.5	0.5	18.9	18.9	23.7	19.7	11.2	16.7	12.4	0.6	23.4	6.9	11.3	10.0	6.2	9.4	4.9	12.1	7.7	6.8	8.6	1.6	16.2	2.8	26.5	0.9	4.2	6.1	2.5	6.5	11.9	31.8	0.0	14.6	11.3	0.0	0.3	0.2	0.0	9.8	14.1	7.0	13.8	0.7	7.8	0.0	3.2	17.9	0.8	23.1	0.0	16.1	4.2	0.0	5.8	8.1	10.3	0.0	0.5	0.0	0.0	6.2	25.5	0.0	3.8	28.8	0.1	0.0	0.0	0.0	14.3	0.0	0.0	0.0	14.0	48.1	0.0	0.0	5.7	0.0	10.5	2.7	18.9	17.8	5.5	0.0	0.0	2.7	0.0	13.8	0.0	10.7	6.6	0.0	0.0	1.0	0.0	0.0	15.2	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.7	23.1	20.7	27.5	23.9	25.8	18.9	18.9	23.7	23.4	8.6	26.5	31.8	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PGM2	FLJ10983	ENSG00000169299	"Phosphoglucomutase 2"	Q96G03	4	37826660-37862937	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Muller glia cells: 334.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040676	Uncertain		Approved	"Intermediate filaments"		NA	NA		1700000	"Intermediate filaments"		"HPA040676: AB_2677076"	"unprognostic (3.11e-2)"	"unprognostic (1.01e-2)"	"prognostic favorable (2.14e-5)"	"unprognostic (2.29e-1)"	"unprognostic (3.94e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.09e-3)"	"unprognostic (5.32e-2)"	"unprognostic (7.02e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.22e-2)"	"unprognostic (6.72e-3)"	"unprognostic (3.21e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.97e-2)"	"unprognostic (1.02e-1)"	7.6	11.4	3.3	9.6	3.5	10.2	8.9	4.7	4.6	8.0	4.7	9.9	7.7	10.2	4.9	36.9	7.9	11.4	5.2	4.5	4.0	8.0	14.9	7.0	10.1	3.6	3.2	3.1	7.0	4.4	8.5	3.0	11.8	3.7	7.9	9.1	18.4	7.8	5.2	1.2	17.6	7.9	13.8	3.6	8.4	6.1	5.3	3.8	10.3	9.8	1.9	22.9	19.1	16.6	3.9	27.4	9.5	14.6	16.6	10.2	12.4	19.8	32.6	18.9	27.8	26.4	18.0	19.2	38.0	15.5	17.8	34.9	13.8	36.0	32.0	65.1	23.0	21.0	40.1	15.2	12.3	23.2	44.2	26.5	17.0	36.0	22.0	18.6	16.2	41.6	31.2	53.6	6.2	24.3	15.6	49.8	49.6	17.3	19.2	15.5	35.8	23.1	14.8	15.7	52.3	31.8	10.8	17.5	23.3	12.0	19.5	21.5	45.4	37.0	19.7	24.9	27.3	67.1	14.0	38.4	40.3	10.9	56.2	32.9	19.8	27.5	67.2	9.8	22.4	11.5	9.4	8.0	11.1	31.9	5.5	7.7	9.8	33.6	28.1	18.2	7.1	14.9	17.0	3.3	3.5	4.7	4.6	4.5	4.0	3.6	3.2	3.1	3.7	3.6	3.8	3.9	16.9	0.0	8.2	5.2	13.8	14.7	14.3	32.9	17.6	7.8	12.6	6.9	4.5	14.3	23.1	3.7	0.0	31.9	11.9	10.6	5.9	16.0	0.9	9.0	12.7	22.9	7.2	8.0	8.3	11.8	37.8	10.3	5.6	14.7	12.7	56.4	42.5	9.7	37.9	6.7	5.6	9.2	4.1	24.4	15.2	2.0	8.4	24.5	5.4	4.7	46.1	334.1	13.4	8.0	0.9	14.5	6.7	9.8	10.5	17.7	6.9	10.4	9.8	16.0	13.1	5.8	23.8	0.6	2.1	42.5	32.1	79.8	14.7	19.8	12.9	20.4
PIM2		ENSG00000102096	"Pim-2 proto-oncogene, serine/threonine kinase"	Q9P1W9	X	48913182-48919024	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 103.2;intestine: 88.4;lymphoid tissue: 165.2"	"Cell type enriched"	"Detected in many"	4	"Plasma cells: 738.8"	"Cancer enriched"	"Detected in all"	6	"testis cancer: 171.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"HDLM-2: 567.6;Karpas-707: 675.0;RPMI-8226: 703.9;U-266/70: 1218.7;U-266/84: 1160.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000285			Approved	Cytosol		NA	NA			Cytosol		"HPA000285: AB_1079619"	"unprognostic (2.34e-3)"	"prognostic favorable (4.05e-5)"	"unprognostic (8.04e-2)"	"unprognostic (7.30e-2)"	"unprognostic (6.41e-3)"	"unprognostic (2.74e-3)"	"unprognostic (2.84e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.73e-1)"	"prognostic unfavorable (1.17e-11)"	"unprognostic (3.36e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.38e-2)"	8.0	7.1	10.6	86.2	11.7	103.2	8.9	9.9	12.7	5.4	10.9	41.2	88.4	5.2	10.1	8.3	12.0	16.9	5.2	14.6	11.6	9.8	10.5	23.7	115.2	9.7	11.2	11.4	10.4	4.7	3.8	10.2	4.9	10.8	7.4	51.4	5.7	36.7	7.3	2.5	6.1	46.8	7.0	8.9	165.2	45.5	10.1	12.0	45.9	10.2	2.8	105.6	46.0	6.5	12.1	17.5	14.8	8.0	15.4	2.8	2.0	11.7	10.5	13.1	14.8	13.2	13.3	12.9	74.5	4.8	5.3	5.6	10.6	25.1	10.0	14.1	567.6	19.6	90.8	15.0	13.9	6.2	21.7	58.7	5.9	8.4	15.3	9.2	12.1	5.5	9.8	97.8	675.0	8.4	12.6	8.4	45.2	165.2	6.1	22.7	9.9	5.4	703.9	14.9	2.6	5.4	7.8	11.5	8.0	8.3	36.9	19.3	29.8	3.6	3.5	2.5	3.1	10.6	1218.7	1160.5	144.1	14.0	19.0	3.7	279.1	8.2	77.7	60.4	9.7	102.3	124.8	165.9	85.6	13.2	73.5	172.4	113.3	195.5	92.7	17.4	15.2	331.9	79.0	10.6	11.7	9.9	12.7	14.6	11.6	9.7	11.2	11.4	10.8	8.9	12.0	12.1	2.9	12.8	36.0	1.0	161.6	20.3	9.0	7.1	45.5	2.6	16.2	4.7	3.5	2.8	9.9	3.7	2.1	5.8	46.8	5.7	3.9	3.3	1.9	15.6	1.0	5.3	13.1	49.9	2.3	3.5	9.1	5.1	10.7	3.9	23.4	1.3	4.2	6.3	7.2	11.8	2.2	7.5	18.3	7.5	123.1	1.8	1.8	19.8	94.3	0.0	99.5	2.2	38.1	0.5	1.0	2.0	3.7	4.1	738.8	4.6	4.1	6.8	16.3	2.1	0.0	3.8	6.2	2.2	1.6	15.7	13.8	2.5	97.1	8.6	11.8	3.4
PIWIL3	HIWI3	ENSG00000184571	"Piwi like RNA-mediated gene silencing 3"	Q7Z3Z3	22	24719034-24774720	"Predicted intracellular proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis, Translation regulation"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	8	"Early spermatids: 23.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA061955	Uncertain					NA	NA					"HPA061955: AB_2684647"					"unprognostic (9.05e-2)"				"unprognostic (2.20e-1)"				"unprognostic (3.12e-4)"	"unprognostic (2.73e-1)"	"unprognostic (7.33e-2)"		"unprognostic (1.72e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PLCL1	"PLC-L, PLCE, PLCL, PPP1R127, PRIP"	ENSG00000115896	"Phospholipase C like 1 (inactive)"	Q15111	2	197804593-198572581	"Metabolic proteins, Predicted intracellular proteins"		Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 65.7;tongue: 41.2"	"Cell type enriched"	"Detected in many"	10	"Oligodendrocytes: 2062.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.4"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.4"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 8.7;K-562: 15.6;Karpas-707: 10.7;MOLT-4: 11.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031849	Enhanced					NA	NA					"HPA031849: AB_10602192"	"unprognostic (7.77e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.18e-3)"	"unprognostic (4.40e-2)"	"unprognostic (7.14e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.42e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.02e-2)"	"unprognostic (7.42e-2)"	"prognostic favorable (3.91e-7)"	"unprognostic (1.07e-4)"	"unprognostic (6.74e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.20e-2)"	4.0	4.2	18.9	2.7	37.7	1.6	2.4	31.0	23.5	4.5	9.1	3.3	0.6	14.9	3.1	3.6	3.3	3.1	32.7	14.1	30.0	31.8	0.5	3.2	3.5	40.2	38.3	9.0	7.1	1.6	14.9	2.1	8.0	43.0	10.6	1.4	4.1	2.3	7.1	31.1	0.8	1.8	6.1	28.5	1.9	2.3	1.7	29.3	17.4	3.3	41.2	2.6	4.1	2.0	65.7	0.0	0.0	0.1	0.0	1.6	0.4	0.0	0.4	0.2	0.1	0.1	0.0	0.1	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	1.5	0.0	0.2	0.0	1.8	4.2	0.0	0.0	0.0	0.0	8.7	2.9	15.6	10.7	0.1	0.4	11.4	0.0	0.1	0.0	0.0	0.0	0.0	4.7	0.2	0.0	1.6	0.9	1.8	0.0	2.5	0.8	0.2	0.0	0.7	0.2	0.0	0.0	0.1	4.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.6	0.0	0.0	0.0	0.4	0.1	0.2	0.0	0.0	0.0	1.4	0.0	18.9	37.7	31.0	23.5	14.1	30.0	40.2	38.3	9.0	43.0	28.5	29.3	65.7	7.0	19.2	4.4	44.4	0.9	1.3	0.8	0.0	0.6	14.8	2.0	1.8	159.0	1.5	1.9	14.7	0.0	0.1	0.8	1.8	58.7	0.9	15.5	2.0	102.7	5.4	1.8	0.0	201.0	0.4	0.0	6.0	1.1	1.9	6.3	3.8	0.4	0.0	3.1	15.2	160.9	0.0	2.0	4.1	2.0	3.8	1.8	4.6	0.0	49.6	2.9	2.7	0.0	181.5	2062.6	0.2	0.0	7.9	3.8	0.6	0.6	52.4	2.2	1.2	32.9	5.4	31.8	1.0	1.8	0.2	1.3	0.1	8.2	1.6	0.1	0.3
PLD1		ENSG00000075651	"Phospholipase D1"	Q13393	3	171600404-171810950	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 87.6"	"Cell type enriched"	"Detected in many"	5	"Oligodendrocytes: 519.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 8.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 57.5;SK-MEL-30: 31.1;TIME: 50.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004527, HPA042396, HPA066938"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"CAB004527: AB_677324, HPA042396: AB_2677977, HPA066938: "	"unprognostic (3.23e-1)"	"unprognostic (3.27e-1)"	"unprognostic (5.82e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.58e-1)"	"unprognostic (4.76e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.23e-2)"	"unprognostic (8.02e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (4.76e-6)"	7.9	26.6	11.1	6.7	21.7	7.8	7.6	17.2	13.2	7.9	5.5	14.7	47.3	6.3	2.9	33.3	6.4	87.6	24.6	9.6	16.9	12.1	33.9	4.8	9.2	22.7	21.2	4.8	24.4	21.4	1.6	2.3	10.8	22.6	3.4	14.8	0.5	14.0	6.0	2.5	29.5	44.3	4.8	17.9	15.8	8.2	5.1	18.5	4.1	3.7	6.8	10.8	5.1	12.5	41.3	4.5	7.2	3.7	1.4	11.2	12.6	7.7	2.3	9.9	3.5	4.3	1.1	6.4	0.0	17.0	0.9	24.0	15.2	0.6	2.0	5.7	3.6	3.2	4.2	11.5	26.1	4.9	7.3	18.9	4.9	10.9	4.2	2.0	10.0	57.5	1.2	2.8	0.0	0.9	1.3	0.0	6.4	0.8	11.9	5.1	0.2	1.5	0.1	8.9	1.8	0.1	0.1	7.9	4.7	31.1	5.1	9.0	9.7	50.7	1.5	5.7	4.0	2.5	9.6	8.2	0.1	6.7	8.6	1.9	8.3	1.8	2.3	0.3	1.1	2.6	0.0	0.2	0.6	0.6	0.0	0.0	0.1	1.0	2.2	0.4	0.0	0.8	0.6	11.1	21.7	17.2	13.2	9.6	16.9	22.7	21.2	4.8	22.6	17.9	18.5	41.3	7.7	0.0	4.7	2.0	0.9	7.1	3.4	11.0	10.8	0.4	4.9	5.6	33.6	57.2	11.1	1.8	0.0	3.0	1.9	37.5	3.9	8.4	13.1	1.0	4.8	7.4	4.2	6.3	8.9	3.4	3.7	15.7	27.0	1.3	27.9	10.4	6.4	15.9	20.0	0.0	12.1	23.6	6.1	13.2	2.4	9.5	10.5	10.2	12.4	98.4	5.4	0.0	1.0	12.5	519.6	2.4	18.3	4.5	3.4	0.7	38.3	48.0	9.9	0.1	19.7	3.8	8.4	6.1	5.3	93.5	34.9	2.3	2.3	12.1	17.8	4.7
PLD4	C14orf175	ENSG00000166428	"Phospholipase D family member 4"	Q96BZ4	14	104924713-104937761	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 13.5;brain: 15.8;lymphoid tissue: 11.4"	"Cell type enriched"	"Detected in many"	7	"dendritic cells: 284.8"	"Cancer enhanced"	"Detected in many"		"glioma: 4.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"plasmacytoid DC: 3621.6"	"Lineage enriched"	"Detected in all"	5	"dendritic cells: 3621.6"	"Group enriched"	"Detected in some"	4	"HMC-1: 127.3;RPMI-8226: 85.5;THP-1: 191.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051512	Uncertain					NA	NA		2900000			"HPA051512: AB_2681515"	"unprognostic (4.50e-3)"	"unprognostic (1.78e-4)"	"unprognostic (7.12e-2)"	"unprognostic (5.30e-3)"	"unprognostic (5.54e-2)"	"unprognostic (2.91e-3)"	"unprognostic (2.56e-1)"	"unprognostic (4.76e-3)"	"unprognostic (1.45e-3)"	"unprognostic (1.19e-3)"	"unprognostic (3.45e-3)"	"unprognostic (3.89e-1)"	"unprognostic (6.90e-3)"	"unprognostic (8.94e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.41e-1)"	0.4	1.1	3.9	5.7	4.8	13.5	1.6	6.3	7.2	1.0	0.1	0.8	3.8	1.0	0.2	0.7	1.8	2.5	0.5	3.7	8.2	0.6	0.6	1.8	11.4	14.8	5.7	1.2	0.5	1.1	1.2	2.1	0.8	9.5	1.7	0.5	0.5	3.6	1.8	0.3	0.6	5.2	0.5	15.8	10.5	2.9	0.7	7.1	2.8	0.6	0.0	9.5	1.9	0.4	14.0	0.1	0.2	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.1	0.0	9.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	127.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	0.0	0.0	0.1	10.7	0.1	0.0	0.1	30.0	0.1	85.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	191.5	0.0	0.1	0.3	0.1	0.2	0.4	0.0	0.1	0.2	1.6	0.3	4.6	43.0	699.5	1.0	188.4	1.9	222.7	0.8	1.2	545.8	198.4	1.7	0.4	9.8	25.4	297.9	3621.6	1.0	72.9	3.9	4.8	6.3	7.2	3.7	8.2	14.8	5.7	1.2	9.5	15.8	7.1	14.0	0.8	0.0	0.0	0.3	34.7	0.4	0.1	0.0	0.0	2.7	0.6	2.8	1.4	0.0	0.0	0.0	0.0	0.2	284.8	0.0	0.0	0.0	0.7	0.1	0.3	2.7	0.0	5.5	0.1	0.0	0.4	1.1	1.1	0.4	3.8	0.0	0.0	0.0	30.6	1.7	0.1	0.0	0.0	1.3	32.0	4.7	0.0	38.0	5.4	22.5	11.3	0.1	2.1	0.5	0.1	0.0	0.0	0.0	2.3	0.1	0.0	0.1	0.0	1.1	6.6	1.6	0.3	1.6	1.6	0.0	0.4	0.3	2.2	0.0	0.1	0.0
PLEKHG7	"C12orf74, FLJ46688"	ENSG00000187510	"Pleckstrin homology and RhoGEF domain containing G7"	Q32Q52	12	92702843-92772455	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix: 1.8;epididymis: 1.9;fallopian tube: 2.8"	"Cell type enriched"	"Detected in some"	4	"Respiratory ciliated cells: 72.0"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	18	"memory B-cell: 1.9;naive B-cell: 1.6"	"Lineage enriched"	"Detected in single"	20	"B-cells: 1.9"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 1.8;SK-BR-3: 1.5"									HPA060632	Uncertain					NA	NA					"HPA060632: AB_2684333"	"unprognostic (4.47e-3)"	"unprognostic (3.95e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.80e-2)"	"unprognostic (9.91e-5)"	"unprognostic (1.38e-1)"	"unprognostic (9.44e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.75e-1)"		"unprognostic (3.27e-5)"	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.5	0.3	0.3	1.9	0.0	2.8	0.4	0.0	0.0	0.0	0.3	0.2	0.8	1.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.4	0.0	0.0	0.6	0.0	0.0	0.4	1.7	0.0	0.0	0.2	0.0	0.0	1.6	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.8	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	6.9	0.1	0.3	6.1	0.0	0.4	0.0	0.0	0.7	0.0	16.3	1.8	0.0	0.0	0.0	0.2	0.0	0.6	1.0	13.7	0.3	0.1	1.2	0.0	0.1	0.2	0.0	0.0	1.1	1.6	1.3	0.1	0.0	0.0	0.0	0.0	0.1	0.2	4.1	0.0	0.0	0.9	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.3	0.3	0.2	0.1	72.0	0.6	0.0	0.1	0.7	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.3	1.3
PLSCR5		ENSG00000231213	"Phospholipid scramblase family member 5"	A0PG75	3	146576555-146605346	"Predicted membrane proteins"				"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"Inhibitory neurons: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	17	"SuSa: 1.6"	"Region enhanced"	"Detected in single"		"midbrain: 1.0"	"Low region specificity"	"Detected in some"			HPA047249	Uncertain					NA	NA					"HPA047249: AB_2679997"																		0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.3	0.3	0.5	0.0	0.2	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PLTP	BPIFE	ENSG00000100979	"Phospholipid transfer protein"	P55058	20	45898621-45912155	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Hofbauer cells: 1640.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 33.1;eosinophil: 29.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 220.8;BEWO: 186.8;HHSteC: 233.2;HSkMC: 302.2;U-87 MG: 326.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB032873	Approved				"Secreted to blood"	NA	NA	9720000000	210000000			"CAB032873: AB_2283977"	"unprognostic (1.27e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.72e-2)"	"unprognostic (4.19e-2)"	"unprognostic (8.30e-2)"	"unprognostic (3.19e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.87e-1)"	"prognostic unfavorable (9.52e-8)"	"unprognostic (3.04e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.21e-1)"	"unprognostic (9.68e-2)"	441.9	190.4	104.4	81.2	90.4	20.9	123.6	101.4	143.1	156.0	190.6	73.8	42.0	115.9	73.3	62.6	175.1	183.9	103.4	85.7	168.4	194.3	29.7	97.9	61.8	106.4	113.1	73.1	160.9	299.5	22.3	38.8	432.4	98.9	51.1	42.8	4.9	133.2	72.2	24.2	66.9	72.2	183.7	118.0	58.1	90.5	32.6	103.5	232.0	44.8	21.0	21.3	342.9	114.0	155.8	13.8	1.9	94.9	0.1	220.8	66.8	186.8	5.3	16.3	18.5	11.0	78.7	15.9	3.5	151.6	23.6	0.4	154.7	29.2	0.6	8.4	1.8	0.2	28.8	3.3	37.7	233.2	0.0	35.5	302.2	7.7	49.1	0.9	74.1	41.3	3.2	9.5	44.9	6.2	3.9	3.2	123.1	16.9	12.5	74.5	1.3	0.1	1.7	0.5	0.0	10.1	35.4	3.7	110.3	160.9	15.7	1.5	117.2	9.0	46.2	1.1	24.2	0.8	19.7	5.3	5.4	326.4	34.3	7.8	33.1	2.7	29.7	1.6	7.1	1.2	8.7	0.4	1.6	2.5	3.2	0.0	1.0	1.4	4.9	12.6	17.5	0.8	2.7	104.4	90.4	101.4	143.1	85.7	168.4	106.4	113.1	73.1	98.9	118.0	103.5	155.8	21.9	0.0	2.3	30.3	3.8	40.7	34.9	53.0	33.0	0.4	9.5	22.6	1.5	5.7	9.6	27.6	0.0	14.8	3.5	0.5	1.9	3.4	16.3	54.6	36.9	27.9	0.0	9.0	0.8	103.2	97.7	256.8	3.6	5.7	0.0	23.4	121.1	2.8	1640.3	3.3	1.4	1.2	12.2	254.0	40.9	24.9	307.9	71.8	35.6	4.7	3.8	13.8	7.2	0.5	0.2	9.9	0.0	199.0	11.8	15.7	0.0	18.2	70.8	1.1	32.9	16.1	35.6	5.7	7.3	24.0	35.8	31.7	3.3	99.5	0.7	18.4
POLR1B	"FLJ10816, FLJ21921, RPA135, RPA2, Rpo1-2"	ENSG00000125630	"RNA polymerase I subunit B"	Q9H9Y6	2	112541915-112579818	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	"Nucleotidyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Early spermatids: 181.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037528			Supported	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Nucleoli fibrillar center"	Cytosol	"HPA037528: AB_10671627"	"unprognostic (1.66e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (2.71e-5)"	"unprognostic (2.07e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (5.52e-4)"	"unprognostic (6.12e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.56e-2)"	5.7	4.6	2.9	5.6	3.2	4.1	8.3	3.5	3.2	5.3	3.6	5.5	4.5	4.7	4.4	8.1	6.8	3.7	4.2	2.9	3.3	8.2	10.8	4.2	9.4	2.8	2.8	3.0	6.4	8.2	12.0	4.5	5.6	2.9	5.0	6.2	5.2	3.9	4.8	7.5	5.2	3.8	5.3	2.8	6.8	4.4	8.5	3.1	7.2	10.8	6.5	10.9	8.0	3.7	3.6	21.1	21.6	11.2	28.2	13.9	13.2	24.0	15.1	11.9	24.0	21.5	48.8	12.5	46.1	22.9	9.8	18.8	29.5	56.1	30.6	28.4	22.3	30.9	26.5	21.4	37.1	14.2	43.6	18.1	12.7	21.6	25.4	39.6	9.8	19.9	10.2	55.0	16.8	13.2	17.5	20.5	29.7	66.3	29.5	42.8	30.9	21.3	54.1	17.2	19.2	34.3	29.1	12.1	34.7	19.7	13.8	16.3	15.6	15.9	14.6	23.2	13.7	21.8	24.3	44.4	40.9	11.0	28.8	13.1	0.4	8.0	3.3	10.0	8.3	21.5	11.4	9.9	10.7	14.2	11.6	12.4	12.5	0.8	15.3	6.5	3.5	15.2	9.6	2.9	3.2	3.5	3.2	2.9	3.3	2.8	2.8	3.0	2.9	2.8	3.1	3.6	4.8	16.0	5.9	4.6	8.5	15.0	4.7	4.1	9.6	3.6	4.2	3.7	6.4	7.2	5.8	9.2	2.1	3.4	6.5	2.0	5.9	3.9	181.9	3.5	7.6	5.8	3.6	5.9	8.8	4.6	2.8	3.5	8.6	4.2	5.1	6.5	1.4	9.4	3.8	1.7	9.2	3.8	0.0	4.3	3.7	40.9	3.1	3.8	1.8	3.7	4.5	4.3	8.2	7.5	8.1	3.8	5.8	3.0	6.4	6.2	1.2	5.1	3.2	2.9	0.0	5.1	3.5	10.3	7.9	12.7	17.2	0.5	6.2	6.8	5.5	3.9
POPDC2	POP2	ENSG00000121577	"Popeye domain containing 2"	Q9HBU9	3	119636457-119665324	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 343.9;tongue: 97.8"	"Cell type enriched"	"Detected in many"	4	"Cardiomyocytes: 272.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	10	"SH-SY5Y: 24.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA024255	Enhanced					NA	NA					"HPA024255: AB_1855545"	"unprognostic (1.13e-1)"	"unprognostic (1.17e-3)"	"unprognostic (8.91e-3)"	"unprognostic (9.48e-2)"	"unprognostic (5.56e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.86e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.24e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.66e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.06e-2)"	2.9	2.1	0.6	3.9	0.5	0.3	3.3	0.7	0.9	6.7	1.2	64.6	2.8	12.6	2.6	2.0	9.7	11.0	343.9	0.5	0.6	2.4	1.0	2.5	6.7	0.6	0.6	0.4	2.0	1.3	8.4	1.3	1.4	0.6	16.4	6.3	0.9	3.3	49.7	78.4	2.6	12.3	24.2	0.5	2.9	10.8	1.0	0.6	1.6	2.4	97.8	2.6	35.6	6.1	0.5	0.1	0.2	0.5	0.0	0.2	0.2	0.0	0.4	0.1	0.1	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.3	0.0	0.4	1.0	0.0	0.3	0.1	0.1	0.0	0.1	0.4	0.2	0.2	0.0	0.3	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.2	24.8	0.0	0.0	0.6	2.5	0.0	0.3	0.0	0.2	0.1	0.2	0.1	1.0	0.0	0.2	0.2	0.3	0.5	0.5	0.0	0.7	0.3	0.0	0.4	0.1	0.5	0.4	0.0	0.4	0.8	0.2	0.0	0.2	1.3	0.2	0.7	0.1	0.6	0.5	0.7	0.9	0.5	0.6	0.6	0.6	0.4	0.6	0.5	0.6	0.5	4.7	0.0	0.5	1.0	0.6	0.4	0.3	0.5	0.0	3.1	0.9	3.0	272.7	0.0	0.9	0.0	0.0	0.5	2.3	0.4	0.0	0.5	0.3	0.6	0.5	6.4	3.0	0.0	0.8	0.2	0.1	8.0	0.5	0.3	1.3	1.6	1.4	0.2	1.6	1.7	1.2	0.8	0.0	1.0	2.3	0.8	1.2	1.6	0.0	2.8	1.8	1.2	0.0	1.0	1.9	0.5	0.2	1.9	0.0	0.8	0.7	0.3	1.9	2.4	59.2	5.9	11.1	1.0	0.3	0.1	0.6	1.2	1.6	0.6	0.3	0.2
PPBP	"b-TG1, Beta-TG, CTAP3, CTAPIII, CXCL7, LA-PF4, LDGF, MDGF, NAP-2, NAP-2-L1, PBP, SCYB7, TGB, TGB1, THBGB1"	ENSG00000163736	"Pro-platelet basic protein"	P02775	4	73986439-73988190	"Plasma proteins, Predicted secreted proteins"	Chemotaxis	"Antibiotic, Antimicrobial, Cytokine, Growth factor, Mitogen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 99.5;lymphoid tissue: 54.1"	"Cell type enriched"	"Detected in some"	18	"Macrophages: 1497.3"	"Cancer enriched"	"Detected in many"	7	"colorectal cancer: 86.8"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	13	"basophil: 394.2;neutrophil: 132.3"	"Lineage enriched"	"Detected in all"	20	"granulocytes: 394.2"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 1.0;HEL: 3.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA008354, CAB017624"	Supported				"Secreted to blood"	NA	NA	24500000	2900000000			"CAB017624: AB_1127132, HPA008354: AB_1847353"	"unprognostic (2.13e-1)"	"prognostic unfavorable (6.17e-4)"	"unprognostic (7.69e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.37e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.79e-1)"	"unprognostic (6.98e-3)"	"unprognostic (2.58e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.15e-3)"	"unprognostic (2.59e-2)"	1.0	0.5	0.5	0.5	0.5	99.5	0.6	0.5	2.4	0.1	1.8	0.1	0.0	0.1	0.0	0.3	0.8	0.8	1.1	0.4	0.7	0.8	3.0	19.5	0.0	0.7	1.4	0.4	0.1	0.1	0.0	0.4	5.3	1.0	0.1	0.0	0.0	0.6	0.0	1.4	0.1	0.0	0.1	0.9	54.1	0.2	0.0	0.8	0.1	1.0	4.2	0.0	8.5	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	394.2	13.0	9.3	2.0	5.3	2.9	1.5	1.2	0.6	8.0	2.3	4.1	1.0	132.3	1.9	5.0	20.1	2.1	1791.5	0.5	0.5	0.5	2.4	0.4	0.7	0.7	1.4	0.4	1.0	0.9	0.8	0.6	0.3	3.2	1.1	0.0	10.5	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.5	4.0	1.8	0.0	0.0	9.3	0.1	0.0	4.7	0.0	0.0	0.0	12.3	0.0	2.7	0.0	0.2	0.2	0.4	0.0	0.0	0.0	0.0	36.8	1.1	0.1	0.0	0.0	0.0	0.0	23.2	0.0	0.0	0.0	1497.3	0.0	0.0	80.8	0.0	75.2	0.0	0.0	7.0	0.0	0.0	0.1	0.0	0.0	0.3	1.7	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.1	7.8	0.0	0.0	0.0
PPIAL4A	"COAS2, PPIAL4, PPIAL4B"	ENSG00000263353	"Peptidylprolyl isomerase A like 4A"	Q9Y536	1	120889746-120890405	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	9	"Distal tubular cells: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.6;NB-4: 1.8;SK-BR-3: 1.9"									HPA058345	Uncertain					NA	NA					"HPA058345: AB_2683685"	"unprognostic (3.49e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.17e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.42e-2)"	"unprognostic (7.94e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.11e-2)"	"unprognostic (5.32e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.74e-1)"	0.0	0.2	0.0	0.2	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.7	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.1	0.4	0.8	1.8	1.0	0.0	0.0	0.3	0.6	0.8	0.0	0.0	0.4	0.1	0.1	1.9	0.2	0.0	1.3	1.1	0.3	1.2	0.4	1.2	0.7	0.5	0.4	1.0	1.1	0.7	1.3	0.0	0.4	0.2	0.4	0.4	0.4	0.8	0.6	0.7	0.9	0.6	0.4	0.7	0.0	0.7	0.3	0.9	0.7	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PPIAL4C		ENSG00000263464	"Peptidylprolyl isomerase A like 4C"	A0A0B4J2A2	1	149583865-149584464	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"intestine: 3.5;lymphoid tissue: 2.2"	"Cell type enriched"	"Detected in single"	5	"Cardiomyocytes: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 18.8;THP-1: 22.5"									HPA058345	Uncertain					NA	NA					"HPA058345: AB_2683685"	"unprognostic (3.16e-1)"	"unprognostic (2.83e-2)"			"unprognostic (1.50e-2)"	"unprognostic (7.93e-2)"		"unprognostic (5.98e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.79e-1)"				"unprognostic (6.61e-2)"			"unprognostic (2.25e-1)"	0.3	1.9	0.5	2.2	0.5	0.2	0.4	0.7	0.9	0.4	0.4	0.8	3.5	0.9	0.0	0.1	0.1	0.1	0.0	0.5	0.5	0.7	0.3	1.0	2.1	0.5	0.5	0.4	0.2	0.0	0.2	0.2	0.9	0.5	0.4	0.2	0.0	0.0	0.1	0.5	0.3	1.8	0.1	0.4	1.7	0.8	0.0	0.5	0.0	0.1	0.0	0.8	0.1	0.1	0.5	4.1	0.0	0.5	3.2	0.2	0.5	2.8	0.5	0.2	1.2	0.9	0.0	6.4	1.9	2.4	0.0	3.1	4.5	0.0	0.3	0.8	4.8	0.0	0.4	0.0	0.0	0.1	1.1	1.7	0.2	1.0	0.8	0.4	0.0	0.0	0.2	0.9	6.1	0.9	0.7	7.4	18.8	7.6	0.8	0.1	7.2	0.1	12.2	0.0	0.0	5.0	6.8	0.8	13.1	7.9	0.0	6.1	22.5	0.0	4.4	6.1	3.2	10.5	4.4	6.9	11.9	5.0	5.8	9.8	1.6	3.8	1.6	4.1	5.2	4.8	7.0	4.6	4.5	8.0	6.2	3.8	5.0	0.3	3.3	3.6	8.3	6.1	12.0	0.5	0.5	0.7	0.9	0.5	0.5	0.5	0.5	0.4	0.5	0.4	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PPP1R1A		ENSG00000135447	"Protein phosphatase 1 regulatory inhibitor subunit 1A"	Q13522	12	54575387-54588659	"Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 243.4;skeletal muscle: 839.5;tongue: 273.5"	"Cell type enriched"	"Detected in many"	4	"Distal tubular cells: 1348.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 17.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC diff: 8.8;NTERA-2: 29.4;RPTEC TERT1: 32.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007811, HPA041542"	Approved					NA	NA					"CAB007811: AB_598171, HPA041542: AB_2677542"	"unprognostic (6.39e-3)"	"unprognostic (2.61e-1)"	"unprognostic (4.61e-3)"	"prognostic unfavorable (2.36e-5)"	"unprognostic (1.55e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.19e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.04e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.76e-3)"	"unprognostic (2.88e-3)"	"unprognostic (7.68e-3)"	"unprognostic (2.17e-1)"	"unprognostic (8.49e-3)"	"unprognostic (7.49e-2)"	243.4	2.6	36.1	1.1	60.4	0.3	171.2	25.7	45.0	1.5	19.5	21.6	3.1	2.2	0.7	10.4	3.9	1.5	108.1	38.1	41.2	93.3	139.2	1.0	0.5	37.1	31.3	35.1	7.8	14.3	21.0	1.8	0.0	41.2	8.0	1.8	14.7	9.8	3.2	839.5	6.2	13.3	3.3	23.7	0.5	28.0	2.2	28.5	0.2	2.6	273.5	0.5	5.4	1.5	33.3	0.0	0.0	3.9	0.0	8.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	5.4	0.0	0.0	0.1	2.1	0.1	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.2	29.4	0.0	0.0	0.0	0.0	0.2	32.6	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.3	0.0	0.0	1.5	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.1	60.4	25.7	45.0	38.1	41.2	37.1	31.3	35.1	41.2	23.7	28.5	33.3	7.9	0.0	0.0	3.3	3.4	0.1	0.0	0.0	0.0	2.2	23.7	40.6	300.7	5.7	0.0	18.4	0.0	0.0	0.5	0.0	1348.0	3.5	1.6	10.4	0.5	4.6	2.4	2.7	3.1	0.4	0.1	24.5	0.0	13.8	0.0	21.0	6.4	218.4	0.6	112.7	1.8	2.1	0.0	3.8	0.0	1.9	1.2	1.6	0.0	0.0	0.0	3.7	0.0	0.0	0.5	2.5	0.1	1.2	0.0	0.3	0.5	156.8	0.0	2.8	0.0	19.2	21.6	0.2	5.9	0.0	0.3	0.0	0.9	4.2	2.0	0.2
PRDM16	"KIAA1675, KMT8F, MEL1, MGC166915, PFM13"	ENSG00000142611	"PR/SET domain 16"	Q9HAZ2	1	3069168-3438621	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 13.4;stomach 1: 9.4"	"Cell type enriched"	"Detected in many"	4	"Astrocytes: 173.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	16	"NK-cell: 2.4"	"Lineage enriched"	"Detected in single"	16	"NK-cells: 2.4"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.8;HHSteC: 2.0;hTERT-RPE1: 6.7;MCF7: 1.6;OE19: 3.5"	"Region enriched"	"Detected in many"	5	"basal ganglia: 15.7"	"Low region specificity"	"Detected in many"			"HPA050343, HPA060467"			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA050343: AB_2681099, HPA060467: AB_2684287"	"unprognostic (2.44e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.31e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.95e-2)"	"unprognostic (9.15e-3)"	"unprognostic (5.68e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.07e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.71e-1)"	"unprognostic (7.80e-6)"	"unprognostic (2.14e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (4.70e-5)"	"unprognostic (4.06e-2)"	1.3	0.2	3.2	0.5	4.5	0.0	1.1	0.0	4.0	1.3	13.4	1.0	7.5	1.0	2.1	0.3	1.4	1.1	3.3	2.8	1.1	3.8	0.2	2.5	0.5	1.5	1.0	0.4	1.5	5.8	0.9	0.6	0.1	2.8	0.8	0.2	0.0	0.4	2.2	0.5	0.4	2.7	0.2	0.0	2.2	9.4	0.7	3.8	0.1	8.1	0.6	0.3	0.9	1.1	2.5	0.0	0.0	0.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.3	0.0	0.2	0.0	0.2	0.0	1.3	0.0	0.0	0.1	1.8	0.0	0.0	0.3	2.0	0.0	0.7	0.0	0.0	0.0	0.0	6.7	0.0	0.1	0.0	0.0	0.0	1.6	0.1	0.0	0.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	3.2	4.5	0.0	4.0	2.8	1.1	1.5	1.0	0.4	2.8	0.0	3.8	2.5	4.5	35.3	10.5	173.7	0.1	0.6	0.3	2.1	0.6	0.1	0.2	0.3	5.2	22.8	6.3	7.3	0.0	0.0	0.1	0.2	5.9	10.0	0.3	0.2	0.0	2.1	5.4	0.8	1.2	4.9	4.2	0.6	30.5	0.4	0.0	0.3	0.0	0.0	0.0	1.7	1.0	0.9	0.0	0.0	0.4	0.2	1.5	0.1	0.0	14.0	0.0	1.4	0.0	6.6	1.8	7.1	0.8	1.9	0.1	0.8	0.5	0.2	1.9	0.3	0.0	3.3	9.0	0.3	1.8	0.2	0.0	0.0	0.4	0.0	1.5	0.2
PRDM8	KMT8D	ENSG00000152784	"PR/SET domain 8"	Q9NQV8	4	80183879-80204329	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Transferase"	"Disease variant, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 26.3;retina: 24.3;seminal vesicle: 27.4"	"Cell type enriched"	"Detected in many"	9	"Bipolar cells: 271.5"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 4.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 27.3;LHCN-M2: 41.7;NB-4: 48.2;SCLC-21H: 99.3"	"Region enhanced"	"Detected in many"		"hippocampal formation: 28.7"	"Low region specificity"	"Detected in all"			HPA057253			Supported	"Nucleoplasm,Nuclear bodies"		No	NA			"Nuclear bodies"	Nucleoplasm	"HPA057253: AB_2683382"	"unprognostic (2.33e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.95e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.89e-11)"	"unprognostic (4.64e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.56e-1)"	3.9	2.3	5.7	5.1	8.7	4.0	4.0	0.0	17.4	11.1	0.0	8.4	1.1	9.4	1.9	1.7	5.3	1.7	1.7	14.9	0.0	0.9	0.3	1.6	5.2	2.8	0.7	5.3	5.2	0.9	0.0	5.4	4.4	6.3	26.3	1.6	24.3	1.5	27.4	2.2	2.5	5.8	3.8	0.8	1.8	5.0	1.1	0.7	0.7	1.2	1.0	2.4	10.3	9.9	6.0	2.3	0.2	0.7	0.0	2.1	7.2	0.1	5.8	20.5	2.8	3.2	0.0	2.2	0.0	0.0	7.2	1.8	0.7	0.1	2.4	12.1	8.8	1.8	0.8	0.0	0.0	4.1	9.1	2.5	4.4	0.2	11.1	3.2	27.3	0.4	2.4	0.0	3.7	41.7	0.0	4.2	48.2	0.0	0.2	17.0	1.6	0.0	0.2	1.2	0.3	99.3	13.8	0.3	0.0	0.1	0.1	0.0	4.5	8.8	7.1	1.0	5.2	0.4	1.7	0.0	0.0	17.8	4.2	1.0	0.0	0.0	0.0	0.4	0.0	0.6	0.1	0.5	0.5	0.1	0.7	0.3	0.1	0.5	0.2	0.0	0.1	0.2	0.1	5.7	8.7	0.0	17.4	14.9	0.0	2.8	0.7	5.3	6.3	0.8	0.7	6.0	0.9	0.0	0.5	2.3	8.2	0.6	3.4	0.4	0.0	271.5	0.1	0.4	1.8	0.0	5.2	1.8	2.1	0.0	2.5	0.0	0.0	0.0	1.5	0.3	6.5	2.2	0.0	2.5	29.9	0.2	0.2	8.8	0.0	0.5	0.0	0.1	0.0	0.0	0.5	3.3	2.0	0.2	2.0	1.2	6.2	6.7	3.1	5.9	1.8	3.7	0.9	6.1	2.1	7.1	17.0	0.7	0.0	3.4	2.7	3.7	0.0	0.2	5.0	11.6	0.0	4.2	2.9	0.3	0.4	0.0	0.1	0.1	5.0	0.1	0.0	0.6
PRDM9	"KMT8B, MSBP3, PFM6, ZNF899"	ENSG00000164256	"PR/SET domain 9"	Q9NQV7	5	23443586-23528093	"Enzymes, Predicted intracellular proteins, Transcription factors"	"Meiosis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.5;epididymis: 1.6;testis: 4.0"	"Cell type enriched"	"Detected in some"	4	"Spermatocytes: 44.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	12	"U-266/70: 6.9"									HPA059555	Uncertain					NA	NA					"HPA059555: AB_2684061"							"unprognostic (1.23e-4)"			"unprognostic (8.64e-2)"				"unprognostic (2.18e-2)"	"unprognostic (8.34e-2)"		"unprognostic (4.11e-1)"	0.0	0.0	0.6	0.0	1.5	0.9	0.0	0.5	1.0	0.0	1.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.3	2.2	0.1	0.0	0.0	0.1	1.8	1.0	0.2	0.1	0.4	0.0	0.0	0.0	1.9	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.1	0.0	4.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	4.5	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.5	0.0	0.0	6.9	0.1	0.0	0.0	0.1	0.0	1.0	0.2	0.0	0.2	0.1	0.2	0.3	0.2	0.1	0.1	0.4	0.2	0.2	1.2	0.6	0.1	0.1	0.1	0.0	0.6	1.5	0.5	1.0	0.3	2.2	1.8	1.0	0.2	1.9	0.7	1.2	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.4	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRODH	"HSPOX2, PIG6, PRODH1, PRODH2, TP53I6"	ENSG00000100033	"Proline dehydrogenase 1"	O43272	22	18912777-18936553	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Proline metabolism"	Oxidoreductase	"Disease variant, Schizophrenia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 49.6;skin 1: 39.0"	"Cell type enriched"	"Detected in some"	7	"Astrocytes: 183.1"	"Cancer enhanced"	"Detected in many"		"testis cancer: 11.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"OE19: 91.3;RPTEC TERT1: 35.9"									HPA020361	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA			Mitochondria	"Nucleoplasm, Vesicles"	"HPA020361: AB_10963116"	"unprognostic (2.46e-2)"	"prognostic favorable (1.54e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.49e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.61e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.94e-2)"	7.1	0.7	5.4	0.4	4.4	0.0	8.6	3.0	9.8	3.8	29.9	3.0	5.7	1.5	0.1	11.7	5.8	0.1	11.4	6.1	3.4	14.3	15.8	20.7	0.2	6.4	3.2	2.8	0.5	1.5	0.0	5.4	0.2	9.8	3.2	0.3	0.6	4.2	0.2	49.6	39.0	32.8	0.0	2.0	0.5	3.5	1.7	4.9	0.3	7.4	6.3	0.9	4.2	8.6	5.0	0.0	0.8	0.0	0.3	0.9	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.3	0.0	0.0	2.9	3.9	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.9	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.6	4.5	91.3	0.0	0.0	0.0	0.4	35.9	0.9	0.1	0.2	0.8	1.4	0.3	5.2	1.4	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.4	4.4	3.0	9.8	6.1	3.4	6.4	3.2	2.8	9.8	2.0	4.9	5.0	0.1	16.0	25.6	183.1	0.0	5.1	0.3	13.1	0.0	0.0	0.2	0.1	1.8	0.0	11.5	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.6	1.2	0.2	0.4	3.5	0.0	0.5	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	1.1	0.0	2.0	0.0	1.5	0.1	0.0	0.1	21.4	17.8	0.0	0.6	0.0	14.1	2.1	0.0	2.3	0.0	0.0	0.0	8.0	0.1	21.0	0.1	0.0	1.1	0.6	0.2	0.4	1.0	15.2	0.0	0.3	0.0	1.6	0.2
PRR33	"C11orf89, LOC728008"	ENSG00000283787	"Proline rich 33"		11	1888078-1891895	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"adrenal gland: 23.6;lymphoid tissue: 28.6;skeletal muscle: 35.6"	"Cell type enriched"	"Detected in single"	14	"Cardiomyocytes: 2.9"					"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	6	"neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.4"	"Group enriched"	"Detected in some"	5	"Daudi: 3.0;HDLM-2: 8.6;Karpas-707: 6.1;U-937: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA																							4.5	23.6	0.0	6.1	0.0	9.7	3.0	0.0	0.2	5.1	0.1	2.4	1.4	2.8	0.0	3.2	3.1	1.5	5.1	0.0	0.1	0.5	1.1	2.7	6.3	0.2	0.0	0.0	0.5	0.6	0.0	0.6	1.4	0.1	1.3	0.0	0.0	3.4	0.0	35.6	11.1	6.1	0.0	0.3	28.6	2.9	1.2	0.1	0.0	1.8	4.1	0.0	6.9	4.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.1	0.0	0.0	0.4	1.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	1.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.1	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0
PRR5L	"FLJ14213, PROTOR-2"	ENSG00000135362	"Proline rich 5 like"	Q6MZQ0	11	36296288-36465204	"Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.0;intestine: 35.1;lymphoid tissue: 36.7"	"Cell type enriched"	"Detected in many"	5	"Oligodendrocytes: 302.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 35.5;HMC-1: 55.7;hTERT-HME1: 57.9;SiHa: 40.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070174			Approved	"Cytokinetic bridge,Cytosol"		Yes	No			"Cytokinetic bridge, Cytosol"		"HPA070174: AB_2686231"	"unprognostic (6.76e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.48e-2)"	"prognostic favorable (7.30e-5)"	"unprognostic (2.34e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.45e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.46e-2)"	"unprognostic (3.03e-3)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (7.71e-8)"	"prognostic unfavorable (4.86e-4)"	"unprognostic (1.66e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.98e-2)"	3.2	1.6	13.7	9.0	24.5	4.8	2.7	21.2	13.9	11.5	2.9	35.1	3.3	2.8	2.0	1.4	6.3	7.2	2.1	8.3	18.7	3.6	2.9	13.7	9.4	35.2	23.1	4.4	12.9	1.2	0.9	2.7	3.6	30.1	2.4	28.1	0.7	7.8	2.0	0.9	1.6	12.3	6.0	29.9	36.7	3.5	1.5	22.1	3.4	3.3	0.7	3.4	4.3	3.9	47.0	0.0	5.5	10.3	0.2	1.4	0.0	0.1	13.2	8.9	25.7	27.2	0.0	0.2	0.1	4.4	15.7	5.9	0.5	2.1	5.9	12.9	5.0	3.7	1.5	35.5	0.0	3.5	0.0	55.7	3.8	9.0	2.3	57.9	25.2	9.4	0.0	0.0	0.1	13.6	3.3	0.7	0.1	0.8	0.1	2.3	4.1	1.1	1.1	27.0	6.9	0.0	0.4	40.1	0.0	2.2	6.5	0.0	0.6	7.8	22.3	6.8	0.0	16.4	0.2	0.0	0.0	9.7	1.5	6.7	36.1	2.0	24.9	34.6	21.4	8.2	0.0	12.2	29.7	2.5	1.6	2.6	18.0	11.8	9.6	24.6	7.7	0.0	15.4	13.7	24.5	21.2	13.9	8.3	18.7	35.2	23.1	4.4	30.1	29.9	22.1	47.0	2.1	19.2	4.2	17.6	0.7	0.4	0.2	5.0	0.0	0.1	1.9	0.9	0.9	1.5	6.8	7.3	0.0	0.2	25.9	44.3	1.9	1.3	17.6	1.5	0.8	7.7	1.8	7.0	1.8	2.2	0.1	2.1	1.1	2.5	5.1	0.5	22.5	0.4	8.8	0.0	1.1	22.7	10.2	11.7	0.7	54.9	0.6	5.4	0.0	16.9	4.7	1.2	58.7	31.7	302.0	3.9	37.0	0.4	4.2	0.7	13.2	0.5	9.0	0.2	6.6	1.8	2.6	0.3	0.6	0.4	0.6	0.3	14.5	0.9	17.5	0.5
PRRG1	PRGP1	ENSG00000130962	"Proline rich and Gla domain 1"	O14668	X	37349309-37457292	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.8"	"Cell type enriched"	"Detected in many"	6	"Oligodendrocytes: 229.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 79.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078129			Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"	Nucleoplasm	"HPA078129: AB_2686878"	"unprognostic (8.82e-2)"	"prognostic unfavorable (4.65e-4)"	"unprognostic (8.34e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.11e-3)"	"unprognostic (2.24e-2)"	"unprognostic (7.23e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (8.21e-2)"	"prognostic favorable (2.05e-7)"	"unprognostic (1.43e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.48e-1)"	8.7	3.7	14.8	2.2	25.5	0.2	5.2	23.0	21.4	4.4	7.4	4.1	2.9	4.3	1.5	4.1	2.6	8.9	6.4	14.7	18.6	10.6	7.9	5.5	1.7	25.8	23.6	11.2	4.2	1.6	1.2	1.4	8.2	26.0	3.4	4.1	1.5	2.9	7.9	16.1	2.1	3.0	5.5	23.3	2.9	2.4	1.5	21.7	1.5	8.4	7.9	1.0	5.6	3.8	41.8	32.3	7.2	5.6	5.6	18.7	15.4	2.4	14.1	17.6	4.7	8.2	17.1	20.2	0.0	21.8	10.4	8.9	10.7	15.6	10.0	8.3	0.1	5.2	5.2	7.7	5.7	22.6	0.0	7.2	23.2	8.1	9.1	7.7	9.4	24.8	0.0	2.6	0.1	16.5	2.4	0.1	0.1	6.8	5.1	13.4	0.0	13.1	0.0	79.2	1.7	0.0	0.1	9.7	15.6	6.1	15.3	0.1	3.5	17.6	7.5	4.2	14.2	4.1	0.0	0.1	0.0	7.3	0.0	7.3	0.7	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	14.8	25.5	23.0	21.4	14.7	18.6	25.8	23.6	11.2	26.0	23.3	21.7	41.8	29.7	6.4	4.2	15.7	0.0	11.3	4.8	7.6	5.2	2.2	5.3	5.3	8.1	15.7	2.7	33.1	0.0	7.0	0.2	7.6	7.9	6.8	0.7	3.3	12.9	18.4	3.0	0.0	23.3	3.1	14.9	9.6	4.6	9.2	1.3	3.9	17.9	16.3	4.8	18.5	10.8	5.7	14.2	4.1	5.3	0.4	4.7	1.4	3.6	31.9	0.8	2.2	0.0	12.5	229.8	18.7	7.5	2.6	0.0	9.1	4.3	9.4	2.9	0.5	6.6	8.3	8.4	2.5	4.2	5.2	6.3	10.4	0.4	3.5	4.8	8.1
PRUNE2	"A214N16.3, bA214N16.3, BMCC1, BNIPXL, C9orf65, KIAA0367"	ENSG00000106772	"Prune homolog 2 with BCH domain"	Q8WUY3	9	76611376-76906114	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 117.2"	"Cell type enriched"	"Detected in many"	6	"Oligodendrocytes: 918.7"	"Cancer enhanced"	"Detected in many"		"renal cancer: 15.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 51.1;LHCN-M2: 83.2;RH-30: 71.5;RPTEC TERT1: 40.1"	"Low region specificity"	"Detected in all"							"HPA022470, HPA031079"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus, Cytosol"	"Nucleoplasm, Nucleoli"	"HPA022470: AB_1845832, HPA031079: AB_10603230"	"unprognostic (1.21e-1)"	"unprognostic (3.65e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.13e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.43e-3)"	"unprognostic (8.56e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.60e-1)"	"unprognostic (8.69e-2)"	"unprognostic (2.11e-2)"	"unprognostic (9.79e-2)"	"prognostic favorable (1.37e-6)"	"unprognostic (7.75e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.25e-3)"	"unprognostic (3.80e-4)"	8.7	23.4	30.7	12.0	72.8	3.0	5.3	47.1	55.2	15.0	0.3	80.9	7.1	51.0	18.7	34.3	29.7	16.6	5.0	25.5	46.4	15.5	1.9	5.2	2.8	79.1	52.7	21.6	4.7	4.4	4.1	31.1	4.0	103.8	48.0	18.6	39.4	14.7	65.4	16.8	4.6	27.9	55.8	39.9	4.5	37.4	5.0	48.4	0.9	2.6	57.3	2.6	69.7	14.5	117.2	0.0	0.0	1.5	0.0	51.1	25.8	0.2	1.8	3.6	6.6	14.7	0.4	0.0	0.3	3.9	4.5	13.6	0.0	0.1	0.0	18.0	0.4	2.9	6.3	3.7	0.0	8.5	0.1	0.3	28.7	0.1	26.7	0.7	15.1	14.4	0.4	0.0	20.8	83.2	0.1	4.6	1.8	4.0	0.0	0.0	0.5	71.5	0.3	40.1	0.0	17.4	0.0	0.0	0.3	4.9	2.8	0.1	0.7	11.9	14.2	0.7	34.9	1.2	22.2	3.2	0.0	11.5	0.3	0.0	0.3	0.5	0.1	0.0	0.6	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.4	0.3	0.2	0.1	0.0	0.2	30.7	72.8	47.1	55.2	25.5	46.4	79.1	52.7	21.6	103.8	39.9	48.4	117.2	0.4	0.0	1.1	27.7	0.0	2.3	0.4	0.5	0.0	47.5	1.2	3.4	11.1	0.0	1.0	11.0	0.0	0.0	1.6	3.5	1.9	0.0	12.6	37.7	4.7	3.7	54.3	0.0	152.4	0.5	0.2	2.9	3.1	34.7	0.0	0.1	21.8	0.2	3.2	15.2	65.4	36.4	4.1	3.1	3.1	30.0	0.9	2.3	5.4	13.1	1.7	9.9	2.1	134.7	918.7	0.4	8.8	1.5	0.1	5.1	9.9	20.3	17.0	6.5	0.0	27.2	9.6	4.3	4.2	0.0	1.4	0.0	0.7	0.5	5.2	0.6
PSEN1	"AD3, FAD, PS1, S182"	ENSG00000080815	"Presenilin 1"	P49768	14	73136418-73223691	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Cell adhesion, Notch signaling pathway"	"Hydrolase, Protease"	"Alzheimer disease, Amyloidosis, Cancer-related genes, Cardiomyopathy, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"Oligodendrocytes: 395.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006844, HPA030760, HPA067496"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Cell Junctions"		Yes	No			"Golgi apparatus"	"Nucleoplasm, Cell Junctions"	"CAB006844: , HPA030760: AB_10696211, HPA067496: AB_2685853"	"unprognostic (1.67e-1)"	"unprognostic (4.79e-2)"	"unprognostic (7.39e-2)"	"unprognostic (8.68e-3)"	"unprognostic (3.84e-1)"	"unprognostic (5.48e-3)"	"prognostic unfavorable (1.99e-5)"	"unprognostic (1.65e-1)"	"unprognostic (8.99e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.76e-3)"	"unprognostic (2.74e-1)"	"prognostic favorable (1.52e-8)"	"unprognostic (2.29e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.12e-3)"	"unprognostic (1.85e-1)"	25.3	22.8	49.7	26.7	77.1	40.0	28.5	62.9	58.5	28.4	48.0	50.0	50.7	25.5	27.2	35.5	23.1	32.0	18.1	47.6	57.0	35.8	32.2	32.4	22.6	69.0	66.0	39.9	22.2	23.1	35.4	11.7	43.4	70.6	24.5	46.7	23.6	23.1	23.6	18.5	38.5	49.4	27.3	64.3	22.8	31.3	32.8	64.6	26.4	37.2	23.5	31.0	35.3	19.4	122.3	37.1	55.9	50.6	20.0	68.9	49.9	46.7	52.5	60.1	52.6	66.7	69.9	88.9	23.7	34.1	50.5	43.0	94.9	43.2	40.1	57.3	54.6	26.7	27.1	35.1	34.4	63.8	27.7	50.7	50.4	71.9	44.3	54.4	48.5	43.2	26.2	31.0	46.6	50.0	72.8	21.0	35.7	22.0	64.5	40.4	26.4	42.7	30.2	73.7	76.5	28.1	38.3	57.4	53.0	47.1	45.4	66.3	60.7	45.7	53.1	43.5	44.1	25.3	30.3	47.9	23.7	44.9	32.8	33.3	126.8	94.5	96.3	23.1	106.0	22.6	23.1	22.3	19.0	83.4	31.8	20.7	20.1	129.3	42.8	125.0	43.6	37.0	70.3	49.7	77.1	62.9	58.5	47.6	57.0	69.0	66.0	39.9	70.6	64.3	64.6	122.3	22.2	28.9	30.5	35.9	25.8	28.6	24.6	24.7	12.0	17.1	25.0	17.7	12.5	15.7	30.2	23.9	39.6	27.1	30.7	79.1	5.9	27.1	22.9	26.3	26.4	22.3	16.2	12.0	38.9	26.7	29.2	23.7	32.1	47.4	18.3	29.6	15.7	24.6	30.5	13.5	40.2	39.5	24.4	50.5	40.8	12.9	16.4	52.3	16.0	39.4	51.8	13.8	14.4	48.7	395.8	38.2	58.8	15.4	23.6	38.8	76.2	13.0	29.0	28.0	26.3	20.0	19.0	40.2	14.4	20.4	33.0	49.9	21.6	18.6	41.3	51.5
PTCHD4	"C6orf138, dJ402H5.2, FLJ41841, PTCH53"	ENSG00000244694	"Patched domain containing 4"	Q6ZW05	6	47856673-48111197	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	5	"Inhibitory neurons: 479.8"	"Group enriched"	"Detected in some"	6	"melanoma: 1.1;renal cancer: 1.6;thyroid cancer: 4.0"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 9.4;BEWO: 12.4;Hep G2: 21.8;LHCN-M2: 9.6;SuSa: 20.1;TIME: 9.9;WM-115: 11.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA041276	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA041276: AB_10796570"	"unprognostic (1.35e-4)"	"unprognostic (1.66e-2)"	"unprognostic (3.25e-1)"	"unprognostic (3.11e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.57e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.59e-3)"	"unprognostic (2.80e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.92e-1)"	"prognostic favorable (1.49e-6)"	"unprognostic (5.03e-4)"	"unprognostic (9.84e-2)"	"unprognostic (1.57e-2)"	"unprognostic (5.56e-3)"	0.4	0.1	0.3	0.0	0.6	0.0	0.3	0.0	1.4	0.6	0.1	0.2	0.1	0.4	0.6	0.3	0.5	0.2	0.4	0.8	0.4	0.4	0.3	0.5	0.0	0.2	0.9	0.2	0.2	0.2	0.0	0.9	0.3	0.2	0.5	0.1	0.8	0.5	1.0	0.1	0.0	0.1	0.3	0.1	0.0	0.1	0.2	0.2	0.0	0.9	0.1	0.0	0.3	0.3	0.6	0.0	0.0	9.4	0.0	1.3	3.9	12.4	1.2	2.8	0.0	0.4	0.0	0.5	0.0	0.0	0.9	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.2	21.8	0.5	0.0	0.0	6.2	5.4	0.0	0.1	4.4	1.8	2.5	0.0	0.0	9.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.8	0.5	0.1	0.0	0.0	20.1	0.0	0.0	9.9	2.3	1.9	0.0	0.2	0.0	0.0	0.0	3.3	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	1.4	0.8	0.4	0.2	0.9	0.2	0.2	0.1	0.2	0.6	0.5	0.0	1.1	6.5	0.0	0.1	0.0	1.0	0.0	1.0	0.4	0.3	0.2	0.0	1.3	1.8	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.6	0.0	0.0	90.6	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	479.8	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	89.9	0.0	0.6	0.0	2.5	2.8	0.1	0.0	0.4	0.0	0.2	0.0	0.0	1.1	0.9	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1
PTGER1	EP1	ENSG00000160951	"Prostaglandin E receptor 1"	P34995	19	14472466-14475354	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"kidney: 11.6;lymphoid tissue: 6.6"	"Cell type enriched"	"Detected in some"	70	"Collecting duct cells: 198.6"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 4.1"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 2.4;NB-4: 1.3;PC-3: 3.2;SH-SY5Y: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (3.44e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.68e-1)"	"unprognostic (3.50e-4)"	"unprognostic (8.69e-2)"	"unprognostic (5.58e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.19e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.74e-8)"	"unprognostic (1.19e-1)"	"unprognostic (4.41e-2)"	"unprognostic (4.27e-3)"	"unprognostic (4.88e-2)"	0.6	1.4	0.6	0.5	0.6	0.0	0.4	0.3	2.0	0.8	0.7	0.4	0.3	0.5	0.0	0.8	1.0	0.0	0.1	0.3	0.8	11.6	0.3	2.4	0.0	0.7	0.3	0.2	0.1	0.3	0.1	1.4	0.0	0.8	0.7	0.0	0.0	0.3	0.0	0.1	0.1	1.4	0.4	0.2	6.6	3.0	0.2	0.4	0.0	0.5	0.0	0.0	1.1	0.6	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.3	0.1	0.0	3.2	0.3	0.0	0.1	0.0	0.0	0.2	1.8	0.0	0.0	0.1	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.6	0.6	0.3	2.0	0.3	0.8	0.7	0.3	0.2	0.8	0.2	0.4	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.3	0.3	0.9	2.8	0.0	198.6	0.0	0.1	1.3	0.3	0.0	0.1	0.1	1.5	0.4	0.2	0.0	0.0	0.0	0.0	0.2	2.5	1.1	1.4	0.0	0.4	0.4	0.5	0.3	0.0	0.1	0.2	0.0	0.3	0.0	0.5	0.3	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.6	1.8	0.0	0.0	0.0	0.8	0.0	0.8	0.1	0.1	0.0	0.4	2.5	0.3	0.9	0.3	0.0	0.0	0.6	0.8	0.2	0.4
PTGES2	"C9orf15, FLJ14038"	ENSG00000148334	"Prostaglandin E synthase 2"	Q9H7Z7	9	128120693-128128462	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 118.9"	"Cell type enriched"	"Detected in all"	4	"Cardiomyocytes: 700.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020631, HPA020733"	Approved		Approved	Mitochondria		No	No			Mitochondria		"HPA020631: AB_1855887, HPA020733: AB_2670508"	"unprognostic (1.23e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.68e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.10e-2)"	"unprognostic (2.81e-2)"	"unprognostic (4.33e-2)"	"prognostic favorable (5.83e-7)"	"unprognostic (2.10e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-1)"	15.5	50.2	27.5	15.7	30.0	6.6	16.2	25.0	46.2	17.8	26.5	27.5	27.8	21.8	4.1	35.6	17.7	11.5	81.5	31.1	28.8	36.6	38.0	15.0	17.7	28.2	29.5	29.3	16.3	37.9	35.6	41.7	9.8	29.0	24.8	9.3	10.1	26.3	17.0	118.9	19.9	24.0	7.6	22.8	21.3	29.8	14.6	28.0	12.0	23.7	79.4	9.8	22.5	22.2	29.6	46.1	114.0	15.5	54.4	13.5	12.8	47.9	30.7	20.6	48.6	24.9	86.9	75.6	43.5	45.7	15.9	36.9	108.8	22.5	47.1	6.5	28.3	62.3	21.0	92.7	79.5	41.0	42.1	39.5	18.6	32.3	39.5	26.9	14.2	31.6	47.8	50.2	26.4	16.7	130.0	56.9	75.6	42.7	58.7	113.9	39.6	26.5	111.6	32.8	33.1	69.1	45.6	47.3	86.3	34.2	6.7	78.7	23.5	34.0	46.3	50.2	62.8	63.1	48.9	25.5	38.3	39.1	33.2	44.5	1.4	3.3	0.7	3.1	3.7	3.8	3.8	2.2	3.5	4.3	2.7	2.4	3.0	0.6	2.7	1.8	5.8	3.1	1.9	27.5	30.0	25.0	46.2	31.1	28.8	28.2	29.5	29.3	29.0	22.8	28.0	29.6	18.8	16.0	6.4	10.4	32.0	22.9	38.1	32.7	25.0	37.8	34.2	36.3	700.2	51.5	25.9	23.9	20.9	82.1	30.8	86.1	146.8	74.6	2.1	12.7	20.9	29.4	45.1	13.2	15.5	51.8	62.1	32.7	46.4	17.3	14.7	31.9	13.9	37.8	57.6	37.0	15.8	62.2	46.8	25.3	43.6	4.8	30.7	30.8	56.9	3.7	105.7	21.9	38.1	12.1	7.2	57.6	60.4	21.8	45.4	68.0	93.4	99.3	9.3	44.8	19.7	17.8	37.2	3.6	45.6	48.3	24.6	66.6	25.6	84.1	105.5	52.9
PTP4A1	"PRL-1, PRL1, PTPCAAX1"	ENSG00000112245	"Protein tyrosine phosphatase 4A1"	Q93096	6	63521746-63583436	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle"	"Developmental protein, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 497.8"	"Cell type enriched"	"Detected in all"	4	"Late spermatids: 3071.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 533.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA003281	Approved					NA	NA					"HPA003281: AB_1855903"	"unprognostic (8.63e-2)"	"prognostic unfavorable (5.53e-4)"	"unprognostic (9.05e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.71e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.28e-2)"	"unprognostic (2.33e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.07e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.11e-2)"	32.6	141.9	29.2	37.8	33.5	229.4	31.7	34.9	36.3	41.8	32.8	108.9	55.6	44.2	15.4	53.9	34.9	59.4	28.8	29.7	96.0	51.0	497.8	55.3	24.6	37.7	36.8	27.3	55.2	70.0	16.2	41.4	73.1	37.1	44.6	111.1	22.7	68.8	21.2	302.4	54.9	51.2	57.1	40.7	19.6	55.7	62.9	32.5	26.4	39.6	114.0	24.8	52.1	33.8	49.7	71.5	122.9	106.2	128.3	85.8	77.2	239.1	113.9	97.6	58.4	79.2	103.5	45.4	65.1	50.6	88.7	95.7	41.8	97.0	197.9	94.3	61.0	51.6	43.8	320.2	533.9	175.7	118.6	57.7	91.3	383.6	124.7	320.5	63.5	80.3	65.0	106.1	148.7	151.5	140.9	52.4	69.1	50.6	91.0	53.7	70.9	53.4	60.5	132.4	120.6	44.7	62.5	278.5	71.8	140.1	156.9	59.8	122.0	77.5	132.9	130.6	89.5	122.3	90.7	94.9	121.7	60.9	72.5	154.1	45.4	20.4	15.1	12.8	21.3	20.1	12.9	14.5	14.3	17.2	10.7	12.8	12.9	48.4	16.3	16.6	9.1	18.8	15.4	29.2	33.5	34.9	36.3	29.7	96.0	37.7	36.8	27.3	37.1	40.7	32.5	49.7	33.3	22.4	90.3	4.6	105.4	681.3	268.7	94.1	261.8	22.3	98.4	55.4	78.5	207.3	83.0	75.4	16.7	248.7	99.8	336.5	80.3	186.9	716.1	189.8	68.8	47.0	129.6	30.9	11.7	193.9	215.1	90.8	178.4	279.5	63.0	41.2	41.4	528.8	98.6	11.8	9.9	253.4	63.1	71.6	236.5	3071.4	28.6	99.7	170.7	5.6	47.4	22.0	15.5	9.5	20.4	151.8	196.9	24.0	110.6	166.4	181.3	112.1	61.2	24.6	6.6	44.4	110.2	47.2	26.3	181.8	641.0	459.6	123.4	79.1	214.6	164.1
PTPRZ1	"phosphacan, PTP18, PTPRZ, PTPZ, RPTPB"	ENSG00000106278	"Protein tyrosine phosphatase receptor type Z1"	P23471	7	121873089-122062036	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 89.2;skin 1: 32.1"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocyte precursor cells: 2714.3"	"Cancer enriched"	"Detected in many"	14	"glioma: 175.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"AF22: 425.5;NTERA-2: 126.3;WM-115: 193.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015103	Enhanced		Approved	Vesicles,Cytosol	"Secreted in brain"	NA	NA		3400000	Cytosol	Vesicles	"HPA015103: AB_1855946"	"unprognostic (8.49e-4)"	"unprognostic (3.96e-3)"	"unprognostic (4.11e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.18e-2)"	"unprognostic (2.41e-2)"	"unprognostic (8.30e-3)"	"unprognostic (3.78e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.53e-1)"	"unprognostic (9.17e-4)"	"unprognostic (1.83e-1)"	"unprognostic (8.72e-6)"	"unprognostic (2.00e-1)"	"unprognostic (2.16e-1)"	"unprognostic (8.77e-2)"	"prognostic unfavorable (9.36e-4)"	0.8	1.6	66.2	1.2	59.7	0.0	4.0	62.2	89.2	1.4	24.6	3.1	0.6	0.1	0.8	8.0	0.3	0.7	0.8	67.8	73.2	0.1	0.1	1.2	0.0	63.2	60.3	51.9	0.8	2.8	0.0	2.3	0.2	61.6	1.0	1.2	19.2	3.4	0.7	0.1	32.1	1.0	1.3	59.8	1.0	13.9	0.3	63.4	0.2	0.1	0.3	2.6	0.9	2.4	74.9	0.1	0.0	425.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.1	0.0	27.7	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	126.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	5.4	15.2	0.1	0.0	0.0	0.1	0.0	0.0	0.7	10.9	5.6	0.0	0.6	0.0	193.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	66.2	59.7	62.2	89.2	67.8	73.2	63.2	60.3	51.9	61.6	59.8	63.4	74.9	0.1	0.0	1.5	625.2	0.2	25.2	8.6	82.2	44.9	18.3	5.6	12.2	1.3	0.0	39.7	0.0	4.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.0	0.0	37.7	0.7	0.1	1.3	9.2	0.0	0.0	10.1	0.0	0.0	0.1	65.6	72.0	0.0	0.0	0.0	1.6	0.7	0.3	0.1	19.6	22.5	0.0	90.4	0.0	2714.3	3.6	0.9	0.3	0.0	1.2	1.8	0.0	0.1	16.9	6.6	0.0	1.2	1.7	0.1	1.6	14.8	21.5	0.3	0.2	0.5	0.0	7.8
QSOX1	QSCN6	ENSG00000116260	"Quiescin sulfhydryl oxidase 1"	O00391	1	180154869-180204030	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"Extravillous trophoblasts: 1616.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 1918.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056243			Supported	"Golgi apparatus,Vesicles"	"Secreted to extracellular matrix"	NA	NA		2600000000	"Golgi apparatus"	Vesicles	"HPA056243: AB_2683077"	"unprognostic (1.13e-1)"	"unprognostic (2.62e-3)"	"unprognostic (2.46e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.94e-1)"	"unprognostic (3.12e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.80e-3)"	"prognostic unfavorable (1.86e-5)"	"unprognostic (3.25e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.40e-1)"	66.1	85.6	39.7	52.5	41.6	116.5	53.7	45.1	47.6	73.5	42.8	88.6	68.1	75.8	70.8	179.8	83.0	151.6	191.2	43.3	44.6	68.2	82.3	201.7	16.4	52.2	43.6	36.8	197.8	137.5	21.1	60.6	160.2	45.3	93.1	81.7	15.3	106.5	58.0	91.9	54.3	86.5	60.6	48.9	62.4	179.7	174.3	46.5	12.2	32.2	46.4	19.7	175.6	109.6	59.6	441.4	62.0	14.8	181.0	179.1	367.8	712.5	456.5	456.6	381.6	267.1	7.3	137.7	6.8	276.7	367.8	52.6	93.7	17.6	123.5	185.0	26.4	28.0	14.1	33.6	19.4	1918.6	48.6	129.2	197.9	55.5	408.0	484.3	499.9	569.4	32.1	20.2	66.3	255.3	76.4	10.4	89.7	49.4	302.6	174.6	19.7	33.0	11.8	63.1	123.6	51.9	52.6	133.8	179.8	91.9	32.2	33.0	226.3	678.3	473.8	187.5	322.0	392.9	48.3	84.4	12.2	180.9	153.9	146.0	16.2	53.1	20.6	14.0	29.9	10.2	5.4	9.1	9.6	39.2	3.2	8.1	8.0	40.2	16.9	28.6	8.0	11.5	28.6	39.7	41.6	45.1	47.6	43.3	44.6	52.2	43.6	36.8	45.3	48.9	46.5	59.6	36.6	57.7	101.6	8.5	7.7	13.8	27.4	81.2	7.4	11.5	86.2	47.9	48.3	51.5	112.5	71.7	25.0	19.5	10.7	138.1	0.0	230.4	49.2	49.2	19.4	41.7	46.2	6.9	17.2	130.1	1616.7	78.0	136.6	80.4	25.4	27.1	89.3	4.3	68.6	6.7	17.0	185.7	132.2	45.2	35.3	20.1	177.7	48.9	44.4	8.4	49.7	53.5	10.3	24.6	23.9	249.8	165.6	71.1	12.8	35.7	9.0	9.1	47.8	6.7	32.9	13.6	31.3	30.2	32.7	10.2	9.9	154.3	13.9	13.9	89.9	68.0
RAB11FIP3	"eferin, KIAA0665, Rab11-FIP3"	ENSG00000090565	"RAB11 family interacting protein 3"	O75154	16	425649-523011	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 147.9"	"Cell type enriched"	"Detected in many"	5	"Proximal tubular cells: 384.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028088, HPA028631, HPA030086"	Enhanced		Enhanced	"Nucleoplasm,Vesicles,Cytokinetic bridge,Centriolar satellite,Mitochondria"		Yes	No			"Vesicles, Centriolar satellite"	"Nucleoplasm, Cytokinetic bridge, Mitochondria"	"HPA028088: AB_10601672, HPA028631: AB_10601853, HPA030086: AB_10669596"	"unprognostic (6.65e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.22e-4)"	"unprognostic (2.87e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (9.87e-5)"	"unprognostic (6.71e-2)"	"unprognostic (4.74e-1)"	"unprognostic (9.66e-2)"	"prognostic favorable (3.16e-5)"	"unprognostic (1.12e-1)"	"prognostic favorable (7.99e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.44e-1)"	23.9	32.6	17.1	5.3	18.0	7.0	19.7	18.2	22.8	27.8	7.6	28.9	9.1	31.6	5.5	12.4	27.8	7.5	31.3	21.0	13.5	147.9	37.6	25.4	5.9	13.6	14.2	17.2	34.1	47.8	16.0	41.8	6.5	15.6	30.1	3.1	6.2	19.5	7.9	52.6	19.1	27.7	7.2	11.4	26.6	22.4	34.8	16.4	5.3	25.0	16.0	3.2	32.0	20.1	18.6	5.9	14.9	14.6	11.9	20.2	13.2	10.0	10.6	11.6	10.7	7.6	11.5	3.0	15.3	11.0	18.7	8.9	5.5	8.9	13.4	3.9	10.8	14.9	7.9	14.8	31.7	20.9	9.5	8.6	12.7	8.8	11.6	9.9	11.7	17.3	10.7	3.5	6.0	14.4	22.5	10.2	15.9	11.7	5.0	6.8	22.8	10.8	4.6	11.3	4.0	13.8	12.0	11.5	13.6	7.5	5.0	7.6	13.9	29.9	14.8	8.8	13.6	7.0	6.9	6.7	18.8	6.5	5.8	11.7	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	17.1	18.0	18.2	22.8	21.0	13.5	13.6	14.2	17.2	15.6	11.4	16.4	18.6	9.4	3.2	1.7	36.9	3.8	3.7	0.7	1.1	2.2	7.7	3.5	4.3	12.4	7.2	4.3	5.5	6.2	1.0	5.7	5.9	27.4	1.6	1.2	6.4	8.7	7.1	3.0	1.7	73.5	1.2	0.2	5.5	2.0	13.1	1.3	8.4	17.9	15.9	0.8	21.9	60.3	3.0	0.0	3.7	1.6	2.6	0.6	4.7	0.0	19.7	0.6	7.2	2.1	46.8	40.7	1.4	3.9	1.9	3.4	0.9	8.1	384.2	3.1	7.6	6.6	5.3	5.4	4.0	2.8	0.3	2.3	0.8	4.4	6.1	5.9	0.3
RABIF	"mss4, RASGRF3"	ENSG00000183155	"RAB interacting factor"	P47224	1	202878282-202889149	"Predicted intracellular proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Late spermatids: 3764.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027715	Approved					NA	NA					"HPA027715: AB_10602151"	"unprognostic (4.87e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (1.70e-1)"	"unprognostic (5.62e-3)"	"prognostic favorable (5.64e-5)"	"unprognostic (4.40e-2)"	"unprognostic (2.94e-1)"	"prognostic unfavorable (2.61e-5)"	"unprognostic (1.23e-1)"	"unprognostic (5.21e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.47e-1)"	3.7	3.9	6.3	5.7	7.0	8.4	4.0	6.1	8.5	4.1	4.9	5.5	5.7	3.4	3.9	9.0	3.0	4.1	4.2	7.1	7.0	5.6	5.3	4.8	6.8	6.5	6.2	6.6	2.0	3.3	3.2	4.0	4.9	6.8	4.2	6.0	6.9	4.8	3.2	4.9	5.5	5.4	4.8	6.3	6.3	3.8	18.1	6.8	5.7	3.1	4.4	8.7	5.1	4.9	7.8	11.7	12.2	8.8	10.6	13.4	9.9	9.5	12.9	7.1	12.8	11.8	8.9	9.9	9.6	6.0	10.0	8.8	10.9	6.9	8.0	9.7	11.8	12.7	7.9	9.8	9.1	10.8	11.1	13.4	8.5	11.2	16.0	4.1	6.3	16.9	12.4	12.7	10.3	12.5	19.5	12.5	12.0	7.2	9.1	15.1	8.7	12.3	13.2	13.2	12.2	12.3	11.0	11.0	19.1	10.4	10.6	12.6	8.1	13.3	8.9	8.2	4.3	11.2	5.4	13.0	10.1	8.8	10.3	8.5	32.4	21.1	31.6	18.4	23.2	13.5	17.8	17.3	17.4	19.0	17.8	15.6	16.5	33.3	17.9	22.0	18.1	21.1	18.3	6.3	7.0	6.1	8.5	7.1	7.0	6.5	6.2	6.6	6.8	6.3	6.8	7.8	11.8	0.0	15.9	4.6	26.2	54.3	37.8	53.3	17.6	5.4	18.9	12.3	11.2	17.2	33.8	12.9	2.1	52.5	39.1	42.4	15.6	37.3	696.1	17.9	8.5	20.6	23.4	21.2	9.0	53.4	50.5	16.6	13.7	14.5	12.7	8.0	20.3	34.9	42.1	1.7	7.0	14.7	40.7	37.4	36.0	3764.0	28.3	29.1	53.4	5.6	48.4	18.2	62.8	5.5	7.3	77.5	40.9	30.1	27.1	28.2	34.3	59.1	32.0	6.0	13.1	9.5	21.7	98.0	62.7	23.4	51.9	78.9	35.0	10.8	14.6	49.2
RANBP3L	FLJ25422	ENSG00000164188	"RAN binding protein 3 like"	Q86VV4	5	36246913-36302114	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.3;kidney: 24.8"	"Cell type enriched"	"Detected in some"	7	"Astrocytes: 355.9"	"Group enriched"	"Detected in some"	5	"breast cancer: 1.4;glioma: 3.7;prostate cancer: 4.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"ASC diff: 12.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA037471, HPA037472, HPA061526"	Approved		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA037471: AB_10671756, HPA037472: AB_2675489, HPA061526: AB_2684552"	"unprognostic (1.19e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.41e-3)"	"unprognostic (5.52e-3)"	"unprognostic (2.85e-1)"	"unprognostic (2.35e-3)"	"unprognostic (1.08e-2)"	"unprognostic (9.56e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.76e-4)"	"unprognostic (1.68e-2)"	"unprognostic (9.13e-2)"	"unprognostic (8.87e-3)"	"unprognostic (5.71e-2)"	3.8	1.7	26.6	0.3	25.6	0.0	7.6	6.3	32.3	1.2	7.8	0.6	0.2	0.7	1.8	0.5	1.2	1.9	1.5	26.8	13.2	24.8	9.9	2.0	0.2	13.5	15.7	17.4	2.1	0.4	0.2	2.9	5.1	15.1	13.6	0.4	5.3	0.6	3.0	0.4	0.3	0.4	0.6	12.0	0.2	1.8	4.8	18.5	0.1	2.2	3.0	0.6	6.9	0.8	16.8	0.0	0.0	0.1	0.2	12.1	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.6	25.6	6.3	32.3	26.8	13.2	13.5	15.7	17.4	15.1	12.0	18.5	16.8	0.3	0.0	0.0	355.9	0.0	0.0	0.1	0.0	0.6	0.4	4.1	2.3	0.3	0.0	0.0	9.2	0.0	0.0	1.3	0.0	46.9	0.0	0.1	0.1	0.7	0.4	0.0	0.0	5.1	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.4	1.3	1.9	0.0	4.5	0.0	0.0	0.0	0.3	0.8	2.1	0.2	1.8	23.4	0.0	16.1	0.0	5.5	2.8	0.0	0.0	2.2	0.0	1.3	0.0	0.2	0.0	0.6	13.1	0.6	8.3	0.0	0.1	0.0	0.0	0.1	0.0	3.0	0.0	0.1
RANGAP1	"Fug1, KIAA1835, SD"	ENSG00000100401	"Ran GTPase activating protein 1"	P46060	22	41244779-41286187	"Plasma proteins, Predicted intracellular proteins, Transporters"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"Late spermatids: 1717.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004293, HPA050110, HPA062034"	Supported		Enhanced	"Nuclear membrane,Vesicles,Cytosol"		Yes	Yes		75000	"Nuclear membrane"	"Vesicles, Cytosol"	"CAB004293: AB_2176987, HPA050110: AB_2681018, HPA062034: AB_2684667"	"unprognostic (1.30e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.97e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (8.28e-3)"	"unprognostic (8.09e-2)"	"unprognostic (9.87e-2)"	"unprognostic (5.84e-2)"	"unprognostic (7.56e-2)"	"unprognostic (7.07e-3)"	"prognostic favorable (5.39e-4)"	"unprognostic (2.06e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.68e-1)"	26.1	73.5	92.7	26.3	82.4	48.6	29.9	70.1	120.8	28.9	61.4	28.5	18.2	25.1	12.1	80.4	23.8	17.3	38.3	97.8	82.9	43.8	88.7	42.0	30.9	101.8	81.6	81.0	32.7	61.5	12.8	57.8	23.0	112.4	39.6	13.3	33.0	38.3	17.8	43.3	94.5	30.8	17.7	75.7	42.7	39.9	179.5	87.8	40.8	34.7	14.4	32.1	35.0	45.8	111.7	228.0	112.2	75.9	77.3	38.8	31.4	85.9	194.5	103.8	182.8	98.4	135.9	71.9	118.0	154.0	137.4	94.8	203.0	135.5	145.4	125.2	95.7	199.2	103.3	115.0	107.9	46.7	171.6	72.5	30.0	69.5	132.2	123.4	67.6	102.1	45.0	127.7	83.3	111.9	186.1	96.3	130.0	84.5	217.6	127.6	118.8	73.4	126.0	72.5	123.7	66.6	44.1	139.1	117.7	71.7	74.6	72.2	64.4	146.5	141.7	138.5	78.6	154.6	60.1	92.8	124.2	99.3	119.3	82.0	2.7	7.6	6.9	8.1	9.0	9.5	5.9	8.2	7.8	5.6	6.4	7.4	5.9	2.0	5.9	12.9	5.9	9.5	8.2	92.7	82.4	70.1	120.8	97.8	82.9	101.8	81.6	81.0	112.4	75.7	87.8	111.7	10.9	3.2	20.9	8.5	15.0	23.1	22.2	10.9	18.2	16.0	22.4	16.9	19.6	25.8	9.6	9.2	14.6	22.7	20.3	22.9	3.9	33.3	270.7	21.0	14.7	16.1	25.0	16.6	28.3	20.3	35.3	13.3	25.5	25.1	6.3	74.4	8.9	21.8	16.6	15.2	20.8	19.1	16.2	13.9	20.9	1717.0	14.9	16.8	12.4	5.6	8.9	10.1	14.4	6.0	32.2	39.8	5.7	12.0	25.8	37.4	7.1	13.1	11.4	26.4	0.0	6.8	18.2	25.6	17.7	38.8	31.0	23.7	24.3	42.5	24.8	23.3
RBM20		ENSG00000203867	"RNA binding motif protein 20"	Q5T481	10	110644336-110839468	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 41.1;pancreas: 20.4;skeletal muscle: 15.7"	"Cell type enriched"	"Detected in many"	8	"Cardiomyocytes: 151.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 6.0;HEL: 5.2;K-562: 5.0;RH-30: 16.2;SH-SY5Y: 15.0;SuSa: 4.9;T-47d: 9.2"	"Low region specificity"	"Detected in single"							"HPA035806, HPA070358"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytokinetic bridge"		Yes	No			"Nucleoplasm, Golgi apparatus"	"Nucleoli, Cytokinetic bridge"	"HPA035806: AB_10672097, HPA070358: "	"unprognostic (2.43e-1)"	"unprognostic (8.24e-3)"	"unprognostic (5.81e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.75e-2)"	"unprognostic (5.47e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.78e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.39e-3)"	"unprognostic (3.34e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.46e-2)"	1.1	0.1	0.8	0.2	2.1	0.1	2.5	0.5	0.8	1.4	1.7	3.0	0.1	2.9	0.6	5.6	2.6	0.4	41.1	0.8	0.7	0.7	0.1	0.9	0.1	1.2	0.9	0.4	2.8	20.4	1.2	1.7	1.7	1.1	1.4	0.5	1.2	7.3	0.7	15.7	1.1	0.8	2.2	0.4	0.1	1.0	0.8	0.7	0.5	1.0	3.8	0.6	1.0	5.6	0.7	0.0	1.6	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.1	0.1	0.0	0.0	2.5	6.0	5.2	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	1.4	0.0	16.2	0.0	0.0	0.0	0.1	15.0	0.1	0.0	0.6	4.9	9.2	0.0	0.0	0.3	0.5	0.0	0.0	0.4	0.1	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.1	0.5	0.8	0.8	0.7	1.2	0.9	0.4	1.1	0.4	0.7	0.7	0.3	0.0	0.0	0.7	0.2	0.1	0.2	0.4	1.2	1.4	0.8	0.5	151.5	0.0	0.1	0.0	2.1	1.6	0.0	0.7	1.9	0.0	0.8	0.5	1.2	1.5	0.0	0.0	14.8	0.2	0.2	3.3	0.0	0.1	0.0	14.6	1.4	0.0	0.1	0.0	15.4	0.7	2.0	0.0	0.0	0.8	4.4	0.0	0.0	17.8	0.0	0.1	0.0	1.5	0.6	0.0	0.1	13.5	1.0	0.0	2.0	1.5	12.4	2.7	6.6	3.7	5.4	0.5	0.8	3.7	0.0	3.1	0.2	1.7	0.2	0.3
RBP5	CRBPIII	ENSG00000139194	"Retinol binding protein 5"	P82980	12	7115736-7128889	"Plasma proteins, Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 435.6;liver: 326.8"	"Cell type enriched"	"Detected in many"	8	"Proximal tubular cells: 3197.2"	"Group enriched"	"Detected in all"	8	"liver cancer: 70.1;renal cancer: 126.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 6.0;Hep G2: 13.4;K-562: 26.3"									HPA038723	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	Vesicles	"HPA038723: AB_2676175"	"unprognostic (5.70e-3)"	"unprognostic (7.34e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.39e-3)"	"unprognostic (2.49e-2)"	"prognostic favorable (8.37e-4)"	"unprognostic (1.04e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.83e-2)"	"unprognostic (3.33e-2)"	"unprognostic (4.22e-1)"	"prognostic favorable (3.68e-4)"	5.5	11.8	0.1	15.1	0.1	1.6	5.2	0.2	0.3	9.8	0.5	6.2	4.7	8.7	3.2	3.9	8.2	6.0	1.3	0.0	0.8	435.6	326.8	3.8	31.4	0.5	0.2	0.0	5.0	5.2	1.4	6.2	0.3	0.3	10.1	5.0	0.8	3.7	5.0	0.7	2.4	20.8	5.4	0.0	97.9	5.3	2.2	0.2	14.3	8.0	0.0	21.6	7.5	4.6	0.7	0.9	1.3	0.0	0.3	0.0	0.0	0.2	1.1	0.0	0.0	0.2	1.1	1.2	1.0	0.3	0.0	0.1	1.2	0.1	0.0	0.0	1.6	0.0	6.0	3.9	13.4	0.0	0.2	0.9	0.2	0.0	0.0	0.0	2.4	0.0	0.6	26.3	0.7	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.2	0.0	0.1	0.1	1.2	0.0	0.2	1.4	0.9	0.0	0.6	0.5	0.7	0.7	0.6	0.5	2.8	0.4	0.3	0.1	0.0	0.3	1.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.2	0.3	0.0	0.8	0.5	0.2	0.0	0.3	0.0	0.2	0.7	4.9	0.0	0.6	0.7	15.2	1.5	0.5	0.1	0.0	1.2	1.3	1.3	0.1	5.7	0.1	80.9	0.0	0.1	0.3	0.1	352.1	0.2	4.1	0.3	1.7	28.8	0.0	0.0	2.1	0.4	0.0	8.2	0.0	0.5	0.0	0.2	8.9	361.1	0.1	5.0	1.1	0.0	0.0	8.1	2.6	6.7	2.5	16.6	0.0	1.9	0.0	1.4	0.0	0.5	0.1	0.2	0.0	0.4	0.1	0.5	0.0	3197.2	0.9	1.7	0.0	0.1	4.3	0.7	0.4	0.2	2.3	0.0	7.3	2.4	0.1	0.3
RBPMS2		ENSG00000166831	"RNA binding protein, mRNA processing factor 2"	Q6ZRY4	15	64739891-64775589	"Predicted intracellular proteins"		"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 268.0"	"Cell type enriched"	"Detected in many"	4	"Cardiomyocytes: 215.3"	"Cancer enriched"	"Detected in all"	4	"testis cancer: 37.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 39.0;AN3-CA: 55.4;HEL: 86.2;NTERA-2: 76.4;SuSa: 86.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.68e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.07e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.51e-2)"	"unprognostic (6.41e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.47e-2)"	"prognostic favorable (1.48e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.68e-3)"	20.1	4.9	4.8	6.7	4.7	1.6	12.6	2.4	4.7	17.3	13.2	105.3	6.0	53.6	7.5	20.5	31.0	10.0	268.0	3.3	3.7	17.7	14.0	7.7	1.0	3.6	4.6	2.2	10.6	2.7	16.7	4.1	7.7	2.8	27.7	8.2	2.0	2.5	46.3	5.6	4.1	30.4	37.9	2.2	4.4	52.4	6.4	8.8	2.5	13.9	5.0	0.6	94.8	14.5	2.9	0.0	6.3	39.0	55.4	0.0	0.0	5.9	1.2	0.2	7.0	1.6	4.9	0.5	0.0	5.2	1.1	6.5	0.0	28.8	0.0	2.6	0.0	9.0	86.2	9.5	9.9	3.7	0.0	0.7	0.1	0.0	4.4	0.0	1.5	0.7	1.9	0.5	0.0	0.5	2.9	0.0	0.3	76.4	0.0	0.0	2.2	0.0	0.0	0.1	0.0	0.1	13.5	8.5	0.1	1.6	86.5	7.9	0.3	0.0	0.0	28.4	3.7	3.7	0.4	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	4.8	4.7	2.4	4.7	3.3	3.7	3.6	4.6	2.2	2.8	2.2	8.8	2.9	3.1	0.0	0.0	0.0	1.1	0.8	0.3	0.0	0.6	0.3	0.5	0.5	215.3	0.0	0.0	3.7	0.0	0.6	2.0	0.0	9.8	0.4	4.7	0.4	3.4	6.4	0.0	7.4	0.3	1.6	1.1	11.1	5.1	0.7	0.0	0.9	2.9	8.5	0.3	0.0	0.2	0.0	0.0	1.3	1.3	1.0	3.7	10.4	1.8	1.0	0.2	3.3	9.2	0.0	0.0	1.2	0.0	6.4	0.0	1.5	0.0	31.0	0.0	1.7	46.0	1.7	51.0	0.8	14.1	0.3	1.1	3.1	0.7	1.0	0.0	0.2
RCC1	CHC1	ENSG00000180198	"Regulator of chromosome condensation 1"	P18754	1	28505943-28539300	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"DNA-binding, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Late spermatids: 789.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015413, HPA027573, HPA027574"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA		47000	Nucleoplasm	"Nuclear membrane"	"CAB015413: AB_831160, HPA027573: AB_10599303, HPA027574: AB_10601236"	"unprognostic (6.23e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (1.91e-5)"	"unprognostic (3.93e-2)"	"unprognostic (2.03e-3)"	"unprognostic (1.53e-1)"	"unprognostic (5.79e-3)"	"unprognostic (8.50e-2)"	"prognostic unfavorable (2.43e-11)"	"unprognostic (1.04e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.02e-1)"	"unprognostic (6.23e-2)"	12.7	12.2	6.4	31.3	6.4	59.0	17.4	7.4	7.6	14.8	7.0	24.7	27.4	14.4	10.4	32.4	19.1	13.0	6.4	6.5	7.3	7.8	24.1	12.4	37.7	7.4	6.5	5.7	16.2	16.2	5.8	3.8	17.8	7.6	11.0	28.4	6.1	20.8	9.3	13.4	14.7	23.6	19.4	8.0	16.2	18.7	58.3	7.7	44.7	11.8	8.1	38.3	23.8	15.9	10.0	263.2	109.7	94.8	112.9	68.4	86.5	106.2	100.2	60.2	158.5	122.9	111.9	206.2	331.0	60.0	99.2	65.3	155.0	306.6	158.1	125.1	133.7	185.0	295.0	140.0	147.2	51.6	329.0	171.5	111.6	106.0	150.0	125.6	100.7	110.6	194.5	222.8	101.1	66.0	140.8	260.5	118.0	205.3	117.8	106.4	252.9	163.3	164.0	60.5	119.9	150.6	76.7	105.3	171.5	87.6	52.7	72.6	99.8	84.5	81.6	162.5	102.0	198.2	60.9	91.2	248.8	80.5	469.7	89.5	5.1	7.7	3.3	5.0	7.9	9.4	7.1	7.8	8.2	14.0	7.2	6.8	7.6	1.8	5.9	5.7	7.7	7.6	6.3	6.4	6.4	7.4	7.6	6.5	7.3	7.4	6.5	5.7	7.6	8.0	7.7	10.0	8.9	0.0	10.3	2.0	57.4	36.7	12.4	13.6	92.2	0.8	18.9	15.4	4.6	5.7	16.2	7.3	2.1	25.6	10.7	10.7	3.9	34.0	176.5	12.7	21.1	16.6	5.4	118.1	4.5	23.7	43.5	17.4	68.8	17.4	1.3	14.8	2.9	6.6	20.8	13.5	5.0	16.0	12.2	11.3	20.0	789.4	17.1	21.3	14.2	1.9	16.6	0.5	15.5	2.0	2.9	39.5	7.0	10.5	75.5	21.6	9.6	5.7	14.1	0.3	6.6	15.0	16.6	19.2	18.4	185.3	33.8	24.5	31.7	12.5	25.0	18.4
REELD1		ENSG00000250673	"Reeler domain containing 1"	A0A1B0GV85	4	146214515-146230878	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	5	"Respiratory ciliated cells: 1.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	88	"HDLM-2: 9.6"					"Low region specificity"	"Detected in single"									NA	NA						"unprognostic (6.26e-3)"	"unprognostic (1.40e-1)"		"unprognostic (3.81e-2)"	"unprognostic (8.94e-2)"	"unprognostic (3.77e-2)"	"unprognostic (7.75e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.55e-6)"	"unprognostic (2.19e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.90e-1)"	"unprognostic (3.13e-2)"	0.6	0.2	0.2	0.2	0.3	0.1	0.7	0.3	0.5	0.3	0.2	0.1	0.0	0.2	0.3	0.1	0.5	0.0	0.3	0.3	0.3	0.5	0.6	0.4	0.0	0.3	0.3	0.3	0.2	0.4	0.0	0.1	0.0	0.5	0.6	0.0	0.4	0.3	0.0	0.4	0.5	0.6	0.0	0.3	1.3	0.2	0.5	0.3	0.0	0.2	0.0	0.2	0.3	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.3	0.5	0.3	0.3	0.3	0.3	0.3	0.5	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0
RFESD		ENSG00000175449	"Rieske Fe-S domain containing"	Q8TAC1	5	95646754-95684773	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 27.1"	"Cell type enriched"	"Detected in many"	7	"Erythroid cells: 278.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 41.3;K-562: 78.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB016546	Uncertain		Approved	Nucleoplasm		NA	NA		48000	Nucleoplasm		"CAB016546: AB_630417"	"unprognostic (1.15e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.37e-2)"	"unprognostic (6.07e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.91e-2)"	"unprognostic (8.24e-3)"	"unprognostic (4.89e-2)"	"unprognostic (5.83e-3)"	"unprognostic (6.78e-2)"	"unprognostic (9.03e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.09e-1)"	1.6	2.3	1.5	1.2	1.8	27.1	2.9	2.2	3.4	2.2	1.8	1.5	1.2	2.0	4.5	2.4	2.0	1.2	3.2	1.6	2.0	2.4	2.5	1.5	3.1	1.9	1.8	1.5	2.9	3.6	3.9	2.8	1.6	1.9	3.1	1.5	3.6	4.8	1.5	5.8	7.7	1.4	1.4	1.7	2.4	2.5	12.3	1.8	4.9	3.3	3.5	3.3	2.3	1.9	2.3	3.6	5.5	1.0	3.5	3.4	6.2	0.0	1.9	2.9	3.1	3.1	4.4	3.8	5.8	3.8	1.6	7.3	5.2	3.8	3.0	3.3	8.7	3.3	41.3	5.2	1.6	4.3	3.8	4.2	2.8	5.5	4.0	3.6	2.8	3.1	17.1	78.3	4.5	4.9	2.4	12.4	16.4	4.4	1.6	5.2	6.0	0.7	2.6	1.1	2.1	5.3	3.8	5.4	2.4	0.0	0.3	2.8	2.0	1.6	3.9	3.1	2.9	3.4	3.9	10.1	4.7	3.4	4.5	2.1	0.0	0.7	0.4	3.6	0.9	9.6	3.9	8.7	6.2	1.6	3.3	12.7	7.5	0.0	6.1	0.9	1.9	5.4	2.7	1.5	1.8	2.2	3.4	1.6	2.0	1.9	1.8	1.5	1.9	1.7	1.8	2.3	2.0	12.8	3.3	1.6	2.8	3.2	4.5	6.0	3.4	2.1	2.3	3.4	7.8	0.0	5.5	1.8	0.0	3.5	4.2	0.5	1.9	2.4	18.2	2.3	2.4	1.4	0.0	278.7	1.6	1.8	12.1	3.2	2.0	1.8	3.8	2.0	2.9	2.1	3.8	1.7	1.9	1.1	14.2	1.6	0.8	8.5	1.8	1.2	0.0	2.8	2.3	3.8	3.1	0.0	1.7	1.7	0.3	1.2	1.0	2.5	0.9	2.9	5.3	1.9	6.6	2.8	2.7	37.2	14.3	4.5	6.8	2.1	4.6	2.5	1.2	2.5
RGPD3	RGP3	ENSG00000153165	"RANBP2 like and GRIP domain containing 3"	A6NKT7	2	106391290-106468413	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 7.0"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 19.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HEL: 1.5;MOLT-4: 4.6;RPMI-8226: 1.4"									"HPA049497, HPA051675, HPA067564"	Uncertain		Approved	"Nuclear membrane,Vesicles"		NA	NA			"Nuclear membrane, Vesicles"		"HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862"	"unprognostic (2.91e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.51e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.86e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.70e-1)"	"unprognostic (3.44e-1)"	"unprognostic (4.74e-3)"	"unprognostic (5.05e-2)"	"unprognostic (3.70e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.34e-1)"	0.2	0.1	0.4	0.1	0.4	0.4	0.2	0.4	0.6	0.1	0.8	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.4	0.4	0.7	0.7	0.2	0.1	0.8	0.6	0.4	0.2	0.2	0.2	0.5	0.2	1.1	0.2	0.1	1.0	0.2	0.2	0.2	0.3	0.1	0.1	0.4	0.6	0.1	7.0	0.6	1.9	0.2	0.1	0.2	0.3	0.1	0.8	0.1	0.2	0.2	0.2	0.1	0.2	0.1	0.2	0.2	0.1	0.1	0.2	0.0	0.0	0.1	0.1	0.5	0.1	0.6	0.1	0.2	0.1	0.0	1.5	0.2	0.2	0.1	0.0	0.0	0.0	0.1	0.5	0.1	0.1	0.1	0.4	0.3	0.0	0.2	0.1	4.6	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.1	0.3	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.4	0.4	0.6	0.4	0.4	0.8	0.6	0.4	1.1	0.4	0.6	0.8	0.0	0.0	1.1	1.6	0.1	0.1	0.1	0.0	0.0	1.6	0.0	0.0	2.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.1	0.1	0.5	0.0	0.0	2.4	0.2	0.0	0.4	0.0	0.1	1.3	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.3	4.4	0.0	0.1	0.0	1.9	0.0	0.0	0.0	2.0	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.7	0.2	0.0	0.0	0.4	3.2	1.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0
RGS18	RGS13	ENSG00000150681	"Regulator of G protein signaling 18"	Q9NS28	1	192158462-192185815	"Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 13.3;lymphoid tissue: 25.7"	"Cell type enriched"	"Detected in some"	4	"Macrophages: 527.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 353.1"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 353.1"	"Group enriched"	"Detected in some"	5	"HEL: 60.2;HL-60: 46.7;NB-4: 43.6;U-937: 39.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA028727, HPA045780"	Uncertain		Approved	"Golgi apparatus"		NA	NA		340000	"Golgi apparatus"		"HPA028727: AB_2797219, HPA045780: AB_10962728"	"unprognostic (3.09e-2)"	"unprognostic (4.32e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.30e-3)"	"unprognostic (8.21e-3)"	"unprognostic (2.81e-4)"	"unprognostic (1.73e-2)"	"unprognostic (9.91e-2)"	4.3	2.3	0.6	14.2	0.8	13.3	2.4	0.9	0.8	2.4	1.1	2.5	2.9	1.0	0.5	1.9	1.3	5.4	0.8	0.6	1.1	1.0	5.4	4.1	8.5	1.5	1.0	0.4	0.8	0.8	0.4	0.3	2.2	1.4	1.1	2.9	0.6	0.7	1.0	0.9	0.4	5.8	2.9	1.3	25.7	1.9	0.4	0.9	4.3	0.8	3.2	4.4	4.8	0.4	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.2	0.0	0.0	0.0	46.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	2.7	0.0	0.0	0.0	43.6	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	39.9	0.0	195.5	50.7	353.1	0.8	66.7	6.8	0.1	0.8	1.3	51.0	0.2	0.1	0.2	164.8	0.6	82.1	12.0	0.0	94.4	0.6	0.8	0.9	0.8	0.6	1.1	1.5	1.0	0.4	1.4	1.3	0.9	1.6	0.3	6.4	0.0	0.0	2.9	0.3	0.0	0.0	0.0	0.0	0.2	0.6	0.4	0.0	1.8	0.0	0.0	0.0	22.5	0.0	0.0	0.0	0.1	0.0	0.0	3.3	0.0	16.0	0.0	0.0	0.0	0.8	0.0	0.0	24.7	0.0	5.7	1.1	7.3	0.0	0.0	0.0	0.0	124.9	27.3	0.8	0.3	527.4	0.0	15.9	128.3	0.1	28.8	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.3	1.5	0.3	13.1	0.3	0.1	0.1	0.2	0.1	0.1	0.1	7.6	0.0	0.1	0.0
RGS20	"RGSZ1, ZGAP1"	ENSG00000147509	"Regulator of G protein signaling 20"	O76081	8	53851795-53959303	"Plasma proteins, Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.4;retina: 4.9"	"Cell type enriched"	"Detected in some"	7	"Astrocytes: 238.6"	"Cancer enhanced"	"Detected in many"		"melanoma: 12.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 27.7;SK-MEL-30: 30.4;U-87 MG: 28.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070193	Enhanced					NA	NA					"HPA070193: AB_2732150"	"unprognostic (2.14e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.91e-5)"	"unprognostic (5.03e-5)"	"unprognostic (2.15e-1)"	"unprognostic (1.57e-2)"	"unprognostic (8.86e-3)"	"unprognostic (5.28e-2)"	"unprognostic (2.75e-8)"	"unprognostic (3.71e-3)"	"unprognostic (9.78e-3)"	"unprognostic (8.32e-2)"	"unprognostic (1.69e-2)"	0.1	0.0	6.7	0.0	9.7	0.0	0.1	4.9	11.4	0.4	2.4	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	6.5	5.1	0.0	0.0	0.0	0.0	5.3	3.5	6.3	0.0	0.0	0.0	0.1	1.2	5.1	0.0	0.0	4.9	0.3	0.0	0.0	2.2	0.0	0.0	3.6	0.0	0.0	0.1	4.1	0.0	1.3	0.0	0.2	0.0	1.0	6.4	14.6	10.1	19.3	0.3	0.7	2.3	0.0	7.9	4.6	6.7	4.0	0.0	8.8	0.0	0.4	2.2	27.7	10.6	0.4	12.8	4.5	0.0	1.5	2.5	1.5	1.7	3.1	0.0	0.9	0.4	8.1	5.5	16.0	14.9	2.6	0.0	0.7	0.0	11.3	0.0	0.0	0.4	0.3	2.1	4.0	0.0	0.6	0.0	12.9	0.9	12.0	1.1	0.6	0.0	30.4	2.8	0.0	0.1	8.5	1.7	0.0	14.4	5.9	2.4	0.0	0.0	28.9	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	9.7	4.9	11.4	6.5	5.1	5.3	3.5	6.3	5.1	3.6	4.1	6.4	0.2	0.0	0.0	238.6	0.1	2.0	0.5	10.9	0.6	1.3	0.2	0.0	0.8	0.0	2.7	0.0	31.3	0.7	0.0	0.1	0.0	0.6	0.5	4.2	1.0	0.2	0.0	0.0	3.2	0.4	0.8	0.6	0.0	5.5	0.0	0.0	0.0	0.0	0.2	0.0	6.0	0.0	4.1	0.0	0.0	0.0	0.3	0.1	5.4	9.4	0.0	5.5	0.0	5.0	0.7	1.3	0.0	0.0	0.0	5.1	0.0	0.0	2.6	13.7	0.0	0.1	0.5	0.1	1.3	0.4	0.4	0.7	0.1	0.0	0.0	0.6
RGS21		ENSG00000253148	"Regulator of G protein signaling 21"	Q2M5E4	1	192316992-192367285	"Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"Early spermatids: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA052843	Uncertain					NA	NA					"HPA052843: AB_2681971"																		0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RNF182	MGC33993	ENSG00000180537	"Ring finger protein 182"	Q8N6D2	6	13924446-13980310	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.2;choroid plexus: 11.9"	"Cell type enriched"	"Detected in some"	4	"Astrocytes: 85.2"	"Cancer enhanced"	"Detected in many"		"glioma: 5.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 81.3;RPTEC TERT1: 67.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012309	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Nucleoplasm, Golgi apparatus"	Vesicles	"HPA012309: AB_1856349"	"unprognostic (1.29e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (4.66e-5)"	"unprognostic (6.16e-2)"	"unprognostic (2.08e-1)"	"unprognostic (9.01e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.21e-1)"	"unprognostic (6.04e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.05e-1)"	"unprognostic (9.33e-5)"	"unprognostic (6.66e-3)"	"unprognostic (1.33e-3)"	"unprognostic (1.26e-1)"	1.0	0.1	12.4	0.1	13.8	8.5	0.6	22.7	17.9	0.6	11.9	0.2	0.2	0.6	1.1	0.3	1.2	0.2	0.3	16.8	13.0	1.1	0.0	3.3	0.2	17.0	17.6	8.5	0.3	1.7	5.9	1.8	1.3	16.9	0.4	0.1	8.9	1.3	2.1	0.2	0.4	0.3	0.3	13.8	0.2	0.2	3.7	24.2	1.5	1.3	0.1	0.0	0.3	0.4	14.1	0.2	6.5	12.0	0.0	4.1	5.0	0.7	6.3	8.6	17.0	16.4	0.3	0.1	0.0	0.1	6.8	18.5	0.0	14.3	0.1	30.9	0.0	4.7	0.4	81.3	0.0	0.0	0.1	0.0	2.8	0.0	26.3	0.2	19.5	0.3	3.5	0.5	0.0	11.9	0.2	0.1	2.2	6.9	0.1	23.9	3.8	2.9	1.0	67.3	0.0	14.2	13.7	0.6	0.0	24.8	4.4	0.0	2.4	6.5	20.7	4.4	0.2	14.3	0.0	0.0	0.0	14.1	0.0	30.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	13.8	22.7	17.9	16.8	13.0	17.0	17.6	8.5	16.9	13.8	24.2	14.1	0.2	0.0	0.0	85.2	0.1	0.3	0.1	0.0	0.0	19.3	0.2	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.6	0.4	0.1	0.2	0.0	9.7	8.6	0.0	0.1	0.4	0.0	0.1	0.0	5.4	0.0	0.1	0.1	15.2	1.5	0.1	0.0	0.0	0.3	1.4	0.3	0.0	0.0	5.6	0.0	14.7	0.0	2.5	0.4	0.1	0.0	0.0	0.0	0.1	0.0	1.1	0.1	1.3	6.6	0.0	1.3	5.7	3.2	0.0	0.0	0.3	0.3	0.0	0.1	0.1
RTL9	"KIAA1318, Mar9, Mart9, RGAG1, SIRH10"	ENSG00000243978	"Retrotransposon Gag like 9"	Q8NET4	X	110358816-110456334	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.6;testis: 10.4"	"Cell type enriched"	"Detected in single"	6	"Theca cells: 6.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 2.0;U-2197: 1.5;U-87 MG: 1.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA001242	Enhanced					NA	NA					"HPA001242: AB_1079804"	"unprognostic (6.03e-2)"	"unprognostic (5.59e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.85e-4)"	"unprognostic (8.17e-2)"	"unprognostic (3.04e-1)"	"unprognostic (9.65e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.45e-2)"	"unprognostic (8.05e-3)"	"unprognostic (1.03e-1)"	"unprognostic (7.61e-3)"	"unprognostic (6.98e-4)"	"unprognostic (2.02e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.10e-2)"	0.1	0.1	0.4	0.0	0.8	0.0	0.0	0.5	0.8	0.0	2.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.2	1.5	0.0	0.2	0.0	0.0	0.7	2.6	0.4	0.8	0.0	0.0	0.2	0.7	2.2	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	10.4	1.1	0.1	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.5	0.3	0.2	0.7	0.1	0.0	0.0	0.3	0.8	0.1	0.0	0.1	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	2.0	0.3	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.2	1.5	0.5	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.5	0.8	0.2	1.5	0.7	2.6	0.4	2.2	0.0	1.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0
RXFP2	"GPR106, GREAT, INSL3R, LGR8, RXFPR2"	ENSG00000133105	"Relaxin family peptide receptor 2"	Q8WXD0	13	31739526-31803389	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	7	"Early spermatids: 8.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	10	"classical monocyte: 1.7"	"Lineage enriched"	"Detected in single"	18	"monocytes: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	10	"basal ganglia: 2.6"							NA	NA																					"unprognostic (1.77e-2)"		0.0	0.5	0.0	0.0	0.5	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.1	0.4	0.2	0.0	0.3	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RXFP4	"GPCR142, GPR100, RLN3R2, RXFPR4"	ENSG00000173080	"Relaxin family peptide/INSL5 receptor 4"	Q8TDU9	1	155941638-155943087	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.9;intestine: 1.8"	"Cell type enriched"	"Detected in some"	21	"Enteroendocrine cells: 58.3"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 2.4"	"Region enhanced"	"Detected in single"		"cerebellum: 1.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (4.90e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.19e-1)"	"unprognostic (5.94e-2)"	"unprognostic (3.17e-2)"	"unprognostic (4.73e-2)"	"unprognostic (2.87e-1)"	"unprognostic (8.33e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.86e-2)"	0.0	0.0	0.0	0.2	0.2	0.6	0.0	1.9	0.2	0.0	0.0	1.8	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.2	1.9	0.2	0.0	0.0	0.3	0.2	0.0	0.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	58.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1
S100A1	"S100-alpha, S100A"	ENSG00000160678	"S100 calcium binding protein A1"	P23297	1	153627926-153632039	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 3105.8;skeletal muscle: 3089.2;tongue: 4955.1"	"Cell type enriched"	"Detected in many"	4	"Proximal tubular cells: 1848.3"	"Group enriched"	"Detected in all"	5	"melanoma: 210.5;ovarian cancer: 110.1;thyroid cancer: 123.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"Hep G2: 325.8;SK-MEL-30: 1130.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002599, HPA006462"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		290000	Cytosol	"Nucleoplasm, Golgi apparatus"	"CAB002599: AB_2315307, HPA006462: AB_1079857"	"unprognostic (6.13e-2)"	"unprognostic (7.60e-2)"	"unprognostic (5.96e-5)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.34e-3)"	"unprognostic (6.83e-3)"	"unprognostic (5.22e-1)"	"unprognostic (5.04e-3)"	"unprognostic (9.62e-2)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (1.68e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.70e-3)"	"unprognostic (9.74e-4)"	181.3	8.3	724.3	6.5	774.6	2.3	78.0	766.5	960.2	2.4	564.9	11.2	11.2	4.2	1.0	81.7	42.1	4.9	3105.8	695.3	710.4	192.2	4.5	4.0	5.1	844.2	800.4	660.0	2.0	16.9	162.4	55.1	18.2	802.7	29.2	1.2	36.8	627.5	9.4	3089.2	22.5	7.0	1.7	813.2	4.3	23.3	6.0	811.0	9.5	169.4	4955.1	4.0	4.4	3.0	920.4	6.0	3.4	3.9	33.7	0.5	0.2	2.9	7.7	0.2	0.6	0.2	6.6	3.4	3.7	137.7	0.6	2.7	10.3	0.3	0.4	0.0	4.2	3.3	8.2	5.4	325.8	0.4	3.0	2.3	0.7	0.0	0.0	0.1	7.9	0.0	1.5	27.2	3.7	0.1	10.6	1.2	4.9	1.8	4.3	2.6	22.5	3.3	8.0	6.0	12.1	6.1	1.9	3.5	10.6	1130.2	11.1	32.8	16.2	2.7	3.3	2.8	3.0	3.8	6.1	5.7	6.2	2.5	6.2	2.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	724.3	774.6	766.5	960.2	695.3	710.4	844.2	800.4	660.0	802.7	813.2	811.0	920.4	4.3	0.0	0.0	59.4	9.5	9.7	1.2	0.4	1.8	1.1	369.9	354.1	74.4	8.6	0.2	154.5	2.1	1.1	5.9	1.1	162.4	0.9	0.6	90.5	17.3	5.3	1.8	0.0	0.3	3.7	1.9	6.0	0.0	193.3	0.0	0.0	7.9	4.7	199.1	0.0	0.3	3.7	0.0	0.6	3.5	2.2	6.5	15.6	341.5	2.8	0.0	163.5	0.0	2.0	45.8	1.9	0.6	9.1	0.0	1.8	0.9	1848.3	0.2	2.7	0.0	67.0	4.2	3.8	2.8	1.0	2.3	3.4	8.2	2.3	1.8	0.7
SALL4	"dJ1112F19.1, ZNF797"	ENSG00000101115	"Spalt like transcription factor 4"	Q9UJQ4	20	51782331-51802521	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease variant, Oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 4.0;thyroid gland: 5.9"	"Cell type enriched"	"Detected in some"	4	"Horizontal cells: 26.9"	"Cancer enriched"	"Detected in many"	11	"testis cancer: 22.7"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	9	"NK-cell: 2.5"	"Lineage enriched"	"Detected in single"	9	"NK-cells: 2.5"	"Cell line enhanced"	"Detected in some"		"AF22: 25.0;AN3-CA: 17.5;BEWO: 33.2;NTERA-2: 60.2;SiHa: 15.6;SuSa: 39.7"	"Not detected"	"Not detected"							"HPA015291, HPA015791"	Enhanced		Enhanced	Nucleoplasm		Yes	No			Nucleoplasm		"HPA015291: AB_1856548, HPA015791: AB_1856547"	"unprognostic (1.30e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.09e-3)"	"unprognostic (3.55e-2)"	"unprognostic (7.43e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.23e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.42e-8)"	"unprognostic (5.90e-3)"	"unprognostic (1.82e-1)"	"unprognostic (5.00e-5)"	"unprognostic (7.41e-2)"	0.2	0.3	0.2	0.2	0.2	0.8	0.2	0.3	0.2	0.1	0.2	0.1	0.1	0.2	0.4	0.2	0.2	0.0	0.1	0.2	0.3	0.4	1.6	0.2	0.1	0.2	0.2	0.2	0.1	2.1	2.0	0.5	0.2	0.2	2.5	0.2	0.5	0.9	0.2	0.1	0.2	0.4	0.1	0.1	0.6	0.2	4.0	0.2	0.0	5.9	0.0	0.1	0.4	0.1	0.4	0.0	1.7	25.0	17.5	0.0	0.1	33.2	0.0	0.2	0.1	0.3	9.0	0.2	0.0	0.3	0.3	0.3	4.3	0.2	0.1	0.3	0.4	0.0	0.0	7.0	0.4	0.1	0.0	1.9	0.7	0.5	0.1	0.1	0.0	0.4	0.0	0.0	0.1	0.0	1.8	0.0	0.1	60.2	0.2	0.4	2.3	0.0	0.0	0.0	0.5	5.7	3.1	15.6	0.1	1.5	39.7	0.1	1.0	0.0	0.9	3.3	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.1	0.2	0.4	0.1	0.0	2.0	1.6	0.0	0.0	1.1	0.1	0.0	0.4	0.3	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	3.6	0.0	0.2	0.1	0.2	1.2	0.0	4.1	0.2	0.0	0.4	0.0	0.4	0.0	0.2	0.0	0.6	0.2	26.9	3.5	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	4.7	0.0	0.2	1.0	2.0	2.0	0.2	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.4	0.0	0.2	0.2	0.7	5.5	0.0	0.0	0.0	0.0	0.1	0.0	1.2
SAMD11	MGC45873	ENSG00000187634	"Sterile alpha motif domain containing 11"	Q96NU1	1	923923-944575	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	6	"Rod photoreceptor cells: 266.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	11	"NK-cell: 1.3"	"Lineage enriched"	"Detected in single"	11	"NK-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"HEK 293: 87.6;HeLa: 142.1;SCLC-21H: 71.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA030110			Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA030110: "	"unprognostic (9.96e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.28e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (3.35e-5)"	"unprognostic (3.01e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.18e-1)"	2.1	9.1	4.0	3.3	4.0	1.0	1.8	5.9	6.5	6.7	8.3	4.9	5.1	9.7	9.5	2.0	17.8	3.3	7.4	5.1	10.5	14.2	4.3	3.9	2.1	22.5	8.7	2.1	3.3	1.5	1.6	27.8	0.3	9.6	17.1	1.2	24.7	2.0	19.7	0.8	0.7	5.5	4.2	9.0	17.2	4.9	4.8	6.5	0.1	4.8	0.3	0.4	14.2	7.9	9.4	0.3	8.0	0.1	7.4	0.4	0.1	2.0	9.2	0.5	0.6	0.3	0.4	2.4	0.0	19.0	26.0	5.1	15.3	8.8	0.0	0.0	0.8	87.6	0.0	142.1	0.4	1.9	0.0	0.9	5.3	0.0	0.1	0.0	12.1	0.0	0.2	3.5	0.0	0.2	8.4	0.0	0.1	3.8	0.5	0.8	0.7	1.4	5.6	1.2	0.0	71.1	20.9	23.8	12.3	0.2	6.1	12.8	0.5	1.4	3.8	14.4	0.2	2.6	1.3	0.0	0.3	5.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	4.0	4.0	5.9	6.5	5.1	10.5	22.5	8.7	2.1	9.6	9.0	6.5	9.4	0.1	0.0	1.8	12.1	0.3	0.4	0.1	0.3	0.6	25.5	0.7	0.4	0.9	2.8	1.9	3.7	29.2	0.2	0.1	0.2	0.0	1.0	3.9	20.1	43.9	6.1	26.5	0.0	0.1	0.4	0.9	17.0	2.0	6.4	0.0	3.8	4.6	0.2	0.3	35.3	0.2	1.0	0.0	0.6	0.0	12.1	0.9	0.7	0.0	1.0	0.0	25.8	0.0	0.0	0.1	1.6	2.6	4.1	0.4	2.1	0.0	0.3	0.1	266.9	0.0	0.2	4.1	1.5	26.0	0.1	0.6	0.1	0.6	0.0	0.2	0.3
SAMD14	FLJ36890	ENSG00000167100	"Sterile alpha motif domain containing 14"	Q8IZD0	17	50110040-50130160	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.3"	"Cell type enriched"	"Detected in many"	4	"Bipolar cells: 56.1"	"Cancer enhanced"	"Detected in some"		"glioma: 3.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 12.7;HEL: 8.6;HMC-1: 28.0;SH-SY5Y: 12.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051916	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA051916: AB_2681662"	"unprognostic (2.33e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.31e-1)"	"unprognostic (8.84e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.93e-2)"	"unprognostic (4.00e-2)"	"unprognostic (9.01e-2)"	"unprognostic (7.48e-4)"	0.9	1.4	14.0	0.8	11.9	0.3	0.5	17.3	14.6	1.4	0.0	0.9	0.2	3.2	0.8	0.5	0.5	0.3	1.1	14.4	9.1	3.1	0.8	6.1	0.3	8.9	7.6	9.2	1.3	0.2	0.7	3.4	0.7	9.5	3.0	0.1	1.3	0.1	0.7	1.4	0.3	0.9	0.4	4.2	1.7	1.1	2.1	8.7	0.1	0.9	0.5	0.5	1.8	1.1	8.0	0.0	0.2	4.2	0.0	1.1	0.3	0.0	3.0	1.1	0.1	0.0	0.6	0.0	0.1	4.1	1.3	0.0	0.1	0.3	0.0	0.1	12.7	0.1	8.6	0.3	0.0	0.7	0.0	28.0	0.4	0.0	0.0	0.0	0.6	0.7	0.0	0.3	0.3	0.0	0.0	0.1	0.7	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.1	4.4	12.9	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.6	1.6	0.3	0.1	0.2	0.0	0.1	2.2	0.1	1.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	11.9	17.3	14.6	14.4	9.1	8.9	7.6	9.2	9.5	4.2	8.7	8.0	0.6	0.0	0.5	6.2	0.0	0.4	0.1	0.2	0.6	56.1	0.2	0.3	1.1	0.0	0.0	1.8	0.0	0.1	0.1	0.0	0.0	0.2	3.1	0.0	1.4	6.1	12.7	2.7	8.3	0.4	0.2	2.3	0.5	0.1	2.5	0.1	8.2	0.3	0.1	11.8	7.2	0.3	0.0	0.6	1.0	2.2	1.5	5.7	0.0	1.0	2.0	2.2	0.0	2.5	0.4	0.2	0.1	3.4	0.2	0.0	0.3	1.1	0.0	4.6	0.0	0.1	2.8	1.5	1.1	0.2	0.1	0.4	0.2	0.7	0.1	0.1
SAPCD1	"C6orf26, NG23"	ENSG00000228727	"Suppressor APC domain containing 1"	Q5SSQ6	6	31762996-31764851	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 21.7"	"Cell type enriched"	"Detected in single"	15	"Respiratory ciliated cells: 1.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 1.4;U-2 OS: 1.1;U-937: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA071699			Approved	"Vesicles,Cell Junctions"		NA	NA			Vesicles	"Cell Junctions"	"HPA071699: AB_2686433"	"unprognostic (9.25e-4)"	"unprognostic (1.32e-1)"	"unprognostic (3.41e-2)"	"unprognostic (3.28e-1)"	"unprognostic (9.34e-2)"	"unprognostic (8.02e-4)"	"unprognostic (1.63e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.16e-3)"	"unprognostic (1.56e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.15e-10)"	"unprognostic (2.65e-2)"	"unprognostic (4.45e-1)"	"unprognostic (3.57e-1)"	"unprognostic (7.98e-5)"	2.2	1.1	0.4	0.0	0.3	0.2	2.5	0.4	0.9	2.3	0.4	3.3	0.0	2.6	0.1	2.6	4.0	0.0	1.2	0.4	0.3	7.4	3.1	2.0	0.6	0.4	0.3	0.3	3.8	2.1	0.0	6.1	0.1	0.3	6.1	0.3	1.2	2.3	0.1	1.0	21.7	3.9	0.1	0.4	4.9	2.6	3.6	0.4	0.2	2.3	0.0	0.1	2.5	2.3	0.4	0.4	0.0	0.0	0.2	0.1	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.1	0.1	0.0	0.5	0.0	0.3	0.2	0.0	0.1	0.5	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.3	0.7	0.4	0.2	0.2	0.2	0.5	0.0	0.1	0.7	1.4	0.0	0.2	0.0	0.1	0.1	0.0	0.3	0.0	0.2	0.2	0.1	0.0	0.3	0.4	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.7	0.1	0.4	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.4	0.9	0.4	0.3	0.4	0.3	0.3	0.3	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SBK3	SgK110	ENSG00000231274	"SH3 domain binding kinase family member 3"	P0C264	19	55540656-55545543	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 27.9;tongue: 15.2"	"Cell type enriched"	"Detected in single"	5	"Cardiomyocytes: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 5.0;CACO-2: 1.8;CAPAN-2: 2.9;K-562: 1.2;NTERA-2: 1.3;RH-30: 2.2"	"Not detected"	"Not detected"							HPA078322			Approved	Mitochondria		NA	NA			Mitochondria		"HPA078322: AB_2732379"	"unprognostic (2.15e-1)"	"unprognostic (1.99e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.39e-3)"	"unprognostic (7.52e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.47e-5)"	"unprognostic (4.64e-3)"		"unprognostic (7.24e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.38e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.21e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.79e-1)"	2.5	0.0	0.1	0.1	0.0	0.0	1.0	0.3	0.1	0.2	0.2	0.1	0.4	0.2	0.0	2.0	0.2	0.3	27.9	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.0	0.2	0.2	0.0	0.0	0.5	0.0	6.6	0.2	0.2	0.2	0.1	0.0	0.4	0.2	0.1	0.0	0.5	15.2	0.0	0.3	0.1	0.2	0.0	5.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	1.8	2.9	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.5	0.0	0.0	1.3	0.0	0.3	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SBSN	"HLAR698, UNQ698"	ENSG00000189001	Suprabasin	Q6UWP8	19	35523367-35528351	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 1064.7;skin 1: 2395.8;vagina: 762.7"	"Cell type enriched"	"Detected in some"	11	"Suprabasal keratinocytes: 1017.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 355.2;melanoma: 153.1"	"Region enhanced"	"Detected in some"		"basal ganglia: 3.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 62.2;ASC TERT1: 107.5;HSkMC: 146.1;U-2197: 51.6;U-87 MG: 119.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA062568, HPA067734"	Enhanced		Approved	Vesicles	"Secreted - unknown location"	NA	NA		89000000	Vesicles		"HPA062568: AB_2684794, HPA067734: AB_2685894"	"unprognostic (1.10e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.23e-3)"	"unprognostic (3.45e-3)"	"unprognostic (2.56e-1)"	"unprognostic (4.83e-4)"	"unprognostic (4.31e-4)"	"unprognostic (6.97e-2)"	"unprognostic (9.08e-14)"	"unprognostic (6.37e-2)"	"unprognostic (6.51e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.36e-3)"	2.4	0.6	0.4	0.1	3.7	0.8	95.4	0.4	1.1	222.6	0.2	0.8	0.0	0.5	0.0	1064.7	0.2	0.3	1.3	0.5	0.6	0.4	1.7	0.9	0.0	0.8	0.4	0.5	0.7	1.6	0.0	0.9	0.3	0.6	0.6	0.0	0.0	354.6	0.0	13.2	2395.8	0.7	0.2	0.4	0.5	1.1	1.0	0.4	6.6	0.7	0.0	170.4	1.2	762.7	0.5	0.1	0.1	0.0	0.1	62.2	107.5	0.1	5.1	7.2	2.4	0.9	0.0	0.1	0.1	1.2	4.8	1.7	0.3	0.0	1.8	1.0	0.1	0.2	0.0	0.1	0.0	0.6	0.0	0.1	146.1	8.2	30.0	7.1	2.1	0.0	0.0	0.1	0.3	0.0	0.4	0.0	0.1	0.1	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.1	1.4	0.3	0.2	0.0	0.4	18.4	3.8	51.6	1.4	0.5	0.3	0.0	119.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.7	0.4	1.1	0.5	0.6	0.8	0.4	0.5	0.6	0.4	0.4	0.5	0.0	0.0	0.0	0.0	0.0	89.3	0.1	0.6	0.0	0.0	0.1	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	1.4	0.8	1.8	0.0	0.0	0.2	0.6	0.2	3.1	0.0	4.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	25.2	4.0	0.0	0.2	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.1	1.0	0.2	0.2	13.4	1017.6	0.3	0.7	0.0	0.0	0.4
SCART1	CD163c-alpha	ENSG00000214279	"Scavenger receptor family member expressed on T cells 1"	Q4G0T1	10	133453928-133523558	"Predicted membrane proteins"	Immunity			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 1.1"	"Cell type enriched"	"Detected in some"	4	"Cardiomyocytes: 7.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HMC-1: 3.7;NB-4: 3.6;THP-1: 1.1;U-266/84: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043101	Supported					NA	NA					"HPA043101: AB_10797026"	"unprognostic (4.32e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.40e-2)"	"unprognostic (7.42e-2)"	"unprognostic (8.20e-4)"	"unprognostic (1.29e-3)"	"unprognostic (4.28e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.24e-2)"	"unprognostic (6.24e-5)"	"unprognostic (8.53e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.94e-1)"	0.0	0.1	0.3	0.0	0.5	0.2	0.1	1.0	1.1	0.1	0.6	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.8	0.4	0.1	0.1	0.1	0.0	0.3	0.3	0.3	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.1	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.2	0.4	0.0	0.0	0.0	0.1	3.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	3.6	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.2	0.2	4.0	0.5	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	1.0	1.1	0.8	0.4	0.3	0.3	0.3	0.3	0.2	0.4	0.6	0.8	0.0	1.5	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.6	7.4	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.2	0.0	0.9	0.8	0.5	0.0	0.0	1.3	0.2	0.0	0.4	0.0	0.6	0.0	1.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	1.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.5	0.6	0.1	0.0
SCEL	"FLJ21667, MGC22531"	ENSG00000136155	Sciellin	O95171	13	77535674-77645263	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 388.6;skin 1: 305.2;vagina: 122.6"	"Cell type enriched"	"Detected in many"	12	"Alveolar cells type 1: 679.5"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 17.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 28.6;HaCaT: 54.6;HBEC3-KT: 25.3;OE19: 74.2;RPTEC TERT1: 107.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA039737, HPA040154"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA039737: AB_10805485, HPA040154: AB_10795359"	"unprognostic (1.18e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.00e-1)"	"prognostic unfavorable (4.07e-4)"	"unprognostic (5.91e-2)"	"unprognostic (4.54e-2)"		"unprognostic (6.62e-2)"	"unprognostic (3.51e-1)"	"unprognostic (8.08e-3)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (4.57e-2)"	"prognostic favorable (6.87e-4)"	"unprognostic (1.81e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.75e-3)"	"prognostic unfavorable (1.73e-5)"	1.7	0.1	0.0	0.1	0.1	0.1	19.7	0.1	0.1	33.5	0.0	1.2	0.0	0.1	0.1	388.6	0.4	0.1	0.1	0.0	0.0	0.4	0.1	60.4	0.0	0.1	0.2	0.0	0.2	0.2	0.3	0.5	0.8	0.2	0.1	2.0	0.1	58.3	0.0	1.5	305.2	0.1	0.0	0.0	0.0	0.6	2.4	0.1	0.5	2.2	0.0	77.4	0.1	122.6	0.2	16.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.6	0.0	1.8	0.0	0.0	54.6	0.0	25.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	74.2	14.9	0.0	0.0	0.0	107.2	0.0	2.5	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.1	0.2	0.1	679.5	31.6	0.0	0.0	10.7	0.1	12.9	0.0	0.0	0.0	0.0	0.2	0.0	49.7	0.0	0.0	0.3	0.0	0.7	0.0	3.2	6.6	0.7	0.1	0.2	0.0	0.0	0.2	0.2	0.0	2.0	0.0	1.0	1.3	0.0	0.0	0.0	0.0	0.0	0.6	7.8	8.2	0.0	1.1	20.9	0.0	0.3	1.8	0.0	0.0	1.6	0.0	1.0	1.7	45.5	0.2	0.0	0.0	0.1	0.0	0.1	7.1	0.0	0.0	0.0	1.2	7.9	5.0	48.8	55.8	0.1	0.3	0.8	0.1	2.7
SCG5	"7B2, SGNE1, SgV"	ENSG00000166922	"Secretogranin V"	P05408	15	32641676-32697098	"Predicted secreted proteins"	Transport	"Chaperone, Neuropeptide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 134.1;pituitary gland: 405.8"	"Cell type enriched"	"Detected in many"	4	"Enteroendocrine cells: 470.8"	"Group enriched"	"Detected in many"	5	"glioma: 38.2;pancreatic cancer: 82.9;thyroid cancer: 22.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 26.9;HSkMC: 33.5;NTERA-2: 15.3;SCLC-21H: 31.5;SH-SY5Y: 36.4;U-87 MG: 47.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013136, HPA074618"	Enhanced				"Secreted to blood"	NA	NA		100000			"HPA013136: AB_1856657, HPA074618: AB_2732262"	"unprognostic (1.71e-1)"	"unprognostic (9.87e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.59e-3)"	"prognostic unfavorable (9.64e-4)"	"unprognostic (2.69e-1)"	"unprognostic (1.27e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.62e-3)"	"unprognostic (3.92e-1)"	"prognostic unfavorable (4.51e-9)"	"unprognostic (3.57e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.08e-3)"	"unprognostic (8.88e-2)"	1.1	61.7	59.7	3.3	69.5	0.3	3.7	61.3	90.1	0.9	80.9	7.9	18.1	5.4	42.9	0.5	3.5	5.6	0.9	69.7	74.9	0.9	3.7	3.9	1.3	68.7	63.7	67.8	3.3	134.1	74.2	405.8	0.3	68.3	5.0	9.9	27.0	0.2	0.9	0.2	1.3	5.7	6.7	59.6	0.5	38.1	5.3	62.1	0.3	5.8	0.1	0.3	2.6	2.7	92.8	0.5	0.2	0.1	0.2	0.6	4.5	0.1	4.2	0.4	0.4	0.4	0.1	0.0	0.5	1.9	0.4	1.7	1.2	0.5	0.2	1.2	0.7	0.3	0.6	0.0	0.1	26.9	0.2	0.7	33.5	0.1	0.8	0.4	0.9	0.7	1.0	0.3	0.6	0.8	0.0	0.3	0.3	15.3	0.1	0.8	0.1	0.4	0.6	0.4	0.0	31.5	36.4	0.2	0.0	0.2	0.4	0.1	0.4	0.0	5.2	3.8	0.3	0.5	0.6	2.3	0.4	47.2	1.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.7	69.5	61.3	90.1	69.7	74.9	68.7	63.7	67.8	68.3	59.6	62.1	92.8	0.2	0.0	0.5	20.2	0.3	0.6	0.2	6.2	0.0	51.0	0.5	16.5	0.4	0.0	3.9	0.0	2.1	0.2	0.1	1.1	0.0	0.6	52.1	3.7	19.3	1.1	470.8	0.0	82.8	78.3	0.3	17.9	23.0	0.6	2.5	51.4	0.4	11.9	6.0	50.5	97.8	14.5	97.6	0.6	0.8	80.0	2.1	1.6	3.6	20.6	0.6	15.6	0.0	52.3	79.7	22.9	1.1	7.9	0.3	1.4	0.5	0.0	0.5	32.6	0.0	0.3	34.2	39.2	2.9	0.1	0.3	0.3	0.3	51.8	2.4	1.0
SCGB1C1	RYD5	ENSG00000188076	"Secretoglobin family 1C member 1"	Q8TD33	11	193078-194575	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.3;pancreas: 1.4;retina: 3.4;salivary gland: 1.1"	"Cell type enriched"	"Detected in single"	5	"Macrophages: 2.7"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.6"	"Region enhanced"	"Detected in single"		"pons: 1.3"	"Group enriched"	"Detected in some"	32	"basophil: 5.0;neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	50	"granulocytes: 5.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"												"Secreted - unknown location"	NA	NA															"unprognostic (5.09e-3)"								0.0	0.1	0.1	0.1	0.1	0.7	0.1	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.3	0.0	0.0	3.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	3.3	0.1	0.1	0.5	0.4	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	2.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SCGB1C2		ENSG00000268320	"Secretoglobin family 1C member 2"	P0DMR2	17	137569-139067	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pancreas: 1.5;retina: 1.0"	"Cell type enriched"	"Detected in some"	4	"Muller glia cells: 5.0"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in other tissues"	NA	NA															"unprognostic (4.65e-2)"								0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.1	0.0	0.9	0.0	0.0	0.1	5.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SCNN1G	"ENaCgamma, SCNEG"	ENSG00000166828	"Sodium channel epithelial 1 subunit gamma"	P51170	16	23182745-23216883	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Sodium transport, Taste, Transport"	"Ion channel, Sodium channel"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 42.8"	"Cell type enriched"	"Detected in some"	4	"Collecting duct cells: 90.1"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 15.6"	"Region enhanced"	"Detected in some"		"cerebellum: 3.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"hTCEpi: 46.8;RT4: 21.7"	"Region enriched"	"Detected in single"	13	"cerebellum: 2.5"	"Not detected"	"Not detected"			HPA071194			Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA071194: AB_2686359"	"unprognostic (2.90e-1)"	"unprognostic (5.21e-3)"	"unprognostic (5.79e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.92e-3)"	"unprognostic (1.71e-3)"		"unprognostic (1.97e-1)"	"unprognostic (4.85e-2)"	"unprognostic (7.84e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (3.20e-7)"	"unprognostic (2.80e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.17e-3)"	0.4	0.2	0.4	0.0	0.3	0.3	2.3	3.9	0.2	16.1	0.2	6.0	0.0	1.8	0.7	10.0	0.4	0.0	0.0	0.7	0.3	42.8	0.0	7.5	0.0	0.2	0.4	0.2	0.0	3.3	0.0	3.8	0.5	1.8	13.9	1.2	0.2	17.9	3.5	0.0	8.9	0.4	0.1	0.0	0.0	10.2	0.1	0.1	2.1	5.7	0.0	1.2	1.4	15.4	0.3	1.1	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	46.8	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	2.9	0.0	0.0	0.1	0.0	21.7	1.5	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.3	3.9	0.2	0.7	0.3	0.2	0.4	0.2	1.8	0.0	0.1	0.3	0.4	19.2	4.2	0.0	0.0	0.4	4.7	8.8	19.9	0.0	0.8	1.3	0.8	0.0	17.4	90.1	0.0	0.2	0.0	3.4	0.0	2.0	0.0	9.8	1.1	0.1	0.0	0.0	0.2	1.7	0.0	0.4	15.3	18.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	10.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.5	1.1	0.0	0.1	5.3	0.0	0.2	1.9	0.0	0.0	0.0	0.2	0.1	0.1	4.4	0.3	0.1	0.2	0.0	0.4	1.8
SELE	"CD62E, ELAM, ELAM1, ESEL"	ENSG00000007908	"Selectin E"	P16581	1	169722640-169764705	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"urinary bladder: 56.6"	"Cell type enriched"	"Detected in some"	4	"Endothelial cells: 379.5"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"hypothalamus: 7.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"HUVEC TERT2: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB002143	Enhanced					NA	NA	8140000	180000000			"CAB002143: AB_563608"	"unprognostic (2.39e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.94e-1)"	"unprognostic (3.63e-1)"	"unprognostic (3.88e-1)"	"unprognostic (9.74e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.13e-3)"	"unprognostic (4.69e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.55e-1)"	17.1	5.6	1.2	12.7	0.8	0.5	12.1	0.4	1.7	3.7	3.6	3.0	0.7	5.3	0.5	4.0	24.0	10.8	7.7	0.7	7.5	4.6	7.0	10.4	3.0	1.7	1.1	0.6	3.3	1.2	12.6	4.1	1.4	1.6	28.0	2.7	0.3	3.1	3.8	0.8	5.5	2.4	18.9	1.3	0.0	5.3	2.5	2.3	8.5	13.9	1.0	3.6	56.6	5.6	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.8	0.4	1.7	0.7	7.5	1.7	1.1	0.6	1.6	1.3	2.3	2.5	34.6	0.0	3.8	0.0	0.0	46.1	1.1	0.0	1.2	0.0	0.5	0.3	4.0	1.5	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.2	0.3	379.5	0.0	0.0	0.1	0.0	0.0	12.7	0.0	0.2	1.3	0.0	3.9	8.5	0.0	0.0	0.0	0.0	0.0	0.0	81.9	3.0	0.0	0.9	46.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	1.3	4.1	0.2	0.0	1.2	47.7	0.0	3.4	0.1	0.1	2.5
SEMA3G	"FLJ00014, sem2"	ENSG00000010319	"Semaphorin 3G"	Q9NS98	3	52433035-52445103	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 69.9;breast: 64.7"	"Cell type enriched"	"Detected in many"	6	"Adipocytes: 151.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	15	"T-reg: 1.4"	"Lineage enriched"	"Detected in single"	15	"T-cells: 1.4"	"Cell line enhanced"	"Detected in some"		"ASC diff: 26.1;Hep G2: 7.1;HUVEC TERT2: 7.4;THP-1: 6.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001761	Uncertain				"Secreted to blood"	NA	NA		5600000			"HPA001761: AB_1079902"	"unprognostic (2.10e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.85e-1)"	"unprognostic (5.79e-4)"	"unprognostic (5.20e-3)"	"unprognostic (9.14e-2)"	"unprognostic (5.54e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.14e-1)"	"prognostic favorable (8.86e-5)"	"unprognostic (5.63e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.14e-1)"	69.9	2.0	9.8	3.4	8.7	0.1	64.7	17.8	10.9	4.9	10.0	6.2	3.0	6.0	1.3	4.6	5.2	5.9	14.6	8.1	8.6	19.8	1.3	24.1	1.6	10.8	10.0	6.7	3.2	3.1	1.8	2.4	26.9	10.7	4.7	3.7	0.4	10.7	2.5	12.9	11.7	9.7	4.0	9.3	8.0	5.8	1.3	11.3	1.7	7.8	18.8	1.8	8.4	7.9	9.1	0.0	0.1	0.1	0.2	26.1	0.2	2.5	0.0	0.0	0.0	0.0	0.7	0.3	3.3	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	1.2	3.9	0.2	7.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	7.4	2.6	0.0	0.4	0.0	0.3	0.2	4.3	1.2	0.7	0.1	0.0	0.0	4.1	0.0	0.3	0.5	0.5	0.0	0.4	0.5	0.1	1.9	6.5	2.9	0.1	2.4	0.0	0.0	0.5	2.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	9.8	8.7	17.8	10.9	8.1	8.6	10.8	10.0	6.7	10.7	9.3	11.3	9.1	151.5	3.2	1.3	0.0	0.3	0.4	0.1	0.1	0.0	1.7	5.1	5.5	10.7	0.0	0.0	3.7	0.0	1.7	0.9	0.3	0.0	0.0	3.0	2.8	1.6	20.4	9.6	0.0	0.0	0.0	0.2	3.6	1.1	5.8	0.0	0.0	2.5	0.0	0.3	0.0	0.0	0.1	0.0	0.0	1.3	5.0	0.3	0.5	0.0	24.4	0.0	0.5	0.0	0.0	0.0	0.0	0.1	1.2	0.2	0.0	9.4	0.0	0.1	0.2	0.0	4.1	3.0	0.1	0.1	0.5	0.1	7.5	0.4	0.1	0.2	0.0
SEMA5A	"SEMAF, semF"	ENSG00000112902	"Semaphorin 5A"	Q13591	5	9035033-9546075	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.1"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocyte precursor cells: 1189.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	12	"plasmacytoid DC: 2.9"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 2.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 64.2;fHDF/TERT166: 37.1;RT4: 66.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004632	Approved					NA	NA		13000			"HPA004632: AB_1079905"	"unprognostic (1.48e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.40e-2)"	"unprognostic (6.67e-2)"	"unprognostic (3.65e-1)"	"prognostic favorable (2.45e-4)"	"unprognostic (7.02e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.10e-2)"	"unprognostic (8.15e-2)"	"prognostic favorable (3.66e-8)"	"unprognostic (8.51e-3)"	"unprognostic (1.27e-2)"	"unprognostic (3.57e-1)"	"unprognostic (3.01e-2)"	4.6	1.2	8.3	2.7	8.9	0.0	6.9	5.2	24.0	13.1	3.5	9.6	3.0	9.0	2.2	3.1	2.9	5.5	9.5	30.1	12.1	11.7	4.9	11.2	4.7	10.5	11.1	6.9	1.7	4.5	1.9	2.3	7.0	10.3	3.0	7.6	7.1	2.1	5.0	1.4	4.4	5.4	2.5	8.5	6.3	2.0	1.6	14.4	1.8	1.9	3.1	3.7	5.8	3.9	14.0	0.0	0.0	15.0	0.0	10.1	14.1	0.0	24.2	64.2	4.7	2.5	0.0	0.1	0.0	0.0	37.1	0.3	21.6	0.0	1.4	2.4	0.0	0.2	0.0	0.1	0.0	1.4	0.0	0.1	3.6	0.7	5.3	21.6	10.5	0.0	0.0	0.0	0.0	5.7	0.7	0.0	0.0	1.5	13.2	1.1	0.0	0.0	0.9	1.8	66.7	3.1	0.3	0.2	0.0	19.9	5.1	0.0	0.0	0.0	23.0	0.5	0.0	0.5	0.0	0.0	0.0	21.4	0.0	17.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	8.3	8.9	5.2	24.0	30.1	12.1	10.5	11.1	6.9	10.3	8.5	14.4	14.0	8.0	150.6	5.6	63.6	0.3	9.2	6.4	30.8	8.0	2.8	1.6	49.0	37.0	22.8	14.3	1.8	0.0	1.8	9.6	23.9	0.0	3.4	32.6	6.3	151.5	6.4	5.4	0.0	60.6	2.3	1.2	27.8	0.5	9.3	1.3	1.8	5.3	4.3	1.3	247.3	53.1	10.9	0.0	0.0	5.2	50.5	10.2	0.8	33.8	134.9	0.1	44.8	0.0	1189.7	152.3	1.2	8.0	14.7	0.0	8.2	16.9	14.4	2.0	3.6	39.5	4.3	40.5	0.6	0.5	11.4	4.8	1.9	1.4	29.0	20.5	14.1
SERF1B	"FAM2B, H4F5C"	ENSG00000205572	"Small EDRK-rich factor 1B"	O75920	5	70025247-70043113	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 155.6"	"Cell type enriched"	"Detected in some"	4	"Cardiomyocytes: 40.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 11.3"									HPA075271			Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA075271: AB_2686740"	"unprognostic (1.00e-1)"	"unprognostic (2.52e-4)"	"unprognostic (2.60e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.32e-1)"	"unprognostic (5.98e-2)"	"unprognostic (4.92e-3)"	"unprognostic (1.48e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.08e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.44e-2)"	"unprognostic (7.82e-2)"	"unprognostic (6.74e-2)"	"unprognostic (3.52e-1)"	26.1	27.3	0.6	1.6	1.3	1.7	30.6	1.4	3.2	34.1	0.2	41.6	0.7	32.2	0.5	28.8	25.7	1.0	39.3	1.3	1.8	32.3	15.0	30.8	2.1	0.8	1.7	0.7	27.3	27.9	1.4	38.3	1.0	2.4	30.7	1.2	11.5	25.3	2.1	46.9	21.6	31.1	3.0	1.0	23.5	28.6	155.6	1.3	1.3	34.0	1.2	1.6	28.5	32.7	0.9	2.6	0.7	4.1	6.0	3.8	1.5	1.1	1.0	1.8	1.7	3.7	0.6	3.0	3.1	11.3	1.1	3.8	1.3	2.6	1.9	1.6	8.0	0.9	3.0	1.3	1.6	1.5	0.1	2.9	1.2	5.3	1.9	0.3	1.3	1.7	0.9	1.2	2.5	0.5	0.2	4.7	2.1	3.6	0.0	0.4	2.4	6.3	5.0	1.3	1.5	7.8	5.1	2.7	0.1	3.7	1.8	2.6	1.1	6.3	1.6	1.8	1.0	1.7	2.0	3.4	3.5	1.6	0.2	3.2	0.3	0.2	1.8	4.1	1.5	4.8	3.3	5.9	2.9	2.9	6.3	7.0	4.9	0.5	2.6	1.5	4.6	2.8	1.9	0.6	1.3	1.4	3.2	1.3	1.8	0.8	1.7	0.7	2.4	1.0	1.3	0.9	0.4	9.6	2.2	0.0	1.0	0.4	0.7	0.3	1.2	0.1	0.5	0.5	40.3	0.0	3.2	0.0	2.1	0.1	0.4	0.6	1.9	0.2	1.6	0.3	0.7	4.4	0.0	0.4	0.0	0.0	0.1	3.4	0.0	0.2	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.7	1.0	1.8	0.2	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.1	1.1	5.2	1.4	0.0	0.5	8.8	1.6	0.6	0.9	0.6	0.0	0.7	0.1	0.4	0.4
SERPINB4	"LEUPIN, PI11, SCCA-2, SCCA1, SCCA2"	ENSG00000206073	"Serpin family B member 4"	P48594	18	63637259-63644256	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 94.1;vagina: 152.1"	"Cell type enriched"	"Detected in some"	4	"Basal respiratory cells: 3577.0"	"Group enriched"	"Detected in many"	5	"cervical cancer: 104.1;head and neck cancer: 29.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 2.2;HSkMC: 1.1;SiHa: 1.7;U-2197: 6.1"									"HPA048341, HPA049988, HPA055992"	Supported					NA	NA		10000000			"HPA048341: AB_2680364, HPA049988: AB_2680985, HPA055992: AB_2682998"		"unprognostic (8.81e-3)"				"unprognostic (9.43e-2)"		"unprognostic (8.96e-3)"	"unprognostic (4.38e-1)"	"unprognostic (1.63e-2)"	"prognostic unfavorable (5.48e-4)"	"unprognostic (2.46e-1)"		"unprognostic (4.37e-2)"			"unprognostic (1.27e-2)"	0.0	0.0	0.0	2.7	0.0	0.0	0.1	0.0	0.0	37.8	0.0	0.0	0.0	0.6	0.0	94.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	2.3	0.0	0.0	23.5	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.4	0.0	0.0	4.5	21.2	152.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	3577.0	0.0	0.0	0.0	0.0	0.0	0.0	825.8	0.0	0.0	0.0	0.0	0.0	0.0	23.9	1.4	0.1	0.1	0.2	0.0	0.0	0.0	21.7	0.2	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	97.6	0.0	0.0	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.3	0.0	0.0	0.0	32.4	0.0	0.3	53.0	0.0	0.0	0.0	10.7	0.1	0.0	14.8	0.0	0.8	0.0	0.0	0.0	60.5
SERPINB9	"CAP3, PI9"	ENSG00000170542	"Serpin family B member 9"	P50453	6	2887270-2903309	"Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 41.4;placenta: 52.7"	"Cell type enriched"	"Detected in many"	5	"Langerhans cells: 1527.7"	"Cancer enriched"	"Detected in all"	5	"testis cancer: 46.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 225.3;SuSa: 227.6;U-698: 98.8"					"Low region specificity"	"Detected in all"			HPA030067	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		3400000	Nucleoplasm	Cytosol	"HPA030067: AB_2673295"	"unprognostic (6.82e-3)"	"unprognostic (8.59e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.12e-2)"	"unprognostic (9.48e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.06e-1)"	"unprognostic (9.85e-2)"	"prognostic unfavorable (1.66e-6)"	"unprognostic (9.90e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.76e-2)"	9.6	11.1	6.0	35.7	7.0	19.1	5.3	7.3	8.0	6.4	5.9	5.3	4.4	4.5	3.1	9.3	8.3	11.4	7.5	6.3	11.2	5.3	16.5	26.6	41.3	8.6	7.6	4.9	3.0	2.4	6.8	8.9	52.7	9.2	5.2	6.5	4.8	4.4	2.8	2.4	2.4	10.8	5.9	8.0	28.4	5.0	8.7	7.8	13.9	7.7	1.8	41.4	17.1	7.5	8.5	0.2	9.8	0.3	0.1	0.7	0.3	225.3	1.9	0.5	2.3	3.4	2.9	18.8	38.2	22.8	2.1	0.1	0.1	27.6	0.0	2.0	12.4	2.7	3.8	3.3	5.5	12.9	0.0	0.1	10.1	0.1	4.1	0.0	0.2	50.2	3.4	17.8	0.3	1.9	0.9	0.0	0.3	31.7	0.1	0.1	3.7	0.1	0.4	1.6	0.1	1.5	0.5	22.7	0.1	0.0	227.6	0.1	0.6	52.5	0.0	0.4	0.1	0.1	0.2	49.5	98.8	0.0	0.1	0.1	4.7	48.6	0.3	43.6	100.8	36.3	22.4	31.3	41.7	16.1	24.9	28.7	41.4	7.6	51.3	62.7	17.0	35.7	37.9	6.0	7.0	7.3	8.0	6.3	11.2	8.6	7.6	4.9	9.2	8.0	7.8	8.5	26.2	19.2	17.6	12.1	105.1	35.3	2.2	4.2	1.8	1.5	13.8	6.7	5.3	1.5	12.1	5.5	0.0	83.1	100.8	4.7	0.0	15.8	1.0	68.0	10.8	44.1	15.5	11.6	21.4	0.2	143.7	35.6	3.6	82.2	46.3	2.2	66.4	7.1	17.9	8.4	23.1	2.7	2.0	59.6	1527.7	4.9	4.4	232.6	88.9	92.8	99.8	5.3	43.3	1.0	3.2	9.3	6.0	17.7	115.7	2.5	0.1	2.4	10.4	3.0	13.1	55.3	14.6	0.4	2.2	3.8	36.9	270.2	100.6	8.1	3.4	6.9
SFMBT2	KIAA1617	ENSG00000198879	"Scm like with four mbt domains 2"	Q5VUG0	10	7158624-7411486	"Predicted intracellular proteins"		Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 34.4"	"Cell type enriched"	"Detected in many"	4	"Microglial cells: 618.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 4.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 23.0;REH: 21.0;RPMI-8226: 20.2;SH-SY5Y: 16.6;THP-1: 25.0;U-937: 16.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035447, HPA035448, HPA070388"	Uncertain		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nucleoplasm, Nuclear speckles"		"HPA035447: AB_2674628, HPA035448: AB_10669904, HPA070388: "	"unprognostic (4.36e-2)"	"unprognostic (2.29e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.42e-3)"	"unprognostic (3.23e-2)"	"unprognostic (2.05e-3)"	"unprognostic (4.65e-1)"	"unprognostic (4.56e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.51e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.17e-3)"	"unprognostic (5.37e-3)"	"unprognostic (7.29e-2)"	3.3	4.1	12.5	6.0	12.1	6.7	5.5	9.6	10.4	3.2	5.8	2.8	2.0	4.1	3.7	1.1	4.0	3.6	4.0	6.7	34.4	3.1	1.3	4.7	7.4	16.0	11.2	3.9	9.2	1.3	5.7	6.5	3.5	21.3	6.7	3.2	18.1	2.3	3.1	4.3	1.6	4.0	3.3	13.6	9.1	3.1	1.8	17.1	4.5	6.9	2.7	5.8	4.2	4.2	16.8	0.0	4.0	0.3	0.0	0.0	0.0	4.9	0.1	0.0	0.0	0.0	0.0	1.1	7.6	0.0	0.0	0.0	1.9	7.6	0.0	0.0	0.4	7.9	0.0	13.0	0.0	0.7	8.0	1.1	1.1	0.4	0.0	0.3	0.0	0.1	10.0	11.5	23.0	0.0	3.5	7.0	14.3	1.6	0.0	0.0	21.0	2.2	20.2	0.0	0.8	2.0	16.6	0.0	0.1	0.0	2.1	1.3	25.0	0.0	0.0	2.6	0.4	0.2	10.1	13.3	0.0	1.1	16.5	0.3	0.1	0.2	1.1	0.7	2.3	0.4	0.0	0.2	0.5	0.4	0.0	1.0	0.6	0.1	0.9	4.6	3.1	0.0	0.2	12.5	12.1	9.6	10.4	6.7	34.4	16.0	11.2	3.9	21.3	13.6	17.1	16.8	8.2	0.0	5.2	148.2	10.2	1.5	1.5	0.0	1.2	8.1	9.3	8.6	9.7	1.5	0.6	0.0	81.3	7.7	22.1	0.1	0.0	0.4	0.2	0.8	15.8	10.1	4.2	6.1	77.3	0.2	2.5	4.2	2.0	3.5	4.5	7.1	5.7	1.1	15.5	0.0	103.9	0.0	0.0	15.7	9.9	0.8	5.0	26.3	5.4	618.3	11.4	12.4	15.5	26.2	113.7	0.1	0.0	2.2	25.8	11.4	0.0	0.3	0.7	34.1	0.0	4.4	2.6	0.3	3.9	0.2	1.3	4.4	25.8	2.5	0.2	0.6
SFRP2	"FRP-2, SARP1, SDF-5"	ENSG00000145423	"Secreted frizzled related protein 2"	Q96HF1	4	153780591-153789083	"Predicted secreted proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 321.6;urinary bladder: 309.6"	"Cell type enriched"	"Detected in many"	4	"Fibroblasts: 806.1"	"Cancer enhanced"	"Detected in all"		"pancreatic cancer: 370.9"	"Region enhanced"	"Detected in all"		"hypothalamus: 44.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"AF22: 229.1;ASC diff: 85.2;HSkMC: 140.2;NTERA-2: 318.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA002652			Approved	"Intermediate filaments"	"Secreted in other tissues"	NA	NA			"Intermediate filaments"		"HPA002652: AB_2732394"	"unprognostic (2.63e-1)"	"unprognostic (2.47e-1)"	"unprognostic (7.21e-3)"	"unprognostic (1.80e-2)"	"unprognostic (2.73e-1)"	"unprognostic (8.80e-3)"	"unprognostic (5.71e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.47e-3)"	"unprognostic (1.44e-2)"	"unprognostic (5.29e-2)"	"prognostic unfavorable (8.56e-6)"	"unprognostic (9.29e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (4.39e-4)"	189.8	16.2	5.3	85.4	3.9	0.3	156.5	3.5	11.4	21.8	21.9	72.9	18.5	12.1	22.4	214.7	62.7	321.6	4.3	12.2	44.9	4.4	0.3	63.1	11.9	4.5	6.4	2.1	8.4	45.5	7.0	73.1	0.4	6.7	57.0	44.7	2.3	84.1	71.2	6.5	78.7	57.8	90.4	3.9	0.7	34.7	1.5	3.2	9.6	93.1	39.1	3.7	309.6	63.5	10.4	0.0	0.0	229.1	0.2	85.2	15.1	0.1	0.2	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	140.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	318.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.1	0.1	0.1	0.0	8.1	0.2	0.0	0.0	0.4	0.1	0.0	12.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	3.9	3.5	11.4	12.2	44.9	4.5	6.4	2.1	6.7	3.9	3.2	10.4	15.5	3.2	0.6	9.4	0.5	115.5	0.8	0.0	5.7	0.0	3.7	7.9	0.3	0.0	1.9	0.0	0.0	0.1	2.0	0.0	0.0	0.2	0.0	0.1	0.1	11.8	0.0	0.0	0.7	0.0	0.2	806.1	38.7	0.3	1.3	0.0	0.0	0.0	4.4	0.0	0.6	0.0	0.0	0.0	175.0	0.5	4.1	5.0	119.2	0.0	0.6	0.0	0.0	0.5	0.1	0.1	0.0	7.2	4.1	0.7	0.0	0.1	2.9	0.0	0.0	6.7	59.4	0.0	0.1	6.9	106.0	0.1	8.6	0.0	0.0	0.9
SFRP5	SARP3	ENSG00000120057	"Secreted frizzled related protein 5"	Q5T4F7	10	97766751-97771999	"Predicted secreted proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 87.0;pancreas: 144.4"	"Cell type enriched"	"Detected in some"	7	"Cholangiocytes: 273.1"	"Cancer enriched"	"Detected in many"	4	"pancreatic cancer: 30.4"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	4	"naive CD8 T-cell: 3.6"	"Lineage enriched"	"Detected in single"	4	"T-cells: 3.6"	"Cell line enhanced"	"Detected in some"		"A549: 2.5;CACO-2: 12.4;RPMI-8226: 4.5;SCLC-21H: 2.0"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	8	"spinal cord: 120.7"						"Secreted in other tissues"	NA	NA						"unprognostic (2.63e-4)"	"unprognostic (3.03e-3)"	"unprognostic (6.74e-2)"	"unprognostic (3.43e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.51e-9)"	"unprognostic (1.67e-2)"	"unprognostic (1.57e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.62e-1)"	2.1	9.7	2.9	0.3	3.8	0.3	2.5	3.0	1.3	3.2	87.0	27.8	30.1	1.8	2.2	2.0	2.2	4.1	41.0	6.3	6.2	0.4	8.9	3.4	0.3	4.0	7.9	0.5	0.6	144.4	0.0	0.9	0.0	9.8	6.8	0.5	0.2	2.8	4.1	1.3	2.5	26.5	0.4	1.5	0.1	10.6	0.8	11.2	0.1	1.0	3.0	0.1	3.2	4.9	0.5	0.0	2.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	4.5	0.0	0.0	2.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	3.6	0.0	0.0	0.0	0.8	0.0	0.2	2.9	3.8	3.0	1.3	6.3	6.2	4.0	7.9	0.5	9.8	1.5	11.2	0.5	0.0	3.2	3.6	0.3	0.3	0.0	0.1	0.0	0.0	0.4	0.0	0.0	7.8	273.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	18.2	0.0	0.0	0.1	0.6	0.0	0.0	0.2	16.8	0.0	3.2	0.0	0.0	0.0	0.0	2.2	0.7	0.0	0.0	0.3	1.3	0.0	0.6	0.0	0.0	1.8	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.2	3.3	2.5	0.0	0.0	0.0	37.8	0.0	0.0	0.2	0.0	1.2	0.4	0.1	5.9	0.0	0.0	0.0	0.1	0.0	0.5	0.0
SH3RF2	"FLJ23654, Hepp1, POSHER, PPP1R39, RNF158"	ENSG00000156463	"SH3 domain containing ring finger 2"	Q8TEC5	5	145936578-146081791	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Protein phosphatase inhibitor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 42.2;skeletal muscle: 42.7;skin 1: 57.2"	"Cell type enriched"	"Detected in many"	5	"Late spermatids: 7869.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 70.3;GAMG: 29.8;hTERT-RPE1: 33.5"	"Region enriched"	"Detected in many"	14	"basal ganglia: 26.7"	"Region enhanced"	"Detected in many"		"basal ganglia: 9.7"	"HPA035903, HPA058119"	Uncertain		Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA035903: AB_10696515, HPA058119: AB_2683611"	"unprognostic (8.90e-3)"	"unprognostic (2.00e-3)"	"unprognostic (5.11e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.47e-2)"	"unprognostic (9.96e-3)"	"unprognostic (8.22e-2)"	"unprognostic (3.92e-1)"	"unprognostic (7.37e-3)"	"unprognostic (2.44e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.98e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.64e-2)"	"unprognostic (4.13e-3)"	1.9	0.9	0.9	2.5	5.9	0.0	4.7	0.0	4.5	4.2	1.1	14.4	16.1	1.1	3.7	34.3	6.2	12.1	42.2	0.9	1.4	0.9	7.1	2.7	0.2	1.7	0.3	0.7	0.4	15.6	0.0	1.6	0.1	3.2	2.7	14.5	0.5	12.2	0.6	42.7	57.2	13.8	1.1	0.0	0.0	20.6	6.9	1.5	1.0	6.3	8.9	7.8	1.2	20.8	0.4	21.0	5.7	0.2	1.1	0.0	0.0	0.0	0.2	1.7	4.1	1.7	70.3	19.0	0.0	10.5	0.9	29.8	18.9	0.0	22.4	4.0	0.3	0.3	0.0	8.5	9.5	1.2	0.0	0.0	0.2	11.9	6.4	14.8	33.5	0.2	0.5	0.0	0.0	1.8	0.1	0.0	0.0	1.6	17.3	1.5	0.0	0.2	0.0	8.7	2.0	0.0	0.0	1.2	0.4	0.5	1.0	6.6	0.1	9.8	0.8	17.3	1.5	6.7	0.0	0.0	0.0	10.6	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.9	5.9	0.0	4.5	0.9	1.4	1.7	0.3	0.7	3.2	0.0	1.5	0.4	4.1	16.0	2.3	1.6	0.0	55.1	5.4	14.5	38.7	0.4	3.9	3.3	510.0	8.6	6.7	1.8	0.0	0.2	0.2	38.9	0.0	5.7	1511.3	11.9	0.9	9.7	1.2	0.0	10.5	8.7	0.0	15.4	50.4	26.7	1.3	0.1	0.7	8.4	0.2	0.0	2.2	16.1	8.2	0.0	4.9	7869.1	25.7	2.6	8.8	10.3	0.6	1.6	0.0	1.5	0.7	21.4	22.9	34.6	0.6	2.2	26.6	0.9	4.4	0.1	13.1	1.6	6.3	31.4	20.7	70.9	50.0	0.0	0.7	2.9	33.2	6.6
SHISAL1	KIAA1644	ENSG00000138944	"Shisa like 1"	Q3SXP7	22	44243665-44312951	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.7;endometrium 1: 33.9;smooth muscle: 29.6"	"Cell type enriched"	"Detected in single"	6	"Endometrial stromal cells: 4.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SiHa: 36.2;U-2197: 80.8;U-87 MG: 46.3;WM-115: 27.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051178	Uncertain		Approved	Vesicles,Cytosol		No	No			"Vesicles, Cytosol"		"HPA051178: AB_2681374"	"unprognostic (4.07e-3)"	"unprognostic (9.01e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.54e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.64e-2)"	"unprognostic (8.10e-3)"	"unprognostic (1.93e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.51e-7)"	"unprognostic (1.48e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.99e-4)"	"unprognostic (1.10e-4)"	1.0	1.8	18.6	1.3	17.2	0.0	0.2	0.0	13.0	15.4	0.0	13.2	2.0	33.9	0.5	1.6	4.6	3.1	0.7	16.5	12.3	0.2	0.1	0.3	0.4	8.4	17.9	20.1	1.0	0.8	0.1	2.6	0.5	5.8	3.8	2.0	5.6	0.3	11.1	0.0	0.7	2.4	29.6	0.0	0.1	1.6	1.1	49.7	2.6	0.4	0.1	0.8	12.0	5.3	8.9	0.0	0.3	3.5	1.2	0.0	0.0	0.0	1.0	2.3	2.4	1.4	0.0	0.0	0.0	0.0	2.3	14.5	0.0	5.0	0.3	0.3	0.0	2.3	0.0	13.0	0.0	0.0	0.0	0.0	0.0	0.4	4.5	1.8	11.2	0.5	0.0	0.0	0.1	0.1	0.0	0.4	0.0	3.3	0.0	0.8	0.0	0.0	0.1	0.0	0.0	12.9	0.0	36.2	0.1	0.2	0.4	0.0	0.3	0.1	13.1	2.0	80.8	0.5	0.0	0.0	0.0	46.3	0.0	27.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.6	17.2	0.0	13.0	16.5	12.3	8.4	17.9	20.1	5.8	0.0	49.7	8.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.3	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0
SIRT1	SIR2L1	ENSG00000096717	"Sirtuin 1"	Q96EB6	10	67884656-67918390	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Differentiation, Host-virus interaction, Myogenesis, Transcription, Transcription regulation"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Early spermatids: 292.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003855, HPA006295, HPA052351"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Mitochondria,Cytosol"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center, Mitochondria, Cytosol"	"CAB003855: AB_365497, HPA006295: AB_1079975, HPA052351: AB_2681796"	"unprognostic (1.55e-1)"	"unprognostic (2.78e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.61e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.83e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	16.6	30.5	9.7	11.1	11.4	19.9	17.7	15.6	11.9	17.2	9.1	11.0	9.3	18.6	12.0	11.0	12.0	14.2	10.7	9.5	10.8	13.6	17.4	12.7	17.9	10.2	10.3	8.5	25.3	12.2	14.1	6.9	12.8	10.7	14.1	12.1	13.6	10.0	11.3	14.7	9.7	9.8	13.8	10.3	14.4	10.4	27.0	10.4	19.4	14.9	18.7	15.2	15.6	9.6	14.0	15.1	16.8	26.2	29.4	24.4	18.7	16.3	20.4	21.0	27.4	24.3	18.7	12.6	31.4	10.8	13.7	17.1	11.7	32.8	6.9	29.3	16.9	19.0	16.7	12.1	14.7	22.3	18.1	12.3	17.3	16.2	16.6	28.3	29.4	11.2	17.6	21.6	16.7	20.3	12.1	17.0	25.0	32.5	9.6	26.6	30.3	20.6	12.4	13.1	9.1	16.8	23.0	37.4	24.4	26.8	22.5	17.7	16.6	9.4	21.2	19.8	19.0	20.1	13.9	17.7	61.8	10.9	27.2	8.9	1.3	0.8	1.1	1.1	1.0	1.6	1.8	1.2	1.5	1.3	1.0	2.2	1.3	1.0	1.2	1.3	1.2	1.0	0.6	9.7	11.4	15.6	11.9	9.5	10.8	10.2	10.3	8.5	10.7	10.3	10.4	14.0	35.7	19.2	7.4	17.0	27.6	39.1	20.9	7.2	22.8	12.5	48.3	33.4	34.8	11.5	8.7	5.5	27.1	7.1	42.5	31.2	5.9	4.3	292.2	38.4	26.2	20.6	42.9	10.3	16.0	5.6	5.4	28.0	23.4	57.1	12.0	14.8	15.4	15.8	9.1	11.8	18.4	21.0	10.2	23.4	28.7	45.6	17.7	34.1	16.0	30.9	14.8	7.1	9.2	18.6	30.7	6.2	20.6	19.5	15.8	26.0	11.2	8.4	4.1	14.0	0.0	43.4	28.8	24.2	16.3	21.1	47.5	12.4	29.1	8.9	18.7	17.2
SLC12A7	"DKFZP434F076, KCC4"	ENSG00000113504	"Solute carrier family 12 member 7"	Q9Y666	5	1050384-1112063	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Horizontal cells: 281.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 43.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041652	Approved		Uncertain	Cytosol		NA	NA			Cytosol		"HPA041652: AB_10793971"	"unprognostic (2.22e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.92e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.69e-2)"	"unprognostic (8.72e-2)"	"prognostic unfavorable (2.12e-6)"	"unprognostic (1.67e-1)"	"unprognostic (1.71e-3)"	"unprognostic (4.40e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.17e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.93e-2)"	"prognostic favorable (3.16e-5)"	18.1	14.7	7.7	7.3	7.6	4.1	18.9	6.6	10.5	14.3	11.6	21.3	24.2	13.9	1.0	8.0	16.7	12.1	57.9	7.2	10.4	45.0	73.0	23.3	5.8	7.0	9.1	4.7	12.4	27.8	4.5	20.7	2.9	6.7	20.9	5.4	5.6	19.1	3.0	6.4	15.5	32.2	3.4	6.1	35.2	28.3	30.1	8.8	7.9	24.9	3.1	2.2	14.6	10.9	8.1	3.8	10.0	5.5	17.3	0.8	0.9	8.7	0.2	1.1	0.8	0.0	24.5	6.4	0.0	20.0	0.3	6.8	7.6	4.6	6.1	0.0	23.0	6.1	4.8	13.4	8.6	12.2	0.0	10.4	1.8	0.8	0.0	1.8	0.3	5.5	2.2	7.6	0.2	0.0	12.0	14.8	0.1	11.9	14.4	16.3	43.9	24.0	20.5	6.5	14.8	3.1	3.8	5.6	0.1	6.0	3.3	9.7	2.7	4.8	0.0	5.7	0.0	0.0	0.3	0.0	2.5	0.0	0.6	2.8	0.2	1.8	0.0	1.1	2.7	1.2	0.6	1.1	1.3	2.1	0.6	1.2	1.2	0.0	1.4	3.8	0.9	1.1	1.3	7.7	7.6	6.6	10.5	7.2	10.4	7.0	9.1	4.7	6.7	6.1	8.8	8.1	21.3	9.6	15.2	8.5	7.3	7.0	6.3	8.9	6.8	25.3	18.4	13.8	35.8	31.5	13.6	29.5	2.1	0.2	14.2	42.0	1.9	23.5	0.4	40.9	11.0	27.9	13.2	19.1	0.3	18.1	0.4	11.6	39.8	63.4	8.2	16.6	11.7	34.5	19.8	281.0	0.5	19.4	18.3	28.0	19.8	1.9	3.7	29.0	16.0	14.0	9.1	5.2	5.2	1.5	0.0	28.8	35.8	5.7	5.3	15.7	27.3	23.2	23.1	3.6	19.7	5.2	8.4	1.0	3.4	3.5	6.8	0.3	9.8	5.4	19.3	15.2
SLC14A2	"HUT2, UT2"	ENSG00000132874	"Solute carrier family 14 member 2"	Q15849	18	45212995-45683688	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 1.5;kidney: 3.2"	"Cell type enriched"	"Detected in many"	7	"Collecting duct cells: 77.3"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.1"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 1.5"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.5"	"Cell line enriched"	"Detected in single"	7	"U-266/70: 4.9"	"Region enhanced"	"Detected in many"		"basal ganglia: 16.9"	"Not detected"	"Not detected"									NA	NA						"unprognostic (2.33e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.80e-2)"	"unprognostic (1.11e-2)"	"unprognostic (7.89e-3)"	"unprognostic (3.76e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.27e-3)"	"unprognostic (8.96e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.20e-1)"	"unprognostic (7.64e-2)"	"unprognostic (7.52e-2)"	"unprognostic (6.62e-2)"	1.5	1.1	0.2	0.2	0.2	0.3	0.1	0.3	0.6	0.0	0.0	0.1	0.3	0.1	0.0	0.1	0.0	0.1	0.1	0.4	0.0	3.2	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.2	0.1	0.0	0.2	0.2	0.1	0.1	0.2	1.1	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.7	0.1	0.1	0.0	0.0	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.2	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.3	0.0	0.1	0.2	0.2	0.1	0.0	0.2	0.1	0.0	0.5	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.7	0.2	4.9	0.2	0.1	0.2	0.7	0.1	0.5	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.2	0.2	0.3	0.6	0.4	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.4	6.4	9.6	5.2	0.7	0.6	0.9	0.3	0.0	1.1	0.4	0.3	0.9	0.0	1.9	77.3	2.1	0.3	0.6	0.3	0.0	0.0	1.3	0.2	0.3	0.9	0.0	0.0	8.8	0.0	0.5	2.4	0.0	0.3	3.8	0.1	1.1	0.0	0.4	1.7	10.6	0.5	0.0	0.3	2.0	1.4	0.6	0.8	1.8	2.8	0.2	0.9	1.0	6.6	1.0	0.1	1.2	0.7	0.1	0.5	4.9	0.2	1.5	2.0	0.0	0.4	0.2	0.3	0.4	0.0	0.1	0.8	1.0	0.2	0.2	0.5
SLC18A2	"SVAT, SVMT, VMAT2"	ENSG00000165646	"Solute carrier family 18 member A2"	Q05940	10	117241093-117279430	"Disease related genes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"		"Disease variant, Dystonia, FDA approved drug targets, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 67.3;cervix: 30.3"	"Cell type enriched"	"Detected in many"	5	"granulocytes: 636.0"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"midbrain: 67.3;pons: 44.8"	"Immune cell enriched"	"Detected in some"	15	"basophil: 59.5"	"Lineage enriched"	"Detected in many"	15	"granulocytes: 59.5"	"Cell line enriched"	"Detected in some"	19	"HMC-1: 351.0"	"Region enhanced"	"Detected in many"		"midbrain: 62.7"	"Region enriched"	"Detected in all"	4	"midbrain: 111.6"	HPA073224	Enhanced		Approved	Vesicles,Centrosome		NA	NA			"Vesicles, Centrosome"		"HPA073224: AB_2732222"	"unprognostic (1.49e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.33e-3)"	"unprognostic (9.00e-2)"	"unprognostic (2.85e-1)"	"unprognostic (5.33e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.06e-3)"	"unprognostic (7.94e-5)"	"unprognostic (2.95e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.57e-2)"	1.0	14.7	0.3	0.9	0.8	2.4	1.8	0.0	1.6	30.3	0.1	2.3	1.5	2.6	1.6	2.5	0.5	3.7	0.6	0.2	12.7	0.9	2.8	7.5	0.6	4.1	67.3	0.0	10.5	3.4	0.2	0.2	0.2	44.8	9.3	3.5	0.5	0.8	1.4	0.8	6.3	2.2	2.3	0.0	0.3	4.4	0.9	10.8	6.1	0.0	0.5	1.0	2.9	8.0	12.0	0.2	1.1	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.3	0.6	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.7	18.6	0.1	0.2	0.0	1.0	351.0	0.0	0.0	0.0	0.0	0.2	0.0	3.7	0.0	0.7	0.0	0.1	1.0	0.3	0.2	0.3	0.6	0.2	0.4	0.2	0.0	0.2	3.4	0.7	0.3	0.1	0.0	0.2	0.0	0.1	0.3	0.1	2.5	0.3	0.8	0.5	0.4	0.2	0.4	1.9	0.3	59.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.3	0.0	0.0	3.8	0.0	2.0	0.3	0.8	0.0	1.6	0.2	12.7	4.1	67.3	0.0	44.8	0.0	10.8	12.0	0.0	9.6	16.2	1.0	0.2	1.9	0.0	0.0	0.0	2.1	0.2	0.0	0.3	0.0	2.5	0.0	4.2	0.0	5.7	0.4	0.0	0.0	0.0	13.1	16.1	0.7	8.9	4.2	1.1	0.0	0.0	3.4	4.1	112.4	636.0	2.4	9.7	0.3	0.8	0.0	1.7	0.0	0.0	1.0	3.6	0.2	0.6	3.5	1.8	0.0	0.1	0.4	0.0	0.5	0.6	0.1	0.1	4.9	1.9	3.8	0.0	0.1	0.7	0.8	0.0	0.4	1.3	0.2	2.1	0.0	2.7	0.0	5.6	9.8	0.1	0.1
SLC22A15	FLIPT1	ENSG00000163393	"Solute carrier family 22 member 15"	Q8IZD6	1	115976513-116070054	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 30.9;brain: 32.3"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 250.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 1.3;non-classical monocyte: 1.2"	"Group enriched"	"Detected in many"	8	"granulocytes: 1.3;monocytes: 1.2"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 36.0;hTERT-HME1: 47.4;NB-4: 27.4;THP-1: 29.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019785	Uncertain					NA	NA					"HPA019785: AB_1857011"	"unprognostic (3.81e-1)"	"unprognostic (1.11e-2)"	"unprognostic (7.65e-3)"	"unprognostic (1.01e-3)"	"unprognostic (5.62e-2)"	"unprognostic (5.22e-2)"	"unprognostic (5.85e-5)"	"unprognostic (8.91e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.97e-2)"	"unprognostic (5.15e-2)"	"unprognostic (9.06e-2)"	"unprognostic (7.29e-3)"	"unprognostic (8.78e-3)"	"unprognostic (3.44e-1)"	"unprognostic (9.97e-4)"	"unprognostic (1.30e-1)"	2.5	3.1	8.2	2.3	15.3	30.9	1.7	11.7	12.6	2.5	1.2	1.3	1.0	1.1	1.3	5.2	1.5	1.9	4.8	8.5	12.0	3.5	1.1	4.9	1.0	13.1	11.8	7.1	1.1	3.1	4.3	2.8	2.0	14.7	2.0	1.7	6.8	4.5	1.6	0.6	9.5	1.9	1.0	11.6	3.4	3.5	1.1	12.4	0.5	2.8	1.0	1.1	1.7	5.0	32.3	3.0	0.2	2.1	0.0	3.7	4.4	1.5	4.7	6.9	2.8	5.0	0.0	0.5	3.3	5.0	2.3	2.4	4.5	3.6	9.7	2.7	0.0	2.3	3.2	3.7	0.5	12.3	4.9	4.3	4.5	36.0	0.1	47.4	0.2	0.0	0.0	0.1	0.0	4.7	2.7	0.0	27.4	3.0	2.8	2.3	0.0	0.0	0.1	3.9	1.6	2.2	1.9	8.1	1.7	13.8	3.1	0.4	29.4	0.0	5.0	2.7	1.0	1.2	4.8	4.8	0.4	5.3	8.0	8.1	0.3	0.8	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	1.2	0.0	0.0	0.1	8.2	15.3	11.7	12.6	8.5	12.0	13.1	11.8	7.1	14.7	11.6	12.4	32.3	0.2	0.0	13.7	46.7	2.3	2.8	3.1	3.6	5.2	3.0	0.3	0.4	7.8	0.0	3.2	5.5	10.4	0.6	0.8	0.5	1.9	1.1	1.3	2.5	0.7	0.2	8.4	0.4	44.2	0.4	0.4	4.6	4.6	1.4	1.3	0.6	1.1	0.0	2.8	8.4	33.9	0.3	0.0	9.4	0.5	0.1	0.9	6.9	1.8	9.4	8.7	1.0	1.0	53.3	250.2	1.6	1.2	0.4	0.7	1.1	0.1	0.3	5.2	2.1	0.0	0.4	1.4	0.3	0.7	5.7	3.0	0.0	1.0	1.2	0.5	1.3
SLC25A34	DKFZp781A10161	ENSG00000162461	"Solute carrier family 25 member 34"	Q6PIV7	1	15736258-15741392	"Predicted membrane proteins, Transporters"	Transport			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 38.1;tongue: 47.7"	"Cell type enriched"	"Detected in many"	5	"Proximal enterocytes: 44.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 3.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069806			Approved	Mitochondria		NA	NA			Mitochondria		"HPA069806: AB_2686202"	"unprognostic (2.06e-1)"	"unprognostic (4.72e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.58e-1)"	"unprognostic (8.08e-3)"	"unprognostic (1.98e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.80e-4)"	"unprognostic (5.74e-2)"	"unprognostic (6.10e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.82e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.40e-4)"	2.3	4.4	3.3	1.0	3.3	3.4	1.8	6.0	4.8	3.5	2.1	4.4	14.1	3.2	0.8	1.8	3.0	1.5	8.9	3.1	2.9	4.8	5.6	2.5	1.3	2.9	2.7	3.2	4.2	4.9	0.6	3.8	1.3	3.6	2.4	2.0	1.9	4.8	0.8	38.1	1.6	13.8	1.1	2.0	3.7	2.2	2.6	3.1	0.5	3.5	47.7	0.5	2.8	2.3	3.6	0.3	0.2	1.5	0.6	0.7	0.3	0.6	0.2	0.1	0.3	0.2	0.6	0.8	0.4	0.3	0.3	0.8	0.3	0.2	0.2	0.3	0.5	0.3	0.7	0.5	0.2	0.2	0.2	0.9	0.3	1.1	0.4	0.1	0.9	0.2	2.0	0.3	1.3	0.2	0.7	1.7	0.9	1.3	0.2	0.4	0.9	1.3	0.4	0.1	0.0	0.3	1.2	0.3	0.4	3.4	1.4	0.7	1.0	0.8	0.7	1.0	1.0	0.2	1.7	1.6	0.3	0.2	0.9	0.6	0.5	0.1	0.1	0.4	0.0	0.9	0.1	0.9	0.6	0.0	0.2	1.2	0.7	0.6	0.6	0.0	0.1	0.4	0.3	3.3	3.3	6.0	4.8	3.1	2.9	2.9	2.7	3.2	3.6	2.0	3.1	3.6	0.9	0.0	0.0	6.2	0.4	0.3	0.3	0.6	0.0	2.6	0.5	0.5	2.7	1.5	0.2	0.0	0.0	0.3	0.3	8.8	0.0	0.2	0.3	0.4	1.3	1.2	3.5	0.0	5.1	0.2	0.4	0.8	2.0	1.7	0.0	1.3	2.2	2.3	1.5	3.3	4.6	3.1	0.0	1.9	0.3	1.0	0.9	1.5	0.0	2.8	1.1	1.8	0.0	2.5	1.7	0.3	8.0	0.4	0.0	0.6	44.6	3.7	0.0	1.8	0.0	2.7	0.9	0.6	0.6	1.1	0.1	1.4	0.6	0.4	5.5	0.7
SLC2A4	GLUT4	ENSG00000181856	"Solute carrier family 2 member 4"	P14672	17	7281718-7288257	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 75.8;skeletal muscle: 225.5"	"Cell type enriched"	"Detected in many"	4	"Cardiomyocytes: 135.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	4	"Hep G2: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			CAB016544	Enhanced					NA	NA					"CAB016544: AB_629533"	"unprognostic (2.53e-1)"	"unprognostic (7.40e-3)"	"unprognostic (2.27e-1)"	"unprognostic (8.12e-4)"	"unprognostic (2.40e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.83e-2)"	"unprognostic (9.66e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.23e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.07e-2)"	14.9	5.2	1.4	0.2	1.4	1.1	11.3	0.9	1.5	8.4	0.9	37.4	0.8	9.4	1.2	5.9	11.4	0.7	75.8	1.2	1.2	2.5	3.8	2.1	0.2	1.2	1.4	1.0	3.2	0.8	3.4	4.4	0.6	1.6	9.9	1.1	0.4	6.3	3.3	225.5	3.7	9.8	4.4	0.9	0.3	11.8	3.3	1.2	0.1	4.6	63.8	0.0	27.2	5.6	1.1	0.0	0.0	0.4	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.6	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.4	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	1.4	0.9	1.5	1.2	1.2	1.2	1.4	1.0	1.6	0.9	1.2	1.1	1.7	0.0	0.0	1.0	0.0	1.8	0.9	0.3	2.2	0.1	1.5	1.3	135.2	0.0	0.2	0.0	0.0	0.3	0.0	1.0	7.9	0.1	16.6	0.2	0.1	3.7	0.0	10.7	0.0	0.0	0.0	4.0	0.0	0.1	0.0	0.3	1.8	2.8	0.1	0.0	0.0	0.8	0.0	0.3	0.3	4.8	0.0	0.1	7.2	1.0	0.0	6.0	0.0	0.0	0.0	0.1	1.2	8.6	0.0	0.8	0.8	0.3	0.4	0.4	32.9	7.0	19.8	1.7	2.2	0.5	1.1	1.0	0.1	0.5	1.0	0.7
SLC35A5	FLJ20730	ENSG00000138459	"Solute carrier family 35 member A5"	Q9BS91	3	112561709-112585579	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Early spermatids: 156.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035519, HPA057964"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA035519: AB_10601487, HPA057964: AB_2683566"	"unprognostic (7.89e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.89e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.78e-2)"	"unprognostic (8.60e-3)"	"unprognostic (2.60e-1)"	"unprognostic (8.21e-2)"	"unprognostic (3.51e-1)"	"prognostic favorable (4.10e-5)"	"unprognostic (2.26e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.05e-2)"	"unprognostic (3.42e-1)"	15.7	19.5	21.2	13.6	26.2	5.8	14.9	25.0	27.2	15.6	20.8	15.8	16.9	15.7	16.1	14.5	14.7	15.5	9.8	21.2	24.2	20.4	21.1	14.8	15.8	26.2	24.8	20.8	18.0	9.6	17.3	9.2	18.5	26.3	16.1	16.3	21.9	11.5	14.0	6.1	9.3	18.5	16.1	24.7	14.4	14.7	19.0	24.0	12.8	26.3	10.3	15.4	12.7	8.4	32.9	20.4	18.4	31.2	18.8	39.3	37.4	18.0	33.2	23.7	27.5	31.5	13.6	22.8	18.1	27.4	28.8	31.3	25.3	22.4	15.6	34.6	14.2	11.1	23.2	15.9	11.4	33.6	20.7	21.5	31.8	30.9	24.3	14.9	34.8	25.1	13.8	13.5	22.1	38.7	7.2	16.2	13.1	20.8	24.0	19.2	14.4	11.4	19.7	34.2	14.9	18.3	24.1	21.3	10.4	38.0	20.9	14.2	13.9	28.3	40.3	21.8	8.6	15.7	15.7	24.4	32.2	29.9	17.2	30.8	14.8	16.4	21.0	10.9	25.9	10.3	14.7	10.2	8.6	19.7	13.6	13.6	11.2	14.6	7.3	27.4	9.4	11.2	10.8	21.2	26.2	25.0	27.2	21.2	24.2	26.2	24.8	20.8	26.3	24.7	24.0	32.9	9.9	3.2	10.1	13.1	12.5	6.4	8.3	9.9	11.4	12.8	8.5	6.5	5.5	7.2	12.6	14.7	0.0	36.1	12.5	16.4	9.8	7.8	156.8	9.2	9.1	12.9	7.7	9.2	15.0	7.7	25.6	14.0	10.7	10.0	14.0	9.0	19.6	13.1	17.9	37.0	15.2	11.8	20.3	23.2	9.2	23.5	17.1	13.0	26.6	5.6	14.0	20.3	9.2	23.1	36.6	8.1	13.1	17.3	14.3	8.5	25.8	14.8	10.4	16.9	26.3	9.6	10.6	14.9	15.7	8.9	6.7	29.8	10.7	14.6	10.0	6.5
SLC35D3	FRCL1	ENSG00000182747	"Solute carrier family 35 member D3"	Q5M8T2	6	136922301-136925660	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 3.4"	"Cell type enriched"	"Detected in single"	9	"Ionocytes: 8.2"	"Group enriched"	"Detected in some"	5	"colorectal cancer: 3.3;stomach cancer: 0.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SH-SY5Y: 15.4"	"Group enriched"	"Detected in many"	5	"basal ganglia: 29.6;olfactory bulb: 8.5"	"Region enriched"	"Detected in many"	6	"basal ganglia: 20.1"	"HPA030431, HPA067497"	Uncertain		Approved	"Centriolar satellite"		NA	NA			"Centriolar satellite"		"HPA030431: AB_10601716, HPA067497: AB_2685854"	"unprognostic (6.56e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.43e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.84e-2)"		"unprognostic (2.48e-1)"		"unprognostic (9.94e-2)"	"unprognostic (7.36e-2)"	"unprognostic (4.65e-2)"		"unprognostic (1.37e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.45e-1)"	"unprognostic (1.03e-1)"	0.0	0.9	0.3	0.0	2.2	0.2	0.0	0.0	1.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.4	0.0	1.1	2.0	0.2	0.0	0.4	0.0	0.0	0.0	1.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.6	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.6	15.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	2.2	0.0	1.2	0.0	3.2	1.1	2.0	0.2	1.7	0.1	3.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.1	0.1	0.1
SLC35F4	"C14orf36, FLJ37712"	ENSG00000151812	"Solute carrier family 35 member F4"	A4IF30	14	57563920-57982194	"Predicted membrane proteins, Transporters"	Transport			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 5.8;retina: 6.5;seminal vesicle: 3.6"	"Cell type enriched"	"Detected in some"	12	"Inhibitory neurons: 166.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"RPMI-8226: 1.5;U-87 MG: 2.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA043853	Uncertain		Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA043853: AB_10963083"	"unprognostic (2.37e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.56e-1)"	"unprognostic (2.66e-4)"	"unprognostic (4.88e-2)"	"unprognostic (8.64e-2)"		"unprognostic (1.38e-1)"		"unprognostic (1.76e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.03e-3)"	"unprognostic (3.50e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.68e-3)"	"unprognostic (9.23e-2)"	0.0	0.0	0.7	0.0	0.9	0.0	0.0	5.8	0.6	0.3	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.4	1.4	0.0	0.0	0.0	0.0	1.7	1.5	0.4	0.0	0.1	0.0	0.0	0.0	1.9	1.3	0.0	6.5	0.0	3.6	0.0	0.0	0.0	0.3	2.1	0.0	0.0	1.0	2.0	0.0	0.8	0.0	0.0	0.0	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	5.8	0.6	0.4	1.4	1.7	1.5	0.4	1.9	2.1	2.0	1.2	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.4	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.1	11.7	0.1	0.0	0.2	0.0	0.0	12.2	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	166.3	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.5	5.3	0.1	0.0	3.0	0.0	0.0	0.0	0.1	0.0	13.7	0.0	0.0	0.1	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC35G5	"AMAC, AMAC1L2"	ENSG00000177710	"Solute carrier family 35 member G5"	Q96KT7	8	11331012-11332360	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 2.4"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 13.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA						"unprognostic (7.00e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.67e-2)"	"unprognostic (2.60e-4)"	"unprognostic (6.48e-3)"	"unprognostic (4.09e-1)"	"unprognostic (5.79e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.61e-2)"	"unprognostic (3.44e-1)"	"unprognostic (2.06e-6)"	"unprognostic (7.88e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.04e-3)"	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.6	0.1	2.4	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.3	0.7	0.1	0.2	0.2	0.0	1.7	0.5	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.5	0.1	0.0	0.2	13.8	0.2	0.3	0.4	0.0	0.0	0.3	0.4	0.3	0.2	0.0	0.2	0.0	0.2	2.2	0.1	0.5	1.7	0.3	0.3	2.0	0.3	0.3	1.8	0.0	0.2	0.0	1.0	0.1	0.2	0.0	1.0	0.6	0.4	0.0	0.4	0.1	0.5	0.1	0.0	0.4	3.1	0.0	1.3	0.1	2.3	0.3	0.0	0.1	0.0	0.6	0.1	0.4	0.3
SLC44A1	"CD92, CDW92, CHTL1, CTL1"	ENSG00000070214	"Solute carrier family 44 member 1"	Q8WWI5	9	105244622-105439171	"CD markers, Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 289.4"	"Cell type enriched"	"Detected in all"	8	"Oligodendrocytes: 2444.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"ASC diff: 285.9;ASC TERT1: 224.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064714, HPA074007"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA		99000	Mitochondria	Nucleoplasm	"HPA064714: AB_2685334, HPA074007: "	"unprognostic (3.49e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.54e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (4.49e-4)"	"unprognostic (2.48e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.64e-3)"	"unprognostic (6.20e-2)"	"prognostic favorable (1.85e-4)"	"unprognostic (2.13e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.07e-2)"	17.1	13.4	118.0	13.1	196.0	11.5	26.5	170.0	138.6	16.9	83.5	50.7	22.8	16.0	32.7	18.5	15.4	20.4	12.9	117.5	141.3	22.0	38.3	18.6	9.8	197.1	173.5	95.6	14.2	15.3	23.4	5.4	23.5	195.3	11.9	49.5	14.2	9.6	25.3	9.5	21.6	27.2	17.4	177.3	9.6	35.5	3.6	159.7	13.7	44.0	20.4	15.6	22.0	15.7	289.4	29.0	23.8	6.4	7.9	285.9	224.1	20.3	23.9	61.7	15.1	20.2	25.6	74.8	38.4	12.0	90.2	17.1	56.1	19.3	34.4	25.7	34.0	15.7	47.8	15.8	32.0	19.3	9.6	23.7	125.3	27.6	29.0	26.1	38.8	48.6	19.7	1.4	77.1	17.3	40.8	38.8	10.9	35.9	51.1	22.9	8.0	24.7	29.3	20.9	66.6	30.6	12.0	33.4	36.5	33.3	37.8	36.2	28.7	41.9	15.1	13.5	16.5	17.7	59.1	41.7	28.4	29.2	20.6	20.2	1.7	3.3	0.7	0.7	1.2	0.4	1.1	0.7	0.4	2.2	2.0	0.8	0.3	0.5	5.3	0.7	0.8	0.8	0.9	118.0	196.0	170.0	138.6	117.5	141.3	197.1	173.5	95.6	195.3	177.3	159.7	289.4	48.6	35.3	26.5	83.2	22.2	70.6	36.0	28.3	75.1	10.3	76.9	27.2	10.1	67.2	19.9	106.7	235.6	53.3	7.6	296.5	3.9	17.5	2.9	59.2	40.3	45.2	157.2	20.4	174.2	36.5	12.1	64.0	84.1	175.2	100.1	16.7	48.9	170.0	21.3	6.7	108.1	160.0	14.2	46.5	46.5	6.1	110.0	48.6	74.7	81.5	91.0	9.0	13.4	257.3	2444.2	36.9	161.2	79.7	162.9	23.8	95.4	27.1	31.4	53.3	39.5	43.8	34.9	2.3	4.4	86.9	74.3	70.6	20.3	12.1	199.1	34.8
SLC47A2	"FLJ31196, MATE2, MATE2-K"	ENSG00000180638	"Solute carrier family 47 member 2"	Q86VL8	17	19678288-19718979	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 14.1;choroid plexus: 32.2;kidney: 54.5"	"Cell type enriched"	"Detected in some"	4	"Proximal tubular cells: 91.3"	"Cancer enhanced"	"Detected in some"		"glioma: 2.6;renal cancer: 4.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"hTCEpi: 2.1"					"Not detected"	"Not detected"									NA	NA						"unprognostic (4.52e-3)"	"unprognostic (8.28e-3)"	"unprognostic (1.54e-1)"	"unprognostic (4.99e-2)"	"prognostic unfavorable (8.95e-4)"	"unprognostic (5.22e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.99e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.36e-3)"	"unprognostic (7.77e-2)"	"unprognostic (1.04e-3)"	"unprognostic (4.33e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.44e-2)"	"unprognostic (5.71e-2)"	0.1	0.2	4.1	0.0	2.7	0.0	0.2	5.8	2.4	0.1	32.2	0.0	0.0	0.1	6.7	0.4	10.1	0.0	0.1	2.5	14.1	54.5	0.0	0.0	0.0	10.4	13.4	0.4	0.1	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.6	0.4	0.2	1.1	2.3	0.3	0.1	9.3	0.0	0.0	0.0	5.7	0.0	0.2	0.2	0.0	0.0	0.1	4.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.3	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	2.7	5.8	2.4	2.5	14.1	10.4	13.4	0.4	10.5	9.3	5.7	4.8	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.7	0.6	0.0	0.0	0.9	0.7	0.0	0.2	5.5	0.0	0.1	0.0	0.2	5.9	0.0	0.6	20.9	0.4	0.1	0.0	0.0	3.3	0.0	0.0	0.5	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.0	2.0	0.0	0.0	0.7	0.3	0.9	0.0	1.9	0.0	1.3	0.0	2.0	1.4	0.1	0.0	0.0	0.0	0.8	1.7	91.3	2.5	0.5	0.0	3.5	0.1	0.6	0.8	1.0	0.3	0.0	0.6	0.0	0.2	0.2
SLC4A5	NBC4	ENSG00000188687	"Solute carrier family 4 member 5"	Q9BY07	2	74216242-74343414	"Cancer-related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Ion transport, Sodium transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 62.0;retina: 42.4;thyroid gland: 26.9"	"Cell type enriched"	"Detected in many"	4	"Horizontal cells: 168.2"	"Cancer enriched"	"Detected in single"	11	"thyroid cancer: 3.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 4.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"U-266/70: 8.8"	"Group enriched"	"Detected in many"	5	"basal ganglia: 1.6;hippocampal formation: 5.2;pons and medulla: 6.5;thalamus: 3.5"	"Low region specificity"	"Detected in many"			HPA036621	Uncertain					NA	NA					"HPA036621: AB_10696779"	"unprognostic (1.30e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.83e-4)"	"unprognostic (3.38e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.56e-3)"	"unprognostic (5.37e-4)"	"unprognostic (1.39e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.55e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.72e-5)"	"unprognostic (1.57e-1)"	"unprognostic (1.06e-2)"	"unprognostic (8.47e-2)"	"unprognostic (9.27e-4)"	1.3	0.7	3.7	1.2	5.4	2.4	1.5	12.3	4.4	1.3	62.0	1.0	0.8	1.4	2.3	0.9	2.1	1.0	1.4	6.6	3.0	1.0	1.0	2.6	1.8	6.0	5.2	2.3	1.6	1.5	12.5	2.4	0.6	7.2	1.2	0.7	42.4	1.7	1.3	1.9	5.0	1.0	1.5	2.7	1.3	0.9	16.3	4.6	1.0	26.9	1.6	0.8	1.1	1.1	8.8	0.3	0.5	0.9	0.9	0.9	1.6	0.9	0.2	0.9	0.5	0.7	0.3	0.7	1.5	0.2	0.0	0.3	0.1	1.0	0.1	0.2	1.2	0.6	2.2	0.7	0.5	0.1	0.5	1.3	0.4	1.3	0.0	0.2	0.5	0.3	1.0	0.5	1.5	0.2	3.5	0.3	1.5	0.4	0.5	0.3	0.8	0.7	0.0	0.2	0.6	0.6	1.2	0.3	1.1	1.6	0.7	0.8	1.5	0.0	0.9	1.6	0.9	0.3	8.8	1.4	1.0	0.6	0.8	0.2	4.3	0.3	0.3	0.6	0.3	0.4	0.7	1.0	0.9	0.3	0.9	0.8	1.0	1.9	0.7	0.1	2.5	1.2	0.2	3.7	5.4	12.3	4.4	6.6	3.0	6.0	5.2	2.3	7.2	2.7	4.6	8.8	1.1	3.2	10.8	16.0	0.5	0.6	0.6	0.3	0.0	13.9	0.6	0.5	0.4	1.5	2.6	0.0	35.5	0.1	3.3	0.3	0.0	0.4	0.6	1.0	0.7	0.9	0.0	0.4	7.3	0.6	0.0	0.8	0.0	0.8	0.0	1.1	0.7	0.0	0.1	168.2	10.6	0.5	0.0	0.0	0.4	0.6	1.2	0.4	1.8	4.7	0.1	3.3	2.1	4.0	31.1	0.5	0.3	0.4	0.1	0.6	0.3	0.1	4.1	40.4	0.0	2.5	1.1	1.7	1.3	0.0	0.4	0.0	0.6	0.3	0.2	0.7
SLC9C2	"MGC43026, SLC9A11"	ENSG00000162753	"Solute carrier family 9 member C2 (putative)"	Q5TAH2	1	173500460-173603072	"Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.3;choroid plexus: 1.6;testis: 6.0"	"Cell type enriched"	"Detected in some"	4	"Astrocytes: 27.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"HPA059122, HPA079529"	Enhanced		Approved	"Nuclear speckles,Plasma membrane"		NA	NA			"Plasma membrane"	"Nuclear speckles"	"HPA059122: , HPA079529: "	"unprognostic (2.10e-1)"	"unprognostic (2.69e-1)"		"unprognostic (8.52e-2)"	"unprognostic (5.88e-3)"	"unprognostic (3.24e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.21e-2)"	"unprognostic (4.92e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.18e-6)"	"unprognostic (1.66e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.81e-1)"	0.0	0.0	1.1	0.0	0.5	0.0	0.0	0.5	0.4	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.5	1.3	0.0	0.0	0.0	0.0	1.2	0.8	0.1	0.2	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.1	6.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.5	0.5	0.4	0.5	1.3	1.2	0.8	0.1	0.7	1.0	0.5	0.6	0.0	0.0	0.0	27.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.6	0.0	1.3	0.0	6.2	0.1	1.3	0.1	0.0	0.1	6.2	1.7	0.1	0.4	0.0	0.0	5.0	0.0	0.5	0.3	0.0	0.1	0.0	0.5	0.4	1.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	4.7	0.0	0.7	0.0	1.5	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.1	0.1	5.4	0.4	0.0	0.0	0.1	0.0	1.3	0.0	0.0
SLCO1A2	"OATP, OATP-A, OATP1A2, SLC21A3"	ENSG00000084453	"Solute carrier organic anion transporter family member 1A2"	P46721	12	21264600-21419594	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 88.2;choroid plexus: 35.1"	"Cell type enriched"	"Detected in some"	4	"Oligodendrocytes: 487.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 16.7;RPMI-8226: 12.0;SuSa: 16.1;U-266/70: 23.1;U-266/84: 9.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA071152			Supported	"Plasma membrane"		No	No			"Plasma membrane"		"HPA071152: AB_2686350"	"unprognostic (5.43e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.36e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.82e-2)"	"unprognostic (1.66e-4)"	"unprognostic (2.52e-2)"	"unprognostic (3.20e-1)"		"unprognostic (1.24e-1)"	0.0	0.1	54.4	0.1	69.4	0.1	4.0	49.7	64.5	0.0	35.1	0.1	0.0	0.1	0.2	0.1	0.3	0.2	0.9	46.8	53.0	1.2	11.6	2.8	0.7	66.1	59.7	39.2	0.2	2.4	0.2	0.4	1.2	63.4	0.7	0.0	0.6	15.9	0.0	0.4	0.5	0.1	0.0	52.5	0.5	0.4	1.9	56.8	0.6	0.2	0.0	0.4	0.2	0.0	88.2	2.1	0.6	0.8	0.1	0.0	0.0	3.4	0.0	0.0	0.1	0.0	3.8	1.4	0.1	2.1	0.2	0.0	0.3	0.3	0.2	0.5	0.7	0.9	0.0	0.5	1.5	0.0	0.4	0.3	0.0	1.7	0.2	0.2	1.5	0.1	0.4	4.0	1.2	0.0	2.6	0.4	0.1	16.7	2.0	0.2	0.2	0.2	12.0	0.0	2.2	1.9	2.9	0.0	0.2	0.2	16.1	3.2	0.9	0.0	0.1	1.7	0.8	0.4	23.1	9.8	0.2	0.1	0.3	0.0	0.2	0.1	0.1	0.4	0.1	0.6	0.4	0.6	0.4	0.0	0.2	0.6	0.4	1.3	0.3	0.0	0.2	0.5	0.1	54.4	69.4	49.7	64.5	46.8	53.0	66.1	59.7	39.2	63.4	52.5	56.8	88.2	0.0	35.3	3.1	5.9	0.0	0.0	0.0	0.0	0.0	0.2	3.5	2.8	0.5	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.0	0.0	5.0	0.0	0.0	2.8	0.0	0.0	0.7	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.8	0.0	0.0	0.0	0.0	4.5	0.0	0.1	0.0	102.1	0.0	0.1	0.0	2.5	487.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.1	0.4	1.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0
SLCO3A1	"OATP-D, OATP3A1, SLC21A11"	ENSG00000176463	"Solute carrier organic anion transporter family member 3A1"	Q9UIG8	15	91853708-92172435	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 39.4"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 625.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 63.1;HaCaT: 95.5;HMC-1: 55.3;RPMI-8226: 44.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066327	Approved					NA	NA					"HPA066327: AB_2732743"	"unprognostic (1.05e-3)"	"prognostic favorable (8.61e-4)"	"unprognostic (5.40e-2)"	"prognostic unfavorable (6.57e-6)"	"unprognostic (1.03e-1)"	"unprognostic (7.39e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.62e-2)"	11.4	6.2	21.3	6.9	27.2	9.7	8.7	32.4	24.0	7.3	21.6	3.8	1.8	5.3	3.3	10.7	7.0	6.3	23.8	20.2	21.3	6.3	2.9	13.9	6.4	29.8	29.9	15.2	4.2	3.0	15.8	6.7	1.0	29.3	4.3	3.5	1.6	4.7	6.3	5.9	15.3	4.2	5.0	26.3	11.2	4.7	18.0	25.5	2.6	10.7	9.7	6.2	8.7	10.9	39.4	10.1	12.3	13.9	0.2	20.9	12.6	0.2	4.0	3.4	1.6	0.4	0.0	63.1	12.1	5.3	1.3	9.1	95.5	2.7	6.3	0.2	8.8	0.4	27.8	20.9	0.0	0.9	0.6	55.3	5.7	6.7	2.9	7.3	5.4	0.0	3.6	0.0	0.1	0.0	1.8	0.0	5.1	3.7	0.2	1.7	0.0	1.1	44.0	13.4	10.0	2.0	3.3	10.5	0.9	0.1	2.0	0.1	8.5	0.0	3.3	4.7	0.0	10.3	25.5	16.0	11.7	4.2	16.9	6.0	4.3	2.4	6.9	1.4	2.0	1.1	0.2	1.5	1.7	1.6	0.0	0.5	0.6	7.5	0.3	1.7	0.0	2.7	0.6	21.3	27.2	32.4	24.0	20.2	21.3	29.8	29.9	15.2	29.3	26.3	25.5	39.4	53.5	48.1	32.0	17.0	4.3	39.0	29.3	14.2	22.8	28.1	3.1	13.0	44.0	24.3	16.4	51.5	4.2	0.0	33.1	6.2	1.9	26.6	105.6	15.8	29.0	26.2	37.8	6.1	89.5	8.7	0.1	22.9	0.5	36.2	22.8	94.9	34.6	0.8	4.6	0.0	149.4	7.2	8.2	24.7	95.2	38.5	5.0	34.0	10.6	56.2	43.6	5.2	25.7	20.6	625.8	8.4	11.1	3.0	17.3	41.5	0.0	0.4	22.1	3.1	39.5	17.4	62.0	69.5	11.9	22.6	60.1	0.0	23.3	0.8	7.9	38.2
SLX1A	GIYD1	ENSG00000132207	"SLX1 homolog A, structure-specific endonuclease subunit"	Q9BQ83	16	30193875-30197561	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Proximal enterocytes: 48.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA047038	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA047038: AB_2679913"	"unprognostic (3.46e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.60e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.67e-1)"		"unprognostic (1.26e-6)"	"unprognostic (2.52e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.86e-1)"	19.0	24.2	17.3	18.3	16.8	31.4	19.3	16.1	23.6	10.1	17.0	23.7	62.1	7.2	6.2	26.0	6.8	8.2	20.4	17.2	18.0	30.7	59.9	16.9	15.4	25.0	17.3	18.4	4.1	31.8	6.6	13.0	13.8	22.5	12.1	11.4	5.3	18.3	11.2	26.5	16.4	52.6	6.3	17.8	39.7	32.1	5.6	20.2	4.9	13.5	6.4	16.0	16.5	12.9	20.9	75.9	38.8	33.3	16.3	7.0	10.0	117.1	27.4	34.2	25.3	24.4	7.0	59.4	60.3	62.9	11.9	16.0	48.7	12.8	18.4	9.3	46.3	46.8	40.9	12.1	70.0	21.2	47.6	65.8	10.7	21.4	12.2	12.2	17.4	37.9	36.6	28.9	49.8	15.1	65.3	33.3	106.8	42.5	46.8	42.0	106.8	34.2	159.5	29.6	18.0	29.7	96.0	6.0	145.3	29.5	5.1	21.6	28.2	17.3	36.4	41.4	39.6	25.4	157.6	98.3	42.7	40.8	42.8	29.0	27.7	199.5	219.4	79.3	183.6	56.2	68.1	58.9	65.1	167.1	64.0	29.0	49.7	80.8	73.6	142.6	65.8	112.2	119.3	17.3	16.8	16.1	23.6	17.2	18.0	25.0	17.3	18.4	22.5	17.8	20.2	20.9	1.5	0.0	1.1	0.0	1.7	0.6	1.3	1.7	0.0	0.6	0.4	0.3	3.1	1.5	1.3	3.7	0.0	5.9	1.4	4.4	0.0	7.2	0.6	0.3	0.1	1.4	3.6	4.6	0.0	12.0	2.3	0.8	3.1	0.2	0.0	0.3	1.4	2.5	2.8	0.0	0.0	6.3	2.0	6.9	5.5	0.1	0.9	2.1	7.2	0.0	3.3	0.2	1.0	0.0	0.0	10.5	7.8	0.0	0.5	1.0	48.3	3.6	0.5	0.3	0.0	0.2	1.6	0.4	0.5	0.0	2.3	4.1	1.9	0.1	5.0	0.7
SMIM11A	"C21orf51, FAM165B, SMIM11"	ENSG00000205670	"Small integral membrane protein 11A"	P58511	21	34375480-34416961	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"Gastric mucus-secreting cells: 12.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA051321	Uncertain		Approved	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"HPA051321: AB_2681440"	"unprognostic (2.62e-2)"	"unprognostic (4.28e-2)"			"unprognostic (1.27e-1)"		"unprognostic (5.86e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.04e-1)"		"unprognostic (4.48e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.74e-1)"		"unprognostic (8.84e-2)"	"unprognostic (4.83e-3)"	10.3	9.0	22.2	12.2	22.7	13.2	6.7	22.3	32.8	10.4	25.9	7.6	15.0	9.8	14.6	9.4	9.3	13.7	22.1	22.0	22.5	17.9	14.7	8.2	15.9	23.0	22.2	21.3	16.9	11.7	11.3	3.7	5.9	23.6	10.6	6.6	13.4	14.4	4.8	36.3	6.3	11.8	11.4	24.0	11.5	30.8	6.4	22.7	6.7	20.8	11.5	6.5	12.9	2.7	25.9	24.7	9.8	11.1	33.0	21.0	6.5	22.6	9.0	4.3	12.5	25.1	12.7	22.7	57.4	11.8	11.6	16.5	15.1	18.8	0.7	11.9	32.0	8.9	33.1	23.0	12.7	19.0	55.6	7.8	15.5	10.8	13.6	31.1	24.5	14.2	12.1	51.4	65.7	13.2	13.2	2.2	43.5	52.2	15.5	34.5	31.1	25.2	82.5	10.8	6.2	28.3	20.4	14.8	18.5	39.0	20.3	18.2	25.1	18.1	18.1	13.4	8.0	16.9	25.1	28.3	54.0	33.6	70.0	33.0	5.6	6.3	14.9	6.9	10.1	11.4	6.5	11.7	16.8	8.5	17.1	8.5	11.4	3.6	14.4	9.2	7.6	14.1	9.5	22.2	22.7	22.3	32.8	22.0	22.5	23.0	22.2	21.3	23.6	24.0	22.7	25.9	0.1	3.2	2.6	0.0	0.4	0.0	0.4	0.0	0.0	0.8	0.8	0.3	0.0	0.0	0.6	0.0	0.0	0.3	0.1	0.3	1.9	1.5	0.4	0.1	0.4	0.7	1.2	0.0	0.0	0.7	0.3	0.7	12.8	0.2	0.0	0.2	0.7	1.4	0.7	0.0	0.0	0.8	0.0	0.6	0.0	0.3	0.0	0.6	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.9	0.3	0.4	0.6	0.3	1.4	2.2	2.2	0.4	0.0	0.3	0.3	0.6	0.5	0.0	0.0	0.1	0.4	0.1	0.6	0.1
SNX31	MGC39715	ENSG00000174226	"Sorting nexin 31"	Q8N9S9	8	100572889-100663415	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 6.6;urinary bladder: 16.5"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 81.8"	"Cancer enriched"	"Detected in many"	22	"urothelial cancer: 24.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	49	"RT4: 80.7"	"Region enriched"	"Detected in single"	5	"thalamus: 2.6"	"Not detected"	"Not detected"			"HPA024284, HPA053466"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA024284: AB_1853894, HPA053466: AB_2682161"	"unprognostic (1.39e-1)"	"unprognostic (3.83e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.20e-5)"	"unprognostic (1.04e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.69e-1)"	"unprognostic (7.79e-3)"	"unprognostic (1.66e-1)"	"prognostic favorable (1.47e-4)"	"unprognostic (2.54e-1)"	"unprognostic (4.05e-2)"	0.5	0.1	1.5	0.0	1.4	0.2	0.4	0.9	3.3	0.4	0.4	0.2	0.0	0.3	0.2	6.6	0.3	1.1	1.7	2.3	0.8	0.2	0.5	0.1	0.4	1.6	0.1	0.9	0.4	0.3	0.3	0.2	0.0	1.8	1.4	0.1	0.2	1.2	0.2	0.6	0.6	0.1	0.5	0.3	0.1	0.7	4.0	1.6	0.3	0.5	0.5	3.6	16.5	1.7	1.7	0.0	0.0	0.0	0.3	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.6	0.1	0.1	0.1	0.1	0.0	0.0	0.0	80.7	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	1.6	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	1.5	1.4	0.9	3.3	2.3	0.8	1.6	0.1	0.9	1.8	0.3	1.6	1.7	0.5	0.0	0.0	6.2	0.1	0.4	3.3	0.2	9.6	0.0	0.2	0.6	0.6	0.0	0.3	0.0	0.0	0.0	0.1	0.0	1.9	0.0	81.8	0.2	0.1	0.4	0.0	0.0	12.8	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	19.7	0.6	0.2	0.0	1.0	0.0	0.0	0.0	1.0	0.9	0.0	0.0	1.2	0.1	0.8	0.0	0.1	0.0	0.0	0.0	0.3	3.7	0.3	0.5	9.7	0.4	0.0	0.1	0.0	0.0	6.0
SORT1	"Gp95, NT3"	ENSG00000134243	"Sortilin 1"	Q99523	1	109309568-109397918	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Endocytosis, Osteogenesis, Transport"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 282.9"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 447.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 9.2;non-classical monocyte: 10.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006889, CAB011498"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA	7170000	110000	"Golgi apparatus, Cytosol"	"Plasma membrane"	"CAB011498: AB_2192606, HPA006889: AB_1080056"	"unprognostic (2.10e-2)"	"unprognostic (7.46e-2)"	"prognostic favorable (7.74e-6)"	"unprognostic (4.12e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.23e-4)"	"unprognostic (3.34e-3)"	"unprognostic (4.27e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.45e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.95e-1)"	"unprognostic (4.46e-3)"	48.6	11.4	74.0	12.1	155.0	21.7	25.3	123.1	120.6	17.8	26.6	29.8	22.3	24.9	141.0	41.9	27.7	17.9	65.3	133.0	100.5	39.1	6.6	37.7	2.8	134.5	136.1	70.7	6.1	17.7	46.9	11.4	45.2	138.3	18.5	27.2	40.3	25.4	44.4	85.7	17.4	22.1	28.0	132.4	10.3	18.4	43.9	117.1	6.5	43.1	72.5	10.3	17.1	18.2	282.9	38.8	15.3	37.5	45.8	107.0	21.2	107.3	28.2	44.9	27.2	29.0	39.8	14.0	0.3	35.2	11.9	19.9	9.4	44.7	22.3	38.9	1.1	21.2	10.7	23.5	43.1	41.8	0.2	33.5	53.2	3.6	33.3	7.3	72.6	4.2	31.7	81.3	4.0	38.7	41.1	27.9	0.8	14.1	17.5	6.3	30.7	87.9	18.9	52.0	27.8	38.3	21.8	16.6	109.3	120.6	53.1	46.1	6.7	1.1	5.8	21.7	1.0	47.6	37.0	32.2	0.3	9.8	0.3	24.3	0.0	7.1	2.5	0.0	9.2	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	1.8	0.4	10.8	1.6	0.0	2.0	74.0	155.0	123.1	120.6	133.0	100.5	134.5	136.1	70.7	138.3	132.4	117.1	282.9	10.6	38.5	47.9	54.5	1.9	1.3	4.7	6.7	1.2	14.9	27.5	14.2	98.9	27.1	20.3	75.4	35.5	30.6	3.2	70.2	5.9	23.9	65.1	33.2	5.2	15.9	16.8	4.0	87.9	23.7	30.2	9.8	16.8	34.9	7.6	10.4	7.9	22.1	30.1	13.5	56.7	27.7	6.1	38.7	9.9	79.7	8.7	34.6	21.4	78.7	37.7	21.7	0.0	48.7	447.8	25.6	23.2	49.7	1.5	7.1	64.0	13.1	29.6	50.7	32.9	25.1	53.6	46.3	21.6	9.3	1.8	36.8	2.1	1.8	28.3	10.8
SP9	ZNF990	ENSG00000217236	"Sp9 transcription factor"	P0CG40	2	174334954-174338500	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 3.0"	"Cell type enriched"	"Detected in some"	5	"Inhibitory neurons: 11.1"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 7.2;fHDF/TERT166: 5.5;HEK 293: 2.2;THP-1: 11.6"	"Group enriched"	"Detected in many"	6	"basal ganglia: 5.8;olfactory bulb: 11.7"	"Group enriched"	"Detected in many"	4	"basal ganglia: 5.6;olfactory bulb: 21.6"	HPA062616	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA062616: AB_2684808"	"unprognostic (2.04e-2)"	"unprognostic (6.94e-3)"		"unprognostic (1.44e-1)"	"unprognostic (3.95e-1)"	"unprognostic (7.55e-3)"		"unprognostic (8.54e-2)"	"unprognostic (3.12e-1)"						"unprognostic (1.01e-1)"			0.0	0.0	2.5	0.0	3.0	0.0	0.2	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.0	1.3	0.3	1.2	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.2	7.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	5.5	0.0	0.1	0.2	0.0	0.0	0.0	2.2	0.5	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	3.0	0.0	2.8	0.6	0.9	1.3	0.3	1.2	0.7	0.0	0.6	0.4	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	1.3	0.5	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.5	0.0	0.1	0.0	0.1	0.1	0.0	0.0
SPAAR	"LINC00961, SPAR"	ENSG00000235387	"Small regulatory polypeptide of amino acid response"	A0A1B0GVQ0	9	35909490-35937153	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 10.8;breast: 10.9"	"Cell type enriched"	"Detected in some"	7	"Adipocytes: 42.3"	"Cancer enhanced"	"Detected in many"		"renal cancer: 2.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"HUVEC TERT2: 34.0;TIME: 40.1"	"Not detected"	"Not detected"													NA	NA						"unprognostic (3.17e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.91e-2)"	"unprognostic (7.00e-3)"	"unprognostic (4.23e-2)"	"unprognostic (2.61e-3)"	"unprognostic (6.95e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.40e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.72e-2)"	"unprognostic (7.12e-3)"	"unprognostic (1.67e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.22e-1)"	10.8	1.2	3.2	0.6	2.6	0.0	10.9	2.4	3.3	0.7	1.4	1.1	0.3	1.2	0.1	0.5	1.2	0.7	6.4	2.5	2.3	3.1	0.8	3.2	0.5	3.2	2.8	1.8	0.7	0.5	0.5	0.7	4.7	3.0	1.0	0.4	1.4	0.7	0.5	3.1	0.8	0.9	0.6	2.4	0.7	0.9	7.5	2.9	0.2	1.9	1.8	0.0	1.5	0.8	2.9	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.6	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.4	0.0	0.0	0.4	0.1	0.2	0.0	0.0	34.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	40.1	0.0	0.8	2.7	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	2.6	2.4	3.3	2.5	2.3	3.2	2.8	1.8	3.0	2.4	2.9	2.9	42.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	5.4	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0
SPATA18	FLJ32906	ENSG00000163071	"Spermatogenesis associated 18"	Q8TC71	4	52051304-52097299	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 68.9;testis: 29.0"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 2341.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 31.5;BEWO: 24.4;BJ hTERT+: 15.9;HSkMC: 29.3;hTCEpi: 28.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA036854, HPA036855"	Enhanced		Supported	Mitochondria		NA	NA			Mitochondria		"HPA036854: AB_10670927, HPA036855: AB_2675352"	"unprognostic (6.54e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.32e-5)"	"unprognostic (1.02e-2)"	"unprognostic (1.53e-2)"	"unprognostic (7.27e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.13e-2)"	"prognostic favorable (3.73e-9)"	"unprognostic (4.38e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.01e-2)"	"unprognostic (4.00e-2)"	2.1	5.0	5.4	0.7	2.2	0.0	6.3	2.6	1.5	10.8	13.2	4.2	2.1	4.2	2.0	4.7	68.9	6.7	1.6	1.9	16.3	5.4	5.5	8.0	0.3	6.0	5.5	0.8	1.8	2.0	4.5	4.9	1.9	5.3	4.2	5.6	0.1	10.2	5.6	0.8	6.6	2.2	3.1	8.3	0.6	5.0	29.0	2.6	3.2	1.2	1.3	0.9	2.8	3.4	3.9	0.0	3.8	1.8	0.0	12.7	31.5	24.4	9.3	15.9	0.6	0.7	0.0	1.5	0.0	0.0	12.3	0.2	0.3	0.1	7.1	0.3	0.0	1.1	0.0	0.0	8.0	11.2	0.0	0.0	29.3	28.7	1.0	4.5	5.1	6.9	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.9	2.0	1.0	0.0	0.0	9.7	0.0	0.2	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	2.2	2.6	1.5	1.9	16.3	6.0	5.5	0.8	5.3	8.3	2.6	3.9	0.3	9.6	3.0	0.3	0.0	5.2	8.5	9.4	8.6	0.0	6.0	6.7	2.2	8.6	15.1	0.0	0.0	1.7	0.3	1.8	1.9	1.2	561.1	124.6	1.8	1.2	1.8	0.0	1.7	2.6	1.8	4.3	11.2	4.7	2.5	1.9	1.4	3.4	0.3	0.0	0.5	1.6	6.1	0.6	1.6	2341.5	10.8	1.1	0.0	2.8	0.1	0.0	0.0	0.5	0.1	2.0	2.7	10.9	0.0	5.1	1.9	7.4	141.4	0.0	0.0	1.8	3.9	13.9	7.1	7.1	7.5	0.8	0.2	2.5	4.3	6.8
SPATA25	"C20orf165, dJ337O18.8, TSG23"	ENSG00000149634	"Spermatogenesis associated 25"	Q9BR10	20	45886489-45887635	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 24.2"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 304.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 6.7;HeLa: 6.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA041386			Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA041386: AB_2677446"	"unprognostic (1.88e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.92e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.75e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.57e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.67e-2)"	"unprognostic (3.14e-1)"	"unprognostic (5.07e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.93e-5)"	"unprognostic (1.12e-1)"	3.0	1.8	1.5	1.8	2.5	0.6	1.6	4.2	2.4	2.4	3.8	2.6	4.6	3.2	2.3	2.2	2.8	2.1	3.2	1.3	2.6	5.4	5.2	1.1	1.5	2.2	1.9	1.1	6.5	2.4	2.5	1.6	1.8	1.8	2.1	2.2	4.3	2.5	3.1	10.0	2.7	3.3	3.6	1.2	1.8	1.6	24.2	2.2	6.8	2.9	3.4	1.1	3.1	2.1	2.5	0.6	2.1	1.5	1.7	2.3	1.4	1.7	0.4	1.8	0.9	0.3	6.7	3.7	1.2	0.5	0.8	1.9	2.8	0.8	0.5	0.3	0.4	1.4	0.6	6.2	4.4	1.7	0.1	1.0	3.2	1.0	0.4	0.5	2.4	0.6	2.0	0.9	1.6	0.7	1.4	0.8	0.0	0.9	0.6	1.1	1.6	1.0	0.8	0.1	0.9	2.9	1.6	1.9	1.3	1.9	0.6	2.2	1.6	0.5	1.1	1.2	0.8	0.6	1.4	0.9	0.3	1.5	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.5	4.2	2.4	1.3	2.6	2.2	1.9	1.1	1.8	1.2	2.2	2.5	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	304.2	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.0	58.3	2.1	0.1	0.0	1.0	0.0	0.0	0.0	0.5	1.5	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.1	1.1	0.7	0.0	0.0	0.0	0.0	0.1	0.1	0.0
SPINK5	"DKFZp686K19184, FLJ21544, FLJ97536, FLJ97596, FLJ99794, LEKTI, LETKI, NETS, NS, VAKTI"	ENSG00000133710	"Serine peptidase inhibitor Kazal type 5"	Q9NQ38	5	148025683-148137382	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Hypotrichosis, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 1024.4;lymphoid tissue: 295.4;skin 1: 320.8;vagina: 587.3"	"Cell type enriched"	"Detected in many"	4	"Squamous epithelial cells: 1622.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 45.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 14.7;HeLa: 22.7;Karpas-707: 19.3;SuSa: 6.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA009067, HPA011351, CAB015347"	Enhanced		Enhanced	Vesicles	"Secreted in other tissues"	NA	NA		43000000	Vesicles		"CAB015347: AB_2196138, HPA009067: AB_1080084, HPA011351: AB_1857447"	"unprognostic (9.66e-3)"	"unprognostic (1.42e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.45e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.92e-3)"	"unprognostic (4.56e-1)"	"unprognostic (2.44e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.82e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.59e-1)"	1.1	0.3	0.0	0.5	0.1	0.0	17.7	0.0	0.2	162.0	0.0	4.8	0.3	0.6	0.3	1024.4	0.4	1.8	1.7	0.1	0.0	0.8	0.4	2.0	0.1	0.1	0.1	0.0	0.3	0.8	1.0	2.0	2.4	0.2	1.3	10.7	0.0	146.2	0.5	1.8	320.8	0.7	0.5	0.0	0.3	5.0	1.6	0.1	9.2	2.2	1.1	295.4	0.7	587.3	0.3	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.2	1.8	0.0	0.0	14.7	0.0	1.3	0.0	0.0	0.0	0.0	22.7	0.0	0.0	0.3	0.0	0.0	3.9	0.0	0.0	0.0	0.2	0.0	0.9	19.3	0.0	2.1	0.0	0.0	2.6	2.0	0.3	0.0	0.0	0.0	0.0	5.7	2.8	0.0	0.6	0.0	0.0	6.6	4.6	0.0	0.0	0.0	0.1	0.0	0.0	5.0	2.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.3	5.7	9.6	45.4	0.3	0.2	53.7	1.5	331.1	102.4	0.0	4.2	3.4	1.2	34.3	115.6	0.0	0.0	1.9	0.0	177.9	0.0	0.2	11.0	2.5	0.7	12.9	4.2	0.0	0.7	1.3	2.1	2.6	17.9	4.8	1.3	0.0	7.9	0.2	0.1	0.0	0.8	33.8	16.2	0.8	2.1	3.8	0.6	0.7	3.6	2.8	0.0	0.0	0.0	2.0	1.2	7.6	60.3	0.0	3.7	0.7	0.0	0.0	9.4	0.0	0.0	0.2	2.4	1.3	4.6	1622.6	64.4	1.5	1.1	1.0	97.9	2.7
SPP1	"BNSP, BSPI, ETA-1, OPN"	ENSG00000118785	"Secreted phosphoprotein 1"	P10451	4	87975650-87983426	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Biomineralization, Cell adhesion"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 1911.4;gallbladder: 2446.6;kidney: 3595.2;placenta: 2815.3"	"Cell type enriched"	"Detected in many"	8	"Hofbauer cells: 60702.5"	"Group enriched"	"Detected in all"	4	"glioma: 1690.9;renal cancer: 1385.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	10	"neutrophil: 24.8"	"Lineage enriched"	"Detected in single"	249	"granulocytes: 24.8"	"Cell line enhanced"	"Detected in many"		"EFO-21: 4825.8;Hep G2: 2469.7;RPTEC TERT1: 10348.3"	"Region enhanced"	"Detected in all"		"pons and medulla: 316.8"	"Low region specificity"	"Detected in all"			"HPA027540, HPA027541"	Enhanced		Enhanced	"Golgi apparatus"	"Secreted to blood"	NA	NA	114000000	73000000	"Golgi apparatus"		"HPA027540: AB_10600222, HPA027541: AB_10601446"	"unprognostic (4.74e-2)"	"prognostic unfavorable (9.52e-4)"	"unprognostic (1.13e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.31e-2)"	"unprognostic (6.96e-3)"	"prognostic unfavorable (2.84e-6)"	"unprognostic (2.46e-3)"	"unprognostic (7.86e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (5.89e-4)"	"unprognostic (4.31e-2)"	"unprognostic (2.55e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.48e-1)"	"unprognostic (2.63e-2)"	93.0	24.6	589.6	60.0	601.1	1.0	70.8	752.2	742.8	27.7	402.8	33.0	9.6	132.4	9.9	4.9	53.3	2446.6	26.4	454.8	930.8	3595.2	35.9	18.9	9.2	941.4	689.7	385.0	10.0	294.4	19.4	20.8	2815.3	817.7	15.9	7.7	752.0	89.4	22.3	16.2	2.3	14.5	38.6	904.2	9.3	11.1	11.8	708.7	8.5	8.4	0.4	5.8	25.3	6.0	1911.4	2.2	144.0	19.1	1.1	0.0	0.2	0.3	5.6	4.4	1.4	9.1	0.6	0.2	0.2	4825.8	2.3	371.5	1.4	0.0	0.0	3.1	11.2	0.0	0.0	1.8	2469.7	0.3	6.8	5.1	0.5	0.3	34.9	0.1	118.8	4.2	0.2	0.1	10.8	1.3	0.2	1.2	21.3	227.5	0.3	0.0	2.4	0.5	1189.8	10348.3	1.8	1.1	0.9	0.3	0.8	339.1	441.9	0.5	5.2	0.3	11.5	27.1	0.4	25.8	0.9	7.9	13.9	436.3	1.1	457.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.8	0.0	0.0	0.0	0.0	0.0	589.6	601.1	752.2	742.8	454.8	930.8	941.4	689.7	385.0	817.7	904.2	708.7	1911.4	35.7	3.2	4.7	5.2	34.0	1.5	5.2	0.1	1.2	46.6	1767.7	22.4	17.9	1584.2	0.3	2183.1	27.1	335.6	6.9	0.0	1003.7	7273.8	0.1	61.2	25.2	367.9	0.0	2.7	1.4	71.7	294.5	48.9	0.0	154.2	0.0	1.7	5.7	5.0	60702.5	785.7	9.9	0.0	0.0	57.4	7.7	1.0	0.9	247.7	1.8	99.3	69.2	3862.9	0.0	4.5	532.1	215.4	0.0	0.0	0.1	0.4	0.0	5594.0	1.6	169.7	0.0	0.9	21.6	0.5	0.2	1.1	1.0	667.8	30.0	0.4	0.0	9.9
SRGAP2	"ARHGAP34, FNBP2, KIAA0456, SRGAP2A"	ENSG00000266028	"SLIT-ROBO Rho GTPase activating protein 2"	O75044	1	206203345-206464443	"Disease related genes, Predicted intracellular proteins"	Neurogenesis	"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 107.9"	"Cell type enriched"	"Detected in many"	4	"Microglial cells: 497.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028191, HPA028196, HPA078079"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA028191: AB_10600309, HPA028196: AB_10601113, HPA078079: "	"unprognostic (2.57e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.40e-3)"	"unprognostic (1.67e-2)"	"unprognostic (5.20e-2)"	"unprognostic (4.22e-2)"	"prognostic unfavorable (9.61e-5)"	"unprognostic (1.98e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.09e-2)"	"unprognostic (3.06e-2)"	"unprognostic (6.08e-2)"	"prognostic unfavorable (4.61e-7)"	"unprognostic (2.70e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.18e-3)"	23.5	20.0	30.1	16.0	36.8	22.5	18.1	107.9	39.0	16.0	26.1	10.9	5.8	13.9	13.6	13.0	14.7	11.8	12.0	34.9	38.0	15.3	8.0	21.0	15.4	47.3	38.0	26.5	18.4	8.0	25.5	10.5	20.2	55.4	9.0	6.0	10.0	10.1	9.0	6.8	46.0	10.7	15.4	43.9	24.9	8.8	10.8	47.2	14.0	10.0	18.1	13.8	12.0	16.7	51.9	45.6	30.0	99.7	25.6	46.4	41.6	39.0	38.5	28.7	32.9	35.9	20.7	34.0	17.6	21.6	42.9	43.8	36.1	30.0	25.4	32.7	22.2	24.4	36.5	56.4	31.2	19.3	25.4	39.4	37.6	21.6	42.2	29.3	35.7	57.9	22.6	30.6	55.4	21.2	31.6	20.3	22.4	32.2	8.1	34.1	45.3	40.8	42.6	14.1	8.2	33.2	15.2	32.7	23.9	47.5	37.4	29.7	44.4	57.9	32.1	38.4	39.9	35.8	36.8	35.7	16.5	38.4	34.6	80.0	1.0	12.2	0.7	3.2	11.8	1.3	2.6	2.6	3.3	8.3	5.3	1.0	2.2	17.7	2.1	14.0	16.2	4.0	3.7	30.1	36.8	107.9	39.0	34.9	38.0	47.3	38.0	26.5	55.4	43.9	47.2	51.9	45.5	9.6	12.1	9.4	18.0	23.8	6.1	7.5	8.6	39.5	3.6	4.4	4.6	11.5	7.9	11.0	4.2	4.1	17.1	0.3	0.0	7.2	57.7	16.4	18.4	37.2	1.2	13.2	72.2	2.1	18.3	18.6	10.2	9.7	8.2	12.0	28.9	2.9	19.0	1.7	105.0	3.3	0.0	46.2	62.5	51.0	7.8	54.1	16.0	497.5	25.4	6.6	5.2	54.3	58.5	4.8	1.3	2.6	16.0	4.2	1.4	0.8	14.5	5.8	0.0	18.5	17.9	19.0	11.6	12.1	36.4	4.2	11.9	9.7	1.8	5.8
SRGAP2B	SRGAP2P2	ENSG00000196369	"SLIT-ROBO Rho GTPase activating protein 2B"	P0DMP2	1	144887265-145095528	"Predicted intracellular proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 44.8"	"Cell type enriched"	"Detected in many"	4	"Microglial cells: 239.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 3.6;granulocytes: 3.9;monocytes: 7.9"	"Low cell line specificity"	"Detected in all"											HPA078079			Approved	Cytosol		NA	NA			Cytosol		"HPA078079: "	"unprognostic (1.13e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.48e-3)"	"unprognostic (3.52e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.49e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.89e-2)"	"unprognostic (7.27e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.16e-5)"	"unprognostic (3.12e-1)"	"unprognostic (5.43e-1)"	"unprognostic (8.54e-2)"	"unprognostic (2.38e-1)"	9.2	10.6	9.4	6.9	9.1	7.8	6.2	44.8	10.0	6.0	5.8	4.1	2.8	6.2	4.2	5.7	6.8	5.8	4.7	10.2	11.6	8.1	4.2	8.7	5.6	14.9	13.1	6.6	8.7	3.7	13.2	3.1	10.9	17.8	3.7	2.8	3.7	3.3	4.6	9.0	19.0	3.6	7.1	15.7	12.5	3.0	3.5	16.1	6.4	4.3	5.8	3.7	5.1	6.5	16.0	13.4	28.5	60.3	12.5	28.3	24.3	19.0	14.6	12.8	12.2	14.0	8.7	24.1	6.7	19.1	8.7	21.7	22.8	15.6	8.5	15.0	6.3	15.8	9.8	20.6	12.1	19.8	8.8	12.5	17.3	12.6	30.1	26.4	18.4	24.8	5.7	5.3	23.1	6.7	15.1	3.8	10.3	11.2	6.7	10.2	10.3	12.9	11.6	10.5	5.8	7.5	9.5	19.3	6.9	31.6	14.9	14.4	22.1	45.3	26.1	26.7	23.3	17.1	9.6	12.7	4.1	9.5	11.6	37.7	1.2	3.8	0.5	0.6	5.4	0.5	0.9	1.0	1.2	2.7	0.9	0.6	0.7	3.9	0.4	7.9	3.6	1.1	0.9	9.4	9.1	44.8	10.0	10.2	11.6	14.9	13.1	6.6	17.8	15.7	16.1	16.0	37.3	25.6	7.7	5.5	14.0	0.0	3.5	0.0	6.8	17.6	3.1	3.4	3.3	5.7	2.5	9.2	2.1	4.7	20.3	0.5	0.0	6.8	1.1	13.8	14.0	35.1	2.4	29.3	37.5	3.0	21.5	15.3	3.1	6.0	1.3	3.3	54.3	4.3	12.9	0.0	55.6	2.0	0.0	58.7	0.0	2.7	15.2	40.1	0.0	239.8	38.4	8.1	16.5	24.6	9.5	6.0	0.2	9.8	8.4	4.8	0.8	1.2	8.0	2.9	6.6	16.9	12.3	4.5	6.9	19.9	0.0	2.9	6.9	8.6	1.8	4.2
SRMS	"C20orf148, dJ697K14.1, PTK70, SRM"	ENSG00000125508	"Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites"	Q9H3Y6	20	63540810-63547504	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"stomach 1: 1.6"	"Cell type enriched"	"Detected in single"	4	"Gastric mucus-secreting cells: 3.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.3;MCF7: 3.0;OE19: 4.4;RT4: 6.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB044668, CAB044669, HPA073987"	Uncertain		Approved	"Intermediate filaments,Actin filaments,Cytosol"		No	NA			"Intermediate filaments"	"Actin filaments, Cytosol"	"CAB044668: AB_10609403, CAB044669: AB_10608235, HPA073987: AB_2686650"	"unprognostic (2.26e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.52e-3)"	"unprognostic (8.32e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.47e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.63e-2)"	"unprognostic (6.48e-3)"	"unprognostic (7.28e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.73e-3)"	"unprognostic (2.58e-3)"	"unprognostic (4.75e-2)"	"unprognostic (4.97e-2)"	"unprognostic (2.54e-3)"	0.0	0.0	0.0	0.2	0.1	0.1	0.4	0.6	0.2	0.0	0.0	0.7	0.2	0.0	0.7	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.8	0.0	0.0	0.4	0.2	0.0	0.1	0.9	1.6	0.2	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.3	0.1	1.3	0.0	0.0	1.5	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.0	0.0	0.1	0.0	4.4	0.4	0.0	0.1	0.0	0.0	6.0	0.4	0.5	0.1	1.2	0.2	0.0	1.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SSX5		ENSG00000165583	"SSX family member 5"	O60225	X	48186220-48196795	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 1.1"	"Cell type enriched"	"Detected in single"	7	"Spermatogonia: 5.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"BEWO: 4.7"									"HPA045683, HPA071685"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA045683: AB_2679418, HPA071685: "									"unprognostic (1.20e-1)"						"unprognostic (2.96e-1)"	"unprognostic (1.23e-1)"		0.0	0.0	0.7	0.0	0.5	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.5	0.3	0.5	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.4	0.7	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.7	0.5	0.2	0.5	0.3	0.5	0.8	0.0	0.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ST8SIA6	SIAT8F	ENSG00000148488	"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6"	P61647	10	17315421-17454595	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.7;lung: 5.9"	"Cell type enriched"	"Detected in some"	5	"Microglial cells: 137.7"	"Cancer enhanced"	"Detected in some"		"breast cancer: 5.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	8	"HMC-1: 208.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA011635, HPA072708"	Uncertain		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"		"HPA011635: AB_2194921, HPA072708: "	"unprognostic (4.86e-3)"	"unprognostic (7.01e-2)"	"unprognostic (5.85e-3)"	"unprognostic (2.21e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.23e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.26e-4)"	"unprognostic (2.43e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.07e-3)"	0.7	0.3	5.6	0.4	3.6	1.8	5.2	2.9	3.8	0.3	2.7	0.6	0.3	0.4	4.6	0.5	0.3	0.5	3.4	2.7	2.8	0.8	1.0	5.9	0.2	5.0	9.7	2.3	0.4	0.2	0.0	0.3	1.1	4.2	1.5	0.4	0.5	0.6	0.2	0.2	1.1	0.4	0.3	3.2	0.6	0.3	0.3	7.8	0.3	0.4	0.8	0.4	0.2	0.4	4.0	0.2	0.2	0.1	1.7	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.6	0.6	0.0	0.1	0.3	0.3	0.5	0.1	0.0	0.0	0.4	0.2	25.9	0.4	0.5	0.0	0.0	208.0	0.1	0.0	0.2	0.1	1.8	0.0	0.3	4.6	0.4	2.5	1.9	1.1	0.4	2.1	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.0	9.3	0.2	1.1	0.0	3.6	0.1	0.3	0.0	0.1	0.1	0.2	0.1	0.1	0.4	0.1	1.7	0.5	0.5	0.5	0.1	0.2	0.1	0.3	0.3	0.2	0.3	0.3	0.4	1.0	0.7	0.3	0.2	0.8	0.2	5.6	3.6	2.9	3.8	2.7	2.8	5.0	9.7	2.3	4.2	3.2	7.8	4.0	0.6	0.0	0.0	2.6	0.1	0.6	0.1	0.2	0.0	0.0	10.0	3.9	0.8	0.0	0.2	0.0	0.0	0.0	5.5	1.2	0.0	0.0	0.5	0.1	0.0	10.9	0.0	25.5	3.0	0.0	0.0	0.3	0.0	0.8	10.2	2.8	26.7	0.0	0.1	0.0	4.4	0.0	0.0	0.9	0.0	0.6	0.0	0.2	8.8	137.7	0.2	0.0	8.2	1.5	1.1	0.1	0.1	0.0	1.8	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.8	0.3	0.0	0.0	0.0	2.4	0.1	0.0	0.1
STAB1	"CLEVER-1, FEEL-1, FELE-1, FEX1, KIAA0246, SCARH2, STAB-1"	ENSG00000010327	"Stabilin 1"	Q9NY15	3	52495338-52524495	"Predicted membrane proteins, Transporters"	"Inflammatory response"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 443.1"	"Cell type enriched"	"Detected in many"	4	"Hepatic stellate cells: 745.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	59	"classical monocyte: 9.4;intermediate monocyte: 5.7;myeloid DC: 2.5"	"Group enriched"	"Detected in many"	60	"dendritic cells: 2.5;monocytes: 9.4"	"Group enriched"	"Detected in some"	46	"HUVEC TERT2: 103.1;NB-4: 146.9;TIME: 128.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005434	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		96000000	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA005434: AB_1080097"	"unprognostic (1.18e-1)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (7.59e-4)"	"unprognostic (3.63e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.00e-3)"	"unprognostic (2.66e-2)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (3.88e-7)"	"unprognostic (3.16e-2)"	"unprognostic (9.40e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.08e-1)"	161.4	161.7	37.7	50.8	41.1	13.9	85.2	38.7	58.8	51.2	70.7	82.7	29.9	45.7	8.6	29.4	80.0	26.0	70.7	38.6	70.1	85.7	103.0	105.6	13.1	47.3	42.1	36.5	32.5	32.4	5.1	52.4	55.9	45.5	58.1	31.3	0.7	46.0	16.1	26.1	23.4	95.9	34.1	39.3	443.1	53.7	21.2	56.5	6.8	55.6	4.7	8.2	106.6	49.0	49.0	0.1	0.0	0.1	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.7	0.2	0.2	0.6	0.0	0.0	1.8	0.1	0.0	0.1	0.0	103.1	0.1	0.3	0.1	0.0	0.0	0.0	146.9	0.0	0.2	0.2	0.1	0.1	0.3	0.0	0.0	0.4	0.4	0.0	0.3	0.0	0.1	0.0	0.0	128.8	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.1	0.1	0.0	9.4	0.0	0.0	5.7	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	37.7	41.1	38.7	58.8	38.6	70.1	47.3	42.1	36.5	45.5	39.3	56.5	49.0	31.3	0.0	3.8	0.0	5.5	6.0	0.6	0.0	1.8	1.0	1.5	2.7	2.4	11.5	0.0	3.7	0.0	1.7	1.9	0.0	0.0	0.0	0.5	0.4	0.5	43.0	1.2	21.5	0.3	0.0	2.0	3.3	0.5	0.3	18.3	0.0	745.0	19.7	130.7	0.0	0.3	0.0	0.0	185.4	30.3	2.9	4.4	147.0	12.4	30.0	21.9	0.5	2.1	0.5	0.1	0.0	0.0	20.3	2.0	0.2	0.0	0.8	0.0	0.1	19.7	2.0	1.4	0.9	2.2	1.5	4.8	2.2	2.3	0.5	0.0	0.2
STAC2	24b2	ENSG00000141750	"SH3 and cysteine rich domain 2"	Q6ZMT1	17	39210541-39225945	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 57.3;breast: 56.7;retina: 122.0;skin 1: 44.3"	"Cell type enriched"	"Detected in many"	9	"Muller glia cells: 496.8"	"Cancer enhanced"	"Detected in many"		"breast cancer: 15.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"GAMG: 9.8;HeLa: 32.5;U-87 MG: 13.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA076925			Approved	Cytosol		NA	NA			Cytosol		"HPA076925: "	"unprognostic (1.70e-3)"	"unprognostic (1.05e-1)"	"unprognostic (3.09e-2)"	"prognostic unfavorable (4.05e-5)"	"prognostic unfavorable (5.61e-4)"	"unprognostic (1.42e-1)"	"unprognostic (8.66e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (6.66e-4)"	"unprognostic (1.12e-2)"	"unprognostic (5.16e-2)"	"unprognostic (2.35e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.17e-1)"	1.7	0.5	7.6	0.2	21.4	0.0	56.7	9.6	57.3	6.7	2.7	0.8	0.1	5.2	10.8	0.5	4.8	0.0	1.6	17.4	20.3	14.0	0.0	0.8	0.0	30.9	17.3	13.0	2.5	0.2	0.1	1.6	0.2	31.2	5.2	0.1	122.0	15.3	23.7	0.3	44.3	0.6	0.8	4.8	0.1	0.4	0.3	8.1	0.0	0.1	0.6	0.0	0.5	2.6	33.1	0.0	0.0	0.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	9.8	0.0	3.9	0.0	0.0	0.0	0.5	0.0	32.5	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.4	0.3	3.4	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	21.4	9.6	57.3	17.4	20.3	30.9	17.3	13.0	31.2	4.8	8.1	33.1	0.6	3.2	5.8	2.0	0.7	0.4	1.0	0.2	0.0	13.3	52.7	45.3	2.7	0.0	2.5	3.7	10.4	0.1	1.8	0.1	5.9	0.0	0.2	0.3	3.9	1.7	0.0	0.0	19.0	0.0	0.2	1.9	0.0	0.3	0.0	0.2	0.0	0.0	0.1	18.5	16.6	0.0	16.2	0.6	1.5	0.0	2.8	0.8	42.7	3.7	0.0	496.8	2.1	1.0	1.0	0.0	0.0	0.0	0.1	0.5	0.0	0.3	1.5	17.5	0.0	0.2	1.4	0.2	1.0	0.0	1.7	0.3	1.2	0.1	0.1	0.2
STEAP1B		ENSG00000105889	"STEAP family member 1B"	Q6NZ63	7	22419444-22727613	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.9;choroid plexus: 3.7"	"Cell type enriched"	"Detected in some"	10	"Oligodendrocytes: 129.9"	"Cancer enhanced"	"Detected in many"		"melanoma: 5.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	67	"memory B-cell: 8.4;naive B-cell: 4.9"	"Lineage enriched"	"Detected in single"	84	"B-cells: 8.4"	"Group enriched"	"Detected in many"	5	"hTEC/SVTERT24-B: 80.7;HUVEC TERT2: 105.0;K-562: 45.4;WM-115: 112.0"															NA	NA						"unprognostic (7.35e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.34e-3)"	"unprognostic (3.96e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.31e-5)"	"unprognostic (2.29e-3)"	"unprognostic (4.96e-2)"	"unprognostic (7.37e-3)"	"unprognostic (7.38e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.85e-10)"	"unprognostic (1.06e-4)"	"unprognostic (3.46e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.21e-3)"	1.0	0.5	1.2	1.1	3.2	0.1	0.8	1.9	2.7	0.9	3.7	0.6	0.1	0.2	0.4	0.6	0.3	0.7	0.4	1.7	2.2	0.1	0.2	0.4	1.6	3.5	2.7	1.3	0.1	0.3	0.1	0.3	1.2	3.6	0.5	0.5	0.3	0.4	0.6	1.2	0.4	0.3	0.6	1.5	1.8	0.4	2.3	2.1	1.1	0.2	0.6	1.6	0.8	1.7	6.9	13.5	0.1	8.3	0.0	6.3	9.2	0.0	9.7	1.1	0.2	0.3	0.0	0.3	1.7	2.7	16.9	2.8	0.0	12.3	0.1	0.4	0.5	1.1	0.0	0.3	0.0	0.9	0.0	0.1	10.6	0.0	80.7	0.2	9.7	105.0	0.4	45.4	4.5	0.0	0.0	0.1	0.0	16.8	0.0	0.1	1.7	0.0	5.4	0.1	0.0	0.0	0.2	0.3	0.0	6.4	1.0	0.1	0.0	12.3	1.0	0.4	11.5	0.1	1.1	9.8	12.2	17.7	0.0	112.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.2	3.2	1.9	2.7	1.7	2.2	3.5	2.7	1.3	3.6	1.5	2.1	6.9	2.4	0.0	0.0	1.6	4.6	0.0	0.0	0.2	0.0	0.1	0.2	0.3	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	5.1	0.4	0.1	1.3	0.0	0.0	9.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.1	0.5	11.8	2.1	0.0	0.0	0.3	0.5	1.5	0.0	1.3	3.6	5.6	11.9	0.0	0.0	7.5	129.9	0.4	0.0	0.4	0.8	0.1	0.0	0.0	0.1	0.2	0.0	0.0	2.7	7.4	11.6	0.1	0.1	0.1	0.0	5.1	0.2	0.1
STK19	"D6S60, G11, RP1"	ENSG00000204344	"Serine/threonine kinase 19"	P49842	6	31971091-31982821	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in all"	4	"Proximal tubular cells: 348.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.4;HEL: 1.5;HL-60: 1.6;REH: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031511, HPA068559"	Uncertain		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA031511: AB_2673915, HPA068559: AB_2686004"	"unprognostic (1.65e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.15e-2)"	"unprognostic (4.26e-2)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (3.95e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.40e-1)"	"unprognostic (4.10e-1)"	1.3	3.6	0.1	0.2	0.2	0.0	1.3	0.5	0.9	1.8	0.0	1.8	0.0	1.4	0.3	1.9	1.0	0.1	1.0	0.2	0.1	1.0	2.2	1.3	0.0	0.2	0.0	0.1	1.1	1.1	0.2	1.4	0.4	0.1	2.1	0.0	0.2	0.9	0.1	1.4	2.3	0.7	0.0	0.0	1.2	1.3	1.5	0.1	0.1	1.2	0.0	0.1	2.0	1.5	0.5	0.0	0.1	0.0	0.4	1.1	0.7	0.0	0.3	0.1	0.2	0.4	0.0	0.7	0.6	0.3	0.5	0.0	0.6	0.0	0.2	0.3	1.4	0.4	1.5	0.3	0.0	0.5	1.6	0.0	0.6	0.0	0.3	0.1	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	1.1	0.4	0.0	0.0	0.1	0.3	0.1	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.9	0.0	0.7	0.2	0.0	0.0	1.1	0.0	0.1	0.3	0.2	0.6	0.2	0.0	0.8	0.2	0.3	0.1	0.1	0.3	0.4	0.4	0.0	0.1	0.1	0.2	0.5	0.9	0.2	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.5	21.2	9.6	21.5	13.7	16.4	13.0	14.0	23.0	13.6	11.8	26.6	27.6	8.1	18.6	24.6	22.0	20.9	37.2	22.4	13.8	39.2	26.3	85.8	27.8	31.8	20.6	19.3	4.6	8.7	28.3	20.0	23.3	19.4	20.7	9.5	20.1	14.3	21.1	19.3	10.1	8.0	17.3	18.3	8.8	10.0	76.0	20.2	18.3	17.8	11.2	12.5	30.2	13.4	4.5	6.5	23.6	16.4	18.4	11.9	13.2	15.0	348.9	41.8	21.9	32.9	19.6	21.1	39.5	21.0	17.9	18.2	49.7	19.8	45.1	13.1	11.8
STK32A	"MGC22688, YANK1"	ENSG00000169302	"Serine/threonine kinase 32A"	Q8WU08	5	147234963-147387855	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.1"	"Cell type enriched"	"Detected in many"	19	"Oligodendrocyte precursor cells: 306.6"	"Group enriched"	"Detected in many"	5	"glioma: 4.3;melanoma: 11.9;thyroid cancer: 9.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"RT4: 13.6;SK-MEL-30: 48.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040236			Approved	Centrosome		NA	NA			Centrosome		"HPA040236: AB_10795416"	"unprognostic (1.90e-1)"	"unprognostic (4.71e-4)"	"unprognostic (5.32e-2)"	"unprognostic (3.49e-2)"	"unprognostic (7.62e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.96e-3)"	"unprognostic (4.85e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.87e-1)"	"unprognostic (8.38e-2)"	"unprognostic (2.50e-3)"	"unprognostic (5.53e-5)"	"unprognostic (2.48e-1)"	"unprognostic (3.20e-2)"	"unprognostic (3.67e-3)"	1.1	11.3	6.0	0.6	8.3	0.0	1.3	13.0	3.7	1.0	0.9	1.7	0.5	0.5	2.6	0.3	0.8	1.5	0.8	3.4	37.1	3.4	0.1	1.2	0.0	11.7	17.2	2.2	2.6	2.7	0.1	8.1	0.1	14.6	1.0	0.3	2.6	0.9	0.8	0.2	3.4	0.7	0.4	10.3	0.3	1.2	1.0	13.1	0.1	8.8	0.5	0.0	1.7	1.0	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.5	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.5	0.0	1.1	0.0	0.0	0.2	4.4	13.6	1.2	0.5	0.0	0.0	48.6	0.2	0.0	0.0	0.1	0.0	0.5	0.7	0.4	1.0	0.2	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	8.3	13.0	3.7	3.4	37.1	11.7	17.2	2.2	14.6	10.3	13.1	17.5	0.2	0.0	2.6	8.5	0.0	1.5	0.2	1.4	0.0	1.8	1.3	0.5	0.5	0.0	1.0	1.8	0.0	0.0	0.0	0.1	1.9	1.8	6.9	0.2	0.5	0.1	0.0	0.0	4.6	2.7	0.0	2.7	0.0	0.7	0.0	4.2	0.0	0.0	0.1	0.0	5.2	0.0	2.0	0.0	1.0	10.5	0.9	0.2	16.0	0.0	0.0	4.0	0.0	306.6	0.7	5.5	0.0	4.1	0.0	0.3	0.0	4.1	0.2	1.0	0.0	5.4	0.5	0.0	0.1	0.0	0.3	0.1	0.1	1.4	0.0	0.6
STRN	"PPP2R6A, STRN1"	ENSG00000115808	Striatin	O43815	2	36837698-36966536	"Cancer-related genes, Predicted intracellular proteins"		Calmodulin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 294.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017286	Approved		Approved	Nucleoplasm,Cytosol		No	No			Cytosol	Nucleoplasm	"HPA017286: AB_1857618"	"unprognostic (1.65e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.57e-3)"	"unprognostic (2.23e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.63e-3)"	"unprognostic (7.37e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.33e-1)"	"prognostic favorable (2.27e-4)"	"unprognostic (1.13e-1)"	"unprognostic (6.43e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.43e-2)"	8.4	4.8	4.7	9.5	15.2	15.1	8.7	10.8	11.2	7.3	1.3	9.2	8.1	6.2	3.9	21.4	5.3	6.9	21.4	5.4	9.2	8.5	7.6	7.9	7.8	12.2	12.0	2.7	7.8	5.7	7.4	2.5	10.1	11.9	5.5	10.8	10.2	10.8	5.0	11.7	11.1	8.7	7.8	12.0	8.2	9.1	8.1	12.1	13.4	6.2	11.6	12.7	8.5	10.1	24.4	38.3	19.0	25.2	10.4	13.3	18.0	24.6	14.8	14.2	14.5	13.3	19.4	12.2	24.7	11.8	19.7	20.6	17.6	21.4	17.0	17.9	27.9	16.0	40.2	16.4	10.3	12.1	24.9	21.8	11.4	12.9	23.2	18.3	10.7	18.6	10.0	30.4	19.2	18.2	11.1	24.7	7.4	19.8	15.7	9.4	15.9	38.5	11.2	9.7	31.0	4.5	15.1	22.4	16.9	13.6	13.7	12.2	9.2	24.9	25.4	25.4	16.0	20.1	19.5	31.0	21.6	13.2	23.2	18.2	1.3	0.2	0.4	0.5	0.4	0.2	0.4	0.4	0.3	0.1	0.2	0.2	0.2	1.0	0.2	0.4	0.2	0.1	0.1	4.7	15.2	10.8	11.2	5.4	9.2	12.2	12.0	2.7	11.9	12.0	12.1	24.4	26.5	9.6	10.0	38.8	18.8	20.6	12.3	11.3	21.6	12.7	16.0	9.4	55.4	8.6	17.4	23.9	20.9	8.0	22.8	25.0	9.8	10.5	1.9	14.2	14.3	19.4	11.4	26.5	65.3	8.4	10.3	13.6	20.4	26.2	5.1	16.0	16.4	7.9	8.8	18.5	55.2	17.8	10.2	20.7	10.0	2.1	9.6	18.0	8.8	47.8	20.3	10.1	35.0	55.3	294.0	16.8	14.1	12.4	14.3	19.3	13.0	8.5	8.2	16.9	0.0	13.6	16.5	15.2	19.2	31.4	33.2	16.3	19.4	17.7	16.0	39.4
SULT1A3	"STM, TL-PST"	ENSG00000261052	"Sulfotransferase family 1A member 3"	P0DMM9	16	30199228-30204310	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Catecholamine metabolism, Lipid metabolism, Steroid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 239.4"	"Cell type enriched"	"Detected in many"	4	"Proximal enterocytes: 129.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"classical monocyte: 61.3;intermediate monocyte: 53.2;myeloid DC: 33.7;non-classical monocyte: 25.0"	"Group enriched"	"Detected in all"	11	"dendritic cells: 33.7;monocytes: 61.3"	"Cell line enhanced"	"Detected in all"		"CAPAN-2: 166.9;Hep G2: 303.6;Karpas-707: 239.4"									"HPA049500, HPA051051"	Supported					NA	NA		160000			"HPA049500: AB_2680796, HPA051051: AB_2681327"	"unprognostic (2.61e-1)"	"unprognostic (1.72e-3)"	"unprognostic (1.98e-3)"	"unprognostic (4.98e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.27e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.18e-8)"	"unprognostic (2.34e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.48e-5)"	15.9	13.8	56.4	22.1	56.8	37.1	15.9	59.6	73.5	15.5	57.7	57.9	239.4	17.0	18.1	14.5	18.1	15.0	10.4	56.9	57.5	25.8	34.8	26.8	30.5	57.1	57.1	57.3	10.9	16.0	17.7	24.0	22.6	61.1	20.2	46.9	23.4	26.0	17.9	11.2	25.9	147.8	24.7	54.7	32.1	22.4	9.7	57.7	16.5	20.4	19.1	29.6	13.6	10.6	63.1	32.6	48.8	30.6	21.3	28.4	19.8	46.0	15.8	16.9	16.7	18.9	21.1	166.9	16.9	150.0	16.0	10.9	45.5	38.8	14.0	16.7	19.9	30.6	93.2	61.2	303.6	11.1	14.2	34.9	21.9	20.9	25.4	5.9	34.2	30.6	21.9	19.0	239.4	12.0	55.4	9.6	62.3	19.1	76.2	20.9	38.6	14.8	32.2	29.4	22.0	15.3	24.7	4.8	43.0	7.8	11.4	23.8	22.1	38.3	34.0	17.4	29.4	11.7	28.8	78.1	8.7	17.4	31.7	20.5	1.9	61.3	0.3	4.3	53.2	0.9	3.4	1.1	1.5	33.7	1.7	0.8	0.7	1.6	1.4	25.0	0.5	0.9	20.4	56.4	56.8	59.6	73.5	56.9	57.5	57.1	57.1	57.3	61.1	54.7	57.7	63.1	3.3	12.8	12.0	0.0	4.2	2.0	2.2	1.2	0.6	5.3	2.4	1.3	1.8	4.3	7.6	0.0	8.4	5.3	2.8	13.9	0.0	3.3	1.3	0.9	0.9	5.8	1.2	6.1	0.0	4.0	2.3	4.4	2.6	1.3	1.3	1.7	3.9	2.8	1.5	1.7	0.0	13.4	2.0	5.0	3.7	0.5	0.9	2.6	1.8	0.0	4.9	2.6	4.1	0.0	0.0	6.3	25.3	1.9	1.4	4.3	129.1	0.5	2.3	6.7	0.0	1.7	1.7	0.8	0.3	0.9	2.7	3.0	3.8	1.2	26.8	2.1
SULT1C2	"ST1C1, SULT1C1"	ENSG00000198203	"Sulfotransferase family 1C member 2"	O00338	2	108288639-108309915	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 70.6;stomach 1: 164.8"	"Cell type enriched"	"Detected in many"	7	"Gastric mucus-secreting cells: 553.0"	"Cancer enhanced"	"Detected in many"		"renal cancer: 10.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"RPTEC TERT1: 25.4;RT4: 7.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA007190	Approved					NA	NA					"HPA007190: AB_1857647"	"unprognostic (3.31e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.17e-3)"	"unprognostic (3.61e-2)"	"unprognostic (3.78e-1)"	"unprognostic (3.62e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.76e-1)"	"unprognostic (3.19e-2)"	"unprognostic (9.27e-2)"	"unprognostic (6.28e-2)"	"unprognostic (4.63e-2)"	"unprognostic (9.96e-5)"	0.7	0.0	0.4	0.6	0.4	0.0	0.9	0.3	1.1	2.4	6.2	2.5	29.5	0.5	16.0	0.3	2.0	6.2	1.0	0.5	0.4	70.6	2.9	2.2	1.9	0.3	0.4	0.1	0.2	5.4	6.0	2.9	1.3	0.3	0.5	5.2	0.0	1.4	0.9	0.6	0.1	3.3	0.8	0.8	0.5	164.8	0.1	0.6	0.4	19.6	0.6	0.8	0.7	0.5	1.3	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	2.8	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	1.0	0.0	0.0	0.2	1.8	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.3	0.0	25.4	7.3	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.3	1.1	0.5	0.4	0.3	0.4	0.1	0.3	0.8	0.6	1.3	7.0	3.2	14.1	0.3	1.0	1.5	1.6	0.0	0.0	0.9	0.3	0.1	2.2	15.7	3.1	20.2	2.1	0.3	0.0	3.9	58.7	7.6	0.1	5.7	0.8	4.8	0.0	0.0	0.4	0.2	0.3	2.6	553.0	5.6	1.3	0.2	3.3	0.9	18.6	1.7	0.2	6.4	12.2	0.3	5.4	0.2	0.0	2.7	0.0	3.7	0.1	0.1	0.0	0.0	0.1	6.2	6.8	0.0	2.0	2.8	9.6	73.4	1.0	1.5	0.0	2.9	1.2	0.7	0.3	0.0	1.8	0.1	1.1	0.1	4.9	1.3
SVOPL	MGC46715	ENSG00000157703	"SVOP like"	Q8N434	7	138594285-138701362	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"parathyroid gland: 4.2;salivary gland: 4.0"	"Cell type enriched"	"Detected in some"	8	"granulocytes: 76.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	14	"eosinophil: 2.1"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 2.1"	"Cell line enhanced"	"Detected in some"		"HMC-1: 8.8;MOLT-4: 2.0;NTERA-2: 1.9;RT4: 2.0;T-47d: 5.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA018035	Uncertain					NA	NA					"HPA018035: AB_2197028"	"unprognostic (6.70e-5)"	"unprognostic (1.96e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.49e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.69e-3)"	"unprognostic (2.59e-3)"	"unprognostic (7.16e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.46e-3)"	"unprognostic (5.03e-3)"	"unprognostic (2.22e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.51e-1)"	"unprognostic (8.51e-2)"	0.0	2.0	0.5	0.1	0.5	0.2	0.9	0.3	0.4	0.5	1.9	0.9	0.1	0.2	0.8	0.1	1.9	0.0	0.2	0.3	0.5	1.6	0.0	0.2	0.1	0.7	0.7	0.2	0.5	0.5	4.2	0.9	0.6	0.5	0.4	0.3	3.3	4.0	0.8	0.0	0.2	0.2	0.0	0.5	0.1	0.1	0.9	0.6	0.5	0.7	0.0	0.0	0.4	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.6	0.2	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	2.0	1.1	1.9	0.0	0.0	0.5	0.0	0.1	0.0	2.0	0.1	0.6	0.0	0.4	0.0	0.3	5.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.3	0.4	0.3	0.5	0.7	0.7	0.2	0.5	0.5	0.6	0.7	0.0	0.0	1.9	0.7	0.0	0.1	1.9	2.0	0.0	0.6	1.2	1.4	2.1	0.0	3.1	1.8	0.0	3.7	0.4	0.4	0.0	0.0	0.7	8.2	0.1	0.1	0.0	5.5	1.1	0.0	0.8	0.3	0.0	0.9	76.0	1.2	0.0	0.1	0.1	0.0	1.8	0.1	4.1	0.0	0.2	0.5	0.6	0.1	0.0	0.0	0.1	0.5	0.0	1.0	1.5	0.1	0.0	0.4	0.1	0.2	0.1	0.0	5.6	8.6	0.0	0.0	0.3	2.2	0.7	0.0	0.1	1.9	0.7	0.3	0.5	0.5
SYCP2	SCP2	ENSG00000196074	"Synaptonemal complex protein 2"	Q9BX26	20	59863564-59933655	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Meiosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 43.5"	"Cell type enriched"	"Detected in many"	5	"Spermatocytes: 468.5"	"Group enriched"	"Detected in many"	6	"breast cancer: 6.7;cervical cancer: 11.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 25.9;JURKAT: 47.2;MOLT-4: 54.4;SiHa: 92.2;T-47d: 82.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA062401, HPA065613"			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA062401: AB_2684752, HPA065613: AB_2685519"	"unprognostic (8.10e-3)"	"unprognostic (8.28e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.19e-3)"	"unprognostic (2.50e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.74e-1)"	"unprognostic (7.02e-3)"	"unprognostic (4.84e-3)"	"unprognostic (8.48e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.87e-3)"	"unprognostic (1.21e-1)"	3.3	0.8	2.5	1.5	3.2	2.4	14.1	10.2	4.7	2.1	0.2	1.3	1.7	1.6	1.2	1.0	1.3	2.4	2.0	2.6	2.0	4.4	1.1	2.2	2.6	3.3	3.1	1.8	0.7	6.7	0.7	1.9	4.0	5.3	3.8	1.1	1.5	4.4	1.0	1.3	2.8	2.4	0.7	1.6	3.1	6.2	43.5	2.2	1.3	2.4	1.0	1.7	1.8	1.5	4.2	0.3	1.3	0.2	1.4	0.6	0.8	1.4	4.1	1.1	1.8	0.2	25.9	2.6	0.1	4.0	1.8	0.8	0.6	0.5	0.1	1.0	8.5	0.6	0.2	6.1	0.4	0.2	0.4	19.0	0.4	0.4	0.4	0.0	0.9	0.0	47.2	0.2	0.0	0.9	12.5	54.4	2.9	0.4	1.5	0.3	0.0	0.1	0.2	2.1	6.1	0.2	4.5	92.2	13.3	3.3	1.6	82.6	4.7	0.5	0.1	2.8	11.2	0.0	0.0	0.0	0.0	0.0	1.7	5.2	0.7	0.1	0.7	0.8	0.0	0.8	0.2	0.4	0.5	0.0	0.2	0.2	0.4	0.7	0.0	0.0	0.0	0.3	0.2	2.5	3.2	10.2	4.7	2.6	2.0	3.3	3.1	1.8	5.3	1.6	2.2	4.2	11.5	0.0	1.1	24.5	1.4	1.0	1.1	1.0	0.0	1.9	12.7	9.4	3.6	2.8	6.3	1.8	2.1	0.8	3.0	0.1	1.9	0.9	82.3	0.4	5.0	6.5	0.0	0.0	27.5	3.6	0.4	2.1	2.6	0.5	2.5	1.2	2.9	0.0	0.5	0.0	14.6	0.1	0.0	1.2	0.8	21.8	4.7	1.6	5.4	13.1	1.4	2.3	5.2	28.6	11.1	1.2	1.2	1.9	0.4	1.8	0.3	5.4	8.6	1.1	52.6	1.7	3.8	468.5	92.4	0.6	0.0	0.4	4.1	0.2	0.3	1.2
SYT13	KIAA1427	ENSG00000019505	"Synaptotagmin 13"	Q7L8C5	11	45240302-45286341	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.2;gallbladder: 21.0;pituitary gland: 16.9"	"Cell type enriched"	"Detected in many"	7	"Enteroendocrine cells: 336.8"	"Group enriched"	"Detected in many"	5	"breast cancer: 13.5;colorectal cancer: 7.4;pancreatic cancer: 19.9;renal cancer: 16.9;stomach cancer: 11.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 19.1;NTERA-2: 8.8;RPTEC TERT1: 56.8;SCLC-21H: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046224, HPA056602"	Uncertain		Supported	Vesicles		NA	NA			Vesicles		"HPA046224: AB_10961288, HPA056602: AB_2683185"	"unprognostic (4.96e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.92e-2)"	"prognostic unfavorable (7.79e-5)"	"unprognostic (1.00e-2)"	"unprognostic (4.17e-2)"	"unprognostic (3.75e-2)"	"unprognostic (9.83e-3)"	"unprognostic (2.19e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.47e-1)"	"unprognostic (5.66e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.70e-2)"	"unprognostic (5.13e-2)"	0.1	4.7	4.9	1.5	12.5	0.0	0.2	1.5	30.7	0.0	0.0	12.4	12.7	0.2	0.0	0.0	0.2	21.0	5.2	15.7	14.0	9.0	0.3	0.5	0.0	6.8	8.3	17.3	0.0	7.1	0.4	16.9	0.0	12.2	1.9	12.7	11.4	1.9	0.0	0.1	0.2	12.9	0.8	0.0	0.1	11.1	1.7	9.0	0.3	1.6	0.1	0.0	0.0	0.0	31.2	0.0	19.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.2	0.0	1.1	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	8.8	0.0	0.2	0.0	0.0	0.0	56.8	0.0	15.0	0.7	0.0	0.0	0.1	0.7	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	12.5	1.5	30.7	15.7	14.0	6.8	8.3	17.3	12.2	0.0	9.0	31.2	0.0	0.0	0.0	4.6	0.1	0.0	0.2	0.0	0.0	3.3	0.1	0.3	15.3	17.2	0.0	3.7	25.0	0.0	0.0	10.2	5.9	1.2	3.1	0.4	0.2	0.1	336.8	0.0	41.6	0.6	0.0	1.7	3.6	2.0	0.0	2.5	0.0	0.0	0.0	1.7	43.8	37.3	4.1	0.0	0.0	9.7	0.3	0.0	0.0	5.6	0.0	0.7	0.0	1.5	3.5	8.2	14.3	0.0	0.0	2.3	13.9	0.5	0.0	2.7	0.0	0.0	0.2	2.0	0.2	0.0	0.0	0.0	0.0	0.0	32.8	0.2
TACR1	"NK1R, NKIR, SPR, TAC1R"	ENSG00000115353	"Tachykinin receptor 1"	P25103	2	75046463-75199520	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	7	"Inhibitory neurons: 83.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	23	"basophil: 2.2"	"Lineage enriched"	"Detected in single"	23	"granulocytes: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA074573	Enhanced					NA	NA					"HPA074573: AB_2686701"	"unprognostic (5.74e-4)"	"unprognostic (2.41e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.62e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.33e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.63e-2)"	"unprognostic (5.91e-4)"	"unprognostic (1.03e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.76e-2)"	4.5	0.3	1.5	0.8	2.6	0.0	5.1	0.0	5.8	5.0	0.5	0.9	0.2	3.0	0.7	1.2	2.9	1.1	0.1	0.5	3.9	0.7	0.0	0.8	1.3	2.2	3.6	1.1	0.6	0.1	0.2	0.1	0.5	5.9	1.5	0.5	1.0	1.5	1.0	0.3	4.0	0.7	2.8	0.7	0.0	0.5	0.0	1.9	1.1	0.5	0.3	1.3	2.0	2.7	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.6	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.6	0.0	5.8	0.5	3.9	2.2	3.6	1.1	5.9	0.7	1.9	3.4	7.6	0.0	0.0	1.0	0.0	2.5	0.0	0.0	0.0	1.0	0.3	0.3	1.4	0.0	0.0	0.0	2.1	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	11.8	0.0	0.0	4.5	0.0	0.2	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	83.2	0.2	0.0	0.0	2.6	0.9	0.0	0.0	7.2	2.8	0.0	0.4	0.0	3.5	4.2	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	3.3	0.0	0.2	0.2	0.0	0.0	0.1	1.8	0.1	0.1	0.0	0.0	0.2
TAL1	"bHLHa17, SCL, TCL5"	ENSG00000162367	"TAL bHLH transcription factor 1, erythroid differentiation factor"	P17542	1	47216290-47232220	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 29.6"	"Cell type enriched"	"Detected in some"	4	"Erythroid cells: 151.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 153.7;HMC-1: 70.6;HUVEC TERT2: 31.2;JURKAT: 60.0;K-562: 48.9;MOLT-4: 26.3;TIME: 34.4"	"Region enriched"	"Detected in many"	5	"midbrain: 14.3"	"Low region specificity"	"Detected in many"			"CAB017805, HPA047866, HPA073983"	Approved		Enhanced	Nucleoplasm		Yes	NA			Nucleoplasm		"CAB017805: , HPA047866: AB_2680192, HPA073983: AB_2732246"	"unprognostic (2.63e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.80e-3)"	"unprognostic (3.95e-3)"	"unprognostic (1.33e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.99e-2)"	"unprognostic (5.42e-3)"	"unprognostic (3.68e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.18e-2)"	7.0	2.6	5.0	1.0	4.3	29.6	6.4	4.6	4.9	2.8	4.0	2.1	0.8	2.9	0.6	1.8	3.6	2.4	4.7	4.3	4.7	4.4	1.5	13.1	1.4	6.2	6.3	3.2	1.2	0.9	0.9	1.7	7.0	6.4	2.1	1.3	0.2	1.1	0.9	2.1	1.6	3.1	2.7	7.2	7.2	1.8	0.9	7.0	0.4	5.4	2.6	0.7	2.5	2.5	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.2	0.1	153.7	0.0	0.0	0.0	0.0	70.6	0.0	0.0	0.0	0.0	0.0	31.2	60.0	48.9	0.1	0.0	0.0	26.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.1	34.4	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.5	5.0	4.3	4.6	4.9	4.3	4.7	6.2	6.3	3.2	6.4	7.2	7.0	6.9	23.9	0.0	0.0	0.0	0.5	0.9	0.0	0.0	0.0	0.0	0.1	0.1	3.7	1.5	1.3	1.8	0.0	0.1	0.0	0.0	0.0	0.1	5.3	0.0	0.1	18.1	0.0	151.5	0.0	0.0	0.3	0.6	0.0	0.0	36.8	0.0	26.7	0.1	10.6	0.0	0.1	0.0	0.0	1.6	1.5	18.2	0.0	4.8	1.8	29.0	0.8	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.4	1.3	0.4	0.1	1.0	0.0	2.0	0.0	0.0	0.0
TASL	"CXorf21, FLJ11577"	ENSG00000120280	"TLR adaptor interacting with endolysosomal SLC15A4"	Q9HAI6	X	30558809-30577766	"Disease related genes, Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.7;lymphoid tissue: 11.0"	"Cell type enriched"	"Detected in some"	5	"Hofbauer cells: 22.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	7	"THP-1: 166.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA001185	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA001185: AB_1078591"	"unprognostic (1.37e-1)"	"unprognostic (2.52e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.47e-2)"	"unprognostic (5.25e-3)"	"unprognostic (9.07e-3)"	"unprognostic (5.94e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.43e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.66e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.23e-2)"	1.8	1.8	0.7	11.0	0.8	19.7	2.1	0.8	1.6	1.1	1.8	3.5	4.8	0.6	0.4	1.6	0.8	3.9	0.6	0.8	1.5	1.1	2.4	4.8	10.5	1.4	0.9	0.5	0.3	0.3	0.7	0.3	2.9	1.3	1.0	3.4	0.2	1.0	0.7	0.1	0.7	3.0	2.2	1.6	9.9	3.6	0.3	1.4	5.8	0.6	0.4	10.3	4.1	0.3	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.2	0.0	0.0	13.8	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	21.5	0.0	0.0	0.0	20.5	0.0	21.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	166.0	0.0	0.0	0.0	0.0	0.1	15.0	1.6	7.5	0.0	23.9	0.0	8.6	21.9	24.1	1.6	19.8	0.3	23.0	2.0	1.1	25.3	23.6	1.8	1.3	30.6	7.1	44.4	45.9	3.4	8.0	0.7	0.8	0.8	1.6	0.8	1.5	1.4	0.9	0.5	1.3	1.6	1.4	2.1	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	22.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0
TBC1D16	"FLJ20748, MGC25062"	ENSG00000167291	"TBC1 domain family member 16"	Q8TBP0	17	79932343-80035872	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Horizontal cells: 307.9"	"Cancer enhanced"	"Detected in all"		"melanoma: 35.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.9;non-classical monocyte: 2.3"	"Lineage enhanced"	"Detected in single"		"monocytes: 2.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 179.1;SK-MEL-30: 192.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024482, HPA065839"	Approved		Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA024482: AB_1857790, HPA065839: AB_2685566"	"unprognostic (4.53e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.06e-2)"	"unprognostic (4.92e-2)"	"unprognostic (7.21e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.72e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.23e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.52e-3)"	"unprognostic (3.02e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.65e-3)"	"unprognostic (3.99e-3)"	37.6	8.2	14.8	8.8	22.6	0.9	18.6	19.1	16.1	10.3	4.5	7.9	8.0	12.5	11.6	10.2	13.1	9.6	10.8	7.7	11.6	17.3	7.4	9.0	7.9	14.4	19.9	7.1	11.9	15.8	13.0	7.0	7.5	19.2	17.9	6.0	7.7	29.7	10.9	5.2	17.4	9.1	10.6	9.6	7.3	8.5	4.1	32.1	4.0	10.2	6.7	3.5	8.6	6.2	12.4	30.3	28.2	43.1	50.8	179.1	93.7	8.2	17.3	17.1	10.7	12.0	53.6	10.3	0.1	11.9	29.2	20.3	9.4	45.8	16.2	8.2	1.5	21.5	0.0	13.3	25.1	30.5	0.6	4.1	106.1	28.1	23.2	16.7	17.1	45.9	19.8	7.2	19.6	20.2	18.4	8.1	2.7	51.8	39.3	15.4	25.4	27.2	17.5	12.6	36.5	43.8	56.8	15.4	42.5	192.4	26.7	27.9	13.6	31.3	37.1	26.1	29.5	15.3	59.9	11.4	3.3	15.9	11.2	47.8	0.0	0.1	0.0	0.0	1.9	0.2	0.0	0.0	0.1	0.1	0.5	0.1	0.1	0.0	0.0	2.3	0.0	0.0	0.2	14.8	22.6	19.1	16.1	7.7	11.6	14.4	19.9	7.1	19.2	9.6	32.1	12.4	5.7	0.0	7.9	15.7	1.7	5.5	5.2	4.3	2.8	8.5	12.3	7.5	8.1	17.2	5.5	7.3	10.4	6.1	0.3	3.1	9.8	15.1	0.9	15.3	22.7	10.4	31.8	3.6	7.3	22.1	1.5	17.5	9.7	26.0	7.6	23.8	14.6	17.9	3.2	307.9	8.9	6.3	14.2	58.4	3.1	2.2	5.9	6.4	76.5	37.5	0.9	23.1	2.1	14.6	4.9	17.4	4.8	7.9	0.4	12.5	3.5	13.5	8.2	7.0	6.6	19.3	10.3	0.3	4.3	5.8	4.5	1.9	2.7	7.6	7.0	5.9
TBC1D3B	"PRC17, TBC1D3I"	ENSG00000274808	"TBC1 domain family member 3B"	A6NDS4	17	36165681-36176636	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 13.9"	"Cell type enriched"	"Detected in some"	12	"Early spermatids: 20.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 8.6;HeLa: 8.7;T-47d: 5.9"									"HPA046969, HPA047745, HPA052553"	Approved		Uncertain	Vesicles		NA	NA			Vesicles		"HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869"	"unprognostic (1.05e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.17e-1)"	"unprognostic (7.15e-2)"	"unprognostic (9.96e-3)"	"unprognostic (1.05e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.34e-1)"	2.3	4.1	3.6	1.3	2.5	0.9	2.5	3.7	4.4	3.4	2.5	3.5	1.4	2.2	0.2	5.8	3.2	0.7	2.1	4.8	3.8	3.6	4.3	3.1	1.0	4.5	3.1	3.4	4.0	3.6	0.4	5.0	0.5	5.3	5.1	0.5	2.4	4.3	1.0	3.7	5.9	4.3	0.5	0.4	4.9	3.1	13.9	3.1	0.8	3.2	0.3	0.6	4.2	5.1	5.9	1.1	1.8	1.1	1.3	1.1	1.3	3.6	0.9	0.5	1.0	1.5	0.4	8.6	0.2	0.7	0.5	0.4	3.8	0.5	0.8	0.3	1.5	2.8	0.6	8.7	0.5	0.6	0.2	1.0	1.1	1.7	1.1	0.2	2.4	0.7	0.9	0.5	0.8	0.3	0.1	0.8	3.4	0.4	0.3	0.4	1.1	0.3	0.1	1.1	1.1	0.7	0.9	0.8	0.5	0.6	1.4	5.9	0.8	2.0	0.4	0.3	2.9	0.4	1.2	1.0	0.4	1.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.6	2.5	3.7	4.4	4.8	3.8	4.5	3.1	3.4	5.3	0.4	3.1	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1
TBC1D3C	MGC44903	ENSG00000278299	"TBC1 domain family member 3C"	Q6IPX1	17	38057693-38068592	"Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 7.1"	"Cell type enriched"	"Detected in single"	9	"Early spermatids: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"CAPAN-2: 34.4"									"HPA046969, HPA047745, HPA052553"	Approved		Uncertain	Vesicles		NA	NA			Vesicles		"HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869"																		1.0	1.5	1.5	0.5	1.5	1.8	1.2	1.7	2.8	0.9	1.5	1.3	0.5	2.1	0.0	2.3	2.3	0.7	0.9	1.5	1.3	1.5	2.1	1.3	0.7	2.1	2.0	1.5	1.8	1.6	0.0	1.9	0.2	3.0	2.5	0.0	1.6	1.7	0.1	1.3	2.2	2.1	0.2	0.6	2.3	1.3	7.1	1.2	1.5	1.2	0.0	0.6	1.6	2.1	1.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.4	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.1	7.7	0.1	1.2	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.8	0.0	1.0	0.1	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.6	0.3	0.0	1.2	0.0	0.0	3.3	6.9	3.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.5	1.7	2.8	1.5	1.3	2.1	2.0	1.5	3.0	0.6	1.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TBCE	"HRD, KCS, KCS1, pac2"	ENSG00000284770	"Tubulin folding cofactor E"	Q15813	1	235367360-235452443	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Chaperone	"Disease variant, Dwarfism, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	14	"Cardiomyocytes: 16.4"					"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"											"HPA026552, HPA026557"	Approved					NA	NA					"HPA026552: AB_1857797, HPA026557: AB_1857798"																		2.8	4.2	2.2	2.4	2.2	2.1	2.5	3.1	4.1	2.8	2.1	3.9	2.7	2.6	0.6	3.5	1.9	2.4	5.2	2.1	2.5	3.7	5.6	1.9	2.2	2.3	2.3	2.2	2.0	1.6	3.0		3.2	2.4	2.6	3.3	4.5	3.3	1.9	8.0	2.1	1.3	2.0	2.1	2.0	3.7	1.7	2.3	2.1	6.8	1.6	2.9	2.7		2.4	14.5	26.9	12.6	7.9	14.1	15.8	11.2	20.3	9.9	21.6	26.9	23.0	11.1	14.7	36.6	8.7	14.4	7.6	18.6	12.6	16.5	24.8	28.2	15.7	11.4	17.8	20.4	25.0	10.8	17.1	11.7	17.1	17.8	7.9	10.9	18.2	60.5	6.5	21.4	7.6	9.2	10.6	23.8	40.3	2.3	14.1	26.7	30.4	21.2	11.4	10.5	6.5	15.4	8.3	16.9	12.0	21.7	14.0	12.8	13.9	8.7	18.0	17.8	9.8	29.1	16.8	11.4	14.8	20.8	0.3	0.8	0.6	0.5	1.7	0.5	0.1	0.5	0.4	0.9	0.4	0.1	0.3	0.1	0.3	0.7	0.2	0.3	0.4	2.2	2.2	3.1	4.1	2.1	2.5	2.3	2.3	2.2	2.4	2.1	2.3	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TBX1	"CATCH22, VCF"	ENSG00000184058	"T-box transcription factor 1"	O43435	22	19756703-19783593	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 62.0;tongue: 36.8"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 181.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 24.6;K-562: 121.6;NB-4: 28.6;TIME: 40.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA029330			Approved	"Nuclear bodies,Cytoplasmic bodies"		NA	NA			"Nuclear bodies, Cytoplasmic bodies"		"HPA029330: AB_2673002"	"unprognostic (2.54e-1)"	"unprognostic (4.28e-3)"	"unprognostic (7.53e-3)"	"unprognostic (1.59e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.63e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.53e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.30e-3)"	"unprognostic (9.14e-2)"	"unprognostic (4.44e-1)"	"unprognostic (8.31e-2)"	"prognostic favorable (8.90e-4)"	3.8	0.6	0.5	1.0	0.6	0.1	8.0	0.5	2.2	5.8	1.8	1.8	0.7	2.7	0.2	3.0	7.8	0.4	0.6	0.5	0.3	0.4	0.4	4.3	2.9	0.5	0.3	0.2	2.3	0.3	7.7	0.7	0.1	0.7	5.3	0.3	0.0	8.2	0.5	62.0	8.9	3.0	0.6	0.2	0.6	1.2	16.9	0.7	0.0	11.3	36.8	1.2	2.7	7.1	1.0	15.3	1.4	0.2	10.7	0.0	0.0	2.1	0.2	0.0	0.0	0.0	1.1	0.1	0.3	0.3	0.3	1.5	0.8	12.0	10.4	0.0	0.6	24.6	0.2	2.9	0.0	0.0	0.1	0.1	0.1	0.1	2.4	0.0	0.0	0.0	0.5	121.6	0.0	7.7	2.8	0.3	28.6	1.7	0.0	16.8	0.3	10.6	0.1	0.0	0.0	1.5	0.4	0.0	0.2	0.0	3.1	5.1	7.7	40.0	0.1	0.4	0.2	0.2	0.3	0.5	0.1	0.0	0.2	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.5	2.2	0.5	0.3	0.5	0.3	0.2	0.7	0.2	0.7	1.0	11.4	0.0	2.8	0.0	0.3	2.4	1.6	3.3	0.0	0.6	1.1	0.9	2.4	0.0	1.6	0.0	0.0	0.2	0.6	0.1	0.0	0.0	43.3	0.2	0.1	7.5	0.0	0.0	0.3	0.2	1.7	1.5	0.0	0.2	2.5	0.1	2.5	0.0	2.0	0.0	0.9	1.0	6.1	1.3	3.6	181.9	2.5	1.0	0.0	0.0	0.1	0.3	2.1	0.0	0.0	0.1	0.0	2.2	0.0	1.0	0.1	0.0	2.3	0.1	0.0	1.1	0.8	1.9	12.8	0.3	2.4	0.1	0.7	0.0	0.2	2.0
TBX18		ENSG00000112837	"T-box transcription factor 18"	O95935	6	84687351-84764598	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"Microglial cells: 91.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 57.4;ASC diff: 39.0;ASC TERT1: 40.4;RH-30: 37.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA006807			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA006807: "	"unprognostic (8.04e-2)"	"unprognostic (7.06e-3)"	"unprognostic (9.71e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.00e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.92e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.88e-14)"	"unprognostic (4.81e-5)"	"unprognostic (1.86e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.78e-1)"	6.9	2.0	1.9	0.9	2.3	0.0	6.1	1.1	4.0	1.8	7.0	0.7	0.1	1.4	0.4	3.1	1.9	1.5	5.0	1.3	1.5	0.3	0.3	0.3	1.8	2.1	1.6	0.6	2.7	0.5	0.4	1.6	1.8	1.6	0.6	0.4	0.1	1.6	1.1	1.3	4.1	1.1	0.5	1.5	0.0	0.4	1.0	1.9	0.6	1.7	1.4	0.2	4.6	2.9	1.7	0.0	57.4	0.0	0.0	39.0	40.4	0.0	23.5	11.5	17.4	16.5	0.4	0.0	0.1	0.0	9.8	0.0	3.0	0.0	13.8	14.0	0.0	23.2	0.0	0.0	0.0	5.0	0.0	23.1	17.1	1.3	12.1	25.8	0.0	20.2	0.0	30.7	0.2	12.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	37.3	0.0	0.3	0.0	0.2	1.2	0.0	1.0	9.0	1.4	0.0	31.0	18.2	0.0	4.8	17.6	0.0	0.3	0.0	0.0	10.9	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.3	1.1	4.0	1.3	1.5	2.1	1.6	0.6	1.6	1.5	1.9	1.7	1.6	0.0	0.0	0.3	0.0	5.5	0.0	0.4	0.0	0.0	0.2	0.3	2.3	0.0	0.3	0.0	0.0	0.1	0.1	0.2	0.0	0.0	6.9	0.0	0.1	1.6	0.0	0.0	0.1	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.4	0.0	2.1	6.1	2.3	1.2	0.1	8.8	91.8	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.4	0.0	0.0	1.0	0.1	0.2	0.1	0.0	1.6	16.9	0.4	3.1	0.1	4.4	0.1	0.8	0.8	0.3	0.0
TBX3	"TBX3-ISO, UMS, XHL"	ENSG00000135111	"T-box transcription factor 3"	O15119	12	114670255-114684175	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 179.9"	"Cell type enriched"	"Detected in many"	4	"Syncytiotrophoblasts: 613.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 49.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 103.0;BJ hTERT+: 97.3;RT4: 129.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA005799, HPA075876"			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA005799: AB_1857817, HPA075876: "	"unprognostic (3.27e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.40e-2)"	"unprognostic (5.97e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.99e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.64e-3)"	"unprognostic (1.09e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.01e-1)"	"prognostic favorable (3.28e-4)"	13.0	179.9	6.0	2.5	4.3	0.0	34.4	3.8	5.8	35.8	3.3	7.3	37.9	33.1	45.0	2.9	24.2	4.6	10.3	3.8	18.8	9.5	31.5	33.1	1.4	4.5	4.4	2.7	44.6	2.9	1.0	13.0	41.6	5.1	81.1	3.8	1.9	19.1	53.7	10.5	14.7	30.5	10.1	3.6	7.1	6.1	1.3	6.0	1.3	50.5	16.7	1.8	54.4	34.5	4.5	2.4	18.2	0.0	0.0	26.1	35.6	40.1	103.0	97.3	39.0	38.3	16.3	4.4	0.0	1.6	18.0	2.4	4.7	8.4	3.6	47.7	0.0	12.3	0.0	4.8	48.1	8.4	0.0	0.0	16.0	2.4	13.1	26.8	0.0	0.5	0.0	3.8	0.0	3.4	1.6	0.0	0.5	0.2	53.0	5.4	0.0	0.0	2.6	0.0	129.3	6.6	19.4	14.6	6.6	3.6	44.6	5.1	0.2	0.0	11.9	7.7	6.8	33.9	0.0	0.0	0.0	24.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	4.3	3.8	5.8	3.8	18.8	4.5	4.4	2.7	5.1	3.6	6.0	4.5	48.9	0.0	1.9	0.3	1.8	9.8	85.2	5.8	7.4	14.3	110.3	80.5	12.5	0.0	1.1	35.0	4.2	60.7	0.7	12.0	0.0	0.6	1.5	3.3	144.7	38.6	4.9	0.0	0.0	0.0	7.0	41.3	5.1	3.8	0.0	3.9	1.1	40.2	6.1	1.7	0.0	23.9	4.1	0.9	4.6	2.8	5.3	2.9	3.6	14.0	0.0	1.9	0.0	0.0	0.0	0.3	22.4	6.0	0.0	72.4	37.9	0.1	0.4	2.0	39.5	27.2	58.2	0.1	3.8	3.2	9.8	613.9	2.0	112.0	12.1	69.1
TCF15	"bHLHa40, EC2, PARAXIS"	ENSG00000125878	"Transcription factor 15"	Q12870	20	603797-610398	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 17.5;skeletal muscle: 13.3;tongue: 9.2"	"Cell type enriched"	"Detected in some"	6	"Adipocytes: 260.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 3.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HEL: 10.6;HMC-1: 16.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA050998, HPA060221"	Approved		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA050998: AB_2681302, HPA060221: AB_2684225"	"unprognostic (2.12e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (3.25e-4)"	"unprognostic (1.52e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.27e-3)"	"unprognostic (7.21e-2)"	"unprognostic (8.56e-2)"	"unprognostic (5.11e-1)"	"unprognostic (6.99e-2)"	5.8	0.6	1.5	0.1	1.1	0.0	4.6	1.2	1.4	0.2	0.9	1.2	0.1	0.8	0.0	0.3	0.4	0.1	17.5	1.1	1.2	0.7	0.2	0.6	0.1	1.3	1.3	1.0	0.2	0.3	0.1	0.4	3.3	1.4	0.3	0.0	0.0	0.6	0.0	13.3	0.2	0.5	0.2	1.2	0.0	0.6	2.0	1.5	0.0	0.5	9.2	0.0	0.9	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	1.5	0.0	0.0	0.0	2.9	10.6	0.0	0.0	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	1.5	0.0	1.3	0.0	3.0	0.0	1.4	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.1	1.2	1.4	1.1	1.2	1.3	1.3	1.0	1.4	1.2	1.5	1.3	260.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.6	0.5	0.6	1.0	15.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.7	0.2	0.2	41.2	0.0	0.0	0.0	0.0	0.1	2.2	0.0	0.6	0.0	0.1	7.1	0.0	0.1	1.7	0.5	0.0	0.0	0.0	0.4	0.2	0.0	0.5	0.0	2.8	0.0	0.1	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	13.1	3.7	23.3	2.3	0.6	0.0	0.0	0.0	0.2	0.5	0.0	0.0
TCL1B	TML1	ENSG00000213231	"TCL1 family AKT coactivator B"	O95988	14	95686426-95692628	"Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 1.2;lymphoid tissue: 2.5;testis: 2.6"	"Cell type enriched"	"Detected in some"	8	"Syncytiotrophoblasts: 72.7"	"Cancer enriched"	"Detected in single"	72	"testis cancer: 8.3"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	24	"naive B-cell: 11.7;plasmacytoid DC: 6.2"	"Group enriched"	"Detected in many"	24	"B-cells: 11.7;dendritic cells: 6.2"	"Cell line enriched"	"Detected in some"	7	"U-698: 511.8"					"Not detected"	"Not detected"			HPA053163	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA053163: AB_2682064"															"unprognostic (1.55e-1)"			0.1	0.0	0.2	0.5	0.6	1.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.4	0.5	0.0	0.0	2.2	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.8	0.0	2.6	0.3	0.2	0.0	0.0	2.5	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.1	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	73.5	0.1	0.0	0.0	0.0	0.2	0.0	0.4	0.5	0.0	2.5	0.6	0.4	0.0	0.0	1.3	0.0	0.2	0.2	0.4	511.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.3	0.3	0.0	6.2	0.0	0.3	0.2	0.6	0.1	0.2	0.1	0.4	0.5	0.3	0.0	0.5	0.2	0.3	1.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.1	9.0	0.0	0.0	72.7	0.0	0.1	0.0	0.1
TDGF1	"CR, CR-1, CRIPTO, Cripto-1"	ENSG00000241186	"Teratocarcinoma-derived growth factor 1"	P13385	3	46574534-46582457	"Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 8.6;lymphoid tissue: 21.1"	"Cell type enriched"	"Detected in some"	6	"Distal tubular cells: 121.3"	"Cancer enriched"	"Detected in many"	4	"testis cancer: 27.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 25.7;NTERA-2: 110.6;SuSa: 66.3"	"Group enriched"	"Detected in many"	5	"cerebellum: 11.2;pons and medulla: 8.7"	"Low region specificity"	"Detected in single"			HPA051928			Uncertain	Vesicles,Cytosol	"Secreted in other tissues"	NA	NA			Vesicles	Cytosol	"HPA051928: "	"unprognostic (7.84e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.72e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.76e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.05e-1)"	0.3	3.4	2.2	0.5	1.8	0.4	0.3	1.9	3.1	0.7	1.3	2.6	0.7	1.1	2.1	0.1	0.1	0.7	0.4	2.1	1.7	8.6	1.3	0.4	0.4	2.3	1.7	1.4	7.8	0.4	0.1	0.1	0.2	2.4	0.4	4.6	0.4	1.0	0.3	1.5	0.3	0.5	1.2	1.6	21.1	2.7	0.6	3.3	15.2	0.8	1.5	0.1	0.2	0.1	1.9	0.1	0.2	0.1	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.4	0.2	0.1	0.1	0.1	0.0	1.8	0.0	0.2	0.0	0.0	25.7	0.2	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.2	110.6	4.0	0.0	0.2	0.2	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.0	66.3	0.1	0.1	1.8	0.2	0.1	0.2	0.1	0.2	0.0	0.0	0.1	0.0	0.2	0.7	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.9	0.3	0.1	0.1	0.0	0.0	2.2	1.8	1.9	3.1	2.1	1.7	2.3	1.7	1.4	2.4	1.6	3.3	1.9	0.9	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	5.5	0.0	0.0	0.0	0.9	121.3	0.2	5.0	0.3	0.1	8.2	2.4	0.0	0.0	0.0	0.0	0.3	8.2	0.2	0.0	14.3	0.4	1.4	0.1	0.0	0.0	5.5	0.0	0.0	0.0	1.0	0.3	0.1	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.0	3.1	0.0	0.0	0.0	0.3	0.6	0.0	0.2	0.0	0.1	0.3	0.1	0.3	0.0	0.0	0.0	0.1	17.7	6.1	0.0
TENM3	"KIAA1455, ODZ3, Ten-M3, TEN3"	ENSG00000218336	"Teneurin transmembrane protein 3"	Q9P273	4	182143987-182803024	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Differentiation"		"Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.2;placenta: 13.3"	"Cell type enriched"	"Detected in many"	4	"Inhibitory neurons: 635.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 66.3;BEWO: 63.3;HDLM-2: 90.0;T-47d: 86.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047043	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA047043: AB_2679914"	"unprognostic (5.79e-2)"	"unprognostic (3.01e-2)"	"unprognostic (6.62e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.28e-2)"	"unprognostic (8.68e-3)"	"unprognostic (1.82e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.47e-3)"	"unprognostic (8.59e-2)"	"unprognostic (1.07e-2)"	"unprognostic (5.25e-4)"	5.1	5.2	6.9	1.6	20.0	0.0	2.0	0.0	11.0	1.5	0.0	3.0	0.8	2.9	0.7	0.8	1.0	2.4	1.2	23.2	10.6	0.9	0.3	0.9	0.8	5.5	2.9	13.1	3.9	1.2	5.1	4.5	13.3	3.6	3.8	0.8	3.9	0.6	3.6	2.1	0.3	0.9	2.3	0.6	2.3	0.7	2.1	5.7	2.9	6.1	4.3	1.2	1.6	1.4	6.1	0.3	2.6	66.3	0.4	13.2	23.5	63.3	7.8	2.7	6.9	6.1	33.9	17.6	0.0	0.9	52.6	28.6	3.3	16.0	3.4	6.8	90.0	26.7	0.0	0.0	0.0	1.3	0.0	0.0	31.2	1.2	21.5	15.0	15.4	9.6	0.0	0.0	0.4	10.6	2.3	0.1	0.1	21.4	0.0	2.8	0.0	17.1	0.2	0.1	0.1	27.2	25.2	4.0	0.5	0.1	35.8	86.0	3.4	21.2	53.7	38.2	0.2	39.6	0.0	0.0	0.0	28.2	0.0	40.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	20.0	0.0	11.0	23.2	10.6	5.5	2.9	13.1	3.6	0.6	5.7	6.1	0.1	0.0	0.0	23.8	0.0	0.4	0.2	0.7	1.8	50.8	1.6	2.2	3.9	0.0	0.1	3.7	4.2	112.7	0.0	0.0	1.9	0.1	12.4	0.1	4.5	0.7	5.3	0.0	115.6	1.8	54.6	4.1	0.0	0.6	0.0	7.7	1.1	0.7	10.4	5.0	635.6	0.0	0.0	0.0	0.7	3.2	8.4	0.0	1.8	8.4	0.0	10.6	0.0	12.1	24.4	0.4	0.0	2.6	0.0	0.4	0.0	0.3	0.0	3.1	0.0	4.8	3.2	3.8	7.2	1.8	0.0	133.4	0.1	4.1	0.1	0.1
TESK2		ENSG00000070759	"Testis associated actin remodelling kinase 2"	Q96S53	1	45343883-45491163	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 222.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 14.6;RT4: 14.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027257, HPA063869"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA027257: AB_10602477, HPA063869: AB_2685137"	"unprognostic (2.95e-1)"	"prognostic favorable (2.22e-4)"	"unprognostic (3.90e-2)"	"unprognostic (5.04e-3)"	"unprognostic (6.03e-2)"	"unprognostic (1.87e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.15e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.86e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.01e-1)"	3.3	2.2	6.8	2.8	10.3	10.3	6.7	10.0	8.8	5.0	5.2	5.4	8.6	3.2	3.8	7.1	3.0	2.6	2.0	7.0	7.7	2.3	7.0	3.9	4.0	11.7	10.0	5.7	9.9	3.6	3.4	2.4	3.5	10.6	15.6	7.1	2.9	8.5	2.7	8.3	12.6	10.9	2.9	9.4	5.3	4.5	9.7	9.2	4.3	3.4	4.8	5.2	4.7	7.5	15.1	1.9	0.0	0.9	0.1	3.5	1.8	14.6	0.7	4.9	2.1	3.6	4.3	1.7	6.2	0.6	1.8	5.4	2.3	3.9	3.1	1.6	4.4	4.9	4.2	2.0	3.2	1.9	1.4	11.1	1.9	3.2	2.4	3.4	3.2	1.7	8.1	0.8	12.4	1.4	0.7	3.6	2.9	3.8	1.8	1.8	5.2	0.1	1.5	1.9	14.7	0.4	1.6	3.8	7.3	14.1	8.6	11.3	1.8	0.0	0.2	2.1	1.3	1.3	8.0	5.0	1.2	1.1	0.0	1.0	12.8	4.6	13.3	2.7	3.4	1.9	8.0	2.5	1.8	2.4	6.6	4.1	2.3	19.0	1.5	8.0	1.3	1.9	3.4	6.8	10.3	10.0	8.8	7.0	7.7	11.7	10.0	5.7	10.6	9.4	9.2	15.1	3.9	0.0	2.8	54.2	10.7	7.8	7.1	2.8	14.2	2.4	11.9	9.4	1.3	4.3	3.4	0.0	14.6	8.3	4.2	13.9	0.0	1.3	23.7	4.6	1.8	3.2	4.2	5.0	10.2	2.7	2.8	3.7	7.7	8.9	7.0	2.4	2.2	6.3	6.8	0.0	6.7	6.9	4.1	5.5	4.4	7.8	2.8	6.0	3.6	15.9	4.6	1.1	4.1	18.6	222.9	1.1	7.3	1.9	9.8	10.6	14.9	1.2	2.0	3.1	6.6	2.6	6.1	22.0	13.6	12.6	8.5	14.8	4.7	1.8	4.9	8.0
TFB1M	"CGI-75, mtTFB"	ENSG00000029639	"Transcription factor B1, mitochondrial"	Q8WVM0	6	155256134-155314493	"Disease related genes, Metabolic proteins, Predicted intracellular proteins"	"rRNA processing, Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in all"	5	"Early spermatids: 239.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029428	Approved					NA	NA					"HPA029428: AB_2673038"	"unprognostic (2.20e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.33e-3)"	"unprognostic (7.73e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.54e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.95e-3)"	"unprognostic (3.39e-2)"	"unprognostic (2.68e-1)"	"unprognostic (7.68e-3)"	"unprognostic (7.77e-2)"	4.6	17.4	1.9	3.1	2.9	1.5	5.2	3.1	4.0	5.7	0.9	6.9	5.1	5.1	4.0	9.5	4.8	2.8	9.5	2.7	1.9	6.9	15.1	4.6	5.6	1.2	1.6	2.5	6.1	7.1	3.9	7.4	2.1	1.8	5.7	4.9	5.3	6.8	3.2	17.4	8.0	6.5	3.9	1.0	8.5	6.9	11.4	2.1	3.9	7.2	5.5	5.0	7.1	6.9	2.8	7.3	3.5	7.9	12.5	5.9	11.8	6.5	8.9	8.4	8.9	11.9	5.8	6.3	11.6	5.4	3.5	6.5	11.8	5.6	8.8	15.1	11.1	7.3	5.2	4.2	33.2	16.4	6.9	3.8	11.7	3.8	13.3	11.8	10.9	10.6	9.0	13.5	3.1	11.4	4.5	5.2	10.0	8.3	7.3	9.4	6.5	4.7	11.3	9.7	4.9	5.9	14.4	2.4	8.2	8.1	10.6	5.1	9.6	4.2	3.6	7.6	8.5	9.3	5.2	7.0	7.0	12.5	11.8	9.2	5.9	2.8	4.5	4.1	5.0	6.4	7.5	6.3	5.7	6.5	7.0	7.9	6.2	2.5	6.7	5.2	5.3	7.8	3.6	1.9	2.9	3.1	4.0	2.7	1.9	1.2	1.6	2.5	1.8	1.0	2.1	2.8	5.9	22.4	12.0	25.8	16.5	6.2	14.1	31.7	16.5	16.2	9.6	10.2	21.6	8.6	14.6	12.9	22.9	19.6	8.9	4.8	31.3	20.9	239.4	7.4	6.2	5.1	6.0	19.1	41.9	17.8	19.0	9.0	11.2	5.1	27.8	10.7	4.2	24.3	14.9	30.3	47.4	8.9	24.4	10.7	5.1	24.6	5.0	9.9	3.6	44.0	13.3	13.4	9.2	42.3	46.3	13.8	8.5	8.6	9.3	8.0	5.9	21.4	11.5	21.6	13.1	7.1	11.6	35.1	17.2	17.1	11.4	7.3	14.2	28.6	13.7	9.6
THBS4		ENSG00000113296	"Thrombospondin 4"	P35443	5	79991311-80083287	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Tissue remodeling, Unfolded protein response"	"Growth factor, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 218.6;heart muscle: 169.5;smooth muscle: 253.8;tongue: 216.5"	"Cell type enriched"	"Detected in many"	4	"Sertoli cells: 493.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	46	"eosinophil: 4.5"	"Lineage enriched"	"Detected in single"	46	"granulocytes: 4.5"	"Cell line enhanced"	"Detected in some"		"AF22: 3.1;THP-1: 7.0;U-2 OS: 2.8;U-266/70: 2.6"	"Region enriched"	"Detected in many"	8	"white matter: 85.7"	"Region enriched"	"Detected in many"	27	"spinal cord: 89.3"	"CAB004597, HPA042426"	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		510000000	Vesicles		"CAB004597: AB_628352, HPA042426: AB_2677992"	"unprognostic (1.41e-1)"	"unprognostic (5.33e-2)"	"unprognostic (4.26e-3)"	"unprognostic (3.64e-2)"	"unprognostic (9.94e-2)"	"unprognostic (8.10e-2)"	"unprognostic (5.64e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.96e-3)"	"unprognostic (2.74e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.76e-3)"	"prognostic unfavorable (3.33e-4)"	218.6	1.2	15.4	5.2	18.8	10.7	27.0	14.2	12.8	1.6	4.8	38.6	2.2	27.1	1.6	6.1	2.5	10.5	169.5	12.4	23.3	0.7	0.3	1.3	1.1	22.2	22.9	12.6	4.2	23.0	36.0	14.4	0.2	18.1	9.1	8.8	7.6	46.8	5.8	77.9	3.0	3.4	253.8	21.1	0.3	8.6	8.8	23.0	3.6	27.3	216.5	4.0	3.5	5.8	20.8	0.1	0.0	3.1	0.2	0.2	1.3	0.3	0.1	0.1	0.9	0.3	0.1	0.4	0.1	0.1	0.2	0.8	0.1	0.1	0.4	0.8	0.1	0.4	0.3	0.0	0.2	1.7	0.0	0.0	0.9	0.2	0.1	0.1	0.3	0.0	0.0	0.0	0.2	0.2	0.5	0.0	0.0	2.4	0.0	0.0	0.0	0.9	0.0	0.2	0.0	2.5	0.7	0.0	0.0	0.2	1.3	0.0	7.0	0.0	0.0	2.8	0.2	0.2	2.6	0.1	0.4	1.1	2.2	0.6	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	18.8	14.2	12.8	12.4	23.3	22.2	22.9	12.6	18.1	21.1	23.0	20.8	57.0	0.0	1.1	37.2	0.7	0.3	0.1	0.2	2.2	1.3	0.8	1.8	9.1	0.0	0.7	3.7	56.3	0.1	0.5	0.0	0.0	0.2	40.8	0.3	0.8	9.4	9.0	0.0	9.7	0.0	0.0	84.2	0.5	0.3	0.0	5.9	0.4	0.2	0.1	1.7	12.7	0.0	0.0	0.0	0.3	7.2	0.9	2.7	1.8	6.5	0.0	2.2	0.0	60.3	24.0	0.0	0.0	43.6	0.3	1.0	0.0	0.8	0.2	1.9	493.0	78.9	116.9	14.5	2.1	0.6	1.0	0.0	2.1	1.2	0.0	0.0
THRSP	"Lpgp, LPGP1, S14, SPOT14, THRP"	ENSG00000151365	"Thyroid hormone responsive"	Q92748	11	78063861-78068351	"Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 211.8;liver: 412.3"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 128.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 44.1"	"Region enhanced"	"Detected in single"		"cerebellum: 2.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"ASC diff: 76.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040642	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA040642: AB_10794878"	"unprognostic (1.19e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.07e-1)"	"unprognostic (9.91e-3)"	"unprognostic (1.59e-2)"	"unprognostic (9.60e-2)"	"unprognostic (1.07e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.58e-1)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (9.64e-2)"	"unprognostic (1.57e-1)"	"prognostic favorable (3.28e-4)"	"unprognostic (1.69e-3)"	211.8	6.0	0.2	0.4	0.2	0.0	96.1	2.8	0.4	0.1	0.0	2.6	0.0	0.1	0.4	0.3	1.0	3.5	18.7	0.3	0.0	4.5	412.3	0.1	0.7	0.1	0.3	0.2	0.1	3.7	15.7	0.1	0.0	0.8	0.1	0.2	1.5	49.3	2.3	8.3	21.2	4.7	0.5	0.0	0.1	0.7	0.1	0.0	0.2	5.8	3.3	0.0	0.8	1.1	0.2	0.0	0.0	0.0	0.0	76.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.2	2.8	0.4	0.3	0.0	0.1	0.3	0.2	0.8	0.0	0.0	0.2	2.2	0.0	0.0	0.0	0.8	0.1	0.1	0.0	0.0	2.3	21.1	11.2	0.1	4.3	0.0	0.0	0.0	0.0	0.2	0.0	9.8	0.0	0.0	0.6	0.1	0.4	0.0	2.7	0.5	0.0	0.0	0.1	0.0	0.3	0.0	0.1	2.9	128.4	0.0	0.0	0.4	0.3	0.0	3.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.7	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.1
TIMP4		ENSG00000157150	"TIMP metallopeptidase inhibitor 4"	Q99727	3	12153068-12158912	"Plasma proteins, Predicted secreted proteins"		"Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 179.3;breast: 120.6"	"Cell type enriched"	"Detected in many"	10	"Adipocytes: 363.9"	"Cancer enriched"	"Detected in many"	13	"glioma: 66.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 212.9;ASC TERT1: 53.0;HSkMC: 91.9;NTERA-2: 50.7;U-87 MG: 53.6"	"Region enhanced"	"Detected in all"		"cerebellum: 106.1"	"Region enriched"	"Detected in all"	9	"cerebellum: 47.7"						"Secreted to extracellular matrix"	NA	NA						"unprognostic (2.99e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.02e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.97e-4)"	"unprognostic (9.33e-3)"	"unprognostic (4.26e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.78e-1)"	"unprognostic (6.81e-2)"	"unprognostic (4.99e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.66e-5)"	"unprognostic (2.86e-1)"	179.3	8.4	8.1	3.9	8.5	0.6	120.6	49.7	7.4	9.3	4.6	11.9	1.4	8.1	1.0	2.9	6.9	4.4	28.3	7.1	8.7	2.7	1.1	6.6	0.6	14.0	9.5	7.0	3.8	4.0	1.4	12.4	10.0	17.3	5.5	4.3	1.1	9.0	2.4	16.8	7.5	11.1	4.5	10.9	3.4	9.3	0.7	7.0	2.1	23.3	30.4	0.1	9.9	8.8	11.7	0.7	24.2	0.7	0.0	212.9	53.0	26.4	0.8	8.9	1.0	1.3	0.5	0.1	0.0	2.2	0.9	0.8	0.9	0.0	0.8	0.4	1.0	0.0	0.0	12.7	0.9	33.2	0.0	0.1	91.9	2.2	5.8	0.2	1.6	0.0	0.0	0.5	17.3	0.2	0.6	0.0	0.0	50.7	0.0	6.0	0.0	0.0	0.4	0.0	0.1	0.3	0.0	5.0	0.0	0.0	6.1	0.0	0.0	1.0	0.1	0.0	0.6	0.9	0.0	0.1	0.0	53.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	8.5	49.7	7.4	7.1	8.7	14.0	9.5	7.0	17.3	10.9	7.0	11.7	363.9	0.0	0.0	0.0	0.4	0.1	1.3	0.3	0.6	0.4	12.4	2.8	7.0	0.0	0.2	0.0	0.0	0.4	1.4	1.3	0.0	0.6	1.6	0.2	2.1	33.6	6.6	5.3	0.1	2.6	2.7	15.7	0.0	0.0	0.0	0.2	22.5	0.0	3.4	0.0	0.2	2.8	0.0	1.2	0.3	7.5	12.2	0.8	3.6	0.0	0.0	0.7	0.0	9.0	0.1	4.6	4.8	2.6	0.0	4.2	2.7	0.5	5.5	0.0	32.9	3.1	29.1	0.1	0.0	0.2	0.1	0.1	0.4	0.2	2.0	2.2
TJAP1	"PILT, TJP4"	ENSG00000137221	"Tight junction associated protein 1"	Q5JTD0	6	43477523-43506556	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Oligodendrocytes: 117.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030164, HPA030165, HPA030166"	Supported		Enhanced	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA030164: AB_10599849, HPA030165: AB_2673350, HPA030166: AB_10601858"	"unprognostic (5.05e-3)"	"unprognostic (2.82e-2)"	"unprognostic (6.89e-3)"	"unprognostic (1.03e-3)"	"unprognostic (3.09e-2)"	"unprognostic (4.50e-3)"	"prognostic unfavorable (9.02e-6)"	"unprognostic (4.27e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.61e-3)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (2.29e-1)"	"unprognostic (2.95e-1)"	"unprognostic (5.15e-3)"	"unprognostic (7.51e-3)"	23.0	32.3	24.8	17.4	33.8	18.7	24.6	26.1	33.1	30.4	22.0	26.9	20.5	31.4	10.2	16.9	29.0	13.5	22.8	24.2	26.9	22.0	26.1	21.9	20.8	31.8	31.9	20.9	37.5	33.5	13.3	24.7	15.1	33.6	31.6	9.3	11.4	24.2	14.7	44.5	19.0	26.1	15.2	25.2	32.5	26.2	20.5	30.8	17.3	30.6	16.9	15.0	28.9	23.7	48.7	40.6	15.7	27.1	40.7	21.5	20.1	30.0	25.1	26.8	26.2	28.4	23.8	17.2	22.4	18.6	23.3	25.0	35.0	22.9	30.0	16.8	38.7	35.2	28.5	30.8	26.3	25.8	29.2	39.6	23.0	39.7	32.6	28.6	20.7	17.4	28.6	24.9	41.2	23.5	22.5	28.7	48.3	23.7	69.0	23.9	34.2	17.8	24.0	16.3	22.1	17.8	24.7	21.4	13.0	33.5	16.7	23.2	56.7	15.3	34.9	26.9	29.3	37.9	30.0	26.9	40.0	15.3	33.1	30.2	13.6	7.1	5.7	7.1	8.2	9.2	6.3	5.8	6.2	5.4	6.7	6.5	7.2	4.0	5.5	7.5	5.7	3.5	7.1	24.8	33.8	26.1	33.1	24.2	26.9	31.8	31.9	20.9	33.6	25.2	30.8	48.7	10.9	12.8	10.3	12.1	10.3	7.5	14.7	9.3	13.6	11.1	9.9	13.0	7.7	10.0	6.3	12.9	29.2	21.3	7.3	7.2	3.9	10.0	1.4	7.3	10.6	10.5	11.4	7.8	11.6	8.4	18.6	10.6	8.6	9.8	14.7	21.9	8.2	8.3	9.8	8.4	9.4	8.5	14.2	7.7	8.7	2.2	10.5	9.1	5.4	14.0	8.3	10.0	6.2	19.6	117.1	9.5	7.2	12.8	10.2	14.9	7.9	6.2	5.9	15.2	6.6	9.5	10.0	14.1	14.8	4.9	3.7	18.7	9.8	10.6	7.0	9.0
TLL2		ENSG00000095587	"Tolloid like 2"	Q9Y6L7	10	96364608-96513926	"Predicted secreted proteins"	Differentiation	"Developmental protein, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.8;heart muscle: 2.0;tongue: 1.9"	"Cell type enriched"	"Detected in some"	4	"Granulosa cells: 82.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"RPTEC TERT1: 20.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted - unknown location"	NA	NA						"unprognostic (1.28e-2)"	"unprognostic (7.54e-4)"	"unprognostic (1.50e-1)"	"unprognostic (3.31e-3)"	"unprognostic (2.67e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.31e-2)"	"unprognostic (3.52e-4)"	"unprognostic (7.08e-2)"	"unprognostic (2.50e-1)"	"unprognostic (6.71e-2)"	"unprognostic (3.37e-2)"	"unprognostic (4.98e-4)"	"unprognostic (2.90e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.95e-4)"	"unprognostic (2.30e-1)"	0.0	0.1	1.3	0.1	1.7	0.2	0.0	0.8	1.7	0.0	0.4	0.1	0.3	0.1	0.1	0.0	0.0	0.3	2.0	1.4	1.8	0.0	0.0	0.0	0.1	2.5	1.4	1.4	0.1	0.2	0.0	0.4	0.1	3.2	0.1	0.1	0.2	0.2	0.0	0.9	0.0	0.4	0.1	1.5	0.1	0.3	0.1	3.8	0.0	0.1	1.9	0.0	0.0	0.0	2.1	0.2	0.1	0.4	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	1.0	0.1	0.2	0.1	0.2	0.1	0.0	2.0	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.6	0.1	0.1	0.4	0.0	20.1	0.0	0.7	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.7	0.8	1.7	1.4	1.8	2.5	1.4	1.4	3.2	1.5	3.8	2.1	0.4	0.0	1.1	0.3	0.7	0.1	0.5	1.9	0.0	0.0	0.0	0.0	5.5	1.5	1.0	0.0	0.0	2.4	0.1	0.0	0.0	0.2	6.9	0.2	0.1	1.4	0.0	0.0	1.9	0.6	0.1	2.4	1.5	0.5	0.0	82.4	0.0	0.0	0.3	0.0	5.6	1.7	2.0	0.3	1.4	5.5	0.3	0.3	0.0	0.0	0.0	0.0	0.0	1.5	18.6	0.7	0.0	0.0	1.4	0.8	1.0	0.2	0.2	0.0	0.0	0.7	0.4	0.2	2.6	0.0	0.4	3.4	0.3	0.1	0.2	0.6
TM4SF19		ENSG00000145107	"Transmembrane 4 L six family member 19"	Q96DZ7	3	196319342-196338503	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 4.7"	"Cell type enriched"	"Detected in some"	8	"Hofbauer cells: 74.6"	"Group enriched"	"Detected in some"	4	"cervical cancer: 1.4;head and neck cancer: 3.4;lung cancer: 1.4;melanoma: 1.0;urothelial cancer: 0.9"	"Region enhanced"	"Detected in single"		"thalamus: 1.8"	"Group enriched"	"Detected in some"	6	"gdT-cell: 14.8;memory CD8 T-cell: 3.9;naive CD8 T-cell: 4.9"	"Lineage enriched"	"Detected in single"	16	"T-cells: 14.8"	"Cell line enriched"	"Detected in many"	12	"GAMG: 427.6"															NA	NA						"unprognostic (9.90e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.19e-2)"	"unprognostic (8.90e-5)"	"unprognostic (8.86e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.06e-3)"	"unprognostic (4.23e-2)"	"unprognostic (4.20e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.18e-3)"	3.9	0.3	0.0	0.5	0.2	0.7	2.9	0.2	0.9	0.8	0.0	0.3	0.2	0.3	0.0	3.4	0.3	0.1	0.1	0.2	0.3	0.2	0.5	3.6	0.5	0.2	0.2	0.1	0.7	0.3	0.0	0.1	0.8	0.3	0.5	0.2	0.5	1.5	0.0	1.6	1.8	0.2	0.1	0.1	0.6	0.5	4.7	1.8	0.2	0.7	0.5	0.8	0.3	1.7	0.8	15.6	7.2	0.2	0.4	0.9	4.6	0.3	0.0	4.4	1.6	2.9	0.0	8.2	0.2	2.6	0.0	427.6	2.2	0.0	1.7	1.1	0.6	0.0	0.3	2.1	0.0	1.0	0.5	0.4	0.5	1.4	18.8	31.3	0.0	0.0	0.9	9.8	0.9	4.8	1.2	0.1	0.8	0.0	0.2	36.2	0.2	3.2	0.9	0.0	0.4	0.3	0.0	2.5	0.1	0.7	0.4	0.6	0.2	1.4	18.6	15.6	2.9	9.1	0.5	5.6	0.3	20.2	0.7	0.3	0.9	0.3	0.4	14.8	0.4	0.1	0.1	1.3	3.9	0.1	0.3	0.7	4.9	0.6	0.7	0.1	0.6	0.4	1.6	0.0	0.2	0.2	0.9	0.2	0.3	0.2	0.2	0.1	0.3	0.1	1.8	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	2.9	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	74.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	9.3	4.9	4.9	0.0	0.4	0.9	0.1	0.0	0.0
TMEM211	bA9F11.1	ENSG00000206069	"Transmembrane protein 211"	Q6ICI0	22	24934954-24946695	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"cervix: 2.6;salivary gland: 5.8;stomach 1: 3.2"	"Cell type enriched"	"Detected in some"	19	"Ionocytes: 36.7"	"Group enriched"	"Detected in some"	5	"colorectal cancer: 4.8;endometrial cancer: 3.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA066784	Uncertain					NA	NA					"HPA066784: AB_2685722"	"unprognostic (7.89e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.09e-2)"		"unprognostic (5.97e-3)"		"unprognostic (5.88e-2)"		"unprognostic (1.31e-3)"	"unprognostic (3.26e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.65e-2)"	"unprognostic (8.61e-3)"	"unprognostic (3.59e-1)"	"unprognostic (4.43e-2)"	0.0	0.0	0.1	0.3	0.3	0.0	0.5	0.4	0.2	2.6	0.0	0.3	0.0	0.6	0.1	0.1	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	5.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	3.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	1.3	1.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	36.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
TMEM35A	"FLJ14084, NACHO, TMEM35, TUF-1"	ENSG00000126950	"Transmembrane protein 35A"	Q53FP2	X	101078879-101096367	"Predicted membrane proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 56.9;seminal vesicle: 51.4"	"Cell type enriched"	"Detected in some"	5	"Theca cells: 37.5"	"Cancer enhanced"	"Detected in many"		"glioma: 6.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 10.1;HUVEC TERT2: 52.5;SH-SY5Y: 13.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048583	Enhanced	Supported	Supported	"Vesicles,Focal adhesion sites,Cytosol"		NA	NA			Vesicles	"Focal adhesion sites, Cytosol"	"HPA048583: AB_2680451"	"unprognostic (7.98e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.02e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.66e-3)"	"unprognostic (1.05e-1)"	"unprognostic (3.34e-3)"	"unprognostic (9.20e-2)"	"unprognostic (4.72e-2)"	"unprognostic (3.49e-4)"	"unprognostic (5.91e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.48e-2)"	"unprognostic (9.37e-3)"	3.5	7.0	21.9	1.3	22.1	0.0	0.8	21.0	30.8	4.1	5.7	26.5	3.4	7.9	3.7	11.4	4.1	3.5	0.5	30.6	56.9	0.5	0.0	2.3	0.1	24.0	27.9	21.2	8.0	0.2	12.8	2.3	0.1	31.2	22.5	9.7	10.3	0.6	51.4	0.8	0.5	7.3	10.4	16.5	0.8	5.2	1.4	40.3	0.2	0.8	2.5	0.3	9.8	4.4	45.1	0.0	0.0	5.4	0.0	3.9	10.1	0.0	1.1	0.7	0.4	0.2	0.0	0.0	0.0	0.1	3.2	0.0	0.0	3.4	0.0	1.0	0.0	0.2	0.0	0.1	0.0	1.2	0.0	0.0	3.5	0.0	1.9	0.0	7.5	52.5	0.0	0.0	0.1	6.6	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.3	13.2	0.0	0.0	0.0	1.3	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.9	22.1	21.0	30.8	30.6	56.9	24.0	27.9	21.2	31.2	16.5	40.3	45.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	7.4	0.4	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.2	0.0	6.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	37.5	0.0	0.0
TMEM53	"FLJ22353, NET4"	ENSG00000126106	"Transmembrane protein 53"	Q6P2H8	1	44635238-44674481	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 59.9"	"Cell type enriched"	"Detected in many"	5	"Late spermatids: 999.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	4	"plasmacytoid DC: 99.4"	"Lineage enriched"	"Detected in all"	4	"dendritic cells: 99.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021134	Approved		Approved	"Golgi apparatus,Focal adhesion sites"		NA	NA			"Golgi apparatus"	"Focal adhesion sites"	"HPA021134: AB_2205162"	"unprognostic (5.28e-2)"	"unprognostic (2.60e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.19e-2)"	"prognostic favorable (6.96e-4)"	"unprognostic (3.00e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (1.02e-5)"	"unprognostic (1.15e-3)"	"unprognostic (1.84e-2)"	"unprognostic (4.07e-2)"	"unprognostic (2.29e-2)"	12.9	12.1	4.9	4.5	7.9	6.7	12.2	6.0	8.4	6.9	4.9	11.0	16.5	9.0	6.9	6.0	7.1	6.2	13.1	4.9	6.3	18.1	59.9	10.6	4.1	7.8	7.8	4.3	10.7	8.4	6.4	10.1	4.0	8.4	7.2	7.0	7.2	7.3	3.3	7.6	6.6	14.7	4.2	5.7	6.3	10.2	35.2	7.2	3.3	8.0	3.7	2.1	7.5	6.1	14.8	12.9	14.7	13.0	9.6	16.6	12.5	15.6	3.8	11.1	7.2	10.5	4.7	39.9	4.1	11.8	3.6	27.4	11.5	3.6	7.8	3.8	6.5	9.2	4.7	6.0	22.7	16.5	3.7	16.6	14.8	11.9	14.4	3.1	7.9	4.0	9.1	2.0	5.1	4.3	7.7	4.5	11.2	7.6	9.9	8.5	6.8	1.8	40.0	21.6	13.4	9.0	8.7	4.1	15.7	21.3	9.3	4.8	9.9	1.7	5.3	8.8	7.5	4.7	3.7	4.7	2.3	13.6	9.6	6.3	14.1	12.9	6.3	7.3	23.1	6.3	13.9	7.4	6.3	6.6	14.8	3.5	4.5	1.4	7.8	16.2	99.4	8.1	7.6	4.9	7.9	6.0	8.4	4.9	6.3	7.8	7.8	4.3	8.4	5.7	7.2	14.8	10.9	6.4	12.0	8.1	3.5	1.7	9.5	24.2	1.8	6.9	9.0	7.6	35.5	10.0	20.4	20.2	4.2	14.5	9.5	53.1	45.0	18.6	188.3	14.0	4.6	8.5	14.4	10.1	2.9	25.7	15.5	6.9	8.2	5.7	6.3	8.6	10.0	93.0	34.3	18.5	3.6	22.6	44.7	12.6	0.7	999.9	9.0	14.0	8.8	1.9	3.8	17.1	5.2	3.0	4.8	17.5	51.3	12.4	2.6	8.9	74.3	45.9	32.8	13.8	26.3	3.7	10.6	15.6	13.2	3.9	2.3	9.3	3.7	8.3	18.0	12.7
TMEM81	"HC3107, KVLA2788, MGC75217, UNQ2788"	ENSG00000174529	"Transmembrane protein 81"	Q6P7N7	1	205083129-205084460	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Early spermatids: 15.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA052515			Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA052515: AB_2681858"	"unprognostic (9.19e-3)"	"unprognostic (3.53e-1)"	"unprognostic (1.91e-3)"	"unprognostic (6.48e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (3.25e-6)"	"unprognostic (3.66e-2)"	"unprognostic (2.68e-2)"	"unprognostic (6.18e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.48e-2)"	"prognostic unfavorable (6.65e-9)"	"unprognostic (8.91e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.42e-1)"	"prognostic favorable (2.67e-4)"	1.9	3.8	9.4	1.2	9.6	1.5	1.8	12.0	12.4	4.0	8.8	2.5	0.9	2.4	2.0	2.8	2.7	0.8	3.7	9.6	9.5	4.5	6.1	2.9	1.7	9.2	9.5	9.3	4.0	2.5	1.5	3.9	1.3	9.9	3.7	1.1	4.3	2.1	1.3	6.7	3.3	2.6	1.1	9.3	5.5	2.6	5.9	9.7	3.2	2.8	2.4	1.7	2.7	3.3	10.1	1.8	2.8	4.6	6.0	6.6	2.6	2.3	3.4	2.0	1.7	1.0	5.0	1.2	3.4	2.4	1.9	2.5	1.6	7.5	2.8	3.0	3.0	2.9	2.9	3.8	2.5	4.5	1.5	1.5	2.6	5.1	2.7	1.3	4.5	3.4	4.0	6.5	1.4	2.2	3.6	3.4	6.3	3.5	2.3	4.0	2.3	5.3	3.6	4.0	1.8	2.9	4.5	2.1	2.5	5.6	7.1	1.9	6.2	1.6	3.2	1.6	4.1	3.7	3.2	4.2	2.7	4.5	2.2	5.5	1.7	0.4	0.0	1.8	0.6	0.0	0.6	0.8	0.4	0.6	0.5	0.8	1.4	1.0	0.0	0.6	0.6	1.1	0.4	9.4	9.6	12.0	12.4	9.6	9.5	9.2	9.5	9.3	9.9	9.3	9.7	10.1	0.5	0.0	0.0	2.0	0.7	2.3	0.5	0.6	0.0	0.8	1.6	1.4	2.0	1.5	0.4	3.7	0.0	0.2	1.6	0.8	0.0	0.7	15.6	1.1	0.6	0.9	0.0	0.0	2.0	0.6	0.5	0.6	0.0	1.3	0.0	2.3	0.4	1.0	0.6	1.7	1.5	0.5	2.0	0.3	2.1	3.1	0.0	0.9	1.8	1.0	0.4	1.4	3.1	1.0	1.3	0.8	0.1	0.4	1.3	1.2	0.4	1.3	0.5	1.1	0.0	1.0	0.6	0.9	1.1	0.5	2.6	0.1	0.9	0.4	0.6	1.0
TMPRSS11E	"DESC1, TMPRSS11E2"	ENSG00000087128	"Transmembrane serine protease 11E"	Q9UL52	4	68447463-68497604	"Enzymes, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 221.9;vagina: 157.6"	"Cell type enriched"	"Detected in some"	14	"Ionocytes: 476.0"	"Group enriched"	"Detected in many"	6	"cervical cancer: 22.0;head and neck cancer: 25.3;lung cancer: 11.5;urothelial cancer: 7.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.5;OE19: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043816, HPA051062"	Enhanced		Approved	"Golgi apparatus"	"Secreted in other tissues"	NA	NA			"Golgi apparatus"		"HPA043816: , HPA051062: AB_2681329"	"unprognostic (2.53e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.84e-1)"	"unprognostic (9.14e-2)"		"unprognostic (5.03e-2)"		"prognostic unfavorable (6.73e-4)"	"unprognostic (2.22e-1)"		"unprognostic (9.70e-3)"	"unprognostic (2.16e-1)"	"unprognostic (3.74e-2)"	"unprognostic (4.03e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.08e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	42.8	0.0	0.0	0.0	0.0	18.4	221.9	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	2.2	0.0	0.0	57.1	0.7	0.0	3.2	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.1	0.0	0.0	24.7	6.5	157.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	12.9	0.7	0.0	0.0	0.5	0.3	0.3	0.0	2.8	0.0	0.0	0.0	0.3	0.0	0.0	0.3	6.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	476.0	0.0	0.3	1.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.1	0.2	6.6	0.3	1.1	0.7	0.0	0.0	32.6
TNFRSF17	"BCM, BCMA, CD269, TNFRSF13A"	ENSG00000048462	"TNF receptor superfamily member 17"	Q02223	16	11965210-11968068	"Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 29.3;lymphoid tissue: 48.3;stomach 1: 24.6"	"Cell type enriched"	"Detected in some"	4	"Plasma cells: 449.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	62	"memory B-cell: 124.9;naive B-cell: 108.5;plasmacytoid DC: 103.3"	"Group enriched"	"Detected in many"	63	"B-cells: 124.9;dendritic cells: 103.3"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 179.6;RPMI-8226: 296.0;U-266/70: 829.4;U-266/84: 453.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA		2000000				"prognostic favorable (1.35e-5)"	"unprognostic (3.41e-2)"	"unprognostic (4.00e-3)"	"unprognostic (1.41e-2)"	"unprognostic (6.47e-2)"	"prognostic favorable (1.58e-6)"	"unprognostic (9.75e-3)"	"unprognostic (5.93e-2)"	"unprognostic (2.13e-2)"	"unprognostic (7.96e-3)"	"unprognostic (2.46e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.85e-6)"	"unprognostic (2.06e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.10e-1)"	0.4	1.2	0.2	15.1	0.5	1.9	14.2	0.6	0.5	1.4	0.1	29.1	29.3	0.5	0.2	1.9	0.6	3.1	0.5	0.2	0.2	0.3	1.0	2.0	32.2	0.4	0.1	0.0	0.8	0.5	0.1	0.1	0.1	0.5	0.4	22.3	0.1	15.6	0.9	0.0	0.3	15.3	0.6	0.0	20.5	24.6	2.2	0.4	14.9	0.7	0.1	48.3	10.0	0.3	1.5	1.0	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.8	0.3	0.1	0.0	0.0	49.2	0.1	0.3	0.1	0.3	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	179.6	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.6	0.0	296.0	0.0	0.1	0.0	0.2	0.0	0.2	0.3	0.1	0.0	0.6	0.0	0.5	0.5	0.0	0.5	829.4	453.4	68.1	0.7	0.2	0.0	1.2	0.4	0.2	0.3	0.1	0.4	124.9	0.2	0.2	0.2	108.5	0.1	0.2	1.8	0.7	0.1	103.3	0.1	12.6	0.2	0.5	0.6	0.5	0.2	0.2	0.4	0.1	0.0	0.5	0.0	0.4	1.5	0.0	0.0	0.0	0.0	91.7	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	10.9	0.0	0.0	0.7	0.0	5.3	0.1	0.0	0.0	0.4	2.0	0.0	0.0	0.4	1.8	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.7	5.0	0.0	0.3	106.7	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	449.5	0.2	0.0	0.1	0.0	0.0	6.6	0.0	0.1	0.7	0.6	0.0	0.6	0.0	6.0	0.0	1.0	0.0
TNMD	"BRICD4, ChM1L, myodulin, TEM, tendin"	ENSG00000000005	Tenomodulin	Q9H2S6	X	100584936-100599885	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 17.6;breast: 13.0;seminal vesicle: 26.3"	"Cell type enriched"	"Detected in some"	7	"Adipocytes: 73.6"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"HAP1: 6.9;NTERA-2: 16.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA034961, HPA055634"	Uncertain					NA	NA					"HPA034961: AB_10670285, HPA055634: AB_2682868"	"unprognostic (3.60e-2)"		"unprognostic (9.84e-3)"	"unprognostic (3.19e-2)"	"unprognostic (7.77e-3)"		"unprognostic (2.42e-1)"			"unprognostic (2.15e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.40e-2)"	"unprognostic (9.60e-4)"	"unprognostic (6.82e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.48e-1)"	17.6	0.2	0.2	0.6	0.1	0.0	13.0	0.1	0.2	0.5	1.0	0.8	0.1	0.3	0.2	0.3	0.3	0.5	1.0	0.2	0.4	0.9	0.0	0.1	0.1	0.5	0.5	0.1	2.1	0.1	0.0	0.0	2.4	0.2	1.3	0.5	0.0	0.5	26.3	3.3	2.8	0.5	0.7	0.2	0.2	0.1	0.1	0.3	0.4	0.2	5.8	0.1	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.2	0.4	0.5	0.5	0.1	0.2	0.2	0.3	0.2	73.6	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.4	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.8	3.9	0.0	0.0	0.0	0.1	5.3	0.0	0.0	0.1	0.0	0.0	4.5	0.0	0.0	0.0	3.2	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.7	0.5	9.3	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	5.5	0.0	0.0	0.0	2.7	3.2	0.0	0.1	0.0	1.0	0.0	0.3	0.7	0.6	0.0
TP53I11	PIG11	ENSG00000175274	"Tumor protein p53 inducible protein 11"	O14683	11	44885903-44951306	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Late spermatids: 461.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 41.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 133.9;SCLC-21H: 357.9;T-47d: 209.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059727, HPA061276"	Uncertain		Supported	"Endoplasmic reticulum,Golgi apparatus"		NA	NA			"Endoplasmic reticulum, Golgi apparatus"		"HPA059727: AB_2684113, HPA061276: AB_2684461"	"prognostic unfavorable (7.33e-5)"	"unprognostic (1.87e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (6.12e-4)"	"unprognostic (6.55e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (4.65e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.10e-1)"	66.5	18.7	41.0	20.6	17.6	29.9	64.2	37.0	25.8	30.0	18.3	34.0	20.4	36.3	4.9	24.7	45.9	24.9	62.0	23.2	19.1	28.0	10.6	46.1	12.8	16.3	32.3	24.4	20.1	38.0	5.7	20.4	24.1	22.2	48.2	27.7	2.2	43.0	11.8	15.1	30.3	39.1	33.1	21.5	61.7	30.1	16.3	17.4	9.2	41.4	10.4	12.4	29.5	32.2	12.9	0.0	82.0	27.3	38.2	28.0	2.2	0.5	23.9	46.3	8.5	10.7	5.1	0.5	14.3	20.5	6.9	21.7	14.5	14.6	0.5	2.8	28.0	12.3	1.3	0.8	0.0	52.5	0.8	101.1	118.0	1.9	11.5	4.9	2.0	29.6	31.6	2.2	0.1	11.3	73.0	1.4	133.9	48.9	53.4	26.9	60.3	16.1	7.2	0.0	5.2	357.9	13.0	44.2	96.8	0.1	33.9	209.9	7.5	6.8	55.8	39.3	87.3	0.1	0.5	0.5	0.3	0.1	7.8	16.1	0.0	5.9	0.0	5.2	5.8	7.0	8.0	1.0	5.1	4.7	8.4	0.0	1.7	41.2	8.1	21.2	25.3	0.9	4.8	41.0	17.6	37.0	25.8	23.2	19.1	16.3	32.3	24.4	22.2	21.5	17.4	12.9	52.2	22.4	30.9	0.3	13.2	10.8	36.9	12.9	13.6	1.7	29.5	22.7	10.3	24.3	23.7	42.3	0.0	57.8	8.7	31.0	1.9	32.0	96.5	9.0	6.3	45.1	36.0	3.2	2.7	21.3	22.0	15.0	23.0	9.7	0.0	7.8	76.8	1.6	35.7	0.0	10.2	30.1	38.7	7.5	20.3	461.2	12.2	9.3	10.6	5.6	11.5	0.8	0.0	0.0	0.5	28.5	16.0	7.5	2.1	28.6	17.7	0.1	14.5	0.8	13.1	1.4	22.4	3.4	6.3	4.4	4.4	68.3	8.7	5.1	54.0	45.7
TPRG1	"FAM79B, FLJ41238, FLJ43694"	ENSG00000188001	"Tumor protein p63 regulated 1"	Q6ZUI0	3	188947214-189325304	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 51.0;vagina: 32.5"	"Cell type enriched"	"Detected in many"	5	"Early spermatids: 199.7"	"Cancer enriched"	"Detected in many"	4	"breast cancer: 7.0"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 9.6;Karpas-707: 4.7;OE19: 23.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA044751, HPA060187"	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA044751: AB_2679073, HPA060187: AB_2684217"	"prognostic favorable (5.43e-4)"	"unprognostic (8.71e-3)"	"unprognostic (2.10e-3)"	"unprognostic (2.36e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.33e-3)"	"unprognostic (1.55e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.79e-1)"	"unprognostic (3.52e-8)"	"unprognostic (8.50e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.73e-2)"	10.3	2.0	0.3	1.8	1.1	0.0	23.5	0.5	2.2	13.7	3.0	0.5	0.3	3.1	2.8	51.0	8.5	2.9	1.4	0.4	1.5	0.4	9.0	4.4	0.9	1.3	0.5	0.3	2.2	0.6	0.1	0.2	1.2	1.4	1.3	0.3	0.4	6.2	1.4	9.2	24.1	0.7	3.0	0.8	0.7	0.5	4.8	2.7	1.5	1.4	0.4	9.1	1.0	32.5	1.4	0.9	0.2	0.3	0.0	2.0	1.7	0.0	0.0	0.0	0.1	0.1	1.1	2.2	1.3	3.4	0.1	0.6	0.2	0.0	0.0	0.0	9.6	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.5	0.4	0.0	0.0	0.5	0.0	0.0	0.0	4.7	0.2	0.4	0.0	0.0	0.6	23.4	0.3	0.0	0.0	1.7	0.0	1.8	0.0	0.0	0.2	0.5	0.0	0.7	4.1	0.6	0.0	0.1	0.3	0.0	0.3	4.3	3.7	0.4	0.1	0.0	0.1	0.0	1.5	0.0	3.8	1.2	0.5	0.1	3.0	4.0	0.4	0.0	0.6	1.5	0.7	0.0	1.1	0.0	3.8	0.9	0.3	1.1	0.5	2.2	0.4	1.5	1.3	0.5	0.3	1.4	0.8	2.7	1.4	0.9	38.5	1.7	3.6	0.9	5.6	19.9	10.5	13.6	1.3	9.8	31.1	0.8	0.0	6.4	0.0	0.0	0.4	5.3	0.2	0.0	0.3	199.7	1.2	1.1	1.0	0.0	2.7	2.8	0.6	0.2	5.5	0.5	0.2	1.3	0.3	0.0	8.4	4.8	0.0	7.9	0.3	2.0	3.5	2.7	24.4	7.2	2.5	0.0	3.7	0.6	0.2	2.1	9.5	2.1	4.5	0.1	3.0	5.6	1.7	0.2	0.2	1.0	0.2	0.0	30.7	5.3	5.1	1.1	4.3	5.8	0.3	14.4	1.2	0.2	5.7
TPSAB1	"TPS1, TPS2, TPSB1"	ENSG00000172236	"Tryptase alpha/beta 1"	Q15661	16	1240379-1242554	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	13	"granulocytes: 5873.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	893	"basophil: 89.3"	"Lineage enriched"	"Detected in single"	893	"granulocytes: 89.3"	"Cell line enriched"	"Detected in some"	166	"HMC-1: 3813.2"									"CAB016369, CAB022175, HPA049153, HPA049554"	Supported				"Secreted to blood"	NA	NA					"CAB016369: AB_628406, CAB022175: , HPA049153: AB_2680656, HPA049554: AB_2680815"	"unprognostic (2.06e-2)"	"unprognostic (5.14e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.64e-2)"	"unprognostic (9.31e-3)"	"prognostic favorable (9.62e-6)"	"unprognostic (1.02e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.36e-2)"	78.4	2.9	0.6	23.8	0.5	2.4	47.6	0.4	0.9	47.1	0.8	67.8	72.2	73.9	6.0	64.9	26.8	130.9	12.7	0.5	0.4	13.7	12.3	129.6	21.4	0.6	0.4	0.4	3.2	19.0	2.3	3.6	1.2	0.9	66.5	35.0	0.0	60.7	22.7	10.1	106.0	150.0	18.1	0.4	6.0	104.9	9.0	0.5	14.3	4.7	13.2	13.4	114.4	53.1	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	2.7	0.0	0.0	0.0	0.0	0.0	19.3	0.0	0.0	0.0	1.3	3813.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.3	2.1	6.1	0.5	0.4	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.1	1.1	0.0	0.0	2.8	22.9	2.0	89.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.6	0.5	0.4	0.9	0.5	0.4	0.6	0.4	0.4	0.9	0.4	0.5	0.6	0.0	25.6	135.5	0.0	2.9	18.6	5.1	0.0	1.2	0.0	0.9	0.1	0.3	0.0	8.1	0.0	0.0	0.0	0.2	0.9	0.0	1.2	0.3	0.0	0.0	4.1	0.0	3.8	0.0	0.0	0.2	7.6	0.5	0.0	5873.9	0.0	0.0	0.3	5.2	0.0	0.0	0.0	0.0	0.3	25.6	0.2	0.0	7.7	19.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	11.7	4.0	0.4	0.1	5.1	0.0	0.0	0.3	3.2	0.0	0.1	0.1	9.9	0.3	440.9	0.0	0.5	5.6
TPSB2		ENSG00000197253	"Tryptase beta 2"	P20231	16	1227272-1230184	"Enzymes, Metabolic proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	25	"granulocytes: 8966.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	50	"basophil: 5.0"	"Lineage enriched"	"Detected in single"	50	"granulocytes: 5.0"	"Cell line enriched"	"Detected in some"	7	"HMC-1: 297.5"									"HPA049153, HPA049554"	Supported				"Secreted to blood"	NA	NA		16000000			"HPA049153: AB_2680656, HPA049554: AB_2680815"	"unprognostic (9.05e-2)"	"unprognostic (8.46e-3)"	"unprognostic (2.42e-3)"	"unprognostic (2.27e-2)"	"unprognostic (4.97e-3)"	"unprognostic (1.02e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.55e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.95e-1)"	"unprognostic (8.30e-3)"	"unprognostic (1.91e-2)"	"unprognostic (5.76e-2)"	"unprognostic (2.41e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.17e-2)"	77.8	2.5	0.3	20.4	0.4	4.3	48.2	0.3	0.9	53.7	0.7	61.1	35.8	72.4	9.9	65.1	30.6	104.9	12.8	0.4	0.4	15.2	12.3	128.9	26.4	0.4	0.3	0.3	3.5	19.1	1.5	3.9	1.3	0.7	67.5	20.0	0.0	65.0	13.4	10.0	107.0	147.3	22.2	0.4	5.2	103.0	10.0	0.3	4.9	4.7	10.5	10.0	119.6	53.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	41.2	0.0	0.0	0.2	0.4	297.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	4.7	0.3	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.7	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.3	0.9	0.4	0.4	0.4	0.3	0.3	0.7	0.4	0.3	0.5	0.1	38.5	275.3	0.0	2.8	0.0	4.4	0.0	0.0	0.0	1.5	0.0	1.5	0.0	16.7	0.0	0.0	0.1	0.6	0.7	0.0	2.4	0.6	0.0	0.0	3.2	0.0	18.9	0.0	0.0	0.2	6.0	2.0	0.0	8966.1	0.0	0.0	0.0	3.8	0.0	0.1	0.7	0.0	0.0	0.0	1.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	25.8	5.4	0.7	0.1	3.6	0.0	0.0	0.4	1.1	0.0	0.7	0.0	0.0	0.1	345.1	0.0	1.0	6.1
TPSD1		ENSG00000095917	"Tryptase delta 1"	Q9BZJ3	16	1256059-1259008	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 21.4"	"Cell type enriched"	"Detected in some"	19	"granulocytes: 202.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	29	"basophil: 2.9"	"Lineage enriched"	"Detected in single"	29	"granulocytes: 2.9"	"Group enriched"	"Detected in some"	49	"HEL: 28.2;HMC-1: 40.4"									"CAB002215, CAB032871, HPA040182, HPA049554"	Supported				"Intracellular and membrane"	NA	NA					"CAB002215: AB_563870, CAB032871: AB_2206475, HPA040182: AB_2676875, HPA049554: AB_2680815"	"unprognostic (5.99e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.97e-3)"	"unprognostic (1.15e-4)"	"unprognostic (1.70e-1)"	"unprognostic (5.45e-2)"	"unprognostic (9.00e-2)"	"unprognostic (2.88e-1)"	"unprognostic (4.30e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.50e-3)"	"unprognostic (3.74e-2)"	"unprognostic (4.14e-1)"	"unprognostic (3.89e-1)"	"unprognostic (7.46e-3)"	6.2	0.5	1.3	1.9	1.3	1.6	4.6	1.3	2.7	3.9	1.0	7.9	3.9	8.6	1.9	8.2	3.2	14.0	0.9	1.4	1.2	1.2	0.7	17.9	5.4	1.3	1.3	1.3	0.3	1.5	0.2	0.4	0.1	1.6	5.6	0.9	0.1	4.9	1.2	1.4	8.4	13.6	5.5	1.1	0.4	21.4	1.3	1.3	1.2	0.3	1.1	2.3	13.5	5.1	1.6	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	28.2	0.0	0.0	0.0	0.2	40.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.3	1.3	2.7	1.4	1.2	1.3	1.3	1.3	1.6	1.1	1.3	1.6	0.0	3.2	7.7	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	10.5	0.0	0.0	0.0	0.2	0.0	0.0	202.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.1
TRBV10-2	"TCRBV10S2, TCRBV12S3, TRBV102"	ENSG00000229769	"T cell receptor beta variable 10-2"	A0A0K0K1G8	7	142424965-142425465	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"lymphoid tissue: 2.7"	"Cell type enriched"	"Detected in single"	20	"T-cells: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"memory CD4 T-cell: 11.8;memory CD8 T-cell: 33.8;naive CD4 T-cell: 10.3;naive CD8 T-cell: 9.1;T-reg: 24.5"	"Lineage enriched"	"Detected in single"	338	"T-cells: 33.8"	"Not detected"	"Not detected"																	NA	NA						"unprognostic (1.30e-3)"	"unprognostic (5.71e-2)"	"unprognostic (3.57e-2)"	"unprognostic (5.26e-2)"		"unprognostic (2.24e-5)"		"unprognostic (2.97e-2)"		"unprognostic (5.84e-2)"	"unprognostic (2.77e-1)"	"unprognostic (5.65e-1)"	"unprognostic (2.55e-3)"	"unprognostic (5.27e-2)"	"unprognostic (3.55e-3)"	"unprognostic (3.51e-1)"		0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.2	0.7	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.5	0.0	0.0	2.7	0.4	0.2	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	1.4	0.0	11.8	33.8	0.0	0.0	10.3	9.1	0.0	0.0	0.0	0.0	24.5	4.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0
TRBV24-1	"TCRBV15S1, TCRBV24S1, TRBV241"	ENSG00000211750	"T cell receptor beta variable 24-1"	A0A075B6N3	7	142656701-142657213	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 2.7;lymphoid tissue: 6.8"	"Cell type enriched"	"Detected in single"	23	"T-cells: 2.4"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	4	"basal ganglia: 2.7"	"Immune cell enhanced"	"Detected in many"		"naive CD8 T-cell: 26.6"	"Lineage enriched"	"Detected in single"	129	"T-cells: 26.6"	"Not detected"	"Not detected"																	NA	NA						"unprognostic (1.42e-2)"	"unprognostic (1.64e-5)"	"unprognostic (1.59e-1)"	"unprognostic (9.71e-3)"	"unprognostic (3.82e-1)"	"unprognostic (9.30e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.81e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.43e-7)"	"unprognostic (2.36e-1)"	"unprognostic (5.80e-2)"	"unprognostic (7.76e-3)"	"unprognostic (4.39e-2)"	0.1	0.0	0.1	0.0	2.7	0.2	0.0	0.0	0.4	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.2	0.1	0.2	0.3	0.1	0.1	0.5	2.3	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.6	0.1	0.3	0.0	0.1	0.0	1.0	0.0	0.9	0.2	0.0	1.3	1.6	0.4	0.6	6.8	0.1	0.0	0.5	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	9.0	0.0	5.7	0.0	15.4	15.5	0.0	0.0	11.4	26.6	0.2	0.0	0.0	0.0	23.2	4.6	0.1	2.7	0.0	0.4	0.2	0.3	0.2	0.0	0.0	0.6	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0
TRBV6-4	"TCRBV13S5, TCRBV6S4, TRBV64"	ENSG00000211713	"T cell receptor beta variable 6-4"	A0A1B0GX49	7	142380806-142381261	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"lymphoid tissue: 1.2"	"Cell type enriched"	"Detected in single"	6	"T-cells: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	13	"MAIT T-cell: 231.6"	"Lineage enriched"	"Detected in single"	1381	"T-cells: 231.6"	"Not detected"	"Not detected"																	NA	NA						"unprognostic (2.60e-3)"							"unprognostic (4.64e-2)"		"unprognostic (1.17e-1)"	"unprognostic (2.64e-2)"		"unprognostic (4.79e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.07e-3)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.7	0.0	0.0	0.0	1.2	0.0	0.0	0.3	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	231.6	0.0	2.4	17.3	0.0	0.0	4.1	3.0	0.0	0.0	0.0	0.0	4.4	2.3	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0
TRDV2	"hDV102S1, MGC117421"	ENSG00000211821	"T cell receptor delta variable 2"	A0JD36	14	22422371-22423042	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 1.2;lymphoid tissue: 3.4"	"Cell type enriched"	"Detected in some"	7	"T-cells: 24.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	218	"gdT-cell: 3222.2"	"Lineage enriched"	"Detected in all"	575	"T-cells: 3222.2"	"Cell line enriched"	"Detected in single"	25	"REH: 7.3"															NA	NA																							0.1	0.0	0.0	1.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.2	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.3	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	2.3	0.1	0.0	0.0	3.4	0.0	0.0	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	3.9	3222.2	4.4	1.6	2.1	1.9	14.7	5.6	0.4	1.7	4.2	5.1	1.3	0.8	2.3	5.9	384.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.6	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.5	0.0	0.0	0.0
TREM2	"TREM-2, Trem2a, Trem2b, Trem2c"	ENSG00000095970	"Triggering receptor expressed on myeloid cells 2"	Q9NZC2	6	41158506-41163186	"Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"		Receptor	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 62.0;choroid plexus: 33.5;lung: 30.3"	"Cell type enriched"	"Detected in many"	8	"Hofbauer cells: 1014.1"	"Cancer enhanced"	"Detected in all"		"glioma: 93.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 2.0"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 2.0"	"Group enriched"	"Detected in some"	4	"hTCEpi: 74.6;THP-1: 42.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010917, HPA012571"	Approved				"Secreted in brain"	NA	NA		50000			"HPA010917: AB_1080365, HPA012571: AB_1858260"	"unprognostic (3.89e-1)"	"unprognostic (4.44e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (4.24e-4)"	"unprognostic (4.83e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.57e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.58e-3)"	"unprognostic (8.04e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.85e-2)"	8.2	13.3	30.8	3.6	35.3	0.2	9.9	38.2	62.0	6.6	33.5	3.6	0.9	1.7	2.3	0.6	7.5	9.8	2.0	30.7	41.2	1.1	2.3	30.3	2.6	42.9	36.1	27.4	2.4	4.0	7.4	4.0	10.8	44.3	2.0	4.3	2.0	6.1	3.2	0.4	0.4	1.4	4.6	51.4	0.5	2.5	0.7	41.9	1.8	1.7	0.0	0.4	4.5	0.6	52.6	0.0	0.3	0.0	0.0	0.1	0.3	0.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.0	1.2	74.6	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	42.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	30.8	35.3	38.2	62.0	30.7	41.2	42.9	36.1	27.4	44.3	51.4	41.9	52.6	1.8	6.4	7.5	0.0	0.7	0.8	0.2	79.8	0.0	0.3	1.8	58.8	0.1	1.5	9.6	0.0	0.0	5.0	0.4	0.0	0.0	0.0	0.6	0.0	0.1	10.4	0.0	0.0	0.0	0.0	4.9	1.2	0.0	0.0	2.5	0.0	2.2	0.2	1014.1	0.0	0.0	0.0	2.0	34.7	5.2	1.0	0.6	120.5	0.0	12.2	8.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	3.3	1.0	6.6	0.1	1.0	0.0	0.0	0.0	0.1	7.3	0.8	0.0	0.0	0.1
TRGV8	"TCRGV8, V1S8"	ENSG00000211696	"T cell receptor gamma variable 8"	A0A0C4DH27	7	38330343-38330935	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 6.9;prostate: 4.9"	"Cell type enriched"	"Detected in some"	4	"T-cells: 12.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	6	"gdT-cell: 34.4;MAIT T-cell: 40.6;memory CD8 T-cell: 31.1;naive CD8 T-cell: 17.2"	"Lineage enriched"	"Detected in many"	7	"T-cells: 40.6"	"Cell line enriched"	"Detected in some"	4	"JURKAT: 44.9"															NA	NA																							0.4	0.3	0.3	1.5	0.1	0.7	0.3	0.0	0.3	0.4	0.2	0.8	0.8	0.7	0.6	0.7	0.9	1.2	0.3	0.5	0.2	0.2	1.4	2.3	3.5	0.8	0.7	0.0	0.3	0.3	0.1	0.0	1.4	1.0	4.9	1.2	0.0	0.3	0.4	0.1	0.0	2.0	0.9	0.2	6.9	0.8	0.4	0.4	4.6	0.2	0.0	2.0	1.4	0.1	0.8	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.2	2.4	0.1	0.5	0.0	0.0	0.9	0.0	0.3	0.2	0.0	0.0	0.0	2.1	3.1	0.0	1.4	0.0	0.0	0.0	3.6	0.5	0.0	0.0	1.2	0.0	0.0	0.0	44.9	1.0	2.5	0.0	0.7	0.0	1.7	0.0	0.0	0.0	3.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.5	0.0	0.3	0.1	0.0	0.0	0.0	2.7	10.6	0.0	0.0	0.7	0.0	34.4	0.1	40.6	0.0	3.7	31.1	0.9	0.0	0.2	17.2	0.2	5.5	0.1	0.2	0.1	4.5	0.3	0.1	0.0	0.3	0.5	0.2	0.8	0.7	0.0	1.0	0.2	0.4	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	2.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.3	0.0	0.0
TRH		ENSG00000170893	"Thyrotropin releasing hormone"	P20396	3	129974688-129977935	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 110.9;cervix: 26.2;retina: 35.5"	"Cell type enriched"	"Detected in some"	10	"Muller glia cells: 234.5"	"Group enriched"	"Detected in some"	5	"breast cancer: 13.3;endometrial cancer: 10.2;glioma: 4.3"	"Group enriched"	"Detected in many"	5	"hypothalamus: 28.6;medulla oblongata: 110.9;pons: 41.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SuSa: 1.0"	"Group enriched"	"Detected in many"	5	"hypothalamus: 175.6;olfactory bulb: 148.0"	"Low region specificity"	"Detected in many"			HPA035596	Enhanced				"Secreted in other tissues"	NA	NA					"HPA035596: AB_2674695"	"unprognostic (1.22e-1)"	"unprognostic (8.94e-2)"		"unprognostic (5.82e-3)"	"unprognostic (5.24e-2)"	"unprognostic (2.82e-1)"		"unprognostic (1.11e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.44e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.82e-2)"	0.2	0.0	11.2	0.1	3.1	3.8	1.9	1.9	0.9	26.2	0.2	0.0	0.1	18.9	0.0	0.0	2.5	0.0	0.3	2.2	28.6	0.1	0.0	0.6	0.0	110.9	4.5	0.6	3.9	0.0	0.0	0.2	0.2	41.3	0.1	0.0	35.5	0.5	0.1	0.1	0.5	0.0	0.3	1.7	0.1	0.0	1.3	10.1	0.4	0.0	0.0	0.0	0.0	0.4	2.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	11.2	3.1	1.9	0.9	2.2	28.6	110.9	4.5	0.6	41.3	1.7	10.1	2.7	0.3	0.0	0.0	0.3	0.2	0.8	0.7	0.0	0.0	10.4	1.6	1.4	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	7.1	9.0	0.8	0.7	0.0	0.0	0.2	0.0	0.1	0.2	0.0	22.5	0.0	0.1	0.0	0.0	0.1	5.0	0.3	0.0	0.0	0.0	11.5	2.7	0.0	2.0	0.0	0.0	0.0	234.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	9.2	0.0	0.0	0.2	0.7	1.6	0.0	0.1	0.1	0.2	0.1	0.0	4.3
TRIM10	"HERF1, RFB30, RNF9"	ENSG00000204613	"Tripartite motif containing 10"	Q9UDY6	6	30151943-30161211	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 7.9;kidney: 2.1;liver: 2.9"	"Cell type enriched"	"Detected in some"	21	"Erythroid cells: 126.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	16	"HEL: 22.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	11	"hippocampal formation: 3.4"	HPA043325	Uncertain					NA	NA					"HPA043325: AB_2678428"		"unprognostic (2.98e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.99e-2)"		"unprognostic (2.13e-1)"	"unprognostic (2.98e-1)"	"unprognostic (9.53e-3)"	"unprognostic (6.32e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.64e-2)"		"unprognostic (1.74e-3)"	"unprognostic (1.46e-2)"	"unprognostic (4.37e-2)"		"unprognostic (1.22e-2)"	0.0	0.0	0.0	0.1	0.0	7.9	0.0	0.0	0.0	0.1	0.0	1.2	1.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.1	2.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	1.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.5	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	1.2	126.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	1.9	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	5.9	0.0	0.0	0.0	3.1	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.3	0.0
TRIM2	"CMT2R, KIAA0517, RNF86"	ENSG00000109654	"Tripartite motif containing 2"	Q9C040	4	153152163-153339319	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 107.1"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 1132.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"memory CD4 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 47.0;SK-MEL-30: 46.8"									"HPA035853, HPA035854"	Supported		Uncertain	Centrosome		NA	NA			Centrosome		"HPA035853: AB_10669533, HPA035854: AB_10669659"	"unprognostic (8.94e-2)"	"unprognostic (7.89e-2)"	"unprognostic (6.21e-3)"	"unprognostic (7.51e-3)"	"unprognostic (2.07e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.30e-3)"	"unprognostic (5.30e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.42e-2)"	"prognostic favorable (6.58e-14)"	"unprognostic (5.89e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.19e-2)"	"unprognostic (4.13e-2)"	5.5	11.9	17.4	4.9	49.0	0.1	11.9	26.6	44.1	23.8	0.0	21.8	17.6	10.0	8.0	10.8	15.4	12.7	8.5	43.2	26.4	21.6	8.0	7.3	2.2	33.0	30.1	23.4	13.0	12.8	1.0	21.7	2.5	47.3	13.2	19.4	19.5	43.3	13.5	2.2	6.9	17.4	7.0	34.3	10.7	27.7	2.0	29.6	3.0	51.0	3.0	4.0	12.1	11.6	107.1	10.2	0.2	47.0	24.2	22.0	27.2	0.5	12.7	15.4	3.6	4.5	4.1	0.2	0.1	7.7	21.7	8.5	6.4	24.7	4.7	3.2	0.0	5.4	0.1	4.6	0.5	24.7	0.1	0.1	13.5	2.3	5.4	4.7	12.9	3.4	0.4	0.2	0.0	4.9	0.4	2.4	0.1	37.4	27.5	8.8	1.0	9.4	0.0	37.0	11.8	14.5	27.3	4.4	2.7	46.8	6.9	1.7	0.5	2.8	12.7	3.0	10.8	3.9	0.0	0.0	0.1	20.9	0.0	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.1	17.4	49.0	26.6	44.1	43.2	26.4	33.0	30.1	23.4	47.3	34.3	29.6	107.1	11.2	6.4	33.7	189.0	2.6	7.0	15.3	40.2	9.1	67.7	40.5	29.1	39.6	17.2	82.1	58.8	29.2	2.0	0.7	59.4	101.8	9.6	3.3	113.3	16.3	17.3	62.3	0.4	266.4	26.1	0.5	22.0	80.0	95.6	1.3	4.8	21.0	12.4	1.4	111.0	211.2	64.1	54.9	0.8	7.7	2.4	29.5	2.2	64.0	21.5	3.2	86.9	0.0	237.2	1132.8	22.5	41.4	32.7	1.5	17.8	62.9	14.7	106.0	23.4	26.3	14.7	16.2	0.4	1.3	5.0	4.0	0.7	2.8	8.7	90.8	33.7
TRIM59	"Mrf1, RNF104, TRIM57, TSBF1"	ENSG00000213186	"Tripartite motif containing 59"	Q8IWR1	3	160432445-160485773	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 68.0"	"Cell type enriched"	"Detected in many"	12	"Oligodendrocytes: 391.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017750	Uncertain		Approved	"Rods & Rings"		NA	Yes			"Rods & Rings"		"HPA017750: AB_1858312"	"unprognostic (3.74e-1)"	"prognostic favorable (4.36e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.02e-1)"	"unprognostic (8.00e-4)"	"unprognostic (1.88e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (1.15e-5)"	"unprognostic (1.02e-3)"	"unprognostic (2.44e-11)"	"unprognostic (7.92e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.03e-2)"	"unprognostic (5.91e-3)"	0.6	0.8	7.7	5.1	32.7	17.8	2.1	14.1	24.3	1.2	0.0	2.7	2.8	3.1	0.9	4.9	2.1	2.7	0.7	9.2	14.7	1.2	1.0	2.0	12.2	20.0	21.7	4.4	1.3	1.5	1.8	1.2	2.0	21.9	2.0	2.7	1.4	1.7	1.0	1.3	5.5	2.9	2.9	7.0	5.1	2.6	8.7	19.4	13.7	2.0	0.1	12.2	3.1	2.3	68.0	20.4	15.8	19.8	1.3	7.8	10.6	26.0	31.5	27.3	38.5	36.9	1.9	34.8	54.5	22.9	23.7	12.1	34.1	0.0	12.9	50.7	49.1	19.2	2.0	5.4	2.4	10.9	24.3	3.2	9.0	3.8	18.7	13.4	23.6	27.1	8.0	25.8	22.6	36.7	21.9	15.0	1.9	52.5	13.2	26.1	20.7	17.2	24.6	13.8	6.6	13.0	2.8	9.0	26.3	0.7	26.5	31.2	22.4	20.9	2.8	8.9	4.5	3.1	37.0	14.5	13.4	3.4	31.0	3.1	29.1	2.8	5.4	10.9	3.1	12.7	10.4	17.9	15.0	4.5	9.3	12.0	14.5	2.2	12.4	1.5	6.7	22.0	3.7	7.7	32.7	14.1	24.3	9.2	14.7	20.0	21.7	4.4	21.9	7.0	19.4	68.0	0.6	0.0	6.5	0.3	7.8	4.8	4.7	2.1	3.4	0.4	2.8	1.8	2.5	2.8	1.4	1.8	6.2	7.2	6.1	1.2	0.0	2.0	31.2	1.9	2.1	2.5	10.8	29.5	0.4	2.0	11.7	2.1	5.1	2.9	1.3	10.1	2.2	0.1	2.9	0.0	0.5	2.9	2.0	2.2	2.3	12.5	0.3	1.8	3.6	0.0	2.1	0.5	3.1	0.0	391.8	1.9	2.8	0.7	6.4	3.3	1.2	2.3	2.1	1.7	0.0	2.4	2.7	14.0	15.1	5.6	4.4	2.5	10.9	2.7	4.8	3.6
TRIM6	RNF89	ENSG00000121236	"Tripartite motif containing 6"	Q9C030	11	5596109-5612958	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 21.1"	"Cell type enriched"	"Detected in many"	4	"Proximal tubular cells: 74.4"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.8"	"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 22.2;SuSa: 36.7;TIME: 19.2;U-2 OS: 21.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA060514	Uncertain					NA	NA					"HPA060514: AB_2684300"	"unprognostic (9.00e-2)"	"unprognostic (2.10e-3)"	"unprognostic (9.16e-3)"	"unprognostic (1.82e-1)"	"unprognostic (3.25e-3)"	"unprognostic (3.25e-3)"	"unprognostic (2.35e-2)"	"unprognostic (3.26e-3)"	"unprognostic (8.59e-2)"	"unprognostic (3.40e-2)"	"unprognostic (8.61e-2)"	"unprognostic (3.90e-1)"	"unprognostic (5.68e-2)"	"unprognostic (4.65e-4)"	"unprognostic (4.77e-1)"	"unprognostic (3.33e-2)"	"unprognostic (4.36e-1)"	2.8	3.8	0.4	1.8	0.3	2.0	3.3	0.2	0.4	1.9	0.8	1.7	0.5	3.3	4.9	4.3	3.2	2.3	0.9	0.2	1.1	21.1	0.8	2.1	0.7	0.7	0.5	0.3	4.4	1.3	1.3	0.9	5.4	0.5	2.6	1.7	0.2	10.6	3.6	0.8	1.0	1.1	5.2	0.6	3.8	1.0	9.4	0.5	1.3	3.9	0.6	1.3	2.6	2.8	0.7	0.7	16.2	1.1	0.0	2.0	2.9	18.7	4.4	3.3	4.3	4.2	0.4	3.6	0.0	2.5	4.5	12.1	2.9	7.5	6.7	6.1	0.6	5.0	2.0	1.6	0.1	0.7	6.6	8.7	5.1	6.4	6.2	4.3	6.4	3.8	0.1	8.0	0.2	1.8	0.2	0.0	0.9	22.2	2.6	5.7	7.7	0.0	0.1	0.9	6.6	0.1	0.2	0.0	8.4	0.8	36.7	3.2	1.1	19.2	4.0	21.3	0.1	4.7	0.2	0.1	0.0	3.7	0.0	3.5	0.2	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	1.1	0.3	0.0	0.2	0.0	0.1	0.4	0.3	0.2	0.4	0.2	1.1	0.7	0.5	0.3	0.5	0.6	0.5	0.7	1.2	0.0	4.8	0.0	0.1	0.5	0.6	0.5	1.8	0.0	3.1	1.8	0.4	0.0	0.8	1.8	0.0	12.5	0.0	0.2	3.9	1.2	1.2	0.7	1.7	1.5	0.0	2.1	0.0	0.2	15.5	2.1	0.0	1.0	0.0	4.1	0.0	0.5	3.1	0.0	0.0	0.3	2.0	3.5	0.3	0.8	0.9	1.1	1.8	0.0	2.2	0.0	0.0	0.0	0.0	0.6	0.1	1.9	0.0	0.4	0.3	74.4	1.1	0.0	0.0	0.5	0.7	10.8	3.3	1.8	0.4	5.7	0.4	4.1	0.2	0.3
TRMT5	"KIAA1393, TRM5"	ENSG00000126814	"TRNA methyltransferase 5"	Q32P41	14	60971441-60981170	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Early spermatids: 221.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000943	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA000943: AB_1080388"	"unprognostic (1.58e-2)"	"unprognostic (3.62e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.11e-2)"	"unprognostic (7.70e-3)"	"unprognostic (2.26e-2)"	"unprognostic (7.82e-3)"	"unprognostic (4.50e-2)"	"unprognostic (3.95e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.40e-1)"	7.3	5.5	3.5	4.5	4.0	4.8	9.9	6.2	4.2	6.6	3.2	6.8	5.7	7.0	7.8	7.7	7.5	5.2	4.2	3.5	4.4	7.0	6.8	5.1	6.1	2.9	3.4	3.4	10.0	6.8	10.6	3.5	7.0	3.8	6.9	6.0	5.2	7.7	4.8	7.6	6.8	4.6	7.1	3.1	4.7	5.8	17.4	3.7	6.2	7.3	7.2	5.8	6.8	3.9	3.9	49.7	12.5	17.9	25.0	15.5	23.6	19.4	18.2	14.0	19.1	15.2	9.8	28.7	25.2	19.9	13.3	14.3	22.3	22.9	26.4	25.0	25.3	11.5	18.6	8.1	10.2	25.1	33.2	9.9	18.3	25.1	17.4	25.4	17.0	17.0	21.6	24.5	8.8	28.3	18.7	17.1	16.8	16.4	19.4	20.3	5.4	41.5	21.4	16.3	16.7	22.1	21.6	20.2	20.1	16.6	15.4	33.5	19.7	16.1	22.1	26.7	15.7	17.5	5.3	10.8	11.6	15.6	7.2	21.0	0.1	3.2	0.7	2.4	5.5	3.3	4.9	3.4	3.5	3.0	4.1	3.8	3.4	0.3	1.4	5.9	5.2	4.5	2.5	3.5	4.0	6.2	4.2	3.5	4.4	2.9	3.4	3.4	3.8	3.1	3.7	3.9	7.0	6.4	10.9	3.9	4.5	6.4	19.5	15.9	9.6	5.7	6.3	10.0	8.0	1.5	19.6	11.0	4.2	12.8	5.7	3.2	1.9	7.7	221.8	8.2	17.4	9.2	5.4	10.7	5.4	7.5	12.4	12.4	9.7	8.1	6.3	12.1	8.6	7.0	10.9	3.3	6.7	8.3	8.2	6.2	7.6	50.2	11.1	6.0	7.2	3.7	4.1	12.2	1.0	9.0	6.3	8.2	4.8	7.5	4.7	8.2	3.9	11.1	14.9	5.4	13.1	14.7	9.5	23.3	12.6	11.1	4.3	19.2	5.2	14.4	7.6	10.6
TRPC4	"HTRP4, TRP4"	ENSG00000133107	"Transient receptor potential cation channel subfamily C member 4"	Q9UBN4	13	37632063-37869802	"Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 12.0;seminal vesicle: 9.1;smooth muscle: 12.7"	"Cell type enriched"	"Detected in some"	4	"Inhibitory neurons: 133.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 8.7;BJ: 20.2;BJ hTERT+ SV40 Large T+: 9.1;fHDF/TERT166: 19.6;U-2197: 9.3"	"Region enhanced"	"Detected in many"		"basal ganglia: 43.1"	"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (4.52e-4)"	"unprognostic (9.99e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.47e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.07e-6)"	"unprognostic (3.73e-3)"	"unprognostic (1.93e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.43e-2)"	0.8	0.4	3.4	0.8	7.3	0.0	0.3	0.1	3.4	2.1	0.0	2.2	0.4	12.0	0.8	0.1	1.3	3.3	0.9	4.4	3.7	1.5	0.2	3.4	0.1	0.9	2.2	2.2	2.7	1.3	0.2	0.2	1.3	0.7	6.7	0.6	0.2	0.2	9.1	0.2	0.1	1.0	12.7	0.5	0.2	2.0	0.1	1.8	0.0	0.7	0.2	0.0	1.6	1.6	1.2	0.0	0.0	8.7	0.0	1.2	2.6	0.0	20.2	2.9	9.1	4.4	0.0	0.3	0.0	0.0	19.6	3.1	0.0	0.1	0.0	4.2	0.0	0.1	0.0	0.4	0.0	3.1	0.0	0.0	1.3	0.0	2.6	0.0	1.3	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	1.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.2	0.1	9.3	1.8	4.7	1.2	0.0	1.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	7.3	0.1	3.4	4.4	3.7	0.9	2.2	2.2	0.7	0.5	1.8	1.2	0.3	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.8	0.0	0.3	12.3	0.6	0.0	0.0	32.0	0.0	0.0	3.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	133.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	15.0	0.0	0.0	0.0	2.5	1.4	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.2	0.0	0.2	7.1	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.1
TRPC7		ENSG00000069018	"Transient receptor potential cation channel subfamily C member 7"	Q9HCX4	5	136212745-136365545	"Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"Inhibitory neurons: 10.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB022592, HPA031126"	Uncertain					NA	NA					"CAB022592: , HPA031126: AB_10603221"			"unprognostic (1.49e-1)"		"unprognostic (2.08e-1)"					"unprognostic (3.03e-2)"	"unprognostic (2.89e-5)"	"unprognostic (3.26e-1)"	"unprognostic (2.75e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.78e-2)"		0.0	0.3	0.3	0.0	0.3	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.6	0.0	0.0	0.0	0.6	0.6	0.1	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.0	0.9	0.6	0.6	0.1	0.7	0.3	0.3	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRPM5	"LTRPC5, MTR1"	ENSG00000070985	"Transient receptor potential cation channel subfamily M member 5"	Q9NZQ8	11	2404515-2423045	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 1.8;intestine: 3.3;pancreas: 2.4;seminal vesicle: 1.8"	"Cell type enriched"	"Detected in some"	4	"Gastric mucus-secreting cells: 9.7"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"													NA	NA						"unprognostic (1.82e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.47e-5)"	"unprognostic (6.81e-4)"	"unprognostic (7.90e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.24e-2)"	"unprognostic (4.75e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.19e-1)"	"unprognostic (5.07e-3)"	"unprognostic (2.40e-1)"	"unprognostic (5.21e-1)"	"unprognostic (5.72e-2)"	"unprognostic (4.91e-2)"	0.0	0.8	0.0	0.1	0.0	0.1	0.0	0.2	0.2	0.0	0.0	1.1	2.9	0.0	1.8	0.0	0.1	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.3	0.0	0.0	0.1	0.3	0.0	0.0	1.8	0.0	0.0	3.3	0.0	0.0	0.1	0.3	0.6	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.8	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	2.0	0.1
TSC22D4	"THG-1, TILZ2"	ENSG00000166925	"TSC22 domain family member 4"	Q9Y3Q8	7	100463359-100479232	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 583.8"	"Cell type enriched"	"Detected in all"	4	"Muller glia cells: 778.8"	"Cancer enhanced"	"Detected in all"		"glioma: 118.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 198.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006757	Uncertain		Approved	Cytosol		NA	NA		160000	Cytosol		"HPA006757: AB_1080403"	"unprognostic (2.34e-2)"	"unprognostic (3.06e-2)"	"prognostic unfavorable (2.66e-4)"	"unprognostic (5.77e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.06e-1)"	"prognostic unfavorable (9.45e-4)"	"unprognostic (9.96e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.54e-2)"	"unprognostic (3.84e-2)"	"unprognostic (7.36e-2)"	"unprognostic (3.81e-3)"	35.5	53.1	399.8	33.9	509.8	72.6	36.5	478.7	460.5	43.4	187.6	44.0	23.7	40.8	10.2	73.6	37.1	14.5	56.1	345.1	402.7	52.4	30.2	43.0	40.9	583.8	521.0	279.9	44.4	37.6	18.6	52.5	22.9	495.8	56.2	10.8	22.1	98.5	22.4	26.5	57.5	44.8	14.1	425.1	95.9	38.9	37.0	452.4	31.5	34.8	28.9	23.4	38.2	47.2	525.5	42.0	30.8	10.3	33.7	34.2	40.5	19.9	30.5	49.6	28.3	25.8	16.9	25.0	36.8	36.1	24.4	66.0	31.2	12.2	26.7	9.9	65.6	25.2	34.2	34.5	14.6	54.4	44.1	86.3	45.7	24.0	32.4	32.2	33.0	58.3	29.0	75.2	64.2	22.9	74.3	55.6	198.4	14.0	35.7	42.6	89.7	8.1	51.6	23.2	22.3	8.8	25.1	41.4	78.8	65.5	16.7	22.5	63.1	50.2	38.4	39.1	95.0	22.8	40.9	42.6	27.1	35.7	66.4	47.8	9.7	18.7	30.0	19.0	20.2	14.9	11.9	16.3	17.9	12.7	11.8	15.2	16.2	56.1	18.8	20.5	13.3	25.0	18.2	399.8	509.8	478.7	460.5	345.1	402.7	583.8	521.0	279.9	495.8	425.1	452.4	525.5	16.7	12.8	8.9	123.4	50.8	32.8	35.9	50.7	37.5	15.4	47.3	61.3	17.7	44.3	32.5	40.5	6.2	30.7	69.3	60.3	137.0	63.5	1.7	14.0	25.5	26.1	33.6	60.6	3.8	33.9	35.3	29.8	21.4	19.9	15.9	36.1	42.1	11.1	79.9	18.5	4.6	32.1	38.7	57.7	67.1	5.2	45.7	56.7	55.2	14.0	77.2	778.8	116.4	50.8	162.6	60.6	52.7	39.9	31.8	59.2	62.8	21.0	13.7	18.2	46.0	16.1	34.5	1.7	5.4	32.8	33.8	79.1	78.2	28.9	31.7	80.3
TSKU	"E2IG4, LRRC54, TSK"	ENSG00000182704	"Tsukushi, small leucine rich proteoglycan"	Q8WUA8	11	76782251-76798153	"Predicted secreted proteins"	Neurogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 239.2"	"Cell type enriched"	"Detected in many"	7	"Hepatocytes: 506.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 168.0;ASC diff: 282.5;OE19: 188.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA008164	Approved		Approved	"Nucleoplasm,Nuclear bodies"	"Secreted to blood"	NA	NA		6200000	Nucleoplasm	"Nuclear bodies"	"HPA008164: AB_1853327"	"unprognostic (1.07e-2)"	"unprognostic (2.29e-3)"	"unprognostic (6.15e-2)"	"prognostic favorable (3.66e-4)"	"unprognostic (7.05e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.17e-3)"	"unprognostic (4.81e-2)"	"unprognostic (4.62e-2)"	"prognostic unfavorable (2.87e-4)"	"prognostic favorable (1.66e-4)"	"prognostic unfavorable (2.80e-8)"	"unprognostic (1.47e-1)"	"unprognostic (4.93e-2)"	"unprognostic (6.71e-2)"	"unprognostic (3.88e-2)"	90.1	12.2	4.2	8.4	4.5	2.1	81.1	6.5	5.1	135.3	23.5	19.3	37.5	46.8	20.8	63.3	68.3	15.1	28.3	6.7	4.4	41.9	239.2	15.2	2.5	4.4	3.0	4.5	47.4	16.9	6.4	14.9	30.6	5.0	44.4	14.5	4.1	34.2	24.8	9.6	57.2	32.6	41.5	1.7	7.0	28.5	9.2	3.8	4.7	37.9	5.7	5.6	41.9	100.4	5.2	3.7	168.0	19.1	18.4	282.5	36.1	34.6	5.9	32.2	12.6	12.0	22.2	48.0	0.3	32.7	21.1	53.7	68.6	10.9	42.7	3.9	35.7	5.9	8.3	43.5	63.1	53.6	3.0	11.9	37.3	46.0	22.5	18.2	24.0	15.7	6.4	19.9	1.4	11.7	81.9	0.5	6.5	24.5	188.9	7.4	5.9	18.3	28.7	29.7	29.7	16.8	28.5	32.7	25.7	15.4	15.8	34.5	2.7	4.9	35.4	28.2	86.8	14.2	1.1	0.6	1.4	16.6	8.9	6.4	0.4	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.3	0.1	0.2	0.3	0.1	0.0	0.1	0.1	0.0	4.2	4.5	6.5	5.1	6.7	4.4	4.4	3.0	4.5	5.0	1.7	3.8	5.2	6.2	0.0	0.5	1.0	0.5	17.3	12.1	25.8	27.9	3.5	13.6	13.2	3.2	11.5	12.1	1.8	0.0	50.0	0.1	33.2	0.0	6.7	0.2	8.1	35.6	5.8	7.8	13.5	0.5	21.7	71.8	33.0	14.8	10.6	1.3	38.7	9.7	506.3	9.9	0.0	0.1	12.4	26.4	9.1	6.4	2.0	37.3	0.8	5.4	1.9	1.6	9.2	0.0	0.0	0.0	21.3	21.2	45.1	0.1	14.6	28.6	21.9	3.0	0.6	0.0	1.0	11.3	0.4	2.0	22.3	22.6	43.8	1.6	8.6	13.8	20.1
TSPAN19		ENSG00000231738	"Tetraspanin 19"	P0C672	12	85014311-85036277	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"retina: 4.4;testis: 4.5"	"Cell type enriched"	"Detected in some"	5	"Respiratory ciliated cells: 382.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 2.5;SK-BR-3: 1.7;U-266/70: 1.6"					"Low region specificity"	"Detected in many"			HPA057066	Uncertain					NA	NA					"HPA057066: AB_2683325"				"unprognostic (1.94e-1)"	"unprognostic (9.81e-4)"	"unprognostic (8.57e-2)"		"unprognostic (8.37e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.26e-3)"	"unprognostic (9.52e-2)"	"unprognostic (5.09e-3)"		"unprognostic (2.22e-1)"	"unprognostic (3.78e-2)"		0.1	0.3	1.2	0.3	0.9	1.1	0.0	2.3	1.4	0.2	1.3	0.2	0.4	0.3	0.9	0.1	0.9	0.3	0.0	0.7	0.7	0.4	0.0	2.7	0.3	1.3	0.7	1.0	0.2	0.8	0.1	2.0	0.1	1.2	0.5	0.1	4.4	0.0	0.0	0.9	1.3	0.2	0.0	0.5	0.3	0.1	4.5	0.9	0.0	1.8	0.5	0.2	0.1	0.0	1.6	0.3	0.0	0.6	0.2	0.3	0.5	0.8	0.4	0.0	0.0	0.2	0.3	0.0	0.3	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.4	0.5	0.0	0.3	0.3	0.9	0.6	0.7	0.4	0.4	0.4	0.2	1.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.5	1.1	0.0	1.7	0.4	0.2	0.4	0.0	0.5	1.0	0.3	0.5	0.3	1.6	0.0	0.2	1.3	0.0	0.5	0.3	0.2	0.2	0.2	0.1	0.1	0.2	0.2	0.1	0.0	0.4	0.2	0.2	1.4	0.2	0.1	0.2	0.0	0.0	1.2	0.9	2.3	1.4	0.7	0.7	1.3	0.7	1.0	1.2	0.5	0.9	1.6	0.1	3.2	2.0	0.7	0.0	0.1	0.0	18.2	0.0	3.5	0.1	0.1	1.1	0.0	30.3	0.0	8.4	0.0	0.0	0.0	0.0	0.0	72.7	0.6	0.0	0.5	0.0	0.0	2.8	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	14.2	0.0	0.3	6.9	0.0	0.1	0.0	1.0	0.0	5.1	0.0	0.0	3.1	0.0	0.0	0.4	0.1	0.6	0.0	0.1	382.1	9.1	6.6	0.4	5.2	7.6	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1
TUBB1	dJ543J19.4	ENSG00000101162	"Tubulin beta 1 class VI"	Q9H4B7	20	59019429-59026654	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 8.5;lymphoid tissue: 4.3"	"Cell type enriched"	"Detected in some"	10	"Macrophages: 191.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	17	"basophil: 63.5;neutrophil: 26.0"	"Lineage enriched"	"Detected in many"	24	"granulocytes: 63.5"	"Cell line enriched"	"Detected in some"	19	"HEL: 29.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB004286, HPA043640, HPA046280"	Approved		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA		87000000	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB004286: AB_2288090, HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (3.76e-1)"	"unprognostic (2.69e-1)"	"unprognostic (6.10e-4)"	"unprognostic (1.02e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.86e-2)"	"unprognostic (7.51e-4)"	"unprognostic (1.90e-2)"	"unprognostic (2.63e-1)"	"unprognostic (6.80e-5)"	"unprognostic (3.46e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.00e-1)"	0.2	0.2	0.2	0.3	0.3	8.5	0.1	0.6	0.6	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.2	0.1	0.3	2.4	0.2	0.4	0.3	0.1	0.1	0.1	0.0	0.3	1.1	0.4	0.0	0.0	0.2	0.1	0.0	0.4	0.1	0.2	0.0	0.5	4.3	0.1	0.9	0.3	0.0	0.2	1.5	0.0	0.0	0.0	0.4	0.1	0.3	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.2	0.4	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	29.5	0.8	1.5	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.3	1.4	0.0	0.0	0.1	0.3	0.3	0.0	0.1	0.4	0.2	0.1	0.3	0.0	0.3	0.3	0.2	0.2	0.6	0.1	0.1	0.1	0.2	0.0	0.2	0.2	0.3	0.1	0.2	0.3	0.2	0.1	0.2	0.4	63.5	2.4	1.9	0.5	0.6	0.4	0.9	0.2	0.0	1.1	0.5	0.4	0.0	26.0	0.2	0.3	2.6	0.5	281.6	0.2	0.3	0.6	0.6	0.1	0.2	0.4	0.3	0.1	0.4	0.5	0.3	0.4	0.1	0.0	1.1	0.3	1.4	0.0	0.0	0.0	0.0	1.7	0.1	0.1	0.1	0.0	0.6	0.0	4.2	0.0	3.1	0.0	0.0	0.0	16.0	0.3	0.2	1.5	0.0	19.0	0.2	0.0	0.1	0.1	0.0	0.7	1.3	0.0	3.6	0.2	0.3	0.0	0.2	0.0	0.0	2.8	0.0	5.9	0.3	191.2	0.0	0.0	13.8	0.2	13.4	0.0	0.1	0.0	0.0	0.4	0.4	0.0	0.0	0.1	0.0	1.9	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.1	1.0	0.1	0.1	0.1
TXN	TRX	ENSG00000136810	Thioredoxin	P10599	9	110243810-110256507	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transcription, Transcription regulation, Transport"	Activator	Allergen	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 1067.3"	"Cell type enriched"	"Detected in all"	4	"monocytes: 15775.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 1642.2;granulocytes: 1355.4"	"Cell line enhanced"	"Detected in all"		"OE19: 3836.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008678, HPA047478, HPA055752"	Enhanced		Enhanced	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		16000000	"Nucleoplasm, Cytosol"		"CAB008678: AB_1623676, HPA047478: AB_2680063, HPA055752: AB_2682907"	"unprognostic (2.12e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.77e-2)"	"prognostic favorable (3.40e-6)"	"unprognostic (1.80e-2)"	"unprognostic (2.13e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.36e-2)"	"unprognostic (5.93e-3)"	"unprognostic (1.66e-1)"	"unprognostic (4.96e-3)"	"unprognostic (7.80e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.99e-2)"	"unprognostic (8.51e-2)"	140.0	128.8	164.7	146.7	168.3	370.7	220.8	166.7	227.3	151.2	157.7	459.5	352.4	132.1	169.9	1067.3	242.8	143.4	88.9	167.4	176.9	434.6	439.6	159.8	132.6	176.1	171.5	165.6	84.5	120.1	73.6	61.6	106.7	175.5	114.6	439.1	46.6	394.9	130.1	85.5	242.1	335.0	141.5	171.4	106.3	224.5	36.9	165.5	263.7	94.6	77.0	210.1	220.1	232.7	180.0	672.9	920.0	238.7	265.6	601.0	782.3	352.7	792.5	756.2	555.6	419.4	606.8	785.6	598.9	331.5	754.7	1181.3	1464.8	351.0	1081.1	544.6	887.6	778.5	298.2	804.7	1061.8	684.7	747.2	864.2	556.2	703.5	809.0	607.8	504.7	498.7	369.7	515.9	553.1	775.4	557.1	621.9	1119.7	505.4	3836.3	1110.5	256.6	810.3	696.3	721.7	479.4	520.9	183.7	860.0	687.5	572.7	458.6	661.2	508.6	587.9	556.4	357.3	1050.2	1006.1	271.4	872.5	512.7	804.8	654.4	789.5	484.8	311.2	1355.4	169.2	195.5	165.2	154.2	237.7	207.3	475.7	75.9	87.4	129.3	1212.7	195.0	131.6	1642.2	337.0	279.2	164.7	168.3	166.7	227.3	167.4	176.9	176.1	171.5	165.6	175.5	171.4	165.5	180.0	458.7	391.0	298.2	12.4	165.9	1304.5	1072.4	3654.4	435.4	38.0	514.2	752.8	108.5	418.9	1810.0	263.0	20.9	637.2	443.0	1297.7	972.4	1172.8	31.2	1560.7	1465.0	587.0	556.4	388.4	18.2	1341.7	993.1	526.8	662.1	775.9	268.6	247.1	216.0	842.8	571.8	28.6	18.3	1111.2	2191.1	286.1	1752.9	31.6	403.2	682.7	763.1	10.3	15775.8	86.3	128.8	7.5	21.9	1994.7	1227.7	285.5	388.5	2151.2	1439.2	3670.6	1516.8	34.8	144.7	211.8	557.8	10.6	76.3	2725.7	1491.0	468.2	266.6	879.4	1621.8	1742.1
TXNDC11	EFP1	ENSG00000153066	"Thioredoxin domain containing 11"	Q6PKC3	16	11679083-11742857	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	6	"Plasma cells: 307.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 141.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041174, HPA041390"	Supported		Supported	"Plasma membrane,Cytosol"		No	No			"Plasma membrane, Cytosol"		"HPA041174: AB_10794191, HPA041390: AB_10796670"	"unprognostic (1.96e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.82e-3)"	"prognostic favorable (2.12e-5)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (2.43e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.68e-3)"	"unprognostic (4.90e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.35e-2)"	"unprognostic (9.96e-2)"	"unprognostic (8.30e-2)"	"unprognostic (3.23e-2)"	"unprognostic (2.34e-2)"	15.8	14.4	4.5	22.7	5.4	55.9	16.7	7.6	5.9	20.9	14.3	30.3	38.8	15.3	23.8	13.2	16.3	17.5	13.8	5.0	7.3	25.9	44.7	35.2	25.5	5.0	5.0	4.5	16.8	26.7	45.4	12.6	17.2	5.7	24.6	30.1	15.4	35.1	15.0	30.4	11.9	32.3	15.8	4.6	22.6	36.4	8.6	5.0	20.8	34.8	15.0	28.1	25.6	11.9	5.2	26.1	17.7	8.2	11.2	21.6	18.0	14.4	25.3	34.5	22.7	29.1	8.8	40.5	65.2	41.6	32.0	30.9	22.9	10.2	21.4	18.5	29.4	13.5	13.9	19.4	43.8	31.7	20.6	27.1	13.7	23.6	25.4	39.9	17.6	28.9	14.6	21.5	81.8	20.2	23.7	16.1	7.9	10.7	18.6	9.1	20.5	16.5	141.9	26.0	13.7	11.5	10.9	49.6	38.2	27.3	9.1	23.4	28.1	30.1	10.5	12.0	49.8	14.7	110.5	64.8	39.5	22.3	25.7	17.9	3.5	2.4	7.7	1.8	1.7	4.5	3.8	3.3	4.1	2.6	4.6	3.2	2.1	0.7	5.6	2.2	2.0	6.8	2.8	4.5	5.4	7.6	5.9	5.0	7.3	5.0	5.0	4.5	5.7	4.6	5.0	5.2	16.2	44.8	46.2	21.9	49.2	14.7	24.8	12.9	23.3	16.2	16.1	18.0	9.1	18.6	24.6	18.4	50.1	21.1	27.2	45.8	15.6	20.4	3.1	19.9	14.6	15.2	24.5	6.5	23.0	39.7	29.8	14.0	45.3	28.5	15.2	13.0	15.7	39.3	30.3	23.5	25.5	44.0	8.2	18.1	26.9	1.4	20.2	29.2	23.2	18.7	21.2	16.4	15.5	22.1	18.6	26.1	21.0	13.2	307.9	28.0	37.1	15.2	15.9	23.4	6.6	13.8	16.2	11.6	13.1	17.5	11.8	25.0	25.2	11.3	27.7	32.1
TXNDC5	"EndoPDI, ERp46, FLJ21353, FLJ90810, Hcc-2, MGC3178, PDIA15"	ENSG00000239264	"Thioredoxin domain containing 5"	Q8NBS9	6	7881517-7910788	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	42	"Plasma cells: 677.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	14	"memory B-cell: 13.0;naive B-cell: 6.9;plasmacytoid DC: 26.7"	"Group enriched"	"Detected in many"	21	"B-cells: 13.0;dendritic cells: 26.7"	"Cell line enhanced"	"Detected in all"		"RPMI-8226: 2833.2;U-266/84: 6053.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034677, HPA034678"	Enhanced		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		6900000	"Endoplasmic reticulum"		"HPA034677: AB_2674275, HPA034678: AB_2674276"	"unprognostic (3.15e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.27e-2)"	"unprognostic (5.43e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.20e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.81e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (1.05e-1)"	"unprognostic (7.98e-2)"	"unprognostic (6.23e-2)"	"unprognostic (1.08e-2)"	98.3	75.5	20.9	174.6	22.2	62.4	165.0	21.2	22.7	133.3	49.4	268.7	265.9	81.3	86.5	78.9	64.5	99.5	59.0	19.2	25.3	63.6	134.4	91.7	195.8	23.7	23.0	18.7	97.2	155.9	69.1	42.9	135.2	22.3	73.8	215.7	4.5	221.3	94.5	25.3	31.9	195.6	123.0	24.2	252.6	290.2	28.6	26.3	54.6	70.2	29.5	266.0	192.6	57.4	24.6	166.1	159.0	111.5	365.9	911.2	388.1	175.9	361.5	349.7	246.2	265.2	238.8	119.0	176.1	620.7	557.2	273.6	127.3	195.5	178.6	280.3	148.8	166.6	267.6	128.3	435.9	268.5	307.2	255.0	266.7	256.8	236.6	259.2	542.1	1334.0	109.7	170.5	1216.5	171.7	147.7	75.2	185.7	142.8	260.5	340.6	128.0	160.4	2833.2	201.1	149.6	168.7	90.5	462.4	280.2	209.4	514.9	143.5	133.9	369.7	280.5	194.2	243.0	386.5	1408.7	6053.9	305.0	144.7	191.7	392.2	0.0	0.4	0.0	0.9	0.7	0.7	13.0	0.2	0.7	1.0	6.9	0.2	0.4	0.0	0.0	0.1	26.7	0.9	0.5	20.9	22.2	21.2	22.7	19.2	25.3	23.7	23.0	18.7	22.3	24.2	26.3	24.6	1.3	0.0	4.8	0.0	14.6	0.9	0.2	0.4	3.4	0.0	1.8	1.3	0.2	0.0	2.0	0.0	0.0	0.9	5.6	1.2	0.0	9.0	0.1	1.1	6.9	3.2	4.9	11.2	0.0	10.7	1.9	4.1	6.1	2.3	1.3	0.6	3.9	4.9	1.5	0.0	0.0	15.9	0.0	0.8	0.7	0.0	0.0	1.3	3.6	0.0	1.8	0.1	0.0	0.0	0.0	9.5	1.5	0.4	677.7	0.4	3.2	0.5	1.7	0.5	6.6	0.5	4.2	0.1	0.1	3.9	0.1	1.2	2.0	0.2	5.8	0.2
TYRP1	"b-PROTEIN, CAS2, CATB, GP75, OCA3, TRP, TYRP"	ENSG00000107165	"Tyrosinase related protein 1"	P17643	9	12685439-12710285	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Melanin biosynthesis"	"Monooxygenase, Oxidoreductase"	"Albinism, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 36.0;heart muscle: 60.4;skin 1: 146.2"	"Cell type enriched"	"Detected in some"	17	"Melanocytes: 2486.6"	"Cancer enriched"	"Detected in some"	262	"melanoma: 313.2"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	55	"SK-MEL-30: 1395.0"	"Group enriched"	"Detected in some"	5	"olfactory bulb: 4.6;thalamus: 1.8"	"Low region specificity"	"Detected in all"			"HPA000937, CAB002520"	Enhanced		Approved	Vesicles		NA	NA		51000	Vesicles		"CAB002520: AB_564153, HPA000937: AB_1080437"	"unprognostic (7.48e-2)"	"unprognostic (1.10e-3)"	"unprognostic (2.28e-1)"	"unprognostic (3.16e-3)"	"unprognostic (8.10e-2)"	"unprognostic (3.82e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.25e-3)"	"unprognostic (4.46e-1)"	"unprognostic (8.71e-2)"	"unprognostic (6.17e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.68e-6)"	"unprognostic (1.27e-1)"	"unprognostic (5.99e-2)"		"unprognostic (1.95e-2)"	0.3	0.0	0.1	0.6	0.3	0.2	4.9	0.2	0.9	0.0	36.0	2.2	5.1	0.0	1.3	10.1	0.2	4.6	60.4	2.7	0.1	16.3	0.0	3.7	0.0	1.1	1.1	0.2	0.0	0.0	0.0	0.1	0.1	2.1	0.1	5.3	2.7	1.4	0.0	4.8	146.2	4.7	1.9	0.1	0.0	2.1	1.1	0.3	0.0	0.0	7.6	0.0	1.1	0.4	0.8	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	25.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.5	0.0	0.0	4.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.2	0.0	0.0	1395.0	0.1	19.5	1.5	0.0	0.0	0.7	0.0	0.9	0.0	0.7	0.4	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.9	2.7	0.1	1.1	1.1	0.2	2.1	0.1	0.3	0.8	0.0	0.0	0.0	0.0	0.0	92.3	0.1	0.0	0.0	11.7	0.0	0.0	44.3	0.0	0.0	3.7	2.1	0.0	0.0	0.0	144.8	0.3	2.5	0.0	0.0	1.3	0.0	0.0	0.9	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	17.5	4.7	0.3	0.0	2486.6	0.0	0.0	15.9	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	1.6	0.0	0.0	1.4	0.7	0.7	0.0	16.8	0.0	0.5	0.0	0.0	0.2
UBTFL1	C11orf27	ENSG00000255009	"Upstream binding transcription factor like 1"	P0CB47	11	90085950-90087131	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	18	"Distal tubular cells: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"									NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UBXN6	"UBXD1, UBXDC2"	ENSG00000167671	"UBX domain protein 6"	Q9BZV1	19	4444999-4457794	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Late spermatids: 1342.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040906, HPA041313, HPA061872"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus, Cytosol"		"HPA040906: AB_10794997, HPA041313: AB_10795004, HPA061872: AB_2684629"	"unprognostic (1.53e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.50e-2)"	"prognostic favorable (5.68e-5)"	"unprognostic (1.67e-1)"	"unprognostic (2.65e-3)"	"unprognostic (1.83e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.48e-1)"	"prognostic favorable (6.95e-4)"	"unprognostic (3.93e-2)"	"prognostic favorable (2.78e-5)"	"unprognostic (4.61e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.79e-1)"	97.5	190.3	51.8	35.4	53.5	86.6	90.2	44.2	92.3	93.8	53.8	83.7	49.7	95.3	21.2	90.4	89.9	34.0	111.9	65.7	45.9	118.0	123.2	72.6	35.4	55.8	58.6	52.8	116.2	101.2	65.3	147.2	35.1	57.7	94.6	14.2	24.0	86.8	51.2	218.3	112.0	68.2	23.4	44.2	78.4	89.2	176.2	47.9	27.1	112.7	85.1	18.2	92.6	86.1	50.4	71.7	49.4	23.3	50.6	57.7	70.6	35.1	71.3	84.3	50.9	54.1	30.8	58.8	31.8	63.5	70.8	26.3	40.8	18.2	54.8	18.6	56.3	39.4	26.4	53.5	41.4	94.5	33.6	51.1	65.2	70.4	40.1	38.7	62.3	62.9	42.7	55.6	83.6	38.3	45.4	67.2	56.8	37.6	27.4	42.9	30.4	33.3	76.0	48.3	43.9	67.1	97.3	40.1	40.9	116.7	10.8	48.5	54.4	76.8	67.4	51.4	145.0	47.7	186.6	80.7	33.2	128.7	62.5	61.4	6.4	6.6	10.4	3.8	8.0	6.2	5.3	4.5	5.2	6.7	6.0	5.3	4.2	6.7	2.7	4.9	10.2	5.5	4.9	51.8	53.5	44.2	92.3	65.7	45.9	55.8	58.6	52.8	57.7	44.2	47.9	50.4	26.7	41.7	30.1	13.7	25.1	37.2	44.9	26.7	15.9	37.2	36.3	25.1	47.2	64.3	21.2	44.1	27.1	54.5	31.9	105.0	80.3	58.1	297.0	29.1	35.6	30.5	46.8	172.0	14.4	65.0	43.1	39.0	28.5	32.2	34.3	50.0	47.5	61.6	54.8	13.5	11.9	66.2	20.3	52.8	35.9	1342.0	100.0	37.5	53.4	1.9	49.0	60.1	25.7	5.5	10.3	65.6	90.1	73.0	16.4	50.9	136.9	112.2	21.4	35.2	72.3	38.8	29.5	139.9	68.9	20.4	41.1	79.6	18.5	41.4	58.4	48.5
UCN3	"SPC, UCNIII"	ENSG00000178473	"Urocortin 3"	Q969E3	10	5364966-5374692	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 8.9;pancreas: 5.8;stomach 1: 3.4"	"Cell type enriched"	"Detected in some"	29	"Enteroendocrine cells: 242.5"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 15.4"	"Group enriched"	"Detected in some"	5	"amygdala: 1.8;medulla oblongata: 2.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"SCLC-21H: 1.2"	"Region enhanced"	"Detected in some"		"hypothalamus: 5.1"					HPA038281	Uncertain				"Secreted to blood"	NA	NA					"HPA038281: AB_10672408"			"unprognostic (2.00e-2)"	"unprognostic (2.31e-1)"				"unprognostic (1.60e-1)"		"unprognostic (2.10e-1)"	"unprognostic (3.18e-3)"	"unprognostic (8.42e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.91e-2)"				0.0	0.8	1.8	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.1	2.3	8.9	0.0	0.0	0.0	1.0	1.0	0.0	0.0	0.4	0.7	0.0	0.6	0.0	2.0	0.3	0.0	0.0	5.8	0.0	2.7	0.1	0.1	0.3	2.4	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.1	0.0	3.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.3	0.0	0.1	0.0	0.4	2.0	0.3	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.1	242.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.3	0.0	0.0	0.3	0.6	2.9	0.7	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.2
UNC5C		ENSG00000182168	"Unc-5 netrin receptor C"	O95185	4	95162504-95549206	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"Developmental protein, Receptor"	"Alzheimer disease, Amyloidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 39.8"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 2078.8"	"Cancer enriched"	"Detected in many"	4	"thyroid cancer: 6.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SH-SY5Y: 82.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		310000				"unprognostic (1.55e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.45e-2)"	"unprognostic (3.03e-1)"	"unprognostic (3.20e-1)"	"unprognostic (3.48e-1)"	"unprognostic (3.40e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.70e-5)"	"unprognostic (1.25e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.62e-4)"	1.1	9.1	8.0	1.0	15.9	0.0	1.3	5.0	17.9	1.8	0.0	2.9	1.4	2.4	1.8	0.6	1.9	2.0	2.3	6.7	10.1	1.1	1.0	2.6	0.5	17.1	13.5	5.9	2.8	0.3	0.1	1.2	1.8	19.9	3.4	3.4	6.5	6.3	3.9	0.1	0.2	1.9	2.0	7.1	4.3	2.1	2.7	10.2	1.9	12.0	0.4	0.3	2.6	1.6	39.8	0.0	0.5	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.2	4.2	0.0	0.2	0.0	1.1	0.2	0.0	0.2	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.6	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	82.9	0.0	0.0	0.2	4.8	0.3	12.3	0.0	0.1	1.2	0.0	7.9	0.0	0.0	0.0	0.1	9.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	15.9	5.0	17.9	6.7	10.1	17.1	13.5	5.9	19.9	7.1	10.2	39.8	0.7	0.0	0.0	105.4	0.0	0.1	0.1	0.1	0.0	1.9	0.7	1.5	1.7	0.0	0.2	1.8	0.0	0.5	0.0	2.6	0.0	0.0	0.7	0.5	3.4	0.7	1.2	0.0	326.1	0.0	0.1	4.6	0.0	1.2	0.0	20.2	0.4	0.0	1.8	0.0	448.3	0.5	0.0	0.8	0.0	0.8	21.1	0.4	1.8	57.1	0.0	1.3	0.0	308.1	2078.8	0.0	26.9	11.7	0.0	0.3	0.0	0.1	0.0	12.5	6.6	0.3	4.6	0.0	0.1	0.0	0.0	0.0	0.1	0.1	1.1	0.0
UPK1A	TSPAN21	ENSG00000105668	"Uroplakin 1A"	O00322	19	35666516-35678483	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 43.5;urinary bladder: 207.4;vagina: 52.8"	"Cell type enriched"	"Detected in some"	4	"Urothelial cells: 29.1"	"Cancer enriched"	"Detected in many"	41	"urothelial cancer: 148.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RT4: 39.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA049879	Enhanced					NA	NA					"HPA049879: AB_2680929"	"unprognostic (3.29e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.19e-3)"	"unprognostic (3.40e-4)"	"unprognostic (4.05e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.11e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.48e-9)"	"unprognostic (1.48e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.72e-1)"	0.8	0.0	0.2	0.1	0.2	0.1	0.3	0.5	0.4	15.2	0.2	0.1	0.0	0.0	0.0	43.5	0.5	0.2	0.1	0.3	0.3	0.5	0.2	0.1	0.1	0.2	0.2	0.3	0.1	0.0	0.0	0.1	0.1	0.3	6.9	0.0	0.1	4.3	0.2	0.1	19.7	0.1	0.0	0.2	0.1	0.1	0.8	0.3	0.1	0.0	0.0	0.3	207.4	52.8	0.2	0.0	0.4	0.2	0.2	0.4	0.1	0.4	0.0	0.1	0.2	0.6	1.1	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.2	3.8	0.3	0.0	0.2	0.2	0.2	0.1	0.5	0.1	0.4	0.2	0.0	0.6	0.0	0.0	0.1	0.1	0.0	0.7	0.0	0.2	0.5	8.1	0.0	0.0	0.0	0.1	0.0	39.2	0.1	0.1	0.2	0.2	0.5	0.2	0.3	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.5	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.2	0.0	0.1	0.3	0.2	0.0	0.1	0.0	0.1	0.2	0.2	0.5	0.4	0.3	0.3	0.2	0.2	0.3	0.3	0.2	0.3	0.2	0.1	0.0	0.0	0.3	0.0	0.3	0.9	0.2	0.0	0.0	0.2	0.4	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.4	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.6	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.4	1.3	0.0	0.4	0.1	0.1	0.0	0.0	29.1
UQCRHL		ENSG00000233954	"Ubiquinol-cytochrome c reductase hinge protein like"	A0A096LP55	1	15807169-15809348	"Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 13.9"	"Cell type enriched"	"Detected in many"	9	"Cardiomyocytes: 444.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"											HPA042574	Approved					NA	NA					"HPA042574: AB_10960998"	"unprognostic (8.91e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.19e-2)"	"unprognostic (7.10e-2)"	"unprognostic (4.01e-3)"	"unprognostic (4.83e-1)"	"unprognostic (6.76e-2)"	"unprognostic (6.46e-2)"	"unprognostic (4.60e-1)"	"unprognostic (9.67e-3)"	"unprognostic (9.76e-3)"	"unprognostic (2.71e-3)"	"unprognostic (1.16e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.02e-1)"	3.0	2.2	1.6	0.3	1.4	1.2	2.8	2.7	1.8	3.0	0.9	4.0	0.3	2.3	0.7	4.7	2.7	0.3	13.9	1.5	1.0	4.7	3.4	2.4	0.3	1.6	1.4	1.3	3.9	3.0	0.1	2.7	0.1	1.8	2.6	0.2	2.9	3.4	0.1	10.5	3.0	3.3	0.2	0.9	2.8	3.5	1.7	1.3	0.3	2.4	0.2	0.2	3.0	3.3	2.4	0.2	0.1	0.8	0.8	0.2	0.2	0.3	0.1	0.1	0.0	0.1	0.2	0.6	0.3	0.2	0.1	0.2	0.3	0.1	0.1	0.1	0.6	0.1	0.3	0.6	0.1	0.1	0.2	0.3	0.1	0.2	0.1	0.1	0.3	0.0	0.4	0.2	0.5	0.0	0.5	0.1	0.4	0.4	0.1	0.3	0.3	0.2	0.2	0.0	0.4	0.5	0.4	0.2	0.5	0.2	0.2	0.2	0.7	0.1	0.5	0.3	0.3	0.2	0.5	0.2	0.3	0.2	0.5	0.2	1.8	0.3	0.3	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.4	0.3	0.3	1.6	0.4	0.2	0.4	0.2	0.2	1.6	1.4	2.7	1.8	1.5	1.0	1.6	1.4	1.3	1.8	0.9	1.3	2.4	1.4	0.0	1.1	6.2	12.3	0.0	39.0	0.0	1.8	3.8	3.1	6.2	444.8	24.3	0.6	9.2	6.2	21.4	4.1	6.1	23.5	1.1	3.0	4.0	6.7	10.7	7.3	6.6	5.3	0.7	21.5	13.9	1.5	4.6	2.5	9.7	17.9	23.1	20.6	1.7	5.4	12.6	0.0	48.3	0.0	3.6	11.1	11.9	0.0	0.0	12.9	3.0	16.5	1.0	2.9	0.6	6.1	12.4	7.8	31.9	11.5	10.3	0.0	6.9	6.6	33.2	12.7	6.2	12.5	5.5	0.0	23.5	5.4	3.9	15.4	31.1
UROD		ENSG00000126088	"Uroporphyrinogen decarboxylase"	P06132	1	45010950-45015575	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	"Decarboxylase, Lyase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"Erythroid cells: 806.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 420.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027468, HPA028668, HPA030350"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		2600000	"Nucleoplasm, Cytosol"		"HPA027468: AB_1858654, HPA028668: AB_10603458, HPA030350: AB_2673440"	"unprognostic (5.90e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.49e-1)"	"unprognostic (9.61e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (2.31e-2)"	"unprognostic (4.76e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.72e-3)"	"unprognostic (3.92e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.73e-2)"	"unprognostic (8.12e-2)"	52.2	121.1	69.8	25.8	70.1	200.6	48.7	68.9	79.9	41.1	72.0	42.6	29.5	47.3	55.2	34.5	49.6	31.1	71.3	69.3	71.9	58.5	101.7	35.1	35.5	69.4	70.2	67.2	51.6	45.5	116.0	42.9	39.7	69.2	35.4	30.4	24.9	61.9	44.6	76.6	30.9	31.0	55.2	69.4	38.1	38.8	45.1	71.0	44.4	54.5	84.5	36.4	40.6	33.0	71.2	66.0	42.5	67.0	89.1	113.4	107.7	31.8	87.4	209.8	163.9	125.2	59.9	32.3	46.4	82.3	122.8	116.3	31.1	127.2	153.6	116.9	42.9	133.4	245.4	95.4	200.7	132.4	79.0	42.6	115.1	97.6	154.1	132.3	121.8	208.9	92.9	420.8	48.5	157.6	53.5	49.9	62.9	104.1	51.5	145.9	76.5	96.5	69.9	141.7	54.4	73.9	57.3	89.1	63.9	134.3	73.7	50.8	77.6	137.5	96.9	71.6	34.2	130.5	49.4	60.1	38.1	141.0	117.6	47.2	72.3	111.9	65.5	57.4	81.5	58.8	84.9	69.2	56.7	149.7	81.9	63.6	58.0	20.1	87.4	50.9	102.3	88.7	122.1	69.8	70.1	68.9	79.9	69.3	71.9	69.4	70.2	67.2	69.2	69.4	71.0	71.2	25.8	44.8	38.0	7.8	25.4	22.9	35.8	101.4	43.9	27.3	31.0	37.1	74.4	41.5	45.3	27.6	16.7	98.6	22.1	21.4	90.1	73.5	8.1	20.3	30.7	42.7	18.0	806.8	9.4	63.7	54.6	57.1	17.3	21.2	52.6	20.4	38.6	98.5	101.8	13.5	6.7	20.2	73.2	37.9	29.4	16.2	79.6	38.5	48.0	5.6	103.6	89.7	24.7	7.1	7.3	51.2	23.7	56.1	36.8	15.9	32.7	134.5	32.9	25.3	39.5	29.4	75.0	37.3	42.3	31.6	24.7	49.8	23.3	72.7	20.9	29.1
USP24	KIAA1057	ENSG00000162402	"Ubiquitin specific peptidase 24"	Q9UPU5	1	55066359-55215364	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Oligodendrocyte precursor cells: 552.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026723, HPA028428, HPA067124"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA026723: AB_10599851, HPA028428: AB_10600991, HPA067124: AB_2685785"	"unprognostic (2.28e-1)"	"unprognostic (9.81e-3)"	"unprognostic (4.70e-3)"	"unprognostic (4.86e-3)"	"unprognostic (9.31e-3)"	"unprognostic (4.84e-3)"	"prognostic unfavorable (1.34e-7)"	"unprognostic (2.04e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.98e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.42e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.64e-1)"	16.7	8.2	13.4	14.3	13.4	57.2	13.6	25.4	13.7	9.4	13.4	11.3	8.4	10.8	9.3	9.4	10.0	9.1	12.4	12.8	13.6	15.9	15.5	10.7	22.3	13.5	13.5	12.0	16.7	11.5	20.4	12.9	9.7	14.5	10.2	13.5	17.3	12.9	9.7	48.4	13.7	12.7	9.8	11.7	18.8	12.5	8.5	13.6	22.1	9.3	37.0	21.0	10.5	9.3	14.1	32.5	17.4	21.3	11.6	27.2	23.5	24.6	14.0	17.5	19.6	20.3	25.0	11.1	25.9	15.1	26.1	40.1	25.6	28.5	23.6	30.5	27.2	17.4	51.5	40.2	29.6	16.1	36.0	38.6	21.0	20.6	30.0	33.7	19.0	18.2	25.7	48.5	10.6	26.6	7.6	21.9	19.1	31.4	15.5	21.0	22.3	27.1	11.3	34.6	21.4	18.7	13.1	23.8	16.8	21.1	32.3	11.7	17.5	24.7	17.9	17.3	21.7	22.6	13.2	10.6	33.2	16.9	29.4	16.3	5.4	1.3	1.7	2.8	1.1	1.7	3.0	2.2	2.2	1.2	3.4	1.9	2.5	1.4	2.3	1.5	6.9	1.3	0.7	13.4	13.4	25.4	13.7	12.8	13.6	13.5	13.5	12.0	14.5	11.7	13.6	14.1	20.4	16.0	20.0	92.4	27.7	14.9	8.4	5.6	9.1	14.0	13.4	10.2	37.7	10.0	13.0	12.9	73.0	4.2	42.6	11.1	0.0	10.3	0.7	11.9	15.1	16.1	17.3	37.4	84.5	10.2	7.8	11.9	21.4	15.0	12.7	18.2	12.1	11.9	9.7	38.7	100.4	16.2	8.2	19.2	18.8	2.5	11.8	18.6	10.6	87.1	19.6	7.0	15.5	552.4	115.2	11.8	11.4	7.9	18.1	12.7	8.3	5.9	10.0	16.9	6.6	18.0	13.5	7.7	7.1	13.9	17.2	1.5	21.8	9.8	16.0	12.1
USP26		ENSG00000134588	"Ubiquitin specific peptidase 26"	Q9BXU7	X	133024631-133097109	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"Spermatogonia: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA000424, HPA027310, HPA079124"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA000424: , HPA027310: , HPA079124: "	"unprognostic (7.92e-4)"		"unprognostic (3.59e-2)"											"unprognostic (1.99e-2)"	"unprognostic (2.08e-1)"			0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
USP44	FLJ14528	ENSG00000136014	"Ubiquitin specific peptidase 44"	Q9H0E7	12	95516560-95551476	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 24.4"	"Cell type enriched"	"Detected in many"	4	"Early spermatids: 482.2"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.0"	"Group enriched"	"Detected in some"	4	"cerebellum: 7.0;pons: 2.5"	"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 6.1"	"Group enriched"	"Detected in many"	41	"B-cells: 4.6;T-cells: 6.1"	"Cell line enhanced"	"Detected in some"		"HEL: 26.4;JURKAT: 58.4;NTERA-2: 138.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA026543			Approved	"Nucleoli fibrillar center,Microtubules"		NA	NA			"Nucleoli fibrillar center, Microtubules"		"HPA026543: AB_1858692"	"unprognostic (2.12e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.83e-4)"	"unprognostic (7.18e-4)"	"unprognostic (5.55e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.73e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.97e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.41e-2)"	"unprognostic (7.07e-2)"	0.7	0.6	0.6	1.0	0.7	0.3	0.9	7.0	0.9	0.8	0.1	0.9	0.3	1.3	0.7	0.4	1.2	0.8	0.5	0.5	0.8	1.4	0.1	3.9	1.1	0.7	1.1	0.4	0.9	2.4	1.7	1.3	0.1	2.5	0.7	0.4	1.7	1.1	1.6	0.2	0.3	0.9	0.9	0.5	1.6	0.6	24.4	0.5	3.7	1.3	0.3	1.2	0.5	0.5	1.0	0.2	0.4	11.4	0.0	0.1	0.1	0.4	1.1	3.3	1.4	0.5	0.0	0.1	0.1	3.4	0.0	0.0	0.1	0.0	0.0	1.9	0.0	5.8	26.4	0.0	0.0	5.8	10.8	0.5	0.1	0.0	0.8	0.0	0.6	0.6	58.4	4.3	0.0	0.0	0.0	13.9	0.1	138.3	0.0	0.0	0.0	0.0	0.0	2.4	0.8	8.8	5.9	0.0	0.0	0.1	13.2	0.1	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.3	4.6	0.0	1.0	0.3	0.0	0.0	0.0	1.1	0.0	2.4	4.6	1.7	1.5	0.0	3.7	6.1	4.0	0.1	0.1	0.0	0.0	0.2	1.0	0.6	0.7	7.0	0.9	0.5	0.8	0.7	1.1	0.4	2.5	0.5	0.5	1.0	1.9	12.8	31.0	1.3	5.7	1.0	3.4	0.3	4.6	8.6	1.5	3.2	1.8	0.0	3.8	7.3	6.2	2.8	0.6	0.1	0.0	4.4	482.2	0.9	2.2	2.5	0.0	0.4	5.1	3.1	0.5	3.5	1.1	1.8	0.0	10.6	1.8	0.0	0.1	0.0	16.2	0.0	0.0	0.3	1.0	116.6	5.6	0.8	3.6	1.9	0.6	2.4	1.0	15.6	4.0	0.9	0.1	3.4	1.1	5.0	0.1	1.0	0.3	9.5	6.6	2.9	3.7	77.6	6.7	0.6	0.9	1.1	3.2	2.5	0.1	1.9
USP54	"bA137L10.3, bA137L10.4, C10orf29, FLJ37318"	ENSG00000166348	"Ubiquitin specific peptidase 54"	Q70EL1	10	73497538-73625994	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 136.3"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 476.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"OE19: 33.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047663, HPA063665"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA047663: AB_2680116, HPA063665: "	"unprognostic (2.46e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.48e-2)"	"unprognostic (4.89e-3)"	"unprognostic (6.63e-4)"	"prognostic favorable (7.00e-4)"	"unprognostic (6.24e-2)"	"unprognostic (4.35e-2)"	"unprognostic (8.91e-3)"	"unprognostic (3.49e-1)"	"unprognostic (1.95e-3)"	"unprognostic (8.18e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.31e-1)"	4.7	3.1	65.0	5.5	97.5	2.1	16.5	85.4	71.8	14.7	34.1	15.2	5.0	9.4	13.3	14.0	12.1	5.6	7.1	59.7	75.4	5.2	1.5	18.0	2.8	96.1	98.5	49.8	6.9	10.9	8.9	2.9	2.8	103.4	12.3	19.9	15.0	17.0	7.7	50.1	15.3	6.8	7.2	82.3	2.9	20.9	9.2	84.5	8.5	41.0	17.2	7.1	6.7	4.9	136.3	10.0	8.4	15.9	13.7	4.4	4.8	4.7	4.7	11.2	7.9	8.6	8.1	16.7	6.6	6.5	3.7	6.1	14.2	10.7	4.3	10.2	2.8	8.6	5.0	6.3	8.0	4.1	5.6	2.3	3.9	3.8	9.0	10.9	20.6	3.4	5.7	7.5	3.0	6.3	5.6	4.5	6.8	8.0	33.4	30.2	7.0	11.9	3.0	8.7	7.6	4.8	5.4	10.1	11.7	15.8	10.2	15.8	5.8	4.9	3.5	11.2	6.6	6.8	2.4	4.3	4.1	8.3	5.3	3.1	0.2	0.4	0.5	0.6	0.4	0.7	0.4	0.5	0.4	0.4	0.3	0.7	0.4	0.0	0.3	0.5	0.4	0.6	0.4	65.0	97.5	85.4	71.8	59.7	75.4	96.1	98.5	49.8	103.4	82.3	84.5	136.3	5.9	48.1	34.3	33.0	1.7	2.7	8.5	11.0	4.0	7.7	15.3	8.4	7.2	5.7	18.9	12.9	16.7	1.0	1.2	19.6	0.0	4.7	2.4	25.8	12.9	6.3	10.3	2.1	23.1	8.0	1.0	7.6	40.2	44.3	3.8	3.5	2.5	3.0	1.4	5.0	33.4	23.4	2.0	1.3	1.4	2.2	3.4	1.8	8.8	76.8	0.8	12.5	0.0	116.1	476.0	12.2	9.7	10.9	2.3	52.6	10.5	1.9	21.7	12.2	6.6	19.6	3.8	9.2	6.0	7.7	4.0	1.4	3.0	2.9	11.2	15.2
UST	2OST	ENSG00000111962	"Uronyl 2-sulfotransferase"	Q9Y2C2	6	148747030-149076990	"Metabolic proteins, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Oligodendrocyte precursor cells: 339.8"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 15.7"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 2.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"OE19: 32.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032022	Approved					NA	NA					"HPA032022: AB_10603326"	"unprognostic (3.43e-1)"	"unprognostic (1.90e-1)"	"unprognostic (7.87e-3)"	"unprognostic (3.22e-5)"	"unprognostic (1.83e-3)"	"unprognostic (1.50e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.96e-2)"	"unprognostic (8.31e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.25e-3)"	"unprognostic (9.48e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.02e-2)"	6.0	12.3	8.2	3.0	7.2	0.2	6.2	11.9	6.8	7.2	6.8	7.4	1.7	6.9	5.7	4.7	9.2	6.1	3.2	5.8	15.6	3.6	1.4	5.2	3.9	29.2	15.7	4.4	11.7	13.2	4.6	1.9	4.6	15.7	6.4	2.7	6.8	3.2	4.9	1.7	6.6	5.7	8.9	13.0	6.6	5.0	6.8	19.2	6.6	27.7	5.8	3.7	8.9	7.7	15.9	0.1	3.2	18.2	14.0	21.5	17.8	0.1	7.9	20.5	3.8	9.8	0.0	1.2	6.7	1.7	12.3	9.5	5.7	13.0	6.6	7.6	9.1	9.9	0.2	10.0	0.1	7.9	0.3	2.8	9.2	14.6	9.8	18.1	7.6	0.2	11.1	0.0	0.0	3.0	8.3	0.1	0.0	10.7	32.4	4.2	3.3	2.5	7.7	0.1	14.8	9.4	0.0	26.4	6.3	5.0	13.0	4.7	0.3	0.4	10.9	1.3	2.5	7.4	0.0	0.0	0.0	12.1	5.4	6.3	0.0	0.0	0.0	0.6	0.2	0.4	0.3	0.4	0.5	0.4	0.5	0.0	0.2	0.0	2.5	0.3	0.4	0.1	0.1	8.2	7.2	11.9	6.8	5.8	15.6	29.2	15.7	4.4	15.7	13.0	19.2	15.9	0.9	3.2	3.2	70.2	4.5	9.4	5.4	2.6	3.4	0.1	1.7	1.5	1.7	0.0	2.7	1.8	0.0	2.0	8.9	0.2	0.0	0.1	1.1	0.3	8.7	0.6	0.0	0.0	36.3	2.0	0.3	16.3	7.1	0.4	0.0	12.3	1.4	0.3	1.7	0.0	39.7	1.8	10.2	1.0	20.9	3.4	18.3	2.8	5.4	80.6	1.0	14.6	5.2	339.8	3.2	1.1	0.3	11.3	0.4	5.9	0.0	0.6	2.3	0.8	0.0	6.8	3.5	2.9	5.7	1.9	11.6	1.4	2.0	10.2	0.5	6.8
VEGFD	"FIGF, VEGF-D"	ENSG00000165197	"Vascular endothelial growth factor D"	O43915	X	15345596-15384413	"Cancer-related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 43.0"	"Cell type enriched"	"Detected in some"	12	"Fibroblasts: 39.8"	"Cancer enhanced"	"Detected in some"		"liver cancer: 2.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.4;ASC TERT1: 2.8;EFO-21: 1.3;HSkMC: 2.8"	"Group enriched"	"Detected in many"	4	"amygdala: 2.1;cerebral cortex: 3.5;hippocampal formation: 3.3;white matter: 2.6"	"Not detected"	"Not detected"			HPA027342	Uncertain				"Secreted to blood"	NA	NA	592000	450000			"HPA027342: AB_1848597"	"unprognostic (5.90e-2)"	"unprognostic (9.79e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.07e-1)"	"unprognostic (6.06e-3)"	"unprognostic (5.57e-2)"	"unprognostic (2.24e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.59e-5)"	"unprognostic (3.08e-2)"	"unprognostic (2.03e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.75e-2)"	11.5	10.0	1.8	0.8	1.8	0.0	20.5	1.6	2.3	14.2	1.5	4.4	1.2	3.8	5.0	2.7	4.2	2.8	9.2	1.7	2.0	1.7	1.6	43.0	0.4	1.8	1.8	1.7	4.5	0.8	2.7	7.0	0.2	2.1	1.5	2.0	0.4	2.3	1.9	17.7	1.1	4.3	3.4	1.5	2.9	5.9	0.6	2.0	0.3	1.5	23.2	1.3	6.1	8.2	2.2	0.0	0.6	0.5	0.9	3.4	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.3	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.1	0.0	0.3	2.8	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.2	0.1	0.0	0.3	0.6	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.2	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.8	1.6	2.3	1.7	2.0	1.8	1.8	1.7	2.1	1.5	2.0	2.2	3.1	3.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.5	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	39.8	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.3	1.6	0.0	0.0
VPREB3	8HS20	ENSG00000128218	"V-set pre-B cell surrogate light chain 3"	Q9UKI3	22	23752743-23754425	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 51.9;intestine: 73.1;lymphoid tissue: 119.5"	"Cell type enriched"	"Detected in some"	12	"B-cells: 287.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	709	"memory B-cell: 753.3;naive B-cell: 803.7"	"Lineage enriched"	"Detected in many"	732	"B-cells: 803.7"	"Group enriched"	"Detected in some"	46	"Daudi: 263.3;REH: 309.9;U-698: 85.2"	"Low region specificity"	"Detected in single"							HPA003041	Supported				"Intracellular and membrane"	NA	NA					"HPA003041: AB_1080577"	"unprognostic (2.06e-3)"	"unprognostic (4.75e-3)"	"unprognostic (2.35e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.75e-2)"	"unprognostic (4.79e-2)"	"unprognostic (6.63e-3)"	"unprognostic (9.15e-2)"	"unprognostic (1.38e-2)"	"unprognostic (4.93e-2)"	"unprognostic (4.84e-2)"	"unprognostic (8.44e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.87e-1)"	"unprognostic (4.12e-1)"	1.7	21.2	2.0	41.7	1.9	26.0	0.4	2.6	3.9	0.3	2.4	4.0	1.7	1.1	51.9	1.2	0.3	2.8	1.1	1.8	1.9	1.6	1.9	0.8	113.3	2.0	2.1	1.6	0.1	0.5	0.6	2.5	0.2	2.2	1.6	3.7	2.2	2.6	0.3	1.6	0.5	73.1	0.3	1.9	60.8	6.1	0.6	2.8	8.0	1.7	0.5	119.5	6.2	0.3	2.0	0.1	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.6	263.3	0.3	0.2	0.0	0.1	0.5	0.2	0.1	0.6	2.8	0.1	0.0	0.2	0.2	0.3	0.1	1.1	0.7	0.0	0.0	0.0	0.0	0.4	0.4	1.1	0.0	1.3	0.5	1.0	0.3	0.3	1.1	309.9	0.5	4.7	0.1	0.1	0.7	1.0	0.3	0.7	3.5	0.2	0.6	0.4	1.2	0.0	0.5	0.9	0.0	1.3	0.3	85.2	0.0	0.5	0.3	0.9	0.7	0.6	0.4	0.3	0.4	753.3	0.4	0.5	0.7	803.7	0.5	0.5	1.0	0.4	0.7	0.6	1.0	17.5	2.0	1.9	2.6	3.9	1.8	1.9	2.0	2.1	1.6	2.2	1.9	2.8	2.0	0.1	0.0	0.5	0.3	287.8	0.4	0.8	0.6	0.6	4.5	0.3	0.5	0.9	1.5	0.8	0.0	2.1	0.0	5.4	1.1	1.9	0.1	0.3	0.1	0.8	0.1	5.4	2.7	0.2	0.0	0.0	1.5	1.5	0.3	0.0	0.7	1.1	1.0	0.3	0.0	0.2	0.6	2.0	0.3	0.8	0.2	0.0	1.2	5.4	0.0	0.7	0.8	2.1	0.5	0.1	0.1	0.3	0.0	22.6	0.2	1.5	2.4	0.0	2.1	0.0	0.5	0.4	0.1	0.2	0.4	0.1	0.0	3.5	0.1	0.7	0.3
VRK2		ENSG00000028116	"VRK serine/threonine kinase 2"	Q86Y07	2	57907629-58159920	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"Oligodendrocytes: 540.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046459, HPA047503"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB046459: AB_1858773, HPA047503: AB_2680071"	"unprognostic (1.87e-1)"	"unprognostic (5.84e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (6.32e-6)"	"unprognostic (3.90e-2)"	"unprognostic (4.76e-2)"	"unprognostic (2.96e-2)"	"prognostic unfavorable (4.65e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (4.66e-5)"	"unprognostic (3.48e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.56e-1)"	14.9	13.3	15.1	20.4	23.7	19.0	17.4	14.8	15.1	10.9	8.7	14.1	11.0	15.5	16.9	19.7	13.5	12.0	15.7	11.5	15.3	10.8	16.9	16.1	22.6	20.4	20.3	7.1	10.8	19.9	14.8	7.7	14.7	25.1	14.4	16.6	4.9	14.0	11.5	14.4	13.4	11.1	19.6	16.1	18.1	13.8	13.4	18.4	12.9	18.8	15.3	26.2	14.8	12.7	40.9	37.1	24.3	2.7	16.3	16.7	30.6	48.4	32.8	33.3	22.7	22.9	49.8	38.5	44.3	43.0	29.8	37.1	27.4	34.9	36.7	33.7	80.9	23.1	50.9	19.0	35.8	27.8	44.1	29.0	17.7	42.6	36.3	52.8	26.1	64.9	6.2	50.2	28.5	38.2	21.2	0.3	32.9	29.9	56.9	11.6	49.4	12.0	30.6	36.8	30.2	9.4	0.3	52.5	31.2	27.5	26.2	22.0	26.1	37.0	0.5	74.4	20.6	0.6	40.5	33.9	24.0	18.2	52.7	38.4	31.0	24.5	35.3	15.1	32.2	18.4	30.6	14.2	17.7	25.5	31.7	10.6	13.6	9.0	18.7	34.3	26.4	18.5	15.4	15.1	23.7	14.8	15.1	11.5	15.3	20.4	20.3	7.1	25.1	16.1	18.4	40.9	17.9	22.4	11.2	1.3	26.4	9.8	12.6	21.8	14.8	1.0	14.0	10.2	21.8	7.2	22.4	18.4	0.0	21.2	13.7	6.5	15.6	27.1	23.0	12.7	10.9	15.8	6.6	39.1	2.7	26.2	21.1	14.0	16.3	12.7	17.7	9.6	8.9	8.4	18.4	0.0	4.7	5.1	30.5	19.1	19.1	8.4	5.9	26.2	10.6	54.4	41.7	5.3	16.5	32.2	540.8	24.8	8.7	6.0	25.7	18.4	2.5	9.5	30.7	4.0	6.6	7.4	14.3	22.0	10.9	19.2	8.4	19.4	16.5	6.8	7.9	16.4
VWA5A	"BCSC-1, LOH11CR2A"	ENSG00000110002	"Von Willebrand factor A domain containing 5A"	O00534	11	124115404-124147721	"Predicted intracellular proteins"			"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"granulocytes: 563.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 57.8"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 57.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 59.7;HEL: 44.1;HHSteC: 32.1;HUVEC TERT2: 39.5;RPTEC TERT1: 43.0"					"Low region specificity"	"Detected in all"			"HPA037813, HPA037814, HPA061500"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA037813: AB_10672727, HPA037814: AB_10672287, HPA061500: AB_2684542"	"unprognostic (2.69e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.58e-2)"	"unprognostic (6.48e-2)"	"unprognostic (8.49e-3)"	"unprognostic (2.48e-1)"	"unprognostic (8.18e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.15e-2)"	"unprognostic (4.53e-2)"	"unprognostic (2.38e-2)"	"prognostic favorable (1.55e-5)"	"unprognostic (4.54e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.65e-1)"	14.3	25.1	20.4	13.0	16.2	3.1	24.4	13.3	18.3	22.6	13.7	38.3	26.7	14.1	25.5	15.1	15.2	31.4	5.5	17.0	40.3	16.9	6.4	31.0	12.3	21.6	20.3	16.8	10.3	20.9	4.4	37.7	10.3	25.1	18.0	43.7	12.0	30.3	19.4	4.4	28.8	36.9	16.1	16.3	8.4	28.4	9.7	37.5	8.0	11.6	12.4	14.8	23.0	12.7	22.4	0.0	0.6	7.6	0.5	7.9	7.4	2.8	1.1	0.6	0.6	0.3	0.4	59.7	0.0	7.2	1.3	10.3	0.4	1.5	13.6	0.0	20.9	0.2	44.1	10.5	1.4	32.1	0.6	19.8	21.8	1.5	1.3	4.4	2.9	39.5	5.8	2.4	7.3	2.4	0.2	0.9	0.7	11.9	0.0	1.5	0.0	26.2	0.3	43.0	0.5	6.7	0.7	1.1	0.4	2.1	17.3	5.4	1.9	1.0	0.2	5.5	0.3	0.0	2.7	2.5	0.0	24.1	0.9	0.4	57.8	7.9	0.9	4.7	5.5	1.1	7.1	5.0	2.7	8.0	3.8	6.3	4.1	0.6	8.1	9.3	4.3	12.7	6.1	20.4	16.2	13.3	18.3	17.0	40.3	21.6	20.3	16.8	25.1	16.3	37.5	22.4	5.0	9.6	28.3	4.6	1.3	17.2	14.6	14.9	4.6	3.8	12.6	8.8	2.6	5.7	33.2	33.1	2.1	7.9	2.0	25.0	9.8	27.8	50.6	11.5	4.8	4.3	15.0	3.4	4.0	28.1	2.5	11.4	17.3	7.6	563.0	3.8	3.9	3.2	35.7	32.0	17.1	22.3	30.5	6.6	7.2	6.0	2.8	6.7	5.4	1.9	3.6	14.3	3.1	8.0	2.6	17.7	16.8	0.4	2.5	6.5	50.6	15.1	59.1	1.4	0.0	9.5	5.7	0.7	4.1	4.8	12.5	1.9	9.4	5.9	23.7	13.6
WASH6P	"CXYorf1, FAM39A"	ENSG00000182484	"WASP family homolog 6, pseudogene"		X	156020826-156025710	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	6	"granulocytes: 225.3"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 10.6"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"											HPA002689	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA002689: AB_1078803"	"unprognostic (2.01e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (7.56e-4)"	"unprognostic (4.69e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.33e-3)"	"unprognostic (3.94e-2)"	"unprognostic (8.18e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.86e-3)"	1.0	1.3	0.9	1.7	1.2	3.5	1.0	1.0	1.5	0.5	1.0	1.0	2.7	1.6	2.7	0.4	1.2	0.8	1.2	1.1	1.0	2.3	0.7	1.2	1.8	2.2	0.9	0.5	1.7	4.2	0.7		1.2	1.7	1.1	0.7	3.6	0.9	1.2	6.5	3.1	2.2	0.6	0.5	2.9	1.7	2.3	1.2	1.2	1.2	0.6	0.9	0.7		1.8	9.6	1.5	1.6	5.0	0.7	0.0	5.9	2.5	0.4	0.8	1.5	0.4	5.2	3.1	1.7	1.4	4.0	7.3	1.2	2.0	0.7	0.7	1.7	4.7	0.6	1.3	0.0	1.8	3.7	0.2	0.9	1.4	2.0	0.5	1.2	0.9	6.2	4.6	0.0	1.2	7.9	4.1	2.3	4.2	0.9	7.0	3.0	2.0	0.3	0.4	4.2	6.3	3.1	4.7	5.7	1.3	6.6	5.8	3.1	3.5	3.4	3.3	3.9	8.0	9.8	1.8	0.8	3.1	3.9	0.4	0.2	0.0	0.3	0.2	0.3	0.4	0.0	0.3	0.2	0.3	0.1	0.2	0.1	0.8	1.1	0.2	0.4	0.3	0.9	1.2	1.0	1.5	1.1	1.0	2.2	0.9	0.5	1.7	0.5	1.2	1.8	0.0	35.3	23.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.2	5.3	0.0	0.0	0.0	0.0	1.5	0.0	0.0	225.3	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	5.3	0.0
WIF1		ENSG00000156076	"WNT inhibitory factor 1"	Q9Y5W5	12	65050626-65121305	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 232.4;retina: 605.0"	"Cell type enriched"	"Detected in many"	13	"Muller glia cells: 2736.1"	"Group enriched"	"Detected in many"	5	"endometrial cancer: 16.9;lung cancer: 14.6"	"Region enriched"	"Detected in all"	5	"hypothalamus: 232.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 2.2;LHCN-M2: 1.0;NTERA-2: 3.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"								"Secreted to extracellular matrix"	NA	NA						"unprognostic (5.96e-3)"	"unprognostic (2.00e-1)"	"unprognostic (4.29e-3)"	"unprognostic (3.26e-3)"	"unprognostic (9.66e-2)"	"unprognostic (1.91e-1)"		"unprognostic (1.26e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.92e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.30e-5)"	"unprognostic (3.02e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.24e-3)"	0.6	2.7	21.6	0.3	31.6	0.0	23.1	14.2	45.0	1.6	13.7	0.3	0.0	8.7	24.0	4.7	1.6	0.0	0.3	23.5	232.4	0.7	0.0	118.5	0.1	17.4	14.4	21.9	1.2	0.3	0.0	46.8	0.0	18.9	14.4	0.3	605.0	45.5	2.8	0.1	6.6	2.2	0.9	13.6	0.1	1.4	0.7	18.5	0.2	0.0	0.7	0.0	1.7	2.2	18.7	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.3	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.6	31.6	14.2	45.0	23.5	232.4	17.4	14.4	21.9	18.9	13.6	18.5	18.7	0.0	35.3	197.8	186.1	0.0	12.6	34.5	0.0	2.2	25.0	0.7	13.7	1.6	0.0	26.6	1.8	8.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	4.7	0.0	0.0	0.6	0.0	0.0	27.8	0.5	0.1	7.6	1.0	0.0	0.0	0.0	15.2	46.5	0.0	0.0	0.0	20.4	0.0	0.0	0.8	23.2	12.2	0.0	2736.1	0.0	1.5	0.9	0.0	0.0	0.4	0.2	25.5	0.0	1.2	34.2	80.8	0.0	1.8	1.5	2.5	2.0	0.4	10.5	0.0	1.2	0.0	0.0	0.8
WNK4	PRKWNK4	ENSG00000126562	"WNK lysine deficient protein kinase 4"	Q96J92	17	42780610-42797066	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 9.0;intestine: 11.1;kidney: 17.8;prostate: 11.7"	"Cell type enriched"	"Detected in some"	4	"Distal tubular cells: 160.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 32.6;K-562: 36.8;TIME: 34.1;WM-115: 23.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016500	Approved					NA	NA					"HPA016500: AB_10962984"	"unprognostic (6.34e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.15e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.84e-2)"	"unprognostic (3.94e-1)"	"unprognostic (2.08e-3)"	"unprognostic (4.33e-3)"	"unprognostic (7.70e-3)"	"unprognostic (1.62e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.99e-2)"	0.6	0.0	0.9	1.1	1.0	0.0	2.9	1.1	3.3	0.4	0.3	8.9	1.9	0.2	0.7	9.0	0.4	0.0	0.1	1.9	3.8	17.8	0.2	0.1	0.1	1.2	0.9	0.2	4.3	0.2	0.0	1.2	0.0	0.9	11.7	11.1	0.6	1.8	1.1	0.0	0.3	3.7	0.4	0.9	0.1	3.4	0.2	1.0	0.0	0.0	0.3	0.1	0.2	0.4	1.1	2.1	1.2	0.6	0.0	0.7	0.2	4.8	11.9	4.8	4.5	1.3	0.7	1.0	0.6	6.8	32.6	1.2	0.0	0.2	0.3	8.6	0.6	1.8	0.1	0.0	4.7	7.4	0.3	0.7	3.9	1.4	6.4	2.1	2.1	0.3	0.4	36.8	1.3	0.0	1.0	0.0	1.1	0.3	2.0	8.2	0.6	1.2	0.0	0.0	0.5	0.0	0.2	0.1	0.2	1.7	4.1	2.4	2.7	34.1	0.3	3.1	0.5	0.4	6.2	5.3	1.2	0.0	2.1	23.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	1.1	3.3	1.9	3.8	1.2	0.9	0.2	0.9	0.9	1.0	1.1	0.2	0.0	0.6	0.0	0.5	0.0	0.2	0.0	0.6	0.2	7.1	4.1	1.0	1.5	0.6	7.3	0.0	0.0	0.3	8.0	160.4	0.0	0.0	5.1	1.1	0.2	13.1	0.0	0.2	0.2	0.2	0.1	3.1	6.7	4.5	0.1	0.7	0.0	0.0	0.0	0.2	40.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	3.2	0.4	0.0	3.6	0.9	1.0	2.9	0.5	0.0	0.2	0.5	0.8	0.8	12.1	0.4	0.0	0.2	0.0	13.1	0.3
WNT6		ENSG00000115596	"Wnt family member 6"	Q9Y6F9	2	218859805-218874233	"Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"Sertoli cells: 92.1"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 8.7"	"Region enhanced"	"Detected in many"		"basal ganglia: 8.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"BEWO: 34.4"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 7.7"	HPA070759	Approved				"Secreted to extracellular matrix"	NA	NA					"HPA070759: AB_2732164"	"unprognostic (1.86e-2)"	"unprognostic (6.03e-2)"	"unprognostic (5.14e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.32e-2)"	"unprognostic (7.34e-2)"	"unprognostic (8.08e-3)"	"unprognostic (4.73e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.24e-3)"	"unprognostic (5.26e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.07e-1)"	3.3	0.6	0.8	0.1	8.1	0.0	3.6	0.2	3.1	3.9	0.6	5.7	0.1	2.4	0.0	1.3	3.2	0.0	2.8	0.7	1.2	1.1	0.3	0.3	0.1	4.0	0.8	0.5	3.1	0.8	0.0	2.0	2.0	2.1	3.1	0.0	0.1	1.1	0.1	1.1	2.6	2.8	0.0	0.4	7.2	2.7	3.6	1.7	0.0	1.1	0.0	0.1	2.0	3.7	0.1	0.0	0.0	0.0	1.2	0.0	0.0	34.4	0.0	0.0	0.0	0.0	3.3	0.5	0.0	3.7	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	3.7	0.1	0.0	0.0	5.0	1.7	0.0	0.0	3.7	0.1	4.7	0.0	0.0	2.7	0.0	0.0	0.1	0.0	0.0	0.0	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.8	8.1	0.2	3.1	0.7	1.2	4.0	0.8	0.5	2.1	0.4	1.7	0.1	2.5	0.0	0.0	0.0	1.6	0.5	21.0	1.1	0.6	3.5	1.4	8.5	0.6	0.0	0.1	0.0	0.0	7.9	0.0	0.0	0.0	0.1	3.4	0.4	3.1	5.9	0.0	0.0	0.2	0.0	1.6	2.0	0.0	0.1	0.0	0.4	2.5	0.0	0.8	1.7	0.1	0.0	0.0	0.0	0.3	4.5	0.0	0.3	1.8	0.0	0.1	0.7	0.0	0.0	0.1	0.0	0.0	0.4	3.1	5.5	0.0	0.0	0.0	2.0	92.1	0.3	15.5	16.9	0.3	0.2	0.1	0.7	0.2	0.1	0.0	1.3
XCR1	"CCXCR1, GPR5"	ENSG00000173578	"X-C motif chemokine receptor 1"	P46094	3	46017007-46027487	"G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 11.3"	"Cell type enriched"	"Detected in some"	5	"Langerhans cells: 10.2"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	5	"myeloid DC: 3.8"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 3.8"	"Cell line enhanced"	"Detected in some"		"HEL: 1.6;Karpas-707: 2.5;RT4: 2.0;U-266/84: 2.2;U-87 MG: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA013169	Uncertain					NA	NA					"HPA013169: AB_1846211"	"unprognostic (3.49e-3)"	"unprognostic (4.23e-3)"	"unprognostic (1.15e-2)"	"unprognostic (5.91e-3)"	"unprognostic (7.91e-2)"	"unprognostic (8.53e-6)"	"unprognostic (3.89e-6)"	"unprognostic (9.27e-3)"	"unprognostic (4.41e-3)"	"unprognostic (3.40e-3)"	"unprognostic (2.03e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.87e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.80e-1)"	0.9	0.1	0.3	3.9	0.3	3.0	0.6	0.7	0.8	0.7	0.5	1.1	1.7	0.5	4.5	1.9	0.6	3.0	0.5	0.5	0.4	0.3	1.1	1.4	11.3	0.4	0.2	0.3	0.9	0.1	0.1	0.0	4.3	0.4	0.6	1.1	0.7	0.2	0.6	0.1	2.8	1.7	1.5	0.1	7.2	1.2	0.4	0.3	8.9	0.5	0.4	4.6	1.6	0.2	0.8	0.0	0.8	0.3	0.0	0.0	0.0	0.7	0.3	0.8	0.0	0.0	0.7	0.0	0.7	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.6	0.6	0.0	0.4	0.0	0.0	0.4	0.3	0.5	2.5	0.0	0.8	0.4	0.0	0.0	0.4	0.0	0.3	0.0	0.3	0.3	2.0	0.1	0.0	0.0	0.2	0.0	0.7	0.2	0.0	0.0	0.4	0.9	0.2	0.1	1.2	2.2	0.7	1.7	0.0	0.2	0.7	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.3	3.8	0.0	0.0	0.1	0.3	0.1	0.1	0.1	0.0	0.3	0.3	0.3	0.7	0.8	0.5	0.4	0.4	0.2	0.3	0.4	0.1	0.3	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.8	10.2	1.5	0.0	2.0	1.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0
XYLT1	"PXYLT1, XT-I"	ENSG00000103489	"Xylosyltransferase 1"	Q86Y38	16	17101769-17470960	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted secreted proteins"		"Glycosyltransferase, Transferase"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	6	"Oligodendrocyte precursor cells: 1194.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 2.0"	"Lineage enriched"	"Detected in single"	4	"monocytes: 2.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 55.1;ASC TERT1: 34.0;U-2197: 57.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007478, HPA007966"	Approved		Approved	"Endoplasmic reticulum,Plasma membrane"	"Secreted to blood"	NA	NA		150000	"Plasma membrane"	"Endoplasmic reticulum"	"HPA007478: AB_1080616, HPA007966: AB_1080618"	"unprognostic (1.82e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.83e-1)"	"unprognostic (9.12e-2)"	"unprognostic (8.13e-2)"	"unprognostic (9.40e-2)"	"unprognostic (2.41e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.66e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.95e-1)"	"unprognostic (6.05e-2)"	6.0	6.2	6.4	4.9	8.4	7.2	4.5	2.6	6.3	7.9	7.0	7.4	4.4	8.0	1.0	5.1	3.8	2.4	3.7	9.1	4.2	1.0	0.3	3.6	5.2	4.0	4.4	6.0	5.3	2.8	0.9	0.6	6.1	5.3	2.8	5.2	8.4	2.5	4.5	1.1	4.9	5.3	5.7	2.7	5.4	3.5	2.3	4.6	4.1	2.2	1.2	4.3	4.4	4.7	5.8	0.0	0.3	8.0	0.1	55.1	34.0	9.6	25.6	12.9	2.7	1.0	0.3	0.6	6.1	0.0	31.3	0.9	0.6	0.0	5.1	4.5	12.1	0.6	8.0	0.0	0.0	0.6	11.5	10.2	12.6	0.7	15.0	2.4	4.6	0.0	0.3	0.0	23.8	2.8	0.8	0.1	12.4	8.5	4.4	0.0	3.5	0.0	1.2	0.0	11.5	2.0	15.2	1.9	7.9	1.4	5.9	1.9	7.2	0.0	24.6	2.9	57.2	0.0	26.4	1.4	11.6	28.9	12.8	22.4	0.3	0.2	0.4	0.2	1.2	0.3	0.1	0.1	0.1	0.4	0.3	0.2	0.1	0.1	0.4	2.0	0.1	0.3	0.2	6.4	8.4	2.6	6.3	9.1	4.2	4.0	4.4	6.0	5.3	2.7	4.6	5.8	1.0	3.2	2.5	45.4	9.2	7.9	1.6	0.0	1.2	12.9	3.8	3.7	3.4	0.0	0.7	0.0	98.0	12.7	12.4	9.1	0.0	1.5	0.5	0.5	24.7	2.9	12.6	7.4	172.8	1.6	20.1	12.2	2.6	0.8	2.5	6.4	1.4	0.2	3.5	0.0	72.8	4.3	4.1	9.7	27.6	0.8	12.8	8.5	3.6	29.0	6.1	1.9	11.3	1194.8	63.0	4.0	7.4	50.0	6.2	5.3	6.1	0.2	0.0	4.4	6.6	7.9	5.9	0.3	1.6	4.1	18.5	13.1	7.7	8.1	6.9	6.4
YAF2		ENSG00000015153	"YY1 associated factor 2"	Q8IY57	12	42157104-42238349	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	8	"Cardiomyocytes: 1187.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-937: 82.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026867	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA026867: AB_1858911"	"unprognostic (1.41e-1)"	"unprognostic (2.24e-1)"	"unprognostic (9.30e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.06e-2)"	"unprognostic (4.12e-1)"	"unprognostic (7.10e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.86e-3)"	"unprognostic (2.44e-2)"	"unprognostic (3.58e-2)"	"unprognostic (5.57e-2)"	"unprognostic (4.57e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.33e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.20e-2)"	10.8	9.6	11.2	8.2	12.1	10.9	10.1	15.6	13.3	9.7	6.3	7.5	6.0	9.5	8.8	7.0	8.9	8.7	36.9	12.7	14.8	9.6	18.2	8.2	12.6	10.8	11.5	11.2	9.1	6.3	7.9	8.7	9.1	12.0	8.3	7.4	14.3	6.7	8.4	29.6	6.3	8.0	10.4	11.4	10.7	6.9	7.4	14.1	13.6	11.2	21.3	10.1	10.0	9.0	14.3	13.5	10.6	15.3	12.1	19.1	16.9	9.9	19.1	17.1	15.5	15.1	14.4	10.7	8.6	14.0	16.6	6.2	11.5	15.0	10.7	21.7	20.5	14.9	18.0	4.6	6.8	11.0	17.6	11.1	12.1	14.9	12.8	25.3	15.7	16.3	8.3	17.2	20.1	20.1	5.6	20.4	21.2	3.9	16.0	14.1	15.0	16.6	13.9	20.1	10.1	11.6	14.6	16.0	18.3	14.8	6.9	12.4	13.0	14.4	13.6	12.1	16.7	9.5	16.6	26.4	31.7	15.0	82.3	6.8	43.2	15.6	28.9	18.2	18.9	18.6	20.6	17.6	20.9	12.5	24.2	13.4	14.5	56.6	27.1	17.2	19.3	26.5	9.7	11.2	12.1	15.6	13.3	12.7	14.8	10.8	11.5	11.2	12.0	11.4	14.1	14.3	41.9	22.4	13.4	68.2	41.1	58.1	40.8	31.0	33.0	75.0	45.2	35.1	1187.5	31.5	27.6	20.2	85.5	40.1	71.2	22.7	62.6	32.2	33.6	27.7	43.1	61.7	38.9	36.2	105.5	45.5	22.4	49.7	18.3	37.0	70.5	88.4	50.7	104.7	27.8	144.7	89.4	33.1	46.8	44.7	61.3	15.9	58.1	37.6	42.7	83.4	48.8	94.6	84.5	97.0	57.8	35.3	26.8	76.8	44.6	37.2	29.9	66.0	20.1	99.7	105.2	44.8	63.8	38.0	38.2	30.5	51.1	45.3	58.7	36.2	27.5	32.7
ZBED2	MGC10796	ENSG00000177494	"Zinc finger BED-type containing 2"	Q9BTP6	3	111592900-111595346	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 48.0;thyroid gland: 71.7"	"Cell type enriched"	"Detected in some"	5	"Alveolar cells type 1: 44.8"	"Cancer enriched"	"Detected in many"	5	"thyroid cancer: 64.0"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 2.1"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 54.8;EFO-21: 37.4;HaCaT: 53.1;HBEC3-KT: 119.3;RPTEC TERT1: 77.6"					"Not detected"	"Not detected"			HPA029786			Approved	"Nuclear bodies,Mitochondria,Cytosol"		No	No			"Mitochondria, Cytosol"	"Nuclear bodies"	"HPA029786: AB_10601028"	"unprognostic (7.31e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.98e-3)"	"unprognostic (1.66e-1)"		"unprognostic (2.39e-3)"	"unprognostic (3.49e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.84e-1)"	"prognostic unfavorable (8.83e-4)"	"unprognostic (2.59e-1)"	"unprognostic (1.47e-6)"	"unprognostic (3.81e-2)"	"unprognostic (4.34e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.29e-2)"	0.1	0.0	0.0	1.8	0.5	0.3	0.2	0.0	0.1	2.6	0.1	0.1	0.1	0.1	0.2	12.9	20.1	0.3	0.1	0.0	0.0	0.2	0.0	10.5	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.2	0.2	0.1	0.0	2.8	0.4	0.0	1.7	0.5	0.0	0.0	0.3	0.5	0.0	0.0	48.0	71.7	0.0	13.0	0.4	10.0	0.0	15.3	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	54.8	0.5	37.4	0.0	0.0	53.1	0.0	119.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	10.8	0.0	5.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	77.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.3	1.2	0.2	0.1	0.0	2.1	0.6	0.8	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	44.8	1.1	0.0	0.6	4.5	0.3	3.1	4.6	0.0	0.0	0.0	0.1	0.0	4.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	8.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.1	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.6	3.8	0.0	4.5	0.0	0.1	0.2
ZDHHC20	"DHHC20, FLJ25952"	ENSG00000180776	"Zinc finger DHHC-type palmitoyltransferase 20"	Q5W0Z9	13	21372571-21459370	"Enzymes, Metabolic proteins, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 93.1"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 434.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014483, HPA014702"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"		"HPA014483: AB_1859000, HPA014702: AB_1859001"	"unprognostic (1.31e-1)"	"unprognostic (2.16e-3)"	"unprognostic (7.31e-3)"	"unprognostic (8.89e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.77e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (6.55e-4)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (3.76e-2)"	"unprognostic (7.65e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.13e-2)"	11.0	9.2	15.3	17.7	46.7	30.3	11.6	46.9	24.4	16.3	2.5	17.0	19.4	14.0	9.7	30.5	11.0	17.2	7.9	10.7	31.6	6.8	9.9	17.1	18.1	59.8	39.4	5.2	9.8	9.0	8.9	4.4	18.9	59.9	15.2	16.2	5.7	8.5	12.3	4.0	22.3	19.2	15.4	44.0	16.2	39.8	32.0	39.2	22.8	16.6	9.5	19.7	23.1	9.3	93.1	32.9	16.4	27.7	18.1	24.5	26.7	68.3	35.6	36.3	23.3	20.6	33.8	102.5	34.8	19.3	44.7	23.8	52.7	30.5	26.5	44.8	40.0	20.4	61.8	11.7	19.6	14.1	43.3	25.8	24.2	19.4	23.6	16.2	30.0	37.6	45.9	17.3	14.9	35.3	27.2	62.0	17.2	22.9	87.3	18.0	49.8	49.1	12.7	28.9	59.7	25.2	11.4	46.0	28.7	19.3	28.6	27.0	21.8	62.6	25.0	24.0	41.7	27.4	15.6	19.9	37.7	18.2	23.6	73.1	12.6	16.2	3.8	10.1	14.9	9.3	4.6	8.7	8.7	8.4	3.4	8.1	8.4	3.0	11.2	13.8	4.1	10.4	13.5	15.3	46.7	46.9	24.4	10.7	31.6	59.8	39.4	5.2	59.9	44.0	39.2	93.1	27.6	51.3	31.5	29.0	19.9	1.0	7.8	1.4	18.2	7.4	21.9	13.7	7.4	14.3	20.7	11.0	8.4	20.7	34.7	35.5	0.0	8.5	91.3	23.4	25.2	25.7	24.0	8.4	69.1	12.2	20.9	13.6	53.0	34.5	14.0	16.1	20.0	20.8	21.7	18.5	80.0	29.1	2.0	92.5	3.2	81.2	15.5	49.0	1.8	46.9	48.4	3.7	30.9	54.8	434.3	22.8	25.5	10.9	18.1	14.5	30.3	6.3	11.7	9.5	19.7	12.7	11.6	10.4	14.1	28.1	1.6	44.6	28.4	9.7	25.1	25.6
ZFP92	ZNF897	ENSG00000189420	"ZFP92 zinc finger protein"	A6NM28	X	153418322-153426481	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"Sertoli cells: 19.7"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 3.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 3.8;HMC-1: 3.5;THP-1: 2.4;U-937: 6.2"	"Region enhanced"	"Detected in many"		"hypothalamus: 8.8"	"Low region specificity"	"Detected in all"			HPA003030	Uncertain					NA	NA					"HPA003030: AB_2666758"	"unprognostic (6.94e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.57e-4)"	"unprognostic (1.01e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.62e-2)"	"unprognostic (6.51e-3)"	"unprognostic (6.71e-2)"	"unprognostic (1.84e-1)"	"unprognostic (8.49e-4)"	"unprognostic (1.81e-1)"	"unprognostic (2.71e-2)"	"unprognostic (6.66e-3)"	1.5	2.3	1.7	0.5	2.1	3.0	1.1	2.3	1.9	1.1	2.0	0.7	0.3	1.2	2.6	0.2	3.3	0.4	1.0	1.5	1.6	0.7	0.6	2.6	0.4	1.3	1.9	1.7	3.8	0.7	4.4	2.6	0.7	1.6	0.9	0.2	0.5	0.2	1.6	0.3	0.2	0.9	1.1	0.7	1.1	0.6	0.7	2.1	0.2	0.7	0.6	0.5	0.3	0.3	1.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.8	0.8	0.4	0.0	0.0	0.5	0.6	0.2	0.4	0.3	0.4	0.6	3.8	0.0	1.4	0.0	0.0	1.4	0.4	3.5	0.2	0.5	0.0	0.0	0.0	1.4	0.9	1.1	0.0	0.0	0.0	0.9	0.3	0.2	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.9	0.0	0.0	0.9	0.0	0.0	2.4	0.0	0.0	1.7	0.0	0.0	0.8	0.0	0.9	0.0	6.2	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	2.1	2.3	1.9	1.5	1.6	1.3	1.9	1.7	1.6	0.7	2.1	1.5	3.4	0.0	0.0	1.6	0.2	0.0	0.1	0.0	0.0	0.4	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	1.1	3.1	0.5	0.0	0.0	1.5	0.0	0.0	0.7	0.0	2.2	0.0	1.1	0.4	0.1	0.8	0.0	1.7	0.0	0.0	0.8	0.0	0.2	2.5	0.5	0.0	0.0	0.5	0.2	1.0	2.0	0.1	0.2	0.0	3.4	0.2	0.0	0.0	0.3	0.0	0.2	19.7	0.8	1.4	0.4	0.8	0.0	0.0	0.0	0.3	0.8	0.0	0.0
ZNF106	"SH3BP3, ZFP106, ZNF474"	ENSG00000103994	"Zinc finger protein 106"	Q9H2Y7	15	42412823-42491141	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 396.2;tongue: 469.6"	"Cell type enriched"	"Detected in all"	9	"Cardiomyocytes: 1836.4"	"Cancer enhanced"	"Detected in all"		"melanoma: 29.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 161.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054267	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Nucleoli	"Nucleoplasm, Cytosol"	"HPA054267: AB_2682431"	"unprognostic (2.15e-2)"	"unprognostic (3.31e-1)"	"unprognostic (7.10e-2)"	"unprognostic (2.61e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.32e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.76e-3)"	"unprognostic (8.71e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.36e-1)"	"unprognostic (4.09e-3)"	32.7	11.3	26.3	14.4	28.5	24.6	18.1	22.4	28.2	18.1	95.7	16.9	10.1	16.0	17.4	18.6	12.8	17.4	177.2	24.2	25.6	16.6	8.8	21.1	17.6	28.1	28.2	18.3	16.0	10.4	17.9	10.3	13.0	22.9	21.1	14.1	22.2	13.1	14.9	396.2	11.8	13.4	23.2	22.2	17.3	12.9	14.4	26.0	15.7	13.3	469.6	18.7	14.7	9.2	31.8	27.2	15.1	29.0	33.5	86.8	68.5	16.1	21.7	22.2	19.6	20.5	33.9	7.8	17.8	19.0	27.7	22.8	31.8	28.3	23.4	29.5	29.0	13.1	34.7	37.9	13.6	23.2	43.1	20.2	55.4	17.8	28.0	32.6	19.5	32.3	23.2	43.0	2.7	36.9	11.9	16.2	13.3	11.0	26.1	15.1	15.2	54.3	10.8	12.1	31.5	16.5	10.2	45.0	22.8	28.7	23.4	20.0	30.0	42.2	20.8	32.5	26.1	32.3	14.8	32.2	76.5	18.4	33.6	37.6	86.8	63.8	27.1	15.6	52.3	13.5	21.8	13.0	13.3	35.6	26.8	11.3	10.6	161.0	12.5	66.8	36.0	13.0	18.0	26.3	28.5	22.4	28.2	24.2	25.6	28.1	28.2	18.3	22.9	22.2	26.0	31.8	58.0	134.6	107.7	46.0	49.6	38.5	57.9	41.9	44.3	58.5	50.9	46.0	1836.4	62.9	57.0	29.5	95.9	37.9	67.2	31.7	41.1	43.2	197.2	75.2	67.1	69.9	40.2	50.5	73.3	42.4	39.3	141.7	31.1	37.5	44.9	49.5	62.8	40.1	53.5	35.3	62.9	32.6	32.6	132.7	43.4	105.2	37.6	89.8	65.8	47.8	124.3	53.6	66.9	31.2	34.2	65.7	26.9	92.6	50.7	74.8	39.7	41.5	161.1	79.9	46.0	151.2	70.0	62.3	38.1	49.8	29.8	30.6	46.0	85.9	36.6	68.2
ZNF189		ENSG00000136870	"Zinc finger protein 189"	O75820	9	101398873-101410660	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 86.7"	"Cell type enriched"	"Detected in all"	4	"Oligodendrocytes: 124.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034814	Uncertain		Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA034814: AB_10601030"	"unprognostic (3.87e-2)"	"unprognostic (3.47e-1)"	"unprognostic (5.30e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.59e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.10e-1)"	"prognostic favorable (5.32e-4)"	"unprognostic (3.31e-1)"	"unprognostic (4.58e-1)"	"unprognostic (1.86e-2)"	"unprognostic (6.57e-2)"	24.4	21.8	17.8	9.5	23.5	4.0	16.4	20.4	26.3	12.6	15.7	10.1	12.4	13.9	86.7	7.5	10.6	23.5	14.8	27.6	17.7	14.8	18.7	9.6	10.8	18.8	18.4	18.6	16.1	31.6	14.4	19.9	8.9	19.0	14.1	10.3	12.8	9.9	11.7	16.6	6.0	12.4	13.4	20.2	12.8	12.8	13.9	19.2	11.3	13.4	16.9	15.3	8.5	7.0	29.2	7.4	6.0	19.1	14.0	16.7	11.6	9.1	10.3	15.8	11.9	10.2	12.7	5.7	9.9	6.8	12.5	12.4	14.1	9.6	9.8	10.5	13.1	6.6	10.8	9.6	27.3	12.4	11.5	9.1	14.2	13.3	10.6	16.3	16.3	15.0	11.9	13.0	13.9	17.7	4.1	13.8	4.9	13.8	16.2	6.7	9.7	27.3	7.6	11.4	8.4	19.7	12.4	11.2	7.6	11.4	12.5	6.3	14.3	12.6	11.6	8.4	9.6	8.1	13.1	21.7	4.7	10.0	4.4	12.0	0.5	0.8	1.4	0.7	1.0	0.7	0.9	1.2	1.5	0.7	1.0	1.4	1.2	0.4	1.3	0.8	0.5	0.6	0.6	17.8	23.5	20.4	26.3	27.6	17.7	18.8	18.4	18.6	19.0	20.2	19.2	29.2	7.5	9.6	6.4	11.1	9.7	9.8	8.2	4.9	8.0	7.4	8.9	6.5	22.2	25.8	11.9	1.8	4.2	4.6	6.4	6.2	9.8	7.2	3.1	5.2	8.7	9.4	5.4	6.5	29.1	18.0	2.1	9.0	6.1	5.4	9.5	9.8	8.9	9.0	5.5	8.4	17.4	6.3	8.2	14.4	7.6	3.1	11.1	9.6	7.2	11.2	3.9	6.8	6.2	17.1	124.9	7.2	6.7	10.9	4.9	6.2	7.2	14.5	8.2	3.9	13.1	10.6	8.9	7.0	3.6	9.1	6.5	1.9	6.2	7.8	5.9	5.2
ZNF222		ENSG00000159885	"Zinc finger protein 222"	Q9UK12	19	44025342-44033110	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"Early spermatids: 78.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA004086	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA004086: AB_2273259"	"unprognostic (1.91e-3)"	"unprognostic (3.41e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.81e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.75e-3)"	"unprognostic (6.75e-2)"	"unprognostic (1.58e-2)"	"unprognostic (7.58e-2)"	"prognostic favorable (5.56e-7)"	"unprognostic (2.19e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.44e-1)"	"unprognostic (8.42e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.16e-3)"	2.7	4.2	3.6	3.0	3.8	5.3	4.6	5.9	5.4	3.2	3.6	2.4	1.7	2.8	3.9	1.9	3.0	3.4	4.3	3.5	4.5	2.8	2.8	3.2	4.4	4.3	4.0	3.5	4.7	3.1	3.8	5.2	3.1	4.4	3.6	2.7	6.9	2.6	3.3	2.3	2.6	2.7	3.3	3.4	4.6	3.2	9.2	4.1	5.8	4.1	2.3	4.3	3.9	2.0	4.9	3.8	4.5	7.4	6.7	5.5	5.5	0.3	4.1	7.3	4.7	7.4	2.1	2.4	1.2	6.1	4.4	5.5	1.3	5.2	3.6	5.9	4.9	4.7	6.4	6.5	3.8	7.0	0.2	5.2	4.2	5.4	3.9	6.5	7.4	4.5	5.2	1.2	2.4	5.9	0.5	4.3	2.4	4.5	1.8	1.7	0.1	7.7	2.1	3.8	12.1	4.0	9.0	6.4	1.2	5.4	6.3	1.6	6.2	3.3	5.1	4.9	2.9	5.0	10.6	9.1	0.1	2.7	0.1	5.8	7.7	2.4	5.0	5.9	1.6	4.8	4.7	5.4	5.7	2.5	5.9	6.2	4.6	4.8	4.9	2.0	2.9	4.2	2.8	3.6	3.8	5.9	5.4	3.5	4.5	4.3	4.0	3.5	4.4	3.4	4.1	4.9	2.1	0.0	1.5	1.0	1.9	2.5	1.9	2.3	0.0	5.3	2.1	2.0	1.9	0.0	1.8	5.5	0.0	1.8	3.1	0.8	7.9	2.4	78.5	1.6	1.7	2.4	3.0	4.8	3.7	1.2	1.1	3.0	1.5	2.7	4.5	3.5	3.3	1.1	2.3	6.7	4.2	2.1	6.1	1.3	1.5	6.9	1.8	1.5	1.8	1.0	1.7	6.3	3.1	3.5	3.6	0.8	0.4	2.2	1.5	0.8	1.1	1.3	0.3	2.8	0.0	2.8	3.0	9.9	3.5	0.7	1.7	1.1	3.7	3.5	1.2	1.1
ZNF385C		ENSG00000187595	"Zinc finger protein 385C"	Q66K41	17	42025576-42098479	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.6;testis: 8.6"	"Cell type enriched"	"Detected in many"	4	"Early spermatids: 27.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	10	"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 1.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 4.3;Hep G2: 16.6;MOLT-4: 4.9;SCLC-21H: 8.6"	"Region enriched"	"Detected in many"	12	"cerebellum: 28.2"	"Region enhanced"	"Detected in all"		"cerebellum: 19.7"							NA	NA						"unprognostic (1.58e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.02e-3)"	"unprognostic (3.95e-2)"	"unprognostic (3.95e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.48e-1)"	"unprognostic (8.67e-3)"	"unprognostic (1.10e-1)"	"unprognostic (8.90e-2)"	"unprognostic (2.59e-1)"	"unprognostic (8.71e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.22e-2)"	"unprognostic (6.05e-2)"	0.4	0.1	2.3	0.3	2.2	0.9	1.6	12.6	3.1	0.8	1.4	0.4	0.1	0.9	1.3	0.6	1.9	0.3	0.3	2.2	2.8	0.7	0.3	0.5	0.5	2.3	2.7	2.1	2.6	2.1	0.9	2.5	0.4	5.7	1.2	0.3	4.9	1.5	0.6	2.2	0.7	0.4	0.2	1.9	0.3	0.4	8.6	2.4	1.8	0.5	5.4	0.3	0.4	0.7	2.7	0.3	0.1	0.8	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.4	1.8	0.0	0.6	0.0	0.0	0.5	0.3	0.1	0.0	4.3	3.2	0.2	0.1	16.6	0.3	0.0	0.4	0.0	2.5	0.0	0.6	0.1	0.0	2.5	0.2	0.0	0.0	0.4	4.9	0.2	0.6	0.8	0.0	0.3	0.0	1.0	0.1	0.2	8.6	0.3	0.1	0.4	0.4	0.9	1.6	1.2	0.0	0.0	0.2	0.1	0.0	1.2	0.4	0.3	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	2.3	2.2	12.6	3.1	2.2	2.8	2.3	2.7	2.1	5.7	1.9	2.4	2.7	0.6	0.0	0.5	1.6	0.5	0.4	1.9	2.2	0.0	5.0	1.2	2.2	0.5	1.5	1.5	1.8	0.0	0.2	2.7	0.4	1.9	0.5	27.3	0.3	0.3	0.3	0.0	0.0	2.1	0.5	0.1	0.5	0.5	0.7	0.0	0.8	0.0	0.0	0.8	1.7	3.0	0.5	2.0	0.6	0.9	5.1	1.5	0.3	0.0	5.6	0.0	3.0	1.0	3.5	4.2	0.2	0.3	0.0	0.0	4.1	0.6	0.1	0.5	2.2	0.0	1.4	0.5	1.0	1.9	0.0	0.6	0.0	0.2	0.0	0.6	1.3
ZNF385D	"FLJ22419, ZNF659"	ENSG00000151789	"Zinc finger protein 385D"	Q9H6B1	3	21412218-22373321	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.6;testis: 15.2"	"Cell type enriched"	"Detected in many"	5	"Inhibitory neurons: 1766.6"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	4	"cerebellum: 41.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 4.8;hTERT-RPE1: 5.4;LHCN-M2: 5.3;PC-3: 5.3;RPTEC TERT1: 15.1;U-87 MG: 21.1"					"Low region specificity"	"Detected in all"			HPA036190	Uncertain					NA	NA					"HPA036190: AB_10602355"	"unprognostic (4.07e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.44e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.20e-2)"	"unprognostic (6.60e-2)"	"unprognostic (7.84e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.35e-1)"	"unprognostic (9.01e-2)"	"unprognostic (3.49e-7)"	"unprognostic (8.70e-3)"	"unprognostic (5.38e-2)"	"unprognostic (7.76e-3)"	"unprognostic (2.15e-5)"	3.9	0.2	2.3	1.4	4.0	0.3	2.3	41.6	5.2	1.8	0.0	0.7	0.3	1.1	0.5	2.0	0.7	2.7	1.8	2.3	2.3	1.5	0.1	0.6	0.8	3.0	7.1	2.3	0.6	0.6	0.2	0.1	0.0	10.0	1.3	0.5	7.3	0.7	1.1	1.0	0.7	0.5	1.7	0.4	0.4	0.4	15.2	3.9	0.7	0.5	3.3	1.0	2.7	1.2	5.0	0.0	0.0	0.3	0.0	2.0	4.3	0.1	0.2	0.0	0.1	0.4	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.2	0.0	5.4	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.5	0.0	5.3	0.0	0.0	0.0	15.1	0.0	1.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.1	0.1	0.0	0.0	0.0	0.0	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	2.3	4.0	41.6	5.2	2.3	2.3	3.0	7.1	2.3	10.0	0.4	3.9	5.0	82.2	12.8	13.4	17.3	1.4	9.7	0.7	6.2	1.8	58.8	1.5	6.3	3.6	1.5	19.2	1.8	8.4	0.3	1.4	0.9	27.4	0.6	174.9	0.2	1.9	89.0	0.0	12.6	267.5	0.7	0.2	20.5	0.0	0.3	5.1	1.8	2.2	5.8	0.4	323.0	1766.6	0.7	0.0	0.0	14.0	274.5	16.8	4.9	12.4	64.6	0.6	114.3	1.0	159.3	12.7	1.4	0.6	13.5	0.3	1.7	2.3	6.6	4.4	31.0	13.1	22.0	20.2	50.4	2.0	0.6	7.7	0.1	1.5	34.3	0.7	1.0
ZNF391	dJ153G14.3	ENSG00000124613	"Zinc finger protein 391"	Q9UJN7	6	27374615-27403908	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Early spermatids: 52.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA050886	Uncertain					NA	NA					"HPA050886: AB_2681262"	"unprognostic (1.59e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.68e-3)"	"unprognostic (6.27e-5)"	"unprognostic (2.18e-2)"	"unprognostic (2.50e-1)"	"prognostic favorable (1.89e-4)"	"unprognostic (5.62e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.82e-2)"	2.4	2.1	1.7	0.9	3.7	0.3	3.3	1.1	3.9	3.7	0.0	1.4	0.8	3.2	3.2	1.8	4.0	1.3	1.1	3.3	1.2	2.8	0.3	1.9	1.9	1.3	0.4	2.8	5.0	2.2	3.8	1.7	1.4	1.0	2.6	1.7	2.1	2.2	3.4	0.6	1.8	1.1	2.4	0.1	2.3	1.6	5.0	0.7	1.4	4.0	0.8	1.7	1.7	1.5	2.9	4.9	0.7	2.9	10.2	1.2	1.6	5.9	1.2	0.9	1.7	3.9	2.7	1.0	0.0	4.3	1.1	3.4	1.6	5.8	4.5	2.7	0.0	3.5	1.8	0.2	0.9	1.9	5.4	2.5	4.9	5.7	0.3	4.5	3.5	0.2	8.1	8.1	0.0	0.3	1.0	6.4	7.6	3.6	0.7	3.2	0.0	0.0	1.3	1.1	1.9	1.1	4.7	0.0	6.7	0.5	4.7	1.1	4.6	0.6	5.5	1.7	0.3	3.7	3.1	8.1	0.0	0.2	0.5	6.0	0.1	0.0	0.0	0.3	0.0	0.7	1.4	0.5	0.2	0.0	1.3	1.0	0.7	0.0	0.3	0.0	0.4	0.1	0.2	1.7	3.7	1.1	3.9	3.3	1.2	1.3	0.4	2.8	1.0	0.1	0.7	2.9	1.7	0.0	1.1	2.3	1.2	0.9	0.5	0.7	0.6	2.2	1.8	1.7	1.0	0.0	2.9	1.8	0.0	2.4	0.1	0.1	0.0	1.0	52.5	7.0	2.4	2.0	1.8	1.3	12.1	1.4	1.1	2.4	0.0	1.7	0.0	3.9	1.8	0.0	1.1	3.3	6.7	0.2	2.0	0.0	0.6	4.7	1.8	0.4	0.0	3.7	0.0	4.4	0.0	7.5	1.7	1.2	0.6	2.6	0.3	0.2	0.0	1.3	12.4	0.9	0.0	1.6	1.3	6.5	2.8	1.3	0.3	0.3	0.6	1.9	1.1	0.4
ZNF563	FLJ34797	ENSG00000188868	"Zinc finger protein 563"	Q8TA94	19	12317477-12333720	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 14.6"	"Cell type enriched"	"Detected in many"	6	"Early spermatids: 200.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 4.2;T-cells: 8.9"	"Cell line enhanced"	"Detected in many"		"Hep G2: 9.0"									HPA042136	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA042136: AB_10795395"	"unprognostic (1.40e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.81e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.16e-4)"	"unprognostic (1.02e-2)"	"unprognostic (5.38e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.29e-3)"	"unprognostic (9.90e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.18e-2)"	2.3	2.8	2.0	2.0	1.9	1.1	3.8	2.8	1.9	3.2	1.4	1.9	1.4	2.2	2.3	2.5	3.2	1.5	3.5	1.9	1.2	3.8	10.1	1.9	2.9	1.7	1.5	1.6	3.6	2.1	2.5	2.2	1.1	2.1	4.9	2.1	2.8	2.7	2.6	1.9	3.8	2.2	2.0	1.0	2.7	1.8	14.6	1.6	3.0	5.5	3.0	3.0	2.7	3.2	2.8	2.0	0.2	0.7	2.7	2.8	1.8	0.2	2.3	4.5	2.8	4.1	2.6	0.7	4.6	2.4	2.9	3.1	1.6	2.4	5.4	2.5	0.1	0.4	0.6	0.5	9.0	2.2	0.4	2.8	3.0	3.7	2.8	1.9	2.1	0.1	2.5	0.9	1.0	2.5	1.3	2.5	0.9	1.1	1.0	2.0	0.1	2.0	0.1	3.0	2.7	0.7	1.3	0.3	0.5	0.3	3.1	2.2	0.2	0.3	4.4	0.8	5.1	1.4	4.4	3.8	0.3	0.8	0.4	1.6	0.8	1.1	0.7	2.7	1.2	1.6	3.2	4.6	2.5	1.4	4.2	8.9	5.2	0.8	1.5	1.4	1.4	3.9	2.2	2.0	1.9	2.8	1.9	1.9	1.2	1.7	1.5	1.6	2.1	1.0	1.6	2.8	3.2	3.2	1.7	2.3	4.6	1.3	2.0	3.0	4.6	8.4	2.4	3.4	5.5	5.7	2.1	1.8	0.0	0.3	2.6	1.1	1.9	4.7	200.4	3.6	2.3	3.7	0.0	19.4	4.2	4.9	0.2	2.6	2.0	2.0	0.0	9.5	3.3	8.3	2.2	5.0	2.6	2.4	2.0	1.9	0.4	32.3	7.8	1.7	5.4	3.7	1.8	13.9	8.2	3.5	2.7	2.6	4.5	5.7	1.5	2.0	2.6	7.8	4.9	3.4	13.1	3.1	3.3	15.8	6.3	2.8	2.0	0.1	4.7	3.3	2.5	0.9
ZNF703	"FLJ14299, NLZ1, ZEPPO1, ZNF503L, Zpo1"	ENSG00000183779	"Zinc finger protein 703"	Q9H7S9	8	37695782-37700019	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 109.3"	"Cell type enriched"	"Detected in many"	4	"Syncytiotrophoblasts: 434.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"intermediate monocyte: 3.3;non-classical monocyte: 4.3"	"Lineage enriched"	"Detected in single"	12	"monocytes: 4.3"	"Cell line enhanced"	"Detected in many"		"HEK 293: 156.8;OE19: 61.2;SK-MEL-30: 60.0;T-47d: 52.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023930, CAB068249"	Supported					NA	NA					"CAB068249: AB_2665667, HPA023930: AB_1859425"	"unprognostic (4.64e-2)"	"unprognostic (3.15e-2)"	"unprognostic (7.01e-3)"	"unprognostic (1.71e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.93e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.09e-1)"	"unprognostic (9.63e-2)"	"prognostic unfavorable (2.70e-7)"	"unprognostic (5.63e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.23e-1)"	21.3	14.5	16.1	7.7	13.3	1.9	27.6	9.7	17.0	36.1	7.8	42.5	15.2	28.0	12.8	18.3	33.5	6.3	16.2	12.7	9.3	5.5	4.2	10.8	4.1	20.9	15.8	10.3	19.8	8.8	1.9	6.0	12.2	14.5	21.9	12.8	0.5	18.4	8.8	109.3	51.8	26.1	11.7	13.4	19.1	23.0	2.9	12.5	2.8	10.7	33.6	2.9	37.1	28.9	11.1	3.2	6.6	0.8	5.2	15.1	7.9	5.2	29.1	13.6	8.8	7.4	27.2	36.0	0.0	7.2	18.4	4.0	17.2	3.0	4.4	6.8	0.8	156.8	0.0	9.5	17.5	14.9	0.0	3.0	26.6	8.2	9.1	3.7	19.0	7.8	0.3	0.4	0.0	14.1	27.4	0.1	0.8	2.6	61.2	11.6	2.7	4.7	3.7	2.7	14.2	2.9	0.2	5.4	4.6	60.0	6.2	52.6	3.1	23.1	10.3	23.7	16.1	12.3	1.9	0.1	0.2	9.1	3.2	6.7	0.0	0.4	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.1	16.1	13.3	9.7	17.0	12.7	9.3	20.9	15.8	10.3	14.5	13.4	12.5	11.1	11.9	6.4	0.0	14.7	15.3	48.2	13.2	28.9	103.0	3.7	39.3	27.8	9.1	2.8	14.5	5.5	0.0	41.4	7.7	52.0	3.9	7.1	0.4	30.8	37.0	9.5	79.6	0.0	1.5	2.5	37.2	36.0	14.8	20.3	0.0	5.8	2.5	2.2	36.2	0.0	2.8	95.4	10.2	23.6	31.9	0.7	31.4	31.2	33.8	11.2	7.9	9.3	0.0	0.0	0.6	3.7	56.9	15.8	1.9	9.7	35.4	2.8	7.7	0.9	52.6	54.9	66.4	0.0	0.6	99.7	74.6	434.1	6.0	6.1	92.6	10.7
ZNF85	"HPF4, HTF1"	ENSG00000105750	"Zinc finger protein 85"	Q03923	19	20923222-20950697	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	5	"Early spermatids: 128.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA044760	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA044760: AB_10960412"	"unprognostic (1.26e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.69e-2)"	"prognostic unfavorable (5.20e-5)"	"unprognostic (1.98e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.01e-4)"	"prognostic favorable (6.45e-6)"	"unprognostic (2.51e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.90e-3)"	"unprognostic (6.01e-2)"	2.5	5.0	0.9	2.0	1.0	5.0	5.2	3.4	1.2	2.7	0.6	1.9	0.4	2.4	1.6	2.9	2.5	1.7	1.8	1.0	1.0	2.5	0.9	1.8	5.8	1.0	1.1	1.0	6.6	8.2	2.1	1.4	3.6	1.8	2.4	2.6	1.1	2.9	1.6	0.7	2.9	2.3	2.4	0.9	3.6	5.6	11.6	1.0	5.5	7.8	0.3	6.1	2.3	2.8	1.4	0.9	0.6	12.6	12.5	3.5	3.2	9.0	8.1	3.6	12.5	12.7	0.1	4.9	13.8	9.1	3.4	5.6	1.1	0.2	7.9	13.2	0.5	6.4	2.1	0.9	0.9	0.9	0.1	3.1	1.6	2.3	5.8	6.9	2.6	3.6	12.5	0.2	4.2	6.6	1.8	20.9	7.5	11.0	0.0	11.4	9.9	17.6	6.9	4.0	5.3	10.3	5.4	0.2	0.3	2.6	10.7	5.2	9.7	3.0	7.2	1.3	15.7	10.4	5.4	15.3	13.2	0.2	0.0	5.1	0.4	0.7	2.8	1.8	2.3	1.5	5.4	2.2	1.3	1.7	3.6	2.6	2.1	2.1	5.3	1.3	2.0	2.8	1.4	0.9	1.0	3.4	1.2	1.0	1.0	1.0	1.1	1.0	1.8	0.9	1.0	1.4	5.4	3.2	1.7	2.0	8.5	0.8	2.2	1.5	1.8	4.7	4.5	4.4	3.4	1.5	2.0	5.5	0.0	9.9	8.5	1.0	1.9	6.9	128.4	2.4	4.1	8.3	0.0	9.0	3.4	6.1	14.2	5.0	3.6	3.9	12.0	10.3	5.7	0.3	8.8	3.3	4.8	2.6	4.1	1.9	3.3	24.1	3.1	4.3	5.4	6.5	5.0	3.7	5.2	9.0	5.3	3.5	2.1	3.8	3.8	2.4	0.1	3.9	2.6	2.0	19.7	2.5	5.3	23.2	13.6	3.1	1.4	7.5	4.7	6.5	1.3	3.3
ZNRF3	"BK747E2.3, FLJ22057, KIAA1133, RNF203"	ENSG00000183579	"Zinc and ring finger 3"	Q9ULT6	22	28883572-29057488	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	6	"Astrocytes: 504.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 46.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036702, HPA036703"	Uncertain		Uncertain	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA036702: , HPA036703: AB_10672227"	"unprognostic (1.07e-1)"	"unprognostic (2.13e-3)"	"unprognostic (7.48e-3)"	"unprognostic (5.72e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.68e-2)"	"unprognostic (5.18e-2)"	"unprognostic (3.94e-1)"	"unprognostic (9.55e-5)"	"unprognostic (6.49e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.70e-2)"	"unprognostic (2.55e-2)"	2.8	7.2	11.2	1.4	11.2	0.3	2.6	7.6	13.9	4.5	1.1	3.3	3.0	5.1	13.5	3.4	4.8	2.1	2.6	12.2	10.3	8.3	6.6	4.4	0.5	12.3	8.8	7.0	5.9	3.4	8.8	2.7	5.1	10.6	7.3	3.4	1.1	7.6	7.8	3.8	5.3	2.8	4.7	4.4	1.2	4.4	5.0	13.5	1.3	4.1	1.9	0.6	3.3	3.3	7.2	5.8	13.7	12.5	3.5	2.3	2.6	23.7	3.5	1.7	2.7	2.6	20.8	3.2	0.1	5.4	1.8	4.9	9.8	8.7	5.5	3.3	7.8	8.9	2.3	2.5	46.1	2.0	6.9	2.3	2.7	5.0	4.3	4.3	2.3	2.4	4.1	5.0	3.2	3.9	5.6	0.2	3.5	4.6	7.3	5.4	6.9	8.2	5.3	11.6	8.5	20.6	7.6	6.2	6.1	3.5	3.8	4.1	3.1	2.3	10.3	8.8	8.2	5.8	4.3	6.3	8.1	4.4	3.9	5.5	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	11.2	11.2	7.6	13.9	12.2	10.3	12.3	8.8	7.0	10.6	4.4	13.5	7.2	4.2	12.8	23.6	504.1	0.3	12.6	5.2	4.9	15.9	3.7	5.7	9.5	7.5	8.6	5.3	12.9	0.0	28.1	0.5	2.1	1.9	5.0	12.7	8.0	8.0	5.8	8.4	4.0	62.9	2.5	2.5	5.8	5.6	15.5	0.0	5.4	2.2	17.6	3.5	1.7	37.4	9.4	0.0	1.0	3.1	15.0	10.8	0.8	0.0	82.4	0.0	6.0	0.0	54.8	34.4	3.7	2.1	12.8	0.6	9.6	2.4	11.6	4.9	3.9	0.0	16.0	6.6	4.6	3.2	7.8	7.5	7.7	0.7	14.5	12.9	2.8
